PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Huang, CW; Lai, MC; Cheng, JT; Tsai, JJ; Huang, CC; Wu, SN				Huang, Chin-Wei; Lai, Ming-Chi; Cheng, Juei-Tang; Tsai, Jing-Jane; Huang, Chao-Ching; Wu, Sheng-Nan			Pregabalin Attenuates Excitotoxicity in Diabetes	PLOS ONE			English	Article							SENSITIVE POTASSIUM CHANNELS; ANTIEPILEPTIC DRUGS; PILOCARPINE MODEL; GLUTAMATE RELEASE; DOUBLE-BLIND; K+ CHANNEL; SEIZURES; NEURONS; EPILEPSY; BRAIN	Diabetes can exacerbate seizures and worsen seizure-related brain damage. In the present study, we aimed to determine whether the standard antiepileptic drug pregabalin (PGB) protects against pilocarpine-induced seizures and excitotoxicity in diabetes. Adult male Sprague-Dawley rats were divided into either a streptozotocin (STZ)-induced diabetes group or a normal saline (NS) group. Both groups were further divided into subgroups that were treated intravenously with either PGB (15 mg/kg) or a vehicle; all groups were treated with subcutaneous pilocarpine (60 mg/kg) to induce seizures. To evaluate spontaneous recurrent seizures (SRS), PGB-pretreated rats were fed rat chow containing oral PGB (450 mg) for 28 consecutive days; vehicle-pretreated rats were fed regular chow. SRS frequency was monitored for 2 weeks from post-status epilepticus day 15. We evaluated both acute neuronal loss and chronic mossy fiber sprouting in the CA3 area. In addition, we performed patch clamp recordings to study evoked excitatory postsynaptic currents (eEPSCs) in hippocampal CA1 neurons for both vehicle-treated rats with SRS. Finally, we used an RNA interference knockdown method for Kir6.2 in a hippocampal cell line to evaluate PGB's effects in the presence of high-dose ATP. We found that compared to vehicle-treated rats, PGB-treated rats showed less severe acute seizure activity, reduced acute neuronal loss, and chronic mossy fiber sprouting. In the vehicle-treated STZ rats, eEPSC amplitude was significantly lower after PGB administration, but glibenclamide reversed this effect. The RNA interference study confirmed that PGB could counteract the ATP-sensitive potassium channel (K-ATP)-closing effect of high-dose ATP. By opening K-ATP, PGB protects against neuronal excitotoxicity, and is therefore a potential antiepileptogenic in diabetes. These findings might help develop a clinical algorithm for treating patients with epilepsy and comorbid metabolic disorders.	[Huang, Chin-Wei; Cheng, Juei-Tang] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Neurol, Tainan 70101, Taiwan; [Lai, Ming-Chi] Chi Mei Fdn Med Ctr, Dept Pediat, Tainan, Taiwan; [Cheng, Juei-Tang] Natl Cheng Kung Univ, Dept Pharmacol, Tainan 70101, Taiwan; [Huang, Chao-Ching] Natl Cheng Kung Univ Hosp, Dept Pediat, Tainan 70428, Taiwan; [Wu, Sheng-Nan] Natl Cheng Kung Univ, Dept Physiol, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital; Chi Mei Hospital; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University	Huang, CW (corresponding author), Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Neurol, Tainan 70101, Taiwan.	huangcw@mail.ncku.edu.tw; snwu@mail.ncku.edu.tw	Wu, Sheng-Nan/B-9224-2009	Huang, Chao-Ching/0000-0003-2799-7181; Wu, Sheng-Nan/0000-0002-5208-3253	Taiwan National Science Council [NSC-100-2314-B-006-002, NSC-101-2314-B-006-059]; National Cheng Kung University Hospital [NCKUH-10103010]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan); National Cheng Kung University Hospital	This project was funded by grants NSC-100-2314-B-006-002 and NSC-101-2314-B-006-059 from the Taiwan National Science Council and grant NCKUH-10103010 from National Cheng Kung University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre V, 2007, EPILEPSIA, V48, P41, DOI 10.1111/j.1528-1167.2007.01288.x; Bancila V, 2004, J NEUROCHEM, V90, P1243, DOI 10.1111/j.1471-4159.2004.02587.x; Betourne A, 2009, NEUROPHARMACOLOGY, V56, P615, DOI 10.1016/j.neuropharm.2008.11.001; Bialer M, 2004, EPILEPSY RES, V61, P1, DOI 10.1016/j.eplepsyres.2004.07.010; Chang YC, 2003, ANN NEUROL, V54, P706, DOI 10.1002/ana.10789; Chuang YC, 2012, EPILEPSIA, V53, P120, DOI 10.1111/j.1528-1167.2011.03316.x; Csicsvari J, 2000, NEURON, V28, P585, DOI 10.1016/S0896-6273(00)00135-5; Curia G, 2008, J NEUROSCI METH, V172, P143, DOI 10.1016/j.jneumeth.2008.04.019; Dunn-Meynell AA, 1998, BRAIN RES, V814, P41, DOI 10.1016/S0006-8993(98)00956-1; Eckstein-Ludwig U, 1999, BRIT J PHARMACOL, V128, P92, DOI 10.1038/sj.bjp.0702794; FERNER RE, 1992, BAILLIERE CLIN ENDOC, V6, P849, DOI 10.1016/S0950-351X(05)80170-3; Ford ES, 2005, DIABETES CARE, V28, P2745, DOI 10.2337/diacare.28.11.2745; HENNINGSEN L, 1978, HORM METAB RES, V10, P565, DOI 10.1055/s-0028-1095850; Holmes GL, 1998, NEURON, V21, P1231, DOI 10.1016/S0896-6273(00)80642-X; Huang CW, 2008, EPILEPSY RES, V79, P71, DOI 10.1016/j.eplepsyres.2007.12.012; Huang CW, 2007, J NEUROSCI RES, V85, P1468, DOI 10.1002/jnr.21284; Huang CW, 2012, PSYCHOPHARMACOLOGY, V221, P575, DOI 10.1007/s00213-011-2603-y; Huang CW, 2010, NEUROTOX RES, V17, P305, DOI 10.1007/s12640-009-9104-3; Huang CW, 2009, NEUROTOX RES, V15, P71, DOI 10.1007/s12640-009-9008-2; Huang CW, 2006, EPILEPSIA, V47, P720, DOI 10.1111/j.1528-1167.2006.00498.x; Ingram EA, 2009, EPILEPSIA, V50, P56, DOI 10.1111/j.1528-1167.2008.01704.x; Lee EB, 2011, J NEUROSCI, V31, P14361, DOI 10.1523/JNEUROSCI.3171-11.2011; Levin BE, 1998, BRAIN RES BULL, V46, P513, DOI 10.1016/S0361-9230(98)00053-7; Liu D, 2010, J ALZHEIMERS DIS, V22, P443, DOI 10.3233/JAD-2010-101017; Lydiard RB, 2010, INT J NEUROPSYCHOPH, V13, P229, DOI 10.1017/S1461145709990460; MATTIA D, 1994, NEUROPHARMACOLOGY, V33, P1515, DOI 10.1016/0028-3908(94)90124-4; McClelland David, 2004, BMC Pharmacology, V4, P14, DOI 10.1186/1471-2210-4-14; MELLO LEAM, 1993, EPILEPSIA, V34, P985, DOI 10.1111/j.1528-1157.1993.tb02123.x; Morrione A, 2000, CANCER RES, V60, P2263; OBEMBE A, 1991, CENT AFR J MED, V37, P96; Pathak HR, 2007, J NEUROSCI, V27, P14012, DOI 10.1523/JNEUROSCI.4390-07.2007; Pitkanen A, 2006, MODELS OF SEIZURES AND EPILEPSY, P1; Qi H, 1996, CLIN EXP PHARMACOL P, V23, P893, DOI 10.1111/j.1440-1681.1996.tb01140.x; Queiroz CMT, 2007, EUR J NEUROSCI, V25, P3071, DOI 10.1111/j.1460-9568.2007.05573.x; Quintero JE, 2011, J PHARMACOL EXP THER, V338, P240, DOI 10.1124/jpet.110.178384; Rauchenzauner M, 2008, EPILEPSY RES, V80, P142, DOI 10.1016/j.eplepsyres.2008.03.017; Rosenstock J, 2004, PAIN, V110, P628, DOI 10.1016/j.pain.2004.05.001; Rosenstock J, 2007, DIABETES CARE, V30, P1480, DOI 10.2337/dc06-2001; Ryu JH, 2012, BRIT J ANAESTH, V109, P234, DOI 10.1093/bja/aes120; Santos FA, 2005, LIFE SCI, V77, P2953, DOI 10.1016/j.lfs.2005.05.032; Sarantopoulos C, 2003, NEUROSCI LETT, V343, P185, DOI 10.1016/S0304-3940(03)00383-5; Schmitz B, 2010, EPILEPSIA, V51, P2231, DOI 10.1111/j.1528-1167.2010.02759.x; Sharma AK, 2007, TOXICOL PATHOL, V35, P984, DOI 10.1080/01926230701748305; Shyng SL, 1997, J GEN PHYSIOL, V110, P655, DOI 10.1085/jgp.110.6.655; SINGH BM, 1980, ANN NEUROL, V8, P155, DOI 10.1002/ana.410080205; Soundarapandian MM, 2007, J NEUROCHEM, V103, P1982, DOI 10.1111/j.1471-4159.2007.04883.x; Szczepanska-Sadowska E, 2010, J PHYSIOL PHARMACOL, V61, P509; Tay AS, 2010, NEUROSCIENCE, V167, P277, DOI 10.1016/j.neuroscience.2010.02.006; Taylor CP, 2007, EPILEPSY RES, V73, P137, DOI 10.1016/j.eplepsyres.2006.09.008; Tomson T, 2011, EPILEPSY RES, V96, P64, DOI 10.1016/j.eplepsyres.2011.05.001; Wulfsen I, 2000, J NEUROENDOCRINOL, V12, P263; Yamada K, 2001, SCIENCE, V292, P1543, DOI 10.1126/science.1059829; Yoon JS, 2011, NEUROBIOL DIS, V41, P624, DOI 10.1016/j.nbd.2010.11.011; Zawar C, 1999, J PHYSIOL-LONDON, V514, P327; Zhang H, 2008, MOL CELL NEUROSCI, V37, P1, DOI 10.1016/j.mcn.2007.08.007; Zhao M, 2008, MOL BIOTECHNOL, V40, P19, DOI 10.1007/s12033-008-9043-x; Zoga V, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-6	57	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65154	10.1371/journal.pone.0065154	http://dx.doi.org/10.1371/journal.pone.0065154			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785408	Green Submitted, gold, Green Published			2022-12-27	WOS:000321038800112
J	Kushniarevich, A; Sivitskaya, L; Danilenko, N; Novogrodskii, T; Tsybovsky, I; Kiseleva, A; Kotova, S; Chaubey, G; Metspalu, E; Sahakyan, H; Bahmanimehr, A; Reidla, M; Rootsi, S; Parik, J; Reisberg, T; Achilli, A; Kashani, BH; Gandini, F; Olivieri, A; Behar, DM; Torroni, A; Davydenko, O; Villems, R				Kushniarevich, Alena; Sivitskaya, Larysa; Danilenko, Nina; Novogrodskii, Tadeush; Tsybovsky, Iosif; Kiseleva, Anna; Kotova, Svetlana; Chaubey, Gyaneshwer; Metspalu, Ene; Sahakyan, Hovhannes; Bahmanimehr, Ardeshir; Reidla, Maere; Rootsi, Siiri; Parik, Jueri; Reisberg, Tuuli; Achilli, Alessandro; Kashani, Baharak Hooshiar; Gandini, Francesca; Olivieri, Anna; Behar, Doron M.; Torroni, Antonio; Davydenko, Oleg; Villems, Richard			Uniparental Genetic Heritage of Belarusians: Encounter of Rare Middle Eastern Matrilineages with a Central European Mitochondrial DNA Pool	PLOS ONE			English	Article							Y-CHROMOSOME STR; MTDNA VARIATION; NEAR-EASTERN; HAPLOGROUP-H; WESTERN; DIVERSITY; LANDSCAPE; ORIGIN; TREE; ASIA	Ethnic Belarusians make up more than 80% of the nine and half million people inhabiting the Republic of Belarus. Belarusians together with Ukrainians and Russians represent the East Slavic linguistic group, largest both in numbers and territory, inhabiting East Europe alongside Baltic-, Finno-Permic- and Turkic-speaking people. Till date, only a limited number of low resolution genetic studies have been performed on this population. Therefore, with the phylogeographic analysis of 565 Y-chromosomes and 267 mitochondrial DNAs from six well covered geographic sub-regions of Belarus we strove to complement the existing genetic profile of eastern Europeans. Our results reveal that around 80% of the paternal Belarusian gene pool is composed of R1a, I2a and N1c Y-chromosome haplogroups - a profile which is very similar to the two other eastern European populations - Ukrainians and Russians. The maternal Belarusian gene pool encompasses a full range of West Eurasian haplogroups and agrees well with the genetic structure of central-east European populations. Our data attest that latitudinal gradients characterize the variation of the uniparentally transmitted gene pools of modern Belarusians. In particular, the Y-chromosome reflects movements of people in central-east Europe, starting probably as early as the beginning of the Holocene. Furthermore, the matrilineal legacy of Belarusians retains two rare mitochondrial DNA haplogroups, N1a3 and N3, whose phylogeographies were explored in detail after de novo sequencing of 20 and 13 complete mitogenomes, respectively, from all over Eurasia. Our phylogeographic analyses reveal that two mitochondrial DNA lineages, N3 and N1a3, both of Middle Eastern origin, might mark distinct events of matrilineal gene flow to Europe: during the mid-Holocene period and around the Pleistocene-Holocene transition, respectively.	[Kushniarevich, Alena; Chaubey, Gyaneshwer; Sahakyan, Hovhannes; Rootsi, Siiri; Parik, Jueri; Reisberg, Tuuli] Estonian Biocentre, Tartu, Estonia; [Sivitskaya, Larysa; Danilenko, Nina; Davydenko, Oleg] Natl Acad Sci Belarus, Inst Cytol & Genet, Minsk, BELARUS; [Novogrodskii, Tadeush] Belarusian State Univ, Fac Hist, Dept Ethnol Museol & Hist Arts, Minsk, BELARUS; [Tsybovsky, Iosif; Kiseleva, Anna; Kotova, Svetlana] Ctr Forens Expertise & Criminalist, Minsk, BELARUS; [Metspalu, Ene; Reidla, Maere; Parik, Jueri; Reisberg, Tuuli] Univ Tartu, Dept Evolutionary Biol, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia; [Sahakyan, Hovhannes; Bahmanimehr, Ardeshir] Armenian Acad Sci, Inst Mol Biol, Human Genet Grp, Yerevan, Armenia; [Achilli, Alessandro] Univ Perugia, Dipartimento Biol Cellulare & Ambientale, I-06100 Perugia, Italy; [Kashani, Baharak Hooshiar; Gandini, Francesca; Olivieri, Anna; Torroni, Antonio] Univ Pavia, Dipartimento Biol & Biotecnol L Spallanzani, I-27100 Pavia, Italy; [Behar, Doron M.] Mol Med Lab, Haifa, Israel; [Villems, Richard] Estonian Acad Sci, EE-200103 Tallinn, Estonia	National Academy of Sciences of Belarus (NASB); Institute of Genetics & Cytology of the National Academy of Sciences of Belarus; Belarusian State University; University of Tartu; National Academy of Sciences of Armenia; Institute of Molecular Biology - NAS RA; Institute of Radiophysics & Electronics - NAS RA; University of Perugia; University of Pavia; Rambam Health Care Campus; Estonian Academy of Sciences	Kushniarevich, A (corresponding author), Estonian Biocentre, Tartu, Estonia.	lkushniarevich@gmail.com	Gandini, Francesca/H-8936-2015; Torroni, Antonio/E-1557-2011; Chaubey, Gyaneshwer/AAC-6409-2019; Achilli, Alessandro/I-9236-2012; Sivitskaya, Larysa/AAD-8068-2020; Bahmanimehr, Ardeshir/K-4367-2019; Chaubey, Gyaneshwer/H-2753-2012; Sivitskaya, Larysa/HHN-4021-2022; OLIVIERI, ANNA/I-9235-2012	Gandini, Francesca/0000-0001-8930-8295; Torroni, Antonio/0000-0002-4163-4478; Chaubey, Gyaneshwer/0000-0003-2899-3852; Achilli, Alessandro/0000-0001-6871-3451; Chaubey, Gyaneshwer/0000-0003-2899-3852; Sivitskaya, Larysa/0000-0001-6359-4967; OLIVIERI, ANNA/0000-0002-3941-8098; Sahakyan, Hovhannes/0000-0003-1596-2838; Svetlana, Kotova/0000-0002-6521-7732; Reisberg, Tuuli/0000-0002-1193-5616	State Committee on Science and Technology of the Republic of Belarus (SCST); Progetti Ricerca Interesse Nazionale (Italian Ministry of the University); FIRB-Futuro in Ricerca (Italian Ministry of the University); Fondazione Alma Mater Ticinensis; Estonian Basic Research [SF0182474]; Estonian Science Foundation [7858]; European Commission [ECOGENE205419]; European Union Regional Development Fund (through the Centre of Excellence in Genomics	State Committee on Science and Technology of the Republic of Belarus (SCST); Progetti Ricerca Interesse Nazionale (Italian Ministry of the University); FIRB-Futuro in Ricerca (Italian Ministry of the University); Fondazione Alma Mater Ticinensis; Estonian Basic Research; Estonian Science Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre); European Union Regional Development Fund (through the Centre of Excellence in Genomics	This study was supported by the State Committee on Science and Technology of the Republic of Belarus (SCST), Progetti Ricerca Interesse Nazionale 2009 (Italian Ministry of the University) (to AA and AT), FIRB-Futuro in Ricerca 2008 (Italian Ministry of the University) (to AA and AO), Fondazione Alma Mater Ticinensis (to AT), Estonian Basic Research grant SF0182474 (to RV and EM), Estonian Science Foundation grants (7858) (to EM), European Commission grant (ECOGENE205419) (to RV), the European Union Regional Development Fund (through the Centre of Excellence in Genomics (to RV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amero KK, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-45; Al-Zahery N, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-288; Alekseeva T, 2001, VOSTOCHNYE SLAVIANE; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Balanovsky O, 2008, AM J HUM GENET, V82, P236, DOI 10.1016/j.ajhg.2007.09.019; Balanovsky O, 2011, MOL BIOL EVOL, V28, P2905, DOI 10.1093/molbev/msr126; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Behar DM, 2012, AM J HUM GENET, V90, P675, DOI 10.1016/j.ajhg.2012.03.002; Bellusci G, 2010, ANN HUM BIOL, V37, P367, DOI 10.3109/03014461003614358; Belyaeva O, 2003, HUM BIOL, V75, P647, DOI 10.1353/hub.2003.0069; Bermisheva MA, 2002, MOL BIOL+, V36, P802, DOI 10.1023/A:1021677708482; Bramanti B, 2009, SCIENCE, V326, P137, DOI 10.1126/science.1176869; Derenko M, 2007, AM J HUM GENET, V81, P1025, DOI 10.1086/522933; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fechner A, 2008, AM J PHYS ANTHROPOL, V137, P41, DOI 10.1002/ajpa.20838; Fernandes V, 2012, AM J HUM GENET, V90, P347, DOI 10.1016/j.ajhg.2011.12.010; Forster P, 1996, AM J HUM GENET, V59, P935; Grzybowski T, 2007, FORENSIC SCI INT-GEN, V1, P141, DOI 10.1016/j.fsigen.2007.01.010; Haak W, 2005, SCIENCE, V310, P1016, DOI 10.1126/science.1118725; Hudjashov G, 2007, P NATL ACAD SCI USA, V104, P8726, DOI 10.1073/pnas.0702928104; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; Karskii EF, 1955, BELORUSY YAZYK BELOR; Kasperaviciute D, 2004, ANN HUM GENET, V68, P438, DOI 10.1046/j.1529-8817.2003.00119.x; Kasperaviciute Dalia, 2002, Journal of Applied Genetics, V43, P255; Kayser M, 2005, HUM GENET, V117, P428, DOI 10.1007/s00439-005-1333-9; Khar'kov V N, 2005, Genetika, V41, P1132; Kharkov V. N., 2004, Genetika, V40, P415; Klimchuk FD, 1983, HAVORKI ZAKHODNIAHA; Lappalainen T, 2009, ANN HUM GENET, V73, P61, DOI 10.1111/j.1469-1809.2008.00487.x; Lappalainen T, 2006, GENE, V376, P207, DOI 10.1016/j.gene.2006.03.004; Loogvali EL, 2004, MOL BIOL EVOL, V21, P2012, DOI 10.1093/molbev/msh209; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; Mahnach AS, 2001, GEOLOGIYA BELARUSI; Maliarchuk B A, 2008, Genetika, V44, P401; Malyarchuk B, 2008, MOL BIOL EVOL, V25, P1651, DOI 10.1093/molbev/msn114; Malyarchuk B. A., 2002, Genetika, V38, P1532; Malyarchuk B. A., 2001, Genetika, V37, P1411; Malyarchuk BA, 2002, ANN HUM GENET, V66, P261, DOI 10.1017/S0003480002001161; Malyarchuk B, 2010, MOL BIOL EVOL, V27, P2220, DOI 10.1093/molbev/msq065; Malyarchuk B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010285; Mathew C G, 1985, Methods Mol Biol, V2, P31, DOI 10.1385/0-89603-064-4:31; Mielnik-Sikorska M, 2013, FORENSIC SCI INT-GEN, V7, P200, DOI 10.1016/j.fsigen.2012.05.007; Mirabal S, 2009, EUR J HUM GENET, V17, P1260, DOI 10.1038/ejhg.2009.6; Morozova I, 2012, AM J PHYS ANTHROPOL, V147, P341, DOI 10.1002/ajpa.21649; Myres NM, 2011, EUR J HUM GENET, V19, P95, DOI 10.1038/ejhg.2010.146; Ottoni C, 2009, ANN HUM BIOL, V36, P785, DOI 10.3109/03014460903198509; Pala M, 2012, AM J HUM GENET, V90, P915, DOI 10.1016/j.ajhg.2012.04.003; Pericic M, 2005, MOL BIOL EVOL, V22, P1964, DOI 10.1093/molbev/msi185; Pliss L, 2006, ANN HUM GENET, V70, P439, DOI 10.1111/j.1469-1809.2005.00238.x; Rebala K, 2007, J HUM GENET, V52, P406, DOI 10.1007/s10038-007-0125-6; Rebala K, 2011, FORENSIC SCI INT-GEN, V5, pE17, DOI 10.1016/j.fsigen.2009.10.011; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Rieder MJ, 1998, NUCLEIC ACIDS RES, V26, P967, DOI 10.1093/nar/26.4.967; Roewer L, 2008, INT J LEGAL MED, V122, P219, DOI 10.1007/s00414-007-0222-2; Roostalu U, 2007, MOL BIOL EVOL, V24, P436, DOI 10.1093/molbev/msl173; Rootsi S, 2004, AM J HUM GENET, V75, P128, DOI 10.1086/422196; Rootsi S, 2007, EUR J HUM GENET, V15, P204, DOI 10.1038/sj.ejhg.5201748; Rootsi S, 2012, EUR J HUM GENET, V20, P1275, DOI 10.1038/ejhg.2012.86; Rosenberg MS, 2001, PASSAGE PATTERN ANAL; Rosser ZH, 2000, AM J HUM GENET, V67, P1526, DOI 10.1086/316890; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Schonberg A, 2011, EUR J HUM GENET, V19, P988, DOI 10.1038/ejhg.2011.62; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Semino O, 2004, AM J HUM GENET, V74, P1023, DOI 10.1086/386295; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; SVEZHENTSEV YS, 1993, RADIOCARBON, V35, P495, DOI 10.1017/S0033822200060525; Tambets K, 2004, AM J HUM GENET, V74, P661, DOI 10.1086/383203; Torroni A, 2001, AM J HUM GENET, V69, P1348, DOI 10.1086/324511; Torroni A, 2001, AM J HUM GENET, V69, P844, DOI 10.1086/323485; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; Underhill PA, 2010, EUR J HUM GENET, V18, P479, DOI 10.1038/ejhg.2009.194; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Wozniak M, 2010, AM J PHYS ANTHROPOL, V142, P540, DOI 10.1002/ajpa.21253; Yunusbayev B, 2012, MOL BIOL EVOL, V29, P359, DOI 10.1093/molbev/msr221; Zaikouski EM, 1997, ARHEALOGIYA BELARUSI, VI, P21; Zerjal T, 2001, MOL BIOL EVOL, V18, P1077, DOI 10.1093/oxfordjournals.molbev.a003879	77	21	23	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66499	10.1371/journal.pone.0066499	http://dx.doi.org/10.1371/journal.pone.0066499			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785503	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000321038800018
J	Lamarre, Y; Lalanne-Mistrih, ML; Romana, M; Lemonne, N; Mougenel, D; Waltz, X; Tressieres, B; Etienne-Julan, M; Tarer, V; Hardy-Dessources, MD; Connes, P				Lamarre, Yann; Lalanne-Mistrih, Marie-Laure; Romana, Marc; Lemonne, Nathalie; Mougenel, Daniele; Waltz, Xavier; Tressieres, Benoit; Etienne-Julan, Maryse; Tarer, Vanessa; Hardy-Dessources, Marie-Dominique; Connes, Philippe			Male Gender, Increased Blood Viscosity, Body Mass Index and Triglyceride Levels Are Independently Associated with Systemic Relative Hypertension in Sickle Cell Anemia	PLOS ONE			English	Article							CHOLESTEROL LEVELS; ATHEROGENIC INDEX; HDL-CHOLESTEROL; RISK-FACTORS; LIPID-LEVELS; DISEASE; PRESSURE; CHILDREN; PLASMA; PATHOPHYSIOLOGY	Patients with sickle cell anemia (SCA) have usually lower diastolic, systolic and mean blood pressure (BP) than the general population. However, BP values >= 120/70 mmHg considerably increase the risk for acute and chronic complications in SCA. The aim of this study was to identify biological factors associated with relative hypertension in adults with SCA. We compared the hematological, lipid and hemolytic profiles, as well as blood viscosity, between SCA patients with normal BP (<120/70 mmHg, n = 54) and those with relative hypertension (BP >= 120/70 mmHg, n = 43). Our results demonstrated that male gender (OR: 3.49; 95% CI 1.20 to 10.16, p<0.05), triglycerides (OR: 9.19; 95% CI 2.29 to 36.95, p<0.01), blood viscosity (OR: 1.35; 95% CI 1.01 to 1.81, p<0.05) and body mass index (OR: 1.37; 95% CI 1.14 to 1.64, p<0.01) were independent risks factors for relative hypertension in SCA. No association was found between the BP status and the positive history of painful vaso-occlusive crisis or acute chest syndrome. An association between triglycerides level and the occurrence of these two major acute complications was detected. Our study suggests that male gender, increased triglycerides level, BMI and blood viscosity could increase the risk for developing relative hypertension in SCA. In addition, our results support a role of moderately elevated triglycerides in the pathophysiology of vaso-occlusive events.	[Lamarre, Yann; Lalanne-Mistrih, Marie-Laure; Romana, Marc; Waltz, Xavier; Etienne-Julan, Maryse; Hardy-Dessources, Marie-Dominique; Connes, Philippe] Ctr Hosp Univ Pointe A Pitre, Hop Ricou, Inst Natl Sante & Rech Med UMR 665, Pointe A Pitre, Guadeloupe, France; [Lamarre, Yann; Lalanne-Mistrih, Marie-Laure; Romana, Marc; Waltz, Xavier; Etienne-Julan, Maryse; Hardy-Dessources, Marie-Dominique; Connes, Philippe] Univ Antilles Guyane, Pointe A Pitre, Guadeloupe, France; [Lamarre, Yann; Romana, Marc; Waltz, Xavier; Hardy-Dessources, Marie-Dominique; Connes, Philippe] PRES Sorbonne Paris Cite, Lab Excellence GR Ex Red Cell Genesis Death, Paris, France; [Lalanne-Mistrih, Marie-Laure; Tressieres, Benoit] Ctr Hosp Univ Pointe A Pitre, Ctr Invest Clin Epidemiol Clin Inserm Antilles Gu, Pointe A Pitre, Guadeloupe, France; [Lemonne, Nathalie; Mougenel, Daniele; Etienne-Julan, Maryse; Tarer, Vanessa] Ctr Hosp Univ Pointe A Pitre, Unite Transversale Drepanocytose, Pointe A Pitre, Guadeloupe, France; [Waltz, Xavier] Univ Antilles Guyane, Dept Physiol, Lab EA3596, Pointe A Pitre, Guadeloupe, France	CHU Guadeloupe; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite des Antilles; CHU Guadeloupe; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Guadeloupe; Universite des Antilles	Connes, P (corresponding author), Ctr Hosp Univ Pointe A Pitre, Hop Ricou, Inst Natl Sante & Rech Med UMR 665, Pointe A Pitre, Guadeloupe, France.	pconnes@yahoo.fr	Romana, Marc/K-6442-2017; Connes, Philippe/J-7835-2019; WALTZ, Xavier/M-3606-2016; TRESSIERES, Benoit/ABH-1085-2020; Lamarre, Yann/ABC-2074-2020; , Hardy-dessources/K-9189-2017	Romana, Marc/0000-0002-8715-9836; Connes, Philippe/0000-0002-9232-0268; WALTZ, Xavier/0000-0002-0838-290X; , Hardy-dessources/0000-0003-0861-3648; Lamarre, Yann/0000-0003-0669-793X; Philippe, Connes/0000-0001-8449-7998; ETIENNE-JULAN, Maryse/0000-0003-1339-6545				[Anonymous], BR J HAEMAT IN PRESS; [Anonymous], 2012, HAEMATOLOGICA; [Anonymous], BLOOD IN PRESS; Athanassiou G, 2006, CLIN HEMORHEOL MICRO, V35, P291; Ballas SK, 2012, BLOOD, V120, P3647, DOI 10.1182/blood-2012-04-383430; BALLAS SK, 1989, AM J HEMATOL, V32, P104, DOI 10.1002/ajh.2830320206; Barden EM, 2000, J PEDIATR-US, V136, P73, DOI 10.1016/S0022-3476(00)90053-2; Baskurt OK, 2009, CLIN HEMORHEOL MICRO, V42, P75, DOI 10.3233/CH-2009-1202; Belhassen L, 2001, BLOOD, V97, P1584, DOI 10.1182/blood.V97.6.1584; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; Choy E, 2009, ANN RHEUM DIS, V68, P460, DOI 10.1136/ard.2008.101964; da Luz PL, 2008, CLINICS, V63, P427, DOI 10.1590/S1807-59322008000400003; Dart AM, 2001, J AM COLL CARDIOL, V37, P975, DOI 10.1016/S0735-1097(01)01108-1; Dobiasova M, 2006, Vnitr Lek, V52, P64; Dobiasova M, 2004, CLIN CHEM, V50, P1113, DOI 10.1373/clinchem.2004.033175; Dobiasova M, 2001, CLIN BIOCHEM, V34, P583, DOI 10.1016/S0009-9120(01)00263-6; Ernst AA, 2000, SOUTHERN MED J, V93, P590; Frontini MG, 2008, PEDIATRICS, V121, P924, DOI 10.1542/peds.2007-1472; Galie N, 2005, LUPUS, V14, P713, DOI 10.1191/0961203305lu2206oa; Goldberg IJ, 2011, ARTERIOSCL THROM VAS, V31, P1716, DOI 10.1161/ATVBAHA.111.226100; Gordeuk VR, 2008, AM J HEMATOL, V83, P15, DOI 10.1002/ajh.21016; Jankowski P, 2007, BLOOD PRESSURE, V16, P238, DOI 10.1080/08037050701428166; Johnson CS, 2005, HEMATOL ONCOL CLIN N, V19, P827, DOI 10.1016/j.hoc.2005.08.006; Krentz AJ, 2003, DIABETES OBES METAB, V5, pS19, DOI 10.1046/j.1462-8902.2003.0310.x; Lamarre Y, CLIN HEMORH IN PRESS; Lamarre Y, 2012, HAEMATOL-HEMATOL J, V97, P1641, DOI 10.3324/haematol.2012.066670; LANDSBERG L, 1994, J CARDIOVASC PHARM, V23, pS1, DOI 10.1097/00005344-199423001-00002; Lemogoum D, 2004, HYPERTENSION, V44, P924, DOI 10.1161/01.HYP.0000148506.73622.ba; Lemonne N, 2012, AM J HEMATOL, V87, pE129, DOI 10.1002/ajh.23312; Meiselman HJ, 1999, CLIN HEMORHEOL MICRO, V21, P195; Nebor D, 2011, HAEMATOL-HEMATOL J, V96, P1589, DOI 10.3324/haematol.2011.047365; Oguanobi NI, 2010, J CARDIOL, V56, P326, DOI 10.1016/j.jjcc.2010.07.001; Ohene-Frempong K, 1998, BLOOD, V91, P288; Pegelow CH, 1997, AM J MED, V102, P171; Pickering Thomas G., 2005, Hypertension (Baltimore), V45, P142; Rahimi Z, 2006, CLIN CHIM ACTA, V365, P217, DOI 10.1016/j.cca.2005.08.022; Redon J, 2001, NUTR METAB CARDIOVAS, V11, P344; RODGERS GP, 1993, AM J MED SCI, V305, P150, DOI 10.1097/00000441-199303000-00004; Rodriguez-Moran M, 2013, DIABETES VASC DIS RE, V10, P17, DOI 10.1177/1479164112440713; SANDHAGEN B, 1990, J INTERN MED, V228, P623, DOI 10.1111/j.1365-2796.1990.tb00289.x; Seixas MO, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-91; Shores J, 2003, J NATL MED ASSOC, V95, P813; Tan ASC, 2001, BLOOD, V98, P250, DOI 10.1182/blood.V98.1.250; Tarer V, 2006, EUR J HAEMATOL, V76, P193, DOI 10.1111/j.1600-0609.2005.00590.x; Tripette J, 2009, HAEMATOL-HEMATOL J, V94, P1060, DOI 10.3324/haematol.2008.005371; Wang LM, 2009, J LIPID RES, V50, P204, DOI 10.1194/jlr.M700505-JLR200; Wang W, 2003, CLIN CHEM, V49, P1679, DOI 10.1373/49.10.1679; Weng S, PLOS ONE IN PRESS; Woods K. F., 2001, Ethnicity and Disease, V11, P30; Yuditskaya S, 2009, BLOOD, V113, P1122, DOI 10.1182/blood-2008-03-142604; Zhang WY, 2006, ARTERIOSCL THROM VAS, V26, P514, DOI 10.1161/01.ATV.0000200226.53994.09; Zieman SJ, 2005, ARTERIOSCL THROM VAS, V25, P932, DOI 10.1161/01.ATV.0000160548.78317.29; Zorca S, 2010, BRIT J HAEMATOL, V149, P436, DOI 10.1111/j.1365-2141.2010.08109.x	53	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66004	10.1371/journal.pone.0066004	http://dx.doi.org/10.1371/journal.pone.0066004			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785465	Green Submitted, Green Published, gold			2022-12-27	WOS:000321038800057
J	Prole, DL; Taylor, CW				Prole, David L.; Taylor, Colin W.			Identification and Analysis of Putative Homologues of Mechanosensitive Channels in Pathogenic Protozoa	PLOS ONE			English	Article							ESCHERICHIA-COLI; TRP CHANNELS; MECHANICAL STIMULATION; CA2+ CHANNEL; ION CHANNELS; MEMBRANE; PARAMECIUM; TENSION; PROTEIN; YEAST	Mechanosensitive channels play important roles in the physiology of many organisms, and their dysfunction can affect cell survival. This suggests that they might be therapeutic targets in pathogenic organisms. Pathogenic protozoa lead to diseases such as malaria, dysentery, leishmaniasis and trypanosomiasis that are responsible for millions of deaths each year worldwide. We analyzed the genomes of pathogenic protozoa and show the existence within them of genes encoding putative homologues of mechanosensitive channels. Entamoeba histolytica, Leishmania spp., Trypanosoma cruzi and Trichomonas vaginalis have genes encoding homologues of Piezo channels, while most pathogenic protozoa have genes encoding homologues of mechanosensitive small-conductance (MscS) and K+-dependent (MscK) channels. In contrast, all parasites examined lack genes encoding mechanosensitive large-conductance (MscL), mini-conductance (MscM) and degenerin/epithelial Na+ (DEG/ENaC) channels. Multiple sequence alignments of evolutionarily distant protozoan, amoeban, plant, insect and vertebrate Piezo channel subunits define an absolutely conserved motif that may be involved in channel conductance or gating. MscS channels are not present in humans, and the sequences of protozoan and human homologues of Piezo channels differ substantially. This suggests the possibility for specific targeting of mechanosensitive channels of pathogens by therapeutic drugs.	[Prole, David L.; Taylor, Colin W.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1QJ, England	University of Cambridge	Prole, DL (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1QJ, England.	dp350@cam.ac.uk	Taylor, Colin/G-2447-2010	Taylor, Colin/0000-0001-7771-1044; Prole, David/0000-0003-2782-6665	Meres from St. John's College, Cambridge; Wellcome Trust [085295]	Meres from St. John's College, Cambridge; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by a Meres senior research associateship from St. John's College, Cambridge (to DLP) and by the Wellcome Trust (grant number 085295, to CWT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akitake B, 2005, J GEN PHYSIOL, V125, P143, DOI 10.1085/jgp.200409198; Alam A, 2011, J GEN PHYSIOL, V137, P397, DOI 10.1085/jgp.201010546; Arnadottir J, 2010, ANNU REV BIOPHYS, V39, P111, DOI 10.1146/annurev.biophys.37.032807.125836; Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; Bae C, 2013, P NATL ACAD SCI USA, V110, pE1162, DOI 10.1073/pnas.1219777110; Bae C, 2011, BIOCHEMISTRY-US, V50, P6295, DOI 10.1021/bi200770q; Balleza D, 2009, EUR BIOPHYS J BIOPHY, V38, P1013, DOI 10.1007/s00249-009-0460-y; Barritt G, 2005, NAT CELL BIOL, V7, P105, DOI 10.1038/ncb0205-105; Bass RB, 2002, SCIENCE, V298, P1582, DOI 10.1126/science.1077945; Ben-Shahar Y, 2011, ADV GENET, V76, P1, DOI 10.1016/B978-0-12-386481-9.00001-8; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Berrier C, 1996, J MEMBRANE BIOL, V151, P175, DOI 10.1007/s002329900068; Booth IR, 2011, BIOCHEM SOC T, V39, P733, DOI 10.1042/BST0390733; Booth IR, 1999, CURR OPIN MICROBIOL, V2, P166, DOI 10.1016/S1369-5274(99)80029-0; Castillo E, 2010, CURR MED CHEM, V17, P4027, DOI 10.2174/092986710793205345; Chiang CS, 2004, BIOPHYS J, V86, P2846, DOI 10.1016/S0006-3495(04)74337-4; Christensen AP, 2007, NAT REV NEUROSCI, V8, P510, DOI 10.1038/nrn2149; Cibulsky SM, 2000, J GEN PHYSIOL, V116, P349, DOI 10.1085/jgp.116.3.349; Coste B, 2013, P NATL ACAD SCI USA, V110, P4667, DOI 10.1073/pnas.1221400110; Coste B, 2012, NATURE, V483, P176, DOI 10.1038/nature10812; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; DEITMER JW, 1982, J EXP BIOL, V96, P239; Denis V, 2002, J CELL BIOL, V156, P29, DOI 10.1083/jcb.200111004; DEPEYER JE, 1980, J EXP BIOL, V88, P73; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dong XP, 2010, J NEUROCHEM, V113, P313, DOI 10.1111/j.1471-4159.2010.06626.x; ECKERT R, 1972, J EXP BIOL, V56, P683; Edwards MD, 2005, NAT STRUCT MOL BIOL, V12, P113, DOI 10.1038/nsmb895; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Gebauer M, 1999, NATURWISSENSCHAFTEN, V86, P352, DOI 10.1007/s001140050634; Gees M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003962; Ghochani M, 2010, BIOPHYS J, V99, P3244, DOI 10.1016/j.bpj.2010.09.038; Gillespie PG, 2001, NATURE, V413, P194, DOI 10.1038/35093011; Goldstein SAN, 1998, J MOL MED-JMM, V76, P13, DOI 10.1007/s109-1998-8100-0; Grigoriev IV, 2012, NUCLEIC ACIDS RES, V40, pD26, DOI 10.1093/nar/gkr947; Hader DP, 2003, ADV SPACE RES-SERIES, V31, P2181, DOI 10.1016/S0273-1177(03)00242-4; Hader DP, 2001, ADV SPACE RES-SERIES, V27, P861, DOI 10.1016/S0273-1177(01)00149-1; Haswell ES, 2008, CURR BIOL, V18, P730, DOI 10.1016/j.cub.2008.04.039; Haswell ES, 2011, STRUCTURE, V19, P1356, DOI 10.1016/j.str.2011.09.005; Haswell ES, 2006, CURR BIOL, V16, P1, DOI 10.1016/j.cub.2005.11.044; Hemmersbach R, 2005, ADV SPACE RES-SERIES, V35, P296, DOI 10.1016/j.asr.2005.03.024; Kaneko T, 2009, J MEMBRANE BIOL, V228, P33, DOI 10.1007/s00232-009-9156-6; Kang LJ, 2010, NEURON, V67, P381, DOI 10.1016/j.neuron.2010.06.032; Kim J, 2003, NATURE, V424, P81, DOI 10.1038/nature01733; Kim SE, 2012, NATURE, V483, P209, DOI 10.1038/nature10801; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Kloda Anna, 2002, Archaea, V1, P35, DOI 10.1155/2002/419261; Krause M, 2006, PROTOPLASMA, V229, P109, DOI 10.1007/s00709-006-0207-x; KRUPPEL T, 1993, J MEMBRANE BIOL, V135, P253; Kung C, 2010, ANNU REV MICROBIOL, V64, P313, DOI 10.1146/annurev.micro.112408.134106; Kurusu T, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-11; Levina N, 1999, EMBO J, V18, P1730, DOI 10.1093/emboj/18.7.1730; Li C, 2007, MOL MICROBIOL, V64, P560, DOI 10.1111/j.1365-2958.2007.05672.x; Li W, 2006, NATURE, V440, P684, DOI 10.1038/nature04538; Li YZ, 2002, EMBO J, V21, P5323, DOI 10.1093/emboj/cdf537; MACHEMER H, 1979, J PHYSIOL-LONDON, V296, P49, DOI 10.1113/jphysiol.1979.sp012990; Malcolm HR, 2011, BIOPHYS J, V101, P345, DOI 10.1016/j.bpj.2011.05.058; Martinac B, 2003, PROG BIOPHYS MOL BIO, V82, P11, DOI 10.1016/S0079-6107(03)00002-6; Martinac B, 2008, PHYSIOL REV, V88, P1449, DOI 10.1152/physrev.00005.2008; Miller C., 2000, GENOME BIOL, V1, DOI [10.1186/gb-2000-1-4-reviews0004.REVIEWS0004, DOI 10.1186/GB-2000-1-4-REVIEWS0004.REVIEWS0004, 10.1186/gb-2000-1-4-reviews0004, DOI 10.1186/GB-2000-1-4-REVIEWS0004]; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Monzote Lianet, 2011, Open Med Chem J, V5, P1, DOI 10.2174/1874104501105010001; NAITOH Y, 1969, SCIENCE, V164, P963, DOI 10.1126/science.164.3882.963; Nakagawa Y, 2007, P NATL ACAD SCI USA, V104, P3639, DOI 10.1073/pnas.0607703104; Nakayama Y, 2007, P NATL ACAD SCI USA, V104, P5883, DOI 10.1073/pnas.0609996104; Nakayama Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2014; O'Hagan R, 2005, NAT NEUROSCI, V8, P43, DOI 10.1038/nn1362; Palmer CP, 2001, P NATL ACAD SCI USA, V98, P7801, DOI 10.1073/pnas.141036198; Petersen I, 2011, FEBS LETT, V585, P1551, DOI 10.1016/j.febslet.2011.04.042; Peyronnet R, 2008, PLANT SIGNAL BEHAV, V3, P726, DOI 10.4161/psb.3.9.6487; Pivetti CD, 2003, MICROBIOL MOL BIOL R, V67, P66, DOI 10.1128/MMBR.67.1.66-85.2003; Prole DL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042404; Prole DL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032264; Prole DL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026218; Roux A, 2010, P NATL ACAD SCI USA, V107, P4141, DOI 10.1073/pnas.0913734107; Salmi ML, 2011, PLANTA, V233, P911, DOI 10.1007/s00425-010-1343-2; Schumann U, 2010, P NATL ACAD SCI USA, V107, P12664, DOI 10.1073/pnas.1001405107; Shiono H, 1997, J EXP BIOL, V200, P2249; Sibley LD, 2011, IMMUNOL REV, V240, P72, DOI 10.1111/j.1600-065X.2010.00990.x; Su ZW, 2011, J GEN PHYSIOL, V138, P627, DOI 10.1085/jgp.201110693; Sukharev SI, 1999, J GEN PHYSIOL, V113, P525, DOI 10.1085/jgp.113.4.525; Tani T, 2002, CELL BIOL INT, V26, P853, DOI 10.1006/cbir.2002.0937; Taylor CW, 2009, BIOCHEMISTRY-US, V48, P12062, DOI 10.1021/bi901739t; TOMINAGA T, 1994, J EXP BIOL, V189, P117; Toyota M, 2008, PLANT PHYSIOL, V146, P505, DOI 10.1104/pp.107.106450; Upadhyaya A, 2004, BIOPHYS J, V86, P2923, DOI 10.1016/S0006-3495(04)74343-X; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; Waller KL, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-19; Wilson ME, 2011, PLANT CELL, V23, P2939, DOI 10.1105/tpc.111.088112; Wiser MF, 2011, PROTOZOA AND HUMAN DISEASE, P1; Wolstenholme AJ, 2011, ADV EXP MED BIOL, V704, P359, DOI 10.1007/978-94-007-0265-3_20; WOOD DC, 1985, J EXP BIOL, V117, P215; Xiao R, 2010, CURR BIOL, V20, pR936, DOI 10.1016/j.cub.2010.09.053; Yamanaka T, 2010, PLANT PHYSIOL, V152, P1284, DOI 10.1104/pp.109.147371; Yoshimura K, 1998, J MEMBRANE BIOL, V166, P149, DOI 10.1007/s002329900456; Yu Frank H, 2004, Sci STKE, V2004, pre15, DOI 10.1126/stke.2532004re15; Zhong LX, 2010, CURR BIOL, V20, P429, DOI 10.1016/j.cub.2009.12.057; Zhou XL, 2003, P NATL ACAD SCI USA, V100, P7105, DOI 10.1073/pnas.1230540100	98	38	38	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66068	10.1371/journal.pone.0066068	http://dx.doi.org/10.1371/journal.pone.0066068			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785469	Green Published, Green Submitted, gold			2022-12-27	WOS:000321038800053
J	Ali, H; Ries, MI; Nijland, JG; Lankhorst, PP; Hankemeier, T; Bovenberg, RAL; Vreeken, RJ; Driessen, AJM				Ali, Hazrat; Ries, Marco I.; Nijland, Jeroen G.; Lankhorst, Peter P.; Hankemeier, Thomas; Bovenberg, Roel A. L.; Vreeken, Rob J.; Driessen, Arnold J. M.			A Branched Biosynthetic Pathway Is Involved in Production of Roquefortine and Related Compounds in Penicillium chrysogenum	PLOS ONE			English	Article							GENE CLUSTERS; ALKALOIDS; METABOLITES; CULTURES; IDENTIFICATION; PURIFICATION; INHIBITION; MYCOTOXINS; EXPRESSION; EVOLUTION	Profiling and structural elucidation of secondary metabolites produced by the filamentous fungus Penicillium chrysogenum and derived deletion strains were used to identify the various metabolites and enzymatic steps belonging to the roquefortine/meleagrin pathway. Major abundant metabolites of this pathway were identified as histidyltryptophanyldi-ketopiperazine (HTD), dehydrohistidyltryptophanyldi-ketopiperazine (DHTD), roquefortine D, roquefortine C, glandicoline A, glandicoline B and meleagrin. Specific genes could be assigned to each enzymatic reaction step. The nonribosomal peptide synthetase RoqA accepts L-histidine and L-tryptophan as substrates leading to the production of the diketopiperazine HTD. DHTD, previously suggested to be a degradation product of roquefortine C, was found to be derived from HTD involving the cytochrome P450 oxidoreductase RoqR. The dimethylallyltryptophan synthetase RoqD prenylates both HTD and DHTD yielding directly the products roquefortine D and roquefortine C without the synthesis of a previously suggested intermediate and the involvement of RoqM. This leads to a branch in the otherwise linear pathway. Roquefortine C is subsequently converted into glandicoline B with glandicoline A as intermediates, involving two monooxygenases (RoqM and RoqO) which were mixed up in an earlier attempt to elucidate the biosynthetic pathway. Eventually, meleagrin is produced from glandicoline B involving a methyltransferase (RoqN). It is concluded that roquefortine C and meleagrin are derived from a branched biosynthetic pathway.	[Ali, Hazrat; Nijland, Jeroen G.; Driessen, Arnold J. M.] Univ Groningen, Zernike Inst Adv Mat, Groningen Biomol Sci & Biotechnol Inst, Groningen, Netherlands; [Ali, Hazrat; Nijland, Jeroen G.; Driessen, Arnold J. M.] Kluyver Ctr Genom Ind Fermentat, Delft, Netherlands; [Ries, Marco I.; Hankemeier, Thomas; Vreeken, Rob J.] Leiden Univ, Leiden Amsterdam Ctr Drug, Div Analyt Biosci, Leiden, Netherlands; [Lankhorst, Peter P.; Bovenberg, Roel A. L.] DSM Biotechnol Ctr, Delft, Netherlands; [Hankemeier, Thomas; Vreeken, Rob J.] Leiden Univ, Netherlands Metabol Ctr, Leiden, Netherlands; [Bovenberg, Roel A. L.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Groningen, Netherlands	University of Groningen; Leiden University; Leiden University - Excl LUMC; DSM NV; Leiden University; Leiden University - Excl LUMC; University of Groningen	Driessen, AJM (corresponding author), Univ Groningen, Zernike Inst Adv Mat, Groningen Biomol Sci & Biotechnol Inst, Groningen, Netherlands.	a.j.m.driessen@rug.nl	Driessen, Arnold J.M./D-1876-2012; Hankemeier, Thomas/V-5407-2019; Vreeken, Rob/AAA-4563-2021; Institute, Zernike/W-7033-2019	Hankemeier, Thomas/0000-0001-7871-2073; Driessen, Arnold J.M./0000-0001-9258-9104; Vreeken, Rob/0000-0003-3568-1371; Lankhorst, Peter/0000-0002-0373-5673	Perspective Genbiotics program; STW (Stichting Technische Wetenschappen); NWO-ACTS ibos program; Netherlands Metabolomics Centre (NMC), which is a part of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research	Perspective Genbiotics program; STW (Stichting Technische Wetenschappen)(Technologiestichting STW); NWO-ACTS ibos program; Netherlands Metabolomics Centre (NMC), which is a part of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Perspective Genbiotics program subsidized by STW (Stichting Technische Wetenschappen) and by the NWO-ACTS ibos program and co-financed by the Netherlands Metabolomics Centre (NMC), which is a part of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZ E, 1987, ANTIMICROB AGENTS CH, V31, P1675, DOI 10.1128/AAC.31.11.1675; Aninat C, 2001, CHEM RES TOXICOL, V14, P1259, DOI 10.1021/tx015512l; BARROW KD, 1979, J CHEM SOC CHEM COMM, P225, DOI 10.1039/c39790000225; Challis GL, 2008, MICROBIOL-SGM, V154, P1555, DOI 10.1099/mic.0.2008/018523-0; Covert SF, 1996, MOL GEN GENET, V251, P397; Demain AL, 2000, ADV BIOCHEM ENG BIOT, V69, P1; Donadio S, 2005, MOL GENET GENOMICS, V274, P40, DOI 10.1007/s00438-005-1156-3; Fischbach MA, 2008, P NATL ACAD SCI USA, V105, P4601, DOI 10.1073/pnas.0709132105; Fleming A, 2001, B WORLD HEALTH ORGAN, V79, P780; Frisvad JC, 2004, STUD MYCOL, P201; Garcia-Estrada C, 2011, CHEM BIOL, V18, P1499, DOI 10.1016/j.chembiol.2011.08.012; Harju S, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-8; Kasper PT, 2012, RAPID COMMUN MASS SP, V26, P2275, DOI 10.1002/rcm.6340; Keller NP, 2005, NAT REV MICROBIOL, V3, P937, DOI 10.1038/nrmicro1286; Khaldi N, 2010, FUNGAL GENET BIOL, V47, P736, DOI 10.1016/j.fgb.2010.06.003; KOLAR M, 1988, GENE, V62, P127, DOI 10.1016/0378-1119(88)90586-0; KOPP B, 1981, EUR J APPL MICROBIOL, V13, P232, DOI 10.1007/BF00500104; Kopp-Holtwiesche B, 1990, J Environ Pathol Toxicol Oncol, V10, P41; Kovalchuk A, 2012, METHODS MOL BIOL, V835, P1, DOI 10.1007/978-1-61779-501-5_1; Kulakovskaya TV, 1997, PROCESS BIOCHEM, V32, P29, DOI 10.1016/S0032-9592(96)00041-6; Ma LJ, 2010, NATURE, V464, P367, DOI 10.1038/nature08850; Martins MB, 2007, TETRAHEDRON, V63, P9923, DOI 10.1016/j.tet.2007.04.105; Medema MH, 2011, NUCLEIC ACIDS RES, V39, pW339, DOI 10.1093/nar/gkr466; Nielsen KF, 2006, J AGR FOOD CHEM, V54, P3756, DOI 10.1021/jf060114f; Nijland JG, 2008, FUNGAL GENET BIOL, V45, P1415, DOI 10.1016/j.fgb.2008.07.008; OHMOMO S, 1975, AGR BIOL CHEM TOKYO, V39, P1333, DOI 10.1080/00021369.1975.10861780; OHMOMO S, 1980, AGR BIOL CHEM TOKYO, V44, P1929, DOI 10.1080/00021369.1980.10864236; Overy DP, 2005, J CHEM ECOL, V31, P2373, DOI 10.1007/s10886-005-7107-y; POLONSKY J, 1977, ANN NUTR ALIMENT, V31, P693; POULSEN C, 1993, EUR J BIOCHEM, V212, P431, DOI 10.1111/j.1432-1033.1993.tb17679.x; Rojas-Cherto M, 2012, ANAL CHEM, V84, P5524, DOI 10.1021/ac2034216; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Scherlach K, 2006, ORG BIOMOL CHEM, V4, P3517, DOI 10.1039/b607011f; SCOTT PM, 1976, J AGR FOOD CHEM, V24, P865, DOI 10.1021/jf60206a028; SCOTT PM, 1979, J AGR FOOD CHEM, V27, P201, DOI 10.1021/jf60221a052; Shwab EK, 2008, MYCOL RES, V112, P225, DOI 10.1016/j.mycres.2007.08.021; STEYN PS, 1983, J CHEM SOC CHEM COMM, P560, DOI 10.1039/c39830000560; van den Berg MA, 2008, NAT BIOTECHNOL, V26, P1161, DOI 10.1038/nbt.1498; Vinokurova NG, 2001, J ANAL CHEM+, V56, P258, DOI 10.1023/A:1009458623849; Weber SS, 2012, BIOTECHNOL J, V7, P225, DOI 10.1002/biot.201100065; Yin WB, 2009, J BIOL CHEM, V284, P100, DOI 10.1074/jbc.M807606200	41	61	71	5	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65328	10.1371/journal.pone.0065328	http://dx.doi.org/10.1371/journal.pone.0065328			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776469	Green Published, gold			2022-12-27	WOS:000320322400018
J	Bosse, G; Mtatifikolo, F; Abels, W; Strosing, C; Breuer, JP; Spies, C				Bosse, Goetz; Mtatifikolo, Ferdinand; Abels, Wiltrud; Strosing, Christian; Breuer, Jan-Philipp; Spies, Claudia			Immediate Outcome Indicators in Perioperative Care: A Controlled Intervention Study on Quality Improvement in Hospitals in Tanzania	PLOS ONE			English	Article							HEALTH-CARE; SURGICAL CARE; MEDICAL-CARE; COUNTRIES; ASSURANCE; IMPACT	Introduction: Outcome assessment is the standard for evaluating the quality of health services worldwide. In this study, outcome has been divided into immediate and final outcome. Aim was to compare an intervention hospital with a Continuous Quality Improvement approach to a control group using benchmark assessments of immediate outcome indicators in surgical care. Results were compared to final outcome indicators. Method: Surgical care quality in six hospitals in Tanzania was assessed from 2006-2011, using the Hospital Performance Assessment Tool. Independent observers assessed structural, process and outcome quality using checklists based on evidence-based guidelines. The number of surgical key procedures over the benchmark of 80% was compared between the intervention hospital and the control group. Results were compared to Case Fatality Rates. Results: In the intervention hospital, in 2006, two of nine key procedures reached the benchmark, one in 2009, and four in 2011. In the control group, one of nine key procedures reached the benchmark in 2006, one in 2009, and none in 2011. Case Fatality Rate for all in-patients in the intervention hospital was 5.5% (n = 12,530) in 2006, 3.5% (n = 21,114) in 2009 and 4.6% (n = 18,840) in 2011. In the control group it was 3.1% (n = 17,827) in 2006, 4.2% (n = 13,632) in 2009 and 3.8% (n = 17,059) in 2011. Discussion: Results demonstrated that quality assurance improved performance levels in both groups. After the introduction of Continuous Quality Improvement, performance levels improved further in the intervention hospital while quality in the district hospital did not. Immediate outcome indicators appeared to be a better steering tool for quality improvement compared to final outcome indicators. Immediate outcome indicators revealed a need for improvement in pre- and postoperative care. Conclusion: Quality assurance programs based on immediate outcome indicators can be effective if embedded in Continuous Quality Improvement. Nevertheless, final outcome indicators cannot be neglected.	[Bosse, Goetz; Abels, Wiltrud; Breuer, Jan-Philipp; Spies, Claudia] Charite Univ Med Berlin, Dept Anaesthesiol & Intens Care Med, Campus Charite Mitte, Berlin, Germany; [Bosse, Goetz; Abels, Wiltrud; Breuer, Jan-Philipp; Spies, Claudia] Charite Univ Med Berlin, Dept Anaesthesiol & Intens Care Med, Campus Virchow Klinikum, Berlin, Germany; [Mtatifikolo, Ferdinand] Bombo Reg Hosp, Tanga, Tanzania; [Strosing, Christian] Havellandkliniken Klinikum Rathenow, Dept Surg, Rathenow, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Bosse, G (corresponding author), Charite Univ Med Berlin, Dept Anaesthesiol & Intens Care Med, Campus Charite Mitte, Berlin, Germany.	goetz.bosse@charite.de	Spies, Claudia/AAJ-5412-2020	Spies, Claudia/0000-0002-1062-0495	GIZ Esther Project [81114592]	GIZ Esther Project	The project has been supported by the GIZ Esther Project No. 81114592. The funder's website is www.esther.eu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agyepong I A, 2001, Qual Manag Health Care, V9, P1; Birkmeyer JD, 2004, J AM COLL SURGEONS, V198, P626, DOI 10.1016/j.jamcollsurg.2003.11.017; Bosse G, 2011, East Afr J Public Health, V8, P199; Bosse G, 2001, ASSESSMENT QUALITY O; Daley J, 2001, ANNU REV MED, V52, P275, DOI 10.1146/annurev.med.52.1.275; de Geyndt W, 1995, MANAGING QUALITY HLT; Deming W E, 1990, J Soc Health Syst, V2, P74; DONABEDIAN A, 1966, MILBANK FUND Q, V44, P166, DOI 10.2307/3348969; Donabedian A, 1980, Med Care Rev, V37, P653; Donabedian A., 1980, EXPLORATION QUALITY; Dussault Gilles, 2003, Hum Resour Health, V1, P1, DOI 10.1186/1478-4491-1-1; English M, 2004, LANCET, V363, P1948, DOI 10.1016/S0140-6736(04)16408-8; Grol R BR, 2004, QUALITY IMPROVEMENT; GUINANE CS, 1994, JOINT COMM J QUAL IM, V20, P696, DOI 10.1016/S1070-3241(16)30118-3; Haynes AB, 2009, NEW ENGL J MED, V360, P491, DOI 10.1056/NEJMsa0810119; HEQC TCoHE, 2004, FRAM MON EV S AFR HI; Kingham TP, 2009, ARCH SURG-CHICAGO, V144, P122, DOI 10.1001/archsurg.2008.540; Lilford R, 2004, LANCET, V363, P1147, DOI 10.1016/S0140-6736(04)15901-1; Loveday M, 2011, SAMJ S AFR MED J, V101, P887; ManceyJones M, 1997, HEALTH POLICY PLANN, V12, P183, DOI 10.1093/heapol/12.3.183; Mant J, 2001, INT J QUAL HEALTH C, V13, P475, DOI 10.1093/intqhc/13.6.475; Nachtigall I, 2009, CRIT CARE MED, V37, P159, DOI 10.1097/CCM.0b013e3181934f1b; Nolan T, 2001, LANCET, V357, P106, DOI 10.1016/S0140-6736(00)03542-X; Nyamtema A S, 2008, Afr J Reprod Health, V12, P113; Reerink IH, 1996, INT J QUAL HEALTH C, V8, P131, DOI 10.1093/intqhc/8.2.131; Reyburn H, 2008, B WORLD HEALTH ORGAN, V86, P132, DOI 10.2471/BLT.07.041723; Rubin HR, 2001, INT J QUAL HEALTH C, V13, P469, DOI 10.1093/intqhc/13.6.469; Simoes E, 2004, GESUNDHEITSWESEN, V66, P370, DOI 10.1055/s-2004-813230; Watson Diane E, 2009, Healthc Policy, V5 Spec no, P33; Weiser TG, 2008, LANCET, V372, P139, DOI 10.1016/S0140-6736(08)60878-8	30	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65428	10.1371/journal.pone.0065428	http://dx.doi.org/10.1371/journal.pone.0065428			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	163FW	23776482	gold, Green Published			2022-12-27	WOS:000320322400026
J	Gautreau, A; Hoen, M; Meunier, F				Gautreau, Aurore; Hoen, Michel; Meunier, Fanny			Let's All Speak Together! Exploring the Masking Effects of Various Languages on Spoken Word Identification in Multi-Linguistic Babble	PLOS ONE			English	Article							IN-SPEECH COMPREHENSION; INFORMATIONAL MASKING; INTERFERING-SPEECH; NATIVE-LANGUAGE; PERCEPTION; NOISE; RECOGNITION; MASKER; APPROXIMANTS; ACCESS	This study aimed to characterize the linguistic interference that occurs during speech-in-speech comprehension by combining offline and online measures, which included an intelligibility task (at a -5 dB Signal-to-Noise Ratio) and 2 lexical decision tasks (at a -5 dB and 0 dB SNR) that were performed with French spoken target words. In these 3 experiments we always compared the masking effects of speech backgrounds (i.e., 4-talker babble) that were produced in the same language as the target language (i.e., French) or in unknown foreign languages (i.e., Irish and Italian) to the masking effects of corresponding non-speech backgrounds (i.e., speech-derived fluctuating noise). The fluctuating noise contained similar spectro-temporal information as babble but lacked linguistic information. At -5 dB SNR, both tasks revealed significantly divergent results between the unknown languages (i.e., Irish and Italian) with Italian and French hindering French target word identification to a similar extent, whereas Irish led to significantly better performances on these tasks. By comparing the performances obtained with speech and fluctuating noise backgrounds, we were able to evaluate the effect of each language. The intelligibility task showed a significant difference between babble and fluctuating noise for French, Irish and Italian, suggesting acoustic and linguistic effects for each language. However, the lexical decision task, which reduces the effect of post-lexical interference, appeared to be more accurate, as it only revealed a linguistic effect for French. Thus, although French and Italian had equivalent masking effects on French word identification, the nature of their interference was different. This finding suggests that the differences observed between the masking effects of Italian and Irish can be explained at an acoustic level but not at a linguistic level.	[Gautreau, Aurore; Hoen, Michel; Meunier, Fanny] INSERM, Lyon Neurosci Res Ctr, Brain Dynam & Cognit Team, U1028, F-69000 Lyon, France; [Gautreau, Aurore; Hoen, Michel; Meunier, Fanny] CNRS, Lyon Neurosci Res Ctr, Brain Dynam & Cognit Team, UMR5292, F-69000 Lyon, France; [Gautreau, Aurore; Hoen, Michel; Meunier, Fanny] Univ Lyon, F-69000 Lyon, France; [Meunier, Fanny] CNRS, L2C2, Inst Sci Cognit Lyon, UMR5304, F-69000 Lyon, France	CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Gautreau, A (corresponding author), INSERM, Lyon Neurosci Res Ctr, Brain Dynam & Cognit Team, U1028, F-69000 Lyon, France.	aurore.gautreau@isc.cnrs.fr	Michel, Hoen/C-7721-2012	Michel, Hoen/0000-0003-2099-8130	European Research Council [209234]; French "Direction Generale de l'Armement"	European Research Council(European Research Council (ERC)European Commission); French "Direction Generale de l'Armement"(French National Research Agency (ANR))	This research was supported by a European Research Council grant to the SpiN project No209234 (awarded to Fanny Meunier) and by the French "Direction Generale de l'Armement" (awarded to AG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEST CT, 1992, J PHONETICS, V20, P305, DOI 10.1016/S0095-4470(19)30637-0; Boersma P., 2013, PRAAT DOING PHONETIC; Boulenger V, 2010, SPEECH COMMUN, V52, P246, DOI 10.1016/j.specom.2009.11.002; Bradlow A, 2010, SPEECH COMMUN, V52, P930, DOI 10.1016/j.specom.2010.06.003; Bronkhorst AW, 2000, ACUSTICA, V86, P117; Brouwer S, 2012, J ACOUST SOC AM, V131, P1449, DOI 10.1121/1.3675943; Brungart DS, 2001, J ACOUST SOC AM, V110, P2527, DOI 10.1121/1.1408946; Calandruccio L, 2010, J SPEECH LANG HEAR R, V53, P1458, DOI 10.1044/1092-4388(2010/09-0210); Calandruccio L, 2010, J ACOUST SOC AM, V128, P860, DOI 10.1121/1.3458857; Cooke M, 2008, J ACOUST SOC AM, V123, P414, DOI 10.1121/1.2804952; Felty RA, 2009, J ACOUST SOC AM, V125, pEL93, DOI 10.1121/1.3073733; FESTEN JM, 1990, J ACOUST SOC AM, V88, P1725, DOI 10.1121/1.400247; Forster KI, 2003, BEHAV RES METH INS C, V35, P116, DOI 10.3758/BF03195503; Halle PA, 1999, J PHONETICS, V27, P281, DOI 10.1006/jpho.1999.0097; Hoen M, 2007, SPEECH COMMUN, V49, P905, DOI 10.1016/j.specom.2007.05.008; LANGHANS A, 1992, J ACOUST SOC AM, V91, P3456, DOI 10.1121/1.402834; Lecumberri MLG, 2006, J ACOUST SOC AM, V119, P2445, DOI 10.1121/1.2180210; Luce PA, 1998, EAR HEARING, V19, P1, DOI 10.1097/00003446-199802000-00001; MarslenWilson W, 1996, J EXP PSYCHOL HUMAN, V22, P1376, DOI 10.1037/0096-1523.22.6.1376; McClelland JL, 1986, COGNITIVE PSYCHOL, V8, P1; New B, 2004, BEHAV RES METH INS C, V36, P516, DOI 10.3758/BF03195598; NORRIS D, 1994, COGNITION, V52, P189, DOI 10.1016/0010-0277(94)90043-4; POLLACK I, 1975, J ACOUST SOC AM, V57, pS5, DOI 10.1121/1.1995329; Reel LA, 2012, J SPEECH LANG HEAR R, V55, P89, DOI 10.1044/1092-4388(2011/10-0193); Rhebergen KS, 2005, J ACOUST SOC AM, V118, P1274, DOI 10.1121/1.2000751; Simpson SA, 2005, J ACOUST SOC AM, V118, P2775, DOI 10.1121/1.2062650; Spinelli E, 2010, ATTEN PERCEPT PSYCHO, V72, P775, DOI 10.3758/APP.72.3.775; STUDEBAKER GA, 1985, J SPEECH HEAR RES, V28, P455, DOI 10.1044/jshr.2803.455; Van Engen KJ, 2007, J ACOUST SOC AM, V121, P519, DOI 10.1121/1.2400666	29	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65668	10.1371/journal.pone.0065668	http://dx.doi.org/10.1371/journal.pone.0065668			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	163FW	23785442	gold, Green Submitted, Green Published			2022-12-27	WOS:000320322400042
J	Li, M; Zhang, H; Luo, XJ; Gao, L; Qi, XB; Gourraud, PA; Su, B				Li, Ming; Zhang, Hui; Luo, Xiong-jian; Gao, Lei; Qi, Xue-bin; Gourraud, Pierre-Antoine; Su, Bing			Meta-Analysis Indicates That the European GWAS-Identified Risk SNP rs1344706 within ZNF804A Is Not Associated with Schizophrenia in Han Chinese Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; COMMON VARIANTS; SUSCEPTIBILITY; GENE	Recent genetic association studies have implicated several candidate susceptibility variants for schizophrenia among general populations. Rs1344706, an intronic SNP within ZNF804A, was identified as one of the most compelling candidate risk SNPs for schizophrenia in Europeans through genome-wide association studies (GWASs) and replications as well as large-scale meta-analyses. However, in Han Chinese, the results for rs1344706 are inconsistent, and whether rs1344706 is an authentic risk SNP for schizophrenia in Han Chinese is inconclusive. Here, we conducted a systematic meta-analysis of rs1344706 with schizophrenia in Chinese population by combining all available case-control samples (N = 12), including a total of 8,982 cases and 12,342 controls. The results of our meta-analysis were not able to confirm an association of rs1344706 A-allele with schizophrenia (p = 0.10, odds ratio = 1.06, 95% confidence interval = 0.99-1.13). Such absence of association was further confirmed by the non-superiority test (p = 0.0003), suggesting that rs1344706 is not a risk SNP for schizophrenia in Han Chinese. Detailed examinations of individual samples revealed potential sampling bias in previous replication studies in Han Chinese. The absence of rs1344706 association in Han Chinese suggest a potential genetic heterogeneity in the susceptibility of schizophrenia on this locus and also demonstrate the difficulties in replicating genome-wide association findings of schizophrenia across different ethnic populations.	[Li, Ming; Zhang, Hui; Qi, Xue-bin; Su, Bing] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Yunnan, Peoples R China; [Luo, Xiong-jian] Univ Rochester, Flaum Eye Inst, Rochester, NY USA; [Gao, Lei] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China; [Gourraud, Pierre-Antoine] Univ Calif San Francisco, Sch Med, Dept Neurol, San Francisco, CA USA; [Li, Ming; Gao, Lei] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; University of Rochester; Chinese Academy of Sciences; Institute of Psychology, CAS; University of California System; University of California San Francisco; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Su, B (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Yunnan, Peoples R China.	sub@mail.kiz.ac.cn	Gourraud, Pierre-Antoine FD/O-3024-2015; Xuebin, Qi/L-7139-2019	Gourraud, Pierre-Antoine/0000-0003-1131-9554	National 973 project of China [2011CBA00401]; National Natural Science Foundation of China [U1202225, 31130051, 31071101]	National 973 project of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National 973 project of China (grant numbers, 2011CBA00401) and the National Natural Science Foundation of China (U1202225, 31130051 and 31071101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Chen M, 2012, NEUROPSYCHOPHARMACOL, V37, P1572, DOI 10.1038/npp.2012.1; DUPONT WD, 1990, CONTROL CLIN TRIALS, V11, P116, DOI 10.1016/0197-2456(90)90005-M; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Gourraud PA, 2011, GENET EPIDEMIOL, V35, P568, DOI 10.1002/gepi.20592; Li M, 2012, SCHIZOPHR RES, V142, P200, DOI 10.1016/j.schres.2012.10.008; Li M, 2013, WORLD J BIOL PSYCHIA, V14, P91, DOI 10.3109/15622975.2011.587891; Li M, 2012, AM J MED GENET B, V159B, P794, DOI 10.1002/ajmg.b.32084; Li T, 2010, BIOL PSYCHIAT, V68, P671, DOI 10.1016/j.biopsych.2010.06.014; Lichtenstein P, 2006, PSYCHOL MED, V36, P1417, DOI 10.1017/S0033291706008385; Liou YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033598; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; Owen MJ, 2010, ARCH GEN PSYCHIAT, V67, P667, DOI 10.1001/archgenpsychiatry.2010.69; Pagel T, 2013, ACTA PSYCHIAT SCAND, V128, P238, DOI 10.1111/acps.12109; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Rietschel M, 2012, MOL PSYCHIATR, V17, P906, DOI 10.1038/mp.2011.80; Riley B, 2010, MOL PSYCHIATR, V15, P29, DOI 10.1038/mp.2009.109; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Saha S, 2005, PLOS MED, V2, P413, DOI 10.1371/journal.pmed.0020141; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Shi YY, 2011, NAT GENET, V43, P1224, DOI 10.1038/ng.980; Shifman S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040028; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Steinberg S, 2011, MOL PSYCHIATR, V16, P59, DOI 10.1038/mp.2009.149; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; WILLIAMS H, 2011, TLS TIMES LIT S 0114, P16; Williams HJ, 2009, BRIT MED BULL, V91, P61, DOI 10.1093/bmb/ldp017; Xiao B, 2011, PSYCHIAT RES, V190, P379, DOI 10.1016/j.psychres.2011.05.031; Xu SH, 2009, AM J HUM GENET, V85, P762, DOI 10.1016/j.ajhg.2009.10.015; Yue WH, 2011, NAT GENET, V43, P1228, DOI 10.1038/ng.979; Zhang FY, 2011, BIOL PSYCHIAT, V69, P914, DOI 10.1016/j.biopsych.2011.01.003; Zhang R, 2011, MOL PSYCHIATR, V16, P360, DOI 10.1038/mp.2010.55; Zhong R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028839	36	20	21	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65780	10.1371/journal.pone.0065780	http://dx.doi.org/10.1371/journal.pone.0065780			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776546	Green Published, Green Submitted, gold			2022-12-27	WOS:000320322400055
J	Nguyen, DTK; Leung, KK; McIntyre, L; Ghali, WA; Sauve, R				Nguyen, Duyen Thi Kim; Leung, Karen K.; McIntyre, Lynn; Ghali, William A.; Sauve, Reg			Does Integrated Management of Childhood Illness (IMCI) Training Improve the Skills of Health Workers? A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							QUALITY-OF-CARE; PUBLIC-HEALTH; SICK CHILDREN; MULTICOUNTRY EVALUATION; NATIONAL CAUSES; UNDER-FIVES; ALMA-ATA; MORTALITY; SURVIVAL; IMPACT	Background: An estimated 6.9 million children die annually in low and middle-income countries because of treatable illneses including pneumonia, diarrhea, and malaria. To reduce morbidity and mortality, the Integrated Management of Childhood Illness strategy was developed, which included a component to strengthen the skills of health workers in identifying and managing these conditions. A systematic review and meta-analysis were conducted to determine whether IMCI training actually improves performance. Methods: Database searches of CIHAHL, CENTRAL, EMBASE, Global Health, Medline, Ovid Healthstar, and PubMed were performed from 1990 to February 2013, and supplemented with grey literature searches and reviews of bibliographies. Studies were included if they compared the performance of IMCI and non-IMCI health workers in illness classification, prescription of medications, vaccinations, and counseling on nutrition and admistration of oral therapies. Dersminion-Laird random effect models were used to summarize the effect estimates. Results: The systematic review and meta-analysis included 46 and 26 studies, respectively. Four cluster-randomized controlled trials, seven pre-post studies, and 15 cross-sectional studies were included. Findings were heterogeneous across performance domains with evidence of effect modification by health worker performance at baseline. Overall, IMCI-trained workers were more likely to correctly classify illnesses (RR = 1.93, 95% CI: 1.66-2.24). Studies of workers with lower baseline performance showed greater improvements in prescribing medications (RR = 3.08, 95% CI: 2.04-4.66), vaccinating children (RR = 3.45, 95% CI: 1.49-8.01), and counseling families on adequate nutrition (RR = 10.12, 95% CI: 6.03-16.99) and administering oral therapies (RR = 3.76, 95% CI: 2.30-6.13). Trends toward greater training benefits were observed in studies that were conducted in lower resource settings and reported greater supervision. Conclusion: Findings suggest that IMCI training improves health worker performance. However, these estimates need to be interpreted cautiously given the observational nature of the studies and presence of heterogeneity.	[Nguyen, Duyen Thi Kim; Leung, Karen K.; McIntyre, Lynn; Ghali, William A.; Sauve, Reg] Univ Calgary, Fac Med, Dept Community Hlth Sci, Calgary, AB T2N 1N4, Canada; [Nguyen, Duyen Thi Kim; McIntyre, Lynn] Univ Calgary, Populat Hlth & Inequ Res Ctr, Calgary, AB T2N 1N4, Canada; [Nguyen, Duyen Thi Kim; McIntyre, Lynn] Univ Calgary, Populat Hlth Intervent Res Network, Calgary, AB T2N 1N4, Canada; [Leung, Karen K.] Univ Alberta, Fac Med, Dept Family Med, Edmonton, AB T6G 2M7, Canada; [Ghali, William A.] Univ Calgary, Fac Med, Dept Med, Calgary, AB T2N 1N4, Canada; [McIntyre, Lynn; Ghali, William A.] Univ Calgary, Inst Publ Hlth, Calgary, AB T2N 1N4, Canada; [Sauve, Reg] Univ Calgary, Fac Med, Dept Paediat, Calgary, AB T2N 1N4, Canada	University of Calgary; University of Calgary; University of Calgary; University of Alberta; University of Calgary; University of Calgary; University of Calgary	Nguyen, DTK (corresponding author), Univ Calgary, Fac Med, Dept Community Hlth Sci, Calgary, AB T2N 1N4, Canada.	duyen.thi.nguyen@gmail.com		Blair, Mitch/0000-0001-7442-0188	Canadian Institutes of Health Research (CIHR) Population Health Intervention Research Centre (PHIRC) Doctoral Scholarship; CIHR Population Health Intervention Research Network (PHIRNET) Doctoral Scholarship; Queen Elizabeth II Doctoral Award; CIHR Master's Canada Graduate Scholarship; Nat Christie Foundation Medical Entrance Award; CIHR Chair in Gender and Health; Alberta Innovates Health Solutions (AIHS) Senior Health Scholar Award; CIHR; AIHS	Canadian Institutes of Health Research (CIHR) Population Health Intervention Research Centre (PHIRC) Doctoral Scholarship(Canadian Institutes of Health Research (CIHR)); CIHR Population Health Intervention Research Network (PHIRNET) Doctoral Scholarship(Canadian Institutes of Health Research (CIHR)); Queen Elizabeth II Doctoral Award; CIHR Master's Canada Graduate Scholarship(Canadian Institutes of Health Research (CIHR)); Nat Christie Foundation Medical Entrance Award; CIHR Chair in Gender and Health(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Health Solutions (AIHS) Senior Health Scholar Award; CIHR(Canadian Institutes of Health Research (CIHR)); AIHS	DTKN's work was supported by the Canadian Institutes of Health Research (CIHR) Population Health Intervention Research Centre (PHIRC) Doctoral Scholarship, CIHR Population Health Intervention Research Network (PHIRNET) Doctoral Scholarship, and Queen Elizabeth II Doctoral Award. KKL's work was supported by the CIHR Master's Canada Graduate Scholarship and the Nat Christie Foundation Medical Entrance Award. LM is supported by a CIHR Chair in Gender and Health. WAG is supported by Alberta Innovates Health Solutions (AIHS) Senior Health Scholar Award. RS is supported by CIHR and AIHS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed HM, 2010, HEALTH POLICY, V96, P128, DOI 10.1016/j.healthpol.2010.01.013; Altman DG, 2002, BMC MED RES METHODOL, V2; Amaral J, 2005, HEALTH POLICY PLANN, V20, pI42, DOI 10.1093/heapol/czi058; Amaral J, 2002, MANEJO CASOS A UNPUB; Amaral João Joaquim Freitas do, 2008, Rev. Bras. Saude Mater. Infant., V8, P151, DOI 10.1590/S1519-38292008000200002; Amaral João, 2004, Cad. Saúde Pública, V20, pS209, DOI 10.1590/S0102-311X2004000800016; Anand K, 2004, J TROP PEDIATRICS, V50, P41, DOI 10.1093/tropej/50.1.41; Anand S, 2004, LANCET, V364, P1603, DOI 10.1016/S0140-6736(04)17313-3; Anand S, 2007, LANCET, V369, P1277, DOI 10.1016/S0140-6736(07)60599-6; [Anonymous], 2013, COMMUNICATION; Arifeen S, 2000, HLTH FACILITY UNPUB, pxxv; Arifeen SE, 2005, B WORLD HEALTH ORGAN, V83, P260; Arifeen SE, 2009, LANCET, V374, P393, DOI 10.1016/S0140-6736(09)60828-X; BERLIN JA, 1995, AM J EPIDEMIOL, V142, P383, DOI 10.1093/oxfordjournals.aje.a117645; Bhutta ZA, 2008, LANCET, V372, P972, DOI 10.1016/S0140-6736(08)61407-5; Bhutta ZA, 2013, LANCET, V381, P1417, DOI 10.1016/S0140-6736(13)60648-0; Binkin N, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-456; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Briggs J, 2002, SENEGAL ASSESS UNPUB; Bryce J, 2005, HEALTH POLICY PLANN, V20, pI5, DOI 10.1093/heapol/czi055; Bryce J, 2004, AM J PUBLIC HEALTH, V94, P406, DOI 10.2105/AJPH.94.3.406; Bryce J, 2003, LANCET, V362, P159, DOI 10.1016/S0140-6736(03)13870-6; Burnham GM, 1997, EVALUATION INT UNPUB; Campbell H, 1996, ARCH DIS CHILD, V75, P468, DOI 10.1136/adc.75.6.468; Choi M, 2003, ASSESSMENT CHI UNPUB; Chopra M, 2005, ARCH DIS CHILD, V90, P397, DOI 10.1136/adc.2004.059147; Chopra M, 2013, LANCET; Chopra M, 2012, ARCH DIS CHILD, V97, P350, DOI 10.1136/archdischild-2011-301191; Cochrane-EPOC-Group, 2002, DAT EXTR FORM EPOC R; Cochrane-EPOC-Group, 2002, DAT COLL CHECKL; COLDITZ GA, 1995, AM J EPIDEMIOL, V142, P371, DOI 10.1093/oxfordjournals.aje.a117644; Degbey H, 2005, B D INFORM BUREAU RE, V40, P6; Des Jarlais DC, 2004, AM J PUBLIC HEALTH, V94, P361, DOI 10.2105/AJPH.94.3.361; Dieleman Marjolein, 2009, Health Res Policy Syst, V7, P7, DOI 10.1186/1478-4505-7-7; Donner A, 2002, STAT MED, V21, P2971, DOI 10.1002/sim.1301; Dzayisse YA, 2006, ARCH PEDIATRIE, V13, P1552, DOI 10.1016/j.arcped.2006.09.012; Egger M., 2001, SYSTEMATIC REV HLTH; El Arifeen S, 2004, LANCET, V364, P1595, DOI 10.1016/S0140-6736(04)17312-1; El Mahalli AA, 2011, J FAM COMMUNITY MED, V18, P118, DOI 10.4103/2230-8229.90010; Eshaghi SR, 2012, J ISFAHAN MED SCH, V30, P1048; FMOH-Sudan, 2004, WHOEMCAH013EG0204500; GALBRAITH RF, 1988, STAT MED, V7, P889, DOI 10.1002/sim.4780070807; Gill CJ, 2013, LANCET; Gillam S, 2008, BMJ-BRIT MED J, V336, P536, DOI 10.1136/bmj.39469.432118.AD; Gilroy K, 2004, PATIENT EDUC COUNS, V54, P35, DOI 10.1016/s0738-3991(03)00189-7; Goga Ameena E, 2009, Health Res Policy Syst, V7, P18, DOI 10.1186/1478-4505-7-18; Gouws E, 2004, B WORLD HEALTH ORGAN, V82, P509; Haines A, 2007, LANCET, V369, P2121, DOI 10.1016/S0140-6736(07)60325-0; Harbord RM, 2008, STATA J, V8, P493, DOI 10.1177/1536867X0800800403; Herrero C, 2012, J HUM DEV CAPABIL, V13, P247, DOI 10.1080/19452829.2011.645027; Higgins JPT, 2022, COCHRANE HDB SYSTEMA, DOI DOI 10.1002/9781119536604; Huicho L, 2005, HEALTH POLICY PLANN, V20, P14, DOI 10.1093/heapol/czi002; Huicho L, 2008, LANCET, V372, P910, DOI 10.1016/S0140-6736(08)61401-4; Jackson N, 2005, HEALTH PROMOT INT, V20, P367, DOI 10.1093/heapro/dai022; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Kallander K, 2004, ACTA TROP, V90, P211, DOI 10.1016/j.actatropica.2003.11.013; Kristensen I, 2000, BRIT MED J, V321, P1435, DOI 10.1136/bmj.321.7274.1435; Laird N M, 1990, Int J Technol Assess Health Care, V6, P5; Lambrechts T, 2003, ANAL REV INTEGRATED; Lau J, 1998, LANCET, V351, P123, DOI 10.1016/S0140-6736(97)08468-7; Lee LA, 2001, EFFECTIVENESS UNPUB; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Mansouri M, 2007, J CONTIN EDUC HEALTH, V27, P6, DOI 10.1002/chp.88; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; Mathers C, 2010, PLOS MED, V7; Mbuya C, 2003, IMCI IMPLEMENT UNPUB; McMichael C, 2005, J PUBLIC HEALTH-UK, V27, P215, DOI 10.1093/pubmed/fdi024; Mehari M, 2000, PREPAREDNESS E UNPUB; Meremikwu M, 2009, MATERNAL AND CHILD HEALTH: GLOBAL CHALLENGES, PROGRAMS AND POLICIES, P497, DOI 10.1007/b106524_27; Mgalula L, 2000, ACTIVITIES MET UNPUB; MOH-Peru, 2000, EV SERV SAL SE UNPUB; MOH-VietNam, 2002, IMCI HLTH FAC SURV V; Mushi HP, 2011, HEALTH POLICY PLANN, V26, P395, DOI 10.1093/heapol/czq068; Naimoli JF, 2006, INT J QUAL HEALTH C, V18, P134, DOI 10.1093/intqhc/mzi097; Naimoli JF, 2000, PREL RES EV MA UNPUB; Naimoli JF, 2001, THESIS HARVARD U CAM; Osterholt DM, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-77; Pariyo GW, 2005, HEALTH POLICY PLANN, V20, pI58, DOI 10.1093/heapol/czi051; Pawson Ray, 2005, J Health Serv Res Policy, V10 Suppl 1, P21, DOI 10.1258/1355819054308530; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; Rakha MA, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001852; Rathmony H, 2006, CAMBODIA HLTH UNPUB; Rehlis N, 2007, HLTH FACILITY UNPUB; Rehlis N, 2003, FINAL REPORT E UNPUB; Rosenthal R, 2001, ANNU REV PSYCHOL, V52, P59, DOI 10.1146/annurev.psych.52.1.59; Rowe AK, 2005, LANCET, V366, P1026, DOI 10.1016/S0140-6736(05)67028-6; Rowe AK, 2001, AM J PUBLIC HEALTH, V91, P1625, DOI 10.2105/AJPH.91.10.1625; Rowe AK, 2012, HEALTH POLICY PLANN, V27, P179, DOI 10.1093/heapol/czr033; Rowe AK, 2012, TROP MED INT HEALTH, V17, P438, DOI 10.1111/j.1365-3156.2012.02976.x; Rowe AK, 2011, AM J PUBLIC HEALTH, V101, P2333, DOI 10.2105/AJPH.2010.300068; Rowe AK, 2009, AM J PUBLIC HEALTH, V99, P837, DOI 10.2105/AJPH.2008.134411; Rychetnik L, 2002, J EPIDEMIOL COMMUN H, V56, P119, DOI 10.1136/jech.56.2.119; Salgado R, 2002, HLTH FACILITY UNPUB; Santos I, 2001, J NUTR, V131, P2866, DOI 10.1093/jn/131.11.2866; Schellenberg JA, 2004, HEALTH POLICY PLANN, V19, P1, DOI 10.1093/heapol/czh001; Schellenberg JRMA, 2004, LANCET, V364, P1583, DOI 10.1016/S0140-6736(04)17311-X; STATA-Corp, 2012, STATA DAT AN STAT SO; Thompson S.G., 2001, SYSTEMATIC REV HLTH, P157; Travis P, 2004, LANCET, V364, P900, DOI 10.1016/S0140-6736(04)16987-0; Tulloch J., 1999, Lancet (British edition), V354, P16, DOI 10.1016/S0140-6736(99)90252-0; UNDP, 2012, INT HUM DEV IND HDI; UNICEF, 2011, LEV TRENDS CHILD MOR; Uzochukwu BSC, 2008, PUBLIC HEALTH, V122, P367, DOI 10.1016/j.puhe.2007.07.001; Victora CG, 2005, HEALTH POLICY PLANN, V20, pI18, DOI 10.1093/heapol/czi050; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Wang JH, 2011, CHINESE J CHILD HLTH, V19, P187; WHO, 2003, HLTH FAC SURV TOOL E; WHO-EMRO, 2004, IMPL IMCI SUD SYST A; Winfrey W, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S32; Zaman S, 2008, J HEALTH POPUL NUTR, V26, P210; Zhang YF, 2007, J PAEDIATR CHILD H, V43, P681, DOI 10.1111/j.1440-1754.2007.01187.x	113	44	44	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66030	10.1371/journal.pone.0066030	http://dx.doi.org/10.1371/journal.pone.0066030			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	163FW	23776599	Green Published, Green Submitted, gold			2022-12-27	WOS:000320322400071
J	Alt, KW; Benz, M; Muller, W; Berner, ME; Schultz, M; Schmidt-Schultz, TH; Knipper, C; Gebel, HGK; Nissen, HJ; Vach, W				Alt, Kurt W.; Benz, Marion; Mueller, Wolfgang; Berner, Margit E.; Schultz, Michael; Schmidt-Schultz, Tyede H.; Knipper, Corina; Gebel, Hans-Georg K.; Nissen, Hans J.; Vach, Werner			Earliest Evidence for Social Endogamy in the 9,000-Year-Old-Population of Basta, Jordan	PLOS ONE			English	Article							DENTAL AGENESIS; KINSHIP; HYPODONTIA; POPULATION; GENETICS; BURIAL; FAMILY; MSX1	The transition from mobile to sedentary life was one of the greatest social challenges of the human past. Yet little is known about the impact of this fundamental change on social interactions amongst early Neolithic communities, which are best recorded in the Near East. The importance of social processes associated with these economic and ecological changes has long been underestimated. However, ethnographic observations demonstrate that generalized reciprocity - such as open access to resources and land - had to be reduced to a circumscribed group before regular farming and herding could be successfully established. Our aim was thus to investigate the role of familial relationships as one possible factor within this process of segregation as recorded directly in the skeletal remains, rather than based on hypothetical correlations such as house types and social units. Here we present the revealing results of the systematically recorded epigenetic characteristics of teeth and skulls of the late Pre-Pottery Neolithic community of Basta in Southern Jordan (Figure S1). Additionally, mobility was reconstructed via a systematic strontium (Sr) isotope analysis of tooth enamel of the Basta individuals. The frequency of congenitally missing maxillary lateral incisors in the 9,000-year-old community of Basta is exceptionally high (35.7%). Genetic studies and a worldwide comparison of the general rate of this dental anomaly in modern and historic populations show that the enhanced frequency can only be explained by close familial relationships akin to endogamy. This is supported by strontium isotope analyses of teeth, indicating a local origin of almost all investigated individuals. Yet, the accompanying archaeological finds document far-reaching economic exchange with neighboring groups and a population density hitherto unparalleled. We thus conclude that endogamy in the early Neolithic village of Basta was not due to geographic isolation or a lack of exogamous mating partners but a socio-cultural choice.	[Alt, Kurt W.; Knipper, Corina] Johannes Gutenberg Univ Mainz, Dept Anthropol, D-55122 Mainz, Germany; [Benz, Marion] Univ Freiburg, Dept Near Eastern Archaeol, D-79106 Freiburg, Germany; [Mueller, Wolfgang] Royal Holloway Univ London, Dept Earth Sci, Egham, Surrey, England; [Berner, Margit E.] Museum Nat Hist, Dept Anthropol, Vienna, Austria; [Schultz, Michael] Univ Gottingen, Dept Anat, Gottingen, Germany; [Schmidt-Schultz, Tyede H.] Univ Gottingen, Dept Biochem, D-37073 Gottingen, Germany; [Gebel, Hans-Georg K.; Nissen, Hans J.] Free Univ Berlin, Dept Near Eastern Archaeol, Berlin, Germany; [Vach, Werner] Univ Freiburg, Univ Med Ctr, Inst Med Biometry & Med Informat, D-79106 Freiburg, Germany	Johannes Gutenberg University of Mainz; University of Freiburg; University of London; Royal Holloway University London; University of Gottingen; University of Gottingen; Free University of Berlin; University of Freiburg	Alt, KW (corresponding author), Johannes Gutenberg Univ Mainz, Dept Anthropol, D-55122 Mainz, Germany.	altkw@uni-mainz.de	Vach, Werner/F-2512-2011	Vach, Werner/0000-0003-1865-8399; Muller, Wolfgang/0000-0001-5368-8011	Elite Programme for Post-Docs of the Baden-Wurttemberg Stiftung; University of Freiburg	Elite Programme for Post-Docs of the Baden-Wurttemberg Stiftung; University of Freiburg	Financial support for this study was granted by the Elite Programme for Post-Docs of the Baden-Wurttemberg Stiftung and the University of Freiburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alt K. W., 1997, ODONTOLOGISCHE VERWA; ALT KW, 1995, FORENSIC SCI INT, V74, P99, DOI 10.1016/0379-0738(95)01740-A; Alt KW, 1996, HOMO, V46, P256; Alt KW, 1997, AM J PHYS ANTHROPOL, V102, P123, DOI 10.1002/(SICI)1096-8644(199701)102:1<123::AID-AJPA10>3.0.CO;2-2; Alt KW, 2005, JB RGZM, V52, P157; ALVESALO L, 1969, ACTA ODONTOL SCAND, V27, P563, DOI 10.3109/00016356909026309; [Anonymous], 2004, MONOGR FACUL ARCHAEO; [Anonymous], 2006, MONOGRAPH FACULTY AR; Arte S, 2001, J DENT RES, V80, P1445, DOI 10.1177/00220345010800051201; AS Bouwman, 2009, ANNU BRIT SCH ATHENS, V104, P293; Baird D., 2005, CATALHOYUK PERSPECTI, P55; Belfer-Cohen A., 1988, PALEORIENT, V14, P297, DOI DOI 10.3406/PALE0.1988.4476; Bentley RA, 2012, P NATL ACAD SCI USA, V109, P9326, DOI 10.1073/pnas.1113710109; Benz M, 2012, ELITES, V215, P169; Benz M, 2010, PPND PLATFORM PUBLIC; Benz M, 2010, LEVANT SUPPLEMENTARY, V8, P77; Bittles AH, 2010, ANNU REV ANTHROPOL, V39, P193, DOI 10.1146/annurev.anthro.012809.105051; Bittles A. H., 2012, CONSANGUINITY CONTEX; BROOK AH, 1984, ARCH ORAL BIOL, V29, P373, DOI 10.1016/0003-9969(84)90163-8; Dietrich O, 1932, FAMILIENFORSCHUNGEN; Fernandez E, 2006, SYRIA, V83, P107; Flannery KV, 2002, AM ANTIQUITY, V67, P417, DOI 10.2307/1593820; Gebel H.G.K., 2010, PRINCIPLE SHARING SE, P35; Gebel HGK, 2004, CENTRAL SETTLEMENTS, V5, P1; Gebel HGK, 2002, GRUNDZUGE SOZIALEN W; Hauptmann A, 2004, BASTA, V4, P169; Hermansen BD, 2004, MONOGRAPH FACULTY AR, V4, P117; JOHR ALBERT C., 1934, ARCH JULIUS KLAUS STIFT, V9, P73; Kamp U, 2004, MONOGRAPH FACULTY AR, V4, P53; MAHANEY MC, 1990, AM J PHYS ANTHROPOL, V82, P165, DOI 10.1002/ajpa.1330820205; Markovic M, 1982, Swed Dent J Suppl, V15, P153; Molleson TI, 2000, VILLAGE EUPHRATES, P533; Mostowska A, 2012, ARCH ORAL BIOL, V57, P790, DOI 10.1016/j.archoralbio.2012.01.003; Muller W, 2003, SCIENCE, V302, P862, DOI 10.1126/science.1089837; Nieminen P, 2009, J EXP ZOOL PART B, V312B, P320, DOI 10.1002/jez.b.21277; Pilloud MA, 2011, AM J PHYS ANTHROPOL, V145, P519, DOI 10.1002/ajpa.21520; Pinho T, 2010, J DENT RES, V89, P621, DOI 10.1177/0022034510364486; Pinho T, 2010, EUR J ORTHODONT, V32, P582, DOI 10.1093/ejo/cjp155; Polder BJ, 2004, COMMUNITY DENT ORAL, V32, P217, DOI 10.1111/j.1600-0528.2004.00158.x; Rohrer-Ertl O, 1978, NEOLITHISCHE REVOLUT; Schultz M, 2007, BAR INT SERIES, V1603, P82; Schulze C., 1987, ANOMALIEN MISSBILDUN; Shewan L, 2004, BAR INT SERIES, V1320, P55; Sholts SB, 2010, AM J PHYS ANTHROPOL, V143, P155, DOI 10.1002/ajpa.21343; Starck J, 1988, PREHISTORY JORDAN ST, V396, P137; SUAREZ BK, 1974, J DENT RES, V53, P781, DOI 10.1177/00220345740530040201; Thomsen SQ, 1952, AM J PHYS ANTHROP-NE, V10, P155, DOI 10.1002/ajpa.1330100214; Van Tuinen M, 2005, BRIT I ARCHAEOLOGY A, V38, P307; Vastardis H, 2000, AM J ORTHOD DENTOFAC, V117, P650, DOI 10.1016/S0889-5406(00)70173-9; WOOLF CM, 1971, AM J HUM GENET, V23, P289	50	17	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65649	10.1371/journal.pone.0065649	http://dx.doi.org/10.1371/journal.pone.0065649			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	169CU	23776517	gold, Green Published, Green Submitted			2022-12-27	WOS:000320755400052
J	Brown, MJ; Thacker, LR; Cohen, SA				Brown, Monique J.; Thacker, Leroy R.; Cohen, Steven A.			Association between Adverse Childhood Experiences and Diagnosis of Cancer	PLOS ONE			English	Article							ISCHEMIC-HEART-DISEASE; HOUSEHOLD DYSFUNCTION; SUBSTANCE-ABUSE; 5 STATES; RISK; SMOKING; ADULTS; DISORDERS; NEGLECT; WOMEN	Objective: Adverse childhood experiences (ACEs) are linked to multiple adverse health outcomes. This study examined the association between ACEs and cancer diagnosis. Methods: Data from the 2010 Behavioral Risk Factor Surveillance System (BRFSS) survey were used. The BRFSS is the largest ongoing telephone health survey, conducted in all US states, the District of Columbia, Puerto Rico, Guam and the U. S. Virgin Islands, and provides data on a variety of health issues among the non-institutionalized adult population. Principal component analysis (PCA) was used to derive components for ACEs. Multivariable logistic regression models were used to provide adjusted odds ratios (OR) and 95% confidence intervals (CI) for the association between ACE components and overall, childhood and adulthood cancer, adjusting for confounders such as age, gender, race/ethnicity, income, educational status, marital status, and insurance status. Results: Approximately 62% of respondents reported being exposed to ACEs and about one in ten respondents reported ever having been diagnosed with cancer. Component 1, which had the sexual abuse variables with the highest weights, was significantly associated with adulthood cancer (adjusted OR: 1.21; 95% CI: 1.03-1.43). Conclusion: The association between ACEs and adulthood cancer may be attributable to disease progression through association of ACEs with risk factors for other chronic diseases. More research should focus on the impact of sexual abuse ACEs and adverse health outcomes.	[Brown, Monique J.; Cohen, Steven A.] Virginia Commonwealth Univ, Sch Med, Dept Family Med & Populat Hlth, Richmond, VA 23284 USA; [Thacker, Leroy R.] Virginia Commonwealth Univ, Sch Med, Dept Biostat, Richmond, VA USA; [Thacker, Leroy R.] Virginia Commonwealth Univ, Sch Med, Ctr Clin & Translat Res, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Brown, MJ (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Family Med & Populat Hlth, Richmond, VA 23284 USA.	brownmj7@vcu.edu			National Institutes of Health (NIH) from the National Centers for Advancing Translational Sciences [UL1TR00058]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000058] Funding Source: NIH RePORTER	National Institutes of Health (NIH) from the National Centers for Advancing Translational Sciences; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Dr. Thacker's efforts on this research were supported in part by National Institutes of Health (NIH) Grant # UL1TR00058 from the National Centers for Advancing Translational Sciences. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	American Cancer Society, CANC PREV MAN PEOPL; Anda RF, 1999, JAMA-J AM MED ASSOC, V282, P1652, DOI 10.1001/jama.282.17.1652; Anda RF, 2008, AM J PREV MED, V34, P396, DOI 10.1016/j.amepre.2008.02.002; Anda RF, 2010, AM J PREV MED, V39, P93, DOI 10.1016/j.amepre.2010.03.015; [Anonymous], BREAST CANC STAT; BARKER DJP, 1986, LANCET, V1, P1077; Brown DW, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-20; Brown DW, 2009, AIDS, V23, P2231, DOI 10.1097/QAD.0b013e3283314769; Cambois E, 2011, EUR J PUBLIC HEALTH, V21, P667, DOI 10.1093/eurpub/ckq119; Centers for Disease Control and Prevention, PROST CANC RISK AG; Centers for Disease Control and Prevention, BEH RISK FACT SURV S; Centers for Disease Control and Prevention, 2010, BEH RISK FACT SURV S; Centers for Disease Control and Prevention (CDC), 2010, MMWR Morb Mortal Wkly Rep, V59, P1609; Centers for Disease Control and Prevention (CDC), CANC PREV CONTR CANC; Centers for Disease Control and Prevention (CDC), BREAST CANC RISK AG; Centers for Disease Control and Prevention (CDC), COL COL CANC RAT RAC; Centers for Disease Control and Prevention (CDC), CANC PREV CONTR CAN; Centers for Disease Control and Prevention (CDC), BRESAT CANC RAT RAC; Chapman DP, 2004, J AFFECT DISORDERS, V82, P217, DOI 10.1016/j.jad.2003.12.013; Dong M, 2003, CHILD ABUSE NEGLECT, V27, P625, DOI 10.1016/S0145-2134(03)00105-4; Dong MX, 2004, CIRCULATION, V110, P1761, DOI 10.1161/01.CIR.0000143074.54995.7F; Dong MX, 2004, CHILD ABUSE NEGLECT, V28, P771, DOI 10.1016/j.chiabu.2004.01.008; Dube SR, 2010, PREV CHRONIC DIS, V7; Dube SR, 2004, CHILD ABUSE NEGLECT, V28, P729, DOI 10.1016/j.chiabu.2003.08.009; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Ford ES, 2011, PREV MED, V53, P188, DOI 10.1016/j.ypmed.2011.06.015; Gupta V, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-72; Hillis SD, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.1.e11; Jewkes RK, 2010, CHILD ABUSE NEGLECT, V34, P833, DOI 10.1016/j.chiabu.2010.05.002; Jun HJ, 2008, J ADOLESCENT HEALTH, V43, P55, DOI 10.1016/j.jadohealth.2007.12.003; Kelly-Irving M., 2012, INT J PUBLIC HLTH; Klein H, 2007, CHILD ABUSE NEGLECT, V31, P39, DOI 10.1016/j.chiabu.2006.08.005; Lanoue M, 2012, COMMUNITY MENT HLTH; LaNoue M, 2012, COMMUNITY MENT HLT J, V48, P187, DOI 10.1007/s10597-010-9369-2; Mock SE, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2010.00246; Oladeji BD, 2010, BRIT J PSYCHIAT, V196, P186, DOI 10.1192/bjp.bp.109.063677; Pickles A, 2010, PSYCHOL MED, V40, P1453, DOI 10.1017/S0033291709991905; Slopen N, 2012, PSYCHONEUROENDOCRINO; Stavrou E, 2011, CANCER EPIDEMIOL, V35, pE75, DOI 10.1016/j.canep.2011.02.005; Strine TW, 2012, AM J HEALTH BEHAV, V36, P408, DOI 10.5993/AJHB.36.3.11; U.S. Census Bureau, 2010 CENS PROF GEN P; van der Meer LB, 2012, CLIN GENET, V81, P18, DOI 10.1111/j.1399-0004.2011.01778.x; Vander Weg MW, 2011, NICOTINE TOB RES, V13, P616, DOI 10.1093/ntr/ntr023; Wu NS, 2010, ADDICT BEHAV, V35, P68, DOI 10.1016/j.addbeh.2009.09.003	44	104	104	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65524	10.1371/journal.pone.0065524	http://dx.doi.org/10.1371/journal.pone.0065524			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	169CU	23776494	Green Published, gold			2022-12-27	WOS:000320755400037
J	Fleuchot, B; Guillot, A; Mezange, C; Besset, C; Chambellon, E; Monnet, V; Gardan, R				Fleuchot, Betty; Guillot, Alain; Mezange, Christine; Besset, Colette; Chambellon, Emilie; Monnet, Veronique; Gardan, Rozenn			Rgg-Associated SHP Signaling Peptides Mediate Cross-Talk in Streptococci	PLOS ONE			English	Article							QUORUM-SENSING SYSTEM; SEX-PHEROMONE; GENOME SEQUENCE; MOLECULAR-BASIS; COMPETENCE; SPECIFICITY; IDENTIFICATION; THERMOPHILUS; POLYMORPHISM; AGALACTIAE	We described a quorum-sensing mechanism in the streptococci genus involving a short hydrophobic peptide (SHP), which acts as a pheromone, and a transcriptional regulator belonging to the Rgg family. The shp/rgg genes, found in nearly all streptococcal genomes and in several copies in some, have been classified into three groups. We used a genetic approach to evaluate the functionality of the SHP/Rgg quorum-sensing mechanism, encoded by three selected shp/rgg loci, in pathogenic and non-pathogenic streptococci. We characterized the mature form of each SHP pheromone by mass-spectrometry. We produced synthetic peptides corresponding to these mature forms, and used them to study functional complementation and cross-talk between these different SHP/Rgg systems. We demonstrate that a SHP pheromone of one system can influence the activity of a different system. Interestingly, this does not seem to be dependent on the SHP/Rgg group and cross-talk between pathogenic and non-pathogenic streptococci is observed.	[Fleuchot, Betty; Guillot, Alain; Mezange, Christine; Besset, Colette; Chambellon, Emilie; Monnet, Veronique; Gardan, Rozenn] INRA, MICALIS, UMR1319, Jouy En Josas, France; [Fleuchot, Betty; Guillot, Alain; Mezange, Christine; Besset, Colette; Chambellon, Emilie; Monnet, Veronique; Gardan, Rozenn] AgroParistech, UMR MICALIS, Jouy En Josas, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay	Gardan, R (corresponding author), INRA, MICALIS, UMR1319, Jouy En Josas, France.	rozenn.gardan@jouy.inra.fr	Monnet, Veronique/E-9022-2014	Monnet, Veronique/0000-0001-7438-5618	Institut National de la Recherche Agronomique (INRA); Ministere de l'Education Nationale de la Recherche et de la Technologie (MENRT); Ile de France regional council; CEMAGREF; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034933, R37DK041122] Funding Source: NIH RePORTER	Institut National de la Recherche Agronomique (INRA); Ministere de l'Education Nationale de la Recherche et de la Technologie (MENRT); Ile de France regional council(Region Ile-de-France); CEMAGREF; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the Institut National de la Recherche Agronomique (INRA) and the Ministere de l'Education Nationale de la Recherche et de la Technologie (MENRT). The PAPPSO platform received the financial support from the Ile de France regional council and from CEMAGREF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajdic D, 2002, P NATL ACAD SCI USA, V99, P14434, DOI 10.1073/pnas.172501299; Altstein M, 2004, PEPTIDES, V25, P1373, DOI 10.1016/j.peptides.2004.07.002; An FY, 1999, J BACTERIOL, V181, P5915, DOI 10.1128/JB.181.19.5915-5921.1999; An FY, 2002, J BACTERIOL, V184, P1880, DOI 10.1128/JB.184.7.1880-1887.2002; BISWAS I, 1993, J BACTERIOL, V175, P3628, DOI 10.1128/JB.175.11.3628-3635.1993; Bouillaut L, 2008, NUCLEIC ACIDS RES, V36, P3791, DOI 10.1093/nar/gkn149; Chandler JA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002272; Chandler JR, 2008, J BACTERIOL, V190, P1172, DOI 10.1128/JB.01327-07; Chen T., 2010, DATABASE, V2010; Claverys JP, 2006, ANNU REV MICROBIOL, V60, P451, DOI 10.1146/annurev.micro.60.080805.142139; DEBARBOUILLE M, 1990, J BACTERIOL, V172, P3966, DOI 10.1128/jb.172.7.3966-3973.1990; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Dubern JF, 2006, J BACTERIOL, V188, P2898, DOI 10.1128/JB.188.8.2898-2906.2006; Fleuchot B, 2011, MOL MICROBIOL, V80, P1102, DOI 10.1111/j.1365-2958.2011.07633.x; Fuqua C, 2002, NAT REV MOL CELL BIO, V3, P685, DOI 10.1038/nrm907; Gardan R, 2013, J BACTERIOL, V195, P1845, DOI 10.1128/JB.02196-12; Gardan R, 2009, J BACTERIOL, V191, P4647, DOI 10.1128/JB.00257-09; Gevers D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001377; Glaser P, 2002, MOL MICROBIOL, V45, P1499, DOI 10.1046/j.1365-2958.2002.03126.x; Gordon CP, 2012, J MED CHEM; Henry R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-223; Higgins D, 2012, FEMS MICROBIOL REV, V36, P131, DOI 10.1111/j.1574-6976.2011.00310.x; Ibrahim M, 2007, J BACTERIOL, V189, P8844, DOI 10.1128/JB.01057-07; Ibrahim M, 2007, MICROBIOL-SGM, V153, P3631, DOI 10.1099/mic.0.2007/006205-0; Jarraud S, 2000, J BACTERIOL, V182, P6517, DOI 10.1128/JB.182.22.6517-6522.2000; Ji GY, 1997, SCIENCE, V276, P2027, DOI 10.1126/science.276.5321.2027; KAWAMURA Y, 1995, INT J SYST BACTERIOL, V45, P406, DOI 10.1099/00207713-45-2-406; LaSarre B, 2012, MBIO, V3, DOI 10.1128/mBio.00333-12; Lazazzera BA, 2001, PEPTIDES, V22, P1519, DOI 10.1016/S0196-9781(01)00488-0; Letort C, 2001, J APPL MICROBIOL, V91, P1023, DOI 10.1046/j.1365-2672.2001.01469.x; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; Novick RP, 2008, ANNU REV GENET, V42, P541, DOI 10.1146/annurev.genet.42.110807.091640; Pozzi G, 1996, J BACTERIOL, V178, P6087, DOI 10.1128/jb.178.20.6087-6090.1996; Rocha-Estrada J, 2010, APPL MICROBIOL BIOT, V87, P913, DOI 10.1007/s00253-010-2651-y; Samen UM, 2006, INFECT IMMUN, V74, P5625, DOI 10.1128/IAI.00667-06; Schuster M, 2006, INT J MED MICROBIOL, V296, P73, DOI 10.1016/j.ijmm.2006.01.036; Slamti L, 2005, J BACTERIOL, V187, P1182, DOI 10.1128/JB.187.3.1182-1187.2005; Stefanic P, 2012, ENVIRON MICROBIOL, V14, P1378, DOI 10.1111/j.1462-2920.2012.02717.x; Tortosa P, 2001, J BACTERIOL, V183, P451, DOI 10.1128/JB.183.2.451-460.2001; Tran LSP, 2000, MOL MICROBIOL, V37, P1159, DOI 10.1046/j.1365-2958.2000.02069.x; Zadoks RN, 2004, J FOOD PROTECT, V67, P2644, DOI 10.4315/0362-028X-67.12.2644	41	33	34	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66042	10.1371/journal.pone.0066042	http://dx.doi.org/10.1371/journal.pone.0066042			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776602	Green Published, Green Submitted, gold			2022-12-27	WOS:000320755400104
J	Messaritakis, I; Christodoulou, V; Mazeris, A; Koutala, E; Vlahou, A; Papadogiorgaki, S; Antoniou, M				Messaritakis, Ippokratis; Christodoulou, Vasiliki; Mazeris, Apostolos; Koutala, Eleni; Vlahou, Antonia; Papadogiorgaki, Sevasti; Antoniou, Maria			Drug Resistance in Natural Isolates of Leishmania donovani s.l. Promastigotes Is Dependent of Pgp 170 Expression	PLOS ONE			English	Article							P-GLYCOPROTEIN GENE; MULTIDRUG-RESISTANCE; VISCERAL LEISHMANIASIS; ABC TRANSPORTERS; INFANTUM; AMPLIFICATION; PROTEIN; CYPRUS; TARENTOLAE; MEMBRANE	Resistance of pathogens to drugs is a growing concern regarding many diseases. Parasites like Leishmania, Plasmodium and Entamoeba histolytica; and neoplastic cells, present the multidrug-resistant phenotype rendering chemotherapy ineffective. The acquired resistance of Leishmania to antimony has generated intense research on the mechanisms involved but the question has not yet been resolved. To test the hypothesis that drug efflux in Leishmania, as measured by flow cytometry using the fluorescent dye Rhodamine-123, is largely dependent on the number of efflux pumps an isolate can express, the amount of Pgp 170 molecules was assessed in ten field isolates (5 "resistant'' and 5 "susceptible'') using: Western Blotting, Confocal and Transmission Electron Microscopy, and proteomics. Their survival after exposure to three antileishmanial drugs, in vitro, was evaluated and clinical data were compared to the in vitro results. All isolates were resistant to Glucantime but susceptible to Miltefosine, whilst Amphotericin B was more effective on the ``susceptible'' isolates. The MDR gene, expressing the transmembrane efflux pump Pgp 170, appears to play a key role in the phenomenon of drug resistance. When "susceptible'' versus "resistant'' parasites were compared, it was shown that the higher the number of Pgp 170 molecules the higher the Rhodamine-123 efflux from the parasite body and, when exposed to the drug, the number of efflux pumps increased. However, the rate of this increase was not linear and it is possible that there is a maximum number of Pgp 170 molecules an isolate can express. Nevertheless, the phenomenon is a complex one and other factors and proteins are involved in which the HSP-70 group proteins, detected in the "resistant'' isolates, may play a significant role.	[Messaritakis, Ippokratis; Christodoulou, Vasiliki; Antoniou, Maria] Univ Crete, Fac Med, Lab Clin Bacteriol Parasitol Zoonoses & Geog Med, Iraklion, Greece; [Christodoulou, Vasiliki; Mazeris, Apostolos] Vet Serv Cyprus, Nicosia, Cyprus; [Koutala, Eleni] Univ Crete, Fac Med, Lab Flow Cytometry, Iraklion, Greece; [Vlahou, Antonia] Acad Athens, Inst Biomed Res, Athens, Greece; [Papadogiorgaki, Sevasti] Univ Crete, Dept Biol, Vassilis Galanopoulos Electron Microscope Facil, Iraklion, Greece	University of Crete; University of Crete; Academy of Athens; University of Crete	Antoniou, M (corresponding author), Univ Crete, Fac Med, Lab Clin Bacteriol Parasitol Zoonoses & Geog Med, Iraklion, Greece.	antoniou@med.uoc.gr	Messaritakis, Ippokratis/H-6668-2019; Antoniou, Maria-Christina/GVT-7881-2022	Vlahou, Antonia/0000-0003-3284-5713; Messaritakis, Ippokratis/0000-0003-1877-500X	ELKE (Research Committee of the University of Crete) [2561/2007]	ELKE (Research Committee of the University of Crete)	The work was supported by the ELKE (Research Committee of the University of Crete, Grant No. 2561/2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Antoniou M, 2004, AM J TROP MED HYG, V71, P71, DOI 10.4269/ajtmh.2004.71.71; Antoniou M, 2008, LANCET INFECT DIS, V8, P6, DOI 10.1016/S1473-3099(07)70297-9; Assimon VA, 2013, CURR PHARM DESIGN, V19, P404; Basu JM, 2008, ANTIMICROB AGENTS CH, V52, P1080, DOI 10.1128/AAC.01196-07; CALLAHAN HL, 1991, J BIOL CHEM, V266, P18427; CHOW LMC, 1993, MOL BIOCHEM PARASIT, V60, P195, DOI 10.1016/0166-6851(93)90131-G; Coelho AC, 2007, ANTIMICROB AGENTS CH, V51, P3030, DOI 10.1128/AAC.00404-07; Croft SL, 2006, CLIN MICROBIOL REV, V19, P111, DOI 10.1128/CMR.19.1.111-126.2006; Cuervo P, 2007, MOL BIOCHEM PARASIT, V154, P6, DOI 10.1016/j.molbiopara.2007.03.013; Da Silva EC, 2008, PARASITOL LATINOAM, V70, P4; Delgadillo DM, 2002, MICROB DRUG RESIST, V8, P15, DOI 10.1089/10766290252913719; Dey S, 1996, P NATL ACAD SCI USA, V93, P2192, DOI 10.1073/pnas.93.5.2192; DEY S, 1994, MOL BIOCHEM PARASIT, V67, P49, DOI 10.1016/0166-6851(94)90095-7; Gouzelou E, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001507; GRAMICCIA M, 1992, ANN TROP MED PARASIT, V86, P613, DOI 10.1080/00034983.1992.11812717; Haralambous C, 2008, DIAGN MICR INFEC DIS, V60, P33, DOI 10.1016/j.diagmicrobio.2007.07.019; HENDERSON DM, 1992, MOL CELL BIOL, V12, P2855, DOI 10.1128/MCB.12.6.2855; HENDRICKSON N, 1993, MOL BIOCHEM PARASIT, V60, P53, DOI 10.1016/0166-6851(93)90028-V; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; HUGHES AL, 1994, MOL BIOL EVOL, V11, P899; Jha TK, 1998, BRIT MED J, V316, P1200, DOI 10.1136/bmj.316.7139.1200; Kamau SW, 2000, CYTOMETRY, V40, P353, DOI 10.1002/1097-0320(20000801)40:4&lt;353::AID-CYTO11&gt;3.0.CO;2-0; KATAKURA K, 1989, MOL BIOCHEM PARASIT, V34, P189, DOI 10.1016/0166-6851(89)90010-8; Koliou MG, 2008, J PEDIAT HEMATOL ONC, V30, P704, DOI 10.1097/MPH.0b013e31816916f6; Kumar A, 2010, BRIT J CLIN PHARMACO, V70, P609, DOI 10.1111/j.1365-2125.2010.03716.x; Lee GY, 1998, BIOL REPROD, V58, P330, DOI 10.1095/biolreprod58.2.330; LEMESRE JL, 1988, ACTA TROP, V45, P99; Leu JIJ, 2011, MOL CANCER RES, V9, P936, DOI 10.1158/1541-7786.MCR-11-0019; Leu JIJ, 2009, MOL CELL, V36, P15, DOI 10.1016/j.molcel.2009.09.023; LIGHTNER LK, 1983, AM J TROP MED HYG, V32, P296, DOI 10.4269/ajtmh.1983.32.296; Ling V, 1997, CANCER CHEMOTH PHARM, V40, pS3, DOI 10.1007/s002800051053; Mandal G, 2009, INDIAN J BIOCHEM BIO, V46, P86; MARY C, 2010, INT J MICROBIOL, V2010, DOI DOI 10.811155/812010/819060; Mazeris A, 2010, AM J TROP MED HYG, V82, P441, DOI 10.4269/ajtmh.2010.09-0282; Messaritakis I, 2010, EXP PARASITOL, V125, P384, DOI 10.1016/j.exppara.2010.03.006; OUELLETTE M, 1991, EMBO J, V10, P1009, DOI 10.1002/j.1460-2075.1991.tb08035.x; OUELLETTE M, 1990, EMBO J, V9, P1027, DOI 10.1002/j.1460-2075.1990.tb08206.x; Ouellette M W S, 2002, MOL MED PARASITOLOGY, P395; Purkait B, 2012, ANTIMICROB AGENTS CH, V56, P1031, DOI 10.1128/AAC.00030-11; Ravel C, 2006, INT J PARASITOL, V36, P1383, DOI 10.1016/j.ijpara.2006.06.019; RIORDAN JR, 1985, NATURE, V316, P817, DOI 10.1038/316817a0; RIOUX JA, 1990, ANN PARASIT HUM COMP, V65, P111, DOI 10.1051/parasite/1990653111; Roubelakis MG, 2007, STEM CELLS DEV, V16, P931, DOI 10.1089/scd.2007.0036; Schonian G, 2008, TRENDS PARASITOL, V24, P135, DOI 10.1016/j.pt.2007.12.006; SINGH AK, 1994, MOL BIOCHEM PARASIT, V66, P161, DOI 10.1016/0166-6851(94)90049-3; Singh R, 2010, INT J ANTIMICROB AG, V36, P50, DOI 10.1016/j.ijantimicag.2010.03.012; Sundar S, 2001, TROP MED INT HEALTH, V6, P849, DOI 10.1046/j.1365-3156.2001.00778.x; THAKUR CP, 1991, AM J TROP MED HYG, V45, P435, DOI 10.4269/ajtmh.1991.45.435; TWENTYMAN PR, 1994, EUR J CANCER, V30A, P1360, DOI 10.1016/0959-8049(94)90187-2; Vega VL, 2008, J IMMUNOL, V180, P4299, DOI 10.4049/jimmunol.180.6.4299; Vergnes B, 2007, MOL CELL PROTEOMICS, V6, P88, DOI 10.1074/mcp.M600319-MCP200; Yah CS, 2010, J COMPUT BIOL BIOINF, V2, P005	53	16	16	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65467	10.1371/journal.pone.0065467	http://dx.doi.org/10.1371/journal.pone.0065467			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776486	Green Submitted, Green Published, gold			2022-12-27	WOS:000320755400033
J	Sun, P; Wang, T; Zhou, YR; Liu, H; Jiang, HL; Zhu, WL; Wang, HY				Sun, Peng; Wang, Ting; Zhou, Yuren; Liu, Hong; Jiang, Hualiang; Zhu, Weiliang; Wang, Heyao			DC260126: A Small-Molecule Antagonist of GPR40 that Protects against Pancreatic beta-Cells Dysfunction in db/db Mice	PLOS ONE			English	Article							FREE FATTY-ACIDS; STIMULATED INSULIN-SECRETION; ENDOPLASMIC-RETICULUM STRESS; IMPAIRED GLUCOSE-TOLERANCE; IN-VIVO; ELEVATED GLUCOSE; RECEPTOR GPR40; DIABETIC MICE; ER STRESS; PALMITATE	G protein-coupled receptor 40 (GPR40) mediates both acute and chronic effects of free fatty acids (FFAs) on insulin secretion. However, it remains controversial whether inhibition of GPR40 would be beneficial in prevention of type 2 diabetes. This study is designed to evaluate the potential effects of DC260126, a small molecule antagonist of GPR40, on beta-cell function following administration of 10 mg/kg dose of DC260126 to obese diabetic db/db mice. Oral glucose tolerance test, glucose stimulated insulin secretion and insulin tolerance test were used to investigate the pharmacological effects of DC260126 on db/db mice after 21-days treatment. Immunohistochemistry and serum biochemical analysis were also performed in this study. Although no significant change of blood glucose levels was found in DC260126-treated mice, DC260126 significantly inhibited glucose stimulated insulin secretion, reduced blood insulin level and improved insulin sensitivity after 3 weeks administration in db/db mice. Moreover, DC260126 reduced the proinsulin/insulin ratio and the apoptotic rate of pancreatic beta-cells remarkably in DC260126-treated db/db mice compared to vehicle-treated mice (p<0.05, n = 8). The results suggest that although DC260126 could not provide benefit for improving hyperglycemia, it could protect against pancreatic b-cells dysfunction through reducing overload of beta-cells, and it increases insulin sensitivity possibly via alleviation of hyperinsulinemia in db/db mice.	[Sun, Peng; Wang, Ting; Zhou, Yuren; Liu, Hong; Jiang, Hualiang; Zhu, Weiliang; Wang, Heyao] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Zhu, WL (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 200031, Peoples R China.	wlzhu@mail.shcnc.ac.cn; hywang@mail.shcnc.ac.cn	Sun, Peng/AAU-2124-2021	Sun, Peng/0000-0002-7820-712X	National Nature Science Foundation of China [81072681]; National High Technology Research and Development Program of China (863 Program) [2007AA02Z301]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This work was supported by Grant from the National Nature Science Foundation of China (81072681), from the National High Technology Research and Development Program of China (863 Program) (2007AA02Z301). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaraviciene SM, 2008, CELL MOL LIFE SCI, V65, P2256, DOI 10.1007/s00018-008-8100-8; Bindom SM, 2010, DIABETES, V59, P2540, DOI 10.2337/db09-0782; Bjorklund A, 1999, DIABETES, V48, P1409, DOI 10.2337/diabetes.48.7.1409; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Burant CF, 2012, LANCET, V379, P1403, DOI 10.1016/S0140-6736(11)61879-5; Edfalk S, 2008, DIABETES, V57, P2280, DOI 10.2337/db08-0307; El-Assaad W, 2003, ENDOCRINOLOGY, V144, P4154, DOI 10.1210/en.2003-0410; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Giacca A, 2011, AM J PHYSIOL-ENDOC M, V300, pE255, DOI 10.1152/ajpendo.00416.2010; Gwiazda KS, 2009, AM J PHYSIOL-ENDOC M, V296, pE690, DOI 10.1152/ajpendo.90525.2008; Han MS, 2009, DIABETES, V58, P329, DOI 10.2337/db08-0080; Hu H, 2009, BIOCHEM BIOPH RES CO, V390, P557, DOI 10.1016/j.bbrc.2009.10.004; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Jeffrey KD, 2008, P NATL ACAD SCI USA, V105, P8452, DOI 10.1073/pnas.0711232105; Kahn BB, 1998, CELL, V92, P593, DOI 10.1016/S0092-8674(00)81125-3; KAHN SE, 1995, DIABETES, V44, P173, DOI 10.2337/diabetes.44.2.173; Kahn SE, 2001, J CLIN ENDOCR METAB, V86, P4047, DOI 10.1210/jc.86.9.4047; Kebede M, 2008, DIABETES, V57, P2432, DOI 10.2337/db08-0553; Lan H, 2008, DIABETES, V57, P2999, DOI 10.2337/db08-0596; Larsson H, 1999, J CLIN ENDOCR METAB, V84, P2068, DOI 10.1210/jc.84.6.2068; Latour MG, 2007, DIABETES, V56, P1087, DOI 10.2337/db06-1532; Martinez SC, 2008, DIABETES, V57, P846, DOI 10.2337/db07-0595; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mehran AE, 2012, CELL METAB, V16, P723, DOI 10.1016/j.cmet.2012.10.019; Nagasumi K, 2009, DIABETES, V58, P1067, DOI 10.2337/db08-1233; Nijpels G, 1996, DIABETOLOGIA, V39, P113; Nolan CJ, 2006, DIABETES, V55, pS16, DOI 10.2337/db06-S003; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Remizov O, 2003, MOL CELL ENDOCRINOL, V212, P1, DOI 10.1016/j.mce.2003.09.026; Rizzuto R, 2003, ONCOGENE, V22, P8619, DOI 10.1038/sj.onc.1207105; Salehi A, 2005, CELL TISSUE RES, V322, P207, DOI 10.1007/s00441-005-0017-z; Schnell S, 2007, MOL CELL ENDOCRINOL, V263, P173, DOI 10.1016/j.mce.2006.09.013; Shafrir E, 1996, DIABETES METAB, V22, P122; Shanik MH, 2008, DIABETES CARE, V31, pS262, DOI 10.2337/dc08-s264; Steneberg R, 2005, CELL METAB, V1, P245, DOI 10.1016/j.cmet.2005.03.007; Tan CP, 2008, DIABETES, V57, P2211, DOI 10.2337/db08-0130; Tikellis C, 2004, DIABETES, V53, P989, DOI 10.2337/diabetes.53.4.989; Tsujihata Y, 2011, J PHARMACOL EXP THER, V339, P228, DOI 10.1124/jpet.111.183772; Wilding JPH, 2007, DIABETIC MED, V24, P934, DOI 10.1111/j.1464-5491.2007.02186.x; Wu JW, 2012, J CELL BIOCHEM, V113, P1152, DOI 10.1002/jcb.23450; Zhang XD, 2010, BIOMED PHARMACOTHER, V64, P647, DOI 10.1016/j.biopha.2010.06.008	41	39	40	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66744	10.1371/journal.pone.0066744	http://dx.doi.org/10.1371/journal.pone.0066744			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776696	Green Published, gold, Green Submitted			2022-12-27	WOS:000320755400155
J	Vuyyuri, SB; Rinkinen, J; Worden, E; Shim, H; Lee, S; Davis, KR				Vuyyuri, Saleha B.; Rinkinen, Jacob; Worden, Erin; Shim, Hyekyung; Lee, Sukchan; Davis, Keith R.			Ascorbic Acid and a Cytostatic Inhibitor of Glycolysis Synergistically Induce Apoptosis in Non-Small Cell Lung Cancer Cells	PLOS ONE			English	Article							DOSE VITAMIN-C; HYDROGEN-PEROXIDE; SODIUM ASCORBATE; PHARMACOLOGICAL ASCORBATE; ENZYME-INHIBITORS; PANCREATIC-CANCER; REACTIVE OXYGEN; MELANOMA-CELLS; CULTURE-MEDIUM; UP-REGULATION	Ascorbic acid (AA) exhibits significant anticancer activity at pharmacologic doses achievable by parenteral administration that have minimal effects on normal cells. Thus, AA has potential uses as a chemotherapeutic agent alone or in combination with other therapeutics that specifically target cancer-cell metabolism. We compared the effects of AA and combinations of AA with the glycolysis inhibitor 3-(3-pyridinyl)-1-(4-pyridinyl)-2-propen-1-one (3-PO) on the viability of three non-small cell lung cancer (NSCLC) cell lines to the effects on an immortalized lung epithelial cell line. AA concentrations of 0.5 to 5 mM caused a complete loss of viability in all NSCLC lines compared to a <10% loss of viability in the lung epithelial cell line. Combinations of AA and 3-PO synergistically enhanced cell death in all NSCLC cell lines at concentrations well below the IC50 concentrations for each compound alone. A synergistic interaction was not observed in combination treatments of lung epithelial cells and combination treatments that caused a complete loss of viability in NSCLC cells had modest effects on normal lung cell viability and reactive oxygen species (ROS) levels. Combination treatments induced dramatically higher ROS levels compared to treatment with AA and 3-PO alone in NSCLC cells and combination-induced cell death was inhibited by addition of catalase to the medium. Analyses of DNA fragmentation, poly (ADP-ribose) polymerase cleavage, annexin V-binding, and caspase activity demonstrated that AA-induced cell death is caused via the activation of apoptosis and that the combination treatments caused a synergistic induction of apoptosis. These results demonstrate the effectiveness of AA against NSCLC cells and that combinations of AA with 3-PO synergistically induce apoptosis via a ROS-dependent mechanism. These results support further evaluation of pharmacologic concentrations of AA as an adjuvant treatment for NSCLC and that combination of AA with glycolysis inhibitors may be a promising therapy for the treatment of NSCLC.	[Vuyyuri, Saleha B.; Rinkinen, Jacob; Worden, Erin; Shim, Hyekyung; Davis, Keith R.] Owensboro Canc Res Program, Owensboro, KY USA; [Lee, Sukchan] Sungkyunkwan Univ, Coll Biotechnol & Bioengn, Dept Genet Engn, Suwon, South Korea; [Shim, Hyekyung; Davis, Keith R.] Univ Louisville, James Graham Brown Canc Ctr, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA	Sungkyunkwan University (SKKU); University of Louisville	Davis, KR (corresponding author), Owensboro Canc Res Program, Owensboro, KY USA.	keith.davis@louisville.edu	Davis, Keith/H-3242-2019	Davis, Keith/0000-0002-7432-8610	U.S. Army Medical Research & Materiel Command (USAMRMC); Telemedicine & Advanced Technology Research Center (TATRC) [W81XWH-09-2-0022]	U.S. Army Medical Research & Materiel Command (USAMRMC)(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Telemedicine & Advanced Technology Research Center (TATRC)	Portions of this project were made possible by a contract that was awarded and administered by the U.S. Army Medical Research & Materiel Command (USAMRMC) and the Telemedicine & Advanced Technology Research Center (TATRC), under Contract Number: W81XWH-09-2-0022. The views, opinions and/or findings contained in this research are those of the authors and do not necessarily reflect the views of the Department of Defense and should not be construed as an official DoD/Army position, policy or decision unless so designated by other documentation. No official endorsement should be made. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Akers LJ, 2011, LEUKEMIA RES, V35, P814, DOI 10.1016/j.leukres.2010.12.028; An SH, 2011, BMB REP, V44, P211, DOI 10.5483/BMBRep.2011.44.3.211; Atsumi T, 2002, CANCER RES, V62, P5881; Belin S, 2010, CURR GENOMICS, V11, P52, DOI 10.2174/138920210790217936; Belin S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004409; BRAM S, 1980, NATURE, V284, P629, DOI 10.1038/284629a0; Buzzai M, 2007, CANCER RES, V67, P6745, DOI 10.1158/0008-5472.CAN-06-4447; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Cardaci S, 2012, J BIOENERG BIOMEMBR; Chen P, 2011, FREE RADICAL BIO MED, V51, P681, DOI 10.1016/j.freeradbiomed.2011.05.031; Chen Q, 2005, P NATL ACAD SCI USA, V102, P13604, DOI 10.1073/pnas.0506390102; Chen Q, 2008, P NATL ACAD SCI USA, V105, P11105, DOI 10.1073/pnas.0804226105; Chen Q, 2007, P NATL ACAD SCI USA, V104, P8749, DOI 10.1073/pnas.0702854104; Cheong JH, 2011, MOL CANCER THER, V10, P2350, DOI 10.1158/1535-7163.MCT-11-0497; Cho D, 2003, MELANOMA RES, V13, P549, DOI 10.1097/00008390-200312000-00002; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Clem B, 2008, MOL CANCER THER, V7, P110, DOI 10.1158/1535-7163.MCT-07-0482; Clement MV, 2001, ANTIOXID REDOX SIGN, V3, P157, DOI 10.1089/152308601750100687; CREAGAN ET, 1979, NEW ENGL J MED, V301, P687, DOI 10.1056/NEJM197909273011303; DREWINKO B, 1976, CANCER BIOCHEM BIOPH, V1, P187; Du JA, 2010, CLIN CANCER RES, V16, P509, DOI 10.1158/1078-0432.CCR-09-1713; Duconge J, 2008, P R HEALTH SCI J, V27, P7; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Edinger AL, 2004, CURR OPIN CELL BIOL, V16, P663, DOI 10.1016/j.ceb.2004.09.011; Espey MG, 2011, FREE RADICAL BIO MED, V50, P1610, DOI 10.1016/j.freeradbiomed.2011.03.007; FENG J, 1977, IN VITRO CELL DEV B, V13, P91; Floridi A, 1998, BIOCHEM PHARMACOL, V56, P841, DOI 10.1016/S0006-2952(98)00054-9; Fromberg A, 2010, CANCER CHEMOTH PHARM, P1; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Ha YM, 2009, CANCER LETT, V277, P48, DOI 10.1016/j.canlet.2008.11.020; Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341; Harakeh S, 2007, ANTICANCER RES, V27, P289; Heaney ML, 2008, CANCER RES, V68, P8031, DOI 10.1158/0008-5472.CAN-08-1490; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hong SW, 2007, ONCOL REP, V18, P811; Hsieh BS, 2011, J NUTR BIOCHEM, V22, P234, DOI 10.1016/j.jnutbio.2010.01.009; Hsieh BS, 2010, J NUTR BIOCH; Kaya F, 2007, NEUROMUSCULAR DISORD, V17, P248, DOI 10.1016/j.nmd.2006.12.008; KIPP DE, 1990, J NUTR, V120, P185, DOI 10.1093/jn/120.2.185; Kurbacher CM, 1996, CANCER LETT, V103, P183, DOI 10.1016/0304-3835(96)04212-7; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Levine M, 2011, ADV NUTR, V2, P78, DOI 10.3945/an.110.000109; Levine M, 2009, FREE RADICAL BIO MED, V47, P27, DOI 10.1016/j.freeradbiomed.2009.04.001; Levy AG, 2012, INVEST NEW DRUG, V30, P191, DOI 10.1007/s10637-010-9551-y; Lin SY, 2006, MELANOMA RES, V16, P509, DOI 10.1097/01.cmr.0000232297.99160.9e; MA M, 1992, P NATL ACAD SCI USA, V89, P7924, DOI 10.1073/pnas.89.17.7924; Madhok BM, 2011, AM J CLIN ONCOL-CANC, V34, P628, DOI 10.1097/COC.0b013e3181e84dec; Mandl J, 2009, BRIT J PHARMACOL, V157, P1097, DOI 10.1111/j.1476-5381.2009.00282.x; Martin DS, 2001, APOPTOSIS, V6, P125, DOI 10.1023/A:1009692631748; Maschek G, 2004, CANCER RES, V64, P31, DOI 10.1158/0008-5472.CAN-03-3294; MOERTEL CG, 1985, NEW ENGL J MED, V312, P137, DOI 10.1056/NEJM198501173120301; Monti DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029794; Ohno S, 2009, ANTICANCER RES, V29, P809; Ouyang L, 2012, CELL PROLIFERAT, V45, P487, DOI 10.1111/j.1365-2184.2012.00845.x; Padayatty SJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011414, 10.1371/journal.pone.0015288]; Padayatty SJ, 2004, ANN INTERN MED, V140, P533, DOI 10.7326/0003-4819-140-7-200404060-00010; Pathi SS, 2011, NUTR CANCER, V63, P1133, DOI 10.1080/01635581.2011.605984; PRASAD KN, 1979, P NATL ACAD SCI USA, V76, P829, DOI 10.1073/pnas.76.2.829; Queiros O, 2012, J BIOENERG BIOMEMBR; Ranzato E, 2011, AM J RESP CELL MOL, V44, P108, DOI 10.1165/rcmb.2009-0340OC; Sakagami H, 1996, LIFE SCI, V58, P1131, DOI 10.1016/0024-3205(96)00071-9; Scatena R, 2008, EXPERT OPIN INV DRUG, V17, P1533, DOI 10.1517/13543784.17.10.1533 ; Seo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024179; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; SONG EJ, 1995, EUR J PHARM-ENVIRON, V292, P119; Sram RJ, 2011, MUTAT RES; Tang Z, 2012, J BIOENERG BIOMEMBR; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; Traber MG, 2011, FREE RADICAL BIO MED, V51, P1000, DOI 10.1016/j.freeradbiomed.2011.05.017; Ullah MF, 2010, CANC CHEMOTHER PHARM; Verrax J, 2009, FREE RADICAL BIO MED, V47, P32, DOI 10.1016/j.freeradbiomed.2009.02.016; Villani MG, 2006, CANCER RES, V66, P3238, DOI 10.1158/0008-5472.CAN-05-3362; Yeom CH, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-70	75	39	41	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e67081	10.1371/journal.pone.0067081	http://dx.doi.org/10.1371/journal.pone.0067081			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776707	Green Published, Green Submitted, gold			2022-12-27	WOS:000320755400160
J	Xu, J; Yin, ZQ; Li, L; Cheng, AC; Jia, RY; Song, X; Lu, HK; Dai, SJ; Lv, C; Liang, XX; He, CL; Zhao, L; Su, G; Ye, G; Shi, F				Xu, Jiao; Yin, Zhongqiong; Li, Li; Cheng, Anchun; Jia, Renyong; Song, Xu; Lu, Hongke; Dai, Shujun; Lv, Cheng; Liang, Xiaoxia; He, Changliang; Zhao, Ling; Su, Gang; Ye, Gang; Shi, Fei			Inhibitory Effect of Resveratrol against Duck Enteritis Virus In Vitro	PLOS ONE			English	Article							VIRULENT; DEV	Duck viral enteritis (DVE) is an acute, contagious herpesvirus infection of ducks, geese, and swans of all ages and species. This disease has been responsible for significant economic losses in domestic and wild waterfowl as a result of mortality, and decreased egg production. Resveratrol is a naturally occurring phytoalexin in specific plants and exhibits inhibitory activity against many kinds of virus. In this paper, resveratrol was found to inhibit duck enteritis virus (DEV) replication in a dose-dependent manner, with a 50% inhibition concentration of 3.85 mu g/mL. The inhibition in virus multiplication in the presence of resveratrol was not attributed to direct inactivation or inhibition of virus attachment to the host cells, but to the inhibition of viral multiplication in host cells. The assay of the time of addition limited the drug effect during the first 8 h of infection. This conclusion was supported by the ultrastructure images of the early stage of DEV infection, which showed that the replication of virus nucleic acid and the formation of the capsid in the cell nucleus were suppressed. In the indirect immunofluorescence assay, proteins expression in DEV infected duck embryo fibroblasts (DEFs) within 24 h post-infection (p.i.) was also effectively suppressed by resveratrol. In summary, the resveratrol has a good activity against DEV infection in vitro, which could be attributed to that fact that several essential immediate early viral proteins for virus replication were impacted by resveratrol.	[Xu, Jiao; Yin, Zhongqiong; Li, Li; Cheng, Anchun; Jia, Renyong; Song, Xu; Lu, Hongke; Dai, Shujun; Lv, Cheng; Liang, Xiaoxia; He, Changliang; Zhao, Ling; Su, Gang; Ye, Gang; Shi, Fei] Sichuan Agr Univ, Coll Vet Med, Yaan, Peoples R China; [Yin, Zhongqiong; Cheng, Anchun; Jia, Renyong] Sichuan Agr Univ, Inst Prevent Vet Med, Chengdu, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University	Yin, ZQ (corresponding author), Sichuan Agr Univ, Coll Vet Med, Yaan, Peoples R China.	yinzhongq@163.com	Dai, Shujun/D-5777-2013	Dai, Shujun/0000-0002-2918-470X; Yin, Zhongqiong/0000-0003-1752-644X	National Science & Technology Program in Rural Areas [2011BAD34B03-4]; Foundation for the Author of Excellent Doctoral Dissertation of Sichuan agriculture university	National Science & Technology Program in Rural Areas; Foundation for the Author of Excellent Doctoral Dissertation of Sichuan agriculture university	These studies were supported by National Science & Technology Program in Rural Areas During the 12th Five Year Plan Period (2011BAD34B03-4) and Foundation for the Author of Excellent Doctoral Dissertation of Sichuan agriculture university. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOYLE P, 1995, UROLOGY, V46, P47, DOI 10.1016/S0090-4295(99)80250-7; Briskin DP, 2000, PLANT PHYSIOL, V124, P507, DOI 10.1104/pp.124.2.507; Cheng AnChun, 2004, Chinese Journal of Virology, V20, P364; Clouser CL, 2012, BIOORG MED CHEM LETT, V22, P6642, DOI 10.1016/j.bmcl.2012.08.108; Cowan MM, 1999, CLIN MICROBIOL REV, V12, P564, DOI 10.1128/CMR.12.4.564; Docherty JJ, 1999, ANTIVIR RES, V43, P145, DOI 10.1016/S0166-3542(99)00042-X; Docherty JJ, 2005, ANTIVIR RES, V67, P155, DOI 10.1016/j.antiviral.2005.06.008; Docherty JJ, 2004, ANTIVIR RES, V61, P19, DOI 10.1016/j.antiviral.2003.07.001; Docherty JJ, 2006, ANTIVIR RES, V72, P171, DOI 10.1016/j.antiviral.2006.07.004; Evers DL, 2004, ANTIVIR RES, V63, P85, DOI 10.1016/j.antiviral.2004.03.002; Fioravanti R, 2012, BIOORGAN MED CHEM, V20, P5046, DOI 10.1016/j.bmc.2012.05.062; Galindo I, 2011, ANTIVIR RES, V91, P57, DOI 10.1016/j.antiviral.2011.04.013; Guo Yu-fei, 2008, Chinese Journal of Virology, V24, P352; [郭宇飞 GUO Yufei], 2006, [畜牧兽医学报, Acta Veterinaria et Zootechnica Sinica], V37, P274; Heredia A, 2000, J ACQ IMMUN DEF SYND, V25, P246, DOI 10.1097/00126334-200011010-00006; HUSSAIN RF, 1993, J IMMUNOL METHODS, V160, P89, DOI 10.1016/0022-1759(93)90012-V; Jassim SAA, 2003, J APPL MICROBIOL, V95, P412, DOI 10.1046/j.1365-2672.2003.02026.x; Johnson DC, 2011, NAT REV MICROBIOL, V9, P382, DOI 10.1038/nrmicro2559; Kaleta EF, 2007, DEUT TIERARZTL WOCH, V114, P3; KALETA EF, 1990, AVIAN PATHOL, V19, P193, DOI 10.1080/03079459008418673; Lee JW, 2010, KOREAN J UROL, V51, P870, DOI 10.4111/kju.2010.51.12.870; Li T, 2013, ANTIVIR RES, V97, P1, DOI 10.1016/j.antiviral.2012.10.006; Li YL, 2005, ANTIVIR RES, V68, P1, DOI 10.1016/j.antiviral.2005.06.004; Li YQ, 2006, EUR J MED CHEM, V41, P1084, DOI 10.1016/j.ejmech.2006.03.024; Mimaki Y, 2001, BIOL PHARM BULL, V24, P1286, DOI 10.1248/bpb.24.1286; Mondal B, 2010, BIOLOGICALS, V38, P401, DOI 10.1016/j.biologicals.2010.01.016; Naesens L, 2006, J CLIN VIROL, V37, pS69, DOI 10.1016/S1386-6532(06)70015-4; Reed L., 1938, AM J HYG, V27, P943; Saif Y., 2003, Diseases of poultry; Seth A.F., 2006, ANTIVIR RES, V72, P242; Wang J, 2011, VIRUS RES, V160, P316, DOI 10.1016/j.virusres.2011.07.004; Wang JC, 2011, VIRUS RES, V159, P23, DOI 10.1016/j.virusres.2011.04.013; Williams J E, 2001, Altern Med Rev, V6, P567; Wu Y, 2012, J VIROL, V86, P5965, DOI 10.1128/JVI.00529-12; Xu J, 2012, POULTRY SCI, V91, P2802, DOI 10.3382/ps.2012-02468; Xu J, 2012, CHINESE VET SCI, V41, P1302; Yiu CY, 2010, MOLECULES, V15, P7115, DOI 10.3390/molecules15107115	37	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65213	10.1371/journal.pone.0065213	http://dx.doi.org/10.1371/journal.pone.0065213			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776451	Green Published, gold, Green Submitted			2022-12-27	WOS:000320755400014
J	Zhang, L; Xu, JW; Qu, X; Liu, DR; Liu, P; Zhao, XZ				Zhang, Lu; Xu, Jia-Wei; Qu, Xin; Liu, Dong-Rui; Liu, Ping; Zhao, Xin-Zhi			Association of a Rare Haplotype in Kinesin Light Chain 1 Gene with Age-Related Cataract in a Han Chinese Population	PLOS ONE			English	Article							TRANSPORT; DISEASES; PITX3	Purpose: The causal genes for congenital cataract are good candidates for the genetic susceptibility for age-related cataract (ARC). The aim of this study was to investigate association between the polymorphisms in the causal genes for congenital cataract and ARC in a Chinese population. Meanwhile, we performed the replication study for previous identified risk genes for ARC. Methods: We recruited 212 sporadic Han Chinese patients with age-related cataracts (ARC) and 172 normal controls in this study. We analyzed 31 SNPs from 13 genes which mostly possible contributes the progress of ARC in a Chinese population, comprising 212 cataract patients and 172 controls. Polymorphism-spanning fragments were amplified by using the multiplex polymerase chain reaction (PCR) and genotyped using primer extension method in MassARRAY platform. Allelic and haplotypic difference in the frequencies were estimated using the SHEsis software platform. P-value was adjusted by the Bonferroni correction. Results: There was no difference in the frequencies of the genotype and allele of the all SNPs between the patients with ARC and the controls. In the haplotypic analysis, the haplotypes consisting of rs7154572, rs7150141 and rs12432994 in Kinesin Light Chain 1 Gene (KLC1) showed significant association with ARC (p = 0.000878). A rare haplotype CGT was more frequent in patients (p = 0.000106, and p = 0.00795 after corrected for 75 tests). Conclusions: Our study provides evidence that the combined effect of three variants within the KLC1 gene may predispose to ARC, but the precise mechanism needs further investigating.	[Zhang, Lu; Liu, Dong-Rui; Liu, Ping] Harbin Med Univ, Affiliated Hosp 1, Hosp Eye, Harbin, Peoples R China; [Xu, Jia-Wei; Zhao, Xin-Zhi] Fudan Univ, Childrens Hosp, Shanghai 200433, Peoples R China; [Xu, Jia-Wei; Zhao, Xin-Zhi] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Qu, Xin] Harbin Med Univ, Affiliated Hosp 3, Harbin, Peoples R China	Harbin Medical University; Fudan University; Fudan University; Harbin Medical University	Zhang, L (corresponding author), Harbin Med Univ, Affiliated Hosp 1, Hosp Eye, Harbin, Peoples R China.	13796089809@163.com; xzzhao@fudan.edu.cn	xu, jiawei/GWM-9710-2022		Natural Science Foundation of China [81200722]; Heilongjiang Postdoctoral Science-Research Foundation [LBH-Q10032]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Heilongjiang Postdoctoral Science-Research Foundation	This research was supported with funds from the Natural Science Foundation of China (81200722) and the Heilongjiang Postdoctoral Science-Research Foundation (LBH-Q10032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson ME, 2007, MOL VIS, V13, P993; Asbell PA, 2005, LANCET, V365, P599; Berry V, MOL VIS, V17, P1249; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Goldstein LSB, 2001, P NATL ACAD SCI USA, V98, P6999, DOI 10.1073/pnas.111145298; Hammond CJ, 2000, NEW ENGL J MED, V342, P1786, DOI 10.1056/NEJM200006153422404; Hammond CJ, 2001, INVEST OPHTH VIS SCI, V42, P601; Hirokawa N, 2008, PHYSIOL REV, V88, P1089, DOI 10.1152/physrev.00023.2007; Jamieson RV, 2002, HUM MOL GENET, V11, P33, DOI 10.1093/hmg/11.1.33; Jun G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000584; Medina-Martinez O, 2009, DEV DYNAM, V238, P2193, DOI 10.1002/dvdy.21924; Reddy MA, 2004, SURV OPHTHALMOL, V49, P300, DOI 10.1016/j.survophthal.2004.02.013; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Robman L, 2005, EYE, V19, P1074, DOI 10.1038/sj.eye.6701964; Semina EV, 1998, NAT GENET, V19, P167, DOI 10.1038/527; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Shiels A, 2008, MOL VIS, V14, P2042; Stokin GB, 2006, ANNU REV BIOCHEM, V75, P607, DOI 10.1146/annurev.biochem.75.103004.142637; Sundaresan P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033001; von Otter M, 2010, NEUROMOL MED, V12, P229, DOI 10.1007/s12017-009-8103-0; Zhang TX, 2009, HUM MUTAT, V30, pE603, DOI 10.1002/humu.20995; Zhang Y, 2011, MOL VIS, V17, P2325	22	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e64052	10.1371/journal.pone.0064052	http://dx.doi.org/10.1371/journal.pone.0064052			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776437	Green Published, Green Submitted, gold			2022-12-27	WOS:000320755400006
J	Papazzo, A; Conlan, XA; Lexis, L; Charchar, FJ; Lewandowski, PA				Papazzo, Annateresa; Conlan, Xavier A.; Lexis, Louise; Charchar, Fadi J.; Lewandowski, Paul A.			Salt Loading in Canola Oil Fed SHRSP Rats Induces Endothelial Dysfunction	PLOS ONE			English	Article							SPONTANEOUSLY HYPERTENSIVE-RATS; 13-WEEK DIETARY-INTAKE; WISTAR-KYOTO RATS; OXIDATIVE STRESS; RAPESEED OIL; VEGETABLE-OILS; SURVIVAL-TIME; NADPH OXIDASE; SOYBEAN OIL; BLOOD-PRESSURE	This study aimed to determine if 50 days of canola oil intake in the absence or presence of salt loading affects: (1) antioxidant and oxidative stress markers, (2) aortic mRNA of NADPH oxidase (NOX) subunits and superoxide dismutase (SOD) isoforms and (3) endothelial function in SHRSP rats. SHRSP rats were fed a diet containing 10 wt/wt% soybean oil or 10 wt/wt% canola oil, and given tap water or water containing 1% NaCl for 50 days. Without salt, canola oil significantly increased RBC SOD, plasma cholesterol and triglycerides, aortic p22(phox), NOX2 and CuZn-SOD mRNA, and decreased RBC glutathione peroxidase activity. With salt, canola oil reduced RBC SOD and catalase activity, LDL-C, and p22(phox) mRNA compared with canola oil alone, whereas plasma malondialdehyde (MDA) was reduced and RBC MDA and LDL-C were higher. With salt, the canola oil group had significantly reduced endothelium-dependent vasodilating responses to ACh and contractile responses to norepinephrine compared with the canola oil group without salt and to the WKY rats. These results indicate that ingestion of canola oil increases O-2(-) generation, and that canola oil ingestion in combination with salt leads to endothelial dysfunction in the SHRSP model.	[Papazzo, Annateresa; Lewandowski, Paul A.] Deakin Univ, Sch Med, Geelong, Vic 3217, Australia; [Conlan, Xavier A.] Deakin Univ, Sch Life & Environm Sci, Ctr Chem & Biotechnol, Geelong, Vic 3217, Australia; [Lexis, Louise] La Trobe Univ, Dept Human Biosci, Bundoora, Vic 3086, Australia; [Charchar, Fadi J.] Univ Ballarat, Sch Hlth Sci, Ballarat, Vic 3353, Australia	Deakin University; Deakin University; La Trobe University; Federation University Australia	Lewandowski, PA (corresponding author), Deakin Univ, Sch Med, Geelong, Vic 3217, Australia.	paul.lewandowski@deakin.edu.au	Charchar, Fadi/I-6656-2017	Charchar, Fadi/0000-0002-6164-9941; Conlan, Xavier/0000-0003-0829-0551				Ballantyne C, 2005, EUR HEART J, V26, P2224, DOI 10.1093/eurheartj/ehi373; Berry C, 2001, CURR OPIN NEPHROL HY, V10, P247, DOI 10.1097/00041552-200103000-00014; Blankenberg S, 2003, NEW ENGL J MED, V349, P1605, DOI 10.1056/NEJMoa030535; Bragulat Ernesto, 2002, J Clin Hypertens (Greenwich), V4, P41, DOI 10.1111/j.1524-6175.2002.00503.x; Cediel E, 2003, AM J PHYSIOL-REG I, V285, pR674, DOI 10.1152/ajpregu.00643.2002; Chabrashvili T, 2003, AM J PHYSIOL-REG I, V285, pR117, DOI 10.1152/ajpregu.00476.2002; Chen QX, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-11; Cimen MYB, 2008, CLIN CHIM ACTA, V390, P1, DOI 10.1016/j.cca.2007.12.025; Datla SR, 2010, HYPERTENSION, V56, P325, DOI 10.1161/HYPERTENSIONAHA.109.142422; Davies PF, 2009, NAT CLIN PRACT CARD, V6, P16, DOI 10.1038/ncpcardio1397; de Cavanagh EMV, 2010, AM J HYPERTENS, V23, P1318, DOI 10.1038/ajh.2010.167; Huang MZ, 1996, BIOL PHARM BULL, V19, P554, DOI 10.1248/bpb.19.554; Huang MZ, 1997, LIPIDS, V32, P745, DOI 10.1007/s11745-997-0095-z; Jiang F, 2004, ENDOTHELIUM-J ENDOTH, V11, P79, DOI 10.1080/10623320490482600; Kalenikova EI, 2004, BIOCHEMISTRY-MOSCOW+, V69, P311, DOI 10.1023/B:BIRY.0000022063.32185.7c; Kitiyakara C, 2003, J AM SOC NEPHROL, V14, P2775, DOI 10.1097/01.ASN.0000092145.90389.65; Li J, 2009, J NUTR, V139, P447, DOI 10.3945/jn.108.097451; Naito Y, 2000, PHARMACOL TOXICOL, V87, P144, DOI 10.1111/j.0901-9928.2000.870308.x; Naito Y, 2000, FOOD CHEM TOXICOL, V38, P811, DOI 10.1016/S0278-6915(00)00076-4; Naito Y, 2003, TOXICOLOGY, V187, P205, DOI 10.1016/S0300-483X(03)00052-0; Natio Y, 2000, TOXICOL LETT, V117, P209; Ogawa H, 2003, CLIN EXP PHARMACOL P, V30, P919, DOI 10.1111/j.1440-1681.2003.03939.x; Ohara N, 2008, FOOD CHEM TOXICOL, V46, P2573, DOI 10.1016/j.fct.2008.04.015; Ohara N, 2006, FOOD CHEM TOXICOL, V44, P952, DOI 10.1016/j.fct.2005.11.004; Ohara N, 2009, FOOD CHEM TOXICOL, V47, P157, DOI 10.1016/j.fct.2008.10.022; Papazzo A, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-180; Papazzo A, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-98; Ratnayake WMN, 2000, J NUTR, V130, P1166, DOI 10.1093/jn/130.5.1166; Ratnayake WMN, 2000, LIPIDS, V35, P409, DOI 10.1007/s11745-000-539-5; Reinehr R, 2007, GLIA, V55, P758, DOI 10.1002/glia.20504; Schulz E, 2011, HYPERTENS RES, V34, P665, DOI 10.1038/hr.2011.39; SHARMA AM, 1990, KLIN WOCHENSCHR, V68, P664, DOI 10.1007/BF01667013; Sim AS, 2003, J CHROMATOGR B, V785, P337, DOI 10.1016/S1570-0232(02)00956-X; Tatematsu K, 2004, FOOD CHEM TOXICOL, V42, P1443, DOI 10.1016/j.fct.2004.04.005; Adler Alma J, 2014, Cochrane Database Syst Rev, pCD009217, DOI [10.1002/14651858.CD009217, 10.1002/14651858.CD009217.pub3]; Ulker S, 2003, HYPERTENSION, V41, P534, DOI 10.1161/01.HYP.0000057421.28533.37; WARNICK GR, 1990, CLIN CHEM, V36, P15; Zalba G, 2000, HYPERTENSION, V35, P1055, DOI 10.1161/01.HYP.35.5.1055	38	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e66655	10.1371/journal.pone.0066655	http://dx.doi.org/10.1371/journal.pone.0066655			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762494	Green Published, Green Submitted, gold			2022-12-27	WOS:000321094800102
J	Bertsche, U; Yang, SJ; Kuehner, D; Wanner, S; Mishra, NN; Roth, T; Nega, M; Schneider, A; Mayer, C; Grau, T; Bayer, AS; Weidenmaier, C				Bertsche, Ute; Yang, Soo-Jin; Kuehner, Daniel; Wanner, Stefanie; Mishra, Nagendra N.; Roth, Tobias; Nega, Mulugeta; Schneider, Alexander; Mayer, Christoph; Grau, Timo; Bayer, Arnold S.; Weidenmaier, Christopher			Increased Cell Wall Teichoic Acid Production and D-alanylation Are Common Phenotypes among Daptomycin-Resistant Methicillin-Resistant Staphylococcus aureus (MRSA) Clinical Isolates	PLOS ONE			English	Article							REDUCED VANCOMYCIN SUSCEPTIBILITY; ANTIMICROBIAL PEPTIDE RESISTANCE; INTERMEDIATE; STRAINS; MPRF; NONSUSCEPTIBILITY; PEPTIDOGLYCAN; BIOSYNTHESIS; MECHANISMS; EXPRESSION	Multiple mechanisms have been correlated with daptomycin-resistance (DAP-R) in Staphylococcus aureus. However, one common phenotype observed in many DAP-R S. Aureus strains is a thickened cell wall (CW). The first evidence for an impact of CW-linked glycopolymers on this phenotype was recently demonstrated in a single, well-characterized DAP-R methicillin-susceptible S. aureus (MSSA) strain. In this isolate the thickened CW phenotype was linked to an increased production and D-alanylation of wall teichoic acids (WTA). In the current report, we extended these observations to methicillin-resistant daptomycin-sensitive/daptomyin-resistant (DAP-S/DAP-R) strain-pairs. These pairs included methicillin-resistant S. aureus (MRSA) isolates with and without single nucleotide polymorphisms (SNPs) in mprF (a genetic locus linked to DAP-R phenotype). We found increased CW dry mass in all DAP-R vs DAP-S isolates. This correlated with an increased expression of the WTA biosynthesis gene tagA, as well as an increased amount of WTA in the DAP-R vs DAP-S isolates. In addition, all DAP-R isolates showed a higher proportion of WTA D-alanylation vs their corresponding DAP-S isolate. We also detected an increased positive surface charge amongst the DAP-R strains (presumably related to the enhanced D-alanylation). In comparing the detailed CW composition of all isolate pairs, substantive differences were only detected in one DAP-S/DAP-R pair. The thickened CW phenotype, together with an increased surface charge most likely contributes to either: i) a charge-dependent repulsion of calcium complexed-DAP; and/or ii) steric-limited access of DAP to the bacterial cell envelope target. Taken together well-defined perturbations of CW structural and functional metrics contribute to the DAP-R phenotype and are common phenotypes in DAP-R S. Aureus isolates, both MSSA and MRSA. Note: Although "daptomycin-nonsusceptibility" is the generally accepted terminology, we have utilized the term "daptomycin resistance" for ease of presentation in this manuscript	[Bertsche, Ute; Kuehner, Daniel; Wanner, Stefanie; Roth, Tobias; Nega, Mulugeta; Schneider, Alexander; Mayer, Christoph; Grau, Timo; Weidenmaier, Christopher] Univ Tubingen, Interfak Inst Mikrobiol & Infektionsmed, Tubingen, Germany; [Yang, Soo-Jin; Mishra, Nagendra N.; Bayer, Arnold S.] Harbor UCLA Med Ctr, Div Infect Dis, LA Biomed Res Inst, Torrance, CA 90509 USA; [Yang, Soo-Jin; Bayer, Arnold S.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Kuehner, Daniel] Cecolabs UG, Tubingen, Germany	Eberhard Karls University of Tubingen; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Weidenmaier, C (corresponding author), Univ Tubingen, Interfak Inst Mikrobiol & Infektionsmed, Tubingen, Germany.	christopher.weidenmaier@med.uni-tuebingen.de	Mayer, Christoph/S-8666-2017	Mayer, Christoph/0000-0003-4731-4851; Weidenmaier, Christopher/0000-0003-4107-739X	German Research Foundation [SFB766, TR-SFB34]; National Institutes of Health (NIAID) [RO1-AI-039108-15]; American Heart Association (Western States Affiliate) [12BGIA11780035]; Los Angeles Biomedical Research Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039108] Funding Source: NIH RePORTER	German Research Foundation(German Research Foundation (DFG)); National Institutes of Health (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Heart Association (Western States Affiliate)(American Heart Association); Los Angeles Biomedical Research Institute(University of California System); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	UB was supported by German Research Foundation Grant SFB766. CW was supported by German Research Foundation Grants TR-SFB34 and SFB766. This study was supported in part by a grant from the National Institutes of Health (NIAID) RO1-AI-039108-15 (to ASB), a Beginning Grant-in-Aid from the American Heart Association (Western States Affiliate) 12BGIA11780035 (to S-JY) and a Research Seed Grant from the Los Angeles Biomedical Research Institute (to S-JY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayer AS, 2013, ANN NY ACAD SCI, V1277, P139, DOI 10.1111/j.1749-6632.2012.06819.x; Bertsche U, 2011, ANTIMICROB AGENTS CH; Boneca IG, 1997, J BIOL CHEM, V272, P29053, DOI 10.1074/jbc.272.46.29053; Boucher HW, 2007, CLIN INFECT DIS, V45, P601, DOI 10.1086/520655; Boyle-Vavra S, 2011, ANTIMICROB AGENTS CH, V55, P2018, DOI 10.1128/AAC.01593-10; Camargo ILBD, 2008, ANTIMICROB AGENTS CH, V52, P4289, DOI 10.1128/AAC.00417-08; Cui LZ, 2006, ANTIMICROB AGENTS CH, V50, P1079, DOI 10.1128/AAC.50.3.1079-1082.2006; DEJONGE BLM, 1993, J BACTERIOL, V175, P2779, DOI 10.1128/JB.175.9.2779-2782.1993; DEJONGE BLM, 1992, J BIOL CHEM, V267, P11248; Dubrac S, 2008, MOL MICROBIOL, V70, P1307, DOI 10.1111/j.1365-2958.2008.06483.x; Ernst CM, 2011, MOL MICROBIOL, V80, P290, DOI 10.1111/j.1365-2958.2011.07576.x; Fischer A, 2011, J ANTIMICROB CHEMOTH, V66, P1696, DOI 10.1093/jac/dkr195; Ginsberg C, 2006, ACS CHEM BIOL, V1, P25, DOI 10.1021/cb0500041; Gohring N, 2011, ANTIMICROB AGENTS CH, V55, P5452, DOI 10.1128/AAC.00286-11; Hayden MK, 2005, J CLIN MICROBIOL, V43, P5285, DOI 10.1128/JCM.43.10.5285-5287.2005; Howden BP, 2010, CLIN MICROBIOL REV, V23, P99, DOI 10.1128/CMR.00042-09; Jones T, 2008, ANTIMICROB AGENTS CH, V52, P269, DOI 10.1128/AAC.00719-07; Julian K, 2007, ANTIMICROB AGENTS CH, V51, P3445, DOI 10.1128/AAC.00559-07; Kristian SA, 2005, J BACTERIOL, V187, P6719, DOI 10.1128/JB.187.19.6719-6725.2005; Liu C, 2011, CLIN INFECT DIS, V52, P285, DOI 10.1093/cid/cir034; McAleese F, 2006, J BACTERIOL, V188, P1120, DOI 10.1128/JB.188.3.1120-1133.2006; Mishra NN, 2011, ANTIMICROB AGENTS CH, V55, P4012, DOI 10.1128/AAC.00223-11; Mishra NN, 2009, ANTIMICROB AGENTS CH, V53, P2312, DOI 10.1128/AAC.01682-08; Mohedano ML, 2005, J BACTERIOL, V187, P2357, DOI 10.1128/JB.187.7.2357-2367.2005; Muthaiyan A, 2008, ANTIMICROB AGENTS CH, V52, P980, DOI 10.1128/AAC.01121-07; Peschel A, 2000, ANTIMICROB AGENTS CH, V44, P2845, DOI 10.1128/AAC.44.10.2845-2847.2000; Peschel A, 1996, FEMS MICROBIOL LETT, V137, P279; Peschel A, 1999, J BIOL CHEM, V274, P8405, DOI 10.1074/jbc.274.13.8405; Peschel A, 2001, J EXP MED, V193, P1067, DOI 10.1084/jem.193.9.1067; Pillai SK, 2007, ANTIMICROB AGENTS CH, V51, P2223, DOI 10.1128/AAC.00202-07; Sakoulas G, 2003, J INFECT DIS, V187, P929, DOI 10.1086/368128; Skiest DJ, 2006, J CLIN MICROBIOL, V44, P655, DOI 10.1128/JCM.44.2.655-656.2006; Stranden AM, 1997, J BACTERIOL, V179, P9, DOI 10.1128/jb.179.1.9-16.1997; Weidenmaier C, 2004, NAT MED, V10, P243, DOI 10.1038/nm991; Wootton M, 2006, ANTIMICROB AGENTS CH, V50, P4195, DOI 10.1128/AAC.00678-06; Xia G, 2008, CHEM BIOL, V15, P95, DOI 10.1016/j.chembiol.2008.02.005; Yang SJ, 2010, ANTIMICROB AGENTS CH, V54, P3079, DOI 10.1128/AAC.00122-10; Yang SJ, 2009, J INFECT DIS, V200, P1916, DOI 10.1086/648473; Yang SJ, 2009, ANTIMICROB AGENTS CH, V53, P2636, DOI 10.1128/AAC.01415-08; Zhou XX, 2012, BIOCHEMISTRY-US, V51, P8143, DOI 10.1021/bi3012115	40	65	65	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e67398	10.1371/journal.pone.0067398	http://dx.doi.org/10.1371/journal.pone.0067398			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785522	Green Submitted, gold, Green Published			2022-12-27	WOS:000321038800002
J	Kim, JH; Kim, HK; Ko, JH; Bang, H; Lee, DC				Kim, Jung-Ha; Kim, Hye Kyung; Ko, Jae-Hong; Bang, Hyoweon; Lee, Duk-Chul			The Relationship between Leukocyte Mitochondrial DNA Copy Number and Telomere Length in Community-Dwelling Elderly Women	PLOS ONE			English	Article							PERIPHERAL-BLOOD; CALORIC RESTRICTION; RHESUS-MONKEYS; DIETARY RESTRICTION; QUANTITATIVE PCR; HEALTHY WOMEN; LIFE-SPAN; DYSFUNCTION; HYPERTENSION; STRESS	Purpose: Both telomere length and mitochondrial function are accepted as reflective indices of aging. Recent studies have shown that telomere dysfunction may influence impaired mitochondrial biogenesis and function. However, there has been no study regarding the possible association between telomere and mitochondrial function in humans. Therefore, the purpose of the study was to identify any relationships between mitochondrial and telomere function. Methods: The present study included 129 community-dwelling, elderly women. The leukocyte mitochondrial DNA copy number and telomere length were measured using a quantitative real-time polymerase chain reaction method. Anthropometric measurement, biochemical blood testing, a depression screening questionnaire using a 15-question geriatric depression scale (GDS-15), and a cognitive function test using the Korean version of the mini mental state examination (K-MMSE) were performed. Results: Leukocyte mtDNA copy number was positively associated with telomere length (r=0.39, p=<0.0001) and K-MMSE score (r=0.06, p=0.02). Additionally, leukocyte mtDNA copy number was negatively correlated with GDS-15 score (r=-0.17, p=0.04). Age (r=-0.15, p=0.09), waist circumference (r=-0.16, p=0.07), and serum ferritin level (r=-0.13, p=0.07) tended to be inversely correlated with leukocyte mtDNA copy number. With a stepwise multiple regression analysis, telomere length was found to be an independent factor associated with leukocyte mtDNA copy number after adjustment for confounding variables including age, body mass index, waist circumference, total cholesterol, HDL-cholesterol, LDL-cholesterol, triglycerides, hs-CRP, serum ferritin, HOMA-IR, K-MMSE, GDS-15, hypertension, diabetes, dyslipidemia, currently smoking, alcohol drinking, and regular exercise. Conclusions: This study showed that leukocyte mtDNA copy number was positively correlated with leukocyte telomere length in community-dwelling elderly women. Our findings suggest that telomere function may influence mitochondrial function in humans.	[Kim, Jung-Ha] Chung Ang Univ Healthcare Syst, Dept Family Med, Seoul, South Korea; [Kim, Hye Kyung] Yonsei Univ, Coll Med, Hlth Promot Ctr, Gangnam Severance Hosp, Seoul, South Korea; [Ko, Jae-Hong; Bang, Hyoweon] Chung Ang Univ, Coll Med, Dept Physiol, Seoul 156756, South Korea; [Lee, Duk-Chul] Yonsei Univ, Coll Med, Dept Family Med, Severance Hosp, Seoul, South Korea	Yonsei University; Yonsei University Health System; Chung Ang University; Chung Ang University Hospital; Yonsei University; Yonsei University Health System	Bang, H (corresponding author), Chung Ang Univ, Coll Med, Dept Physiol, Seoul 156756, South Korea.	haena@cau.ac.kr; faith@yuhs.ac		Lee, Duk Chul/0000-0001-9166-1813; , Jung-Ha/0000-0002-7630-9501				Alder JK, 2011, AM J RESP CRIT CARE, V184, P904, DOI 10.1164/rccm.201103-0520OC; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Cho M. J., 1999, J KOREAN NEUROPSYCHI, V38, P48; Colman RJ, 2008, J GERONTOL A-BIOL, V63, P556, DOI 10.1093/gerona/63.6.556; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Conley KE, 2007, CURR OPIN CLIN NUTR, V10, P688, DOI 10.1097/MCO.0b013e3282f0dbfb; Das M, 2004, Obes Rev, V5, P13, DOI 10.1111/j.1467-789X.2004.00115.x; Dedkova EN, 2008, CELL CALCIUM, V44, P77, DOI 10.1016/j.ceca.2007.11.002; Eisenberg DTA, 2011, AM J HUM BIOL, V23, P149, DOI 10.1002/ajhb.21127; Entringer S, 2011, P NATL ACAD SCI USA, V108, pE513, DOI 10.1073/pnas.1107759108; Epel ES, 2009, HORM-INT J ENDOCRINO, V8, P7, DOI 10.14310/horm.2002.1217; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Heidinger BJ, 2012, P NATL ACAD SCI USA, V109, P1743, DOI 10.1073/pnas.1113306109; Jin HS, 2011, AM J HYPERTENS, V24, P1127, DOI 10.1038/ajh.2011.131; Kang HT, 2012, CLIN CHIM ACTA, V413, P636, DOI 10.1016/j.cca.2011.12.011; Kiefel BR, 2006, INT REV CYTOL, V254, P151, DOI 10.1016/S0074-7696(06)54004-5; Kim CH, 2011, METABOLISM, V60, P414, DOI 10.1016/j.metabol.2010.03.007; Kim MY, 2011, ARCH GERONTOL GERIAT, V53, pE218, DOI 10.1016/j.archger.2010.11.019; Lee HK, 1998, DIABETES RES CLIN PR, V42, P161, DOI 10.1016/S0168-8227(98)00110-7; Lee JW, 2010, CLIN CHIM ACTA, V411, P592, DOI 10.1016/j.cca.2010.01.024; Lim Chae Young, 2010, Korean J Gastroenterol, V55, P384, DOI 201006256; Lim S, 2001, ATHEROSCLEROSIS, V158, P399, DOI 10.1016/S0021-9150(01)00436-1; Lim S, 2000, EUR J APPL PHYSIOL, V82, P407, DOI 10.1007/s004210000238; Liu CS, 2005, ANN NY ACAD SCI, V1042, P70, DOI 10.1196/annals.1338.008; Lombard David B, 2011, Handb Exp Pharmacol, V206, P163, DOI 10.1007/978-3-642-21631-2_8; Mainous AG, 2010, ATHEROSCLEROSIS, V210, P262, DOI 10.1016/j.atherosclerosis.2009.10.047; Masoro EJ, 2006, J GERONTOL A-BIOL, V61, P14, DOI 10.1093/gerona/61.1.14; Mur C, 2004, LIFE SCI, V75, P611, DOI 10.1016/j.lfs.2003.12.026; Njajou OT, 2007, P NATL ACAD SCI USA, V104, P12135, DOI 10.1073/pnas.0702703104; Puddu P, 2007, CLIN EXP HYPERTENS, V29, P427, DOI 10.1080/10641960701613852; Ramachandran A, 2002, FREE RADICAL BIO MED, V33, P1465, DOI 10.1016/S0891-5849(02)01142-5; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787; Smith DL, 2011, J GERONTOL A-BIOL, V66, P1163, DOI 10.1093/gerona/glr136; Song J, 2001, DIABETES CARE, V24, P865, DOI 10.2337/diacare.24.5.865; Syrovatka P, 2009, ANN NUTR METAB, V54, P268, DOI 10.1159/000229507; Tentolouris N, 2007, DIABETES CARE, V30, P2909, DOI 10.2337/dc07-0633; von Zglinicki T, 2000, LAB INVEST, V80, P1739, DOI 10.1038/labinvest.3780184; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang CF, 2010, AGING-US, V2, P555, DOI 10.18632/aging.100196; Wei YH, 1998, ANN NY ACAD SCI, V854, P155, DOI 10.1111/j.1749-6632.1998.tb09899.x; Weindruch R., 1988, RETARDATION AGING DI; Weng SW, 2009, DIABETES RES CLIN PR, V83, P94, DOI 10.1016/j.diabres.2008.10.002; Wong Alice, 2002, Methods Mol Biol, V197, P129, DOI 10.1385/1-59259-284-8:129; Yamaguchi Y, 2005, EUR J CLIN INVEST, V35, P186, DOI 10.1111/j.1365-2362.2005.01472.x; Zimmerman MC, 2009, HYPERTENSION, V53, P112, DOI 10.1161/HYPERTENSIONAHA.108.125567	48	56	58	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e67227	10.1371/journal.pone.0067227	http://dx.doi.org/10.1371/journal.pone.0067227			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	172XB	23785520	Green Published, Green Submitted, gold			2022-12-27	WOS:000321038800004
J	Ming, FP; Yang, J; Chu, PP; Ma, MP; Shi, JQ; Cai, HM; Huang, CY; Li, HZ; Jiang, ZG; Wang, HG; Wang, WF; Zhang, SQ; Zhang, LH				Ming, Feiping; Yang, Jun; Chu, Pinpin; Ma, Miaopeng; Shi, Juqing; Cai, Haiming; Huang, Chaoyuan; Li, Huazhou; Jiang, Zhenggu; Wang, Houguang; Wang, Weifang; Zhang, Shuiqing; Zhang, Linghua			Immunization of Aged Pigs with Attenuated Pseudorabies Virus Vaccine Combined with CpG Oligodeoxynucleotide Restores Defective Th1 Immune Responses	PLOS ONE			English	Article							SYNTHETIC IMMUNOSTIMULATORY MOTIFS; RAPID COLORIMETRIC ASSAY; IN-VIVO; T-CELLS; CYTOKINES; CD4(+); INNATE; SUBPOPULATIONS; ACTIVATION; ADJUVANT	Background and Aims: Attempts to immunize aged subjects often result in the failure to elicit a protective immune response. Murine model studies have shown that oligonucleotides containing CpG motifs (CpG ODN) can stimulate immune system in aged mice as effectively as in young mice. Since many physiological and pathophysiological data of pigs can be transferred to humans, research in pigs is important to confirm murine data. Here we investigated whether immunization of aged pig model with attenuated pseudorabies virus vaccine (PRV vaccine) formulated with CpG ODN could promote a successful development of immune responses that were comparable to those induced in young pigs in a similar manner. Methodology: Young and aged pigs were immunized IM with PRV vaccine alone, or in combination with CpG ODN respectively. At days 3, 7, 14 post immunization sera were assayed by ELISA for IgG titres, at day 7 for IgG1 and IgG2 subtypes titres. All blood samples collected in evacuated test tubes with K-EDTA at day 7 were analyzed for flow cytometer assay. Blood samples at day 7 collected in evacuated test tubes with heparin were analysed for antigen-specific cytokines production and peripheral blood mononuclear cells (PBMCs) proliferative responses. Results: CpG ODN could enhance Th1 responses (PRV-specific IgG2/IgG1 ratio, proliferative responses, Th1 cytokines production) when used as an adjuvant for the vaccination of aged pigs, which were correlated with enhanced CD4+ T cells percentage, decreased CD4+CD8+CD45RO+ T cells percentage and improved PRV-specific CD4+ T cells activation. Conclusions: Our results demonstrate a utility for CpG ODN, as a safe vaccine adjuvant for promoting effective systemic immune responses in aged pig model. This agent could have important clinical uses in overcoming some of age-associated depressions in immune function that occur in response to vaccination.	[Ming, Feiping; Yang, Jun; Chu, Pinpin; Ma, Miaopeng; Shi, Juqing; Cai, Haiming; Huang, Chaoyuan; Zhang, Shuiqing; Zhang, Linghua] South China Agr Univ, Coll Life Sci, Guangzhou, Guangdong, Peoples R China; [Li, Huazhou; Jiang, Zhenggu; Wang, Houguang; Wang, Weifang] Swine Seed Breeding Ctr Guangzhou, Guangzhou, Guangdong, Peoples R China; [Zhang, Linghua] South China Agr Univ, Guangdong Prov Key Lab Prot Funct & Regulat Agr O, Guangzhou, Guangdong, Peoples R China	South China Agricultural University; South China Agricultural University	Zhang, LH (corresponding author), South China Agr Univ, Coll Life Sci, Guangzhou, Guangdong, Peoples R China.	lhzhang73212000@yahoo.com.cn			National Natural Science Foundation of China [31072114]; Guangdong Provincial Key Laboratory of Protein Function and Regulation in Agricultural Organisms; Guangdong Province Agricultural Technological Project [2009B020307010]; Guangzhou Sciences and Technologies Project [2013Z1]; Project and Key Laboratory of Animal Disease Control and Prevention of the Ministry of Agriculture	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Provincial Key Laboratory of Protein Function and Regulation in Agricultural Organisms; Guangdong Province Agricultural Technological Project; Guangzhou Sciences and Technologies Project; Project and Key Laboratory of Animal Disease Control and Prevention of the Ministry of Agriculture	This study was supported by National Natural Science Foundation of China (No. 31072114), Guangdong Provincial Key Laboratory of Protein Function and Regulation in Agricultural Organisms, Guangdong Province Agricultural Technological Project (No. 2009B020307010), Guangzhou Sciences and Technologies Project (No. 2013Z1), Project and Key Laboratory of Animal Disease Control and Prevention of the Ministry of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti S, 2006, MECH AGEING DEV, V127, P560, DOI 10.1016/j.mad.2006.01.014; Bailey M, 1998, SCAND J IMMUNOL, V48, P177; Boeker M, 1999, IMMUNOBIOLOGY, V201, P74, DOI 10.1016/S0171-2985(99)80048-5; Cao D, 2010, VACCINE, V28, P6006, DOI 10.1016/j.vaccine.2010.06.103; Chan KG, 2007, INFECT IMMUN, V75, P3033, DOI 10.1128/IAI.01549-06; COUTELIER JP, 1991, J IMMUNOL, V147, P1383; COUTELIER JP, 1988, J EXP MED, V168, P2373, DOI 10.1084/jem.168.6.2373; Deng YP, 2004, J IMMUNOL, V172, P3437, DOI 10.4049/jimmunol.172.6.3437; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; Estes DM, 1996, VET IMMUNOL IMMUNOP, V54, P61, DOI 10.1016/S0165-2427(96)05684-X; Fulop T, 2006, MECH AGEING DEV, V127, P526, DOI 10.1016/j.mad.2006.01.025; Gomez CR, 2008, EXP GERONTOL, V43, P718, DOI 10.1016/j.exger.2008.05.016; Grubeck-Loebenstein B, 2002, ADV IMMUNOL, V80, P243, DOI 10.1016/S0065-2776(02)80017-7; Haynes L, 2005, IMMUNOL REV, V205, P220, DOI 10.1111/j.0105-2896.2005.00255.x; Holtmeier W, 2002, J IMMUNOL, V169, P1993, DOI 10.4049/jimmunol.169.4.1993; KAWANO Y, 1994, J IMMUNOL, V153, P4948; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Linton PJ, 2004, NAT IMMUNOL, V5, P133, DOI 10.1038/ni1033; Lipford GB, 1997, EUR J IMMUNOL, V27, P3420, DOI 10.1002/eji.1830271242; Ma MP, 2012, MOL IMMUNOL, V52, P217, DOI 10.1016/j.molimm.2012.05.016; Maletto BA, 2005, CLIN IMMUNOL, V117, P251, DOI 10.1016/j.clim.2005.08.016; Manz RA, 1997, NATURE, V388, P133, DOI 10.1038/40540; Masuda K, 2000, J VET MED SCI, V62, P995, DOI 10.1292/jvms.62.995; McCluskie MJ, 2006, CURR TOP MICROBIOL, V311, P155; Morgan EL, 2010, VACCINE, V28, P8275, DOI 10.1016/j.vaccine.2010.10.008; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Pawelec G, 2002, FRONT BIOSCI-LANDMRK, V7, pD1056; Rogers CS, 2008, J CLIN INVEST, V118, P1571, DOI 10.1172/JCI34773; Schellack C, 2006, VACCINE, V24, P5461, DOI 10.1016/j.vaccine.2006.03.071; Schwab R, 1997, J IMMUNOL, P158; SNAPPER CM, 1987, SCIENCE, V236, P944, DOI 10.1126/science.3107127; Snapper CM, 1998, FUNDAMENTAL IMMUNOLO, P831; Tsiagbe VK, 1996, CRIT REV IMMUNOL, V16, P381; Vollmer J, 2009, ADV DRUG DELIVER REV, V61, P195, DOI 10.1016/j.addr.2008.12.008; Zhang LH, 2006, DEV COMP IMMUNOL, V30, P589, DOI 10.1016/j.dci.2005.07.005; Zhang LH, 2006, RES VET SCI, V80, P281, DOI 10.1016/j.rvsc.2005.07.009; Zhang LH, 2006, VACCINE, V24, P1874, DOI 10.1016/j.vaccine.2005.10.033; Zhang LH, 2008, VACCINE, V26, P224, DOI 10.1016/j.vaccine.2007.10.058; Zhang LH, 2007, MOL IMMUNOL, V44, P1141, DOI 10.1016/j.molimm.2006.07.001; Zhang LH, 2007, VACCINE, V25, P1735, DOI 10.1016/j.vaccine.2006.11.033; Zheng B, 1997, IMMUNOL REV, V160, P63, DOI 10.1111/j.1600-065X.1997.tb01028.x; Zuckermann FA, 2000, VET RES, V31, P121, DOI 10.1051/vetres:2000060	42	9	10	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65536	10.1371/journal.pone.0065536	http://dx.doi.org/10.1371/journal.pone.0065536			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785433	Green Submitted, Green Published, gold			2022-12-27	WOS:000321038800088
J	Rabus, M; Sollradl, T; Clausen-Schaumann, H; Laforsch, C				Rabus, Max; Soellradl, Thomas; Clausen-Schaumann, Hauke; Laforsch, Christian			Uncovering Ultrastructural Defences in Daphnia magna - An Interdisciplinary Approach to Assess the Predator-Induced Fortification of the Carapace	PLOS ONE			English	Article							INDUCIBLE DEFENSES; MORPHOLOGICAL DEFENSES; PHENOTYPIC PLASTICITY; WATERBORNE CUES; RESPONSES; PLANKTON; ELASTICITY; INDUCTION; ECOLOGY; BIOLOGY	The development of structural defences, such as the fortification of shells or exoskeletons, is a widespread strategy to reduce predator attack efficiency. In unpredictable environments these defences may be more pronounced in the presence of a predator. The cladoceran Daphnia magna (Crustacea: Branchiopoda: Cladocera) has been shown to develop a bulky morphotype as an effective inducible morphological defence against the predatory tadpole shrimp Triops cancriformis (Crustacea: Branchiopoda: Notostraca). Mediated by kairomones, the daphnids express an increased body length, width and an elongated tail spine. Here we examined whether these large scale morphological defences are accompanied by additional ultrastructural defences, i.e. a fortification of the exoskeleton. We employed atomic force microscopy (AFM) based nanoindentation experiments to assess the cuticle hardness along with tapping mode AFM imaging to visualise the surface morphology for predator exposed and non-predator exposed daphnids. We used semi-thin sections of the carapace to measure the cuticle thickness, and finally, we used fluorescence microscopy to analyse the diameter of the pillars connecting the two carapace layers. We found that D. magna indeed expresses ultrastructural defences against Triops predation. The cuticle in predator exposed individuals is approximately five times harder and two times thicker than in control daphnids. Moreover, the pillar diameter is significantly increased in predator exposed daphnids. These predator-cue induced changes in the carapace architecture should provide effective protection against being crushed by the predator's mouthparts and may add to the protective effect of bulkiness. This study highlights the potential of interdisciplinary studies to uncover new and relevant aspects even in extensively studied fields of research.	[Rabus, Max] Ludwig Maximilians Univ Munchen, Dept Biol 2, Munich, Germany; [Rabus, Max; Laforsch, Christian] Univ Bayreuth, Dept Anim Ecol 1, Bayreuth, Germany; [Soellradl, Thomas; Clausen-Schaumann, Hauke] Univ Appl Sci Munich, Dept Precis & Microengn Engn Phys, Munich, Germany; [Clausen-Schaumann, Hauke] Ludwig Maximilians Univ Munchen, Ctr NanoSci, Munich, Germany; [Laforsch, Christian] Ludwig Maximilians Univ Munchen, Geo Bio Ctr, Munich, Germany	University of Munich; University of Bayreuth; University of Munich; University of Munich	Rabus, M (corresponding author), Ludwig Maximilians Univ Munchen, Dept Biol 2, Munich, Germany.	rabus@bio.lmu.de	Clausen-Schaumann, Hauke/W-1830-2017	Clausen-Schaumann, Hauke/0000-0002-9413-0310	Universitat Bayern e.V.; German Excellence Initiative via the "Nanosystems Initiative Munich (NIM)"; ESF; DFG [LA 2159/6-1]	Universitat Bayern e.V.; German Excellence Initiative via the "Nanosystems Initiative Munich (NIM)"; ESF(European Commission); DFG(German Research Foundation (DFG))	MR was funded by a research scholarschip awarded by the Universitat Bayern e.V. http://www.unibayern.de/ TS and HCS were funded by the German Excellence Initiative via the "Nanosystems Initiative Munich (NIM)". http://www.nano-initiative-munich.de/en/ CL was funded by the ESF (project "stressflea") and the DFG (project LA 2159/6-1). www.esf.org/www.dfg.de/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson BG, 1933, BIOL BULL-US, V64, P70, DOI 10.2307/1537501; Auld JR, 2011, EVOL ECOL, V25, P189, DOI 10.1007/s10682-010-9394-1; Barry MJ, 2000, OECOLOGIA, V124, P396, DOI 10.1007/s004420000420; Beyer MK, 2005, CHEM REV, V105, P2921, DOI 10.1021/cr030697h; BILODEAU GG, 1992, J APPL MECH-T ASME, V59, P519, DOI 10.1115/1.2893754; BLACK AR, 1990, OECOLOGIA, V83, P117, DOI 10.1007/BF00324642; BRONMARK C, 1992, SCIENCE, V258, P1348, DOI 10.1126/science.258.5086.1348; Bronmark C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021773; BUTT HJ, 1995, NANOTECHNOLOGY, V6, P1, DOI 10.1088/0957-4484/6/1/001; Clausen-Schaumann H, 2000, CURR OPIN CHEM BIOL, V4, P524, DOI 10.1016/S1367-5931(00)00126-5; Clausen-Schaumann H, 2000, BIOPHYS J, V78, P1997, DOI 10.1016/S0006-3495(00)76747-6; Docheva D, 2008, J CELL MOL MED, V12, P537, DOI 10.1111/j.1582-4934.2007.00138.x; Docheva D, 2010, BIOCHEM BIOPH RES CO, V402, P361, DOI 10.1016/j.bbrc.2010.10.034; DODSON SI, 1984, ECOLOGY, V65, P1249, DOI 10.2307/1938331; DODSON SI, 1974, LIMNOL OCEANOGR, V19, P721, DOI 10.4319/lo.1974.19.5.0721; Domke J, 1998, LANGMUIR, V14, P3320, DOI 10.1021/la9713006; Flenner I, 2009, ECOL ENTOMOL, V34, P735, DOI 10.1111/j.1365-2311.2009.01129.x; FRYER G, 1988, PHILOS T ROY SOC B, V321, P27, DOI 10.1098/rstb.1988.0091; GILBERT JJ, 1966, SCIENCE, V151, P1234, DOI 10.1126/science.151.3715.1234; Grandbois M, 1999, SCIENCE, V283, P1727, DOI 10.1126/science.283.5408.1727; Grandbois M, 1998, BIOPHYS J, V74, P2398, DOI 10.1016/S0006-3495(98)77948-2; GRANT JWG, 1981, LIMNOL OCEANOGR, V26, P201, DOI 10.4319/lo.1981.26.2.0201; Harvell CD, 1999, ECOLOGY EVOLUTION IN; HAVEL JE, 1985, HYDROBIOLOGIA, V124, P141, DOI 10.1007/BF00006796; HAVEL JE, 1984, LIMNOL OCEANOGR, V29, P487, DOI 10.4319/lo.1984.29.3.0487; HEBERT PDN, 1985, LIMNOL OCEANOGR, V30, P1291, DOI 10.4319/lo.1985.30.6.1291; Kerfoot W. C., 1987, PREDATION DIRECT IND; Kishida O, 2010, POPUL ECOL, V52, P37, DOI 10.1007/s10144-009-0182-0; KRUEGER DA, 1981, LIMNOL OCEANOGR, V26, P219, DOI 10.4319/lo.1981.26.2.0219; Laforsch C, 2004, P NATL ACAD SCI USA, V101, P15911, DOI 10.1073/pnas.0404860101; Laforsch C, 2004, ECOLOGY, V85, P2302, DOI 10.1890/03-0286; Laforsch C, 2000, ARCH HYDROBIOL, V149, P587; Laforsch C, 2009, ENCY INLAND WATERS, P643; LAMPERT W, 1989, FUNCT ECOL, V3, P21, DOI 10.2307/2389671; Lampert W, 2011, DAPHNIA DEV MODEL OR, P5; Lass S, 2003, HYDROBIOLOGIA, V491, P221, DOI 10.1023/A:1024487804497; Leonard GH, 1999, ECOLOGY, V80, P1; Lively CM, 2000, ECOLOGY, V81, P1240, DOI 10.1890/0012-9658(2000)081[1240:PIDVFI]2.0.CO;2; Lord JP, 2012, MAR BIOL, V159, P1177, DOI 10.1007/s00227-012-1896-7; Petrusek A, 2009, P NATL ACAD SCI USA, V106, P2248, DOI 10.1073/pnas.0808075106; Pijanowska J, 1997, FRESHWATER BIOL, V37, P649, DOI 10.1046/j.1365-2427.1997.00192.x; Rabus M, 2012, J PLANKTON RES, V34, P152, DOI 10.1093/plankt/fbr092; Rabus M, 2011, FUNCT ECOL, V25, P1137, DOI 10.1111/j.1365-2435.2011.01840.x; RICHARDSON KC, 1960, STAIN TECHNOL, V35, P313, DOI 10.3109/10520296009114754; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Rief M, 1999, NAT STRUCT BIOL, V6, P346; Riessen HP, 2012, P NATL ACAD SCI USA, V109, P15377, DOI 10.1073/pnas.1209938109; Riessen HP, 2009, ECOLOGY, V90, P3455, DOI 10.1890/08-1652.1; Schmidt SW, 2012, ACS NANO, V6, P1314, DOI 10.1021/nn204111w; Seda J, 2011, J LIMNOL, V70, P337, DOI 10.4081/jlimnol.2011.337; Selden R, 2009, MAR BIOL, V156, P1057, DOI 10.1007/s00227-009-1150-0; Sih A, 1998, TRENDS ECOL EVOL, V13, P350, DOI 10.1016/S0169-5347(98)01437-2; Spaak Piet, 1997, Aquatic Ecology, V31, P89, DOI 10.1023/A:1009935100804; Stolz M, 2009, NAT NANOTECHNOL, V4, P186, DOI [10.1038/nnano.2008.410, 10.1038/NNANO.2008.410]; TALBOT P, 1972, TISSUE CELL, V4, P613, DOI 10.1016/S0040-8166(72)80034-X; TOLLRIAN R, 1994, ARCH HYDROBIOL, V130, P69; Tollrian R, 1999, ENCY ECOLOGY; Trussell GC, 2002, ECOLOGY, V83, P1635, DOI 10.2307/3071984; Trussell GC, 1996, EVOLUTION, V50, P448, DOI 10.1111/j.1558-5646.1996.tb04507.x; WEIDER LJ, 1993, OIKOS, V67, P385, DOI 10.2307/3545351	60	32	33	0	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e67856	10.1371/journal.pone.0067856	http://dx.doi.org/10.1371/journal.pone.0067856			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776711	gold, Green Published, Green Submitted			2022-12-27	WOS:000320322400127
J	Zajac, RN; Vozarik, JM; Gibbons, BR				Zajac, Roman N.; Vozarik, Joseph M.; Gibbons, Brittney R.			Spatial and Temporal Patterns in Macrofaunal Diversity Components Relative to Sea Floor Landscape Structure	PLOS ONE			English	Article							LONG-ISLAND SOUND; SPECIES-DIVERSITY; BETA-DIVERSITY; MARINE BIODIVERSITY; ALPHA-DIVERSITY; DEEP-SEA; BENTHIC COMMUNITIES; CONTINENTAL-SHELF; HABITAT STRUCTURE; SCALES	We examined temporal changes in macrofaunal alpha- and beta-diversity over several spatial scales (within patches, among patches, across landscapes and across regions) in Long Island Sound on the northeast USA coast. Regional epsilon-diversity was estimated at 144 taxa, however gamma-diversity fluctuated over time as did alpha- and beta-diversity components. Based on additive partitioning, patch-and region-scale beta-diversity components generally had the highest contributions to gamma-diversity; lower percentages were found at within-patch and landscape scales. Multiplicative diversity partitioning indicated highest species turnover at within-and among patch scales. For all partition results, within-patch and patch-scale beta-diversity increased sharply when hypoxia impacted benthic communities. Spatial variation in diversity components can be attributed to the collection of different patch types at varying spatial scales and their associated habitats across the benthic landscapes, as well as gradients in depth and other estuarine-scale characteristics. Temporal variation in diversity components across spatial scales may be related to seasonal changes in habitat heterogeneity, species population dynamics, and seasonal disturbances. Rare species were significant and temporally consistent components of macrofaunal diversity patterns over different spatial scales. Our findings agree with other marine and terrestrial studies that show diversity components vary significantly over different spatial scales and the importance of habitat/landscape heterogeneity in supporting diversity. However, our results indicate that the relative contributions of scale-specific beta-diversity components can also change significantly over time. Thus, studies of diversity patterns across patches and landscapes based on data collected at one time, or assembled into a single data set from different times, may not capture the full suite of diversity patterns that occur over varying spatial scales and any time-specific determinants of those patterns. Many factors that shape and maintain sedimentary communities vary temporally, and appear to play an important role in determining and maintaining macrofaunal diversity over different spatial scales.	[Zajac, Roman N.; Gibbons, Brittney R.] Univ New Haven, Dept Biol & Environm Sci, West Haven, CT USA; [Vozarik, Joseph M.] Millstone Power Stn, Millstone Environm Lab, Waterford, CT USA	University New Haven	Zajac, RN (corresponding author), Univ New Haven, Dept Biol & Environm Sci, West Haven, CT USA.	rzajac@newhaven.edu			Connecticut Department of Environmental Protection; Long Island Sound Research Fund [CWF-317-R]; University of New Haven	Connecticut Department of Environmental Protection; Long Island Sound Research Fund; University of New Haven	This work was supported, in part, by the Connecticut Department of Environmental Protection, Long Island Sound Research Fund Grant CWF-317-R and a University of New Haven Research Award to R.N. Zajac; additional funding was provided by the University of New Haven for graduate student assistantships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belmaker J, 2008, ECOLOGY, V89, P2829, DOI 10.1890/07-1464.1; Bevilacqua S, 2012, ECOL INDIC, V18, P140, DOI 10.1016/j.ecolind.2011.11.006; Capriulo GM, 2002, HYDROBIOLOGIA, V475, P263, DOI 10.1023/A:1020387325081; Colwell RK, 2013, ESTIMATES STAT ESTIM; Costello MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012110; Crist TO, 2006, ECOL LETT, V9, P923, DOI 10.1111/j.1461-0248.2006.00941.x; Crist TO, 2003, AM NAT, V162, P734, DOI 10.1086/378901; DAYTON PK, 1972, DEEP-SEA RES, V19, P199, DOI 10.1016/0011-7471(72)90031-9; Declerck SAJ, 2011, ECOGRAPHY, V34, P296, DOI 10.1111/j.1600-0587.2010.06462.x; DOBBS FC, 1983, MAR ECOL PROG SER, V11, P273, DOI 10.3354/meps011273; Ellingsen KE, 2007, J SEA RES, V58, P291, DOI 10.1016/j.seares.2007.10.001; Ellingsen KE, 2002, MAR ECOL PROG SER, V232, P15, DOI 10.3354/meps232015; Ellingsen KE, 2002, J ANIM ECOL, V71, P373, DOI 10.1046/j.1365-2656.2002.00606.x; Ellingsen KE, 2001, MAR ECOL PROG SER, V218, P1, DOI 10.3354/meps218001; Ellis J. I., 2000, Journal of Aquatic Ecosystem Stress and Recovery, V7, P57, DOI 10.1023/A:1009923530894; Eros T, 2007, FRESHWATER BIOL, V52, P1400, DOI 10.1111/j.1365-2427.2007.01777.x; ETTER RJ, 1992, NATURE, V360, P576, DOI 10.1038/360576a0; Forman R., 2014, ECOLOGICAL DESIGN PL, P217; Gabriel D, 2006, ECOL APPL, V16, P2011, DOI 10.1890/1051-0761(2006)016[2011:BDADSS]2.0.CO;2; Gering JC, 2003, CONSERV BIOL, V17, P488, DOI 10.1046/j.1523-1739.2003.01465.x; Golodets C, 2011, J APPL ECOL, V48, P1260, DOI 10.1111/j.1365-2664.2011.02031.x; Gossner MM, 2011, LANDSCAPE ECOL, V26, P411, DOI 10.1007/s10980-010-9568-9; GRASSLE JF, 1992, AM NAT, V139, P313, DOI 10.1086/285329; Gray JS, 2001, SCI MAR, V65, P41, DOI 10.3989/scimar.2001.65s241; Gray JS, 2002, MAR ECOL PROG SER, V244, P285, DOI 10.3354/meps244285; Gray JS, 1997, BIODIVERS CONSERV, V6, P153, DOI 10.1023/A:1018335901847; Gray JS, 2000, J EXP MAR BIOL ECOL, V250, P23, DOI 10.1016/S0022-0981(00)00178-7; Harris PT, 2012, ELSEV INSIGHT, P1; Hewitt JE, 2005, ECOLOGY, V86, P1619, DOI 10.1890/04-1099; Hewitt JE, 2004, ECOL APPL, V14, P1203, DOI 10.1890/03-5177; Hirao T, 2007, ECOL ENTOMOL, V32, P627, DOI 10.1111/j.1365-2311.2007.00913.x; Josefson AB, 2009, MAR ECOL PROG SER, V396, P283, DOI 10.3354/meps08375; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Kostylev V., 2007, SPEC PAP GEOL ASS CA, V47, P171; Kraufvelin P, 2011, MAR ECOL PROG SER, V426, P13, DOI 10.3354/meps09038; Levin LA, 2001, ECOSYSTEMS, V4, P430, DOI 10.1007/s10021-001-0021-4; MAY RM, 1994, PHILOS T R SOC B, V343, P105, DOI 10.1098/rstb.1994.0014; O'Dor R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011871; Rodriguez D, 2011, J ARID ENVIRON, V75, P424, DOI 10.1016/j.jaridenv.2010.12.007; Rodriguez-Zaragoza FA, 2008, CARIBB J SCI, V44, P90; Sala E, 2006, ANNU REV ENV RESOUR, V31, P93, DOI 10.1146/annurev.energy.31.020105.100235; SANDERS HL, 1968, AM NAT, V102, P243, DOI 10.1086/282541; Schlacher TA, 1998, MAR ECOL PROG SER, V174, P159, DOI 10.3354/meps174159; Signell RP, 2000, J COASTAL RES, V16, P551; Snelgrove PVR, 2002, OCEANOGR MAR BIOL, V40, P311; Snelgrove PVR, 1999, BIOSCIENCE, V49, P129, DOI 10.2307/1313538; Snelgrove PVR, 2000, BIOSCIENCE, V50, P1076, DOI 10.1641/0006-3568(2000)050[1076:LBAABT]2.0.CO;2; Stendera SES, 2005, FRESHWATER BIOL, V50, P1360, DOI 10.1111/j.1365-2427.2005.01403.x; Stireman JO, 2008, ANN ENTOMOL SOC AM, V101, P362, DOI 10.1603/0013-8746(2008)101[362:ADOATP]2.0.CO;2; Summerville KS, 2003, CONSERV BIOL, V17, P1045, DOI 10.1046/j.1523-1739.2003.02059.x; Thrush SF, 2001, MAR ECOL PROG SER, V221, P255, DOI 10.3354/meps221255; Thrush SF, 2006, ECOL APPL, V16, P1636, DOI 10.1890/1051-0761(2006)016[1636:PTEOHH]2.0.CO;2; Thrush SF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011899; Twichell DC, 1997, GEOLOGIC INVESTIGATI; Twichell DC, 1998, GEOLOGIC INVESTIGATI; Veech JA, 2002, OIKOS, V99, P3, DOI 10.1034/j.1600-0706.2002.990101.x; Veech JA, 2009, PARTITION SOFTWARE H; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190; Witman JD, 2004, P NATL ACAD SCI USA, V101, P15664, DOI 10.1073/pnas.0404300101; Zajac RN, 2003, LIMNOL OCEANOGR, V48, P829, DOI 10.4319/lo.2003.48.2.0829; Zajac RN, 2000, J COASTAL RES, V16, P627; Zajac RN, 1999, NATO ASI 2, V59, P211; ZAJAC RN, 1998, SPATIAL TEMPORAL CHA; Zajac RN, 2008, J EXP MAR BIOL ECOL, V366, P198, DOI 10.1016/j.jembe.2008.07.025; Zvuloni A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009941	65	32	32	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65823	10.1371/journal.pone.0065823	http://dx.doi.org/10.1371/journal.pone.0065823			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776552	Green Published, gold			2022-12-27	WOS:000320322400058
J	Dehzangi, A; Larki, F; Hutagalung, SD; Naseri, MG; Majlis, BY; Navasery, M; Hamid, NA; Noor, MM				Dehzangi, Arash; Larki, Farhad; Hutagalung, Sabar D.; Naseri, Mahmood Goodarz; Majlis, Burhanuddin Y.; Navasery, Manizheh; Hamid, Norihan Abdul; Noor, Mimiwaty Mohd			Impact of Parameter Variation in Fabrication of Nanostructure by Atomic Force Microscopy Nanolithography	PLOS ONE			English	Article							ANISOTROPIC ETCHING PROPERTIES; SCANNING PROBE MICROSCOPE; SILICON-OXIDE; DOUBLE-GATE; ALKALINE-SOLUTIONS; NANO-OXIDATION; KOH; LITHOGRAPHY; FIELD; TRANSISTOR	In this letter, we investigate the fabrication of Silicon nanostructure patterned on lightly doped (10(15) cm(-3)) p-type silicon-on- insulator by atomic force microscope nanolithography technique. The local anodic oxidation followed by two wet etching steps, potassium hydroxide etching for silicon removal and hydrofluoric etching for oxide removal, are implemented to reach the structures. The impact of contributing parameters in oxidation such as tip materials, applying voltage on the tip, relative humidity and exposure time are studied. The effect of the etchant concentration (10% to 30% wt) of potassium hydroxide and its mixture with isopropyl alcohol (10% vol. IPA) at different temperatures on silicon surface are expressed. For different KOH concentrations, the effect of etching with the IPA admixture and the effect of the immersing time in the etching process on the structure are investigated. The etching processes are accurately optimized by 30% wt. KOH + 10% vol. IPA in appropriate time, temperature, and humidity.	[Dehzangi, Arash; Larki, Farhad; Majlis, Burhanuddin Y.; Hamid, Norihan Abdul; Noor, Mimiwaty Mohd] Univ Kebangsaan Malaysia, Inst Microengn & Nanoelect, Bangi 43600, Selangor, Malaysia; [Hutagalung, Sabar D.] Univ Sains Malaysia, Sch Mat & Mineral Resources Engn, Nibongtebal, Penang, Malaysia; [Naseri, Mahmood Goodarz; Navasery, Manizheh] Univ Putra Malaysia, Fac Sci, Dept Phys, Serdang 43400, Selangor, Malaysia; [Naseri, Mahmood Goodarz] Malayer Univ, Fac Sci, Dept Phys, Malayer, Hamedan, Iran	Universiti Kebangsaan Malaysia; Universiti Sains Malaysia; Universiti Putra Malaysia	Dehzangi, A (corresponding author), Univ Kebangsaan Malaysia, Inst Microengn & Nanoelect, Bangi 43600, Selangor, Malaysia.	arashd53@hotmail.com; mrsabar@eng.usm.my	Dehzangi, Arash/H-6493-2013; Hutagalung, Sabar D/L-1929-2019; Hutagalung, Sabar/B-4169-2009; Majlis, Burhanuddin/D-4093-2014; Hamid, Norihan Abdul/AAZ-5384-2020; Dehzangi, Arash/I-4378-2019	Dehzangi, Arash/0000-0001-5043-2678; Hutagalung, Sabar D/0000-0002-5744-3553; Hutagalung, Sabar/0000-0002-5744-3553; Dehzangi, Arash/0000-0001-5043-2678; larki, farhad/0000-0002-5336-1905	Universiti Kebangsaan Malaysia [DIP-2012-16]; Universiti Sains Malaysia, USM RU Grant [1001/PBAHAN/814167]	Universiti Kebangsaan Malaysia; Universiti Sains Malaysia, USM RU Grant(Universiti Sains Malaysia)	The authors gratefully acknowledge that this work was financially supported by Universiti Kebangsaan Malaysia through the grant funded under "DANA IMPAC PERDANA, DIP-2012-16'' and Universiti Sains Malaysia, USM RU Grant no. 1001/PBAHAN/814167. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah AM, 2010, INT J NANOSCI, V9, P251, DOI 10.1142/S0219581X10006752; Avouris P, 1997, APPL PHYS LETT, V71, P285, DOI 10.1063/1.119521; Biswas K, 2006, MICROELECTRON J, V37, P765, DOI 10.1016/j.mejo.2005.10.010; Biswas K, 2006, MICROELECTRON J, V37, P519, DOI 10.1016/j.mejo.2005.07.012; Cabrera N, 1949, REP PROGR PHYS, V12, P163; Camon H, 1997, MICROELECTR J, V28, P509, DOI 10.1016/S0026-2692(96)00067-5; Campbell S, 1999, J MICROMECH MICROENG, V5, P209; Chiesa M, 2012, NANO LETT, V12, P1275, DOI 10.1021/nl2037547; Choi YK, 2003, JPN J APPL PHYS 1, V42, P2073, DOI 10.1143/JJAP.42.2073; Cook MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001546; Dagata JA, 2004, J APPL PHYS, V96, P2386, DOI 10.1063/1.1771820; Dagata JA, 1998, APPL PHYS LETT, V73, P271, DOI 10.1063/1.121777; Dehzangi A, 2012, MICRO NANO LETT, V7, P981, DOI 10.1049/mnl.2012.0590; Dehzangi A, 2013, NANO HYBRIDS COMPOS, V3, P93, DOI 10.4028/www.scientific.net/NH.3.93; Dehzangi A, 2012, NANOSCALE RES LETT, V7, DOI 10.1186/1556-276X-7-381; Fang TH, 2004, MICROELECTRON J, V35, P701, DOI 10.1016/j.mejo.2004.06.022; Garcia R, 2006, CHEM SOC REV, V35, P29, DOI 10.1039/b501599p; Gordon AE, 1995, J VAC SCI TECHNOL B, V13, P2805, DOI 10.1116/1.588270; GRAF D, 1989, J VAC SCI TECHNOL A, V7, P808, DOI 10.1116/1.575845; Guo LJ, 2007, ADV MATER, V19, P495, DOI 10.1002/adma.200600882; Haiss W, 2006, J ELECTROANAL CHEM, V597, P1, DOI 10.1016/j.jelechem.2006.07.027; Hsu HF, 2008, ULTRAMICROSCOPY, V108, P1076, DOI 10.1016/j.ultramic.2008.04.025; Hu XD, 2003, APPL SURF SCI, V217, P34, DOI 10.1016/S0169-4332(03)00554-3; Ionica I, 2005, SOLID STATE ELECTRON, V49, P1497, DOI 10.1016/j.sse.2005.07.012; Jansen H, 1996, J MICROMECH MICROENG, V6, P14, DOI 10.1088/0960-1317/6/1/002; JU CS, 1992, THIN SOLID FILMS, V215, P58, DOI 10.1016/0040-6090(92)90701-C; KERN W, 1970, RCA REV, V31, P187; Knoll AW, 2010, ADV MATER, V22, P3361, DOI 10.1002/adma.200904386; Kohli R, 2007, DEV SURFACE CONTAMIN; Kuramochi H, 2003, SURF SCI, V542, P56, DOI 10.1016/S0039-6028(03)00912-9; Larki F, 2012, BEILSTEIN J NANOTECH, V3, P817, DOI 10.3762/bjnano.3.91; Legrand B, 2002, J VAC SCI TECHNOL B, V20, P862, DOI 10.1116/1.1470519; Marchi F, 1998, J VAC SCI TECHNOL B, V16, P2952, DOI 10.1116/1.590325; Martinez RV, 2007, NANO LETT, V7, P1846, DOI 10.1021/nl070328r; MERLOS A, 1993, SENSOR ACTUAT A-PHYS, V37-8, P737, DOI 10.1016/0924-4247(93)80125-Z; Mo YF, 2009, ULTRAMICROSCOPY, V109, P247, DOI 10.1016/j.ultramic.2008.10.025; Pennelli G, 2006, MICROELECTRON ENG, V83, P1710, DOI 10.1016/j.mee.2006.01.144; Pennelli G, 2006, J APPL PHYS, V100, DOI 10.1063/1.2338599; Pennelli G, 2009, MICROELECTRON ENG, V86, P2139, DOI 10.1016/j.mee.2009.02.032; Philipsen HGG, 2009, ELECTROCHIM ACTA, V54, P3526, DOI 10.1016/j.electacta.2008.12.044; Qin D, 2010, NAT PROTOC, V5, P491, DOI 10.1038/nprot.2009.234; SCHMUKI P, 1995, J ELECTROCHEM SOC, V142, P1705, DOI 10.1149/1.2048644; SEIDEL H, 1990, J ELECTROCHEM SOC, V137, P3612, DOI 10.1149/1.2086277; Shikida M, 2000, SENSOR ACTUAT A-PHYS, V80, P179, DOI 10.1016/S0924-4247(99)00264-2; Snow ES, 2000, APPL PHYS LETT, V76, P1782, DOI 10.1063/1.126166; SNOW ES, 1994, APPL PHYS LETT, V64, P1932, DOI 10.1063/1.111746; Stievenard D, 1997, APPL PHYS LETT, V70, P3272, DOI 10.1063/1.118425; SUGIMURA H, 1995, NANOTECHNOLOGY, V6, P29, DOI 10.1088/0957-4484/6/1/005; Tello M, 2005, ADV MATER, V17, P1480, DOI 10.1002/adma.200401466; TEUSCHLER T, 1995, APPL PHYS LETT, V67, P3144, DOI 10.1063/1.114861; VERHAVERBEKE S, 2002, SEMICONDUCTOR INT, V25, P91; Viheriala J, 2011, NANOIMPRINT LITHOGRA; Xie XN, 2006, MAT SCI ENG R, V54, P1, DOI 10.1016/j.mser.2006.10.001; Yang CR, 2005, SENSOR ACTUAT A-PHYS, V119, P271, DOI 10.1016/j.sna.2004.09.017; Yang P, 2010, EVOLUTION THEORY DRA; Youn SW, 2006, WEAR, V261, P328, DOI 10.1016/j.wear.2005.11.007; Yun MH, 2000, J KOREAN PHYS SOC, V37, P605; Zhang Y, 2010, PROC IEEE MICR ELECT, P336, DOI 10.1109/MEMSYS.2010.5442496; Zubel I, 2001, SENSOR ACTUAT A-PHYS, V93, P138, DOI 10.1016/S0924-4247(01)00648-3; Zubel I, 2002, SENSOR ACTUAT A-PHYS, V101, P255, DOI 10.1016/S0924-4247(02)00265-0; Zubel I, 2001, SENSOR ACTUAT A-PHYS, V87, P163, DOI 10.1016/S0924-4247(00)00481-7	61	11	12	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65409	10.1371/journal.pone.0065409	http://dx.doi.org/10.1371/journal.pone.0065409			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776479	Green Published, gold, Green Submitted			2022-12-27	WOS:000320755400029
J	Huang, L; Zhang, QY; Li, SQ; Guan, LP; Xiao, XS; Zhang, JG; Jia, XY; Sun, WM; Zhu, ZH; Gao, Y; Yin, Y; Wang, PF; Guo, XM; Wang, J; Zhang, QJ				Huang, Li; Zhang, Qingyan; Li, Shiqiang; Guan, Liping; Xiao, Xueshan; Zhang, Jianguo; Jia, Xiaoyun; Sun, Wenmin; Zhu, Zhihong; Gao, Yang; Yin, Ye; Wang, Panfeng; Guo, Xiangming; Wang, Jun; Zhang, Qingjiong			Exome Sequencing of 47 Chinese Families with Cone-Rod Dystrophy: Mutations in 25 Known Causative Genes	PLOS ONE			English	Article							AUTOSOMAL-DOMINANT CONE; RECESSIVE RETINAL DYSTROPHIES; GUANYLATE-CYCLASE; JAPANESE FAMILY; HOMEOBOX GENE; ABCA4 GENE; VARIANTS; PHOTORECEPTOR; GUCA1A; IDENTIFICATION	Objective: The goal of this study was to identify mutations in 25 known causative genes in 47 unrelated Chinese families with cone-rod dystrophy (CORD). Methods: Forty-seven probands from unrelated families with CORD were recruited. Genomic DNA prepared from leukocytes was analyzed by whole exome sequencing. Variants in the 25 genes were selected and then validated by Sanger sequencing. Results: Fourteen potential pathogenic mutations, including nine novel and five known, were identified in 10 of the 47 families (21.28%). Homozygous, compound heterozygous, and hemizygous mutations were detected in three, four, or three families, respectively. The 14 mutations in the 10 families were distributed among CNGB3 (three families), PDE6C (two families), ABCA4 (one family), RPGRIP1 (one family), RPGR (two families), and CACNA1F (one family). Conclusions: This study provides a brief view on mutation spectrum of the 25 genes in a Chinese cohort with CORD. Identification of novel mutations enriched our understanding of variations in these genes and their associated phenotypes. To our knowledge, this is the first systemic exome-sequencing analysis of all of the 25 CORD-associated genes.	[Huang, Li; Li, Shiqiang; Xiao, Xueshan; Jia, Xiaoyun; Sun, Wenmin; Gao, Yang; Wang, Panfeng; Guo, Xiangming; Zhang, Qingjiong] Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Qingyan; Guan, Liping; Zhang, Jianguo; Zhu, Zhihong; Yin, Ye; Wang, Jun] BGI Shenzhen, Shenzhen, Guangdong, Peoples R China	Sun Yat Sen University; Beijing Genomics Institute (BGI)	Wang, J (corresponding author), BGI Shenzhen, Shenzhen, Guangdong, Peoples R China.	wangj@genomics.cn; zhangqji@mail.sysu.edu.cn	Zhang, Qingjiong/AAR-6331-2021; Wang, Jun/A-7261-2013; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Zhang, Qingjiong/0000-0001-7508-848X; Wang, Jun/0000-0002-8540-8931; Wang, Jun/0000-0002-2113-5874	National Natural Science Foundation of China [81170881, U1201221]; Guangdong Translational Medicine Public Platform; Sun Yat-sen University; Fundamental Research Funds of the State Key Laboratory of Ophthalmology	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Translational Medicine Public Platform; Sun Yat-sen University; Fundamental Research Funds of the State Key Laboratory of Ophthalmology	This study was supported by the National Natural Science Foundation of China (81170881, U1201221, http://www.nsfc.gov.cn/Portal0/default152.htm), Guangdong Translational Medicine Public Platform, the "985 project" of Sun Yat-sen University, and the Fundamental Research Funds of the State Key Laboratory of Ophthalmology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abid A, 2006, J MED GENET, V43, P378, DOI 10.1136/jmg.2005.035055; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Cremers FPM, 1998, HUM MOL GENET, V7, P355, DOI 10.1093/hmg/7.3.355; den Dunnen JT, 2000, HUM MUTAT, V15, P7; den Hollander AI, 2010, J CLIN INVEST, V120, P3042, DOI 10.1172/JCI42258; Ducroq D, 2002, AM J HUM GENET, V71, P1480, DOI 10.1086/344829; Estrada-Cuzcano A, 2012, AM J HUM GENET, V90, P102, DOI 10.1016/j.ajhg.2011.11.015; Fishman GA, 2003, ARCH OPHTHALMOL-CHIC, V121, P851, DOI 10.1001/archopht.121.6.851; Fishman GA, 1997, OPHTHALMOLOGY, V104, P299, DOI 10.1016/S0161-6420(97)30320-0; Freund CL, 1997, CELL, V91, P543, DOI 10.1016/S0092-8674(00)80440-7; Garcia-Hoyos M, 2011, MOL VIS, V17, P1103; Hameed A, 2003, J MED GENET, V40, P616, DOI 10.1136/jmg.40.8.616; Huang L, 2013, MOL MED REP, V7, P1779, DOI 10.3892/mmr.2013.1415; Huang L, 2013, NEUROSCI LETT, V541, P179, DOI 10.1016/j.neulet.2013.02.013; Huang L, 2012, BIOCHEM BIOPH RES CO, V426, P498, DOI 10.1016/j.bbrc.2012.08.110; Ito S, 2004, INVEST OPHTH VIS SCI, V45, P1480, DOI 10.1167/iovs.03-0315; Jalkanen R, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.040741; Kelsell RE, 1998, AM J HUM GENET, V63, P274, DOI 10.1086/301905; Kelsell RE, 1998, HUM MOL GENET, V7, P1179, DOI 10.1093/hmg/7.7.1179; Kitiratschky VBD, 2009, HUM MUTAT, V30, pE782, DOI 10.1002/humu.21055; Kobayashi A, 2000, INVEST OPHTH VIS SCI, V41, P3268; Kohl S, 2012, ADV EXP MED BIOL, V723, P337, DOI 10.1007/978-1-4614-0631-0_44; Kohn L, 2007, EUR J HUM GENET, V15, P664, DOI 10.1038/sj.ejhg.5201817; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Li L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019458; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Li YR, 2010, NAT GENET, V42, P969, DOI 10.1038/ng.680; Littink KW, 2010, INVEST OPHTH VIS SCI, V51, P5943, DOI 10.1167/iovs.10-5797; Maugeri A, 2000, AM J HUM GENET, V67, P960, DOI 10.1086/303079; Michaelides M, 2004, INVEST OPHTH VIS SCI, V45, P1975, DOI 10.1167/iovs.03-0898; Ostergaard E, 2010, J MED GENET, V47, P665, DOI 10.1136/jmg.2009.069120; Parry DA, 2009, AM J HUM GENET, V84, P683, DOI 10.1016/j.ajhg.2009.04.005; Payne AM, 1998, HUM MOL GENET, V7, P273, DOI 10.1093/hmg/7.2.273; Polok B, 2009, AM J HUM GENET, V84, P259, DOI 10.1016/j.ajhg.2009.01.006; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Rozen S, 2000, Methods Mol Biol, V132, P365; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Sohocki MM, 2000, MOL GENET METAB, V70, P142, DOI 10.1006/mgme.2000.3001; Thiadens AAHJ, 2012, OPHTHALMOLOGY, V119, P819, DOI 10.1016/j.ophtha.2011.10.011; Thiadens AAHJ, 2009, AM J HUM GENET, V85, P240, DOI 10.1016/j.ajhg.2009.06.016; Wada Y, 2001, ARCH OPHTHALMOL-CHIC, V119, P1059, DOI 10.1001/archopht.119.7.1059; Wang Q, 2010, MOL VIS, V16, P303; Wang QL, 2004, HUM MOL GENET, V13, P1025, DOI 10.1093/hmg/ddh117; Wu HM, 2006, AM J HUM GENET, V79, P574, DOI 10.1086/507568; Wycisk KA, 2006, INVEST OPHTH VIS SCI, V47, P3523, DOI 10.1167/iovs.06-0271; Xiao XS, 2011, MOL VIS, V17, P3271; Yang ZL, 2008, J CLIN INVEST, V118, P2908, DOI 10.1172/JCI35891; Yesim F, 2002, AM J HUM GENET, V70, P1049, DOI 10.1086/339620	50	43	43	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65546	10.1371/journal.pone.0065546	http://dx.doi.org/10.1371/journal.pone.0065546			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776498	gold, Green Submitted, Green Published			2022-12-27	WOS:000320755400040
J	Knap, N; Avsic-Zupanc, T				Knap, Natasa; Avsic-Zupanc, Tatjana			Correlation of TBE Incidence with Red Deer and Roe Deer Abundance in Slovenia	PLOS ONE			English	Article							TICK-BORNE ENCEPHALITIS; IXODES-RICINUS TICKS; GEOGRAPHICAL-DISTRIBUTION; RISK-ASSESSMENT; LYME-DISEASE; VIRUS; DENSITY; ACARI; INFESTATION; PREVALENCE	Tick-borne encephalitis (TBE) is a virus infection which sometimes causes human disease. The TBE virus is found in ticks and certain vertebrate tick hosts in restricted endemic localities termed TBE foci. The formation of natural foci is a combination of several factors: the vectors, a suitable and numerous enough number of hosts and in a habitat with suitable vegetation and climate. The present study investigated the influence of deer on the incidence of tick-borne encephalitis. We were able to obtain data from deer culls. Using this data, the abundance of deer was estimated and temporal and spatial analysis was performed. The abundance of deer has increased in the past decades, as well as the incidence of tick-borne encephalitis. Temporal analysis confirmed a correlation between red deer abundance and tick-borne encephalitis occurrence. Additionally, spatial analysis established, that in areas with high incidence of tick-borne encephalitis red deer density is higher, compared to areas with no or few human cases of tick-borne encephalitis. However, such correlation could not be confirmed between roe deer density and the incidence of tick-borne encephalitis. This is presumably due to roe deer density being above a certain threshold so that availability of tick reproduction hosts has no apparent effect on ticks' host finding and consequently may not be possible to correlate with incidence of human TBE.	[Knap, Natasa; Avsic-Zupanc, Tatjana] Univ Ljubljana, Fac Med, Inst Microbiol & Immunol, Ljubljana, Slovenia	University of Ljubljana	Avsic-Zupanc, T (corresponding author), Univ Ljubljana, Fac Med, Inst Microbiol & Immunol, Ljubljana, Slovenia.	tatjana.avsic@mf.uni-lj.si		Knap, Natasa/0000-0002-8068-7302; AVSIC ZUPANC, TATJANA/0000-0001-6243-0688	EU [GOCE-2003-010284 EDEN]; Ministry of Higher Education, Science and Sport of Slovenia [P3-0083]	EU(European Commission); Ministry of Higher Education, Science and Sport of Slovenia	This study was partially funded by EU grant GOCE-2003-010284 EDEN and by the Ministry of Higher Education, Science and Sport of Slovenia (grant no. P3-0083). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achazi K, 2011, VECTOR-BORNE ZOONOT, V11, P641, DOI 10.1089/vbz.2010.0236; Adamic M, 1990, THESIS BELGRADE U; Brinkley C, 2008, INT J MED MICROBIOL, V298, P73, DOI 10.1016/j.ijmm.2007.12.005; Brokera M, 2008, VACCINE, V26, P863, DOI 10.1016/j.vaccine.2007.11.046; Cagnacci F, 2012, INT J PARASITOL, V42, P365, DOI 10.1016/j.ijpara.2012.02.012; Carpi G, 2008, EPIDEMIOL INFECT, V136, P1416, DOI 10.1017/S0950268807000039; Cernac J, 2004, LOV LOVCI SKOZI CAS; Daniel M, 2003, EUR J CLIN MICROBIOL, V22, P327, DOI 10.1007/s10096-003-0918-2; Daniel M, 2006, INT J MED MICROBIOL, V296, P41, DOI 10.1016/j.ijmm.2006.02.008; Danielova V, 2010, VECTOR-BORNE ZOONOT, V10, P223, DOI 10.1089/vbz.2009.0020; Dobson ADM, 2011, J APPL ECOL, V48, P1029, DOI 10.1111/j.1365-2664.2011.02004.x; GRAY JS, 1992, J MED ENTOMOL, V29, P915, DOI 10.1093/jmedent/29.6.915; Hartemink NA, 2008, AM NAT, V171, P743, DOI 10.1086/587530; Heinz FX, 2007, VACCINE, V25, P7559, DOI 10.1016/j.vaccine.2007.08.024; Hudson PJ, 2001, MED VET ENTOMOL, V15, P304, DOI 10.1046/j.0269-283x.2001.00317.x; Jaaskelainen AE, 2011, EMERG INFECT DIS, V17, P323, DOI 10.3201/eid1702.101487; JAENSON TGT, 1994, J MED ENTOMOL, V31, P240, DOI 10.1093/jmedent/31.2.240; Jaenson TGT, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-184; Jaenson TGT, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-8; Jaenson TGT, 2011, TICKS TICK-BORNE DIS, V2, P44, DOI 10.1016/j.ttbdis.2010.10.006; Jensen PM, 2000, SCAND J INFECT DIS, V32, P545, DOI 10.1080/003655400458857; Jordan RA, 2007, J MED ENTOMOL, V44, P752, DOI 10.1603/0022-2585(2007)44[752:EORDDO]2.0.CO;2; Kiffner C, 2012, MED VET ENTOMOL, V26, P18, DOI 10.1111/j.1365-2915.2011.00961.x; Kiffner C, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-42; Knap N, 2012, VECTOR-BORNE ZOONOT, V12, P236, DOI 10.1089/vbz.2011.0728; Knap N, 2009, VET PARASITOL, V164, P275, DOI 10.1016/j.vetpar.2009.06.001; KOZUCH O, 1981, ACTA VIROL, V25, P219; Krech T, 2002, INT J MED MICROBIOL, V291, P30, DOI 10.1016/S1438-4221(02)80006-6; Krystufek B., 1991, SESALCI SLOVENIJE; Labuda M, 1997, VIROLOGY, V235, P138, DOI 10.1006/viro.1997.8622; Labuda M, 2002, INT J MED MICROBIOL, V291, P43, DOI 10.1016/S1438-4221(02)80008-X; Labuda M, 1996, VIROLOGY, V219, P357, DOI 10.1006/viro.1996.0261; LABUDA M, 1993, EXPERIENTIA, V49, P802, DOI 10.1007/BF01923553; Lindgren E, 2001, LANCET, V358, P16, DOI 10.1016/S0140-6736(00)05250-8; Medlock JM, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-1; Ostfeld RS, 2006, PLOS BIOL, V4, P1058, DOI 10.1371/journal.pbio.0040145; Perkins SE, 2006, ECOLOGY, V87, P1981, DOI 10.1890/0012-9658(2006)87[1981:LDALTT]2.0.CO;2; Perkins SE, 2003, INT J PARASITOL, V33, P909, DOI 10.1016/S0020-7519(03)00128-0; Pugliese A, 2008, PARASITOLOGY, V135, P1531, DOI 10.1017/S003118200800036X; Rand PW, 2003, J MED ENTOMOL, V40, P179, DOI 10.1603/0022-2585-40.2.179; Randolph S, 2001, LANCET, V358, P1731, DOI 10.1016/S0140-6736(01)06754-X; Randolph SE, 2008, MICROBES INFECT, V10, P209, DOI 10.1016/j.micinf.2007.12.005; Randolph SE, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-44; Randolph SE, 1996, PARASITOL TODAY, V12, P472, DOI 10.1016/S0169-4758(96)10072-7; Randolph SE, 2000, PARASITOLOGY, V121, P15, DOI 10.1017/S0031182099006083; Rizzoli A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004336; Sumilo D, 2009, CLIN MICROBIOL INFEC, V15, P75, DOI 10.1111/j.1469-0691.2008.02121.x; Sumilo D, 2008, REV MED VIROL; Sumilo D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000500; Suss J, 2008, Euro Surveill, V13; Suss J, 2003, VACCINE, V21, pS19, DOI 10.1016/S0264-410X(02)00812-5; Talleklint L, 1997, EXP APPL ACAROL, V21, P755, DOI 10.1023/A:1018473122070; Talleklint L, 1996, J MED ENTOMOL, V33, P805, DOI 10.1093/jmedent/33.5.805; Tonteri E, 2011, EMERG INFECT DIS, V17, P72, DOI 10.3201/eid1701.100051; Vor T, 2010, EXP APPL ACAROL, V51, P405, DOI 10.1007/s10493-010-9337-0	55	17	17	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66380	10.1371/journal.pone.0066380	http://dx.doi.org/10.1371/journal.pone.0066380			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776668	gold, Green Published, Green Submitted			2022-12-27	WOS:000320755400143
J	Liu, D; Okwor, I; Mou, ZR; Beverley, SM; Uzonna, JE				Liu, Dong; Okwor, Ifeoma; Mou, Zhirong; Beverley, Stephen M.; Uzonna, Jude E.			Deficiency of Leishmania Phosphoglycans Influences the Magnitude but Does Not Affect the Quality of Secondary (Memory) Anti-Leishmania Immunity	PLOS ONE			English	Article							INTERFERON-GAMMA; CUTANEOUS LEISHMANIASIS; PROTECTIVE IMMUNITY; T-CELLS; MICE; VACCINATION; VACCINES; IMMUNIZATION; RESISTANCE; VIRULENCE	Despite inducing very low IFN-gamma response and highly attenuated in vivo, infection of mice with phosphoglycan (PG) deficient Leishmania major (lpg2-) induces protection against virulent L. major challenge. Here, we show that mice infected with lpg2-L. major generate Leishmania-specific memory T cells. However, in vitro and in vivo proliferation, IL-10 and IFN-gamma production by lpg2- induced memory cells were impaired in comparison to those induced by wild type (WT) parasites. Interestingly, TNF recall response was comparable to WT infected mice. Despite the impaired proliferation and IFN-gamma response, lpg2- infected mice were protected against virulent L. major challenge and their T cells mediated efficient infection-induced immunity. In vivo depletion and neutralization studies with mAbs demonstrated that lpg2-L. major-induced resistance was strongly dependent on IFN-gamma, but independent of TNF and CD8(+) T cells. Collectively, these data show that the effectiveness of secondary anti-Leishmania immunity depends on the quality (and not the magnitude) of IFN-gamma response. These observations provide further support for consideration of lpg2-L. major as a live-attenuated candidate for leishmanization in humans since it protects strongly against virulent challenge, without inducing pathology in infected animals.	[Liu, Dong; Mou, Zhirong; Uzonna, Jude E.] Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada; [Okwor, Ifeoma; Uzonna, Jude E.] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [Beverley, Stephen M.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA	University of Manitoba; University of Manitoba; Washington University (WUSTL)	Uzonna, JE (corresponding author), Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada.	uzonna@cc.umanitoba.ca		Okwor, Ifeoma/0000-0003-0297-3589; Beverley, Stephen/0000-0001-5319-0811	Canadian Institutes of Health Research; Manitoba Health Research Council; National Institutes of Health (NIH) [AI31078]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI031078] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Manitoba Health Research Council; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this study was provided by the Canadian Institutes of Health Research and the Manitoba Health Research Council (JU) and National Institutes of Health (NIH) AI31078 (SB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander J, 1998, J IMMUNOL, V161, P6794; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Amante FH, 2010, J IMMUNOL, V185, P3632, DOI 10.4049/jimmunol.1000944; Anderson CF, 2005, J IMMUNOL, V174, P2934, DOI 10.4049/jimmunol.174.5.2934; Belkaid Y, 2002, J IMMUNOL, V168, P3992, DOI 10.4049/jimmunol.168.8.3992; Belkaid Y, 2001, J EXP MED, V194, P1497, DOI 10.1084/jem.194.10.1497; Bern C, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000313; Brodskyn C, 2000, CLIN EXP IMMUNOL, V119, P299, DOI 10.1046/j.1365-2249.2000.01122.x; Capul AA, 2007, INFECT IMMUN; Capul AA, 2007, J BIOL CHEM, V282, P14006, DOI 10.1074/jbc.M610869200; Chakravarty J, 2010, J GLOB INFECT DIS, V2, P167, DOI 10.4103/0974-777X.62887; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; DeGrendele HC, 1997, SCIENCE, V278, P672, DOI 10.1126/science.278.5338.672; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; GREENBLATT CL, 1988, PARASITOL TODAY, V4, P53, DOI 10.1016/0169-4758(88)90067-1; Handman E, 2008, ADV EXP MED BIOL, V625, P48, DOI 10.1007/978-0-387-77570-8_5; HUANG CC, 1993, J BIOL CHEM, V268, P24060; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kebaier C, 2006, INFECT IMMUN, V74, P777, DOI 10.1128/IAI.74.1.777-780.2006; Kedzierski L, 2006, PARASITOLOGY, V133, pS87, DOI 10.1017/S0031182006001831; Khamesipour A, 2005, VACCINE, V23, P3642, DOI 10.1016/j.vaccine.2005.02.015; Korner H, 2010, INT J PARASITOL, V40, P879, DOI 10.1016/j.ijpara.2010.03.011; Kriegel MA, 2011, P NATL ACAD SCI USA, V108, P11548, DOI 10.1073/pnas.1108924108; LIEW FY, 1991, IMMUNOLOGY, V74, P304; Liu D, 2010, J IMMUNOL, V184, P3098, DOI 10.4049/jimmunol.0903177; Liu D, 2009, J IMMUNOL, V183, P1921, DOI 10.4049/jimmunol.0901099; Liu D, 2009, INFECT IMMUN, V77, P3272, DOI 10.1128/IAI.01447-08; LOCKSLEY RM, 1991, IMMUNOPARASITOL TOD, pA58, DOI 10.1016/S0167-5699(05)80017-9; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; Markey KA, 2010, BLOOD, V115, P122, DOI 10.1182/blood-2009-01-199927; MULLER I, 1993, INFECT IMMUN, V61, P3730; Okwor I, 2009, HUM VACCINES, V5, P291, DOI 10.4161/hv.5.5.7607; Puig L, 2003, ANN TROP MED PARASIT, V97, P107, DOI 10.1179/000349803225002589; REINER SL, 1995, CURR OPIN IMMUNOL, V7, P360, DOI 10.1016/0952-7915(95)80111-1; Sacks D, 2002, NAT REV IMMUNOL, V2, P845, DOI 10.1038/nri933; Scott P, 2004, IMMUNOL REV, V201, P318, DOI 10.1111/j.0105-2896.2004.00198.x; SCOTT P, 1987, J IMMUNOL, V139, P221; Selvapandiyan A, 2006, INDIAN J MED RES, V123, P455; Singer SM, 2000, J INFECT DIS, V181, P1510, DOI 10.1086/315409; Singh N, 2006, INDIAN J MED RES, V123, P411; Spath GF, 2000, P NATL ACAD SCI USA, V97, P9258, DOI 10.1073/pnas.160257897; Spath GF, 2004, INFECT IMMUN, V72, P3622, DOI 10.1128/IAI.72.6.3622-3627.2004; Spath GF, 2003, SCIENCE, V301, P1241, DOI 10.1126/science.1087499; TITUS RG, 1989, J EXP MED, V170, P2097, DOI 10.1084/jem.170.6.2097; TITUS RG, 1995, P NATL ACAD SCI USA, V92, P10267, DOI 10.1073/pnas.92.22.10267; TITUS RG, 1985, PARASITE IMMUNOL, V7, P545, DOI 10.1111/j.1365-3024.1985.tb00098.x; Uzonna JE, 2004, J EXP MED, V199, P1559, DOI 10.1084/jem.20040172; Uzonna JE, 2004, J IMMUNOL, V172, P3793, DOI 10.4049/jimmunol.172.6.3793; Uzonna JE, 2001, J IMMUNOL, V167, P6967, DOI 10.4049/jimmunol.167.12.6967; WANG ZE, 1994, J EXP MED, V179, P1367, DOI 10.1084/jem.179.4.1367	50	3	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66058	10.1371/journal.pone.0066058	http://dx.doi.org/10.1371/journal.pone.0066058			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776605	Green Published, gold, Green Submitted			2022-12-27	WOS:000320755400106
J	Millet, JP; Shaw, E; Orcau, A; Casals, M; Miro, JM; Cayla, JA				Millet, Juan-Pablo; Shaw, Evelyn; Orcau, Angels; Casals, Marti; Miro, Jose M.; Cayla, Joan A.		Barcelona TB Recurrence Working Gr	Tuberculosis Recurrence after Completion Treatment in a European City: Reinfection or Relapse?	PLOS ONE			English	Article							EXOGENOUS REINFECTION; RISK-FACTORS; HIV-INFECTION; UNITED-STATES; EPIDEMIOLOGY; COHORT	Background: Tuberculosis (TB) recurrence can be due to reinfection or relapse. The contribution of each to TB incidence and the factors associated with recurrence are not well known. Effectiveness of TB control programs is assessed in part by recurrence rates. The aim of this study was to establish the recurrence rate of TB in Barcelona, the associated risk factors and the role of reinfection. Methods: A population-based retrospective longitudinal study was performed in Barcelona, Spain. TB patients with positive culture results who completed treatment between Jan 1st, 2003 and Dec 31st, 2006 were followed-up until December 31st, 2009 by the TB Control Program. The incidence rate of recurrence was calculated per person-year of follow-up (py). Kaplan-Meier and Cox regression methods were used for the survival analysis by calculating the hazard ratio (HR) with 95% confidence intervals (CI). Results: Of the 1,823 TB cases identified, 971 fulfilled the inclusion criteria and 13 (1.3%) had recurrent TB. The recurrence rate was 341 cases per 100,000 py, 13 times higher than the TB incidence of the general population. Likelihood of TB recurrence at the 1st, 3rd and 5th year of follow-up was 0.1%, 1.4% and 1.6%, respectively. Factors associated with recurrence were HIV infection (HR: 4.7, CI: 1.4-15.7), living in the inner city district (HR: 3.9, CI: 1.3-11.8) and history of TB treatment (HR: 5.2, CI: 1.7-16.2). Genotyping results of recurrent cases were available for 6 patients (3 reinfections and 3 relapses). Conclusion: The rate of TB recurrence in Barcelona is low and most episodes occur within the first three years. Patients at higher risk of recurrence are co-infected with HIV, living in neighborhoods with high TB incidence or with a history of TB treatment. When available, genotyping results help determine whether the recurrence is due to reinfection or relapse.	[Millet, Juan-Pablo; Shaw, Evelyn; Orcau, Angels; Casals, Marti; Cayla, Joan A.] Publ Hlth Agcy Barcelona, Epidemiol Serv, Barcelona, Spain; [Millet, Juan-Pablo; Orcau, Angels; Casals, Marti; Cayla, Joan A.] CIBER Epidemiol & Salud Publ, Barcelona, Spain; [Millet, Juan-Pablo] Univ Autonoma Barcelona, Dept Pediat Ginecol & Med Prevent, E-08193 Barcelona, Spain; [Casals, Marti] Univ Barcelona, Dept Salut Publ, Barcelona, Spain; [Casals, Marti] Univ Int Catalunya, Dept Ciencies Basiques, Barcelona, Spain; [Miro, Jose M.] Hosp Clin Univ IDIBAPS Barcelona, Infect Dis Serv, Barcelona, Spain	Public Health Agency of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Autonomous University of Barcelona; University of Barcelona; Universitat Internacional de Catalunya (UIC); University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Millet, JP (corresponding author), Publ Hlth Agcy Barcelona, Epidemiol Serv, Barcelona, Spain.	jmillet@aspb.es	Casals, Martí/M-8388-2019; Fernández, María Teresa Tórtola/ABC-8046-2020	Casals, Martí/0000-0002-1775-8331; Fernández, María Teresa Tórtola/0000-0002-9188-298X; Cayla, Joan A./0000-0003-3891-111X; Coll, Pere/0000-0003-1782-9782; Shaw, Evelyn/0000-0002-1882-1259; Millet, Joan Pau/0000-0003-0200-2459; de Souza Galvao, Maria Luiza/0000-0001-9703-989X; Tudo, Griselda/0000-0002-9241-7051	CIBER de Epidemiologia y Salud Publica, (CIBERESP), Spain	CIBER de Epidemiologia y Salud Publica, (CIBERESP), Spain	This work was supported by CIBER de Epidemiologia y Salud Publica, (CIBERESP), Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Bandera A, 2001, J CLIN MICROBIOL, V39, P2213, DOI 10.1128/JCM.39.6.2213-2218.2001; Bang D, 2010, INT J TUBERC LUNG D, V14, P447; Borrell S, 2009, J CLIN MICROBIOL, V47, P198, DOI 10.1128/JCM.00507-08; Cacho J, 2007, EUR RESPIR J, V30, P333, DOI 10.1183/09031936.00005107; Caminero JA, 2001, AM J RESP CRIT CARE, V163, P717, DOI 10.1164/ajrccm.163.3.2003070; CDC, 2009, REP TUB US; Charalambous S, 2008, INT J TUBERC LUNG D, V12, P942; Crofts JP, 2010, THORAX, V65, P310, DOI 10.1136/thx.2009.124677; Dobler CC, 2009, EUR RESPIR J, V33, P160, DOI 10.1183/09031936.00104108; Ospina JE, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-158; [European Center for Disease Prevention and Control (ECDC) WHO], 2012, TUB SURV MON EUR; Faustini A, 2005, EUR RESPIR J, V26, P503, DOI 10.1183/09031936.05.00103504; Fine PEM, 1999, NEW ENGL J MED, V341, P1226, DOI 10.1056/NEJM199910143411609; Garcia de Viedma D, 2002, ARCH INTERN MED, V162, P1873, DOI 10.1001/archinte.162.16.1873; Grp de Trabajo de TB de las Soc Ci, 2009, ARCH BRONCONEUMOL, V45, P139, DOI 10.1016/j.arbres.2009.01.001; Jasmer RM, 2004, AM J RESP CRIT CARE, V170, P1360, DOI 10.1164/rccm.200408-1081OC; Kim L, 2013, INT J TUBERC LUNG D, V17, P357, DOI 10.5588/ijtld.12.0640; Millet JP, 2009, J EPIDEMIOL COMMUN H, V63, P799, DOI 10.1136/jech.2008.077560; Millet JP, 2013, ENFERM INFEC MICR CL, V31, P227, DOI 10.1016/j.eimc.2012.08.008; Narayanan S, 2010, J INFECT DIS, V201, P691, DOI 10.1086/650528; Orcau A, 2010, TUBERCULOSIS BARCELO; Panjabi R, 2007, INT J TUBERC LUNG D, V11, P828; Pettit AC, 2011, INT J TUBERC LUNG D, V15, P906, DOI 10.5588/ijtld.10.0448; Pfyffer GE, 2003, J CLIN MICROBIOL; Poblacio i demografia, 2009, AN EST CIUT BARC 200; Shen GM, 2006, EMERG INFECT DIS, V12, P1776, DOI 10.3201/eid1211.051207; Sonnenberg P, 2001, LANCET, V358, P1687, DOI 10.1016/S0140-6736(01)06712-5; Supply PC, 2006, J CLIN MICROBIOL; Supply PE, 2000, MOL MICROBIOL, P36762; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Van Rie A, 1999, NEW ENGL J MED, V341, P1174, DOI 10.1056/NEJM199910143411602; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; Verver S, 2005, AM J RESP CRIT CARE, V171, P1430, DOI 10.1164/rccm.200409-1200OC; World Health Organization, 2003, TREATM TUB GUID NAT	34	53	56	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e64898	10.1371/journal.pone.0064898	http://dx.doi.org/10.1371/journal.pone.0064898			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776440	Green Published, Green Submitted, gold			2022-12-27	WOS:000320755400009
J	Singh, AN; Singh, S; Dubey, VK				Singh, Abhay Narayan; Singh, Sushant; Dubey, Vikash Kumar			Immobilization of Procerain B, a Cysteine Endopeptidase, on Amberlite MB-150 Beads	PLOS ONE			English	Article							ENZYMES; PROTEASES; LATEX; WATER	Proteases are involved in several crucial biological processes and reported to have important physiological functions. They also have multifarious applications in different industries. The immobilized form of the enzyme further improves its industrial applicability. Here, we report covalent immobilization of a novel cysteine endopeptidase (procerain B) on amberlite MB-150 beads through glutaraldehyde by Schiff base linkage. The immobilized product was examined extensively by Fourier Transform Infrared Spectroscopy (FTIR), Scanning electron microscopy (SEM) and Energy Dispersive X-ray (EDX) analysis. The characterization of the immobilized product showed broader pH and thermal optima compared to the soluble form of the enzyme. The immobilized form of procerain B also showed lower Km (180.27 +/- 6 mu M) compared to the soluble enzyme using azocasein as substrate. Further, immobilized procerain B retains 38.6% activity till the 10th use, which strongly represents its industrial candidature.	[Singh, Abhay Narayan; Dubey, Vikash Kumar] Indian Inst Technol Guwahati, Dept Biotechnol, Gauhati, Assam, India; [Singh, Sushant; Dubey, Vikash Kumar] Indian Inst Technol Guwahati, Ctr Environm, Gauhati, Assam, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Guwahati; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Guwahati	Dubey, VK (corresponding author), Indian Inst Technol Guwahati, Dept Biotechnol, Gauhati, Assam, India.	vdubey@iitg.ernet.in	Dubey, Vikash Kumar/B-3542-2008; Singh, Sushant/AAP-3860-2020; Singh, Sushant/AAQ-7930-2021	Dubey, Vikash Kumar/0000-0002-4281-2504; Singh, Sushant/0000-0002-0858-4405; NARAYAN SINGH, ABHAY/0000-0001-6875-9775; Dubey, Vikash Kumar/0000-0002-3870-2660	Indian Institute of Technology Guwahati	Indian Institute of Technology Guwahati	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Department of Biotechnology, Government of India in the form of infrastructure; Indian Institute of Technology Guwahati for research fellowship to ANS and SS.	Anwar A., 2009, WORLD APPL SCI J, V7, P1281; Ashie INA, 2002, J FOOD SCI, V67, P2138, DOI 10.1111/j.1365-2621.2002.tb09516.x; Beg QK, 2001, APPL MICROBIOL BIOT, V56, P326, DOI 10.1007/s002530100704; Bernholdt HF, 1975, ENZYMES FOOD PROCESS, P473; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cao LQ, 2000, ORG LETT, V2, P1361, DOI 10.1021/ol005593x; Dubey VK, 2007, AFR J BIOTECHNOL, V6, P1077; Dubey VK, 2003, PHYTOCHEMISTRY, V62, P1057, DOI 10.1016/S0031-9422(02)00676-3; Duran N, 2000, APPL CATAL B-ENVIRON, V28, P83, DOI 10.1016/S0926-3373(00)00168-5; Dwevedi A, 2009, BIORESOURCE TECHNOL, V100, P2667, DOI 10.1016/j.biortech.2008.12.048; FALCH EA, 1991, BIOTECHNOL ADV, V9, P643, DOI 10.1016/0734-9750(91)90736-F; Gupta R, 2002, APPL MICROBIOL BIOT, V59, P15, DOI 10.1007/s00253-002-0975-y; Katchalski-Katzir E, 2000, J MOL CATAL B-ENZYM, V10, P157, DOI 10.1016/S1381-1177(00)00124-7; Khan A. A., 2010, RES J BIOL SCI, V5, P565, DOI DOI 10.3923/rjbsci.2010.565.575; Kirk O, 2002, CURR OPIN BIOTECH, V13, P345, DOI 10.1016/S0958-1669(02)00328-2; KLIBANOV AM, 1983, SCIENCE, V219, P722, DOI 10.1126/science.219.4585.722; Krajewska B, 2004, ENZYME MICROB TECH, V35, P126, DOI 10.1016/j.enzmictec.2003.12.013; Kumar S, 2001, J ETHNOPHARMACOL, V76, P115, DOI 10.1016/S0378-8741(01)00219-7; Lalonde J., 2008, ENZYME CATALYSIS ORG; LYONS TP, 1982, BIOCHEM SOC T, V10, P287, DOI 10.1042/bst0100287; Mateo C, 2007, ENZYME MICROB TECH, V40, P1451, DOI 10.1016/j.enzmictec.2007.01.018; RAHMAN MA, 1991, NORD J BOT, V11, P301, DOI 10.1111/j.1756-1051.1991.tb01408.x; Rao MB, 1998, MICROBIOL MOL BIOL R, V62, P597, DOI 10.1128/MMBR.62.3.597-635.1998; Sarath G., 1989, PROTEOLYTIC ENZYMES, P25; Silva CJSM, 2006, ENZYME MICROB TECH, V39, P634, DOI 10.1016/j.enzmictec.2005.11.016; Singh A. N., 2013, PLOS ONE, DOI [10.1371/journal.pone.0059806, DOI 10.1371/J0URNAL.P0NE.0059806]; Singh AN, 2010, PROCESS BIOCHEM, V45, P399, DOI 10.1016/j.procbio.2009.10.014; Singh AN, 2011, J AGR FOOD CHEM, V59, P6256, DOI 10.1021/jf200472x; Singh AN, 2011, APPL BIOCHEM BIOTECH, V164, P573, DOI 10.1007/s12010-011-9158-6; Tischer W, 1999, TOP CURR CHEM, V200, P95; Warren SJ, 1992, European Patent Appl EP, Patent No. [04: 714-770, 04714770]	31	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66000	10.1371/journal.pone.0066000	http://dx.doi.org/10.1371/journal.pone.0066000			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776589	Green Published, Green Submitted, gold			2022-12-27	WOS:000320755400095
J	Burns, MM; Hedin, M; Shultz, JW				Burns, Mercedes M.; Hedin, Marshal; Shultz, Jeffrey W.			Comparative Analyses of Reproductive Structures in Harvestmen (Opiliones) Reveal Multiple Transitions from Courtship to Precopulatory Antagonism	PLOS ONE			English	Article							ANCESTRAL CHARACTER STATES; SEXUAL CONFLICT; FEMALE CHOICE; CORRELATED EVOLUTION; BAYESIAN-ESTIMATION; NUPTIAL GIFTS; SELECTION; DISCRETE; HYPOTHESIS; PHYLOGENETICS	Explaining the rapid, species-specific diversification of reproductive structures and behaviors is a long-standing goal of evolutionary biology, with recent research tending to attribute reproductive phenotypes to the evolutionary mechanisms of female mate choice or intersexual conflict. Progress in understanding these and other possible mechanisms depends, in part, on reconstructing the direction, frequency and relative timing of phenotypic evolution of male and female structures in species-rich clades. Here we examine evolution of reproductive structures in the leiobunine harvestmen or "daddy long-legs" of eastern North America, a monophyletic group that includes species in which males court females using nuptial gifts and other species that are equipped for apparent precopulatory antagonism (i.e., males with long, hardened penes and females with sclerotized pregenital barriers). We used parsimony-and Bayesian likelihood-based analyses to reconstruct character evolution in categorical reproductive traits and found that losses of ancestral gift-bearing penile sacs are strongly associated with gains of female pregenital barriers. In most cases, both events occur on the same internal branch of the phylogeny. These coevolutionary changes occurred at least four times, resulting in clade-specific designs in the penis and pregenital barrier. The discovery of convergent origins and/or enhancements of apparent precopulatory antagonism among closely related species offers an unusual opportunity to investigate how major changes in reproductive morphology have occurred. We propose new hypotheses that attribute these enhancements to changes in ecology or life history that reduce the duration of breeding seasons, an association that is consistent with female choice, sexual conflict, and/or an alternative evolutionary mechanism.	[Burns, Mercedes M.; Shultz, Jeffrey W.] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; [Hedin, Marshal] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA	University System of Maryland; University of Maryland College Park; California State University System; San Diego State University	Burns, MM (corresponding author), Univ Maryland, Dept Entomol, College Pk, MD 20742 USA.	mmburns@umd.edu			National Science Foundation [DEB-0640179, DEB-0640173]; Maryland Agricultural Experiment Station; NSF Graduate Research Fellowship; NSF Doctoral Dissertation Improvement Grant; Division Of Integrative Organismal Systems [1110729] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Maryland Agricultural Experiment Station; NSF Graduate Research Fellowship(National Science Foundation (NSF)); NSF Doctoral Dissertation Improvement Grant(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding was provided by a collaborative National Science Foundation grant awarded to JWS (DEB-0640179) and M. H. (DEB-0640173). JWS was supported by the Maryland Agricultural Experiment Station. MB was supported by a NSF Graduate Research Fellowship and a NSF Doctoral Dissertation Improvement Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonzo SH, 2000, EVOL ECOL RES, V2, P149; ALONZO SH, 2013, PHIL T R B IN PRESS, V368; Armbruster WS, 2009, P NATL ACAD SCI USA, V106, P18085, DOI 10.1073/pnas.0907051106; Arnqvist G, 2000, P NATL ACAD SCI USA, V97, P10460, DOI 10.1073/pnas.97.19.10460; Arnqvist G., 2005, SEXUAL CONFLICT, P360; Bailey NW, 2012, EVOLUTION, V66, P2674, DOI 10.1111/j.1558-5646.2012.01647.x; Boettiger C, 2012, EVOLUTION, V66, P2240, DOI 10.1111/j.1558-5646.2011.01574.x; Boggs Carol L., 1995, P215; Bollback JP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-88; Boughman JW, 2002, TRENDS ECOL EVOL, V17, P571, DOI 10.1016/S0169-5347(02)02595-8; Brennan PLR, 2012, PHILOS T R SOC B, V367, P2324, DOI 10.1098/rstb.2011.0284; Burns M, 2012, MOL PHYLOGENET EVOL, V63, P291, DOI 10.1016/j.ympev.2011.12.025; Cameron E, 2003, J EVOLUTION BIOL, V16, P1055, DOI 10.1046/j.1420-9101.2003.00584.x; Cayetano L, 2011, EVOLUTION, V65, P2171, DOI 10.1111/j.1558-5646.2011.01309.x; Chapman T, 2003, TRENDS ECOL EVOL, V18, P41, DOI 10.1016/S0169-5347(02)00004-6; Chapman T, 2006, CURR BIOL, V16, pR744, DOI 10.1016/j.cub.2006.08.020; Cooper N, 2010, J EVOLUTION BIOL, V23, P2529, DOI 10.1111/j.1420-9101.2010.02144.x; Cordero C, 2003, J EVOLUTION BIOL, V16, P1, DOI 10.1046/j.1420-9101.2003.00506.x; Cothran RD, 2004, ANIM BEHAV, V68, P1133, DOI 10.1016/j.anbehav.2003.09.021; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Eberhard WG, 2004, EVOLUTION, V58, P1947; EBERHARD WG, 1996, FEMALE CONTROL SEXUA, P472; Emlen DJ, 2001, SCIENCE, V291, P1534, DOI 10.1126/science.1056607; FELSENSTEIN J, 2004, INFERRING PHYLOGENIE, P73; Felsenstein J, 2012, AM NAT, V179, P145, DOI 10.1086/663681; Friberg U, 2005, EVOLUTION, V59, P1540; Gage MJG, 2012, P NATL ACAD SCI USA, V109, P4341, DOI 10.1073/pnas.1201827109; Gasparini C, 2012, EVOLUTION, V66, P532, DOI 10.1111/j.1558-5646.2011.01455.x; Gavrilets S, 2005, EVOL ECOL, V19, P167, DOI 10.1007/s10682-004-7916-4; Gwynne DT, 2008, ANNU REV ENTOMOL, V53, P83, DOI 10.1146/annurev.ento.53.103106.093423; Hedin M, 2012, MOL PHYLOGENET EVOL, V62, P224, DOI 10.1016/j.ympev.2011.09.017; Hedin M, 2010, J ARACHNOL, V38, P9, DOI 10.1636/HA09-49.1; Hosken DJ, 2004, TRENDS ECOL EVOL, V19, P87, DOI 10.1016/j.tree.2003.11.012; Huelsenbeck JP, 2003, SYST BIOL, V52, P641, DOI 10.1080/10635150390235467; Huelsenbeck JP, 2001, SYST BIOL, V50, P351, DOI 10.1080/106351501300317978; Huelsenbeck JP, 2000, SCIENCE, V288, P2349, DOI 10.1126/science.288.5475.2349; Huk T, 2008, BEHAV ECOL, V19, P456, DOI 10.1093/beheco/arm150; Ingianni EA, 2011, J ARACHNOL, V39, P454, DOI 10.1636/Ha11-42.1; Jagadeeshan S, 2006, J EVOLUTION BIOL, V19, P1058, DOI 10.1111/j.1420-9101.2006.01099.x; Jeffreys H, 1961, THEOR PROB, P432; Lewis SM, 2004, INTEGR COMP BIOL, V44, P234, DOI 10.1093/icb/44.3.234; Losos JB, 2003, TRENDS ECOL EVOL, V18, P220, DOI 10.1016/S0169-5347(03)00037-5; Machado Glauco, 2007, P414; Macias-Ordonez Rogelio, 2010, P285; Maddison WP, 2011, MESQUITE MODULAR SYS; Maklakov AA, 2005, AM NAT, V165, pS38, DOI 10.1086/429351; Maklakov AA, 2009, CURR BIOL, V19, P1903, DOI 10.1016/j.cub.2009.08.058; Masly John P., 2012, International Journal of Evolutionary Biology, P1, DOI 10.1155/2012/247352; Mayr E., 1963, ANIMAL SPECIES EVOLU, P811; McGhee C.R., 1970, THESIS VIRGINIA POLY; MCGHEE CR, 1977, J ARACHNOL, V5, P169; Muller MN, 2007, P ROY SOC B-BIOL SCI, V274, P1009, DOI 10.1098/rspb.2006.0206; NEWTON MA, 1994, J R STAT SOC B, V56, P3; PAGEL M, 1994, P ROY SOC B-BIOL SCI, V255, P37, DOI 10.1098/rspb.1994.0006; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; Pagel M, 2006, AM NAT, V167, P808, DOI 10.1086/503444; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pomiankowski A, 1998, P NATL ACAD SCI USA, V95, P5106, DOI 10.1073/pnas.95.9.5106; *R DEV COR TEAM, 2013, R LANG ENV STAT COMP; Raftery AE, 2007, BAYESIAN STAT, V8, P1; RAMBAUT A, 2009, FIGTREE V 1 3 1 MOL; RAMBAUT A, 2007, TRACER V 1 5 MOL EVO; Reinhold K, 2004, ORG DIVERS EVOL, V4, P157, DOI 10.1016/j.ode.2003.10.002; Schultz TR, 1999, SYST BIOL, V48, P651, DOI 10.1080/106351599260229; SHAPIRO AM, 1989, ANNU REV ENTOMOL, V34, P231, DOI 10.1146/annurev.en.34.010189.001311; Shultz JW, 2008, J ARACHNOL, V36, P184, DOI 10.1636/H07-48SC.1; Shultz JW, 2012, J ARACHNOL, V40, P296, DOI 10.1636/B12-31.1; SHULTZ JW, 2008, ZOOL J LINN SOC-LOND, V128, P401; Simmons L. W., 2001, MG BEH ECOL; Snook RR, 2005, TRENDS ECOL EVOL, V20, P46, DOI 10.1016/j.tree.2004.10.011; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Tallamy DW, 2003, P ROY SOC B-BIOL SCI, V270, P77, DOI 10.1098/rspb.2002.2198; Vahed K, 2007, ETHOLOGY, V113, P105, DOI 10.1111/j.1439-0310.2006.01312.x; Wong BBM, 2005, BIOL REV, V80, P559, DOI 10.1017/S1464793105006809; Xie WG, 2011, SYST BIOL, V60, P150, DOI 10.1093/sysbio/syq085; Zatz C, 2011, BEHAV ECOL SOCIOBIOL, V65, P995, DOI 10.1007/s00265-010-1103-0	78	29	29	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e66767	10.1371/journal.pone.0066767	http://dx.doi.org/10.1371/journal.pone.0066767			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762497	Green Published, gold, Green Submitted			2022-12-27	WOS:000320440500070
J	Huang, H; Quint, M; Gray, WM				Huang, He; Quint, Marcel; Gray, William M.			The eta7/csn3-3 Auxin Response Mutant of Arabidopsis Defines a Novel Function for the CSN3 Subunit of the COP9 Signalosome	PLOS ONE			English	Article							CONSTITUTIVE PHOTOMORPHOGENIC9 SIGNALOSOME; MULTIFACETED DEVELOPMENTAL PROCESSES; MEDIATING LIGHT CONTROL; E3 UBIQUITIN LIGASE; BOX PROTEIN TIR1; AUX/IAA PROTEINS; GENE-EXPRESSION; DROSOPHILA-MELANOGASTER; CULLIN ATCUL1; CELL-CYCLE	The COP9 signalosome (CSN) is an eight subunit protein complex conserved in all higher eukaryotes. In Arabidopsis thaliana, the CSN regulates auxin response by removing the ubiquitin-like protein NEDD8/RUB1 from the CUL1 subunit of the SCFTIR1/AFB ubiquitin-ligase (deneddylation). Previously described null mutations in any CSN subunit result in the pleiotropic cop/det/fus phenotype and cause seedling lethality, hampering the study of CSN functions in plant development. In a genetic screen to identify enhancers of the auxin response defects conferred by the tir1-1 mutation, we identified a viable csn mutant of subunit 3 (CSN3), designated eta7/csn3-3. In addition to enhancing tir1-1 mutant phenotypes, the csn3-3 mutation alone confers several phenotypes indicative of impaired auxin signaling including auxin resistant root growth and diminished auxin responsive gene expression. Unexpectedly however, csn3-3 plants are not defective in either the CSN-mediated deneddylation of CUL1 or in SCFTIR1-mediated degradation of Aux/IAA proteins. These findings suggest that csn3-3 is an atypical csn mutant that defines a novel CSN or CSN3-specific function. Consistent with this possibility, we observe dramatic differences in double mutant interactions between csn3-3 and other auxin signaling mutants compared to another weak csn mutant, csn1-10. Lastly, unlike other csn mutants, assembly of the CSN holocomplex is unaffected in csn3-3 plants. However, we detected a small CSN3-containing protein complex that is altered in csn3-3 plants. We hypothesize that in addition to its role in the CSN as a cullin deneddylase, CSN3 functions in a distinct protein complex that is required for proper auxin signaling.	[Huang, He; Quint, Marcel; Gray, William M.] Univ Minnesota, Dept Plant Biol, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Gray, WM (corresponding author), Univ Minnesota, Dept Plant Biol, St Paul, MN 55108 USA.	grayx051@umn.edu	Huang, He/K-1176-2016; Gray, William M/F-9402-2010; quint, marcel/J-8483-2012; Huang, He/E-4579-2017	Huang, He/0000-0002-4564-7604; Gray, William M/0000-0002-1320-290X; Huang, He/0000-0002-4564-7604; Quint, Marcel/0000-0003-2935-4083	National Institutes of Health [GM067203]; Deutsche Forschungsgemeinschaft; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067203] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (GM067203 to WMG) and a postdoctoral fellowship from the Deutsche Forschungsgemeinschaft (to MQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chamovitz DA, 1996, CELL, V86, P115, DOI 10.1016/S0092-8674(00)80082-3; Chen HD, 2006, PLANT CELL, V18, P1991, DOI 10.1105/tpc.106.043224; Chuang HW, 2004, PLANT CELL, V16, P1883, DOI 10.1105/tpc.021923; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cope GA, 2003, CELL, V114, P663, DOI 10.1016/S0092-8674(03)00722-0; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; del Pozo JC, 1999, P NATL ACAD SCI USA, V96, P15342, DOI 10.1073/pnas.96.26.15342; del Pozo JC, 2002, PLANT CELL, V14, P421, DOI 10.1105/tpc.010282; Dharmasiri N, 2005, DEV CELL, V9, P109, DOI 10.1016/j.devcel.2005.05.014; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Dharmasiri N, 2007, PLANT J, V52, P114, DOI 10.1111/j.1365-313X.2007.03211.x; Dharmasiri S, 2003, EMBO J, V22, P1762, DOI 10.1093/emboj/cdg190; Dohmann EMN, 2005, PLANT CELL, V17, P1967, DOI 10.1105/tpc.105.032870; Dohmann EMN, 2010, EUR J CELL BIOL, V89, P163, DOI 10.1016/j.ejcb.2009.12.001; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Emberley ED, 2012, J BIOL CHEM, V287, P29679, DOI 10.1074/jbc.M112.352484; Enchev RI, 2012, CELL REPORTS, V2, P616, DOI 10.1016/j.celrep.2012.08.019; Feng SH, 2003, PLANT CELL, V15, P1083, DOI 10.1105/tpc.010207; Fukumoto A, 2005, FEBS LETT, V579, P1047, DOI 10.1016/j.febslet.2004.12.076; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Gray WM, 1999, GENE DEV, V13, P1678, DOI 10.1101/gad.13.13.1678; Gray WM, 2003, PLANT CELL, V15, P1310, DOI 10.1105/tpc.010884; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Gusmaroli G, 2004, PLANT CELL, V16, P2984, DOI 10.1105/tpc.104.025999; Gusmaroli G, 2007, PLANT CELL, V19, P564, DOI 10.1105/tpc.106.047571; Harari-Steinberg O, 2007, GENES CELLS, V12, P183, DOI 10.1111/j.1365-2443.2007.01049.x; Hardtke CS, 1998, EMBO J, V17, P1405, DOI 10.1093/emboj/17.5.1405; Hobbie L, 2000, DEVELOPMENT, V127, P23; Ito H, 2006, PLANT PHYSIOL, V142, P63, DOI 10.1104/pp.106.084533; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Kwok SF, 1998, PLANT CELL, V10, P1779, DOI 10.1105/tpc.10.11.1779; LINCOLN C, 1990, PLANT CELL, V2, P1071, DOI 10.1105/tpc.2.11.1071; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Lykke-Andersen K, 2003, MOL CELL BIOL, V23, P6790, DOI 10.1128/MCB.23.19.6790-6797.2003; Maraschin FD, 2009, PLANT J, V59, P100, DOI 10.1111/j.1365-313X.2009.03854.x; Menon S, 2007, NAT IMMUNOL, V8, P1236, DOI 10.1038/ni1514; Mirjam E, 2008, PLANT PHYSIOL, V147, P1369, DOI 10.1104/pp.108.121061; Mundt KE, 2002, MOL BIOL CELL, V13, P493, DOI 10.1091/mbc.01-10-0521; Olma MH, 2009, J CELL SCI, V122, P1035, DOI 10.1242/jcs.043539; Oono Y, 1998, PLANT CELL, V10, P1649, DOI 10.1105/tpc.10.10.1649; Oron E, 2002, DEVELOPMENT, V129, P4399; Oron E, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100150; Patton EE, 1998, TRENDS GENET, V14, P236, DOI 10.1016/S0168-9525(98)01473-5; Peng ZH, 2001, DEVELOPMENT, V128, P4277; Peng ZH, 2001, PLANT CELL, V13, P2393, DOI 10.1105/tpc.13.11.2393; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; PRINGLE JR, 1989, METHOD CELL BIOL, V31, P357; Quint M, 2005, PLANT J, V43, P371, DOI 10.1111/j.1365-313X.2005.02449.x; Quint M, 2009, PLANT PHYSIOL, V150, P748, DOI 10.1104/pp.109.136671; Rubio V, 2005, PLANT J, V41, P767, DOI 10.1111/j.1365-313X.2004.02328.x; Ruegger M, 1998, GENE DEV, V12, P198, DOI 10.1101/gad.12.2.198; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Schwechheimer C, 2001, SCIENCE, V292, P1379, DOI 10.1126/science.1059776; Serino G, 1999, PLANT CELL, V11, P1967, DOI 10.1105/tpc.11.10.1967; Serino G, 2003, PLANT CELL, V15, P719, DOI 10.1105/tpc.009092; Sharon M, 2009, STRUCTURE, V17, P31, DOI 10.1016/j.str.2008.10.012; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Strader LC, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-41; Stuttmann J, 2009, J BIOL CHEM, V284, P7920, DOI 10.1074/jbc.M809069200; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Tiwari SB, 2004, PLANT CELL, V16, P533, DOI 10.1105/tpc.017384; Tomoda K, 2002, J BIOL CHEM, V277, P2302, DOI 10.1074/jbc.M104431200; Tsuge T, 2001, J MOL BIOL, V305, P1, DOI 10.1006/jmbi.2000.4288; Uhle S, 2003, EMBO J, V22, P1302, DOI 10.1093/emboj/cdg127; Ullah Z, 2007, MOL BIOL CELL, V18, P1179, DOI 10.1091/mbc.E06-09-0790; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Wee S, 2005, NAT CELL BIOL, V7, P387, DOI 10.1038/ncb1241; Wei N, 2003, ANNU REV CELL DEV BI, V19, P261, DOI 10.1146/annurev.cellbio.19.111301.112449; WEI N, 1994, CELL, V78, P117, DOI 10.1016/0092-8674(94)90578-9; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083; Wu JT, 2005, NAT CELL BIOL, V7, P1014, DOI 10.1038/ncb1301; Wu JT, 2006, TRENDS CELL BIOL, V16, P362, DOI 10.1016/j.tcb.2006.05.001; Wu K, 2000, J BIOL CHEM, V275, P32317, DOI 10.1074/jbc.M004847200; Yang XM, 2002, CURR BIOL, V12, P667, DOI 10.1016/S0960-9822(02)00791-1; Zhang WD, 2008, ECON LETT, V99, P1, DOI 10.1016/j.econlet.2007.09.029; Zhou CS, 2003, MOL CELL, V11, P927, DOI 10.1016/S1097-2765(03)00136-9	78	10	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e66578	10.1371/journal.pone.0066578	http://dx.doi.org/10.1371/journal.pone.0066578			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762492	Green Submitted, gold, Green Published			2022-12-27	WOS:000321094800100
J	Kassam, KS; Mendes, WB				Kassam, Karim S.; Mendes, Wendy Berry			The Effects of Measuring Emotion: Physiological Reactions to Emotional Situations Depend on whether Someone Is Asking	PLOS ONE			English	Article							SELF-CONSCIOUS EMOTIONS; NEGATIVE EXPERIENCES; FOCUSED ATTENTION; BLOOD-PRESSURE; RUMINATION; RESPONSES; ANGER; SHAME; GUILT; FEELINGS	Measurement effects exist throughout the sciences-the act of measuring often changes the properties of the observed. We suggest emotion research is no exception. The awareness and conscious assessment required by self-report of emotion may significantly alter emotional processes. In this study, participants engaged in a difficult math task designed to induce anger or shame while their cardiovascular responses were measured. Half of the participants were asked to report on their emotional states and appraise their feelings throughout the experiment, whereas the other half completed a control questionnaire. Among those in the anger condition, participants assigned to report on their emotions exhibited qualitatively different physiological responses from those who did not report. For participants in the shame condition, there were no significant differences in physiology based on the self-report manipulation. The study demonstrates that the simple act of reporting on an emotional state may have a substantial impact on the body's reaction to an emotional situation.	[Kassam, Karim S.] Carnegie Mellon Univ, Dept Social & Decis Sci, Pittsburgh, PA 15213 USA; [Mendes, Wendy Berry] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA	Carnegie Mellon University; University of California System; University of California San Francisco	Kassam, KS (corresponding author), Carnegie Mellon Univ, Dept Social & Decis Sci, Pittsburgh, PA 15213 USA.	kskassam@cmu.edu; wendy.mendes@ucsf.edu			National Heart, Lung and Blood Institute (NHLBI) [HL079383]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079383] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by funding from National Heart, Lung and Blood Institute (NHLBI) grant (HL079383) to WBM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, HDB PSYCHOPHYSIOLOGY; [Anonymous], 2000, HDB PSYCHOPHYSIOLOGY, DOI DOI 10.3109/07853890008995935; Ayduk O, 2008, PSYCHOL SCI, V19, P229, DOI 10.1111/j.1467-9280.2008.02073.x; Barrett LF, 2006, PERSPECT PSYCHOL SCI, V1, P28, DOI 10.1111/j.1745-6916.2006.00003.x; Barrett LF, 2009, ADV EXP SOC PSYCHOL, V41, P167, DOI 10.1016/S0065-2601(08)00404-8; Blascovich J, 1996, ADV EXP SOC PSYCHOL, V28, P1, DOI 10.1016/S0065-2601(08)60235-X; Blascovich J., 2010, HDB SOCIAL PSYCHOL, V5th ed., P194, DOI DOI 10.1002/9780470561119.SOCPSY001006; Bridewell WB, 1997, PERS INDIV DIFFER, V22, P587, DOI 10.1016/S0191-8869(96)00224-3; Brosschot JF, 2006, J PSYCHOSOM RES, V60, P113, DOI 10.1016/j.jpsychores.2005.06.074; Bushman BJ, 2001, J PERS SOC PSYCHOL, V81, P17, DOI 10.1037//0022-3514.81.1.17; Carretie L, 2001, J COGNITIVE NEUROSCI, V13, P1109, DOI 10.1162/089892901753294400; CARVER CS, 1982, PSYCHOL BULL, V92, P111, DOI 10.1037/0033-2909.92.1.111; CARVER CS, 1979, J PERS SOC PSYCHOL, V37, P1186, DOI 10.1037/0022-3514.37.7.1186; CLAY DL, 1993, J COUNS DEV, V72, P91, DOI 10.1002/j.1556-6676.1993.tb02283.x; Cohen TR, 2011, J PERS SOC PSYCHOL, V100, P947, DOI 10.1037/a0022641; Conner TS, 2012, SOC PSYCHOL PERS SCI, V3, P315, DOI 10.1177/1948550611419677; Creswell JD, 2007, PSYCHOSOM MED, V69, P560, DOI 10.1097/PSY.0b013e3180f6171f; EKMAN P, 1983, SCIENCE, V221, P1208, DOI 10.1126/science.6612338; Feynman R. P., 1971, FEYNMAN LECT PHYS, V3; Frattaroli J, 2006, PSYCHOL BULL, V132, P823, DOI 10.1037/0033-2909.132.6.823; Gendron M, 2012, EMOTION, V12, P314, DOI 10.1037/a0026007; GERIN W, 2012, INT J HYPERTENS, P53465, DOI DOI 10.1155/2012/453465; Glynn LM, 2007, INT J PSYCHOPHYSIOL, V66, P135, DOI 10.1016/j.ijpsycho.2007.03.018; GROSS JJ, 1995, COGNITION EMOTION, V9, P87, DOI 10.1080/02699939508408966; Gross JJ, 2002, PSYCHOPHYSIOLOGY, V39, P281, DOI 10.1017/S0048577201393198; Heerey EA, 2003, EMOTION, V3, P394, DOI 10.1037/1528-3542.3.4.394; Herrald MM, 2002, J PERS SOC PSYCHOL, V83, P434, DOI 10.1037//0022-3514.83.2.434; HUGHES CF, 1994, J PERS, V62, P565, DOI 10.1111/j.1467-6494.1994.tb00309.x; Jamieson JP, 2013, PSYCHOL SCI, V24, P131, DOI 10.1177/0956797612448194; Jamieson JP, 2012, J EXP PSYCHOL GEN, V141, P417, DOI 10.1037/a0025719; Jefferson AL, 2010, J ALZHEIMERS DIS, V20, P813, DOI 10.3233/JAD-2010-100081; Keltner D., 2010, HDB SOCIAL PSYCHOL, P312, DOI DOI 10.1002/9780470561119.SOCPSY001009; Kron A, 2010, J EXP PSYCHOL GEN, V139, P520, DOI 10.1037/a0020008; Kross E, 2011, CURR DIR PSYCHOL SCI, V20, P187, DOI 10.1177/0963721411408883; Lambie JA, 2002, PSYCHOL REV, V109, P219, DOI 10.1037//0033-295X.109.2.219; Larsen J.T., 2008, HDB EMOTIONS, P180, DOI DOI 10.1249/00005768-200405001-00432; Larsen R.J., 1999, WELL BEING FDN HEDON, P40, DOI DOI 10.1007/S00441-018-2908-9; Levenson RW, 2003, SER AFFECTIVE SCI, P212; Leventhal H., 1987, COGNITION EMOTION, V1, P3, DOI [DOI 10.1080/02699938708408361, 10.1080/02699938708408361]; Lewis H., 1971, SHAME GUILT NEUROSIS; Lewis M., 1993, HDB EMOTIONS, P563; Lieberman MD, 2007, PSYCHOL SCI, V18, P421, DOI 10.1111/j.1467-9280.2007.01916.x; Lieberman MD, 2011, EMOTION, V11, P468, DOI 10.1037/a0023503; Lindquist KA, 2008, PSYCHOL SCI, V19, P898, DOI 10.1111/j.1467-9280.2008.02174.x; Lyubomirsky S, 2005, REV GEN PSYCHOL, V9, P111, DOI 10.1037/1089-2680.9.2.111; LYUBOMIRSKY S, 1995, J PERS SOC PSYCHOL, V69, P176, DOI 10.1037/0022-3514.69.1.176; Matthews KA, 2005, AM PSYCHOL, V60, P783, DOI 10.1037/0003-066X.60.8.783; Mauss IB, 2007, INT J PSYCHOPHYSIOL, V66, P116, DOI 10.1016/j.ijpsycho.2007.03.017; Mendes WB, 2003, J PERS SOC PSYCHOL, V84, P771, DOI 10.1037/0022-3514.84.4.771; Mendes WB, 2008, J PERS SOC PSYCHOL, V94, P278, DOI 10.1037/0022-3514.94.2.278; Miller S, 1985, SHAME EXPERIENCE; Mischkowski D, J EXP SOC P IN PRESS; Nolen-Hoeksema S, 2000, J ABNORM PSYCHOL, V109, P504, DOI 10.1037/0021-843X.109.3.504; Northoff G, 2000, CEREB CORTEX, V10, P93, DOI 10.1093/cercor/10.1.93; Orth U, 2006, PERS SOC PSYCHOL B, V32, P1608, DOI 10.1177/0146167206292958; Pedersen WC, 2011, BRIT J SOC PSYCHOL, V50, P281, DOI 10.1348/014466610X515696; Pennebaker JW, 1997, PSYCHOL SCI, V8, P162, DOI 10.1111/j.1467-9280.1997.tb00403.x; Ray RD, 2008, J PERS SOC PSYCHOL, V94, P133, DOI 10.1037/0022-3514.94.1.133; Robinson MD, 2002, PSYCHOL BULL, V128, P934, DOI 10.1037//0033-2909.128.6.934; Rosenman RH, 1985, ANGER HOSTILITY CARD; SCHEIER MF, 1977, J PERS SOC PSYCHOL, V35, P625, DOI 10.1037/0022-3514.35.9.625; SCHEIER MF, 1981, J RES PERS, V15, P1, DOI 10.1016/0092-6566(81)90002-7; SCHEIER MF, 1976, J PERS, V44, P627, DOI 10.1111/j.1467-6494.1976.tb00142.x; Scherer KR, 2005, SOC SCI INFORM, V44, P695, DOI 10.1177/0539018405058216; Spielberger C.D., 1985, ANGER HOSTILITY CARD, P5; Spielberger CD, 1994, USE PSYCHOL TESTING, P292, DOI DOI 10.1002/9780470479216.CORPSY0943; STEMMLER G, 1989, PSYCHOPHYSIOLOGY, V26, P617, DOI 10.1111/j.1469-8986.1989.tb03163.x; SULS J, 1995, HEALTH PSYCHOL, V14, P444, DOI 10.1037/0278-6133.14.5.444; TANGNEY JP, 1992, J PERS SOC PSYCHOL, V62, P669, DOI 10.1037/0022-3514.62.4.669; Tracy JL, 2006, PERS SOC PSYCHOL B, V32, P1339, DOI 10.1177/0146167206290212; Tracy JL, 2004, PSYCHOL INQ, V15, P103, DOI 10.1207/s15327965pli1502_01; Treynor W, 2003, COGNITIVE THER RES, V27, P247, DOI 10.1023/A:1023910315561; Wechsler D, 1974, WECHSLER INTELLIGENC; Weiner B., 1980, EDUC RESEARCHER, V9, P4, DOI [https://doi.org/10.3102/0013189X009007004, DOI 10.3102/0013189X009007004]; Wilson TD, 2005, J PERS SOC PSYCHOL, V88, P5, DOI 10.1037/0022-3514.88.1.5; Yamasaki H, 2002, P NATL ACAD SCI USA, V99, P11447, DOI 10.1073/pnas.182176499; Zoccola PM, 2008, PSYCHOSOM MED, V70, P661, DOI 10.1097/PSY.0b013e31817bbc77	77	86	87	3	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e64959	10.1371/journal.pone.0064959	http://dx.doi.org/10.1371/journal.pone.0064959			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	166TB	23785407	gold, Green Published, Green Submitted			2022-12-27	WOS:000320579400032
J	Cieplak, M; Robbins, MO				Cieplak, Marek; Robbins, Mark O.			Nanoindentation of 35 Virus Capsids in a Molecular Model: Relating Mechanical Properties to Structure	PLOS ONE			English	Article							CHLOROTIC MOTTLE VIRUS; VIRAL CAPSIDS; PROTEIN; DYNAMICS; SHELL; PART	A coarse-grained model is used to study the mechanical response of 35 virus capsids of symmetries T = 1, T = 2, T = 3, pseudo T = 3, T = 4, and T = 7. The model is based on the native structure of the proteins that constitute the capsids and is described in terms of the C-alpha atoms associated with each amino acid. The number of these atoms ranges between 8 460 (for SPMV - satellite panicum mosaic virus) and 135 780 (for NBV - nudaureli virus). Nanoindentation by a broad AFM tip is modeled as compression between two planes: either both flat or one flat and one curved. Plots of the compressive force versus plate separation show a variety of behaviors, but in each case there is an elastic region which extends to a characteristic force F-c. Crossing F-c results in a drop in the force and irreversible damage. Across the 35 capsids studied, both F-c and the elastic stiffness are observed to vary by a factor of 20. The changes in mechanical properties do not correlate simply with virus size or symmetry. There is a strong connection to the mean coordination number < z >, defined as the mean number of interactions to neighboring amino acids. The Young's modulus for thin shell capsids rises roughly quadratically with < z >-6, where 6 is the minimum coordination for elastic stability in three dimensions.	[Cieplak, Marek] Polish Acad Sci, Inst Phys, Warsaw, Poland; [Robbins, Mark O.] Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA	Polish Academy of Sciences; Institute of Physics - Polish Academy of Sciences; Johns Hopkins University	Cieplak, M (corresponding author), Polish Acad Sci, Inst Phys, Warsaw, Poland.	mc@ifpan.edu.pl		Robbins, Mark Owen/0000-0001-7160-3608	European Regional Development Fund under the Operational Programme Innovative Economy NanoFun [POIG.02.02.00-00-025/09]; Polish National Science Centre Grant [011/01/B/ST3/02190]; National Science Foundation [DMR 1006805]; Simons Foundation; Direct For Mathematical & Physical Scien [1006805] Funding Source: National Science Foundation	European Regional Development Fund under the Operational Programme Innovative Economy NanoFun; Polish National Science Centre Grant; National Science Foundation(National Science Foundation (NSF)); Simons Foundation; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	The computer resources were financed by the European Regional Development Fund under the Operational Programme Innovative Economy NanoFun POIG.02.02.00-00-025/09. This research has been supported by the Polish National Science Centre Grant No. 011/01/B/ST3/02190 (MC), the National Science Foundation under Grant No. DMR 1006805 (MR), and the Simons Foundation (MR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen M. P., 1987, COMPUTER SIMULATIONS; Arkhipov A, 2006, STRUCTURE, V14, P1767, DOI 10.1016/j.str.2006.10.003; Arkhipov A, 2009, BIOPHYS J, V97, P2061, DOI 10.1016/j.bpj.2009.07.039; Baclayon M, 2011, NANO LETT, V11, P4865, DOI 10.1021/nl202699r; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Buenemann M, 2007, P NATL ACAD SCI USA, V104, P9925, DOI 10.1073/pnas.0611472104; Buenemann M, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.051924; Carrasco C, 2006, P NATL ACAD SCI USA, V103, P13706, DOI 10.1073/pnas.0601881103; Carrasco C, 2008, P NATL ACAD SCI USA, V105, P4150, DOI 10.1073/pnas.0708017105; Carrillo-Tripp M, 2009, NUCLEIC ACIDS RES, V37, pD436, DOI 10.1093/nar/gkn840; CASPAR DLD, 1962, COLD SPRING HARB SYM, V27, P1, DOI 10.1101/sqb.1962.027.001.005; Castellanos M, 2012, BIOPHYS J, V102, P2615, DOI 10.1016/j.bpj.2012.04.026; Cieplak M, 2004, PROTEINS, V56, P285, DOI 10.1002/prot.20081; Cieplak M, 2003, BIOPHYS J, V84, P475, DOI 10.1016/S0006-3495(03)74867-X; Cieplak M, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3276287; Ding JP, 2002, STRUCTURE, V10, P999, DOI 10.1016/S0969-2126(02)00793-1; FENG S, 1984, PHYS REV LETT, V52, P216, DOI 10.1103/PhysRevLett.52.216; Gibbons MM, 2008, BIOPHYS J, V95, P3640, DOI 10.1529/biophysj.108.136176; Gibbons MM, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.031901; GREST GS, 1986, PHYS REV A, V33, P3628, DOI 10.1103/PhysRevA.33.3628; JACOBS DJ, 1995, PHYS REV LETT, V75, P4051, DOI 10.1103/PhysRevLett.75.4051; Klug WS, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.228101; Liu AJ, 2010, ANNU REV CONDEN MA P, V1, P347, DOI 10.1146/annurev-conmatphys-070909-104045; Mao XM, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.085504; Michel JP, 2006, P NATL ACAD SCI USA, V103, P6184, DOI 10.1073/pnas.0601744103; Reddy VS, 2001, J VIROL, V75, P11943, DOI 10.1128/JVI.75.24.11943-11947.2001; Roos WH, 2010, NAT PHYS, V6, P733, DOI 10.1038/NPHYS1797; Roos WH, 2010, BIOPHYS J, V99, P1175, DOI 10.1016/j.bpj.2010.05.033; Roos WH, 2012, P NATL ACAD SCI USA, V109, P2342, DOI 10.1073/pnas.1109590109; Sikora M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000547; SPEIR JA, 1995, STRUCTURE, V3, P63, DOI 10.1016/S0969-2126(01)00135-6; STEELE WA, 1973, SURF SCI, V36, P317, DOI 10.1016/0039-6028(73)90264-1; Sulkowska JI, 2008, BIOPHYS J, V95, P3174, DOI 10.1529/biophysj.107.127233; Sulkowska JI, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/28/283201; Szymczak P, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2358346; Tama F, 2005, J MOL BIOL, V345, P299, DOI 10.1016/j.jmb.2004.10.054; Tsai J, 1999, J MOL BIOL, V290, P253, DOI 10.1006/jmbi.1999.2829; Veitshans T, 1997, FOLD DES, V2, P1, DOI 10.1016/S1359-0278(97)00002-3; VRIEND G, 1986, J MOL BIOL, V191, P453, DOI 10.1016/0022-2836(86)90140-3; Zink M, 2009, BIOPHYS J, V96, P1350, DOI 10.1016/j.bpj.2008.11.028	40	42	42	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e63640	10.1371/journal.pone.0063640	http://dx.doi.org/10.1371/journal.pone.0063640			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785395	gold, Green Submitted, Green Published			2022-12-27	WOS:000321038800122
J	Gradstedt, H; Iovino, F; Bijlsma, JJE				Gradstedt, Henrik; Iovino, Federico; Bijlsma, Jetta J. E.			Streptococcus pneumoniae Invades Endothelial Host Cells via Multiple Pathways and Is Killed in a Lysosome Dependent Manner	PLOS ONE			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; BLOOD-BRAIN-BARRIER; EPITHELIAL-CELLS; INVASION; INTERNALIZATION; VIRUS; PNEUMOCOCCI; INFECTION; DISEASE; KINASE	Streptococcus pneumoniae is one of the major causative agents of pneumonia, sepsis, meningitis and other morbidities. In spite of its heavy disease burden, surprisingly little is known about the mechanisms involved in the switch of life style, from commensal colonizer of the nasopharynx to invasive pathogen. In vitro experiments, and mouse models have shown that S. pneumoniae can be internalized by host cells, which coupled with intracellular vesicle transport through the cells, i.e. transcytosis, is suggested to be the first step of invasive disease. To further dissect the process of S. pneumoniae internalization, we chemically inhibited discrete parts of the cellular uptake system. We show that this invasion of the host cells was facilitated via both clathrin- and caveolae-mediated endocytosis. After internalization we demonstrated that the bulk of the internalized S. pneumoniae was killed in the lysosome. Interestingly, inhibition of the lysosome altered transcytosis dynamics as it resulted in an increase in the transport of the internalized bacteria out of the cells via the basal side. These results show that uptake of S. pneumoniae into host cells occurs via multiple pathways, as opposed to the often proposed view of invasion being dependent on specific, and singular receptor-mediated endocytosis. This indicates that the endothelium not only has a critical role as a physical barrier against S. pneumoniae in the blood stream, but also in degrading S. pneumonia cells that have adhered to, and invaded the endothelial cells.	[Gradstedt, Henrik; Iovino, Federico; Bijlsma, Jetta J. E.] Univ Groningen, Univ Med Ctr Groningen, Lab Mol Bacteriol, Dept Med Microbiol, Groningen, Netherlands	University of Groningen	Bijlsma, JJE (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Lab Mol Bacteriol, Dept Med Microbiol, Groningen, Netherlands.	j.j.e.bijlsma@umcg.nl	Iovino, Federico/AGW-9968-2022; Iovino, Federico/R-2721-2017	Iovino, Federico/0000-0001-5249-9120; Iovino, Federico/0000-0001-5249-9120	NWO [40-00506-98-9021, 175-010-2009-023]; Rosalind Franklin Fellowship of the UMCG	NWO(Netherlands Organization for Scientific Research (NWO)); Rosalind Franklin Fellowship of the UMCG	Part of this work has been performed at the UMCG Microscopy and Imaging Center (UMIC), which is sponsored by NWO-grants 40-00506-98-9021 and 175-010-2009-023. J.J.E. Bijlsma is a Rosalind Franklin Fellow of the UMCG; H. Gradstedt is funded by the Rosalind Franklin Fellowship of the UMCG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal V, 2010, J BIOL CHEM, V285, P23484, DOI 10.1074/jbc.M110.142703; Agarwal V, 2009, J BIOL CHEM, V284, P19427, DOI 10.1074/jbc.M109.003442; Bergmann S, 2006, MICROBIOL-SGM, V152, P295, DOI 10.1099/mic.0.28610-0; Bergmann S, 2009, J CELL SCI, V122, P256, DOI 10.1242/jcs.035600; Bhattacharyya S, 2010, VIROLOGY, V401, P18, DOI 10.1016/j.virol.2010.02.015; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Burghout P, 2010, J BACTERIOL, V192, P4054, DOI 10.1128/JB.00151-10; Cantin C, 2007, J GEN VIROL, V88, P559, DOI 10.1099/vir.0.82150-0; Chiaraviglio L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002012; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Elm C, 2004, J BIOL CHEM, V279, P6296, DOI 10.1074/jbc.M310528200; Futter CE, 1998, J CELL BIOL, V141, P611, DOI 10.1083/jcb.141.3.611; Hammerschmidt S, 2005, INFECT IMMUN, V73, P4653, DOI 10.1128/IAI.73.8.4653-4667.2005; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; Hofmann I, 2006, J CELL SCI, V119, P1494, DOI 10.1242/jcs.02958; Jia LJ, 2009, INT J BIOCHEM CELL B, V41, P2594, DOI 10.1016/j.biocel.2009.08.019; Misinzo G, 2008, J VIROL, V82, P1128, DOI 10.1128/JVI.01229-07; Nizet V, 1997, INFECT IMMUN, V65, P5074, DOI 10.1128/IAI.65.12.5074-5081.1997; Orihuela CJ, 2009, J CLIN INVEST, V119, P1638, DOI 10.1172/JCI36759; Pizarro-Cerda J, 2010, BIOESSAYS, V32, P496, DOI 10.1002/bies.200900172; Radin JN, 2005, INFECT IMMUN, V73, P7827, DOI 10.1128/IAI.73.12.7827-7835.2005; Rahner C, 2000, GASTROENTEROLOGY, V119, P1692, DOI 10.1053/gast.2000.20233; Ring A, 1998, J CLIN INVEST, V102, P347, DOI 10.1172/JCI2406; Schroder A, 2006, MED MICROBIOL IMMUN, V195, P185, DOI 10.1007/s00430-006-0015-0; Stins MF, 2001, MICROB PATHOGENESIS, V30, P19, DOI 10.1006/mpat.2000.0406; Sukumaran SK, 2002, J BIOL CHEM, V277, P50716, DOI 10.1074/jbc.M208830200; Uchiyama S, 2009, J EXP MED, V206, P1845, DOI 10.1084/jem.20090386; Uriarte SM, 2009, AM J PHYSIOL-CELL PH, V296, pC857, DOI 10.1152/ajpcell.00454.2008; Van Hamme E, 2008, J GEN VIROL, V89, P2147, DOI 10.1099/vir.0.2008/001602-0; Wang YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030632; Zhang JR, 2000, CELL, V102, P827, DOI 10.1016/S0092-8674(00)00071-4	31	22	22	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65626	10.1371/journal.pone.0065626	http://dx.doi.org/10.1371/journal.pone.0065626			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785439	Green Published, gold, Green Submitted			2022-12-27	WOS:000321038800081
J	Hao, J; Wang, C; Yuan, J; Chen, M; Zhao, MH				Hao, Jian; Wang, Chen; Yuan, Jun; Chen, Min; Zhao, Ming-Hui			A Pro-Inflammatory Role of C5L2 in C5a-Primed Neutrophils for ANCA-Induced Activation	PLOS ONE			English	Article							ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES; 2ND C5A RECEPTOR; COMPLEMENT ACTIVATION; SIGNAL-TRANSDUCTION; VASCULITIS; PROTEIN; GLOMERULONEPHRITIS; AUTOANTIBODIES; RESPONSIVENESS; ANAPHYLATOXIN	Background: The complement system is crucial for the development of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). In particular, C5a and its receptor on neutrophils, CD88, play a central role. The functional role of the second receptor of C5a, C5L2, remains unclear. In the current study, we investigated the role of C5L2 in C5a-primed neutrophils for ANCA-induced activation. Methods: The effect of blocking C5L2 by anti-human C5L2 blocking antibody were tested on respiratory burst and degranulation of C5a-primed neutrophils activated with ANCA, as well as on membrane-bound proteinase 3 (mPR3) and concentration of myeloperoxidase (MPO) in supernatant of C5a-primed neutrophils. An antagonist for CD88 was also employed. Results: Blocking C5L2 resulted in a significantly decreased MPO concentration in the supernatant of C5a-primed neutrophils. mPR3 expression increased from 209.0 +/- 43.0 in untreated cells to 444.3 +/- 60.8 after C5a treatment (P<0.001), and decreased to 375.8 +/- 65.44, 342.2 +/- 54.3 and 313.7 +/- 43.6 by pre-incubating blocking C5L2 antibody at 2.5 mg/ml, 5 mg/ml or 10 mg/ml (compared with C5a-priming group, P<0.001, P<0.001, and P<0.001), respectively. In C5a-primed neutrophils, subsequently activating with MPO-ANCA-positive IgG, the MFI value was 425.8 +/- 160.6, which decreased to 292.8 +/- 141.2, 289.7 +/- 130.0 and 280.3 +/- 136.4 upon pre-incubation with mouse anti-human C5L2 blocking antibody at 2.5 mg/ml, 5 mg/ml or 10 mg/ml (compared with C5a-primed neutrophils, for MPO-ANCA-positive IgG-induced activation, P<0.05, P<0.05, and P<0.05), respectively. Blocking C5L2 also resulted in significantly decreased C5a-primed neutrophils for PR3-ANCA-positive IgG-induced activation. Moreover, the lactoferrin concentration in the supernant significantly decreased in pre-incubation with anti-human C5L2 blocking antibody, compared with C5a-primed neutrophils induced by PR3- or MPO-ANCA-positive IgG. Conclusions: C5L2 may be implicated in the pro-inflammatory role in C5a-primed neutrophils for ANCA-induced activation.	[Hao, Jian; Wang, Chen; Yuan, Jun; Chen, Min; Zhao, Ming-Hui] Peking Univ, Hosp 1,Peking Tsinghua Ctr Life Sci,Dept Med,Rena, Inst Nephrol,Key Lab Chron Kidney Dis Prevent & T, Key Lab Renal Dis,Minist Hlth China,Minist Educ, Beijing 100871, Peoples R China	Peking University	Chen, M (corresponding author), Peking Univ, Hosp 1,Peking Tsinghua Ctr Life Sci,Dept Med,Rena, Inst Nephrol,Key Lab Chron Kidney Dis Prevent & T, Key Lab Renal Dis,Minist Hlth China,Minist Educ, Beijing 100871, Peoples R China.	leimeng@public3.bta.net.cn			Chinese 973 project [2012CB517702]; Research Fund for the Doctoral Program of Higher Education of China [20120001110018]; "National Key Technology Research and Development (R&D) Program" of the Ministry of Science and Technology of China [2011BAI10B04]; National Natural Science Fund [81021004]	Chinese 973 project(National Basic Research Program of China); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); "National Key Technology Research and Development (R&D) Program" of the Ministry of Science and Technology of China; National Natural Science Fund(National Natural Science Foundation of China (NSFC))	This study is supported by a grant of Chinese 973 project (No. 2012CB517702), the Research Fund for the Doctoral Program of Higher Education of China (No. 20120001110018), "National Key Technology Research and Development (R&D) Program" of the Ministry of Science and Technology of China (No. 2011BAI10B04) and a grant of the National Natural Science Fund (No. 81021004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker EN, 2005, CELL MOL LIFE SCI, V62, P2531, DOI 10.1007/s00018-005-5368-9; Bamberg CE, 2010, J BIOL CHEM, V285, P7633, DOI 10.1074/jbc.M109.092106; Cain SA, 2002, J BIOL CHEM, V277, P7165, DOI 10.1074/jbc.C100714200; CHARLES LA, 1991, J LEUKOCYTE BIOL, V50, P539, DOI 10.1002/jlb.50.6.539; Chen M, 2009, NEPHROL DIAL TRANSPL, V24, P1247, DOI 10.1093/ndt/gfn586; Chen NJ, 2007, NATURE, V446, P203, DOI 10.1038/nature05559; Choi M, 2003, KIDNEY INT, V63, P96, DOI 10.1046/j.1523-1755.2003.00718.x; FALK RJ, 1990, P NATL ACAD SCI USA, V87, P4115, DOI 10.1073/pnas.87.11.4115; Gao HW, 2005, FASEB J, V19, P1003, DOI 10.1096/fj.04-3424fje; Gavrilyuk V, 2005, J NEUROCHEM, V92, P1140, DOI 10.1111/j.1471-4159.2004.02942.x; GERARD NP, 1989, J BIOL CHEM, V264, P1760; GERARD NP, 1991, NATURE, V349, P614, DOI 10.1038/349614a0; Gou SJ, 2013, KIDNEY INT, V83, P129, DOI 10.1038/ki.2012.313; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; Hao J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038317; Hess C, 2000, BLOOD, V96, P2822; Hewins P, 2006, KIDNEY INT, V69, P605, DOI 10.1038/sj.ki.5000167; Huugen D, 2007, KIDNEY INT, V71, P646, DOI 10.1038/sj.ki.5002103; Jennette JC, 2013, ARTHRITIS RHEUM-US, V65, P1, DOI 10.1002/art.37715; Kalant D, 2005, J BIOL CHEM, V280, P23936, DOI 10.1074/jbc.M406921200; KEOGAN MT, 1992, CLIN EXP IMMUNOL, V90, P228; Kettritz R, 2001, J AM SOC NEPHROL, V12, P37, DOI 10.1681/ASN.V12137; Lee H, 2008, IMMUNOL CELL BIOL, V86, P153, DOI 10.1038/sj.icb.7100166; Manthey HD, 2009, INT J BIOCHEM CELL B, V41, P2114, DOI 10.1016/j.biocel.2009.04.005; MULDER AHL, 1994, CLIN EXP IMMUNOL, V98, P270; Okinaga S, 2003, BIOCHEMISTRY-US, V42, P9406, DOI 10.1021/bi034489v; PORGES AJ, 1994, J IMMUNOL, V153, P1271; Raby AC, 2011, EUR J IMMUNOL, V41, P2741, DOI 10.1002/eji.201041350; REUMAUX D, 1995, BLOOD, V86, P3189; Rittirsch D, 2008, NAT MED, V14, P551, DOI 10.1038/nm1753; Schreiber A, 2010, KIDNEY INT, V77, P118, DOI 10.1038/ki.2009.420; Schreiber A, 2009, J AM SOC NEPHROL, V20, P289, DOI 10.1681/ASN.2008050497; Scola AM, 2009, MOL IMMUNOL, V46, P1149, DOI 10.1016/j.molimm.2008.11.001; Talor MV, 2007, CLIN EXP IMMUNOL, V150, P42, DOI 10.1111/j.1365-2249.2007.03453.x; Ward PA, 2009, J MOL MED, V87, P375, DOI 10.1007/s00109-009-0442-7; Witko-Sarsat V, 1999, BLOOD, V94, P2487, DOI 10.1182/blood.V94.7.2487.419k07_2487_2496; Xiao H, 2007, AM J PATHOL, V170, P52, DOI 10.2353/ajpath.2007.060573; Xing GQ, 2009, J CLIN IMMUNOL, V29, P282, DOI 10.1007/s10875-008-9268-2; Yuan J, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3873; Zhang X, 2010, J IMMUNOL, V185, P6741, DOI 10.4049/jimmunol.1000892	40	22	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66305	10.1371/journal.pone.0066305	http://dx.doi.org/10.1371/journal.pone.0066305			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785491	gold, Green Published, Green Submitted			2022-12-27	WOS:000321038800031
J	Jensen, BAH; Pedersen, SR; Christensen, JP; Thomsen, AR				Jensen, Benjamin A. H.; Pedersen, Sara R.; Christensen, Jan P.; Thomsen, Allan R.			The Availability of a Functional Tumor Targeting T-Cell Repertoire Determines the Anti-Tumor Efficiency of Combination Therapy with Anti-CTLA-4 and Anti-4-1BB Antibodies	PLOS ONE			English	Article							ANTIGEN; BLOCKADE; CTLA-4; VACCINATION; REGRESSION; IMMUNITY; SIGNALS; TIM-3; LEAD; VIVO	It has previously been found that combination therapy with anti-CTLA-4 and anti-4-1BB antibodies may enhance tumor immunity. However, this treatment is not efficient against all tumors, and it has been suggested that variations in tumor control may reflect differences in the immunogenicity of different tumors. In the present report, we have formally tested this hypothesis. Comparing the efficiency of combination antibody therapy against two antigenically distinct variants of the B16.F10 melanoma cell line, we observed that antibody therapy delayed the growth of a variant expressing an exogenous antigen (P<0.0001), while this treatment failed to protect against the non-transfected parental line (P = 0.1850) consistent with published observations. As both cell lines are poorly immunogenic in wild type mice, these observations suggested that the magnitude of the tumor targeting T-cell repertoire plays a major role in deciding the efficiency of this antibody treatment. To directly test this assumption, we made use of mice expressing the exogenous antigen as a self-antigen and therefore carrying a severely purged T-cell repertoire directed against the major tumor antigen. Notably, combination therapy completely failed to inhibit tumor growth in the latter mice (P = 0.8584). These results underscore the importance of a functionally intact T-cell population as a precondition for the efficiency of treatment with immunomodulatory antibodies. Clinically, the implication is that this type of antibody therapy should be attempted as an early form of tumor-specific immunotherapy before extensive exhaustion of the tumor-specific T-cell repertoire has occurred.	[Jensen, Benjamin A. H.; Pedersen, Sara R.; Christensen, Jan P.; Thomsen, Allan R.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark	University of Copenhagen	Thomsen, AR (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Int Hlth Immunol & Microbiol, Blegdamsvej 3C, Copenhagen, Denmark.	athomsen@sund.ku.dk	Jensen, Benjamin A. H./M-4661-2014; Christensen, Jan Pravsgaard/I-4782-2017	Jensen, Benjamin A. H./0000-0001-6991-0828; Christensen, Jan Pravsgaard/0000-0002-4299-9479; Thomsen, Allan Randrup/0000-0002-2392-9803	Novo Nordisk Foundation	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	The project was funded by the Novo Nordisk Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Curran MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019499; Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; Fourcade J, 2010, J EXP MED, V207, P2175, DOI 10.1084/jem.20100637; Gray JC, 2008, EUR J IMMUNOL, V38, P2499, DOI 10.1002/eji.200838208; Holst PJ, 2008, J IMMUNOL, V180, P3339, DOI 10.4049/jimmunol.180.5.3339; Kocak E, 2006, CANCER RES, V66, P7276, DOI 10.1158/0008-5472.CAN-05-2128; Lynch DH, 2008, IMMUNOL REV, V222, P277, DOI 10.1111/j.1600-065X.2008.00621.x; Melero I, 2007, NAT REV CANCER, V7, P95, DOI 10.1038/nrc2051; Ochsenbein AF, 2001, NATURE, V411, P1058, DOI 10.1038/35082583; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Pedersen AE, 2006, CANCER LETT, V235, P229, DOI 10.1016/j.canlet.2005.04.012; Phan GQ, 2003, P NATL ACAD SCI USA, V100, P8372, DOI 10.1073/pnas.1533209100; Prevost-Blondel A, 1998, J IMMUNOL, V161, P2187; Robertson SJ, 2008, J IMMUNOL, V180, P5267, DOI 10.4049/jimmunol.180.8.5267; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Scalapino KJ, 2008, IMMUNOL REV, V223, P143, DOI 10.1111/j.1600-065X.2008.00639.x; Seliger B, 2001, CANCER RES, V61, P1095; Shuford WW, 1997, J EXP MED, V186, P47, DOI 10.1084/jem.186.1.47; Sorensen MR, 2010, VACCINE, V28, P6757, DOI 10.1016/j.vaccine.2010.07.066; Sorensen MR, 2009, EUR J IMMUNOL, V39, P2725, DOI 10.1002/eji.200939543; Sun YL, 2002, NAT MED, V8, P1405, DOI 10.1038/nm796; Voehringer D, 2000, J IMMUNOL, V165, P2415, DOI 10.4049/jimmunol.165.5.2415; Weinberg AD, 2011, IMMUNOL REV, V244, P218, DOI 10.1111/j.1600-065X.2011.01069.x; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062	24	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66081	10.1371/journal.pone.0066081	http://dx.doi.org/10.1371/journal.pone.0066081			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785471	Green Published, gold			2022-12-27	WOS:000321038800051
J	Jiang, SY; Jiao, J; Zhang, TT; Xu, YP				Jiang, Su-yun; Jiao, Jian; Zhang, Ting-ting; Xu, Yong-ping			Pharmacokinetics Study of Recombinant Hirudin in the Plasma of Rats Using Chromogenic Substrate, ELISA, and Radioisotope Assays	PLOS ONE			English	Article								Aim: To compare the analytical methods used to study the pharmacokinetics of recombinant hirudin in the plasma of rats that had been injected with I-125-recombinant hirudin. Methods: 2.0 mg/kg I-125-recombinant hirudin were injected intravenously into rats. The recombinant hirudins in the plasma was analyzed by chromogenic substrate assay, enzyme-linked immunosorbent assay (ELISA), total radioisotope assay (RA) and trichloroacetic acid pre-treated total radioisotope assay (TCA-RA). Results: The chromogenic substrate assay standard curve was linear over the concentration range from 3.12 to 40.00 ng/ml for the recombinant hirudin in plasma. The relative standard deviations (RSD) for the intra- and inter-day variation were 5.0 to 6.3% and 11.9 to 12.6%, respectively. The recoveries of recombinant hirudin was 89.8% to 100.7%. The limit of quantification (LOQ) was 3.12 ng/ml. The concentration-time curve of the recombinant hirudin in the plasma could be explained as a two-compartment model. Pharmacokinetic parameters, including the half-life of distribution phase (t(1/2) alpha), the half-life of elimination phase (t(1/2) beta), volume of apparent distribution (Vd), and area under the concentration-time curve from zero to infinite time (AUC(0-t)) were 7.59 min, 46.99 min, 0.17 L/kg, and 204.5 mg/L/min, respectively, as determined by chromogenic substrate assay; 6.41 min, 47.28 min, 1.24 L/kg, and 575.18 mg/L/min, respectively, as determined by ELISA; 3.69 min, 701.90 min, 0.04 L/kg, and 4189 mg/L/min, respectively as determined by RA; and 4.57 min, 724.9 min, 0.09 L/kg, and 2329 mg/L/min, respectively, as determined by TCA-RA. Conclusions: The chromogenic substrate assay on the concentration dynamics of the recombinant hirudin in the plasma is a specific, sensitive, and accurate analytical method for pharmacokinetic studies. Moreover, the pharmacokinetic parameters determined by the chromogenic substrate assay and ELISA are congruent except for AUC.	[Jiang, Su-yun; Xu, Yong-ping] Dalian Univ Technol, Dalian, Peoples R China; [Jiang, Su-yun; Jiao, Jian; Zhang, Ting-ting] Dalian Inst Food & Drug Control, Dalian, Peoples R China	Dalian University of Technology	Jiang, SY (corresponding author), Dalian Univ Technol, Dalian, Peoples R China.	syjiangsy@263.net			Technology Research and Development Funding of Dalian Finance Bureau [2007E11SF059]	Technology Research and Development Funding of Dalian Finance Bureau	This work was supported by the Technology Research and Development Funding of Dalian Finance Bureau (No. 2007E11SF059). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	GRIESSBACH U, 1985, THROMB RES, V37, P347, DOI 10.1016/0049-3848(85)90023-4; Han G, 2003, CHINESE TRADITIONAL, V8, P6; Han G, 2000, HER MED, V19, P1; HARVEY RP, 1986, P NATL ACAD SCI USA, V83, P1084, DOI 10.1073/pnas.83.4.1084; [黄玉荣 Huang Yurong], 2005, [中草药, Chinese Traditional and Herbal Drugs], V36, P1352; Jiang S, 2002, CHIN J PHARM SCI, V7, P556; MARKWARDT F, 1985, BIOMED BIOCHIM ACTA, V44, P1007; MARKWARDT F, 1994, THROMB RES, V74, P1, DOI 10.1016/0049-3848(94)90032-9; Markwardt F., 1970, METHOD ENZYMOL, V19, P924, DOI [10.1016/0076-6879(70)19082-3, DOI 10.1016/0076-6879(70)19082-3]; Meiring SM, 1999, J PHARM SCI, V88, P523, DOI 10.1021/js980407q; Richter M, 1988, Folia Haematol Int Mag Klin Morphol Blutforsch, V115, P64; SCHARF M, 1989, FEBS LETT, V255, P105, DOI 10.1016/0014-5793(89)81070-1; Yan H, 2005, MED STAT, P133; [张婷婷 Zhang Tingting], 2011, [中国新药杂志, Chinese Journal New Drugs], V20, P372	14	5	6	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e64336	10.1371/journal.pone.0064336	http://dx.doi.org/10.1371/journal.pone.0064336			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785400	Green Published, Green Submitted, gold			2022-12-27	WOS:000321038800117
J	Lee, SM; Park, JS; Norwitz, ER; Koo, JN; Oh, IH; Park, JW; Kim, SM; Kim, YH; Park, CW; Song, YS				Lee, Seung Mi; Park, Joong Shin; Norwitz, Errol R.; Koo, Ja Nam; Oh, Ig Hwan; Park, Jeong Woo; Kim, Sun Min; Kim, Yun Hwan; Park, Chan-Wook; Song, Yong Sang			Risk of Vertical Transmission of Human Papillomavirus throughout Pregnancy: A Prospective Study	PLOS ONE			English	Article							RECURRENT RESPIRATORY PAPILLOMATOSIS; PERINATAL TRANSMISSION; TRANSPLACENTAL TRANSMISSION; INFECTION-RATE; CANCER; INFANTS; HEAD; DNA; ASSOCIATION; CONCORDANCE	Objective: Much controversy still exists about maternal-to-infant transmission of human papillomavirus (HPV) infection, specifically about the magnitude of the risk and the route and timing of such vertical transmission. This prospective cohort study examines the risk of vertical transmission of maternal HPV in each trimester of pregnancy. Study design: One hundred fifty three healthy pregnant women were followed longitudinally throughout pregnancy and cervical swabs obtained in each trimester and postpartum for HPV detection. Cord blood, neonatal nasopharyngeal aspirates, and placental biopsies were collected at delivery. DNA isolation, polymerase chain reaction, and hybridization were performed using the GG HPV Genotyping Chip Kit (Goodgene Inc., Seoul, Korea). Detection of HPV in neonates was defined as the presence of HPV DNA in either cord blood or neonatal nasopharyngeal aspirate. Results: HPV DNA was detected in 14%(22/153) of healthy women in the first trimester, 18%(22/124) in the second trimester, and 10%(15/153) in the third trimester; 24%(37/153) were positive for HPV DNA on at least one occasion in pregnancy. At birth, 5.2%(8/153) of neonates were HPV DNA positive. Seven of these eight infants were born to HPV-positive mothers. Placental HPV DNA was positive in 3.3%(5/152) of cases, and all five cases were from mothers with at least one HPV-positive test. Detection of HPV DNA in neonates was associated with detection of HPV in mothers during any of the three trimesters of pregnancy. Conclusion: HPV DNA was detected at birth in 5.2%(8/153) of neonates born to healthy women, and was associated with the detection of HPV in mothers during any of the three trimesters of pregnancy.	[Lee, Seung Mi; Park, Joong Shin; Kim, Sun Min; Park, Chan-Wook; Song, Yong Sang] Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea; [Lee, Seung Mi] Seoul Natl Univ, Boramae Med Ctr, Seoul Metropolitan Govt, Dept Obstet & Gynecol, Seoul, South Korea; [Norwitz, Errol R.] Tufts Univ, Sch Med, Dept Obstet & Gynecol, Boston, MA 02111 USA; [Koo, Ja Nam; Oh, Ig Hwan] Seoul Womens Hosp, Inchon, South Korea; [Park, Jeong Woo] Inje Univ, Coll Med, Dept Obstet & Gynecol, Ilsan Paik Hosp, Gyeonggi, South Korea; [Kim, Yun Hwan] Ewha Womans Univ, Dept Obstet & Gynecol, Sch Med, Seoul, South Korea; [Song, Yong Sang] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea; [Song, Yong Sang] Seoul Natl Univ, World Class Univ, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Tufts University; Inje University; Ewha Womans University; Seoul National University (SNU); Seoul National University (SNU)	Park, JS (corresponding author), Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea.	jsparkmd@snu.ac.kr	Park, Joong Shin/D-5741-2012; PARK, Chan-Wook/G-3663-2013	Park, Joong Shin/0000-0002-5246-0477; PARK, Chan-Wook/0000-0002-1290-6438; Park, Jeong Woo/0000-0001-6499-0814; Kim, Yun Hwan/0000-0001-9498-2938; SONG, YONGSANG/0000-0001-7115-4021	National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology, Republic of Korea [2009-0074892]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported by a grant of the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2009-0074892), Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anaya-Saavedra G, 2008, ARCH MED RES, V39, P189, DOI 10.1016/j.arcmed.2007.08.003; Applebaum KM, 2007, JNCI-J NATL CANCER I, V99, P1801, DOI 10.1093/jnci/djm233; ARMBRUSTERMORAES E, 1994, GYNECOL ONCOL, V54, P152, DOI 10.1006/gyno.1994.1185; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; CASON J, 1995, J MED VIROL, V47, P209, DOI 10.1002/jmv.1890470305; Czegledy Judit, 2001, Acta Microbiologica et Immunologica Hungarica, V48, P511, DOI 10.1556/AMicr.48.2001.3-4.17; D'Souza G, 2007, NEW ENGL J MED, V356, P1944, DOI 10.1056/NEJMoa065497; Derkay CS, 2008, LARYNGOSCOPE, V118, P1236, DOI 10.1097/MLG.0b013e31816a7135; FREDERICKS BD, 1993, AUST NZ J OBSTET GYN, V33, P30, DOI 10.1111/j.1479-828X.1993.tb02047.x; Gallagher TQ, 2008, CURR OPIN OTOLARYNGO, V16, P536, DOI 10.1097/MOO.0b013e328316930e; Gillison ML, 2008, JNCI-J NATL CANCER I, V100, P407, DOI 10.1093/jnci/djn025; Huh WK, 2009, OBSTET GYNECOL, V114, P139, DOI 10.1097/AOG.0b013e3181ab6878; Koskimaa HM, 2012, J PEDIATR-US, V160, P837, DOI 10.1016/j.jpeds.2011.10.027; Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551; LEVI JE, 1989, AM J PATHOL, V135, P1179; Marur S, 2010, LANCET ONCOL, V11, P781, DOI 10.1016/S1470-2045(10)70017-6; Medeiros Lidia Rosi, 2005, Cad. Saúde Pública, V21, P1006, DOI 10.1590/S0102-311X2005000400003; PAKARIAN F, 1994, BRIT J OBSTET GYNAEC, V101, P514, DOI 10.1111/j.1471-0528.1994.tb13153.x; Park H, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-80; Rintala MAM, 2005, CLIN INFECT DIS, V41, P1728, DOI 10.1086/498114; Rombaldi Renato L, 2009, Virol J, V6, P83, DOI 10.1186/1743-422X-6-83; Rombaldi RL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-106; Sarkola M, 2008, ACTA OBSTET GYN SCAN, V87, P1181, DOI 10.1080/00016340802468308; Smith EM, 2004, INT J CANCER, V108, P766, DOI 10.1002/ijc.11633; Smith EM, 2004, SEX TRANSM DIS, V31, P57, DOI 10.1097/01.OLQ.0000105327.40288.DB; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114; Syrjanen S, 2000, CRIT REV ORAL BIOL M, V11, P259, DOI 10.1177/10454411000110020801; Tenti P, 1999, OBSTET GYNECOL, V93, P475, DOI 10.1016/S0029-7844(98)00459-1; TSENG CJ, 1992, AM J OBSTET GYNECOL, V166, P35, DOI 10.1016/0002-9378(92)91825-U; Tseng CJ, 1998, OBSTET GYNECOL, V91, P92, DOI 10.1016/S0029-7844(97)00593-0; Xu Shushen, 1998, Chinese Medical Sciences Journal, V13, P29	31	37	44	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66368	10.1371/journal.pone.0066368	http://dx.doi.org/10.1371/journal.pone.0066368			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785495	gold, Green Published, Green Submitted			2022-12-27	WOS:000321038800027
J	Lovero, KL; Blankenship, SM; Shi, Y; Nicoll, RA				Lovero, Kathryn L.; Blankenship, Sabine M.; Shi, Yun; Nicoll, Roger A.			SynDIG1 Promotes Excitatory Synaptogenesis Independent of AMPA Receptor Trafficking and Biophysical Regulation	PLOS ONE			English	Article							LONG-TERM POTENTIATION; AUXILIARY SUBUNITS; SYNAPTIC PLASTICITY; GLUTAMATE RECEPTORS; CORNICHON PROTEINS; ION CHANNELS; HIPPOCAMPUS; MODULATION; TARPS	AMPA receptors-mediators of fast, excitatory transmission and synaptic plasticity in the brain-achieve great functional diversity through interaction with different auxiliary subunits, which alter both the trafficking and biophysical properties of these receptors. In the past several years an abundance of new AMPA receptor auxiliary subunits have been identified, adding astounding variety to the proteins known to directly bind and modulate AMPA receptors. SynDIG1 was recently identified as a novel AMPA receptor interacting protein that directly binds to the AMPA receptor subunit GluA2 in heterologous cells. Functionally, SynDIG1 was found to regulate the strength and density of AMPA receptor containing synapses in hippocampal neurons, though the way in which SynDIG1 exerts these effects remains unknown. Here, we aimed to determine if SynDIG1 acts as a traditional auxiliary subunit, directly regulating the function and localization of AMPA receptors in the rat hippocampus. We find that, unlike any of the previously characterized AMPA receptor auxiliary subunits, SynDIG1 expression does not impact AMPA receptor gating, pharmacology, or surface trafficking. Rather, we show that SynDIG1 regulates the number of functional excitatory synapses, altering both AMPA and NMDA receptor mediated transmission. Our findings suggest that SynDIG1 is not a typical auxiliary subunit to AMPA receptors, but instead is a protein critical to excitatory synaptogenesis.	[Lovero, Kathryn L.; Blankenship, Sabine M.; Shi, Yun; Nicoll, Roger A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Lovero, Kathryn L.; Blankenship, Sabine M.; Shi, Yun; Nicoll, Roger A.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA USA; [Lovero, Kathryn L.] Univ Calif San Francisco, Neurosci Grad Program, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Nicoll, RA (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.	nicoll@cmp.ucsf.edu	Shi, Yun S/T-8845-2018; Shi, Yun/B-5623-2009	Shi, Yun/0000-0002-8842-9818	National Science Foundation; German Academic Exchange Service; National Institute of Mental Health [R37 MH038256-29, R01 MH080379-01]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070957, R01MH080379] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	K.L.L. is funded by a National Science Foundation Graduate Research Fellowship. S. M. B. was supported by a fellowship from the German Academic Exchange Service. R.A.N. is funded by grants from the National Institute of Mental Health (R37 MH038256-29, R01 MH080379-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arikkath J, 2003, CURR OPIN NEUROBIOL, V13, P298, DOI 10.1016/S0959-4388(03)00066-7; BEKKERS JM, 1990, NATURE, V346, P724, DOI 10.1038/346724a0; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P560, DOI 10.1113/jphysiol.1954.sp005129; Herring BE, 2013, NEURON, V77, P1083, DOI 10.1016/j.neuron.2013.01.017; Jackson AC, 2011, J NEUROSCI, V31, P7511, DOI 10.1523/JNEUROSCI.6688-10.2011; Jackson AC, 2011, NEURON, V70, P178, DOI 10.1016/j.neuron.2011.04.007; Jackson AC, 2011, J NEUROSCI, V31, P3939, DOI 10.1523/JNEUROSCI.5134-10.2011; Jonas P, 2000, NEWS PHYSIOL SCI, V15, P83; Kalashnikova E, 2010, NEURON, V65, P80, DOI 10.1016/j.neuron.2009.12.021; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; MANABE T, 1993, J NEUROPHYSIOL, V70, P1451, DOI 10.1152/jn.1993.70.4.1451; Mayer ML, 2005, CURR OPIN NEUROBIOL, V15, P282, DOI 10.1016/j.conb.2005.05.004; Milstein AD, 2008, TRENDS PHARMACOL SCI, V29, P333, DOI 10.1016/j.tips.2008.04.004; Milstein AD, 2007, NEURON, V55, P905, DOI 10.1016/j.neuron.2007.08.022; Pongs O, 2010, PHYSIOL REV, V90, P755, DOI 10.1152/physrev.00020.2009; Priel A, 2005, J NEUROSCI, V25, P2682, DOI 10.1523/JNEUROSCI.4834-04.2005; Schwenk J, 2012, NEURON, V74, P621, DOI 10.1016/j.neuron.2012.03.034; Schwenk J, 2009, SCIENCE, V323, P1313, DOI 10.1126/science.1167852; Shanks NF, 2012, CELL REP, V1, P590, DOI 10.1016/j.celrep.2012.05.004; Shi Y, 2010, P NATL ACAD SCI USA, V107, P16315, DOI 10.1073/pnas.1011706107; Soto D, 2007, NAT NEUROSCI, V10, P1260, DOI 10.1038/nn1966; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Tomita S, 2005, NATURE, V435, P1052, DOI 10.1038/nature03624; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Vacher H, 2008, PHYSIOL REV, V88, P1407, DOI 10.1152/physrev.00002.2008; von Engelhardt J, 2010, SCIENCE, V327, P1518, DOI 10.1126/science.1184178	27	22	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66171	10.1371/journal.pone.0066171	http://dx.doi.org/10.1371/journal.pone.0066171			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785483	Green Published, Green Submitted, gold			2022-12-27	WOS:000321038800039
J	Park, MJ; Green, J; Ishikawa, H; Yamazaki, Y; Kitagawa, A; Ono, M; Yasukata, F; Kiuchi, T				Park, M. J.; Green, Joseph; Ishikawa, Hirono; Yamazaki, Yoshihiko; Kitagawa, Akira; Ono, Miho; Yasukata, Fumiko; Kiuchi, Takahiro			Decay of Impact after Self-Management Education for People with Chronic Illnesses: Changes in Anxiety and Depression over One Year	PLOS ONE			English	Article							QUALITY-OF-LIFE; LONG-TERM OUTCOMES; CHRONIC DISEASE; HEALTH-STATUS; CLINICAL-SIGNIFICANCE; FOLLOW-UP; PROGRAM; ARTHRITIS; CHINESE; IMPLEMENTATION	Background: In people with chronic illnesses, self-management education can reduce anxiety and depression. Those benefits, however, decay over time. Efforts have been made to prevent or minimize that "decay of impact", but they have not been based on information about the decay's characteristics, and they have failed. Here we show how the decay's basic characteristics (prevalence, timing, and magnitude) can be quantified. Regarding anxiety and depression, we also report the prevalence, timing, and magnitude of the decay. Methods: Adults with various chronic conditions participated in a self-management educational program (n = 369). Data were collected with the Hospital Anxiety and Depression Scale four times over one year. Using within-person effect sizes, we defined decay of impact as a decline of >= 0.5 standard deviations after improvement by at least the same amount. We also interpret the results using previously-set criteria for non-cases, possible cases, and probable cases. Results: Prevalence: On anxiety, decay occurred in 19% of the participants (70/369), and on depression it occurred in 24% (90/369). Timing: In about one third of those with decay, it began 3 months after the baseline measurement (6 weeks after the educational program ended). Magnitude: The median magnitudes of decay on anxiety and on depression were both 4 points, which was about 1 standard deviation. Early in the follow-up year, many participants with decay moved into less severe clinical categories (e.g., becoming non-cases). Later, many of them moved into more severe categories (e.g., becoming probable cases). Conclusions: Decay of impact can be identified and quantified from within-person effect sizes. This decay occurs in about one fifth or more of this program's participants. It can start soon after the program ends, and it is large enough to be clinically important. These findings can be used to plan interventions aimed at preventing or minimizing the decay of impact.	[Park, M. J.; Ishikawa, Hirono; Kiuchi, Takahiro] Univ Tokyo, Grad Sch Med, Dept Hlth Commun, Tokyo, Japan; [Green, Joseph] Univ Tokyo, Grad Sch Med, Tokyo, Japan; [Yamazaki, Yoshihiko] Nihon Fukushi Univ, Fac Social Welf, Nagoya, Aichi, Japan; [Kitagawa, Akira; Yasukata, Fumiko] Fukuoka Prefectural Univ, Dept Fundamental Nursing, Tagawa, Fukuoka, Japan; [Ono, Miho] Kawasaki Univ Med Welf, Dept Hlth Sci & Nursing, Kurashiki, Okayama, Japan	University of Tokyo; University of Tokyo	Park, MJ (corresponding author), Univ Tokyo, Grad Sch Med, Dept Hlth Commun, Tokyo, Japan.	mjpark417@gmail.com			Japanese Ministry of Health, Labor and Welfare Aids for Scientific Research (health disease prevention, treatment and research projects for allergy and immunology)	Japanese Ministry of Health, Labor and Welfare Aids for Scientific Research (health disease prevention, treatment and research projects for allergy and immunology)	This work was supported by the Japanese Ministry of Health, Labor and Welfare Aids for Scientific Research (health disease prevention, treatment and research projects for allergy and immunology). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2009, J CLIN EPIDEMIOL, V62, P1165, DOI 10.1016/j.jclinepi.2009.03.015; [Anonymous], 2008, IMPL MAN STANF SELF; Barlow J, 2009, RHEUMATOLOGY, V48, P128, DOI 10.1093/rheumatology/ken429; Barlow JH, 2005, BRIT J HEALTH PSYCH, V10, P589, DOI 10.1348/135910705X26317; Barlow JH, 1998, BRIT J RHEUMATOL, V37, P1315; Barlow J, 2009, PATIENT EDUC COUNS, V77, P81, DOI 10.1016/j.pec.2009.02.009; Barth J., 2005, HEALTH QUAL LIFE OUT, V3, P15, DOI DOI 10.1186/1477-7525-3-15; Bennette C, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-21; BJELLAND I, 2002, J PSYCHOSOM RES, V0052; Campbell D.T., 1999, PRIMER REGRESSION AR; Caplin DL, 2001, J ASTHMA, V38, P343, DOI 10.1081/JAS-100000263; Cappellery JC, 2013, STAT METHODS MED RES; Chan SCC, 2005, INT J REHABIL RES, V28, P351, DOI 10.1097/00004356-200512000-00008; Clark NM, 2003, ANNU REV PUBL HEALTH, V24, P289, DOI 10.1146/annurev.publhealth.24.100901.141021; Cohen J.E., 1988, STAT POWER ANAL BEHA; Damush TM, 2003, ARCH INTERN MED, V163, P2632, DOI 10.1001/archinte.163.21.2632; Edwards PJ, 2009, COCHRANE DB SYST REV, V3, P1; Elzen H, 2007, SOC SCI MED, V64, P1832, DOI 10.1016/j.socscimed.2007.02.008; Foster G, 2007, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD005108.PUB2; Franks P, 2009, BRIT J HEALTH PSYCH, V14, P473, DOI 10.1348/135910708X360700; Fu DB, 2003, B WORLD HEALTH ORGAN, V81, P174; Gitlin LN, 2008, GERONTOLOGIST, V48, P698, DOI 10.1093/geront/48.5.698; Glasgow RE, 2002, PATIENT EDUC COUNS, V48, P115, DOI 10.1016/S0738-3991(02)00025-3; Goeppinger J, 2007, ARTHRIT RHEUM-ARTHR, V57, P1081, DOI 10.1002/art.22896; GREEN LW, 1977, AM J PUBLIC HEALTH, V67, P155, DOI 10.2105/AJPH.67.2.155; Guyatt GH, 2002, MAYO CLIN PROC, V77, P371, DOI 10.4065/77.4.371; GUYATT GH, 1987, THORAX, V42, P773, DOI 10.1136/thx.42.10.773; Gwaltney CJ, 2005, J ABNORM PSYCHOL, V114, P661, DOI 10.1037/0021-843X.114.4.661; Haas M, 2005, J MANIP PHYSIOL THER, V28, P228, DOI 10.1016/j.jmpt.2005.03.010; Hennessy M, 1999, STRUCT EQU MODELING, V6, P322, DOI 10.1080/10705519909540139; JAESCHKE R, 1989, CONTROL CLIN TRIALS, V10, P407, DOI 10.1016/0197-2456(89)90005-6; Jerant A, 2008, MED CARE, V46, P523, DOI 10.1097/MLR.0b013e31815f53a4; Jerant A, 2009, ANN FAM MED, V7, P319, DOI 10.1370/afm.996; Jordan JE, 2009, J CLIN EPIDEMIOL, V62, P642, DOI 10.1016/j.jclinepi.2008.07.019; KENNY DA, 1995, J CONSULT CLIN PSYCH, V63, P52, DOI 10.1037/0022-006X.63.1.52; Krebs P, 2010, PREV MED, V51, P214, DOI 10.1016/j.ypmed.2010.06.004; Linden M, 2013, CLIN PSYCHOL PSYCHOT, V20, P286, DOI 10.1002/cpp.1765; LORIG K, 1989, SOC SCI MED, V29, P221, DOI 10.1016/0277-9536(89)90170-6; Lorig K., 2020, LIVING HLTHY LIFE CH; Lorig K, 2001, LIVING HLTH LIFE CHR; Lorig K, 2000, LIVING HLTH LIFE CHR; Lorig K R, 2001, Eff Clin Pract, V4, P256; Lorig K, 2008, DIABETES CARE, V31, P408, DOI 10.2337/dc07-1313; Lorig K, 2010, DIABETES CARE, V33, P1275, DOI 10.2337/dc09-2153; Lorig KR, 2006, MED CARE, V44, P964, DOI 10.1097/01.mlr.0000233678.80203.c1; Lorig KR, 1999, MED CARE, V37, P5, DOI 10.1097/00005650-199901000-00003; Lorig KR, 2005, DIABETES EDUCATOR, V31, P401, DOI 10.1177/0145721705276574; Lorig KR, 2004, MED CARE, V42, P346, DOI 10.1097/01.mlr.0000118709.74348.65; Matsudaira T, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-42; McArdle JJ, 2002, DEV PSYCHOL, V38, P115, DOI 10.1037//0012-1649.38.1.115; McDowell I, 2006, MEASURING HLTH GUIDE, P294; McLeod LD, 2011, EXPERT REV PHARM OUT, V11, P163, DOI [10.1586/erp.11.12, 10.1586/ERP.11.12]; Mulligan K, 2007, CAMBRIDGE HANDBOOK OF PSYCHOLOGY, HEALTH AND MEDICINE, 2ND EDITION, P393; Muschalla B, 2011, REHABILITATION, V50, P103, DOI 10.1055/s-0030-1265182; Newman S, 2009, CHRONIC PHYS ILLNESS, P72; Nguyen HQ, 2005, HEART LUNG, V34, P51, DOI 10.1016/j.hrtlng.2004.06.005; Nolte S, 2007, PATIENT EDUC COUNS, V65, P351, DOI 10.1016/j.pec.2006.08.016; Norman Geoffrey R, 2004, Expert Rev Pharmacoecon Outcomes Res, V4, P581, DOI 10.1586/14737167.4.5.581; Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004; Osborne RH, 2007, PATIENT EDUC COUNS, V66, P192, DOI 10.1016/j.pec.2006.12.002; Osborne RH, 2006, ARTHRIT RHEUM-ARTHR, V55, P458, DOI 10.1002/art.21982; Park MJ, 2013, CHRONIC ILLN, V9, P73, DOI 10.1177/1742395312453351; Park MJ, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-145; Puhan MA, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-46; Riemsma RP, 2003, ARTHRIT RHEUM-ARTHR, V49, P556, DOI 10.1002/art.11207; Schwartz C, 2006, QUAL LIFE RES, V15, P1503, DOI 10.1007/s11136-006-0008-x; Siu AMH, 2007, PATIENT EDUC COUNS, V65, P42, DOI 10.1016/j.pec.2006.04.013; Smith L, 2007, SOC SCI MED, V64, P1501, DOI 10.1016/j.socscimed.2006.11.006; Swerissen H, 2006, PATIENT EDUC COUNS, V64, P360, DOI 10.1016/j.pec.2006.04.003; Tousman S, 2010, CLIN NURS RES, V19, P71, DOI 10.1177/1054773809354290; Wyrwich KW, 2013, QUAL LIFE RES, V22, P475, DOI 10.1007/s11136-012-0175-x; Wyrwich KW, 2005, QUAL LIFE RES, V14, P285, DOI 10.1007/s11136-004-0705-2; Yip Yin-Bing, 2008, Psychol Health Med, V13, P402, DOI 10.1080/13548500701584030	73	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65316	10.1371/journal.pone.0065316	http://dx.doi.org/10.1371/journal.pone.0065316			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	172XB	23785418	Green Published, Green Submitted, gold			2022-12-27	WOS:000321038800102
J	Wang, H; Gondre-Lewis, MC				Wang, Hong; Gondre-Lewis, Marjorie C.			Prenatal Nicotine and Maternal Deprivation Stress De-Regulate the Development of CA1, CA3, and Dentate Gyrus Neurons in Hippocampus of Infant Rats	PLOS ONE			English	Article							NEUROTROPHIC FACTOR EXPRESSION; HYPORESPONSIVE PERIOD; SYNAPTIC PLASTICITY; CELL-PROLIFERATION; PREFRONTAL CORTEX; RECEPTOR FUNCTION; MAJOR DEPRESSION; CHILDHOOD TRAUMA; NMDA RECEPTORS; MESSENGER-RNA	Adverse experiences by the developing fetus and in early childhood are associated with profound effects on learning, emotional behavior, and cognition as a whole. In this study we investigated the effects of prenatal nicotine exposure (NIC), postnatal maternal deprivation (MD) or the combination of the two (NIC+MD) to determine if hippocampal neuron development is modulated by exposure to drugs of abuse and/or stress. Growth of rat offspring exposed to MD alone or NIC+MD was repressed until after weaning. In CA1 but not CA3 of postnatal day 14 (P14) pups, MD increased pyramidal neurons, however, in dentate gyrus (DG), decreased granule neurons. NIC had no effect on neuron number in CA1, CA3 or DG. Unexpectedly, NIC plus MD combined caused a synergistic increase in the number of CA1 or CA3 neurons. Neuron density in CA regions was unaffected by treatment, but in the DG, granule neurons had a looser packing density after NIC, MD or NIC+MD exposure. When septotemporal axes were analyzed, the synergism of stress and drug exposure in CA1 and CA3 was associated with rostral, whereas MD effects were predominantly associated with caudal neurons. TUNEL labeling suggests no active apoptosis at P14, and doublecortin positive neurons and mossy fibers were diminished in NIC+MD relative to controls. The laterality of the effect of nicotine and/or maternal deprivation in right versus left hippocampus was also analyzed and found to be insiginificant. We report for the first time that early life stressors such as postnatal MD and prenatal NIC exposure, when combined, may exhibit synergistic consequences for CA1 and CA3 pyramidal neuron development, and a potential antagonistic influence on developing DG neurons. These results suggest that early stressors may modulate neurogenesis, apoptosis, or maturation of glutamatergic neurons in the hippocampus in a region-specific manner during critical periods of neurodevelopment.	[Wang, Hong; Gondre-Lewis, Marjorie C.] Howard Univ, Coll Med, Dept Anat, Lab Neurodevelopment, Washington, DC 20059 USA	Howard University	Gondre-Lewis, MC (corresponding author), Howard Univ, Coll Med, Dept Anat, Lab Neurodevelopment, Washington, DC 20059 USA.	mgondre-lewis@howard.edu	Gondre-Lewis, Marjorie/M-8055-2017		Howard University;  [NS065385]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [SC2NS065385] Funding Source: NIH RePORTER	Howard University; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grant # NS065385 (www.nih.gov) and a Howard University intramural SEED grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agid O, 1999, MOL PSYCHIATR, V4, P163, DOI 10.1038/sj.mp.4000473; Aisa B, 2009, HIPPOCAMPUS, V19, P1222, DOI 10.1002/hipo.20586; Aisa B, 2009, PSYCHONEUROENDOCRINO, V34, P1495, DOI 10.1016/j.psyneuen.2009.05.003; Neto JBB, 2012, NEUROPHARMACOLOGY, V62, P518, DOI 10.1016/j.neuropharm.2011.09.011; Bendel O, 2005, MOL BRAIN RES, V137, P119, DOI 10.1016/j.molbrainres.2005.02.023; Biagini G, 1998, INT J DEV NEUROSCI, V16, P187, DOI 10.1016/S0736-5748(98)00019-7; Blood-Siegfried J, 2010, J MIDWIFERY WOM HEAL, V55, P143, DOI 10.1016/j.jmwh.2009.05.006; Chen WJA, 2006, LIFE SCI, V79, P2221, DOI 10.1016/j.lfs.2006.07.019; Davila-Garcia MI, 2003, J NEUROCHEM, V85, P1237, DOI 10.1046/j.1471-4159.2003.01774.x; De Bellis MD, 2002, PSYCHONEUROENDOCRINO, V27, P155, DOI 10.1016/S0306-4530(01)00042-7; De Bellis MD, 2002, BIOL PSYCHIAT, V51, P544, DOI 10.1016/S0006-3223(01)01374-9; De Bellis MD, 2002, BIOL PSYCHIAT, V51, P553, DOI 10.1016/S0006-3223(01)01375-0; Dent G, 2007, BRAIN RES, V1138, P1, DOI 10.1016/j.brainres.2006.04.082; Dong HX, 2003, J NEUROSCI, V23, P1742; Enoch MA, 2011, PSYCHOPHARMACOLOGY, V214, P17, DOI 10.1007/s00213-010-1916-6; Enoch MA, 2010, BIOL PSYCHIAT, V67, P20, DOI 10.1016/j.biopsych.2009.08.019; Eppolito AK, 2010, NEUROTOXICOL TERATOL, V32, P336, DOI 10.1016/j.ntt.2009.12.009; Eyler FD, 1999, CLIN PERINATOL, V26, P107, DOI 10.1016/S0095-5108(18)30075-7; Fabricius K, 2008, BRAIN STRUCT FUNCT, V212, P403, DOI 10.1007/s00429-007-0169-6; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Gondre-Lewis MC, 2012, INT REV CEL MOL BIO, V299, P27, DOI 10.1016/B978-0-12-394310-1.00002-3; Gondre-Lewis MC, 2003, CURR BIOL, V13, P1324, DOI 10.1016/S0960-9822(03)00531-1; Goto K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015468; Greisen MH, 2005, J NEUROSCI RES, V79, P772, DOI 10.1002/jnr.20418; Gruss M, 2008, NEUROSCIENCE, V152, P1, DOI 10.1016/j.neuroscience.2007.12.033; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Heim C, 2001, BIOL PSYCHIAT, V49, P1023, DOI 10.1016/S0006-3223(01)01157-X; Heim C, 2008, BIOL PSYCHIAT, V63, P398, DOI 10.1016/j.biopsych.2007.07.002; Hosseini-Sharifabad M, 2007, J NEUROSCI METH, V162, P206, DOI 10.1016/j.jneumeth.2007.01.009; Huang LT, 2002, EPILEPSIA, V43, P1141, DOI 10.1046/j.1528-1157.2002.14602.x; Hulshof HJ, 2011, BEHAV BRAIN RES, V216, P552, DOI 10.1016/j.bbr.2010.08.038; Huot RL, 2002, BRAIN RES, V950, P52, DOI 10.1016/S0006-8993(02)02985-2; Jabes A, 2011, J COMP NEUROL, V519, P1051, DOI 10.1002/cne.22549; Kaffman A, 2009, BIOL PSYCHIAT, V66, DOI 10.1016/j.biopsych.2009.08.002; Ku HY, 2008, NEUROPSYCHOPHARMACOL, V33, P2847, DOI 10.1038/npp.2008.36; Kuma H, 2004, NEUROSCI LETT, V372, P68, DOI 10.1016/j.neulet.2004.09.012; Lajud N, 2012, PSYCHONEUROENDOCRINO, V37, P410, DOI 10.1016/j.psyneuen.2011.07.011; Law AJ, 2009, NEUROPSYCHOPHARMACOL, V34, P1381, DOI 10.1038/npp.2008.106; Lee HJ, 2001, MOL PSYCHIATR, V6, P725, DOI 10.1038/sj.mp.4000947; Litvin Y, 2010, HORM BEHAV, V58, P241, DOI 10.1016/j.yhbeh.2010.03.010; Manaye KF, 2011, AGE DORDR; Marco EM, 2012, NEUROPHARMACOLOGY; Marco EM, 2007, PHARMACOL BIOCHEM BE, V86, P334, DOI 10.1016/j.pbb.2006.10.006; Monroy E, 2010, J CHEM NEUROANAT, V40, P93, DOI 10.1016/j.jchemneu.2010.05.005; MURRIN LC, 1987, LIFE SCI, V40, P1699, DOI 10.1016/0024-3205(87)90020-8; O'Neil JN, 2007, J CHEM NEUROANAT, V34, P102, DOI 10.1016/j.jchemneu.2007.05.008; Parameshwaran K, 2012, CELL MOL LIFE SCI, V69, P829, DOI 10.1007/s00018-011-0805-4; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Pickering C, 2006, BRAIN RES, V1099, P101, DOI 10.1016/j.brainres.2006.04.136; Ramachandra R, 2011, ATLAS NEONATAL RAT B, Vxxiii; Reus GZ, 2011, NEUROCHEM RES, V36, P460, DOI 10.1007/s11064-010-0364-3; Roceri M, 2004, BIOL PSYCHIAT, V55, P708, DOI 10.1016/j.biopsych.2003.12.011; Roceri M, 2002, MOL PSYCHIATR, V7, P609, DOI 10.1038/sj.mp.4001036; Rodenas-Ruano A, 2012, NAT NEUROSCI, V15, P1382, DOI 10.1038/nn.3214; Roy TS, 1998, NEUROTOXICOL TERATOL, V20, P465, DOI 10.1016/S0892-0362(97)00137-2; Shinohara Y, 2008, P NATL ACAD SCI USA, V105, P19498, DOI 10.1073/pnas.0807461105; SORIANO E, 1994, J COMP NEUROL, V342, P571, DOI 10.1002/cne.903420406; Strange BA, 1999, P NATL ACAD SCI USA, V96, P4034, DOI 10.1073/pnas.96.7.4034; Talge NM, 2007, J CHILD PSYCHOL PSYC, V48, P245, DOI 10.1111/j.1469-7610.2006.01714.x; Tottenham N, 2010, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.068.2009; Uysal N, 2005, NEUROSCI LETT, V384, P98, DOI 10.1016/j.neulet.2005.04.052; Vaglenova J, 2008, NEUROBIOL LEARN MEM, V90, P527, DOI 10.1016/j.nlm.2008.06.009; Wang H, 2011, NEUROSCIENCE, V188, P168, DOI 10.1016/j.neuroscience.2011.04.069; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; White LD, 2001, CELL DEATH DIFFER, V8, P345, DOI 10.1038/sj.cdd.4400816	65	29	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65517	10.1371/journal.pone.0065517	http://dx.doi.org/10.1371/journal.pone.0065517			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785432	Green Submitted, Green Published, gold			2022-12-27	WOS:000321038800089
J	Yuan, RH; Chang, KT; Chen, YL; Hsu, HC; Lee, PH; Lai, PL; Jeng, YM				Yuan, Ray-Hwang; Chang, Ko-Tung; Chen, Yu-Ling; Hsu, Hey-Chi; Lee, Po-Huang; Lai, Po-Lin; Jeng, Yung-Ming			S100P Expression Is a Novel Prognostic Factor in Hepatocellular Carcinoma and Predicts Survival in Patients with High Tumor Stage or Early Recurrent Tumors	PLOS ONE			English	Article							BETA-CATENIN MUTATIONS; BINDING PROTEIN S100P; POOR-PROGNOSIS; P53 GENE; FAVORABLE PROGNOSIS; PANCREATIC-CANCER; PERIPHERAL-TYPE; CELL-MIGRATION; OVEREXPRESSION; GROWTH	The calcium-binding protein S100P is expressed in a variety of human cancer cells and is important in cancer cell growth and invasion. Using differential display, we found S100P is overexpressed in human hepatocellular carcinoma (HCC). We examined the expression of 305 unifocal, primary HCC tumors using immunohistochemistry. The S100P protein was expressed in 173 of the 305 (56.7%) HCC tumors. The expression of S100P correlated with female sex (P=0.0162), high serum a-fetoprotein level (P=0.0001), high tumor grade (P=0.0029), high tumor stage (P=0.0319), the presence of the p53 mutation (P=0.0032), and the absence of the beta-catenin mutation (P=0.0489). Patients with HCC tumors that expressed S100P were more likely to have early tumor recurrence (ETR) (P=0.0189) and lower 5-year survival (P=0.0023). The multivariate analysis confirmed that S100P expression was an independent prognostic factor in HCC. The combinatorial analysis showed an additive unfavorable prognostic interaction between S100P expression and the p53 mutation. In contrast, the beta-catenin mutation was associated with better prognosis in both S100P-positive and -negative HCCs. Furthermore, S100P expression was a predictor of survival in HCC patients with high tumor stage or ETR (P=0.0026 and P=0.0002, respectively). Our study indicates the expression of the S100P protein is a novel independent predictor for poor prognosis in HCC, and it is also an unfavorable prognostic predictor in HCC patients with high tumor stage or ETR.	[Yuan, Ray-Hwang; Lee, Po-Huang] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Yuan, Ray-Hwang; Lee, Po-Huang] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Yuan, Ray-Hwang] Natl Taiwan Univ Hosp, Dept Surg, Yun Lin Branch, Yunlin, Taiwan; [Chang, Ko-Tung] Natl Pingtung Univ Sci & Technol, Dept Life Sci, Pingtung, Taiwan; [Chen, Yu-Ling; Hsu, Hey-Chi; Jeng, Yung-Ming] Natl Taiwan Univ, Grad Inst Pathol, Taipei 10764, Taiwan; [Hsu, Hey-Chi; Lai, Po-Lin] Natl Taiwan Univ Hosp, Dept Pathol, Taipei 100, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Pingtung University Science & Technology; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Jeng, YM (corresponding author), Natl Taiwan Univ, Grad Inst Pathol, Taipei 10764, Taiwan.	d83409009@ntu.edu.tw		LEE, PO-HUANG/0000-0001-5831-035X; Yuan, Ray-Hwang/0000-0002-2767-633X; JENG, YUNG-MING/0000-0002-3878-4491	National Taiwan University Hospital, Yun-Lin Branch [NTUHYL101.N004]	National Taiwan University Hospital, Yun-Lin Branch	This research was supported by a grant from National Taiwan University Hospital, Yun-Lin Branch (NTUHYL101.N004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El All Howayda, 2007, Diagn Pathol, V2, P9, DOI 10.1186/1746-1596-2-9; Aishima S, 2011, AM J SURG PATHOL, V35, P590, DOI 10.1097/PAS.0b013e31820ffdf1; Arumugam T, 2004, J BIOL CHEM, V279, P5059, DOI 10.1074/jbc.M310124200; Arumugam T, 2005, CLIN CANCER RES, V11, P5356, DOI 10.1158/1078-0432.CCR-05-0092; Austermann J, 2008, J BIOL CHEM, V283, P29331, DOI 10.1074/jbc.M806145200; Bartling B, 2007, EUR J CANCER, V43, P1935, DOI 10.1016/j.ejca.2007.06.010; Basu GD, 2008, INT J CANCER, V123, P330, DOI 10.1002/ijc.23447; BECKER T, 1992, EUR J BIOCHEM, V207, P541, DOI 10.1111/j.1432-1033.1992.tb17080.x; Befeler AS, 2002, GASTROENTEROLOGY, V122, P1609, DOI 10.1053/gast.2002.33411; Chandramouli A, 2010, CANCER BIOL THER, V10, P1057, DOI 10.4161/cbt.10.10.13373; Chang XF, 2010, CANCER RES, V70, P2870, DOI 10.1158/0008-5472.CAN-09-3427; Crnogorac-Jurcevic T, 2003, J PATHOL, V201, P63, DOI 10.1002/path.1418; Da Silva IDCG, 2000, INT J ONCOL, V16, P231; Dowen SE, 2005, AM J PATHOL, V166, P81, DOI 10.1016/S0002-9440(10)62234-1; Du M, 2012, J BIOL CHEM, V287, P15330, DOI 10.1074/jbc.M112.349787; Edge SB, 2010, AJCC CANC STAGING MA; EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E; Filipek A, 2002, J BIOL CHEM, V277, P28848, DOI 10.1074/jbc.M203602200; Fuentes MK, 2007, DIS COLON RECTUM, V50, P1230, DOI 10.1007/s10350-006-0850-5; Hamada S, 2011, CANCER SCI, V102, P150, DOI 10.1111/j.1349-7006.2010.01757.x; Heizmann CW, 2007, SUBCELL BIOCH, P45; Hsieh HL, 2004, BIOCHEM BIOPH RES CO, V316, P949, DOI 10.1016/j.bbrc.2004.02.135; Hsu HC, 1997, CANCER RES, V57, P5179; HSU HC, 1993, CANCER RES, V53, P4691; Hsu HC, 2000, AM J PATHOL, V157, P763, DOI 10.1016/S0002-9440(10)64590-7; HSU HC, 1994, HEPATOLOGY, V19, P122, DOI 10.1016/0270-9139(94)90062-0; HSU HC, 1994, INT J ONCOL, V4, P1341; HUANG LR, 1995, CANCER RES, V55, P4717; Jiang HF, 2012, J CANCER RES CLIN, V138, P1, DOI 10.1007/s00432-011-1062-5; Kim JK, 2009, INT J ONCOL, V35, P1257, DOI 10.3892/ijo_00000442; Koltzscher M, 2003, MOL BIOL CELL, V14, P2372, DOI 10.1091/mbc.E02-09-0553; Laurent-Puig P, 2001, GASTROENTEROLOGY, V120, P1763, DOI 10.1053/gast.2001.24798; Lee YC, 2007, EUR J CANCER, V43, P736, DOI 10.1016/j.ejca.2006.11.020; Ohuchida K, 2006, CLIN CANCER RES, V12, P5411, DOI 10.1158/1078-0432.CCR-06-0298; Pan HW, 2006, CELL CYCLE, V5, P2676, DOI 10.4161/cc.5.22.3500; Pan HW, 2003, CANCER-AM CANCER SOC, V98, P119, DOI 10.1002/cncr.11487; Parkkila S, 2008, BMC CLIN PATHOL, V8, DOI 10.1186/1472-6890-8-2; Peng SY, 2008, ONCOL REP, V19, P1045; Peng SY, 2004, INT J CANCER, V112, P44, DOI 10.1002/ijc.20279; Sato N, 2002, ANAT REC, V267, P60, DOI 10.1002/ar.10085; Schafer DF, 1999, LANCET, V353, P1253, DOI 10.1016/S0140-6736(98)09148-X; Schor APT, 2006, ONCOL REP, V15, P3; Surowiak P, 2007, HISTOPATHOLOGY, V51, P125, DOI 10.1111/j.1365-2559.2007.02714.x; Tsai JH, 2012, HISTOPATHOLOGY, V61, P1106, DOI 10.1111/j.1365-2559.2012.04316.x; Wang GZ, 2006, CANCER RES, V66, P1199, DOI 10.1158/0008-5472.CAN-05-2605; Wang Q, 2012, ONCOL REP, V28, P303, DOI 10.3892/or.2012.1794; Yuan RH, 2006, J PATHOL, V209, P549, DOI 10.1002/path.2011; Yuan RH, 2007, CLIN CANCER RES, V13, P5368, DOI 10.1158/1078-0432.CCR-07-1113; Yuan RH, 2011, J GASTROINTEST SURG, V15, P321, DOI 10.1007/s11605-010-1373-x; Yuan RH, 2005, CLIN CANCER RES, V11, P2568, DOI 10.1158/1078-0432.CCR-04-2039; Zhou CH, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3144	51	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65501	10.1371/journal.pone.0065501	http://dx.doi.org/10.1371/journal.pone.0065501			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785431	gold, Green Published, Green Submitted			2022-12-27	WOS:000321038800090
J	Zunini, RAL; Thivierge, JP; Kousaie, S; Sheppard, C; Taler, V				Zunini, Rocio A. Lopez; Thivierge, Jean-Philippe; Kousaie, Shanna; Sheppard, Christine; Taler, Vanessa			Alterations in Resting-State Activity Relate to Performance in a Verbal Recognition Task	PLOS ONE			English	Article							ALPHA OSCILLATIONS; WORKING-MEMORY; EEG; FREQUENCY; SYNCHRONIZATION; RETRIEVAL; ATTENTION	In the brain, resting-state activity refers to non-random patterns of intrinsic activity occurring when participants are not actively engaged in a task. We monitored resting-state activity using electroencephalogram (EEG) both before and after a verbal recognition task. We show a strong positive correlation between accuracy in verbal recognition and pre-task resting-state alpha power at posterior sites. We further characterized this effect by examining resting-state post-task activity. We found marked alterations in resting-state alpha power when comparing pre- and post-task periods, with more pronounced alterations in participants that attained higher task accuracy. These findings support a dynamical view of cognitive processes where patterns of ongoing brain activity can facilitate -or interfere- with optimal task performance.	[Zunini, Rocio A. Lopez; Thivierge, Jean-Philippe; Sheppard, Christine; Taler, Vanessa] Univ Ottawa, Sch Psychol, Ottawa, ON K1N 6N5, Canada; [Zunini, Rocio A. Lopez; Kousaie, Shanna; Sheppard, Christine; Taler, Vanessa] Bruyere Res Inst, Ottawa, ON, Canada	University of Ottawa; University of Ottawa	Zunini, RAL (corresponding author), Univ Ottawa, Sch Psychol, Ottawa, ON K1N 6N5, Canada.	rlope056@ottawa.ca	López Zunini, Rocío/T-5432-2017	López Zunini, Rocío/0000-0001-9579-7718; Kousaie, Shanna/0000-0002-8218-2746	Alzheimer Society of Canada [1122]; Canadian Institutes of Health Research [112241]	Alzheimer Society of Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This research was supported by a Young Investigator Award from the Alzheimer Society of Canada and (grant number: 1122, http://www.alzheimer.ca/en)a Canadian Institutes of Health Research Catalyst Grant (grant number: 112241, http://www.cihr-irsc.gc.ca/) to VT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Angelakis E, 2004, CLIN NEUROPHYSIOL, V115, P887, DOI 10.1016/j.clinph.2003.11.034; Baayen R. H., 1993, CELEX LEXICAL DATABA; Babiloni C, 2007, EUR J NEUROSCI, V25, P3742, DOI 10.1111/j.1460-9568.2007.05601.x; Barry RJ, 2007, CLIN NEUROPHYSIOL, V118, P2765, DOI 10.1016/j.clinph.2007.07.028; Basar E, 2001, INT J PSYCHOPHYSIOL, V39, P241, DOI 10.1016/S0167-8760(00)00145-8; Caravaglios G, 2010, J NEURAL TRANSM, V117, P1195, DOI 10.1007/s00702-010-0488-2; Dockree PM, 2007, EUR J NEUROSCI, V25, P900, DOI 10.1111/j.1460-9568.2007.05324.x; Finnigan S, 2011, PSYCHOPHYSIOLOGY, V48, P1083, DOI 10.1111/j.1469-8986.2010.01173.x; Foxe JJ, 1998, NEUROREPORT, V9, P3929, DOI 10.1097/00001756-199812010-00030; Freyer F, 2011, J NEUROSCI, V31, P6353, DOI 10.1523/JNEUROSCI.6693-10.2011; Gevins A, 2000, CEREB CORTEX, V10, P829, DOI 10.1093/cercor/10.9.829; Haig AR, 1998, PSYCHOPHYSIOLOGY, V35, P591, DOI 10.1017/S0048577298970512; Hsieh LT, 2011, J NEUROSCI, V31, P10803, DOI 10.1523/JNEUROSCI.0828-11.2011; Jacobs J, 2006, NEUROIMAGE, V32, P978, DOI 10.1016/j.neuroimage.2006.02.018; Jensen O, 2007, TRENDS COGN SCI, V11, P267, DOI 10.1016/j.tics.2007.05.003; Klimesch W, 2001, COGNITIVE BRAIN RES, V12, P33, DOI 10.1016/S0926-6410(01)00024-6; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Klimesch W, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00118; Lewisa CM, 2009, P NATL ACAD SCI USA, V106, P17558, DOI 10.1073/pnas.0902455106; Maltseva IV, 1997, INT J PSYCHOPHYSIOL, V26, P369, DOI 10.1016/S0167-8760(97)00776-9; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Mathewson KE, 2012, PSYCHOPHYSIOLOGY, V49, P1558, DOI 10.1111/j.1469-8986.2012.01474.x; Montez T, 2009, P NATL ACAD SCI USA, V106, P1614, DOI 10.1073/pnas.0811699106; Northoff G, 2010, TRENDS NEUROSCI, V33, P277, DOI 10.1016/j.tins.2010.02.006; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Sauseng P, 2005, HUM BRAIN MAPP, V26, P148, DOI 10.1002/hbm.20150; Smit DJA, 2011, J NEUROSCI, V31, P13128, DOI 10.1523/JNEUROSCI.1678-11.2011; Sporns O., 2011, NETWORKS BRAIN; Taubert M, 2010, J NEUROSCI, V30, P11670, DOI 10.1523/JNEUROSCI.2567-10.2010; Thatcher RW, 2008, HUM BRAIN MAPP, V29, P1400, DOI 10.1002/hbm.20474; THEILER J, 1992, PHYSICA D, V58, P77, DOI 10.1016/0167-2789(92)90102-S; van der Hiele K, 2007, CLIN NEUROPHYSIOL, V118, P1931, DOI 10.1016/j.clinph.2007.05.070; Vogt F, 1998, J CLIN NEUROPHYSIOL, V15, P167, DOI 10.1097/00004691-199803000-00011; Vul E, 2009, PERSPECT PSYCHOL SCI, V4, P274, DOI 10.1111/j.1745-6924.2009.01125.x	34	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65608	10.1371/journal.pone.0065608	http://dx.doi.org/10.1371/journal.pone.0065608			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785436	Green Published, Green Submitted, gold			2022-12-27	WOS:000321038800085
J	Bianchi, M; Crinelli, R; Giacomini, E; Carloni, E; Radici, L; Magnani, M				Bianchi, Marzia; Crinelli, Rita; Giacomini, Elisa; Carloni, Elisa; Radici, Lucia; Magnani, Mauro			Yin Yang 1 Intronic Binding Sequences and Splicing Elicit Intron-Mediated Enhancement of Ubiquitin C Gene Expression	PLOS ONE			English	Article							MESSENGER-RNA; 1ST INTRON; IN-VIVO; PROMOTER; YY1; ELEMENT; MECHANISM; PROTEINS; REVEALS; FAMILY	In a number of organisms, introns affect expression of the gene in which they are contained. Our previous studies revealed that the 59-UTR intron of human ubiquitin C (UbC) gene is responsible for the boost of reporter gene expression and is able to bind, in vitro, Yin Yang 1 (YY1) trans-acting factor. In this work, we demonstrate that intact YY1 binding sequences are required for maximal promoter activity and YY1 silencing causes downregulation of luciferase mRNA levels. However, YY1 motifs fail to enhance gene expression when the intron is moved upstream of the proximal promoter, excluding the typical enhancer hypothesis and supporting a context-dependent action, like intron-mediated enhancement (IME). Yet, almost no expression is seen in the construct containing an unspliceable version of UbC intron, indicating that splicing is essential for promoter activity. Moreover, mutagenesis of YY1 binding sites and YY1 knockdown negatively affect UbC intron removal from both endogenous and reporter transcripts. Modulation of splicing efficiency by YY1 cis-elements and protein factor may thus be part of the mechanism(s) by which YY1 controls UbC promoter activity. Our data highlight the first evidence of the involvement of a sequence-specific DNA binding factor in IME.	[Bianchi, Marzia; Crinelli, Rita; Giacomini, Elisa; Carloni, Elisa; Radici, Lucia; Magnani, Mauro] Univ Urbino Carlo Bo, Biochem & Mol Biol Sect, Dept Biomol Sci, Urbino, Italy	University of Urbino	Bianchi, M (corresponding author), Univ Urbino Carlo Bo, Biochem & Mol Biol Sect, Dept Biomol Sci, Urbino, Italy.	marzia.bianchi@uniurb.it	Magnani, Mauro/A-1919-2008; Giacomini, Elisa/K-3208-2016	Giacomini, Elisa/0000-0003-3289-3221; Crinelli, Rita/0000-0002-1235-8910; Carloni, Elisa/0000-0003-1178-9353; Bianchi, Marzia/0000-0001-9352-7319; Magnani, Mauro/0000-0001-6456-6626	MINISTERO DELL'ISTRUZIONE DELL'UNIVERSITA E DELLA RICERCA [2008BP25KN_001]	MINISTERO DELL'ISTRUZIONE DELL'UNIVERSITA E DELLA RICERCA(Ministry of Education, Universities and Research (MIUR))	This work was supported by MINISTERO DELL'ISTRUZIONE DELL'UNIVERSITA E DELLA RICERCA (PRIN 2008 2008BP25KN_001) granted to M. Magnani. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DJ, 2001, J CELL BIOL, V154, P25, DOI 10.1083/jcb.200010059; Akua T, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-93; BAKER RT, 1987, NUCLEIC ACIDS RES, V15, P443, DOI 10.1093/nar/15.2.443; Baltz AG, 2012, MOL CELL, V46, P674, DOI 10.1016/j.molcel.2012.05.021; Bartlett JG, 2009, PLANT BIOTECHNOL J, V7, P856, DOI 10.1111/j.1467-7652.2009.00448.x; Baum C, 2011, HUM GENE THER, V22, P255, DOI 10.1089/hum.2011.2280; Bedford L, 2011, NAT REV DRUG DISCOV, V10, P29, DOI 10.1038/nrd3321; Belak ZR, 2008, BIOCHEM CELL BIOL, V86, P31, DOI [10.1139/O07-155, 10.1139/o07-155]; Bianchi M, 2009, GENE, V448, P88, DOI 10.1016/j.gene.2009.08.013; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Byun HM, 2005, BIOCHEM BIOPH RES CO, V332, P518, DOI 10.1016/j.bbrc.2005.04.155; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Charron M, 2007, BIOL REPROD, V76, P813, DOI 10.1095/biolreprod.106.057851; Clague MJ, 2010, CELL, V143, P682, DOI 10.1016/j.cell.2010.11.012; Crinelli R, 2002, NUCLEIC ACIDS RES, V30, P2435, DOI 10.1093/nar/30.11.2435; Culler SJ, 2010, NUCLEIC ACIDS RES, V38, P5152, DOI 10.1093/nar/gkq248; Do Kim J, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-108; Do Kim J, 2009, GENOMICS, V93, P152, DOI 10.1016/j.ygeno.2008.09.013; Eliassen KA, 1998, MOL CELL BIOL, V18, P7106, DOI 10.1128/MCB.18.12.7106; FINLEY D, 1989, NATURE, V338, P394, DOI 10.1038/338394a0; FORNACE AJ, 1989, NUCLEIC ACIDS RES, V17, P1215, DOI 10.1093/nar/17.3.1215; Foti DN, 2004, J MOL ENDOCRINOL, V33, P99, DOI 10.1677/jme.0.0330099; Galvagni F, 1998, J BIOL CHEM, V273, P33708, DOI 10.1074/jbc.273.50.33708; Gazdhar A, 2006, J GENE MED, V8, P910, DOI 10.1002/jgm.911; Gill DR, 2001, GENE THER, V8, P1539, DOI 10.1038/sj.gt.3301561; Gordon S, 2006, ONCOGENE, V25, P1125, DOI 10.1038/sj.onc.1209080; Guo AM, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat007; Hasannia S, 2006, BIOTECHNOL LETT, V28, P1545, DOI 10.1007/s10529-006-9121-8; Ho SH, 2001, DEV DYNAM, V221, P422, DOI 10.1002/dvdy.1161; Jensen KB, 2000, NEURON, V25, P359, DOI 10.1016/S0896-6273(00)80900-9; Jeon Y, 2011, CELL, V146, P119, DOI 10.1016/j.cell.2011.06.026; Kimura Y, 2010, J BIOCHEM, V147, P793, DOI 10.1093/jb/mvq044; Krupka N, 2010, PLASMID, V63, P155, DOI 10.1016/j.plasmid.2010.01.002; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lalmansingh AS, 2011, J BIOL CHEM, V286, P10970, DOI 10.1074/jbc.M110.166587; Liu HF, 2005, MOL B INT U, P182; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUND PK, 1985, J BIOL CHEM, V260, P7609; MAGIN TM, 1992, GENE, V122, P289, DOI 10.1016/0378-1119(92)90217-D; Marinovic AC, 2002, J BIOL CHEM, V277, P16673, DOI 10.1074/jbc.M200501200; Morello L, 2008, CURR GENOMICS, V9, P227, DOI 10.2174/138920208784533629; Morello L, 2011, J EXP BOT, V62, P533, DOI 10.1093/jxb/erq273; Nott A, 2003, RNA, V9, P607, DOI 10.1261/rna.5250403; Parra G, 2011, NUCLEIC ACIDS RES, V39, P5328, DOI 10.1093/nar/gkr043; Ratajewski M, 2009, GENOMICS, V94, P407, DOI 10.1016/j.ygeno.2009.08.014; Rose AB, 2008, CURR TOP MICROBIOL, V326, P277; Rose AB, 2000, PLANT PHYSIOL, V122, P535, DOI 10.1104/pp.122.2.535; Rose AB, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00098; Rylski M, 2008, J BIOL CHEM, V283, P35140, DOI 10.1074/jbc.M804540200; Ryu KY, 2007, EMBO J, V26, P2693, DOI 10.1038/sj.emboj.7601722; Samadder P, 2008, MOL GENET GENOMICS, V279, P429, DOI 10.1007/s00438-008-0323-8; Schorpp M, 1996, NUCLEIC ACIDS RES, V24, P1787, DOI 10.1093/nar/24.9.1787; Schug J., 2008, CURR PROTOC BIOINFOR, V2; Selth LA, 2011, METHODS MOL BIOL, V791, P253, DOI 10.1007/978-1-61779-316-5_19; Takahashi K, 2001, EUR J IMMUNOL, V31, P590, DOI 10.1002/1521-4141(200102)31:2<590::AID-IMMU590>3.3.CO;2-4; Towbin H, 1992, Biotechnology, V24, P145; Varma NRS, 2011, J STEM CELLS REGEN, V7, P41; WIBORG O, 1985, EMBO J, V4, P755, DOI 10.1002/j.1460-2075.1985.tb03693.x; Yokoyama NN, 2010, NUCLEIC ACIDS RES, V38, P6375, DOI 10.1093/nar/gkq492; Zaravinos A, 2010, CELL CYCLE, V9, P512, DOI 10.4161/cc.9.3.10588	61	20	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65932	10.1371/journal.pone.0065932	http://dx.doi.org/10.1371/journal.pone.0065932			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776572	Green Published, gold, Green Submitted			2022-12-27	WOS:000320322400064
J	Chen, YJ; Sheu, ML; Tsai, KS; Sen Yang, R; Liu, SH				Chen, Ying Ju; Sheu, Meei Ling; Tsai, Keh Sung; Sen Yang, Rong; Liu, Shing Hwa			Advanced Glycation End Products Induce Peroxisome Proliferator-Activated Receptor gamma Down-Regulation-Related Inflammatory Signals in Human Chondrocytes via Toll-Like Receptor-4 and Receptor for Advanced Glycation End Products	PLOS ONE			English	Article							HUMAN OSTEOARTHRITIC CHONDROCYTES; MAILLARD REACTION-PRODUCTS; HUMAN ARTICULAR-CARTILAGE; SYNOVIAL FIBROBLASTS; PPAR-GAMMA; KAPPA-B; EXPRESSION; COLLAGEN; MATRIX-METALLOPROTEINASE-13; STIMULATION	Accumulation of advanced glycation end products (AGEs) in joints is important in the development of cartilage destruction and damage in age-related osteoarthritis (OA). The aim of this study was to investigate the roles of peroxisome proliferator-activated receptor gamma (PPAR gamma), toll-like receptor 4 (TLR4), and receptor for AGEs (RAGE) in AGEs-induced inflammatory signalings in human OA chondrocytes. Human articular chondrocytes were isolated and cultured. The productions of metalloproteinase-13 and interleukin-6 were quantified using the specific ELISA kits. The expressions of related signaling proteins were determined by Western blotting. Our results showed that AGEs enhanced the productions of interleukin-6 and metalloproteinase-13 and the expressions of cyclooxygenase-2 and high-mobility group protein B1 and resulted in the reduction of collagen II expression in human OA chondrocytes. AGEs could also activate nuclear factor (NF)-kappa B activation. Stimulation of human OA chondrocytes with AGEs significantly induced the up-regulation of TLR4 and RAGE expressions and the down-regulation of PPAR gamma expression in a time-and concentration-dependent manner. Neutralizing antibodies of TLR4 and RAGE effectively reversed the AGEs-induced inflammatory signalings and PPAR gamma down-regulation. PPAR gamma agonist pioglitazone could also reverse the AGEs-increased inflammatory signalings. Specific inhibitors for p38 mitogen-activated protein kinases, c-Jun N-terminal kinase and NF-kappa B suppressed AGEs-induced PPAR gamma down-regulation and reduction of collagen II expression. Taken together, these findings suggest that AGEs induce PPAR gamma down-regulation-mediated inflammatory signalings and reduction of collagen II expression in human OA chondrocytes via TLR4 and RAGE, which may play a crucial role in the development of osteoarthritis pathogenesis induced by AGEs accumulation.	[Chen, Ying Ju; Liu, Shing Hwa] Natl Taiwan Univ, Coll Med, Inst Toxicol, Taipei 10764, Taiwan; [Sheu, Meei Ling] Natl Chung Hsing Univ, Inst Biomed Sci, Taichung 40227, Taiwan; [Sheu, Meei Ling] Taichung Vet Gen Hosp, Dept Educ & Res, Taichung, Taiwan; [Tsai, Keh Sung] Natl Taiwan Univ, Coll Med, Dept Lab Med, Taipei 10764, Taiwan; [Sen Yang, Rong] Natl Taiwan Univ, Coll Med, Dept Orthopaed, Taipei 10764, Taiwan	National Taiwan University; National Chung Hsing University; Taichung Veterans General Hospital; National Taiwan University; National Taiwan University	Sen Yang, R (corresponding author), Natl Taiwan Univ, Coll Med, Dept Orthopaed, Taipei 10764, Taiwan.	rsyang@ntuh.gov.tw; shinghwaliu@ntu.edu.tw	Sheu, Meei-Ling/AAT-3401-2020	Sheu, Meei-Ling/0000-0002-0431-1282; LIU, SHING-HWA/0000-0002-9976-1197; TSAI, KEH-SUNG/0000-0001-8528-1566; Yang, Rong-Sen/0000-0002-0553-4779	National Science Council of Taiwan [NSC97-2314-B-002-052-MY3]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by the grant from the National Science Council of Taiwan (NSC97-2314-B-002-052-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afif H, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2151; AKIRA S, 1993, ADV IMMUNOL, V54, P1, DOI 10.1016/S0065-2776(08)60532-5; Andersson U, 2004, J INTERN MED, V255, P344, DOI 10.1111/j.1365-2796.2003.01303.x; Barish GD, 2006, J CLIN INVEST, V116, P590, DOI 10.1172/JCI27955; Berenbaum F, 2011, ANN RHEUM DIS, V70, P1354, DOI 10.1136/ard.2010.146399; Billinghurst RC, 1997, J CLIN INVEST, V99, P1534, DOI 10.1172/JCI119316; Blagojevic M, 2010, OSTEOARTHR CARTILAGE, V18, P24, DOI 10.1016/j.joca.2009.08.010; Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354; CHAWLA A, 1994, ENDOCRINOLOGY, V135, P798, DOI 10.1210/en.135.2.798; Cho MC, 2008, PPAR RES, V2008, DOI 10.1155/2008/679137; DeGroot J, 2004, CURR OPIN PHARMACOL, V4, P301, DOI 10.1016/j.coph.2004.01.007; DeGroot J, 2001, OSTEOARTHR CARTILAGE, V9, P720, DOI 10.1053/joca.2001.0469; Fahmi H, 2002, OSTEOARTHR CARTILAGE, V10, P845, DOI 10.1053/joca.2002.0835; Fahmi H, 2002, OSTEOARTHR CARTILAGE, V10, P100, DOI 10.1053/joca.2001.0485; Fahmi H, 2001, ARTHRITIS RHEUM, V44, P595, DOI 10.1002/1529-0131(200103)44:3<595::AID-ANR108>3.3.CO;2-#; Fahmi H, 2011, MOD RHEUMATOL, V21, P1, DOI 10.1007/s10165-010-0347-x; Felson DT, 1998, ARTHRITIS RHEUM, V41, P1343, DOI 10.1002/1529-0131(199808)41:8<1343::AID-ART3>3.0.CO;2-9; Glass GG, 2006, DM-DIS MON, V52, P343, DOI 10.1016/j.disamonth.2006.09.001; Goldring MB, 2007, J CELL PHYSIOL, V213, P626, DOI 10.1002/jcp.21258; Ji JD, 2001, J AUTOIMMUN, V17, P215, DOI 10.1006/jaut.2001.0542; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Kim HA, 2006, ARTHRITIS RHEUM-US, V54, P2152, DOI 10.1002/art.21951; Kobayashi T, 2005, ARTHRITIS RHEUM-US, V52, P479, DOI 10.1002/art.20792; Lin L, 2009, FRONT BIOSCI-LANDMRK, V14, P1403, DOI 10.2741/3315; Loeser RF, 2005, ARTHRITIS RHEUM, V52, P2376, DOI 10.1002/art.21199; MCCANCE DR, 1993, J CLIN INVEST, V91, P2470, DOI 10.1172/JCI116482; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Nah SS, 2007, FEBS LETT, V581, P1928, DOI 10.1016/j.febslet.2007.03.090; Noguchi T, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/490406; Qin YH, 2009, J IMMUNOL, V183, P6244, DOI 10.4049/jimmunol.0900390; Rasheed Z, 2012, BBA-MOL CELL RES, V1823, P2179, DOI 10.1016/j.bbamcr.2012.08.021; Rasheed Z, 2011, RHEUMATOLOGY, V50, P838, DOI 10.1093/rheumatology/keq380; Schelbergen RFP, 2012, ARTHRITIS RHEUM-US, V64, P1477, DOI 10.1002/art.33495; Schett G, 2013, DIABETES CARE, V36, P403, DOI 10.2337/dc12-0924; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; Steenvoorden MMC, 2006, ARTHRITIS RHEUM-US, V54, P253, DOI 10.1002/art.21523; Takano H, 2009, CIRC J, V73, P214, DOI 10.1253/circj.CJ-08-1071; Terada C, 2011, ACTA MED OKAYAMA, V65, P369; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; van Beijnum JR, 2008, ANGIOGENESIS, V11, P91, DOI 10.1007/s10456-008-9093-5; van Lent PLEM, 2007, ANN RHEUM DIS, V66, P334, DOI 10.1136/ard.2006.057471; Verzijl N, 2000, BIOCHEM J, V350, P381, DOI 10.1042/0264-6021:3500381; Verzijl N, 2002, ARTHRITIS RHEUM, V46, P114, DOI 10.1002/1529-0131(200201)46:1<114::AID-ART10025>3.0.CO;2-P; Wada J, 2013, CLIN SCI, V124, P139, DOI 10.1042/CS20120198; WOLFF DA, 1992, J ORTHOPAED RES, V10, P49, DOI 10.1002/jor.1100100106; Yammani RR, 2006, ARTHRITIS RHEUM-US, V54, P2901, DOI 10.1002/art.22042; Yang QS, 2010, EUR J PHARMACOL, V649, P108, DOI 10.1016/j.ejphar.2010.09.025	47	69	71	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66611	10.1371/journal.pone.0066611	http://dx.doi.org/10.1371/journal.pone.0066611			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776688	Green Submitted, Green Published, gold			2022-12-27	WOS:000320322400113
J	Cohen, CA; Shea, AA; Heffron, CL; Schmelz, EM; Roberts, PC				Cohen, Courtney A.; Shea, Amanda A.; Heffron, C. Lynn; Schmelz, Eva M.; Roberts, Paul C.			Intra-Abdominal Fat Depots Represent Distinct Immunomodulatory Microenvironments: A Murine Model	PLOS ONE			English	Article							DIET-INDUCED OBESITY; OMENTAL MILKY SPOTS; ADIPOSE-TISSUE; GENE-EXPRESSION; B-CELLS; MICE; CAVITY; WOMEN; TRANSPLANTATION; MACROPHAGES	White adipose tissue (WAT) is a multi-faceted endocrine organ involved in energy storage, metabolism, immune function and disease pathogenesis. In contrast to subcutaneous fat, visceral fat (V-WAT) has been associated with numerous diseases and metabolic disorders, indicating specific functions related to anatomical location. Although visceral depots are often used interchangeably in V-WAT-associated disease studies, there has been a recent subdivision of V-WAT into "true visceral" and non-visceral intra-abdominal compartments. These were associated with distinct physiological roles, illustrating a need for depot-specific information. Here, we use FACS analysis to comparatively characterize the leukocyte and progenitor populations in the stromal vascular fraction (SVF) of peritoneal serous fluid (PSF), parametrial (pmWAT), retroperitoneal (rpWAT), and omental (omWAT) adipose tissue from seven-month old C57BL/6 female mice. We found significant differences in SVF composition between all four microenvironments. PSF SVF was comprised almost entirely of CD45(+) leukocytes (>99%), while omWAT contained less, but still almost two-fold more leukocytes than pmWAT and rpWAT (75%, 38% and 38% respectively; p<0.01). PmWAT was composed primarily of macrophages, whereas rpWAT more closely resembled omWAT, denoted by high levels of B1 B-cell and monocyte populations. Further, omWAT harbored significantly higher proportions of T-cells than the other tissues, consistent with its role as a secondary lymphoid organ. These SVF changes were also reflected in the gene expression profiles of the respective tissues. Thus, intra-abdominal fat pads represent independent immunomodulatory microenvironments and should be evaluated as distinct entities with unique contributions to physiological and pathological processes.	[Cohen, Courtney A.; Heffron, C. Lynn; Roberts, Paul C.] Virginia Polytech Inst & State Univ, Dept Biomed Sci & Pathobiol, Blacksburg, VA 24061 USA; [Shea, Amanda A.; Schmelz, Eva M.] Virginia Polytech Inst & State Univ, Dept Human Nutr Foods & Exercise, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Schmelz, EM (corresponding author), Virginia Polytech Inst & State Univ, Dept Human Nutr Foods & Exercise, Blacksburg, VA 24061 USA.	eschmelz@vt.edu; pcroberts@vt.edu	Schmelz, Eva M/E-6579-2012	Shea, Amanda/0000-0002-8846-8841	National Institutes of Health [R01 CA118846]; Fralin Life Sciences Institute at Virginia Tech; NATIONAL CANCER INSTITUTE [R01CA118846] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fralin Life Sciences Institute at Virginia Tech; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported in part by National Institutes of Health R01 CA118846 (EMS, PCR) and funds provided by the Fralin Life Sciences Institute at Virginia Tech (PCR, EMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansel KM, 2002, IMMUNITY, V16, P67, DOI 10.1016/S1074-7613(01)00257-6; Baglioni S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036569; Berberich S, 2008, J IMMUNOL, V180, P2196, DOI 10.4049/jimmunol.180.4.2196; BJORNTORP P, 1990, ARTERIOSCLEROSIS, V10, P493, DOI 10.1161/01.ATV.10.4.493; Ghosn EEB, 2010, P NATL ACAD SCI USA, V107, P2568, DOI 10.1073/pnas.0915000107; Brake DK, 2006, AM J PHYSIOL-CELL PH, V291, pC1232, DOI 10.1152/ajpcell.00008.2006; Caspar-Bauguil S, 2005, FEBS LETT, V579, P3487, DOI 10.1016/j.febslet.2005.05.031; Dromard C, 2011, EXP CELL RES, V317, P770, DOI 10.1016/j.yexcr.2011.01.001; Fang ST, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001407; Foster M, 2011, DIABETOLOGIA, V54, P2890, DOI 10.1007/s00125-011-2259-5; Foster MT, 2010, PHYSIOL BEHAV, V101, P282, DOI 10.1016/j.physbeh.2010.05.014; Gerber SA, 2006, AM J PATHOL, V169, P1739, DOI 10.2353/ajpath.2006.051222; Horikawa K, 2006, IMMUNOLOGY, V118, P497, DOI 10.1111/j.1365-2567.2006.02382.x; Kawanishi N, 2010, EXERC IMMUNOL REV, V16, P105; Khan SM, 2010, CLIN EXP METASTAS, V27, P185, DOI 10.1007/s10585-010-9317-0; Kidd S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030563; Kwon EY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-450; Lee M. J., 2012, MOL ASPECTS MED; Linder K, 2004, J LIPID RES, V45, P148, DOI 10.1194/jlr.M300256-JLR200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; Macotela Y, 2012, DIABETES, V61, P1691, DOI 10.2337/db11-1753; Matsushita T, 2011, METHODS MOL BIOL, V677, P99, DOI 10.1007/978-1-60761-869-0_7; Montague CT, 1998, DIABETES, V47, P1384, DOI 10.2337/diabetes.47.9.1384; Montecino-Rodriguez E, 2006, TRENDS IMMUNOL, V27, P428, DOI 10.1016/j.it.2006.07.005; Park HT, 2012, CLIN ENDOCRINOL, V76, P59, DOI 10.1111/j.1365-2265.2011.04141.x; Poe JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022464; Rangel-Moreno J, 2009, IMMUNITY, V30, P731, DOI 10.1016/j.immuni.2009.03.014; Ray A, 2010, J VIS EXP; Rubtsov AV, 2011, BLOOD, V118, P1305, DOI 10.1182/blood-2011-01-331462; Rubtsova K, 2012, EXPERT REV CLIN IMMU, V8, P5, DOI [10.1586/ECI.11.83, 10.1586/eci.11.83]; Sandoval P, 2010, LAB INVEST, V90, P1517, DOI 10.1038/labinvest.2010.111; Smyth MJ, 2005, MOL IMMUNOL, V42, P501, DOI 10.1016/j.molimm.2004.07.034; Tchkonia T, 2007, AM J PHYSIOL-ENDOC M, V292, pE298, DOI 10.1152/ajpendo.00202.2006; Wueest S, 2012, AM J PHYSIOL-ENDOC M, V302, pE153, DOI 10.1152/ajpendo.00338.2011; Yanaba K, 2008, IMMUNITY, V28, P639, DOI 10.1016/j.immuni.2008.03.017; Yu G, 2011, METHODS MOL BIOL, V702, P29, DOI 10.1007/978-1-61737-960-4_3; Yu JH, 2009, J IMMUNOL, V183, P4968, DOI 10.4049/jimmunol.0900907; Zhang Yan, 2010, World J Stem Cells, V2, P103, DOI 10.4252/wjsc.v2.i5.103	39	30	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66477	10.1371/journal.pone.0066477	http://dx.doi.org/10.1371/journal.pone.0066477			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776677	Green Published, gold			2022-12-27	WOS:000320322400105
J	Hol, WHG; de Boer, W; ten Hooven, F; van der Putten, WH				Hol, W. H. Gera; de Boer, Wietse; ten Hooven, Freddy; van der Putten, Wim H.			Competition Increases Sensitivity of Wheat (Triticum aestivum) to Biotic Plant-Soil Feedback	PLOS ONE			English	Article							COMMUNITY STRUCTURE; ECOLOGY; PATHOGENS; DIVERSITY; DISEASES; FUNGI	Plant-soil feedback (PSF) and plant competition play an important role in structuring vegetation composition, but their interaction remains unclear. Recent studies suggest that competing plants could dilute pathogenic effects, whereas the standing view is that competition may increase the sensitivity of the focal plant to PSF. In agro-ecosystems each of these two options would yield contrasting outcomes: reduced versus enhanced effects of weeds on crop biomass production. To test the effect of competition on sensitivity to PSF, we grew Triticum aestivum (Common wheat) with and without competition from a weed community composed of Vicia villosa, Chenopodium album and Myosotis arvensis. Plants were grown in sterilized soil, with or without living field inoculum from 4 farms in the UK. In the conditioning phase, field inocula had both positive and negative effects on T. aestivum shoot biomass, depending on farm. In the feedback phase the differences between shoot biomass in T. aestivum monoculture on non-inoculated and inoculated soils had mostly disappeared. However, T. aestivum plants growing in mixtures in the feedback phase were larger on non-inoculated soil than on inoculated soil. Hence, T. aestivum was more sensitive to competition when the field soil biota was present. This was supported by the statistically significant negative correlation between shoot biomass of weeds and T. aestivum, which was absent on sterilized soil. In conclusion, competition in cereal crop-weed systems appears to increase cereal crop sensitivity to soil biota.	[Hol, W. H. Gera; ten Hooven, Freddy; van der Putten, Wim H.] Netherlands Inst Ecol, Dept Terr Ecol, Wageningen, Netherlands; [de Boer, Wietse] Netherlands Inst Ecol, Dept Microbial Ecol, Wageningen, Netherlands; [de Boer, Wietse] Wageningen Univ, Dept Soil Qual, NL-6700 AP Wageningen, Netherlands; [van der Putten, Wim H.] Wageningen Univ, Nematol Lab, NL-6700 AP Wageningen, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Wageningen University & Research; Wageningen University & Research	Hol, WHG (corresponding author), Netherlands Inst Ecol, Dept Terr Ecol, Wageningen, Netherlands.	g.hol@nioo.knaw.nl	de Boer, Wietse/C-2737-2011; van der Putten, Wim H/C-3707-2011; Hol, Gera W. H./B-4490-2008; KNAW, NIOO-KNAW/A-4320-2012	de Boer, Wietse/0000-0002-5380-2993; van der Putten, Wim H/0000-0002-9341-4442; Hol, Gera W. H./0000-0002-1256-495X; KNAW, NIOO-KNAW/0000-0002-3835-159X	EU	EU(European Commission)	The work was funded by the EU project SOILSERVICE. SOILSERVICE is a collaborative, medium scale focussed research project, which is funded by EU's Seventh Framework Programme. (http://www4.lu.se/soil-ecology-group/research/soilservice.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera AG, 2011, ECOL MODEL, V222, P3413, DOI 10.1016/j.ecolmodel.2011.06.018; Bever JD, 1997, J ECOL, V85, P561, DOI 10.2307/2960528; BEVER JD, 1994, ECOLOGY, V75, P1965, DOI 10.2307/1941601; Brandt AJ, 2009, ECOLOGY, V90, P1063, DOI 10.1890/08-0054.1; Brinkman EP, 2010, J ECOL, V98, P1063, DOI 10.1111/j.1365-2745.2010.01695.x; BULLOCK DG, 1992, CRIT REV PLANT SCI, V11, P309, DOI 10.1080/07352689209382349; Callaway RM, 2004, ECOLOGY, V85, P1062, DOI 10.1890/02-0775; Callaway RM, 2004, NATURE, V427, P731, DOI 10.1038/nature02322; Callaway RM, 2003, ECOLOGY, V84, P129, DOI 10.1890/0012-9658(2003)084[0129:SFATEO]2.0.CO;2; Casper BB, 2007, ECOL LETT, V10, P394, DOI 10.1111/j.1461-0248.2007.01030.x; Eviner VT, 2008, RESTOR ECOL, V16, P713, DOI 10.1111/j.1526-100X.2008.00482.x; Fine PVA, 2006, ECOLOGY, V87, pS150, DOI 10.1890/0012-9658(2006)87[150:TGTAHS]2.0.CO;2; Gilbert GS, 2002, ANNU REV PHYTOPATHOL, V40, P13, DOI 10.1146/annurev.phyto.40.021202.110417; Harrison KA, 2010, J ECOL, V98, P384, DOI 10.1111/j.1365-2745.2009.01614.x; Hauggaard-Nielsen H, 2009, NUTR CYCL AGROECOSYS, V85, P141, DOI 10.1007/s10705-009-9254-y; Hendriks M, 2013, J ECOL, V101, P287, DOI 10.1111/1365-2745.12032; HOAGLAND D. R., 1950, Circular. California Agricultural Experiment Station, V347; Hol WHG, 2011, FRONT ECOL ENVIRON, V9, P431, DOI 10.1890/11.WB.024; Inderjit, 2010, TRENDS ECOL EVOL, V25, P512, DOI 10.1016/j.tree.2010.06.006; Jiang LL, 2010, ECOL RES, V25, P1101, DOI 10.1007/s11284-010-0735-x; Jordan NR, 2011, INVAS PLANT SCI MANA, V4, P11, DOI 10.1614/IPSM-D-10-00004.1; Kardol P, 2007, ECOL MONOGR, V77, P147, DOI 10.1890/06-0502; Kardol P, 2006, ECOL LETT, V9, P1080, DOI 10.1111/j.1461-0248.2006.00953.x; Kulmatiski A, 2008, ECOL LETT, V11, P980, DOI 10.1111/j.1461-0248.2008.01209.x; Lundkvist A, 2008, EUR J AGRON, V28, P570, DOI 10.1016/j.eja.2008.01.001; Manning P, 2008, OECOLOGIA, V157, P661, DOI 10.1007/s00442-008-1104-0; Maron JL, 2011, ECOL LETT, V14, P36, DOI 10.1111/j.1461-0248.2010.01547.x; Otten W, 2006, EUR J SOIL SCI, V57, P26, DOI 10.1111/j.1365-2389.2006.00766.x; Petermann JS, 2008, ECOLOGY, V89, P2399, DOI 10.1890/07-2056.1; R Core Team, 2018, R LANG ENV STAT COMP; Reynolds HL, 2003, ECOLOGY, V84, P2281, DOI 10.1890/02-0298; Schnitzer SA, 2011, ECOLOGY, V92, P296, DOI 10.1890/10-0773.1; Shannon S, 2012, OECOLOGIA, V169, P235, DOI 10.1007/s00442-011-2195-6; SNAYDON RW, 1991, J APPL ECOL, V28, P930, DOI 10.2307/2404218; Tilman D., 1982, Monographs in Population Biology, pi; VanderPutten WH, 1997, ECOLOGY, V78, P1785, DOI 10.1890/0012-9658(1997)078[1785:HSBPMA]2.0.CO;2	36	28	28	6	116	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66085	10.1371/journal.pone.0066085	http://dx.doi.org/10.1371/journal.pone.0066085			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776610	Green Published, gold			2022-12-27	WOS:000320322400078
J	Chung, YE; Kim, MJ; Kim, YE; Park, MS; Choi, JY; Kim, KW				Chung, Yong Eun; Kim, Myeong-Jin; Kim, Yeo-Eun; Park, Mi-Suk; Choi, Jin Young; Kim, Ki Whang			Characterization of Incidental Liver Lesions: Comparison of Multidetector CT versus Gd-EOB-DTPA-Enhanced MR Imaging	PLOS ONE			English	Article							FOCAL NODULAR HYPERPLASIA; HEPATOCELLULAR-CARCINOMA; HEPATIC HEMANGIOMA; DIAGNOSIS; DIMEGLUMINE; TUMORS	As a result of recent developments in imaging modalities and wide spread routine medical checkups and screening, more incidental liver lesions are found frequently on US these days. When incidental liver lesions are found on US, physicians have to make a decision whether to just follow up or to undergo additional imaging studies for lesion characterization. In order to choose the next appropriate imaging modality, the diagnostic accuracy of each imaging study needs to be considered. Therefore, we tried to compare the accuracy of contrast-enhanced multidetector CT (MDCT) and Gd-EOB-DTPA-enhanced MRI for characterization of incidental liver masses. We included 127 incidentally found focal liver lesions (94 benign and 33 malignant) from 80 patients (M: F = 45: 35) without primary extrahepatic malignancy or chronic liver disease. Two radiologists independently reviewed Gd-EOB-DTPA-enhanced MRI and MDCT. The proportion of confident interpretations for differentiation of benign and malignant lesions and for the specific diagnosis of diseases were compared. The proportion of confident interpretations for the differentiation of benign and malignant lesions was significantly higher with EOB-MRI(94.5%-97.6%) than with MDCT (74.0%-92.9%). In terms of specific diagnosis, sensitivity and accuracy were significantly higher with EOB-MRI than with MDCT for the diagnosis of focal nodular hyperplasia (FNH) and focal eosinophilic infiltration. The diagnoses of the remaining diseases were comparable between EOB-MRI and MDCT. Hence, our results suggested that Gd-EOB-MRI may provide a higher proportion of confident interpretations than MDCT, especially for the diagnosis of incidentally found FNH and focal eosinophilic infiltration.	[Chung, Yong Eun; Kim, Myeong-Jin; Kim, Yeo-Eun; Park, Mi-Suk; Choi, Jin Young; Kim, Ki Whang] Yonsei Univ, Coll Med, Dept Radiol, Severance Hosp, Seoul, South Korea	Yonsei University; Yonsei University Health System	Kim, KW (corresponding author), Yonsei Univ, Coll Med, Dept Radiol, Severance Hosp, Seoul, South Korea.	kimnex@yuhs.ac	; Kim, Myeong-Jin/E-1623-2011	Chung, Yong Eun/0000-0003-0811-9578; Choi, Jin-Young/0000-0002-9025-6274; Kim, Myeong-Jin/0000-0001-7949-5402; Park, Mi-Suk/0000-0001-5817-2444				Ahn SS, 2010, RADIOLOGY, V255, P459, DOI 10.1148/radiol.10091388; Bartolotta TV, 2011, INVEST RADIOL, V46, P106, DOI 10.1097/RLI.0b013e3181f44184; Boutros C, 2010, SURG CLIN N AM, V90, P699, DOI 10.1016/j.suc.2010.04.005; Brancatelli G, 2002, RADIOLOGY, V222, P89, DOI 10.1148/radiol.2221010767; Cicchetti DV., 1971, AM J EEG TECHNOL, V11, P101, DOI [10.1080/00029238.1971.11080840, DOI 10.1080/00029238.1971.11080840]; Doo KW, 2009, AM J ROENTGENOL, V193, pW490, DOI 10.2214/AJR.08.1732; Furtado CD, 2005, RADIOLOGY, V237, P385, DOI 10.1148/radiol.2372041741; Gore RM, 2011, RADIOL CLIN N AM, V49, P291, DOI 10.1016/j.rcl.2010.10.004; Grazioli L, 2003, J MAGN RESON IMAGING, V17, P593, DOI 10.1002/jmri.10289; Jang HJ, 2003, AM J ROENTGENOL, V180, P135, DOI 10.2214/ajr.180.1.1800135; KARHUNEN PJ, 1986, J CLIN PATHOL, V39, P183, DOI 10.1136/jcp.39.2.183; Kim MJ, 2011, GUT LIVER, V5, P15, DOI 10.5009/gnl.2011.5.1.15; Kovach SJ, 2006, J SURG ONCOL, V94, P385, DOI 10.1002/jso.20516; Lee J, 2010, MAGN RESON IMAGING, V28, P1327, DOI 10.1016/j.mri.2010.06.013; Park G, 2010, BRIT J RADIOL, V83, P1010, DOI 10.1259/bjr/66686028; Purysko AS, 2011, CLIN RADIOL, V66, P673, DOI 10.1016/j.crad.2011.01.014; Soussan M, 2010, EUR RADIOL, V20, P1715, DOI 10.1007/s00330-009-1700-3; Yoon SS, 2003, J AM COLL SURGEONS, V197, P392, DOI 10.1016/S1072-7515(03)00420-4; Yu JS, 2005, J COMPUT ASSIST TOMO, V29, P765, DOI 10.1097/01.rct.0000182856.75273.dd; Zech CJ, 2008, INVEST RADIOL, V43, P504, DOI 10.1097/RLI.0b013e3181705cd1	20	29	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66141	10.1371/journal.pone.0066141	http://dx.doi.org/10.1371/journal.pone.0066141			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776623	Green Published, Green Submitted, gold			2022-12-27	WOS:000320755400115
J	Gulec, S; Collins, JF				Gulec, Sukru; Collins, James F.			Investigation of Iron Metabolism in Mice Expressing a Mutant Menke's Copper Transporting ATPase (Atp7a) Protein with Diminished Activity (Brindled; Mo-Br/y)	PLOS ONE			English	Article							MOTTLED MOUSE MUTANTS; INDUCIBLE FACTOR-I; DEFICIENT MICE; GENE-EXPRESSION; RAT DUODENUM; CERULOPLASMIN; HEPHAESTIN; HYPOXIA; ABSORPTION; DIETARY	During iron deficiency, perturbations in copper homeostasis have frequently been documented. Previous studies in iron-deprived rats demonstrated that enterocyte and hepatic copper levels increase and a copper transporter (the Menkes Copper ATPase; Atp7a) is induced in the duodenal epithelium in parallel to iron transport-related genes (e.g. Dmt1, Dcytb, Fpn1). Moreover, two ferroxidase proteins involved in iron homeostasis, hephaestin expressed in enterocytes and ceruloplasmin, produced and secreted into blood by the liver, are copper-dependent enzymes. We thus aimed to test the hypothesis that Atp7a function is important for the copper-related compensatory response of the intestinal epithelium to iron deficiency. Accordingly, iron homeostasis was studied for the first time in mice expressing a mutant Atp7a protein with minimal activity (Brindled [Mo-Br/y]). Mutant mice were rescued by perinatal copper injections, and, after a 7-8 week recovery period, were deprived of dietary iron for 3 weeks (along with WT littermates). Adult Mo-Br/y mice displayed copper-deficiency anemia but had normal iron status; in contrast, iron-deprived Mo-Br/y mice were iron deficient and more severely anemic with partial amelioration of the copper-deficient phenotype. Intestinal iron absorption in both genotypes (WT and Mo-Br/y) increased similar to 3-fold when mice consumed a low-iron diet and similar to 6-fold when mice were concurrently bled. WT mice exhibited no alterations in copper homeostasis in response to iron deprivation or phlebotomy. Conversely, upregulation of iron absorption was associated with increased enterocyte and liver copper levels and serum ferroxidase (ceruloplasmin) activity in Mo-Br/y mice, typifying the response to iron deprivation in many mammalian species. We thus speculate that a copper threshold exists that is necessary to allow appropriate regulate of iron absorption. In summary, Mo-Br/y mice were able to adequately regulate iron absorption, but unlike in WT mice, concurrent increases in enterocyte and liver copper levels and serum ferroxidase activity may have contributed to maintenance of iron homeostasis.	[Gulec, Sukru; Collins, James F.] Univ Florida, Dept Food Sci & Human Nutr, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Collins, JF (corresponding author), Univ Florida, Dept Food Sci & Human Nutr, Gainesville, FL 32611 USA.	jfcollins@ufl.edu		Gulec, Sukru/0000-0002-6789-1050	National Institutes of Health [DK074867]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074867] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded by National Institutes of Health grant DK074867 (J.F.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GJ, 2002, BLOOD CELL MOL DIS, V29, P367, DOI 10.1006/bcmd.2002.0576; Auclair S, 2006, BLOOD CELL MOL DIS, V36, P15, DOI 10.1016/j.bcmd.2005.11.003; Bellier S, 2005, AM J PHYSIOL-GASTR L, V288, pG151, DOI 10.1152/ajpgi.00048.2004; Benita Y, 2009, NUCLEIC ACIDS RES, V37, P4587, DOI 10.1093/nar/gkp425; CAMAKARIS J, 1979, BIOCHEM J, V180, P597, DOI 10.1042/bj1800597; CHASE MS, 1952, J BIOL CHEM, V199, P757; Chen HJ, 2006, J NUTR, V136, P1236, DOI 10.1093/jn/136.5.1236; Chen HJ, 2003, BLOOD, V102, P1893, DOI 10.1182/blood-2003-02-0347; Cherukuri S, 2005, CELL METAB, V2, P309, DOI 10.1016/j.cmet.2005.10.003; Collins JF, 2009, AM J PHYSIOL-GASTR L, V297, pG695, DOI 10.1152/ajpgi.00203.2009; Collins JF, 2005, AM J PHYSIOL-GASTR L, V288, pG964, DOI 10.1152/ajpgi.00489.2004; Donsante A, 2011, MOL THER, V19, P2114, DOI 10.1038/mt.2011.143; Ece A, 1997, BIOL TRACE ELEM RES, V59, P31, DOI 10.1007/BF02783227; Fox PL, 2003, BIOMETALS, V16, P9, DOI 10.1023/A:1020799512190; Ganz T, 2009, SEMIN HEMATOL, V46, P387, DOI 10.1053/j.seminhematol.2009.06.001; Gitlin JD, 1998, PEDIATR RES, V44, P271, DOI 10.1203/00006450-199809000-00001; Grimes A, 1997, HUM MOL GENET, V6, P1037, DOI 10.1093/hmg/6.7.1037; Hellman NE, 2002, ANNU REV NUTR, V22, P439, DOI 10.1146/annurev.nutr.22.012502.114457; Hu ZH, 2010, AM J PHYSIOL-CELL PH, V299, pC930, DOI 10.1152/ajpcell.00238.2010; Jenkitkasemwong S, 2010, J NUTR, V140, P723, DOI 10.3945/jn.109.117077; Kim BE, 2007, J MED GENET, V44, P641, DOI 10.1136/jmg.2007.049627; Klevay LM, 1997, J NUTR, V127, pS1034; Kuo YM, 2004, GUT, V53, P201, DOI 10.1136/gut.2003.019026; LEE GR, 1968, J CLIN INVEST, V47, P2058, DOI 10.1172/JCI105891; MANN JR, 1979, BIOCHEM J, V180, P605, DOI 10.1042/bj1800605; MANN JR, 1980, BIOCHEM J, V186, P629, DOI 10.1042/bj1860629; MANN JR, 1979, BIOCHEM J, V180, P613, DOI 10.1042/bj1800613; Mastrogiannaki M, 2009, J CLIN INVEST, V119, P1159, DOI 10.1172/JCI38499; Mukhopadhyay CK, 2000, J BIOL CHEM, V275, P21048, DOI 10.1074/jbc.M000636200; NAVEH Y, 1981, PEDIATRICS, V68, P397; Prohaska J. R., 1981, Nutrition Research, V1, P159, DOI 10.1016/S0271-5317(81)80098-X; Prohaska JR, 2012, BIOMETALS, V25, P633, DOI 10.1007/s10534-012-9521-2; PROHASKA JR, 1982, J NUTR, V112, P1706, DOI 10.1093/jn/112.9.1706; Prohaska JR, 2006, COMP BIOCHEM PHYS B, V143, P360, DOI 10.1016/j.cbpb.2005.12.010; PROHASKA JR, 1984, J NUTR, V114, P422, DOI 10.1093/jn/114.2.422; Ranganathan PN, 2012, BIOMETALS, V25, P687, DOI 10.1007/s10534-012-9527-9; Ranganathan PN, 2011, BLOOD, V118, P3146, DOI 10.1182/blood-2011-05-352112; Rankin EB, 2007, J CLIN INVEST, V117, P1068, DOI 10.1172/JCI30117; Ravia JJ, 2005, J BIOL CHEM, V280, P36221, DOI 10.1074/jbc.M506727200; Reeves PG, 2005, J NUTR, V135, P92, DOI 10.1093/jn/135.1.92; ROYCE PM, 1982, BIOCHEM J, V202, P369, DOI 10.1042/bj2020369; Shah YM, 2009, CELL METAB, V9, P152, DOI 10.1016/j.cmet.2008.12.012; SHERMAN AR, 1984, J NUTR, V114, P298, DOI 10.1093/jn/114.2.298; SOURKES TL, 1968, CAN J BIOCHEM CELL B, V46, P267, DOI 10.1139/o68-038; SUZUKI K, 1981, ACTA NEUROPATHOL, V55, P251, DOI 10.1007/BF00690986; Taylor M, 2011, GASTROENTEROLOGY, V140, P2044, DOI 10.1053/j.gastro.2011.03.007; VULPE C, 1993, NAT GENET, V3, P7, DOI 10.1038/ng0193-7; Yamamoto K, 2002, BBA-MOL BASIS DIS, V1588, P195, DOI 10.1016/S0925-4439(02)00165-5; YOKOI K, 1991, BIOL TRACE ELEM RES, V29, P257, DOI 10.1007/BF03032682	49	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66010	10.1371/journal.pone.0066010	http://dx.doi.org/10.1371/journal.pone.0066010			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776592	Green Published, gold, Green Submitted			2022-12-27	WOS:000320755400098
J	Kainz, KP; Krenn, L; Erdem, Z; Kaehlig, H; Zehl, M; Bursch, W; Berger, W; Marian, B				Kainz, Kerstin P.; Krenn, Liselotte; Erdem, Zeynep; Kaehlig, Hanspeter; Zehl, Martin; Bursch, Wilfried; Berger, Walter; Marian, Brigitte			2-Deprenyl-Rheediaxanthone B Isolated from Metaxya rostrata Induces Active Cell Death in Colorectal Tumor Cells	PLOS ONE			English	Article							INDUCED MITOTIC CATASTROPHE; ALPHA-MANGOSTIN; CANCER-CELLS; COLON-CANCER; IN-VITRO; APOPTOSIS; EXPRESSION; XANTHONES; MITOCHONDRIA; PROGRESSION	Metaxya rostrata C. Presl (Metaxyaceae) is a common tree fern in Central and South America that is used for the treatment of intestinal ulcers and tumours in ethnic medicine. Using a bioactivity-guided strategy 2-deprenyl-rheediaxanthone B (XB) has been isolated as one of the active principles in this plant. XB induced loss of cell viability in colorectal cancer cell lines at IC50 concentrations of 11-23 mu M. This was caused by both accumulation of cells in the G2- and S-phase as well as by induction of active cell death in a time and concentration-dependent manner. Cells exposed to XB were incapable of undergoing regular mitosis due to down-regulation of FoxM1 and absence of chromosome condensation. The apoptosis-related proteins Bcl(2) and Bcl(xl) were up-regulated so that Caspase 3 was not activated and classical apoptosis was not observed. However, XB triggered damage pathways down-stream of ATR and activated Caspase 2 causing cell death by a mechanism similar to mitotic catastrophe. Our observations are the first to show the cytotoxic activity of 2-deprenyl-rheediaxanthone B and indicate that XB is an interesting new lead compound for cancer therapy that merits further development.	[Kainz, Kerstin P.; Erdem, Zeynep; Bursch, Wilfried; Berger, Walter; Marian, Brigitte] Med Univ Vienna, Dept Med 1, Inst Canc Res, Vienna, Austria; [Kainz, Kerstin P.; Krenn, Liselotte; Zehl, Martin] Univ Vienna, Dept Pharmacognosy, Vienna, Austria; [Kaehlig, Hanspeter] Univ Vienna, Dept Organ Chem, Vienna, Austria	Medical University of Vienna; University of Vienna; University of Vienna	Marian, B (corresponding author), Med Univ Vienna, Dept Med 1, Inst Canc Res, Vienna, Austria.	brigitte.marian@meduniwien.ac.at	Zehl, Martin/B-5901-2008	Zehl, Martin/0000-0001-9685-0373; Berger, Walter/0000-0003-0014-1658; Krenn, Liselotte/0000-0002-9526-4396; Kaehlig, Hanspeter/0000-0002-3898-6501	Austrian Science Foundation [P20354]	Austrian Science Foundation(Austrian Science Fund (FWF))	The study was suppported by the Austrian Science Foundation (P20354). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao Y, 2008, INT J MOL SCI, V9, P355, DOI 10.3390/ijms9030355; Batova A, 2010, MOL CANCER THER, V9, P2869, DOI 10.1158/1535-7163.MCT-10-0517; Boutros R, 2006, CURR OPIN CELL BIOL, V18, P185, DOI 10.1016/j.ceb.2006.02.003; Castanheiro RAP, 2009, PHARMACEUTICALS, V2, P33, DOI 10.3390/ph2020033; Chao AC, 2011, J AGR FOOD CHEM, V59, P2086, DOI 10.1021/jf1042757; Cheng JH, 2011, EUR J MED CHEM, V46, P1222, DOI 10.1016/j.ejmech.2011.01.043; de Bruin EC, 2008, CANCER TREAT REV, V34, P737, DOI 10.1016/j.ctrv.2008.07.001; Ding L, 2009, TOXICOL IN VITRO, V23, P408, DOI 10.1016/j.tiv.2009.01.010; Eng C, 2010, ONCOLOGIST, V15, P73, DOI 10.1634/theoncologist.2009-0167; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Garcia-Rivera D, 2011, CANCER LETT, V305, P21, DOI 10.1016/j.canlet.2011.02.011; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hausott B, 2004, INT J CANCER, V109, P933, DOI 10.1002/ijc.20033; Hay AE, 2004, LIFE SCI, V75, P3077, DOI 10.1016/j.lfs.2004.07.009; Hinoshita E, 2000, CLIN CANCER RES, V6, P2401; Ianzini F, 2006, CANCER CELL INT, V6, DOI 10.1186/1475-2867-6-11; Kalabis J, 2003, FASEB J, V17, P1115, DOI 10.1096/fj.02-0852fje; Kim Jinwoong, 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P485; Krajarng A, 2011, J AGR FOOD CHEM, V59, P5746, DOI 10.1021/jf200620n; Krajewska M, 1996, CANCER RES, V56, P2422; Lavaud A, 2012, BIOCHEM PHARMACOL, V83, P514, DOI 10.1016/j.bcp.2011.12.002; Lim CK, 2011, LETT DRUG DES DISCOV, V8, P523; Macdonald JS, 2001, SEMIN ONCOL, V28, P30, DOI 10.1053/sonc.2001.20750; Matsumoto K, 2004, BIOORGAN MED CHEM, V12, P5799, DOI 10.1016/j.bmc.2004.08.034; Monache FD, 1981, J CHEM SOC, V1, P484; Nakagawa Y, 2007, BIOORGAN MED CHEM, V15, P5620, DOI 10.1016/j.bmc.2007.04.071; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Niu SL, 2012, PHYTOCHEMISTRY, V77, P280, DOI 10.1016/j.phytochem.2012.01.010; Palmeira A, 2010, CHEM BIOL DRUG DES, V76, P43, DOI 10.1111/j.1747-0285.2010.00978.x; Partik G, 1998, VIRCHOWS ARCH, V432, P415, DOI 10.1007/s004280050185; Pekarek B, 2003, THESIS U NATURAL RES; Peng KC, 1999, J HISTOCHEM CYTOCHEM, V47, P757, DOI 10.1177/002215549904700605; Peterson C, 2011, EUR J CLIN PHARMACOL, V67, P437, DOI 10.1007/s00228-011-1011-x; Portugal J, 2010, CURR PHARM DESIGN, V16, P69, DOI 10.2174/138161210789941801; Ragnhammar P, 2001, ACTA ONCOL, V40, P282, DOI 10.1080/02841860151116367; Rath G, 1996, PHYTOCHEMISTRY, V43, P513, DOI 10.1016/0031-9422(96)00284-1; Raychaudhuri P, 2011, CANCER RES, V71, P4329, DOI 10.1158/0008-5472.CAN-11-0640; Richter M, 2002, EUR J CANCER, V38, P1937, DOI 10.1016/S0959-8049(02)00158-2; Shen R, 2010, J FLUORESC, V20, P1287, DOI 10.1007/s10895-010-0680-7; Singh R, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-4; Virtbauer J, 2008, Z NATURFORSCH C, V63, P469; Wang IC, 2005, MOL CELL BIOL, V25, P10875, DOI 10.1128/MCB.25.24.10875-10894.2005; Watanapokasin R, 2011, WORLD J GASTROENTERO, V17, P2086, DOI 10.3748/wjg.v17.i16.2086; Wei Y, 1999, CELL, V97, P99, DOI 10.1016/S0092-8674(00)80718-7	44	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65745	10.1371/journal.pone.0065745	http://dx.doi.org/10.1371/journal.pone.0065745			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776538	Green Published, gold, Green Submitted			2022-12-27	WOS:000320755400064
J	Margadant, C; Kreft, M; Zambruno, G; Sonnenberg, A				Margadant, Coert; Kreft, Maaike; Zambruno, Giovanna; Sonnenberg, Arnoud			Kindlin-1 Regulates Integrin Dynamics and Adhesion Turnover	PLOS ONE			English	Article							KINDLER-SYNDROME; EXTRACELLULAR-MATRIX; KERATINOCYTE MIGRATION; PROTEIN; BETA-1-INTEGRIN; MUTATIONS; LAMININ-5; GROWTH; SKIN; PROLIFERATION	Loss-of-function mutations in the gene encoding the integrin co-activator kindlin-1 cause Kindler syndrome. We report a novel kindlin-1-deficient keratinocyte cell line derived from a Kindler syndrome patient. Despite the expression of kindlin-2, the patient's cells display several hallmarks related to reduced function of beta 1 integrins, including abnormal cell morphology, cell adhesion, cell spreading, focal adhesion assembly, and cell migration. Defective cell adhesion was aggravated by kindlin-2 depletion, indicating that kindlin-2 can compensate to a certain extent for the loss of kindlin-1. Intriguingly, beta b1 at the cell-surface was aberrantly glycosylated in the patient's cells, and its expression was considerably reduced, both in cells in vitro and in the patient's epidermis. Reconstitution with wild-type kindlin-1 but not with a beta 1-binding defective mutant restored the aberrant beta 1 expression and glycosylation, and normalized cell morphology, adhesion, spreading, and migration. Furthermore, the expression of wild-type kindlin-1, but not of the integrin-binding-defective mutant, increased the stability of integrin-mediated cell-matrix adhesions and enhanced the redistribution of internalized integrins to the cell surface. Thus, these data uncover a role for kindlin-1 in the regulation of integrin trafficking and adhesion turnover.	[Margadant, Coert; Kreft, Maaike; Sonnenberg, Arnoud] Netherlands Canc Inst, Div Cell Biol, Amsterdam, Netherlands; [Zambruno, Giovanna] IDI IRCCS, Lab Mol & Cell Biol, Rome, Italy	Netherlands Cancer Institute; IRCCS Istituto Dermopatico dell'Immacolata (IDI)	Sonnenberg, A (corresponding author), Netherlands Canc Inst, Div Cell Biol, Amsterdam, Netherlands.	a.sonnenberg@nki.nl	Zambruno, Giavanna/K-2933-2018	Zambruno, Giovanna/0000-0002-1295-056X	DEBRA UK	DEBRA UK	The work was supported by a grant from DEBRA UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashton GHS, 2004, CLIN EXP DERMATOL, V29, P116, DOI 10.1111/j.1365-2230.2004.01465.x; Bandyopadhyay A, 2012, J CELL SCI, V125, P2172, DOI 10.1242/jcs.096214; Bottcher RT, 2012, NAT CELL BIOL, V14, P584, DOI 10.1038/ncb2501; Brakebusch C, 2000, EMBO J, V19, P3990, DOI 10.1093/emboj/19.15.3990; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; DeHart GW, 2003, EXP CELL RES, V283, P67, DOI 10.1016/S0014-4827(02)00028-9; DiPersio CM, 1997, J CELL BIOL, V137, P729, DOI 10.1083/jcb.137.3.729; GagnouxPalacios L, 1996, J BIOL CHEM, V271, P18437, DOI 10.1074/jbc.271.31.18437; Geiger B, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005033; Hamill KJ, 2009, J CELL SCI, V122, P4409, DOI 10.1242/jcs.041095; Harburger DS, 2009, J BIOL CHEM, V284, P11485, DOI 10.1074/jbc.M809233200; Hartwig B, 2007, EXP CELL RES, V313, P1575, DOI 10.1016/j.yexcr.2007.02.003; Has C, 2008, BRIT J DERMATOL, V159, P1192, DOI 10.1111/j.1365-2133.2008.08760.x; Has C, 2006, J INVEST DERMATOL, V126, P1776, DOI 10.1038/sj.jid.5700339; Has C, 2012, NEW ENGL J MED, V366, P1508, DOI 10.1056/NEJMoa1110813; Has C, 2011, HUM MUTAT, V32, P1204, DOI 10.1002/humu.21576; Has C, 2009, AM J PATHOL, V175, P1442, DOI 10.2353/ajpath.2009.090203; He YH, 2011, AM J PATHOL, V178, P975, DOI 10.1016/j.ajpath.2010.11.053; Herz C, 2006, J BIOL CHEM, V281, P36082, DOI 10.1074/jbc.M606259200; Hodivala-Dilke KM, 1998, J CELL BIOL, V142, P1357, DOI 10.1083/jcb.142.5.1357; Jobard F, 2003, HUM MOL GENET, V12, P925, DOI 10.1093/hmg/ddg097; Kern J S, 2007, J Pathol, V213, P462, DOI 10.1002/path.2253; Kim C, 2011, ANNU REV CELL DEV BI, V27, P321, DOI 10.1146/annurev-cellbio-100109-104104; KIM JP, 1992, J INVEST DERMATOL, V98, P764, DOI 10.1111/1523-1747.ep12499947; Kloeker S, 2004, J BIOL CHEM, V279, P6824, DOI 10.1074/jbc.M307978200; Kruger M, 2008, CELL, V134, P353, DOI 10.1016/j.cell.2008.05.033; Lai-Cheong JE, 2008, J INVEST DERMATOL, V128, P2156, DOI 10.1038/jid.2008.58; Lai-Cheong JE, 2010, DERMATOL CLIN, V28, P119, DOI 10.1016/j.det.2009.10.013; Lai-Cheong JE, 2009, AM J PATHOL, V175, P1431, DOI 10.2353/ajpath.2009.081154; Larjava H, 2008, EMBO REP, V9, P1203, DOI 10.1038/embor.2008.202; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Legate KR, 2009, J CELL SCI, V122, P187, DOI 10.1242/jcs.041624; Margadant C, 2008, CURR OPIN CELL BIOL, V20, P589, DOI 10.1016/j.ceb.2008.05.001; Margadant C, 2012, CURR BIOL, V22, P1554, DOI 10.1016/j.cub.2012.06.060; Margadant C, 2011, CURR OPIN CELL BIOL, V23, P607, DOI 10.1016/j.ceb.2011.08.005; Margadant C, 2010, FASEB J, V24, P4133, DOI 10.1096/fj.09-151449; Margadant C, 2009, J CELL SCI, V122, P278, DOI 10.1242/jcs.029108; Meves A, 2009, TRENDS CELL BIOL, V19, P504, DOI 10.1016/j.tcb.2009.07.006; Miquel C, 1996, EXP CELL RES, V224, P279, DOI 10.1006/excr.1996.0138; OToole EA, 1997, EXP CELL RES, V233, P330, DOI 10.1006/excr.1997.3586; Postel R, 2013, J INVEST DERMATOL, V133, P2180, DOI 10.1038/jid.2013.154; Powelka AM, 2004, TRAFFIC, V5, P20, DOI 10.1111/j.1600-0854.2004.00150.x; Qu HY, 2012, AM J PATHOL, V180, P1581, DOI 10.1016/j.ajpath.2012.01.005; Raghavan S, 2000, J CELL BIOL, V150, P1149, DOI 10.1083/jcb.150.5.1149; Sadler E, 2006, ARCH DERMATOL, V142, P1619, DOI 10.1001/archderm.142.12.1619; Schaapveld RQJ, 1998, J CELL BIOL, V142, P271, DOI 10.1083/jcb.142.1.271; Siegel DH, 2003, AM J HUM GENET, V73, P174, DOI 10.1086/376609; Steinberg F, 2012, J CELL BIOL, V197, P219, DOI 10.1083/jcb.201111121; Ussar S, 2006, EXP CELL RES, V312, P3142, DOI 10.1016/j.yexcr.2006.06.030; Ussar S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000289; Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399; Wen TT, 2010, WOUND REPAIR REGEN, V18, P325, DOI 10.1111/j.1524-475X.2010.00590.x; White SJ, 2005, J DERMATOL SCI, V38, P169, DOI 10.1016/j.jdermsci.2004.12.026	53	23	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65341	10.1371/journal.pone.0065341	http://dx.doi.org/10.1371/journal.pone.0065341			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776470	Green Submitted, Green Published, gold			2022-12-27	WOS:000320755400024
J	Patwardhan, RS; Checker, R; Sharma, D; Sandur, SK; Sainis, KB				Patwardhan, Raghavendra S.; Checker, Rahul; Sharma, Deepak; Sandur, Santosh K.; Sainis, Krishna B.			Involvement of ERK-Nrf-2 Signaling in Ionizing Radiation Induced Cell Death in Normal and Tumor Cells	PLOS ONE			English	Article							NF-KAPPA-B; TARGETING INFLAMMATORY PATHWAYS; GENE-EXPRESSION; PRO-OXIDANTS; NRF2; CANCER; ACTIVATION; MECHANISMS; APOPTOSIS; ROS	Prolonged oxidative stress favors tumorigenic environment and inflammation. Oxidative stress may trigger redox adaptation mechanism(s) in tumor cells but not normal cells. This may increase levels of intracellular antioxidants and establish a new redox homeostasis. Nrf-2, a master regulator of battery of antioxidant genes is constitutively activated in many tumor cells. Here we show that, murine T cell lymphoma EL-4 cells show constitutive and inducible radioresistance via activation of Nrf-2/ERK pathway. EL-4 cells contained lower levels of ROS than their normal counterpart murine splenic lymphocytes. In response to radiation, the thiol redox circuits, GSH and thioredoxin were modified in EL-4 cells. Pharmacological inhibitors of ERK and Nrf-2 significantly enhanced radiosensitivity and reduced clonogenic potential of EL-4 cells. Unirradiated lymphoma cells showed nuclear accumulation of Nrf-2, upregulation of its dependent genes and protein levels. Interestingly, MEK inhibitor abrogated its nuclear translocation suggesting role of ERK in basal and radiation induced Nrf-2 activation in tumor cells. Double knockdown of ERK and Nrf-2 resulted in higher sensitivity to radiation induced cell death as compared to individual knockdown cells. Importantly, NF-kB which is reported to be constitutively active in many tumors was not present at basal levels in EL-4 cells and its inhibition did not influence radiosensitivity of EL-4 cells. Thus our results reveal that, tumor cells which are subjected to heightened oxidative stress employ master regulator cellular redox homeostasis Nrf-2 for prevention of radiation induced cell death. Our study reveals the molecular basis of tumor radioresistance and highlights role of Nrf-2 and ERK.	[Patwardhan, Raghavendra S.; Checker, Rahul; Sharma, Deepak; Sandur, Santosh K.; Sainis, Krishna B.] Bhabha Atom Res Ctr, Biomed Grp, Radiat Biol & Hlth Sci Div, Bombay 400085, Maharashtra, India	Bhabha Atomic Research Center (BARC)	Sainis, KB (corresponding author), Bhabha Atom Res Ctr, Biomed Grp, Radiat Biol & Hlth Sci Div, Bombay 400085, Maharashtra, India.	kbsainis@barc.gov.in		Sharma, Deepak/0000-0002-7529-5574; patwardhan, Raghvendra/0000-0001-6608-8779; Checker, Rahul/0000-0001-7704-3613	Department of Atomic Energy, Government of India	Department of Atomic Energy, Government of India(Department of Atomic Energy (DAE))	Funding was provided by Department of Atomic Energy, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2006, BIOCHEM PHARMACOL, V72, P1605, DOI 10.1016/j.bcp.2006.06.029; Aggarwal BB, 2009, CLIN CANCER RES, V15, P425, DOI 10.1158/1078-0432.CCR-08-0149; Cakir Y, 2005, ANTIOXID REDOX SIGN, V7, P726, DOI 10.1089/ars.2005.7.726; Checker R, 2008, INT IMMUNOPHARMACOL, V8, P661, DOI 10.1016/j.intimp.2008.01.012; Checker R, 2009, INT IMMUNOPHARMACOL, V9, P949, DOI 10.1016/j.intimp.2009.03.022; Copple IM, 2008, TOXICOLOGY, V246, P24, DOI 10.1016/j.tox.2007.10.029; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; den Hertog J, 2005, ARCH BIOCHEM BIOPHYS, V434, P11, DOI 10.1016/j.abb.2004.05.024; Deorukhkar A, 2010, BIOCHEM PHARMACOL, V80, P1904, DOI 10.1016/j.bcp.2010.06.039; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Fang J, 2009, ADV DRUG DELIVER REV, V61, P290, DOI 10.1016/j.addr.2009.02.005; Hayes JD, 2006, MOL CELL, V21, P732, DOI 10.1016/j.molcel.2006.03.004; Hayes JD, 2009, TRENDS BIOCHEM SCI, V34, P176, DOI 10.1016/j.tibs.2008.12.008; Ikeda H, 2004, BIOCHEM J, V380, P515, DOI 10.1042/BJ20031948; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Jackson AL, 2001, MUTAT RES-FUND MOL M, V477, P7, DOI 10.1016/S0027-5107(01)00091-4; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; Khan NM, 2011, FREE RADICAL BIO MED, V51, P115, DOI 10.1016/j.freeradbiomed.2011.03.037; Kim AN, 2010, FREE RADICAL BIO MED, V49, P323, DOI 10.1016/j.freeradbiomed.2010.04.015; Klaunig JE, 2011, TOXICOL APPL PHARM, V254, P86, DOI 10.1016/j.taap.2009.11.028; Kunwar A, 2011, ARCH TOXICOL; Kwak MK, 2002, MOL CELL BIOL, V22, P2883, DOI 10.1128/MCB.22.9.2883-2892.2002; Li F, 2011, BIOCHIM BIOPHYS ACTA, V1805, P167; Li WG, 2009, MOL CARCINOGEN, V48, P91, DOI 10.1002/mc.20465; McDonald JT, 2010, CANCER RES, V70, P8886, DOI 10.1158/0008-5472.CAN-10-0171; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Muppidi Jagan, 2004, Curr Protoc Immunol, VChapter 3, DOI 10.1002/0471142735.im0317s59; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Ohta T, 2008, CANCER RES, V68, P1303, DOI 10.1158/0008-5472.CAN-07-5003; Paine A, 2011, BIOCHEM PHARMACOL, V80, P1895; Patwardhan RS, 2011, BIOCHEM PHARMACOL, V82, P642, DOI 10.1016/j.bcp.2011.06.024; Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; Rodemann HP, 2009, RADIOTHER ONCOL, V92, P293, DOI 10.1016/j.radonc.2009.08.023; Ryter SW, 2007, ANTIOXID REDOX SIGN, V9, P49, DOI 10.1089/ars.2007.9.49; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Sandur SK, 2007, FREE RADICAL BIO MED, V43, P568, DOI 10.1016/j.freeradbiomed.2007.05.009; Sandur SK, 2006, J BIOL CHEM, V281, P17023, DOI 10.1074/jbc.M601595200; Shankar B, 2003, RADIAT RES, V160, P478, DOI 10.1667/RR3050; Singh A, 2008, CANCER RES, V68, P7975, DOI 10.1158/0008-5472.CAN-08-1401; Sun Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006588; Surh YJ, 2008, PLANTA MED, V74, P1526, DOI 10.1055/s-0028-1088302; Surh YJ, 2008, GENES NUTR, V2, P313, DOI 10.1007/s12263-007-0063-0; Surh YJ, 2008, ASIA PAC J CLIN NUTR, V17, P269; Tanaka H, 2002, MOL CELL, V9, P1017, DOI 10.1016/S1097-2765(02)00522-1; Wakabayashi N, 2003, NAT GENET, V35, P238, DOI 10.1038/ng1248; Wang XJ, 2008, CARCINOGENESIS, V29, P1235, DOI 10.1093/carcin/bgn095; Willis D, 1996, NAT MED, V2, P87, DOI 10.1038/nm0196-87; Zipper LM, 2003, TOXICOL SCI, V73, P124, DOI 10.1093/toxsci/kfg083	50	23	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65929	10.1371/journal.pone.0065929	http://dx.doi.org/10.1371/journal.pone.0065929			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776571	Green Published, Green Submitted, gold			2022-12-27	WOS:000320755400083
J	Rieber, N; Zapatka, M; Lasitschka, B; Jones, D; Northcott, P; Hutter, B; Jager, N; Kool, M; Taylor, M; Lichter, P; Pfister, S; Wolf, S; Brors, B; Eils, R				Rieber, Nora; Zapatka, Marc; Lasitschka, Baerbel; Jones, David; Northcott, Paul; Hutter, Barbara; Jaeger, Natalie; Kool, Marcel; Taylor, Michael; Lichter, Peter; Pfister, Stefan; Wolf, Stephan; Brors, Benedikt; Eils, Roland			Coverage Bias and Sensitivity of Variant Calling for Four Whole-genome Sequencing Technologies	PLOS ONE			English	Article							PLATFORMS; ACCURATE; SANGER	The emergence of high-throughput, next-generation sequencing technologies has dramatically altered the way we assess genomes in population genetics and in cancer genomics. Currently, there are four commonly used whole-genome sequencing platforms on the market: Illumina's HiSeq2000, Life Technologies' SOLiD 4 and its completely redesigned 5500xl SOLiD, and Complete Genomics' technology. A number of earlier studies have compared a subset of those sequencing platforms or compared those platforms with Sanger sequencing, which is prohibitively expensive for whole genome studies. Here we present a detailed comparison of the performance of all currently available whole genome sequencing platforms, especially regarding their ability to call SNVs and to evenly cover the genome and specific genomic regions. Unlike earlier studies, we base our comparison on four different samples, allowing us to assess the between-sample variation of the platforms. We find a pronounced GC bias in GC-rich regions for Life Technologies' platforms, with Complete Genomics performing best here, while we see the least bias in GC-poor regions for HiSeq2000 and 5500xl. HiSeq2000 gives the most uniform coverage and displays the least sample-to-sample variation. In contrast, Complete Genomics exhibits by far the smallest fraction of bases not covered, while the SOLiD platforms reveal remarkable shortcomings, especially in covering CpG islands. When comparing the performance of the four platforms for calling SNPs, HiSeq2000 and Complete Genomics achieve the highest sensitivity, while the SOLiD platforms show the lowest false positive rate. Finally, we find that integrating sequencing data from different platforms offers the potential to combine the strengths of different technologies. In summary, our results detail the strengths and weaknesses of all four whole-genome sequencing platforms. It indicates application areas that call for a specific sequencing platform and disallow other platforms. This helps to identify the proper sequencing platform for whole genome studies with different application scopes.	[Rieber, Nora; Hutter, Barbara; Jaeger, Natalie; Brors, Benedikt; Eils, Roland] German Canc Res Ctr, Div Theoret Bioinformat, Heidelberg, Germany; [Zapatka, Marc; Lichter, Peter] German Canc Res Ctr, Div Mol Genet, Heidelberg, Germany; [Lasitschka, Baerbel; Wolf, Stephan] German Canc Res Ctr, High Throughput Sequencing Unit, Heidelberg, Germany; [Jones, David; Kool, Marcel; Pfister, Stefan] German Canc Res Ctr, Div Pediat Neurooncol, Heidelberg, Germany; [Northcott, Paul; Taylor, Michael] Univ Toronto, Hosp Sick Children, Res Inst, Arthur & Sonia Labatt Brain Tumor Res Ctr, Toronto, ON, Canada; [Taylor, Michael] Univ Toronto, Hosp Sick Children, Div Neurosurg, Toronto, ON, Canada; [Pfister, Stefan] Univ Heidelberg Hosp, Dept Pediat Hematol & Oncol, Heidelberg, Germany; [Eils, Roland] Heidelberg Univ, Inst Pharm & Mol Biotechnol, Dept Bioinformat & Funct Genom, Heidelberg, Germany; [Eils, Roland] Heidelberg Univ, Bioquant, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Eils, R (corresponding author), German Canc Res Ctr, Div Theoret Bioinformat, Heidelberg, Germany.	r.eils@dkfz.de	Pfister, Stefan M/F-6860-2013; Brors, Benedikt/E-5620-2013; Northcott, Paul A/N-4022-2018; Kool, Marcel/H-2541-2013; Zapatka, Marc/G-9896-2013; Jones, David T. W./Z-1963-2019; Eils, Roland/B-6121-2009	Pfister, Stefan M/0000-0002-5447-5322; Brors, Benedikt/0000-0001-5940-3101; Northcott, Paul A/0000-0002-1220-5252; Zapatka, Marc/0000-0001-8287-5967; Eils, Roland/0000-0002-0034-4036; Hutter, Barbara/0000-0002-9034-0329; Jaeger, Natalie/0000-0002-9589-7580	MedSys-Network OncoPred [0315416C]; German Federal Ministry of Education and Research (BMBF); PedBrain consortium; German Cancer Aid [109252]	MedSys-Network OncoPred; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); PedBrain consortium; German Cancer Aid(Deutsche Krebshilfe)	This work was supported by the MedSys-Network OncoPred (0315416C) funded by the German Federal Ministry of Education and Research (BMBF) and by the PedBrain consortium contributing to the International Cancer Genome Consortium, funded by German Cancer Aid (109252) and the BMBF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; Ajay SS, 2011, GENOME RES, V21, P1498, DOI 10.1101/gr.123638.111; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Benjamini Y, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks001; Cheung MS, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr425; DiGuistini S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r94; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Kircher M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-382; Kudapa H, 2012, MOL PLANT, V5, P1020, DOI 10.1093/mp/ssr111; Lam HYK, 2012, NAT BIOTECHNOL, V30, P78, DOI 10.1038/nbt.2065; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Luo CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030087; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meyerson M, 2010, NAT REV GENET, V11, P685, DOI 10.1038/nrg2841; Northcott PA, 2012, NATURE, V488, P49, DOI 10.1038/nature11327; Nothnagel M, 2011, HUM GENET, V130, P505, DOI 10.1007/s00439-011-0971-3; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Suzuki S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019534; Wang WX, 2011, SCI REP-UK, V1, DOI 10.1038/srep00055	21	53	56	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66621	10.1371/journal.pone.0066621	http://dx.doi.org/10.1371/journal.pone.0066621			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776689	Green Published, gold, Green Submitted			2022-12-27	WOS:000320755400151
J	Trentin, DS; Silva, DB; Amaral, MW; Zimmer, KR; Silva, MV; Lopes, NP; Giordani, RB; Macedo, AJ				Trentin, Danielle S.; Silva, Denise B.; Amaral, Matheus W.; Zimmer, Karine R.; Silva, Marcia V.; Lopes, Norberto P.; Giordani, Raquel B.; Macedo, Alexandre J.			Tannins Possessing Bacteriostatic Effect Impair Pseudomonas aeruginosa Adhesion and Biofilm Formation	PLOS ONE			English	Review							TOF MASS-SPECTROMETRY; POLYFLAVONOID TANNINS; BACTERIAL BIOFILMS; CONDENSED TANNINS; RESISTANCE; PLANTS; DEATH; LIFE	Plants produce many compounds that are biologically active, either as part of their normal program of growth and development or in response to pathogen attack or stress. Traditionally, Anadenanthera colubrina, Commiphora leptophloeos and Myracrodruon urundeuva have been used by communities in the Brazilian Caatinga to treat several infectious diseases. The ability to impair bacterial adhesion represents an ideal strategy to combat bacterial pathogenesis, because of its importance in the early stages of the infectious process; thus, the search for anti-adherent compounds in plants is a very promising alternative. This study investigated the ability of stem-bark extracts from these three species to control the growth and prevent biofilm formation of Pseudomonas aeruginosa, an important opportunistic pathogen that adheres to surfaces and forms protective biofilms. A kinetic study (0-72 h) demonstrated that the growth of extract-treated bacteria was inhibited up to 9 h after incubation, suggesting a bacteriostatic activity. Transmission electron microscopy and fluorescence microscopy showed both viable and nonviable cells, indicating bacterial membrane damage; crystal violet assay and scanning electron microscopy demonstrated that treatment strongly inhibited biofilm formation during 6 and 24 h and that matrix production remained impaired even after growth was restored, at 24 and 48 h of incubation. Herein, we propose that the identified (condensed and hydrolyzable) tannins are able to inhibit biofilm formation via bacteriostatic properties, damaging the bacterial membrane and hindering matrix production. Our findings demonstrate the importance of this abundant class of Natural Products in higher plants against one of the most challenging issues in the hospital setting: biofilm resilience.	[Trentin, Danielle S.; Amaral, Matheus W.; Zimmer, Karine R.; Macedo, Alexandre J.] Univ Fed Rio Grande do Sul, Fac Farm, Porto Alegre, RS, Brazil; [Trentin, Danielle S.; Zimmer, Karine R.; Macedo, Alexandre J.] Univ Fed Rio Grande do Sul, Ctr Biotecnol Estado Rio Grande Sul, Porto Alegre, RS, Brazil; [Silva, Denise B.; Lopes, Norberto P.] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, NPPNS, Sao Paulo, Brazil; [Silva, Denise B.] Lychnoflora Pesquisa & Desenvolvimento Prod Nat L, Incubadora Supera, Sao Paulo, Brazil; [Silva, Marcia V.] Univ Fed Pernambuco, Ctr Ciencias Biol, Recife, PE, Brazil; [Silva, Marcia V.] Univ Fed Pernambuco, Dept Bioquim, Recife, PE, Brazil; [Giordani, Raquel B.] Univ Fed Rio Grande do Norte, Dept Farm, Ctr Ciencias Saude, BR-59072970 Natal, RN, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade de Sao Paulo; Universidade Federal de Pernambuco; Universidade Federal de Pernambuco; Universidade Federal do Rio Grande do Norte	Macedo, AJ (corresponding author), Univ Fed Rio Grande do Sul, Fac Farm, Porto Alegre, RS, Brazil.	alexandre.macedo@ufrgs.br	Macedo, Alexandre J/C-5178-2013; da Silva, Denise Brentan/G-1460-2012; Zimmer, Karine Rigon/H-3357-2013; Trentin, Danielle/AFJ-8173-2022; Fapesp, Biota/F-8655-2017; Lopes, Norberto P/C-7148-2012; Trentin, Danielle/AAF-5027-2022; GIORDANI, RAQUEL/B-8671-2014	Macedo, Alexandre J/0000-0002-8951-4029; da Silva, Denise Brentan/0000-0003-0872-2756; Trentin, Danielle/0000-0002-8622-1052; Fapesp, Biota/0000-0002-9887-8449; Lopes, Norberto P/0000-0002-8159-3658; Trentin, Danielle/0000-0002-8622-1052; Brandt Giordani, Raquel/0000-0001-6500-0755; Dague, Etienne/0000-0003-3290-9166	FAPERGS; FAPESP; MCTI/CNPq; INCT-IF/CNPq; NANOBIOTEC-Brasil from CAPES [703/2009]	FAPERGS(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); MCTI/CNPq; INCT-IF/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NANOBIOTEC-Brasil from CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The authors acknowledge FAPERGS, FAPESP, MCTI/CNPq, INCT-IF/CNPq and NANOBIOTEC-Brasil (703/2009) from CAPES for fellowships and financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agra Maria de Fátima, 2007, Rev. bras. farmacogn., V17, P114, DOI 10.1590/S0102-695X2007000100021; Agra MF, 2007, J ETHNOPHARMACOL, V111, P383, DOI 10.1016/j.jep.2006.12.007; Bavington C, 2005, RESPIRATION, V72, P335, DOI 10.1159/000086243; Bayles KW, 2007, NAT REV MICROBIOL, V5, P721, DOI 10.1038/nrmicro1743; Behrens A, 2003, PHYTOCHEMISTRY, V62, P1159, DOI 10.1016/S0031-9422(02)00660-X; de Almeida CDCBR, 2012, PHARM BIOL, V50, P201, DOI 10.3109/13880209.2011.596205; Cegelski L, 2008, NAT REV MICROBIOL, V6, P17, DOI 10.1038/nrmicro1818; Chaieb K, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-29; CHUNG KT, 2008, CRIT REV FOOD SCI NU, V38, P421; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; da Silva VC, 2011, EUR J MASS SPECTROM, V17, P365, DOI 10.1255/ejms.1141; Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008; Siqueira CFD, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/434782; Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Lewis K, 2000, MICROBIOL MOL BIOL R, V64, P503, DOI 10.1128/MMBR.64.3.503-514.2000; Luna JM, 2011, CURR MICROBIOL, V62, P1527, DOI 10.1007/s00284-011-9889-1; Madigan M.T., 2010, MICROBIOLOGIA BROCK, V12th; Monagas M, 2010, J PHARMACEUT BIOMED, V51, P358, DOI 10.1016/j.jpba.2009.03.035; Mueller-Harvey I, 2001, ANIM FEED SCI TECH, V91, P3, DOI 10.1016/S0377-8401(01)00227-9; Noferi M, 1997, J APPL POLYM SCI, V63, P475, DOI 10.1002/(SICI)1097-4628(19970124)63:4<475::AID-APP9>3.0.CO;2-O; Pankey GA, 2004, CLIN INFECT DIS, V38, P864, DOI 10.1086/381972; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Pasch H, 2001, POLYMER, V42, P7531, DOI 10.1016/S0032-3861(01)00216-6; Radebe N, 2013, J APPL POLYM SCI, V127, P1937, DOI 10.1002/app.37568; Richards MJ, 1999, CRIT CARE MED, V27, P887, DOI 10.1097/00003246-199905000-00020; Rocha TD, 2012, PARASITOL RES, V110, P2551, DOI 10.1007/s00436-011-2798-1; Rossi F, 2011, CLIN INFECT DIS, V52, P1138, DOI 10.1093/cid/cir120; Sa NC, 2012, ARCH ORAL BIOL, V57, P550, DOI 10.1016/j.archoralbio.2011.10.016; SCALBERT A, 1991, PHYTOCHEMISTRY, V30, P3875, DOI 10.1016/0031-9422(91)83426-L; Schillaci D, 2010, J APPL MICROBIOL, V108, P17, DOI 10.1111/j.1365-2672.2009.04394.x; Schofield P, 2001, ANIM FEED SCI TECH, V91, P21, DOI 10.1016/S0377-8401(01)00228-0; Trentin DD, 2011, J ETHNOPHARMACOL, V137, P327, DOI 10.1016/j.jep.2011.05.030; WAISBREN SJ, 1980, ANTIMICROB AGENTS CH, V18, P969, DOI 10.1128/AAC.18.6.969; Wang W, 2012, PEPTIDES, V33, P212, DOI 10.1016/j.peptides.2012.01.006	35	62	64	2	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66257	10.1371/journal.pone.0066257	http://dx.doi.org/10.1371/journal.pone.0066257			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776646	Green Submitted, gold, Green Published			2022-12-27	WOS:000320755400128
J	Van de Waal, DB; John, U; Ziveri, P; Reichart, GJ; Hoins, M; Sluijs, A; Rost, B				Van de Waal, Dedmer B.; John, Uwe; Ziveri, Patrizia; Reichart, Gert-Jan; Hoins, Mirja; Sluijs, Appy; Rost, Bjoern			Ocean Acidification Reduces Growth and Calcification in a Marine Dinoflagellate	PLOS ONE			English	Article							THORACOSPHAERA-HEIMII DINOPHYCEAE; CARBON-ISOTOPE FRACTIONATION; LIFE-CYCLE; CONCENTRATING MECHANISMS; CO2; SEAWATER; WATER; LIGHT; ACID; PHYTOPLANKTON	Ocean acidification is considered a major threat to marine ecosystems and may particularly affect calcifying organisms such as corals, foraminifera and coccolithophores. Here we investigate the impact of elevated pCO(2) and lowered pH on growth and calcification in the common calcareous dinoflagellate Thoracosphaera heimii. We observe a substantial reduction in growth rate, calcification and cyst stability of T. heimii under elevated pCO(2). Furthermore, transcriptomic analyses reveal CO2 sensitive regulation of many genes, particularly those being associated to inorganic carbon acquisition and calcification. Stable carbon isotope fractionation for organic carbon production increased with increasing pCO(2) whereas it decreased for calcification, which suggests interdependence between both processes. We also found a strong effect of pCO(2) on the stable oxygen isotopic composition of calcite, in line with earlier observations concerning another T. heimii strain. The observed changes in stable oxygen and carbon isotope composition of T. heimii cysts may provide an ideal tool for reconstructing past seawater carbonate chemistry, and ultimately past pCO(2). Although the function of calcification in T. heimii remains unresolved, this trait likely plays an important role in the ecological and evolutionary success of this species. Acting on calcification as well as growth, ocean acidification may therefore impose a great threat for T. heimii.	[Van de Waal, Dedmer B.; John, Uwe; Hoins, Mirja; Rost, Bjoern] Alfred Wegener Inst Polar & Marine Res, Bremerhaven, Germany; [Van de Waal, Dedmer B.] Netherlands Inst Ecol NIOO KNAW, Dept Aquat Ecol, Wageningen, Netherlands; [Ziveri, Patrizia] Univ Autonoma Barcelona, Inst Environm Sci & Technol ICTA, E-08193 Barcelona, Spain; [Ziveri, Patrizia] Vrije Univ Amsterdam, Dept Earth Sci, Amsterdam, Netherlands; [Reichart, Gert-Jan; Hoins, Mirja; Sluijs, Appy] Univ Utrecht, Dept Earth Sci, Utrecht, Netherlands; [Reichart, Gert-Jan] Royal Netherlands Inst Sea Res NIOZ, Dept Geol, Den Hoorn, Texel, Netherlands	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Autonomous University of Barcelona; Vrije Universiteit Amsterdam; Utrecht University; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Van de Waal, DB (corresponding author), Alfred Wegener Inst Polar & Marine Res, Bremerhaven, Germany.	d.vandewaal@nioo.knaw.nl	john, uwe/S-3009-2016; Rost, Bjoern/B-4447-2015; Reichart, Gert-Jan/N-6308-2018; Van de Waal, Dedmer B/B-8002-2012; Ziveri, Patrizia/I-3856-2015; Sluijs, Appy/B-3726-2009; KNAW, NIOO-KNAW/A-4320-2012	john, uwe/0000-0002-1297-4086; Rost, Bjoern/0000-0001-5452-5505; Reichart, Gert-Jan/0000-0002-7256-2243; Van de Waal, Dedmer B/0000-0001-8803-1247; Ziveri, Patrizia/0000-0002-5576-0301; Sluijs, Appy/0000-0003-2382-0215; KNAW, NIOO-KNAW/0000-0002-3835-159X	BIOACID; German Ministry of Education and Research; European Community's Seventh Framework Programme/ERC [205150, 259627]; EC [211384, 265103]	BIOACID; German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); European Community's Seventh Framework Programme/ERC; EC(European CommissionEuropean Commission Joint Research Centre)	The work was funded by BIOACID, financed by the German Ministry of Education and Research. Furthermore, this work was supported by the European Community's Seventh Framework Programme/ERC grant agreements #205150 and #259627, and contributes to the EC FP7 projects EPOCA, grant agreement #211384, and MedSeA, grant agreement #265103. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki Y, 1998, J PHYCOL, V34, P79, DOI 10.1046/j.1529-8817.1998.340079.x; Bach LT, 2011, LIMNOL OCEANOGR, V56, P2040, DOI 10.4319/lo.2011.56.6.2040; Beaufort L, 2011, NATURE, V476, P80, DOI 10.1038/nature10295; Beck WC, 2005, GEOCHIM COSMOCHIM AC, V69, P3493, DOI 10.1016/j.gca.2005.02.003; Bemis BE, 1998, PALEOCEANOGRAPHY, V13, P150, DOI 10.1029/98PA00070; Beyenbach KW, 2006, J EXP BIOL, V209, P577, DOI 10.1242/jeb.02014; Collins S, 2004, NATURE, V431, P566, DOI 10.1038/nature02945; Dale B., 1992, DINOFLAGELLATE CONTR; DICKSON AG, 1990, J CHEM THERMODYN, V22, P113, DOI 10.1016/0021-9614(90)90074-Z; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Evitt WR, 1985, SPOROPOLLEN DINOFLAG; Freeman KH, 1992, GLOBAL BIOGEOCHEM CY, V6, P185, DOI 10.1029/92GB00190; Giordano M, 2005, ANNU REV PLANT BIOL, V56, P99, DOI 10.1146/annurev.arplant.56.032604.144052; Gussone N, 2010, EARTH PLANET SC LETT, V289, P180, DOI 10.1016/j.epsl.2009.11.006; Hildebrand-Habel T, 2000, INT J EARTH SCI, V88, P694, DOI 10.1007/s005310050298; Hoppe CJM, 2011, J EXP MAR BIOL ECOL, V406, P54, DOI 10.1016/j.jembe.2011.06.008; INOUYE I, 1983, S AFR J BOT, V2, P63, DOI 10.1016/S0022-4618(16)30147-4; Karwath B, 2000, INT J EARTH SCI, V88, P668, DOI 10.1007/s005310050296; Kohn M, 2011, PALAEOGEOGR PALAEOCL, V302, P311, DOI 10.1016/j.palaeo.2011.01.019; Kranz SA, 2010, PLANT PHYSIOL, V154, P334, DOI 10.1104/pp.110.159145; Le Quere C, 2009, NAT GEOSCI, V2, P831, DOI 10.1038/ngeo689; Lohbeck KT, 2012, NAT GEOSCI, V5, P346, DOI [10.1038/ngeo1441, 10.1038/NGEO1441]; Mackinder L, 2011, EUR J PHYCOL, V46, P142; Mackinder L, 2010, GEOMICROBIOL J, V27, P585, DOI 10.1080/01490451003703014; MCCREA JM, 1950, J CHEM PHYS, V18, P849, DOI 10.1063/1.1747785; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Meier KJS, 2007, EUR J PHYCOL, V42, P81, DOI 10.1080/09670260600937833; MOOK WG, 1974, EARTH PLANET SC LETT, V22, P169, DOI 10.1016/0012-821X(74)90078-8; Moy AD, 2009, NAT GEOSCI, V2, P276, DOI 10.1038/NGEO460; Nelson ST, 2000, RAPID COMMUN MASS SP, V14, P1044, DOI 10.1002/1097-0231(20000630)14:12<1044::AID-RCM987>3.0.CO;2-3; Paasche E, 2001, PHYCOLOGIA, V40, P503, DOI 10.2216/i0031-8884-40-6-503.1; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Pierrot D., 2006, ORNLCDIAC105A US DEP; Quinn GP, 2003, EXPT DESIGN DATA ANA; Reinfelder JR, 2011, ANNU REV MAR SCI, V3, P291, DOI 10.1146/annurev-marine-120709-142720; Riebesell U, 2000, NATURE, V407, P364, DOI 10.1038/35030078; Riebesell U, 2007, NATURE, V450, P545, DOI 10.1038/nature06267; Rokitta SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052212; Rokitta SD, 2012, LIMNOL OCEANOGR, V57, P607, DOI 10.4319/lo.2012.57.2.0607; Rost B, 2002, LIMNOL OCEANOGR, V47, P120, DOI 10.4319/lo.2002.47.1.0120; Rost B, 2008, MAR ECOL PROG SER, V373, P227, DOI 10.3354/meps07776; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Sharkey TD, 1985, INORGANIC CARBON UPT; Solomon S., 2007, PHYS SCI BASIS WORKI; Spero HJ, 1997, NATURE, V390, P497, DOI 10.1038/37333; TANGEN K, 1982, MAR MICROPALEONTOL, V7, P193, DOI 10.1016/0377-8398(82)90002-0; Taylor AR, 2012, TRENDS PLANT SCI, V17, P675, DOI 10.1016/j.tplants.2012.06.009; Taylor AR, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001085; Tortell PD, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032583; Trimborn S, 2008, PHYSIOL PLANTARUM, V133, P92, DOI 10.1111/j.1399-3054.2007.01038.x; Uehlein N, 2003, NATURE, V425, P734, DOI 10.1038/nature02027; von Dassow P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r114; Wendler I, 2002, MAR MICROPALEONTOL, V46, P1, DOI 10.1016/S0377-8398(02)00049-X; Wolf-Gladrow DA, 1999, TELLUS B, V51, P461, DOI 10.1034/j.1600-0889.1999.00023.x; Zeebe RE, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2007GC001663; Zeebe R. E., 2001, CO2 SEAWATER EQUILIB; Zeebe RE, 1999, GEOCHIM COSMOCHIM AC, V63, P2001, DOI 10.1016/S0016-7037(99)00091-5; ZHANG J, 1995, GEOCHIM COSMOCHIM AC, V59, P107, DOI 10.1016/0016-7037(95)91550-D; Ziveri P, 2012, BIOGEOSCIENCES, V9, P1025, DOI 10.5194/bg-9-1025-2012; Ziveri P, 2003, EARTH PLANET SC LETT, V210, P137, DOI 10.1016/S0012-821X(03)00101-8; Ziveri P, 2000, DEEP-SEA RES PT II, V47, P1853, DOI 10.1016/S0967-0645(00)00009-6; Zonneveld K, 2004, MAR MICROPALEONTOL, V50, P307, DOI 10.1016/S0377-8398(03)00097-5; Zonneveld KAF, 2007, MAR MICROPALEONTOL, V64, P80, DOI 10.1016/j.marmicro.2007.03.002	63	36	36	1	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65987	10.1371/journal.pone.0065987	http://dx.doi.org/10.1371/journal.pone.0065987			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776586	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000320755400093
J	Dwidar, M; Leung, BM; Yaguchi, T; Takayama, S; Mitchell, RJ				Dwidar, Mohammed; Leung, Brendan M.; Yaguchi, Toshiyuki; Takayama, Shuichi; Mitchell, Robert J.			Patterning Bacterial Communities on Epithelial Cells	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; BDELLOVIBRIO-BACTERIOVORUS; ESCHERICHIA-COLI; BIOFILM FORMATION; LARGE PLASMID; GENE-TRANSFER; SALMONELLA; VIRULENCE; COLONIZATION; RECOMBINANT	Micropatterning of bacteria using aqueous two phase system (ATPS) enables the localized culture and formation of physically separated bacterial communities on human epithelial cell sheets. This method was used to compare the effects of Escherichia coli strain MG1655 and an isogenic invasive counterpart that expresses the invasin (inv) gene from Yersinia pseudotuberculosis on the underlying epithelial cell layer. Large portions of the cell layer beneath the invasive strain were killed or detached while the non-invasive E. coli had no apparent effect on the epithelial cell layer over a 24 h observation period. In addition, simultaneous testing of the localized effects of three different bacterial species; E. coli MG1655, Shigella boydii KACC 10792 and Pseudomonas sp DSM 50906 on an epithelial cell layer is also demonstrated. The paper further shows the ability to use a bacterial predator, Bdellovibrio bacteriovorus HD 100, to selectively remove the E. coli, S. boydii and P. sp communities from this bacteria-patterned epithelial cell layer. Importantly, predation and removal of the P. Sp was critical for maintaining viability of the underlying epithelial cells. Although this paper focuses on a few specific cell types, the technique should be broadly applicable to understand a variety of bacteria-epithelial cell interactions.	[Dwidar, Mohammed; Leung, Brendan M.; Yaguchi, Toshiyuki; Takayama, Shuichi; Mitchell, Robert J.] Ulsan Natl Inst Sci & Technol, Sch Nanobiosci & Chem Engn, Ulsan, South Korea; [Yaguchi, Toshiyuki] Nagoya Inst Technol, Biomechan Lab, Showa Ku, Nagoya, Aichi, Japan; [Takayama, Shuichi] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Takayama, Shuichi] Univ Michigan, Macromol Sci & Engn Program, Ann Arbor, MI 48109 USA	Ulsan National Institute of Science & Technology (UNIST); Nagoya Institute of Technology; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Takayama, S (corresponding author), Ulsan Natl Inst Sci & Technol, Sch Nanobiosci & Chem Engn, Ulsan, South Korea.	takayama@umich.edu; esgott@unist.ac.kr	Dwidar, Mohammed/AAD-3451-2019; Mitchell, Robert J./E-9062-2010	Dwidar, Mohammed/0000-0003-1366-0393; Mitchell, Robert J./0000-0002-9608-5381; Dague, Etienne/0000-0003-3290-9166	Creativity and Innovation Project [1.120051.01]; UNIST (Ulsan National Institute of Science and Technology); WCU (World Class University) through the National Research Foundation of Korea (NRF) [R322008000200540]; Ministry of Education, Science and Technology (MEST)	Creativity and Innovation Project; UNIST (Ulsan National Institute of Science and Technology); WCU (World Class University) through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by Grant # 1.120051.01 from the Creativity and Innovation Project funded by UNIST (Ulsan National Institute of Science and Technology) and by the WCU (World Class University) program (No. R322008000200540) through the National Research Foundation of Korea (NRF) as funded by the Ministry of Education, Science and Technology (MEST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atterbury RJ, 2011, APPL ENVIRON MICROB, V77, P5794, DOI 10.1128/AEM.00426-11; Bansal T, 2007, INFECT IMMUN, V75, P4597, DOI 10.1128/IAI.00630-07; Boddicker JD, 2002, MOL MICROBIOL, V45, P1255, DOI 10.1046/j.1365-2958.2002.03121.x; Boudeau J, 1999, INFECT IMMUN, V67, P4499, DOI 10.1128/IAI.67.9.4499-4509.1999; Byun CK, 2013, J AM CHEM SOC, V135, P2242, DOI 10.1021/ja3094923; Canny GO, 2008, INFECT IMMUN, V76, P3360, DOI 10.1128/IAI.00187-08; Courvalin P, 1995, CR ACAD SCI III-VIE, V318, P1207; Critchley R, 2004, GENE THER, V11, P1224, DOI 10.1038/sj.gt.3302281; Dashiff A, 2011, J APPL MICROBIOL, V110, P431, DOI 10.1111/j.1365-2672.2010.04900.x; Dwidar M, 2012, BMB REP, V45, P71, DOI 10.5483/BMBRep.2012.45.2.71; Elliott N, 2011, INTEGR BIOL-UK, V3, P696, DOI 10.1039/c0ib00137f; Esteves CLC, 2005, INFECT IMMUN, V73, P5198, DOI 10.1128/IAI.73.8.5198-5203.2005; Fang Y, 2012, TISSUE ENG PART C-ME, V18, P647, DOI [10.1089/ten.tec.2011.0709, 10.1089/ten.TEC.2011.0709]; Feng WJ, 2003, ANAL CHEM, V75, P4148, DOI 10.1021/ac0343127; Frampton JP, 2013, JOVE-J VIS EXP, DOI 10.3791/50304; Frampton JP., 2013, ADV HEALTHC MAT MEDL, DOI [10.1002/adhm. 201300049, DOI 10.1002/ADHM.201300049.PUBMED:23592706.PUBMED:23592706]; Grillot-Courvalin C, 1998, NAT BIOTECHNOL, V16, P862, DOI 10.1038/nbt0998-862; Kadouri D, 2005, APPL ENVIRON MICROB, V71, P4044, DOI 10.1128/AEM.71.7.4044-4051.2005; Kadouri D, 2007, APPL ENVIRON MICROB, V73, P605, DOI 10.1128/AEM.01893-06; Kim J, 2010, LAB CHIP, V10, P43, DOI 10.1039/b911367c; Lee JH, 2010, FEMS MICROBIOL REV, V34, P426, DOI 10.1111/j.1574-6976.2009.00204.x; LENZ RW, 1978, ARCH MICROBIOL, V119, P245, DOI 10.1007/BF00405402; Monnappa AK, 2013, SOIL BIOL BIOCHEM, V57, P427, DOI 10.1016/j.soilbio.2012.09.010; PAL T, 1989, INFECT IMMUN, V57, P2580; Pawelek JM, 1997, CANCER RES, V57, P4537; SASAKAWA C, 1992, CURR TOP MICROBIOL, V180, P21; SASAKAWA C, 1986, INFECT IMMUN, V51, P470, DOI 10.1128/IAI.51.2.470-475.1986; Schmid-Hempel P, 2007, PLOS PATHOG, V3, P1372, DOI 10.1371/journal.ppat.0030147; Schwudke D, 2003, J BIOL CHEM, V278, P27502, DOI 10.1074/jbc.M303012200; Sockett RE, 2004, NAT REV MICROBIOL, V2, P669, DOI 10.1038/nrmicro959; Sperandio V, 2003, P NATL ACAD SCI USA, V100, P8951, DOI 10.1073/pnas.1537100100; STOLP H, 1963, ANTON VAN LEE J M S, V29, P217, DOI 10.1007/BF02046064; TAKAHASHI K, 1988, MICROBIOL IMMUNOL, V32, P221, DOI 10.1111/j.1348-0421.1988.tb01380.x; Tavana H, 2009, NAT MATER, V8, P736, DOI [10.1038/NMAT2515, 10.1038/nmat2515]; Tavana H, 2010, ADV MATER, V22, P2628, DOI 10.1002/adma.200904271; TOBE T, 1992, J BACTERIOL, V174, P6359, DOI 10.1128/JB.174.20.6359-6367.1992; Tomlin KL, 2004, J MICROBIOL METH, V57, P95, DOI 10.1016/j.mimet.2003.12.007; Uliczka F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002117; Wang X, 2006, CELL MOL LIFE SCI, V63, P2352, DOI 10.1007/s00018-006-6222-4; WESTERGAARD JM, 1977, APPL ENVIRON MICROB, V34, P506, DOI 10.1128/AEM.34.5.506-511.1977; Xavier KB, 2003, CURR OPIN MICROBIOL, V6, P191, DOI 10.1016/S1369-5274(03)00028-6; Yaguchi T, 2012, BIOMACROMOLECULES, V13, P2655, DOI 10.1021/bm300500y; Yaguchi T, 2010, ANALYST, V135, P2848, DOI 10.1039/c0an00464b	43	25	25	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e67165	10.1371/journal.pone.0067165	http://dx.doi.org/10.1371/journal.pone.0067165			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785519	Green Published, gold, Green Submitted			2022-12-27	WOS:000321038800005
J	He, LN; Yang, ZH; Zhao, ZH; Lin, HF; Li, YP				He, Linna; Yang, Zhihao; Zhao, Zhehuan; Lin, Hongfei; Li, Yanpeng			Extracting Drug-Drug Interaction from the Biomedical Literature Using a Stacked Generalization-Based Approach	PLOS ONE			English	Article							KERNELS; ISSUES	Drug-drug interaction (DDI) detection is particularly important for patient safety. However, the amount of biomedical literature regarding drug interactions is increasing rapidly. Therefore, there is a need to develop an effective approach for the automatic extraction of DDI information from the biomedical literature. In this paper, we present a Stacked Generalization-based approach for automatic DDI extraction. The approach combines the feature-based, graph and tree kernels and, therefore, reduces the risk of missing important features. In addition, it introduces some domain knowledge based features (the keyword, semantic type, and DrugBank features) into the feature-based kernel, which contribute to the performance improvement. More specifically, the approach applies Stacked generalization to automatically learn the weights from the training data and assign them to three individual kernels to achieve a much better performance than each individual kernel. The experimental results show that our approach can achieve a better performance of 69.24% in F-score compared with other systems in the DDI Extraction 2011 challenge task.	[He, Linna; Yang, Zhihao; Zhao, Zhehuan; Lin, Hongfei; Li, Yanpeng] Dalian Univ Technol, Sch Comp Sci & Technol, Dalian, Peoples R China	Dalian University of Technology	Yang, ZH (corresponding author), Dalian Univ Technol, Sch Comp Sci & Technol, Dalian, Peoples R China.	yangzh@dlut.edu.cn			Natural Science Foundation of China [61070098, 61272373]; Fundamental Research Funds for the Central Universities [DUT13JB09]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work is supported by grants from the Natural Science Foundation of China (No. 61070098 and 61272373, http://www.nsfc.gov.cn/Portal0/default152.htm) and the Fundamental Research Funds for the Central Universities (No. DUT13JB09, http://www.moe.edu.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAMODT A, 1994, AI COMMUN, V7, P39; Aiken LS., 2003, HDB PSYCHOL, P481; Airola A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S11-S2; Bartlett P. J., 2000, ADV LARGE MARGIN CLA; Bjorne J., 2011, P DDIEXTRACTION 2011, P35; Blasco SG, 2011, CEUR WORKSHOP P, V761, P51; Breiman L, 1996, MACH LEARN, V24, P49; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; Breiman L., 1996, BIAS VARIANCE ARCING; Bunescu RC, 2005, P C HUM LANG TECHN E, P724, DOI DOI 10.3115/1220575.1220666; Chowdhury M., 2011, P 1 CHALL TASK DRUG, P27; Chowdhury M.F.M., 2011, P BIONLP 2011 WORKSH, P124; Collins M, 2002, ADV NEUR IN, V14, P625; Culotta A, 2004, P 42 ANN M ASS COMP, P423, DOI [10.3115/1218955.1219009, DOI 10.3115/1218955.1219009]; Fayruzov T, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-374; Giuliano C., 2006, P 11 C EUR CHAPT ASS, P401; Kim S, 2008, BIOINFORMATICS, V24, P118, DOI 10.1093/bioinformatics/btm544; Minard A L, 2011, CHALLENGE TASK DRUG; Miwa M, 2009, INT J MED INFORM, V78, pE39, DOI 10.1016/j.ijmedinf.2009.04.010; Mooney RJ, 2006, ADV NEURAL INFORM PR, P171; Moschitti A, 2006, P 11 C EUR CHAPT ASS, P113; Moschitti A., 2004, P 42 ANN M ASS COMP; Neves ML, 2009, P BIONLP 2009 WORKSH, P68; Rodriguez-Terol A, 2009, Farm Hosp, V33, P134; SAETRE R, 2008, P 2 INT S LANG BIOL; Segura-Bedmar I., 2011, CHALLENGE TASK DRUG, P1; Segura-Bedmar I, 2011, J BIOMED INFORM, V44, P789, DOI 10.1016/j.jbi.2011.04.005; Segura-Bedmar I, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S2-S1; Thomas P., 2011, P 1 CHALL TASK DRUG, P11; Tikk D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000837; Ting KM, 1999, J ARTIF INTELL RES, V10, P271, DOI 10.1613/jair.594; Vapnik V., 1998, STAT LEARNING THEORY; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; WOLPERT DH, 1992, NEURAL NETWORKS, V5, P241, DOI 10.1016/S0893-6080(05)80023-1; Xiao J, 2005, P S SEM MIN BIOM, P51; Yang ZH, 2011, PROTEOMICS, V11, P3811, DOI 10.1002/pmic.201100188; Yang ZH, 2011, ARTIF INTELL MED, V51, P163, DOI 10.1016/j.artmed.2010.12.002; Zweigenbaum P, 2007, BRIEF BIOINFORM, V8, P358, DOI 10.1093/bib/bbm045	38	34	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65814	10.1371/journal.pone.0065814	http://dx.doi.org/10.1371/journal.pone.0065814			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785452	Green Published, gold			2022-12-27	WOS:000321038800070
J	Manocheewa, S; Swain, JV; Lanxon-Cookson, E; Rolland, M; Mullins, JI				Manocheewa, Siriphan; Swain, J. Victor; Lanxon-Cookson, Erinn; Rolland, Morgane; Mullins, James I.			Fitness Costs of Mutations at the HIV-1 Capsid Hexamerization Interface	PLOS ONE			English	Article							T-CELL RESPONSES; REPLICATION; PROTEIN; CORE; DIVERSITY	The recently available x-ray crystal structure of HIV-1 capsid hexamers has provided insight into the molecular interactions crucial for the virus's mature capsid formation. Amino acid changes at these interaction points are likely to have a strong impact on capsid functionality and, hence, viral infectivity and replication fitness. To test this hypothesis, we introduced the most frequently observed single amino acid substitution at 30 sites: 12 at the capsid hexamerization interface and 18 at non-interface sites. Mutations at the interface sites were more likely to be lethal (Fisher's exact test p = 0.027) and had greater negative impact on viral replication fitness (Wilcoxon rank sum test p = 0.040). Among the interface mutations studied, those located in the cluster of hydrophobic contacts at NTD-NTD interface and those that disrupted NTD-CTD inter-domain helix capping hydrogen bonds were the most detrimental, indicating that these interactions are particularly important for maintaining capsid structure and/or function. These functionally constrained sites provide potential targets for novel HIV drug development and vaccine immunogen design.	[Manocheewa, Siriphan; Swain, J. Victor; Lanxon-Cookson, Erinn; Rolland, Morgane; Mullins, James I.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Mullins, JI (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.	jmullins@uw.edu			U.S. Public Health Service [AI47734, AI57005]; University of Washington Center for AIDS Research Computational Biology Core [AI27757]; Bill and Melinda Gates Foundation [43437]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047734, P30AI027757, P01AI057005, R37AI047734] Funding Source: NIH RePORTER	U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); University of Washington Center for AIDS Research Computational Biology Core; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the U.S. Public Health Service to JIM (AI47734 and AI57005), the University of Washington Center for AIDS Research Computational Biology Core (AI27757), and the Bill and Melinda Gates Foundation (43437). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TM, 2005, J VIROL, V79, P13239, DOI 10.1128/JVI.79.21.13239-13249.2005; Bailey GD, 2012, J MOL BIOL, V417, P212, DOI 10.1016/j.jmb.2012.01.014; Bartonova V, 2008, J BIOL CHEM, V283, P32024, DOI 10.1074/jbc.M804230200; Berthet-Colominas C, 1999, EMBO J, V18, P1124, DOI 10.1093/emboj/18.5.1124; Bocanegra R, 2012, VIRUS RES; Briggs JAG, 2003, EMBO J, V22, P1707, DOI 10.1093/emboj/cdg143; Carlson JM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000225; Deng WJ, 2010, BIOTECHNIQUES, V48, P405, DOI 10.2144/000113370; Forshey BM, 2002, J VIROL, V76, P5667, DOI 10.1128/JVI.76.11.5667-5677.2002; Ganser BK, 1999, SCIENCE, V283, P80, DOI 10.1126/science.283.5398.80; Ganser-Pornillos BK, 2008, CURR OPIN STRUC BIOL, V18, P203, DOI 10.1016/j.sbi.2008.02.001; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Laskowski RA, 2009, NUCLEIC ACIDS RES, V37, pD355, DOI 10.1093/nar/gkn860; LIU Y, 2012, J VIROL MET IN PRESS; Liu Y, 2006, J VIROL, V80, P9519, DOI 10.1128/JVI.00575-06; Ma JM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-261; Maddison WP, 2011, MESQUITE MODULAR SYS; McClure J, 2007, JAIDS-J ACQ IMM DEF, V44, P254, DOI 10.1097/QAI.0b013e318030f5c5; Mothe B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029717; Mothe B, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-208; Nickle DC, 2003, SCIENCE, V299, P1515; Niu LG, 2011, VACCINE, V29, P2110, DOI 10.1016/j.vaccine.2010.12.131; Pornillos O, 2011, NATURE, V469, P424, DOI 10.1038/nature09640; Pornillos O, 2009, CELL, V137, P1282, DOI 10.1016/j.cell.2009.04.063; REED L. J., 1938, AMER JOUR HYG, V27, P493; ROLLAND M, 2013, J VIROL; Rolland M, 2007, PLOS PATHOG, V3, P1551, DOI 10.1371/journal.ppat.0030157; Rolland M, 2007, J VIROL, V81, P8507, DOI 10.1128/JVI.02683-06; Tang SX, 2001, J VIROL, V75, P9357, DOI 10.1128/JVI.75.19.9357-9366.2001; Troyer RM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000365; von Schwedler UK, 2003, J VIROL, V77, P5439, DOI 10.1128/JVI.77.9.5439-5450.2003; Wu HL, 2006, J VIROL, V80, P2380, DOI 10.1128/JVI.80.5.2380-2389.2006	33	20	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66065	10.1371/journal.pone.0066065	http://dx.doi.org/10.1371/journal.pone.0066065			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785468	Green Published, Green Submitted, gold			2022-12-27	WOS:000321038800054
J	van de Pasch, LAL; Miles, AJ; Nijenhuis, W; Brabers, NACH; van Leenen, D; Lijnzaad, P; Brown, MK; Ouellet, J; Barral, Y; Kops, GJPL; Holstege, FCP				van de Pasch, Loes A. L.; Miles, Antony J.; Nijenhuis, Wilco; Brabers, Nathalie A. C. H.; van Leenen, Dik; Lijnzaad, Philip; Brown, Markus K.; Ouellet, Jimmy; Barral, Yves; Kops, Geert J. P. L.; Holstege, Frank C. P.			Centromere Binding and a Conserved Role in Chromosome Stability for SUMO-Dependent Ubiquitin Ligases	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; KINETOCHORE PROTEIN; SUMOYLATION; RNF4; LOCALIZATION; ANAPHASE; SLX5; DEGRADATION; DISSECTION; REGULATOR	The Saccharomyces cerevisiae Slx5/8 complex is the founding member of a recently defined class of SUMO-targeted ubiquitin ligases (STUbLs). Slx5/8 has been implicated in genome stability and transcription, but the precise contribution is unclear. To characterise Slx5/8 function, we determined genome-wide changes in gene expression upon loss of either subunit. The majority of mRNA changes are part of a general stress response, also exhibited by mutants of other genome integrity pathways and therefore indicative of an indirect effect on transcription. Genome-wide binding analysis reveals a uniquely centromeric location for Slx5. Detailed phenotype analyses of slx5 Delta and slx8 Delta mutants show severe mitotic defects that include aneuploidy, spindle mispositioning, fish hooks and aberrant spindle kinetics. This is associated with accumulation of the PP2A regulatory subunit Rts1 at centromeres prior to entry into anaphase. Knockdown of the human STUbL orthologue RNF4 also results in chromosome segregation errors due to chromosome bridges. The study shows that STUbLs have a conserved role in maintenance of chromosome stability and links SUMO-dependent ubiquitination to a centromere-specific function during mitosis.	[van de Pasch, Loes A. L.; Miles, Antony J.; Nijenhuis, Wilco; Brabers, Nathalie A. C. H.; van Leenen, Dik; Lijnzaad, Philip; Brown, Markus K.; Kops, Geert J. P. L.; Holstege, Frank C. P.] Univ Med Ctr Utrecht, Mol Canc Res, Utrecht, Netherlands; [Ouellet, Jimmy; Barral, Yves] ETH Honggerberg, Swiss Fed Inst Technol, Inst Biochem, CH-8093 Zurich, Switzerland	Utrecht University; Utrecht University Medical Center; Swiss Federal Institutes of Technology Domain; ETH Zurich	Holstege, FCP (corresponding author), Univ Med Ctr Utrecht, Mol Canc Res, Univ Weg 100, Utrecht, Netherlands.	f.c.p.holstege@umcutrecht.nl	Holstege, Frank/AAM-9944-2021; Lijnzaad, Philip/ABE-4205-2021	Lijnzaad, Philip/0000-0002-7535-583X; Barral, Yves/0000-0002-0989-3373; Ouellet, Jimmy/0000-0002-0215-7023; Kops, Geert/0000-0003-3555-5295	Netherlands Bioinformatics Centre (NBIC); Netherlands Organization of Scientific Research (NWO) [016.108.607, 817.02.015, 050.71.057, 911.06.009]	Netherlands Bioinformatics Centre (NBIC); Netherlands Organization of Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was funded by the Netherlands Bioinformatics Centre (NBIC) and the Netherlands Organization of Scientific Research (NWO), grants 016.108.607, 817.02.015, 050.71.057, 911.06.009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Burgess RC, 2007, MOL CELL BIOL, V27, P6153, DOI 10.1128/MCB.00787-07; Caydasi AK, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-28; Chan LY, 2009, GENE DEV, V23, P1639, DOI 10.1101/gad.1804609; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Cook CE, 2009, CELL CYCLE, V8, P1080, DOI 10.4161/cc.8.7.8123; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Darst RP, 2008, MOL CELL BIOL, V28, P1361, DOI 10.1128/MCB.01291-07; Dobbelaere J, 2003, DEV CELL, V4, P345, DOI 10.1016/S1534-5807(03)00061-3; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gentry MS, 2002, MOL BIOL CELL, V13, P3477, DOI 10.1091/mbc.02-05-0065; GOH PY, 1993, J CELL BIOL, V121, P503, DOI 10.1083/jcb.121.3.503; Grava S, 2006, DEV CELL, V10, P425, DOI 10.1016/j.devcel.2006.02.018; Guo BQ, 2009, MOL CELL BIOL, V29, P3204, DOI 10.1128/MCB.01128-08; HIETER P, 1985, CELL, V40, P381, DOI 10.1016/0092-8674(85)90152-7; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Hughes TR, 2000, NAT GENET, V25, P333, DOI 10.1038/77116; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Hyland KM, 1999, J CELL BIOL, V145, P15, DOI 10.1083/jcb.145.1.15; Ii T, 2007, CELL CYCLE, V6, P2800, DOI 10.4161/cc.6.22.4882; Indjeian VB, 2005, SCIENCE, V307, P130, DOI 10.1126/science.1101366; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kosoy A, 2007, J BIOL CHEM, V282, P20388, DOI 10.1074/jbc.M702652200; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Lenstra TL, 2011, MOL CELL, V42, P536, DOI 10.1016/j.molcel.2011.03.026; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; MacIsaac KD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-113; Margaritis T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.21; Martin N, 2009, EMBO J, V28, P3534, DOI 10.1038/emboj.2009.279; MartinezPastor MT, 1996, EMBO J, V15, P2227, DOI 10.1002/j.1460-2075.1996.tb00576.x; McAinsh AD, 2003, ANNU REV CELL DEV BI, V19, P519, DOI 10.1146/annurev.cellbio.19.111301.155607; Montpetit B, 2006, J CELL BIOL, V174, P653, DOI 10.1083/jcb.200605019; Mukhopadhyay D, 2010, J CELL BIOL, V188, P681, DOI 10.1083/jcb.200909008; Mullen JR, 2001, GENETICS, V157, P103; Nagai S, 2008, SCIENCE, V322, P597, DOI 10.1126/science.1162790; Neurohr G, 2011, SCIENCE, V332, P465, DOI 10.1126/science.1201578; Nixon CE, 2010, GENETICS, V185, P497, DOI 10.1534/genetics.110.115907; Perry JJP, 2008, TRENDS BIOCHEM SCI, V33, P201, DOI 10.1016/j.tibs.2008.02.001; Prudden J, 2007, EMBO J, V26, P4089, DOI 10.1038/sj.emboj.7601838; Riedel CG, 2006, NATURE, V441, P53, DOI 10.1038/nature04664; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; SPENCER F, 1990, GENETICS, V124, P237; Straight AF, 1997, SCIENCE, V277, P574, DOI 10.1126/science.277.5325.574; Sun H, 2007, EMBO J, V26, P4102, DOI 10.1038/sj.emboj.7601839; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Tsalik EL, 1998, YEAST, V14, P847, DOI 10.1002/(SICI)1097-0061(19980630)14:9<847::AID-YEA285>3.0.CO;2-9; Uzunova K, 2007, J BIOL CHEM, V282, P34167, DOI 10.1074/jbc.M706505200; van Bakel H, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1144; van Hagen M, 2010, NUCLEIC ACIDS RES, V38, P1922, DOI 10.1093/nar/gkp1157; van Wageningen S, 2010, CELL, V143, P991, DOI 10.1016/j.cell.2010.11.021; van Werven FJ, 2008, GENE DEV, V22, P2359, DOI 10.1101/gad.1682308; Vizeacoumar FJ, 2010, J CELL BIOL, V188, P69, DOI 10.1083/jcb.200909013; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Wang Z, 2009, MOL CELL BIOL, V29, P1694, DOI 10.1128/MCB.01470-08; Xie Y, 2007, J BIOL CHEM, V282, P34176, DOI 10.1074/jbc.M706025200; Zhang CY, 2006, DNA REPAIR, V5, P336, DOI 10.1016/j.dnarep.2005.10.010; Zhao Y, 1997, J BIOL CHEM, V272, P8256, DOI 10.1074/jbc.272.13.8256	59	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65628	10.1371/journal.pone.0065628	http://dx.doi.org/10.1371/journal.pone.0065628			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785440	Green Published, Green Submitted, gold			2022-12-27	WOS:000321038800084
J	Ioannidis, JPA; Chang, CQ; Lam, TK; Schully, SD; Khoury, MJ				Ioannidis, John P. A.; Chang, Christine Q.; Lam, Tram Kim; Schully, Sheri D.; Khoury, Muin J.			The Geometric Increase in Meta-Analyses from China in the Genomic Era	PLOS ONE			English	Article							WIDE ASSOCIATION; KNOWLEDGE INTEGRATION; GENETIC ASSOCIATIONS; CONTROLLED-TRIALS; COMMON DISEASES; COMPLEX TRAITS; EPIDEMIOLOGY; BIAS; POLYMORPHISMS; REPLICATION	Meta-analyses are increasingly popular. It is unknown whether this popularity is driven by specific countries and specific meta-analyses types. PubMed was used to identify meta-analyses since 1995 (last update 9/1/2012) and catalogue their types and country of origin. We focused more on meta-analyses from China (the current top producer of meta-analyses) versus the USA (top producer until recently). The annual number of meta-analyses from China increased 40-fold between 2003 and 2011 versus 2.4-fold for the USA. The growth of Chinese meta-analyses was driven by genetics (110-fold increase in 2011 versus 2003). The HuGE Navigator identified 612 meta-analyses of genetic association studies published in 2012 from China versus only 109 from the USA. We compared in-depth 50 genetic association meta-analyses from China versus 50 from USA in 2012. Meta-analyses from China almost always used only literature-based data (92%), and focused on one or two genes (94%) and variants (78%) identified with candidate gene approaches (88%), while many USA meta-analyses used genome-wide approaches and raw data. Both groups usually concluded favorably for the presence of genetic associations (80% versus 74%), but nominal significance (P<0.05) typically sufficed in the China group. Meta-analyses from China typically neglected genome-wide data, and often included candidate gene studies published in Chinese-language journals. Overall, there is an impressive rise of meta-analyses from China, particularly on genetic associations. Since most claimed candidate gene associations are likely false-positives, there is an urgent global need to incorporate genome-wide data and state-of-the art statistical inferences to avoid a flood of false-positive genetic meta-analyses.	[Ioannidis, John P. A.; Chang, Christine Q.; Lam, Tram Kim; Schully, Sheri D.; Khoury, Muin J.] NCI, Epidemiol & Genom Res Program, Div Canc Control & Populat Sci, NIH, Bethesda, MD 20892 USA; [Ioannidis, John P. A.] Stanford Univ, Sch Med, Stanford Prevent Res Ctr, Dept Med, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Sch Humanities & Sci, Dept Stat, Stanford, CA 94305 USA; [Khoury, Muin J.] Ctr Dis Control & Prevent, Off Publ Hlth Genom, Atlanta, GA USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Stanford University; Stanford University; Stanford University; Centers for Disease Control & Prevention - USA	Ioannidis, JPA (corresponding author), NCI, Epidemiol & Genom Res Program, Div Canc Control & Populat Sci, NIH, Bethesda, MD 20892 USA.	jioannid@stanford.edu	Ioannidis, John P. A./G-9836-2011					Barrett JC, 2006, NAT GENET, V38, P659, DOI 10.1038/ng1801; Chabris CF, 2012, PSYCHOL SCI, V23, P1314, DOI 10.1177/0956797611435528; Chen K, 2005, WORLD J GASTROENTERO, V11, P331, DOI 10.3748/wjg.v11.i3.331; Cyranoski D, 2011, NATURE, V469, P455, DOI 10.1038/469455a; Cyranoski D, 2010, NATURE, V467, P380, DOI 10.1038/467380a; DUPONT WD, 1990, CONTROL CLIN TRIALS, V11, P116, DOI 10.1016/0197-2456(90)90005-M; Egger E, 1997, LANCET, V350, P326, DOI 10.1016/S0140-6736(97)02419-7; He Han-Qing, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P992; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Ioannidis JPA, 2008, INT J EPIDEMIOL, V37, P120, DOI 10.1093/ije/dym159; Ioannidis JPA, 2011, EPIDEMIOLOGY, V22, P450, DOI 10.1097/EDE.0b013e31821b506e; Ioannidis JPA, 1998, LANCET, V352, P590, DOI 10.1016/S0140-6736(98)22034-4; Juni P, 2002, INT J EPIDEMIOL, V31, P115, DOI 10.1093/ije/31.1.115; Khoury MJ, 2012, GENET MED, V14, P643, DOI 10.1038/gim.2012.43; Khoury MJ, 2009, AM J EPIDEMIOL, V170, P269, DOI 10.1093/aje/kwp119; Li Hong-tao, 2006, Zhonghua Liu Xing Bing Xue Za Zhi, V27, P428; Li HT, 2006, INT J TUBERC LUNG D, V10, P3; Lill CM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002548; Liu YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028130; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Morgan TM, 2007, JAMA-J AM MED ASSOC, V297, P1551, DOI 10.1001/jama.297.14.1551; Ntzani EE, 2007, AM J EPIDEMIOL, V165, P973, DOI 10.1093/aje/kwk085; Pan ZL, 2005, PLOS MED, V2, P1309, DOI 10.1371/journal.pmed.0020334; Patsopoulos NA, 2005, JAMA-J AM MED ASSOC, V293, P2362, DOI 10.1001/jama.293.19.2362; Philippi S, 2008, BRIEF BIOINFORM, V9, P451, DOI 10.1093/bib/bbn046; Seminara D, 2007, EPIDEMIOLOGY, V18, P1, DOI 10.1097/01.ede.0000249540.17855.b7; Siontis KCM, 2010, EUR J HUM GENET, V18, P832, DOI 10.1038/ejhg.2010.26; Stone R, 2009, SCIENCE, V323, P1417, DOI 10.1126/science.323.5920.1417; Thompson M., 2012, FRAMEWORK FACILITATE; Vickers A, 1998, CONTROL CLIN TRIALS, V19, P159, DOI 10.1016/S0197-2456(97)00150-5; Wu TX, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-46; Yu W, 2008, NAT GENET, V40, P124, DOI 10.1038/ng0208-124; Zhang DL, 2011, J CLIN EPIDEMIOL, V64, P90, DOI 10.1016/j.jclinepi.2010.02.010	35	37	37	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65602	10.1371/journal.pone.0065602	http://dx.doi.org/10.1371/journal.pone.0065602			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776510	Green Published, Green Submitted, gold			2022-12-27	WOS:000320322400037
J	Qin, ZZ; Wang, YR; Cao, SY; He, YS; Ma, HX; Jin, GF; Hu, ZB; Guan, XX; Shen, HB				Qin, Zhenzhen; Wang, Yanru; Cao, Songyu; He, Yisha; Ma, Hongxia; Jin, Guangfu; Hu, Zhibin; Guan, Xiaoxiang; Shen, Hongbing			Genetic Variants at 12p11 and 12q24 Are Associated with Breast Cancer Risk in a Chinese Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; COMMON VARIANTS; CONFER SUSCEPTIBILITY; LOCUS; ALLELES; 9Q31.2; 9P21; ASIA	Background: A recent genome-wide association study (GWAS) has identified three new breast cancer susceptibility loci at 12p11, 12q24 and 21q21 in populations of European descent. However, because of the genetic heterogeneity, it is largely unknown for the role of these loci in the breast cancer susceptibility in the populations of non-European descent. Methodology/Principal Findings: Here, we genotyped three variants (rs10771399 at 12p11, rs1292011 at 12q24 and rs2823093 at 21q21) in an independent case-control study with a total of 1792 breast cancer cases and 1867 cancer-free controls in a Chinese population. We found that rs10771399 and rs1292011 were significantly associated with risk of breast cancer with per-allele odds ratios (ORs) of 0.85 (95% confidence interval (CI): 0.76-0.96; P = 0.010) and 0.84 (95% CI: 0.76-0.95; P = 4.50x10(-3)), respectively, which was consistent with those reported in populations of European descent. Similar effects were observed between ER/PR positive and negative breast cancer for both loci. However, we did not found significant association between rs2823093 and breast cancer risk (OR = 0.97, 95% CI = 0.76-1.24; P = 0.795). Conclusions/Significance: Our results indicate that genetic variants at 12p11 and 12q24 may also play an important role in breast cancer development in Chinese women.	[Qin, Zhenzhen; Ma, Hongxia; Jin, Guangfu; Hu, Zhibin; Shen, Hongbing] Nanjing Med Univ, Inst Toxicol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Qin, Zhenzhen; Cao, Songyu; He, Yisha; Ma, Hongxia; Jin, Guangfu; Hu, Zhibin; Shen, Hongbing] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, MOE Key Lab Modern Toxicol, Nanjing, Jiangsu, Peoples R China; [Qin, Zhenzhen; Ma, Hongxia; Jin, Guangfu; Hu, Zhibin; Shen, Hongbing] Nanjing Med Univ, Ctr Canc, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Clin Epidemiol Sect, Nanjing, Jiangsu, Peoples R China; [Wang, Yanru; Guan, Xiaoxiang] Southern Med Univ, Jinling Hosp, Dept Med Oncol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Southern Medical University - China	Shen, HB (corresponding author), Southern Med Univ, Jinling Hosp, Dept Med Oncol, Nanjing, Jiangsu, Peoples R China.	xxguan@hotmail.com; hbshen@njmu.edu.cn		Guan, Xiaoxiang/0000-0001-6145-0046	National Natural Science Foundation of China [81071715, 81102179]; Key Project of the National Natural Science Foundation of China [81230067]; Program for Changjiang Scholars and Innovative Research Team in University [IRT0631]; Young Talents Support Program from the Organization Department of the CPC Central Committee; Priority Academic Program for the Development of Jiangsu Higher Education Institutions [Public Health and Preventive Medicine]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Young Talents Support Program from the Organization Department of the CPC Central Committee; Priority Academic Program for the Development of Jiangsu Higher Education Institutions [Public Health and Preventive Medicine]	This work was supported in part by National Natural Science Foundation of China (81071715; 81102179); Key Project of the National Natural Science Foundation of China (81230067); The Program for Changjiang Scholars and Innovative Research Team in University (IRT0631), The Young Talents Support Program from the Organization Department of the CPC Central Committee and the Priority Academic Program for the Development of Jiangsu Higher Education Institutions [Public Health and Preventive Medicine]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2009, NAT GENET, V41, P585, DOI 10.1038/ng.354; Antoniou AC, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3121; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Cai QY, 2011, HUM MOL GENET, V20, P4991, DOI 10.1093/hmg/ddr405; Chen JP, 2012, BREAST CANCER RES TR, V132, P741, DOI 10.1007/s10549-011-1927-y; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Fletcher O, 2011, JNCI-J NATL CANCER I, V103, P425, DOI 10.1093/jnci/djq563; Ghoussaini M, 2012, NAT GENET, V44, P312, DOI 10.1038/ng.1049; Gold B, 2008, P NATL ACAD SCI USA, V105, P4340, DOI 10.1073/pnas.0800441105; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kakonen SM, 2003, CANCER-AM CANCER SOC, V97, P834, DOI 10.1002/cncr.11132; Long JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001002; Long N, 2010, ASIAN PAC J CANCER P, V11, P107; Porter P, 2008, NEW ENGL J MED, V358, P213, DOI 10.1056/NEJMp0708307; Stacey SN, 2008, NAT GENET, V40, P703, DOI 10.1038/ng.131; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; SUVA LJ, 1987, SCIENCE, V237, P893, DOI 10.1126/science.3616618; Thomas G, 2009, NAT GENET, V41, P579, DOI 10.1038/ng.353; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586; Zheng W, 2013, HUM MOL GENET   0327, V27; Zheng W, 2009, NAT GENET, V41, P324, DOI 10.1038/ng.318	22	5	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66519	10.1371/journal.pone.0066519	http://dx.doi.org/10.1371/journal.pone.0066519			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776684	gold, Green Published, Green Submitted			2022-12-27	WOS:000320322400109
J	Thyagarajan, B; Wang, R; Nelson, H; Barcelo, H; Koh, WP; Yuan, JM				Thyagarajan, Bharat; Wang, Renwei; Nelson, Heather; Barcelo, Helene; Koh, Woon-Puay; Yuan, Jian-Min			Mitochondrial DNA Copy Number Is Associated with Breast Cancer Risk	PLOS ONE			English	Article							OXIDATIVE STRESS; D-LOOP; MUTATIONS; CELLS; TRANSCRIPTION; DEPLETION; DECREASE; INCREASE; SAMPLES	Mitochondrial DNA (mtDNA) copy number in peripheral blood is associated with increased risk of several cancers. However, data from prospective studies on mtDNA copy number and breast cancer risk are lacking. We evaluated the association between mtDNA copy number in peripheral blood and breast cancer risk in a nested case-control study of 183 breast cancer cases with pre-diagnostic blood samples and 529 individually matched controls among participants of the Singapore Chinese Health Study. The mtDNA copy number was measured using real time PCR. Conditional logistic regression analyses showed that there was an overall positive association between mtDNA copy number and breast cancer risk (P-trend = 0.01). The elevated risk for higher mtDNA copy numbers was primarily seen for women with,3 years between blood draw and cancer diagnosis; ORs (95% CIs) for 2nd, 3rd, 4th, and 5th quintile of mtDNA copy number were 1.52 (0.61, 3.82), 2.52 (1.03, 6.12), 3.12 (1.31, 7.43), and 3.06 (1.25, 7.47), respectively, compared with the 1st quintile (P-trend = 0.004). There was no association between mtDNA copy number and breast cancer risk among women who donated a blood sample >= 3 years before breast cancer diagnosis (P-trend = 0.41). This study supports a prospective association between increased mtDNA copy number and breast cancer risk that is dependent on the time interval between blood collection and breast cancer diagnosis. Future studies are warranted to confirm these findings and to elucidate the biological role of mtDNA copy number in breast cancer risk.	[Thyagarajan, Bharat; Barcelo, Helene] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Wang, Renwei; Yuan, Jian-Min] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA; [Nelson, Heather] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA; [Nelson, Heather] Univ Minnesota, Dept Epidemiol & Community Hlth, Minneapolis, MN USA; [Koh, Woon-Puay] Duke NUS Grad Med Sch Singapore, Singapore, Singapore; [Koh, Woon-Puay] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Yuan, Jian-Min] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA	University of Minnesota System; University of Minnesota Twin Cities; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; National University of Singapore; National University of Singapore; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Thyagarajan, B (corresponding author), Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA.	thya0003@umn.edu		Nelson, Heather/0000-0003-1901-9513; Yuan, Jian-Min/0000-0002-4620-3108	Eunice Kennedy Shriver National Institutes of Child Health and Human Development (NICHD) [K12HD055887]; Office of Research on Women's Health; National Institute on Aging, National Institutes of Health; National Cancer Institute, Bethesda, Maryland, United States of America [R01 CA55069, R35 CA53890, R01 CA80205, R01 CA144034]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD055887] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA144034, R01CA055069, R35CA053890, R01CA080205] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institutes of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Office of Research on Women's Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Office of Research on Women's Health (ORWH)); National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Cancer Institute, Bethesda, Maryland, United States of America; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research study was supported by the Building Interdisciplinary Research Careers in Women's Health Grant (K12HD055887) from the Eunice Kennedy Shriver National Institutes of Child Health and Human Development (NICHD), the Office of Research on Women's Health, and the National Institute on Aging, National Institutes of Health, administered by the University of Minnesota Deborah E. Powell Center for Women's Health. The Singapore Chinese Health Study was supported by grants R01 CA55069, R35 CA53890, R01 CA80205, and R01 CA144034 from the National Cancer Institute, Bethesda, Maryland, United States of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benz CC, 2008, NAT REV CANCER, V8, P875, DOI 10.1038/nrc2522; Bray F, 2012, LANCET ONCOL, V13, P790, DOI 10.1016/S1470-2045(12)70211-5; Chang SC, 2009, INT J COLORECTAL DIS, V24, P623, DOI 10.1007/s00384-009-0663-9; Dai Q, 2009, J CLIN ONCOL, V27, P2482, DOI 10.1200/JCO.2008.19.7970; Delsite RL, 2003, MUTAGENESIS, V18, P497, DOI 10.1093/mutage/geg027; Fan AXC, 2009, J CANCER RES CLIN, V135, P983, DOI 10.1007/s00432-008-0533-9; Fernandez-Silva P, 2003, EXP PHYSIOL, V88, P41, DOI 10.1113/eph8802514; Hankin JH, 2001, NUTR CANCER, V39, P187, DOI 10.1207/S15327914nc392_5; Hosgood HD, 2010, CARCINOGENESIS, V31, P847, DOI 10.1093/carcin/bgq045; Hsu CW, 2010, BREAST J, V16, P264, DOI 10.1111/j.1524-4741.2010.00908.x; Lan Q, 2008, BLOOD, V112, P4247, DOI 10.1182/blood-2008-05-157974; Lee HC, 2000, BIOCHEM J, V348, P425, DOI 10.1042/0264-6021:3480425; Lee HC, 2005, ANN NY ACAD SCI, V1042, P109, DOI 10.1196/annals.1338.011; Lee HC, 2005, INT J BIOCHEM CELL B, V37, P822, DOI 10.1016/j.biocel.2004.09.010; Lee HC, 2004, MUTAT RES-FUND MOL M, V547, P71, DOI 10.1016/j.mrfmmm.2003.12.011; Liao LM, 2011, CANC EPIDEMIOL BIOMA; Lin PC, 2008, INT J COLORECTAL DIS, V23, P1223, DOI 10.1007/s00384-008-0539-4; Liu CS, 2003, FREE RADICAL RES, V37, P1307, DOI 10.1080/10715760310001621342; Losanoff JE, 2008, BREAST, V17, P540, DOI 10.1016/j.breast.2008.04.005; Lynch SM, 2011, CANCER PREV RES, V4, P1912, DOI 10.1158/1940-6207.CAPR-11-0002; Mambo E, 2005, INT J CANCER, V116, P920, DOI 10.1002/ijc.21110; Meierhofer D, 2004, CARCINOGENESIS, V25, P1005, DOI 10.1093/carcin/bgh104; Montier LLC, 2009, J GENET GENOMICS, V36, P125, DOI 10.1016/S1673-8527(08)60099-5; Parkin DM, 2002, CANC INCIDENCE 5 CON; Penta JS, 2001, MUTAT RES-REV MUTAT, V488, P119, DOI 10.1016/S1383-5742(01)00053-9; Purdue MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043149; Qu FL, 2011, CANCER-AM CANCER SOC, V117, P3148, DOI 10.1002/cncr.25906; Radpour R, 2009, BREAST J, V15, P505, DOI 10.1111/j.1524-4741.2009.00767.x; Rossner P, 2006, CANCER EPIDEM BIOMAR, V15, P639, DOI 10.1158/1055-9965.EPI-05-0554; SEOW A, 2004, TRENDS CANC INCIDENC; Shen J, 2010, MITOCHONDRION, V10, P62, DOI 10.1016/j.mito.2009.09.004; Society AC, 2012, CANC FACTS FIG 2012; Thyagarajan B, 2012, CANCER EPIDEM BIOMAR, V21, P1574, DOI 10.1158/1055-9965.EPI-12-0138-T; Wang Y, 2006, BRIT J CANCER, V95, P1087, DOI 10.1038/sj.bjc.6603377; Wang Y, 2005, GYNECOL ONCOL, V98, P104, DOI 10.1016/j.ygyno.2005.04.015; Wu CW, 2005, GENE CHROMOSOME CANC, V44, P19, DOI 10.1002/gcc.20213; Xia P, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-454; Xing JL, 2008, JNCI-J NATL CANCER I, V100, P1104, DOI 10.1093/jnci/djn213; Yu M, 2007, IUBMB LIFE, V59, P450, DOI 10.1080/15216540701509955; Yu M, 2011, LIFE SCI, V89, P65, DOI 10.1016/j.lfs.2011.05.010	40	60	60	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65968	10.1371/journal.pone.0065968	http://dx.doi.org/10.1371/journal.pone.0065968			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776581	Green Published, gold, Green Accepted			2022-12-27	WOS:000320322400066
J	Addabbo, F; Chen, QY; Patel, DP; Rabadi, M; Ratliff, B; Zhang, F; Jasmin, JF; Wolin, M; Lisanti, M; Gross, SS; Goligorsky, MS				Addabbo, Francesco; Chen, Qiuying; Patel, Dhara P.; Rabadi, May; Ratliff, Brian; Zhang, Frank; Jasmin, Jean-Francois; Wolin, Michael; Lisanti, Michael; Gross, Steven S.; Goligorsky, Michael S.			Glutamine Supplementation Alleviates Vasculopathy and Corrects Metabolic Profile in an In Vivo Model of Endothelial Cell Dysfunction	PLOS ONE			English	Article							OXIDE SYNTHASE INHIBITION; NITRIC-OXIDE; L-ARGININE; ASYMMETRICAL DIMETHYLARGININE; PULMONARY-HYPERTENSION; CARDIOVASCULAR RISK; RELAXING FACTOR; UREMIC TOXINS; RENAL-DISEASE; RAT	Endothelial Cell Dysfunction (ECD) is a recognized harbinger of a host of chronic cardiovascular diseases. Using a mouse model of ECD triggered by treatment with L-Nv-methylarginine (L-NMMA), we previously demonstrated that renal microvasculature displays a perturbed protein profile, including diminished expression of two key enzymes of the Krebs cycle associated with a Warburg-type suppression of mitochondrial metabolism. We hypothesized that supplementation with L-glutamine (GLN), that can enter the Krebs cycle downstream this enzymatic bottleneck, would normalize vascular function and alleviate mitochondrial dysfunction. To test this hypothesis, mice with chronic L-NMMA-induced ECD were cotreated with GLN at different concentrations for 2 months. Results confirmed that L-NMMA led to a defect in acetylcholineinduced relaxation of aortic rings that was dose-dependently prevented by GLN. In caveolin-1 transgenic mice characterized by eNOS inactivation, L-NMMA further impaired vasorelaxation which was partially rescued by GLN co-treatment. Proinflammatory profile induced by L-NMMA was blunted in mice co-treated with GLN. Using an LC/MS platform for metabolite profiling, we sought to identify metabolic perturbations associated with ECD and offset by GLN supplementation. 3453 plasma molecules could be detected with 100% frequency in mice from at least one treatment group. Among these, 37 were found to be differentially expressed in a 4-way comparison of control vs. LNMMA both with and without GLN. One of such molecules, hippuric acid, an "uremic toxin'' was found to be elevated in our non-uremic mice receiving L-NMMA, but normalized by treatment with GLN. Ex vivo analysis of hippuric acid effects on vasomotion demonstrated that it significantly reduced acetylcholine-induced vasorelaxation of vascular rings. In conclusion, functional and metabolic profiling of animals with early ECD revealed macrovasculopathy and that supplementation GLN is capable of improving vascular function. Metabolomic analyses reveal elevation of hippuric acid, which may further exacerbate vasculopathy even before the development of uremia.	[Addabbo, Francesco; Patel, Dhara P.; Rabadi, May; Ratliff, Brian; Zhang, Frank; Wolin, Michael; Goligorsky, Michael S.] New York Med Coll, Dept Med, Valhalla, NY 10595 USA; [Addabbo, Francesco; Patel, Dhara P.; Rabadi, May; Ratliff, Brian; Zhang, Frank; Wolin, Michael; Goligorsky, Michael S.] New York Med Coll, Dept Pharmacol, Valhalla, NY 10595 USA; [Addabbo, Francesco; Patel, Dhara P.; Rabadi, May; Ratliff, Brian; Zhang, Frank; Wolin, Michael; Goligorsky, Michael S.] New York Med Coll, Dept Physiol, Valhalla, NY 10595 USA; [Chen, Qiuying; Gross, Steven S.] Weill Cornell Med Coll, Dept Pharmacol, New York, NY USA; [Jasmin, Jean-Francois; Lisanti, Michael] Thomas Jefferson Univ, Ctr Canc, Philadelphia, PA 19107 USA; [Lisanti, Michael] Univ Manchester, Breakthrough Breast Canc Res Unit, Manchester M13 9PL, Lancs, England	New York Medical College; New York Medical College; New York Medical College; Cornell University; Jefferson University; University of Manchester	Addabbo, F (corresponding author), New York Med Coll, Dept Med, Valhalla, NY 10595 USA.	f.addabbo@biologia.uniba.it; Michael_goligorsky@nymc.edu	Lisanti, Michael/B-6131-2018	Lisanti, Michael/0000-0003-2034-1382; Patel (Lakhkar), Dr. Dhara/0000-0002-2547-0645	NIH [DK54602, DK052783, DK45462]; Westchester Artificial Kidney Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052783, R01DK045462, R01DK054602] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Westchester Artificial Kidney Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	These studies were supported in part by NIH grants DK54602, DK052783, DK45462 and the Westchester Artificial Kidney Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABUSOUD HM, 1994, J BIOL CHEM, V269, P32318; Achan V, 2003, ARTERIOSCL THROM VAS, V23, P1455, DOI 10.1161/01.ATV.0000081742.92006.59; Addabbo F, 2009, AM J PATHOL, V174, P34, DOI 10.2353/ajpath.2009.080650; ARNAL JF, 1995, J CLIN INVEST, V95, P2565, DOI 10.1172/JCI117957; Bogle RG, 1996, J PHYSIOL-LONDON, V490, P229, DOI 10.1113/jphysiol.1996.sp021138; Brunengraber H, 2006, J INHERIT METAB DIS, V29, P327, DOI 10.1007/s10545-006-0320-1; Chen QY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037149, 10.1371/journal.pone.0042971]; Ciborowski M, 2011, J PROTEOME RES, V10, P1374, DOI 10.1021/pr101138m; Coeffier M, 2005, NUTR REV, V63, P65, DOI 10.1111/j.1753-4887.2005.tb00123.x; Deguchi T, 2005, J PHARMACOL EXP THER, V314, P932, DOI 10.1124/jpet.105.085613; Feron O, 1998, J BIOL CHEM, V273, P3125, DOI 10.1074/jbc.273.6.3125; Goligorsky MS, 2000, ACTA PHYSIOL SCAND, V168, P33; Goligorsky MS, 2005, AM J PHYSIOL-RENAL, V288, pF871, DOI 10.1152/ajprenal.00333.2004; Goligorsky MS, 1999, AM J PHYSIOL-CELL PH, V276, pC1271, DOI 10.1152/ajpcell.1999.276.6.C1271; Gorg B, 2005, HEPATOLOGY, V41, P1065, DOI 10.1002/hep.20662; Hassan GS, 2004, BIOCHEMISTRY-US, V43, P8312, DOI 10.1021/bi049609t; Hayashi Y, 2002, CIRCULATION, V106, P2601, DOI 10.1161/01.CIR.0000035651.72240.07; Jeong SM, 2013, CANCER CELL, V23, P450, DOI 10.1016/j.ccr.2013.02.024; KREBS HA, 1966, BIOCHEM J, V101, P242, DOI 10.1042/bj1010242; Levey AS, 1998, AM J KIDNEY DIS, V32, P853, DOI 10.1016/S0272-6386(98)70145-3; Linder AE, 2005, J CARDIOVASC PHARM, V46, P438, DOI 10.1097/01.fjc.0000175879.14994.63; LINDNER A, 1974, NEW ENGL J MED, V290, P697, DOI 10.1056/NEJM197403282901301; Morris CR, 2008, BLOOD, V111, P402, DOI 10.1182/blood-2007-04-081703; Murphy C, 1998, CLIN SCI, V95, P397, DOI 10.1042/CS19980194; Mutsaers HAM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018438; Noiri E, 1998, AM J PHYSIOL-CELL PH, V274, pC236, DOI 10.1152/ajpcell.1998.274.1.C236; O'Riordan E, 2007, AM J PHYSIOL-HEART C, V292, pH285, DOI 10.1152/ajpheart.00560.2006; Owen OE, 2002, J BIOL CHEM, V277, P30409, DOI 10.1074/jbc.R200006200; Park HC, 2010, AM J PHYSIOL-RENAL, V298, pF357, DOI 10.1152/ajprenal.00542.2009; PARRYBILLINGS M, 1990, LANCET, V336, P523, DOI 10.1016/0140-6736(90)92083-T; Razani B, 2001, J BIOL CHEM, V276, P38121; Reid MA, 2013, MOL CELL, V50, P200, DOI 10.1016/j.molcel.2013.02.008; Roth E, 2008, J NUTR, V138, p2025S, DOI 10.1093/jn/138.10.2025S; Satoh M, 2003, NEPHRON EXP NEPHROL, V95, pE111, DOI 10.1159/000074327; Schachter D, 2007, AM J PHYSIOL-CELL PH, V293, pC142, DOI 10.1152/ajpcell.00589.2006; SESSA WC, 1990, P NATL ACAD SCI USA, V87, P8607, DOI 10.1073/pnas.87.21.8607; Shanware NP, 2011, J MOL MED, V89, P229, DOI 10.1007/s00109-011-0731-9; Spustova V, 1987, Czech Med, V10, P79; Stoessel A, 2008, AM J PHYSIOL-RENAL, V295, pF717, DOI 10.1152/ajprenal.00071.2008; SWIERKOSZ TA, 1990, BIOCHEM BIOPH RES CO, V172, P143, DOI 10.1016/S0006-291X(05)80184-6; Tourkina E, 2008, AM J PHYSIOL-LUNG C, V294, pL843, DOI 10.1152/ajplung.00295.2007; Valkonen VP, 2001, LANCET, V358, P2127, DOI 10.1016/S0140-6736(01)07184-7; Vallance P, 2004, ARTERIOSCL THROM VAS, V24, P1023, DOI 10.1161/01.ATV.0000128897.54893.26; Vallance P, 2001, LANCET, V358, P2096, DOI 10.1016/S0140-6736(01)07229-4; Vanholder R, 2003, KIDNEY INT, V63, P1934, DOI 10.1046/j.1523-1755.2003.00924.x; Vita JA, 2002, CIRCULATION, V106, P640, DOI 10.1161/01.CIR.0000028581.07992.56; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wernerman J, 2008, J NUTR, V138, p2040S, DOI 10.1093/jn/138.10.2040S; Wernerman J, 2008, CURR OPIN ANESTHESIO, V21, P155, DOI 10.1097/ACO.0b013e3282f54fd6; Wilmore DW, 2001, J NUTR, V131, p2543S, DOI 10.1093/jn/131.9.2543S; Wischmeyer PE, 2007, CRIT CARE MED, V35, pS541, DOI 10.1097/01.CCM.0000278064.32780.D3; XU H, 1994, PHARMACOLOGY, V48, P260, DOI 10.1159/000139188; ZIEGLER TR, 1990, JPEN-PARENTER ENTER, V14, pS137, DOI 10.1177/0148607190014004201; Zoccali C, 2001, LANCET, V358, P2113, DOI 10.1016/S0140-6736(01)07217-8	54	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65458	10.1371/journal.pone.0065458	http://dx.doi.org/10.1371/journal.pone.0065458			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776484	Green Published, gold, Green Submitted			2022-12-27	WOS:000320755400031
J	Gajewska-Wozniak, O; Skup, M; Kasicki, S; Ziemlinska, E; Czarkowska-Bauch, J				Gajewska-Wozniak, Olga; Skup, Malgorzata; Kasicki, Stefan; Ziemlinska, Ewelina; Czarkowska-Bauch, Julita			Enhancing Proprioceptive Input to Motoneurons Differentially Affects Expression of Neurotrophin 3 and Brain-Derived Neurotrophic Factor in Rat Hoffmann-Reflex Circuitry	PLOS ONE			English	Article							SPINAL-CORD; MESSENGER-RNAS; SCHWANN-CELLS; HORSERADISH-PEROXIDASE; MUSCLE AFFERENTS; FIRING PATTERNS; NERVOUS-SYSTEM; MOTOR-NEURONS; TRK-RECEPTORS; ADULT RATS	The importance of neurotrophin 3 (NT-3) for motor control prompted us to ask the question whether direct electrical stimulation of low-threshold muscle afferents, strengthening the proprioceptive signaling, could effectively increase the endogenous pool of this neurotrophin and its receptor TrkC in the Hoffmann-reflex (H-reflex) circuitry. The effects were compared with those of brain-derived neurotrophic factor (BDNF) and its TrkB receptor. Continuous bursts of stimuli were delivered unilaterally for seven days, 80 min daily, by means of a cuff-electrode implanted over the tibial nerve in awake rats. The H-reflex was recorded in the soleus muscle to control the strength of stimulation. Stimulation aimed at activation of Ia fibers produced a strong increase of NT-3 protein, measured with ELISA, in the lumbar L3-6 segments of the spinal cord and in the soleus muscle. This stimulation exerted much weaker effect on BDNF protein level which slightly increased only in L3-6 segments of the spinal cord. Increased protein level of NT-3 and BDNF corresponded to the changes of NT-3 mRNA and BDNF mRNA expression in L3-6 segments but not in the soleus muscle. We disclosed tissue-specificity of TrkC mRNA and TrkB mRNA responses. In the spinal cord TrkC and TrkB transcripts tended to decrease, whereas in the soleus muscle TrkB mRNA decreased and TrkC mRNA expression strongly increased, suggesting that stimulation of Ia fibers leads to sensitization of the soleus muscle to NT-3 signaling. The possibility of increasing NT-3/TrkC signaling in the neuromuscular system, with minor effects on BDNF/TrkB signaling, by means of low-threshold electrical stimulation of peripheral nerves, which in humans might be applied in non-invasive way, offers an attractive therapeutic tool.	[Gajewska-Wozniak, Olga; Skup, Malgorzata; Kasicki, Stefan; Ziemlinska, Ewelina; Czarkowska-Bauch, Julita] Nencki Inst Expt Biol, Dept Neurophysiol, Warsaw, Poland	Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences	Skup, M (corresponding author), Nencki Inst Expt Biol, Dept Neurophysiol, Warsaw, Poland.	m.skup@nencki.gov.pl; j.czarkowska@nencki.gov.pl	Kasicki, Stefan/Q-1227-2016; Czarkowska-Bauch, Julita/AAB-6872-2020	Kasicki, Stefan/0000-0001-7472-8422; Skup, Malgorzata/0000-0002-2605-0124; Ziemlinska, Ewelina/0000-0002-7602-3239; Gajewska-Wozniak, Olga/0000-0003-3529-5788	Ministry of Science and Higher Education [0480/B/P01/2007/33 (N N 401 048033)]; EU FP 7 Capacities Programme BIOIMAGINE funds	Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); EU FP 7 Capacities Programme BIOIMAGINE funds	This study was supported by grant of the Ministry of Science and Higher Education 0480/B/P01/2007/33 (N N 401 048033), by EU FP 7 Capacities Programme BIOIMAGINE funds and by statutory funds for the Nencki Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Majed AA, 2000, EUR J NEUROSCI, V12, P4381, DOI 10.1046/j.1460-9568.2000.01341.x; Arvanian VL, 2003, J NEUROSCI, V23, P8706; BARBACID M, 1994, J NEUROBIOL, V25, P1386, DOI 10.1002/neu.480251107; Bawa P, 2008, MUSCLE NERVE, V38, P1604, DOI 10.1002/mus.21184; Boyce VS, 2012, EUR J NEUROSCI, V35, P221, DOI 10.1111/j.1460-9568.2011.07950.x; Bradbury EJ, 1999, EUR J NEUROSCI, V11, P3873, DOI 10.1046/j.1460-9568.1999.00809.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burke RE, 1996, J COMP NEUROL, V372, P465; Carp JS, 2001, EXP BRAIN RES, V136, P269, DOI 10.1007/s002210000608; Carroll P, 1998, NAT NEUROSCI, V1, P42, DOI 10.1038/242; COPRAY JCVM, 1994, NEUROSCIENCE, V63, P1125, DOI 10.1016/0306-4522(94)90578-9; Copray S, 2000, NEUROSCI LETT, V289, P217, DOI 10.1016/S0304-3940(00)01305-7; Cote MP, 2011, J NEUROTRAUM, V28, P299, DOI 10.1089/neu.2010.1594; CZARKOWSKA J, 1976, BRAIN RES, V118, P115, DOI 10.1016/0006-8993(76)90844-1; CZARKOWSKA J, 1981, J PHYSIOL-LONDON, V310, P367, DOI 10.1113/jphysiol.1981.sp013555; de Carrizosa MADL, 2009, J NEUROSCI, V29, P575, DOI 10.1523/JNEUROSCI.5312-08.2009; ECCLES JC, 1951, PROC R SOC SER B-BIO, V138, P475, DOI 10.1098/rspb.1951.0036; Elmer E, 1996, BRAIN RES, V712, P19, DOI 10.1016/0006-8993(95)01424-1; ERNFORS P, 1994, CELL, V77, P503, DOI 10.1016/0092-8674(94)90213-5; FARINAS I, 1994, NATURE, V369, P658, DOI 10.1038/369658a0; FUNAKOSHI H, 1995, SCIENCE, V268, P1495, DOI 10.1126/science.7770776; Gajewska-Wozniak O, 2012, LOW THRESHOLD STIMUL; Gomez-Pinilla F, 2001, EUR J NEUROSCI, V13, P1078, DOI 10.1046/j.0953-816x.2001.01484.x; Gonzalez M, 1997, J NEUROPHYSIOL, V77, P502, DOI 10.1152/jn.1997.77.1.502; Gonzalez-Martinez T, 2005, NEUROSCI LETT, V377, P12, DOI 10.1016/j.neulet.2004.11.078; Heckman CJ, 2008, NEUROSCIENTIST, V14, P264, DOI 10.1177/1073858408314986; Hess DM, 2007, J COMP NEUROL, V501, P465, DOI 10.1002/cne.21163; Hyngstrom AS, 2007, NAT NEUROSCI, V10, P363, DOI 10.1038/nn1852; JANKOWSKA E, 1992, PROG NEUROBIOL, V38, P335, DOI 10.1016/0301-0082(92)90024-9; Jankowska E, 2008, J NEUROSCI, V28, P3615, DOI 10.1523/JNEUROSCI.0466-08.2008; Jankowska E, 2008, BRAIN RES REV, V57, P46, DOI 10.1016/j.brainresrev.2007.06.022; KLEIN R, 1994, NATURE, V368, P249, DOI 10.1038/368249a0; Kokaia Z, 1996, NEUROSCIENCE, V75, P197, DOI 10.1016/0306-4522(96)00257-6; LAPORTE Y, 1952, AM J PHYSIOL, V169, P609, DOI 10.1152/ajplegacy.1952.169.3.609; Loeb G. E., 1986, ELECTROMYOGRAPHY EXP; Lu P, 2008, EXP NEUROL, V209, P313, DOI 10.1016/j.expneurol.2007.08.004; Macias M, 2002, NEUROREPORT, V13, P2527, DOI 10.1097/00001756-200212200-00029; Macias M, 2007, EUR J NEUROSCI, V25, P2425, DOI 10.1111/j.1460-9568.2007.05498.x; Macias M, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-144; MCMAHON SB, 1994, NEURON, V12, P1161, DOI 10.1016/0896-6273(94)90323-9; Meier C, 1999, J NEUROSCI, V19, P3847; Mendell LM, 1999, J NEUROSCI, V19, P3162; Mentis GZ, 2010, ANN NY ACAD SCI, V1198, P220, DOI 10.1111/j.1749-6632.2010.05538.x; MERLIO JP, 1992, NEUROSCIENCE, V51, P513, DOI 10.1016/0306-4522(92)90292-A; Munson JB, 1997, J NEUROSCI, V17, P470, DOI 10.1523/JNEUROSCI.17-01-00470.1997; Omura T, 2005, J PERIPHER NERV SYST, V10, P293, DOI 10.1111/j.1085-9489.2005.10307.x; Petruska JC, 2010, EUR J NEUROSCI, V32, P997, DOI 10.1111/j.1460-9568.2010.07392.x; Riley CP, 2004, J MOL HISTOL, V35, P771, DOI 10.1007/s10735-004-0778-9; SCHIEPPATI M, 1987, PROG NEUROBIOL, V28, P345, DOI 10.1016/0301-0082(87)90007-4; Shen H, 1999, MOL BRAIN RES, V64, P186, DOI 10.1016/S0169-328X(98)00314-3; Skup M, 2002, EXP NEUROL, V176, P289, DOI 10.1006/exnr.2002.7943; Skup M, 2012, EUR J NEUROSCI, V36, P2679, DOI 10.1111/j.1460-9568.2012.08182.x; STEIN RB, 1977, BRAIN RES, V128, P21, DOI 10.1016/0006-8993(77)90233-5; Tauszig-Delamasure S, 2007, P NATL ACAD SCI USA, V104, P13361, DOI 10.1073/pnas.0701243104; Wang TH, 2008, NEUROCHEM RES, V33, P1, DOI 10.1007/s11064-007-9398-6; Wilson-Gerwing TD, 2008, EXP NEUROL, V213, P303, DOI 10.1016/j.expneurol.2008.06.002; Woolley AG, 2008, GLIA, V56, P306, DOI 10.1002/glia.20614; Wright DE, 1997, NEURON, V19, P503, DOI 10.1016/S0896-6273(00)80367-0; Ying Z, 2003, BRAIN RES, V987, P93, DOI 10.1016/S0006-8993(03)03258-X; Zagoraiou L, 2009, NEURON, V64, P645, DOI 10.1016/j.neuron.2009.10.017; Ziemlinska E, 2010, ADENO ASS VIRAL VECT	61	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65937	10.1371/journal.pone.0065937	http://dx.doi.org/10.1371/journal.pone.0065937			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776573	gold, Green Submitted, Green Published			2022-12-27	WOS:000320755400084
J	Milaneschi, Y; Cesari, M; Simonsick, EM; Vogelzangs, N; Kanaya, AM; Yaffe, K; Patrignani, P; Metti, A; Kritchevsky, SB; Pahor, M; Ferrucci, L; Penninx, BWJH				Milaneschi, Yuri; Cesari, Matteo; Simonsick, Eleanor M.; Vogelzangs, Nicole; Kanaya, Alka M.; Yaffe, Kristine; Patrignani, Paola; Metti, Andrea; Kritchevsky, Stephen B.; Pahor, Marco; Ferrucci, Luigi; Penninx, Brenda W. J. H.		Hlth ABC Study	Lipid Peroxidation and Depressed Mood in Community-Dwelling Older Men and Women	PLOS ONE			English	Article							C-REACTIVE PROTEIN; OXIDATIVE STRESS; MAJOR DEPRESSION; PLATELET ACTIVATION; 8-ISO-PROSTAGLANDIN F2-ALPHA; SEX-DIFFERENCES; INFLAMMATION; RISK; GLUCOCORTICOIDS; OBESITY	It has been hypothesized that cellular damage caused by oxidative stress is associated with late-life depression but epidemiological evidence is limited. In the present study we evaluated the association between urinary 8-iso-prostaglandin F-2 alpha (8-iso-PGF(2 alpha) ), a biomarker of lipid peroxidation, and depressed mood in a large sample of community-dwelling older adults. Participants were selected from the Health, Aging and Body Composition study, a community-based longitudinal study of older persons (aged 70-79 years). The present analyses was based on a subsample of 1027 men and 948 women free of mobility disability. Urinary concentration of 8-iso-PGF(2 alpha) was measured by radioimmunoassay methods and adjusted for urinary creatinine. Depressed mood was defined as a score greater than 5 on the 15-item Geriatric Depression Scale and/or use of antidepressant medications. Depressed mood was present in 3.0% of men and 5.5% of women. Depressed men presented higher urinary concentrations of 8-iso-PGF(2 alpha) than non-depressed men even after adjustment for multiple sociodemographic, lifestyle and health factors (p= 0.03, Cohen's d = 0.30). This association was not present in women (depressed status-by-sex interaction p = 0.04). Our study showed that oxidative damage may be linked to depression in older men from a large sample of the general population. Further studies are needed to explore whether the modulation of oxidative stress may break down the link between late-life depression and its deleterious health consequences.	[Milaneschi, Yuri; Vogelzangs, Nicole; Penninx, Brenda W. J. H.] Vrije Univ Amsterdam, Med Ctr GGZ InGeest, Dept Psychiat, Amsterdam, Netherlands; [Milaneschi, Yuri; Vogelzangs, Nicole; Penninx, Brenda W. J. H.] Vrije Univ Amsterdam, Med Ctr GGZ InGeest, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Milaneschi, Yuri; Simonsick, Eleanor M.; Ferrucci, Luigi] NIH, Longitudinal Studies Sect, Clin Res Branch, Baltimore, MD USA; [Cesari, Matteo] Univ Toulouse, Inst Vieillissement, Toulouse, France; [Cesari, Matteo; Pahor, Marco] Univ Florida, Dept Aging & Geriatr Res, Inst Aging, Gainesville, FL USA; [Kanaya, Alka M.] Univ Calif San Francisco, Div Gen Internal Med, San Francisco, CA 94143 USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Patrignani, Paola] Univ G DAnnunzio, Dept Neurosci & Imaging, Chieti, Italy; [Patrignani, Paola] Univ G DAnnunzio, Ctr Excellent Aging, Chieti, Italy; [Metti, Andrea] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA; [Kritchevsky, Stephen B.] Wake Forest Univ, Bowman Gray Sch Med, Sticht Ctr Aging, Winston Salem, NC USA	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Universite de Toulouse; State University System of Florida; University of Florida; University of California System; University of California San Francisco; University of California System; University of California San Francisco; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Wake Forest University; Wake Forest Baptist Medical Center	Milaneschi, Y (corresponding author), Vrije Univ Amsterdam, Med Ctr GGZ InGeest, Dept Psychiat, Amsterdam, Netherlands.	y.milaneschi@ggzingeest.nl	Cesari, Matteo/A-4649-2008; Patrignani, Paola/B-4844-2011; Simonsick, Eleanor/W-6864-2019; Penninx, Brenda WJH/S-7627-2017	Cesari, Matteo/0000-0002-0348-3664; Patrignani, Paola/0000-0003-1419-2691; Penninx, Brenda WJH/0000-0001-7779-9672; Kritchevsky, Stephen/0000-0003-3336-6781	National Institute on Aging (NIA) Contracts [N01-AG-6-2101, N01-AG-6-2103, N01-AG-6-2106]; NIA [R01-AG028050]; National Institute of Nursing Research [R01-NR012459]; Intramural Research Program of the National Institutes of Health; National Institute on Aging; National Institute on Aging [R01AG26556]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR012459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG028740, ZIAAG000015, N01AG062103, R01AG026556, R01AG028050, N01AG062101, N01AG062106] Funding Source: NIH RePORTER	National Institute on Aging (NIA) Contracts; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Nursing Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); Intramural Research Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by National Institute on Aging (NIA) Contracts N01-AG-6-2101; N01-AG-6-2103; N01-AG-6-2106; NIA grant R01-AG028050, and National Institute of Nursing Research grant R01-NR012459. This research was supported (in part) by the Intramural Research Program of the National Institutes of Health, National Institute on Aging. Assaying of 8-iso-PGF2 alpha was supported by the by the National Institute on Aging (R01AG26556). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Alexapoulos GS, 2005, LANCET, V365, P1961, DOI 10.1016/S0140-6736(05)66665-2; Alexopoulos GS, 1997, ARCH GEN PSYCHIAT, V54, P915; Almeida OP, 1999, INT J GERIATR PSYCH, V14, P858, DOI 10.1002/(SICI)1099-1166(199910)14:10<858::AID-GPS35>3.0.CO;2-8; Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624; Beasley LE, 2009, OBESITY, V17, P1062, DOI 10.1038/oby.2008.627; Bilici M, 2001, J AFFECT DISORDERS, V64, P43, DOI 10.1016/S0165-0327(00)00199-3; Cesari M, 2012, J GERONTOL A-BIOL, V67, P671, DOI 10.1093/gerona/glr246; Cohen D, 1998, STAT POWER ANAL BEHA; Davi G, 2004, CHEM PHYS LIPIDS, V128, P149, DOI 10.1016/j.chemphyslip.2003.10.001; Davi G, 1999, CIRCULATION, V99, P224; Dimopoulos N, 2008, PSYCHIAT RES, V161, P59, DOI 10.1016/j.psychres.2007.07.019; Dworski R, 2001, CLIN EXP ALLERGY, V31, P387, DOI 10.1046/j.1365-2222.2001.01055.x; Facecchia K, 2011, J TOXICOL IN PRESS; Forlenza MJ, 2006, PSYCHOSOM MED, V68, P1, DOI 10.1097/01.psy.0000195780.37277.2a; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Galecki P, 2009, HUM PSYCHOPHARM CLIN, V24, P277, DOI 10.1002/hup.1014; Halliwell B, 2000, CARDIOVASC RES, V47, P410, DOI 10.1016/S0008-6363(00)00097-3; Howren MB, 2009, PSYCHOSOM MED, V71, P171, DOI 10.1097/PSY.0b013e3181907c1b; IL'Yasova D, 2008, BIOMARKERS, V13, P41, DOI 10.1080/13547500701617708; Keaney JF, 2003, ARTERIOSCL THROM VAS, V23, P434, DOI 10.1161/01.ATV.0000058402.34138.11; Kendler KS, 2005, AM J PSYCHIAT, V162, P250, DOI 10.1176/appi.ajp.162.2.250; Koster A, 2010, OBESITY, V18, P2354, DOI 10.1038/oby.2010.86; Maciejewski PK, 2001, PSYCHOL MED, V31, P593, DOI 10.1017/S0033291701003877; MacQueen G, 2011, MOL PSYCHIATR, V16, P252, DOI 10.1038/mp.2010.80; Maes M, 2009, NEUROENDOCRINOL LETT, V30, P715; Maes M, 2009, METAB BRAIN DIS, V24, P27, DOI 10.1007/s11011-008-9118-1; McIntosh LJ, 1996, EXP NEUROL, V141, P201, DOI 10.1006/exnr.1996.0154; McIntosh LJ, 1996, NEUROTOXICOLOGY, V17, P873; McIntosh LJ, 1998, BRAIN RES, V791, P209, DOI 10.1016/S0006-8993(98)00115-2; Milaneschi Y, 2012, WORLD J BIOL PSYCHIA, V13, P588, DOI 10.3109/15622975.2011.597876; Milaneschi Y, 2012, J CLIN PSYCHIAT, V73, P1205, DOI 10.4088/JCP.11m07552; Minuz Pietro, 2006, Pharmacol Rep, V58 Suppl, P57; Molendijk ML, 2011, MOL PSYCHIATR, V16, P1088, DOI 10.1038/mp.2010.98; Montorio I, 1996, Int Psychogeriatr, V8, P103, DOI 10.1017/S1041610296002505; PAHOR M, 1994, EUR J EPIDEMIOL, V10, P405, DOI 10.1007/BF01719664; Pomara N, 2012, AM J PSYCHIAT, V169, P523, DOI 10.1176/appi.ajp.2011.11081153; Schwedhelm E, 2004, CIRCULATION, V109, P843, DOI 10.1161/01.CIR.0000116761.93647.30; Slinin Y, 2010, NEUROLOGY, V74, P33, DOI 10.1212/WNL.0b013e3181c7197b; TENG EL, 1987, J CLIN PSYCHIAT, V48, P314; Terracciano A, 2010, GENES BRAIN BEHAV, V9, P512, DOI 10.1111/j.1601-183X.2010.00579.x; Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823; van Gool CH, 2003, AGE AGEING, V32, P81, DOI 10.1093/ageing/32.1.81; vanKooten F, 1997, STROKE, V28, P1557, DOI 10.1161/01.STR.28.8.1557; Vogelzangs N, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.8; Vogelzangs N, 2010, J CLIN PSYCHIAT, V71, P391, DOI 10.4088/JCP.08m04743blu; Volpato S, 2004, CIRCULATION, V109, P607, DOI 10.1161/01.CIR.0000109503.13955.00; Vreeburg SA, 2009, ARCH GEN PSYCHIAT, V66, P617, DOI 10.1001/archgenpsychiatry.2009.50; Wang B, 2006, ATHEROSCLEROSIS, V184, P425, DOI 10.1016/j.atherosclerosis.2005.05.008; WANG ZY, 1995, J PHARMACOL EXP THER, V275, P94; Wilson RS, 1999, ARCH NEUROL-CHICAGO, V56, P1274, DOI 10.1001/archneur.56.10.1274; Yager S, 2010, PSYCHONEUROENDOCRINO, V35, P1356, DOI 10.1016/j.psyneuen.2010.03.010; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4; Zanjani FAK, 2006, BEHAV MED, V32, P36, DOI 10.3200/BMED.32.2.36-46	55	30	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65406	10.1371/journal.pone.0065406	http://dx.doi.org/10.1371/journal.pone.0065406			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776478	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000320755400028
J	Roth, B; Gustafsson, RJ; Ohlsson, B				Roth, Bodil; Gustafsson, Rita J.; Ohlsson, Bodil			Auto-Antibodies and Their Association with Clinical Findings in Women Diagnosed with Microscopic Colitis	PLOS ONE			English	Article							QUALITY-OF-LIFE; IRRITABLE-BOWEL-SYNDROME; GASTROINTESTINAL SYMPTOMS; LYMPHOCYTIC-COLITIS; COLLAGENOUS COLITIS; CIGARETTE-SMOKING; DOUBLE-BLIND; ANTIBODIES; DISEASE; RISK	Background: Microscopic colitis (MC) is a disease manifested by diarrhoea and is divided into collagenous and lymphocytic colitis. The aetiology is unknown, but auto-immunity is suggested. Auto-antibodies have been only rarely examined in this entity. The aim of the study was to examine the prevalence of auto-antibodies, and to examine associations between the presence of antibodies and clinical findings. Methods and Findings: Women with MC verified by biopsy and younger than 73 years, at any Department of Gastroenterology, in the district of Skane, between 2002 and 2010 were invited to participate in this study. The patients were asked to complete both a questionnaire describing their medical history and the Gastrointestinal Symptom Rating Scale (GSRS). Blood samples were collected. Anti-nuclear antibodies (ANA), anti-neutrophil cytoplasmic antibodies (ANCA), anti-Saccharomyces cerevisiae antibodies (ASCA), and antibodies against glutamic acid decarboxylase (anti-GAD), islet antigens-like insulin 2 (anti-IA2), thyroid peroxidase (anti-TPO), and thyrotropin receptor (TRAK) were analysed. Of 240 women identified, 133 were finally included in the study, median age 63 (59-67) years. Apart from the MC diagnosis, 52% also suffered from irritable bowel syndrome, 31% from hypertension and 31% from allergy. The prevalence of ANA (14%), ASCA IgG (13%), and anti-TPO antibodies (14%) for these patients was slightly higher than for the general population, and were found together with other concomitant diseases. Patients had more of all gastrointestinal symptoms compared with norm values, irrespective of antibody expression. Conclusions: Women with MC have a slightly increased prevalence of some auto-antibodies. These antibodies are not associated with symptoms, but are expressed in patients with concomitant diseases, obscuring the pathophysiology and clinical picture of MC.	[Ohlsson, Bodil] Skane Univ Hosp, Dept Clin Sci, Dept Gastroenterol, Malmo, Sweden; Lund Univ, Lund, Sweden	Lund University; Skane University Hospital; Lund University	Ohlsson, B (corresponding author), Skane Univ Hosp, Dept Clin Sci, Dept Gastroenterol, Malmo, Sweden.	bodil.ohlsson@med.lu.se			Bengt Ihre Foundation; Development Foundation of Region Skane	Bengt Ihre Foundation; Development Foundation of Region Skane	This study was sponsored by the Bengt Ihre Foundation and the Development Foundation of Region Skane. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjornbak C, 2011, ALIMENT PHARM THER, V34, P1225, DOI 10.1111/j.1365-2036.2011.04865.x; Bohr J, 1996, GUT, V39, P73, DOI 10.1136/gut.39.1.73; Bonderup OK, 2009, GUT, V58, P68, DOI 10.1136/gut.2008.156513; Bonifacio E, 1997, ACTA DIABETOL, V34, P185, DOI 10.1007/s005920050072; Carmack SW, 2009, ADV ANAT PATHOL, V16, P290, DOI 10.1097/PAP.0b013e3181b5073a; Costagliola S, 1999, J CLIN ENDOCR METAB, V84, P90, DOI 10.1210/jc.84.1.90; Dahlquist GG, 2011, DIABETES CARE, V34, P1754, DOI 10.2337/dc11-0056; DIMENAS E, 1995, SCAND J GASTROENTERO, V30, P1046, DOI 10.3109/00365529509101605; DIMENAS E, 1993, SCAND J GASTROENTERO, V28, P681, DOI 10.3109/00365529309098272; Dimenas E, 1996, SCAND J GASTROENTERO, V31, P8, DOI 10.3109/00365529609095544; Drossman D, 2006, ROME 3 FUNCTIONAL GA; DUERR RH, 1991, GASTROENTEROLOGY, V100, P1590, DOI 10.1016/0016-5085(91)90657-7; Fernandez-Banares F, 2007, AM J GASTROENTEROL, V102, P324, DOI 10.1111/j.1572-0241.2006.00902.x; Gal AA, 2002, MODERN PATHOL, V15, P197, DOI 10.1038/modpathol.3880516; Holstein A, 2006, J GASTROEN HEPATOL, V21, P1016, DOI 10.1111/j.1440-1746.2005.04027.x; Karabulut G, 2011, MOD RHEUMATOL, V21, P602, DOI 10.1007/s10165-011-0446-3; Koskela RM, 2008, EUR J GASTROEN HEPAT, V20, P276, DOI 10.1097/MEG.0b013e3282f2468d; Lee S, 2009, HISTOPATHOLOGY, V55, P660, DOI 10.1111/j.1365-2559.2009.03431.x; Mankai A, 2013, RHEUMATOL INT, V33, P665, DOI 10.1007/s00296-012-2431-3; Matthiesen LS, 1999, EUR J OBSTET GYN R B, V83, P21, DOI 10.1016/S0301-2115(98)00233-4; Miehlke S, 2009, GASTROENTEROLOGY, V136, P2092, DOI 10.1053/j.gastro.2009.02.078; Olesen M, 2004, GUT, V53, P536, DOI 10.1136/gut.2003.023440; Op de Beeck K, 2012, ARTHRITIS RHEUM-US, V64, P213, DOI 10.1002/art.33327; Pardi DS, 2011, GASTROENTEROLOGY, V140, P1155, DOI 10.1053/j.gastro.2011.02.003; Persson A, 2010, EXP DIABETES RES, DOI 10.1155/2010/173652; Pilia S, 2011, DIABETIC MED, V28, P896, DOI 10.1111/j.1464-5491.2011.03313.x; Prideaux L, 2012, INFLAMM BOWEL DIS, V18, P1340, DOI 10.1002/ibd.21903; Prummel MF, 2005, BEST PRACT RES CL EN, V19, P1, DOI 10.1016/j.beem.2004.11.003; Rahmati K, 2008, CLIN LAB, V54, P227; Rasmussen MA, 2012, ALIMENT PHARM THER, V36, P79, DOI 10.1111/j.1365-2036.2012.05166.x; Reichlin M, 2006, MEASUREMENT CLIN SIG; Roth B, 2013, SCAND J GASTROENTERO, V48, P27, DOI 10.3109/00365521.2012.741614; Simren M, 2001, SCAND J GASTROENTERO, V36, P545, DOI 10.1080/003655201750153476; Stewart M, 2011, ALIMENT PHARM THER, V33, P1340, DOI 10.1111/j.1365-2036.2011.04666.x; SVEDLUND J, 1988, DIGEST DIS SCI, V33, P129, DOI 10.1007/BF01535722; Symmons DPM, 2002, BEST PRACT RES CL RH, V16, P707, DOI 10.1053/berh.2002.0257; Tuomilehto J, 1998, NUTRITION, V14, P403; Weng JP, 2002, DIABETES CARE, V25, P68, DOI 10.2337/diacare.25.1.68; Westman KWA, 1998, KIDNEY INT, V53, P1230, DOI 10.1046/j.1523-1755.1998.00873.x; Yen EF, 2012, INFLAMM BOWEL DIS, V18, P1835, DOI 10.1002/ibd.22838	40	18	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66088	10.1371/journal.pone.0066088	http://dx.doi.org/10.1371/journal.pone.0066088			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776613	Green Published, Green Submitted, gold			2022-12-27	WOS:000320755400109
J	Yuan, ZX; Wang, XY; Qin, QY; Chen, DF; Zhong, QH; Wang, L; Wang, JP				Yuan, Zi-Xu; Wang, Xiao-Yan; Qin, Qi-Yuan; Chen, De-Feng; Zhong, Qing-Hua; Wang, Lei; Wang, Jian-Ping			The Prognostic Role of BRAF Mutation in Metastatic Colorectal Cancer Receiving Anti-EGFR Monoclonal Antibodies: A Meta-Analysis	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; CETUXIMAB PLUS IRINOTECAN; 1ST-LINE TREATMENT; CLINICAL-TRIALS; PHASE-II; KRAS; THERAPY; RESISTANCE; DEREGULATION; FLUOROURACIL	Background: BRAF mutation has been investigated as a prognostic factor in metastatic colorectal cancer (mCRC) undergoing anti-EGFR monoclonal antibodies (moAbs), but current results are still inconclusive. The aim of this meta-analysis was to evaluate the relationship between BRAF mutation status and the prognosis of mCRC patients treated with moAbs. Methods: Eligible studies were identified by systematically searching Pubmed, the Cochrane Library, Web of Knowledge, and OVID. Risk ratio (RR) for overall response rate (ORR), Hazard ratios (HRs) for Progression free survival (PFS) and Overall survival (OS) were extracted or calculated. Prespecified subgroup analyses were conducted in KRAS wild-type and in different study types. The source of between-trial variation was explored by sensitivity analyses. Quality assessment was conducted by the Hayden's criteria. Results: A total of twenty one trials including 5229 patients were identified for the meta-analysis. 343 patients displayed BRAF mutations of 4616 (7.4%) patients with known BRAF status. Patients with BRAF wild-type (WT) showed decreased risks of progression and death with an improved PFS(HR 0.38, 95% confidence intervals 0.29-0.51) and an improved OS (HR 0.35 [0.29-0.42]), compared to BRAF mutant. In KRAS WT population, there were even larger PFS benefit (HR 0.29[0.19,0.43]) and larger OS benefit (HR 0.26 [0.20,0.35]) in BRAF WT. A response benefit for BRAF WT was observed (RR 0.31[0.18,0.53]) in KRAS WT patients, but not observed in unselected patients (RR 0.76 [0.43-1.33]). The results were consistent in the subgroup analysis of different study types. Heterogeneity between trials decreased in the subgroup and explained by sensitivity analysis. No publication bias of ORR, PFS and OS were detected. Conclusions: The results indicate that BRAF mutant is a predictive biomarker for poor prognosis in mCRC patients undergoing anti-EGFR MoAbs therapy, especially in KRAS WT patients. Additional large prospective trials are required to confirm the predictive role of BRAF status.	[Yuan, Zi-Xu; Qin, Qi-Yuan; Chen, De-Feng; Zhong, Qing-Hua; Wang, Lei; Wang, Jian-Ping] Sun Yat Sen Univ, Dept Colorectal Surg, Affiliated Hosp 6, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Xiao-Yan; Wang, Lei; Wang, Jian-Ping] Sun Yat Sen Univ, Gastrointestinal Dis Inst, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Wang, L (corresponding author), Sun Yat Sen Univ, Dept Colorectal Surg, Affiliated Hosp 6, Guangzhou 510275, Guangdong, Peoples R China.	leiwangyinghu@yahoo.com.cn; wangjpgz@yahoo.com.cn	Wang, Xiaoyan/AAU-6258-2021	Wang, Xiaoyan/0000-0002-5140-676X	National Natural Science Foundation of China (NSFC) [81072042]; Chinese Ministry of Education's "Doctor Station'' Foundation [20120171110096]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Education's "Doctor Station'' Foundation	The study was supported by National Natural Science Foundation of China (NSFC) (grant no. 81072042, URL: http://www.gov.cn/banshi/qy/rlzy/2005-09/03/content_29011.htm) and supported by Chinese Ministry of Education's "Doctor Station'' Foundation (grant no. 20120171110096, URL: http://www.moe.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegra CJ, 2009, J CLIN ONCOL, V27, P2091, DOI 10.1200/JCO.2009.21.9170; Benvenuti S, 2007, CANCER RES, V67, P2643, DOI 10.1158/0008-5472.CAN-06-4158; Bokemeyer C, 2011, ANN ONCOL, V22, P1535, DOI 10.1093/annonc/mdq632; Bokemeyer C, 2012, EUR J CANCER, V48, P1466, DOI 10.1016/j.ejca.2012.02.057; Cappuzzo F, 2008, BRIT J CANCER, V99, P83, DOI 10.1038/sj.bjc.6604439; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Di Nicolantonio F, 2008, J CLIN ONCOL, V26, P5705, DOI 10.1200/JCO.2008.18.0786; Duffaud F, 2000, B CANCER, V87, P881, DOI 10.1093/jnci/92.3.205; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ferlay J, 2007, ANN ONCOL, V18, P581, DOI 10.1093/annonc/mdl498; Fornaro L, 2011, CRIT REV ONCOL HEMAT, V78, P243, DOI 10.1016/j.critrevonc.2010.06.003; Frattini M, 2004, ONCOGENE, V23, P7436, DOI 10.1038/sj.onc.1207980; Freeman DJ, 2008, CLIN COLORECTAL CANC, V7, P184, DOI 10.3816/CCC.2008.n.024; Hayden JA, 2006, ANN INTERN MED, V144, P427, DOI 10.7326/0003-4819-144-6-200603210-00010; Hedges LV, 2001, PSYCHOL METHODS, V6, P203, DOI 10.1037/1082-989X.6.3.203; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Laurent-Puig P, 2009, J CLIN ONCOL, V27, P5924, DOI 10.1200/JCO.2008.21.6796; Linardou H, 2008, LANCET ONCOL, V9, P962, DOI 10.1016/S1470-2045(08)70206-7; Loupakis F, 2009, BRIT J CANCER, V101, P715, DOI 10.1038/sj.bjc.6605177; Lui KJ, 2005, STAT MED, V24, P1275, DOI 10.1002/sim.1989; Maan ZN, 2012, BRIT J SURG, V99, P1610, DOI 10.1002/bjs.8893; Mao C, 2011, MOL BIOL REP, V38, P2219, DOI 10.1007/s11033-010-0351-4; MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6; Modest DP, 2012, INT J CANCER, V131, P980, DOI 10.1002/ijc.26467; Molinari F, 2009, BRIT J CANCER, V100, P1087, DOI 10.1038/sj.bjc.6604848; Moroni M, 2005, LANCET ONCOL, V6, P279, DOI 10.1016/S1470-2045(05)70102-9; Park JH, 2011, CANCER CHEMOTH PHARM, V68, P1045, DOI 10.1007/s00280-011-1586-z; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Perrone F, 2009, ANN ONCOL, V20, P84, DOI 10.1093/annonc/mdn541; Saltz LB, 2004, J CLIN ONCOL, V22, P1201, DOI 10.1200/JCO.2004.10.182; Saridaki Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015980; Saridaki Z, 2010, WORLD J GASTROENTERO, V16, P1177, DOI 10.3748/wjg.v16.i10.1177; Sartore-Bianchi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007287; Spindler KLG, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-107; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Tol J, 2010, EUR J CANCER, V46, P1997, DOI 10.1016/j.ejca.2010.03.036; Tol J, 2009, NEW ENGL J MED, V361, P98, DOI 10.1056/NEJMc0904160; Tveit KM, 2012, J CLIN ONCOL, V30, P1755, DOI 10.1200/JCO.2011.38.0915; Vale CL, 2012, CANCER TREAT REV, V38, P618, DOI 10.1016/j.ctrv.2011.11.002; Van Cutsem E, 2011, J CLIN ONCOL, V29, P2011, DOI 10.1200/JCO.2010.33.5091; Wong NS, 2011, ANTICANCER RES, V31, P255; Yan J, 1998, J BIOL CHEM, V273, P24052, DOI 10.1074/jbc.273.37.24052	48	68	75	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65995	10.1371/journal.pone.0065995	http://dx.doi.org/10.1371/journal.pone.0065995			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776587	Green Published, Green Submitted, gold			2022-12-27	WOS:000320755400094
J	Zhang, Y; Schuff, N; Camacho, M; Chao, LL; Fletcher, TP; Yaffe, K; Woolley, SC; Madison, C; Rosen, HJ; Miller, BL; Weiner, MW				Zhang, Yu; Schuff, Norbert; Camacho, Monica; Chao, Linda L.; Fletcher, Thomas P.; Yaffe, Kristine; Woolley, Susan C.; Madison, Catherine; Rosen, Howard J.; Miller, Bruce L.; Weiner, Michael W.			MRI Markers for Mild Cognitive Impairment: Comparisons between White Matter Integrity and Gray Matter Volume Measurements	PLOS ONE			English	Article							MINI-MENTAL-STATE; ALZHEIMERS-DISEASE; HIPPOCAMPAL VOLUME; POSTERIOR CINGULATE; ENTORHINAL CORTEX; DIAGNOSTIC UTILITY; ABNORMAL INTEGRITY; FIBER TRACTS; DIFFUSION; ATROPHY	The aim of the study was to evaluate the value of assessing white matter integrity using diffusion tensor imaging (DTI) for classification of mild cognitive impairment (MCI) and prediction of cognitive impairments in comparison to brain atrophy measurements using structural MRI. Fifty-one patients with MCI and 66 cognitive normal controls (CN) underwent DTI and T1-weighted structural MRI. DTI measures included fractional anisotropy (FA) and radial diffusivity (DR) from 20 predetermined regions-of-interest (ROIs) in the commissural, limbic and association tracts, which are thought to be involved in Alzheimer's disease; measures of regional gray matter (GM) volume included 21 ROIs in medial temporal lobe, parietal cortex, and subcortical regions. Significant group differences between MCI and CN were detected by each MRI modality: In particular, reduced FA was found in splenium, left isthmus cingulum and fornix; increased DR was found in splenium, left isthmus cingulum and bilateral uncinate fasciculi; reduced GM volume was found in bilateral hippocampi, left entorhinal cortex, right amygdala and bilateral thalamus; and thinner cortex was found in the left entorhinal cortex. Group classifications based on FA or DR was significant and better than classifications based on GM volume. Using either DR or FA together with GM volume improved classification accuracy. Furthermore, all three measures, FA, DR and GM volume were similarly accurate in predicting cognitive performance in MCI patients. Taken together, the results imply that DTI measures are as accurate as measures of GM volume in detecting brain alterations that are associated with cognitive impairment. Furthermore, a combination of DTI and structural MRI measurements improves classification accuracy.	[Zhang, Yu; Schuff, Norbert; Camacho, Monica; Chao, Linda L.; Weiner, Michael W.] San Francisco VA Med Ctr, Ctr Imaging Neurodegenerat Dis, San Francisco, CA USA; [Zhang, Yu; Schuff, Norbert; Camacho, Monica; Chao, Linda L.; Weiner, Michael W.] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Fletcher, Thomas P.] Univ Utah, Sci Comp & Imaging Inst, Salt Lake City, UT USA; [Yaffe, Kristine] San Francisco VA Med Ctr, Dept Psychiat Neurol & Epidemiol, San Francisco, CA USA; [Yaffe, Kristine] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Woolley, Susan C.; Madison, Catherine] Calif Pacific Med Ctr, Dept Neurol, San Francisco, CA USA; [Rosen, Howard J.; Miller, Bruce L.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco; California Pacific Medical Center; University of California System; University of California San Francisco	Zhang, Y (corresponding author), San Francisco VA Med Ctr, Ctr Imaging Neurodegenerat Dis, San Francisco, CA USA.	Yu.Zhang@ucsf.edu		Chao, Linda/0000-0002-8593-2434; Zhang, Yu/0000-0001-8066-7275	National Institutes of Health/National Institute on Aging [P01AG19724, P01AG12435]; NIH/National Center for Research Resources [P41RR023953]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR023953] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG019724, P01AG012435] Funding Source: NIH RePORTER	National Institutes of Health/National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH/National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported in part by National Institutes of Health/National Institute on Aging grants P01AG19724, P01AG12435 and grant from NIH/National Center for Research Resources P41RR023953, which were administered by the Northern California Institute for Research and Education, and with resources of the Veterans Affairs Medical Center, San Francisco, California. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Cabronero J, 2010, BRAIN, V133, P529, DOI 10.1093/brain/awp257; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Bai F, 2009, J NEUROL SCI, V278, P102, DOI 10.1016/j.jns.2008.12.009; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bottino CMC, 2002, INT PSYCHOGERIATR, V14, P59, DOI 10.1017/S1041610202008281; Bozoki AC, 2012, HUM BRAIN MAPP, V33, P1792, DOI 10.1002/hbm.21320; Bozzali M, 2012, HUM BRAIN MAPP, V33, P1295, DOI 10.1002/hbm.21287; Callen DJA, 2001, NEUROLOGY, V57, P1669, DOI 10.1212/WNL.57.9.1669; Chen TF, 2009, PSYCHIAT RES-NEUROIM, V173, P15, DOI 10.1016/j.pscychresns.2008.09.002; Cho H, 2008, J KOREAN MED SCI, V23, P477, DOI 10.3346/jkms.2008.23.3.477; Choo IH, 2010, NEUROBIOL AGING, V31, P772, DOI 10.1016/j.neurobiolaging.2008.06.015; Chua TC, 2008, CURR OPIN NEUROL, V21, P83, DOI 10.1097/WCO.0b013e3282f4594b; Chua TC, 2009, AM J GERIAT PSYCHIAT, V17, P602, DOI 10.1097/JGP.0b013e3181a76e0b; Clerx L, 2012, J ALZHEIMERS DIS, V29, P405, DOI 10.3233/JAD-2011-110797; Colliot O, 2008, RADIOLOGY, V248, P194, DOI 10.1148/radiol.2481070876; Cui Y, 2012, NEUROIMAGE, V59, P1209, DOI 10.1016/j.neuroimage.2011.08.013; Davatzikos C, 2005, NEUROIMAGE, V28, P663, DOI 10.1016/j.neuroimage.2005.08.009; De Santi S, 2001, NEUROBIOL AGING, V22, P529, DOI 10.1016/S0197-4580(01)00230-5; Delano-Wood L, 2010, NEUROBIOL AGING, V31, P1721, DOI 10.1016/j.neurobiolaging.2008.09.013; Delis DC, 2001, DELIS KAPLAN EXECUTI; Delis DC, 2000, CALIFORNIA VERBAL LE, DOI DOI 10.1016/j.schres.2003.09.011; Desikan RS, 2009, BRAIN, V132, P2048, DOI 10.1093/brain/awp123; Douaud G, 2011, NEUROIMAGE, V55, P880, DOI 10.1016/j.neuroimage.2010.12.008; Du AT, 2001, J NEUROL NEUROSUR PS, V71, P441, DOI 10.1136/jnnp.71.4.441; Edison P, 2007, NEUROLOGY, V68, P501, DOI 10.1212/01.wnl.0000244749.20056.d4; Fellgiebel A, 2005, NEUROBIOL AGING, V26, P1193, DOI 10.1016/j.neurobiolaging.2004.11.006; Fellgiebel A, 2004, DEMENT GERIATR COGN, V18, P101, DOI 10.1159/000077817; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frisoni GB, 2003, ARCH NEUROL-CHICAGO, V60, P1023, DOI 10.1001/archneur.60.7.1023-a; Frisoni GB, 2010, NAT REV NEUROL, V6, P67, DOI 10.1038/nrneurol.2009.215; Grambaite R, 2011, J ALZHEIMERS DIS, V27, P453, DOI 10.3233/JAD-2011-110290; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; Grundman M, 2003, J MOL NEUROSCI, V20, P241, DOI 10.1385/JMN:20:3:241; Grundman M, 2002, J MOL NEUROSCI, V19, P23, DOI 10.1007/s12031-002-0006-6; Hastie T., 2009, UNSUPERVISED LEARNIN; Hoeft F, 2007, J NEUROSCI, V27, P11960, DOI 10.1523/JNEUROSCI.3591-07.2007; Jack CR, 1999, NEUROLOGY, V52, P1397, DOI 10.1212/WNL.52.7.1397; Jacobs HIL, 2012, NEUROSCI BIOBEHAV R, V36, P297, DOI 10.1016/j.neubiorev.2011.06.009; Jauhiainen AM, 2009, HIPPOCAMPUS, V19, P166, DOI 10.1002/hipo.20494; Jones BF, 2006, CEREB CORTEX, V16, P1701, DOI 10.1093/cercor/bhj105; Kantarci K, 2002, DEMENT GERIATR COGN, V14, P198, DOI 10.1159/000066021; Kiuchi K, 2009, BRAIN RES, V1287, P184, DOI 10.1016/j.brainres.2009.06.052; Lee DY, 2009, NEUROLOGY, V73, P1722, DOI 10.1212/WNL.0b013e3181c33afb; Loewenstein DA, 2009, AM J GERIAT PSYCHIAT, V17, P1050, DOI 10.1097/JGP.0b013e3181b7ef42; Mielke MM, 2009, NEUROIMAGE, V46, P47, DOI 10.1016/j.neuroimage.2009.01.054; Morra JH, 2009, HUM BRAIN MAPP, V30, P2766, DOI 10.1002/hbm.20708; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Mosconi L, 2007, EXP GERONTOL, V42, P129, DOI 10.1016/j.exger.2006.05.016; Muller MJ, 2007, NEUROBIOL AGING, V28, P398, DOI 10.1016/j.neurobiolaging.2006.01.009; Oishi Kenichi, 2011, Front Neurol, V2, P54, DOI 10.3389/fneur.2011.00054; PEARSON RCA, 1987, J NEURAL TRANSM, P139; Pennanen C, 2004, NEUROBIOL AGING, V25, P303, DOI 10.1016/S0197-4580(03)00084-8; Petersen RC, 2000, NEUROLOGY, V54, P581, DOI 10.1212/WNL.54.3.581; Petersen RC, 2009, CURR ALZHEIMER RES, V6, P324, DOI 10.2174/156720509788929237; Pievani M, 2010, HUM BRAIN MAPP, V31, P1862, DOI 10.1002/hbm.20978; Ramani A, 2006, RADIOLOGY, V241, P26, DOI 10.1148/radiol.2411050628; Ringman JM, 2007, BRAIN, V130, P1767, DOI 10.1093/brain/awm102; Rogalski EJ, 2009, BEHAV NEUROL, V21, P51, DOI [10.3233/BEN-2009-0235, 10.1155/2009/408037]; Rose SE, 2006, J NEUROL NEUROSUR PS, V77, P1122, DOI 10.1136/jnnp.2005.074336; Sexton CE, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.05.019; Slavin MJ, 2007, AM J ROENTGENOL, V188, P1404, DOI 10.2214/AJR.06.1052; Sluimer JD, 2010, NEUROBIOL AGING, V31, P758, DOI 10.1016/j.neurobiolaging.2008.06.016; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Stahl R, 2007, RADIOLOGY, V243, P483, DOI 10.1148/radiol.2432051714; Tao R, 2009, LECT NOTES COMPUT SC, V5636, P664; Teipel SJ, 2011, HUM BRAIN MAPP, V32, P1349, DOI 10.1002/hbm.21111; Ukmar M, 2008, RADIOL MED, V113, P915, DOI 10.1007/s11547-008-0286-1; Vemuri P, 2009, NEUROLOGY, V73, P287, DOI 10.1212/WNL.0b013e3181af79e5; Walhovd KB, 2010, NEUROBIOL AGING, V31, P1107, DOI 10.1016/j.neurobiolaging.2008.08.013; Walhovd KB, 2009, NEUROIMAGE, V45, P215, DOI 10.1016/j.neuroimage.2008.10.053; Wang L, 2009, AM J NEURORADIOL, V30, P893, DOI 10.3174/ajnr.A1484; Whitwell JL, 2007, ARCH NEUROL-CHICAGO, V64, P1130, DOI 10.1001/archneur.64.8.1130; Wolf H, 2001, NEUROBIOL AGING, V22, P177, DOI 10.1016/S0197-4580(00)00238-4; Xu Y, 2000, NEUROLOGY, V54, P1760, DOI 10.1212/WNL.54.9.1760; Ystad Martin A, 2009, BMC Med Imaging, V9, P17, DOI 10.1186/1471-2342-9-17; Zhang Y, 2007, NEUROLOGY, V68, P13, DOI 10.1212/01.wnl.0000250326.77323.01; Zhuang L, 2010, NEUROIMAGE, V53, P16, DOI 10.1016/j.neuroimage.2010.05.068	79	52	54	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e66367	10.1371/journal.pone.0066367	http://dx.doi.org/10.1371/journal.pone.0066367			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762488	Green Published, gold			2022-12-27	WOS:000321099000132
J	Craigo, JK; Ezzelarab, C; Cook, SJ; Chong, L; Horohov, D; Issel, CJ; Montelaro, RC				Craigo, Jodi K.; Ezzelarab, Corin; Cook, Sheila J.; Chong, Liu; Horohov, David; Issel, Charles J.; Montelaro, Ronald C.			Envelope Determinants of Equine Lentiviral Vaccine Protection	PLOS ONE			English	Article							INFECTIOUS-ANEMIA VIRUS; SIMIAN IMMUNODEFICIENCY VIRUS; ATTENUATED HIV VACCINES; PRINCIPAL NEUTRALIZING DOMAIN; TRANSIENT IMMUNE SUPPRESSION; TERM INAPPARENT CARRIER; CYTOTOXIC T-LYMPHOCYTE; REPLICATION IN-VITRO; PERSISTENT INFECTION; VIRAL REPLICATION	Lentiviral envelope (Env) antigenic variation and associated immune evasion present major obstacles to vaccine development. The concept that Env is a critical determinant for vaccine efficacy is well accepted, however defined correlates of protection associated with Env variation have yet to be determined. We reported an attenuated equine infectious anemia virus (EIAV) vaccine study that directly examined the effect of lentiviral Env sequence variation on vaccine efficacy. The study identified a significant, inverse, linear correlation between vaccine efficacy and increasing divergence of the challenge virus Env gp90 protein compared to the vaccine virus gp90. The report demonstrated approximately 100% protection of immunized ponies from disease after challenge by virus with a homologous gp90 (EV0), and roughly 40% protection against challenge by virus (EV13) with a gp90 13% divergent from the vaccine strain. In the current study we examine whether the protection observed when challenging with the EV0 strain could be conferred to animals via chimeric challenge viruses between the EV0 and EV13 strains, allowing for mapping of protection to specific Env sequences. Viruses containing the EV13 proviral backbone and selected domains of the EV0 gp90 were constructed and in vitro and in vivo infectivity examined. Vaccine efficacy studies indicated that homology between the vaccine strain gp90 and the N-terminus of the challenge strain gp90 was capable of inducing immunity that resulted in significantly lower levels of post-challenge virus and significantly delayed the onset of disease. However, a homologous N-terminal region alone inserted in the EV13 backbone could not impart the 100% protection observed with the EV0 strain. Data presented here denote the complicated and potentially contradictory relationship between in vitro virulence and in vivo pathogenicity. The study highlights the importance of structural conformation for immunogens and emphasizes the need for antibody binding, not neutralizing, assays that correlate with vaccine protection.	[Craigo, Jodi K.; Ezzelarab, Corin; Montelaro, Ronald C.] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA 15213 USA; [Craigo, Jodi K.; Montelaro, Ronald C.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA USA; [Cook, Sheila J.; Chong, Liu; Horohov, David; Issel, Charles J.] Univ Kentucky, Gluck Equine Res Ctr, Dept Vet Sci, Lexington, KY USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Kentucky	Craigo, JK (corresponding author), Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA 15213 USA.	craigoj@pitt.edu	Liu, Chong/G-1734-2014		NIH/NIAID [RO1 AI25850]; Lucille P. Markey Charitable Trust; University of Kentucky Agricultural Experiment Station; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI025850] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Lucille P. Markey Charitable Trust; University of Kentucky Agricultural Experiment Station; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH/NIAID Grant RO1 AI25850 and by funds from the Lucille P. Markey Charitable Trust, the University of Kentucky Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel K, 2003, J VIROL, V77, P3099, DOI 10.1128/JVI.77.5.3099-3118.2003; Almond N, 1999, IMMUNOL LETT, V66, P167, DOI 10.1016/S0165-2478(98)00153-9; Amara RR, 2005, J VIROL, V79, P15356, DOI 10.1128/JVI.79.24.15356-15367.2005; Baba TW, 1999, NAT MED, V5, P194, DOI 10.1038/5557; BABA TW, 1995, SCIENCE, V267, P1820, DOI 10.1126/science.7892606; BALL JM, 1992, J VIROL, V66, P732, DOI 10.1128/JVI.66.2.732-742.1992; Berkhout B, 1999, J VIROL, V73, P1138, DOI 10.1128/JVI.73.2.1138-1145.1999; Blower SM, 2001, P NATL ACAD SCI USA, V98, P3618, DOI 10.1073/pnas.061029998; Bogers WMJM, 2000, AIDS, V14, pS141; Busch M, 2005, VACCINE, V23, P4036, DOI 10.1016/j.vaccine.2005.03.013; COGGINS L, 1970, CORNELL VET, V60, P330; Cook RF, 2002, J VIROL METHODS, V105, P171, DOI 10.1016/S0166-0934(02)00101-5; Craigo J.K., 2008, ENCY VIROL, V3, P167; Craigo JK, 2006, VIROLOGY, V344, P340, DOI 10.1016/j.virol.2005.09.006; Craigo JK, 2005, J VIROL, V79, P2666, DOI 10.1128/JVI.79.5.2666-2677.2005; Craigo JK, 2002, J GEN VIROL, V83, P1353, DOI 10.1099/0022-1317-83-6-1353; Craigo JK, 2007, P NATL ACAD SCI USA, V104, P15105, DOI 10.1073/pnas.0706449104; Craigo JK, 2007, VACCINE, V25, P834, DOI 10.1016/j.vaccine.2006.09.040; Craigo JK, 2012, J VIROL METHODS, V185, P221, DOI 10.1016/j.jviromet.2012.07.007; Craigo JK, 2010, VACCINE, V28, P8095, DOI 10.1016/j.vaccine.2010.10.003; Craigo JK, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-95; Das AT, 2005, J VIROL, V79, P3855, DOI 10.1128/JVI.79.6.3855-3858.2005; GRUND CH, 1994, J GEN VIROL, V75, P657, DOI 10.1099/0022-1317-75-3-657; Hambleton S, 2008, FRONT BIOSCI-LANDMRK, V13, P2696, DOI 10.2741/2876; Hammond SA, 1999, VIROLOGY, V254, P37, DOI 10.1006/viro.1998.9550; Hammond SA, 2000, J VIROL, V74, P5968, DOI 10.1128/JVI.74.13.5968-5981.2000; Hammond SA, 1997, J VIROL, V71, P3840, DOI 10.1128/JVI.71.5.3840-3852.1997; Harrold SM, 2000, J VIROL, V74, P3112, DOI 10.1128/JVI.74.7.3112-3121.2000; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hofmann-Lehmann R, 2003, AIDS, V17, P157, DOI 10.1097/00002030-200301240-00004; Howe L, 2005, J GEN VIROL, V86, P139, DOI 10.1099/vir.0.80374-0; Howe L, 2002, J VIROL, V76, P10588, DOI 10.1128/JVI.76.21.10588-10597.2002; HUSSAIN KA, 1988, ARCH VIROL, V98, P213, DOI 10.1007/BF01322170; ISSEL CJ, 1992, J VIROL, V66, P3398, DOI 10.1128/JVI.66.6.3398-3408.1992; Johnson RP, 1999, J VIROL, V73, P4952, DOI 10.1128/JVI.73.6.4952-4961.1999; Johnson RP, 1999, NAT MED, V5, P154, DOI 10.1038/5515; Johnson RP, 1998, CURR OPIN IMMUNOL, V10, P436, DOI 10.1016/S0952-7915(98)80118-0; Koff WC, 2006, NAT IMMUNOL, V7, P19, DOI 10.1038/ni1296; KONO Y, 1976, NATL I ANIM HEALTH Q, V16, P8; Kumar A, 2002, VIROLOGY, V301, P189, DOI 10.1006/viro.2002.1544; Kumar A, 2008, VIROLOGY, V371, P238, DOI 10.1016/j.virol.2007.10.008; Leroux C, 1997, J VIROL, V71, P9627, DOI 10.1128/JVI.71.12.9627-9639.1997; Leroux C, 2004, VET RES, V35, P485, DOI 10.1051/vetres:2004020; Leroux C, 2001, J VIROL, V75, P4570, DOI 10.1128/JVI.75.10.4570-4583.2001; Li F, 1998, J VIROL, V72, P8344, DOI 10.1128/JVI.72.10.8344-8348.1998; Li F, 2000, J VIROL, V74, P573, DOI 10.1128/JVI.74.1.573-579.2000; Li F, 2003, J VIROL, V77, P7244, DOI 10.1128/JVI.77.13.7244-7253.2003; LICHTENSTEIN DL, 1995, J VIROL, V69, P2881, DOI 10.1128/JVI.69.5.2881-2888.1995; Lichtenstein DL, 1996, J VIROL, V70, P3346, DOI 10.1128/JVI.70.6.3346-3354.1996; McMichael AJ, 2012, NAT IMMUNOL, V13, P423, DOI 10.1038/ni.2264; Melink JA, 1994, VACCINES, P155; Mills J, 2000, AIDS RES HUM RETROV, V16, P1453, DOI 10.1089/088922200750005976; Mims CA, 1987, PATHOGENESIS INFECT, P303; Montefiori DC, 2012, J INFECT DIS, V206, P431, DOI 10.1093/infdis/jis367; Montelaro R C, 1995, AIDS, V9 Suppl A, pS111; Montelaro R. C., 1993, The Retroviridae, volume 2., P257; Montelaro RC, 1998, AIDS RES HUM RETROV, V14, pS255; Papandreou MJ, 1996, FEBS LETT, V379, P171, DOI 10.1016/0014-5793(95)01505-1; PAYNE SL, 1987, VIROLOGY, V161, P321, DOI 10.1016/0042-6822(87)90124-3; Raabe ML, 1998, VIROLOGY, V245, P151, DOI 10.1006/viro.1998.9142; Raabe MR, 1998, J VIROL METHODS, V71, P87, DOI 10.1016/S0166-0934(97)00204-8; Reynolds MR, 2008, J EXP MED, V205, P2537, DOI 10.1084/jem.20081524; Ruprecht RM, 1999, IMMUNOL REV, V170, P135, DOI 10.1111/j.1600-065X.1999.tb01335.x; RWAMBO PM, 1990, ARCH VIROL, V111, P199, DOI 10.1007/BF01311054; RWAMBO PM, 1990, ARCH VIROL, V111, P275, DOI 10.1007/BF01311062; SHEN RX, 1985, EIAV NATL REV POLICI; Shental-Bechor D, 2008, P NATL ACAD SCI USA, V105, P8256, DOI 10.1073/pnas.0801340105; Sponseller BA, 2007, VIROLOGY, V363, P156, DOI 10.1016/j.virol.2007.01.037; Tagmyer TL, 2008, J VIROL, V82, P4052, DOI 10.1128/JVI.02028-07; Tagmyer TL, 2007, J GEN VIROL, V88, P1324, DOI 10.1099/vir.0.82391-0; Uhl EW, 2002, VET IMMUNOL IMMUNOP, V90, P113, DOI 10.1016/S0165-2427(02)00227-1; WANG SZS, 1994, VIROLOGY, V199, P247, DOI 10.1006/viro.1994.1120; Whitney JB, 2004, CURR OPIN INFECT DIS, V17, P17, DOI 10.1097/00001432-200402000-00004; Zheng YH, 1997, J GEN VIROL, V78, P807, DOI 10.1099/0022-1317-78-4-807; Zheng YH, 1997, J VIROL, V71, P5031, DOI 10.1128/JVI.71.7.5031-5039.1997	75	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66093	10.1371/journal.pone.0066093	http://dx.doi.org/10.1371/journal.pone.0066093			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785473	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000321038800049
J	Toscano, MJ; Wilkins, LJ; Millburn, G; Thorpe, K; Tarlton, JF				Toscano, Michael J.; Wilkins, Lindsay J.; Millburn, Georgina; Thorpe, Katherine; Tarlton, John F.			Development of an Ex Vivo Protocol to Model Bone Fracture in Laying Hens Resulting from Collisions	PLOS ONE			English	Article							BROKEN BONES; OSTEOPOROSIS; STRENGTH; KEEL; PREVALENCE; SYSTEM	Fractures of the keel bone, a bone extending ventrally from the sternum, are a serious health and welfare problem in free range laying hens. Recent findings suggest that a major cause of keel damage within extensive systems is collisions with internal housing structures, though investigative efforts have been hindered by difficulties in examining mechanisms and likely influencing factors at the moment of fracture. The objectives of this study were to develop an ex vivo impact protocol to model bone fracture in hens caused by collision, to assess impact and bird-related factors influencing fracture occurrence and severity, and to identify correlations of mechanical and structural properties between different skeletal sites. We induced keel bone fractures in euthanized hens using a drop-weight impact tester able to generate a range of impact energies, producing fractures that replicate those commonly found in commercial settings. The results demonstrated that impact energies of a similar order to those expected in normal housing were able to produce fractures, and that greater collision energies resulted in an increased likelihood of fractures and of greater severity. Relationships were also seen with keel's lateral surface bone mineral density, and the peak reactive force (strength) at the base of the manubrial spine. Correlations were also identified between the keel and long bones with respect to both strength and bone mineral density. This is the first study able to relate impact and bone characteristics with keel bone fracture at the moment of collision. Greater understanding of these relationships will provide means to reduce levels of breakage and severity in commercial systems.	[Toscano, Michael J.; Wilkins, Lindsay J.; Millburn, Georgina; Thorpe, Katherine; Tarlton, John F.] Univ Bristol, Sch Vet Sci, Lower Langford, North Somerset, England	University of Bristol	Toscano, MJ (corresponding author), Univ Bristol, Sch Vet Sci, Lower Langford, North Somerset, England.	Michael.toscano@vetsuisse.unibe.ch		Tarlton, John/0000-0002-4886-6634	UK's Biological and Biotechnology Scientific Research Council [BB/G012709/1]; Welcome Trust; Nuffield Foundation; Biotechnology and Biological Sciences Research Council [BB/K001906/1, BB/G012709/1] Funding Source: researchfish; BBSRC [BB/G012709/1, BB/K001906/1] Funding Source: UKRI	UK's Biological and Biotechnology Scientific Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Welcome Trust(Wellcome Trust); Nuffield Foundation; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Work on this grant was supported by the UK's Biological and Biotechnology Scientific Research Council (BB/G012709/1) as well as grants from the Welcome Trust and Nuffield Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEIC, 2012, EGG FACTS FIG; Bishop SC, 2000, BRIT POULTRY SCI, V41, P33, DOI 10.1080/00071660086376; Clark WD, 2008, POULTRY SCI, V87, P1964, DOI 10.3382/ps.2008-00115; Donaldson CJ, 2012, POULTRY SCI, V91, P304, DOI 10.3382/ps.2011-01774; Dunn IC, 2007, ANIM GENET, V38, P45, DOI 10.1111/j.1365-2052.2006.01547.x; FAWC, 2010, OP OST BON FRACT LAY; Gregory NG, 1996, NEW ZEAL VET J, V44, P31, DOI 10.1080/00480169.1996.35928; GREGORY NG, 1990, BRIT POULTRY SCI, V31, P59, DOI 10.1080/00071669008417231; HEWSON P, 1986, BRIT POULTRY SCI, V27, P525, DOI 10.1080/00071668608416912; King AS, 1975, SISSON GROSSMANS ANA, P1787; Nelson HD, 2002, ANN INTERN MED, V137, P529, DOI 10.7326/0003-4819-137-6-200209170-00015; Rasbash J, 2009, USERS GUIDE MLWIN V2, V2, P10; Sambrook P, 2006, LANCET, V367, P2010, DOI 10.1016/S0140-6736(06)68891-0; Sandilands V., 2010, P 44 C INT SOC APPL, P249; Tarlton JF, 2013, BONE, V52, P578, DOI 10.1016/j.bone.2012.11.003; Whitehead CC, 2004, POULT SCI S, V27, P259, DOI 10.1079/9780851998138.0259; Wilkins LJ, 2011, VET REC, V169, P414, DOI 10.1136/vr.d4831; Wilkins LJ, 2004, VET REC, V155, P547, DOI 10.1136/vr.155.18.547	18	27	27	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66215	10.1371/journal.pone.0066215	http://dx.doi.org/10.1371/journal.pone.0066215			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785487	Green Submitted, Green Published, gold			2022-12-27	WOS:000321038800036
J	Tzoulis, C; Johansson, S; Haukanes, BI; Boman, H; Knappskog, PM; Bindoff, LA				Tzoulis, Charalampos; Johansson, Stefan; Haukanes, Bjorn Ivar; Boman, Helge; Knappskog, Per Morten; Bindoff, Laurence A.			Novel SACS Mutations Identified by Whole Exome Sequencing in a Norwegian Family with Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay	PLOS ONE			English	Article							CEREBELLAR-ATAXIA; ARSACS; GENE; POPULATION; LINKAGE; TOOL; MRI	We employed whole exome sequencing to investigate three Norwegian siblings with an autosomal recessive spastic ataxia and epilepsy. All patients were compound heterozygous (c.13352T>C, p.Leu4451Pro; c.6890T>G, p.Leu2297Trp) for mutations in the SACS gene establishing the diagnosis of autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS). The clinical features shown by our patients were typical of this disorder with the exception of epilepsy, which is a rare manifestation. This is the first report of ARSACS in Scandinavian patients and our findings expand the genetic and clinical spectrum of this rare disorder. Moreover, we show that exome sequencing is a powerful and cost-effective tool for the diagnosis of genetically heterogeneous disorders such as the hereditary ataxias.	[Tzoulis, Charalampos; Bindoff, Laurence A.] Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway; [Tzoulis, Charalampos; Boman, Helge; Knappskog, Per Morten; Bindoff, Laurence A.] Univ Bergen, Dept Clin Med, Bergen, Norway; [Johansson, Stefan; Haukanes, Bjorn Ivar; Boman, Helge; Knappskog, Per Morten] Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway; [Johansson, Stefan] Univ Bergen, Dept Biomed, Bergen, Norway; [Johansson, Stefan; Knappskog, Per Morten] Univ Bergen, KG Jebsen Ctr Res Neuropsychiat Disorders, Bergen, Norway	University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen	Bindoff, LA (corresponding author), Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway.	laurence.bindoff@helse-bergen.no	Johansson, Stefan/C-4394-2011; Tzoulis, Charalampos/AGD-5114-2022	Johansson, Stefan/0000-0002-2298-7008; Tzoulis, Charalampos/0000-0003-0341-5191; Haukanes, Bjorn Ivar/0000-0003-1559-3366; Bindoff, Laurence/0000-0003-0988-276X	Western Norway Health Trust, University of Bergen	Western Norway Health Trust, University of Bergen	This work was supported by grants from the Western Norway Health Trust, University of Bergen. Western Norway Regional Health Authority (Helse Vest). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anheim M, 2008, REV NEUROL-FRANCE, V164, P363, DOI 10.1016/j.neurol.2008.02.001; BOUCHARD JP, 1978, CAN J NEUROL SCI, V5, P61, DOI 10.1017/S0317167100024793; Bouchard JP, 1998, NEUROMUSCULAR DISORD, V8, P474, DOI 10.1016/S0960-8966(98)00055-8; Bouchard JP, 1991, RECESSIVE SPASTIC AT, P451; BOUCHARD RW, 1979, CAN J NEUROL SCI, V6, P191, DOI 10.1017/S0317167100119626; Criscuolo C, 2005, MOVEMENT DISORD, V20, P1358, DOI 10.1002/mds.20579; Criscuolo C, 2004, NEUROLOGY, V62, P100, DOI 10.1212/WNL.62.1.100; El Euch-Fayache G, 2003, ARCH NEUROL-CHICAGO, V60, P982, DOI 10.1001/archneur.60.7.982; Engert JC, 2000, NAT GENET, V24, P120, DOI 10.1038/72769; Erichsen AK, 2009, BRAIN, V132, P1577, DOI 10.1093/brain/awp056; Gazulla J, 2012, J NEUROL, V259, P869, DOI 10.1007/s00415-011-6269-5; Girard M, 2012, P NATL ACAD SCI USA, V109, P1661, DOI 10.1073/pnas.1113166109; Grieco GS, 2004, NEUROLOGY, V62, P103, DOI 10.1212/01.WNL.0000104491.66816.77; Haugarvoll K, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-1; Ku CS, 2012, ANN NEUROL, V71, P5, DOI 10.1002/ana.22647; Martin MH, 2007, AM J NEURORADIOL, V28, P1606, DOI 10.3174/ajnr.A0603; Mrissa N, 2000, NEUROLOGY, V54, P1408, DOI 10.1212/WNL.54.7.1408; Ogawa T, 2004, NEUROLOGY, V62, P107, DOI 10.1212/01.WNL.0000099371.14478.73; Ouyang Y, 2008, J NEUROL SCI, V264, P73, DOI 10.1016/j.jns.2007.07.022; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Pyle A, 2012, ARCH NEUROL-CHICAGO, V69, P1661, DOI 10.1001/2013.jamaneurol.389; Richter A, 1999, AM J HUM GENET, V64, P768, DOI 10.1086/302274; Richter A., 1996, American Journal of Human Genetics, V59, pA379; Richter AM, 2004, NEUROGENETICS, V5, P165, DOI 10.1007/s10048-004-0179-y; Sailer A, 2012, NEUROLOGY, V79, P127, DOI 10.1212/WNL.0b013e31825f048e; Shimazaki H, 2007, J NEUROL SCI, V255, P87, DOI 10.1016/j.jns.2007.02.002; Thiffault I, 2013, CAN J NEUROL SCI, V40, P61, DOI 10.1017/S0317167100012968; Tzoulis C, 2010, BRAIN, V133, P1428, DOI 10.1093/brain/awq067; Vanrietvelde F, 2000, EUR RADIOL, V10, P576, DOI 10.1007/s003300050964; Vermeer S, 2008, NEUROGENETICS, V9, P207, DOI 10.1007/s10048-008-0131-7	30	15	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66145	10.1371/journal.pone.0066145	http://dx.doi.org/10.1371/journal.pone.0066145			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785480	Green Published, gold, Green Submitted			2022-12-27	WOS:000321038800042
J	Lu, P; Bar-Yoseph, F; Levi, L; Lifshitz, Y; Witte-Bouma, J; de Bruijn, ACJM; Korteland-van Male, AM; van Goudoever, JB; Renes, IB				Lu, Peng; Bar-Yoseph, Fabiana; Levi, Liora; Lifshitz, Yael; Witte-Bouma, Janneke; de Bruijn, Adrianus C. J. M.; Korteland-van Male, Anita M.; van Goudoever, Johannes B.; Renes, Ingrid B.			High Beta-Palmitate Fat Controls the Intestinal Inflammatory Response and Limits Intestinal Damage in Mucin Muc2 Deficient Mice	PLOS ONE			English	Article							REGULATORY T-CELLS; PROLIFERATOR-ACTIVATED RECEPTOR; HUMAN-MILK FAT; SN-2 POSITION; PPAR-GAMMA; OXIDATIVE STRESS; INDUCED COLITIS; HOST-DEFENSE; ACID; TRIACYLGLYCEROLS	Background: Palmitic-acid esterified to the sn-1,3 positions of the glycerol backbone (alpha, alpha'-palmitate), the predominant palmitate conformation in regular infant formula fat, is poorly absorbed and might cause abdominal discomfort. In contrast, palmitic-acid esterified to the sn-2 position (beta-palmitate), the main palmitate conformation in human milk fat, is well absorbed. The aim of the present study was to examine the influence of high alpha, alpha'-palmitate fat (HAPF) diet and high beta-palmitate fat (HBPF) diet on colitis development in Muc2 deficient (Muc2(-/-)) mice, a well-described animal model for spontaneous enterocolitis due to the lack of a protective mucus layer. Methods: Muc2(-/-) mice received AIN-93G reference diet, HAPF diet or HBPF diet for 5 weeks after weaning. Clinical symptoms, intestinal morphology and inflammation in the distal colon were analyzed. Results: Both HBPF diet and AIN-93G diet limited the extent of intestinal erosions and morphological damage in Muc2(-/-) mice compared with HAPF diet. In addition, the immunosuppressive regulatory T (Treg) cell response as demonstrated by the up-regulation of Foxp3, Tgfb1 and Ebi3 gene expression levels was enhanced by HBPF diet compared with AIN-93G and HAPF diets. HBPF diet also increased the gene expression of Pparg and enzymatic antioxidants (Sod1, Sod3 and Gpx1), genes all reported to be involved in promoting an immunosuppressive Treg cell response and to protect against colitis. Conclusions: This study shows for the first time that HBPF diet limits the intestinal mucosal damage and controls the inflammatory response in Muc2(-/-) mice by inducing an immunosuppressive Treg cell response.	[Lu, Peng; Witte-Bouma, Janneke; de Bruijn, Adrianus C. J. M.; Korteland-van Male, Anita M.; Renes, Ingrid B.] Erasmus MC Sophia, Dept Pediat, Div Neonatol, Rotterdam, Netherlands; [Lu, Peng; van Goudoever, Johannes B.; Renes, Ingrid B.] Emma Childrens Hosp AMC, Dept Pediat, Amsterdam, Netherlands; [Bar-Yoseph, Fabiana; Levi, Liora; Lifshitz, Yael] Enzymotec LTD, Kfar Baruch, Israel; [van Goudoever, Johannes B.] Vrije Univ Amsterdam, Med Ctr, Dept Pediat, Amsterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Renes, IB (corresponding author), Erasmus MC Sophia, Dept Pediat, Div Neonatol, Rotterdam, Netherlands.	i.b.renes@amc.uva.nl	van Goudoever, Johannes Bernard/Y-4520-2018; Renes, Ingrid/C-4801-2013	van Goudoever, Johannes (Hans)/0000-0003-3960-1703	Enzymotec LTD.	Enzymotec LTD.	The study was funded by Enzymotec LTD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bento AF, 2011, AM J PATHOL, V178, P1153, DOI 10.1016/j.ajpath.2010.11.052; Boden EK, 2008, CURR OPIN GASTROEN, V24, P733, DOI 10.1097/MOG.0b013e328311f26e; Bommireddy R, 2007, TRENDS MOL MED, V13, P492, DOI 10.1016/j.molmed.2007.08.005; Burger-van Paassen N, 2011, AM J PHYSIOL-GASTR L, V301, pG667, DOI 10.1152/ajpgi.00199.2010; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; DEFOUW NJ, 1994, LIPIDS, V29, P765, DOI 10.1007/BF02536698; Dharmani P, 2009, J INNATE IMMUN, V1, P123, DOI 10.1159/000163037; Esworthy RS, 2001, AM J PHYSIOL-GASTR L, V281, pG848, DOI 10.1152/ajpgi.2001.281.3.G848; Forsythe CE, 2007, BRIT J NUTR, V98, P337, DOI 10.1017/S0007114507704993; Guri AJ, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-60; Hecht G, 1999, AM J PHYSIOL-CELL PH, V277, pC351, DOI 10.1152/ajpcell.1999.277.3.C351; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Hontecillas R, 2007, J IMMUNOL, V178, P2940, DOI 10.4049/jimmunol.178.5.2940; Jeffery NM, 1997, BBA-LIPID LIPID MET, V1345, P223, DOI 10.1016/S0005-2760(96)00174-9; Johansson MEV, 2011, CELL MOL LIFE SCI, V68, P3635, DOI 10.1007/s00018-011-0822-3; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Lee Yeon-Sook, 2008, Nutr Res Pract, V2, P3, DOI 10.4162/nrp.2008.2.1.3; Lei J, 2010, J IMMUNOL, V185, P7186, DOI 10.4049/jimmunol.1001437; Lopez-Lopez A, 2002, EUR J CLIN NUTR, V56, P1242, DOI 10.1038/sj.ejcn.1601470; Lopez-Lopez A, 2001, EARLY HUM DEV, V65, pS83, DOI 10.1016/S0378-3782(01)00210-9; Lu P., 2011, INFLAMM BOWEL DIS; Ma X, 2007, HEPATOLOGY, V46, P1519, DOI 10.1002/hep.21823; Manson WG, 1997, ARCH DIS CHILD-FETAL, V76, pF206, DOI 10.1136/fn.76.3.F206; Mohapatra SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010215; Nelson CM, 1999, AM J CLIN NUTR, V70, P62; Pina-Rodriguez AM, 2009, J AGR FOOD CHEM, V57, P4657, DOI 10.1021/jf900242g; Reeves PG, 1997, J NUTR, V127, pS838; Renes IB, 2002, INT J COLORECTAL DIS, V17, P317, DOI 10.1007/s00384-002-0409-4; Rezaie A, 2007, DIGEST DIS SCI, V52, P2015, DOI 10.1007/s10620-006-9622-2; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Sanders TAB, 2011, AM J CLIN NUTR, V94, P1433, DOI 10.3945/ajcn.111.017459; Segui J, 2004, J LEUKOCYTE BIOL, V76, P537, DOI 10.1189/jlb.0304196; Suzuki Y, 2008, COLORECTAL DIS, V10, P931, DOI 10.1111/j.1463-1318.2008.01487.x; Tan PH, 2005, J IMMUNOL, V174, P7633, DOI 10.4049/jimmunol.174.12.7633; Teichert SA, 2011, J AGR FOOD CHEM, V59, P5692, DOI 10.1021/jf200336t; Tsai PY, 2011, FREE RADICAL BIO MED, V51, P744, DOI 10.1016/j.freeradbiomed.2011.05.016; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; Velcich A, 1997, J BIOL CHEM, V272, P7968, DOI 10.1074/jbc.272.12.7968; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094	40	19	22	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65878	10.1371/journal.pone.0065878	http://dx.doi.org/10.1371/journal.pone.0065878			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776564	gold, Green Submitted, Green Published			2022-12-27	WOS:000320322400061
J	Souza, AP; Soto, M; Costa, JML; Boaventura, VS; de Oliveira, CI; Cristal, JR; Barral-Netto, M; Barral, A				Souza, Ana Paula; Soto, Manuel; Costa, Jackson M. L.; Boaventura, Viviane S.; de Oliveira, Camila I.; Cristal, Juqueline R.; Barral-Netto, Manoel; Barral, Aldina			Towards a More Precise Serological Diagnosis of Human Tegumentary Leishmaniasis Using Leishmania Recombinant Proteins	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; AMERICAN CUTANEOUS LEISHMANIASIS; HEAT-SHOCK PROTEINS; IMMUNE-RESPONSE; VISCERAL LEISHMANIASIS; ANTIGENIC DETERMINANTS; VIANNIA BRAZILIENSIS; CHIMERIC ANTIGEN; CHAGAS-DISEASE; SERODIAGNOSIS	Background: Exposure to Leishmania induces a humoral immune response that can be used as a marker of parasite exposure. Methodology/Principal Findings: Herein, ELISA was used to screen sera from patients with Tegumentary Leishmaniasis (TL) against different L. infantum-chagasi-derived recombinant proteins (rHSP70, rH2A, rH2B, rH3, rH4 and rKMP11). Among the recombinant proteins, rHSP70 and rH2A showed the best reactivity against human sera obtained from endemic areas of TL. Receiver-Operator Characteristics (ROC) curve analysis was used to identify the effectiveness of these proteins for serodiagnosis of TL. ROC curves confirmed the superior performance of rHSP70 and rH2A, in comparison to the other tested recombinant proteins. Additionally, we evaluated the specificity of the response to rHSP70 and rH2A by testing sera obtained from patients with Chagas' disease, Tuberculosis, Leprosy or Systemic Lupus Erythematosus. In this case, rHSP70 displayed an increased ability to discriminate diseases, in comparison to SLA. Conclusion: Our results raise possibility of using rHSP70 for the serodiagnosis of TL	[Souza, Ana Paula; Costa, Jackson M. L.; Boaventura, Viviane S.; de Oliveira, Camila I.; Cristal, Juqueline R.; Barral-Netto, Manoel; Barral, Aldina] Fundacao Oswaldo Cruz FIOCRUZ, Ctr Pesquisas Goncalo Moniz CPqGM, Salvador, BA, Brazil; [Soto, Manuel] Univ Autonoma Madrid, Ctr Biol Mol, Ctr Biol Mol Severo Ochoa CSIC UAM, E-28049 Madrid, Spain; [Boaventura, Viviane S.; de Oliveira, Camila I.; Barral-Netto, Manoel; Barral, Aldina] Univ Fed Bahia UFBA, Fac Med Bahia, Salvador, BA, Brazil; [de Oliveira, Camila I.; Barral-Netto, Manoel; Barral, Aldina] Inst Nacl Ciencia & Tecnol Invest Imunol Iii INCT, Salvador, BA, Brazil	Fundacao Oswaldo Cruz; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Universidade Federal da Bahia	Barral, A (corresponding author), Fundacao Oswaldo Cruz FIOCRUZ, Ctr Pesquisas Goncalo Moniz CPqGM, Salvador, BA, Brazil.	abarral@bahia.fiocruz.br	de Oliveira, Camila I/B-4358-2009; Boaventura, Viviane S/H-9165-2015; Barral-Netto, Manoel/B-3904-2009; Barral, Aldina/B-4191-2009; Álvarez, Manuel Soto/Q-5234-2018	de Oliveira, Camila I/0000-0002-7868-5164; Barral-Netto, Manoel/0000-0002-5823-7903; Barral, Aldina/0000-0002-7177-464X; Álvarez, Manuel Soto/0000-0001-6825-841X; Boaventura, Viviane/0000-0002-7241-6844	Pronex: CNPq/FAPESB; Ministerio de Economia y Competitividad [FIS PI11/00095]; CNPq	Pronex: CNPq/FAPESB(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ministerio de Economia y Competitividad(Spanish Government); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The research and publication process was supported by grants from from Pronex: CNPq/FAPESB. This study was in part supported in Spain by grant FIS PI11/00095 from Ministerio de Economia y Competitividad. APS received fellowship from CNPq. JML, CIO, MB-N and AB are senior investigators from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTHONY RL, 1987, AM J TROP MED HYG, V37, P271, DOI 10.4269/ajtmh.1987.37.271; ARDESHIR F, 1987, EMBO J, V6, P493, DOI 10.1002/j.1460-2075.1987.tb04780.x; BARRAL A, 1987, Memorias do Instituto Oswaldo Cruz, V82, P579, DOI 10.1590/S0074-02761987000400018; Barral A, 2000, AM J TROP MED HYG, V62, P740, DOI 10.4269/ajtmh.2000.62.740; Boarino A, 2005, CLIN DIAGN LAB IMMUN, V12, P647, DOI 10.1128/CDLI.12.5.647-653.2005; Boaventura VS, 2010, EUR J IMMUNOL, V40, P2830, DOI 10.1002/eji.200940115; Boggild AK, 2010, CLIN INFECT DIS, V50, pE1, DOI 10.1086/648730; Braz RFS, 2002, AM J TROP MED HYG, V67, P344, DOI 10.4269/ajtmh.2002.67.344; Carmelo E, 2002, CLIN DIAGN LAB IMMUN, V9, P808, DOI 10.1128/CDLI.9.4.808-811.2002; Carrillo E, 2008, VACCINE, V26, P1902, DOI 10.1016/j.vaccine.2008.01.042; CARVALHO EM, 1995, AM J TROP MED HYG, V53, P273, DOI 10.4269/ajtmh.1995.53.273; Cataldo JI, 2010, J CLIN LAB ANAL, V24, P289, DOI 10.1002/jcla.20402; Celeste BI, 2004, BRAZ J MED BIOL RES, V37, P1591, DOI 10.1590/S0100-879X2004001100001; Coelho EAF, 2009, CLIN VACCINE IMMUNOL, V16, P1774, DOI 10.1128/CVI.00295-09; de Carvalho LP, 2003, MICROBES INFECT, V5, P7, DOI 10.1016/S1286-4579(02)00051-5; de Oliveira CI, 2009, PARASITOL INT, V58, P319, DOI 10.1016/j.parint.2009.07.013; de Oliveira CI, 2003, CLIN INFECT DIS, V37, pE149, DOI 10.1086/379610; De Souza CM, 2012, PARASITE IMMUNOL, V34, P1, DOI 10.1111/j.1365-3024.2011.01334.x; DEANDRADE CR, 1992, J CLIN MICROBIOL, V30, P330, DOI 10.1128/JCM.30.2.330-335.1992; Dias SD, 2005, AM J TROP MED HYG, V72, P126, DOI 10.4269/ajtmh.2005.72.126; Fagundes A, 2010, MEM I OSWALDO CRUZ, V105, P109, DOI 10.1590/S0074-02762010000100018; Fuertes MA, 2001, J BIOL INORG CHEM, V6, P107, DOI 10.1007/s007750000175; Goto H, 2010, EXPERT REV ANTI-INFE, V8, P419, DOI [10.1586/eri.10.19, 10.1586/ERI.10.19]; GUIMARAES MCS, 1991, REV I MED TROP, V33, P503, DOI 10.1590/S0036-46651991000600012; HEDSTROM R, 1987, J EXP MED, V165, P1430, DOI 10.1084/jem.165.5.1430; Iborra S, 2004, VACCINE, V22, P3865, DOI 10.1016/j.vaccine.2004.04.015; Iniesta L, 2002, CLIN DIAGN LAB IMMUN, V9, P1137, DOI 10.1128/CDLI.9.5.1137-1141.2002; JONES TC, 1987, J INFECT DIS, V156, P73, DOI 10.1093/infdis/156.1.73; KALTER DC, 1994, DERMATOL CLIN, V12, P37, DOI 10.1016/S0733-8635(18)30200-6; Kubar J, 2005, LANCET INFECT DIS, V5, P107, DOI 10.1016/S1473-3099(05)70085-2; Lunedo SN, 2012, ACTA HISTOCHEM, V114, P252, DOI 10.1016/j.acthis.2011.06.002; LYNCH NR, 1986, T ROY SOC TROP MED H, V80, P6, DOI 10.1016/0035-9203(86)90183-5; Maalej IA, 2003, AM J TROP MED HYG, V68, P312, DOI 10.4269/ajtmh.2003.68.312; Mabey D, 2004, NAT REV MICROBIOL, V2, P231, DOI 10.1038/nrmicro841; Meddeb-Garnaoui A, 2010, VACCINE, V28, P1881, DOI 10.1016/j.vaccine.2009.11.075; Montoya Y, 1997, T ROY SOC TROP MED H, V91, P674, DOI 10.1016/S0035-9203(97)90520-4; Ndao M., 2009, Interdisciplinary Perspectives on Infectious Diseases, V2009, P278246, DOI 10.1155/2009/278246; Oliveira F, 2011, AM J TROP MED HYG, V85, P70, DOI 10.4269/ajtmh.2011.10-0680; Oliveira JGS, 2005, ACTA TROP, V94, P55, DOI 10.1016/j.actatropica.2004.12.003; Passos S, 2005, CLIN DIAGN LAB IMMUN, V12, P1164, DOI 10.1128/CDLI.12.10.1164-1167.2005; Perinoto AC, 2010, ANAL CHEM, V82, P9763, DOI 10.1021/ac101920t; Luz ZMP, 2009, MEM I OSWALDO CRUZ, V104, P62, DOI 10.1590/S0074-02762009000100010; Quijada L, 1998, IMMUNOL LETT, V63, P169, DOI 10.1016/S0165-2478(98)00071-6; Quijada L, 1996, PARASITOLOGY, V112, P277, DOI 10.1017/S0031182000065793; Rafati S, 2006, CLIN VACCINE IMMUNOL, V13, P1104, DOI 10.1128/CVI.00188-06; Requena JM, 2000, PARASITOL TODAY, V16, P246, DOI 10.1016/S0169-4758(00)01651-3; ReyLadino JA, 1997, EXP PARASITOL, V85, P249, DOI 10.1006/expr.1996.4137; ROFFI J, 1980, AM J TROP MED HYG, V29, P183, DOI 10.4269/ajtmh.1980.29.183; Romero GAS, 2005, ACTA TROP, V93, P49, DOI 10.1016/j.actatropica.2004.09.005; SARAVIA NG, 1989, J INFECT DIS, V159, P725, DOI 10.1093/infdis/159.4.725; SKEIKY YAW, 1995, INFECT IMMUN, V63, P4105, DOI 10.1128/IAI.63.10.4105-4114.1995; Skeiky YAW, 1997, INFECT IMMUN, V65, P5368, DOI 10.1128/IAI.65.12.5368-5370.1997; Soto M, 1996, CLIN EXP IMMUNOL, V106, P454, DOI 10.1046/j.1365-2249.1996.d01-865.x; Soto M, 1996, CLIN DIAGN LAB IMMUN, V3, P387, DOI 10.1128/CDLI.3.4.387-391.1996; Soto M, 1995, IMMUNOL LETT, V48, P209, DOI 10.1016/0165-2478(95)02473-5; Soto M, 1998, J CLIN MICROBIOL, V36, P58, DOI 10.1128/JCM.36.1.58-63.1998; Trujillo C, 1999, IMMUNOL LETT, V70, P203; WEIGLE KA, 1987, AM J TROP MED HYG, V36, P489, DOI 10.4269/ajtmh.1987.36.489; Weigle KA, 2002, J CLIN MICROBIOL, V40, P601, DOI 10.1128/JCM.40.2.601-606.2002; Zugel U, 1999, IMMUNOBIOLOGY, V201, P22; Zurita AI, 2003, J PARASITOL, V89, P372, DOI 10.1645/0022-3395(2003)089[0372:CACOTL]2.0.CO;2	61	41	42	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66110	10.1371/journal.pone.0066110	http://dx.doi.org/10.1371/journal.pone.0066110			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776617	Green Published, Green Submitted, gold			2022-12-27	WOS:000320322400082
J	White, DJ; Unwin, RD; Bindels, E; Pierce, A; Teng, HY; Muter, J; Greystoke, B; Somerville, TD; Griffiths, J; Lovell, S; Somervaille, TCP; Delwel, R; Whetton, AD; Meyer, S				White, Daniel J.; Unwin, Richard D.; Bindels, Eric; Pierce, Andrew; Teng, Hsiang-Ying; Muter, Joanne; Greystoke, Brigit; Somerville, Tim D.; Griffiths, John; Lovell, Simon; Somervaille, Tim C. P.; Delwel, Ruud; Whetton, Anthony D.; Meyer, Stefan			Phosphorylation of the Leukemic Oncoprotein EVI1 on Serine 196 Modulates DNA Binding, Transcriptional Repression and Transforming Ability	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; HEMATOPOIETIC STEM-CELLS; FANCONI-ANEMIA; ZINC-FINGER; MEDIATED PHOSPHORYLATION; MYELODYSPLASTIC SYNDROME; INTEGRATION SITE; RAT1 FIBROBLASTS; PROTEIN; GENE	The EVI1 (ecotropic viral integration site 1) gene at 3q26 codes for a transcriptional regulator with an essential role in haematopoiesis. Overexpression of EVI1 in acute myeloid leukaemia (AML) is frequently associated with 3q26 rearrangements and confers extremely poor prognosis. EVI1 mediates transcriptional regulation, signalling, and epigenetic modifications by interacting with DNA, proteins and protein complexes. To explore to what extent protein phosphorylation impacts on EVI1 functions, we analysed endogenous EVI1 protein from a high EVI1 expressing Fanconi anaemia (FA) derived AML cell line. Mass spectrometric analysis of immunoprecipitated EVI1 revealed phosphorylation at serine 196 (S196) in the sixth zinc finger of the N-terminal zinc finger domain. Mutated EVI1 with an aspartate substitution at serine 196 (S196D), which mimics serine phosphorylation of this site, exhibited reduced DNA-binding and transcriptional repression from a gene promotor selectively targeted by the N-terminal zinc finger domain. Forced expression of the S196D mutant significantly reduced EVI1 mediated transformation of Rat1 fibroblasts. While EVI1-mediated serial replating of murine haematopoietic progenitors was maintained by EVI1-S196D, this was associated with significantly higher Evi1-trancript levels compared with WT-EVI1 or EVI1-S196A, mimicking S196 non-phosphorylated EVI1. These data suggest that EVI1 function is modulated by phosphorylation of the first zinc finger domain.	[White, Daniel J.; Unwin, Richard D.; Pierce, Andrew; Teng, Hsiang-Ying; Muter, Joanne; Griffiths, John; Whetton, Anthony D.; Meyer, Stefan] Univ Manchester, Manchester Acad Hlth Sci Ctr, Stem Cell & Leukaemia Prote Lab, Manchester, Lancs, England; [Bindels, Eric; Delwel, Ruud] Erasmus Univ, Dept Hematol, Rotterdam, Netherlands; [Greystoke, Brigit; Somerville, Tim D.; Somervaille, Tim C. P.] Paterson Inst Canc Res, Canc Res UK Leukaemia Biol Lab, Manchester M20 9BX, Lancs, England; [Lovell, Simon] Univ Manchester, Fac Life Sci, Acad Hlth Sci Ctr, Manchester, Lancs, England; [Meyer, Stefan] Manchester Acad Hlth Sci Ctr, Royal Manchester Childrens Hosp, Manchester, Lancs, England; [Meyer, Stefan] Manchester Acad Hlth Sci Ctr, Christie NHS Fdn Trust, Manchester, Lancs, England	University of Manchester; Erasmus University Rotterdam; Paterson Institute for Cancer Research; University of Manchester; Royal Manchester Children's Hospital; University of Manchester; Christie NHS Foundation Trust; University of Manchester	Meyer, S (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Stem Cell & Leukaemia Prote Lab, Manchester, Lancs, England.	stefan.meyer@manchester.ac.uk	Unwin, Richard/C-1258-2008	Unwin, Richard/0000-0001-7955-9111; Pierce, Andrew/0000-0001-5995-2469; Lovell, Simon/0000-0002-4092-8458; Somervaille, Tim/0000-0002-9188-4379; WHETTON, ANTHONY D/0000-0002-1098-3878	Cancer Research UK (CRUK); Clinician Scientist Fellowship [C1860/A5901]; LLR (UK)	Cancer Research UK (CRUK)(Cancer Research UK); Clinician Scientist Fellowship; LLR (UK)	This work was funded by a Cancer Research UK (CRUK, http://www.cancerresearchuk.org/) Clinician Scientist Fellowship to SM (C1860/A5901) and LLR (UK) (http://leukaemialymphomaresearch.org.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bard-Chapeau EA, 2012, P NATL ACAD SCI USA, V109, P2168, DOI 10.1073/pnas.1119229109; Bartholomew C, 1997, ONCOGENE, V14, P569, DOI 10.1038/sj.onc.1200864; Black AR, 1999, J BIOL CHEM, V274, P1207, DOI 10.1074/jbc.274.3.1207; Buitenhuis M, 2008, BLOOD, V111, P112, DOI 10.1182/blood-2006-07-037572; Buonamici S, 2004, J CLIN INVEST, V114, P713, DOI 10.1172/JCI200421716; Castillo P, 2011, DNA REPAIR, V10, P518, DOI 10.1016/j.dnarep.2011.02.007; Chen VB, 2009, PROTEIN SCI, V18, P2403, DOI 10.1002/pro.250; Costoya JA, 2008, ONCOGENE, V27, P3789, DOI 10.1038/onc.2008.7; DELWEL R, 1993, MOL CELL BIOL, V13, P4291, DOI 10.1128/MCB.13.7.4291; Dickstein J, 2010, P NATL ACAD SCI USA, V107, P9783, DOI 10.1073/pnas.1004297107; Du Y, 2005, BLOOD, V106, P3932, DOI 10.1182/blood-2005-03-1113; FUNABIKI T, 1994, ONCOGENE, V9, P1575; Goyama S, 2008, CELL STEM CELL, V3, P207, DOI 10.1016/j.stem.2008.06.002; Jin GA, 2007, BLOOD, V109, P3998, DOI 10.1182/blood-2006-08-041202; Kilbey A, 1998, ONCOGENE, V16, P2287, DOI 10.1038/sj.onc.1201732; Kilbey A, 1999, CELL GROWTH DIFFER, V10, P601; KUROKAWA M, 1995, ONCOGENE, V11, P833; Kustikova OS, 2012, LEUKEMIA; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lovell SC, 2000, PROTEINS, V40, P389, DOI 10.1002/1097-0134(20000815)40:3<389::AID-PROT50>3.0.CO;2-2; Lugthart S, 2008, BLOOD, V111, P4329, DOI 10.1182/blood-2007-10-119230; Lugthart S, 2011, BLOOD, V117, P234, DOI 10.1182/blood-2010-04-281337; MATSUGI T, 1990, MOL CELL BIOL, V10, P1259, DOI 10.1128/MCB.10.3.1259; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Metais JY, 2008, MOL THER, V16, P439, DOI 10.1038/sj.mt.6300372; Meyer S, 2005, GENE CHROMOSOME CANC, V42, P404, DOI 10.1002/gcc.20153; Meyer S, 2007, GENE CHROMOSOME CANC, V46, P359, DOI 10.1002/gcc.20417; Meyer S, 2011, BLOOD, V117, P6047, DOI 10.1182/blood-2011-03-343897; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Palmer S, 2001, J BIOL CHEM, V276, P25834, DOI 10.1074/jbc.M102343200; PERKINS AS, 1991, MOL CELL BIOL, V11, P2665, DOI 10.1128/MCB.11.5.2665; Pradhan AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025370; Sakamoto Y, 1997, ONCOGENE, V15, P2001, DOI 10.1038/sj.onc.1201391; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sasaki MS, 2002, MUTAT RES-FUND MOL M, V504, P101, DOI 10.1016/S0027-5107(02)00084-2; Shimabe M, 2009, ONCOGENE, V28, P4364, DOI 10.1038/onc.2009.288; Shimahara A, 2010, J BIOL CHEM, V285, P16967, DOI 10.1074/jbc.M110.102046; Somervaille TCP, 2009, CELL STEM CELL, V4, P129, DOI 10.1016/j.stem.2008.11.015; Takahashi S, 2002, LEUKEMIA, V16, P1755, DOI 10.1038/sj.leu.2402682; Tonnies H, 2003, BLOOD, V101, P3872, DOI 10.1182/blood-2002-10-3243; Unwin RD, 2005, MOL CELL PROTEOMICS, V4, P1134, DOI 10.1074/mcp.M500113-MCP200; Unwin RD, 2009, NAT PROTOC, V4, P870, DOI 10.1038/nprot.2009.57; van Doorn-Khosrovani SBV, 2003, BLOOD, V101, P837, DOI 10.1182/blood-2002-05-1459; Vijapurkar U, 2004, MOL CELL BIOL, V24, P3827, DOI 10.1128/MCB.24.9.3827-3837.2004; Yoshimi A, 2011, BLOOD, V117, P3617, DOI 10.1182/blood-2009-12-261602; Zhang SC, 2011, J CELL BIOL, V193, P295, DOI 10.1083/jcb.201009074	49	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66510	10.1371/journal.pone.0066510	http://dx.doi.org/10.1371/journal.pone.0066510			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776681	gold, Green Published			2022-12-27	WOS:000320322400107
J	Blarquez, O; Finsinger, W; Carcaillet, C				Blarquez, Olivier; Finsinger, Walter; Carcaillet, Christopher			Assessing Paleo-Biodiversity Using Low Proxy Influx	PLOS ONE			English	Article							MODEL-BASED RECONSTRUCTION; SPECIES-AREA RELATIONSHIPS; PLANT MACROFOSSILS; POLLEN DIVERSITY; BOREAL FOREST; FOSSIL POLLEN; SAMPLE-SIZE; SWISS ALPS; HOLOCENE; VEGETATION	We developed an algorithm to improve richness assessment based on paleoecological series, considering sample features such as their temporal resolutions or their volumes. Our new method can be applied to both high- and low-count size proxies, i.e. pollen and plant macroremain records, respectively. While pollen generally abounds in sediments, plant macroremains are generally rare, thus leading to difficulties to compute paleo-biodiversity indices. Our approach uses resampled macroremain influxes that enable the computation of the rarefaction index for the low influx records. The raw counts are resampled to a constant resolution and sample volume by interpolating initial sample ages at a constant time interval using the age similar to depth model. Then, the contribution of initial counts and volume to each interpolated sample is determined by calculating a proportion matrix that is in turn used to obtain regularly spaced time series of pollen and macroremain influx. We applied this algorithm to sedimentary data from a subalpine lake situated in the European Alps. The reconstructed total floristic richness at the study site increased gradually when both pollen and macroremain records indicated a decrease in relative abundances of shrubs and an increase in trees from 11,000 to 7,000 cal BP. This points to an ecosystem change that favored trees against shrubs, whereas herb abundance remained stable. Since 6,000 cal BP, local richness decreased based on plant macroremains, while pollen-based richness was stable. The reconstructed richness and evenness are interrelated confirming the difficulty to distinguish these two aspects for the studies in paleo-biodiversity. The present study shows that low-influx bio-proxy records (here macroremains) can be used to reconstruct stand diversity and address ecological issues. These developments on macroremain and pollen records may contribute to bridge the gap between paleoecology and biodiversity studies.	[Blarquez, Olivier; Finsinger, Walter; Carcaillet, Christopher] Univ Montpellier 2, CNRS, Ctr Bioarchaeol & Ecol, Montpellier, France; [Blarquez, Olivier; Carcaillet, Christopher] Ecole Prat Hautes Etud, Montpellier, France; [Blarquez, Olivier] Univ Quebec, Ctr Forest Res, Montreal, PQ H3C 3P8, Canada	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universite de Montpellier; University of Quebec; University of Quebec Montreal	Blarquez, O (corresponding author), Univ Montpellier 2, CNRS, Ctr Bioarchaeol & Ecol, Montpellier, France.	blarquez@gmail.com	Carcaillet, Christopher/G-1218-2011; Finsinger, Walter/A-7937-2011	Carcaillet, Christopher/0000-0002-6632-1507; Finsinger, Walter/0000-0002-8297-0574	FP7 European Research Area Programme (ANR/ERA-net BiodivERsA); FIREMAN program (ANR/ERA-net BiodivERsA); Ecole Pratique des Hautes Etudes (EPHE-Paris)	FP7 European Research Area Programme (ANR/ERA-net BiodivERsA)(French National Research Agency (ANR)); FIREMAN program (ANR/ERA-net BiodivERsA)(French National Research Agency (ANR)); Ecole Pratique des Hautes Etudes (EPHE-Paris)	This research was funded by the FP7 European Research Area Programme (ANR/ERA-net BiodivERsA). This work was developed following a FIREMAN Project's Workshop held in Montpellier. Financial support was provided by the FIREMAN program (ANR/ERA-net BiodivERsA) to CC and by grants from the Ecole Pratique des Hautes Etudes (EPHE-Paris) to OB. The research was carried out in the framework of the International Associated Laboratory (LIA France-Canada) CNRS-UM2-EPHE-UQAT-UQAM-UQAC "MONTABOR: Forets montagnardes et boreales : chrono-ecologie et amenagement ecosystemique durable". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthelme F, 2007, J VEG SCI, V18, P355, DOI 10.1111/j.1654-1103.2007.tb02547.x; Arrhenius O, 1921, J ECOL, V9, P95, DOI 10.2307/2255763; Birks HJB, 1992, HOLOCENE, V2, P1, DOI 10.1177/095968369200200101; Birks HH, 2000, J BIOGEOGR, V27, P31, DOI 10.1046/j.1365-2699.2000.00375.x; Blarquez O, 2012, HOLOCENE, V22, P579, DOI 10.1177/0959683611427333; Blarquez O, 2010, J ECOL, V98, P1358, DOI 10.1111/j.1365-2745.2010.01721.x; BRADSHAW RHW, 1985, ECOLOGY, V66, P721, DOI 10.2307/1940533; Carcaillet C, 2010, INT J WILDLAND FIRE, V19, P1026, DOI 10.1071/WF09097; Colwell RK, 2012, J PLANT ECOL, V5, P3, DOI 10.1093/jpe/rtr044; Crist TO, 2006, ECOL LETT, V9, P923, DOI 10.1111/j.1461-0248.2006.00941.x; CURRIE DJ, 1991, AM NAT, V137, P27, DOI 10.1086/285144; Elzein TM, 2011, ALPINE BOT, V121, P129, DOI 10.1007/s00035-011-0095-3; Finsinger W, 2007, HOLOCENE, V17, P1119, DOI 10.1177/0959683607082552; Gleason HA, 1922, ECOLOGY, V3, P158, DOI 10.2307/1929150; He FL, 2011, NATURE, V473, P368, DOI 10.1038/nature09985; HECK KL, 1975, ECOLOGY, V56, P1459, DOI 10.2307/1934716; Heiri C, 2006, J ECOL, V94, P206, DOI 10.1111/j.1365-2745.2005.01072.x; Heiri O, 2001, J PALEOLIMNOL, V26, P343, DOI 10.1023/A:1017568913302; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; JACKSON ST, 1991, ECOLOGY, V72, P641, DOI 10.2307/2937204; Jackson ST, 2007, ENCY QUATERNARY SCI, P2413; Karger DN, 2011, J BIOGEOGR, V38, P1177, DOI 10.1111/j.1365-2699.2010.02468.x; Long CJ, 1998, CAN J FOREST RES, V28, P774, DOI 10.1139/cjfr-28-5-774; Nilsson MC, 2005, FRONT ECOL ENVIRON, V3, P421, DOI 10.2307/3868658; Nyman M, 2008, HOLOCENE, V18, P215, DOI 10.1177/0959683607086760; Odgaard Bent Vad, 2001, Diversity and Distributions, V7, P197, DOI 10.1111/j.1472-4642.2001.00110.x; Odgaard BV, 1999, J BIOGEOGR, V26, P7, DOI 10.1046/j.1365-2699.1999.00280.x; Olszewski TD, 2004, OIKOS, V104, P377, DOI 10.1111/j.0030-1299.2004.12519.x; Oris F, 2013, J PALEOLIMNOL, V49, P633, DOI 10.1007/s10933-013-9680-3; Peros MC, 2008, J PALEOLIMNOL, V40, P357, DOI 10.1007/s10933-007-9166-2; Ponel P, 2003, BIODIVERS CONSERV, V12, P2077, DOI 10.1023/A:1024121327109; RAUP D M, 1975, Paleobiology, V1, P333; Renssen H, 2009, NAT GEOSCI, V2, P410, DOI 10.1038/NGEO513; RULL V, 1987, Pollen et Spores, V29, P471; SANDERS HL, 1968, AM NAT, V102, P243, DOI 10.1086/282541; Stahli M, 2006, HOLOCENE, V16, P805, DOI 10.1191/0959683606hol967rp; Tappeiner U, 2008, ECOSYSTEMS, V11, P1383, DOI 10.1007/s10021-008-9195-3; Tinner W, 2005, J ECOL, V93, P936, DOI 10.1111/j.1365-2745.2005.01023.x; Tinner W, 2001, GEOLOGY, V29, P551, DOI 10.1130/0091-7613(2001)029<0551:CEVRTA>2.0.CO;2; TIPPER JC, 1979, PALEOBIOLOGY, V5, P423, DOI 10.1017/S0094837300016924; van der Knaap WO, 2009, HOLOCENE, V19, P159, DOI 10.1177/0959683608098962; Weng CY, 2006, DIVERS DISTRIB, V12, P310, DOI 10.1111/j.1366-9516.2006.00230.x; White EP, 2010, PHILOS T R SOC B, V365, P3633, DOI 10.1098/rstb.2010.0280; WHITTAKER RH, 1965, SCIENCE, V147, P250, DOI 10.1126/science.147.3655.250; Willis KJ, 2010, TRENDS ECOL EVOL, V25, P583, DOI 10.1016/j.tree.2010.07.006; Wolfe AP, 2003, HOLOCENE, V13, P29, DOI 10.1191/0959683603hl592rp	46	8	8	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65852	10.1371/journal.pone.0065852	http://dx.doi.org/10.1371/journal.pone.0065852			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776556	Green Published, Green Submitted, gold			2022-12-27	WOS:000320755400072
J	Chen, DF; Li, Y; Zhou, ZY; Wu, CG; Xing, YG; Zou, XN; Tian, W; Zhang, C				Chen, Dafu; Li, Yang; Zhou, Zhiyu; Wu, Chengai; Xing, Yonggang; Zou, Xuenong; Tian, Wei; Zhang, Chi			HIF-1 alpha Inhibits Wnt Signaling Pathway by Activating Sost Expression in Osteoblasts	PLOS ONE			English	Article							TRANSCRIPTION FACTOR OSTERIX; RECEPTOR-MEDIATED TRANSCRIPTION; GROWTH-FACTOR VEGF; BONE-FORMATION; SKELETAL DEVELOPMENT; MASS; OSX; SCLEROSTIN; HYPOXIA; PROTEIN	The nature of the cellular and molecular mechanisms for the transition of avascular cartilage replacement with bone during endochondral ossification remains poorly understood. One of the driving forces is hypoxia. As a master regulator of hypoxia, hypoxia-inducible factor-1 alpha (HIF-1 alpha) has been reported to couple angiogenesis to osteogenesis. Our recent study has demonstrated that osteoblast growth is inhibited under hypoxia and that HIF-1 alpha cooperates with Osterix (Osx) to inhibit Wnt pathway. However, molecular mechanisms for inhibitory effects of HIF-1 alpha on Wnt pathway are not well understood. In this study, our quantitative RT-PCR results revealed that the expression of a Wnt antagonist Sclerostin (Sost) was upregulated in osteoblasts during hypoxia while HIF-1 alpha was upregulated. Treatment of desferrioxamine (DFO), a HIF-1 alpha activator, led to further increase of Sost expression, suggesting that HIF-1 alpha may activate Sost expression. The regulation of Sost gene expression by HIF-1 alpha was then investigated. We performed loss-of-function experiments to examine Sost expression by using siRNA approach against HIF-1 alpha, and found that the inhibition of HIF-1 alpha by siRNA in osteoblasts led to the decrease of Sost expression. To address transcriptional regulation of Sost gene by HIF-1 alpha, transient transfection assay was performed and showed that HIF-1 alpha activated Sost-1 kb promoter reporter activity in a dose-dependent manner. To narrow down the minimal region of Sost promoter activated by HIF-1 alpha, we generated a series of deletion mutants of Sost constructs. It was demonstrated that Sost-260 was the minimal region of Sost promoter for HIF-1 alpha activation and that Sost-106 construct, which lack hypoxia response element, abolished HIF-1 alpha-mediated Sost reporter activation. Gel shift assay showed that HIF-1 bound to the promoter sequence of Sost directly. These findings support our hypothesis that HIF-1 alpha activates Sost expression. This study provides a novel molecular mechanism through which HIF-1 alpha inhibits Wnt signaling in osteoblasts.	[Chen, Dafu; Wu, Chengai; Xing, Yonggang; Tian, Wei] Beijing JiShuiTan Hosp, Beijing Res Inst Traumatol & Orthopaed, Lab Bone Tissue Engn, Beijing, Peoples R China; [Li, Yang; Zhang, Chi] Univ Texas SW Med Ctr Dallas, Texas Scottish Rite Hosp Children, Bone Res Lab, Dallas, TX 75390 USA; [Zhou, Zhiyu; Zou, Xuenong] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Spine, Guangzhou 510275, Guangdong, Peoples R China	Texas Scottish Rite Hospital for Children; University of Texas System; University of Texas Southwestern Medical Center Dallas; Sun Yat Sen University	Tian, W (corresponding author), Beijing JiShuiTan Hosp, Beijing Res Inst Traumatol & Orthopaed, Lab Bone Tissue Engn, Beijing, Peoples R China.	tianweijst@yahoo.com.cn; Chi5.Zhang@utsouthwestern.edu	ZHOU, ZHIYU/AAU-5036-2021; Zhang, Chi/K-4467-2012	ZHOU, ZHIYU/0000-0002-8101-2083; 	Arthritis Foundation; National Basic Research Program of China (973 Program) [2012CB619105]; Ministry of Science and Technology of the China [2012BAI10B02]	Arthritis Foundation; National Basic Research Program of China (973 Program)(National Basic Research Program of China); Ministry of Science and Technology of the China(Ministry of Science and Technology, China)	Work in Bone Research Laboratory is supported by Research Grant from Arthritis Foundation (To Chi Zhang). This work is also supported by National Basic Research Program of China (973 Program, No. 2012CB619105 to Xuenong Zou). This work is also in part supported by The Ministry of Science and Technology of the China (Grants 2012BAI10B02 to Wei Tian). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosini G, 2002, J BIOL CHEM, V277, P34601, DOI 10.1074/jbc.M205172200; Balemans W, 2008, CALCIFIED TISSUE INT, V82, P445, DOI 10.1007/s00223-008-9130-9; Baron R, 2006, CURR TOP DEV BIOL, V76, P103, DOI 10.1016/S0070-2153(06)76004-5; Chen DF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052948; Chen DF, 2012, BIOCHEM BIOPH RES CO, V424, P176, DOI 10.1016/j.bbrc.2012.06.104; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; ERLEBACHER A, 1995, CELL, V80, P371, DOI 10.1016/0092-8674(95)90487-5; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Harper J, 1999, NAT MED, V5, P617, DOI 10.1038/9460; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Hu HL, 2005, DEVELOPMENT, V132, P49, DOI 10.1242/dev.01564; Issack Paul S, 2008, HSS J, V4, P66, DOI 10.1007/s11420-007-9072-1; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Li J, 2006, BONE, V39, P754, DOI 10.1016/j.bone.2006.03.017; Maxwell PH, 2002, CLIN MED, V2, P356, DOI 10.7861/clinmedicine.2-4-356; Morvan F, 2006, J BONE MINER RES, V21, P934, DOI 10.1359/JBMR.060311; Piters E, 2008, ARCH BIOCHEM BIOPHYS, V473, P112, DOI 10.1016/j.abb.2008.03.006; Rajpurohit R, 1996, J CELL PHYSIOL, V168, P424, DOI 10.1002/(SICI)1097-4652(199608)168:2<424::AID-JCP21>3.0.CO;2-1; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Semenov M, 2005, J BIOL CHEM, V280, P26770, DOI 10.1074/jbc.M504308200; Tang WJ, 2012, J BIOL CHEM, V287, P1671, DOI 10.1074/jbc.M111.288472; Tang WJ, 2011, J BIOL CHEM, V286, P32995, DOI 10.1074/jbc.M111.244236; ten Dijke P, 2008, J BONE JOINT SURG AM, V90A, P31, DOI 10.2106/JBJS.G.01183; Wan C, 2010, ANN NY ACAD SCI, V1192, P322, DOI 10.1111/j.1749-6632.2009.05238.x; Wang Y, 2007, J CLIN INVEST, V117, P1616, DOI 10.1172/JCI31581; Wergedal JE, 2003, J CLIN ENDOCR METAB, V88, P5778, DOI 10.1210/jc.2003-030201; Winkler DG, 2003, EMBO J, V22, P6267, DOI 10.1093/emboj/cdg599; Zhang C, 2001, J BIOL CHEM, V276, P40614, DOI 10.1074/jbc.M106263200; Zhang C, 2003, J BIOL CHEM, V278, P35325, DOI 10.1074/jbc.M305191200; Zhang C, 2008, P NATL ACAD SCI USA, V105, P6936, DOI 10.1073/pnas.0710831105; Zhang C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050525; Zhang Chi, 2012, Beijing Da Xue Xue Bao Yi Xue Ban, V44, P659; Zhang C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026504; Zhang C, 2010, J ORTHOP SURG RES, V5, DOI 10.1186/1749-799X-5-37	35	33	33	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65940	10.1371/journal.pone.0065940	http://dx.doi.org/10.1371/journal.pone.0065940			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776575	Green Submitted, Green Published, gold			2022-12-27	WOS:000320755400086
J	Harris, L; Dixon, C; Cato, K; Heng, YHE; Kurniawan, ND; Ullmann, JFP; Janke, AL; Gronostajski, RM; Richards, LJ; Burne, THJ; Piper, M				Harris, Lachlan; Dixon, Chantelle; Cato, Kathleen; Heng, Yee Hsieh Evelyn; Kurniawan, Nyoman D.; Ullmann, Jeremy F. P.; Janke, Andrew L.; Gronostajski, Richard M.; Richards, Linda J.; Burne, Thomas H. J.; Piper, Michael			Heterozygosity for Nuclear Factor One X Affects Hippocampal-Dependent Behaviour in Mice	PLOS ONE			English	Article							DNA-BINDING/DIMERIZATION DOMAIN; PROTEIN MESSENGER-RNA; MORRIS WATER MAZE; SOTOS-LIKE; DEVELOPMENTAL EXPRESSION; CEREBELLAR CONTRIBUTION; NFIA CONTROLS; POPULATIONS; IMPAIRMENT; PRECURSORS	Identification of the genes that regulate the development and subsequent functioning of the hippocampus is pivotal to understanding the role of this cortical structure in learning and memory. One group of genes that has been shown to be critical for the early development of the hippocampus is the Nuclear factor one (Nfi) family, which encodes four site-specific transcription factors, NFIA, NFIB, NFIC and NFIX. In mice lacking Nfia, Nfib or Nfix, aspects of early hippocampal development, including neurogenesis within the dentate gyrus, are delayed. However, due to the perinatal lethality of these mice, it is not clear whether this hippocampal phenotype persists to adulthood and affects hippocampal-dependent behaviour. To address this we examined the hippocampal phenotype of mice heterozygous for Nfix (Nfix(+/-)), which survive to adulthood. We found that Nfix(+/-) mice had reduced expression of NFIX throughout the brain, including the hippocampus, and that early hippocampal development in these mice was disrupted, producing a phenotype intermediate to that of wild-type mice and Nfix(+/-) mice. The abnormal hippocampal morphology of Nfix(-/-) mice persisted to adulthood, and these mice displayed a specific performance deficit in the Morris water maze learning and memory task. These findings demonstrate that the level of Nfix expression during development and within the adult is essential for the function of the hippocampus during learning and memory.	[Harris, Lachlan; Dixon, Chantelle; Cato, Kathleen; Heng, Yee Hsieh Evelyn; Richards, Linda J.; Burne, Thomas H. J.; Piper, Michael] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia; [Heng, Yee Hsieh Evelyn; Richards, Linda J.; Burne, Thomas H. J.; Piper, Michael] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Kurniawan, Nyoman D.; Ullmann, Jeremy F. P.; Janke, Andrew L.] Univ Queensland, Ctr Adv Imaging, Brisbane, Qld, Australia; [Gronostajski, Richard M.] SUNY Buffalo, Dept Biochem, New York State Ctr Excellence Bioinformat & Life, Buffalo, NY 14214 USA; [Gronostajski, Richard M.] SUNY Buffalo, New York State Ctr Excellence Bioinformat & Life, Dev Genom Grp, Program Neurosci, Buffalo, NY 14260 USA	University of Queensland; University of Queensland; University of Queensland; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Piper, M (corresponding author), Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia.	m.piper@uq.edu.au	Harris, Lachlan/Y-6438-2018; Piper, Michael J/B-2805-2010; Janke, Andrew L/E-6149-2011; Kurniawan, Nyoman/D-9764-2011; Ullmann, Jeremy/E-6170-2011; Burne, Thomas H/C-5656-2009; Richards AO, Linda/P-6372-2014	Harris, Lachlan/0000-0002-7820-0921; Piper, Michael J/0000-0002-6759-2560; Janke, Andrew L/0000-0003-0547-5171; Kurniawan, Nyoman/0000-0001-6340-182X; Ullmann, Jeremy/0000-0002-3073-9151; Burne, Thomas H/0000-0003-3502-9789; Gronostajski, Richard/0000-0003-4264-208X; Richards AO, Linda/0000-0002-7590-7390	National Health and Medical Research Council (NHMRC) project [1003462, 1022308]; Australian Research Council discovery project [DP0984643]; NYSTEM [C026429]; National Institutes of Health (NIH) [HL080624]; NHMRC fellowships; LJR; University of Queensland International Scholarship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080624] Funding Source: NIH RePORTER	National Health and Medical Research Council (NHMRC) project(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council discovery project(Australian Research Council); NYSTEM; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHMRC fellowships(National Health and Medical Research Council (NHMRC) of Australia); LJR; University of Queensland International Scholarship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by National Health and Medical Research Council (NHMRC) project grants (grant numbers 1003462 and 1022308; MP), an Australian Research Council discovery project grant (DP0984643 to LJR) and by awards from NYSTEM (C026429; RMG) and the National Institutes of Health (NIH) (HL080624; RMG). The following authors were supported by NHMRC fellowships: MP (Biomedical Career Development Fellowship) and LJR (Principal Research Fellowship). YHEH was supported by a University of Queensland International Scholarship. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adriano F, 2012, NEUROSCIENTIST, V18, P180, DOI 10.1177/1073858410395147; ALTMAN J, 1990, J COMP NEUROL, V301, P365, DOI 10.1002/cne.903010304; ALTMAN J, 1990, J COMP NEUROL, V301, P325, DOI 10.1002/cne.903010302; Barry G, 2008, J NEUROSCI, V28, P12328, DOI 10.1523/JNEUROSCI.4000-08.2008; Brun M, 2009, J MOL BIOL, V391, P282, DOI 10.1016/j.jmb.2009.06.041; Campbell CE, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-52; Chen J, 2009, GENESIS, V47, P122, DOI 10.1002/dvg.20465; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Deneen B, 2006, NEURON, V52, P953, DOI 10.1016/j.neuron.2006.11.019; Driller K, 2007, MOL CELL BIOL, V27, P3855, DOI 10.1128/MCB.02293-06; Dupret D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001959; Fox IJ, 2004, DEV BRAIN RES, V153, P121, DOI 10.1016/j.devbrainres.2004.07.011; GRANT SGN, 1992, SCIENCE, V258, P1903, DOI 10.1126/science.1361685; Heng YHE, 2014, CEREB CORTEX, V24, P261, DOI 10.1093/cercor/bhs307; LANDRY CF, 1990, J NEUROSCI RES, V25, P194, DOI 10.1002/jnr.490250207; Leggio MG, 1999, EXP BRAIN RES, V127, P1, DOI 10.1007/s002210050768; LEHERICY S, 1995, AM J NEURORADIOL, V16, P617; Malan V, 2010, AM J HUM GENET, V87, P189, DOI 10.1016/j.ajhg.2010.07.001; Marin-Burgin A, 2012, BEHAV BRAIN RES, V227, P391, DOI 10.1016/j.bbr.2011.07.001; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MOSER E, 1993, J NEUROSCI, V13, P3916; Namihira M, 2009, DEV CELL, V16, P245, DOI 10.1016/j.devcel.2008.12.014; Nedelska Z, 2012, P NATL ACAD SCI USA, V109, P2590, DOI 10.1073/pnas.1121588109; Petrosini L, 1996, EUR J NEUROSCI, V8, P1882, DOI 10.1111/j.1460-9568.1996.tb01332.x; Piper M, 2011, J COMP NEUROL, V519, P3532, DOI 10.1002/cne.22721; Piper M, 2010, J NEUROSCI, V30, P9127, DOI 10.1523/JNEUROSCI.6167-09.2010; Piper M, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-43; Piper M, 2009, CEREB CORTEX, V19, pI11, DOI 10.1093/cercor/bhp027; Plachez C, 2008, J COMP NEUROL, V508, P385, DOI 10.1002/cne.21645; Pleasure SJ, 2000, J NEUROSCI, V20, P6095, DOI 10.1523/JNEUROSCI.20-16-06095.2000; Priolo M, 2012, GENE, V511, P103, DOI 10.1016/j.gene.2012.08.040; Richards K, 2011, NEUROIMAGE, V58, P732, DOI 10.1016/j.neuroimage.2011.06.025; Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551; Seri B, 2004, J COMP NEUROL, V478, P359, DOI 10.1002/cne.20288; Shu TZ, 2003, J NEUROSCI, V23, P203; Tatton-Brown K, 2005, AM J HUM GENET, V77, P193, DOI 10.1086/432082; van Balkom IDC, 2011, J INTELL DISABIL RES, V55, P973, DOI 10.1111/j.1365-2788.2011.01451.x; von Bohlen und Halbach O, 2007, CELL TISSUE RES, V329, P409, DOI 10.1007/s00441-007-0432-4; Wahlsten D, 2005, BEHAV BRAIN RES, V165, P36, DOI 10.1016/j.bbr.2005.06.047; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Wang W, 2007, J NEUROSCI, V27, P6115, DOI 10.1523/JNEUROSCI.0180-07.2007; Wang W, 2010, J NEUROSCI RES, V88, P258, DOI 10.1002/jnr.22199; Yoneda Y, 2012, J HUM GENET, V57, P207, DOI 10.1038/jhg.2012.7	43	15	15	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65478	10.1371/journal.pone.0065478	http://dx.doi.org/10.1371/journal.pone.0065478			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776487	Green Submitted, Green Published, gold			2022-12-27	WOS:000320755400034
J	Israeli-Korn, SD; Hocherman, S; Hassin-Baer, S; Cohen, OS; Inzelberg, R				Israeli-Korn, Simon D.; Hocherman, Shraga; Hassin-Baer, Sharon; Cohen, Oren S.; Inzelberg, Rivka			Subthalamic Nucleus Deep Brain Stimulation Does Not Improve Visuo-Motor Impairment in Parkinson's Disease	PLOS ONE			English	Article							CHRONIC BILATERAL STIMULATION; EXECUTIVE FUNCTION; FOLLOW-UP; COGNITIVE IMPAIRMENT; NONMOTOR SYMPTOMS; DOUBLE-BLIND; ATTENTION; GAIT; SURGERY; PROFILE	Objective: To evaluate how bilateral subthalamic nucleus deep brain stimulation (STN-DBS) affects visuo-motor coordination (VMC) in patients with Parkinson's disease (PD). Background: VMC involves multi-sensory integration, motor planning, executive function and attention. VMC deficits are well-described in PD. STN-DBS conveys marked motor benefit in PD, but pyscho-cognitive complications are recognized and the effect on VMC is not known. Methods: Thirteen PD patients with bilateral STN-DBS underwent neurological, cognitive, and mood assessment before VMC testing with optimal DBS stimulation parameters ('on-stimulation') and then, on the same day without any medication changes, after DBS silencing and establishing motor function deterioration ('off-stimulation'). Twelve age-matched healthy controls performed 2 successive VMC testing sessions, with a break of similar duration to that of the PD group. The computer cursor was controlled with a dome-shaped 'mouse' hidden from view that minimized tremor effects. Movement duration, hand velocity, tracking continuity, directional control variables, and feedback utilization variables were measured. MANOVA was performed on (1) clinically measured motor function, (2) VMC performance and (3) mood and attention, looking for main and interaction effects of: (1) group (controls/PD), (2) test-order (controls: first/second, PD: on-stimulation/off-stimulation), (3) path (sine/square/circle) and (4) hand (dominant/non-dominant). Results: Unified PD Rating Scale (UPDRS) Part III worsened off-stimulation versus on-stimulation (mean: 42.3 versus 21.6, p = 0.02), as did finger tapping (p = 0.02), posture-gait (p = 0.01), upper limb function (p < 0.001) and backwards digit span (p = 0.02). Stimulation state did not affect mood. PD patients performed worse in non-velocity related VMC variables than controls (F-(5,F-18) = 8.5, p < 0.001). In the control group there were significant main effects of hand (dominant/non-dominant), path (sine/square/circle) and test-order (Test_1/Test_2). In the PD group, hand and path effects, but no test-order (on-stimulation/off-stimulation), were found. Conclusions: 'Low-level' clinically-measured motor function responds to STN-DBS but 'high-level' motor and cognitive functions relating to VMC may be unresponsive to STN-DBS.	[Israeli-Korn, Simon D.; Hassin-Baer, Sharon; Cohen, Oren S.; Inzelberg, Rivka] Chaim Sheba Med Ctr, Parkinsons Dis & Movement Disorders Clin, Sagol Neurosci Ctr, IL-52621 Tel Hashomer, Israel; [Israeli-Korn, Simon D.; Hassin-Baer, Sharon; Cohen, Oren S.; Inzelberg, Rivka] Chaim Sheba Med Ctr, Dept Neurol, IL-52621 Tel Hashomer, Israel; [Hocherman, Shraga] Technion Israel Inst Technol, Fac Med, Dept Physiol, Haifa, Israel; [Hassin-Baer, Sharon; Cohen, Oren S.; Inzelberg, Rivka] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel	Chaim Sheba Medical Center; Chaim Sheba Medical Center; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine	Israeli-Korn, SD (corresponding author), Chaim Sheba Med Ctr, Parkinsons Dis & Movement Disorders Clin, Sagol Neurosci Ctr, IL-52621 Tel Hashomer, Israel.	simon.korn@gmail.com	Inzelberg, Rivka/E-5861-2010; Israeli-Korn, Simon/X-1668-2019	Inzelberg, Rivka/0000-0002-0720-0502; Israeli-Korn, Simon/0000-0002-0244-8891				Ahearn EP, 1997, J PSYCHIATR RES, V31, P569, DOI 10.1016/S0022-3956(97)00029-0; Amboni M, 2012, MOVEMENT DISORD, V27, P1536, DOI 10.1002/mds.25165; Arruda JE, 1999, ARCH PHYS MED REHAB, V80, P676, DOI 10.1016/S0003-9993(99)90171-5; Badarny S, 2006, ACTA NEUROL SCAND, V113, P294, DOI 10.1111/j.1600-0404.2006.00601.x; Berney A, 2002, NEUROLOGY, V59, P1427, DOI 10.1212/01.WNL.0000032756.14298.18; BOLLER F, 1984, ARCH NEUROL-CHICAGO, V41, P485, DOI 10.1001/archneur.1984.04050170031011; Botha H, 2012, PARKINSONISM RELAT D, V18, P742, DOI 10.1016/j.parkreldis.2012.03.004; BROWN RG, 1988, BRAIN, V111, P323, DOI 10.1093/brain/111.2.323; Buchman AS, 2007, MUSCLE NERVE, V35, P354, DOI 10.1002/mus.20702; Castelli L, 2007, J NEUROL, V254, P1238, DOI 10.1007/s00415-006-0510-7; Castro-Garcia A, 2006, REV NEUROLOGIA, V43, P218, DOI 10.33588/rn.4304.2005581; Chaudhuri KR, 2006, LANCET NEUROL, V5, P235, DOI 10.1016/S1474-4422(06)70373-8; Chung SJ, 2006, EUR NEUROL, V56, P127, DOI 10.1159/000095704; Contarino MF, 2007, J NEUROL NEUROSUR PS, V78, P248, DOI 10.1136/jnnp.2005.086660; Contreras-Vidal JL, 2003, EXP BRAIN RES, V150, P25, DOI 10.1007/s00221-003-1403-y; COOPER JA, 1991, BRAIN, V114, P2095, DOI 10.1093/brain/114.5.2095; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; Dujardin K, 2001, J NEUROL, V248, P603, DOI 10.1007/s004150170139; Fahn S., 1987, RECENT DEV PARKINSON, VVol. 2, P153; FLASH T, 1992, EXP NEUROL, V118, P215, DOI 10.1016/0014-4886(92)90038-R; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; George RJS, 2010, NEUROLOGY, V75, P1292, DOI 10.1212/WNL.0b013e3181f61329; GEORGIOU N, 1993, BRAIN, V116, P1575, DOI 10.1093/brain/116.6.1575; Gervais-Bernard H, 2009, J NEUROL, V256, P225, DOI 10.1007/s00415-009-0076-2; Giladi N, 1999, CLIN NEUROPHARMACOL, V22, P54, DOI 10.1097/00002826-199901000-00010; Goetz CG, 2002, MOVEMENT DISORD, V17, P283, DOI 10.1002/mds.10024; GOLDENBERG G, 1986, J NEUROL NEUROSUR PS, V49, P1266, DOI 10.1136/jnnp.49.11.1266; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Green J, 2002, NEUROLOGY, V59, P1320, DOI 10.1212/01.WNL.0000031426.21683.E2; Hallett M, 1999, NEUROLOGY, V53, P1910, DOI 10.1212/WNL.53.9.1910; Hausdorff JM, 2006, EXP AGING RES, V32, P411, DOI 10.1080/03610730600875817; Hocherman S, 1998, NEUROLOGY, V50, P1648, DOI 10.1212/WNL.50.6.1648; Hocherman S, 2004, COGNITIVE BRAIN RES, V21, P77, DOI 10.1016/j.cogbrainres.2004.05.008; Hocherman S, 1998, Parkinsonism Relat Disord, V4, P129, DOI 10.1016/S1353-8020(98)00034-0; Hocherman S GN, 1996, EARLY DIAGNOSIS PARK; Inzelberg R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003663; Juri C, 2010, J NEUROL SCI, V289, P60, DOI 10.1016/j.jns.2009.08.018; Kahn E, 2012, J NEUROL NEUROSUR PS, V83, P164, DOI 10.1136/jnnp-2011-300008; Kave G, 2005, J CLIN EXP NEUROPSYC, V27, P690, DOI 10.1080/13803390490918499; Kleiner-Fisman G, 2003, J NEUROSURG, V99, P489, DOI 10.3171/jns.2003.99.3.0489; Knobl P, 2012, J NEUROL NEUROSUR PS, V83, P98, DOI 10.1136/jnnp-2011-300869; Konczak J, 2009, J MOTOR BEHAV, V41, P543, DOI 10.3200/35-09-002; Krack P, 2003, NEW ENGL J MED, V349, P1925, DOI 10.1056/NEJMoa035275; Krack P, 1998, BRAIN, V121, P451, DOI 10.1093/brain/121.3.451; Kumar R, 1999, NEUROLOGY, V53, P561, DOI 10.1212/WNL.53.3.561; Kumar R, 1998, NEUROLOGY, V51, P850, DOI 10.1212/WNL.51.3.850; Limousin P, 1998, NEW ENGL J MED, V339, P1105, DOI 10.1056/NEJM199810153391603; Lopiano L, 2001, NEUROL SCI, V22, P67, DOI 10.1007/s100720170050; Lopiano L, 2001, NEUROLOGY, V56, P552, DOI 10.1212/WNL.56.4.552; Lu C, 2010, EXP BRAIN RES, V205, P69, DOI 10.1007/s00221-010-2341-0; McKinlay A, 2010, J INT NEUROPSYCH SOC, V16, P268, DOI 10.1017/S1355617709991299; Meyers L. S., 2006, APPL MULTIVARIATE RE; Moreau C, 2008, NEUROLOGY, V71, P80, DOI 10.1212/01.wnl.0000303972.16279.46; Moro E, 1999, NEUROLOGY, V53, P85, DOI 10.1212/WNL.53.1.85; Muslimovic D, 2005, NEUROLOGY, V65, P1239, DOI 10.1212/01.wnl.0000180516.69442.95; OWEN AM, 1992, BRAIN, V115, P1727, DOI 10.1093/brain/115.6.1727; Parsons TD, 2006, LANCET NEUROL, V5, P578, DOI 10.1016/S1474-4422(06)70475-6; Perlmutter JS, 2006, ANNU REV NEUROSCI, V29, P229, DOI 10.1146/annurev.neuro.29.051605.112824; Pinter MM, 1999, J NEUROL, V246, P907, DOI 10.1007/s004150050481; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Pollak P, 1998, PARKINSONS DIS MOVEM, P1085; Porat O, 2009, J NEUROPSYCH CLIN N, V21, P398, DOI 10.1176/jnp.2009.21.4.398; Ribaric S, 2011, SYMPTOMS PARKINSONS, P25; RICHARDS M, 1994, MOVEMENT DISORD, V9, P89, DOI 10.1002/mds.870090114; Rodriguez-Oroz MC, 2004, J NEUROL NEUROSUR PS, V75, P1382, DOI 10.1136/jnnp.2003.031294; ROGERS MW, 1988, BRAIN RES, V438, P271, DOI 10.1016/0006-8993(88)91346-7; Saint-Cyr JA, 2000, BRAIN, V123, P2091, DOI 10.1093/brain/123.10.2091; Saint-Cyr JA, 2006, NEUROLOGY, V66, P1799, DOI 10.1212/01.wnl.0000227468.17113.07; Salkind N., 2007, ENCY MEASUREMENT STA; Schrag A, 2000, J NEUROL NEUROSUR PS, V69, P308, DOI 10.1136/jnnp.69.3.308; Schuepbach WMM, 2013, NEW ENGL J MED, V368, P610, DOI 10.1056/NEJMoa1205158; Sestini S, 2002, J NUCL MED, V43, P725; Stern, 1996, Semin Clin Neuropsychiatry, V1, P315; STERN Y, 1983, J NEUROL NEUROSUR PS, V46, P145, DOI 10.1136/jnnp.46.2.145; Temperli P, 2003, NEUROLOGY, V60, P78, DOI 10.1212/WNL.60.1.78; Tolosa E, 2007, PARKINSONISM RELAT D, V13, pS2, DOI 10.1016/j.parkreldis.2007.06.007; VANHILTEN JJ, 1994, J NEURAL TRANSM-PARK, V8, P117; Vaugoyeau M, 2011, HUM MOVEMENT SCI, V30, P405, DOI 10.1016/j.humov.2010.10.006; Visser M, 2006, MOVEMENT DISORD, V21, P668, DOI 10.1002/mds.20792; Wechsler D., 1997, WECHSLER ADULT INTEL; Weintraub D, 2005, DEMENT GERIATR COGN, V20, P140, DOI 10.1159/000087043; Weintraub D, 2004, J AM GERIATR SOC, V52, P784, DOI 10.1111/j.1532-5415.2004.52219.x; Witt K, 2008, LANCET NEUROL, V7, P605, DOI 10.1016/S1474-4422(08)70114-5; Wolters EC, 2000, J NEUROL, V247, P103; Yogev G, 2005, EUR J NEUROSCI, V22, P1248, DOI 10.1111/j.1460-9568.2005.04298.x	85	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65270	10.1371/journal.pone.0065270	http://dx.doi.org/10.1371/journal.pone.0065270			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776460	gold, Green Submitted, Green Published			2022-12-27	WOS:000320755400021
J	Liu, XJ; Gao, N; Li, MT; Xu, D; Hou, Y; Wang, Q; Zhang, GH; Sun, QN; Zhang, HH; Zeng, XF				Liu, Xinjuan; Gao, Na; Li, Mengtao; Xu, Dong; Hou, Yong; Wang, Qian; Zhang, Guohua; Sun, Qiuning; Zhang, Henghui; Zeng, Xiaofeng			Elevated Levels of CD4(+)CD25(+)FoxP3(+) T Cells in Systemic Sclerosis Patients Contribute to the Secretion of IL-17 and Immunosuppression Dysfunction	PLOS ONE			English	Article							TGF-BETA; INCREASED FREQUENCY; REGULATORY CELLS; CTLA-4 GENE; EXPRESSION; TH17; ASSOCIATION; DISEASE; FOXP3; ACTIVATION	Objective: Immune imbalance between regulatory T (Treg) and Th17 cells is a characteristic of systemic sclerosis (SSc). The functional heterogeneity among Treg can be elucidated by separating Treg into different subsets based on the expression of FoxP3 and CD45RA. The aim of this study was to investigate the role of Treg subsets in the immune imbalance in naive SSc. Methods: Peripheral blood mononuclear cells (PBMCs) of 31 SSc patients and 33 healthy controls were analyzed for the expression of CD4, CD25, CD45RA, CTLA-4, FoxP3, and IL-17 using flow cytometry. Treg immunesuppression capacity was measured in co-culture experiments. The expression of FoxP3, CTLA-4, IL-17A, and RORC mRNA was measured by real-time PCR. Results: The frequency of CD4(+)CD25(+)FoxP3(+) Treg cells was significantly elevated in patients with SSc (3.62 +/- 1.14 vs 1.97 +/- 0.75, p<0.001) with diminished immunosuppression capacity. In SSc, the proportion of FoxP3(high)CD45RA(-) activated Treg cells (aTreg) was decreased, the proportion of FoxP3(low)CD45RA(-) T cells was increased, and the proportion of FoxP3(low)CD45RA(+) resting Treg cells (rTreg) was decreased. The immune suppression capacity of aTreg and rTreg was diminished, while FoxP3(low)CD45RA(-) T cells exhibited a lack of suppression capacity. The immune dysfunction of aTreg was accompanied by the abnormal expression of CTLA-4. Th17 cell numbers were elevated in SSc, FoxP3(low)CD45RA(-) T cells produced IL-17, confirming their Th17 potential, which was consistent with the elevated levels of FoxP3(+)IL-17(+) cells in SSc. Conclusion: A decrease in aTreg levels, along with functional deficiency, and an increase in the proportion of FoxP3(low)CD45RA(-) T cells, was the reason for the increase in dysfunctional Treg in SSc patients, potentially causing the immune imbalance between Treg and Th17 cells.	[Liu, Xinjuan; Gao, Na; Li, Mengtao; Xu, Dong; Hou, Yong; Wang, Qian; Zhang, Guohua; Zeng, Xiaofeng] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Rheumatol, Beijing 100730, Peoples R China; [Liu, Xinjuan; Gao, Na; Li, Mengtao; Xu, Dong; Hou, Yong; Wang, Qian; Zhang, Guohua; Sun, Qiuning; Zeng, Xiaofeng] Peking Union Med Coll, Beijing 100021, Peoples R China; [Sun, Qiuning] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Dermatol, Beijing 100730, Peoples R China; [Zhang, Henghui] Peking Univ, Inst Hepatol, Peoples Hosp, Beijing Key Lab Hepatitis C & Immunotherapy Liver, Beijing 100871, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Peking University	Zhang, HH (corresponding author), Peking Univ, Inst Hepatol, Peoples Hosp, Beijing Key Lab Hepatitis C & Immunotherapy Liver, Beijing 100871, Peoples R China.	zhhbao@163.com; zengxfpumc@yahoo.cn	Sun, Qiuning/AAJ-3692-2021; meng, li/GVT-2063-2022	Sun, Qiuning/0000-0002-1912-341X; 	National Natural Science Foundation of China [81072485, 81001072, 81071300, 81102268]; EULAR Scleroderma Trial & Research group (EUSTAR), Fund of Capital Medical Development and Research	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); EULAR Scleroderma Trial & Research group (EUSTAR), Fund of Capital Medical Development and Research	This study was supported by National Natural Science Foundation of China (81072485, 81001072, 81071300, and 81102268), and EULAR Scleroderma Trial & Research group (EUSTAR), Fund of Capital Medical Development and Research (2009-2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham DJ, 2009, RHEUMATOLOGY, V48, P3, DOI 10.1093/rheumatology/ken481; Antiga E, 2010, BRIT J DERMATOL, V162, P1056, DOI 10.1111/j.1365-2133.2010.09633.x; Balbi G, 2007, CLIN EXP IMMUNOL, V149, P40, DOI 10.1111/j.1365-2249.2007.03394.x; Besliu Alina Nicoleta, 2009, Roum Arch Microbiol Immunol, V68, P5; Bovenschen HJ, 2011, J INVEST DERMATOL, V131, P1853, DOI 10.1038/jid.2011.139; Chavele KM, 2011, FEBS LETT; Chen WJ, 2003, CYTOKINE GROWTH F R, V14, P85, DOI 10.1016/S1359-6101(03)00003-0; El-Far M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054295; Fenoglio D, 2011, CLIN IMMUNOL, V139, P249, DOI 10.1016/j.clim.2011.01.013; Fife BT, 2008, IMMUNOL REV, V224, P166, DOI 10.1111/j.1600-065X.2008.00662.x; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Jago CB, 2004, CLIN EXP IMMUNOL, V136, P463, DOI 10.1111/j.1365-2249.2004.02478.x; Khoury SJ, 2011, CLIN IMMUNOL, V139, P231, DOI 10.1016/j.clim.2011.03.014; Kurasawa K, 2000, ARTHRITIS RHEUM-US, V43, P2455, DOI 10.1002/1529-0131(200011)43:11<2455::AID-ANR12>3.0.CO;2-K; Kurusu S, 2007, PROSTAG OTH LIPID M, V83, P250, DOI 10.1016/j.prostaglandins.2006.12.003; LeRoy EC, 2001, J RHEUMATOL, V28, P1573; Li RB, 2007, J IMMUNOL, V179, P5191, DOI 10.4049/jimmunol.179.8.5191; Linsley PS, 1996, IMMUNITY, V4, P535, DOI 10.1016/S1074-7613(00)80480-X; Maitra U, 2009, J IMMUNOL, V182, P5763, DOI 10.4049/jimmunol.0900124; Mathian A, 2012, ANN RHEUM DIS, V71, P1227, DOI 10.1136/annrheumdis-2011-200709; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Murata M, 2008, J DERMATOL SCI, V50, P240, DOI 10.1016/j.jdermsci.2008.01.001; Nocentini G, 2007, EUR J IMMUNOL, V37, P1165, DOI 10.1002/eji.200636933; Oida T, 2006, J IMMUNOL, V177, P2331, DOI 10.4049/jimmunol.177.4.2331; Qureshi OS, 2011, SCIENCE, V332, P600, DOI 10.1126/science.1202947; Radstake TRDJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005903; Radstake TRDJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005981; Rajaee A, 2006, RHEUMATOL INT, V26, P687, DOI 10.1007/s00296-005-0047-6; Rodriguez-Reyna TS, 2012, RHEUMATOL INT, V32, P2653, DOI 10.1007/s00296-011-2056-y; Rodriguez-Reyna TS, 2011, RHEUMATOL INT; Sakaguchi S, 2011, J IMMUNOL, V186, P3808; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Sancho D, 2005, TRENDS IMMUNOL, V26, P136, DOI 10.1016/j.it.2004.12.006; Slobodin G, 2010, CELL IMMUNOL, V261, P77, DOI 10.1016/j.cellimm.2009.12.009; Steen VD, 2007, ANN RHEUM DIS, V66, P940, DOI 10.1136/ard.2006.066068; Takeuchi F, 2002, CLIN EXP RHEUMATOL, V20, P395; Takeuchi F, 2007, RHEUMATOL INT, V27, P785, DOI 10.1007/s00296-006-0298-x; Truchetet ME, 2012, ANN RHEUM DIS, V71, P2044, DOI 10.1136/annrheumdis-2012-201400; Truchetet ME, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3486; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Voo KS, 2009, P NATL ACAD SCI USA, V106, P4793, DOI 10.1073/pnas.0900408106; Weaver CT, 2009, NAT REV IMMUNOL, V9, P883, DOI 10.1038/nri2660; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Zheng SG, 2006, J IMMUNOL, V176, P3321, DOI 10.4049/jimmunol.176.6.3321; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774; Zhou XY, 2009, CURR OPIN IMMUNOL, V21, P281, DOI 10.1016/j.coi.2009.05.007; Zuber JP, 2006, RHEUMATOLOGY, V45, P23, DOI 10.1093/rheumatology/kel285	48	51	55	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e64531	10.1371/journal.pone.0064531	http://dx.doi.org/10.1371/journal.pone.0064531			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776439	gold, Green Submitted, Green Published			2022-12-27	WOS:000320755400008
J	Perea, R; Venturas, M; Gil, L				Perea, Ramon; Venturas, Martin; Gil, Luis			Empty Seeds Are Not Always Bad: Simultaneous Effect of Seed Emptiness and Masting on Animal Seed Predation	PLOS ONE			English	Article							EVOLUTIONARY ECOLOGY; POSTDISPERSAL PREDATION; WIND POLLINATION; DISPERSAL; SATIATION; PARTHENOCARPY; BENEFITS; REMOVAL; FORESTS; MODELS	Seed masting and production of empty seeds have often been considered independently as different strategies to reduce seed predation by animals. Here, we integrate both phenomena within the whole assemblage of seed predators (both pre and post-dispersal) and in two contrasting microsites (open vs. sheltered) to improve our understanding of the factors controlling seed predation in a wind-dispersed tree (Ulmus laevis). In years with larger crop sizes more avian seed predators were attracted with an increase in the proportion of full seeds predated on the ground. However, for abundant crops, the presence of empty seeds decreased the proportion of full seeds predated. Empty seeds remained for a very long period in the tree, making location of full seeds more difficult for pre-dispersal predators and expanding the overall seed drop period at a very low cost (in dry biomass and allocation of C, N and P). Parthenocarpy (non-fertilized seeds) was the main cause of seed emptiness whereas seed abortion was produced in low quantity. These aborted seeds fell prematurely and, thus, could not work as deceptive seeds. A proportion of 50% empty seeds significantly reduced ground seed predation by 26%. However, a high rate of parthenocarpy (beyond 50% empty seeds) did not significantly reduce seed predation in comparison to 50% empty seeds. We also found a high variability and unpredictability in the production of empty seeds, both at tree and population level, making predator deception more effective. Open areas were especially important to facilitate seed survival since rodents (the main post-dispersal predators) consumed seeds mostly under shrub cover. In elm trees parthenocarpy is a common event that might work as an adaptive strategy to reduce seed predation. Masting per se did not apparently reduce the overall proportion of seeds predated in this wind-dispersed tree, but kept great numbers of seeds unconsumed.	[Perea, Ramon; Venturas, Martin; Gil, Luis] Univ Politecn Madrid, ETSI, Dept Silvopascicultura, Montes, Madrid, Spain	Universidad Politecnica de Madrid	Gil, L (corresponding author), Univ Politecn Madrid, ETSI, Dept Silvopascicultura, Montes, Ciudad Univ, Madrid, Spain.	luis.gil@upm.es	Perea, Ramon/A-9120-2017; Gil, Luis/E-3216-2014; Venturas, Martin D./J-2423-2014	Perea, Ramon/0000-0002-2206-3614; Gil, Luis/0000-0002-5252-2607; Venturas, Martin D./0000-0001-5972-9064	Comunidad de Madrid [S2009AMB-1668]	Comunidad de Madrid(Comunidad de Madrid)	Financial support was provided by the Comunidad de Madrid(project S2009AMB-1668). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, PLANT ANIMAL INTERAC; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bonal R, 2007, EVOL ECOL, V21, P367, DOI 10.1007/s10682-006-9107-y; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; BURNHAM KP, 1980, WILDLIFE MONOGR, P7; Burns R.M., 1990, AGR HDB, V654; Castro J, 1999, PLANT ECOL, V145, P115, DOI 10.1023/A:1009865703906; Crawley M. J., 2000, Seeds: the ecology of regeneration in plant communities, P167, DOI 10.1079/9780851994321.0167; Crawley M.J., 1997, PLANT ECOL; CRAWLEY MJ, 1995, J ECOL, V83, P683, DOI 10.2307/2261636; DAVIDAR P, 1986, ECOLOGY, V67, P262, DOI 10.2307/1938529; Fedriani JM, 2011, ECOLOGY, V92, P304, DOI 10.1890/09-2194.1; Fenner M., 2000, SEEDS ECOLOGY REGENE; Forget PM, 1999, J TROP ECOL, V15, P61, DOI 10.1017/S026646749900067X; Fuentes M, 1998, EVOL ECOL, V12, P823, DOI 10.1023/A:1006594532392; Garcia D, 2001, J ECOL, V89, P639, DOI 10.1046/j.1365-2745.2001.00577.x; Honek A, 2005, J ECOL, V93, P345, DOI 10.1111/j.1365-2745.2005.00987.x; HOWE HF, 1982, ANNU REV ECOL SYST, V13, P201, DOI 10.1146/annurev.es.13.110182.001221; HULME PE, 1994, J ECOL, V82, P645, DOI 10.2307/2261271; Hulme PE, 1999, PLANT ECOL, V145, P149, DOI 10.1023/A:1009821919855; Janzen D. H., 1971, A Rev Ecol Syst, V2, P465, DOI 10.1146/annurev.es.02.110171.002341; JANZEN DH, 1969, EVOLUTION, V23, P1, DOI [10.2307/2406478, 10.1111/j.1558-5646.1969.tb03489.x]; Karkkainen K, 1999, EVOL ECOL, V13, P305, DOI 10.1023/A:1006746900736; KELLY D, 1994, TRENDS ECOL EVOL, V9, P465, DOI 10.1016/0169-5347(94)90310-7; Kelly D, 2002, ANNU REV ECOL SYST, V33, P427, DOI 10.1146/annurev.ecolsys.33.020602.095433; Kelly D, 1997, OIKOS, V78, P143, DOI 10.2307/3545810; Kelly D, 2001, ECOLOGY, V82, P117, DOI 10.1890/0012-9658(2001)082[0117:ETWPBO]2.0.CO;2; Koenig WD, 2003, OIKOS, V102, P581, DOI 10.1034/j.1600-0706.2003.12272.x; LIMA SL, 1990, OIKOS, V58, P151, DOI 10.2307/3545422; Lopez-Almansa J. C., 2004, Investigacion Agraria, Sistemas y Recursos Forestales, V13, P17; Lopez-Almansa JC, 2003, SILVAE GENET, V52, P241; MUSTART PJ, 1995, AFR J ECOL, V33, P224, DOI 10.1111/j.1365-2028.1995.tb00799.x; NILSSON SG, 1987, ECOLOGY, V68, P260, DOI 10.2307/1939256; Nystrand O, 1997, OECOLOGIA, V110, P353, DOI 10.1007/s004420050169; Perea R, 2013, OIKOS, V122, P943, DOI 10.1111/j.1600-0706.2012.20940.x; Perea R, 2011, BASIC APPL ECOL, V12, P432, DOI 10.1016/j.baae.2011.05.002; Perea R, 2011, J ECOL, V99, P194, DOI 10.1111/j.1365-2745.2010.01749.x; Pizo MA, 1997, J TROP ECOL, V13, P559, DOI 10.1017/S0266467400010713; Ramos-Ordonez MF, 2011, J ARID ENVIRON, V75, P757, DOI 10.1016/j.jaridenv.2011.04.013; SHAW MW, 1968, J ECOL, V56, P565, DOI 10.2307/2258251; SILVERTOWN JW, 1980, BIOL J LINN SOC, V14, P235, DOI 10.1111/j.1095-8312.1980.tb00107.x; TRAVESET A, 1993, EVOL ECOL, V7, P357, DOI 10.1007/BF01237867; Vander Wall SB, 2001, BOT REV, V67, P74, DOI 10.1007/BF02857850; Vander Wall SB, 2002, ECOLOGY, V83, P3508, DOI 10.2307/3072099; VANDERWALL SB, 1994, OIKOS, V69, P125, DOI 10.2307/3545292; Venturas M, 2013, PLANT ECOL, V214, P317, DOI 10.1007/s11258-013-0170-5; Verdu M, 2001, PLANT ECOL, V156, P245, DOI 10.1023/A:1012653002598; WALLER DM, 1979, J THEOR BIOL, V80, P223, DOI 10.1016/0022-5193(79)90207-8; WILLSON MF, 1983, B TORREY BOT CLUB, V110, P298, DOI 10.2307/2996182; ZANGERL AR, 1991, EVOL ECOL, V5, P136, DOI 10.1007/BF02270830	50	20	20	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65573	10.1371/journal.pone.0065573	http://dx.doi.org/10.1371/journal.pone.0065573			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776503	Green Published, gold, Green Submitted			2022-12-27	WOS:000320755400043
J	Makinodan, M; Okuda-Yamamoto, A; Ikawa, D; Toritsuka, M; Takeda, T; Kimoto, S; Tatsumi, K; Okuda, H; Nakamura, Y; Wanaka, A; Kishimoto, T				Makinodan, Manabu; Okuda-Yamamoto, Aya; Ikawa, Daisuke; Toritsuka, Michihiro; Takeda, Tomohiko; Kimoto, Sohei; Tatsumi, Kouko; Okuda, Hiroaki; Nakamura, Yu; Wanaka, Akio; Kishimoto, Toshifumi			Oligodendrocyte Plasticity with an Intact Cell Body In Vitro	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; NMDA RECEPTORS; RAT MODEL; MYELINATION; PATHOGENESIS; INJURY; DEATH	Demyelination is generally regarded as a consequence of oligodendrocytic cell death. Oligodendrocyte processes that form myelin sheaths may, however, degenerate and regenerate independently of the cell body, in which case cell death does not necessarily occur. We provide here the first evidence of retraction and regeneration of oligodendrocyte processes with no cell death in vitro, using time-lapse imaging. When processes were severed mechanically in vitro, the cells did not undergo cell death and the processes regenerated in 36 h. In a separate experiment, moderate N-methyl-D-aspartate (NMDA) stimuli caused process retraction without apparent cell death, and the processes regained their elaborate morphology after NMDA was removed from the culture medium. These results strongly suggest that demyelination and remyelination can take place without concomitant cell death, at least in vitro. Process regeneration may therefore become a target for future therapy of demyelinating disorders.	[Makinodan, Manabu; Ikawa, Daisuke; Toritsuka, Michihiro; Takeda, Tomohiko; Kimoto, Sohei; Kishimoto, Toshifumi] Nara Med Univ, Dept Psychiat, Nara, Japan; [Tatsumi, Kouko; Okuda, Hiroaki; Wanaka, Akio] Nara Med Univ, Dept Anat & Neurosci, Nara, Japan; [Okuda-Yamamoto, Aya; Nakamura, Yu] Kagawa Univ, Dept Psychiat & Neurol, Takamatsu, Kagawa 760, Japan	Nara Medical University; Nara Medical University; Kagawa University	Makinodan, M (corresponding author), Nara Med Univ, Dept Psychiat, Nara, Japan.	mmm@naramed-u.ac.jp	Wanaka, Akio/GPW-8926-2022; Okuda, Hiroaki/S-4959-2019; Wanaka, Akio/AAC-9754-2019; Wanaka, Akio/ABE-4671-2020; Okuda, Hiroaki/E-9418-2018	Okuda, Hiroaki/0000-0002-6252-9634; Wanaka, Akio/0000-0001-9951-9862; Okuda, Hiroaki/0000-0002-6252-9634; Kimoto, Sohei/0000-0002-3148-690X	Ministry of Education, Culture, Sports, and Science of Japanese Government	Ministry of Education, Culture, Sports, and Science of Japanese Government	Grant-in-Aid from the Ministry of Education, Culture, Sports, and Science of Japanese Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Butt AM, 2006, GLIA, V54, P666, DOI 10.1002/glia.20424; Colaianna M, 2013, ANTIOXID REDOX SIGN, V18, P1385, DOI 10.1089/ars.2012.4569; Cudrici C, 2006, J REHABIL RES DEV, V43, P123, DOI 10.1682/JRRD.2004.08.0111; Duncan ID, 2008, J NEUROL SCI, V265, P89, DOI 10.1016/j.jns.2007.04.043; Fernandez-Gamba A, 2012, J NEUROCHEM, V121, P985, DOI 10.1111/j.1471-4159.2012.07742.x; Greenberg BM, 2008, SEMIN NEUROL, V28, P121, DOI 10.1055/s-2007-1019133; Islam MS, 2009, NEUROCHEM INT, V54, P192, DOI 10.1016/j.neuint.2008.10.011; Itoh K, 2002, BRAIN RES PROTOC, V10, P23; Jessen KR, 2008, GLIA, V56, P1552, DOI 10.1002/glia.20761; Jiang Z, 2013, BIOL PSYCHI IN PRESS; Karadottir R, 2005, NATURE, V438, P1162, DOI 10.1038/nature04302; Korde AS, 2012, J BIOL CHEM, V287, P35192, DOI 10.1074/jbc.M111.322032; Lassmann H, 2003, BRAIN, V126, P1347, DOI 10.1093/brain/awg127; Ligon KL, 2006, P NATL ACAD SCI USA, V103, P7853, DOI 10.1073/pnas.0511001103; Liu J, 2012, NAT NEUROSCI, V15, P1621, DOI 10.1038/nn.3263; Makinodan M, 2012, SCIENCE, V337, P1357, DOI 10.1126/science.1220845; Manning SM, 2008, J NEUROSCI, V28, P6670, DOI 10.1523/JNEUROSCI.1702-08.2008; Matute C, 2005, TRENDS NEUROSCI, V28, P173, DOI 10.1016/j.tins.2005.01.006; Matute C, 2007, NEURON GLIA BIOL, V3, P281, DOI 10.1017/S1740925X08000033; Micu I, 2006, NATURE, V439, P988, DOI 10.1038/nature04474; Micu I, 2007, NAT MED, V13, P874, DOI 10.1038/nm1568; Mirsky R, 2008, J PERIPHER NERV SYST, V13, P122, DOI 10.1111/j.1529-8027.2008.00168.x; Newcombe J, 2008, BRAIN PATHOL, V18, P52, DOI 10.1111/j.1750-3639.2007.00101.x; Parkinson DB, 2008, J CELL BIOL, V181, P625, DOI 10.1083/jcb.200803013; Rodriguez M, 1999, NEUROLOGY, V53, P1615, DOI 10.1212/WNL.53.8.1615; Salter MG, 2005, NATURE, V438, P1167, DOI 10.1038/nature04301; SHOLL DA, 1953, J ANAT, V87, P387; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.0.CO;2-J	28	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e66124	10.1371/journal.pone.0066124	http://dx.doi.org/10.1371/journal.pone.0066124			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762472	Green Submitted, Green Published, gold			2022-12-27	WOS:000321094800090
J	Averna, M; Pedrazzi, M; Minicucci, L; De Tullio, R; Cresta, F; Salamino, F; Pontremoli, S; Melloni, E				Averna, Monica; Pedrazzi, Marco; Minicucci, Laura; De Tullio, Roberta; Cresta, Federico; Salamino, Franca; Pontremoli, Sandro; Melloni, Edon			Calpain Inhibition Promotes the Rescue of F(508)del-CFTR in PBMC from Cystic Fibrosis Patients	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; PROTEIN-QUALITY CONTROL; CFTR; DEGRADATION; TRAFFICKING; CALPASTATIN; PROTEASOME; SECRETION; SYSTEM; LEVEL	A basal calpain activity promotes the limited proteolysis of wild type (WT) cystic fibrosis conductance regulator (CFTR), inducing the internalization of the split channel. This process contributes to the regulation in the level of the active CFTR at the plasma membranes. In peripheral blood mononuclear cells (PBMC) from 16 healthy donors, the inhibition of calpain activity induces a 3-fold increase in the amount of active WT CFTR at the plasma membranes. Instead, in PBMC from cystic fibrosis (CF) patients, calpain activity is expressed at aberrant levels causing the massive removal of F(508)del-CFTR from the cell surface. In these patients, the inhibition of such abnormal proteolysis rescues physiological amounts of active mutated CFTR in 90% of the patients (25 over 28). The recovery of functional F(508)del-CFTR at the physiological location, in cells treated with a synthetic calpain inhibitor, indicates that F(508)del-CFTR folding, maturation, and trafficking operate in CF-PBMC at significant rate. Thus, an increase in the basal calpain activity seems primarily involved in the CFTR defect observed in various CF cells. Furthermore, in CF-PBMC the recovery of the scaffolding protein Na+/H+ exchanger regulatory factor 1 (NHERF-1), occurring following inhibition of the aberrant calpain activity, can contribute to rescue CFTR-functional clusters.	[Averna, Monica; Pedrazzi, Marco; De Tullio, Roberta; Salamino, Franca; Pontremoli, Sandro; Melloni, Edon] Univ Genoa, Biochem Sect, Dept Expt Med DIMES, Genoa, Italy; [Averna, Monica; Pedrazzi, Marco; De Tullio, Roberta; Salamino, Franca; Pontremoli, Sandro; Melloni, Edon] Univ Genoa, CEBR, Genoa, Italy; [Minicucci, Laura; Cresta, Federico] Univ Genoa, Dept Neurosci Rehabil Ophthalmol Genet & Sci Moth, G Gaslini Hosp, Cyst Fibrosis Pediat Ctr, Genoa, Italy	University of Genoa; University of Genoa; University of Genoa; IRCCS Istituto Giannina Gaslini	Melloni, E (corresponding author), Univ Genoa, Biochem Sect, Dept Expt Med DIMES, Genoa, Italy.	melloni@unige.it	AVERNA, MONICA/R-5719-2019; Cresta, Federico/AAA-7564-2020	AVERNA, MONICA/0000-0002-9463-7533; Cresta, Federico/0000-0002-2483-5374	Ministero dell'Istruzione dell'Universita e della Ricerca; University of Genoa	Ministero dell'Istruzione dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); University of Genoa	The work was supported by grants from Ministero dell'Istruzione dell'Universita e della Ricerca (PRIN 2008), and from the University of Genoa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antigny F, 2008, CELL CALCIUM, V43, P175, DOI 10.1016/j.ceca.2007.05.002; Antigny F, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-70; Aronson N N Jr, 1974, Methods Enzymol, V31, P90; Averna M, 2011, BBA-MOL BASIS DIS, V1812, P1649, DOI 10.1016/j.bbadis.2011.09.013; Averna M, 2011, BBA-MOL CELL RES, V1813, P50, DOI 10.1016/j.bbamcr.2010.11.008; Averna M, 2010, BIOCHEM J, V430, P255, DOI 10.1042/BJ20100344; Brodsky JL, 2001, AM J PHYSIOL-LUNG C, V281, pL39, DOI 10.1152/ajplung.2001.281.1.L39; Caci E, 2008, BIOCHEM J, V413, P135, DOI 10.1042/BJ20080029; Coligan JE, 1991, CURRENT PROTOCOL IMM; DAUBNER SC, 1987, P NATL ACAD SCI USA, V84, P8912, DOI 10.1073/pnas.84.24.8912; De Tullio R, 2003, BIOCHEM J, V375, P689, DOI 10.1042/BJ20030706; De Tullio R, 1999, BIOCHEM J, V343, P467; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Favia M, 2010, MOL BIOL CELL, V21, P73, DOI 10.1091/mbc.E09-03-0185; Galietta LJV, 2001, FEBS LETT, V499, P220, DOI 10.1016/S0014-5793(01)02561-3; Gentzsch M, 2004, MOL BIOL CELL, V15, P2684, DOI 10.1091/mbc.E04-03-0176; Grove DE, 2009, MOL BIOL CELL, V20, P4059, DOI 10.1091/mbc.E08-09-0929; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; Hwang TC, 1997, AM J PHYSIOL-CELL PH, V273, pC988, DOI 10.1152/ajpcell.1997.273.3.C988; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; KOPITO RR, 1999, PHYSIOL REV, V79, P167; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Le Gars M, 2012, AM J RESP C IN PRESS; Loo TW, 2009, BIOCHEMISTRY-US, V48, P9882, DOI 10.1021/bi9004842; Molinski S, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00160; Moran O, 2005, FEBS LETT, V579, P3979, DOI 10.1016/j.febslet.2005.06.026; Mueller C, 2011, AM J RESP CELL MOL, V44, P922, DOI 10.1165/rcmb.2010-0224OC; Norez C, 2006, TRAFFIC, V7, P562, DOI 10.1111/j.1600-0854.2006.00409.x; Okiyoneda T, 2010, SCIENCE, V329, P805, DOI 10.1126/science.1191542; Ono Y, 2012, BBA-PROTEINS PROTEOM, V1824, P224, DOI 10.1016/j.bbapap.2011.08.005; PALEJWALA S, 1992, P NATL ACAD SCI USA, V89, P4202, DOI 10.1073/pnas.89.9.4202; Regamey N, 2012, THORAX, V67, P170, DOI 10.1136/thoraxjnl-2011-200585; Ribeiro CMP, 2005, J BIOL CHEM, V280, P10202, DOI 10.1074/jbc.M410317200; Sasaki T, 1990, J Enzyme Inhib, V3, P195, DOI 10.3109/14756369009035837; Sharma M, 2004, J CELL BIOL, V164, P923, DOI 10.1083/jcb.200312018; Sorio C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022212; Stifanese R, 2008, ARCH BIOCHEM BIOPHYS, V479, P145, DOI 10.1016/j.abb.2008.09.002; Swiatecka-Urban A, 2005, J BIOL CHEM, V280, P36762, DOI 10.1074/jbc.M508944200; Tang XX, 2012, J CELL PHYSIOL, V227, P3887, DOI 10.1002/jcp.24101; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Wolins N, 1997, J CELL BIOL, V139, P1735, DOI 10.1083/jcb.139.7.1735	42	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66089	10.1371/journal.pone.0066089	http://dx.doi.org/10.1371/journal.pone.0066089			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785472	Green Published, Green Submitted, gold			2022-12-27	WOS:000321038800050
J	Gierthmuehlen, M; Freiman, TM; Haastert-Talini, K; Mueller, A; Kaminsky, J; Stieglitz, T; Plachta, DTT				Gierthmuehlen, Mortimer; Freiman, Thomas M.; Haastert-Talini, Kirsten; Mueller, Alexandra; Kaminsky, Jan; Stieglitz, Thomas; Plachta, Dennis T. T.			Computational Tissue Volume Reconstruction of a Peripheral Nerve Using High-Resolution Light-Microscopy and Reconstruct	PLOS ONE			English	Article							SELECTIVE STIMULATION; NEURAL PROCESSES; SEGMENTATION; CUFF; FIBERS; IMAGES; INTERFACE; TIME	The development of neural cuff-electrodes requires several in vivo studies and revisions of the electrode design before the electrode is completely adapted to its target nerve. It is therefore favorable to simulate many of the steps involved in this process to reduce costs and animal testing. As the restoration of motor function is one of the most interesting applications of cuff-electrodes, the position and trajectories of myelinated fibers in the simulated nerve are important. In this paper, we investigate a method for building a precise neuroanatomical model of myelinated fibers in a peripheral nerve based on images obtained using high-resolution light microscopy. This anatomical model describes the first aim of our "Virtual workbench" project to establish a method for creating realistic neural simulation models based on image datasets. The imaging, processing, segmentation and technical limitations are described, and the steps involved in the transition into a simulation model are presented. The results showed that the position and trajectories of the myelinated axons were traced and virtualized using our technique, and small nerves could be reliably modeled based on of light microscopy images using low-cost OpenSource software and standard hardware. The anatomical model will be released to the scientific community.	[Gierthmuehlen, Mortimer; Freiman, Thomas M.; Kaminsky, Jan] Univ Med Ctr Freiburg, Dept Neurosurg, Freiburg, Germany; [Haastert-Talini, Kirsten] Hannover Med Sch, Inst Neuroanat, Hannover, Germany; [Mueller, Alexandra] Univ Med Ctr Freiburg, Dept Neuropathol, Freiburg, Germany; [Kaminsky, Jan] St Gertrauden Hosp, Dept Neurosurg, Berlin, Germany; [Stieglitz, Thomas; Plachta, Dennis T. T.] Univ Freiburg, Dept Microsyst Engn, Lab Biomed Microtechnol, D-79106 Freiburg, Germany	University of Freiburg; Hannover Medical School; University of Freiburg; University of Freiburg	Gierthmuehlen, M (corresponding author), Univ Med Ctr Freiburg, Dept Neurosurg, Freiburg, Germany.	mortimer.gierthmuehlen@uniklinik-freiburg.de	Haastert-Talini, Kirsten/D-2348-2010; Freiman, Thomas/AAV-8494-2021; Stieglitz, Thomas/C-7916-2013	Haastert-Talini, Kirsten/0000-0003-2502-8969; Freiman, Thomas/0000-0002-2591-2829; Stieglitz, Thomas/0000-0002-7349-4254; Gierthmuehlen, Mortimer/0000-0001-8575-6445	German Society of Neurosurgery	German Society of Neurosurgery	This study was supported by a scholarship from the "German Society of Neurosurgery" (http://www.dgnc.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres B, 2012, MED IMAGE ANAL, V16, P796, DOI 10.1016/j.media.2011.11.004; [Anonymous], 2010, COMMUNICATION; Boretius T, 2010, BIOSENS BIOELECTRON, V26, P62, DOI 10.1016/j.bios.2010.05.010; Chomiak T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007754; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Dercksen VJ, 2008, MATH VIS, P3, DOI 10.1007/978-3-540-72630-2_1; Dhillon GS., 2004, NEUROPROSTHETICS THE; Fazan VPS, 2001, AM J PHYSIOL-HEART C, V280, pH1560, DOI 10.1152/ajpheart.2001.280.4.H1560; Forkert ND, 2009, METHOD INFORM MED, V48, P399, DOI 10.3414/ME9237; Freeman TL, 2004, BASIC ANATOMY PHYSL; Gijtenbeek J. M. M., 2005, Angiogenesis, V8, P297; Grill W M, 1998, IEEE Trans Rehabil Eng, V6, P364, DOI 10.1109/86.736150; Grill WM, 2000, J BIOMED MATER RES, V50, P215; Haastert-Talini K, 2010, TISSUE ENG PT A, V16, P3085, DOI [10.1089/ten.tea.2010.0180, 10.1089/ten.TEA.2010.0180]; Haugland M. K., 1994, IEEE Transactions on Rehabilitation Engineering, V2, P18, DOI 10.1109/86.296346; Jabaley M E, 1980, J Hand Surg Am, V5, P1; Jeong WK, 2009, IEEE T VIS COMPUT GR, V15, P1505, DOI 10.1109/TVCG.2009.178; Joswig H, 2011, END ZU END VS END ZU; Jurrus E, 2009, MED IMAGE ANAL, V13, P180, DOI 10.1016/j.media.2008.05.002; Karen P, 2003, MICROSC RES TECHNIQ, V62, P415, DOI 10.1002/jemt.10405; KARNOVSKY MJ, 1965, J CELL BIOL, V27, pA137; Lang S, 2011, J COMPUT NEUROSCI, V31, P533, DOI 10.1007/s10827-011-0316-1; Lell MM, 2006, RADIOGRAPHICS, V26, pS45, DOI 10.1148/rg.26si065508; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Lu J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005655; Morales J, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00018; More HL, 2011, J NEUROSCI METH, V201, P149, DOI 10.1016/j.jneumeth.2011.07.026; Narayanaswamy A, 2010, IEEE T MED IMAGING, V29, P583, DOI 10.1109/TMI.2009.2022086; Plachta DTT, 2012, IEEE ENG MED BIO, P3416, DOI 10.1109/EMBC.2012.6346699; Plachta DTT, 2012, BIOMEDIZINISCHE TECH; Plachta DTT, 2012, VDI AUTOMED, V17, P61; Richerson S, 2005, BIOMED ENG ONLINE, V4, DOI 10.1186/1475-925X-4-53; Rodriguez FJ, 2000, J NEUROSCI METH, V98, P105, DOI 10.1016/S0165-0270(00)00192-8; Romero E, 2000, J NEUROSCI METH, V97, P111, DOI 10.1016/S0165-0270(00)00167-9; ROZMAN J, 1992, J MED ENG TECHNOL, V16, P194, DOI 10.3109/03091909209021983; Schultze O., 1910, Z WISS MIKROSK, V27, P465; Stieglitz T, 2012, P SPIE, V8251, p82510 A; Tyler DJ, 2002, IEEE T NEUR SYS REH, V10, P294, DOI 10.1109/TNSRE.2002.806840; Vollmer J, 1999, EUROGRAPHICS, P18; YOSHIDA K, 1993, IEEE T BIO-MED ENG, V40, P492, DOI 10.1109/10.243412; Yoshida K., 2004, THEORY PERIPHERAL NE, P342; Zariffa J, 2009, IFMBE P 25 9 WORLD C; Zariffa J, 2009, IEEE T NEUR SYS REH, V17, P53, DOI 10.1109/TNSRE.2008.2010475; Zariffa J, 2008, IEEE ENG MED BIO, P4216, DOI 10.1109/IEMBS.2008.4650139	44	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66191	10.1371/journal.pone.0066191	http://dx.doi.org/10.1371/journal.pone.0066191			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785485	Green Published, gold, Green Submitted			2022-12-27	WOS:000321038800037
J	Hussain, G; Schmitt, F; Henriques, A; Lequeu, T; Rene, F; Bindler, F; Dirrig-Grosch, S; Oudart, H; Palamiuc, L; Metz-Boutigue, MH; Dupuis, L; Marchioni, E; De Aguilar, JLG; Loeffler, JP				Hussain, Ghulam; Schmitt, Florent; Henriques, Alexandre; Lequeu, Thiebault; Rene, Frederique; Bindler, Francoise; Dirrig-Grosch, Sylvie; Oudart, Hugues; Palamiuc, Lavinia; Metz-Boutigue, Marie-Helene; Dupuis, Luc; Marchioni, Eric; De Aguilar, Jose-Luis Gonzalez; Loeffler, Jean-Philippe			Systemic Down-Regulation of Delta-9 Desaturase Promotes Muscle Oxidative Metabolism and Accelerates Muscle Function Recovery following Nerve Injury	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; STEAROYL-COA DESATURASE; SKELETAL-MUSCLE; PLASMA TRIGLYCERIDES; GENE-EXPRESSION; TRANSGENIC MICE; ANIMAL-MODEL; MOUSE MODEL; PGC-1-ALPHA; TRANSCRIPTION	The progressive deterioration of the neuromuscular axis is typically observed in degenerative conditions of the lower motor neurons, such as amyotrophic lateral sclerosis (ALS). Neurodegeneration in this disease is associated with systemic metabolic perturbations, including hypermetabolism and dyslipidemia. Our previous gene profiling studies on ALS muscle revealed down-regulation of delta-9 desaturase, or SCD1, which is the rate-limiting enzyme in the synthesis of monounsaturated fatty acids. Interestingly, knocking out SCD1 gene is known to induce hypermetabolism and stimulate fatty acid beta-oxidation. Here we investigated whether SCD1 deficiency can affect muscle function and its restoration in response to injury. The genetic ablation of SCD1 was not detrimental per se to muscle function. On the contrary, muscles in SCD1 knockout mice shifted toward a more oxidative metabolism, and enhanced the expression of synaptic genes. Repressing SCD1 expression or reducing SCD-dependent enzymatic activity accelerated the recovery of muscle function after inducing sciatic nerve crush. Overall, these findings provide evidence for a new role of SCD1 in modulating the restorative potential of skeletal muscles.	[Hussain, Ghulam; Schmitt, Florent; Henriques, Alexandre; Lequeu, Thiebault; Rene, Frederique; Dirrig-Grosch, Sylvie; Palamiuc, Lavinia; Dupuis, Luc; De Aguilar, Jose-Luis Gonzalez; Loeffler, Jean-Philippe] INSERM, U1118, Strasbourg, France; [Hussain, Ghulam; Schmitt, Florent; Henriques, Alexandre; Lequeu, Thiebault; Rene, Frederique; Dirrig-Grosch, Sylvie; Palamiuc, Lavinia; Dupuis, Luc; De Aguilar, Jose-Luis Gonzalez; Loeffler, Jean-Philippe] Univ Strasbourg, UMRS1118, Strasbourg, France; [Bindler, Francoise; Marchioni, Eric] Inst Pluridisciplinaire Hubert Curien, CNRS, UMR7178, Equipe Chim Analyt Mol Bioact, Illkirch Graffenstaden, France; [Oudart, Hugues] Inst Pluridisciplinaire Hubert Curien, UPR9010, CNRS, Dept Ecol Physiol & Ethol, Strasbourg, France; [Metz-Boutigue, Marie-Helene] INSERM, U977, Lab Biomat & Ingn Tissulaire, Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	De Aguilar, JLG (corresponding author), INSERM, U1118, Strasbourg, France.	gonzalez@unistra.fr; loeffler@unistra.fr	Dupuis, Luc/A-6981-2012; LOEFFLER, Jean-Philippe/AAS-4401-2020; Hussain, Ghulam/Y-9776-2019; HUSSAIN, Ghulam/S-7609-2016	Hussain, Ghulam/0000-0001-9090-7789; HUSSAIN, Ghulam/0000-0001-9090-7789	European Community's Health Seventh Framework Programme [259867]; Thierry Latran Foundation; "Appel a Projets 2009 du Conseil Scientifique" (University of Strasbourg); Association pour la Recherche sur la Sclerose Laterale Amyotrophique et autres Maladies du Motoneurone; Higher Education Commission of the Pakistani government; "Association pour la Recherche et le Developpement de Moyens de Lutte contre les Maladies Neurodegeneratives" (AREMANE); Association Francaise contre les Myopathies; AREMANE; FP7; Chaire d'Exellence INSERM/Universite de Strasbourg	European Community's Health Seventh Framework Programme; Thierry Latran Foundation; "Appel a Projets 2009 du Conseil Scientifique" (University of Strasbourg); Association pour la Recherche sur la Sclerose Laterale Amyotrophique et autres Maladies du Motoneurone; Higher Education Commission of the Pakistani government; "Association pour la Recherche et le Developpement de Moyens de Lutte contre les Maladies Neurodegeneratives" (AREMANE); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); AREMANE; FP7; Chaire d'Exellence INSERM/Universite de Strasbourg	This work was supported by funds from European Community's Health Seventh Framework Programme under grant agreement no. 259867 (FP7/2007-2013) and Thierry Latran Foundation to JPL; "Appel a Projets 2009 du Conseil Scientifique" (University of Strasbourg) to JLGDA; and "Association pour la Recherche sur la Sclerose Laterale Amyotrophique et autres Maladies du Motoneurone" to JLGDA and FR. GH is supported by the Higher Education Commission of the Pakistani government and "Association pour la Recherche et le Developpement de Moyens de Lutte contre les Maladies Neurodegeneratives" (AREMANE). FS is granted by "Association Francaise contre les Myopathies" and AREMANE. AH is a research fellow receiving funds from FP7/2007-2013. JLGDA is recipient of a "Chaire d'Exellence INSERM/Universite de Strasbourg". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attie AD, 2002, J LIPID RES, V43, P1899, DOI 10.1194/jlr.M200189-JLR200; Blanchet E, 2011, NAT CELL BIOL, V13, P1146, DOI 10.1038/ncb2309; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Bouteloup C, 2009, J NEUROL, V256, P1236, DOI 10.1007/s00415-009-5100-z; de Aguilar JLG, 2008, PHYSIOL GENOMICS, V32, P207, DOI 10.1152/physiolgenomics.00017.2007; Diaz-Amarilla P, 2011, P NATL ACAD SCI USA, V108, P18126, DOI 10.1073/pnas.1110689108; Dobrzyn A, 2005, AM J PHYSIOL-ENDOC M, V288, pE599, DOI 10.1152/ajpendo.00439.2004; Dupuis L, 2008, NEUROLOGY, V70, P1004, DOI 10.1212/01.wnl.0000285080.70324.27; Dupuis L, 2004, P NATL ACAD SCI USA, V101, P11159, DOI 10.1073/pnas.0402026101; Dupuis L, 2011, LANCET NEUROL, V10, P75, DOI 10.1016/S1474-4422(10)70224-6; Dupuis L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005390; ENOCH HG, 1976, J BIOL CHEM, V251, P5095; Fergani A, 2007, J LIPID RES, V48, P1571, DOI 10.1194/jlr.M700017-JLR200; Halter B, 2010, FREE RADICAL BIO MED, V48, P915, DOI 10.1016/j.freeradbiomed.2010.01.014; Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200; Handschin C, 2007, GENE DEV, V21, P770, DOI 10.1101/gad.1525107; Ibrahimi A, 1999, J BIOL CHEM, V274, P26761, DOI 10.1074/jbc.274.38.26761; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; Leger S, 2010, BIOORG MED CHEM LETT, V20, P499, DOI 10.1016/j.bmcl.2009.11.111; LOWRIE MB, 1982, J PHYSIOL-LONDON, V331, P51, DOI 10.1113/jphysiol.1982.sp014364; MARTINOU JC, 1991, J NEUROSCI, V11, P1291; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Perez-Garcia MJ, 2012, CELL REPORTS, V2, P497, DOI 10.1016/j.celrep.2012.08.004; Pradat PF, 2012, NEURODEGENER DIS, V9, P38, DOI 10.1159/000329723; RIPPS ME, 1995, P NATL ACAD SCI USA, V92, P689, DOI 10.1073/pnas.92.3.689; Rouaux C, 2007, J NEUROSCI, V27, P5535, DOI 10.1523/JNEUROSCI.1139-07.2007; Sampath H, 2011, ANN NY ACAD SCI, V1243, P47, DOI 10.1111/j.1749-6632.2011.06303.x; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Selsby JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030063; Sharp PS, 2005, NEUROSCIENCE, V130, P897, DOI 10.1016/j.neuroscience.2004.09.069; Wang J, 2005, BIOCHEM BIOPH RES CO, V332, P735, DOI 10.1016/j.bbrc.2005.05.013; Wong M, 2010, HUM MOL GENET, V19, P2284, DOI 10.1093/hmg/ddq106	33	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e64525	10.1371/journal.pone.0064525	http://dx.doi.org/10.1371/journal.pone.0064525			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785402	Green Published, gold, Green Submitted			2022-12-27	WOS:000321038800115
J	Mwitari, PG; Ayeka, PA; Ondicho, J; Matu, EN; Bii, CC				Mwitari, Peter G.; Ayeka, Peter A.; Ondicho, Joyce; Matu, Esther N.; Bii, Christine C.			Antimicrobial Activity and Probable Mechanisms of Action of Medicinal Plants of Kenya: Withania somnifera, Warbugia ugandensis, Prunus africana and Plectrunthus barbatus	PLOS ONE			English	Article							T-CELLS; EXPRESSION; IL-7; PROLIFERATION; ANTIBACTERIAL; SECRETION	Withania somnifera, Warbugia ugandensis, Prunus africana and Plectrunthus barbatus are used traditionally in Kenya for treatment of microbial infections and cancer. Information on their use is available, but scientific data on their bioactivity, safety and mechanisms of action is still scanty. A study was conducted on the effect of organic extracts of these plants on both bacterial and fungal strains, and their mechanisms of action. Extracts were evaluated through the disc diffusion assay. Bacteria and yeast test strains were cultured on Mueller-Hinton agar and on Sabouraud dextrose agar for the filamentous fungi. A 0.5 McFarland standard suspension was prepared. Sterile paper discs 6 mm in diameter impregnated with 10 ml of the test extract (100 mg/ml) were aseptically placed onto the surface of the inoculated media. Chloramphenicol (30 mu g) and fluconazole (25 mu g) were used as standards. Discs impregnated with dissolution medium were used as controls. Activity of the extracts was expressed according to zone of inhibition diameter. MIC was determined at 0.78-100 mg/ml. Safety studies were carried using Cell Counting Kit 8 cell proliferation assay protocol. To evaluate extracts mechanisms of action, IEC-6 cells and RT-PCR technique was employed in vitro to evaluate Interleukin 7 cytokine. Investigated plants extracts have both bactericidal and fungicidal activity. W. ugandensis is cytotoxic at IC50<50 mu g/ml with MIC values of less than 0.78 mg/ml. Prunus africana shuts down expression of IL 7 mRNA at 50 mu g/ml. W. somnifera has the best antimicrobial (1.5625 mg/ml), immunopotentiation (2 times IL 7 mRNA expression) and safety level (IC50>200 mu g/ml). Fractions from W. ugandensis and W. somnifera too demonstrated antimicrobial activity. Mechanisms of action can largely be attributed to cytotoxicity, Gene silencing and immunopotentiation. Use of medicinal plants in traditional medicine has been justified and possible mechanisms of action demonstrated. Studies to isolate and characterize the bioactive constituents continue.	[Mwitari, Peter G.; Ondicho, Joyce; Matu, Esther N.] Kenya Govt Med Res Ctr, Ctr Tradit Med & Drug Res, Nairobi, Kenya; [Mwitari, Peter G.; Ayeka, Peter A.] Tianjin Univ Tradit Chinese Med, Tianjin, Peoples R China; [Ayeka, Peter A.] Egerton Univ, Egerton, Kenya; [Bii, Christine C.] Kenya Govt Med Res Ctr, Ctr Microbiol Res, Nairobi, Kenya	Kenya Medical Research Institute; Tianjin University of Traditional Chinese Medicine; Egerton University; Kenya Medical Research Institute	Mwitari, PG (corresponding author), Kenya Govt Med Res Ctr, Ctr Tradit Med & Drug Res, Nairobi, Kenya.	pmwitari67@yahoo.com	Ayeka, Peter/AAE-7421-2020					Abu-Shanab Bassam, 2004, Turkish Journal of Biology, V28, P99; Akwatulira F, 2011, J MED PLANTS RES, V5, P6615, DOI 10.5897/JMPR11.160; Beentje H., 1994, KENYA TREES SHRUBS L; Bii C, 2010, J MED PLANTS RES, V4, P995; Comber JD, 2012, VACCINE, V30, P2140, DOI 10.1016/j.vaccine.2012.01.037; Davis L, 2002, J EXP CLIN CANC RES, V21, P115; Dorman HJD, 2000, J APPL MICROBIOL, V88, P308, DOI 10.1046/j.1365-2672.2000.00969.x; Foster S., 2006, DESK REFERENCE NATUR, Vfirst; Gagnon J, 2010, IMMUNOL CELL BIOL, V88, P451, DOI 10.1038/icb.2009.109; Ichikawa H, 2006, MOL CANCER THER, V14, P34; ICRAF, 2009, AGR TREE DAT TREE SP; Ivana BS, 2006, BRAZILIAN J INFECT D, V10; Kariba RM, 2001, J ETHNOPHARMACOL, V74, P41, DOI 10.1016/S0378-8741(00)00337-8; Kobayashi H, 2005, BLOOD, V105, P721, DOI 10.1182/blood-2003-12-4187; Kokwaro J.O., 1993, MED PLANTS E AFRICA; Kwok JMM, 2008, MOL CANCER THER, V7, P2022, DOI 10.1158/1535-7163.MCT-08-0188; Lukhoba CW, 2006, J ETHNOPHARMACOL, V103, P1, DOI 10.1016/j.jep.2005.09.011; Matu EN, 2003, J ETHNOPHARMACOL, V87, P35, DOI 10.1016/S0378-8741(03)00107-7; McGee DW, 1996, CLIN EXP IMMUNOL, V105, P274, DOI 10.1046/j.1365-2249.1996.d01-750.x; Mishra L C, 2000, Altern Med Rev, V5, P334; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mwangi JW, 2005, J ESSENTIAL OIL RES; Noor A, 2013, CURRENT SCI, V104; Olila D, 2002, J AFR HLTH SCI, V210, P2; Pellegrini M, 2011, CELL, V144, P601, DOI 10.1016/j.cell.2011.01.011; Phillipson J D, 1994, Trans R Soc Trop Med Hyg, V88 Suppl 1, pS17; Rasoanaivo P, 1993, IFS NAPLECA WORKSH B; Ray AB, 2004, MED PROPERTIES PLANT; Rios JL, 2005, J ETHNOPHARMACOL, V100, P80, DOI 10.1016/j.jep.2005.04.025; Rozen S, 2000, Methods Mol Biol, V132, P365; Runyoro D. K., 2006, BMC COMPLEM ALTERN M, V30, P6, DOI DOI 10.1186/1472-6882-6-11; Schmelzer GH, 2008, PLANTS RESOURCES TRO; Singh G., 2010, Annals of Biological Research, V1, P56; Suzuki S, 2007, INT ARCH ALLERGY IMM, V143, P89, DOI 10.1159/000101413; Vlientink J, 1995, J ETHNOPHARMACOL, V46, P31; Wamalwa NL., 2006, GENETIC VARIATION WA; Yoshioka A, 2008, CYTOKINE, V44, P57, DOI 10.1016/j.cyto.2008.06.004	37	45	49	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65619	10.1371/journal.pone.0065619	http://dx.doi.org/10.1371/journal.pone.0065619			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785437	Green Published, gold, Green Submitted			2022-12-27	WOS:000321038800083
J	Strathdee, SA; Abramovitz, D; Lozada, R; Martinez, G; Rangel, MG; Vera, A; Staines, H; Magis-Rodriguez, C; Patterson, TL				Strathdee, Steffanie A.; Abramovitz, Daniela; Lozada, Remedios; Martinez, Gustavo; Gudelia Rangel, Maria; Vera, Alicia; Staines, Hugo; Magis-Rodriguez, Carlos; Patterson, Thomas L.			Reductions in HIV/STI Incidence and Sharing of Injection Equipment among Female Sex Workers Who Inject Drugs: Results from a Randomized Controlled Trial	PLOS ONE			English	Article							HEPATITIS-C VIRUS; HIV-INFECTION; BEHAVIORAL INTERVENTION; RISK BEHAVIORS; CONDOM USE; USERS; PREVENTION; MEXICO; WOMEN; PREVALENCE	Background: We evaluated brief combination interventions to simultaneously reduce sexual and injection risks among female sex workers who inject drugs (FSW-IDUs) in Tijuana and Ciudad Juarez, Mexico during 2008-2010, when harm reduction coverage was expanding rapidly in Tijuana, but less so in Juarez. Methods: FSW-IDUs >= 18 years reporting sharing injection equipment and unprotected sex with clients within the last month participated in a randomized factorial trial comparing four brief, single-session conditions combining either an interactive or didactic version of a sexual risk intervention to promote safer sex in the context of drug use, and an injection risk intervention to reduce sharing of needles/injection paraphernalia. Women underwent quarterly interviews and testing for HIV, syphilis, gonorrhea, Chlamydia and Trichomonas, blinding interviewers and assessors to assignment. Poisson regression with robust variance estimation and repeated measures ordinal logistic regression examined effects on combined HIV/STI incidence and receptive needle sharing frequency. Findings: Of 584 initially HIV-negative FSW-IDUs, retention was >= 90%. After 12 months, HIV/STI incidence decreased >= 50% in the interactive vs. didactic sex intervention (Tijuana:AdjRR:0.38,95% CI: 0.16-0.89; Juarez:AdjRR:0.44,95% CI: 0.19-0.99). In Juarez, women receiving interactive vs. didactic injection risk interventions decreased receptive needle-sharing by 85% vs. 71%, respectively (p = 0.04); in Tijuana, receptive needle sharing declined by 95%, but was similar in active versus didactic groups. Tijuana women reported significant increases in access to syringes and condoms, but Juarez women did not. Interpretation: After 12 months in both cities, the interactive sexual risk intervention significantly reduced HIV/STI incidence. Expanding free access to sterile syringes coupled with brief, didactic education on safer injection was necessary and sufficient for achieving robust, sustained injection risk reductions in Tijuana. In the absence of expanding syringe access in Juarez, the injection risk intervention achieved significant, albeit more modest reductions, suggesting that community-level interventions incorporating harm reduction are more powerful than individual-level interventions.	[Strathdee, Steffanie A.; Abramovitz, Daniela; Vera, Alicia] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Lozada, Remedios] Inst Serv Salud Publ, Tijuana, Baja California, Mexico; [Martinez, Gustavo] Federac Mexicana Asociac Privadas, Ciudad Juarez, Chihuahua, Mexico; [Gudelia Rangel, Maria] Colegio Frontera Norte, Tijuana, Baja California, Mexico; [Staines, Hugo] Univ Autonoma Ciudad Juarez, Ciudad Juarez, Chihuahua, Mexico; [Magis-Rodriguez, Carlos] Concorcio Invest HIV AIDS & TB, Mexico City, DF, Mexico; [Patterson, Thomas L.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Colegio Frontera Norte; Universidad Autonoma de Ciudad Juarez; University of California System; University of California San Diego	Strathdee, SA (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	sstrathdee@ucsd.edu	Strathdee, Steffanie A/B-9042-2009	Strathdee, Steffanie/0000-0002-7724-691X; HARVEY-VERA, ALICIA/0000-0002-8708-8169; Magis-Rodriguez, Carlos/0000-0001-5481-1253	National Institute on Drug Abuse [R01 DA23877]; Fogarty International Center [D43TW008633]; FOGARTY INTERNATIONAL CENTER [D43TW008633] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA023877] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was funded by the National Institute on Drug Abuse (R01 DA23877). Ms. Vera is funded as a predoctoral scholar by the Fogarty International Center (D43TW008633). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baggaley RF, 2006, AIDS, V20, P805, DOI 10.1097/01.aids.0000218543.46963.6d; Bandea CI, 2009, J CLIN MICROBIOL, V47, P215, DOI 10.1128/JCM.01338-08; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Bautista CT, 2006, SEX TRANSM INFECT, V82, P311, DOI 10.1136/sti.2005.018234; Benotsch EG, 2004, INT J STD AIDS, V15, P343, DOI 10.1258/095646204323012850; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Bucardo J, 2005, DRUG ALCOHOL DEPEN, V79, P281, DOI 10.1016/j.drugalcdep.2005.02.003; Burgos JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011413; Centers fDCaP, 2011, HIV COUNS TEST NONH; Choi SYP, 2006, SOC SCI MED, V62, P1672, DOI 10.1016/j.socscimed.2005.08.046; Couture MC, 2012, DRUG ALCOHOL DEPEN, V120, P119, DOI 10.1016/j.drugalcdep.2011.07.005; Davidson PJ, 2012, INT J DRUG POLICY, V23, P286, DOI 10.1016/j.drugpo.2012.05.001; de-Salud Secretaria, 2002, PREV CONTR INF TRANS; Decker MR, 2012, SEX TRANSM INFECT, V88, P278, DOI 10.1136/sextrans-2011-050171; Degenhardt L, 2010, LANCET, V376, P285, DOI 10.1016/S0140-6736(10)60742-8; DEGRAAF R, 1995, AIDS CARE, V7, P35, DOI 10.1080/09540129550126948; El-Bassel N, 2012, CURR OPIN HIV AIDS, V7, P326, DOI 10.1097/COH.0b013e3283536ab2; Frost SDW, 2006, J URBAN HEALTH, V83, pI83, DOI 10.1007/s11524-006-9104-z; Garfein RS, 2007, DRUG ALCOHOL DEPEN, V91, pS4, DOI 10.1016/j.drugalcdep.2007.05.007; Garfein RS, 2007, AIDS, V21, P1923, DOI 10.1097/QAD.0b013e32823f9066; GOSSOP M, 1995, AIDS CARE, V7, P253, DOI 10.1080/09540129550126498; Iniguez-Stevens E, 2009, GAC MED MEX, V145, P189; Johnston LG, 2013, AIDS BEHAV, V17, P574, DOI 10.1007/s10461-012-0278-y; Latka MH, 2008, AM J PUBLIC HEALTH, V98, P853, DOI 10.2105/AJPH.2007.113415; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; LITTLE RJA, 1988, J AM STAT ASSOC, V83, P1198, DOI 10.2307/2290157; Markosyan K, 2010, AIDS BEHAV, V14, P530, DOI 10.1007/s10461-010-9689-9; Mathers BM, 2010, LANCET, V375, P1014, DOI 10.1016/S0140-6736(10)60232-2; Mausbach BT, 2007, ANN BEHAV MED, V34, P263, DOI 10.1007/BF02874551; McAlister FA, 2003, JAMA-J AM MED ASSOC, V289, P2545, DOI 10.1001/jama.289.19.2545; Morisky DE, 2010, AIDS EDUC PREV, V22, P371, DOI 10.1521/aeap.2010.22.4.371; Olsen A, 2012, INT J DRUG POLICY, V23, P312, DOI 10.1016/j.drugpo.2012.01.003; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; Patterson TL, 2008, AM J PUBLIC HEALTH, V98, P2051, DOI 10.2105/AJPH.2007.130096; Patterson TL, 2008, J INFECT DIS, V197, P728, DOI 10.1086/527379; Platt L, 2007, AM J PUBLIC HEALTH, V97, P478, DOI 10.2105/AJPH.2005.069732; Pollini RA, 2008, ADDICTION, V103, P101, DOI 10.1111/j.1360-0443.2007.02051.x; Roy E, 2011, AIDS, V25, P1897, DOI 10.1097/QAD.0b013e32834ad6bb; Shannon K, 2009, AM J PUBLIC HEALTH, V99, P659, DOI 10.2105/AJPH.2007.129858; Sosa-Estani S, 2003, CLIN INFECT DIS, V37, pS338, DOI 10.1086/377556; Strathdee SA, 2008, DRUG ALCOHOL DEPEN, V92, P132, DOI 10.1016/j.drugalcdep.2007.07.001; Strathdee SA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019048; Strathdee SA, 2009, JAIDS-J ACQ IMM DEF, V51, pS42, DOI 10.1097/QAI.0b013e3181a265b2; Strathdee SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002690; Surratt HL, 2010, J PREV INTERV COMMUN, V38, P118, DOI 10.1080/10852351003640732; Vera A, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-653; Vlahov D, 2010, CLIN INFECT DIS, V50, pS114, DOI 10.1086/651482; Wechsberg WM, 2012, SUBST ABUSE TREAT PR, V7, DOI 10.1186/1747-597X-7-1; White EF, 2007, SALUD PUBLICA MEXICO, V49, P165, DOI 10.1590/S0036-36342007000300001; Witte SS, 2011, AIDS BEHAV, V15, P1785, DOI 10.1007/s10461-011-9984-0	50	63	63	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65812	10.1371/journal.pone.0065812	http://dx.doi.org/10.1371/journal.pone.0065812			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	172XB	23785451	Green Published, gold			2022-12-27	WOS:000321038800071
J	Yoshimura, T; Benny, O; Bazinet, L; D'Amato, RJ				Yoshimura, Takeru; Benny, Ofra; Bazinet, Lauren; D'Amato, Robert J.			Suppression of Autoimmune Retinal Inflammation by an Antiangiogenic Drug	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; CELL-CYCLE INHIBITION; ANGIOGENESIS INHIBITOR; UVEORETINITIS; TNP-470; UVEITIS; DISEASE; MODEL; P53	Chronic and recurrent uveitis account for approximately 10% of legal blindness in the western world. Autoimmune uveitis is driven by activated CD4(+) T cells that differentiate into effector T helper cells (Th1, Th2, and Th17) which release proinflammatory cytokines that damage the retina. In this study we investigated the effect of the methionine aminopeptidase 2 (MetAP2) inhibitor, Lodamin, on T cell activation and differentiation. MetAp2 is an enzyme which regulates cellular protein synthesis and is highly expressed in T cells. Lodamin was found to suppress T cell receptor (TCR) mediated T cell proliferation and reduced the production of Th1 and Th17 cells. Further, Lodamin suppressed overall inflammation in the mouse model of experimental autoimmune uveitis (EAU) by a six fold. This effect was attributed in part to a reduction in retinal proinflammatory cytokines, down regulation of MetAP2 expression in purified lymph node CD4+ T cells, and a general normalization of the systemic immune reaction.	[Yoshimura, Takeru; Benny, Ofra; Bazinet, Lauren; D'Amato, Robert J.] Harvard Univ, Sch Med, Dept Surg, Boston Childrens Hosp,Vasc Biol Program, Boston, MA 02115 USA; [D'Amato, Robert J.] Harvard Univ, Sch Med, Dept Ophthalmol, Boston Childrens Hosp, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School	Benny, O (corresponding author), Harvard Univ, Sch Med, Dept Surg, Boston Childrens Hosp,Vasc Biol Program, Boston, MA 02115 USA.	ofra.bennyratsaby@childrens.harvard.edu	Benny, Ofra/AAB-3294-2021	Yoshimura, Takeru/0000-0002-5983-7193				Amadi-Obi A, 2007, NAT MED, V13, P711, DOI 10.1038/nm1585; Avichezer D, 2000, INVEST OPHTH VIS SCI, V41, P127; Benita Y, 2010, BLOOD, V115, P5376, DOI 10.1182/blood-2010-01-263855; Benny O, 2008, NAT BIOTECHNOL, V26, P799, DOI 10.1038/nbt1415; Benny O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012515; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Brahn E, 2009, J PHARMACOL EXP THER, V329, P615, DOI 10.1124/jpet.108.148478; Caspi RR, 2008, OPHTHAL RES, V40, P169, DOI 10.1159/000119871; Caspi RR, 2003, CURR PROTOC IMMUNOL, V15, P16; Chao CC, 1997, J IMMUNOL, V159, P1686; Chi W, 2008, INVEST OPHTH VIS SCI, V49, P3058, DOI 10.1167/iovs.07-1390; Clavel G, 2003, JOINT BONE SPINE, V70, P321, DOI 10.1016/S1297-319X(03)00088-5; Damsker JM, 2010, ANN NY ACAD SCI, V1183, P211, DOI 10.1111/j.1749-6632.2009.05133.x; de Smet MD, 2011, PROG RETIN EYE RES, V30, P452, DOI 10.1016/j.preteyeres.2011.06.005; Griffith EC, 1998, P NATL ACAD SCI USA, V95, P15183, DOI 10.1073/pnas.95.26.15183; Hansel TT, 2010, NAT REV DRUG DISCOV, V9, P325, DOI 10.1038/nrd3003; Horai R, 2011, J INTERF CYTOK RES, V31, P733, DOI 10.1089/jir.2011.0042; Mauriz JL, 2007, TRANSL RES, V149, P46, DOI 10.1016/j.trsl.2006.07.004; McEwen BS, 1997, BRAIN RES REV, V23, P79, DOI 10.1016/S0165-0173(96)00012-4; Mora JR, 2006, TRENDS IMMUNOL, V27, P235, DOI 10.1016/j.it.2006.03.007; Ogata A, 2012, INT J RHEUMATOL, V2012, DOI 10.1155/2012/946048; OLIVER SJ, 1994, CELL IMMUNOL, V157, P291, DOI 10.1006/cimm.1994.1223; PEACOCK DJ, 1992, J EXP MED, V175, P1135, DOI 10.1084/jem.175.4.1135; Smolen JS, 2011, ARTHRITIS RES THER, V13, DOI [10.1186/ar3094, 10.1186/1478-6354-13-S1-S2]; Thurau SR, 1997, CLIN EXP IMMUNOL, V109, P370, DOI 10.1046/j.1365-2249.1997.4571356.x; Venturi GM, 2003, IMMUNITY, V19, P713, DOI 10.1016/S1074-7613(03)00295-4; Weninger W, 2003, J IMMUNOL, V170, P4638, DOI 10.4049/jimmunol.170.9.4638; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P6427, DOI 10.1073/pnas.97.12.6427	28	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66219	10.1371/journal.pone.0066219	http://dx.doi.org/10.1371/journal.pone.0066219			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785488	gold, Green Submitted, Green Published			2022-12-27	WOS:000321038800034
J	Morfini, GA; Bosco, DA; Brown, H; Gatto, R; Kaminska, A; Song, YY; Molla, L; Baker, L; Marangoni, MN; Berth, S; Tavassoli, E; Bagnato, C; Tiwari, A; Hayward, LJ; Pigino, GF; Watterson, DM; Huang, CF; Banker, G; Brown, RH; Brady, ST				Morfini, Gerardo A.; Bosco, Daryl A.; Brown, Hannah; Gatto, Rodolfo; Kaminska, Agnieszka; Song, Yuyu; Molla, Linda; Baker, Lisa; Marangoni, M. Natalia; Berth, Sarah; Tavassoli, Ehsan; Bagnato, Carolina; Tiwari, Ashutosh; Hayward, Lawrence J.; Pigino, Gustavo F.; Watterson, D. Martin; Huang, Chun-Fang; Banker, Gary; Brown, Robert H., Jr.; Brady, Scott T.			Inhibition of Fast Axonal Transport by Pathogenic SOD1 Involves Activation of p38 MAP Kinase	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MOTOR-NEURON DEGENERATION; ZINC SUPEROXIDE-DISMUTASE; SQUID GIANT-AXON; PROTEIN-KINASE; MOUSE MODEL; CYTOPLASMIC DYNEIN; IN-VIVO; NEUROFILAMENT PROTEIN; HEXANUCLEOTIDE REPEAT	Dying-back degeneration of motor neuron axons represents an established feature of familial amyotrophic lateral sclerosis (FALS) associated with superoxide dismutase 1 (SOD1) mutations, but axon-autonomous effects of pathogenic SOD1 remained undefined. Characteristics of motor neurons affected in FALS include abnormal kinase activation, aberrant neurofilament phosphorylation, and fast axonal transport (FAT) deficits, but functional relationships among these pathogenic events were unclear. Experiments in isolated squid axoplasm reveal that FALS-related SOD1 mutant polypeptides inhibit FAT through a mechanism involving a p38 mitogen activated protein kinase pathway. Mutant SOD1 activated neuronal p38 in mouse spinal cord, neuroblastoma cells and squid axoplasm. Active p38 MAP kinase phosphorylated kinesin-1, and this phosphorylation event inhibited kinesin-1. Finally, vesicle motility assays revealed previously unrecognized, isoform-specific effects of p38 on FAT. Axon-autonomous activation of the p38 pathway represents a novel gain of toxic function for FALS-linked SOD1 proteins consistent with the dying-back pattern of neurodegeneration characteristic of ALS.	[Morfini, Gerardo A.; Gatto, Rodolfo; Kaminska, Agnieszka; Song, Yuyu; Marangoni, M. Natalia; Berth, Sarah; Tavassoli, Ehsan; Pigino, Gustavo F.; Brady, Scott T.] Univ Illinois, Dept Anat & Cell Biol, Chicago, IL 60607 USA; [Morfini, Gerardo A.; Brown, Hannah; Kaminska, Agnieszka; Song, Yuyu; Molla, Linda; Baker, Lisa; Marangoni, M. Natalia; Berth, Sarah; Pigino, Gustavo F.; Brady, Scott T.] Marine Biol Lab, Woods Hole, MA 02543 USA; [Bosco, Daryl A.; Hayward, Lawrence J.; Brown, Robert H., Jr.] Univ Massachusetts, Med Ctr, Dept Neurol, Worcester, MA 01655 USA; [Tiwari, Ashutosh] Michigan Technol Univ, Dept Chem, Houghton, MI 49931 USA; [Brown, Hannah] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Watterson, D. Martin] Northwestern Univ, Ctr Mol Innovat & Drug Discovery, Chicago, IL 60611 USA; [Watterson, D. Martin] Northwestern Univ, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA; [Huang, Chun-Fang; Banker, Gary] Oregon Hlth & Sci Univ, Jungers Ctr Neurosci Res, Portland, OR 97201 USA; [Bagnato, Carolina] Natl Univ Rio Negro, Dept Nat Sci & Engn, Rio Negro, Argentina	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Marine Biological Laboratory - Woods Hole; University of Massachusetts System; University of Massachusetts Worcester; Michigan Technological University; Harvard University; Massachusetts General Hospital; Northwestern University; Northwestern University; Oregon Health & Science University	Morfini, GA (corresponding author), Univ Illinois, Dept Anat & Cell Biol, Chicago, IL 60607 USA.	gmorfini@uic.edu; stbrady@uic.edu	Gatto, Rodolfo/R-7155-2018; Song, Yuyu/J-8939-2019; Tiwari, Ashutosh/A-7458-2008; Pigino, Gustavo/L-7002-2019	Gatto, Rodolfo/0000-0003-2170-6662; Song, Yuyu/0000-0002-9196-1610; Tiwari, Ashutosh/0000-0001-7373-349X; Watterson, Daniel/0000-0001-7605-5866; Hayward, Lawrence/0000-0003-0579-0358	Marine Biological Laboratory; NIH [NS066942A, R01NS44170, NS23868, NS23320, NS41170, MH066179, R01AG031311, R01NS055951, U01NS05225, R01NS050557, 1RC1NS068391, 1RC2NS070342, R01NS067206]; Howard Hughes Medical Institute-USE [52006287]; Muscular Dystrophy Association (MDA); ALS Association; ALS/CVS Therapy Alliance; Angel Fund; DeBourgknecht Fund for ALS Research; P2ALS; Project ALS; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023868, R01NS055951, R01NS067206, RC2NS070342, R56NS023868, R01NS044170, R01NS023320, R01NS050557, R01NS066942, R01NS041170, RC1NS068391] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG043415, R01AG031311] Funding Source: NIH RePORTER	Marine Biological Laboratory; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute-USE(Howard Hughes Medical Institute); Muscular Dystrophy Association (MDA)(Muscular Dystrophy Association); ALS Association; ALS/CVS Therapy Alliance; Angel Fund; DeBourgknecht Fund for ALS Research; P2ALS; Project ALS; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Support was provided by 2007/2008 Marine Biological Laboratory summer fellowships and NIH (NS066942A) grants to GM; Howard Hughes Medical Institute-USE Grant #52006287 to Hunter College of CUNY (LM); Muscular Dystrophy Association (MDA) and NIH (R01NS44170) grants to LJH; MDA and NIH (NS23868, NS23320, NS41170) grants to STB; NIH grant MH066179 to GB; NIH grants R01AG031311 and R01NS055951 to DMW; NIH (U01NS05225, R01NS050557, 1RC1NS068391, 1RC2NS070342) grants to RHB; R01NS067206 to DAB; ALS Association grants to GM, AT, RHB, and STB; and ALS/CVS Therapy Alliance grants to RHB, GM, AT, LJH, and DAB. RHB and AT received support from the Angel Fund. RHB also received support from the DeBourgknecht Fund for ALS Research, P2ALS and Project ALS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerley S, 2004, MOL CELL NEUROSCI, V26, P354, DOI 10.1016/j.mcn.2004.02.009; Banks GT, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-214; Barr RK, 2002, J BIOL CHEM, V277, P10987, DOI 10.1074/jbc.M107565200; Bendotti C, 2004, J NEUROPATH EXP NEUR, V63, P113, DOI 10.1093/jnen/63.2.113; Bilsland LG, 2010, P NATL ACAD SCI USA, V107, P20523, DOI 10.1073/pnas.1006869107; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; BORCHELT DR, 1994, P NATL ACAD SCI USA, V91, P8292, DOI 10.1073/pnas.91.17.8292; Bosco DA, 2010, CNS NEUROL DISORD-DR, V9, P779; Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660; BRADY ST, 1993, METHOD CELL BIOL, V39, P191, DOI 10.1016/S0091-679X(08)60171-5; BRADY ST, 1990, CELL MOTIL CYTOSK S2, V17, P22; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Chen XJ, 2007, J NEUROSCI, V27, P14515, DOI 10.1523/JNEUROSCI.4338-07.2007; Coffey ET, 2002, J NEUROSCI, V22, P4335, DOI 10.1523/JNEUROSCI.22-11-04335.2002; COHEN RS, 1987, J NEUROSCI, V7, P2056; Conforti L, 2007, TRENDS NEUROSCI, V30, P159, DOI 10.1016/j.tins.2007.02.004; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Dadon-Nachum M, 2011, J MOL NEUROSCI, V43, P470, DOI 10.1007/s12031-010-9467-1; De Vos KJ, 2007, HUM MOL GENET, V16, P2720, DOI 10.1093/hmg/ddm226; DeBoer SR, 2008, BIOCHEMISTRY-US, V47, P4535, DOI 10.1021/bi702445j; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Dewil M, 2007, NEUROBIOL DIS, V26, P332, DOI 10.1016/j.nbd.2006.12.023; Dion PA, 2009, NAT REV GENET, V10, P769, DOI 10.1038/nrg2680; Dong Hang, 2007, Zhonghua Yi Xue Za Zhi, V87, P53; Dupuis L, 2009, EXP NEUROL, V215, P146, DOI 10.1016/j.expneurol.2008.09.019; Elluru R, 1995, J NEUROSCI RES UNPUB; ELLURU RG, 1995, MOL BIOL CELL, V6, P21, DOI 10.1091/mbc.6.1.21; Eschbach J, 2011, PHARMACOL THERAPEUT, V130, P348, DOI 10.1016/j.pharmthera.2011.03.004; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Gallo KA, 2002, NAT REV MOL CELL BIO, V3, P663, DOI 10.1038/nrm906; Gould TW, 2006, J NEUROSCI, V26, P8774, DOI 10.1523/JNEUROSCI.2315-06.2006; Grant P, 2000, J NEUROCYTOL, V29, P843, DOI 10.1023/A:1010999509251; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; GURNEY ME, 1994, NEW ENGL J MED, V331, P1721, DOI 10.1056/NEJM199412223312516; Hafezparast M, 2003, SCIENCE, V300, P808, DOI 10.1126/science.1083129; Hayward LJ, 2002, J BIOL CHEM, V277, P15923, DOI 10.1074/jbc.M112087200; HOLLENBECK PJ, 1993, J NEUROCHEM, V60, P2265, DOI 10.1111/j.1471-4159.1993.tb03513.x; HOLLENBECK PJ, 1990, J CELL BIOL, V115, pA390; Ilieva HS, 2008, P NATL ACAD SCI USA, V105, P12599, DOI 10.1073/pnas.0805422105; Jacobson C, 2006, NEURON, V49, P797, DOI 10.1016/j.neuron.2006.02.005; Jonsson PA, 2006, BRAIN, V129, P451, DOI 10.1093/brain/awh704; Kaether C, 2000, MOL BIOL CELL, V11, P1213, DOI 10.1091/mbc.11.4.1213; Kamenecka T, 2009, J BIOL CHEM, V284, P12853, DOI 10.1074/jbc.M809430200; Kieran D, 2005, J CELL BIOL, V169, P561, DOI 10.1083/jcb.200501085; Krieger C, 2003, TRENDS PHARMACOL SCI, V24, P535, DOI 10.1016/j.tips.2003.08.003; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; LaPointe NE, 2009, J NEUROSCI RES, V87, P440, DOI 10.1002/jnr.21850; Lazarov O, 2005, J NEUROSCI, V25, P2386, DOI 10.1523/JNEUROSCI.3089-04.2005; LEE KD, 1995, J BIOL CHEM, V270, P5600, DOI 10.1074/jbc.270.10.5600; Lee SH, 2000, J NEUROSCI RES, V60, P623, DOI 10.1002/(SICI)1097-4547(20000601)60:5<623::AID-JNR7>3.0.CO;2-4; Levy JR, 2006, INT J DEV NEUROSCI, V24, P103, DOI 10.1016/j.ijdevneu.2005.11.013; Lobsiger CS, 2005, P NATL ACAD SCI USA, V102, P10351, DOI 10.1073/pnas.0503862102; MANETTO V, 1988, J NEUROPATH EXP NEUR, V47, P642, DOI 10.1097/00005072-198811000-00007; Marinkovic P, 2012, P NATL ACAD SCI USA, V109, P4296, DOI 10.1073/pnas.1200658109; MARTZ D, 1984, CELL MOTIL CYTOSKEL, V4, P89, DOI 10.1002/cm.970040203; Morfini G, 2002, EMBO J, V21, P281, DOI 10.1093/emboj/21.3.281; Morfini G, 2007, P NATL ACAD SCI USA, V104, P2442, DOI 10.1073/pnas.0611231104; Morfini G, 2007, J NEUROSCI RES, V85, P2620, DOI 10.1002/jnr.21154; Morfini G, 2006, NAT NEUROSCI, V9, P907, DOI 10.1038/nn1717; Morfini GA, 2009, J NEUROSCI, V29, P12776, DOI 10.1523/JNEUROSCI.3463-09.2009; Morfini GA, 2009, NAT NEUROSCI, V12, P864, DOI 10.1038/nn.2346; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Munoz L, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-21; Murakata C, 2002, BIOORG MED CHEM LETT, V12, P147, DOI 10.1016/S0960-894X(01)00690-4; PANT HC, 1978, J CELL BIOL, V78, pR23, DOI 10.1083/jcb.78.2.R23; Pasinelli P, 2000, P NATL ACAD SCI USA, V97, P13901, DOI 10.1073/pnas.240305897; Pasinelli P, 1998, P NATL ACAD SCI USA, V95, P15763, DOI 10.1073/pnas.95.26.15763; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Perlson E, 2009, J NEUROSCI, V29, P9903, DOI 10.1523/JNEUROSCI.0813-09.2009; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Rothstein JD, 2009, ANN NEUROL, V65, pS3, DOI 10.1002/ana.21543; Sack S, 1997, BIOCHEMISTRY-US, V36, P16155, DOI 10.1021/bi9722498; Sau D, 2011, BIOL CELL, V103, P87, DOI 10.1042/BC20100093; Saxton WM, 2012, J CELL SCI; Sharma R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013463; Shi P, 2010, BBA-MOL BASIS DIS, V1802, P707, DOI 10.1016/j.bbadis.2010.05.008; Song YY, 2013, P NATL ACAD SCI USA, V110, P5428, DOI 10.1073/pnas.1303279110; Strom AL, 2008, J NEUROCHEM, V106, P495, DOI 10.1111/j.1471-4159.2008.05393.x; Szodorai A, 2009, J NEUROSCI, V29, P14534, DOI 10.1523/JNEUROSCI.1546-09.2009; Takekawa M, 2005, MOL CELL, V18, P295, DOI 10.1016/j.molcel.2005.04.001; Teuchert M, 2006, EXP NEUROL, V198, P271, DOI 10.1016/j.expneurol.2005.12.005; Tortarolo M, 2003, MOL CELL NEUROSCI, V23, P180, DOI 10.1016/S1044-7431(03)00022-8; Tsai MY, 2000, MOL BIOL CELL, V11, P2161, DOI 10.1091/mbc.11.6.2161; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; Veglianese P, 2006, MOL CELL NEUROSCI, V31, P218, DOI 10.1016/j.mcn.2005.09.009; Warita H, 1999, BRAIN RES, V819, P120, DOI 10.1016/S0006-8993(98)01351-1; Williamson TL, 1999, NAT NEUROSCI, V2, P50, DOI 10.1038/4553; Wishart TM, 2006, J NEUROPATH EXP NEUR, V65, P733, DOI 10.1097/01.jnen.0000228202.35163.c4; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257	90	71	73	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65235	10.1371/journal.pone.0065235	http://dx.doi.org/10.1371/journal.pone.0065235			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776455	Green Published, gold			2022-12-27	WOS:000320322400010
J	Moriyama, H; Moriyama, M; Sawaragi, K; Okura, H; Ichinose, A; Matsuyama, A; Hayakawa, T				Moriyama, Hiroyuki; Moriyama, Mariko; Sawaragi, Kei; Okura, Hanayuki; Ichinose, Akihiro; Matsuyama, Akifumi; Hayakawa, Takao			Tightly Regulated and Homogeneous Transgene Expression in Human Adipose-Derived Mesenchymal Stem Cells by Lentivirus with Tet-Off System	PLOS ONE			English	Article							MULTILINEAGE PROGENITOR CELLS; INSULIN-PRODUCING CELLS; STROMAL CELLS; PROMOTER SUPPRESSION; GENE DELIVERY; CMV PROMOTER; VECTORS; TRANSPLANTATION; GENERATION; ISCHEMIA	Genetic modification of human adipose tissue-derived multilineage progenitor cells (hADMPCs) is highly valuable for their exploitation in therapeutic applications. Here, we have developed a novel single tet-off lentiviral vector platform. This vector combines (1) a modified tetracycline (tet)-response element composite promoter, (2) a multi-cistronic strategy to express an improved version of the tet-controlled transactivator and the blasticidin resistance gene under the control of a ubiquitous promoter, and (3) acceptor sites for easy recombination cloning of the gene of interest. In the present study, we used the cytomegalovirus (CMV) or the elongation factor 1 alpha (EF-1 alpha) promoter as the ubiquitous promoter, and EGFP was introduced as the gene of interest. hADMPCs transduced with a lentiviral vector carrying either the CMV promoter or the EF-1 alpha promoter were effectively selected by blasticidin without affecting their stem cell properties, and EGFP expression was strictly regulated by doxycycline (Dox) treatment in these cells. However, the single tet-off lentiviral vector carrying the EF-1 alpha promoter provided more homogenous expression of EGFP in hADMPCs. Intriguingly, differentiated cells from these Dox-responsive cell lines constitutively expressed EGFP only in the absence of Dox. This single tet-off lentiviral vector thus provides an important tool for applied research on hADMPCs.	[Moriyama, Hiroyuki; Moriyama, Mariko; Sawaragi, Kei; Hayakawa, Takao] Kinki Univ, Pharmaceut Res & Technol Inst, Higashiosaka, Osaka 577, Japan; [Moriyama, Mariko; Okura, Hanayuki; Matsuyama, Akifumi] Fdn Biomed Res & Innovat, Platform Realizat Regenerat Med, Chuo Ku, Kobe, Hyogo, Japan; [Ichinose, Akihiro] Kobe Univ Hosp, Dept Plast Surg, Chuo Ku, Kobe, Hyogo, Japan	Kindai University (Kinki University); Institute for Biomedical Research & Innovation (IBRI); Kobe University	Moriyama, H (corresponding author), Kinki Univ, Pharmaceut Res & Technol Inst, Higashiosaka, Osaka 577, Japan.	moriyama@phar.kindai.ac.jp			MEXT KAKENHI [23791304, 24791927]; Ministry of Health, Labor, and Welfare of Japan; Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO)	MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO)(National Institute of Biomedical Innovation)	This work was supported in part by MEXT KAKENHI Grant Number 23791304 to M. M. and 24791927 to H. M. This work was also supported in part by grants from the Ministry of Health, Labor, and Welfare of Japan and a grant from the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benabdellah K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023734; Brooks AR, 2004, J GENE MED, V6, P395, DOI 10.1002/jgm.516; Chinnasamy D, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-14; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Dezawa M, 2004, J CLIN INVEST, V113, P1701, DOI 10.1172/JCI200420935; Duan HF, 2003, MOL THER, V8, P467, DOI 10.1016/S1525-0016(03)00186-2; EMERMAN M, 1986, NUCLEIC ACIDS RES, V14, P9381, DOI 10.1093/nar/14.23.9381; Fan L, 2009, EUR J HEART FAIL, V11, P1023, DOI 10.1093/eurjhf/hfp135; Ghosh SS, 2006, APPL BIOCHEM BIOTECH, V133, P9, DOI 10.1385/ABAB:133:1:9; Goudenege S, 2009, MOL THER, V17, P1064, DOI 10.1038/mt.2009.67; Hioki H, 2009, NEUROSCI RES, V63, P149, DOI 10.1016/j.neures.2008.10.010; Ibrahimi A, 2009, HUM GENE THER, V20, P845, DOI 10.1089/hum.2008.188; Ikegame Y, 2011, CYTOTHERAPY, V13, P675, DOI 10.3109/14653249.2010.549122; Karnieli O, 2007, STEM CELLS, V25, P2837, DOI 10.1634/stemcells.2007-0164; Kawabata K, 2005, MOL THER, V12, P547, DOI 10.1016/j.ymthe.2005.04.015; Kim S, 2007, STEM CELLS DEV, V16, P537, DOI 10.1089/scd.2006.0088; Lee EY, 2009, WOUND REPAIR REGEN, V17, P540, DOI 10.1111/j.1524-475X.2009.00499.x; Leu S, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-63; Li YH, 2007, J CELL PHYSIOL, V211, P36, DOI 10.1002/jcp.20897; Liang ZX, 2007, BIOCHEM BIOPH RES CO, V363, P542, DOI 10.1016/j.bbrc.2007.09.007; McGinley L, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt53; Meilinger D, 2009, EMBO REP, V10, P1259, DOI 10.1038/embor.2009.201; Moriyama M, 2012, BMC CELL BIOL, V13, DOI 10.1186/1471-2121-13-21; Okura H, 2010, TISSUE ENG PART C-ME, V16, P417, DOI [10.1089/ten.tec.2009.0362, 10.1089/ten.TEC.2009.0362]; Okura H, 2010, TISSUE ENG PART C-ME, V16, P761, DOI [10.1089/ten.tec.2009.0208, 10.1089/ten.TEC.2009.0208]; Okura H, 2011, TISSUE ENG PART C-ME, V17, P145, DOI [10.1089/ten.tec.2010.0139, 10.1089/ten.TEC.2010.0139]; Okura H, 2009, J ARTIF ORGANS, V12, P123, DOI 10.1007/s10047-009-0455-6; Pfeifer A, 2002, P NATL ACAD SCI USA, V99, P2140, DOI 10.1073/pnas.251682798; Qin JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010611; Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1; Reid AJ, 2011, NEUROSCIENCE; Safford KM, 2004, EXP NEUROL, V187, P319, DOI 10.1016/j.expneurol.2004.01.027; Saga A, 2011, BIOCHEM BIOPH RES CO, V412, P50, DOI 10.1016/j.bbrc.2011.07.035; Shi Q, 2011, RHEUMATOL INT; Tai K, 2008, TISSUE ENG PT A, V14, P1709, DOI 10.1089/ten.tea.2007.0241; Tan B, 2011, NEUROSCIENCE, V181, P40, DOI 10.1016/j.neuroscience.2011.02.038; Temple G, 2009, GENOME RES, V19, P2324, DOI 10.1101/gr.095976.109; Tian J, 2009, GENE THER, V16, P874, DOI 10.1038/gt.2009.46; Villemure JF, 2001, J MOL BIOL, V312, P963, DOI 10.1006/jmbi.2001.5015; Weber W, 2006, J GENE MED, V8, P535, DOI 10.1002/jgm.903; Wiederschain D, 2009, CELL CYCLE, V8, P498, DOI 10.4161/cc.8.3.7701; Wu H, 2011, MOL PHARMACEUT, V8, P1458, DOI 10.1021/mp200135e	42	9	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66274	10.1371/journal.pone.0066274	http://dx.doi.org/10.1371/journal.pone.0066274			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776652	gold, Green Submitted, Green Published			2022-12-27	WOS:000320322400094
J	Aihara, K; Handa, T; Oga, T; Watanabe, K; Tanizawa, K; Ikezoe, K; Taguchi, Y; Sato, H; Chin, K; Nagai, S; Narumiya, S; Wells, AU; Mishima, M				Aihara, Kensaku; Handa, Tomohiro; Oga, Toru; Watanabe, Kizuku; Tanizawa, Kiminobu; Ikezoe, Kohei; Taguchi, Yoshio; Sato, Hiroe; Chin, Kazuo; Nagai, Sonoko; Narumiya, Shuh; Wells, Athol U.; Mishima, Michiaki			Clinical Relevance of Plasma Prostaglandin F-2 alpha Metabolite Concentrations in Patients with Idiopathic Pulmonary Fibrosis	PLOS ONE			English	Article							ARTERIAL-HYPERTENSION; SURVIVAL; LUNG; PREVALENCE; PREDICTION; PHYSIOLOGY	Background: Idiopathic pulmonary fibrosis (IPF) is a devastating lung disease of unknown etiology with few current treatment options. Recently, we determined an important role of prostaglandin F-2 alpha (PGF(2 alpha)) in pulmonary fibrosis by using a bleomycin-induced pulmonary fibrosis model and found an abundance of PGF(2 alpha) in bronchoalveolar lavage fluid of IPF patients. We investigated the role of PGF(2 alpha) in human IPF by assessing plasma concentrations of 15-keto-dihydro PGF(2 alpha), a stable metabolite of PGF(2 alpha). Methods: We measured plasma concentrations of 15-keto-dihydro PGF(2 alpha) in 91 IPF patients and compared these values with those of controls (n = 25). We further investigated the relationships of plasma 15-keto-dihydro PGF(2 alpha) concentrations with disease severity and mortality. Results: Plasma concentrations of 15-keto-dihydro PGF(2 alpha) were significantly higher in IPF patients than controls (p<0.001). Plasma concentrations of this metabolite were significantly correlated with forced expiratory volume in 1 second (Rs [correlation coefficient] = -0.34, p = 0.004), forced vital capacity (Rs = -0.33, p = 0.005), diffusing capacity for carbon monoxide (Rs = -0.36, p = 0.003), the composite physiologic index (Rs = 0.40, p = 0.001), 6-minute walk distance (Rs = -0.24, p = 0.04) and end-exercise oxygen saturation (Rs = -0.25, p = 0.04) when patients with emphysema were excluded. Multivariate analysis using stepwise Cox proportional hazards model showed that a higher composite physiologic index (relative risk = 1.049, p = 0.002) and plasma 15-keto-dihydro PGF(2 alpha) concentrations (relative risk = 1.005, p = 0.002) were independently associated with an increased risk of mortality. Conclusions: We demonstrated significant associations of plasma concentrations of PGF(2 alpha) metabolites with disease severity and prognosis, which support a potential pathogenic role for PGF(2 alpha) in human IPF.	[Aihara, Kensaku; Handa, Tomohiro; Watanabe, Kizuku; Tanizawa, Kiminobu; Ikezoe, Kohei; Mishima, Michiaki] Kyoto Univ, Grad Sch Med, Dept Resp Med, Kyoto, Japan; [Handa, Tomohiro] Kyoto Univ Hosp, Dept Rehabil Med, Kyoto 606, Japan; [Oga, Toru; Chin, Kazuo] Kyoto Univ, Grad Sch Med, Dept Resp Care & Sleep Control Med, Kyoto, Japan; [Taguchi, Yoshio] Tenri Hosp, Dept Resp Med, Tenri, Nara 632, Japan; [Sato, Hiroe; Wells, Athol U.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Nagai, Sonoko] Clin Res Ctr, Kyoto Cent Clin, Kyoto, Japan; [Narumiya, Shuh] Kyoto Univ, Grad Sch Med, Dept Pharmacol, Kyoto, Japan; [Wells, Athol U.] Royal Brompton Hosp, London SW3 6LY, England	Kyoto University; Kyoto University; Kyoto University; Tenri Hospital; Imperial College London; Kyoto University; Royal Brompton Hospital	Handa, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Resp Med, Kyoto, Japan.	hanta@kuhp.kyoto-u.ac.jp	Aihara, Kensaku/AAB-9889-2021; Tanizawa, Kiminobu/GPC-4728-2022	Ikezoe, Kohei/0000-0003-1097-2084; Tanizawa, Kiminobu/0000-0002-5719-0744	Diffuse Lung Diseases Research Group; Respiratory Failure study group; Research Program of Intractable Disease from the Ministry of Health, Labour and Welfare, Japan; Kato Memorial Trust for Nambyo Research; Kanae Foundation for the Promotion of Medical Science	Diffuse Lung Diseases Research Group; Respiratory Failure study group; Research Program of Intractable Disease from the Ministry of Health, Labour and Welfare, Japan; Kato Memorial Trust for Nambyo Research(Kato Memorial Trust for Nambyo Research); Kanae Foundation for the Promotion of Medical Science	This study was partly supported by grants to the Diffuse Lung Diseases Research Group, the Respiratory Failure study group, and the Research Program of Intractable Disease from the Ministry of Health, Labour and Welfare, Japan. This study was also supported by a grant from the Kato Memorial Trust for Nambyo Research and Kanae Foundation for the Promotion of Medical Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer SL, 2010, CIRCULATION, V121, P2045, DOI 10.1161/CIRCULATIONAHA.108.847707; Basu S, 2007, MED RES REV, V27, P435, DOI 10.1002/med.20098; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Farkas L, 2011, AM J RESP CELL MOL, V45, P1, DOI 10.1165/rcmb.2010-0365TR; Fernandez-Perez ER, 2010, CHEST, V137, P242, DOI [10.1378/chest.09-1002, 10.1378/chest.09-1871]; Flaherty KR, 2006, AM J RESP CRIT CARE, V174, P803, DOI 10.1164/rccm.200604-488OC; Fukui M, 1996, J HISTOCHEM CYTOCHEM, V44, P251, DOI 10.1177/44.3.8648085; Hamada K, 2007, CHEST, V131, P650, DOI 10.1378/chest.06-1466; Handa T, 2006, CHEST, V129, P1246, DOI 10.1378/chest.129.5.1246; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; Hirata T, 2011, CHEM REV, V111, P6209, DOI 10.1021/cr200010h; HSUEH W, 1979, AM J PATHOL, V97, P137; Huang SK, 2008, CHEST, V133, P1442, DOI 10.1378/chest.08-0306; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; King TE, 2001, AM J RESP CRIT CARE, V164, P1171, DOI 10.1164/ajrccm.164.7.2003140; KOHNO N, 1989, CHEST, V96, P68, DOI 10.1378/chest.96.1.68; Lappi-Blanco E, 2006, AM J CLIN PATHOL, V126, P717, DOI 10.1309/PFGXCLNG2N17PJX9; Lettieri CJ, 2006, CHEST, V129, P746, DOI 10.1378/chest.129.3.746; Ley B, 2012, AM J RESP CRIT CARE, V185, P6, DOI 10.1164/rccm.201111-1960ED; Ley B, 2011, AM J RESP CRIT CARE, V183, P431, DOI 10.1164/rccm.201006-0894CI; Martinez FJ, 2005, ANN INTERN MED, V142, P963, DOI 10.7326/0003-4819-142-12_Part_1-200506210-00005; Mason RJ, 1998, AM J PHYSIOL-LUNG C, V275, pL1, DOI 10.1152/ajplung.1998.275.1.L1; Mogulkoc N, 2001, THORAX, V56, P916, DOI 10.1136/thorax.56.12.916; Nagase T, 2002, NAT MED, V8, P480, DOI 10.1038/nm0502-480; Oga T, 2009, NAT MED, V15, P1426, DOI 10.1038/nm.2066; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Schmidt SL, 2011, EUR RESPIR J, V38, P176, DOI 10.1183/09031936.00114010; Tager AM, 2008, NAT MED, V14, P45, DOI 10.1038/nm1685; Tanabe T, 2002, PROSTAG OTH LIPID M, V68-9, P95, DOI 10.1016/S0090-6980(02)00024-2; TAYLOR L, 1979, BIOCHIM BIOPHYS ACTA, V572, P502, DOI 10.1016/0005-2760(79)90157-7; Wells AU, 2003, AM J RESP CRIT CARE, V167, P962, DOI 10.1164/rccm.2111053; Wynn TA, 2011, J EXP MED, V208, P1339, DOI 10.1084/jem.20110551	33	16	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66017	10.1371/journal.pone.0066017	http://dx.doi.org/10.1371/journal.pone.0066017			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776595	Green Submitted, Green Published, gold			2022-12-27	WOS:000320755400101
J	Fan, HX; Yan, XL; Zhang, Y; Zhang, XJ; Gao, YZ; Xu, YX; Wang, FS; Meng, SD				Fan, Hongxia; Yan, Xiaoli; Zhang, Yu; Zhang, Xiaojun; Gao, Yanzhou; Xu, Yaxing; Wang, Fusheng; Meng, Songdong			Increased Expression of Gp96 by HBx-Induced NF-kappa B Activation Feedback Enhances Hepatitis B Virus Production	PLOS ONE			English	Article							SHOCK-PROTEIN GP96; CHAPERONE; GRP94; REPLICATION; STRESS	Elevated expression of heat shock protein gp96 in hepatitis B virus (HBV)-infected patients is positively correlated with the progress of HBV-induced diseases, but little is known regarding the molecular mechanism of virus-induced gp96 expression and its impact on HBV infection. In this study, up-regulation of gp96 by HBV replication was confirmed both in vitro and in vivo. Among HBV components, HBV x protein (HBx) was found to increase gp96 promoter activity and enhance gp96 expression by using a luciferase reporter system, and western blot analysis. Further, we found that HBx-mediated regulation of gp96 expression requires a NF-kappa B cis-regulatory element on the gp96 promoter, and chromatin immunoprecipitation results demonstrated that HBx promotes the binding of NF-kappa B to the gp96 promoter. Significantly, both gain-and loss-of-function studies showed that gp96 enhances HBV production in HBV-transfected cells and a mouse model based on hydrodynamic transfection. Moreover, up-regulated gp96 expression was observed in HBV-infected patients, and gp96 levels were correlated with serum viral loads. Thus, our work demonstrates a positive feedback regulatory pathway involving gp96 and HBV, which may contribute to persistent HBV infection. Our data also indicate that modulation of gp96 function may represent a novel strategy for the intervention of HBV infection.	[Fan, Hongxia; Yan, Xiaoli; Zhang, Yu; Zhang, Xiaojun; Gao, Yanzhou; Xu, Yaxing; Meng, Songdong] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China; [Wang, Fusheng] Beijing 302 Hosp, Beijing Inst Infect Dis, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Fifth Medical Center of Chinese PLA General Hospital	Meng, SD (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China.	mengsd@im.ac.cn	zhang, jin/GXV-9154-2022		National Natural Science Foundation of China [31230026, 30970146, 91029724, 81021003, 81102018]; Key Projects in the National Science and Technology Program [2013ZX10002001-003-003]; Beijing Natural Science Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Projects in the National Science and Technology Program; Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by grants from the National Natural Science Foundation of China (31230026, 30970146, 91029724, 81021003 and 81102018), a grant from Key Projects in the National Science and Technology Program (2013ZX10002001-003-003), and a grant from Beijing Natural Science Foundation (Role of heat-shock protein gp96 in antigen presentation and development of new gp96-based vaccines). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENN J, 1994, P NATL ACAD SCI USA, V91, P10350, DOI 10.1073/pnas.91.22.10350; Cho HK, 2011, BIOCHEM J, V435, P431, DOI 10.1042/BJ20102071; Chung TW, 2004, FASEB J, V18, P1123, DOI 10.1096/fj.03-1429fje; Dienstag JL, 2008, NEW ENGL J MED, V359, P1486, DOI 10.1056/NEJMra0801644; Eletto D, 2010, SEMIN CELL DEV BIOL, V21, P479, DOI 10.1016/j.semcdb.2010.03.004; Hicks DG, 2005, HUM PATHOL, V36, P250, DOI 10.1016/j.humpath.2004.11.010; Hosel M, 2009, HEPATOLOGY, V50, P1773, DOI 10.1002/hep.23226; Hu JM, 2004, J VIROL, V78, P13122, DOI 10.1128/JVI.78.23.13122-13131.2004; Koo BH, 2010, J BIOL CHEM, V285, P197, DOI 10.1074/jbc.M109.039677; Lambert C, 2003, P NATL ACAD SCI USA, V100, P5199, DOI 10.1073/pnas.0930813100; Li BZ, 2007, VIRUS RES, V124, P44, DOI 10.1016/j.virusres.2006.09.011; Li L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005489; Lim SO, 2005, WORLD J GASTROENTERO, V11, P2072, DOI 10.3748/wjg.v11.i14.2072; Liu B, 2008, BLOOD, V112, P1223, DOI 10.1182/blood-2008-03-143107; Liu Z, 2009, EUR J IMMUNOL, V39, P3110, DOI 10.1002/eji.200939593; McLaughlin M, 2011, BRIT J PHARMACOL, V162, P328, DOI 10.1111/j.1476-5381.2010.01064.x; MELNICK J, 1994, NATURE, V370, P373, DOI 10.1038/370373a0; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; Nguyen DH, 2008, J CELL PHYSIOL, V216, P289, DOI 10.1002/jcp.21416; Ostrovsky O, 2010, BBA-MOL CELL RES, V1803, P333, DOI 10.1016/j.bbamcr.2009.11.005; Ostrovsky O, 2009, MOL BIOL CELL, V20, P1855, DOI 10.1091/mbc.E08-04-0346; Park SG, 2001, J VIROL, V75, P6962, DOI 10.1128/JVI.75.15.6962-6968.2001; Prange R, 1999, BIOL CHEM, V380, P305, DOI 10.1515/BC.1999.042; Seeger C., 2007, FIELDS VIROLOGY, V1, P2977; Staron M, 2011, BLOOD, V117, P7136, DOI 10.1182/blood-2011-01-330464; Turelli P, 2004, SCIENCE, V303, P1829, DOI 10.1126/science.1092066; Wang HC, 2003, AM J PATHOL, V163, P2441, DOI 10.1016/S0002-9440(10)63599-7; Wang SF, 2012, HEPATOLOGY, V55, P730, DOI 10.1002/hep.24809; Wang XT, 2002, J BIOL CHEM, V277, P24361, DOI 10.1074/jbc.M202198200; Xia LM, 2012, J IMMUNOL, V188, P753, DOI 10.4049/jimmunol.1101652; Xu ZC, 1997, J VIROL, V71, P7387, DOI 10.1128/JVI.71.10.7387-7392.1997; Yang Y, 2005, MOL CELLS, V20, P173; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005; Yao Deng-Fu, 2006, Hepatobiliary Pancreat Dis Int, V5, P381; Yuan TTT, 1998, J VIROL, V72, P2168, DOI 10.1128/JVI.72.3.2168-2176.1998; Yue X, 2012, J IMMUNOL, V189, P279, DOI 10.4049/jimmunol.1103405; Zhu XD, 2004, WORLD J GASTROENTERO, V10, P1141	37	27	31	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65588	10.1371/journal.pone.0065588	http://dx.doi.org/10.1371/journal.pone.0065588			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776506	Green Submitted, Green Published, gold			2022-12-27	WOS:000320755400045
J	Hansen, CF; Bueter, M; Theis, N; Lutz, T; Paulsen, S; Dalboge, LS; Vrang, N; Jelsing, J				Hansen, Carl Frederik; Bueter, Marco; Theis, Nadine; Lutz, Thomas; Paulsen, Sarah; Dalboge, Louise S.; Vrang, Niels; Jelsing, Jacob			Hypertrophy Dependent Doubling of L-Cells in Roux-en-Y Gastric Bypass Operated Rats	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; INTESTINAL EPITHELIAL PROLIFERATION; BARIATRIC SURGERY; WEIGHT-LOSS; GUT HORMONES; BILIOPANCREATIC DIVERSION; JEJUNOILEAL BYPASS; INCRETIN LEVELS; GLUCOSE; ADAPTATION	Background and Aims: Roux-en-Y gastric bypass (RYGB) leads to a rapid remission of type 2 diabetes mellitus (T2DM), but the underlying mode of action remains incompletely understood. L-cell derived gut hormones such as glucagon-like peptide-1 (GLP-1) and peptide YY (PYY) are thought to play a central role in the anti-diabetic effects of RYGB; therefore, an improved understanding of intestinal endocrine L-cell adaptability is considered pivotal. Methods: The full rostrocaudal extension of the gut was analyzed in rats after RYGB and in sham-operated controls ad libitum fed or food restricted to match the body weight of RYGB rats. Total number of L-cells, as well as regional numbers, densities and mucosa volumes were quantified using stereological methods. Preproglucagon and PYY mRNA transcripts were quantified by qPCR to reflect the total and relative hormone production capacity of the L-cells. Results: RYGB surgery induced hypertrophy of the gut mucosa in the food exposed regions of the small intestine coupled with a doubling in the total number of L-cells. No changes in L-cell density were observed in any region regardless of surgery or food restriction. The total gene expression capacity of the entire gut revealed a near 200% increase in both PYY and preproglucagon mRNA levels in RYGB rats associated with both increased L-cell number as well as region-specific increased transcription per cell. Conclusions: Collectively, these findings indicate that RYGB in rats is associated with gut hypertrophy, an increase in L-cell number, but not density, and increased PYY and preproglucagon gene expression. This could explain the enhanced gut hormone dynamics seen after RYGB.	[Hansen, Carl Frederik; Paulsen, Sarah; Dalboge, Louise S.; Vrang, Niels; Jelsing, Jacob] Gubra, Dept Histol, Horsholm, Denmark; [Hansen, Carl Frederik] Univ Copenhagen, Dept Human Nutr, Frederiksberg, Denmark; [Bueter, Marco] Univ Zurich Hosp, Dept Visceral & Transplant Surg, CH-8091 Zurich, Switzerland; [Bueter, Marco; Lutz, Thomas] Univ Zurich, Ctr Integrat Human Physiol, Zurich, Switzerland; [Theis, Nadine; Lutz, Thomas] Univ Zurich, Vetsuisse Fac, Inst Vet Physiol, Zurich, Switzerland	University of Copenhagen; University of Zurich; University Zurich Hospital; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Zurich	Jelsing, J (corresponding author), Gubra, Dept Histol, Horsholm, Denmark.	Jacob@gubra.dk		Lutz, Thomas/0000-0002-5056-8548; Dalboge, Louise Schjellerup/0000-0001-7773-6313				Adrian TE, 2012, DIABETOLOGIA, V55, P2343, DOI 10.1007/s00125-012-2593-2; ADRIAN TE, 1986, GASTROENTEROLOGY, V90, P379, DOI 10.1016/0016-5085(86)90936-4; Bertoni S, 2001, J ANAT, V199, P725, DOI 10.1046/j.1469-7580.2001.19960725.x; BESTERMAN HS, 1982, GUT, V23, P854, DOI 10.1136/gut.23.10.854; Borg CM, 2007, OBES SURG, V17, P1193, DOI 10.1007/s11695-007-9211-2; Bueter M, 2011, PHYSIOL BEHAV, V104, P709, DOI 10.1016/j.physbeh.2011.07.025; Bueter M, 2012, JOVE-J VIS EXP, DOI 10.3791/3940; Bueter M, 2010, GASTROENTEROLOGY, V138, P1845, DOI 10.1053/j.gastro.2009.11.012; Bueter M, 2010, OBES SURG, V20, P616, DOI 10.1007/s11695-010-0075-5; Clements RH, 2004, AM SURGEON, V70, P1; de Wit NJW, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-14; DeMaria EJ, 2007, NEW ENGL J MED, V356, P2176, DOI 10.1056/NEJMct067019; Dirksen C, 2012, DIABETOLOGIA, V55, P1890, DOI 10.1007/s00125-012-2556-7; Dou Y, 2002, NEUROGASTROENT MOTIL, V14, P43, DOI 10.1046/j.1365-2982.2002.00301.x; DOWLING RH, 1982, SCAND J GASTROENTERO, V17, P53; Drucker DJ, 1996, P NATL ACAD SCI USA, V93, P7911, DOI 10.1073/pnas.93.15.7911; DUDRICK SJ, 1977, ANN SURG, V185, P642, DOI 10.1097/00000658-197706000-00005; EISSELE R, 1992, EUR J CLIN INVEST, V22, P283, DOI 10.1111/j.1365-2362.1992.tb01464.x; Eldar S, 2011, INT J OBESITY, V35, pS16, DOI 10.1038/ijo.2011.142; EVRARD S, 1993, INT J OBESITY, V17, P541; Field BCT, 2010, NAT REV ENDOCRINOL, V6, P444, DOI 10.1038/nrendo.2010.93; Furet JP, 2010, DIABETES, V59, P3049, DOI 10.2337/db10-0253; Ghatei MA, 2001, DIGEST DIS SCI, V46, P1255, DOI 10.1023/A:1010615429639; Grundy SM, 2004, J CLIN ENDOCR METAB, V89, P2595, DOI 10.1210/jc.2004-0372; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Gundersen HJG, 1999, J MICROSC-OXFORD, V193, P199, DOI 10.1046/j.1365-2818.1999.00457.x; Hansen CF, 2013, AM J TRANSL RES, V5, P347; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; HOLST JJ, 1979, SCAND J GASTROENTERO, V14, P205, DOI 10.3109/00365527909179871; Jorgensen NB, 2012, AM J PHYSIOL-ENDOC M, V303, pE122, DOI 10.1152/ajpendo.00073.2012; Katsuma S, 2005, BIOCHEM BIOPH RES CO, V329, P386, DOI 10.1016/j.bbrc.2005.01.139; Korner J, 2009, INT J OBESITY, V33, P786, DOI 10.1038/ijo.2009.79; Laferrere B, 2008, J CLIN ENDOCR METAB, V93, P2479, DOI 10.1210/jc.2007-2851; Laferrere B, 2007, DIABETES CARE, V30, P1709, DOI 10.2337/dc06-1549; le Roux CW, 2007, ANN SURG, V246, P780, DOI 10.1097/SLA.0b013e3180caa3e3; le Roux CW, 2010, ANN SURG, V252, P50, DOI 10.1097/SLA.0b013e3181d3d21f; le Roux CW, 2006, ANN SURG, V243, P108, DOI 10.1097/01.sla.0000183349.16877.84; Morinigo R, 2006, J CLIN ENDOCR METAB, V91, P1735, DOI 10.1210/jc.2005-0904; Mortensen K, 2003, REGUL PEPTIDES, V114, P189, DOI 10.1016/S0167-0115(03)00125-3; Mumphrey MB, 2012, NEUROGASTROENTEROL M; Nadreau E, 2006, INT J OBESITY, V30, P419, DOI 10.1038/sj.ijo.0803166; O'Brien PE, 2010, J GASTROEN HEPATOL, V25, P1358, DOI 10.1111/j.1440-1746.2010.06391.x; Ockander L, 2003, OBES SURG, V13, P584, DOI 10.1381/096089203322190781; Olivan B, 2009, ANN SURG, V249, P948, DOI 10.1097/SLA.0b013e3181a6cdb0; ORSKOV C, 1986, ENDOCRINOLOGY, V119, P1467, DOI 10.1210/endo-119-4-1467; PAKKENBERG B, 1988, J MICROSC-OXFORD, V150, P1, DOI 10.1111/j.1365-2818.1988.tb04582.x; Rubino F, 2004, ANN SURG, V240, P236, DOI 10.1097/01.sla.0000133117.12646.48; Schauer PR, 2003, ANN SURG, V238, P467, DOI 10.1097/01.sla.0000089851.41115.1b; Schonhoff SE, 2004, ENDOCRINOLOGY, V145, P2639, DOI 10.1210/en.2004-0051; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; SOLHAUG JH, 1978, SCAND J GASTROENTERO, V13, P401, DOI 10.3109/00365527809181913; SOLHAUG JH, 1976, SCAND J GASTROENTERO, V11, P155; Stearns AT, 2009, AM J PHYSIOL-GASTR L, V297, pG950, DOI 10.1152/ajpgi.00253.2009; STERIO DC, 1984, J MICROSC-OXFORD, V134, P127, DOI 10.1111/j.1365-2818.1984.tb02501.x; STOCKDAMGE C, 1986, SCAND J GASTROENTERO, V21, P1115, DOI 10.3109/00365528608996431; Strader AD, 2006, PHYSIOL BEHAV, V88, P277, DOI 10.1016/j.physbeh.2006.05.034; Suzuki K, 2010, ENDOCR J, V57, P359, DOI 10.1507/endocrj.K10E-077; Taqia E, 2010, J PEDIATR SURG, V45, P987, DOI 10.1016/j.jpedsurg.2010.02.036; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Vrang N, 2007, BRAIN RES, V1149, P118, DOI 10.1016/j.brainres.2007.02.043; Wang Y, 2007, EPIDEMIOL REV, V29, P6, DOI 10.1093/epirev/mxm007	63	80	82	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65696	10.1371/journal.pone.0065696	http://dx.doi.org/10.1371/journal.pone.0065696			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776529	Green Published, gold, Green Accepted			2022-12-27	WOS:000320755400057
J	Overman, MJ; Zhang, JX; Kopetz, S; Davies, M; Jiang, ZQ; Stemke-Hale, K; Rummele, P; Pilarsky, C; Grutzmann, R; Hamilton, S; Hwang, R; Abbruzzese, JL; Varadhachary, G; Broom, B; Wang, HM				Overman, Michael J.; Zhang, Jiexin; Kopetz, Scott; Davies, Michael; Jiang Zhi-Qin; Stemke-Hale, Katherine; Ruemmele, Petra; Pilarsky, Christian; Gruetzmann, Robert; Hamilton, Stanley; Hwang, Rosa; Abbruzzese, James L.; Varadhachary, Gauri; Broom, Bradley; Wang, Huamin			Gene Expression Profiling of Ampullary Carcinomas Classifies Ampullary Carcinomas into Biliary-Like and Intestinal-Like Subtypes That Are Prognostic of Outcome	PLOS ONE			English	Article							PAPILLA; SURVIVAL; VATER; ADENOCARCINOMAS; GEMCITABINE; MUTATIONS; CLUSTERIN; PROTEIN	Background: Adenocarcinomas of the ampulla of Vater are classified as biliary cancers, though the exact epithelium of origin for these cancers is not known. We sought to molecularly classify ampullary adenocarcinomas in comparison to known adenocarcinomas of the pancreas, bile duct, and duodenum by gene expression analysis. Methods: We analyzed 32 fresh-frozen resected, untreated periampullary adenocarcinomas (8 pancreatic, 2 extrahepatic biliary, 8 duodenal, and 14 ampullary) using the Affymetrix U133 Plus 2.0 genome array. Unsupervised and supervised hierarchical clustering identified two subtypes of ampullary carcinomas that were molecularly and histologically characterized. Results: Hierarchical clustering of periampullary carcinomas segregated ampullary carcinomas into two subgroups, which were distinctly different from pancreatic carcinomas. Non-pancreatic periampullary adenocarcinomas were segregated into two subgroups with differing prognoses: 5 year RFS (77% vs. 0%, p = 0.007) and 5 year OS (100% vs. 35%, p = 0.005). Unsupervised clustering analysis of the 14 ampullary samples also identified two subgroups: a good prognosis intestinal-like subgroup and a poor prognosis biliary-like subgroup with 5 year OS of 70% vs. 28%, P = 0.09. Expression of CK7+/CK20- but not CDX-2 correlated with these two subgroups. Activation of the AKT and MAPK pathways were both increased in the poor prognostic biliary-like subgroup. In an independent 80 patient ampullary validation dataset only histological subtype (intestinal vs. pancreaticobiliary) was significantly associated with OS in both univariate (p = 0.006) and multivariate analysis (P = 0.04). Conclusions: Gene expression analysis discriminated pancreatic adenocarcinomas from other periampullary carcinomas and identified two prognostically relevant subgroups of ampullary adenocarcinomas. Histological subtype was an independent prognostic factor in ampullary adenocarcinomas.	[Overman, Michael J.; Kopetz, Scott; Jiang Zhi-Qin; Abbruzzese, James L.; Varadhachary, Gauri] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA; [Zhang, Jiexin; Broom, Bradley] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Hamilton, Stanley; Wang, Huamin] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Davies, Michael] Univ Texas MD Anderson Canc Ctr, Dept Melanoma, Houston, TX 77030 USA; [Stemke-Hale, Katherine] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Hwang, Rosa] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Ruemmele, Petra] Univ Regensburg, Inst Pathol, D-93053 Regensburg, Germany; [Pilarsky, Christian; Gruetzmann, Robert] Univ Hosp Carl Gustav Carus, Dept Visceral Thorac & Vasc Surg, Dresden, Germany	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Regensburg; Technische Universitat Dresden; Carl Gustav Carus University Hospital	Overman, MJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA.	moverman@mdanderson.org	Davies, Michael/GWV-2527-2022; Jiang, Zhi-Qin/O-8999-2014; Stemke-Hale, Katherine/K-9113-2013; Kopetz, Scott/AAC-1387-2019	Jiang, Zhi-Qin/0000-0002-0931-5418; Stemke-Hale, Katherine/0000-0002-1231-4192; Kopetz, Scott/0000-0001-9647-3416; Pilarsky, Christian/0000-0002-7968-3283	Kavanagh Family Foundation; National Cancer Institute [CA 16672]; NATIONAL CANCER INSTITUTE [P01CA130821, P30CA016672] Funding Source: NIH RePORTER	Kavanagh Family Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank the Kavanagh Family Foundation and National Cancer Institute Core Grant #CA 16672 for their financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berberat PO, 2009, EJSO-EUR J SURG ONC, V35, P187, DOI 10.1016/j.ejso.2008.01.030; Chen QF, 2011, WORLD J SURG ONCOL, V9, DOI 10.1186/1477-7819-9-59; Djeu JY, 2009, ADV CANCER RES, V105, P77, DOI 10.1016/S0065-230X(09)05005-2; Ehehalt F, 2011, ANN SURG, V254, P302, DOI 10.1097/SLA.0b013e31821994a8; Fischer HP, 2004, J HEPATO-BILIARY-PAN, V11, P301, DOI 10.1007/s00534-004-0898-3; Freund JN, 1998, BIOCHEM CELL BIOL, V76, P957, DOI 10.1139/bcb-76-6-957; Hansel DE, 2005, J CLIN ONCOL, V23, P1811, DOI 10.1200/JCO.2005.03.068; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jiang Z VG, 2013, ANN ONCOLOG IN PRESS; KIMURA W, 1994, JPN J CANCER RES, V85, P161, DOI 10.1111/j.1349-7006.1994.tb02077.x; Kohler I, 2011, AM J CLIN PATHOL, V135, P202, DOI 10.1309/AJCPCTCUQSYI89YT; Levi E, 2004, J CLIN PATHOL, V57, P456, DOI 10.1136/jcp.2003.013292; Matsubayashi H, 1999, CANCER-AM CANCER SOC, V86, P596, DOI 10.1002/(SICI)1097-0142(19990815)86:4<596::AID-CNCR8>3.3.CO;2-8; Morris-Stiff G, 2009, EJSO-EUR J SURG ONC, V35, P746, DOI 10.1016/j.ejso.2008.10.010; Neoptolemos JP, 2012, JAMA-J AM MED ASSOC, V308, P147, DOI 10.1001/jama.2012.7352; Overman MJ, 2009, J CLIN ONCOL, V27, P2598, DOI 10.1200/JCO.2008.19.7145; Park ES, 2010, MOL CANCER THER, V9, P257, DOI 10.1158/1535-7163.MCT-09-0743; Rechreche H, 1997, EUR J BIOCHEM, V248, P225, DOI 10.1111/j.1432-1033.1997.00225.x; Ritter G, 1997, BIOCHEM BIOPH RES CO, V236, P682, DOI 10.1006/bbrc.1997.6966; Roh YH, 2007, HEPATO-GASTROENTEROL, V54, P1641; Roy LD, 2011, ONCOGENE, V30, P1449, DOI 10.1038/onc.2010.526; Ruemmele P, 2009, AM J SURG PATHOL, V33, P691, DOI 10.1097/PAS.0b013e3181983ef7; Santini D, 2008, ANN ONCOL, V19, P724, DOI 10.1093/annonc/mdm576; Sessa F, 2007, VIRCHOWS ARCH, V451, P649, DOI 10.1007/s00428-007-0444-1; Shankavaram UT, 2007, MOL CANCER THER, V6, P820, DOI 10.1158/1535-7163.MCT-06-0650; Stemke-Hale K, 2008, CANCER RES, V68, P6084, DOI 10.1158/0008-5472.CAN-07-6854; Tian Q, 2004, MOL CELL PROTEOMICS, V3, P960, DOI 10.1074/mcp.M400055-MCP200; Valle J, 2010, NEW ENGL J MED, V362, P1273, DOI 10.1056/NEJMoa0908721; Vincenzi B, 2009, ANN ONCOL, V20, P78, DOI 10.1093/annonc/mdn558; Waldman SA, 2009, JAMA-J AM MED ASSOC, V301, P745, DOI 10.1001/jama.2009.141; Westgaard A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-5; Zhou H, 2004, AM J SURG PATHOL, V28, P875, DOI 10.1097/00000478-200407000-00005	32	46	46	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65144	10.1371/journal.pone.0065144	http://dx.doi.org/10.1371/journal.pone.0065144			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776447	Green Published, Green Submitted, gold			2022-12-27	WOS:000320755400011
J	Perino, MG; Moldobaeva, A; Jenkins, J; Wagner, EM				Perino, Maria Grazia; Moldobaeva, Aigul; Jenkins, John; Wagner, Elizabeth M.			Chemokine Localization in Bronchial Angiogenesis	PLOS ONE			English	Article							INDUCED NEUTROPHIL CHEMOATTRACTANT; MACROPHAGE INFLAMMATORY PROTEIN-2; CXC CHEMOKINES; TUMOR ANGIOGENESIS; IL-8 RECEPTOR; LUNG INJURY; GROWTH; DEXAMETHASONE; EXPRESSION; CELLS	Angiogenesis in the lung involves the systemic bronchial vasculature and becomes prominent when chronic inflammation prevails. Mechanisms for neovascularization following pulmonary ischemia include growth factor transit from ischemic parenchyma to upstream bronchial arteries, inflammatory cell migration/recruitment through the perfusing artery, and paracrine effects of lung cells within the left bronchus, the niche where arteriogenesis takes place. We analyzed left lung bronchoalveolar lavage (BAL) fluid and left bronchus homogenates after left pulmonary artery ligation (LPAL) in rats, immediately after the onset of ischemia (0 h), 6 h and 24 h later. Additionally, we tested the effectiveness of dexamethasone on decreasing inflammation (0-24 h LPAL) and angiogenesis at early (3 d LPAL; bronchial endothelial proliferation) and late (14 d LPAL; blood flow) stages. After LPAL (6 h), BAL protein, total inflammatory cells, macrophages, and polymorphonuclear cells increased significantly. In parallel, pro-angiogenic CXC chemokines increased in BAL and the left main-stem bronchus (CXCL1) or only within the bronchus (CXCL2). Dexamethasone treatment reduced total BAL protein, inflammatory cells (total and polymorphonuclear cells), and CXCL1 but not CXCL2 in BAL. By contrast, no decrease was seen in either chemokine within the bronchial tissue, in proliferating bronchial endothelial cells, or in systemic perfusion of the left lung. Our results confirm the presence of CXC chemokines within BAL fluid as well as within the left mainstem bronchus. Despite significant reduction in lung injury and inflammation with dexamethasone treatment, chemokine expression within the bronchial tissue as well as angiogenesis were not affected. Our results suggest that early changes within the bronchial niche contribute to subsequent neovascularization during pulmonary ischemia.	[Perino, Maria Grazia; Moldobaeva, Aigul; Jenkins, John; Wagner, Elizabeth M.] Johns Hopkins Sch Med, Dept Med, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine	Wagner, EM (corresponding author), Johns Hopkins Sch Med, Dept Med, Baltimore, MD USA.	wagnerem@jhmi.edu			NIH NHLBI [RO1 HL088005]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113392, R01HL088005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR053503] Funding Source: NIH RePORTER	NIH NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was funded by NIH NHLBI, RO1 HL088005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenberg DA, 1997, J LEUKOCYTE BIOL, V62, P554, DOI 10.1002/jlb.62.5.554; Baluk P, 1997, AM J PHYSIOL-LUNG C, V273, pL565, DOI 10.1152/ajplung.1997.273.3.L565; Belperio JA, 2000, J LEUKOCYTE BIOL, V68, P1; BOWDEN JJ, 1994, AM J RESP CRIT CARE, V150, P1391, DOI 10.1164/ajrccm.150.5.7524980; Brinson GM, 1998, AM J RESP CRIT CARE, V157, P1951, DOI 10.1164/ajrccm.157.6.9708067; Cai SS, 2010, J IMMUNOL, V185, P6214, DOI 10.4049/jimmunol.0903843; Chao J, 2012, AM J PHYSIOL-HEART C, V303, pH168, DOI 10.1152/ajpheart.00106.2012; Endrys J, 1997, HEART, V78, P171, DOI 10.1136/hrt.78.2.171; Garcia CSNB, 2006, BRAZ J MED BIOL RES, V39, P697, DOI 10.1590/S0100-879X2006000600001; Heil M, 2004, CIRC RES, V95, P449, DOI 10.1161/01.RES.0000141145.78900.44; Hsieh CS, 2006, J PEDIATR SURG, V41, P1669, DOI 10.1016/j.jpedsurg.2006.05.039; Keane MP, 2002, J IMMUNOL, V169, P6515, DOI 10.4049/jimmunol.169.11.6515; Li X, 1997, AM J RESP CRIT CARE, V156, P229, DOI 10.1164/ajrccm.156.1.9607066; LIU MY, 1995, AM J PHYSIOL-LUNG C, V269, pL178, DOI 10.1152/ajplung.1995.269.2.L178; Matzer SP, 2004, INT IMMUNOL, V16, P1675, DOI 10.1093/intimm/dxh169; McDonald DM, 2001, AM J RESP CRIT CARE, V164, pS39, DOI 10.1164/ajrccm.164.supplement_2.2106065; Moore BB, 1998, J LAB CLIN MED, V132, P97, DOI 10.1016/S0022-2143(98)90004-X; Moore BB, 1998, J INVEST MED, V46, P113; MULLER KM, 1978, PATHOL RES PRACT, V163, P34; Murphy PM, 2001, NEW ENGL J MED, V345, P833, DOI 10.1056/NEJM200109133451113; Nakao S, 2012, INVEST OPHTH VIS SCI, V53, P3296, DOI 10.1167/iovs.11-8114; Oynebraten I, 2005, J IMMUNOL, V175, P5358, DOI 10.4049/jimmunol.175.8.5358; Pappa CA, 2011, CYTOKINE, V56, P616, DOI 10.1016/j.cyto.2011.08.034; Quinton LJ, 2004, AM J PHYSIOL-LUNG C, V286, pL465, DOI 10.1152/ajplung.00153.2003; Remy-Jardin M, 2004, RADIOLOGY, V233, P741, DOI 10.1148/radiol.2333040031; Ribeiro JCML, 2012, OPHTHALMIC RES, V48, P177, DOI 10.1159/000337137; Rocco PRM, 2001, AM J RESP CRIT CARE, V164, P1067, DOI 10.1164/ajrccm.164.6.2007062; Sabroe I, 1997, J IMMUNOL, V158, P1361; Sanchez J, 2007, J APPL PHYSIOL, V103, P594, DOI 10.1152/japplphysiol.00037.2007; Sevaljevic L, 2001, BIOL SIGNAL RECEPT, V10, P299; Stillie R, 2009, J LEUKOCYTE BIOL, V86, P529, DOI 10.1189/jlb.0208125; STRIETER RM, 1995, SHOCK, V4, P155, DOI 10.1097/00024382-199509000-00001; STRIETER RM, 1995, J BIOL CHEM, V270, P27348, DOI 10.1074/jbc.270.45.27348; Strieter RM, 2007, J CLIN INVEST, V117, P549, DOI 10.1172/JCI30562; Sukkar A, 2008, J APPL PHYSIOL, V104, P1470, DOI 10.1152/japplphysiol.00974.2007; Tang KH, 2012, HEPATOLOGY, V55, P807, DOI 10.1002/hep.24739; Vanderbilt JN, 2003, AM J RESP CELL MOL, V29, P661, DOI 10.1165/rcmb.2002-0227OC; Wagner EM, 2011, J APPL PHYSIOL, V110, P538, DOI 10.1152/japplphysiol.01308.2010; WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161; Yao LC, 2012, AM J PATHOL, V180, P2561, DOI 10.1016/j.ajpath.2012.02.019; Zamjahn JB, 2011, AM J PHYSIOL-LUNG C, V301, pL568, DOI 10.1152/ajplung.00340.2010; Zhang P, 2002, SHOCK, V17, P104, DOI 10.1097/00024382-200202000-00004	42	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66432	10.1371/journal.pone.0066432	http://dx.doi.org/10.1371/journal.pone.0066432			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776670	gold, Green Published, Green Submitted			2022-12-27	WOS:000320755400144
J	Torres-Martin, M; Lassaletta, L; de Campos, JM; Isla, A; Gavilan, J; Pinto, GR; Burbano, RR; Latif, F; Melendez, B; Castresana, JS; Rey, JA				Torres-Martin, Miguel; Lassaletta, Luis; de Campos, Jose M.; Isla, Alberto; Gavilan, Javier; Pinto, Giovanny R.; Burbano, Rommel R.; Latif, Farida; Melendez, Barbara; Castresana, Javier S.; Rey, Juan A.			Global Profiling in Vestibular Schwannomas Shows Critical Deregulation of MicroRNAs and Upregulation in Those Included in Chromosomal Region 14q32	PLOS ONE			English	Article							GENE-EXPRESSION; TUMOR-SUPPRESSOR; NF2 GENE; MICROARRAY ANALYSIS; CELL PROLIFERATION; DOWN-REGULATION; METHYLATION; MIGRATION; CANCER; PROMOTES	Background: Vestibular schwannomas are benign tumors that arise from Schwann cells in the VIII cranial pair and usually present NF2 gene mutations and/or loss of heterozygosity on chromosome 22q. Deregulation has also been found in several genes, such as ERBB2 and NRG1. MicroRNAs are non-coding RNAs approximately 21 to 23 nucleotides in length that regulate mRNAs, usually by degradation at the post-transcriptional level. Methods: We used microarray technology to test the deregulation of miRNAs and other non-coding RNAs present in GeneChip miRNA 1.0 (Affymetrix) over 16 vestibular schwannomas and 3 control-nerves, validating 10 of them by qRT-PCR. Findings: Our results showed the deregulation of 174 miRNAs, including miR-10b, miR-206, miR-183 and miR-204, and the upregulation of miR-431, miR-221, miR-21 and miR-720, among others. The results also showed an aberrant expression of other non-coding RNAs. We also found a general upregulation of the miRNA cluster located at chromosome 14q32. Conclusion: Our results suggest that several miRNAs are involved in tumor formation and/or maintenance and that global upregulation of the 14q32 chromosomal site contains miRNAs that may represent a therapeutic target for this neoplasm.	[Torres-Martin, Miguel; Rey, Juan A.] IdiPAZ, La Paz Univ Hosp, Neurooncol Lab, Res Unit, Madrid, Spain; [Lassaletta, Luis; Gavilan, Javier] IdiPAZ, La Paz Univ Hosp, Dept Otolaryngol, Madrid, Spain; [de Campos, Jose M.] Fdn Jimenez Diaz, Dept Neurosurg, E-28040 Madrid, Spain; [Isla, Alberto] IdiPAZ, La Paz Univ Hosp, Dept Neurosurg, Madrid, Spain; [Pinto, Giovanny R.] Univ Fed Piaui, Genet & Mol Biol Lab, Parnaiba, Brazil; [Burbano, Rommel R.] Fed Univ Para, Human Cytogenet Lab, BR-66059 Belem, Para, Brazil; [Latif, Farida] Univ Birmingham, Sch Clin & Expt Med, Ctr Rare Dis & Personalised Med, Birmingham, W Midlands, England; [Melendez, Barbara] Virgen Salud Hosp, Mol Pathol Res Unit, Toledo, Spain; [Castresana, Javier S.] Univ Navarra, Sch Sci, Brain Tumor Biol Unit, E-31080 Pamplona, Spain	Hospital Universitario La Paz; Hospital Universitario La Paz; Hospital Universitario La Paz; Universidade Federal do Piaui; Universidade Federal do Para; University of Birmingham; University of Navarra	Torres-Martin, M (corresponding author), IdiPAZ, La Paz Univ Hosp, Neurooncol Lab, Res Unit, Madrid, Spain.	migtorres.martin@gmail.com	Pinto, Giovanny R/G-9852-2012; Burbano, Rommel R/C-4149-2012; Melendez, Barbara/E-1216-2017; Rey, Juan A/H-5026-2013; Castresana, Javier S/AFT-2167-2022; Pinto, Giovanny Rebouças/AAB-9308-2020	Pinto, Giovanny R/0000-0001-9110-1840; Burbano, Rommel R/0000-0002-4872-234X; Melendez, Barbara/0000-0001-5004-8895; Torres Martin, Miguel/0000-0003-1589-8936; Castresana, Javier S./0000-0002-2373-482X	FIS, Ministerio de Sanidad, Servicios Sociales e Igualdad, Spain [PI 07/0577, 10/1972]; Fundacion Sociosanitaria de Castilla-La Mancha of the Consejeria de Salud y Bienestar Social, Junta de Comunidades de Castilla-La Mancha, Spain [PI10-045]	FIS, Ministerio de Sanidad, Servicios Sociales e Igualdad, Spain; Fundacion Sociosanitaria de Castilla-La Mancha of the Consejeria de Salud y Bienestar Social, Junta de Comunidades de Castilla-La Mancha, Spain(Junta de Comunidades de Castilla-La Mancha)	Supported by grants PI 07/0577 and 10/1972 from FIS, Ministerio de Sanidad, Servicios Sociales e Igualdad, Spain and grant PI10-045 from the Fundacion Sociosanitaria de Castilla-La Mancha of the Consejeria de Salud y Bienestar Social, Junta de Comunidades de Castilla-La Mancha, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarhus M, 2010, NEUROSURGERY, V67, P998, DOI 10.1227/NEU.0b013e3181ec7b71; Altuvia Y, 2005, NUCLEIC ACIDS RES, V33, P2697, DOI 10.1093/nar/gki567; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Babak T, 2004, RNA, V10, P1813, DOI 10.1261/rna.7119904; Bai AHC, 2012, ACTA NEUROPATHOL, V123, P529, DOI 10.1007/s00401-011-0924-x; Bello MJ, 2007, CANCER GENET CYTOGEN, V172, P84, DOI 10.1016/j.cancergencyto.2006.02.022; BELLO MJ, 1993, GENE CHROMOSOME CANC, V6, P206, DOI 10.1002/gcc.2870060403; Benetatos L, 2013, CELL MOL LIFE SCI, V70, P795, DOI 10.1007/s00018-012-1080-8; Caye-Thomasen P, 2010, OTOL NEUROTOL, V31, P256, DOI 10.1097/MAO.0b013e3181be6478; Cioffi JA, 2010, OTOL NEUROTOL, V31, P1455, DOI 10.1097/MAO.0b013e3181f20655; Curto M, 2007, J CELL BIOL, V177, P893, DOI 10.1083/jcb.200703010; de Vries M, 2013, VIRCHOWS ARCH, V462, P211, DOI 10.1007/s00428-012-1342-8; Dixon-McIver A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002141; Dong XY, 2009, J GENET GENOMICS, V36, P447, DOI 10.1016/S1673-8527(08)60134-4; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Evans DGR, 2000, J MED GENET, V37, P897, DOI 10.1136/jmg.37.12.897; Gabriely G, 2011, CANCER RES, V71, P3563, DOI 10.1158/0008-5472.CAN-10-3568; Garcia-Orti L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047717; Gong M, 2012, NEURO-ONCOLOGY, V14, P1007, DOI 10.1093/neuonc/nos124; Gonzalez-Gomez P, 2003, CLIN CANCER RES, V9, P5601; Hadfield KD, 2010, ONCOGENE, V29, P6216, DOI 10.1038/onc.2010.363; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jesuraj NJ, 2012, J NEUROSCI RES, V90, P96, DOI 10.1002/jnr.22752; Kim BS, 2011, AGING CELL, V10, P277, DOI 10.1111/j.1474-9726.2011.00670.x; Kino T, 2001, GENES CELLS, V6, P441, DOI 10.1046/j.1365-2443.2001.00432.x; Koutsimpelas D, 2012, ORL J OTO-RHINO-LARY, V74, P33, DOI 10.1159/000334968; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kullar PJ, 2010, NEUROPATH APPL NEURO, V36, P505, DOI 10.1111/j.1365-2990.2010.01090.x; Lallemand D, 2009, ONCOGENE, V28, P854, DOI 10.1038/onc.2008.427; Lavon I, 2010, NEURO-ONCOLOGY, V12, P422, DOI 10.1093/neuonc/nop061; Leone PE, 1998, INT J MOL MED, V1, P889; Li W, 2010, CELL, V140, P477, DOI 10.1016/j.cell.2010.01.029; Liu ZL, 2013, MOL CELL BIOCHEM, V372, P35, DOI 10.1007/s11010-012-1443-3; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Martinez-Glez V, 2009, INT J ONCOL, V34, P493, DOI 10.3892/ijo_00000174; Mihelich BL, 2011, J BIOL CHEM, V286, P44503, DOI 10.1074/jbc.M111.262915; Nakata K, 2011, SURGERY, V150, P916, DOI 10.1016/j.surg.2011.06.017; Nohata N, 2012, ONCOTARGET, V3, P9; ODA Y, 1989, J NEUROSCI METH, V28, P163, DOI 10.1016/0165-0270(89)90032-0; Papagiannakopoulos T, 2012, ONCOGENE, V31, P1884, DOI 10.1038/onc.2011.380; REY JA, 1987, CANCER GENET CYTOGEN, V28, P187, DOI 10.1016/0165-4608(87)90372-4; ROULEAU GA, 1993, NATURE, V363, P515, DOI 10.1038/363515a0; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sandberg A.A., 2008, GENETICS MOL BIOL NE; Saydam O, 2011, CANCER RES, V71, P852, DOI 10.1158/0008-5472.CAN-10-1219; Saydam O, 2009, MOL CELL BIOL, V29, P5923, DOI 10.1128/MCB.00332-09; Smith AL, 2012, ONCOGENE, V31, P5162, DOI 10.1038/onc.2012.11; Torres-Martin M, 2013, CLIN TRANSL ONCOL, V15, P409, DOI 10.1007/s12094-012-0937-5; Torres-Martin M, 2013, INT J ONCOL, V42, P848, DOI 10.3892/ijo.2013.1798; TROFATTER JA, 1993, CELL, V72, P791, DOI 10.1016/0092-8674(93)90406-G; Ueno K, 2012, MOL CANCER THER, V11, P244, DOI 10.1158/1535-7163.MCT-11-0592; Valleron W, 2012, LEUKEMIA, V26, P2052, DOI 10.1038/leu.2012.111; Wang GF, 2008, FEBS LETT, V582, P3663, DOI 10.1016/j.febslet.2008.09.051; Wang Y, 2012, FASEB J, V26, P3032, DOI 10.1096/fj.11-201855; Warren C, 2003, J MED GENET, V40, P802, DOI 10.1136/jmg.40.11.802; Welling DB, 2002, OTOL NEUROTOL, V23, P736, DOI 10.1097/00129492-200209000-00022; Wu ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045825; Yu B, 2012, NUCLEIC ACIDS RES, V40, P10356, DOI 10.1093/nar/gks750; Yu B, 2012, J CELL SCI, V125, P2675, DOI 10.1242/jcs.098996; Yuan QG, 2013, HEPATOLOGY, V57, P299, DOI 10.1002/hep.25984; Zhang W, 2012, MOL BIOL+, V46, P557, DOI 10.1134/S0026893312040139; Zhu JF, 2012, AM J PATHOL, V180, P2440, DOI 10.1016/j.ajpath.2012.02.023	65	25	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65868	10.1371/journal.pone.0065868	http://dx.doi.org/10.1371/journal.pone.0065868			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776562	Green Published, Green Submitted, gold			2022-12-27	WOS:000320755400078
J	Bourgine, A; Pilet, P; Diouani, S; Sourice, S; Lesoeur, J; Beck-Cormier, S; Khoshniat, S; Weiss, P; Friedlander, G; Guicheux, J; Beck, L				Bourgine, Annabelle; Pilet, Paul; Diouani, Sara; Sourice, Sophie; Lesoeur, Julie; Beck-Cormier, Sarah; Khoshniat, Solmaz; Weiss, Pierre; Friedlander, Gerard; Guicheux, Jerome; Beck, Laurent			Mice with Hypomorphic Expression of the Sodium-Phosphate Cotransporter PiT1/Slc20a1 Have an Unexpected Normal Bone Mineralization	PLOS ONE			English	Article							OSTEOBLAST-LIKE CELLS; TRANSPORTER RETROVIRUS RECEPTOR; INORGANIC-PHOSPHATE; CALCIUM-PHOSPHATE; GROWTH; MATRIX; PIT1; GLVR-1; PHASE; CHONDROCYTES	The formation of hydroxyapatite crystals and their insertion into collagen fibrils of the matrix are essential steps for bone mineralization. As phosphate is a main structural component of apatite crystals, its uptake by skeletal cells is critical and must be controlled by specialized membrane proteins. In mammals, in vitro studies have suggested that the high-affinity sodium-phosphate cotransporter PiT1 could play this role. In vivo, PiT1 expression was detected in hypertrophic chondrocytes of murine metatarsals, but its implication in bone physiology is not yet deciphered. As the complete deletion of PiT1 results in embryonic lethality at E12.5, we took advantage of a mouse model bearing two copies of PiT1 hypomorphic alleles to study the effect of a low expression of PiT1 on bone mineralization in vivo. In this report, we show that a 85% down-regulation of PiT1 in long bones resulted in a slight (6%) but significant reduction of femur length in young mice (15- and 30-day-old). However, despite a defect in alcian blue / alizarin red S and Von Kossa staining of hypomorphic 1-day-old mice, using X-rays micro-computed tomography, energy dispersive X-ray spectroscopy and histological staining techniques we could not detect differences between hypomorphic and wild-type mice of 15- to 300-days old. Interestingly, the expression of PiT2, the paralog of PiT1, was increased 2-fold in bone of PiT1 hypomorphic mice accounting for a normal phosphate uptake in mutant cells. Whether this may contribute to the absence of bone mineralization defects remains to be further deciphered.	[Bourgine, Annabelle; Pilet, Paul; Sourice, Sophie; Lesoeur, Julie; Beck-Cormier, Sarah; Khoshniat, Solmaz; Weiss, Pierre; Guicheux, Jerome; Beck, Laurent] STEP Grp Skeletal Tissue Engn & Physiopathol, LIOAD, INSERM, U791, Nantes, France; [Bourgine, Annabelle; Pilet, Paul; Sourice, Sophie; Lesoeur, Julie; Beck-Cormier, Sarah; Khoshniat, Solmaz; Weiss, Pierre; Guicheux, Jerome; Beck, Laurent] Univ Nantes, UFR Odontol, Nantes, France; [Diouani, Sara; Friedlander, Gerard] Ctr Rech Croissance & Signalisat, INSERM, U845, Paris, France; [Diouani, Sara; Friedlander, Gerard] Univ Paris 05, Paris, France	Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Institut National de la Sante et de la Recherche Medicale (Inserm); Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Nantes Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Beck, L (corresponding author), STEP Grp Skeletal Tissue Engn & Physiopathol, LIOAD, INSERM, U791, Nantes, France.	laurent.beck@inserm.fr	Paul, Pilet/A-3755-2015; WEISS, Pierre/AAE-9260-2020; Beck-Cormier, Sarah/P-3091-2014; Weiss, Pierre/P-1372-2014; BECK, Laurent/P-2952-2014; guicheux, Jerome/F-7767-2013	WEISS, Pierre/0000-0002-6159-8590; Beck-Cormier, Sarah/0000-0001-5258-1933; Weiss, Pierre/0000-0002-6159-8590; BECK, Laurent/0000-0002-6730-2762; guicheux, Jerome/0000-0003-2754-3024; Friedlander, Gerard/0000-0002-6854-4261	INSERM; Fondation pour la Recherche Medicale (FRM); Region des Pays de la Loire [R10125NN, 2010-2817, 2010-2818]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Region des Pays de la Loire(Region Pays de la Loire)	This work was supported by grants from INSERM, the Fondation pour la Recherche Medicale (FRM), the Region des Pays de la Loire ("Bioregos II" project, "CIMATH 2" project #R10125NN and "Nouvelles thematiques Nouvelles equipes" project #2010-2817 and 2010-2818). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson HC, 2005, FRONT BIOSCI-LANDMRK, V10, P822, DOI 10.2741/1576; Beck GR, 2003, J BIOL CHEM, V278, P41921, DOI 10.1074/jbc.M304470200; Beck L, 1998, P NATL ACAD SCI USA, V95, P5372, DOI 10.1073/pnas.95.9.5372; Beck L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009148; Beck L, 2009, J BIOL CHEM, V284, P31363, DOI 10.1074/jbc.M109.053132; Bottger P, 2006, AM J PHYSIOL-CELL PH, V291, pC1377, DOI 10.1152/ajpcell.00015.2006; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Byskov K, 2012, CELL DIV, V7, DOI 10.1186/1747-1028-7-7; ESCOUBET B, 1992, J ENDOCRINOL, V133, P301, DOI 10.1677/joe.0.1330301; Fernandez-Vojvodich P, 2012, HORM RES PAEDIAT, V77, P180, DOI 10.1159/000337569; GLIMCHER MJ, 1984, PHILOS T R SOC B, V304, P479, DOI 10.1098/rstb.1984.0041; Guicheux J, 2000, BONE, V27, P69, DOI 10.1016/S8756-3282(00)00302-1; HALE JE, 1987, J BIOL CHEM, V262, P1916; HANSEN NM, 1976, BIOCHIM BIOPHYS ACTA, V451, P549, DOI 10.1016/0304-4165(76)90150-1; Jahnen-Dechent W, 2000, PROGR BIOL MOL BIOL, P21; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahamid J, 2008, P NATL ACAD SCI USA, V105, P12748, DOI 10.1073/pnas.0803354105; Mahamid J, 2011, J STRUCT BIOL, V174, P527, DOI 10.1016/j.jsb.2011.03.014; MCLEOD MJ, 1980, TERATOLOGY, V22, P299, DOI 10.1002/tera.1420220306; Nielsen LB, 2001, BONE, V28, P160, DOI 10.1016/S8756-3282(00)00418-X; Olszta MJ, 2003, CONNECT TISSUE RES, V44, P326, DOI 10.1080/03008200390181852; Palmer G, 2000, ENDOCRINOLOGY, V141, P2236, DOI 10.1210/en.141.6.2236; Palmer G, 1997, ENDOCRINOLOGY, V138, P5202, DOI 10.1210/en.138.12.5202; Palmer G, 1999, BONE, V24, P1, DOI 10.1016/S8756-3282(98)00151-3; POSNER AS, 1978, METAB BONE DIS RELAT, V1, P179, DOI 10.1016/0221-8747(78)90057-7; Ravera S, 2007, AM J PHYSIOL-CELL PH, V293, pC606, DOI 10.1152/ajpcell.00064.2007; Sabbagh Y, 2009, J AM SOC NEPHROL, V20, P2348, DOI 10.1681/ASN.2009050559; Salaun C, 2010, J BIOL CHEM, V285, P34408, DOI 10.1074/jbc.M110.130989; Segawa H, 2002, J BIOL CHEM, V277, P19665, DOI 10.1074/jbc.M200943200; Segawa H, 2009, AM J PHYSIOL-RENAL, V297, pF671, DOI 10.1152/ajprenal.00156.2009; Silverstein D, 1996, KIDNEY INT, V49, P1023, DOI 10.1038/ki.1996.148; Suzuki A, 2006, J BONE MINER RES, V21, P674, DOI 10.1359/JBMR.020603; Suzuki A, 2001, BONE, V28, P589, DOI 10.1016/S8756-3282(01)00459-8; Suzuki A, 2010, J BONE MINER METAB, V28, P139, DOI 10.1007/s00774-009-0121-3; Wang DS, 2001, J BIOL CHEM, V276, P33995, DOI 10.1074/jbc.M007757200; Wittrant Y, 2009, BIOCHEM BIOPH RES CO, V381, P259, DOI 10.1016/j.bbrc.2009.02.034; Yoshiko Y, 2007, MOL CELL BIOL, V27, P4465, DOI 10.1128/MCB.00104-07; Zoidis E, 2004, J ENDOCRINOL, V181, P531, DOI 10.1677/joe.0.1810531	38	26	26	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65979	10.1371/journal.pone.0065979	http://dx.doi.org/10.1371/journal.pone.0065979			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785462	Green Published, gold, Green Submitted			2022-12-27	WOS:000321038800060
J	Aly, H; Rohatgi, N; Marshall, CA; Grossenheider, TC; Miyoshi, H; Stappenbeck, TS; Matkovich, SJ; McDaniel, ML				Aly, Haytham; Rohatgi, Nidhi; Marshall, Connie A.; Grossenheider, Tiffani C.; Miyoshi, Hiroyuki; Stappenbeck, Thaddeus S.; Matkovich, Scot J.; McDaniel, Michael L.			A Novel Strategy to Increase the Proliferative Potential of Adult Human beta-Cells While Maintaining Their Differentiated Phenotype	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; INSULIN-RECEPTOR SUBSTRATE-1; PROTEIN-KINASE; GROWTH-FACTOR; SIGNALING PATHWAY; RHO-KINASE; MAMMALIAN TARGET; GENE-EXPRESSION; ROK-ALPHA; CATENIN	Our previous studies demonstrated that Wnt/GSK-3/beta-catenin and mTOR signaling are necessary to stimulate proliferative processes in adult human beta-cells. Direct inhibition of GSK-3, that engages Wnt signaling downstream of the Wnt receptor, increases beta-catenin nuclear translocation and beta-cell proliferation but results in lower insulin content. Our current goal was to engage canonical and non-canonical Wnt signaling at the receptor level to significantly increase human beta-cell proliferation while maintaining a beta-cell phenotype in intact islets. We adopted a system that utilized conditioned medium from L cells that expressed Wnt3a, R-spondin-3 and Noggin (L-WRN conditioned medium). In addition we used a ROCK inhibitor (Y-27632) and SB-431542 (that results in RhoA inhibition) in these cultures. Treatment of intact human islets with L-WRN conditioned medium plus inhibitors significantly increased DNA synthesis similar to 6 fold in a rapamycin-sensitive manner. Moreover, this treatment strikingly increased human beta-cell proliferation similar to 20 fold above glucose alone. Only the combination of L-WRN conditioned medium with RhoA/ROCK inhibitors resulted in substantial proliferation. Transcriptome-wide gene expression profiling demonstrated that L-WRN medium provoked robust changes in several signaling families, including enhanced beta-catenin-mediated and beta-cell-specific gene expression. This treatment also increased expression of Nr4a2 and Irs2 and resulted in phosphorylation of Akt. Importantly, glucose-stimulated insulin secretion and content were not downregulated by L-WRN medium treatment. Our data demonstrate that engaging Wnt signaling at the receptor level by this method leads to necessary crosstalk between multiple signaling pathways including activation of Akt, mTOR, Wnt/beta-catenin, PKA/CREB, and inhibition of RhoA/ROCK that substantially increase human beta-cell proliferation while maintaining the beta-cell phenotype.	[Aly, Haytham; Rohatgi, Nidhi; Marshall, Connie A.; Miyoshi, Hiroyuki; Stappenbeck, Thaddeus S.; McDaniel, Michael L.] Washington Univ, Dept Pathol & Immunol, St Louis, MO 63130 USA; [Grossenheider, Tiffani C.; Matkovich, Scot J.] Washington Univ, Dept Med, Ctr Pharmacogenom, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL)	McDaniel, ML (corresponding author), Washington Univ, Dept Pathol & Immunol, St Louis, MO 63130 USA.	mmcdaniel@wustl.edu	Matkovich, Scot J/B-9077-2009; Rohatgi, Nidhi/GWR-1096-2022; Matkovich, Scot J/AFP-0908-2022	Matkovich, Scot J/0000-0002-7398-6857; Matkovich, Scot J/0000-0002-7398-6857; Miyoshi, Hiroyuki/0000-0001-7400-0714	NIH [DK006181, DK00618146S1, DK07296]; NIH Washington University Diabetes Research Center Morphology and Metabolic Analysis Core [DK20579]; American Diabetes Association [7-04-MN-32]; Barnes-Jewish Hospital Foundation [7401-00]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Juvenile Diabetes Research Foundation International (JDRFI); JDRFI Sponsored Islets for Research Program at Washington University [JDRF-31-2008-382]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579, T32DK007296, R01DK006181, R56DK006181, R01DK071619, P60DK020579] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Washington University Diabetes Research Center Morphology and Metabolic Analysis Core; American Diabetes Association(American Diabetes Association); Barnes-Jewish Hospital Foundation; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Juvenile Diabetes Research Foundation International (JDRFI)(Juvenile Diabetes Research Foundation); JDRFI Sponsored Islets for Research Program at Washington University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding provided by NIH Grants DK006181 (MLM), NIH DK00618146S1 (MLM), DK07296 (MLM), NIH Washington University Diabetes Research Center Morphology and Metabolic Analysis Core DK20579 (MLM), American Diabetes Association Grant 7-04-MN-32 (MLM), Barnes-Jewish Hospital Foundation Grant 7401-00 (MLM). Human islets were obtained from the Integrated Islet Distribution Program (IIDP) sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the Juvenile Diabetes Research Foundation International (JDRFI) and the JDRFI Sponsored Islets for Research Program at Washington University (JDRF-31-2008-382). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Aspenstrom P, 1999, CURR OPIN CELL BIOL, V11, P95, DOI 10.1016/S0955-0674(99)80011-8; Begum N, 2002, J BIOL CHEM, V277, P6214, DOI 10.1074/jbc.M110508200; Briaud I, 2005, J BIOL CHEM, V280, P2282, DOI 10.1074/jbc.M412179200; Buongiorno P, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-73; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Cozar-Castellano I, 2004, DIABETES, V53, P149, DOI 10.2337/diabetes.53.1.149; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Farah S, 1998, J BIOL CHEM, V273, P4740, DOI 10.1074/jbc.273.8.4740; Fiaschi-Taesch N, 2009, DIABETES, V58, P882, DOI 10.2337/db08-0631; Fiaschi-Taesch NM, 2013, DIABETES, V62, P2460, DOI 10.2337/db12-0778; Fiaschi-Taesch NM, 2010, DIABETES, V59, P1926, DOI 10.2337/db09-1776; Fiaschi-Taesch NM, 2013, DIABETES; Filippa N, 1999, MOL CELL BIOL, V19, P4989; FIOL CJ, 1994, J BIOL CHEM, V269, P32187; Furukawa N, 2005, CELL METAB, V2, P119, DOI 10.1016/j.cmet.2005.06.011; Gurevitch D, 2010, DIABETES, V59, P2188, DOI 10.2337/db09-0890; Haq S, 2003, P NATL ACAD SCI USA, V100, P4610, DOI 10.1073/pnas.0835895100; Hu YX, 2012, P NATL ACAD SCI USA, V109, P19864, DOI 10.1073/pnas.1214996109; Impey S, 2001, SCI STKE; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Kaidanovich-Beilin O, 2006, J PHARMACOL EXP THER, V316, P17, DOI 10.1124/jpet.105.090266; Kanda T, 2005, FASEB J, V19, P169, DOI 10.1096/fj.05-4197fje; Karslioglu E, 2011, MOL ENDOCRINOL, V25, P1760, DOI 10.1210/me.2011-1074; Kazanskaya O, 2004, DEV CELL, V7, P525, DOI 10.1016/j.devcel.2004.07.019; Kazanskaya O, 2008, DEVELOPMENT, V135, P3655, DOI 10.1242/dev.027284; Kim KA, 2006, CELL CYCLE, V5, P23, DOI 10.4161/cc.5.1.2305; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Kondegowda NG, 2010, DIABETES, V59, P3131, DOI 10.2337/db09-1796; Liu AJ, 2011, CHINESE MED J-PEKING, V124, P3098, DOI 10.3760/cma.j.issn.0366-6999.2011.19.027; Liu H, 2009, DIABETES, V58, P663, DOI 10.2337/db07-1208; Liu YM, 2009, DIABETES OBES METAB, V11, P54, DOI 10.1111/j.1463-1326.2009.01107.x; Liu ZY, 2010, ADV EXP MED BIOL, V654, P391, DOI 10.1007/978-90-481-3271-3_17; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lu ZM, 2004, CELL CYCLE, V3, P571; Matkovich SJ, 2012, CIRC RES, V111, P521, DOI 10.1161/CIRCRESAHA.112.265736; Meier JJ, 2008, DIABETES, V57, P1584, DOI 10.2337/db07-1369; Miyoshi H, 2012, SCIENCE, V338, P108, DOI 10.1126/science.1223821; Mizukami Y, 2006, J BIOL CHEM, V281, P13957, DOI 10.1074/jbc.M511763200; Negash S, 2008, FASEB J, V22; NIELSEN JH, 1979, DIABETOLOGIA, V16, P97, DOI 10.1007/BF01225457; Noguchi M, 2007, J BIOL CHEM, V282, P29574, DOI 10.1074/jbc.M705972200; Pirone DM, 2006, J CELL BIOL, V174, P277, DOI 10.1083/jcb.200510062; Portha B, 2011, EXP DIABETES RES, DOI [10.1155/2011/105076, 10.1155/2011/376509]; Pradeep A, 2004, ONCOGENE, V23, P3689, DOI 10.1038/sj.onc.1207454; Rieck S, 2012, MOL ENDOCRINOL, V26, P1590, DOI 10.1210/me.2012-1019; Rohatgi N, 2013, PLOS ONE, DOI [10.1371/journal.pone.0062012, DOI 10.1371/J0URNAL.P0NE.0062012]; Rohatgi N, 2010, TOEJ, V4, P40; Russ HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025566; Rutti S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035801; Sable CL, 1997, FEBS LETT, V409, P253, DOI 10.1016/S0014-5793(97)00518-8; Seasholtz TM, 1999, MOL PHARMACOL, V55, P949, DOI 10.1124/mol.55.6.949; Shang YC, 2007, ACTA PHARMACOL SIN, V28, P1761, DOI 10.1111/j.1745-7254.2007.00671.x; Summers SA, 1999, J BIOL CHEM, V274, P17934, DOI 10.1074/jbc.274.25.17934; Teramura T, 2012, BIOCHEM BIOPH RES CO, V417, P836, DOI 10.1016/j.bbrc.2011.12.052; Teta M, 2007, DEV CELL, V12, P817, DOI 10.1016/j.devcel.2007.04.011; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tura A, 2009, INVEST OPHTH VIS SCI, V50, P452, DOI 10.1167/iovs.08-1973; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Velmurugan K, 2012, ENDOCRINOLOGY, V153, P1116, DOI 10.1210/en.2011-1895; Wang Y, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/395974; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Willert K, 2006, GENE DEV, V20, P1394, DOI 10.1101/gad.1424006; Wong VSC, 2010, J BIOL CHEM, V285, P21292, DOI 10.1074/jbc.M110.129874; Wu XM, 2008, CELL, V133, P340, DOI 10.1016/j.cell.2008.01.052; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443	70	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66131	10.1371/journal.pone.0066131	http://dx.doi.org/10.1371/journal.pone.0066131			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776620	Green Published, Green Submitted, gold			2022-12-27	WOS:000320322400083
J	Juarez, SP; Merlo, J				Juarez, Sol Pia; Merlo, Juan			The Effect of Swedish Snuff (Snus) on Offspring Birthweight: A Sibling Analysis	PLOS ONE			English	Article							MATERNAL SMOKING; GESTATIONAL-AGE; CARBON-MONOXIDE; PUBLIC-HEALTH; TOBACCO-SMOKE; PRETERM BIRTH; PREGNANCY; NICOTINE; RISK; EXPOSURE	Current observational evidence indicates that maternal smoking during pregnancy is associated with reduced birthweight in offspring. However, less is known about the effect of smokeless tobacco on birthweight and about the possible mechanisms involved in this relationship. This paper studies the effect of Swedish smokeless tobacco (snus) on offspring birthweight comparing the results obtained from a conventional linear regression analysis and from a quasi-experimental sibling design using a multilevel linear regression analysis. From the Swedish Medical Birth Register, we investigated 604,804 singletons born between 2002 and 2010. From them, we isolated 8,861 siblings from 4,104 mothers with discrepant snus-use habits (i.e., women who had at least one pregnancy during which they used snus and at least one other pregnancy in which they did not). The conventional analysis shows that continuous snus use throughout the pregnancy reduces birthweight in 47 g while quitting or relapsing snus has a minor and statistically non-significant effect (-6 g and -4 g, respectively). However, using a sibling analysis the effect observed for mothers who continue to use snus during pregnancy is less intense than that observed with previous conventional analyses (-20 g), and this effect is not statistically significant. Sibling analysis shows that quitting or relapsing snus use after the first trimester slightly reduces birthweight (14 g). However, this small change is not statistically significant. The sibling analysis provides strong causal evidence indicating that exposure to snus during pregnancy has a minor effect on birthweight reduction. Our findings provide a new piece of causal evidence concerning the effect of tobacco on birthweight and support the hypothesis that the harmful effect of smoking on birthweight is not mainly due to nicotine.	[Juarez, Sol Pia] Lund Univ, Ctr Econ Demog, Lund, Sweden; [Juarez, Sol Pia; Merlo, Juan] Lund Univ, Fac Med, Dept Clin Sci, Unit Social Epidemiol, Lund, Sweden	Lund University; Lund University	Juarez, SP (corresponding author), Lund Univ, Ctr Econ Demog, Lund, Sweden.	sol.juarez@ekh.lu.se	Merlo, Juan/E-2136-2011	Merlo, Juan/0000-0001-8379-9708; Juarez, Sol Pia/0000-0001-9086-7588	Swedish Council for Working Life and Social Research (FAS) [Dnr 2010-0402]; Swedish Research Council (VR) [Dnr K2011-69X-15377-07-6]	Swedish Council for Working Life and Social Research (FAS)(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Research Council (VR)(Swedish Research Council)	This work was supported by the Swedish Council for Working Life and Social Research (FAS)(Dnr 2010-0402, PI Juan Merlo), the Swedish Research Council (VR) (Dnr K2011-69X-15377-07-6, PI Juan Merlo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahluwalia IB, 1997, AM J EPIDEMIOL, V146, P42; Aubard Y, 2000, BRIT J OBSTET GYNAEC, V107, P833, DOI 10.1111/j.1471-0528.2000.tb11078.x; Baba S, 2013, BJOG-INT J OBSTET GY, V120, P456, DOI 10.1111/1471-0528.12067; Boffetta P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3060; Browne WJ, 2009, J R STAT SOC A STAT, V172, P579, DOI 10.1111/j.1467-985X.2009.00586.x; Carlin JB, 2005, INT J EPIDEMIOL, V34, P1089, DOI 10.1093/ije/dyi153; Carmines EL, 2008, TOXICOL SCI, V102, P383, DOI 10.1093/toxsci/kfn009; Cnattingius S, 2004, NICOTINE TOB RES, V6, pS125, DOI 10.1080/14622200410001669187; CNATTINGIUS S, 1990, SCAND J SOC MED, V18, P143, DOI 10.1177/140349489001800209; Cunningham FG, 2005, WILLIAMS OBSTET; D'Onofrio BM, 2008, DEV PSYCHOPATHOL, V20, P139, DOI 10.1017/S0954579408000072; D'Onofrio BM, 2010, ARCH GEN PSYCHIAT, V67, P529, DOI 10.1001/archgenpsychiatry.2010.33; Donovan SJ, 2011, INT J EPIDEMIOL, V40, P345, DOI 10.1093/ije/dyr057; England LJ, 2003, AM J OBSTET GYNECOL, V189, P939, DOI 10.1067/S0002-9378(03)00661-6; England LJ, 2012, ACTA OBSTET GYN SCAN, V91, P93, DOI 10.1111/j.1600-0412.2011.01273.x; Foulds J, 2003, TOB CONTROL, V12, P349, DOI 10.1136/tc.12.4.349; Foulds J, 2007, LANCET, V369, P1976, DOI 10.1016/S0140-6736(07)60679-5; Frisell T, 2012, EPIDEMIOLOGY, V23, P713, DOI 10.1097/EDE.0b013e31825fa230; George L, 2006, ACTA OBSTET GYN SCAN, V85, P1331, DOI 10.1080/00016340600935433; Goldstein H, 1995, MULTILEVEL STAT MODE, V2nd; Gonzalez A, 2005, TRATADO OBSTETRICIA, P162; Gray N, 2005, LANCET, V366, P966, DOI 10.1016/S0140-6736(05)67352-7; Haug K, 2000, ACTA OBSTET GYN SCAN, V79, P485, DOI 10.1034/j.1600-0412.2000.079006485.x; Hegaard HK, 2006, ACTA OBSTET GYN SCAN, V85, P675, DOI 10.1080/00016340600607032; HILL AE, 1988, ULSTER MED J, V57, P22; HOLM H, 1992, PSYCHOPHARMACOLOGY, V108, P507, DOI 10.1007/BF02247429; Holmes D, 2007, NATURE REV CANC, V7; Huizink AC, 2006, NEUROSCI BIOBEHAV R, V30, P24, DOI 10.1016/j.neubiorev.2005.04.005; Iliadou AN, 2010, INT J EPIDEMIOL, V39, P1193, DOI 10.1093/ije/dyq064; Jaddoe VWV, 2008, PAEDIATR PERINAT EP, V22, P162, DOI 10.1111/j.1365-3016.2007.00916.x; Kotlyar M, 2011, CANCER EPIDEM BIOMAR, V20, P91, DOI 10.1158/1055-9965.EPI-10-0349; Kyrklund-Blomberg NB, 1998, AM J OBSTET GYNECOL, V179, P1051, DOI 10.1016/S0002-9378(98)70214-5; Kyrklund-Blomberg NB, 2005, ACTA OBSTET GYN SCAN, V84, P572, DOI 10.1111/j.0001-6349.2005.00848.x; Lahey BB, 2010, CURR DIR PSYCHOL SCI, V19, P319, DOI 10.1177/0963721410383977; Lassen TH, 2010, PAEDIATR PERINAT EP, V24, P272, DOI 10.1111/j.1365-3016.2010.01104.x; Lawlor DA, 2009, FAMILY MATTERS DESIG; Lee PN, 2011, REGUL TOXICOL PHARM, V59, P197, DOI 10.1016/j.yrtph.2010.12.002; Luo J, 2007, LANCET, V369, P2015, DOI 10.1016/S0140-6736(07)60678-3; Merlo J, 2010, INT J EPIDEMIOL, V39, P936; Merlo J, 2013, SOC SCI MED, V76, P39, DOI 10.1016/j.socscimed.2012.08.034; Meyer S, 2009, EUR J OBSTET GYN R B, V146, P37, DOI 10.1016/j.ejogrb.2009.05.031; NORDSTROM ML, 1994, EARLY HUM DEV, V37, P195, DOI 10.1016/0378-3782(94)90079-5; Rasbash J., 2004, USERS GUIDE MLWIN VE; Rogers JM, 2003, TOXICOL SCI, V75, P227, DOI 10.1093/toxsci/kfg215; Rogers John M., 2008, Birth Defects Research, V84, P1, DOI 10.1002/bdrc.20119; Salihu HM, 2007, EARLY HUM DEV, V83, P713, DOI 10.1016/j.earlhumdev.2007.08.002; Wickstrom R, 2007, CURR NEUROPHARMACOL, V5, P213, DOI 10.2174/157015907781695955; Wikstrom AK, 2010, BJOG-INT J OBSTET GY, V117, P1005, DOI 10.1111/j.1471-0528.2010.02575.x; Wikstrom AK, 2010, EPIDEMIOLOGY, V21, P772, DOI 10.1097/EDE.0b013e3181f20d7e; Zdravkovic T, 2005, PLACENTA, V26, pS81, DOI 10.1016/j.placenta.2005.02.003	50	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65611	10.1371/journal.pone.0065611	http://dx.doi.org/10.1371/journal.pone.0065611			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776512	gold, Green Submitted, Green Published			2022-12-27	WOS:000320322400038
J	Kemeny, SF; Figueroa, DS; Clyne, AM				Kemeny, Steven Frank; Figueroa, Dannielle Solomon; Clyne, Alisa Morss			Hypo- and Hyperglycemia Impair Endothelial Cell Actin Alignment and Nitric Oxide Synthase Activation in Response to Shear Stress	PLOS ONE			English	Article							PROTEIN-KINASE-C; HIGH GLUCOSE; EXPRESSION; ATHEROSCLEROSIS; PHOSPHORYLATION; DISEASE; MECHANOTRANSDUCTION; INVOLVEMENT; PROGRESSION; DEFICIENCY	Uncontrolled blood glucose in people with diabetes correlates with endothelial cell dysfunction, which contributes to accelerated atherosclerosis and subsequent myocardial infarction, stroke, and peripheral vascular disease. In vitro, both low and high glucose induce endothelial cell dysfunction; however the effect of altered glucose on endothelial cell fluid flow response has not been studied. This is critical to understanding diabetic cardiovascular disease, since endothelial cell cytoskeletal alignment and nitric oxide release in response to shear stress from flowing blood are atheroprotective. In this study, porcine aortic endothelial cells were cultured in 1, 5.55, and 33 mM D-glucose medium (low, normal, and high glucose) and exposed to 20 dynes/cm(2) shear stress for up to 24 hours in a parallel plate flow chamber. Actin alignment and endothelial nitric oxide synthase phosphorylation increased with shear stress for cells in normal glucose, but not cells in low and high glucose. Both low and high glucose elevated protein kinase C (PKC) levels; however PKC blockade only restored actin alignment in high glucose cells. Cells in low glucose instead released vascular endothelial growth factor (VEGF), which translocated beta-catenin away from the cell membrane and disabled the mechanosensory complex. Blocking VEGF in low glucose restored cell actin alignment in response to shear stress. These data suggest that low and high glucose alter endothelial cell alignment and nitric oxide production in response to shear stress through different mechanisms.	[Kemeny, Steven Frank; Clyne, Alisa Morss] Drexel Univ, Philadelphia, PA 19104 USA; [Figueroa, Dannielle Solomon] Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA	Drexel University; Drexel University	Clyne, AM (corresponding author), Drexel Univ, Philadelphia, PA 19104 USA.	asm67@drexel.edu	Clyne, Alisa/D-5471-2011	Clyne, Alisa/0000-0003-2462-2122	National Science Foundation [CBET-0846751, DGE-0947936]; American Heart Association [10SDG4460068]; UNCF-Merck	National Science Foundation(National Science Foundation (NSF)); American Heart Association(American Heart Association); UNCF-Merck(Merck & Company)	This research was funded by an National Science Foundation CAREER award (CBET-0846751) to ASMC, American Heart Association Scientist Development Grant (10SDG4460068) to ASMC, National Science Foundation GK-12 fellowship (DGE-0947936) to SFK, and UNCF-Merck graduate dissertation fellowship to DSF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abid MR, 2001, FASEB J, V15, P2548, DOI 10.1096/fj.01-0338fje; Biswas P, 2003, BIOCHEM BIOPH RES CO, V303, P212, DOI 10.1016/S0006-291X(03)00313-9; Brower JB, 2010, CYTOSKELETON, V67, P135, DOI 10.1002/cm.20430; Brower JB, 2009, CELL MOL BIOENG, V2, P533, DOI 10.1007/s12195-009-0080-8; BROWNLEE M, 1995, ANNU REV MED, V46, P223, DOI 10.1146/annurev.med.46.1.223; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; Centers for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET; Chakravarthy U, 1998, DIABETES, V47, P945, DOI 10.2337/diabetes.47.6.945; Chen JS, 2004, J BIOMED SCI, V11, P142, DOI 10.1159/000076026; DAVIES PF, 1995, PHYSIOL REV, V75, P519, DOI 10.1152/physrev.1995.75.3.519; Dejana E, 1999, EXP CELL RES, V252, P13, DOI 10.1006/excr.1999.4601; DEWEY CF, 1981, J BIOMECH ENG-T ASME, V103, P177, DOI 10.1115/1.3138276; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Du XL, 2000, P NATL ACAD SCI USA, V97, P12222, DOI 10.1073/pnas.97.22.12222; Esser S, 1998, J CELL SCI, V111, P1853; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; Figueroa DS, 2011, CELL MOL BIOENG, V4, P220, DOI 10.1007/s12195-011-0176-9; Fisslthaler B, 2000, ACTA PHYSIOL SCAND, V168, P81; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Hahn C, 2009, NAT REV MOL CELL BIO, V10, P53, DOI 10.1038/nrm2596; Hamuro M, 2002, ATHEROSCLEROSIS, V162, P277, DOI 10.1016/S0021-9150(01)00719-5; Hempel A, 1997, CIRC RES, V81, P363, DOI 10.1161/01.RES.81.3.363; HERBERT JM, 1990, BIOCHEM BIOPH RES CO, V172, P993, DOI 10.1016/0006-291X(90)91544-3; Hsieh HJ, 1998, J CELL PHYSIOL, V175, P156, DOI 10.1002/(SICI)1097-4652(199805)175:2<156::AID-JCP5>3.0.CO;2-N; Hsu HJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012470; Hu YL, 1997, J HISTOCHEM CYTOCHEM, V45, P237, DOI 10.1177/002215549704500209; Kemeny SF, 2011, J BIOMECH, V44, P1927, DOI 10.1016/j.jbiomech.2011.04.026; Kemeny SF, 2011, MICROSC MICROANAL, V17, P156, DOI 10.1017/S143192761100002X; KUCHAN MJ, 1993, AM J PHYSIOL, V264, pH150, DOI 10.1152/ajpheart.1993.264.1.H150; LEE TS, 1989, P NATL ACAD SCI USA, V86, P5141, DOI 10.1073/pnas.86.13.5141; Lewis JM, 1996, J CELL BIOL, V134, P1323, DOI 10.1083/jcb.134.5.1323; LORENZI M, 1985, DIABETES, V34, P621, DOI 10.2337/diabetes.34.7.621; Malek AM, 1999, JAMA-J AM MED ASSOC, V282, P2035, DOI 10.1001/jama.282.21.2035; Martin A, 2003, MED RES REV, V23, P117, DOI 10.1002/med.10024; Michiels C, 2003, J CELL PHYSIOL, V196, P430, DOI 10.1002/jcp.10333; MOLNAR GD, 1974, DIABETOLOGIA, V10, P139, DOI 10.1007/BF01219670; Monaghan-Benson E, 2009, J BIOL CHEM, V284, P25602, DOI 10.1074/jbc.M109.009894; Morss AS, 2007, J BIOL CHEM, V282, P14635, DOI 10.1074/jbc.M608565200; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Ngu H, 2010, ANN BIOMED ENG, V38, P208, DOI 10.1007/s10439-009-9826-7; Nicholls SJ, 2008, J AM COLL CARDIOL, V52, P255, DOI 10.1016/j.jacc.2008.03.051; Nicholls SJ, 2006, J AM COLL CARDIOL, V47, P1967, DOI 10.1016/j.jacc.2005.12.058; NIEDEL JE, 1983, P NATL ACAD SCI-BIOL, V80, P36, DOI 10.1073/pnas.80.1.36; Osawa M, 2002, J CELL BIOL, V158, P773, DOI 10.1083/jcb.200205049; RICHARDSON M, 1994, ARTERIOSCLER THROMB, V14, P760, DOI 10.1161/01.ATV.14.5.760; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Shay-Salit A, 2002, P NATL ACAD SCI USA, V99, P9462, DOI 10.1073/pnas.142224299; Shikata Y, 2005, EXP CELL RES, V304, P40, DOI 10.1016/j.yexcr.2004.11.001; SHWEIKI D, 1995, P NATL ACAD SCI USA, V92, P768, DOI 10.1073/pnas.92.3.768; Tarbell JM, 2006, J INTERN MED, V259, P339, DOI 10.1111/j.1365-2796.2006.01620.x; TSENG H, 1995, CIRC RES, V77, P869, DOI 10.1161/01.RES.77.5.869; Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952; Tzima E, 2001, EMBO J, V20, P4639, DOI 10.1093/emboj/20.17.4639; VIGORITA VJ, 1980, AM J CARDIOL, V46, P535, DOI 10.1016/0002-9149(80)90500-7; Wagenknecht LE, 2003, ARTERIOSCL THROM VAS, V23, P1035, DOI 10.1161/01.ATV.0000072273.67342.6D; Wang JL, 2012, ARTERIOSCL THROM VAS, V32, P712, DOI 10.1161/ATVBAHA.111.227389; Xia P, 1996, J CLIN INVEST, V98, P2018, DOI 10.1172/JCI119006	59	45	47	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66176	10.1371/journal.pone.0066176	http://dx.doi.org/10.1371/journal.pone.0066176			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776627	Green Published, gold, Green Submitted			2022-12-27	WOS:000320322400086
J	Morlat, P; Vivot, A; Vandenhende, MA; Dauchy, FA; Asselineau, J; Deti, E; Gerard, Y; Lazaro, E; Duffau, P; Neau, D; Bonnet, F; Chene, G				Morlat, Philippe; Vivot, Alexandre; Vandenhende, Marie-Anne; Dauchy, Frederic-Antoine; Asselineau, Julien; Deti, Edouard; Gerard, Yann; Lazaro, Estibaliz; Duffau, Pierre; Neau, Didier; Bonnet, Fabrice; Chene, Genevieve		Grp D'epidemiologie Clin du Sida e	Role of Traditional Risk Factors and Antiretroviral Drugs in the Incidence of Chronic Kidney Disease, ANRS CO3 Aquitaine Cohort, France, 2004-2012	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; HIV-INFECTED PATIENTS; TENOFOVIR DISOPROXIL FUMARATE; CHRONIC-RENAL-FAILURE; THERAPY; SAFETY; INDIVIDUALS; PROTEINURIA; DYSFUNCTION; PROGRESSION	Objective: To examine the role of antiretroviral drugs (ART), HIV-related and traditional risk factors on the incidence of chronic kidney disease (CKD) in HIV-infected patients. Design: Prospective hospital-based cohort of HIV-infected patients from 2004 to 2012. Methods: CKD was defined using MDRD equation as an estimated glomerular filtration rate (eGFR) less than 60 ml/mn/1.73 m 2 at 2 consecutive measurements >= 3 months apart. Poisson regression models were used to study determinants of CKD either measured at baseline or updated. ART exposure was classified as ever or never. We additionally tested the role of tenofovir (TDF), whether or not prescribed concomitantly with a Protease Inhibitor (PI), taking into account the cumulative exposure to the drug. Results: 4,350 patients (74% men) with baseline eGFR > 60 ml/mn/1.73 m(2) were followed for a median of 5.8 years. At the end of follow-up, 96% had received ART, one third of them (35%) jointly received TDF and a PI. Average incidence rate of CKD was 0.95% person-years of follow-up. Incidence of CKD was higher among women (IRR = 2.2), older patients (> 60 y vs,45 y: IRR = 2.5 and 45-60 y: IRR = 1.7), those with diabetes (IRR = 1.9), high blood pressure (IRR = 1.5), hyperlipidemia (IRR = 1.5), AIDS stage (IRR = 1.4), low baseline eGFR (IRR = 15.8 for 60, eGFR, 70 ml/mn/1.73 m(2) vs > 90 and IRR = 7.1 for 70<eGFR<80 ml/mn/1.73 m(2)), current CD4+<200 cells/mm(3) vs>500/mm(3) (IRR = 2.5), and exposure to TDF (IRR = 2.0). Exposure to TDF was even strongly associated with CKD when co-administered with PIs (IRR = 3.1 vs 1.3 when not, p<0,001). A higher risk of CKD was found when tenofovir exposure was>12 months [IRR = 3.0 with joint PIs vs 1.3 without (p<0.001)]. A vast majority of those developing CKD (76.6%) had a baseline eGFR between 60 and 80 ml/mn/1.73 m(2). Conclusion: In patients with eGFR between 60 and 80 mL/min/1.73 m(2), a thorough control of CKD risk factors is warranted. The use of TDF, especially when co-administered with PIs, should be mentioned as a relative contraindication in presence of at least one of these risk factors.	[Morlat, Philippe; Vandenhende, Marie-Anne; Bonnet, Fabrice; Chene, Genevieve] Univ Bordeaux, ISPED, Ctr INSERM Epidemiol Biostat U897, Bordeaux, France; [Morlat, Philippe; Vandenhende, Marie-Anne; Bonnet, Fabrice; Chene, Genevieve] INSERM, ISPED, Ctr INSERM Epidemiol Biostat U897, Bordeaux, France; [Morlat, Philippe; Vandenhende, Marie-Anne; Bonnet, Fabrice; Chene, Genevieve] CIC EC7, Bordeaux, France; [Vivot, Alexandre; Asselineau, Julien; Deti, Edouard; Chene, Genevieve] CHU Bordeaux, Clin Epidemiol Unit USMR, Pole Sante Publ, Bordeaux, France; [Morlat, Philippe; Vandenhende, Marie-Anne; Dauchy, Frederic-Antoine; Lazaro, Estibaliz; Duffau, Pierre; Neau, Didier; Bonnet, Fabrice] CHU Bordeaux, Pole Sante Publ, Coordinat Reg Lutte VIH COREVIH, Bordeaux, France; [Gerard, Yann] CH Dax, Serv Malad Infectieuses, Dax, France; [Lazaro, Estibaliz; Neau, Didier] Univ Bordeaux, UFR Sci Med, Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Bordeaux; CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux	Morlat, P (corresponding author), Univ Bordeaux, ISPED, Ctr INSERM Epidemiol Biostat U897, Bordeaux, France.	philippe.morlat@chu-bordeaux.fr	chene, genevieve/H-8665-2014; Dauchy, Frédéric-Antoine/T-4652-2019; Vivot, Alexandre/K-3816-2017; Vandenhende, Marie-Anne/T-6625-2019; Bonnet, Fabrice/T-3254-2019	chene, genevieve/0000-0002-8368-6460; Vivot, Alexandre/0000-0001-9281-3129; 	Agence Nationale de Recherches sur le SIDA et les Hepatites Virales (ANRS, France)	Agence Nationale de Recherches sur le SIDA et les Hepatites Virales (ANRS, France)(ANRS)	The ANRS CO3 Aquitaine Cohort is supported by a grant from the Agence Nationale de Recherches sur le SIDA et les Hepatites Virales (ANRS, France) within the Coordinated Action no. 7 (AC7): http://www.anrs.fr/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albini L, 2012, JAIDS-J ACQ IMM DEF, V59, P18, DOI 10.1097/QAI.0b013e31823a6124; Bige N, 2012, NEPHROL DIAL TRANSPL, V27, P1114, DOI 10.1093/ndt/gfr376; Brennan A, 2011, AIDS, V25, P1603, DOI 10.1097/QAD.0b013e32834957da; Buehring B, 2011, J CLIN DENSITOM, DOI [10.1016/j.jocd.2011.10.003, DOI 10.1016/J.J0CD.2011.10.003]; Campbell LJ, 2009, HIV MED, V10, P329, DOI 10.1111/j.1468-1293.2008.00691.x; Clark WF, 2011, J AM SOC NEPHROL, V22, P1729, DOI 10.1681/ASN.2010111217; Cooper RD, 2010, CLIN INFECT DIS, V51, P496, DOI 10.1086/655681; Dauchy FA, 2011, KIDNEY INT, V80, P302, DOI 10.1038/ki.2011.124; De Beaudrap P, 2010, AIDS RES HUM RETROV, V26, P1221, DOI 10.1089/aid.2009.0261; Deti EK, 2010, HIV MED, V11, P308, DOI 10.1111/j.1468-1293.2009.00780.x; Di Angelantonio E, 2007, PLOS MED, V4, P1497, DOI 10.1371/journal.pmed.0040270; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Fux CA, 2007, AIDS, V21, P1483, DOI 10.1097/QAD.0b013e328216f15b; Gallant JE, 2008, AIDS, V22, P2155, DOI 10.1097/QAD.0b013e3283112b8e; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; Goicoechea M, 2008, J INFECT DIS, V197, P102, DOI 10.1086/524061; Gupta SK, 2008, AIDS PATIENT CARE ST, V22, P99, DOI 10.1089/apc.2007.0052; Gupta SK, 2005, CLIN INFECT DIS, V41, P570, DOI 10.1086/432124; Horberg M, 2010, JAIDS-J ACQ IMM DEF, V53, P62, DOI 10.1097/QAI.0b013e3181be6be2; Jones C, 2006, NEPHROL DIAL TRANSPL, V21, P2133, DOI 10.1093/ndt/gfl198; Kalayjian RC, 2012, AIDS, V26, P1907, DOI 10.1097/QAD.0b013e328357f5ed; Kearney BP, 2006, JAIDS-J ACQ IMM DEF, V43, P278, DOI 10.1097/01.qai.0000243103.03265.2b; Kiser JJ, 2008, CLIN PHARMACOL THER, V83, P265, DOI 10.1038/sj.clpt.6100269; Krawczyk CS, 2004, AIDS, V18, P2171, DOI 10.1097/00002030-200411050-00009; Leport C, 2009, CLIN INFECT DIS, V49, P1950, DOI 10.1086/648445; Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Lucas GM, 2008, J INFECT DIS, V197, P1548, DOI 10.1086/587994; Mocroft A, 2007, AIDS, V21, P1119, DOI 10.1097/QAD.0b013e3280f774ee; Mocroft A, 2010, AIDS, V24, P1667, DOI 10.1097/QAD.0b013e328339fe53; Peters L, 2012, AIDS, V26, P1917, DOI 10.1097/QAD.0b013e3283574e71; Rodriguez-Novoa S, 2009, CLIN INFECT DIS, V48, pE108, DOI 10.1086/598507; Saydah S., 2007, Morbidity and Mortality Weekly Report, V56, P161; Scherzer R, 2012, AIDS, V26, P867, DOI 10.1097/QAD.0b013e328351f68f; Sorli ML, 2008, JAIDS-J ACQ IMM DEF, V48, P506, DOI 10.1097/QAI.0b013e31817bbecb; Szczech LA, 2002, KIDNEY INT, V61, P195, DOI 10.1046/j.1523-1755.2002.00094.x; Thiebaut R, 2000, AIDS, V14, P971, DOI 10.1097/00002030-200005260-00008; Tordato F, 2011, HIV MED, V12, P4, DOI 10.1111/j.1468-1293.2010.00855.x; Winston J, 2008, CLIN INFECT DIS, V47, P1449, DOI 10.1086/593099; Young J, 2012, AIDS, V26, P567, DOI 10.1097/QAD.0b013e32834f337c	41	48	48	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66223	10.1371/journal.pone.0066223	http://dx.doi.org/10.1371/journal.pone.0066223			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776637	Green Published, Green Submitted, gold			2022-12-27	WOS:000320322400089
J	Spikman, JM; Milders, MV; Visser-Keizer, AC; Westerhof-Evers, HJ; Herben-Dekker, M; van der Naalt, J				Spikman, Jacoba M.; Milders, Maarten V.; Visser-Keizer, Annemarie C.; Westerhof-Evers, Herma J.; Herben-Dekker, Meike; van der Naalt, Joukje			Deficits in Facial Emotion Recognition Indicate Behavioral Changes and Impaired Self-Awareness after Moderate to Severe Traumatic Brain Injury	PLOS ONE			English	Article							DYSEXECUTIVE QUESTIONNAIRE; EXECUTIVE DYSFUNCTION; EXPRESSION; IMPAIRMENTS; VALIDITY; ADULTS; METAANALYSIS; ASSOCIATION; RELIABILITY; PERCEPTION	Traumatic brain injury (TBI) is a leading cause of disability, specifically among younger adults. Behavioral changes are common after moderate to severe TBI and have adverse consequences for social and vocational functioning. It is hypothesized that deficits in social cognition, including facial affect recognition, might underlie these behavioral changes. Measurement of behavioral deficits is complicated, because the rating scales used rely on subjective judgement, often lack specificity and many patients provide unrealistically positive reports of their functioning due to impaired self-awareness. Accordingly, it is important to find performance based tests that allow objective and early identification of these problems. In the present study 51 moderate to severe TBI patients in the sub-acute and chronic stage were assessed with a test for emotion recognition (FEEST) and a questionnaire for behavioral problems (DEX) with a self and proxy rated version. Patients performed worse on the total score and on the negative emotion subscores of the FEEST than a matched group of 31 healthy controls. Patients also exhibited significantly more behavioral problems on both the DEX self and proxy rated version, but proxy ratings revealed more severe problems. No significant correlation was found between FEEST scores and DEX self ratings. However, impaired emotion recognition in the patients, and in particular of Sadness and Anger, was significantly correlated with behavioral problems as rated by proxies and with impaired self-awareness. This is the first study to find these associations, strengthening the proposed recognition of social signals as a condition for adequate social functioning. Hence, deficits in emotion recognition can be conceived as markers for behavioral problems and lack of insight in TBI patients. This finding is also of clinical importance since, unlike behavioral problems, emotion recognition can be objectively measured early after injury, allowing for early detection and treatment of these problems.	[Spikman, Jacoba M.; Visser-Keizer, Annemarie C.; Westerhof-Evers, Herma J.] Univ Groningen, Dept Clin & Dev Neuropsychol, Groningen, Netherlands; [Spikman, Jacoba M.; Herben-Dekker, Meike; van der Naalt, Joukje] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [Milders, Maarten V.] Heriot Watt Univ, Sch Life Sci, Edinburgh, Midlothian, Scotland; [Visser-Keizer, Annemarie C.] Univ Groningen, Univ Med Ctr Groningen, Ctr Rehabil, Haren, Netherlands; [Herben-Dekker, Meike] Rehabil Ctr Friesland, Beetsterzwaag, Netherlands	University of Groningen; University of Groningen; Heriot Watt University; University of Groningen	Spikman, JM (corresponding author), Univ Groningen, Dept Clin & Dev Neuropsychol, Groningen, Netherlands.	j.m.spikman@rug.nl	Milders, Maarten/GWD-1508-2022	van der Naalt, Joukje/0000-0001-9873-2418; Spikman, Jacoba/0000-0002-6477-0763	Dutch Brain Foundation [F2008-1-18]	Dutch Brain Foundation	The study was partly funded by the Dutch Brain Foundation (grant nr F2008-1-18) [https://www.hersenstichting.nl/]. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. No additional external funding received for this study.	Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Bennett PC, 2005, J INT NEUROPSYCH SOC, V11, P606, DOI 10.1017/S1355617705050721; Biehl M, 1997, J NONVERBAL BEHAV, V21, P3, DOI 10.1023/A:1024902500935; Blair RJR, 2003, PHILOS T R SOC B, V358, P561, DOI 10.1098/rstb.2002.1220; Bodenburg S, 2008, J NERV MENT DIS, V196, P75, DOI 10.1097/NMD.0b013e31815faa2b; Bornhofen C, 2008, J INT NEUROPSYCH SOC, V14, P511, DOI 10.1017/S1355617708080703; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Chan RCK, 2008, J NEUROL NEUROSUR PS, V79, P86, DOI 10.1136/jnnp.2007.117184; Chaytor N, 2007, BRAIN INJURY, V21, P615, DOI 10.1080/02699050701426949; Cohen J.E., 1988, STAT POWER ANAL BEHA; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; Diehl-Schmid J, 2007, ARCH CLIN NEUROPSYCH, V22, P459, DOI 10.1016/j.acn.2007.01.024; Ekman P., 1976, PICTURES FACIAL AFFE; Engberg AW, 2004, BRAIN INJURY, V18, P533, DOI 10.1080/02699050310001645829; Fujiwara E, 2008, NEUROPSYCHOLOGIA, V46, P461, DOI 10.1016/j.neuropsychologia.2007.08.027; Fusar-Poli P, 2009, J PSYCHIATR NEUROSCI, V34, P418; Green REA, 2004, NEUROPSYCHOLOGIA, V42, P133, DOI 10.1016/j.neuropsychologia.2003.07.005; GURDJIAN ES, 1976, J TRAUMA, V16, P35, DOI 10.1097/00005373-197601000-00005; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P333, DOI 10.1097/00001199-200507000-00005; Hart T, 2004, ARCH PHYS MED REHAB, V85, P1450, DOI 10.1016/j.apmr.2004.01.030; Hawthorne G, 2009, J NEUROTRAUM, V26, P1623, DOI [10.1089/neu.2008.0735, 10.1089/neu.2008-0735]; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P1623, DOI 10.1016/j.neuropsychologia.2006.03.020; HOLM S, 1979, SCAND J STAT, V6, P65; Hopkins MJ, 2002, BRAIN INJURY, V16, P245, DOI 10.1080/02699050110103346; Ietswaart M, 2008, NEUROPSYCHOLOGIA, V46, P148, DOI 10.1016/j.neuropsychologia.2007.08.002; JACKSON HF, 1987, CORTEX, V23, P293, DOI 10.1016/S0010-9452(87)80039-4; Knox L, 2009, BRAIN COGNITION, V69, P442, DOI 10.1016/j.bandc.2008.09.009; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; Levine B, 2006, J NEUROTRAUM, V23, P1396, DOI 10.1089/neu.2006.23.1396; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marsh AA, 2008, NEUROSCI BIOBEHAV R, V32, P454, DOI 10.1016/j.neubiorev.2007.08.003; Marsh AA, 2011, J CHILD PSYCHOL PSYC, V52, P834, DOI 10.1111/j.1469-7610.2010.02353.x; McDonald S, 2006, DISABIL REHABIL, V28, P1529, DOI 10.1080/09638280600646185; Milders M, 2003, NEUROPSYCHOLOGIA, V41, P1484, DOI 10.1016/S0028-3932(03)00079-4; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Milders M, 2006, NEUROPSYCHOLOGY, V20, P400, DOI 10.1037/0894-4105.20.4.400; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Radice-Neumann D, 2007, BRAIN INJURY, V21, P807, DOI 10.1080/02699050701504281; Rapcsak SZ, 2000, NEUROLOGY, V54, P575, DOI 10.1212/WNL.54.3.575; Sherer M, 2005, J HEAD TRAUMA REHAB, V20, P287, DOI 10.1097/00001199-200507000-00002; Simblett SK, 2011, NEUROPSYCHOL REHABIL, V21, P1, DOI [10.1080/09602011.2010.531216, 10.1080/09602011.2011.592099]; Spikman JM, 2012, J NEUROTRAUM, V29, P101, DOI 10.1089/neu.2011.2084; Spikman JM, 2010, J NEUROTRAUMA; Sprengelmeyer R, 1998, P ROY SOC B-BIOL SCI, V265, P1927, DOI 10.1098/rspb.1998.0522; Struchen MA, 2008, NEUROREHABILITATION, V23, P185; Stuss D.T., 2011, J INT NEUROPSYCH SOC, V17, P1; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Wallesch CW, 2001, J NEUROTRAUM, V18, P11, DOI 10.1089/089771501750055730; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; Wilson B.A., 1996, BEHAV ASSESSMENT DYS; Wise K, 2005, BRAIN INJURY, V19, P765, DOI 10.1080/0269905050019977; Young AW, 2002, FACIAL EXPRESSIONS E; Zappala G, 2012, CORTEX, V48, P156, DOI 10.1016/j.cortex.2011.06.020	59	89	90	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65581	10.1371/journal.pone.0065581	http://dx.doi.org/10.1371/journal.pone.0065581			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	163FW	23776505	gold, Green Published, Green Submitted			2022-12-27	WOS:000320322400035
J	Wei, W; Qi, XG; Garber, PA; Guo, ST; Zhang, P; Li, BG				Wei, Wei; Qi, XiaoGuang; Garber, Paul A.; Guo, SongTao; Zhang, Pei; Li, BaoGuo			Supply and Demand Determine the Market Value of Access to Infants in the Golden Snub-Nosed Monkey (Rhinopithecus roxellana)	PLOS ONE			English	Article							WILD CEBUS-CAPUCINUS; QINLING MOUNTAINS; SOCIAL RELATIONSHIPS; FEMALE PRIMATES; BABOONS; RECIPROCATION; INTERCHANGE; MANGABEYS; DYNAMICS; EXCHANGE	According to a biological market paradigm, trading decisions between partners will be influenced by the current 'exchange rate' of commodities (good and services), which is affected by supply and demand, and the trader's ability to outbid competitors. In several species of nonhuman primates, newborn infants are attractive to female group members and may become a desired commodity that can be traded for grooming within a biological market place. We investigated whether grooming was interchanged for infant handling in female golden snub-nosed monkeys (Rhinopithecus roxellana) inhabiting the Qinling Mountains of central China. R. roxellana exhibit a multilevel social organization characterized by over 100 troop members organized into 6-11 one-male units each composed one adult male and several adult females and their offspring. Behavioral data were collected over the course of 28 months on grooming patterns between mothers with infants less than 6 months old (N = 36) and other adult female troop members. Our results provide strong evidence for the interchange of grooming for access to infants. Grooming for infant access was more likely to be initiated by potential handlers (nonmothers) and less likely reciprocated by mothers. Moreover, grooming bout duration was inversely related to the number of infants per female present in each one-male unit indicating the possibility of a supply and demand market effect. The rank difference between mothers and handlers was negatively correlated with grooming duration. With increasing infant age, the duration of grooming provided by handlers was shorter suggesting that the 'value' of older infants had decreased. Finally, frequent grooming partners were allowed to handle and maintain access to infants longer than infrequent groomers. These results support the contention that grooming and infant handling may be traded in R. roxellana and that the price individuals paid for access to infants fluctuated with supply and demand.	[Wei, Wei; Qi, XiaoGuang; Guo, SongTao; Zhang, Pei; Li, BaoGuo] Northwest Univ, Coll Life Sci, Key Lab Resource Biol & Biotechnol Western China, Xian, Peoples R China; [Li, BaoGuo] Shaanxi Acad Sci, Inst Zool, Xian, Peoples R China; [Garber, Paul A.] Univ Illinois, Dept Anthropol, Urbana, IL 61801 USA	Northwest University Xi'an; University of Illinois System; University of Illinois Urbana-Champaign	Li, BG (corresponding author), Northwest Univ, Coll Life Sci, Key Lab Resource Biol & Biotechnol Western China, Xian, Peoples R China.	baoguoli@nwu.edu.cn		Qi, Xiao-Guang/0000-0003-2602-4441	National Nature Science Foundation of China [31130061, 31270438, 31270441, 31201721]; Research Fund for the Doctoral Program of Higher Education of China [20106101110005]; Specialized Foundation of Department of Education of Shaanxi Province, China [12JK0825]; Academy of Sciences of Shaanxi Province [2012k-01]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Specialized Foundation of Department of Education of Shaanxi Province, China; Academy of Sciences of Shaanxi Province	This research was supported by the grants from the Key Program of National Nature Science Foundation of China (31130061); the National Nature Science Foundation of China (31270438, 31270441, 31201721); the Research Fund for the Doctoral Program of Higher Education of China (20106101110005); Specialized Foundation of Department of Education of Shaanxi Province, China (12JK0825); Key Program of Academy of Sciences of Shaanxi Province (2012k-01). The funding organizations had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Altmann J., 1980, BABOON MOTHERS INFAN; Aureli F, 1999, J COMP PSYCHOL, V113, P59, DOI 10.1037/0735-7036.113.1.59; Bales K, 2000, FOLIA PRIMATOL, V71, P27, DOI 10.1159/000021728; Barrett L, 2000, ANIM BEHAV, V59, P763, DOI 10.1006/anbe.1999.1361; Barrett L, 2002, ANIM BEHAV, V63, P1047, DOI 10.1006/anbe.2002.3008; Barrett L, 2006, COOPERATION IN PRIMATES AND HUMANS: MECHANISMS AND EVOLUTIONS, P209, DOI 10.1007/3-540-28277-7_12; Barrett Louise, 2001, P119, DOI 10.1017/CBO9780511752421.009; Chancellor RL, 2009, BEHAV ECOL, V20, P79, DOI 10.1093/beheco/arn117; CHEN F, 1983, Acta Theriologica Sinica, V3, P141; Cheney D.L., 1990, MONKEYS SEE WORLD IN, DOI [10.7208/chicago/9780226218526.001.0001, DOI 10.7208/CHICAGO/9780226218526.001.0001]; Clutton-Brock T, 1995, ANIM BEHAV; de Waal FBM, 1997, EVOL HUM BEHAV, V18, P375, DOI 10.1016/S1090-5138(97)00085-8; Dunbar R.I.M., 1988, PRIMATE SOCIAL SYSTE; Frank RE, 2009, BEHAVIOUR, V146, P889, DOI 10.1163/156853908X396656; Fruteau C, 2011, ANIM BEHAV, V81, P153, DOI 10.1016/j.anbehav.2010.09.028; Fruteau C, 2009, P NATL ACAD SCI USA, V106, P12007, DOI 10.1073/pnas.0812280106; Garber Paul A., 1997, Evolutionary Anthropology, V5, P187, DOI 10.1002/(SICI)1520-6505(1997)5:6<187::AID-EVAN1>3.0.CO;2-A; Goldizen A.W., 1987, P34; Gumert MD, 2007, ANIM BEHAV, V74, P1655, DOI 10.1016/j.anbehav.2007.03.009; Gumert MD, 2007, INT J PRIMATOL, V28, P1059, DOI 10.1007/s10764-007-9202-0; Guo SG, 2007, PRIMATES, V48, P268, DOI 10.1007/s10329-007-0048-z; Henzi SP, 2002, ANIM BEHAV, V63, P915, DOI 10.1006/anbe.2001.1986; Henzi SP, 1999, PRIMATES, V40, P47, DOI 10.1007/BF02557701; Hrdy SB., 1976, ADV STUD BEHAV, P101, DOI [DOI 10.1016/S0065-3454(08)60083-2, DOI 10.1002/AJP.22456]; Hu Songmei, 2006, Acta Theriologica Sinica, V26, P417; Kirkpatrick RC, 2011, PRIMATES PERSPECTIVE, P189; Kutsukake N, 2006, ANIM BEHAV, V72, P1059, DOI 10.1016/j.anbehav.2006.02.016; LANCASTER JB, 1971, FOLIA PRIMATOL, V15, P161, DOI 10.1159/000155377; Lazaro-Perea C, 2004, ANIM BEHAV, V67, P627, DOI 10.1016/j.anbehav.2003.06.004; Li BG, 2007, PRIMATES, V48, P190, DOI 10.1007/s10329-006-0029-7; Li BG, 2000, FOLIA PRIMATOL, V71, P375, DOI 10.1159/000052734; MAESTRIPIERI D, 1994, FOLIA PRIMATOL, V63, P192, DOI 10.1159/000156819; MAESTRIPIERI D, 1994, INT J PRIMATOL, V15, P531, DOI 10.1007/BF02735970; Manson JH, 2004, ANIM BEHAV, V67, P493, DOI 10.1016/j.anbehav.2003.05.009; Manson JH, 1999, ANIM BEHAV, V57, P911, DOI 10.1006/anbe.1998.1052; Manson JH, 1999, INT J PRIMATOL, V20, P679, DOI 10.1023/A:1020700718458; Nicolson NA, 1987, PRIMATE SOC; NOE R, 1994, BEHAV ECOL SOCIOBIOL, V35, P1; NOE R, 1995, TRENDS ECOL EVOL, V10, P336, DOI 10.1016/S0169-5347(00)89123-5; Noe R., 2001, EC NATURE SOCIAL DIL; Norscia I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004679; Payne HFP, 2003, BEHAVIOUR, V140, P453, DOI 10.1163/156853903322127931; Port M, 2009, ANIM BEHAV, V77, P29, DOI 10.1016/j.anbehav.2008.08.032; Qi XG, 2008, AM J PRIMATOL, V70, P311, DOI 10.1002/ajp.20480; Qi Xiao-Guang, 2004, Acta Zoologica Sinica, V50, P697; Qi XG, 2009, AM J PRIMATOL, V71, P670, DOI 10.1002/ajp.20702; Ren R, 2000, FIELD STUDY SOC RHIN; Schaffner CM, 2005, INT J PRIMATOL, V26, P1093, DOI 10.1007/s10764-005-6460-6; SCHINO G, 1988, AM J PRIMATOL, V16, P43, DOI 10.1002/ajp.1350160106; Schino G, 2008, BIOL LETTERS, V4, P9, DOI 10.1098/rsbl.2007.0506; Schino G, 2007, BEHAV ECOL, V18, P115, DOI 10.1093/beheco/arl045; SEYFARTH RM, 1976, ANIM BEHAV, V24, P917, DOI 10.1016/S0003-3472(76)80022-X; SEYFARTH RM, 1984, NATURE, V308, P541, DOI 10.1038/308541a0; Silk JB, 2003, SCIENCE, V302, P1231, DOI 10.1126/science.1088580; Slater KY, 2007, ANIM BEHAV, V74, P455, DOI 10.1016/j.anbehav.2006.11.026; Stopka P, 1999, ETHOLOGY, V105, P969, DOI 10.1046/j.1439-0310.1999.00485.x; Stopka P, 2001, BEHAV ECOL, V12, P584, DOI 10.1093/beheco/12.5.584; Stumpf Rebecca, 2011, PRIMATES PERSPECTIVE, V2nd, P608; Tiddi B, 2010, ANIM BEHAV, V79, P1115, DOI 10.1016/j.anbehav.2010.02.008; Watts DP, 2002, BEHAVIOUR, V139, P343, DOI 10.1163/156853902760102708; Wei W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036802; Xi WZ, 2008, INT J PRIMATOL, V29, P593, DOI 10.1007/s10764-008-9260-y; Zhang P, 2006, PRIMATES, V47, P374, DOI 10.1007/s10329-006-0178-8; Zhang SY, 2000, AM J PRIMATOL, V51, P265, DOI 10.1002/1098-2345(200008)51:4<265::AID-AJP6>3.3.CO;2-#; Zhao HT, 2011, STUDY CORRELATIONSHI; ZUMPE D, 1986, AM J PRIMATOL, V10, P291, DOI 10.1002/ajp.1350100402	67	10	12	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65962	10.1371/journal.pone.0065962	http://dx.doi.org/10.1371/journal.pone.0065962			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776580	Green Published, Green Submitted, gold			2022-12-27	WOS:000320322400065
J	Xiang, L; Su, JT; Zheng, GL; Liang, J; Zhang, GY; Wang, HZ; Xie, LP; Zhang, RQ				Xiang, Liang; Su, Jingtan; Zheng, Guilan; Liang, Jian; Zhang, Guiyou; Wang, Hongzhong; Xie, Liping; Zhang, Rongqing			Patterns of Expression in the Matrix Proteins Responsible for Nucleation and Growth of Aragonite Crystals in Flat Pearls of Pinctada fucata	PLOS ONE			English	Article							INNER-SHELL FILM; NACREOUS LAYER; CARBONIC-ANHYDRASE; HALIOTIS-RUFESCENS; OYSTER; BIOMINERALIZATION; FRAMEWORK; GENES; MACROMOLECULES; BIOFABRICATION	The initial growth of the nacreous layer is crucial for comprehending the formation of nacreous aragonite. A flat pearl method in the presence of the inner-shell film was conducted to evaluate the role of matrix proteins in the initial stages of nacre biomineralization in vivo. We examined the crystals deposited on a substrate and the expression patterns of the matrix proteins in the mantle facing the substrate. In this study, the aragonite crystals nucleated on the surface at 5 days in the inner-shell film system. In the film-free system, the calcite crystals nucleated at 5 days, a new organic film covered the calcite, and the aragonite nucleated at 10 days. This meant that the nacre lamellae appeared in the inner-shell film system 5 days earlier than that in the film-free system, timing that was consistent with the maximum level of matrix proteins during the first 20 days. In addition, matrix proteins (Nacrein, MSI60, N19, N16 and Pif80) had similar expression patterns in controlling the sequential morphologies of the nacre growth in the inner-film system, while these proteins in the film-free system also had similar patterns of expression. These results suggest that matrix proteins regulate aragonite nucleation and growth with the inner-shell film in vivo.	[Xiang, Liang; Su, Jingtan; Zheng, Guilan; Liang, Jian; Zhang, Guiyou; Wang, Hongzhong; Xie, Liping; Zhang, Rongqing] Tsinghua Univ, Sch Life Sci, Inst Marine Biotechnol, Beijing 100084, Peoples R China; [Xie, Liping; Zhang, Rongqing] Tsinghua Univ, Minist Educ, Prot Sci Lab, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University	Xie, LP (corresponding author), Tsinghua Univ, Sch Life Sci, Inst Marine Biotechnol, Beijing 100084, Peoples R China.	lpxie@mail.tsinghua.edu.cn; rqzhang@mail.tsinghua.edu.cn			National Basic Research Program of China [2010CB126405]; National High Technology Research and Development Program of China [2010AA09Z405]; National Natural Science Foundation of China [31172382, U0831001]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20090002110055]; Independent Research Projects of Tsinghua University [20111080964]	National Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Independent Research Projects of Tsinghua University	This work was supported by the National Basic Research Program of China Grant 2010CB126405, http://www.973.gov.cn/English/Index.aspx, the National High Technology Research and Development Program of China 2010AA09Z405, http://www.most.gov.cn/eng/index.htm, the National Natural Science Foundation of China Grants 31172382 and U0831001 (Joint Fund with Guangdong) http://www.nsfc.gov.cn/Portal0/default124.htm, the Specialized Research Fund for the Doctoral Program of Higher Education of China Grant 20090002110055, and Independent Research Projects of Tsinghua University Grant 20111080964. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addadi L, 2006, CHEM-EUR J, V12, P981, DOI 10.1002/chem.200500980; Addadi L, 1997, NATURE, V389, P912, DOI 10.1038/40010; Belcher AM, 1996, NATURE, V381, P56, DOI 10.1038/381056a0; Bezares J, 2008, J STRUCT BIOL, V163, P61, DOI 10.1016/j.jsb.2008.04.009; Bezares J, 2010, J STRUCT BIOL, V170, P484, DOI 10.1016/j.jsb.2010.01.006; Chec AG, 2009, P NATL ACAD SCI USA, V106, P38, DOI 10.1073/pnas.0808796106; Dauphin Y, 2008, ANAL BIOANAL CHEM, V390, P1659, DOI 10.1007/s00216-008-1860-z; Falini G, 1996, SCIENCE, V271, P67, DOI 10.1126/science.271.5245.67; Fang D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035715; Fang D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021860; FRITZ M, 1994, NATURE, V371, P49, DOI 10.1038/371049a0; Gaume B, 2011, MAR BIOL, V158, P341, DOI 10.1007/s00227-010-1562-x; Gotliv BA, 2003, CHEMBIOCHEM, V4, P522, DOI 10.1002/cbic.200200548; Gries K, 2011, CRYST GROWTH DES, V11, P729, DOI 10.1021/cg101240e; Heinemann F, 2006, BIOCHEM BIOPH RES CO, V344, P45, DOI 10.1016/j.bbrc.2006.03.150; Inoue N, 2011, MAR BIOTECHNOL, V13, P48, DOI 10.1007/s10126-010-9267-1; Kinoshita S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021238; Lin AYM, 2008, ACTA BIOMATER, V4, P131, DOI 10.1016/j.actbio.2007.05.005; Liu XJ, 2012, P ROY SOC B-BIOL SCI, V279, P1000, DOI 10.1098/rspb.2011.1661; LOPEZ E, 1992, TISSUE CELL, V24, P667, DOI 10.1016/0040-8166(92)90037-8; Ma ZJ, 2007, J BIOL CHEM, V282, P23253, DOI 10.1074/jbc.M700001200; Marin F, 2008, CURR TOP DEV BIOL, V80, P209, DOI 10.1016/S0070-2153(07)80006-8; Masaoka T, 2013, AQUACULTURE, V384, P56, DOI 10.1016/j.aquaculture.2012.12.019; Mayer G, 2005, SCIENCE, V310, P1144, DOI 10.1126/science.1116994; Miyamoto H, 2005, ZOOL SCI, V22, P311, DOI 10.2108/zsj.22.311; Miyamoto H, 1996, P NATL ACAD SCI USA, V93, P9657, DOI 10.1073/pnas.93.18.9657; Miyazaki Y, 2010, COMP BIOCHEM PHYS B, V155, P241, DOI 10.1016/j.cbpb.2009.11.009; Mount AS, 2004, SCIENCE, V304, P297, DOI 10.1126/science.1090506; Samata T, 1999, FEBS LETT, V462, P225, DOI 10.1016/S0014-5793(99)01387-3; Sanchez C, 2005, NAT MATER, V4, P277, DOI 10.1038/nmat1339; SARIKAYA M, 1994, MICROSC RES TECHNIQ, V27, P360, DOI 10.1002/jemt.1070270503; Saruwatari K, 2009, BIOMATERIALS, V30, P3028, DOI 10.1016/j.biomaterials.2009.03.011; Schaffer TE, 1997, CHEM MATER, V9, P1731, DOI 10.1021/cm960429i; Shen XY, 1997, J BIOL CHEM, V272, P32472, DOI 10.1074/jbc.272.51.32472; Sudo S, 1997, NATURE, V387, P563, DOI 10.1038/42391; Suzuki M, 2009, SCIENCE, V325, P1388, DOI 10.1126/science.1173793; Takeuchi T, 2006, MAR BIOTECHNOL, V8, P52, DOI 10.1007/s10126-005-5037-x; Wang N, 2012, MAR BIOTECHNOL, V14, P177, DOI 10.1007/s10126-011-9400-9; Wang N, 2009, COMP BIOCHEM PHYS B, V154, P346, DOI 10.1016/j.cbpb.2009.07.012; WEINER S, 1984, PHILOS T ROY SOC B, V304, P425, DOI 10.1098/rstb.1984.0036; Wilt FH, 2005, DEV BIOL, V280, P15, DOI 10.1016/j.ydbio.2005.01.019; Wilt FH, 2003, DIFFERENTIATION, V71, P237, DOI 10.1046/j.1432-0436.2003.7104501.x; Yan ZG, 2008, CHEMBIOCHEM, V9, P1093, DOI 10.1002/cbic.200700553; Yan ZG, 2011, ACTA OCEANOL SIN, V30, P87, DOI 10.1007/s13131-011-0094-7; Yano M, 2007, BIOCHEM BIOPH RES CO, V362, P158, DOI 10.1016/j.bbrc.2007.07.172; Zaremba CM, 1996, CHEM MATER, V8, P679, DOI 10.1021/cm9503285; Zhang C, 2006, MAR BIOTECHNOL, V8, P572, DOI 10.1007/s10126-005-6029-6; Zhang Y, 2003, COMP BIOCHEM PHYS B, V135, P565, DOI 10.1016/S1096-4959(03)00138-6	48	28	28	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66564	10.1371/journal.pone.0066564	http://dx.doi.org/10.1371/journal.pone.0066564			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776687	gold, Green Published, Green Submitted			2022-12-27	WOS:000320322400112
J	Ek-Ramos, MJ; Zhou, WQ; Valencia, CU; Antwi, JB; Kalns, LL; Morgan, GD; Kerns, DL; Sword, GA				Ek-Ramos, Maria J.; Zhou, Wenqing; Valencia, Cesar U.; Antwi, Josephine B.; Kalns, Lauren L.; Morgan, Gaylon D.; Kerns, David L.; Sword, Gregory A.			Spatial and Temporal Variation in Fungal Endophyte Communities Isolated from Cultivated Cotton (Gossypium hirsutum)	PLOS ONE			English	Article							BEAUVERIA-BASSIANA; PLANT; DIVERSITY; LEAVES; GROWTH; PATHOGENS; PROGRESS; ECOLOGY; TISSUES; DISEASE	Studies of fungi in upland cotton (Gossypium hirsutum) cultivated in the United States have largely focused on monitoring and controlling plant pathogens. Given increasing interest in asymptomatic fungal endophytes as potential biological control agents, surveys are needed to better characterize their diversity, distribution patterns and possible applications in integrated pest management. We sampled multiple varieties of cotton in Texas, USA and tested for temporal and spatial variation in fungal endophyte diversity and community composition, as well as for differences associated with organic and conventional farming practices. Fungal isolates were identified by morphological and DNA identification methods. We found members of the genera Alternaria, Colletotrichum and Phomopsis, previously isolated as endophytes from other plant species. Other recovered species such as Drechslerella dactyloides (formerly Arthrobotrys dactyloides) and Exserohilum rostratum have not, to our knowledge, been previously reported as endophytes in cotton. We also isolated many latent pathogens, but some species such as Alternaria tennuissima, Epicoccum nigrum, Acremonium alternatum, Cladosporium cladosporioides, Chaetomium globosum and Paecilomyces sp., are known to be antagonists against plant pathogens, insects and nematode pests. We found no differences in endophyte species richness or diversity among different cotton varieties, but did detect differences over time and in different plant tissues. No consistent patterns of community similarity associated with variety, region, farming practice, time of the season or tissue type were observed regardless of the ecological community similarity measurements used. Results indicated that local fungal endophyte communities may be affected by both time of the year and plant tissue, but the specific community composition varies across sites. In addition to providing insights into fungal endophyte community structure, our survey provides candidates for further evaluation as potential management tools against a variety of pests and diseases when present as endophytes in cotton and other plants.	[Ek-Ramos, Maria J.; Zhou, Wenqing; Valencia, Cesar U.; Antwi, Josephine B.; Kalns, Lauren L.; Kerns, David L.; Sword, Gregory A.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA; [Morgan, Gaylon D.] Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX 77843 USA; [Morgan, Gaylon D.] Texas A&M Univ, Texas AgriLife Extens, College Stn, TX 77843 USA; [Kerns, David L.] Texas A&M Univ, AgriLife Extens Serv, Lubbock, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System	Ek-Ramos, MJ (corresponding author), Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA.	ekramos@neo.tamu.edu	Zhou, Wenqing/GPS-7266-2022; Ramos, Maria Julissa Ek/W-1017-2018	Ramos, Maria Julissa Ek/0000-0002-1556-0823; Kalns, Lauren/0000-0002-5924-7118	Texas A&M University Department of Entomology	Texas A&M University Department of Entomology	This work was supported by Texas A&M University Department of Entomology start-up funds (to GAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarenkov K, 2010, EVOL BIOINFORM, V6, P189, DOI 10.4137/EBO.S6271; Abarenkov K, 2010, NEW PHYTOL, V186, P281, DOI 10.1111/j.1469-8137.2009.03160.x; Alva P, 2002, FUNG DIVERS RES SER, V7, P167; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Arnold AE, 2007, ECOLOGY, V88, P541, DOI 10.1890/05-1459; Arnold A. Elizabeth, 2007, Fungal Biology Reviews, V21, P51, DOI 10.1016/j.fbr.2007.05.003; Arnold AE, 2003, P NATL ACAD SCI USA, V100, P15649, DOI 10.1073/pnas.2533483100; Arnold AE, 2000, ECOL LETT, V3, P267, DOI 10.1046/j.1461-0248.2000.00159.x; Azevedo J.L., 2000, ELECTRON J BIOTECHN, V3, P40, DOI [DOI 10.2225/V0L3-ISSUE, 10.2225/vol3-issue1-fulltext-4.228, DOI 10.2225/VOL3-ISSUE1-FULLTEXT-4.228]; Azevedo JL, 2007, FUNGI MULTIFACETED M, P189; Bae H, 2009, J EXP BOT, V60, P3279, DOI 10.1093/jxb/erp165; Baird R., 1998, Journal of Cotton Science, V2, P27; Barnes HA, 1998, INST MATH A, P1; BASHAN Y, 1994, CAN J BOT, V72, P1580, DOI 10.1139/b94-195; Bayman P., 2006, Microbial ecology of aerial plant surfaces, P37, DOI 10.1079/9781845930615.0037; Bellemain E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-189; Bing L.A., 1992, Biocontrol Science and Technology, V2, P39, DOI 10.1080/09583159209355216; Boyle C, 2001, SYMBIOSIS, V31, P259; CARROLL G, 1995, CAN J BOT, V73, pS1316, DOI 10.1139/b95-393; CAYROL J-C, 1983, Revue de Nematologie, V6, P265; Cheplick G. P., 2009, ECOLOGY EVOLUTION GR, P1; Colwell RK, 2012, J PLANT ECOL, V5, P3, DOI 10.1093/jpe/rtr044; COTTY PJ, 1987, PLANT DIS, V71, P1082, DOI 10.1094/PD-71-1082; Crawford RF, 1923, PHYTOPATHOLOGY, V13, P501; Dugan FM, 2008, IDENTIFICATION FUNGI, P1; Faeth SH, 2002, OIKOS, V98, P25, DOI 10.1034/j.1600-0706.2002.980103.x; Farr D. F., 1989, Fungi on plants and plant products in the United States.; FREEMAN MF, 1950, ANN MATH STAT, V21, P607, DOI 10.1214/aoms/1177729756; Frohlich J, 2000, MYCOL RES, V104, P1202, DOI 10.1017/S095375620000263X; Gamboa Miguel A., 2002, Mycopathologia, V156, P41, DOI 10.1023/A:1021362217723; Gonthier P, 2006, FUNGAL DIVERS, V21, P69; Guo LD, 2001, MOL PHYLOGENET EVOL, V20, P1, DOI 10.1006/mpev.2001.0942; Gurulingappa P, 2010, BIOL CONTROL, V55, P34, DOI 10.1016/j.biocontrol.2010.06.011; Hyde KD, 2008, FUNGAL DIVERS, V33, P163; Jeyarani S., 2011, Journal of Entomology, V8, P274, DOI 10.3923/je.2011.274.279; Johnson J. Michal, 2009, ENDOCYTOBIOSIS CELL, V19, P81; Kasselaki AM, 2006, EUR J PLANT PATHOL, V115, P263, DOI 10.1007/s10658-006-9010-y; KLICH MA, 1986, MYCOLOGIA, V78, P706, DOI 10.2307/3807514; Li WC, 2007, FUNGAL DIVERS, V25, P69; Lingfei L, 2005, MYCORRHIZA, V17, P103; Liu CH, 2001, J BIOTECHNOL, V88, P277, DOI 10.1016/S0168-1656(01)00285-1; Lodge DJ, 1996, MYCOLOGIA, V88, P733, DOI 10.2307/3760967; Mao BZ, 2010, AFR J BIOTECHNOL, V9, P5955; McGee PA, 2002, AUST J EXP AGR, V42, P995, DOI 10.1071/EA01124; McKenna JE, 2003, ENVIRON MODELL SOFTW, V18, P205, DOI 10.1016/S1364-8152(02)00094-4; Nilsson RH, 2008, EVOL BIOINFORM, V4, P193; Oses R, 2008, FUNGAL DIVERS, V33, P77; Ownley BH, 2008, J INVERTEBR PATHOL, V98, P267, DOI 10.1016/j.jip.2008.01.010; Ownley BH, 2010, BIOCONTROL, V55, P113, DOI 10.1007/s10526-009-9241-x; Palmateer AJ, 2004, MYCOPATHOLOGIA, V157, P303, DOI 10.1023/B:MYCO.0000024184.56337.f5; PETRINI O, 1982, CAN J BOT, V60, P789, DOI 10.1139/b82-102; Pineda A, 2010, TRENDS PLANT SCI, V15, P507, DOI 10.1016/j.tplants.2010.05.007; Pinto LSRC, 2000, NEW PHYTOL, V147, P609, DOI 10.1046/j.1469-8137.2000.00722.x; Porras-Alfaro A, 2008, PLANT SOIL, V296, P65; Porras-Alfaro A, 2011, ANNU REV PHYTOPATHOL, V49, P291, DOI 10.1146/annurev-phyto-080508-081831; Quinn GP, 2002, EXPT DESIGN DATA ANA, P473, DOI DOI 10.1017/CBO9780511806384.019; Ragazzi A, 1997, Z PFLANZENK PFLANZEN, V104, P133; Raps A, 1998, OECOLOGIA, V114, P541, DOI 10.1007/s004420050478; Redman RS, 2002, SCIENCE, V298, P1581, DOI 10.1126/science.1072191; RODRIGUES KF, 1994, MYCOLOGIA, V86, P376, DOI 10.2307/3760568; Rodriguez RJ, 2009, NEW PHYTOL, V182, P314, DOI 10.1111/j.1469-8137.2009.02773.x; ROY KW, 1982, PHYTOPATHOLOGY, V72, P868, DOI 10.1094/Phyto-72-868; Saikkonen K, 1998, ANNU REV ECOL SYST, V29, P319, DOI 10.1146/annurev.ecolsys.29.1.319; Sambrook J., 1989, MOL CLONING LAB MANU, V1; Santamaria J, 2005, MICROB ECOL, V50, P1, DOI 10.1007/s00248-004-0002-1; SAYRE RM, 1986, CROP PROT, V5, P268, DOI 10.1016/0261-2194(86)90062-1; Schardl C.L., 1997, PLANT RELATIONSHIPS, V5B, DOI DOI 10.1007/978-3-642-60647-2_14; Schardl CL, 1997, PLANT DIS, V81, P430, DOI 10.1094/PDIS.1997.81.5.430; Schulz B, 1998, SYMBIOSIS, V25, P213; Schulz B, 2002, MYCOL RES, V106, P996, DOI 10.1017/S0953756202006342; Seifert KA, 2009, MOL ECOL RESOUR, V9, P83, DOI 10.1111/j.1755-0998.2009.02635.x; Selosse MA, 2004, CR BIOL, V327, P639, DOI 10.1016/j.crvi.2003.12.008; Sikora RA, 2008, BIOL CONTROL, V46, P15, DOI 10.1016/j.biocontrol.2008.02.011; Stone JK, 2000, BOOK SOIL P, P3; Taylor JE, 1999, NEW PHYTOL, V142, P335, DOI 10.1046/j.1469-8137.1999.00391.x; Vega FE, 2008, J INVERTEBR PATHOL, V98, P277, DOI 10.1016/j.jip.2008.01.008; Vieira P. D. de S., 2011, Mycology - An International Journal on Fungal Biology, V2, P91, DOI 10.1080/21501203.2011.584390; Vralstad T, 2011, MOL ECOL, V20, P2873, DOI 10.1111/j.1365-294X.2011.05149.x; Wang B, 2007, MYCOL RES, V111, P347, DOI 10.1016/j.mycres.2006.11.004; Wilson D, 2000, BOOK SOIL P, P389; Yan XN, 2011, J ZHEJIANG UNIV-SC B, V12, P219, DOI 10.1631/jzus.B1000165; Zimmerman NB, 2012, P NATL ACAD SCI USA, V109, P13022, DOI 10.1073/pnas.1209872109	82	55	71	2	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66049	10.1371/journal.pone.0066049	http://dx.doi.org/10.1371/journal.pone.0066049			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776604	gold, Green Published, Green Submitted			2022-12-27	WOS:000320755400105
J	Gao, JL; Gu, XF; Mahuran, DJ; Wang, ZG; Zhang, HW				Gao, Jialin; Gu, Xuefan; Mahuran, Don J.; Wang, Zhugang; Zhang, Huiwen			Impaired Glucose Tolerance in a Mouse Model of Sidt2 Deficiency	PLOS ONE			English	Article							KISS-AND-RUN; EXOCYTOSIS; RELEASE; HOMEOSTASIS; LANGERHANS; VESICLES; SYSTEM; ISLETS; ENZYME	Sidt2 was identified as a novel integral lysosomal membrane protein recently. We generated global Sidt2 knockout mice by gene targeting. These mice have a comparatively higher random and fasting glucose concentration. Intraperitoneal and oral glucose tolerance tests in Sidt2 knockout mice indicated glucose intolerance and decreased serum insulin level. Notably, the Sidt2(-/-) mice had hypertrophic islets compared with control mice. By Western blot and immunofluorescence, Sidt2(-/-) mouse islets were shown to have increased insulin protein, which actually contained more insulin secretory granules than their controls, demonstrated by electromicroscopy. Consistent with the in vivo study, isolated islet culture from the Sidt2(-/-) mice produced less insulin when stimulated by a high concentration of glucose or a depolarizing concentration of KCl. Under electromicroscope less empty vesicles and more mature ones in Sidt2(-/-) mice islets were observed, supporting impaired insulin secretory granule release. In conclusion, Sidt2 may play a critical role in the regulation of mouse insulin secretory granule secretion.	[Gao, Jialin; Gu, Xuefan; Zhang, Huiwen] Shanghai Jiao Tong Univ, Sch Med, Dept Pediat Endocrinol & Genet Metab, Xinhua Hosp,Shanghai Inst Pediat Res, Shanghai 200030, Peoples R China; [Mahuran, Don J.] Univ Toronto, Hosp Sick Children, Res Inst, Dept Lab Med & Pathobiol, Toronto, ON M5G 1X8, Canada; [Wang, Zhugang] Shanghai Res Ctr Model Organisms, Shanghai, Peoples R China	Shanghai Jiao Tong University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Gu, XF (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Pediat Endocrinol & Genet Metab, Xinhua Hosp,Shanghai Inst Pediat Res, Shanghai 200030, Peoples R China.	gu_xf53@yahoo.com.cn; huiwenzhang@yahoo.com	GAO, JIALIN/GWN-1905-2022		National Science and Technology Program [81071121, 81270936]; Shanghai Rising-Star Program [12QH1401800]; Major Program of Shanghai Committee of Science and Technology [11dz195030]; National Key Technology RD Program [2012BAI09B04]	National Science and Technology Program; Shanghai Rising-Star Program; Major Program of Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee); National Key Technology RD Program(National Key Technology R&D Program)	This work was supported by grants from the National Science and Technology Program (81071121, 81270936), Shanghai Rising-Star Program (12QH1401800), the Major Program of Shanghai Committee of Science and Technology (11dz195030), and The National Key Technology R&D Program (2012BAI09B04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrejewski N, 1999, J BIOL CHEM, V274, P12692, DOI 10.1074/jbc.274.18.12692; Boadu E, 2012, BBA-MOL CELL BIOL L, V1821, P396, DOI 10.1016/j.bbalip.2011.11.013; BONNERWEIR S, 1982, DIABETES, V31, P883, DOI 10.2337/diabetes.31.10.883; Brunner Y, 2007, MOL CELL PROTEOMICS, V6, P1007, DOI 10.1074/mcp.M600443-MCP200; Ceridono M, 2011, TRAFFIC, V12, P72, DOI 10.1111/j.1600-0854.2010.01125.x; Chakrabarti S, 2003, J CELL BIOL, V162, P543, DOI 10.1083/jcb.200305131; Cullen Peter J, 2012, Subcell Biochem, V59, P65, DOI 10.1007/978-94-007-3015-1_3; Dixit SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058655; Dong XP, 2008, NATURE, V455, P992, DOI 10.1038/nature07311; Elhassan MO, 2012, J BIOL CHEM, V287, P5267, DOI 10.1074/jbc.M111.318865; Gao JL, 2010, BIOCHEM BIOPH RES CO, V402, P588, DOI 10.1016/j.bbrc.2010.09.133; Gustavsson N, 2008, P NATL ACAD SCI USA, V105, P3992, DOI 10.1073/pnas.0711700105; Hanna ST, 2009, PFLUG ARCH EUR J PHY, V457, P1343, DOI 10.1007/s00424-008-0588-0; Kos CH, 2004, NUTR REV, V62, P243, DOI 10.1301/nr2004.jun243-246; LACY PE, 1967, DIABETES, V16, P35, DOI 10.2337/diab.16.1.35; LaPlante JM, 2006, MOL GENET METAB, V89, P339, DOI 10.1016/j.ymgme.2006.05.016; Lloyd-Evans E, 2011, CELL CALCIUM, V50, P200, DOI 10.1016/j.ceca.2011.03.010; LUNDQUIST I, 1983, HORM METAB RES, V15, P11, DOI 10.1055/s-2007-1018615; Lundquist I, 1996, ENDOCRINOLOGY, V137, P1219, DOI 10.1210/en.137.4.1219; MacDonald PE, 2005, DIABETES, V54, P736, DOI 10.2337/diabetes.54.3.736; Meijer AJ, 2008, CELL METAB, V8, P275, DOI 10.1016/j.cmet.2008.09.001; Nishino I, 2000, NATURE, V406, P906, DOI 10.1038/35022604; O'Prey J, 2009, CELL CYCLE, V8, P2260, DOI 10.4161/cc.8.14.9050; Obermuller S, 2005, J CELL SCI, V118, P4271, DOI 10.1242/jcs.02549; Obermuller S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008936; POON PYW, 1979, CLIN ENDOCRINOL, V11, P625, DOI 10.1111/j.1365-2265.1979.tb03117.x; Ramonet D, 2012, HUM MOL GENET, V21, P1725, DOI 10.1093/hmg/ddr606; Ren RW, 2011, DEV COMP IMMUNOL, V35, P692, DOI 10.1016/j.dci.2011.02.003; Rosa-Ferreira C, 2011, DEV CELL, V21, P1171, DOI 10.1016/j.devcel.2011.10.007; Rutter GA, 2006, CELL CALCIUM, V40, P539, DOI 10.1016/j.ceca.2006.08.015; Rutter GA, 2006, PHYSIOLOGY, V21, P189, DOI 10.1152/physiol.00002.2006; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; Salehi A, 1999, ENDOCRINOLOGY, V140, P3045, DOI 10.1210/en.140.7.3045; Schroder B, 2007, TRAFFIC, V8, P1676, DOI 10.1111/j.1600-0854.2007.00643.x; Schwake M, 2013, TRAFFIC; WATERS PJ, 1992, DIABETOLOGIA, V35, P991, DOI 10.1007/BF00401431; Zhang HW, 2007, J PROTEOME RES, V6, P240, DOI 10.1021/pr060407o; Zheng BH, 2000, MOL CELL BIOL, V20, P648, DOI 10.1128/MCB.20.2.648-655.2000	38	21	22	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66139	10.1371/journal.pone.0066139	http://dx.doi.org/10.1371/journal.pone.0066139			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776622	Green Published, Green Submitted, gold			2022-12-27	WOS:000320755400114
J	Huttermann, S; Memmert, D; Simons, DJ; Bock, O				Huettermann, Stefanie; Memmert, Daniel; Simons, Daniel J.; Bock, Otmar			Fixation Strategy Influences the Ability to Focus Attention on Two Spatially Separate Objects	PLOS ONE			English	Article							VISUAL-SEARCH STRATEGIES; SOCCER; FIELD; EXPERTISE; PLAYERS; SPAN	The ability to devote attention simultaneously to multiple visual objects plays an important role in domains ranging from everyday activities to the workplace. Yet, no studies have systematically explored the fixation strategies that optimize attention to two spatially distinct objects. Assuming the two objects require attention nearly simultaneously, subjects either could fixate one object or they could fixate between the objects. Studies measuring the breadth of attention have focused almost exclusively on the former strategy, by having subjects simultaneously perform one attention-demanding task at fixation and another in the periphery. We compared performance when one object was at fixation and the other was in the periphery to a condition in which both objects were in the periphery and subjects fixated between them. Performance was better with two peripheral stimuli than with one central and one peripheral stimulus, meaning that a strategy of fixating between stimuli permitted greater attention breadth. Consistent with the idea that both measures tap attention breadth, sport experts consistently outperformed novices with both fixation strategies. Our findings suggest a way to improve performance when observers must pay attention to multiple objects across spatial regions. We discuss possible explanations for this performance advantage.	[Huettermann, Stefanie; Memmert, Daniel] German Sport Univ Cologne, Racket Sport Res, Inst Cognit & Team, Cologne, Germany; [Simons, Daniel J.] Univ Illinois, Dept Psychol, Champaign, IL 61820 USA; [Bock, Otmar] German Sport Univ Cologne, Inst Physiol & Anat, Cologne, Germany	German Sport University Cologne; University of Illinois System; University of Illinois Urbana-Champaign; German Sport University Cologne	Huttermann, S (corresponding author), German Sport Univ Cologne, Racket Sport Res, Inst Cognit & Team, Cologne, Germany.	s.huettermann@dshs-koeln.de	Klatt, Stefanie/AAP-8354-2020; Simons, Daniel J./P-3625-2019	Klatt, Stefanie/0000-0002-2477-8699; 				Adolphe R., 1997, INT J SPORTS VISION, V4, P28; Anzeneder CP, 1998, EUR J COGN PSYCHOL, V10, P247; BALL K, 1990, CLIN VISION SCI, V5, P113; Ball K., 1992, J AM OPTOM ASSOC, V63, P71; Bichot NP, 1999, PERCEPT PSYCHOPHYS, V61, P403, DOI 10.3758/BF03211962; Blundell NL., 1985, AUSTR J SCI MED SPOR, V17, P3; Campbell B, 1966, TRAFFIC SAFETY RES R, V10, P36; Canal-Bruland R, 2011, J COGN PSYCHOL, V23, P302, DOI 10.1080/20445911.2011.496723; CASTIELLO U, 1992, J EXP PSYCHOL HUMAN, V18, P837, DOI 10.1037/0096-1523.18.3.837; Cavanagh P, 2005, TRENDS COGN SCI, V9, P349, DOI 10.1016/j.tics.2005.05.009; Cavanagh P., 2004, COGNITIVE NEUROSCIEN, P13; Chen HC, 1996, J GERONTOL A-BIOL, V51, pM116, DOI 10.1093/gerona/51A.3.M116; Ericsson KA, 1996, ROAD TO EXCELLENCE, P1; ERIKSEN CW, 1986, PERCEPT PSYCHOPHYS, V40, P225, DOI 10.3758/BF03211502; Feng J, 2007, LECT NOTES ARTIF INT, V4562, P279; Fortenbaugh FC, 2011, ATTEN PERCEPT PSYCHO, V73, P809, DOI 10.3758/s13414-010-0075-5; Harle SK, 2001, SPORT PSYCHOL, V15, P289, DOI 10.1123/tsp.15.3.289; Helsen W, 1993, COGNITIVE ISSUES MOT, V102, P109, DOI DOI 10.1016/S0166-4115(08)61468-5; Hughes PK, 1993, CLIN EXP OPTOM, V76, P51, DOI DOI 10.1111/J.1444-0938.1993.TB05090.X; Intriligator J, 2001, COGNITIVE PSYCHOL, V43, P171, DOI 10.1006/cogp.2001.0755; Iordanescu L, 2009, J VISION, V9, DOI 10.1167/9.4.1; Jans B, 2010, PSYCHOL REV, V117, P637, DOI 10.1037/a0019082; Kline D, 1986, INV C WORK AG VIS CO; Knudson D., 1997, J PHYS ED RECREATION, V68, P17, DOI [DOI 10.1080/07303084.1997.10604922, 10.1080/07303084.1997.10604922]; Kuhn W., 1988, SCI FOOTBALL, P489; Mack A., 1998, INATTENTIONAL BLINDN; Mackworth N. H., 1976, EYE MOVEMENTS PSYCHO, P307; Maruenda FB, 2004, BMJ-BRIT MED J, V329, P1470, DOI 10.1136/bmj.329.7480.1470; McAuliffe J, 2004, J GEN PSYCHOL, V131, P426, DOI 10.3200/GENP.131.4.426-437; Memmert D, 2009, PSYCHOL SPORT EXERC, V10, P146, DOI 10.1016/j.psychsport.2008.06.002; Moore RL, 1982, 718 OECD TRANSP ROAD; Myers RS, 2000, PERCEPT MOTOR SKILL, V91, P279, DOI 10.2466/PMS.91.5.279-290; Nagano T, 2004, PERCEPT MOTOR SKILL, V99, P968, DOI 10.2466/pms.99.3.968-974; NOUGIER V, 1992, J EXP CHILD PSYCHOL, V54, P315, DOI 10.1016/0022-0965(92)90023-Y; Owsley C, 1998, Ophthalmic Epidemiol, V5, P101, DOI 10.1076/opep.5.2.101.1574; Planek TW, 1973, N CAR S HIGHW SAF, V7; Reingold EM, 2001, PSYCHOL SCI, V12, P48, DOI 10.1111/1467-9280.00309; SANDERS A F, 1970, Ergonomics, V13, P101, DOI 10.1080/00140137008931124; Scharlau I, 2004, PERCEPT PSYCHOPHYS, V66, P988, DOI 10.3758/BF03194990; Schneider W., 1984, VARIETIES ATTENTION, P1; SEKULER R, 1986, J OPT SOC AM A, V3, P864, DOI 10.1364/JOSAA.3.000864; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; Stalvey BT, 1999, J APPL GERONTOL, V18, P460, DOI 10.1177/073346489901800404; Turatto M, 1999, INT J SPORT PSYCHOL, V30, P339; Vine SJ, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00008; Vine SJ, 2011, ACTA PSYCHOL, V136, P340, DOI 10.1016/j.actpsy.2010.12.008; West KL, 1996, INT J SPORTS VISION, V3, P41; WILLIAMS AM, 1994, RES Q EXERCISE SPORT, V65, P127, DOI 10.1080/02701367.1994.10607607; Williams AM, 1998, RES Q EXERCISE SPORT, V69, P111, DOI 10.1080/02701367.1998.10607677	49	46	46	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65673	10.1371/journal.pone.0065673	http://dx.doi.org/10.1371/journal.pone.0065673			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	169CU	23776524	Green Submitted, Green Published, gold			2022-12-27	WOS:000320755400055
J	Huang, H; Cao, Y; Wei, W; Liu, W; Lu, SY; Chen, YB; Wang, Y; Yan, H; Wu, YL				Huang, He; Cao, Yang; Wei, Wei; Liu, Wei; Lu, Shao-Yong; Chen, Yu-Bao; Wang, Yan; Yan, Hua; Wu, Ying-Li			Targeting Poly (ADP-Ribose) Polymerase Partially Contributes to Bufalin-Induced Cell Death in Multiple Myeloma Cells	PLOS ONE			English	Article							HUMAN HEPATOCELLULAR-CARCINOMA; HUMAN LEUKEMIA-CELLS; POLY(ADP-RIBOSE) POLYMERASE; CANCER-CELLS; TOPOISOMERASE-II; OVARIAN-CANCER; LUNG-CANCER; APOPTOSIS; INHIBITORS; INDUCTION	Despite recent pharmaceutical advancements in therapeutic drugs, multiple myeloma (MM) remains an incurable disease. Recently, ploy(ADP-ribose) polymerase 1 (PARP1) has been shown as a potentially promising target for MM therapy. A previous report suggested bufalin, a component of traditional Chinese medicine ("Chan Su''), might target PARP1. However, this hypothesis has not been verified. We here showed that bufalin could inhibit PARP1 activity in vitro and reduce DNA-damage-induced poly(ADP-ribosyl)ation in MM cells. Molecular docking analysis revealed that the active site of bufalin interaction is within the catalytic domain of PAPR1. Thus, PARP1 is a putative target of bufalin. Furthermore, we showed, for the first time that the proliferation of MM cell lines (NCI-H929, U266, RPMI8226 and MM. 1S) and primary CD138(+) MM cells could be inhibited by bufalin, mainly via apoptosis and G(2)-M phase cell cycle arrest. MM cell apoptosis was confirmed by apoptotic cell morphology, Annexin-V positive cells, and the caspase3 activation. We further evaluated the role of PARP1 in bufalin-induced apoptosis, discovering that PARP1 overexpression partially suppressed bufalin-induced cell death. Moreover, bufalin can act as chemosensitizer to enhance the cell growth-inhibitory effects of topotecan, camptothecin, etoposide and vorinostat in MM cells. Collectively, our data suggest that bufalin is a novel PARP1 inhibitor and a potentially promising therapeutic agent against MM alone or in combination with other drugs.	[Huang, He; Cao, Yang; Wei, Wei; Chen, Yu-Bao; Wang, Yan; Yan, Hua] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Hematol, Shanghai 200030, Peoples R China; [Liu, Wei; Lu, Shao-Yong; Wu, Ying-Li] Shanghai Jiao Tong Univ, Shanghai Univ E Inst, Sch Med,Key Lab Cell Differentiat & Apoptos, Chem Biol,Chinese Minist Educ,Dept Pathoph, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Yan, H (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Hematol, Shanghai 200030, Peoples R China.	yanhua_candy@yahoo.com.cn; wuyingli@shsmu.edu.cn	Wei, Weijun/AAZ-3551-2021		National Basic Research Program of China (973 Program) [2010CB912104]; National Natural Science Foundation of China [91013008, 81070433, 81170509, 81272886]; Science and Technology Committee of Shanghai [11JC1406500]; SMC Program of Shanghai Jiao Tong University	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Committee of Shanghai(Shanghai Science & Technology Committee); SMC Program of Shanghai Jiao Tong University	This work was supported partly by grants from National Basic Research Program of China (973 Program) (No. 2010CB912104), National Natural Science Foundation of China (91013008, 81070433, 81170509, 81272886), Science and Technology Committee of Shanghai (11JC1406500), SMC Program of Shanghai Jiao Tong University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghajan M, 2010, NAT BIOTECHNOL, V28, P738, DOI 10.1038/nbt.1645; Arnaud-Batista FJ, 2012, AM J PHYSIOL-RENAL, V302, pF959, DOI 10.1152/ajprenal.00130.2011; Banasik M, 2004, ACTA NEUROBIOL EXP, V64, P467; Beevers CS, 2009, CANCER RES, V69, P1000, DOI 10.1158/0008-5472.CAN-08-2367; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; CARSON DA, 1986, EXP CELL RES, V164, P273, DOI 10.1016/0014-4827(86)90028-5; Chen AL, 2009, BIOTECHNOL LETT, V31, P487, DOI 10.1007/s10529-008-9888-x; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Han KQ, 2007, WORLD J GASTROENTERO, V13, P3374, DOI 10.3748/wjg.v13.i24.3374; Hashimoto S, 1997, LEUKEMIA RES, V21, P875, DOI 10.1016/S0145-2126(97)00061-1; Hideshima T, 2002, NAT REV CANCER, V2, P927, DOI 10.1038/nrc952; HONG Z, 1992, J PHARM PHARMACOL, V44, P1023, DOI 10.1111/j.2042-7158.1992.tb07086.x; Javle M, 2011, Ther Adv Med Oncol, V3, P257, DOI 10.1177/1758834011417039; Jeggo PA, 1998, CURR BIOL, V8, pR49, DOI 10.1016/S0960-9822(98)70032-6; Kameoka M, 2004, J VIROL, V78, P8931, DOI 10.1128/JVI.78.16.8931-8934.2004; Kawazoe N, 1999, J BIOCHEM-TOKYO, V126, P278, DOI 10.1093/oxfordjournals.jbchem.a022446; Krishnakumar R, 2010, MOL CELL, V39, P8, DOI 10.1016/j.molcel.2010.06.017; Li D, 2009, ANTI-CANCER DRUG, V20, P59, DOI 10.1097/CAD.0b013e3283160fd6; Lomenick B, 2011, ACS CHEM BIOL, V6, P34, DOI 10.1021/cb100294v; Lu SY, 2011, J COMPUT CHEM, V32, P1907, DOI 10.1002/jcc.21775; Ma HY, 2009, J NANJING U TRADITIO, V25, P370; Marchetti C, 2012, EXPERT OPIN INV DRUG, V21, P1575, DOI 10.1517/13543784.2012.707189; Meng ZQ, 2009, CANCER-AM CANCER SOC, V115, P5309, DOI 10.1002/cncr.24602; Meyer-Ficca ML, 2005, INT J BIOCHEM CELL B, V37, P920, DOI 10.1016/j.biocel.2004.09.011; MORISHITA S, 1986, FOLIA PHARMACOL JPN, V87, P361, DOI 10.1254/fpj.87.361; Neri P, 2011, BLOOD, V118, P6368, DOI 10.1182/blood-2011-06-363911; Pastor N, 2003, DNA REPAIR, V2, P1353, DOI 10.1016/j.dnarep.2003.08.001; Penning TD, 2010, J MED CHEM, V53, P3142, DOI 10.1021/jm901775y; Petruccelli LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020987; Premkumar DR, 2013, MOL CARCINOGEN, V52, P118, DOI 10.1002/mc.21835; Pyndiah S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001556; Qi FH, 2010, J ETHNOPHARMACOL, V128, P654, DOI 10.1016/j.jep.2010.02.022; SCHRAUFSTATTER IU, 1986, P NATL ACAD SCI USA, V83, P4908, DOI 10.1073/pnas.83.13.4908; Staker BL, 2002, P NATL ACAD SCI USA, V99, P15387, DOI 10.1073/pnas.242259599; Takai N, 2008, INT J MOL MED, V21, P637; Takai N, 2012, ASIAN PAC J CANCER P, V13, P399, DOI 10.7314/APJCP.2012.13.1.399; Watabe M, 1997, CELL GROWTH DIFFER, V8, P871; WIELCKENS K, 1983, J BIOL CHEM, V258, P4098; Yeh JY, 2003, PROSTATE, V54, P112, DOI 10.1002/pros.10172; Zhang JX, 2012, HEPATOLOGY, V55, P1840, DOI 10.1002/hep.25566; ZHANG L, 1991, BIOCHEM BIOPH RES CO, V178, P686, DOI 10.1016/0006-291X(91)90162-Z; ZHANG LS, 1992, CANCER RES, V52, P4634; Zhao Y, 2009, J NAT PROD, V72, P988, DOI 10.1021/np9000366; Zhu ZT, 2012, INT J MOL SCI, V13, P2025, DOI 10.3390/ijms13022025	44	11	12	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e66130	10.1371/journal.pone.0066130	http://dx.doi.org/10.1371/journal.pone.0066130			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762475	Green Submitted, Green Published, gold			2022-12-27	WOS:000321094800092
J	Osaki, LH; Gama, P				Osaki, Luciana H.; Gama, Patricia			MAPK Signaling Pathway Regulates p27 Phosphorylation at Threonin 187 as Part of the Mechanism Triggered by Early-Weaning to Induce Cell Proliferation in Rat Gastric Mucosa	PLOS ONE			English	Article							GROWTH-FACTOR-ALPHA; KINASE-ACTIVITY; CDK INHIBITORS; FACTOR-BETA; EPITHELIAL MONOLAYERS; P27(KIP1) DEGRADATION; MAMMALIAN-CELLS; CYCLIN E-CDK2; ADULT RATS; ACTIVATION	During rat postnatal development, gastric cell proliferation and differentiation depend on many elements, which include dietary pattern, hormones, growth factors and their signaling pathways. Among them, EGFR activity is increased through MAPK and Src cascades in response to early weaning that represents the abrupt transition from milk to solid food. We herein investigated the direct involvement of ERK pathway in the control of cell cycle progression during early weaning, and studied the specific role of p27. At 15 days, Wistar rats were separated from dams, fed with powdered chow and daily injected with PD98059 (MEK inhibitor, 300 mu g/kg) or 0.5% DMSO (control). By using HE staining and immunohistochemistry for PCNA, we respectively detected mitotic (MI) and proliferative (PI) indices in 18-day-old pups, and observed that both were reduced by PD98059. As cell cycle-related proteins (cyclin E, CDK2, cyclin D1, CDK4, p21 and p27) are involved in proliferative regulation, we compared samples obtained at 17 days in the morning (17 d) and evening (17.5 d). We found that they were not altered after ERK inhibition, but cyclin D1, p21 and p27 levels changed throughout the day in the control group. As p27 activity depends on its integrity, we studied p27 phosphorylation (threonin 187), and observed that ERK inhibition reduced this process. We suggest that MAPK pathway interferes in the regulation of p27 function in the gastric mucosa during early weaning, possibly by controlling its degradation, and altogether this mechanism might contribute to the increase of epithelial proliferation at this condition.	[Osaki, Luciana H.; Gama, Patricia] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Sao Paulo, Brazil	Universidade de Sao Paulo	Osaki, LH (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Sao Paulo, Brazil.	luciana.osaki@usp.br	Gama, Patricia/D-4756-2012; Osaki, Luciana H/I-3624-2012	Gama, Patricia/0000-0002-1863-893X; Osaki, Luciana/0000-0003-0665-7567	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (Sao Paulo, Brazil) [2011/07089-1]; CAPES-PNPD; FAPESP [2010/17851-5]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (Sao Paulo, Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES-PNPD(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (Sao Paulo, Brazil) (2011/07089-1). LHO was a recipient of CAPES-PNPD and FAPESP (2010/17851-5) postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvares E P, 1987, Prog Clin Biol Res, V227A, P353; Alvares EP, 2007, HISTOL HISTOPATHOL, V22, P147, DOI 10.14670/HH-22.147; ALVARES EP, 1993, BRAZ J MED BIOL RES, V26, P869; Blain SW, 2008, CELL CYCLE, V7, P892, DOI 10.4161/cc.7.7.5637; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; de Andrade Sa Eunice Ribeiro, 2008, Regul Pept, V146, P293, DOI 10.1016/j.regpep.2007.11.001; Delmas C, 2001, J BIOL CHEM, V276, P34958, DOI 10.1074/jbc.M101714200; Gama P, 2000, J NUTR, V130, P2594, DOI 10.1093/jn/130.10.2594; Hengst L, 1996, SCIENCE, V271, P1861, DOI 10.1126/science.271.5257.1861; Huang KT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046072; Jasleen J, 2000, J SURG RES, V90, P13, DOI 10.1006/jsre.2000.5818; Jiang RL, 2012, INT J BIOCHEM CELL B, V44, P91, DOI 10.1016/j.biocel.2011.10.002; Jiang RL, 2011, J CELL PHYSIOL, V226, P3022, DOI 10.1002/jcp.22650; Jung YS, 2010, CELL SIGNAL, V22, P1003, DOI 10.1016/j.cellsig.2010.01.013; Kanai M, 2001, GASTROENTEROLOGY, V121, P56, DOI 10.1053/gast.2001.25544; Kawada M, 1997, ONCOGENE, V15, P629, DOI 10.1038/sj.onc.1201228; KOFF A, 1992, SCIENCE, V257, P1689, DOI 10.1126/science.1388288; Lavoie JN, 1996, J BIOL CHEM, V271, P20608, DOI 10.1074/jbc.271.34.20608; Lee JG, 2011, INVEST OPHTH VIS SCI, V52, P417, DOI 10.1167/iovs.10-6140; Lin CH, 2001, DIGESTION, V63, P214, DOI 10.1159/000051892; Lu ZM, 2010, CELL CYCLE, V9, P2342, DOI 10.4161/cc.9.12.11988; Luo JC, 2008, BIOCHEM PHARMACOL, V76, P841, DOI 10.1016/j.bcp.2008.07.010; MATSUSHIME H, 1994, MOL CELL BIOL, V14, P2066, DOI 10.1128/MCB.14.3.2066; MEYERSON M, 1994, MOL CELL BIOL, V14, P2077, DOI 10.1128/MCB.14.3.2077; Montagnoli A, 1999, GENE DEV, V13, P1181, DOI 10.1101/gad.13.9.1181; Nakajima N, 1995, J CLIN GASTROENTEROL, V21, pS45; NAKAJIMA N, 1993, J CLIN GASTROENTEROL, V17, pS121, DOI 10.1097/00004836-199312001-00022; Nakamizo H, 2012, DIGEST DIS SCI, V57, P2545, DOI 10.1007/s10620-012-2208-2; Ogias D, 2010, NUTRITION, V26, P224, DOI 10.1016/j.nut.2009.03.014; Ogias D, 2010, AM J PHYSIOL-GASTR L, V298, pG117, DOI 10.1152/ajpgi.00245.2009; Osaki LH, 2011, CELL PROLIFERAT, V44, P174, DOI 10.1111/j.1365-2184.2011.00733.x; Osaki LH, 2010, DIFFERENTIATION, V79, P48, DOI 10.1016/j.diff.2009.09.001; Osawa H, 2006, BIOCHEM BIOPH RES CO, V344, P680, DOI 10.1016/j.bbrc.2006.03.188; PAGANO M, 1992, EMBO J, V11, P961, DOI 10.1002/j.1460-2075.1992.tb05135.x; Qiao WL, 2006, J GASTROENTEROL, V41, P1158, DOI 10.1007/s00535-006-1902-2; Ramos JW, 2008, INT J BIOCHEM CELL B, V40, P2707, DOI 10.1016/j.biocel.2008.04.009; Rivard N, 1999, AM J PHYSIOL-CELL PH, V277, pC652, DOI 10.1152/ajpcell.1999.277.4.C652; Sasaki E, 2003, DIGEST DIS SCI, V48, P2257, DOI 10.1023/B:DDAS.0000007860.87503.09; Schneider R, 2001, HORM METAB RES, V33, P1, DOI 10.1055/s-2001-12617; Sheaff RJ, 1997, GENE DEV, V11, P1464, DOI 10.1101/gad.11.11.1464; SLINGERLAND JM, 1994, MOL CELL BIOL, V14, P3683, DOI 10.1128/MCB.14.6.3683; Starostina NG, 2012, TRENDS CELL BIOL, V22, P33, DOI 10.1016/j.tcb.2011.10.004; Tetreault MP, 2008, J CELL PHYSIOL, V214, P545, DOI 10.1002/jcp.21239; Tetreault MP, 2008, J CELL BIOCHEM, V105, P1240, DOI 10.1002/jcb.21924; Xiao ZQ, 2003, AM J PHYSIOL-GASTR L, V285, pG396, DOI 10.1152/ajpgi.00530.2002; Xu RJ, 1996, REPROD FERT DEVELOP, V8, P35, DOI 10.1071/RD9960035	48	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e66651	10.1371/journal.pone.0066651	http://dx.doi.org/10.1371/journal.pone.0066651			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762493	gold, Green Submitted, Green Published			2022-12-27	WOS:000321094800101
J	de Carvalho, MDC; De Mesquita, JF				Castela de Carvalho, Mariana Dias; De Mesquita, Joelma Freire			Structural Modeling and In Silico Analysis of Human Superoxide Dismutase 2	PLOS ONE			English	Article							PLACEBO-CONTROLLED TRIAL; N-ACETYL CYSTEINE; PROTEIN-STRUCTURE; BIPOLAR DISORDER; DOUBLE-BLIND; DISEASE; MUTATIONS; POLYMORPHISMS; ASSOCIATION; SEQUENCE	Aging in the world population has increased every year. Superoxide dismutase 2 (Mn-SOD or SOD2) protects against oxidative stress, a main factor influencing cellular longevity. Polymorphisms in SOD2 have been associated with the development of neurodegenerative diseases, such as Alzheimer's and Parkinson's disease, as well as psychiatric disorders, such as schizophrenia, depression and bipolar disorder. In this study, all of the described natural variants (S10I, A16V, E66V, G76R, I82T and R156W) of SOD2 were subjected to in silico analysis using eight different algorithms: SNPeffect, PolyPhen-2, PhD-SNP, PMUT, SIFT, SNAP, SNPs&GO and nsSNPAnalyzer. This analysis revealed disparate results for a few of the algorithms. The results showed that, from at least one algorithm, each amino acid substitution appears to harmfully affect the protein. Structural theoretical models were created for variants through comparative modelling performed using the MHOLline server (which includes MODELLER and PROCHECK) and ab initio modelling, using the I-Tasser server. The predicted models were evaluated using TM-align, and the results show that the models were constructed with high accuracy. The RMSD values of the modelled mutants indicated likely pathogenicity for all missense mutations. Structural phylogenetic analysis using ConSurf revealed that human SOD2 is highly conserved. As a result, a human-curated database was generated that enables biologists and clinicians to explore SOD2 nsSNPs, including predictions of their effects and visualisation of the alignment of both the wild-type and mutant structures. The database is freely available at http://bioinfogroup.com/database/ and will be regularly updated.	[Castela de Carvalho, Mariana Dias; De Mesquita, Joelma Freire] Univ Fed Estado Rio de Janeiro, Bioinformat & Computat Biol Grp, Dept Genet & Mol Biol, Rio De Janeiro, Brazil	Universidade Federal do Estado do Rio de Janeiro	De Mesquita, JF (corresponding author), Univ Fed Estado Rio de Janeiro, Bioinformat & Computat Biol Grp, Dept Genet & Mol Biol, Rio De Janeiro, Brazil.	jomesquita@gmail.com	De Mesquita, Joelma/J-4837-2012; De Mesquita, Joelma/W-5553-2019	De Mesquita, Joelma/0000-0003-1684-3830	Federal University of Rio de Janeiro State	Federal University of Rio de Janeiro State	MDCC received a fellowship from the Federal University of Rio de Janeiro State. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Akyol O, 2005, PROG NEURO-PSYCHOPH, V29, P123, DOI 10.1016/j.pnpbp.2004.10.014; [Anonymous], CLIN BIOCH; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Bao L, 2005, NUCLEIC ACIDS RES, V33, pW480, DOI 10.1093/nar/gki372; Berk M, 2008, BIOL PSYCHIAT, V64, P468, DOI 10.1016/j.biopsych.2008.04.022; Berk M, 2008, BIOL PSYCHIAT, V64, P361, DOI 10.1016/j.biopsych.2008.03.004; Borgstahl GEO, 1996, BIOCHEMISTRY-US, V35, P4287, DOI 10.1021/bi951892w; Bromberg Y, 2008, BIOINFORMATICS, V24, P2397, DOI 10.1093/bioinformatics/btn435; Bromberg Y, 2007, NUCLEIC ACIDS RES, V35, P3823, DOI 10.1093/nar/gkm238; Calabrese R, 2009, HUM MUTAT, V30, P1237, DOI 10.1002/humu.21047; Capriles PVSZ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-610; Capriotti E, 2006, BIOINFORMATICS, V22, P2729, DOI 10.1093/bioinformatics/btl423; De Baets G, 2012, NUCLEIC ACIDS RES, V40, pD935, DOI 10.1093/nar/gkr996; Ferrer-Costa C, 2002, J MOL BIOL, V315, P771, DOI 10.1006/jmbi.2001.5255; Fullerton JM, 2010, BIPOLAR DISORD, V12, P550, DOI 10.1111/j.1399-5618.2010.00834.x; Galecki P, 2010, PSYCHIAT RES, V179, P43, DOI 10.1016/j.psychres.2009.06.016; Jimenez-Lopez JC, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-43; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Mistri M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039122; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sanchez R, 1997, PROTEINS, P50; ShimodaMatsubayashi S, 1996, BIOCHEM BIOPH RES CO, V226, P561, DOI 10.1006/bbrc.1996.1394; Singh M, 2008, MOL CELL BIOCHEM, V312, P131, DOI 10.1007/s11010-008-9728-2; Wang V, 2010, CLIN BIOCH; Wiener HW, 2007, GENES BRAIN BEHAV, V6, P770, DOI 10.1111/j.1601-183X.2007.00308.x; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524	29	24	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65558	10.1371/journal.pone.0065558	http://dx.doi.org/10.1371/journal.pone.0065558			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785434	Green Published, gold			2022-12-27	WOS:000321038800087
J	Christoforou, N; Liau, B; Chakraborty, S; Chellapan, M; Bursac, N; Leong, KW				Christoforou, Nicolas; Liau, Brian; Chakraborty, Syandan; Chellapan, Malathi; Bursac, Nenad; Leong, Kam W.			Induced Pluripotent Stem Cell-Derived Cardiac Progenitors Differentiate to Cardiomyocytes and Form Biosynthetic Tissues	PLOS ONE			English	Article							IN-VITRO; MYOCARDIAL-INFARCTION; SMOOTH-MUSCLE; CARDIOVASCULAR PROGENITORS; ISCHEMIC CARDIOMYOPATHY; MAMMALIAN HEART; PRECURSOR CELLS; DEFINED FACTORS; DRUG DISCOVERY; ES CELLS	The mammalian heart has little capacity to regenerate, and following injury the myocardium is replaced by non-contractile scar tissue. Consequently, increased wall stress and workload on the remaining myocardium leads to chamber dilation, dysfunction, and heart failure. Cell-based therapy with an autologous, epigenetically reprogrammed, and cardiac-committed progenitor cell source could potentially reverse this process by replacing the damaged myocardium with functional tissue. However, it is unclear whether cardiac progenitor cell-derived cardiomyocytes are capable of attaining levels of structural and functional maturity comparable to that of terminally-fated cardiomyocytes. Here, we first describe the derivation of mouse induced pluripotent stem (iPS) cells, which once differentiated allow for the enrichment of Nkx2-5(+) cardiac progenitors, and the cardiomyocyte-specific expression of the red fluorescent protein. We show that the cardiac progenitors are multipotent and capable of differentiating into endothelial cells, smooth muscle cells and cardiomyocytes. Moreover, cardiac progenitor selection corresponds to cKit(+) cell enrichment, while cardiomyocyte cell-lineage commitment is concomitant with dual expression of either cKit/Flk1 or cKit/Sca-1. We proceed to show that the cardiac progenitor-derived cardiomyocytes are capable of forming electrically and mechanically coupled large-scale 2D cell cultures with mature electrophysiological properties. Finally, we examine the cell progenitors' ability to form electromechanically coherent macroscopic tissues, using a physiologically relevant 3D culture model and demonstrate that following long-term culture the cardiomyocytes align, and form robust electromechanical connections throughout the volume of the biosynthetic tissue construct. We conclude that the iPS cell-derived cardiac progenitors are a robust cell source for tissue engineering applications and a 3D culture platform for pharmacological screening and drug development studies.	[Christoforou, Nicolas; Liau, Brian; Chakraborty, Syandan; Chellapan, Malathi; Bursac, Nenad; Leong, Kam W.] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA	Duke University	Leong, KW (corresponding author), Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.	kam.leong@duke.edu	Bursac, Nenad/AAU-5548-2021; Leong, Kam W/A-7270-2009; Leong, Kam/O-9302-2019	Bursac, Nenad/0000-0002-5688-6061; Leong, Kam W/0000-0002-8133-4955; Leong, Kam/0000-0002-8133-4955; Liau, Brian/0000-0002-8233-771X	Flight Attendant Medical Research Institute; NIH [HL104326, HL095069, EB015300]; NIH Common Fund for the Microphysiological Systems Initiative;  [UH2TR000505]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UH2TR000505] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL095069, R01HL104326] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB015300] Funding Source: NIH RePORTER	Flight Attendant Medical Research Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Common Fund for the Microphysiological Systems Initiative; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the Flight Attendant Medical Research Institute (Young Clinical Scientist Award to N.C.) and NIH (HL104326 and HL095069 to N.B., and EB015300 to K.W.L.). The work was also supported by UH2TR000505 and the NIH Common Fund for the Microphysiological Systems Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai A, 1997, DEV DYNAM, V210, P344, DOI 10.1002/(SICI)1097-0177(199711)210:3<344::AID-AJA13>3.0.CO;2-A; Bian WN, 2009, NAT PROTOC, V4, P1522, DOI 10.1038/nprot.2009.155; Blin G, 2010, J CLIN INVEST, V120, P1125, DOI 10.1172/JCI40120; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Bursac N, 2002, CIRC RES, V91, pE45, DOI 10.1161/01.RES.0000047530.88338.EB; Carey BW, 2009, P NATL ACAD SCI USA, V106, P157, DOI 10.1073/pnas.0811426106; Christoforou N, 2008, J CLIN INVEST, V118, P894, DOI 10.1172/JCI33942; Christoforou N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011536; Chugh AR, 2012, CIRCULATION, V126, pS54, DOI 10.1161/CIRCULATIONAHA.112.092627; David R, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-012-0312-2; Davis RP, 2011, TRENDS MOL MED, V17, P475, DOI 10.1016/j.molmed.2011.05.001; Domian IJ, 2009, SCIENCE, V326, P426, DOI 10.1126/science.1177350; Fijnvandraat AC, 2003, J MOL CELL CARDIOL, V35, P1461, DOI 10.1016/j.yjmcc.2003.09.011; Gepstein L, 2010, STEM CELLS, V28, P2151, DOI 10.1002/stem.545; Grskovic M, 2011, NAT REV DRUG DISCOV, V10, P915, DOI 10.1038/nrd3577; GULICK J, 1991, J BIOL CHEM, V266, P9180; Hidaka K, 2003, FASEB J, V17, P740, DOI 10.1096/fj.02-0104fje; Hong YK, 2004, FASEB J, V18, P1111, DOI 10.1096/fj.03-1179fje; Hu XY, 2007, EUR J CARDIO-THORAC, V31, P438, DOI 10.1016/j.ejcts.2006.11.057; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Kamkin A, 2003, PFLUG ARCH EUR J PHY, V446, P220, DOI 10.1007/s00424-003-1018-y; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kawamura M, 2012, CIRCULATION, V126, pS29, DOI 10.1161/CIRCULATIONAHA.111.084343; Kensah G, 2013, EUR HEART J, V34, P1134, DOI 10.1093/eurheartj/ehs349; Kim C, 2010, STEM CELLS DEV, V19, P783, DOI 10.1089/scd.2009.0349; Klinger R, 2008, IEEE ENG MED BIOL, V27, P72, DOI 10.1109/MEMB.2007.913849; Klug MG, 1996, J CLIN INVEST, V98, P216, DOI 10.1172/JCI118769; KUBALAK SW, 1994, J BIOL CHEM, V269, P16961; Kuzmenkin A, 2009, FASEB J, V23, P4168, DOI 10.1096/fj.08-128546; Liau B, 2012, REGEN MED, V7, P187, DOI [10.2217/RME.11.122, 10.2217/rme.11.122]; Liau B, 2011, BIOMATERIALS, V32, P9180, DOI 10.1016/j.biomaterials.2011.08.050; Lien CL, 1999, DEVELOPMENT, V126, P75; MAHDAVI V, 1987, CIRC RES, V60, P804, DOI 10.1161/01.RES.60.6.804; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0; MALTSEV VA, 1994, CIRC RES, V75, P233, DOI 10.1161/01.RES.75.2.233; MALTSEV VA, 1993, MECH DEVELOP, V44, P41, DOI 10.1016/0925-4773(93)90015-P; Matsuura K, 2009, J CLIN INVEST, V119, P2204, DOI 10.1172/JCI37456; Miake J, 2003, J CLIN INVEST, V111, P1529, DOI 10.1172/JCI200317959; Miller RA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002176; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Moretti A, 2010, FASEB J, V24, P700, DOI 10.1096/fj.09-139477; Muller M, 2000, FASEB J, V14, P2540, DOI 10.1096/fj.00-0002com; Pillekamp F, 2005, CELL PHYSIOL BIOCHEM, V16, P127, DOI 10.1159/000087739; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Saga Y, 2000, TRENDS CARDIOVAS MED, V10, P345, DOI 10.1016/S1050-1738(01)00069-X; Schaaf S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026397; SHEKHONIN BV, 1990, J MOL CELL CARDIOL, V22, P533, DOI 10.1016/0022-2828(90)90955-2; Shiba Y, 2012, NATURE, V489, P322, DOI 10.1038/nature11317; Stevens KR, 2009, P NATL ACAD SCI USA, V106, P16568, DOI 10.1073/pnas.0908381106; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takamiya M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025265; Terami H, 2007, BIOCHEM BIOPH RES CO, V355, P47, DOI 10.1016/j.bbrc.2007.01.109; Tulloch NL, 2011, CIRC RES, V109, P47, DOI 10.1161/CIRCRESAHA.110.237206; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028; Xu HS, 2012, CELL RES, V22, P142, DOI 10.1038/cr.2011.171; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Zhang M, 2001, J MOL CELL CARDIOL, V33, P907, DOI 10.1006/jmcc.2001.1367; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267; Zwi-Dantsis L, 2012, CELL MOL LIFE SCI, V69, P3285, DOI 10.1007/s00018-012-1078-2	62	49	51	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65963	10.1371/journal.pone.0065963	http://dx.doi.org/10.1371/journal.pone.0065963			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785459	Green Published, Green Submitted, gold			2022-12-27	WOS:000321038800063
J	Liao, Y; He, F; Gong, T; Bi, EF; Gao, XD				Liao, Yuan; He, Fei; Gong, Ting; Bi, Erfei; Gao, Xiang-Dong			Msb1 Interacts with Cdc42, Boi1, and Boi2 and May Coordinate Cdc42 and Rho1 Functions during Early Stage of Bud Development in Budding Yeast	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; POLARIZED GROWTH; CELL POLARITY; 1,3-BETA-GLUCAN SYNTHASE; SMALL GTPASES; PROTEIN; IDENTIFICATION; GENES; ROLES; MORPHOGENESIS	Msb1 is not essential for growth in the budding yeast Saccharomyces cerevisiae since msb1 Delta cells do not display obvious phenotypes. Genetic studies suggest that Msb1 positively regulates Cdc42 function during bud development, since high-copy MSB1 suppressed the growth defect of temperature-sensitive cdc24 and cdc42 mutants at restrictive temperature, while deletion of MSB1 showed synthetic lethality with cdc24, bem1, and bem2 mutations. However, the mechanism of how Msb1 regulates Cdc42 function remains poorly understood. Here, we show that Msb1 localizes to sites of polarized growth during bud development and interacts with Cdc42 in the cells. In addition, Msb1 interacts with Boi1 and Boi2, two scaffold proteins that also interact with Cdc42 and Bem1. These findings suggest that Msb1 may positively regulate Cdc42 function by interacting with Cdc42, Boi1, and Boi2, which may promote the efficient assembly of Cdc42, Cdc24, and other proteins into a functional complex. We also show that Msb1 interacts with Rho1 in the cells and Msb1 overproduction inhibits the growth of rho1-104 and rho1-3 but not rho1-2 cells. The growth inhibition appears to result from the down-regulation of Rho1 function in glucan synthesis, specifically during early stage of bud development. These results suggest that Msb1 may coordinate Cdc42 and Rho1 functions during early stage of bud development by promoting Cdc42 function and inhibiting Rho1 function. Msb1 overproduction also affects cell morphology, septin organization, and causes increased, aberrant deposition of 1,3-beta-glucan and chitin at the mother-bud neck. However, the stimulation of glucan synthesis mainly occurs during late, but not early, stage of bud development.	[Liao, Yuan; He, Fei; Gong, Ting; Gao, Xiang-Dong] Wuhan Univ, State Key Lab Virol, Coll Life Sci, Wuhan 430072, Peoples R China; [Bi, Erfei] Univ Penn, Dept Cell & Dev Biol, Perelman Sch Med, Philadelphia, PA 19104 USA	Wuhan University; University of Pennsylvania; Pennsylvania Medicine	Gao, XD (corresponding author), Wuhan Univ, State Key Lab Virol, Coll Life Sci, Wuhan 430072, Peoples R China.	xdgao@whu.edu.cn		Gao, Xiang-Dong/0000-0002-1008-2324	National Natural Science Foundation of China [30770017, 30871347]; Chinese 111 Project [B06018]; National Institutes of Health [GM59216]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese 111 Project(Ministry of Education, China - 111 Project); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Natural Science Foundation of China (grant numbers 30770017 and 30871347) and the Chinese 111 Project (number B06018) to XDG, and by the National Institutes of Health grant (GM59216) to EB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo JE, 2001, J CELL BIOL, V155, P581, DOI 10.1083/jcb.200106065; ADAMS AEM, 1990, J CELL BIOL, V111, P131, DOI 10.1083/jcb.111.1.131; Barral Y, 2000, MOL CELL, V5, P841, DOI 10.1016/S1097-2765(00)80324-X; BENDER A, 1991, MOL CELL BIOL, V11, P1295, DOI 10.1128/MCB.11.3.1295; BENDER A, 1989, P NATL ACAD SCI USA, V86, P9976, DOI 10.1073/pnas.86.24.9976; Bender L, 1996, J CELL BIOL, V133, P879, DOI 10.1083/jcb.133.4.879; Bi EF, 2000, MOL BIOL CELL, V11, P773, DOI 10.1091/mbc.11.2.773; Bi EF, 1996, MOL CELL BIOL, V16, P5264; Bouquin N, 2000, J CELL SCI, V113, P1435; Caviston JP, 2003, MOL BIOL CELL, V14, P4051, DOI 10.1091/mbc.E03-04-0247; Caviston JP, 2002, P NATL ACAD SCI USA, V99, P12185, DOI 10.1073/pnas.182370299; Drgonova J, 1996, SCIENCE, V272, P277, DOI 10.1126/science.272.5259.277; Gandhi M, 2006, GENETICS, V174, P665, DOI 10.1534/genetics.106.058180; Gao XD, 2004, MOL BIOL CELL, V15, P3977, DOI 10.1091/mbc.E04-01-0079; Gao XD, 2003, J CELL BIOL, V162, P635, DOI 10.1083/jcb.200302038; Gao XD, 2007, MOL BIOL CELL, V18, P2542, DOI 10.1091/mbc.e06-09-0822; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gong T, 2013, EUKARYOT CELL, V12, P368, DOI 10.1128/EC.00277-12; Guo J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016744; Guo W, 2001, NAT CELL BIOL, V3, P353, DOI 10.1038/35070029; Guthrie C, 1991, METHODS ENZYMOL, V194; Kuroda S, 1996, J BIOL CHEM, V271, P23363, DOI 10.1074/jbc.271.38.23363; Longtine MS, 2000, MOL CELL BIOL, V20, P4049, DOI 10.1128/MCB.20.11.4049-4061.2000; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Mack D, 1996, MOL CELL BIOL, V16, P4387; Matsui Y, 1996, J CELL BIOL, V133, P865, DOI 10.1083/jcb.133.4.865; Park HO, 2007, MICROBIOL MOL BIOL R, V71, P48, DOI 10.1128/MMBR.00028-06; Qadota H, 1996, SCIENCE, V272, P279, DOI 10.1126/science.272.5259.279; Richman TJ, 2002, EUKARYOT CELL, V1, P458, DOI 10.1128/EC.1.3.458-468.2002; Saka A, 2001, J BIOL CHEM, V276, P46165, DOI 10.1074/jbc.M103805200; Sekiya-Kawasaki M, 2002, GENETICS, V162, P663; TYERS M, 1993, EMBO J, V12, P1955, DOI 10.1002/j.1460-2075.1993.tb05845.x; YAMOCHI W, 1994, J CELL BIOL, V125, P1077, DOI 10.1083/jcb.125.5.1077; Zhang XY, 2001, J BIOL CHEM, V276, P46745, DOI 10.1074/jbc.M107464200	34	7	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66321	10.1371/journal.pone.0066321	http://dx.doi.org/10.1371/journal.pone.0066321			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785492	Green Submitted, Green Published, gold			2022-12-27	WOS:000321038800030
J	Marion, V; Sankaranarayanan, S; de Theije, C; van Dijk, P; Hakvoort, TBM; Lamers, WH; Kohler, ES				Marion, Vincent; Sankaranarayanan, Selvakumari; de Theije, Chiel; van Dijk, Paul; Hakvoort, Theo B. M.; Lamers, Wouter H.; Koehler, Eleonore S.			Hepatic Adaptation Compensates Inactivation of Intestinal Arginine Biosynthesis in Suckling Mice	PLOS ONE			English	Article							LYSINURIC PROTEIN INTOLERANCE; AMINO-ACID-CONCENTRATIONS; NECROTIZING ENTEROCOLITIS; NEONATAL PIGLETS; TRANSGENIC MICE; METABOLISM; MOUSE; PIGS; DEFICIENCY; PROLINE	Suckling mammals, including mice, differ from adults in the abundant expression of enzymes that synthesize arginine from citrulline in their enterocytes. To investigate the importance of the small-intestinal arginine synthesis for whole-body arginine production in suckling mice, we floxed exon 13 of the argininosuccinate synthetase (Ass) gene, which codes for a key enzyme in arginine biosynthesis, and specifically and completely ablated Ass in enterocytes by crossing Ass(fl) and Villin-Cre mice. Unexpectedly, Ass(fl/fl)/VilCre(tg/-) mice showed no developmental impairments. Amino-acid fluxes across the intestine, liver, and kidneys were calculated after determining the blood flow in the portal vein, and hepatic and renal arteries (86%, 14%, and 33%, respectively, of the transhepatic blood flow in 14-day-old mice). Relative to control mice, citrulline production in the splanchnic region of Ass(fl/fl)/VilCre(tg/-) mice doubled, while arginine production was abolished. Furthermore, the net production of arginine and most other amino acids in the liver of suckling control mice declined to naught or even changed to consumption in Ass(fl/fl)/VilCre(tg/-) mice, and had, thus, become remarkably similar to that of post-weaning wild-type mice, which no longer express arginine-biosynthesizing enzymes in their small intestine. The adaptive changes in liver function were accompanied by an increased expression of genes involved in arginine metabolism (Asl, Got1, Gpt2, Glud1, Arg1, and Arg2) and transport (Slc25a13, Slc25a15, and Slc3a2), whereas no such changes were found in the intestine. Our findings suggest that the genetic premature deletion of arginine synthesis in enterocytes causes a premature induction of the post-weaning pattern of amino-acid metabolism in the liver.	[Marion, Vincent; Sankaranarayanan, Selvakumari; de Theije, Chiel; van Dijk, Paul; Hakvoort, Theo B. M.; Lamers, Wouter H.; Koehler, Eleonore S.] Maastricht Univ, Dept Anat & Embryol, Maastricht, Netherlands; [Marion, Vincent] INSERM, Med Genet Lab, U1112, Strasbourg, France; [Hakvoort, Theo B. M.; Lamers, Wouter H.] Univ Amsterdam, Acad Med Ctr, Tytgat Inst Liver & Gastrointestinal Res, NL-1105 AZ Amsterdam, Netherlands	Maastricht University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Amsterdam; Academic Medical Center Amsterdam	Kohler, ES (corresponding author), Maastricht Univ, Dept Anat & Embryol, Maastricht, Netherlands.	Leo.Koehler@maastrichtuniversity.nl	Marion, Vincent/H-9730-2016; Lamers, Wouter H./D-2965-2012; Köhler, Eleonore/D-2915-2012	Köhler, Eleonore/0000-0003-1977-9977; Marion, Vincent/0000-0002-8271-7376	graduate school NUTRIM, Maastricht University	graduate school NUTRIM, Maastricht University	This study was supported by a grant from the graduate school NUTRIM, Maastricht University, to WHL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman D.G., 1991, PRACTICAL STATISTIC; BATSHAW ML, 1984, J PEDIATR-US, V105, P86, DOI 10.1016/S0022-3476(84)80369-8; Becker RM, 2000, J PEDIATR-US, V137, P785, DOI 10.1067/mpd.2000.109145; Bertolo RFP, 2000, J NUTR, V130, P1261, DOI 10.1093/jn/130.5.1261; Bertolo RFP, 2003, AM J PHYSIOL-ENDOC M, V284, pE915, DOI 10.1152/ajpendo.00269.2002; BLACHIER F, 1993, EUR J BIOCHEM, V216, P109, DOI 10.1111/j.1432-1033.1993.tb18122.x; Borsani G, 1999, NAT GENET, V21, P297, DOI 10.1038/6815; Brunton JA, 1999, AM J PHYSIOL-ENDOC M, V277, pE223, DOI 10.1152/ajpendo.1999.277.2.E223; DAVIS TA, 1994, J NUTR, V124, P1126, DOI 10.1093/jn/124.7.1126; DAVIS TA, 1993, J NUTR, V123, P947, DOI 10.1093/jn/123.5.947; de Jonge WJ, 2002, AM J CLIN NUTR, V76, P128, DOI 10.1093/ajcn/76.1.128; de Jonge WJ, 2002, J CLIN INVEST, V110, P1539, DOI [10.1172/JCI200216143, 10.1172/JCI0216143]; De Jonge WJ, 1998, PEDIATR RES, V43, P442, DOI 10.1203/00006450-199804000-00002; de Jonge WJ, 2001, J NUTR, V131, P2732, DOI 10.1093/jn/131.10.2732; Deutz NEP, 1998, J NUTR, V128, P2435, DOI 10.1093/jn/128.12.2435; Flynn NE, 2002, BIOMED PHARMACOTHER, V56, P427, DOI 10.1016/S0753-3322(02)00273-1; Geng MM, 2011, AMINO ACIDS, V40, P1513, DOI 10.1007/s00726-010-0761-6; GOLDBLUM OM, 1986, J AM ACAD DERMATOL, V14, P321, DOI 10.1016/S0190-9622(86)70035-2; Hallemeesch MM, 2001, LAB ANIM-UK, V35, P101, DOI 10.1258/0023677011911426; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; HURWITZ R, 1986, AM J PHYSIOL, V251, pG103, DOI 10.1152/ajpgi.1986.251.1.G103; Illnerova H, 1965, Biol Neonat, V9, P197; Kohler ES, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-107; LEVILLAIN O, 1993, AM J PHYSIOL, V264, pF1038, DOI 10.1152/ajprenal.1993.264.6.F1038; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; MALO C, 1994, COMP BIOCHEM PHYS A, V109, P1049, DOI 10.1016/0300-9629(94)90254-2; MAUNOURY R, 1992, DEVELOPMENT, V115, P717; MEIJER AJ, 1990, PHYSIOL REV, V70, P701, DOI 10.1152/physrev.1990.70.3.701; Moonen RMJ, 2007, PEDIATR RES, V62, P188, DOI 10.1203/PDR.0b013e3180a0324e; NAGY LE, 1988, J NUTR, V118, P189, DOI 10.1093/jn/118.2.189; Palacin M, 2001, CURR OPIN GENET DEV, V11, P328, DOI 10.1016/S0959-437X(00)00198-2; PATEJUNAS G, 1994, SOMAT CELL MOLEC GEN, V20, P55, DOI 10.1007/BF02257486; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Ruijter JM, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-2; Sangild PT, 2006, GASTROENTEROLOGY, V130, P1776, DOI 10.1053/j.gastro.2006.02.026; SARIN SK, 1990, AM J PHYSIOL, V258, pG365, DOI 10.1152/ajpgi.1990.258.3.G365; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; SOUTHERN LL, 1983, J ANIM SCI, V57, P402, DOI 10.2527/jas1983.572402x; Torrents D, 1999, NAT GENET, V21, P293, DOI 10.1038/6809; Toyoshima K, 1998, J HISTOCHEM CYTOCHEM, V46, P1329, DOI 10.1177/002215549804601113; Urschel KL, 2007, AM J PHYSIOL-ENDOC M, V293, pE811, DOI 10.1152/ajpendo.00290.2007; Urschel KL, 2007, J NUTR, V137, P601, DOI 10.1093/jn/137.3.601; VANEIJK HMH, 1993, J CHROMATOGR-BIOMED, V620, P143, DOI 10.1016/0378-4347(93)80062-9; VISEK WJ, 1986, J NUTR, V116, P36, DOI 10.1093/jn/116.1.36; WANG T, 1995, NAT GENET, V11, P185, DOI 10.1038/ng1095-185; WU GY, 1994, J NUTR, V124, P415, DOI 10.1093/jn/124.3.415; Wu GY, 1997, AM J PHYSIOL-GASTR L, V272, pG1382, DOI 10.1152/ajpgi.1997.272.6.G1382; WU GY, 1994, J NUTR, V124, P2437, DOI 10.1093/jn/124.12.2437; WU GY, 1995, AM J PHYSIOL-REG I, V269, pR621, DOI 10.1152/ajpregu.1995.269.3.R621; Wu GY, 2004, J NUTR BIOCHEM, V15, P442, DOI 10.1016/j.jnutbio.2003.11.010; Wu GY, 1998, BIOCHEM J, V336, P1, DOI 10.1042/bj3360001; Zamora SA, 1997, J PEDIATR-US, V131, P226, DOI 10.1016/S0022-3476(97)70158-6	52	5	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e67021	10.1371/journal.pone.0067021	http://dx.doi.org/10.1371/journal.pone.0067021			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785515	gold, Green Published, Green Submitted			2022-12-27	WOS:000321038800008
J	Martinez-Giner, M; Noguera, JL; Balcells, I; Fernandez-Rodriguez, A; Pena, RN				Martinez-Giner, Maria; Luis Noguera, Jose; Balcells, Ingrid; Fernandez-Rodriguez, Amanda; Pena, Ramona N.			Selection of Internal Control Genes for Real-Time Quantitative PCR in Ovary and Uterus of Sows across Pregnancy	PLOS ONE			English	Article							REVERSE TRANSCRIPTION-PCR; POLYMERASE-CHAIN-REACTION; RT-PCR; EXPRESSION; QUANTIFICATION; NORMALIZATION	Background: Reproductive traits play a key role in pig production in order to reduce costs and increase economic returns. Among others, gene expression analyses represent a useful approach to study genetic mechanisms underlying reproductive traits in pigs. The application of reverse-transcription quantitative PCR requires the selection of appropriate reference genes, whose expression levels should not be affected by the experimental conditions, especially when comparing gene expression across different physiological stages. Results: The gene expression stability of ten potential reference genes was studied by three different methods (geNorm, NormFinder and BestKeeper) in ovary and uterus collected at five different physiological time points (heat, and 15, 30, 45 and 60 days of pregnancy). Although final ranking differed, the three algorithms gave very similar results. Thus, the most stable genes across time were TBP and UBC in uterus and TBP and HPRT1 in ovary, while HMBS and ACTB showed the less stable expression in uterus and ovary, respectively. When studied as a systematic effect, the reproductive stage did not significantly affect the expression of the candidate reference genes except at 30d and 60d of pregnancy, when a general drop in expression was observed in ovary. Conclusions: Based in our results, we propose the use of TBP, UBC and SDHA in uterus and TBP, GNB2L1 and HPRT1 in ovary for normalization of longitudinal expression studies using quantitative PCR in sows.	[Martinez-Giner, Maria; Luis Noguera, Jose; Pena, Ramona N.] IRTA, Lleida, Spain; [Balcells, Ingrid] Univ Autonoma Barcelona, Dept Genet Anim, CRAG, E-08193 Barcelona, Spain; [Fernandez-Rodriguez, Amanda] INIA, Madrid, Spain; [Pena, Ramona N.] Univ Lleida, Dept Anim Prod, Lleida, Spain	IRTA; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); University of Barcelona; Universitat de Lleida	Pena, RN (corresponding author), IRTA, Lleida, Spain.	romi.pena@prodan.udl.cat	Rodríguez, Amanda Fernández/Q-4062-2016; Pena, Romi/C-7756-2011	Rodríguez, Amanda Fernández/0000-0002-5110-2213; Pena, Romi/0000-0002-3558-7302	Spanish Ministerio de Ciencia e Innovacion [AGL2004-08368-C03/GAN]; INIA; MICINN	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); INIA(Instituto de Investigacion Agropecuaria (INIA)); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission)	This study was funded by the Spanish Ministerio de Ciencia e Innovacion (grant AGL2004-08368-C03/GAN). RN Pena received a contractual grant from INIA. M Martinez-Giner received a predoctoral fellowship from MICINN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Fleige Simone, 2006, Molecular Aspects of Medicine, V27, P126, DOI 10.1016/j.mam.2005.12.003; GELFAND AE, 1990, J AM STAT ASSOC, V85, P398, DOI 10.2307/2289776; Hafez B.H.E.S.E., 2000, REPROD FARM ANIMALS, V7th ed.; Haller F, 2004, ANAL BIOCHEM, V335, P1, DOI 10.1016/j.ab.2004.08.024; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Kuijk EW, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-58; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Noguera JL, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-636; Nygard AB, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-67; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Raftery AE., 1992, BAYESIAN STAT, V4, P763; Robert C, 2002, BIOL REPROD, V67, P1465, DOI 10.1095/biolreprod.102.006320; Rodriguez C, 2005, ANIM GENET, V36, P490, DOI 10.1111/j.1365-2052.2005.01358.x; Sambrook J., 2001, MOL CLONING LAB MANU; Svobodova K, 2008, J APPL GENET, V49, P263, DOI 10.1007/BF03195623; Tramontana S, 2008, J DAIRY SCI, V91, P3057, DOI 10.3168/jds.2008-1164; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; Wang SQ, 2011, BIOCHEM BIOPH RES CO, V408, P265, DOI 10.1016/j.bbrc.2011.04.010; Wessels JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028940; Zhang XZ, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-4	22	23	23	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66023	10.1371/journal.pone.0066023	http://dx.doi.org/10.1371/journal.pone.0066023			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785467	Green Submitted, Green Published, gold			2022-12-27	WOS:000321038800055
J	Corlett, PR; Cambridge, V; Gardner, JM; Piggot, JS; Turner, DC; Everitt, JC; Arana, FS; Morgan, HL; Milton, AL; Lee, JL; Aitken, MRF; Dickinson, A; Everitt, BJ; Absalom, AR; Adapa, R; Subramanian, N; Taylor, JR; Krystal, JH; Fletcher, PC				Corlett, Philip R.; Cambridge, Victoria; Gardner, Jennifer M.; Piggot, Jennifer S.; Turner, Danielle C.; Everitt, Jessica C.; Arana, Fernando Sergio; Morgan, Hannah L.; Milton, Amy L.; Lee, Jonathan L.; Aitken, Michael R. F.; Dickinson, Anthony; Everitt, Barry J.; Absalom, Anthony R.; Adapa, Ram; Subramanian, Naresh; Taylor, Jane R.; Krystal, John H.; Fletcher, Paul C.			Ketamine Effects on Memory Reconsolidation Favor a Learning Model of Delusions	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; PREDICTION-ERROR SIGNAL; SPONTANEOUS CONFABULATION; SCHIZOPHRENIA-PATIENTS; INDIVIDUAL-DIFFERENCES; HEALTHY-VOLUNTEERS; PREFRONTAL CORTEX; KAMIN BLOCKING; FRONTAL-CORTEX; FEAR MEMORIES	Delusions are the persistent and often bizarre beliefs that characterise psychosis. Previous studies have suggested that their emergence may be explained by disturbances in prediction error-dependent learning. Here we set up complementary studies in order to examine whether such a disturbance also modulates memory reconsolidation and hence explains their remarkable persistence. First, we quantified individual brain responses to prediction error in a causal learning task in 18 human subjects (8 female). Next, a placebo-controlled within-subjects study of the impact of ketamine was set up on the same individuals. We determined the influence of this NMDA receptor antagonist (previously shown to induce aberrant prediction error signal and lead to transient alterations in perception and belief) on the evolution of a fear memory over a 72 hour period: they initially underwent Pavlovian fear conditioning; 24 hours later, during ketamine or placebo administration, the conditioned stimulus (CS) was presented once, without reinforcement; memory strength was then tested again 24 hours later. Re-presentation of the CS under ketamine led to a stronger subsequent memory than under placebo. Moreover, the degree of strengthening correlated with individual vulnerability to ketamine's psychotogenic effects and with prediction error brain signal. This finding was partially replicated in an independent sample with an appetitive learning procedure (in 8 human subjects, 4 female). These results suggest a link between altered prediction error, memory strength and psychosis. They point to a core disruption that may explain not only the emergence of delusional beliefs but also their persistence.	[Corlett, Philip R.; Taylor, Jane R.; Krystal, John H.] Yale Univ, Dept Psychiat, Ribicoff Res Facil, New Haven, CT 06520 USA; [Cambridge, Victoria; Arana, Fernando Sergio; Morgan, Hannah L.; Subramanian, Naresh; Fletcher, Paul C.] Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Brain Mapping Unit,Dept Psychiat, Cambridge CB2 2QQ, England; [Gardner, Jennifer M.; Piggot, Jennifer S.] Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Cambridge CB2 2QQ, England; [Turner, Danielle C.; Everitt, Jessica C.; Milton, Amy L.; Aitken, Michael R. F.; Dickinson, Anthony; Everitt, Barry J.] Univ Cambridge, Dept Psychol, Cambridge, England; [Lee, Jonathan L.] Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England; [Absalom, Anthony R.] Univ Groningen, Univ Med Ctr Groningen, Dept Anesthesiol, Groningen, Netherlands; [Adapa, Ram] Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Div Anaesthesia, Cambridge CB2 2QQ, England; [Fletcher, Paul C.] Fulbourn Hosp, Cambridgeshire & Peterborough NHS Fdn Trust, Cambridge, England	Yale University; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; University of Birmingham; University of Groningen; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Corlett, PR (corresponding author), Yale Univ, Dept Psychiat, Ribicoff Res Facil, New Haven, CT 06520 USA.	philip.corlett@yale.edu	Absalom, Anthony/GPG-1582-2022; Lee, Jonathan LC/A-9629-2008; Adapa, Ram/D-7925-2012; Milton, Amy L/B-6839-2009; Fletcher, Paul/F-5380-2011	Lee, Jonathan LC/0000-0002-2284-2482; Adapa, Ram/0000-0002-9845-8532; Milton, Amy L/0000-0003-0175-9417; Everitt, Barry/0000-0003-4431-6536; Absalom, Anthony/0000-0001-7563-9157; Aitken Deakin, Michael/0000-0001-9763-8999; Corlett, Philip/0000-0002-5368-1992; Fletcher, Paul/0000-0001-8257-1517; Everitt, Jeffrey/0000-0003-0273-6284	Wellcome Trust; Bernard Wolfe Health Neuroscience fund; Medical Research Council; MRC [G1002231] Funding Source: UKRI; Medical Research Council [G1000183B, G0001354B, G1002231, G0001354] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Bernard Wolfe Health Neuroscience fund; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by the Wellcome Trust and the Bernard Wolfe Health Neuroscience fund. It was conducted at the Wellcome Trust Clinical Research Facility and the Wolfson Brain Imaging Centre (Addenbrooke's Hospital, Cambridge) and within the Behavioral and Clinical Neuroscience Institute supported by the Medical Research Council and the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren T, 2012, SCIENCE, V337, P1550, DOI 10.1126/science.1223006; Anand A, 2000, ARCH GEN PSYCHIAT, V57, P270, DOI 10.1001/archpsyc.57.3.270; Anticevic A, 2012, P NATL ACAD SCI USA, V109, P16720, DOI 10.1073/pnas.1208494109; BEGG IM, 1992, J EXP PSYCHOL GEN, V121, P446, DOI 10.1037/0096-3445.121.4.446; Behrens TEJ, 2008, NATURE, V456, P245, DOI 10.1038/nature07538; Bhatt R, 2010, PSYCHIAT RES, V178, P260, DOI 10.1016/j.psychres.2009.02.006; Bleuler E., 1908, ALLG Z PSYCHIAT, V65, P436; Bouton ME, 2000, HEALTH PSYCHOL, V19, P57, DOI 10.1037/0278-6133.19.Suppl1.57; Bouton ME, 2002, BIOL PSYCHIAT, V52, P976, DOI 10.1016/S0006-3223(02)01546-9; Bremner JD, 1998, J TRAUMA STRESS, V11, P125, DOI 10.1023/A:1024465317902; Corlett PR, 2007, BRAIN, V130, P2387, DOI 10.1093/brain/awm173; Corlett PR, 2007, J PSYCHOPHARMACOL, V21, P238, DOI 10.1177/0269881107077716; Corlett PR, 2012, NEUROPSYCHOLOGIA, V50, P3612, DOI 10.1016/j.neuropsychologia.2012.09.045; Corlett PR, 2009, PSYCHOPHARMACOLOGY, V206, P515, DOI 10.1007/s00213-009-1561-0; Corlett PR, 2006, ARCH GEN PSYCHIAT, V63, P611, DOI 10.1001/archpsyc.63.6.611; Corlett Philip R, 2010, Biol Psychiatry, V68, pe1, DOI 10.1016/j.biopsych.2010.02.015; Corlett PR, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.053.2009; Corlett PR, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.012.2009; Corlett PR, 2004, NEURON, V44, P877, DOI 10.1016/j.neuron.2004.11.022; Corlett PR, 2010, PROG NEUROBIOL; Corlett PR, 2010, NEUROPSYCHOPHARMACOL; Daw ND, 2011, NEURON, V69, P1204, DOI 10.1016/j.neuron.2011.02.027; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Deakin JFW, 2008, ARCH GEN PSYCHIAT, V65, P154, DOI 10.1001/archgenpsychiatry.2007.37; Dickinson A, 2001, Q J EXP PSYCHOL-B, V54, P3, DOI 10.1080/02724990042000010; Duman RS, 2012, NEUROPHARMACOLOGY, V62, P35, DOI 10.1016/j.neuropharm.2011.08.044; Duvarci S, 2005, EUR J NEUROSCI, V21, P283, DOI 10.1111/j.1460-9568.2004.03824.x; Eisenhardt D, 2007, NEUROBIOL LEARN MEM, V87, P167, DOI 10.1016/j.nlm.2006.09.005; Fletcher PC, 2001, BRAIN, V124, P849, DOI 10.1093/brain/124.5.849; Fletcher PC, 2006, TRENDS COGN SCI, V10, P167, DOI 10.1016/j.tics.2006.02.008; Fletcher PC, 2001, NAT NEUROSCI, V4, P1043, DOI 10.1038/nn733; Freeman TP, 2012, PSYCHOPHARMACOLOGY; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Glascher J, 2010, NEURON, V66, P585, DOI 10.1016/j.neuron.2010.04.016; GOLD JM, 1992, J ABNORM PSYCHOL, V101, P487, DOI 10.1037/0021-843X.101.3.487; GRAY JA, 1991, BEHAV BRAIN SCI, V14, P1, DOI 10.1017/S0140525X00065055; GROSS G, 1972, ARCH PSYCHIAT NERVEN, V216, P119, DOI 10.1007/BF00346414; Hamm AO, 2005, INT J PSYCHOPHYSIOL, V57, P5, DOI 10.1016/j.ijpsycho.2005.01.006; Hoffken O, 2012, EXPT BRAIN RES EXPT; HOLLAND PC, 1984, J EXP PSYCHOL ANIM B, V10, P476, DOI 10.1037/0097-7403.10.4.476; Holt DJ, 2008, BIOL PSYCHIAT; Honey GD, 2008, J NEUROSCI, V28, P6295, DOI 10.1523/JNEUROSCI.0910-08.2008; Jaspers Karl, 1963, GEN PSYCHOPATHOLOGY; Javadi AH, 2012, BRAIN STIMULATION; Jensen J, 2008, NEUROPSYCHOPHARMACOL, V33, P473, DOI 10.1038/sj.npp.1301437; Kamin L, 1969, PUNISHMENT AVERSIVE; Kapur S, 2003, AM J PSYCHIAT, V160, P13, DOI 10.1176/appi.ajp.160.1.13; Kiekkas P, 2010, INT NURS REV, V57, P288, DOI 10.1111/j.1466-7657.2010.00809.x; Kindt M, 2009, NAT NEUROSCI, V12, P256, DOI 10.1038/nn.2271; Kosslyn SM, 2002, AM PSYCHOL, V57, P341, DOI 10.1037//0003-066X.57.5.341; Le Pelley ME, 2005, J EXP PSYCHOL ANIM B, V31, P56, DOI 10.1037/0097-7403.31.1.56; Lee JLC, 2008, NAT NEUROSCI, V11, P1264, DOI 10.1038/nn.2205; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Lovibond PF, 2008, Q J EXP PSYCHOL, V61, P1199, DOI 10.1080/17470210701503229; Lovibond PF, 2009, BEHAV RES THER, V47, P716, DOI 10.1016/j.brat.2009.04.013; Lovibond PF, 2004, LEARN MEMORY, V11, P495, DOI 10.1101/lm.79604; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; McDannald MA, 2011, J NEUROSCI, V31, P2700, DOI 10.1523/JNEUROSCI.5499-10.2011; McGhee LL, 2008, J TRAUMA, V64, pS195, DOI 10.1097/TA.0b013e318160ba1d; MCGHIE A, 1961, BRIT J MED PSYCHOL, V34, P103, DOI 10.1111/j.2044-8341.1961.tb00936.x; McNally JM, 2011, NEUROSCIENCE, V199, P51, DOI 10.1016/j.neuroscience.2011.10.015; Menon M, 2007, BIOL PSYCHIAT, V62, P765, DOI 10.1016/j.biopsych.2006.10.020; MISANIN JR, 1968, SCIENCE, V160, P554, DOI 10.1126/science.160.3827.554; Mishara AL, 2009, BEHAV BRAIN SCI, V32, P530, DOI 10.1017/S0140525X09991464; Moghaddam B, 1997, J NEUROSCI, V17, P2921; Moore JW, 2011, COGN NEUROPSYCHIATRY, V16, P364, DOI 10.1080/13546805.2010.546074; Moran PM, 2003, J PSYCHIAT RES, V37, P155, DOI 10.1016/S0022-3956(02)00099-7; Morgan HL, 2011, BIOL PSYCHIAT, V69, P35, DOI 10.1016/j.biopsych.2010.07.032; Moritz S, 2012, J BEHAV THERAPY EXPT; Murray GK, 2008, MOL PSYCHIATR, V13, P267, DOI 10.1038/sj.mp.4002058; Murray JD, 2012, CEREBRAL CORTEX; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Narimatsu E, 2002, BRAIN RES, V953, P272, DOI 10.1016/S0006-8993(02)03375-9; Nomura H, 2008, NEUROPSYCHOPHARMACOL, V33, P2912, DOI 10.1038/npp.2008.13; O'Tuathaigh CMP, 2003, BEHAV PHARMACOL, V14, P315, DOI 10.1097/01.fbp.0000080416.18561.3e; Ohman A, 1998, J EXP PSYCHOL GEN, V127, P69, DOI 10.1037/0096-3445.127.1.69; Ohman A, 2001, PSYCHOL REV, V108, P483, DOI 10.1037//0033-295X.108.3.483; Orr SP, 2000, J ABNORM PSYCHOL, V109, P290, DOI 10.1037//0021-843X.109.2.290; Pan WX, 2008, J NEUROSCI, V28, P9619, DOI 10.1523/JNEUROSCI.0255-08.2008; PEARCE JM, 1980, PSYCHOL REV, V87, P532, DOI 10.1037/0033-295X.87.6.532; Pedreira ME, 2004, LEARN MEMORY, V11, P579, DOI 10.1101/lm.76904; Petrakis IL, 2004, AM J PSYCHIAT, V161, P1776, DOI 10.1176/appi.ajp.161.10.1776; Pomarol-Clotet E, 2006, BRIT J PSYCHIAT, V189, P173, DOI 10.1192/bjp.bp.105.015263; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Rao-Ruiz P, 2011, NAT NEUROSCI, V14, P1302, DOI 10.1038/nn.2907; Rescorla R.A., 1972, CLASSICAL CONDITIONI; Romaniuk L, 2010, ARCH GEN PSYCHIAT, V67, P1246, DOI 10.1001/archgenpsychiatry.2010.169; Samartgis JR, 2012, NEUROBIOLOGY LEARNIN; Schiller D, 2010, NATURE, V463, P49, DOI 10.1038/nature08637; Schlagenhauf F, 2009, BIOL PSYCHIAT, V65, P1032, DOI 10.1016/j.biopsych.2008.12.016; Schmidt A, 2012, NEUROPSYCHOPHARMACOL, V37, P865, DOI 10.1038/npp.2011.261; Schnider A, 2005, NEUROLOGY, V65, P1117, DOI 10.1212/01.wnl.0000178900.37611.8d; Schnider A, 2001, BRAIN RES REV, V36, P150, DOI 10.1016/S0165-0173(01)00090-X; Schonenberg M, 2008, J PSYCHOPHARMACOL, V22, P493, DOI 10.1177/0269881107082481; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; SCHULTZ W, 1993, J NEUROSCI, V13, P900; Schwabe L, 2012, BIOL PSYCHIAT, V71, P380, DOI 10.1016/j.biopsych.2011.10.028; Sevenster D, 2012, NEUROBIOL LEARN MEM, V97, P338, DOI 10.1016/j.nlm.2012.01.009; Soeter M, 2010, NEUROBIOL LEARN MEM, V94, P30, DOI 10.1016/j.nlm.2010.03.004; STEINBER.HR, 1969, PSYCHOL REP, V25, P195, DOI 10.2466/pr0.1969.25.1.195; Turner DC, 2004, CEREB CORTEX, V14, P872, DOI 10.1093/cercor/bhh046; UNDERWOOD BJ, 1975, AM PSYCHOL, V30, P128, DOI 10.1037/h0076759; Vul E, 2012, NEUROIMAGE; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500; Weike AI, 2007, PSYCHOPHYSIOLOGY, V44, P170, DOI 10.1111/j.1469-8986.2006.00469.x; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Zhai HF, 2008, BEHAV PHARMACOL, V19, P211, DOI 10.1097/FBP.0b013e3282fe88a0	108	39	39	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65088	10.1371/journal.pone.0065088	http://dx.doi.org/10.1371/journal.pone.0065088			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776445	Green Published, gold, Green Submitted			2022-12-27	WOS:000320322400008
J	de Seny, D; Cobraiville, G; Charlier, E; Neuville, S; Esser, N; Malaise, D; Malaise, O; Calvo, FQ; Relic, B; Malaise, MG				de Seny, Dominique; Cobraiville, Gael; Charlier, Edith; Neuville, Sophie; Esser, Nathalie; Malaise, Denis; Malaise, Olivier; Calvo, Florence Quesada; Relic, Biserka; Malaise, Michel G.			Acute-Phase Serum Amyloid A in Osteoarthritis: Regulatory Mechanism and Proinflammatory Properties	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; C-REACTIVE PROTEIN; RHEUMATOID-ARTHRITIS; ARTICULAR CHONDROCYTES; GENE-EXPRESSION; SYNOVIAL-FLUID; IN-VITRO; KAPPA-B; RECEPTOR; BINDING	Objective: To determine if serum amyloid A (A-SAA) could be detected in human osteoarthritic (OA) joints and further clarify if high A-SAA level in joints result from a local production or from a diffusion process from abnormally elevated plasma concentration. Regulatory mechanism of A-SAA expression and its pro-inflammatory properties were also investigated. Methods: A-SAA levels in serum and synovial fluid of OA (n = 29) and rheumatoid arthritis (RA) (n = 27) patients were measured and compared to matched-healthy volunteers (HV) (n = 35). In vitro cell cultures were performed on primary joint cells provided from osteoarthritis patients. Regulatory mechanisms were studied using Western-blotting, ELISA and lentiviral transfections. Results: A-SAA was statistically increased in OA plasma patients compared to HV. Moreover, A-SAA level in OA plasma and synovial fluid increased with the Kellgren & Lauwrence grade. For all OA and RA patients, A-SAA plasma level was higher and highly correlated with its corresponding level in the synovial fluid, therefore supporting that A-SAA was mainly due to the passive diffusion process from blood into the joint cavity. However, A-SAA expression was also observed in vitro under corticosteroid treatment and/or under IL-1beta stimuli. A-SAA expression was down-regulated by PPAR-gamma agonists (genistein and rosiglitazone) and up-regulated by TGF-beta 1 through Alk1 (Smad1/5) pathway. RhSAA induced proinflammatory cytokines (IL-6, IL-8, GRO-alpha and MCP-1) and metalloproteinases (MMP-1, MMP-3 and MMP-13) expression in FLS and chondrocytes, which expression was downregulated by TAK242, a specific TLR4 inhibitor. Conclusion: Systemic or local A-SAA expression inside OA joint cavity may play a key role in inflammatory process seen in osteoarthritis, which could be counteracted by TLR4 inhibition.	[de Seny, Dominique; Cobraiville, Gael; Charlier, Edith; Neuville, Sophie; Malaise, Denis; Malaise, Olivier; Calvo, Florence Quesada; Relic, Biserka; Malaise, Michel G.] Univ Liege, CHU Liege, GIGA Res, Lab Rheumatol, Liege, Belgium; [Esser, Nathalie] Univ Liege, GIGA Res, Virol & Immunol Unit, Liege, Belgium	University of Liege; University of Liege	de Seny, D (corresponding author), Univ Liege, CHU Liege, GIGA Res, Lab Rheumatol, Liege, Belgium.	ddeseny@chu.ulg.ac.be		Malaise, Denis/0000-0001-7454-819X	"Fond d'Investissement pour la Recherche Scientifique" (FIRS), CHU Liege, Belgium	"Fond d'Investissement pour la Recherche Scientifique" (FIRS), CHU Liege, Belgium	This study was supported by the "Fond d'Investissement pour la Recherche Scientifique" (FIRS), CHU Liege, Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Baranova IN, 2010, J BIOL CHEM, V285, P8492, DOI 10.1074/jbc.M109.007526; BENYA PD, 1978, CELL, V15, P1313, DOI 10.1016/0092-8674(78)90056-9; Bozinovski S, 2012, P NATL ACAD SCI USA, V109, P935, DOI 10.1073/pnas.1109382109; Brennan FM, 2008, J CLIN INVEST, V118, P3537, DOI 10.1172/JCI36389; Cai H, 2007, J IMMUNOL, V178, P1852, DOI 10.4049/jimmunol.178.3.1852; Cai L, 2005, J BIOL CHEM, V280, P2954, DOI 10.1074/jbc.M411555200; Cheng N, 2008, J IMMUNOL, V181, P22, DOI 10.4049/jimmunol.181.1.22; Conde J, 2011, ARTHRITIS, DOI 10.1155/2011/203901; Conde J, 2011, ANN RHEUM DIS, V70, P551, DOI 10.1136/ard.2010.132399; Connolly M, 2012, ARTHRITIS RHEUM-US, V64, P1035, DOI 10.1002/art.33455; Connolly M, 2010, J IMMUNOL, V184, P6427, DOI 10.4049/jimmunol.0902941; Cunnane G, 2000, J RHEUMATOL, V27, P58; Dahaghin S, 2007, ANN RHEUM DIS, V66, P916, DOI 10.1136/ard.2005.045724; Davidson ENB, 2009, J IMMUNOL, V182, P7937, DOI 10.4049/jimmunol.0803991; de Seny D, 2008, CLIN CHEM, V54, P1066, DOI 10.1373/clinchem.2007.099549; EMI N, 1991, J VIROL, V65, P1202, DOI 10.1128/JVI.65.3.1202-1207.1991; Fukui N, 2011, ARTHRITIS RHEUM-US, V63, P1938, DOI 10.1002/art.30351; GANAPATHI MK, 1991, J IMMUNOL, V147, P1261; Gomez R, 2011, NAT REV RHEUMATOL, V7, P528, DOI 10.1038/nrrheum.2011.107; Hayes AJ, 2007, J HISTOCHEM CYTOCHEM, V55, P853, DOI 10.1369/jhc.7A7210.2007; Jousilahti P, 2001, ATHEROSCLEROSIS, V156, P451, DOI 10.1016/S0021-9150(00)00681-X; Katz JD, 2010, CURR OPIN RHEUMATOL, V22, P512, DOI 10.1097/BOR.0b013e32833bfb4b; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Koga T, 2008, FEBS LETT, V582, P579, DOI 10.1016/j.febslet.2008.01.022; Kumon Y, 2002, SCAND J IMMUNOL, V56, P504, DOI 10.1046/j.1365-3083.2002.01169.x; KUSHNER I, 1994, BAILLIERE CLIN RHEUM, V8, P513, DOI 10.1016/S0950-3579(05)80113-X; KUSHNER I, 1982, ANN NY ACAD SCI, V389, P39, DOI 10.1111/j.1749-6632.1982.tb22124.x; Lee MS, 2006, J IMMUNOL, V177, P5585, DOI 10.4049/jimmunol.177.8.5585; Matsunaga N, 2011, MOL PHARMACOL, V79, P34, DOI 10.1124/mol.110.068064; Miida T, 2006, BBA-MOL CELL BIOL L, V1761, P424, DOI 10.1016/j.bbalip.2006.03.013; Mullan RH, 2006, ARTHRITIS RHEUM-US, V54, P105, DOI 10.1002/art.21518; Mullan RH, 2010, AM J PATHOL, V176, P1999, DOI 10.2353/ajpath.2010.090014; Nair A, 2012, ARTHRITIS RHEUM-US, V64, P2268, DOI 10.1002/art.34495; O'Hara R, 2000, ARTHRITIS RES, V2, P142, DOI 10.1186/ar78; O'Hara R, 2004, ARTHRITIS RHEUM-US, V50, P1788, DOI 10.1002/art.20301; Okamoto H, 2008, J RHEUMATOL, V35, P752; Oliviero F, 2012, CLIN CHIM ACTA, V413, P303, DOI 10.1016/j.cca.2011.10.019; Pottie P, 2006, ANN RHEUM DIS, V65, P1403, DOI 10.1136/ard.2006.061994; Puenpatom RA, 2009, POSTGRAD MED, V121, P9, DOI 10.3810/pgm.2009.11.2073; Relic B, 2002, LAB INVEST, V82, P1661, DOI 10.1097/01.LAB.0000041714.05322.C0; Relic B, 2006, J BIOL CHEM, V281, P22597, DOI 10.1074/jbc.M512807200; Relic B, 2009, LAB INVEST, V89, P811, DOI 10.1038/labinvest.2009.41; Sandri S, 2008, J LEUKOCYTE BIOL, V83, P1174, DOI 10.1189/jlb.0407203; Stokes DG, 2001, BIOCHEM J, V360, P461, DOI 10.1042/0264-6021:3600461; Thorn CF, 2004, SCAND J IMMUNOL, V59, P152, DOI 10.1111/j.0300-9475.2004.01369.x; Thorn CF, 2002, J IMMUNOL, V169, P399, DOI 10.4049/jimmunol.169.1.399; Vallon R, 2001, J IMMUNOL, V166, P2801, DOI 10.4049/jimmunol.166.4.2801; van den Berg WB, 2011, OSTEOARTHR CARTILAGE, V19, P338, DOI 10.1016/j.joca.2011.01.022; van der Westhuyzen DR, 2005, J BIOL CHEM, V280, P35890, DOI 10.1074/jbc.M505685200; Vlasova MA, 2006, BIOCHEMISTRY-MOSCOW+, V71, P1051, DOI 10.1134/S0006297906100014; VONDERMARK K, 1977, NATURE, V267, P531, DOI 10.1038/267531a0; Wentworth JM, 2010, DIABETES, V59, P1648, DOI 10.2337/db09-0287; Yang RZ, 2006, PLOS MED, V3, P884, DOI 10.1371/journal.pmed.0030287; Yoon YM, 2002, J BIOL CHEM, V277, P8412, DOI 10.1074/jbc.M110608200; Zeddou M, 2012, STEM CELLS DEV, V21, P1948, DOI 10.1089/scd.2011.0321	57	55	55	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66769	10.1371/journal.pone.0066769	http://dx.doi.org/10.1371/journal.pone.0066769			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776697	Green Published, gold, Green Submitted			2022-12-27	WOS:000320322400117
J	Acosta-Gonzalez, G; Rodriguez-Zaragoza, FA; Hernandez-Landa, RC; Arias-Gonzalez, JE				Acosta-Gonzalez, Gilberto; Rodriguez-Zaragoza, Fabian A.; Hernandez-Landa, Roberto C.; Arias-Gonzalez, Jesus E.			Additive Diversity Partitioning of Fish in a Caribbean Coral Reef Undergoing Shift Transition	PLOS ONE			English	Article							MULTIPLE SPATIAL SCALES; BETA-DIVERSITY; SPECIES-DIVERSITY; PHASE-SHIFTS; ECOSYSTEM FUNCTION; ALPHA-DIVERSITY; BIODIVERSITY; COMMUNITY; HABITAT; CONSERVATION	Shift transitions in dominance on coral reefs from hard coral cover to fleshy macroalgae are having negative effects on Caribbean coral reef communities. Data on spatiotemporal changes in biodiversity during these modifications are important for decision support for coral reef biodiversity protection. The main objective of this study is to detect the spatiotemporal patterns of coral reef fish diversity during this transition using additive diversity-partitioning analysis. We examined alpha, beta and gamma fish diversity from 2000 to 2010, during which time a shift transition occurred at Mahahual Reef, located in Quintana Roo, Mexico. Data on coral reef fish and benthic communities were obtained from 12 transects per geomorphological unit (GU) in two GUs (reef slope and terrace) over six years (2000, 2005, 2006, 2007, 2008, 2010). Spatial analysis within and between the GUs indicated that the gamma-diversity was primarily related to higher beta-diversity. Throughout the six study years, there were losses of alpha, beta and gamma-diversity associated spatially with the shallow (reef slope) and deeper (reef terrace) GUs and temporally with the transition in cover from mound corals to fleshy macroalgae and boulder corals. Despite a drastic reduction in the number of species over time, beta-diversity continues to be the highest component of gamma-diversity. The shift transition had a negative effect on alpha, beta and gamma-diversity, primarily by impacting rare species, leading a group of small and less vulnerable fish species to become common and an important group of rare species to become locally extinct. The maintenance of fish heterogeneity (beta-diversity) over time may imply the abetment of vulnerability in the face of local and global changes.	[Acosta-Gonzalez, Gilberto; Hernandez-Landa, Roberto C.; Arias-Gonzalez, Jesus E.] IPN, Unidad Merida, Ctr Invest & Estudios Avanzados, Lab Ecol Ecosistemas Arrecifes Coralinos, Merida, Yucatan, Mexico; [Rodriguez-Zaragoza, Fabian A.] Univ Guadalajara, CUCBA, Dept Ecol, LEMA, Guadalajara, Jalisco, Mexico	Instituto Politecnico Nacional - Mexico; Universidad de Guadalajara	Arias-Gonzalez, JE (corresponding author), IPN, Unidad Merida, Ctr Invest & Estudios Avanzados, Lab Ecol Ecosistemas Arrecifes Coralinos, Merida, Yucatan, Mexico.	earias@mda.cinvestav.mx	Zaragoza, Fabian Alejandro Rodriguez/B-3477-2015	Zaragoza, Fabian Alejandro Rodriguez/0000-0002-0066-4275; Arias-Gonzalez, Jesus Ernesto/0000-0003-4601-710X	Consejo Nacional de Ciencia y Tecnologia, Mexico (CONACyT) [201]; Laboratorio de Ecologia de Ecosistemas de Arrecifes Coralinos (LEEAC); Centro de Investigacion y de Estudios Avanzados del I.P.N.	Consejo Nacional de Ciencia y Tecnologia, Mexico (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Laboratorio de Ecologia de Ecosistemas de Arrecifes Coralinos (LEEAC); Centro de Investigacion y de Estudios Avanzados del I.P.N.	This study was funded by the Consejo Nacional de Ciencia y Tecnologia, Mexico (CONACyT: project 201); the Laboratorio de Ecologia de Ecosistemas de Arrecifes Coralinos (LEEAC) and by the Centro de Investigacion y de Estudios Avanzados del I.P.N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almany GR, 2004, OIKOS, V106, P275, DOI 10.1111/j.0030-1299.2004.13193.x; Alvarez-Filip L, 2009, P ROYAL SOC BIOL SCI, V276, P1669; Alvarez-Filip L, 2011, CORAL REEFS, V30, P1051, DOI 10.1007/s00338-011-0795-6; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Andrefouet S, 2005, CORAL REEFS, V24, P31, DOI 10.1007/s00338-004-0444-4; Arias-Gonzalez JE, 2011, CIENC MAR, V37, P87, DOI 10.7773/cm.v37i1.1746; BELL JD, 1984, MAR ECOL PROG SER, V15, P265, DOI 10.3354/meps015265; Bellwood DR, 2006, P ROY SOC B-BIOL SCI, V273, P101, DOI 10.1098/rspb.2005.3276; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bellwood DR, 2001, SCIENCE, V292, P1532, DOI 10.1126/science.1058635; Belmaker J, 2008, ECOLOGY, V89, P2829, DOI 10.1890/07-1464.1; Bozec YM, 2008, P 11 INT COR REEF S, V18, P691; Bozec YM, 2011, MAR BIOL, V158, P969, DOI 10.1007/s00227-011-1623-9; Bruckner A. W, 2006, Rev. biol. trop, V54, P45; Chabanet P, 1997, CORAL REEFS, V16, P93, DOI 10.1007/s003380050063; CHATTERJEE S, 2000, REGRESION ANAL EXAMP; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Colwell RK, 2012, J PLANT ECOL, V5, P3, DOI 10.1093/jpe/rtr044; Crist TO, 2003, AM NAT, V162, P734, DOI 10.1086/378901; DeVries PJ, 1997, BIOL J LINN SOC, V62, P343, DOI 10.1111/j.1095-8312.1997.tb01630.x; Diekotter T, 2008, BASIC APPL ECOL, V9, P298, DOI 10.1016/j.baae.2007.03.003; Dornelas M, 2006, NATURE, V440, P80, DOI 10.1038/nature04534; Edmunds PJ, 2000, MAR ECOL PROG SER, V202, P113, DOI 10.3354/meps202113; Arias-Gonzalez JE, 2012, BIODIVERS CONSERV, V21, P115, DOI 10.1007/s10531-011-0169-y; Arias-Gonzalez JE, 2008, J EXP MAR BIOL ECOL, V366, P28, DOI 10.1016/j.jembe.2008.07.035; Fisher WS, 2008, MAR POLLUT BULL, V56, P1737, DOI 10.1016/j.marpolbul.2008.07.002; Folke C, 1996, ECOL APPL, V6, P1018, DOI 10.2307/2269584; Friedlander AM, 2003, CORAL REEFS, V22, P291, DOI 10.1007/s00338-003-0317-2; Garcia-Lopez A, 2010, ANN ENTOMOL SOC AM, V103, P956, DOI 10.1603/AN10078; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Gering JC, 2003, CONSERV BIOL, V17, P488, DOI 10.1046/j.1523-1739.2003.01465.x; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; Grotan V, 2012, J ANIM ECOL, V81, P714, DOI 10.1111/j.1365-2656.2011.01950.x; Harborne AR, 2011, MAR ECOL PROG SER, V437, P201, DOI 10.3354/meps09280; Harrison S, 2006, J ECOL, V94, P110, DOI 10.1111/j.1365-2745.2005.01078.x; Hewitt J, 2010, BIODIVERS CONSERV, V19, P1315, DOI 10.1007/s10531-009-9763-7; Holbrook SJ, 2002, ECOLOGY, V83, P2855, DOI 10.2307/3072021; Holland SM, 2010, PALAEONTOLOGY, V53, P1237, DOI 10.1111/j.1475-4983.2010.01017.x; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Humann P, 2002, REEF CORAL IDENTIFIC, P86; Idjadi JA, 2006, CORAL REEFS, V25, P209, DOI 10.1007/s00338-006-0088-7; Johansen JL, 2008, MAR ECOL PROG SER, V360, P219, DOI 10.3354/meps07482; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; Knowlton N, 2001, P NATL ACAD SCI USA, V98, P5419, DOI 10.1073/pnas.091092998; Koleff P, 2003, J ANIM ECOL, V72, P367, DOI 10.1046/j.1365-2656.2003.00710.x; Lande R, 1996, OIKOS, V76, P5, DOI 10.2307/3545743; Lande R., 2003, OXFORD SERIES ECOLOG; Lara EN, 1998, J FISH BIOL, V53, P209, DOI 10.1111/j.1095-8649.1998.tb01028.x; Layou KM, 2007, PALEOBIOLOGY, V33, P116, DOI 10.1666/06025.1; Lyons KG, 2001, ECOL LETT, V4, P358, DOI 10.1046/j.1461-0248.2001.00235.x; Magurran A.E., 2004, MEASURING BIOL DIVER, P162; Maliao RJ, 2008, MAR BIOL, V154, P841, DOI 10.1007/s00227-008-0977-0; McManus JW, 2000, ICES J MAR SCI, V57, P572, DOI 10.1006/jmsc.2000.0720; Moreno CE, 2001, BIODIVERS CONSERV, V10, P367, DOI 10.1023/A:1016614510040; Mumby PJ, 2008, TRENDS ECOL EVOL, V23, P555, DOI 10.1016/j.tree.2008.06.011; Mumby PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008657; Nunez-Lara E, 2005, J EXP MAR BIOL ECOL, V324, P157, DOI 10.1016/j.jembe.2005.04.011; Oksanen J., 2016, R PACKAG; Pandolfi JM, 2006, ECOL LETT, V9, P818, DOI 10.1111/j.1461-0248.2006.00933.x; R Development Core Team, 2011, R LANG ENV STAT COMP; Ricotta C, 2003, ACTA BIOTHEOR, V51, P91, DOI 10.1023/A:1024539526618; Rodriguez-Zaragoza FA, 2008, CARIBB J SCI, V44, P90; Rodriguez-Zaragoza FA, 2011, BIODIVERS CONSERV, V20, P1655, DOI 10.1007/s10531-011-0053-9; Rosenzweig ML, 1999, SCIENCE, V284, P276, DOI 10.1126/science.284.5412.276; Ruiz-Zarate Miguel A., 2003, Atoll Research Bulletin, V496, P318; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; SEPKOSKI JJ, 1988, PALEOBIOLOGY, V14, P221, DOI 10.1017/S0094837300011969; SMITH EP, 1984, BIOMETRICS, V40, P119, DOI 10.2307/2530750; Smith MD, 2003, ECOL LETT, V6, P509, DOI 10.1046/j.1461-0248.2003.00454.x; SOLOW AR, 1993, J ANIM ECOL, V62, P191, DOI 10.2307/5493; Stendera SES, 2005, FRESHWATER BIOL, V50, P1360, DOI 10.1111/j.1365-2427.2005.01403.x; Summerville KS, 2005, BIODIVERS CONSERV, V14, P3393, DOI 10.1007/s10531-004-0546-x; Syms C, 2001, OECOLOGIA, V127, P560, DOI 10.1007/s004420000617; ter Braak C.J.F., 2002, CANOCO REFERENCE MAN, P500; Ter Braak CJF, 1991, BOOTSTRAPPING RELATE, P79; Veech JA, 2002, OIKOS, V99, P3, DOI 10.1034/j.1600-0706.2002.990101.x; Veech JA, 2009, PARTITION SOFTWARE H; Veech JA, 2007, GLOBAL ECOL BIOGEOGR, V16, P650, DOI 10.1111/j.1466-8238.2007.00315.x; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190; WHITTAKER RH, 1960, ECOL MONOGR, V30, P280, DOI 10.2307/1943563; Wiens JA, 1996, ECOL APPL, V6, P828, DOI 10.2307/2269488; Zar JH, 1999, BIOSTATISTICAL ANAL; Zavaleta ES, 2004, SCIENCE, V306, P1175, DOI 10.1126/science.1102643; Zuur A.F., 2007, ANAL ECOLOGICAL DATA; Zvuloni A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009941	88	32	32	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65665	10.1371/journal.pone.0065665	http://dx.doi.org/10.1371/journal.pone.0065665			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776521	Green Published, gold, Green Submitted			2022-12-27	WOS:000320755400054
J	Arnberg, FK; Melin, L				Arnberg, Filip K.; Melin, Lennart			Can Demographic and Exposure Characteristics Predict Levels of Social Support in Survivors from a Natural Disaster?	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; CRISIS SUPPORT; TSUNAMI SURVIVORS; MENTAL-HEALTH; RISK-FACTORS; GENDER; SYMPTOMATOLOGY; DETERIORATION; POPULATION; LONELINESS	Objective: Lack of social support is a strong predictor for poor mental health after disasters. Psychosocial post-disaster interventions may benefit from targeting survivors at risk of low support, yet it is unknown whether demographic and disaster exposure characteristics are associated with social support. This study assessed if age, gender, educational status, cohabitation, and disaster exposure severity predicted aspects of informal social support in a cohort of Swedish survivors from the 2004 Southeast Asian tsunami. Methods: The participants were 3,536 disaster survivors who responded to a mail survey 14 months after the disaster (49% response rate). Their perceptions of present emotional support, contact with others, tangible support, negative support and overall satisfaction with informal support were assessed with the Crisis Support Scale and analysed in five separate ordinal regressions. Results: Demographic factors and exposure severity explained variation in social supports although the effect size and predictive efficiency were modest. Cohabitation and female gender were associated with both more positive and more negative support. Single-household men were at risk for low emotional support and younger women were more likely to perceive negative support. Higher education was associated with more positive support, whereas no clear pattern was found regarding age as a predictor. Disaster exposure severity was associated with more negative support and less overall support satisfaction. Conclusions: After a disaster that entailed little disruptions to the community the associations between demographic characteristics and social support concur with findings in the general population. The findings suggest that psychosocial disaster interventions may benefit from targeting specific groups of survivors.	[Arnberg, Filip K.] Uppsala Univ, Dept Neurosci, Natl Ctr Disaster Psychiat, Uppsala, Sweden; [Melin, Lennart] Uppsala Univ, Dept Psychol, Uppsala, Sweden	Uppsala University; Uppsala University	Arnberg, FK (corresponding author), Uppsala Univ, Dept Neurosci, Natl Ctr Disaster Psychiat, Uppsala, Sweden.	filip.arnberg@neuro.uu.se	Arnberg, Filip/I-5756-2019	Arnberg, Filip/0000-0002-1317-2093	Swedish Emergency Management Agency; Swedish National Board of Health and Welfare	Swedish Emergency Management Agency; Swedish National Board of Health and Welfare	The work was funded by The Swedish Emergency Management Agency (www.msb.se) and The Swedish National Board of Health and Welfare (www.socialstyrelsen.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews B, 2003, J TRAUMA STRESS, V16, P421, DOI 10.1023/A:1024478305142; [Anonymous], 2007, PSYCHIATRY, V70, P283, DOI 10.1521/psyc.2007.70.4.283; Arnberg FK, 2012, J TRAUMA STRESS, V25, P721, DOI 10.1002/jts.21758; Arnberg FK, 2011, J TRAUMA STRESS, V24, P183, DOI 10.1002/jts.20629; ASHTON WA, 1993, SEX ROLES, V28, P461, DOI 10.1007/BF00289608; Boscarino JA, 2009, SOC PSYCH PSYCH EPID, V44, P887, DOI 10.1007/s00127-009-0011-y; BOYLE GJ, 1991, PERS INDIV DIFFER, V12, P291, DOI 10.1016/0191-8869(91)90115-R; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; BROOKINGS JB, 1988, AM J COMMUN PSYCHOL, V16, P137, DOI 10.1007/BF00906076; Brymer M., 2006, PSYCHOL 1 AID FIELD, V2nd; Christiansen Dorte M, 2008, Ann Gen Psychiatry, V7, P24, DOI 10.1186/1744-859X-7-24; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037/0033-2909.98.2.310; Corcoran P, 2010, SOC PSYCH PSYCH EPID, V45, P795, DOI 10.1007/s00127-009-0120-7; Dalgleish T, 1996, J TRAUMA STRESS, V9, P833, DOI 10.1007/BF02104105; Durkheim, 2006, ON SUICIDE; Elklit A, 2001, PERS INDIV DIFFER, V31, P1291, DOI 10.1016/S0191-8869(00)00220-8; FOA EB, 1989, BEHAV THER, V20, P155, DOI 10.1016/S0005-7894(89)80067-X; Guay S, 2006, J TRAUMA STRESS, V19, P327, DOI 10.1002/jts.20124; Heinrich LA, 2006, CLIN PSYCHOL REV, V26, P695, DOI 10.1016/j.cpr.2006.04.002; Heir T, 2008, PSYCHIATRY, V71, P266, DOI 10.1521/psyc.2008.71.3.266; Hewitt B, 2011, J EPIDEMIOL COMMUNIT, P21; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; Hussain A, 2009, J TRAUMA STRESS, V22, P324, DOI 10.1002/jts.20431; Janszky I, 2010, EUR J EPIDEMIOL, V25, P361, DOI 10.1007/s10654-010-9462-4; Johannesson KB, 2009, J NERV MENT DIS, V197, P316, DOI 10.1097/NMD.0b013e3181a206f7; JOSEPH S, 1992, BRIT J CLIN PSYCHOL, V31, P63, DOI 10.1111/j.2044-8260.1992.tb00968.x; Kaniasty K, 2008, J TRAUMA STRESS, V21, P274, DOI 10.1002/jts.20334; KESSLER RC, 1985, ANNU REV PSYCHOL, V36, P531, DOI 10.1146/annurev.ps.36.020185.002531; MCCULLAGH P, 1980, J ROY STAT SOC B MET, V42, P109; MCFARLANE AC, 1988, BRIT J PSYCHIAT, V152, P116, DOI 10.1192/bjp.152.1.116; Michel PO, 2011, EUR PSYCHIAT, V26, P436, DOI 10.1016/j.eurpsy.2010.09.009; NEWCOMB MD, 1986, PERS SOC PSYCHOL B, V12, P520, DOI 10.1177/0146167286124015; Norris FH, 2005, AM J COMMUN PSYCHOL, V36, P15, DOI 10.1007/s10464-005-6230-9; Norris FH, 1996, J PERS SOC PSYCHOL, V71, P498, DOI 10.1037/0022-3514.71.3.498; OConnell A. A., 2006, LOGISTIC REGRESSION, DOI [10.4135/9781412984812, DOI 10.4135/9781412984812]; RAEL EGS, 1995, J EPIDEMIOL COMMUN H, V49, P474, DOI 10.1136/jech.49.5.474; Rothon C, 2011, SOC PSYCH PSYCH EPID, P1; Ruggiero KJ, 2009, PSYCHIATRY, V72, P195, DOI 10.1521/psyc.2009.72.2.195; Schnurr PP, 2004, J TRAUMA STRESS, V17, P85, DOI 10.1023/B:JOTS.0000022614.21794.f4; Taylor SE, 2004, J PERS SOC PSYCHOL, V87, P354, DOI 10.1037/0022-3514.87.3.354; Thoits PA, 2011, J HEALTH SOC BEHAV, V52, P145, DOI 10.1177/0022146510395592; Vandervoort D, 2000, CURR PSYCHOL, V19, P229, DOI 10.1007/s12144-000-1017-5; VANOOSTROM MA, 1995, J EPIDEMIOL COMMUN H, V49, P518, DOI 10.1136/jech.49.5.518; Wang JL, 2009, SOC PSYCH PSYCH EPID, V44, P666, DOI 10.1007/s00127-008-0482-2; Yehuda R, 2002, NEW ENGL J MED, V346, P108, DOI 10.1056/NEJMra012941	46	6	6	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65709	10.1371/journal.pone.0065709	http://dx.doi.org/10.1371/journal.pone.0065709			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	169CU	23776531	gold, Green Published, Green Submitted			2022-12-27	WOS:000320755400059
J	Fujieda, Y; Manno, A; Hayashi, Y; Rhodes, N; Guo, LN; Arita, M; Bamba, T; Fukusaki, E				Fujieda, Yusuke; Manno, Atsushi; Hayashi, Yasuhiro; Rhodes, Nelson; Guo, Lining; Arita, Makoto; Bamba, Takeshi; Fukusaki, Eiichiro			Inflammation and Resolution Are Associated with Upregulation of Fatty Acid beta-Oxidation in Zymosan-Induced Peritonitis	PLOS ONE			English	Article							PPAR-ALPHA; SKELETAL-MUSCLE; NICOTINIC-ACID; IDENTIFICATION; RECEPTOR; MECHANISMS; MEDIATORS; KETOACIDOSIS; ACTIVATION; INFLUENZA	Inflammation is a fundamental defensive response to harmful stimuli. However, it can cause damage if it does not subside. To avoid such damage, organisms have developed a mechanism called resolution of inflammation. Here we applied an untargeted metabolomics approach to a sterile and self-resolving animal model of acute inflammation, namely zymosan-induced peritonitis in mice, to examine the effect of inflammation and resolution on the metabolomic profiles. Significant and time-dependent changes in metabolite profiles after zymosan administration were observed in both peritoneal wash fluid (PWF) and plasma. These metabolomic changes correlated well with inflammatory chemokine or cytokine production. In PWF, most of metabolites that could detected increased in zymosan-treated mice, which is suggestive of inflammation, oxidative stress and increased energy demands. In plasma, most metabolites in the central metabolic pathway (glycolysis and TCA cycle) were significantly downregulated after zymosan administration. The concentration of the ketone body 3-hydroxybutyric acid (3-HB) in plasma and PWF increased in zymosan-injected animals indicating upregulation of fatty acid beta-oxidation. Increased 3-HB level was observed in the cells that infiltrated into the peritoneal cavity and these infiltrated cells might contribute, at least in part, to the production of 3-HB in the peritoneal cavity.	[Fujieda, Yusuke; Bamba, Takeshi; Fukusaki, Eiichiro] Osaka Univ, Dept Biotechnol, Grad Sch Engn, Suita, Osaka, Japan; [Fujieda, Yusuke; Manno, Atsushi; Hayashi, Yasuhiro] Asubio Pharma Co Ltd, Kobe, Hyogo, Japan; [Rhodes, Nelson; Guo, Lining] Metabolon Inc, Durham, NC USA; [Arita, Makoto] Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Hlth Chem, Tokyo 1138654, Japan	Osaka University; Asubio Pharma Co., Ltd.; Metabolon; University of Tokyo	Fujieda, Y (corresponding author), Osaka Univ, Dept Biotechnol, Grad Sch Engn, Suita, Osaka, Japan.	fujieda.yusuke.aw@asubio.co.jp; fukusaki@bio.eng.osaka-u.ac.jp		Arita, Makoto/0000-0001-9902-0463				Azuma YT, 2010, INT IMMUNOPHARMACOL, V10, P1261, DOI 10.1016/j.intimp.2010.07.007; BOUTER KP, 1991, DIABETES RES CLIN PR, V12, P61, DOI 10.1016/0168-8227(91)90131-V; Cash JL, 2009, METHOD ENZYMOL, V461, P379, DOI 10.1016/S0076-6879(09)05417-2; Csoka B, 2010, J IMMUNOL, V185, P542, DOI 10.4049/jimmunol.0901295; Digby JE, 2012, ARTERIOSCL THROM VAS, V32, P669, DOI 10.1161/ATVBAHA.111.241836; Eltzschig HK, 2012, NEW ENGL J MED, V367, P2322, DOI 10.1056/NEJMra1205750; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Fujieda Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043152; Gambhir D, 2012, INVEST OPHTH VIS SCI, V53, P2208, DOI 10.1167/iovs.11-8447; Gijon MA, 1999, J LEUKOCYTE BIOL, V65, P330, DOI 10.1002/jlb.65.3.330; Guyton JR, 2007, CURR OPIN LIPIDOL, V18, P415, DOI 10.1097/MOL.0b013e3282364add; Hasko G, 2008, J LEUKOCYTE BIOL, V83, P447, DOI 10.1189/jlb.0607359; Isobe Y, 2012, J BIOL CHEM, V287, P10525, DOI 10.1074/jbc.M112.340612; Konig B, 2008, BBA-GEN SUBJECTS, V1780, P899, DOI 10.1016/j.bbagen.2008.03.002; LI PK, 1980, CLIN CHEM, V26, P1713; Lindon JC, 2007, FEBS J, V274, P1140, DOI 10.1111/j.1742-4658.2007.05673.x; Liu TF, 2012, J BIOL CHEM, V287, P25758, DOI 10.1074/jbc.M112.362343; Lommen A, 2009, ANAL CHEM, V81, P3079, DOI 10.1021/ac900036d; Minnich A, 2001, AM J PHYSIOL-ENDOC M, V280, pE270, DOI 10.1152/ajpendo.2001.280.2.E270; Muoio DM, 2002, DIABETES, V51, P901, DOI 10.2337/diabetes.51.4.901; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Navarro-Xavier RA, 2010, J IMMUNOL, V184, P1516, DOI 10.4049/jimmunol.0902866; Nguyen DH, 2011, BRIT J PHARMACOL, V162, P1119, DOI 10.1111/j.1476-5381.2010.01117.x; Pyper Sean R, 2010, Nucl Recept Signal, V8, pe002, DOI 10.1621/nrs.08002; Ramanan S, 2008, FREE RADICAL BIO MED, V45, P1695, DOI 10.1016/j.freeradbiomed.2008.09.002; Reid BN, 2008, J BIOL CHEM, V283, P13087, DOI 10.1074/jbc.M800533200; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; Serhan CN, 2011, CURR TOP MED CHEM, V11, P629; Serhan CN, 2009, J EXP MED, V206, P15, DOI 10.1084/jem.20081880; Sha W, 2010, FASEB J, V24, P2962, DOI 10.1096/fj.09-154054; Shiomi Y, 2011, INFLAMM BOWEL DIS, V17, P2261, DOI 10.1002/ibd.21616; Shriver LP, 2011, SCI REP-UK, V1, DOI 10.1038/srep00079; Soehnlein O, 2010, NAT REV IMMUNOL, V10, P427, DOI 10.1038/nri2779; Soudijn W, 2007, MED RES REV, V27, P417, DOI 10.1002/med.20102; Stables MJ, 2011, BLOOD, V118, pE192, DOI 10.1182/blood-2011-04-345330; Tan HW, 2012, AM J MED SCI, V343, P180, DOI 10.1097/MAJ.0b013e3182376cc4; Tsugawa H, 2011, J BIOSCI BIOENG, V112, P292, DOI 10.1016/j.jbiosc.2011.05.001; Tsugawa H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-131; Wang WY, 1998, CRIT CARE MED, V26, P101, DOI 10.1097/00003246-199801000-00023; Yamada T, 2011, FASEB J, V25, P561, DOI 10.1096/fj.10-170027; Yue TL, 2003, CIRCULATION, V108, P2393, DOI 10.1161/01.CIR.0000093187.42015.6C	43	29	30	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66270	10.1371/journal.pone.0066270	http://dx.doi.org/10.1371/journal.pone.0066270			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776651	Green Published, gold, Green Submitted			2022-12-27	WOS:000320755400133
J	Leviatan, N; Alkan, N; Leshkowitz, D; Fluhr, R				Leviatan, Noam; Alkan, Noam; Leshkowitz, Dena; Fluhr, Robert			Genome-Wide Survey of Cold Stress Regulated Alternative Splicing in Arabidopsis thaliana with Tiling Microarray	PLOS ONE			English	Article							MESSENGER-RNA DECAY; FULL-LENGTH; GENE-EXPRESSION; TRANSCRIPTIONAL ACTIVITY; INTRON RETENTION; HIGH-SALINITY; SR PROTEINS; DROUGHT; NORMALIZATION; TOLERANCE	Alternative splicing plays a major role in expanding the potential informational content of eukaryotic genomes. It is an important post-transcriptional regulatory mechanism that can increase protein diversity and affect mRNA stability. Alternative splicing is often regulated in a tissue-specific and stress-responsive manner. Cold stress, which adversely affects plant growth and development, regulates the transcription and splicing of plant splicing factors. This can affect the prem-RNA processing of many genes. To identify cold regulated alternative splicing we applied Affymetrix Arabidopsis tiling arrays to survey the transcriptome under cold treatment conditions. A novel algorithm was used for detection of statistically relevant changes in intron expression within a transcript between control and cold growth conditions. A reverse transcription polymerase chain reaction (RT-PCR) analysis of a number of randomly selected genes confirmed the changes in splicing patterns under cold stress predicted by tiling array. Our analysis revealed new types of cold responsive genes. While their expression level remains relatively unchanged under cold stress their splicing pattern shows detectable changes in the relative abundance of isoforms. The majority of cold regulated alternative splicing introduced a premature termination codon (PTC) into the transcripts creating potential targets for degradation by the nonsense mediated mRNA decay (NMD) process. A number of these genes were analyzed in NMD-defective mutants by RT-PCR and shown to evade NMD. This may result in new and truncated proteins with altered functions or dominant negative effects. The results indicate that cold affects both quantitative and qualitative aspects of gene expression.	[Leviatan, Noam; Alkan, Noam; Fluhr, Robert] Weizmann Inst Sci, Dept Plant Sci, IL-76100 Rehovot, Israel; [Leshkowitz, Dena] Weizmann Inst Sci, Biol Serv Dept, Bioinformat Unit, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Fluhr, R (corresponding author), Weizmann Inst Sci, Dept Plant Sci, IL-76100 Rehovot, Israel.	robert.fluhr@weizmann.ac.il	Alkan, Noam/GRJ-3904-2022	Leviatan, Noam/0000-0001-8743-3789	Ministry of Agriculture and Rural Development ERA-NET Plant Genomics Grant [403/8]; Dr. Angel Faivovich Foundation	Ministry of Agriculture and Rural Development ERA-NET Plant Genomics Grant; Dr. Angel Faivovich Foundation	The research was funded by the Ministry of Agriculture and Rural Development ERA-NET Plant Genomics Grant 403/8 and supported by a research grant from the Dr. Angel Faivovich Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; [Anonymous], [No title captured]; Balasubramanian S, 2006, PLOS GENET, V2, P980, DOI 10.1371/journal.pgen.0020106; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Benjamini Y, 2000, J EDUC BEHAV STAT, V25, P60, DOI 10.3102/10769986025001060; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brogna S, 2009, NAT STRUCT MOL BIOL, V16, P107, DOI 10.1038/nsmb.1550; Campbell MA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-327; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Castle JC, 2008, NAT GENET, V40, P1416, DOI 10.1038/ng.264; Chinnusamy V, 2003, GENE DEV, V17, P1043, DOI 10.1101/gad.1077503; Chinnusamy V, 2007, TRENDS PLANT SCI, V12, P444, DOI 10.1016/j.tplants.2007.07.002; Chung HS, 2010, PLANT J, V63, P613, DOI 10.1111/j.1365-313X.2010.04265.x; Culbertson MR, 2003, CURR OPIN GENET DEV, V13, P207, DOI 10.1016/S0959-437X(03)00014-5; Downey T, 2006, METHOD ENZYMOL, V411, P256, DOI 10.1016/S0076-6879(06)11013-7; Egawa C, 2006, GENES GENET SYST, V81, P77, DOI 10.1266/ggs.81.77; Farlow A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000819; Filichkin SA, 2010, GENOME RES, V20, P45, DOI 10.1101/gr.093302.109; Fowler S, 2002, PLANT CELL, V14, P1675, DOI 10.1105/tpc.003483; Gullerova M, 2006, RNA, V12, P631, DOI 10.1261/rna.2226106; Hannah MA, 2005, PLOS GENET, V1, P179, DOI 10.1371/journal.pgen.0010026; Hartemink A., 2001, SPIE BIOS; He Q, 2011, MOL BIOL REP; Hess A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-96; Hori K, 2005, PLANT J, V43, P530, DOI 10.1111/j.1365-313X.2005.02473.x; Hori K, 2007, PLANT CELL PHYSIOL, V48, P1072, DOI 10.1093/pcp/pcm075; Hughes TA, 2006, TRENDS GENET, V22, P119, DOI 10.1016/j.tig.2006.01.001; Iida K, 2004, NUCLEIC ACIDS RES, V32, P5096, DOI 10.1093/nar/gkh845; Iida K, 2009, DNA RES, V16, P155, DOI 10.1093/dnares/dsp009; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jaillon O, 2008, NATURE, V451, P359, DOI 10.1038/nature06495; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Kalyna M, 2012, NUCLEIC ACIDS RES, V40, P2454, DOI 10.1093/nar/gkr932; Kampa D, 2004, GENOME RES, V14, P331, DOI 10.1101/gr.2094104; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kilian J, 2007, PLANT J, V50, P347, DOI 10.1111/j.1365-313X.2007.03052.x; Kim SK, 2001, SCIENCE, V293, P2087, DOI 10.1126/science.1061603; Kreps JA, 2002, PLANT PHYSIOL, V130, P2129, DOI 10.1104/pp.008532; Kurihara Y, 2009, P NATL ACAD SCI USA, V106, P2453, DOI 10.1073/pnas.0808902106; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lareau LF, 2007, ADV EXP MED BIOL, V623, P190, DOI 10.1007/978-0-387-77374-2_12; Lee BH, 2005, PLANT CELL, V17, P3155, DOI 10.1105/tpc.105.035568; Lee BH, 2006, PLANT CELL, V18, P1736, DOI 10.1105/tpc.106.042184; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Li L, 2006, NAT GENET, V38, P124, DOI 10.1038/ng1704; Macknight R, 2002, PLANT CELL, V14, P877, DOI 10.1105/tpc.010456; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Martienssen RA, 2005, CHROMOSOME RES, V13, P299, DOI 10.1007/s10577-005-1507-2; Mastrangelo AM, 2005, PLANTA, V221, P705, DOI 10.1007/s00425-004-1475-3; Matsui A, 2008, PLANT CELL PHYSIOL, V49, P1135, DOI 10.1093/pcp/pcn101; McGlincy NJ, 2008, TRENDS BIOCHEM SCI, V33, P385, DOI 10.1016/j.tibs.2008.06.001; Mockler TC, 2005, GENOMICS, V85, P1, DOI 10.1016/j.ygeno.2004.10.005; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Morello L, 2008, CURR GENOMICS, V9, P227, DOI 10.2174/138920208784533629; Naef F, 2002, GENOME BIOL, V3; Nagasaki H, 2005, GENE, V364, P53, DOI 10.1016/j.gene.2005.07.027; Ner-Gaon H, 2004, PLANT J, V39, P877, DOI 10.1111/j.1365-313X.2004.02172.x; Ner-Gaon H, 2007, PLANT PHYSIOL, V144, P1632, DOI 10.1104/pp.107.098640; Ner-Gaon H, 2006, DNA RES, V13, P111, DOI 10.1093/dnares/dsl003; Palusa SG, 2010, NEW PHYTOL, V185, P83, DOI 10.1111/j.1469-8137.2009.03065.x; Palusa SG, 2007, PLANT J, V49, P1091, DOI 10.1111/j.1365-313X.2006.03020.x; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pleiss JA, 2007, MOL CELL, V27, P928, DOI 10.1016/j.molcel.2007.07.018; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Rayson S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031917; Royce TE, 2005, TRENDS GENET, V21, P466, DOI 10.1016/j.tig.2005.06.007; Savaldi-Goldstein S, 2003, PLANT CELL, V15, P926, DOI 10.1105/tpc.011056; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Seo PJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1303; Shinozaki K, 2003, CURR OPIN PLANT BIOL, V6, P410, DOI 10.1016/S1369-5266(03)00092-X; Stolc V, 2005, P NATL ACAD SCI USA, V102, P4453, DOI 10.1073/pnas.0408203102; Swarbreck D, 2008, NUCLEIC ACIDS RES, V36, pD1009, DOI 10.1093/nar/gkm965; Szecsi J, 2006, EMBO J, V25, P3912, DOI 10.1038/sj.emboj.7601270; Tan S, 2007, FEBS LETT, V581, P1081, DOI 10.1016/j.febslet.2007.02.009; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vogel JT, 2005, PLANT J, V41, P195, DOI 10.1111/j.1365-313X.2004.02288.x; Volodarsky D, 2009, PLANT PHYSIOL, V150, P1796, DOI 10.1104/pp.109.138289; Wang BB, 2006, P NATL ACAD SCI USA, V103, P7175, DOI 10.1073/pnas.0602039103; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wu ZJ, 2004, NAT BIOTECHNOL, V22, P656, DOI 10.1038/nbt0604-656b; Xin ZG, 2007, PLANT J, V49, P786, DOI 10.1111/j.1365-313X.2006.02994.x; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305; Yazaki J, 2007, CURR OPIN PLANT BIOL, V10, P534, DOI 10.1016/j.pbi.2007.07.006; ZAHLER AM, 1992, GENE DEV, V6, P837, DOI 10.1101/gad.6.5.837; Zhang JZ, 2004, PLANT PHYSIOL, V135, P615, DOI 10.1104/pp.104.040295; Zhang XC, 2003, PLANT CELL, V15, P2333, DOI 10.1105/tpc.013474; Zhang XN, 2009, PLANT PHYSIOL, V150, P1450, DOI 10.1104/pp.109.138180; Zhang XC, 2007, PLANT PHYSIOL, V145, P1577, DOI 10.1104/pp.107.108720; Zhu JH, 2007, CURR OPIN PLANT BIOL, V10, P290, DOI 10.1016/j.pbi.2007.04.010	92	46	52	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66511	10.1371/journal.pone.0066511	http://dx.doi.org/10.1371/journal.pone.0066511			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776682	Green Published, Green Submitted, gold			2022-12-27	WOS:000320755400150
J	Ramanunninair, M; Le, JH; Onodera, S; Fulvini, AA; Pokorny, BA; Silverman, J; Devis, R; Arroyo, JM; He, Y; Boyne, A; Bera, J; Halpin, R; Hine, E; Spiro, DJ; Bucher, D				Ramanunninair, Manojkumar; Le, Jianhua; Onodera, Shiroh; Fulvini, Andrew A.; Pokorny, Barbara A.; Silverman, Jeanmarie; Devis, Rene; Arroyo, Jennifer M.; He, Yu; Boyne, Alex; Bera, Jayati; Halpin, Rebecca; Hine, Erin; Spiro, David J.; Bucher, Doris			Molecular Signature of High Yield (Growth) Influenza A Virus Reassortants Prepared as Candidate Vaccine Seeds	PLOS ONE			English	Article							AMINO-ACID SUBSTITUTIONS; SYNONYMOUS MUTATIONS; MESSENGER-RNA; GENE SEGMENTS; NS1 PROTEIN; HEMAGGLUTININ; EVOLUTION; REPLICATION; GENERATION; NEURAMINIDASE	Background: Human influenza virus isolates generally grow poorly in embryonated chicken eggs. Hence, gene reassortment of influenza A wild type (wt) viruses is performed with a highly egg adapted donor virus, A/Puerto Rico/8/1934 (PR8), to provide the high yield reassortant (HYR) viral 'seeds' for vaccine production. HYR must contain the hemagglutinin (HA) and neuraminidase (NA) genes of wt virus and one to six 'internal' genes from PR8. Most studies of influenza wt and HYRs have focused on the HA gene. The main objective of this study is the identification of the molecular signature in all eight gene segments of influenza A HYR candidate vaccine seeds associated with high growth in ovo. Methodology: The genomes of 14 wt parental viruses, 23 HYRs (5 H1N1; 2, 1976 H1N1-SOIV; 2, 2009 H1N1pdm; 2 H2N2 and 12 H3N2) and PR8 were sequenced using the high-throughput sequencing pipeline with big dye terminator chemistry. Results: Silent and coding mutations were found in all internal genes derived from PR8 with the exception of the M gene. The M gene derived from PR8 was invariant in all 23 HYRs underlining the critical role of PR8 M in high yield phenotype. None of the wt virus derived internal genes had any silent change(s) except the PB1 gene in X-157. The highest number of recurrent silent and coding mutations was found in NS. With respect to the surface antigens, the majority of HYRs had coding mutations in HA; only 2 HYRs had coding mutations in NA. Significance: In the era of application of reverse genetics to alter influenza A virus genomes, the mutations identified in the HYR gene segments associated with high growth in ovo may be of great practical benefit to modify PR8 and/or wt virus gene sequences for improved growth of vaccine 'seed' viruses.	[Ramanunninair, Manojkumar; Le, Jianhua; Onodera, Shiroh; Fulvini, Andrew A.; Pokorny, Barbara A.; Silverman, Jeanmarie; Devis, Rene; Arroyo, Jennifer M.; He, Yu; Bucher, Doris] New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA; [Boyne, Alex; Bera, Jayati; Halpin, Rebecca; Hine, Erin] J Craig Venter Inst, Dept Infect Dis, Rockville, MD USA; [Spiro, David J.] NIAID, SARS & Related Viral Resp Dis Branch, Div Microbiol & Infect Dis, NIH,DHHS, Bethesda, MD 20892 USA	New York Medical College; J. Craig Venter Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Bucher, D (corresponding author), New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA.	doris_bucher@nymc.edu			National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN272200900007C]; International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)-Influenza Vaccine Supply Task Force	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)-Influenza Vaccine Supply Task Force	Research support for preparation of the NYMC reassortants was provided by the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)-Influenza Vaccine Supply Task Force. This project has been funded in part with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services under contract number HHSN272200900007C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAEZ M, 1980, J INFECT DIS, V141, P362, DOI 10.1093/infdis/141.3.362; Baigent SJ, 2003, BIOESSAYS, V25, P657, DOI 10.1002/bies.10303; Bergeron C, 2010, PLOS CURR, V5; Bush RM, 1999, SCIENCE, V286, P1921, DOI 10.1126/science.286.5446.1921; Chen GL, 2009, CURR TOP MICROBIOL, V333, P109, DOI 10.1007/978-3-540-92165-3_5; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Chen ZY, 2010, J VIROL, V84, P44, DOI 10.1128/JVI.02106-09; COLMAN PM, 1983, NATURE, V303, P41, DOI 10.1038/303041a0; Cox NJ, 1999, LANCET, V354, P1277, DOI 10.1016/S0140-6736(99)01241-6; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; DOWNIE JC, 1984, J BIOL STAND, V12, P101, DOI 10.1016/S0092-1157(84)80026-8; Fodor E, 1999, J VIROL, V73, P9679, DOI 10.1128/JVI.73.11.9679-9682.1999; FRANCIS T, 1945, AM J HYG, V42, P1; Fulvini AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020823; Garcia-Sastre A, 1998, VIROLOGY, V252, P324, DOI 10.1006/viro.1998.9508; Garcia-Sastre A, 2001, VIROLOGY, V279, P375, DOI 10.1006/viro.2000.0756; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gerdil C, 2003, VACCINE, V21, P1776, DOI 10.1016/S0264-410X(03)00071-9; Gonzalez S, 1996, NUCLEIC ACIDS RES, V24, P4456, DOI 10.1093/nar/24.22.4456; GORMAN OT, 1991, J VIROL, V65, P3704, DOI 10.1128/JVI.65.7.3704-3714.1991; Greenbaum BD, 2012, P NATL ACAD SCI USA, V109, P3341, DOI 10.1073/pnas.1113300109; Greenbaum BD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005969; GREENSPAN D, 1988, J VIROL, V62, P3020, DOI 10.1128/JVI.62.8.3020-3026.1988; Guu TSY, 2008, VIROLOGY, V379, P135, DOI 10.1016/j.virol.2008.06.022; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hamano T, 2007, J VIROL, V81, P1528, DOI 10.1128/JVI.01596-06; Hara K, 2001, GENES CELLS, V6, P87, DOI 10.1046/j.1365-2443.2001.00399.x; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; HOLLAND J, 1982, SCIENCE, V215, P1577, DOI 10.1126/science.7041255; Horimoto T, 2007, VIROLOGY, V366, P23, DOI 10.1016/j.virol.2007.07.002; Iwai A, 2010, J BIOL CHEM, V285, P32064, DOI 10.1074/jbc.M110.112458; Jagger BW, 2012, SCIENCE, V337, P199, DOI 10.1126/science.1222213; Jin H, 2005, VIROLOGY, V336, P113, DOI 10.1016/j.virol.2005.03.010; JUKES TH, 1980, SCIENCE, V210, P973, DOI 10.1126/science.7434017; KILBOURN.ED, 1971, J INFECT DIS, V124, P449, DOI 10.1093/infdis/124.5.449; KILBOURN.ED, 1969, B WORLD HEALTH ORGAN, V41, P643; KILBOURNE ED, 1983, P NATL ACAD SCI-BIOL, V80, P6399, DOI 10.1073/pnas.80.20.6399; KILBOURNE ED, 1988, P NATL ACAD SCI USA, V85, P7782, DOI 10.1073/pnas.85.20.7782; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; KLIMOV A, 1983, ACTA VIROL, V27, P434; KLIMOV AI, 1991, VIRUS RES, V19, P105, DOI 10.1016/0168-1702(91)90098-G; Kryazhimskiy S, 2008, J VIROL, V82, P4938, DOI 10.1128/JVI.02415-07; Kumari K, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-42; Lamb R. A., 1996, FIELDS VIROLOGY, P1353; LAMB RA, 1983, ANNU REV BIOCHEM, V52, P467, DOI 10.1146/annurev.bi.52.070183.002343; LAMB RA, 1979, P NATL ACAD SCI USA, V76, P4908, DOI 10.1073/pnas.76.10.4908; Lambert LC, 2010, NEW ENGL J MED, V363, P2036, DOI 10.1056/NEJMra1002842; LAZAROWITZ SG, 1971, VIROLOGY, V46, P830, DOI 10.1016/0042-6822(71)90084-5; Liu T, 2002, VIROLOGY, V304, P89, DOI 10.1006/viro.2002.1669; Liu T, 2002, J VIROL, V76, P13055, DOI 10.1128/JVI.76.24.13055-13061.2002; Lu B, 2006, VACCINE, V24, P6691, DOI 10.1016/j.vaccine.2006.05.062; LUBECK MD, 1978, J VIROL, V28, P710, DOI 10.1128/JVI.28.3.710-716.1978; Ludwig S, 2006, CELL MICROBIOL, V8, P375, DOI 10.1111/j.1462-5822.2005.00678.x; Marion RM, 1997, J GEN VIROL, V78, P2447, DOI 10.1099/0022-1317-78-10-2447; MARKOFF L, 1982, VIROLOGY, V119, P288, DOI 10.1016/0042-6822(82)90089-7; Marsh GA, 2008, J VIROL, V82, P2295, DOI 10.1128/JVI.02267-07; Matrosovich M, 2000, J VIROL, V74, P8502, DOI 10.1128/JVI.74.18.8502-8512.2000; Mitnaul LJ, 2000, J VIROL, V74, P6015, DOI 10.1128/JVI.74.13.6015-6020.2000; MIYATA T, 1980, J MOL EVOL, V16, P23, DOI 10.1007/BF01732067; Muramoto Y, 2006, J VIROL, V80, P2318, DOI 10.1128/JVI.80.5.2318-2325.2006; Nackley AG, 2006, SCIENCE, V314, P1930, DOI 10.1126/science.1131262; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Nichol KL, 2006, J INFECT DIS, V194, pS111, DOI 10.1086/507544; Nicolson C, 2005, VACCINE, V23, P2943, DOI 10.1016/j.vaccine.2004.08.054; Novella IS, 2004, J MOL BIOL, V342, P1415, DOI 10.1016/j.jmb.2004.08.003; O'Neill E, 2009, CURR TOP MICROBIOL, V333, P83, DOI 10.1007/978-3-540-92165-3_4; O'Neill RE, 1998, EMBO J, V17, P288, DOI 10.1093/emboj/17.1.288; Offringa DP, 2000, J VIROL METHODS, V88, P15, DOI 10.1016/S0166-0934(00)00180-4; OXFORD JS, 1978, NATURE, V273, P778, DOI 10.1038/273778a0; Pancucharova H, 2006, ACTA VIROL, V50, P269; Parmley JL, 2007, BIOESSAYS, V29, P515, DOI 10.1002/bies.20592; PAYNE A M, 1953, Bull World Health Organ, V8, P755; PEREZ DR, 1995, J VIROL, V69, P6932; PLYUSNIN A, 1995, VIRUS RES, V38, P25, DOI 10.1016/0168-1702(95)00038-R; Rabadan R, 2006, J VIROL, V80, P11887, DOI 10.1128/JVI.01414-06; Robb NC, 2009, J GEN VIROL, V90, P1398, DOI 10.1099/vir.0.009639-0; Robertson JS, 2011, VACCINE, V29, P1836, DOI 10.1016/j.vaccine.2010.12.044; ROBERTSON JS, 1987, VIROLOGY, V160, P31, DOI 10.1016/0042-6822(87)90040-7; Sanz-Ezquerro JJ, 1996, J VIROL, V69, P2420; Schickli JH, 2001, PHILOS T ROY SOC B, V356, P1965, DOI 10.1098/rstb.2001.0979; Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018; Sironen T, 2001, J VIROL, V75, P11803, DOI 10.1128/JVI.75.23.11803-11810.2001; Stevens J, 2010, J VIROL, V84, P8287, DOI 10.1128/JVI.00058-10; Stohr Klaus, 2012, Methods Mol Biol, V865, P147, DOI 10.1007/978-1-61779-621-0_9; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TIAN SF, 1985, J VIROL, V53, P771, DOI 10.1128/JVI.53.3.771-775.1985; Varga ZT, 2011, VIRULENCE, V2, P542, DOI 10.4161/viru.2.6.17812; VARGHESE JN, 1983, NATURE, V303, P35, DOI 10.1038/303035a0; Varich NL, 2008, ARCH VIROL, V153, P1149, DOI 10.1007/s00705-008-0070-5; Verity EE, 2012, INFLUENZA OTHER RESP, V6, P101, DOI 10.1111/j.1750-2659.2011.00273.x; Vodeiko GM, 2003, VACCINE, V21, P3867, DOI 10.1016/S0264-410X(03)00312-8; Wang TT, 2009, CELL, V137, P983, DOI 10.1016/j.cell.2009.05.032; Wanitchang A, 2010, VIRUS RES, V147, P145, DOI 10.1016/j.virusres.2009.10.010; Widjaja L, 2006, VIROLOGY, V350, P137, DOI 10.1016/j.virol.2006.02.020; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; Wise HM, 2009, J VIROL, V83, P8021, DOI 10.1128/JVI.00826-09; Wong EHM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-253; YASUDA J, 1994, J VIROL, V68, P8141, DOI 10.1128/JVI.68.12.8141-8146.1994; Zamarin D, 2006, J VIROL, V80, P7976, DOI 10.1128/JVI.00415-06	101	13	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65955	10.1371/journal.pone.0065955	http://dx.doi.org/10.1371/journal.pone.0065955			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776579	Green Published, gold, Green Submitted			2022-12-27	WOS:000320755400090
J	Steede, NK; Rust, BJ; Hossain, MM; Freytag, LC; Robinson, JE; Landry, SJ				Steede, N. Kalaya; Rust, Blake J.; Hossain, Mohammad M.; Freytag, Lucy C.; Robinson, James E.; Landry, Samuel J.			Shaping T Cell - B Cell Collaboration in the Response to Human Immunodeficiency Virus Type 1 Envelope Glycoprotein gp120 by Peptide Priming	PLOS ONE			English	Article							ANTIBODY-RESPONSES; ESCHERICHIA-COLI; IMMUNE-RESPONSES; HELPER-CELLS; ANTIGEN; HIV-1; SPECIFICITY; INFECTION; VACCINE; DETERMINANTS	Prime-boost vaccination regimes have shown promise for obtaining protective immunity to HIV. Poorly understood mechanisms of cellular immunity could be responsible for improved humoral responses. Although CD4+ T-cell help promotes B-cell development, the relationship of CD4+ T-cell specificity to antibody specificity has not been systematically investigated. Here, protein and peptide-specific immune responses to HIV-1 gp120 were characterized in groups of ten mucosally immunized BALB/c mice. Protein and peptide reactivity of serum antibody was tested for correlation with cytokine secretion by splenocytes restimulated with individual gp120 peptides. Antibody titer for gp120 correlated poorly with the peptide-stimulated T-cell response. In contrast, titers for conformational epitopes, measured as crossreactivity or CD4-blocking, correlated with average interleukin-2 and interleukin-5 production in response to gp120 peptides. Antibodies specific for conformational epitopes and individual gp120 peptides typically correlated with T-cell responses to several peptides. In order to modify the specificity of immune responses, animals were primed with a gp120 peptide prior to immunization with protein. Priming induced distinct peptide-specific correlations of antibodies and T-cells. The majority of correlated antibodies were specific for the primed peptides or other peptides nearby in the gp120 sequence. These studies suggest that the dominant B-cell subsets recruit the dominant T-cell subsets and that T-B collaborations can be shaped by epitope-specific priming.	[Steede, N. Kalaya; Rust, Blake J.; Hossain, Mohammad M.; Landry, Samuel J.] Tulane Univ, Sch Med, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA; [Freytag, Lucy C.] Tulane Univ, Sch Med, Dept Microbiol & Immunol, New Orleans, LA 70112 USA; [Robinson, James E.] Tulane Univ, Sch Med, Dept Pediat, New Orleans, LA 70112 USA	Tulane University; Tulane University; Tulane University	Landry, SJ (corresponding author), Tulane Univ, Sch Med, Dept Biochem & Mol Biol, 1430 Tulane Ave, New Orleans, LA 70112 USA.	landry@tulane.edu	Landry, Samuel/AAK-5778-2020	Landry, Samuel/0000-0002-4082-0543; Rust, Blake/0000-0002-7197-0990	National Institutes of Health [R01-AI080367]; Bill and Melinda Gates Foundation Phase I Grand Challenges program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080367] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation Phase I Grand Challenges program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health (R01-AI080367) and the Bill and Melinda Gates Foundation Phase I Grand Challenges program to SJL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbosa RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022848; BERZOFSKY JA, 1983, SURV IMMUNOL RES, V2, P223; Bonsignori M, 2012, TRENDS MICROBIOL, V20, P532, DOI 10.1016/j.tim.2012.08.011; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Chong C, 1998, VACCINE, V16, P732, DOI 10.1016/S0264-410X(97)00255-7; CROFT M, 1992, J IMMUNOL, V149, P3157; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Dai GX, 2001, J BIOL CHEM, V276, P41913, DOI 10.1074/jbc.M106018200; DAVIDSON HW, 1989, J CELL BIOL, V109, P85, DOI 10.1083/jcb.109.1.85; Depoil D, 2005, IMMUNITY, V22, P185, DOI 10.1016/j.immuni.2004.12.010; Dzuris JL, 2001, J VIROL, V75, P10958, DOI 10.1128/JVI.75.22.10958-10968.2001; Gao F, 2003, AIDS RES HUM RETROV, V19, P817, DOI 10.1089/088922203769232610; Harvey BP, 2008, J IMMUNOL, V181, P4043, DOI 10.4049/jimmunol.181.6.4043; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Horikawa K, 2006, IMMUNOLOGY, V118, P497, DOI 10.1111/j.1365-2567.2006.02382.x; Illick MM, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-161; Ise W, 2011, NAT IMMUNOL, V12, P536, DOI 10.1038/ni.2037; Jin H, 2006, J LEUKOCYTE BIOL, V80, P1416, DOI 10.1189/jlb.0206096; Lai LL, 2011, J INFECT DIS, V204, P164, DOI 10.1093/infdis/jir199; Lang KS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001162; Letvin NL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002351; Li HL, 2009, J IMMUNOL, V182, P6369, DOI 10.4049/jimmunol.0804287; Ma CS, 2012, J EXP MED, V209, P1241, DOI 10.1084/jem.20120994; MANCA F, 1988, J IMMUNOL, V140, P2893; MANCA F, 1985, EUR J IMMUNOL, V15, P345, DOI 10.1002/eji.1830150408; Maric M, 2001, SCIENCE, V294, P1361, DOI 10.1126/science.1065500; McLellan AD, 2009, CRIT REV IMMUNOL, V29, P203, DOI 10.1615/CritRevImmunol.v29.i3.20; Mirano-Bascos D, 2010, J VIROL, V84, P3303, DOI 10.1128/JVI.02242-09; Mitsdoerffer M, 2010, P NATL ACAD SCI USA, V107, P14292, DOI 10.1073/pnas.1009234107; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Moss CX, 2007, EMBO J, V26, P2137, DOI 10.1038/sj.emboj.7601660; Nayak JL, 2013, J INFECT DIS, V207, P297, DOI 10.1093/infdis/jis684; NOELLE RJ, 1992, J IMMUNOL, V149, P1164; Nutt SL, 2011, SEMIN IMMUNOL, V23, P341, DOI 10.1016/j.smim.2011.08.010; Pancera M, 2010, J VIROL, V84, P8098, DOI 10.1128/JVI.00966-10; Perona-Wright G, 2010, NAT IMMUNOL, V11, P520, DOI 10.1038/ni.1866; PUNNONEN J, 1994, J IMMUNOL, V152, P1094; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Sangster MY, 2003, J EXP MED, V198, P1011, DOI 10.1084/jem.20021745; Schwickert TA, 2011, J EXP MED; Sette A, 2008, IMMUNITY, V28, P847, DOI 10.1016/j.immuni.2008.04.018; SIMITSEK PD, 1995, J EXP MED, V181, P1957, DOI 10.1084/jem.181.6.1957; Singh A, 2007, J VIROL, V81, P6502, DOI 10.1128/JVI.00163-07; Turcanu V, 2008, CLIN EXP ALLERGY, V38, P1132, DOI 10.1111/j.1365-2222.2008.03016.x; Watts C, 1998, IMMUNOL REV, V164, P11, DOI 10.1111/j.1600-065X.1998.tb01203.x; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532	47	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65748	10.1371/journal.pone.0065748	http://dx.doi.org/10.1371/journal.pone.0065748			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776539	Green Submitted, gold, Green Published			2022-12-27	WOS:000320755400065
J	Xu, HY; Sun, QS; Luo, N; Cao, G; Xia, DS				Xu, Huanyu; Sun, Quansen; Luo, Nan; Cao, Guo; Xia, Deshen			Iterative Nonlocal Total Variation Regularization Method for Image Restoration	PLOS ONE			English	Article							TOTAL VARIATION MINIMIZATION; ALGORITHM; PARAMETER; TV; SELECTION	In this paper, a Bregman iteration based total variation image restoration algorithm is proposed. Based on the Bregman iteration, the algorithm splits the original total variation problem into sub-problems that are easy to solve. Moreover, non-local regularization is introduced into the proposed algorithm, and a method to choose the non-local filter parameter locally and adaptively is proposed. Experiment results show that the proposed algorithms outperform some other regularization methods.	[Xu, Huanyu; Sun, Quansen; Luo, Nan; Cao, Guo; Xia, Deshen] Nanjing Univ Sci & Technol, Sch Comp Sci & Technol, Nanjing, Jiangsu, Peoples R China	Nanjing University of Science & Technology	Sun, QS (corresponding author), Nanjing Univ Sci & Technol, Sch Comp Sci & Technol, Nanjing, Jiangsu, Peoples R China.	qssun@126.com	, Guo/AAC-1388-2022	, Guo/0000-0002-2689-0932	Programs of the National Natural Science Foundation of China [61273251, 61003108]; Ministry of Education of China [200802880017]; Fundamental Research Funds for the Central Universities [NUST2011ZDJH26]	Programs of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by grants from Programs of the National Natural Science Foundation of China (61273251, 61003108), (http://www.nsfc.gov.cn) Doctoral Fund of Ministry of Education of China (200802880017) (http://www.cutech.edu.cn) and the Fundamental Research Funds for the Central Universities No. NUST2011ZDJH26. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almansa A, 2008, J SCI COMPUTING, V34, P612; [Anonymous], TR0710 CAAM; [Anonymous], P VLSM; Babacan SD, 2008, IEEE T IMAGE PROCESS, V17, P326, DOI 10.1109/TIP.2007.916051; Bertalmio M, 2003, J SCI COMPUT, V19, P95, DOI 10.1023/A:1025391506181; Buades A, 2005, MULTISCALE MODEL SIM, V4, P490, DOI 10.1137/040616024; Cai JF, 2009, SIAM J IMAGING SCI, V2, P226, DOI 10.1137/080733371; Carter J, 2001, DUAL METHODS TOTAL V; Chambolle A, 2004, J MATH IMAGING VIS, V20, P89; Chan TF, 2006, MULTISCALE MODEL SIM, V5, P615, DOI 10.1137/050644999; Chantas G, 2010, IEEE T IMAGE PROCESS, V19, P351, DOI 10.1109/TIP.2009.2033398; Chantas G, 2008, IEEE T IMAGE PROCESS, V17, P1795, DOI 10.1109/TIP.2008.2002828; Chen DQ, 2010, OPT ENG, V49, DOI 10.1117/1.3463019; Combettes PL, 2005, MULTISCALE MODEL SIM, V4, P1168, DOI 10.1137/050626090; Esser E, 2009, GEN FRAMEWORK CLASS, P1; Esser J, 2010, PRIMAL DUAL ALGORITH; Gilboa G, 2008, MULTISCALE MODEL SIM, V7, P1005, DOI 10.1137/070698592; Goldstein T, 2009, SIAM J IMAGING SCI, V2, P323, DOI 10.1137/080725891; Hintermuller M, 2006, SIAM J SCI COMPUT, V28, P1, DOI 10.1137/040613263; Huang YM, 2008, MULTISCALE MODEL SIM, V7, P774, DOI 10.1137/070703533; Kindermann S, 2005, MULTISCALE MODEL SIM, V4, P1091, DOI 10.1137/050622249; Li F, 2009, J VIS COMMUN IMAGE R, V20, P293, DOI 10.1016/j.jvcir.2009.01.003; Liao HY, 2009, J OPT SOC AM A, V26, P2311, DOI 10.1364/JOSAA.26.002311; Liu HT, 2010, IEEE T IMAGE PROCESS, V19, P1414, DOI 10.1109/TIP.2010.2041406; Lou YF, 2010, J SCI COMPUT, V42, P185, DOI 10.1007/s10915-009-9320-2; Nasonov A, 2010, IEEE INT C IM PROC I, P2793; Neelamani R, 2004, IEEE T SIGNAL PROCES, V52, P418, DOI 10.1109/TSP.2003.821103; Ng MK, 2007, J MATH IMAGING VIS, V27, P265, DOI 10.1007/s10851-007-0650-0; Nikolova M, 2005, SIAM J SCI COMPUT, V27, P937, DOI 10.1137/030600862; Nikolova M, 2004, J MATH IMAGING VIS, V20, P99, DOI 10.1023/B:JMIV.0000011920.58935.9c; Oliveira JP, 2009, SIGNAL PROCESS, V89, P1683, DOI 10.1016/j.sigpro.2009.03.018; Osher S, 2005, MULTISCALE MODEL SIM, V4, P460, DOI 10.1137/040605412; Pang ZF, 2011, IMAGE VISION COMPUT, V29, P117, DOI 10.1016/j.imavis.2010.08.012; Prasath VBS, 2009, ICAPR 2009: SEVENTH INTERNATIONAL CONFERENCE ON ADVANCES IN PATTERN RECOGNITION, PROCEEDINGS, P333, DOI 10.1109/ICAPR.2009.57; RUDIN LI, 1992, PHYSICA D, V60, P259, DOI 10.1016/0167-2789(92)90242-F; Takeda H, 2008, IEEE T IMAGE PROCESS, V17, P550, DOI 10.1109/TIP.2007.918028; Wang YL, 2008, SIAM J IMAGING SCI, V1, P248, DOI 10.1137/080724265; Wen YW, 2009, NUMER MATH-THEORY ME, V2, P427, DOI 10.4208/nmtma.2009.m9005s; Wu CL, 2010, SIAM J IMAGING SCI, V3, P300, DOI 10.1137/090767558; Yin WT, 2008, SIAM J IMAGING SCI, V1, P143, DOI 10.1137/070703983; Zhang XQ, 2010, SIAM J IMAGING SCI, V3, P253, DOI 10.1137/090746379	41	8	8	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65865	10.1371/journal.pone.0065865	http://dx.doi.org/10.1371/journal.pone.0065865			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776560	Green Submitted, gold, Green Published			2022-12-27	WOS:000320755400076
J	Jian, SL; Hsieh, HY; Liao, CT; Yen, TC; Nien, SW; Cheng, AJ; Juang, JL				Jian, Shiou-Ling; Hsieh, Hsin-Yi; Liao, Chun-Ta; Yen, Tzu-Chen; Nien, Shu-Wei; Cheng, Ann-Joy; Juang, Jyh-Lyh			G alpha(12) Drives Invasion of Oral Squamous Cell Carcinoma through Up-Regulation of Proinflammatory Cytokines	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; HETEROTRIMERIC G-PROTEINS; NF-KAPPA-B; NECK-CANCER; EXTRACAPSULAR SPREAD; POTENTIAL BIOMARKERS; LYMPH-NODES; G12 FAMILY; TNF-ALPHA; HEAD	Oral squamous cell carcinoma (OSCC) ranks among the top ten most prevalent cancers worldwide. Like most head and neck squamous cell carcinomas (HNSCCs), OSCC is highly inflammatory and aggressive. However, the signaling pathways triggering the activation of its inflammatory processes remain elusive. G protein-coupled receptor signaling regulates the inflammatory response and invasiveness of cancers, but it remains unclear whether G alpha(12) is a critical player in the inflammatory cytokine pathway during the tumorigenesis of OSCC. This study was undertaken to determine the role of G alpha(12) signaling in the regulation of proinflammatory cytokines in their mediation of OSCC invasion. We found that both the transcription and protein levels of G alpha(12) are up-regulated in OSCC tumors. The elevated G alpha(12) expressions in OSCC patients also correlated with extra-capsular spread, an indicator of tumor invasiveness in HNSCCs. This clinical finding was supported by the studies of overexpression and RNAi knockdown of G alpha(12) in OSCC cells, which demonstrated that G alpha(12) promoted tumor cell migration and invasion. To understand how G alpha(12) modulates OSCC invasiveness, we analyzed key biological processes in microarray data upon depletion of G alpha(12) and found that cytokine- and other immune-related pathways were severely impaired. Importantly, the mRNA levels of IL-6 and IL-8 proinflammatory cytokines in clinical samples were found to be significantly correlated with the increased G alpha(12) levels, suggesting a potential role of G alpha(12) in modulating the IL-6 and IL-8 expressions. Supporting this hypothesis, overexpression or RNAi knockdown of G alpha(12) in OSCC cell lines both showed that G alpha(12) positively regulated the mRNA and protein levels of IL-6 and IL-8. Finally, we demonstrated that the G alpha(12) promotion of tumor cell invasiveness was suppressed by the neutralization of IL-6 and IL-8 in OSCC cells. Together, these findings suggest that G alpha(12) drives OSCC invasion through the up-regulation of IL-6 and IL-8 cytokines.	[Jian, Shiou-Ling; Juang, Jyh-Lyh] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Jian, Shiou-Ling; Hsieh, Hsin-Yi; Nien, Shu-Wei; Juang, Jyh-Lyh] Natl Hlth Res Inst, Inst Mol & Genom Med, Miaoli, Taiwan; [Liao, Chun-Ta; Yen, Tzu-Chen] Chang Gung Mem Hosp, Head & Neck Oncol Grp, Tao Yuan, Taiwan; [Liao, Chun-Ta; Yen, Tzu-Chen] Chang Gung Univ, Tao Yuan, Taiwan; [Cheng, Ann-Joy] Chang Gung Univ, Grad Sch Med Biotechnol, Tao Yuan, Taiwan; [Juang, Jyh-Lyh] China Med Univ, PhD Program Aging, Taichung, Taiwan	National Defense Medical Center; National Health Research Institutes - Taiwan; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; China Medical University Taiwan	Juang, JL (corresponding author), Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan.	juang@nhri.org.tw	Juang, Jyh-Lyh/E-3944-2010; Cheng, Ann-Joy/AAI-4374-2020		National Health Research Institutes [01A1-MGPP02014]	National Health Research Institutes(National Health Research Institutes, JapanNational Health Research Institutes - Taiwan)	Funding was provided by National Health Research Institutes (http://www.nhri.org.tw/NHRI_WEB/nhriw001Action.do), Grant number: 01A1-MGPP02014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aki Y, 2008, ARCH ORAL BIOL, V53, P207, DOI 10.1016/j.archoralbio.2007.08.006; Bian D, 2006, ONCOGENE, V25, P2234, DOI 10.1038/sj.onc.1209261; Chen C-J, 2012, PLOS ONE, V7; Chen SU, 2008, J CLIN ENDOCR METAB, V93, P935, DOI 10.1210/jc.2007-1512; Chen YJ, 2008, CANCER SCI, V99, P1507, DOI 10.1111/j.1349-7006.2008.00863.x; Chen Z, 1999, CLIN CANCER RES, V5, P1369; Chung CH, 2009, CLIN CANCER RES, V15, P6758, DOI 10.1158/1078-0432.CCR-09-0784; Cotton M, 2009, CELL SIGNAL, V21, P1045, DOI 10.1016/j.cellsig.2009.02.008; Culig Z, 2013, EXPERT OPIN THER TAR, V17, P53, DOI 10.1517/14728222.2013.733368; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Duffy SA, 2008, CANCER-AM CANCER SOC, V113, P750, DOI 10.1002/cncr.23615; Facchinetti MM, 2010, CELLS TISSUES ORGANS, V192, P314, DOI 10.1159/000318173; Fraser CC, 2008, INT REV IMMUNOL, V27, P320, DOI 10.1080/08830180802262765; Freier K, 2008, ORAL ONCOL, V44, P116, DOI 10.1016/j.oraloncology.2007.01.006; Gokhale AS, 2005, ORAL ONCOL, V41, P70, DOI 10.1016/j.oraloncology.2004.06.005; Greenberg JS, 2003, CANCER, V97, P1464, DOI 10.1002/cncr.11202; Ho M K C, 2009, Curr Mol Pharmacol, V2, P19; Hwang YS, 2012, ORAL ONCOL, V48, P40, DOI 10.1016/j.oraloncology.2011.08.022; Juneja J, 2009, BRIT J PHARMACOL, V158, P32, DOI 10.1111/j.1476-5381.2009.00180.x; Kelly P, 2006, J BIOL CHEM, V281, P26483, DOI 10.1074/jbc.M604376200; Kelly P, 2006, P NATL ACAD SCI USA, V103, P8173, DOI 10.1073/pnas.0510254103; Ki SH, 2007, J BIOL CHEM, V282, P1938, DOI 10.1074/jbc.M606080200; Lebman DA, 2008, J LIPID RES, V49, P1388, DOI 10.1194/jlr.R800008-JLR200; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Li SY, 2005, INT J ONCOL, V27, P1329; Liao CT, 2011, INT J RADIAT ONCOL, V81, P930, DOI 10.1016/j.ijrobp.2010.07.1988; Lin SC, 2004, J ORAL PATHOL MED, V33, P79, DOI 10.1111/j.1600-0714.2004.00034.x; Liu SC, 2009, CANCER RES, V69, P6122, DOI 10.1158/0008-5472.CAN-08-3435; Lu YC, 2012, CANCER PREV RES, V5, P665, DOI 10.1158/1940-6207.CAPR-11-0358; de Oliveira MVM, 2009, HEAD NECK-J SCI SPEC, V31, P1439, DOI 10.1002/hed.21121; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Pai SI, 2009, ANNU REV PATHOL-MECH, V4, P49, DOI 10.1146/annurev.pathol.4.110807.092158; Peng C-H, 2011, PLOS ONE, V6; Penson RT, 2000, INT J GYNECOL CANCER, V10, P33, DOI 10.1046/j.1525-1438.2000.00003.x; Pries R, 2006, EXPERT REV ANTICANC, V6, P1195, DOI 10.1586/14737140.6.9.1195; Radhika V, 2005, ONCOGENE, V24, P4597, DOI 10.1038/sj.onc.1208665; Ramqvist T, 2010, EMERG INFECT DIS, V16, P1671, DOI 10.3201/eid1611.100452; Rao SK, 2010, J BIOL CHEM, V285, P32512, DOI 10.1074/jbc.M110.150490; Riedel F, 2005, ANTICANCER RES, V25, P2761; SahebJamee M, 2008, MED ORAL PATOL ORAL, V13, pE292; Shaw RJ, 2010, HEAD NECK-J SCI SPEC, V32, P714, DOI 10.1002/hed.21244; Spiegelberg BD, 2007, CURR OPIN GENET DEV, V17, P40, DOI 10.1016/j.gde.2006.12.002; St John MAR, 2004, ARCH OTOLARYNGOL, V130, P929, DOI 10.1001/archotol.130.8.929; Tung CL, 2013, J PHARMACEUT BIOMED, V75, P7, DOI 10.1016/j.jpba.2012.11.017; Wang F, 2009, CURR OPIN PHARMACOL, V9, P389, DOI 10.1016/j.coph.2009.06.005; Wang Y, 2010, CANCER LETT, V295, P110, DOI 10.1016/j.canlet.2010.02.019; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Wenzel S, 2004, EUR ARCH OTO-RHINO-L, V261, P270, DOI 10.1007/s00405-003-0678-8; Wu JY, 2010, ORAL ONCOL, V46, P226, DOI 10.1016/j.oraloncology.2010.01.007	50	15	18	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e66133	10.1371/journal.pone.0066133	http://dx.doi.org/10.1371/journal.pone.0066133			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762476	Green Published, gold, Green Submitted			2022-12-27	WOS:000321094800093
J	Adamski, J; Price, A; Dive, C; Makin, G				Adamski, Jennifer; Price, Andrew; Dive, Caroline; Makin, Guy			Hypoxia-Induced Cytotoxic Drug Resistance in Osteosarcoma Is Independent of HIF-1Alpha	PLOS ONE			English	Article							INDUCIBLE FACTOR-I; ETOPOSIDE-INDUCED APOPTOSIS; GROWTH-FACTOR EXPRESSION; BREAST-CANCER CELLS; P53-DEPENDENT APOPTOSIS; INDUCED CHEMORESISTANCE; NEUROBLASTOMA-CELLS; GLIOBLASTOMA CELLS; CONFERS PROTECTION; GENE-EXPRESSION	Survival rates from childhood cancer have improved dramatically in the last 40 years, such that over 80% of children are now cured. However in certain subgroups, including metastatic osteosarcoma, survival has remained stubbornly poor, despite dose intensive multi-agent chemotherapy regimens, and new therapeutic approaches are needed. Hypoxia is common in adult solid tumours and is associated with treatment resistance and poorer outcome. Hypoxia induces chemotherapy resistance in paediatric tumours including neuroblastoma, rhabdomyosarcoma and Ewing's sarcoma, in vitro, and this drug resistance is dependent on the oxygen-regulated transcription factor hypoxia inducible factor-1 (HIF-1). In this study the effects of hypoxia on the response of the osteosarcoma cell lines 791T, HOS and U2OS to the clinically relevant cytotoxics cisplatin, doxorubicin and etoposide were evaluated. Significant hypoxia-induced resistance to all three agents was seen in all three cell lines and hypoxia significantly reduced drug-induced apoptosis. Hypoxia also attenuated drug-induced activation of p53 in the p53 wild-type U2OS osteosarcoma cells. Drug resistance was not induced by HIF-1 alpha stabilisation in normoxia by cobalt chloride nor reversed by the suppression of HIF-1 alpha in hypoxia by shRNAi, siRNA, dominant negative HIF or inhibition with the small molecule NSC-134754, strongly suggesting that hypoxia-induced drug resistance in osteosarcoma cells is independent of HIF-1 alpha. Inhibition of the phosphoinositide 3-kinase (PI3K) pathway using the inhibitor PI-103 did not reverse hypoxia-induced drug resistance, suggesting the hypoxic activation of Akt in osteosarcoma cells does not play a significant role in hypoxia-induced drug resistance. Targeting hypoxia is an exciting prospect to improve current anti-cancer therapy and combat drug resistance. Significant hypoxia-induced drug resistance in osteosarcoma cells highlights the potential importance of hypoxia as a target to reverse drug resistance in paediatric osteosarcoma. The novel finding of HIF-1 alpha independent drug resistance suggests however other hypoxia related targets may be more relevant in paediatric osteosarcoma.	[Adamski, Jennifer; Price, Andrew; Dive, Caroline; Makin, Guy] Paterson Inst Canc Res, Manchester M20 9BX, Lancs, England; [Adamski, Jennifer; Dive, Caroline; Makin, Guy] Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester Canc Res Ctr, Inst Canc Sci, Manchester, Lancs, England; [Adamski, Jennifer; Makin, Guy] Royal Manchester Childrens Hosp, Dept Paediat Oncol, Manchester M27 1HA, Lancs, England	Paterson Institute for Cancer Research; University of Manchester; Royal Manchester Children's Hospital	Makin, G (corresponding author), Paterson Inst Canc Res, Manchester M20 9BX, Lancs, England.	Guy.makin@manchester.ac.uk		Makin, Guy/0000-0003-3513-3957; Dive, Caroline/0000-0002-1726-8850	Friends of Rosie Children's Cancer Charity; Cancer Research United Kingdom; Christie Hospital endowment fund	Friends of Rosie Children's Cancer Charity; Cancer Research United Kingdom(Cancer Research UK); Christie Hospital endowment fund	This work was supported by the Friends of Rosie Children's Cancer Charity, Cancer Research United Kingdom and the Christie Hospital endowment fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achison M, 2003, ONCOGENE, V22, P3431, DOI 10.1038/sj.onc.1206434; Alvarez-Tejado M, 2001, J BIOL CHEM, V276, P22368, DOI 10.1074/jbc.M011688200; Blancher C, 2001, CANCER RES, V61, P7349; Boller YC, 2001, ONCOL RES, V12, P383, DOI 10.3727/096504001108747846; Brown LM, 2006, MOL PHARMACOL, V69, P411, DOI 10.1124/mol.105.015743; Carroll VA, 2006, CANCER RES, V66, P6264, DOI 10.1158/0008-5472.CAN-05-2519; Chau NM, 2005, CANCER RES, V65, P4918, DOI 10.1158/0008-5472.CAN-04-4453; Chen EY, 2001, CANCER RES, V61, P2429; Chen J, 2009, ONCOGENE, V28, P2581, DOI 10.1038/onc.2009.124; Chen WL, 2008, ORAL SURG ORAL MED O, V106, P254, DOI 10.1016/j.tripleo.2008.01.029; Clark AS, 2002, MOL CANCER THER, V1, P707; Comerford KM, 2002, CANCER RES, V62, P3387; Cosse JPJ, 2009, NEOPLASIA, V11, P976, DOI 10.1593/neo.09632; Dai S, 2003, INT J RADIAT ONCOL, V55, P1027, DOI 10.1016/S0360-3016(02)04507-8; Dai T, 2008, ACTA PHARMACOL SIN, V29, P1425, DOI 10.1111/j.1745-7254.2008.00904.x; Damia G, 2001, NEOPLASIA, V3, P10, DOI 10.1038/sj.neo.7900122; Dong Z, 2001, J BIOL CHEM, V276, P18702, DOI 10.1074/jbc.M011774200; Ema M, 1997, P NATL ACAD SCI USA, V94, P4273, DOI 10.1073/pnas.94.9.4273; Erler JT, 2004, MOL CELL BIOL, V24, P2875, DOI 10.1128/MCB.24.7.2875-2889.2004; FLORENES VA, 1994, J NATL CANCER I, V86, P1297, DOI 10.1093/jnci/86.17.1297; Gatta G, 2003, ANN ONCOL, V14, pV119, DOI 10.1093/annonc/mdg755; Graeber TG, 1996, NATURE, V379, P88, DOI 10.1038/379088a0; Graziani I, 2008, CANCER RES, V68, P9678, DOI 10.1158/0008-5472.CAN-08-0969; Hammond EM, 2005, BIOCHEM BIOPH RES CO, V331, P718, DOI 10.1016/j.bbrc.2005.03.154; Hao J, 2008, CANCER GENE THER, V15, P449, DOI 10.1038/cgt.2008.4; Harting MT, 2006, J PEDIATR SURG, V41, P194, DOI 10.1016/j.jpedsurg.2005.10.089; Hovelmann S, 2004, BRIT J CANCER, V90, P2370, DOI 10.1038/sj.bjc.6601876; Huang L, 2010, J CANCER RES CLIN, V136, P447, DOI 10.1007/s00432-009-0675-4; Hussein D, 2006, MOL CANCER THER, V5, P2241, DOI 10.1158/1535-7163.MCT-06-0145; Jackson MW, 2004, ONCOGENE, V23, P4477, DOI 10.1038/sj.onc.1207575; KALRA R, 1993, INT J CANCER, V54, P650, DOI 10.1002/ijc.2910540421; Kaya M, 2000, CLIN CANCER RES, V6, P572; Kilic M, 2007, ONCOGENE, V26, P2027, DOI 10.1038/sj.onc.1210008; Klymenko T, 2011, MOL CANCER THER, V10, P2373, DOI 10.1158/1535-7163.MCT-11-0326; Koch S, 2003, BRIT J CANCER, V89, P2133, DOI 10.1038/sj.bjc.6601375; Lee SM, 2006, CANCER LETT, V242, P231, DOI 10.1016/j.canlet.2005.11.001; LINK MP, 1986, NEW ENGL J MED, V314, P1600, DOI 10.1056/NEJM198606193142502; Liu LL, 2008, CANCER SCI, V99, P121, DOI 10.1111/j.1349-7006.2007.00643.x; Liu XW, 2010, PHARMACOL RES, V62, P416, DOI 10.1016/j.phrs.2010.07.002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; MEYERS PA, 1993, J CLIN ONCOL, V11, P449, DOI 10.1200/JCO.1993.11.3.449; Mizobuchi H, 2008, CLIN ORTHOP RELAT R, V466, P2052, DOI 10.1007/s11999-008-0328-y; Opel D, 2008, CANCER RES, V68, P6271, DOI 10.1158/0008-5472.CAN-07-6769; Park SY, 2002, BIOCHEM BIOPH RES CO, V291, P150, DOI 10.1006/bbrc.2002.6421; Piret JP, 2006, EXP CELL RES, V312, P2908, DOI 10.1016/j.yexcr.2006.05.018; Ravizza R, 2009, EUR J CANCER, V45, P890, DOI 10.1016/j.ejca.2008.12.021; Risbud MV, 2005, SPINE, V30, P2503, DOI 10.1097/01.brs.0000186326.82747.13; Roberts AM, 2009, CANCER RES, V69, P9056, DOI 10.1158/0008-5472.CAN-09-1770; Roberts DL, 2009, BRIT J CANCER, V101, P1290, DOI 10.1038/sj.bjc.6605311; Rohwer N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012038; Sabbatini P, 1999, J BIOL CHEM, V274, P24263, DOI 10.1074/jbc.274.34.24263; Schnitzer SE, 2006, CELL DEATH DIFFER, V13, P1611, DOI 10.1038/sj.cdd.4401864; Selvendiran K, 2009, INT J CANCER, V125, P2198, DOI 10.1002/ijc.24601; Sermeus A, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-27; Song JR, 2009, AUTOPHAGY, V5, P1131, DOI 10.4161/auto.5.8.9996; Song XR, 2006, CANCER CHEMOTH PHARM, V58, P776, DOI 10.1007/s00280-006-0224-7; Stiller CA, 2007, CANCER TREAT REV, V33, P631, DOI 10.1016/j.ctrv.2007.01.001; Sullivan R, 2008, MOL CANCER THER, V7, P1961, DOI 10.1158/1535-7163.MCT-08-0198; Sullivan R, 2009, MOL CANCER THER, V8, P1702, DOI 10.1158/1535-7163.MCT-08-1090; TEICHER BA, 1981, CANCER RES, V41, P73; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang DD, 2010, PHARMAZIE, V65, P51, DOI 10.1691/ph.2010.9618; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang JZ, 2006, J AM SOC NEPHROL, V17, P1875, DOI 10.1681/ASN.2005121371; Yang QC, 2007, JPN J CLIN ONCOL, V37, P127, DOI 10.1093/jjco/hyl137; Yokoi K, 2004, CLIN CANCER RES, V10, P2299, DOI 10.1158/1078-0432.CCR-03-0488; Yuan XW, 2007, ACTA PHARMACOL SIN, V28, P1835, DOI 10.1111/j.1745-7254.2007.00662.x; Zhang L, 2004, CANCER RES, V64, P4180, DOI 10.1158/0008-5472.CAN-03-3038	71	56	59	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65304	10.1371/journal.pone.0065304	http://dx.doi.org/10.1371/journal.pone.0065304			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785417	Green Published, gold, Green Submitted			2022-12-27	WOS:000321038800103
J	Hoesein, FAAM; de Jong, PA; Lammers, JWJ; Mali, WP; Schmidt, M; de Koning, HJ; van der Aalst, C; Oudkerk, M; Vliegenthart, R; van Ginneken, B; van Rikxoort, EM; Zanen, P				Hoesein, Firdaus A. A. Mohamed; de Jong, Pim A.; Lammers, Jan-Willem J.; Mali, Willem PThM; Schmidt, Michael; de Koning, Harry J.; van der Aalst, Carlijn; Oudkerk, Matthijs; Vliegenthart, Rozemarijn; van Ginneken, Bram; van Rikxoort, Eva M.; Zanen, Pieter			Computed Tomography Structural Lung Changes in Discordant Airflow Limitation	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; FEV1/FVC LESS-THAN-0.70; DIAGNOSING COPD; EMPHYSEMA; POPULATION; PREVALENCE; RISK; ASSOCIATION; THRESHOLDS; BURDEN	Background: There is increasing evidence that structural lung changes may be present before the occurrence of airflow limitation as assessed by spirometry. This study investigated the prevalence of computed tomography (CT) quantified emphysema, airway wall thickening and gas trapping according to classification of airflow limitation (FEV1/FVC <70% and/or < the lower limit of normal (LLN)) in (heavy) smokers. Methods: A total number of 1,140 male former and current smokers participating in a lung cancer screenings trial (NELSON) were included and underwent chest CT scanning and spirometry. Emphysema was quantified by the 15th percentile, air way wall thickening by the square root of wall area for a theoretical airway with 10mm lumen perimeter (Pi10) and gas trapping by the mean lung density expiratory/inspiratory (E/I)-ratio. Participants were classified by entry FEV1/FVC: group 1>70%; group 2<70% but >LLN; and group 3<LLN. 32 restricted subjects, i.e. FEV1/FVC >70% but FEV1 <80% predicted, were excluded. Multivariate regression analysis correcting for covariates was used to asses the extent of emphysema, airway wall thickening and gas trapping according to three groups of airflow limitation. Results: Mean (standard deviation) age was 62.5 (5.2) years and packyears smoked was 41.0 (18.0). Group 2 subjects when compared to group 1 had a significantly lower 15th percentile, -920.6 HU versus -912.2 HU; a higher Pi10, 2.87 mm versus 2.57 mm; and a higher E/I-ratio, 88.6% versus 85.6% (all p<0.001). Conclusion: Subjects with an FEV1/FVC <70%, but above the LLN, have a significant greater degree of structural lung changes on CT compared to subjects without airflow limitation.	[Hoesein, Firdaus A. A. Mohamed; Lammers, Jan-Willem J.; Zanen, Pieter] Univ Med Ctr Utrecht, Dept Resp Med, Div Heart & Lungs, Utrecht, Netherlands; [Hoesein, Firdaus A. A. Mohamed; de Jong, Pim A.; Mali, Willem PThM] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [Schmidt, Michael] Inst Med Image Comp, Fraunhofer MEVIS, Bremen, Germany; [de Koning, Harry J.; van der Aalst, Carlijn] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Oudkerk, Matthijs] Univ Groningen, Univ Med Ctr Groningen, Ctr Med Imaging North East Netherlands, Groningen, Netherlands; [Vliegenthart, Rozemarijn] Univ Groningen, Univ Med Ctr Groningen, Dept Radiol, Groningen, Netherlands; [van Ginneken, Bram; van Rikxoort, Eva M.] Radboud Univ Nijmegen, Med Ctr, Dept Radiol, NL-6525 ED Nijmegen, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus MC; University of Groningen; University of Groningen; Radboud University Nijmegen	Hoesein, FAAM (corresponding author), Univ Med Ctr Utrecht, Dept Resp Med, Div Heart & Lungs, Utrecht, Netherlands.	fmohamedhoesein@gmail.com	de+Koning, Harry/AAF-9062-2019; van Rikxoort, Eva/P-2640-2014; Mali, Willem PThM/I-1123-2014; van Ginneken, Bram/A-3728-2012; van der Aalst, Carlijn/AAG-7522-2019; de Jong, Pim A/G-7220-2014	de+Koning, Harry/0000-0003-4682-3646; van Rikxoort, Eva/0000-0001-6418-9760; Mali, Willem PThM/0000-0003-4391-0904; van Ginneken, Bram/0000-0003-2028-8972; de Jong, Pim A/0000-0003-4840-6854; zanen, pieter/0000-0002-5318-8276; Oudkerk, Matthijs/0000-0003-2800-4110	European Union (EU) Framework Package Seven (FP7) [201379]; Netherlands Organisation for Health Research and Development (ZonMw); Dutch Cancer Society Koningin Wilhelmina Fonds (KWF); Stichting Centraal Fonds Reserves van Voormalig Vrijwillige Ziekenfondsverzekeringen (RvvZ); Siemens Germany; Roche Diagnostics; Rotterdam Oncologic Thoracic Steering committee (ROTS); G.Ph.Verhagen Trust; Flemish League Against Cancer; Foundation Against Cancer; Erasmus Trust Fund	European Union (EU) Framework Package Seven (FP7); Netherlands Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Dutch Cancer Society Koningin Wilhelmina Fonds (KWF); Stichting Centraal Fonds Reserves van Voormalig Vrijwillige Ziekenfondsverzekeringen (RvvZ); Siemens Germany(Siemens AG); Roche Diagnostics; Rotterdam Oncologic Thoracic Steering committee (ROTS); G.Ph.Verhagen Trust; Flemish League Against Cancer; Foundation Against Cancer; Erasmus Trust Fund	Funding was provided by European Union (EU) Framework Package Seven (FP7), grant number 201379, COPACETIC. The NELSON-trial was sponsored by: Netherlands Organisation for Health Research and Development (ZonMw); Dutch Cancer Society Koningin Wilhelmina Fonds (KWF); Stichting Centraal Fonds Reserves van Voormalig Vrijwillige Ziekenfondsverzekeringen (RvvZ); Siemens Germany; Roche Diagnostics; Rotterdam Oncologic Thoracic Steering committee (ROTS); and G.Ph.Verhagen Trust, Flemish League Against Cancer, Foundation Against Cancer and Erasmus Trust Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; HK is member of the medical advisory board of Roche Diagnostics. Siemens Germany and Roche Diagnostics provided funding towards this study. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Baggerman W., 2009, P 2 INT WORKSH PULM, P341; BARBERA JA, 1994, AM J RESP CRIT CARE, V149, P423, DOI 10.1164/ajrccm.149.2.8306040; Bednarek M, 2008, THORAX, V63, P402, DOI 10.1136/thx.2007.085456; Celli BR, 2010, CHEST, V138, P1037, DOI 10.1378/chest.10-2049; Danielsson P, 2012, CLIN RESPIR J, V6, P120, DOI 10.1111/j.1752-699X.2011.00257.x; Garcia-Rio F, 2011, CHEST, V139, P1072, DOI 10.1378/chest.10-1721; Grydeland TB, 2009, EUR RESPIR J, V34, P858, DOI 10.1183/09031936.00167908; Hackx M, 2012, RADIOLOGY, V265, P34, DOI 10.1148/radiol.12111270; Hoesein FAAM, 2011, EUR RESPIR J, V38, P1012, DOI 10.1183/09031936.00050711; Hoesein FAAM, 2012, COPD, V9, P338, DOI 10.3109/15412555.2012.667851; Hoesein FAAM, 2011, THORAX, V66, P782, DOI 10.1136/thx.2010.145995; Hoesein FAAM, 2011, RESP MED, V105, P907, DOI 10.1016/j.rmed.2011.01.008; Hogg JC, 2004, LANCET, V364, P709, DOI 10.1016/S0140-6736(04)16900-6; Alonso JLI, 2012, ARCH BRONCONEUMOL, V48, P223, DOI 10.1016/j.arbres.2012.02.007; Jordan RE, 2010, THORAX, V65, P492, DOI 10.1136/thx.2009.129395; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Mannino DM, 2012, CHEST, V141, P73, DOI 10.1378/chest.11-0797; Mets OM, 2011, JAMA-J AM MED ASSOC, V306, P1775, DOI 10.1001/jama.2011.1531; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Ofir D, 2008, AM J RESP CRIT CARE, V177, P622, DOI 10.1164/rccm.200707-1064OC; Patel BD, 2008, AM J RESP CRIT CARE, V178, P500, DOI 10.1164/rccm.200801-059OC; Prentice HA, 2010, COPD, V7, P323, DOI 10.3109/15412555.2010.510161; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Rodriguez-Roisin R, 2009, J APPL PHYSIOL, V106, P1902, DOI 10.1152/japplphysiol.00085.2009; Schilham AMR, 2006, IEEE T MED IMAGING, V25, P451, DOI 10.1109/TMI.2006.871545; Schmidt M, 2010, P SPIE SPIE, V7624; van Iersel CA, 2007, INT J CANCER, V120, P868, DOI 10.1002/ijc.22134; van Rikxoort EM, 2009, MED PHYS, V36, P2934, DOI 10.1118/1.3147146; Vestbo J, 2012, AM J RESP CRIT CARE, DOI [10.1164/rccm.201204-0596, DOI 10.1164/RCCM.201204-0596]	29	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65177	10.1371/journal.pone.0065177	http://dx.doi.org/10.1371/journal.pone.0065177			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785411	Green Published, gold, Green Submitted			2022-12-27	WOS:000321038800109
J	Meseda, CA; Campbell, J; Kumar, A; Garcia, AD; Merchlinsky, M; Weir, JP				Meseda, Clement A.; Campbell, Joseph; Kumar, Arunima; Garcia, Alonzo D.; Merchlinsky, Michael; Weir, Jerry P.			Effect of the Deletion of Genes Encoding Proteins of the Extracellular Virion Form of Vaccinia Virus on Vaccine Immunogenicity and Protective Effectiveness in the Mouse Model	PLOS ONE			English	Article							HUMORAL IMMUNE-RESPONSE; OUTER-MEMBRANE PROTEINS; 2 INFECTIOUS FORMS; SMALLPOX VACCINE; DNA VACCINE; NEUTRALIZING ANTIBODY; ENVELOPE PROTEIN; MONKEYPOX; MICE; ANTIGENS	Antibodies to both infectious forms of vaccinia virus, the mature virion (MV) and the enveloped virion (EV), as well as cell-mediated immune response appear to be important for protection against smallpox. EV virus particles, although more labile and less numerous than MV, are important for dissemination and spread of virus in infected hosts and thus important in virus pathogenesis. The importance of the EV A33 and B5 proteins for vaccine induced immunity and protection in a murine intranasal challenge model was evaluated by deletion of both the A33R and B5R genes in a vaccine-derived strain of vaccinia virus. Deletion of either A33R or B5R resulted in viruses with a small plaque phenotype and reduced virus yields, as reported previously, whereas deletion of both EV proteinen-coding genes resulted in a virus that formed small infection foci that were detectable and quantifiable only by immunostaining and an even more dramatic decrease in total virus yield in cell culture. Deletion of B5R, either as a single gene knockout or in the double EV gene knockout virus, resulted in a loss of EV neutralizing activity, but all EV gene knockout viruses still induced a robust neutralizing activity against the vaccinia MV form of the virus. The effect of elimination of A33 and/or B5 on the protection afforded by vaccination was evaluated by intranasal challenge with a lethal dose of either vaccinia virus WR or IHD-J, a strain of vaccinia virus that produces relatively higher amounts of EV virus. The results from multiple experiments, using a range of vaccination doses and virus challenge doses, and using mortality, morbidity, and virus dissemination as endpoints, indicate that the absence of A33 and B5 have little effect on the ability of a vaccinia vaccine virus to provide protection against a lethal intranasal challenge in a mouse model.	[Meseda, Clement A.; Campbell, Joseph; Kumar, Arunima; Garcia, Alonzo D.; Merchlinsky, Michael; Weir, Jerry P.] US FDA, Div Viral Prod, Ctr Biol Evaluat & Res, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Meseda, CA (corresponding author), US FDA, Div Viral Prod, Ctr Biol Evaluat & Res, Rockville, MD 20857 USA.	Clement.Meseda@fda.hhs.gov	Meseda, Clement/I-6336-2019		US Food and Drug Administration [Y1-AI-6153-01]; National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIAID) [Y1-AI-6153-01]	US Food and Drug Administration; National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIAID)	Funding for this work was partly provided by an Inter- Agency Agreement between the US Food and Drug Administration and the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIAID Agreement number Y1-AI-6153-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo JE, 2009, J GEN VIROL, V90, P2604, DOI 10.1099/vir.0.008474-0; Arness MK, 2004, AM J EPIDEMIOL, V160, P642, DOI 10.1093/aje/kwh269; Bell E, 2004, VIROLOGY, V325, P425, DOI 10.1016/j.virol.2004.05.004; Benhnia MREI, 2008, J VIROL, V82, P3751, DOI 10.1128/JVI.02244-07; BOULTER EA, 1971, AM J EPIDEMIOL, V94, P612, DOI 10.1093/oxfordjournals.aje.a121360; Breman JG, 2002, NEW ENGL J MED, V346, P1300, DOI 10.1056/NEJMra020025; Chakrabarti S, 1997, BIOTECHNIQUES, V23, P1094, DOI 10.2144/97236st07; Davies DH, 2005, P NATL ACAD SCI USA, V102, P547, DOI 10.1073/pnas.0408782102; DUNCAN SA, 1992, J VIROL, V66, P1610, DOI 10.1128/JVI.66.3.1610-1621.1992; Earl PL, 1998, CURRENT PROTOCOLS MO; Empig C, 2006, VACCINE, V24, P3686, DOI 10.1016/j.vaccine.2005.03.029; ENGELSTAD M, 1993, VIROLOGY, V194, P627, DOI 10.1006/viro.1993.1302; Fang M, 2006, VIROLOGY, V345, P231, DOI 10.1016/j.virol.2005.09.056; Fogg C, 2004, J VIROL, V78, P10230, DOI 10.1128/JVI.78.19.10230-10237.2004; Fulginiti VA, 2003, CLIN INFECT DIS, V37, P241, DOI 10.1086/375824; Galmiche MC, 1999, VIROLOGY, V254, P71, DOI 10.1006/viro.1998.9516; Garcia AD, 2007, CLIN VACCINE IMMUNOL, V14, P1032, DOI 10.1128/CVI.00050-07; GOEBEL SJ, 1990, VIROLOGY, V179, P247, DOI 10.1016/0042-6822(90)90294-2; Golden JW, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-441; Halsell JS, 2003, JAMA-J AM MED ASSOC, V289, P3283, DOI 10.1001/jama.289.24.3283; Heymann DL, 1998, BRIT MED BULL, V54, P693, DOI 10.1093/oxfordjournals.bmb.a011720; Hooper JW, 2004, J VIROL, V78, P4433, DOI 10.1128/JVI.78.9.4433-4443.2004; Jezek Z, 1988, HUMAN MONKEYPOX; Jing LC, 2005, J IMMUNOL, V175, P7550, DOI 10.4049/jimmunol.175.11.7550; Jones-Trower A, 2005, VIROLOGY, V343, P128, DOI 10.1016/j.virol.2005.08.008; Kidokoro M, 2005, P NATL ACAD SCI USA, V102, P4152, DOI 10.1073/pnas.0406671102; KOTWAL GJ, 1988, VIROLOGY, V167, P524, DOI 10.1016/S0042-6822(88)90115-8; LENNETTE EH, 1964, DIAGNOSTIC PROCEDURE, P45; Lustig S, 2004, VIROLOGY, V328, P30, DOI 10.1016/j.virol.2004.07.024; Meseda CA, 2005, VIROLOGY, V339, P164, DOI 10.1016/j.virol.2005.06.002; Meseda CA, 2002, J INFECT DIS, V186, P1065, DOI 10.1086/344234; Meseda CA, 2010, FUTURE MICROBIOL, V5, P1367, DOI 10.2217/FMB.10.98; Meseda CA, 2009, CLIN VACCINE IMMUNOL, V16, P1261, DOI 10.1128/CVI.00040-09; Meyer H, 2002, J CLIN MICROBIOL, V40, P2919, DOI 10.1128/JCM.40.8.2919-2921.2002; Moss B, 2011, IMMUNOL REV, V239, P8, DOI 10.1111/j.1600-065X.2010.00975.x; Orr N, 2004, J INFECT DIS, V190, P1295, DOI 10.1086/423851; Pelkonen PM, 2003, EMERG INFECT DIS, V9, P1458, DOI 10.3201/eid0911.020814; Putz MM, 2006, NAT MED, V12, P1310, DOI 10.1038/nm1457; Reed KD, 2004, NEW ENGL J MED, V350, P342, DOI 10.1056/NEJMoa032299; Roberts KL, 2008, TRENDS MICROBIOL, V16, P472, DOI 10.1016/j.tim.2008.07.009; Roper RL, 1998, J VIROL, V72, P4192, DOI 10.1128/JVI.72.5.4192-4204.1998; Saijo M, 2006, J VIROL, V80, P5179, DOI 10.1128/JVI.02642-05; Smith GL, 2002, J GEN VIROL, V83, P2915, DOI 10.1099/0022-1317-83-12-2915; TURNER GS, 1971, J GEN VIROL, V13, P19, DOI 10.1099/0022-1317-13-1-19; Viner KM, 2005, MICROBES INFECT, V7, P579, DOI 10.1016/j.micinf.2005.02.004; Vorou RM, 2008, CURR OPIN INFECT DIS, V21, P153, DOI 10.1097/QCO.0b013e3282f44c74; Weltzin R, 2003, NAT MED, V9, P1125, DOI 10.1038/nm916; WOLFFE EJ, 1993, J VIROL, V67, P4732, DOI 10.1128/JVI.67.8.4732-4741.1993; Wyatt LS, 2004, P NATL ACAD SCI USA, V101, P4590, DOI 10.1073/pnas.0401165101; Wyatt LS, 1996, VACCINE, V14, P1451, DOI 10.1016/S0264-410X(96)00072-2; Yadav S, 2010, ARCH VIROL, V155, P255, DOI 10.1007/s00705-009-0562-y; Zaitseva M, 2011, J VIROL, V85, P9147, DOI 10.1128/JVI.00121-11; Zaitseva M, 2009, J VIROL, V83, P10437, DOI 10.1128/JVI.01296-09	54	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e67984	10.1371/journal.pone.0067984	http://dx.doi.org/10.1371/journal.pone.0067984			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785523	Green Published, gold, Green Submitted			2022-12-27	WOS:000321038800001
J	Surova, Y; Szczepankiewicz, F; Latt, J; Nilsson, M; Eriksson, B; Leemans, A; Hansson, O; van Westen, D; Nilsson, C				Surova, Yulia; Szczepankiewicz, Filip; Latt, Jimmy; Nilsson, Markus; Eriksson, Bengt; Leemans, Alexander; Hansson, Oskar; van Westen, Danielle; Nilsson, Christer			Assessment of Global and Regional Diffusion Changes along White Matter Tracts in Parkinsonian Disorders by MR Tractography	PLOS ONE			English	Article							MULTIPLE-SYSTEM ATROPHY; PROGRESSIVE SUPRANUCLEAR PALSY; VOXEL BASED MORPHOMETRY; MEAN DIFFUSIVITY; CORPUS-CALLOSUM; HUMAN BRAIN; DISEASE; DIAGNOSIS; VARIANT; CINGULUM	Purpose: The aim of the study was to determine the usefulness of diffusion tensor tractography (DTT) in parkinsonian disorders using a recently developed method for normalization of diffusion data and tract size along white matter tracts. Furthermore, the use of DTT in selected white matter tracts for differential diagnosis was assessed. Methods: We quantified global and regional diffusion parameters in major white matter tracts in patients with multiple system atrophy (MSA), progressive nuclear palsy (PSP), idiopathic Parkinson's disease (IPD) and healthy controls). Diffusion tensor imaging data sets with whole brain coverage were acquired at 3 T using 48 diffusion encoding directions and a voxel size of 26262 mm(3). DTT of the corpus callosum (CC), cingulum (CG), corticospinal tract (CST) and middle cerebellar peduncles (MCP) was performed using multiple regions of interest. Regional evaluation comprised projection of fractional anisotropy (FA), mean diffusivity (MD), radial diffusivity (RD) and the apparent area coefficient (AAC) onto a calculated mean tract and extraction of their values along each structure. Results: There were significant changes of global DTT parameters in the CST (MSA and PSP), CC (PSP) and CG (PSP). Consistent tract-specific variations in DTT parameters could be seen along each tract in the different patient groups and controls. Regional analysis demonstrated significant changes in the anterior CC (MD, RD and FA), CST (MD) and CG (AAC) of patients with PSP compared to controls. Increased MD in CC and CST, as well as decreased AAC in CG, was correlated with a diagnosis of PSP compared to IPD. Conclusions: DTT can be used for demonstrating disease-specific regional white matter changes in parkinsonian disorders. The anterior portion of the CC was identified as a promising region for detection of neurodegenerative changes in patients with PSP, as well as for differential diagnosis between PSP and IPD.	[Surova, Yulia; Eriksson, Bengt; Hansson, Oskar; van Westen, Danielle] Lund Univ, Dept Clin Sci, Lund, Sweden; [Surova, Yulia] Skane Univ Hosp, Dept Neurol Lund, Lund, Sweden; [Szczepankiewicz, Filip] Lund Univ, Dept Med Radiat Phys, Lund, Sweden; [Latt, Jimmy; van Westen, Danielle] Skane Univ Hosp, Ctr Med Imaging & Physiol, Lund, Sweden; [Nilsson, Markus] Lund Univ, Bioimaging Ctr, Lund, Sweden; [Eriksson, Bengt; Hansson, Oskar; Nilsson, Christer] Lund Univ, Dept Clin Sci Malmo, Clin Memory Res Unit, Lund, Sweden; [Leemans, Alexander] Univ Med Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands	Lund University; Lund University; Skane University Hospital; Lund University; Lund University; Skane University Hospital; Lund University; Lund University; Utrecht University; Utrecht University Medical Center	Surova, Y (corresponding author), Lund Univ, Dept Clin Sci, Lund, Sweden.	yulia.surova@med.lu.se	Leemans, Alexander/A-1784-2011; Szczepankiewicz, Filip/AAV-9958-2021; Hansson, Oskar/A-7134-2013; Nilsson, Markus/C-6920-2012	Leemans, Alexander/0000-0002-9306-6126; Szczepankiewicz, Filip/0000-0002-5251-587X; Hansson, Oskar/0000-0001-8467-7286; Nilsson, Markus/0000-0002-3140-8223; van Westen, Danielle/0000-0001-8649-9874	Swedish Parkinson foundation; Swedish Science Council through the Linnaeus project BAGADILICO; Swedish Parkinson Academy; province of Skane University Hospital; ALF; Swedish Cancer Society [CAN 2009/1076, CAN 2012/597]	Swedish Parkinson foundation; Swedish Science Council through the Linnaeus project BAGADILICO; Swedish Parkinson Academy; province of Skane University Hospital; ALF; Swedish Cancer Society(Swedish Cancer Society)	This research was supported by the Swedish Parkinson foundation, the Swedish Science Council grants through the Linnaeus project BAGADILICO, the Swedish Parkinson Academy and research funds from province of Skane University Hospital and state grants (inclusively ALF) and in part by the Swedish Cancer Society (GrantNo CAN 2009/1076 and CAN 2012/597). The funders had no role in study design, data collection and analysis, decision to publish and preparation of the manuscript.	[Anonymous], 2013, MAGMA IN PRESS; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Brenneis C, 2004, J NEUROL NEUROSUR PS, V75, P246; CALNE DB, 1992, ANN NEUROL, V32, pS125, DOI 10.1002/ana.410320721; Canu E, 2011, MOVEMENT DISORD, V26, P1752, DOI 10.1002/mds.23739; Colby JB, 2012, NEUROIMAGE, V59, P3227, DOI 10.1016/j.neuroimage.2011.11.004; Cordato NJ, 2005, BRAIN, V128, P1259, DOI 10.1093/brain/awh508; Deprez S, 2013, BRAIN IMAGI IN PRESS, V18; Descoteaux M, 2009, IEEE T MED IMAGING, V28, P269, DOI 10.1109/TMI.2008.2004424; Douaud G, 2011, NEUROIMAGE, V55, P880, DOI 10.1016/j.neuroimage.2010.12.008; Erbetta A, 2009, AM J NEURORADIOL, V30, P1482, DOI 10.3174/ajnr.A1615; Fillard P, 2003, LECT NOTES COMPUT SC, V2879, P16; Gilman S, 1999, J NEUROL SCI, V163, P94, DOI 10.1016/S0022-510X(98)00304-9; Gong GL, 2005, HUM BRAIN MAPP, V24, P92, DOI 10.1002/hbm.20072; Hattori T, 2012, HUM BRAIN MAPP, V33, P727, DOI 10.1002/hbm.21245; Hofer S, 2006, NEUROIMAGE, V32, P989, DOI 10.1016/j.neuroimage.2006.05.044; Hrabetova S, 2007, FRONT NEUROENG, V1, P167; Hsu JL, 2008, NEUROIMAGE, V39, P566, DOI 10.1016/j.neuroimage.2007.09.017; Hsu JL, 2010, NEUROIMAGE, V49, P32, DOI 10.1016/j.neuroimage.2009.08.031; Hughes AJ, 2002, BRAIN, V125, P861, DOI 10.1093/brain/awf080; Ito S, 2008, NEURORADIOLOGY, V50, P981, DOI 10.1007/s00234-008-0447-x; Jeurissen B, 2013, HUM BRAIN MAPP, V34, P2747, DOI 10.1002/hbm.22099; Jeurissen B, 2011, HUM BRAIN MAPP, V32, P461, DOI 10.1002/hbm.21032; Jones DK, 2011, METHODS MOL BIOL, V711, P127, DOI 10.1007/978-1-61737-992-5_6; Kamagata K, 2012, AM J NEURORADIOL, V33, P890, DOI 10.3174/ajnr.A2860; Kamagata K, 2013, EUR RADIOL IN PRESS, P13; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Knake S, 2010, MOVEMENT DISORD, V25, P1232, DOI 10.1002/mds.23054; Kollensperger M, 2007, MOVEMENT DISORD, V22, P1771, DOI 10.1002/mds.21614; Kollensperger M, 2010, MOVEMENT DISORD, V25, P2604, DOI 10.1002/mds.23192; KUME A, 1993, J NEUROL SCI, V117, P33, DOI 10.1016/0022-510X(93)90151-N; Kvickstrom P, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-13; Lee CEC, 2009, NEURORADIOLOGY, V51, P3, DOI 10.1007/s00234-008-0441-3; Leemans A., 2009, P 17 ANN M INT SOC M, P3537; Leemans A, 2009, MAGN RESON MED, V61, P1336, DOI 10.1002/mrm.21890; Lim KO, 1999, ARCH GEN PSYCHIAT, V56, P367, DOI 10.1001/archpsyc.56.4.367; Litvan I, 1996, NEUROLOGY, V47, P1, DOI 10.1212/WNL.47.1.1; Makino T, 2011, J NEUROL SCI, V303, P61, DOI 10.1016/j.jns.2011.01.014; Martensson J, 2011, P INT SOC MAG RESON, P4876; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Muller MJ, 2007, NEUROBIOL AGING, V28, P398, DOI 10.1016/j.neurobiolaging.2006.01.009; Nicoletti G, 2008, MOVEMENT DISORD, V23, P2370, DOI 10.1002/mds.22279; Nilsson C, 2007, NEURORADIOLOGY, V49, P111, DOI 10.1007/s00234-006-0165-1; Nucifora PGP, 2007, RADIOLOGY, V245, P367, DOI 10.1148/radiol.2452060445; Padovani A, 2006, J NEUROL NEUROSUR PS, V77, P457, DOI 10.1136/jnnp.2005.075713; Paviour DC, 2007, MOVEMENT DISORD, V22, P68, DOI 10.1002/mds.21204; Peran P, 2010, BRAIN, V133, P3423, DOI 10.1093/brain/awq212; Piccini P, 2006, MOVEMENT DISORD, V21, P2035, DOI 10.1002/mds.20845; Reich DS, 2006, AM J NEURORADIOL, V27, P2168; Salat DH, 2009, DIFFUSION MRI: FROM QUANTITATIVE MEASUREMENT TO IN VIVO NEUROANATOMY, P205, DOI 10.1016/B978-0-12-374709-9.00010-9; Schocke MFH, 2004, NEUROIMAGE, V21, P1443, DOI 10.1016/j.neuroimage.2003.12.005; Schocke MFH, 2002, NEUROLOGY, V58, P575, DOI 10.1212/WNL.58.4.575; Seppi K, 2003, NEUROLOGY, V60, P922, DOI 10.1212/01.WNL.0000049911.91657.9D; Seppi K, 2006, NEUROIMAGE, V31, P240, DOI 10.1016/j.neuroimage.2005.12.006; Shiga K, 2005, J NEUROL, V252, P589, DOI 10.1007/s00415-005-0708-0; Stieltjes B, 2001, NEUROIMAGE, V14, P723, DOI 10.1006/nimg.2001.0861; Szczepankiewicz F, 2012, P INT SOC MAG RESON, P3628; Tha KK, 2010, RADIOLOGY, V255, P563, DOI 10.1148/radiol.10090988; Tournier JD, 2011, MAGN RESON MED, V65, P1532, DOI 10.1002/mrm.22924; Tsukamoto K, 2012, NEURORADIOLOGY, V54, P947, DOI 10.1007/s00234-012-1009-9; Vaillancourt DE, 2009, NEUROLOGY, V72, P1378, DOI 10.1212/01.wnl.0000340982.01727.6e; Van Camp N, 2009, NMR BIOMED, V22, P697, DOI 10.1002/nbm.1381; Vos SB, 2012, NEUROIMAGE, V59, P2208, DOI 10.1016/j.neuroimage.2011.09.086; Vos SB, 2011, NEUROIMAGE, V55, P1566, DOI 10.1016/j.neuroimage.2011.01.048; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Wang HC, 2012, ARCH NEUROL-CHICAGO, V23, P1, DOI DOI 10.1001/ARCHNEUR0L.2012.633; Wang JJ, 2010, J MAGN RESON IMAGING, V32, P69, DOI 10.1002/jmri.22229; Wedeen VJ, 2008, NEUROIMAGE, V41, P1267, DOI 10.1016/j.neuroimage.2008.03.036; Wenning GK, 1997, MOVEMENT DISORD, V12, P133, DOI 10.1002/mds.870120203; Whitwell JL, 2011, ARCH NEUROL-CHICAGO, V68, P753, DOI 10.1001/archneurol.2011.107; Xu DR, 2002, NEUROIMAGE, V17, P1131, DOI 10.1006/nimg.2002.1285; Yoshikawa K, 2004, J NEUROL NEUROSUR PS, V75, P481, DOI 10.1136/jnnp.2003.021873; Zhan W, 2012, MOVEMENT DISORD, V27, P90, DOI 10.1002/mds.23917; Zhang Y, 2007, NEUROLOGY, V68, P13, DOI 10.1212/01.wnl.0000250326.77323.01	74	24	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66022	10.1371/journal.pone.0066022	http://dx.doi.org/10.1371/journal.pone.0066022			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785466	Green Published, gold, Green Submitted			2022-12-27	WOS:000321038800056
J	Tan, K; Yang, S; Wang, ZW; Menzel, R				Tan, Ken; Yang, Shuang; Wang, Zhengwei; Menzel, Randolf			Effect of Flumethrin on Survival and Olfactory Learning in Honeybees	PLOS ONE			English	Article							PROBOSCIS EXTENSION; BEES HYMENOPTERA; TOXICITY; PESTICIDES; EXPOSURE; SPERMATOGENESIS; FLUVALINATE; COUMAPHOS; VARROA; APIDAE	Flumethrin has been widely used as an acaricide for the control of Varroa mites in commercial honeybee keeping throughout the world for many years. Here we test the mortality of the Asian honeybee Apis cerana cerana after treatment with flumethrin. We also ask (1) how bees react to the odor of flumethrin, (2) whether its odor induces an innate avoidance response, (3) whether its taste transmits an aversive reinforcing component in olfactory learning, and (4) whether its odor or taste can be associated with reward in classical conditioning. Our results show that flumethrin has a negative effect on Apis cerana's lifespan, induces an innate avoidance response, acts as a punishing reinforcer in olfactory learning, and interferes with the association of an appetitive conditioned stimulus. Furthermore flumethrin uptake within the colony reduces olfactory learning over an extended period of time.	[Tan, Ken] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Kunming, Peoples R China; [Tan, Ken; Yang, Shuang; Wang, Zhengwei] Yunnan Agr Univ, Eastern Bee Res Inst, Kunming, Peoples R China; [Menzel, Randolf] Free Univ Berlin, Inst Biol & Neurobiol, Berlin, Germany	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Yunnan Agricultural University; Free University of Berlin	Tan, K (corresponding author), Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Kunming, Peoples R China.	kentan@xtbg.ac.cn			Key Laboratory of Tropical Forest Ecology, Xishuangbanna Tropical Botanical Garden, Chinese Academy of Science; China National Research Fund [31260585]; China National Agricultural Production Systematic Fund [CARS-45-kxj14]	Key Laboratory of Tropical Forest Ecology, Xishuangbanna Tropical Botanical Garden, Chinese Academy of Science(Chinese Academy of Sciences); China National Research Fund; China National Agricultural Production Systematic Fund	This work was supported by the Key Laboratory of Tropical Forest Ecology, Xishuangbanna Tropical Botanical Garden, Chinese Academy of Science, China National Research Fund (31260585) and China National Agricultural Production Systematic Fund (CARS-45-kxj14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliouane Y, 2009, ENVIRON TOXICOL CHEM, V28, P113, DOI 10.1897/08-110.1; Andreatta M, 2010, P ROY SOC B-BIOL SCI, V277, P2411, DOI 10.1098/rspb.2010.0103; Bernadou A, 2009, J INSECT PHYSIOL, V55, P1099, DOI 10.1016/j.jinsphys.2009.08.019; BITTERMAN ME, 1983, J COMP PSYCHOL, V97, P107, DOI 10.1037/0735-7036.97.2.107; Bogdanov S, 1998, J APICULT RES, V37, P57, DOI 10.1080/00218839.1998.11100956; [陈亚 CHEN Ya], 2007, [云南农业大学学报, Journal of Yunnan Agricultural University], V22, P309; Collins AM, 2004, J APICULT RES, V43, P128, DOI 10.1080/00218839.2004.11101123; Costa L, 1997, BASIC TOXICOLOGY PES, P251; Davies TGE, 2007, IUBMB LIFE, V59, P151, DOI 10.1080/15216540701352042; Decourtye A, 2005, ARCH ENVIRON CON TOX, V48, P242, DOI 10.1007/s00244-003-0262-7; Decourtye A, 2004, ECOTOX ENVIRON SAFE, V57, P410, DOI 10.1016/j.ecoenv.2003.08.001; Ecocichon D., 1999, CASARETT DOULLS TOXI, V5th; El Hassani AK, 2009, INVERTEBR NEUROSCI, V9, P91, DOI 10.1007/s10158-009-0092-z; ELLIS M, 1988, AM BEE J, V128, P262; EMEA, 1998, SUMM REP COMM VET ME; Farina WM, 2007, NATURWISSENSCHAFTEN, V94, P55, DOI 10.1007/s00114-006-0157-3; Grunewald B, 2004, ACTA BIOL HUNG, V55, P53, DOI 10.1556/ABiol.55.2004.1-4.7; Haarmann T, 2002, J ECON ENTOMOL, V95, P28, DOI 10.1603/0022-0493-95.1.28; Johnson RM, 2006, J ECON ENTOMOL, V99, P1046, DOI 10.1603/0022-0493-99.4.1046; Johnson RM, 2010, APIDOLOGIE, V41, P312, DOI 10.1051/apido/2010018; Joshi SC, 2011, TOXICOL ENVIRON CHEM, V93, P593, DOI 10.1080/02772248.2010.537441; Leahey J.P, 1985, PYRETHROID INSECTICI; Mamood AN, 2008, PHYSIOL ENTOMOL, V15, P55; Matsumoto Y, 2012, J NEUROSCI METH, V211, P159, DOI 10.1016/j.jneumeth.2012.08.018; Menzel Randolf, 2006, Behav Cogn Neurosci Rev, V5, P24, DOI 10.1177/1534582306289522; Mota T, 2011, LEARN MEMORY, V18, P144, DOI 10.1101/lm.2073511; Oruc HH, 2012, J ECON ENTOMOL, V105, P1890, DOI 10.1603/EC12055; Pettis JS, 2004, APIDOLOGIE, V35, P605, DOI 10.1051/apido:2004056; Rinderer TE, 1999, AM BEE J, V139, P134; SATTELLE DB, 1988, ADV INSECT PHYSIOL, V20, P147, DOI 10.1016/S0065-2806(08)60025-9; Schneider CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030023; SODERLUND DM, 1989, ANNU REV ENTOMOL, V34, P77, DOI 10.1146/annurev.en.34.010189.000453; TAYLOR KS, 1987, APIDOLOGIE, V18, P243, DOI 10.1051/apido:19870304; VitaEuropeLtd, 2009, APIGUARD; Yarali A, 2009, J NEUROGENET, V23, P235, DOI 10.1080/01677060802441372; Yousef MI, 2010, FOOD CHEM TOXICOL, V48, P1152, DOI 10.1016/j.fct.2010.02.002; Zhang H, 2010, J APPL TOXICOL, V30, P369, DOI 10.1002/jat.1507; Zhang H, 2010, FOOD CHEM TOXICOL, V48, P1160, DOI 10.1016/j.fct.2010.02.003; Zhao XF, 2011, ARCH TOXICOL, V85, P1101, DOI 10.1007/s00204-011-0654-9; Zlotkin E, 1999, ANNU REV ENTOMOL, V44, P429, DOI 10.1146/annurev.ento.44.1.429	40	16	19	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66295	10.1371/journal.pone.0066295	http://dx.doi.org/10.1371/journal.pone.0066295			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785490	Green Published, gold			2022-12-27	WOS:000321038800032
J	Everett, C				Everett, Caleb			Evidence for Direct Geographic Influences on Linguistic Sounds: The Case of Ejectives	PLOS ONE			English	Article							ALTITUDE; SONORITY; POPULATION; CONSONANTS; LANGUAGES; CLIMATE	We present evidence that the geographic context in which a language is spoken may directly impact its phonological form. We examined the geographic coordinates and elevations of 567 language locations represented in a worldwide phonetic database. Languages with phonemic ejective consonants were found to occur closer to inhabitable regions of high elevation, when contrasted to languages without this class of sounds. In addition, the mean and median elevations of the locations of languages with ejectives were found to be comparatively high. The patterns uncovered surface on all major world landmasses, and are not the result of the influence of particular language families. They reflect a significant and positive worldwide correlation between elevation and the likelihood that a language employs ejective phonemes. In addition to documenting this correlation in detail, we offer two plausible motivations for its existence. We suggest that ejective sounds might be facilitated at higher elevations due to the associated decrease in ambient air pressure, which reduces the physiological effort required for the compression of air in the pharyngeal cavity-a unique articulatory component of ejective sounds. In addition, we hypothesize that ejective sounds may help to mitigate rates of water vapor loss through exhaled air. These explications demonstrate how a reduction of ambient air density could promote the usage of ejective phonemes in a given language. Our results reveal the direct influence of a geographic factor on the basic sound inventories of human languages.	Univ Miami, Dept Anthropol, Coral Gables, FL 33124 USA	University of Miami	Everett, C (corresponding author), Univ Miami, Dept Anthropol, Coral Gables, FL 33124 USA.	caleb@miami.edu			University of Miami	University of Miami	This research was funded by salary from the University of Miami. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, PHONOLOGY COGNITIVE; Atkinson QD, 2011, SCIENCE, V332, P346, DOI 10.1126/science.1199295; Beall CM, 2003, LANCET, V362, pS14, DOI 10.1016/S0140-6736(03)15058-1; Beall CM, 2007, P NATL ACAD SCI USA, V104, P8655, DOI 10.1073/pnas.0701985104; Boersma P., 2013, PRAAT DOING PHONETIC; Brown Cecil H., 2011, WORLD ATLAS LANGUAGE; Catford I, 1974, NATURAL SOUND CHANGE, P21; Cohen JE, 1998, P NATL ACAD SCI USA, V95, P14009, DOI 10.1073/pnas.95.24.14009; Comrie B, 2011, WORLD ATLAS LANGUAGE; Debley JS, 2011, CHEST, V139, P16, DOI 10.1378/chest.10-0101; Demolin D, 2002, PHONOL PHONET, V4-1, P455; Donohue M, 2011, LINGUIST TYPOL, V15, P161, DOI [10.1515/lity.2011.011, DOI 10.1515/LITY.2011.011, DOI 10.1515/LITY.20]; Ember CR, 2007, AM ANTHROPOL, V109, P180, DOI 10.1525/AA.2007.109.1.180; Fallon P., 2002, SYNCHRONIC DIACHRONI; Fought JG, 2004, CROSS-CULT RES, V38, P27, DOI 10.1177/1069397103259439; GREENBERG JH, 1970, INT J AM LINGUIST, V36, P123, DOI 10.1086/465105; Hay J, 2007, LANGUAGE, V83, P388, DOI 10.1353/lan.2007.0071; Javkin H, 1977, BERKELEY LINGUISTICS, V3, P557; Kingston John C., 1985, DISSERTATION; Lewis Paul M., 2009, ETHNOLOGUE; Liberman M, 2008, LANGUAGE LOG PO 0511; Lupyan G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008559; Maddieson, 1996, SOUNDS WORLDS LANGUA; Maddieson I, 2011, WORLD ATLAS LANGUAGE; Munroe RL, 2009, CROSS-CULT RES, V43, P123, DOI 10.1177/1069397109331485; Nettle D, 2012, PHILOS T R SOC B, V367, P1829, DOI 10.1098/rstb.2011.0216; SUSSMAN HM, 1991, J ACOUST SOC AM, V90, P1309, DOI 10.1121/1.401923	27	47	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65275	10.1371/journal.pone.0065275	http://dx.doi.org/10.1371/journal.pone.0065275			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	163FW	23776463	gold, Green Published, Green Submitted			2022-12-27	WOS:000320322400013
J	Kirkbride, RC; Fischer, RL; Harada, JJ				Kirkbride, Ryan C.; Fischer, Robert L.; Harada, John J.			LEAFY COTYLEDON1, a Key Regulator of Seed Development, Is Expressed in Vegetative and Sexual Propagules of Selaginella moellendorffii	PLOS ONE			English	Article							ARABIDOPSIS LEAFY COTYLEDON1; EMBRYO DEVELOPMENT; TRANSCRIPTION FACTOR; PLANT; MATURATION; ORIGIN; EVOLUTION; HETEROSPORY; THALIANA; NETWORKS	LEAFY COTYLEDON1 (LEC1) is a central regulator of seed development that plays a key role in controlling the maturation phase during which storage macromolecules accumulate and the embryo becomes tolerant of desiccation. We queried the genomes of seedless plants and identified a LEC1 homolog in the lycophyte, Selaginella moellendorffii, but not in the bryophyte, Physcomitrella patens. Genetic suppression experiments indicated that Selaginella LEC1 is the functional ortholog of Arabidopsis LEC1. Together, these results suggest that LEC1 originated at least 30 million years before the first seed plants appeared in the fossil record. The accumulation of Selaginella LEC1 RNA primarily in sexual and asexual reproductive structures suggests its involvement in cellular processes similar to those that occur during the maturation phase of seed development.	[Kirkbride, Ryan C.; Harada, John J.] Univ Calif Davis, Dept Plant Biol, Davis, CA 95616 USA; [Kirkbride, Ryan C.; Harada, John J.] Univ Calif Davis, Grad Program Plant Biol, Davis, CA 95616 USA; [Fischer, Robert L.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Berkeley	Harada, JJ (corresponding author), Univ Calif Davis, Dept Plant Biol, Davis, CA 95616 USA.	jjharada@ucdavis.edu		Kirkbride, Ryan/0000-0001-9523-259X	Department of Energy [DE-FG02-03ER15392]; National Science Foundation [IOS-1027494]; Division Of Integrative Organismal Systems [1027494] Funding Source: National Science Foundation	Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Department of Energy http://energy.gov/ DE-FG02-03ER15392 and National Science Foundation http://www.nsf.gov/ IOS-1027494 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Banks JA, 2011, SCIENCE, V332, P960, DOI 10.1126/science.1203810; BATEMAN RM, 1994, BIOL REV, V69, P345, DOI 10.1111/j.1469-185X.1994.tb01276.x; Braybrook SA, 2008, TRENDS PLANT SCI, V13, P624, DOI 10.1016/j.tplants.2008.09.008; Capron A, 2009, ARABIDOPSIS BOOK, V7; DIMICHELE WA, 1989, TAXON, V38, P1, DOI 10.2307/1220881; DUCKETT JG, 1995, ANN BOT-LONDON, V76, P405, DOI 10.1006/anbo.1995.1114; Edwards D, 1998, PLANT PHYSIOL, V117, P1015, DOI 10.1104/pp.117.3.1015; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Gerrienne P, 2004, SCIENCE, V306, P856, DOI 10.1126/science.1102491; Gusmaroli G, 2001, GENE, V264, P173, DOI 10.1016/S0378-1119(01)00323-7; Gutierrez L, 2007, TRENDS PLANT SCI, V12, P294, DOI 10.1016/j.tplants.2007.06.003; Harada JJ, 1997, ADV CELL MOL BIOL PL, V4, P545; Haughn G, 2005, TRENDS PLANT SCI, V10, P472, DOI 10.1016/j.tplants.2005.08.005; Hilton J, 1996, REV PALAEOBOT PALYNO, V93, P235, DOI 10.1016/0034-6667(95)00128-X; Hoekstra FA, 2005, INTEGR COMP BIOL, V45, P725, DOI 10.1093/icb/45.5.725; JERNSTEDT JA, 1992, ANN BOT-LONDON, V69, P351, DOI 10.1093/oxfordjournals.aob.a088352; Kenrick P, 1997, NATURE, V389, P33, DOI 10.1038/37918; Kwong RW, 2003, PLANT CELL, V15, P5, DOI 10.1105/tpc.006973; Lee HS, 2003, P NATL ACAD SCI USA, V100, P2152, DOI 10.1073/pnas.0437909100; Li J, 2012, NEW PHYTOL, V195, P290, DOI 10.1111/j.1469-8137.2012.04182.x; Little DP, 2007, GENOME, V50, P351, DOI 10.1139/G06-138; Lotan T, 1998, CELL, V93, P1195, DOI 10.1016/S0092-8674(00)81463-4; MEINKE DW, 1992, SCIENCE, V258, P1647, DOI 10.1126/science.258.5088.1647; MEINKE DW, 1994, PLANT CELL, V6, P1049, DOI 10.1105/tpc.6.8.1049; Mu JY, 2008, PLANT PHYSIOL, V148, P1042, DOI 10.1104/pp.108.126342; Ohto MA, 2009, SEX PLANT REPROD, V22, P277, DOI 10.1007/s00497-009-0116-1; OLSEN LJ, 1993, PLANT CELL, V5, P941, DOI 10.1105/tpc.5.8.941; Proctor Michael C. F., 2002, P207, DOI 10.1079/9780851995342.0207; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; ROTHWELL GW, 1989, BOT GAZ, V150, P170, DOI 10.1086/337763; Santos-Mendoza M, 2008, PLANT J, V54, P608, DOI 10.1111/j.1365-313X.2008.03461.x; Siefers N, 2009, PLANT PHYSIOL, V149, P625, DOI 10.1104/pp.108.130591; Smith RW, 1920, BOT GAZ, V69, P426, DOI 10.1086/332675; STEEVES TA, 1983, CAN J BOT, V61, P3550, DOI 10.1139/b83-404; Tan HL, 2011, PLANT PHYSIOL, V156, P1577, DOI 10.1104/pp.111.175000; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vicente-Carbajosa J, 2005, INT J DEV BIOL, V49, P645, DOI 10.1387/ijdb.052046jc; WEST MAL, 1994, PLANT CELL, V6, P1731, DOI 10.1105/tpc.6.12.1731; Xie ZY, 2008, MOL BIOL EVOL, V25, P1581, DOI 10.1093/molbev/msn105; Yamagishi K, 2005, PLANT PHYSIOL, V139, P163, DOI 10.1104/pp.105.060467; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85	41	18	19	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e67971	10.1371/journal.pone.0067971	http://dx.doi.org/10.1371/journal.pone.0067971			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776713	Green Published, gold, Green Submitted			2022-12-27	WOS:000320322400129
J	Li, L; Wang, Y; Lin, MK; Yuan, GH; Yang, GB; Zheng, YQ; Chen, YP				Li, Lu; Wang, Ying; Lin, Minkui; Yuan, Guohua; Yang, Guobin; Zheng, Yuqian; Chen, YiPing			Augmented BMPRIA-Mediated BMP Signaling in Cranial Neural Crest Lineage Leads to Cleft Palate Formation and Delayed Tooth Differentiation	PLOS ONE			English	Article							MORPHOGENETIC PROTEIN-RECEPTOR; CELL-PROLIFERATION; JUVENILE POLYPOSIS; SECONDARY PALATE; DENTIN FORMATION; MICE EXHIBIT; EXPRESSION; NOGGIN; MESENCHYME; INDUCTION	The importance of BMP receptor Ia (BMPRIa) mediated signaling in the development of craniofacial organs, including the tooth and palate, has been well illuminated in several mouse models of loss of function, and by its mutations associated with juvenile polyposis syndrome and facial defects in humans. In this study, we took a gain-of-function approach to further address the role of BMPR-IA-mediated signaling in the mesenchymal compartment during tooth and palate development. We generated transgenic mice expressing a constitutively active form of BmprIa (caBmprIa) in cranial neural crest (CNC) cells that contributes to the dental and palatal mesenchyme. Mice bearing enhanced BMPRIa-mediated signaling in CNC cells exhibit complete cleft palate and delayed odontogenic differentiation. We showed that the cleft palate defect in the transgenic animals is attributed to an altered cell proliferation rate in the anterior palatal mesenchyme and to the delayed palatal elevation in the posterior portion associated with ectopic cartilage formation. Despite enhanced activity of BMP signaling in the dental mesenchyme, tooth development and patterning in transgenic mice appeared normal except delayed odontogenic differentiation. These data support the hypothesis that a finely tuned level of BMPRIa-mediated signaling is essential for normal palate and tooth development.	[Li, Lu; Wang, Ying; Lin, Minkui; Yuan, Guohua; Yang, Guobin; Zheng, Yuqian; Chen, YiPing] Tulane Univ, Dept Cell & Mol Biol, New Orleans, LA 70118 USA; [Wang, Ying] Fourth Mil Med Univ, Coll Stomatol, Dept Operat Dent & Endodont, Xian 710032, Shaanxi, Peoples R China; [Lin, Minkui; Zheng, Yuqian] Fujian Med Univ, Coll Stomatol, Dept Periodontol, Fuzhou, Fujian Province, Peoples R China; [Yuan, Guohua; Yang, Guobin] Wuhan Univ, Coll Stomatol, Dept Pediat Dent, Wuhan 430072, Hubei Province, Peoples R China	Tulane University; Air Force Military Medical University; Fujian Medical University; Wuhan University	Chen, YP (corresponding author), Tulane Univ, Dept Cell & Mol Biol, New Orleans, LA 70118 USA.	ychen@tulane.edu			China Scholarship Council; Fourth Military Medical University College of Stomatology, P.R. China; Department of Health, Fujian Province, P.R. China; NIH [R01DE14044]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014044] Funding Source: NIH RePORTER	China Scholarship Council(China Scholarship Council); Fourth Military Medical University College of Stomatology, P.R. China; Department of Health, Fujian Province, P.R. China; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	LL was funded by a China Scholarship Council grant. YW was supported by a fellowship from the Fourth Military Medical University College of Stomatology, P.R. China. ML was supported by a fellowship from the Department of Health, Fujian Province, P.R. China. This work was supported by NIH grant R01DE14044 to YPC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alappat SR, 2005, DEV BIOL, V277, P102, DOI 10.1016/j.ydbio.2004.09.010; Andl T, 2004, DEVELOPMENT, V131, P2257, DOI 10.1242/dev.01125; Baek JA, 2011, DEV BIOL, V350, P520, DOI 10.1016/j.ydbio.2010.12.028; Baur ST, 2000, DEVELOPMENT, V127, P605; Bei M, 2009, J EXP ZOOL PART B, V312B, P437, DOI 10.1002/jez.b.21261; Bush JO, 2012, DEVELOPMENT, V139, P231, DOI 10.1242/dev.067082; Chen YP, 1996, DEVELOPMENT, V122, P3035; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Delnatte C, 2006, AM J HUM GENET, V78, P1066, DOI 10.1086/504301; Dudas M, 2006, DEV BIOL, V296, P298, DOI 10.1016/j.ydbio.2006.05.030; He FL, 2008, DEVELOPMENT, V135, P3871, DOI 10.1242/dev.025767; He FL, 2010, DEV BIOL, V347, P109, DOI 10.1016/j.ydbio.2010.08.014; Hilliard SA, 2005, J ANAT, V207, P655, DOI 10.1111/j.1469-7580.2005.00474.x; Hosoya A, 2008, CELL TISSUE RES, V333, P503, DOI 10.1007/s00441-008-0655-z; Hu X, 2012, J DENT RES, V91, P394, DOI 10.1177/0022034511435939; Huang XF, 2010, J BONE MINER RES, V25, P1167, DOI 10.1359/jbmr.091103; Ito Y, 2003, DEVELOPMENT, V130, P5269, DOI 10.1242/dev.00708; Iwata J, 2012, J BIOL CHEM, V287, P2353, DOI 10.1074/jbc.M111.280974; Jacoby RF, 1997, AM J MED GENET, V70, P361, DOI 10.1002/(SICI)1096-8628(19970627)70:4<361::AID-AJMG6>3.0.CO;2-W; Jernvall J, 1998, DEVELOPMENT, V125, P161; Jussila M, 2013, STEM CELLS IN CRANIOFACIAL DEVELOPMENT AND REGENERATION, P109; Komatsu Y, 2012, J BONE MINER RES, DOI [10.1002/jbmr.1857, DOI 10.1002/JBMR.1857.(EPUB]; Lana-Elola E, 2011, HUM MOL GENET, V20, P4005, DOI 10.1093/hmg/ddr329; Li J, 2011, DEVELOPMENT, V138, P1799; Li L, 2011, DEV BIOL, V349, P451, DOI 10.1016/j.ydbio.2010.10.023; Liu W, 2005, DEVELOPMENT, V132, P1453, DOI 10.1242/dev.01676; Lu HB, 2000, ARCH ORAL BIOL, V45, P133, DOI 10.1016/S0003-9969(99)00118-1; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Menko FH, 2008, CLIN GENET, V74, P145, DOI 10.1111/j.1399-0004.2008.01026.x; Mishina Y, 1995, GENE DEV, V9, P3027, DOI 10.1101/gad.9.24.3027; NAKASHIMA M, 1994, J DENT RES, V73, P1515, DOI 10.1177/00220345940730090601; Neubuser A, 1997, CELL, V90, P247, DOI 10.1016/S0092-8674(00)80333-5; Nie XG, 2006, INT J DEV BIOL, V50, P511, DOI 10.1387/ijdb.052101.xn; O'Connell DJ, 2013, STEM CELLS IN CRANIOFACIAL DEVELOPMENT AND REGENERATION, P179; Rice R, 2004, J CLIN INVEST, V113, P1692, DOI 10.1172/JCI200420384; RUTHERFORD RB, 1994, ARCH ORAL BIOL, V39, P833, DOI 10.1016/0003-9969(94)90014-0; Saito H, 2012, DIS MODEL MECH, V5, P948, DOI 10.1242/dmm.009274; St Amand TR, 2000, DEV BIOL, V217, P323, DOI 10.1006/dbio.1999.9547; Stottmann RW, 2001, DEV BIOL, V240, P457, DOI 10.1006/dbio.2001.0479; Tucker AS, 1998, SCIENCE, V282, P1136, DOI 10.1126/science.282.5391.1136; Wang XP, 2004, DEV DYNAM, V231, P98, DOI 10.1002/dvdy.20118; Wang Y, 2012, J DENT RES, V91, P690, DOI 10.1177/0022034512448660; Yamashiro T, 2003, J DENT RES, V82, P172, DOI 10.1177/154405910308200305; Yao SM, 2010, CONNECT TISSUE RES, V51, P59, DOI 10.3109/03008200903019703; Yi SE, 2000, DEVELOPMENT, V127, P621; Yu L, 2005, DEVELOPMENT, V132, P4397, DOI 10.1242/dev.02013; Zhang YD, 2000, DEVELOPMENT, V127, P1431; Zhang YD, 2003, DEV DYNAM, V226, P713, DOI 10.1002/dvdy.10274; Zhang ZY, 2002, DEVELOPMENT, V129, P4135; Zhao X, 2000, MECH DEVELOP, V99, P29, DOI 10.1016/S0925-4773(00)00467-6; Zhou XP, 2001, AM J HUM GENET, V69, P704, DOI 10.1086/323703	51	28	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66107	10.1371/journal.pone.0066107	http://dx.doi.org/10.1371/journal.pone.0066107			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776616	Green Submitted, gold, Green Published			2022-12-27	WOS:000320322400081
J	Fiume, G; Rossi, A; de Laurentiis, A; Falcone, C; Pisano, A; Vecchio, E; Pontoriero, M; Scala, I; Scialdone, A; Masci, FF; Mimmi, S; Palmieri, C; Scala, G; Quinto, I				Fiume, Giuseppe; Rossi, Annalisa; de laurentiis, Annamaria; Falcone, Cristina; Pisano, Antonio; Vecchio, Eleonora; Pontoriero, Marilena; Scala, Iris; Scialdone, Annarita; Masci, Francesca Fasanella; Mimmi, Selena; Palmieri, Camillo; Scala, Giuseppe; Quinto, Ileana			Eukaryotic Initiation Factor 4H Is under Transcriptional Control of p65/NF-kappa B	PLOS ONE			English	Article							NF-KAPPA-B; RNA HELICASE ACTIVITY; TRANSLATION INITIATION; MESSENGER-RNA; KINETIC CHARACTERIZATION; PROTEIN-KINASE; IMMUNE-SYSTEM; PHOSPHORYLATION; INHIBITOR; GROWTH	Protein synthesis is mainly regulated at the initiation step, allowing the fast, reversible and spatial control of gene expression. Initiation of protein synthesis requires at least 13 translation initiation factors to assemble the 80S ribosomal initiation complex. Loss of translation control may result in cell malignant transformation. Here, we asked whether translational initiation factors could be regulated by NF-kappa B transcription factor, a major regulator of genes involved in cell proliferation, survival, and inflammatory response. We show that the p65 subunit of NF-kB activates the transcription of eIF4H gene, which is the regulatory subunit of eIF4A, the most relevant RNA helicase in translation initiation. The p65-dependent transcriptional activation of eIF4H increased the eIF4H protein content augmenting the rate of global protein synthesis. In this context, our results provide novel insights into protein synthesis regulation in response to NF-kB activation signalling, suggesting a transcription-translation coupled mechanism of control.	[Fiume, Giuseppe; Rossi, Annalisa; de laurentiis, Annamaria; Falcone, Cristina; Pisano, Antonio; Vecchio, Eleonora; Pontoriero, Marilena; Scialdone, Annarita; Masci, Francesca Fasanella; Mimmi, Selena; Palmieri, Camillo; Scala, Giuseppe; Quinto, Ileana] Univ Catanzaro Magna Graecia, Dept Expt & Clin Med, Catanzaro, Italy; [Scala, Iris] Univ Naples Federico II, Dept Pediat, Naples, Italy; [Quinto, Ileana] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy	Magna Graecia University of Catanzaro; University of Naples Federico II; University of Naples Federico II	Fiume, G (corresponding author), Univ Catanzaro Magna Graecia, Dept Expt & Clin Med, Catanzaro, Italy.	fiume@unicz.it; scala@unicz.it; quinto@unicz.it	vecchio, eleonora/AAT-4287-2020; Mimmi, Selena/AAB-9585-2019; Falcone, Cristina/AAP-9529-2020; Mimmi, Selena/J-7860-2016; Palmieri, Camillo/A-3195-2009	Mimmi, Selena/0000-0003-2187-9176; Mimmi, Selena/0000-0003-2187-9176; QUINTO, Ileana/0000-0001-8212-8515; Palmieri, Camillo/0000-0001-6707-4723; Scala, Iris/0000-0003-2725-437X; FIUME, Giuseppe/0000-0002-5414-6190	Ministero dell'Istruzione, dell'Universita e della Ricerca [PON01_02782, PON01_00862]; Ministero della Salute [RF-2010-2306943, GR-2009-1606801]; Associazione Italiana per la Ricerca sul Cancro [IG-2009-9411]; Fondazione Italiana per la Ricerca sul Cancro	Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Ministero della Salute(Ministry of Health, Italy); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Fondazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	This work was granted by Ministero dell'Istruzione, dell'Universita e della Ricerca (PON01_02782 and PON01_00862); Ministero della Salute (RF-2010-2306943 and GR-2009-1606801); Associazione Italiana per la Ricerca sul Cancro (IG-2009-9411). A.R. and E.V. were supported by fellowships from Fondazione Italiana per la Ricerca sul Cancro. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMSON RD, 1988, J BIOL CHEM, V263, P6016; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Bilanges B, 2007, ONCOGENE, V26, P5973, DOI 10.1038/sj.onc.1210431; De Laurentiis A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.007898; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Duffey DC, 1999, CANCER RES, V59, P3468; Fiume G, 2012, NUCLEIC ACIDS RES, V40, P3548, DOI 10.1093/nar/gkr1224; Fiume G, 2009, COMPUT BIOL CHEM, V33, P434, DOI 10.1016/j.compbiolchem.2009.08.001; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Giordano A, 2008, CARDIOVASC RES, V79, P519, DOI 10.1093/cvr/cvn079; GRIFO JA, 1984, J BIOL CHEM, V259, P8648; HASKILL S, 1991, CELL, V65, P1281, DOI 10.1016/0092-8674(91)90022-Q; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Janda E, 2011, BLOOD, V117, P6520, DOI 10.1182/blood-2010-09-308080; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; LIN TA, 1994, SCIENCE, V266, P653, DOI 10.1126/science.7939721; Marintchev A, 2009, CELL, V136, P447, DOI 10.1016/j.cell.2009.01.014; Meric F, 2002, MOL CANCER THER, V1, P971; Palmieri Camillo, 2004, Retrovirology, V1, P45, DOI 10.1186/1742-4690-1-45; Parsyan A, 2011, NAT REV MOL CELL BIO, V12, P235, DOI 10.1038/nrm3083; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Proud CG, 2005, SEMIN CELL DEV BIOL, V16, P3, DOI 10.1016/j.semcdb.2004.11.004; Puca A, 2007, J BIOL CHEM, V282, P37146, DOI 10.1074/jbc.M705815200; Quinto I, 1999, J BIOL CHEM, V274, P17567, DOI 10.1074/jbc.274.25.17567; RAY BK, 1985, J BIOL CHEM, V260, P7651; Richter NJ, 1999, J BIOL CHEM, V274, P35415, DOI 10.1074/jbc.274.50.35415; Rogers GW, 1999, J BIOL CHEM, V274, P12236, DOI 10.1074/jbc.274.18.12236; Rogers GW, 2001, J BIOL CHEM, V276, P30914, DOI 10.1074/jbc.M100157200; ROZEN F, 1990, MOL CELL BIOL, V10, P1134, DOI 10.1128/MCB.10.3.1134; Schiavone M, 2012, INT J MOL SCI, V13, P5674, DOI 10.3390/ijms13055674; Shahbazian D, 2006, EMBO J, V25, P2781, DOI 10.1038/sj.emboj.7601166; Shahbazian D, 2010, MOL CELL BIOL, V30, P1478, DOI 10.1128/MCB.01218-09; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Spatuzza C, 2008, NUCLEIC ACIDS RES, V36, P4402, DOI 10.1093/nar/gkn413; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Vitagliano L, 2011, BIOCHIMIE, V93, P1592, DOI 10.1016/j.biochi.2011.05.025; Watkins SJ, 2002, BRIT J CANCER, V86, P1023, DOI 10.1038/sj/bjc/6600222; Wu D, 2011, INT J CANCER, V128, P1018, DOI 10.1002/ijc.25419	38	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66087	10.1371/journal.pone.0066087	http://dx.doi.org/10.1371/journal.pone.0066087			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776612	Green Published, gold, Green Submitted			2022-12-27	WOS:000320755400108
J	Kovacs, K; Polasky, S; Nelson, E; Keeler, BL; Pennington, D; Plantinga, AJ; Taff, SJ				Kovacs, Kent; Polasky, Stephen; Nelson, Erik; Keeler, Bonnie L.; Pennington, Derric; Plantinga, Andrew J.; Taff, Steven J.			Evaluating the Return in Ecosystem Services from Investment in Public Land Acquisitions	PLOS ONE			English	Article							WILLINGNESS-TO-PAY; MAXIMIZING RETURN; BIODIVERSITY CONSERVATION; CARBON SEQUESTRATION; UNITED-STATES; PHOSPHORUS; EFFICIENCY; INVENTORY; POLLUTION; POLICIES	We evaluate the return on investment (ROI) from public land conservation in the state of Minnesota, USA. We use a spatially-explicit modeling tool, the Integrated Valuation of Ecosystem Services and Tradeoffs (InVEST), to estimate how changes in land use and land cover (LULC), including public land acquisitions for conservation, influence the joint provision and value of multiple ecosystem services. We calculate the ROI of a public conservation acquisition as the ratio of the present value of ecosystem services generated by the conservation to the cost of the conservation. For the land scenarios analyzed, carbon sequestration services generated the greatest benefits followed by water quality improvements and recreation opportunities. We found ROI values ranged from 0.21 to 5.28 depending on assumptions about future land use change, service values, and discount rate. Our study suggests conservation is a good investment as long as investments are targeted to areas with low land costs and high service values.	[Kovacs, Kent] Univ Arkansas, Dept Agr Econ & Agribusiness, Fayetteville, AR 72701 USA; [Polasky, Stephen; Taff, Steven J.] Univ Minnesota, Dept Appl Econ, St Paul, MN 55108 USA; [Nelson, Erik] Bowdoin Coll, Dept Econ, Brunswick, ME 04011 USA; [Keeler, Bonnie L.] Univ Minnesota, Inst Environm, St Paul, MN 55108 USA; [Pennington, Derric] World Wildlife Fund, Washington, DC 20037 USA; [Plantinga, Andrew J.] Oregon State Univ, Dept Agr & Resource Econ, Corvallis, OR 97331 USA	University of Arkansas System; University of Arkansas Fayetteville; University of Minnesota System; University of Minnesota Twin Cities; Bowdoin College; University of Minnesota System; University of Minnesota Twin Cities; World Wildlife Fund; Oregon State University	Kovacs, K (corresponding author), Univ Arkansas, Dept Agr Econ & Agribusiness, Fayetteville, AR 72701 USA.	kkovacs@uark.edu	Polasky, Stephen/AAC-5341-2019; Nelson, Erik J./J-4192-2019	Nelson, Erik J./0000-0002-7291-5192; Keeler, Bonnie/0000-0001-6269-9425	Direct For Social, Behav & Economic Scie [0814628] Funding Source: National Science Foundation	Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))		Abbitt RJF, 2000, BIOL CONSERV, V96, P169, DOI 10.1016/S0006-3207(00)00064-1; Ando A, 1998, SCIENCE, V279, P2126, DOI 10.1126/science.279.5359.2126; Armsworth PR, 2006, P NATL ACAD SCI USA, V103, P5403, DOI 10.1073/pnas.0505278103; Blackard JA, 2008, REMOTE SENS ENVIRON, V112, P1658, DOI 10.1016/j.rse.2007.08.021; CARLSON RE, 1977, LIMNOL OCEANOGR, V22, P361, DOI 10.4319/lo.1977.22.2.0361; Carpenter SR, 1998, ECOL APPL, V8, P559, DOI 10.1890/1051-0761(1998)008[0559:NPOSWW]2.0.CO;2; CARSON RT, 1993, WATER RESOUR RES, V29, P2445, DOI 10.1029/93WR00495; Caudill J, 2005, BANKING NATURE 2004; Church RL, 1996, BIOL CONSERV, V76, P105, DOI 10.1016/0006-3207(95)00102-6; Costello C, 2004, RESOUR ENERGY ECON, V26, P157, DOI 10.1016/j.reseneeco.2003.11.005; Dobson AP, 1997, SCIENCE, V275, P550, DOI 10.1126/science.275.5299.550; Forman R., 2014, ECOLOGICAL DESIGN PL, P217; Fry J.A., 2009, COMPLETION NATL LAND; Goldstein JH, 2008, CONSERV LETT, V1, P236, DOI 10.1111/j.1755-263X.2008.00031.x; Hill J, 2009, P NATL ACAD SCI USA, V106, P2077, DOI 10.1073/pnas.0812835106; Howarth RB, 2009, LAND ECON, V85, P24, DOI 10.3368/le.85.1.24; Irwin EG, 2002, J ECON GEOGR, V2, P31, DOI 10.1093/jeg/2.1.31; Johnston RJ, 2005, CAN J AGR ECON, V53, P221, DOI 10.1111/j.1744-7976.2005.04018.x; Johnston RJ, 2009, ENV EC WATERSHED RES; Lessard-Sams Outdoor Heritage Council (LSOHC), 2009, STRAT PLANN REC DEV; Lewis DJ, 2007, LAND ECON, V83, P109, DOI 10.3368/le.83.2.109; Lewis DJ, 2011, RESOUR ENERGY ECON, V33, P192, DOI 10.1016/j.reseneeco.2010.04.012; Lewis DJ, 2009, J ENVIRON ECON MANAG, V57, P239, DOI 10.1016/j.jeem.2008.11.001; Lindenmayer D, 2008, ECOL LETT, V11, P78, DOI 10.1111/j.1461-0248.2007.01114.x; Loomis J, 2008, BENEFIT TRANSFER VIS; Loomis J. B., 2005, PNWGTR658 USDA FOR S; Lubowski RN, 2006, J ENVIRON ECON MANAG, V51, P135, DOI 10.1016/j.jeem.2005.08.001; Lubowski RN, 2002, THESIS HARVARD U CAM; Lubowski RN, 2008, LAND ECON, V84, P529, DOI 10.3368/le.84.4.529; Mathews LG, 2002, J AM WATER RESOUR AS, V38, P1217, DOI 10.1111/j.1752-1688.2002.tb04343.x; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; Minnesota Department of Administration Office of Geographic and Demographic Analysis State Demographic Center, 2007, MINN POP PROJ 2005 2; Minnesota Department of Natural Resources, 2001, PRES; Minnesota Department of Natural Resources, 2011, MN DNR FEE TITL LAND; Murdoch W, 2007, BIOL CONSERV, V139, P375, DOI 10.1016/j.biocon.2007.07.011; Murdoch W, 2010, P NATL ACAD SCI USA, V107, P20855, DOI 10.1073/pnas.1011851107; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nelson E, 2009, FRONT ECOL ENVIRON, V7, P4, DOI 10.1890/080023; Nelson E, 2008, P NATL ACAD SCI USA, V105, P9471, DOI 10.1073/pnas.0706178105; Newburn DA, 2006, AM J AGR ECON, V88, P28, DOI 10.1111/j.1467-8276.2006.00837.x; Nusser SM, 1997, ENVIRON ECOL STAT, V4, P181, DOI 10.1023/A:1018574412308; Polasky S, 2013, MODELING LAND UNPUB; Polasky S, 2012, OXFORD REV ECON POL, V28, P139, DOI 10.1093/oxrep/grs011; Polasky S, 2011, ENVIRON RESOUR ECON, V48, P219, DOI 10.1007/s10640-010-9407-0; PRESSEY RL, 1993, TRENDS ECOL EVOL, V8, P124, DOI 10.1016/0169-5347(93)90023-I; Protected areas database (PAD) - US Technical Working Group, 2009, PROT AR DAT US TECHN; Smith JE., 2006, METHODS CALCULATING; Tol RSJ, 2009, J ECON PERSPECT, V23, P29, DOI 10.1257/jep.23.2.29; U.S. Department of Agriculture, 1973, SOIL CONS SERV HDB, V210; U.S. Department of Agriculture Office of the Chief Economist World Agricultural Outlook Board, 2010, OCE20101 USDA WORLD; Underwood EC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001515; Vogelmann JE, 2001, PHOTOGRAMM ENG REM S, V67, P650; Wilson KA, 2009, ANN NY ACAD SCI, V1162, P237, DOI 10.1111/j.1749-6632.2009.04149.x; Withey JC, 2012, ECOL LETT, V15, P1249, DOI 10.1111/j.1461-0248.2012.01847.x; Wolny, 2011, INVEST 2 1 BETA USER	55	34	36	1	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e62202	10.1371/journal.pone.0062202	http://dx.doi.org/10.1371/journal.pone.0062202			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	169CU	23776429	Green Submitted, Green Published, gold			2022-12-27	WOS:000320755400001
J	Lim, KJ; Sung, BH; Shin, JR; Lee, YW; Kim, DJ; Yang, KS; Kim, SC				Lim, Ki Jung; Sung, Bong Hyun; Shin, Ju Ri; Lee, Young Woong; Kim, Da Jung; Yang, Kyung Seok; Kim, Sun Chang			A Cancer Specific Cell-Penetrating Peptide, BR2, for the Efficient Delivery of an scFv into Cancer Cells	PLOS ONE			English	Article							LYTIC PEPTIDES; NUCLEIC-ACIDS; MECHANISM; MEMBRANE; PROTEINS; TRANSDUCTION; ANTIBODY	Cell-penetrating peptides (CPPs) have proven very effective as intracellular delivery vehicles for various therapeutics. However, there are some concerns about non-specific penetration and cytotoxicity of CPPs for effective cancer treatments. Herein, based on the cell-penetrating motif of an anticancer peptide, buforin IIb, we designed several CPP derivatives with cancer cell specificity. Among the derivatives, a 17-amino acid peptide (BR2) was found to have cancer-specificity without toxicity to normal cells. After specifically targeting cancer cells through interaction with gangliosides, BR2 entered cells via lipid-mediated macropinocytosis. Moreover, BR2 showed higher membrane translocation efficiency than the well-known CPP Tat (49-57). The capability of BR2 as a cancer-specific drug carrier was demonstrated by fusion of BR2 to a single-chain variable fragment (scFv) directed toward a mutated K-ras (G12V). BR2-fused scFv induced a higher degree of apoptosis than Tat-fused scFv in K-ras mutated HCT116 cells. These results suggest that the novel cell-penetrating peptide BR2 has great potential as a useful drug delivery carrier with cancer cell specificity.	[Lim, Ki Jung; Shin, Ju Ri; Lee, Young Woong; Kim, Da Jung; Yang, Kyung Seok; Kim, Sun Chang] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Sung, Bong Hyun] Korea Res Inst Biosci & Biotechnol, Biochem & Synthet Biol Res Ctr, Taejon, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Kim, SC (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea.	sunkim@kaist.ac.kr	Kim, Sun/GSN-4867-2022; Kim, Sun Chang/C-2026-2011	Sung, Bong Hyun/0000-0002-8992-1118	Intelligent Synthetic Biology Center of Global Frontier Project; Ministry of Education, Science and Technology [2011-0031955]	Intelligent Synthetic Biology Center of Global Frontier Project; Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Intelligent Synthetic Biology Center of Global Frontier Project funded by the Ministry of Education, Science and Technology (2011-0031955). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOUDY Y, 1994, INT J PEPT PROT RES, V43, P573; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cappelli G, 1999, TUMORI, V85, pS19, DOI 10.1177/030089169908501s06; Cawthorn TR, 2009, CLIN EXP METASTAS, V26, P935, DOI 10.1007/s10585-009-9284-5; Chen YX, 2005, J BIOL CHEM, V280, P12316, DOI 10.1074/jbc.M413406200; Chiu YL, 2004, CHEM BIOL, V11, P1165, DOI 10.1016/j.chembiol.2004.06.006; Cho JH, 2009, BBA-BIOMEMBRANES, V1788, P1564, DOI 10.1016/j.bbamem.2008.10.025; Cochet O, 1998, CANCER RES, V58, P1170; Crombez L, 2009, MOL THER, V17, P95, DOI 10.1038/mt.2008.215; DESHPANDE AK, 1987, MOL CELL BIOL, V7, P1285, DOI 10.1128/MCB.7.3.1285; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Elmquist A, 2001, EXP CELL RES, V269, P237, DOI 10.1006/excr.2001.5316; FAWELL S, 1994, P NATL ACAD SCI USA, V91, P664, DOI 10.1073/pnas.91.2.664; FOX PL, 1994, ONCOGENE, V9, P3519; Geisler I, 2009, CHEM BIOL DRUG DES, V73, P39, DOI 10.1111/j.1747-0285.2008.00759.x; Gupta Manish S. V., 2011, RES J CHEM SCI, V2, P135; Heitz F, 2009, BRIT J PHARMACOL, V157, P195, DOI 10.1111/j.1476-5381.2009.00057.x; Hoyer J, 2012, ACCOUNTS CHEM RES, V45, P1048, DOI 10.1021/ar2002304; Huang YB, 2012, INT J MOL SCI, V13, P6849, DOI 10.3390/ijms13066849; JEYAPAUL J, 1990, P NATL ACAD SCI USA, V87, P7030, DOI 10.1073/pnas.87.18.7030; Johnson LN, 2008, MOL THER, V16, P107, DOI 10.1038/sj.mt.6300324; Kamada H, 2007, BIOL PHARM BULL, V30, P218, DOI 10.1248/bpb.30.218; Kersemans V, 2010, PHARMACEUTICALS, V3, P600, DOI 10.3390/ph3030600; Lee HS, 2008, CANCER LETT, V271, P47, DOI 10.1016/j.canlet.2008.05.041; Leuschner C, 2004, CURR PHARM DESIGN, V10, P2299, DOI 10.2174/1381612043383971; Lewin M, 2000, NAT BIOTECHNOL, V18, P410, DOI 10.1038/74464; Lundberg M, 2002, BIOCHEM BIOPH RES CO, V291, P367, DOI 10.1006/bbrc.2002.6450; Madani Fatemeh, 2011, J Biophys, V2011, P414729, DOI 10.1155/2011/414729; Martin I, 2010, PHARMACEUTICALS, V3, P1456, DOI 10.3390/ph3051456; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Mussbach F, 2011, J CELL BIOCHEM, V112, P3824, DOI 10.1002/jcb.23313; Papo N, 2003, BIOCHEMISTRY-US, V42, P9346, DOI 10.1021/bi027212o; Park CB, 2000, P NATL ACAD SCI USA, V97, P8245, DOI 10.1073/pnas.150518097; Pujals S, 2008, ADV DRUG DELIVER REV, V60, P473, DOI 10.1016/j.addr.2007.09.012; Richard JP, 2003, J BIOL CHEM, V278, P585, DOI 10.1074/jbc.M209548200; Rothbard JB, 2000, NAT MED, V6, P1253, DOI 10.1038/81359; Sandvig K, 2011, CURR OPIN CELL BIOL, V23, P413, DOI 10.1016/j.ceb.2011.03.007; Shin SY, 2001, J PEPT RES, V58, P504, DOI 10.1034/j.1399-3011.2001.00934.x; Tanaka T, 2003, EMBO J, V22, P1025, DOI 10.1093/emboj/cdg106; Torchilin V, 2008, EXPERT OPIN DRUG DEL, V5, P1003, DOI [10.1517/17425247.5.9.1003, 10.1517/17425247.5.9.1003 ]; Trabulo S, 2010, PHARMACEUTICALS, V3, P961, DOI 10.3390/ph3040961; Turner JJ, 2005, NUCLEIC ACIDS RES, V33, P6837, DOI 10.1093/nar/gki991; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Wang B, 2005, WILEY SER DRUG DISC, P1, DOI 10.1002/0471475734; Yukawa H, 2010, BIOMATERIALS, V31, P4094, DOI 10.1016/j.biomaterials.2010.01.134; Zorko M, 2005, ADV DRUG DELIVER REV, V57, P529, DOI 10.1016/j.addr.2004.10.010	46	81	87	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66084	10.1371/journal.pone.0066084	http://dx.doi.org/10.1371/journal.pone.0066084			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776609	gold, Green Published, Green Submitted			2022-12-27	WOS:000320755400107
J	Miyoshi-Akiyama, T; Hayakawa, K; Ohmagari, N; Shimojima, M; Kirikae, T				Miyoshi-Akiyama, Tohru; Hayakawa, Kayoko; Ohmagari, Norio; Shimojima, Masahiro; Kirikae, Teruo			Multilocus Sequence Typing (MLST) for Characterization of Enterobacter cloacae	PLOS ONE			English	Article							POPULATION-GROWTH; TESTS; POLYMORPHISM; NEUTRALITY; BACTERIA	Enterobacter cloacae is an important emerging pathogen, which sometime causes respiratory infection, surgical site infection, urinary infection, sepsis, and outbreaks at neonatal units. We have developed a multilocus sequence typing (MLST) scheme utilizing seven housekeeping genes and evaluated the performance in 101 clinical isolates. The MLST scheme yielded 83 sequence types (ST) including 78 novel STs found in the clinical isolates. These findings supported the robustness of the MLST scheme developed in this study.	[Miyoshi-Akiyama, Tohru; Kirikae, Teruo] Natl Ctr Global Hlth & Med, Dept Infect Dis, Shinjuku Ku, Tokyo, Japan; [Hayakawa, Kayoko; Ohmagari, Norio] Natl Ctr Global Hlth & Med, Dis Control & Prevent Ctr, Shinjuku Ku, Tokyo, Japan; [Shimojima, Masahiro] BML Inc, Kawagoe, Saitama, Japan	National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; BML, Inc.	Miyoshi-Akiyama, T (corresponding author), Natl Ctr Global Hlth & Med, Dept Infect Dis, Shinjuku Ku, Tokyo, Japan.	takiyam@ri.ncgm.go.jp	Ohmagari, Norio/GLN-5290-2022; Hayakawa, Kayoko/GNW-2394-2022	Ohmagari, Norio/0000-0002-4622-8970; Hayakawa, Kayoko/0000-0002-5480-4405	Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases, the Ministry of Education, Culture, Sports, Science and Technology, Japan; Ministry of Health, Labor, and Welfare, Japan [23A301]	Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases, the Ministry of Education, Culture, Sports, Science and Technology, Japan; Ministry of Health, Labor, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported by the Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases, the Ministry of Education, Culture, Sports, Science and Technology, Japan (http://www.riken.jp/en/research/labs/crnid/). TMA was supported by a Grant for International Health Research (23A301) from the Ministry of Health, Labor, and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bush K, 2010, CURR OPIN MICROBIOL, V13, P558, DOI 10.1016/j.mib.2010.09.006; Dai W, 2013, INFECT GENET EVOL, V14, P1, DOI 10.1016/j.meegid.2012.10.010; Dalben M, 2008, J HOSP INFECT, V70, P7, DOI 10.1016/j.jhin.2008.05.003; Fernandez A, 2011, J CLIN MICROBIOL, V49, P822, DOI 10.1128/JCM.01872-10; Fu YX, 1997, GENETICS, V147, P915; Hamada Y, 2012, J INFECT CHEMOTHER; Heller I, 2012, J MED MICROBIOL, V61, P567, DOI 10.1099/jmm.0.038646-0; Huang SF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047636; Jolley KA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-86; Jolley KA, 2001, BIOINFORMATICS, V17, P1230, DOI 10.1093/bioinformatics/17.12.1230; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Paauw A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003018; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Rozas J, 1995, COMPUT APPL BIOSCI, V11, P621; Sanders WE, 1997, CLIN MICROBIOL REV, V10, P220, DOI 10.1128/CMR.10.2.220; SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384; TAJIMA F, 1989, GENETICS, V123, P585	17	124	144	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66358	10.1371/journal.pone.0066358	http://dx.doi.org/10.1371/journal.pone.0066358			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776664	Green Published, Green Submitted, gold			2022-12-27	WOS:000320755400140
J	Octavia, S; Salim, A; Kurniawan, J; Lam, C; Leung, Q; Ahsan, S; Reeves, PR; Nair, GB; Lan, RT				Octavia, Sophie; Salim, Anna; Kurniawan, Jacob; Lam, Connie; Leung, Queenie; Ahsan, Sunjukta; Reeves, Peter R.; Nair, G. Balakrish; Lan, Ruiting			Population Structure and Evolution of Non-O1/Non-O139 Vibrio cholerae by Multilocus Sequence Typing	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; PILUS PROTEIN TCPA; PATHOGENICITY ISLAND; ENVIRONMENTAL STRAINS; COMPARATIVE GENOMICS; NUCLEOTIDE-SEQUENCE; VIRULENCE FACTORS; NON-O1; TOXIN; GENES	Pathogenic non-O1/non-O139 Vibrio cholerae strains can cause sporadic outbreaks of cholera worldwide. In this study, multilocus sequence typing (MLST) of seven housekeeping genes was applied to 55 non-O1/non-O139 isolates from clinical and environmental sources. Data from five published O1 isolates and 17 genomes were also included, giving a total of 77 isolates available for analysis. There were 66 sequence types (STs), with the majority being unique, and only three clonal complexes. The V. cholerae strains can be divided into four subpopulations with evidence of recombination among the subpopulations. Subpopulations I and III contained predominantly clinical strains. PCR screening for virulence factors including Vibrio pathogenicity island (VPI), cholera toxin prophage (CTX Phi), type III secretion system (T3SS), and enterotoxin genes (rtxA and sto/stn) showed that combinations of these factors were present in the clinical isolates with 85.7% having rtxA, 51.4% T3SS, 31.4% VPI, 31.4% sto/stn (NAG-ST) and 11.4% CTX Phi. These factors were also present in environmental isolates but at a lower frequency. Five strains previously mis-identified as V. cholerae serogroups O114 to O117 were also analysed and formed a separate population with V. mimicus. The MLST scheme developed in this study provides a framework to identify sporadic cholera isolates by genetic identity.	[Octavia, Sophie; Kurniawan, Jacob; Lam, Connie; Leung, Queenie; Lan, Ruiting] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Salim, Anna; Ahsan, Sunjukta; Reeves, Peter R.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Nair, G. Balakrish] Translat Hlth Sci & Technol Inst, Gurgaon, Haryana, India	University of New South Wales Sydney; University of Sydney; Department of Biotechnology (DBT) India; Translational Health Science & Technology Institute (THSTI)	Lan, RT (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia.	r.lan@unsw.edu.au	Reeves, Peter R/A-6064-2008	Reeves, Peter R/0000-0003-4479-7974; Octavia, Sophie/0000-0001-8506-9127; Lan, Ruiting/0000-0001-9834-5258	Australian Research Council	Australian Research Council(Australian Research Council)	This study was supported by an Australian Research Council discovery project grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam A, 2011, INFECT IMMUN, V79, P1728, DOI 10.1128/IAI.01194-10; ARITA M, 1986, INFECT IMMUN, V52, P45, DOI 10.1128/IAI.52.1.45-49.1986; Bag PK, 2008, APPL ENVIRON MICROB, V74, P5635, DOI 10.1128/AEM.00029-08; BAGCHI K, 1993, J CLIN MICROBIOL, V31, P1315, DOI 10.1128/JCM.31.5.1315-1317.1993; Bhowmick TS, 2009, J MED MICROBIOL, V58, P1160, DOI 10.1099/jmm.0.008466-0; BLAKE PA, 1980, ANNU REV MICROBIOL, V34, P341, DOI 10.1146/annurev.mi.34.100180.002013; Boyd EF, 2002, MICROBIOL-SGM, V148, P1655, DOI 10.1099/00221287-148-6-1655; Boyd EF, 2000, J BACTERIOL, V182, P5530, DOI 10.1128/JB.182.19.5530-5538.2000; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Cariri FAMO, 2010, CLIN MICROBIOL INFEC, V16, P62, DOI 10.1111/j.1469-0691.2009.02763.x; Ch'ng SL, 2011, APPL ENVIRON MICROB, V77, P768, DOI 10.1128/AEM.01993-10; Chakraborty S, 2000, APPL ENVIRON MICROB, V66, P4022, DOI 10.1128/AEM.66.9.4022-4028.2000; Chakraborty S, 2001, J MED MICROBIOL, V50, P879, DOI 10.1099/0022-1317-50-10-879; Chatterjee S, 2009, J CLIN MICROBIOL, V47, P1087, DOI 10.1128/JCM.02026-08; Chin CS, 2011, NEW ENGL J MED, V364, P33, DOI 10.1056/NEJMoa1012928; Chun J, 2009, P NATL ACAD SCI USA, V106, P15442, DOI 10.1073/pnas.0907787106; Dalsgaard A, 1999, EPIDEMIOL INFECT, V122, P217, DOI 10.1017/S0950268899002137; Dalsgaard A, 2001, J CLIN MICROBIOL, V39, P4086, DOI 10.1128/JCM.39.11.4086-4092.2001; DALSGAARD A, 1995, J CLIN MICROBIOL, V33, P2715, DOI 10.1128/JCM.33.10.2715-2722.1995; Didelot X, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002191; Theophilo Grace Nazareth Diogo, 2006, Rev. Inst. Med. trop. S. Paulo, V48, P65, DOI 10.1590/S0036-46652006000200002; Dziejman M, 2005, P NATL ACAD SCI USA, V102, P3465, DOI 10.1073/pnas.0409918102; Faruque SM, 2004, P NATL ACAD SCI USA, V101, P2123, DOI 10.1073/pnas.0308485100; Faruque SM, 2003, INFECT IMMUN, V71, P1020, DOI 10.1128/IAI.71.2.1020-1025.2003; Feil EJ, 2000, GENETICS, V154, P1439; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Feng L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004053; Fraga SG, 2007, J APPL MICROBIOL, V103, P2448, DOI 10.1111/j.1365-2672.2007.03468.x; Ghosh C, 1997, MICROB PATHOGENESIS, V22, P199, DOI 10.1006/mpat.1996.0105; Glenn Morris J., 1994, VIBRIO CHOLERAE CHOL, P103; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Haley BJ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-154; Hasan NA, 2010, P NATL ACAD SCI USA, V107, P21134, DOI 10.1073/pnas.1013825107; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; Jagadeeshan S, 2009, J BASIC MICROB, V49, P538, DOI 10.1002/jobm.200900085; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Keymer DP, 2011, APPL ENVIRON MICROB, V77, P537, DOI 10.1128/AEM.02062-10; Ko WC, 1998, CLIN INFECT DIS, V27, P774, DOI 10.1086/514947; Lee Ya-Ling, 2007, Journal of Microbiology Immunology and Infection, V40, P474; Li MR, 2003, APPL ENVIRON MICROB, V69, P1728, DOI 10.1128/AEM.69.3.1728-1738.2003; Li MR, 2002, INFECT IMMUN, V70, P2441, DOI 10.1128/IAI.70.5.2441-2453.2002; Lin W, 1999, P NATL ACAD SCI USA, V96, P1071, DOI 10.1073/pnas.96.3.1071; McVean G, 2002, GENETICS, V160, P1231; Mukhopadhyay AK, 2001, J BACTERIOL, V183, P4737, DOI 10.1128/JB.183.16.4737-4746.2001; Nandi B, 2000, INFECT IMMUN, V68, P948, DOI 10.1128/IAI.68.2.948-952.2000; O'Shea YA, 2004, J CLIN MICROBIOL, V42, P4657, DOI 10.1128/JCM.42.10.4657-4671.2004; OGAWA A, 1990, INFECT IMMUN, V58, P3325, DOI 10.1128/IAI.58.10.3325-3329.1990; Onifade TJM, 2011, EUROSURVEILLANCE, V16, P10; Ottaviani D, 2009, INT J FOOD MICROBIOL, V132, P47, DOI 10.1016/j.ijfoodmicro.2009.03.014; Pritchard JK, 2000, GENETICS, V155, P945; Rahman MH, 2008, DNA CELL BIOL, V27, P347, DOI 10.1089/dna.2008.0737; Reeves PR, 1998, BRIT MED BULL, V54, P611, DOI 10.1093/oxfordjournals.bmb.a011714; REEVES PR, 1994, COMPUT APPL BIOSCI, V10, P281; Rivera ING, 2001, APPL ENVIRON MICROB, V67, P2421, DOI 10.1128/AEM.67.6.2421-2429.2001; Safa A, 2010, TRENDS MICROBIOL, V18, P46, DOI 10.1016/j.tim.2009.10.003; Salim A, 2005, EMERG INFECT DIS, V11, P1758, DOI 10.3201/eid1111.041170; Sharma C, 1998, J CLIN MICROBIOL, V36, P756, DOI 10.1128/JCM.36.3.756-763.1998; SHIMADA T, 1994, CURR MICROBIOL, V28, P175, DOI 10.1007/BF01571061; Shin OS, 2011, MBIO, V2, DOI 10.1128/mBio.00106-11; SHIRAI H, 1991, J CLIN MICROBIOL, V29, P2517, DOI 10.1128/JCM.29.11.2517-2521.1991; Spratt Brian G, 2004, Methods Mol Biol, V266, P323; Talkington D, 2011, EMERG INFECT DIS, V17, P2122, DOI 10.3201/eid1711.110805; Tay CY, 2008, FEMS MICROBIOL LETT, V289, P210, DOI 10.1111/j.1574-6968.2008.01385.x; Thompson CC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-258; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tobin-D'Angelo M, 2008, CLIN INFECT DIS, V47, P1035, DOI 10.1086/591973; Wang DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021299; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x	69	42	48	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65342	10.1371/journal.pone.0065342	http://dx.doi.org/10.1371/journal.pone.0065342			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776471	Green Submitted, Green Published, gold			2022-12-27	WOS:000320755400025
J	Payne, SC; Bartlett, CA; Savigni, DL; Harvey, AR; Dunlop, SA; Fitzgerald, M				Payne, Sophie C.; Bartlett, Carole A.; Savigni, Donna L.; Harvey, Alan R.; Dunlop, Sarah A.; Fitzgerald, Melinda			Early Proliferation Does Not Prevent the Loss of Oligodendrocyte Progenitor Cells during the Chronic Phase of Secondary Degeneration in a CNS White Matter Tract	PLOS ONE			English	Article							SPINAL-CORD-INJURY; CENTRAL-NERVOUS-SYSTEM; TRANSCRIPTION FACTOR OLIG2; OPTIC-NERVE; ADULT CNS; RAT-BRAIN; CHRONIC DEMYELINATION; NG2-EXPRESSING CELLS; MULTIPLE-SCLEROSIS; PRECURSOR CELLS	Partial injury to the central nervous system (CNS) is exacerbated by additional loss of neurons and glia via toxic events known as secondary degeneration. Using partial transection of the rat optic nerve (ON) as a model, we have previously shown that myelin decompaction persists during secondary degeneration. Failure to repair myelin abnormalities during secondary degeneration may be attributed to insufficient OPC proliferation and/or differentiation to compensate for loss of oligodendrocyte lineage cells (oligodendroglia). Following partial ON transection, we found that sub-populations of oligodendroglia and other olig2+ glia were differentially influenced by injury. A high proportion of NG2+/olig2-, NG2+/olig2+ and CC1-/olig2+ cells proliferated (Ki67+) at 3 days, prior to the onset of death (TUNEL+) at 7 days, suggesting injury-related cues triggered proliferation rather than early loss of oligodendroglia. Despite this, a high proportion (20%) of the NG2+/olig2+ OPCs were TUNEL+ at 3 months, and numbers remained chronically lower, indicating that proliferation of these cells was insufficient to maintain population numbers. There was significant death of NG2+/olig2- and NG2-/olig2+ cells at 7 days, however population densities remained stable, suggesting proliferation was sufficient to sustain cell numbers. Relatively few TUNEL+/CC1+ cells were detected at 7 days, and no change in density indicated that mature CC1+ oligodendrocytes were resistant to secondary degeneration in vivo. Mature CC1+/olig2-oligodendrocyte density increased at 3 days, reflecting early oligogenesis, while the appearance of shortened myelin internodes at 3 months suggested remyelination. Taken together, chronic OPC decreases may contribute to the persistent myelin abnormalities and functional loss seen in ON during secondary degeneration.	[Payne, Sophie C.; Bartlett, Carole A.; Savigni, Donna L.; Dunlop, Sarah A.; Fitzgerald, Melinda] Univ Western Australia, Sch Anim Biol, Crawley, WA, Australia; [Harvey, Alan R.] Univ Western Australia, Sch Anat Physiol & Human Biol, Crawley, WA, Australia	University of Western Australia; University of Western Australia	Fitzgerald, M (corresponding author), Univ Western Australia, Sch Anim Biol, Crawley, WA, Australia.	lindy.fitzgerald@uwa.edu.au	Fitzgerald, Melinda/C-4235-2011; Dunlop, Sarah A/G-9357-2013	Fitzgerald, Melinda/0000-0002-4823-8179; , Alan/0000-0002-2590-831X; Dunlop, Sarah/0000-0002-1306-3962	Neurotrauma Research Program (Western Australia); National Health & Medical Research Council [572550]; NHMRC, Australia [APP1002347]	Neurotrauma Research Program (Western Australia); National Health & Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NHMRC, Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Neurotrauma Research Program (Western Australia) and National Health & Medical Research Council (Grant ID: 572550). Prof. Dunlop is a Principal Research Fellow of the NH&MRC, Australia (Grant ID: APP1002347). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Back SA, 1998, J NEUROSCI, V18, P6241; BARRES BA, 1993, CURR BIOL, V3, P489, DOI 10.1016/0960-9822(93)90039-Q; Barrett RD, 2012, BRAIN RES, V1469, P35, DOI 10.1016/j.brainres.2012.06.018; Bhat RV, 1996, GLIA, V17, P169; BLAKEMORE WF, 1974, NATURE, V249, P577, DOI 10.1038/249577a0; Bu J, 2001, GLIA, V34, P296, DOI 10.1002/glia.1063; Buffo A, 2005, P NATL ACAD SCI USA, V102, P18183, DOI 10.1073/pnas.0506535102; BUNGE MB, 1961, J BIOPHYS BIOCHEM CY, V10, P67, DOI 10.1083/jcb.10.1.67; Butt AM, 1999, GLIA, V26, P84, DOI 10.1002/(SICI)1098-1136(199903)26:1<84::AID-GLIA9>3.3.CO;2-C; Butts BD, 2008, CELL DEATH DIFFER, V15, P1178, DOI 10.1038/cdd.2008.70; Carroll WM, 1998, BRAIN, V121, P293, DOI 10.1093/brain/121.2.293; Chen Y, 2008, J NEUROSCI, V28, P10983, DOI 10.1523/JNEUROSCI.3545-08.2008; Dawson MRL, 2003, MOL CELL NEUROSCI, V24, P476, DOI 10.1016/S1044-7431(03)00210-0; Dawson MRL, 2000, J NEUROSCI RES, V61, P471, DOI 10.1002/1097-4547(20000901)61:5<471::AID-JNR1>3.3.CO;2-E; Deng WB, 2003, P NATL ACAD SCI USA, V100, P6801, DOI 10.1073/pnas.1136624100; Di Bello IC, 1999, J NEUROCYTOL, V28, P365, DOI 10.1023/A:1007069815302; Fancy SPJ, 2004, MOL CELL NEUROSCI, V27, P247, DOI 10.1016/j.mcn.2004.06.015; Fancy SPJ, 2010, EXP NEUROL, V225, P18, DOI 10.1016/j.expneurol.2009.12.020; Fern R, 2000, J NEUROSCI, V20, P34, DOI 10.1523/JNEUROSCI.20-01-00034.2000; Fitzgerald M, 2010, J NEUROTRAUM, V27, P439, DOI 10.1089/neu.2009.1112; Fitzgerald M, 2009, EXP NEUROL, V216, P219, DOI 10.1016/j.expneurol.2008.11.026; Franklin RJM, 1997, J NEUROSCI RES, V50, P337, DOI 10.1002/(SICI)1097-4547(19971015)50:2<337::AID-JNR21>3.0.CO;2-3; Frei E, 2000, EXP NEUROL, V163, P373, DOI 10.1006/exnr.2000.7379; Fuss B, 2000, DEV BIOL, V218, P259, DOI 10.1006/dbio.1999.9574; Gensert JM, 1997, NEURON, V19, P197, DOI 10.1016/S0896-6273(00)80359-1; GERDES J, 1984, J IMMUNOL, V133, P1710; GLEDHILL RF, 1973, NATURE, V244, P443, DOI 10.1038/244443a0; GRASLKRAUPP B, 1995, HEPATOLOGY, V21, P1465, DOI 10.1016/0270-9139(95)90071-3; Hughes S, 2004, INVEST OPHTH VIS SCI, V45, P2795, DOI 10.1167/iovs.03-1312; Jeffery ND, 1997, BRAIN, V120, P27, DOI 10.1093/brain/120.1.27; Jones LL, 2002, J NEUROSCI, V22, P2792, DOI 10.1523/JNEUROSCI.22-07-02792.2002; Karadottir R, 2008, NAT NEUROSCI, V11, P450, DOI 10.1038/nn2060; Keirstead HS, 1997, J NEUROPATH EXP NEUR, V56, P1191, DOI 10.1097/00005072-199711000-00003; Keirstead HS, 1998, GLIA, V22, P161, DOI 10.1002/(SICI)1098-1136(199802)22:2<161::AID-GLIA7>3.3.CO;2-Z; Kitada M, 2006, GLIA, V54, P35, DOI 10.1002/glia.20354; Lasiene J, 2008, J NEUROSCI, V28, P3887, DOI 10.1523/JNEUROSCI.4756-07.2008; Levine JM, 2001, TRENDS NEUROSCI, V24, P39, DOI 10.1016/S0166-2236(00)01691-X; Levkovitch-Verbin H, 2003, INVEST OPHTH VIS SCI, V44, P3388, DOI 10.1167/iovs.02-0646; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Ligon KL, 2006, P NATL ACAD SCI USA, V103, P7853, DOI 10.1073/pnas.0511001103; Lotocki G, 2011, NEUROSCI LETT, V499, P143, DOI 10.1016/j.neulet.2011.05.056; McTigue DM, 2008, J NEUROCHEM, V107, P1, DOI 10.1111/j.1471-4159.2008.05570.x; McTigue DM, 2001, J NEUROSCI, V21, P3392, DOI 10.1523/JNEUROSCI.21-10-03392.2001; Nishiyama A, 2002, J NEUROCYTOL, V31, P437, DOI 10.1023/A:1025783412651; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Osborne NN, 2004, PROG RETIN EYE RES, V23, P91, DOI 10.1016/j.preteyeres.2003.12.001; Payne SC, 2012, INVEST OPHTH VIS SCI, V53, P6093, DOI 10.1167/iovs.12-10080; Payne SC, 2011, J NEUROTRAUM, V28, P1077, DOI 10.1089/neu.2010.1665; Penderis J, 2003, BRAIN, V126, P1382, DOI 10.1093/brain/awg126; Petersen JA, 2012, J NEUROTRAUM, V29, P1556, DOI 10.1089/neu.2011.2027; Polito A, 2005, J ANAT, V207, P707, DOI 10.1111/j.1469-7580.2005.00454.x; Powers BE, 2012, J NEUROSCI, V32, P5120, DOI 10.1523/JNEUROSCI.0002-12.2012; Prineas J, 1997, DEMYELINATING DIS, P813; Psachoulia K, 2009, NEURON GLIA BIOL, V5, P57, DOI 10.1017/S1740925X09990354; Reynolds R, 2002, J NEUROCYTOL, V31, P523, DOI 10.1023/A:1025747832215; Rhodes KE, 2006, NEUROSCIENCE, V140, P87, DOI 10.1016/j.neuroscience.2006.01.055; Richardson WD, 2011, NEURON, V70, P661, DOI 10.1016/j.neuron.2011.05.013; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; Rosenberg PA, 2003, J NEUROSCI RES, V71, P237, DOI 10.1002/jnr.10472; Schonberg DL, 2007, J NEUROPATH EXP NEUR, V66, P1124, DOI 10.1097/nen.0b013e31815c2530; Sim FJ, 2002, J NEUROSCI, V22, P2451, DOI 10.1523/JNEUROSCI.22-07-02451.2002; SMITH KJ, 1979, NATURE, V280, P395, DOI 10.1038/280395a0; STALLCUP WB, 1981, DEV BIOL, V83, P154, DOI 10.1016/S0012-1606(81)80018-8; Totoiu MO, 2005, J COMP NEUROL, V486, P373, DOI 10.1002/cne.20517; Tripathi R, 2007, GLIA, V55, P698, DOI 10.1002/glia.20491; Trotter J, 2010, BRAIN RES REV, V63, P72, DOI 10.1016/j.brainresrev.2009.12.006; Watanabe M, 2002, J NEUROSCI RES, V69, P826, DOI 10.1002/jnr.10338; Wolswijk G, 1998, J NEUROSCI, V18, P601; Yang H, 2006, J NEUROSCI, V26, P2157, DOI 10.1523/JNEUROSCI.4070-05.2005; Zai LJ, 2005, GLIA, V50, P247, DOI 10.1002/glia.20176; Zhao JW, 2009, EUR J NEUROSCI, V29, P1853, DOI 10.1111/j.1460-9568.2009.06736.x; Zhu L, 2012, GLIA, V60, P1417, DOI 10.1002/glia.22362	72	27	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65710	10.1371/journal.pone.0065710	http://dx.doi.org/10.1371/journal.pone.0065710			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776532	Green Published, gold			2022-12-27	WOS:000320755400060
J	Ren, LY; Nie, XW; Dong, YC				Ren, LiYong; Nie, XiaoWen; Dong, YuChi			Applying Pebble-Rotating Game to Enhance the Robustness of DHTs	PLOS ONE			English	Article							PEER; CHORD	Distributed hash tables (DHTs) are usually used in the open networking environment, where they are vulnerable to Sybil attacks. Pebble-Rotating Game (PRG) mixes the nodes of the honest and the adversarial randomly, and can resist the Sybil attack efficiently. However, the adversary may have some tricks to corrupt the rule of PRG. This paper proposes a set of mechanisms to make the rule of PRG be obliged to obey. A new joining node must ask the Certificate Authority (CA) for its signature and certificate, which records the complete process on how a node joins the network and obtains the legitimacy of the node. Then, to prevent the adversary from accumulating identifiers, any node can make use of the latest certificate to judge whether one identifier is expired with the help of the replacement property of RPG. This paper analyzes in details the number of expired certificates which are needed to store in every node, and gives asymptotic solution of this problem. The analysis and simulations show that the mean number of the certificates stored in each node are O(log(2) n), where n is the size of the network.	[Ren, LiYong; Nie, XiaoWen; Dong, YuChi] Univ Elect Sci & Technol China, Sch Engn & Comp Sci, Chengdu 610054, Peoples R China	University of Electronic Science & Technology of China	Nie, XW (corresponding author), Univ Elect Sci & Technol China, Sch Engn & Comp Sci, Chengdu 610054, Peoples R China.	niexiaowen@uestc.edu.cn			National Natural Science Foundation of China [61073181]; CNGI of the Peoples Republic of China [CNGI-04-12-1D]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CNGI of the Peoples Republic of China	This work is not only sponsored by National Natural Science Foundation of China under Contract number 61073181, but also sponsored by CNGI of the Peoples Republic of China under Contract number CNGI-04-12-1D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awerbuch B, 2009, THEOR COMPUT SYST, V45, P234, DOI 10.1007/s00224-008-9099-9; Bazzi RA, 2007, DISTRIB COMPUT, V19, P267, DOI 10.1007/s00446-006-0012-y; Castro M, 2002, USENIX ASSOCIATION PROCEEDINGS OF THE FIFTH SYMPOSIUM ON OPERATING SYSTEMS DESIGN AND IMPLEMENTATION, P299, DOI 10.1145/1060289.1060317; Condie T, 2006, P 13 ANN NETW DISTR; Corless RM, 1996, ADV COMPUT MATH, V5, P329, DOI 10.1007/BF02124750; Dabek F., 2001, Operating Systems Review, V35, P202, DOI 10.1145/502059.502054; Danezis G, 2005, LECT NOTES COMPUT SC, V3679, P305; DOMB C, 1989, J STAT PHYS, V55, P441, DOI 10.1007/BF01042611; Douceur JR, 2002, LECT NOTES COMPUT SC, V2429, P251, DOI 10.1007/3-540-45748-8_24; Fiat A, 2005, LECT NOTES COMPUT SC, V3669, P803; GRUBBS FE, 1967, TECHNOMETRICS, V9, P342, DOI 10.2307/1266435; Johansen H., 2006, Operating Systems Review, V40, P3, DOI 10.1145/1218063.1217937; King V, 2006, ANN IEEE SYMP FOUND, P87; King V, 2007, ALGORITHMICA, V49, P147, DOI 10.1007/s00453-007-9029-2; Lefebvre KR, 2000, TECHNICAL REPORT; Ratnasamy S, 2001, ACM SIGCOMM COMP COM, V31, P161, DOI 10.1145/964723.383072; Rowaihy H, 2007, IEEE INFOCOM SER, P2596, DOI 10.1109/INFCOM.2007.328; ROWSTRON A., IFIP ACM INT C DISTR, P329, DOI DOI 10.1007/3-540-45518-3_18; SCHEIDELER C., 2005, P 37 ANN ACM S THEOR, P704; SIEGEL AF, 1982, J APPL PROBAB, V19, P373, DOI 10.2307/3213488; Stoica I, 2003, IEEE ACM T NETWORK, V11, P17, DOI 10.1109/TNET.2002.808407; Yu HF, 2006, ACM SIGCOMM COMP COM, V36, P267, DOI 10.1145/1151659.1159945; Zhao B. Y., 2001, COMPUTER SCI	23	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65460	10.1371/journal.pone.0065460	http://dx.doi.org/10.1371/journal.pone.0065460			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776485	Green Published, gold, Green Submitted			2022-12-27	WOS:000320755400032
J	Teodoro, GS; van den Berg, E; Arruda, R				Teodoro, Grazielle Sales; van den Berg, Eduardo; Arruda, Rafael			Metapopulation Dynamics of the Mistletoe and Its Host in Savanna Areas with Different Fire Occurrence	PLOS ONE			English	Article							COLONIZATION-EXTINCTION DYNAMICS; SCALE SPATIAL DYNAMICS; EPIPHYTE METAPOPULATION; DWARF MISTLETOE; DISPERSAL; PATTERNS; FORESTS; MODELS; PLANTS; LORANTHACEAE	Mistletoes are aerial hemiparasitic plants which occupy patches of favorable habitat (host trees) surrounded by unfavorable habitat and may be possibly modeled as a metapopulation. A metapopulation is defined as a subdivided population that persists due to the balance between colonization and extinction in discrete habitat patches. Our aim was to evaluate the dynamics of the mistletoe Psittacanthus robustus and its host Vochysia thyrsoidea in three Brazilian savanna areas using a metapopulation approach. We also evaluated how the differences in terms of fire occurrence affected the dynamic of those populations (two areas burned during the study and one was fire protected). We monitored the populations at six-month intervals. P. robustus population structure and dynamics met the expected criteria for a metapopulation: i) the suitable habitats for the mistletoe occur in discrete patches; (ii) local populations went extinct during the study and (iii) colonization of previously non-occupied patches occurred. The ratio of occupied patches decreased in all areas with time. Local mistletoe populations went extinct due to two different causes: patch extinction in area with no fire and fire killing in the burned areas. In a burned area, the largest decrease of occupied patch ratios occurred due to a fire event that killed the parasites without, however, killing the host trees. The greatest mortality of V. thyrsoidea occurred in the area without fire. In this area, all the dead trees supported mistletoe individuals and no mortality was observed for parasite-free trees. Because P. robustus is a fire sensitive species and V. thyrsoidea is fire tolerant, P. robustus seems to increase host mortality, but its effect is lessened by periodic burning that reduces the parasite loads.	[Teodoro, Grazielle Sales] Univ Estadual Campinas, Inst Biol, Dept Bot, Campinas, SP, Brazil; [van den Berg, Eduardo] Univ Fed Lavras, Dept Biol, Setor Bot Sistemat, Lavras, Brazil; [Arruda, Rafael] Univ Fed Mato Grosso, Inst Ciencias Nat Humanas & Sociais, Sinop, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Federal de Lavras; Universidade Federal de Mato Grosso	Teodoro, GS (corresponding author), Univ Estadual Campinas, Inst Biol, Dept Bot, Campinas, SP, Brazil.	gsales.bio@gmail.com	van den Berg, eduardo/L-9617-2014; Arruda, Rafael/D-4362-2012; Teodoro, Grazielle S/K-2586-2014	van den Berg, eduardo/0000-0002-0843-6437; Arruda, Rafael/0000-0003-2869-5134; Teodoro, Grazielle S/0000-0002-5528-8828	FAPEMIG; FAPEMAT	FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); FAPEMAT(Fundacao de Amparo a Pesquisa do Estado de Mato Grosso (FAPEMAT))	The authors thank FAPEMIG for master fellowships and financial support to Grazielle Sales Teodoro and FAPEMAT for post-doctoral fellowships to Rafael Arruda. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZBUYLLA ER, 1994, AM NAT, V143, P155, DOI 10.1086/285599; Arruda R, 2012, ACTA BOT BRAS, V26, P264, DOI 10.1590/S0102-33062012000200003; Aukema JE, 2004, ECOGRAPHY, V27, P137, DOI 10.1111/j.0906-7590.2004.03640.x; Aukema Juliann E., 2002, P99, DOI 10.1079/9780851995250.0099; Blick R, 2009, PERSPECT PLANT ECOL, V11, P41, DOI 10.1016/j.ppees.2008.10.002; Burns KC, 2010, ECOLOGY, V91, P377, DOI 10.1890/08-2004.1; Burns KC, 2009, OIKOS, V118, P191, DOI 10.1111/j.1600-0706.2008.16816.x; Caires CS, 2010, CATALOGO PLANTAS FUN, V2, P1172; Calvin CL, 2006, FLORA, V201, P51, DOI 10.1016/j.flora.2005.03.001; Caruso A, 2010, OIKOS, V119, P1947, DOI 10.1111/j.1600-0706.2010.18713.x; Ehrlen J, 2003, J ECOL, V91, P316, DOI 10.1046/j.1365-2745.2003.00753.x; Fadini RF, 2012, BIOTROPICA, V44, P27, DOI 10.1111/j.1744-7429.2011.00773.x; Fedrowitz K, 2012, J APPL ECOL, V49, P493, DOI 10.1111/j.1365-2664.2012.02113.x; Freckleton RP, 2002, J ECOL, V90, P419, DOI 10.1046/j.1365-2745.2002.00692.x; Freckleton RP, 2003, J ECOL, V91, P321, DOI 10.1046/j.1365-2745.2003.00769.x; Glatzel G, 2009, BOTANY, V87, P10, DOI 10.1139/B08-096; Guerra TJA, 2010, THESIS U ESTADUAL CA; HANSKI I, 1991, BIOL J LINN SOC, V42, P17, DOI 10.1111/j.1095-8312.1991.tb00549.x; Hanski Ilkka, 1997, P69, DOI 10.1016/B978-012323445-2/50007-9; Hessburg PF, 2008, FOREST ECOL MANAG, V255, P2907, DOI 10.1016/j.foreco.2008.01.066; Hessburg PF, 2000, FOREST ECOL MANAG, V136, P53, DOI 10.1016/S0378-1127(99)00263-7; Jurskis V., 2005, Australian Forestry, V68, P221; Kavanagh PH, 2012, BIOL J LINN SOC, V106, P459, DOI 10.1111/j.1095-8312.2012.01890.x; Kipfmueller KF, 1998, FOREST ECOL MANAG, V108, P77, DOI 10.1016/S0378-1127(98)00217-5; Laube S, 2007, J VEG SCI, V18, P613, DOI 10.1111/j.1654-1103.2007.tb02575.x; Lobel S, 2006, ECOGRAPHY, V29, P169, DOI 10.1111/j.2006.0906-7590.04348.x; Lobel S, 2006, J ECOL, V94, P856, DOI 10.1111/j.1365-2745.2006.01114.x; Melbourne BA, 2008, NATURE, V454, P100, DOI 10.1038/nature06922; MOILANEN A, 1995, J ANIM ECOL, V64, P141, DOI 10.2307/5836; Moilanen A, 1998, ECOLOGY, V79, P2503, DOI 10.1890/0012-9658(1998)079[2503:MDEOHQ]2.0.CO;2; MONTEIRO RF, 1992, J TROP ECOL, V8, P307, DOI 10.1017/S026646740000657X; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Oliveira Filho A. T., 1999, Cerne, V5, P51; OVERTON JM, 1994, J ECOL, V82, P711, DOI 10.2307/2261437; Press MC, 2005, NEW PHYTOL, V166, P737, DOI 10.1111/j.1469-8137.2005.01358.x; R Core Team, 2012, R LANG ENV STAT COMP; Ribeiro JF, 2008, CERRADO ECOLOGIA FLO, P153, DOI DOI 10.1023/A:1015819219386; Roxburgh L, 2008, PLANT ECOL, V195, P21, DOI 10.1007/s11258-007-9295-8; Salle G., 1983, BIOL MISTLETOES, P145; SHAFFER ML, 1981, BIOSCIENCE, V31, P131, DOI 10.2307/1308256; Shaw DC, 2004, AUST J BOT, V52, P481, DOI 10.1071/BT03074; Sheil D, 2000, J TROP ECOL, V16, P765, DOI 10.1017/S0266467400001723; SHEIL D, 1995, J ECOL, V83, P331, DOI 10.2307/2261571; Snall T, 2005, OIKOS, V109, P209, DOI 10.1111/j.0030-1299.2005.13616.x; Snall T, 2005, ECOLOGY, V86, P106, DOI 10.1890/04-0531; Snall T, 2004, ECOGRAPHY, V27, P757, DOI 10.1111/j.0906-7590.2004.04026.x; Snall T, 2003, OIKOS, V103, P566, DOI 10.1034/j.1600-0706.2003.12551.x; Teodoro GS, 2010, FLORA, V205, P797, DOI 10.1016/j.flora.2010.04.013; Watson DM, 2007, AUSTRAL ECOL, V32, P359, DOI 10.1111/j.1442-9993.2007.01701.x; Wilson CA, 2006, AM J BOT, V93, P787, DOI 10.3732/ajb.93.5.787	51	12	12	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65836	10.1371/journal.pone.0065836	http://dx.doi.org/10.1371/journal.pone.0065836			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776554	Green Submitted, Green Published, gold			2022-12-27	WOS:000320755400070
J	Young, SE; Duvernay, MT; Schulte, ML; Lindsley, CW; Hamm, HE				Young, Summer E.; Duvernay, Matthew T.; Schulte, Michael L.; Lindsley, Craig W.; Hamm, Heidi E.			Synthesis of Indole Derived Protease-Activated Receptor 4 Antagonists and Characterization in Human Platelets	PLOS ONE			English	Article							SECONDARY PREVENTION; INTERNAL POOL; THROMBIN; INHIBITION; YD-3; AGGREGATION; VORAPAXAR; DISCOVERY; HEMOSTASIS; PEPTIDE	Protease activated receptor-4 (PAR4) is one of the thrombin receptors on human platelets and is a potential target for the management of thrombotic disorders. We sought to develop potent, selective, and novel PAR4 antagonists to test the role of PAR4 in thrombosis and hemostasis. Development of an expedient three-step synthetic route to access a novel series of indole-based PAR4 antagonists also necessitated the development of a platelet based high-throughput screening assay. Screening and subsequent structure activity relationship analysis yielded several selective PAR4 antagonists as well as possible new scaffolds for future antagonist development.	[Young, Summer E.; Duvernay, Matthew T.; Lindsley, Craig W.; Hamm, Heidi E.] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA; [Schulte, Michael L.; Lindsley, Craig W.] Vanderbilt Univ, Sch Med, Dept Chem, Nashville, TN 37212 USA; [Lindsley, Craig W.] Vanderbilt Univ, Sch Med, Vanderbilt Specialized Chem Ctr, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Hamm, HE (corresponding author), Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA.	heidi.hamm@vanderbilt.edu	Hamm, Heidi E/G-2374-2014		National Institues of Health, MLPCN [U54MH084659]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007563] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS081669] Funding Source: NIH RePORTER	National Institues of Health, MLPCN; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institues of Health, MLPCN, Grant U54MH084659 (http://mli.nih.gov/mli/mlpcn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HS, 2000, BIOCHEM PHARMACOL, V60, P1425, DOI 10.1016/S0006-2952(00)00460-3; Andrade-Gordon P, 1999, P NATL ACAD SCI USA, V96, P12257, DOI 10.1073/pnas.96.22.12257; Bernatowicz MS, 1996, J MED CHEM, V39, P4879, DOI 10.1021/jm960455s; CAVALLINI L, 1995, BIOCHEM J, V310, P449, DOI 10.1042/bj3100449; Chen HS, 2008, BIOORGAN MED CHEM, V16, P1262, DOI 10.1016/j.bmc.2007.10.070; Clasby MC, 2006, BIOORG MED CHEM LETT, V16, P1544, DOI 10.1016/j.bmcl.2005.12.042; Cleator JH, 2006, BLOOD, V107, P2736, DOI 10.1182/blood-2004-07-2698; Dormann D, 2000, BLOOD, V96, P2469, DOI 10.1182/blood.V96.7.2469.h8002469_2469_2478; Duvernay MT, 2013, MOL PHARM; Gawaz M, 2000, THROMB HAEMOSTASIS, V83, P915; Hamilton JR, 2004, J THROMB HAEMOST, V2, P1429, DOI 10.1111/j.1538-7836.2004.00783.x; Holinstat M, 2006, J BIOL CHEM, V281, P26665, DOI 10.1074/jbc.M602174200; Holinstat M, 2011, ARTERIOSCL THROM VAS, V31, P435, DOI 10.1161/ATVBAHA.110.219527; Jardin I, 2007, BIOCHEM J, V401, P167, DOI 10.1042/BJ20060888; Kahn ML, 1999, J CLIN INVEST, V103, P879, DOI 10.1172/JCI6042; Kahn ML, 1998, NATURE, V394, P690, DOI 10.1038/29325; Kennedy JP, 2008, J COMB CHEM, V10, P345, DOI 10.1021/cc700187t; KLEIMAN NS, 1995, J AM COLL CARDIOL, V26, P1665, DOI 10.1016/0735-1097(95)00391-6; Kudo N, 2006, ANGEW CHEM INT EDIT, V45, P1282, DOI 10.1002/anie.200503479; Lee FY, 2001, J MED CHEM, V44, P3746, DOI 10.1021/jm010001h; Lindsley CW, 2005, BIOORG MED CHEM LETT, V15, P761, DOI 10.1016/j.bmcl.2004.11.011; MISTRY AG, 1986, TETRAHEDRON LETT, V27, P1051, DOI 10.1016/S0040-4039(86)80045-4; Morrow DA, 2012, NEW ENGL J MED, V366, P1404, DOI 10.1056/NEJMoa1200933; Peng CY, 2010, SHOCK, V34, P580, DOI 10.1097/SHK.0b013e3181df00a3; Sambrano GR, 2001, NATURE, V413, P74, DOI 10.1038/35092573; Scirica BM, 2012, LANCET, V380, P1317, DOI 10.1016/S0140-6736(12)61269-0; Shapiro MJ, 2000, J BIOL CHEM, V275, P25216, DOI 10.1074/jbc.M004589200; Tricoci P, 2012, NEW ENGL J MED, V366, P20, DOI 10.1056/NEJMoa1109719; Voss B, 2007, MOL PHARMACOL, V71, P1399, DOI 10.1124/mol.106.033365; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; Wu CC, 2002, THROMB HAEMOSTASIS, V87, P1026, DOI 10.1055/s-0037-1613128; Wu CC, 2000, BRIT J PHARMACOL, V130, P1289, DOI 10.1038/sj.bjp.0703437; Xu WF, 1998, P NATL ACAD SCI USA, V95, P6642, DOI 10.1073/pnas.95.12.6642; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	34	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65528	10.1371/journal.pone.0065528	http://dx.doi.org/10.1371/journal.pone.0065528			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776495	Green Submitted, Green Published, gold			2022-12-27	WOS:000320755400038
J	Leone, MA; Barizzone, N; Esposito, F; Lucenti, A; Harbo, HF; Goris, A; Kockum, I; Oturai, AB; Celius, EG; Mero, IL; Dubois, B; Olsson, T; Sondergaard, HB; Cusi, D; Lupoli, S; Andreassen, BK; Myhr, KM; Guerini, FR; Comi, G; Martinelli-Boneschi, F; D'Alfonso, S				Leone, Maurizio A.; Barizzone, Nadia; Esposito, Federica; Lucenti, Ausiliatrice; Harbo, Hanne F.; Goris, An; Kockum, Ingrid; Oturai, Annette Bang; Celius, Elisabeth Gulowsen; Mero, Inger L.; Dubois, Benedicte; Olsson, Tomas; Sondergaard, Helle Bach; Cusi, Daniele; Lupoli, Sara; Andreassen, Bettina Kulle; Myhr, Kjell-Morten; Guerini, Franca R.; Comi, Giancarlo; Martinelli-Boneschi, Filippo; D'Alfonso, Sandra		International Multiple Sclerosis G	Association of Genetic Markers with CSF Oligoclonal Bands in Multiple Sclerosis Patients	PLOS ONE			English	Article							DISABILITY	Objective: to explore the association between genetic markers and Oligoclonal Bands (OCB) in the Cerebro Spinal Fluid (CSF) of Italian Multiple Sclerosis patients. Methods: We genotyped 1115 Italian patients for HLA-DRB1*15 and HLA-A*02. In a subset of 925 patients we tested association with 52 non-HLA SNPs associated with MS susceptibility and we calculated a weighted Genetic Risk Score. Finally, we performed a Genome Wide Association Study (GWAS) with OCB status on a subset of 562 patients. The best associated SNPs of the Italian GWAS were replicated in silico in Scandinavian and Belgian populations, and meta-analyzed. Results: HLA-DRB1*15 is associated with OCB+: p = 0.03, Odds Ratio (OR) = 1.6, 95% Confidence Limits (CL) = 1.1-2.4. None of the 52 non-HLA MS susceptibility loci was associated with OCB, except one SNP (rs2546890) near IL12B gene (OR: 1.45; 1.09-1.92). The weighted Genetic Risk Score mean was significantly (p = 0.0008) higher in OCB+ (7.668) than in OCB- (7.412) patients. After meta-analysis on the three datasets (Italian, Scandinavian and Belgian) for the best associated signals resulted from the Italian GWAS, the strongest signal was a SNP (rs9320598) on chromosome 6q (p = 9.4 x 10(-7)) outside the HLA region (65 Mb). Discussion: genetic factors predispose to the development of OCB.	[Leone, Maurizio A.; Lucenti, Ausiliatrice] MS Ctr, SCDU Neurol, Novara, Italy; [Leone, Maurizio A.; Barizzone, Nadia; D'Alfonso, Sandra] Univ Piemonte Orientale, IRCAD, Novara, Italy; [Barizzone, Nadia; D'Alfonso, Sandra] Univ Piemonte Orientale, Dept Hlth Sci, Novara, Italy; [Esposito, Federica; Comi, Giancarlo; Martinelli-Boneschi, Filippo] Ist Sci San Raffaele, Inst Expt Neurol, CNS Inflammatory Unit, Dept Neurol & Lab Neurogenet Complex Dis, I-20132 Milan, Italy; [Harbo, Hanne F.; Celius, Elisabeth Gulowsen; Mero, Inger L.] Oslo Univ Hosp, Dept Neurol, Oslo, Norway; [Harbo, Hanne F.; Mero, Inger L.] Univ Oslo, Inst Clin Med, Oslo, Norway; [Goris, An; Dubois, Benedicte] Katholieke Univ Leuven, Sect Expt Neurol, Lab Neuroimmunol, Louvain, Belgium; [Olsson, Tomas] Karolinska Hosp, Karolinska Inst, Ctr Mol Med CMM, Dept Clin Neurosci, S-10401 Stockholm, Sweden; [Oturai, Annette Bang; Sondergaard, Helle Bach] Copenhagen Univ Hosp, Rigshosp, Danish Multiple Sclerosis Ctr, Copenhagen, Denmark; [Cusi, Daniele; Lupoli, Sara] Univ Milan, Dept Hlth Sci, Milan, Italy; [Andreassen, Bettina Kulle] Univ Oslo, Dept Clin Mol Biol & Lab Sci EpiGen, Oslo, Norway; Haukeland Hosp, Dept Neurol, Norwegian Multiple Sclerosis Registry & Biobank, N-5021 Bergen, Norway; Univ Bergen, Dept Clin Med, KG Jebsen Ctr MS Res, Bergen, Norway; [Guerini, Franca R.] Fdn Don C Gnocchi, IRCCS S Maria Nascente, Milan, Italy	University of Eastern Piedmont Amedeo Avogadro; University of Eastern Piedmont Amedeo Avogadro; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Oslo; University of Oslo; KU Leuven; Karolinska Institutet; Karolinska University Hospital; Rigshospitalet; University of Copenhagen; University of Milan; University of Oslo; University of Bergen; Haukeland University Hospital; University of Bergen; IRCCS Fondazione Don Carlo Gnocchi Onlus	Leone, MA (corresponding author), MS Ctr, SCDU Neurol, Novara, Italy.	maurizio.leone@maggioreosp.novara.it	Goris, An/F-2943-2010; Goris, An/L-5852-2019; Leone, Maurizio A./J-4130-2016; Esposito, Federica/K-6537-2016; Kockum, Ingrid/O-8781-2018; Boneschi, Filippo Martinelli/H-8592-2012; Galimberti, Daniela/N-7209-2019; Myhr, Kjell-Morten/H-1528-2018; Celius, Elisabeth Gulowsen/S-1387-2019; D'Alfonso, Sandra/K-7295-2014; Scarpini, Elio/K-6547-2016; Liberatore, Giuseppe/ABH-3685-2020; Dubois, Benedicte/A-4338-2019	Goris, An/0000-0002-1276-6682; Goris, An/0000-0002-1276-6682; Leone, Maurizio A./0000-0002-6339-5738; Esposito, Federica/0000-0003-2550-0805; Kockum, Ingrid/0000-0002-0867-4726; Galimberti, Daniela/0000-0002-9284-5953; Myhr, Kjell-Morten/0000-0002-0980-510X; Celius, Elisabeth Gulowsen/0000-0002-9127-6488; D'Alfonso, Sandra/0000-0002-3983-9925; Scarpini, Elio/0000-0002-6395-2119; Liberatore, Giuseppe/0000-0003-2666-1678; Di Sapio, Alessia/0000-0002-5575-7567; Cavalla, Paola/0000-0003-4589-4864; Comabella Lopez, Manuel/0000-0002-2373-6657; Sondergaard, Helle Bach/0000-0001-9435-0658; Rapa, Anna/0000-0002-5523-5224; Olsson, Tomas/0000-0002-2938-1877; martinelli boneschi, filippo/0000-0002-9955-1368; Benedetti, Maria Donata/0000-0002-8340-2915; moiola, lucia/0000-0001-6313-4952; Dubois, Benedicte/0000-0003-0604-8702; McCauley, Jacob/0000-0002-1805-1733	Italian Foundation for Multiple Sclerosis (FISM grant "Progetto Speciale Immunochip," Fondazione Cariplo) [2010-0728]; Italian Ministry of University and Research (MIUR); CRT Foundation, Turin; Belgian Charcot Foundation; Onderzoeksfonds KU Leuven/ Research Fund KU Leuven [OT/11/087]; Wetenschappelijk Onderzoek Multiple Sclerose - Vlaanderen; Belgian Neurological Society; Bibbi and Niels Jensens Foundation; Hjarnfonden; Swedish Medical Research Council [8691]; Stockholm County Council [562183]; Swedish Council for Working life and Social Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049477] Funding Source: NIH RePORTER	Italian Foundation for Multiple Sclerosis (FISM grant "Progetto Speciale Immunochip," Fondazione Cariplo); Italian Ministry of University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); CRT Foundation, Turin(Fondazione CRT); Belgian Charcot Foundation; Onderzoeksfonds KU Leuven/ Research Fund KU Leuven(KU Leuven); Wetenschappelijk Onderzoek Multiple Sclerose - Vlaanderen; Belgian Neurological Society; Bibbi and Niels Jensens Foundation; Hjarnfonden; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Stockholm County Council(Stockholm County Council); Swedish Council for Working life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The study was funded by the Italian Foundation for Multiple Sclerosis (FISM grant "Progetto Speciale Immunochip," Fondazione Cariplo (no 2010-0728); the Italian Ministry of University and Research (MIUR, PRIN08), and the CRT Foundation, Turin. The Belgian part of this project was supported by a Research Grant from the Belgian Charcot Foundation (AG); and Onderzoeksfonds KU Leuven/ Research Fund KU Leuven (OT/11/087, AG and BD). AG and BD are supported by Wetenschappelijk Onderzoek Multiple Sclerose - Vlaanderen; and the Belgian Neurological Society. BD is a Clinical Investigator of the Research Foundation Flanders (FWO - Vlaanderen) and holds the Biogen Idec Chair Translational Research in Multiple Sclerosis, and the Bayer Chair on Fundamental Genetic Research regarding the Neuroimmunological aspects of Multiple Sclerosis. The Swedish part of this project was supported by Bibbi and Niels Jensens Foundation, Hjarnfonden and Swedish Medical Research Council (8691), Stockholm County Council (562183) and Swedish Council for Working life and Social Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balnyte R, 2011, MEDICINA-LITHUANIA, V47, P368, DOI 10.3390/medicina47070052; Bergamaschi L, 2010, GENES IMMUN, V11, P173, DOI 10.1038/gene.2009.101; De Jager PL, 2009, LANCET NEUROL, V8, P1111, DOI 10.1016/S1474-4422(09)70275-3; Dilthey AT, 2011, BIOINFORMATICS, V27, P968, DOI 10.1093/bioinformatics/btr061; Dobson R, 2013, J NEUROL NEUROSUR PS, V84, P909, DOI 10.1136/jnnp-2012-304695; Imrell K, 2006, NEUROLOGY, V67, P1062, DOI 10.1212/01.wnl.0000237343.93389.35; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lechner-Scott J, 2012, MULT SCLER J, V18, P974, DOI 10.1177/1352458511431729; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; OLSSON T, 1984, CLIN CHEM, V30, P1246; Piwko W, 2010, EMBO J, V29, P4210, DOI 10.1038/emboj.2010.304; Romero-Pinel L, 2011, EUR J NEUROL, V18, P1258, DOI 10.1111/j.1468-1331.2011.03379.x; Roxburgh RHSR, 2005, NEUROLOGY, V64, P1144, DOI 10.1212/01.WNL.0000156155.19270.F8; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251	14	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e64408	10.1371/journal.pone.0064408	http://dx.doi.org/10.1371/journal.pone.0064408			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785401	Green Submitted, Green Published, gold			2022-12-27	WOS:000321038800116
J	Micholt, L; Gartner, A; Prodanov, D; Braeken, D; Dotti, CG; Bartic, C				Micholt, Liesbeth; Gartner, Annette; Prodanov, Dimiter; Braeken, Dries; Dotti, Carlos G.; Bartic, Carmen			Substrate Determines Neuronal Polarization and Growth In Vitro	PLOS ONE			English	Article							FOCAL ADHESION KINASE; HIPPOCAMPAL-NEURONS; MYOSIN-II; POLARITY; CENTROSOME; TOPOGRAPHY; GUIDANCE; MICROTOPOGRAPHY; DIFFERENTIATION; MECHANOSENSORS	The establishment of neuronal connectivity depends on the correct initial polarization of the young neurons. In vivo, developing neurons sense a multitude of inputs and a great number of molecules are described that affect their outgrowth. In vitro, many studies have shown the possibility to influence neuronal morphology and growth by biophysical, i.e. topographic, signaling. In this work we have taken this approach one step further and investigated the impact of substrate topography in the very early differentiation stages of developing neurons, i.e. when the cell is still at the round stage and when the first neurite is forming. For this purpose we fabricated micron sized pillar structures with highly reproducible feature sizes, and analyzed neurons on the interface of flat and topographic surfaces. We found that topographic signaling was able to attract the polarization markers of mouse embryonic neurons -N-cadherin, Golgi-centrosome complex and the first bud were oriented towards topographic stimuli. Consecutively, the axon was also preferentially extending along the pillars. These events seemed to occur regardless of pillar dimensions in the range we examined. However, we found differences in neurite length that depended on pillar dimensions. This study is one of the first to describe in detail the very early response of hippocampal neurons to topographic stimuli.	[Micholt, Liesbeth; Prodanov, Dimiter; Braeken, Dries; Bartic, Carmen] IMEC, Louvain, Belgium; [Micholt, Liesbeth; Bartic, Carmen] Katholieke Univ Leuven, Solid State Phys & Magnetism Sect, Louvain, Belgium; [Gartner, Annette; Dotti, Carlos G.] VIB Ctr Biol Dis, Louvain, Belgium; [Dotti, Carlos G.] CSIC UAM, Ctr Biol Mol Severo Ochoa, Madrid, Spain	IMEC; KU Leuven; Flanders Institute for Biotechnology (VIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Gartner, A (corresponding author), VIB Ctr Biol Dis, Louvain, Belgium.	annette.gaertner@med.kuleuven.be; dries.braeken@imec.be; cdotti@cbm.uam.es	Gaertner, Annette/B-5393-2013; Bartic, Carmen/I-1310-2013; Bartic, Carmen/AAA-6514-2022; Prodanov, Dimiter/AAE-8938-2019; Dotti, Carlos G/I-5533-2015	Prodanov, Dimiter/0000-0001-8694-0535; Dotti, Carlos G/0000-0003-4052-1719; Bartic, Carmen/0000-0001-9577-2844; Braeken, Dries/0000-0002-5752-3203	Flanders Fund for Scientific Research [FWO G 0.666.10N]; Federal Office for Scientific Affairs [IUAP p6/43]; Flemish Government Methusalem Grant; Spanish Ministry of Science and Innovation Ingenio-Consolider [CSD2010-00064, SAF2010-14906]	Flanders Fund for Scientific Research(FWO); Federal Office for Scientific Affairs; Flemish Government Methusalem Grant; Spanish Ministry of Science and Innovation Ingenio-Consolider(Ministry of Science and Innovation, Spain (MICINN))	Part of this work was supported by the Flanders Fund for Scientific Research (FWO G 0.666.10N, www.fwo.be), the Federal Office for Scientific Affairs (IUAP p6/43), Flemish Government Methusalem Grant and Spanish Ministry of Science and Innovation Ingenio-Consolider CSD2010-00064 and SAF2010-14906 (CGD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Barnes AP, 2008, CURR OPIN NEUROBIOL, V18, P44, DOI 10.1016/j.conb.2008.05.003; Braeken D, 2010, BIOSENS BIOELECTRON; Bruder JM, 2007, J BIOMAT SCI-POLYM E, V18, P967, DOI 10.1163/156856207781494412; Burkel BM, 2007, CELL MOTIL CYTOSKEL, V64, P822, DOI 10.1002/cm.20226; Chacon MR, 2012, DEVELOPMENT, V139, P3200, DOI 10.1242/dev.080564; Cheng PL, 2012, ANNU REV NEUROSCI, V35, P181, DOI 10.1146/annurev-neuro-061010-113618; CLARK P, 1993, J CELL SCI, V105, P203; de Anda FC, 2005, NATURE, V436, P704, DOI 10.1038/nature03811; de Anda FC, 2008, J CELL SCI, V121, P178, DOI 10.1242/jcs.023143; de Anda Froylan Calderon, 2011, Commun Integr Biol, V4, P304, DOI 10.4161/cib.4.3.14781; Diggle PJ, 1983, STAT ANAL SPATIAL PO; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Dowell-Mesfin NM, 2004, J NEURAL ENG, V1, P78, DOI 10.1088/1741-2560/1/2/003; Esch T, 1999, J NEUROSCI, V19, P6417; Ferrari A, 2010, BIOMATERIALS, V31, P4682, DOI 10.1016/j.biomaterials.2010.02.032; Fozdar DY, 2011, INT J NANOMED, V6, P45, DOI 10.2147/IJN.S12376; Fozdar DY, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/3/035005; Frey MT, 2006, BIOPHYS J, V90, P3774, DOI 10.1529/biophysj.105.074526; Gartner A, 2012, EMBO J, V31, P1893, DOI 10.1038/emboj.2012.41; Ganz A, 2006, BIOL CELL, V98, P721, DOI 10.1042/BC20060039; Gartner A, 2011, ADV NEUROBIOL, V5, P161, DOI 10.1007/978-1-4419-7368-9_9; Gomez N, 2007, BIOMATERIALS, V28, P271, DOI 10.1016/j.biomaterials.2006.07.043; GOSLIN K, 1989, J CELL BIOL, V108, P1507, DOI 10.1083/jcb.108.4.1507; HALFTER W, 1985, J COMP NEUROL, V232, P466, DOI 10.1002/cne.902320405; Hanson JN, 2009, LAB CHIP, V9, P122, DOI 10.1039/b803595d; Higginbotham HR, 2007, TRENDS NEUROSCI, V30, P276, DOI 10.1016/j.tins.2007.04.001; Hoffman-Kim D, 2010, ANNU REV BIOMED ENG, V12, P203, DOI 10.1146/annurev-bioeng-070909-105351; Huys R, 2012, LAB CHIP, V12, P1274, DOI 10.1039/c2lc21037a; HYNES RO, 1986, J NEUROSCI, V6, P867; Jang KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015966; Kim DH, 2009, BIOMATERIALS, V30, P5433, DOI 10.1016/j.biomaterials.2009.06.042; Lamoureux P, 2002, J CELL BIOL, V159, P499, DOI 10.1083/jcb.200207174; Makino A, 2006, AM J PHYSIOL-CELL PH, V290, pC1633, DOI 10.1152/ajpcell.00576.2005; Matschegewski C, 2010, BIOMATERIALS, V31, P5729, DOI 10.1016/j.biomaterials.2010.03.073; Migliorini E, 2011, BIOTECHNOL BIOENG, V108, P2736, DOI 10.1002/bit.23232; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Moore SW, 2011, DEV NEUROBIOL, V71, P1090, DOI 10.1002/dneu.20947; O'Connor TP, 1999, CELL MOL LIFE SCI, V55, P1358, DOI 10.1007/s000180050376; Pasapera AM, 2010, J CELL BIOL, V188, P877, DOI 10.1083/jcb.200906012; Pollarolo G, 2011, NAT NEUROSCI, V14, P1525, DOI 10.1038/nn.2976; Prodanov D, 2007, J NEUROSCI METH, V160, P93, DOI 10.1016/j.jneumeth.2006.08.017; Rajnicek AM, 1997, J CELL SCI, V110, P2905; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Robles E, 2006, NAT NEUROSCI, V9, P1274, DOI 10.1038/nn1762; Roth S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033623; Seo CH, 2011, BIOMATERIALS, V32, P9568, DOI 10.1016/j.biomaterials.2011.08.077; Sero JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028303; Solecki DJ, 2009, NEURON, V63, P63, DOI 10.1016/j.neuron.2009.05.028; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Whitington PM, 2004, INT J DEV NEUROSCI, V22, P157, DOI 10.1016/j.ijdevneu.2004.01.001; Zmuda JF, 1998, CELL MOTIL CYTOSKEL, V41, P18, DOI 10.1002/(SICI)1097-0169(1998)41:1<18::AID-CM2>3.0.CO;2-B	53	53	53	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66170	10.1371/journal.pone.0066170	http://dx.doi.org/10.1371/journal.pone.0066170			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785482	gold, Green Published, Green Submitted			2022-12-27	WOS:000321038800040
J	Asanuma, M; Miyazaki, I; Diaz-Corrales, FJ; Higashi, Y; Namba, M; Ogawa, N				Asanuma, Masato; Miyazaki, Ikuko; Diaz-Corrales, Francisco J.; Higashi, Youichirou; Namba, Masayoshi; Ogawa, Norio			Transplantation of Melanocytes Obtained from the Skin Ameliorates Apomorphine-Induced Abnormal Behavior in Rodent Hemi-Parkinsonian Models	PLOS ONE			English	Article							LIPOSOME-ENTRAPPED TYROSINASE; MOUSE EPIDERMAL MELANOCYTES; HUMAN SUBSTANTIA-NIGRA; NEUROTROPHIC FACTOR; RAT MODEL; DISEASE; DOPAMINE; CELLS; MICE; DIFFERENTIATION	Tyrosinase, which catalyzes both the hydroxylation of tyrosine and consequent oxidation of L-DOPA to form melanin in melanocytes, is also expressed in the brain, and oxidizes L-DOPA and dopamine. Replacement of dopamine synthesis by tyrosinase was reported in tyrosine hydroxylase null mice. To examine the potential benefits of autograft cell transplantation for patients with Parkinson's disease, tyrosinase-producing cells including melanocytes, were transplanted into the striatum of hemi-parkinsonian model rats or mice lesioned with 6-hydroxydopamine. Marked improvement in apomorphine-induced rotation was noted at day 40 after intrastriatal melanoma cell transplantation. Transplantation of tyrosinase cDNA-transfected hepatoma cells, which constitutively produce L-DOPA, resulted in marked amelioration of the asymmetric apomorphine-induced rotation in hemi-parkinsonian mice and the effect was present up to 2 months. Moreover, parkinsonian mice transplanted with melanocytes from the back skin of black newborn mice, but not from albino mice, showed marked improvement in the apomorphine-induced rotation behavior up to 3 months after the transplantation. Dopamine-positive signals were seen around the surviving transplants in these experiments. Taken together with previous studies showing dopamine synthesis and metabolism by tyrosinase, these results highlight therapeutic potential of intrastriatal autograft cell transplantation of melanocytes in patients with Parkinson's disease.	[Asanuma, Masato; Miyazaki, Ikuko; Diaz-Corrales, Francisco J.; Higashi, Youichirou; Ogawa, Norio] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Brain Sci, Okayama, Japan; [Namba, Masayoshi] Niimi Coll, Niimi, Japan	Okayama University	Asanuma, M (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Brain Sci, Okayama, Japan.	asachan@cc.okayama-u.ac.jp	Diaz-Corrales, Francisco/L-7559-2014	Diaz-Corrales, Francisco/0000-0002-5752-0205	Japanese Ministry of Education, Culture, Sports, Science and Technology; Japanese Ministry of Health, Labour and Welfare; Grants-in-Aid for Scientific Research [24659431] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in part, by Grants-in-aid for Scientific Research on Innovative Areas "Brain Environment'' (M. A.), for Scientific Research (C) (M. A. and I. M.) and for the Encouragement of Young Scientists () (I. M.) from the Japanese Ministry of Education, Culture, Sports, Science and Technology, and by Health and Labour Sciences Research Grants for Research on Measures for Intractable Diseases (M. A.), for Research on Psychiatric and Neurological Diseases and Mental Health (M. A. and N.O.), and for Comprehensive Research on Aging and Health (M. A. and N.O.) from the Japanese Ministry of Health, Labour and Welfare. The funders had no role in study design, data collection, analyses, decision to prepare or submit the manuscript.	Amicarelli F, 1999, CELL MOL BIOL, V45, P1093; Asanuma M, 1998, NEUROSCIENCE, V85, P907, DOI 10.1016/S0306-4522(97)00665-9; DOI I, 1975, GANN, V66, P385; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; FREED WJ, 1989, BRAIN RES, V485, P349, DOI 10.1016/0006-8993(89)90579-9; Gross RE, 2011, LANCET NEUROL, V10, P509, DOI 10.1016/S1474-4422(11)70097-7; Higashi Y, 2000, J NEUROCHEM, V75, P1771, DOI 10.1046/j.1471-4159.2000.0751771.x; Hirobe T, 1999, PIGM CELL RES, V12, P147, DOI 10.1111/j.1600-0749.1999.tb00508.x; HIROBE T, 1992, J CELL PHYSIOL, V152, P337, DOI 10.1002/jcp.1041520215; Inden M, 2013, J NEUROSCI RES, V91, P62, DOI 10.1002/jnr.23128; Kaneko S, 2000, SCIENCE, V289, P633, DOI 10.1126/science.289.5479.633; Lindvall O, 2011, NEUROTHERAPEUTICS, V8, P539, DOI 10.1007/s13311-011-0069-6; MIRANDA M, 1984, GEN PHARMACOL-VASC S, V15, P541, DOI 10.1016/0306-3623(84)90212-X; MIRANDA M, 1983, GEN PHARMACOL, V14, P231, DOI 10.1016/0306-3623(83)90002-2; MIRANDA M, 1988, BIOCHIM BIOPHYS ACTA, V966, P276, DOI 10.1016/0304-4165(88)90077-3; Miyazaki I, 2006, FASEB J, V20, P571, DOI 10.1096/fj.05-4996fje; Motoori S, 2001, CANCER RES, V61, P5382; Nakao N, 2000, J NEUROSURG, V92, P659, DOI 10.3171/jns.2000.92.4.0659; Ogawa N, 2000, NEUROCHEM RES, V25, P755, DOI 10.1023/A:1007530720544; Olanow CW, 2009, ANN NEUROL, V66, P591, DOI 10.1002/ana.21778; Pawitan JA, 2011, ANAT CELL BIOL, V44, P256, DOI 10.5115/acb.2011.44.4.256; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; Pellegrino L. J., 1979, STEREOTAXIC ATLAS RA; PEZZOLI G, 1988, BRAIN RES, V459, P398; Rios M, 1999, J NEUROSCI, V19, P3519; Smith GA, 2012, NEUROPHARMACOLOGY, V63, P818, DOI 10.1016/j.neuropharm.2012.06.011; Tief K, 1998, MOL BRAIN RES, V53, P307, DOI 10.1016/S0169-328X(97)00301-X; Tsuji T, 1998, BIOCHEM BIOPH RES CO, V242, P317, DOI 10.1006/bbrc.1997.7958; Xu YM, 1997, MOL BRAIN RES, V45, P159, DOI 10.1016/S0169-328X(96)00308-7; Xu YM, 1998, J NEUROSCI RES, V54, P691, DOI 10.1002/(SICI)1097-4547(19981201)54:5<691::AID-JNR14>3.0.CO;2-F; Yasuhara T, 2005, J NEUROSURG, V102, P80, DOI 10.3171/jns.2005.102.1.0080	31	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65983	10.1371/journal.pone.0065983	http://dx.doi.org/10.1371/journal.pone.0065983			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776585	Green Published, gold, Green Submitted			2022-12-27	WOS:000320322400068
J	Eerland, A; Engelen, JAA; Zwaan, RA				Eerland, Anita; Engelen, Jan A. A.; Zwaan, Rolf A.			The Influence of Direct and Indirect Speech on Mental Representations	PLOS ONE			English	Article							VOICE-SELECTIVE AREAS; SITUATION MODELS; VERB ASPECT; ACCESSIBILITY; ACTIVATION; MEMORY	Language can be viewed as a set of cues that modulate the comprehender's thought processes. It is a very subtle instrument. For example, the literature suggests that people perceive direct speech (e.g., Joanne said: 'I went out for dinner last night') as more vivid and perceptually engaging than indirect speech (e.g., Joanne said that she went out for dinner last night). But how is this alleged vividness evident in comprehenders' mental representations? We sought to address this question in a series of experiments. Our results do not support the idea that, compared to indirect speech, direct speech enhances the accessibility of information from the communicative or the referential situation during comprehension. Neither do our results support the idea that the hypothesized more vivid experience of direct speech is caused by a switch from the visual to the auditory modality. However, our results do show that direct speech leads to a stronger mental representation of the exact wording of a sentence than does indirect speech. These results show that language has a more subtle influence on memory representations than was previously suggested.	[Eerland, Anita] Open Univ, Dept Psychol, Heerlen, Netherlands; [Engelen, Jan A. A.; Zwaan, Rolf A.] Erasmus Univ, Dept Psychol, Rotterdam, Netherlands	Open University Netherlands; Erasmus University Rotterdam	Eerland, A (corresponding author), Open Univ, Dept Psychol, Heerlen, Netherlands.	anita.eerland@ou.nl		Engelen, Jan/0000-0003-1885-3530; Zwaan, Rolf/0000-0001-9967-7879	Erasmus University Rotterdam	Erasmus University Rotterdam	The authors received no external funding for the studies described in the manuscript. The authors used research money from the Erasmus University Rotterdam to pay the participants. The university played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohan J, 2008, 14 ANN C ARCH MECH L; CLARK HH, 1990, LANGUAGE, V66, P764, DOI 10.2307/414729; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen J.E., 1988, STAT POWER ANAL BEHA; Erdfelder E, 1996, BEHAV RES METH INS C, V28, P1, DOI 10.3758/BF03203630; GLENBERG AM, 1987, J MEM LANG, V26, P69, DOI 10.1016/0749-596X(87)90063-5; Green D. M., 1966, SIGNAL DETECTION THE, DOI DOI 10.1086/405615; JACOBY LL, 1981, J EXP PSYCHOL GEN, V110, P306, DOI 10.1037/0096-3445.110.3.306; Johnson-Laird P.N., 1983, MENTAL MODELS COGNIT; Kaup B, 2003, J EXP PSYCHOL LEARN, V29, P439, DOI 10.1037/0278-7393.29.3.439; Kurby CA, 2009, COGNITION, V112, P457, DOI 10.1016/j.cognition.2009.05.007; LONG DL, 1992, J MEM LANG, V31, P634, DOI 10.1016/0749-596X(92)90032-S; Madden CJ, 2003, MEM COGNITION, V31, P663, DOI 10.3758/BF03196106; Magliano JP, 2000, DISCOURSE PROCESS, V29, P83, DOI 10.1207/S15326950dp2902_1; Masson MEJ, 2011, BEHAV RES METHODS, V43, P679, DOI 10.3758/s13428-010-0049-5; MONSEN RB, 1977, J ACOUST SOC AM, V62, P981, DOI 10.1121/1.381593; MORROW DG, 1987, J MEM LANG, V26, P165, DOI 10.1016/0749-596X(87)90122-7; Pinker Steven, 1994, LANGUAGE INSTINCT; Rouder JN, 2009, PSYCHON B REV, V16, P225, DOI 10.3758/PBR.16.2.225; Schooler LJ, 2005, BEHAV RES METHODS, V37, P3, DOI 10.3758/BF03206393; Spence C, 1998, PERCEPT PSYCHOPHYS, V60, P125, DOI 10.3758/BF03211923; Stites MC, 2013, MEM COGNITION, V41, P137, DOI 10.3758/s13421-012-0248-7; SUH SY, 1993, J MEM LANG, V32, P279, DOI 10.1006/jmla.1993.1015; Sundermeier BA, 2005, MEM COGNITION, V33, P462, DOI 10.3758/BF03193063; van Dijk T., 1983, STRATEGIES DISCOURSE; Wagenmakers EJ, 2007, PSYCHON B REV, V14, P779, DOI 10.3758/BF03194105; Wagenmakers EJ, 2012, PERSPECT PSYCHOL SCI, V7, P632, DOI 10.1177/1745691612463078; Westerman DL, 2002, J MEM LANG, V47, P607, DOI 10.1016/S0749-596X(02)00022-0; Yao B, 2012, NEUROIMAGE, V60, P1832, DOI 10.1016/j.neuroimage.2012.01.111; Yao B, 2011, COGNITION, V121, P447, DOI 10.1016/j.cognition.2011.08.007; Yao B, 2011, J COGNITIVE NEUROSCI, V23, P3146, DOI 10.1162/jocn_a_00022; Zwaan RA, 1996, J EXP PSYCHOL LEARN, V22, P1196, DOI 10.1037/0278-7393.22.5.1196; ZWAAN RA, 1994, J EXP PSYCHOL LEARN, V20, P920, DOI 10.1037/0278-7393.20.4.920; Zwaan RA, 1998, PSYCHOL BULL, V123, P162, DOI 10.1037/0033-2909.123.2.162; Zwaan RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051382	35	14	14	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65480	10.1371/journal.pone.0065480	http://dx.doi.org/10.1371/journal.pone.0065480			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	163FW	23776488	Green Published, gold			2022-12-27	WOS:000320322400028
J	Havland, I; Lundholm, C; Lichtenstein, P; Neiderhiser, JM; Ganiban, JM; Spotts, EL; Walum, H; Reiss, D; Almqvist, C				Havland, Ida; Lundholm, Cecilia; Lichtenstein, Paul; Neiderhiser, Jenae M.; Ganiban, Jody M.; Spotts, Erica L.; Walum, Hasse; Reiss, David; Almqvist, Catarina			The Observed Association between Maternal Anxiety and Adolescent Asthma: Children of Twin Design Suggest Familial Effects	PLOS ONE			English	Article							CHILDHOOD ASTHMA; ENVIRONMENTAL-INFLUENCES; STRESS; BEHAVIOR; MOTHERS; DEPRESSION; RISK	Background: Previous studies indicate that maternal anxiety is associated with asthma in the adolescent child, but mechanisms are unclear. Objective: To investigate the association between maternal anxiety and maternal, self-and register-based report of asthma in the adolescent child, and whether the association remains after control of familial confounding (shared environmental and genetic factors). Method: From the Twin and Offspring Study of Sweden, 1691 mothers (1058 twins) and their adolescent child were included. The association between maternal self-reported anxiety (Beck Anxiety Inventory (BAI) and Karolinska Scales of Personality (KSP) somatic or psychic anxiety) and asthma based on subjective (maternal or child report) or objective (register-based diagnosis and medication) measures were analysed using logistic regression. The children-of-twins design was used to explore whether genes or environment contribute to the association. Results: Maternal BAI anxiety (OR 2.02, CI 1.15-3.55) was significantly associated with adolescent asthma reported by the mother. Maternal KSP somatic anxiety (OR 1.74, CI 1.04-2.91) and psychic anxiety (OR 1.74, CI 1.05-2.86) was significantly associated with breathlessness reported by the adolescent child. In contrast, maternal anxiety was not associated with increased risk for the register-based outcomes of asthma diagnosis or medication. The results remained also after adjusting for covariates and the children-of-twins analyses which indicate that the association was due to familial confounding. Conclusions: We found some associations between maternal anxiety and subjectively reported offspring asthma or breathlessness which may be due to familial effects. A likely candidate for explaining this familial confounding is heritable personality traits associated with both anxiety and subjective measures of asthma.	[Havland, Ida; Lundholm, Cecilia; Lichtenstein, Paul; Walum, Hasse; Almqvist, Catarina] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Neiderhiser, Jenae M.] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA; [Ganiban, Jody M.] George Washington Univ, Dept Psychol, Washington, DC 20052 USA; [Spotts, Erica L.] NIA, Div Behav & Social Res, NIH, Bethesda, MD 20892 USA; [Reiss, David] Yale Univ, Sch Med, Yale Child Study Ctr, New Haven, CT USA; [Almqvist, Catarina] Dept Womens & Childrens Hlth, Stockholm, Sweden; [Almqvist, Catarina] Astrid Lindgren Childrens Hosp, Stockholm, Sweden	Karolinska Institutet; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; George Washington University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Yale University	Almqvist, C (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.	catarina.almqvist@ki.se		lichtenstein, paul/0000-0003-3037-5287; Neiderhiser, Jenae/0000-0003-4474-5330; Lundholm, Cecilia/0000-0002-6546-3650	National Institute of Mental Health [R01MH54610]; Stockholm County Council; Karolinska Institutet; Swedish Research Council [80748301, 2011-3060]; Swedish Heart and Lung Foundation; Strategic Research Program in Epidemiology at Karolinska Institutet; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054610] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Strategic Research Program in Epidemiology at Karolinska Institutet; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This project was supported by grant R01MH54610 from the National Institute of Mental Health. Financial support was provided through the regional agreement on medical training and clinical research (ALF) between Stockholm County Council and Karolinska Institutet, grants from the Swedish Research Council (grant numbers 80748301 and 2011-3060), the Swedish Heart and Lung Foundation and the Strategic Research Program in Epidemiology at Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHENBACH TM, 1979, J CONSULT CLIN PSYCH, V47, P223, DOI 10.1037/0022-006X.47.2.223; Bakkeheim E, 2010, ACTA PAEDIATR, V99, P1705, DOI 10.1111/j.1651-2227.2009.01598.x; Beijers R, 2010, PEDIATRICS, V126, pE401, DOI 10.1542/peds.2009-3226; Bouchard TJ, 2003, J NEUROBIOL, V54, P4, DOI 10.1002/neu.10160; Brown ES, 2006, PEDIATRICS, V118, pE1715, DOI 10.1542/peds.2006-1119; BUTZ AM, 1993, J ASTHMA, V30, P199, DOI 10.3109/02770909309054518; BYRNE DG, 1977, AUST NZ J PSYCHIAT, V11, P179, DOI 10.3109/00048677709159558; Calam R, 2003, J ALLERGY CLIN IMMUN, V112, P499, DOI 10.1067/mai.2003.1639; Cookson H, 2009, J ALLERGY CLIN IMMUN, V123, P847, DOI 10.1016/j.jaci.2009.01.042; D'Onofrio BM, 2003, J CHILD PSYCHOL PSYC, V44, P1130, DOI 10.1111/1469-7610.00196; Dietert RR, 2011, REPROD TOXICOL, V32, P198, DOI 10.1016/j.reprotox.2011.04.007; Dreger LC, 2010, J ALLERGY CLIN IMMUN, V125, P116, DOI 10.1016/j.jaci.2009.09.051; Enns MW, 1998, J AFFECT DISORDERS, V47, P195, DOI 10.1016/S0165-0327(97)00103-1; Fang F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027202; Koppelman GH, 1999, EUR RESPIR J, V13, P2, DOI 10.1183/09031936.99.13100299; Kozyrskyj AL, 2008, AM J RESP CRIT CARE, V177, P142, DOI 10.1164/rccm.200703-381OC; Kumar RK, 2009, DIS MODEL MECH, V2, P549, DOI 10.1242/dmm.001719; Magne P., 2012, P IEEE TRANSP EL C E, P1, DOI [10.1109/ITEC.2012.6243469, DOI 10.1109/ITEC.2012.6243469]; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Organization WH, 2002, WHO WAO M PREV ALL A, P14; Ortet G, 2002, EUR J PSYCHOL ASSESS, V18, P139, DOI 10.1027//1015-5759.18.2.139; Reiss D, 2001, FAM PROCESS, V40, P261, DOI 10.1111/j.1545-5300.2001.4030100261.x; Silver EJ, 2005, J ASTHMA, V42, P379, DOI 10.1081/JAS-200062999; Slattery MJ, 2010, J PSYCHIAT RES; von Hertzen LC, 2002, J ALLERGY CLIN IMMUN, V109, P923, DOI 10.1067/mai.2002.124776; WAHLER HJ, 1968, J CLIN PSYCHOL, V24, P207, DOI 10.1002/1097-4679(196804)24:2<207::AID-JCLP2270240223>3.0.CO;2-G; Wright RJ, 2002, AM J RESP CRIT CARE, V165, P358, DOI 10.1164/ajrccm.165.3.2102016; Wright RJ, 2011, IMMUNOL ALLERGY CLIN, V31, P19, DOI 10.1016/j.iac.2010.09.011; Yuksel H, 2007, RESP MED, V101, P2550, DOI 10.1016/j.rmed.2007.07.025	29	7	7	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66040	10.1371/journal.pone.0066040	http://dx.doi.org/10.1371/journal.pone.0066040			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776601	Green Published, gold			2022-12-27	WOS:000320322400073
J	Kimirei, IA; Nagelkerken, I; Mgaya, YD; Huijbers, CM				Kimirei, Ismael A.; Nagelkerken, Ivan; Mgaya, Yunus D.; Huijbers, Chantal M.			The Mangrove Nursery Paradigm Revisited: Otolith Stable Isotopes Support Nursery-to-Reef Movements by Indo-Pacific Fishes	PLOS ONE			English	Article							SEAGRASS BEDS; CORAL-REEFS; TEMPORAL PATTERNS; FEEDING HABITATS; FRENCH GRUNTS; JUVENILE; CONNECTIVITY; ASSEMBLAGES; ESTUARINE; ZANZIBAR	Mangroves and seagrass beds have long been perceived as important nurseries for many fish species. While there is growing evidence from the Western Atlantic that mangrove habitats are intricately connected to coral reefs through ontogenetic fish migrations, there is an ongoing debate of the value of these coastal ecosystems in the Indo-Pacific. The present study used natural tags, viz. otolith stable carbon and oxygen isotopes, to investigate for the first time the degree to which multiple tropical juvenile habitats subsidize coral reef fish populations in the Indo Pacific (Tanzania). Otoliths of three reef fish species (Lethrinus harak, L. lentjan and Lutjanus fulviflamma) were collected in mangrove, seagrass and coral reef habitats and analyzed for stable isotope ratios in the juvenile and adult otolith zones. delta C-13 signatures were significantly depleted in the juvenile compared to the adult zones, indicative of different habitat use through ontogeny. Maximum likelihood analysis identified that 82% of adult reef L. harak had resided in either mangrove (29%) or seagrass (53%) or reef (18%) habitats as juveniles. Of adult L. fulviflamma caught from offshore reefs, 99% had passed through mangroves habitats as juveniles. In contrast, L. lentjan adults originated predominantly from coral reefs (65-72%) as opposed to inshore vegetated habitats (28-35%). This study presents conclusive evidence for a nursery role of Indo-Pacific mangrove habitats for reef fish populations. It shows that intertidal habitats that are only temporarily available can form an important juvenile habitat for some species, and that reef fish populations are often replenished by multiple coastal habitats. Maintaining connectivity between inshore vegetated habitats and coral reefs, and conserving habitat mosaics rather than single nursery habitats, is a major priority for the sustainability of various Indo Pacific fish populations.	[Kimirei, Ismael A.; Nagelkerken, Ivan; Huijbers, Chantal M.] Radboud Univ Nijmegen, Inst Water & Wetland Res, Dept Anim Ecol & Ecophysiol, NL-6525 ED Nijmegen, Netherlands; [Kimirei, Ismael A.] Tanzania Fisheries Res Inst, Kigoma, Tanzania; [Nagelkerken, Ivan] Univ Adelaide, Sch Earth & Environm Sci, So Seas Ecol Labs, Adelaide, SA, Australia; [Mgaya, Yunus D.] Univ Dar Es Salaam, Dept Aquat Sci & Fisheries, Coll Nat & Appl Sci, Dar Es Salaam, Tanzania; [Huijbers, Chantal M.] Griffith Univ, Australian Rivers Inst Coasts & Estuaries, Southport, Qld 4215, Australia	Radboud University Nijmegen; University of Adelaide; University of Dar es Salaam; Griffith University	Nagelkerken, I (corresponding author), Radboud Univ Nijmegen, Inst Water & Wetland Res, Dept Anim Ecol & Ecophysiol, NL-6525 ED Nijmegen, Netherlands.	ivan.nagelkerken@adelaide.edu.au	Huijbers, Chantal/J-5176-2014; Nagelkerken, Ivan/E-1093-2011; Kimirei, Ismael Aaron/F-7385-2012	Huijbers, Chantal/0000-0001-5206-3415; Nagelkerken, Ivan/0000-0003-4499-3940; Kimirei, Ismael Aaron/0000-0002-1101-5262; Mgaya, Yunus/0000-0002-9592-4913	WOTRO Science for Global Development (WOTRO); Netherlands Organization for Scientific Research (NWO); NWO; Schure-Beijerinck-Popping Fonds; Western Indian Ocean Marine Science Association (WIOMSA)	WOTRO Science for Global Development (WOTRO); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NWO(Netherlands Organization for Scientific Research (NWO)); Schure-Beijerinck-Popping Fonds; Western Indian Ocean Marine Science Association (WIOMSA)	This study was funded through WOTRO Science for Global Development (WOTRO) by the Netherlands Organization for Scientific Research (NWO). I.N. was funded by a Vidi grant from NWO. The field work was supported by a grant from Schure-Beijerinck-Popping Fonds and Western Indian Ocean Marine Science Association (WIOMSA) to I.A.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AJ, 2006, MAR ECOL PROG SER, V318, P287, DOI 10.3354/meps318287; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; BLABER SJM, 2000, FISH AQUATIC RESOURC, V7; Blaber SJM, 2009, ECOLOGICAL CONNECTIVITY AMONG TROPICAL COASTAL ECOSYSTEMS, P533, DOI 10.1007/978-90-481-2406-0_15; Bouillon S, 2011, TREATISE ON ESTUARINE AND COASTAL SCIENCE, VOL 7: FUNCTIONING OF ECOSYSTEMS AT THE LAND-OCEAN INTERFACE, P143; Campana SE, 1999, MAR ECOL PROG SER, V188, P263, DOI 10.3354/meps188263; Campana SE, 2005, MAR FRESHWATER RES, V56, P485, DOI 10.1071/MF04147; Chittaro PM, 2004, J EXP MAR BIOL ECOL, V308, P169, DOI 10.1016/j.jembe.2004.02.021; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Dorenbosch M, 2004, ENVIRON BIOL FISH, V70, P203, DOI 10.1023/B:EBFI.0000033336.10737.f5; Dorenbosch M, 2007, MAR ECOL PROG SER, V334, P103, DOI 10.3354/meps334103; Dorenbosch M, 2006, HYDROBIOLOGIA, V563, P45, DOI 10.1007/s10750-005-1428-2; Dorenbosch M, 2006, BIOL CONSERV, V129, P277, DOI 10.1016/j.biocon.2005.10.032; Dorenbosch M, 2005, MAR ECOL PROG SER, V302, P63, DOI 10.3354/meps302063; Duke NC, 2007, SCIENCE, V317, P41, DOI 10.1126/science.317.5834.41b; Elsdon TS, 2008, OCEANOGR MAR BIOL, V46, P297, DOI 10.1201/9781420065756.ch7; Faunce CH, 2009, ECOLOGICAL CONNECTIVITY AMONG TROPICAL COASTAL ECOSYSTEMS, P401, DOI 10.1007/978-90-481-2406-0_11; Field A, 2013, DISCOVERING STAT USI; Gillanders BM, 2002, MAR ECOL PROG SER, V240, P215, DOI 10.3354/meps240215; Gillanders BM, 1997, ENVIRON BIOL FISH, V49, P153, DOI 10.1023/A:1007315201690; Gillanders BM, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P503; Gillanders BM, 2009, ECOLOGICAL CONNECTIVITY AMONG TROPICAL COASTAL ECOSYSTEMS, P457, DOI 10.1007/978-90-481-2406-0_13; Carman VG, 2012, J EXP MAR BIOL ECOL, V429, P64, DOI 10.1016/j.jembe.2012.06.007; Huijbers CM, 2013, ECOLOGY, V94, P1859, DOI 10.1890/11-1759.1; Kimirei IA, 2013, ECOSYSTEMS, V16, P783, DOI 10.1007/s10021-013-9645-4; Kimirei IA, 2011, ESTUAR COAST SHELF S, V92, P47, DOI 10.1016/j.ecss.2010.12.016; Kruitwagen G, 2010, ESTUAR COAST SHELF S, V88, P464, DOI 10.1016/j.ecss.2010.05.002; Laroche J, 1997, J FISH BIOL, V51, P3, DOI 10.1111/j.1095-8649.1997.tb02509.x; Lugendo BR, 2006, J FISH BIOL, V69, P1639, DOI 10.1111/j.1095-8649.2006.01231.x; Lugendo BR, 2007, B MAR SCI, V80, P497; Lugendo BR, 2005, AQUAT LIVING RESOUR, V18, P149, DOI 10.1051/alr:2005016; Mateo I, 2010, MAR ECOL PROG SER, V402, P197, DOI 10.3354/meps08445; McMahon KW, 2011, CORAL REEFS, V30, P1135, DOI 10.1007/s00338-011-0816-5; MILLAR RB, 1990, CAN J FISH AQUAT SCI, V47, P2235, DOI 10.1139/f90-248; Mumby PJ, 2008, J APPL ECOL, V45, P854, DOI 10.1111/j.1365-2664.2008.01459.x; Mumby PJ, 2004, NATURE, V427, P533, DOI 10.1038/nature02286; Nagelkerken I, 2008, MAR ECOL PROG SER, V368, P155, DOI 10.3354/meps07528; Nagelkerken I, 2008, AQUAT BOT, V89, P155, DOI 10.1016/j.aquabot.2007.12.007; Nagelkerken I, 2000, MAR ECOL PROG SER, V202, P175, DOI 10.3354/meps202175; Nagelkerken I, 2007, B MAR SCI, V80, P595; Nagelkerken I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036906; Nagelkerken I, 2009, ECOLOGICAL CONNECTIVITY AMONG TROPICAL COASTAL ECOSYSTEMS, P357, DOI 10.1007/978-90-481-2406-0_10; Nakamura Y, 2008, MAR ECOL PROG SER, V355, P257, DOI 10.3354/meps07234; Nakamura Y, 2008, ESTUAR COAST SHELF S, V76, P345, DOI 10.1016/j.ecss.2007.07.014; Nakamura Y, 2012, MAR BIOL, V159, P1305, DOI 10.1007/s00227-012-1911-z; Newton K, 2007, CURR BIOL, V17, P655, DOI 10.1016/j.cub.2007.02.054; Olds AD, 2012, CONSERV LETT, V5, P56, DOI 10.1111/j.1755-263X.2011.00204.x; Sheaves M, 2005, MAR ECOL PROG SER, V302, P293, DOI 10.3354/meps302293; Sheaves M, 2001, MAR ECOL PROG SER, V222, P279, DOI 10.3354/meps222279; Sheaves M, 2009, MAR ECOL PROG SER, V391, P107, DOI 10.3354/meps08121; Sheaves M, 2009, MAR ECOL PROG SER, V385, P245, DOI 10.3354/meps08040; Thollot P, 1992, P 7 INT COR REEF S G, V2, P934; Unsworth RKF, 2008, MAR ECOL PROG SER, V353, P213, DOI 10.3354/meps07199; Unsworth RKF, 2007, J MAR BIOL ASSOC UK, V87, P1287, DOI 10.1017/S002531540705638X; URT, 2009, FISH REG 2009 GNNO 3; Valiela I, 2001, BIOSCIENCE, V51, P807, DOI 10.1641/0006-3568(2001)051[0807:MFOOTW]2.0.CO;2; Verweij MC, 2008, LIMNOL OCEANOGR, V53, P1540, DOI 10.4319/lo.2008.53.4.1540; Verweij MC, 2007, HYDROBIOLOGIA, V592, P257, DOI 10.1007/s10750-007-0772-9; Verweij MC, 2006, MAR BIOL, V149, P1291, DOI 10.1007/s00227-006-0305-5; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Yates PM, 2012, MAR ECOL PROG SER, V458, P269, DOI 10.3354/meps09759	62	60	61	3	115	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66320	10.1371/journal.pone.0066320	http://dx.doi.org/10.1371/journal.pone.0066320			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776658	Green Published, gold, Green Submitted			2022-12-27	WOS:000320322400096
J	Michel, J; Owens, EH; Zengel, S; Graham, A; Nixon, Z; Allard, T; Holton, W; Reimer, PD; Lamarche, A; White, M; Rutherford, N; Childs, C; Mauseth, G; Challenger, G; Taylor, E				Michel, Jacqueline; Owens, Edward H.; Zengel, Scott; Graham, Andrew; Nixon, Zachary; Allard, Teresa; Holton, William; Reimer, P. Doug; Lamarche, Alain; White, Mark; Rutherford, Nicolle; Childs, Carl; Mauseth, Gary; Challenger, Greg; Taylor, Elliott			Extent and Degree of Shoreline Oiling: Deepwater Horizon Oil Spill, Gulf of Mexico, USA	PLOS ONE			English	Article							SALT MARSHES	The oil from the 2010 Deepwater Horizon spill in the Gulf of Mexico was documented by shoreline assessment teams as stranding on 1,773 km of shoreline. Beaches comprised 50.8%, marshes 44.9%, and other shoreline types 4.3% of the oiled shoreline. Shoreline cleanup activities were authorized on 660 km, or 73.3% of oiled beaches and up to 71 km, or 8.9% of oiled marshes and associated habitats. One year after the spill began, oil remained on 847 km; two years later, oil remained on 687 km, though at much lesser degrees of oiling. For example, shorelines characterized as heavily oiled went from a maximum of 360 km, to 22.4 km one year later, and to 6.4 km two years later. Shoreline cleanup has been conducted to meet habitat-specific cleanup endpoints and will continue until all oiled shoreline segments meet endpoints. The entire shoreline cleanup program has been managed under the Shoreline Cleanup Assessment Technique (SCAT) Program, which is a systematic, objective, and inclusive process to collect data on shoreline oiling conditions and support decision making on appropriate cleanup methods and endpoints. It was a particularly valuable and effective process during such a complex spill.	[Michel, Jacqueline; Zengel, Scott; Nixon, Zachary; Holton, William; White, Mark; Rutherford, Nicolle; Childs, Carl] Natl Ocean & Atmospher Adm, Natl Ocean Serv, Off Response & Restorat, Emergency Response Div, Seattle, WA USA; [Michel, Jacqueline; Nixon, Zachary; Holton, William; White, Mark] Res Planning Inc, Columbia, SC USA; [Owens, Edward H.] Owens Coastal Consultants Ltd, Bainbridge Isl, WA USA; [Zengel, Scott] Atkins, Tallahassee, FL USA; [Graham, Andrew; Allard, Teresa; Reimer, P. Doug; Lamarche, Alain; Mauseth, Gary; Challenger, Greg; Taylor, Elliott] Polaris Appl Sci Inc, Kirkland, WA USA; [Reimer, P. Doug] EML, Saanichton, BC, Canada; [Lamarche, Alain] Triox, Montreal, PQ, Canada	National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA	Michel, J (corresponding author), Natl Ocean & Atmospher Adm, Natl Ocean Serv, Off Response & Restorat, Emergency Response Div, Seattle, WA USA.	jmichel@researchplanning.com			BP; NOAA	BP; NOAA(National Oceanic Atmospheric Admin (NOAA) - USA)	This work was conducted under the Deepwater Horizon oil spill Unified Command. Funding was provided by BP, as the Responsible Party. However, the NOAA, RPI, and Atkins authors were funded through NOAA, who is the Scientific Support Coordinator to the US Coast Guard. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, UNIFIED COMMAND SHOR; GUNDLACH ER, 1993, MAR POLLUT BULL, V27, P93, DOI 10.1016/0025-326X(93)90012-9; HAYES MO, 1993, MAR POLLUT BULL, V27, P135, DOI 10.1016/0025-326X(93)90017-E; Lin QX, 2012, ENVIRON SCI TECHNOL, V46, P3737, DOI 10.1021/es203552p; McNutt M., 2011, ASSESSMENT FLOW RATE; McNutt MK, 2012, P NATL ACAD SCI USA, V109, P20260, DOI 10.1073/pnas.1112139108; Michel J, 1999, P 1999 INT OIL SPILL; National Oceanic and Atmospheric Administration, 2000, SHOR ASS MAN; NOAA, 2010, CHAR COAST HAB CHOOS; Operational Science Advisory Team, 2011, REP FED ON SCEN COOR; OWENS E, 1990, PROCEEDINGS OF THE THIRTEENTH ARCTIC AND MARINE OIL SPILL PROGRAM TECHNICAL SEMINAR, P411; Owens E, 2011, P 2011 INT OIL SPILL; Owens E.H., 1991, P 14 ARCT MAR OIL SP, P579; OWENS EH, 2000, SCAT MANUAL FIELD GU; Owens EH, 2008, P 2008 INT OIL SPILL, P1193; Rosati JD, 2009, J COASTAL RES, V25, P8, DOI 10.2112/07-0934.1; Santner R., 2011, P INT OIL SPILL C AM; Silliman BR, 2012, P NATL ACAD SCI USA, V109, P11234, DOI 10.1073/pnas.1204922109; Zengel S, 2012, 2012 INTECOL INT WET; Zengel S., 2013, 42 NOAA OFF RESP RES, V42	20	277	279	1	179	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65087	10.1371/journal.pone.0065087	http://dx.doi.org/10.1371/journal.pone.0065087			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776444	Green Submitted, Green Published, gold			2022-12-27	WOS:000320322400007
J	Soto-Azat, C; Valenzuela-Sanchez, A; Collen, B; Rowcliffe, JM; Veloso, A; Cunningham, AA				Soto-Azat, Claudio; Valenzuela-Sanchez, Andres; Collen, Ben; Rowcliffe, J. Marcus; Veloso, Alberto; Cunningham, Andrew A.			The Population Decline and Extinction of Darwin's Frogs	PLOS ONE			English	Article							BATRACHOCHYTRIUM-DENDROBATIDIS; RHINODERMA-DARWINII; SIGHTING RECORD; XENOPUS-LAEVIS; RAIN-FORESTS; CONSERVATION; DIVERSITY; CHILE; RANGE; AMPHIBIANS	Darwin's frogs (Rhinoderma darwinii and R. rufum) are two species of mouth-brooding frogs from Chile and Argentina. Here, we present evidence on the extent of declines, current distribution and conservation status of Rhinoderma spp.; including information on abundance, habitat and threats to extant Darwin's frog populations. All known archived Rhinoderma specimens were examined in museums in North America, Europe and South America. Extensive surveys were carried out throughout the historical ranges of R. rufum and R. darwinii from 2008 to 2012. Literature review and location data of 2,244 archived specimens were used to develop historical distribution maps for Rhinoderma spp. Based on records of sightings, optimal linear estimation was used to estimate whether R. rufum can be considered extinct. No extant R. rufum was found and our modelling inferred that this species became extinct in 1982 (95% CI, 1980-2000). Rhinoderma darwinii was found in 36 sites. All populations were within native forest and abundance was highest in Chiloe Island, when compared with Coast, Andes and South populations. Estimated population size and density (five populations) averaged 33.2 frogs/population (range, 10.2-56.3) and 14.9 frogs/100 m(2) (range, 5.3-74.1), respectively. Our results provide further evidence that R. rufum is extinct and indicate that R. darwinii has declined to a much greater degree than previously recognised. Although this species can still be found across a large part of its historical range, remaining populations are small and severely fragmented. Conservation efforts for R. darwinii should be stepped up and the species re-classified as Endangered.	[Soto-Azat, Claudio; Valenzuela-Sanchez, Andres] Univ Andres Bello, Fac Ecol & Recursos Nat, Lab Salud Ecosistemas, Santiago, Chile; [Soto-Azat, Claudio; Rowcliffe, J. Marcus; Cunningham, Andrew A.] Zool Soc London, Inst Zool, London NW1 4RY, England; [Collen, Ben] UCL, Ctr Biodivers & Environm Res, London, England; [Veloso, Alberto] Univ Chile, Fac Ciencias, Dept Ciencias Ecol, Las Palmeras, Nunoa, Chile	Universidad Andres Bello; Zoological Society of London; University of London; University College London; Universidad de Chile	Soto-Azat, C (corresponding author), Univ Andres Bello, Fac Ecol & Recursos Nat, Lab Salud Ecosistemas, Republ 252, Santiago, Chile.	csoto@unab.cl	Cunningham, Andrew A/E-7536-2010; Rowcliffe, Marcus/G-3713-2018; Collen, Ben/F-2543-2016; Valenzuela-Sánchez, Andrés/AAG-2762-2019	Rowcliffe, Marcus/0000-0002-4286-6887; Collen, Ben/0000-0003-2564-4243; Valenzuela-Sánchez, Andrés/0000-0002-0445-9156; Azat, Claudio/0000-0001-9201-7886	Institute of Zoology, Zoological Society of London (ZSL); ZSL EDGE Fellowship Programme; Direccion General de Investigacion y Doctorados, Universidad Andres Bello; Field Veterinary Programme; Wildlife Health Fund; Wildlife Conservation Society (WCS); Fundacion Futuro Scholarship; Royal Society Wolfson Research Merit Award	Institute of Zoology, Zoological Society of London (ZSL); ZSL EDGE Fellowship Programme; Direccion General de Investigacion y Doctorados, Universidad Andres Bello; Field Veterinary Programme; Wildlife Health Fund; Wildlife Conservation Society (WCS); Fundacion Futuro Scholarship; Royal Society Wolfson Research Merit Award(Royal Society of London)	This research was funded by the Institute of Zoology, Zoological Society of London (ZSL) and the ZSL EDGE Fellowship Programme; the Direccion General de Investigacion y Doctorados, Universidad Andres Bello; the Field Veterinary Programme, Wildlife Health Fund, Wildlife Conservation Society (WCS); and a Fundacion Futuro Scholarship. AAC is supported by a Royal Society Wolfson Research Merit Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amstrup S, 2005, HANDBOOK OF CAPTURE-RECAPTURE ANALYSIS, P58; Babbitt Kimberly J., 2010, P299; Barros R., 1918, Revista Chilena Santiago, V22, P71; Bell T., 1843, ZOOLOGY VOYAGE HMS B; Bourke J, 2010, DIS AQUAT ORGAN, V92, P217, DOI 10.3354/dao02239; Bourke J, 2012, NORTH-WEST J ZOOL, V8, P99; Bourke J, 2011, J NAT HIST, V45, P2661, DOI 10.1080/00222933.2011.597885; Burger O., 1905, NEOMELIA RHINODERMA; Burgman MA, 2003, ANIM CONSERV, V6, P19, DOI 10.1017/S1367943003003044; Busse K, 2004, CRIA CAUTIVIDAD FAUN, P139; Busse Klaus, 2002, Reptilia (GB), V25, P63; Bustamante RO, 2005, BIOL INVASIONS, V7, P243, DOI 10.1007/s10530-004-0740-5; Butchart S. H. M., 2006, Bulletin of the British Ornithologists' Club, V126, P7; Camus P., 2006, AMBIENTE BOSQUES GES; Carn SA, 2009, T AM GEOPHYS UNION, V90, P205, DOI DOI 10.1029/2009EO240001; CAUGHLEY G, 1994, J ANIM ECOL, V63, P215, DOI 10.2307/5542; CEI J.M., 1962, BATRACIOS CHILE; Chancellor G., 2009, C DARWINS NOTEBOOKS; Collen B, 2010, DIVERS DISTRIB, V16, P755, DOI 10.1111/j.1472-4642.2010.00689.x; Crump Martha L., 2002, Herpetological Natural History, V9, P21; Daszak P, 2003, DIVERS DISTRIB, V9, P141, DOI 10.1046/j.1472-4642.2003.00016.x; Delpino, 2011, ACTIVIDAD COMPLEJO V; Donoso-Barros R, 1970, CHILE, V31, P49; Duffy KJ, 2011, CONSERV BIOL, V25, P392, DOI 10.1111/j.1523-1739.2010.01612.x; Dumeril AMC, 1841, LIBRARIE ENVY RORET, V8; Echeverria C, 2006, BIOL CONSERV, V130, P481, DOI 10.1016/j.biocon.2006.01.017; Eterovick Paula C., 2009, South American Journal of Herpetology, V4, P235, DOI 10.2994/057.004.0306; Formas J.R., 1995, DIVERSIDAD BIOL CHIL, P314; FORMAS R, 1975, Physis Seccion C los Continentes y los Organismos Terrestres, V34, P147; Formas R, 1976, EXPERIENTIA, V32, P1000; Frost DR, 2013, AMPHIBIAN SPECIES WO; GOICOECHEA O, 1986, J HERPETOL, V20, P168, DOI 10.2307/1563941; Hamer AJ, 2010, ANIM CONSERV, V13, P275, DOI 10.1111/j.1469-1795.2009.00335.x; Huang CY, 2004, ZOOL STUD, V43, P795; Iriarte JA, 2005, REV CHIL HIST NAT, V78, P143, DOI 10.4067/S0716-078X2005000100010; Isaac NJB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000296; Jimenez de la Espada DM, 1872, AN SOC HIST NAT MADR, V1, P139; JORQUERA B, 1982, J HERPETOL, V16, P204, DOI 10.2307/1563714; Jorquera B, 1981, MEDIO AMBIENTE, V5, P58; Kuzmin Sergius L., 2010, Russian Journal of Herpetology, V17, P259; Lips KR, 2008, PLOS BIOL, V6, P441, DOI 10.1371/journal.pbio.0060072; Lobos G, 2005, BIODIVERS CONSERV, V14, P429, DOI 10.1007/s10531-004-6403-0; Lockwood J.P., 2010, VOLCANOES GLOBAL PER; Measey GJ, 2012, BIOL INVASIONS, V14, P2255, DOI 10.1007/s10530-012-0227-8; MENDEZ M, 2005, HIST BIODIVERSIDAD E, P441; Ortiz, 1988, COMUNICACIONES MUSEO, V2, P37; PENNA M, 1990, J HERPETOL, V24, P23, DOI 10.2307/1564285; Philippi R.A., 1902, SUPLEMENTO BATRAQUIO; Raffel TR, 2013, NAT CLIM CHANGE, V3, P146, DOI [10.1038/nclimate1659, 10.1038/NCLIMATE1659]; Rageot R, 1978, OBSERVACIONES BIOL R; Richardson David M., 1998, P450; Scribner KT, 2001, BIOL CONSERV, V98, P201, DOI 10.1016/S0006-3207(00)00155-5; Seimon TA, 2007, GLOBAL CHANGE BIOL, V13, P288, DOI 10.1111/j.1365-2486.2006.01278.x; Smith-Ramirez C, 2004, BIODIVERS CONSERV, V13, P373, DOI 10.1023/B:BIOC.0000006505.67560.9f; Solis R, 2010, BIOL INVASIONS, V12, P1641, DOI 10.1007/s10530-009-9577-2; Solow AR, 2005, MATH BIOSCI, V195, P47, DOI 10.1016/j.mbs.2005.02.001; Soto-Azat C, 2010, DIVERS DISTRIB, V16, P126, DOI 10.1111/j.1472-4642.2009.00618.x; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Tabassum F, 2011, ASIAN HERPETOL RES, V2, P245, DOI 10.3724/SP.J.1245.2011.00245; Torres D, 1973, SANTIAGO, V203-204, P7; Ubeda C, 2010, RHINODERMA DARWINII; Valdovinos C., 2005, HIST BIODIVERSIDAD E, P452; Vallan D, 2002, J TROP ECOL, V18, P725, DOI 10.1017/S026646740200247X; Veloso A, 2010, RHINODERMA RUFUM IUC; Voyles J, 2012, ECOL EVOL, V2, P2241, DOI 10.1002/ece3.334; Weldon C, 2004, EMERG INFECT DIS, V10, P2100, DOI 10.3201/eid1012.030804; Werning H, 2009, IRCF REPTILES AMPHIB, V16, P247; Wilhelm O, 1927, B SOC BIOL CONCEPCIO, V1, P11; Young BE, 2001, CONSERV BIOL, V15, P1213, DOI 10.1046/j.1523-1739.2001.00218.x	69	33	36	2	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66957	10.1371/journal.pone.0066957	http://dx.doi.org/10.1371/journal.pone.0066957			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776705	Green Published, Green Submitted, gold			2022-12-27	WOS:000320322400122
J	Suikkanen, S; Pulina, S; Engstrom-Ost, J; Lehtiniemi, M; Lehtinen, S; Brutemark, A				Suikkanen, Sanna; Pulina, Silvia; Engstrom-Ost, Jonna; Lehtiniemi, Maiju; Lehtinen, Sirpa; Brutemark, Andreas			Climate Change and Eutrophication Induced Shifts in Northern Summer Plankton Communities	PLOS ONE			English	Article							LONG-TERM CHANGES; REGIME SHIFTS; BALTIC SEA; PHYTOPLANKTON; DYNAMICS; PHENOLOGY; ECOSYSTEM; TRENDS; BLOOMS; GROWTH	Marine ecosystems are undergoing substantial changes due to human-induced pressures. Analysis of long-term data series is a valuable tool for understanding naturally and anthropogenically induced changes in plankton communities. In the present study, seasonal monitoring data were collected in three sub-basins of the northern Baltic Sea between 1979 and 2011 and statistically analysed for trends and interactions between surface water hydrography, inorganic nutrient concentrations and phyto-and zooplankton community composition. The most conspicuous hydrographic change was a significant increase in late summer surface water temperatures over the study period. In addition, salinity decreased and dissolved inorganic nutrient concentrations increased in some basins. Based on redundancy analysis (RDA), warming was the key environmental factor explaining the observed changes in plankton communities: the general increase in total phytoplankton biomass, Cyanophyceae, Prymnesiophyceae and Chrysophyceae, and decrease in Cryptophyceae throughout the study area, as well as increase in rotifers and decrease in total zooplankton, cladoceran and copepod abundances in some basins. We conclude that the plankton communities in the Baltic Sea have shifted towards a food web structure with smaller sized organisms, leading to decreased energy available for grazing zooplankton and planktivorous fish. The shift is most probably due to complex interactions between warming, eutrophication and increased top-down pressure due to overexploitation of resources, and the resulting trophic cascades.	[Suikkanen, Sanna; Lehtiniemi, Maiju; Lehtinen, Sirpa] Finnish Environm Inst, Ctr Marine Res, Helsinki, Finland; [Pulina, Silvia] Univ Sassari, Dept Sci Nat & Environm Resources, I-07100 Sassari, Italy; [Engstrom-Ost, Jonna; Brutemark, Andreas] Novia Univ Appl Sci, ARONIA Coastal Zone Res Team, Ekenas, Finland; [Engstrom-Ost, Jonna; Brutemark, Andreas] Abo Akad Univ, Ekenas, Finland; [Engstrom-Ost, Jonna; Brutemark, Andreas] Tvarminne Zool Stn, SF-10900 Hango, Finland	Finnish Environment Institute; University of Sassari; Novia University of Applied Sciences; Abo Akademi University	Suikkanen, S (corresponding author), Finnish Environm Inst, Ctr Marine Res, Helsinki, Finland.	sanna.suikkanen@ymparisto.fi	Lehtiniemi, Maiju/AAN-6012-2020; Pulina, Silvia/Q-2684-2017; Engström-Öst, Jonna/C-7373-2008	Pulina, Silvia/0000-0002-4861-4170; Engström-Öst, Jonna/0000-0003-1792-7702; Suikkanen, Sanna/0000-0002-0768-8149; Lehtinen, Sirpa/0000-0001-7784-8497	Finnish Institute of Marine Research; Finnish Environment Institute; Department of Natural Science and Environmental Resources of the University of Sassari; Academy of Finland [259357, 255566]; Walter and Andree de Nottbeck Foundation	Finnish Institute of Marine Research; Finnish Environment Institute; Department of Natural Science and Environmental Resources of the University of Sassari; Academy of Finland(Academy of Finland); Walter and Andree de Nottbeck Foundation	This study was supported by the Finnish Institute of Marine Research, Finnish Environment Institute, Department of Natural Science and Environmental Resources of the University of Sassari, the Academy of Finland (grant numbers 259357 to SS and 255566 to JEO) and Walter and Andree de Nottbeck Foundation (post-doctoral scholarship to AB). The funders had no role in study design and analyses, decision to publish, or in the preparation of the manuscript. The major part of the monitoring data used in the study was collected by personnel of the Finnish Institute of Marine Research and Finnish Environment Institute.	B.A.C.C. Author Team, 2008, ASS CLIM CHANG BALT; Beaugrand G, 2012, MAR ECOL PROG SER, V445, P293, DOI 10.3354/meps09493; Berglund J, 2007, LIMNOL OCEANOGR, V52, P121, DOI 10.4319/lo.2007.52.1.0121; Casini M, 2008, P ROY SOC B-BIOL SCI, V275, P1793, DOI 10.1098/rspb.2007.1752; Chassot E, 2010, ECOL LETT, V13, P495, DOI 10.1111/j.1461-0248.2010.01443.x; Dahl E, 2005, J SEA RES, V54, P15, DOI 10.1016/j.seares.2005.02.004; Dame R, 2000, ESTUARIES, V23, P793, DOI 10.2307/1352999; Daufresne M, 2009, P NATL ACAD SCI USA, V106, P12788, DOI 10.1073/pnas.0902080106; DEBERNARDI R, 1990, HYDROBIOLOGIA, V200, P29, DOI 10.1007/BF02530326; Dippner JW, 2012, J MARINE SYST, V105, P115, DOI 10.1016/j.jmarsys.2012.07.001; Domingues CM, 2008, NATURE, V453, P1090, DOI 10.1038/nature07080; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Engstrom-Ost J, 2011, HARMFUL ALGAE, V10, P530, DOI 10.1016/j.hal.2011.04.002; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Fleming-Lehtinen V, 2008, AMBIO, V37, P86, DOI 10.1579/0044-7447(2008)37[86:LDOINA]2.0.CO;2; FLINKMAN J, 1992, CAN J FISH AQUAT SCI, V49, P73, DOI 10.1139/f92-008; Graham LP, 2004, AMBIO, V33, P235, DOI 10.1639/0044-7447(2004)033[0235:CCEORF]2.0.CO;2; Grasshoff K, 1999, METHODS SEAWATER ANA; Grubisic LM, 2012, MAR ECOL PROG SER, V453, P37, DOI 10.3354/meps09634; Hallegraeff GM, 2010, J PHYCOL, V46, P220, DOI 10.1111/j.1529-8817.2010.00815.x; Hallfors H, 2013, HYDROBIOLOGIA, V707, P109, DOI 10.1007/s10750-012-1414-4; *HELCOM, 1988, BALT SEA ENV P D, V27; HELGOM, 2009, BALT SEA ENV P B, V115B; Hillebrand H, 2010, GLOBAL CHANGE BIOL, V16, P1181, DOI 10.1111/j.1365-2486.2009.02045.x; Intergovernmental Panel on Climate Change, 2022, CLIMATE CHANGE 2022; Johansson N, 1999, MAR BIOL, V135, P209, DOI 10.1007/s002270050618; Klais R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021567; Klaveness D., 1988, P105; Koeller P, 2009, SCIENCE, V324, P791, DOI 10.1126/science.1170987; Koroleff F., 1979, MERI, V7, P1; LEGENDRE L, 1995, OPHELIA, V41, P153, DOI 10.1080/00785236.1995.10422042; LEHMAN JT, 1985, LIMNOL OCEANOGR, V30, P34, DOI 10.4319/lo.1985.30.1.0034; Lekve K, 2006, P ROY SOC B-BIOL SCI, V273, P3047, DOI 10.1098/rspb.2006.3656; Lepparanta M, 2009, SPRINGER-PRAX BOOKS, pXI; Ljunggren L, 2010, ICES J MAR SCI, V67, P1587, DOI 10.1093/icesjms/fsq109; McKnight DM, 2000, J PHYCOL, V36, P852, DOI 10.1046/j.1529-8817.2000.00031.x; Mollmann C, 2008, ICES J MAR SCI, V65, P302, DOI 10.1093/icesjms/fsm197; O'Neil JM, 2012, HARMFUL ALGAE, V14, P313, DOI 10.1016/j.hal.2011.10.027; Ohlberger J, 2011, AM NAT, V177, P211, DOI 10.1086/657925; Ojaveer H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012467; Olenina I., 2006, BALT SEA ENV P, V106; Olli K, 2011, BOREAL ENVIRON RES, V16, P3; Platt T, 2003, NATURE, V423, P398, DOI 10.1038/423398b; R Core Team, 2012, R LANG ENV STAT COMP; Rabalais NN, 2009, ICES J MAR SCI, V66, P1528, DOI 10.1093/icesjms/fsp047; Richardson AJ, 2012, BIOL LETTERS, V8, P907, DOI 10.1098/rsbl.2012.0530; Sopanen S, 2008, MAR ECOL PROG SER, V361, P191, DOI 10.3354/meps07374; Suikkanen S, 2007, ESTUAR COAST SHELF S, V71, P580, DOI 10.1016/j.ecss.2006.09.004; ter Braak CJF, 1994, ECOSCIENCE, V1, P127, DOI 10.1080/11956860.1994.11682237; Uitto A, 1997, J PLANKTON RES, V19, P655, DOI 10.1093/plankt/19.6.655; Utermohl H, 1958, MITT INT VER LIMNOL, V9, P1; Wasmund N, 2003, ICES J MAR SCI, V60, P177, DOI 10.1016/S1054-3139(02)00280-1; Wasmund N, 2011, J MARINE SYST, V87, P145, DOI 10.1016/j.jmarsys.2011.03.010; Winder M, 2012, HYDROBIOLOGIA, V698, P5, DOI 10.1007/s10750-012-1149-2	54	139	144	6	204	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66475	10.1371/journal.pone.0066475	http://dx.doi.org/10.1371/journal.pone.0066475			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776676	Green Published, gold, Green Submitted			2022-12-27	WOS:000320322400104
J	Vasilopoulou, E; Loubiere, LS; Heuer, H; Trajkovic-Arsic, M; Darras, VM; Visser, TJ; Lash, GE; Whitley, GS; McCabe, CJ; Franklyn, JA; Kilby, MD; Chan, SY				Vasilopoulou, Elisavet; Loubiere, Laurence S.; Heuer, Heike; Trajkovic-Arsic, Marija; Darras, Veerle M.; Visser, Theo J.; Lash, Gendie E.; Whitley, Guy S.; McCabe, Christopher J.; Franklyn, Jayne A.; Kilby, Mark D.; Chan, Shiao Y.			Monocarboxylate Transporter 8 Modulates the Viability and Invasive Capacity of Human Placental Cells and Fetoplacental Growth in Mice	PLOS ONE			English	Article							THYROID-HORMONE TRANSPORT; SUBCLINICAL HYPOTHYROIDISM; DEIODINASE ACTIVITY; EXPRESSION; TRIIODOTHYRONINE; PREGNANCY; PROTEIN; 3,5,3'-TRIIODOTHYRONINE; CYTOTROPHOBLASTS; IDENTIFICATION	Monocarboxylate transporter 8 (MCT8) is a well-established thyroid hormone (TH) transporter. In humans, MCT8 mutations result in changes in circulating TH concentrations and X-linked severe global neurodevelopmental delay. MCT8 is expressed in the human placenta throughout gestation, with increased expression in trophoblast cells from growth-restricted pregnancies. We postulate that MCT8 plays an important role in placental development and transplacental TH transport. We investigated the effect of altering MCT8 expression in human trophoblast in vitro and in a Mct8 knockout mouse model. Silencing of endogenous MCT8 reduced T3 uptake into human extravillous trophoblast-like cells (SGHPL-4; 40%, P<0.05) and primary cytotrophoblast (15%, P<0.05). MCT8 over-expression transiently increased T3 uptake (SGHPL-4: 30%, P<0.05; cytotrophoblast: 15%, P<0.05). Silencing MCT8 did not significantly affect SGHPL-4 invasion, but with MCT8 over-expression T3 treatment promoted invasion compared with no T3 (3.3-fold; P<0.05). Furthermore, MCT8 silencing increased cytotrophoblast viability (similar to 20%, P<0.05) and MCT8 over-expression reduced cytotrophoblast viability independently of T3 (similar to 20%, P<0.05). In vivo, Mct8 knockout reduced fetal: placental weight ratios compared with wild-type controls at gestational day 18 (25%, P<0.05) but absolute fetal and placental weights were not significantly different. The volume fraction of the labyrinthine zone of the placenta, which facilitates maternal-fetal exchange, was reduced in Mct8 knockout placentae (10%, P<0.05). However, there was no effect on mouse placental cell proliferation in vivo. We conclude that MCT8 makes a significant contribution to T3 uptake into human trophoblast cells and has a role in modulating human trophoblast cell invasion and viability. In mice, Mct8 knockout has subtle effects upon fetoplacental growth and does not significantly affect placental cell viability probably due to compensatory mechanisms in vivo.	[Vasilopoulou, Elisavet; Loubiere, Laurence S.; McCabe, Christopher J.; Franklyn, Jayne A.; Kilby, Mark D.; Chan, Shiao Y.] Univ Birmingham, Coll Med & Dent Sci, Sch Clin & Expt Med, Birmingham, W Midlands, England; [Heuer, Heike; Trajkovic-Arsic, Marija] Fritz Lipmann Inst, Leibniz Inst Age Res, Jena, Germany; [Darras, Veerle M.] Katholieke Univ, Lab Comparat Endocrinol, Louvain, Belgium; [Visser, Theo J.] Erasmus MC, Rotterdam, Netherlands; [Lash, Gendie E.] Newcastle Univ, Inst Cellular Med, Reprod & Vasc Biol Grp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Whitley, Guy S.] St Georges Univ London, Div Biomed Sci, London, England	University of Birmingham; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); KU Leuven; Erasmus University Rotterdam; Erasmus MC; Newcastle University - UK; St Georges University London	Chan, SY (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Sch Clin & Expt Med, Birmingham, W Midlands, England.	s.chan@bham.ac.uk	Heuer, Heike/AAF-1515-2020; Lash, Gendie/AAI-4116-2021; Whitley, Guy/N-5070-2019; FRCPI, Mark D Kilby MB BS DSc MD FRCOG/AAW-9704-2020; Vasilopoulou, Elisavet/AHB-3024-2022	Whitley, Guy/0000-0002-9670-3004; FRCPI, Mark D Kilby MB BS DSc MD FRCOG/0000-0001-9987-4223; Vasilopoulou, Elisavet/0000-0002-1940-0333; Lash, Gendie/0000-0002-3606-1361; Chan, Shiao-Yng/0000-0002-3530-3023	Medical Research Council [G0501548, G0600285]; British Thyroid Foundation; Action Medical Research - Henry Smith Charity [SP4335]; Wellbeing of Women [RG/1082/09]; Health Foundation [6462/4335]; Clinician Scientist Fellowship; Academy of Medical Sciences (AMS) [AMS-CSF2-Chan] Funding Source: researchfish; Medical Research Council [MR/J001414/1] Funding Source: researchfish; Wellbeing of Women [RG1082] Funding Source: researchfish; MRC [MR/J001414/1, G0501548] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Thyroid Foundation; Action Medical Research - Henry Smith Charity; Wellbeing of Women(Wellbeing of Women (WoW)); Health Foundation; Clinician Scientist Fellowship; Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellbeing of Women(Wellbeing of Women (WoW)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the following grants and fellowships: Medical Research Council (G0501548 to SYC, MDK, JAF, CJM; G0600285 to SYC and MDK), British Thyroid Foundation (to SYC), Action Medical Research - Henry Smith Charity (SP4335 to MDK, SYC, LSL, JAF) and Wellbeing of Women (RG/1082/09 to SYC, MDK, JAF, LSL, GEL). Dr Chan was supported by a Clinician Scientist Fellowship awarded by the Health Foundation (6462/4335). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abalovich M, 2002, THYROID, V12, P63, DOI 10.1089/105072502753451986; Angiolini E, 2006, PLACENTA, V27, pS98, DOI 10.1016/j.placenta.2005.12.008; Barber KJ, 2005, J CLIN ENDOCR METAB, V90, P1655, DOI 10.1210/jc.2004-0785; Cartwright JE, 1999, BRIT J PHARMACOL, V128, P181, DOI 10.1038/sj.bjp.0702757; Casey BM, 2005, OBSTET GYNECOL, V105, P239, DOI 10.1097/01.AOG.0000152345.99421.22; Chan S, 2003, J CLIN ENDOCR METAB, V88, P4488, DOI 10.1210/jc.2003-030228; Chan SY, 2006, J ENDOCRINOL, V189, P465, DOI 10.1677/joe.1.06582; Coan PM, 2008, J PHYSIOL-LONDON, V586, P4567, DOI 10.1113/jphysiol.2008.156133; Coan PM, 2004, BIOL REPROD, V70, P1806, DOI 10.1095/biolreprod.103.024166; Dash PR, 2007, EXP CELL RES, V313, P3421, DOI 10.1016/j.yexcr.2007.05.030; Dumitrescu AM, 2006, ENDOCRINOLOGY, V147, P4036, DOI 10.1210/en.2006-0390; Dumitrescu AM, 2004, AM J HUM GENET, V74, P168, DOI 10.1086/380999; EMERSON CH, 1988, ENDOCRINOLOGY, V122, P809, DOI 10.1210/endo-122-3-809; Fowden AL, 2009, J PHYSIOL-LONDON, V587, P3459, DOI 10.1113/jphysiol.2009.173013; Friesema ECH, 2004, LANCET, V364, P1435, DOI 10.1016/S0140-6736(04)17226-7; Friesema ECH, 2003, J BIOL CHEM, V278, P40128, DOI 10.1074/jbc.M300909200; Friesema ECH, 2001, ENDOCRINOLOGY, V142, P4339, DOI 10.1210/en.142.10.4339; Friesema ECH, 2008, MOL ENDOCRINOL, V22, P1357, DOI 10.1210/me.2007-0112; Friesema ECH, 2006, MOL ENDOCRINOL, V20, P2761, DOI 10.1210/me.2005-0256; Friesema ECH, 2010, MOL CELL ENDOCRINOL, V322, P107, DOI 10.1016/j.mce.2010.01.016; Fujiwara K, 2001, ENDOCRINOLOGY, V142, P2005, DOI 10.1210/en.142.5.2005; Greenwood SL, 1996, J PHYSIOL-LONDON, V492, P629, DOI 10.1113/jphysiol.1996.sp021333; Hamilton GS, 1998, EXP CELL RES, V244, P147, DOI 10.1006/excr.1998.4195; Heuer H, 2009, ENDOCRINOLOGY, V150, P1078, DOI 10.1210/en.2008-1518; James SR, 2009, ENDOCRINOLOGY, V150, P1961, DOI 10.1210/en.2008-1031; Kilby MD, 1998, J CLIN ENDOCR METAB, V83, P2964, DOI 10.1210/jc.83.8.2964; Kilby MD, 2005, PLACENTA, V26, P105, DOI 10.1016/j.placenta.2004.08.004; Kinne A, 2010, J BIOL CHEM, V285, P28054, DOI 10.1074/jbc.M110.129577; Kinne A, 2009, J MOL ENDOCRINOL, V43, P263, DOI 10.1677/JME-09-0043; KLIMAN HJ, 1986, ENDOCRINOLOGY, V118, P1567, DOI 10.1210/endo-118-4-1567; KoopdonkKool JM, 1996, J CLIN ENDOCR METAB, V81, P2154, DOI 10.1210/jc.81.6.2154; LaFranchi SH, 2005, THYROID, V15, P60, DOI 10.1089/thy.2005.15.60; LAFRENIERE RG, 1994, HUM MOL GENET, V3, P1133, DOI 10.1093/hmg/3.7.1133; LAGA EM, 1973, BIOL NEONATE, V23, P231; Laoag-Fernandez JB, 2004, J CLIN ENDOCR METAB, V89, P4069, DOI 10.1210/jc.2003-032208; Lash GE, 2010, PLACENTA, V31, P545, DOI 10.1016/j.placenta.2010.02.020; Loubiere LS, 2012, ENDOCRINOLOGY, V153, P6126, DOI 10.1210/en.2012-1753; Loubiere LS, 2010, PLACENTA, V31, P295, DOI 10.1016/j.placenta.2010.01.013; MATSUO H, 1993, ACTA ENDOCRINOL-COP, V128, P225, DOI 10.1530/acta.0.1280225; Mestman JH, 2004, BEST PRACT RES CL EN, V18, P267, DOI 10.1016/j.beem.2004.03.005; Mortimer RH, 1996, J CLIN ENDOCR METAB, V81, P2247, DOI 10.1210/jc.81.6.2247; Oki N, 2004, J CLIN ENDOCR METAB, V89, P5213, DOI 10.1210/jc.2004-0352; Price NT, 1998, BIOCHEM J, V329, P321; Reyns GE, 2002, COMP BIOCHEM PHYS B, V132, P239, DOI 10.1016/S1096-4959(01)00528-0; Schwartz CE, 2005, AM J HUM GENET, V77, P41, DOI 10.1086/431313; Suzuki S, 2007, TRENDS ENDOCRIN MET, V18, P286, DOI 10.1016/j.tem.2007.07.002; Trajkovic M, 2007, J CLIN INVEST, V117, P627, DOI 10.1172/JCI28253; Trajkovic-Arsic M, 2010, ENDOCRINOLOGY, V151, P802, DOI 10.1210/en.2009-1053; Vasilopoulou E, 2010, J CLIN ENDOCR METAB, V95, P4762, DOI 10.1210/jc.2010-0354; Vie MP, 1997, MOL ENDOCRINOL, V11, P1728, DOI 10.1210/me.11.11.1728; Visser WE, 2011, MOL ENDOCRINOL, V25, P1, DOI 10.1210/me.2010-0095; Wirth EK, 2011, EUR J ENDOCRINOL, V165, P555, DOI 10.1530/EJE-11-0369	52	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65402	10.1371/journal.pone.0065402	http://dx.doi.org/10.1371/journal.pone.0065402			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776477	Green Published, Green Accepted, gold			2022-12-27	WOS:000320322400022
J	Zacharia, J; Mauban, JRH; Raina, H; Fisher, SA; Wier, WG				Zacharia, Joseph; Mauban, Joseph R. H.; Raina, Hema; Fisher, Steven A.; Wier, Withrow G.			High Vascular Tone of Mouse Femoral Arteries In Vivo Is Determined by Sympathetic Nerve Activity Via alpha(1A)- and alpha(1D)-Adrenoceptor Subtypes	PLOS ONE			English	Article							ALPHA-1B ADRENERGIC-RECEPTOR; ALPHA(1)-ADRENOCEPTOR SUBTYPES; SMOOTH-MUSCLE; SELECTIVE ANTAGONIST; RESISTANCE ARTERIES; BLOOD-PRESSURE; MYOGENIC TONE; CONTRACTION; NORADRENALINE; ACTIVATION	Background and purpose: Determining the role of vascular receptors in vivo is difficult and not readily accomplished by systemic application of antagonists or genetic manipulations. Here we used intravital microscopy to measure the contributions of sympathetic receptors, particularly alpha(1)-adrenoceptor subtypes, to contractile activation of femoral artery in vivo. Experimental approach: Diameter and intracellular calcium ([Ca2+](i)) in femoral arteries were determined by intravital fluorescence microscopy in mice expressing a Myosin Light Chain Kinase (MLCK) based calcium-calmodulin biosensor. Pharmacological agents were applied locally to the femoral artery to determine the contributions of vascular receptors to tonic contraction and [Ca2+](i). Key results: In the anesthetized animal, femoral arteries were constricted to a diameter equal to 54% of their passive diameter (i.e. tone=46%). Of this total basal tone, 16% was blocked by RS79948 (0.1 mu M) and thus attributable to alpha(2)-adrenoceptors. A further 46% was blocked by prazosin (0.1 mu M) and thus attributable to alpha(1)-adrenoceptors. Blockade of P-2X and NPY1 receptors with suramin (0.5 mM) and BIBP3226 (1.0 mu M) respectively, reduced tone by a further 22%, leaving 16% of basal tone unaffected at these concentrations of antagonists. Application of RS100329 (alpha(1A)-selective antagonist) and BMY7378 (alpha(1D)-selective) decreased tone by 29% and 26%, respectively, and reduced [Ca2+](i). Chloroethylclonidine (1 mu M preferential for alpha(1B)-) had no effect. Abolition of sympathetic nerve activity (hexamethonium, i. p.) reduced basal tone by 90%. Conclusion and Implications: Tone of mouse femoral arteries in vivo is almost entirely sympathetic in origin. Activation of alpha(1A)- and alpha(1D)-adrenoceptors elevates [Ca2+](i) and accounts for at least 55% of the tone.	[Zacharia, Joseph; Mauban, Joseph R. H.; Raina, Hema; Fisher, Steven A.; Wier, Withrow G.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Zacharia, J (corresponding author), Univ Maryland, Sch Med, Baltimore, MD 21201 USA.	jzach001@umaryland.edu	Wier, Withrow/AAE-2451-2020		National Heart, Lung, and Blood Institute [1RO1 HL091969]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091969] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Heart, Lung, and Blood Institute Grants 1RO1 HL091969 to WGW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARUNLAKSHANA O, 1959, BRIT J PHARM CHEMOTH, V14, P48, DOI 10.1111/j.1476-5381.1959.tb00928.x; Bautista DL, 2006, J CHEM INF MODEL, V46, P334, DOI 10.1021/ci050116k; CAMBRIDGE D, 1977, BRIT J PHARMACOL, V59, pP514; Crassous PA, 2009, BRIT J PHARMACOL, V158, P1344, DOI 10.1111/j.1476-5381.2009.00403.x; Daly CJ, 2002, PHYSIOL GENOMICS, V9, P85, DOI 10.1152/physiolgenomics.00065.2001; Davis MJ, 1999, PHYSIOL REV, V79, P387, DOI 10.1152/physrev.1999.79.2.387; Docherty JR, 2010, CELL MOL LIFE SCI, V67, P405, DOI 10.1007/s00018-009-0174-4; FLAVAHAN NA, 1986, TRENDS PHARMACOL SCI, V7, P347, DOI 10.1016/0165-6147(86)90383-4; Ford APDW, 1997, BRIT J PHARMACOL, V121, P1127, DOI 10.1038/sj.bjp.0701207; FUJIMOTO S, 1994, CAN J PHYSIOL PHARM, V72, P862, DOI 10.1139/y94-122; Geary GG, 1998, AM J PHYSIOL-HEART C, V275, pH292, DOI 10.1152/ajpheart.1998.275.1.H292; GOETZ AS, 1995, EUR J PHARMACOL, V272, pR5, DOI 10.1016/0014-2999(94)00751-R; HAN C, 1987, NATURE, V329, P333, DOI 10.1038/329333a0; Hieble J P, 1996, Prog Drug Res, V47, P81; Hirasawa A, 1997, MOL PHARMACOL, V52, P764, DOI 10.1124/mol.52.5.764; Hosoda C, 2007, AM J PHYSIOL-HEART C, V293, pH514, DOI 10.1152/ajpheart.00626.2006; Huggett RJ, 2004, HYPERTENSION, V44, P847, DOI 10.1161/01.HYP.0000147893.08533.d8; Ibrahim J, 2006, AM J PHYSIOL-HEART C, V290, pH1081, DOI 10.1152/ajpheart.00752.2005; Isotani E, 2004, P NATL ACAD SCI USA, V101, P6279, DOI 10.1073/pnas.0308742101; Jarajapu YPR, 2001, EUR J PHARMACOL, V422, P127, DOI 10.1016/S0014-2999(01)01051-2; Kuroki MT, 2012, AM J PHYSIOL-HEART C, V302, pH763, DOI 10.1152/ajpheart.00930.2011; Lopez-Guerrero J. J., 2005, Autonomic & Autacoid Pharmacology, V25, P101, DOI 10.1111/j.1474-8673.2005.00338.x; Lyssand JS, 2008, J BIOL CHEM, V283, P18792, DOI 10.1074/jbc.M801860200; Marti D, 2005, AM J PHYSIOL-HEART C, V289, pH1923, DOI 10.1152/ajpheart.00288.2005; Mauban JRH, 2013, MICROCIRCULATION, V20, P269, DOI 10.1111/micc.12025; Methven L, 2009, BRIT J PHARMACOL, V158, P1663, DOI 10.1111/j.1476-5381.2009.00462.x; Moore AW, 2010, J PHYSIOL-LONDON, V588, P4261, DOI 10.1113/jphysiol.2010.194993; MULVANY MJ, 1977, CIRC RES, V41, P19, DOI 10.1161/01.RES.41.1.19; MURAMATSU I, 1990, BRIT J PHARMACOL, V101, P662, DOI 10.1111/j.1476-5381.1990.tb14137.x; Muramatsu I, 2008, BRIT J PHARMACOL, V155, P1224, DOI 10.1038/bjp.2008.360; MURAMATSU I, 1990, BRIT J PHARMACOL, V99, P197, DOI 10.1111/j.1476-5381.1990.tb14678.x; Parati G, 2012, EUR HEART J, V33, P1058, DOI 10.1093/eurheartj/ehs041; Piascik MT, 1997, J PHARMACOL EXP THER, V283, P854; Reimann K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025659; Rokosh DG, 2002, P NATL ACAD SCI USA, V99, P9474, DOI 10.1073/pnas.132552699; Rummery NM, 2007, J PHYSIOL-LONDON, V582, P745, DOI 10.1113/jphysiol.2007.134825; SCHILD HO, 1949, BRIT J PHARM CHEMOTH, V4, P277, DOI 10.1111/j.1476-5381.1949.tb00548.x; SCHWINN DA, 1991, MOL PHARMACOL, V40, P619; Stam WB, 1999, BRIT J PHARMACOL, V127, P661, DOI 10.1038/sj.bjp.0702598; Taki N, 2004, BRIT J PHARMACOL, V142, P647, DOI 10.1038/sj.bjp.0705817; Tanoue A, 2002, J CLIN INVEST, V109, P765, DOI 10.1172/JCI200214001; Tarasova O, 2003, ACTA PHYSIOL SCAND, V177, P157, DOI 10.1046/j.1365-201X.2003.01057.x; Townsend SA, 2004, HYPERTENSION, V44, P776, DOI 10.1161/01.HYP.0000145405.01113.0e; Tsurumaki T, 2003, J CARDIOVASC PHARM, V42, pS33, DOI 10.1097/00005344-200312001-00009; Wier WG, 2008, J PHYSIOL-LONDON, V586, P2437, DOI 10.1113/jphysiol.2008.151522; Wier WG, 2009, EXP PHYSIOL, V94, P31, DOI 10.1113/expphysiol.2008.043638; Williams TJ, 1999, BRIT J PHARMACOL, V127, P252, DOI 10.1038/sj.bjp.0702541; Yang M, 1998, J PHARMACOL EXP THER, V286, P841; Zacharia J, 2005, BRIT J PHARMACOL, V146, P942, DOI 10.1038/sj.bjp.0706395; Zacharia J, 2004, BRIT J PHARMACOL, V141, P915, DOI 10.1038/sj.bjp.0705690; Zhang HY, 2007, CIRC RES, V100, P730, DOI 10.1161/01.RES.0000260189.38975.35; Zhang J, 2010, AM J PHYSIOL-HEART C, V299, pH946, DOI 10.1152/ajpheart.00359.2010; Ziani K, 2002, AM J PHYSIOL-HEART C, V282, pH475, DOI 10.1152/ajpheart.00411.2001	53	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65969	10.1371/journal.pone.0065969	http://dx.doi.org/10.1371/journal.pone.0065969			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776582	Green Submitted, Green Published, gold			2022-12-27	WOS:000320322400067
J	Chen, HY; Chou, MX; Wang, XY; Liu, SS; Zhang, FL; Wei, GH				Chen, Hongyan; Chou, Minxia; Wang, Xinye; Liu, Sisi; Zhang, Feilong; Wei, Gehong			Profiling of Differentially Expressed Genes in Roots of Robinia pseudoacacia during Nodule Development Using Suppressive Subtractive Hybridization	PLOS ONE			English	Article							MEDICAGO-TRUNCATULA; TRANSCRIPTION FACTOR; LOTUS-JAPONICUS; ARABIDOPSIS-THALIANA; POTENTIAL REGULATORS; LEAF SENESCENCE; NODULATION; PROTEIN; INFECTION; SYNAPTOTAGMIN	Background: Legume-rhizobium symbiosis is a complex process that is regulated in the host plant cell through gene expression network. Many nodulin genes that are upregulated during different stages of nodulation have been identified in leguminous herbs. However, no nodulin genes in woody legume trees, such as black locust (Robinia pseudoacacia), have yet been reported. Methodology/Principal findings: To identify the nodulin genes involved in R. pseudoacacia-Mesorhizobium amorphae CCNWGS0123 symbiosis, a suppressive subtractive hybridization approach was applied to reveal profiling of differentially expressed genes and two subtracted cDNA libraries each containing 600 clones were constructed. Then, 114 unigenes were identified from forward SSH library by differential screening and the putative functions of these translational products were classified into 13 categories. With a particular interest in regulatory genes, twenty-one upregulated genes encoding potential regulatory proteins were selected based on the result of reverse transcription-polymerase chain reaction (RT-PCR) analysis. They included nine putative transcription genes, eight putative post-translational regulator genes and four membrane protein genes. The expression patterns of these genes were further analyzed by quantitative RT-PCR at different stages of nodule development. Conclusions: The data presented here offer the first insights into the molecular foundation underlying R. pseudoacacia-M. amorphae symbiosis. A number of regulatory genes screened in the present study revealed a high level of regulatory complexity (transcriptional, post-transcriptional, translational and post-translational) that is likely essential to develop symbiosis. In addition, the possible roles of these genes in black locust nodulation are discussed.	[Chen, Hongyan; Chou, Minxia; Wang, Xinye; Liu, Sisi; Zhang, Feilong; Wei, Gehong] Northwest Agr & Forestry Univ, State Key Lab Crop Stress Biol Arid Areas, Coll Life Sci, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Wei, GH (corresponding author), Northwest Agr & Forestry Univ, State Key Lab Crop Stress Biol Arid Areas, Coll Life Sci, Yangling, Shaanxi, Peoples R China.	weigehong@nwsuaf.edu.cn			Special Foundation for Basic Research of Central University of China [QN2009068]; National Science Foundation of China [31125007, 3117225]	Special Foundation for Basic Research of Central University of China; National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by projects from the Special Foundation for Basic Research of Central University of China (QN2009068), and National Science Foundation of China (31125007, 3117225). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson A, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-r24; Blanco FA, 2009, PLANT CELL, V21, P2797, DOI 10.1105/tpc.108.063420; Asamizu E, 2005, MOL PLANT MICROBE IN, V18, P487, DOI 10.1094/MPMI-18-0487; Baima S, 1995, DEVELOPMENT, V121, P4171; Baima S, 2001, PLANT PHYSIOL, V126, P643, DOI 10.1104/pp.126.2.643; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Ben-Naim O, 2006, PLANT J, V46, P462, DOI 10.1111/j.1365-313X.2006.02706.x; BIRNEY E, 1993, NUCLEIC ACIDS RES, V21, P5803, DOI 10.1093/nar/21.25.5803; Bloemberg GV, 2000, MOL PLANT MICROBE IN, V13, P1170, DOI 10.1094/MPMI.2000.13.11.1170; Brechenimacher L, 2008, MOL PLANT MICROBE IN, V21, P631, DOI 10.1094/MPMI-21-5-0631; Capoen W, 2011, P NATL ACAD SCI USA, V108, P14348, DOI 10.1073/pnas.1107912108; Cardenas L, 2000, PLANT PHYSIOL, V123, P443, DOI 10.1104/pp.123.2.443; Catalano CM, 2007, PLANTA, V225, P541, DOI 10.1007/s00425-006-0369-y; CHAPMAN ER, 1995, J BIOL CHEM, V270, P23667, DOI 10.1074/jbc.270.40.23667; Chou MX, 2006, J EXP BOT, V57, P2673, DOI 10.1093/jxb/erl030; Combier JP, 2008, GENE DEV, V22, P1549, DOI 10.1101/gad.461808; Combier JP, 2006, GENE DEV, V20, P3084, DOI 10.1101/gad.402806; Craxton M, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-43; Czarnecka AM, 2006, CELL STRESS CHAPERON, V11, P287, DOI 10.1379/CSC-200.1; de Zelicourt A, 2012, PLANT J, V70, P220, DOI 10.1111/j.1365-313X.2011.04859.x; Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; El Yahyaoui F, 2004, PLANT PHYSIOL, V136, P3159, DOI 10.1104/pp.104.043612; FAHRAEUS G, 1957, J GEN MICROBIOL, V16, P374, DOI 10.1099/00221287-16-2-374; Frugier F, 2000, GENE DEV, V14, P475; Godiard L, 2007, MOL PLANT MICROBE IN, V20, P321, DOI 10.1094/MPMI-20-3-0321; Gronlund M, 2003, PLANT MOL BIOL, V52, P303, DOI 10.1023/A:1023967214199; Guo Y, 2004, PLANT CELL ENVIRON, V27, P521, DOI 10.1111/j.1365-3040.2003.01158.x; Guo YF, 2006, PLANT J, V46, P601, DOI 10.1111/j.1365-313X.2006.02723.x; Hao XL, 2012, J BACTERIOL, V194, P736, DOI 10.1128/JB.06475-11; Huang XW, 2007, APPL MICROBIOL BIOT, V76, P753, DOI 10.1007/s00253-007-1076-8; Jorgensen JE, 1999, PLANT MOL BIOL, V40, P65, DOI 10.1023/A:1026463506376; Kang H, 2011, PLANT PHYSIOL, V155, P1312, DOI 10.1104/pp.110.167965; Kondorosi E, 2005, PLANT PHYSIOL, V137, P1197, DOI 10.1104/pp.105.060004; Lee MY, 2005, PLANT PHYSIOL, V139, P1881, DOI 10.1104/pp.105.067884; Libault M, 2009, PLANT PHYSIOL, V151, P1207, DOI 10.1104/pp.109.144030; Lin LY, 2007, PROTEINS, V67, P505, DOI 10.1002/prot.21270; Lohar DP, 2006, PLANT PHYSIOL, V140, P221, DOI 10.1104/pp.105.070326; Lohar DP, 2005, J EXP BOT, V56, P1643, DOI 10.1093/jxb/eri160; Mai HT, 2006, PLANT CELL PHYSIOL, V47, P829, DOI 10.1093/pcp/pcj054; Mbengue M, 2010, PLANT CELL, V22, P3474, DOI 10.1105/tpc.110.075861; Meschini EP, 2008, MOL PLANT MICROBE IN, V21, P459, DOI 10.1094/MPMI-21-4-0459; Morita K, 2001, EMBO J, V20, P6028, DOI 10.1093/emboj/20.21.6028; Olsen AN, 2005, TRENDS PLANT SCI, V10, P79, DOI 10.1016/j.tplants.2004.12.010; Pandey R, 2002, NUCLEIC ACIDS RES, V30, P5036, DOI 10.1093/nar/gkf660; Park S, 2003, TREE PHYSIOL, V23, P815, DOI 10.1093/treephys/23.12.815; PEROTTO S, 1994, MOL PLANT MICROBE IN, V7, P99, DOI 10.1094/MPMI-7-0099; Schapire AL, 2008, PLANT CELL, V20, P3374, DOI 10.1105/tpc.108.063859; Shaw SL, 2003, PLANT PHYSIOL, V131, P976, DOI 10.1104/pp.005546; Tian L, 2001, P NATL ACAD SCI USA, V98, P200, DOI 10.1073/pnas.011347998; Timmers ACJ, 1999, DEVELOPMENT, V126, P3617; Udvardi MK, 2007, PLANT PHYSIOL, V144, P538, DOI 10.1104/pp.107.098061; van Spronsen PC, 2001, MOL PLANT MICROBE IN, V14, P839, DOI 10.1094/MPMI.2001.14.7.839; Warpeha KM, 2007, PLANT PHYSIOL, V143, P1590, DOI 10.1104/pp.106.089904; Wei GH, 2009, FEMS MICROBIOL ECOL, V68, P320, DOI 10.1111/j.1574-6941.2009.00673.x; Wizemann TM, 1996, P NATL ACAD SCI USA, V93, P7985, DOI 10.1073/pnas.93.15.7985; Wu KQ, 2000, PLANT MOL BIOL, V44, P167, DOI 10.1023/A:1006498413543; Yang XJ, 2003, CURR OPIN GENET DEV, V13, P143, DOI 10.1016/S0959-437X(03)00015-7; Yano K, 2009, PLANT J, V60, P168, DOI 10.1111/j.1365-313X.2009.03943.x; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031	60	11	14	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e63930	10.1371/journal.pone.0063930	http://dx.doi.org/10.1371/journal.pone.0063930			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776436	Green Published, gold			2022-12-27	WOS:000320755400005
J	Gong, GL				Gong, Gaolang			Local Diffusion Homogeneity (LDH): An Inter-Voxel Diffusion MRI Metric for Assessing Inter-Subject White Matter Variability	PLOS ONE			English	Article							TENSOR IMAGING TRACTOGRAPHY; MULTIPLE FIBER ORIENTATIONS; ALZHEIMERS-DISEASE; WATER DIFFUSION; BRAIN; ARCHITECTURE; CONNECTIVITY; RELIABILITY; ANISOTROPY; INTEGRITY	Many diffusion parameters and indices (e.g., fractional anisotropy [FA] and mean diffusivity [MD]) have been derived from diffusion magnetic resonance imaging (MRI) data. These parameters have been extensively applied as imaging markers for localizing white matter (WM) changes under various conditions (e.g., development, degeneration and disease). However, the vast majority of the existing parameters is derived from intra-voxel analyses and represents the diffusion properties solely within the voxel unit. Other types of parameters that characterize inter-voxel relationships have been largely overlooked. In the present study, we propose a novel inter-voxel metric referred to as the local diffusion homogeneity (LDH). This metric quantifies the local coherence of water molecule diffusion in a model-free manner. It can serve as an additional marker for evaluating the WM microstructural properties of the brain. To assess the distinguishing features between LDH and FA/MD, the metrics were systematically compared across space and subjects. As an example, both the LDH and FA/MD metrics were applied to measure age-related WM changes. The results indicate that LDH reveals unique inter-subject variability in specific WM regions (e.g., cerebral peduncle, internal capsule and splenium). Furthermore, there are regions in which measurements of age-related WM alterations with the LDH and FA/MD metrics yield discrepant results. These findings suggest that LDH and FA/MD have different sensitivities to specific WM microstructural properties. Taken together, the present study shows that LDH is complementary to the conventional diffusion-MRI markers and may provide additional insights into inter-subject WM variability. Further studies, however, are needed to uncover the neuronal mechanisms underlying the LDH.	Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China	Beijing Normal University	Gong, GL (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	gaolang.gong@bnu.edu.cn			National Science Foundation of China [31000499, 81271649]; Beijing Nova Program [Z121110002512032]; 973 program [2013CB837300]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Nova Program(Beijing Municipal Science & Technology Commission); 973 program(National Basic Research Program of China)	This work was supported by the National Science Foundation of China (No. 31000499, 81271649), the Beijing Nova Program (No. Z121110002512032), and the 973 program (No. 2013CB837300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Bennett CM, 2010, ANN NY ACAD SCI, V1191, P133, DOI 10.1111/j.1749-6632.2010.05446.x; Bennett IJ, 2010, HUM BRAIN MAPP, V31, P378, DOI 10.1002/hbm.20872; Bihel E, 2011, STROKE, V42, P1412, DOI 10.1161/STROKEAHA.110.596650; Budde MD, 2007, MAGN RESON MED, V57, P688, DOI 10.1002/mrm.21200; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cao QJ, 2006, NEUROREPORT, V17, P1033, DOI 10.1097/01.wnr.0000224769.92454.5d; CICCHETTI DV, 1981, AM J MENT DEF, V86, P127; Cui ZX, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00042; Fields RD, 2008, TRENDS NEUROSCI, V31, P361, DOI 10.1016/j.tins.2008.04.001; Fox RJ, 2008, ARCH NEUROL-CHICAGO, V65, P1179, DOI 10.1001/archneur.65.9.1179; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Golby AJ, 2011, NEUROSURGERY, V68, P496, DOI 10.1227/NEU.0b013e3182061ebb; Gong GL, 2009, J NEUROSCI, V29, P15684, DOI 10.1523/JNEUROSCI.2308-09.2009; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Gong GL, 2005, HUM BRAIN MAPP, V24, P92, DOI 10.1002/hbm.20072; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; Hosey T, 2005, MAGN RESON MED, V54, P1480, DOI 10.1002/mrm.20723; Johansen-Berg H, 2010, CURR OPIN NEUROL; Kendall MG, 1990, RANK CORRELATION MET, Vvii, P260; Kim S, 2008, NMR BIOMED, V21, P208, DOI 10.1002/nbm.1183; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Lebel C, 2011, MAGN RESON MED; Lenglet C, 2009, NEUROIMAGE, V45, pS111, DOI 10.1016/j.neuroimage.2008.10.054; Marenco S, 2007, P NATL ACAD SCI USA, V104, P15117, DOI 10.1073/pnas.0704311104; Michielse S, 2010, NEUROIMAGE, V52, P1190, DOI 10.1016/j.neuroimage.2010.05.019; Pagani E, 2008, NEUROIMAGE, V41, P657, DOI 10.1016/j.neuroimage.2008.03.021; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; Rose SE, 2000, J NEUROL NEUROSUR PS, V69, P528, DOI 10.1136/jnnp.69.4.528; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Van Essen DC, 2012, NEUROIMAGE, V62, P1299, DOI 10.1016/j.neuroimage.2012.01.032; Wedeen VJ, 2012, SCIENCE, V335, P1628, DOI 10.1126/science.1215280; Wedeen VJ, 2005, MAGN RESON MED, V54, P1377, DOI 10.1002/mrm.20642; Wu T, 2009, HUM BRAIN MAPP, V30, P1502, DOI 10.1002/hbm.20622; Xu DR, 2009, MAGN RESON IMAGING, V27, P311, DOI 10.1016/j.mri.2008.07.018; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zhan L, 2010, NEUROIMAGE, V49, P1357, DOI 10.1016/j.neuroimage.2009.09.057	44	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66366	10.1371/journal.pone.0066366	http://dx.doi.org/10.1371/journal.pone.0066366			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776665	gold, Green Published, Green Submitted			2022-12-27	WOS:000320755400141
J	Horn, KC; Eubanks, MD; Siemann, E				Horn, Katherine C.; Eubanks, Micky D.; Siemann, Evan			The Effect of Diet and Opponent Size on Aggressive Interactions Involving Caribbean Crazy Ants (Nylanderia fulva)	PLOS ONE			English	Article							ARGENTINE ANT; ANOPLOLEPIS-GRACILIPES; NESTMATE RECOGNITION; LINEPITHEMA-HUMILE; INVASIVE ANTS; HYMENOPTERA; CONSEQUENCES; FORMICIDAE; RESOURCES; SUCCESS	Biotic interactions are often important in the establishment and spread of invasive species. In particular, competition between introduced and native species can strongly influence the distribution and spread of exotic species and in some cases competition among introduced species can be important. The Caribbean crazy ant, Nylanderia fulva, was recently introduced to the Gulf Coast of Texas, and appears to be spreading inland. It has been hypothesized that competition with the red imported fire ant, Solenopsis invicta, may be an important factor in the spread of crazy ants. We investigated the potential of interspecific competition among these two introduced ants by measuring interspecific aggression between Caribbean crazy ant workers and workers of Solenopsis invicta. Specifically, we examined the effect of body size and diet on individual-level aggressive interactions among crazy ant workers and fire ants. We found that differences in diet did not alter interactions between crazy ant workers from different nests, but carbohydrate level did play an important role in antagonistic interactions with fire ants: crazy ants on low sugar diets were more aggressive and less likely to be killed in aggressive encounters with fire ants. We found that large fire ants engaged in fewer fights with crazy ants than small fire ants, but fire ant size affected neither fire ant nor crazy ant mortality. Overall, crazy ants experienced higher mortality than fire ants after aggressive encounters. Our findings suggest that fire ant workers might outcompete crazy ant workers on an individual level, providing some biotic resistance to crazy ant range expansion. However, this resistance may be overcome by crazy ants that have a restricted sugar intake, which may occur when crazy ants are excluded from resources by fire ants.	[Horn, Katherine C.; Siemann, Evan] Rice Univ, Dept Ecol & Evolutionary Biol, Houston, TX 77251 USA; [Eubanks, Micky D.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA	Rice University; Texas A&M University System; Texas A&M University College Station	Siemann, E (corresponding author), Rice Univ, Dept Ecol & Evolutionary Biol, Houston, TX 77251 USA.	siemann@rice.edu			Wray-Todd Fellowship;  [NSF-DEB-0315796]	Wray-Todd Fellowship; 	Financial support was provided by a Wray-Todd Fellowship to KH and NSF-DEB-0315796 to ES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLOWAY TM, 1991, INSECT SOC, V38, P189, DOI 10.1007/BF01240968; ANDERSEN AN, 1994, OECOLOGIA, V98, P15, DOI 10.1007/BF00326085; Buczkowski G, 2006, ANIM BEHAV, V71, P327, DOI 10.1016/j.anbehav.2005.04.012; BUREN WF, 1974, J NEW YORK ENTOMOL S, V82, P113; Corin SE, 2007, INSECT SOC, V54, P275, DOI 10.1007/s00040-007-0942-9; Drescher J, 2011, BIOTROPICA, V43, P93, DOI 10.1111/j.1744-7429.2010.00662.x; Gotzek D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045314; Gotzek D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007713; Grover CD, 2007, P ROY SOC B-BIOL SCI, V274, P2951, DOI 10.1098/rspb.2007.1065; Helms KR, 2008, ENVIRON ENTOMOL, V37, P487, DOI 10.1603/0046-225X(2008)37[487:PRACGI]2.0.CO;2; Holldobler B., 1990, pi; Holway DA, 2002, ANNU REV ECOL SYST, V33, P181, DOI 10.1146/annurev.ecolsys.33.010802.150444; Kaspari M, 1999, FUNCT ECOL, V13, P530, DOI 10.1046/j.1365-2435.1999.00343.x; Liang D, 2001, COMP BIOCHEM PHYS B, V129, P871, DOI 10.1016/S1096-4959(01)00404-3; Lim SP, 2003, SOCIOBIOLOGY, V41, P295; Lowe S., 2004, 100 WORLDS WORST INV; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Menke SB, 2007, ECOLOGY, V88, P3164, DOI 10.1890/07-0122.1; Meyers JM, 2008, THESIS TX A M U COLL; Mitchell CE, 2003, NATURE, V421, P625, DOI 10.1038/nature01317; Ness JH, 2004, BIOL INVASIONS, V6, P445, DOI 10.1023/B:BINV.0000041556.88920.dd; Pimentel D, 2000, BIOSCIENCE, V50, P53, DOI 10.1641/0006-3568(2000)050[0053:EAECON]2.3.CO;2; Ricklefs R.E., 2001, EC NATURE; Roulston TH, 2003, INSECT SOC, V50, P151, DOI 10.1007/s00040-003-0624-1; Savage AM, 2011, AUSTRAL ECOL, V36, P310, DOI 10.1111/j.1442-9993.2010.02152.x; SAVOLAINEN R, 1988, OIKOS, V51, P135, DOI 10.2307/3565636; Silverman J, 2001, NATURWISSENSCHAFTEN, V88, P73, DOI 10.1007/s001140000198; Sorvari J, 2008, BEHAV ECOL, V19, P441, DOI 10.1093/beheco/arm160; Suarez Andrew V., 1999, Biological Invasions, V1, P43, DOI 10.1023/A:1010038413690; Torchin ME, 2004, FRONT ECOL ENVIRON, V2, P183, DOI 10.1890/1540-9295(2004)002[0183:PPAIBP]2.0.CO;2; TRAGER JC, 1984, SOCIOBIOLOGY, V9, P51; Walters AC, 2005, AUSTRAL ECOL, V30, P395, DOI 10.1111/j.1442-9993.2005.01481.x; Williams DF, 1994, EXOTIC ANTS BIOL IMP; Wundrow EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048444; Zhao LM, 2012, ENVIRON ENTOMOL, V41, P1008, DOI 10.1603/EN11287	35	9	9	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66912	10.1371/journal.pone.0066912	http://dx.doi.org/10.1371/journal.pone.0066912			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776702	Green Published, gold			2022-12-27	WOS:000320755400157
J	Huang, JD; Zheng, R; Emery, S				Huang, Jidong; Zheng, Rong; Emery, Sherry			Assessing the Impact of the National Smoking Ban in Indoor Public Places in China: Evidence from Quit Smoking Related Online Searches	PLOS ONE			English	Article							NICOTINE DELIVERY-SYSTEMS; DISEASE; HEALTH; MORTALITY; IMPLEMENTATION; PATTERNS; TRENDS	Background: Despite the tremendous economic and health costs imposed on China by tobacco use, China lacks a proactive and systematic tobacco control surveillance and evaluation system, hampering research progress on tobacco-focused surveillance and evaluation studies. Methods: This paper uses online search query analyses to investigate changes in online search behavior among Chinese Internet users in response to the adoption of the national indoor public place smoking ban. Baidu Index and Google Trends were used to examine the volume of search queries containing three key search terms "Smoking Ban and "Electronic Cigarette(s)," along with the news coverage on the smoking ban, for the period 2009-2011. Findings: Our results show that announcement and adoption of the indoor public place smoking ban in China generated significant increases in news coverage on smoking bans. There was a strong positive correlation between the media coverage of smoking bans and the volume of "Smoking Ban(s)," "Quit Smoking," related search queries. The volume of search queries related to "Electronic Cigarette(s)" was also correlated with the smoking ban news coverage. Interpretation: To the extent is altered smoking-related online searches, our analyses suggest that the smoking ban had a significant effect, at least in the short run, on Chinese Internet users' smoking-related behaviors. This research introduces a novel analytic tool, which could serve as an alternative tobacco control evaluation and behavior surveillance tool in the absence of timely or comprehensive population surveillance system. This research also highlights the importance of a comprehensive approach to tobacco control in China.	[Huang, Jidong; Emery, Sherry] Univ Illinois, Inst Hlth Res & Policy, Chicago, IL 60607 USA; [Zheng, Rong] Univ Int Business & Econ, Sch Int Trade & Econ, Beijing, Peoples R China	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of International Business & Economics	Huang, JD (corresponding author), Univ Illinois, Inst Hlth Res & Policy, Chicago, IL 60607 USA.	jhuang12@uic.edu		Huang, Jidong/0000-0002-3425-9155	National Cancer Institute [1U01CA154254]; NATIONAL CANCER INSTITUTE [U01CA154254] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Support for this project was provided in part by a National Cancer Institute-funded grant (Grant No. 1U01CA154254), titled "Tobacco Control in a Rapidly Changing Media Environment" (Principal investigator: Dr Sherry Emery). No additional external funding received for this study. The National Cancer Institute did not play any role in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. The opinions expressed here are those of the authors, and do not necessarily reflect those of the sponsors.	Brownstein JS, 2009, NEW ENGL J MED, V360, P2153, DOI 10.1056/NEJMp0904012; CDC, 2010, GLOB TOB CONTR SURV; Chan EH, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001206; China Internet Network Information Center, 2011, CHIN SEARCH ENG MARK; China Internet Network Information Center, 2012, STAT REP CHIN INT DE; China Internet Network Information Center, 2010, CHIN SEARCH ENG MARK; China Ministry of Health, 2011, MIN HLTH IMPL RUL RE; Chunara R, 2012, AM J TROP MED HYG, V86, P39, DOI 10.4269/ajtmh.2012.11-0597; Cobb NK, 2010, AM J PUBLIC HEALTH, V100, P2340, DOI 10.2105/AJPH.2010.199281; DOLL R, 1976, BRIT MED J, V2, P1525, DOI 10.1136/bmj.2.6051.1525; Dugas AF, 2012, CLIN INFECT DIS, V54, P463, DOI 10.1093/cid/cir883; Etter JF, 2011, TOB CONTROL, V20, P243, DOI 10.1136/tc.2010.042168; Eysenbach Gunther, 2006, AMIA Annu Symp Proc, P244; Ezzati M, 2003, LANCET, V362, P847, DOI 10.1016/S0140-6736(03)14338-3; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Giovino GA, 2012, LANCET, V380, P668, DOI 10.1016/S0140-6736(12)61085-X; Gu DF, 2009, NEW ENGL J MED, V360, P150, DOI 10.1056/NEJMsa0802902; Henningfield JE, 2010, TOB CONTROL, V19, P89, DOI 10.1136/tc.2009.035279; Hulth A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004378; National Cancer Institute, 1994, TOB CLIN INT MED DEN; Polgreen PM, 2008, CLIN INFECT DIS, V47, P1443, DOI 10.1086/593098; qq.com, 2010, CHIN WILL BAN SMOK P; Reis BY, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-514; Seifter A, 2010, GEOSPATIAL HEALTH, V4, P135, DOI 10.4081/gh.2010.195; Stead LF, 2008, COCHRANE DATABASE SY; Wakefield MA, 2010, LANCET, V376, P1261, DOI 10.1016/S0140-6736(10)60809-4; Wan X, 2012, TOB CONTROL, V21, P412, DOI 10.1136/tc.2010.041327; WHO, WHO MPOWER; Wilson K, 2009, CAN MED ASSOC J, V180, P829, DOI [10.1503/cmaj.090215, 10.1503/cmaj.1090215]; World Health Organization, 2019, WHO REPORT GLOBAL TO; Yang GH, 2010, BIOMED ENVIRON SCI, V23, P422, DOI 10.1016/S0895-3988(11)60002-0; Yang L, 2011, TOB CONTROL, V20, P266, DOI 10.1136/tc.2010.042028; Zhou XC, 2010, J ZHEJIANG U-SCI C, V11, P241, DOI 10.1631/jzus.C0910371	33	15	16	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65577	10.1371/journal.pone.0065577	http://dx.doi.org/10.1371/journal.pone.0065577			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776504	gold, Green Published, Green Submitted			2022-12-27	WOS:000320755400044
J	Park, CR; Moon, MJ; Park, S; Kim, DK; Cho, EB; Millar, RP; Hwang, JI; Seong, JY				Park, Cho Rong; Moon, Mi Jin; Park, Sumi; Kim, Dong-Kyu; Cho, Eun Bee; Millar, Robert Peter; Hwang, Jong-Ik; Seong, Jae Young			A Novel Glucagon-Related Peptide (GCRP) and Its Receptor GCRPR Account for Coevolution of Their Family Members in Vertebrates	PLOS ONE			English	Article							DIFFERENTIAL LIGAND SELECTIVITY; GONADOTROPIN-RELEASING-HORMONE; GASTRIC-INHIBITORY POLYPEPTIDE; MOLECULAR COEVOLUTION; EXTRACELLULAR LOOP-3; CRYSTAL-STRUCTURE; GENE-EXPRESSION; GNRH RECEPTORS; BINDING-SITE; GLP-1	The glucagon (GCG) peptide family consists of GCG, glucagon-like peptide 1 (GLP1), and GLP2, which are derived from a common GCG precursor, and the glucose-dependent insulinotropic polypeptide (GIP). These peptides interact with cognate receptors, GCGR, GLP1R, GLP2R, and GIPR, which belong to the secretin-like G protein-coupled receptor (GPCR) family. We used bioinformatics to identify genes encoding a novel GCG-related peptide (GCRP) and its cognate receptor, GCRPR. The GCRP and GCRPR genes were found in representative tetrapod taxa such as anole lizard, chicken, and Xenopus, and in teleosts including medaka, fugu, tetraodon, and stickleback. However, they were not present in mammals and zebrafish. Phylogenetic and genome synteny analyses showed that GCRP emerged through two rounds of whole genome duplication (2R) during early vertebrate evolution. GCRPR appears to have arisen by local tandem gene duplications from a common ancestor of GCRPR, GCGR, and GLP2R after 2R. Biochemical ligand-receptor interaction analyses revealed that GCRP had the highest affinity for GCRPR in comparison to other GCGR family members. Stimulation of chicken, Xenopus, and medaka GCRPRs activated Gas-mediated signaling. In contrast to chicken and Xenopus GCRPRs, medaka GCRPR also induced G alpha(q/11)mediated signaling. Chimeric peptides and receptors showed that the K-16 M-17 K-18 and G(16) Q(17) A(18) motifs in GCRP and GLP1, respectively, may at least in part contribute to specific recognition of their cognate receptors through interaction with the receptor core domain. In conclusion, we present novel data demonstrating that GCRP and GCRPR evolved through gene/genome duplications followed by specific modifications that conferred selective recognition to this ligand-receptor pair.	[Park, Cho Rong; Moon, Mi Jin; Park, Sumi; Kim, Dong-Kyu; Cho, Eun Bee; Hwang, Jong-Ik; Seong, Jae Young] Korea Univ, Grad Sch Med, Lab G Prot Coupled Receptors, Seoul, South Korea; [Millar, Robert Peter] Univ Pretoria, Dept Zool & Entomol, Mammal Res Inst, Hatfield, South Africa; [Millar, Robert Peter] Univ Cape Town, MRC, Receptor Biol Unit, ZA-7925 Observatory, South Africa; [Millar, Robert Peter] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland	Korea University; Korea University Medicine (KU Medicine); University of Pretoria; University of Cape Town; University of Edinburgh	Hwang, JI (corresponding author), Korea Univ, Grad Sch Med, Lab G Prot Coupled Receptors, Seoul, South Korea.	hjibio@korea.ac.kr; jyseong@korea.ac.kr	Seong, Jae Young/A-5794-2012	Seong, Jae Young/0000-0002-3312-6924; Hwang, Jong-Ik/0000-0002-0729-1782; Millar, Robert P/0000-0003-3606-2708	National Research Foundation of Korea [2011-0019205, 2010-0022054, 2012K1A3A1A09033014]; National Research Foundation of South Africa	National Research Foundation of Korea(National Research Foundation of Korea); National Research Foundation of South Africa(National Research Foundation - South Africa)	This work was supported by grants from the Brain Research Program (2011-0019205), Basic Research Program (2010-0022054) and Korea-South Africa Collaboration Program (2012K1A3A1A09033014) of the National Research Foundation of Korea and the National Research Foundation of South Africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharjee S, 2004, J BIOL CHEM, V279, P54445, DOI 10.1074/jbc.M408909200; ADELHORST K, 1994, J BIOL CHEM, V269, P6275; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Bode HP, 1999, ENDOCRINOLOGY, V140, P3919, DOI 10.1210/en.140.9.3919; Castro M, 2005, P NATL ACAD SCI USA, V102, P16084, DOI 10.1073/pnas.0503942102; Chen QA, 2010, J BIOL CHEM, V285, P24508, DOI 10.1074/jbc.M110.135749; Chen Q, 2009, J BIOL CHEM, V284, P34135, DOI 10.1074/jbc.M109.038109; de Maturana RL, 2004, PROTEIN PEPTIDE LETT, V11, P15, DOI 10.2174/0929866043478491; de Maturana RL, 2002, FEBS LETT, V530, P244, DOI 10.1016/S0014-5793(02)03492-0; Drucker DJ, 2003, MOL ENDOCRINOL, V17, P161, DOI 10.1210/me.2002-0306; DRUCKER DJ, 1987, P NATL ACAD SCI USA, V84, P3434, DOI 10.1073/pnas.84.10.3434; Drucker DJ, 1996, P NATL ACAD SCI USA, V93, P7911, DOI 10.1073/pnas.93.15.7911; During MJ, 2003, NAT MED, V9, P1173, DOI 10.1038/nm919; FEHMANN HC, 1995, PANCREAS, V11, P196, DOI 10.1097/00006676-199508000-00014; GALLWITZ B, 1994, EUR J BIOCHEM, V225, P1151, DOI 10.1111/j.1432-1033.1994.1151b.x; Gallwitz B, 1996, REGUL PEPTIDES, V63, P17, DOI 10.1016/0167-0115(96)00019-5; Gault VA, 2007, DIABETOLOGIA, V50, P1752, DOI 10.1007/s00125-007-0710-4; GOKE R, 1993, J BIOL CHEM, V268, P19650; Grace CRR, 2004, P NATL ACAD SCI USA, V101, P12836, DOI 10.1073/pnas.0404702101; Harmar AJ, 2012, BRIT J PHARMACOL, V166, P4, DOI 10.1111/j.1476-5381.2012.01871.x; Harmar AJ, 2001, GENOME BIOL, V2; Hisadome K, 2010, DIABETES, V59, P1890, DOI 10.2337/db10-0128; Hwang JI, 2013, MOL BIOL EVOL, V30, P1119, DOI 10.1093/molbev/mst031; Irwin DM, 2011, DIABETES OBES METAB, V13, P69, DOI 10.1111/j.1463-1326.2011.01444.x; Irwin DM, 2001, REGUL PEPTIDES, V98, P1, DOI 10.1016/S0167-0115(00)00232-9; Kang GX, 2001, J PHYSIOL-LONDON, V536, P375, DOI 10.1111/j.1469-7793.2001.0375c.xd; Kieffer TJ, 1999, ENDOCR REV, V20, P876, DOI 10.1210/er.20.6.876; Kim DK, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00003; Kim DK, 2011, GEN COMP ENDOCR, V170, P68, DOI 10.1016/j.ygcen.2010.10.018; Kimple AJ, 2009, J BIOL CHEM, V284, P19402, DOI 10.1074/jbc.M109.024711; Lee YR, 2009, ENDOCRINOLOGY, V150, P2837, DOI 10.1210/en.2008-1679; Li JH, 2005, MOL PHARMACOL, V67, P1099, DOI 10.1124/mol.104.004887; Lin F, 2009, J MOL MODEL, V15, P53, DOI 10.1007/s00894-008-0372-2; Lovshin J, 2001, J BIOL CHEM, V276, P21489, DOI 10.1074/jbc.M009382200; Mayo KE, 2003, PHARMACOL REV, V55, P167, DOI 10.1124/pr.55.1.6; MOJSOV S, 1986, J BIOL CHEM, V261, P1880; Moon Mi Jin, 2012, Front Endocrinol (Lausanne), V3, P141, DOI 10.3389/fendo.2012.00141; Moon MJ, 2012, J BIOL CHEM, V287, P3873, DOI 10.1074/jbc.M111.276808; Moon MJ, 2011, MOL CELLS, V32, P389, DOI 10.1007/s10059-011-0157-9; Moon MJ, 2010, MOL CELLS, V30, P149, DOI 10.1007/s10059-010-0100-5; Nauck MA, 2002, J CLIN ENDOCR METAB, V87, P1239, DOI 10.1210/jc.87.3.1239; NAUCK MA, 1993, J CLIN ENDOCR METAB, V76, P912, DOI 10.1210/jcem.76.4.8473405; Oh DY, 2008, J BIOL CHEM, V283, P21054, DOI 10.1074/jbc.M708908200; Oh DY, 2005, MOL ENDOCRINOL, V19, P722, DOI 10.1210/me.2004-0220; Parthier C, 2007, P NATL ACAD SCI USA, V104, P13942, DOI 10.1073/pnas.0706404104; Perry T, 2007, EXP NEUROL, V203, P293, DOI 10.1016/j.expneurol.2006.09.028; Roch GJ, 2009, GEN COMP ENDOCR, V161, P3, DOI 10.1016/j.ygcen.2008.10.017; Runge S, 2003, BRIT J PHARMACOL, V138, P787, DOI 10.1038/sj.bjp.0705120; Runge S, 2008, J BIOL CHEM, V283, P11340, DOI 10.1074/jbc.M708740200; Tang-Christensen M, 2000, NAT MED, V6, P802, DOI 10.1038/77535; Um HN, 2010, ANN NY ACAD SCI, V1200, P67, DOI 10.1111/j.1749-6632.2010.05508.x; Underwood CR, 2010, J BIOL CHEM, V285, P723, DOI 10.1074/jbc.M109.033829; Vrang N, 2007, BRAIN RES, V1149, P118, DOI 10.1016/j.brainres.2007.02.043; Wang CB, 2004, MOL ENDOCRINOL, V18, P105, DOI 10.1210/me.2003-0101; Xiao Q, 2000, J MOL ENDOCRINOL, V25, P321, DOI 10.1677/jme.0.0250321; Yegorov S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032923; Zander M, 2002, LANCET, V359, P824, DOI 10.1016/S0140-6736(02)07952-7	57	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65420	10.1371/journal.pone.0065420	http://dx.doi.org/10.1371/journal.pone.0065420			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776481	Green Published, gold, Green Submitted			2022-12-27	WOS:000320755400030
J	Reveron, I; Rodriguez, H; Campos, G; Curiel, JA; Ascaso, C; Carrascosa, AV; Prieto, A; de Las Rivas, B; Munoz, R; de Felipe, FL				Reveron, Ines; Rodriguez, Hector; Campos, Gema; Curiel, Jose Antonio; Ascaso, Carmen; Carrascosa, Alfonso V.; Prieto, Alicia; de las Rivas, Blanca; Munoz, Rosario; de Felipe, Felix Lopez			Tannic Acid-Dependent Modulation of Selected Lactobacillus plantarum Traits Linked to Gastrointestinal Survival	PLOS ONE			English	Article							INTESTINAL-TRACT; HUMAN ISOLATE; IDENTIFICATION; EXPRESSION; IMPACT; GROWTH; GENES	Background: Owing to its antimicrobial properties dietary tannins may alter the functional efficacy of probiotic lactobacilli in the gastrointestinal (GI)-tract influencing their growth, viability and molecular adaptation to the intestinal environment. Methods and Findings: The effects of tannic acid on Lactobacillus plantarum WCFS1 were studied by in vitro growth monitoring and visualizing the morphological alteration on the cell wall using transmission electron microscopy. Growth upon tannic acid was characterized by dose-dependent reductions of initial viable counts and extended lag phases. Lag phase-cells growing upon 0.5 mM tannic acid were abnormally shaped and experienced disturbance on the cell wall such as roughness, occasional leakage and release of cell debris, but resumed growth later at tannic acid concentrations high as 2.5 mM. To gain insight on how the response to tannic acid influenced the molecular adaptation of L. plantarum to the GI-tract conditions, gene expression of selected biomarkers for GI-survival was assessed by RT-qPCR on cDNA templates synthetized from mRNA samples obtained from cells treated with 0.5 or 2 mM tannic acid. Tannic acid-dependent gene induction was confirmed for selected genes highly expressed in the gut or with confirmed roles in GI-survival. No differential expression was observed for the pbp2A gene, a biomarker negatively related with GI-survival. However PBP2A was not labeled by Bocillin FL, a fluorescent dye-labeled penicillin V derivative, in the presence of tannic acid which suggests for enhanced GI-survival reportedly associated with the inactivation of this function. Conclusions: Probiotic L. plantarum WCFS1 is able to overcome the toxic effects of tannic acid. This dietary constituent modulates molecular traits linked to the adaptation to intestinal environment in ways previously shown to enhance GI-survival.	[Reveron, Ines; Rodriguez, Hector; Campos, Gema; Curiel, Jose Antonio; de las Rivas, Blanca; Munoz, Rosario; de Felipe, Felix Lopez] CSIC, ICTAN, Lab Biotecnol Bacteriana, Madrid, Spain; [Ascaso, Carmen] CSIC, MNCN, Dpto Biol Ambiental, Madrid, Spain; [Carrascosa, Alfonso V.] CSIC, Inst Invest & Ciencias Alimentac, Grp Microbiol & Biocatalisis Alimentos, CIAL, Madrid, Spain; [Prieto, Alicia] CSIC, Ctr Invest Biol, Dpto Biol Medioambiental, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencia y Tecnologia de Alimentos y Nutricion (ICTAN); Consejo Superior de Investigaciones Cientificas (CSIC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UAM - Instituto de Investigacion en Ciencias de la Alimentacion (CIAL); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	de Felipe, FL (corresponding author), CSIC, ICTAN, Lab Biotecnol Bacteriana, Madrid, Spain.	fxlopez@ictan.csic.es	de Felipe Toledano, Felix López/ABF-5849-2021; Muñoz, Rosario/H-8597-2012; de las Rivas, Blanca/K-3899-2014; Rodríguez, Héctor/E-6887-2013; J.A., Curiel/H-8831-2015; Ascaso, Carmen/F-5369-2011; Prieto, Alicia/M-7899-2017	de Felipe Toledano, Felix López/0000-0001-5661-8115; Muñoz, Rosario/0000-0003-4170-9713; de las Rivas, Blanca/0000-0002-8357-5226; Rodríguez, Héctor/0000-0002-9948-2497; J.A., Curiel/0000-0002-0111-1437; Ascaso, Carmen/0000-0001-9665-193X; Prieto, Alicia/0000-0002-5075-4025	CICYT grant [AGL2008-001052, AGL2011-22745]; I3P (CSIC); FPI (MICINN); Consolider INGENIO [CSD2007-00063 FUN-C-FOOD]; CAM grant (ALIBIRD) [S2009/AGR-1469]; MINECO grant [CTM2012-38222-C02-02]	CICYT grant(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); I3P (CSIC); FPI (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consolider INGENIO(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CAM grant (ALIBIRD); MINECO grant(Spanish Government)	H. Rodriguez and J. A. Curiel acknowledge I3P (CSIC) or FPI (MICINN) PhD grants, respectively. The authors gratefully acknowledge the partial financial support of the CICYT grants AGL2008-001052, AGL2011-22745, Consolider INGENIO 2010 CSD2007-00063 FUN-C-FOOD, the CAM grant S2009/AGR-1469 (ALIBIRD) and the MINECO grant CTM2012-38222-C02-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Curiel JA, 2011, MOL NUTR FOOD RES, V55, P1454, DOI 10.1002/mnfr.201000621; Blanco AR, 2005, ANTIMICROB AGENTS CH, V49, P4339, DOI 10.1128/AAC.49.10.4339-4343.2005; Bossi A, 2007, J APPL MICROBIOL, V102, P787, DOI 10.1111/j.1365-2672.2006.03118.x; Bron PA, 2007, J APPL MICROBIOL, V103, P1424, DOI 10.1111/j.1365-2672.2007.03376.x; Bron PA, 2004, J BACTERIOL, V186, P5721, DOI 10.1128/JB.186.17.5721-5729.2004; Bron PA, 2004, J BACTERIOL, V186, P7829, DOI 10.1128/JB.186.23.7829-7835.2004; Cecconi D, 2009, ELECTROPHORESIS, V30, P957, DOI 10.1002/elps.200800310; Chung KT, 1998, FOOD CHEM TOXICOL, V36, P1053, DOI 10.1016/S0278-6915(98)00086-6; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; de los Rios Asuncion, 2002, P87; DE MAN J. C., 1960, JOUR APPL BACT, V23, P130, DOI 10.1111/j.1365-2672.1960.tb00188.x; de Vries M. C, 2006, THESIS WAGENINGEN U; De Vuyst L, 1999, FEMS MICROBIOL REV, V23, P153, DOI 10.1016/S0168-6445(98)00042-4; Dolara P, 2005, MUTAT RES-FUND MOL M, V591, P237, DOI 10.1016/j.mrfmmm.2005.04.022; Groenewald W. H., 2006, SOUTH AFRICAN JOURNAL OF ENOLOGY AND VITICULTURE, V27, P46; Hakenbeck R, 1999, MOL MICROBIOL, V33, P673, DOI 10.1046/j.1365-2958.1999.01521.x; Laine RA, 1972, METHOD ENZYMOL, V28, P159, DOI [10.1016/0076-6879(72)28012-0, DOI 10.1016/0076-6879(72)28012-0]; Lebeer S, 2011, MICROB BIOTECHNOL, V4, P368, DOI 10.1111/j.1751-7915.2010.00199.x; Licandro-Seraut H, 2008, J MOL MICROB BIOTECH, V14, P41, DOI 10.1159/000106081; Marco ML, 2007, APPL ENVIRON MICROB, V73, P124, DOI 10.1128/AEM.01475-06; Marco ML, 2010, ISME J, V4, P1481, DOI 10.1038/ismej.2010.61; Marco ML, 2009, ENVIRON MICROBIOL, V11, P2747, DOI 10.1111/j.1462-2920.2009.02001.x; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; O'Donovan L, 2001, MICROBIOL-SGM, V147, P1025, DOI 10.1099/00221287-147-4-1025; Osawa R, 2000, APPL ENVIRON MICROB, V66, P3093, DOI 10.1128/AEM.66.7.3093-3097.2000; Remus DM, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-149; Reveron I, 2012, MOL NUTR FOOD RES, V56, P1848, DOI 10.1002/mnfr.201200384; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Rodriguez H, 2008, INT J FOOD MICROBIOL, V121, P92, DOI 10.1016/j.ijfoodmicro.2007.11.002; Rozes N, 1998, APPL MICROBIOL BIOT, V49, P108, DOI 10.1007/s002530051145; Saulnier DAA, 2007, APPL ENVIRON MICROB, V73, P1753, DOI 10.1128/AEM.01151-06; Saulnier DM, 2009, CURR PHARM DESIGN, V15, P1403, DOI 10.2174/138161209788168128; SCALBERT A, 1991, PHYTOCHEMISTRY, V30, P3875, DOI 10.1016/0031-9422(91)83426-L; Serrano J, 2009, MOL NUTR FOOD RES, V53, pS310, DOI 10.1002/mnfr.200900039; Smith A, 2005, SIGHT SOUND, V15, P50; Smith AH, 2004, APPL ENVIRON MICROB, V70, P1104, DOI 10.1128/AEM.70.2.1104-1115.2004; van Bokhorst-van de Veen H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039053; Vesa T, 2000, ALIMENT PHARM THER, V14, P823; WHO and FAO, 2003, WHO TECH REP SER, V916, P1	39	24	26	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66473	10.1371/journal.pone.0066473	http://dx.doi.org/10.1371/journal.pone.0066473			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776675	Green Published, gold, Green Submitted			2022-12-27	WOS:000320755400147
J	Tanaka, S; Ikeda, H; Kasahara, K; Kato, R; Tsubomi, H; Sugawara, SK; Mori, M; Hanakawa, T; Sadato, N; Honda, M; Watanabe, K				Tanaka, Satoshi; Ikeda, Hanako; Kasahara, Kazumi; Kato, Ryo; Tsubomi, Hiroyuki; Sugawara, Sho K.; Mori, Makoto; Hanakawa, Takashi; Sadato, Norihiro; Honda, Manabu; Watanabe, Katsumi			Larger Right Posterior Parietal Volume in Action Video Game Experts: A Behavioral and Voxel-Based Morphometry (VBM) Study	PLOS ONE			English	Article							BRAIN STRUCTURE CHANGES; VISUAL WORKING-MEMORY; SHORT-TERM-MEMORY; INDIVIDUAL-DIFFERENCES; NEURAL BASIS; ATTENTION; CAPACITY; TIME; NEUROPLASTICITY; PLASTICITY	Recent studies suggest that action video game players exhibit superior performance in visuospatial cognitive tasks compared with non-game players. However, the neural basis underlying this visuospatial cognitive performance advantage remains largely unknown. The present human behavioral and imaging study compared gray matter volume in action video game experts and non-experts using structural magnetic resonance imaging and voxel-based morphometry analysis. The results revealed significantly larger gray matter volume in the right posterior parietal cortex in experts compared with non-experts. Furthermore, the larger gray matter volume in the right posterior parietal cortex significantly correlated with individual performance in a visual working memory task in experts. These results suggest that differences in brain structure may be linked to extensive video game play, leading to superior visuospatial cognitive performance in action video game experts.	[Tanaka, Satoshi] Nagoya Inst Technol, Nagoya, Aichi, Japan; [Ikeda, Hanako] Rikkyo Univ, Tokyo 171, Japan; [Kasahara, Kazumi; Sugawara, Sho K.] Japan Soc Promot Sci, Tokyo, Japan; [Kasahara, Kazumi; Hanakawa, Takashi; Honda, Manabu] Natl Ctr Neurol & Psychiat, Tokyo, Japan; [Kato, Ryo] Waseda Univ, Tokyo, Japan; [Tsubomi, Hiroyuki] Toyama Univ, Toyama 930, Japan; [Mori, Makoto] Chiba Prefectural Board Educ, Chiba, Japan; [Hanakawa, Takashi; Watanabe, Katsumi] Japan Sci & Technol Agcy, Saitama, Japan; [Watanabe, Katsumi] Univ Tokyo, Tokyo, Japan	Nagoya Institute of Technology; Rikkyo University; Japan Society for the Promotion of Science; National Center for Neurology & Psychiatry - Japan; Waseda University; University of Toyama; Japan Science & Technology Agency (JST); University of Tokyo	Tanaka, S (corresponding author), Nagoya Inst Technol, Nagoya, Aichi, Japan.	tanaka.satoshi@nitech.ac.jp	HONDA, Manabu/AAO-1202-2020; Hanakawa, Takashi/AEU-7951-2022	Sadato, Norihiro/0000-0002-9786-3907; Kasahara, Kazumi/0000-0002-1306-3989; Watanabe, Katsumi/0000-0003-1282-9994	Hayao Nakayama Foundation for Science & Technology and Culture; Funds for the Development of Human Resources in Science and Technology; Grants-in-Aid for Scientific Research [24118511] Funding Source: KAKEN	Hayao Nakayama Foundation for Science & Technology and Culture; Funds for the Development of Human Resources in Science and Technology; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Hayao Nakayama Foundation for Science & Technology and Culture, and Funds for the Development of Human Resources in Science and Technology, awarded to Satoshi Tanaka. The funding agencies had no role in the study design, data collection and analysis, decision to publish, or manuscript preparation.	Achtman RL, 2008, RESTOR NEUROL NEUROS, V26, P435; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Basak C, 2011, BRAIN COGNITION, V76, P407, DOI 10.1016/j.bandc.2011.03.017; Bavelier D, 2012, VISION RES, V61, P132, DOI 10.1016/j.visres.2011.08.007; Bavelier D, 2011, NAT REV NEUROSCI, V12, P763, DOI 10.1038/nrn3135; Bezzola L, 2011, J NEUROSCI, V31, P12444, DOI 10.1523/JNEUROSCI.1996-11.2011; Boot WR, 2012, ACTA PSYCHOL, V141, P276, DOI 10.1016/j.actpsy.2012.06.011; Boot WR, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00226; Boot WR, 2008, ACTA PSYCHOL, V129, P387, DOI 10.1016/j.actpsy.2008.09.005; Boyke J, 2008, J NEUROSCI, V28, P7031, DOI 10.1523/JNEUROSCI.0742-08.2008; Castel AD, 2005, ACTA PSYCHOL, V119, P217, DOI 10.1016/j.actpsy.2005.02.004; Colzato LS, 2013, PSYCHOL RES-PSYCH FO, V77, P234, DOI 10.1007/s00426-012-0415-2; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2011, ANNU REV NEUROSCI, V34, P569, DOI 10.1146/annurev-neuro-061010-113731; Coull JT, 1998, NEUROIMAGE, V8, P176, DOI 10.1006/nimg.1998.0354; Cuadra MB, 2005, IEEE T MED IMAGING, V24, P1548, DOI 10.1109/TMI.2005.857652; Cusack R, 2009, PSYCHON B REV, V16, P641, DOI 10.3758/PBR.16.4.641; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Draganski B, 2006, J NEUROSCI, V26, P6314, DOI 10.1523/JNEUROSCI.4628-05.2006; Driemeyer J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002669; Dye MWG, 2009, NEUROPSYCHOLOGIA, V47, P1780, DOI 10.1016/j.neuropsychologia.2009.02.002; Dye MWG, 2009, CURR DIR PSYCHOL SCI, V18, P321, DOI 10.1111/j.1467-8721.2009.01660.x; Edgington E.S., 2007, RANDOMIZATION TESTS; Erickson KI, 2010, CEREB CORTEX, V20, P2522, DOI 10.1093/cercor/bhp293; Feng J, 2007, PSYCHOL SCI, V18, P850, DOI 10.1111/j.1467-9280.2007.01990.x; Friston KJ, 1996, NEUROIMAGE, V4, P223, DOI 10.1006/nimg.1996.0074; Fukuda K, 2011, PSYCHOL SCI, V22, P361, DOI 10.1177/0956797611398493; Fukuda K, 2009, J NEUROSCI, V29, P8726, DOI 10.1523/JNEUROSCI.2145-09.2009; Gaser C, 2003, J NEUROSCI, V23, P9240; Good P, 2000, PERMUTATION TESTS PR; Green CS, 2007, PSYCHOL SCI, V18, P88, DOI 10.1111/j.1467-9280.2007.01853.x; Green CS, 2006, COGNITION, V101, P217, DOI 10.1016/j.cognition.2005.10.004; Green CS, 2008, PSYCHOL AGING, V23, P692, DOI 10.1037/a0014345; Green CS, 2006, J EXP PSYCHOL HUMAN, V32, P1465, DOI 10.1037/0096-1523.32.6.1465; Green CS, 2003, NATURE, V423, P534, DOI 10.1038/nature01647; Greenfield PM, 2009, SCIENCE, V323, P69, DOI 10.1126/science.1167190; GRIFFITH JL, 1983, PERCEPT MOTOR SKILL, V57, P155, DOI 10.2466/pms.1983.57.1.155; Hanggi J, 2010, HUM BRAIN MAPP, V31, P1196, DOI 10.1002/hbm.20928; Hanggi J, 2010, J COGNITIVE NEUROSCI, V22, P139, DOI 10.1162/jocn.2008.21175; Halligan PW, 2003, TRENDS COGN SCI, V7, P125, DOI 10.1016/S1364-6613(03)00032-9; Holmes AP, 1996, J CEREBR BLOOD F MET, V16, P7, DOI 10.1097/00004647-199601000-00002; Hu YZ, 2011, HUM BRAIN MAPP, V32, P10, DOI 10.1002/hbm.20996; Hubert-Wallander B, 2011, ATTEN PERCEPT PSYCHO, V73, P2399, DOI 10.3758/s13414-011-0194-7; Jancke L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004785; Karle JW, 2010, ACTA PSYCHOL, V134, P70, DOI 10.1016/j.actpsy.2009.12.007; Kuhn S, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.53; Li RW, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001135; Linke AC, 2011, NEUROPSYCHOLOGIA, V49, P1476, DOI 10.1016/j.neuropsychologia.2010.11.034; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Mishra J, 2011, J NEUROSCI, V31, P992, DOI 10.1523/JNEUROSCI.4834-10.2011; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Rajapakse JC, 1997, IEEE T MED IMAGING, V16, P176, DOI 10.1109/42.563663; Schlickum MK, 2009, WORLD J SURG, V33, P2360, DOI 10.1007/s00268-009-0151-y; Todd JJ, 2004, NATURE, V428, P751, DOI 10.1038/nature02466; Tohka J, 2004, NEUROIMAGE, V23, P84, DOI 10.1016/j.neuroimage.2004.05.007; Vogel EK, 2005, NATURE, V438, P500, DOI 10.1038/nature04171; Wei GX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028309; West GL, 2008, J VISION, V8, DOI 10.1167/8.16.13; Xu YD, 2006, NATURE, V440, P91, DOI 10.1038/nature04262	61	44	47	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66998	10.1371/journal.pone.0066998	http://dx.doi.org/10.1371/journal.pone.0066998			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	169CU	23776706	Green Submitted, gold, Green Published			2022-12-27	WOS:000320755400159
J	Tseng, JR; Chen, KY; Lee, MH; Huang, CT; Wen, YH; Yen, TC				Tseng, Jing-Ren; Chen, Ke-Yuan; Lee, Ming-Hsun; Huang, Ching-Tai; Wen, Ying-Hao; Yen, Tzu-Chen			Potential Usefulness of FDG PET/CT in Patients with Sepsis of Unknown Origin	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; F-18-FDG PET/CT; METASTATIC INFECTION; LIVER-CIRRHOSIS; SCINTIGRAPHY; INFLAMMATION; TOMOGRAPHY	Purpose: The role of FDG PET in the evaluation of patients with sepsis of unknown origin remains unclear. We sought to assess the value of FDG PET/CT in patients with sepsis of unknown cause and to define its priority in this group of subjects. Methods: A total of 53 patients with sepsis of unknown origin underwent FDG PET/CT within two weeks of diagnosis. All of the patients were followed up for at least 3 months after discharge to determine the clinical outcomes. The impact of FDG PET/CT was assessed according to the number of cases who had their treatment modified on the basis of the imaging results. Logistic regression analysis was used to identify the independent predictors of positive FDG PET/CT findings. Results: Of the 53 study patients, 35 (66%) had positive FDG PET/CT findings, and 13 (25%) had their treatment modified on the basis of the imaging results. Logistic regression analysis identified normal serum aspartate aminotransferase (odds ratio [OR] = 6.134; 95% confidence interval [CI] = 1.443-26.076, P = 0.014) and increased serum alkaline phosphatase levels (OR = 5.813; 95% CI = 1.386-24.376, P = 0.016) at diagnosis as independent predictors of positive FDG PET/CT findings. A scoring system using these two covariates was developed, which defined three distinct priority groups for FDG PET/CT imaging. Conclusion: Our findings suggest that FDG PET/CT may be clinically useful for the detection of occult foci of infection in patients with sepsis of unknown origin.	[Tseng, Jing-Ren; Yen, Tzu-Chen] Chang Gung Mem Hosp Linkou, Nucl Med & Mol Imaging Ctr, Tao Yuan, Taiwan; [Chen, Ke-Yuan; Lee, Ming-Hsun; Huang, Ching-Tai] Chang Gung Mem Hosp Linkou, Dept Internal Med, Div Infect Dis, Tao Yuan, Taiwan; [Wen, Ying-Hao] Chang Gung Mem Hosp Linkou, Dept Pathol, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Yen, TC (corresponding author), Chang Gung Mem Hosp Linkou, Nucl Med & Mol Imaging Ctr, Tao Yuan, Taiwan.	yen1110@adm.cgmh.org.tw		Tseng, Jing-Ren/0000-0002-2232-9347				ANTHONY PP, 1978, J CLIN PATHOL, V31, P395, DOI 10.1136/jcp.31.5.395; Bleeker-Rovers CP, 2005, J NUCL MED, V46, P2014; BONE RC, 1992, CHEST, V101, P1481, DOI 10.1378/chest.101.6.1481; Chen WC, 2012, INTERN EMERG MED, V7, P53, DOI 10.1007/s11739-011-0739-8; Cuijpers MLH, 2007, EUR J CLIN MICROBIOL, V26, P105, DOI 10.1007/s10096-006-0238-4; Dellinger RP, 2008, INTENS CARE MED, V34, P17, DOI 10.1007/s00134-007-0934-2; Fowler VG, 2003, ARCH INTERN MED, V163, P2066, DOI 10.1001/archinte.163.17.2066; Gotthardt M, 2010, J NUCL MED, V51, P1937, DOI 10.2967/jnumed.110.076232; Gratz S, 2002, EUR J NUCL MED MOL I, V29, P516, DOI 10.1007/s00259-001-0719-8; Haroon A, 2012, CLIN INFECT DIS, V54, P1333, DOI 10.1093/cid/cis193; Kalicke T, 2000, EUR J NUCL MED, V27, P524, DOI 10.1007/s002590050538; Lesens O, 2004, J INFECTION, V48, P245, DOI 10.1016/j.jinf.2003.10.010; Lever A, 2007, BMJ-BRIT MED J, V335, P879, DOI 10.1136/bmj.39346.495880.AE; Lew DP, 2004, LANCET, V364, P369, DOI 10.1016/S0140-6736(04)16727-5; Prati D, 2002, ANN INTERN MED, V137, P1, DOI 10.7326/0003-4819-137-1-200207020-00006; Rabkin Z, 2010, J NUCL MED, V51, P1015, DOI 10.2967/jnumed.109.074294; SELBERG O, 1993, J CLIN INVEST, V91, P1897, DOI 10.1172/JCI116407; Tietge UE, 2004, LIVER TRANSPLANT, V10, P1030, DOI 10.1002/lt.20147; VANHOOF VO, 1994, CRIT REV CL LAB SCI, V31, P197, DOI 10.3109/10408369409084677; Vos FJ, 2012, MEDICINE, V91, P86, DOI 10.1097/MD.0b013e31824d7ed2; Vos FJ, 2012, EUR J NUCL MED MOL I, V39, P120, DOI 10.1007/s00259-011-1939-1; Vos FJ, 2010, J NUCL MED, V51, P1234, DOI 10.2967/jnumed.109.072371; WEISDORF DJ, 1982, BLOOD, V60, P888; Wolf G, 2002, AM J KIDNEY DIS, V39, P1, DOI 10.1053/ajkd.2002.29865	24	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66132	10.1371/journal.pone.0066132	http://dx.doi.org/10.1371/journal.pone.0066132			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776621	Green Published, gold, Green Submitted			2022-12-27	WOS:000320755400113
J	Batty, EM; Wong, THN; Trebes, A; Argoud, K; Attar, M; Buck, D; Ip, CLC; Golubchik, T; Cule, M; Bowden, R; Manganis, C; Klenerman, P; Barnes, E; Walker, AS; Wyllie, DH; Wilson, DJ; Dingle, KE; Peto, TEA; Crook, DW; Piazza, P				Batty, Elizabeth M.; Wong, T. H. Nicholas; Trebes, Amy; Argoud, Karene; Attar, Moustafa; Buck, David; Ip, Camilla L. C.; Golubchik, Tanya; Cule, Madeleine; Bowden, Rory; Manganis, Charis; Klenerman, Paul; Barnes, Eleanor; Walker, A. Sarah; Wyllie, David H.; Wilson, Daniel J.; Dingle, Kate E.; Peto, Tim E. A.; Crook, Derrick W.; Piazza, Paolo			A Modified RNA-Seq Approach for Whole Genome Sequencing of RNA Viruses from Faecal and Blood Samples	PLOS ONE			English	Article							ALGORITHMS; EVOLUTION; TOOL	To date, very large scale sequencing of many clinically important RNA viruses has been complicated by their high population molecular variation, which creates challenges for polymerase chain reaction and sequencing primer design. Many RNA viruses are also difficult or currently not possible to culture, severely limiting the amount and purity of available starting material. Here, we describe a simple, novel, high-throughput approach to Norovirus and Hepatitis C virus whole genome sequence determination based on RNA shotgun sequencing (also known as RNA-Seq). We demonstrate the effectiveness of this method by sequencing three Norovirus samples from faeces and two Hepatitis C virus samples from blood, on an Illumina MiSeq benchtop sequencer. More than 97% of reference genomes were recovered. Compared with Sanger sequencing, our method had no nucleotide differences in 14,019 nucleotides (nt) for Noroviruses (from a total of 2 Norovirus genomes obtained with Sanger sequencing), and 8 variants in 9,542 nt for Hepatitis C virus (1 variant per 1,193 nt). The three Norovirus samples had 2, 3, and 2 distinct positions called as heterozygous, while the two Hepatitis C virus samples had 117 and 131 positions called as heterozygous. To confirm that our sample and library preparation could be scaled to true high-throughput, we prepared and sequenced an additional 77 Norovirus samples in a single batch on an Illumina HiSeq 2000 sequencer, recovering.90% of the reference genome in all but one sample. No discrepancies were observed across 118,757 nt compared between Sanger and our custom RNA-Seq method in 16 samples. By generating viral genomic sequences that are not biased by primer-specific amplification or enrichment, this method offers the prospect of large-scale, affordable studies of RNA viruses which could be adapted to routine diagnostic laboratory workflows in the near future, with the potential to directly characterize within-host viral diversity.	[Batty, Elizabeth M.; Trebes, Amy; Argoud, Karene; Attar, Moustafa; Buck, David; Bowden, Rory; Wilson, Daniel J.; Piazza, Paolo] Wellcome Trust Ctr Human Genet, Oxford, England; [Wong, T. H. Nicholas; Manganis, Charis; Klenerman, Paul; Barnes, Eleanor; Walker, A. Sarah; Wyllie, David H.; Wilson, Daniel J.; Peto, Tim E. A.; Crook, Derrick W.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Med, Oxford OX3 9DU, England; [Wong, T. H. Nicholas; Walker, A. Sarah; Wyllie, David H.; Dingle, Kate E.; Peto, Tim E. A.; Crook, Derrick W.] John Radcliffe Hosp, Oxford NIHR Biomed Res Ctr, Oxford OX3 9DU, England; [Ip, Camilla L. C.; Golubchik, Tanya; Cule, Madeleine] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Dingle, Kate E.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Lab Sci, Oxford OX3 9DU, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Oxford; University of Oxford; University of Oxford	Wong, THN (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Med, Oxford OX3 9DU, England.	nick.wong@ndm.ox.ac.uk	Golubchik, Tanya/B-4226-2018; Walker, Sarah/HDM-8717-2022; Wilson, Daniel J/AAE-8975-2019	Golubchik, Tanya/0000-0003-2765-9828; Wilson, Daniel J/0000-0002-0940-3311; klenerman, paul/0000-0003-4307-9161; Barnes, Eleanor/0000-0002-0860-0831; peto, tim/0000-0003-3477-8307; Batty, Liz/0000-0001-8559-452X; Piazza, Paolo/0000-0002-3736-1841; Dingle, Kate/0000-0002-2303-5957	National Institute for Health Research (NIHR) Oxford Biomedical Research Centre; UKCRC Modernising Medical Microbiology Consortium; UKCRC Translational Infection Research Initiative; Medical Research Council, Biotechnology and Biological Sciences Research Council; NIHR on behalf of the Department of Health [G0800778]; Wellcome Trust [087646/Z/08/Z]; Wellcome Trust core funding [090532/Z/09/Z]; MRC Hub [G0900747 91070]; Medical Research Council [MR/K010239/1, G0800778] Funding Source: researchfish; National Institute for Health Research [ACF-2008-13-003, NF-SI-0510-10204, NF-SI-0512-10047, NF-SI-0508-10279] Funding Source: researchfish; MRC [MR/K010239/1, G0800778] Funding Source: UKRI	National Institute for Health Research (NIHR) Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); UKCRC Modernising Medical Microbiology Consortium; UKCRC Translational Infection Research Initiative; Medical Research Council, Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Biotechnology and Biological Sciences Research Council (BBSRC)); NIHR on behalf of the Department of Health; Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust core funding; MRC Hub(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre and the UKCRC Modernising Medical Microbiology Consortium, the latter funded under the UKCRC Translational Infection Research Initiative supported by Medical Research Council, Biotechnology and Biological Sciences Research Council and the NIHR on behalf of the Department of Health (grant G0800778) and the Wellcome Trust (grant 087646/Z/08/Z). The authors acknowledge the support of Wellcome Trust core funding (grant 090532/Z/09/Z) and MRC Hub (grant G0900747 91070). TEAP and DWC are NIHR Senior Investigators. THNW is an NIHR Oxford BRC Doctoral Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astrovskaya I, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S6-S1; Bailey JR, 2012, J VIROL, V86, P12582, DOI 10.1128/JVI.01440-12; Bull RA, 2011, TRENDS MICROBIOL, V19, P233, DOI 10.1016/j.tim.2011.01.002; Chan JZM, 2012, NAT BIOTECHNOL, V30, P1068, DOI 10.1038/nbt.2410; Chin CS, 2011, NEW ENGL J MED, V364, P33, DOI 10.1056/NEJMoa1012928; Croville G, 2012, J CLIN MICROBIOL, V50, P2881, DOI 10.1128/JCM.01142-12; Daly GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028879; Depledge DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027805; Dingle KE, 2004, J CLIN MICROBIOL, V42, P3950, DOI 10.1128/JCM.42.9.3950-3957.2004; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Eisenstein M, 2012, NAT BIOTECHNOL, V30, P295, DOI 10.1038/nbt0412-295; Eyre DW, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001124; Hansen KD, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq224; Henn MR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002529; Holmes EC, 2002, J VIROL, V76, P460, DOI 10.1128/JVI.76.1.460-462.2002; Humphreys I, 2009, J VIROL, V83, P11456, DOI 10.1128/JVI.00884-09; Iqbal Z, 2012, NAT GENET, V44, P226, DOI 10.1038/ng.1028; Kageyama T, 2003, J CLIN MICROBIOL, V41, P1548, DOI 10.1128/JCM.41.4.1548-1557.2003; Lauck M, 2012, J VIROL, V86, P3952, DOI 10.1128/JVI.06627-11; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; Malboeuf CM, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks794; Mamanova L, 2010, NAT METHODS, V7, P111, DOI 10.1038/nmeth.1419; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; NAGALAKSHMI U, 2010, CURR PROTOC MOL BIOL, P1; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Nakamura S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004219; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; Prosperi MCF, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-5; Pybus OG, 2009, NAT REV GENET, V10, P540, DOI 10.1038/nrg2583; Simmonds P, 2008, NUCLEIC ACIDS RES, V36, P2530, DOI 10.1093/nar/gkn096; Staden R, 1996, MOL BIOTECHNOL, V5, P233, DOI 10.1007/BF02900361; van Beek J, 2013, EUROSURVEILLANCE, V18, P8; Vennema H, 2002, J CLIN VIROL, V25, P233, DOI 10.1016/S1386-6532(02)00126-9; Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Willerth SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013564; Wilson DJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002874; Yang X, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-475; Yu Q, 2011, BIOINFORMATICS, V27, P266, DOI 10.1093/bioinformatics/btq624; Zagordi O, 2010, NUCLEIC ACIDS RES, V38, P7400, DOI 10.1093/nar/gkq655; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	42	46	48	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e66129	10.1371/journal.pone.0066129	http://dx.doi.org/10.1371/journal.pone.0066129			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762474	Green Published, gold, Green Submitted			2022-12-27	WOS:000320440500064
J	Bauer, CA; Wisner, KW; Baizer, JS; Brozoski, TJ				Bauer, Carol A.; Wisner, Kurt W.; Baizer, Joan S.; Brozoski, Thomas J.			Tinnitus, Unipolar Brush Cells, and Cerebellar Glutamatergic Function in an Animal Model	PLOS ONE			English	Article							DORSAL COCHLEAR NUCLEUS; DOUBLECORTIN EXPRESSION; ADULT NEUROGENESIS; NEURAL ACTIVITY; RAT; PLASTICITY; CORTEX; PARAFLOCCULUS; INTERNEURONS; HYPERACUSIS	Unipolar brush cells (UBCs) are excitatory interneurons found in the dorsal cochlear nucleus (DCN) and the granule cell layer of cerebellar cortex, being particularly evident in the paraflocculus (PFL) and flocculus (FL). UBCs receive glutamatergic inputs and make glutamatergic synapses with granule cells and other UBCs. It has been hypothesized that UBCs comprise local networks of tunable feed-forward amplifiers. In the DCN they might also participate in feed-back amplification of signals from higher auditory centers. Recently it has been shown that UBCs, in the vestibulocerebellum and DCN of adult rats, express doublecortin (DCX), previously considered a marker of newborn and migrating neurons. In an animal model, both the DCN, and more recently the PFL, have been implicated in contributing to the sensation of acoustic-exposure-induced tinnitus. These studies support the working hypothesis that tinnitus emerges after loss of peripheral sensitivity because inhibitory processes homeostatically down regulate, and excitatory processes up regulate. Here we report the results of two sequential experiments that examine the potential role of DCN and cerebellar UBCs in tinnitus, and the contribution of glutamatergic transmission in the PFL. In Experiment 1 it was shown that adult rats with psychophysical evidence of tinnitus induced by a single unilateral high-level noise exposure, had elevated DCX in the DCN and ventral PFL. In Experiment 2 it was shown that micro-quantities of glutamatergic antagonists, delivered directly to the PFL, reversibly reduced chronically established tinnitus, while similarly applied glutamatergic agonists induced tinnitus-like behavior in non-tinnitus controls. These results are consistent with the hypothesis that UBC up regulation and enhanced glutamatergic transmission in the cerebellum contribute to the pathophysiology of tinnitus.	[Bauer, Carol A.; Wisner, Kurt W.; Brozoski, Thomas J.] So Illinois Univ, Sch Med, Dept Otolaryngol, Springfield, IL 62702 USA; [Baizer, Joan S.] SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14260 USA	Southern Illinois University System; Southern Illinois University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Brozoski, TJ (corresponding author), So Illinois Univ, Sch Med, Dept Otolaryngol, Springfield, IL 62702 USA.	tbrozoski@siumed.edu			National Institute on Deafness and Other Communication Disorders [1R01DC009669-01]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009669] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This project was supported by the National Institute on Deafness and Other Communication Disorders, 1R01DC009669-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibardi L., 2004, Journal of Submicroscopic Cytology and Pathology, V36, P193; Andersson G, 2001, ARCH OTOLARYNGOL, V127, P175, DOI 10.1001/archotol.127.2.175; AXELSSON A, 1985, British Journal of Audiology, V19, P271, DOI 10.3109/03005368509078983; Azevedo Andreia A, 2005, Braz J Otorhinolaryngol, V71, P618; AZIZI SA, 1985, EXP BRAIN RES, V59, P36; AZIZI SA, 1990, BRAIN RES, V533, P255, DOI 10.1016/0006-8993(90)91347-J; Bartnik G, 2001, SCAND AUDIOL, V30, P187, DOI 10.1080/010503901300007489; Bauer CA, 2001, JARO-J ASSOC RES OTO, V2, P54, DOI 10.1007/s101620010030; Bauer CA, 2013, HEARING RES, V295, P130, DOI 10.1016/j.heares.2012.03.009; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Brozoski TJ, 2007, HEARING RES, V228, P168, DOI 10.1016/j.heares.2007.02.003; Brozoski TJ, 2007, JARO-J ASSOC RES OTO, V8, P105, DOI 10.1007/s10162-006-0067-2; Brozoski TJ, 2010, HEARING RES, V270, P71, DOI 10.1016/j.heares.2010.09.006; Brozoski TJ, 2012, JARO-J ASSOC RES OTO, V13, P55, DOI 10.1007/s10162-011-0290-3; Brozoski TJ, 2005, HEARING RES, V206, P227, DOI 10.1016/j.heares.2004.12.013; Brozoski TJ, 2002, J NEUROSCI, V22, P2383, DOI 10.1523/JNEUROSCI.22-06-02383.2002; Coles RR, 1984, J LARYNGOL OTOL S, V9, P7; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; D'Angelo E, 2009, TRENDS NEUROSCI, V32, P30, DOI 10.1016/j.tins.2008.09.007; Dauman R, 2005, ACTA OTO-LARYNGOL, V125, P503, DOI 10.1080/00016480510027565; Dorrn AL, 2010, NATURE, V465, P932, DOI 10.1038/nature09119; EISENMAN LM, 1980, BRAIN RES, V188, P550, DOI 10.1016/0006-8993(80)90053-0; FLORIS A, 1994, ANAT EMBRYOL, V189, P495; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Glitsch M, 1999, J NEUROSCI, V19, P511; HINCHCLIFF R, 1961, BRIT J PREV SOC MED, V15, P128; Ito M, 1984, CEREBELLUM NEURAL CO; Ito M, 2006, PROG NEUROBIOL, V78, P272, DOI 10.1016/j.pneurobio.2006.02.006; Kaltenbach JA, 2000, HEARING RES, V147, P282, DOI 10.1016/S0378-5955(00)00138-6; Kaltenbach JA, 2008, AM J AUDIOL, V17, pS148, DOI 10.1044/1059-0889(2008/08-0004); Kenyon GT, 1997, P NATL ACAD SCI USA, V94, P14200, DOI 10.1073/pnas.94.25.14200; Lakowicz J. R., 2009, PRINCIPLES FLUORESCE; Li FW, 2011, BEHAV BRAIN RES, V224, P376, DOI 10.1016/j.bbr.2011.06.021; Liberman M C, 1978, Acta Otolaryngol Suppl, V358, P1; Manohar S, 2012, NEUROSCIENCE, V202, P169, DOI 10.1016/j.neuroscience.2011.12.013; Meikle M. B., 2004, TINNITUS ARCH; Morest DK, 1997, HEARING RES, V103, P151, DOI 10.1016/S0378-5955(96)00172-4; MORTIMER JA, 1975, BRAIN RES, V83, P369, DOI 10.1016/0006-8993(75)90831-8; MUGNAINI E, 1994, J COMP NEUROL, V339, P174, DOI 10.1002/cne.903390203; Mugnaini E, 2011, BRAIN RES REV, V66, P220, DOI 10.1016/j.brainresrev.2010.10.001; Muhr P, 2010, INT J AUDIOL, V49, P317, DOI 10.3109/14992020903431280; Nacher J, 2001, EUR J NEUROSCI, V14, P629, DOI 10.1046/j.0953-816x.2001.01683.x; Nondahl David M, 2002, J Am Acad Audiol, V13, P323; Norena AJ, 2011, NEUROSCI BIOBEHAV R, V35, P1089, DOI 10.1016/j.neubiorev.2010.11.003; Oertel D, 2004, TRENDS NEUROSCI, V27, P104, DOI 10.1016/j.tins.2003.12.001; Osaki Y, 2005, NEUROREPORT, V16, P1625, DOI 10.1097/01.wnr.0000183899.85277.08; Rasmussen G., 1990, RES NOTEBOOKS HIST M, P1; Roberts LE, 2010, J NEUROSCI, V30, P14972, DOI 10.1523/JNEUROSCI.4028-10.2010; Rousseau CV, 2012, J NEUROSCI, V32, P4632, DOI 10.1523/JNEUROSCI.5122-11.2012; Ruigrok TJH, 2011, J NEUROSCI, V31, P712, DOI 10.1523/JNEUROSCI.1959-10.2011; Sekerkova G, 2004, NEUROSCIENCE, V127, P845, DOI 10.1016/j.neuroscience.2004.05.050; Shore SE, 2008, EUR J NEUROSCI, V27, P155, DOI 10.1111/j.1460-9568.2007.05983.x; SHU SY, 1988, NEUROSCI LETT, V85, P169, DOI 10.1016/0304-3940(88)90346-1; Tan AYY, 2004, J NEUROPHYSIOL, V92, P630, DOI 10.1152/jn.01020.2003; TRUSSELL LO, 1988, P NATL ACAD SCI USA, V85, P4562, DOI 10.1073/pnas.85.12.4562-a; TURNER J, 2012, J NEUROSCI RES; Turner JG, 2008, AM J AUDIOL, V17, pS185, DOI 10.1044/1059-0889(2008/08-0006); Turner JG, 2006, BEHAV NEUROSCI, V120, P188, DOI 10.1037/0735-7044.120.1.188; Van der Gucht E, 2006, ANAT REC PART A, V288A, P753, DOI 10.1002/ar.a.20350; Wang HN, 2011, HEARING RES, V279, P111, DOI 10.1016/j.heares.2011.04.004; Yang SC, 2011, P NATL ACAD SCI USA, V108, P14974, DOI 10.1073/pnas.1107998108; Zeng CH, 2009, J NEUROSCI, V29, P4210, DOI 10.1523/JNEUROSCI.0208-09.2009; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	63	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e64726	10.1371/journal.pone.0064726	http://dx.doi.org/10.1371/journal.pone.0064726			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785405	Green Submitted, Green Published, gold			2022-12-27	WOS:000321038800114
J	Davis, BJ; Risinger, JI; Chandramouli, GVR; Bushel, PR; Baird, DD; Peddada, SD				Davis, Barbara J.; Risinger, John I.; Chandramouli, Gadisetti V. R.; Bushel, Pierre R.; Baird, Donna Day; Peddada, Shyamal D.			Gene Expression in Uterine Leiomyoma from Tumors Likely to Be Growing (from Black Women over 35) and Tumors Likely to Be Non-Growing (from White Women over 35)	PLOS ONE			English	Article							SUPPRESSOR PROTEIN; GROWTH; PREGNANCY; DIFFERENTIATION; FIBROIDS; INSIGHTS; ARRAYS; PVHL	The study of uterine leiomyomata (fibroids) provides a unique opportunity to investigate the physiological and molecular determinants of hormone dependent tumor growth and spontaneous tumor regression. We conducted a longitudinal clinical study of premenopausal women with leiomyoma that showed significantly different growth rates between white and black women depending on their age. Growth rates for leiomyoma were on average much higher from older black women than for older white women, and we now report gene expression pattern differences in tumors from these two groups of study participants. Total RNA from 52 leiomyoma and 8 myometrial samples were analyzed using Affymetrix Gene Chip expression arrays. Gene expression data was first compared between all leiomyoma and normal myometrium and then between leiomyoma from older black women (age 35 or older) and from older white women. Genes that were found significant in pairwise comparisons were further analyzed for canonical pathways, networks and biological functions using the Ingenuity Pathway Analysis (IPA) software. Whereas our comparison of leiomyoma to myometrium produced a very large list of genes highly similar to numerous previous studies, distinct sets of genes and signaling pathways were identified in comparisons of older black and white women whose tumors were likely to be growing and non-growing, respectively. Key among these were genes associated with regulation of apoptosis. To our knowledge, this is the first study to compare two groups of tumors that are likely to have different growth rates in order to reveal molecular signals likely to be influential in tumor growth.	[Davis, Barbara J.] Tufts Univ, Cummings Sch Vet Med, North Grafton, MA USA; [Risinger, John I.; Chandramouli, Gadisetti V. R.] Michigan State Univ, Coll Human Med, Grand Rapids, MI USA; [Bushel, Pierre R.; Peddada, Shyamal D.] NIEHS, Biostat Branch, NIH, Res Triangle Pk, NC 27709 USA; [Baird, Donna Day] NIEHS, Epidemiol Branch, NIH, Res Triangle Pk, NC 27709 USA	Tufts University; Michigan State University; Michigan State University College of Human Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Peddada, SD (corresponding author), NIEHS, Biostat Branch, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	Peddada@niehs.nih.gov	Baird, Donna D/D-5214-2017	Baird, Donna D/0000-0002-5544-2653; Peddada, Shyamal/0000-0002-5014-6513	Intramural Research Program of the NIEHS, National Institutes of Health [Z01ES 101663-05, Z01 ES102345-04]; National Center on Minority Health and Health Disparities Grant [MO1RR00046]; NIEHS [N01-ES-95446, 273-01-C-0157]; Integrated Laboratory Systems in RT-PCR assays; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES102345, ZIAES049013, ZIAES101663, ZIAES102345, N01ES095446, Z01ES101663] Funding Source: NIH RePORTER	Intramural Research Program of the NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Center on Minority Health and Health Disparities Grant; NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Integrated Laboratory Systems in RT-PCR assays; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This project was supported by Intramural Research Program of the NIEHS, National Institutes of Health (Grant Z01ES 101663-05 and Z01 ES102345-04), with partial funding from the National Center on Minority Health and Health Disparities Grant MO1RR00046 and NIEHS Contracts N01-ES-95446 and 273-01-C-0157. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the study participants; the contributions of Dr. Pamela Blackshear and support of Integrated Laboratory Systems in RT-PCR assays; and Dr. Kissling (NIEHS), Dr. Leppert (Duke University) for careful reading of an earlier version of the manuscript.	Arslan AA, 2005, HUM REPROD, V20, P852, DOI 10.1093/humrep/deh698; Baird DD, 2003, EPIDEMIOLOGY, V14, P247; Baird DD, 2011, FERTIL STERIL, V95, P242, DOI 10.1016/j.fertnstert.2010.05.011; Breton S, 2001, JOP, V2, P159; Burroughs KD, 2002, J ENDOCRINOL, V172, P83, DOI 10.1677/joe.0.1720083; Catherino WH, 2004, GENE CHROMOSOME CANC, V40, P204, DOI 10.1002/gcc.20035; Catherino WH, 2003, FERTIL STERIL, V80, P293, DOI 10.1016/S0015-0282(03)00958-0; Catherino WH, 2007, FERTIL STERIL, V87, P1388, DOI 10.1016/j.fertnstert.2006.11.093; Cesen-Cummings K, 2003, J SOC GYNECOL INVEST, V10, P11, DOI 10.1016/S1071-5576(02)00191-0; Cesen-Cummings K, 2000, MED HYPOTHESES, V55, P485, DOI 10.1054/mehy.2000.1098; Chiquet M, 2009, BIOCHIM BIOPHYS ACTA, V1793, p[1793, 1795]; Chou Jeff W., 2005, Journal of Bioinformatics and Computational Biology, V3, P225, DOI 10.1142/S0219720005001028; Davis BJ, 2009, J WOMENS HEALTH, V18, P725, DOI 10.1089/jwh.2008.0903; Ding N, 2009, J BIOL CHEM, V284, P2648, DOI 10.1074/jbc.M806514200; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Esteban-Barragan MA, 2002, CANCER RES, V62, P2929; Fuller SJ, 2008, J MOL CELL CARDIOL, V44, P831, DOI 10.1016/j.yjmcc.2008.02.278; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Hergovich A, 2003, NAT CELL BIOL, V5, P64, DOI 10.1038/ncb899; Hoffman PJ, 2004, FERTIL STERIL, V82, P639, DOI 10.1016/j.fertnstert.2004.01.047; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Makinen N, 2011, SCIENCE, V334, P252, DOI 10.1126/science.1208930; Mao ZY, 2011, SCIENCE, V332, P1443, DOI 10.1126/science.1202723; Mayer A, 2008, CANCER RES, V68, P4719, DOI 10.1158/0008-5472.CAN-07-6339; Negro A, 2006, P NATL ACAD SCI USA, V103, P15889, DOI 10.1073/pnas.0607499103; Norian JM, 2012, MATRIX BIOL, V31, P57, DOI 10.1016/j.matbio.2011.09.001; Ono M, 2007, P NATL ACAD SCI USA, V104, P18700, DOI 10.1073/pnas.0704472104; Peddada S, 2005, BIOINFORMATICS, V21, P3933, DOI 10.1093/bioinformatics/bti637; Peddada SD, 2003, BIOINFORMATICS, V19, P834, DOI 10.1093/bioinformatics/btg093; Peddada SD, 2008, P NATL ACAD SCI USA, V105, P19887, DOI 10.1073/pnas.0808188105; Rajagopalan V, 2008, AM J PHYSIOL-HEART C, V295, pH543, DOI 10.1152/ajpheart.91436.2007; Sleeman JP, 2011, CELL, V145, DOI 10.1016/j.cell.2011.03.029; Sutton TA, 2008, AM J PHYSIOL-RENAL, V295, pF1666, DOI 10.1152/ajprenal.90304.2008; Thoma CR, 2010, J CELL BIOL, V190, P991, DOI 10.1083/jcb.201006059; Tsibris JCM, 2003, BIOCHEM BIOPH RES CO, V312, P249, DOI 10.1016/j.bbrc.2003.09.189; Tsibris JCM, 2002, FERTIL STERIL, V78, P114, DOI 10.1016/S0015-0282(02)03191-6; Turcotte S, 2004, AM J PHYSIOL-RENAL, V286, pF338, DOI 10.1152/ajprenal.00254.2003; Walker CL, 2001, CARCINOGENESIS, V22, P2049, DOI 10.1093/carcin/22.12.2049; Wang TS, 2007, GENE CHROMOSOME CANC, V46, P336, DOI 10.1002/gcc.20415; Wei JJ, 2006, HUM REPROD, V21, P57, DOI 10.1093/humrep/dei309; Wray S, 2007, EXP PHYSIOL, V92, P621, DOI 10.1113/expphysiol.2007.038125; Zhao SL, 1997, INT REV CYTOL, V171, P225; Zhou QY, 2011, FASEB J, V25, P3032, DOI 10.1096/fj.10-177824	43	21	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e63909	10.1371/journal.pone.0063909	http://dx.doi.org/10.1371/journal.pone.0063909			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785396	Green Published, Green Submitted, gold			2022-12-27	WOS:000321038800121
J	Gunka, K; Stannek, L; Care, RA; Commichau, FM				Gunka, Katrin; Stannek, Lorena; Care, Rachel A.; Commichau, Fabian M.			Selection-Driven Accumulation of Suppressor Mutants in Bacillus subtilis: The Apparent High Mutation Frequency of the Cryptic gudB Gene and the Rapid Clonal Expansion of gudB(+) Suppressors Are Due to Growth under Selection	PLOS ONE			English	Article							STRESS-INDUCED MUTAGENESIS; GLUTAMATE-DEHYDROGENASE ROCG; ESCHERICHIA-COLI; TRANSCRIPTION FACTOR; MOLECULAR-MECHANISM; NITROGEN-METABOLISM; REPEAT INSTABILITY; DNA BREAKS; BIOSYNTHESIS; BACTERIA	Soil bacteria like Bacillus subtilis can cope with many growth conditions by adjusting gene expression and metabolic pathways. Alternatively, bacteria can spontaneously accumulate beneficial mutations or shape their genomes in response to stress. Recently, it has been observed that a B. subtilis mutant lacking the catabolically active glutamate dehydrogenase (GDH), RocG, mutates the cryptic gudB(CR) gene at a high frequency. The suppressor mutants express the active GDH GudB, which can fully replace the function of RocG. Interestingly, the cryptic gudB(CR) allele is stably inherited as long as the bacteria synthesize the functional GDH RocG. Competition experiments revealed that the presence of the cryptic gudB(CR) allele provides the bacteria with a selective growth advantage when glutamate is scarce. Moreover, the lack of exogenous glutamate is the driving force for the selection of mutants that have inactivated the active gudB gene. In contrast, two functional GDHs are beneficial for the cells when glutamate was available. Thus, the amount of GDH activity strongly affects fitness of the bacteria depending on the availability of exogenous glutamate. At a first glance the high mutation frequency of the cryptic gudB(CR) allele might be attributed to stress-induced adaptive mutagenesis. However, other loci on the chromosome that could be potentially mutated during growth under the selective pressure that is exerted on a GDH-deficient mutant remained unaffected. Moreover, we show that a GDH-proficient B. subtilis strain has a strong selective growth advantage in a glutamate-dependent manner. Thus, the emergence and rapid clonal expansion of the active gudB allele can be in fact explained by spontaneous mutation and growth under selection without an increase of the mutation rate. Moreover, this study shows that the selective pressure that is exerted on a maladapted bacterium strongly affects the apparent mutation frequency of mutational hot spots.	[Gunka, Katrin; Stannek, Lorena; Care, Rachel A.; Commichau, Fabian M.] Univ Gottingen, Dept Gen Microbiol, D-37073 Gottingen, Germany	University of Gottingen	Commichau, FM (corresponding author), Univ Gottingen, Dept Gen Microbiol, D-37073 Gottingen, Germany.	fcommic1@gwdg.de	Commichau, Fabian/A-9664-2018	Commichau, Fabian/0000-0003-0323-7479	Deutsche Forschungsgemeinschaft [CO 1139/1-1]; Fonds der Chemischen Industrie; Gottingen Centre for Molecular Biology (GZMB); Fulbright Scholar Grant;  [SFB860]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Gottingen Centre for Molecular Biology (GZMB); Fulbright Scholar Grant; 	Work in the author's lab was supported by the Deutsche Forschungsgemeinschaft (http://www.dfg.de; CO 1139/1-1), the Fonds der Chemischen Industrie and the Gottingen Centre for Molecular Biology (GZMB). Rachel A. Care was supported by a Fulbright Scholar Grant. Work of KG in the authors lab was supported by the grant SFB860. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Mamun AM, 2012, SCIENCE, V338, P1344, DOI 10.1126/science.1226683; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Belitsky BR, 1998, J BACTERIOL, V180, P6298; Belitsky BR, 2004, J BACTERIOL, V186, P3399, DOI 10.1128/JB.186.11.3399-3407.2004; Belitsky BR, 2004, J BACTERIOL, V186, P5939; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Bichara M, 2006, MUTAT RES-FUND MOL M, V598, P144, DOI 10.1016/j.mrfmmm.2006.01.020; Bisicchia P, 2010, PLASMID, V64, P143, DOI 10.1016/j.plasmid.2010.06.002; Bjedov I, 2003, SCIENCE, V300, P1404, DOI 10.1126/science.1082240; Blom EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027160; Blount ZD, 2012, NATURE, V489, P513, DOI 10.1038/nature11514; BOHANNON DE, 1989, J BACTERIOL, V171, P4718, DOI 10.1128/jb.171.9.4718-4727.1989; Brill J, 2011, J BACTERIOL, V193, P5335, DOI 10.1128/JB.05490-11; Buescher JM, 2012, SCIENCE, V335, P1099, DOI 10.1126/science.1206871; Burch LH, 2011, CELL CYCLE, V10, P1073, DOI 10.4161/cc.10.7.15319; BURKHOLDER PR, 1947, AM J BOT, V34, P345, DOI 10.2307/2437147; CAIRNS J, 1988, NATURE, V335, P142, DOI 10.1038/335142a0; Commichau FM, 2008, MOL MICROBIOL, V67, P692, DOI 10.1111/j.1365-2958.2007.06071.x; Commichau FM, 2008, J BACTERIOL, V190, P3557, DOI 10.1128/JB.00099-08; Commichau FM, 2007, MOL MICROBIOL, V65, P642, DOI 10.1111/j.1365-2958.2007.05816.x; Commichau FM, 2007, J MOL MICROB BIOTECH, V12, P106, DOI 10.1159/000096465; Commichau FM, 2006, CURR OPIN MICROBIOL, V9, P167, DOI 10.1016/j.mib.2006.01.001; de Jong IG, 2011, JOVE-J VIS EXP, DOI 10.3791/3145; FISHER SH, 1984, J BACTERIOL, V158, P379, DOI 10.1128/JB.158.1.379-382.1984; Florez LA, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-5; Foster PL, 2007, CRIT REV BIOCHEM MOL, V42, P373, DOI 10.1080/10409230701648494; Frimmersdorf E, 2010, ENVIRON MICROBIOL, V12, P1734, DOI 10.1111/j.1462-2920.2010.02253.x; Gerth U, 2008, J BACTERIOL, V190, P321, DOI 10.1128/JB.01233-07; Gunka K, 2012, MOL MICROBIOL, V85, P213, DOI 10.1111/j.1365-2958.2012.08105.x; Gunka K, 2012, J BACTERIOL, V194, P1036, DOI 10.1128/JB.06470-11; Gunka K, 2010, J MOL BIOL, V400, P815, DOI 10.1016/j.jmb.2010.05.055; Hu P, 1999, J BACTERIOL, V181, P5042, DOI 10.1128/JB.181.16.5042-5050.1999; Koonin EV, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-33; Kovtun IV, 2008, CELL RES, V18, P198, DOI 10.1038/cr.2008.5; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; KUNST F, 1995, J BACTERIOL, V177, P2403, DOI 10.1128/jb.177.9.2403-2407.1995; Lee YH, 2012, J BACTERIOL, V194, P993, DOI 10.1128/JB.06547-11; Leigh JA, 2007, ANNU REV MICROBIOL, V61, P349, DOI 10.1146/annurev.micro.61.080706.093409; Magasanik B, 2003, EUKARYOT CELL, V2, P827, DOI 10.1128/EC.2.5.827-829.2003; Manabe K, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-18; Martin DD, 1999, APPL ENVIRON MICROB, V65, P1815; Moxon R, 2006, ANNU REV GENET, V40, P307, DOI 10.1146/annurev.genet.40.110405.090442; Nicolas P, 2012, SCIENCE, V335, P1103, DOI 10.1126/science.1206848; Picossi S, 2007, J MOL BIOL, V365, P1298, DOI 10.1016/j.jmb.2006.10.100; Rosenberg SM, 2012, BIOESSAYS, V34, P885, DOI 10.1002/bies.201200050; Rosenberg SM, 2011, MBIO, V2, DOI 10.1128/mBio.00200-11; Roth JR, 2006, ANNU REV MICROBIOL, V60, P477, DOI 10.1146/annurev.micro.60.080805.142045; Rothe FM, 2013, J BACTERIOL, V195, P2146, DOI 10.1128/JB.00117-13; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Saum SH, 2006, J BACTERIOL, V188, P6808, DOI 10.1128/JB.00781-06; Sonenshein AL, 2007, NAT REV MICROBIOL, V5, P917, DOI 10.1038/nrmicro1772; Stulke J, 1997, MOL MICROBIOL, V25, P65, DOI 10.1046/j.1365-2958.1997.4351797.x; Taddei F, 1997, MOL GEN GENET, V256, P277, DOI 10.1007/s004380050570; Wacker I, 2003, MICROBIOL-SGM, V149, P3001, DOI 10.1099/mic.0.26479-0; Wang Q, 2012, SCIENCE, V327, P1004; Wohlhueter R, 1973, ENZYMES GLUTAMINE ME, P45; Wrande M, 2008, P NATL ACAD SCI USA, V105, P11863, DOI 10.1073/pnas.0804739105; Zeigler DR, 2008, J BACTERIOL, V190, P6983, DOI 10.1128/JB.00722-08	58	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66120	10.1371/journal.pone.0066120	http://dx.doi.org/10.1371/journal.pone.0066120			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785476	Green Published, gold, Green Submitted			2022-12-27	WOS:000321038800048
J	Huang, ZC; Zhao, XK; Zhang, L; Zhong, ZH; Xu, R; Zhang, LP				Huang, Zhichao; Zhao, Xiaokun; Zhang, Lei; Zhong, Zhaohui; Xu, Ran; Zhang, Lianping			Extracorporeal Shock Wave Lithotripsy for Management of Residual Stones after Ureterolithotripsy versus Mini-Percutaneous Nephrolithotomy: A Retrospective Study	PLOS ONE			English	Article							URETERAL CALCULI; INDUCED DESTRUCTION; KIDNEY-STONES; COMPLICATIONS; URETEROSCOPY; GUIDELINES; SUCCESS	Purpose: To compare the efficacy of extracorporeal shock wave lithotripsy in managing residual stones after ureterolithotripsy and mini-percutaneous nephrolithotomy. Materials and Methods: A retrospective study was carried out of 71 patients with proximal urinary tract stones (greater than 10 mm) who underwent ureterolithotripsy or mini-percutaneous nephrolithotomy at a single institution from 2009 to 2011. The 71 patients were divided into two groups: group I (n = 37) comprised patients who underwent ureterolithotripsy, and group II (n = 34) comprised patients who underwent mini-percutaneous nephrolithotomy. Clinical characteristics, stone-free rates, stone demographics, and complications were evaluated. Results: The overall stone-free rate was 90.1%. The stone-free rates in groups I and II were 97.3% and 82.4%, respectively. There was a statistically significant difference in the stone-free rates between groups I and II (P = 0.035). Neither serious intraoperative nor postoperative complications were observed. No significant difference in complications was observed between the two groups (P = 0.472). Conclusions: The results of our study suggest that extracorporeal shock wave lithotripsy is an effective and safe auxiliary procedure for managing residual stones after primary endoscopic surgery. This procedure is associated with a satisfactory stone-free rate and a low complication rate, particularly for residual stones after ureteroscopic procedures.	[Huang, Zhichao; Zhao, Xiaokun; Zhang, Lei; Zhong, Zhaohui; Xu, Ran; Zhang, Lianping] Cent S Univ, Dept Urol, Xiangya Hosp 2, Changsha 410083, Hunan, Peoples R China	Central South University	Zhang, LP (corresponding author), Cent S Univ, Dept Urol, Xiangya Hosp 2, Changsha 410083, Hunan, Peoples R China.	417139503@qq.com			Science and Technology Foundation of Department of Public Health of Human, P. R. China [B2006-061]	Science and Technology Foundation of Department of Public Health of Human, P. R. China	This work supported by Science and Technology Foundation of Department of Public Health of Human, P. R. China (B2006-061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ansari A, 2006, INT UROL NEPHROL, V38, P63, DOI 10.1007/s11255-005-3155-z; CHAUSSY C, 1980, LANCET, V2, P1265; CHAUSSY C, 1982, J UROLOGY, V127, P417, DOI 10.1016/S0022-5347(17)53841-0; CHAUSSY CG, 1989, J UROLOGY, V141, P782, DOI 10.1016/S0022-5347(17)41010-X; Conort P, 2004, PROG UROL, V14, P1095; El-Nahas AR, 2007, EUR UROL, V51, P1688, DOI 10.1016/j.eururo.2006.11.048; Elbahnasy AM, 1998, J UROLOGY, V159, P676, DOI 10.1016/S0022-5347(01)63699-1; Galvin DJ, 2006, BJU INT, V98, P1283, DOI 10.1111/j.1464-410X.2006.06514.x; Hatiboglu G, 2011, BJU INT, V108, P1192, DOI 10.1111/j.1464-410X.2010.10007.x; Klingler HC, 2003, EUR UROL, V43, P75, DOI 10.1016/S0302-2838(02)00538-9; Michel MS, 2007, EUR UROL, V51, P899, DOI 10.1016/j.eururo.2006.10.020; MULLERMATTHEIS VGO, 1991, J UROLOGY, V146, P733, DOI 10.1016/S0022-5347(17)37908-9; Pareek G, 2005, UROLOGY, V65, P33, DOI 10.1016/j.urology.2004.08.004; Preminger GM, 2007, EUR UROL, V52, P1610, DOI 10.1016/j.eururo.2007.09.039; RAZ R, 1994, J UROLOGY, V151, P329, DOI 10.1016/S0022-5347(17)34939-X; Salem S, 2010, UROL RES, V38, P135, DOI 10.1007/s00240-009-0247-8; Schuster TG, 2001, J UROLOGY, V166, P538, DOI 10.1016/S0022-5347(05)65978-2; Segura JW, 1997, J UROLOGY, V158, P1915, DOI 10.1016/S0022-5347(01)64173-9; Shen PF, 2011, J UROLOGY, V186, P1328, DOI 10.1016/j.juro.2011.05.073; Shiroyanagi Y, 2002, INT J UROL, V9, P304, DOI 10.1046/j.1442-2042.2002.00475.x; Sighinolfi MC, 2008, J ENDOUROL, V22, P2223, DOI 10.1089/end.2008.9704; Singla M, 2008, UROLOGY, V71, P1039, DOI 10.1016/j.urology.2007.11.072; Skolarikos A, 2006, EUR UROL, V50, P981, DOI 10.1016/j.eururo.2006.01.045; Turk C, 2011, GUIDELINES UROLITHIA	24	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e67046	10.1371/journal.pone.0067046	http://dx.doi.org/10.1371/journal.pone.0067046			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785516	gold, Green Published, Green Submitted			2022-12-27	WOS:000321038800007
J	Ninomiya, M; Kondo, Y; Funayama, R; Nagashima, T; Kogure, T; Kakazu, E; Kimura, O; Ueno, Y; Nakayama, K; Shimosegawa, T				Ninomiya, Masashi; Kondo, Yasuteru; Funayama, Ryo; Nagashima, Takeshi; Kogure, Takayuki; Kakazu, Eiji; Kimura, Osamu; Ueno, Yoshiyuki; Nakayama, Keiko; Shimosegawa, Tooru			Distinct MicroRNAs Expression Profile in Primary Biliary Cirrhosis and Evaluation of miR 505-3p and miR197-3p as Novel Biomarkers	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CIRCULATING MICRORNAS; SUSCEPTIBILITY LOCI; SERUM; HLA; ANTIGEN; GENES; IDENTIFICATION; CHOLANGITIS; DIAGNOSIS	Background and Aims: MicroRNAs are small endogenous RNA molecules with specific expression patterns that can serve as biomarkers for numerous diseases. However, little is known about the expression profile of serum miRNAs in PBC. Methods: First, we employed Illumina deep sequencing for the initial screening to indicate the read numbers of miRNA expression in 10 PBC, 5 CH-C, 5 CH-B patients and 5 healthy controls. Comparing the differentially expressed miRNAs in the 4 groups, analysis of variance was performed on the number of sequence reads to evaluate the statistical significance. Hierarchical clustering was performed using an R platform and we have found candidates for specific miRNAs in the PBC patients. Second, a quantitative reverse transcription PCR validation study was conducted in 10 samples in each group. The expression levels of the selected miRNAs were presented as fold-changes (2(-Delta Delta Ct)). Finally, computer analysis was conducted to predict target genes and biological functions with MiRror 2.0 and DAVID v6.7. Results: We obtained about 12 million 32-mer short RNA reads on average per sample and the mapping rates to miRBase were 16.60% and 81.66% to hg19. In the statistical significance testing, the expression levels of 81 miRNAs were found to be differentially expressed in the 4 groups. The heat map and hierarchical clustering demonstrated that the miRNA profiles from PBC clustered with those of CH-B, CH-C and healthy controls. Additionally, the circulating levels of hsa-miR-505-3p, 197-3p, and 500a-3p were significantly decreased in PBC compared with healthy controls and the expression levels of hsa-miR-505-3p, 139-5p and 197-3p were significantly reduced compared with the viral hepatitis group. Conclusions: Our results indicate that sera from patients with PBC have a unique miRNA expression profile and that the down-regulated expression of hsa-miR-505-3p and miR-197-3p can serve as clinical biomarkers of PBC.	[Ninomiya, Masashi; Kondo, Yasuteru; Kogure, Takayuki; Kakazu, Eiji; Kimura, Osamu; Shimosegawa, Tooru] Tohoku Univ Hosp, Div Gastroenterol, Sendai, Miyagi, Japan; [Funayama, Ryo; Nagashima, Takeshi; Nakayama, Keiko] Tohoku Univ, Sch Med, Div Cell Proliferat, Sendai, Miyagi 980, Japan; [Ueno, Yoshiyuki] Yamagata Univ, Fac Med, Dept Gastroenterol, Yamagata 990, Japan	Tohoku University; Tohoku University; Yamagata University	Kondo, Y (corresponding author), Tohoku Univ Hosp, Div Gastroenterol, Sendai, Miyagi, Japan.	yasuteru@ebony.plala.or.jp	Ueno, Yoshiyuki/R-9242-2019; Kondo, Yasuteru/A-6893-2010; Kogure, Takayuki/AAI-3946-2021	Ueno, Yoshiyuki/0000-0001-5623-4250; Kondo, Yasuteru/0000-0001-5935-4346; 	 [23790765]		Financial support for this study was provided by Grant-in-Aid for Young Scientists (B) (23790765). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai J, 2010, BIOCHEM BIOPH RES CO, V391, P73, DOI 10.1016/j.bbrc.2009.11.005; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Balaga O, 2012, NUCLEIC ACIDS RES, V40, P9404, DOI 10.1093/nar/gks759; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BEGOVICH AB, 1994, TISSUE ANTIGENS, V43, P71, DOI 10.1111/j.1399-0039.1994.tb02303.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berg CP, 2008, APOPTOSIS, V13, P63, DOI 10.1007/s10495-007-0157-6; Bihrer V, 2011, AM J GASTROENTEROL, V106, P1663, DOI 10.1038/ajg.2011.161; Cermelli S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023937; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chim SSC, 2008, CLIN CHEM, V54, P482, DOI 10.1373/clinchem.2007.097972; COPPEL RL, 1988, P NATL ACAD SCI USA, V85, P7317, DOI 10.1073/pnas.85.19.7317; Corpechot C, 2007, HEPATOLOGY, V46, P963, DOI 10.1002/hep.21871; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Donaldson PT, 2006, HEPATOLOGY, V44, P667, DOI 10.1002/hep.21316; Friedman Y, 2010, BIOINFORMATICS, V26, P1920, DOI 10.1093/bioinformatics/btq298; GERSHWIN ME, 1987, J IMMUNOL, V138, P3525; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Hirschfield GM, 2011, SEMIN LIVER DIS, V31, P147, DOI 10.1055/s-0031-1276644; Hirschfield GM, 2009, NEW ENGL J MED, V360, P2544, DOI 10.1056/NEJMoa0810440; Juran BD, 2010, J AUTOIMMUN, V35, P181, DOI 10.1016/j.jaut.2010.06.005; KNODELL RG, 1981, HEPATOLOGY, V1, P431, DOI 10.1002/hep.1840010511; Kong XY, 2011, DIGEST DIS SCI, V56, P602, DOI 10.1007/s10620-010-1285-3; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kyriakou DS, 2003, J HEPATOL, V39, P679, DOI 10.1016/S0168-8278(03)00387-8; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Lewis PJS, 2011, HEPATOLOGY, V54, P1767, DOI 10.1002/hep.24538; Li LM, 2010, CANCER RES, V70, P9798, DOI 10.1158/0008-5472.CAN-10-1001; Li M, 2009, WORLD J SURG, V33, P667, DOI 10.1007/s00268-008-9836-x; Liang Y, 2008, CLIN EXP MED, V8, P1, DOI 10.1007/s10238-008-0149-z; Lindor KD, 2009, HEPATOLOGY, V50, P291, DOI 10.1002/hep.22906; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; LUDWIG J, 1978, VIRCHOWS ARCH A, V379, P103, DOI 10.1007/BF00432479; Maglott D, 2011, NUCLEIC ACIDS RES, V39, pD52, DOI 10.1093/nar/gkq1237; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mells GF, 2011, NAT GENET, V43, P329, DOI 10.1038/ng.789; Metcalf JV, 1996, LANCET, V348, P1399, DOI 10.1016/S0140-6736(96)04410-8; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Morita K, 2011, LIVER INT, V31, P474, DOI 10.1111/j.1478-3231.2010.02433.x; Nakagome Y, 2007, J AUTOIMMUN, V29, P20, DOI 10.1016/j.jaut.2007.03.004; Nakamura M, 2012, AM J HUM GENET, V91, P721, DOI 10.1016/j.ajhg.2012.08.010; NAKANUMA Y, 1979, GASTROENTEROLOGY, V76, P1326; ONISHI S, 1994, J HEPATOL, V21, P1053, DOI 10.1016/S0168-8278(05)80617-8; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; SCHEUER PJ, 1967, P ROY SOC MED, V60, P1257, DOI 10.1177/003591576706001205; Selmi C, 2004, GASTROENTEROLOGY, V127, P485, DOI 10.1053/j.gastro.2004.05.005; Silva J, 2011, EUR RESPIR J, V37, P617, DOI 10.1183/09031936.00029610; Singh R, 2011, CLIN IMMUNOL, V138, P41, DOI 10.1016/j.clim.2010.09.006; Team R. D. C, 2011, R LANG ENV STAT COMP; Tsujiura M, 2010, BRIT J CANCER, V102, P1174, DOI 10.1038/sj.bjc.6605608; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Zhang R, 2007, GENOME RES, V17, P612, DOI 10.1101/gr.6146507; Zhang Y, 2010, CLIN CHEM, V56, P1830, DOI 10.1373/clinchem.2010.147850	56	68	74	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66086	10.1371/journal.pone.0066086	http://dx.doi.org/10.1371/journal.pone.0066086			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776611	Green Submitted, Green Published, gold			2022-12-27	WOS:000320322400079
J	Zhao, XQ; Fitzgerald, M				Zhao, Xiangqian; Fitzgerald, Melissa			Climate Change: Implications for the Yield of Edible	PLOS ONE			English	Article							RICE MILLING QUALITY; ORYZA-SATIVA L.; HIGH-TEMPERATURE; KERNEL DEVELOPMENT; FIELD; PHOTOSYNTHESIS; DIMENSIONS; CHALKY	Global warming affects not only rice yield but also grain quality. A better understanding of the effects of climate factors on rice quality provides information for new breeding strategies to develop varieties of rice adapted to a changing world. Chalkiness is a key trait of physical quality, and along with head rice yield, is used to determine the price of rice in all markets. In the present study, we show that for every, 1% decrease in chalkiness, an increase of, 1% in head rice yield follows, illustrating the dual impact of chalk on amount of marketable rice and its value. Previous studies in controlled growing conditions report that chalkiness is associated with high temperature. From 1980-2009 at IRRI, Los Banos, the Philippines, annual minimum and mean temperatures, and diurnal variation changed significantly. The objective of this study was to determine how climate impacts chalkiness in field conditions over four wet and dry seasons. We show that low relative humidity and a high vapour pressure deficit in the dry season associate with low chalk and high head rice yield in spite of higher maximum temperature, but in the opposite conditions of the wet season, chalk is high and head rice yield is low. The data therefore suggest that transpirational cooling is a key factor affecting chalkiness and head rice yield, and global warming per se might not be the major factor that decreases the amount and quality of rice, but other climate factors in combination, that enable the crop to maintain a cool canopy.	[Zhao, Xiangqian; Fitzgerald, Melissa] IRRI, Grain Qual & Nutr Ctr, Manila, Philippines	CGIAR; International Rice Research Institute (IRRI)	Fitzgerald, M (corresponding author), Univ Queensland, Sch Agr & Food Sci, St Lucia, Qld, Australia.	m.fitzgerald@irri.org	Fitzgerald, Melissa/AAP-6672-2020; Zhao, Xiangqian/AAF-9295-2020	Fitzgerald, Melissa/0000-0002-0761-764X; 	Australian Centre for International Agricultural Research [CIM-2006-176]	Australian Centre for International Agricultural Research	Funding was from the Australian Centre for International Agricultural Research (www.aciar.gov.au) under the grant CIM-2006-176. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah Z, 2001, J AGRON CROP SCI, V187, P25, DOI 10.1046/j.1439-037X.2001.00500.x; Ambardekar AA, 2011, FIELD CROP RES, V122, P179, DOI 10.1016/j.fcr.2011.03.012; Cooper NTW, 2008, CEREAL CHEM, V85, P276, DOI 10.1094/CCHEM-85-3-0276; Cooper NTW, 2006, CEREAL CHEM, V83, P447, DOI 10.1094/CC-83-0447; Counce PA, 2005, CEREAL CHEM, V82, P645, DOI 10.1094/CC-82-0645; Ebata M, 1960, JAPANESE J CROP SCI, V29, P93; Fan YP, 1988, CROP RES, V2, P18; Fitzgerald MA, 2009, FUNCT PLANT BIOL, V36, P1037, DOI 10.1071/FP09055; Haefele SM, 2009, FIELD CROP RES, V111, P1, DOI 10.1016/j.fcr.2008.09.008; Hansen J, 2010, REV GEOPHYS, V48, DOI 10.1029/2010RG000345; Hirasawa T, 1999, FIELD CROP RES, V62, P53, DOI 10.1016/S0378-4290(99)00005-2; Lisle AJ, 2000, CEREAL CHEM, V77, P627, DOI 10.1094/CCHEM.2000.77.5.627; Lobell DB, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/1/014002; Matsui T, 2007, PLANT PROD SCI, V10, P57, DOI 10.1626/pps.10.57; Nicholls N, 1995, CLIMATE CHANGE 1995: THE SCIENCE OF CLIMATE CHANGE, P133; Peng SB, 2004, P NATL ACAD SCI USA, V101, P9971, DOI 10.1073/pnas.0403720101; Rosegrant MW, 2003, SCIENCE, V302, P1917, DOI 10.1126/science.1092958; Shi CH, 2002, FIELD CROP RES, V76, P1, DOI 10.1016/S0378-4290(02)00011-4; Tashiro T., 1975, Proceedings of the Crop Science Society of Japan, V44, P86; TASHIRO T, 1991, AUST J AGR RES, V42, P485, DOI 10.1071/AR9910485; Tsukaguchi T, 2008, PLANT PROD SCI, V11, P203, DOI 10.1626/pps.11.203; Wanjura DF, 1997, AGR WATER MANAGE, V34, P217, DOI 10.1016/S0378-3774(97)00024-3; Welch JR, 2010, P NATL ACAD SCI USA, V107, P14562, DOI 10.1073/pnas.1001222107; Yamakawa H, 2007, PLANT PHYSIOL, V144, P258, DOI 10.1104/pp.107.098665; Zhu DeFeng, 2010, Scientia Agricultura Sinica, V43, P474; Ziska LH, 1998, GLOBAL CHANGE BIOL, V4, P637, DOI 10.1046/j.1365-2486.1998.00179.x	26	74	78	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66218	10.1371/journal.pone.0066218	http://dx.doi.org/10.1371/journal.pone.0066218			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776635	Green Submitted, gold, Green Published			2022-12-27	WOS:000320322400087
J	Guo, BJ; Chen, YH; Zhang, GP; Xing, JW; Hu, ZR; Feng, WJ; Yao, YY; Peng, HR; Du, JK; Zhang, YR; Ni, ZF; Sun, QX				Guo, Baojian; Chen, Yanhong; Zhang, Guiping; Xing, Jiewen; Hu, Zhaorong; Feng, Wanjun; Yao, Yingyin; Peng, Huiru; Du, Jinkun; Zhang, Yirong; Ni, Zhongfu; Sun, Qixin			Comparative Proteomic Analysis of Embryos between a Maize Hybrid and Its Parental Lines during Early Stages of Seed Germination	PLOS ONE			English	Article							NONADDITIVE PROTEIN ACCUMULATION; DIFFERENTIAL GENE-EXPRESSION; RICE CULTIVAR; INBRED LINES; HETEROSIS; ROOT; IDENTIFICATION; MICROARRAY; DOMINANCE; SEQUENCE	In spite of commercial use of heterosis in agriculture, the molecular basis of heterosis is poorly understood. It was observed that maize hybrid Zong3/87-1 exhibited an earlier onset or heterosis in radicle emergence. To get insights into the underlying mechanism of heterosis in radicle emergence, differential proteomic analysis between hybrid and its parental lines was performed. In total, the number of differentially expressed protein spots between hybrid and its parental lines in dry and 24 h imbibed seed embryos were 134 and 191, respectively, among which 47.01% (63/134) and 34.55% (66/191) protein spots displayed nonadditively expressed pattern. Remarkably, 54.55% of nonadditively accumulated proteins in 24 h imbibed seed embryos displayed above or equal to the level of the higher parent patterns. Moreover, 155 differentially expressed protein spots were identified, which were grouped into eight functional classes, including transcription & translation, energy & metabolism, signal transduction, disease & defense, storage protein, transposable element, cell growth & division and unclassified proteins. In addition, one of the upregulated proteins in F-1 hybrids was ZmACT2, a homolog of Arabidopsis thaliana ACT7 (AtACT7). Expressing ZmACT2 driven by the AtACT7 promoter partially complemented the low germination phenotype in the Atact7 mutant. These results indicated that hybridization between two parental lines can cause changes in the expression of a variety of proteins, and it is concluded that the altered pattern of gene expression at translational level in the hybrid may be responsible for the observed heterosis.	[Guo, Baojian; Chen, Yanhong; Zhang, Guiping; Xing, Jiewen; Hu, Zhaorong; Feng, Wanjun; Yao, Yingyin; Peng, Huiru; Du, Jinkun; Zhang, Yirong; Ni, Zhongfu; Sun, Qixin] China Agr Univ, Beijing Key Lab Crop Genet Improvement, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Guo, Baojian; Chen, Yanhong; Zhang, Guiping; Xing, Jiewen; Hu, Zhaorong; Feng, Wanjun; Yao, Yingyin; Peng, Huiru; Du, Jinkun; Zhang, Yirong; Ni, Zhongfu; Sun, Qixin] China Agr Univ, Beijing Key Lab Crop Genet Improvement, Key Lab Crop Heterosis & Utilizat MOE, Beijing 100094, Peoples R China; [Guo, Baojian; Chen, Yanhong; Zhang, Guiping; Xing, Jiewen; Hu, Zhaorong; Feng, Wanjun; Yao, Yingyin; Peng, Huiru; Du, Jinkun; Zhang, Yirong; Ni, Zhongfu; Sun, Qixin] Natl Plant Gene Res Ctr Beijing, Beijing, Peoples R China	China Agricultural University; China Agricultural University	Ni, ZF (corresponding author), China Agr Univ, Beijing Key Lab Crop Genet Improvement, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	nzhf2002@aliyun.com; qxsun@cau.edu.cn			National Basic Research Program of China (973 Program) [2012CB910900]; National Natural Science Foundation of China [31230054, 30925023]; 863 Project of China [2012AA10A305]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 863 Project of China(National High Technology Research and Development Program of China)	This work was financially supported by the National Basic Research Program of China (973 Program) (2012CB910900), the National Natural Science Foundation of China (31230054 and 30925023) and 863 Project of China (2012AA10A305) (http://www.sciencedirect.com/science/article/pii/S0378111912004131#gts0005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andorf S, 2010, THEOR APPL GENET, V120, P249, DOI 10.1007/s00122-009-1214-z; Bevan M, 1998, NATURE, V391, P485, DOI 10.1038/35140; Bewley JD, 1997, PLANT CELL, V9, P1055, DOI 10.1105/tpc.9.7.1055; Birchler JA, 2003, PLANT CELL, V15, P2236, DOI 10.1105/tpc.151030; Dahal D, 2012, PLANT J, V72, P70, DOI 10.1111/j.1365-313X.2012.05056.x; Diaz-Camino C, 2005, J EXP BOT, V56, P557, DOI 10.1093/jxb/eri034; Donnelly BE, 2005, PROTEOMICS, V5, P1624, DOI 10.1002/pmic.200401042; Fu HH, 2002, P NATL ACAD SCI USA, V99, P9573, DOI 10.1073/pnas.132259199; Fu ZY, 2011, PROTEOMICS, V11, P1462, DOI 10.1002/pmic.201000481; Gilliland LU, 2003, PLANT J, V33, P319, DOI 10.1046/j.1365-313X.2003.01626.x; GONELLA JA, 1978, MAYDICA, V23, P55; Guo M, 2006, THEOR APPL GENET, V113, P831, DOI 10.1007/s00122-006-0335-x; HEIDRICHSOBRINHO E, 1975, THEOR APPL GENET, V46, P197, DOI 10.1007/BF00281670; Hoecker N, 2008, PROTEOMICS, V8, P3882, DOI 10.1002/pmic.200800023; Hua JP, 2003, P NATL ACAD SCI USA, V100, P2574, DOI 10.1073/pnas.0437907100; Huang Y, 2006, SCI CHINA SER C, V49, P519, DOI 10.1007/s11427-006-2031-0; HUNTER RB, 1971, CAN J GENET CYTOL, V13, P649, DOI 10.1139/g71-093; Limami AM, 2002, PLANT PHYSIOL, V130, P1860, DOI 10.1104/pp.009647; Liu PP, 2007, PLANT J, V52, P133, DOI 10.1111/j.1365-313X.2007.03218.x; Marcon C, 2010, J PROTEOME RES, V9, P6511, DOI 10.1021/pr100718d; Meagher R.B., 2000, ACTIN DYNAMIC FRAMEW, P3; Meagher RB, 1999, TRENDS GENET, V15, P278, DOI 10.1016/S0168-9525(99)01759-X; Meyer S, 2007, PLANT MOL BIOL, V63, P381, DOI 10.1007/s11103-006-9095-x; Morita-Yamamuro C, 2004, PLANT CELL PHYSIOL, V45, P781, DOI 10.1093/pcp/pch093; Morris K, 2011, PLANT PHYSIOL, V155, P1851, DOI 10.1104/pp.110.169706; Niogret MF, 1996, PLANT J, V9, P549, DOI 10.1046/j.1365-313X.1996.09040549.x; Porubleva L, 2001, ELECTROPHORESIS, V22, P1724, DOI 10.1002/1522-2683(200105)22:9&lt;1724::AID-ELPS1724&gt;3.0.CO;2-2; Potokina E, 2002, FUNCT INTEGR GENOMIC, V2, P28, DOI 10.1007/s10142-002-0050-x; Ramagli LS, 1999, METH MOL B, V112, P99; ROMAGNOLI S, 1990, THEOR APPL GENET, V80, P769, DOI 10.1007/BF00224190; SARKISSIAN IV, 1964, P NATL ACAD SCI USA, V51, P212, DOI 10.1073/pnas.51.2.212; Song SH, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-49; Song X, 2009, THEOR APPL GENET, V118, P213, DOI 10.1007/s00122-008-0890-4; Song X, 2007, PROTEOMICS, V7, P3538, DOI 10.1002/pmic.200700147; SOPORY SK, 1980, PLANT CELL PHYSIOL, V21, P649, DOI 10.1093/oxfordjournals.pcp.a076039; STUBER CW, 1992, GENETICS, V132, P823; Stupar RM, 2007, PLANT PHYSIOL, V145, P411, DOI 10.1104/pp.107.101428; Swanson-Wagner RA, 2006, P NATL ACAD SCI USA, V103, P6805, DOI 10.1073/pnas.0510430103; Wang WW, 2008, PROTEOMICS, V8, P4808, DOI 10.1002/pmic.200701164; XIAO JH, 1995, GENETICS, V140, P745; Xu H, 2004, ACTA BIOCH BIOPH SIN, V36, P169, DOI 10.1093/abbs/36.3.169; Yao YY, 2006, PLANT SCI, V170, P579, DOI 10.1016/j.plantsci.2005.10.012; Yao YY, 2005, PLANT MOL BIOL, V58, P367, DOI 10.1007/s11103-005-5102-x; Yu SB, 1997, P NATL ACAD SCI USA, V94, P9226, DOI 10.1073/pnas.94.17.9226	44	43	45	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65867	10.1371/journal.pone.0065867	http://dx.doi.org/10.1371/journal.pone.0065867			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776561	Green Published, gold, Green Submitted			2022-12-27	WOS:000320755400077
J	Illuzzi, JL; Harris, NA; Manvilla, BA; Kim, D; Li, MX; Drohat, AC; Wilson, DM				Illuzzi, Jennifer L.; Harris, Nicole A.; Manvilla, Brittney A.; Kim, Daemyung; Li, Mengxia; Drohat, Alexander C.; Wilson, David M., III			Functional Assessment of Population and Tumor-Associated APE1 Protein Variants	PLOS ONE			English	Article							BASE-EXCISION-REPAIR; DNA-POLYMERASE-BETA; HUMAN APURINIC ENDONUCLEASE; MAJOR HUMAN; APURINIC/APYRIMIDINIC ENDONUCLEASE; MECHANISTIC INSIGHTS; CANCER-RISK; SITE; IDENTIFICATION; MICE	Apurinic/apyrimidinic endonuclease 1 (APE1) is the predominant AP site repair enzyme in mammals. APE1 also maintains 3'-5' exonuclease and 3'-repair activities, and regulates transcription factor DNA binding through its REF-1 function. Since complete or severe APE1 deficiency leads to embryonic lethality and cell death, it has been hypothesized that APE1 protein variants with slightly impaired function will contribute to disease etiology. Our data indicate that except for the endometrial cancer-associated APE1 variant R237C, the polymorphic variants Q51H, I64V and D148E, the rare population variants G241R, P311S and A317V, and the tumor-associated variant P112L exhibit normal thermodynamic stability of protein folding; abasic endonuclease, 3'-5' exonuclease and REF-1 activities; coordination during the early steps of base excision repair; and intracellular distribution when expressed exogenously in HeLa cells. The R237C mutant displayed reduced AP-DNA complex stability, 3'-5' exonuclease activity and 3'-damage processing. Re-sequencing of the exonic regions of APE1 uncovered no novel amino acid substitutions in the 60 cancer cell lines of the NCI-60 panel, or in HeLa or T98G cancer cell lines; only the common D148E and Q51H variants were observed. Our results indicate that APE1 missense mutations are seemingly rare and that the cancer-associated R237C variant may represent a reduced-function susceptibility allele.	[Illuzzi, Jennifer L.; Li, Mengxia; Wilson, David M., III] NIA, Lab Mol Gerontol, NIH, Baltimore, MD 21224 USA; [Harris, Nicole A.] Sanford Burnham Med Res Inst, Dept Cardiopathol, Orlando, FL USA; [Manvilla, Brittney A.; Drohat, Alexander C.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Drohat, Alexander C.] Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Kim, Daemyung] Cheongju Univ, Dept Genet Engn, Cheongju, South Korea	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Sanford Burnham Prebys Medical Discovery Institute; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Cheongju University	Wilson, DM (corresponding author), NIA, Lab Mol Gerontol, NIH, Baltimore, MD 21224 USA.	wilsonda@mail.nih.gov	Wilson, David M/AAK-5409-2021; Li, Mengxia/AAM-4289-2020	Wilson, David M/0000-0002-8945-0395; Li, Mengxia/0000-0003-4443-740X; Drohat, Alex/0000-0002-7458-8770	National Institutes of Health (NIH), National Institute on Aging; NIH [R01-GM72711, T32GM 066706-07]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066706, R01GM072711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000750] Funding Source: NIH RePORTER	National Institutes of Health (NIH), National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the Intramural Research Program at the National Institutes of Health (NIH), National Institute on Aging, and an NIH grant to ACD (R01-GM72711). BAM was supported by an NIH training grant (T32GM 066706-07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbotts R, 2010, CANCER TREAT REV, V36, P425, DOI 10.1016/j.ctrv.2009.12.006; Barnes T, 2009, NUCLEIC ACIDS RES, V37, P3946, DOI 10.1093/nar/gkp275; BARZILAY G, 1995, NUCLEIC ACIDS RES, V23, P1544, DOI 10.1093/nar/23.9.1544; Berquist BR, 2010, NUCLEIC ACIDS RES, V38, P5023, DOI 10.1093/nar/gkq193; Buetow KH, 1999, NAT GENET, V21, P323, DOI 10.1038/6851; Busso CS, 2010, CELL MOL LIFE SCI, V67, P3609, DOI 10.1007/s00018-010-0487-3; Cabelof DC, 2006, CANCER RES, V66, P7460, DOI 10.1158/0008-5472.CAN-06-1177; Cabelof DC, 2012, CELL MOL LIFE SCI, V69, P727, DOI 10.1007/s00018-011-0839-7; Daviet S, 2007, DNA REPAIR, V6, P8, DOI 10.1016/j.dnarep.2006.08.001; DEMPLE B, 1994, ANNU REV BIOCHEM, V63, P915, DOI 10.1146/annurev.biochem.63.1.915; Erzberger JP, 1998, NUCLEIC ACIDS RES, V26, P2771, DOI 10.1093/nar/26.11.2771; Fortini P, 2007, DNA REPAIR, V6, P398, DOI 10.1016/j.dnarep.2006.10.008; Georgiadis MM, 2008, MUTAT RES-FUND MOL M, V643, P54, DOI 10.1016/j.mrfmmm.2008.04.008; Hadi MZ, 2000, NUCLEIC ACIDS RES, V28, P3871, DOI 10.1093/nar/28.20.3871; Hakem R, 2008, EMBO J, V27, P589, DOI 10.1038/emboj.2008.15; Hung RJ, 2005, AM J EPIDEMIOL, V162, P925, DOI 10.1093/aje/kwi318; Illuzzi JL, 2012, CURR MED CHEM, V19, P3922; Kelley Mark R, 2012, Curr Mol Pharmacol, V5, P36; Leatherbarrow RJ, 1998, STAINES; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; LOEB LA, 1986, ANNU REV GENET, V20, P201, DOI 10.1146/annurev.ge.20.120186.001221; Loeb LA, 2011, NAT REV CANCER, V11, P450, DOI 10.1038/nrc3063; Manyusa S, 1999, BIOCHEMISTRY-US, V38, P9533, DOI 10.1021/bi990550d; McNeill DR, 2011, NUCLEIC ACIDS RES, V39, P7992, DOI 10.1093/nar/gkr280; Nemec AA, 2010, SEMIN CANCER BIOL, V20, P320, DOI 10.1016/j.semcancer.2010.10.010; Nguyen LH, 2000, J MOL BIOL, V298, P447, DOI 10.1006/jmbi.2000.3653; Pieretti M, 2001, MUTAT RES-GENOMICS, V432, P53, DOI 10.1016/S1383-5726(00)00002-9; Robertson AB, 2009, CELL MOL LIFE SCI, V66, P981, DOI 10.1007/s00018-009-8736-z; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; SEKI S, 1991, BIOCHIM BIOPHYS ACTA, V1079, P57, DOI 10.1016/0167-4838(91)90024-T; Sobol RW, 1996, NATURE, V379, P183, DOI 10.1038/379183a0; Sokhansanj BA, 2002, NUCLEIC ACIDS RES, V30, P1817, DOI 10.1093/nar/30.8.1817; Sugo N, 2000, EMBO J, V19, P1397, DOI 10.1093/emboj/19.6.1397; Sweasy JB, 2005, P NATL ACAD SCI USA, V102, P14350, DOI 10.1073/pnas.0505166102; Tebbs RS, 1999, DEV BIOL, V208, P513, DOI 10.1006/dbio.1999.9232; Ventrella-Lucente LF, 2010, J BIOL CHEM, V285, P19246, DOI 10.1074/jbc.M109.069807; Wiederhold L, 2004, MOL CELL, V15, P209, DOI 10.1016/j.molcel.2004.06.003; Wilson DM, 2011, MUTAT RES-FUND MOL M, V711, P100, DOI 10.1016/j.mrfmmm.2010.12.004; Wilson DM, 2001, MUTAT RES-DNA REPAIR, V485, P283, DOI 10.1016/S0921-8777(01)00063-5; Wilson DM, 2003, J MOL BIOL, V330, P1027, DOI 10.1016/S0022-2836(03)00712-5; WILSON DM, 1995, J BIOL CHEM, V270, P16002, DOI 10.1074/jbc.270.27.16002; Wilson DM, 1997, NUCLEIC ACIDS RES, V25, P933, DOI 10.1093/nar/25.5.933; Wilson SH, 2000, NAT STRUCT BIOL, V7, P176; Xanthoudakis S, 1996, P NATL ACAD SCI USA, V93, P8919, DOI 10.1073/pnas.93.17.8919; XANTHOUDAKIS S, 1994, P NATL ACAD SCI USA, V91, P23, DOI 10.1073/pnas.91.1.23; XANTHOUDAKIS S, 1992, EMBO J, V11, P653, DOI 10.1002/j.1460-2075.1992.tb05097.x; Xi T, 2004, GENOMICS, V83, P970, DOI 10.1016/j.ygeno.2003.12.016; Yamtich J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003052; Yates LR, 2012, NAT REV GENET, V13, P795, DOI 10.1038/nrg3317	49	24	24	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65922	10.1371/journal.pone.0065922	http://dx.doi.org/10.1371/journal.pone.0065922			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776569	Green Submitted, Green Published, gold			2022-12-27	WOS:000320755400081
J	Margalida, A; Carrete, M; Hegglin, D; Serrano, D; Arenas, R; Donazar, JA				Margalida, Antoni; Carrete, Martina; Hegglin, Daniel; Serrano, David; Arenas, Rafael; Donazar, Jose A.			Uneven Large-Scale Movement Patterns in Wild and Reintroduced Pre-Adult Bearded Vultures: Conservation Implications	PLOS ONE			English	Article							GYPAETUS-BARBATUS; POPULATION VIABILITY; GENETIC-VARIABILITY; DISPERSAL; DEPRESSION; DIVERSITY; SURVIVAL; MODELS	After the quasi-extinction of much of the European vertebrate megafauna during the last few centuries, many reintroduction projects seek to restore decimated populations. However, the future of numerous species depends on the management scenarios of metapopulations where the flow of individuals can be critical to ensure their viability. This is the case of the bearded vulture Gypaetus barbatus, an Old World, large body-sized and long-lived scavenger living in mountain ranges. Although persecution in Western Europe restrained it to the Pyrenees, the species is nowadays present in other mountains thanks to reintroduction projects. We examined the movement patterns of pre-adult non-breeding individuals born in the wild population of the Pyrenees (n = 9) and in the reintroduced populations of the Alps (n = 24) and Andalusia (n = 13). Most birds were equipped with GPS-GSM radio transmitters, which allowed accurate determination of individual dispersal patterns. Two estimators were considered: i) step length (i. e., the distance travelled per day by each individual, calculated considering only successive days); and ii)total dispersal distance (i. e., the distance travelled between each mean daily location and the point of release). Both dispersal estimators showed a positive relationship with age but were also highly dependent on the source population, birds in Andalusia and Alps moving farther than in Pyrenees. Future research should confirm if differences in dispersal distances are the rule, in which case the dynamics of future populations would be strongly influenced. In summary, our findings highlight that inter-population differences can affect the flow of individuals among patches (a key aspect to ensure the viability of the European metapopulation of the endangered bearded vulture), and thus should be taken into account when planning reintroduction programs. This result also raises questions about whether similar scenarios may occur in other restoration projects of European megafauna.	[Margalida, Antoni] Univ Bern, Inst Ecol & Evolut, Div Conservat Biol, Bern, Switzerland; [Margalida, Antoni] Bearded Vulture Study & Protect Grp, El Pont De Suert, Lleida, Spain; [Carrete, Martina] Univ Pablo Olavide, Dept Phys Chem & Nat Syst, Seville, Spain; [Hegglin, Daniel] Stiftung Pro Bartgeier, Zurich, Switzerland; [Hegglin, Daniel] SWILD Urban Ecol & Wildlife Res, Zurich, Switzerland; [Hegglin, Daniel] Vulture Conservat Fdn, Zurich, Switzerland; [Hegglin, Daniel] FSWILD Urban Ecol & Wildlife Res, Zurich, Switzerland; [Serrano, David; Donazar, Jose A.] CSIC, Estn Biol Donana, Dept Conservat Biol, E-41080 Seville, Spain; [Arenas, Rafael] Consejeria Medio Ambiente, Direcc Prov Cordoba, Cordoba, Spain	University of Bern; Fundacion para la Conservacion del Quebranthuesos (FCQ); Universidad Pablo de Olavide; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Margalida, A (corresponding author), Univ Bern, Inst Ecol & Evolut, Div Conservat Biol, Bern, Switzerland.	antoni.margalida@iee.unibe.ch	Carrete, Martina/A-6376-2009; Margalida, Antoni/A-2723-2011; Serrano, David/B-5352-2013; Margalida, Antoni/AAG-5337-2020; Carrete, Martina/D-2618-2017; Margalida, Antoni/A-2723-2011	Carrete, Martina/0000-0002-0491-2950; Margalida, Antoni/0000-0002-0576-3993; Serrano, David/0000-0001-6205-386X; Donazar, Jose Antonio/0000-0002-9433-9755; Margalida, Antoni/0000-0002-3904-6212; Margalida, Antoni/0000-0002-7383-671X	Ministerio de Ciencia e Innovacion [RYC-2009-04860]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	The authors acknowledge Ministerio de Medio Ambiente, Tragsatec, Generalitat de Catalunya, Junta de Andalucia, Fundacion Gypaetus, Gobierno de Navarra, Nationalpark Hohe Tauern, Parc National du Mercantour, Parco Naturale delle Alpi Marittime, Nationalpark Stilfserjoch and Parc naturel regional du Vercors. MC was supported by a Ramon y Cajal research contract from the Ministerio de Ciencia e Innovacion (RYC-2009-04860). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beissinger S. R., 2002, POPULATION VIABILITY; Butler H, 2005, WILDLIFE RES, V32, P157, DOI 10.1071/WR04027; Calvete C, 2004, BIOL CONSERV, V120, P507, DOI 10.1016/j.biocon.2004.03.023; Carrete M, 2006, ECOL APPL, V16, P1674, DOI 10.1890/1051-0761(2006)016[1674:DPDIPB]2.0.CO;2; Carrete M, 2006, BIOL LETTERS, V2, P624, DOI 10.1098/rsbl.2006.0498; Doerr ED, 2005, OECOLOGIA, V142, P1, DOI 10.1007/s00442-004-1707-z; Doligez B, 2009, P R SOC B, V276, P2829, DOI 10.1098/rspb.2009.0454; Donazar JA, 2002, ECOL APPL, V12, P1445, DOI 10.1890/1051-0761(2002)012[1445:EOFAOL]2.0.CO;2; Ellegren H, 1996, P ROY SOC B-BIOL SCI, V263, P1635, DOI 10.1098/rspb.1996.0239; Fave MJ, 2008, CONSERV GENET, V9, P281, DOI 10.1007/s10592-007-9339-6; Flagstad O, 2003, MOL ECOL, V12, P869, DOI 10.1046/j.1365-294X.2003.01784.x; Frankham R, 1995, ANNU REV GENET, V29, P305, DOI 10.1146/annurev.ge.29.120195.001513; Fuller MR, 1987, J RAPTOR RES, V21, P126; Gautschi B, 2003, CONSERV GENET, V4, P479, DOI 10.1023/A:1024730128819; Godoy JA, 2004, MOL ECOL, V13, P371, DOI 10.1046/j.1365-294X.2003.02075.x; Grande JM, 2009, OIKOS, V118, P580, DOI 10.1111/j.1600-0706.2009.17218.x; GREENWOOD PJ, 1982, ANNU REV ECOL SYST, V13, P1, DOI 10.1146/annurev.es.13.110182.000245; HANSKI I, 1991, BIOL J LINN SOC, V42, P17, DOI 10.1111/j.1095-8312.1991.tb00549.x; Hanski I, 1999, OIKOS, V87, P209, DOI 10.2307/3546736; Hatfield T, 1999, EVOLUTION, V53, P866, DOI 10.1111/j.1558-5646.1999.tb05380.x; Hiraldo F, 1979, MONOGRAFIAS I CONSER, V22; Hirzel AH, 2004, J APPL ECOL, V41, P1103, DOI 10.1111/j.0021-8901.2004.00980.x; Huff DD, 2011, MOL ECOL, V20, P4246, DOI 10.1111/j.1365-294X.2011.05271.x; JOHNSON ML, 1990, ANNU REV ECOL SYST, V21, P449, DOI 10.1146/annurev.ecolsys.21.1.449; Kuemmerle T, 2011, J APPL ECOL, V48, P317, DOI 10.1111/j.1365-2664.2010.01954.x; Macdonald David W., 2001, P358; Margalida A, 2010, THESIS U BERN BERN; Margalida A, 2008, BIRD CONSERV INT, V18, P1, DOI 10.1017/S0959270908000026; Margalida A, 2008, IBIS, V150, P242, DOI 10.1111/j.1474-919X.2007.00768.x; Margalida A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00753; Margalida A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026784; Margalida A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020248; Mathews F, 2005, BIOL CONSERV, V121, P569, DOI 10.1016/j.biocon.2004.06.007; McPhee ME, 2004, BIOL CONSERV, V115, P71, DOI 10.1016/S0006-3207(03)00095-8; Morris W. F., 2002, QUANTITATIVE CONSERV; Negro JJ, 1999, BIOL CONSERV, V87, P249, DOI 10.1016/S0006-3207(98)00056-1; Nichols J., 2001, DISPERSAL; Oro D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004084; Ortega E, 2009, ORYX, V43, P113, DOI 10.1017/S0030605307991048; Perez I, 2012, FRONT ECOL ENVIRON, V10, P494, DOI 10.1890/110175; Proctor MF, 2012, WILDLIFE MONOGR, P1, DOI 10.1002/wmon.6; Rodriguez A, 2003, BIOL CONSERV, V109, P321, DOI 10.1016/S0006-3207(02)00158-1; SAS Institure Inc, 2008, SAS COMP LANG 9 2; Schaub M, 2009, J APPL ECOL, V46, P92, DOI 10.1111/j.1365-2664.2008.01585.x; Schlaepfer MA, 2002, TRENDS ECOL EVOL, V17, P474, DOI 10.1016/S0169-5347(02)02580-6; Serrano D, 2003, J ANIM ECOL, V72, P400, DOI 10.1046/j.1365-2656.2003.00707.x; Simon MA, 2005, BIOL CONSERVACION QU, P255; Skjelseth S, 2007, P ROY SOC B-BIOL SCI, V274, P1763, DOI 10.1098/rspb.2007.0338	48	49	51	0	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65857	10.1371/journal.pone.0065857	http://dx.doi.org/10.1371/journal.pone.0065857			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776559	Green Published, Green Submitted, gold			2022-12-27	WOS:000320755400075
J	Oksanen, T; Kawachi, I; Kouvonen, A; Takao, S; Suzuki, E; Virtanen, M; Pentti, J; Kivimaki, M; Vahtera, J				Oksanen, Tuula; Kawachi, Ichiro; Kouvonen, Anne; Takao, Soshi; Suzuki, Etsuji; Virtanen, Marianna; Pentti, Jaana; Kivimaki, Mika; Vahtera, Jussi			Workplace Determinants of Social Capital: Cross-Sectional and Longitudinal Evidence from a Finnish Cohort Study	PLOS ONE			English	Article							NEIGHBORHOOD DETERMINANTS; ENVIRONMENT; MULTILEVEL; HEALTH; PARTICIPATION; DEPRESSION; PREDICTOR; INCOME; LEVEL; WORK	Objective: To examine which contextual features of the workplace are associated with social capital. Methods: This is a cohort study of 43,167 employees in 3090 Finnish public sector workplaces who responded to a survey of individual workplace social capital in 2000-02 (response rate 68%). We used ecometrics approach to estimate social capital of work units. Features of the workplace were work unit's demographic and employment patterns and size, obtained from employers' administrative records. We used multilevel-multinomial logistic regression models to examine cross-sectionally whether these features were associated with social capital between individuals and work units. Fixed effects models were used for longitudinal analyses in a subsample of 12,108 individuals to examine the effects of changes in workplace characteristics on changes in social capital between 2000 and 2004. Results: After adjustment for individual characteristics, an increase in work unit size reduced the odds of high levels of individual workplace social capital (odds ratio 0.94, 95% confidence interval 0.91-0.98 per 30-person-year increase). A 20% increase in the proportion of manual and male employees reduced the odds of high levels of social capital by 8% and 23%, respectively. A 30% increase in temporary employees and a 20% increase in employee turnover were associated with 11% (95% confidence interval 1.04-1.17) and 24% (95% confidence interval 1.18-1.30) higher odds of having high levels of social capital respectively). Results from fixed effects models within individuals, adjusted for time-varying covariates, and from social capital of the work units yielded consistent results. Conclusions: These findings suggest that workplace social capital is contextually patterned. Workplace demographic and employment patterns as well as the size of the work unit are important in understanding variations in workplace social capital between individuals and workplaces.	[Oksanen, Tuula; Virtanen, Marianna; Pentti, Jaana; Kivimaki, Mika; Vahtera, Jussi] Finnish Inst Occupat Hlth, Turku, Finland; [Oksanen, Tuula; Virtanen, Marianna; Pentti, Jaana; Kivimaki, Mika; Vahtera, Jussi] Finnish Inst Occupat Hlth, Helsinki, Finland; [Kawachi, Ichiro] Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA; [Kouvonen, Anne] Queens Univ Belfast, Sch Sociol Social Policy & Social Work, Belfast, Antrim, North Ireland; [Kouvonen, Anne] Queens Univ Belfast, UKCRC Ctr Excellence Publ Hlth NI, Belfast, Antrim, North Ireland; [Takao, Soshi; Suzuki, Etsuji] Okayama Univ, Dept Epidemiol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan; [Kivimaki, Mika] UCL, Dept Epidemiol & Publ Hlth, London, England; [Kivimaki, Mika] Univ Helsinki, Inst Behav Sci, Helsinki, Finland; [Vahtera, Jussi] Univ Turku, Dept Publ Hlth, Turku, Finland; [Vahtera, Jussi] Turku Univ Hosp, FIN-20520 Turku, Finland	Finnish Institute of Occupational Health; Finnish Institute of Occupational Health; Harvard University; Harvard T.H. Chan School of Public Health; Queens University Belfast; Queens University Belfast; Okayama University; University of London; University College London; University of Helsinki; University of Turku; University of Turku	Oksanen, T (corresponding author), Finnish Inst Occupat Hlth, Turku, Finland.	tuula.oksanen@ttl.fi	Suzuki, Etsuji/B-2342-2011; Kivimaki, Mika/B-3607-2012; Vahtera, Jussi/J-3271-2013; Oksanen, Tuula/AAK-5599-2021	Suzuki, Etsuji/0000-0002-1290-5793; Kivimaki, Mika/0000-0002-4699-5627; Kouvonen, Anne/0000-0001-6997-8312; Vahtera, Jussi/0000-0002-6036-061X	Academy of Finland [129262, 132944]; EU New OSH ERA research programme; British Heart Foundation [RG/13/2/30098] Funding Source: researchfish; Economic and Social Research Council [ES/J023299/1] Funding Source: researchfish; Medical Research Council [MR/K013351/1] Funding Source: researchfish; ESRC [ES/J023299/1] Funding Source: UKRI; MRC [MR/K013351/1] Funding Source: UKRI	Academy of Finland(Academy of Finland); EU New OSH ERA research programme; British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Finnish Public Sector study was supported by the Academy of Finland (projects #129262, and 132944) and the participating organisations. Mika Kivimaki was supported by the EU New OSH ERA research programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison P.D., 2005, FIXED EFFECTS REGRES; [Anonymous], 1984, DISTINCTION SOCIAL C; Baum FE, 2000, J EPIDEMIOL COMMUN H, V54, P414, DOI 10.1136/jech.54.6.414; Brueckner JK, 2008, J URBAN ECON, V64, P18, DOI 10.1016/j.jue.2007.08.002; Burt R. S, 1992, STRUCTURAL HOLES; Coleman J., 1990, FDN SOCIAL THEORY; COLEMAN JS, 1988, AM J SOCIOL, V94, pS95, DOI 10.1086/228943; du Toit L, 2007, URBAN STUD, V44, P1677, DOI 10.1080/00420980701426665; Ferrie JE, 2007, SCAND J PUBLIC HEALT, V35, P62, DOI 10.1080/14034940600813073; Gittell R., 1998, COMMUNITY ORG BUILDI; Goldberg D.P., 1988, USERS GUIDE GEN HLTH; Goldstein H, 1995, MULTILEVEL STAT MODE, DOI 10.1002/9780470973394; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Halonen JI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032937; Halpern D., 2005, SOCIAL CAPITAL; Hanibuchi T, 2012, HEALTH PLACE, V18, P229, DOI 10.1016/j.healthplace.2011.09.015; Hofferth SL, 1999, RATION SOC, V11, P79, DOI 10.1177/104346399011001004; Holi MM, 2003, NORD J PSYCHIAT, V57, P233, DOI 10.1080/08039480310001418; Kaasa A, 2008, ACTA SOCIOL, V51, P145, DOI 10.1177/0001699308090040; Kawachi I, 1997, BMJ-BRIT MED J, V314, P1037, DOI 10.1136/bmj.314.7086.1037; Kawachi I., 2000, SOCIAL EPIDEMIOLOGY, V174, P290; Kouvonen A, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-251; Kouvonen A, 2008, AM J EPIDEMIOL, V167, P1143, DOI 10.1093/aje/kwn067; Leana CR, 1999, ACAD MANAGE REV, V24, P538, DOI 10.2307/259141; Leyden KM, 2003, AM J PUBLIC HEALTH, V93, P1546, DOI 10.2105/AJPH.93.9.1546; Lindstrom M, 2002, SOC SCI MED, V54, P1779, DOI 10.1016/S0277-9536(01)00147-2; Lund H, 2003, J AM PLANN ASSOC, V69, P414, DOI 10.1080/01944360308976328; Macinko J, 2001, MILBANK Q, V79, P387, DOI 10.1111/1468-0009.00213; Marmot MG, 1998, LANCET, V351, P57, DOI 10.1016/S0140-6736(97)08084-7; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Mohnen SM, 2011, SOC SCI MED, V72, P660, DOI 10.1016/j.socscimed.2010.12.004; Mujahid MS, 2007, AM J EPIDEMIOL, V165, P858, DOI 10.1093/aje/kwm040; Nahapiet J, 1998, ACAD MANAGE REV, V23, P242, DOI 10.2307/259373; Nguyen D, 2010, ENVIRON PLANN B, V37, P610, DOI 10.1068/b35120; OECD, 2002, EMPL OUTL; Oksanen T, 2008, SOC SCI MED, V66, P637, DOI 10.1016/j.socscimed.2007.10.013; Oksanen T, 2012, J HYPERTENS, V30, P1129, DOI 10.1097/HJH.0b013e32835377ed; Oksanen T, 2011, AM J PUBLIC HEALTH, V101, P1742, DOI 10.2105/AJPH.2011.300166; Oksanen T, 2010, J EPIDEMIOL COMMUN H, V64, P684, DOI 10.1136/jech.2008.086074; PUTNAM RD, 1995, J DEMOCRACY, V0006; Putnam RD., 2000, BOWLING ALONE COLLAP; Raudenbush SW, 1999, SOCIOL METHODOL, V29, P1, DOI 10.1111/0081-1750.00059; Sampson RJ, 1997, SCIENCE, V277, P918, DOI 10.1126/science.277.5328.918; Scribner R, 2007, J STUD ALCOHOL DRUGS, V68, P934, DOI 10.15288/jsad.2007.68.934; Subramanian SV, 2003, HEALTH PLACE, V9, P33, DOI 10.1016/S1353-8292(02)00028-X; Van Pelt J, 2006, CASCADIA SCORECARD 7; Wilkinson R., 1996, UNHEALTHY SOC AFFLIC	47	21	22	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65846	10.1371/journal.pone.0065846	http://dx.doi.org/10.1371/journal.pone.0065846			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	169CU	23776555	gold, Green Published, Green Submitted			2022-12-27	WOS:000320755400071
J	Wu, CP; Zhou, L; Xie, M; Du, HD; Tian, J; Sun, S; Li, JY				Wu, Chun-Ping; Zhou, Liang; Xie, Ming; Du, Huai-Dong; Tian, Jie; Sun, Shan; Li, Jin-Yan			Identification of Cancer Stem-Like Side Population Cells in Purified Primary Cultured Human Laryngeal Squamous Cell Carcinoma Epithelia	PLOS ONE			English	Article							THERAPEUTIC IMPLICATIONS; INITIATING CELLS; LINES; EXPRESSION; PHENOTYPE; TUMORS; BCRP1; MICE	Cancer stem-like side population (SP) cells have been identified in many solid tumors; however, most of these investigations are performed using established cancer cell lines. Cancer cells in tumor tissue containing fibroblasts and many other types of cells are much more complex than any cancer cell line. Although SP cells were identified in the laryngeal squamous cell carcinoma (LSCC) cell line Hep-2 in our pilot study, it is unknown whether the LSCC tissue contains SP cells. In this study, LSCC cells (LSCCs) were primary cultured and purified from a surgically resected LSCC specimen derived from a well-differentiated epiglottic neoplasm of a Chinese male. This was followed by the verification of epithelium-specific characteristics, such as ultrastructure and biomarkers. A distinct SP subpopulation (4.45 +/- 1.07%) was isolated by Hoechst 33342 efflux analysis from cultured LSCCs by using a flow cytometer. Cancer stem cell (CSC)-associated assays, including expression of self-renewal and CSC marker genes, proliferation, differentiation, spheroid formation, chemotherapy resistance, and tumorigenicity were then conducted between SP and non-SP (NSP) LSCCs. In vitro and in vivo assays revealed that SP cells manifested preferential expression of self-renewal and CSC marker genes, higher capacity for proliferation, differentiation, and spheroid formation; enhanced resistance to chemotherapy; and greater xenograft tumorigenicity in immunodeficient mice compared with NSP cells. These findings suggest that the primary cultured and purified LSCCs contain cancer stem-like SP cells, which may serve as a valuable model for CSC research in LSCC.	[Wu, Chun-Ping; Zhou, Liang; Xie, Ming; Du, Huai-Dong] Fudan Univ, Dept Otolaryngol Head & Neck Surg, Eye Ear Nose & Throat Hosp, Shanghai 200433, Peoples R China; [Tian, Jie; Sun, Shan] Fudan Univ, Cent Lab, Eye Ear Nose & Throat Hosp, Shanghai 200433, Peoples R China; [Sun, Shan] Fudan Univ, Shanghai Med Coll, Inst Biomed Sci Stem Cell & Regenerat Med, Shanghai 200433, Peoples R China; [Li, Jin-Yan] Fudan Univ, Shanghai Med Coll, Dept Cellular & Genet Med, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University	Zhou, L (corresponding author), Fudan Univ, Dept Otolaryngol Head & Neck Surg, Eye Ear Nose & Throat Hosp, Shanghai 200433, Peoples R China.	zhoulent@126.com	Sun, Shan/GLR-2365-2022; Zhou, Liang/AAJ-4024-2020	Sun, Shan/0000-0003-2142-4307; Wu, Chunping/0000-0002-0712-8715	National Natural Science Foundation of China [30872855]; Shanghai Science and Technology Foundation of China [12JC1402101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Foundation of China	This research was partly supported by the National Natural Science Foundation of China (30872855) and the Shanghai Science and Technology Foundation of China (12JC1402101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addla SK, 2008, AM J PHYSIOL-RENAL, V295, pF680, DOI 10.1152/ajprenal.90286.2008; Albers AE, 2012, CRIT REV ONCOL HEMAT, V81, P224, DOI 10.1016/j.critrevonc.2011.03.004; Chiba T, 2006, HEPATOLOGY, V44, P240, DOI 10.1002/hep.21227; Christgen M, 2007, MOL CELL BIOCHEM, V306, P201, DOI 10.1007/s11010-007-9570-y; Fukaya R, 2010, CANCER LETT, V291, P150, DOI 10.1016/j.canlet.2009.10.010; Fukuda K, 2009, INT J ONCOL, V34, P1201, DOI 10.3892/ijo_00000248; Golebiewska A, 2011, CELL STEM CELL, V8, P136, DOI 10.1016/j.stem.2011.01.007; Hadnagy A, 2006, EXP CELL RES, V312, P3701, DOI 10.1016/j.yexcr.2006.08.030; Haraguchi N, 2006, STEM CELLS, V24, P506, DOI 10.1634/stemcells.2005-0282; Hayashi S, 2011, PEDIATR SURG INT, V27, P9, DOI 10.1007/s00383-010-2719-x; Jaggupilli A, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/708036; Jonker JW, 2005, STEM CELLS, V23, P1059, DOI 10.1634/stemcells.2005-0150; Kato K, 2012, KAOHSIUNG J MED SCI, V28, P63, DOI 10.1016/j.kjms.2011.06.028; Klonisch T, 2008, TRENDS MOL MED, V14, P450, DOI 10.1016/j.molmed.2008.08.003; Li XX, 2012, BIOCHEM BIOPH RES CO, V419, P728, DOI 10.1016/j.bbrc.2012.02.090; Liu WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023311; Luo YC, 2012, J INVEST DERMATOL, V132, P2440, DOI 10.1038/jid.2012.161; Ma YY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029170; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Moserle L, 2010, CANCER LETT, V288, P1, DOI 10.1016/j.canlet.2009.05.020; Murase M, 2009, BRIT J CANCER, V101, P1425, DOI 10.1038/sj.bjc.6605330; Nakanishi T, 2010, BRIT J CANCER, V102, P815, DOI 10.1038/sj.bjc.6605553; Nishii T, 2009, CANCER SCI, V100, P1397, DOI 10.1111/j.1349-7006.2009.01211.x; Oates JE, 2009, STEM CELLS DEV, V18, P1515, DOI 10.1089/scd.2008.0302; Shi GM, 2008, J CANCER RES CLIN, V134, P1155, DOI 10.1007/s00432-008-0407-1; Shi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033358; Song Z, 2010, MOL BIOL REP, V37, P4091, DOI 10.1007/s11033-010-0069-3; Tabor MH, 2011, LARYNGOSCOPE, V121, P527, DOI 10.1002/lary.21032; Vathipadiekal V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029079; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wan GL, 2010, HEAD NECK-J SCI SPEC, V32, P1302, DOI 10.1002/hed.21325; Wang J, 2007, CANCER RES, V67, P3716, DOI 10.1158/0008-5472.CAN-06-4343; Wu C, 2008, CANCER LETT, V268, P1, DOI 10.1016/j.canlet.2008.03.048; Wu CL, 2007, CANCER RES, V67, P8216, DOI 10.1158/0008-5472.CAN-07-0999; Yanamoto S, 2011, ORAL ONCOL, V47, P855, DOI 10.1016/j.oraloncology.2011.06.501; Yang M, 2011, CANCER SCI, V102, P1774, DOI 10.1111/j.1349-7006.2011.02028.x; Yao J, 2010, ONCOL REP, V23, P1375, DOI 10.3892/or_00000774; Zhang P, 2009, CANCER LETT, V277, P227, DOI 10.1016/j.canlet.2008.12.015; Zhang SN, 2010, TUMORI J, V96, P985, DOI 10.1177/548.6520; Zhang SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038996; Zhou S, 2002, P NATL ACAD SCI USA, V99, P12339, DOI 10.1073/pnas.192276999; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	42	16	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65750	10.1371/journal.pone.0065750	http://dx.doi.org/10.1371/journal.pone.0065750			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776540	Green Published, gold, Green Submitted			2022-12-27	WOS:000320755400066
J	Yu, WY; Zhao, CY; Shen, C; Wang, YD; Lu, HZ; Fan, J				Yu, Weiyan; Zhao, Caiyan; Shen, Chuan; Wang, Yadong; Lu, Hongzhi; Fan, Jing			The Efficacy and Safety of Nucleos(t)ide Analogues in Patients with Spontaneous Acute Exacerbation of Chronic Hepatitis B: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							E-ANTIGEN SEROCONVERSION; LAMIVUDINE THERAPY; VIRUS-INFECTION; CLINICAL-PRACTICE; DECOMPENSATION; MONOTHERAPY; ENTECAVIR; LEVEL	Background: Spontaneous acute exacerbation (AE) of chronic hepatitis B (CHB) is often detrimental but sometimes leads to sustained immune control and disease remission. The efficacy and safety of nucleos(t)ide analogues (NAs) in patients with spontaneous AE of CHB remains unclear. Methods: We performed a systematic review and meta-analysis of NAs in patients with spontaneous AE of CHB. We calculated pooled effects of NAs in these patients of each study and conducted quantitative meta-analysis, displaying results using Forest plots. Results: 15 studies were included and substantial heterogeneity was noted in the inclusion/exclusion criteria and controls. Pooled data showed no benefit of lamivudine (LAM) vs. untreated controls for transplant-free survival in patients with spontaneous AE of CHB (OR = 0.98 (95% CI, 0.50-1.92; P = 0.956)), hepatic decompensation (OR = 0.94 (95% CI, 0.47-1.88; P = 0.862)) and liver failure owing to AE (OR = 2.30 (95% CI, 0.35-15.37; P = 0.387)) at 3 months. Entecavir achieved even higher short-term mortality than LAM. NAs led to rates of ALT normalization, undetectable HBV DNA, HBeAg loss, HBeAg seroconversion and drug resistance at 1 year in 88%, 61%, 46%, 35% and 5%. Pooled data also showed benefit favoring LAM vs. untreated controls for ALT normalization (OR = 1.98 (95% CI, 1.03-3.80; P = 0.039)) and undetectable HBV DNA (OR = 38.50 (95% CI, 7.68-192.99; P<0.001)) at 3 months. All NAs were relatively safe and well tolerated. Conclusion: NAs had no obvious impact on short-term survival in patients with AE of CHB, despite of possible better antiviral responses. We suggest additional studies to evaluate the efficacy of other NAs and early introduction of immunosuppressant in combination with NAs. We highlight developing prognostic models to identify predictors of mortality and disease progression for AE of CHB.	[Yu, Weiyan; Zhao, Caiyan; Shen, Chuan; Wang, Yadong; Lu, Hongzhi] Hebei Med Univ, Affiliated Hosp 3, Dept Infect Dis, Shijiazhuang, Peoples R China; [Fan, Jing] Hebei Gen Hosp, Intens Care Unit, Shijiazhuang, Peoples R China	Hebei Medical University	Zhao, CY (corresponding author), Hebei Med Univ, Affiliated Hosp 3, Dept Infect Dis, Shijiazhuang, Peoples R China.	zhaocy2005@163.com						Akuta N, 2003, J HEPATOL, V38, P91, DOI 10.1016/S0168-8278(02)00335-5; Chan HLY, 2006, ANTIVIR THER, V11, P465; Chan HLY, 2002, J VIRAL HEPATITIS, V9, P424, DOI 10.1046/j.1365-2893.2002.00385.x; Chen JJ, 2006, ALIMENT PHARM THER, V23, P85, DOI 10.1111/j.1365-2036.2006.02718.x; Chien RN, 1999, HEPATOLOGY, V30, P770, DOI 10.1002/hep.510300313; Chien RN, 2003, J HEPATOL, V38, P322, DOI 10.1016/S0168-8278(02)00419-1; European Association For The Study Of The Liver, 2012, J HEPATOL, V57, P167; Fujiwara K, 2008, J GASTROENTEROL, V43, P711, DOI 10.1007/s00535-008-2222-5; Fujiwara K, 2005, WORLD J GASTROENTERO, V11, P1109, DOI 10.3748/wjg.v11.i8.1109; Fung J, 2011, AM J GASTROENTEROL, V106, P1766, DOI 10.1038/ajg.2011.253; Jeng WJ, 2010, CLIN GASTROENTEROL H, V8, P541, DOI 10.1016/j.cgh.2010.02.023; Kanda T, 2012, INT J MED SCI, V9, P27, DOI 10.7150/ijms.9.27; Lee CM, 2002, J HEPATOL, V37, P669, DOI 10.1016/S0168-8278(02)00267-2; LIAW YF, 1990, LIVER, V10, P177; Liaw YF, 2012, HEPATOL INT, V6, P531, DOI 10.1007/s12072-012-9365-4; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; LOK ASF, 1990, J HEPATOL, V10, P29, DOI 10.1016/0168-8278(90)90069-4; Lv GC, 2010, WORLD J GASTROENTERO, V16, P4095, DOI 10.3748/wjg.v16.i32.4095; Matsumoto K, 2009, WORLD J GASTROENTERO, V15, P1650, DOI 10.3748/wjg.15.1650; Mori N, 2012, J GASTROENTEROL, V47, P1022, DOI 10.1007/s00535-012-0561-8; Peng CY, 2011, HEPATOL INT, V5, P586, DOI 10.1007/s12072-010-9227-x; Scaglione SJ, 2012, GASTROENTEROLOGY, V142, P1360, DOI 10.1053/j.gastro.2012.01.044; SEEFF LB, 1986, SEMIN LIVER DIS, V6, P11, DOI 10.1055/s-2008-1040788; SHEEN IS, 1985, GASTROENTEROLOGY, V89, P732, DOI 10.1016/0016-5085(85)90566-9; Sheu MJ, 2009, EUR J GASTROEN HEPAT, V21, P357, DOI 10.1097/MEG.0b013e3283131389; Tsang SWC, 2001, ALIMENT PHARM THERAP, V15, P1737, DOI 10.1046/j.1365-2036.2001.01107.x; Tseng TC, 2008, LIVER INT, V28, P1034, DOI 10.1111/j.1478-3231.2008.01766.x; Tsubota A, 2005, J GASTROEN HEPATOL, V20, P426, DOI 10.1111/j.1440-1746.2004.03534.x; Tsubota A, 2001, AM J GASTROENTEROL, V96, P557, DOI 10.1111/j.1572-0241.2001.03559.x; Wong VWS, 2008, ANTIVIR THER, V13, P571; Wong VWS, 2011, J HEPATOL, V54, P236, DOI 10.1016/j.jhep.2010.06.043; Wong VWS, 2009, J GASTROEN HEPATOL, V24, P1179, DOI 10.1111/j.1440-1746.2009.05924.x; Yao GB, 2009, J DIGEST DIS, V10, P131, DOI 10.1111/j.1751-2980.2009.00375.x; Zeuzem S, 2009, J HEPATOL, V51, P11, DOI 10.1016/j.jhep.2008.12.019	34	9	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65952	10.1371/journal.pone.0065952	http://dx.doi.org/10.1371/journal.pone.0065952			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776577	Green Published, gold, Green Submitted			2022-12-27	WOS:000320755400088
J	Bordin, AI; Suchodolski, JS; Markel, ME; Weaver, KB; Steiner, JM; Dowd, SE; Pillai, S; Cohen, ND				Bordin, Angela I.; Suchodolski, Jan S.; Markel, Melissa E.; Weaver, Kaytee B.; Steiner, Joerg M.; Dowd, Scot E.; Pillai, Suresh; Cohen, Noah D.			Effects of Administration of Live or Inactivated Virulent Rhodococccus equi and Age on the Fecal Microbiome of Neonatal Foals	PLOS ONE			English	Article							CYTOTOXIC T-LYMPHOCYTES; ORAL IMMUNIZATION; VACCINE STRAIN; PROTECTION; PNEUMONIA; INFECTIONS; IMMUNITY; VAPA; TUBERCULOSIS; INTESTINE	Background: Rhodococcus equi is an important pathogen of foals. Enteral administration of live, virulent R. equi during early life has been documented to protect against subsequent intrabronchial challenge with R. equi, indicating that enteral mucosal immunization may be protective. Evidence exists that mucosal immune responses develop against both live and inactivated micro-organisms. The extent to which live or inactivated R. equi might alter the intestinal microbiome of foals is unknown. This is an important question because the intestinal microbiome of neonates of other species is known to change over time and to influence host development. To our knowledge, changes in the intestinal microbiome of foals during early life have not been reported. Thus, the purpose of this study was to determine whether age (during the first month of life) or administration of either live virulent R. equi (at a dose reported to protect foals against subsequent intrabronchial challenge, viz., 1x10(10) colony forming units [CFU]) or inactivated virulent R. equi (at higher doses, viz., 2x10(10) and 1x10(11) [CFU]) altered the fecal microbiome of foals. Methodology/Principal Findings: Fecal swab samples from 42 healthy foals after vaccination with low-dose inactivated R. equi (n = 9), high-dose inactivated R. equi (n = 10), live R. equi (n = 6), control with cholera toxin B (CTB, n = 9), and control without CTB (n = 8) were evaluated by 454-pyrosequencing of the 16S rRNA gene and by qPCR. No impact of treatment was observed among vaccinated foals; however, marked and significant differences in microbial communities and diversity were observed between foals at 30 days of age relative to 2 days of age. Conclusions: The results suggest age-related changes in the fecal microbial population of healthy foals do occur, however, mucosal vaccination does not result in major changes of the fecal microbiome in foals.	[Bordin, Angela I.; Weaver, Kaytee B.; Cohen, Noah D.] Texas A&M Univ, Dept Large Anim Clin Sci, Equine Infect Dis Lab, Coll Vet Med & Biomed Sci, College Stn, TX 77843 USA; [Suchodolski, Jan S.; Markel, Melissa E.; Steiner, Joerg M.] Texas A&M Univ, Coll Vet Med & Biomed Sci, Gastrointestinal Lab, College Stn, TX USA; [Dowd, Scot E.] Mol Res DNA Lab, Shallowater, TX USA; [Pillai, Suresh] Texas A&M Univ, Natl Ctr Elect Beam Res, College Stn, TX USA; [Dowd, Scot E.] Texas A&M Univ, Dept Poultry Sci, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Cohen, ND (corresponding author), Texas A&M Univ, Dept Large Anim Clin Sci, Equine Infect Dis Lab, Coll Vet Med & Biomed Sci, College Stn, TX 77843 USA.	ncohen@cvm.tamu.edu	Dowd, Scot E/M-5386-2017	Dowd, Scot E/0000-0002-6296-1427; Suchodolski, Jan/0000-0002-2176-6932; Cohen, Noah/0000-0002-0384-2903	Link Equine Research Endowment at Texas AM University; Gastrointestinal Laboratory at Texas AM University; Boehringer-Ingelheim Vetmedica; Fort Dodge Animal Health/Pfizer Animal Health	Link Equine Research Endowment at Texas AM University; Gastrointestinal Laboratory at Texas AM University; Boehringer-Ingelheim Vetmedica(Boehringer Ingelheim); Fort Dodge Animal Health/Pfizer Animal Health	This work was supported by the Link Equine Research Endowment at Texas A&M University with additional support provided by the Gastrointestinal Laboratory at Texas A&M University and Boehringer-Ingelheim Vetmedica. Dr. Bordin was supported by a fellowship from Fort Dodge Animal Health/Pfizer Animal Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancelet LR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045888; Arnold H, 2004, INFECT IMMUN, V72, P6546, DOI 10.1128/IAI.72.11.6546-6553.2004; Buddington RK, 2003, AM J VET RES, V64, P646, DOI 10.2460/ajvr.2003.64.646; Chaffin MK, 2008, JAVMA-J AM VET MED A, V232, P1035, DOI 10.2460/javma.232.7.1035; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; CHIRINOTREJO JM, 1987, CAN J VET RES, V51, P444; Clark SO, 2010, VACCINE, V28, P7109, DOI 10.1016/j.vaccine.2010.07.087; Costa M, 2011, HORSES 2 GENOME META; Daly K, 2001, FEMS MICROBIOL ECOL, V38, P141, DOI 10.1111/j.1574-6941.2001.tb00892.x; Dawson TRMY, 2010, VET IMMUNOL IMMUNOP, V135, P1, DOI 10.1016/j.vetimm.2009.12.004; Dougal K, 2012, FEMS MICROBIOL ECOL, V82, P642, DOI 10.1111/j.1574-6941.2012.01441.x; Fanaro S, 2003, ACTA PAEDIATR, V92, P48; Garcia-Mazcorro JF, 2012, MICROBIOLOGYOPEN, V1, P340, DOI 10.1002/mbo3.36; Garcia-Mazcorro JF, 2011, FEMS MICROBIOL ECOL, V78, P542, DOI 10.1111/j.1574-6941.2011.01185.x; Garrido JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024905; Giguere S, 2011, J VET INTERN MED, V25, P1221, DOI 10.1111/j.1939-1676.2011.00804.x; Giguere S, 2011, J VET INTERN MED, V25, P1209, DOI 10.1111/j.1939-1676.2011.00835.x; Halbert ND, 2005, AM J VET RES, V66, P1380, DOI 10.2460/ajvr.2005.66.1380; Harris SP, 2010, MICROBIOL-SGM, V156, P1836, DOI 10.1099/mic.0.035915-0; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Hooper-McGrevy KE, 2005, VACCINE, V23, P5760, DOI 10.1016/j.vaccine.2005.07.050; Horowitz ML, 2001, J VET INTERN MED, V15, P171, DOI 10.1892/0891-6640(2001)015&lt;0171:AOSMLD&gt;2.3.CO;2; Inman CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033707; Jain S, 2003, MOL MICROBIOL, V50, P115, DOI 10.1046/j.1365-2958.2003.03689.x; Jia J, 2011, FEMS MICROBIOL ECOL, V78, P395, DOI 10.1111/j.1574-6941.2011.01172.x; KuoLee R, 2007, VACCINE, V25, P3781, DOI 10.1016/j.vaccine.2007.02.014; Mashoof S, 2012, MUCOSAL IMMUNOLOGY; Meijer WG, 2004, VET RES, V35, P383, DOI 10.1051/vetres:2004024; Minamoto Yasushi, 2012, Animal Health Research Reviews, V13, P64, DOI 10.1017/S1466252312000060; Mshvildadze M, 2010, EARLY HUM DEV, V86, pS67, DOI 10.1016/j.earlhumdev.2010.01.018; Muscatello G, 2007, EQUINE VET J, V39, P470, DOI 10.2746/042516407X209217; Paillot R, 2013, VET MICROBIOL, V162, P396, DOI 10.1016/j.vetmic.2012.10.019; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Patton KM, 2005, INFECT IMMUN, V73, P2083, DOI 10.1128/IAI.73.4.2083-2093.2005; PRESCOTT JF, 1991, CLIN MICROBIOL REV, V4, P20, DOI 10.1128/CMR.4.1.20-34.1991; Quan FS, 2012, VACCINE, V30, P180, DOI 10.1016/j.vaccine.2011.11.028; Scholtens PAMJ, 2012, ANNU REV FOOD SCI T, V3, P425, DOI 10.1146/annurev-food-022811-101120; Sealy R, 2012, INT IMMUNOL; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Shannon C.E., 1963, MATH THEORY COMMUNIC; Shepherd ML, 2012, FEMS MICROBIOL LETT, V326, P62, DOI 10.1111/j.1574-6968.2011.02434.x; Smith PD, 2013, PRINCIPLES OF MUCOSAL IMMUNOLOGY, P1; Suchodolski JS, 2011, J ANIM SCI, V89, P1520, DOI 10.2527/jas.2010-3377; Suchodolski JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051907; Takai S, 1997, VET MICROBIOL, V56, P167, DOI 10.1016/S0378-1135(97)00085-0; Tompkins DM, 2013, VACCINE, V31, P893, DOI 10.1016/j.vaccine.2012.12.003; Torrazza RM, 2011, J PERINATOL, V31, pS29, DOI 10.1038/jp.2010.172; van der Geize R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002181; Venturi A, 1999, ALIMENT PHARM THER, V13, P1103; Villena J, 2008, CAN J MICROBIOL, V54, P845, DOI [10.1139/W08-077, 10.1139/w08-077]; Vitali B, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-4; Whitehead AE, 2012, VET IMMUNOL IMMUNOP, V145, P479, DOI 10.1016/j.vetimm.2011.10.011; Willing BP, 2007, J ANIM SCI, V85, P3256, DOI 10.2527/jas.2007-0320	53	17	17	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66640	10.1371/journal.pone.0066640	http://dx.doi.org/10.1371/journal.pone.0066640			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785508	Green Published, Green Submitted, gold			2022-12-27	WOS:000321038800013
J	Castelhano, J; Rebola, J; Leitao, B; Rodriguez, E; Castelo-Branco, M				Castelhano, Joao; Rebola, Jose; Leitao, Bruno; Rodriguez, Eugenio; Castelo-Branco, Miguel			To Perceive or Not Perceive: The Role of Gamma-band Activity in Signaling Object Percepts	PLOS ONE			English	Article							PHASE SYNCHRONY; ELECTROMAGNETIC TOMOGRAPHY; VISUAL RESPONSES; NEURAL ACTIVITY; EYE TRACKING; OSCILLATIONS; FACE; EEG; INVERSION; CORTEX	The relation of gamma-band synchrony to holistic perception in which concerns the effects of sensory processing, high level perceptual gestalt formation, motor planning and response is still controversial. To provide a more direct link to emergent perceptual states we have used holistic EEG/ERP paradigms where the moment of perceptual "discovery'' of a global pattern was variable. Using a rapid visual presentation of short-lived Mooney objects we found an increase of gamma-band activity locked to perceptual events. Additional experiments using dynamic Mooney stimuli showed that gamma activity increases well before the report of an emergent holistic percept. To confirm these findings in a data driven manner we have further used a support vector machine classification approach to distinguish between perceptual vs. non perceptual states, based on time-frequency features. Sensitivity, specificity and accuracy were all above 95%. Modulations in the 30-75 Hz range were larger for perception states. Interestingly, phase synchrony was larger for perception states for high frequency bands. By focusing on global gestalt mechanisms instead of local processing we conclude that gamma-band activity and synchrony provide a signature of holistic perceptual states of variable onset, which are separable from sensory and motor processing.	[Castelhano, Joao; Rebola, Jose; Castelo-Branco, Miguel] Univ Coimbra, Visual Neurosci Lab, Inst Biomed Imaging & Life Sci, Fac Med, Coimbra, Portugal; [Leitao, Bruno] Univ Coimbra, Ctr Informat & Syst, Coimbra, Portugal; [Rodriguez, Eugenio] Max Planck Inst Brain Res, Frankfurt, Germany; [Rodriguez, Eugenio] Pontificia Univ Catolica Chile, Escuela Psicol, Santiago, Chile	Universidade de Coimbra; Universidade de Coimbra; Max Planck Society; Pontificia Universidad Catolica de Chile	Castelo-Branco, M (corresponding author), Univ Coimbra, Visual Neurosci Lab, Inst Biomed Imaging & Life Sci, Fac Med, Coimbra, Portugal.	mcbranco@fmed.uc.pt	Castelo-Branco, Miguel/F-3866-2019; Direito, Bruno/Y-6099-2018; Castelhano, Joao/I-5090-2019; Castelo-Branco, Miguel/E-5689-2010	Castelo-Branco, Miguel/0000-0003-4364-6373; Direito, Bruno/0000-0002-3259-8815; Castelhano, Joao/0000-0002-8996-1515; Rebola, Jose/0000-0002-6963-9414	COMPETE [PIC/IC/82986/2007]; Bial Foundation; Foundation for Science and Technology Portugal [SFRH/BD/65341/2009];  [PTDC/PSI/67381/2006];  [PEst-C/SAU/UI3282/2013];  [CENTRO-07-ST24-FEDER-00205]	COMPETE; Bial Foundation(Bial Foundation); Foundation for Science and Technology Portugal(Portuguese Foundation for Science and Technology); ; ; 	This work was supported by PTDC/PSI/67381/2006 and COMPETE PIC/IC/82986/2007, PEst-C/SAU/UI3282/2013, CENTRO-07-ST24-FEDER-00205, Bial Foundation grants and a PhD fellowship (SFRH/BD/65341/2009) to JC from the Foundation for Science and Technology Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basar E, 1999, NEUROSCI LETT, V259, P165, DOI 10.1016/S0304-3940(98)00934-3; Belluscio MA, 2012, J NEUROSCI, V32, P423, DOI 10.1523/JNEUROSCI.4122-11.2012; Bernardino I, 2013, NEUROPSYCHO IN PRESS; Castelo-Branco M, 1998, J NEUROSCI, V18, P6395; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Delorme A, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/130714; Engbert R, 2003, VISION RES, V43, P1035, DOI 10.1016/S0042-6989(03)00084-1; Engel J, 2012, PROGR NEUROBIOLOGY, P38; Ewald A, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00166; Ewald A, 2012, NEUROIMAGE, V60, P476, DOI 10.1016/j.neuroimage.2011.11.084; FARAH MJ, 1995, J EXP PSYCHOL HUMAN, V21, P628, DOI 10.1037/0096-1523.21.3.628; Fingelkurts AA, 2003, BRAIN LANG, V85, P297, DOI 10.1016/S0093-934X(03)00059-2; Fries P, 2008, NEURON, V58, P303, DOI 10.1016/j.neuron.2008.04.020; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; Golland P, 2005, INF PROC MED IM P C, V18, P330; Grill-Spector K, 2004, NAT NEUROSCI, V7, P555, DOI 10.1038/nn1224; Gruber T, 2001, NEUROSCI LETT, V316, P29, DOI 10.1016/S0304-3940(01)02361-8; Gruber T, 2008, NEURON ONLINE COMMEN; Grutzner C, 2010, J NEUROSCI, V30, P8342, DOI 10.1523/JNEUROSCI.5434-09.2010; Herrmann CS, 2004, TRENDS COGN SCI, V8, P347, DOI 10.1016/j.tics.2004.06.006; HOLM S, 1979, SCAND J STAT, V6, P65; Jemel B, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-100; Kaiser J, 2003, NEUROSCIENTIST, V9, P475, DOI 10.1177/1073858403259137; Keil A, 2001, NEUROSCI BIOBEHAV R, V25, P527, DOI 10.1016/S0149-7634(01)00031-8; Keil A, 1999, J NEUROSCI, V19, P7152, DOI 10.1523/JNEUROSCI.19-16-07152.1999; Keren AS, 2010, NEUROIMAGE, V49, P2248, DOI 10.1016/j.neuroimage.2009.10.057; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Melloni L, 2007, J NEUROSCI, V27, P2858, DOI 10.1523/JNEUROSCI.4623-06.2007; Melloni L, 2011, J NEUROSCI, V31, P1386, DOI 10.1523/JNEUROSCI.4570-10.2011; MOONEY CM, 1957, CAN J PSYCHOLOGY, V11, P219, DOI 10.1037/h0083717; Mullen T, 2010, SOC NEUROSCIENCE, V1, P2; Nagasawa T, 2011, NEUROIMAGE, V58, P1101, DOI 10.1016/j.neuroimage.2011.07.043; Nasr S, 2009, J VISION, V9, DOI 10.1167/9.5.5; Nolte G, 2004, CLIN NEUROPHYSIOL, V115, P2292, DOI 10.1016/j.clinph.2004.04.029; Nolte G, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00209; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; Pazo-Alvarez P, 2003, BIOL PSYCHOL, V63, P199, DOI 10.1016/S0301-0511(03)00049-8; Pereira Francisco, 2009, Neuroimage, V45, pS199, DOI 10.1016/j.neuroimage.2008.11.007; Plochl M, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00278; Pockett S, 2009, CLIN NEUROPHYSIOL, V120, P695, DOI 10.1016/j.clinph.2008.12.044; Rebola J, 2012, NEUROPSYCHOLOGIA, V50, P3693, DOI 10.1016/j.neuropsychologia.2012.06.020; RHODES G, 1993, COGNITION, V47, P25, DOI 10.1016/0010-0277(93)90061-Y; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Rossion B, 2000, NEUROREPORT, V11, P69, DOI 10.1097/00001756-200001170-00014; Rossion B, 2008, J VISION, V8, DOI 10.1167/8.4.3; Rossion Bruno, 2002, Behav Cogn Neurosci Rev, V1, P63, DOI 10.1177/1534582302001001004; Roux F, 2012, J NEUROSCI, V32, P12411, DOI 10.1523/JNEUROSCI.0421-12.2012; Scheeringa R, 2011, NEURON, V69, P572, DOI 10.1016/j.neuron.2010.11.044; Schiltz C, 2006, NEUROIMAGE, V32, P1385, DOI 10.1016/j.neuroimage.2006.05.037; Schwartzman DJ, 2011, INT J PSYCHOPHYSIOL, V79, P73, DOI 10.1016/j.ijpsycho.2010.10.006; Schyns PG, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001064; SIMSON R, 1977, ELECTROEN CLIN NEURO, V42, P528, DOI 10.1016/0013-4694(77)90216-4; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.neuro.18.1.555; Strother L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018705; Supp GG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000684; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; Tognoli E, 2009, PROG NEUROBIOL, V87, P31, DOI 10.1016/j.pneurobio.2008.09.014; Treisman A, 1996, CURR OPIN NEUROBIOL, V6, P171, DOI 10.1016/S0959-4388(96)80070-5; Uhlhaas PJ, 2008, SCHIZOPHRENIA BULL, V34, P927, DOI 10.1093/schbul/sbn062; Uhlhaas PJ, 2006, J NEUROSCI, V26, P8168, DOI 10.1523/JNEUROSCI.2002-06.2006; VALENTINE T, 1988, BRIT J PSYCHOL, V79, P471, DOI 10.1111/j.2044-8295.1988.tb02747.x; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474; Yovel G, 2005, CURR BIOL, V15, P2256, DOI 10.1016/j.cub.2005.10.072; Yuval-Greenberg S, 2008, NEURON, V58, P429, DOI 10.1016/j.neuron.2008.03.027	66	25	27	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66363	10.1371/journal.pone.0066363	http://dx.doi.org/10.1371/journal.pone.0066363			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785494	Green Published, gold, Green Submitted			2022-12-27	WOS:000321038800028
J	Ciapa, B; Philippe, L				Ciapa, Brigitte; Philippe, Laetitia			Intracellular and Extracellular pH and Ca Are Bound to Control Mitosis in the Early Sea Urchin Embryo via ERK and MPF Activities	PLOS ONE			English	Article							CELL-CYCLE; PROTEIN-SYNTHESIS; ACTIVATION; KINASE; EGGS; FERTILIZATION; PHOSPHORYLATION; XENOPUS; ENTRY; ACIDIFICATION	Studies aiming to predict the impact on marine life of ocean acidification and of altered salinity have shown altered development in various species including sea urchins. We have analyzed how external Na, Ca, pH and bicarbonate control the first mitotic divisions of sea urchin embryos. Intracellular free Ca (Cai) and pH (pHi) and the activities of the MAP kinase ERK and of MPF regulate mitosis in various types of cells including oocytes and early embryos. We found that intracellular acidification of fertilized eggs by Na-acetate induces a huge activation of ERK at time of mitosis. This also stops the cell cycle and leads to cell death, which can be bypassed by treatment with the MEK inhibitor U0126. Similar intracellular acidification induced in external medium containing low sodium or 5-(N-Methyl-N-isobutyl) amiloride, an inhibitor of the Na+/H+ exchanger, also stops the cell cycle and leads to cell death. In that case, an increase in Cai and in the phosphorylation of tyr-cdc2 occurs during mitosis, modifications that depend on external Ca. Our results indicate that the levels of pHi and Cai determine accurate levels of Ptyr-Cdc2 and P-ERK capable of ensuring progression through the first mitotic cycles. These intracellular parameters rely on external Ca, Na and bicarbonate, alterations of which during climate changes could act synergistically to perturb the early marine life.	[Ciapa, Brigitte; Philippe, Laetitia] Univ Paris 06, CNRS UMR 8195, CNPS, Orsay, France	UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Universite Jean Monnet	Ciapa, B (corresponding author), Univ Paris 06, CNRS UMR 8195, CNPS, Orsay, France.	brigitte.ciapa@u-psud.fr			CNRS	CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amirand C, 2000, BIOL CELL, V92, P409, DOI 10.1016/S0248-4900(00)01080-7; ARION D, 1989, EXP CELL RES, V183, P361, DOI 10.1016/0014-4827(89)90397-2; Berridge MJ, 2009, BBA-MOL CELL RES, V1793, P933, DOI 10.1016/j.bbamcr.2008.10.005; Carballeira C, 2011, MAR ENVIRON RES, V72, P196, DOI 10.1016/j.marenvres.2011.08.008; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; Chiri S, 1998, J CELL SCI, V111, P2519; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; EDGECOMBE M, 1991, EMBO J, V10, P3769, DOI 10.1002/j.1460-2075.1991.tb04946.x; Epel D., 1978, Current Topics in Developmental Biology, V12, P185, DOI 10.1016/S0070-2153(08)60597-9; Fremin C, 2009, HEPATOLOGY, V49, P930, DOI 10.1002/hep.22730; GRAINGER JL, 1979, DEV BIOL, V68, P396, DOI 10.1016/0012-1606(79)90213-6; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HACCARD O, 1993, SCIENCE, V262, P1262, DOI 10.1126/science.8235656; Hamaguchi MS, 2001, DEV GROWTH DIFFER, V43, P447, DOI 10.1046/j.1440-169x.2001.00578.x; Hara M, 2009, DEVELOPMENT, V136, P1687, DOI 10.1242/dev.035261; Harrison PK, 2002, CELL CALCIUM, V31, P289, DOI 10.1016/S0143-4160(02)00057-X; Huang WC, 2009, CELL CALCIUM, V45, P391, DOI 10.1016/j.ceca.2009.01.002; Iwamoto T, 2004, J PHARMACOL SCI, V96, P27, DOI 10.1254/jphs.FMJ04002X6; JOHNSON CH, 1981, J CELL BIOL, V89, P284, DOI 10.1083/jcb.89.2.284; Kishimoto T, 2003, CURR OPIN CELL BIOL, V15, P654, DOI 10.1016/j.ceb.2003.10.010; KLEYMAN TR, 1988, J MEMBRANE BIOL, V105, P1, DOI 10.1007/BF01871102; Kumano M, 2001, DEV BIOL, V236, P244, DOI 10.1006/dbio.2001.0328; Kurihara H, 2004, MAR ECOL PROG SER, V274, P161, DOI 10.3354/meps274161; Liu Y, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.096826; LOPO A, 1977, NATURE, V269, P590, DOI 10.1038/269590a0; Machaca K, 2007, J CELL PHYSIOL, V213, P331, DOI 10.1002/jcp.21194; Malo ME, 2006, CAN J PHYSIOL PHARM, V84, P1081, DOI 10.1139/Y06-065; Martin S, 2011, J EXP BIOL, V214, P1357, DOI 10.1242/jeb.051169; McCarty MF, 2010, ALTERN MED REV, V15, P264; Mukai S, 2011, ARCH TOXICOL, V85, P149, DOI 10.1007/s00204-010-0556-2; Murakami MS, 1998, DEVELOPMENT, V125, P237; O'Donnell M, 2009, MAR BIOL, V156, P439, DOI 10.1007/s00227-008-1097-6; Patel R, 1999, J BIOL CHEM, V274, P7958, DOI 10.1074/jbc.274.12.7958; PAYAN P, 1983, DEV BIOL, V100, P29, DOI 10.1016/0012-1606(83)90197-5; Philipova R, 2005, J BIOL CHEM, V280, P24957, DOI 10.1074/jbc.M414437200; Place SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034068; Putney LK, 2003, J BIOL CHEM, V278, P44645, DOI 10.1074/jbc.M308099200; REES BB, 1995, DEV BIOL, V169, P683, DOI 10.1006/dbio.1995.1179; Roderick HL, 2008, NAT REV CANCER, V8, P361, DOI 10.1038/nrc2374; Ruknudin AM, 2007, ANN NY ACAD SCI, V1099, P86, DOI 10.1196/annals.1387.045; Santo-Domingo J, 2007, BRIT J PHARMACOL, V151, P647, DOI 10.1038/sj.bjp.0707260; Sato T, 2006, J PHARMACOL EXP THER, V316, P182, DOI 10.1124/jpet.105.094029; Schreiber R, 2005, J MEMBRANE BIOL, V205, P129, DOI 10.1007/s00232-005-0778-z; Shaul YD, 2007, BBA-MOL CELL RES, V1773, P1213, DOI 10.1016/j.bbamcr.2006.10.005; Soliman EM, 2009, CELL CALCIUM, V45, P284, DOI 10.1016/j.ceca.2008.11.006; Stumpp M, 2012, P NATL ACAD SCI USA, V109, P18192, DOI 10.1073/pnas.1209174109; Sunda WG, 2012, ENVIRON SCI TECHNOL, V46, P10651, DOI 10.1021/es300626f; SUPRYNOWICZ FA, 1985, P NATL ACAD SCI USA, V82, P2389, DOI 10.1073/pnas.82.8.2389; Toyoshima C, 2009, BBA-MOL CELL RES, V1793, P941, DOI 10.1016/j.bbamcr.2008.10.008; Tseng IC, 2010, J BIOL CHEM, V285, P3261, DOI 10.1074/jbc.M109.055640; Uhlen P, 2010, BIOCHEM BIOPH RES CO, V396, P28, DOI 10.1016/j.bbrc.2010.02.117; Vaughan-Jones RD, 2009, J MOL CELL CARDIOL, V46, P318, DOI 10.1016/j.yjmcc.2008.10.024; Whitaker M, 2006, CELL CALCIUM, V40, P585, DOI 10.1016/j.ceca.2006.08.018; Wilding M, 1996, J CELL BIOL, V135, P191, DOI 10.1083/jcb.135.1.191; Wu JQ, 2008, J CELL SCI, V121, P3509, DOI 10.1242/jcs.036855; Yue JB, 2004, CURR BIOL, V14, P1581, DOI 10.1016/j.cub.2004.08.056; Zhang WL, 2005, DEV BIOL, V282, P192, DOI 10.1016/j.ydbio.2005.03.008; Zhang WL, 2006, J CELL SCI, V119, P491; ZOREC R, 1993, PFLUG ARCH EUR J PHY, V423, P41, DOI 10.1007/BF00374959	59	18	21	1	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66113	10.1371/journal.pone.0066113	http://dx.doi.org/10.1371/journal.pone.0066113			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785474	Green Submitted, gold, Green Published			2022-12-27	WOS:000321038800047
J	Luo, C; Wang, XY				Luo, Chao; Wang, Xingyuan			Dynamics of Random Boolean Networks under Fully Asynchronous Stochastic Update Based on Linear Representation	PLOS ONE			English	Article							NEURAL-NETWORKS; METABOLIC NETWORKS; FINDING ATTRACTORS; NONLINEAR-SYSTEMS; TIME DELAYS; STABILITY; CONTROLLABILITY; OBSERVABILITY; OBSERVER; TOPOLOGY	A novel algebraic approach is proposed to study dynamics of asynchronous random Boolean networks where a random number of nodes can be updated at each time step (ARBNs). In this article, the logical equations of ARBNs are converted into the discrete-time linear representation and dynamical behaviors of systems are investigated. We provide a general formula of network transition matrices of ARBNs as well as a necessary and sufficient algebraic criterion to determine whether a group of given states compose an attractor of lengths in ARBNs. Consequently, algorithms are achieved to find all of the attractors and basins in ARBNs. Examples are showed to demonstrate the feasibility of the proposed scheme.	[Luo, Chao; Wang, Xingyuan] Dalian Univ Technol, Fac Elect Informat & Elect Engn, Dalian, Peoples R China	Dalian University of Technology	Wang, XY (corresponding author), Dalian Univ Technol, Fac Elect Informat & Elect Engn, Dalian, Peoples R China.	wangxy@dlut.edu.cn	Wang, Xing-yuan/I-6353-2015		National Natural Science Foundation of China [61173183, 60973152, 60573172]; Superior University Doctor Subject Special Scientific Research Foundation of China [20070141014]; Program for Liaoning Excellent Talents in University [LR2012003]; National Natural Science Foundation of Liaoning province [20082165]; Fundamental Research Funds for the Central Universities [DUT12JB06]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Superior University Doctor Subject Special Scientific Research Foundation of China; Program for Liaoning Excellent Talents in University; National Natural Science Foundation of Liaoning province; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research is supported by the National Natural Science Foundation of China (Nos: 61173183, 60973152, and 60573172), the Superior University Doctor Subject Special Scientific Research Foundation of China (No: 20070141014), Program for Liaoning Excellent Talents in University (No: LR2012003), the National Natural Science Foundation of Liaoning province (No: 20082165) and the Fundamental Research Funds for the Central Universities (No: DUT12JB06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akutsu T, 2012, IEEE ACM T COMPUT BI, V9, P1410, DOI 10.1109/TCBB.2012.87; Aldana M, 2003, PHYSICA D, V185, P45, DOI 10.1016/S0167-2789(03)00174-X; Aracena J, 2009, BIOSYSTEMS, V97, P1, DOI 10.1016/j.biosystems.2009.03.006; Aubry L, 1999, ANNU REV CELL DEV BI, V15, P469, DOI 10.1146/annurev.cellbio.15.1.469; Bassler KE, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.038101; Cheng DZ, 2010, AUTOMATICA, V46, P62, DOI 10.1016/j.automatica.2009.10.036; Cheng DZ, 2009, AUTOMATICA, V45, P1659, DOI 10.1016/j.automatica.2009.03.006; Cheng DH, 2011, COMMUN CONTROL ENG, P1, DOI 10.1007/978-0-85729-097-7; Chmiel AM, 2007, PHYSICA A, V383, P134, DOI 10.1016/j.physa.2007.04.095; Colizza V, 2006, P NATL ACAD SCI USA, V103, P2015, DOI 10.1073/pnas.0510525103; DELLAERT F, 1994, P ARTIFICIAL LIFE, V4, P246; Deng XT, 2007, BIOSYSTEMS, V88, P16, DOI 10.1016/j.biosystems.2006.04.002; Di Paolo EA, 2001, BIOSYSTEMS, V59, P185, DOI 10.1016/S0303-2647(01)00102-2; Drossel B., 2008, ANN REV NONLINEAR DY, V1; Dubrova E, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.056116; Dubrova E, 2011, IEEE ACM T COMPUT BI, V8, P1393, DOI 10.1109/TCBB.2010.20; Farrow C, 2004, IEEE T NEURAL NETWOR, V15, P348, DOI 10.1109/TNN.2004.824262; Fu J, 2010, NEUROCOMPUTING, V73, P795, DOI 10.1016/j.neucom.2009.10.010; Goldbeter A., 1996, BIOCH OSCILLATIONS C; Gonze D, 2001, J THEOR BIOL, V210, P167, DOI 10.1006/jtbi.2000.2294; Greil F, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.048701; Greil F, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/10/373; Hallinan J, 2004, 9 INT C SIM SYNTH LI; HARVEY I, 1997, COM ADAP SY, P67; Heidel J, 2003, INT J BIFURCAT CHAOS, V13, P535, DOI 10.1142/S0218127403006765; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Kauffman S.A., 1993, ORIGINS ORDER; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Klemm K, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.055101; Krawitz P, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.158701; Li FF, 2011, AUTOMATICA, V47, P2765, DOI 10.1016/j.automatica.2011.09.016; Li FF, 2011, IEEE T NEURAL NETWOR, V22, P948, DOI 10.1109/TNN.2011.2126594; Liu YJ, 2013, IEEE T FUZZY SYST, V21, P275, DOI 10.1109/TFUZZ.2012.2212200; Liu YJ, 2011, IEEE T NEURAL NETWOR, V22, P1328, DOI 10.1109/TNN.2011.2159865; Liu YJ, 2011, IEEE T NEURAL NETWOR, V22, P1162, DOI 10.1109/TNN.2011.2146788; Lloyd-Price J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042018; Paul U, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.026118; Shreim A, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.035102; Skodawessely T, 2011, ADV COMPLEX SYST, V14, P439, DOI 10.1142/S0219525911003098; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Steuer R, 2007, PHYTOCHEMISTRY, V68, P2139, DOI 10.1016/j.phytochem.2007.04.041; Steuer R, 2006, P NATL ACAD SCI USA, V103, P11868, DOI 10.1073/pnas.0600013103; Uchida S, 2008, THESIS TU DARMSTADT, pD17; Yang LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057009; Zhang HG, 2008, IEEE T NEURAL NETWOR, V19, P366, DOI 10.1109/TNN.2007.910738; Zhang HG, 2010, IEEE T SYST MAN CY B, V40, P831, DOI 10.1109/TSMCB.2009.2030506; Zhang HG, 2009, IEEE T NEURAL NETWOR, V20, P1490, DOI 10.1109/TNN.2009.2027233	47	15	16	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66491	10.1371/journal.pone.0066491	http://dx.doi.org/10.1371/journal.pone.0066491			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785502	Green Published, Green Submitted, gold			2022-12-27	WOS:000321038800019
J	Stuber, EF; Verpeut, J; Horvat-Gordon, M; Ramachandran, R; Bartell, PA				Stuber, Erica F.; Verpeut, Jessica; Horvat-Gordon, Maria; Ramachandran, Ramesh; Bartell, Paul A.			Differential Regulation of Adipokines May Influence Migratory Behavior in the White-Throated Sparrow (Zonotrichia albicollis)	PLOS ONE			English	Article							FATTY-ACID OXIDATION; CIRCADIAN-RHYTHMS; ADIPOSE-TISSUE; ENDOCRINE ORGAN; ENERGETIC CONDITION; METABOLIC SYNDROME; SKELETAL-MUSCLE; CHICKEN LEPTIN; BIRD MIGRATION; WEIGHT-LOSS	White-throated sparrows increase fat deposits during pre-migratory periods and rely on these fat stores to fuel migration. Adipose tissue produces hormones and signaling factors in a rhythmic fashion and may be controlled by a clock in adipose tissue or driven by a master clock in the brain. The master clock may convey photoperiodic information from the environment to adipose tissue to facilitate pre-migratory fattening, and adipose tissue may, in turn, release adipokines to indicate the extent of fat energy stores. Here, we present evidence that a change in signal from the adipokines adiponectin and visfatin may act to indicate body condition, thereby influencing an individual's decision to commence migratory flight, or to delay until adequate fat stores are acquired. We quantified plasma adiponectin and visfatin levels across the day in captive birds held under constant photoperiod. The circadian profiles of plasma adiponectin in non-migrating birds were approximately inverse the profiles from migrating birds. Adiponectin levels were positively correlated to body fat, and body fat was inversely related to the appearance of nocturnal migratory restlessness. Visfatin levels were constant across the day and did not correlate with fat deposits; however, a reduction in plasma visfatin concentration occurred during the migratory period. The data suggest that a significant change in the biological control of adipokine expression exists between the two migratory conditions and we propose a role for adiponectin, visfatin and adipose clocks in the regulation of migratory behaviors.	[Stuber, Erica F.; Verpeut, Jessica; Horvat-Gordon, Maria; Ramachandran, Ramesh; Bartell, Paul A.] Penn State Univ, Dept Anim Sci, University Pk, PA 16802 USA; [Stuber, Erica F.; Bartell, Paul A.] Penn State Univ, Grad Program Ecol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Bartell, PA (corresponding author), Penn State Univ, Dept Anim Sci, University Pk, PA 16802 USA.	pab43@psu.edu	Stuber, Erica/AAT-2803-2020	Stuber, Erica/0000-0002-2687-6874; Verpeut, Jessica/0000-0003-2941-7697	Pennsylvania State University Dept. of Poultry Science; Pennsylvania State University College of Agricultural Sciences	Pennsylvania State University Dept. of Poultry Science; Pennsylvania State University College of Agricultural Sciences	This project was funded by The Pennsylvania State University Dept. of Poultry Science and College of Agricultural Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aamidor SE, 2011, INTEGR COMP BIOL, V51, P385, DOI 10.1093/icb/icr054; Ahima RS, 2006, OBESITY, V14, P242, DOI 10.1038/oby.2006.317; Ahima RS, 2006, OBESITY, V14, p9S, DOI 10.1038/oby.2006.276; Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Alfaro ME, 2006, SYST BIOL, V55, P89, DOI 10.1080/10635150500433565; Arble DM, 2011, PLOS ONE, P6; Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Arizaga J, 2011, J ORNITHOL, V152, P991, DOI 10.1007/s10336-011-0685-2; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Attie AD, 2009, J LIPID RES, V50, pS395, DOI 10.1194/jlr.R800057-JLR200; Barnea M, 2009, ENDOCRINOLOGY, V150, P161, DOI 10.1210/en.2008-0944; Bartell PA, 2005, J BIOL RHYTHM, V20, P538, DOI 10.1177/0748730405281826; Bartness TJ, 2007, PHYSIOL BEHAV, V91, P343, DOI 10.1016/j.physbeh.2007.04.002; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; BERTHOLD P, 1984, BIRD STUDY, V31, P19, DOI 10.1080/00063658409476810; BERTHOLD P, 1990, EXPERIENTIA, V46, P363, DOI 10.1007/BF01952169; Bottcher Y, 2006, J CLIN ENDOCR METAB, V91, P2725, DOI 10.1210/jc.2006-0149; Bray MS, 2007, OBES REV, V8, P169, DOI 10.1111/j.1467-789X.2006.00277.x; CAGNACCI A, 1992, J CLIN ENDOCR METAB, V75, P447, DOI 10.1210/jc.75.2.447; Cajochen C, 2003, J NEUROENDOCRINOL, V15, P432, DOI 10.1046/j.1365-2826.2003.00989.x; Calvani M, 2004, DIABETES, V53, P939, DOI 10.2337/diabetes.53.4.939; Cerasale DJ, 2011, GEN COMP ENDOCR, V174, P276, DOI 10.1016/j.ygcen.2011.08.025; Coppack T, 2011, J ORNITHOL, V152, P67, DOI 10.1007/s10336-011-0708-z; Covino KM, 2011, AUK, V128, P313, DOI 10.1525/auk.2011.09225; Del Turco S, 2011, MICROVASC RES, V82, P73, DOI 10.1016/j.mvr.2011.03.003; Dioum EM, 2002, SCIENCE, V298, P2385, DOI 10.1126/science.1078456; EYSTER MB, 1954, ECOL MONOGR, V24, P1, DOI 10.2307/1943509; FARNER DS, 1957, ANAT REC, V128, P546; Farooqi IS, 2009, AM J CLIN NUTR, V89, p980S, DOI 10.3945/ajcn.2008.26788C; Friedman-Einat M, 1999, GEN COMP ENDOCR, V115, P354, DOI 10.1006/gcen.1999.7322; Froy O, 2010, ENDOCR REV, V31, P1, DOI 10.1210/er.2009-0014; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; Fusani L, 2009, BIOL LETTERS, V5, P302, DOI 10.1098/rsbl.2008.0755; Gomez-Abellan P, 2010, ENDOCRINOLOGY, V151, P115, DOI 10.1210/en.2009-0647; Goto T, 2012, J NUTR BIOCHEM, V23, P768, DOI 10.1016/j.jnutbio.2011.04.001; Goymann W, 2010, BIOL LETTERS, V6, P478, DOI 10.1098/rsbl.2009.1028; Guglielmo CG, 2010, INTEGR COMP BIOL, V50, P336, DOI 10.1093/icb/icq097; Gwinner E, 1996, IBIS, V138, P47, DOI 10.1111/j.1474-919X.1996.tb04312.x; GWINNER E, 1977, ANNU REV ECOL SYST, V8, P381, DOI 10.1146/annurev.es.08.110177.002121; Gwinner E, 1996, J EXP BIOL, V199, P39; Hendricks GL, 2009, ENDOCRINOLOGY, V150, P3092, DOI 10.1210/en.2008-1558; Hui XY, 2012, BRIT J PHARMACOL, V165, P574, DOI 10.1111/j.1476-5381.2011.01395.x; Hut R, 2007, CIRCWAVE; Janovska A, 2008, MOL CELL ENDOCRINOL, V284, P1, DOI 10.1016/j.mce.2007.12.013; Jenni L, 1998, J AVIAN BIOL, V29, P521, DOI 10.2307/3677171; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; KAISER A, 1992, BIRD STUDY, V39, P96, DOI 10.1080/00063659209477105; KAISER A, 1993, J FIELD ORNITHOL, V64, P246; Kalra SP, 2003, REGUL PEPTIDES, V111, P1, DOI 10.1016/S0167-0115(02)00305-1; Kalsbeek A, 2001, ENDOCRINOLOGY, V142, P2677, DOI 10.1210/en.142.6.2677; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; King DP, 2000, ANNU REV NEUROSCI, V23, P713, DOI 10.1146/annurev.neuro.23.1.713; KING JAMES R., 1963, CONDOR, V65, P200, DOI 10.2307/1365665; Knutson KL, 2008, ANN NY ACAD SCI, V1129, P287, DOI 10.1196/annals.1417.033; Krzysik-Walker SM, 2008, ENDOCRINOLOGY, V149, P1543, DOI 10.1210/en.2007-1301; Kumar V, 2010, PHYSIOL BIOCHEM ZOOL, V83, P827, DOI 10.1086/652243; LABOVITZ S, 1970, AM SOCIOL REV, V35, P515, DOI 10.2307/2092993; Lago F, 2009, TRENDS BIOCHEM SCI, V34, P500, DOI 10.1016/j.tibs.2009.06.008; Lara-Castro C, 2006, DIABETES, V55, P249, DOI 10.2337/diabetes.55.1.249; Liu QQ, 2012, P NATL ACAD SCI USA, V109, P14568, DOI 10.1073/pnas.1211611109; Maddineni S, 2005, ENDOCRINOLOGY, V146, P4250, DOI 10.1210/en.2005-0254; Marra PP, 1998, SCIENCE, V282, P1884, DOI 10.1126/science.282.5395.1884; Mattevi A, 2006, NAT STRUCT MOL BIOL, V13, P563, DOI 10.1038/nsmb0706-563; McMillan J.P., 1972, Journal Comp Physiol, V79, P105, DOI 10.1007/BF00697766; MCMILLAN JP, 1970, BIOSCIENCE, V20, P1259, DOI 10.2307/1295520; MEIER AH, 1976, AM ZOOL, V16, P649; Mohamed-Ali V, 1998, INT J OBESITY, V22, P1145, DOI 10.1038/sj.ijo.0800770; OBRIEN RM, 1979, AM SOCIOL REV, V44, P851, DOI 10.2307/2094532; Ocon-Grove OM, 2008, REPRODUCTION, V136, P627, DOI 10.1530/REP-07-0446; ODUM EP, 1960, AM J CLIN NUTR, V8, P621, DOI 10.1093/ajcn/8.5.621; Ohkubo T, 2008, J POULT SCI, V45, P233, DOI 10.2141/jpsa.45.233; Pajvani UB, 2003, J BIOL CHEM, V278, P9073, DOI 10.1074/jbc.M207198200; Partecke J, 2007, ECOLOGY, V88, P882, DOI 10.1890/06-1105; Penicaud L, 2012, BIOCHIMIE, V94, P2069, DOI 10.1016/j.biochi.2012.04.013; PILO B, 1983, COMP BIOCHEM PHYS A, V74, P601, DOI 10.1016/0300-9629(83)90554-6; Pitel F, 2000, ANIM GENET, V31, P281, DOI 10.1046/j.1365-2052.2000.00610.x; Qi Y, 2004, NAT MED, V10, P524, DOI 10.1038/nm1029; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Rutter J, 2002, ANNU REV BIOCHEM, V71, P307, DOI 10.1146/annurev.biochem.71.090501.142857; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Salewski V, 2010, J ORNITHOL, V151, P371, DOI 10.1007/s10336-009-0464-5; Sassone-Corsi P, 2012, ENDOCRINOLOGY, V153, P1, DOI 10.1210/en.2011-1535; Schaub M, 2000, OECOLOGIA, V122, P306, DOI 10.1007/s004420050036; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; Scheuerlein A, 2001, P ROY SOC B-BIOL SCI, V268, P1575, DOI 10.1098/rspb.2001.1691; Sharp PJ, 2008, GEN COMP ENDOCR, V158, P2, DOI 10.1016/j.ygcen.2008.05.018; SNYDER SH, 1964, LIFE SCI, V3, P1175, DOI 10.1016/0024-3205(64)90137-7; Staiger H, 2003, OBES RES, V11, P368, DOI 10.1038/oby.2003.48; Studds CE, 2005, ECOLOGY, V86, P2380, DOI 10.1890/04-1145; Stutchbury BJM, 2011, P ROY SOC B-BIOL SCI, V278, P131, DOI 10.1098/rspb.2010.1220; te Marvelde L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034090; Team R. D. C., 2008, R LANG ENV STAT COMP; Ukkola O, 2002, J MOL MED, V80, P696, DOI 10.1007/s00109-002-0378-7; Waldstreicher J, 1996, J CLIN ENDOCR METAB, V81, P1483, DOI 10.1210/jc.81.4.1483; WEISE CM, 1956, ECOLOGY, V37, P274, DOI 10.2307/1933139; Xie H, 2007, CALCIFIED TISSUE INT, V80, P201, DOI 10.1007/s00223-006-0155-7; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; YOKOYAMA K, 1976, CELL TISSUE RES, V174, P391; Zajac DM, 2011, GEN COMP ENDOCR, V174, P269, DOI 10.1016/j.ygcen.2011.08.024; Zvonic S, 2006, DIABETES, V55, P962, DOI 10.2337/diabetes.55.04.06.db05-0873	101	14	14	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e59097	10.1371/journal.pone.0059097	http://dx.doi.org/10.1371/journal.pone.0059097			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785393	Green Submitted, gold, Green Published			2022-12-27	WOS:000321038800124
J	Bloem, K; Vuist, IM; van der Plas, AJ; Knippels, LMJ; Garssen, J; Garcia-Vallejo, JJ; van Vliet, SJ; van Kooyk, Y				Bloem, Karien; Vuist, Ilona M.; van der Plas, Arend-Jan; Knippels, Leon M. J.; Garssen, Johan; Garcia-Vallejo, Juan J.; van Vliet, Sandra J.; van Kooyk, Yvette			Ligand Binding and Signaling of Dendritic Cell Immunoreceptor (DCIR) Is Modulated by the Glycosylation of the Carbohydrate Recognition Domain	PLOS ONE			English	Article							C-TYPE LECTIN; VIVO GENE DELIVERY; MANNOSE RECEPTOR; ANTIGEN PRESENTATION; IMMUNE-RESPONSES; INHIBITORY MOTIF; SURFACE-RECEPTOR; CUTTING EDGE; ITIM; HIV-1	C-type lectins are innate receptors expressed on antigen-presenting cells that are involved in the recognition of glycosylated pathogens and self-glycoproteins. Upon ligand binding, internalization and/or signaling often occur. Little is known on the glycan specificity and ligands of the Dendritic Cell Immunoreceptor (DCIR), the only classical C-type lectin that contains an intracellular immunoreceptor tyrosine-based inhibitory motif (ITIM). Here we show that purified DCIR binds the glycan structures Lewis(b) and Man(3). Interestingly, binding could not be detected when DCIR was expressed on cells. Since DCIR has an N-glycosylation site inside its carbohydrate recognition domain (CRD), we investigated the effect of this glycan in ligand recognition. Removing or truncating the glycans present on purified DCIR increased the affinity for DCIR-binding glycans. Nevertheless, altering the glycosylation status of the DCIR expressing cell or mutating the N-glycosylation site of DCIR itself did not increase glycan binding. In contrast, cis and trans interactions with glycans induced DCIR mediated signaling, resulting in a decreased phosphorylation of the ITIM sequence. These results show that glycan binding to DCIR is influenced by the glycosylation of the CRD region in DCIR and that interaction with its ligands result in signaling via its ITIM motif.	[Bloem, Karien; Vuist, Ilona M.; van der Plas, Arend-Jan; Garcia-Vallejo, Juan J.; van Vliet, Sandra J.; van Kooyk, Yvette] Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, Amsterdam, Netherlands; [Bloem, Karien; Knippels, Leon M. J.; Garssen, Johan] Danone Res, Ctr Specialized Nutr, Wageningen, Netherlands; [Knippels, Leon M. J.; Garssen, Johan] Univ Utrecht, Dept Pharmacol & Pathophysiol, UIPS, Utrecht, Netherlands	Vrije Universiteit Amsterdam; Danone Nutricia; Utrecht University	van Kooyk, Y (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, Amsterdam, Netherlands.	y.vankooyk@vumc.nl	Garcia-Vallejo, Juan/H-4162-2012; Van Vliet, Sandra/AAO-9534-2020; Vallejo, Juan Garcia/AAA-3765-2020; garssen, johan/I-7159-2016	Garcia-Vallejo, Juan/0000-0001-6238-7069; Van Kooyk, Yvette/0000-0001-5997-3665; van Vliet, Sandra/0000-0003-1811-2687	Dutch Top Institute Pharma [T1-214]; MS Research; Dutch Asthma Foundation [3.210.040]; Veni grant from the Netherlands organization for Scientific Research (NWO) [863.10.017]	Dutch Top Institute Pharma; MS Research; Dutch Asthma Foundation; Veni grant from the Netherlands organization for Scientific Research (NWO)	K. Bloem was supported by the Dutch Top Institute Pharma, project T1-214, I.M. Vuist was supported by MS Research, J.J. Garcia-Vallejo was supported by the Dutch Asthma Foundation (3.210.040) and S.J. van Vliet was supported by a Veni grant (863.10.017) from the Netherlands organization for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appelmelk BJ, 2003, J IMMUNOL, V170, P1635, DOI 10.4049/jimmunol.170.4.1635; Barrow AD, 2004, J IMMUNOL, V172, P5838, DOI 10.4049/jimmunol.172.10.5838; Barrow AD, 2006, EUR J IMMUNOL, V36, P1646, DOI 10.1002/eji.200636195; Bates EEM, 1999, J IMMUNOL, V163, P1973; Bax M, 2007, J IMMUNOL, V179, P8216, DOI 10.4049/jimmunol.179.12.8216; Cambi A, 2012, ACS CHEM BIOL, V7, P139, DOI 10.1021/cb200326g; Ceroni A, 2007, SOURCE CODE BIOL MED, V2, DOI 10.1186/1751-0473-2-3; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Chen CH, 2006, BLOOD, V107, P1459, DOI 10.1182/blood-2005-08-3264; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Danzer CP, 2003, INT IMMUNOL, V15, P1137, DOI 10.1093/intimm/dxg114; de Witte L, 2007, NAT MED, V13, P367, DOI 10.1038/nm1541; DEUTSCHER SL, 1986, J BIOL CHEM, V261, P96; Engering A, 2002, J IMMUNOL, V168, P2118, DOI 10.4049/jimmunol.168.5.2118; Engering AJ, 1997, EUR J IMMUNOL, V27, P2417, DOI 10.1002/eji.1830270941; FAWCETT J, 1992, NATURE, V360, P481, DOI 10.1038/360481a0; Fontijn RD, 2008, AM J PHYSIOL-HEART C, V294, pH891, DOI 10.1152/ajpheart.01248.2007; Fujikado N, 2008, NAT MED, V14, P176, DOI 10.1038/nm1697; Garcia-Vallejo JJ, 2009, IMMUNOL REV, V230, P22, DOI 10.1111/j.1600-065X.2009.00786.x; Geijtenbeek TBH, 1999, BLOOD, V94, P754, DOI 10.1182/blood.V94.2.754.414k11_754_764; Geijtenbeek TBH, 2002, J BIOL CHEM, V277, P11314, DOI 10.1074/jbc.M111532200; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Guo JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041228; Hsu TL, 2009, J BIOL CHEM, V284, P34479, DOI 10.1074/jbc.M109.065961; Huang X, 2001, BIOCHEM BIOPH RES CO, V281, P131, DOI 10.1006/bbrc.2001.4322; Iida SI, 1999, J BIOL CHEM, V274, P10697, DOI 10.1074/jbc.274.16.10697; Kajiho Y, 2012, FEBS J, V279, P3010, DOI 10.1111/j.1742-4658.2012.08682.x; Kanazawa N, 2002, J INVEST DERMATOL, V118, P261, DOI 10.1046/j.0022-202x.2001.01633.x; Kawar ZS, 2005, J BIOL CHEM, V280, P12810, DOI 10.1074/jbc.M414273200; Kurihara H, 2010, AM J PHYSIOL-RENAL, V299, pF517, DOI 10.1152/ajprenal.00571.2009; Lambert AA, 2008, BLOOD, V112, P1299, DOI 10.1182/blood-2008-01-136473; Lambert AA, 2011, BLOOD, V117, P6589, DOI 10.1182/blood-2011-01-331363; Lee RT, 2011, GLYCOBIOLOGY, V21, P512, DOI 10.1093/glycob/cwq193; Lorentzen JC, 2007, ARTHRITIS RHEUM-US, V56, P2620, DOI 10.1002/art.22813; Marshall ASJ, 2004, J BIOL CHEM, V279, P14792, DOI 10.1074/jbc.M313127200; Meyer-Wentrup F, 2008, BLOOD, V111, P4245, DOI 10.1182/blood-2007-03-081398; Meyer-Wentrup F, 2009, J LEUKOCYTE BIOL, V85, P518, DOI 10.1189/jlb.0608352; Motegi S, 2003, EMBO J, V22, P2634, DOI 10.1093/emboj/cdg278; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; North SJ, 2010, J BIOL CHEM, V285, P5759, DOI 10.1074/jbc.M109.068353; Ohnishi H, 1999, J NEUROCHEM, V72, P1402, DOI 10.1046/j.1471-4159.1999.721402.x; Richard M, 2006, MOL IMMUNOL, V43, P1716, DOI 10.1016/j.molimm.2005.10.006; Richard M, 2003, BIOCHEM BIOPH RES CO, V310, P767, DOI 10.1016/j.bbrc.2003.09.077; STANLEY P, 1983, SOMAT CELL GENET, V9, P593, DOI 10.1007/BF01574260; STANLEY P, 1989, MOL CELL BIOL, V9, P377, DOI 10.1128/MCB.9.2.377; Su YP, 2005, J BIOL CHEM, V280, P32811, DOI 10.1074/jbc.M503457200; Taylor PR, 2005, TRENDS IMMUNOL, V26, P104, DOI 10.1016/j.it.2004.12.001; Unkeless JC, 1997, CURR OPIN IMMUNOL, V9, P338, DOI 10.1016/S0952-7915(97)80079-9; van Kooyk Y, 2008, BIOCHEM SOC T, V36, P1478, DOI 10.1042/BST0361478; van Vliet SJ, 2007, EUR J IMMUNOL, V37, P2075, DOI 10.1002/eji.200636838; van Vliet SJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000625; van Vliet SJ, 2005, INT IMMUNOL, V17, P661, DOI 10.1093/intimm/dxh246; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	54	31	31	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66266	10.1371/journal.pone.0066266	http://dx.doi.org/10.1371/journal.pone.0066266			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776650	Green Published, gold			2022-12-27	WOS:000320755400132
J	Choi, HJ; Ebersbacher, CF; Kim, MC; Kang, SM; Montemagno, CD				Choi, Hyo-Jick; Ebersbacher, Charles F.; Kim, Min-Chul; Kang, Sang-Moo; Montemagno, Carlo D.			A Mechanistic Study on the Destabilization of Whole Inactivated Influenza Virus Vaccine in Gastric Environment	PLOS ONE			English	Article							LIGHT-SCATTERING METHOD; OSMOTIC-PRESSURE; UNILAMELLAR VESICLES; EMPTYING TIME; PH OPTIMUM; HEMAGGLUTININ; STABILITY; IMMUNOGENICITY; PROTECTION; IMMUNITY	Oral immunization using whole inactivated influenza virus vaccine promises an efficient vaccination strategy. While oral vaccination was hampered by harsh gastric environment, a systematic understanding about vaccine destabilization mechanisms was not performed. Here, we investigated the separate and combined effects of temperature, retention time, pH, and osmotic stress on the stability of influenza vaccine by monitoring the time-dependent morphological change using stopped-flow light scattering. When exposed to osmotic stress, clustering of vaccine particles was enhanced in an acidic medium (pH 2.0) at >= 25 degrees C. Fluorescence spectroscopic studies showed that hyper-osmotic stress at pH 2.0 and 37 degrees C caused a considerable increase in conformational change of antigenic proteins compared to that in acidic iso-osmotic medium. A structural integrity of membrane was destroyed upon exposure to hyper-osmotic stress, leading to irreversible morphological change, as observed by undulation in stopped-flow light scattering intensity and transmission electron microscopy. Consistent with these analyses, hemagglutination activity decreased more significantly with an increasing magnitude of hyper-osmotic stress than in the presence of the hypo- and iso-osmotic stresses. This study shows that the magnitude and direction of the osmotic gradient has a substantial impact on the stability of orally administrated influenza vaccine.	[Choi, Hyo-Jick; Ebersbacher, Charles F.] Univ Cincinnati, Sch Energy Environm Biol & Med Engn, Cincinnati, OH USA; [Kim, Min-Chul; Kang, Sang-Moo] Georgia State Univ, Ctr Inflammat Immun & Infect, Atlanta, GA 30303 USA; [Kim, Min-Chul; Kang, Sang-Moo] Georgia State Univ, Dept Biol, Atlanta, GA USA; [Kim, Min-Chul] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA USA; [Kim, Min-Chul] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Montemagno, Carlo D.] Univ Alberta, Natl Inst Nanotechnol, Edmonton, AB, Canada; [Montemagno, Carlo D.] Univ Alberta, Dept Chem & Mat Engn, Edmonton, AB, Canada	University System of Ohio; University of Cincinnati; University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; Emory University; Emory University; National Research Council Canada; University of Alberta; University of Alberta	Choi, HJ (corresponding author), Univ Cincinnati, Sch Energy Environm Biol & Med Engn, Cincinnati, OH USA.	choihc@ucmail.uc.edu; montemag@ualberta.ca		Tripp, Ralph/0000-0002-2924-9956; Choi, Hyo-Jick/0000-0001-8233-5864	Bill & Melinda Gates Foundation through the Grand Challenges Exploration Initiative; National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID) [AI093772, AI087782, AI105170]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI087782, R01AI105170, R01AI093772] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation through the Grand Challenges Exploration Initiative; National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was funded by a grant from the Bill & Melinda Gates Foundation through the Grand Challenges Exploration Initiative (CDM and HJC), and in part by National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID) grants AI093772 (SMK), AI087782 (SMK), and AI105170 (SMK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azizi A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001147; BITTMAN R, 1981, CHEM PHYS LIPIDS, V28, P323, DOI 10.1016/0009-3084(81)90018-9; BLOUGH HA, 1971, J GEN VIROL, V12, P317, DOI 10.1099/0022-1317-12-3-317; Brown JD, 2009, VET MICROBIOL, V136, P20, DOI 10.1016/j.vetmic.2008.10.027; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; Choi HJ, 2013, J CONTROL RELEASE, V166, P159, DOI 10.1016/j.jconrel.2012.12.002; Choi HJ, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/5/055603; Choi HJ, 2012, BIOMATERIALS, V33, P3756, DOI 10.1016/j.biomaterials.2012.01.054; COLWELL WM, 1975, AVIAN DIS, V19, P781, DOI 10.2307/1589191; Cox RJ, 2004, SCAND J IMMUNOL, V59, P1, DOI 10.1111/j.0300-9475.2004.01382.x; DANIELS RS, 1984, VIROLOGY, V138, P174, DOI 10.1016/0042-6822(84)90158-2; DANIELS RS, 1983, J GEN VIROL, V64, P1657, DOI 10.1099/0022-1317-64-8-1657; ELLIOTT JR, 1983, BIOCHIM BIOPHYS ACTA, V735, P95, DOI 10.1016/0005-2736(83)90264-X; FARAGMAHMOD FI, 1988, VACCINE, V6, P262, DOI 10.1016/0264-410X(88)90222-8; Fatouros DG, 2002, J COLLOID INTERF SCI, V251, P271, DOI 10.1006/jcis.2002.8432; Fatouros DG, 2001, J DRUG TARGET, V9, P61, DOI 10.3109/10611860108995633; Fauci AS, 2006, CELL, V124, P665, DOI 10.1016/j.cell.2006.02.010; Nuorti J. Pekka, 2010, Morbidity and Mortality Weekly Report, V59, P1; Giudice EL, 2006, ADV DRUG DELIVER REV, V58, P68, DOI 10.1016/j.addr.2005.12.003; Kroger Andrew T., 2011, Morbidity and Mortality Weekly Report, V60, P3; Hellmig S, 2006, J GASTROEN HEPATOL, V21, P1832, DOI 10.1111/j.1440-1746.2006.04449.x; HUNT JN, 1959, PHYSIOL REV, V39, P491, DOI 10.1152/physrev.1959.39.3.491; KATES M, 1961, BIOCHIM BIOPHYS ACTA, V52, P455, DOI 10.1016/0006-3002(61)90403-6; Keitel WA, 2002, PERSP MED V, V7, P145; Kim CH, 1998, BIOCHEMISTRY-US, V37, P137, DOI 10.1021/bi971982w; KNOWLES CJ, 1971, BIOCHIM BIOPHYS ACTA, V234, P144, DOI 10.1016/0005-2728(71)90139-3; Lammert AM, 1998, FOOD CHEM, V61, P139, DOI 10.1016/S0308-8146(97)00132-5; LAZZELL V, 1984, J BIOL STAND, V12, P315, DOI 10.1016/S0092-1157(84)80012-8; MALMBERG CG, 1950, J RES NAT BUR STAND, V45, P299, DOI 10.6028/jres.045.030; McSwiney BA, 1933, J PHYSIOL-LONDON, V79, P437, DOI 10.1113/jphysiol.1933.sp003057; Miller GL, 1944, J EXP MED, V80, P507, DOI 10.1084/jem.80.6.507; MILON A, 1986, BIOCHIM BIOPHYS ACTA, V859, P1, DOI 10.1016/0005-2736(86)90311-1; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Mutsch M, 2004, NEW ENGL J MED, V350, P896, DOI 10.1056/NEJMoa030595; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; ONG BY, 1978, CAN ANAESTH SOC J, V25, P36, DOI 10.1007/BF03006781; Palese P, 2006, EMERG INFECT DIS, V12, P61, DOI 10.3201/eid1201.051043; Ponder E, 1944, J GEN PHYSIOL, V27, P273, DOI 10.1085/jgp.27.4.273; Quan FS, 2008, J VIROL, V82, P1350, DOI 10.1128/JVI.01615-07; Quan FS, 2011, VIROLOGY, V417, P196, DOI 10.1016/j.virol.2011.05.014; Quan FS, 2010, J VIROL, V84, P7760, DOI 10.1128/JVI.01849-09; Quan FS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007152; RICH GT, 1968, J GEN PHYSIOL, V52, P941, DOI 10.1085/jgp.52.6.941; ROSE EF, 1979, J FORENSIC SCI, V24, P200; SCHEIE PO, 1969, J BACTERIOL, V98, P335, DOI 10.1128/JB.98.2.335-340.1969; Schwarz H, 1995, MICROBIOL-UK, V141, P3161, DOI 10.1099/13500872-141-12-3161; Shastri PN, 2012, J PHARM SCI-US, V101, P3623, DOI 10.1002/jps.23220; SKEHEL JJ, 1982, P NATL ACAD SCI-BIOL, V79, P968, DOI 10.1073/pnas.79.4.968; Skehel JJ, 1995, COLD SPRING HARB SYM, V60, P573, DOI 10.1101/SQB.1995.060.01.061; Stanekova Z, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-351; SUN ST, 1986, BIOCHIM BIOPHYS ACTA, V860, P525, DOI 10.1016/0005-2736(86)90549-3; Szarka LA, 2009, AM J PHYSIOL-GASTR L, V296, pG461, DOI 10.1152/ajpgi.90467.2008; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; WAITE MRF, 1968, J VIROL, V2, P759, DOI 10.1128/JVI.2.7.759-760.1968; WILEY DC, 1987, ANNU REV BIOCHEM, V56, P365, DOI 10.1146/annurev.bi.56.070187.002053; WOODLE MC, 1989, METHOD ENZYMOL, V171, P193; YEWDELL JW, 1983, J VIROL, V48, P239, DOI 10.1128/JVI.48.1.239-248.1983	57	12	12	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66316	10.1371/journal.pone.0066316	http://dx.doi.org/10.1371/journal.pone.0066316			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776657	Green Submitted, Green Published, gold			2022-12-27	WOS:000320755400137
J	Marchi, C; Andersen, LW; Loeschcke, V				Marchi, Chiara; Andersen, Liselotte Wesley; Loeschcke, Volker			Effects of Land Management Strategies on the Dispersal Pattern of a Beneficial Arthropod	PLOS ONE			English	Article							WORKING GROUP PESTICIDES; BEETLES COLEOPTERA; BAYESIAN METHOD; LANDSCAPE; CARABIDAE; POPULATION; ABUNDANCE; INTENSITY; DENSITY; SIZE	Several arthropods are known to be highly beneficial to agricultural production. Consequently it is of great relevance to study the importance of land management and land composition for the conservation of beneficial aphid-predator arthropod species in agricultural areas. Therefore our study focusing on the beneficial arthropod Bembidion lampros had two main purposes: I) identifying the physical barriers to the species' dispersal in the agricultural landscape, and II) assessing the effect of different land management strategies (i.e. use of pesticides and intensiveness) on the dispersal patterns. The study was conducted using genetic analysis (microsatellite markers) applied to samples from two agricultural areas (in Denmark) with different agricultural intensity. Land management effects on dispersal patterns were investigated with particular focus on: physical barriers, use of pesticide and intensity of cultivation. The results showed that Bembidion lampros disperse preferably through hedges rather than fields, which act as physical barriers to gene flow. Moreover the results support the hypothesis that organic fields act as reservoirs for the re-colonization of conventional fields, but only when cultivation intensity is low. These results show the importance of non-cultivated areas and of low intensity organic managed areas within the agricultural landscape as corridors for dispersal (also for a species typically found within fields). Hence, the hypothesis that pesticide use cannot be used as the sole predictor of agriculture's effect on wild species is supported as land structure and agricultural intensity can be just as important.	[Marchi, Chiara; Loeschcke, Volker] Aarhus Univ, Dept Biosci, Aarhus, Denmark; [Andersen, Liselotte Wesley] Aarhus Univ, Dept Biosci, Ronde, Denmark	Aarhus University; Aarhus University	Marchi, C (corresponding author), Aarhus Univ, Dept Biosci, Aarhus, Denmark.	chiarapuspa@gmail.com	Loeschcke, Volker/J-2527-2013; Andersen, Liselotte Wesley/O-7115-2019	Loeschcke, Volker/0000-0003-1450-0754; Andersen, Liselotte Wesley/0000-0003-3225-9917	Ministry of Food, Agriculture and Fisheries [24.33.02.10]; AGSoS (Aarhus Graduate School of Science)	Ministry of Food, Agriculture and Fisheries; AGSoS (Aarhus Graduate School of Science)	Funded by the Ministry of Food, Agriculture and Fisheries under the Finance and Appropriation Act, Sections 24.33.02.10. Part of the Ph.D. project is funded by AGSoS (Aarhus Graduate School of Science). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen LW, 2004, P ROY SOC B-BIOL SCI, V271, P1293, DOI 10.1098/rspb.2004.2720; Brickle NW, 2000, J APPL ECOL, V37, P742, DOI 10.1046/j.1365-2664.2000.00542.x; Cameron KH, 2012, BIODIVERS CONSERV, V21, P763, DOI 10.1007/s10531-011-0215-9; CHIVERTON PA, 1986, ANN APPL BIOL, V109, P49, DOI 10.1111/j.1744-7348.1986.tb03183.x; EDWARDS CA, 1979, J APPL ECOL, V16, P811, DOI 10.2307/2402855; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Eyre MD, 2009, AGR ECOSYST ENVIRON, V131, P340, DOI 10.1016/j.agee.2009.02.006; Faubet P, 2008, GENETICS, V178, P1491, DOI 10.1534/genetics.107.082560; Faubet P, 2007, MOL ECOL, V16, P1149, DOI 10.1111/j.1365-294X.2007.03218.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; HASSAN SA, 1988, J APPL ENTOMOL, V105, P321, DOI 10.1111/j.1439-0418.1988.tb00194.x; HASSAN SA, 1991, ENTOMOPHAGA, V36, P55, DOI 10.1007/BF02374636; Hendrickx F, 2007, J APPL ECOL, V44, P340, DOI 10.1111/j.1365-2664.2006.01270.x; Honek A, 2000, EUR J ENTOMOL, V97, P517, DOI 10.14411/eje.2000.080; Huusela-Veistola E, 1996, ANN ZOOL FENN, V33, P197; Jansen JP, 2010, PEST MANAG SCI, V66, P650, DOI 10.1002/ps.1924; Landis DA, 2000, ANNU REV ENTOMOL, V45, P175, DOI 10.1146/annurev.ento.45.1.175; Milligan B. G., 1992, Molecular genetic analysis of populations: a practical approach., P59; Ovenden JR, 2007, MOL ECOL, V16, P127, DOI 10.1111/j.1365-294X.2006.03132.x; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; PEDERSEN M, 1990, PEDOBIOLOGIA, V34, P367; Petersen MK, 1999, ENTOMOL EXP APPL, V90, P221, DOI 10.1023/A:1003513706764; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Pudovkin AI, 1996, GENETICS, V144, P383; Purvis G, 2002, PEDOBIOLOGIA, V46, P452, DOI 10.1078/0031-4056-00152; PURVIS G, 1984, J APPL ECOL, V21, P271, DOI 10.2307/2403053; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Safner T, 2011, INT J MOL SCI, V12, P865, DOI 10.3390/ijms12020865; Smith HG, 2010, OECOLOGIA, V162, P1071, DOI 10.1007/s00442-010-1588-2; Smith RK, 2005, MAMMAL REV, V35, P1, DOI 10.1111/j.1365-2907.2005.00057.x; Wallin H, 1989, ECOGRAPHY, V12, P193; WAPLES RS, 1989, GENETICS, V121, P379	34	11	11	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66208	10.1371/journal.pone.0066208	http://dx.doi.org/10.1371/journal.pone.0066208			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776633	gold, Green Published			2022-12-27	WOS:000320755400122
J	Weber, J; Rose, JD; Vazquez, AC; Winner, D; Margot, N; McColl, DJ; Miller, MD; Quinones-Mateu, ME				Weber, Jan; Rose, Justine D.; Vazquez, Ana C.; Winner, Dane; Margot, Nicolas; McColl, Damian J.; Miller, Michael D.; Quinones-Mateu, Miguel E.			Resistance Mutations outside the Integrase Coding Region Have an Effect on Human Immunodeficiency Virus Replicative Fitness but Do Not Affect Its Susceptibility to Integrase Strand Transfer Inhibitors	PLOS ONE			English	Article							HIV-1 REVERSE-TRANSCRIPTASE; CONNECTION DOMAIN; CROSS-RESISTANCE; DOLUTEGRAVIR S/GSK1349572; DELETERIOUS MUTATIONS; COMBINATION THERAPY; TYPE-1 FITNESS; VIRAL FITNESS; RALTEGRAVIR; ELVITEGRAVIR	Most studies describing phenotypic resistance to integrase strand transfer inhibitors have analyzed viruses carrying only patient-derived HIV-1 integrase genes (INT-recombinant viruses). However, to date, many of the patients on INSTI-based treatment regimes, such as raltegravir (RAL), elvitegravir (EVG), and dolutegravir (DTG) are infected with multidrug-resistant HIV-1 strains. Here we analyzed the effect of drug resistance mutations in Gag (p2/NCp7/p1/p6), protease (PR), reverse transcriptase (RT), and integrase (IN) coding regions on susceptibility to INSTIs and viral replicative fitness using a novel HIV-1 phenotyping assay. Initial characterization based on site-directed mutant INSTI-resistant viruses confirmed the effect of a series of INSTI mutations on reduced susceptibility to EVG and RAL and viral replicative fitness (0.6% to 99% relative to the HIV-1(NL4-3) control). Two sets of recombinant viruses containing a 3,428-bp gag-p2/NCp7/p1/p6/pol-PR/RT/IN (p2-INT) or a 1,088 bp integrase (INT) patient-derived fragment were constructed from plasma samples obtained from 27 virologic failure patients participating in a 48-week dose-ranging study of elvitegravir, GS-US-183-0105. A strong correlation was observed when susceptibility to EVG and RAL was assayed using p2-INT-vs. INT-recombinant viruses (Pearson coefficient correlation 0.869 and 0.918, P<0.0001 for EVG and RAL, respectively), demonstrating that mutations in the protease and RT have limited effect on susceptibility to these INSTIs. On the other hand, the replicative fitness of viruses harboring drug resistance mutations in PR, RT, and IN was generally impaired compared to viruses carrying only INSTI-resistance mutations. Thus, in the absence of drug pressure, drug resistance mutations in the PR and RT contribute to decrease the replicative fitness of the virus already impaired by mutations in the integrase. The use of recombinant viruses containing most or all HIV-1 regions targeted by antiretroviral drugs might be essential to understand the collective effect of epistatic interactions in multidrug-resistant viruses.	[Weber, Jan] Acad Sci Czech Republ, Inst Organ Chem & Biochem, Prague, Czech Republic; [Rose, Justine D.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Vazquez, Ana C.] Kent State Univ, Sch Biomed Sci, Kent, OH 44242 USA; [Winner, Dane; Quinones-Mateu, Miguel E.] Univ Hosp Case Med Ctr, Univ Hosp Translat Lab, Cleveland, OH USA; [Margot, Nicolas; McColl, Damian J.; Miller, Michael D.] Gilead Sci Inc, Foster City, CA 94404 USA; [Quinones-Mateu, Miguel E.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA	Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; Case Western Reserve University; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; Case Western Reserve University; Case Western Reserve University Hospital; Gilead Sciences; Case Western Reserve University	Quinones-Mateu, ME (corresponding author), Univ Hosp Case Med Ctr, Univ Hosp Translat Lab, Cleveland, OH USA.	meq@case.edu	Weber, Jan/B-5405-2013; Quinones-Mateu, Miguel/H-3846-2019	Weber, Jan/0000-0002-2799-7352; Quinones-Mateu, Miguel/0000-0001-9170-5601	Ministry of Education, Youth and Sports of the Czech Republic [LK11207]; State of Ohio; Department of Development; Third Frontier Commission;  [NIH-AI-71747]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI071747] Funding Source: NIH RePORTER	Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); State of Ohio; Department of Development; Third Frontier Commission; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	MEQ-M was supported by research grant NIH-AI-71747. JW was supported by research grant from the Ministry of Education, Youth and Sports of the Czech Republic (LK11207). The authors thank Doug Wylie and Ariel Rhea (Diagnostic Hybrids, Inc., Athens, Ohio) for their involvement in the drug susceptibility assays. Diagnostic Hybrids, Inc. acknowledges the contribution of the State of Ohio, Department of Development and Third Frontier Commission, which provided funding in support of the Platform for Antiviral Resistance Testing and Vaccine Development project. The content reflects the views of Diagnostic Hybrids, Inc. and does not purport to reflect the views of the State of Ohio. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram ME, 2012, ANTIVIR THER, V17, pA11; Armenia D, 2012, J INFECT DIS, V205, P557, DOI 10.1093/infdis/jir821; Blanco JL, 2011, J INFECT DIS, V203, P1204, DOI 10.1093/infdis/jir025; Bonhoeffer S, 2004, SCIENCE, V306, P1547, DOI 10.1126/science.1101786; Canducci F, 2011, CLIN MICROBIOL INFEC, V17, P928, DOI 10.1111/j.1469-0691.2010.03375.x; Canducci F, 2011, J INFECT DIS, V204, P1811, DOI 10.1093/infdis/jir636; Ceccherini-Silberstein F, 2010, J ANTIMICROB CHEMOTH, V65, P2305, DOI 10.1093/jac/dkq326; Ceccherini-Silberstein F, 2010, ANTIMICROB AGENTS CH, V54, P3938, DOI 10.1128/AAC.01720-09; Cooper DA, 2008, NEW ENGL J MED, V359, P355, DOI 10.1056/NEJMoa0708978; da SJ, 2010, GENETICS; Dam E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000345; Delelis O, 2009, NUCLEIC ACIDS RES, V37, P1193, DOI 10.1093/nar/gkn1050; Dudley DM, 2009, BIOTECHNIQUES, V46, P458, DOI 10.2144/000113119; Ehteshami M, 2008, J BIOL CHEM, V283, P22222, DOI 10.1074/jbc.M803521200; Ehteshami M, 2008, AIDS REV, V10, P224; Ferns RB, 2009, AIDS, V23, P2159, DOI 10.1097/QAD.0b013e32832ec4ae; Fransen S, 2012, J VIROL, V86, P7249, DOI 10.1128/JVI.06618-11; Fransen S, 2009, J VIROL, V83, P11440, DOI 10.1128/JVI.01168-09; Fransen S, 2009, ANTIMICROB AGENTS CH, V53, P4522, DOI 10.1128/AAC.00651-09; Fun A, 2010, J ANTIMICROB CHEMOTH, V65, P2300, DOI 10.1093/jac/dkq319; Goethals O, 2008, J VIROL, V82, P10366, DOI 10.1128/JVI.00470-08; Goodman D, 2008, 17 INT HIV DRUG RES; Gupta S, 2010, ANTIMICROB AGENTS CH, V54, P1973, DOI 10.1128/AAC.00870-09; Hazuda DJ, 2000, SCIENCE, V287, P646, DOI 10.1126/science.287.5453.646; Hinkley T, 2011, NAT GENET, V43, P487, DOI 10.1038/ng.795; Hu ZX, 2010, JAIDS-J ACQ IMM DEF, V55, P148, DOI 10.1097/QAI.0b013e3181e9a87a; Jegede O, 2008, AIDS REV, V10, P172; Buzon MJ, 2010, AIDS, V24, P17, DOI 10.1097/QAD.0b013e328331c81e; Kobayashi M, 2011, ANTIMICROB AGENTS CH, V55, P813, DOI 10.1128/AAC.01209-10; Kouyos RD, 2007, TRENDS ECOL EVOL, V22, P308, DOI 10.1016/j.tree.2007.02.014; Larrouy L, 2011, ANTIMICROAGENTS CHEM; Larrouy L, 2010, ANTIMICROB AGENTS CH, V54, P2910, DOI 10.1128/AAC.00194-10; Lennox JL, 2009, LANCET, V374, P796, DOI 10.1016/S0140-6736(09)60918-1; LEVY JA, 1993, MICROBIOL REV, V57, P183, DOI 10.1128/MMBR.57.1.183-289.1993; Malet I, 2009, J ANTIMICROB CHEMOTH, V63, P795, DOI 10.1093/jac/dkp014; Margot NA, 2012, ANTIVIR RES, V93, P288, DOI 10.1016/j.antiviral.2011.12.008; Martinez JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018375; McColl DJ, 2007, ANTIVIR THER, V12, pS11; McColl DJ, 2010, ANTIVIR RES, V85, P101, DOI 10.1016/j.antiviral.2009.11.004; Mesplede T, 2012, J INT AIDS SOC, V15, P8, DOI 10.7448/IAS.15.6.18113; Mesplede T, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-22; Nijhuis M, 2001, CURR OPIN INFECT DIS, V14, P23, DOI 10.1097/00001432-200102000-00005; Parera M, 2009, J MOL BIOL, V392, P243, DOI 10.1016/j.jmb.2009.07.015; Quashie PK, 2013, CURR OPIN INFECT DIS, V26, P43, DOI 10.1097/QCO.0b013e32835ba81c; Quashie PK, 2012, J VIROL, V86, P2696, DOI 10.1128/JVI.06591-11; Quercia R, 2009, J VIROL, V83, P10245, DOI 10.1128/JVI.00894-09; Quinones-Mateu ME, 2000, J VIROL, V74, P9222, DOI 10.1128/JVI.74.19.9222-9233.2000; Quinones-Mateu ME, 2006, CURR TOP MICROBIOL, V299, P83; Quinones-Mateu ME, 2002, DRUG RESIST UPDATE, V5, P224, DOI 10.1016/S1368-7646(02)00123-1; Quinones-Mateu ME, 2001, HIV SEQUENCE COMPEND, P134; Raffi F, 2013, LANCET; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rockstroh J, 2012, J INT AIDS SOC, V15, P18220; Sato M, 2006, J MED CHEM, V49, P1506, DOI 10.1021/jm0600139; Selhorst P, 2011, ANTIMICROB AGENTS CH, V55, P1403, DOI 10.1128/AAC.01426-10; Shimura K, 2008, J VIROL, V82, P764, DOI 10.1128/JVI.01534-07; Summa V, 2008, J MED CHEM, V51, P5843, DOI 10.1021/jm800245z; van Lunzen J, 2012, LANCET INFECT DIS, V12, P111, DOI 10.1016/S1473-3099(11)70290-0; Van Wesenbeeck L, 2011, ANTIMICROB AGENTS CH, V55, P321, DOI 10.1128/AAC.01733-09; Weber J, 2007, ANTIVIR THER, V12, pS155; Weber J, 2003, J GEN VIROL, V84, P2217, DOI 10.1099/vir.0.19123-0; Weber J, 2003, JAIDS-J ACQ IMM DEF, V33, P448, DOI 10.1097/00126334-200308010-00005; Weber J, 2006, J VIROL METHODS, V136, P102, DOI 10.1016/j.jviromet.2006.04.004; Weber J, 2011, ANTIMICROB AGENTS CH, V55, P3729, DOI 10.1128/AAC.00396-11; Wilkinson TA, 2009, J BIOL CHEM, V284, P7931, DOI 10.1074/jbc.M806241200; Winters MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040514; Yap SH, 2007, PLOS MED, V4, P1887, DOI 10.1371/journal.pmed.0040335; Zolopa A, 2012, J INT AIDS SOC, V15, P23, DOI 10.7448/IAS.15.6.18219; Zolopa AR, 2010, J INFECT DIS, V201, P814, DOI 10.1086/650698	69	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65631	10.1371/journal.pone.0065631	http://dx.doi.org/10.1371/journal.pone.0065631			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776513	Green Published, Green Submitted, gold			2022-12-27	WOS:000320755400049
J	Lai, CH; Lai, CK; Lin, YJ; Hung, CL; Chu, CH; Feng, CL; Chang, CS; Su, HL				Lai, Chih-Ho; Lai, Cheng-Kuo; Lin, Ying-Ju; Hung, Chiu-Lien; Chu, Chia-Han; Feng, Chun-Lung; Chang, Chia-Shuo; Su, Hong-Lin			Characterization of Putative Cholesterol Recognition/Interaction Amino Acid Consensus-Like Motif of Campylobacter jejuni Cytolethal Distending Toxin C	PLOS ONE			English	Article							CELL-CYCLE ARREST; GPI-ANCHORED PROTEIN; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; MEMBRANE CHOLESTEROL; BACTERIAL GENOTOXIN; SIGNAL-TRANSDUCTION; MOLECULAR DOCKING; ENDOCYTOSIS; SUBUNITS; RECOGNITION	Cytolethal distending toxin (CDT) produced by Campylobacter jejuni comprises a heterotrimeric complex formed by CdtA, CdtB, and CdtC. Among these toxin subunits, CdtA and CdtC function as essential proteins that mediate toxin binding to cytoplasmic membranes followed by delivery of CdtB into the nucleus. The binding of CdtA/CdtC to the cell surface is mediated by cholesterol, a major component in lipid rafts. Although the putative cholesterol recognition/interaction amino acid consensus (CRAC) domain of CDT has been reported from several bacterial pathogens, the protein regions contributing to CDT binding to cholesterol in C. jejuni remain unclear. Here, we selected a potential CRAC-like region present in the CdtC from C. jejuni for analysis. Molecular modeling showed that the predicted functional domain had the shape of a hydrophobic groove, facilitating cholesterol localization to this domain. Mutation of a tyrosine residue in the CRAC-like region decreased direct binding of CdtC to cholesterol rather than toxin intermolecular interactions and led to impaired CDT intoxication. These results provide a molecular link between C. jejuni CdtC and membrane-lipid rafts through the CRAC-like region, which contributes to toxin recognition and interaction with cholesterol.	[Lai, Chih-Ho; Lai, Cheng-Kuo; Chang, Chia-Shuo] China Med Univ, Grad Inst Basic Med Sci, Sch Med, Dept Microbiol, Taichung, Taiwan; [Lai, Cheng-Kuo; Su, Hong-Lin] Natl Chung Hsing Univ, Agr Biotechnol Ctr, Dept Life Sci, Taichung 40227, Taiwan; [Lin, Ying-Ju] China Med Univ, Sch Chinese Med, Taichung, Taiwan; [Hung, Chiu-Lien] Univ Calif Davis, Dept Biochem & Mol Med, Ctr Comprehens Canc, Sacramento, CA 95817 USA; [Chu, Chia-Han] Natl Tsing Hua Univ, Biomed Sci & Engn Ctr, Hsinchu, Taiwan; [Feng, Chun-Lung] China Med Univ Hosp, Dept Internal Med, Taichung, Taiwan; [Su, Hong-Lin] China Med Univ, Dept Phys Therapy, Taichung, Taiwan	China Medical University Taiwan; National Chung Hsing University; China Medical University Taiwan; University of California System; University of California Davis; National Tsing Hua University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Lai, CH (corresponding author), China Med Univ, Grad Inst Basic Med Sci, Sch Med, Dept Microbiol, Taichung, Taiwan.	chl@mail.cmu.edu.tw; suhonglin@nchu.edu.tw	Chu, Chu/T-6038-2019; Lai, Chih-Ho/M-2433-2013	Lai, Chih-Ho/0000-0001-9229-818X	National Science Council [NSC101-2313-B-039-004-MY3]; China Medical University, Taiwan [CMU101-S-13]; Tomorrow Medicine Foundation	National Science Council(Ministry of Science and Technology, Taiwan); China Medical University, Taiwan(China Medical University); Tomorrow Medicine Foundation	This work was supported by the National Science Council (NSC101-2313-B-039-004-MY3), China Medical University, Taiwan (CMU101-S-13), and Tomorrow Medicine Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrami L, 2003, J CELL BIOL, V160, P321, DOI 10.1083/jcb.200211018; Abrami L, 1998, J CELL BIOL, V140, P525, DOI 10.1083/jcb.140.3.525; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BLACK RE, 1988, J INFECT DIS, V157, P472, DOI 10.1093/infdis/157.3.472; Boesze-Battaglia K, 2006, CELL MICROBIOL, V8, P823, DOI 10.1111/j.1462-5822.2005.00669.x; Boesze-Battaglia K, 2009, J BIOL CHEM, V284, P10650, DOI 10.1074/jbc.M809094200; Coconnier MH, 2000, CELL MICROBIOL, V2, P487, DOI 10.1046/j.1462-5822.2000.00073.x; Damek-Poprawa M, 2012, INFECT IMMUN, V80, P2761, DOI 10.1128/IAI.00385-12; Eshraghi A, 2010, J BIOL CHEM, V285, P18199, DOI 10.1074/jbc.M110.112912; Farrand AJ, 2010, P NATL ACAD SCI USA, V107, P4341, DOI 10.1073/pnas.0911581107; Guerra L, 2005, CELL MICROBIOL, V7, P921, DOI 10.1111/j.1462-5822.2005.00520.x; Jinadasa RN, 2011, MICROBIOL-SGM, V157, P1851, DOI 10.1099/mic.0.049536-0; Lai CH, 2013, BIOMEDICINE-TAIWAN, V3, P27, DOI 10.1016/j.biomed.2012.12.002; Lara-Tejero M, 2000, SCIENCE, V290, P354, DOI 10.1126/science.290.5490.354; Lara-Tejero M, 2001, INFECT IMMUN, V69, P4358, DOI 10.1128/IAI.69.7.4358-4365.2001; Lee RB, 2003, INFECT IMMUN, V71, P4883, DOI 10.1128/IAI.71.9.4883-4890.2003; Li H, 1998, ENDOCRINOLOGY, V139, P4991, DOI 10.1210/en.139.12.4991; Lin CD, 2011, INFECT IMMUN, V79, P3563, DOI 10.1128/IAI.05175-11; Lin CJ, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/682418; Mao XQ, 2002, CELL MICROBIOL, V4, P245, DOI 10.1046/j.1462-5822.2002.00186.x; McSweeney LA, 2005, INFECT IMMUN, V73, P2051, DOI 10.1128/IAI.73.4.2051-2060.2005; McSweeney LA, 2004, CELL MICROBIOL, V6, P447, DOI 10.1111/j.1462-5822.2004.00373.x; Mise K, 2005, INFECT IMMUN, V73, P4846, DOI 10.1128/IAI.73.8.4846-4852.2005; Nesic D, 2004, NATURE, V429, P429, DOI 10.1038/nature02532; Nesic D, 2005, PLOS PATHOG, V1, P214, DOI 10.1371/journal.ppat.0010028; Ricci V, 2000, MOL BIOL CELL, V11, P3897, DOI 10.1091/mbc.11.11.3897; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Smith JL, 2006, CRIT REV MICROBIOL, V32, P227, DOI 10.1080/10408410601023557; Tauxe RV, 1997, EMERG INFECT DIS, V3, P425, DOI 10.3201/eid0304.970403; Wolf AA, 2002, J BIOL CHEM, V277, P16249, DOI 10.1074/jbc.M109834200; Wooldridge KG, 1996, MICROB PATHOGENESIS, V21, P299, DOI 10.1006/mpat.1996.0063; Wu GS, 2003, J COMPUT CHEM, V24, P1549, DOI 10.1002/jcc.10306; Yamada T, 2006, PROTEIN SCI, V15, P362, DOI 10.1110/ps.051790506; Yang JM, 2004, PROTEINS, V55, P288, DOI 10.1002/prot.20035; Zhou MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032580; Zitzer A, 2001, J BIOL CHEM, V276, P14628, DOI 10.1074/jbc.M100241200	36	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e66202	10.1371/journal.pone.0066202	http://dx.doi.org/10.1371/journal.pone.0066202			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762481	Green Submitted, gold, Green Published			2022-12-27	WOS:000321099000129
J	Ballesteros, NA; Castro, R; Abos, B; Saint-Jean, SSR; Perez-Prieto, SI; Tafalla, C				Ballesteros, Natalia A.; Castro, Rosario; Abos, Beatriz; Rodriguez Saint-Jean, Sylvia S.; Perez-Prieto, Sara I.; Tafalla, Carolina			The Pyloric Caeca Area Is a Major Site for IgM(+) and IgT(+) B Cell Recruitment in Response to Oral Vaccination in Rainbow Trout	PLOS ONE			English	Article							PANCREATIC NECROSIS VIRUS; CYPRINUS-CARPIO L; POSSIBLE IMMUNOLOGICAL IMPLICATIONS; OMENTAL MILKY SPOTS; ADIPOSE-TISSUE; T-CELLS; TELEOST FISH; PLASMA-CELLS; EXPRESSION; OBESITY	Although previous studies have characterized some aspects of the immune response of the teleost gut in response to diverse pathogens or stimuli, most studies have focused on the posterior segments exclusively. However, there are still many details of how teleost intestinal immunity is regulated that remain unsolved, including the location of IgM(+) and IgT(+) B cells along the digestive tract and their role during the course of a local stimulus. Thus, in the current work, we have studied the B cell response in five different segments of the rainbow trout (Oncorhynchus mykiss) digestive tract in both naive fish and fish orally vaccinated with an alginate-encapsulated DNA vaccine against infectious pancreatic necrosis virus (IPNV). IgM(+) and IgT(+) cells were identified all along the tract with the exception of the stomach in naive fish. While IgM(+) cells were mostly located in the lamina propria (LP), IgT(+) cells were primarily localized as intraepithelial lymphocytes (IELs). Scattered IgM(+) IELs were only detected in the pyloric caeca. In response to oral vaccination, the pyloric caeca region was the area of the digestive tract in which a major recruitment of B cells was demonstrated through both real time PCR and immunohistochemistry, observing a significant increase in the number of both IgM(+) and IgT(+) IELs. Our findings demonstrate that both IgM(+) and IgT(+) respond to oral stimulation and challenge the paradigm that teleost IELs are exclusively T cells. Unexpectedly, we have also detected B cells in the fat tissue associated to the digestive tract that respond to vaccination, suggesting that these cells surrounded by adipocytes also play a role in mucosal defense.	[Ballesteros, Natalia A.; Rodriguez Saint-Jean, Sylvia S.; Perez-Prieto, Sara I.] Ctr Invest Biol, Dpto Microbiol Mol & Biol Infecc, E-28006 Madrid, Spain; [Castro, Rosario; Abos, Beatriz; Tafalla, Carolina] Ctr Invest Sanidad Anim, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Tafalla, C (corresponding author), Ctr Invest Sanidad Anim, Madrid, Spain.	tafalla@inia.es	Tafalla, Carolina/J-8074-2014; Ballesteros, Natalia A./AAD-5766-2019	Tafalla, Carolina/0000-0002-0860-2976; Ballesteros, Natalia A./0000-0003-0797-3107	Starting grant TEBLYM from the European Research Council; Spanish Ministerio de Economia y Competitividad [AGL2010-18454]	Starting grant TEBLYM from the European Research Council; Spanish Ministerio de Economia y Competitividad(Spanish Government)	This work was supported by the Starting grant TEBLYM from the European Research Council and by the project AGL2010-18454 from the Spanish Ministerio de Economia y Competitividad. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso M, 1999, ARCH VIROL, V144, P657, DOI 10.1007/s007050050534; Ballesteros NA, 2012, FISH SHELLFISH IMMUN, V33, P1249, DOI 10.1016/j.fsi.2012.09.004; Ballesteros NA, 2012, FISH SHELLFISH IMMUN, V33, P174, DOI 10.1016/j.fsi.2012.03.016; Bedford PA, 2006, J LEUKOCYTE BIOL, V80, P546, DOI 10.1189/jlb.0905501; BEELEN RHJ, 1980, J RETICULOENDOTH SOC, V28, P585; Bengten E, 2006, DEV COMP IMMUNOL, V30, P77, DOI 10.1016/j.dci.2005.06.016; Bernard D, 2006, J IMMUNOL, V176, P3942, DOI 10.4049/jimmunol.176.7.3942; Boyaka PN, 2000, AM J PATHOL, V157, P2023, DOI 10.1016/S0002-9440(10)64841-9; Brandtzaeg P, 2005, IMMUNOL REV, V206, P32, DOI 10.1111/j.0105-2896.2005.00283.x; Castro R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003098; Chaves-Pozo E, 2010, DEV COMP IMMUNOL, V34, P648, DOI 10.1016/j.dci.2010.01.009; Danilova N, 2005, NAT IMMUNOL, V6, P295, DOI 10.1038/ni1166; de las Heras AI, 2010, FISH SHELLFISH IMMUN, V28, P562, DOI 10.1016/j.fsi.2009.12.006; GAUTHIER GF, 1972, ANAT RECORD, V172, P675, DOI 10.1002/ar.1091720408; Gray KS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043196; Hansen JD, 2005, P NATL ACAD SCI USA, V102, P6919, DOI 10.1073/pnas.0500027102; Hayday A, 2001, NAT IMMUNOL, V2, P997, DOI 10.1038/ni1101-997; John BJ, 2006, ALIMENT PHARM THER, V23, P1511, DOI 10.1111/j.1365-2036.2006.02915.x; Jorgensen LV, 2011, J FISH DIS, V34, P749, DOI 10.1111/j.1365-2761.2011.01291.x; Kaminski DA, 2010, TRENDS IMMUNOL, V31, P384, DOI 10.1016/j.it.2010.08.001; Lin KI, 2002, MOL CELL BIOL, V22, P4771, DOI 10.1128/MCB.22.13.4771-4780.2002; LOBB CJ, 1987, DEV COMP IMMUNOL, V11, P727, DOI 10.1016/0145-305X(87)90060-7; Lynch L, 2009, EUR J IMMUNOL, V39, P1893, DOI 10.1002/eji.200939349; Martinez-Alonso S, 2012, DEV COMP IMMUNOL, V36, P378, DOI 10.1016/j.dci.2011.07.010; Mesin L, 2011, J IMMUNOL, V187, P2867, DOI 10.4049/jimmunol.1003181; Olsen MM, 2011, FISH SHELLFISH IMMUN, V30, P859, DOI 10.1016/j.fsi.2011.01.010; Rangel-Moreno J, 2009, IMMUNITY, V30, P731, DOI 10.1016/j.immuni.2009.03.014; Rombout JHWM, 2011, FISH SHELLFISH IMMUN, V31, P616, DOI 10.1016/j.fsi.2010.09.001; ROMBOUT JHWM, 1993, DEV COMP IMMUNOL, V17, P55, DOI 10.1016/0145-305X(93)90015-I; ROMBOUT JHWM, 1985, CELL TISSUE RES, V239, P519, DOI 10.1007/BF00219230; ROMBOUT JHWM, 1985, CELL BIOL INT REP, V9, P516, DOI 10.1016/0309-1651(85)90003-7; Scapigliati G, 2000, FISH SHELLFISH IMMUN, V10, P329, DOI 10.1006/fsim.1999.0243; Tumang JR, 2005, J IMMUNOL, V174, P3173, DOI 10.4049/jimmunol.174.6.3173; vanVugt E, 1996, ANAT REC, V244, P235; Yang YK, 2008, CELL PHYSIOL BIOCHEM, V22, P531, DOI 10.1159/000185527; Zhang YA, 2011, FISH SHELLFISH IMMUN, V31, P627, DOI 10.1016/j.fsi.2011.03.021; Zhang YA, 2010, NAT IMMUNOL, V11, P827, DOI 10.1038/ni.1913; Zwollo P, 2005, J IMMUNOL, V174, P6608, DOI 10.4049/jimmunol.174.11.6608; Zwollo P, 2008, DEV COMP IMMUNOL, V32, P1482, DOI 10.1016/j.dci.2008.06.008	39	52	52	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66118	10.1371/journal.pone.0066118	http://dx.doi.org/10.1371/journal.pone.0066118			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785475	Green Published, gold			2022-12-27	WOS:000321038800046
J	Emeville, E; Giton, F; Giusti, A; Oliva, A; Fiet, J; Thome, JP; Blanchet, P; Multigner, L				Emeville, Elise; Giton, Frank; Giusti, Arnaud; Oliva, Alejandro; Fiet, Jean; Thome, Jean-Pierre; Blanchet, Pascal; Multigner, Luc			Persistent Organochlorine Pollutants with Endocrine Activity and Blood Steroid Hormone Levels in Middle-Aged Men	PLOS ONE			English	Article							ESTROGEN-RECEPTOR; REPRODUCTIVE HORMONES; DISRUPTING CHEMICALS; PLASMA-LEVELS; SERUM-LEVELS; EXPOSURE; CHLORDECONE; CB-153; DDT; P,P'-DDE	Background: Studies relating long-term exposure to persistent organochlorine pollutants (POPs) with endocrine activities (endocrine disrupting chemicals) on circulating levels of steroid hormones have been limited to a small number of hormones and reported conflicting results. Objective: We examined the relationship between serum concentrations of dehydroepiandrosterone, dehydroepiandrosterone sulphate, androstenedione, androstenediol, testosterone, free and bioavailable testosterone, dihydrotestosterone, estrone, estrone sulphate, estradiol, sex-hormone binding globulin, follicle-stimulating hormone, and luteinizing hormone as a function of level of exposure to three POPs known to interfere with hormone-regulated processes in different way: dichlorodiphenyl dichloroethene (DDE), polychlorinated biphenyl (PCB) congener 153, and chlordecone. Methods: We collected fasting, morning serum samples from 277 healthy, non obese, middle-aged men from the French West Indies. Steroid hormones were determined by gas chromatography-mass spectrometry, except for dehydroepiandrosterone sulphate, which was determined by immunological assay, as were the concentrations of sex-hormone binding globulin, follicle-stimulating hormone and luteinizing hormone. Associations were assessed by multiple linear regression analysis, controlling for confounding factors, in a backward elimination procedure, in multiple bootstrap samples. Results: DDE exposure was negatively associated to dihydrotestosterone level and positively associated to luteinizing hormone level. PCB 153 was positively associated to androstenedione and estrone levels. No association was found for chlordecone. Conclusions: These results suggested that the endocrine response pattern, estimated by determining blood levels of steroid hormones, varies depending on the POPs studied, possibly reflecting differences in the modes of action generally attributed to these compounds. It remains to be investigated whether this response pattern is predictive of the subsequent occurrence of disease.	[Giton, Frank] Hosp Henri Mondor, AP HP CIB GHU Sud, Creteil, France; [Giton, Frank; Fiet, Jean] Ctr Recherches Chirurg, Eq07, Inserm U955, Creteil, France; [Giusti, Arnaud; Thome, Jean-Pierre] Univ Liege, Ctr Analyt Res & Technol, Liege, Belgium; [Oliva, Alejandro] Univ Nacl Rosario, Programa Medio Ambiente & Salud, RA-2000 Rosario, Argentina	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Liege; National University of Rosario		luc.multigner@inserm.fr	Blanchet, Pascal/K-3532-2015; Multigner, Luc/AAA-6214-2020; Multigner, Luc/I-2926-2015	Multigner, Luc/0000-0003-3205-8568; Multigner, Luc/0000-0003-3205-8568; GITON, Frank/0000-0002-4959-1214	French National Health Directorate; Ligue Nationale Contre le Cancer Ph.D. fellowship	French National Health Directorate; Ligue Nationale Contre le Cancer Ph.D. fellowship	This work was supported by the French National Health Directorate. E Emeville is supported by a Ligue Nationale Contre le Cancer Ph.D. fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amory JK, 2003, J STEROID BIOCHEM, V85, P357, DOI 10.1016/S0960-0760(03)00205-X; Asawasinsopon R, 2006, SCI TOTAL ENVIRON, V355, P98, DOI 10.1016/j.scitotenv.2005.03.004; Ayotte P, 2001, EPIDEMIOLOGY, V12, P366, DOI 10.1097/00001648-200105000-00022; Becker K. L., 2001, PRINCIPLES PRACTICE, V3rd; Benachour N, 2007, TOXICOL APPL PHARM, V222, P129, DOI 10.1016/j.taap.2007.03.033; Bernert JT, 2007, CHEMOSPHERE, V68, P824, DOI 10.1016/j.chemosphere.2007.02.043; Blanco-Munoz J, 2012, OCCUP ENVIRON MED, V69, P5, DOI 10.1136/oem.2010.059667; Bonefeld-Jorgensen EC, 2001, TOXICOLOGY, V158, P141, DOI 10.1016/S0300-483X(00)00368-1; Centers for Disease Control and Prevention, 2009, 4 US DEP HLTH HUM SE; COCHRAN RC, 1984, TOXICOL APPL PHARM, V76, P519, DOI 10.1016/0041-008X(84)90356-9; Cohen RA, 2009, 2592009 SAS GLOB FOR, P19; Cooke Paul S., 2001, P257; Dalvie MA, 2004, ENVIRON RES, V96, P9, DOI 10.1016/j.envres.2003.09.003; Danzo BJ, 1997, ENVIRON HEALTH PERSP, V105, P294, DOI 10.2307/3433266; Debier C, 2003, MAR ECOL PROG SER, V247, P237, DOI 10.3354/meps247237; Diamanti-Kandarakis E, 2010, HORM METAB RES, V42, P543, DOI 10.1055/s-0030-1252034; Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002; Dubuisson C, 2007, REGUL TOXICOL PHARM, V49, P5, DOI 10.1016/j.yrtph.2007.04.008; Eriksson AL, 2009, J CLIN ENDOCR METAB, V94, P1033, DOI 10.1210/jc.2008-1283; Ferguson KK, 2012, REPROD TOXICOL, V34, P429, DOI 10.1016/j.reprotox.2012.04.006; Giton F, 2007, CLIN CHEM, V53, P2160, DOI 10.1373/clinchem.2007.087312; Giton F, 2011, EUR J ENDOCRINOL, V165, P917, DOI 10.1530/EJE-11-0551; Giton F, 2010, CLIN CHIM ACTA, V411, P1208, DOI 10.1016/j.cca.2010.04.022; Giwercman A, 2006, ENVIRON HEALTH PERSP, V114, P1348, DOI 10.1289/ehp.8935; Goncharov A, 2009, ENVIRON HEALTH PERSP, V117, P1454, DOI 10.1289/ehp.0800134; Hagmar L, 2001, ARCH ENVIRON HEALTH, V56, P138, DOI 10.1080/00039890109604065; Haugen TB, 2011, REPROD TOXICOL, V32, P261, DOI 10.1016/j.reprotox.2011.06.072; Hsing AW, 2007, CANCER EPIDEM BIOMAR, V16, P1004, DOI 10.1158/1055-9965.EPI-06-0792; HUANG ESR, 1986, TOXICOL APPL PHARM, V82, P62, DOI 10.1016/0041-008X(86)90438-2; Jin Y, 2011, ANN OCCUP HYG, V55, P97, DOI 10.1093/annhyg/meq061; KELCE WR, 1995, NATURE, V375, P581, DOI 10.1038/375581a0; Kelce WR, 1997, TOXICOL APPL PHARM, V142, P192, DOI 10.1006/taap.1996.7966; Kester MHA, 2000, ENDOCRINOLOGY, V141, P1897, DOI 10.1210/en.141.5.1897; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; Langer P, 2012, Endocr Regul, V46, P51; Langer P, 2010, Endocr Regul, V44, P109; Lee JG, 2008, TOXICOL APPL PHARM, V233, P193, DOI 10.1016/j.taap.2008.08.011; Lemaire G, 2006, LIFE SCI, V79, P1160, DOI 10.1016/j.lfs.2006.03.023; Lo S, 2007, TOXICOL IN VITRO, V21, P502, DOI 10.1016/j.tiv.2006.10.016; Machala M, 1998, COMP BIOCHEM PHYS A, V120, P65, DOI 10.1016/S1095-6433(98)10011-9; Martin SA, 2002, EPIDEMIOLOGY, V13, P454, DOI 10.1097/00001648-200207000-00014; Multigner L, 2006, EPIDEMIOLOGY, V17, pS372, DOI 10.1097/00001648-200611001-00989; Multigner L, 2010, J CLIN ONCOL, V28, P3457, DOI 10.1200/JCO.2009.27.2153; Oh SM, 2007, ARCH PHARM RES, V30, P199, DOI 10.1007/BF02977695; Owens W, 2007, ENVIRON HEALTH PERSP, V115, P671, DOI 10.1289/ehp.9666; Persky V, 2001, ENVIRON HEALTH PERSP, V109, P1275, DOI 10.2307/3454751; Pliskova M, 2005, ENVIRON HEALTH PERSP, V113, P1277, DOI 10.1289/ehp.7745; Ray S, 2007, ENDOCRINOLOGY, V148, P4774, DOI 10.1210/en.2007-0537; Richthoff J, 2003, ENVIRON HEALTH PERSP, V111, P409, DOI 10.1289/ehp.5767; Rignell-Hydbom A, 2004, HUM REPROD, V19, P2066, DOI 10.1093/humrep/deh362; Rylander L, 2006, CHEMOSPHERE, V65, P375, DOI 10.1016/j.chemosphere.2006.02.012; SAUERBREI W, 1992, STAT MED, V11, P2093, DOI 10.1002/sim.4780111607; Schmidt KL, 2008, GEN COMP ENDOCR, V157, P266, DOI 10.1016/j.ygcen.2008.03.025; Soto AM, 2010, NAT REV ENDOCRINOL, V6, P364, DOI 10.1038/nrendo.2010.87; Stanczyk FZ, 2010, J STEROID BIOCHEM, V121, P491, DOI 10.1016/j.jsbmb.2010.05.001; Thomas P, 2006, J STEROID BIOCHEM, V102, P175, DOI 10.1016/j.jsbmb.2006.09.017; Turyk ME, 2006, ENVIRON RES, V102, P299, DOI 10.1016/j.envres.2006.01.009; Zoeller RT, 2012, ENDOCRINOLOGY, V153, P4097, DOI 10.1210/en.2012-1422	58	14	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66460	10.1371/journal.pone.0066460	http://dx.doi.org/10.1371/journal.pone.0066460			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785499	Green Published, gold, Green Submitted			2022-12-27	WOS:000321038800022
J	Liu, Y; Quang, P; Braggio, E; Ngo, H; Badalian-Very, G; Flores, L; Zhang, Y; Sacco, A; Maiso, P; Azab, AK; Azab, F; Carrasco, R; Rollins, BJ; Roccaro, AM; Ghobrial, IM				Liu, Yang; Phong Quang; Braggio, Esteban; Hai Ngo; Badalian-Very, Gayane; Flores, Ludmila; Zhang, Yong; Sacco, Antonio; Maiso, Patricia; Azab, Abdel Kareem; Azab, Feda; Carrasco, Ruben; Rollins, Barrett J.; Roccaro, Aldo M.; Ghobrial, Irene M.			Novel Tumor Suppressor Function of Glucocorticoid-Induced TNF Receptor GITR in Multiple Myeloma	PLOS ONE			English	Article							NF-KAPPA-B; NK CELLS; T-CELLS; SUPERFAMILY; PATHWAY; ACTIVATION; BIOLOGY; LIGAND; CANCER; NEUROBLASTOMA	Glucocorticoid-induced TNF receptor (GITR) plays a crucial role in modulating immune response and inflammation, however the role of GITR in human cancers is poorly understood. In this study, we demonstrated that GITR is inactivated during tumor progression in Multiple Myeloma (MM) through promoter CpG island methylation, mediating gene silencing in primary MM plasma cells and MM cell lines. Restoration of GITR expression in GITR deficient MM cells led to inhibition of MM proliferation in vitro and in vivo and induction of apoptosis. These findings were supported by the presence of induction of p21 and PUMA, two direct downstream targets of p53, together with modulation of NF-kappa B in GITR-overexpressing MM cells. Moreover, the unbalanced expression of GITR in clonal plasma cells correlated with MM disease progression, poor prognosis and survival. These findings provide novel insights into the pivotal role of GITR in MM pathogenesis and disease progression.	[Liu, Yang; Phong Quang; Hai Ngo; Badalian-Very, Gayane; Flores, Ludmila; Zhang, Yong; Sacco, Antonio; Maiso, Patricia; Azab, Abdel Kareem; Azab, Feda; Carrasco, Ruben; Rollins, Barrett J.; Roccaro, Aldo M.; Ghobrial, Irene M.] Harvard Univ, Sch Med, Dept Med Oncol, Dana Farber Canc Inst, Boston, MA 02114 USA; [Braggio, Esteban] Mayo Clin, Coll Med, Div Haematol, Dept Med, Scottsdale, AZ USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Mayo Clinic; Mayo Clinic Phoenix	Ghobrial, IM (corresponding author), Harvard Univ, Sch Med, Dept Med Oncol, Dana Farber Canc Inst, Boston, MA 02114 USA.	irene_ghobrial@dfci.harvard.edu	Badalian-Very, Gayane/GLN-6049-2022; Dimopoulos, Meletios Athanasios/AAD-4130-2019; Sacco, Antonio/K-4681-2016; Roccaro, Aldo/AAA-8957-2022	Sacco, Antonio/0000-0003-2945-9416; Roccaro, Aldo/0000-0002-1872-5128; Maiso, Patricia/0000-0003-3745-1924	NIH [R01CA125690, R01CA133799]; NATIONAL CANCER INSTITUTE [R01CA133799, R01CA125690] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIHR01CA125690 and R01CA133799	Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Baltz KM, 2007, FASEB J, V21, P2442, DOI 10.1096/fj.06-7724com; Berenson JR, 2001, SEMIN ONCOL, V28, P626, DOI 10.1053/sonc.2001.29542; Best CJM, 2005, CLIN CANCER RES, V11, P6823, DOI 10.1158/1078-0432.CCR-05-0585; BIEGEL JA, 1993, AM J HUM GENET, V52, P176; Buechele C, 2012, LEUKEMIA, V26, P991, DOI 10.1038/leu.2011.313; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chauhan D, 2011, CLIN CANCER RES, V17, P5311, DOI 10.1158/1078-0432.CCR-11-0476; Cheng X, 2003, IMMUNOL RES, V27, P287, DOI 10.1385/IR:27:2-3:287; Demchenko YN, 2010, ONCOTARGET, V1, P59, DOI 10.18632/oncotarget.109; Demchenko YN, 2010, BLOOD, V115, P3541, DOI 10.1182/blood-2009-09-243535; Dimberg LY, 2005, BLOOD, V106, P1346, DOI 10.1182/blood-2004-04-1322; Gilmore TD, 2007, CANCER CELL, V12, P95, DOI 10.1016/j.ccr.2007.07.010; Hanabuchi S, 2006, BLOOD, V107, P3617, DOI 10.1182/blood-2005-08-3419; Hehlgans T, 2005, IMMUNOLOGY, V115, P1, DOI 10.1111/j.1365-2567.2005.02143.x; Katzenberger T, 2009, BLOOD, V113, P1053, DOI 10.1182/blood-2008-07-168682; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Kwon B, 2003, EXP MOL MED, V35, P8, DOI 10.1038/emm.2003.2; Liu BY, 2008, J BIOL CHEM, V283, P8202, DOI 10.1074/jbc.M708944200; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Mitsiades N, 2002, BLOOD, V99, P4079, DOI 10.1182/blood.V99.11.4079; Nomoto S, 2000, GENE CHROMOSOME CANC, V28, P342, DOI 10.1002/1098-2264(200007)28:3<342::AID-GCC13>3.0.CO;2-A; Poetsch M, 2002, ONCOGENE, V21, P3038, DOI 10.1038/sj.onc.1205457; Rauert H, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.78; Ronchetti S, 2002, BLOOD, V100, P350, DOI 10.1182/blood-2001-12-0276; Schultheis B, 1999, LEUKEMIA, V13, P2099, DOI 10.1038/sj.leu.2401609; Shen XJ, 2011, MOL CELL BIOCHEM, V357, P21, DOI 10.1007/s11010-011-0871-9; Shimizu J, 2002, NAT IMMUNOL, V3, P135, DOI 10.1038/ni759; Silke J, 2010, CELL DEATH DIFFER, V17, P35, DOI 10.1038/cdd.2009.114; Tai YT, 2003, BLOOD, V101, P2762, DOI 10.1182/blood-2002-09-2813; Tai YT, 2006, CANCER RES, V66, P6675, DOI 10.1158/0008-5472.CAN-06-0190; Tamada K, 2006, CANCER IMMUNOL IMMUN, V55, P355, DOI 10.1007/s00262-005-0081-y; Teodorovic LS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031632; Tuyaerts S, 2007, J LEUKOCYTE BIOL, V82, P93, DOI 10.1189/jlb.0906568; Vecchiarelli A, 2009, CELL IMMUNOL, V257, P13, DOI 10.1016/j.cellimm.2009.02.001; WHITE PS, 1995, P NATL ACAD SCI USA, V92, P5520, DOI 10.1073/pnas.92.12.5520; Yang F, 2003, J IMMUNOL, V170, P5630, DOI 10.4049/jimmunol.170.11.5630; Zhou T, 2002, IMMUNOL RES, V26, P323, DOI 10.1385/IR:26:1-3:323	38	43	46	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66982	10.1371/journal.pone.0066982	http://dx.doi.org/10.1371/journal.pone.0066982			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785514	Green Submitted, gold, Green Published			2022-12-27	WOS:000321038800009
J	Maggi, U; Consonni, D; Manini, MA; Gatti, S; Cuccaro, F; Donato, F; Conte, G; Bertazzi, PA; Rossi, G				Maggi, Umberto; Consonni, Dario; Manini, Matteo Angelo; Gatti, Stefano; Cuccaro, Francesco; Donato, Francesca; Conte, Grazia; Bertazzi, Pier Alberto; Rossi, Giorgio			Early and Late De Novo Tumors after Liver Transplantation in Adults: The Late Onset of Bladder Tumors in Men	PLOS ONE			English	Article							RISK-FACTORS; CANCER-RISK; MAJOR CAUSE; FOLLOW-UP; MALIGNANCIES; RECIPIENTS; POPULATION; ORGAN; OUTCOMES; COHORT	Background: De novo tumors (DNT) after liver transplantation (LT) represent a growing concern. Patients and Methods: We analyzed the incidence of DNT, type, time of onset, risk factors and mortality (as of 2010) in 494 adult patients transplanted in the last 26 years (1983-2009). Results: DNT occurred in 41 (8.3%) of the patients. The Standardized Incidence Ratio (SIR) compared with the Italian population was 1.8. There was a higher incidence in males (SIR 2.0), an expected extremely high rate of Kaposi's sarcoma (SIR 127.95) and unexpected higher rates of tumors of the bladder in males (SIR 3.3). The incidence of DNT was higher within the first two years of LT (SIR 2.7) for Kaposi's sarcoma (SIR 393.3) and after 10 years (SIR 1.7) for bladder tumors (SIR 10.6). Multivariate analysis identified alcoholic cirrhosis (HR = 3.0, 95% CI = 1.2-7.8) and sclerosing cholangitis (HR = 3.5, 95% CI = 1.1-11.3) in the recipient as main risk factors for the occurrence of DNT. Conclusions: Surveillance protocols for DNT must be specifically oriented to patients transplanted for alcoholic cirrhosis and sclerosing cholangitis. They should focus on early detection of Kaposi's sarcomas, and more remarkably, on late development bladder tumors in men after LT.	[Maggi, Umberto] Fdn IRCCS Ist Ricovero & Cura Carattere Sci Ca Gr, UO Unita Operat Chirurg Gen & Trapianti, Milan, Italy; [Maggi, Umberto] Univ Paris, AP HP, UFR Unite Format & Rech Med, Dept Digest & Hepatobiliary Surg, F-75252 Paris, France; [Gatti, Stefano; Conte, Grazia; Rossi, Giorgio] Fdn IRCCS Ist Ricovero & Cura Carattere Sci Ca Gr, UO Chirurg Gen & Trapianti Fegato, Milan, Italy; [Consonni, Dario; Bertazzi, Pier Alberto] Fdn IRCCS Ist Ricovero & Cura Carattere Sci Ca Gr, UO Epidemiol, Milan, Italy; [Cuccaro, Francesco] Unita Operat Epidemiol & Stat Barletta, Azienda Sanitaria Locale BAT Barletta Andria Tran, Barletta, Italy; [Donato, Francesca] Univ Milan, Fdn IRCCS Ist Ricovero & Cura Carattere Sci Ca Gr, Milan, Italy; [Bertazzi, Pier Alberto] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy; [Rossi, Giorgio] Univ Milan, Dept Surg Sci, Gen Surg & Liver Transplantat Unit, Milan, Italy	Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Universite Paris Cite; University of Milan; University of Milan; University of Milan	Maggi, U (corresponding author), Fdn IRCCS Ist Ricovero & Cura Carattere Sci Ca Gr, UO Unita Operat Chirurg Gen & Trapianti, Milan, Italy.	maggi.umberto@gmail.com	Consonni, Dario/K-7943-2016; Manini, Matteo Angelo/J-3887-2015; bertazzi, pietro alberto/D-5039-2017; maggi, Umberto/M-3074-2015; Consonni, Dario/AAM-2947-2020; Gatti, Stefano/M-1780-2015; Rossi, Giorgio/M-3445-2015; conte, grazia/AAM-4451-2021; Gatti, Stefano/AAE-3281-2022	Consonni, Dario/0000-0002-8935-3843; Manini, Matteo Angelo/0000-0002-2194-5658; bertazzi, pietro alberto/0000-0003-3475-2449; maggi, Umberto/0000-0002-5337-2866; Consonni, Dario/0000-0002-8935-3843; Gatti, Stefano/0000-0003-2209-4338; Rossi, Giorgio/0000-0002-5588-1306; Gatti, Stefano/0000-0003-2209-4338; Cuccaro, Francesco/0000-0002-7012-2885; Conte, Grazia/0000-0002-3877-7355				Aberg F, 2008, LIVER TRANSPLANT, V14, P1428, DOI 10.1002/lt.21475; Adami J, 2003, BRIT J CANCER, V89, P1221, DOI 10.1038/sj.bjc.6601219; Aseni P, 2006, PATHOL INT, V56, P712, DOI 10.1111/j.1440-1827.2006.02035.x; Baccarani U, 2010, DIGEST LIVER DIS, V42, P55, DOI 10.1016/j.dld.2009.04.017; Baccarani U, 2009, TRANSPL P, V41, P1303, DOI 10.1016/j.transproceed.2009.03.079; BenEliyahu S, 1996, NAT MED, V2, P457, DOI 10.1038/nm0496-457; Boin I, 2007, TRANSPL P, V39, P3284, DOI 10.1016/j.transproceed.2007.07.084; Breslow NE., 1987, STAT METHODS CANC RE, P81; Buell JF, 2008, LIVER TRANSPLANT, V14, P1561, DOI 10.1002/lt.21634; Collett D, 2010, AM J TRANSPLANT, V10, P1889, DOI 10.1111/j.1600-6143.2010.03181.x; Delco F, 2006, J HEPATOL, V44, P32, DOI 10.1016/j.jhep.2005.10.011; Di Benedetto F, 2008, J CANCER RES CLIN, V134, P653, DOI 10.1007/s00432-007-0329-3; Fung JJ, 2001, LIVER TRANSPLANT, V7, pS109, DOI 10.1053/jlts.2001.28645; Galve ML, 1999, TRANSPL P, V31, P1275, DOI 10.1016/S0041-1345(98)01994-0; Haagsma EB, 2001, J HEPATOL, V34, P84, DOI 10.1016/S0168-8278(00)00077-5; Hills, 1993, STAT MODELS EPIDEMIO; Herrero JI, 2011, LIVER TRANSPLANT, V17, P402, DOI 10.1002/lt.22247; Jain A, 2008, LIVER TRANSPLANT, V14, P1406, DOI 10.1002/lt.21609; Jimenez C, 2002, TRANSPLANT P, V34, P297, DOI 10.1016/S0041-1345(01)02770-1; Jimenez C, 2007, TRANSPL INT, V20, P57, DOI 10.1111/j.1432-2277.2006.00397.x; Jimenez-Romero C, 2006, TRANSPL P, V38, P2505, DOI 10.1016/j.transproceed.2006.08.065; Kenngott S, 2003, TRANSPLANT INT, V16, P639, DOI 10.1007/s00147-003-0600-8; Lash TL, 2009, J CLIN ONCOL, V27, pE55, DOI 10.1200/JCO.2009.24.1877; LOTZOVA E, 1993, NAT IMMUN, V12, P169; MATHER GG, 1994, IMMUNOBIOLOGY, V190, P333, DOI 10.1016/S0171-2985(11)80606-6; Miao Y, 2009, TRANSPLANTATION, V87, P1347, DOI 10.1097/TP.0b013e3181a238f6; Oo YH, 2005, TRANSPLANTATION, V80, P759, DOI 10.1097/01.TP.0000173775.16579.18; Paul CF, 2003, J INVEST DERMATOL, V120, P211, DOI 10.1046/j.1523-1747.2003.12040.x; Romero-Vargas ME, 2006, TRANSPL P, V38, P2508, DOI 10.1016/j.transproceed.2006.08.028; Sanchez W, 2006, J HEPATOL, V44, P13, DOI 10.1016/j.jhep.2005.10.007; Xiol X, 2001, LIVER TRANSPLANT, V7, P971, DOI 10.1053/jlts.2001.28744; Yao FY, 2006, CLIN TRANSPLANT, V20, P617, DOI 10.1111/j.1399-0012.2006.00527.x	32	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65238	10.1371/journal.pone.0065238	http://dx.doi.org/10.1371/journal.pone.0065238			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785414	Green Published, gold, Green Submitted			2022-12-27	WOS:000321038800106
J	Powers-Fletcher, MV; Feng, XZ; Krishnan, K; Askew, DS				Powers-Fletcher, Margaret V.; Feng, Xizhi; Krishnan, Karthik; Askew, David S.			Deletion of the sec4 Homolog srgA from Aspergillus fumigatus Is Associated with an Impaired Stress Response, Attenuated Virulence and Phenotypic Heterogeneity	PLOS ONE			English	Article							ENCODING SMALL GTPASES; FUNCTIONAL-ANALYSIS; PROTEIN SECRETION; HYPHAL GROWTH; GENE; LOCALIZATION; MUTATION; PATHOGENESIS; REQUIRES; REVEALS	Small GTPases of the Rab family are master regulators of membrane trafficking, responsible for coordinating the sorting, packaging and delivery of membrane-bound vesicles to specific sites within eukaryotic cells. The contribution of these proteins to the biology of the human pathogenic fungus Aspergillus fumigatus has not been explored. In this study, we characterized the srgA gene, encoding a Rab GTPase closely related to Sec4. We found that a GFP-SrgA fusion protein accumulated preferentially at hyphal tips and mature condiophores. The radial growth of a Delta srgA mutant was impaired on both rich and minimal medium, consistent with a role for SrgA in filamentous growth. In addition, the Delta srgA mutant revealed dysmorphic conidiophores that produced conidia with heterogeneous morphology. The Delta srgA mutant was hypersensitive to brefeldin A-mediated inhibition of vesicular trafficking and showed increased temperature sensitivity relative to wild type A. fumigatus. However, the most striking phenotype of this mutant was its phenotypic heterogeneity. Individual colonies isolated from the original Delta srgA mutant showed variable morphology with colony sectoring. In addition, each isolate of the Delta srgA mutant displayed divergent phenotypes with respect to thermotolerance, in vitro stress response and virulence in a Galleria mellonella infection model. Taken together, these results indicate that SrgA contributes to the asexual development and filamentous growth of A. fumigatus. However, the discordant phenotypes observed among individual isolates of the Delta srgA mutant suggest that the absence of srgA exerts selective pressure for the acquisition of compensatory changes, such as second-site suppressor mutations.	[Powers-Fletcher, Margaret V.; Feng, Xizhi; Krishnan, Karthik; Askew, David S.] Univ Cincinnati, Coll Med, Dept Pathol & Lab Med, Cincinnati, OH 45267 USA	University of Cincinnati	Askew, DS (corresponding author), Univ Cincinnati, Coll Med, Dept Pathol & Lab Med, Cincinnati, OH 45267 USA.	David.Askew@uc.edu		Askew, David/0000-0002-6477-2515; Mosur Krishnan, Karthik/0000-0003-4411-4029	National Institutes of Health [R01AI072297]; University of Cincinnati Summer Research Fellowship; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072297] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Cincinnati Summer Research Fellowship; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by National Institutes of Health grant R01AI072297 to DSA and a University of Cincinnati Summer Research Fellowship to MPF (URL: NIH.gov/grants). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkowitz RA, 2011, SEMIN CELL DEV BIOL, V22, P806, DOI 10.1016/j.semcdb.2011.08.010; Back SH, 2005, METHODS, V35, P395, DOI 10.1016/j.ymeth.2005.03.001; Bhabhra R, 2004, INFECT IMMUN, V72, P4731, DOI 10.1128/IAI.72.8.4731-4740.2004; Bishop A, 2010, EMBO J, V29, P2930, DOI 10.1038/emboj.2010.158; Calero G, 2003, J BIOL CHEM, V278, P37957, DOI 10.1074/jbc.M301225200; Catlett N.L., 2003, FUNGAL GENET NEWSL, V50, P9, DOI DOI 10.4148/1941-4765.1150; CRAIGHEAD MW, 1993, MOL BIOL CELL, V4, P1069, DOI 10.1091/mbc.4.10.1069; Fallon John, 2012, Methods Mol Biol, V845, P469, DOI 10.1007/978-1-61779-539-8_33; Feng XZ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002330; Frigieri MC, 2008, MOL GENET GENOMICS, V280, P211, DOI 10.1007/s00438-008-0357-y; Georgiev A, 2008, CURR GENET, V53, P235, DOI 10.1007/s00294-008-0183-0; GERASSIMENKO OG, 1994, CURR GENET, V25, P178, DOI 10.1007/BF00309545; HAUBRUCK H, 1990, EMBO J, V9, P1957, DOI 10.1002/j.1460-2075.1990.tb08323.x; Jiang SY, 2006, PHYSIOL GENOMICS, V24, P235, DOI 10.1152/physiolgenomics.00210.2005; Jones LA, 2010, EUKARYOT CELL, V9, P1455, DOI 10.1128/EC.00109-10; Joubert A, 2011, MOL MICROBIOL, V79, P1305, DOI 10.1111/j.1365-2958.2010.07522.x; KABCENELL AK, 1990, J BIOL CHEM, V265, P9366; Krishnan K, 2013, EUKARYOT CELL; Li BJ, 1996, J BIOL CHEM, V271, P16813, DOI 10.1074/jbc.271.28.16813; Mao YX, 1999, J BACTERIOL, V181, P7235, DOI 10.1128/JB.181.23.7235-7242.1999; Momany M, 2002, CURR OPIN MICROBIOL, V5, P580, DOI 10.1016/S1369-5274(02)00368-5; MOUKHA SM, 1993, J GEN MICROBIOL, V139, P969, DOI 10.1099/00221287-139-5-969; Mylonakis E, 2008, MYCOPATHOLOGIA, V165, P1, DOI 10.1007/s11046-007-9082-z; Nebenfuhr A, 2002, PLANT PHYSIOL, V130, P1102, DOI 10.1104/pp.011569; Ortiz D, 2002, J CELL BIOL, V157, P1005, DOI 10.1083/jcb.200201003; Punt PJ, 2001, MOL MICROBIOL, V41, P513, DOI 10.1046/j.1365-2958.2001.02541.x; Read ND, 2011, MOL MICROBIOL, V81, P4, DOI 10.1111/j.1365-2958.2011.07702.x; Richie DL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000258; Riquelme M, 2011, FUNGAL BIOL-UK, V115, P446, DOI 10.1016/j.funbio.2011.02.008; SALMINEN A, 1987, CELL, V49, P527, DOI 10.1016/0092-8674(87)90455-7; Sapperstein SK, 1996, J CELL BIOL, V132, P755, DOI 10.1083/jcb.132.5.755; Segal BH, 2009, NEW ENGL J MED, V360, P1870, DOI 10.1056/NEJMra0808853; Siriputthaiwan P, 2005, J CELL SCI, V118, P323, DOI 10.1242/jcs.01616; Slater JL, 2011, MED MYCOL, V49, pS107, DOI 10.3109/13693786.2010.523852; Steinberg G, 2007, EUKARYOT CELL, V6, P351, DOI 10.1128/EC.00381-06; Sudbery P, 2011, FUNGAL GENET BIOL, V48, P849, DOI 10.1016/j.fgb.2011.02.004; WOSTEN HAB, 1991, J GEN MICROBIOL, V137, P2017, DOI 10.1099/00221287-137-8-2017; Yamamoto K, 2002, CURR GENET, V42, P85, DOI 10.1007/s00294-002-0336-5; Yoneda A, 2006, MOL BIOL CELL, V17, P5131, DOI 10.1091/mbc.E06-08-0701; Yoo JS, 1999, MOL GEN GENET, V261, P80, DOI 10.1007/s004380050944	40	21	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66741	10.1371/journal.pone.0066741	http://dx.doi.org/10.1371/journal.pone.0066741			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785510	Green Published, gold, Green Submitted			2022-12-27	WOS:000321038800012
J	Takata, N; Nagai, T; Ozawa, K; Oe, Y; Mikoshiba, K; Hirase, H				Takata, Norio; Nagai, Terumi; Ozawa, Katsuya; Oe, Yuki; Mikoshiba, Katsuhiko; Hirase, Hajime			Cerebral Blood Flow Modulation by Basal Forebrain or Whisker Stimulation Can Occur Independently of Large Cytosolic Ca2+ Signaling in Astrocytes	PLOS ONE			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE; NUCLEUS BASALIS; RAT-BRAIN; CELLS; IP3; PLASTICITY; INCREASES; DYNAMICS; RELEASE; CORTEX	We report that a brief electrical stimulation of the nucleus basalis of Meynert (NBM), the primary source of cholinergic projection to the cerebral cortex, induces a biphasic cerebral cortical blood flow (CBF) response in the somatosensory cortex of C57BL/6J mice. This CBF response, measured by laser Doppler flowmetry, was attenuated by the muscarinic type acetylcholine receptor antagonist atropine, suggesting a possible involvement of astrocytes in this type of CBF modulation. However, we find that IP3R2 knockout mice, which lack cytosolic Ca2+ surges in astrocytes, show similar CBF changes. Moreover, whisker stimulation resulted in similar degrees of CBF increase in IP3R2 knockout mice and the background strain C57BL/6J. Our results show that neural activity-driven CBF modulation could occur without large cytosolic increases of Ca2+ in astrocytes.	[Takata, Norio; Nagai, Terumi; Ozawa, Katsuya; Oe, Yuki; Hirase, Hajime] RIKEN Brain Sci Inst, Lab Neuron Glia Circuit, Wako, Saitama, Japan; [Mikoshiba, Katsuhiko] RIKEN Brain Sci Inst, Dev Neurobiol Lab, Wako, Saitama, Japan; [Mikoshiba, Katsuhiko] Japan Sci & Technol Agcy, ICORP & SORST, Calcium Oscillat Project, Saitama, Japan; [Hirase, Hajime] Saitama Univ, Brain Sci Inst, Saitama 3388570, Japan	RIKEN; RIKEN; Japan Science & Technology Agency (JST); Saitama University	Takata, N (corresponding author), Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo, Japan.	takata@a8.keio.jp; hirase@brain.riken.jp	Hirase, Hajime/A-3709-2012; Mikoshiba, Katsuhiko/N-7943-2015	Hirase, Hajime/0000-0003-3806-6905; 	KAKENHI from the Ministry of Education, Culture, Sports, Science, and Technology of Japan [23700399, 23115522]; RIKEN	KAKENHI from the Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); RIKEN	This work was supported by KAKENHI grants (23700399, 23115522) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and RIKEN intramural funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badaut J, 2000, NEUROSCI LETT, V292, P75, DOI 10.1016/S0304-3940(00)01364-1; BIESOLD D, 1989, NEUROSCI LETT, V98, P39, DOI 10.1016/0304-3940(89)90370-4; Chen NY, 2012, P NATL ACAD SCI USA, V109, pE2832, DOI 10.1073/pnas.1206557109; DAUPHIN F, 1991, BRAIN RES, V553, P75, DOI 10.1016/0006-8993(91)90232-K; DAWSON TM, 1994, J NEUROSCI, V14, P5147; Di Castro MA, 2011, NAT NEUROSCI, V14, P1276, DOI 10.1038/nn.2929; Filosa JA, 2004, CIRC RES, V95, pE73, DOI 10.1161/01.RES.0000148636.60732.2e; Filosa JA, 2006, NAT NEUROSCI, V9, P1397, DOI 10.1038/nn1779; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; Futatsugi A, 2005, SCIENCE, V309, P2232, DOI 10.1126/science.1114110; Girouard H, 2010, P NATL ACAD SCI USA, V107, P3811, DOI 10.1073/pnas.0914722107; Gordon GRJ, 2008, NATURE, V456, P745, DOI 10.1038/nature07525; Gritti I, 1997, J COMP NEUROL, V383, P163; Harder DR, 1998, STROKE, V29, P229, DOI 10.1161/01.STR.29.1.229; He LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042194; Hirase H, 2004, NEUROSCIENCE, V128, P209, DOI 10.1016/j.neuroscience.2004.07.002; Hirose K, 1999, SCIENCE, V284, P1527, DOI 10.1126/science.284.5419.1527; Holtzclaw LA, 2002, GLIA, V39, P69, DOI 10.1002/glia.10085; Hur EE, 2005, J COMP NEUROL, V483, P351, DOI 10.1002/cne.20444; Kanemaru K, 2007, J NEUROSCI, V27, P8957, DOI 10.1523/JNEUROSCI.2276-07.2007; Kleinfeld D, 1998, P NATL ACAD SCI USA, V95, P15741, DOI 10.1073/pnas.95.26.15741; Koehler RC, 2009, TRENDS NEUROSCI, V32, P160, DOI 10.1016/j.tins.2008.11.005; LAXMINARAYAN KM, 1994, J BIOL CHEM, V269, P17305; LINDAUER U, 1993, AM J PHYSIOL, V264, pH1223, DOI 10.1152/ajpheart.1993.264.4.H1223; Marpegan L, 2011, J NEUROSCI, V31, P8342, DOI 10.1523/JNEUROSCI.6537-10.2011; Metea MR, 2006, J NEUROSCI, V26, P2862, DOI 10.1523/JNEUROSCI.4048-05.2006; Mulligan SJ, 2004, NATURE, V431, P195, DOI 10.1038/nature02827; Petravicz J, 2008, J NEUROSCI, V28, P4967, DOI 10.1523/JNEUROSCI.5572-07.2008; Petzold GC, 2008, NEURON, V58, P897, DOI 10.1016/j.neuron.2008.04.029; Shen ZM, 2012, NAT METHODS, V9, P273, DOI [10.1038/NMETH.1857, 10.1038/nmeth.1857]; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Takata N, 2011, J NEUROSCI, V31, P18155, DOI 10.1523/JNEUROSCI.5289-11.2011; Tanaka M, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-6; Uchiyama T, 2002, J BIOL CHEM, V277, P8106, DOI 10.1074/jbc.M108337200; VANDERZEE EA, 1993, GLIA, V8, P42, DOI 10.1002/glia.440080106; Wang XH, 2006, NAT NEUROSCI, V9, P816, DOI 10.1038/nn1703; Wu DM, 2003, AM J PHYSIOL-HEART C, V284, pH2083, DOI 10.1152/ajpheart.01007.2002; Xie Y, 2010, NEUROSCIENCE, V170, P992, DOI 10.1016/j.neuroscience.2010.08.034; Zonta M, 2003, NAT NEUROSCI, V6, P43, DOI 10.1038/nn980	39	66	68	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66525	10.1371/journal.pone.0066525	http://dx.doi.org/10.1371/journal.pone.0066525			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785506	gold, Green Published, Green Submitted			2022-12-27	WOS:000321038800015
J	Nielsen, JDJ; Laverty, AA; Millett, C; Mainous, AG; Majeed, A; Saxena, S				Nielsen, Jessica D. Jones; Laverty, Anthony A.; Millett, Christopher; Mainous, Arch G., III; Majeed, Azeem; Saxena, Sonia			Rising Obesity-Related Hospital Admissions among Children and Young People in England: National Time Trends Study	PLOS ONE			English	Article							BODY-MASS INDEX; CHILDHOOD OBESITY; ECONOMIC BURDEN; SECONDARY DIAGNOSIS; RISK-FACTORS; OVERWEIGHT; HEALTH; PREVALENCE; CHARGES; ADOLESCENCE	Objective: To describe the trends in hospital admissions associated with obesity as a primary diagnosis and comorbidity, and bariatric surgery procedures among children and young people in England. Design: National time trends study of hospital admissions data between 2000 and 2009. Participants: Children and young people aged 5 to 19 years who were admitted to hospital with any diagnosis of obesity. Main outcome measures: Age-and sex-specific admission rates per million children. Results: Between 2000 and 2009, age-and sex-specific hospital admission rates in 5-19 year olds for total obesity-related diagnoses increased more than four-fold from 93.0 (95% CI 86.0 to 100.0) per million children to 414.0 (95% CI 410.7 to 417.5) per million children, largely due to rising admissions where obesity was mentioned as a co-morbidity. The median age of admission to hospital over the study period was 14.0 years; 5,566 (26.7%) admissions were for obesity and 15,319 (73.3%) mentioned obesity as a comorbidity. Admissions were more common in girls than boys (56.2% v 43.8%). The most common reasons for admission where obesity was a comorbid condition were sleep apnoea, asthma, and complications of pregnancy. The number of bariatric surgery procedures has risen from 1 per year in 2000 to 31 in 2009, with the majority were performed in obese girls (75.6%) aged 13-19 years. Conclusions: Hospital admission rates for obesity and related comorbid conditions have increased more than four-fold over the past decade amongst children and young people. Although some of the increase is likely to be due to improved case ascertainment, conditions associated with obesity in children and young people are imposing greater challenges for health care providers in English hospitals. Most inpatient care is directed at dealing with associated conditions rather than primary assessment and management of obesity itself.	[Nielsen, Jessica D. Jones; Laverty, Anthony A.; Millett, Christopher; Majeed, Azeem; Saxena, Sonia] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Primary Care & Publ Hlth, London, England; [Mainous, Arch G., III] Med Univ S Carolina, Dept Family Med, Charleston, SC 29425 USA	Imperial College London; Medical University of South Carolina	Saxena, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Primary Care & Publ Hlth, London, England.	s.saxena@imperial.ac.uk	Saxena, Sonia/ABD-7737-2021; Saxena, Sonia K/G-4821-2013; Jones Nielsen, Jessica/HGB-4089-2022	Saxena, Sonia/0000-0003-3787-2083; Saxena, Sonia K/0000-0003-3787-2083; Millett, Christopher/0000-0002-0793-9884; Mainous, Arch/0000-0002-2535-7685; Laverty, Anthony/0000-0003-1318-8439; Jones Nielsen, Jessica/0000-0001-6874-1268; Majeed, Azeem/0000-0002-2357-9858	Higher Education Funding Council for England; National Institute for Health Research; National Institute for Health Research Biomedical Research Centre Funding scheme; National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care scheme; Imperial Centre for Patient Safety and Service Quality; National Institute for Health Research [RP-PG-0608-10035, CDF-2011-04-048] Funding Source: researchfish	Higher Education Funding Council for England(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); National Institute for Health Research(National Institute for Health Research (NIHR)); National Institute for Health Research Biomedical Research Centre Funding scheme(National Institute for Health Research (NIHR)); National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care scheme; Imperial Centre for Patient Safety and Service Quality; National Institute for Health Research(National Institute for Health Research (NIHR))	CM is funded by the Higher Education Funding Council for England and the National Institute for Health Research. AL is funded by the National Institute for Health Research. The Department of Primary Care and Public Health at Imperial College is grateful for support from the National Institute for Health Research Biomedical Research Centre Funding scheme, the National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care scheme, and the Imperial Centre for Patient Safety and Service Quality. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHRQ, CLIN CLASS SOFTW ICD; Burns EM, 2012, J PUBLIC HEALTH-UK, V34, P138, DOI 10.1093/pubmed/fdr054; Carroll CL, 2007, PEDIATRICS, V120, P734, DOI 10.1542/peds.2007-0409; Cattaneo A, 2010, OBES REV, V11, P389, DOI 10.1111/j.1467-789X.2009.00639.x; Fagot-Campagna A, 2000, J PEDIATR ENDOCR MET, V13, P1395; Guo SS, 2000, INT J OBESITY, V24, P1628, DOI 10.1038/sj.ijo.0801461; Gupta RS, 2006, AMBUL PEDIATR, V6, P15, DOI 10.1016/j.ambp.2005.07.001; Hampl SE, 2007, ARCH PEDIAT ADOL MED, V161, P11, DOI 10.1001/archpedi.161.1.11; Hlaing WM, 2011, PROG PEDIATR CARDIOL, V31, P67, DOI 10.1016/j.ppedcard.2010.11.011; Langille JLD, 2010, HEALTH EDUC BEHAV, V37, P879, DOI 10.1177/1090198110367877; Lawlor DA, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6224; Muller-Riemenschneider F, 2008, EUR J EPIDEMIOL, V23, P499, DOI 10.1007/s10654-008-9239-1; Nader PR, 2006, PEDIATRICS, V118, pE594, DOI 10.1542/peds.2005-2801; Office for National Statistics, 2012, POP EST UK ENGL WAL; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Oyetunji TA, 2012, AM SURGEON, V78, P788; Reilly JJ, 2005, BMJ-BRIT MED J, V330, P1357, DOI 10.1136/bmj.38470.670903.E0; Saxena S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007484; Scarborough P, 2011, J PUBLIC HEALTH-UK, V33, P527, DOI 10.1093/pubmed/fdr033; Stamatakis E, 2005, ARCH DIS CHILD, V90, P999, DOI 10.1136/adc.2004.068932; Stamatakis E, 2012, DIABETOLOGIA, V55, P311, DOI 10.1007/s00125-011-2358-3; Stamatakis E, 2010, INT J OBESITY, V34, P41, DOI 10.1038/ijo.2009.217; Stamatakis E, 2010, J EPIDEMIOL COMMUN H, V64, P167, DOI 10.1136/jech.2009.098723; Trasande L, 2012, EXPERT REV PHARM OUT, V12, P39, DOI [10.1586/erp.11.93, 10.1586/ERP.11.93]; Trasande L, 2009, HEALTH AFFAIR, V28, pW751, DOI 10.1377/hlthaff.28.4.w751; Uauy R., 2004, OBES REV S1, V5, P4, DOI [10.1111/j.1467-789X.2004.00133.x, DOI 10.1111/J.1467-789X.2004.00133.X]; van Emmerik NMA, 2012, ARCH DIS CHILD; Viner RM, 2005, BRIT MED J, V330, P1354, DOI 10.1136/bmj.38453.422049.E0; von Mutius E, 2001, THORAX, V56, P835, DOI 10.1136/thorax.56.11.835; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; Wang Y, 2006, INT J PEDIATR OBES, V1, P11, DOI 10.1080/17477160600586747; Wijga AH, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-184; Woolford SJ, 2007, OBESITY, V15, P1895, DOI 10.1038/oby.2007.224; Woolford SJ, 2009, J HOSP MED, V4, P149, DOI 10.1002/jhm.388	34	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65764	10.1371/journal.pone.0065764	http://dx.doi.org/10.1371/journal.pone.0065764			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776541	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000320322400050
J	Pontes, O; Vitins, A; Ream, TS; Hong, E; Pikaard, CS; Costa-Nunes, P				Pontes, Olga; Vitins, Alexa; Ream, Thomas S.; Hong, Evelyn; Pikaard, Craig S.; Costa-Nunes, Pedro			Intersection of Small RNA Pathways in Arabidopsis thaliana Sub-Nuclear Domains	PLOS ONE			English	Article							TRANS-ACTING SIRNAS; CAJAL BODIES; MESSENGER-RNA; COILED BODIES; ENDOGENOUS SIRNA; POLYMERASE-II; DNA; PROTEINS; GENE; METHYLATION	In Arabidopsis thaliana, functionally diverse small RNA (smRNA) pathways bring about decreased RNA accumulation of target genes via several different mechanisms. Cytological experiments have suggested that the processing of microRNAs (miRNAs) and heterochromatic small interfering RNAs (hc-siRNAs) occurs within a specific nuclear domain that can present Cajal Body (CB) characteristics. It is unclear whether single or multiple smRNA-related domains are found within the same CB and how specialization of the smRNA pathways is determined within this specific sub-compartment. To ascertain whether nuclear smRNA centers are spatially related, we localized key proteins required for siRNA or miRNA biogenesis by immunofluorescence analysis. The intranuclear distribution of the proteins revealed that hc-siRNA, miRNA and trans-acting siRNA (ta-siRNA) pathway proteins accumulate and colocalize within a sub-nuclear structure in the nucleolar periphery. Furthermore, colocalization of miRNA-and siRNA-pathway members with CB markers, and reduced wild-type localization patterns in CB mutants indicates that proper nuclear localization of these proteins requires CB integrity. We hypothesize that these nuclear domains could be important for RNA silencing and may partially explain the functional redundancies and interactions among components of the same protein family. The CB may be the place in the nucleus where Dicer-generated smRNA precursors are processed and assigned to a specific pathway, and where storage, recycling or assembly of RNA interference components takes place.	[Pontes, Olga; Vitins, Alexa; Ream, Thomas S.; Hong, Evelyn; Pikaard, Craig S.; Costa-Nunes, Pedro] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Pontes, Olga; Costa-Nunes, Pedro] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Pikaard, Craig S.] Indiana Univ, Dept Biol, Bloomington, IN USA; [Pikaard, Craig S.] Indiana Univ, Dept Mol & Cellular Biochem, Bloomington, IN USA	University of New Mexico; Washington University (WUSTL); Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Pontes, O (corresponding author), Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA.	opontes@unm.edu	Pikaard, Craig S/K-8772-2012	Pikaard, Craig S/0000-0001-8204-7459	Edward Mallinckrodt, Jr. Foundation award; Monsanto Company; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077590] Funding Source: NIH RePORTER	Edward Mallinckrodt, Jr. Foundation award; Monsanto Company; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	OP, EH and PC-N were supported by an Edward Mallinckrodt, Jr. Foundation award and Monsanto Company. TR is a Gordon and Betty Moore Foundation Fellow of the Life Sciences Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayne EH, 2008, SCIENCE, V322, P602, DOI 10.1126/science.1164029; BEVEN AF, 1995, J CELL SCI, V108, P509; Bies-Etheve N, 2009, EMBO REP, V10, P649, DOI 10.1038/embor.2009.31; Bollman KM, 2003, DEVELOPMENT, V130, P1493, DOI 10.1242/dev.00362; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Boudonck K, 1999, MOL BIOL CELL, V10, P2297, DOI 10.1091/mbc.10.7.2297; Brahms H, 2000, J BIOL CHEM, V275, P17122, DOI 10.1074/jbc.M000300200; Chen XM, 2002, DEVELOPMENT, V129, P1085; Cioce M, 2005, ANNU REV CELL DEV BI, V21, P105, DOI 10.1146/annurev.cellbio.20.010403.103738; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Collier S, 2006, MOL BIOL CELL, V17, P2942, DOI 10.1091/mbc.E05-12-1157; Dunoyer P, 2010, SCIENCE, V328, P912, DOI 10.1126/science.1185880; Earley K, 2006, GENE DEV, V20, P1283, DOI 10.1101/gad.1417706; Elmayan T, 2009, FEBS J, V276, P835, DOI 10.1111/j.1742-4658.2008.06828.x; Fang YD, 2007, CURR BIOL, V17, P818, DOI 10.1016/j.cub.2007.04.005; Fujioka Y, 2007, PLANT CELL PHYSIOL, V48, P1243, DOI 10.1093/pcp/pcm099; Gall JG, 2000, ANNU REV CELL DEV BI, V16, P273, DOI 10.1146/annurev.cellbio.16.1.273; Gao ZH, 2010, NATURE, V465, P106, DOI 10.1038/nature09025; He XJ, 2009, GENE DEV, V23, P318, DOI 10.1101/gad.1765209; Hernandez-Pinzon I, 2007, PLANT J, V50, P140, DOI 10.1111/j.1365-313X.2007.03043.x; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; Hiraguri A, 2005, PLANT MOL BIOL, V57, P173, DOI 10.1007/s11103-004-6853-5; Hoffer P, 2011, P NATL ACAD SCI USA, V108, P409, DOI 10.1073/pnas.1009805108; Hunter C, 2003, CURR BIOL, V13, P1734, DOI 10.1016/j.cub.2003.09.004; Jauvion V, 2010, PLANT CELL, V22, P2697, DOI 10.1105/tpc.110.076638; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jouannet V, 2012, EMBO J, V31, P1704, DOI 10.1038/emboj.2012.20; Kanno T, 2004, CURR BIOL, V14, P801, DOI 10.1016/j.cub.2004.04.037; Kanno T, 2008, NAT GENET, V40, P670, DOI 10.1038/ng.119; Katiyar-Agarwal S, 2006, P NATL ACAD SCI USA, V103, P18002, DOI 10.1073/pnas.0608258103; Kiss T, 2006, COLD SPRING HARB SYM, V71, P407, DOI 10.1101/sqb.2006.71.025; Kota KP, 2008, J CELL SCI, V121, P1526, DOI 10.1242/jcs.021055; Kumakura N, 2009, FEBS LETT, V583, P1261, DOI 10.1016/j.febslet.2009.03.055; Law JA, 2010, CURR BIOL, V20, P951, DOI 10.1016/j.cub.2010.03.062; Li CF, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040027; Li CF, 2006, CELL, V126, P93, DOI 10.1016/j.cell.2006.05.032; Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029; Lukowiak AA, 2001, RNA, V7, P1833; Luo ZH, 2007, PLANT CELL, V19, P943, DOI 10.1105/tpc.106.045724; Lynn K, 1999, DEVELOPMENT, V126, P469; Matera AG, 1998, J CELL BIOCHEM, V70, P181; Matzke M, 2009, CURR OPIN CELL BIOL, V21, P367, DOI 10.1016/j.ceb.2009.01.025; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Montgomery TA, 2008, CELL, V133, P128, DOI 10.1016/j.cell.2008.02.033; OCHS RL, 1994, J CELL SCI, V107, P385; Ogg SC, 2002, J CELL BIOL, V159, P17, DOI 10.1083/jcb.200206111; Onodera Y, 2005, CELL, V120, P613, DOI 10.1016/j.cell.2005.02.007; Park MY, 2005, P NATL ACAD SCI USA, V102, P3691, DOI 10.1073/pnas.0405570102; Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804; Pontes O, 2008, CURR OPIN GENET DEV, V18, P197, DOI 10.1016/j.gde.2008.01.008; Pontes O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001157; Pontes O, 2006, CELL, V126, P79, DOI 10.1016/j.cell.2006.05.031; Qi YJ, 2006, NATURE, V443, P1008, DOI 10.1038/nature05198; Ruiz-Ferrer V, 2019, ANN REV PLANT BIOL, V60, P485; Schott G, 2012, EMBO J, V31, P2553, DOI 10.1038/emboj.2012.92; Scofield DG, 2008, MOL BIOL EVOL, V25, P2255, DOI 10.1093/molbev/msn175; Shaw PJ, 2004, CURR OPIN PLANT BIOL, V7, P614, DOI 10.1016/j.pbi.2004.09.011; Sleeman JE, 2003, J CELL SCI, V116, P2039, DOI 10.1242/jcs.00400; Smith LM, 2007, PLANT CELL, V19, P1507, DOI 10.1105/tpc.107.051540; Song L, 2007, P NATL ACAD SCI USA, V104, P5437, DOI 10.1073/pnas.0701061104; Stanek D, 2008, MOL BIOL CELL, V19, P2534, DOI 10.1091/mbc.E07-12-1259; Stanek D, 2006, CHROMOSOMA, V115, P343, DOI 10.1007/s00412-006-0056-6; Takeda A, 2008, PLANT CELL PHYSIOL, V49, P493, DOI 10.1093/pcp/pcn043; Vaucheret H, 2008, TRENDS PLANT SCI, V13, P350, DOI 10.1016/j.tplants.2008.04.007; Vaucheret Herve, 2005, Sci STKE, V2005, ppe43, DOI 10.1126/stke.3002005pe43; Verheggen C, 2002, EMBO J, V21, P2736, DOI 10.1093/emboj/21.11.2736; Wierzbicki AT, 2008, CELL, V135, P635, DOI 10.1016/j.cell.2008.09.035; Wierzbicki AT, 2009, NAT GENET, V41, P630, DOI 10.1038/ng.365; Xie ZD, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-25; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Yang ZY, 2006, NUCLEIC ACIDS RES, V34, P667, DOI 10.1093/nar/gkj474; Ye RQ, 2012, MOL CELL, V46, P859, DOI 10.1016/j.molcel.2012.04.013; Yelina NE, 2010, P NATL ACAD SCI USA, V107, P13948, DOI 10.1073/pnas.0911341107; Yoshikawa M, 2005, GENE DEV, V19, P2164, DOI 10.1101/gad.1352605; Yu B, 2005, SCIENCE, V307, P932, DOI 10.1126/science.1107130; Zheng BL, 2009, GENE DEV, V23, P2850, DOI 10.1101/gad.1868009; Zhu YS, 2004, MOL BIOL CELL, V15, P81, DOI 10.1091/mbc.E03-07-0525; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	78	29	29	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65652	10.1371/journal.pone.0065652	http://dx.doi.org/10.1371/journal.pone.0065652			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776518	Green Published, gold, Green Submitted			2022-12-27	WOS:000320322400040
J	Despars, G; Pandruvada, SNM; Anginot, A; Domenget, C; Jurdic, P; Mazzorana, M				Despars, Genevieve; Pandruvada, Subramanya N. M.; Anginot, Adrienne; Domenget, Chantal; Jurdic, Pierre; Mazzorana, Marlene			DAP12 Overexpression Induces Osteopenia and Impaired Early Hematopoiesis	PLOS ONE			English	Article							DENDRITIC CELL TRANSDIFFERENTIATION; ACTIVATED-T-CELLS; BONE-MARROW; OSTEOCLAST DIFFERENTIATION; ADAPTER PROTEINS; GENE-EXPRESSION; CD34(+) CELLS; MICE; SHIP; PROGENITOR	ITAM-bearing transmembrane signaling adaptors such as DAP12 and FcR gamma are important players in bone homeostasis, but their precise role and functions are still unknown. It has been shown that osteoclast differentiation results from the integration of the RANK and of the DAP12 and FcR gamma signaling pathways. DAP12-deficient mice suffer from a mild osteopetrosis and culture of their bone marrow cells in the presence of M-CSF and RANKL, fails to give rise to multinucleated osteoclasts. Here, we report that mice overexpressing human DAP12 have an osteopenic bone phenotype due to an increased number of osteoclasts on the surface of trabecular and cortical bone. This enhanced number of osteoclasts is associated with an increased number of proliferating myeloid progenitors in Tg-hDAP12 mice. It is concomitant with an arrest of B cell development at the Pre-Pro B/Pre B stage in the bone marrow of Tg-hDAP12 mice and important decrease of follicular and marginal B cells in the spleen of these animals. Our data show that the overexpression of DAP12 results in both increased osteoclastogenesis and impaired hematopoiesis underlining the relationship between bone homeostasis and hematopoiesis.	[Despars, Genevieve; Pandruvada, Subramanya N. M.; Anginot, Adrienne; Domenget, Chantal; Jurdic, Pierre; Mazzorana, Marlene] Univ Lyon 1, Inst Genom Fonct Lyon, Ecole Normale Super Lyon, CNRS, F-69365 Lyon, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON)	Mazzorana, M (corresponding author), Univ Lyon 1, Inst Genom Fonct Lyon, Ecole Normale Super Lyon, CNRS, F-69365 Lyon, France.	marlene.mazzorana@ens-lyon.fr	pandruvada, subramanya/AAA-3072-2019; Anginot, Adrienne/N-9299-2017; Pandruvada, Subramanya/E-4373-2012	Pandruvada, Subramanya/0000-0001-9568-7666; MAZZORANA, Marlene/0000-0002-3956-4319	Fondation pour la Recherche Medicale [DEQ20051205752]	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work has been supported by grants from the Fondation pour la Recherche Medicale (DEQ20051205752) (http://www.frm.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Anginot A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000585; Barrow AD, 2011, J CLIN INVEST, V121, P3505, DOI 10.1172/JCI45913; Bauer W, 2011, HAEMATOL-HEMATOL J, V96, P1580, DOI 10.3324/haematol.2011.042515; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Cho KA, 2010, INT J MOL MED, V26, P557, DOI 10.3892/ijmm_00000499; David V, 2003, J BONE MINER RES, V18, P1622, DOI 10.1359/jbmr.2003.18.9.1622; Feng X, 2011, ANNU REV PATHOL-MECH, V6, P121, DOI 10.1146/annurev-pathol-011110-130203; Helgason CD, 2000, J EXP MED, V191, P781, DOI 10.1084/jem.191.5.781; Helgason CD, 1998, GENE DEV, V12, P1610, DOI 10.1101/gad.12.11.1610; Hodge JM, 2004, J BONE MINER RES, V19, P190, DOI 10.1359/JBMR.0301232; Humphrey MB, 2005, IMMUNOL REV, V208, P50, DOI 10.1111/j.0105-2896.2005.00325.x; Humphrey MB, 2004, J BONE MINER RES, V19, P224, DOI 10.1359/JBMR.0301234; Jurdic P, 2006, EUR J CELL BIOL, V85, P195, DOI 10.1016/j.ejcb.2005.09.008; Kaifu T, 2003, J CLIN INVEST, V111, P323, DOI 10.1172/JCI200316923; Kiani A, 2004, J LEUKOCYTE BIOL, V76, P1057, DOI 10.1189/jlb.0404259; Kiani A, 2007, EXP HEMATOL, V35, P757, DOI 10.1016/j.exphem.2007.02.001; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Kollet O, 2006, NAT MED, V12, P657, DOI 10.1038/nm1417; Kotani M, 2013, J IMMUNOL, V190, P605, DOI 10.4049/jimmunol.1201345; Kulterer B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-70; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; Li Y, 2007, BLOOD, V109, P3839, DOI 10.1182/blood-2006-07-037994; Lucas M, 2002, EUR J IMMUNOL, V32, P2653, DOI 10.1002/1521-4141(200209)32:9<2653::AID-IMMU2653>3.0.CO;2-V; Mocsai A, 2004, P NATL ACAD SCI USA, V101, P6158, DOI 10.1073/pnas.0401602101; Mourcin F, 2011, BLOOD, V117, P6552, DOI 10.1182/blood-2010-12-323113; Muller MR, 2009, P NATL ACAD SCI USA, V106, P7034, DOI 10.1073/pnas.0813296106; Nagasawa T, 2006, NAT REV IMMUNOL, V6, P107, DOI 10.1038/nri1780; Nakamura K, 2004, J EXP MED, V199, P243, DOI 10.1084/jem.20031193; Nataf S, 2005, AM J PATHOL, V166, P275, DOI 10.1016/S0002-9440(10)62251-1; Paloneva J, 2000, NAT GENET, V25, P357, DOI 10.1038/77153; Paloneva J, 2001, NEUROLOGY, V56, P1552, DOI 10.1212/WNL.56.11.1552; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Peng QS, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000500; Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071; Rivollier A, 2004, BLOOD, V104, P4029, DOI 10.1182/blood-2004-01-0041; Schleinitz N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006264; Shinohara M, 2008, CELL, V132, P794, DOI 10.1016/j.cell.2007.12.037; Speziani C, 2007, EUR J IMMUNOL, V37, P747, DOI 10.1002/eji.200636534; Takeshita S, 2002, NAT MED, V8, P943, DOI 10.1038/nm752; Tomasello E, 2005, EUR J IMMUNOL, V35, P1670, DOI 10.1002/eji.200425932; Wang LD, 2011, NAT REV MOL CELL BIO, V12, P643, DOI 10.1038/nrm3184; Wu YL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000586; Zhao C, 2006, CELL METAB, V4, P111, DOI 10.1016/j.cmet.2006.05.012	44	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65297	10.1371/journal.pone.0065297	http://dx.doi.org/10.1371/journal.pone.0065297			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776468	Green Submitted, Green Published, gold			2022-12-27	WOS:000320755400023
J	Ning, Q; Liu, CG; Hou, L; Meng, M; Zhang, XJ; Luo, MN; Shao, S; Zuo, XX; Zhao, XH				Ning, Qian; Liu, Caigang; Hou, Lei; Meng, Min; Zhang, Xiaojin; Luo, Minna; Shao, Shan; Zuo, Xiaoxiao; Zhao, Xinhan			Vascular Endothelial Growth Factor Receptor-1 Activation Promotes Migration and Invasion of Breast Cancer Cells through Epithelial-Mesenchymal Transition	PLOS ONE			English	Article							N-CADHERIN EXPRESSION; TUMOR PROGRESSION; GENE-EXPRESSION; PROSTATE-CANCER; VEGFR-1 FLT-1; CARCINOMA; METASTASIS; SNAIL; SURVIVAL; REPRESSOR	Vascular endothelial growth factor receptor-1 (VEGFR-1 or Flt-1), a tyrosine kinase receptor, is highly expressed in breast cancer tissues, but near absent in normal breast tissue. While VEGFR-1 expression is associated with poor prognosis of women with breast cancer, it is not clear whether it is involved in the aggressiveness of breast cancer. Thus, the present study examined whether VEGFR-1 activation is associated with the invasiveness of breast cancer. We reported that VEGFR-1 was detected in 60.6% of invasive breast carcinoma tissue sections. In addition, VEGFR-1 expression positively correlated with lymph node-positive tumor status, low expression level of membranous E-cadherin, and high expression levels of N-cadherin and Snail. We found that PlGF-mediated VEGFR-1 activation promoted migration and invasion in MCF-7 (luminal) cells and led to morphologic and molecular changes of epithelial-mesenchymal transition (EMT). This was blocked by the down-regulation of VEGFR-1. Conversely, down-regulation of VEGFR-1 in MDA-MB-231 (post-EMT) cells resulted in morphologic and molecular changes similar to mesenchymal-epithelial transition (MET), and exogenous PlGF could not reverse these changes. Moreover, VEGFR-1 activation led to an increase in nuclear translocation of Snail. Finally, MDA-MB-231 cells expressing shRNA against VEGFR-1 significantly decreased the tumor growth and metastasis capacity in a xenograft model. Histological examination of VEGFR-1/shRNA-expressing tumor xenografts showed up-regulation of E-cadherin and down-regulation of N-cadherin and Snail. These findings suggest that VEGFR-1 may promote breast cancer progression and metastasis, and therapies that target VEGFR-1 may be beneficial in the treatment of breast cancer patients.	[Ning, Qian; Hou, Lei; Meng, Min; Zhang, Xiaojin; Luo, Minna; Shao, Shan; Zuo, Xiaoxiao; Zhao, Xinhan] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Dept Oncol, Xian 710049, Shaanxi Provinc, Peoples R China; [Liu, Caigang] China Med Univ, Affiliated Hosp 1, Dept Oncol, Shenyang, Liaoning Provin, Peoples R China	Xi'an Jiaotong University; China Medical University	Zhao, XH (corresponding author), Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Dept Oncol, Xian 710049, Shaanxi Provinc, Peoples R China.	zhaoxinhanprof@163.com	Liu, Caigang/C-7179-2018; meng, meng/GWZ-7461-2022	Liu, Caigang/0000-0003-2083-235X; 	National Nature Science Foundation of China [30801119]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Nature Science Foundation of China (No: 30801119). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ElMoneim HMA, 2011, CLINICS, V66, P1765, DOI 10.1590/S1807-59322011001000015; ANDERSON JM, 1995, AM J PHYSIOL-GASTR L, V269, pG467, DOI 10.1152/ajpgi.1995.269.4.G467; Bates RC, 2003, CURR BIOL, V13, P1721, DOI 10.1016/j.cub.2003.09.002; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Blanco MJ, 2002, ONCOGENE, V21, P3241, DOI 10.1038/sj.onc.1205416; Blick T, 2008, CLIN EXP METASTAS, V25, P629, DOI 10.1007/s10585-008-9170-6; Carver EA, 2001, MOL CELL BIOL, V21, P8184, DOI 10.1128/MCB.21.23.8184-8188.2001; Cavallaro U, 2004, ANN NY ACAD SCI, V1014, P58, DOI 10.1196/annals.1294.006; Cavallaro U, 2002, CANCER LETT, V176, P123, DOI 10.1016/S0304-3835(01)00759-5; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; Dales JP, 2004, BRIT J CANCER, V90, P1216, DOI 10.1038/sj.bjc.6601452; Dales JP, 2003, ANN PATHOL, V23, P297; Decaussin M, 1999, J PATHOL, V188, P369; Dong F, 2005, BRIT J PHARMACOL, V145, P323, DOI 10.1038/sj.bjp.0706193; Ferrer FA, 1999, UROLOGY, V54, P567, DOI 10.1016/S0090-4295(99)00156-9; Fischer C, 2008, NAT REV CANCER, V8, P942, DOI 10.1038/nrc2524; Graeven U, 1999, J CANCER RES CLIN, V125, P621, DOI 10.1007/s004320050325; Gravdal K, 2007, CLIN CANCER RES, V13, P7003, DOI 10.1158/1078-0432.CCR-07-1263; Hulit J, 2007, CANCER RES, V67, P3106, DOI 10.1158/0008-5472.CAN-06-3401; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Knudsen KA, 2005, J CELL BIOCHEM, V95, P488, DOI 10.1002/jcb.20419; Lee TH, 2007, PLOS MED, V4, P1101, DOI 10.1371/journal.pmed.0040186; Linos E, 2008, JNCI-J NATL CANCER I, V100, P1352, DOI 10.1093/jnci/djn305; Maeda M, 2005, J CELL SCI, V118, P873, DOI 10.1242/jcs.01634; Mylona E, 2007, GYNECOL ONCOL, V104, P557, DOI 10.1016/j.ygyno.2006.09.031; Nagi C, 2005, BREAST CANCER RES TR, V94, P225, DOI 10.1007/s10549-005-7727-5; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Prasad CP, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-325; Schmidt M, 2008, ANTICANCER RES, V28, P1719; Starzec A, 2006, LIFE SCI, V79, P2370, DOI 10.1016/j.lfs.2006.08.005; Sugimachi K, 2003, CLIN CANCER RES, V9, P2657; Taylor AP, 2010, BRIT J CANCER, V103, P82, DOI 10.1038/sj.bjc.6605746; Taylor AP, 2007, MOL CANCER THER, V6, P524, DOI 10.1158/1535-7163.MCT-06-0461; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Trimboli AJ, 2008, CANCER RES, V68, P937, DOI 10.1158/0008-5472.CAN-07-2148; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wey JS, 2005, CANCER-AM CANCER SOC, V104, P427, DOI 10.1002/cncr.21145; Wu Y, 2006, INT J CANCER, V119, P1519, DOI 10.1002/ijc.21865; Yang AD, 2006, CANCER RES, V66, P46, DOI 10.1158/0008-5472.CAN-05-3086; Yang Shengyu, 2012, Methods Mol Biol, V928, P221, DOI 10.1007/978-1-62703-008-3_17; YONEMURA S, 1995, J CELL SCI, V108, P127	43	39	40	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65217	10.1371/journal.pone.0065217	http://dx.doi.org/10.1371/journal.pone.0065217			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776453	Green Published, Green Submitted, gold			2022-12-27	WOS:000320755400016
J	Sanz, E; Evanoff, R; Quintana, A; Evans, E; Miller, JA; Ko, C; Amieux, PS; Griswold, MD; McKnight, GS				Sanz, Elisenda; Evanoff, Ryan; Quintana, Albert; Evans, Elizabeth; Miller, Jeremy A.; Ko, Chemyong; Amieux, Paul S.; Griswold, Michael D.; McKnight, G. Stanley			RiboTag Analysis of Actively Translated mRNAs in Sertoli and Leydig Cells In Vivo	PLOS ONE			English	Article							FOLLICLE-STIMULATING-HORMONE; FIBROBLAST GROWTH-FACTORS; GENE-EXPRESSION; PLASMINOGEN-ACTIVATOR; INTERSTITIAL FLUID; TISSUE KALLIKREIN; RECEPTOR; ANDROGEN; GONADOTROPIN; MICE	Male spermatogenesis is a complex biological process that is regulated by hormonal signals from the hypothalamus (GnRH), the pituitary gonadotropins (LH and FSH) and the testis (androgens, inhibin). The two key somatic cell types of the testis, Leydig and Sertoli cells, respond to gonadotropins and androgens and regulate the development and maturation of fertilization competent spermatozoa. Although progress has been made in the identification of specific transcripts that are translated in Sertoli and Leydig cells and their response to hormones, efforts to expand these studies have been restricted by technical hurdles. In order to address this problem we have applied an in vivo ribosome tagging strategy (RiboTag) that allows a detailed and physiologically relevant characterization of the "translatome'' (polysome-associated mRNAs) of Leydig or Sertoli cells in vivo. Our analysis identified all previously characterized Leydig and Sertoli cell-specific markers and identified in a comprehensive manner novel markers of Leydig and Sertoli cells; the translational response of these two cell types to gonadotropins or testosterone was also investigated. Modulation of a small subset of Sertoli cell genes occurred after FSH and testosterone stimulation. However, Leydig cells responded robustly to gonadotropin deprivation and LH restoration with acute changes in polysome-associated mRNAs. These studies identified the transcription factors that are induced by LH stimulation, uncovered novel potential regulators of LH signaling and steroidogenesis, and demonstrate the effects of LH on the translational machinery in vivo in the Leydig cell.	[Sanz, Elisenda; Amieux, Paul S.; McKnight, G. Stanley] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Evanoff, Ryan; Evans, Elizabeth; Griswold, Michael D.] Washington State Univ, Sch Mol Biosci, Ctr Reprod Biol, Pullman, WA 99164 USA; [Quintana, Albert] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Quintana, Albert] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Miller, Jeremy A.] Allen Inst Brain Sci, Seattle, WA USA; [Ko, Chemyong] Univ Illinois, Coll Vet Med, Dept Comparat Biosci, Urbana, IL USA	University of Washington; University of Washington Seattle; Washington State University; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Allen Institute for Brain Science; University of Illinois System; University of Illinois Urbana-Champaign	McKnight, GS (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.	mcknight@u.washington.edu	Sanz, Elisenda/I-2765-2015; Quintana, Albert/N-5544-2015; Ko, CheMyong Jay/A-7475-2019; Amieux, Paul/AAG-4102-2021	Sanz, Elisenda/0000-0002-7932-8556; Quintana, Albert/0000-0003-1674-7160; Ko, CheMyong Jay/0000-0002-0963-3731; 	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)/National Institutes of Health (NIH) [1R21HD057790-01, 2 R01 HD010808]; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)/NIH [U54HD12629]; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)/NIH Contraception Center Research Grant [U54 HD042454, MH086386]; Spanish Ministry of Science and Innovation (MICINN); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD028934, U54HD042454, R01HD010808] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U54HD012629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086386] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)/National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)/NIH Contraception Center Research Grant; Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)/National Institutes of Health (NIH) grant 1R21HD057790-01 (P.S.A.) and 2 R01 HD010808 (M.D.G); the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)/NIH through cooperative agreement grant U54HD12629 as part of the Specialized Centers Program in Reproduction and Infertility Research (Project 3, G.S.M.); the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)/NIH Contraception Center Research Grant U54 HD042454 (M.D.G.) and MH086386 to G.S.M. and P.S.A.E.S. and A.Q. were supported by the postdoctoral mobility program of the Spanish Ministry of Science and Innovation (MICINN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel MH, 2009, J MOL ENDOCRINOL, V42, P291, DOI 10.1677/JME-08-0107; Aitken RJ, 2008, J CLIN INVEST, V118, P1330, DOI 10.1172/JCI33873; Bakker ML, 2008, CIRC RES, V102, P1340, DOI 10.1161/CIRCRESAHA.107.169565; Bartles JR, 1996, J CELL SCI, V109, P1229; Bridges PJ, 2008, GENESIS, V46, P499, DOI 10.1002/dvg.20428; Cancilla B, 2000, J ENDOCRINOL, V164, P149, DOI 10.1677/joe.0.1640149; Canipari R, 2000, BIOL REPROD, V63, P544, DOI 10.1095/biolreprod63.2.544; Clark BJ, 2012, J ENDOCRINOL, V212, P257, DOI 10.1530/JOE-11-0313; Colvin JS, 2001, CELL, V104, P875, DOI 10.1016/S0092-8674(01)00284-7; Cotton LM, 2008, ENDOCR REV, V29, P193, DOI 10.1210/er.2007-0028; Davenport TG, 2003, DEVELOPMENT, V130, P2263, DOI 10.1242/dev.00431; Douglas NC, 2012, DEV DYNAM, V241, P365, DOI 10.1002/dvdy.23710; Eacker SM, 2007, MOL ENDOCRINOL, V21, P895, DOI 10.1210/me.2006-0113; GEYER PK, 1982, MOL CELL BIOL, V2, P685, DOI 10.1128/MCB.2.6.685; HALL SH, 1991, ENDOCRINOLOGY, V129, P1243, DOI 10.1210/endo-129-3-1243; Harrelson Z, 2004, DEVELOPMENT, V131, P5041, DOI 10.1242/dev.01378; Hedger MP, 2000, J ANDROL, V21, P747; HETTLE JA, 1986, BIOL REPROD, V34, P895, DOI 10.1095/biolreprod34.5.895; Holdcraft RW, 2004, DEVELOPMENT, V131, P459, DOI 10.1242/dev.00957; Hornstein E, 2001, COLD SPRING HARB SYM, V66, P477, DOI 10.1101/sqb.2001.66.477; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; Jameson SA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002575; JEFFERIES HBJ, 1994, P NATL ACAD SCI USA, V91, P4441, DOI 10.1073/pnas.91.10.4441; Kumar TR, 1997, NAT GENET, V15, P201, DOI 10.1038/ng0297-201; LASLETT AL, 1995, J STEROID BIOCHEM, V54, P245, DOI 10.1016/0960-0760(95)00138-P; LEVY S, 1991, P NATL ACAD SCI USA, V88, P3319, DOI 10.1073/pnas.88.8.3319; Lin YM, 2010, INT J ANDROL, V33, P545, DOI 10.1111/j.1365-2605.2009.00966.x; Ma XP, 2004, P NATL ACAD SCI USA, V101, P17294, DOI 10.1073/pnas.0404743101; Martinez-Pomares L, 2012, J LEUKOCYTE BIOL, V92, P1177, DOI 10.1189/jlb.0512231; Matsui H, 2000, EUR J BIOCHEM, V267, P6858, DOI 10.1046/j.1432-1033.2000.01786.x; Matsui H, 2005, INT J BIOCHEM CELL B, V37, P2333, DOI 10.1016/j.biocel.2005.05.011; Matsui H, 2001, ENDOCRINOLOGY, V142, P4918, DOI 10.1210/en.142.11.4918; Matzuk MM, 2008, NAT MED, V14, P1197, DOI 10.1038/nm.f.1895; McLean DJ, 2002, MOL ENDOCRINOL, V16, P2780, DOI 10.1210/me.2002-0059; Meachem SJ, 2001, EUR J ENDOCRINOL, V145, P561, DOI 10.1530/eje.0.1450561; Midzak AS, 2011, BIOL REPROD, V84, P976, DOI 10.1095/biolreprod.110.087460; Miller JA, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-322; Musnier A, 2012, MOL ENDOCRINOL, V26, P669, DOI 10.1210/me.2011-1267; Nalam RL, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001468; NARITA M, 1995, J CLIN INVEST, V96, P1164, DOI 10.1172/JCI118105; Nelson RD, 1998, AM J PHYSIOL-CELL PH, V275, pC216, DOI 10.1152/ajpcell.1998.275.1.C216; O'Shaughnessy PJ, 2009, MOL CELL ENDOCRINOL, V306, P2, DOI 10.1016/j.mce.2008.11.005; Oakley AE, 2009, ENDOCR REV, V30, P713, DOI 10.1210/er.2009-0005; Oatley JA, 2008, ANNU REV CELL DEV BI, V24, P263, DOI 10.1146/annurev.cellbio.24.110707.175355; OTTER M, 1991, J BIOL CHEM, V266, P13931; PAYNE AH, 1990, BIOL REPROD, V42, P399, DOI 10.1095/biolreprod42.3.399; Plant TM, 2008, J NEUROENDOCRINOL, V20, P719, DOI 10.1111/j.1365-2826.2008.01708.x; Ross AJ, 2005, TRENDS ENDOCRIN MET, V16, P19, DOI 10.1016/j.tem.2004.11.004; Roth MY, 2011, CLIN PHARMACOL THER, V89, P133, DOI 10.1038/clpt.2010.103; Sadate-Ngatchou PI, 2004, MOL ENDOCRINOL, V18, P2805, DOI 10.1210/me.2003-0203; Sadate-Ngatchou PI, 2004, MOL ENDOCRINOL, V18, P422, DOI 10.1210/me.2003-0188; Sanz E, 2009, P NATL ACAD SCI USA, V106, P13939, DOI 10.1073/pnas.0907143106; SHARPE RM, 1979, J REPROD FERTIL, V55, P365, DOI 10.1530/jrf.0.0550365; Shima JE, 2004, BIOL REPROD, V71, P319, DOI 10.1095/biolreprod.103.026880; Singh M, 2012, NAT BIOTECHNOL, V30, P648, DOI 10.1038/nbt.2286; Small CL, 2005, BIOL REPROD, V72, P492, DOI 10.1095/biolreprod.104.033696; Soccio RE, 2005, J BIOL CHEM, V280, P19410, DOI 10.1074/jbc.M501778200; Song KH, 2001, ENDOCRINOLOGY, V142, P5116, DOI 10.1210/en.142.12.5116; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Stolovich M, 2002, MOL CELL BIOL, V22, P8101, DOI 10.1128/MCB.22.23.8101-8113.2002; SWINNEN JV, 1991, J BIOL CHEM, V266, P18370; Tai P, 2011, MOL ENDOCRINOL, V25, P885, DOI 10.1210/me.2010-0489; Tang H, 2001, MOL CELL BIOL, V21, P8671, DOI 10.1128/MCB.21.24.8671-8683.2001; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Ujioka T, 2000, BIOL REPROD, V63, P1513, DOI 10.1095/biolreprod63.5.1513; Vicini E, 1997, MOL ENDOCRINOL, V11, P839, DOI 10.1210/me.11.7.839; Wang XM, 2006, PHYSIOLOGY, V21, P362, DOI 10.1152/physiol.00024.2006; Weinbauer G F, 1995, Adv Exp Med Biol, V377, P55; Weiss RB, 2011, SCIENCE, V334, P1509, DOI 10.1126/science.1216974; Willems A, 2010, INT J ANDROL, V33, P507, DOI 10.1111/j.1365-2605.2009.00964.x; Wu YL, 2008, CHINESE J PHYSIOL, V51, P282; Young EA, 1995, CRIT REV NEUROBIOL, V9, P371; Zhou Q, 2005, BIOL REPROD, V72, P1010, DOI 10.1095/biolreprod.104.035915	73	56	56	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66179	10.1371/journal.pone.0066179	http://dx.doi.org/10.1371/journal.pone.0066179			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776628	Green Published, gold, Green Submitted			2022-12-27	WOS:000320755400117
J	Burton, JP; Wescombe, PA; Macklaim, JM; Chai, MHC; MacDonald, K; Hale, JDF; Tagg, J; Reid, G; Gloor, GB; Cadieux, PA				Burton, Jeremy P.; Wescombe, Philip A.; Macklaim, Jean M.; Chai, Melissa H. C.; MacDonald, Kyle; Hale, John D. F.; Tagg, John; Reid, Gregor; Gloor, Gregory B.; Cadieux, Peter A.			Persistence of the Oral Probiotic Streptococcus salivarius M18 Is Dose Dependent and Megaplasmid Transfer Can Augment Their Bacteriocin Production and Adhesion Characteristics	PLOS ONE			English	Article							INTERFERING ALPHA-STREPTOCOCCI; BETA-HEMOLYTIC STREPTOCOCCI; GRAM-POSITIVE BACTERIA; CELL-SURFACE; CONTROLLED-TRIAL; GENOME SEQUENCE; K12; FIMBRIAE; STRAINS; MODEL	Bacteriocin-producing probiotic Streptococcus salivarius M18 offers beneficial modulatory capabilities within the oral microbiome, apparently through potent inhibitory activity against potentially deleterious bacteria, such as Streptococcus pyogenes. The oral cavity persistence of S. salivarius M18 was investigated in 75 subjects receiving four different doses for 28 days. Sixty per cent of the subjects already had some inhibitor-producing S. salivarius in their saliva prior to probiotic intervention. Strain M18's persistence was dependent upon the dose, but not the period of administration. Culture analysis indicated that in some individuals the introduced strain had almost entirely replaced the indigenous S. salivarius, though the total numbers of the species did not increase. Selected subjects showing either high or low probiotic persistence had their salivary populations profiled using Illumina sequencing of the V6 region of the 16S rRNA gene. Analysis indicated that while certain bacterial phenotypes were markedly modulated, the overall composition of the oral microbiome was not modified by the probiotic treatment. Megaplasmids encoding bacteriocins and adhesion factors were transferred in vitro to generate a transconjugant S. salivarius exhibiting enhanced antimicrobial production and binding capabilities to HEp-2 cells. Since no widespread perturbation of the existing indigenous microbiota was associated with oral instillation and given its antimicrobial activity against potentially pathogenic streptococci, it appears that application of probiotic strain M18 offers potential low impact alternative to classical antibiotic prophylaxis. For candidate probiotic strains having relatively poor antimicrobial or adhesive properties, unique derivatives displaying improved probiotic performance may be engineered in vitro by megaplasmid transfer.	[Burton, Jeremy P.; Reid, Gregor] Lawson Hlth Res Inst, Canadian Res & Dev Ctr Probiot, London, ON, Canada; [Burton, Jeremy P.; Reid, Gregor; Cadieux, Peter A.] Univ Western Ontario, Dept Surg, Div Urol, London, ON N6A 3K7, Canada; [Burton, Jeremy P.; MacDonald, Kyle; Reid, Gregor; Cadieux, Peter A.] Univ Western Ontario, Dept Microbiol & Immunol, London, ON, Canada; [Macklaim, Jean M.; Gloor, Gregory B.] Univ Western Ontario, Dept Biochem, Schulich Sch Med & Dent, London, ON, Canada; [Chai, Melissa H. C.; Tagg, John] Univ Otago, Dept Microbiol & Immunol, Dunedin, New Zealand; [Wescombe, Philip A.; Hale, John D. F.] Univ Otago, Ctr Innovat, BLIS Technol Ltd, Dunedin, New Zealand	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); University of Otago; University of Otago	Burton, JP (corresponding author), Lawson Hlth Res Inst, Canadian Res & Dev Ctr Probiot, London, ON, Canada.	Jeremy.burton@Lawsonresearch.com	Gloor, Greg B/D-1671-2013; Reid, Gregor/ABE-8327-2020; Burton, Jeremy/AAR-8902-2020; Wescombe, Philip/F-8699-2015	Reid, Gregor/0000-0001-9658-5696; Burton, Jeremy/0000-0002-3591-6436; Wescombe, Philip/0000-0001-8754-6265; Gloor, Gregory/0000-0001-5803-3380	funds for University of Otago Post Graduates; Canadian Research and Development Centre for Probiotics at the Lawson Health Research Institute	funds for University of Otago Post Graduates; Canadian Research and Development Centre for Probiotics at the Lawson Health Research Institute	The study was proposed by BLIS Technologies Ltd to gain further insight into the persistence properties of the organism. The company provided the lozenges for the study but did not fund the analysis of the samples collected at the university or the in vitro components of the study. Analysis and other experiments were supported by funds for University of Otago Post Graduates and by the Canadian Research and Development Centre for Probiotics at the Lawson Health Research Institute. The funders had some role in study design, assisted by providing personnel to collect raw data, but did not have a role in the analysis, decision to publish, or preparation of the manuscript (other than for final proof reading purposes).	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Andersson DI, 1996, P NATL ACAD SCI USA, V93, P906, DOI 10.1073/pnas.93.2.906; BOCHKOV IA, 1981, ZH MIKROB EPID IMMUN, P38; Bron PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038720; Burton JP, 2006, APPL ENVIRON MICROB, V72, P3050, DOI 10.1128/AEM.72.4.3050-3053.2006; Burton JP, 2006, J APPL MICROBIOL, V100, P754, DOI 10.1111/j.1365-2672.2006.02837.x; Burton JP, 2003, APPL ENVIRON MICROB, V69, P97, DOI 10.1128/AEM.69.1.97-101.2003; Caglar E, 2009, INT J PAEDIATR DENT, V19, P377, DOI 10.1111/j.1365-263X.2009.00989.x; Corr SC, 2007, P NATL ACAD SCI USA, V104, P7617, DOI 10.1073/pnas.0700440104; Cosseau C, 2008, INFECT IMMUN, V76, P4163, DOI 10.1128/IAI.00188-08; Daly KM, 2010, J BACTERIOL, V192, P1131, DOI 10.1128/JB.01375-09; Di Pierro F, 2013, EXPERT OPIN BIOL THE; Dierksen K.P., 2000, STREPTOCOCCI STREPTO, P81; Dierksen KP, 2007, FEMS MICROBIOL ECOL, V59, P584, DOI 10.1111/j.1574-6941.2006.00228.x; Dierksen KP, 2000, J CLIN MICROBIOL, V38, P643, DOI 10.1128/JCM.38.2.643-650.2000; Dobson A, 2011, FEMS MICROBIOL ECOL, V76, P602, DOI 10.1111/j.1574-6941.2011.01069.x; Filkins LM, 2012, J BACTERIOL; Foster JS, 2004, APPL ENVIRON MICROB, V70, P4340, DOI 10.1128/AEM.70.7.4340-4348.2004; Gloor GB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015406; Grzeskowiak L, 2011, BRIT J NUTR, V105, P887, DOI 10.1017/S0007114510004496; Guedon E, 2011, J BACTERIOL, V193, P5024, DOI 10.1128/JB.05390-11; Guglielmetti S, 2010, APPL ENV MICROBIOL; Hamada S, 1998, ORAL MICROBIOL IMMUN, V13, P129, DOI 10.1111/j.1399-302X.1998.tb00724.x; HANDLEY PS, 1987, J GEN MICROBIOL, V133, P3207; HANDLEY PS, 1984, J BACTERIOL, V157, P64, DOI 10.1128/JB.157.1.64-72.1984; Heng NCK, 2011, J BACTERIOL, V193, P6402, DOI 10.1128/JB.06001-11; Hummelen R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026602; Hyink O, 2007, APPL ENVIRON MICROB, V73, P1107, DOI 10.1128/AEM.02265-06; Ishijima SA, 2012, APPL ENVIRON MICROB, V78, P2190, DOI 10.1128/AEM.07055-11; Jenkinson HF, 1997, MOL MICROBIOL, V23, P183, DOI 10.1046/j.1365-2958.1997.2021577.x; KELSTRUP J, 1981, SCAND J DENT RES, V89, P374; Leblebicioglu B, 2009, ANAEROBE, V15, P82, DOI 10.1016/j.anaerobe.2008.12.005; Levesque C, 2004, MICROBIOL-SGM, V150, P189, DOI 10.1099/mic.0.26592-0; Levesque C, 2003, ORAL MICROBIOL IMMUN, V18, P333, DOI 10.1034/j.1399-302X.2003.00085.x; Masdea L, 2012, ARCH ORAL BIOL, V57, P1041, DOI 10.1016/j.archoralbio.2012.02.011; McNulty NP, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002701; Miles AA, 1938, J HYG-CAMBRIDGE, V38, P732, DOI 10.1017/S002217240001158X; Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174, DOI 10.1128/MMBR.63.1.174-229.1999; O'Shea EF, 2013, CURR OPIN BIOTECHNOL; Offenbacher S, 2009, J PERIODONTOL, V80, P190, DOI [10.1902/jop.2009.080007, 10.1902/jop.2009.080007 ]; Postollec F, 2006, J DENT RES, V85, P231, DOI 10.1177/154405910608500305; Roos K, 2001, BRIT MED J, V322, P210, DOI 10.1136/bmj.322.7280.210; ROOS K, 1993, SCAND J INFECT DIS, V25, P31, DOI 10.3109/00365549309169666; ROOS K, 1993, INT J PEDIATR OTORHI, V25, P141, DOI 10.1016/0165-5876(93)90047-7; SANDERS CC, 1977, INFECT IMMUN, V16, P599, DOI 10.1128/IAI.16.2.599-603.1977; Sybesma W, 2013, APPL ENV MICROBIOL; TAGG JR, 1976, BACTERIOL REV, V40, P722, DOI 10.1128/MMBR.40.3.722-756.1976; TAGG JR, 1979, J MED MICROBIOL, V12, P397, DOI 10.1099/00222615-12-4-397; Tannock GW, 2000, APPL ENVIRON MICROB, V66, P2578, DOI 10.1128/AEM.66.6.2578-2588.2000; TANZER JM, 1985, INFECT IMMUN, V48, P44, DOI 10.1128/IAI.48.1.44-50.1985; Upton M, 2001, J BACTERIOL, V183, P3931, DOI 10.1128/JB.183.13.3931-3938.2001; van Bokhorst-van de Veen H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039053; Wescombe PA, 2006, ANTON LEEUW INT J G, V90, P269, DOI 10.1007/s10482-006-9081-y; Wescombe PA, 2009, FUTURE MICROBIOL, V4, P819, DOI 10.2217/FMB.09.61; Whittaker CJ, 1996, ANNU REV MICROBIOL, V50, P513, DOI 10.1146/annurev.micro.50.1.513	55	46	48	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65991	10.1371/journal.pone.0065991	http://dx.doi.org/10.1371/journal.pone.0065991			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785463	Green Submitted, Green Published, gold			2022-12-27	WOS:000321038800059
J	Huang, L; Li, LQ; Klonowski, KD; Tompkins, SM; Tripp, RA; Mellor, AL				Huang, Lei; Li, Lingqian; Klonowski, Kim D.; Tompkins, S. Mark; Tripp, Ralph A.; Mellor, Andrew L.			Induction and Role of Indoleamine 2,3 Dioxygenase in Mouse Models of Influenza A Virus Infection	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; T-CELLS; 2,3-DIOXYGENASE; TRYPTOPHAN; IDO; SUPPRESSION; EXPRESSION; INFLAMMATION; KYNURENINE; SELECTION	Influenza infection stimulates protective host immune responses but paradoxically enhances lung indoleamine 2,3 dioxygenase (IDO) activity, an enzyme that suppresses helper/effector T cells and activates Foxp3-lineage regulatory CD4 T cells (Tregs). Influenza A/PR/8/34 (PR8) infection stimulated rapid elevation of IDO activity in lungs and lung-draining mediastinal lymph nodes (msLNs). Mice lacking intact IDO1 genes (IDO1-KO mice) exhibited significantly lower morbidity after sub-lethal PR8 infection, and genetic or pharmacologic IDO ablation led to much faster recovery after virus clearance. More robust influenza-specific effector CD8 T cell responses manifested in lungs of PR8-infected IDO1-KO mice, though virus clearance rates were unaffected by IDO ablation. Similar outcomes manifested in mice infected with a less virulent influenza A strain (X31). IDO induction in X31-infected lungs was dependent on IFN type II (IFN gamma) signaling and was restricted to non-hematopoietic cells, while redundant IFN type 1 or type II signaling induced IDO exclusively in hematopoietic cells from msLNs. Memory T cells generated in X31-primed IDO1-KO mice protected mice from subsequent challenge with lethal doses of PR8 (100xLD(50)). However recall T cell responses were less robust in lung interstitial tissues, and classic dominance of TCR V beta 8.3 chain usage amongst memory CD8(+) T cells specific for influenza nucleoprotein (NP366) did not manifest in IDO1-KO mice. Thus, influenza induced IDO activity in lungs enhanced morbidity, slowed recovery, restrained effector T cell responses in lungs and shaped memory T cell repertoire generation, but did not attenuate virus clearance during primary influenza A infection.	[Huang, Lei; Li, Lingqian; Mellor, Andrew L.] Georgia Regents Univ, Ctr Canc, Canc Immunol Inflammat & Tolerance Program, Augusta, GA USA; [Huang, Lei] Georgia Regents Univ, Dept Radiol, Augusta, GA USA; [Klonowski, Kim D.] Univ Georgia, Coll Arts & Sci, Dept Cell Biol, Athens, GA 30602 USA; [Tompkins, S. Mark; Tripp, Ralph A.] Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA 30602 USA; [Klonowski, Kim D.; Mellor, Andrew L.] Georgia Regents Univ, Dept Med, Augusta, GA USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; Augusta University	Mellor, AL (corresponding author), Georgia Regents Univ, Ctr Canc, Canc Immunol Inflammat & Tolerance Program, Augusta, GA USA.	amellor@gru.edu	Tompkins, Stephen/A-3317-2008	Tompkins, Stephen/0000-0002-1523-5588; Tripp, Ralph/0000-0002-2924-9956; huang, lei/0000-0002-1996-944X	National Institutes of Health/National Institute of Allergy and Infectious Diseases Immune Mechanisms of Virus Control (IMVC) Program [AI-83005]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI083005] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Diseases Immune Mechanisms of Virus Control (IMVC) Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding to support this study was provided via a U01 grant (AI-83005) awarded to ALM and RAT from the National Institutes of Health/National Institute of Allergy and Infectious Diseases Immune Mechanisms of Virus Control (IMVC) Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Baban B, 2005, INT IMMUNOL, V17, P909, DOI 10.1093/intimm/dxh271; Baban B, 2004, J REPROD IMMUNOL, V61, P67, DOI 10.1016/j.jri.2003.11.003; Baban B, 2011, J IMMUNOL, V187, P2329, DOI 10.4049/jimmunol.1100276; Baban B, 2009, J IMMUNOL, V183, P2475, DOI 10.4049/jimmunol.0900986; Ball HJ, 2007, GENE, V396, P203, DOI 10.1016/j.gene.2007.04.010; DECKHUT AM, 1993, J IMMUNOL, V151, P2658; Desvignes L, 2009, IMMUNITY, V31, P974, DOI 10.1016/j.immuni.2009.10.007; Divanovic S, 2012, J INFECT DIS, V205, P152, DOI 10.1093/infdis/jir621; Fallarino F, 2006, EUR J IMMUNOL, V36, P8, DOI 10.1002/eji.200535667; Fallarino F, 2006, J IMMUNOL, V176, P6752, DOI 10.4049/jimmunol.176.11.6752; Grohmann U, 2002, NAT IMMUNOL, V3, P1097, DOI 10.1038/ni846; Guillonneau C, 2009, P NATL ACAD SCI USA, V106, P3330, DOI 10.1073/pnas.0813309106; Hoshi M, 2010, J IMMUNOL, V185, P3305, DOI 10.4049/jimmunol.0901150; Huang L, 2012, J IMMUNOL, V188, P4913, DOI 10.4049/jimmunol.1103668; Huang L, 2010, INT REV IMMUNOL, V29, P133, DOI 10.3109/08830180903349669; Johnson BA, 2010, P NATL ACAD SCI USA, V107, P10644, DOI 10.1073/pnas.0914347107; Kochanek K, 2011, NATL VITAL STAT REP, V54, P1; Laich A, 2002, CLIN CHEM, V48, P579; Li LQ, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00109; Makala LHC, 2011, J INFECT DIS, V203, P715, DOI 10.1093/infdis/jiq095; McCullers JA, 2002, J INFECT DIS, V186, P341, DOI 10.1086/341462; Mellor AL, 2005, J IMMUNOL, V175, P5601, DOI 10.4049/jimmunol.175.9.5601; Mellor AL, 2008, NAT REV IMMUNOL, V8, P74, DOI 10.1038/nri2233; Metz R, 2007, CANCER RES, V67, P7082, DOI 10.1158/0008-5472.CAN-07-1872; Muller AJ, 2008, P NATL ACAD SCI USA, V105, P17073, DOI 10.1073/pnas.0806173105; Munn David H, 2012, Front Biosci (Elite Ed), V4, P734; Munn DH, 2004, J CLIN INVEST, V114, P280, DOI 10.1172/JCI200421583; O'Connor JC, 2009, J IMMUNOL, V182, P3202, DOI 10.4049/jimmunol.0802722; Ou R, 2001, J VIROL, V75, P8407, DOI 10.1128/JVI.75.18.8407-8423.2001; Parker D, 2012, SEMIN IMMUNOPATHOL, V34, P281, DOI 10.1007/s00281-011-0291-7; Price GE, 2005, J VIROL, V79, P8545, DOI 10.1128/JVI.79.13.8545-8559.2005; Romani L, 2008, NATURE, V451, P211, DOI 10.1038/nature06471; Sharma MD, 2007, J CLIN INVEST, V117, P2570, DOI 10.1172/JCI31911; van der Sluijs KF, 2006, J INFECT DIS, V193, P214, DOI 10.1086/498911; Wang YT, 2010, NAT MED, V16, P279, DOI 10.1038/nm.2092; Yeung AWS, 2012, J LEUKOCYTE BIOL, V91, P657, DOI 10.1189/jlb.1011532; YOSHIDA R, 1979, P NATL ACAD SCI USA, V76, P4084, DOI 10.1073/pnas.76.8.4084; Zelante T, 2009, MICROBES INFECT, V11, P133, DOI 10.1016/j.micinf.2008.10.007; Zhong WM, 2004, INT IMMUNOL, V16, P1549, DOI 10.1093/intimm/dxh156; Zhou SH, 2004, J VIROL, V78, P3578, DOI 10.1128/JVI.78.7.3578-3600.2004	41	38	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66546	10.1371/journal.pone.0066546	http://dx.doi.org/10.1371/journal.pone.0066546			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785507	Green Submitted, gold, Green Published			2022-12-27	WOS:000321038800014
J	Minguez, L; Brule, N; Sohm, B; Devin, S; Giamberini, L				Minguez, Laetitia; Brule, Nelly; Sohm, Benedicte; Devin, Simon; Giamberini, Laure			Involvement of Apoptosis in Host-Parasite Interactions in the Zebra Mussel	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; PROGRAMMED CELL-DEATH; DREISSENA-POLYMORPHA; ANAPLASMA-PHAGOCYTOPHILUM; EHRLICHIA-CHAFFEENSIS; CRASSOSTREA-VIRGINICA; BACTERIAL PATHOGENS; DIGESTIVE GLAND; IMMUNE-SYSTEM; OSTREA-EDULIS	The question of whether cell death by apoptosis plays a biological function during infection is key to understanding host-parasite interactions. We investigated the involvement of apoptosis in several host-parasite systems, using zebra mussels Dreissena polymorpha as test organisms and their micro-and macroparasites. As a stress response associated with parasitism, heat shock proteins (Hsp) can be induced. In this protein family, Hsp70 are known to be apoptosis inhibitors. Mussels were diagnosed for their respective infections by standard histological methods; apoptosis was detected using the TUNEL methods on paraffin sections and Hsp70 by immunohistochemistry on cryosections. Circulating hemocytes were the main cells observed in apoptosis whereas infected tissues displayed no or few apoptotic cells. Parasitism by intracellular bacteria Rickettsiales-like and the trematode Bucephalus polymorphus were associated with the inhibition of apoptosis whereas ciliates Ophryoglena spp. or the trematode Phyllodistomum folium did not involve significant differences in apoptosis. Even if some parasites were able to modulate apoptosis in zebra mussels, we did not see evidence of any involvement of Hsp70 on this mechanism.	[Minguez, Laetitia; Brule, Nelly; Sohm, Benedicte; Devin, Simon; Giamberini, Laure] Univ Lorraine, LIEBE, CNRS UMR 7146, Metz, France	Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine	Minguez, L (corresponding author), Univ Lorraine, LIEBE, CNRS UMR 7146, Metz, France.	laetitia-minguez@hotmail.fr; laure.giamberini@univ-lorraine.fr	SOHM, Bénédicte/C-1339-2012	Minguez, Laetitia/0000-0003-4840-1607; Devin, Simon/0000-0003-4431-4987; SOHM, Benedicte/0000-0002-7204-5414	CNRS, Region Lorraine	CNRS, Region Lorraine(Region Grand-EstCentre National de la Recherche Scientifique (CNRS))	CNRS, Region Lorraine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMEISEN JC, 1994, AIDS, V8, P1197, DOI 10.1097/00002030-199409000-00001; Lopez-Sanchez JA, 2009, COMP BIOCHEM PHYS A, V154, P425, DOI 10.1016/j.cbpa.2009.07.021; Auffret M, 2006, ECOTOX ENVIRON SAFE, V63, P393, DOI 10.1016/j.ecoenv.2005.10.016; Barcinski MA, 1999, BRAZ J MED BIOL RES, V32, P395, DOI 10.1590/S0100-879X1999000400003; Bayne CJ, 2001, PARASITOLOGY, V123, pS159; Briken V, 2008, CURR DRUG TARGETS, V9, P150, DOI 10.2174/138945008783502449; Bruchhaus I, 2007, TRENDS PARASITOL, V23, P376, DOI 10.1016/j.pt.2007.06.004; Cho SungHwan, 2004, Journal of Asia-Pacific Entomology, V7, P195, DOI 10.1016/S1226-8615(08)60215-0; Creagh EM, 2000, LEUKEMIA, V14, P1161, DOI 10.1038/sj.leu.2401841; da Silva PM, 2002, J INVERTEBR PATHOL, V79, P154, DOI 10.1016/S0022-2011(02)00026-5; David JADO, 2008, MICRON, V39, P329, DOI 10.1016/j.micron.2007.06.002; Fabbri E., 2008, ISJ, V5, P135; Faherty CS, 2008, TRENDS MICROBIOL, V16, P173, DOI 10.1016/j.tim.2008.02.001; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Gao LY, 2000, TRENDS MICROBIOL, V8, P306, DOI 10.1016/S0966-842X(00)01784-4; Giamberini L, 2005, ENVIRON RES, V98, P210, DOI 10.1016/j.envres.2004.11.003; Goedken M, 2005, J SHELLFISH RES, V24, P177; Hacker G, 2006, MED MICROBIOL IMMUN, V195, P11, DOI 10.1007/s00430-005-0239-4; Hewitson JP, 2009, MOL BIOCHEM PARASIT, V167, P1, DOI 10.1016/j.molbiopara.2009.04.008; Hughes FM, 2010, FISH SHELLFISH IMMUN, V29, P247, DOI 10.1016/j.fsi.2010.03.003; James ER, 2004, TRENDS PARASITOL, V20, P280, DOI 10.1016/j.pt.2004.04.004; Kiss T, 2010, APOPTOSIS, V15, P313, DOI 10.1007/s10495-009-0446-3; Labbe K, 2008, CELL DEATH DIFFER, V15, P1339, DOI 10.1038/cdd.2008.91; Lacoste A, 2002, J CELL SCI, V115, P761; Lancellotti Marcelo, 2006, Brazilian Journal of Morphological Sciences, V23, P75; Lapied E, 2011, ENVIRON INT, V37, P1105, DOI 10.1016/j.envint.2011.01.009; Laruelle F, 2002, J PARASITOL, V88, P856, DOI 10.1645/0022-3395(2002)088[0856:HAOTID]2.0.CO;2; MASTITSKY SE, 2004, THESIS NATL ACAD SCI; Menaker RJ, 2003, MICROBES INFECT, V5, P1149, DOI 10.1016/J.MICINF.2003.08.001; Minguez L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034029; Minguez L, 2012, ECOTOXICOLOGY, V21, P538, DOI 10.1007/s10646-011-0814-y; Minguez L, 2012, ENVIRON POLLUT, V162, P234, DOI 10.1016/j.envpol.2011.11.005; Minguez L, 2009, ENVIRON RES, V109, P843, DOI 10.1016/j.envres.2009.07.012; Molloy Daniel P., 1997, Reviews in Fisheries Science, V5, P27; Molloy DP, 2005, DIS AQUAT ORGAN, V65, P237, DOI 10.3354/dao065237; Molloy DP, 2001, DIS AQUAT ORGAN, V44, P203, DOI 10.3354/dao044203; Morga B, 2012, FISH SHELLFISH IMMUN, V32, P958, DOI 10.1016/j.fsi.2012.01.026; Muller A, 2001, INT J MED MICROBIOL, V291, P197, DOI 10.1078/1438-4221-00125; Opferman JT, 2003, NAT IMMUNOL, V4, P410, DOI 10.1038/ni0503-410; OSADA M, 1989, COMP BIOCHEM PHYS C, V93, P171, DOI 10.1016/0742-8413(89)90029-7; Renault T, 2000, DIS AQUAT ORGAN, V42, P173, DOI 10.3354/dao042173; Rikihisa Y, 2010, NAT REV MICROBIOL, V8, P328, DOI 10.1038/nrmicro2318; Rikihisa Y, 2010, VET PARASITOL, V167, P155, DOI 10.1016/j.vetpar.2009.09.017; Rojas V, 2010, J CELL BIOCHEM, V110, P468, DOI 10.1002/jcb.22560; Romero A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017003; Russo J, 2007, CELL TISSUE RES, V328, P431, DOI 10.1007/s00441-006-0353-7; Schmid MC, 2006, PLOS PATHOG, V2, P1083, DOI 10.1371/journal.ppat.0020115; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Singer C, 2005, AQUAT TOXICOL, V75, P65, DOI 10.1016/j.aquatox.2005.07.004; Sokolova IM, 2009, ISJ-INVERT SURVIV J, V6, P49; Sokolova IM, 2004, J EXP BIOL, V207, P3369, DOI 10.1242/jeb.01152; Strahl J, 2010, MAR BIOL, V157, P1283, DOI 10.1007/s00227-010-1408-6; Sunila I, 2003, DIS AQUAT ORGAN, V56, P163, DOI 10.3354/dao056163; Tourari A.L., 1988, Haliotis, V18, P85; Vijayavel K, 2009, FISH SHELLFISH IMMUN, V26, P133, DOI 10.1016/j.fsi.2008.02.015; Walker AJ, 2006, TRENDS PARASITOL, V22, P154, DOI 10.1016/j.pt.2006.02.003; Wei Wang X, 2006, PNAS US, V103, P4204; Xu W, 2009, COMP BIOCHEM PHYS B, V154, P143, DOI 10.1016/j.cbpb.2009.05.012; Zahoor Z, 2010, CELL STRESS CHAPERON, V15, P639, DOI 10.1007/s12192-010-0176-z	59	7	7	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65822	10.1371/journal.pone.0065822	http://dx.doi.org/10.1371/journal.pone.0065822			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785455	Green Published, gold, Green Submitted			2022-12-27	WOS:000321038800067
J	Shoji, M; Takahashi, E; Hatakeyama, D; Iwai, Y; Morita, Y; Shirayama, R; Echigo, N; Kido, H; Nakamura, S; Mashino, T; Okutani, T; Kuzuhara, T				Shoji, Masaki; Takahashi, Etsuhisa; Hatakeyama, Dai; Iwai, Yuma; Morita, Yuka; Shirayama, Riku; Echigo, Noriko; Kido, Hiroshi; Nakamura, Shigeo; Mashino, Tadahiko; Okutani, Takeshi; Kuzuhara, Takashi			Anti-Influenza Activity of C-60 Fullerene Derivatives	PLOS ONE			English	Article							RNA-POLYMERASE; PA SUBUNIT; INFLUENZA; ENDONUCLEASE; OSELTAMIVIR; CELLS	The H1N1 influenza A virus, which originated in swine, caused a global pandemic in 2009, and the highly pathogenic H5N1 avian influenza virus has also caused epidemics in Southeast Asia in recent years. Thus, the threat from influenza A remains a serious global health issue, and novel drugs that target these viruses are highly desirable. Influenza A RNA polymerase consists of the PA, PB1, and PB2 subunits, and the N-terminal domain of the PA subunit demonstrates endonuclease activity. Fullerene (C-60) is a unique carbon molecule that forms a sphere. To identify potential new anti-influenza compounds, we screened 12 fullerene derivatives using an in vitro PA endonuclease inhibition assay. We identified 8 fullerene derivatives that inhibited the endonuclease activity of the PA N-terminal domain or full-length PA protein in vitro. We also performed in silico docking simulation analysis of the C-60 fullerene and PA endonuclease, which suggested that fullerenes can bind to the active pocket of PA endonuclease. In a cell culture system, we found that several fullerene derivatives inhibit influenza A viral infection and the expression of influenza A nucleoprotein and nonstructural protein 1. These results indicate that fullerene derivatives are possible candidates for the development of novel anti-influenza drugs.	[Shoji, Masaki; Hatakeyama, Dai; Iwai, Yuma; Morita, Yuka; Shirayama, Riku; Echigo, Noriko; Okutani, Takeshi; Kuzuhara, Takashi] Tokushima Bunri Univ, Fac Pharmaceut Sci, Biochem Lab, Yamashiro, Tokushima 770, Japan; [Takahashi, Etsuhisa; Kido, Hiroshi] Univ Tokushima, Inst Enzyme Res, Div Enzyme Chem, Tokushima 770, Japan; [Nakamura, Shigeo] Nippon Med Sch, Dept Chem, Nakahara Ku, Kawasaki, Kanagawa, Japan; [Mashino, Tadahiko] Keio Univ, Fac Pharm, Dept Pharmaceut Sci, Minato Ku, Tokyo, Japan	Tokushima Bunri University; Tokushima University; Nippon Medical School; Keio University	Kuzuhara, T (corresponding author), Tokushima Bunri Univ, Fac Pharmaceut Sci, Biochem Lab, Yamashiro, Tokushima 770, Japan.	kuzuhara@ph.bunri-u.ac.jp	中村, 成夫/R-7695-2019; ハタケヤマ, ダイ/HHS-5095-2022	ハタケヤマ, ダイ/0000-0001-6047-7124; Nakamura, Shigeo/0000-0002-9681-3510; Kuzuhara, Takashi/0000-0003-0565-6060	Japan Society for the Promotion of Science [20890273, 22590422, 22790098, 23780051]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by the Japan Society for the Promotion of Science (grant no. 20890273, 22590422, 22790098, and 23780051). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson D., 1995, FOCUS, V17, P53; Bosi S, 2003, EUR J MED CHEM, V38, P913, DOI 10.1016/j.ejmech.2003.09.005; Chemical Computing Group C, 2004, MOL OP ENV MOE, P0707; Cianci Christopher, 2013, Antiviral Chemistry & Chemotherapy, V23, P77, DOI 10.3851/IMP2235; Collins PJ, 2008, NATURE, V453, P1258, DOI 10.1038/nature06956; De Clercq E, 2006, NAT REV DRUG DISCOV, V5, P1015, DOI 10.1038/nrd2175; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; DuBois RM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002830; Furuta Y, 2005, ANTIMICROB AGENTS CH, V49, P981, DOI 10.1128/AAC.49.3.981-986.2005; Goto J, 2008, J CHEM INF MODEL, V48, P583, DOI 10.1021/ci700352q; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Hayden FG, 1999, NEW ENGL J MED, V341, P1336, DOI 10.1056/NEJM199910283411802; Honda A, 1997, BIOL CHEM, V378, P483; Honda A, 2002, P NATL ACAD SCI USA, V99, P13166, DOI 10.1073/pnas.152456799; Horimoto T, 2005, NAT REV MICROBIOL, V3, P591, DOI 10.1038/nrmicro1208; Ishikawa Y, 2011, BIOINFORMATION, V6, P221, DOI 10.6026/97320630006221; Iwai Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019825; Iwai Y, 2010, BIOORGAN MED CHEM, V18, P5379, DOI 10.1016/j.bmc.2010.05.035; JANKNECHT R, 1991, P NATL ACAD SCI USA, V88, P8972, DOI 10.1073/pnas.88.20.8972; KROTO HW, 1985, NATURE, V318, P162, DOI 10.1038/318162a0; Kuzuhara T., 2009, PLOS CURR, V1; Kuzuhara T, 2009, J BIOL CHEM, V284, P6855, DOI 10.1074/jbc.C800224200; Li L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035234; Mashino T, 2005, BIOORG MED CHEM LETT, V15, P1107, DOI 10.1016/j.bmcl.2004.12.030; Mashino T, 2003, BIOORG MED CHEM LETT, V13, P4395, DOI 10.1016/j.bmcl.2003.09.040; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; Nakamura S, 2012, J NIPPON MED SCH, V79, P248, DOI 10.1272/jnms.79.248; NAKAMURA Y, 1991, J BIOCHEM-TOKYO, V110, P395, DOI 10.1093/oxfordjournals.jbchem.a123592; Nakazawa M, 2008, ANTIVIR RES, V78, P194, DOI 10.1016/j.antiviral.2007.12.010; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Nishizawa C, 2009, FREE RADICAL RES, V43, P1240, DOI [10.3109/10715760903273849, 10.3109/13814780903260764]; Noble E, 2012, VIROLOGY, V433, P27, DOI 10.1016/j.virol.2012.07.008; Okuda K, 1996, BIOORG MED CHEM LETT, V6, P539, DOI 10.1016/0960-894X(96)00064-9; Reece PA, 2007, J MED VIROL, V79, P1577, DOI 10.1002/jmv.20951; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Sukeguchi D, 2009, BEILSTEIN J ORG CHEM, V5, DOI 10.3762/bjoc.5.7; Tado M, 2001, ANTIVIR CHEM CHEMOTH, V12, P353, DOI 10.1177/095632020101200605; Takahashi E, 2012, J VIROL, V86, P10924, DOI 10.1128/JVI.01207-12; Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230; TOKUYAMA H, 1993, J AM CHEM SOC, V115, P7918, DOI 10.1021/ja00070a064; Yuan PW, 2009, NATURE, V458, P909, DOI 10.1038/nature07720; Zhao C, 2009, J VIROL, V83, P9024, DOI 10.1128/JVI.00911-09	43	52	58	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66337	10.1371/journal.pone.0066337	http://dx.doi.org/10.1371/journal.pone.0066337			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785493	Green Published, gold, Green Submitted			2022-12-27	WOS:000321038800029
J	Larson, JL; Redmond, CT; Potter, DA				Larson, Jonathan L.; Redmond, Carl T.; Potter, Daniel A.			Assessing Insecticide Hazard to Bumble Bees Foraging on Flowering Weeds in Treated Lawns	PLOS ONE			English	Article							BOMBUS-TERRESTRIS HYMENOPTERA; IMPATIENS HYMENOPTERA; APIDAE; NEONICOTINOIDS; CLOTHIANIDIN; MANAGEMENT; COLONIES; EXPOSURE; SUCCESS; DECLINE	Maintaining bee-friendly habitats in cities and suburbs can help conserve the vital pollination services of declining bee populations. Despite label precautions not to apply them to blooming plants, neonicotinoids and other residual systemic insecticides may be applied for preventive control of lawn insect pests when spring-flowering weeds are present. Dietary exposure to neonicotinoids adversely affects bees, but the extent of hazard from field usage is controversial. We exposed colonies of the bumble bee Bombus impatiens to turf with blooming white clover that had been treated with clothianidin, a neonicotinoid, or with chlorantraniliprole, the first anthranilic diamide labeled for use on lawns. The sprays were applied at label rate and lightly irrigated. After residues had dried, colonies were confined to forage for six days, and then moved to a non-treated rural site to openly forage and develop. Colonies exposed to clothianidin-treated weedy turf had delayed weight gain and produced no new queens whereas those exposed to chlorantraniliprole-treated plots developed normally compared with controls. Neither bumble bees nor honey bees avoided foraging on treated white clover in open plots. Nectar from clover blooms directly contaminated by spray residues contained 171 +/- 44 ppb clothianidin. Notably, neither insecticide adversely impacted bee colonies confined on the treated turf after it had been mown to remove clover blooms present at the time of treatment, and new blooms had formed. Our results validate EPA label precautionary statements not to apply neonicotinoids to blooming nectar-producing plants if bees may visit the treatment area. Whatever systemic hazard through lawn weeds they may pose appears transitory, however, and direct hazard can be mitigated by adhering to label precautions, or if blooms inadvertently are contaminated, by mowing to remove them. Chlorantraniliprole usage on lawns appears non-hazardous to bumble bees.	[Larson, Jonathan L.; Redmond, Carl T.; Potter, Daniel A.] Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA	University of Kentucky	Potter, DA (corresponding author), Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA.	dapotter@uky.edu	Serrano, Jose/A-2854-2009	Serrano, Jose/0000-0002-1565-5216; Redmond, Carl/0000-0001-6898-8682	University of Kentucky's B.C.	University of Kentucky's B.C.	This work was supported by the University of Kentucky's B.C. Pass Research Professorship and Graduate Assistantship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Analytical Software, 2008, STAT VERS 9 0 US MAN; Blacquiere T, 2012, ECOTOXICOLOGY, V21, P973, DOI 10.1007/s10646-012-0863-x; Blaine TW, 2012, ENVIRON MANAGE, V50, P257, DOI 10.1007/s00267-012-9874-x; Bonmatin JM, 2005, ENVIRONMENTAL CHEMISTRY: GREEN CHEMISTRY AND POLLUTANTS IN ECOSYSTEMS, P483; Bonmatin JM, 2003, ANAL CHEM, V75, P2027, DOI 10.1021/ac020600b; Brugger KE, 2010, PEST MANAG SCI, V66, P1075, DOI 10.1002/ps.1977; Byrne FJ, 2012, PEST MANAG SCI, V68, P811, DOI 10.1002/ps.2337; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Cordova D, 2006, PESTIC BIOCHEM PHYS, V84, P196, DOI 10.1016/j.pestbp.2005.07.005; Cresswell JE, 2011, ECOTOXICOLOGY, V20, P149, DOI 10.1007/s10646-010-0566-0; Cutler GC, 2007, J ECON ENTOMOL, V100, P765, DOI 10.1603/0022-0493(2007)100[765:ETCSCH]2.0.CO;2; Decourtye A, 2004, ECOTOX ENVIRON SAFE, V57, P410, DOI 10.1016/j.ecoenv.2003.08.001; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Franklin MT, 2004, J ECON ENTOMOL, V97, P369, DOI 10.1603/0022-0493-97.2.369; Gels JA, 2002, J ECON ENTOMOL, V95, P722, DOI 10.1603/0022-0493-95.4.722; Gerloff CU, 2005, OIKOS, V111, P67, DOI 10.1111/j.0030-1299.2005.13980.x; Gill RJ, 2012, NATURE, V491, P105, DOI 10.1038/nature11585; Girolami V, 2009, J ECON ENTOMOL, V102, P1808, DOI 10.1603/029.102.0511; Goulson D, 2008, ANNU REV ENTOMOL, V53, P191, DOI 10.1146/annurev.ento.53.103106.093454; Held D, 2012, ANNU REV ENTOMOL, V57, P329, DOI 10.1146/annurev-ento-120710-100542; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Hernandez JL, 2009, CITIES ENV, V2, P1, DOI DOI 10.15365/cate.2132009; Hopwood J., 2012, ARE NEONICOTINOIDS K; JAKOBSEN HB, 1994, ANN BOT-LONDON, V74, P327, DOI 10.1006/anbo.1994.1125; Larson JL, 2012, PEST MANAG SCI, V68, P740, DOI 10.1002/ps.2321; Laycock I, 2012, ECOTOXICOLOGY, V21, P1937, DOI 10.1007/s10646-012-0927-y; McFrederick QS, 2006, BIOL CONSERV, V129, P372, DOI 10.1016/j.biocon.2005.11.004; Milesi C, 2005, ENVIRON MANAGE, V36, P426, DOI 10.1007/s00267-004-0316-2; Mommaerts V, 2010, ECOTOXICOLOGY, V19, P207, DOI 10.1007/s10646-009-0406-2; MORSE RA, 1990, J ECON ENTOMOL, V83, P81, DOI 10.1093/jee/83.1.81; MULLER CB, 1992, ECOL ENTOMOL, V17, P343, DOI 10.1111/j.1365-2311.1992.tb01068.x; Paya P, 2007, ANAL BIOANAL CHEM, V389, P1697, DOI 10.1007/s00216-007-1610-7; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Schmid-Hempel P, 2001, NATURWISSENSCHAFTEN, V88, P147, DOI 10.1007/s001140100222; Schonherr J, 2001, PEST MANAG SCI, V57, P17, DOI 10.1002/1526-4998(200101)57:1<17::AID-PS266>3.0.CO;2-8; Tasei JN, 2000, PEST MANAG SCI, V56, P784, DOI 10.1002/1526-4998(200009)56:9<784::AID-PS208>3.0.CO;2-T; Tasei JN, 2001, J ECON ENTOMOL, V94, P623, DOI 10.1603/0022-0493-94.3.623; Tomizawa M, 2003, ANNU REV ENTOMOL, V48, P339, DOI 10.1146/annurev.ento.48.091801.112731; Tommasi D, 2004, CAN ENTOMOL, V136, P851; U.S. Environmental Protection Agency, 2003, EPA PEST FACT SHEET; Wang JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036623; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025	42	89	92	7	187	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66375	10.1371/journal.pone.0066375	http://dx.doi.org/10.1371/journal.pone.0066375			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776667	gold, Green Published			2022-12-27	WOS:000320322400100
J	Li, YS; Xu, J; Chen, H; Zhao, Z; Li, SL; Bai, J; Wu, AW; Jiang, CJ; Wang, Y; Su, B; Li, X				Li, Yongsheng; Xu, Juan; Chen, Hong; Zhao, Zheng; Li, Shengli; Bai, Jing; Wu, Aiwei; Jiang, Chunjie; Wang, Yuan; Su, Bin; Li, Xia			Characterizing Genes with Distinct Methylation Patterns in the Context of Protein-Protein Interaction Network: Application to Human Brain Tissues	PLOS ONE			English	Article							DNA METHYLATION; SYSTEMS BIOLOGY; MOUSE; MODULES; EPIGENETICS; PREDICTION; ACTIVATORS; RESOURCE; DATABASE; TARGETS	Background: DNA methylation is an essential epigenetic mechanism involved in transcriptional control. However, how genes with different methylation patterns are assembled in the protein-protein interaction network (PPIN) remains a mystery. Results: In the present study, we systematically dissected the characterization of genes with different methylation patterns in the PPIN. A negative association was detected between the methylation levels in the brain tissues and topological centralities. By focusing on two classes of genes with considerably different methylation levels in the brain tissues, namely the low methylated genes (LMGs) and high methylated genes (HMGs), we found that their organizing principles in the PPIN are distinct. The LMGs tend to be the center of the PPIN, and attacking them causes a more deleterious effect on the network integrity. Furthermore, the LMGs express their functions in a modular pattern and substantial differences in functions are observed between the two types of genes. The LMGs are enriched in the basic biological functions, such as binding activity and regulation of transcription. More importantly, cancer genes, especially recessive cancer genes, essential genes, and aging-related genes were all found more often in the LMGs. Additionally, our analysis presented that the intra-classes communications are enhanced, but inter-classes communications are repressed. Finally, a functional complementation was revealed between methylation and miRNA regulation in the human genome. Conclusions: We have elucidated the assembling principles of genes with different methylation levels in the context of the PPIN, providing key insights into the complex epigenetic regulation mechanisms.	[Li, Yongsheng; Xu, Juan; Chen, Hong; Zhao, Zheng; Li, Shengli; Bai, Jing; Wu, Aiwei; Jiang, Chunjie; Wang, Yuan; Su, Bin; Li, Xia] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China	Harbin Medical University	Li, X (corresponding author), Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China.	lixia@hrbmu.edu.cn	Jiang, Chunjie/AAU-1775-2020; li, xia/HHZ-7468-2022	Jiang, Chunjie/0000-0002-3033-092X; Wu, Aiwei/0000-0001-8531-4815; Li, Yongsheng/0000-0003-1914-0727; Xu, Juan/0000-0002-3709-4165; Li, Shengli/0000-0001-5430-303X	National Natural Science Foundation of China [81121003, 91129710, 61170154, 3001304, 61203264]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20102307110022]; China Postdoctoral Science Foundation [2012M520764]; Innovation Research Fund for Graduate Students of Heilongjiang province [YJSCX2012-196HLJ]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Innovation Research Fund for Graduate Students of Heilongjiang province	This work was supported by the Funds for Creative Research Groups of The National Natural Science Foundation of China (Grant Nos. 81121003), the National Natural Science Foundation of China (Grant Nos. 91129710, 61170154, 3001304, 61203264), the Specialized Research Fund for the Doctoral Program of Higher Education of China (Grant Nos. 20102307110022), China Postdoctoral Science Foundation (Grant Nos. 2012M520764) and The Innovation Research Fund for Graduate Students of Heilongjiang province (YJSCX2012-196HLJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamcsek B, 2006, BIOINFORMATICS, V22, P1021, DOI 10.1093/bioinformatics/btl039; Attisano L, 2000, CURR OPIN CELL BIOL, V12, P235, DOI 10.1016/S0955-0674(99)00081-2; Awan A, 2007, IET SYST BIOL, V1, P292, DOI 10.1049/iet-syb:20060068; Baylin SB, 2000, TRENDS GENET, V16, P168, DOI 10.1016/S0168-9525(99)01971-X; Bell JT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r10; Bibikova M, 2009, EPIGENOMICS-UK, V1, P177, DOI [10.2217/epi.09.14, 10.2217/EPI.09.14]; Blake JA, 2003, NUCLEIC ACIDS RES, V31, P193, DOI 10.1093/nar/gkg047; Blake JA, 2000, NUCLEIC ACIDS RES, V28, P108, DOI 10.1093/nar/28.1.108; Bossi A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.17; Bundo M, 2012, CLIN EPIGENETICS, V4, DOI 10.1186/1868-7083-4-22; Campbell DB, 2009, PEDIATRICS, V123, P1018, DOI 10.1542/peds.2008-0819; de Magalhaes JP, 2004, FEBS LETT, V571, P243, DOI 10.1016/j.febslet.2004.07.006; Deneberg S, 2011, BLOOD, V118, P5573, DOI 10.1182/blood-2011-01-332353; Derynck R, 1998, CELL, V95, P737, DOI 10.1016/S0092-8674(00)81696-7; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Fernandez AF, 2009, GENOME RES, V19, P438, DOI 10.1101/gr.083550.108; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Gronniger E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000971; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Heard E, 1997, ANNU REV GENET, V31, P571, DOI 10.1146/annurev.genet.31.1.571; Hernandez DG, 2011, HUM MOL GENET, V20, P1164, DOI 10.1093/hmg/ddq561; Horvath S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-10-r97; Hsu CW, 2008, PROTEOMICS, V8, P1975, DOI 10.1002/pmic.200701004; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Jiang CZ, 2007, MOL BIOL EVOL, V24, P1991, DOI 10.1093/molbev/msm128; Jiang QH, 2009, NUCLEIC ACIDS RES, V37, pD98, DOI 10.1093/nar/gkn714; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kefas B, 2008, CANCER RES, V68, P3566, DOI 10.1158/0008-5472.CAN-07-6639; Kesavapany S, 2004, J NEUROSCI, V24, P4421, DOI 10.1523/JNEUROSCI.0690-04.2004; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Mani KM, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.2; Numata S, 2012, AM J HUM GENET, V90, P260, DOI 10.1016/j.ajhg.2011.12.020; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; QUILLIAM LA, 1995, BIOESSAYS, V17, P395, DOI 10.1002/bies.950170507; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Su ZX, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S5-S15; Tang P, 1997, J NEURO-ONCOL, V35, P303, DOI 10.1023/A:1005824802617; Vergoulis T, 2012, NUCLEIC ACIDS RES, V40, pD222, DOI 10.1093/nar/gkr1161; Wang JG, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000521; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Winnefeld M, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-7-165, 10.1186/gb4033]; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Xiao Y, 2012, NUCLEIC ACIDS RES, V40, P7653, DOI 10.1093/nar/gks538; Yang XJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002604; Zeng J, 2012, AM J HUM GENET, V91, P455, DOI 10.1016/j.ajhg.2012.07.024; Zhang QC, 2012, NATURE, V490, P556, DOI 10.1038/nature11503	55	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65871	10.1371/journal.pone.0065871	http://dx.doi.org/10.1371/journal.pone.0065871			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776563	gold, Green Published, Green Submitted			2022-12-27	WOS:000320322400060
J	Perez-Sanchez, J; Estensoro, I; Redondo, MJ; Calduch-Giner, JA; Kaushik, S; Sitja-Bobadilla, A				Perez-Sanchez, Jaume; Estensoro, Itziar; Redondo, Maria Jose; Calduch-Giner, Josep Alvar; Kaushik, Sadasivam; Sitja-Bobadilla, Ariadna			Mucins as Diagnostic and Prognostic Biomarkers in a Fish-Parasite Model: Transcriptional and Functional Analysis	PLOS ONE			English	Article							GILTHEAD SEA BREAM; ENTEROMYXUM-LEEI MYXOZOA; CELL-SURFACE MUCIN; SPARUS-AURATA; GENE-EXPRESSION; INTESTINAL EPITHELIUM; TRANSMEMBRANE MUCINS; DIGESTIVE-TRACT; IMMUNE-RESPONSE; MUCOUS CELLS	Mucins are O-glycosylated glycoproteins present on the apex of all wet-surfaced epithelia with a well-defined expression pattern, which is disrupted in response to a wide range of injuries or challenges. The aim of this study was to identify mucin gene sequences of gilthead sea bream (GSB), to determine its pattern of distribution in fish tissues and to analyse their transcriptional regulation by dietary and pathogenic factors. Exhaustive search of fish mucins was done in GSB after de novo assembly of next-generation sequencing data hosted in the IATS transcriptome database ( www.nutrigroup-iats.org/seabreamdb). Six sequences, three categorized as putative membrane-bound mucins and three putative secreted-gel forming mucins, were identified. The transcriptional tissue screening revealed that Muc18 was the predominant mucin in skin, gills and stomach of GSB. In contrast, Muc19 was mostly found in the oesophagus and Muc13 was along the entire intestinal tract, although the posterior intestine exhibited a differential pattern with a high expression of an isoform that does not share a clear orthologous in mammals. This mucin was annotated as intestinal mucin (I-Muc). Its RNA expression was highly regulated by the nutritional background, whereas the other mucins, including Muc2 and Muc2-like, were expressed more constitutively and did not respond to high replacement of fish oil (FO) by vegetable oils (VO) in plant protein-based diets. After challenge with the intestinal parasite Enteromyxum leei, the expression of a number of mucins was decreased mainly in the posterior intestine of infected fish. But, interestingly, the highest down-regulation was observed for the I-Muc. Overall, the magnitude of the changes reflected the intensity and progression of the infection, making mucins and I-Muc, in particular, reliable markers of prognostic and diagnostic value of fish intestinal health.	[Perez-Sanchez, Jaume; Calduch-Giner, Josep Alvar] IATS CSIC, Nutrigenom & Fish Growth Endocrinol Grp, Castellon de La Plana, Spain; [Estensoro, Itziar; Redondo, Maria Jose; Sitja-Bobadilla, Ariadna] IATS CSIC, Fish Pathol Grp, Castellon de La Plana, Spain; [Kaushik, Sadasivam] INRA, NuMeA Nutr UR1067, St Pee Sur Nivelle, France	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Acuicultura de Torre de la Sal (IATS); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Acuicultura de Torre de la Sal (IATS); INRAE; Universite de Pau et des Pays de l'Adour	Perez-Sanchez, J (corresponding author), IATS CSIC, Nutrigenom & Fish Growth Endocrinol Grp, Castellon de La Plana, Spain.	jperez@iats.csic.es	Sánchez, Jaume Pérez/AAJ-6628-2021; Sitjà-Bobadilla, Ariadna/J-2715-2014; Calduch-Giner, Josep/K-8253-2014; Calduch-Giner, Josep/AAY-1475-2021; Kaushik, Sadasivam J/B-9824-2009; sanchez, jaume perez/K-3231-2014; estensoro, itziar/AAX-4469-2020	Sánchez, Jaume Pérez/0000-0003-2506-1523; Sitjà-Bobadilla, Ariadna/0000-0002-7473-3413; Calduch-Giner, Josep/0000-0003-3124-5986; Calduch-Giner, Josep/0000-0003-3124-5986; Kaushik, Sadasivam J/0000-0001-7856-8374; sanchez, jaume perez/0000-0003-2506-1523; estensoro, itziar/0000-0002-6218-2191	EU ARRAINA project (Advanced Research Initiatives for Nutrition Aquaculture) [288925]; Spanish Ministry of Science and Innovation (MICINN) [AGL2009-13282-C02-01, CSD2007-00002]; Generalitat Valenciana [PROMETEO 2010/006, ISIC 2011/003]	EU ARRAINA project (Advanced Research Initiatives for Nutrition Aquaculture); Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission)	This work was funded by the EU ARRAINA project (Advanced Research Initiatives for Nutrition & Aquaculture, FP7/2007/2013; grant agreement no. 288925) and by the Spanish Ministry of Science and Innovation (MICINN) through the projects AGL2009-13282-C02-01 and AQUAGENOMICS (CSD2007-00002, Improvement of Aquaculture Production by the Use of Biotechnological Tools). Additional funding was obtained from the "Generalitat Valenciana" (research grants PROMETEO 2010/006, ISIC 2011/003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	alvarez-Pellitero P., 2011, MUCOSAL INTESTINAL I; Andrianifahanana M, 2006, BBA-REV CANCER, V1765, P189, DOI 10.1016/j.bbcan.2006.01.002; Artis D, 2008, MUCOSAL IMMUNOL, V1, P252, DOI 10.1038/mi.2008.21; Bergstrom KSB, 2008, INFECT IMMUN, V76, P796, DOI 10.1128/IAI.00093-07; Bermudez R, 2009, 14 EUR ASS FISH PATH; Bosi G, 2005, DIS AQUAT ORGAN, V64, P45, DOI 10.3354/dao064045; Burger-van Paassen N, 2009, BIOCHEM J, V420, P211, DOI 10.1042/BJ20082222; Calduch-Giner JA, 2003, COMP BIOCHEM PHYS B, V136, P1, DOI 10.1016/S1096-4959(03)00150-7; Calduch-Giner JA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-178; Calduch-Giner JA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-470; Carraway KL, 2003, BIOESSAYS, V25, P66, DOI 10.1002/bies.10201; Chaturvedi P, 2008, FASEB J, V22, P966, DOI 10.1096/fj.07-9673rev; Chauhan SC, 2009, CANCER RES, V69, P765, DOI 10.1158/0008-5472.CAN-08-0587; Chen Y, 2004, AM J RESP CELL MOL, V30, P155, DOI 10.1165/rcmb.2003-0103OC; Desseyn JL, 2008, GENE, V410, P215, DOI 10.1016/j.gene.2007.12.014; Desseyn JL, 2009, MOL PHYLOGENET EVOL, V52, P284, DOI 10.1016/j.ympev.2009.03.035; Desseyn JL, 2002, EUR J BIOCHEM, V269, P3150, DOI 10.1046/j.1432-1033.2002.02988.x; Desseyn JL, 2000, MOL BIOL EVOL, V17, P1175, DOI 10.1093/oxfordjournals.molbev.a026400; Dezfuli BS, 2010, J FISH DIS, V33, P481, DOI 10.1111/j.1365-2761.2010.01146.x; Duraisamy S, 2006, GENE, V373, P28, DOI 10.1016/j.gene.2005.12.021; Dykstra NS, 2011, PEDIATR RES, V69, P206, DOI 10.1203/PDR.0b013e3182096ff0; Estensoro I, 2013, PARASITOL RES, V112, P567, DOI 10.1007/s00436-012-3168-3; Estensoro I, 2012, DIS AQUAT ORGAN, V100, P29, DOI 10.3354/dao02486; Estensoro I, 2011, VET PARASITOL, V175, P141, DOI 10.1016/j.vetpar.2010.09.015; Estensoro I, 2010, DIS AQUAT ORGAN, V92, P51, DOI 10.3354/dao02267; Fange R., 1979, FISH PHYSIOL, V7, P161, DOI DOI 10.1016/S1546-5098(08)60027-8; Fleurance R, 2008, DIS AQUAT ORGAN, V79, P219, DOI 10.3354/dao01832; FUJINO T, 1993, J HELMINTHOL, V67, P179, DOI 10.1017/S0022149X00013110; Gaudier E, 2004, AM J PHYSIOL-GASTR L, V287, pG1168, DOI 10.1152/ajpgi.00219.2004; GENDLER SJ, 1995, ANNU REV PHYSIOL, V57, P607, DOI 10.1146/annurev.ph.57.030195.003135; Gheorghiu C, 2012, DIS AQUAT ORGAN, V98, P143, DOI 10.3354/dao02434; Harikrishnan R, 2011, FISH SHELLFISH IMMUN, V31, P310, DOI 10.1016/j.fsi.2011.05.020; Hino S, 2012, J NUTR, V142, P1429, DOI 10.3945/jn.112.159731; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; LAMBERT ME, 1979, BRIT MED J, V1, P857, DOI 10.1136/bmj.1.6167.857; Lang T, 2004, GLYCOBIOLOGY, V14, P521, DOI 10.1093/glycob/cwh066; Lang TA, 2007, P NATL ACAD SCI USA, V104, P16209, DOI 10.1073/pnas.0705984104; Lee KD, 2010, J PARASITOL, V96, P58, DOI 10.1645/GE-2195.1; Lee SY, 2012, PHYTOTHER RES, V26, P1082, DOI 10.1002/ptr.3701; Li N, 2012, INT IMMUNOPHARMACOL, V14, P195, DOI 10.1016/j.intimp.2012.07.008; Lien KA, 2001, J ANIM FEED SCI, V10, P223; Linden SK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003952; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maher DM, 2011, MOL CANCER RES, V9, P531, DOI 10.1158/1541-7786.MCR-10-0443; Mahomed F, 2011, ORAL ONCOL, V47, P797, DOI 10.1016/j.oraloncology.2011.06.008; Martinez-Maqueda D, 2012, J AGR FOOD CHEM, V60, P8600, DOI 10.1021/jf301279k; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; Menzies M, 2010, PARASITE IMMUNOL, V32, P36, DOI 10.1111/j.1365-3024.2009.01156.x; Micallef G, 2012, MAR BIOTECHNOL, V14, P559, DOI 10.1007/s10126-012-9447-2; Moncada DM, 2003, TRENDS PARASITOL, V19, P305, DOI 10.1016/S1471-4922(03)00122-3; Moniaux N, 2001, FRONT BIOSCI-LANDMRK, V6, pD1192, DOI 10.2741/Moniaux; Montero D, 2010, FISH SHELLFISH IMMUN, V29, P1073, DOI 10.1016/j.fsi.2010.08.024; Redondo MJ, 2010, PARASITOL INT, V59, P445, DOI 10.1016/j.parint.2010.06.005; Rinaldi M, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-61; Rothberg BEG, 2009, JNCI-J NATL CANCER I, V101, P452, DOI 10.1093/jnci/djp038; SACHDEV HPS, 1993, J PEDIATR GASTR NUTR, V16, P33, DOI 10.1097/00005176-199301000-00006; Sasaki M, 2007, PROG HISTOCHEM CYTO, V42, P61, DOI 10.1016/j.proghi.2007.02.001; Schroers V, 2009, AQUACULTURE, V288, P184, DOI 10.1016/j.aquaculture.2008.12.013; SERS C, 1993, P NATL ACAD SCI USA, V90, P8514, DOI 10.1073/pnas.90.18.8514; Sheng YH, 2012, J GASTROEN HEPATOL, V27, P28, DOI 10.1111/j.1440-1746.2011.06909.x; Sheng YH, 2011, GUT, V60, P1661, DOI 10.1136/gut.2011.239194; Shimamura T, 2005, CANCER SCI, V96, P265, DOI 10.1111/j.1349-7006.2005.00043.x; Sitja-Bobadilla A, 2005, AQUACULTURE, V249, P387, DOI 10.1016/j.aquaculture.2005.03.031; Sitja-Bobadilla A, 2008, FISH SHELLFISH IMMUN, V24, P610, DOI 10.1016/j.fsi.2008.01.014; Sitja-Bobadilla A, 2012, FISH PARASITES: PATHOBIOLOGY AND PROTECTION, P163, DOI 10.1079/9781845938062.0163; Skoog EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036378; Smith AG, 2011, BRIT J NUTR, V105, P669, DOI 10.1017/S0007114510004277; Soga K, 2008, PARASITOL RES, V103, P1427, DOI 10.1007/s00436-008-1152-8; STEINBERG SE, 1975, GASTROENTEROLOGY, V68, P309; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Theodoropoulos G, 2007, J CELL BIOCHEM, V102, P1103, DOI 10.1002/jcb.21539; Torrecillas S, 2011, AQUACULT NUTR, V17, P223, DOI 10.1111/j.1365-2095.2009.00730.x; Valque H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046699; van der Marel M, 2012, FISH SHELLFISH IMMUN, V32, P494, DOI 10.1016/j.fsi.2011.12.008; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094; Walsh MD, 2007, HUM PATHOL, V38, P883, DOI 10.1016/j.humpath.2006.11.020; Williams SJ, 2001, J BIOL CHEM, V276, P18327, DOI 10.1074/jbc.M008850200; Yonezawa S, 2011, PATHOL INT, V61, P697, DOI 10.1111/j.1440-1827.2011.02734.x	79	75	77	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65457	10.1371/journal.pone.0065457	http://dx.doi.org/10.1371/journal.pone.0065457			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776483	Green Submitted, Green Published, gold			2022-12-27	WOS:000320322400027
J	Schissler, AJ; Rozenshtein, A; Kulon, ME; Pearson, GDN; Green, RA; Stetson, PD; Brenner, DJ; D'Souza, B; Tsai, WY; Schluger, NW; Einstein, AJ				Schissler, Andrew J.; Rozenshtein, Anna; Kulon, Michal E.; Pearson, Gregory D. N.; Green, Robert A.; Stetson, Peter D.; Brenner, David J.; D'Souza, Belinda; Tsai, Wei-Yann; Schluger, Neil W.; Einstein, Andrew J.			CT Pulmonary Angiography: Increasingly Diagnosing Less Severe Pulmonary Emboli	PLOS ONE			English	Article							RIGHT-VENTRICULAR DYSFUNCTION; ROW COMPUTED-TOMOGRAPHY; CARDIAC TROPONIN-I; EMERGENCY-DEPARTMENT; UTILIZATION PATTERNS; TERM MORTALITY; TRENDS; MANAGEMENT; YIELD	Background: It is unknown whether the observed increase in computed tomography pulmonary angiography (CTPA) utilization has resulted in increased detection of pulmonary emboli (PEs) with a less severe disease spectrum. Methods: Trends in utilization, diagnostic yield, and disease severity were evaluated for 4,048 consecutive initial CTPAs performed in adult patients in the emergency department of a large urban academic medical center between 1/1/2004 and 10/31/2009. Transthoracic echocardiography (TTE) findings and peak serum troponin levels were evaluated to assess for the presence of PE-associated right ventricular (RV) abnormalities (dysfunction or dilatation) and myocardial injury, respectively. Statistical analyses were performed using multivariate logistic regression. Results: 268 CTPAs (6.6%) were positive for acute PE, and 3,780 (93.4%) demonstrated either no PE or chronic PE. There was a significant increase in the likelihood of undergoing CTPA per year during the study period (odds ratio [OR] 1.05, 95% confidence interval [CI] 1.04-1.07, P<0.01). There was no significant change in the likelihood of having a CTPA diagnostic of an acute PE per year (OR 1.03, 95% CI 0.95-1.11, P = 0.49). The likelihood of diagnosing a less severe PE on CTPA with no associated RV abnormalities or myocardial injury increased per year during the study period (OR 1.39, 95% CI 1.10-1.75, P = 0.01). Conclusions: CTPA utilization has risen with no corresponding change in diagnostic yield, resulting in an increase in PE detection. There is a concurrent rise in the likelihood of diagnosing a less clinically severe spectrum of PEs.	[Schissler, Andrew J.; Schluger, Neil W.; Einstein, Andrew J.] Columbia Univ, Med Ctr, Dept Med, New York, NY 10027 USA; [Schissler, Andrew J.; Rozenshtein, Anna; Kulon, Michal E.; Pearson, Gregory D. N.; Green, Robert A.; Stetson, Peter D.; Brenner, David J.; D'Souza, Belinda; Schluger, Neil W.; Einstein, Andrew J.] NewYork Presbyterian Hosp, New York, NY USA; [Rozenshtein, Anna; Kulon, Michal E.; Pearson, Gregory D. N.; D'Souza, Belinda; Einstein, Andrew J.] Columbia Univ, Med Ctr, Dept Radiol, New York, NY USA; [Green, Robert A.] Columbia Univ, Med Ctr, Dept Emergency Med, New York, NY USA; [Stetson, Peter D.] Columbia Univ, Med Ctr, Dept Biomed Informat, New York, NY USA; [Stetson, Peter D.] Columbia Univ, Med Ctr, Dept Med, New York, NY USA; [Brenner, David J.] Columbia Univ, Med Ctr, Ctr Radiol Res, New York, NY USA; [Tsai, Wei-Yann] Columbia Univ, Mailman Sch Publ Hlth, Dept Biostat, New York, NY USA; [Schluger, Neil W.] Columbia Univ, Med Ctr, Dept Med, Div Pulm Allergy & Crit Care Med, New York, NY USA; Columbia Univ, Med Ctr, Dept Med, Div Cardiol, New York, NY USA	Columbia University; NewYork-Presbyterian Hospital; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University	Einstein, AJ (corresponding author), Columbia Univ, Med Ctr, Dept Med, New York, NY 10027 USA.	andrew.einstein@columbia.edu	Schluger, Neil/ABA-1793-2021		National Center for Advancing Translational Sciences, National Institutes of Health [UL1 TR000040]; National Center for Research Resources [UL1 RR024156]; Louis V. Gerstner, Jr., Scholars Program; Victoria and Esther Aboodi Assistant Professorship; Herbert Irving Assistant Professorship; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000040] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024156] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Louis V. Gerstner, Jr., Scholars Program; Victoria and Esther Aboodi Assistant Professorship; Herbert Irving Assistant Professorship; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This publication was supported by the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant Number UL1 TR000040, formerly the National Center for Research Resources, Grant Number UL1 RR024156. Dr. Einstein was supported by the Louis V. Gerstner, Jr., Scholars Program, by a Victoria and Esther Aboodi Assistant Professorship, and by a Herbert Irving Assistant Professorship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnelli G, 2010, NEW ENGL J MED, V363, P266, DOI 10.1056/NEJMra0907731; [Anonymous], 2006, ABB AXSYM SYST TROP; [Anonymous], 2008, STRAT CS STAT FLUOR; [Anonymous], 2003, ABB AXSYM SYST TROP; Araoz PA, 2012, AM J ROENTGENOL, V198, P1313, DOI 10.2214/AJR.11.8461; BARRITT DW, 1960, LANCET, V1, P1309; Becattini C, 2007, CIRCULATION, V116, P427, DOI 10.1161/CIRCULATIONAHA.106.680421; Burge AJ, 2008, CLIN RADIOL, V63, P381, DOI 10.1016/j.crad.2007.10.004; Calder KK, 2005, ANN EMERG MED, V45, P302, DOI 10.1016/j.annemergmed.2004.10.001; Donohoo JH, 2008, J COMPUT ASSIST TOMO, V32, P421, DOI 10.1097/RCT.0b013e31812e6af3; Fink DJ, 2001, CORE LAB POLICY PROC; Furlan A, 2012, RADIOLOGY, V265, P283, DOI 10.1148/radiol.12110802; Goldhaber SZ, 2012, LANCET, V379, P1835, DOI 10.1016/S0140-6736(11)61904-1; Heit JA, 2001, THROMB HAEMOSTASIS, V86, P452, DOI 10.1161/ATVBAHA.108.162545; Kluge Alexander, 2006, AJR Am J Roentgenol, V187, pW7, DOI 10.2214/AJR.04.1814; Kocher KE, 2011, ANN EMERG MED, V58, P452, DOI 10.1016/j.annemergmed.2011.05.020; Konstantinides S, 2002, CIRCULATION, V106, P1263, DOI 10.1161/01.CIR.0000028422.51668.A2; Kreit JW, 2004, CHEST, V125, P1539, DOI 10.1378/chest.125.4.1539; Kucher N, 2005, ARCH INTERN MED, V165, P1777, DOI 10.1001/archinte.165.15.1777; La Vecchia L, 2004, HEART, V90, P633, DOI 10.1136/hrt.2003.019745; Meyer M, 2012, EUR J RADIOL, V81, P3294, DOI 10.1016/j.ejrad.2012.06.023; Morris MF, 2012, AM J ROENTGENOL, V198, P1346, DOI 10.2214/AJR.11.6801; Onyedika C, 2013, SEMIN NUCL MED, V43, P82, DOI 10.1053/j.semnuclmed.2012.11.002; Perrier A, 2005, NEW ENGL J MED, V352, P1760, DOI 10.1056/NEJMoa042905; Prologo JD, 2004, AM J ROENTGENOL, V183, P1093, DOI 10.2214/ajr.183.4.1831093; Raja AS, 2012, RADIOLOGY, V262, P468, DOI 10.1148/radiol.11110951; Sheh SH, 2012, AM J ROENTGENOL, V198, P1340, DOI 10.2214/AJR.11.6426; Stein PD, 2006, NEW ENGL J MED, V354, P2317, DOI 10.1056/NEJMoa052367; Stein PD, 2011, AM J CARDIOL, V107, P774, DOI 10.1016/j.amjcard.2010.10.061; STEIN PD, 1995, CHEST, V107, P931, DOI 10.1378/chest.107.4.931; Torbicki A, 2008, EUR HEART J, V29, P2276, DOI 10.1093/eurheartj/ehn310; Wang Joanne H, 2013, Hosp Pract (1995), V41, P122, DOI 10.3810/hp.2013.02.1018; Weir Ian D, 2010, Conn Med, V74, P5; Weiss CR, 2006, ACAD RADIOL, V13, P434, DOI 10.1016/j.acra.2006.01.002; Wells PS, 2001, ANN INTERN MED, V135, P98, DOI 10.7326/0003-4819-135-2-200107170-00010; Wicki J, 2001, ARCH INTERN MED, V161, P92, DOI 10.1001/archinte.161.1.92; Wiener RS, 2011, ARCH INTERN MED, V171, P831, DOI 10.1001/archinternmed.2011.178; Wittram C, 2004, J THORAC IMAG, V19, P164, DOI 10.1097/01.rti.0000117623.02841.e6; Wittram C, 2006, AM J ROENTGENOL, V186, pS421, DOI 10.2214/AJR.04.1955; Wood KE, 2002, CHEST, V121, P877, DOI 10.1378/chest.121.3.877	40	44	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65669	10.1371/journal.pone.0065669	http://dx.doi.org/10.1371/journal.pone.0065669			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776522	Green Published, Green Submitted, gold			2022-12-27	WOS:000320322400043
J	Shimamoto, T; Yamamichi, N; Kodashima, S; Takahashi, Y; Fujishiro, M; Oka, M; Mitsushima, T; Koike, K				Shimamoto, Takeshi; Yamamichi, Nobutake; Kodashima, Shinya; Takahashi, Yu; Fujishiro, Mitsuhiro; Oka, Masashi; Mitsushima, Toru; Koike, Kazuhiko			No Association of Coffee Consumption with Gastric Ulcer, Duodenal Ulcer, Reflux Esophagitis, and Non-Erosive Reflux Disease: A Cross-Sectional Study of 8,013 Healthy Subjects in Japan	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; GASTROESOPHAGEAL-REFLUX; PEPTIC-ULCER; RISK-FACTORS; SPHINCTER PRESSURE; ACID-SECRETION; ALCOHOL; CAFFEINE; SMOKING; POPULATION	Probably due to caffeine-induced gastric acid secretion, negative effects of coffee upon various upper-gastrointestinal diseases have been precariously accepted, despite the inadequate epidemiological evidence. Our aim is to evaluate the effect of coffee consumption on four major acid-related diseases: gastric ulcer (GU), duodenal ulcer (DU), reflux esophagitis (RE), and non-erosive reflux disease (NERD) based on the large-scale multivariate analysis. Of the 9,517 healthy adults, GU, DU, and RE were diagnosed by endoscopy, and NERD was diagnosed by the symptoms of heartburn and regurgitation without esophageal erosion. Associations between coffee consumption and the four disorders were evaluated, together with age, gender, body mass index (BMI), Helicobacter pylori (HP) infection status, pepsinogen I/II ratio, smoking, and alcohol. We further performed meta-analysis using the random effects model to redefine the relationship between coffee intake and peptic ulcer disease. The eligible 8,013 study subjects comprised of 5,451 coffee drinkers and 2,562 non-coffee drinkers. By univariate analysis, age, BMI, pepsinogen I/II ratio, smoking, and alcohol showed significant associations with coffee consumption. By multiple logistic regression analysis, positively correlated factors with significance were HP infection, current smoking, BMI, and pepsinogen I/II ratio for GU; HP infection, pepsinogen I/II ratio, and current smoking for DU; HP non-infection, male, BMI, pepsinogen I/II ratio, smoking, age, and alcohol for RE; younger age, smoking, and female for NERD. The meta-analyses could detect any association of coffee consumption with neither GU nor DU. In conclusion, there are no significant relationship between coffee consumption and the four major acid-related upper gastrointestinal disorders.	[Shimamoto, Takeshi; Mitsushima, Toru] Kameda Med Ctr Makuhari, Chiba, Japan; [Shimamoto, Takeshi; Yamamichi, Nobutake; Kodashima, Shinya; Takahashi, Yu; Fujishiro, Mitsuhiro; Koike, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan; [Oka, Masashi] Saitama Med Univ, Fac Med, Dept Gastroenterol & Hepatol, Saitama, Japan	University of Tokyo; Saitama Medical University	Yamamichi, N (corresponding author), Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan.	nyamamic-tky@umin.ac.jp	藤城, 光弘/AAN-3131-2020; Takahashi, Yu/I-4665-2015	Takahashi, Yu/0000-0002-3066-9501	Tokyo Society of Medical Sciences; Daiwa Security Health Foundation; Grants-in-Aid for Scientific Research [25460381] Funding Source: KAKEN	Tokyo Society of Medical Sciences; Daiwa Security Health Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a research grant from the Tokyo Society of Medical Sciences, and was also supported in part by a research grant from the Daiwa Security Health Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Farsakh NA, 2002, SAUDI MED J, V23, P168; Aldoori WH, 1997, EPIDEMIOLOGY, V8, P420, DOI 10.1097/00001648-199707000-00012; [Anonymous], 2011, J DIGEST DIS, V12, P319, DOI 10.1111/j.1751-2980.2011.00529.x; Araki S, 1985, Sangyo Igaku, V27, P242; Boekema PJ, 1999, SCAND J GASTROENTERO, V34, P35, DOI 10.1080/003655299750025525; Brenner H, 1997, BRIT MED J, V315, P1489, DOI 10.1136/bmj.315.7121.1489; Brenner H, 1999, EPIDEMIOLOGY, V10, P214, DOI 10.1097/00001648-199905000-00004; COHEN S, 1975, New England Journal of Medicine, V293, P897, DOI 10.1056/NEJM197510302931803; EISIG JN, 1989, SCAND J GASTROENTERO, V24, P796, DOI 10.3109/00365528909089216; El-Serag HB, 2007, CLIN GASTROENTEROL H, V5, P17, DOI 10.1016/j.cgh.2006.09.016; ELTA GH, 1990, AM J GASTROENTEROL, V85, P1339; Eslick GD, 2009, J CLIN GASTROENTEROL, V43, P111, DOI 10.1097/MCG.0b013e31815ea27b; FELDMAN EJ, 1981, JAMA-J AM MED ASSOC, V246, P248, DOI 10.1001/jama.246.3.248; FRIEDMAN GD, 1974, NEW ENGL J MED, V290, P469, DOI 10.1056/NEJM197402282900901; Gomez-Ruiz JA, 2007, J AGR FOOD CHEM, V55, P6962, DOI 10.1021/jf0710985; Huang JQ, 2002, LANCET, V359, P14, DOI 10.1016/S0140-6736(02)07273-2; Kaltenbach T, 2006, ARCH INTERN MED, V166, P965, DOI 10.1001/archinte.166.9.965; Kang NJ, 2009, CARCINOGENESIS, V30, P321, DOI 10.1093/carcin/bgn282; KATO I, 1992, AM J EPIDEMIOL, V135, P521, DOI 10.1093/oxfordjournals.aje.a116319; KLAUSER AG, 1990, LANCET, V335, P205, DOI 10.1016/0140-6736(90)90287-F; Li ZS, 2010, AM J GASTROENTEROL, V105, P2570, DOI 10.1038/ajg.2010.324; Lundell LR, 1999, GUT, V45, P172, DOI 10.1136/gut.45.2.172; Malfertheiner P, 2009, LANCET, V374, P1449, DOI 10.1016/S0140-6736(09)60938-7; Meucci G, 2000, J CLIN GASTROENTEROL, V31, P42, DOI 10.1097/00004836-200007000-00010; Misaki F, 1983, Nihon Shokakibyo Gakkai Zasshi, V80, P2504; Nakamura T, 1983, Nihon Shokakibyo Gakkai Zasshi, V80, P2493; Nechige R, 1981, YAMAGUCHI MED J, V30, P455; OSTENSEN H, 1985, SCAND J GASTROENTERO, V20, P1227, DOI 10.3109/00365528509089281; Pehl C, 1997, ALIMENT PHARM THER, V11, P483, DOI 10.1046/j.1365-2036.1997.00161.x; Quartero AO, 1998, BRIT MED J, V316, P1020; Richter JE, 1998, AM J GASTROENTEROL, V93, P1800, DOI 10.1111/j.1572-0241.1998.00523.x; Rosenstock S, 2003, GUT, V52, P186, DOI 10.1136/gut.52.2.186; Roth JA, 1944, AM J PHYSIOL, V141, P0454, DOI 10.1152/ajplegacy.1944.141.4.454; Schottker B, 2012, CLIN GASTROENTEROL H, V10, P487, DOI 10.1016/j.cgh.2011.12.036; Schubert ML, 2008, GASTROENTEROLOGY, V134, P1842, DOI 10.1053/j.gastro.2008.05.021; Seo HS, 2008, J AGR FOOD CHEM, V56, P4665, DOI 10.1021/jf8001137; Sugisawa A, 1998, J OCCUP HEALTH, V40, P22, DOI 10.1539/joh.40.22; THOMAS FB, 1980, GASTROENTEROLOGY, V79, P1262; VANDEVENTER G, 1992, DIGEST DIS SCI, V37, P558, DOI 10.1007/BF01307580; Wang JY, 1996, INT J EPIDEMIOL, V25, P638, DOI 10.1093/ije/25.3.638; WATANABE Y, 1992, J CLIN GASTROENTEROL, V15, P68, DOI 10.1097/00004836-199207000-00016; WENDL B, 1994, ALIMENT PHARM THER, V8, P283; Yaghoobi M, 2010, AM J GASTROENTEROL, V105, P1007, DOI 10.1038/ajg.2009.734; Yamaji Y, 2001, GUT, V49, P335, DOI 10.1136/gut.49.3.335; Yamamichi N, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-45	47	38	41	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65996	10.1371/journal.pone.0065996	http://dx.doi.org/10.1371/journal.pone.0065996			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776588	gold, Green Submitted, Green Published			2022-12-27	WOS:000320322400069
J	Sim, X; Jensen, RA; Ikram, MK; Cotch, MF; Li, XH; MacGregor, S; Xie, J; Smith, AV; Boerwinkle, E; Mitchell, P; Klein, R; Klein, BEK; Glazer, NL; Lumley, T; McKnight, B; Psaty, BM; de Jong, PTVM; Hofman, A; Rivadeneira, F; Uitterlinden, AG; van Duijn, CM; Aspelund, T; Eiriksdottir, G; Harris, TB; Jonasson, F; Launer, LJ; Attia, J; Baird, PN; Harrap, S; Holliday, EG; Inouye, M; Rochtchina, E; Scott, RJ; Viswanathan, A; Li, G; Smith, NL; Wiggins, KL; Kuo, JZ; Taylor, KD; Hewitt, AW; Martin, NG; Montgomery, GW; Sun, C; Young, TL; Mackey, DA; van Zuydam, NR; Doney, ASF; Palmer, CNA; Morris, AD; Rotter, JI; Tai, ES; Gudnason, V; Vingerling, JR; Siscovick, DS; Wang, JJ; Wong, TY				Sim, Xueling; Jensen, Richard A.; Ikram, M. Kamran; Cotch, Mary Frances; Li, Xiaohui; MacGregor, Stuart; Xie, Jing; Smith, Albert Vernon; Boerwinkle, Eric; Mitchell, Paul; Klein, Ronald; Klein, Barbara E. K.; Glazer, Nicole L.; Lumley, Thomas; McKnight, Barbara; Psaty, Bruce M.; de Jong, Paulus T. V. M.; Hofman, Albert; Rivadeneira, Fernando; Uitterlinden, Andre G.; van Duijn, Cornelia M.; Aspelund, Thor; Eiriksdottir, Gudny; Harris, Tamara B.; Jonasson, Fridbert; Launer, Lenore J.; Attia, John; Baird, Paul N.; Harrap, Stephen; Holliday, Elizabeth G.; Inouye, Michael; Rochtchina, Elena; Scott, Rodney J.; Viswanathan, Ananth; Li, Guo; Smith, Nicholas L.; Wiggins, Kerri L.; Kuo, Jane Z.; Taylor, Kent D.; Hewitt, Alex W.; Martin, Nicholas G.; Montgomery, Grant W.; Sun, Cong; Young, Terri L.; Mackey, David A.; van Zuydam, Natalie R.; Doney, Alex S. F.; Palmer, Colin N. A.; Morris, Andrew D.; Rotter, Jerome I.; Tai, E. Shyong; Gudnason, Vilmundur; Vingerling, Johannes R.; Siscovick, David S.; Wang, Jie Jin; Wong, Tien Y.		Wellcome Trust Case Control Consor; Global BPGen Consortium	Genetic Loci for Retinal Arteriolar Microcirculation	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; VESSEL DIAMETERS; VASCULAR CALIBER; MICROVASCULAR ABNORMALITIES; ATHEROSCLEROSIS RISK; FASTING GLUCOSE; BLOOD-PRESSURE; HYPERTENSION; AGE; PREVALENCE	Narrow arterioles in the retina have been shown to predict hypertension as well as other vascular diseases, likely through an increase in the peripheral resistance of the microcirculatory flow. In this study, we performed a genome-wide association study in 18,722 unrelated individuals of European ancestry from the Cohorts for Heart and Aging Research in Genomic Epidemiology consortium and the Blue Mountain Eye Study, to identify genetic determinants associated with variations in retinal arteriolar caliber. Retinal vascular calibers were measured on digitized retinal photographs using a standardized protocol. One variant (rs2194025 on chromosome 5q14 near the myocyte enhancer factor 2C MEF2C gene) was associated with retinal arteriolar caliber in the meta-analysis of the discovery cohorts at genome-wide significance of P-value <5x10(-8). This variant was replicated in an additional 3,939 individuals of European ancestry from the Australian Twins Study and Multi-Ethnic Study of Atherosclerosis (rs2194025, P-value = 2.11x10(-12) in combined meta-analysis of discovery and replication cohorts). In independent studies of modest sample sizes, no significant association was found between this variant and clinical outcomes including coronary artery disease, stroke, myocardial infarction or hypertension. In conclusion, we found one novel loci which underlie genetic variation in microvasculature which may be relevant to vascular disease. The relevance of these findings to clinical outcomes remains to be determined.	[Sim, Xueling] Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Jensen, Richard A.; Glazer, Nicole L.; Lumley, Thomas; McKnight, Barbara; Psaty, Bruce M.; Li, Guo; Wiggins, Kerri L.; Wellcome Trust Case Control Consor] Univ Washington, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Jensen, Richard A.; Psaty, Bruce M.; Siscovick, David S.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Ikram, M. Kamran; Wong, Tien Y.] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore; [Ikram, M. Kamran; Vingerling, Johannes R.] Erasmus MC, Dept Ophthalmol, Rotterdam, Netherlands; [Cotch, Mary Frances] NEI, Div Epidemiol & Clin Applicat, Intramural Res Program, NIH, Bethesda, MD 20892 USA; [Li, Xiaohui; Kuo, Jane Z.; Taylor, Kent D.; Rotter, Jerome I.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [MacGregor, Stuart; Martin, Nicholas G.; Montgomery, Grant W.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Xie, Jing; Baird, Paul N.; Hewitt, Alex W.; Mackey, David A.; Wang, Jie Jin] Univ Melbourne, Ctr Eye Res Australia, Royal Victorian Eye & Ear Hosp, Melbourne, Vic, Australia; [Smith, Albert Vernon; Aspelund, Thor; Eiriksdottir, Gudny; Gudnason, Vilmundur] Iceland Heart Assoc, Kopavogur Capital Region, Iceland; [Smith, Albert Vernon; Aspelund, Thor; Gudnason, Vilmundur] Univ Iceland, Dept Med, Reykjavik, Iceland; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX 77030 USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Inst Mol Med, Houston, TX 77030 USA; [Mitchell, Paul; Rochtchina, Elena] Univ Sydney, Ctr Vision Res, Dept Ophthalmol, Sydney, NSW 2006, Australia; [Mitchell, Paul; Rochtchina, Elena] Univ Sydney, Westmead Millennium Inst, Sydney, NSW 2006, Australia; [Klein, Ronald; Klein, Barbara E. K.] Univ Wisconsin, Dept Ophthalmol & Visual Sci, Sch Med & Publ Hlth, Madison, WI USA; [Glazer, Nicole L.; Siscovick, David S.] Univ Washington, Dept Med, Seattle, WA USA; [Glazer, Nicole L.] Boston Univ, Dept Med, Boston, MA USA; [Lumley, Thomas; McKnight, Barbara] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Lumley, Thomas] Univ Auckland, Dept Stat, Auckland 1, New Zealand; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Psaty, Bruce M.; Smith, Nicholas L.] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA USA; [de Jong, Paulus T. V. M.] Netherlands Inst Neurosci, Dept Clin & Mol Ophthalmogenet, Amsterdam, Netherlands; [de Jong, Paulus T. V. M.] Univ Amsterdam, Acad Med Ctr, Dept Ophthalmol, NL-1105 AZ Amsterdam, Netherlands; [de Jong, Paulus T. V. M.; Hofman, Albert; Rivadeneira, Fernando; Uitterlinden, Andre G.; van Duijn, Cornelia M.; Vingerling, Johannes R.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Rivadeneira, Fernando; Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Uitterlinden, Andre G.] Erasmus MC, Dept Clin Chem, Rotterdam, Netherlands; [Harris, Tamara B.; Launer, Lenore J.] NIA, Lab Epidemiol Demog & Biometry, Intramural Res Program, NIH, Bethesda, MD 20892 USA; [Jonasson, Fridbert] Univ Iceland, Dept Ophthalmol, Reykjavik, Iceland; [Jonasson, Fridbert] Landspitalinn Univ Hosp, Dept Ophthalmol, Reykjavik, Iceland; [Attia, John; Holliday, Elizabeth G.] Univ Newcastle, Sch Med & Publ Hlth, Newcastle, NSW 2300, Australia; [Attia, John] John Hunter Hosp, Dept Med, Newcastle, NSW, Australia; [Attia, John] Hunter Med Res Inst, Newcastle, NSW, Australia; [Harrap, Stephen] Univ Melbourne, Dept Physiol, Melbourne, Australia; [Inouye, Michael] Walter & Eliza Hall Inst Med Res, Div Immunol, Parkville, Vic, Australia; [Inouye, Michael] Univ Melbourne, Dept Med Biol, Melbourne, Vic 3010, Australia; [Scott, Rodney J.] Univ Newcastle, Sch Biomed Sci, Newcastle, NSW 2300, Australia; [Viswanathan, Ananth] Moorfields Eye Hosp, NIHR, Biomed Res Ctr Ophthalmol, London, England; [Viswanathan, Ananth] UCL, Inst Ophthalmol, London, England; [Smith, Nicholas L.] Vet Affairs Off Res & Dev, Seattle Epidemiol Res & Informat Ctr, Seattle, WA USA; [Sun, Cong] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Young, Terri L.] Duke Univ, Med Ctr, Ctr Human Genet, Durham, NC USA; [Mackey, David A.] Univ Western Australia, Lions Eye Inst, Ctr Ophthalmol & Visual Sci, Perth, WA 6009, Australia; [van Zuydam, Natalie R.; Doney, Alex S. F.; Palmer, Colin N. A.; Morris, Andrew D.] Univ Dundee, Med Res Inst, Dundee, Scotland; [Tai, E. Shyong] Natl Univ Singapore, Dept Med, Singapore 117548, Singapore; [Tai, E. Shyong] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Tai, E. Shyong] Duke Natl Univ Singapore, Grad Sch Med, Singapore, Singapore; [Wong, Tien Y.] Natl Univ Singapore, Dept Ophthalmol, Singapore 117548, Singapore	University of Michigan System; University of Michigan; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; National University of Singapore; Singapore National Eye Center; Erasmus University Rotterdam; Erasmus MC; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Cedars Sinai Medical Center; QIMR Berghofer Medical Research Institute; Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne; Icelandic Heart Association; University of Iceland; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Sydney; University of Sydney; Westmead Institute for Medical Research; University of Wisconsin System; University of Wisconsin Madison; University of Washington; University of Washington Seattle; Boston University; University of Washington; University of Washington Seattle; University of Auckland; University of Washington; University of Washington Seattle; Group Health Cooperative; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); University of Amsterdam; Academic Medical Center Amsterdam; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Iceland; Landspitali National University Hospital; University of Newcastle; John Hunter Hospital; Hunter Medical Research Institute; University of Newcastle; University of Melbourne; Walter & Eliza Hall Institute; University of Melbourne; University of Newcastle; University of London; King's College London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Duke University; Lions Eye Institute; University of Western Australia; University of Dundee; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore	Wong, TY (corresponding author), Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore.	tien_yin_wong@nuhs.edu.sg	Hewitt, Alex W/D-1936-2013; Attia, John R/F-5376-2013; Smith, Albert Vernon/K-5150-2015; Rivadeneira, Fernando/O-5385-2015; Beckmann, Jacques S/A-9772-2008; Montgomery, Grant W/B-7148-2008; Meitinger, Thomas/O-1318-2015; Gudnason, Vilmundur/K-6885-2015; Aspelund, Thor/K-7022-2019; Colaus, PsyColaus/K-6607-2013; Aspelund, Thor/C-5983-2008; Newhouse, Stephen J/C-9330-2011; Altshuler, David M/A-4476-2009; Belllenguez, Céline/Y-3183-2018; Doney, Alexander SF/P-7437-2017; Dominiczak, Anna F/P-9390-2017; Wong, Tien Yin/AAC-9724-2020; Bochud, Murielle/A-3981-2010; Matullo, Giuseppe/K-6383-2016; Jonasson, Fridbert/ABA-9889-2021; Onland-Moret, N. Charlotte/G-9185-2011; Palmer, Colin NA/C-7053-2008; Study, GoDARTS/K-9448-2016; van der Schouw, Yvonne T./F-8327-2014; Pfeufer, Arne/B-6634-2013; Tai, E Shyong/J-9831-2013; Sim, Xueling/AAZ-6652-2020; Grobbee, Diederick/C-7651-2014; Martin, Nicholas/R-9235-2019; Scott, Rodney J/B-2827-2013; Uda, Manuela/AAC-2645-2019; wang, jie/GRS-0942-2022; Mackey, David A/H-5340-2014; Blackwell, Jenefer M/H-3015-2015; Gudnason, Vilmundur/AAE-7126-2019; Bellenguez, Céline/X-4004-2019; xie, jing/GRY-1689-2022; Mitchell, Paul/P-1498-2014; Rotter, Jerome/AAY-6598-2021; Wang, Jie Jin/P-1499-2014; Macgregor, Stuart/C-6442-2009; Luben, Robert/H-5519-2015	Hewitt, Alex W/0000-0002-5123-5999; Attia, John R/0000-0001-9800-1308; Smith, Albert Vernon/0000-0003-1942-5845; Rivadeneira, Fernando/0000-0001-9435-9441; Beckmann, Jacques S/0000-0002-9741-1900; Montgomery, Grant W/0000-0002-4140-8139; Gudnason, Vilmundur/0000-0001-5696-0084; Aspelund, Thor/0000-0002-7998-5433; Aspelund, Thor/0000-0002-7998-5433; Newhouse, Stephen J/0000-0002-1843-9842; Altshuler, David M/0000-0002-7250-4107; Belllenguez, Céline/0000-0002-1240-7874; Doney, Alexander SF/0000-0002-6210-5620; Dominiczak, Anna F/0000-0003-4913-3608; Wong, Tien Yin/0000-0002-8448-1264; Bochud, Murielle/0000-0002-5727-0218; Matullo, Giuseppe/0000-0003-0674-7757; Onland-Moret, N. Charlotte/0000-0002-2360-913X; Palmer, Colin NA/0000-0002-6415-6560; van der Schouw, Yvonne T./0000-0002-4605-435X; Sim, Xueling/0000-0002-1233-7642; Grobbee, Diederick/0000-0003-4472-4468; Martin, Nicholas/0000-0003-4069-8020; Scott, Rodney J/0000-0001-7724-3404; Uda, Manuela/0000-0002-4890-6456; Mackey, David A/0000-0001-7914-4709; Gudnason, Vilmundur/0000-0001-5696-0084; Bellenguez, Céline/0000-0002-1240-7874; Wang, Jie Jin/0000-0001-9491-4898; Macgregor, Stuart/0000-0001-6731-8142; Inouye, Michael/0000-0001-9413-6520; Tai, E Shyong/0000-0003-2929-8966; Sacerdote, Carlotta/0000-0002-8008-5096; Meitinger, Thomas/0000-0002-8838-8403; Seedorf, Udo/0000-0003-4652-5358; Dorr, Marcus/0000-0001-7471-475X; Cotch, Mary Frances/0000-0002-2046-4350; Melander, Olle/0000-0002-2581-484X; Ikram, Mohammad Kamran/0000-0003-0173-9571; Org, Elin/0000-0001-8688-9717; Marrugat, Jaume/0000-0003-3320-554X; Van Duijn, Cornelia/0000-0002-2374-9204; Klein, Ronald/0000-0002-4428-6237; Wain, Louise/0000-0003-4951-1867; Baird, Paul/0000-0002-1305-3502; Plomin, Robert/0000-0002-0756-3629; Munroe, Patricia/0000-0002-4176-2947; Lakatta, Edward/0000-0002-4772-0035; /0000-0001-6694-3587; Forouhi, Nita/0000-0002-5041-248X; Luben, Robert/0000-0002-5088-6343; Glazer, Nicole/0000-0002-6397-609X; Harrap, Stephen/0000-0003-2907-6714; Org, Elin/0000-0003-1451-9375; Zeggini, Eleftheria/0000-0003-4238-659X; Gillman, Matthew S./0000-0002-2340-6930	National Institute on Aging [ZIAAG007380]; National Institutes of Health (NIH) [N01-AG-12100]; National Eye Institute at the NIH in the United States [ZIAEY000401]; Hjartavernd (the Icelandic Heart Association); Althingi (the Icelandic Parliament); National Heart, Lung, and Blood Institute c [HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C, R01HL087641, R01HL59367, R01HL086694]; National Human Genome Research Institute [U01HG004402]; National Institutes of Health [HHSN268200625226C, UL1RR025005]; NIH Roadmap for Medical Research; National Heart, Lung, and Blood Institute (NHLBI) [N01-HC-85239, N01-HC-85079, N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, N01-HC45133, HL075366, HL080295, HL087652]; National Institute on Aging (NIA) [AG-023269, AG-15928, AG-20098,, AG-027058]; National Center for Research Resources [M01-RR00425]; National Institute of Diabetes and Digestive and Kidney Diseases [DK063491]; Cedars-Sinai Board of Governors' Chair in Medical Genetics; National Heart, Lung, and Blood Institute [T32HL007902]; Netherlands Organization of Scientific Research NWO [175.010.2005.011]; Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO) [050-060-810]; Erasmus Medical Center and Erasmus University, Rotterdam; Netherlands Organization for scientific research (NWO); Netherlands Organization for the Health Research and Development (ZonMw); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture, and Science; Ministry for Health, Welfare, and Sports; European commission (DG XII); Municipality of Rotterdam; Lijf en Leven, Krimpen a/d Lek; MD Fonds, Utrecht. Oogfonds Nederland, Utrecht; Stichting Nederlands Oogheelkundig Onderzoek, Nijmegen/Rotterdam; Swart van Essen, Rotterdam; Netherlands Organisation for Scientific Research (NWO); Bevordering van Volkskracht, Rotterdam; Blindenhulp, The Hague; Rotterdamse Vereniging Blindenbelangen, Rotterdam; OOG, The Hague; Algemene Nederlandse Vereniging ter Voorkoming van Blindheid, Doorn; Blinden-Penning, Amsterdam; Blindenhulp, Gravenzande; Henkes Stichting, Rotterdam; Topcon Europe BV, Capelle aan de IJssel; Medical Workshop BV, Groningen; Australian National Health & Medical Research Council, Canberra Australia [974159, 211069, 457349, 512423, 475604, 529912]; Wellcome Trust, UK as part of Wellcome Trust Case Control Consortium 2; BMES [085475/B/08/Z, 085475/08/Z]; National Institutes of Health Research (NIHR) Biomedical Research Centre for Ophthalmology; Moorfields Eye Hospital; UCL Institute of Ophthalmology, London, UK; Australian National Health and Medical Research Council (NHMRC); Clifford Craig Medical Research Trust; Ophthalmic Research Institute of Australia (ORIA); Glaucoma Australia; American Health Assistance Foundation (AHAF); Peggy and Leslie Cranbourne Foundation; Foundation for Children; NHMRC; Jack Brockhoff Foundation; NEI; NIH/National Eye Institute (NEI) [1RO1EY018246]; Netherlands Scientific Organization [NWO 480-05-003]; National Heart, Lung, and Blood Institute (NHLBI); MESA; NHLBI [N02-HL-6-4278];  [N01 HC-95159];  [N01-HC-95160];  [N01-HC-95161];  [N01-HC-95162];  [N01-HC-95163];  [N01-HC-95164];  [N01-HC-95165];  [N01-HC-95166];  [N01-HC-95167];  [N01-HC-95168];  [N01-HC-95169];  [RR-024156]; Medical Research Council [G0801056, G0401527, G1000143] Funding Source: researchfish; MRC [G0801056] Funding Source: UKRI; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095166, N01HC085083, N01HC075150, N01HC045133, N01HC055222, N01HC095167, N01HC095163, N01HC095159, N01HC085082, N01HC035129, N01HC095165, N01HC085079, N01HC085080, N01HC085086, N01HC085085, N01HC095164, N01HC095168, N01HC095160, N01HC085081, N01HC095162, N01HC085084, N01HC015103, N01HC095169, N01HC095161] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000425, UL1RR025005, UL1RR024156] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [ZIAEY000401, ZIAEY000403, ZIAEY000426, R01EY018246] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085251, R01HL073410, R01HL064278, R01HL087641, U01HL080295, R01HL075366, R01HL086694, R01HL059367, R01HL105756, R01HL080295, T32HL007902, R01HL087652] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004402, ZIAHG000024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG006000, R01AG020098, R01AG027058, ZIAAG007380, R01AG015928, R56AG020098, N01AG012100] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Eye Institute at the NIH in the United States; Hjartavernd (the Icelandic Heart Association); Althingi (the Icelandic Parliament); National Heart, Lung, and Blood Institute c; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Cedars-Sinai Board of Governors' Chair in Medical Genetics; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Netherlands Organization of Scientific Research NWO(Netherlands Organization for Scientific Research (NWO)); Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)Netherlands Government); Erasmus Medical Center and Erasmus University, Rotterdam; Netherlands Organization for scientific research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for the Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture, and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry for Health, Welfare, and Sports; European commission (DG XII)(European CommissionEuropean Commission Joint Research Centre); Municipality of Rotterdam; Lijf en Leven, Krimpen a/d Lek; MD Fonds, Utrecht. Oogfonds Nederland, Utrecht; Stichting Nederlands Oogheelkundig Onderzoek, Nijmegen/Rotterdam; Swart van Essen, Rotterdam; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Bevordering van Volkskracht, Rotterdam; Blindenhulp, The Hague; Rotterdamse Vereniging Blindenbelangen, Rotterdam; OOG, The Hague; Algemene Nederlandse Vereniging ter Voorkoming van Blindheid, Doorn; Blinden-Penning, Amsterdam; Blindenhulp, Gravenzande; Henkes Stichting, Rotterdam; Topcon Europe BV, Capelle aan de IJssel; Medical Workshop BV, Groningen; Australian National Health & Medical Research Council, Canberra Australia(National Health and Medical Research Council (NHMRC) of Australia); Wellcome Trust, UK as part of Wellcome Trust Case Control Consortium 2(Wellcome Trust); BMES; National Institutes of Health Research (NIHR) Biomedical Research Centre for Ophthalmology(National Institute for Health Research (NIHR)); Moorfields Eye Hospital; UCL Institute of Ophthalmology, London, UK; Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Clifford Craig Medical Research Trust; Ophthalmic Research Institute of Australia (ORIA); Glaucoma Australia; American Health Assistance Foundation (AHAF); Peggy and Leslie Cranbourne Foundation; Foundation for Children; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Jack Brockhoff Foundation; NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIH/National Eye Institute (NEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Netherlands Scientific Organization; National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); MESA; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ; ; ; ; ; ; ; ; ; ; ; ; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by multiple funding agencies and details for each cohort were given below. The Age, Gene/Environment Susceptibility - Reykjavik Study was funded by the Intramural Research Program of the National Institute on Aging (ZIAAG007380, National Institutes of Health (NIH) contract N01-AG-12100); and the National Eye Institute (ZIAEY000401) at the NIH in the United States; Hjartavernd (the Icelandic Heart Association); and the Althingi (the Icelandic Parliament). The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C), R01HL087641, R01HL59367 and R01HL086694; National Human Genome Research Institute contract U01HG004402; and National Institutes of Health contract HHSN268200625226C. Infrastructure was partly supported by Grant Number UL1RR025005, a component of the National Institutes of Health and NIH Roadmap for Medical Research. The Cardiovascular Health Study research reported in this article was supported by the National Heart, Lung, and Blood Institute (NHLBI) contracts N01-HC-85239, N01-HC-85079 through N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, N01-HC45133, and grants HL075366, HL080295, HL087652, with additional contribution from the National Institute of Neurological Disorders and Stroke (NINDS). This research was also supported by the National Institute on Aging (NIA) contracts AG-023269, AG-15928, AG-20098, and AG-027058. A full list of principal CHS investigators and institutions can be found at http://www.chs-nhlbi.org/pi.htm. DNA handling and genotyping was supported in part by National Center for Research Resources grant M01-RR00425 to the Cedars-Sinai General Clinical Research Center Genotyping core and National Institute of Diabetes and Digestive and Kidney Diseases grant DK063491 to the Southern California Diabetes Endocrinology Research Center. Additional funding came from the Cedars-Sinai Board of Governors' Chair in Medical Genetics (JIR) and the National Heart, Lung, and Blood Institute Training Grant T32HL007902 (RAJ). The GWA database of the Rotterdam Study was funded through the Netherlands Organization of Scientific Research NWO (no. 175.010.2005.011). This study was further supported by the Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO) project nr. 050-060-810. The Rotterdam Study is supported by the Erasmus Medical Center and Erasmus University, Rotterdam; the Netherlands Organization for scientific research (NWO); the Netherlands Organization for the Health Research and Development (ZonMw); The Research Institute for Diseases in the Elderly (RIDE); the Ministry of Education, Culture, and Science; the Ministry for Health, Welfare, and Sports; The European commission (DG XII); and the Municipality of Rotterdam. The ophthalmic part of the Rotterdam Study was supported by Lijf en Leven, Krimpen a/d Lek; MD Fonds, Utrecht.; Oogfonds Nederland, Utrecht; Stichting Nederlands Oogheelkundig Onderzoek, Nijmegen/Rotterdam; Swart van Essen, Rotterdam; Netherlands Organisation for Scientific Research (NWO); Bevordering van Volkskracht, Rotterdam; Blindenhulp, The Hague; Rotterdamse Vereniging Blindenbelangen, Rotterdam; OOG, The Hague; Algemene Nederlandse Vereniging ter Voorkoming van Blindheid, Doorn; Blinden-Penning, Amsterdam; Blindenhulp, Gravenzande; Henkes Stichting, Rotterdam; Topcon Europe BV, Capelle aan de IJssel; Medical Workshop BV, Groningen; all in the Netherlands; Heidelberg Engineering, Dossenheim, Germany. The Blue Mountains Eye Study has been supported by the Australian National Health & Medical Research Council, Canberra Australia (Grant Numbers 974159, 211069, 457349, 512423, 475604, 529912, and the funding for Centre for Clinical Research Excellence in Translational Clinical Research in Eye Diseases, CCRE in TCR-Eye); In addition, funding by the Wellcome Trust, UK as part of Wellcome Trust Case Control Consortium 2 (A Viswanathan, P McGuffin, P Mitchell, F Topouzis, P Foster) has supported the genotyping costs of the entire BMES population (Grant numbers 085475/B/08/Z and 085475/08/Z). We also acknowledge the funding body National Institutes of Health Research (NIHR) Biomedical Research Centre for Ophthalmology, Moorfields Eye Hospital and UCL Institute of Ophthalmology, London, UK. The Australian Twin Registry is supported by an Australian National Health and Medical Research Council (NHMRC) Enabling Grant (2004-2009). We also thank the following organisations for their financial support: Clifford Craig Medical Research Trust, Ophthalmic Research Institute of Australia (ORIA), Glaucoma Australia, American Health Assistance Foundation (AHAF), Peggy and Leslie Cranbourne Foundation, Foundation for Children, NHMRC project grant (2005-2007), Jack Brockhoff Foundation, NEI Project Grant (2007-2010). Genotyping for part of the Australian sample was funded by an NHMRC Medical Genomics Grant. Genotyping for the remainder was performed by the NIH Center for Inherited Research (CIDR) as part of an NIH/National Eye Institute (NEI) grant 1RO1EY018246, Principal Investigator Terri L Young and we are grateful to Dr Camilla Day and staff. Australian sample imputation analyses were carried out on the Genetic Cluster Computer, which is financially supported by the Netherlands Scientific Organization (NWO 480-05-003). The Multi-Ethnic Study of Atherosclerosis (MESA) and MESA SNP Health Association Resource (SHARe) are conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with MESA investigators. MESA and the MESA SHARe project are conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with MESA investigators. Support is provided by grants and contracts N01 HC-95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168, N01-HC-95169 and RR-024156. Funding for SHARe genotyping was provided by NHLBI Contract N02-HL-6-4278. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aulchenko YS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-134; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Boeckel JN, 2011, P NATL ACAD SCI USA, V108, P3276, DOI 10.1073/pnas.1008098108; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; de Jong FJ, 2007, ANN NEUROL, V61, P491, DOI 10.1002/ana.21129; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Han JH, 2000, TRENDS CARDIOVAS MED, V10, P19, DOI 10.1016/S1050-1738(00)00039-6; Harris TB, 2007, AM J EPIDEMIOL, V165, P1076, DOI 10.1093/aje/kwk115; Hennebry A, 2009, AM J PHYSIOL-CELL PH, V296, pC525, DOI 10.1152/ajpcell.00259.2007; Hofman A, 2009, EUR J EPIDEMIOL, V24, P553, DOI 10.1007/s10654-009-9386-z; Hubbard LD, 1999, OPHTHALMOLOGY, V106, P2269, DOI 10.1016/S0161-6420(99)90525-0; Ikram MK, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001184; Ikram MK, 2006, HYPERTENSION, V47, P189, DOI 10.1161/01.HYP.0000199104.61945.33; Ikram MK, 2006, BRAIN, V129, P182, DOI 10.1093/brain/awh688; Ikram MK, 2004, INVEST OPHTH VIS SCI, V45, P2129, DOI 10.1167/iovs.03-1390; Kawasaki R, 2009, J HYPERTENS, V27, P2386, DOI 10.1097/HJH.0b013e3283310f7e; Kifley A, 2008, MICROCIRCULATION, V15, P373, DOI 10.1080/10739680701812220; Kifley A, 2007, AM J OPHTHALMOL, V143, P1024, DOI 10.1016/j.ajo.2007.01.034; Klein R, 2006, OPHTHALMOLOGY, V113, P373, DOI 10.1016/j.ophtha.2005.12.013; Klungel OH, 2001, ARCH INTERN MED, V161, P37, DOI 10.1001/archinte.161.1.37; Knudtson MD, 2003, CURR EYE RES, V27, P143, DOI 10.1076/ceyr.27.3.143.16049; Liew G, 2007, ARCH OPHTHALMOL-CHIC, V125, P813, DOI 10.1001/archopht.125.6.813; Liew G, 2006, HYPERTENSION, V48, pE10, DOI 10.1161/01.HYP.0000231652.97173.4c; Lin Q, 1997, SCIENCE, V276, P1404, DOI 10.1126/science.276.5317.1404; Longstreth WT, 2007, AM J EPIDEMIOL, V165, P78, DOI 10.1093/aje/kwj350; Mackey DA, 2009, TWIN RES HUM GENET, V12, P441, DOI 10.1375/twin.12.5.441; McGeechan K, 2009, AM J EPIDEMIOL, V170, P1323, DOI 10.1093/aje/kwp306; McGeechan K, 2009, ANN INTERN MED, V151, P404, DOI 10.7326/0003-4819-151-6-200909150-00005; MITCHELL P, 1995, OPHTHALMOLOGY, V102, P1450; Morris AD, 1997, BMJ-BRIT MED J, V315, P524, DOI 10.1136/bmj.315.7107.524; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Nguyen TT, 2008, DIABETES CARE, V31, P544, DOI 10.2337/dc07-1528; PSATY BM, 1995, JAMA-J AM MED ASSOC, V274, P620, DOI 10.1001/jama.274.8.620; Psaty BM, 2009, CIRC-CARDIOVASC GENE, V2, P73, DOI 10.1161/CIRCGENETICS.108.829747; Qiu CX, 2008, DIABETES, V57, P1645, DOI 10.2337/db07-1455; Rivadeneira F, 2009, NAT GENET, V41, P1199, DOI 10.1038/ng.446; Sasongko MB, 2011, DIABETOLOGIA; Sasongko MB, 2010, MICROCIRCULATION, V17, P21, DOI 10.1111/j.1549-8719.2009.00007.x; Smith W, 2004, HYPERTENSION, V44, P442, DOI 10.1161/01.HYP.0000140772.40322.ec; Sun C, 2009, HYPERTENSION, V54, P788, DOI 10.1161/HYPERTENSIONAHA.109.132902; Sun C, 2009, HYPERTENSION, V53, P487, DOI 10.1161/HYPERTENSIONAHA.108.125914; Taarnhoj NCBB, 2006, INVEST OPHTH VIS SCI, V47, P3539, DOI 10.1167/iovs.05-1372; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Wang JJ, 2006, HEART, V92, P1583, DOI 10.1136/hrt.2006.090522; Wang JJ, 2008, AM J EPIDEMIOL, V168, P80, DOI 10.1093/aje/kwn100; Wang JJ, 2007, EUR HEART J, V28, P1984, DOI 10.1093/eurheartj/ehm221; Wang JJ, 2006, HYPERTENSION, V47, P644, DOI 10.1161/01.HYP.0000208303.74884.78; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Wong TY, 2006, INVEST OPHTH VIS SCI, V47, P2341, DOI 10.1167/iovs.05-1539; Wong TY, 2004, BMJ-BRIT MED J, V329, P79, DOI 10.1136/bmj.38124.682523.55; Wong TY, 2004, OPHTHALMOLOGY, V111, P1183, DOI 10.1016/j.ophtha.2003.09.039; Wong TY, 2004, ANN INTERN MED, V140, P248, DOI 10.7326/0003-4819-140-4-200402170-00006; Wong TY, 2003, OPHTHALMOLOGY, V110, P658, DOI 10.1016/S0161-6420(02)01931-0; Wong TY, 2002, JAMA-J AM MED ASSOC, V287, P2528, DOI 10.1001/jama.287.19.2528; Wong TY, 2001, SURV OPHTHALMOL, V46, P59, DOI 10.1016/S0039-6257(01)00234-X; Xing C, 2006, HYPERTENSION, V47, P797, DOI 10.1161/01.HYP.0000208330.68355.72; Xu J, 2006, J BIOL CHEM, V281, P9152, DOI 10.1074/jbc.M510217200; Zhang C, 2011, DIABETOLOGIA, V54, P1491, DOI 10.1007/s00125-011-2079-7	60	18	18	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65804	10.1371/journal.pone.0065804	http://dx.doi.org/10.1371/journal.pone.0065804			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776548	Green Submitted, Green Published, gold			2022-12-27	WOS:000320322400057
J	Joyner-Matos, J; Hicks, KA; Cousins, D; Keller, M; Denver, DR; Baer, CF; Estes, S				Joyner-Matos, Joanna; Hicks, Kiley A.; Cousins, Dustin; Keller, Michelle; Denver, Dee R.; Baer, Charles F.; Estes, Suzanne			Evolution of a Higher Intracellular Oxidizing Environment in Caenorhabditis elegans under Relaxed Selection	PLOS ONE			English	Article							BASE-SUBSTITUTION MUTATION; OXIDATIVE DNA-DAMAGE; GENOME-WIDE VIEW; LIFE-SPAN; SOMATIC MOSAICISM; NATURAL VARIATION; PROTEIN CARBONYL; C-ELEGANS; ACCUMULATION; STRESS	We explored the relationship between relaxed selection, oxidative stress, and spontaneous mutation in a set of mutation-accumulation (MA) lines of the nematode Caenorhabditis elegans and in their common ancestor. We measured steady-state levels of free radicals and oxidatively damaged guanosine nucleosides in the somatic tissues of five MA lines for which nuclear genome base substitution and GC-TA transversion frequencies are known. The two markers of oxidative stress are highly correlated and are elevated in the MA lines relative to the ancestor; point estimates of the per-generation rate of mutational decay (DM) of these measures of oxidative stress are similar to those reported for fitness-related traits. Conversely, there is no significant relationship between either marker of oxidative stress and the per-generation frequencies of base substitution or GC-TA transversion. Although these results provide no direct evidence for a causative relationship between oxidative damage and base substitution mutations, to the extent that oxidative damage may be weakly mutagenic in the germline, the case for condition-dependent mutation is advanced.	[Joyner-Matos, Joanna; Cousins, Dustin; Keller, Michelle] Eastern Washington Univ, Dept Biol, Cheney, WA 99004 USA; [Hicks, Kiley A.; Estes, Suzanne] Portland State Univ, Dept Biol, Portland, OR 97207 USA; [Denver, Dee R.] Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA; [Denver, Dee R.] Oregon State Univ, Ctr Genome Res & Biocomp, Corvallis, OR 97331 USA; [Baer, Charles F.] Univ Florida, Dept Biol, Gainesville, FL USA; [Baer, Charles F.] Univ Florida, Genet Inst, Gainesville, FL USA	Eastern Washington University; Portland State University; Oregon State University; Oregon State University; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Joyner-Matos, J (corresponding author), Eastern Washington Univ, Dept Biol, Cheney, WA 99004 USA.	jmatos@ewu.edu		Joyner-Matos, Joanna/0000-0002-0289-5982	Eastern Washington University; National Institutes of Health [R01 GM072639, 5 R01 GM087628-02]; PSU Faculty Enhancement grant; American Heart Association [11PRE4880069]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087628, R01GM072639] Funding Source: NIH RePORTER	Eastern Washington University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PSU Faculty Enhancement grant; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by an Eastern Washington University Start Something Big Grant to JJM (http://sites.ewu.edu/foundation/resources/start-something-big-grant/); National Institutes of Health (http://www.nih.gov/) grant R01 GM072639 to CFB and DRD, National Institutes of Health grant 5 R01 GM087628-02 to DRD and SE; PSU Faculty Enhancement grant to SE (http://www.pdx.edu/oaa/faculty-enhancement-grants) and American Heart Association Predoctoral Fellowship 11PRE4880069 to KAH (http://my.americanheart. org/professional/Research/FundingOpportunities/Funding-Opportunities_UCM_316909_SubHomePage.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi H, 1998, J GERONTOL A-BIOL, V53, pB240, DOI 10.1093/gerona/53A.4.B240; Agrawal AF, 2008, PLOS BIOL, V6, P389, DOI 10.1371/journal.pbio.0060030; Aitlhadj L, 2010, MECH AGEING DEV, V131, P364, DOI 10.1016/j.mad.2010.03.002; Arczewska KD, 2011, DNA REPAIR, V10, P176, DOI 10.1016/j.dnarep.2010.10.009; Baer CF, 2005, P NATL ACAD SCI USA, V102, P5785, DOI 10.1073/pnas.0406056102; Baer CF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008750; Berquist BR, 2012, CANCER LETT, V327, P61, DOI 10.1016/j.canlet.2012.02.001; Busuttil RA, 2005, CANCER RES, V65, P11271, DOI 10.1158/0008-5472.CAN-05-2980; Busuttil RA, 2003, AGING CELL, V2, P287, DOI 10.1046/j.1474-9728.2003.00066.x; Busuttil RA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000876; Cardoso AR, 2012, FREE RADICAL BIO MED, V52, P2201, DOI 10.1016/j.freeradbiomed.2012.03.008; CHENG KC, 1992, J BIOL CHEM, V267, P166; Cooke MS, 2007, P NATL ACAD SCI USA, V104, P13535, DOI 10.1073/pnas.0706878104; Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev; DARR D, 1995, FREE RADICAL BIO MED, V18, P195, DOI 10.1016/0891-5849(94)00118-4; Davies SK, 2012, MECH AGEING DEV, V133, P46, DOI 10.1016/j.mad.2011.11.002; Delsite RL, 2003, MUTAGENESIS, V18, P497, DOI 10.1093/mutage/geg027; DEMPLE B, 1994, ANNU REV BIOCHEM, V63, P915, DOI 10.1146/annurev.biochem.63.1.915; Denver DR, 2006, GENETICS, V174, P57, DOI 10.1534/genetics.106.059840; Denver DR, 2012, GENOME BIOL EVOL, V4, P513, DOI 10.1093/gbe/evs028; Denver DR, 2009, P NATL ACAD SCI USA, V106, P16310, DOI 10.1073/pnas.0904895106; Denver DR, 2005, GENETICS, V170, P107, DOI 10.1534/genetics.104.038521; Denver DR, 2003, MOL BIOL EVOL, V20, P1603, DOI 10.1093/molbev/msg177; Dingley S, 2010, MITOCHONDRION, V10, P125, DOI 10.1016/j.mito.2009.11.003; Dolle MET, 2000, P NATL ACAD SCI USA, V97, P8403, DOI 10.1073/pnas.97.15.8403; Drake JW, 1998, GENETICS, V148, P1667; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Estes S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-11; Fortune MT, 2000, HUM MOL GENET, V9, P439, DOI 10.1093/hmg/9.3.439; GANDHI S, 1980, MECH AGEING DEV, V12, P137, DOI 10.1016/0047-6374(80)90090-1; Garcia AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000950; GILLE JJP, 1994, CARCINOGENESIS, V15, P2695, DOI 10.1093/carcin/15.12.2695; Halligan DL, 2009, ANNU REV ECOL EVOL S, V40, P151, DOI 10.1146/annurev.ecolsys.39.110707.173437; Halliwell B., 2007, FREE RADICALS BIOL M; Hartman P, 2004, MECH AGEING DEV, V125, P417, DOI 10.1016/j.mad.2004.02.007; Helbock HJ, 1998, P NATL ACAD SCI USA, V95, P288, DOI 10.1073/pnas.95.1.288; Hicks KA, 2010, PLOS ONE, V7; Hicks KA, 2013, MITOCHONDRION, V13, P44, DOI 10.1016/j.mito.2012.12.006; Hill KA, 2005, ENVIRON MOL MUTAGEN, V45, P442, DOI 10.1002/em.20119; HSIE AW, 1986, P NATL ACAD SCI USA, V83, P9616, DOI 10.1073/pnas.83.24.9616; Ishii N, 2004, MECH AGEING DEV, V125, P41, DOI 10.1016/j.mad.2003.10.002; ISHII N, 1990, MUTAT RES, V237, P165, DOI 10.1016/0921-8734(90)90022-J; Ishii N, 1998, NATURE, V394, P694, DOI 10.1038/29331; ISHIZAWA M, 1991, NUCLEIC ACIDS RES, V19, P5792, DOI 10.1093/nar/19.20.5792; Jeffreys AJ, 1997, HUM MOL GENET, V6, P129, DOI 10.1093/hmg/6.1.129; Keightley PD, 1997, P NATL ACAD SCI USA, V94, P3823, DOI 10.1073/pnas.94.8.3823; Kim SY, 2010, EVOLUTION, V64, P852, DOI 10.1111/j.1558-5646.2009.00862.x; KIMURA M, 1962, GENETICS, V47, P713; KONDRASHOV AS, 1994, P ROY SOC B-BIOL SCI, V258, P221, DOI 10.1098/rspb.1994.0166; Kondrashov FA, 2006, J THEOR BIOL, V240, P616, DOI 10.1016/j.jtbi.2005.10.020; Lynch M, 2008, P NATL ACAD SCI USA, V105, P9272, DOI 10.1073/pnas.0803466105; Lynch M, 2010, TRENDS GENET, V26, P345, DOI 10.1016/j.tig.2010.05.003; MAKI H, 1992, NATURE, V355, P273, DOI 10.1038/355273a0; MARTIN AP, 1993, P NATL ACAD SCI USA, V90, P4087, DOI 10.1073/pnas.90.9.4087; Martorell L, 2000, EUR J HUM GENET, V8, P423, DOI 10.1038/sj.ejhg.5200478; Matsuba C, 2012, G3-GENES GENOM GENET, V2, P1497, DOI 10.1534/g3.112.003947; MITCHELL DH, 1979, J GERONTOL, V34, P28, DOI 10.1093/geronj/34.1.28; Noguera JC, 2011, BIOL LETT IN PRESS; Paul C, 2013, NAT REV URO IN PRESS; Roerink SF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002800; Rowe LA, 2003, FREE RADIC BIOL MED, V45, P1167; Sharp NP, 2012, P NATL ACAD SCI USA, V109, P6142, DOI 10.1073/pnas.1118918109; Stiernagle T, 1999, PRACT APPROACH SER, V213, P51; Stoltzfus A, 2008, MUTAT RES-FUND MOL M, V644, P71, DOI 10.1016/j.mrfmmm.2008.05.003; TKESHELASHVILI LK, 1991, J BIOL CHEM, V266, P6401; Tudek B, 2003, J BIOCHEM MOL BIOL, V36, P12; Uehara Y, 2009, MUTAT RES-FUND MOL M, V670, P24, DOI 10.1016/j.mrfmmm.2009.06.018; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Yasuda K, 1999, J GERONTOL A-BIOL, V54, pB47, DOI 10.1093/gerona/54.2.B47; Yasuda K, 2006, MECH AGEING DEV, V127, P763, DOI 10.1016/j.mad.2006.07.002; Zielonka J, 2010, FREE RADICAL BIO MED, V48, P983, DOI 10.1016/j.freeradbiomed.2010.01.028	71	5	5	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65604	10.1371/journal.pone.0065604	http://dx.doi.org/10.1371/journal.pone.0065604			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776511	Green Published, gold, Green Submitted			2022-12-27	WOS:000320755400048
J	Li, YQ; Qin, YG; Yang, N; Sun, YF; Yang, XL; Sun, RF; Wang, QM; Ling, Y				Li, Yongqiang; Qin, Yaoguo; Yang, Na; Sun, Yufeng; Yang, Xinling; Sun, Ranfeng; Wang, Qingmin; Ling, Yun			Studies on Insecticidal Activities and Action Mechanism of Novel Benzoylphenylurea Candidate NK-17	PLOS ONE			English	Article							SULFONYLUREA RECEPTOR; GROWTH-REGULATORS; INHIBITION; DESIGN; DIFLUBENZURON; BIOACTIVITY; PUPAE; MODE	Insecticidal activity of NK-17 was evaluated both in laboratory and in field. It was found that the toxicity of NK-17 against S. exigua was 1.93 times and 2.69 times those of hexaflumuron and chlorfluazuron respectively, and the toxicity of NK-17 against P. xylostella was 1.36 times and 1.90 times those of hexaflumuron and chlorfluazuron respectively, and the toxicity of NK-17 against M. separate was 18.24 times those of hexaflumuron in laboratory, and 5% NK-17 EC at 60 g a.i ha(-1) can control S. exigua and P. xylostella with the best control efficiency of about 89% and over 88% respectively in Changsha and Tianjin in field. The insecticidal mechanism of NK-17 was explored for the first time by utilizing the fluorescence polarization method. NK-17 could bind to sulfonylurea receptor (SUR) of B. germanica with stronger affinity comparing to diflubenzuron and glibenclamide, which suggested that NK-17 may also act on the site of SUR to inhibit the chitin synthesis in insect body and the result can well explain that NK-17 exhibited stronger toxicity against B. germanica than diflubenzuron and glibenclamide in vivo.	[Li, Yongqiang; Qin, Yaoguo; Sun, Yufeng; Yang, Xinling; Ling, Yun] China Agr Univ, Key Lab Pesticide Chem & Applicat, MOA, Dept Appl Chem,Coll Sci, Beijing 100094, Peoples R China; [Li, Yongqiang; Yang, Na; Sun, Ranfeng; Wang, Qingmin] Nankai Univ, Inst Elementoorgan Chem, State Key Lab Elementoorgan Chem, Tianjin 300071, Peoples R China	China Agricultural University; Nankai University	Wang, QM (corresponding author), Nankai Univ, Inst Elementoorgan Chem, State Key Lab Elementoorgan Chem, Tianjin 300071, Peoples R China.	wangqm@nankai.edu.cn; lyun@cau.edu.cn	Yang, xinling/HHC-1621-2022; Yang, Xinling/C-8289-2015		National Key Project for Basic Research [2010CB126100]; National Natural Science Foundation of China [21132003, 21102077, 21072109]; National 12th Five-year Key Technology RD Program [2011BAE06B08-04]	National Key Project for Basic Research(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 12th Five-year Key Technology RD Program	The authors greatly acknowledge financial support for this work from the National Key Project for Basic Research (2010CB126100) and the National Natural Science Foundation of China (21132003, 21102077, 21072109) and the National 12th Five-year Key Technology R&D Program (2011BAE06B08-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abo-Elghar GE, 2004, INSECT BIOCHEM MOLEC, V34, P743, DOI 10.1016/j.ibmb.2004.03.009; [Anonymous], 1925, J ECON ENTOMOL; Burke MA, 2008, CIRC RES, V102, P164, DOI 10.1161/CIRCRESAHA.107.165324; Chen L, 2005, J AGR FOOD CHEM, V53, P38, DOI 10.1021/jf048561n; Chen L, 2007, BIOORGAN MED CHEM, V15, P3678, DOI 10.1016/j.bmc.2007.03.049; Chen L, 2007, J AGR FOOD CHEM, V55, P2659, DOI 10.1021/jf063564g; COHEN E, 1980, PESTIC BIOCHEM PHYS, V13, P129, DOI 10.1016/0048-3575(80)90064-4; DELOACH JR, 1981, PESTIC BIOCHEM PHYS, V15, P172, DOI 10.1016/0048-3575(81)90083-3; FAO, 1979, FAO PLANT PROTECT B, V18, P6; Harris A, 2003, J BIOMOL SCREEN, V8, P410, DOI 10.1177/1087057103256319; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; Matsumura F, 2010, PESTIC BIOCHEM PHYS, V97, P133, DOI 10.1016/j.pestbp.2009.10.001; MAYER RT, 1981, EXPERIENTIA, V37, P337, DOI 10.1007/BF01959848; MEOLA SM, 1980, SCIENCE, V207, P985, DOI 10.1126/science.207.4434.985; Miki T, 2001, NAT NEUROSCI, V4, P507, DOI 10.1038/87455; Oberlander H, 1998, PESTIC SCI, V54, P300, DOI 10.1002/(SICI)1096-9063(1998110)54:3&lt;300::AID-PS830&gt;3.0.CO;2-8; POST LC, 1973, NATURWISSENSCHAFTEN, V60, P431, DOI 10.1007/BF00623561; Qian XH, 1999, J AGR FOOD CHEM, V47, P4415, DOI 10.1021/jf981174r; Qian XH, 2010, J AGR FOOD CHEM, V58, P2613, DOI 10.1021/jf904098w; Shang J, 2010, J AGR FOOD CHEM, V58, P1834, DOI 10.1021/jf903642s; Siegel S, 1988, NONPARAMETRIC STAT B, V2; Sun RF, 2011, J AGR FOOD CHEM, V59, P4851, DOI 10.1021/jf200395g; Sun RF, 2011, J AGR FOOD CHEM, V59, P2471, DOI 10.1021/jf104578j; Sun RF, 2009, J AGR FOOD CHEM, V57, P6356, DOI 10.1021/jf900882c; Sun RF, 2009, J AGR FOOD CHEM, V57, P3661, DOI 10.1021/jf900324a; Sun RF, 2008, J AGR FOOD CHEM, V56, P11376, DOI 10.1021/jf801901h; Sun YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032759; VANDAALEN JJ, 1972, NATURWISSENSCHAFTEN, V59, P312, DOI 10.1007/BF00593360; Xu XY, 2003, J FLUORINE CHEM, V121, P51, DOI 10.1016/S0022-1139(02)00330-5; Yang XL, 1998, PESTIC SCI, V52, P282, DOI 10.1002/(SICI)1096-9063(199803)52:3&lt;282::AID-PS723&gt;3.0.CO;2-J; Yoon C, 2008, J PESTIC SCI, V33, P44, DOI 10.1584/jpestics.G07-09; [No title captured]	32	13	14	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66251	10.1371/journal.pone.0066251	http://dx.doi.org/10.1371/journal.pone.0066251			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776644	Green Submitted, Green Published, gold			2022-12-27	WOS:000320755400126
J	Marttila, S; Jylhava, J; Nevalainen, T; Nykter, M; Jylha, M; Hervonen, A; Tserel, L; Peterson, P; Hurme, M				Marttila, Saara; Jylhava, Juulia; Nevalainen, Tapio; Nykter, Matti; Jylha, Marja; Hervonen, Antti; Tserel, Liina; Peterson, Part; Hurme, Mikko			Transcriptional Analysis Reveals Gender-Specific Changes in the Aging of the Human Immune System	PLOS ONE			English	Article							SEXUAL-DIMORPHISM; AGE; EXPRESSION	Aging and gender have a strong influence on the functional capacity of the immune system. In general, the immune response in females is stronger than that in males, but there is scant information about the effect of aging on the gender difference in the immune response. To address this question, we performed a transcriptomic analysis of peripheral blood mononuclear cells derived from elderly individuals (nonagenarians, n = 146) and young controls (aged 19-30 years, n = 30). When compared to young controls, we found 339 and 248 genes that were differentially expressed (p < 0.05, fold change >1.5 or <-1.5) in nonagenarian females and males, respectively, 180 of these genes were changed in both genders. An analysis of the affected signaling pathways revealed a clear gender bias: there were 48 pathways that were significantly changed in females, while only 29 were changed in males. There were 24 pathways that were shared between both genders. Our results indicate that female nonagenarians have weaker T cell defenses and a more prominent pro-inflammatory response as compared to males. In males significantly fewer pathways were affected, two of which are known to be regulated by estrogen. These data show that the effects of aging on the human immune system are significantly different in males and females.	[Marttila, Saara; Jylhava, Juulia; Nevalainen, Tapio; Hurme, Mikko] Univ Tampere, Sch Med, Dept Microbiol & Immunol, FIN-33101 Tampere, Finland; [Marttila, Saara; Jylhava, Juulia; Nevalainen, Tapio; Jylha, Marja; Hervonen, Antti; Hurme, Mikko] Gerontol Res Ctr, Tampere, Finland; [Nykter, Matti] Univ Tampere, Inst Biomed Technol, FIN-33101 Tampere, Finland; [Jylha, Marja; Hervonen, Antti] Univ Tampere, Sch Hlth Sci, FIN-33101 Tampere, Finland; [Tserel, Liina; Peterson, Part] Univ Tartu, EE-50090 Tartu, Estonia; [Hurme, Mikko] Tampere Univ Hosp, Ctr Lab Med, Tampere, Finland	Tampere University; Tampere University; Tampere University; University of Tartu; Tampere University; Tampere University Hospital	Marttila, S (corresponding author), Univ Tampere, Sch Med, Dept Microbiol & Immunol, FIN-33101 Tampere, Finland.	saara.marttila@uta.fi	Peterson, Pärt/A-5788-2009	Peterson, Pärt/0000-0001-6755-791X; Jylhava, Juulia/0000-0003-0250-4491; Hurme, Mikko/0000-0002-8614-1044; Nykter, Matti/0000-0001-6956-2843; Marttila, Saara/0000-0003-3071-3784; Nevalainen, Tapio/0000-0003-1141-9854	Academy of Finland [132704]; Competitive Research Fund of Pirkanmaa Hospital District [9M017, 9N013]; European Regional Development Fund; Archimedes Foundation; Centre for Translational Genomics of Tartu University; Estonian targeted grant [SF0180021s07]	Academy of Finland(Academy of Finland); Competitive Research Fund of Pirkanmaa Hospital District; European Regional Development Fund(European Commission); Archimedes Foundation; Centre for Translational Genomics of Tartu University; Estonian targeted grant	This work was financially supported by grants from the Academy of Finland (132704) (http://www.aka.fi/eng), the Competitive Research Fund of Pirkanmaa Hospital District (9M017 and 9N013) (http://www.pshp.fi/default.aspx?nodeid = 10066&contentlan = 2) (MH), European Regional Development Fund (http://www.communities.gov.uk/regeneration/regenerationfunding/europeanregionaldevelopment/), Archimedes Foundation (http://archimedes.ee/), Centre for Translational Genomics of Tartu University (http://www.ctg.ut.ee/) and Estonian targeted grant SF0180021s07 (LT, PP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ademokun A, 2010, BIOGERONTOLOGY, V11, P125, DOI 10.1007/s10522-009-9256-9; Arnold CR, 2011, J CLIN IMMUNOL, V31, P137, DOI 10.1007/s10875-010-9499-x; Bianchi I, 2012, J AUTOIMMUN, V38, pJ187, DOI 10.1016/j.jaut.2011.11.012; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Brown DM, 2010, CELL IMMUNOL, V262, P89, DOI 10.1016/j.cellimm.2010.02.008; Cao JN, 2010, AGING CELL, V9, P19, DOI 10.1111/j.1474-9726.2009.00534.x; Coulthard LR, 2009, TRENDS MOL MED, V15, P369, DOI 10.1016/j.molmed.2009.06.005; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Dunning Mark J, 2008, BMC Res Notes, V1, P18, DOI 10.1186/1756-0500-1-18; Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016; Gangemi S, 2005, MEDIAT INFLAMM, P245, DOI 10.1155/MI.2005.245; Goebeler S, 2003, AGING CLIN EXP RES, V15, P154; Graves BM, 2006, AM J HUM BIOL, V18, P161, DOI 10.1002/ajhb.20488; Harries LW, 2011, AGING CELL, V10, P868, DOI 10.1111/j.1474-9726.2011.00726.x; Hewagama A, 2009, GENES IMMUN, V10, P509, DOI 10.1038/gene.2009.12; Hong MG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003024; Horstman AM, 2012, J GERONTOL A-BIOL, V67, P1140, DOI 10.1093/gerona/gls068; Jylhava J, 2010, BIOGERONTOLOGY, V11, P671, DOI 10.1007/s10522-010-9274-7; Kallio MA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-507; Kuparinen T, 2013, EXP GERONTOL, V48, P305, DOI 10.1016/j.exger.2012.12.010; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; McClelland EE, 2011, ARCH IMMUNOL THER EX, V59, P203, DOI 10.1007/s00005-011-0124-3; Mengel-From J, 2012, EUR J HUM GENET, V20, P361, DOI 10.1038/ejhg.2011.215; Nunn CL, 2009, PHILOS T R SOC B, V364, P61, DOI 10.1098/rstb.2008.0148; Passtoors WM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0027759; Pautz A, 2010, NITRIC OXIDE-BIOL CH, V23, P75, DOI 10.1016/j.niox.2010.04.007; Pawelec G, 2010, J COMP PATHOL, V141, pS39, DOI 10.1016/j.jcpa.2009.09.005; Schenk M, 2007, J CLIN INVEST, V117, P3097, DOI 10.1172/JCI30602; SMYTH GK, 2004, STAT APPL GENET MOL, V3; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Weigel MT, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3191; Zampieri M, 2010, MECH AGEING DEV, V131, P89, DOI 10.1016/j.mad.2009.12.005	32	43	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66229	10.1371/journal.pone.0066229	http://dx.doi.org/10.1371/journal.pone.0066229			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776639	Green Published, Green Submitted, gold			2022-12-27	WOS:000320755400124
J	Neu, C; Sedlag, A; Bayer, C; Forster, S; Crauwels, P; Niess, JH; van Zandbergen, G; Frascaroli, G; Riedel, CU				Neu, Caroline; Sedlag, Anne; Bayer, Carina; Foerster, Sabine; Crauwels, Peter; Niess, Jan-Hendrik; van Zandbergen, Ger; Frascaroli, Giada; Riedel, Christian U.			CD14-Dependent Monocyte Isolation Enhances Phagocytosis of Listeria monocytogenes by Proinflammatory, GM-CSF-Derived Macrophages	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; INTESTINAL MACROPHAGES; TYPE-2 MACROPHAGES; POLARIZATION; DIFFERENTIATION; CD14; CELLS; INFLAMMATION; EXPRESSION; INFECTION	Macrophages are an important line of defence against invading pathogens. Human macrophages derived by different methods were tested for their suitability as models to investigate Listeria monocytogenes (Lm) infection and compared to macrophage-like THP-1 cells. Human primary monocytes were isolated by either positive or negative immunomagnetic selection and differentiated in the presence of granulocyte macrophage colony-stimulating factor (GM-CSF) or macrophage colony-stimulating factor (M-CSF) into pro- or anti-inflammatory macrophages, respectively. Regardless of the isolation method, GM-CSF-derived macrophages (GM-M phi) stained positive for CD206 and M-CSF-derived macrophages (M-M phi) for CD163. THP-1 cells did not express CD206 or CD163 following incubation with PMA, M-or GM-CSF alone or in combination. Upon infection with Lm, all primary macrophages showed good survival at high multiplicities of infection whereas viability of THP-1 was severely reduced even at lower bacterial numbers. M-M phi generally showed high phagocytosis of Lm. Strikingly, phagocytosis of Lm by GM-M phi was markedly influenced by the method used for isolation of monocytes. GM-M phi derived from negatively isolated monocytes showed low phagocytosis of Lm whereas GM-M phi generated from positively selected monocytes displayed high phagocytosis of Lm. Moreover, incubation with CD14 antibody was sufficient to enhance phagocytosis of Lm by GM-M phi generated from negatively isolated monocytes. By contrast, non-specific phagocytosis of latex beads by GM-M phi was not influenced by treatment with CD14 antibody. Furthermore, phagocytosis of Lactococcus lactis, Escherichia coli, human cytomegalovirus and the protozoan parasite Leishmania major by GM-M phi was not enhanced upon treatment with CD14 antibody indicating that this effect is specific for Lm. Based on these observations, we propose macrophages derived by ex vivo differentiation of negatively selected human primary monocytes as the most suitable model to study Lm infection of macrophages.	[Neu, Caroline; Sedlag, Anne; Riedel, Christian U.] Univ Ulm, Inst Microbiol & Biotechnol, D-89069 Ulm, Germany; [Bayer, Carina; Frascaroli, Giada] Univ Med Ctr Ulm, Inst Virol, Ulm, Germany; [Foerster, Sabine; Crauwels, Peter; van Zandbergen, Ger] Fed Inst Vaccines & Biomed, Paul Ehrlich Inst, Div Immunol, Langen, Germany; [Niess, Jan-Hendrik] Inselspital Bern, Dept Visceral Med & Surg, CH-3010 Bern, Switzerland	Ulm University; Ulm University; Paul Ehrlich Institute; University of Bern; University Hospital of Bern	Riedel, CU (corresponding author), Univ Ulm, Inst Microbiol & Biotechnol, D-89069 Ulm, Germany.	christian.riedel@uni-ulm.de	Niess, Jan/E-8361-2017; van Zandbergen, Ger/M-1571-2013	Niess, Jan/0000-0001-6902-5650; Riedel, Christian U./0000-0001-7134-7085	Carl Zeiss Foundation in the "Programm zur 3 Starkung von Forschungsstrukturen an Universitaten	Carl Zeiss Foundation in the "Programm zur 3 Starkung von Forschungsstrukturen an Universitaten	This study was partially funded by a grant of the Carl Zeiss Foundation in the "Programm zur 3 Starkung von Forschungsstrukturen an Universitaten to GF, GvZ and CUR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Akagawa KS, 2002, INT J HEMATOL, V76, P27, DOI 10.1007/BF02982715; Akashi-Takamura S, 2008, CURR OPIN IMMUNOL, V20, P420, DOI 10.1016/j.coi.2008.07.001; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alberti-Segui C, 2007, CELL MICROBIOL, V9, P179, DOI 10.1111/j.1462-5822.2006.00780.x; Bayer C, 2013, J VIROL, V87, P67, DOI 10.1128/JVI.01585-12; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Cossart P, 2011, P NATL ACAD SCI USA, V108, P19484, DOI 10.1073/pnas.1112371108; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; Diget EA, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/208412; Edelson BT, 2000, CURR OPIN IMMUNOL, V12, P425, DOI 10.1016/S0952-7915(00)00112-6; Fleetwood AJ, 2007, J IMMUNOL, V178, P5245, DOI 10.4049/jimmunol.178.8.5245; GRIFFIN JD, 1981, J CLIN INVEST, V68, P932, DOI 10.1172/JCI110348; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; Hamon M, 2006, NAT REV MICROBIOL, V4, P423, DOI 10.1038/nrmicro1413; Hawley KL, 2012, P NATL ACAD SCI USA, V109, P1228, DOI 10.1073/pnas.1112078109; Janot L, 2008, J INFECT DIS, V198, P115, DOI 10.1086/588815; Jersmann HPA, 2005, IMMUNOL CELL BIOL, V83, P462, DOI 10.1111/j.1440-1711.2005.01370.x; Lacey DC, 2012, J IMMUNOL, V188, P5752, DOI 10.4049/jimmunol.1103426; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Mantovani A, 2005, IMMUNITY, V23, P344, DOI 10.1016/j.immuni.2005.10.001; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Miller JL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040017; Misslitz A, 2000, MOL BIOCHEM PARASIT, V107, P251, DOI 10.1016/S0166-6851(00)00195-X; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; MUNN DH, 1995, J EXP MED, V181, P127, DOI 10.1084/jem.181.1.127; Nathan C, 2006, SCIENCE, V312, P1874; Porcheray F, 2005, CLIN EXP IMMUNOL, V142, P481, DOI 10.1111/j.1365-2249.2005.02934.x; Schenk M, 2007, SEMIN IMMUNOL, V19, P84, DOI 10.1016/j.smim.2006.09.002; Schneemann M, 2002, NAT IMMUNOL, V3, P102, DOI 10.1038/ni0202-102a; SETOGUCHI M, 1989, BIOCHIM BIOPHYS ACTA, V1008, P213, DOI 10.1016/0167-4781(80)90012-3; Sierra-Filardi E, 2011, BLOOD, V117, P5092, DOI 10.1182/blood-2010-09-306993; Smith PD, 2011, MUCOSAL IMMUNOL, V4, P31, DOI 10.1038/mi.2010.66; Smith PD, 2005, IMMUNOL REV, V206, P149, DOI 10.1111/j.0105-2896.2005.00288.x; Smythies LE, 2005, J CLIN INVEST, V115, P66, DOI 10.1172/JCI200519229; TILNEY LG, 1989, J CELL BIOL, V109, P1597, DOI 10.1083/jcb.109.4.1597; Trofimov S, 2004, EUR J ENDOCRINOL, V150, P305, DOI 10.1530/eje.0.1500305; Vazquez-Boland JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001; Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101; Verreck FAW, 2006, J LEUKOCYTE BIOL, V79, P285, DOI 10.1189/jlb.0105015; Wenzel UA, 2012, FASEB J, V26, P29, DOI 10.1096/fj.11-184895; Wu MF, 2013, BLOOD, V121, P95, DOI 10.1182/blood-2012-05-430090; Xu W, 2013, MOL IMMUNOL, V53, P179, DOI 10.1016/j.molimm.2012.07.005; Zizzo G, 2012, J IMMUNOL, V189, P3508, DOI 10.4049/jimmunol.1200662	44	32	34	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66898	10.1371/journal.pone.0066898	http://dx.doi.org/10.1371/journal.pone.0066898			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776701	Green Published, gold, Green Submitted			2022-12-27	WOS:000320755400156
J	Jin, R; Yu, SY; Song, ZF; Zhu, XL; Wang, CP; Yan, JC; Wu, FS; Nanda, A; Granger, DN; Li, GH				Jin, Rong; Yu, Shiyong; Song, Zifang; Zhu, Xiaolei; Wang, Cuiping; Yan, Jinchuan; Wu, Fusheng; Nanda, Anil; Granger, D. Neil; Li, Guohong			Soluble CD40 Ligand Stimulates CD40-Dependent Activation of the beta 2 Integrin Mac-1 and Protein Kinase C Zeda (PKC zeta) in Neutrophils: Implications for Neutrophil-Platelet Interactions and Neutrophil Oxidative Burst	PLOS ONE			English	Article							NEOINTIMAL FORMATION; ADHESION MOLECULES; WALL INJURY; P-SELECTIN; EXPRESSION; INFLAMMATION; RESTENOSIS; HYPERPLASIA; RECRUITMENT; SURFACE	Recent work has revealed an essential involvement of soluble CD40L (sCD40L) in inflammation and vascular disease. Activated platelets are the major source of sCD40L, which has been implicated in platelet and leukocyte activation, although its exact functional impact on leukocyte-platelet interactions and the underlying mechanisms remain undefined. We aimed to determine the impact and the mechanisms of sCD40L on neutrophils. We studied neutrophil interactions with activated, surface-adherent platelets as a model for leukocyte recruitment to the sites of injury. Our data show that CD40L contributes to neutrophil firm adhesion to and transmigration across activated surface-adherent platelets, possibly through two potential mechanisms. One involves the direct interaction of ligand-receptor (CD40L-CD40), i.e., platelet surface CD40L interaction with neutrophil CD40; another involves an indirect mechanism, i.e. soluble CD40L stimulates activation of the leukocyte-specific beta 2 integrin Mac-1 in neutrophils and thereby further promotes neutrophil adhesion and migration. Activation of the integrin Mac-1 is known to be critical for mediating neutrophil adhesion and migration. sCD40L activated Mac-1 in neutrophils and enhanced neutrophil-platelet interactions in wild-type neutrophils, but failed to elicit such responses in CD40-deficient neutrophils. Furthermore, our data show that the protein kinase C zeta (PKC zeta) is critically required for sCD40L-induced Mac-1 activation and neutrophil adhesive function. sCD40L strongly stimulated the focal clustering of Mac-1 (CD11b) and the colocalization of Mac-1 with PKC zeta in wild-type neutrophils, but had minimal effect in CD40-deficient neutrophils. Blocking PKC zeta completely inhibited sCD40L-induced neutrophil firm adhesion. Moreover, sCD40L strongly stimulates neutrophil oxidative burst via CD40-dependent activation of PI3K/NF-KB, but independent of Mac-1 and PKC zeta. These findings may contribute to a better understanding of the underlying mechanisms by which sCD40L/CD40 pathway contributes to inflammation and vascular diseases.	[Jin, Rong; Yu, Shiyong; Song, Zifang; Zhu, Xiaolei; Wang, Cuiping; Nanda, Anil; Li, Guohong] Louisiana State Univ, Hlth Sci Ctr Shreveport, Dept Neurosurg, Vasc Biol & Stroke Res Lab, Shreveport, LA 71105 USA; [Granger, D. Neil; Li, Guohong] Louisiana State Univ, Hlth Sci Ctr Shreveport, Dept Physiol, Shreveport, LA 71105 USA; [Yu, Shiyong] Third Mil Med Univ, Xinqiao Hosp, Inst Cardiovasc Dis, Chongqing, Peoples R China; [Wang, Cuiping; Yan, Jinchuan] Jiangsu Univ, Affiliated Hosp, Dept Cardiol, Zhenjiang, Jiangsu, Peoples R China; [Wu, Fusheng] Zhejiang Univ, Affiliated Hosp 1, Dept Surg Oncol, Hangzhou 310003, Zhejiang, Peoples R China	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Army Medical University; Jiangsu University; Zhejiang University	Li, GH (corresponding author), Louisiana State Univ, Hlth Sci Ctr Shreveport, Dept Neurosurg, Vasc Biol & Stroke Res Lab, Shreveport, LA 71105 USA.	gli@lsuhsc.edu	Song, Zifang/AAA-8467-2022; Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454	NIH [HL087990, HL026441]; American Heart Association [0530166N]; National Natural Science Foundation of China [81272354]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087990, R01HL026441] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH grant HL087990 (GL) and by a scientist development grant (0530166N, GL) from the American Heart Association, and in part by NIH grant HL026441 (DNG) and by National Natural Science Foundation of China (81272354, FW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre P, 2002, CIRCULATION, V106, P896, DOI 10.1161/01.CIR.0000028962.04520.01; Andre P, 2002, NAT MED, V8, P247, DOI 10.1038/nm0302-247; Antoniades C, 2009, J AM COLL CARDIOL, V54, P669, DOI 10.1016/j.jacc.2009.03.076; Beland JL, 1998, BLOOD, V92, P4472, DOI 10.1182/blood.V92.11.4472.423k47_4472_4478; Bienvenu JG, 2001, J VASC RES, V38, P153, DOI 10.1159/000051042; Chakrabarti S, 2008, MICROCIRCULATION, V15, P555, DOI 10.1080/10739680801949732; Davidson DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051793; Diacovo TG, 1996, BLOOD, V88, P146; Evangelista V, 1996, BLOOD, V88, P4183, DOI 10.1182/blood.V88.11.4183.bloodjournal88114183; Hassan GS, 2012, IMMUNOBIOLOGY, V217, P521, DOI 10.1016/j.imbio.2011.03.010; Hristov M, 2010, CIRCULATION, V121, P315, DOI 10.1161/CIRCULATIONAHA.109.862771; Inoue T, 2006, THROMB HAEMOSTASIS, V95, P43, DOI 10.1160/TH05-08-0591; Inoue T, 2003, CIRCULATION, V107, P1757, DOI 10.1161/01.CIR.0000060487.15126.56; Inoue T, 1998, CIRCULATION, V97, P2511, DOI 10.1161/01.CIR.97.25.2511; Inoue T, 1996, J AM COLL CARDIOL, V28, P1127, DOI 10.1016/S0735-1097(96)00308-7; Laudanna C, 1998, J BIOL CHEM, V273, P30306, DOI 10.1074/jbc.273.46.30306; Li G, 2008, AM J PATHOL, V172, P1141, DOI 10.2353/ajpath.2008.070633; Lievens D, 2009, THROMB HAEMOSTASIS, V102, P206, DOI 10.1160/TH09-01-0029; Massberg S, 2002, J EXP MED, V196, P887, DOI 10.1084/jem.20012044; MAZZEI GJ, 1995, J BIOL CHEM, V270, P7025, DOI 10.1074/jbc.270.13.7025; McDonald PP, 1997, BLOOD, V89, P3421, DOI 10.1182/blood.V89.9.3421; Neumann FJ, 1996, J AM COLL CARDIOL, V27, P819, DOI 10.1016/0735-1097(95)00563-3; Osaka M, 2007, AM J PHYSIOL-HEART C, V292, pH1876, DOI 10.1152/ajpheart.00708.2006; Pamukcu B, 2011, ANN MED, V43, P331, DOI 10.3109/07853890.2010.546362; Roque M, 2000, ARTERIOSCL THROM VAS, V20, P335, DOI 10.1161/01.ATV.20.2.335; Sanguigni V, 2005, J AM COLL CARDIOL, V45, P35, DOI 10.1016/j.jacc.2004.09.047; Sergeant S, 1997, J IMMUNOL, V159, P2877; Shah PK, 2003, CIRCULATION, V107, P2175, DOI 10.1161/01.CIR.0000069943.41206.BD; Simon DI, 2000, J CLIN INVEST, V105, P293, DOI 10.1172/JCI7811; Song ZF, 2012, ARTERIOSCL THROM VAS, V32, P50, DOI 10.1161/ATVBAHA.111.238329; Song ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023239; Sun RH, 2005, CANCER RES, V65, P1433, DOI 10.1158/0008-5472.CAN-04-1163; Tanguay JF, 2003, J ENDOVASC THER, V10, P968, DOI 10.1583/1545-1550(2003)010<0968:CPANAA>2.0.CO;2; Welt FGP, 2002, ARTERIOSCL THROM VAS, V22, P1769, DOI 10.1161/01.ATV.0000037100.44766.5B; Yacoub D, 2010, ARTERIOSCL THROM VAS, V30, P2424, DOI 10.1161/ATVBAHA.110.216143; Zarbock A, 2007, BLOOD REV, V21, P99, DOI 10.1016/j.blre.2006.06.001	36	36	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e64631	10.1371/journal.pone.0064631	http://dx.doi.org/10.1371/journal.pone.0064631			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23785403	gold, Green Published, Green Submitted			2022-12-27	WOS:000321099000010
J	Chen, W; Jia, WW; Wang, K; Si, XX; Zhu, SC; Duan, T; Kang, JH				Chen, Wen; Jia, Wenwen; Wang, Kai; Si, Xiaoxing; Zhu, Songcheng; Duan, Tao; Kang, Jiuhong			Distinct Roles for CBP and p300 on the RA-Mediated Expression of the Meiosis Commitment Gene Stra8 in Mouse Embryonic Stem Cells	PLOS ONE			English	Article							RETINOIC-ACID; GERM-CELLS; DIFFERENTIAL ROLES; MEIOTIC INITIATION; COACTIVATORS P300; BINDING PROTEIN; INHIBITION; REPRESSION; GENERATION; OVARIES	In mammalian germ cells, meiotic commitment requires the expression of Stimulated by retinoic acid gene 8 (Stra8), which is transcriptionally activated by retinoic acid (RA). However, little is known about the epigenetic mechanism by which RA induces Stra8 expression. Utilizing a chromatin immunoprecipitation assay (ChIP), we showed that RA increases histone acetylation at the Stra8 promoter in murine embryonic stem cells (ESCs), a model for germ cell differentiation. Furthermore, we explored whether two coregulators with histone acetyltransferase (HAT) activity, Creb-binding protein (CBP) and p300, are involved in the activation of Stra8. The lentiviral shRNA knockdown of endogenous CBP led to Stra8 repression, while the overexpression of CBP enhanced Stra8 expression at both the mRNA and protein levels. ChIP analysis confirmed that CBP is the crucial coactivator for RA-mediated Stra8 transcription and that it enhances the level of histone acetylation and recruits RNA polymerase II to establish transcriptionally active chromatin. Furthermore, shRNA of p300 enhanced Stra8 expression, and the overexpression of p300 reduced Stra8 expression, independently of its HAT activity. ChIP showed that the knockdown of p300 significantly increased the level of CBP at the Stra8 promoter. These findings demonstrate that CBP and p300 play distinct roles in RA-mediated Stra8 gene transcription.	[Chen, Wen; Jia, Wenwen; Wang, Kai; Si, Xiaoxing; Zhu, Songcheng; Duan, Tao; Kang, Jiuhong] Tongji Univ, Shanghai Matern & Infant Hlth Hosp 1, Clin & Translat Res Ctr, Sch Life Sci & Technol,Shanghai Key Lab Signaling, Shanghai 200092, Peoples R China; [Duan, Tao] Tongji Univ, Shanghai Matern & Infant Hlth Hosp 1, Sch Med, Dept Obstet, Shanghai 200092, Peoples R China	Tongji University; Tongji University	Duan, T (corresponding author), Tongji Univ, Shanghai Matern & Infant Hlth Hosp 1, Clin & Translat Res Ctr, Sch Life Sci & Technol,Shanghai Key Lab Signaling, Shanghai 200092, Peoples R China.	tduan@yahoo.com; jhkang@tongji.edu.cn			Ministry of Science and Technology [2011CB965100, 2011DFA30480, 2010CB944900, 2010CB945000, 2012CB966603, 2011CBA01100]; National Natural Science Foundation of China [90919028, 31210103905, 31201107, 31101061, 81170499, 31071306, 31000378, 31171432, 30971451]; Science and Technology Commission of Shanghai Municipality [11ZR1438500, 11XD1405300]; Ministry of Education [IRT1168, 20110072110039]; Fundamental Research Funds for the Central Universities [2000219067, 2000219066]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Ministry of Education; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by grants from the Ministry of Science and Technology (2011CB965100, 2011DFA30480, 2010CB944900, 2010CB945000, 2012CB966603 and 2011CBA01100), the National Natural Science Foundation of China (90919028, 31210103905, 31201107, 31101061, 81170499, 31071306, 31000378, 31171432, and 30971451), the Science and Technology Commission of Shanghai Municipality (11ZR1438500, 11XD1405300), and IRT1168 and 20110072110039 from Ministry of Education. The work was also supported by Fundamental Research Funds for the Central Universities (2000219067, 2000219066). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baltus AE, 2006, NAT GENET, V38, P1430, DOI 10.1038/ng1919; Baluchamy S, 2003, P NATL ACAD SCI USA, V100, P9524, DOI 10.1073/pnas.1633700100; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Bowles J, 2006, SCIENCE, V312, P596, DOI 10.1126/science.1125691; Chakravarti D, 1996, NATURE, V383, P99, DOI 10.1038/383099a0; Chen W, 2012, BIOCHEM BIOPH RES CO, V418, P571, DOI 10.1016/j.bbrc.2012.01.078; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Geijsen N, 2004, NATURE, V427, P148, DOI 10.1038/nature02247; Girdwood D, 2003, MOL CELL, V11, P1043, DOI 10.1016/S1097-2765(03)00141-2; Giuili G, 2002, EMBO REP, V3, P753, DOI 10.1093/embo-reports/kvf149; Glass CK, 2000, GENE DEV, V14, P121; Ianculescu I, 2012, J BIOL CHEM, V287, P4000, DOI 10.1074/jbc.M111.300194; Johnson J, 2005, CELL, V122, P303, DOI 10.1016/j.cell.2005.06.031; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Kasper LH, 2005, EMBO J, V24, P3846, DOI 10.1038/sj.emboj.7600846; Kawasaki H, 1998, NATURE, V393, P284, DOI 10.1038/30538; Koubova J, 2006, P NATL ACAD SCI USA, V103, P2474, DOI 10.1073/pnas.0510813103; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; Kumar S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1136; Lee S, 2009, NEURON, V62, P641, DOI 10.1016/j.neuron.2009.04.025; Ma H, 2005, ONCOGENE, V24, P3619, DOI 10.1038/sj.onc.1208433; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Mark Manuel, 2009, Nucl Recept Signal, V7, pe002, DOI 10.1621/nrs.07002; Miyabayashi T, 2007, P NATL ACAD SCI USA, V104, P5668, DOI 10.1073/pnas.0701331104; Nayernia K, 2006, DEV CELL, V11, P125, DOI 10.1016/j.devcel.2006.05.010; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Ramos YFM, 2010, NUCLEIC ACIDS RES, V38, P5396, DOI 10.1093/nar/gkq184; Rebel VI, 2002, P NATL ACAD SCI USA, V99, P14789, DOI 10.1073/pnas.232568499; Sangster-Guity N, 2004, CANCER BIOL THER, V3, P1109, DOI 10.4161/cbt.3.11.1190; Shikama N, 2003, EMBO J, V22, P5175, DOI 10.1093/emboj/cdg502; Toyooka Y, 2003, P NATL ACAD SCI USA, V100, P11457, DOI 10.1073/pnas.1932826100; Wang N, 2010, CELL CYCLE, V9, P339, DOI 10.4161/cc.9.2.10447; Wang ZB, 2010, CELL CYCLE, V9, P2640, DOI 10.4161/cc.9.13.12120	34	10	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66076	10.1371/journal.pone.0066076	http://dx.doi.org/10.1371/journal.pone.0066076			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785470	Green Published, gold, Green Submitted			2022-12-27	WOS:000321038800052
J	Gilmore, C; Attridge, N; Clayton, S; Cragg, L; Johnson, S; Marlow, N; Simms, V; Inglis, M				Gilmore, Camilla; Attridge, Nina; Clayton, Sarah; Cragg, Lucy; Johnson, Samantha; Marlow, Neil; Simms, Victoria; Inglis, Matthew			Individual Differences in Inhibitory Control, Not Non-Verbal Number Acuity, Correlate with Mathematics Achievement	PLOS ONE			English	Article							EXECUTIVE FUNCTIONS; NONSYMBOLIC NUMBER; PRESCHOOL-CHILDREN; WORKING-MEMORY; MATH; ABILITY; REPRESENTATIONS; SENSE; PREDICTOR; ADULTS	Given the well-documented failings in mathematics education in many Western societies, there has been an increased interest in understanding the cognitive underpinnings of mathematical achievement. Recent research has proposed the existence of an Approximate Number System (ANS) which allows individuals to represent and manipulate non-verbal numerical information. Evidence has shown that performance on a measure of the ANS (a dot comparison task) is related to mathematics achievement, which has led researchers to suggest that the ANS plays a critical role in mathematics learning. Here we show that, rather than being driven by the nature of underlying numerical representations, this relationship may in fact be an artefact of the inhibitory control demands of some trials of the dot comparison task. This suggests that recent work basing mathematics assessments and interventions around dot comparison tasks may be inappropriate.	[Gilmore, Camilla; Attridge, Nina; Clayton, Sarah; Inglis, Matthew] Univ Loughborough, Math Educ Ctr, Loughborough, Leics, England; [Cragg, Lucy] Univ Nottingham, Sch Psychol, Nottingham NG7 2RD, England; [Johnson, Samantha; Simms, Victoria] Univ Leicester, Dept Hlth Sci, Leicester LE1 7RH, Leics, England; [Marlow, Neil] UCL, Inst Womens Hlth, London WC1E 6BT, England	Loughborough University; University of Nottingham; University of Leicester; University of London; University College London	Gilmore, C (corresponding author), Univ Loughborough, Math Educ Ctr, Loughborough, Leics, England.	c.gilmore@lboro.ac.uk	Cragg, Lucy/B-2070-2010; Inglis, Matthew/U-3677-2017; Johnson, Samantha/G-2260-2018; Clayton, Sarah/I-6294-2018; Marlow, Neil/D-2918-2009; Johnson, Samantha/S-6876-2019	Cragg, Lucy/0000-0001-7523-0204; Inglis, Matthew/0000-0001-7617-4689; Johnson, Samantha/0000-0001-8963-7881; Clayton, Sarah/0000-0002-0193-1443; Marlow, Neil/0000-0001-5890-2953; Attridge, Nina/0000-0001-9586-372X; Simms, Victoria/0000-0001-5664-6810	British Academy Postdoctoral Fellowship; Royal Society Worshipful Company of Actuaries Educational Research Fellowship; Department of Health's NIHR Biomedical Research Centre's funding scheme at UCLH / UCL; Economic and Social Research Council; Action Medical Research; ESRC [ES/G007454/1] Funding Source: UKRI; Economic and Social Research Council [ES/G007454/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10034] Funding Source: researchfish; Action Medical Research [1780] Funding Source: researchfish	British Academy Postdoctoral Fellowship; Royal Society Worshipful Company of Actuaries Educational Research Fellowship; Department of Health's NIHR Biomedical Research Centre's funding scheme at UCLH / UCL; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Action Medical Research; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Action Medical Research	C.G. is supported by a British Academy Postdoctoral Fellowship and M. I. is supported by a Royal Society Worshipful Company of Actuaries Educational Research Fellowship. N.M. receives part funding from the Department of Health's NIHR Biomedical Research Centre's funding scheme at UCLH / UCL. Experiment 1 was funded by a grant from the Economic and Social Research Council and Experiment 2 was funded by a grant from Action Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barth H, 2005, P NATL ACAD SCI USA, V102, P14116, DOI 10.1073/pnas.0505512102; Barth H, 2003, COGNITION, V86, P201, DOI 10.1016/S0010-0277(02)00178-6; Blair C, 2007, CHILD DEV, V78, P647, DOI 10.1111/j.1467-8624.2007.01019.x; Bonny JW, 2013, J EXP CHILD PSYCHOL, V114, P375, DOI 10.1016/j.jecp.2012.09.015; Bull R, 2001, DEV NEUROPSYCHOL, V19, P273, DOI 10.1207/S15326942DN1903_3; Castronovo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033832; Cordes S, 2001, PSYCHON B REV, V8, P698, DOI 10.3758/BF03196206; Cragg L, 2008, DEVELOPMENTAL SCI, V11, P819, DOI 10.1111/j.1467-7687.2008.00730.x; Dehaene S., 2011, NUMBER SENSE MIND CR; Desoete A, 2012, BRIT J EDUC PSYCHOL, V82, P64, DOI 10.1348/2044-8279.002002; Espy KA, 2004, DEV NEUROPSYCHOL, V26, P465, DOI 10.1207/s15326942dn2601_6; Feigenson L, 2004, TRENDS COGN SCI, V8, P307, DOI 10.1016/j.tics.2004.05.002; Fuhs MW, 2013, DEVELOPMENTAL SCI, V16, P136, DOI 10.1111/desc.12013; Gebuis T, 2011, BEHAV RES METHODS, V43, P981, DOI 10.3758/s13428-011-0097-5; Halberda J, 2008, NATURE, V455, P665, DOI 10.1038/nature07246; Halberda J, 2012, P NATL ACAD SCI USA, V109, P11116, DOI 10.1073/pnas.1200196109; Holloway ID, 2009, J EXP CHILD PSYCHOL, V103, P17, DOI 10.1016/j.jecp.2008.04.001; Huizinga M, 2006, NEUROPSYCHOLOGIA, V44, P2017, DOI 10.1016/j.neuropsychologia.2006.01.010; Inglis M, 2011, PSYCHON B REV, V18, P1222, DOI 10.3758/s13423-011-0154-1; Iuculano T, 2008, DEVELOPMENTAL SCI, V11, P669, DOI 10.1111/j.1467-7687.2008.00716.x; Kolkman ME, 2013, LEARN INSTR, V25, P95, DOI 10.1016/j.learninstruc.2012.12.001; Korkman M., 2007, NEPSY 2 BATERIA NEUR; Kramer P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017378; Libertus ME, 2013, LEARN INDIVID DIFFER, V25, P126, DOI 10.1016/j.lindif.2013.02.001; Libertus ME, 2012, ACTA PSYCHOL, V141, P373, DOI 10.1016/j.actpsy.2012.09.009; Libertus ME, 2011, DEVELOPMENTAL SCI, V14, P1292, DOI 10.1111/j.1467-7687.2011.01080.x; Lourenco SF, 2012, P NATL ACAD SCI USA, V109, P18737, DOI 10.1073/pnas.1207212109; Mazzocco MMM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023749; National Mathematics Advisory Panel, 2008, FDN SUCC FIN REP NAT; Parsons S., 2005, DOES NUMERACY MATTER; Piazza M, 2010, COGNITION, V116, P33, DOI 10.1016/j.cognition.2010.03.012; Pica P, 2004, SCIENCE, V306, P499, DOI 10.1126/science.1102085; Price GR, 2012, ACTA PSYCHOL, V140, P50, DOI 10.1016/j.actpsy.2012.02.008; Sasanguie D, 2013, J EXP CHILD PSYCHOL, V114, P418, DOI 10.1016/j.jecp.2012.10.012; Sasanguie D, 2012, MIND BRAIN EDUC, V6, P119, DOI 10.1111/j.1751-228X.2012.01147.x; St Clair-Thompson HL, 2006, Q J EXP PSYCHOL, V59, P745, DOI 10.1080/17470210500162854; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Vanbinst K, 2012, MIND BRAIN EDUC, V6, P129, DOI 10.1111/j.1751-228X.2012.01148.x; Vorderman C, 2011, WORLD CLASS MATH ED; Wechsler D., 2009, WECHSLER INDIVIDUAL, V3rd; Wilson AJ, 2006, BEHAV BRAIN FUNCT, V2, DOI [10.86/1744-9081-2-20, DOI 10.1186/1744-9081-2-20.PUBMED:16734906]; Woodcock R. W., 2001, WOODCOCK JOHNSON 3 T	42	293	301	7	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e67374	10.1371/journal.pone.0067374	http://dx.doi.org/10.1371/journal.pone.0067374			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	172XB	23785521	Green Published, Green Submitted, gold			2022-12-27	WOS:000321038800003
J	Tahir, H; Bona-Casas, C; Hoekstra, AG				Tahir, Hannan; Bona-Casas, Carles; Hoekstra, Alfons G.			Modelling the Effect of a Functional Endothelium on the Development of In-Stent Restenosis	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELL; NITRIC-OXIDE; STRUT THICKNESS; ELUTING STENTS; INJURY; SIMULATIONS; FLOW; PATHOPHYSIOLOGY; PATHOLOGY; IMPACT	Treatment of stenosed coronary arteries by balloon angioplasty and stenting results in arterial injury including severe damage to the endothelium at the site of treatment and initiates a complex cascade of inflammatory processes that may lead to the development of in-stent restenosis (ISR). Many clinical and biological factors involved in the progression of restenotic lesions have been studied in detail over the past few years but the mystery behind the pathophysiological mechanisms of this disease is still unresolved. In the present work, the effects of re-endothelialization and nitric oxide release on neointimal growth are investigated in-silico using a two dimensional multi-scale model of ISR. The effect of stent deployment depths on the development of ISR is studied as a function of time after stenting. Two dimensional domains were prepared by deploying bare metal stent struts at three different deployment depths into the tissue. Shear stress distribution on endothelial cells, obtained by blood flow simulations, was translated into nitric oxide production that keeps the smooth muscle cells in quiescent state. The cellular growth trends were plotted as a function of time and the data indicate a positive correlation between the neointimal growths and strut deployment depths in the presence of a functional endothelium, in qualitative agreement with in-vivo data. Additionally, no ISR is observed if a functional endothelium appears much earlier.	[Tahir, Hannan; Bona-Casas, Carles; Hoekstra, Alfons G.] Univ Amsterdam, Fac Sci, Inst Informat, Amsterdam, Netherlands	University of Amsterdam	Tahir, H (corresponding author), Univ Amsterdam, Fac Sci, Inst Informat, Amsterdam, Netherlands.	h.tahir@uva.nl	Bona-Casas, Carles/M-1049-2014	Bona-Casas, Carles/0000-0002-3217-5257	European Union [238113]	European Union(European Commission)	The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no 238113 (project 'MeDDiCA' - 'Medical Devices Design in Cardiovascular Applications'; http://www.meddica.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahanchi SS, 2007, J VASC SURG, V45, p64A, DOI 10.1016/j.jvs.2007.02.027; [Anonymous], [No title captured]; Artoli AM, 2006, J BIOMECH, V39, P873, DOI 10.1016/j.jbiomech.2005.01.033; Axner L, 2008, J COMPUT PHYS, V227, P4895, DOI 10.1016/j.jcp.2008.01.013; Axner L, 2009, BIOMED ENG ONLINE, V8, DOI 10.1186/1475-925X-8-23; Baim DS., 2005, GROSSMANS CARDIAC CA; BRETON M, 1986, EXP CELL RES, V166, P416, DOI 10.1016/0014-4827(86)90487-8; Bryan NS, 2006, FREE RADICAL BIO MED, V41, P691, DOI 10.1016/j.freeradbiomed.2006.05.019; Caiazzo A, 2011, J COMPUT SCI-NETH, V2, P9, DOI 10.1016/j.jocs.2010.09.002; Carpenter AW, 2012, CHEM SOC REV; Comerford A, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2838026; Coneski PN, 2012, CHEM SOC REV; De Caterina R, 2007, ENDOTHELIAL DYSFUNCT, P1, DOI DOI 10.1002/9780470988473.CH1; Evans DJW, 2008, PHILOS T R SOC A, V366, P3343, DOI 10.1098/rsta.2008.0081; Finn AV, 2007, ARTERIOSCL THROM VAS, V27, P1500, DOI 10.1161/ATVBAHA.107.144220; Forstermann U, 2011, EUROPEAN HEART J; Gunn J, 2002, HEART, V88, P401, DOI 10.1136/heart.88.4.401; Guo X, 2009, ACTA PHYSIOL, V197, P99, DOI 10.1111/j.1748-1716.2009.01999.x; Hamid Huda, 2007, Mcgill J Med, V10, P105; Harnek J, 1999, CARDIOVASC INTER RAD, V22, P56, DOI 10.1007/s002709900329; Hegewald J, 2010, MULTISCALE COUPLING; Hegewald J, 2008, LECT NOTES COMPUT SC, V5102, P227, DOI 10.1007/978-3-540-69387-1_25; Hsu S, 2011, CELL MOL BIOENG, P1; Inoue T, 2011, JACC-CARDIOVASC INTE, V4, P1057, DOI 10.1016/j.jcin.2011.05.025; Jeremy JY, 1999, CARDIOVASC RES, V43, P580, DOI 10.1016/S0008-6363(99)00171-6; Jukema JW, 2012, NAT REV CARDIOL, V9, P53, DOI 10.1038/nrcardio.2011.132; Kakisis JD, 2004, ENDOTHELIUM-J ENDOTH, V11, P17, DOI 10.1080/10623320490432452; Kastrati A, 2001, CIRCULATION, V103, P2816; Lacolley P, 2012, CARDIOVASC RES, V95, P194, DOI 10.1093/cvr/cvs135; Lehti K, 2009, J CELL SCI, V122, P126, DOI 10.1242/jcs.035279; Louis SF, 2010, EXP CLIN CARDIOL, V15, pE75; Lowe HC, 2002, J AM COLL CARDIOL, V39, P183, DOI 10.1016/S0735-1097(01)01742-9; LUDMER PL, 1986, NEW ENGL J MED, V315, P1046, DOI 10.1056/NEJM198610233151702; McCormick ME, 2011, ARTERIOSCL THROM VAS, V31, P643, DOI 10.1161/ATVBAHA.110.216200; Nakazawa G, 2007, HERZ, V32, P274, DOI 10.1007/s00059-007-2997-9; Nakazawa G, 2010, JACC-CARDIOVASC INTE, V3, P68, DOI 10.1016/j.jcin.2009.09.015; Oncel D, 2008, AM J ROENTGENOL, V191, P56, DOI 10.2214/AJR.07.3560; Otsuka F, 2012, NATURE REV CARDIOLOG; Ozkor MA, 2010, ADVANCES IN VASCULAR MEDICINE, P187, DOI 10.1007/978-1-84882-637-3_11; de Prado AP, 2011, VET PATHOL, V48, P1109, DOI 10.1177/0300985811400446; Perk J, 2012, EUROPEAN HEART J; Pober JS, 2009, ANNU REV PATHOL-MECH, V4, P71, DOI 10.1146/annurev.pathol.4.110807.092155; Redmond EM, 2012, MUSCLE FUNDAMENTAL B, P1231, DOI [10.1016/b978-0-12-381510-1.00092-2, DOI 10.1016/B978-0-12-381510-1.00092-2.1231-1242]; Rittersma SZH, 2004, AM J CARDIOL, V93, P477, DOI 10.1016/j.amjcard.2003.10.049; Sandoo A, 2010, OPEN CARDIOVASC MED, V4, P302, DOI 10.2174/1874192401004010302; Schulz C, 2000, HEART, V83, P462, DOI 10.1136/heart.83.4.462; SCHWARTZ RS, 1992, J AM COLL CARDIOL, V19, P267, DOI 10.1016/0735-1097(92)90476-4; Shi ZD, 2011, ANN BIOMED ENG, V39, P1608, DOI 10.1007/s10439-011-0309-2; Shi ZD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012196; Simons M, 2009, ARTERIOSCL THROM VAS, V29, P439, DOI 10.1161/ATVBAHA.109.183970; Sudano I, 2010, SWISS MED WKLY, V140, P139, DOI [smw-12966, 10.4414/smw.2010.13122]; Tahir H, 2011, INTERFACE FOCUS, V1, P365, DOI 10.1098/rsfs.2010.0024; van Beusekom HMM, 2012, CATHETERIZATION CARD; Vanhoutte PM, 2010, CARDIOVASC DRUG THER, V24, P299, DOI 10.1007/s10557-010-6257-5; Verma S, 2002, CIRCULATION, V105, P546, DOI 10.1161/hc0502.104540; Villalobo A, 2006, FEBS J, V273, P2329, DOI 10.1111/j.1742-4658.2006.05250.x; Wong K, 2006, MED BIOL ENG COMPUT, V44, P971, DOI 10.1007/s11517-006-0113-6; Wong KKL, 2011, COMPUT CARDIOL CONF, V38, P157; Wong KKL, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-7; Wong KKL, 2010, INT CONF BIOMED, P113, DOI 10.1109/BMEI.2010.5639477; Wong KK, 2012, INT P CHEM BIOL ENV, V34, P40	61	46	47	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66138	10.1371/journal.pone.0066138	http://dx.doi.org/10.1371/journal.pone.0066138			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785479	Green Published, Green Submitted, gold			2022-12-27	WOS:000321038800043
J	Banos, G; Wall, E; Coffey, MP; Bagnall, A; Gillespie, S; Russell, GC; McNeilly, TN				Banos, Georgios; Wall, Eileen; Coffey, Michael P.; Bagnall, Ainsley; Gillespie, Sandra; Russell, George C.; McNeilly, Tom N.			Identification of Immune Traits Correlated with Dairy Cow Health, Reproduction and Productivity	PLOS ONE			English	Article							ACUTE-PHASE PROTEINS; MULTIPLE IMPLANTATION FAILURES; DIFFERENTIAL LEUKOCYTE COUNTS; RECURRENT PREGNANCY LOSSES; NATURAL-KILLER-CELLS; FLOW-CYTOMETRY; MONOCLONAL-ANTIBODIES; CYTOKINE EXPRESSION; SHORT-COMMUNICATION; GENETIC-PARAMETERS	Detailed biological analyses (e. g. epidemiological, genetic) of animal health and fitness in the field are limited by the lack of large-scale recording of individual animals. An alternative approach is to identify immune traits that are associated with these important functions and can be subsequently used in more detailed studies. We have used an experimental dairy herd with uniquely dense phenotypic data to identify a range of potentially useful immune traits correlated with enhanced (or depressed) health and fitness. Blood samples from 248 dairy cows were collected at two-monthly intervals over a 10-month period and analysed for a number of immune traits, including levels of serum proteins associated with the innate immune response and circulating leukocyte populations. Immune measures were matched to individual cow records related to productivity, fertility and disease. Correlations between traits were calculated using bivariate analyses based on animal repeatability and random regression models with a Bonferroni correction to account for multiple testing. A number of significant correlations were found between immune traits and other recorded traits including: CD4(+): CD8(+) T lymphocyte ratio and subclinical mastitis; % CD8(+) lymphocytes and fertility; % CD335(+) natural killer cells and lameness episodes; and serum haptoglobin levels and clinical mastitis. Importantly these traits were not associated with reduced productivity and, in the case of cellular immune traits, were highly repeatable. Moreover these immune traits displayed significant between-animal variation suggesting that they may be altered by genetic selection. This study represents the largest simultaneous analysis of multiple immune traits in dairy cattle to-date and demonstrates that a number of immune traits are associated with health events. These traits represent useful selection markers for future programmes aimed at improving animal health and fitness.	[Banos, Georgios; Wall, Eileen; Coffey, Michael P.; Bagnall, Ainsley] SRUC, Edinburgh, Midlothian, Scotland; [Banos, Georgios] Aristotle Univ Thessaloniki, Fac Vet Med, GR-54006 Thessaloniki, Greece; [Gillespie, Sandra; Russell, George C.; McNeilly, Tom N.] Moredun Res Inst, Edinburgh EH17 7JH, Midlothian, Scotland	Aristotle University of Thessaloniki; Moredun Research Institute	McNeilly, TN (corresponding author), Moredun Res Inst, 408 Gilmerton Rd, Edinburgh EH17 7JH, Midlothian, Scotland.	Tom.McNeilly@moredun.ac.uk	McNeilly, Tom/AAC-8264-2019	McNeilly, Tom/0000-0001-6469-0512; Russell, George/0000-0002-1951-3215; Banos, Georgios/0000-0002-7674-858X; Coffey, Mike/0000-0003-4890-6218	Rural and Environment Science and Analytical Services (RESAS) Cross-Cutting Theme Fellowship [MRI/102/10]; Scottish Government; Biotechnology and Biological Sciences Research Council [BB/K002260/1] Funding Source: researchfish; BBSRC [BB/K002260/1] Funding Source: UKRI	Rural and Environment Science and Analytical Services (RESAS) Cross-Cutting Theme Fellowship; Scottish Government; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was supported by Rural and Environment Science and Analytical Services (RESAS) Cross-Cutting Theme Fellowship MRI/102/10. EW, MPC, GR and TNM are supported by core funding from the Scottish Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsemgeest SPM, 1996, VET IMMUNOL IMMUNOP, V53, P179, DOI 10.1016/0165-2427(96)05602-4; BAUMANN H, 1994, IMMUNOL TODAY, V15, P74, DOI 10.1016/0167-5699(94)90137-6; Baumgarth N, 2005, SPRINGER SEMIN IMMUN, V26, P347, DOI 10.1007/s00281-004-0182-2; Bell MJ, 2011, J DAIRY SCI, V94, P3662, DOI 10.3168/jds.2010-4023; BENSAID A, 1991, VET IMMUNOL IMMUNOP, V27, P51, DOI 10.1016/0165-2427(91)90078-Q; Bougarn S, 2011, CYTOKINE, V56, P749, DOI 10.1016/j.cyto.2011.09.020; CASALI P, 1989, IMMUNOL TODAY, V10, P364, DOI 10.1016/0167-5699(89)90268-5; Ceciliani F, 2012, J PROTEOMICS, V75, P4207, DOI 10.1016/j.jprot.2012.04.004; Clapperton M, 2008, ANIMAL, V2, P1575, DOI 10.1017/S1751731108002929; Clapperton M, 2005, VET IMMUNOL IMMUNOP, V104, P131, DOI 10.1016/j.vetimm.2004.10.009; Clapperton M, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-54; Davis WC, 1996, VET IMMUNOL IMMUNOP, V52, P275, DOI 10.1016/0165-2427(96)05578-X; DAVIS WC, 1993, VET IMMUNOL IMMUNOP, V39, P85, DOI 10.1016/0165-2427(93)90167-3; Eckersall PD, 2010, VET J, V185, P23, DOI 10.1016/j.tvjl.2010.04.009; Eckersall PD, 2006, J DAIRY SCI, V89, P1488, DOI 10.3168/jds.S0022-0302(06)72216-0; Eckersall PD, 2001, VET REC, V148, P35, DOI 10.1136/vr.148.2.35; Evans D M, 1999, Twin Res, V2, P250, DOI 10.1375/136905299320565735; Ferlazzo G, 2004, J IMMUNOL, V172, P1333, DOI 10.4049/jimmunol.172.3.1333; Ferreira MAR, 2010, AM J HUM GENET, V86, P88, DOI 10.1016/j.ajhg.2009.12.008; Flori L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022717; Flori Laurence, 2011, BMC Proc, V5 Suppl 4, pS32, DOI 10.1186/1753-6561-5-S4-S32; Gilmour A., 2006, ASREML USER GUIDE RE; Glass EJ, 2005, INT J PARASITOL, V35, P337, DOI 10.1016/j.ijpara.2004.12.006; Gregory N, 2011, IN PRACTICE, V33, P328, DOI 10.1136/inp.d4505; Hall MA, 2000, GENES IMMUN, V1, P423, DOI 10.1038/sj.gene.6363702; He Y, 2011, J DAIRY RES, P1; Holm S, 1974, SCANDINAVIAN J STAT, V6, P65; JAIN NC, 1991, AM J VET RES, V52, P630; Jenkins C, 2000, FERTIL STERIL, V73, P1206, DOI 10.1016/S0015-0282(00)00517-3; Kushibiki S, 2003, J DAIRY SCI, V86, P819, DOI 10.3168/jds.S0022-0302(03)73664-9; Kushibiki S, 2011, ANIM SCI J, V82, P504, DOI 10.1111/j.1740-0929.2011.00931.x; Kwak-Kim JYH, 2003, HUM REPROD, V18, P767, DOI 10.1093/humrep/deg156; Lun S, 2007, REPROD DOMEST ANIM, V42, P126, DOI 10.1111/j.1439-0531.2006.00741.x; MACHUGH ND, 1991, VET IMMUNOL IMMUNOP, V27, P65, DOI 10.1016/0165-2427(91)90081-M; Maecker HT, 2010, NAT IMMUNOL, V11, P975, DOI 10.1038/ni1110-975; Marzi M, 1996, CLIN EXP IMMUNOL, V106, P127, DOI 10.1046/j.1365-2249.1996.d01-809.x; Miglior F, 2005, J DAIRY SCI, V88, P1255, DOI 10.3168/jds.S0022-0302(05)72792-2; Moretta A, 2002, NAT REV IMMUNOL, V2, P957, DOI 10.1038/nri956; Moyes KM, 2009, J DAIRY SCI, V92, P4301, DOI 10.3168/jds.2009-2170; Mrode R, 2012, J DAIRY SCI, V95, P4618, DOI 10.3168/jds.2011-4971; Mrode R. A., 1996, Animal Breeding Abstracts, V64, P847; NAESSENS J, 1990, IMMUNOLOGY, V69, P525; Nielsen BH, 2004, VET REC, V154, P361, DOI 10.1136/vr.154.12.361; Ohtsuka H, 2001, J VET MED SCI, V63, P675, DOI 10.1292/jvms.63.675; PARK YH, 1993, VET IMMUNOL IMMUNOP, V36, P137, DOI 10.1016/0165-2427(93)90103-B; Park Yong Ho, 2004, J Vet Sci, V5, P29; Pryce JE, 1999, LIVEST PROD SCI, V57, P193, DOI 10.1016/S0301-6226(98)00180-8; Quesniaux VFJ, 2010, CURR DIR AUTOIMMUN, V11, P157, DOI 10.1159/000289204; Raghupathy R, 2000, HUM REPROD, V15, P713, DOI 10.1093/humrep/15.3.713; Rasmussen M, 2012, VET MICROBIOL, V160, P151, DOI 10.1016/j.vetmic.2012.05.018; RENEAU JK, 1986, J DAIRY SCI, V69, P1708, DOI 10.3168/jds.S0022-0302(86)80590-2; Riollet C, 2001, J DAIRY SCI, V84, P1077, DOI 10.3168/jds.S0022-0302(01)74568-7; SHOOK GE, 1994, J DAIRY SCI, V77, P648, DOI 10.3168/jds.S0022-0302(94)76995-2; Sivori S, 1997, J EXP MED, V186, P1129, DOI 10.1084/jem.186.7.1129; Soltys J, 1999, INFECT IMMUN, V67, P6293; Sopp P, 1997, VET IMMUNOL IMMUNOP, V56, P11, DOI 10.1016/S0165-2427(96)05731-5; Storset AK, 2004, EUR J IMMUNOL, V34, P669, DOI 10.1002/eji.200324504; Suojala L, 2008, ACTA VET SCAND, V50, DOI 10.1186/1751-0147-50-18; Taylor BC, 1997, CELL IMMUNOL, V182, P68, DOI 10.1006/cimm.1997.1215; Thielen MA, 2007, J DAIRY SCI, V90, P1215, DOI 10.3168/jds.S0022-0302(07)71609-0; Thompson-Crispi KA, 2012, J DAIRY SCI, V95, P3888, DOI 10.3168/jds.2011-5201; Thompson-Crispi KA, 2012, J DAIRY SCI, V95, P401, DOI 10.3168/jds.2011-4452; van Knegsel ATM, 2007, J DAIRY SCI, V90, P5490, DOI 10.3168/jds.2007-0289; van Knegsel ATM, 2012, PREV VET MED, V103, P287, DOI 10.1016/j.prevetmed.2011.09.006; WEIL GJ, 1981, BLOOD, V57, P1099; Wilkerson MJ, 2012, VET CLIN N AM-SMALL, V42, P53, DOI 10.1016/j.cvsm.2011.09.012; Wong P, 2003, ANNU REV IMMUNOL, V21, P29, DOI 10.1146/annurev.immunol.21.120601.141114; Yang KM, 2010, AM J REPROD IMMUNOL, V63, P370, DOI 10.1111/j.1600-0897.2010.00811.x; Zitvogel L, 2002, J EXP MED, V195, pf9, DOI 10.1084/jem.20012040	69	58	60	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65766	10.1371/journal.pone.0065766	http://dx.doi.org/10.1371/journal.pone.0065766			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776543	Green Submitted, Green Published, gold			2022-12-27	WOS:000320322400052
J	Brown, CJ; Saunders, MI; Possingham, HP; Richardson, AJ				Brown, Christopher J.; Saunders, Megan I.; Possingham, Hugh P.; Richardson, Anthony J.			Managing for Interactions between Local and Global Stressors of Ecosystems	PLOS ONE			English	Article							CLIMATE-CHANGE; CORAL-REEFS; PROTECTED AREAS; RESILIENCE; TEMPERATURE; STRATEGIES; MORTALITY; IMPACTS; RISK; ACIDIFICATION	Global stressors, including climate change, are a major threat to ecosystems, but they cannot be halted by local actions. Ecosystem management is thus attempting to compensate for the impacts of global stressors by reducing local stressors, such as overfishing. This approach assumes that stressors interact additively or synergistically, whereby the combined effect of two stressors is at least the sum of their isolated effects. It is not clear, however, how management should proceed for antagonistic interactions among stressors, where multiple stressors do not have an additive or greater impact. Research to date has focussed on identifying synergisms among stressors, but antagonisms may be just as common. We examined the effectiveness of management when faced with different types of interactions in two systems - seagrass and fish communities - where the global stressor was climate change but the local stressors were different. When there were synergisms, mitigating local stressors delivered greater gains, whereas when there were antagonisms, management of local stressors was ineffective or even degraded ecosystems. These results suggest that reducing a local stressor can compensate for climate change impacts if there is a synergistic interaction. Conversely, if there is an antagonistic interaction, management of local stressors will have the greatest benefits in areas of refuge from climate change. A balanced research agenda, investigating both antagonistic and synergistic interaction types, is needed to inform management priorities.	[Brown, Christopher J.; Saunders, Megan I.] Univ Queensland, Global Change Inst, St Lucia, Qld, Australia; [Brown, Christopher J.; Saunders, Megan I.] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia; [Possingham, Hugh P.] Univ Queensland, Australian Res Council, Ctr Excellence Environm Decis, Sch Biol Sci, St Lucia, Qld, Australia; [Richardson, Anthony J.] Commonwealth Sci & Ind Res Org, Climate Adaptat Flagship, Marine & Atmospher Res, Brisbane, Qld, Australia; [Richardson, Anthony J.] Univ Queensland, Ctr Applicat Nat Resource Math, Sch Math & Phys, St Lucia, Qld, Australia	University of Queensland; University of Queensland; University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland	Brown, CJ (corresponding author), Univ Queensland, Global Change Inst, St Lucia, Qld, Australia.	c.brown5@uq.edu.au	Saunders, Megan/I-7731-2012; Possingham, Hugh/B-1337-2008; POSSINGHAM, HUGH/R-8310-2019; Brown, Christopher J/G-4287-2011; Richardson, Anthony J/B-3649-2010	Saunders, Megan/0000-0002-8549-5609; Possingham, Hugh/0000-0001-7755-996X; POSSINGHAM, HUGH/0000-0001-7755-996X; Brown, Christopher J/0000-0002-7271-4091; Richardson, Anthony J/0000-0002-9289-7366	Australian Research Council (ARC) Centre of Excellence for Environmental Decisions; ARC; ARC [FT0991722, DP0879365]	Australian Research Council (ARC) Centre of Excellence for Environmental Decisions(Australian Research Council); ARC(Australian Research Council); ARC(Australian Research Council)	CJB's contribution was supported by the Australian Research Council (ARC) Centre of Excellence for Environmental Decisions. MIS was supported by an ARC Super Science Postdoctoral Fellowship. AJR was supported by an ARC Future Fellowship FT0991722. This work forms part of the ARC Discovery Grant DP0879365. ARC: http://www.arc.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altaba CR, 2013, NAT CLIM CHANGE, V3, P2; Anthony KRN, 2007, LIMNOL OCEANOGR, V52, P716, DOI 10.4319/lo.2007.52.2.0716; Ban NC, 2010, MAR POLICY, V34, P876, DOI 10.1016/j.marpol.2010.01.010; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Brown CJ, 2011, GLOBAL CHANGE BIOL, V17, P3697, DOI 10.1111/j.1365-2486.2011.02531.x; Burkholder JM, 2007, J EXP MAR BIOL ECOL, V350, P46, DOI 10.1016/j.jembe.2007.06.024; Carilli JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006324; Carr JA, 2012, MAR ECOL PROG SER, V448, P289, DOI 10.3354/meps09556; Cote IM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000438; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; Darling ES, 2008, ECOL LETT, V11, P1278, DOI 10.1111/j.1461-0248.2008.01243.x; Darling ES, 2012, ECOL LETT, V15, P1378, DOI 10.1111/j.1461-0248.2012.01861.x; Darling ES, 2010, CONSERV LETT, V3, P122, DOI 10.1111/j.1755-263X.2009.00089.x; Ebert TA, 2002, LIMNOL OCEANOGR, V47, P600, DOI 10.4319/lo.2002.47.2.0600; Game ET, 2008, CONSERV BIOL, V22, P1619, DOI 10.1111/j.1523-1739.2008.01037.x; Graham NAJ, 2011, ECOL LETT, V14, P341, DOI 10.1111/j.1461-0248.2011.01592.x; Grantham HS, 2010, FRONT ECOL ENVIRON, V8, P431, DOI 10.1890/080151; Griffith GP, 2012, CONSERV BIOL, V26, P1145, DOI 10.1111/j.1523-1739.2012.01937.x; Griffith GP, 2011, GLOBAL CHANGE BIOL, V17, P3058, DOI 10.1111/j.1365-2486.2011.02453.x; GRIME JP, 1977, AM NAT, V111, P1169, DOI 10.1086/283244; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Halpern BS, 2010, P NATL ACAD SCI USA, V107, P18312, DOI 10.1073/pnas.0908503107; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hof C, 2011, NATURE, V480, P516, DOI 10.1038/nature10650; Jorda G, 2013, NAT CLIM CHANGE, V3, P3; Jorda G, 2012, NAT CLIM CHANGE, V2, P821, DOI [10.1038/NCLIMATE1533, 10.1038/nclimate1533]; Klein CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012431; Ling SD, 2009, P NATL ACAD SCI USA, V106, P22341, DOI 10.1073/pnas.0907529106; Mantyka-Pringle CS, 2012, GLOBAL CHANGE BIOL, V18, P1239, DOI 10.1111/j.1365-2486.2011.02593.x; Marba N, 2010, GLOBAL CHANGE BIOL, V16, P2366, DOI 10.1111/j.1365-2486.2009.02130.x; Morgan CL, 2011, LIMITS ADAPTATION RE; Mumby PJ, 2007, NATURE, V450, P98, DOI 10.1038/nature06252; Mumby PJ, 2011, ECOL LETT, V14, P132, DOI 10.1111/j.1461-0248.2010.01562.x; Orth RJ, 2010, ESTUAR COAST, V33, P1144, DOI [10.1007/s12237-009-9234-0, 10.1007/s12237-010-9311-4]; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; PARSONS PA, 1991, ANNU REV ECOL SYST, V22, P1, DOI 10.1146/annurev.es.22.110191.000245; Planque B, 2010, J MARINE SYST, V79, P403, DOI 10.1016/j.jmarsys.2008.12.018; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Rasheed MA, 2011, MAR ECOL PROG SER, V422, P93, DOI 10.3354/meps08925; Rietkerk M, 1997, OIKOS, V79, P69, DOI 10.2307/3546091; Saunders DL, 2002, CONSERV BIOL, V16, P30, DOI 10.1046/j.1523-1739.2002.99562.x; Selig ER, 2012, GLOBAL CHANGE BIOL, V18, P1561, DOI 10.1111/j.1365-2486.2012.02658.x; Short FT, 1999, AQUAT BOT, V63, P169, DOI 10.1016/S0304-3770(98)00117-X; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Touchette BW, 2003, ESTUARIES, V26, P142, DOI 10.1007/BF02691701; Vinebrooke RD, 2004, OIKOS, V104, P451, DOI 10.1111/j.0030-1299.2004.13255.x; Wernberg T, 2012, GLOBAL CHANGE BIOL, V18, P1491, DOI 10.1111/j.1365-2486.2012.02656.x; Wright SJ, 2005, TRENDS ECOL EVOL, V20, P553, DOI 10.1016/j.tree.2005.07.009	49	162	163	0	164	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65765	10.1371/journal.pone.0065765	http://dx.doi.org/10.1371/journal.pone.0065765			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776542	Green Submitted, Green Published, gold			2022-12-27	WOS:000320322400051
J	Ebina, M; Tsuruta, F; Katoh, MC; Kigoshi, Y; Someya, A; Chiba, T				Ebina, Manato; Tsuruta, Fuminori; Katoh, Megumi C.; Kigoshi, Yu; Someya, Akie; Chiba, Tomoki			Myeloma Overexpressed 2 (Myeov2) Regulates L11 Subnuclear Localization through Nedd8 Modification	PLOS ONE			English	Article							RIBOSOMAL-PROTEIN L11; COP9 SIGNALOSOME; MULTIPLE-MYELOMA; TUMOR-SUPPRESSOR; P53; MDM2; INHIBITION; ARF; ARABIDOPSIS; ACTIVATION	Nucleolus is a dynamic structure that controls biogenesis of ribosomal RNA and senses cellular stresses. Nucleolus contains a number of proteins including ribosomal proteins that conduct cellular stresses to downstream signaling such as p53 pathway. Recently, it has been reported that modification by a ubiquitin-like molecule, Nedd8, regulates subnuclear localization of ribosomal protein L11. Most of L11 is normally localized and neddylated in nucleolus. However, cellular stress triggers deneddylation and redistribution of L11, and subsequent activation of p53. Although Nedd8 modification is thought to be important for L11 localization, the mechanism of how neddylation of L11 is regulated remains largely unknown. Here, we show that Myeloma overexpressed 2 (Myeov2) controls L11 localization through down-regulation of Nedd8 modification. Expression of Myeov2 reduced neddylation of proteins including L11. We also found that Myeov2 associates with L11 and withholds L11 in nucleoplasm. Although Myeov2 interacted with a Nedd8 deconjugation enzyme COP9 signalosome, L11 deneddylation was mediated by another deneddylase Nedp1, independently of Myeov2. Finally, p53 transcriptional activity is upregulated by Myeov2 expression. These data demonstrate that Myeov2 hampers L11 neddylation through their interactions and confines L11 to nucleoplasm to modulate nucleolar integrity. Our findings provide a novel link between oncogenic stress and p53 pathway and may shed light on the protective mechanism against cancer.	[Ebina, Manato; Tsuruta, Fuminori; Katoh, Megumi C.; Kigoshi, Yu; Someya, Akie; Chiba, Tomoki] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan	University of Tsukuba	Tsuruta, F (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan.	ftsuruta@gmail.com; tchiba@biol.tsukuba.ac.jp			Ministry of Education, Science, Sports and Culture of Japan; Grants-in-Aid for Scientific Research [23570221] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid from Ministry of Education, Science, Sports and Culture of Japan to FT and TC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Aoki I, 2012, ONCOGENE; Bhat KP, 2004, EMBO J, V23, P2402, DOI 10.1038/sj.emboj.7600247; Boulon S, 2010, MOL CELL, V40, P216, DOI 10.1016/j.molcel.2010.09.024; Chan Y, 2008, J CELL SCI, V121, P3218, DOI 10.1242/jcs.030445; Chen D, 2007, ONCOGENE, V26, P5029, DOI 10.1038/sj.onc.1210327; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; Dai MS, 2004, J BIOL CHEM, V279, P44475, DOI 10.1074/jbc.M403722200; Fumagalli S, 2009, NAT CELL BIOL, V11, P501, DOI 10.1038/ncb1858; Hideshima T, 2007, NAT REV CANCER, V7, P585, DOI 10.1038/nrc2189; Jin A, 2004, MOL CELL BIOL, V24, P7669, DOI 10.1128/MCB.24.17.7669-7680.2004; Kamijo T, 1998, P NATL ACAD SCI USA, V95, P8292, DOI 10.1073/pnas.95.14.8292; Kato JY, 2009, GENES CELLS, V14, P1209, DOI 10.1111/j.1365-2443.2009.01349.x; Kigoshi Y, 2011, J BIOL CHEM, V286, P33613, DOI 10.1074/jbc.M111.245126; Korgaonkar C, 2005, MOL CELL BIOL, V25, P1258, DOI 10.1128/MCB.25.4.1258-1271.2005; Kwok SF, 1996, PLANT PHYSIOL, V110, P731, DOI 10.1104/pp.110.3.731; Lee M. H., 2011, CELL CYCLE, V10, P3057, DOI [DOI 10.4161/CC.10.18, 10.4161/cc.10.18.17320, DOI 10.4161/CC.10.18.17320]; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Mahata B, 2012, ONCOGENE, V31, P3060, DOI 10.1038/onc.2011.482; Morgan GJ, 2012, NAT REV CANCER, V12, P335, DOI 10.1038/nrc3257; Murayama A, 2008, CELL, V133, P627, DOI 10.1016/j.cell.2008.03.030; Nakasone A, 2012, PLANT PHYSIOL, V160, P93, DOI 10.1104/pp.111.188409; Nakasone A, 2009, J PLANT PHYSIOL, V166, P1307, DOI 10.1016/j.jplph.2009.02.005; Ohki Y, 2009, BIOCHEM BIOPH RES CO, V381, P443, DOI 10.1016/j.bbrc.2009.02.090; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; Rabut G, 2008, EMBO REP, V9, P969, DOI 10.1038/embor.2008.183; Rahman A, 2006, PLANT J, V47, P788, DOI 10.1111/j.1365-313X.2006.02832.x; Roe JS, 2006, MOL CELL, V22, P395, DOI 10.1016/j.molcel.2006.04.006; Ruggero D, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003477; Sasaki M, 2011, NAT MED, V17, P944, DOI 10.1038/nm.2392; Serino G, 2003, ANNU REV PLANT BIOL, V54, P165, DOI 10.1146/annurev.arplant.54.031902.134847; SMETANA K, 1973, CANCER RES, V33, P2300; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Stott FJ, 1998, EMBO J, V17, P5001, DOI 10.1093/emboj/17.17.5001; Sundqvist A, 2009, EMBO REP, V10, P1132, DOI 10.1038/embor.2009.178; Suzuki A, 2010, FEBS LETT, V584, P2801, DOI 10.1016/j.febslet.2010.05.020; [汤立军 Tang Lijun], 2003, [中国生物化学与分子生物学报, Chinese Journal of Biochemistry and Molecular Biology], V19, P60; van Marion AMW, 2003, CURR DIAGN PATHOL, V9, P322; Watson IR, 2010, ONCOGENE, V29, P297, DOI 10.1038/onc.2009.314; Watson IR, 2011, CANCER CELL, V19, P168, DOI 10.1016/j.ccr.2011.01.002; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991; Wei N, 2003, ANNU REV CELL DEV BI, V19, P261, DOI 10.1146/annurev.cellbio.19.111301.112449; Wei N, 2008, TRENDS BIOCHEM SCI, V33, P592, DOI 10.1016/j.tibs.2008.09.004; Xirodimas DP, 2008, BIOCHEM SOC T, V36, P802, DOI 10.1042/BST0360802; Xirodimas DP, 2008, EMBO REP, V9, P280, DOI 10.1038/embor.2008.10; Xirodimas DP, 2004, CELL, V118, P83, DOI 10.1016/j.cell.2004.06.016; Yanamandra N, 2011, J PHARMACOL EXP THER, V337, P636, DOI 10.1124/jpet.110.172809; Yoneda-Kato N, 2005, EMBO J, V24, P1739, DOI 10.1038/sj.emboj.7600656; YonedaKato N, 1996, ONCOGENE, V12, P265; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003; Zhu Y, 2009, MOL CELL, V35, P316, DOI 10.1016/j.molcel.2009.07.014	53	13	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65285	10.1371/journal.pone.0065285	http://dx.doi.org/10.1371/journal.pone.0065285			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776465	Green Submitted, gold, Green Published			2022-12-27	WOS:000320322400015
J	Andrisse, S; Patel, GD; Chen, JE; Webber, AM; Spears, LD; Koehler, RM; Robinson-Hill, RM; Ching, JK; Jeong, I; Fisher, JS				Andrisse, Stanley; Patel, Gaytri D.; Chen, Joseph E.; Webber, Andrea M.; Spears, Larry D.; Koehler, Rikki M.; Robinson-Hill, Rona M.; Ching, James K.; Jeong, Imju; Fisher, Jonathan S.			ATM and GLUT1-S490 Phosphorylation Regulate GLUT1 Mediated Transport in Skeletal Muscle	PLOS ONE			English	Article							DEHYDROASCORBIC ACID TRANSPORT; FACTOR-INDEPENDENT SURVIVAL; GROWTH-FACTOR REGULATION; BETA-CELL DYSFUNCTION; GLUCOSE-TRANSPORTER; INSULIN-RESISTANCE; ATAXIA-TELANGIECTASIA; GENE-EXPRESSION; IONIZING-RADIATION; OXIDATIVE STRESS	Objective: The glucose and dehydroascorbic acid (DHA) transporter GLUT1 contains a phosphorylation site, S490, for ataxia telangiectasia mutated (ATM). The objective of this study was to determine whether ATM and GLUT1-S490 regulate GLUT1. Research Design and Methods: L6 myoblasts and mouse skeletal muscles were used to study the effects of ATM inhibition, ATM activation, and S490 mutation on GLUT1 localization, trafficking, and transport activity. Results: In myoblasts, inhibition of ATM significantly diminished cell surface GLUT1, glucose and DHA transport, GLUT1 externalization, and association of GLUT1 with Ga-interacting protein-interacting protein, C-terminus (GIPC1), which has been implicated in recycling of endosomal proteins. In contrast, ATM activation by doxorubicin (DXR) increased DHA transport, cell surface GLUT1, and the GLUT1/GIPC1 association. S490A mutation decreased glucose and DHA transport, cell surface GLUT1, and interaction of GLUT1 with GIPC1, while S490D mutation increased transport, cell surface GLUT1, and the GLUT1/GIPC1 interaction. ATM dysfunction or ATM inhibition reduced DHA transport in extensor digitorum longus (EDL) muscles and decreased glucose transport in EDL and soleus. In contrast, DXR increased DHA transport in EDL. Conclusions: These results provide evidence that ATM and GLUT1-S490 promote cell surface GLUT1 and GLUT1-mediated transport in skeletal muscle associated with upregulation of the GLUT1/GIPC1 interaction.	[Andrisse, Stanley; Patel, Gaytri D.; Chen, Joseph E.; Webber, Andrea M.; Spears, Larry D.; Koehler, Rikki M.; Robinson-Hill, Rona M.; Ching, James K.; Jeong, Imju; Fisher, Jonathan S.] St Louis Univ, Dept Biol, St Louis, MO 63103 USA	Saint Louis University	Fisher, JS (corresponding author), St Louis Univ, Dept Biol, St Louis, MO 63103 USA.	fisherjs@slu.edu	Fisher, Jonathan/A-3095-2008	Fisher, Jonathan/0000-0001-5170-2692; Spears, Larry/0000-0003-2797-684X	National Institute of Diabetes and Digestive and Kidney Diseases [R15DK091904, R15DK080437, R15DK080437-01S2, R15DK080437-01S3]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R15DK080437, R15DK091904] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The project was supported by Grant Numbers R15DK091904 and R15DK080437 (through American Recovery and Reinvestment Act supplements R15DK080437-01S2 and R15DK080437-01S3) from the National Institute of Diabetes and Digestive and Kidney Diseases. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Diabetes and Digestive and Kidney Diseases or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Beuming T, 2005, BIOINFORMATICS, V21, P827, DOI 10.1093/bioinformatics/bti098; BILAN PJ, 1992, BIOCHEM BIOPH RES CO, V186, P1129, DOI 10.1016/0006-291X(92)90864-H; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601; Bunn RC, 1999, MOL BIOL CELL, V10, P819, DOI 10.1091/mbc.10.4.819; Carruthers A, 2009, AM J PHYSIOL-ENDOC M, V297, pE836, DOI 10.1152/ajpendo.00496.2009; Cheatham B, 2000, TRENDS ENDOCRIN MET, V11, P356, DOI 10.1016/S1043-2760(00)00308-8; Ching JK, 2013, APPL PHYSL IN PRESS; Ciaraldi TP, 2005, J CLIN ENDOCR METAB, V90, P352, DOI 10.1210/jc.2004-0516; Dauterive R, 1996, J BIOL CHEM, V271, P11414, DOI 10.1074/jbc.271.19.11414; De Rosa S, 2010, CURR VASC PHARMACOL, V8, P259; Edinger AL, 2003, DEV CELL, V5, P571, DOI 10.1016/S1534-5807(03)00291-0; GUILLETDENIAU I, 1994, J CELL SCI, V107, P487; Halaby MJ, 2008, CELL SIGNAL, V20, P1555, DOI 10.1016/j.cellsig.2008.04.011; Henriksen EJ, 2011, FREE RADICAL BIO MED, V51, P993, DOI 10.1016/j.freeradbiomed.2010.12.005; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Hirakawa T, 2003, J BIOL CHEM, V278, P49348, DOI 10.1074/jbc.M306557200; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Huang J, 2011, CANCER RES, V71, P6310, DOI 10.1158/0008-5472.CAN-10-3397; Im SS, 2007, IUBMB LIFE, V59, P134, DOI 10.1080/15216540701313788; Ishikura S., 2010, CURR PROTOC CELL BIO; Jeong I, 2010, ACTA PHYSIOL, V198, P465, DOI 10.1111/j.1748-1716.2009.02069.x; Ju JS, 2005, AM J PHYSIOL-ENDOC M, V288, pE347, DOI 10.1152/ajpendo.00238.2004; KAHN BB, 1994, J NUTR, V124, pS1289, DOI 10.1093/jn/124.suppl_8.1289S; KAHN BB, 1990, DIABETES CARE, V13, P548, DOI 10.2337/diacare.13.6.548; Kahn SE, 2003, DIABETOLOGIA, V46, P3, DOI 10.1007/s00125-002-1009-0; Kasahara T, 2009, BBA-BIOMEMBRANES, V1788, P1051, DOI 10.1016/j.bbamem.2009.01.014; KATZ EB, 1995, NATURE, V377, P151, DOI 10.1038/377151a0; KLIP A, 1992, J CELL BIOCHEM, V48, P51, DOI 10.1002/jcb.240480109; Korcok J, 2003, BRAIN RES, V993, P201, DOI 10.1016/j.brainres.2003.09.016; Krook A, 2004, MED SCI SPORT EXER, V36, P1212, DOI 10.1249/01.MSS.0000132387.25853.3B; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Maddux BA, 2001, DIABETES, V50, P404, DOI 10.2337/diabetes.50.2.404; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Miles PD, 2007, AM J PHYSIOL-ENDOC M, V293, pE70, DOI 10.1152/ajpendo.00259.2006; Mueckler M, 2009, BIOCHEMISTRY-US, V48, P5934, DOI 10.1021/bi900521n; Murata H, 2000, J BIOL CHEM, V275, P20251, DOI 10.1074/jbc.C000228200; Rainey MD, 2008, CANCER RES, V68, P7466, DOI 10.1158/0008-5472.CAN-08-0763; Rathmell JC, 2003, MOL CELL BIOL, V23, P7315, DOI 10.1128/MCB.23.20.7315-7328.2003; Reed BC, 2005, MOL BIOL CELL, V16, P4183, DOI 10.1091/mbc.e04-11-0978; Rudich A, 2003, DIABETOLOGIA, V46, P649, DOI 10.1007/s00125-003-1080-1; Rumsey SC, 1997, J BIOL CHEM, V272, P18982, DOI 10.1074/jbc.272.30.18982; Rumsey SC, 2000, J BIOL CHEM, V275, P28246; Schneider JG, 2006, CELL METAB, V4, P377, DOI 10.1016/j.cmet.2006.10.002; Smith JL, 2004, J APPL PHYSIOL, V97, P2339, DOI 10.1152/japplphysiol.01219.2003; Stiffler MA, 2006, J AM CHEM SOC, V128, P5913, DOI 10.1021/ja060943h; Stuart CA, 2009, J CLIN ENDOCR METAB, V94, P3535, DOI 10.1210/jc.2009-0162; Stumvoll M, 2001, CLIN LAB MED, V21, P31; Sun LF, 2012, NATURE, V490, P361, DOI 10.1038/nature11524; VERHEY KJ, 1993, J CELL BIOL, V123, P137, DOI 10.1083/jcb.123.1.137; Viniegra JG, 2005, J BIOL CHEM, V280, P4029, DOI 10.1074/jbc.M410344200; Wieman HL, 2009, BIOCHEM J, V418, P345, DOI 10.1042/BJ20081422; Wiernan HL, 2007, MOL BIOL CELL, V18, P1437, DOI 10.1091/mbc.E06-07-0593; Wijesekara N, 2006, AM J PHYSIOL-ENDOC M, V290, pE1276, DOI 10.1152/ajpendo.00573.2005; WILSON CM, 1995, FEBS LETT, V368, P19, DOI 10.1016/0014-5793(95)00589-2; Wood IS, 2003, BRIT J NUTR, V89, P3, DOI 10.1079/BJN2002763; Zhang JZ, 2001, AM J PHYSIOL-CELL PH, V280, pC1277, DOI 10.1152/ajpcell.2001.280.5.C1277; Zisman A, 2000, NAT MED, V6, P924, DOI 10.1038/78693	60	28	28	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66027	10.1371/journal.pone.0066027	http://dx.doi.org/10.1371/journal.pone.0066027			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776597	Green Submitted, Green Published, gold			2022-12-27	WOS:000320755400102
J	Bielecki, J; Hoeg, JT; Garm, A				Bielecki, Jan; Hoeg, Jens T.; Garm, Anders			Fixational Eye Movements in the Earliest Stage of Metazoan Evolution	PLOS ONE			English	Article							BOX JELLYFISH; TRIPEDALIA-CYSTOPHORA; LIGHT ADAPTATION; NERVOUS-SYSTEM	All known photoreceptor cells adapt to constant light stimuli, fading the retinal image when exposed to an immobile visual scene. Counter strategies are therefore necessary to prevent blindness, and in mammals this is accomplished by fixational eye movements. Cubomedusae occupy a key position for understanding the evolution of complex visual systems and their eyes are assumedly subject to the same adaptive problems as the vertebrate eye, but lack motor control of their visual system. The morphology of the visual system of cubomedusae ensures a constant orientation of the eyes and a clear division of the visual field, but thereby also a constant retinal image when exposed to stationary visual scenes. Here we show that bell contractions used for swimming in the medusae refresh the retinal image in the upper lens eye of Tripedalia cystophora. This strongly suggests that strategies comparable to fixational eye movements have evolved at the earliest metazoan stage to compensate for the intrinsic property of the photoreceptors. Since the timing and amplitude of the rhopalial movements concur with the spatial and temporal resolution of the eye it circumvents the need for post processing in the central nervous system to remove image blur.	[Bielecki, Jan; Hoeg, Jens T.; Garm, Anders] Univ Copenhagen, Marine Biol Sect, Copenhagen, Denmark	University of Copenhagen	Bielecki, J (corresponding author), Univ Copenhagen, Marine Biol Sect, Copenhagen, Denmark.	jbielecki@bio.ku.dk	Hoeg, Jens Thorvald/D-5784-2015; Garm, Anders/K-4362-2014	Hoeg, Jens Thorvald/0000-0002-3596-1691; Garm, Anders/0000-0002-2080-735X	VILLUM Foundation [VKR022166]	VILLUM Foundation(Villum Fonden)	AG acknowledges the financial support from the VILLUM Foundation (grant# VKR022166). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker A, 2005, DALTON T, P1545, DOI 10.1039/b416246c; BROWN KT, 1968, VISION RES, V8, P633, DOI 10.1016/0042-6989(68)90041-2; Buskey EJ, 2003, MAR BIOL, V142, P225, DOI 10.1007/s00227-002-0938-y; Coates MM, 2003, INTEGR COMP BIOL, V43, P542, DOI 10.1093/icb/43.4.542; DUELLI P, 1978, CELL TISSUE RES, V187, P417; Fain GL, 2001, PHYSIOL REV, V81, P117, DOI 10.1152/physrev.2001.81.1.117; Fain GL, 2011, MOL NEUROBIOL, V44, P374, DOI 10.1007/s12035-011-8205-1; Fain GL, 2010, CURR BIOL, V20, pR114, DOI 10.1016/j.cub.2009.12.006; Garm A, 2008, J COMP PHYSIOL A, V194, P641, DOI 10.1007/s00359-008-0336-0; Garm A, 2008, VISION RES, V48, P1061, DOI 10.1016/j.visres.2008.01.019; Garm A, 2007, J EXP BIOL, V210, P3616, DOI 10.1242/jeb.004044; Garm A, 2009, J EXP BIOL, V212, P3951, DOI 10.1242/jeb.031559; Garm A, 2011, CURR BIOL, V21, P798, DOI 10.1016/j.cub.2011.03.054; Kaps F, 1996, J EXP BIOL, V199, P2451; Kowler E, 2011, VISION RES, V51, P1457, DOI 10.1016/j.visres.2010.12.014; Koyanagi M, 2008, P NATL ACAD SCI USA, V105, P15576, DOI 10.1073/pnas.0806215105; Laska G., 1982, Zoologische Jahrbuecher Abteilung fuer Anatomie und Ontogenie der Tiere, V108, P107; LAUGHLIN SB, 1978, J COMP PHYSIOL, V128, P319, DOI 10.1007/BF00657606; MACKIE GO, 1990, AM ZOOL, V30, P907; MAFFEI L, 1981, SCIENCE, V211, P953, DOI 10.1126/science.7466368; Martinez-Conde S, 2004, NAT REV NEUROSCI, V5, P229, DOI 10.1038/nrn1348; MATTHEWS HR, 1988, NATURE, V334, P67, DOI 10.1038/334067a0; Nilsson DE, 2009, PHILOS T R SOC B, V364, P2833, DOI 10.1098/rstb.2009.0083; Nilsson DE, 2005, NATURE, V435, P201, DOI 10.1038/nature03484; O'Connor M, 2010, J COMP PHYSIOL A, V196, P213, DOI 10.1007/s00359-010-0506-8; RIGGS LA, 1953, J OPT SOC AM, V43, P495, DOI 10.1364/JOSA.43.000495; Skogh C, 2006, J MORPHOL, V267, P1391, DOI 10.1002/jmor.10472; WEHNER R, 1987, J COMP PHYSIOL A, V161, P511, DOI 10.1007/BF00603659	28	3	3	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66442	10.1371/journal.pone.0066442	http://dx.doi.org/10.1371/journal.pone.0066442			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776673	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000320755400146
J	Chen, J; Liu, XJ; Chen, X; Guo, ZH; Liu, J; Hao, JY; Zhang, J				Chen, Jing; Liu, Xinjuan; Chen, Xue; Guo, Zihao; Liu, Juan; Hao, Jianyu; Zhang, Jie			Real-Time Monitoring of miRNA Function in Pancreatic Cell Lines Using Recombinant AAV-Based miRNA Asensors	PLOS ONE			English	Article							MIR-200 FAMILY; MESENCHYMAL TRANSITION; REPRESSORS ZEB1; CANCER; MICRORNA; TELOMERASE; EXPRESSION; MIR-155; ESTABLISHMENT; ASSOCIATION	Background: MicroRNAs (miRNAs) are reportedly involved in pancreatic ductal adenocarcinoma (PDAC) development. Current methods do not allow us to reliably monitor miRNA function. Asensors are adeno-associated virus (AAV) vector miRNA sensors for real-time consecutive functional monitoring of miRNA profiling in living cells. Methods: miR-200a, -200b, -21, -96, -146a, -10a, -155, and -221 in three PDAC cell lines (BxPC-3, CFPAC-1, SW1990), pancreatic epithelioid carcinoma cells (PANC-1), and human pancreatic nestin-expressing cells (hTERT-HPNE) were monitored by Asensors. Subsequently, the real-time consecutive functional profile of all miRNAs was evaluated. Results: Selected miRNAs were detectable in all cell lines with high sensitivity and reproducibility. In the three PDAC cell lines, BxPC-3, CFPAC-1, and SW1990, the calibrated signal unit of the eight miRNAs Asensors was significantly lower than that of the Asensor control. However, in PANC-1 cells, miR-200a and -155 showed upregulation of target gene expression at 24 hours after infection with the sensors; at 48 hours, miR-200b and -155 displayed upregulation of reporter expression; and at 72 hours, reporter gene expression was upregulated by miR-200a and -200b. The result that miRNA could upregulate gene expression was further confirmed in miR-155 of hTERT-HPNE cells. Furthermore, miRNA activity varied among cell/tissue types and time. Conclusion: It is possible that miRNA participates in the pathophysiology of pancreatic cancer, but the current popular methods do not accurately reveal the real-time miRNA function. Thus, this report provided a convenient, accurate, and sensitive approach to miRNA research.	[Chen, Jing; Liu, Xinjuan; Chen, Xue; Guo, Zihao; Hao, Jianyu; Zhang, Jie] Capital Med Univ, Beijing Chaoyang Hosp, Dept Gastroenterol, Beijing, Peoples R China; [Liu, Juan] Zhengzhou Tenth Peoples Hosp, Zhengzhou, Henan, Peoples R China	Capital Medical University	Zhang, J (corresponding author), Capital Med Univ, Beijing Chaoyang Hosp, Dept Gastroenterol, Beijing, Peoples R China.	zhangjie4155@gmail.com			Wu Jieping Medical Foundation, China [320.6750.09.161, 320.6700.1181]	Wu Jieping Medical Foundation, China	This work is Supported by Wu Jieping Medical Foundation (No. 320.6750.09.161 and 320.6700.1181), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu Aruna, 2011, Genes Cancer, V2, P108, DOI 10.1177/1947601911409212; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Caponi S, 2013, ANN ONCOL, V24, P734, DOI 10.1093/annonc/mds513; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen CZ, 2005, NEW ENGL J MED, V353, P1768, DOI 10.1056/NEJMp058190; Dong XY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013479; du Rieu MC, 2010, CLIN CHEM, V56, P603, DOI 10.1373/clinchem.2009.137364; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Gironella M, 2007, P NATL ACAD SCI USA, V104, P16170, DOI 10.1073/pnas.0703942104; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Greten FR, 2001, PANCREATOLOGY, V1, P363, DOI 10.1159/000055835; Habbe N, 2009, CANCER BIOL THER, V8, P340, DOI 10.4161/cbt.8.4.7338; Jiang XR, 1999, NAT GENET, V21, P111, DOI 10.1038/5056; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kong YW, 2012, LANCET ONCOL, V13, pE249, DOI 10.1016/S1470-2045(12)70073-6; Koorstra JBM, 2008, PANCREATOLOGY, V8, P110, DOI 10.1159/000123838; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lee KM, 2005, LAB INVEST, V85, P1003, DOI 10.1038/labinvest.3700298; Lee KM, 2003, BIOCHEM BIOPH RES CO, V301, P1038, DOI 10.1016/S0006-291X(03)00086-X; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li A, 2010, CANCER RES, V70, P5226, DOI 10.1158/0008-5472.CAN-09-4227; Li YW, 2010, CANCER RES, V70, P1486, DOI 10.1158/0008-5472.CAN-09-2792; LIEBER M, 1975, INT J CANCER, V15, P741, DOI 10.1002/ijc.2910150505; Liu CG, 2004, P NATL ACAD SCI USA, V101, P9740, DOI 10.1073/pnas.0403293101; Ma J, 2010, CURR BIOL, V20, P265, DOI 10.1016/j.cub.2009.12.042; Miyamoto Y, 2003, CANCER CELL, V3, P565, DOI 10.1016/S1535-6108(03)00140-5; Morales CP, 1999, NAT GENET, V21, P115, DOI 10.1038/5063; Muckstein U, 2006, BIOINFORMATICS, V22, P1177, DOI 10.1093/bioinformatics/btl024; Negrini M, 2007, J CELL SCI, V120, P1833, DOI 10.1242/jcs.03450; Ouellette MM, 2000, HUM MOL GENET, V9, P403, DOI 10.1093/hmg/9.3.403; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; PARSA I, 1985, CANCER RES, V45, P1285; Qi LQ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-163; Qian BY, 2009, BREAST CANCER RES TR, V117, P131, DOI 10.1007/s10549-008-0219-7; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Slack FJ, 2008, NEW ENGL J MED, V359, P2720, DOI 10.1056/NEJMe0808667; Tang GL, 2005, TRENDS BIOCHEM SCI, V30, P106, DOI 10.1016/j.tibs.2004.12.007; Tian WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029551; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Wagner M, 1998, GASTROENTEROLOGY, V115, P1254, DOI 10.1016/S0016-5085(98)70098-8; Weiss FU, 2009, GASTROENTEROLOGY, V137, P2136, DOI 10.1053/j.gastro.2009.08.065; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yang JW, 1999, J BIOL CHEM, V274, P26141, DOI 10.1074/jbc.274.37.26141; Yu S, CANC RES, V70, P6015	47	5	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66315	10.1371/journal.pone.0066315	http://dx.doi.org/10.1371/journal.pone.0066315			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776656	Green Published, Green Submitted, gold			2022-12-27	WOS:000320755400136
J	Nikiforuk, A; Kos, T; Fijal, K; Holuj, M; Rafa, D; Popik, P				Nikiforuk, Agnieszka; Kos, Tomasz; Fijal, Katarzyna; Holuj, Malgorzata; Rafa, Dominik; Popik, Piotr			Effects of the Selective 5-HT7 Receptor Antagonist SB-269970 and Amisulpride on Ketamine-Induced Schizophrenia-like Deficits in Rats	PLOS ONE			English	Article							ANIMAL-MODELS; MEMORY; IMPAIRMENT; BLOCKADE; AGONIST; SB-258741; LAUGHTER; CORTEX	A wide body of evidence suggests that 5-HT7 receptors are implicated in a variety of central nervous system functions, including control of learning and memory processes. According to recent preclinical data, the selective blockade of these receptors may be a potential target for cognitive improvement in schizophrenia. The first aim of the present study was to evaluate the effects of the selective 5-HT7 receptor antagonist, SB-269970, and the antipsychotic drug with a high affinity for 5-HT7 receptors, amisulpride, on ketamine-induced deficits in attentional set-shifting and novel object recognition tasks in rats. Because the role of 5-HT7 receptor blockade in ameliorating positive and negative symptoms of schizophrenia remains equivocal, the second aim of these experiments was to examine the effectiveness of SB-269970 and amisulpride in reversing ketamine-induced deficits in prepulse inhibition of the startle reflex and in social interaction test in rats. The study revealed that acute administration of SB-269970 (1 mg/kg) or amisulpride (3 mg/kg) ameliorated ketamine-induced cognitive inflexibility and novel object recognition deficit in rats. Both compounds were also effective in attenuating ketamine-evoked disruption of social interactions. In contrast, neither SB-269970 nor amisulpride affected ketamine-disrupted prepulse inhibition or 50 kHz USVs accompanying social behaviour. In conclusion, antagonism of 5-HT7 receptors may represent a useful pharmacological approach in the treatment of cognitive deficits and some negative symptoms of schizophrenia.	[Nikiforuk, Agnieszka; Kos, Tomasz; Fijal, Katarzyna; Holuj, Malgorzata; Rafa, Dominik; Popik, Piotr] Polish Acad Sci, Inst Pharmacol, Dept Behav Neurosci & Drug Dev, Krakow, Poland	Polish Academy of Sciences	Nikiforuk, A (corresponding author), Polish Acad Sci, Inst Pharmacol, Dept Behav Neurosci & Drug Dev, Krakow, Poland.	nikifor@if-pan.krakow.pl	Popik, Piotr/R-5383-2016	Popik, Piotr/0000-0003-0722-1263; Nikiforuk, Agnieszka/0000-0002-2424-8348; Holuj, Malgorzata/0000-0001-7867-0643	Statutory Funds of the Institute of Pharmacology; Polish Academy of Sciences and project "Prokog'' [UDA-POIG.01.03.01-12-063/09-00]; European Union from the European Fund of Regional Development (EFRD)	Statutory Funds of the Institute of Pharmacology; Polish Academy of Sciences and project "Prokog''; European Union from the European Fund of Regional Development (EFRD)	This study was supported by the Statutory Funds of the Institute of Pharmacology, the Polish Academy of Sciences and project "Prokog,'' UDA-POIG.01.03.01-12-063/09-00, co-financed by the European Union from the European Fund of Regional Development (EFRD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AI, 2009, PSYCHOPHARMACOLOGY, V205, P119, DOI 10.1007/s00213-009-1521-8; BAKSHI VP, 1994, J PHARMACOL EXP THER, V271, P787; Birrell JM, 2000, J NEUROSCI, V20, P4320; Bonaventure P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020210; Cifariello A, 2008, BEHAV BRAIN RES, V195, P171, DOI 10.1016/j.bbr.2007.12.012; Elvevag B, 2000, CRIT REV NEUROBIOL, V14, P1; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Forbes IT, 2002, BIOORG MED CHEM LETT, V12, P3341, DOI 10.1016/S0960-894X(02)00690-X; Galici R, 2008, BEHAV PHARMACOL, V19, P153, DOI 10.1097/FBP.0b013e3282f62d8c; Gastambide F, 2013, EUR NEUROPSYCHOPHARM, DOI [10.1016/j.euro-neuro.2013.03.002, DOI 10.1016/J.EUR0-NEUR0.2013.03.002]; Gilmour G, 2013, NEUROSCI BIOBEHAV R, V37, P2125, DOI 10.1016/j.neubiorev.2012.04.006; Hagan JJ, 2000, BRIT J PHARMACOL, V130, P539, DOI 10.1038/sj.bjp.0703357; Hedlund PB, 2009, PSYCHOPHARMACOLOGY, V206, P345, DOI 10.1007/s00213-009-1626-0; Horiguchi M, 2011, J PHARMACOL EXP THER, V338, P605, DOI 10.1124/jpet.111.180638; Horisawa T, 2011, BEHAV BRAIN RES, V220, P83, DOI 10.1016/j.bbr.2011.01.034; Ishibashi T, 2010, J PHARMACOL EXP THER, V334, P171, DOI 10.1124/jpet.110.167346; KRYSTAL JH, 1994, ARCH GEN PSYCHIAT, V51, P199, DOI 10.1001/archpsyc.1994.03950030035004; Leopoldo M, 2011, PHARMACOL THERAPEUT, V129, P120, DOI 10.1016/j.pharmthera.2010.08.013; Liy-Salmeron G, 2008, HIPPOCAMPUS, V18, P965, DOI 10.1002/hipo.20459; Lopuch S, 2011, J COMP PSYCHOL, V125, P250, DOI 10.1037/a0021532; Mahe C, 2004, EUR J PHARMACOL, V495, P97, DOI 10.1016/j.ejphar.2004.05.033; Matthys A, 2011, MOL NEUROBIOL, V43, P228, DOI 10.1007/s12035-011-8175-3; McLean SL, 2009, PSYCHOPHARMACOLOGY, V206, P403, DOI 10.1007/s00213-009-1618-0; Meneses A, 2004, BEHAV BRAIN RES, V155, P275, DOI 10.1016/j.bbr.2004.04.026; Moghaddam B, 1998, SCIENCE, V281, P1349, DOI 10.1126/science.281.5381.1349; Neill JC, 2010, PHARMACOL THERAPEUT, V128, P419, DOI 10.1016/j.pharmthera.2010.07.004; Newcomer JW, 1999, NEUROPSYCHOPHARMACOL, V20, P106, DOI 10.1016/S0893-133X(98)00067-0; Nikiforuk A, 2012, BEHAV BRAIN RES, V226, P118, DOI 10.1016/j.bbr.2011.09.006; Nikiforuk A, 2010, EUR NEUROPSYCHOPHARM, V20, P37, DOI 10.1016/j.euroneuro.2009.08.001; Nuechterlein KH, 2004, SCHIZOPHR RES, V72, P29, DOI 10.1016/j.schres.2004.09.007; Panksepp J, 2005, SCIENCE, V308, P62, DOI 10.1126/science.1112066; Panksepp J, 2000, BEHAV BRAIN RES, V115, P25, DOI 10.1016/S0166-4328(00)00238-2; Pouzet B, 2002, PHARMACOL BIOCHEM BE, V71, P655, DOI 10.1016/S0091-3057(01)00744-4; Roberts AJ, 2004, EUR J NEUROSCI, V19, P1913, DOI 10.1111/j.1460-9568.2004.03288.x; Roberts AJ, 2012, HIPPOCAMPUS, V22, P762, DOI 10.1002/hipo.20938; Sarkisyan G, 2009, BEHAV BRAIN RES, V202, P26, DOI 10.1016/j.bbr.2009.03.011; Semenova S, 2008, BIOL PSYCHIAT, V63, P98, DOI 10.1016/j.biopsych.2006.12.011; Slot LAB, 2005, NEUROPHARMACOLOGY, V49, P996, DOI 10.1016/j.neuropharm.2005.05.013; Snigdha S, 2008, BEHAV BRAIN RES, V191, P26, DOI 10.1016/j.bbr.2008.03.018; Varty GB, 1999, NEUROPSYCHOPHARMACOL, V20, P311, DOI 10.1016/S0893-133X(98)00072-4; Waters KA, 2012, BEHAV BRAIN RES, V228, P211, DOI 10.1016/j.bbr.2011.12.009; Watson DJG, 2012, INT J NEUROPSYCHOPH, V15, P471, DOI 10.1017/S1461145711000435; Wesolowska A, 2008, PHARMACOL REP, V60, P464; Wesolowska A, 2006, NEUROPHARMACOLOGY, V51, P578, DOI 10.1016/j.neuropharm.2006.04.017; Willey AR, 2009, BEHAV BRAIN RES, V202, P122, DOI 10.1016/j.bbr.2009.03.025; Wright JM, 2013, PSYCHOPHARMACOLOGY, V225, P853, DOI 10.1007/s00213-012-2871-1; Young JW, 2009, PHARMACOL THERAPEUT, V122, P150, DOI 10.1016/j.pharmthera.2009.02.004	47	77	84	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66695	10.1371/journal.pone.0066695	http://dx.doi.org/10.1371/journal.pone.0066695			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776692	Green Submitted, Green Published, gold			2022-12-27	WOS:000320755400153
J	Shyamasundar, S; Jadhav, SP; Bay, BH; Tay, SSW; Kumar, SD; Rangasamy, D; Dheen, ST				Shyamasundar, Sukanya; Jadhav, Shweta P.; Bay, Boon Huat; Tay, Samuel Sam Wah; Kumar, S. Dinesh; Rangasamy, Danny; Dheen, S. Thameem			Analysis of Epigenetic Factors in Mouse Embryonic Neural Stem Cells Exposed to Hyperglycemia	PLOS ONE			English	Article							ALTERED GENE-EXPRESSION; NEURONAL MIGRATION; DIABETIC PREGNANCY; DNA METHYLATION; CONGENITAL-ANOMALIES; MICRORNA EXPRESSION; FATE SPECIFICATION; LIS1; MIR-124; MALFORMATIONS	Background: Maternal diabetes alters gene expression leading to neural tube defects (NTDs) in the developing brain. The mechanistic pathways that deregulate the gene expression remain unknown. It is hypothesized that exposure of neural stem cells (NSCs) to high glucose/hyperglycemia results in activation of epigenetic mechanisms which alter gene expression and cell fate during brain development. Methods and Findings: NSCs were isolated from normal pregnancy and streptozotocin induced-diabetic pregnancy and cultured in physiological glucose. In order to examine hyperglycemia induced epigenetic changes in NSCs, chromatin reorganization, global histone status at lysine 9 residue of histone H3 (acetylation and trimethylation) and global DNA methylation were examined and found to be altered by hyperglycemia. In NSCs, hyperglycemia increased the expression of Dcx (Doublecortin) and Pafah1b1 (Platelet activating factor acetyl hydrolase, isoform 1b, subunit 1) proteins concomitant with decreased expression of four microRNAs (mmu-miR-200a, mmu-miR-200b, mmu-miR-466a-3p and mmu-miR-466 d-3p) predicted to target these genes. Knockdown of specific microRNAs in NSCs resulted in increased expression of Dcx and Pafah1b1 proteins confirming target prediction and altered NSC fate by increasing the expression of neuronal and glial lineage markers. Conclusion/Interpretation: This study revealed that hyperglycemia alters the epigenetic mechanisms in NSCs, resulting in altered expression of some development control genes which may form the basis for the NTDs. Since epigenetic changes are reversible, they may be valuable therapeutic targets in order to improve fetal outcomes in diabetic pregnancy.	[Shyamasundar, Sukanya; Jadhav, Shweta P.; Bay, Boon Huat; Tay, Samuel Sam Wah; Dheen, S. Thameem] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Anat, Singapore 117595, Singapore; [Kumar, S. Dinesh] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 639798, Singapore; [Rangasamy, Danny] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia	National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Australian National University; John Curtin School of Medical Research	Dheen, ST (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Anat, Singapore 117595, Singapore.	antstd@nus.edu.sg	Dheen, S. Thameem/AAU-8627-2020; Srinivasan, Dinesh Kumar/E-6383-2017; , sukanya/K-2638-2019; Srinivasan, Dinesh Kumar/A-9872-2008; Srinivasan, Dinesh Kumar/P-6528-2019	Srinivasan, Dinesh Kumar/0000-0001-6535-5441; Srinivasan, Dinesh Kumar/0000-0001-6535-5441; Dheen, S. Thameem/0000-0001-9600-6789	NUS bridging fund [R-181-000-130-720]	NUS bridging fund	This study is supported by the NUS bridging fund R-181-000-130-720. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bi WM, 2009, NAT GENET, V41, P168, DOI 10.1038/ng.302; Cao XW, 2007, GENE DEV, V21, P531, DOI 10.1101/gad.1519207; Caspi M, 2000, HUM MOL GENET, V9, P2205, DOI 10.1093/oxfordjournals.hmg.a018911; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Choi PS, 2008, NEURON, V57, P41, DOI 10.1016/j.neuron.2007.11.018; Deo M, 2006, DEV DYNAM, V235, P2538, DOI 10.1002/dvdy.20847; Dimitri P, 2005, BIOESSAYS, V27, P29, DOI 10.1002/bies.20158; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; El-Osta A, 2008, J EXP MED, V205, P2409, DOI 10.1084/jem.20081188; ERIKSSON UJ, 1995, DIABETES METAB REV, V11, P63, DOI 10.1002/dmr.5610110106; Filipovic R, 2012, STEM CELLS, V30, P1852, DOI 10.1002/stem.1162; Fu J, 2006, DIABETOLOGIA, V49, P1027, DOI 10.1007/s00125-006-0153-3; Fu J, 2007, J NEUROCHEM, V103, P1654, DOI 10.1111/j.1471-4159.2007.04880.x; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gambello MJ, 2003, J NEUROSCI, V23, P1719; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Guerrini R, 2008, TRENDS NEUROSCI, V31, P154, DOI 10.1016/j.tins.2007.12.004; HANSON U, 1990, DIABETOLOGIA, V33, P100, DOI 10.1007/BF00401047; Hirotsune S, 1998, NAT GENET, V19, P333, DOI 10.1038/1221; Hsieh J, 2004, CURR OPIN GENET DEV, V14, P461, DOI 10.1016/j.gde.2004.07.006; Hu XL, 2012, PROTEIN CELL, V3, P278, DOI 10.1007/s13238-012-2916-6; Ivey KN, 2008, CELL STEM CELL, V2, P219, DOI 10.1016/j.stem.2008.01.016; Jiang B, 2008, J NEUROSCI RES, V86, P3481, DOI 10.1002/jnr.21800; Jones PL, 1999, SEMIN CANCER BIOL, V9, P339, DOI 10.1006/scbi.1999.0134; Junien C, 2006, J INHERIT METAB DIS, V29, P359, DOI 10.1007/s10545-006-0299-7; Karali M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-715; Kato M, 2003, HUM MOL GENET, V12, pR89, DOI 10.1093/hmg/ddg086; KITZMILLER JL, 1991, JAMA-J AM MED ASSOC, V265, P731, DOI 10.1001/jama.265.6.731; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krichevsky AM, 2006, STEM CELLS, V24, P857, DOI 10.1634/stemcells.2005-0441; KUCERA J, 1971, J REPROD MED, V7, P73; Liao DM, 2004, DIABETOLOGIA, V47, P523, DOI 10.1007/s00125-004-1351-5; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loeken MR, 2005, AM J MED GENET C, V135C, P77, DOI 10.1002/ajmg.c.30056; Maiorano NA, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-40; Miao F, 2007, J BIOL CHEM, V282, P13854, DOI 10.1074/jbc.M609446200; MILLS JL, 1979, DIABETES, V28, P292, DOI 10.2337/diabetes.28.4.292; MILLS JL, 1982, TERATOLOGY, V25, P385, DOI 10.1002/tera.1420250316; Morshead CM, 2003, EUR J NEUROSCI, V18, P76, DOI 10.1046/j.1460-9568.2003.02727.x; Namihira M, 2008, PHILOS T R SOC B, V363, P2099, DOI 10.1098/rstb.2008.2262; Niculescu MD, 2006, FASEB J, V20, P43, DOI 10.1096/fj.05-4707com; Obernosterer G, 2007, NAT PROTOC, V2, P1508, DOI 10.1038/nprot.2007.153; Pramparo T, 2010, J NEUROSCI, V30, P3002, DOI 10.1523/JNEUROSCI.4851-09.2010; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; Shaklai S, 2007, FEBS J, V274, P1383, DOI 10.1111/j.1742-4658.2007.05697.x; ter Braak EWMT, 2002, DIABETES-METAB RES, V18, P96, DOI 10.1002/dmrr.271; Tropepe V, 1999, DEV BIOL, V208, P166, DOI 10.1006/dbio.1998.9192; Villeneuve LM, 2008, P NATL ACAD SCI USA, V105, P9047, DOI 10.1073/pnas.0803623105; Visvanathan J, 2007, GENE DEV, V21, P744, DOI 10.1101/gad.1519107; Waterland RA, 2006, J NUTR, V136, p1706S, DOI 10.1093/jn/136.6.1706S; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Wu GY, 2004, J NUTR, V134, P2169, DOI 10.1093/jn/134.9.2169; Yingling J, 2008, CELL, V132, P474, DOI 10.1016/j.cell.2008.01.026; Yu JY, 2008, EXP CELL RES, V314, P2618, DOI 10.1016/j.yexcr.2008.06.002; Zhao C, 2009, NAT STRUCT MOL BIOL, V16, P365, DOI 10.1038/nsmb.1576	56	34	37	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65945	10.1371/journal.pone.0065945	http://dx.doi.org/10.1371/journal.pone.0065945			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776576	Green Published, gold			2022-12-27	WOS:000320755400087
J	Voncken, F; Gao, F; Wadforth, C; Harley, M; Colasante, C				Voncken, Frank; Gao, Fei; Wadforth, Cath; Harley, Maggie; Colasante, Claudia			The Phosphoarginine Energy-Buffering System of Trypanosoma brucei Involves Multiple Arginine Kinase Isoforms with Different Subcellular Locations	PLOS ONE			English	Article							OXIDATIVE STRESS; BLOOD-STREAM; ADENYLATE KINASE; SACCHAROMYCES-CEREVISIAE; FUNCTIONAL EXPRESSION; ATP DEPLETION; CELL BIOLOGY; GENE FAMILY; CRUZI; PROTEIN	Phosphagen energy-buffering systems play an essential role in regulating the cellular energy homeostasis in periods of high-energy demand or energy supply fluctuations. Here we describe the phosphoarginine/arginine kinase system of the kinetoplastid parasite Trypanosoma brucei, consisting of three highly similar arginine kinase isoforms (TbAK1-3). Immunofluorescence microscopy using myc-tagged protein versions revealed that each isoform is located in a specific subcellular compartment: TbAK1 is exclusively found in the flagellum, TbAK2 in the glycosome, and TbAK3 in the cytosol of T. brucei. The flagellar location of TbAK1 is dependent on a 22 amino acid long N-terminal sequence, which is sufficient for targeting a GFP-fusion protein to the trypanosome flagellum. The glycosomal location of TbAK2 is in agreement with the presence of a conserved peroxisomal targeting signal, the C-terminal tripeptide 'SNL'. TbAK3 lacks any apparent targeting sequences and is accordingly located in the cytosol of the parasite. Northern blot analysis indicated that each TbAK isoform is differentially expressed in bloodstream and procyclic forms of T. brucei, while the total cellular arginine kinase activity was 3-fold higher in bloodstream form trypanosomes. These results suggest a substantial change in the temporal and spatial energy requirements during parasite differentiation. Increased arginine kinase activity improved growth of procyclic form T. brucei during oxidative challenges with hydrogen peroxide. Elimination of the total cellular arginine kinase activity by RNA interference significantly decreased growth (>90%) of procyclic form T. brucei under standard culture conditions and was lethal for this life cycle stage in the presence of hydrogen peroxide. The putative physiological roles of the different TbAK isoforms in T. brucei are further discussed.	[Voncken, Frank; Gao, Fei; Wadforth, Cath; Harley, Maggie; Colasante, Claudia] Univ Hull, Sch Biol Biomed & Environm Sci, Kingston Upon Hull HU6 7RX, N Humberside, England; [Colasante, Claudia] Univ Giessen, Inst Anat & Zellbiol 2, D-35390 Giessen, Germany	University of Hull; Justus Liebig University Giessen	Voncken, F (corresponding author), Univ Hull, Sch Biol Biomed & Environm Sci, Kingston Upon Hull HU6 7RX, N Humberside, England.	F.Voncken@hull.ac.uk	Colasante, Claudia/AAO-1230-2021	Voncken, Frank/0000-0002-2929-276X; Colasante, Claudia/0000-0002-5760-4919				Agalakova NI, 2012, ENVIRON TOXICOL PHAR, V34, P334, DOI 10.1016/j.etap.2012.05.006; Amery L, 1998, BIOCHEM J, V336, P367, DOI 10.1042/bj3360367; Azzi A, 2004, PROTEIN SCI, V13, P575, DOI 10.1110/ps.03428304; Benz C, 2005, MOL BIOCHEM PARASIT, V143, P125, DOI 10.1016/j.molbiopara.2005.05.008; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Biebinger S, 1997, MOL BIOCHEM PARASIT, V85, P99, DOI 10.1016/S0166-6851(96)02815-0; Binder M, 2001, J IMMUNOL, V167, P5470, DOI 10.4049/jimmunol.167.9.5470; Boscardin SB, 2010, J CELL MOL MED, V14, P1373, DOI 10.1111/j.1582-4934.2010.01007.x; Bouvier LA, 2006, BBA-GEN SUBJECTS, V1760, P913, DOI 10.1016/j.bbagen.2006.02.013; Brems S, 2005, MOL BIOCHEM PARASIT, V139, P163, DOI 10.1016/j.molbiopara.2004.11.004; Bringaud F, 2000, MOL BIOCHEM PARASIT, V111, P283, DOI 10.1016/S0166-6851(00)00319-4; Bringaud F, 2006, MOL BIOCHEM PARASIT, V149, P1, DOI 10.1016/j.molbiopara.2006.03.017; Canepa GE, 2011, COMP BIOCHEM PHYS B, V160, P40, DOI 10.1016/j.cbpb.2011.05.006; Canonaco F, 2002, J BIOL CHEM, V277, P31303, DOI 10.1074/jbc.M204052200; Canonaco F, 2003, BIOTECHNOL LETT, V25, P1013, DOI 10.1023/A:1024172518062; Chamberlin ME, 1997, J EXP BIOL, V200, P2789; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Colasante C, 2007, MOL BIOCHEM PARASIT, V151, P193, DOI 10.1016/j.molbiopara.2006.11.003; Colasante C, 2006, PROTEOMICS, V6, P3275, DOI 10.1002/pmic.200500668; Colasante C, 2009, MOL BIOCHEM PARASIT, V167, P104, DOI 10.1016/j.molbiopara.2009.05.004; Ellington WR, 2001, ANNU REV PHYSIOL, V63, P289, DOI 10.1146/annurev.physiol.63.1.289; Fenn K, 2007, CURR OPIN MICROBIOL, V10, P539, DOI 10.1016/j.mib.2007.09.014; Fernandez P, 2007, PROTEINS, V69, P209, DOI 10.1002/prot.21557; Fridberg A, 2007, PARASITOL RES, V100, P205, DOI 10.1007/s00436-006-0329-2; Ginger ML, 2005, J BIOL CHEM, V280, P11781, DOI 10.1074/jbc.M413821200; GLOVER JR, 1994, P NATL ACAD SCI USA, V91, P10541, DOI 10.1073/pnas.91.22.10541; GOULD SJ, 1989, J CELL BIOL, V108, P1657, DOI 10.1083/jcb.108.5.1657; Hart SR, 2009, J AM SOC MASS SPECTR, V20, P167, DOI 10.1016/j.jasms.2008.08.014; HIRD FJR, 1985, COMP BIOCHEM PHYS B, V80, P517, DOI 10.1016/0305-0491(85)90283-4; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; Hoffman GG, 2011, COMP BIOCHEM PHYS D, V6, P171, DOI 10.1016/j.cbd.2011.02.004; Krieger S, 2000, MOL MICROBIOL, V35, P542, DOI 10.1046/j.1365-2958.2000.01721.x; Lee MS, 1997, PLANT CELL, V9, P185, DOI 10.1105/tpc.9.2.185; Lorenz P, 1998, EMBO J, V17, P3542, DOI 10.1093/emboj/17.13.3542; MacLeod ET, 2007, PARASITOLOGY, V134, P827, DOI 10.1017/S0031182007002247; Macleod ET, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000239; Malvy D, 2011, CLIN MICROBIOL INFEC, V17, P986, DOI 10.1111/j.1469-0691.2011.03536.x; Matthews KR, 2005, J CELL SCI, V118, P283, DOI 10.1242/jcs.01649; MICHELS PAM, 1989, EXP PARASITOL, V69, P310, DOI 10.1016/0014-4894(89)90079-9; Michels PAM, 2006, BBA-MOL CELL RES, V1763, P1463, DOI 10.1016/j.bbamcr.2006.08.019; Miranda MR, 2006, EXP PARASITOL, V114, P341, DOI 10.1016/j.exppara.2006.04.004; Miranda MR, 2009, PARASITOLOGY, V136, P1201, DOI 10.1017/S0031182009990448; Mitchell BF, 2005, MOL BIOL CELL, V16, P4509, DOI 10.1091/mbc.E05-04-0347; NEVO AC, 1970, J THEOR BIOL, V26, P11, DOI 10.1016/S0022-5193(70)80027-3; Noguchi M, 2001, J EXP BIOL, V204, P1063; Oberholzer M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010538; OVERATH P, 1986, EUR J BIOCHEM, V160, P175, DOI 10.1111/j.1432-1033.1986.tb09955.x; Pena-Diaz P, 2012, J BIOL CHEM, V287, P41861, DOI 10.1074/jbc.M112.404699; Pereira CA, 2000, J BIOL CHEM, V275, P1495, DOI 10.1074/jbc.275.2.1495; Pereira CA, 2003, FEBS LETT, V554, P201, DOI 10.1016/S0014-5793(03)01171-2; Pereira CA, 2002, J EUKARYOT MICROBIOL, V49, P82, DOI 10.1111/j.1550-7408.2002.tb00346.x; Pereira Claudio A, 2011, Enzyme Res, V2011, P576483, DOI 10.4061/2011/576483; Pullen TJ, 2004, MOL BIOL CELL, V15, P3257, DOI 10.1091/mbc.E04-03-0217; Ralston KS, 2009, ANNU REV MICROBIOL, V63, P335, DOI 10.1146/annurev.micro.091208.073353; RATTO A, 1989, EUR J BIOCHEM, V186, P195, DOI 10.1111/j.1432-1033.1989.tb15195.x; Saleh MA, 2009, VET PARASITOL, V162, P192, DOI 10.1016/j.vetpar.2009.03.035; Snapp EL, 1999, J BIOL CHEM, V274, P29543, DOI 10.1074/jbc.274.41.29543; SOMMER JM, 1994, ANNU REV MICROBIOL, V48, P105, DOI 10.1146/annurev.mi.48.100194.000541; Subramani S, 2002, J CELL BIOL, V156, P415, DOI 10.1083/jcb.200112122; Tiwari BS, 2002, PLANT PHYSIOL, V128, P1271, DOI 10.1104/pp.010999; TOMBES RM, 1985, CELL, V41, P325, DOI 10.1016/0092-8674(85)90085-6; Turrens Julio F., 2004, Molecular Aspects of Medicine, V25, P211, DOI 10.1016/j.mam.2004.02.021; van Hellemond JJ, 2005, BIOCHEM SOC T, V33, P967, DOI 10.1042/BST20050967; Viant MR, 2001, J CHROMATOGR B, V765, P107, DOI 10.1016/S0378-4347(01)00428-5; VICKERMAN K, 1985, BRIT MED BULL, V41, P105, DOI 10.1093/oxfordjournals.bmb.a072036; Voncken F, 2003, J BIOL CHEM, V278, P35299, DOI 10.1074/jbc.M301811200; WALLIMANN T, 1992, BIOCHEM J, V281, P21, DOI 10.1042/bj2810021; WATTS DC, 1970, NATURE, V226, P450, DOI 10.1038/226450a0; Wright-Weber B, 2006, BBA-GEN SUBJECTS, V1760, P364, DOI 10.1016/j.bbagen.2005.11.005	69	42	46	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65908	10.1371/journal.pone.0065908	http://dx.doi.org/10.1371/journal.pone.0065908			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776565	Green Published, gold, Green Submitted			2022-12-27	WOS:000320755400079
J	Chiu, GS; Wu, MA; Lu, L				Chiu, Grace S.; Wu, Margaret A.; Lu, Lin			Model-Based Assessment of Estuary Ecosystem Health Using the Latent Health Factor Index, with Application to the Richibucto Estuary	PLOS ONE			English	Article							MARINE BIOTIC INDEX; HIERARCHICAL-MODELS; QUALITY ASSESSMENT; COMMUNITIES; SIMULATION; VALIDATION; IMPACT; COAST; AMBI	The ability to quantitatively assess ecological health is of great interest to those tasked with monitoring and conserving ecosystems. For decades, biomonitoring research and policies have relied on multimetric health indices of various forms. Although indices are numbers, many are constructed based on qualitative procedures, thus limiting the quantitative rigor of the practical interpretations of such indices. The statistical modeling approach to construct the latent health factor index (LHFI) was recently developed. With ecological data that otherwise are used to construct conventional multimetric indices, the LHFI framework expresses such data in a rigorous quantitative model, integrating qualitative features of ecosystem health and preconceived ecological relationships among such features. This hierarchical modeling approach allows unified statistical inference of health for observed sites (along with prediction of health for partially observed sites, if desired) and of the relevance of ecological drivers, all accompanied by formal uncertainty statements from a single, integrated analysis. Thus far, the LHFI approach has been demonstrated and validated in a freshwater context. We adapt this approach to modeling estuarine health, and illustrate it on the previously unassessed system in Richibucto in New Brunswick, Canada, where active oyster farming is a potential stressor through its effects on sediment properties. Field data correspond to health metrics that constitute the popular AZTI marine biotic index and the infaunal trophic index, as well as abiotic predictors preconceived to influence biota. Our paper is the first to construct a scientifically sensible model that rigorously identifies the collective explanatory capacity of salinity, distance downstream, channel depth, and silt-clay content-all regarded a priori as qualitatively important abiotic drivers-towards site health in the Richibucto ecosystem. This suggests the potential effectiveness of the LHFI approach for assessing not only freshwater systems but aquatic ecosystems in general.	[Chiu, Grace S.] CSIRO, CSIRO Math, Canberra, ACT, Australia; [Wu, Margaret A.] STAT Canada, Business Methods Survey Div, Ottawa, ON, Canada; [Lu, Lin] McGregor GeoSci, Bedford, NS, Canada	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Statistics Canada	Chiu, GS (corresponding author), CSIRO, CSIRO Math, Canberra, ACT, Australia.	grace.chiu@csiro.au	Chiu, Grace/D-1408-2009	Chiu, Grace/0000-0003-4219-1645	NSERC	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	The research of this paper was conducted through research assistantships to MAW at the University of Waterloo funded by an NSERC Strategic Project Grant (http://www.nsercpartnerships.ca/FundingPrograms-ProgrammeDeSubventions/SPG-SPS-eng.asp) to Prof. J. Grant (Dalhousie University) subcontracted to GSC. Funding agency NSERC had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee S., 2004, HIERARCHICAL MODELIN; Bazairi H, 2005, CR BIOL, V328, P977, DOI 10.1016/j.crvi.2005.09.006; Bhatt JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046237; BILYARD GR, 1987, MAR POLLUT BULL, V18, P581, DOI 10.1016/0025-326X(87)90277-3; Borja A, 2000, MAR POLLUT BULL, V40, P1100, DOI 10.1016/S0025-326X(00)00061-8; Borja A, 2009, AQUACULTURE, V293, P231, DOI 10.1016/j.aquaculture.2009.04.037; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; [蔡文倩 Cai Wenqian], 2012, [环境科学学报, Acta Scientiae Circumstantiae], V32, P992; Chiu G, 2006, ENVIRONMETRICS, V17, P285, DOI 10.1002/env.744; Chiu GS, 2011, ENVIRONMETRICS, V22, P243, DOI 10.1002/env.1055; Cromey CJ, 2002, AQUACULTURE, V214, P211, DOI 10.1016/S0044-8486(02)00368-X; DAUER DM, 1993, MAR POLLUT BULL, V26, P249, DOI 10.1016/0025-326X(93)90063-P; Deegan LA, 1997, ESTUARIES, V20, P601, DOI 10.2307/1352618; Dey DK, 1998, TEST, V7, P325, DOI 10.1007/BF02565116; Dobbie MJ, 2013, ECOL INDIC, V29, P270, DOI 10.1016/j.ecolind.2012.12.025; Hoff PD, 2009, SPRINGER TEXTS STAT, P1, DOI 10.1007/978-0-387-92407-6_1; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; Johnston CA, 2009, ECOL APPL, V19, P1739, DOI 10.1890/08-1290.1; Kennedy R, 2011, MAR POLLUT BULL, V62, P1427, DOI 10.1016/j.marpolbul.2011.04.030; Lopez RD, 2002, ECOL APPL, V12, P487, DOI 10.1890/1051-0761(2002)012[0487:TTFQAI]2.0.CO;2; Lu L, 2008, ESTUAR COAST, V31, P994, DOI 10.1007/s12237-008-9097-9; Lunn D, 2009, STAT MED, V28, P3049, DOI 10.1002/sim.3680; Marshall EC, 2007, BAYESIAN ANAL, V2, P409, DOI 10.1214/07-BA218; Medeiros JP, 2012, ECOL INDIC, V19, P79, DOI 10.1016/j.ecolind.2011.09.008; Muniz P, 2012, ECOL INDIC, V19, P89, DOI 10.1016/j.ecolind.2011.07.022; Peet R.K., 1974, Annual Rev Ecol Syst, V5, P285, DOI 10.1146/annurev.es.05.110174.001441; Pla L, 2004, J AGR BIOL ENVIR ST, V9, P42, DOI 10.1198/1085711043136; Rosenberg R, 2004, MAR POLLUT BULL, V49, P728, DOI 10.1016/j.marpolbul.2004.05.013; Schliep EM, 2013, ARXIV12054163; Smith RW, 2001, ECOL APPL, V11, P1073, DOI 10.1890/1051-0761(2001)011[1073:BRIFAI]2.0.CO;2; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Teixeira H, 2012, ECOL INDIC, V12, P84, DOI 10.1016/j.ecolind.2011.05.025; Trebilco R, 2011, BIOL CONSERV, V144, P1758, DOI 10.1016/j.biocon.2011.02.024; Word J. Q., 1980, SO CALIFORNIA COASTA, P103; Wu M, 2009, THESIS U WATERLOO WA	35	2	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65697	10.1371/journal.pone.0065697	http://dx.doi.org/10.1371/journal.pone.0065697			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785443	Green Published, Green Submitted, gold			2022-12-27	WOS:000321038800079
J	Fogelson, N; Fernandez-del-Olmo, M				Fogelson, Noa; Fernandez-del-Olmo, Miguel			Implicit Versus Explicit Local Contextual Processing	PLOS ONE			English	Article							DORSOLATERAL PREFRONTAL CORTEX; EVENT-RELATED POTENTIALS; PARKINSONS-DISEASE; P300 COMPONENT; REACTION-TIME; SEQUENCE; INFORMATION; DEFICITS; MEMORY; ATTENTION	We investigated the effects of implicit local contextual processing using behavioral and electrophysiological measures. EEG recording blocks consisted of targets preceded by either randomized sequences of standards or by sequences including a predictive sequence signaling the occurrence of a target event. Subjects performed two sessions: in the first the regularity of the predictive sequence was implicit, while in the second this regularity was made explicit. Subjects pressed a button in response to targets. Both the implicit and explicit sessions showed shorter reaction times and peak P3b latencies for predicted versus random targets, although to a greater extent in the explicit session. In both sessions the middle and last most-informative stimuli of the three-standard predictive sequence induced a significant larger P3b compared with randomized standards. The findings show that local contextual information is processed implicitly, but that this modulation was significantly greater when subjects were explicitly instructed to attend to target-predictive contextual information. The findings suggest that top-down attentional networks have a role in modulating the extent to which contextual information is utilized.	[Fogelson, Noa] Univ A Coruna, Dept Psychol, La Coruna, Spain; [Fernandez-del-Olmo, Miguel] Univ A Coruna, Dept Phys Educ, La Coruna, Spain	Universidade da Coruna; Universidade da Coruna	Fogelson, N (corresponding author), Univ A Coruna, Dept Psychol, La Coruna, Spain.	nfogelson@udc.es		Fernandez del Olmo, Miguel/0000-0001-5325-503X; Fogelson, Noa/0000-0003-2239-2212	Spanish Ministry of Science and Innovation [PSI2012-34212, DEP2011-22466]; Xunta de Galicia [CN 2012/170]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Xunta de Galicia(Xunta de GaliciaEuropean Commission)	This work was supported by the Spanish Ministry of Science and Innovation [PSI2012-34212 to NF] and [DEP2011-22466 and Xunta de Galicia CN 2012/170 to MFdO]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin KB, 1997, PSYCHOPHYSIOLOGY, V34, P74, DOI 10.1111/j.1469-8986.1997.tb02418.x; Barch DM, 2001, ARCH GEN PSYCHIAT, V58, P280, DOI 10.1001/archpsyc.58.3.280; Beldarrain MG, 2002, EXP BRAIN RES, V142, P529, DOI 10.1007/s00221-001-0935-2; Bo J, 2011, EXP BRAIN RES, V214, P73, DOI 10.1007/s00221-011-2807-8; Chun MM, 1999, NAT NEUROSCI, V2, P844, DOI 10.1038/12222; Chun MM, 1998, COGNITIVE PSYCHOL, V36, P28, DOI 10.1006/cogp.1998.0681; COHEN JD, 1992, PSYCHOL REV, V99, P45, DOI 10.1037/0033-295X.99.1.45; Coull JT, 2008, CURR OPIN NEUROBIOL, V18, P137, DOI 10.1016/j.conb.2008.07.011; CZIGLER I, 1990, PSYCHOPHYSIOLOGY, V27, P669, DOI 10.1111/j.1469-8986.1990.tb03191.x; Darsaud A, 2011, J COGNITIVE NEUROSCI, V23, P1900, DOI 10.1162/jocn.2010.21550; DONCHIN E, 1988, BEHAV BRAIN SCI, V11, P357, DOI 10.1017/S0140525X00058027; DUNCANJOHNSON CC, 1981, PSYCHOPHYSIOLOGY, V18, P207; DUNCANJOHNSON CC, 1982, BIOL PSYCHOL, V14, P1, DOI 10.1016/0301-0511(82)90016-3; Ferdinand NK, 2010, NEUROPSYCHOLOGIA, V48, P2665, DOI 10.1016/j.neuropsychologia.2010.05.013; Ferdinand NK, 2008, J COGNITIVE NEUROSCI, V20, P629, DOI 10.1162/jocn.2008.20046; Fogelson N, 2012, EXP BRAIN RES, V219, P27, DOI 10.1007/s00221-012-3064-1; Fogelson N, 2011, PSYCHOPHYSIOLOGY, V48, P1217, DOI 10.1111/j.1469-8986.2011.01195.x; Fogelson N, 2011, CLIN NEUROPHYSIOL, V122, P539, DOI 10.1016/j.clinph.2010.07.017; Fogelson N, 2011, BRAIN TOPOGR, V23, P385, DOI 10.1007/s10548-010-0160-z; Fogelson N, 2009, BRAIN, V132, P3002, DOI 10.1093/brain/awp230; Fogelson N, 2009, J COGNITIVE NEUROSCI, V21, P1680, DOI 10.1162/jocn.2009.21071; FRENSCH PA, 1994, MEM COGNITION, V22, P95, DOI 10.3758/BF03202765; HILLYARD SA, 1983, ANNU REV PSYCHOL, V34, P33, DOI 10.1146/annurev.ps.34.020183.000341; Huettel SA, 2005, J NEUROSCI, V25, P3304, DOI 10.1523/JNEUROSCI.5070-04.2005; JOHNSON R, 1986, PSYCHOPHYSIOLOGY, V23, P367, DOI 10.1111/j.1469-8986.1986.tb00649.x; King JA, 2012, J NEUROSCI, V32, P8192, DOI 10.1523/JNEUROSCI.0934-12.2012; KUTAS M, 1977, SCIENCE, V197, P792, DOI 10.1126/science.887923; LEWICKI P, 1988, COGNITIVE PSYCHOL, V20, P24, DOI 10.1016/0010-0285(88)90023-0; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; MCCARTHY G, 1981, SCIENCE, V211, P77, DOI 10.1126/science.7444452; Murphy JS, 2009, BIOL PSYCHOL, V82, P234, DOI 10.1016/j.biopsycho.2009.08.002; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; Olson IR, 2001, BRAIN, V124, P1417, DOI 10.1093/brain/124.7.1417; PascualLeone A, 1996, EXP BRAIN RES, V107, P479; Pitts MA, 2012, J COGNITIVE NEUROSCI, V24, P287, DOI 10.1162/jocn_a_00111; Polich J, 2006, INT J PSYCHOPHYSIOL, V60, P172, DOI 10.1016/j.ijpsycho.2005.12.012; Pollmann S, 2009, BRAIN RES, V1263, P87, DOI 10.1016/j.brainres.2009.01.039; Poulsen C, 2005, COGNITIVE BRAIN RES, V24, P133, DOI 10.1016/j.cogbrainres.2005.01.008; Robertson EM, 2001, CEREB CORTEX, V11, P628, DOI 10.1093/cercor/11.7.628; Rose M, 2011, J NEUROSCI, V31, P13739, DOI 10.1523/JNEUROSCI.3020-11.2011; Russeler J, 2003, COGNITIVE BRAIN RES, V15, P116, DOI 10.1016/S0926-6410(02)00145-3; SQUIRES KC, 1976, SCIENCE, V193, P1142, DOI 10.1126/science.959831; SQUIRES KC, 1975, J EXP PSYCHOL HUMAN, V1, P268, DOI 10.1037/0096-1523.1.3.268; Turk-Browne NB, 2006, NEURON, V49, P917, DOI 10.1016/j.neuron.2006.01.030; van Asselen M, 2009, NEUROPSYCHOLOGIA, V47, P1269, DOI 10.1016/j.neuropsychologia.2009.01.008; Verleger R, 2005, J PSYCHOPHYSIOL, V19, P165, DOI 10.1027/0269-8803.19.3.165; WILKINSON RT, 1967, ELECTROEN CLIN NEURO, V23, P50, DOI 10.1016/0013-4694(67)90140-X; Yi DJ, 2005, J NEUROSCI, V25, P3593, DOI 10.1523/JNEUROSCI.4677-04.2005	48	8	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65914	10.1371/journal.pone.0065914	http://dx.doi.org/10.1371/journal.pone.0065914			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	172XB	23785458	gold, Green Published, Green Submitted			2022-12-27	WOS:000321038800064
J	Ghayee, HK; Bhagwandin, VJ; Stastny, V; Click, A; Ding, LH; Mizrachi, D; Zou, YS; Chari, R; Lam, WL; Bachoo, RM; Smith, AL; Story, MD; Sidhu, S; Robinson, BG; Nwariaku, FE; Gazdar, AF; Auchus, RJ; Shay, JW				Ghayee, Hans K.; Bhagwandin, Vikash J.; Stastny, Victor; Click, Arielle; Ding, Liang-Hao; Mizrachi, Dario; Zou, Ying S.; Chari, Raj; Lam, Wan L.; Bachoo, Robert M.; Smith, Alice L.; Story, Michael D.; Sidhu, Stan; Robinson, Bruce G.; Nwariaku, Fiemu E.; Gazdar, Adi F.; Auchus, Richard J.; Shay, Jerry W.			Progenitor Cell Line (hPheo1) Derived from a Human Pheochromocytoma Tumor	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; EPITHELIAL-CELLS; LUNG-CANCER; GENE; EXPRESSION; PARAGANGLIOMA; TELOMERASE; MUTATIONS; IMMORTALIZATION; SPECIMENS	Background: Pheochromocytomas are rare tumors generally arising in the medullary region of the adrenal gland. These tumors release excessive epinephrine and norepinephrine resulting in hypertension and cardiovascular crises for which surgery is the only definitive treatment. Molecular mechanisms that control tumor development and hormone production are poorly understood, and progress has been hampered by the lack of human cellular model systems. To study pheochromocytomas, we developed a stable progenitor pheochromocytoma cell line derived from a primary human tumor. Methods: After IRB approval and written informed consent, human pheochromocytoma tissue was excised, minced, dispersed enzymatically, and cultured in vitro. Primary pheochromocytoma cells were infected with a lentivirus vector carrying the catalytic subunit of human telomerase reverse transcriptase (hTERT). The hTERT immortalized cells (hPheo1) have been passaged >300 population doublings. The resulting cell line was characterized morphologically, biochemically and for expression of neuroendocrine properties. The expression of marker enzymes and proteins was assessed by immunofluorescence staining and immunoblotting. Telomerase activity was determined by using the telomeric repeat amplification protocol (TRAP) assay. Results: We have established a human pheochromocytoma precursor cell line that expresses the neuroendocrine marker, chromogranin A, when differentiated in the presence of bone morphogenic protein 4 (BMP4), nerve growth factor (NGF), and dexamethasone. Phenylethanolamine N-methyltransferase (PNMT) expression is also detected with this differentiation regimen. CD-56 (also known as NCAM, neural cell adhesion molecule) is expressed in these cells, but CD31 (also known as PECAM-1, a marker of endothelial cells) is negative. Conclusions: We have maintained hTERT-immortalized progenitor cells derived from a pheochromocytoma (hPheo1) in culture for over 300 population doublings. This progenitor human cell line is normal diploid except for a deletion in the p16 region and has inducible neuroendocrine biomarkers. These cells should be a valuable reagent for studying mechanisms of tumor development and for testing novel therapeutic approaches.	[Ghayee, Hans K.] Univ Texas SW Med Ctr Dallas, Div Endocrinol, Dept Internal Med, Dallas, TX 75390 USA; [Bhagwandin, Vikash J.] Univ Calif San Francisco, Hooper Res Fdn, San Francisco, CA 94143 USA; [Stastny, Victor; Smith, Alice L.; Gazdar, Adi F.] Univ Texas SW Med Ctr Dallas, Hamon Ctr Therapeut Oncol, Dallas, TX 75390 USA; [Stastny, Victor; Smith, Alice L.; Gazdar, Adi F.] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Click, Arielle; Shay, Jerry W.] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Ding, Liang-Hao; Story, Michael D.] Univ Texas SW Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA; [Mizrachi, Dario] Cornell Univ, Ithaca, NY USA; [Zou, Ying S.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Chari, Raj] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Lam, Wan L.] British Columbia Canc Agcy, Dept Integrat Oncol, Vancouver, BC V5Z 4E6, Canada; [Bachoo, Robert M.] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA; [Sidhu, Stan; Robinson, Bruce G.] Royal N Shore Hosp, Kolling Inst Med Res, Dept Surg, St Leonards, NSW 2065, Australia; [Nwariaku, Fiemu E.] Univ Texas SW Med Ctr Dallas, Dept Surg, Dallas, TX 75390 USA; [Auchus, Richard J.] Univ Michigan, Dept Med, Div Metab Diabet & Endocrinol, Ann Arbor, MI 48109 USA; [Shay, Jerry W.] King Abdulaziz Univ, Ctr Excellence Genom Med Res, Jeddah 21413, Saudi Arabia	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California San Francisco; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Cornell University; University of Washington; University of Washington Seattle; Harvard University; Harvard Medical School; British Columbia Cancer Agency; University of Texas System; University of Texas Southwestern Medical Center Dallas; Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Michigan System; University of Michigan; King Abdulaziz University	Shay, JW (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA.	jerry.shay@utsouthwestern.edu	Story, Michael/AAX-2864-2021; Chari, Raj/G-3285-2019	Story, Michael/0000-0001-6522-4169; Zou, Ying/0000-0003-2787-1917	North American Neuroendocrine Tumor Society; American Cancer Society Institutional Grant; Burroughs Wellcome Fund [1005954]; Canadian Institute of Health Research; NATIONAL CANCER INSTITUTE [P50CA070907] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER	North American Neuroendocrine Tumor Society; American Cancer Society Institutional Grant(American Cancer Society); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the North American Neuroendocrine Tumor Society, American Cancer Society Institutional Grant, Burroughs Wellcome Fund #1005954, and Canadian Institute of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjalle R, 2009, HORM METAB RES, V41, P687, DOI 10.1055/s-0029-1231025; Aguiar RCT, 1996, CLIN ENDOCRINOL, V45, P93, DOI 10.1111/j.1365-2265.1996.tb02065.x; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Chung KF, 2009, STEM CELLS, V27, P2602, DOI 10.1002/stem.180; Comino-Mendez I, 2011, NAT GENET, V43, P663, DOI 10.1038/ng.861; Ding LH, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn234; Elder EE, 2005, J SURG ONCOL, V89, P193, DOI 10.1002/jso.20177; FRANQUEMONT DW, 1994, AM J CLIN PATHOL, V102, P163, DOI 10.1093/ajcp/102.2.163; Gazdar AF, 2010, JNCI-J NATL CANCER I, V102, P1310, DOI 10.1093/jnci/djq279; GAZDAR AF, 1986, CANCER RES, V46, P6011; Ghayee HK, 2008, J ENDOCRINOL INVEST, V31, P450, DOI 10.1007/BF03346390; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; HANING R, 1970, Endocrinology, V87, P1147; Hao HX, 2009, SCIENCE, V325, P1139, DOI 10.1126/science.1175689; Hofland J, 2007, CLIN ENDOCRINOL, V66, P335, DOI 10.1111/j.1365-2265.2007.02732.x; John H, 1999, UROLOGY, V53, P679, DOI 10.1016/S0090-4295(98)00612-8; Joshua AM, 2009, J CLIN ENDOCR METAB, V94, P5, DOI 10.1210/jc.2008-1836; Lewis CM, 2006, BREAST CANCER RES TR, V99, P103, DOI 10.1007/s10549-006-9189-9; Marian CO, 2010, CLIN CANCER RES, V16, P154, DOI 10.1158/1078-0432.CCR-09-2850; Martiniova L, 2009, CLIN EXP METASTAS, V26, P239, DOI 10.1007/s10585-009-9236-0; Muscarella P, 2008, GENE EXPRESSION, V14, P207, DOI 10.3727/105221608786883825; Pfragner R, 1998, J NEUROCYTOL, V27, P175, DOI 10.1023/A:1006959625068; Powers JF, 2000, CELL TISSUE RES, V302, P309, DOI 10.1007/s004410000290; Qin YJ, 2010, NAT GENET, V42, P229, DOI 10.1038/ng.533; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Ribon V, 1996, J BIOL CHEM, V271, P7375, DOI 10.1074/jbc.271.13.7375; STENSTROM G, 1988, ACTA MED SCAND, V223, P345; TAIT JF, 1974, PROC R SOC SER B-BIO, V185, P375, DOI 10.1098/rspb.1974.0025; Thompson F, 1997, CYTOGENETIC METHODS; van Nederveen FH, 2009, ENDOCR-RELAT CANCER, V16, P505, DOI 10.1677/ERC-08-0241; Vaughan MB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007908; Zhuang ZP, 2012, NEW ENGL J MED, V367, P922, DOI 10.1056/NEJMoa1205119	32	31	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65624	10.1371/journal.pone.0065624	http://dx.doi.org/10.1371/journal.pone.0065624			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785438	Green Submitted, Green Published, gold			2022-12-27	WOS:000321038800082
J	Hayashi, T; Yoshida, T; Ra, M; Taguchi, R; Mishina, M				Hayashi, Takashi; Yoshida, Tomoyuki; Ra, Moonjin; Taguchi, Ryo; Mishina, Masayoshi			IL1RAPL1 Associated with Mental Retardation and Autism Regulates the Formation and Stabilization of Glutamatergic Synapses of Cortical Neurons through RhoA Signaling Pathway	PLOS ONE			English	Article							ACCESSORY PROTEIN-LIKE; TRANSSYNAPTIC INTERACTION; SPECTRUM DISORDER; MUTATIONS; PLASTICITY; FAMILY; GENE; NEUROLIGINS; RECEPTORS; INSERTION	Interleukin-1 receptor accessory protein-like 1 (IL1RAPL1) is associated with X-linked mental retardation and autism spectrum disorder. We found that IL1RAPL1 regulates synapse formation of cortical neurons. To investigate how IL1RAPL1 controls synapse formation, we here screened IL1RAPL1-interacting proteins by affinity chromatography and mass spectroscopy. IL1RAPL1 interacted with Mcf2-like (Mcf2l), a Rho guanine nucleotide exchange factor, through the cytoplasmic Toll/IL-1 receptor domain. Knockdown of endogenous Mcf2l and treatment with an inhibitor of Rho-associated protein kinase (ROCK), the downstream kinase of RhoA, suppressed IL1RAPL1-induced excitatory synapse formation of cortical neurons. Furthermore, we found that the expression of IL1RAPL1 affected the turnover of AMPA receptor subunits. Insertion of GluA1-containing AMPA receptors to the cell surface was decreased, whereas that of AMPA receptors composed of GluA2/3 was enhanced. Mcf2l knockdown and ROCK inhibitor treatment diminished the IL1RAPL1-induced changes of AMPA receptor subunit insertions. Our results suggest that Mcf2l-RhoA-ROCK signaling pathway mediates IL1RAPL1-dependent formation and stabilization of glutamatergic synapses of cortical neurons.	[Hayashi, Takashi; Yoshida, Tomoyuki; Mishina, Masayoshi] Univ Tokyo, Grad Sch Med, Dept Mol Neurobiol & Pharmacol, Tokyo, Japan; [Ra, Moonjin; Taguchi, Ryo] Univ Tokyo, Grad Sch Med, Dept Metabolome, Tokyo, Japan; [Yoshida, Tomoyuki] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan; [Mishina, Masayoshi] Ritsumeikan Univ, Res Org Sci & Technol, Brain Sci Lab, Kusatsu, Shiga, Japan	University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); Ritsumeikan University	Mishina, M (corresponding author), Univ Tokyo, Grad Sch Med, Dept Mol Neurobiol & Pharmacol, Tokyo, Japan.	mmishina@fc.ritsumei.ac.jp	ra, moonjin/AAK-3816-2021	Hayashi, Takashi/0000-0003-3591-2109; Yoshida, Tomoyuki/0000-0002-8476-3798	Ministry of Education, Culture, Sports, Science and Technology of Japan; Takeda Science Foundation; Kanae Foundation for the Promotion of Medical Science; Japan Science and Technology Agency	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Kanae Foundation for the Promotion of Medical Science; Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported in part by the Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Takeda Science Foundation, the Kanae Foundation for the Promotion of Medical Science, and Japan Science and Technology Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Araki Y, 2010, P NATL ACAD SCI USA, V107, P11080, DOI 10.1073/pnas.1006584107; Bahi N, 2003, HUM MOL GENET, V12, P1415, DOI 10.1093/hmg/ddg147; Berkel S, 2010, NAT GENET, V42, P489, DOI 10.1038/ng.589; Bill BR, 2009, CURR OPIN GENET DEV, V19, P271, DOI 10.1016/j.gde.2009.04.004; Bito H, 2003, J BIOCHEM, V134, P315, DOI 10.1093/jb/mvg147; Boda B, 2010, CURR OPIN NEUROBIOL, V20, P519, DOI 10.1016/j.conb.2010.03.012; Born TL, 2000, J BIOL CHEM, V275, P29946, DOI 10.1074/jbc.M004077200; Carrie A, 1999, NAT GENET, V23, P25, DOI 10.1038/12623; Chelly J, 2001, NAT REV GENET, V2, P669, DOI 10.1038/35088558; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Fombonne E, 1999, PSYCHOL MED, V29, P769, DOI 10.1017/S0033291799008508; Gambino F, 2007, P NATL ACAD SCI USA, V104, P9063, DOI 10.1073/pnas.0701133104; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; HORII Y, 1994, EMBO J, V13, P4776, DOI 10.1002/j.1460-2075.1994.tb06803.x; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Kenny EF, 2008, CYTOKINE, V43, P342, DOI 10.1016/j.cyto.2008.07.010; Kerr JM, 2012, J NEUROSCI, V32, P658, DOI 10.1523/JNEUROSCI.2927-11.2012; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; Laumonnier F, 2010, MOL PSYCHIATR, V15, P767, DOI 10.1038/mp.2009.14; Levy SE, 2009, LANCET, V374, P1627, DOI 10.1016/S0140-6736(09)61376-3; Lin DT, 2009, NAT NEUROSCI, V12, P879, DOI 10.1038/nn.2351; Loegering D.J., 2011, ENZYME RES; Manchen ST, 2001, BIOCHEM BIOPH RES CO, V287, P1075, DOI 10.1006/bbrc.2001.5701; McCormack SG, 2006, NEURON, V50, P75, DOI 10.1016/j.neuron.2006.02.027; Narumiya S, 2009, CANCER METAST REV, V28, P65, DOI 10.1007/s10555-008-9170-7; Pavlowsky A, 2010, CURR BIOL, V20, P103, DOI 10.1016/j.cub.2009.12.030; Piton A, 2011, MOL PSYCHIATR, V16, P867, DOI 10.1038/mp.2010.54; Piton A, 2008, HUM MOL GENET, V17, P3965, DOI 10.1093/hmg/ddn300; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Tanaka H, 2012, CELL REPORTS, V1, P291, DOI 10.1016/j.celrep.2012.02.004; Uemura T, 2010, CELL, V141, P1068, DOI 10.1016/j.cell.2010.04.035; Valnegri P, 2011, HUM MOL GENET, V20, P4797, DOI 10.1093/hmg/ddr418; Van Aelst L, 2004, CURR OPIN NEUROBIOL, V14, P297, DOI 10.1016/j.conb.2004.05.012; van Bokhoven H, 2011, ANNU REV GENET, V45, P81, DOI 10.1146/annurev-genet-110410-132512; Yoshida T, 2008, MOL CELL NEUROSCI, V39, P218, DOI 10.1016/j.mcn.2008.06.013; Yoshida T, 2011, J NEUROSCI, V31, P13485, DOI 10.1523/JNEUROSCI.2136-11.2011	40	41	44	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66254	10.1371/journal.pone.0066254	http://dx.doi.org/10.1371/journal.pone.0066254			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785489	Green Published, gold, Green Submitted			2022-12-27	WOS:000321038800033
J	Larsson, HE; Jonsson, I; Lernmark, A; Ivarsson, S; Radtke, JR; Hampe, CS				Larsson, Helena Elding; Jonsson, Ida; Lernmark, Ake; Ivarsson, Sten; Radtke, Jared R.; Hampe, Christiane S.		Diabet Prediction Skane DiPiS; Type 1 Diabet Trial Network	Decline in Titers of Anti-Idiotypic Antibodies Specific to Autoantibodies to GAD65 (GAD65Ab) Precedes Development of GAD65Ab and Type 1 Diabetes	PLOS ONE			English	Article							SYSTEMIC LUPUS-ERYTHEMATOSUS; DECARBOXYLASE; IMMUNIZATION; POPULATION; NETWORK; AGE	The humoral Idiotypic Network consisting of antibodies and their anti-idiotypic antibodies (anti-Id) can be temporarily upset by antigen exposure. In the healthy immune response the original equilibrium is eventually restored through counter-regulatory mechanisms. In certain autoimmune diseases however, autoantibody levels exceed those of their respective anti-Id, indicating a permanent disturbance in the respective humoral Idiotypic Network. We investigated anti-Id directed to a major Type 1 diabetes (T1D)-associated autoantibody (GAD65Ab) in two independent cohorts during progression to disease. Samples taken from participants of the Natural History Study showed significantly lower anti-Id levels in individuals that later progressed to T1D compared to non-progressors (anti-Id antibody index of 0.06 vs. 0.08, respectively, p = 0.02). We also observed a significant inverse correlation between anti-Id levels and age at sampling, but only in progressors (p = 0.014). Finally, anti-Id levels in progressors showed a significant decline during progression as compared to longitudinal anti-Id levels in non-progressors (median rate of change: -0.0004 vs. +0.0004, respectively, p = 0.003), suggesting a loss of anti-Id during progression. Our analysis of the Diabetes Prediction in Skane cohort showed that early in life (age 2) individuals at risk have anti-Id levels indistinguishable from those in healthy controls, indicating that low anti-Id levels are not an innate characteristic of the immune response in individuals at risk. Notably, anti-Id levels declined significantly in individuals that later developed GAD65Ab suggesting that the decline in anti-Id levels precedes the emergence of GAD65Ab (median rate of change: -0.005) compared to matched controls (median rate of change: +0.001) (p = 0.0016). We conclude that while anti-Id are present early in life, their levels decrease prior to the appearance of GAD65Ab and to the development of T1D.	[Larsson, Helena Elding; Jonsson, Ida; Lernmark, Ake] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Ivarsson, Sten] Univ Hosp MAS, Dept Pediat, Malmo, Sweden; [Radtke, Jared R.; Hampe, Christiane S.] Univ Washington, Dept Med, Seattle, WA 98195 USA	Lund University; Lund University; Skane University Hospital; University of Washington; University of Washington Seattle	Hampe, CS (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	champe@u.washington.edu	Hampe, Christiane Susanne/GSD-7679-2022; Lernmark, Åke/F-8140-2015; Toledo, Frederico/G-9071-2013	Lernmark, Åke/0000-0003-1735-0499; Toledo, Frederico/0000-0002-6570-9948; Elding Larsson, Helena/0000-0003-3306-1742; Hampe, Christiane/0000-0001-9111-6671	National Institutes of Health [DK063861, DK26190]; Juvenile Diabetes Research Foundation; Swedish Research Council; Childhood Diabetes Fund; Swedish Diabetesfund; Skane County Council for Research and Development; National Institutes of Health (NIH) through the National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Allergy and Infectious Diseases; Eunice Kennedy Shriver National Institute of Child Health and Human Development [U01 DK061010, U01 DK061016, U01 DK061034, U01 DK061036, U01 DK061040, U01 DK061041, U01 DK061042, U01 DK061055, U01 DK061058, U01 DK084565, U01 DK085453, U01 DK085461, U01 DK085463, U01 DK085466, U01 DK085499, U01 DK085505, U01 DK085509, HHSN267200800019C]; National Center for Research Resources, through Clinical Translational Science Awards [UL1 RR024131, UL1 RR024139, UL1 RR024153, UL1 RR024975, UL1 RR024982, UL1 RR025744, UL1 RR025761, UL1 RR025780, UL1 RR029890, UL1 RR031986, P30 DK017047]; General Clinical Research Center Award [M01 RR00400]; Juvenile Diabetes Research Foundation International (JDRF); American Diabetes Association (ADA); Type 1 Diabetes TrialNet Study Group; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001085, UL1TR000005, UL1TR000093, UL1TR000130] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153, UL1RR024975, UL1RR031986, UL1RR025780, UL1RR024982, UL1RR025761, UL1RR024139, UL1RR024131, UL1RR029890, M01RR000400, UL1RR025744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK063861, U01DK085509, U01DK085466, R01DK026190, U01DK061036, U01DK085463, U01DK061034, P30DK017047, U01DK085461, U01DK061055, U01DK061041, U01DK061058, U01DK061010, U01DK085499, U01DK085505, UC4DK063861, U01DK061042, U01DK085453, U01DK061040] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Childhood Diabetes Fund; Swedish Diabetesfund; Skane County Council for Research and Development; National Institutes of Health (NIH) through the National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Center for Research Resources, through Clinical Translational Science Awards; General Clinical Research Center Award; Juvenile Diabetes Research Foundation International (JDRF)(Juvenile Diabetes Research Foundation); American Diabetes Association (ADA)(American Diabetes Association); Type 1 Diabetes TrialNet Study Group; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported the National Institutes of Health (DK063861 and DK26190) and a grant of the Juvenile Diabetes Research Foundation to CSH and by the Swedish Research Council (AL), Childhood Diabetes Fund (HEL), Swedish Diabetesfund (AL) and the Skane County Council for Research and Development. The sponsor of the trial was the Type 1 Diabetes TrialNet Study Group. Type 1 Diabetes TrialNet Study Group is a clinical trials network funded by the National Institutes of Health (NIH) through the National Institute of Diabetes and Digestive and Kidney Diseases, the National Institute of Allergy and Infectious Diseases, and The Eunice Kennedy Shriver National Institute of Child Health and Human Development, through the cooperative agreements U01 DK061010, U01 DK061016, U01 DK061034, U01 DK061036, U01 DK061040, U01 DK061041, U01 DK061042, U01 DK061055, U01 DK061058, U01 DK084565, U01 DK085453, U01 DK085461, U01 DK085463, U01 DK085466, U01 DK085499, U01 DK085505, U01 DK085509, and a contract HHSN267200800019C; the National Center for Research Resources, through Clinical Translational Science Awards UL1 RR024131, UL1 RR024139, UL1 RR024153, UL1 RR024975, UL1 RR024982, UL1 RR025744, UL1 RR025761, UL1 RR025780, UL1 RR029890, UL1 RR031986, P30 DK017047, and General Clinical Research Center Award M01 RR00400; the Juvenile Diabetes Research Foundation International (JDRF); and the American Diabetes Association (ADA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhonen S, 2011, DIABETES CARE, V34, P115, DOI 10.2337/dc10-1091; FALORNI A, 1995, J IMMUNOL METHODS, V186, P89, DOI 10.1016/0022-1759(95)00139-2; GEHA RS, 1985, RES CLIN LAB, V15, P1; GEHA RS, 1983, J IMMUNOL, V130, P1634; GRUBIN CE, 1994, DIABETOLOGIA, V37, P344, DOI 10.1007/BF00408469; Hampe CS, 2012, AUTOIMMUNITY; Harjutsalo V, 2005, DIABETES, V54, P563, DOI 10.2337/diabetes.54.2.563; Hwang WYK, 2005, METHODS, V36, P3, DOI 10.1016/j.ymeth.2005.01.001; JERNE NK, 1974, ANN INST PASTEUR IMM, VC125, P373; Larsson HE, 2005, DIABETOLOGIA, V48, P1484, DOI 10.1007/s00125-005-1813-4; Mahon JL, 2009, PEDIATR DIABETES, V10, P97, DOI 10.1111/j.1399-5448.2008.00464.x; Mire-Sluis AR, 2000, DIABETOLOGIA, V43, P1282, DOI 10.1007/s001250051524; Oak S, 2008, P NATL ACAD SCI USA, V105, P5471, DOI 10.1073/pnas.0800578105; Oak S, 2009, J IMMUNOL METHODS, V351, P55, DOI 10.1016/j.jim.2009.09.004; Ortqvist E, 2010, J CLIN ENDOCRINOL ME; Pundziute-Lycka A, 2002, DIABETOLOGIA, V45, P783, DOI 10.1007/s00125-002-0845-2; Rolandsson O, 1999, 59 SCI SESS SAN DIEG; Routsias JG, 2003, J AUTOIMMUN, V21, P17, DOI 10.1016/S0896-8411(03)00063-5; Routsias JG, 2002, MOL MED, V8, pA3, DOI 10.1007/BF03402155; Shoenfeld Y, 2005, ARTHRITIS RHEUM, V52, P2599, DOI 10.1002/art.21252; SHOENFELD Y, 1994, FASEB J, V8, P1296, DOI 10.1096/fasebj.8.15.8001742; SILVESTRIS F, 1984, ARTHRITIS RHEUM, V27, P1387, DOI 10.1002/art.1780271209; Van der Auwera BJ, 2002, HUM IMMUNOL, V63, P40, DOI 10.1016/S0198-8859(01)00362-7; Verge CF, 1998, DIABETES, V47, P1857, DOI 10.2337/diabetes.47.12.1857; WILLIAMS RC, 1995, J RHEUMATOL, V22, P1075; Winter WE, 2011, CLIN CHEM, V57, P168, DOI 10.1373/clinchem.2010.148205; Zivkovic IP, 2010, BIOL RES, V43, P393, DOI [10.4067/S0716-97602010000400003, /S0716-97602010000400003]	27	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65173	10.1371/journal.pone.0065173	http://dx.doi.org/10.1371/journal.pone.0065173			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785410	Green Published, Green Submitted, gold			2022-12-27	WOS:000321038800110
J	Laugsch, M; Seebach, J; Schnittler, H; Jessberger, R				Laugsch, Magdalena; Seebach, Jochen; Schnittler, Hans; Jessberger, Rolf			Imbalance of SMC1 and SMC3 Cohesins Causes Specific and Distinct Effects	PLOS ONE			English	Article							DE-LANGE-SYNDROME; CHROMATID COHESION; MAMMALIAN-CELLS; DNA-DAMAGE; HINGE; PROTEIN; COMPLEX; EXPRESSION; DIMERIZATION; REPLICATION	SMC1 and SMC3 form a high-affinity heterodimer, which provides an open backbone of the cohesin ring, to be closed by a kleisin protein. RNAi mediated knock-down of either one heterodimer partner, SMC1 or SMC3, is expected to cause very similar if not identical phenotypes. However, we observed highly distinct, protein-specific phenotypes. Upon knock-down of human SMC1, much of SMC3 remains stable, accumulates in the cytoplasm and does not associate with other cohesin proteins. Most of the excess nuclear SMC3 is highly mobile and not or only weakly chromosome-associated. In contrast, human SMC3 knock-down rendered SMC1 instable without cytoplasmic accumulation. As observed by differential protein extraction and in FRAP experiments the remaining SMC1 or SMC3 proteins in the respective SMC1 or SMC3 knock-down experiments constituted a cohesin pool, which is associated with chromatin with highest affinity, likely the least expendable. Expression of bovine EGFP-SMC1 or mouse EGFP-SMC3 in human cells under conditions of human SMC1 or SMC3 knock-down rescued the respective phenotypes, but in untreated cells over-expressed exogenous SMC proteins mis-localized. Paucity of either one of the SMC proteins causes RAD21 degradation. These results argue for great caution in interpreting SMC1 and SMC3 RNAi or over-expression experiments. Under challenged conditions these two proteins unexpectedly behave differently, which may have biological consequences for regulation of cohesin-associated functions and for human cohesin pathologies.	[Laugsch, Magdalena; Jessberger, Rolf] Tech Univ Dresden, Med Fac Carl Gustav Carus, Inst Physiol Chem, Dresden, Germany; [Seebach, Jochen; Schnittler, Hans] Univ Munster, Dept Anat & Vasc Biol, D-48149 Munster, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Munster	Laugsch, M (corresponding author), Univ Clin Carl Gustav Carus Dresden, Dept Pediat, Dresden, Germany.	Magdalena.Laugsch@uniklinikum-dresden.de; rolf.jessberger@tu-dresden.de	Laugsch, Magdalena/AAH-8170-2021		DFG [SPP1384]; German Cancer Aid Society (Deutsche Krebshilfe e.V.)	DFG(German Research Foundation (DFG)); German Cancer Aid Society (Deutsche Krebshilfe e.V.)	This work was in part funded through a grant by the DFG, SPP1384, to RJ, and by the German Cancer Aid Society (Deutsche Krebshilfe e.V.) to RJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DE, 2002, J CELL BIOL, V156, P419, DOI 10.1083/jcb.200111002; Barber TD, 2008, P NATL ACAD SCI USA, V105, P3443, DOI 10.1073/pnas.0712384105; Bauerschmidt C, 2010, NUCLEIC ACIDS RES, V38, P477, DOI 10.1093/nar/gkp976; Behlke-Steinert S, 2009, CELL CYCLE, V8, P2211, DOI 10.4161/cc.8.14.8979; Buheitel J, 2013, EMBO J; Chan KL, 2012, CELL, V150, P961, DOI 10.1016/j.cell.2012.07.028; Chen F, 2002, J BIOL CHEM, V277, P16775, DOI 10.1074/jbc.M201322200; Chiu A, 2004, J BIOL CHEM, V279, P26233, DOI 10.1074/jbc.M402439200; Deardorff MA, 2012, NATURE; Dorsett D, 2011, CURR OPIN GENET DEV, V21, P199, DOI 10.1016/j.gde.2011.01.018; Focarelli ML, 2006, MUTAT RES-FUND MOL M, V595, P23, DOI 10.1016/j.mrfmmm.2005.09.002; Gerlich D, 2006, CURR BIOL, V16, P1571, DOI 10.1016/j.cub.2006.06.068; Ghiselli G, 2000, J BIOL CHEM, V275, P20235, DOI 10.1074/jbc.C000213200; Graumann PL, 1998, J BACTERIOL, V180, P5749, DOI 10.1128/JB.180.21.5749-5755.1998; Gruber S, 2003, CELL, V112, P765, DOI 10.1016/S0092-8674(03)00162-4; Gruber S, 2006, CELL, V127, P523, DOI 10.1016/j.cell.2006.08.048; Haering CH, 2004, MOL CELL, V15, P951, DOI 10.1016/j.molcel.2004.08.030; Haering CH, 2002, MOL CELL, V9, P773, DOI 10.1016/S1097-2765(02)00515-4; Haering CH, 2012, EXP CELL RES; Hirano M, 2002, EMBO J, V21, P5733, DOI 10.1093/emboj/cdf575; Hirano M, 2001, EMBO J, V20, P3238, DOI 10.1093/emboj/20.12.3238; Hirano M, 1998, EMBO J, V17, P7139, DOI 10.1093/emboj/17.23.7139; Jessberger R, 1996, EMBO J, V15, P4061, DOI 10.1002/j.1460-2075.1996.tb00779.x; Jones S, 2001, GENOME BIOL, V2; Kakiuchi S, 2003, MOL CANCER RES, V1, P485; Kim ST, 2002, GENE DEV, V16, P560, DOI 10.1101/gad.970602; Kurze A, 2011, EMBO J, V30, P364, DOI 10.1038/emboj.2010.315; Liu J, 2009, CLIN GENET, V76, P303, DOI 10.1111/j.1399-0004.2009.01271.x; Mannini L, 2010, HUM MUTAT, V31, P5, DOI 10.1002/humu.21129; McNairn AJ, 2008, MUTAT RES-FUND MOL M, V647, P103, DOI 10.1016/j.mrfmmm.2008.08.010; Melby TE, 1998, J CELL BIOL, V142, P1595, DOI 10.1083/jcb.142.6.1595; Mishra A, 2010, CURR BIOL, V20, P279, DOI 10.1016/j.cub.2009.12.059; Murdoch B, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003241; Musio A, 2005, HUM MOL GENET, V14, P525, DOI 10.1093/hmg/ddi049; Nasmyth K, 2011, NAT CELL BIOL, V13, P1170, DOI 10.1038/ncb2349; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; NIKI H, 1992, EMBO J, V11, P5101, DOI 10.1002/j.1460-2075.1992.tb05617.x; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ocampo-Hafalla MT, 2011, J CELL SCI, V124, P685, DOI 10.1242/jcs.073866; Patel CA, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-3; Patel CA, 2005, BIOCHEM BIOPH RES CO, V330, P333, DOI 10.1016/j.bbrc.2005.02.162; Pati D, 2002, MOL CELL BIOL, V22, P8267, DOI 10.1128/MCB.22.23.8267-8277.2002; Peters JM, 2008, GENE DEV, V22, P3089, DOI 10.1101/gad.1724308; Revenkova E, 2009, HUM MOL GENET, V18, P418, DOI 10.1093/hmg/ddn369; Seitan VC, 2012, CURR OPIN GENET DEV, V22, P93, DOI 10.1016/j.gde.2011.11.003; Shintomi K, 2010, CHROMOSOMA, V119, P459, DOI 10.1007/s00412-010-0271-z; Snapp Erik L, 2003, Curr Protoc Cell Biol, VChapter 21, DOI 10.1002/0471143030.cb2101s19; Stursberg S, 1999, GENE, V228, P1, DOI 10.1016/S0378-1119(99)00021-9; Watrin E, 2009, EMBO J, V28, P2625, DOI 10.1038/emboj.2009.202; Wei W, 2004, NATURE, V428, P194, DOI 10.1038/nature02381; Wong RW, 2008, P NATL ACAD SCI USA, V105, P15441, DOI 10.1073/pnas.0807660105; Xiong B, 2010, ANNU REV BIOCHEM, V79, P131, DOI 10.1146/annurev-biochem-061708-092640; Yang D, 2002, P NATL ACAD SCI USA, V99, P9942, DOI 10.1073/pnas.152327299; Yazdi PT, 2002, GENE DEV, V16, P571, DOI 10.1101/gad.970702	54	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65149	10.1371/journal.pone.0065149	http://dx.doi.org/10.1371/journal.pone.0065149			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776448	Green Published, Green Submitted, gold			2022-12-27	WOS:000320322400009
J	Liu, FF; Huang, B; Dong, XY; Sun, Y				Liu, Fu-Feng; Huang, Bo; Dong, Xiao-Yan; Sun, Yan			Molecular Basis for the Dissociation Dynamics of Protein A-Immunoglobulin G1 Complex	PLOS ONE			English	Article							GRAINED FORCE-FIELD; COMPUTER-SIMULATION; MEMBRANE-PROTEINS; LOW PH; AFFINITY; MODELS; ANTIBODY; CHROMATOGRAPHY; BIOMOLECULES; CURVATURE	Staphylococcus aureus protein A (SpA) is the most popular affinity ligand for immunoglobulin G1 (IgG1). However, the molecular basis for the dissociation dynamics of SpA-IgG1 complex is unclear. Herein, coarse-grained (CG) molecular dynamics (MD) simulations with the Martini force field were used to study the dissociation dynamics of the complex. The CG-MD simulations were first verified by the agreement in the structural and interactional properties of SpA and human IgG1 (hIgG1) in the association process between the CG-MD and all-atom MD at different NaCl concentrations. Then, the CG-MD simulation studies focused on the molecular insight into the dissociation dynamics of SpA-hIgG1 complex at pH 3.0. It is found that there are four steps in the dissociation process of the complex. First, there is a slight conformational adjustment of helix II in SpA. This is followed by the phenomena that the electrostatic interactions provided by the three hot spots (Glu143, Arg146 and Lys154) of helix II of SpA break up, leading to the dissociation of helix II from the binding site of hIgG1. Subsequently, breakup of the hydrophobic interactions between helix I (Phe132, Tyr133 and His137) in SpA and hIgG1 occurs, resulting in the disengagement of helix I from its binding site of hIgG1. Finally, the non-specific interactions between SpA and hIgG1 decrease slowly till disappearance, leading to the complete dissociation of the SpA-hIgG1 complex. This work has revealed that CG-MD coupled with the Martini force field is an effective method for studying the dissociation dynamics of protein-protein complex.	[Sun, Yan] Tianjin Univ, Sch Chem Engn & Technol, Minist Educ, Key Lab Syst Bioengn, Tianjin 300072, Peoples R China; Tianjin Univ, Sch Chem Engn & Technol, Dept Biochem Engn, Tianjin 300072, Peoples R China	Tianjin University; Tianjin University	Sun, Y (corresponding author), Tianjin Univ, Sch Chem Engn & Technol, Minist Educ, Key Lab Syst Bioengn, Tianjin 300072, Peoples R China.	ysun@tju.edu.cn	Liu, Fufeng/M-9833-2016	Liu, Fufeng/0000-0002-9454-2382; Sun, Yan/0000-0001-5256-9571	Natural Science Foundation of China [21236005, 20906068]; National Basic Research Program of China (973 Program) [2009CB724705]; Natural Science Foundation of Tianjin from Tianjin Municipal Science and Technology Commission [10JCYBJC04500]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Natural Science Foundation of Tianjin from Tianjin Municipal Science and Technology Commission	This work was supported by the Natural Science Foundation of China (Grant Nos. 21236005 and 20906068), the National Basic Research Program of China (973 Program, Grant No. 2009CB724705) and the Natural Science Foundation of Tianjin from Tianjin Municipal Science and Technology Commission (Contract No. 10JCYBJC04500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkun Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029628; Avila CL, 2011, CURR PROTEIN PEPT SC, V12, P221; Ayton GS, 2010, BIOPHYS J, V99, P2757, DOI 10.1016/j.bpj.2010.08.018; Barderas R, 2008, P NATL ACAD SCI USA, V105, P9029, DOI 10.1073/pnas.0801221105; Bereau T, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3152842; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Boi C, 2009, J CHROMATOGR A, V1216, P8687, DOI 10.1016/j.chroma.2009.05.045; Bond PJ, 2007, J STRUCT BIOL, V157, P593, DOI 10.1016/j.jsb.2006.10.004; Bond PJ, 2006, J AM CHEM SOC, V128, P2697, DOI 10.1021/ja0569104; BOTTOMLEY SP, 1995, J IMMUNOL METHODS, V182, P185, DOI 10.1016/0022-1759(95)00049-G; Braun AR, 2012, J AM CHEM SOC, V134, P2613, DOI 10.1021/ja208316h; Chang CEA, 2007, CHEM BIOL DRUG DES, V69, P5, DOI 10.1111/j.1747-0285.2007.00464.x; Cieplak M, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2939247; Das A, 2012, J CHEM PHYS, V136, DOI 10.1063/1.4705417; de Jong DH, 2012, J CHEM THEORY COMPUT, V8, P1003, DOI 10.1021/ct200599d; DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001; Depa P, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3513365; Di Fenza A, 2009, PROTEINS, V76, P946, DOI 10.1002/prot.22399; Fuhrmans M, 2012, J AM CHEM SOC, V134, P1543, DOI 10.1021/ja207290b; Gattin Z, 2008, CHEMBIOCHEM, V9, P923, DOI 10.1002/cbic.200700434; Hober S, 2007, J CHROMATOGR B, V848, P40, DOI 10.1016/j.jchromb.2006.09.030; Huang B, 2012, J PHYS CHEM B, V116, P424, DOI 10.1021/jp205770p; Huang B, 2011, J PHYS CHEM B, V115, P4168, DOI 10.1021/jp111216g; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hyeon C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1481; Kamerlin SCL, 2011, ANNU REV PHYS CHEM, V62, P41, DOI 10.1146/annurev-physchem-032210-103335; Kamerlin SCL, 2011, PHYS CHEM CHEM PHYS, V13, P10401, DOI 10.1039/c0cp02823a; Karimi-Varzaneh HA, 2012, TOP CURR CHEM, V307, P295, DOI 10.1007/128_2010_122; Karo J, 2012, J BIOL CHEM, V287, P7467, DOI 10.1074/jbc.M111.332320; Khelashvili G, 2012, J AM CHEM SOC, V134, P15858, DOI 10.1021/ja3056485; Kral V, 2008, PROTEINS, V71, P1275, DOI 10.1002/prot.21821; Leguebe M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047332; Liwo A, 2011, PHYS CHEM CHEM PHYS, V13, P16890, DOI 10.1039/c1cp20752k; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; McCue JT, 2003, J CHROMATOGR A, V989, P139, DOI 10.1016/S0021-9673(03)00005-0; Mendez R, 2003, PROTEINS, V52, P51, DOI 10.1002/prot.10393; Moiani D, 2009, J PHYS CHEM B, V113, P16268, DOI 10.1021/jp909405b; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; Morriss-Andrews A, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3624929; Niemela PS, 2010, J AM CHEM SOC, V132, P7574, DOI 10.1021/ja101481b; Orsi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028637; Pan YM, 2008, J AM CHEM SOC, V130, P5140, DOI 10.1021/ja077972s; Patra N, 2011, J AM CHEM SOC, V133, P6146, DOI 10.1021/ja2009778; Perezzan R, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4765057; Periole X, 2009, J CHEM THEORY COMPUT, V5, P2531, DOI 10.1021/ct9002114; Perlmutter JD, 2011, J AM CHEM SOC, V133, P6563, DOI 10.1021/ja106626r; Santo KP, 2012, J PHYS CHEM B, V116, P3021, DOI 10.1021/jp212018f; Seo M, 2012, J CHEM THEORY COMPUT, V8, P1774, DOI 10.1021/ct200876v; Shinoda W, 2012, CURR OPIN STRUC BIOL, V22, P175, DOI 10.1016/j.sbi.2012.01.011; Smith LJ, 1999, PROTEINS, V36, P77, DOI 10.1002/(SICI)1097-0134(19990701)36:1<77::AID-PROT7>3.0.CO;2-X; Spiliotopoulos D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046902; Takada S, 2012, CURR OPIN STRUC BIOL, V22, P130, DOI 10.1016/j.sbi.2012.01.010; Tozzini V, 2005, CURR OPIN STRUC BIOL, V15, P144, DOI 10.1016/j.sbi.2005.02.005; Tozzini V, 2010, ACCOUNTS CHEM RES, V43, P220, DOI 10.1021/ar9001476; van den Bogaart G, 2011, NATURE, V479, P552, DOI 10.1038/nature10545; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wang YT, 2009, PHYS CHEM CHEM PHYS, V11, P2002, DOI 10.1039/b819182d; Ward AB, 2012, PROTEINS, V80, P2178, DOI 10.1002/prot.24108; Wu Z, 2011, J CHEM THEORY COMPUT, V7, P3793, DOI 10.1021/ct200593t; Yu XA, 2010, BIOPHYS J, V99, P666, DOI 10.1016/j.bpj.2010.05.006; Zhang J, 2009, IUBMB LIFE, V61, P627, DOI 10.1002/iub.223; Zhang L, 2011, J MOL GRAPH MODEL, V29, P906, DOI 10.1016/j.jmgm.2011.02.004	62	6	7	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66935	10.1371/journal.pone.0066935	http://dx.doi.org/10.1371/journal.pone.0066935			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776704	Green Published, gold, Green Submitted			2022-12-27	WOS:000320322400121
J	Alsanosy, RM; Mahfouz, MS; Gaffar, AM				Alsanosy, Rashad Mohammed; Mahfouz, Mohamed Salih; Gaffar, Abdelrahim Mutwakel			Khat Chewing Habit among School Students of Jazan Region, Saudi Arabia	PLOS ONE			English	Article							COLLEGE-STUDENTS; SECONDARY-SCHOOL; CATHA-EDULIS; ABUSE; PREVALENCE; PSYCHOSIS	Background: The use of Khat leaves (Catha edulis) in Jazan, southwest of KSA, is prevalent among all segments of the population. Objective: This study was conducted to assess the prevalence and predictors of Khat chewing among intermediate and secondary school students of Jazan region. Methodology: A cross-sectional survey was conducted in late 2011 in Jazan region. A random sample of 3923 students was selected from 72 intermediate and upper secondary schools representing the different educational sectors of the region. A structured self-administered questionnaire was used for data collection. Descriptive statistics, a chi-squared test and logistic regression were performed to examine the prevalence, associations and predictors of Khat chewing. Result: The overall Khat chewing prevalence among students was 20.5% (95% C. I.: 19.27-21.79). The prevalence was significantly higher among males, at 33.1% (95% CI: 31.16-35.08), than among females 4.3% (95% C.I.: 3.39-5.31) (P<0.001). Univariate analysis revealed that gender, age, academic performance, friends' smoking and Khat chewing, and students' smoking status were associated with a significantly high risk of Khat chewing (P<0.001 for all). The multivariate logistic regression analysis suggested that the most important independent predictors of Khat chewing among the students in our sample were students' smoking status (OR = 13.02, P<0.001), friends' use of Khat (OR = 5.65, P<0.001), gender (OR = 4.62, P<0.001), and friend's use of tobacco (OR = 1.43, P<0.001). Conclusion: A significant percentage of students chew Khat. The abuse of Khat is significantly associated with gender, peer influence, and cigarette smoking. Intervention programs are needed to create awareness among school students and to reduce the prevalence of the habit and its unfavorable consequences.	[Alsanosy, Rashad Mohammed; Mahfouz, Mohamed Salih; Gaffar, Abdelrahim Mutwakel] Jazan Univ, Fac Med, Dept Family & Community Med, Jazan, Saudi Arabia; [Alsanosy, Rashad Mohammed] Jazan Univ, Subst Abuse Res Ctr, Jazan, Saudi Arabia	Jazan University; Jazan University	Mahfouz, MS (corresponding author), Jazan Univ, Fac Med, Dept Family & Community Med, Jazan, Saudi Arabia.	mm.mahfouz@gmail.com	Gaffar, Abdelrahim Mutwakel/A-5668-2012; Mahfouz, Mohamed/A-7388-2012	Mahfouz, Mohamed/0000-0002-3155-6381; Gaffar, Abdelrahim/0000-0002-6656-2204; Alsanosy, Rashad/0000-0002-0719-9708	Substance Abuse Research Center, Jazan University, Saudi Arabia	Substance Abuse Research Center, Jazan University, Saudi Arabia	Funding recived from Substance Abuse Research Center, Jazan University, Saudi Arabia (www.Jazanu.edu.sa). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham D, 2000, SIDAMA, V5, P15; ADUGNA F, 1994, ETHIOPIAN MED J, V32, P161; Ageely HM, 2008, J FAMILY COMMUNITY M, V15; Ageely HM, 2009, HARM REDUCT J, V6, DOI 10.1186/1477-7517-6-11; Al-Mugahed L, 2008, B WORLD HEALTH ORGAN, V86, P741, DOI 10.2471/BLT.08.011008; Al-Sanosy RM, 2009, J FAM COMMUNITY MED, V16, P89; Alem A, 1999, ACTA PSYCHIAT SCAND, V100, P84, DOI 10.1111/j.1600-0447.1999.tb10699.x; Alem A, 1977, ETHIOPIAN MED J, V35, P137; Arnett JJ, 2005, J DRUG ISSUES, V35, P235, DOI 10.1177/002204260503500202; BAASHER T, 1981, BRIT J ADDICT, V76, P233; Baasher T, 1980, DRUG PROBLEMS SOCIOC; Bani I., 2011, EUR J SCI RES, V63, P122; Department of Statistics and Information KSA, 2010 1431 POP CENS P; DHADPHALE M, 1981, E AFR MED J, V58, P130; Donahue MJ, 1995, J SOC ISSUES, V51, P145, DOI 10.1111/j.1540-4560.1995.tb01328.x; GOUGH SP, 1984, LANCET, V1, P455, DOI 10.1016/S0140-6736(84)91789-6; Griffiths P, 1998, QAT USE LONDON STUDY; HALBACH H, 1972, B WORLD HEALTH ORGAN, V47, P21; HEACOCK RA, 1974, CAN J PHARM SCI, V9, P64; Hes J P, 1970, Harefuah, V78, P283; KALIX P, 1987, BRIT J ADDICT, V82, P47; KENNEDY JG, 1983, SOC SCI MED, V17, P783, DOI 10.1016/0277-9536(83)90029-1; LUQMAN W, 1976, ANN INTERN MED, V85, P246, DOI 10.7326/0003-4819-85-2-246; Milaat AA, 2006, RES REPORT; Mossie A, 2004, ETHIOPIAN MED J, V42, P125; Odenwald M, 2007, PLOS MED, V4, P1959, DOI 10.1371/journal.pmed.0040341; Odenwald M, 2005, BMC MED, V3, DOI 10.1186/1741-7015-3-5; PANTELIS C, 1989, PSYCHOL MED, V19, P657, DOI 10.1017/S0033291700024259; Patel S.L., 2005, HOME OFFICE ONLINE R, V47; Rahim BEEA, 2012, LIFE SCI J, V9, P2295; Rapeah M.Y., 2008, ANN DENT, V15, P77, DOI [10.22452/adum.vol15no2.4, DOI 10.22452/ADUM.VOL15NO2.4]; Reda AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033946; Regnerus MD, 2003, J SCI STUD RELIG, V42, P189, DOI 10.1111/1468-5906.00172; Rozi S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-312; Siziya S, 2007, Rural Remote Health, V7, P728; YOUSEF G, 1995, BRIT J HOSP MED, V54, P322	36	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65504	10.1371/journal.pone.0065504	http://dx.doi.org/10.1371/journal.pone.0065504			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	169CU	23776490	Green Published, gold, Green Submitted			2022-12-27	WOS:000320755400036
J	Li, JM; Andika, IB; Shen, JF; Lv, YD; Ji, YQ; Sun, LY; Chen, JP				Li, Junmin; Andika, Ida Bagus; Shen, Jiangfeng; Lv, Yuanda; Ji, Yongqiang; Sun, Liying; Chen, Jianping			Characterization of Rice Black-Streaked Dwarf Virus- and Rice Stripe Virus-Derived siRNAs in Singly and Doubly Infected Insect Vector Laodelphax striatellus	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; YELLOW-VEIN-VIRUS; ANTIVIRAL IMMUNITY; PLANT-VIRUSES; DROSOPHILA; REPLICATION; GENOME; SYNERGISM; PROTEINS; SUPPRESSION	Replication of RNA viruses in insect cells triggers an antiviral defense that is mediated by RNA interference (RNAi) which generates viral-derived small interfering RNAs (siRNAs). However, it is not known whether an antiviral RNAi response is also induced in insects by reoviruses, whose double-stranded RNA genome replication is thought to occur within core particles. Deep sequencing of small RNAs showed that when the small brown planthopper (Laodelphax striatellus) was infected by Rice black-streaked dwarf virus (RBSDV) (Reoviridae; Fijivirus), more viral-derived siRNAs accumulated than when the vector insect was infected by Rice stripe virus (RSV), a negative single-stranded RNA virus. RBSDV siRNAs were predominantly 21 and 22 nucleotides long and there were almost equal numbers of positive and negative sense. RBSDV siRNAs were frequently generated from hotspots in the 5' -and 3'-terminal regions of viral genome segments but these hotspots were not associated with any predicted RNA secondary structures. Under laboratory condition, L. striatellus can be infected simultaneously with RBSDV and RSV. Double infection enhanced the accumulation of particular genome segments but not viral coat protein of RBSDV and correlated with an increase in the abundance of siRNAs derived from RBSDV. The results of this study suggest that reovirus replication in its insect vector potentially induces an RNAi-mediated antiviral response.	[Li, Junmin; Andika, Ida Bagus; Sun, Liying; Chen, Jianping] Zhejiang Acad Agr Sci, Key Lab Biotechnol Plant Protect, State Key Lab Breeding Base Zhejiang Sustainable, Inst Virol & Biotechnol,Minist Agr, Hangzhou, Zhejiang Provin, Peoples R China; [Shen, Jiangfeng] Zhejiang Normal Univ, Coll Chem & Life Sci, Jinhua, Zhejiang Provin, Peoples R China; [Lv, Yuanda] Jiangsu Acad Agr Sci, Prov Key Lab Agrobiol, Nanjing, Jiangsu Provinc, Peoples R China; [Ji, Yongqiang] Yangzhou Univ, Coll Biotechnol & Life Sci, Yangzhou, Jiangsu Provinc, Peoples R China	Ministry of Agriculture & Rural Affairs; Zhejiang Academy of Agricultural Sciences; Zhejiang Normal University; Jiangsu Academy of Agricultural Sciences; Yangzhou University	Sun, LY (corresponding author), Zhejiang Acad Agr Sci, Key Lab Biotechnol Plant Protect, State Key Lab Breeding Base Zhejiang Sustainable, Inst Virol & Biotechnol,Minist Agr, Hangzhou, Zhejiang Provin, Peoples R China.	sunliying255@yahoo.com; jpchen2001@yahoo.com.cn		LV, Yuanda/0000-0001-6576-7999; Li, Junmin/0000-0002-8385-8912; Lv, Yuanda/0000-0002-6640-5989	Project of New Varieties Genetically Modified Wheat of China [2008ZX08002-001]; China Agriculture Research System from the Ministry of Agriculture of the P.R. China [CARS-3-1]; Project of Molecular Mechanism of Plant Defense to Pest and Disease from the Ministry of Science and Technology of the P.R. China [2012CB722504]; Modern Agricultural Biotechnology and Crop Disease Control from Key Subject Construction Program of Zhejiang Province, Zhejiang Provincial Natural Science Foundation of China [Q12C140016]; China Postdoctoral Science Foundation [2012M521200]	Project of New Varieties Genetically Modified Wheat of China; China Agriculture Research System from the Ministry of Agriculture of the P.R. China; Project of Molecular Mechanism of Plant Defense to Pest and Disease from the Ministry of Science and Technology of the P.R. China; Modern Agricultural Biotechnology and Crop Disease Control from Key Subject Construction Program of Zhejiang Province, Zhejiang Provincial Natural Science Foundation of China; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This study was funded by grants from the Project of New Varieties Genetically Modified Wheat of China (2008ZX08002-001), China Agriculture Research System (CARS-3-1) from the Ministry of Agriculture of the P.R. China, the Project of Molecular Mechanism of Plant Defense to Pest and Disease (2012CB722504) from the Ministry of Science and Technology of the P.R. China, Modern Agricultural Biotechnology and Crop Disease Control from Key Subject Construction Program of Zhejiang Province, Zhejiang Provincial Natural Science Foundation of China (Q12C140016) and China Postdoctoral Science Foundation (2012M521200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlquist P, 2006, NAT REV MICROBIOL, V4, P371, DOI 10.1038/nrmicro1389; Aliyari R, 2008, CELL HOST MICROBE, V4, P387, DOI 10.1016/j.chom.2008.09.001; Andika IB, 2005, MOL PLANT MICROBE IN, V18, P194, DOI 10.1094/MPMI-18-0194; Andika IB, 2012, J GEN VIROL, V93, P1841, DOI 10.1099/vir.0.043513-0; Attoui H., 2011, VIRUS TAXONOMY, P541; Baulcombe D, 2005, TRENDS BIOCHEM SCI, V30, P290, DOI 10.1016/j.tibs.2005.04.012; Brackney DE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000502; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chang SS, 2012, ANNU REV MICROBIOL, V66, P305, DOI 10.1146/annurev-micro-092611-150138; Chen QH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032860; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Du ZG, 2011, MOL PLANT PATHOL, V12, P808, DOI [10.1111/J.1364-3703.2011.00716.X, 10.1111/j.1364-3703.2011.00716.x]; Endo S, 2002, APPL ENTOMOL ZOOL, V37, P79, DOI 10.1303/aez.2002.79; Flynt A, 2009, P NATL ACAD SCI USA, V106, P5270, DOI 10.1073/pnas.0813412106; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335; Garcia-Cano E, 2006, PHYTOPATHOLOGY, V96, P1263, DOI 10.1094/PHYTO-96-1263; Ghildiyal M, 2010, RNA, V16, P43, DOI 10.1261/rna.1972910; Hemmes H, 2007, RNA, V13, P1079, DOI 10.1261/rna.444007; Hogenhout SA, 2008, ANNU REV PHYTOPATHOL, V46, P327, DOI 10.1146/annurev.phyto.022508.092135; Isogai M, 1998, J GEN VIROL, V79, P1487, DOI 10.1099/0022-1317-79-6-1487; KAKUTANI T, 1991, J GEN VIROL, V72, P465, DOI 10.1099/0022-1317-72-2-465; Llave C, 2010, TRENDS PLANT SCI, V15, P701, DOI 10.1016/j.tplants.2010.09.001; Merkling SH, 2013, J INSECT PHYSIOL, V59, P159, DOI 10.1016/j.jinsphys.2012.07.004; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Myles KM, 2009, RNA BIOL, V6, P387, DOI 10.4161/rna.6.4.8946; Myles KM, 2008, P NATL ACAD SCI USA, V105, P19938, DOI 10.1073/pnas.0803408105; Parameswaran P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000764; Patton JT, 2000, VIROLOGY, V277, P217, DOI 10.1006/viro.2000.0645; Peever TL, 1997, PHYTOPATHOLOGY, V87, P1026, DOI 10.1094/PHYTO.1997.87.10.1026; Pirkooh AA, 2012, INTERVIROLOGY, V55, P62, DOI 10.1159/000324033; Pruss G, 1997, PLANT CELL, V9, P859, DOI 10.1105/tpc.9.6.859; RAMIREZ BC, 1994, J GEN VIROL, V75, P467, DOI 10.1099/0022-1317-75-3-467; Sabin LR, 2010, CURR OPIN IMMUNOL, V22, P4, DOI 10.1016/j.coi.2010.01.007; Sherry B, 2009, J INTERF CYTOK RES, V29, P559, DOI 10.1089/jir.2009.0072; Shi XM, 1997, VIROLOGY, V231, P35, DOI 10.1006/viro.1997.8488; Shinkai A, 1962, B NAT I AGR SCI C, V14, P1; Siu RWC, 2011, J VIROL, V85, P2907, DOI 10.1128/JVI.02052-10; Sun LY, 2006, J GEN VIROL, V87, P3703, DOI 10.1099/vir.0.82213-0; Syller J, 2012, MOL PLANT PATHOL, V13, P204, DOI 10.1111/j.1364-3703.2011.00734.x; Taraporewala ZF, 2004, VIRUS RES, V101, P57, DOI 10.1016/j.virusres.2003.12.006; TORIYAMA S, 1986, MICROBIOL SCI, V3, P347; Tsatsralt-Od B, 2006, J MED VIROL, V78, P542, DOI 10.1002/jmv.20574; van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006; Vodovar N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030861; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Wu QF, 2010, P NATL ACAD SCI USA, V107, P1606, DOI 10.1073/pnas.0911353107; Xiong RY, 2009, VIROLOGY, V387, P29, DOI 10.1016/j.virol.2009.01.045; Xu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046238; Zhang HM, 2001, ARCH VIROL, V146, P2331, DOI 10.1007/s007050170006; Zhou T, 2011, RICE SCI, V18, P152, DOI 10.1016/S1672-6308(11)60022-X; ZHU YF, 1991, J GEN VIROL, V72, P763, DOI 10.1099/0022-1317-72-4-763	53	46	54	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66007	10.1371/journal.pone.0066007	http://dx.doi.org/10.1371/journal.pone.0066007			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776591	Green Published, Green Submitted, gold			2022-12-27	WOS:000320755400097
J	Wu, YT; Lee, HY; Norton, S; Chen, CF; Chen, HX; He, CL; Fleming, J; Matthews, FE; Brayne, C				Wu, Yu-Tzu; Lee, Hsin-yi; Norton, Samuel; Chen, Chuanfeng; Chen, Hongxia; He, Chenglin; Fleming, Jane; Matthews, Fiona E.; Brayne, Carol			Prevalence Studies of Dementia in Mainland China, Hong Kong and Taiwan: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							URBAN AREA; SUBTYPES; COMMUNITY; AGE; SHANGHAI; IMPACT	Background: Many studies have considered the prevalence of dementia in mainland China, Hong Kong and Taiwan. However, area level estimates have not been produced. This study examines area differences across mainland China, Hong Kong and Taiwan adjusting for the effect of methodological factors with the aim of producing estimates of the numbers of people with dementia in these areas. Method and Findings: A search of Chinese and English databases identified 76 dementia prevalence studies based on samples drawn from mainland China, Hong Kong and Taiwan between 1980 and 2012. A pattern of significantly decreasing prevalence was observed from northern, central, southern areas of mainland China, Hong Kong and Taiwan. Area variations in dementia prevalence were not explained by differences in methodological factors (diagnostic criteria, age range, study sample size and sampling method), socioeconomic level or life expectancy between areas. The results of meta-analysis were applied to current population data to provide best estimate. Based on the DSM-IV diagnostic criteria, the total number of people aged 60 and over with dementia in mainland China, Hong Kong and Taiwan is 8.4 million (4.6%, 95% CI: 3.4, 5.8) and in northern, central and southern areas are 3.8 (5.1%, 95% CI: 4.1, 6.1), 3.2 (4.4%, 95% CI: 3.2, 5.6) and 1.2 (3.9%, 95% CI: 2.3, 5.4) million respectively. These estimates were mainly based on the studies existing in highly developed areas and potentially affected by incomplete and insufficient data. Conclusions: The findings of this review provide a robust estimate of area differences in dementia prevalence. Application of the estimated prevalence to population data reveals the number of people with dementia is expected to double every 20 years, areas in mainland China will be facing the greatest dementia challenge.	[Wu, Yu-Tzu; Fleming, Jane; Brayne, Carol] Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge, England; [Lee, Hsin-yi] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD USA; [Norton, Samuel] Kings Coll London, Dept Psychol, Inst Psychiat, London WC2R 2LS, England; [Chen, Chuanfeng] Huzhou Teachers Coll, Coll Teacher Educ, Inst Psychol Sci & Hlth Educ, Huzhou City, Zhejiang, Peoples R China; [Chen, Hongxia; He, Chenglin] Ningbo Univ, Coll Teacher Educ, Dept Psychol, Ningbo, Zhejiang, Peoples R China; [Matthews, Fiona E.] Univ Cambridge, MRC, Biostat Unit, Inst Publ Hlth, Cambridge, England	University of Cambridge; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of London; King's College London; Huzhou University; Ningbo University; MRC Biostatistics Unit; University of Cambridge	Wu, YT (corresponding author), Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge, England.	ytw22@medschl.cam.ac.uk	Matthews, Fiona/O-6932-2015; Norton, Sam J/A-1898-2009; Brayne, Carol/AAA-4285-2020; Fleming, Jane/L-5300-2015	Matthews, Fiona/0000-0002-1728-2388; Norton, Sam J/0000-0003-1714-9963; Brayne, Carol/0000-0001-5307-663X; Fleming, Jane/0000-0002-8127-2061; Wu, Yu-Tzu/0000-0002-0874-4448	Cambridge Taiwan Scholarship from the University of Cambridge; Ministry of Education, Republic of China (Taiwan); United Kingdom Medical Research Council; Medical Research Council [MC_U105292687] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10084] Funding Source: researchfish; MRC [MC_U105292687] Funding Source: UKRI	Cambridge Taiwan Scholarship from the University of Cambridge; Ministry of Education, Republic of China (Taiwan)(Ministry of Education, Taiwan); United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	YTW is funded by Cambridge Taiwan Scholarship from the University of Cambridge (www.cambridgetrusts.org) and the Ministry of Education, Republic of China (Taiwan, www.edu.tw). FEM is funded by United Kingdom Medical Research Council (www.mrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzheimer's Disease International, 2009, WORLD ALZH REP 2009; Borenstein Michael, 2007, METAANALYSIS FIXED E; Census and Statistics Department, 2012, 2011 POP CENS; Chen B, 2009, FUJIAN MED J, V31, P133; Chen C, 1992, CHIN MENT HLTH J, V6, P49; Chen RL, 2012, INT J GERIATR PSYCH, V27, P692, DOI 10.1002/gps.2767; Chen W, 2004, CHINA TROPICAL MED, V14, P4016; Chen Z, 1998, CHIN J NEUROIMMUNOL, V5, P44; Cheng Z, 1989, CHIN J GERIATR, V9, P204; Chiu HFK, 1998, NEUROLOGY, V50, P1002, DOI 10.1212/WNL.50.4.1002; Dong MJ, 2007, AGE AGEING, V36, P619, DOI 10.1093/ageing/afm128; Fan J, 2000, J CLIN PSYCHOL MED S, V10, P137; Fan QingHua, 2011, Modern Preventive Medicine, V38, P3029; Fei W, 2001, SHANGHAI SICHUAN MEN, V14, P31; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Gao S, 1989, CHIN J GERIATR, V2, P75; Gao Z, 1993, CHIN J NEUROL PSYCHI, V26, P209; Gao Z, 1994, HUNAN MED J, V11, P195; Harbord RM, 2008, STATA J, V8, P493, DOI 10.1177/1536867X0800800403; Huang WY, 2007, CHIN J PUBLIC HLTH, V23, P983; Ji M, 2010, CHIN J REHABIL THEOR, V16, P513; [康美玉 KANG Meiyu], 2011, [中国公共卫生, China Public Health], V27, P1123; Kuang P, 1984, CHIN J EPIDEMIOL, V5, P95; Lai M, 2011, CHIN J GERIATR, V31, P4016; Lai S, 2000, CHINESE J GERIATRICS, V19, P450; Lee C, 1997, ACTA NEUROL TAIWAN, V6, P27; LI G, 1989, ACTA PSYCHIAT SCAND, V79, P557, DOI 10.1111/j.1600-0447.1989.tb10303.x; Li Hong, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P772; Li K, 2008, CHIN J HLTH PSYCHOL, V16, P1251; Li LL, 2011, CHIN J DIS CONTROL P, V15, P292; Li S, 1999, CHINESE MENTAL HLTH, V13, P266; Li Z, 1999, CHINESE J GERIATRICS, V19, P3; Liang L, 2003, MOD PREV MED, V30, P515; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lin RT, 1998, J NEUROL SCI, V160, P67, DOI 10.1016/S0022-510X(98)00225-1; Liu CK, 1996, J FORMOS MED ASSOC, V95, P762; Liu CK, 2000, APPL PSYCHOL RES, V7, P157; Liu H, 1998, ALZ DIS ASSOC DIS, V12, P137; LIU HC, 1995, J AM GERIATR SOC, V43, P144, DOI 10.1111/j.1532-5415.1995.tb06379.x; Lou K, 1998, SHANGHAI J PREVENTIV, V10, P187; Lv S, 1998, CHINESE MENTAL HLTH, V31, P225; Mao R, 1993, CHIN J GERONTOL, V13, P226; Ministry of the Interior, 2012, STAT YB INT; National Bureau of Statistics of China, 2012, TAB 2010 POP CENS PE; National Bureau of Statistics of China, 2011, CHINA STAT YB 2010; Peng X, 2010, MED SOC, V23, P58; Qu Q, 2001, CHIN J GERIATR, V20, P283; Rodriguez JJL, 2008, LANCET, V372, P464, DOI 10.1016/S0140-6736(08)61002-8; Shen Q, 2002, SHANGDONG ACT PSYCHI, V15, P187; Sun Y, 2001, CHIN J PSYCHIAT, V34, P26; [孙正海 Sun Zhenghai], 2012, [中国公共卫生, China Public Health], V28, P151; Tan J, 2007, BASIC MED FORUM, V11, P703; Tang M, 1999, J CLIN PSYCHOL MED S, V19, P20; [唐牟尼 TANG Muni], 2007, [中国神经精神疾病杂志, Chinese Journal of Nervous and Mental Diseases], V33, P340; [唐牟尼 Tang Muni], 2005, [中华精神科杂志, Chinese Journal of Psychiatry], V38, P170; Tang X, 1998, CHIN J GERIATR, V17, P307; Tang Z, 2002, CHIN J GERONTOL, V22, P224; United Nations Population Fund China, 2006, POP AG CHIN FACTS FI; Wang D, 2002, CHIN J PUBLIC HLTH, V18, P1498; Wang D, 1995, SHANGHAI ARCH PSYCHI, V7, P76; Wang F, 2010, CHIN J PRACT NERV DI, V13, P9; Wang H, 2009, CHIN J PUBLIC HLTH, V25, P899; Wang JY, 1998, PSYCHIAT CLIN NEUROS, V52, pS295, DOI 10.1111/j.1440-1819.1998.tb03249.x; Wang T, 1999, OCCUP HLTH, V15, P43; Wang WZ, 2000, NEUROEPIDEMIOLOGY, V19, P194, DOI 10.1159/000026255; Wen G, 1995, PRACTICAL GERIATRICS, V9, P186; Wen H, 2008, MODERN PREVENTIVE ME, V35, P847; World Health Organization and Alzheimer Disease International, 2012, DEM PUBL HLTH PRIOR; Wu C, 2003, CHINA TROPICAL MED, V13, P1056; Wu C, 1996, SICHUAN MENTAL HLTH, V9, P1; Xiao Z, 1999, CHIN J CLIN PSYCHOL, V7, P221; Xue G, 1997, J PRACTICAL MED, V13, P371; [闫芳 YAN Fang], 2008, [中国心理卫生杂志, Chinese Mental Health Journal], V22, P110; Ye GC, 2011, CHINESE RURAL HLTH S, V31, P152; Yip PK., 1992, ACTA NEUROL SIN, V1, P347; Yu J, 1998, CHIN J NERV MENT DIS, V24, P30; Yu Ruby, 2012, Int J Alzheimers Dis, V2012, P406852, DOI 10.1155/2012/406852; Yu X, 1994, P HARDW IMPL NEUR NE, P1; Yuan Y, 2005, CHIN J NEUROMED, V4, P65; Zhang M, 1989, SHANGHAI ARCH PSYCHI, V7, P153; Zhang YD, 2012, J CLIN NEUROSCI, V19, P1333, DOI 10.1016/j.jocn.2012.01.029; Zhang Z, 1996, HAINAN MED, V3, P207; Zhang Z, 2000, SHANGHAI J HLTH PSYC, V8, P536; Zhang Z, 2001, CHINESE J NEUROLOGY, V34, P199; Zhang ZX, 2006, NEUROEPIDEMIOLOGY, V27, P177, DOI 10.1159/000096131; Zhao QH, 2010, ALZ DIS ASSOC DIS, V24, P151, DOI 10.1097/WAD.0b013e3181ca0929; Zhou DF, 2006, ACTA NEUROL SCAND, V114, P273, DOI 10.1111/j.1600-0404.2006.00641.x; [邹开利 Zhou Kaili], 2002, [中华老年医学杂志, Chinese Journal of Geriatrics], V21, P433	88	91	97	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66252	10.1371/journal.pone.0066252	http://dx.doi.org/10.1371/journal.pone.0066252			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	169CU	23776645	Green Published, gold			2022-12-27	WOS:000320755400127
J	Zhang, B; Liang, C; He, HB; Zhang, XD				Zhang, Bin; Liang, Chao; He, Hongbo; Zhang, Xudong			Variations in Soil Microbial Communities and Residues Along an Altitude Gradient on the Northern Slope of Changbai Mountain, China	PLOS ONE			English	Article							PARTICLE-SIZE FRACTIONS; OLD-GROWTH FOREST; MURAMIC ACID; AMINO-SUGARS; BACTERIAL COMMUNITIES; ENZYME-ACTIVITIES; ALPINE SOILS; CLIMATE; FUNGAL; PH	Altitudinally-defined climate conditions provide specific vegetation types and soil environments that could influence soil microbial communities, which in turn may affect microbial residues. However, the knowledge is limited in terms of the degree to which microbial communities and residues present and differ along altitude. In this study, we examined the soil microbial communities and residues along the northern slope of Changbai Mountain, China using phospholipid fatty acid (PLFA) and amino sugar analysis, respectively. Soil samples were taken from five different vegetation belts defined by climates. Principal component analysis (PCA) revealed substantial differences in soil microbial community composition among study sites, appeared to be driven primarily by soil pH and C/N ratio on the first principal component (PC1) which accounted for 50.7% of the total sample variance. The alpine tundra was separated from forest sites on the second principal component (PC2) by a signifiscantly higher amount of fungal PLFA (18:2 omega 6,9). Soil pH and C/N ratio were also correlated with the ratios of Gram-positive to Gram-negative bacteria (Gm(+)/Gm(-)), glucosamine to galactosamine (GluN/GalN), and glucosamine to muramic acid (GluN/MurA). Both total PLFAs and amino sugars were positively correlated with soil organic carbon, inorganic nitrogen, available phosphorus and potassium. We concluded that soil pH and C/N ratio were the most important drivers for microbial community structure and amino sugar pattern, while substrate availability was of great importance in determining the concentrations of microbial communities and residues. These findings could be used to facilitate interpretation of soil microbial community and amino sugar data derived from measurements in latitude or managed forests.	[Zhang, Bin; He, Hongbo; Zhang, Xudong] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China; [Zhang, Bin] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Liang, Chao] Univ Wisconsin, Dept Soil Sci, Madison, WI 53706 USA; [Zhang, Xudong] Natl Field Observat & Res Stn Shenyang Agroecosys, Shenyang, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Wisconsin System; University of Wisconsin Madison	He, HB (corresponding author), Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China.	hehongbo@iae.ac.cn; xdzhang@iae.ac.cn		Liang, Chao/0000-0002-9089-6546	National Key Basic Research Foundation of China [2011CB403202]; Natural Science Foundation of China [41130524]; International Partnership Program of Chinese Academy of Sciences [KZCX2-YW-T06]	National Key Basic Research Foundation of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Partnership Program of Chinese Academy of Sciences	This work was supported by the National Key Basic Research Foundation of China (2011CB403202), the Natural Science Foundation of China (41130524) and the International Partnership Program of Chinese Academy of Sciences (KZCX2-YW-T06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AS, 2004, SOIL BIOL BIOCHEM, V10, P215; Amelung W, 1999, SOIL SCI SOC AM J, V63, P86, DOI 10.2136/sssaj1999.03615995006300010014x; Amelung W, 2001, ASSESSMENT METHODS S, P223; [Anonymous], 1997, INTRO SOIL MICROBIOL; Baath E, 2003, SOIL BIOL BIOCHEM, V35, P955, DOI 10.1016/S0038-0717(03)00154-8; Bach LH, 2010, SOIL BIOL BIOCHEM, V42, P1934, DOI 10.1016/j.soilbio.2010.07.002; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bossio DA, 1998, MICROBIAL ECOL, V36, P1, DOI 10.1007/s002489900087; Brockett BFT, 2012, SOIL BIOL BIOCHEM, V44, P9, DOI 10.1016/j.soilbio.2011.09.003; Diaz HF, 2003, CLIMATIC CHANGE, V59, P1, DOI 10.1023/A:1024416227887; Ding XL, 2011, SOIL TILL RES, V114, P43, DOI 10.1016/j.still.2011.03.008; Djukic I, 2010, SOIL BIOL BIOCHEM, V42, P155, DOI 10.1016/j.soilbio.2009.10.006; Engelking B, 2007, SOIL BIOL BIOCHEM, V39, P2111, DOI 10.1016/j.soilbio.2007.03.020; EUDY LW, 1985, ANALYST, V110, P381, DOI 10.1039/an9851000381; Fierer N, 2003, SOIL BIOL BIOCHEM, V35, P167, DOI 10.1016/S0038-0717(02)00251-1; Frostegard A, 1996, BIOL FERT SOILS, V22, P59, DOI 10.1007/BF00384433; Gallet C, 1997, J CHEM ECOL, V23, P2401, DOI 10.1023/B:JOEC.0000006682.50061.83; Giri DD, 2007, SOIL BIOL BIOCHEM, V39, P2424, DOI 10.1016/j.soilbio.2007.04.007; Glaser B, 2004, SOIL BIOL BIOCHEM, V36, P399, DOI 10.1016/j.soilbio.2003.10.013; Guggenberger G, 1999, SOIL SCI SOC AM J, V63, P1188, DOI 10.2136/sssaj1999.6351188x; Hackl E, 2005, SOIL BIOL BIOCHEM, V37, P661, DOI 10.1016/j.soilbio.2004.08.023; He HB, 2011, SOIL BIOL BIOCHEM, V43, P1155, DOI 10.1016/j.soilbio.2011.02.002; He HS, 2005, J BIOGEOGR, V32, P2043, DOI 10.1111/j.1365-2699.2005.01353.x; Hogberg MN, 2007, OECOLOGIA, V150, P590, DOI 10.1007/s00442-006-0562-5; Joergensen RG, 2010, BIOL FERT SOILS, V46, P303, DOI 10.1007/s00374-009-0433-4; Kandeler E, 2000, BIOL FERT SOILS, V32, P390, DOI 10.1007/s003740000268; Kogel-Knaber I, 1993, SOIL BIOCH, P101; Liang C, 2007, BIOL FERT SOILS, V43, P631, DOI 10.1007/s00374-006-0142-1; Liang C, 2008, SOIL BIOL BIOCHEM, V40, P2063, DOI 10.1016/j.soilbio.2008.01.022; Liang C, 2007, BIOL FERT SOILS, V44, P1, DOI 10.1007/s00374-007-0170-5; Liang C, 2007, FORESTRY, V80, P65, DOI 10.1093/forestry/cpl035; Liang C, 2012, APPL SOIL ECOL, V54, P24, DOI 10.1016/j.apsoil.2011.11.015; Liang C, 2011, BIOGEOCHEMISTRY, V106, P303, DOI 10.1007/s10533-010-9525-3; Lu R, 2000, METHODS SOIL AGROCHE; Lucas RW, 2007, SOIL BIOL BIOCHEM, V39, P2508, DOI 10.1016/j.soilbio.2007.05.008; Ma XJ, 2004, FOLIA MICROBIOL, V49, P105, DOI 10.1007/BF02931382; Mannisto MK, 2007, FEMS MICROBIOL ECOL, V59, P452, DOI 10.1111/j.1574-6941.2006.00232.x; Margesin R, 2009, FEMS MICROBIOL ECOL, V67, P208, DOI 10.1111/j.1574-6941.2008.00620.x; MILLAR WN, 1970, CAN J MICROBIOL, V16, P299, DOI 10.1139/m70-054; Moritz LK, 2009, BIOGEOCHEMISTRY, V92, P83, DOI 10.1007/s10533-008-9264-x; Nilsson LO, 2007, OECOLOGIA, V153, P375, DOI 10.1007/s00442-007-0735-x; Parsons J. W., 1981, Soil biochemistry. Volume 5, P197; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; Pettersson M, 2003, FEMS MICROBIOL ECOL, V45, P13, DOI 10.1016/S0168-6496(03)00106-5; Rousk J, 2010, SOIL BIOL BIOCHEM, V42, P516, DOI 10.1016/j.soilbio.2009.11.026; SCHINNER F, 1981, OECOLOGIA, V50, P113, DOI 10.1007/BF00378803; Shen CC, 2013, SOIL BIOL BIOCHEM, V57, P204, DOI 10.1016/j.soilbio.2012.07.013; Singh BK, 2010, NAT REV MICROBIOL, V8, P779, DOI 10.1038/nrmicro2439; Smith SE., 1997, MYCORHIZAL SYMBIOSIS; SOWDEN FJ, 1977, CAN J SOIL SCI, V57, P445, DOI 10.4141/cjss77-050; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Stroud JL, 2007, J APPL MICROBIOL, V102, P1239, DOI 10.1111/j.1365-2672.2007.03401.x; Ushio M, 2008, SOIL BIOL BIOCHEM, V40, P2699, DOI 10.1016/j.soilbio.2008.06.023; van Groenigen KJ, 2010, SOIL BIOL BIOCHEM, V42, P48, DOI 10.1016/j.soilbio.2009.09.023; Wagai R, 2011, ECOL RES, V26, P627, DOI 10.1007/s11284-011-0822-7; WARDLE DA, 1992, BIOL REV, V67, P321, DOI 10.1111/j.1469-185X.1992.tb00728.x; Weand MP, 2010, SOIL BIOL BIOCHEM, V42, P2161, DOI 10.1016/j.soilbio.2010.08.012; Wu YP, 2009, APPL SOIL ECOL, V43, P234, DOI 10.1016/j.apsoil.2009.08.002; Yergeau E, 2007, FEMS MICROBIOL ECOL, V59, P436, DOI 10.1111/j.1574-6941.2006.00200.x; Zhang XD, 1998, SOIL SCI, V163, P220, DOI 10.1097/00010694-199803000-00007; Zhang XD, 2003, APPL SOIL ECOL, V23, P147, DOI 10.1016/S0929-1393(03)00020-9; Zhang XD, 1996, SOIL BIOL BIOCHEM, V28, P1201, DOI 10.1016/0038-0717(96)00117-4	62	76	94	15	204	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66184	10.1371/journal.pone.0066184	http://dx.doi.org/10.1371/journal.pone.0066184			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776630	gold, Green Submitted, Green Published			2022-12-27	WOS:000320755400119
J	Hsieh, CH; Meher, AK; Chen, YC				Hsieh, Cheng-Huan; Meher, Anil Kumar; Chen, Yu-Chie			Automatic Sampling and Analysis of Organics and Biomolecules by Capillary Action-Supported Contactless Atmospheric Pressure Ionization Mass Spectrometry	PLOS ONE			English	Article							ELECTROSPRAY-IONIZATION; CHEMICAL-REACTIONS; SPRAY IONIZATION; ION; MILK	Contactless atmospheric pressure ionization (C-API) method has been recently developed for mass spectrometric analysis. A tapered capillary is used as both the sampling tube and spray emitter in C-API. No electric contact is required on the capillary tip during C-API mass spectrometric analysis. The simple design of the ionization method enables the automation of the C-API sampling system. In this study, we propose an automatic C-API sampling system consisting of a capillary (similar to 1 cm), an aluminium sample holder, and a movable XY stage for the mass spectrometric analysis of organics and biomolecules. The aluminium sample holder is controlled by the movable XY stage. The outlet of the C-API capillary is placed in front of the orifice of a mass spectrometer, whereas the sample well on the sample holder is moved underneath the capillary inlet. The sample droplet on the well can be readily infused into the C-API capillary through capillary action. When the sample solution reaches the capillary outlet, the sample spray is readily formed in the proximity of the mass spectrometer applied with a high electric field. The gas phase ions generated from the spray can be readily monitored by the mass spectrometer. We demonstrate that six samples can be analyzed in sequence within 3.5 min using this automatic C-API MS setup. Furthermore, the well containing the rinsing solvent is alternately arranged between the sample wells. Therefore, the C-API capillary could be readily flushed between runs. No carryover problems are observed during the analyses. The sample volume required for the C-API MS analysis is minimal, with less than 1 nL of the sample solution being sufficient for analysis. The feasibility of using this setup for quantitative analysis is also demonstrated.	[Hsieh, Cheng-Huan; Meher, Anil Kumar; Chen, Yu-Chie] Natl Chiao Tung Univ, Dept Appl Chem, Hsinchu, Taiwan	National Yang Ming Chiao Tung University	Chen, YC (corresponding author), Natl Chiao Tung Univ, Dept Appl Chem, Hsinchu, Taiwan.	yuchie@mail.nctu.edu.tw			National Science Council of Taiwan [NSC 99-2113-M-009-003-MY3]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	The work was supported by the National Science Council of Taiwan (grant no.: NSC 99-2113-M-009-003-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberici RM, 2010, ANAL BIOANAL CHEM, V398, P265, DOI 10.1007/s00216-010-3808-3; Badjagbo K, 2012, ANAL CHEM, V84, P5731, DOI 10.1021/ac300918f; Burton BK, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.6.e69; Chang DY, 2002, ANAL CHEM, V74, P2465, DOI 10.1021/ac010788j; Chen HW, 2006, CHEM COMMUN, P2042, DOI 10.1039/b602614a; Chen TY, 2010, J AM SOC MASS SPECTR, V21, P1547, DOI 10.1016/j.jasms.2010.04.021; Cheng CY, 2008, ANAL CHEM, V80, P7699, DOI 10.1021/ac800952e; Cody RB, 2005, ANAL CHEM, V77, P2297, DOI 10.1021/ac050162j; Corkery LJ, 2005, J AM SOC MASS SPECTR, V16, P363, DOI 10.1016/j.jasms.2004.11.018; Dams R, 2002, ANAL CHEM, V74, P3206, DOI 10.1021/ac0112824; Gobbo-Neto L, 2008, RAPID COMMUN MASS SP, V22, P3802, DOI 10.1002/rcm.3802; HIRABAYASHI A, 1994, ANAL CHEM, V66, P4557, DOI 10.1021/ac00096a025; Hsieh CH, 2012, J MASS SPECTROM, V47, P586, DOI 10.1002/jms.2983; Hsieh CH, 2011, ANAL CHEM, V83, P2866, DOI 10.1021/ac200479s; Huang MZ, 2010, ANNU REV ANAL CHEM, V3, P43, DOI 10.1146/annurev.anchem.111808.073702; Kottke PA, 2010, ANAL CHEM, V82, P19, DOI 10.1021/ac902102x; Laskin J, 2012, ANAL CHEM, V84, P141, DOI 10.1021/ac2021322; Lo TJ, 2012, MASS SPECTROM LETT, V3, P87, DOI 10.5478/MSL.2012.3.4.87; Ma XX, 2012, TRAC-TREND ANAL CHEM, V35, P50, DOI 10.1016/j.trac.2011.12.004; McEwen CN, 2005, ANAL CHEM, V77, P7826, DOI 10.1021/ac051470k; Santos VG, 2011, ANAL CHEM, V83, P1375, DOI 10.1021/ac102765z; Segura PA, 2010, J AGR FOOD CHEM, V58, P1442, DOI 10.1021/jf903362v; Takats Z, 2004, ANAL CHEM, V76, P4050, DOI 10.1021/ac049848m; Takats Z, 2004, SCIENCE, V306, P471, DOI 10.1126/science.1104404; Trimpin S, 2010, MOL CELL PROTEOMICS, V9, P362, DOI 10.1074/mcp.M900527-MCP200; Weston DJ, 2010, ANALYST, V135, P661, DOI 10.1039/b925579f; Zhu ZQ, 2012, ANAL CHEM, V84, P7547, DOI 10.1021/ac3017136	27	9	9	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e66292	10.1371/journal.pone.0066292	http://dx.doi.org/10.1371/journal.pone.0066292			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762484	Green Published, gold, Green Submitted			2022-12-27	WOS:000321099000131
J	Davey, CJ; Harley, C; Elliott, DB				Davey, Christopher J.; Harley, Clare; Elliott, David B.			Levels of State and Trait Anxiety in Patients Referred to Ophthalmology by Primary Care Clinicians: A Cross Sectional Study	PLOS ONE			English	Article							PSYCHOMETRIC PROPERTIES; PSYCHOLOGICAL IMPACT; GLAUCOMA; INVENTORY; VALIDITY; CANCER	Purpose: There is a high level of over-referral from primary eye care leading to significant numbers of people without ocular pathology (false positives) being referred to secondary eye care. The present study used a psychometric instrument to determine whether there is a psychological burden on patients due to referral to secondary eye care, and used Rasch analysis to convert the data from an ordinal to an interval scale. Design: Cross sectional study. Participants and Controls: 322 participants and 80 control participants. Methods: State (i.e. current) and trait (i.e. propensity to) anxiety were measured in a group of patients referred to a hospital eye department in the UK and in a control group who have had a sight test but were not referred. Response category analysis plus infit and outfit Rasch statistics and person separation indices were used to determine the usefulness of individual items and the response categories. Principal components analysis was used to determine dimensionality. Main Outcome Measure: Levels of state and trait anxiety measured using the State-Trait Anxiety Inventory. Results: State anxiety scores were significantly higher in the patients referred to secondary eye care than the controls (p<0.04), but similar for trait anxiety (p>0.1). Rasch analysis highlighted that the questionnaire results needed to be split into "anxiety-absent'' and "anxiety-present'' items for both state and trait anxiety, but both subscales showed the same profile of results between patients and controls. Conclusions: State anxiety was shown to be higher in patients referred to secondary eye care than the controls, and at similar levels to people with moderate to high perceived susceptibility to breast cancer. This suggests that referral from primary to secondary eye care can result in a significant psychological burden on some patients.	[Davey, Christopher J.; Elliott, David B.] Bradford Sch Optometry & Vis Sci, Bradford, W Yorkshire, England; [Harley, Clare] Univ Leeds, Sch Healthcare, Leeds, W Yorkshire, England	University of Bradford; University of Leeds	Davey, CJ (corresponding author), Bradford Sch Optometry & Vis Sci, Bradford, W Yorkshire, England.	chris@chrisdavey.co.uk	Elliott, David/B-1806-2009; Harley, Clare/C-9829-2010	Elliott, David/0000-0001-9959-6841; Harley, Clare/0000-0002-8800-4238; Davey, Christopher/0000-0002-9050-379X	University of Bradford	University of Bradford	The study was funded by the University of Bradford. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absetz P, 2003, PSYCHO-ONCOLOGY, V12, P305, DOI 10.1002/pon.644; Bond TG., 2020, APPL RASCH MODEL FUN; Bowling B, 2005, BRIT J OPHTHALMOL, V89, P1102, DOI 10.1136/bjo.2004.064378; Brett J, 2005, PSYCHO-ONCOLOGY, V14, P917, DOI 10.1002/pon.904; Brewer NT, 2007, ANN INTERN MED, V146, P502, DOI 10.7326/0003-4819-146-7-200704030-00006; Brouwers EPM, 2001, J PSYCHOSOM RES, V51, P659, DOI 10.1016/S0022-3999(01)00245-8; Burr J, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11410; Cleemput I, 2004, VALUE HEALTH, V7, P499, DOI 10.1111/j.1524-4733.2004.74013.x; Cockburn J, 1994, J Med Screen, V1, P7; CORAH NL, 1988, DENT CLIN N AM, V32, P779; Court H, 2010, VALUE HEALTH, V13, P813, DOI 10.1111/j.1524-4733.2010.00758.x; Court H, 2009, OPTOMETRY VISION SCI, V86, P1295, DOI 10.1097/OPX.0b013e3181bb4212; de Boer MR, 2004, OPHTHAL PHYSL OPT, V24, P257, DOI 10.1111/j.1475-1313.2004.00187.x; Deborde AS, 2004, ENCEPHALE, V30, P464; Gotzsche PC, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub4; GRAM IT, 1990, BRIT J CANCER, V62, P1018, DOI 10.1038/bjc.1990.430; Henson DB, 2003, EYE, V17, P21, DOI 10.1038/sj.eye.6700261; Keyzer-Dekker CMG, 2012, BREAST, V21, P83, DOI 10.1016/j.breast.2011.08.137; Kvaal K, 2001, INT J GERIATR PSYCH, V16, P980, DOI 10.1002/gps.458; Lawrenson J, 2013, OPHTHAL PHYSL OPT, V33, P3, DOI 10.1111/opo.12015; Linacre JM, 2012, USERS GUIDE WINSTEPS, P466; Linacre JM, 2003, RASCH MEAS T, V17, P1; MARTEAU TM, 1988, BRIT MED J, V297, P1469, DOI 10.1136/bmj.297.6661.1469-b; Massof RW, 2001, SURV OPHTHALMOL, V45, P531, DOI 10.1016/S0039-6257(01)00194-1; Michopoulos Ioannis, 2008, Ann Gen Psychiatry, V7, P4, DOI 10.1186/1744-859X-7-4; MOOK J, 1992, ANXIETY STRESS COPIN, V5, P113, DOI 10.1080/10615809208250491; Pesudovs K, 2007, OPTOMETRY VISION SCI, V84, P663, DOI 10.1097/OPX.0b013e318141fe75; Pesudovs Konrad, 2006, BMC Ophthalmol, V6, P25, DOI 10.1186/1471-2415-6-25; Salmon NJ, 2007, OPHTHAL PHYSL OPT, V27, P399, DOI 10.1111/j.1475-1313.2007.00497.x; Soury S., 2005, Annales de Readaptation et de Medecine Physique, V48, P61, DOI 10.1016/j.annrmp.2004.08.007; Spielberger C. D., 1983, MIND GARDEN; Stark DPH, 2000, BRIT J CANCER, V83, P1261, DOI 10.1054/bjoc.2000.1405; TYMSTRA T, 1986, FAM PRACT, V3, P92, DOI 10.1093/fampra/3.2.92; Vianya-Estopa M, 2010, INVEST OPHTH VIS SCI, V51, P2496, DOI 10.1167/iovs.09-4381; Wright B.D., 1994, RASCH MEASUREMENT T, V8, P3; WRIGHT BD, 1989, ARCH PHYS MED REHAB, V70, P857	36	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65708	10.1371/journal.pone.0065708	http://dx.doi.org/10.1371/journal.pone.0065708			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	172XB	23785444	Green Accepted, Green Published, gold			2022-12-27	WOS:000321038800078
J	French, SD; McKenzie, JE; O'Connor, DA; Grimshaw, JM; Mortimer, D; Francis, JJ; Michie, S; Spike, N; Schattner, P; Kent, P; Buchbinder, R; Page, MJ; Green, SE				French, Simon D.; McKenzie, Joanne E.; O'Connor, Denise A.; Grimshaw, Jeremy M.; Mortimer, Duncan; Francis, Jill J.; Michie, Susan; Spike, Neil; Schattner, Peter; Kent, Peter; Buchbinder, Rachelle; Page, Matthew J.; Green, Sally E.			Evaluation of a Theory-Informed Implementation Intervention for the Management of Acute Low Back Pain in General Medical Practice: The IMPLEMENT Cluster Randomised Trial	PLOS ONE			English	Article							FEAR-AVOIDANCE BELIEFS; BEHAVIOR-CHANGE INTERVENTIONS; EVIDENCE-BASED GUIDELINES; PRIMARY-CARE; RADIOLOGISTS GUIDELINES; CORRELATION-COEFFICIENT; CLINICAL GUIDELINES; PHYSICIAN PRACTICE; AUSTRALIAN ADULTS; PATIENT OUTCOMES	Introduction: This cluster randomised trial evaluated an intervention to decrease x-ray referrals and increase giving advice to stay active for people with acute low back pain (LBP) in general practice. Methods: General practices were randomised to either access to a guideline for acute LBP (control) or facilitated interactive workshops (intervention). We measured behavioural predictors (e. g. knowledge, attitudes and intentions) and fear avoidance beliefs. We were unable to recruit sufficient patients to measure our original primary outcomes so we introduced other outcomes measured at the general practitioner (GP) level: behavioural simulation (clinical decision about vignettes) and rates of x-ray and CT-scan (medical administrative data). All those not involved in the delivery of the intervention were blinded to allocation. Results: 47 practices (53 GPs) were randomised to the control and 45 practices (59 GPs) to the intervention. The number of GPs available for analysis at 12 months varied by outcome due to missing confounder information; a minimum of 38 GPs were available from the intervention group, and a minimum of 40 GPs from the control group. For the behavioural constructs, although effect estimates were small, the intervention group GPs had greater intention of practising consistent with the guideline for the clinical behaviour of x-ray referral. For behavioural simulation, intervention group GPs were more likely to adhere to guideline recommendations about x-ray (OR 1.76, 95%CI 1.01, 3.05) and more likely to give advice to stay active (OR 4.49, 95%CI 1.90 to 10.60). Imaging referral was not statistically significantly different between groups and the potential importance of effects was unclear; rate ratio 0.87 (95%CI 0.68, 1.10) for x-ray or CT-scan. Conclusions: The intervention led to small changes in GP intention to practice in a manner that is consistent with an evidence-based guideline, but it did not result in statistically significant changes in actual behaviour.	[French, Simon D.; McKenzie, Joanne E.; O'Connor, Denise A.; Page, Matthew J.; Green, Sally E.] Monash Univ, Sch Publ Hlth & Prevent Med, Clayton, Vic 3800, Australia; [French, Simon D.] Univ Melbourne, Ctr Hlth Exercise & Sports Med, Melbourne, Vic, Australia; [Grimshaw, Jeremy M.] Ottawa Hosp, Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Grimshaw, Jeremy M.] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Mortimer, Duncan] Monash Univ, Ctr Hlth Econ, Clayton, Vic 3800, Australia; [Francis, Jill J.] City Univ London, Div Hlth Serv Res & Management, London EC1V 0HB, England; [Michie, Susan] UCL, Ctr Outcomes Res & Effectiveness, London, England; [Spike, Neil] Univ Melbourne, Dept Gen Practice, Melbourne, Vic, Australia; [Spike, Neil] Victorian Metropolitan Alliance Gen Practice Trai, Melbourne, Vic, Australia; [Schattner, Peter] Monash Univ, Dept Gen Practice, Sch Primary Hlth Care, Clayton, Vic 3800, Australia; [Kent, Peter] Spine Ctr Southern Denmark, Res Dept, Middelfart, Denmark; [Kent, Peter] Univ Southern Denmark, Inst Reg Hlth Serv Res, Odense, Denmark; [Buchbinder, Rachelle] Cabrini Hlth, Monash Dept Clin Epidemiol, Melbourne, Vic, Australia; [Buchbinder, Rachelle] Monash Univ, Sch Publ Hlth & Prevent Med, Dept Epidemiol & Prevent Med, Clayton, Vic 3800, Australia	Monash University; University of Melbourne; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Monash University; City University London; University of London; University College London; University of Melbourne; Monash University; University of Southern Denmark; Cabrini Health; Monash University	French, SD (corresponding author), Monash Univ, Sch Publ Hlth & Prevent Med, Clayton, Vic 3800, Australia.	s.french@unimelb.edu.au	McKenzie, Joanne E/I-2925-2014; Buchbinder, Rachelle/G-2952-2011; Francis, Jill/AHE-6998-2022; O'Connor, Denise/ABC-6655-2020; Michie, Susan/A-1745-2010	McKenzie, Joanne E/0000-0003-3534-1641; Buchbinder, Rachelle/0000-0002-0597-0933; O'Connor, Denise/0000-0002-6836-122X; Page, Matthew/0000-0002-4242-7526; French, Simon/0000-0002-7061-7706; Green, Sally Elizabeth/0000-0002-9564-9050; Grimshaw, Jeremy/0000-0001-8015-8243; Francis, Jill/0000-0001-5784-8895; Mortimer, Duncan Stuart/0000-0002-7211-6454; Michie, Susan/0000-0003-0063-6378; Kent, Peter/0000-0002-2429-9233	Australian National Health and Medical Research Council (NHMRC) [334060]; NHMRC Early Career Fellowships; NHMRC Practitioner Fellowship	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Early Career Fellowships(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Practitioner Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	The IMPLEMENT trial was funded by the Australian National Health and Medical Research Council (NHMRC) by way of a Primary Health Care Project Grant (334060). SDF and DAO are supported by NHMRC Early Career Fellowships. RB is supported in part by a NHMRC Practitioner Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar I, 2011, ARCH INTERN MED, V171, P1385, DOI 10.1001/archinternmed.2011.231; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Albada A, 2009, PATIENT EDUC COUNS, V77, P155, DOI 10.1016/j.pec.2009.03.005; Albarracin D, 2005, PSYCHOL BULL, V131, P856, DOI 10.1037/0033-2909.131.6.856; Ammendolia C, 2004, J MANIP PHYSIOL THER, V27, P170, DOI 10.1016/j.jmpt.2003.12.021; Ammerman AS, 2002, PREV MED, V35, P25, DOI 10.1006/pmed.2002.1028; [Anonymous], 2011, STAT STAT SOFTW REL; Austin PC, 2010, J CLIN EPIDEMIOL, V63, P2, DOI 10.1016/j.jclinepi.2008.11.004; Australian Acute Musculoskeletal Pain Guidelines Group (AAMPGG), 2003, EV BAS MAN AC MUSC P; Baker R, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005470.pub2; Becker A, 2008, SPINE, V33, P473, DOI 10.1097/BRS.0b013e3181657e0d; Bekkering GE, 2005, PHYS THER, V85, P544, DOI 10.1093/ptj/85.6.544; Bell-Syer SEM, 2000, FAM PRACT, V17, P187, DOI 10.1093/fampra/17.2.187; Bishop Paul B, 2006, Spine J, V6, P282, DOI 10.1016/j.spinee.2005.10.008; Bonetti D, 2005, SOC SCI MED, V60, P2135, DOI 10.1016/j.socscimed.2004.08.072; Britt H, 2010, GEN PRACTICE SERIES; Buchbinder R, 2001, SPINE, V26, P2535, DOI 10.1097/00007632-200112010-00005; Buchbinder R, 2009, SPINE, V34, P1218, DOI 10.1097/BRS.0b013e318195d688; Campbell MK, 2005, CLIN TRIALS, V2, P99, DOI 10.1191/1740774505cn071oa; Cane J, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-37; Carey TS, 1996, ANN INTERN MED, V125, P807, DOI 10.7326/0003-4819-125-10-199611150-00004; Chou R, 2009, LANCET, V373, P463, DOI 10.1016/S0140-6736(09)60172-0; Coudeyre E, 2006, PAIN, V124, P330, DOI 10.1016/j.pain.2006.05.003; Dahm KT, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007612.pub2; Davies P, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-14; Dey P, 2004, BRIT J GEN PRACT, V54, P33; Di Iorio D, 2000, ARCH FAM MED, V9, P1015, DOI 10.1001/archfami.9.10.1015; Eccles M, 2001, LANCET, V357, P1406, DOI 10.1016/S0140-6736(00)04564-5; Eccles MP, 2006, IMPLEMENT SCI, V1, DOI 10.1186/1748-5908-1-1; Eldridge SM, 2009, INT STAT REV, V77, P378, DOI 10.1111/j.1751-5823.2009.00092.x; Ellis SD, 2007, CONTEMP CLIN TRIALS, V28, P258, DOI 10.1016/j.cct.2006.08.009; Engers Arno J, 2005, Spine (Phila Pa 1976), V30, P559, DOI 10.1097/01.brs.0000155406.79479.3a; Evans DW, 2010, SPINE, V35, P858, DOI 10.1097/BRS.0b013e3181d4e04b; Foster NE, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-108; Francis J., 2004, CONSTRUCTING QUESTIO, V5th ed.; Francis JJ, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-35; Frankel BSM, 1999, FAM PRACT, V16, P216, DOI 10.1093/fampra/16.3.216; Freeborn DK, 1997, J GEN INTERN MED, V12, P619, DOI 10.1046/j.1525-1497.1997.07122.x; French Simon D, 2010, Cochrane Database Syst Rev, pCD006094, DOI 10.1002/14651858.CD006094.pub2; French SD, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-38; Glanz K, 2010, ANNU REV PUBL HEALTH, V31, P399, DOI 10.1146/annurev.publhealth.012809.103604; Gonzaalez-Urzelai V, 2003, EUR SPINE J, V12, P589, DOI 10.1007/s00586-003-0567-2; Green S, 2008, 2008 GEN PRACT PRIM; Grimshaw JM, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-50; Grimshaw JM, 2004, HEALTH TECHNOL ASSES, V8, P1, DOI 10.3310/hta8060; Henschke N, 2009, ARTHRITIS RHEUM-US, V60, P3072, DOI 10.1002/art.24853; Hoy D, 2012, ARTHRITIS RHEUM-US, V64, P2028, DOI 10.1002/art.34347; Hrisos S, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-37; Jellema P, 2005, BMJ-BRIT MED J, V331, P84, DOI 10.1136/bmj.38495.686736.E0; Kerry S, 2000, FAM PRACT, V17, P46, DOI 10.1093/fampra/17.1.46; Koes BW, 2010, EUR SPINE J, V19, P2075, DOI 10.1007/s00586-010-1502-y; Kovacs FM, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-57; Luck J, 2002, BMJ-BRIT MED J, V325, P679, DOI 10.1136/bmj.325.7366.679; Main CJ, 2010, BEST PRACT RES CL RH, V24, P205, DOI 10.1016/j.berh.2009.12.012; McGuirk B, 2001, SPINE, V26, P2615, DOI 10.1097/00007632-200112010-00017; McKenzie JE, 2008, IMPLEMENT SCI, V3, DOI 10.1186/1748-5908-3-11; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; Michie S, 2005, QUAL SAF HEALTH CARE, V14, P26, DOI 10.1136/qshc.2004.011155; Michie S, 2008, APPL PSYCHOL-INT REV, V57, P660, DOI 10.1111/j.1464-0597.2008.00341.x; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-10; Nagle C, 2008, BJOG-INT J OBSTET GY, V115, P339, DOI 10.1111/j.1471-0528.2007.01576.x; O'Connor D, 2007, 2007 GUID INT NETW C; OAKESHOTT P, 1994, BRIT J GEN PRACT, V44, P197; Page MJ, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-35; Peabody JW, 2004, ANN INTERN MED, V141, P771, DOI 10.7326/0003-4819-141-10-200411160-00008; Prestwich A, 2013, METAANALYSI IN PRESS; Rainville J, 2011, SPINE J, V11, P895, DOI 10.1016/j.spinee.2011.08.006; Robling MR, 2002, CLIN RADIOL, V57, P402, DOI 10.1053/crad.2001.0864; Rossignol M, 2000, SPINE, V25, P251, DOI 10.1097/00007632-200001150-00018; Runciman WB, 2012, MED J AUSTRALIA, V197, P100, DOI 10.5694/mja12.10510; Schectman JM, 2003, J GEN INTERN MED, V18, P773, DOI 10.1046/j.1525-1497.2003.10205.x; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; Shekelle PG, 2000, HEALTH SERV RES, V34, P1429; Slater H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038037; Somerville S, 2008, BRIT J GEN PRACT, V58, P790, DOI 10.3399/bjgp08X319909; Stevenson K, 2006, J EVAL CLIN PRACT, V12, P365, DOI 10.1111/j.1365-2753.2006.00565.x; Streiner DL, 2008, HLTH MEASUREMENT SCA, V4th; Taylor N, 2012, HEALTH PSYCHOL REV, V6, P33, DOI 10.1080/17437199.2010.533441; Torgerson DJ, 2001, BMJ-BRIT MED J, V322, P355, DOI 10.1136/bmj.322.7282.355; Treweek S, 2010, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000013.pub5, 10.1002/14651858.MR000013.pub4]; Ukoumunne OC, 2008, STAT MED, V27, P5143, DOI 10.1002/sim.3359; Ukoumunne OC, 1999, HLTH TECHNOLOGY ASSE, V3, piii, DOI DOI 10.3310/HTA3050; WADDELL G, 1993, PAIN, V52, P157, DOI 10.1016/0304-3959(93)90127-B; Walker B F, 2003, Asia Pac J Public Health, V15, P79, DOI 10.1177/101053950301500202; Walker BF, 2004, J MANIP PHYSIOL THER, V27, P327, DOI 10.1016/j.jmpt.2004.04.006; Walker BF, 2004, J MANIP PHYSIOL THER, V27, P238, DOI 10.1016/j.jmpt.2004.02.002; Webb TL, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1376; Wilk V, 2010, CLIN J PAIN, V26, P533, DOI 10.1097/AJP.0b013e3181dc7abb; Williams CM, 2010, ARCH INTERN MED, V170, P271, DOI 10.1001/archinternmed.2009.507; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	90	74	74	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65471	10.1371/journal.pone.0065471	http://dx.doi.org/10.1371/journal.pone.0065471			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785427	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000321038800094
J	Kawamoto, R; Tabara, Y; Kohara, K; Kusunoki, T; Abe, M; Miki, T				Kawamoto, Ryuichi; Tabara, Yasuharu; Kohara, Katsuhiko; Kusunoki, Tomo; Abe, Masanori; Miki, Tetsuro			Serum Uric Acid Is More Strongly Associated with Impaired Fasting Glucose in Women than in Men from a Community-Dwelling Population	PLOS ONE			English	Article							HYPERTENSION; INSULIN; STRESS; RISK	Serum uric acid (SUA) levels are associated with metabolic syndrome (MetS) and its components such as glucose intolerance and type 2 diabetes. It is unknown whether there are gender-specific differences regarding the relationship between SUA levels, impaired fasting glucose (IFG) and newly detected diabetes. We recruited 1,209 men aged 60 +/- 15 (range, 19-89) years and 1,636 women aged 63 +/- 12 (range, 19-89) years during their annual health examination from a single community. We investigated the association between SUA levels and six categories according to fasting plasma glucose (FPG) level {normal fasting glucose (NFG), <100 mg/dL; high NFG-WHO, 100 to 109 mg/dL; IFG-WHO, 110 to 125 mg/dL; IFG-ADA, 100 to 125 mg/dL; newly detected diabetes, >= 126 mg/dL; known diabetes} SUA levels were more strongly associated with the different FPG categories in women compared with men. In women, the associations remained significant for IFG-WHO (OR, 1.23, 95% CI, 1.00-1.50) and newly detected diabetes (OR, 1.33, 95% CI, 1.03-1.72) following multivariate adjustment. However, in men all the associations were not significant. Thus, there was a significant interaction between gender and SUA level for newly detected diabetes (P = 0.005). SUA levels are associated with different categories of impaired fasting glucose in participants from community-dwelling persons, particularly in women.	[Kawamoto, Ryuichi; Kusunoki, Tomo; Abe, Masanori] Ehime Univ, Grad Sch Med, Dept Community Med, Matsuyama, Ehime 790, Japan; [Tabara, Yasuharu] Kyoto Univ, Ctr Genom Med, Grad Sch Med, Kyoto, Japan; [Miki, Tetsuro] Ehime Univ, Grad Sch Med, Dept Geriatr Med, Matsuyama, Ehime 790, Japan	Ehime University; Kyoto University; Ehime University	Kawamoto, R (corresponding author), Ehime Univ, Grad Sch Med, Dept Community Med, Matsuyama, Ehime 790, Japan.	rykawamo@m.ehime-u.ac.jp			Foundation for Development of Community; Grants-in-Aid for Scientific Research [23390188] Funding Source: KAKEN	Foundation for Development of Community; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant-in-aid for Scientific Research from the Foundation for Development of Community (2012). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anker SD, 2003, CIRCULATION, V107, P1991, DOI 10.1161/01.CIR.0000065637.10517.A0; Chiou WK, 2010, J EPIDEMIOL, V20, P219, DOI 10.2188/jea.JE20090078; Doring A, 2008, NAT GENET, V40, P430, DOI 10.1038/ng.107; GALVAN AQ, 1995, AM J PHYSIOL-ENDOC M, V268, pE1, DOI 10.1152/ajpendo.1995.268.1.E1; Glantzounis GK, 2005, CURR PHARM DESIGN, V11, P4145, DOI 10.2174/138161205774913255; GORDON T, 1983, ARCH INTERN MED, V143, P1366, DOI 10.1001/archinte.143.7.1366; Hotamisligil GS, 2003, INT J OBESITY, V27, pS53, DOI 10.1038/sj.ijo.0802502; Imai E, 2009, CLIN EXP NEPHROL, V13, P621, DOI 10.1007/s10157-009-0199-x; Johnson RJ, 2009, ENDOCR REV, V30, P96, DOI 10.1210/er.2008-0033; Kawamoto R, 2006, INTERNAL MED, V45, P605, DOI 10.2169/internalmedicine.45.1661; Kodama S, 2009, DIABETES CARE, V32, P1737, DOI 10.2337/dc09-0288; Kolz M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000504; Lin KC, 2004, J RHEUMATOL, V31, P1159; Mazzali M, 2001, HYPERTENSION, V38, P1101, DOI 10.1161/hy1101.092839; Meisinger C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037180; Nakanishi N, 2003, EUR J EPIDEMIOL, V18, P523, DOI 10.1023/A:1024600905574; Sautin YY, 2007, AM J PHYSIOL-CELL PH, V293, pC584, DOI 10.1152/ajpcell.00600.2006; Savage PJ, 1998, ARCH INTERN MED, V158, P741, DOI 10.1001/archinte.158.7.741; Taniguchi Y, 2001, J HYPERTENS, V19, P1209, DOI 10.1097/00004872-200107000-00005; Wang TG, 2011, ENDOCRINE, V40, P109, DOI 10.1007/s12020-011-9449-2	20	25	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65886	10.1371/journal.pone.0065886	http://dx.doi.org/10.1371/journal.pone.0065886			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785457	Green Submitted, Green Published, gold			2022-12-27	WOS:000321038800065
J	Morris, BD; White, EP				Morris, Benjamin D.; White, Ethan P.			The EcoData Retriever: Improving Access to Existing Ecological Data	PLOS ONE			English	Article								Ecological research relies increasingly on the use of previously collected data. Use of existing datasets allows questions to be addressed more quickly, more generally, and at larger scales than would otherwise be possible. As a result of large-scale data collection efforts, and an increasing emphasis on data publication by journals and funding agencies, a large and ever-increasing amount of ecological data is now publicly available via the internet. Most ecological datasets do not adhere to any agreed-upon standards in format, data structure or method of access. Some may be broken up across multiple files, stored in compressed archives, and violate basic principles of data structure. As a result acquiring and utilizing available datasets can be a time consuming and error prone process. The EcoData Retriever is an extensible software framework which automates the tasks of discovering, downloading, and reformatting ecological data files for storage in a local data file or relational database. The automation of these tasks saves significant time for researchers and substantially reduces the likelihood of errors resulting from manual data manipulation and unfamiliarity with the complexities of individual datasets.	[Morris, Benjamin D.] Utah State Univ, Dept Biol, Logan, UT 84322 USA; Utah State Univ, Ctr Ecol, Logan, UT 84322 USA	Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University	Morris, BD (corresponding author), Utah State Univ, Dept Biol, Logan, UT 84322 USA.	ben@bendmorris.com		Morris, Benjamin/0000-0003-4418-1360; White, Ethan/0000-0001-6728-7745	National Science Foundation [DEB-0953694]; Division Of Environmental Biology [0953694] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was funded by the National Science Foundation as part of a CAREER award to Ethan White(DEB-0953694). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler P. B., 2007, Ecology, V88, P2673, DOI 10.1890/0012-9658(2007)88[2673:LMQFKP]2.0.CO;2; [Anonymous], 2008, ECOLOGY, V89, P881, DOI DOI 10.1890/07-1551.1; Brown J. H., 1995, MACROECOLOGY; Capellini I, 2010, ECOLOGY, V91, P2783, DOI 10.1890/09-0817.1; Casadevall A, 2010, INFECT IMMUN, V78, P4972, DOI 10.1128/IAI.00908-10; Clark D. B., 2006, Ecology, V87, P2132, DOI 10.1890/0012-9658(2006)87[2132:TGMPCA]2.0.CO;2; del Moral R, 2010, ECOLOGY, V91, P2185, DOI DOI 10.1890/09-2357.1; Dunning J., 2008, CRC HDB AVIAN BODY M, V2nd; Ernest S. K. M., 2009, Ecology, V90, P1708, DOI 10.1890/08-1222.1; Ernest SKM, 2003, ECOLOGY, V84, P3402, DOI 10.1890/02-9002; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; Jones MB, 2006, ANNU REV ECOL EVOL S, V37, P519, DOI 10.1146/annurev.ecolsys.37.091305.110031; Lislevand T, 2007, ECOLOGY, V88, P3218; Matthews SN, 2011, ECOGRAPHY, V34, P933, DOI 10.1111/j.1600-0587.2011.06803.x; McGlinn D. J., 2010, ECOLOGY, V91, P1872, DOI DOI 10.1890/09-2017.1; Methratta ET, 2008, ECOLOGY, V89, P3128, DOI 10.1890/07-0849.1; Michener WK, 2012, TRENDS ECOL EVOL, V27, P85, DOI 10.1016/j.tree.2011.11.016; Ramesh B. R., 2010, ECOLOGY, V91, P3118, DOI DOI 10.1890/10-0133.1; Reichman OJ, 2011, SCIENCE, V331, P703, DOI 10.1126/science.1197962; Sauer J. R., 2005, N AM BREEDING BIRD S; Smith FA, 2003, ECOLOGY, V84, P3403, DOI 10.1890/02-9003; Thibault K. M., 2011, ECOLOGY, V92, P2316, DOI DOI 10.1890/11-0262.1; U.S. Department of Agriculture Forest Service, 2010, FOR INV AN NAT COR F; White EP, 2012, ECOLOGY, V93, P1772, DOI 10.1890/11-2177.1; White EP, 2010, AM NAT, V175, pE35, DOI 10.1086/649578; Whitlock MC, 2010, AM NAT, V175, pE45, DOI 10.1086/650340; Woods K. D., 2009, Ecology, V90, P3587, DOI 10.1890/09-0565.1; Zachmann L., 2010, Ecology, V91, P3427, DOI 10.1890/10-0404.1	28	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65848	10.1371/journal.pone.0065848	http://dx.doi.org/10.1371/journal.pone.0065848			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785456	Green Published, gold, Green Submitted			2022-12-27	WOS:000321038800066
J	Zhao, X; Zhou, XH; Feng, ZJ; Guo, PF; He, HY; Zhang, T; Duan, L; Li, XS				Zhao, Xing; Zhou, Xiao-Hua; Feng, Zijian; Guo, Pengfei; He, Hongyan; Zhang, Tao; Duan, Lei; Li, Xiaosong			A Scan Statistic for Binary Outcome Based on Hypergeometric Probability Model, with an Application to Detecting Spatial Clusters of Japanese Encephalitis	PLOS ONE			English	Article							P-VALUES; EVENT DETECTION; TESTS; LIKELIHOOD; HYPOTHESIS; ALGORITHM	As a useful tool for geographical cluster detection of events, the spatial scan statistic is widely applied in many fields and plays an increasingly important role. The classic version of the spatial scan statistic for the binary outcome is developed by Kulldorff, based on the Bernoulli or the Poisson probability model. In this paper, we apply the Hypergeometric probability model to construct the likelihood function under the null hypothesis. Compared with existing methods, the likelihood function under the null hypothesis is an alternative and indirect method to identify the potential cluster, and the test statistic is the extreme value of the likelihood function. Similar with Kulldorff's methods, we adopt Monte Carlo test for the test of significance. Both methods are applied for detecting spatial clusters of Japanese encephalitis in Sichuan province, China, in 2009, and the detected clusters are identical. Through a simulation to independent benchmark data, it is indicated that the test statistic based on the Hypergeometric model outweighs Kulldorff's statistics for clusters of high population density or large size; otherwise Kulldorff's statistics are superior.	[Zhao, Xing; Guo, Pengfei; He, Hongyan; Zhang, Tao; Li, Xiaosong] Sichuan Univ, West China Sch Publ Hlth, Dept Biostat, Chengdu 610064, Sichuan, Peoples R China; [Zhao, Xing; Zhou, Xiao-Hua] Univ Washington, Sch Publ Hlth & Community Med, Dept Biostat, Seattle, WA 98195 USA; [Feng, Zijian] Chinese Ctr Dis Control & Prevent China CDC, Off Dis Control & Emergency Response, Beijing, Peoples R China; [Duan, Lei] Sichuan Univ, Sch Comp Sci, Chengdu 610064, Sichuan, Peoples R China; [Duan, Lei] Wuhan Univ, State Key Lab Software Engn, Wuhan 430072, Hubei, Peoples R China	Sichuan University; University of Washington; University of Washington Seattle; Chinese Center for Disease Control & Prevention; Sichuan University; Wuhan University	Li, XS (corresponding author), Sichuan Univ, West China Sch Publ Hlth, Dept Biostat, Chengdu 610064, Sichuan, Peoples R China.	lixiaosong1101@126.com	Guo, Peng/GWC-0572-2022; guo, peng/AAG-4052-2019	Zhou, Xiaohua/0000-0001-7935-1222; Zhang, Tao/0000-0001-7279-8929	Natural Science Foundation of China [30571618, 61103042]; Ministry of Health, China [200802133]; Research Fund for the Doctoral Program of Higher Education of China [20100181120029]; State Key Laboratory of Software Engineering of China [SKLSE2012-09-32]; China Scholarship Council	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Health, China; Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); State Key Laboratory of Software Engineering of China; China Scholarship Council(China Scholarship Council)	This work was supported by Natural Science Foundation of China (No. 30571618 and No. 61103042), Grants of the Ministry of Health, China (No. 200802133), Research Fund for the Doctoral Program of Higher Education of China (No. 20100181120029), State Key Laboratory of Software Engineering of China (No. SKLSE2012-09-32), and China Scholarship Council (http://en.csc.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assuncao R, 2006, STAT MED, V25, P723, DOI 10.1002/sim.2411; BERGER JO, 1987, J AM STAT ASSOC, V82, P112, DOI 10.2307/2289131; Berkson J, 1942, J AM STAT ASSOC, V37, P325, DOI 10.2307/2279000; Cao M, 2009, THESIS SICHUAN U; Christiansen LE, 2006, J AGR BIOL ENVIR ST, V11, P411, DOI 10.1198/108571106X154858; Cook AJ, 2007, BIOMETRICS, V63, P540, DOI 10.1111/j.1541-0420.2006.00714.x; Costa MA, 2005, ENVIRON ECOL STAT, V12, P301, DOI 10.1007/s10651-005-1515-6; Diagana M, 2007, J NEUROL SCI, V262, P165, DOI 10.1016/j.jns.2007.06.041; Duarte AR, 2010, ENVIRON ECOL STAT, V17, P203, DOI 10.1007/s10651-010-0139-7; Duczmal L, 2006, STAT MED, V25, P743, DOI 10.1002/sim.2403; Duczmal L, 2004, COMPUT STAT DATA AN, V45, P269, DOI 10.1016/S0167-9473(02)00302-X; Duczmal L, 2007, COMPUT STAT DATA AN, V52, P43, DOI 10.1016/j.csda.2007.01.016; DWASS M, 1957, ANN MATH STAT, V28, P181, DOI 10.1214/aoms/1177707045; Gangnon RE, 2001, STAT MED, V20, P2977, DOI 10.1002/sim.917; GIBBONS JD, 1975, AM STAT, V29, P20, DOI 10.2307/2683674; GOODMAN SN, 1993, AM J EPIDEMIOL, V137, P485, DOI 10.1093/oxfordjournals.aje.a116700; Goodman SN, 1999, ANN INTERN MED, V130, P995, DOI 10.7326/0003-4819-130-12-199906150-00008; Hjalmars U, 1996, STAT MED, V15, P707, DOI 10.1002/(SICI)1097-0258(19960415)15:7/9<707::AID-SIM242>3.3.CO;2-W; Huang L, 2009, J AM STAT ASSOC, V104, P886, DOI 10.1198/jasa.2009.ap07613; Huang XL, 2006, BIOMETRICS, V62, P901, DOI 10.1111/j.1541-0420.2005.00520.x; Jung I, 2007, STAT MED, V26, P1594, DOI 10.1002/sim.2607; Jung I, 2010, STAT MED, V29, P1910, DOI 10.1002/sim.3951; Kulldorff M, 1997, AM J EPIDEMIOL, V146, P161; Kulldorff M, 2001, J ROY STAT SOC A STA, V164, P61, DOI 10.1111/1467-985X.00186; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; KULLDORFF M, 1995, STAT MED, V14, P799, DOI 10.1002/sim.4780140809; Kulldorff M, 2003, COMPUT STAT DATA AN, V42, P665, DOI 10.1016/S0167-9473(02)00160-3; Kulldorff M, 2007, STAT MED, V26, P1824, DOI 10.1002/sim.2818; Kulldorff M, 2006, STAT MED, V25, P3929, DOI 10.1002/sim.2490; Kulldorff M, 2006, J AM STAT ASSOC, V101, P1289, DOI 10.1198/016214506000000618; Kulldorff M, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-58; LEHMANN EL, 1993, J AM STAT ASSOC, V88, P1242; Li XZ, 2011, MATH BIOSCI, V233, P135, DOI 10.1016/j.mbs.2011.07.004; Loh JM, 2007, ANN APPL STAT, V1, P560, DOI 10.1214/07-AOAS129; Neill DB, 2011, STAT MED, V30, P455, DOI 10.1002/sim.3881; Neill DB, 2010, MACH LEARN, V79, P261, DOI 10.1007/s10994-009-5144-4; Neill DB, 2006, THESIS CARNEGIE MELL; Patil GP, 2004, ENVIRON ECOL STAT, V11, P183, DOI 10.1023/B:EEST.0000027208.48919.7e; Schervish MJ, 1996, AM STAT, V50, P203, DOI 10.2307/2684655; Solomon T, 2006, NEW ENGL J MED, V355, P869, DOI 10.1056/NEJMp058263; Song C, 2006, STAT MED, V25, P825, DOI 10.1002/sim.2430; Song C, 2003, INT J HEALTH GEOGR, V2, P9, DOI [10.1186/1476-072X-2-9, DOI 10.1186/1476-072X-2-9]; Tango T, 2010, STAT METHODS DIS CLU; Tango T, 2011, BIOMETRICS, V67, P106, DOI 10.1111/j.1541-0420.2010.01412.x; Tango Toshiro, 2005, Int J Health Geogr, V4, P11, DOI 10.1186/1476-072X-4-11; Viel JF, 2005, ENVIRON ECOL STAT, V12, P289, DOI 10.1007/s10651-005-1514-7; Wen SH, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-73; Wong WK, 2005, J MACH LEARN RES, V6, P1961; Yang Z, 2008, MODERN PREVENTIVE ME, V10, P003; Zhang Z, 2010, J PROBABILITY STAT	50	1	2	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65419	10.1371/journal.pone.0065419	http://dx.doi.org/10.1371/journal.pone.0065419			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785424	Green Published, gold, Green Submitted			2022-12-27	WOS:000321038800096
J	Brouillette, RM; Foil, H; Fontenot, S; Correro, A; Allen, R; Martin, CK; Bruce-Keller, AJ; Keller, JN				Brouillette, Robert M.; Foil, Heather; Fontenot, Stephanie; Correro, Anthony; Allen, Ray; Martin, Corby K.; Bruce-Keller, Annadora J.; Keller, Jeffrey N.			Feasibility, Reliability, and Validity of a Smartphone Based Application for the Assessment of Cognitive Function in the Elderly	PLOS ONE			English	Article							HEALTH-CARE; PHYSICAL PERFORMANCE; ALZHEIMERS-DISEASE; MOBILE; GAIT	While considerable knowledge has been gained through the use of established cognitive and motor assessment tools, there is a considerable interest and need for the development of a battery of reliable and validated assessment tools that provide real-time and remote analysis of cognitive and motor function in the elderly. Smartphones appear to be an obvious choice for the development of these "next-generation" assessment tools for geriatric research, although to date no studies have reported on the use of smartphone-based applications for the study of cognition in the elderly. The primary focus of the current study was to assess the feasibility, reliability, and validity of a smartphone-based application for the assessment of cognitive function in the elderly. A total of 57 non-demented elderly individuals were administered a newly developed smartphone application-based Color-Shape Test (CST) in order to determine its utility in measuring cognitive processing speed in the elderly. Validity of this novel cognitive task was assessed by correlating performance on the CST with scores on widely accepted assessments of cognitive function. Scores on the CST were significantly correlated with global cognition (Mini-Mental State Exam: r = 0.515, p < 0.0001) and multiple measures of processing speed and attention (Digit Span: r = 0.427, p < 0.0001; Trail Making Test: r = -0.651, p < 0.00001; Digit Symbol Test: r = 0.508, p < 0.0001). The CST was not correlated with naming and verbal fluency tasks (Boston Naming Test, Vegetable/Animal Naming) or memory tasks (Logical Memory Test). Test re-test reliability was observed to be significant (r = 0.726; p = 0.02). Together, these data are the first to demonstrate the feasibility, reliability, and validity of using a smartphone-based application for the purpose of assessing cognitive function in the elderly. The importance of these findings for the establishment of smartphone-based assessment batteries of cognitive and motor function in the elderly is discussed.	[Brouillette, Robert M.; Foil, Heather; Fontenot, Stephanie; Correro, Anthony; Allen, Ray; Martin, Corby K.; Bruce-Keller, Annadora J.; Keller, Jeffrey N.] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Keller, JN (corresponding author), Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA 70803 USA.	Jeffrey.keller@pbrc.edu	Bruce-Keller, Annadora/N-1954-2017; Martin, Corby K./N-1976-2017; Keller, Jeffrey N/N-1975-2017; Correro, Anthony/HFZ-9417-2022	Martin, Corby K./0000-0002-8125-4015; keller, jeffrey/0000-0002-9892-7423; Correro, Anthony/0000-0001-7207-1471	Hibernia National Bank/Edward G. Schlieder Chair	Hibernia National Bank/Edward G. Schlieder Chair	This work was supported by Hibernia National Bank/Edward G. Schlieder Chair, and the supporters of the Institute for Dementia Research and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barreira TV, 2012, J AGING PHY IN PRESS; Boulos MNK, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-24; Brouillette RM, 2011, J ALZHEIMERS DIS, V23, P665, DOI 10.3233/JAD-2011-101455; Bruce-Keller AJ, 2012, J ALZHEIMERS DIS, V30, P899, DOI 10.3233/JAD-2012-120025; Bruce-Keller AJ, 2012, J AM GERIATR SOC, V60, P176, DOI 10.1111/j.1532-5415.2011.03762.x; Clifford GD, 2012, ANNU REV MED, V63, P479, DOI 10.1146/annurev-med-051210-114650; Doherty SI, 2012, TELEMED E-HEALTH, V18, P185, DOI 10.1089/tmj.2011.0138; Dufau S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024974; Folstein MF, 2004, MINIMENTAL STATE EXA; Fortney JC, 2011, J GEN INTERN MED, V26, pS639, DOI 10.1007/s11606-011-1806-6; Gill PS, 2012, RISK MANAG HEALTHC P, V5, P105, DOI 10.2147/RMHP.S34813; Goodglass H., 1983, BOSTON NAMING TEST; Klasnja P, 2012, J BIOMED INFORM, V45, P184, DOI 10.1016/j.jbi.2011.08.017; Koch S, 2006, INT J MED INFORM, V75, P565, DOI 10.1016/j.ijmedinf.2005.09.002; Levine SR, 1999, STROKE, V30, P464, DOI 10.1161/01.STR.30.2.464; Martin CK, 2012, OBESITY, V20, P891, DOI 10.1038/oby.2011.344; Mellone S, 2012, Z GERONTOL GERIATR, V45, P722, DOI 10.1007/s00391-012-0404-5; Mellone S, 2012, GAIT POSTURE, V36, P163, DOI 10.1016/j.gaitpost.2012.02.006; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; Olshansky SJ, 2009, MILBANK Q, V87, P842, DOI 10.1111/j.1468-0009.2009.00581.x; Panayides A, 2010, IEEE ENG MED BIO, P1045, DOI 10.1109/IEMBS.2010.5628076; Rajan Rajeev, 2012, Biomed Instrum Technol, VSuppl, P26, DOI 10.2345/0899-8205-46.s2.26; Reitan R.M., 1993, HALSTEAD REITAN NEUR; Rogante M, 2010, NEUROREHABILITATION, V27, P287, DOI 10.3233/NRE-2010-0612; Rosser JC, 2001, WORLD J SURG, V25, P1438, DOI 10.1007/s00268-001-0129-X; Schuna JM, 2013, MED SCI SPORT EXER, V45, P914, DOI 10.1249/MSS.0b013e31827e47ac; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; Tudor-Locke C, 2012, J PHYS ACT IN PRESS; Wechsler, 1987, WECHSLER ADULT INTEL; Wechsler D, 1987, WMS R WECHSLER MEMOR; Weintraub S, 2009, ALZ DIS ASSOC DIS, V23, P91, DOI 10.1097/WAD.0b013e318191c7dd; Worringham C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014669	32	70	72	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65925	10.1371/journal.pone.0065925	http://dx.doi.org/10.1371/journal.pone.0065925			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	169CU	23776570	Green Published, gold			2022-12-27	WOS:000320755400082
J	Ciaramella, A; Salani, F; Bizzoni, F; Pontieri, FE; Stefani, A; Pierantozzi, M; Assogna, F; Caltagirone, C; Spalletta, G; Bossu, P				Ciaramella, Antonio; Salani, Francesca; Bizzoni, Federica; Pontieri, Francesco E.; Stefani, Alessandro; Pierantozzi, Mariangela; Assogna, Francesca; Caltagirone, Carlo; Spalletta, Gianfranco; Bossu, Paola			Blood Dendritic Cell Frequency Declines in Idiopathic Parkinson's Disease and Is Associated with Motor Symptom Severity	PLOS ONE			English	Article							INTERFERON-PRODUCING CELLS; NONMOTOR SYMPTOMS; SUBSETS; IMMUNITY; NEUROINFLAMMATION; NEUROMELANIN; ACTIVATION; DEPRESSION; DOPAMINE	The role of inflammation in Parkinson's Disease (PD) is well appreciated, but its underlying mechanisms are still unclear. Our objective was to determine whether dendritic cells (DC), a unique type of migratory immune cells that regulate immunological response and inflammation have an impact on PD. In a case-control study including 80 PD patients and 80 age- and gender-matched healthy control subjects, the two main blood subsets of plasmacytoid and myeloid DC were defined by flow cytometry analysis. Clinical evaluation of subjects consisting of cognition and depression assessment was performed using the Mini Mental State Examination and the Beck Depression Inventory. The severity of motor symptoms was measured using the Unified Parkinson's Disease Rating Scale-Part III. Comparison between patient and control DC measures and their relationships with clinical assessments were evaluated. The following main results were obtained: 1) the level of circulating DC (mainly the myeloid subset) was significantly reduced in PD patients in comparison with healthy controls; 2) after controlling for depressive and cognitive characteristics, the frequency of myeloid DC was confirmed as one of the independent determinants of PD; 3) the number of both myeloid and plasmacytoid DC was negatively associated with motor symptom severity. Overall, the decline of blood DC, perhaps due to the recruitment of immune cells to the site of disease-specific lesions, can be considered a clue of the immune alteration that characterizes PD, suggesting innovative exploitations of DC monitoring as a clinically significant tool for PD treatment. Indeed, this study suggests that reduced peripheral blood DC are a pathologically-relevant factor of PD and also displays the urgency to better understand DC role in PD for unraveling the immune system contribution to disease progression and thus favoring the development of innovative therapies ideally based on immunomodulation.	[Ciaramella, Antonio; Salani, Francesca; Bizzoni, Federica; Assogna, Francesca; Caltagirone, Carlo; Spalletta, Gianfranco; Bossu, Paola] IRCCS Fdn Santa Lucia, Rome, Italy; [Pontieri, Francesco E.] Univ Roma La Sapienza, Dept Neurol & Psychiat, Movement Disorder Unit, St Andrea Hosp, I-00185 Rome, Italy; [Stefani, Alessandro; Pierantozzi, Mariangela] Univ Roma Tor Vergata, Dept Syst Med, Rome, Italy	IRCCS Santa Lucia; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea; University of Rome Tor Vergata	Bossu, P (corresponding author), IRCCS Fdn Santa Lucia, Rome, Italy.	p.bossu@hsantalucia.it	Bossù, Paola/E-4832-2014; Pierantozzi, Mariangela/J-6905-2018; Nacmias, Benedetta/J-5084-2018; Spalletta, Gianfranco/K-3828-2018; Assogna, Francesca/J-9968-2016; SALANI, FRANCESCA/I-1314-2012; ciaramella, antonio/F-1170-2011; ciaramella, antonio/P-9009-2019; PONTIERI, FRANCESCO ERNESTO/K-4232-2018	Bossù, Paola/0000-0002-1432-0078; Nacmias, Benedetta/0000-0001-9338-9040; Spalletta, Gianfranco/0000-0002-7432-4249; Assogna, Francesca/0000-0003-4315-7879; SALANI, FRANCESCA/0000-0002-6901-6057; ciaramella, antonio/0000-0001-9888-8156; ciaramella, antonio/0000-0001-9888-8156; PIERANTOZZI, MARIANGELA/0000-0002-4507-4666; STEFANI, ALESSANDRO/0000-0002-1806-8922; PONTIERI, FRANCESCO ERNESTO/0000-0002-8693-8432	Italian Ministry of Health [RF07-08, RC-08-09-10-11]	Italian Ministry of Health(Ministry of Health, Italy)	This study is not industry-sponsored and it received financial support from Italian Ministry of Health, Grant RF07-08 and RC-08-09-10-11 (PB and GS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Anderson G, 2012, MED HYPOTHESES, V78, P752, DOI 10.1016/j.mehy.2012.02.023; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Barnum CJ, 2012, CURR NEUROL NEUROSCI, V12, P350, DOI 10.1007/s11910-012-0283-6; Beck A.T., 1987, BECK DEPRESSION INVE; Ciaramella A, 2010, J ALZHEIMERS DIS, V19, P559, DOI 10.3233/JAD-2010-1257; Dillon SM, 2008, JAIDS-J ACQ IMM DEF, V48, P1, DOI 10.1097/QAI.0b013e3181664b60; Fahn S., 1987, RECENT DEV PARKINSON, P153; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Funk N, 2013, MOVEMENT DISORD, V28, P392, DOI 10.1002/mds.25300; Garbe K, 2012, HUM IMMUNOL, V73, P493, DOI 10.1016/j.humimm.2012.02.007; GOTHAM AM, 1986, J NEUROL NEUROSUR PS, V49, P381, DOI 10.1136/jnnp.49.4.381; Greter M, 2005, NAT MED, V11, P328, DOI 10.1038/nm1197; Hirsch EC, 2009, LANCET NEUROL, V8, P382, DOI 10.1016/S1474-4422(09)70062-6; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Hughes AJ, 2001, NEUROLOGY, V57, P1497, DOI 10.1212/WNL.57.8.1497; Iribarren P, 2002, ARCH IMMUNOL THER EX, V50, P187; Koutsilieri E, 2013, J NEURAL TRANSM, V120, P75, DOI 10.1007/s00702-012-0842-7; Kunitani H, 2002, J HEPATOL, V36, P734, DOI 10.1016/S0168-8278(02)00062-4; Liu YJ, 2001, CELL, V106, P259, DOI 10.1016/S0092-8674(01)00456-1; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Mabbott NA, 2000, NAT MED, V6, P719, DOI 10.1038/77401; Menza M, 2010, PSYCHOSOMATICS, V51, P474, DOI 10.1176/appi.psy.51.6.474; Oberlander U, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-116; Olweus J, 1997, P NATL ACAD SCI USA, V94, P12551, DOI 10.1073/pnas.94.23.12551; Pacheco R, 2009, J NEUROIMMUNOL, V216, P8, DOI 10.1016/j.jneuroim.2009.07.018; Prado C, 2012, J IMMUNOL, V188, P3062, DOI 10.4049/jimmunol.1103096; Reynolds AD, 2009, J IMMUNOL, V182, P4137, DOI 10.4049/jimmunol.0803982; Rezai-Zadeh K, 2009, J NEUROIMMUNE PHARM, V4, P462, DOI 10.1007/s11481-009-9166-2; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Uehira K, 2002, CLIN IMMUNOL, V105, P296, DOI 10.1006/clim.2002.5287; Ueno H, 2007, IMMUNOL REV, V219, P118, DOI 10.1111/j.1600-065X.2007.00551.x; Wilms H, 2003, FASEB J, V17, P500, DOI 10.1096/fj.02-0314fje; Yilmaz A, 2010, CLIN SCI, V118, P147, DOI 10.1042/CS20090154	34	28	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65352	10.1371/journal.pone.0065352	http://dx.doi.org/10.1371/journal.pone.0065352			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776473	gold, Green Published, Green Submitted			2022-12-27	WOS:000320755400027
J	McKimm-Breschkin, JL; Barrett, S; Pudjiatmoko; Azhar, M; Wong, FYK; Selleck, P; Mohr, PG; McGrane, J; Kim, M				McKimm-Breschkin, Jennifer L.; Barrett, Susan; Pudjiatmoko; Azhar, Muhammad; Wong, Frank Y. K.; Selleck, Paul; Mohr, Peter G.; McGrane, James; Kim, Mia			I222 Neuraminidase Mutations Further Reduce Oseltamivir Susceptibility of Indonesian Clade 2.1 Highly Pathogenic Avian Influenza A(H5N1) Viruses	PLOS ONE			English	Article							A H5N1 VIRUSES; SIALIC-ACID; H1N1 VIRUS; 2.2-A RESOLUTION; A(H1N1) VIRUS; DRUG DESIGN; B VIRUSES; IN-VITRO; RESISTANT; INHIBITORS	We have tested the susceptibility to neuraminidase inhibitors of 155 clade 2.1 H5N1 viruses from Indonesia, isolated between 2006-2008 as well as 12 clade 1 isolates from Thailand and Cambodia from 2004-2007 using a fluorometric MUNANA-based enzyme inhibition assay. The Thailand and Cambodian clade 1 isolates tested here were all susceptible to oseltamivir and zanamivir, and sequence comparison indicated that reduced oseltamivir susceptibility we observed previously with clade 1 Cambodian isolates correlated with an S246G neuraminidase mutation. Eight Indonesian viruses (5%), all bearing I222 neuraminidase mutations, were identified as mild to extreme outliers for oseltamivir based on statistical analysis by box plots. IC(50)s were from 50 to 500-fold higher than the reference clade 1 virus from Viet Nam, ranging from 43-75 nM for I222T/V mutants and from 268-349 nM for I222M mutants. All eight viruses were from different geographic locales; all I222M variants were from central Sumatra. None of the H5N1 isolates tested demonstrated reduced susceptibility to zanamivir (IC(50)s all <5 nM). All I222 mutants showed loss of slow binding specifically for oseltamivir in an IC50 kinetics assay. We identified four other Indonesian isolates with higher IC(50)s which also demonstrated loss of slow binding, including one virus with an I117V mutation. There was a minimal effect on the binding of zanamivir and peramivir for all isolates tested. As H5N1 remains a potential pandemic threat, the incidence of mutations conferring reduced oseltamivir susceptibility is concerning and emphasizes the need for greater surveillance of drug susceptibility.	[McKimm-Breschkin, Jennifer L.; Barrett, Susan] Commonwealth Sci & Ind Res Org, Parkville, Vic, Australia; [McKimm-Breschkin, Jennifer L.; Barrett, Susan; Wong, Frank Y. K.; Selleck, Paul; Mohr, Peter G.] Commonwealth Sci & Ind Res Org, Australian Anim Hlth Lab, Geelong, Vic, Australia; [Pudjiatmoko; Azhar, Muhammad] Minist Agr, Directorate Anim Hlth, Directorate Gen Livestock, Jakarta, Indonesia; [Pudjiatmoko; Azhar, Muhammad] Minist Agr, Anim Hlth Serv, Jakarta, Indonesia; [McGrane, James; Kim, Mia] UN, Food & Agr Org, Emergency Ctr Transboundary Anim Dis, Jakarta, Indonesia; [Kim, Mia] World Org Anim Hlth & Food, Paris, France; [Kim, Mia] United Nations Global Network Expertise Anim Infl, Agr Org, OFFLU, Paris, France; [Kim, Mia] World Org Anim Hlth & Food, Rome, Italy; [Kim, Mia] United Nations Global Network Expertise Anim Infl, Agr Org, OFFLU, Rome, Italy; [Kim, Mia] USDA, Natl Vet Serv Labs, Ames, IA 50010 USA	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Ministry of Agricultire & Rural Development; Ministry of Agricultire & Rural Development; Food & Agriculture Organization of the United Nations (FAO); United States Department of Agriculture (USDA)	McKimm-Breschkin, JL (corresponding author), Commonwealth Sci & Ind Res Org, Parkville, Vic, Australia.	mck245@csiro.au	Wong, Frank/H-1950-2013; McKimm-Breschkin, Jennifer L/D-1880-2013	Wong, Frank/0000-0003-2471-9549; McKimm-Breschkin, Jennifer/0000-0002-2345-6786; Mohr, Peter/0000-0002-2402-3843; Barrett, Susan/0000-0003-1132-5268	Australian Department of Agriculture, Forestry and Fisheries	Australian Department of Agriculture, Forestry and Fisheries(Australian GovernmentDepartment of Agriculture and Water Resources)	Parts of this work were supported by the Australian Department of Agriculture, Forestry and Fisheries. No additional external funding was received for this study. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abed Y, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002431; Babu YS, 2000, J MED CHEM, V43, P3482, DOI 10.1021/jm0002679; Barrett S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023627; Baz M, 2006, CLIN INFECT DIS, V43, P1555, DOI 10.1086/508777; Bloom JD, 2010, SCIENCE, V328, P1272, DOI 10.1126/science.1187816; Boltz DA, 2010, J GEN VIROL, V91, P949, DOI 10.1099/vir.0.017459-0; BURMEISTER WP, 1992, EMBO J, V11, P49, DOI 10.1002/j.1460-2075.1992.tb05026.x; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P969; Collins PJ, 2008, NATURE, V453, P1258, DOI 10.1038/nature06956; Deyde VM, 2009, ANTIMICROB AGENTS CH, V53, P1039, DOI 10.1128/AAC.01446-08; Dharan NJ, 2009, JAMA-J AM MED ASSOC, V301, P1034, DOI 10.1001/jama.2009.294; Eshaghi A, 2011, EMERG INFECT DIS, V17, P1472, DOI 10.3201/eid1708.102004; FAO, 2012, FAOAIDE NEWS AN INFL; Govorkova EA, 2010, J VIROL, V84, P8042, DOI 10.1128/JVI.00689-10; Govorkova EA, 2009, ANTIMICROB AGENTS CH, V53, P3088, DOI 10.1128/AAC.01667-08; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hatakeyama S, 2011, CLIN MICROBIOL INFEC, V17, P1332, DOI 10.1111/j.1469-0691.2010.03313.x; Hatakeyama S, 2007, JAMA-J AM MED ASSOC, V297, P1435, DOI 10.1001/jama.297.13.1435; Hill AW, 2009, INFECT GENET EVOL, V9, P169, DOI 10.1016/j.meegid.2008.10.006; Hurt AC, 2007, ANTIVIR RES, V73, P228, DOI 10.1016/j.antiviral.2006.10.004; Hurt AC, 2012, EMERG INFECT DIS, V18, P109, DOI 10.3201/eid1801.111079; Hurt AC, 2009, ANTIMICROB AGENTS CH, V53, P4433, DOI 10.1128/AAC.00334-09; Hurt AC, 2009, ANTIVIR RES, V83, P90, DOI 10.1016/j.antiviral.2009.03.003; Ilyushina NA, 2008, ANTIMICROB AGENTS CH, V52, P3889, DOI 10.1128/AAC.01579-07; Ilyushina NA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000933; Kim CU, 1997, J AM CHEM SOC, V119, P681, DOI 10.1021/ja963036t; Landon MR, 2008, CHEM BIOL DRUG DES, V71, P106, DOI 10.1111/j.1747-0285.2007.00614.x; Mai TQL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003339; Matsuzaki Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-53; McKimm-Breschkin J, 2003, ANTIMICROB AGENTS CH, V47, P2264, DOI 10.1128/AAC.47.7.2264-2272.2003; McKimm-Breschkin JL, 2007, EMERG INFECT DIS, V13, P1354, DOI 10.3201/eid1309.070164; McKimm-Breschkin JL, 2012, J ANTIMICROB CHEMOTH, V67, P1874, DOI 10.1093/jac/dks150; Meijer A, 2009, EMERG INFECT DIS, V15, P552, DOI [10.3201/eid1504.081280, 10.3201/eid1504.181280]; Monto AS, 2006, ANTIMICROB AGENTS CH, V50, P2395, DOI 10.1128/AAC.01339-05; Morrison D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001305; Naughtin M, 2011, ANTIMICROB AGENTS CH, V55, P2004, DOI 10.1128/AAC.01773-10; Nguyen HT, 2012, ANTIVIR THER, V17, P159, DOI 10.3851/IMP2067; Nguyen HT, 2010, CLIN INFECT DIS, V51, P983, DOI 10.1086/656439; Oakley AJ, 2010, J MED CHEM, V53, P6421, DOI 10.1021/jm100621s; Oo C, 2001, Paediatr Drugs, V3, P229, DOI 10.2165/00128072-200103030-00005; Pizzorno A, 2011, J INFECT DIS, V203, P25, DOI 10.1093/infdis/jiq010; POTIER M, 1979, ANAL BIOCHEM, V94, P287, DOI 10.1016/0003-2697(79)90362-2; Rameix-Welti MA, 2006, ANTIMICROB AGENTS CH, V50, P3809, DOI 10.1128/AAC.00645-06; Rayner JM, 2007, NATURALLY OCCURING A, V68, P48; Sleeman K, 2011, EMERG INFECT DIS, V17, P2043, DOI 10.3201/eid1711.110787; Smith BJ, 2002, J MED CHEM, V45, P2207, DOI 10.1021/jm010528u; Takano R, 2012, J INFECT DIS; Takano R, 2013, J INFECT DIS, V207, P89, DOI 10.1093/infdis/jis633; van der Vries E, 2010, NEW ENGL J MED, V363, P1381, DOI 10.1056/NEJMc1003749; VARGHESE JN, 1992, PROTEINS, V14, P327, DOI 10.1002/prot.340140302; Varghese JN, 1998, STRUCT FOLD DES, V6, P735, DOI 10.1016/S0969-2126(98)00075-6; VARGHESE JN, 1991, J MOL BIOL, V221, P473, DOI 10.1016/0022-2836(91)80068-6; VONITZSTEIN M, 1993, NATURE, V363, P418, DOI 10.1038/363418a0; Wattanagoon Y, 2009, ANTIMICROB AGENTS CH, V53, P945, DOI 10.1128/AAC.00588-08; Wetherall NT, 2003, J CLIN MICROBIOL, V41, P742, DOI 10.1128/JCM.41.2.742-750.2003; WHO, 2013, CUM NUMB CONF HUM CA; Wibawa H, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-425	57	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66105	10.1371/journal.pone.0066105	http://dx.doi.org/10.1371/journal.pone.0066105			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776615	Green Published, Green Submitted, gold			2022-12-27	WOS:000320755400110
J	van Beest, FM; Milner, JM				van Beest, Floris M.; Milner, Jos M.			Behavioural Responses to Thermal Conditions Affect Seasonal Mass Change in a Heat-Sensitive Northern Ungulate	PLOS ONE			English	Article							DEPENDENT REPRODUCTIVE SUCCESS; MOOSE ALCES-ALCES; CLIMATE-CHANGE; HABITAT SELECTION; RESOURCE SELECTION; PHENOTYPIC PLASTICITY; ACTIVITY PATTERNS; LARGE HERBIVORES; TAILED DEER; BODY-MASS	Background: Empirical tests that link temperature-mediated changes in behaviour (activity and resource selection) to individual fitness or condition are currently lacking for endotherms yet may be critical to understanding the effect of climate change on population dynamics. Moose (Alces alces) are thought to suffer from heat stress in all seasons so provide a good biological model to test whether exposure to non-optimal ambient temperatures influence seasonal changes in body mass. Seasonal mass change is an important fitness correlate of large herbivores and affects reproductive success of female moose. Methodology/Principal Findings: Using GPS-collared adult female moose from two populations in southern Norway we quantified individual differences in seasonal activity budget and resource selection patterns as a function of seasonal temperatures thought to induce heat stress in moose. Individual body mass was recorded in early and late winter, and autumn to calculate seasonal mass changes (n = 52 over winter, n = 47 over summer). We found large individual differences in temperature-dependent resource selection patterns as well as within and between season variability in thermoregulatory strategies. As expected, individuals using an optimal strategy, selecting young successional forest (foraging habitat) at low ambient temperatures and mature coniferous forest (thermal shelter) during thermally stressful conditions, lost less mass in winter and gained more mass in summer. Conclusions/Significance: This study provides evidence that behavioural responses to temperature have important consequences for seasonal mass change in moose living in the south of their distribution in Norway, and may be a contributing factor to recently observed declines in moose demographic performance. Although the mechanisms that underlie the observed temperature mediated habitat-fitness relationship remain to be tested, physiological state and individual variation in thermal tolerance are likely contributory factors. Climate-related effects on animal behaviour, and subsequently fitness, are expected to intensify as global warming continues.	[van Beest, Floris M.] Univ Saskatchewan, Dept Anim & Poultry Sci, Coll Agr & Bioresources, Saskatoon, SK S7N 0W0, Canada; [van Beest, Floris M.; Milner, Jos M.] Hedmark Univ Coll, Fac Appl Ecol & Agr Sci, Evenstad, Norway	University of Saskatchewan; Inland Norway University of Applied Sciences	van Beest, FM (corresponding author), Univ Saskatchewan, Dept Anim & Poultry Sci, Coll Agr & Bioresources, Saskatoon, SK S7N 0W0, Canada.	floris.vanbeest@usask.ca	Milner, Jos M./G-7722-2012; van Beest, Floris M./C-6745-2019	Milner, Jos M./0000-0003-0229-3655; van Beest, Floris M./0000-0002-5701-4927	Norwegian Research Council [173868/AREAL]; Innovation Norway, Telemark County, Hedmark County and municipalities in Telemark, Vestfold, and Hedmark	Norwegian Research Council(Research Council of NorwayEuropean Commission); Innovation Norway, Telemark County, Hedmark County and municipalities in Telemark, Vestfold, and Hedmark	Funding was provided by Norwegian Research Council (173868/AREAL), Innovation Norway, Telemark County, Hedmark County and municipalities in Telemark, Vestfold, and Hedmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnemo Jon M., 2003, Alces, V39, P243; Aublet JF, 2009, OECOLOGIA, V159, P237, DOI 10.1007/s00442-008-1198-4; AVERY RA, 1978, J ANIM ECOL, V47, P143, DOI 10.2307/3928; Bertolo A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018603; Bourgoin G, 2011, CAN J ZOOL, V89, P765, DOI [10.1139/Z11-046, 10.1139/z11-046]; Bowyer RT, 2009, CALIF FISH GAME, V95, P128; Boyce MS, 2006, DIVERS DISTRIB, V12, P269, DOI 10.1111/j.1366-9516.2006.00243.x; Boyles JG, 2011, INTEGR COMP BIOL, V51, P676, DOI 10.1093/icb/icr053; Burthe S, 2011, J ANIM ECOL, V80, P1134, DOI 10.1111/j.1365-2656.2011.01865.x; Charmantier A, 2008, SCIENCE, V320, P800, DOI 10.1126/science.1157174; CluttonBrock TH, 1996, J ANIM ECOL, V65, P675, DOI 10.2307/5667; CLUTTONBROCK TH, 1989, NATURE, V337, P260, DOI 10.1038/337260a0; Creel S, 2008, TRENDS ECOL EVOL, V23, P194, DOI 10.1016/j.tree.2007.12.004; Dussault C, 2004, ECOSCIENCE, V11, P321, DOI 10.1080/11956860.2004.11682839; Edwards LJ, 2008, STAT MED, V27, P6137, DOI 10.1002/sim.3429; Festa-Bianchet M, 1998, ECOL LETT, V1, P91; Festa-Bianchet M, 1998, AM NAT, V152, P367, DOI 10.1086/286175; FestaBianchet M, 1996, CAN J ZOOL, V74, P330, DOI 10.1139/z96-041; Gaillard JM, 2010, PHILOS T R SOC B, V365, P2255, DOI 10.1098/rstb.2010.0085; Galanthay TE, 2012, AM NAT, V179, P475, DOI 10.1086/664625; Garel M, 2004, P ROY SOC B-BIOL SCI, V271, pS471, DOI 10.1098/rsbl.2004.0219; Grotan V, 2009, OECOLOGIA, V161, P685, DOI 10.1007/s00442-009-1419-5; Hansen BB, 2011, ECOLOGY, V92, P1917, DOI 10.1890/11-0095.1; Henry RC, 2013, J THEOR BIOL, V321, P1, DOI 10.1016/j.jtbi.2012.12.004; Herfindal I, 2009, ECOGRAPHY, V32, P849, DOI 10.1111/j.1600-0587.2009.05783.x; HUEY RB, 1991, AM NAT, V137, pS91, DOI 10.1086/285141; Knowlton JL, 2010, BIOL CONSERV, V143, P1342, DOI 10.1016/j.biocon.2010.03.011; Leblond M, 2010, ECOGRAPHY, V33, P1102, DOI 10.1111/j.1600-0587.2009.06104.x; Lenarz MS, 2009, J WILDLIFE MANAGE, V73, P503, DOI 10.2193/2008-265; Lowe SJ, 2010, CAN J ZOOL, V88, P1032, DOI 10.1139/Z10-071; LUNDMARK C, 2008, THESIS SWEDISH U AGR; Manly B.F.J., 2002, RESOURCE SELECTION A; McLoughlin PD, 2006, P ROY SOC B-BIOL SCI, V273, P1449, DOI 10.1098/rspb.2006.3486; Milner JM, 2013, OECOLOGIA IN PRESS, DOI [10.1007/s00442-012-2547-x, DOI 10.1007/S00442-012-2547-X]; Moen R, 1997, ECOLOGY, V78, P505; Murtaugh PA, 2009, ECOL LETT, V12, P1061, DOI 10.1111/j.1461-0248.2009.01361.x; Mysterud A, 1999, WILDLIFE SOC B, V27, P385; Mysterud A, 2008, PHILOS T R SOC B, V363, P2359, DOI 10.1098/rstb.2007.2206; Mysterud Atle, 2011, P349; Nielsen SE, 2004, BIOL CONSERV, V120, P101, DOI 10.1016/j.biocon.2004.02.020; Parker KL, 2009, FUNCT ECOL, V23, P57, DOI 10.1111/j.1365-2435.2009.01528.x; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pelletier F, 2007, EVOLUTION, V61, P1969, DOI 10.1111/j.1558-5646.2007.00160.x; Post E, 2009, BIOSCIENCE, V59, P489, DOI 10.1525/bio.2009.59.6.7; Putman RJ, 2004, MAMMAL REV, V34, P285, DOI 10.1111/j.1365-2907.2004.00044.x; RENECKER LA, 1986, CAN J ZOOL, V64, P322, DOI 10.1139/z86-052; Renecker Lyle A., 1990, Alces, V26, P66; RISENHOOVER KL, 1986, J WILDLIFE MANAGE, V50, P727, DOI 10.2307/3800990; Rughetti M, 2012, J MAMMAL, V93, P1301, DOI 10.1644/11-MAMM-A-402.1; Sand H, 1998, CAN J ZOOL, V76, P187, DOI 10.1139/cjz-76-1-187; SCHMITZ OJ, 1991, HOLARCTIC ECOL, V14, P104; Schoener TW, 1971, REV ECOL SYST, V2, P369; SCHWAB FE, 1991, CAN J ZOOL, V69, P3071, DOI 10.1139/z91-431; Stien A, 2010, ECOLOGY, V91, P915, DOI 10.1890/09-0056.1; van Beest FM, 2012, ANIM BEHAV, V84, P723, DOI 10.1016/j.anbehav.2012.06.032; van Beest FM, 2011, J ANIM ECOL, V80, P771, DOI 10.1111/j.1365-2656.2011.01829.x; van Beest FM, 2010, J ANIM ECOL, V79, P910, DOI 10.1111/j.1365-2656.2010.01701.x; van Beest FM, 2010, J WILDLIFE MANAGE, V74, P219, DOI 10.2193/2009-109; Van Moorter B, 2009, OECOLOGIA, V159, P669, DOI 10.1007/s00442-008-1245-1; Van Moorter B, 2010, J WILDLIFE MANAGE, V74, P588, DOI 10.2193/2009-155	60	57	58	2	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65972	10.1371/journal.pone.0065972	http://dx.doi.org/10.1371/journal.pone.0065972			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776584	Green Published, gold			2022-12-27	WOS:000320755400092
J	Nishimura, T; Uratani, Y; Okayasu, T; Nakagawa, S; Hosoi, H				Nishimura, Tadashi; Uratani, Yuka; Okayasu, Tadao; Nakagawa, Seiji; Hosoi, Hiroshi			Magnetoencephalographic Study on Forward Suppression by Ipsilateral, Contralateral, and Binaural Maskers	PLOS ONE			English	Article							BONE-CONDUCTED ULTRASOUND; PRIMARY AUDITORY-CORTEX; N1M AMPLITUDE; MASKING; STIMULATION; MECHANISMS; RESPONSES; DURATION; BURSTS; GROWTH	When two tones are presented in a short time interval, the response to the second tone is suppressed. This phenomenon is referred to as forward suppression. To address the effect of the masker laterality on forward suppression, magnetoencephalographic responses were investigated for eight subjects with normal hearing when the preceding maskers were presented ipsilaterally, contralaterally, and binaurally. We employed three masker intensity conditions: the ipsilateral-strong, left-right-balanced, and contralateral-strong conditions. Regarding the responses to the maskers without signal, the N1m amplitude evoked by the left and binaural maskers was significantly larger than that evoked by the right masker for the left-strong and left-right-balanced conditions. No significant difference was observed for the right-strong condition. Regarding the subsequent N1m amplitudes, they were attenuated by the presence of the left, binaural, and right maskers for all conditions. For the left-and right-strong conditions, the subsequent N1m amplitude in the presence of the left masker was smaller than those of the binaural and right maskers. No difference was observed between the binaural and right masker presentation. For left-right-balanced condition, the subsequent N1m amplitude decreased in the presence of the right, binaural, and left maskers in that order. If the preceding activity reflected the ability to suppress the subsequent activity, the forward suppression by the left masker would be superior to that by the right masker for the left-strong and left-right-balanced conditions. Furthermore, the forward suppression by the binaural masker would be expected to be superior to that by the left masker owing to additional afferent activity from the right ear. Thus, the current results suggest that the forward suppression by ipsilateral maskers is superior to that by contralateral maskers although both maskers evoked the N1m amplitudes to the same degree. Additional masker at the contralateral ear can attenuate the forward suppression by the ipsilateral masker.	[Nishimura, Tadashi; Uratani, Yuka; Okayasu, Tadao; Hosoi, Hiroshi] Nara Med Univ, Dept Otolaryngol Head & Neck Surg, Nara, Japan; [Nakagawa, Seiji] Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, Ikeda, Osaka, Japan	Nara Medical University; National Institute of Advanced Industrial Science & Technology (AIST)	Nishimura, T (corresponding author), Nara Med Univ, Dept Otolaryngol Head & Neck Surg, Nara, Japan.	t-nishim@naramed-u.ac.jp		Okayasu, Tadao/0000-0002-0811-1405				Aran JM, 2000, AUDIOLOGY, V39, P311; Brosch M, 1997, J NEUROPHYSIOL, V77, P923, DOI 10.1152/jn.1997.77.2.923; CALFORD MB, 1995, J NEUROPHYSIOL, V73, P1876, DOI 10.1152/jn.1995.73.5.1876; Devlin JT, 2003, J NEUROSCI, V23, P11516; Jancke L, 2002, HEARING RES, V170, P166, DOI 10.1016/S0378-5955(02)00488-4; JOUTSINIEMI SL, 1989, AUDIOLOGY, V28, P325; Neukirch M, 2002, NEUROPSYCHOBIOLOGY, V45, P41, DOI 10.1159/000048672; Nishimura T, 2003, NEUROREPORT, V14, P891, DOI 10.1097/00001756-200305060-00024; Nishimura T, 2002, NEUROSCI LETT, V327, P119, DOI 10.1016/S0304-3940(02)00409-3; Nishimura T, 2009, ACTA OTO-LARYNGOL, V129, P28, DOI 10.1080/00016480902915707; ONISHI S, 1968, J ACOUST SOC AM, V44, P582, DOI 10.1121/1.1911124; Ozmeral EJ, 2012, J ACOUST SOC AM, V132, P1152, DOI 10.1121/1.4730976; Pantev C, 1998, AUDIOL NEURO-OTOL, V3, P183, DOI 10.1159/000013789; Razak KA, 2012, HEARING RES, V290, P1, DOI 10.1016/j.heares.2012.05.008; RELKIN EM, 1988, J ACOUST SOC AM, V84, P584, DOI 10.1121/1.396836; Soeta Y, 2009, NEUROREPORT, V20, P548, DOI 10.1097/WNR.0b013e32832a6f15; Wehr M, 2005, NEURON, V47, P437, DOI 10.1016/j.neuron.2005.06.009; Woldorff MG, 1999, HUM BRAIN MAPP, V7, P49, DOI 10.1002/(SICI)1097-0193(1999)7:1<49::AID-HBM5>3.3.CO;2-A	18	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e66225	10.1371/journal.pone.0066225	http://dx.doi.org/10.1371/journal.pone.0066225			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762482	Green Submitted, gold, Green Published			2022-12-27	WOS:000321099000130
J	Brolund, A; Franzen, O; Melefors, O; Tegmark-Wisell, K; Sandegren, L				Brolund, Alma; Franzen, Oscar; Melefors, Ojar; Tegmark-Wisell, Karin; Sandegren, Linus			Plasmidome-Analysis of ESBL-Producing Escherichia coli Using Conventional Typing and High-Throughput Sequencing	PLOS ONE			English	Article							SPECTRUM BETA-LACTAMASE; RESISTANCE; GENOME; ENTEROBACTERIACEAE; IDENTIFICATION; INFECTIONS; SELECTION; CARRIAGE; STRAINS; SCHEME	Infections caused by Extended spectrum beta-lactamase (ESBL)-producing E. coli are an emerging global problem, threatening the effectiveness of the extensively used beta-lactam antibiotics. ESBL dissemination is facilitated by plasmids, transposons, and other mobile elements. We have characterized the plasmid content of ESBL-producing E. coli from human urinary tract infections. Ten diverse isolates were selected; they had unrelated pulsed-field gel electrophoresis (PFGE) types (<90% similarity), were from geographically dispersed locations and had diverging antibiotic resistance profiles. Three isolates belonged to the globally disseminated sequence type ST131. ESBL-genes of the CTX-M-1 and CTX-M-9 phylogroups were identified in all ten isolates. The plasmid content (plasmidome) of each strain was analyzed using a combination of molecular methods and high-throughput sequencing. Hidden Markov Model-based analysis of unassembled sequencing reads was used to analyze the genetic diversity of the plasmid samples and to detect resistance genes. Each isolate contained between two and eight distinct plasmids, and at least 22 large plasmids were identified overall. The plasmids were variants of pUTI89, pKF3-70, pEK499, pKF3-140, pKF3-70, p1ESCUM, pEK204, pHK17a, p083CORR, R64, pLF82, pSFO157, and R721. In addition, small cryptic high copy-number plasmids were frequent, containing one to seven open reading frames per plasmid. Three clustered groups of such small cryptic plasmids could be distinguished based on sequence similarity. Extrachromosomal prophages were found in three isolates. Two of them resembled the E. coli P1 phage and one was previously unknown. The present study confirms plasmid multiplicity in multi-resistant E. coli. We conclude that high-throughput sequencing successfully provides information on the extrachromosomal gene content and can be used to generate a genetic fingerprint of possible use in epidemiology. This could be a valuable tool for tracing plasmids in outbreaks.	[Brolund, Alma; Melefors, Ojar; Tegmark-Wisell, Karin] Swedish Inst Communicable Dis Control, Solna, Sweden; [Brolund, Alma; Melefors, Ojar; Tegmark-Wisell, Karin] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Franzen, Oscar] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden; [Sandegren, Linus] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden	Swedish Institute for Infectious Disease Control; Karolinska Institutet; Karolinska Institutet; Uppsala University	Brolund, A (corresponding author), Swedish Inst Communicable Dis Control, Solna, Sweden.	alma.brolund@smi.se	Sandegren, Linus/K-4638-2013; Melefors, Öjar/N-6164-2015	Sandegren, Linus/0000-0001-7382-9782; Melefors, Öjar/0000-0003-4115-1190	NSCMID - Nordic Society of Clinical Microbiology and Infectious Diseases; Swedish Research Council (VR-MH); Carl Tryggers Foundation	NSCMID - Nordic Society of Clinical Microbiology and Infectious Diseases; Swedish Research Council (VR-MH)(Swedish Research Council); Carl Tryggers Foundation	Part of this work was supported with grants from NSCMID - Nordic Society of Clinical Microbiology and Infectious Diseases (to AB), and the Swedish Research Council (VR-MH) and Carl Tryggers Foundation (to LS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBLER RP, 1980, PHILOS T R SOC B, V289, P321, DOI 10.1098/rstb.1980.0049; [Anonymous], 2011, J ANTIMICROB CHEMOTH; BARTON BM, 1995, ANAL BIOCHEM, V226, P235, DOI 10.1006/abio.1995.1220; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bengtsson S, 2012, J ANTIMICROB CHEMOTH, V67, P69, DOI 10.1093/jac/dkr421; Brolund A, 2010, J MICROBIOL METH, V83, P224, DOI 10.1016/j.mimet.2010.09.004; Brolund A, 2010, J MICROBIOL METH, V82, P229, DOI 10.1016/j.mimet.2010.06.006; Brolund A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009233; Burian J, 1997, PLASMID, V37, P2, DOI 10.1006/plas.1996.1273; BUSH K, 1995, ANTIMICROB AGENTS CH, V39, P1211, DOI 10.1128/AAC.39.6.1211; Canton R, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00110; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Carattoli A, 2011, INT J MED MICROBIOL, V301, P654, DOI 10.1016/j.ijmm.2011.09.003; Chen SL, 2006, P NATL ACAD SCI USA, V103, P5977, DOI 10.1073/pnas.0600938103; Coque TM, 2008, EMERG INFECT DIS, V14, P195, DOI 10.3201/eid1402.070350; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Eddy Sean R, 2009, Genome Inform, V23, P205; Garcia-Fernandez A, 2008, J ANTIMICROB CHEMOTH, V61, P1229, DOI 10.1093/jac/dkn131; Garcia-Fernandez A, 2010, J ANTIMICROB CHEMOTH, V65, P1155, DOI 10.1093/jac/dkq101; Giske CG, 2009, J ANTIMICROB CHEMOTH, V63, P1, DOI 10.1093/jac/dkn444; Guy L, 2010, BIOINFORMATICS, V26, P2334, DOI 10.1093/bioinformatics/btq413; Johnson JR, 2010, CLIN INFECT DIS, V51, P286, DOI 10.1086/653932; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lobocka MB, 2004, J BACTERIOL, V186, P7032, DOI 10.1128/JB.186.21.7032-7068.2004; Miquel S, 2010, PLOS ONE, P5; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; Pitout JDD, 2010, DRUGS, V70, P313, DOI 10.2165/11533040-000000000-00000; Ripoll A, 2011, ANTIMICROB AGENTS CH, V55, P4530, DOI 10.1128/AAC.00178-11; Sherley M, 2003, PLASMID, V49, P79, DOI 10.1016/S0147-619X(02)00107-5; Smet A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011202; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tofteland S, 2007, J CLIN MICROBIOL, V45, P199, DOI 10.1128/JCM.01319-06; Wilkins BM, 2002, ENVIRON MICROBIOL, V4, P495, DOI 10.1046/j.1462-2920.2002.00332.x; Woodford N, 2009, ANTIMICROB AGENTS CH, V53, P4472, DOI 10.1128/AAC.00688-09; Yi HG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008601	37	31	32	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65793	10.1371/journal.pone.0065793	http://dx.doi.org/10.1371/journal.pone.0065793			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785449	Green Published, Green Submitted, gold			2022-12-27	WOS:000321038800073
J	Coley, W; Rayavarapu, S; van der Meulen, JH; Duba, AS; Nagaraju, K				Coley, William; Rayavarapu, Sree; van der Meulen, Jack H.; Duba, Ayyappa S.; Nagaraju, Kanneboyina			Daily Supplementation of D-ribose Shows No Therapeutic Benefits in the MHC-I Transgenic Mouse Model of Inflammatory Myositis	PLOS ONE			English	Article							MYOADENYLATE DEAMINASE DEFICIENCY; ENDOPLASMIC-RETICULUM STRESS; HUMAN SKELETAL-MUSCLE; AUTOIMMUNE MYOSITIS; INTENSE EXERCISE; UP-REGULATION; METABOLISM; CAPACITY; DAMAGE	Background: Current treatments for idiopathic inflammatory myopathies (collectively called myositis) focus on the suppression of an autoimmune inflammatory response within the skeletal muscle. However, it has been observed that there is a poor correlation between the successful suppression of muscle inflammation and an improvement in muscle function. Some evidence in the literature suggests that metabolic abnormalities in the skeletal muscle underlie the weakness that continues despite successful immunosuppression. We have previously shown that decreased expression of a purine nucleotide cycle enzyme, adenosine monophosphate deaminase (AMPD1), leads to muscle weakness in a mouse model of myositis and may provide a mechanistic basis for muscle weakness. One of the downstream metabolites of this pathway, D-ribose, has been reported to alleviate symptoms of myalgia in patients with a congenital loss of AMPD1. Therefore, we hypothesized that supplementing exogenous D-ribose would improve muscle function in the mouse model of myositis. We treated normal and myositis mice with daily doses of D-ribose (4 mg/kg) over a 6-week time period and assessed its effects using a battery of behavioral, functional, histological and molecular measures. Results: Treatment with D-ribose was found to have no statistically significant effects on body weight, grip strength, open field behavioral activity, maximal and specific forces of EDL, soleus muscles, or histological features. Histological and gene expression analysis indicated that muscle tissues remained inflamed despite treatment. Gene expression analysis also suggested that low levels of the ribokinase enzyme in the skeletal muscle might prevent skeletal muscle tissue from effectively utilizing D-ribose. Conclusions: Treatment with daily oral doses of D-ribose showed no significant effect on either disease progression or muscle function in the mouse model of myositis.	[Coley, William; Rayavarapu, Sree; van der Meulen, Jack H.; Duba, Ayyappa S.; Nagaraju, Kanneboyina] Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA; [Nagaraju, Kanneboyina] George Washington Univ, Sch Med, Dept Integrat Syst Biol, Washington, DC USA	Children's National Health System; George Washington University	Nagaraju, K (corresponding author), Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA.	knagaraju@childrensnational.org	Nagaraju, Kanneboyina/AAV-7684-2021; Nagaraju, Kanneboyina/ABA-6525-2021		Association Francaise Contre les Myopathies	Association Francaise Contre les Myopathies(Association Francaise contre les Myopathies)	Sree Rayavarapu is supported by a pre-doctoral fellowship from the Association Francaise Contre les Myopathies. William Coley is a predoctoral student in the Microbiology and Immunology Program of the Institute for Biomedical Sciences at the George Washington University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alger HM, 2011, ARTHRITIS RHEUM-US, V63, P3448, DOI 10.1002/art.30530; Berardi JM, 2003, J STRENGTH COND RES, V17, P47; Coley W, 2012, ARTHRITIS RHEUM-US, V64, P3750, DOI 10.1002/art.34625; Englund P, 2001, AM J PATHOL, V159, P1263, DOI 10.1016/S0002-9440(10)62513-8; FISHBEIN WN, 1985, BIOCHEM MED METAB B, V33, P158, DOI 10.1016/0006-2944(85)90024-9; GROSS M, 1989, KLIN WOCHENSCHR, V67, P1205, DOI 10.1007/BF01716208; Hellsten Y, 1999, J PHYSIOL-LONDON, V520, P909, DOI 10.1111/j.1469-7793.1999.00909.x; Kerksick C, 2005, INT J SPORT NUTR EXE, V15, P653, DOI 10.1123/ijsnem.15.6.653; LECKY BRF, 1983, LANCET, V1, P193; Li CKC, 2004, J RHEUMATOL, V31, P605; Nagaraju K, 2005, ARTHRITIS RHEUM, V52, P1824, DOI 10.1002/art.21103; Nagaraju K, 2000, P NATL ACAD SCI USA, V97, P9209, DOI 10.1073/pnas.97.16.9209; Rozen S, 2000, Methods Mol Biol, V132, P365; SABINA RL, 1991, ADV EXP MED BIOL, V309, P203; SABINA RL, 1984, J CLIN INVEST, V73, P720, DOI 10.1172/JCI111265; SABINA RL, 1992, NEUROLOGY, V42, P170, DOI 10.1212/WNL.42.1.170; Sabina RL, 2000, NEUROL CLIN, V18, P185, DOI 10.1016/S0733-8619(05)70184-5; Salomonsson S, 2009, MUSCLE NERVE, V39, P674, DOI 10.1002/mus.21129; Spurney CF, 2009, MUSCLE NERVE, V39, P591, DOI 10.1002/mus.21211; Steele IC, 1996, J NEUROL SCI, V136, P174, DOI 10.1016/0022-510X(95)00320-2; TULLSON PC, 1995, J APPL PHYSIOL, V78, P146, DOI 10.1152/jappl.1995.78.1.146; Vattemi G, 2004, AM J PATHOL, V164, P1, DOI 10.1016/S0002-9440(10)63089-1; Vitadello M, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2963; WAGNER DR, 1991, ANN NUTR METAB, V35, P297, DOI 10.1159/000177660; ZOLLNER N, 1986, KLIN WOCHENSCHR, V64, P1281, DOI 10.1007/BF01785710	25	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65970	10.1371/journal.pone.0065970	http://dx.doi.org/10.1371/journal.pone.0065970			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785461	Green Published, gold, Green Submitted			2022-12-27	WOS:000321038800061
J	Pakradouni, J; Le Goff, W; Calmel, C; Antoine, B; Villard, E; Frisdal, E; Abifadel, M; Tordjman, J; Poitou, C; Bonnefont-Rousselot, D; Bittar, R; Bruckert, E; Clement, K; Feve, B; Martinerie, C; Guerin, M				Pakradouni, Jihane; Le Goff, Wilfried; Calmel, Claire; Antoine, Benedicte; Villard, Elise; Frisdal, Eric; Abifadel, Marianne; Tordjman, Joan; Poitou, Christine; Bonnefont-Rousselot, Dominique; Bittar, Randa; Bruckert, Eric; Clement, Karine; Feve, Bruno; Martinerie, Cecile; Guerin, Maryse			Plasma NOV/CCN3 Levels Are Closely Associated with Obesity in Patients with Metabolic Disorders	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; ADIPOSE-TISSUE; GENDER-DIFFERENCES; NERVOUS-SYSTEM; EXPRESSION; GENE; NOV; ATHEROSCLEROSIS; GROWTH; MICE	Objective: Evidence points to a founder of the multifunctional CCN family, NOV/CCN3, as a circulating molecule involved in cardiac development, vascular homeostasis and inflammation. No data are available on the relationship between plasma NOV/CCN3 levels and cardiovascular risk factors in humans. This study investigated the possible relationship between plasma NOV levels and cardiovascular risk factors in humans. Methods: NOV levels were measured in the plasma from 594 adults with a hyperlipidemia history and/or with lipid-lowering therapy and/or a body mass index (BMI) >30 kg/m(2). Correlations were measured between NOV plasma levels and various parameters, including BMI, fat mass, and plasma triglycerides, cholesterol, glucose, and C-reactive protein. NOV expression was also evaluated in adipose tissue from obese patients and rodents and in primary cultures of adipocytes and macrophages. Results: After full multivariate adjustment, we detected a strong positive correlation between plasma NOV and BMI (r = 0.36 p<0.0001) and fat mass (r = 0.33 p<0.0005). According to quintiles, this relationship appeared to be linear. NOV levels were also positively correlated with C-reactive protein but not with total cholesterol, LDL-C or blood glucose. In patients with drastic weight loss induced by Roux-en-Y bariatric surgery, circulating NOV levels decreased by 28% (p<0.02) and 48% (p<0.0001) after 3 and 6 months, respectively, following surgery. In adipose tissue from obese patients, and in human primary cultures NOV protein was detected in adipocytes and macrophages. In mice fed a high fat diet NOV plasma levels and its expression in adipose tissue were also significantly increased compared to controls fed a standard diet. Conclusion: Our results strongly suggest that in obese humans and mice plasma NOV levels positively correlated with NOV expression in adipose tissue, and support a possible contribution of NOV to obesity-related inflammation.	[Pakradouni, Jihane; Calmel, Claire; Antoine, Benedicte; Feve, Bruno; Martinerie, Cecile] Hop St Antoine, St Antoine Res Ctr, UMR S938, INSERM, F-75571 Paris, France; [Pakradouni, Jihane; Calmel, Claire; Antoine, Benedicte; Feve, Bruno; Martinerie, Cecile] Univ Paris 06, UMR S938, Paris, France; [Pakradouni, Jihane] Sisene SAS, Paris, France; [Le Goff, Wilfried; Villard, Elise; Frisdal, Eric; Bittar, Randa; Bruckert, Eric; Guerin, Maryse] Hop La Pitie Salpetriere, INSERM, UMR S939, Paris, France; [Tordjman, Joan; Poitou, Christine; Clement, Karine] Cordelier Res Ctr, Nutri Team 7, INSERM, U872, Paris, France; [Tordjman, Joan; Poitou, Christine; Clement, Karine] Univ Paris 06, AP HP, Pitie Salpetriere Hosp, Human Nutr Res Ctr CRNH, Paris, France; [Le Goff, Wilfried; Villard, Elise; Frisdal, Eric; Guerin, Maryse] Univ Paris 06, UMR S939, Paris, France; [Bruckert, Eric] Hop La Pitie Salpetriere, AP HP, Dept Endocrinol, Paris, France; [Bonnefont-Rousselot, Dominique; Bittar, Randa] Hop La Pitie Salpetriere, AP HP, Metab Biochem Dept, Paris, France; [Le Goff, Wilfried; Villard, Elise; Frisdal, Eric; Bruckert, Eric; Clement, Karine; Guerin, Maryse] ICAN, Cardiometab & Nutr Inst, Paris, France; [Abifadel, Marianne] Bichat Claude Bernard Hosp, INSERM, UMR S698, Paris, France; [Abifadel, Marianne] St Joseph Univ, Fac Pharm, Beirut, Lebanon	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Martinerie, C (corresponding author), Hop St Antoine, St Antoine Res Ctr, UMR S938, INSERM, F-75571 Paris, France.	cecile.martinerie@inserm.fr	Clément, karine/R-1120-2017; Abifadel, Marianne/ABH-5370-2020; Le Goff, Wilfried/N-6326-2017; Guerin, Maryse/N-5794-2017; Le Goff, Wilfried/N-7593-2019; Rousselot, Bonnefont/U-7434-2019; Poitou, Christine/GVT-6117-2022	Le Goff, Wilfried/0000-0002-7611-9644; Le Goff, Wilfried/0000-0002-7611-9644; Poitou, Christine/0000-0001-7769-6331; Pakradouni, Jihane/0000-0003-0400-6007; Bonnefont-Rousselot, Dominique/0000-0003-4689-9202; CALMEL, Claire/0000-0001-7215-7910; ABIFADEL, Marianne/0000-0001-7645-8323; Feve, Bruno/0000-0001-6577-9009; GUERIN, Maryse/0000-0003-0150-1360	Institut National de la Sante et de la Recherche Medicale (INSERM); Institut National du Cancer (INCA); Groupement des Entreprises Francaises dans la Lutte contre le Cancer (GEFLUC); ANRT (Association National Recherche et Technologie), CIFRE; Assistance Publique-Hopitaux de Paris (APHP); Direction of Clinical Research (CRC) [CRC NCT 0047658]; PHRC [0702]	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Institut National du Cancer (INCA)(Institut National du Cancer (INCA) France); Groupement des Entreprises Francaises dans la Lutte contre le Cancer (GEFLUC); ANRT (Association National Recherche et Technologie), CIFRE; Assistance Publique-Hopitaux de Paris (APHP); Direction of Clinical Research (CRC); PHRC	This work was supported by the Institut National de la Sante et de la Recherche Medicale (INSERM), and by grants from the Institut National du Cancer (INCA) and the Groupement des Entreprises Francaises dans la Lutte contre le Cancer (GEFLUC). JP was a recipient of financial support from the ANRT (Association National Recherche et Technologie), CIFRE. The authors acknowledge support from the Assistance Publique-Hopitaux de Paris (APHP) and the Direction of Clinical Research (CRC), which promoted and supported our clinical investigation (CRC NCT 0047658) and PHRC 0702. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Maksoud M, 2008, J CARDIOVASC PHARM, V51, P331, DOI 10.1097/FJC.0b013e318165e2e7; Benini S, 2005, ONCOGENE, V24, P4349, DOI 10.1038/sj.onc.1208620; Bouloumie A, 2005, CURR OPIN CLIN NUTR, V8, P347, DOI 10.1097/01.mco.0000172571.41149.52; Braunersreuther V, 2007, ARTERIOSCL THROM VAS, V27, P373, DOI 10.1161/01.ATV.0000253886.44609.ae; Breland UM, 2008, ARTERIOSCL THROM VAS, V28, P1005, DOI 10.1161/ATVBAHA.108.162305; Bruun JM, 2005, J CLIN ENDOCR METAB, V90, P2282, DOI 10.1210/jc.2004-1696; Burren CP, 1999, J CLIN ENDOCR METAB, V84, P1096; Calhabeu F, 1876, EXP CELL RES; Chen CC, 2009, INT J BIOCHEM CELL B, V41, P771, DOI 10.1016/j.biocel.2008.07.025; Chevalier G, 1998, AM J PATHOL, V152, P1563; Christiansen T, 2005, INT J OBESITY, V29, P146, DOI 10.1038/sj.ijo.0802839; Couillard C, 1997, DIABETOLOGIA, V40, P1178, DOI 10.1007/s001250050804; Dalmas E, 2011, AM J CLIN NUTR, V94, P450, DOI 10.3945/ajcn.111.013771; Divoux A, 2011, OBES REV, V12, pe494, DOI 10.1111/j.1467-789X.2010.00811.x; Doghman M, 2007, J CLIN ENDOCR METAB, V92, P3253, DOI 10.1210/jc.2007-0342; Fukunaga-Kalabis M, 2008, ONCOGENE, V27, P2552, DOI 10.1038/sj.onc.1210896; Heath E, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-18; Hellstrom L, 2000, J INTERN MED, V247, P457, DOI 10.1046/j.1365-2796.2000.00678.x; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Inoue S, 2002, CIRCULATION, V106, P2700, DOI 10.1161/01.CIR.0000038140.80105.AD; JOLIOT V, 1992, MOL CELL BIOL, V12, P10, DOI 10.1128/MCB.12.1.10; Kimura A, 2010, J BIOL CHEM, V285, P32704, DOI 10.1074/jbc.M110.141804; Kular L, 2011, BIOCHIMIE, V93, P377, DOI 10.1016/j.biochi.2010.11.010; Larrede S, 2009, ARTERIOSCL THROM VAS, V29, P1930, DOI 10.1161/ATVBAHA.109.194548; Le Dreau G, 2010, GLIA, V58, P1510, DOI 10.1002/glia.21025; Libby P, 2010, CIRC J, V74, P213, DOI 10.1253/circj.CJ-09-0706; Lin ZY, 2010, J CELL COMMUN SIGNAL, V4, P141, DOI 10.1007/s12079-010-0095-x; Manara MC, 2002, AM J PATHOL, V160, P849, DOI 10.1016/S0002-9440(10)64908-5; Martinerie C, 2001, J CLIN ENDOCR METAB, V86, P3929, DOI 10.1210/jc.86.8.3929; McCallum L, 2009, J CELL COMMUN SIGNAL, V3, P115, DOI 10.1007/s12079-009-0058-2; Niu ZH, 2005, J UROLOGY, V174, P1460, DOI 10.1097/01.ju.0000173008.73741.80; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Poitou C, 2011, ARTERIOSCL THROM VAS, V31, P2322, DOI 10.1161/ATVBAHA.111.230979; Poitou C, 2009, J CLIN ENDOCR METAB, V94, P1810, DOI 10.1210/jc.2008-2040; Rydziel S, 2007, J BIOL CHEM, V282, P19762, DOI 10.1074/jbc.M700212200; Samad F, 1997, MOL MED, V3, P37, DOI 10.1007/BF03401666; Shimoyama T, 2010, ARTERIOSCL THROM VAS, V30, P675, DOI 10.1161/ATVBAHA.110.203356; Su BY, 2001, J CLIN PATHOL-MOL PA, V54, P184, DOI 10.1136/mp.54.3.184; Thibout H, 2003, J CLIN ENDOCR METAB, V88, P327, DOI 10.1210/jc.2002-020304; Vendrell JA, 2004, J MOL ENDOCRINOL, V32, P397, DOI 10.1677/jme.0.0320397	40	35	36	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66788	10.1371/journal.pone.0066788	http://dx.doi.org/10.1371/journal.pone.0066788			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785511	Green Published, gold, Green Submitted			2022-12-27	WOS:000321038800011
J	Gossing, M; Chidambaram, S; von Mollard, GF				Gossing, Michael; Chidambaram, Subbulakshmi; von Mollard, Gabriele Fischer			Importance of the N-Terminal Domain of the Qb-SNARE Vti1p for Different Membrane Transport Steps in the Yeast Endosomal System	PLOS ONE			English	Article							EPSIN-RELATED PROTEINS; SACCHAROMYCES-CEREVISIAE; LATE GOLGI; ENDOPLASMIC-RETICULUM; TETHERING COMPLEX; R-SNARE; VESICLE TRAFFICKING; VACUOLE FUSION; PATHWAYS; HOMOLOG	SNAREs (soluble N-ethylmaleimide-sensitive factor attachment protein receptor) on transport vesicles and target membranes are crucial for vesicle targeting and fusion. They form SNARE complexes, which contain four a-helical SNARE motifs contributed by three or four different SNAREs. Most SNAREs function only in a single transport step. The yeast SNARE Vti1p participates in four distinct SNARE complexes in transport from the trans Golgi network to late endosomes, in transport to the vacuole, in retrograde transport from endosomes to the trans Golgi network and in retrograde transport within the Golgi. So far, all vti1 mutants investigated had mutations within the SNARE motif. Little is known about the function of the N-terminal domain of Vti1p, which forms a three helix bundle called H-abc domain. Here we generated a temperature-sensitive mutant of this domain to study the effects on different transport steps. The secondary structure of wild type and vti1-3 H-abc domain was analyzed by circular dichroism spectroscopy. The amino acid exchanges identified in the temperature-sensitive vti1-3 mutant caused unfolding of the H-abc domain. Transport pathways were investigated by immunoprecipitation of newly synthesized proteins after pulse-chase labeling and by fluorescence microscopy of a GFP-tagged protein cycling between plasma membrane, early endosomes and Golgi. In vti1-3 cells transport to the late endosome and assembly of the late endosomal SNARE complex was blocked at 37 degrees C. Retrograde transport to the trans Golgi network was affected while fusion with the vacuole was possible but slower. Steady state levels of SNARE complexes mediating these steps were less affected than that of the late endosomal SNARE complex. As different transport steps were affected our data demonstrate the importance of a folded Vti1p H-abc domain for transport.	[Gossing, Michael; Chidambaram, Subbulakshmi; von Mollard, Gabriele Fischer] Univ Bielefeld, Fac Chem, Bielefeld, Germany	University of Bielefeld	von Mollard, GF (corresponding author), Univ Bielefeld, Fac Chem, Bielefeld, Germany.	gabriele.mollard@uni-bielefeld.de	von Mollard, Gabriele Fischer/O-9778-2019; von Mollard, Gabriele Fischer/A-3935-2012	von Mollard, Gabriele Fischer/0000-0003-3236-1401; von Mollard, Gabriele Fischer/0000-0003-3236-1401; Chidambaram, Subbulakshmi/0000-0002-3180-4429	Deutsche Forschungsgemeinschaft (DFG) [FI 583/5-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by grant FI 583/5-1 from the Deutsche Forschungsgemeinschaft (DFG, website: http://www.dfg.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMMERER G, 1986, MOL CELL BIOL, V6, P2490, DOI 10.1128/MCB.6.7.2490; Antonin W, 2002, J BIOL CHEM, V277, P36449, DOI 10.1074/jbc.M204369200; BANFIELD DK, 1995, NATURE, V375, P806, DOI 10.1038/375806a0; Becherer KA, 1996, MOL BIOL CELL, V7, P579, DOI 10.1091/mbc.7.4.579; Boeke JD, 1984, MOL GEN GENET, V197; Brickner JH, 2001, J CELL BIOL, V155, P969, DOI 10.1083/jcb.200104093; Burd CG, 1997, MOL BIOL CELL, V8, P1089, DOI 10.1091/mbc.8.6.1089; Chidambaram S, 2004, J BIOL CHEM, V279, P4175, DOI 10.1074/jbc.M308667200; Chidambaram S, 2008, J CELL SCI, V121, P329, DOI 10.1242/jcs.012708; Conibear E, 2003, MOL BIOL CELL, V14, P1610, DOI 10.1091/mbc.E02-10-0654; Conibear E, 2000, MOL BIOL CELL, V11, P305, DOI 10.1091/mbc.11.1.305; Conibear E, 1998, BBA-MOL CELL RES, V1404, P211, DOI 10.1016/S0167-4889(98)00058-5; DELEAGE G, 1993, COMPUT APPL BIOSCI, V9, P197; Dilcher M, 2003, EMBO J, V22, P3664, DOI 10.1093/emboj/cdg339; Dilcher M, 2001, J BIOL CHEM, V276, P34537, DOI 10.1074/jbc.M101551200; Dulubova I, 2002, EMBO J, V21, P3620, DOI 10.1093/emboj/cdf381; Dulubova I, 2001, NAT STRUCT BIOL, V8, P258, DOI 10.1038/85012; Duncan MC, 2003, NAT CELL BIOL, V5, P77, DOI 10.1038/ncb901; FINLEY D, 1994, MOL CELL BIOL, V14, P5501, DOI 10.1128/MCB.14.8.5501; Fridmann-Sirkis Y, 2006, TRAFFIC, V7, P182, DOI 10.1111/j.1600-0854.2005.00374.x; Holthuis JCM, 1998, EMBO J, V17, P113, DOI 10.1093/emboj/17.1.113; HOLTZER ME, 1992, BIOPOLYMERS, V32, P1675, DOI 10.1002/bip.360321209; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jun Y, 2007, EMBO J, V26, P4935, DOI 10.1038/sj.emboj.7601915; Kloepper TH, 2007, MOL BIOL CELL, V18, P3463, DOI 10.1091/mbc.E07-03-0193; Kramer L, 2011, MOL BIOL CELL, V22, P2601, DOI 10.1091/mbc.E11-02-0104; Kweon Y, 2003, MOL BIOL CELL, V14, P1868, DOI 10.1091/mbc.E02-10-0687; Laage R, 2001, MOL BIOL CELL, V12, P3375, DOI 10.1091/mbc.12.11.3375; Lewis MJ, 1997, EMBO J, V16, P3017, DOI 10.1093/emboj/16.11.3017; Lewis MJ, 2002, TRAFFIC, V3, P922, DOI 10.1034/j.1600-0854.2002.31207.x; Lewis MJ, 2000, MOL BIOL CELL, V11, P23, DOI 10.1091/mbc.11.1.23; Luo L, 2011, MOL BIOL CELL, V22, P2564, DOI 10.1091/mbc.E10-06-0493; Lupashin VV, 1997, MOL BIOL CELL, V8, P2659, DOI 10.1091/mbc.8.12.2659; McNew JA, 1997, J BIOL CHEM, V272, P17776, DOI 10.1074/jbc.272.28.17776; Meiringer CTA, 2011, J BIOL CHEM, V286, P25039, DOI 10.1074/jbc.M110.215327; Mima J, 2008, EMBO J, V27, P2031, DOI 10.1038/emboj.2008.139; NOTHWEHR SF, 1993, J CELL BIOL, V121, P1197, DOI 10.1083/jcb.121.6.1197; NOTHWEHR SF, 1995, J CELL BIOL, V129, P35, DOI 10.1083/jcb.129.1.35; Perez-Victoria FJ, 2010, MOL BIOL CELL, V21, P3386, DOI 10.1091/mbc.E10-05-0392; Pieren M, 2010, NAT STRUCT MOL BIOL, V17, P710, DOI 10.1038/nsmb.1809; Proszynski TJ, 2005, P NATL ACAD SCI USA, V102, P17981, DOI 10.1073/pnas.0509107102; PROTOPOPOV V, 1993, CELL, V74, P855, DOI 10.1016/0092-8674(93)90465-3; Reggiori F, 2003, J BIOL CHEM, V278, P5009, DOI 10.1074/jbc.M210436200; Ren Y, 2009, CELL, V139, P1119, DOI 10.1016/j.cell.2009.11.002; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Sato TK, 2000, MOL CELL, V6, P661, DOI 10.1016/S1097-2765(00)00064-2; SIKORSKI RS, 1989, GENETICS, V122, P19; Siniossoglou S, 2002, J BIOL CHEM, V277, P48318, DOI 10.1074/jbc.M209428200; Starai VJ, 2007, P NATL ACAD SCI USA, V104, P13551, DOI 10.1073/pnas.0704741104; Stein IS, 2009, BIOCHEM J, V419, P229, DOI 10.1042/BJ20081973; Tishgarten T, 1999, PROTEIN SCI, V8, P2465; Toonen RFG, 2003, TRENDS CELL BIOL, V13, P177, DOI 10.1016/S0962-8924(03)00031-X; Ungermann C, 1999, J CELL BIOL, V145, P1435, DOI 10.1083/jcb.145.7.1435; Ungermann C, 1998, NATURE, V396, P543, DOI 10.1038/25069; Valdez-Taubas J, 2005, EMBO J, V24, P2524, DOI 10.1038/sj.emboj.7600724; VATER CA, 1992, J CELL BIOL, V119, P773, DOI 10.1083/jcb.119.4.773; VOJTEK AB, 1995, METHOD ENZYMOL, V255, P331; von Mollard GF, 1998, J BIOL CHEM, V273, P2624, DOI 10.1074/jbc.273.5.2624; von Mollard GF, 1999, MOL BIOL CELL, V10, P1719, DOI 10.1091/mbc.10.6.1719; vonMollard GF, 1997, J CELL BIOL, V137, P1511, DOI 10.1083/jcb.137.7.1511; Wang J, 2011, P NATL ACAD SCI USA, V108, P12277, DOI 10.1073/pnas.1013101108; Yamaguchi T, 2002, DEV CELL, V2, P295, DOI 10.1016/S1534-5807(02)00125-9	62	6	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66304	10.1371/journal.pone.0066304	http://dx.doi.org/10.1371/journal.pone.0066304			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776654	Green Submitted, Green Published, gold			2022-12-27	WOS:000320322400095
J	Koldso, H; Autzen, HE; Grouleff, J; Schiott, B				Koldso, Heidi; Autzen, Henriette Elisabeth; Grouleff, Julie; Schiott, Birgit			Ligand Induced Conformational Changes of the Human Serotonin Transporter Revealed by Molecular Dynamics Simulations	PLOS ONE			English	Article							ANTIDEPRESSANT BINDING-SITE; BACTERIAL HOMOLOG; NEUROTRANSMITTER TRANSPORTERS; SUBSTRATE; LEUT; DOPAMINE; IBOGAINE; INHIBITOR; COCAINE; STATE	The competitive inhibitor cocaine and the non-competitive inhibitor ibogaine induce different conformational states of the human serotonin transporter. It has been shown from accessibility experiments that cocaine mainly induces an outward-facing conformation, while the non-competitive inhibitor ibogaine, and its active metabolite noribogaine, have been proposed to induce an inward-facing conformation of the human serotonin transporter similar to what has been observed for the endogenous substrate, serotonin. The ligand induced conformational changes within the human serotonin transporter caused by these three different types of ligands, substrate, non-competitive and competitive inhibitors, are studied from multiple atomistic molecular dynamics simulations initiated from a homology model of the human serotonin transporter. The results reveal that diverse conformations of the human serotonin transporter are captured from the molecular dynamics simulations depending on the type of the ligand bound. The inward-facing conformation of the human serotonin transporter is reached with noribogaine bound, and this state resembles a previously identified inward-facing conformation of the human serotonin transporter obtained from molecular dynamics simulation with bound substrate, but also a recently published inward-facing conformation of a bacterial homolog, the leucine transporter from Aquifex Aoelicus. The differences observed in ligand induced behavior are found to originate from different interaction patterns between the ligands and the protein. Such atomic-level understanding of how an inhibitor can dictate the conformational response of a transporter by ligand binding may be of great importance for future drug design.	[Koldso, Heidi; Schiott, Birgit] Aarhus Univ, Ctr Insoluble Prot Struct inSPIN, Aarhus, Denmark; [Koldso, Heidi; Schiott, Birgit] Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, Aarhus, Denmark; [Koldso, Heidi; Autzen, Henriette Elisabeth; Grouleff, Julie; Schiott, Birgit] Aarhus Univ, Dept Chem, DK-8000 Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University	Schiott, B (corresponding author), Aarhus Univ, Ctr Insoluble Prot Struct inSPIN, Aarhus, Denmark.	birgit@chem.au.dk	Autzen, Henriette Elisabeth/AAI-1084-2019; Schiott, Birgit/F-5067-2011	Autzen, Henriette Elisabeth/0000-0003-3691-5010; Schiott, Birgit/0000-0001-9937-1562	Danish Council for Independent Research \ Natural Sciences, The Danish Research Foundation [DNRF59]; Lundbeck Foundation	Danish Council for Independent Research \ Natural Sciences, The Danish Research Foundation; Lundbeck Foundation(Lundbeckfonden)	The work was supported by grants from the Danish Council for Independent Research vertical bar Natural Sciences, The Danish Research Foundation (DNRF59), and the Lundbeck Foundation. Computations were made possible through support from the Danish Center for Scientific Computing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aittoniemi J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000762; Alper KR, 1999, AM J ADDICTION, V8, P234; Andersen J, 2010, J BIOL CHEM, V285, P2051, DOI 10.1074/jbc.M109.072587; Andersen J, 2009, J BIOL CHEM, V284, P10276, DOI 10.1074/jbc.M806907200; [Anonymous], 2010, SCHROD SUIT 2010 PRO; [Anonymous], 2010, SCHROD SUIT 2010 IND; [Anonymous], 2010, MAESTR VERS 9 1; [Anonymous], 2005, IMP VERS 5 6; Banks JL, 2005, J COMPUT CHEM, V26, P1752, DOI 10.1002/jcc.20292; Baumann MH, 2001, ALKALOIDS CHEM BIOL, V56, P76; Beuming T, 2008, NAT NEUROSCI, V11, P780, DOI 10.1038/nn.2146; Beuming T, 2006, MOL PHARMACOL, V70, P1630, DOI 10.1124/mol.106.026120; Bisgaard H, 2011, NEUROPHARMACOLOGY, V60, P182, DOI 10.1016/j.neuropharm.2010.08.021; Bulling S, 2012, J BIOL CHEM, V287, P18524, DOI 10.1074/jbc.M112.343681; Celik L, 2008, J AM CHEM SOC, V130, P3853, DOI 10.1021/ja076403h; Celik L, 2008, BIOPHYS J, V94, P1600, DOI 10.1529/biophysj.107.117580; Claxton DP, 2010, NAT STRUCT MOL BIOL, V17, P822, DOI 10.1038/nsmb.1854; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Fjorback AW, 2009, BIOCHEM BIOPH RES CO, V380, P724, DOI 10.1016/j.bbrc.2009.01.128; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; GABE EJ, 1963, ACTA CRYSTALLOGR, V16, P796, DOI 10.1107/S0365110X6300205X; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Indarte M, 2008, PROTEINS, V70, P1033, DOI 10.1002/prot.21598; Jacobs MT, 2007, J BIOL CHEM, V282, P29441, DOI 10.1074/jbc.M704456200; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Jorgensen AM, 2007, CHEMMEDCHEM, V2, P827, DOI 10.1002/cmdc.200600243; Jorgensen AM, 2007, CHEMMEDCHEM, V2, P815, DOI 10.1002/cmdc.200600242; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Koldso H, 2013, ACS CHEM NEUROSCI, V4, P295, DOI 10.1021/cn300148r; Koldso H, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002246; Koldso H, 2010, J AM CHEM SOC, V132, P1311, DOI 10.1021/ja906923j; Kolossvary I, 1996, J AM CHEM SOC, V118, P5011, DOI 10.1021/ja952478m; Korkhov VM, 2006, J BIOL CHEM, V281, P13439, DOI 10.1074/jbc.M511382200; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; Kroncke BM, 2010, BIOCHEMISTRY-US, V49, P10045, DOI 10.1021/bi101148w; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Martens PF, ORIENTATION AN UNPUB; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Mash D C, 2001, Alkaloids Chem Biol, V56, P155, DOI 10.1016/S0099-9598(01)56012-5; MASH DC, 1995, LIFE SCI, V57, pPL45, DOI 10.1016/0024-3205(95)00273-9; NELSON PJ, 1979, J BIOL CHEM, V254, P84; Nnadi Charles U, 2005, J Natl Med Assoc, V97, P1504; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Plenge P, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.371765; POPIK P, 1995, PHARMACOL REV, V47, P235; Quick M, 2009, P NATL ACAD SCI USA, V106, P5563, DOI 10.1073/pnas.0811322106; RITZ MC, 1987, SCIENCE, V237, P1219, DOI 10.1126/science.2820058; RUDNICK G, 1993, BIOCHIM BIOPHYS ACTA, V1144, P249, DOI 10.1016/0005-2728(93)90109-S; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schrodinger LLC, 2010, EP VERS 2 1; Schrodinger LLC, 2010, MACROMODEL VERS 9 8; Severinsen K, 2012, ACS CHEM NEUROSCI, V3, P693, DOI 10.1021/cn300040f; Shaikh SA, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000905; Shan JF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016350; Shelley JC, 2007, J COMPUT AID MOL DES, V21, P681, DOI 10.1007/s10822-007-9133-z; SHEPPARD SG, 1994, J SUBST ABUSE TREAT, V11, P379, DOI 10.1016/0740-5472(94)90049-3; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Sinning S, 2010, J BIOL CHEM, V285, P8363, DOI 10.1074/jbc.M109.045401; Sitte HH, 2004, MOL INTERV, V4, P38, DOI 10.1124/mi.4.1.38; Sofuoglu Mehmet, 2006, Expert Opin Emerg Drugs, V11, P91, DOI 10.1517/14728214.11.1.91; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhang YW, 2006, J BIOL CHEM, V281, P36213, DOI 10.1074/jbc.M605468200; Zhao CF, 2011, BIOCHEMISTRY-US, V50, P1848, DOI 10.1021/bi101454f; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614; Zhou Z, 2009, NAT STRUCT MOL BIOL, V16, P652, DOI 10.1038/nsmb.1602	75	39	39	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e63635	10.1371/journal.pone.0063635	http://dx.doi.org/10.1371/journal.pone.0063635			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776432	Green Published, Green Submitted, gold			2022-12-27	WOS:000320322400001
J	Mansouri, D; McMillan, DC; Grant, Y; Crighton, EM; Horgan, PG				Mansouri, David; McMillan, Donald C.; Grant, Yasmin; Crighton, Emilia M.; Horgan, Paul G.			The Impact of Age, Sex and Socioeconomic Deprivation on Outcomes in a Colorectal Cancer Screening Programme	PLOS ONE			English	Article							FECAL-OCCULT-BLOOD; RANDOMIZED CONTROLLED-TRIAL; SURVIVAL; GENDER	Background: Population-based colorectal cancer screening has been shown to reduce cancer specific mortality and is used across the UK. Despite evidence that older age, male sex and deprivation are associated with an increased incidence of colorectal cancer, uptake of bowel cancer screening varies across demographic groups. The aim of this study was to assess the impact of age, sex and deprivation on outcomes throughout the screening process. Methods: A prospectively maintained database, encompassing the first screening round of a faecal occult blood test screening programme in a single geographical area, was analysed. Results: Overall, 395 096 individuals were invited to screening, 204 139 (52%) participated and 6 079 (3%) tested positive. Of the positive tests, 4 625 (76%) attended for colonoscopy and cancer was detected in 396 individuals (9%). Lower uptake of screening was associated with younger age, male sex and deprivation (all p<0.001). Only deprivation was associated with failure to proceed to colonoscopy following a positive test (p<0.001). Despite higher positivity rates in those that were more deprived (p<0.001), the likelihood of detecting cancer in those attending for colonoscopy was lower (8% most deprived vs 10% least deprived, p = 0.003). Conclusion: Individuals who are deprived are less likely to participate in screening, less likely to undergo colonoscopy and less likely to have cancer identified as a result of a positive test. Therefore, this study suggests that strategies aimed at improving participation of deprived individuals in colorectal cancer screening should be directed at all stages of the screening process and not just uptake of the test.	[Mansouri, David; McMillan, Donald C.; Grant, Yasmin; Horgan, Paul G.] Univ Glasgow, Glasgow Royal Infirm, Sch Med, Acad Surg Unit, Glasgow G31 2ER, Lanark, Scotland; [Crighton, Emilia M.] Gartnaval Royal Hosp, NHS Greater Glasgow & Clyde, Publ Hlth Directorate, Glasgow, Lanark, Scotland	University of Glasgow; Gartnavel Royal Hospital	Mansouri, D (corresponding author), Univ Glasgow, Glasgow Royal Infirm, Sch Med, Acad Surg Unit, Glasgow G31 2ER, Lanark, Scotland.	David.Mansouri@glasgow.ac.uk		McMillan, Donald/0000-0003-4260-5334				Allard J, 2010, CAN J GASTROENTEROL, V24, P113, DOI 10.1155/2010/516363; Atkin WS, 2002, LANCET, V359, P1291, DOI 10.1016/s0140-6736(02)08268-5; Atkin WS, 2002, GUT, V51, pV6, DOI 10.1136/gut.51.suppl_5.v6; Bretthauer M, 2011, J INTERN MED, V270, P87, DOI 10.1111/j.1365-2796.2011.02399.x; DUKES CE, 1958, BRIT J CANCER, V12, P309, DOI 10.1038/bjc.1958.37; Fraser CG, 2012, J MED SCREEN, V19, P8, DOI 10.1258/jms.2011.011098; Harmston C, 2010, COLORECTAL DIS, V12, P416, DOI 10.1111/j.1463-1318.2009.01804.x; Hewitson P, 2008, AM J GASTROENTEROL, V103, P1541, DOI 10.1111/j.1572-0241.2008.01875.x; Hole DJ, 2002, BRIT J SURG, V89, P586, DOI 10.1046/j.1365-2168.2002.02073.x; Kronborg O, 1996, LANCET, V348, P1467, DOI 10.1016/S0140-6736(96)03430-7; Libby G, 2011, J MED SCREEN, V18, P24, DOI 10.1258/jms.2011.011002; Logan RFA, 2012, GUT, V61, P1439, DOI 10.1136/gutjnl-2011-300843; Mandel JS, 2000, NEW ENGL J MED, V343, P1603, DOI 10.1056/NEJM200011303432203; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; Mansouri D, 2013, CRIT REV ONCOL HEMAT, V85, P342, DOI 10.1016/j.critrevonc.2012.08.006; Morris S, 2012, BRIT J CANCER, V107, P765, DOI 10.1038/bjc.2012.303; Oliphant R, 2011, BRIT J CANCER, V104, P1791, DOI 10.1038/bjc.2011.149; Rockey DC, 1999, AM J GASTROENTEROL, V94, P344, DOI 10.1111/j.1572-0241.1999.855_r.x; Scottish Government Publication, 2009, SCOTTISH INDEX MULTI; Steele RJC, 2012, GUT, V61, P576, DOI 10.1136/gutjnl-2011-300535; Steele RJC, 2010, J MED SCREEN, V17, P68, DOI 10.1258/jms.2010.009120; Steele RJC, 2009, GUT, V58, P530, DOI 10.1136/gut.2008.162883; TURNBULL RB, 1967, ANN SURG, V166, P420; von Wagner C, 2011, INT J EPIDEMIOL, V40, P712, DOI 10.1093/ije/dyr008; Whynes DK, 2003, PUBLIC HEALTH, V117, P389, DOI 10.1016/S0033-3506(03)00146-X; Zauber AG, 2012, NEW ENGL J MED, V366, P687, DOI 10.1056/NEJMoa1100370	27	41	42	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66063	10.1371/journal.pone.0066063	http://dx.doi.org/10.1371/journal.pone.0066063			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776606	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000320322400075
J	Roth, LSV; Lind, O				Roth, Lina S. V.; Lind, Olle			The Impact of Domestication on the Chicken Optical Apparatus	PLOS ONE			English	Article							RED JUNGLEFOWL; GALLUS-GALLUS; SIZE; EYE	Domestication processes tend to release animals from natural selection and favour traits desired by humans, such as food-production and co-operative behaviour. A side effect of such selective breeding is the alteration of unintended traits. In this paper, we investigate how active selection for egg production in chickens has affected the visual system, in particular the optical sensitivity that relates to the ability of chickens to see in dim light. We measured eye dimensions as well as the pupil diameter at different light intensities (the steady state pupil dynamics), in adult male and female White Leghorns and the closest relatives to their ancestor, the Red Junglefowls. With this information, we calculated the focal length and optical sensitivity (f-number) of the eyes. Males have larger eyes than females in both breeds and White Leghorn eyes are larger than those of Red Junglefowls in both sexes. The steady state pupil dynamics is less variable, however, the combination of pupil dynamics and eye size gives a higher optical sensitivity in Red Junglefowl eyes than in White Leghorns at light intensities below approximately 10 cd/m(2). While eye size and focal length match the larger body size in White Leghorns compared to Red Junglefowls, the steady state pupil dynamics do not. The reason for this is likely to be that eye morphology and the neuro-muscular control of the pupil have been affected differently by the strong selection for egg production and the simultaneous release of the selection pressure for high performing vision. This study is the first description of how optical sensitivity has changed in a domesticated species and our results demonstrate important considerations regarding domestication processes and sensory ability.	[Roth, Lina S. V.] Linkoping Univ, Dept Phys Chem & Biol, Linkoping, Sweden; [Lind, Olle] Lund Univ, Dept Biol, Lund, Sweden	Linkoping University; Lund University	Roth, LSV (corresponding author), Linkoping Univ, Dept Phys Chem & Biol, Linkoping, Sweden.	linaroth@ifm.liu.se	Roth, Lina S.V./J-6272-2019	Roth, Lina S V/0000-0002-3297-1130				Al-Nasser A, 2007, WORLD POULTRY SCI J, V63, P285, DOI 10.1017/S004393390700147X; Clutton-Brook J, 1981, DOMESTICATED ANIMALS; Evans KE, 2007, ANAT HISTOL EMBRYOL, V36, P151, DOI 10.1111/j.1439-0264.2006.00749.x; Howland HC, 2004, VISION RES, V44, P2043, DOI 10.1016/j.visres.2004.03.023; Jarvis JR, 2002, VISION RES, V42, P99, DOI 10.1016/S0042-6989(01)00268-1; Kerje S, 2003, ANIM GENET, V34, P264, DOI 10.1046/j.1365-2052.2003.01000.x; Land MF, 2002, ANIMAL EYES; LILJEDAHL LE, 1979, ACTA AGR SCAND, V29, P273, DOI 10.1080/00015127909435238; Lind O, 2009, J EXP BIOL, V212, P3693, DOI 10.1242/jeb.035477; Lisney TJ, 2012, J COMP PHYSIOL A, V198, P717, DOI 10.1007/s00359-012-0742-1; Lisney TJ, 2011, VISION RES, V51, P1324, DOI 10.1016/j.visres.2011.04.009; MARTIN GR, 1982, J COMP PHYSIOL, V145, P341, DOI 10.1007/BF00619338; McGreevy P, 2004, BRAIN BEHAV EVOLUT, V63, P13, DOI 10.1159/000073756; Rubene D, 2010, J EXP BIOL, V213, P3357, DOI 10.1242/jeb.042424; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schutz KE, 2001, ETHOLOGY, V107, P753, DOI 10.1046/j.1439-0310.2001.00703.x; Trut LN, 1999, AM SCI, V87, P160, DOI 10.1511/1999.20.813; WEST B, 1988, J ARCHAEOL SCI, V15, P515, DOI 10.1016/0305-4403(88)90080-5	18	12	12	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65509	10.1371/journal.pone.0065509	http://dx.doi.org/10.1371/journal.pone.0065509			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776492	gold, Green Published, Green Submitted			2022-12-27	WOS:000320322400030
J	Zhang, ZH; Lu, YY; Yue, JB				Zhang, Zhe-Hao; Lu, Ying-Ying; Yue, Jianbo			Two Pore Channel 2 Differentially Modulates Neural Differentiation of Mouse Embryonic Stem Cells	PLOS ONE			English	Article							ADENINE-DINUCLEOTIDE PHOSPHATE; CYCLIC ADP-RIBOSE; NEURONAL DIFFERENTIATION; 2-PORE CHANNELS; CA2+ STORES; IN-VITRO; PARKINSONS-DISEASE; RELEASE CHANNEL; BETA-CELLS; ES CELLS	Nicotinic acid adenine dinucleotide phosphate (NAADP) is an endogenous Ca2+ mobilizing nucleotide presented in various species. NAADP mobilizes Ca2+ from acidic organelles through two pore channel 2 (TPC2) in many cell types and it has been previously shown that NAADP can potently induce neuronal differentiation in PC12 cells. Here we examined the role of TPC2 signaling in the neural differentiation of mouse embryonic stem (ES) cells. We found that the expression of TPC2 was markedly decreased during the initial ES cell entry into neural progenitors, and the levels of TPC2 gradually rebounded during the late stages of neurogenesis. Correspondingly, TPC2 knockdown accelerated mouse ES cell differentiation into neural progenitors but inhibited these neural progenitors from committing to neurons. Overexpression of TPC2, on the other hand, inhibited mouse ES cell from entering the early neural lineage. Interestingly, TPC2 knockdown had no effect on the differentiation of astrocytes and oligodendrocytes of mouse ES cells. Taken together, our data indicate that TPC2 signaling plays a temporal and differential role in modulating the neural lineage entry of mouse ES cells, in that TPC2 signaling inhibits ES cell entry to early neural progenitors, but is required for late neuronal differentiation.	[Zhang, Zhe-Hao; Lu, Ying-Ying; Yue, Jianbo] Univ Hong Kong, Dept Physiol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Yue, JB (corresponding author), Univ Hong Kong, Dept Physiol, Hong Kong, Hong Kong, Peoples R China.	jyue@hku.hk	Yue, Jianbo/AAC-4588-2019; Yue, Jianbo/K-8002-2015	Yue, Jianbo/0000-0001-6384-5447; Lu, Yingying/0000-0002-5423-9522	Research Grant Council (RGC) [HKU 782709M, HKU 785911M]; Leukemia and Lymphoma Society of America	Research Grant Council (RGC)(Hong Kong Research Grants Council); Leukemia and Lymphoma Society of America(Leukemia and Lymphoma Society)	This work was supported by Research Grant Council (RGC) grants (HKU 782709M and HKU 785911M), and a Special Fellow Award from the Leukemia and Lymphoma Society of America (J.Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aley PK, 2010, P NATL ACAD SCI USA, V107, P19927, DOI 10.1073/pnas.1007381107; BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085; Bain G., 2000, Functional and Integrative Genomics, V1, P127, DOI 10.1007/s101420000014; Bak J, 1999, CURR BIOL, V9, P751, DOI 10.1016/S0960-9822(99)80335-2; Beck A, 2006, FASEB J, V20, P962, DOI 10.1096/fj.05-5538fje; Berg I, 2000, J CELL BIOL, V150, P581, DOI 10.1083/jcb.150.3.581; BERRIDGE MJ, 1988, FASEB J, V2, P3074, DOI 10.1096/fasebj.2.15.2847949; Bezin S, 2006, J PHYSIOLOGY-PARIS, V99, P111, DOI 10.1016/j.jphysparis.2005.12.007; Bezin S, 2008, J BIOL CHEM, V283, P27859, DOI 10.1074/jbc.M804701200; Brailoiu E, 2005, J BIOL CHEM, V280, P5646, DOI 10.1074/jbc.M408746200; Brailoiu E, 2006, J BIOL CHEM, V281, P15923, DOI 10.1074/jbc.M602249200; Brailoiu E, 2009, J CELL BIOL, V186, P201, DOI 10.1083/jcb.200904073; Brailoiu GC, 2010, J BIOL CHEM, V285, P37133, DOI 10.1074/jbc.C110.169763; Brailoiu GC, 2009, BIOCHEM J, V419, P91, DOI 10.1042/BJ20081138; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Cang CL, 2013, CELL, V152, P778, DOI 10.1016/j.cell.2013.01.023; Chan YS, 2011, PROG DRUG RES, V67, P239, DOI 10.1007/978-3-7643-8989-5_12; Churamani D, 2012, BIOCHEM J, V441, P317, DOI 10.1042/BJ20111617; Churchill GC, 2003, CURR BIOL, V13, P125, DOI 10.1016/S0960-9822(03)00002-2; Dammermann W, 2009, P NATL ACAD SCI USA, V106, P10678, DOI 10.1073/pnas.0809997106; Davis LC, 2012, CURR BIOL; Debnath J, 2005, AUTOPHAGY, V1, P66, DOI 10.4161/auto.1.2.1738; Durlu-Kandilci NT, 2010, J BIOL CHEM, V285, P24925, DOI 10.1074/jbc.M110.129833; Galione A, 2002, CELL CALCIUM, V32, P343, DOI 10.1016/S0143416002001902; Gaspard N, 2008, NATURE, V455, P351, DOI 10.1038/nature07287; Gaspard N, 2009, NAT PROTOC, V4, P1454, DOI 10.1038/nprot.2009.157; Guse AH, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002890; Guse AH, 2009, CURR BIOL, V19, pR521, DOI 10.1016/j.cub.2009.05.045; Harr MW, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005579; Heidemann AC, 2005, J BIOL CHEM, V280, P35630, DOI 10.1074/jbc.M507338200; Hooper R, 2011, J BIOL CHEM, V286, P9141, DOI 10.1074/jbc.M110.189985; Kagalwala MN, 2008, COLD SH Q B, V73, P227, DOI 10.1101/sqb.2008.73.042; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Kawasaki H, 2002, Methods Mol Biol, V185, P217; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; Lee HC, 2004, CURR MOL MED, V4, P227, DOI 10.2174/1566524043360753; Lee HC, 2012, J BIOL CHEM, V287, P31633, DOI 10.1074/jbc.R112.349464; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; Li HW, 2009, BMC NEUROSCI, V10, DOI [10.1186/1471-2202-10-122, 10.1186/1471-2105-10-418]; Li S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031905; Lin-Moshier Y, 2012, J BIOL CHEM, V287, P2296, DOI 10.1074/jbc.M111.305813; Lopez JJ, 2006, CELL SIGNAL, V18, P373, DOI 10.1016/j.cellsig.2005.05.006; Macgregor A, 2007, J BIOL CHEM, V282, P15302, DOI 10.1074/jbc.M611167200; MALTSEV VA, 1994, CIRC RES, V75, P233, DOI 10.1161/01.RES.75.2.233; Masgrau R, 2003, CURR BIOL, V13, P247, DOI 10.1016/S0960-9822(03)00041-1; Moccia F, 2004, CELL CALCIUM, V36, P515, DOI 10.1016/j.ceca.2004.05.004; Pandey V, 2009, BIOCHEM J, V422, P503, DOI 10.1042/BJ20090194; Parkesh R, 2008, CELL CALCIUM, V43, P531, DOI 10.1016/j.ceca.2007.08.006; Patel S, 2010, CELL CALCIUM, V47, P480, DOI 10.1016/j.ceca.2010.05.001; Pitt SJ, 2010, J BIOL CHEM, V285, P35039, DOI 10.1074/jbc.M110.156927; Resende RR, 2008, CELL CALCIUM, V43, P107, DOI 10.1016/j.ceca.2007.04.007; Resende RR, 2010, STEM CELLS DEV, V19, P379, DOI 10.1089/scd.2008.0289; Rietdorf K, 2011, J BIOL CHEM; Ruas M, 2010, CURR BIOL, V20, P703, DOI 10.1016/j.cub.2010.02.049; Shi FX, 2007, EUR J NEUROSCI, V26, P3016, DOI 10.1111/j.1460-9568.2007.05909.x; Walseth TF, 2012, J BIOL CHEM, V287, P2308, DOI 10.1074/jbc.M111.306563; Wang X, 2012, CELL, V151, P372, DOI 10.1016/j.cell.2012.08.036; Wei WJ, 2012, J BIOL CHEM, V287, P35599, DOI 10.1074/jbc.M112.392530; Wong CK, 2012, J CELL PHYSIOL, V227, P2519, DOI 10.1002/jcp.22990; Yamasaki M, 2004, J BIOL CHEM, V279, P7234, DOI 10.1074/jbc.M311088200; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Ying QL, 2003, METHOD ENZYMOL, V365, P327; Yu PL, 2012, J BIOL CHEM, V287, P24774, DOI 10.1074/jbc.M111.329854; Yu PL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051028; Yue JB, 2006, MOL CELL BIOL, V26, P5300, DOI 10.1128/MCB.00273-06; Yue JB, 2009, J BIOL CHEM, V284, P29335, DOI 10.1074/jbc.M109.049767; Zhang F, 2007, J BIOL CHEM, V282, P25259, DOI 10.1074/jbc.M701614200; Zhang F, 2009, J CELL MOL MED, V13, P3174, DOI 10.1111/j.1582-4934.2008.00486.x; Zong XG, 2009, PFLUG ARCH EUR J PHY, V458, P891, DOI 10.1007/s00424-009-0690-y	69	33	36	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66077	10.1371/journal.pone.0066077	http://dx.doi.org/10.1371/journal.pone.0066077			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776607	Green Published, Green Submitted, gold			2022-12-27	WOS:000320322400076
J	Gao, Y; Chen, G; Tian, HM; Lin, LX; Lu, JM; Weng, JP; Jia, WP; Ji, LN; Xiao, JZ; Zhou, ZG; Ran, XW; Ren, Y; Chen, T; Yang, WY				Gao, Yun; Chen, Gang; Tian, Haoming; Lin, Lixiang; Lu, Juming; Weng, Jianping; Jia, Weiping; Ji, Linong; Xiao, Jianzhong; Zhou, Zhiguang; Ran, Xingwu; Ren, Yan; Chen, Tao; Yang, Wenying		China Natl Diabet Metab Disorders	Prevalence of Hypertension in China: A Cross-Sectional Study	PLOS ONE			English	Article							OBESITY; NUTRITION; AWARENESS; OVERWEIGHT; HEALTH; TRENDS; WOMEN; MEN	Aims: The present study aimed to assess the prevalence of hypertension among Chinese adults. Methods: Data were obtained from sphygmomanometer measurements and a questionnaire administered to 46239 Chinese adults >= 20 years of age who participated in the 2007-2008 China National Diabetes and Metabolic Disorders Study. Hypertension was defined as blood pressure >= 140/90 mm Hg or use of antihypertensive medication. Results: A total of 26.6% of Chinese adults had hypertension, and a significantly greater number of men were hypertensive than women (29.2% vs 24.1%, p<0.001). The age-specific prevalence of hypertension was 13.0%, 36.7%, and 56.5% among persons aged 20 to 44 years (young people), 45 to 64 years (middle-aged people), and >= 65 years (elderly people), respectively. In economically developed regions, the prevalence of hypertension was significantly higher among rural residents than among urban residents (31.3% vs 29.2%, p = 0.001). Among women or individuals who lived in the northern region, the disparity in the prevalence of hypertension between urban and rural areas disappeared (women: 24.0% vs. 24.0%, p = 0.942; northern region: 31.6% vs. 31.2%, p = 0.505). Among hypertensive patients, 45.0% were aware of their condition, 36.2% were treated, and 11.1% were adequately controlled. Conclusions: The prevalence of hypertension in China is increasing. The trend of an increase in prevalence is striking in young people and rural populations. Hypertension awareness, treatment, and control are poor. Public health efforts for further improving awareness and enhancing effective control are urgently needed in China, especially in emerging populations.	[Gao, Yun; Tian, Haoming; Ran, Xingwu; Ren, Yan; Chen, Tao] Sichuan Univ, Dept Endocrinol, West China Hosp, Chengdu 610064, Peoples R China; [Chen, Gang; Lin, Lixiang] Fujian Prov Hosp, Dept Endocrinol, Fuzhou, Peoples R China; [Lu, Juming] Chinese Peoples Liberat Army Gen Hosp, Dept Endocrinol, Beijing, Peoples R China; [Weng, Jianping] Sun Yat Sen Univ, Hosp 3, Dept Endocrinol, Guangzhou 510275, Guangdong, Peoples R China; [Jia, Weiping] Shanghai Jiao Tong Univ, Dept Endocrinol, Affiliated Peoples Hosp 6, Shanghai 200030, Peoples R China; [Ji, Linong] Peking Univ, Peoples Hosp, Dept Endocrinol, Beijing 100871, Peoples R China; [Xiao, Jianzhong; Yang, Wenying] China Japan Friendship Hosp, Dept Endocrinol, Beijing, Peoples R China; [Zhou, Zhiguang] Xiangya Second Hosp, Dept Endocrinol, Changsha, Hunan, Peoples R China	Sichuan University; Fujian Provincial Hospital; Chinese People's Liberation Army General Hospital; Sun Yat Sen University; Shanghai Jiao Tong University; Peking University; China-Japan Friendship Hospital; Central South University	Yang, WY (corresponding author), China Japan Friendship Hosp, Dept Endocrinol, Beijing, Peoples R China.	ywy_1010@yahoo.com.cn	Linong, Ji/AAB-6543-2020	Weng, Jianping/0000-0002-7889-1697; Zhou, Zhiguang/0000-0002-0374-1838	Chinese Medical Association Foundation; Chinese Diabetes Society [07020470055]	Chinese Medical Association Foundation; Chinese Diabetes Society	This project was Supported by grants from the Chinese Medical Association Foundation and Chinese Diabetes Society (No. 07020470055). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BURT VL, 1995, HYPERTENSION, V25, P305, DOI 10.1161/01.HYP.25.3.305; Cheung Bernard M Y, 2006, J Clin Hypertens (Greenwich), V8, P93, DOI 10.1111/j.1524-6175.2006.04895.x; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Dahlof B, 2007, AM J CARDIOL, V100, p17J, DOI 10.1016/j.amjcard.2007.05.010; Department of Noncommunicable Disease Surveillance, 1999, DEF DIAGN CLASS DI 1; Guo FJ, 2012, J AM COLL CARDIOL, V60, P599, DOI 10.1016/j.jacc.2012.04.026; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; He J, 1996, AM J HYPERTENS, V9, p74A, DOI DOI 10.1016/0895-7061(96)81695-5; Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177; Ji Cheng-ye, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P103; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Levine JA, 2008, CHINESE MED J-PEKING, V121, P1043, DOI 10.1097/00029330-200806010-00015; Luepker R. V., 2004, Cardiovascular survey methods; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Messerli FH, 2007, LANCET, V370, P591, DOI 10.1016/S0140-6736(07)61299-9; National Bureau of Statistics of China, 2006, CHIN STAT YB 2006; Popkin BM, 2004, INT J OBESITY, V28, pS2, DOI [10.1038/sj.ijo.0802804, 10.1038/sj.ijo.0802557]; Reynolds K, 2003, J HYPERTENS, V21, P1273, DOI 10.1097/00004872-200307000-00014; Roger Veronique L, 2011, Circulation, V123, pe18, DOI 10.1161/CIR.0b013e3182009701; Toft I, 1998, METABOLISM, V47, P848, DOI 10.1016/S0026-0495(98)90125-1; Uauy R., 2004, OBES REV S1, V5, P4, DOI [10.1111/j.1467-789X.2004.00133.x, DOI 10.1111/J.1467-789X.2004.00133.X]; Wang Zhihong, 2008, Wei Sheng Yan Jiu, V37, P62; Wu XG, 1995, INT J CARDIOL, V52, P39, DOI 10.1016/0167-5273(95)02443-Z; Wu YF, 2006, BMJ-BRIT MED J, V333, P362, DOI 10.1136/bmj.333.7564.362; Wu YF, 2008, CIRCULATION, V118, P2679, DOI 10.1161/CIRCULATIONAHA.108.788166; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292	26	170	200	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65938	10.1371/journal.pone.0065938	http://dx.doi.org/10.1371/journal.pone.0065938			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776574	Green Published, gold, Green Submitted			2022-12-27	WOS:000320755400085
J	Sabbatini, ME; Williams, JA				Sabbatini, Maria Eugenia; Williams, John A.			Cholecystokinin-Mediated RhoGDI Phosphorylation via PKC alpha Promotes both RhoA and Rac1 Signaling	PLOS ONE			English	Article							PROTEIN-KINASE-C; GDP-DISSOCIATION INHIBITOR; PANCREATIC ACINAR-CELLS; INDUCED AMYLASE RELEASE; ACTIVATION; EXOCYTOSIS; DELTA; GTPASE; TRANSLOCATION; G-ALPHA(13)	RhoA and Rac1 have been implicated in the mechanism of CCK-induced amylase secretion from pancreatic acini. In all cell types studied to date, inactive Rho GTPases are present in the cytosol bound to the guanine nucleotide dissociation inhibitor RhoGDI. Here, we identified the switch mechanism regulating RhoGDI1-Rho GTPase dissociation and RhoA translocation upon CCK stimulation in pancreatic acini. We found that both G alpha 13 and PKC, independently, regulate CCK-induced RhoA translocation and that the PKC isoform involved is PKC alpha. Both RhoGDI1 and RhoGDI3, but not RhoGDI2, are expressed in pancreatic acini. Cytosolic RhoA and Rac1 are associated with RhoGDI1, and CCK-stimulated PKC alpha activation releases the complex. Overexpression of RhoGDI1, by binding RhoA, inhibits its activation, and thereby, CCK-induced apical amylase secretion. RhoA translocation is also inhibited by RhoGDI1. Inactive Rac1 influences CCK-induced RhoA activation by preventing RhoGDI1 from binding RhoA. By mutational analysis we found that CCK-induced PKC alpha phosphorylation on RhoGDI1 at Ser96 releases RhoA and Rac1 from RhoGDI1 to facilitate Rho GTPases signaling.	[Sabbatini, Maria Eugenia; Williams, John A.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Sabbatini, ME (corresponding author), Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.	mesabba@umich.edu		Williams, John/0000-0002-6063-7615; Sabbatini, Maria Eugenia/0000-0001-7100-2482	NIH [R37 DK-041122]; Protein Identification and Localization Core of the Michigan Gastrointestinal Peptide Center [P30 DK-34933]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034933, R37DK041122, P30DK020572] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Protein Identification and Localization Core of the Michigan Gastrointestinal Peptide Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grant R37 DK-041122 to JAW and by the Protein Identification and Localization Core of the Michigan Gastrointestinal Peptide Center (P30 DK-34933). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adra CN, 1997, P NATL ACAD SCI USA, V94, P4279, DOI 10.1073/pnas.94.9.4279; [Anonymous], 2012, PHYSL GASTROINTESTIN; Bi Y, 2005, AM J PHYSIOL-GASTR L, V289, pG561, DOI 10.1152/ajpgi.00508.2004; Bi Y, 2005, AM J PHYSIOL-CELL PH, V289, pC22, DOI 10.1152/ajpcell.00395.2004; Braz JC, 2002, J CELL BIOL, V156, P905, DOI 10.1083/jcb.200108062; Brunet N, 2002, TRAFFIC, V3, P342, DOI 10.1034/j.1600-0854.2002.30504.x; Chen L, 2001, P NATL ACAD SCI USA, V98, P11114, DOI 10.1073/pnas.191369098; Chen YC, 2005, EXP BIOL MED, V230, P731, DOI 10.1177/153537020523001006; Chen Z, 2003, J BIOL CHEM, V278, P9912, DOI 10.1074/jbc.M212695200; Chianale F, 2010, P NATL ACAD SCI USA, V107, P4182, DOI 10.1073/pnas.0908326107; Cosen-Binker LI, 2007, J BIOL CHEM, V282, P13047, DOI 10.1074/jbc.M611132200; DerMardirossian C, 2004, MOL CELL, V15, P117, DOI 10.1016/j.molcel.2004.05.019; DerMardirossian C, 2006, MOL BIOL CELL, V17, P4760, DOI 10.1091/mbc.E06-06-0533; DerMardirossian CM, 2006, METHOD ENZYMOL, V406, P80, DOI 10.1016/S0076-6879(06)06007-1; Dorn GW, 1999, P NATL ACAD SCI USA, V96, P12798, DOI 10.1073/pnas.96.22.12798; Dovas A, 2005, BIOCHEM J, V390, P1, DOI 10.1042/BJ20050104; Dovas A, 2010, J BIOL CHEM, V285, P23294, DOI 10.1074/jbc.M109.098129; Elfenbein A, 2009, J CELL BIOL, V186, P75, DOI 10.1083/jcb.200810179; Forget MA, 2002, BIOCHEM J, V361, P243, DOI 10.1042/0264-6021:3610243; Garcia-Mata R, 2011, NAT REV MOL CELL BIO, V12, P493, DOI 10.1038/nrm3153; Guilluy C, 2008, CIRC RES, V102, P1265, DOI 10.1161/CIRCRESAHA.107.164764; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; HORI Y, 1991, ONCOGENE, V6, P515; Kelly P, 2006, J BIOL CHEM, V281, P26483, DOI 10.1074/jbc.M604376200; Knezevic N, 2007, MOL CELL BIOL, V27, P6323, DOI 10.1128/MCB.00523-07; Kuribayashi K, 2007, J CELL BIOL, V176, P1049, DOI 10.1083/jcb.200607019; Lang P, 1996, EMBO J, V15, P510, DOI 10.1002/j.1460-2075.1996.tb00383.x; Li CW, 2004, AM J PHYSIOL-GASTR L, V287, pG764, DOI 10.1152/ajpgi.00111.2004; Li QW, 2003, J PHYSIOL-LONDON, V550, P431, DOI 10.1113/jphysiol.2003.039073; Mariot P, 1996, EMBO J, V15, P6476, DOI 10.1002/j.1460-2075.1996.tb01038.x; MUALLEM S, 1995, J CELL BIOL, V128, P589, DOI 10.1083/jcb.128.4.589; Nemoto T, 2004, J BIOL CHEM, V279, P37544, DOI 10.1074/jbc.M403976200; Price LS, 2003, J BIOL CHEM, V278, P39413, DOI 10.1074/jbc.M302083200; Qiao J, 2003, AM J PHYSIOL-LUNG C, V284, pL972, DOI 10.1152/ajplung.00429.2002; Qiao J, 2008, AM J PHYSIOL-CELL PH, V295, pC1161, DOI 10.1152/ajpcell.00139.2008; Sabbatini ME, 2010, AM J PHYSIOL-CELL PH, V298, pC592, DOI 10.1152/ajpcell.00448.2009; Satoh A, 2004, AM J PHYSIOL-GASTR L, V287, pG582, DOI 10.1152/ajpgi.00087.2004; Sauzeau V, 2000, J BIOL CHEM, V275, P21722, DOI 10.1074/jbc.M000753200; Thrower EC, 2009, PANCREAS, V38, P930, DOI 10.1097/MPA.0b013e3181b8476a; Wang ZX, 2010, J BIOL CHEM, V285, P6186, DOI 10.1074/jbc.M109.072421	40	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66029	10.1371/journal.pone.0066029	http://dx.doi.org/10.1371/journal.pone.0066029			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776598	Green Published, Green Submitted, gold			2022-12-27	WOS:000320755400103
J	Sanoja, C; Carbajosa, S; Fresno, M; Girones, N				Sanoja, Cristina; Carbajosa, Sofia; Fresno, Manuel; Girones, Nuria			Analysis of the Dynamics of Infiltrating CD4(+) T Cell Subsets in the Heart during Experimental Trypanosoma cruzi Infection	PLOS ONE			English	Article							HUMAN CHAGAS-DISEASE; NITRIC-OXIDE SYNTHASE; IMMUNE-RESPONSES; BLOOD-SAMPLES; LIMITED ROLE; ACUTE-PHASE; MICE; RESISTANCE; DEFICIENT; MECHANISM	Chagas disease, caused by the protozoan parasite Trypanosoma cruzi, affects several million people in Latin America. Myocarditis, observed during both the acute and chronic phases of the disease, is characterized by an inammatory mononuclear cell infiltrate that includes CD4(+) T cells. It is known that Th1 cytokines help to control infection. The role that T-reg and Th17 cells may play in disease outcome, however, has not been completely elucidated. We performed a comparative study of the dynamics of CD4(+) T cell subsets after infection with the T. cruzi Y strain during both the acute and chronic phases of the disease using susceptible BALB/c and non-susceptible C57BL/6 mice infected with high or low parasite inocula. During the acute phase, infected C57BL/6 mice showed high levels of CD4(+) T cell infiltration and expression of Th1 cytokines in the heart associated with the presence of T-reg cells. In contrast, infected BALB/c mice had a high heart parasite burden, low heart CD4(+) T cell infiltration and low levels of Th1 and inflammatory cytokines, but with an increased presence of Th17 cells. Moreover, an increase in the expression of IL-6 in susceptible mice was associated with lethality upon infection with a high parasite load. Chronically infected BALB/c mice continued to present higher parasite burdens than C57BL/6 mice and also higher levels of IFN-gamma, TNF, IL-10 and TGF-beta. Thus, the regulation of the Th1 response by T-reg cells in the acute phase may play a protective role in non-susceptible mice irrespective of parasite numbers. On the other hand, Th17 cells may protect susceptible mice at low levels of infection, but could, in association with IL-6, be pathogenic at high parasite loads.	[Sanoja, Cristina] Cent Univ Venezuela, Inst Expt Biol, Caracas, Venezuela; [Carbajosa, Sofia; Fresno, Manuel; Girones, Nuria] Univ Autonoma Madrid, CBMSO, CSIC, Madrid, Spain; [Fresno, Manuel; Girones, Nuria] Inst Invest Sanitaria Princesa IP, Madrid, Spain	University of Central Venezuela; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Girones, N (corresponding author), Univ Autonoma Madrid, CBMSO, CSIC, Madrid, Spain.	ngirones@cbm.uam.es	Gironès, Núria/AAR-7436-2020; Carbajosa, Sofía/AAB-1554-2020; Girones, Nuria/L-7865-2017	Gironès, Núria/0000-0002-8130-2750; Girones, Nuria/0000-0002-8130-2750; Carbajosa Gonzalez, Sofia/0000-0002-0133-8287; Girones Pujol, Nuria/0000-0002-0932-5018; Fresno Escudero, Manuel/0000-0002-9223-5477	Ministerio de Ciencia y Tecnologia [SAF2007-61716, SAF2005-02220]; Fondo de Investigaciones Sanitarias [PS09/00538]; Red Tematica de Investigacion en Enfermedades cardiovasculares [RECAVA RD06/0014/1013]; Red de Investigacion de Centros de Enfermedades Tropicales [RICET RD06/0021/0016]; European Union [HEALTH-FE-2008-22303]; Universidad Autonoma de Madrid; Comunidad de Madrid [CC08-UAM/SAL-4440/08]; AECID cooperation with Argentine [A/025417/09]; Fundacion Ramon Areces; "Consejo de Desarrollo Cientifico y Humanistico" de la Universidad Central de Venezuela; Spanish "Ministerio de Ciencia y Tecnologia"	Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Red Tematica de Investigacion en Enfermedades cardiovasculares; Red de Investigacion de Centros de Enfermedades Tropicales; European Union(European Commission); Universidad Autonoma de Madrid; Comunidad de Madrid(Comunidad de Madrid); AECID cooperation with Argentine; Fundacion Ramon Areces; "Consejo de Desarrollo Cientifico y Humanistico" de la Universidad Central de Venezuela; Spanish "Ministerio de Ciencia y Tecnologia"(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by "Ministerio de Ciencia y Tecnologia" (SAF2007-61716; SAF2005-02220); "Fondo de Investigaciones Sanitarias" (PS09/00538); "Red Tematica de Investigacion en Enfermedades cardiovasculares" (RECAVA RD06/0014/1013); "Red de Investigacion de Centros de Enfermedades Tropicales" (RICET RD06/0021/0016); European Union (HEALTH-FE-2008-22303, ChagasEpiNet); "Universidad Autonoma de Madrid" and "Comunidad de Madrid" (CC08-UAM/SAL-4440/08); AECID cooperation with Argentine (A/025417/09) and "Fundacion Ramon Areces". M. Fresno and N. Girones are professors at the "Biologia Molecular" Department ("Universidad Autonoma de Madrid"). C. Sanoja was recipient of a fellowship financed by "Consejo de Desarrollo Cientifico y Humanistico" de la Universidad Central de Venezuela. S. Carbajosa was recipient of an FPI fellowship financed by Spanish "Ministerio de Ciencia y Tecnologia". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsohn IA, 2000, INFECT IMMUN, V68, P1975, DOI 10.1128/IAI.68.4.1975-1979.2000; AGUS DB, 1991, J EXP MED, V173, P1039, DOI 10.1084/jem.173.5.1039; Aliberti JCS, 2001, AM J PATHOL, V158, P1433, DOI 10.1016/S0002-9440(10)64094-1; Andrade LO, 2002, EXP PARASITOL, V100, P269, DOI 10.1016/S0014-4894(02)00024-3; ANDRADE V, 1985, BRAZ J MED BIOL RES, V18, P499; [Anonymous], 1986, COUNC DIR CONV PROT; Antonio CSE, 2008, MOL IMMUNOL, V45, P3580, DOI 10.1016/j.molimm.2008.05.004; Araujo FF, 2007, FRONT BIOSCI-LANDMRK, V12, P2797, DOI 10.2741/2273; Baldeviano GC, 2010, CIRC RES, V106, P1646, DOI 10.1161/CIRCRESAHA.109.213157; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; BRENER Z., 1962, REV INST MED TROP SAO PAULO, V4, P389; Cuervo H, 2008, J INFECT DIS, V197, P1772, DOI 10.1086/529527; Cuervo H, 2011, J IMMUNOL, V187, P2656, DOI 10.4049/jimmunol.1002928; Guedes PMD, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000604; de Araujo FF, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000992; de Meis J, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000417; Dutra WO, 2009, MEM I OSWALDO CRUZ, V104, P208, DOI 10.1590/S0074-02762009000900027; Gao WD, 2002, INT J PARASITOL, V32, P167, DOI 10.1016/S0020-7519(01)00322-8; GAZZINELLI RT, 1992, EUR J IMMUNOL, V22, P2501, DOI 10.1002/eji.1830221006; Girones N, 2005, CURR TOP MICROBIOL, V296, P89; Girones N, 2003, TRENDS PARASITOL, V19, P19, DOI 10.1016/S1471-4922(02)00006-5; Holscher C, 1998, INFECT IMMUN, V66, P1208; Jager A, 2010, SCAND J IMMUNOL, V72, P173, DOI 10.1111/j.1365-3083.2010.02432.x; Kotner J, 2007, INFECT IMMUN, V75, P861, DOI 10.1128/IAI.01500-06; Laucella SA, 2004, J INFECT DIS, V189, P909, DOI 10.1086/381682; Legault J, 2012, J IMMUNOL, V188; Marcon GEB, 2002, DIAGN MICR INFEC DIS, V43, P39, DOI 10.1016/S0732-8893(02)00366-8; Mariano FS, 2008, MICROBES INFECT, V10, P825, DOI 10.1016/j.micinf.2008.04.009; Marin JA, 2007, CIRCULATION, V115, P1109, DOI 10.1161/CIRCULATIONAHA.106.624296; Guedes PMM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001630; MICHIE SA, 1988, J EXP MED, V168, P1929, DOI 10.1084/jem.168.5.1929; Miyazaki Y, 2010, J IMMUNOL, V185, P1150, DOI 10.4049/jimmunol.0900047; MUNOZFERNANDEZ MA, 1992, EUR J IMMUNOL, V22, P301, DOI 10.1002/eji.1830220203; Perez AR, 2005, LIFE SCI, V77, P1945, DOI 10.1016/j.lfs.2005.01.025; Piron M, 2007, ACTA TROP, V103, P195, DOI 10.1016/j.actatropica.2007.05.019; Perez AR, 2011, NEUROIMMUNOMODULAT, V18, P328, DOI 10.1159/000329494; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sales-Junior PA, 2008, MICROBES INFECT, V10, P680, DOI 10.1016/j.micinf.2008.03.008; Savino W, 2006, PLOS PATHOG, V2, P472, DOI 10.1371/journal.ppat.0020062; Stephens LA, 2000, J IMMUNOL, V165, P3105, DOI 10.4049/jimmunol.165.6.3105; Telleria J, 2010, AM TRYPANOSOMIASIS C, P848; Boari JT, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002658; TRISCHMANN TM, 1982, INFECT IMMUN, V35, P546, DOI 10.1128/IAI.35.2.546-551.1982; Vitelli-Avelar DM, 2005, SCAND J IMMUNOL, V62, P297, DOI 10.1111/j.1365-3083.2005.01668.x; Wynn TA, 2005, NAT IMMUNOL, V6, P1069, DOI 10.1038/ni1105-1069; Yamaguchi T, 2007, IMMUNITY, V27, P145, DOI 10.1016/j.immuni.2007.04.017	46	29	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65820	10.1371/journal.pone.0065820	http://dx.doi.org/10.1371/journal.pone.0065820			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776551	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000320755400069
J	Xu, L; Zahid, KR; He, LR; Zhang, WW; He, X; Zhang, XL; Yang, XY; Zhu, LF				Xu, Lian; Zahid, Kashif Rafiq; He, Liangrong; Zhang, Wenwen; He, Xin; Zhang, Xianlong; Yang, Xiyan; Zhu, Longfu			GhCAX3 Gene, a Novel Ca2+/H+ Exchanger from Cotton, Confers Regulation of Cold Response and ABA Induced Signal Transduction	PLOS ONE			English	Article							OSMOTIC-STRESS; CATION/H+ EXCHANGERS; ARABIDOPSIS CAX1; LOW-TEMPERATURE; PROTEIN-KINASE; ABSCISIC-ACID; EXPRESSION; CALCIUM; TOLERANCE; TOBACCO	As a second messenger, Ca2+ plays a major role in cold induced transduction via stimulus-specific increases in [Ca2+](cyt), which is called calcium signature. During this process, CAXs (Ca2+/H+ exchangers) play critical role. For the first time, a putative Ca2+/H+ exchanger GhCAX3 gene from upland cotton (Gossypium hirsutum cv. 'YZ-1') was isolated and characterized. It was highly expressed in all tissues of cotton except roots and fibers. This gene may act as a regulator in cotton's response to abiotic stresses as it could be up-regulated by Ca2+, NaCl, ABA and cold stress. Similar to other CAXs, it was proved that GhCAX3 also had Ca2+ transport activity and the N-terminal regulatory region (NRR) through yeast complementation assay. Over-expression of GhCAX3 in tobacco showed less sensitivity to ABA during seed germination and seedling stages, and the phenotypic difference between wild type (WT) and transgenic plants was more significant when the NRR was truncated. Furthermore, GhCAX3 conferred cold tolerance in yeast as well as in tobacco seedlings based on physiological and molecular studies. However, transgenic plant seeds showed more sensitivity to cold stress compared to WT during seed germination, especially when expressed in N-terminal truncated version. Finally, the extent of sensitivity in transgenic lines was more severe than that in WT line under sodium tungstate treatment (an ABA repressor), indicating that ABA could alleviate cold sensitivity of GhCAX3 seeds, especially in short of its NRR. Meanwhile, we also found that overexpression of GhCAX3 could enhance some cold and ABA responsive marker genes. Taken together, these results suggested that GhCAX3 plays important roles in the cross-talk of ABA and cold signal transduction, and compared to full-length of GhCAX3, the absence of NRR could enhance the tolerance or sensitivity to cold stress, depending on seedling's developmental stages.	[Xu, Lian; Zahid, Kashif Rafiq; He, Liangrong; Zhang, Wenwen; He, Xin; Zhang, Xianlong; Yang, Xiyan; Zhu, Longfu] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Hubei, Peoples R China; [He, Liangrong] Tarim Univ, Coll Plant Sci, Alaer, Xinjiang, Peoples R China	Huazhong Agricultural University; Tarim University	Zhu, LF (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Hubei, Peoples R China.	lfzhu@mail.hzau.edu.cn	He, Xin/C-4371-2017	He, Xin/0000-0002-8602-5166; Zhu, Longfu/0000-0002-4947-8609	Fundamental Research Funds for the Central Universities of China [2010QC034]	Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work was founded by the Department of Science and Technology of China and the Fundamental Research Funds for the Central Universities of China (2010QC034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen GJ, 2000, SCIENCE, V289, P2338, DOI 10.1126/science.289.5488.2338; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Barkla BJ, 2008, PLANT SIGNAL BEHAV, V3, P354, DOI 10.4161/psb.3.5.5600; Catala R, 2003, PLANT CELL, V15, P2940, DOI 10.1105/tpc.015248; Chen H, 2008, P NATL ACAD SCI USA, V105, P4495, DOI 10.1073/pnas.0710778105; Chinnusamy V, 2007, TRENDS PLANT SCI, V12, P444, DOI 10.1016/j.tplants.2007.07.002; Chung MY, 2010, PLANT BIOTECHNOL REP, V4, P15, DOI 10.1007/s11816-009-0112-9; CORBISIER P, 1987, ANAL BIOCHEM, V164, P240, DOI 10.1016/0003-2697(87)90392-7; Helliwell CA, 2002, FUNCT PLANT BIOL, V29, P1217, DOI 10.1071/FP02033; Hirschi KD, 1999, PLANT CELL, V11, P2113, DOI 10.1105/tpc.11.11.2113; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Hu XL, 2010, J PLANT PHYSIOL, V167, P1307, DOI 10.1016/j.jplph.2010.04.014; Kamiya T, 2006, PLANT CELL PHYSIOL, V47, P96, DOI 10.1093/pcp/pci227; Kamiya T, 2005, PLANT CELL PHYSIOL, V46, P1735, DOI 10.1093/pcp/pci173; Kim KN, 2003, PLANT CELL, V15, P411, DOI 10.1105/tpc.006858; Knight H, 1999, PLANT CELL, V11, P875, DOI 10.1105/tpc.11.5.875; Knight H, 2001, TRENDS PLANT SCI, V6, P262, DOI 10.1016/S1360-1385(01)01946-X; Kong XP, 2011, PLANT CELL REP, V30, P2097, DOI 10.1007/s00299-011-1116-9; Luo GZ, 2005, PLANT MOL BIOL, V59, P809, DOI 10.1007/s11103-005-1386-0; Manohar M, 2011, PLANT BIOLOGY, V13, P561, DOI 10.1111/j.1438-8677.2011.00466.x; Manohar M, 2011, BIOCHEMISTRY-US, V50, P6189, DOI 10.1021/bi2003839; Matteucci M, 2011, J EXP BOT, V62, P3403, DOI 10.1093/jxb/err013; McAinsh MR, 2009, NEW PHYTOL, V181, P275, DOI 10.1111/j.1469-8137.2008.02682.x; Mei H, 2007, J EXP BOT, V58, P3419, DOI 10.1093/jxb/erm190; Mei H, 2009, NEW PHYTOL, V183, P95, DOI 10.1111/j.1469-8137.2009.02831.x; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Park S, 2005, PLANT PHYSIOL, V139, P1194, DOI 10.1104/pp.105.066266; Pittman JK, 2001, PLANT PHYSIOL, V127, P1020, DOI 10.1104/pp.010409; Pittman JK, 2009, J BIOL CHEM, V284, P525, DOI 10.1074/jbc.M807173200; POLLE A, 1994, PLANT PHYSIOL, V106, P53, DOI 10.1104/pp.106.1.53; Ruelland E, 2010, ENVIRON EXP BOT, V69, P225, DOI 10.1016/j.envexpbot.2010.05.011; Sanders D, 2002, PLANT CELL, V14, pS401, DOI 10.1105/tpc.002899; Seo PJ, 2010, PLANT J, V61, P661, DOI 10.1111/j.1365-313X.2009.04091.x; Shigaki T, 2006, J MOL EVOL, V63, P815, DOI 10.1007/s00239-006-0048-4; Shigaki T, 2006, PLANT BIOLOGY, V8, P419, DOI 10.1055/s-2006-923950; Shigaki T, 2010, PLANT BIOLOGY, V12, P935, DOI 10.1111/j.1438-8677.2010.00368.x; Suzuki K, 2008, PLANT CELL PHYSIOL, V49, P433, DOI 10.1093/pcp/pcn020; Tamura T, 2003, PLANT PHYSIOL, V131, P454, DOI 10.1104/pp.102.011007; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Tu LL, 2007, PLANT CELL REP, V26, P1309, DOI 10.1007/s00299-007-0337-4; Ueoka-Nakanishi H, 2000, EUR J BIOCHEM, V267, P3090, DOI 10.1046/j.1432-1033.2000.01343.x; Verlues PE, 2005, PLANT J, V45, P523; Wang YuCheng, 2006, Bulletin of Botanical Research, V26, P84; Wu HC, 2012, PLANT CELL ENVIRON, V35, P1543, DOI 10.1111/j.1365-3040.2012.02508.x; Yang GP, 1996, AUST J PLANT PHYSIOL, V23, P437, DOI 10.1071/PP9960437; Zhang MY, 2012, J PLANT PHYSIOL, V169, P1501, DOI 10.1016/j.jplph.2012.06.008; Zhu LF, 2011, AGR SCI CHINA, V10, P499, DOI 10.1016/S1671-2927(11)60030-8; Zhu LongFu, 2005, Acta Agronomica Sinica, V31, P1657	48	14	21	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66303	10.1371/journal.pone.0066303	http://dx.doi.org/10.1371/journal.pone.0066303			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776653	Green Published, gold, Green Submitted			2022-12-27	WOS:000320755400134
J	Prentice, JR; Clark, MJ; Hoggard, N; Morton, AC; Tooth, C; Paley, MN; Stockley, I; Hadjivassiliou, M; Wilkinson, JM				Prentice, Jennifer R.; Clark, Matthew J.; Hoggard, Nigel; Morton, Allison C.; Tooth, Claire; Paley, Martyn N.; Stockley, Ian; Hadjivassiliou, Marios; Wilkinson, J. Mark			Metal-on-Metal Hip Prostheses and Systemic Health: A Cross-Sectional Association Study 8 Years after Implantation	PLOS ONE			English	Article							RESURFACING ARTHROPLASTY; ION LEVELS; INSULIN SENSITIVITY; IN-VIVO; CHROMIUM; COBALT; FAILURE; SINGLE; BLOOD; SIGHT	There is public concern over the long term systemic health effects of metal released from hip replacement prostheses that use large-diameter metal-on-metal bearings. However, to date there has been no systematic study to determine which organs may be at risk, or the magnitude of any effect. We undertook a detailed cross-sectional health screen at a mean of 8 years after surgery in 35 asymptomatic patients who had previously received a metal-on-metal hip resurfacing (MoMHR) versus 35 individually age and sex matched asymptomatic patients who had received a conventional hip replacement. Total body bone mineral density was 5% higher (mean difference 0.05 g/cm(2), P = 0.02) and bone turnover was 14% lower (TRAP 5b, mean difference -0.56IU/L, P = 0.006; osteocalcin, mean difference -3.08 ng/mL, P = 0.03) in the hip resurfacing versus conventional hip replacement group. Cardiac ejection fraction was 7% lower (mean absolute difference -5%, P = 0.04) and left ventricular end-diastolic diameter was 6% larger (mean difference 2.7 mm, P = 0.007) in the hip resurfacing group versus those patients who received a conventional hip replacement. The urinary fractional excretion of metal was low (cobalt 5%, chromium 1.5%) in patients with MoMHR, but creatinine clearance was normal. Diuretic prescription was associated with a 40% increase in the fractional excretion of chromium (mean difference 0.5%, P = 0.03). There was no evidence of difference in neuropsychological, renal tubular, hepatic or endocrine function between groups (P. 0.05). Our findings of differences in bone and cardiac function between patient groups suggest that chronic exposure to low elevated metal concentrations in patients with well-functioning MoMHR prostheses may have systemic effects. Long-term epidemiological studies in patients with well-functioning metal on metal hip prostheses should include musculoskeletal and cardiac endpoints to quantitate the risk of clinical disease.	[Prentice, Jennifer R.; Clark, Matthew J.; Hoggard, Nigel; Paley, Martyn N.; Wilkinson, J. Mark] Univ Sheffield, Dept Human Metab, Sheffield, S Yorkshire, England; [Morton, Allison C.] Sheffield Teaching Hosp NHS Fdn Trust, Dept Cardiol, Sheffield, S Yorkshire, England; [Tooth, Claire; Hadjivassiliou, Marios] Sheffield Teaching Hosp NHS Fdn Trust, Dept Neurol, Sheffield, S Yorkshire, England; [Stockley, Ian; Wilkinson, J. Mark] Sheffield Teaching Hosp NHS Fdn Trust, Dept Orthopaed, Sheffield, S Yorkshire, England	University of Sheffield; University of Sheffield; University of Sheffield; University of Sheffield	Wilkinson, JM (corresponding author), Univ Sheffield, Dept Human Metab, Sheffield, S Yorkshire, England.	j.m.wilkinson@sheffield.ac.uk		Clark, Matthew/0000-0003-2152-2257	Sheffield Musculoskeletal Biomedical Research Unit; National Institute of Health Research in the United Kingdom (NIHR)	Sheffield Musculoskeletal Biomedical Research Unit; National Institute of Health Research in the United Kingdom (NIHR)	This study was funded by Sheffield Musculoskeletal Biomedical Research Unit through its core grant from the National Institute of Health Research in the United Kingdom (NIHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen B, 2000, DIABETIC MED, V17, P124, DOI 10.1046/j.1464-5491.2000.00234.x; ANDREWS RE, 2011, BONE; Back DL, 2005, CLIN ORTHOP RELAT R, P177, DOI 10.1097/01.blo.0000166901.85323.5d; Blake GM, 2007, J CLIN DENSITOM, V10, P259, DOI 10.1016/j.jocd.2007.03.102; CARTWRIGHT GE, 1955, AM J CLIN NUTR, V3, P11, DOI 10.1093/ajcn/3.1.11; Cohen D, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e1410; Costa ML, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2147; Daniel J, 2007, J BONE JOINT SURG BR, V89B, P169, DOI 10.1302/0301-620X.89B2.18519; Daniel J, 2009, J BONE JOINT SURG BR, V91B, P176, DOI 10.1302/0301-620X.91B2.21654; Davda K, 2011, J BONE JOINT SURG BR, V93B, P738, DOI 10.1302/0301-620X.93B6.25804; de Smet K, 2008, J BONE JOINT SURG AM, V90A, P202, DOI 10.2106/JBJS.H.00672; Fassett RG, 2011, KIDNEY INT, V80, P806, DOI 10.1038/ki.2011.198; Hart AJ, 2011, J BONE JOINT SURG BR, V93B, P1308, DOI 10.1302/0301-620X.93B10.26249; HARTMANN A, 2012, CLIN ORTHOP RELAT RE; Heisel C, 2008, J BONE JOINT SURG AM, V90A, P125, DOI 10.2106/JBJS.H.00437; Holland JP, 2012, J BONE JOINT SURG BR, V94B, P471, DOI 10.1302/0301-620X.94B4.27895; Hua Y, 2012, J NUTR BIOCHEM, V23, P313, DOI 10.1016/j.jnutbio.2011.11.001; Ikeda T, 2010, MUSCLE NERVE, V42, P140, DOI 10.1002/mus.21638; Kwon YM, 2011, J ARTHROPLASTY, V26, P511, DOI 10.1016/j.arth.2010.05.030; Langton DJ, 2010, J BONE JOINT SURG BR, V92B, P38, DOI 10.1302/0301-620X.92B1.22770; Legro RS, 1998, J CLIN ENDOCR METAB, V83, P2694, DOI 10.1210/jc.83.8.2694; Linna A, 2004, OCCUP ENVIRON MED, V61, P877, DOI 10.1136/oem.2003.009605; Marker M, 2008, ARCH ORTHOP TRAUM SU, V128, P915, DOI 10.1007/s00402-007-0466-9; MCCARTY MF, 1995, MED HYPOTHESES, V45, P241, DOI 10.1016/0306-9877(95)90112-4; MORIN YL, 1967, CAN MED ASSOC J, V97, P881; MOSTELLER RD, 1987, NEW ENGL J MED, V317, P1098, DOI 10.1056/nejm198710223171717; OLDENBURG M, 2009, J ARTHROPLASTY, V24, P52820; PENNY JO, 2013, ACTA ORTHOP; Quinteros FA, 2007, TOXICOL APPL PHARM, V218, P79, DOI 10.1016/j.taap.2006.10.017; Rising JP, 2012, NEW ENGL J MED, V367, DOI 10.1056/NEJMp1206794; Rizzetti MC, 2009, LANCET, V373, P1052, DOI 10.1016/S0140-6736(09)60490-6; Russell RGG, 1999, BONE, V25, P97, DOI 10.1016/S8756-3282(99)00116-7; Steens W, 2006, ACTA ORTHOP, V77, P830, DOI 10.1080/17453670610013079; Tower SS, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e430; WEDEEN RP, 1991, ENVIRON HEALTH PERSP, V92, P71, DOI 10.2307/3431139; Wilkinson JM, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e7792	36	46	46	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e66186	10.1371/journal.pone.0066186	http://dx.doi.org/10.1371/journal.pone.0066186			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762480	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000320440500066
J	Xiang, YT; Buchanan, RW; Ungvari, GS; Chiu, HFK; Lai, KYC; Li, YH; Si, TM; Wang, CY; Lee, EHM; He, YL; Yang, SY; Chong, MY; Kua, EH; Fujii, S; Sim, K; Yong, MKH; Trivedi, JK; Chung, EK; Udomratn, P; Chee, KY; Sartorius, N; Tan, CH; Shinfuku, N				Xiang, Yu-Tao; Buchanan, Robert W.; Ungvari, Gabor S.; Chiu, Helen F. K.; Lai, Kelly Y. C.; Li, You-Hong; Si, Tian-Mei; Wang, Chuan-Yue; Lee, Edwin H. M.; He, Yan-Ling; Yang, Shu-Yu; Chong, Mian-Yoon; Kua, Ee-Heok; Fujii, Senta; Sim, Kang; Yong, Michael K. H.; Trivedi, Jitendra K.; Chung, Eun-Kee; Udomratn, Pichet; Chee, Kok-Yoon; Sartorius, Norman; Tan, Chay-Hoon; Shinfuku, Naotaka			Use of Clozapine in Older Asian Patients with Schizophrenia between 2001 and 2009	PLOS ONE			English	Article							EAST-ASIA; ATYPICAL ANTIPSYCHOTICS; PRESCRIPTION	Background: To date there has been no large-scale international study that examined the use of clozapine in older patients with schizophrenia. This study examined the use of clozapine and its demographic and clinical correlates in older patients with schizophrenia in East Asia during the period between 2001 and 2009. Method: Information on 1,157 hospitalized patients with schizophrenia aged 50 or older in five East Asian countries and territories (China, Hong Kong, Korea, Singapore and Taiwan) was extracted from the database of the Research on Asian Psychotropic Prescription Patterns (REAP) project. Socio-demographic and clinical characteristics and prescription of psychotropic medications were recorded. Results: Clozapine was prescribed for 20.6% of the pooled sample; 19.0% in 2001, 19.4% in 2004 and 22.9% in 2009. Multiple logistic regression analysis of the whole sample revealed that patients taking clozapine had a longer duration of illness, more negative symptoms and were less likely to receive first generation antipsychotic and anticholinergic drugs, but more likely to report weight gain compared to those not receiving clozapine. Compared to those in other sites, older patients in China were more likely to receive clozapine. Conclusions: The prescription of clozapine for older Asian schizophrenia inpatients has remained at a stable level during the past decade. The appropriateness of use of clozapine in China needs to be further explored.	[Xiang, Yu-Tao; Chiu, Helen F. K.; Lai, Kelly Y. C.] Chinese Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Xiang, Yu-Tao; Wang, Chuan-Yue] Capital Med Univ, Beijing Anding Hosp, Beijing, Peoples R China; [Buchanan, Robert W.] Univ Maryland, Sch Med, Dept Psychiat, Maryland Psychiat Res Ctr, Baltimore, MD 21201 USA; [Ungvari, Gabor S.] Univ Western Australia, Sch Psychiat & Clin Neurosci, Perth, WA 6009, Australia; [Ungvari, Gabor S.] Univ Notre Dame Australia, Marian Ctr, Perth, WA, Australia; [Li, You-Hong; Si, Tian-Mei] Minist Mental Hlth, Key Lab Mental Hlth, Beijing, Peoples R China; [Li, You-Hong; Si, Tian-Mei] Peking Univ, Inst Mental Hlth, Beijing 100871, Peoples R China; [Lee, Edwin H. M.] Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [He, Yan-Ling] Shanghai Mental Hlth Ctr, Dept Psychiat Epidemiol, Shanghai, Peoples R China; [Yang, Shu-Yu] Taipei City Hosp, Dept Pharm, Taipei, Taiwan; [Chong, Mian-Yoon] Kaohsiung Chang Gung Mem Hosp, Kaohsiung, Taiwan; [Chong, Mian-Yoon] Chang Gung Univ, Sch Med, Kaohsiung, Taiwan; [Kua, Ee-Heok] Natl Univ Singapore, Dept Psychol Med, Singapore 117548, Singapore; [Fujii, Senta] Hyogo Inst Traumat Stress, Kobe, Hyogo, Japan; [Sim, Kang] Inst Mental Hlth, Dept Gen Psychiat, Singapore, Singapore; [Yong, Michael K. H.] Jurong Hlth Serv, Alexandra Hospital, Dept Med, Singapore, Singapore; [Trivedi, Jitendra K.] CSM Med Univ UP, Dept Psychiat, Lucknow, Uttar Pradesh, India; [Chung, Eun-Kee] Natl Seoul Hosp, Dept Psychiat, Seoul, South Korea; [Udomratn, Pichet] Prince Songkla Univ, Fac Med, Dept Psychiat, Hat Yai, Thailand; [Chee, Kok-Yoon] Kuala Lumpur Hosp, Tunku Abdul Rahman Inst Neurosci, Dept Psychiat & Mental Hlth, Kuala Lumpur, Malaysia; [Sartorius, Norman] Assoc Improvement Mental Hlth Programs, Geneva, Switzerland; [Tan, Chay-Hoon] Natl Univ Singapore, Dept Pharmacol, Singapore 117548, Singapore; [Shinfuku, Naotaka] Seinan Gakuin Univ, Sch Human Sci, Dept Social Welf, Fukuoka, Japan	Chinese University of Hong Kong; Capital Medical University; University System of Maryland; University of Maryland Baltimore; University of Western Australia; University of Notre Dame Australia; Peking University; University of Hong Kong; Taipei City Hospital; Chang Gung Memorial Hospital; Chang Gung University; National University of Singapore; King George's Medical University; Prince of Songkla University; National University of Singapore	Xiang, YT (corresponding author), Chinese Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China.	xyutly@gmail.com; si.tian-mei@163.com	Wang, Chuan-Yue/C-9369-2015; Lee, Ho Ming Edwin/A-4579-2012	Wang, Chuan-Yue/0000-0001-6549-3713; Lee, Ho Ming Edwin/0000-0002-8909-0676; KUA, Ee Heok/0000-0001-5574-0530; Sim, Kang/0000-0003-3209-9626	National Natural Science Foundation of China [81171270, 30800367, 30770776]; Beijing Nova Program of the Beijing Municipal Science and Technology Commission [2008B59]; Chinese University of Hong Kong [2041454]; Institute of Mental Health Research in Singapore [CRC 249/2008]; Taiwan Bureau of National Health Insurance [DOH92-NH-1025]; Chang Gung Memorial Hospital [CMRPG83043]; Taipei City Government in Taiwan [97001-62-010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Nova Program of the Beijing Municipal Science and Technology Commission; Chinese University of Hong Kong(Chinese University of Hong Kong); Institute of Mental Health Research in Singapore; Taiwan Bureau of National Health Insurance; Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Taipei City Government in Taiwan	This study was supported in part by grants from the National Natural Science Foundation of China (81171270; 30800367; 30770776), the Beijing Nova Program of the Beijing Municipal Science and Technology Commission (2008B59), the Chinese University of Hong Kong (Direct Grant for Research; Project 2041454), the Institute of Mental Health Research Grant (CRC 249/2008) in Singapore, the Taiwan Bureau of National Health Insurance (DOH92-NH-1025), Chang Gung Memorial Hospital (CMRPG83043) and the Taipei City Government (97001-62-010) in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buchanan RW, 2010, SCHIZOPHRENIA BULL, V36, P71, DOI 10.1093/schbul/sbp116; CARPENTER WT, 1995, AM J PSYCHIAT, V152, P827; *CHIN MED ASS, 2003, GUID PREV TREATM SCH; Chong MY, 2004, PSYCHIAT CLIN NEUROS, V58, P61, DOI 10.1111/j.1440-1819.2004.01194.x; [司天梅 Ci Tianmei], 2004, [中华精神科杂志, Chinese Journal of Psychiatry], V37, P152; Dassori AM, 2011, PSYCHIAT SERV, V62, P47, DOI 10.1176/ps.62.1.pss6201_0047; Geddes J, 2000, BRIT MED J, V321, P1371, DOI 10.1136/bmj.321.7273.1371; Henderson DC, 1996, J CLIN PSYCHIAT, V57, P395; Iqbal Mohammad Masud, 2003, Ann Clin Psychiatry, V15, P33, DOI 10.3109/10401230309085668; Kapur S, 2001, AM J PSYCHIAT, V158, P311, DOI 10.1176/appi.ajp.158.2.311; LIU TL, 2003, MED J CHIN PEOPLES H, V15, P289; Meyers BS, 2010, J CLIN PSYCHIAT, V71, P1416, DOI 10.4088/JCP.10r06485gry; Remington G, 2005, CNS DRUGS, V19, P843, DOI 10.2165/00023210-200519100-00004; SEGOVIA J, 1989, CAN J PUBLIC HEALTH, V80, P32; Shinfuku N, 2008, INT REV PSYCHIATR, V20, P460, DOI 10.1080/09540260802397560; Sim K, 2004, BRIT J CLIN PHARMACO, V58, P178, DOI 10.1111/j.1365-2125.2004.02102.x; Suzuki T, 2011, PSYCHOPHARMACOL BULL, V44, P32; Uchida H, 2009, CLIN PHARMACOL THER, V86, P360, DOI 10.1038/clpt.2009.133; Wetterling T, 2001, DRUG SAFETY, V24, P59, DOI 10.2165/00002018-200124010-00005; Xiang YT, 2008, J PSYCHIATR RES, V42, P495, DOI 10.1016/j.jpsychires.2007.06.001; Xiang YT, 2007, HUM PSYCHOPHARM CLIN, V22, P17, DOI 10.1002/hup.821; Xiang YT, 2012, AUST NZ J PSYCHIAT, V46, P1159, DOI 10.1177/0004867412453625	22	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e66154	10.1371/journal.pone.0066154	http://dx.doi.org/10.1371/journal.pone.0066154			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762478	Green Published, gold			2022-12-27	WOS:000320440500065
J	Caballero, JN; Frenette, G; Belleannee, C; Sullivan, R				Caballero, Julieta N.; Frenette, Gilles; Belleannee, Clemence; Sullivan, Robert			CD9-Positive Microvesicles Mediate the Transfer of Molecules to Bovine Spermatozoa during Epididymal Maturation	PLOS ONE			English	Article							MIGRATION INHIBITORY FACTOR; PROTEOMIC ANALYSIS; MEMBRANE-VESICLES; ALDOSE REDUCTASE; SPERM PROTEINS; EXOSOMES; TETRASPANINS; PROSTASOME; CD9; IDENTIFICATION	Acquisition of fertilization ability by spermatozoa during epididymal transit occurs in part by the transfer of molecules from membranous vesicles called epididymosomes. Epididymosomes are heterogeneous in terms of both size and molecular composition. Exosomes and other related small membranous vesicles (30-120 nm) containing tetraspanin proteins on their surface are found in many biological fluids. In this study, we demonstrate that these vesicles are present in bovine cauda epididymal fluid as a subpopulation of epididymosomes. They contain tetraspanin CD9 in addition to other proteins involved in sperm maturation such as P25b, GliPr1L1, and MIF. In order to study the mechanism of protein transfer to sperm, DilC12-labeled unfractionated epididymosomes or CD9-positive microvesicles were coincubated with epididymal spermatozoa, and their transfer was evaluated by flow cytometry. CD9-positive microvesicles from epididymal fluid specifically transferred molecules to spermatozoa, whereas those prepared from blood were unable to do so. The CD9-positive microvesicles transferred molecules to the same sperm regions (acrosome and midpiece) as epididymosomes, with the same kinetics; however, the molecules were preferentially transferred to live sperm and, in contrast to epididymosomes, Zn2+ did not demonstrate potentiated transfer. Tetraspanin CD9 was associated with other proteins on the membrane surface of CD9-positive microvesicles according to coimmunoprecipitation experiments. CD26 cooperated with CD9 in the molecular transfer to sperm since the amount of molecules transferred was significantly reduced in the presence of specific antibodies. In conclusion, CD9-positive microvesicles are present in bovine cauda epididymal fluid and transfer molecules to live maturing sperm in a tissue-specific manner that involves CD9 and CD26.	[Caballero, Julieta N.; Frenette, Gilles; Belleannee, Clemence; Sullivan, Robert] Univ Laval, CRCHU Quebec, Quebec City, PQ, Canada; [Sullivan, Robert] Univ Laval, Ctr Rech Biol Reprod, Dept Obstet Gynecol & Reprod, Quebec City, PQ, Canada	Laval University; Laval University	Sullivan, R (corresponding author), Univ Laval, CRCHU Quebec, Quebec City, PQ, Canada.	robert.sullivan@crchul.ulaval.ca		Caballero, Julieta/0000-0002-5466-3614; Belleannee, Clemence/0000-0001-9284-9420	Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by grants from the Canadian Institutes of Health Research and the Natural Sciences and Engineering Research Council of Canada to RS. The funders had no role in study design, data collection and analysis, decision to publish, or prepartion of the manuscript.	[Anonymous], 2002, EPIDIDYMIS MOL CLIN, P377; Arienti G, 1997, BBA-GEN SUBJECTS, V1336, P533, DOI 10.1016/S0304-4165(97)00071-8; Bard MP, 2004, AM J RESP CELL MOL, V31, P114, DOI 10.1165/rcmb.2003-0238OC; Caballero J, 2012, J CELL PHYSIOL, V227, P3876, DOI 10.1002/jcp.24099; Caby MP, 2005, INT IMMUNOL, V17, P879, DOI 10.1093/intimm/dxh267; Chaput N, 2005, BLOOD CELL MOL DIS, V35, P111, DOI 10.1016/j.bcmd.2005.05.009; Chikhi N, 1999, COMP BIOCHEM PHYS B, V122, P367, DOI 10.1016/S0305-0491(99)00013-9; D'Amours O, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.100990; D'Amours O, 2010, REPRODUCTION, V139, P545, DOI 10.1530/REP-09-0375; Dacheux J. -L., 2002, EPIDIDYMIS MOL CLIN, P151, DOI [10.1007/978-1-4615-0679-9_9, DOI 10.1007/978-1-4615-0679-9_9]; Eickhoff R, 2004, MOL HUM REPROD, V10, P605, DOI 10.1093/molehr/gah075; Engering A, 2003, EUR J BIOCHEM, V270, P2412, DOI 10.1046/j.1432-1033.2003.03609.x; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; Fanaei M, 2011, BIOCHEM SOC T, V39, P524, DOI 10.1042/BST0390524; Florek M, 2007, CELL TISSUE RES, V328, P31, DOI 10.1007/s00441-006-0324-z; Frenette G, 2003, BIOL REPROD, V69, P1586, DOI 10.1095/biolreprod.103.019216; Frenette G, 2002, BIOL REPROD, V67, P308, DOI 10.1095/biolreprod67.1.308; Girouard J, 2011, INT J ANDROL, V34, pE475, DOI 10.1111/j.1365-2605.2011.01203.x; Gonzales PA, 2009, J AM SOC NEPHROL, V20, P363, DOI 10.1681/ASN.2008040406; Gonzalez-Begne M, 2009, J PROTEOME RES, V8, P1304, DOI 10.1021/pr800658c; GOYAL HO, 1985, AM J ANAT, V172, P155, DOI 10.1002/aja.1001720205; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Hermo L, 2002, MOL REPROD DEV, V63, P394, DOI 10.1002/mrd.90023; Jones R., 2002, EPIDIDYMIS MOL CLIN, P405, DOI 10.1007/978-1-4615-0679-9_23; Le Naour F, 2006, MOL CELL PROTEOMICS, V5, P845, DOI 10.1074/mcp.M500330-MCP200; Madore E, 2003, J BIOL CHEM, V278, P11205, DOI 10.1074/jbc.M208318200; Mallegol J, 2007, GASTROENTEROLOGY, V132, P1866, DOI 10.1053/j.gastro.2007.02.043; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Minelli A, 1998, J REPROD FERTIL, V114, P237, DOI 10.1530/jrf.0.1140237; Parent S, 1999, MOL REPROD DEV, V52, P57, DOI 10.1002/(SICI)1098-2795(199901)52:1&lt;57::AID-MRD8&gt;3.0.CO;2-U; Parolini I, 2009, J BIOL CHEM, V284, P34211, DOI 10.1074/jbc.M109.041152; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Rejraji H, 2006, BIOL REPROD, V74, P1104, DOI 10.1095/biolreprod.105.049304; Reyes-Moreno C, 2002, BIOL REPROD, V66, P159, DOI 10.1095/biolreprod66.1.159; Reyes-Moreno C, 2008, MOL REPROD DEV, V75, P512, DOI 10.1002/mrd.20751; Rubinstein E, 2006, DEV BIOL, V290, P351, DOI 10.1016/j.ydbio.2005.11.031; Seigneuret M, 2001, J BIOL CHEM, V276, P40055, DOI 10.1074/jbc.M105557200; Sullivan R, 2007, ASIAN J ANDROL, V9, P483, DOI 10.1111/j.1745-7262.2007.00281.x; Tachibana I, 1999, J CELL BIOL, V146, P893, DOI 10.1083/jcb.146.4.893; Takeda Y, 2003, J CELL BIOL, V161, P945, DOI 10.1083/jcb.200212031; Thery C, 1999, J CELL BIOL, V147, P599, DOI 10.1083/jcb.147.3.599; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Turner TT, 2002, EPIDIDYMIS MOL CLIN, P131, DOI DOI 10.1007/978-1-4615-0679-9_8; Wang HX, 2011, J CELL SCI, V124, P2702, DOI 10.1242/jcs.085449; Yanez-Mo M, 2009, TRENDS CELL BIOL, V19, P434, DOI 10.1016/j.tcb.2009.06.004; Zoller M, 2009, NAT REV CANCER, V9, P40, DOI 10.1038/nrc2543	47	84	87	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65364	10.1371/journal.pone.0065364	http://dx.doi.org/10.1371/journal.pone.0065364			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785420	Green Submitted, gold, Green Published			2022-12-27	WOS:000321038800100
J	Du, JK; Xiao, K; Li, L; Ding, X; Liu, HL; Lu, YJ; Zhou, SN				Du, Jikun; Xiao, Kai; Li, Li; Ding, Xian; Liu, Helu; Lu, Yongjun; Zhou, Shining			Temporal and Spatial Diversity of Bacterial Communities in Coastal Waters of the South China Sea	PLOS ONE			English	Article							BACTERIOPLANKTON COMMUNITIES; MICROBIAL DIVERSITY; SEQUENCE ALIGNMENT; OCEAN; DYNAMICS; ATLANTIC; PACIFIC; ENVIRONMENTS; BIODIVERSITY; BIOSPHERE	Bacteria are recognized as important drivers of biogeochemical processes in all aquatic ecosystems. Temporal and geographical patterns in ocean bacterial communities have been observed in many studies, but the temporal and spatial patterns in the bacterial communities from the South China Sea remained unexplored. To determine the spatiotemporal patterns, we generated 16S rRNA datasets for 15 samples collected from the five regularly distributed sites of the South China Sea in three seasons (spring, summer, winter). A total of 491 representative sequences were analyzed by MOTHUR, yielding 282 operational taxonomic units (OTUs) grouped at 97% stringency. Significant temporal variations of bacterial diversity were observed. Richness and diversity indices indicated that summer samples were the most diverse. The main bacterial group in spring and summer samples was Alphaproteobacteria, followed by Cyanobacteria and Gammaproteobacteria, whereas Cyanobacteria dominated the winter samples. Spatial patterns in the samples were observed that samples collected from the coastal (D151, D221) waters and offshore (D157, D1512, D224) waters clustered separately, the coastal samples harbored more diverse bacterial communities. However, the temporal pattern of the coastal site D151 was contrary to that of the coastal site D221. The LIBSHUFF statistics revealed noticeable differences among the spring, summer and winter libraries collected at five sites. The UPGMA tree showed there were temporal and spatial heterogeneity of bacterial community composition in coastal waters of the South China Sea. The water salinity (P=0.001) contributed significantly to the bacteria-environment relationship. Our results revealed that bacterial community structures were influenced by environmental factors and community-level changes in 16S-based diversity were better explained by spatial patterns than by temporal patterns.	[Du, Jikun; Xiao, Kai; Lu, Yongjun; Zhou, Shining] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Li, Li] Guangdong Med Coll, Dept Pharmacol, Dongguan, Peoples R China; [Du, Jikun; Liu, Helu] Guangzhou Med Univ, Dept Clin Lab, Shenzhen Shajing Affiliated Hosp, Shenzhen, Peoples R China; [Ding, Xian] Chinese Acad Fishery Sci, South China Sea Fisheries Res Inst, Guangzhou, Peoples R China	Sun Yat Sen University; Guangdong Medical University; Guangzhou Medical University; Chinese Academy of Fishery Sciences; South China Sea Fisheries Research Institute, CAFS	Li, L (corresponding author), Guangdong Med Coll, Dept Pharmacol, Dongguan, Peoples R China.	lsszsl@mail.sysu.edu.cn; china_lovelylily@hotmail.com	du, jikun/G-3990-2013		China Marine Commonweal Research Project [201005022-2]; Guangdong Provincial Science and Technique Major Project [2011A080403006]	China Marine Commonweal Research Project; Guangdong Provincial Science and Technique Major Project	This research was supported by grants from China Marine Commonweal Research Project (201005022-2) and Guangdong Provincial Science and Technique Major Project (2011A080403006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allers E, 2013, ISME J, V7, P256, DOI 10.1038/ismej.2012.108; Andersson AF, 2010, ISME J, V4, P171, DOI 10.1038/ismej.2009.108; Azam F, 2001, NATURE, V414, P495, DOI 10.1038/35107174; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Briee C, 2007, RES MICROBIOL, V158, P213, DOI 10.1016/j.resmic.2006.12.012; Brown MV, 2009, ISME J, V3, P1374, DOI 10.1038/ismej.2009.86; CONNELL JH, 1964, AM NAT, V98, P399, DOI 10.1086/282335; Copley J, 2002, NATURE, V415, P572, DOI 10.1038/415572a; Crump BC, 1999, APPL ENVIRON MICROB, V65, P3192; Danovaro R, 2007, ESTUAR COAST SHELF S, V75, P4, DOI 10.1016/j.ecss.2007.02.030; Du HL, 2006, FEMS MICROBIOL ECOL, V57, P92, DOI 10.1111/j.1574-6941.2006.00090.x; Du JK, 2011, ANTON LEEUW INT J G, V100, P317, DOI 10.1007/s10482-011-9587-9; Feingersch R, 2010, ISME J, V4, P78, DOI 10.1038/ismej.2009.92; Feng BW, 2009, FEMS MICROBIOL ECOL, V70, P236, DOI 10.1111/j.1574-6941.2009.00772.x; Field KG, 1997, APPL ENVIRON MICROB, V63, P63, DOI 10.1128/AEM.63.1.63-70.1997; Fuhrman JA, 1995, APPL ENVIRON MICROB, V59, P1294; Fuhrman JA, 2006, P NATL ACAD SCI USA, V103, P13104, DOI 10.1073/pnas.0602399103; Gao Z, 2010, ISME J, V4, P111, DOI 10.1038/ismej.2009.87; Gilbert JA, 2012, ISME J, V6, P298, DOI 10.1038/ismej.2011.107; Gilbert JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015545; GIOVANNONI SJ, 2000, MICROBIAL ECOLOGY OC, P47; Glockner FO, 1999, APPL ENVIRON MICROB, V65, P3721; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Grasshoff K, 1999, METHODS SEAWATER ANA; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Jari O., 2013, MULTIVARIATE ANAL EC; Kanokratana P, 2004, J BASIC MICROB, V44, P430, DOI 10.1002/jobm.200410388; Karl DM, 2002, NATURE, V415, P590, DOI 10.1038/415590b; Kirchman DL, 2002, FEMS MICROBIOL ECOL, V39, P91, DOI 10.1111/j.1574-6941.2002.tb00910.x; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lai XT, 2007, ISME J, V1, P756, DOI 10.1038/ismej.2007.51; Madigan MT, 1997, SCI AM, V276, P82, DOI 10.1038/scientificamerican0497-82; Magalhaes C, 2008, MICROB ECOL, V55, P259, DOI 10.1007/s00248-007-9273-7; Manini E, 2003, OCEANOL ACTA, V26, P27, DOI 10.1016/S0399-1784(02)01227-6; Morris RM, 2005, LIMNOL OCEANOGR, V50, P1687, DOI 10.4319/lo.2005.50.5.1687; Mou XZ, 2008, NATURE, V451, P708, DOI 10.1038/nature06513; Mueller-Spitz SR, 2009, FEMS MICROBIOL ECOL, V67, P511, DOI 10.1111/j.1574-6941.2008.00639.x; Muller-Navarra DC, 2000, NATURE, V403, P74, DOI 10.1038/47469; Nemergut DR, 2011, ENVIRON MICROBIOL, V13, P135, DOI 10.1111/j.1462-2920.2010.02315.x; Newell RC, 1982, OCEANOL ACTA, P347; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; POMEROY LR, 1974, BIOSCIENCE, V24, P499, DOI 10.2307/1296885; Pomeroy LR, 2007, J OCEANOGR, V20; Pommier T, 2007, MOL ECOL, V16, P867, DOI 10.1111/j.1365-294X.2006.03189.x; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schwarz JIK, 2007, SYST APPL MICROBIOL, V30, P239, DOI 10.1016/j.syapm.2006.05.004; Silveira CB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017789; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Treusch AH, 2009, ISME J, V3, P1148, DOI 10.1038/ismej.2009.60; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Ward DM, 1998, MICROBIOL MOL BIOL R, V62, P1353, DOI 10.1128/MMBR.62.4.1353-1370.1998; Wright David H., 1993, P66; Xie SP, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2003JC001867; Yeo SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056207	56	26	30	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66968	10.1371/journal.pone.0066968	http://dx.doi.org/10.1371/journal.pone.0066968			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785512	Green Published, Green Submitted, gold			2022-12-27	WOS:000321038800010
J	Reverdatto, S; Rai, V; Xue, J; Burz, DS; Schmidt, AM; Shekhtman, A				Reverdatto, Sergey; Rai, Vivek; Xue, Jing; Burz, David S.; Schmidt, Ann Marie; Shekhtman, Alexander			Combinatorial Library of Improved Peptide Aptamers, CLIPs to Inhibit RAGE Signal Transduction in Mammalian Cells	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; ESCHERICHIA-COLI THIOREDOXIN; PHAGE DISPLAY LIBRARIES; SECONDARY STRUCTURE; STRUCTURAL BASIS; DNA-POLYMERASE; RECEPTOR; PROTEIN; SELECTION; LIGANDS	Peptide aptamers are small proteins containing a randomized peptide sequence embedded into a stable protein scaffold, such as Thioredoxin. We developed a robust method for building a Combinatorial Library of Improved Peptide aptamers (CLIPs) of high complexity, containing >= 3 x 10(10) independent clones, to be used as a molecular tool in the study of biological pathways. The Thioredoxin scaffold was modified to increase solubility and eliminate aggregation of the peptide aptamers. The CLIPs was used in a yeast two-hybrid screen to identify peptide aptamers that bind to various domains of the Receptor for Advanced Glycation End products (RAGE). NMR spectroscopy was used to identify interaction surfaces between the peptide aptamers and RAGE domains. Cellular functional assays revealed that in addition to directly interfering with known binding sites, peptide aptamer binding distal to ligand sites also inhibits RAGE ligand-induced signal transduction. This finding underscores the potential of using CLIPs to select allosteric inhibitors of biological targets.	[Reverdatto, Sergey; Xue, Jing; Burz, David S.; Shekhtman, Alexander] SUNY Albany, Dept Chem, Albany, NY 12222 USA; [Rai, Vivek; Schmidt, Ann Marie] NYU, Langone Med Ctr, New York, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; New York University; NYU Langone Medical Center	Shekhtman, A (corresponding author), SUNY Albany, Dept Chem, Albany, NY 12222 USA.	ashekhtman@albany.edu		Shekhtman, Alexander/0000-0003-2649-2675	National Institutes of Health grant [RO1GM085006]; Juvenile Diabetes Research Foundation grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL060901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085006] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation grant(Juvenile Diabetes Research Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant RO1GM085006 and Juvenile Diabetes Research Foundation grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed H., 2004, PRINCIPLES REACTIONS; [Anonymous], 1991, FEBS LETT, V284, P178; [Anonymous], 1990, CURRENT RES PROTEIN, P449; [Anonymous], 1980, BLOOD VESSELS, V17, P110; Baines IC, 2006, DRUG DISCOV TODAY, V11, P334, DOI 10.1016/j.drudis.2006.02.007; Bickle MBT, 2006, NAT PROTOC, V1, P1066, DOI 10.1038/nprot.2006.32; Borghouts C, 2008, MOL CANCER RES, V6, P267, DOI 10.1158/1541-7786.MCR-07-0245; BRETT J, 1993, AM J PATHOL, V143, P1699; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Brown CJ, 2010, J MOL BIOL, V395, P871, DOI 10.1016/j.jmb.2009.10.069; Bryksin AV, 2010, BIOTECHNIQUES, V48, P463, DOI 10.2144/000113418; Cavanagh J., 1996, PROTEIN NMR SPECTROS; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; Christ D, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl605; Cohen BA, 1998, P NATL ACAD SCI USA, V95, P14272, DOI 10.1073/pnas.95.24.14272; Colas P, 1996, NATURE, V380, P548, DOI 10.1038/380548a0; Colas P, 2000, CURR OPIN CHEM BIOL, V4, P54, DOI 10.1016/S1367-5931(99)00051-4; Crawford Margaret, 2003, Briefings in Functional Genomics & Proteomics, V2, P72, DOI 10.1093/bfgp/2.1.72; Dattilo BM, 2007, BIOCHEMISTRY-US, V46, P6957, DOI 10.1021/bi7003735; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Dean FB, 2001, GENOME RES, V11, P1095, DOI 10.1101/gr.180501; Derda R, 2011, MOLECULES, V16, P1776, DOI 10.3390/molecules16021776; DOWER WJ, 1988, NUCLEIC ACIDS RES, V16, P6127, DOI 10.1093/nar/16.13.6127; Dyson HJ, 1997, BIOCHEMISTRY-US, V36, P2622, DOI 10.1021/bi961801a; DYSON HJ, 1989, BIOCHEMISTRY-US, V28, P7074, DOI 10.1021/bi00443a044; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Fritz G, 2011, TRENDS BIOCHEM SCI, V36, P625, DOI 10.1016/j.tibs.2011.08.008; Georgiou G, 1997, NAT BIOTECHNOL, V15, P29, DOI 10.1038/nbt0197-29; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Huber D, 2005, P NATL ACAD SCI USA, V102, P18872, DOI 10.1073/pnas.0509583102; James P, 1996, GENETICS, V144, P1425; KATTI SK, 1990, J MOL BIOL, V212, P167, DOI 10.1016/0022-2836(90)90313-B; Kislinger T, 1999, J BIOL CHEM, V274, P31740, DOI 10.1074/jbc.274.44.31740; Kislinger T, 2001, ARTERIOSCL THROM VAS, V21, P905, DOI 10.1161/01.ATV.21.6.905; Klevenz B, 2002, CELL MOL LIFE SCI, V59, P1993, DOI 10.1007/PL00012521; Koch M, 2010, STRUCTURE, V18, P1342, DOI 10.1016/j.str.2010.05.017; LANGSETMO K, 1991, BIOCHEMISTRY-US, V30, P7603, DOI 10.1021/bi00244a032; LANGSETMO K, 1991, BIOCHEMISTRY-US, V30, P7609, DOI 10.1021/bi00244a033; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liliensiek B, 2004, J CLIN INVEST, V113, P1641, DOI 10.1172/JCI200418704; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Masse JE, 2005, J MAGN RESON, V174, P133, DOI 10.1016/j.jmr.2005.01.017; MATTHEAKIS LC, 1994, P NATL ACAD SCI USA, V91, P9022, DOI 10.1073/pnas.91.19.9022; Menendez A, 2005, ANAL BIOCHEM, V336, P145, DOI 10.1016/j.ab.2004.09.048; Newton-Northup J. R., 2012, J MOL IMAGING DYNAM, V2, P1; Ng EWM, 2006, NAT REV DRUG DISCOV, V5, P123, DOI 10.1038/nrd1955; Nimjee SM, 2005, ANNU REV MED, V56, P555, DOI 10.1146/annurev.med.56.062904.144915; Pedone E, 1999, BIOCHEM J, V339, P309, DOI 10.1042/0264-6021:3390309; Reichelt P, 2006, PROTEIN EXPRES PURIF, V46, P483, DOI 10.1016/j.pep.2005.09.027; Roberts RW, 1997, P NATL ACAD SCI USA, V94, P12297, DOI 10.1073/pnas.94.23.12297; Rodi DJ, 2002, J MOL BIOL, V322, P1039, DOI 10.1016/S0022-2836(02)00844-6; Shi H, 2007, P NATL ACAD SCI USA, V104, P3742, DOI 10.1073/pnas.0607805104; Simossis VA, 2005, NUCLEIC ACIDS RES, V33, pW289, DOI 10.1093/nar/gki390; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; TAKESAKO K, 1991, J ANTIBIOT, V44, P919, DOI 10.7164/antibiotics.44.919; Thomas WD, 2010, ANAL BIOCHEM, V407, P237, DOI 10.1016/j.ab.2010.07.037; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Vodnik M, 2011, MOLECULES, V16, P790, DOI 10.3390/molecules16010790; Walters KJ, 2001, METHOD ENZYMOL, V339, P238, DOI 10.1016/S0076-6879(01)39316-3; Worthington MT, 2001, ANAL BIOCHEM, V294, P169, DOI 10.1006/abio.2001.5162; Xie JJ, 2008, J BIOL CHEM, V283, P27255, DOI 10.1074/jbc.M801622200; Xie J, 2007, J BIOL CHEM, V282, P4218, DOI 10.1074/jbc.M608888200; Xue J, 2011, STRUCTURE, V19, P722, DOI 10.1016/j.str.2011.02.013; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0	69	24	26	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65180	10.1371/journal.pone.0065180	http://dx.doi.org/10.1371/journal.pone.0065180			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785412	gold, Green Published, Green Submitted			2022-12-27	WOS:000321038800108
J	Teramoto, S; Shimura, H; Tanaka, R; Shimada, Y; Miyamoto, N; Arai, H; Urabe, T; Hattori, N				Teramoto, Shinichiro; Shimura, Hideki; Tanaka, Ryota; Shimada, Yoshiaki; Miyamoto, Nobukazu; Arai, Hajime; Urabe, Takao; Hattori, Nobutaka			Human-Derived Physiological Heat Shock Protein 27 Complex Protects Brain after Focal Cerebral Ischemia in Mice	PLOS ONE			English	Article							CHAPERONE FUNCTION; OXIDATIVE STRESS; DRUG-RESISTANCE; NEURONAL INJURY; CELL-DEATH; HSP27; HEAT-SHOCK-PROTEIN-27; PHOSPHORYLATION; NEUROPROTECTION; OVEREXPRESSION	Although challenging, neuroprotective therapies for ischemic stroke remain an interesting strategy for countering ischemic injury and suppressing brain tissue damage. Among potential neuroprotective molecules, heat shock protein 27 (HSP27) is a strong cell death suppressor. To assess the neuroprotective effects of HSP27 in a mouse model of transient middle cerebral artery occlusion, we purified a "physiological" HSP27 (hHSP27) from normal human lymphocytes. hHSP27 differed from recombinant HSP27 in that it formed dimeric, tetrameric, and multimeric complexes, was phosphorylated, and contained small amounts of ab-crystallin and HSP20. Mice received intravenous injections of hHSP27 following focal cerebral ischemia. Infarct volume, neurological deficit scores, physiological parameters, and immunohistochemical analyses were evaluated 24 h after reperfusion. Intravenous injections of hHSP27 1 h after reperfusion significantly reduced infarct size and improved neurological deficits. Injected hHSP27 was localized in neurons on the ischemic side of the brain. hHSP27 suppressed neuronal cell death resulting from cytochrome c-mediated caspase activation, oxidative stress, and inflammatory responses. Recombinant HSP27 (rHSP27), which was artificially expressed and purified from Escherichia coli, and dephosphorylated hHSP27 did not have brain protective effects, suggesting that the phosphorylation of hHSP27 may be important for neuroprotection after ischemic insults. The present study suggests that hHSP27 with posttranslational modifications provided neuroprotection against ischemia/reperfusion injury and that the protection was mediated through the inhibition of apoptosis, oxidative stress, and inflammation. Intravenously injected human HSP27 should be explored for the treatment of acute ischemic strokes.	[Teramoto, Shinichiro; Tanaka, Ryota; Shimada, Yoshiaki; Miyamoto, Nobukazu; Hattori, Nobutaka] Juntendo Univ, Sch Med, Dept Neurol, Tokyo 113, Japan; [Teramoto, Shinichiro; Arai, Hajime] Juntendo Univ, Sch Med, Dept Neurosurg, Tokyo 113, Japan; [Shimura, Hideki; Tanaka, Ryota; Urabe, Takao] Juntendo Univ, Sch Med, Urayasu Hosp, Dept Neurol, Chiba, Japan; [Shimura, Hideki; Tanaka, Ryota] Juntendo Univ, Grad Sch Med, Inst Environm & Gender Specif Med, Chiba, Japan	Juntendo University; Juntendo University; Juntendo University; Juntendo University	Shimura, H (corresponding author), Juntendo Univ, Sch Med, Urayasu Hosp, Dept Neurol, Chiba, Japan.	hshimura@juntendo-urayasu.jp; nhattori@juntendo.ac.jp	shimura, hideki/AAA-2864-2020; Hattori, Nobutaka/ACR-0069-2022		High Technology Research Center; Ministry of Education, Culture, Sports, Science and Technology in Japan; Japan Society for the Promotion of Science [21700395, 21500338]; Takeda Science Foundation	High Technology Research Center; Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF))	This study was partly supported by a High Technology Research Center grant and a Grant-in-Aid for exploratory research from the Ministry of Education, Culture, Sports, Science and Technology in Japan and by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (21700395, H. Shimura; 21500338, T. Urabe) and from the Takeda Science Foundation (H. Shimura). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abisambra JF, 2010, J NEUROSCI, V30, P15374, DOI 10.1523/JNEUROSCI.3155-10.2010; Akbar MT, 2003, J BIOL CHEM, V278, P19956, DOI 10.1074/jbc.M207073200; An JJ, 2008, FEBS J, V275, P1296, DOI 10.1111/j.1742-4658.2008.06291.x; Andrabi SA, 2004, FASEB J, V18, P869, DOI 10.1096/fj.03-1031fje; Assimakopoulou M, 1997, ANTICANCER RES, V17, P2677; Badin RA, 2006, J CEREBR BLOOD F MET, V26, P371, DOI 10.1038/sj.jcbfm.9600190; Badin RA, 2009, J CEREBR BLOOD F MET, V29, P254, DOI 10.1038/jcbfm.2008.106; Bukach OV, 2009, BBA-PROTEINS PROTEOM, V1794, P486, DOI 10.1016/j.bbapap.2008.11.010; Chan PH, 2001, J CEREBR BLOOD F MET, V21, P2, DOI 10.1097/00004647-200101000-00002; Ciocca DR, 2005, CELL STRESS CHAPERON, V10, P86, DOI 10.1379/CSC-99r.1; Concannon CG, 2003, APOPTOSIS, V8, P61, DOI 10.1023/A:1021601103096; Currie RW, 2000, BRAIN RES, V863, P169, DOI 10.1016/S0006-8993(00)02133-8; Dhodda VK, 2004, J NEUROCHEM, V89, P73, DOI 10.1111/j.1471-4159.2004.02316.x; DUDICH IV, 1995, BBA-PROTEIN STRUCT M, V1253, P163, DOI 10.1016/0167-4838(95)00135-X; Efthymiou CA, 2004, BASIC RES CARDIOL, V99, P392, DOI 10.1007/s00395-004-0483-6; Faden AI, 2007, ARCH NEUROL-CHICAGO, V64, P794, DOI 10.1001/archneur.64.6.794; FUQUA SAW, 1994, BREAST CANCER RES TR, V32, P67, DOI 10.1007/BF00666207; Ginsberg MD, 2008, NEUROPHARMACOLOGY, V55, P363, DOI 10.1016/j.neuropharm.2007.12.007; Hara H, 1996, J CEREBR BLOOD F MET, V16, P605, DOI 10.1097/00004647-199607000-00010; Hayes D, 2009, J BIOL CHEM, V284, P18801, DOI 10.1074/jbc.M109.011353; Hollander JM, 2004, CIRCULATION, V110, P3544, DOI 10.1161/01.CIR.0000148825.99184.50; Huang QJ, 2010, CLIN CHEM LAB MED, V48, P263, DOI 10.1515/CCLM.2010.043; KATO H, 1995, NEUROSCIENCE, V68, P65, DOI 10.1016/0306-4522(95)00141-5; KATO K, 1994, J BIOL CHEM, V269, P11274; KATO K, 1994, J BIOL CHEM, V269, P15302; Lambert H, 1999, J BIOL CHEM, V274, P9378, DOI 10.1074/jbc.274.14.9378; Lelj-Garolla B, 2005, J MOL BIOL, V345, P631, DOI 10.1016/j.jmb.2004.10.056; Love S, 1999, BRAIN PATHOL, V9, P119; Miyamoto N, 2008, NEUROSCI RES, V61, P249, DOI 10.1016/j.neures.2008.03.003; Phan TG, 2002, CLIN EXP PHARMACOL P, V29, P1, DOI 10.1046/j.1440-1681.2002.03609.x; Rogalla T, 1999, J BIOL CHEM, V274, P18947, DOI 10.1074/jbc.274.27.18947; Sharp P, 2006, EXP NEUROL, V198, P511, DOI 10.1016/j.expneurol.2005.12.031; Sharp PS, 2008, NEUROBIOL DIS, V30, P42, DOI 10.1016/j.nbd.2007.12.002; Shimura H, 2004, J BIOL CHEM, V279, P17957, DOI 10.1074/jbc.M400351200; Spencer BJ, 2007, P NATL ACAD SCI USA, V104, P7594, DOI 10.1073/pnas.0702170104; Stetler RA, 2009, CURR MOL MED, V9, P863, DOI 10.2174/156652409789105561; Stetler RA, 2012, J NEUROSCI, V32, P2667, DOI 10.1523/JNEUROSCI.5169-11.2012; Stetler RA, 2010, PROG NEUROBIOL, V92, P184, DOI 10.1016/j.pneurobio.2010.05.002; Stetler RA, 2008, J NEUROSCI, V28, P13038, DOI 10.1523/JNEUROSCI.4407-08.2008; Tureyen K, 2004, J NEUROSCI METH, V139, P203, DOI 10.1016/j.jneumeth.2004.04.029; van der Weerd L, 2010, J CEREBR BLOOD F MET, V30, P849, DOI 10.1038/jcbfm.2009.249; Vargas-Roig LM, 1998, INT J CANCER, V79, P468, DOI 10.1002/(SICI)1097-0215(19981023)79:5<468::AID-IJC4>3.0.CO;2-Z; Wagstaff MJD, 1999, J BIOL CHEM, V274, P5061, DOI 10.1074/jbc.274.8.5061; Warner DS, 2004, J EXP BIOL, V207, P3221, DOI 10.1242/jeb.01022	45	25	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66001	10.1371/journal.pone.0066001	http://dx.doi.org/10.1371/journal.pone.0066001			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785464	Green Submitted, Green Published, gold			2022-12-27	WOS:000321038800058
J	Andrighetto, G; Brandts, J; Conte, R; Sabater-Mir, J; Solaz, H; Villatoro, D				Andrighetto, Giulia; Brandts, Jordi; Conte, Rosaria; Sabater-Mir, Jordi; Solaz, Hector; Villatoro, Daniel			Punish and Voice: Punishment Enhances Cooperation when Combined with Norm-Signalling	PLOS ONE			English	Article							ALTRUISTIC PUNISHMENT; SANCTIONS; MONETARY; BEHAVIOR	Material punishment has been suggested to play a key role in sustaining human cooperation. Experimental findings, however, show that inflicting mere material costs does not always increase cooperation and may even have detrimental effects. Indeed, ethnographic evidence suggests that the most typical punishing strategies in human ecologies (e. g., gossip, derision, blame and criticism) naturally combine normative information with material punishment. Using laboratory experiments with humans, we show that the interaction of norm communication and material punishment leads to higher and more stable cooperation at a lower cost for the group than when used separately. In this work, we argue and provide experimental evidence that successful human cooperation is the outcome of the interaction between instrumental decision-making and the norm psychology humans are provided with. Norm psychology is a cognitive machinery to detect and reason upon norms that is characterized by a salience mechanism devoted to track how much a norm is prominent within a group. We test our hypothesis both in the laboratory and with an agent-based model. The agent-based model incorporates fundamental aspects of norm psychology absent from previous work. The combination of these methods allows us to provide an explanation for the proximate mechanisms behind the observed cooperative behaviour. The consistency between the two sources of data supports our hypothesis that cooperation is a product of norm psychology solicited by norm-signalling and coercive devices.	[Andrighetto, Giulia; Conte, Rosaria] Natl Res Council CNR, Inst Cognit Sci & Technol, Rome, Italy; [Andrighetto, Giulia] European Univ Inst, Florence, Italy; [Brandts, Jordi] Univ Autonoma Barcelona, CSIC, Inst Anal Econ, E-08193 Barcelona, Spain; [Brandts, Jordi] Barcelona Grad Sch Econ, Barcelona, Spain; [Sabater-Mir, Jordi; Villatoro, Daniel] CSIC, Inst Invest Intelligencia Artificial, Barcelona, Spain; [Solaz, Hector] Univ Oxford, Nuffield Coll, Oxford, England	Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR); European University Institute; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institut d'Analisi Economica (IAE); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Inteligencia Artificial (IIIA); University of Oxford	Andrighetto, G (corresponding author), Natl Res Council CNR, Inst Cognit Sci & Technol, Rome, Italy.	giulia.andrighetto@gmail.com	Sabater-Mir, Jordi/AAC-8236-2020	Brandts, Jordi/0000-0001-9082-9258; Solaz, Hector/0000-0003-4479-2137	MacNorms(Intramurales de frontera CSIC) [PIF08-007]; GLODERS [Gloders 315874]; Spanish Ministerio de Economia y Competitividad [ECO2011-29847-C02-01]; Generalitat de Catalunya [2009 SGR 820, 2009SGR1434]	MacNorms(Intramurales de frontera CSIC); GLODERS; Spanish Ministerio de Economia y Competitividad(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya)	The work presented in this paper has been performed in the frame of the following projects: 1. MacNorms(Intramurales de frontera CSIC - PIF08-007); 2. GLODERS (Grant: Gloders 315874; FP7/2007-2013); 3. The Spanish Ministerio de Economia y Competitividad (Grant: ECO2011-29847-C02-01); 4. The Generalitat de Catalunya (Grant: 2009 SGR 820 and Grant 2009SGR1434); and 5. The Antoni Serra Ramoneda Research Chair (UAB-CatalunyaCaixa). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrighetto G., 2011, EUROPEAN PERSPECTIVE; Bicchieri C., 2006, GRAMMAR SOC; Boehm C., 1999, HIERARCHY FOREST EVO; Boyd R, 2010, SCIENCE, V328, P617, DOI 10.1126/science.1183665; Brandts J, 2004, PUBLIC CHOICE, V119, P381, DOI 10.1023/B:PUCH.0000033329.53595.1b; Carpenter J, 2011, ECON INQ, V49, P612, DOI 10.1111/j.1465-7295.2009.00268.x; Carpenter JP, 2004, J ECON BEHAV ORGAN, V55, P533, DOI 10.1016/j.jebo.2003.11.007; Chudek M, 2011, TRENDS COGN SCI, V15, P218, DOI 10.1016/j.tics.2011.03.003; Cialdini R. B., 1991, ADV EXPT SOCIAL PSYC, V21, P201, DOI [DOI 10.1016/S0065-2601(08)60330-5, 10.1016/S0065-2601(08)60330-5]; Conte R., 1995, COGNITIVE SOCIAL ACT; CRAWFORD SES, 1995, AM POLIT SCI REV, V89, P582, DOI 10.2307/2082975; Dreber A, 2008, NATURE, V452, P348, DOI 10.1038/nature06723; Egas M, 2008, P ROY SOC B-BIOL SCI, V275, P871, DOI 10.1098/rspb.2007.1558; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2004, EVOL HUM BEHAV, V25, P63, DOI 10.1016/S1090-5138(04)00005-4; Fehr E, 2003, NATURE, V422, P137, DOI 10.1038/nature01474; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; Fischbacher U, 2010, AM ECON REV, V100, P541, DOI 10.1257/aer.100.1.541; Gachter S, 2008, SCIENCE, V322, P1510, DOI 10.1126/science.1164744; Galbiati R, 2008, GAME ECON BEHAV, V64, P146, DOI 10.1016/j.geb.2007.09.004; Guala F, 2012, BEHAV BRAIN SCI, V35, DOI 10.1017/S0140525X11000069; Herrmann B, 2008, SCIENCE, V319, P1362, DOI 10.1126/science.1153808; Janssen MA, 2010, SCIENCE, V328, P613, DOI 10.1126/science.1183532; Masclet D, 2003, AM ECON REV, V93, P366, DOI 10.1257/000282803321455359; Noussair C, 2005, ECON INQ, V43, P649, DOI 10.1093/ei/cbi045; OSTROM E, 1992, AM POLIT SCI REV, V86, P404, DOI 10.2307/1964229; Ostrom E., 1990, GOVERNING COMMONS EV; Sigmund K, 2007, TRENDS ECOL EVOL, V22, P593, DOI 10.1016/j.tree.2007.06.012; Sripada C., 2006, INNATE MIND, P237, DOI DOI 10.1093/ACPROF:OSO/9780195310139.003.0017; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Xiao E, 2005, P NATL ACAD SCI USA, V102, P7398, DOI 10.1073/pnas.0502399102; Xiao E, 2011, J PUBLIC ECON, V95, P1006, DOI 10.1016/j.jpubeco.2010.11.021	32	47	48	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e64941	10.1371/journal.pone.0064941	http://dx.doi.org/10.1371/journal.pone.0064941			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	163FW	23776441	Green Published, gold, Green Submitted			2022-12-27	WOS:000320322400004
J	Borgmann, KL; Conway, CJ; Morrison, ML				Borgmann, Kathi L.; Conway, Courtney J.; Morrison, Michael L.			Breeding Phenology of Birds: Mechanisms Underlying Seasonal Declines in the Risk of Nest Predation	PLOS ONE			English	Article							REPRODUCTIVE-PERFORMANCE; CLUTCH SIZE; BEHAVIORAL INDICATORS; DUSKY FLYCATCHER; SITE SELECTION; GREAT TIT; SPACE USE; SUCCESS; FOREST; FITNESS	Seasonal declines in avian clutch size are well documented, but seasonal variation in other reproductive parameters has received less attention. For example, the probability of complete brood mortality typically explains much of the variation in reproductive success and often varies seasonally, but we know little about the underlying cause of that variation. This oversight is surprising given that nest predation influences many other life-history traits and varies throughout the breeding season in many songbirds. To determine the underlying causes of observed seasonal decreases in risk of nest predation, we modeled nest predation of Dusky Flycatchers (Empidonax oberholseri) in northern California as a function of foliage phenology, energetic demand, developmental stage, conspecific nest density, food availability for nest predators, and nest predator abundance. Seasonal variation in the risk of nest predation was not associated with seasonal changes in energetic demand, conspecific nest density, or predator abundance. Instead, seasonal variation in the risk of nest predation was associated with foliage density (early, but not late, in the breeding season) and seasonal changes in food available to nest predators. Supplemental food provided to nest predators resulted in a numerical response by nest predators, increasing the risk of nest predation at nests that were near supplemental feeders. Our results suggest that seasonal changes in foliage density and factors associated with changes in food availability for nest predators are important drivers of temporal patterns in risk of avian nest predation.	[Borgmann, Kathi L.] Univ Arizona, Sch Nat Resources & Environm, Tucson, AZ 85721 USA; [Conway, Courtney J.] Univ Idaho, US Geol Survey, Idaho Cooperat Fish & Wildlife Res Unit, Coll Nat Resources, Moscow, ID 83843 USA; [Morrison, Michael L.] Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA	University of Arizona; Idaho; University of Idaho; United States Department of the Interior; United States Geological Survey; Texas A&M University System; Texas A&M University College Station	Borgmann, KL (corresponding author), Univ Arizona, Sch Nat Resources & Environm, Tucson, AZ 85721 USA.	klborgmann@gmail.com		Chiaradia, Andre/0000-0002-6178-4211	United States Department of Agriculture Forest Service Lake Tahoe Basin Management Unit, Cooper Ornithological Society; University of Arizona's Silliman Research Grant; Biosphere 2 at the University of Arizona; NSF GK-12 BioME teaching fellowship at the University of Arizona	United States Department of Agriculture Forest Service Lake Tahoe Basin Management Unit, Cooper Ornithological Society; University of Arizona's Silliman Research Grant; Biosphere 2 at the University of Arizona; NSF GK-12 BioME teaching fellowship at the University of Arizona	Support was provided by contributions from United States Department of Agriculture Forest Service Lake Tahoe Basin Management Unit, Cooper Ornithological Society (Mewaldt-King Research Award), The University of Arizona's Silliman Research Grant, Biosphere 2 at the University of Arizona, and NSF GK-12 BioME teaching fellowship at the University of Arizona. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alldredge MW, 2007, ECOL APPL, V17, P948, DOI 10.1890/06-0685; Anderson D. R., 2008, MODEL BASED INFERENC; ANDREN H, 1992, ECOLOGY, V73, P794, DOI 10.2307/1940158; ANGELSTAM P, 1986, OIKOS, V47, P365, DOI 10.2307/3565450; Blums P, 2002, J ANIM ECOL, V71, P280, DOI 10.1046/j.1365-2656.2002.00598.x; Borgmann KL, 2010, MECH UNDERLYING INTR; Brinkhof MWG, 1997, P ROY SOC B-BIOL SCI, V264, P291, DOI 10.1098/rspb.1997.0041; Brown CR, 1999, CONDOR, V101, P230, DOI 10.2307/1369986; Brown WP, 2002, ECOLOGY, V83, P958, DOI 10.2307/3071905; Burhans DE, 2002, J WILDLIFE MANAGE, V66, P240, DOI 10.2307/3802890; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cain JW, 2003, J WILDLIFE MANAGE, V67, P600; Chalfoun AD, 2010, CONDOR, V112, P701, DOI 10.1525/cond.2010.090242; Choi SW, 2008, ZOOL SCI, V25, P53, DOI 10.2108/zsj.25.53; Christians JK, 2001, J ANIM ECOL, V70, P1080, DOI 10.1046/j.0021-8790.2001.00566.x; CLUTTONBROCK TH, 1987, J ANIM ECOL, V56, P53, DOI 10.2307/4799; CONNER RN, 1986, AUK, V103, P23, DOI 10.1093/auk/103.1.23; Conway CJ, 2000, EVOLUTION, V54, P670; Conway CJ, 2000, BEHAV ECOL, V11, P178, DOI 10.1093/beheco/11.2.178; CUSHMAN JH, 1994, OECOLOGIA, V99, P194, DOI 10.1007/BF00317101; Davis SK, 2005, CONDOR, V107, P605, DOI 10.1650/0010-5422(2005)107[0605:NSPATI]2.0.CO;2; Dinsmore SJ, 2002, ECOLOGY, V83, P3476, DOI 10.1890/0012-9658(2002)083[3476:ATFMAN]2.0.CO;2; Emery RB, 2005, J WILDLIFE MANAGE, V69, P1181, DOI 10.2193/0022-541X(2005)069[1181:SVIWNS]2.0.CO;2; Farnsworth GL, 1999, AUK, V116, P1075, DOI 10.2307/4089686; FILLIATER TS, 1994, CONDOR, V96, P761, DOI 10.2307/1369479; Fontaine JJ, 2006, AM NAT, V168, P811, DOI 10.1086/508297; Garrison BA, 2005, CALIF FISH GAME, V91, P1; Grant TA, 2005, AUK, V122, P661, DOI 10.1642/0004-8038(2005)122[0661:TVIPNS]2.0.CO;2; Gruebler MU, 2010, J AVIAN BIOL, V41, P282, DOI 10.1111/j.1600-048X.2009.04865.x; HAFTORN S, 1985, AUK, V102, P470, DOI 10.1093/auk/102.3.470; HARTLEY IR, 1994, ARDEA, V82, P173; HOCHACHKA W, 1990, ECOLOGY, V71, P1279, DOI 10.2307/1938265; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Kroll AJ, 2009, J ORNITHOL, V150, P409, DOI 10.1007/s10336-008-0353-3; LANDA K, 1992, EVOLUTION, V46, P121, DOI [10.1111/j.1558-5646.1992.tb01989.x, 10.2307/2409809]; Liebezeit JR, 2002, CONDOR, V104, P507, DOI 10.1650/0010-5422(2002)104[0507:NPNSSA]2.0.CO;2; Lima SL, 2009, BIOL REV, V84, P485, DOI 10.1111/j.1469-185X.2009.00085.x; Lorenz TJ, 2009, CONDOR, V111, P326, DOI 10.1525/cond.2009.080070; Lozano GA, 1996, J AVIAN BIOL, V27, P164, DOI 10.2307/3677146; Luginbuhl JM, 2001, J FIELD ORNITHOL, V72, P556, DOI 10.1648/0273-8570-72.4.556; Martin TE, 2000, P ROY SOC B-BIOL SCI, V267, P2287, DOI 10.1098/rspb.2000.1281; MARTIN TE, 1988, P NATL ACAD SCI USA, V85, P2196, DOI 10.1073/pnas.85.7.2196; MARTIN TE, 1992, ECOLOGY AND CONSERVATION OF NEOTROPICAL MIGRANT LANDBIRDS, P455; MARTIN TE, 1993, J FIELD ORNITHOL, V64, P507; MARTIN TE, 1995, ECOL MONOGR, V65, P101, DOI 10.2307/2937160; Mermoz ME, 1998, AUK, V115, P871, DOI 10.2307/4089506; Messaoud Y, 2007, AM J BOT, V94, P746, DOI 10.3732/ajb.94.5.746; Muller M, 2005, OECOLOGIA, V143, P37, DOI 10.1007/s00442-004-1770-5; MURPHY MT, 1986, ECOLOGY, V67, P1483, DOI 10.2307/1939079; NAGER RG, 1995, AM NAT, V146, P454, DOI 10.1086/285809; Nams VO, 1997, OECOLOGIA, V110, P440, DOI 10.1007/s004420050179; NOLAN V, 1963, ECOLOGY, V44, P305, DOI 10.2307/1932177; Pacifici K, 2008, AUK, V125, P600, DOI 10.1525/auk.2008.07078; PERRINS CM, 1970, IBIS, V112, P242, DOI 10.1111/j.1474-919X.1970.tb00096.x; PERRINS CM, 1965, J ANIM ECOL, V34, P601, DOI 10.2307/2453; PYKE GH, 1977, Q REV BIOL, V52, P137, DOI 10.1086/409852; Rangen SA, 1999, CAN J ZOOL, V77, P1676, DOI 10.1139/cjz-77-11-1676; REITSMA LR, 1990, OIKOS, V57, P375, DOI 10.2307/3565967; Ricklefs R., 1969, SMITHSON CONTRIB ZOO, P1, DOI [10.5479/si.00810282.9, DOI 10.5479/SI.00810282.9]; Rodewald AD, 2001, AUK, V118, P1018, DOI 10.1642/0004-8038(2001)118[1018:ANSIFL]2.0.CO;2; Rodewald AD, 2010, BIOL INVASIONS, V12, P33, DOI 10.1007/s10530-009-9426-3; Roper JJ, 1997, J AVIAN BIOL, V28, P111, DOI 10.2307/3677304; ROSEBERRY JL, 1970, WILSON BULL, V82, P243; Rotella J. J., 2004, Animal Biodiversity and Conservation, V27, P187; SAS Institute, 2008, SAS VERS 9 2; Schmidt KA, 2001, ECOLOGY, V82, P2937, DOI 10.1890/0012-9658(2001)082[2937:INPISB]2.0.CO;2; Schmidt KA, 2007, ISR J ECOL EVOL, V53, P389, DOI 10.1560/IJEE.53.3.389; SCHULTZ ET, 1993, EVOLUTION, V47, P520, DOI 10.1111/j.1558-5646.1993.tb02111.x; Shaffer Terry L., 2007, Studies in Avian Biology, V34, P84; Shaffer TL, 2004, AUK, V121, P526, DOI 10.1642/0004-8038(2004)121[0526:AUATAN]2.0.CO;2; Sieving KE, 1999, CAN J ZOOL, V77, P1829, DOI 10.1139/cjz-77-11-1829; Sieving KE, 1998, ECOLOGY, V79, P2391, DOI 10.1890/0012-9658(1998)079[2391:NPAASD]2.0.CO;2; Skagen SK, 2010, CONDOR, V112, P8, DOI 10.1525/cond.2010.090155; SKUTCH AF, 1949, IBIS, V91, P430, DOI 10.1111/j.1474-919X.1949.tb02293.x; Smith RJ, 2005, BEHAV ECOL SOCIOBIOL, V57, P231, DOI 10.1007/s00265-004-0855-9; Soderstrom B, 1998, OECOLOGIA, V117, P108, DOI 10.1007/s004420050638; Stearns S.C., 1992, pi; Stephens D.W., 1986, pi; Svensson E, 1997, EVOLUTION, V51, P1276, DOI 10.1111/j.1558-5646.1997.tb03974.x; TINBERGEN L., 1960, ARCH NEERLAND ZOOL, V13, P265; Tomback DF, 1998, CLARKS NUTCRACKER NU; VERHULST S, 1995, ECOLOGY, V76, P2392, DOI 10.2307/2265815; Verhulst S, 2008, PHILOS T R SOC B, V363, P399, DOI 10.1098/rstb.2007.2146; Wiebe KL, 2003, OIKOS, V100, P291, DOI 10.1034/j.1600-0706.2003.12046.x; Wilson S, 2007, CONDOR, V109, P377, DOI 10.1650/0010-5422(2007)109[377:NSPIWP]2.0.CO;2; Winter M, 2005, J WILDLIFE MANAGE, V69, P185, DOI 10.2193/0022-541X(2005)069&lt;0185:VIVEOD&gt;2.0.CO;2; Winter M, 2005, J FIELD ORNITHOL, V76, P61, DOI 10.1648/0273-8570-76.1.61; WOODWARD A, 1994, CAN J FOREST RES, V24, P1133, DOI 10.1139/x94-150; Yunger JA, 2002, J MAMMAL, V83, P267, DOI 10.1644/1545-1542(2002)083<0267:ROTLDP>2.0.CO;2	89	37	38	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65909	10.1371/journal.pone.0065909	http://dx.doi.org/10.1371/journal.pone.0065909			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776566	Green Submitted, gold, Green Published			2022-12-27	WOS:000320322400062
J	Mathieu, A; Delmont, TO; Vogel, TM; Robe, P; Nalin, R; Simonet, P				Mathieu, Alban; Delmont, Tom O.; Vogel, Timothy M.; Robe, Patrick; Nalin, Renaud; Simonet, Pascal			Life on Human Surfaces: Skin Metagenomics	PLOS ONE			English	Article							DIVERSITY	The human skin microbiome could provide another example, after the gut, of the strong positive or negative impact that human colonizing bacteria can have on health. Deciphering functional diversity and dynamics within human skin microbial communities is critical for understanding their involvement and for developing the appropriate substances for improving or correcting their action. We present a direct PCR-free high throughput sequencing approach to unravel the human skin microbiota specificities through metagenomic dataset analysis and inter-environmental comparison. The approach provided access to the functions carried out by dominant skin colonizing taxa, including Corynebacterium, Staphylococcus and Propionibacterium, revealing their specific capabilities to interact with and exploit compounds from the human skin. These functions, which clearly illustrate the unique life style of the skin microbial communities, stand as invaluable investigation targets for understanding and potentially modifying bacterial interactions with the human host with the objective of increasing health and well being.	[Mathieu, Alban; Delmont, Tom O.; Vogel, Timothy M.; Simonet, Pascal] Univ Lyon, Ecole Cent Lyon, Lab Ampere, Environm Microbial Genom Grp, Ecully, France; [Mathieu, Alban; Robe, Patrick; Nalin, Renaud] LibraGen, Toulouse, France	Ecole Centrale de Lyon; Institut National des Sciences Appliquees de Lyon - INSA Lyon	Simonet, P (corresponding author), Univ Lyon, Ecole Cent Lyon, Lab Ampere, Environm Microbial Genom Grp, Ecully, France.	pascal.simonet@ec-lyon.fr	Delmont, Tom/A-4331-2018	Delmont, Tom/0000-0001-7053-7848; Vogel, Timothy/0000-0002-9542-3246	company Libragen	company Libragen	AM, PR and RN are affiliated to the commercial company Libragen. The phD thesis of the first author is financed by the company Libragen but not the research developed in the article. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	CASIANOCOLON A, 1988, APPL ENVIRON MICROB, V54, P1318; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Delmont TO, 2011, ISME J, V5, P1837, DOI 10.1038/ismej.2011.61; Fierer N, 2010, P NATL ACAD SCI USA, V107, P6477, DOI 10.1073/pnas.1000162107; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Fitz-Gibbon S, 2013, J INVEST DERMATOL, V133, P2152, DOI 10.1038/jid.2013.21; Fredricks DN, 2001, J INVEST DERM SYMP P, V6, P167, DOI 10.1046/j.0022-202x.2001.00039.x; Gao Z, 2007, P NATL ACAD SCI USA, V104, P2927, DOI 10.1073/pnas.0607077104; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Griffiths RI, 2000, APPL ENVIRON MICROB, V66, P5488, DOI 10.1128/AEM.66.12.5488-5491.2000; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Kuczynski J, 2012, NAT REV GENET, V13, P47, DOI 10.1038/nrg3129; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Radner FPW, 2011, DERM-ENDOCRINOL, V3, P77, DOI 10.4161/derm.3.2.15472; Wilson M, 2004, MICROBIAL INHABITANT	17	34	37	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65288	10.1371/journal.pone.0065288	http://dx.doi.org/10.1371/journal.pone.0065288			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776466	Green Published, Green Submitted, gold			2022-12-27	WOS:000320322400016
J	Monecke, S; Gavier-Widen, D; Mattsson, R; Rangstrup-Christensen, L; Lazaris, A; Coleman, DC; Shore, AC; Ehricht, R				Monecke, Stefan; Gavier-Widen, Dolores; Mattsson, Roland; Rangstrup-Christensen, Lena; Lazaris, Alexandros; Coleman, David C.; Shore, Anna C.; Ehricht, Ralf			Detection of mecC-Positive Staphylococcus aureus (CC130-MRSA-XI) in Diseased European Hedgehogs (Erinaceus europaeus) in Sweden	PLOS ONE			English	Article							METHICILLIN-RESISTANT; HOMOLOG MECA(LGA251); DIVERGENT MECA; GENE; STRAINS; IDENTIFICATION; PREVALENCE; GUIDELINES; DENMARK; CLONING	Recently, a novel mec gene conferring beta-lactam resistance in Staphylococcus aureus has been discovered. This gene, mecC, is situated on a SCCmec XI element that has to date been identified in clonal complexes 49, 130, 425, 599 and 1943. Some of the currently known isolates have been identified from animals. This, and observations of mecA alleles that do not confer beta-lactam resistance, indicate that mec genes might have a reservoir in Staphylococcus species from animals. Thus it is important also to screen wildlife isolates for mec genes. Here, we describe mecC-positive Staphylococcus aureus (ST130-MRSA-XI) and the lesions related to the infection in two diseased free-ranging European hedgehogs (Erinaceus europaeus). One was found dead in 2003 in central Sweden, and suffered from S. aureus septicaemia. The other one, found on the island of Gotland in the Baltic Sea in 2011, showed a severe dermatitis and was euthanised. ST130-MRSA-XI isolates were isolated from lesions from both hedgehogs and were essentially identical to previously described isolates from humans. Both isolates carried the complete SCCmec XI element. They lacked the lukF-PV/lukS-PV and lukM/lukF-P83 genes, but harboured a gene for an exfoliative toxin homologue previously described from Staphylococcus hyicus, Staphylococcus pseudintermedius and other S. aureus of the CC130 lineage. To the best of our knowledge, these are the first reported cases of CC130-MRSA-XI in hedgehogs. Given that one of the samples was taken as early as 2003, this was the earliest detection of this strain and of mecC in Sweden. This and several other recent observations suggest that CC130 might be a zoonotic lineage of S. aureus and that SCCmec XI/mecC may have originated from animal pathogens.	[Monecke, Stefan; Ehricht, Ralf] Alere Technol GmbH, Jena, Germany; [Monecke, Stefan] Tech Univ Dresden, Fac Med Carl Gustav Carus, Inst Med Microbiol & Hyg, D-01062 Dresden, Germany; [Gavier-Widen, Dolores; Mattsson, Roland; Rangstrup-Christensen, Lena] Natl Vet Inst SVA, Dept Pathol & Wildlife Dis, Uppsala, Sweden; [Gavier-Widen, Dolores] Swedish Univ Agr Sci SLU, Dept Biomed Sci & Vet Publ Hlth, Uppsala, Sweden; [Lazaris, Alexandros; Coleman, David C.; Shore, Anna C.] Univ Dublin Trinity Coll, Dublin Dent Univ Hosp, Microbiol Res Unit, Dublin 2, Ireland; [Shore, Anna C.] Univ Dublin Trinity Coll, St Jamess Hosp, Sch Med, Dept Clin Microbiol, Dublin 2, Ireland	Alere; Technische Universitat Dresden; National Veterinary Institute SVA; Swedish University of Agricultural Sciences; Trinity College Dublin; Trinity College Dublin	Monecke, S (corresponding author), Alere Technol GmbH, Jena, Germany.	monecke@rocketmail.com	Coleman, David C./C-2008-2009	Coleman, David C./0000-0003-1797-2888; Shore, Anna/0000-0002-6667-0918	EU [222633]	EU(European Commission)	Staphylococcus aureus isolates were collected within the framework of the Wildtech project (EU 7th Framework Program for Research and Technological Development, grant agreement no. 222633) in which wild animals are screened for various pathogens.	Agency Veterinary Laboratories, 2004, WILDL DIS UK; Basset P, 2013, J HOSP INFECT, V83, P257, DOI 10.1016/j.jhin.2012.12.004; Bengtsson B, 2011, SVARM 2011 SWEDISH V; Couto I, 1996, MICROB DRUG RESIST, V2, P377, DOI 10.1089/mdr.1996.2.377; Cuny C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024360; Elstrom P, 2011, MRSA INFECT HUMANS N; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Futagawa-Saito K, 2009, FEMS MICROBIOL LETT, V301, P176, DOI 10.1111/j.1574-6968.2009.01823.x; Garcia-Alvarez L, 2011, LANCET INFECT DIS, V11, P595, DOI 10.1016/S1473-3099(11)70126-8; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Harrison EM, 2013, ANTIMICROB AGENTS CH, V57, P1524, DOI 10.1128/AAC.01882-12; Ito T, 2012, ANTIMICROB AGENTS CH, V56, P4997, DOI 10.1128/AAC.01199-12; Ito T, 2009, ANTIMICROB AGENTS CH, V53, P4961, DOI 10.1128/AAC.00579-09; Iyori K, 2010, FEMS MICROBIOL LETT, V312, P169, DOI 10.1111/j.1574-6968.2010.02113.x; Laurent F, 2012, EMERG INFECT DIS, V18, P1465, DOI 10.3201/eid1809.111920; Le Marechal C, 2011, J BACTERIOL, V193, P2353, DOI 10.1128/JB.00045-11; Monecke S, 2012, ANTIMICROB AGENTS CH, V56, P5547, DOI 10.1128/AAC.00574-12; Monecke S, 2012, MOL CELL PROBE, V26, P99, DOI 10.1016/j.mcp.2012.01.001; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; Paterson GK, 2012, J ANTIMICROB CHEMOTH, V67, P2809, DOI 10.1093/jac/dks329; Petersen A, 2013, CLIN MICROBIOL INFEC, V19, pE16, DOI 10.1111/1469-0691.12036; Queck SY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000533; Robb A, 2013, VET MICROBIOL, V162, P300, DOI 10.1016/j.vetmic.2012.09.003; Sabat AJ, 2012, J CLIN MICROBIOL, V50, P3374, DOI 10.1128/JCM.01121-12; Shore AC, 2011, ANTIMICROB AGENTS CH, V55, P3765, DOI 10.1128/AAC.00187-11; SMITH JMB, 1965, J HYG-CAMB, V63, P285, DOI 10.1017/S0022172400045162; Stegger M, 2012, CLIN MICROBIOL INFEC, V18, P395, DOI 10.1111/j.1469-0691.2011.03715.x; Unnerstad HE, 2012, SVENSK VETERINARTIDN, P35; Unnerstad HE, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-6; Walther B, 2012, EMERG INFECT DIS, V18, P2017, DOI 10.3201/eid1812.120238; Watanabe T, 2000, J BACTERIOL, V182, P4101, DOI 10.1128/JB.182.14.4101-4103.2000; Wu SW, 1996, MICROB DRUG RESIST, V2, P435, DOI 10.1089/mdr.1996.2.435	32	61	62	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66166	10.1371/journal.pone.0066166	http://dx.doi.org/10.1371/journal.pone.0066166			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776626	Green Published, gold, Green Submitted			2022-12-27	WOS:000320322400085
J	Warfe, DM; Jardine, TD; Pettit, NE; Hamilton, SK; Pusey, BJ; Bunn, SE; Davies, PM; Douglas, MM				Warfe, Danielle M. y; Jardine, Timothy D.; Pettit, Neil E.; Hamilton, Stephen K.; Pusey, Bradley J.; Bunn, Stuart E.; Davies, Peter M.; Douglas, Michael M.			Productivity, Disturbance and Ecosystem Size Have No Influence on Food Chain Length in Seasonally Connected Rivers	PLOS ONE			English	Article							DRY TROPICAL RIVERS; WEB STRUCTURE; FLOODPLAIN RIVER; NORTHERN AUSTRALIA; TROPHIC POSITION; STABLE-ISOTOPE; LITTORAL-ZONE; SPATIAL SCALE; BODY-SIZE; COMMUNITY	The food web is one of the oldest and most central organising concepts in ecology and for decades, food chain length has been hypothesised to be controlled by productivity, disturbance, and/or ecosystem size; each of which may be mediated by the functional trophic role of the top predator. We characterised aquatic food webs using carbon and nitrogen stable isotopes from 66 river and floodplain sites across the wet-dry tropics of northern Australia to determine the relative importance of productivity (indicated by nutrient concentrations), disturbance (indicated by hydrological isolation) and ecosystem size, and how they may be affected by food web architecture. We show that variation in food chain length was unrelated to these classic environmental determinants, and unrelated to the trophic role of the top predator. This finding is a striking exception to the literature and is the first published example of food chain length being unaffected by any of these determinants. We suggest the distinctive seasonal hydrology of northern Australia allows the movement of fish predators, linking isolated food webs and potentially creating a regional food web that overrides local effects of productivity, disturbance and ecosystem size. This finding supports ecological theory suggesting that mobile consumers promote more stable food webs. It also illustrates how food webs, and energy transfer, may function in the absence of the human modifications to landscape hydrological connectivity that are ubiquitous in more populated regions.	[Warfe, Danielle M. y; Douglas, Michael M.] Charles Darwin Univ, Res Inst Environm & Livelihoods, Darwin, NT 0909, Australia; [Jardine, Timothy D.] Univ Saskatchewan, Toxicol Ctr, Saskatoon, SK, Canada; [Jardine, Timothy D.; Pusey, Bradley J.; Bunn, Stuart E.] Griffith Univ, Australian Rivers Inst, Nathan, Qld 4111, Australia; [Pettit, Neil E.; Pusey, Bradley J.; Davies, Peter M.] Univ Western Australia, Ctr Excellence Nat Resource Management, Albany, WA, Australia; [Hamilton, Stephen K.] Michigan State Univ, Kellogg Biol Stn, Hickory Corners, MI 49060 USA; [Hamilton, Stephen K.] Michigan State Univ, Dept Zool, Hickory Corners, MI USA	Charles Darwin University; University of Saskatchewan; Griffith University; University of Western Australia; Michigan State University; Michigan State University	Warfe, DM (corresponding author), Univ Western Australia, Ctr Excellence Nat Resource Management, Albany, WA, Australia.	danielle.warfe@uwa.edu.au	Pettit, Neil E/D-4309-2013; Warfe, Danielle M/C-2426-2013; Bunn, Stuart E/B-9065-2008; Jardine, Timothy Donald/AFZ-4837-2022; Hamilton, Stephen K/N-2979-2014; Douglas, Michael M/I-3149-2012	Bunn, Stuart E/0000-0002-6540-3586; Hamilton, Stephen K/0000-0002-4702-9017; Douglas, Michael M/0000-0003-3650-3374; Jardine, Timothy/0000-0002-5917-9792; Pettit, Neil/0000-0001-6126-8914	Australian Government's Commonwealth Environment Research Facilities initiative; Australian Government; Land and Water Australia; Fisheries Research and Development Corporation; Queensland Government	Australian Government's Commonwealth Environment Research Facilities initiative(Australian Government); Australian Government(Australian GovernmentCGIAR); Land and Water Australia; Fisheries Research and Development Corporation; Queensland Government	This project forms part of the Tropical Rivers and Coastal Knowledge (TRaCK) Program. TRaCK received major funding for its research through the Australian Government's Commonwealth Environment Research Facilities initiative (http://www.environment.gov.au/about/programs/cerf/); the Australian Government's Raising National Water Standards Program (http://archive.nwc.gov.au/rnws); Land and Water Australia (http://lwa.gov.au); the Fisheries Research and Development Corporation (http://www.frdc.com.au) and the Queensland Government's Smart State Innovation Fund (http://www.qld.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrington DA, 2006, J N AM BENTHOL SOC, V25, P126, DOI 10.1899/0887-3593(2006)25[126:HATSFP]2.0.CO;2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BRIAND F, 1987, SCIENCE, V238, P956, DOI 10.1126/science.3672136; Brodie JE, 2005, MAR FRESHWATER RES, V56, P279, DOI 10.1071/MF04081; Bunn SE, 2006, RIVER RES APPL, V22, P179, DOI 10.1002/rra.904; Bunn SE, 2003, FRESHWATER BIOL, V48, P619, DOI 10.1046/j.1365-2427.2003.01031.x; Burford MA, 2011, MAR FRESHWATER RES, V62, P141, DOI 10.1071/MF10224; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; CABANA G, 1994, NATURE, V372, P255, DOI 10.1038/372255a0; Calcagno V, 2011, P ROY SOC B-BIOL SCI, V278, P3042, DOI 10.1098/rspb.2011.0112; CARPENTER SR, 1987, ECOLOGY, V68, P1863, DOI 10.2307/1939878; COHEN JE, 1991, AM NAT, V138, P1542, DOI 10.1086/285299; Davis AM, 2010, J FISH BIOL, V76, P862, DOI 10.1111/j.1095-8649.2010.02541.x; DEANGELIS DL, 1989, AM NAT, V134, P778, DOI 10.1086/285011; DEATH RG, 1994, J N AM BENTHOL SOC, V13, P125, DOI 10.2307/1467232; Doi H, 2009, OIKOS, V118, P138, DOI 10.1111/j.1600-0706.2008.17171.x; Douglas MM, 2005, MAR FRESHWATER RES, V56, P329, DOI 10.1071/MF04084; Elton C., 1927, ANIMAL ECOLOGY; Francoeur SN, 2001, J N AM BENTHOL SOC, V20, P358, DOI 10.2307/1468034; Ganf GG, 2007, MAR FRESHWATER RES, V58, P315, DOI 10.1071/MF06161; Gooderham J., 2002, WATERBUG BOOK; HAIRSTON NG, 1993, AM NAT, V142, P379, DOI 10.1086/285546; Hoeinghaus DJ, 2008, OIKOS, V117, P984, DOI 10.1111/j.0030-1299.2008.16459.x; Holt RD, 2002, ECOL RES, V17, P261, DOI 10.1046/j.1440-1703.2002.00485.x; Hunt RJ, 2012, FRESHWATER BIOL, V57, P435, DOI 10.1111/j.1365-2427.2011.02708.x; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Jardine TD, RIVER RES A IN PRESS; Jardine TD, 2012, OECOLOGIA, V168, P829, DOI 10.1007/s00442-011-2148-0; Jardine TD, 2012, J ANIM ECOL, V81, P310, DOI 10.1111/j.1365-2656.2011.01925.x; Jardine TD, 2011, MAR FRESHWATER RES, V62, P83, DOI 10.1071/MF10211; JENKINS B, 1992, OIKOS, V65, P249, DOI 10.2307/3545016; Jennings S, 2003, P ROY SOC B-BIOL SCI, V270, P1413, DOI 10.1098/rspb.2003.2392; Jepsen DB, 2002, OIKOS, V96, P46, DOI 10.1034/j.1600-0706.2002.960105.x; Kaunzinger CMK, 1998, NATURE, V395, P495, DOI 10.1038/26741; Kennard MJ, 2010, FRESHWATER BIOL, V55, P171, DOI 10.1111/j.1365-2427.2009.02307.x; Lake PS, 2003, FRESHWATER BIOL, V48, P1161, DOI 10.1046/j.1365-2427.2003.01086.x; Layman CA, 2005, ECOLOGY, V86, P2530, DOI 10.1890/04-1098; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Leigh C, 2010, MAR FRESHWATER RES, V61, P357, DOI 10.1071/MF09107; Levin SA, 1998, ECOSYSTEMS, V1, P431, DOI 10.1007/s100219900037; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; McCann KS, 2009, PHILOS T R SOC B, V364, P1789, DOI 10.1098/rstb.2008.0273; McCann KS, 2005, ECOL LETT, V8, P513, DOI 10.1111/j.1461-0248.2005.00742.x; McHugh PA, 2010, ECOL LETT, V13, P881, DOI 10.1111/j.1461-0248.2010.01484.x; Moliere DR, 2009, J HYDROL, V367, P1, DOI 10.1016/j.jhydrol.2008.12.015; Pettit NE, 2012, MAR FRESHWATER RES, V63, P788, DOI 10.1071/MF12114; PIMM SL, 1987, OIKOS, V50, P302, DOI 10.2307/3565490; PIMM SL, 1977, NATURE, V268, P329, DOI 10.1038/268329a0; Polis GA, 1998, NATURE, V395, P744, DOI 10.1038/27323; Polis GA, 1997, ANNU REV ECOL SYST, V28, P289, DOI 10.1146/annurev.ecolsys.28.1.289; Post DM, 2007, OIKOS, V116, P775, DOI 10.1111/j.2007.0030-1299.15552.x; Post DM, 2000, NATURE, V405, P1047, DOI 10.1038/35016565; Post DM, 2002, TRENDS ECOL EVOL, V17, P269, DOI 10.1016/S0169-5347(02)02455-2; Pusey B., 2004, FRESHWATER FISHES N, DOI DOI 10.1071/9780643092082; Reid MA, 2012, RIVER RES APPL, V28, P827, DOI 10.1002/rra.1491; Sabo JL, 2010, SCIENCE, V330, P965, DOI 10.1126/science.1196005; Sabo JL, 2009, ANN NY ACAD SCI, V1162, P187, DOI 10.1111/j.1749-6632.2009.04445.x; Schindler DE, 1997, SCIENCE, V277, P248, DOI 10.1126/science.277.5323.248; Schneider DW, 1997, OECOLOGIA, V110, P567, DOI 10.1007/s004420050197; SCHOENER TW, 1989, ECOLOGY, V70, P1559, DOI 10.2307/1938088; Spencer M, 1996, OIKOS, V75, P419, DOI 10.2307/3545882; Stein JL, 2002, LANDSCAPE URBAN PLAN, V60, P1, DOI 10.1016/S0169-2046(02)00048-8; Stein JL, 2009, ECOHYDROLOGICAL CLAS; Stenroth P, 2008, OECOLOGIA, V156, P681, DOI 10.1007/s00442-008-1019-9; Sterner RW, 1997, ECOLOGY, V78, P2258, DOI 10.1890/0012-9658(1997)078[2258:TEOFCL]2.0.CO;2; Takimoto G, ECOL RES IN PRESS; Takimoto G, 2012, ECOL RES, V27, P481, DOI 10.1007/s11284-012-0929-5; Takimoto G, 2008, ECOLOGY, V89, P3001, DOI 10.1890/07-1990.1; Thompson RM, 2005, OIKOS, V108, P137, DOI 10.1111/j.0030-1299.2005.11600.x; Townsend CR, 1998, ECOL LETT, V1, P200; Townsend SA, 2008, FRESHWATER BIOL, V53, P509, DOI 10.1111/j.1365-2427.2007.01916.x; Townsend SA, 2011, J N AM BENTHOL SOC, V30, P603, DOI 10.1899/10-066.1; Van de Koppel J, 2005, ECOSYSTEMS, V8, P801, DOI 10.1007/s10021-005-0134-2; Vander Zanden MJ, 2007, OIKOS, V116, P1378, DOI 10.1111/j.2007.0030-1299.16036.x; Vander Zanden MJ, 1999, AM NAT, V154, P406, DOI 10.1086/303250; Vanderklift MA, 2003, OECOLOGIA, V136, P169, DOI 10.1007/s00442-003-1270-z; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; Walters AW, 2008, ECOLOGY, V89, P3261, DOI 10.1890/08-0273.1; Ward DP, 2013, ECOHYDROLOGY, V6, P312, DOI 10.1002/eco.1270; Warfe DM, 2011, FRESHWATER BIOL, V56, P2169, DOI 10.1111/j.1365-2427.2011.02660.x; Warfe DM, 2013, FRESHWATER BIOL, V58, P292, DOI 10.1111/fwb.12058; Warren PH, 1996, OIKOS, V75, P407, DOI 10.2307/3545881; Webster IT, 2005, MAR FRESHWATER RES, V56, P303, DOI 10.1071/MF04083; Williams AJ, 2006, HYDROBIOLOGIA, V569, P493, DOI 10.1007/s10750-006-0151-y; WINEMILLER KO, 1990, ECOL MONOGR, V60, P331, DOI 10.2307/1943061; Winemiller KO, 1998, J FISH BIOL, V53, P267, DOI 10.1111/j.1095-8649.1998.tb01032.x	86	33	34	0	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66240	10.1371/journal.pone.0066240	http://dx.doi.org/10.1371/journal.pone.0066240			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776641	Green Published, gold			2022-12-27	WOS:000320322400092
J	Chiu, TY; Chen, PH; Chang, CL; Yang, DM				Chiu, Tai-Yu; Chen, Po-Hsun; Chang, Cha-Ling; Yang, De-Ming			Live-Cell Dynamic Sensing of Cd2+ with a FRET-Based Indicator	PLOS ONE			English	Article							DIVALENT METAL TRANSPORTER-1; FLUORESCENT INDICATORS; CADMIUM RESISTANCE; IONIC MIMICRY; MERR FAMILY; MECHANISMS; CYTOTOXICITY; TOXICITY; CHLORIDE; MUSCLE	Cd2+ causes damages to several human tissues. Although the toxicological and carcinogenetic mechanisms of Cd2+ have been previously established, some basic questions on this toxicant remain unclear. In this study, we constructed Met-cad 1.57, a new fluorescent resonance energy transfer (FRET)-based Cd2+ indicator, which contains a portion of a Cd2+-binding protein (CadR) obtained from Pseudomonas putida as the Cd2+ sensing key. We produced a human embryonic kidney cell line HEK-MCD157 which stably expresses the Met-cad 1.57 for further investigations. Both fluorescence spectroscopy and FRET microscopic ratio imaging were used to monitor the Cd2+ concentration within the living HEK-MCD157 cells. The dissociation constant of Met-cad 1.57 was approximately 271 nM. The function of Ca2+ channels as a potential Cd2+ entry gateway was further confirmed in the HEK-MCD157 cells. The organelle-targeted property of the protein-based Cd2+ indicator directly reveals the nucleus accumulation phenomena. In summary, a human kidney cell line that stably expresses the FRET-based Cd2+ indicator Met-cad 1.57 was constructed for reliable and convenient investigations to determine the Cd2+ concentration within living cells, including the identification of the entry pathway of Cd2+ and sub-cellular sequestration.	[Chiu, Tai-Yu; Chen, Po-Hsun; Chang, Cha-Ling; Yang, De-Ming] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Chiu, Tai-Yu; Chen, Po-Hsun; Yang, De-Ming] Sch Med Technol & Engn, Inst Biophoton, Taipei, Taiwan; [Yang, De-Ming] Natl Yang Ming Univ, Biophoton & Mol Imaging Res Ctr, Taipei 112, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Yang, DM (corresponding author), Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan.	yang.deming@gmail.com	Yang, De-Ming/AAW-9886-2020	Yang, De-Ming/0000-0002-6923-4855; Dague, Etienne/0000-0003-3290-9166	National Science Council of the Republic of China, Taiwan [NSC-100-2320-B-075-004]; Taipei Veterans General Hospital [V100C1-032, V101C1-072, V102C-163]; UTVGH (University System of Taiwan) [VGHUST100-G1-1-2, VGHUST102-G7-1-2E]; National Yang-Ming University (Ministry of Education, Aim for the Top University Plan); Biophotonics and Molecular Imaging Research Center; UTVGH (Taipei Veterans General Hospital) [VGHUST100-G1-1-2, VGHUST102-G7-1-2E]	National Science Council of the Republic of China, Taiwan(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital(Taipei Veterans General Hospital); UTVGH (University System of Taiwan); National Yang-Ming University (Ministry of Education, Aim for the Top University Plan)(Ministry of Education, Taiwan); Biophotonics and Molecular Imaging Research Center; UTVGH (Taipei Veterans General Hospital)(Taipei Veterans General Hospital)	This work is supported by grants from the National Science Council of the Republic of China, Taiwan (Grants NSC-100-2320-B-075-004), Taipei Veterans General Hospital (V100C1-032, V101C1-072, V102C-163), the Joint Projects of UTVGH (University System of Taiwan together with Taipei Veterans General Hospital: VGHUST100-G1-1-2, VGHUST102-G7-1-2E), and National Yang-Ming University (Ministry of Education, Aim for the Top University Plan) and Biophotonics and Molecular Imaging Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Toxic Substances and Disease Registry (ATSDR), 2005, CERCLA PRIOR LIST HA; Bannon DI, 2002, BIOCHEM BIOPH RES CO, V295, P978, DOI 10.1016/S0006-291X(02)00756-8; Bertin G, 2006, BIOCHIMIE, V88, P1549, DOI 10.1016/j.biochi.2006.10.001; Bressler JP, 2004, ANN NY ACAD SCI, V1012, P142, DOI 10.1196/annals.1306.011; Bridges CC, 2005, TOXICOL APPL PHARM, V204, P274, DOI 10.1016/j.taap.2004.09.007; Brown NL, 2003, FEMS MICROBIOL REV, V27, P145, DOI 10.1016/S0168-6445(03)00051-2; Changela A, 2003, SCIENCE, V301, P1383, DOI 10.1126/science.1085950; Cheng TY, 2008, J AM CHEM SOC, V130, P16160, DOI 10.1021/ja806928n; Chiu TY, 2012, TOXICOL SCI, V126, P436, DOI 10.1093/toxsci/kfs007; CLARKSON TW, 1993, ANNU REV PHARMACOL, V33, P545, DOI 10.1146/annurev.pa.33.040193.002553; Dalton TP, 2005, P NATL ACAD SCI USA, V102, P3401, DOI 10.1073/pnas.0406085102; Dean KM, 2012, BBA-MOL CELL RES, V1823, P1406, DOI 10.1016/j.bbamcr.2012.04.001; FLIEGEL L, 1989, J BIOL CHEM, V264, P21522; FUKUDA J, 1977, SCIENCE, V196, P309, DOI 10.1126/science.847472; Goyer RA, 2008, CASARETT DOULLS TOXI; He L, 2009, TOXICOL APPL PHARM, V238, P250, DOI 10.1016/j.taap.2009.02.017; Joseph P, 2009, TOXICOL APPL PHARM, V238, P272, DOI 10.1016/j.taap.2009.01.011; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Lee SW, 2001, APPL ENVIRON MICROB, V67, P1437, DOI 10.1128/AEM.67.4.1437-1444.2001; Leslie EM, 2006, MOL PHARMACOL, V69, P629, DOI 10.1124/mol.105.014241; Li IT, 2006, BIOTECHNOL LETT, V28, P1971, DOI 10.1007/s10529-006-9193-5; LIN CJ, 1995, TOXICOL APPL PHARM, V133, P20, DOI 10.1006/taap.1995.1122; Martineau C, 2010, TOXICOL LETT, V199, P357, DOI 10.1016/j.toxlet.2010.09.019; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Moulis JM, 2010, BIOMETALS, V23, P877, DOI 10.1007/s10534-010-9336-y; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Nishimura Y, 2006, TOXICOL IN VITRO, V20, P211, DOI 10.1016/j.tiv.2005.06.006; Peng XJ, 2007, J AM CHEM SOC, V129, P1500, DOI 10.1021/ja0643319; RIZZUTO R, 1989, J BIOL CHEM, V264, P10595; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Taki M, 2008, J AM CHEM SOC, V130, P12564, DOI 10.1021/ja803429z; Thevenod F, 2010, BIOMETALS, V23, P857, DOI 10.1007/s10534-010-9309-1; Tvermoes BE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020542; Vesey DA, 2010, TOXICOL LETT, V198, P13, DOI 10.1016/j.toxlet.2010.05.004; Vinkenborg JL, 2010, CURR OPIN CHEM BIOL, V14, P231, DOI 10.1016/j.cbpa.2009.11.022; Waisberg M, 2003, TOXICOLOGY, V192, P95, DOI 10.1016/S0300-483X(03)00305-6; Wegner SV, 2010, J AM CHEM SOC, V132, P2567, DOI 10.1021/ja9097324; Weidner WJ, 1997, ARCH TOXICOL, V71, P455, DOI 10.1007/s002040050411	39	28	28	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65853	10.1371/journal.pone.0065853	http://dx.doi.org/10.1371/journal.pone.0065853			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776557	Green Published, gold, Green Submitted			2022-12-27	WOS:000320755400073
J	Cunningham, CJ; Pitschi, V; Anderson, P; Barry, DA; Patterson, C; Peshkur, TA				Cunningham, Colin J.; Pitschi, Vanessa; Anderson, Peter; Barry, D. A.; Patterson, Colin; Peshkur, Tanya A.			Field Application of a Rapid Spectrophotometric Method for Determination of Persulfate in Soil	PLOS ONE			English	Article							OXIDATION	Remediation of hydrocarbon contaminated soils can be performed both in situ and ex situ using chemical oxidants such as sodium persulfate. Standard methods for quantifying persulfate require either centrifugation or prolonged settling times. An optimized soil extraction procedure was developed for persulfate involving simple water extraction using a modified disposable syringe. This allows considerable saving of time and removes the need for centrifugation. The extraction time was reduced to only 5 min compared to 15 min for the standard approach. A comparison of the two approaches demonstrated that each provides comparable results. Comparisons were made using high (93 g kg(-1) soil) and low (9.3 g kg(-1) soil) additions of sodium persulfate to a petroleum hydrocarbon-contaminated soil, as well as sand spiked with diesel. Recoveries of 95 +/- 1% and 96 +/- 10% were observed with the higher application rate in the contaminated soil and spiked sand, respectively. Corresponding recoveries of 86 +/- 5% and 117 +/- 19% were measured for the lower application rate. Results were obtained in only 25 min and the method is well suited to batch analyses. In addition, it is suitable for application in a small field laboratory or even a mobile, vehicle-based system, as it requires minimal equipment and reagents.	[Cunningham, Colin J.; Anderson, Peter; Patterson, Colin; Peshkur, Tanya A.] Univ Strathclyde, Fac Engn, Scottish Environm Technol Network, Glasgow, Lanark, Scotland; [Pitschi, Vanessa; Barry, D. A.] Ecole Polytech Fed Lausanne, Fac Environm Nat Architectural & Construit ENAC, Inst Sci & Technol Environm, Lab Technol Ecol, Lausanne, Switzerland	University of Strathclyde; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Cunningham, CJ (corresponding author), Univ Strathclyde, Fac Engn, Scottish Environm Technol Network, Glasgow, Lanark, Scotland.	colin.cunningham@strath.ac.uk	Barry, D. Andrew/C-6077-2008	Barry, D. Andrew/0000-0002-8621-0425	Contaminated Land Assessment and Remediation Research Centre (CLARRC)	Contaminated Land Assessment and Remediation Research Centre (CLARRC)	The work was funded by Contaminated Land Assessment and Remediation Research Centre (CLARRC). The funders undertook the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Grimshaw H.M., 1989, CHEM ANAL ECOLOGICAL, V2nd, P81; Huang KC, 2002, CHEMOSPHERE, V49, P413, DOI 10.1016/S0045-6535(02)00330-2; Ko S, 2012, J ENVIRON MANAGE, V108, P42, DOI 10.1016/j.jenvman.2012.04.034; Liang CJ, 2008, WATER RES, V42, P4091, DOI 10.1016/j.watres.2008.06.022; Liang CJ, 2008, CHEMOSPHERE, V73, P1540, DOI 10.1016/j.chemosphere.2008.08.043; Liang CJ, 2003, SOIL SEDIMENT CONTAM, V12, P207, DOI 10.1080/713610970; Rivas FJ, 2006, J HAZARD MATER, V138, P234, DOI 10.1016/j.jhazmat.2006.07.048; Schumb WC, 1940, J AM CHEM SOC, V62, P3416, DOI 10.1021/ja01869a036; SHIUNDU PM, 1990, CAN J CHEM, V68, P1750, DOI 10.1139/v90-272; Walker A, 2000, TECHN PRAT, P173; Yazgan MS, 2005, CHEMOSPHERE, V60, P1325, DOI 10.1016/j.chemosphere.2005.01.075; Yen CH, 2011, J HAZARD MATER, V186, P2097, DOI 10.1016/j.jhazmat.2010.12.129	12	27	27	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65106	10.1371/journal.pone.0065106	http://dx.doi.org/10.1371/journal.pone.0065106			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776446	Green Submitted, Green Published, gold			2022-12-27	WOS:000320755400010
J	Hutchison, MR				Hutchison, Michele R.			Mice with a Conditional Deletion of the Neurotrophin Receptor TrkB Are Dwarfed, and Are Similar to Mice with a MAPK14 Deletion	PLOS ONE			English	Article							SRY-RELATED GENE; LONGITUDINAL BONE-GROWTH; AUTOSOMAL SEX REVERSAL; ATDC5 IN-VITRO; CHONDROCYTE DIFFERENTIATION; CLEIDOCRANIAL DYSPLASIA; OSTEOBLAST DIFFERENTIATION; CAMPOMELIC DYSPLASIA; TARGETED DISRUPTION; KINASE PATHWAYS	Long bone growth results from ordered chondrocyte development within the cartilagenous growth plate. Chondrocytes are recruited from a resting pool to proliferate along the long axis of the bone, until various signals trigger differentiation and hypertrophy. We have shown previously that the neurotrophin receptor TrkB is expressed in growth plate chondrocytes, where the tyrosine kinase receptor regulates the pace of hypertrophic differentiation by modulating the activities of ERK and p38 MAP kinases. To investigate the physiological relevance of TrkB to bone growth in vivo, we generated mice with a targeted disruption of the receptor, and compared them to mice targeted for MAPK14, the gene for p38 alpha. The TrkB mutant and p38 alpha mutant mice showed a similar degree of dwarfism and delayed hypertrophic differentiation. To extend these findings, we showed that both the TrkB and p38 alpha mutant mice have altered expression of Runx2 and Sox9, two key transcription factors required for skeletogenesis. The data provides in vivo evidence for the role of TrkB in bone growth, supports the role of p38 downstream of TrkB, and suggests that Runx2 and Sox9 expression is regulated by this pathway at the growth plate.	Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Hutchison, MR (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA.	Michele.hutchison@utsw.edu			National Institutes of Health [K08DK073447, R03DK089151]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK089151, K08DK073447] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by National Institutes of Health Grants K08DK073447 and R03DK089151 to MRH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Allen M, 2000, J EXP MED, V191, P859, DOI 10.1084/jem.191.5.859; ALLEN SJ, 1994, NEUROSCIENCE, V60, P825, DOI 10.1016/0306-4522(94)90507-X; ARMANINI MP, 1995, EUR J NEUROSCI, V7, P1403, DOI 10.1111/j.1460-9568.1995.tb01132.x; Asaumi K, 2000, BONE, V26, P625, DOI 10.1016/S8756-3282(00)00281-7; Baxter GT, 1997, J NEUROSCI, V17, P2683; Beardmore VA, 2005, MOL CELL BIOL, V25, P10454, DOI 10.1128/MCB.25.23.10454-10464.2005; Cobb MH, 1999, PROG BIOPHYS MOL BIO, V71, P479, DOI 10.1016/S0079-6107(98)00056-X; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Eide FF, 1996, J NEUROSCI, V16, P3123; ERNFORS P, 1991, NEURON, V7, P165, DOI 10.1016/0896-6273(91)90084-D; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; HUNZIKER EB, 1994, MICROSC RES TECHNIQ, V28, P505, DOI 10.1002/jemt.1070280606; Hutchison MR, 2010, MOL ENDOCRINOL, V24, P193, DOI 10.1210/me.2009-0228; Hutchison MR, 2012, MOL ENDOCRINOL; Inada M, 1999, DEV DYNAM, V214, P279, DOI 10.1002/(SICI)1097-0177(199904)214:4<279::AID-AJA1>3.0.CO;2-W; Kajiya M, 2008, J BIOL CHEM, V283, P16259, DOI 10.1074/jbc.M800668200; Kim IS, 1999, MECH DEVELOP, V80, P159, DOI 10.1016/S0925-4773(98)00210-X; KLEIN R, 1993, CELL, V75, P113, DOI 10.1016/0092-8674(93)90683-H; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Kurihara H, 2003, J PERIODONTOL, V74, P76, DOI 10.1902/jop.2003.74.1.76; Lee B, 1997, NAT GENET, V16, P307, DOI 10.1038/ng0797-307; Luikart BW, 2003, NEUROSCIENCE, V117, P847, DOI 10.1016/S0306-4522(02)00719-4; Minichiello L, 2002, NEURON, V36, P121, DOI 10.1016/S0896-6273(02)00942-X; Mudgett JS, 2000, P NATL ACAD SCI USA, V97, P10454, DOI 10.1073/pnas.180316397; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Nakahashi T, 2000, FEBS LETT, V470, P113, DOI 10.1016/S0014-5793(00)01302-8; Ng LJ, 1997, DEV BIOL, V183, P108, DOI 10.1006/dbio.1996.8487; NILSSON A, 1994, EUR J CLIN NUTR, V48, pS150; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Ovchinnikov DA, 2000, GENESIS, V26, P145, DOI 10.1002/(SICI)1526-968X(200002)26:2<145::AID-GENE14>3.0.CO;2-C; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Pinski J, 2002, CANCER RES, V62, P986; Sabio G, 2005, EMBO J, V24, P1134, DOI 10.1038/sj.emboj.7600578; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shukunami C, 1997, J BONE MINER RES, V12, P1174, DOI 10.1359/jbmr.1997.12.8.1174; Shukunami C, 1996, J CELL BIOL, V133, P457, DOI 10.1083/jcb.133.2.457; Stanton LA, 2004, BIOCHEM J, V378, P53, DOI 10.1042/BJ20030874; Tamura K, 2000, CELL, V102, P221, DOI 10.1016/S0092-8674(00)00027-1; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; WRIGHT E, 1995, NAT GENET, V9, P15, DOI 10.1038/ng0195-15; Yamashiro T, 2001, BONE, V28, P404, DOI 10.1016/S8756-3282(01)00405-7; Yoshida CA, 2004, GENE DEV, V18, P952, DOI 10.1101/gad.1174704; Yoshimura S, 2010, MULT SCLER J, V16, P1178, DOI 10.1177/1352458510375706; Zhang R, 2006, P NATL ACAD SCI USA, V103, P365, DOI 10.1073/pnas.0507979103; Zhao Q, 1997, DEV DYNAM, V209, P377, DOI 10.1002/(SICI)1097-0177(199708)209:4<377::AID-AJA5>3.0.CO;2-F	47	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66206	10.1371/journal.pone.0066206	http://dx.doi.org/10.1371/journal.pone.0066206			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776632	Green Published, gold, Green Submitted			2022-12-27	WOS:000320755400121
J	Patai, EZ; Buckley, A; Nobre, AC				Patai, Eva Zita; Buckley, Alice; Nobre, Anna Christina			Is Attention Based on Spatial Contextual Memory Preferentially Guided by Low Spatial Frequency Signals?	PLOS ONE			English	Article							TOP-DOWN FACILITATION; PROACTIVE BRAIN; ASSOCIATIONS; SCENE; PERCEPTION; COARSE; MODEL; PARAHIPPOCAMPAL; HIPPOCAMPUS; SELECTION	A popular model of visual perception states that coarse information (carried by low spatial frequencies) along the dorsal stream is rapidly transmitted to prefrontal and medial temporal areas, activating contextual information from memory, which can in turn constrain detailed input carried by high spatial frequencies arriving at a slower rate along the ventral visual stream, thus facilitating the processing of ambiguous visual stimuli. We were interested in testing whether this model contributes to memory-guided orienting of attention. In particular, we asked whether global, low-spatial frequency (LSF) inputs play a dominant role in triggering contextual memories in order to facilitate the processing of the upcoming target stimulus. We explored this question over four experiments. The first experiment replicated the LSF advantage reported in perceptual discrimination tasks by showing that participants were faster and more accurate at matching a low spatial frequency version of a scene, compared to a high spatial frequency version, to its original counterpart in a forced-choice task. The subsequent three experiments tested the relative contributions of low versus high spatial frequencies during memory-guided covert spatial attention orienting tasks. Replicating the effects of memory-guided attention, pre-exposure to scenes associated with specific spatial memories for target locations (memory cues) led to higher perceptual discrimination and faster response times to identify targets embedded in the scenes. However, either high or low spatial frequency cues were equally effective; LSF signals did not selectively or preferentially contribute to the memory-driven attention benefits to performance. Our results challenge a generalized model that LSFs activate contextual memories, which in turn bias attention and facilitate perception.	[Patai, Eva Zita; Buckley, Alice; Nobre, Anna Christina] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; [Patai, Eva Zita] UCL, Inst Child Hlth, London, England; [Nobre, Anna Christina] Univ Oxford, Oxford Ctr Human Brain Act, Oxford, England	University of Oxford; University of London; University College London; University of Oxford	Nobre, AC (corresponding author), Univ Oxford, Dept Expt Psychol, S Parks Rd, Oxford OX1 3UD, England.	kia.nobre@ohba.ox.ac.uk		Nobre, Anna Christina/0000-0001-5762-2802	Wellcome Trust [WT082791MA]; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre based at Oxford University Hospitals Trust Oxford University as part of the Cognitive Health Programme	Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research (NIHR) Oxford Biomedical Research Centre based at Oxford University Hospitals Trust Oxford University as part of the Cognitive Health Programme	This research was supported by a Project Grant to A.C.N. from the Wellcome Trust [WT082791MA]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. In addition, the research was supported by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre based at Oxford University Hospitals Trust Oxford University as part of the Cognitive Health Programme. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.	Bar M, 2003, NEURON, V38, P347, DOI 10.1016/S0896-6273(03)00167-3; Bar M, 2006, P NATL ACAD SCI USA, V103, P449, DOI 10.1073/pnas.0507062103; Bar M, 2004, NAT REV NEUROSCI, V5, P617, DOI 10.1038/nrn1476; Bar M, 2008, J NEUROSCI, V28, P8539, DOI 10.1523/JNEUROSCI.0987-08.2008; Bar M, 2007, TRENDS COGN SCI, V11, P280, DOI 10.1016/j.tics.2007.05.005; Bar M, 2009, PHILOS T R SOC B, V364, P1235, DOI 10.1098/rstb.2008.0310; Bird CM, 2008, NAT REV NEUROSCI, V9, P182, DOI 10.1038/nrn2335; Bullier J, 2001, BRAIN RES REV, V36, P96, DOI 10.1016/S0165-0173(01)00085-6; Burgess N, 2002, Q J EXP PSYCHOL-A, V55, P1057, DOI 10.1080/02724980244000224; Chaumon M, 2008, J VISION, V8, DOI 10.1167/8.3.10; Chun MM, 1998, COGNITIVE PSYCHOL, V36, P28, DOI 10.1006/cogp.1998.0681; Doallo S, 2013, J COGNITIVE NEUROSCI, V25, P245, DOI 10.1162/jocn_a_00314; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Hegde J, 2008, PROG NEUROBIOL, V84, P405, DOI 10.1016/j.pneurobio.2007.09.001; Henderson JM, 2008, BRAIN COGNITION, V66, P40, DOI 10.1016/j.bandc.2007.05.001; Hochstein S, 2002, NEURON, V36, P791, DOI 10.1016/S0896-6273(02)01091-7; Kveraga K, 2007, J NEUROSCI, V27, P13232, DOI 10.1523/JNEUROSCI.3481-07.2007; Kveraga K, 2011, P NATL ACAD SCI USA, V108, P3389, DOI 10.1073/pnas.1013760108; Laycock R, 2008, NEUROSCI BIOBEHAV R, V32, P1409, DOI 10.1016/j.neubiorev.2008.04.008; Masson MEJ, 2011, BEHAV RES METHODS, V43, P679, DOI 10.3758/s13428-010-0049-5; MERIGAN WH, 1993, ANNU REV NEUROSCI, V16, P369, DOI 10.1146/annurev.ne.16.030193.002101; Moores E, 2003, NAT NEUROSCI, V6, P182, DOI 10.1038/nn996; Moscovitch M, 2005, J ANAT, V207, P35, DOI 10.1111/j.1469-7580.2005.00421.x; NAVON D, 1977, COGNITIVE PSYCHOL, V9, P353, DOI 10.1016/0010-0285(77)90012-3; Neri P, 2011, P NATL ACAD SCI USA, V108, P10726, DOI 10.1073/pnas.1101246108; Oliva A, 2006, PROG BRAIN RES, V155, P23, DOI 10.1016/S0079-6123(06)55002-2; Patai EZ, 2012, J COGNITIVE NEUROSCI, V24, P2281, DOI 10.1162/jocn_a_00294; Peyrin C, 2004, NEUROIMAGE, V23, P698, DOI 10.1016/j.neuroimage.2004.06.020; Peyrin C, 2010, J COGNITIVE NEUROSCI, V22, P2768, DOI 10.1162/jocn.2010.21424; Raftery AE, 1995, SOCIOL METHODOL, V25, P111, DOI 10.2307/271063; Romei V, 2011, CURR BIOL, V21, P334, DOI 10.1016/j.cub.2011.01.035; Rotshtein P, 2010, J VISION, V10, DOI 10.1167/10.10.25; SCHYNS PG, 1994, PSYCHOL SCI, V5, P195, DOI 10.1111/j.1467-9280.1994.tb00500.x; Smith ML, 2006, P NATL ACAD SCI USA, V103, P5626, DOI 10.1073/pnas.0508972103; Squire LR, 2011, ANNU REV NEUROSCI, V34, P259, DOI 10.1146/annurev-neuro-061010-113720; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Stokes MG, 2012, P NATL ACAD SCI USA, V109, pE360, DOI 10.1073/pnas.1108555108; Summerfield JJ, 2011, J NEUROSCI, V31, P14952, DOI 10.1523/JNEUROSCI.5541-10.2011; Summerfield JJ, 2006, NEURON, V49, P905, DOI 10.1016/j.neuron.2006.01.021; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; ULLMAN S, 1995, CEREB CORTEX, V5, P1, DOI 10.1093/cercor/5.1.1; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; VANESSEN DC, 1992, SCIENCE, V255, P419, DOI 10.1126/science.1734518; Vann SD, 2009, NAT REV NEUROSCI, V10, P792, DOI 10.1038/nrn2733; Wagenmakers EJ, 2007, PSYCHON B REV, V14, P779, DOI 10.3758/BF03194105	46	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65601	10.1371/journal.pone.0065601	http://dx.doi.org/10.1371/journal.pone.0065601			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	169CU	23776509	Green Published, Green Submitted, gold			2022-12-27	WOS:000320755400047
J	Liu, X; Ru, J; Zhang, J; Zhu, LH; Liu, M; Li, X; Tang, H				Liu, Xue; Ru, Jing; Zhang, Jian; Zhu, Li-hua; Liu, Min; Li, Xin; Tang, Hua			miR-23a Targets Interferon Regulatory Factor 1 and Modulates Cellular Proliferation and Paclitaxel-Induced Apoptosis in Gastric Adenocarcinoma Cells	PLOS ONE			English	Article							FACTOR-I GENE; MULTIDRUG-RESISTANCE; CASPASE 8; CANCER; EPIDEMIOLOGY; IRF-1; TRANSCRIPTION; PROMOTES; GROWTH; BCL2	MicroRNAs are a class of non-coding RNAs that function as key regulators of gene expression at the post-transcriptional level. In our previous research, we found that miR-23a was significantly up-regulated in human gastric adenocarcinoma cells. In the current study, we demonstrate that miR-23a suppresses paclitaxel-induced apoptosis and promotes the cell proliferation and colony formation ability of gastric adenocarcinoma cells. We have identified tumor suppressor interferon regulator factor 1 (IRF1) as a direct target gene of miR-23a. We performed a fluorescent reporter assay to confirm that miR-23a bound to the IRF1 mRNA 3'UTR directly and specifically. The ectopic expression of IRF1 markedly promoted paclitaxel-induced apoptosis and inhibited cell viability and colony formation ability, whereas the knockdown of IRF1 had the opposite effects. The restoration of IRF1 expression counteracted the effects of miR-23a on the paclitaxel-induced apoptosis and cell proliferation of gastric adenocarcinoma cells. Quantitative real-time PCR showed that miR-23a is frequently up-regulated in gastric adenocarcinoma tissues, whereas IRF1 is down-regulated in cancer tissues. Altogether, these results indicate that miR-23a suppresses paclitaxel-induced apoptosis and promotes cell viability and the colony formation ability of gastric adenocarcinoma cells by targeting IRF1 at the post-transcriptional level.	[Liu, Xue; Ru, Jing; Zhang, Jian; Zhu, Li-hua; Liu, Min; Li, Xin; Tang, Hua] Tianjin Med Univ, Sch Basic Med Sci, Tianjin Life Sci Res Ctr, Tianjin, Peoples R China; [Liu, Xue; Ru, Jing; Zhang, Jian; Zhu, Li-hua; Liu, Min; Li, Xin; Tang, Hua] Tianjin Med Univ, Sch Basic Med Sci, Dept Microbiol, Tianjin, Peoples R China; [Zhu, Li-hua] Hebei United Univ, Coll Basic Med, Dept Pathogen Biol & Immunol, Tangshan, Hebei, Peoples R China	Tianjin Medical University; Tianjin Medical University; North China University of Science & Technology	Tang, H (corresponding author), Tianjin Med Univ, Sch Basic Med Sci, Tianjin Life Sci Res Ctr, Tianjin, Peoples R China.	htang2002@yahoo.com			National Natural Science Foundation of China [31270818, 91029714, 31071191]; Natural Science Foundation of Tianjin [12JCZDJC25100, 09JCZDJC17500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Tianjin(Natural Science Foundation of Tianjin)	This work was supported by the National Natural Science Foundation of China (numbers 31270818; 91029714; 31071191) and the Natural Science Foundation of Tianjin (12JCZDJC25100; 09JCZDJC17500). The websites of the funders are http://www.tstc.gov.cn/ and http://www.nsfc.gov.cn/ respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi Salah Y, 2011, Gastrointest Cancer Res, V4, P122; Alcantara FF, 2002, NUCLEIC ACIDS RES, V30, P2068, DOI 10.1093/nar/30.9.2068; Bornschein J, 2011, HELICOBACTER, V16, P45, DOI 10.1111/j.1523-5378.2011.00880.x; Cao MR, 2012, INT J ONCOL, V41, P869, DOI 10.3892/ijo.2012.1535; Cavalli LR, 2010, BREAST CANCER RES TR, V121, P227, DOI 10.1007/s10549-009-0509-8; De Marchis ML, 2009, LEUKEMIA, V23, P856, DOI 10.1038/leu.2008.372; Dhayalan A, 2011, CHEM BIOL, V18, P111, DOI 10.1016/j.chembiol.2010.11.014; Fock KM, 2010, J GASTROEN HEPATOL, V25, P479, DOI 10.1111/j.1440-1746.2009.06188.x; Gao J, 2010, CELL DEATH DIFFER, V17, P699, DOI 10.1038/cdd.2009.156; Gottardo F, 2007, UROL ONCOL-SEMIN ORI, V25, P387, DOI 10.1016/j.urolonc.2007.01.019; Guidotti LG, 2002, J VIROL, V76, P2617, DOI 10.1128/JVI.76.6.2617-2621.2002; Hong S, 2013, J BIOL CHEM, V288, P3560, DOI 10.1074/jbc.M112.400408; Huang SL, 2008, INT J CANCER, V123, P972, DOI 10.1002/ijc.23580; Katada T, 2009, INT J ONCOL, V34, P537, DOI 10.3892/ijo_00000179; Kikuchi Shogo, 2002, Gastric Cancer, V5, P6, DOI 10.1007/s101200200001; Kim YH, 2012, CANCER RES, V72, P2512, DOI 10.1158/0008-5472.CAN-11-3870; Kondo T, 1997, ONCOGENE, V15, P1275, DOI 10.1038/sj.onc.1201286; Kong KY, 2010, EXP HEMATOL, V38, P629, DOI 10.1016/j.exphem.2010.04.004; Lace MJ, 2009, CARCINOGENESIS, V30, P1336, DOI 10.1093/carcin/bgp150; Lee SH, 2003, ONCOGENE, V22, P381, DOI 10.1038/sj.onc.1206133; Li PY, 2012, CANCER LETT, V314, P213, DOI 10.1016/j.canlet.2011.09.031; Li XH, 2011, MOL CANCER RES, V9, P824, DOI 10.1158/1541-7786.MCR-10-0529; Lian J, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.70; Liu LS, 2012, J BIOL CHEM, V287, P16410, DOI 10.1074/jbc.M111.319566; Liu T, 2009, CANCER LETT, V273, P233, DOI 10.1016/j.canlet.2008.08.003; Mandong B M, 2010, Niger J Med, V19, P451; MUHIE S, 2012, GENES IMMUN; Nakajima A, 2009, P NATL ACAD SCI USA, V106, P12448, DOI 10.1073/pnas.0905702106; Ning YX, 2010, MOL CANCER THER, V9, P1274, DOI 10.1158/1535-7163.MCT-09-1169; Nozawa H, 1998, INT J CANCER, V77, P522, DOI 10.1002/(SICI)1097-0215(19980812)77:4<522::AID-IJC8>3.0.CO;2-W; Rathore MG, 2012, INT J BIOCHEM CELL B, V44, P1448, DOI 10.1016/j.biocel.2012.05.011; Schaefer BC, 1997, MOL CELL BIOL, V17, P873, DOI 10.1128/MCB.17.2.873; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Shin A, 2011, J GASTRIC CANCER, V11, P135, DOI 10.5230/jgc.2011.11.3.135; Shridhar R, 2011, CANCER-AM CANCER SOC, V117, P3908, DOI 10.1002/cncr.25995; Stang MT, 2007, ONCOGENE, V26, P6420, DOI 10.1038/sj.onc.1210470; STEVENS AM, 1995, MOL ENDOCRINOL, V9, P513, DOI 10.1210/me.9.4.513; Su RC, 2011, BLOOD, V117, P2649, DOI 10.1182/blood-2010-10-312462; Sun QM, 2010, CANCER SCI, V101, P2241, DOI 10.1111/j.1349-7006.2010.01667.x; Tang WH, 2012, INFECT AGENTS CANCER, V7, DOI 10.1186/1750-9378-7-21; Wang ZW, 2012, CANCER DISCOV, V2, P489, DOI 10.1158/2159-8290.CD-12-0177; Yamaoka Y, 2004, GASTROENTEROLOGY, V126, P1030, DOI 10.1053/j.gastro.2003.12.048; Yamashita M, 2010, CANCER SCI, V101, P1708, DOI 10.1111/j.1349-7006.2010.01581.x; Zhu LH, 2010, FEBS J, V277, P3726, DOI 10.1111/j.1742-4658.2010.07773.x; Zhu W, 2012, CANCER CHEMOTH PHARM, V69, P723, DOI 10.1007/s00280-011-1752-3; Zhu W, 2012, MED ONCOL, V29, P384, DOI 10.1007/s12032-010-9797-4; Zhu W, 2010, INT J CANCER, V127, P2520, DOI 10.1002/ijc.25260	48	4	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e64707	10.1371/journal.pone.0064707	http://dx.doi.org/10.1371/journal.pone.0064707			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23785404	gold, Green Published, Green Submitted			2022-12-27	WOS:000320440500005
J	Schneider, D; Arp, G; Reimer, A; Reitner, J; Daniel, R				Schneider, Dominik; Arp, Gernot; Reimer, Andreas; Reitner, Joachim; Daniel, Rolf			Phylogenetic Analysis of a Microbialite-Forming Microbial Mat from a Hypersaline Lake of the Kiritimati Atoll, Central Pacific	PLOS ONE			English	Article							SULFATE-REDUCING BACTERIUM; SP-NOV.; GEN. NOV.; EUKARYOTIC DIVERSITY; HYDROTHERMAL VENT; CHRISTMAS ISLAND; ARCHAEA; COMMUNITY; STROMATOLITES; COMPLEXITY	On the Kiritimati atoll, several lakes exhibit microbial mat-formation under different hydrochemical conditions. Some of these lakes trigger microbialite formation such as Lake 21, which is an evaporitic, hypersaline lake (salinity of approximately 170%). Lake 21 is completely covered with a thick multilayered microbial mat. This mat is associated with the formation of decimeter-thick highly porous microbialites, which are composed of aragonite and gypsum crystals. We assessed the bacterial and archaeal community composition and its alteration along the vertical stratification by large-scale analysis of 16S rRNA gene sequences of the nine different mat layers. The surface layers are dominated by aerobic, phototrophic, and halotolerant microbes. The bacterial community of these layers harbored Cyanobacteria (Halothece cluster), which were accompanied with known phototrophic members of the Bacteroidetes and Alphaproteobacteria. In deeper anaerobic layers more diverse communities than in the upper layers were present. The deeper layers were dominated by Spirochaetes, sulfate-reducing bacteria (Deltaproteobacteria), Chloroflexi (Anaerolineae and Caldilineae), purple non-sulfur bacteria (Alphaproteobacteria), purple sulfur bacteria (Chromatiales), anaerobic Bacteroidetes (Marinilabiacae), Nitrospirae (OPB95), Planctomycetes and several candidate divisions. The archaeal community, including numerous uncultured taxonomic lineages, generally changed from Euryarchaeota (mainly Halobacteria and Thermoplasmata) to uncultured members of the Thaumarchaeota (mainly Marine Benthic Group B) with increasing depth.	[Schneider, Dominik; Daniel, Rolf] Univ Gottingen, Dept Genom & Appl Microbiol, Inst Microbiol & Genet, D-37073 Gottingen, Germany; [Schneider, Dominik; Daniel, Rolf] Univ Gottingen, Gottingen Genom Lab, Inst Microbiol & Genet, D-37073 Gottingen, Germany; [Arp, Gernot; Reimer, Andreas; Reitner, Joachim] Univ Gottingen, Geosci Ctr, D-37073 Gottingen, Germany	University of Gottingen; University of Gottingen; University of Gottingen	Daniel, R (corresponding author), Univ Gottingen, Dept Genom & Appl Microbiol, Inst Microbiol & Genet, D-37073 Gottingen, Germany.	rdaniel@gwdg.de	Daniel, Rolf/AAQ-5933-2021	Daniel, Rolf/0000-0002-8646-7925; Schneider, Dominik/0000-0002-1134-5026	Deutsche Forschungsgemeinschaft [DFG-FOR 571, DA 374/5-2, AR335/5-3]; Courant Center Geobiology	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Courant Center Geobiology	This study has been supported by the Deutsche Forschungsgemeinschaft (DFG-FOR 571 "Geobiology of Organo- and Biofilms"; DA 374/5-2, AR335/5-3, publication 61) and the Courant Center Geobiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfreider A, 2002, SYST APPL MICROBIOL, V25, P232, DOI 10.1078/0723-2020-00111; Allen MA, 2009, GEOBIOLOGY, V7, P82, DOI 10.1111/j.1472-4669.2008.00187.x; Allwood AC, 2006, NATURE, V441, P714, DOI 10.1038/nature04764; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anton Josefa, 2008, Saline Syst, V4, P15, DOI 10.1186/1746-1448-4-15; Arp G, 2003, J SEDIMENT RES, V73, P105, DOI 10.1306/071002730105; Arp G, 2001, FACIES, V44, P1, DOI 10.1007/BF02668163; Arp G, 2012, GEOMICROBIOL J, V29, P29, DOI 10.1080/01490451.2010.521436; Atanasova NS, 2012, ENVIRON MICROBIOL, V14, P426, DOI 10.1111/j.1462-2920.2011.02603.x; Bardavid RE, 2012, EXTREMOPHILES, V16, P567, DOI 10.1007/s00792-012-0455-y; Baumgartner LK, 2006, SEDIMENT GEOL, V185, P131, DOI 10.1016/j.sedgeo.2005.12.008; Bebout BM, 2002, ASTROBIOLOGY, V2, P383, DOI 10.1089/153110702762470491; Blumenberg M, 2013, ORG GEOCHEM, V55, P55, DOI 10.1016/j.orggeochem.2012.11.004; Bontognali TRR, 2012, P NATL ACAD SCI USA, V109, P15146, DOI 10.1073/pnas.1207491109; Breitbart M, 2009, ENVIRON MICROBIOL, V11, P16, DOI 10.1111/j.1462-2920.2008.01725.x; Brochier-Armanet C, 2008, NAT REV MICROBIOL, V6, P245, DOI 10.1038/nrmicro1852; Buhring SI, 2009, GEOBIOLOGY, V7, P308, DOI 10.1111/j.1472-4669.2009.00198.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cohen Y, 1984, MICROBIAL MATS STROM, P498; Daffonchio D, 2006, NATURE, V440, P203, DOI 10.1038/nature04418; DeLong EE, 2001, SYST BIOL, V50, P470, DOI 10.1080/106351501750435040; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dupraz C, 2005, TRENDS MICROBIOL, V13, P429, DOI 10.1016/j.tim.2005.07.008; Dupraz C, 2009, EARTH-SCI REV, V96, P141, DOI 10.1016/j.earscirev.2008.10.005; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Feazel LM, 2008, APPL ENVIRON MICROB, V74, P329, DOI 10.1128/AEM.01448-07; Ferrer M, 2011, MICROB ECOL, V62, P824, DOI 10.1007/s00248-011-9903-y; Gantner S, 2011, J MICROBIOL METH, V84, P12, DOI 10.1016/j.mimet.2010.10.001; Garcia-Pichel F, 1998, ARCH MICROBIOL, V169, P469, DOI 10.1007/s002030050599; Garrity GM, 2005, GAMMAPROTEOBACTERI B, P1006; Garrity GM, 2001, ARCHAEA DEEPLY BRANC, P721; Garrity GM, 2005, ALPHA BETA DELTA E C, P1388; Goh F, 2009, ISME J, V3, P383, DOI 10.1038/ismej.2008.114; Harris JK, 2013, ISME J, V7, P50, DOI 10.1038/ismej.2012.79; HIRSCH P, 1989, SYST APPL MICROBIOL, V11, P291; Hoehler TM, 2001, NATURE, V412, P324, DOI 10.1038/35085554; Hugenholtz P, 1998, J BACTERIOL, V180, P366, DOI 10.1128/JB.180.2.366-376.1998; Isenbarger TA, 2008, APPL ENVIRON MICROB, V74, P840, DOI 10.1128/AEM.01933-07; Jahnke LL, 2008, GEOBIOLOGY, V6, P394, DOI 10.1111/j.1472-4669.2008.00165.x; Jakobsen TF, 2006, INT J SYST EVOL MICR, V56, P2063, DOI 10.1099/ijs.0.64323-0; Kempe S., 1990, FACETS MODERN BIOGEO, P255, DOI DOI 10.1007/978-3-642-73978-1_21; Knittel K, 2005, APPL ENVIRON MICROB, V71, P467, DOI 10.1128/AEM.71.1.467-479.2005; Krekeler D, 1997, ARCH MICROBIOL, V167, P369, DOI 10.1007/s002030050457; KREKELER D, 1995, FEMS MICROBIOL ECOL, V17, P271; Kunin Victor, 2008, Mol Syst Biol, V4, P198, DOI 10.1038/msb.2008.35; Ley RE, 2006, APPL ENVIRON MICROB, V72, P3685, DOI 10.1128/AEM.72.5.3685-3695.2006; Liu ZZ, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm541; Lloyd KG, 2013, NATURE, V496, P215, DOI 10.1038/nature12033; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Miroshnichenko ML, 2010, INT J SYST EVOL MICR, V60, P2120, DOI 10.1099/ijs.0.016667-0; Miroshnichenko ML, 2003, INT J SYST EVOL MICR, V53, P323, DOI 10.1099/ijs.0.02390-0; Mobberley JM, 2012, ENVIRON MICROBIOL, V14, P82, DOI 10.1111/j.1462-2920.2011.02509.x; Mongodin EF, 2005, P NATL ACAD SCI USA, V102, P18147, DOI 10.1073/pnas.0509073102; Myshrall KL, 2010, GEOBIOLOGY, V8, P337, DOI 10.1111/j.1472-4669.2010.00245.x; Papineau D, 2005, APPL ENVIRON MICROB, V71, P4822, DOI 10.1128/AEM.71.8.4822-4832.2005; Parkhurst D.L., 1999, 994259 US GEOL SURV, VVolume 312, P99; Pester M, 2011, CURR OPIN MICROBIOL, V14, P300, DOI 10.1016/j.mib.2011.04.007; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Pynaert K, 2003, APPL ENVIRON MICROB, V69, P3626, DOI 10.1128/AEM.69.6.3626-3635.2003; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Robertson CE, 2009, APPL ENVIRON MICROB, V75, P1801, DOI 10.1128/AEM.01811-08; Saenger Casey, 2006, Saline Syst, V2, P8, DOI 10.1186/1746-1448-2-8; Sahl JW, 2008, APPL ENVIRON MICROB, V74, P6444, DOI 10.1128/AEM.00879-08; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Seckbach J., 2010, MICROBIAL MATS MODER, P606; Sorensen KB, 2005, APPL ENVIRON MICROB, V71, P7352, DOI 10.1128/AEM.71.11.7352-7365.2005; Spear JR, 2003, BIOL BULL-US, V204, P168, DOI 10.2307/1543553; Stoeck T, 2003, APPL ENVIRON MICROB, V69, P2657, DOI 10.1128/AEM.69.5.2657-2663.2003; Sun H, 2010, STAND GENOMIC SCI, V3, P276, DOI 10.4056/sigs.1243258; Takai K, 1999, GENETICS, V152, P1285; Teske A, 2008, ISME J, V2, P3, DOI 10.1038/ismej.2007.90; Tice MM, 2004, NATURE, V431, P549, DOI 10.1038/nature02888; Trichet J, 2001, SEDIMENT GEOL, V140, P177, DOI 10.1016/S0037-0738(00)00177-9; Trichet J., 1995, NONBIOLOGICALLY SUPP, P203; Turova T P, 2002, Mikrobiologiia, V71, P230; Vaisman N, 2009, INT J SYST EVOL MICR, V59, P2571, DOI 10.1099/ijs.0.010892-0; Van Kranendonk MJ, 2008, PRECAMBRIAN RES, V167, P93, DOI 10.1016/j.precamres.2008.07.003; VANGEMERDEN H, 1993, MAR GEOL, V113, P3, DOI 10.1016/0025-3227(93)90146-M; Vetriani C, 1999, APPL ENVIRON MICROB, V65, P4375; Walters WA, 2011, BIOINFORMATICS, V27, P1159, DOI 10.1093/bioinformatics/btr087; Woodroffe CD, 1998, CORAL REEFS, V17, P235, DOI 10.1007/s003380050124; Yamada T, 2006, INT J SYST EVOL MICR, V56, P1331, DOI 10.1099/ijs.0.64169-0; Zhang HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006108	84	80	82	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e66662	10.1371/journal.pone.0066662	http://dx.doi.org/10.1371/journal.pone.0066662			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762495	gold, Green Submitted, Green Published			2022-12-27	WOS:000320440500068
J	Nikam, A; Patankar, JV; Lackner, C; Schock, E; Kratky, D; Zatloukal, K; Abuja, PM				Nikam, Aniket; Patankar, Jay V.; Lackner, Carolin; Schoeck, Elisabeth; Kratky, Dagmar; Zatloukal, Kurt; Abuja, Peter M.			Transition between Acute and Chronic Hepatotoxicity in Mice Is Associated with Impaired Energy Metabolism and Induction of Mitochondrial Heme Oxygenase-1	PLOS ONE			English	Article							NONALCOHOLIC STEATOHEPATITIS; HEPATIC FERROCHELATASE; RESPIRATORY-CHAIN; ENZYME-ACTIVITIES; ATP HOMEOSTASIS; MALLORY BODIES; LIVER; INHIBITION; DYSFUNCTION; MECHANISM	The formation of protein inclusions is frequently associated with chronic metabolic diseases. In mice, short-term intoxication with 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) leads to hepatocellular damage indicated by elevated serum liver enzyme activities, whereas only minor morphological changes are observed. Conversely, chronic administration of DDC for several weeks results in severe morphological damage, characterized by hepatocellular ballooning, disruption of the intermediate filament cytoskeleton, and formation of Mallory-Denk bodies consisting predominantly of misfolded keratins, Sqstm1/p62, and heat shock proteins. To evaluate the mechanistic underpinnings for this dichotomy we dissected the time-course of DDC intoxication for up to 10 weeks. We determined body weight change, serum liver enzyme activities, morphologic alterations, induction of antioxidant response (heme oxygenase-1, HO-1), oxidative damage and ATP content in livers as well as respiration, oxidative damage and the presence and activity of HO-1 in endoplasmic reticulum and mitochondria (mtHO-1). Elevated serum liver enzyme activity and oxidative liver damage were already present at early intoxication stages without further subsequent increase. After 2 weeks of intoxication, mice had transiently lost 9% of their body weight, liver ATP-content was reduced to 58% of controls, succinate-driven respiration was uncoupled from ATP-production and antioxidant response was associated with the appearance of catalytically active mtHO-1. Oxidative damage was associated with both acute and chronic DDC toxicity whereas the onset of chronic intoxication was specifically associated with mitochondrial dysfunction which was maximal after 2 weeks of intoxication. At this transition stage, adaptive responses involving mtHO-1 were induced, indirectly leading to improved respiration and preventing further drop of ATP levels. Our observations clearly demonstrate principally different mechanisms for acute and chronic toxic damage.	[Nikam, Aniket; Lackner, Carolin; Schoeck, Elisabeth; Zatloukal, Kurt; Abuja, Peter M.] Med Univ Graz, Inst Pathol, Graz, Austria; [Patankar, Jay V.; Kratky, Dagmar] Med Univ Graz, Inst Mol Biol & Biochem, Graz, Austria	Medical University of Graz; Medical University of Graz	Abuja, PM (corresponding author), Med Univ Graz, Inst Pathol, Graz, Austria.	peter.abuja@medunigraz.at	Kratky, Dagmar/ABF-5699-2021	Kratky, Dagmar/0000-0003-1357-7573; Patankar, Jay/0000-0002-1884-7424; Abuja, Peter Michael/0000-0003-1957-4066	Austrian GenAu program, project GATiB II; FWF Austrian Science Fund [P22382, SFB F30]; PhD-program of the Medical University of Graz, Austria; Austrian Science Fund (FWF) [F 3004] Funding Source: researchfish	Austrian GenAu program, project GATiB II; FWF Austrian Science Fund(Austrian Science Fund (FWF)); PhD-program of the Medical University of Graz, Austria; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work has been supported by the Austrian GenAu program (www.genau.at), project GATiB II (to KZ and PMA), by the FWF Austrian Science Fund (www.fwf.ac.at), projects P22382 and SFB F30 (to DK), and the PhD-program of the Medical University of Graz, Austria (www.medunigraz.at) (to AN/PMA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPLEGATE LA, 1991, CANCER RES, V51, P974; Atamna H, 2002, P NATL ACAD SCI USA, V99, P14807, DOI 10.1073/pnas.192585799; Atamna H, 2001, J BIOL CHEM, V276, P48410, DOI 10.1074/jbc.M108362200; Beer S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002493; Berson A, 1998, GASTROENTEROLOGY, V114, P764, DOI 10.1016/S0016-5085(98)70590-6; Bindu S, 2011, J BIOL CHEM, V286, P39387, DOI 10.1074/jbc.M111.279893; Converso DP, 2006, FASEB J, V20, P1236, DOI 10.1096/fj.05-4204fje; Cortez-Pinto H, 1999, JAMA-J AM MED ASSOC, V282, P1659, DOI 10.1001/jama.282.17.1659; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Fickert P, 2007, AM J PATHOL, V171, P525, DOI 10.2353/ajpath.2007.061133; Frezza C, 2011, NATURE, V477, P225, DOI 10.1038/nature10363; Frezza C, 2011, J MOL MED, V89, P213, DOI 10.1007/s00109-011-0728-4; FROMENTY B, 1995, PHARMACOL THERAPEUT, V67, P101, DOI 10.1016/0163-7258(95)00012-6; Giannini EG, 2005, CAN MED ASSOC J, V172, P367, DOI 10.1503/cmaj.1040752; Hanada S, 2010, GASTROENTEROLOGY, V138, P1607, DOI 10.1053/j.gastro.2009.12.055; HUBERWJ, 2007, BIOCHEMISTRY-US, V46, P12212, DOI DOI 10.1021/BI701496Z; Ishii T, 2002, METHOD ENZYMOL, V348, P182, DOI 10.1016/S0076-6879(02)48637-5; Itoh K, 2004, FREE RADICAL BIO MED, V36, P1208, DOI 10.1016/j.freeradbiomed.2004.02.075; King A, 2006, ONCOGENE, V25, P4675, DOI 10.1038/sj.onc.1209594; Lancel S, 2009, J PHARMACOL EXP THER, V329, P641, DOI 10.1124/jpet.108.148049; Lickteig AJ, 2007, J BIOCHEM MOL TOXIC, V21, P216, DOI 10.1002/jbt.20177; Long JG, 2006, LIFE SCI, V79, P1466, DOI 10.1016/j.lfs.2006.04.024; MCCLUSKEY SA, 1989, MOL PHARMACOL, V36, P608; MCCLUSKEY SA, 1988, MOL PHARMACOL, V34, P80; Nan YM, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-124; Navarro S, 2005, EXP DERMATOL, V14, P26, DOI 10.1111/j.0906-6705.2005.00248.x; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Serviddio G, 2008, EUR J CLIN INVEST, V38, P245, DOI 10.1111/j.1365-2362.2008.01936.x; Singla A, 2012, HEPATOLOGY; Slebos DJ, 2007, AM J RESP CELL MOL, V36, P409, DOI 10.1165/rcmb.2006-0214OC; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Stumptner C, 2001, J HEPATOL, V34, P665, DOI 10.1016/S0168-8278(00)00099-4; Suliman HB, 2007, J CELL SCI, V120, P299, DOI 10.1242/jcs.03318; TENHUNEN R, 1969, J BIOL CHEM, V244, P6388; Xiao MT, 2012, GENE DEV, V26, P1326, DOI 10.1101/gad.191056.112; YOKOO H, 1982, GASTROENTEROLOGY, V83, P109; YOSHIDA T, 1991, EUR J BIOCHEM, V199, P729, DOI 10.1111/j.1432-1033.1991.tb16177.x; Yu J, 2009, GASTROENTEROLOGY, V138, p[694, 704, e691]; ZATLOUKAL K, 1990, LAB INVEST, V62, P427; Zatloukal K, 2004, METHOD CELL BIOL, V78, P205; Zatloukal K, 2002, AM J PATHOL, V160, P255, DOI 10.1016/S0002-9440(10)64369-6; Zatloukal K, 2007, EXP CELL RES, V313, P2033, DOI 10.1016/j.yexcr.2007.04.024	42	16	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e66094	10.1371/journal.pone.0066094	http://dx.doi.org/10.1371/journal.pone.0066094			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762471	Green Published, gold, Green Submitted			2022-12-27	WOS:000321099000126
J	Sengupta, B; Pahari, B; Blackmon, L; Sengupta, PK				Sengupta, Bidisha; Pahari, Biswapathik; Blackmon, Laura; Sengupta, Pradeep K.			Prospect of Bioflavonoid Fisetin as a Quadruplex DNA Ligand: A Biophysical Approach	PLOS ONE			English	Article							FLUORESCENCE ANISOTROPY DECAY; STATE PROTON-TRANSFER; FLAVONOID FISETIN; BINDING; 3-HYDROXYFLAVONE; TELOMERASE; MODE	Quadruplex (G(4)) forming sequences in telomeric DNA and c-myc promoter regions of human DNA are associated with tumorogenesis. Ligands that can facilitate or stabilize the formation and increase the stabilization of G(4) can prevent tumor cell proliferation and have been regarded as potential anti-cancer drugs. In the present study, steady state and time-resolved fluorescence measurements provide important structural and dynamical insights into the free and bound states of the therapeutically potent plant flavonoid fisetin (3,3',4',7-tetrahydroxyflavone) in a G(4) DNA matrix. The excited state intramolecular proton transfer (ESPT) of fisetin plays an important role in observing and understanding the binding of fisetin with the G(4) DNA. Differential absorption spectra, thermal melting, and circular dichroism spectroscopic studies provide evidences for the formation of G(4) DNA and size exclusion chromatography (SEC) proves the binding and 1:1 stoichiometry of fisetin in the DNA matrix. Comparative analysis of binding in the presence of EtBr proves that fisetin favors binding at the face of the G-quartet, mostly along the diagonal loop. Time resolved fluorescence anisotropy decay analysis indicates the increase in the restrictions in motion from the free to bound fisetin. We have also investigated the fingerprints of the binding of fisetin in the antiparallel quadruplex using Raman spectroscopy. Preliminary results indicate fisetin to be a prospective candidate as a G(4) ligand.	[Sengupta, Bidisha; Blackmon, Laura] Tougaloo Coll, Dept Chem, Tougaloo, MS USA; [Pahari, Biswapathik; Sengupta, Pradeep K.] Saha Inst Nucl Phys, Div Biophys, Kolkata, W Bengal, India	Tougaloo College; Saha Institute of Nuclear Physics	Sengupta, B (corresponding author), Tougaloo Coll, Dept Chem, Tougaloo, MS USA.	bsengupta@tougaloo.edu; pradeepsinp@yahoo.co.in		Sengupta, Bidisha/0000-0003-4624-9998	AAAS WIRC @ MSIs; National Science Foundation (NSF); National Institutes of Health/National Center on Minority Health and Health Disparities/Research Infrastructure in Minority Institutions [1P20MD002725]; Epscor seed grant [MS- EPS-0903787]; HBCU-UP Grant; NSF [0811638]; CSIR, India [21(0864)/11/EMR-II]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103476] Funding Source: NIH RePORTER; EPSCoR [0903787] Funding Source: National Science Foundation	AAAS WIRC @ MSIs; National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health/National Center on Minority Health and Health Disparities/Research Infrastructure in Minority Institutions; Epscor seed grant; HBCU-UP Grant; NSF(National Science Foundation (NSF)); CSIR, India(Council of Scientific & Industrial Research (CSIR) - India); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EPSCoR(National Science Foundation (NSF)NSF - Office of the Director (OD))	BSG is thankful to the travel award by AAAS WIRC @ MSIs which is funded by National Science Foundation (NSF), for allowing her to initiate the international collaboration, as is described in the present study. BSG also likes to acknowledge the financial support from National Institutes of Health/National Center on Minority Health and Health Disparities/Research Infrastructure in Minority Institutions grant number 1P20MD002725, Epscor seed grant MS- EPS-0903787 and research support from HBCU-UP Grant, NSF ID: 0811638 at Tougaloo College. PKS gratefully acknowledges CSIR, India for the award of a grant under CSIR Emeritus scientist scheme, sanction number 21(0864)/11/EMR-II. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasubramanian S, 2006, RSC BIOMOL SCI, pV; Bang I, 1910, BIOCHEM Z, V26, P293; Baral A, 2012, NUCLEIC ACIDS RES, V40, P3800, DOI 10.1093/nar/gkr1258; Cogoi S, 2006, NUCLEIC ACIDS RES, V34, P2536, DOI 10.1093/nar/gkl286; Eddy J, 2006, NUCLEIC ACIDS RES, V34, P3887, DOI 10.1093/nar/gkl529; Fernando H, 2006, BIOCHEMISTRY-US, V45, P7854, DOI 10.1021/bi0601510; GELLERT M, 1962, P NATL ACAD SCI USA, V48, P2013, DOI 10.1073/pnas.48.12.2013; Giri B, 2011, NUCLEIC ACIDS RES, V39, P7161, DOI 10.1093/nar/gkr234; Gomez D, 2002, CANCER RES, V62, P3365; Guharay J, 1999, SPECTROCHIM ACTA A, V55, P1091, DOI 10.1016/S1386-1425(98)00280-7; Huppert JL, 2007, PHILOS T R SOC A, V365, P2969, DOI 10.1098/rsta.2007.0011; Jana B, 2012, J PHYS CHEM B, V116, P639, DOI 10.1021/jp2094824; Ji XH, 2012, NUCLEIC ACID THER, V22, P127, DOI 10.1089/nat.2012.0342; Khan N, 2008, CANCER RES, V68, P8555, DOI 10.1158/0008-5472.CAN-08-0240; Koeppel F, 2001, NUCLEIC ACIDS RES, V29, P1087, DOI 10.1093/nar/29.5.1087; Kumbhakar M, 2005, PHOTOCHEM PHOTOBIOL, V81, P588, DOI 10.1562/2004-10-12-RA-341.1; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE, V3rd, DOI DOI 10.1007/978-0-387-46312-4; Maher P, 2006, P NATL ACAD SCI USA, V103, P16568, DOI 10.1073/pnas.0607822103; Markovic JMD, 2011, SPECTROCHIM ACTA A, V83, P120, DOI 10.1016/j.saa.2011.08.001; Masiero S, 2010, ORG BIOMOL CHEM, V8, P2683, DOI 10.1039/c003428b; Mergny JL, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni134; Neault JF, 1996, J BIOL CHEM, V271, P8140, DOI 10.1074/jbc.271.14.8140; Neidle S, 2009, CURR OPIN STRUC BIOL, V19, P239, DOI 10.1016/j.sbi.2009.04.001; Pagba CV, 2011, BIOMED OPT EXPRESS, V2, P207, DOI 10.1364/BOE.2.000207; Pahari B, 2013, J PHOTOCH PHOTOBIO B, V118, P33, DOI 10.1016/j.jphotobiol.2012.10.010; Phosrithong N, 2010, MED CHEM RES, V19, P817, DOI 10.1007/s00044-009-9233-5; Rachwal PA, 2007, METHODS, V43, P291, DOI 10.1016/j.ymeth.2007.05.004; Sacca B, 2005, NUCLEIC ACIDS RES, V33, P1182, DOI 10.1093/nar/gki257; Sahoo D, 2010, J PHYS CHEM B, V114, P2044, DOI 10.1021/jp910766q; Selvam S, 2011, PHOTOCH PHOTOBIO SCI, V10, P66, DOI 10.1039/c0pp00120a; Sen S, 2001, J PHYS CHEM A, V105, P7495, DOI 10.1021/jp004275c; Sengupta B, 2004, FEBS LETT, V570, P77, DOI 10.1016/j.febslet.2004.06.027; Sengupta B, 2009, J PHYS CHEM C, V113, P19518, DOI 10.1021/jp906522u; SENGUPTA PK, 1979, CHEM PHYS LETT, V68, P382, DOI 10.1016/0009-2614(79)87221-8; Shida T, 1996, NUCLEOS NUCLEOT, V15, P599, DOI 10.1080/07328319608002408; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; Sun HX, 2006, BIOORG MED CHEM LETT, V16, P3586, DOI 10.1016/j.bmcl.2006.03.087; Sun XG, 1999, SCI CHINA SER B, V42, P62, DOI 10.1007/BF02883038; Touil YS, 2011, CANCER CHEMOTH PHARM, V68, P445, DOI 10.1007/s00280-010-1505-8; Vogel SS, 2009, FLIM MICROSCOPY BIOL, P245; Xu NS, 2012, CHINESE J CHEM, V30, P1433, DOI 10.1002/cjoc.201100641	41	31	31	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65383	10.1371/journal.pone.0065383	http://dx.doi.org/10.1371/journal.pone.0065383			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785423	Green Submitted, Green Published, gold			2022-12-27	WOS:000321038800097
J	Sanchez-Faddeev, H; Pijpe, J; van Bodegom, D; van der Hulle, T; van der Gaag, KJ; Eriksson, UK; Spear, T; Westendorp, RGJ; de Knijff, P				Sanchez-Faddeev, Hernando; Pijpe, Jeroen; van Bodegom, David; van der Hulle, Tom; van der Gaag, Kristiaan J.; Eriksson, Ulrika K.; Spear, Thomas; Westendorp, Rudi G. J.; de Knijff, Peter			Ancestral Stories of Ghanaian Bimoba Reflect Millennia-Old Genetic Lineages	PLOS ONE			English	Article							Y-CHROMOSOME; HISTORY; RESOLUTION; ORIGINS; AFRICA; AGE	Oral history and oral genealogies are mechanisms of collective memory and a main cultural heritage of many populations without a writing system. In the effort to analytically address the correspondence between genetic data and historical genealogies, anthropologists hypothesised that genealogies evolve through time, ultimately containing three parts: literal - where the most recent ancestry is truthfully represented; intended - where ancestry is inferred and reflects political relations among groups; and mythical - that does not represent current social reality. While numerous studies discuss oral genealogies, to our knowledge no genetic studies have been able to investigate to what extent genetic relatedness corresponds to the literal and intended parts of oral genealogies. We report on the correspondence between genetic data and oral genealogies among Bimoba males in a single village in North-Eastern Ghana. We compared the pairwise mismatch distribution of Y chromosome short tandem repeat (Y-STR) haplotypes among all lineages present in this village to the self-reported (oral) relatedness. We found that Bimoba are able to correctly identify unrelated individuals in 92% of the cases. In contrast, they are able to correctly identify related individuals only in 38% of the cases, which can be explained by three processes: (1) the compression of genealogies, leading to increasing inaccuracy with increasing genealogical distance, (2) inclusions into the lineage from intended relations such as clan co-option or adoptions, and (3) false paternities, which in this study were found to have a minor effect on the correspondence between genetic data and oral genealogies. In addition, we observed that 70% of unrelated pairs have from six to eight Y-STR differences, a diversification peak which we attribute to an ancient West African expansion dating around 9454 years ago. We conclude that, despite all caveats, oral genealogies are reflecting ancient lineages more accurately than previously thought.	[Sanchez-Faddeev, Hernando; Pijpe, Jeroen; van der Hulle, Tom; van der Gaag, Kristiaan J.; de Knijff, Peter] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; [van Bodegom, David; Westendorp, Rudi G. J.] Leyden Acad Vital & Ageing, Leiden, Netherlands; [Eriksson, Ulrika K.; Westendorp, Rudi G. J.] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands; [Spear, Thomas] Univ Wisconsin, Dept Hist, Madison, WI USA	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Wisconsin System; University of Wisconsin Madison	de Knijff, P (corresponding author), Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands.	knijff@lumc.nl	de Knijff, Peter/Y-2519-2018	de Knijff, Peter/0000-0002-0899-771X; van der Gaag, Kristiaan/0000-0001-7976-1977; van Bodegom, David/0000-0002-5691-8342	Netherlands Foundation for the Advancements of Tropical Research [WOTRO 93-467]; Netherlands Organization for Scientific Research [NWO 051-14-050]; European Union [FP6 036894]; Board of Leiden University Medical Center; Stichting Dioraphte; Netherlands Genomics Initiative (NGI)/Netherlands Organization for Scientific Research (NWO) within the framework of the Forensic Genomics Consortium Netherlands (FGCN)	Netherlands Foundation for the Advancements of Tropical Research; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Union(European Commission); Board of Leiden University Medical Center; Stichting Dioraphte; Netherlands Genomics Initiative (NGI)/Netherlands Organization for Scientific Research (NWO) within the framework of the Forensic Genomics Consortium Netherlands (FGCN)(Netherlands Organization for Scientific Research (NWO))	The authors' study in northern Ghana, to which the data refer, was supported by The Netherlands Foundation for the Advancements of Tropical Research (WOTRO 93-467), The Netherlands Organization for Scientific Research (NWO 051-14-050) (www.nwo.nl), the European Union funded Network of Excellence LifeSpan (FP6 036894) (www.lifespannetwork.nl), an unrestricted grant of the Board of Leiden University Medical Center (www.lumc.nl), Stichting Dioraphte and The Netherlands Genomics Initiative (NGI)/Netherlands Organization for Scientific Research (NWO) within the framework of the Forensic Genomics Consortium Netherlands (FGCN) (www.forensicgenomics.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alimen H., 1987, B LASSOCIATION FRANC, V24, P215; Ansan Pour N, 2012, EUROPEAN J HUMAN GEN; Ballantyne KN, 2010, AM J HUM GENET, V87, P341, DOI 10.1016/j.ajhg.2010.08.006; Barbieri C, 2012, MOL BIOL EVOL, V29, P1213, DOI 10.1093/molbev/msr291; Barnes JA, 1967, GENEALOGIES CRAFT SO, P101; Behar DM, 2003, AM J HUM GENET, V73, P768, DOI 10.1086/378506; Beidelman TO, 1963, SW J ANTHR, P9; Bohannan L, 1952, AFRICA, V22, P301, DOI 10.2307/1156915; Brooks George E., 1989, HIST AFR, V16, P23, DOI DOI 10.2307/3171777; Chaix R, 2004, AM J HUM GENET, V75, P1113, DOI 10.1086/425938; CUNNISON I, 1957, AM ANTHROPOL, V59, P20, DOI 10.1525/aa.1957.59.1.02a00030; de Filippo C, 2010, MOL BIOL EVOLUTION; Evans-Pritchard E.E., 1940, NUER; Gill P, 2001, FORENSIC SCI INT, V124, P5, DOI 10.1016/S0379-0738(01)00498-4; HARPENDING HC, 1994, HUM BIOL, V66, P591; Henige David P., 1974, CHRONOLOGY ORAL TRAD; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; Mayer I, 1965, KINSHIP COMMON DESCE, P366; MCINTOSH SK, 1988, J WORLD PREHIST, V2, P89, DOI 10.1007/BF00975123; Meij JJ, 2009, J EVOLUTION BIOL, V22, P1014, DOI 10.1111/j.1420-9101.2009.01713.x; Meij JJ, 2008, TESTING LIFE HIST TH; Montano V, 2011, MOL ECOL, V20, P2693, DOI 10.1111/j.1365-294X.2011.05130.x; PEEL JDY, 1984, MAN, V19, P111, DOI 10.2307/2803227; Roberts N., 1993, TIMING YOUNGER DRYAS; Sanchez-Faddeev H, 2012, EUROPEAN J HUMAN GEN; Sanchez-Faddeev H, 2013, EUR J HUM GENET; SHRIVER MD, 1993, GENETICS, V134, P983; SLATKIN M, 1991, GENETICS, V129, P555; SPEAR T, 1981, J PAC HIST, V16, P133, DOI 10.1080/00223348108572420; Tremblay M, 2000, AM J HUM GENET, V66, P651, DOI 10.1086/302770; van Bodegom D, 2009, T ROY SOC TROP MED H, V103, P795, DOI 10.1016/j.trstmh.2008.12.003; Vansina J., 1985, ORAL TRADITION HIST; Vansma JM, 1990, PATHS RAINFORESTS HI; Westoff C. F, 1990, AGE MARRIAGE AGE 1 B; Ziem JB, 2004, ANN TROP MED PARASIT, V98, P385, DOI 10.1179/000349804225003370; Zwernemann J, 1998, STUDIEN KULTUR MOBA	37	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65690	10.1371/journal.pone.0065690	http://dx.doi.org/10.1371/journal.pone.0065690			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776528	Green Published, gold, Green Submitted			2022-12-27	WOS:000320322400047
J	Gregory, JF; Park, Y; Lamers, Y; Bandyopadhyay, N; Chi, YY; Lee, K; Kim, S; da Silva, V; Hove, N; Ranka, S; Kahveci, T; Muller, KE; Stevens, RD; Newgard, CB; Stacpoole, PW; Jones, DP				Gregory, Jesse F., III; Park, Youngja; Lamers, Yvonne; Bandyopadhyay, Nirmalya; Chi, Yueh-Yun; Lee, Kichen; Kim, Steven; da Silva, Vanessa; Hove, Nikolas; Ranka, Sanjay; Kahveci, Tamer; Muller, Keith E.; Stevens, Robert D.; Newgard, Christopher B.; Stacpoole, Peter W.; Jones, Dean P.			Metabolomic Analysis Reveals Extended Metabolic Consequences of Marginal Vitamin B-6 Deficiency in Healthy Human Subjects	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; HOMOCYSTEINE METABOLISM; PLASMA GLUTATHIONE; NUTRITIONAL-STATUS; VASCULAR-DISEASE; INCREASED RISK; YOUNG MEN; WOMEN; FOLATE; RESTRICTION	Marginal deficiency of vitamin B-6 is common among segments of the population worldwide. Because pyridoxal 5'-phosphate (PLP) serves as a coenzyme in the metabolism of amino acids, carbohydrates, organic acids, and neurotransmitters, as well as in aspects of one-carbon metabolism, vitamin B-6 deficiency could have many effects. Healthy men and women (age: 20-40 y; n = 23) were fed a 2-day controlled, nutritionally adequate diet followed by a 28-day low-vitamin B-6 diet (<0.5 mg/d) to induce marginal deficiency, as reflected by a decline of plasma PLP from 52.6 +/- 14.1 (mean +/- SD) to 21.5 +/- 4.6 nmol/L (P < 0.0001) and increased cystathionine from 131 +/- 65 to 199 +/- 56 nmol/L (P < 0.001). Fasting plasma samples obtained before and after vitamin B6 restriction were analyzed by H-1-NMR with and without filtration and by targeted quantitative analysis by mass spectrometry (MS). Multilevel partial least squares-discriminant analysis and S-plots of NMR spectra showed that NMR is effective in classifying samples according to vitamin B-6 status and identified discriminating features. NMR spectral features of selected metabolites indicated that vitamin B-6 restriction significantly increased the ratios of glutamine/glutamate and 2-oxoglutarate/glutamate (P < 0.001) and tended to increase concentrations of acetate, pyruvate, and trimethylamine-N-oxide (adjusted P < 0.05). Tandem MS showed significantly greater plasma proline after vitamin B-6 restriction (adjusted P < 0.05), but there were no effects on the profile of 14 other amino acids and 45 acylcarnitines. These findings demonstrate that marginal vitamin B-6 deficiency has widespread metabolic perturbations and illustrate the utility of metabolomics in evaluating complex effects of altered vitamin B-6 intake.	[Gregory, Jesse F., III; Lamers, Yvonne; da Silva, Vanessa] Univ Florida, Inst Food & Agr Sci, Food Sci & Human Nutr Dept, Gainesville, FL 32611 USA; [Park, Youngja; Lee, Kichen; Kim, Steven; Jones, Dean P.] Emory Univ, Dept Med, Div Pulm Allergy & Crit Care Med, Clin Biomarkers Lab,Dept Med, Atlanta, GA 30322 USA; [Park, Youngja; Lee, Kichen; Kim, Steven; Jones, Dean P.] Emory Univ, Dept Med, Ctr Clin & Mol Nutr, Atlanta, GA 30322 USA; [Bandyopadhyay, Nirmalya; Ranka, Sanjay; Kahveci, Tamer] Univ Florida, Gainesville, FL 32611 USA; [Chi, Yueh-Yun] Univ Florida, Dept Biostat, Gainesville, FL 32611 USA; [Lee, Kichen; Hove, Nikolas] Hanyang Univ, Dept Ind Engn, Seoul 133791, South Korea; [Muller, Keith E.] Univ Florida, Dept Hlth Outcomes & Policy, Gainesville, FL 32611 USA; [Stevens, Robert D.; Newgard, Christopher B.] Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Durham, NC USA; [Stacpoole, Peter W.] Univ Florida, Dept Med, Div Endocrinol & Metab, Gainesville, FL 32611 USA; [Stacpoole, Peter W.] Univ Florida, Coll Med, Dept Biochem & Mol Biol, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; Emory University; Emory University; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Hanyang University; State University System of Florida; University of Florida; Duke University; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Gregory, JF (corresponding author), Univ Florida, Inst Food & Agr Sci, Food Sci & Human Nutr Dept, Gainesville, FL 32611 USA.	jfgy@ufl.edu	Ranka, Sanjay/ABH-9725-2020; Chi, Yueh-Yun/AAL-6234-2020; Lamers, Yvonne/AAA-2385-2019; Ranka, Sanjay/ABH-1391-2020	Ranka, Sanjay/0000-0003-4886-1988; Lamers, Yvonne/0000-0001-7878-0164; Gregory, Jesse/0000-0002-9976-2085	National Institutes of Health (NIH) [DK072398, ES016731, PO1-DK-58398]; NIH National Center for Research Resources CTSA Grant [1UL1RR029890]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029890] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK058398, R01DK072398] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES016731] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Center for Research Resources CTSA Grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by National Institutes of Health (NIH) Grant DK072398 (to Jesse F. Gregory) and NIH National Center for Research Resources CTSA Grant 1UL1RR029890. Support of the Clinical Biomarkers Laboratory, Emory University was from NIH Grant ES016731 to Dean P. Jones, and support of the Sarah W. Stedman Nutrition and Metabolism Center, Duke University, was from NIH Grant PO1-DK-58398 to Christopher B. Newgard. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aristoteli LP, 2007, J PROTEOME RES, V6, P571, DOI 10.1021/pr0602996; Barton RH, 2010, MOL BIOSYST, V6, P215, DOI 10.1039/b907021d; Benderitter M, 1996, FREE RADICAL BIO MED, V21, P541, DOI 10.1016/0891-5849(96)00047-0; Brosnan JT, 2003, J NUTR, V133, p2068S; Cabrini L, 1998, BIOCHEM MOL BIOL INT, V46, P689; Cattaneo M, 2001, CIRCULATION, V104, P2442, DOI 10.1161/hc4501.098925; Centers for Disease Control and Prevention, 2012, 2 CDCP NAT CTR ENV H; Chi YY, 2012, STAT MED, V31, P724, DOI 10.1002/sim.4435; CURTHOYS NP, 1995, ANNU REV NUTR, V15, P133, DOI 10.1146/annurev.nu.15.070195.001025; Cuskelly GJ, 2001, AM J PHYSIOL-ENDOC M, V281, pE1182, DOI 10.1152/ajpendo.2001.281.6.E1182; DALERY K, 1995, AM J CARDIOL, V75, P1107, DOI 10.1016/S0002-9149(99)80739-5; Davis SR, 2006, J NUTR, V136, P373, DOI 10.1093/jn/136.2.373; Davis SR, 2005, AM J CLIN NUTR, V81, P648; Duggan GE, 2011, J BIOMOL NMR, V49, P165, DOI 10.1007/s10858-011-9485-5; Ferrara CT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000034; Food and Nutrition Board - Institute of Medicine, 1998, DIET REF INT THIAM R; Forshed J, 2003, PEAK ALIGNMENT NMR S; Fulgoni VL, 2011, J NUTR, V141, P1847, DOI 10.3945/jn.111.142257; German JB, 2004, J NUTR, V134, P2729, DOI 10.1093/jn/134.10.2729; Gu HW, 2007, ANAL CHEM, V79, P89, DOI 10.1021/ac060946c; Hron G, 2007, HAEMATOLOGICA, V92, P1250, DOI 10.3324/haematol.11318; Johansson M, 2010, JAMA-J AM MED ASSOC, V303, P2377, DOI 10.1001/jama.2010.808; Kelly PJ, 2003, STROKE, V34, pE51, DOI 10.1161/01.STR.0000071109.23410.AB; Lamarre SG, 2012, AM J PHYSIOL-ENDOC M, V302, pE61, DOI 10.1152/ajpendo.00345.2011; Lamers Y, 2007, J NUTR, V137, P2647, DOI 10.1093/jn/137.12.2647; Lamers Y, 2011, J NUTR, V141, P835, DOI 10.3945/jn.110.134197; Lamers Y, 2009, AM J CLIN NUTR, V90, P336, DOI 10.3945/ajcn.2009.27747; Lamers Y, 2009, J NUTR, V139, P666, DOI 10.3945/jn.108.103580; Lamers Y, 2009, J NUTR, V139, P452, DOI 10.3945/jn.108.099184; Larsson SC, 2010, JAMA-J AM MED ASSOC, V303, P1077, DOI 10.1001/jama.2010.263; Lee GC, 2004, ANAL CHIM ACTA, V513, P413, DOI 10.1016/j.aca.2004.02.068; Leklem J, 1998, MODERN NUTR HLTH DIS, P1413; Lima CP, 2006, J NUTR, V136, P2141, DOI 10.1093/jn/136.8.2141; Lotto V, 2011, BR J NUTR, V13, P1; Lussana F, 2003, THROMB RES, V112, P37, DOI 10.1016/j.thromres.2003.11.007; MACKEY A, 2005, MODERN NUTR HLTH DIS, P452; Midttun O, 2011, J NUTR, V141, P611, DOI 10.3945/jn.110.133082; Miller JW, 2002, NEUROLOGY, V58, P1471, DOI 10.1212/WNL.58.10.1471; Morris MS, 2008, AM J CLIN NUTR, V87, P1446, DOI 10.1093/ajcn/87.5.1446; Morris MS, 2010, J NUTR, V140, P103, DOI 10.3945/jn.109.114397; NICHOLSON JK, 1995, ANAL CHEM, V67, P793, DOI 10.1021/ac00101a004; Nijhout HF, 2009, J NUTR, V139, P784, DOI 10.3945/jn.109.104265; PARK YK, 1970, J NUTR, V100, P110, DOI 10.1093/jn/100.1.110; Park Y, 2011, J NUTR, V141, P1424, DOI 10.3945/jn.111.138875; Park Y, 2009, AM J PHYSIOL-REG I, V297, pR202, DOI 10.1152/ajpregu.90757.2008; Pfeiffer CM, 1999, CLIN CHEM, V45, P290; Rimm EB, 1998, JAMA-J AM MED ASSOC, V279, P359, DOI 10.1001/jama.279.5.359; Robinson K, 1998, CIRCULATION, V97, P437; Robinson K, 1996, CIRCULATION, V94, P2743, DOI 10.1161/01.CIR.94.11.2743; SAUBERLICH HE, 1972, AM J CLIN NUTR, V25, P629; Scheer JB, 2005, J NUTR, V135, P233, DOI 10.1093/jn/135.2.233; Silva V. R. da, 2012, Present knowledge in nutrition, P307; Solanky KS, 2003, ANAL BIOCHEM, V323, P197, DOI 10.1016/j.ab.2003.08.028; Storey JD, 2012, STAT METHODOL, V64, P479; Taysi S, 2005, CLIN NUTR, V24, P385, DOI 10.1016/j.clnu.2004.12.001; Tredwell GD, 2011, ANAL CHEM, V83, P8683, DOI 10.1021/ac202123k; UBBINK JB, 1985, J CHROMATOGR, V342, P277, DOI 10.1016/S0378-4347(00)84518-1; Ubbink JB, 1996, J CLIN INVEST, V98, P177, DOI 10.1172/JCI118763; Vanuzzo D, 2007, EUR HEART J, V28, P484, DOI 10.1093/eurheartj/ehl470; Verhoef P, 1996, AM J EPIDEMIOL, V143, P845, DOI 10.1093/oxfordjournals.aje.a008828; VILTER RW, 1953, J LAB CLIN MED, V42, P335; Walsh MC, 2007, AM J CLIN NUTR, V86, P1687; Weljie AM, 2006, ANAL CHEM, V78, P4430, DOI 10.1021/ac060209g; Weljie AM, 2008, ANAL CHEM, V80, P8956, DOI 10.1021/ac8012362; Westerhuis JA, 2010, METABOLOMICS, V6, P119, DOI 10.1007/s11306-009-0185-z; Wiklund S, 2008, ANAL CHEM, V80, P115, DOI 10.1021/ac0713510; Zeisel SH, 2005, J NUTR, V135, P1613, DOI 10.1093/jn/135.7.1613; Zhao M, 2012, J NUTR, V142, P1791, DOI 10.3945/jn.112.163246	68	42	43	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e63544	10.1371/journal.pone.0063544	http://dx.doi.org/10.1371/journal.pone.0063544			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776431	gold, Green Submitted, Green Published			2022-12-27	WOS:000320755400003
J	Hwang, MS; Yu, N; Stinson, SY; Yue, P; Newman, RJ; Allan, BB; Dornan, D				Hwang, Michael S.; Yu, Nancy; Stinson, Susanna Y.; Yue, Peng; Newman, Robert J.; Allan, Bernard B.; Dornan, David			miR-221/222 Targets Adiponectin Receptor 1 to Promote the Epithelial-to-Mesenchymal Transition in Breast Cancer	PLOS ONE			English	Article							NF-KAPPA-B; SIGNALING PATHWAY; TUMOR-METASTASIS; SELF-RENEWAL; CELLS; INHIBITION; PROGRESSION; EXPRESSION; INVASION; CADHERIN	The epithelial-to-mesenchymal transition (EMT) is a highly conserved physiological program involved in development and tissue repair; however, its aberrant activation has been implicated in accelerating the progression of a variety of cancers. In breast cancer, the microRNAs (miRNAs) miR-221 and miR-222 (miR-221/222) are differentially expressed in the clinically more aggressive basal-like subtype compared to luminal subtype of breast cancer and upregulation of miR-221/222 induces the EMT by targeting the 39 untranslated region (3'UTR) of the GATA family transcriptional repressor TRPS1 (tricho-rhinophalangeal syndrome type 1). The complete mechanism through which miR-221/222 promotes the EMT, however, is not fully understood. We identified adiponectin receptor 1 (ADIPOR1), a receptor for the adipocytokine adiponectin, as a direct target of miR-221/222. ADIPOR1 is expressed at higher levels in the luminal compared to the basal-like subtype of breast cancer cell lines, which can be reduced by miR-221/222 targeting of its 3' UTR. In addition, miR-221/222 were negatively correlated with ADIPOR1 expression across breast cancer cell lines and tumors. ADIPOR1 depletion by siRNA in MCF10A cells induced the EMT and increased cell invasion. Depletion of ADIPOR1 by siRNA induced activation of the canonical nuclear factor-kappaB (NF-kappa B) and subsequent phosphorylation of signal transducer and activator of transcription 3 (STAT3) in an interleukin 6 (IL6)-dependent manner. Finally, overexpression of ADIPOR1 in the basal-like cell line, MDA-MB-231, attenuated cell invasion and promoted the mesenchymal-to-epithelial transition (MET). We conclude that ADIPOR1 negatively regulates EMT in breast cancer and provides an additional node by which miR-221/222 induces the EMT. These results suggest that ADIPOR1 may play an important role in breast cancer progression and metastasis, and could potentially offer an alternative therapeutic strategy for basal-like breast cancer patients.	[Hwang, Michael S.; Yu, Nancy; Stinson, Susanna Y.; Dornan, David] Genentech Inc, Dept Mol Diagnost & Canc Cell Biol, San Francisco, CA 94080 USA; [Yue, Peng] Genentech Inc, Dept Bioinformat & Computat Biol, San Francisco, CA 94080 USA; [Newman, Robert J.; Allan, Bernard B.] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Dornan, D (corresponding author), Genentech Inc, Dept Mol Diagnost & Canc Cell Biol, San Francisco, CA 94080 USA.	david.dornan@gilead.com						Andrews JL, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3065; Baldwin AS, 2001, J CLIN INVEST, V107, P241, DOI 10.1172/JCI11991; Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; Blaskovich MA, 2003, CANCER RES, V63, P1270; Cilloni D, 2006, LEUKEMIA, V20, P61, DOI 10.1038/sj.leu.2403998; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Denzel MS, 2010, J CLIN INVEST, V120, P4342, DOI 10.1172/JCI43464; Droebner K, 2008, J VIROL, V82, P11461, DOI 10.1128/JVI.01071-08; Duggan C, 2011, J CLIN ONCOL, V29, P32, DOI 10.1200/JCO.2009.26.4473; Dutta J, 2006, ONCOGENE, V25, P6800, DOI 10.1038/sj.onc.1209938; Fang X, 2011, ONCOGENE, V30, P4707, DOI 10.1038/onc.2011.181; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hebbard LW, 2008, CANCER RES, V68, P1407, DOI 10.1158/0008-5472.CAN-07-2953; Hennessy BT, 2009, CANCER RES, V69, P4116, DOI 10.1158/0008-5472.CAN-08-3441; Holland WL, 2011, NAT MED, V17, P55, DOI 10.1038/nm.2277; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Hutchinson L, 2010, NAT REV CLIN ONCOL, V7, P669, DOI 10.1038/nrclinonc.2010.192; Kaklamani VG, 2008, CANCER RES, V68, P3178, DOI 10.1158/0008-5472.CAN-08-0533; Landskroner-Eiger S, 2009, CLIN CANCER RES, V15, P3265, DOI 10.1158/1078-0432.CCR-08-2649; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Mantzoros C, J CLIN ENDOCRINOL ME, V89, P1102; Meydan N, 1996, NATURE, V379, P645, DOI 10.1038/379645a0; Miyoshi Y, 2003, CLIN CANCER RES, V9, P5699; Nefedova Y, 2005, CANCER RES, V65, P9525, DOI 10.1158/0008-5472.CAN-05-0529; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Reis-Filho JS, 2008, HISTOPATHOLOGY, V52, P108, DOI 10.1111/j.1365-2559.2007.02889.x; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; SOMMERS CL, 1992, CANCER RES, V52, P5190; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stinson S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001538; Sullivan NJ, 2009, ONCOGENE, V28, P2940, DOI 10.1038/onc.2009.180; Taliaferro-Smith L, 2009, ONCOGENE, V28, P2621, DOI 10.1038/onc.2009.129; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thike AA, 2010, MODERN PATHOL, V23, P123, DOI 10.1038/modpathol.2009.145; Tobar N, 2010, MOL CELL BIOCHEM, V340, P195, DOI 10.1007/s11010-010-0418-5; Tomaskovic-Crook E, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2416; Wang CY, 1999, NAT MED, V5, P412, DOI 10.1038/7410; Xie GZ, 2012, INT J ONCOL, V40, P1171, DOI 10.3892/ijo.2011.1275; Xiong H, 2012, J BIOL CHEM, V287, P5819, DOI 10.1074/jbc.M111.295964; Yadav A, 2011, MOL CANCER RES, V9, P1658, DOI 10.1158/1541-7786.MCR-11-0271; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054	46	108	113	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66502	10.1371/journal.pone.0066502	http://dx.doi.org/10.1371/journal.pone.0066502			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776679	Green Submitted, Green Published, gold			2022-12-27	WOS:000320755400149
J	Lam, VKL; Ma, RCW; Lee, HM; Hu, C; Park, KS; Furuta, H; Wang, Y; Tam, CHT; Sim, XL; Ng, DPK; Liu, JJ; Wong, TY; Tai, ES; Morris, AP; Tang, NLS; Woo, J; Leung, PC; Kong, APS; Ozaki, R; Jia, WP; Lee, HK; Nanjo, K; Xu, G; Ng, MCY; So, WY; Chan, JCN				Lam, Vincent Kwok Lim; Ma, Ronald Ching Wan; Lee, Heung Man; Hu, Cheng; Park, Kyong Soo; Furuta, Hiroto; Wang, Ying; Tam, Claudia Ha Ting; Sim, Xueling; Ng, Daniel Peng-Keat; Liu, Jianjun; Wong, Tien-Yin; Tai, E. Shyong; Morris, Andrew P.; Tang, Nelson Leung Sang; Woo, Jean; Leung, Ping Chung; Kong, Alice Pik Shan; Ozaki, Risa; Jia, Wei Ping; Lee, Hong Kyu; Nanjo, Kishio; Xu, Gang; Ng, Maggie Chor Yin; So, Wing-Yee; Chan, Juliana Chung Ngor		DIAGRAM Consortium	Genetic Associations of Type 2 Diabetes with Islet Amyloid Polypeptide Processing and Degrading Pathways in Asian Populations	PLOS ONE			English	Article							HUMAN PANCREATIC-ISLETS; ENDOPLASMIC-RETICULUM STRESS; TRANSCRIPTION FACTOR; SUSCEPTIBILITY LOCI; METABOLIC SYNDROME; INSULIN; MELLITUS; OBESITY; HHEX; RISK	Type 2 diabetes (T2D) is a complex disease characterized by beta cell dysfunctions. Islet amyloid polypeptide (IAPP) is highly conserved and co-secreted with insulin with over 40% of autopsy cases of T2D showing islet amyloid formation due to IAPP aggregation. Dysregulation in IAPP processing, stabilization and degradation can cause excessive oligomerization with beta cell toxicity. Previous studies examining genetic associations of pathways implicated in IAPP metabolism have yielded conflicting results due to small sample size, insufficient interrogation of gene structure and gene-gene interactions. In this multi-staged study, we screened 89 tag single nucleotide polymorphisms (SNPs) in 6 candidate genes implicated in IAPP metabolism and tested for independent and joint associations with T2D and beta cell dysfunctions. Positive signals in the stage-1 were confirmed by de novo and in silico analysis in a multi-centre unrelated case-control cohort. We examined the association of significant SNPs with quantitative traits in a subset of controls and performed bioinformatics and relevant functional analyses. Amongst the tag SNPs, rs1583645 in carboxypeptidase E (CPE) and rs6583813 in insulin degrading enzyme (IDE) were associated with 1.09 to 1.28 fold increased risk of T2D (P-Meta = 9.4x10(-3) and 0.02 respectively) in a meta-analysis of East Asians. Using genetic risk scores (GRS) with each risk variant scoring 1, subjects with GRS >= 3 (8.2% of the cohort) had 56% higher risk of T2D than those with GRS = 0 (P = 0.01). In a subcohort of control subjects, plasma IAPP increased and beta cell function index declined with GRS (P = 0.008 and 0.03 respectively). Bioinformatics and functional analyses of CPE rs1583645 predicted regulatory elements for chromatin modification and transcription factors, suggesting differential DNA-protein interactions and gene expression. Taken together, these results support the importance of dysregulation of IAPP metabolism in T2D in East Asians.	[Lam, Vincent Kwok Lim; Ma, Ronald Ching Wan; Lee, Heung Man; Wang, Ying; Tam, Claudia Ha Ting; Woo, Jean; Kong, Alice Pik Shan; Ozaki, Risa; Xu, Gang; Ng, Maggie Chor Yin; So, Wing-Yee; Chan, Juliana Chung Ngor] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China; [Tang, Nelson Leung Sang] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Chem Pathol, Shatin, Hong Kong, Peoples R China; [Leung, Ping Chung] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Orthopaed & Traumatol, Shatin, Hong Kong, Peoples R China; [Hu, Cheng; Jia, Wei Ping] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Clin Ctr Diabet,Shanghai Key Clin Ctr Me, Dept Endocrinol & Metab,Shanghai Diabet Inst, Shanghai 200030, Peoples R China; [Park, Kyong Soo; Lee, Hong Kyu] Seoul Natl Univ, Coll Med, Dept Internal Med, Dept Mol Med & Biopharmaceut Sci,Grad Sch Converg, Seoul 151, South Korea; [Furuta, Hiroto; Nanjo, Kishio] Wakayama Med Univ, Dept Med 1, Wakayama, Japan; [Ma, Ronald Ching Wan; Xu, Gang; Chan, Juliana Chung Ngor] Chinese Univ Hong Kong, Hong Kong Inst Diabet & Obes, Hong Kong, Hong Kong, Peoples R China; [Ma, Ronald Ching Wan; Xu, Gang; Chan, Juliana Chung Ngor] Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth, Shatin, Hong Kong, Peoples R China; [Sim, Xueling] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Ctr Mol Epidemiol, Singapore 117548, Singapore; [Ng, Daniel Peng-Keat; Liu, Jianjun; Tai, E. Shyong] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Liu, Jianjun] Agcy Sci Technol & Res, Genome Inst Singapore, Singapore, Singapore; [Wong, Tien-Yin] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore; [Wong, Tien-Yin] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Ophthalmol, Singapore 117595, Singapore; [Tai, E. Shyong] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117595, Singapore; [Tai, E. Shyong] Duke Natl Univ Singapore, Grad Sch Med, Singapore, Singapore; [Morris, Andrew P.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Shanghai Jiao Tong University; Seoul National University (SNU); Wakayama Medical University; Chinese University of Hong Kong; Chinese University of Hong Kong; Prince of Wales Hospital; National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; Singapore National Eye Center; National University of Singapore; National University of Singapore; National University of Singapore; University of Oxford; Wellcome Centre for Human Genetics	Chan, JCN (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China.	jchan@cuhk.edu.hk	Sim, Xueling/AAZ-6652-2020; Wong, Tien Yin/AAC-9724-2020; Ma, Ronald/C-2788-2009; Chan, Juliana/B-7918-2016; Tang, Nelson/P-5018-2017; Woo, Jean/K-2625-2014; Park, Kyong Soo/C-2265-2008	Sim, Xueling/0000-0002-1233-7642; Wong, Tien Yin/0000-0002-8448-1264; Ma, Ronald/0000-0002-1227-803X; Chan, Juliana/0000-0003-1325-1194; Tang, Nelson/0000-0002-3607-5819; Woo, Jean/0000-0001-7593-3081; Tai, E Shyong/0000-0003-2929-8966; Hu, Cheng/0000-0003-4314-2386; Park, Kyong Soo/0000-0003-3597-342X; Liu, Jianjun/0000-0002-3255-3019	Chinese University of Hong Kong (CUHK) [2041565]; Research Grants Council (RGC) Central Allocation Scheme [CUHK 1/04C]; earmarked grant [CUHK4462/06M]; National Institutes of Health (NIH) [6903078]; Hong Kong Foundation for Research and Development in Diabetes; Liao Wun Yuk Diabetes Research Memorial Fund; National Natural Scientific Foundation of China [30630061]; Shanghai Key Laboratory of Diabetes Mellitus [08DZ2230200]; National Project for Personalized Genomic Medicine, Ministry for Health & Welfare, Republic of Korea [A111218-GM09]; Ministry of Education, Culture, Sports, Science and Technology of Japan [17019047]; Biomedical Research Council of Singapore [BMRC05/1/36/19/413, 03/1/27/18/216]; National Medical Research Council of Singapore [NMRC/1174/2008]; National Medical Research Council [NMRC0796/2003, NMRC/STaR/0003/2008]; Biomedical Research Council [BMRC09/1/35/19/616]; National Medical Research Council	Chinese University of Hong Kong (CUHK)(Chinese University of Hong Kong); Research Grants Council (RGC) Central Allocation Scheme; earmarked grant; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hong Kong Foundation for Research and Development in Diabetes; Liao Wun Yuk Diabetes Research Memorial Fund; National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Key Laboratory of Diabetes Mellitus; National Project for Personalized Genomic Medicine, Ministry for Health & Welfare, Republic of Korea; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Biomedical Research Council of Singapore(Agency for Science Technology & Research (A*STAR)); National Medical Research Council of Singapore(National Medical Research Council, Singapore); National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Chinese University of Hong Kong (CUHK) - Direct Grant (2041565), the Research Grants Council (RGC) Central Allocation Scheme (CUHK 1/04C), earmarked grant (CUHK4462/06M) and National Institutes of Health (NIH) grant (Project code: 6903078) as well as the Hong Kong Foundation for Research and Development in Diabetes and Liao Wun Yuk Diabetes Research Memorial Fund established under the Chinese University of Hong Kong. The research in Shanghai, China was supported by grants from the National Natural Scientific Foundation of China (30630061) and Shanghai Key Laboratory of Diabetes Mellitus (08DZ2230200). This study was supported by a grant of the National Project for Personalized Genomic Medicine, Ministry for Health & Welfare, Republic of Korea (A111218-GM09). The work in Japan was supported by Grant-in-Aid for Scientific Research on Priority Areas "Applied Genomics" (17019047) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The Singapore Prospective Study Program (SP2) was funded through grants from the Biomedical Research Council of Singapore (BMRC05/1/36/19/413 and 03/1/27/18/216) and the National Medical Research Council of Singapore (NMRC/1174/2008). The Singapore Malay Eye Study (SiMES) was funded by the National Medical Research Council (NMRC0796/2003 and NMRC/STaR/0003/2008) and Biomedical Research Council (BMRC09/1/35/19/616). EST also received additional support from the National Medical Research Council through a clinician scientist award. The Singapore BioBank and the Genome Institute of Singapore, Agency for Science, Technology and Research, Singapore provided services for tissue archival and genotyping, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai JZ, 1999, BIOCHEM J, V343, P53, DOI 10.1042/0264-6021:3430053; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bennett RG, 2003, DIABETES, V52, P2315, DOI 10.2337/diabetes.52.9.2315; Bhandare R, 2010, GENOME RES, V20, P428, DOI 10.1101/gr.102038.109; Cai Y, 2011, MUTAGENESIS, V26, P309, DOI 10.1093/mutage/geq095; Chan JCN, 2011, CURR CARDIOVASC RISK, V5, P230, DOI 10.1007/s12170-011-0172-6; Chen H, 2001, HUM MUTAT, V18, P120, DOI 10.1002/humu.1161; Cho YS, 2012, NAT GENET, V44, P67, DOI 10.1038/ng.1019; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Furukawa Y, 2008, J CLIN ENDOCR METAB, V93, P310, DOI 10.1210/jc.2007-1029; Gaulton KJ, 2010, NAT GENET, V42, P255, DOI 10.1038/ng.530; GERMAN MS, 1992, MOL CELL BIOL, V12, P1777, DOI 10.1128/MCB.12.4.1777; Groves CJ, 2003, DIABETES, V52, P1300, DOI 10.2337/diabetes.52.5.1300; Harrap SB, 2006, HUM GENET, V119, P541, DOI 10.1007/s00439-006-0167-4; He M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004684; Huang CJ, 2007, DIABETES, V56, P2016, DOI 10.2337/db07-0197; Jaikaran ETAS, 2004, BIOCHEM J, V377, P709, DOI 10.1042/bj20030852; Jeffrey KD, 2008, P NATL ACAD SCI USA, V105, P8452, DOI 10.1073/pnas.0711232105; Jia WP, 2007, DIABETOLOGIA, V50, P286, DOI 10.1007/s00125-006-0503-1; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kim MK, 1996, MOL CELL BIOL, V16, P4366; Kwak SH, 2008, DIABETES RES CLIN PR, V79, P284, DOI 10.1016/j.diabres.2007.08.017; Lange C, 2002, AM J HUM GENET, V71, P575, DOI 10.1086/342406; Leak TS, 2007, MOL GENET METAB, V92, P145, DOI 10.1016/j.ymgme.2007.05.014; Li JKY, 2006, DIABETES-METAB RES, V22, P46, DOI 10.1002/dmrr.577; Li XL, 2011, INT J BIOCHEM CELL B, V43, P525, DOI 10.1016/j.biocel.2010.12.008; Liu KH, 2006, DIABETES CARE, V29, P379, DOI 10.2337/diacare.29.02.06.dc05-1578; Martin LJ, 2002, DIABETES, V51, P3568, DOI 10.2337/diabetes.51.12.3568; Matveyenko AV, 2009, DIABETES, V58, P906, DOI 10.2337/db08-1464; McCarthy MI, 2010, NEW ENGL J MED, V363, P2339, DOI 10.1056/NEJMra0906948; Ng MCY, 2010, DIABETIC MED, V27, P1443, DOI 10.1111/j.1464-5491.2010.03124.x; Ng MCY, 2008, DIABETES, V57, P2226, DOI 10.2337/db07-1583; Noonan JP, 2010, ANNU REV GENOM HUM G, V11, P1, DOI 10.1146/annurev-genom-082509-141651; Nordman S, 2009, EXP CLIN ENDOCR DIAB, V117, P186, DOI 10.1055/s-0028-1100419; Paulsson JF, 2005, DIABETES, V54, P2117, DOI 10.2337/diabetes.54.7.2117; Pepys MB, 2002, NATURE, V417, P254, DOI 10.1038/417254a; PIWERNETZ K, 1993, DIABETIC MED, V10, P371, DOI 10.1111/j.1464-5491.1993.tb00083.x; Prokopenko I, 2009, DIABETES, V58, P1704, DOI 10.2337/db09-0081; Qi D, 2009, AM J PHYSIOL-ENDOC M, V298, pE99; Ragvin A, 2010, P NATL ACAD SCI USA, V107, P775, DOI 10.1073/pnas.0911591107; Rudovich N, 2009, J MOL MED, V87, P1145, DOI 10.1007/s00109-009-0540-6; Sim X, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001363; Steiner DF, 2009, DIABETES OBES METAB, V11, P189, DOI 10.1111/j.1463-1326.2009.01106.x; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Stitzel ML, 2010, CELL METAB, V12, P443, DOI 10.1016/j.cmet.2010.09.012; Stumvoll M, 2000, DIABETES CARE, V23, P295, DOI 10.2337/diacare.23.3.295; Utsunomiya N, 1998, DIABETOLOGIA, V41, P701, DOI 10.1007/s001250050971; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wang YD, 2011, MOL GENET METAB, V102, P194, DOI 10.1016/j.ymgme.2010.09.013; Westermark P, 2011, PHYSIOL REV, V91, P795, DOI 10.1152/physrev.00042.2009; Wolford JK, 2003, MOL GENET METAB, V78, P136, DOI 10.1016/S1096-7192(02)00230-5; Yang QH, 2005, INT J EPIDEMIOL, V34, P1129, DOI 10.1093/ije/dyi130; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zhao HL, 2009, TRANSL RES, V153, P24, DOI 10.1016/j.trsl.2008.10.009; Zhao HL, 2003, DIABETES, V52, P2759, DOI 10.2337/diabetes.52.11.2759	55	5	5	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e62378	10.1371/journal.pone.0062378	http://dx.doi.org/10.1371/journal.pone.0062378			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776430	Green Published, gold, Green Submitted			2022-12-27	WOS:000320755400002
J	Morales, JM; Garcia, D; Martinez, D; Rodriguez-Perez, J; Herrera, JM				Manuel Morales, Juan; Garcia, Daniel; Martinez, Daniel; Rodriguez-Perez, Javier; Manuel Herrera, Jose			Frugivore Behavioural Details Matter for Seed Dispersal: A Multi-Species Model for Cantabrian Thrushes and Trees	PLOS ONE			English	Article							POPULATION-DYNAMICS; TEMPORAL VARIATION; BIRDS; FRUIT; LANDSCAPE; PATTERNS; CONSEQUENCES; DISTANCE; ESTABLISHMENT; ENVIRONMENT	Animal movement and behaviour is fundamental for ecosystem functioning. The process of seed dispersal by frugivorous animals is a showcase for this paradigm since their behaviour shapes the spatial patterns of the earliest stage of plant regeneration. However, we still lack a general understanding of how intrinsic (frugivore and plant species traits) and extrinsic (landscape features) factors interact to determine how seeds of a given species are more likely to be deposited in some places more than in others. We develop a multi-species mechanistic model of seed dispersal based on frugivore behavioural responses to landscape heterogeneity. The model was fitted to data from three-years of spatially-explicit field observations on the behaviour of six frugivorous thrushes and the fruiting patterns of three fleshy-fruited trees in a secondary forest of the Cantabrian range (N Spain). With such model we explore how seed rain patterns arise from the interaction between animal behaviour and landscape heterogeneity. We show that different species of thrushes respond differently to landscape heterogeneity even though they belong to the same genus, and that provide complementary seed dispersal functions. Simulated seed rain patterns are only realistic when at least some landscape heterogeneity (forest cover and fruit abundance) is taken into account. The common and simple approach of re-sampling movement data to quantify seed dispersal produces biases in both the distance and the habitat at which seeds arrive. Movement behaviour not only affects dispersal distance and seed rain patterns but also can affect frugivore diet composition even if there is no built-in preference for fruiting species. In summary, the fate of seeds produced by a given plant species is strongly affected by both the composition of the frugivore assemblage and the landscape-scale context of the plant location, including the presence of fruits from other plants (from the same or different species).	[Manuel Morales, Juan] Univ Nacl Comahue, INIBIOMA CONICET, Lab Ecotono, Black River, Argentina; [Garcia, Daniel; Martinez, Daniel; Rodriguez-Perez, Javier; Manuel Herrera, Jose] Univ Oviedo, Dept Biol Organismos & Sistemas, Oviedo, Spain; [Garcia, Daniel; Martinez, Daniel; Rodriguez-Perez, Javier; Manuel Herrera, Jose] CSIC UO PA, UMIB, Unidad Mixta Invest Biodiversidad, Oviedo, Spain	Universidad Nacional del Comahue; University of Oviedo; Consejo Superior de Investigaciones Cientificas (CSIC)	Morales, JM (corresponding author), Univ Nacl Comahue, INIBIOMA CONICET, Lab Ecotono, Black River, Argentina.	jm.morales@conicet.gov.ar	Herrera, José M./L-7432-2013; Javier Rodríguez-Pérez, Ph.D. Biology/C-9773-2009; García, Daniel/A-1236-2011; Morales, Juan/B-6316-2009	Herrera, José M./0000-0001-7968-3438; Javier Rodríguez-Pérez, Ph.D. Biology/0000-0002-1292-9090; García, Daniel/0000-0002-7334-7836; Morales, Juan/0000-0001-7269-7490	European Social Fund; Spanish Ministry of Science [CGL2008-01275, CGL2011-28430]; CONICET; FONCYT [PIP 114-200801-00276]	European Social Fund(European Social Fund (ESF)); Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); FONCYT(FONCyT)	Research was supported by the European Social Fund and Spanish Ministry of Science (FPI grants to DM and JMH; CGL2008-01275 and CGL2011-28430 grants to DG), and CONICET and FONCYT (PIP 114-200801-00276 grant to JMM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JT, 2011, P ROY SOC B-BIOL SCI, V278, P3329, DOI 10.1098/rspb.2011.0155; Blendinger PG, 2011, OECOLOGIA, V167, P61, DOI 10.1007/s00442-011-1956-6; Breitbach N, 2012, J ECOLOGY; Carlo T. A., 2007, Seed dispersal: theory and its application in a changing world, P369, DOI 10.1079/9781845931650.0369; Carlo TA, 2008, J ECOL, V96, P609, DOI 10.1111/j.1365-2745.2008.01379.x; Cousens RD, 2010, FUNCT ECOL, V24, P1163, DOI 10.1111/j.1365-2435.2010.01747.x; Dennis AJ, 2007, ESTIMATING DISPERSAL; Dennis AJ, 2006, OECOLOGIA, V149, P620, DOI 10.1007/s00442-006-0475-3; Donatti CI, 2011, ECOLOGY LETT, V14; Garcia D, 2005, J ECOL, V93, P693, DOI 10.1111/j.1365-2745.2005.01004.x; Garcia D, 2012, P ROYAL SOC B, V279; Garcia D, 2011, ECOL MONOGR, V81, P123; Garcia D, 2012, ECOGRAPHY IN PRESS; GUITIAN J., 2000, ZORZALES ESPINOS SER; HERRERA CM, 1984, ECOLOGY, V65, P609, DOI 10.2307/1941423; Herrera JM, 2010, CONSERVATION BIOL, V24; Herrera JM, 2011, J ECOL, V99, P1100, DOI 10.1111/j.1365-2745.2011.01861.x; Hickey JR, 1999, OIKOS, V87, P499, DOI 10.2307/3546814; Jordano P, 2007, P NATL ACAD SCI USA, V104, P3278, DOI 10.1073/pnas.0606793104; Jordano P., 2000, Seeds: the ecology of regeneration in plant communities, P125, DOI 10.1079/9780851994321.0125; Keitt TH, 2002, ECOGRAPHY, V25, P616, DOI 10.1034/j.1600-0587.2002.250509.x; Lehouck V, 2009, J VEGETATION SCI, V20; Lenz J, 2011, P ROY SOC B-BIOL SCI, V278, P2257, DOI 10.1098/rspb.2010.2383; Levey DJ, 2005, SCIENCE, V309, P146, DOI 10.1126/science.1111479; LEVEY DJ, 1988, ECOL MONOGR, V58, P251, DOI 10.2307/1942539; Levine JM, 2003, ANNU REV ECOL EVOL S, V34, P549, DOI 10.1146/annurev.ecolsys.34.011802.132400; LOISELLE BA, 1991, ECOLOGY, V72, P180, DOI 10.2307/1938913; Lundberg J, 2003, ECOSYSTEMS, V6, P87, DOI 10.1007/s10021-002-0150-4; Marcum HA, 1998, ECOL MODEL, V106, P161, DOI 10.1016/S0304-3800(97)00190-7; Martinez I, 2008, ECOSCIENCE, V15, P189, DOI 10.2980/15-2-3096; Morales JM, 2008, OIKOS, V117, P1362, DOI 10.1111/j.0030-1299.2008.16737.x; Morales JM, 2010, PHILOS T R SOC B, V365, P2289, DOI 10.1098/rstb.2010.0082; Morales JM, 2006, ECOLOGY, V87, P1489, DOI 10.1890/0012-9658(2006)87[1489:TEOPDA]2.0.CO;2; Morales LM, 1999, ECOL LETT, V2, P228; Moran C, 2004, OECOLOGIA, V141, P584, DOI 10.1007/s00442-004-1685-1; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19050, DOI 10.1073/pnas.0808918105; Perry JN, 1995, J ANIMAL ECOLOGY, V64; Rodriguez-Perez J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033246; Sasal Y, 2012, OIKOS IN PRESS; Sasal Y, 2013, OIKOS, V122, P95, DOI 10.1111/j.1600-0706.2012.20669.x; Schupp EW, 2010, NEW PHYTOL, V188, P333, DOI 10.1111/j.1469-8137.2010.03402.x; Spiegel O, 2007, ECOL LETT, V10, P718, DOI 10.1111/j.1461-0248.2007.01062.x; Telleria JL, 2008, ECOGRAPHY, V31, P381, DOI 10.1111/j.0906-7590.2008.05283.x; Uriarte M, 2011, ECOLOGY, V92, P924, DOI 10.1890/10-0709.1; Westcott DA, 2005, OECOLOGIA, V146, P57, DOI 10.1007/s00442-005-0178-1	45	71	72	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65216	10.1371/journal.pone.0065216	http://dx.doi.org/10.1371/journal.pone.0065216			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776452	Green Submitted, Green Published, gold			2022-12-27	WOS:000320755400015
J	Zitomersky, NL; Atkinson, BJ; Franklin, SW; Mitchell, PD; Snapper, SB; Comstock, LE; Bousvaros, A				Zitomersky, Naamah L.; Atkinson, Benjamin J.; Franklin, Sarah W.; Mitchell, Paul D.; Snapper, Scott B.; Comstock, Laurie E.; Bousvaros, Athos			Characterization of Adherent Bacteroidales from Intestinal Biopsies of Children and Young Adults with Inflammatory Bowel Disease	PLOS ONE			English	Article							MUCOSAL FLORA; SYMBIOTIC BACTERIA; CROHNS-DISEASE; IGA RESPONSE; MICROBIOTA; FRAGILIS; DIVERSITY; COLITIS; COMMENSAL; GENE	There is extensive evidence implicating the intestinal microbiota in inflammatory bowel disease [IBD], but no microbial agent has been identified as a sole causative agent. Bacteroidales are numerically dominant intestinal organisms that associate with the mucosal surface and have properties that both positively and negatively affect the host. To determine precise numbers and species of Bacteroidales adherent to the mucosal surface in IBD patients, we performed a comprehensive culture based analysis of intestinal biopsies from pediatric Crohn's disease [CD], ulcerative colitis [UC], and control subjects. We obtained biopsies from 94 patients and used multiplex PCR or 16S rDNA sequencing of Bacteroidales isolates for species identification. Eighteen different Bacteroidales species were identified in the study group, with up to ten different species per biopsy, a number higher than demonstrated using 16S rRNA gene sequencing methods. Species diversity was decreased in IBD compared to controls and with increasingly inflamed tissue. There were significant differences in predominant Bacteroidales species between biopsies from the three groups and from inflamed and uninflamed sites. Parabacteroides distasonis significantly decreased in inflamed tissue. All 373 Bacteroidales isolates collected in this study grew with mucin as the only utilizable carbon source suggesting this is a non-pathogenic feature of this bacterial order. Bacteroides fragilis isolates with the enterotoxin gene [bft], previously associated with flares of colitis, were not found more often at inflamed colonic sites or within IBD subjects. B. fragilis isolates with the ability to synthesize the immunomodulatory polysaccharide A [PSA], previously shown to be protective in murine models of colitis, were not detected more often from healthy versus inflamed tissue.	[Zitomersky, Naamah L.; Atkinson, Benjamin J.; Franklin, Sarah W.; Snapper, Scott B.; Bousvaros, Athos] Harvard Univ, Sch Med, Boston Childrens Hosp, Div Gastroenterol, Boston, MA 02114 USA; [Mitchell, Paul D.] Boston Childrens Hosp, Clin Res Ctr, Boston, MA USA; [Snapper, Scott B.] Brigham & Womens Hosp, Div Gastroenterol, Boston, MA 02115 USA; [Comstock, Laurie E.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Infect Dis, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Zitomersky, NL (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, Div Gastroenterol, Boston, MA 02114 USA.	naamah.zitomersky@childrens.harvard.edu		Zitomersky, Naamah/0000-0002-4047-1048	Children's Hospital Boston Career Development Award; Thrasher Research Fund: Early Career Award; Rasmussen Family Fund; Wolpow Family Chair in IBD Treatment and Research; NIH/NIAID [R01AI081843]; NASPGHAN-CDHNF; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081843] Funding Source: NIH RePORTER	Children's Hospital Boston Career Development Award; Thrasher Research Fund: Early Career Award; Rasmussen Family Fund; Wolpow Family Chair in IBD Treatment and Research; NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NASPGHAN-CDHNF; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding provided by the Children's Hospital Boston Career Development Award (http://www.childrenshospital.org/cfapps/research/data_admin/Site2209/mainpageS2209P0.html); NASPGHAN-CDHNF Fellow to Faculty Transition Award (http://www.naspghan.org/wmspage.cfm?parm1=665); Thrasher Research Fund: Early Career Award (www.thrasherresearch.org) to NLZ; Rasmussen Family Fund to B.J.A, S. W. F. and A. B.; Wolpow Family Chair in IBD Treatment and Research to S. B. S.; and NIH/NIAID R01AI081843 to L.E.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basset C, 2004, DIGEST DIS SCI, V49, P1425, DOI 10.1023/B:DDAS.0000042241.13489.88; Bloom SM, 2011, CELL HOST MICROBE, V9, P390, DOI 10.1016/j.chom.2011.04.009; Chatzidaki-Livanis M, 2010, P NATL ACAD SCI USA, V107, P11976, DOI 10.1073/pnas.1005039107; Chung GT, 1999, INFECT IMMUN, V67, P4945, DOI 10.1128/IAI.67.9.4945-4949.1999; Comelli EM, 2008, GENOMICS, V91, P70, DOI 10.1016/j.ygeno.2007.09.006; Comstock LE, 2000, INFECT IMMUN, V68, P6182, DOI 10.1128/IAI.68.11.6182-6188.2000; Conte MP, 2006, GUT, V55, P1760, DOI 10.1136/gut.2005.078824; Coyne MJ, 2001, INFECT IMMUN, V69, P4342, DOI 10.1128/IAI.69.7.4342-4350.2001; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Gophna U, 2006, J CLIN MICROBIOL, V44, P4136, DOI 10.1128/JCM.01004-06; Gosiewski T, 2012, J PEDIATR GASTR NUTR, V54, P20, DOI 10.1097/MPG.0b013e31822d53e5; HARPER PH, 1985, GUT, V26, P279, DOI 10.1136/gut.26.3.279; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hoentjen F, 2003, GUT, V52, P1721, DOI 10.1136/gut.52.12.1721; Hooper LV, 2003, NAT IMMUNOL, V4, P269, DOI 10.1038/ni888; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; HYAMS JS, 1991, J PEDIATR GASTR NUTR, V12, P439, DOI 10.1097/00005176-199105000-00005; Kaufman J, 2009, INFLAMM BOWEL DIS, V15, P985, DOI 10.1002/ibd.20876; Kellermayer R, 2012, J PEDIATR GASTR NUTR, V55, P243, DOI 10.1097/MPG.0b013e3182617c16; Khan KJ, 2011, AM J GASTROENTEROL, V106, P661, DOI 10.1038/ajg.2011.72; Krinos CM, 2001, NATURE, V414, P555, DOI 10.1038/35107092; Kverka M, 2011, CLIN EXP IMMUNOL, V163, P250, DOI 10.1111/j.1365-2249.2010.04286.x; Liu CX, 2003, FEMS MICROBIOL LETT, V222, P9, DOI 10.1016/S0378-1097(03)00296-9; Lucke K, 2006, J MED MICROBIOL, V55, P617, DOI 10.1099/jmm.0.46198-0; Malaty HM, 2010, J PEDIATR GASTR NUTR, V50, P27, DOI 10.1097/MPG.0b013e3181b99baa; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Nell S, 2010, NAT REV MICROBIOL, V8, P564, DOI 10.1038/nrmicro2403; Neut C, 2002, AM J GASTROENTEROL, V97, P939, DOI 10.1111/j.1572-0241.2002.05613.x; Ott SJ, 2004, GUT, V53, P685, DOI 10.1136/gut.2003.025403; PANTOSTI A, 1995, J CLIN MICROBIOL, V33, P2647, DOI 10.1128/JCM.33.10.2647-2652.1995; Papa E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039242; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Png CW, 2010, AM J GASTROENTEROL, V105, P2420, DOI 10.1038/ajg.2010.281; Prindiville TP, 2000, EMERG INFECT DIS, V6, P171, DOI 10.3201/eid0602.000210; Rath HC, 1999, INFECT IMMUN, V67, P2969, DOI 10.1128/IAI.67.6.2969-2974.1999; Rehman A, 2010, J MED MICROBIOL, V59, P1114, DOI 10.1099/jmm.0.021170-0; Rhee KJ, 2009, INFECT IMMUN, V77, P1708, DOI 10.1128/IAI.00814-08; RUTGEERTS P, 1995, GASTROENTEROLOGY, V108, P1617, DOI 10.1016/0016-5085(95)90121-3; Satsangi J, 2006, GUT, V55, P749, DOI 10.1136/gut.2005.082909; Sears CL, 2009, CLIN MICROBIOL REV, V22, P349, DOI 10.1128/CMR.00053-08; Sheng YH, 2012, J GASTROEN HEPATOL, V27, P28, DOI 10.1111/j.1440-1746.2011.06909.x; Swidsinski A, 2005, J CLIN MICROBIOL, V43, P3380, DOI 10.1128/JCM.43.7.3380-3389.2005; Swidsinski A, 2007, INFLAMM BOWEL DIS, V13, P51, DOI 10.1002/ibd.20003; TSAI HH, 1992, CLIN SCI, V82, P447, DOI 10.1042/cs0820447; Turner D, 2007, GASTROENTEROLOGY, V133, P423, DOI 10.1053/j.gastro.2007.05.029; VAREL VH, 1974, APPL MICROBIOL, V28, P251, DOI 10.1128/AEM.28.2.251-257.1974; Verma R, 2010, J CLIN MICROBIOL, V48, P4279, DOI 10.1128/JCM.01360-10; Walker AW, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-7; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Zitomersky NL, 2011, INFECT IMMUN, V79, P2012, DOI 10.1128/IAI.01348-10; Zoetendal EG, 2002, APPL ENVIRON MICROB, V68, P3401, DOI 10.1128/AEM.68.7.3401-3407.2002	53	61	84	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e63686	10.1371/journal.pone.0063686	http://dx.doi.org/10.1371/journal.pone.0063686			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776434	Green Published, Green Submitted, gold			2022-12-27	WOS:000320755400004
J	Lin, PC; Lin, HJ; Guo, HR; Chen, KT				Lin, Pei-Chen; Lin, Hung-Jung; Guo, How-Ran; Chen, Kuo-Tai			Epidemiological Characteristics of Lower Extremity Cellulitis after a Typhoon Flood	PLOS ONE			English	Article							INFECTIONS; WATERBORNE; DISEASES; SKIN	Objective: The flood after a typhoon may lead to increase in patients with cellulitis of lower limbs. However, the microbiological features of these cases are rarely reported. We conducted a study of patients with lower extremity cellulitis after a typhoon followed in southern Taiwan to study the risk factors of cellulitis and the bacteriological features of the patients. Methods: We reviewed all the medical records of cellulitis at emergency departments of two teaching hospitals in southern Taiwan 30 days before and after the landing of Typhoon Morakot and collected data on the demographic and bacteriological characteristics. In addition, we evaluated the relationship between the daily number of patients and the rainfall in the Tainan area. Results: The number of cellulitis patients increased from 183 to 344 during the 30-day period after the typhoon. The number peaked in the third and fourth days and lasted for 3 weeks. The proportion of patients with water immersion of the affected limb was higher after the typhoon (6% vs. 37%, odds ratio [OR]: 9.0, 95% Confidence interval [CI]: 4.7-17.2). We found cultures from the infected limbs with immersion had more polymicrobial (73% vs. 26%, OR: 7.8, 95% CI: 3.2-19.2) and Gram-negative bacilli infection (86% vs. 34%, OR: 11.8, 95% CI: 4.1-34.5). Conclusions: Flood arose from Typhoon Morakot caused increases in cellulitis patients, which lasted for 3 weeks. Antibiotic treatment that were effective to both Gram-positive cocci and Gram-negative bacilli are recommended for patients with limbs emerged in the water.	[Lin, Pei-Chen; Lin, Hung-Jung; Chen, Kuo-Tai] Chi Mei Med Ctr, Emergency Dept, Tainan, Taiwan; [Lin, Hung-Jung] Southern Tainan Univ Technol, Dept Biotechnol, Tainan, Taiwan; [Guo, How-Ran] Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan; [Chen, Kuo-Tai] Taipei Med Univ, Dept Emergency Med, Taipei, Taiwan	Chi Mei Hospital; Southern Taiwan University of Science & Technology; National Cheng Kung University; Taipei Medical University	Chen, KT (corresponding author), Chi Mei Med Ctr, Emergency Dept, Tainan, Taiwan.	890502@mail.chimei.org.tw	Guo, How-Ran/AAK-9063-2020	Guo, How-Ran/0000-0003-3343-3446				[Anonymous], 2005, CLIN INFECT DIS; Auld H, 2004, J TOXICOL ENV HEAL A, V67, P1879, DOI 10.1080/15287390490493475; BURKE V, 1984, APPL ENVIRON MICROB, V48, P361, DOI 10.1128/AEM.48.2.361-366.1984; Chiller K, 2001, J INVEST DERM SYMP P, V6, P170, DOI 10.1046/j.0022-202x.2001.00043.x; Greer A, 2008, CAN MED ASSOC J, V178, P715, DOI 10.1503/cmaj.081325; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Ki V, 2008, CAN J INFECT DIS MED, V19, P173, DOI 10.1155/2008/846453; Landis S.J., 2008, ADV SKIN WOUND CARE, V21, P531, DOI DOI 10.1097/01.ASW.0000323578.87700.A5; Lin HJ, 2007, EPIDEMIOLOGY, V18, P410, DOI 10.1097/01.ede.0000259989.77630.77; McNeil K. M., 2006, Morbidity and Mortality Weekly Report, V55, P231; Rose JB, 2001, ENVIRON HEALTH PERSP, V109, P211, DOI 10.2307/3435011; Sharpe AH, 2005, ROBBINS COTRAN PATHO, P371; Willams W., 2005, Morbidity and Mortality Weekly Report, V54, P1018	13	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65655	10.1371/journal.pone.0065655	http://dx.doi.org/10.1371/journal.pone.0065655			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785441	Green Published, gold, Green Submitted			2022-12-27	WOS:000321038800080
J	Nickel, KF; Laux, V; Heumann, R; von Degenfeld, G				Nickel, Katrin F.; Laux, Volker; Heumann, Rolf; von Degenfeld, Georges			Thrombin Has Biphasic Effects on the Nitric Oxide-cGMP Pathway in Endothelial Cells and Contributes to Experimental Pulmonary Hypertension	PLOS ONE			English	Article							SOLUBLE GUANYLATE-CYCLASE; CLINICAL-PRACTICE GUIDELINES; ARTERIAL-HYPERTENSION; FACTOR-XA; ACTIVATED RECEPTORS; MEDICAL THERAPY; L-ARGININE; COAGULATION; EXPRESSION; INHIBITION	Background: A potential role for coagulation factors in pulmonary arterial hypertension has been recently described, but the mechanism of action is currently not known. Here, we investigated the interactions between thrombin and the nitric oxide-cGMP pathway in pulmonary endothelial cells and experimental pulmonary hypertension. Principal Findings: Chronic treatment with the selective thrombin inhibitor melagatran (0.9 mg/kg daily via implanted minipumps) reduced right ventricular hypertrophy in the rat monocrotaline model of experimental pulmonary hypertension. In vitro, thrombin was found to have biphasic effects on key regulators of the nitric oxide-cGMP pathway in endothelial cells (HUVECs). Acute thrombin stimulation led to increased expression of the cGMP-elevating factors endothelial nitric oxide synthase (eNOS) and soluble guanylate cyclase (sGC) subunits, leading to increased cGMP levels. By contrast, prolonged exposition of pulmonary endothelial cells to thrombin revealed a characteristic pattern of differential expression of the key regulators of the nitric oxide-cGMP pathway, in which specifically the factors contributing to cGMP elevation (eNOS and sGC) were reduced and the cGMP-hydrolyzing PDE5 was elevated (qPCR and Western blot). In line with the differential expression of key regulators of the nitric oxide-cGMP pathway, a reduction of cGMP by prolonged thrombin stimulation was found. The effects of prolonged thrombin exposure were confirmed in endothelial cells of pulmonary origin (HPAECs and HPMECs). Similar effects could be induced by activation of protease-activated receptor-1 (PAR-1). Conclusion: These findings suggest a link between thrombin generation and cGMP depletion in lung endothelial cells through negative regulation of the nitric oxide-cGMP pathway, possibly mediated via PAR-1, which could be of relevance in pulmonary arterial hypertension.	[Nickel, Katrin F.; Laux, Volker] Bayer HealthCare, Cardiol Res, Wuppertal, Germany; [Nickel, Katrin F.] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Nickel, Katrin F.] Univ Hosp, Stockholm, Sweden; [Heumann, Rolf] Ruhr Univ Bochum, Bochum, Germany; [Heumann, Rolf] Bayer HealthCare, Common Mech Res, Wuppertal, Germany; [von Degenfeld, Georges] Univ Witten Herdecke, Inst Res Operat Med, Cologne, Germany	Bayer AG; Bayer Healthcare Pharmaceuticals; Karolinska Institutet; Ruhr University Bochum; Bayer AG; Bayer Healthcare Pharmaceuticals; Witten Herdecke University	von Degenfeld, G (corresponding author), Bayer HealthCare, Common Mech Res, Wuppertal, Germany.	georges.vondegenfeld@bayer.com	Heumann, Rolf/AAK-4390-2020; Heumann, Rolf/ABB-9675-2021	Heumann, Rolf/0000-0003-4364-2655	Bayer Pharma AG; Bayer Pharma; Bayer HealthCare AG	Bayer Pharma AG; Bayer Pharma; Bayer HealthCare AG(Bayer AGBayer Healthcare Pharmaceuticals)	Katrin Nickel received funding from Bayer Pharma AG. Volker Laux and Georges v. Degenfeld are employees of Bayer Pharma AG. Bayer Pharma provided funding for the in vivo studies and took part in the design, data aquisition and analysis of the in vivo experiments. Bayer Pharma had no role in the interpretation of the data and decision to publish. The authors declare that funding by Bayer Pharma does not influence their adherence to the PLOS ONE policies on sharing data and materials.; The authors have read the journal's policy and have the following conflicts. Bayer HealthCare AG funded this study and is an employer of: Volker Laux and Georges von Degenfeld. Katrin F. Nickel has received funding from Bayer HealthCare AG. There are no patents, products in development or marketed products to declare. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Ahluwalia A, 2004, P NATL ACAD SCI USA, V101, P1386, DOI 10.1073/pnas.0304264101; Badesch DB, 2007, CHEST, V131, P1917, DOI 10.1378/chest.06-2674; Badesch DB, 2004, CHEST, V126, p35S, DOI 10.1378/chest.126.1_suppl.35S; Berger G, 2009, ISR MED ASSOC J, V11, P376; BJORNSSON J, 1985, MAYO CLIN PROC, V60, P16, DOI 10.1016/S0025-6196(12)65277-X; Boerrigter G, 2007, CARDIOVASC DRUG REV, V25, P30, DOI 10.1111/j.1527-3466.2007.00003.x; Borensztajn K, 2008, TRENDS MOL MED, V14, P429, DOI 10.1016/j.molmed.2008.08.001; Borensztajn K, 2008, AM J PATHOL, V172, P309, DOI 10.2353/ajpath.2008.070347; Borissoff JI, 2009, CARDIOVASC RES, V82, P392, DOI 10.1093/cvr/cvp066; Budhiraja R, 2004, CIRCULATION, V109, P159, DOI 10.1161/01.CIR.0000102381.57477.50; Butenas S, 2002, BIOCHEMISTRY-MOSCOW+, V67, P3; CHEN J, 1994, J BIOL CHEM, V269, P16041; Cheung WM, 1999, ARTERIOSCL THROM VAS, V19, P3014, DOI 10.1161/01.ATV.19.12.3014; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Corbin JD, 2005, BIOCHEM BIOPH RES CO, V334, P930, DOI 10.1016/j.bbrc.2005.06.183; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Coughlin SR, 1999, P NATL ACAD SCI USA, V96, P11023, DOI 10.1073/pnas.96.20.11023; Delbeck M, 2011, CARDIOVASC RES, V92, P159, DOI 10.1093/cvr/cvr168; DEMEY JG, 1982, J PHARMACOL EXP THER, V222, P166; Dorfmuller P, 2003, SARCOIDOSIS VASC DIF, V20, P9; Eto M, 2001, CIRC RES, V89, P583, DOI 10.1161/hh1901.097084; Friebe A, 2003, CIRC RES, V93, P96, DOI 10.1161/01.RES.0000082524.34487.31; Giordano D, 2001, BBA-MOL CELL RES, V1539, P16, DOI 10.1016/S0167-4889(01)00086-6; Grimminger F, 2009, EUR RESPIR J, V33, P785, DOI 10.1183/09031936.00039808; Grunig E, 2008, Hamostaseologie, V28, P225; Hassell KL, 1998, BLOOD COAGUL FIBRIN, V9, P107, DOI 10.1097/00001721-199803000-00001; Huang J, 2010, EXP LUNG RES, V36, P57, DOI 10.3109/01902140903104793; Johnson SR, 2006, EUR RESPIR J, V28, P999, DOI 10.1183/09031936.06.00015206; Jurasz P, 2010, PHARMACOL THERAPEUT, V126, P1, DOI 10.1016/j.pharmthera.2009.12.006; Kemp-Harper Barbara, 2009, V191, P447, DOI 10.1007/978-3-540-68964-5_19; Klein M, 2008, CIRCULATION, V118, P2081, DOI 10.1161/CIRCULATIONAHA.108.779751; Kodama K, 1999, J PHARMACOL EXP THER, V290, P748; Krupiczojc MA, 2008, INT J BIOCHEM CELL B, V40, P1228, DOI 10.1016/j.biocel.2008.02.026; Kwapiszewska G, 2012, CIRC RES, V110, P1179, DOI 10.1161/CIRCRESAHA.111.257568; Lange U, 2003, PATHOPHYSIOL HAEMO T, V33, P184, DOI 10.1159/000081506; Levin YD, 2011, DRUG TODAY, V47, P145, DOI 10.1358/dot.2011.47.2.1544337; Licari LG, 2009, J VET EMERG CRIT CAR, V19, P11, DOI 10.1111/j.1476-4431.2009.00383.x; LUSCHER TF, 1988, NEW ENGL J MED, V319, P462, DOI 10.1056/NEJM198808253190802; Macfarlane SR, 2001, PHARMACOL REV, V53, P245; Maki J, 2010, BRIT J PHARMACOL, V159, P919, DOI 10.1111/j.1476-5381.2009.00591.x; Mann KG, 2003, J THROMB HAEMOST, V1, P1504, DOI 10.1046/j.1538-7836.2003.00298.x; Mason NA, 1998, J PATHOL, V185, P313, DOI 10.1002/(SICI)1096-9896(199807)185:3<313::AID-PATH93>3.0.CO;2-8; Mathew Rajamma, 2002, Heart Dis, V4, P152, DOI 10.1097/00132580-200205000-00004; MEHTA S, 1995, CIRCULATION, V92, P1539, DOI 10.1161/01.CIR.92.6.1539; Mittendorf J, 2009, CHEMMEDCHEM, V4, P853, DOI 10.1002/cmdc.200900014; Motley ED, 2007, HYPERTENSION, V49, P577, DOI 10.1161/01.HYP.0000255954.80025.34; Nagaya N, 2001, AM J RESP CRIT CARE, V163, P887, DOI 10.1164/ajrccm.163.4.2007116; O'Brien PJ, 2000, J BIOL CHEM, V275, P13502, DOI 10.1074/jbc.275.18.13502; Papapetropoulos A, 1998, P NATL ACAD SCI USA, V95, P4738, DOI 10.1073/pnas.95.8.4738; PEPKEZABA J, 1991, LANCET, V338, P1173, DOI 10.1016/0140-6736(91)92033-X; PIETRA GG, 1989, CIRCULATION, V80, P1198, DOI 10.1161/01.CIR.80.5.1198; Ramani GV, 2010, DRUG DES DEV THER, V4, P61; Sawamura F, 2009, J PHARMACOL SCI, V111, P235, DOI 10.1254/jphs.09110FP; Schermuly RT, 2008, EUR RESPIR J, V32, P881, DOI 10.1183/09031936.00114407; Schermuly RT, 2005, J CLIN INVEST, V115, P2811, DOI 10.1172/JCI24838; Schermuly RT, 2004, AM J RESP CRIT CARE, V169, P39, DOI 10.1164/rccm.200302-282OC; Schultze AE, 1998, J TOXICOL ENV HEAL B, V1, P271, DOI 10.1080/10937409809524557; Scotton CJ, 2009, J CLIN INVEST, V119, P2550, DOI 10.1172/JCI33288; Stasch JP, 2011, CIRCULATION, V123, P2263, DOI 10.1161/CIRCULATIONAHA.110.981738; Stasch Johannes-Peter, 2009, V191, P277, DOI 10.1007/978-3-540-68964-5_13; Steiner MK, 2005, CURR OPIN PHARMACOL, V5, P245, DOI 10.1016/j.coph.2004.12.008; Stephens RS, 2010, AM J PHYSIOL-LUNG C, V299, pL323, DOI 10.1152/ajplung.00442.2009; VU TKH, 1991, NATURE, V353, P674, DOI 10.1038/353674a0; Wharton J, 2005, AM J RESP CRIT CARE, V172, P105, DOI 10.1164/rccm.200411-1587OC; White TA, 2010, AM J RESP CELL MOL, V43, P35, DOI 10.1165/rcmb.2009-0144OC; Wilkins MR, 2008, EUR RESPIR J, V32, P198, DOI 10.1183/09031936.00124007	66	17	17	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e63504	10.1371/journal.pone.0063504	http://dx.doi.org/10.1371/journal.pone.0063504			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785394	gold, Green Published, Green Submitted			2022-12-27	WOS:000321038800123
J	Qi, WX; Huang, YJ; Yao, Y; Shen, Z; Min, DL				Qi, Wei-Xiang; Huang, Yu-Jing; Yao, Yang; Shen, Zan; Min, Da-Liu			Incidence and Risk of Treatment-Related Mortality with mTOR Inhibitors Everolimus and Temsirolimus in Cancer Patients: A Meta-Analysis	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; PHASE-II; SIROLIMUS THERAPY; MAMMALIAN TARGET; KINASE INHIBITOR; DOSE LEVELS; RAPAMYCIN; EFFICACY; PNEUMONITIS; CCI-779	Background: Two novel mammalian targets of rapamycin (mTOR) inhibitors everolimus and temsirolimus are now approved by regulatory agencies and have been widely investigated among various types of solid tumors, but the risk of fatal adverse events (FAEs) with these drugs is not well defined. Methods: We searched PubMed, EMBASE, and Cochrane library databases for relevant trials. Eligible studies included prospective phase II and III trials evaluating everolimus and temsirolimus in patients with all malignancies and data on FAEs were available. Statistical analyses were conducted to calculate the summary incidence, RRs and 95% confidence intervals (CIs) by using either random effects or fixed effect models according to the heterogeneity of the included studies. Results: A total of 3322 patients with various advanced solid tumors from 12 trials were included. The overall incidence of mTOR inhibitors associated FAEs was 1.8% (95%CI: 1.3-2.5%), and the incidences of everolimus related FAEs were comparable to that of temsirolimus (1.7% versus 1.8%). Compared with the controls, the use of mTOR inhibitors was associated with an increased risk of FAEs, with a RR of 3.24 (95%CI: 1.21-8.67, p = 0.019). On subgroup analysis, a non-statistically significant increase in the risk of FAEs was found according to different mTOR inhibitors, tumor types or controlled therapy. No evidence of publication bias was observed. Conclusion: With the present evidence, the use of mTOR inhibitors seems to increase the risk of FAEs in patients with advanced solid tumors. More high quality trials are still needed to investigate this association.	[Qi, Wei-Xiang; Huang, Yu-Jing; Yao, Yang; Shen, Zan; Min, Da-Liu] Shanghai Jiao Tong Univ, Peoples Hosp 6, Dept Oncol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Min, DL (corresponding author), Shanghai Jiao Tong Univ, Peoples Hosp 6, Dept Oncol, Shanghai 200030, Peoples R China.	yaoyang_6@163.com		Qi, wei-xiang/0000-0001-5484-3343				Albiges L, 2012, ANN ONCOL, V23, P1943, DOI 10.1093/annonc/mds115; [Anonymous], 2012, BR J CLIN PHARM; [Anonymous], 2012, CANC TREAT REV; Assaad U, 2012, CLIN INTERV AGING, V7, P453, DOI 10.2147/CIA.S29675; Atkins MB, 2004, J CLIN ONCOL, V22, P909, DOI 10.1200/JCO.2004.08.185; Barnett CM, 2012, PHARMACOTHERAPY, V32, P383, DOI 10.1002/j.1875-9114.2012.01084.x; Baselga J, 2012, NEW ENGL J MED, V366, P520, DOI 10.1056/NEJMoa1109653; Baselga J, 2009, J CLIN ONCOL, V27, P2630, DOI 10.1200/JCO.2008.18.8391; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bellmunt J, 2008, ANN ONCOL, V19, P1387, DOI 10.1093/annonc/mdn066; Bohler T, 2008, CYTOKINE, V42, P306, DOI 10.1016/j.cyto.2008.02.015; Brugarolas J, 2007, NEW ENGL J MED, V356, P185, DOI 10.1056/NEJMe068263; Brugarolas JB, 2003, CANCER CELL, V4, P147, DOI 10.1016/S1535-6108(03)00187-9; Champion L, 2006, ANN INTERN MED, V144, P505, DOI 10.7326/0003-4819-144-7-200604040-00009; Chan S, 2004, BRIT J CANCER, V91, P1420, DOI 10.1038/sj.bjc.6602162; Chan S, 2005, J CLIN ONCOL, V23, P5314, DOI 10.1200/JCO.2005.66.130; Choueiri TK, 2010, J CLIN ONCOL, V28, P2280, DOI 10.1200/JCO.2009.27.2757; Chu D, 2009, CLIN GENITOURIN CANC, V7, P11, DOI 10.3816/CGC.2009.n.002; Drucker AM, 2012, EUR J HAEMATOL; Faivre S, 2006, NAT REV DRUG DISCOV, V5, P671, DOI 10.1038/nrd2062; Fasolo A, 2012, CURR PHARM DESIGN, V18, P2766, DOI 10.2174/138161212800626210; Floc'h N, 2012, ONCOTARGET; Frost P, 2007, ONCOGENE, V26, P2255, DOI 10.1038/sj.onc.1210019; Galfrascoli E, 2011, DIGEST LIVER DIS, V43, P286, DOI 10.1016/j.dld.2010.10.010; Gnant M, 2012, EXPERT REV ANTICANC, V12, P1579, DOI [10.1586/ERA.12.138, 10.1586/era.12.138]; Hess G, 2009, J CLIN ONCOL, V27, P3822, DOI 10.1200/JCO.2008.20.7977; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Iacovelli R, 2012, ACTA ONCOL, V51, P873, DOI 10.3109/0284186X.2012.705019; Kahan BD, 2000, LANCET, V356, P194, DOI 10.1016/S0140-6736(00)02480-6; Kwitkowski VE, 2010, ONCOLOGIST, V15, P428, DOI 10.1634/theoncologist.2009-0178; Lindenfeld JA, 2005, AM J TRANSPLANT, V5, P1392, DOI 10.1111/j.1600-6143.2005.00849.x; MacDonald AS, 2003, TRANSPL P, V35, p201S, DOI 10.1016/S0041-1345(03)00231-8; Manito N, 2004, J HEART LUNG TRANSPL, V23, P780, DOI 10.1016/j.healun.2003.07.008; Matz M, 2012, TRANSPL INT, V25, P1106, DOI 10.1111/j.1432-2277.2012.01537.x; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; Motzer RJ, 2010, CANCER-AM CANCER SOC, V116, P4256, DOI 10.1002/cncr.25219; NCI, CTC V 2 0 COMM TERM; Pandya KJ, 2007, J THORAC ONCOL, V2, P1036, DOI 10.1097/JTO.0b013e318155a439; Pavel ME, 2011, LANCET, V378, P2005, DOI 10.1016/S0140-6736(11)61742-X; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Petrelli F, 2012, EXPERT OPIN DRUG SAF, V11, pS9, DOI 10.1517/14740338.2011.606213; Qi WX, 2013, CANCER CHEMOTH PHARM, V71, P431, DOI 10.1007/s00280-012-2025-5; Ranpura V, 2011, JAMA-J AM MED ASSOC, V305, P487, DOI 10.1001/jama.2011.51; Sawyers C, 2004, NATURE, V432, P294, DOI 10.1038/nature03095; Schutz FAB, 2012, J CLIN ONCOL, V30, P871, DOI 10.1200/JCO.2011.37.1195; Seeliger H, 2007, CANCER METAST REV, V26, P611, DOI 10.1007/s10555-007-9077-8; Sheppard Karen E., 2012, Critical Reviews in Oncogenesis, V17, P69; Sun Y, 2012, JPN J CLIN ONCOL, V42, P836, DOI 10.1093/jjco/hys110; Tarhini A, 2010, CLIN CANCER RES, V16, P5900, DOI 10.1158/1078-0432.CCR-10-0802; Trotter JF, 2003, TRANSPL P, V35, p193S, DOI 10.1016/S0041-1345(03)00234-3; Vignot S, 2005, ANN ONCOL, V16, P525, DOI 10.1093/annonc/mdi113; Willcocks LC, 2007, AM J TRANSPLANT, V7, P2006, DOI 10.1111/j.1600-6143.2007.01869.x; Xu BH, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-3; Yao JC, 2011, NEW ENGL J MED, V364, P514, DOI 10.1056/NEJMoa1009290; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7; Zintzaras E, 2005, GENET EPIDEMIOL, V28, P123, DOI 10.1002/gepi.20048	59	26	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65166	10.1371/journal.pone.0065166	http://dx.doi.org/10.1371/journal.pone.0065166			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785409	Green Published, gold			2022-12-27	WOS:000321038800111
J	Song, MM; Chen, DF; Lu, BY; Wang, CL; Zhang, JX; Huang, LL; Wang, XY; Timmons, CL; Hu, J; Liu, BD; Wu, XJ; Wang, L; Wang, JP; Liu, HL				Song, Minmin; Chen, Defeng; Lu, Biyan; Wang, Chenliang; Zhang, Junxiao; Huang, Lanlan; Wang, Xiaoyan; Timmons, Christine L.; Hu, Jun; Liu, Bindong; Wu, Xiaojian; Wang, Lei; Wang, Jianping; Liu, Huanliang			PTEN Loss Increases PD-L1 Protein Expression and Affects the Correlation between PD-L1 Expression and Clinical Parameters in Colorectal Cancer	PLOS ONE			English	Article							B7-H1 EXPRESSION; CLINICOPATHOLOGICAL SIGNIFICANCE; CARCINOMA; CELLS; LIGANDS; LYMPHOCYTES; METASTASIS; VALIDATION; APOPTOSIS; PATHWAY	Background: Programmed death ligand-1 (PD-L1) has been identified as a factor associated with poor prognosis in a range of cancers, and was reported to be mainly induced by PTEN loss in gliomas. However, the clinical effect of PD-L1 and its regulation by PTEN has not yet been determined in colorectal cancer (CRC). In the present study, we verified the regulation of PTEN on PD-L1 and further determined the effect of PTEN on the correlation between PD-L1 expression and clinical parameters in CRC. Methods/Results: RNA interference approach was used to down-regulate PTEN expression in SW480, SW620 and HCT116 cells. It was showed that PD-L1 protein, but not mRNA, was significantly increased in cells transfected with siRNA PTEN compared with the negative control. Moreover, the capacity of PTEN to regulate PD-L1 expression was not obviously affected by IFN-gamma, the main inducer of PD-L1. Tissue microarray immunohistochemistry was used to detect PD-L1 and PTEN in 404 CRC patient samples. Overexpression of PD-L1 was significantly correlated with distant metastasis (P<0.001), TNM stage (P<0.01), metastatic progression (P<0.01) and PTEN expression (P<0.001). Univariate analysis revealed that patients with high PD-L1 expression had a poor overall survival (P<0.001). However, multivariate analysis did not support PD-L1 as an independent prognostic factor (P = 0.548). Univariate (P<0.001) and multivariate survival (P<0.001) analysis of 310 located CRC patients revealed that high level of PD-L1 expression was associated with increased risks of metastatic progression. Furthermore, the clinical effect of PD-L1 on CRC was not statistically significant in a subset of 39 patients with no PTEN expression (distant metastasis: P = 0.102; TNM stage: P = 0.634, overall survival: P = 0.482). Conclusions: PD-L1 can be used to identify CRC patients with high risk of metastasis and poor prognosis. This clinical manifestation may be partly associated with PTEN expression.	[Song, Minmin; Chen, Defeng; Lu, Biyan; Wang, Chenliang; Zhang, Junxiao; Huang, Lanlan; Wang, Xiaoyan; Hu, Jun; Wu, Xiaojian; Wang, Lei; Wang, Jianping; Liu, Huanliang] Sun Yat Sen Univ, Inst Gastroenterol, Guangzhou 510275, Guangdong, Peoples R China; [Song, Minmin; Chen, Defeng; Lu, Biyan; Wang, Chenliang; Zhang, Junxiao; Huang, Lanlan; Wang, Xiaoyan; Hu, Jun; Wu, Xiaojian; Wang, Lei; Wang, Jianping; Liu, Huanliang] Sun Yat Sen Univ, Affiliated Hosp 6, Guangzhou 510275, Guangdong, Peoples R China; [Song, Minmin; Lu, Biyan; Wang, Chenliang; Zhang, Junxiao; Huang, Lanlan; Wang, Xiaoyan; Liu, Huanliang] Sun Yat Sen Univ, Inst Human Virol, Guangzhou 510275, Guangdong, Peoples R China; [Song, Minmin; Lu, Biyan; Wang, Chenliang; Zhang, Junxiao; Huang, Lanlan; Wang, Xiaoyan; Liu, Huanliang] Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control, Guangzhou 510275, Guangdong, Peoples R China; [Lu, Biyan] Dongguan Hlth Sch, Dongguan, Guangdong, Peoples R China; [Wang, Chenliang; Timmons, Christine L.; Liu, Bindong] Meharry Med Coll, Dept Microbiol & Immunol, Ctr AIDS Hlth Dispar Res, Nashville, TN 37208 USA	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Meharry Medical College	Wang, JP (corresponding author), Sun Yat Sen Univ, Inst Gastroenterol, Guangzhou 510275, Guangdong, Peoples R China.	wangjply@yahoo.com.cn; huanliang.liu@gmail.com	Wang, Xiaoyan/AAU-6258-2021	Wang, Xiaoyan/0000-0002-5140-676X; Liu, Huanliang/0000-0002-1006-6666; wang, chenliang/0000-0003-4388-681X	Sun Yat-sen University "100 Talents Program"; Guangdong Innovative Research Team Program [2009010058]; Science and Information Technology Bureau of Guangzhou, Guangdong [2011J5200009]; Guangdong Provincial Department of Science and Technology [2012B050500004]; "985 Project" of Sun Yat-sen University and Guangdong Translational Medicine Public Platform [4202037]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR026140] Funding Source: NIH RePORTER	Sun Yat-sen University "100 Talents Program"; Guangdong Innovative Research Team Program; Science and Information Technology Bureau of Guangzhou, Guangdong; Guangdong Provincial Department of Science and Technology; "985 Project" of Sun Yat-sen University and Guangdong Translational Medicine Public Platform; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by Sun Yat-sen University "100 Talents Program"; Guangdong Innovative Research Team Program (2009010058); Science and Information Technology Bureau of Guangzhou, Guangdong (2011J5200009); Guangdong Provincial Department of Science and Technology (2012B050500004); and "985 Project" of Sun Yat-sen University and Guangdong Translational Medicine Public Platform (4202037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma T, 2008, BLOOD, V111, P3635, DOI 10.1182/blood-2007-11-123141; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Bretthauer M, 2010, BEST PRACT RES CL GA, V24, P417, DOI 10.1016/j.bpg.2010.06.005; Colakoglu T, 2008, AM J SURG, V195, P719, DOI 10.1016/j.amjsurg.2007.05.061; Damsky WE, 2011, CANCER CELL, V20, P741, DOI 10.1016/j.ccr.2011.10.030; Davies MA, 1999, CANCER RES, V59, P2551; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Ghebeh H, 2006, NEOPLASIA, V8, P190, DOI 10.1593/neo.05733; Gillett CE, 2000, J PATHOL, V192, P549; Goel A, 2004, CANCER RES, V64, P3014, DOI 10.1158/0008-5472.CAN-2401-2; Hamanishi J, 2007, P NATL ACAD SCI USA, V104, P3360, DOI 10.1073/pnas.0611533104; Hoos A, 2001, AM J PATHOL, V158, P1245, DOI 10.1016/S0002-9440(10)64075-8; Inman BA, 2007, CANCER-AM CANCER SOC, V109, P1499, DOI 10.1002/cncr.22588; Jang KS, 2010, HISTOPATHOLOGY, V56, P229, DOI 10.1111/j.1365-2559.2009.03468.x; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Konishi J, 2004, CLIN CANCER RES, V10, P5094, DOI 10.1158/1078-0432.CCR-04-0428; Langlois MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015742; Liu JZ, 2007, BLOOD, V110, P296, DOI 10.1182/blood-2006-10-051482; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Nomi T, 2007, CLIN CANCER RES, V13, P2151, DOI 10.1158/1078-0432.CCR-06-2746; Parsa AT, 2007, NAT MED, V13, P84, DOI 10.1038/nm1517; Planchon SM, 2008, J CELL SCI, V121, P249, DOI 10.1242/jcs.022459; Ramsay AJ, 2008, J BIOL CHEM, V283, P12293, DOI 10.1074/jbc.M709493200; Roth AD, 2010, J CLIN ONCOL, V28, P466, DOI 10.1200/JCO.2009.23.3452; Sawai H, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-56; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Snietura M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033396; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; Thompson RH, 2006, CANCER RES, V66, P3381, DOI 10.1158/0008-5472.CAN-05-4303; Wu CP, 2006, ACTA HISTOCHEM, V108, P19, DOI 10.1016/j.acthis.2006.01.003; Xavier LL, 2005, BRAIN RES PROTOC, V16, P58, DOI 10.1016/j.brainresprot.2005.10.002; Yamazaki T, 2002, J IMMUNOL, V169, P5538, DOI 10.4049/jimmunol.169.10.5538; Zeng Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023621; Zou WP, 2008, NAT REV IMMUNOL, V8, P467, DOI 10.1038/nri2326	36	148	158	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65821	10.1371/journal.pone.0065821	http://dx.doi.org/10.1371/journal.pone.0065821			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785454	gold, Green Published, Green Submitted			2022-12-27	WOS:000321038800068
J	Umeshappa, CS; Xie, YF; Xu, SL; Nanjundappa, RH; Freywald, A; Deng, YL; Ma, H; Xiang, J				Umeshappa, Channakeshava Sokke; Xie, Yufeng; Xu, Shulin; Nanjundappa, Roopa Hebbandi; Freywald, Andrew; Deng, Yulin; Ma, Hong; Xiang, Jim			Th Cells Promote CTL Survival and Memory via Acquired pMHC-I and Endogenous IL-2 and CD40L Signaling and by Modulating Apoptosis-Controlling Pathways	PLOS ONE			English	Article							NF-KAPPA-B; ANTIGEN PRESENTASOME APS; MHC/COSTIMULATORY COMPLEX; SECONDARY EXPANSION; IMMUNE-RESPONSES; PRESENTING CELLS; RECALL RESPONSES; FAS LIGAND; HELP; LYMPHOCYTES	Involvement of CD4(+) helper T (Th) cells is crucial for CD8(+) cytotoxic T lymphocyte (CTL)-mediated immunity. However, CD4(+) Th's signals that govern CTL survival and functional memory are still not completely understood. In this study, we assessed the role of CD4+ Th cells with acquired antigen-presenting machineries in determining CTL fates. We utilized an adoptive co-transfer into CD4(+) T cell-sufficient or -deficient mice of OTI CTLs and OTII Th cells or Th cells with various gene deficiencies pre-stimulated in vitro by ovalbumin (OVA)-pulsed dendritic cell (DCova). CTL survival was kinetically assessed in these mice using FITC-anti-CD8 and PE-H-2K(b)/OVA(257-264) tetramer staining by flow cytometry. We show that by acting via endogenous CD40L and IL-2, and acquired peptide-MHC-I (pMHC-I) complex signaling, CD4(+) Th cells enhance survival of transferred effector CTLs and their differentiation into the functional memory CTLs capable of protecting against highly-metastasizing tumor challenge. Moreover, RT-PCR, flow cytometry and Western blot analysis demonstrate that increased survival of CD4(+) Th cell-helped CTLs is matched with enhanced Akt1/NF-kappa B activation, down-regulation of TRAIL, and altered expression profiles with up-regulation of prosurvival (Bcl-2) and down-regulation of proapoptotic (Bcl-10, Casp-3, Casp-4, Casp-7) molecules. Taken together, our results reveal a previously unexplored mechanistic role for CD4(+) Th cells in programming CTL survival and memory recall responses. This knowledge could also aid in the development of efficient adoptive CTL cancer therapy.	[Umeshappa, Channakeshava Sokke; Xie, Yufeng; Xu, Shulin; Nanjundappa, Roopa Hebbandi; Xiang, Jim] Saskatchewan Canc Agcy, Canc Res Unit, Saskatoon, SK, Canada; [Freywald, Andrew] Univ Saskatchewan, Dept Pathol, Saskatoon, SK S7N 0W0, Canada; [Deng, Yulin; Ma, Hong] Beijing Inst Technol, Sch Life Sci, Beijing 100081, Peoples R China	University of Saskatchewan; University of Saskatchewan; Beijing Institute of Technology	Xiang, J (corresponding author), Saskatchewan Canc Agcy, Canc Res Unit, Saskatoon, SK, Canada.	jim.xiang@saskcancer.ca			Canadian Institutes of Health Research (CIHR) [MOP 79415]; Beijing Science and Technology Foundation [5121002]; Dean's Scholarship of the University of Saskatchewan; Vanier Canada Graduate Scholarship of CIHR	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Beijing Science and Technology Foundation; Dean's Scholarship of the University of Saskatchewan; Vanier Canada Graduate Scholarship of CIHR	This study was supported by research grants from the Canadian Institutes of Health Research (CIHR) (MOP 79415) and the Beijing Science and Technology Foundation (5121002). Umeshappa was supported by Dean's Scholarship of the University of Saskatchewan and Vanier Canada Graduate Scholarship of CIHR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed KA, 2008, CELL MOL IMMUNOL, V5, P261, DOI 10.1038/cmi.2008.32; Ahmed KA, 2012, J LEUKOCYTE BIOL, V92, P289, DOI 10.1189/jlb.1211631; ALDERSON MR, 1995, J EXP MED, V181, P71, DOI 10.1084/jem.181.1.71; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Arnold PY, 1997, EUR J IMMUNOL, V27, P3198, DOI 10.1002/eji.1830271217; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Blattman JN, 2003, NAT MED, V9, P540, DOI 10.1038/nm866; Bourgeois C, 2002, SCIENCE, V297, P2060, DOI 10.1126/science.1072615; Brenner MK, 2010, CURR OPIN IMMUNOL, V22, P251, DOI 10.1016/j.coi.2010.01.020; Chen M, 2007, MOL IMMUNOL, V44, P2558, DOI 10.1016/j.molimm.2006.12.020; Cox JH, 2007, J IMMUNOL, V179, P830, DOI 10.4049/jimmunol.179.2.830; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Davis DM, 2007, NAT REV IMMUNOL, V7, P238, DOI 10.1038/nri2020; de Herve MGD, 2010, J IMMUNOL, V185, P1028, DOI 10.4049/jimmunol.0904209; Downward J, 2004, SEMIN CELL DEV BIOL, V15, P177, DOI 10.1016/j.semcdb.2004.01.002; Droin NM, 2003, MOL CELL BIOL, V23, P7638, DOI 10.1128/MCB.23.21.7638-7647.2003; Fischer UB, 2007, P NATL ACAD SCI USA, V104, P7181, DOI 10.1073/pnas.0608299104; Fuse S, 2009, J IMMUNOL, V182, P4244, DOI 10.4049/jimmunol.0802041; Hao SG, 2008, J IMMUNOL, V181, P2428, DOI 10.4049/jimmunol.181.4.2428; Helft J, 2008, BLOOD, V112, P1249, DOI 10.1182/blood-2007-09-114389; HoWangYin KY, 2011, J IMMUNOL, V186, P2210, DOI 10.4049/jimmunol.1000547; Huang B, 2010, CELL SIGNAL, V22, P1282, DOI 10.1016/j.cellsig.2010.03.017; Huang H, 2007, IMMUNOLOGY, V120, P148, DOI 10.1111/j.1365-2567.2006.02452.x; Hwang ML, 2007, J IMMUNOL, V179, P5829, DOI 10.4049/jimmunol.179.9.5829; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Janssen EM, 2005, NATURE, V434, P88, DOI 10.1038/nature03337; Johnson LA, 2009, BLOOD, V114, P535, DOI 10.1182/blood-2009-03-211714; Kalia V, 2010, IMMUNITY, V32, P91, DOI 10.1016/j.immuni.2009.11.010; Kennedy R, 2006, J IMMUNOL, V177, P2862, DOI 10.4049/jimmunol.177.5.2862; Kim EY, 2009, J IMMUNOL, V183, P6051, DOI 10.4049/jimmunol.0803482; Klebanoff CA, 2006, IMMUNOL REV, V211, P214, DOI 10.1111/j.0105-2896.2006.00391.x; LeMaoult J, 2007, BLOOD, V109, P2040, DOI 10.1182/blood-2006-05-024547; Li ZG, 2009, BLOOD, V114, P4486, DOI 10.1182/blood-2009-04-218123; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mescher MF, 2006, IMMUNOL REV, V211, P81, DOI 10.1111/j.0105-2896.2006.00382.x; Mostbock S, 2007, BLOOD, V109, P2488, DOI 10.1182/blood-2006-09-047290; Nakanishi Y, 2009, NATURE, V462, P510, DOI 10.1038/nature08511; Nguyen P, 2003, GENE THER, V10, P594, DOI 10.1038/sj.gt.3301932; Novy P, 2007, J IMMUNOL, V179, P8243, DOI 10.4049/jimmunol.179.12.8243; Novy P, 2011, J IMMUNOL, V186, P2729, DOI 10.4049/jimmunol.1003009; Obar JJ, 2010, P NATL ACAD SCI USA, V107, P193, DOI 10.1073/pnas.0909945107; Rapetti L, 2008, J IMMUNOL, V181, P299, DOI 10.4049/jimmunol.181.1.299; REES MA, 1990, P NATL ACAD SCI USA, V87, P2765, DOI 10.1073/pnas.87.7.2765; Rosenberg SA, 2009, CURR OPIN IMMUNOL, V21, P233, DOI 10.1016/j.coi.2009.03.002; Ryu SJ, 2009, BLOOD, V113, P4273, DOI 10.1182/blood-2008-09-181263; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Shi MQ, 2006, J LEUKOCYTE BIOL, V80, P1354, DOI 10.1189/jlb.0506321; Sun JC, 2004, NAT IMMUNOL, V5, P927, DOI 10.1038/ni1105; Tsang JYS, 2003, BLOOD, V101, P2704, DOI 10.1182/blood-2002-04-1230; Umeshappa CS, 2011, IMMUNOL CELL BIOL, V89, P578, DOI 10.1038/icb.2011.28; Umeshappa CS, 2010, CELL MOL LIFE SCI, V67, P4107, DOI 10.1007/s00018-010-0553-x; Umeshappa CS, 2009, J IMMUNOL, V182, P193, DOI 10.4049/jimmunol.182.1.193; Wang L, 2001, J BIOL CHEM, V276, P21405, DOI 10.1074/jbc.M102488200; Wang LX, 2007, BLOOD, V109, P4865, DOI 10.1182/blood-2006-09-045245; Wang ZW, 2010, J CELL BIOCHEM, V109, P726, DOI 10.1002/jcb.22451; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790; Wong SBJ, 2008, J IMMUNOL, V180, P3122, DOI 10.4049/jimmunol.180.5.3122; Xia DJ, 2006, J IMMUNOL, V177, P2976, DOI 10.4049/jimmunol.177.5.2976; Xiang J, 2005, J IMMUNOL, V174, P7497, DOI 10.4049/jimmunol.174.12.7497; Zhou G, 2011, J IMMUNOL, V186, P2148, DOI 10.4049/jimmunol.1002917; Zhou J, 2005, BLOOD, V105, P3238, DOI 10.1182/blood-2004-08-3236; Zhou JH, 2005, J IMMUNOTHER, V28, P53, DOI 10.1097/00002371-200501000-00007; Zhou JH, 2004, J IMMUNOL, V173, P7622, DOI 10.4049/jimmunol.173.12.7622	64	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e64787	10.1371/journal.pone.0064787	http://dx.doi.org/10.1371/journal.pone.0064787			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785406	Green Submitted, Green Published, gold			2022-12-27	WOS:000321038800113
J	Baptista, FI; Pinto, MJ; Elvas, F; Almeida, RD; Ambrosio, AF				Baptista, Filipa I.; Pinto, Maria J.; Elvas, Filipe; Almeida, Ramiro D.; Ambrosio, Antonio F.			Diabetes Alters KIF1A and KIF5B Motor Proteins in the Hippocampus	PLOS ONE			English	Article							RETROGRADE AXONAL-TRANSPORT; NERVE GROWTH-FACTOR; VESICLE PRECURSOR TRANSPORT; ALZHEIMERS-DISEASE; SYNAPTIC PLASTICITY; NEURODEGENERATIVE DISEASES; EXOCYTOTIC PROTEINS; SIGNALING PATHWAY; OXIDATIVE STRESS; GENE-EXPRESSION	Diabetes mellitus is the most common metabolic disorder in humans. Diabetic encephalopathy is characterized by cognitive and memory impairments, which have been associated with changes in the hippocampus, but the mechanisms underlying those impairments triggered by diabetes, are far from being elucidated. The disruption of axonal transport is associated with several neurodegenerative diseases and might also play a role in diabetes-associated disorders affecting nervous system. We investigated the effect of diabetes (2 and 8 weeks duration) on KIF1A, KIF5B and dynein motor proteins, which are important for axonal transport, in the hippocampus. The mRNA expression of motor proteins was assessed by qRT-PCR, and also their protein levels by immunohistochemistry in hippocampal slices and immunoblotting in total extracts of hippocampus from streptozotocin-induced diabetic and age-matched control animals. Diabetes increased the expression and immunoreactivity of KIF1A and KIF5B in the hippocampus, but no alterations in dynein were detected. Since hyperglycemia is considered a major player in diabetic complications, the effect of a prolonged exposure to high glucose on motor proteins, mitochondria and synaptic proteins in hippocampal neurons was also studied, giving particular attention to changes in axons. Hippocampal cell cultures were exposed to high glucose (50 mM) or mannitol (osmotic control; 25 mM plus 25 mM glucose) for 7 days. In hippocampal cultures incubated with high glucose no changes were detected in the fluorescence intensity or number of accumulations related with mitochondria in the axons of hippocampal neurons. Nevertheless, high glucose increased the number of fluorescent accumulations of KIF1A and synaptotagmin-1 and decreased KIF5B, SNAP-25 and synaptophysin immunoreactivity specifically in axons of hippocampal neurons. These changes suggest that anterograde axonal transport mediated by these kinesins may be impaired in hippocampal neurons, which may lead to changes in synaptic proteins, thus contributing to changes in hippocampal neurotransmission and to cognitive and memory impairments.	[Baptista, Filipa I.; Elvas, Filipe; Ambrosio, Antonio F.] Univ Coimbra, Ctr Ophthalmol & Vis Sci, IBILI, Fac Med, Coimbra, Portugal; [Baptista, Filipa I.; Elvas, Filipe; Ambrosio, Antonio F.] Univ Coimbra, IBILI, Fac Med, Coimbra, Portugal; [Pinto, Maria J.; Almeida, Ramiro D.; Ambrosio, Antonio F.] Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Pinto, Maria J.] Univ Coimbra, Ctr Neurosci & Cell Biol, PhD Programme Expt Biol & Biomed PDBEB, Coimbra, Portugal; [Ambrosio, Antonio F.] AIBILI, Coimbra, Portugal	Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra	Ambrosio, AF (corresponding author), Univ Coimbra, Ctr Ophthalmol & Vis Sci, IBILI, Fac Med, Coimbra, Portugal.	afambrosio@fmed.uc.pt	Almeida, Ramiro D./J-2656-2013; Baptista, Filipa/E-2828-2012; Pinto, Maria Joana MJ Guimarães/L-8990-2016; Ambrósio, António F/I-3722-2012	Almeida, Ramiro D./0000-0001-5830-2595; Baptista, Filipa/0000-0001-7972-640X; Pinto, Maria Joana MJ Guimarães/0000-0001-9730-5772; Ambrósio, António F/0000-0002-0477-1641	FCT, Portugal [PEst-C/SAU/UI3282/2011, PEst-/SAU/LA0001/2011]; COMPETE [PEst-C/SAU/UI3282/2011, PEst-/SAU/LA0001/2011, PTDC/SAU-NEU/104100/2008]; Fundacao para a Ciencia e a Tecnologia, Portugal [SFRH/BD/35961/2007, SFRH/BD/51196/2010]; FCT; Marie Curie Actions, 7th Famework programme	FCT, Portugal(Portuguese Foundation for Science and TechnologyEuropean Commission); COMPETE; Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Marie Curie Actions, 7th Famework programme	This work was supported by PEst-C/SAU/UI3282/2011 and PEst-/SAU/LA0001/2011 (FCT, Portugal, and COMPETE). Filipa I. Baptista and Maria J. Pinto acknowledge fellowships from Fundacao para a Ciencia e a Tecnologia, Portugal (SFRH/BD/35961/2007 and SFRH/BD/51196/2010, respectively). Ramiro D. Almeida is supported by FCT and COMPETE (PTDC/SAU-NEU/104100/2008) and by Marie Curie Actions, 7th Famework programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBATE SL, 1991, DIABETES, V40, P111, DOI 10.2337/diabetes.40.1.111; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Baptista FI, 2011, BRAIN RES, V1383, P257, DOI 10.1016/j.brainres.2011.01.071; Biessels GJ, 1998, BRAIN RES, V800, P125, DOI 10.1016/S0006-8993(98)00510-1; Biessels GJ, 1996, DIABETES, V45, P1259, DOI 10.2337/diabetes.45.9.1259; Bronk P, 2007, J NEUROPHYSIOL, V98, P794, DOI 10.1152/jn.00226.2007; Brownlees J, 2002, HUM MOL GENET, V11, P2837, DOI 10.1093/hmg/11.23.2837; CALCUTT NA, 1990, J NEUROL SCI, V96, P283, DOI 10.1016/0022-510X(90)90139-E; Chevalier-Larsen E, 2006, BBA-MOL BASIS DIS, V1762, P1094, DOI 10.1016/j.bbadis.2006.04.002; Chung CY, 2009, J NEUROSCI, V29, P3365, DOI 10.1523/JNEUROSCI.5427-08.2009; De Vos K, 1998, J BIOL CHEM, V273, P9673, DOI 10.1074/jbc.273.16.9673; De Vos K, 2000, J CELL BIOL, V149, P1207, DOI 10.1083/jcb.149.6.1207; De Vos KJ, 2008, ANNU REV NEUROSCI, V31, P151, DOI 10.1146/annurev.neuro.31.061307.090711; Delcroix JD, 1998, DIABETES, V47, P1779, DOI 10.2337/diabetes.47.11.1779; Ebneth A, 1998, J CELL BIOL, V143, P777, DOI 10.1083/jcb.143.3.777; Falzone TL, 2010, HUM MOL GENET, V19, P4399, DOI 10.1093/hmg/ddq363; Falzone TL, 2009, J NEUROSCI, V29, P5758, DOI 10.1523/JNEUROSCI.0780-09.2009; Fang C, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-29; Fernandez DC, 2012, AM J PATHOL, V180, P303, DOI 10.1016/j.ajpath.2011.09.018; Fernyhough Paul, 2010, Expert Rev Endocrinol Metab, V5, P39; Gaspar JM, 2010, NEUROSCIENCE, V171, P981, DOI 10.1016/j.neuroscience.2010.10.019; Gaspar JM, 2010, NEUROSCIENCE, V169, P1589, DOI 10.1016/j.neuroscience.2010.06.021; Grillo CA, 2005, NEUROSCIENCE, V136, P477, DOI 10.1016/j.neuroscience.2005.08.019; HELLWEG R, 1994, EXP NEUROL, V130, P24, DOI 10.1006/exnr.1994.1181; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Ino-ue M, 2000, INVEST OPHTH VIS SCI, V41, P4055; Iqbal K, 2009, ACTA NEUROPATHOL, V118, P53, DOI 10.1007/s00401-009-0486-3; JAKOBSEN J, 1981, DIABETES, V30, P797, DOI 10.2337/diab.30.10.797; Kamal A, 1999, NEUROSCIENCE, V90, P737, DOI 10.1016/S0306-4522(98)00485-0; Karle KN, 2012, NEUROGENETICS, V13, P169, DOI 10.1007/s10048-012-0324-y; Kim B, 2009, ENDOCRINOLOGY, V150, P5294, DOI 10.1210/en.2009-0695; Kondo M, 2012, NEURON, V73, P743, DOI 10.1016/j.neuron.2011.12.020; Kuhad A, 2009, PHARMACOL BIOCHEM BE, V92, P251, DOI 10.1016/j.pbb.2008.12.012; Lee JR, 2003, J BIOL CHEM, V278, P2624, DOI 10.1074/jbc.M211152200; Lee PG, 2002, BRAIN RES, V941, P127, DOI 10.1016/S0006-8993(02)02645-8; Lee PG, 2001, EXP NEUROL, V170, P149, DOI 10.1006/exnr.2001.7673; Li ZG, 2005, BRAIN RES, V1037, P12, DOI 10.1016/j.brainres.2004.11.063; Liu Y, 2011, J PATHOL, V225, P54, DOI 10.1002/path.2912; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo KY, 2011, NEUROSCI LETT, V491, P168, DOI 10.1016/j.neulet.2011.01.018; McLean WG, 1997, NEUROCHEM RES, V22, P951, DOI 10.1023/A:1022466624223; MEDORI R, 1985, P NATL ACAD SCI USA, V82, P7716, DOI 10.1073/pnas.82.22.7716; Obulesu M, 2011, NEUROCHEM RES, V36, P1329, DOI 10.1007/s11064-011-0475-5; Qu ZS, 2011, BRAIN RES, V1383, P300, DOI 10.1016/j.brainres.2011.01.084; Reddy PH, 2011, BRAIN RES, V1415, P136, DOI 10.1016/j.brainres.2011.07.052; Sharma R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013463; Sima AAF, 2005, DIABETES, V54, P1497, DOI 10.2337/diabetes.54.5.1497; Sima Anders A F, 2009, Rev Diabet Stud, V6, P37, DOI 10.1900/RDS.2009.6.37; Stagi M, 2005, J NEUROSCI, V25, P352, DOI 10.1523/JNEUROSCI.3887-04.2005; Stagi M, 2006, FASEB J, V20, P2573, DOI 10.1096/fj.06-6679fje; Stamer K, 2002, J CELL BIOL, V156, P1051, DOI 10.1083/jcb.200108057; YAGIHASHI S, 1990, AM J PATHOL, V136, P1365; Yonekawa Y, 1998, J CELL BIOL, V141, P431, DOI 10.1083/jcb.141.2.431; Zhang LX, 2000, CURR EYE RES, V20, P131, DOI 10.1076/0271-3683(200002)20:2;1-D;FT131	54	35	36	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65515	10.1371/journal.pone.0065515	http://dx.doi.org/10.1371/journal.pone.0065515			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776493	Green Published, Green Submitted, gold			2022-12-27	WOS:000320322400031
J	Kulesskaya, N; Voikar, V; Peltola, M; Yegutkin, GG; Salmi, M; Jalkanen, S; Rauvala, H				Kulesskaya, Natalia; Voikar, Vootele; Peltola, Marjaana; Yegutkin, Gennady G.; Salmi, Marko; Jalkanen, Sirpa; Rauvala, Heikki			CD73 Is a Major Regulator of Adenosinergic Signalling in Mouse Brain	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; ADULT-RATS; RECEPTOR INTERACTIONS; MALLEABLE SYNAPSES; LOCOMOTOR-ACTIVITY; TRANSGENIC MICE; SOCIAL APPROACH; A(1) RECEPTOR; ANIMAL-MODELS; GLIAL-CELLS	CD73 (ecto-5'-nucleotidase) is a cell surface enzyme that regulates purinergic signalling by desphosphorylating extracellular AMP to adenosine. 59-nucleotidases are known to be expressed in brain, but the expression of CD73 and its putative physiological functions at this location remain elusive. Here we found, using immunohistochemistry of wild-type and CD73 deficient mice, that CD73 is prominently expressed in the basal ganglia core comprised of striatum (caudate nucleus and putamen) and globus pallidus. Furthermore, meninges and the olfactory tubercle were found to specifically express CD73. Analysis of wild type (wt) and CD73 deficient mice revealed that CD73 confers the majority of 5'-nucleotidase activity in several areas of the brain. In a battery of behavioural tests and in IntelliCage studies, the CD73 deficient mice demonstrated significantly enhanced exploratory locomotor activity, which probably reflects the prominent expression of CD73 in striatum and globus pallidus that are known to control locomotion. Furthermore, the CD73 deficient mice displayed altered social behaviour. Overall, our data provide a novel mechanistic insight into adenosinergic signalling in brain, which is implicated in the regulation of normal and pathological behaviour.	[Kulesskaya, Natalia; Voikar, Vootele; Peltola, Marjaana; Rauvala, Heikki] Univ Helsinki, Ctr Neurosci, Helsinki, Finland; [Kulesskaya, Natalia; Voikar, Vootele] Univ Helsinki, Dept Biosci, Helsinki, Finland; [Yegutkin, Gennady G.; Salmi, Marko; Jalkanen, Sirpa] Univ Turku, MediCity, Turku, Finland; [Yegutkin, Gennady G.; Salmi, Marko; Jalkanen, Sirpa] Univ Turku, Dept Med Microbiol & Immunol, Turku, Finland; [Yegutkin, Gennady G.; Salmi, Marko; Jalkanen, Sirpa] Natl Inst Hlth & Welf, Turku, Finland; [Salmi, Marko] Univ Turku, Dept Med Biochem & Genet, Turku, Finland	University of Helsinki; University of Helsinki; University of Turku; University of Turku; Finland National Institute for Health & Welfare; University of Turku	Voikar, V (corresponding author), Univ Helsinki, Ctr Neurosci, Helsinki, Finland.	vootele.voikar@gmail.com; heikki.rauvala@helsinki.fi	Yegutkin, Gennady G./K-3815-2014; Voikar, Vootele/V-4542-2019	Yegutkin, Gennady G./0000-0001-6684-7982; Voikar, Vootele/0000-0003-4201-8666; Rauvala, Heikki/0000-0001-7809-9811; Kulesskaya, Natalia/0000-0001-5517-8525	Finnish Academy; Biocenter Finland; Sigrid JusA(C)lius Foundation	Finnish Academy(Academy of Finland); Biocenter Finland; Sigrid JusA(C)lius Foundation	This work was supported by the Finnish Academy, Biocenter Finland and the Sigrid JusA (c) lius Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boison D, 2010, CELL DEATH DIFFER, V17, P1071, DOI 10.1038/cdd.2009.131; Bonan CD, 2000, BRAIN RES, V854, P253, DOI 10.1016/S0006-8993(99)02300-8; Bonan CD, 1998, NEUROCHEM RES, V23, P977, DOI 10.1023/A:1021084422228; Burnstock G, 2011, PROG NEUROBIOL, V95, P229, DOI 10.1016/j.pneurobio.2011.08.006; Crawley JN, 2007, BRAIN PATHOL, V17, P448, DOI 10.1111/j.1750-3639.2007.00096.x; Dunwiddie TV, 2001, ANNU REV NEUROSCI, V24, P31, DOI 10.1146/annurev.neuro.24.1.31; Eltzschig HK, 2012, NEW ENGL J MED, V367, P2322, DOI 10.1056/NEJMra1205750; Ferre S, 1997, TRENDS NEUROSCI, V20, P482, DOI 10.1016/S0166-2236(97)01096-5; Florio C, 1997, LIFE SCI, V60, P1477, DOI 10.1016/S0024-3205(97)00099-4; Gammie SC, 2007, GENES BRAIN BEHAV, V6, P432, DOI 10.1111/j.1601-183X.2006.00271.x; Gimenez-Llort L, 2002, EUR J NEUROSCI, V16, P547, DOI 10.1046/j.1460-9568.2002.02122.x; Gotoh L, 2009, PSYCHIAT GENET, V19, P328, DOI 10.1097/YPG.0b013e3283328e26; Gould TD, 2006, GENES BRAIN BEHAV, V5, P113, DOI 10.1111/j.1601-183X.2005.00186.x; Hasko G, 2008, NAT REV DRUG DISCOV, V7, P759, DOI 10.1038/nrd2638; Ikemoto S, 2007, BRAIN RES REV, V56, P27, DOI 10.1016/j.brainresrev.2007.05.004; Jones BE, 2009, NEURON, V61, P156, DOI 10.1016/j.neuron.2009.01.005; Kalueff AV, 2006, BEHAV PROCESS, V71, P8, DOI 10.1016/j.beproc.2005.09.004; Karpa MJ, 2010, J AGING HEALTH, V22, P154, DOI 10.1177/0898264309353066; Kiss J, 2008, EUR J IMMUNOL, V38, P3041, DOI 10.1002/eji.200838651; Koszalka P, 2004, CIRC RES, V95, P814, DOI 10.1161/01.RES.0000144796.82787.6f; Krackow S, 2010, GENES BRAIN BEHAV, V9, P722, DOI 10.1111/j.1601-183X.2010.00606.x; Langer D, 2008, CELL TISSUE RES, V334, P199, DOI 10.1007/s00441-008-0681-x; Lazic SE, 2007, BRAIN RES, V1151, P219, DOI 10.1016/j.brainres.2007.03.018; Ledent C, 1997, NATURE, V388, P674, DOI 10.1038/41771; MESSERI P, 1975, PHYSIOL BEHAV, V14, P53, DOI 10.1016/0031-9384(75)90141-9; Mills JH, 2008, P NATL ACAD SCI USA, V105, P9325, DOI 10.1073/pnas.0711175105; Moy SS, 2009, GENES BRAIN BEHAV, V8, P129, DOI 10.1111/j.1601-183X.2008.00452.x; Murphy C, 2009, ANN NY ACAD SCI, V1170, P647, DOI 10.1111/j.1749-6632.2009.04486.x; Nadler JJ, 2004, GENES BRAIN BEHAV, V3, P303, DOI 10.1111/j.1601-183X.2004.00071.x; Niemela J, 2008, EUR J IMMUNOL, V38, P2718, DOI 10.1002/eji.200838437; Oka H, 2010, J NEUROL, V257, P969, DOI 10.1007/s00415-009-5447-1; Powell CM, 2006, BIOL PSYCHIAT, V59, P1198, DOI 10.1016/j.biopsych.2006.05.008; Ribeiro JA, 2002, PROG NEUROBIOL, V68, P377, DOI 10.1016/S0301-0082(02)00155-7; Salamone John D, 2008, Parkinsonism Relat Disord, V14 Suppl 2, pS130, DOI 10.1016/j.parkreldis.2008.04.017; Salmi P, 2005, J MOL NEUROSCI, V26, P239, DOI 10.1385/JMN:26:2-3:239; Sanchez-Andrade G, 2009, BEHAV BRAIN RES, V200, P323, DOI 10.1016/j.bbr.2008.12.021; SCHOEN SW, 1995, NEUROSCIENCE, V65, P37, DOI 10.1016/0306-4522(94)00469-L; Schoen SW, 1997, BRAIN RES PROTOC, V1, P33, DOI 10.1016/S1385-299X(96)00006-2; Sebastiao AM, 2009, CURR NEUROPHARMACOL, V7, P180, DOI 10.2174/157015909789152128; Shen HY, 2009, CURR NEUROPHARMACOL, V7, P195, DOI 10.2174/157015909789152191; Sowa NA, 2010, J NEUROSCI, V30, P2235, DOI 10.1523/JNEUROSCI.5324-09.2010; Stork O, 1997, EUR J NEUROSCI, V9, P1117, DOI 10.1111/j.1460-9568.1997.tb01464.x; Thompson LF, 2004, J EXP MED, V200, P1395, DOI 10.1084/Jem.20040915; Vinkers CH, 2009, NEUROSCIENCE, V159, P39, DOI 10.1016/j.neuroscience.2008.12.009; Voikar V, 2004, GENES BRAIN BEHAV, V3, P27, DOI 10.1046/j.1601-183X.2003.0044.x; Voikar V, 2005, GENES BRAIN BEHAV, V4, P240, DOI 10.1111/j.1601-183X.2004.00103.x; Wesson DW, 2010, J NEUROSCI, V30, P505, DOI 10.1523/JNEUROSCI.4622-09.2010; Wrenn CC, 2003, BEHAV NEUROSCI, V117, P21, DOI 10.1037/0735-7044.117.1.21; Xie XB, 2007, COMPARATIVE MED, V57, P538; Yaar R, 2005, J CELL PHYSIOL, V202, P9, DOI 10.1002/jcp.20138; Yegutkin GG, 2008, BBA-MOL CELL RES, V1783, P673, DOI 10.1016/j.bbamcr.2008.01.024; Yegutkin GG, 2001, FASEB J, V15, P251, DOI 10.1096/fj.00-0268com; Zimmermann H, 1996, PROG NEUROBIOL, V49, P589, DOI 10.1016/0301-0082(96)00026-3; Zlomuzica A, 2012, PURINERGIS IN PRESS	54	38	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66896	10.1371/journal.pone.0066896	http://dx.doi.org/10.1371/journal.pone.0066896			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776700	Green Published, gold, Green Submitted			2022-12-27	WOS:000320322400120
J	Pesce, A; Tilleman, L; Donne, J; Aste, E; Ascenzi, P; Ciaccio, C; Coletta, M; Moens, L; Viappiani, C; Dewilde, S; Bolognesi, M; Nardini, M				Pesce, Alessandra; Tilleman, Lesley; Donne, Joke; Aste, Elisa; Ascenzi, Paolo; Ciaccio, Chiara; Coletta, Massimo; Moens, Luc; Viappiani, Cristiano; Dewilde, Sylvia; Bolognesi, Martino; Nardini, Marco			Structure and Haem-Distal Site Plasticity in Methanosarcina acetivorans Protoglobin	PLOS ONE			English	Article							GLOBIN-COUPLED SENSORS; BINDING; HEMOGLOBINS; MYOGLOBIN; PROTEINS; CAVITIES; AFFINITY; MODEL; LIFE	Protoglobin from Methanosarcina acetivorans C2A (MaPgb), a strictly anaerobic methanogenic Archaea, is a dimeric haem-protein whose biological role is still unknown. As other globins, protoglobin can bind O-2, CO and NO reversibly in vitro, but it displays specific functional and structural properties within members of the hemoglobin superfamily. CO binding to and dissociation from the haem occurs through biphasic kinetics, which arise from binding to (and dissociation from) two distinct tertiary states in a ligation-dependent equilibrium. From the structural viewpoint, protoglobin-specific loops and a N-terminal extension of 20 residues completely bury the haem within the protein matrix. Thus, access of small ligand molecules to the haem is granted by two apolar tunnels, not common to other globins, which reach the haem distal site from locations at the B/G and B/E helix interfaces. Here, the roles played by residues Trp(60)B9, Tyr(61)B10 and Phe(93)E11 in ligand recognition and stabilization are analyzed, through crystallographic investigations on the ferric protein and on selected mutants. Specifically, protein structures are reported for protoglobin complexes with cyanide, with azide (also in the presence of Xenon), and with more bulky ligands, such as imidazole and nicotinamide. Values of the rate constant for cyanide dissociation from ferric MaPgb-cyanide complexes have been correlated to hydrogen bonds provided by Trp(60)B9 and Tyr(61)B10 that stabilize the haem-Fe(III)-bound cyanide. We show that protoglobin can strikingly reshape, in a ligand-dependent way, the haem distal site, where Phe(93)E11 acts as ligand sensor and controls accessibility to the haem through the tunnel system by modifying the conformation of Trp(60)B9.	[Pesce, Alessandra; Aste, Elisa] Univ Genoa, Dept Phys, Genoa, Italy; [Tilleman, Lesley; Donne, Joke; Moens, Luc; Dewilde, Sylvia] Univ Antwerp, Dept Biomed Sci, B-2020 Antwerp, Belgium; [Ascenzi, Paolo] Univ Roma Tre, Interdept Lab Electron Microscopy, Rome, Italy; [Ascenzi, Paolo] Natl Res Council CNR, Inst Prot Biochem, Naples, Italy; [Ciaccio, Chiara; Coletta, Massimo] Univ Roma Tor Vergata, Dept Clin Sci & Translat Med, Rome, Italy; [Ciaccio, Chiara; Coletta, Massimo] Interunivers Consortium Res Chem Met Biol Syst, Bari, Italy; [Viappiani, Cristiano] Univ Parma, Dept Phys & Earth Sci, I-43100 Parma, Italy; [Bolognesi, Martino; Nardini, Marco] Univ Milan, Dept Biosci, Milan, Italy; [Bolognesi, Martino] Univ Milan, Natl Res Council Biophys Inst CNR IBF, Milan, Italy; [Bolognesi, Martino] Univ Milan, Interdisciplinary Ctr Nanostruct Mat & Interfaces, Milan, Italy	University of Genoa; University of Antwerp; Roma Tre University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); University of Rome Tor Vergata; University of Parma; University of Milan; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); University of Milan; University of Milan	Nardini, M (corresponding author), Univ Milan, Dept Biosci, Milan, Italy.	marco.nardini@unimi.it	Viappiani, Cristiano/AAC-7579-2019; Nardini, Marco/B-7842-2017; Bolognesi, Martino/B-7924-2017; Pesce, Alessandra/A-3660-2015; Coletta, Massimiliano/GSN-5927-2022; Coletta, Massimo/N-9049-2015	Viappiani, Cristiano/0000-0001-7470-4770; Nardini, Marco/0000-0002-3718-2165; Bolognesi, Martino/0000-0002-9253-5170; COLETTA, Massimiliano/0000-0002-5489-9467	Italian Ministero dell'Istruzione, dell'Universita e della Ricerca [2008BFJ34R]; Azioni Integrate Italia Spagna [IT10L1M59M]; Ministero degli Affari Esteri, Direzione generale per la promozione del sistema Paese [20112013]; University of Antwerp; Fund for Scientific Research, Flanders, Belgium [G.0247.09]; Ministry for University; Research of Italy (University Roma Tre, Roma, Italy; University of Milano	Italian Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Azioni Integrate Italia Spagna; Ministero degli Affari Esteri, Direzione generale per la promozione del sistema Paese; University of Antwerp; Fund for Scientific Research, Flanders, Belgium(FWO); Ministry for University; Research of Italy (University Roma Tre, Roma, Italy; University of Milano	The authors acknowledge the Italian Ministero dell'Istruzione, dell'Universita e della Ricerca (PRIN 2008, 2008BFJ34R, and Azioni Integrate Italia Spagna 2009, IT10L1M59M), and Ministero degli Affari Esteri, Direzione generale per la promozione del sistema Paese (Progetti di Grande Rilevanza, Italia-Argentina 20112013), the University of Antwerp and the Fund for Scientific Research, Flanders, Belgium (Grant No G.0247.09) for financial support. This work was partially supported by grants from the Ministry for University and Research of Italy (University Roma Tre, Roma, Italy, "CLAR 2012''.) and by institutional funds from University of Milano (FIRST-2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbruzzetti S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033614; APPLEBY CA, 1973, P NATL ACAD SCI USA, V70, P564, DOI 10.1073/pnas.70.2.564; Ascenzi P, 2013, BIOCHEM BIOPH RES CO, V430, P1301, DOI 10.1016/j.bbrc.2012.11.122; Ascenzi P, 2010, BIOCHEM BIOPH RES CO, V393, P196, DOI 10.1016/j.bbrc.2010.01.092; Bikiel DE, 2010, J PHYS CHEM B, V114, P8536, DOI 10.1021/jp102135p; Bolognesi M, 1997, PROG BIOPHYS MOL BIO, V68, P29, DOI 10.1016/S0079-6107(97)00017-5; Bolognesi M, 1999, BIOPHYS J, V77, P1093, DOI 10.1016/S0006-3495(99)76959-6; Ciaccio C, 2013, BIOCH BIOPH IN PRESS, DOI [10.1016/j.bbapap.2013.02.026, DOI 10.1016/J.BBAPAP.2013.02.026.IN]; de Sanctis D, 2004, BIOCHEM BIOPH RES CO, V316, P1217, DOI 10.1016/j.bbrc.2004.03.007; Dewilde S, 2001, J BIOL CHEM, V276, P38949, DOI 10.1074/jbc.M106438200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; EVANS PR, 1993, P CCP4 STUD WEEK DAT; Ferry JG, 2006, MOL BIOL EVOL, V23, P1286, DOI 10.1093/molbev/msk014; Freitas TAK, 2005, J INORG BIOCHEM, V99, P23, DOI 10.1016/j.jinorgbio.2004.10.024; Freitas TAK, 2004, P NATL ACAD SCI USA, V101, P6675, DOI 10.1073/pnas.0308657101; Freitas TAK, 2003, FEBS LETT, V552, P99, DOI 10.1016/S0014-5793(03)00923-2; Hou SB, 2001, P NATL ACAD SCI USA, V98, P9353, DOI 10.1073/pnas.161185598; Knapp JE, 2009, STRUCTURE, V17, P1494, DOI 10.1016/j.str.2009.09.004; LASKOWSKI RA, 1995, J MOL GRAPHICS, V13, P323, DOI 10.1016/0263-7855(95)00073-9; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie AGM, 2003, MOSFLM USER GUIDE MO; Marti MA, 2006, J INORG BIOCHEM, V100, P761, DOI 10.1016/j.jinorgbio.2005.12.009; Milani M, 2004, J BIOL CHEM, V279, P21520, DOI 10.1074/jbc.M401320200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nardini M, 2008, EMBO REP, V9, P157, DOI 10.1038/sj.embor.7401153; Pesce A, 2011, IUBMB LIFE, V63, P287, DOI 10.1002/iub.484; Pesce A, 2009, J MOL BIOL, V386, P246, DOI 10.1016/j.jmb.2008.12.023; Rother M, 2004, P NATL ACAD SCI USA, V101, P16929, DOI 10.1073/pnas.0407486101; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Vinogradov SN, 2007, GENE, V398, P132, DOI 10.1016/j.gene.2007.02.041; Zhang W, 2003, STRUCTURE, V11, P1097, DOI 10.1016/S0969-2126(03)00169-2	31	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66144	10.1371/journal.pone.0066144	http://dx.doi.org/10.1371/journal.pone.0066144			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776624	Green Published, gold, Green Submitted			2022-12-27	WOS:000320322400084
J	Hsieh, MH; Chou, PC; Chou, CL; Ho, SC; Joa, WC; Chen, LF; Sheng, TF; Lin, HC; Wang, TY; Chang, PJ; Wang, CH; Kuo, HP				Hsieh, Meng-Heng; Chou, Pai-Chien; Chou, Chun-Liang; Ho, Shu-Chuan; Joa, Wen-Ching; Chen, Li-Fei; Sheng, Te-Fang; Lin, Horng-Chyuan; Wang, Tsai-Yu; Chang, Po-Jui; Wang, Chun-Hua; Kuo, Han-Pin			Matrix Metalloproteinase-1 Polymorphism (-1607G) and Disease Severity in Non-Cystic Fibrosis Bronchiectasis in Taiwan	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISM; IDIOPATHIC PULMONARY-FIBROSIS; MYCOBACTERIUM-TUBERCULOSIS; TISSUE INHIBITOR; EPITHELIAL-CELLS; GENE-EXPRESSION; PROMOTER POLYMORPHISM; DERMAL FIBROBLASTS; MMP-1 PROMOTER; MELANOMA-CELLS	Objectives: Bronchiectasis is characterized by an irreversible dilatation of bronchi and is associated with lung fibrosis. MMP-1 polymorphism may alter its transcriptional activity, and differentially modulate bronchial destruction and lung fibrosis. Design: To investigate the association of MMP-1 polymorphisms with disease severity in non-cystic fibrosis (CF) bronchiectasis patients, 51 normal subjects and 113 patients with bronchiectasis were studied. The associations between MMP-1 polymorphisms, lung function, and disease severity evaluated by high resolution computed tomography (HRCT) were analyzed. Results: The frequency of MMP-1(-1607G) allele was significantly higher in patients with bronchiectasis than normal subjects (70.8% vs 45.1%, p < 0.01). Forced expiratory volume in 1 second (FEV1) was decreased in bronchiectasis patients with 1G/1G (1.2 +/- 0.1 L, n = 14) and 1G/2G (1.3 +/- 0.1 L, n = 66) genotypes compared to the 2G/2G genotype (1.7 +/- 0.1 L, n = 33, p < 0.01). Six minute walking distance was decreased in bronchiectasis patients with 1G/1G and 1G/2G compared to that of 2G/2G genotype. Disease severity evaluated by HRCT score significantly increased in bronchiectasis patients with 1G/1G and 1G/2G genotypes compared to that of 2G/2G genotype. Bronchiectasis patients with at least one MMP-1 (-1607G) allele showed increased tendency for hospitalization. Serum levels of pro-MMP-1, active MMP-1 and TGF-beta 1 were significantly increased in patients with bronchiectasis with 1G/1G and 1G/2G genotype compared with 2G/2G genotype or normal subjects. Under IL-1 beta stimulation, peripheral blood monocytes from subjects with 1G/2G or 1G/1G genotype secreted higher levels of TGF-beta 1compared to subjects with 2G/2G genotype. Conclusion: This is the first report to address the influence of MMP-1 polymorphisms on lung function and airway destruction in non-CF bronchiectasis patients. Bronchiectasis patients with MMP-1(-1607G) polymorphism may be more vulnerable to permanent lung fibrosis or airway destruction due to the enhanced MMP-1 and TGF-beta 1 activity. Upregulated MMP-1 activity results in proteolytic destruction of matrix, and leads to subsequent fibrosis.	[Hsieh, Meng-Heng; Chou, Pai-Chien; Chou, Chun-Liang; Ho, Shu-Chuan; Joa, Wen-Ching; Chen, Li-Fei; Sheng, Te-Fang; Lin, Horng-Chyuan; Wang, Tsai-Yu; Chang, Po-Jui; Wang, Chun-Hua; Kuo, Han-Pin] Chang Gung Med Fdn, Dept Thorac Med, Taipei, Taiwan; [Ho, Shu-Chuan] Taipei Med Univ, Coll Med, Sch Resp Therapy, Taipei, Taiwan	Chang Gung Memorial Hospital; Taipei Medical University	Wang, CH (corresponding author), Chang Gung Med Fdn, Dept Thorac Med, Taipei, Taiwan.	wchunhua@ms7.hinet.net	Wang, Chun-Hua/C-1488-2016; Wang, Chun-Hua/V-9861-2019	Wang, Chun-Hua/0000-0002-3514-9353	Chang Gung Medical foundation, Chang Gung University, Taiwan [CMRPG370961]	Chang Gung Medical foundation, Chang Gung University, Taiwan	This work was supported by CMRPG370961 from the Chang Gung Medical foundation, Chang Gung University, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELAZIZ MM, 1995, AM J RESP CELL MOL, V13, P728, DOI 10.1165/ajrcmb.13.6.7576711; Agarwal AR, 2003, ALLERGY ASTHMA PROC, V24, P35; Benbow U, 2002, J CELL BIOCHEM, V86, P307, DOI 10.1002/jcb.10225; CAMPBELL EJ, 1991, J IMMUNOL, V146, P1286; Cataldo DD, 2004, LAB INVEST, V84, P418, DOI 10.1038/labinvest.3700063; Chen HJ, 2003, AM J PHYSIOL-HEART C, V284, pH1612, DOI 10.1152/ajpheart.00992.2002; Cole P J, 1986, Eur J Respir Dis Suppl, V147, P6; Dunsmore SE, 1996, AM J PHYSIOL-LUNG C, V270, pL3, DOI 10.1152/ajplung.1996.270.1.L3; Eickelberg O, 1999, AM J PHYSIOL-LUNG C, V276, pL814, DOI 10.1152/ajplung.1999.276.5.L814; Elkington P, 2011, J CLIN INVEST, V121, P1827, DOI 10.1172/JCI45666; Elkington PTG, 2005, J IMMUNOL, V175, P5333, DOI 10.4049/jimmunol.175.8.5333; Fineschi S, 2006, FASEB J, V20, P562, DOI 10.1096/fj.05-4870fje; Friedland JS, 2002, MATRIX BIOL, V21, P103, DOI 10.1016/S0945-053X(01)00175-5; Gaggar A, 2008, J IMMUNOL, V180, P5662, DOI 10.4049/jimmunol.180.8.5662; Ghilardi G, 2001, CLIN CANCER RES, V7, P2344; Green JA, 2010, J IMMUNOL, V184, P6492, DOI 10.4049/jimmunol.0903811; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; Henry MT, 2002, EUR RESPIR J, V20, P1220, DOI 10.1183/09031936.02.00022302; Honda A, 2008, J DERMATOL SCI, V49, P63, DOI 10.1016/j.jdermsci.2007.09.007; Joos L, 2002, HUM MOL GENET, V11, P569, DOI 10.1093/hmg/11.5.569; Kanamori Y, 1999, CANCER RES, V59, P4225; Keistinen T, 1997, EUR RESPIR J, V10, P2784, DOI 10.1183/09031936.97.10122784; Kuo HP, 2008, TUBERCULOSIS, V88, P262, DOI 10.1016/j.tube.2007.08.010; Loukides S, 2002, CHEST, V121, P81, DOI 10.1378/chest.121.1.81; Morris DG, 2003, NATURE, V422, P169, DOI 10.1038/nature01413; Ninomiya S, 2004, SARCOIDOSIS VASC DIF, V21, P19; Nishioka Y, 2003, CANCER LETT, V200, P49, DOI 10.1016/S0304-3835(03)00411-7; Okuno T, 2002, SCAND J GASTROENTERO, V37, P317, DOI 10.1080/003655202317284228; Pardo A, 2005, INT J BIOCHEM CELL B, V37, P283, DOI 10.1016/j.biocel.2004.06.017; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; Rutter JL, 1998, CANCER RES, V58, P5321; Selman M, 2000, AM J PHYSIOL-LUNG C, V279, pL562, DOI 10.1152/ajplung.2000.279.3.L562; SEPPER R, 1995, CHEST, V107, P1641, DOI 10.1378/chest.107.6.1641; SEPPER R, 1994, CHEST, V106, P1129, DOI 10.1378/chest.106.4.1129; Shi J, 2004, INFLAMM RES, V53, P377, DOI 10.1007/s00011-004-1271-3; Stankovic M, 2009, J INVEST MED, V57, P500, DOI 10.2310/JIM.0b013e318198277c; Todorova L, 2010, RESP MED, V104, P1799, DOI 10.1016/j.rmed.2010.06.015; Tower GB, 2002, BBA-MOL BASIS DIS, V1586, P265, DOI 10.1016/S0925-4439(01)00105-3; Vairaktaris E, 2007, ANTICANCER RES, V27, P459; Wang CH, 2010, INT J TUBERC LUNG D, V14, P627; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Yamamoto T, 2000, J IMMUNOL, V164, P6174, DOI 10.4049/jimmunol.164.12.6174; Zhu Y, 2001, CANCER RES, V61, P7825; Zuo FR, 2002, P NATL ACAD SCI USA, V99, P6292, DOI 10.1073/pnas.092134099	44	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66265	10.1371/journal.pone.0066265	http://dx.doi.org/10.1371/journal.pone.0066265			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776649	gold, Green Published, Green Submitted			2022-12-27	WOS:000320755400131
J	Jones, KH; Ford, DV; Jones, PA; John, A; Middleton, RM; Lockhart-Jones, H; Peng, J; Osborne, LA; Noble, JG				Jones, Kerina H.; Ford, David V.; Jones, Philip A.; John, Ann; Middleton, Rodden M.; Lockhart-Jones, Hazel; Peng, Jeffrey; Osborne, Lisa A.; Noble, J. Gareth			How People with Multiple Sclerosis Rate Their Quality of Life: An EQ-5D Survey via the UK MS Register	PLOS ONE			English	Article							DRIVES	Introduction: The EQ-5D is a widely-used, standardised, quality of life measure producing health profiles, indices and states. The aims of this study were to assess the role of various factors in how people with Multiple Sclerosis rate their quality of life, based on responses to the EQ-5D received via the web portal of the UK MS Register. Methods: The 4516 responses to the EQ-5D (between May 2011 and April 2012) were collated with basic demographic and descriptive MS data and the resulting dataset was analysed in SPSS (v. 20). Results: The mean health state for people with MS was 59.73 (SD 22.4, median 61), compared to the UK population mean of 82.48 (which is approximately 1SD above the cohort mean). The characteristics of respondents with high health states (at or above + 1SD) were: better health profiles (most predictive dimension: Usual Activities), higher health indices, younger age, shorter durations of MS, female gender, relapsing-remitting MS, higher educational attainment and being in paid employment (all p-values<0.001). Conversely, the characteristics of respondents with low health states (at or below -1SD) were: poorer health profiles (most predictive dimension: Mobility), lower health indices, older age, longer durations of MS, male gender, progressive MS, lower educational attainment and having an employment status of sick/disabled (p = 0.0014 for age, all other p-values<0.001). Particular living arrangements were not associated with either the high or low health status groups. Conclusions: This large-scale study has enabled in-depth analyses on how people with MS rate their quality of life, and it provides new knowledge on the various factors that contribute to their self-assessed health status. These findings demonstrate the impact of MS on quality of life, and they can be used to inform care provision and further research, to work towards enhancing the quality of life of people with MS.	[Jones, Kerina H.; Ford, David V.; Jones, Philip A.; John, Ann; Middleton, Rodden M.; Lockhart-Jones, Hazel; Peng, Jeffrey; Noble, J. Gareth] Swansea Univ, Coll Med, Swansea, W Glam, Wales; [Osborne, Lisa A.] Swansea Univ, Coll Human & Hlth Sci, Long Term & Chron Condit Ctr, Swansea, W Glam, Wales	Swansea University; Swansea University	Jones, KH (corresponding author), Swansea Univ, Coll Med, Swansea, W Glam, Wales.	k.h.jones@swansea.ac.uk		Ford, David/0000-0001-6551-721X; Middleton, Rodden/0000-0002-2130-4420; Noble, Gareth/0000-0002-4588-049X; Jones, Kerina/0000-0001-8164-3718; John, Ann/0000-0002-5657-6995	MS Society of Great Britain and Northern Ireland; Economic and Social Research Council [ES/L007444/1] Funding Source: researchfish; Medical Research Council [MR/K006525/1] Funding Source: researchfish; ESRC [ES/L007444/1] Funding Source: UKRI; MRC [MR/K006525/1] Funding Source: UKRI	MS Society of Great Britain and Northern Ireland; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study is funded by the MS Society of Great Britain and Northern Ireland http://www.mssociety.org.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], ETH REV RES DAT; Boot CRL, 2010, HEALTH INFORM J, V16, P145, DOI 10.1177/1460458210364786; Carr AJ, 2001, BMJ-BRIT MED J, V322, P1240, DOI 10.1136/bmj.322.7296.1240; Cheung K, 2009, EQ 5D USER GUIDE BAS; European Medicines Agency, 2012, EMACHMP771852011; Ford DV, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-73; Ford DV, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-157; Gallacher J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054331; Good Alice, 2007, J Healthc Inf Manag, V21, P72; Hemmett L, 2004, QJM-INT J MED, V97, P671, DOI 10.1093/qjmed/hch105; Hobart J, 2001, BRAIN, V124, P962, DOI 10.1093/brain/124.5.962; Jones KH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055422; Jones KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041910; Juniper EF, 2004, EUR RESPIR J, V23, P287, DOI 10.1183/09031936.04.00064204; Kind P, 1999, 172 U YORK; Lyons RA, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-3; Noble JG, 2012, MULTIPLE SCLEROSIS J, V18; Office for National Statistics, NOM OFF LAB MARK STA; Osborne LA, 2013, INT J HEALT IN PRESS; Osborne LA, 2013, INT J MED I IN PRESS; Osborne LA, 2012, INT J HEALTHC INF SY, V7, P27, DOI 10.4018/jhisi.2012070103; Osborne LA, 2012, CHRONIC ILLN, V8, P112, DOI 10.1177/1742395312436747; Popham F, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001342; Sullivan PW, 2011, MED DECIS MAKING, V31, P800, DOI 10.1177/0272989X11401031; Szende A., 2004, MEASURING SELF REPOR; Whitacre CC, 1999, SCIENCE, V283, P1277, DOI 10.1126/science.283.5406.1277; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	28	49	49	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65640	10.1371/journal.pone.0065640	http://dx.doi.org/10.1371/journal.pone.0065640			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776516	Green Submitted, Green Published, gold			2022-12-27	WOS:000320755400051
J	Cho, YW; Hong, CJ; Hou, A; Gent, PM; Zhang, KX; Won, KJ; Hamilton, BA				Cho, Young-Wook; Hong, Chen-Jei; Hou, Aiju; Gent, Peter M.; Zhang, Kuixing; Won, Kyoung-Jae; Hamilton, Bruce A.			Zfp423 Binds Autoregulatory Sites in P19 Cell Culture Model	PLOS ONE			English	Article							GENE-EXPRESSION; CEREBELLAR DEVELOPMENT; TRANSCRIPTION FACTORS; FINGER PROTEIN; DNA; DIFFERENTIATION; NEUROBLASTOMA; ESTABLISHMENT; MUTATIONS; INTERACTS	Zfp423 is a 30 zinc finger transcription factor that forms regulatory complexes with EBF family members and factors targeted by canonical signaling pathways. Zfp423 mutations produce a range of developmental abnormalities in mice and humans related to the ciliopathies. Surprisingly, computational analysis of clustered Zfp423 and partner motifs in conserved genomic sequences predicts enrichment in Zfp423 and Ebf genes. In cell culture models selected for Zfp423 and EBF expression, we identify strong and reproducible occupancy of two Zfp423 intronic sites using chromatin immunoprecipitation with multiple independent antibodies. Both sites are significantly enriched in either quantitative PCR or massively parallel sequencing assays. A site in intron 5 acts as a classical enhancer in transient assays, but does not require the consensus motif for activity, suggesting a redundant or modulatory role for Zfp423 binding in this context. We speculate that Zfp423 may repress this enhancer as part of a developmental ratchet.	[Cho, Young-Wook; Hong, Chen-Jei; Hou, Aiju; Gent, Peter M.; Zhang, Kuixing; Hamilton, Bruce A.] Univ Calif San Diego, Sch Med, Inst Genom Med & Moores, UCSD Canc Ctr,Dept Med, La Jolla, CA 92093 USA; [Cho, Young-Wook; Hong, Chen-Jei; Hou, Aiju; Gent, Peter M.; Zhang, Kuixing; Hamilton, Bruce A.] Univ Calif San Diego, Sch Med, Inst Genom Med & Moores, UCSD Canc Ctr,Dept cellular & Mol Med, La Jolla, CA 92093 USA; [Won, Kyoung-Jae] Univ Penn, Sch Med, Inst Diabet Obes & Metab, Dept Genet, Philadelphia, PA 19104 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Pennsylvania	Hamilton, BA (corresponding author), Univ Calif San Diego, Sch Med, Inst Genom Med & Moores, UCSD Canc Ctr,Dept Med, La Jolla, CA 92093 USA.	bah@ucsd.edu	Gent, Peter/AAI-1540-2021	Gent, Peter/0000-0002-5519-8654; Hamilton, Bruce/0000-0001-5599-9139; Won, Kyoung Jae/0000-0002-2924-9630	National Institute for Neurological Disorders and Stroke [NS054871, NS010909]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS010909, R01NS060109, R01NS054871] Funding Source: NIH RePORTER	National Institute for Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institute for Neurological Disorders and Stroke to B. A. H. (NS054871, NS010909). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaraz WA, 2006, P NATL ACAD SCI USA, V103, P19424, DOI 10.1073/pnas.0609184103; Alcaraz WA, 2011, HUM MOL GENET, V20, P3822, DOI 10.1093/hmg/ddr300; Chaki M, 2012, CELL IN PRESS; Chaki M, 2012, CELL, V150, P533, DOI 10.1016/j.cell.2012.06.028; Cheng LE, 2007, DEV BIOL, V307, P43, DOI 10.1016/j.ydbio.2007.04.005; Cheng LE, 2007, NEURON, V54, P547, DOI 10.1016/j.neuron.2007.04.029; Floyd JA, 2003, NAT GENET, V35, P221, DOI 10.1038/ng1247; FRIEDMAN HS, 1985, J NEUROPATH EXP NEUR, V44, P592, DOI 10.1097/00005072-198511000-00005; Gupta RK, 2010, NATURE, V464, P619, DOI 10.1038/nature08816; Hata A, 2000, CELL, V100, P229, DOI 10.1016/S0092-8674(00)81561-5; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Huang SD, 2009, CANCER CELL, V15, P328, DOI 10.1016/j.ccr.2009.02.023; Ku MC, 2003, BIOCHEM BIOPH RES CO, V311, P702, DOI 10.1016/j.bbrc.2003.10.053; Masserdotti G, 2010, J BIOL CHEM, V285, P30814, DOI 10.1074/jbc.M110.142869; MCBURNEY MW, 1982, DEV BIOL, V89, P503, DOI 10.1016/0012-1606(82)90338-4; Miyazaki K, 2009, BLOOD; Ovcharenko I, 2005, GENOME RES, V15, P137, DOI 10.1101/gr.3015505; PONTEN J, 1968, ACTA PATHOL MIC SC, V74, P465; Rozen S, 2000, Methods Mol Biol, V132, P365; Tsai RYL, 1998, MOL CELL BIOL, V18, P6447, DOI 10.1128/MCB.18.11.6447; Tsai RYL, 1997, J NEUROSCI, V17, P4159; TUMILOWICZ JJ, 1970, CANCER RES, V30, P2110; WANG MM, 1993, MOL CELL BIOL, V13, P5805, DOI 10.1128/MCB.13.9.5805; Warming S, 2004, ONCOGENE, V23, P2727, DOI 10.1038/sj.onc.1207452; Warming S, 2006, MOL CELL BIOL, V26, P6913, DOI 10.1128/MCB.02255-05; Wen G, 2007, HUM MOL GENET, V16, P1752, DOI 10.1093/hmg/ddm123; WESTERMARK B, 1973, ACTA PATH MICRO IM A, VA 81, P791	28	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e66514	10.1371/journal.pone.0066514	http://dx.doi.org/10.1371/journal.pone.0066514			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762491	Green Published, Green Submitted, gold			2022-12-27	WOS:000321099000133
J	Eskici, G; Gur, M				Eskici, Gozde; Gur, Mert			Computational Design of New Peptide Inhibitors for Amyloid Beta (A beta) Aggregation in Alzheimer's Disease: Application of a Novel Methodology	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; FREE-ENERGY DIFFERENCES; FIBRIL FORMATION; MEAN FORCE; TOXICITY; LIGAND; PROTEIN; OLIGOMERIZATION; RECOGNITION; POTENTIALS	Alzheimer's disease is the most common form of dementia. It is a neurodegenerative and incurable disease that is associated with the tight packing of amyloid fibrils. This packing is facilitated by the compatibility of the ridges and grooves on the amyloid surface. The GxMxG motif is the major factor creating the compatibility between two amyloid surfaces, making it an important target for the design of amyloid aggregation inhibitors. In this study, a peptide, experimentally proven to bind A beta 40 fibrils at the GxMxG motif, was mutated by a novel methodology that systematically replaces amino acids with residues that share similar chemical characteristics and subsequently assesses the energetic favorability of these mutations by docking. Successive mutations are combined and reassessed via docking to a desired level of refinement. This methodology is both fast and efficient in providing potential inhibitors. Its efficiency lies in the fact that it does not perform all possible combinations of mutations, therefore decreasing the computational time drastically. The binding free energies of the experimentally studied reference peptide and its three top scoring derivatives were evaluated as a final assessment/valuation. The potential of mean forces (PMFs) were calculated by applying the Jarzynski's equality to results of steered molecular dynamics simulations. For all of the top scoring derivatives, the PMFs showed higher binding free energies than the reference peptide substantiating the usage of the introduced methodology to drug design.	[Eskici, Gozde; Gur, Mert] Koc Univ, Ctr Computat Biol & Bioinformat, Istanbul, Turkey	Koc University	Gur, M (corresponding author), Univ Pittsburgh, Sch Med, Dept Computat & Syst Biol, Pittsburgh, PA 15260 USA.	MEG78@pitt.edu	Gur, Mert/P-6408-2014; Gur, Mert/O-5304-2015	Gur, Mert/0000-0003-0983-4397				Austen BM, 2008, BIOCHEMISTRY-US, V47, P1984, DOI 10.1021/bi701415b; Ban T, 2004, J MOL BIOL, V344, P757, DOI 10.1016/j.jmb.2004.09.078; Cannon MJ, 2004, ANAL BIOCHEM, V328, P67, DOI 10.1016/j.ab.2004.01.014; Chang WLE, 2010, BIOPHYS J, V98, P2662, DOI 10.1016/j.bpj.2010.02.031; Esler WP, 2000, BIOCHEMISTRY-US, V39, P6288, DOI 10.1021/bi992933h; Ghanta J, 1996, J BIOL CHEM, V271, P29525, DOI 10.1074/jbc.271.47.29525; Gibson TJ, 2005, BIOCHEMISTRY-US, V44, P8898, DOI 10.1021/bi050225s; Giordano C, 2009, EUR J MED CHEM, V44, P179, DOI 10.1016/j.ejmech.2008.03.036; Hard T, 2012, J MOL BIOL, V421, P441, DOI 10.1016/j.jmb.2011.12.062; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jarzynski C, 1997, PHYS REV LETT, V78, P2690, DOI 10.1103/PhysRevLett.78.2690; Jarzynski C, 1997, PHYS REV E, V56, P5018, DOI 10.1103/PhysRevE.56.5018; JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lemkul JA, 2010, BIOCHEMISTRY-US, V49, P3935, DOI 10.1021/bi1000855; Liu R, 2012, CURR MED CHEM, V19, P4157, DOI 10.2174/092986712802430018; Liu W, 2005, BIOCHEMISTRY-US, V44, P3591, DOI 10.1021/bi047827g; Lowe TL, 2001, BIOCHEMISTRY-US, V40, P7882, DOI 10.1021/bi002734u; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; Park S, 2004, J CHEM PHYS, V120, P5946, DOI 10.1063/1.1651473; Park S, 2003, J CHEM PHYS, V119, P3559, DOI 10.1063/1.1590311; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Porat Y, 2004, BIOCHEMISTRY-US, V43, P14454, DOI 10.1021/bi048582a; Raman EP, 2009, BIOPHYS J, V97, P2070, DOI 10.1016/j.bpj.2009.07.032; Sato T, 2006, BIOCHEMISTRY-US, V45, P5503, DOI 10.1021/bi052485f; Sciarretta KL, 2006, METHOD ENZYMOL, V413, P273, DOI 10.1016/S0076-6879(06)13015-3; Shen ZH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033500; Takeda T, 2009, BIOPHYS J, V96, P442, DOI 10.1016/j.bpj.2008.10.008; TAN SY, 1995, AM J KIDNEY DIS, V26, P267, DOI 10.1016/0272-6386(95)90647-9; Taylor M, 2010, BIOCHEMISTRY-US, V49, P3261, DOI 10.1021/bi100144m; Tjernberg LO, 1996, J BIOL CHEM, V271, P8545, DOI 10.1074/jbc.271.15.8545; Torok M, 2002, J BIOL CHEM, V277, P40810, DOI 10.1074/jbc.M205659200; Tycko R, 2004, CURR OPIN STRUC BIOL, V14, P96, DOI 10.1016/j.sbi.2003.12.002; Tycko R, 2006, Q REV BIOPHYS, V39, P1, DOI 10.1017/S0033583506004173; Vashisth H, 2008, BIOPHYS J, V95, P4193, DOI 10.1529/biophysj.108.139675; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Wiesehan K, 2008, PROTEIN ENG DES SEL, V21, P241, DOI 10.1093/protein/gzm054; Zhang DQ, 2006, J AM CHEM SOC, V128, P3019, DOI 10.1021/ja057292u; Zhao JH, 2013, J MOL MODEL, V19, P151, DOI 10.1007/s00894-012-1532-y	39	34	34	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e66178	10.1371/journal.pone.0066178	http://dx.doi.org/10.1371/journal.pone.0066178			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762479	Green Published, gold			2022-12-27	WOS:000321099000128
J	Le, DT; Tarrago, L; Watanabe, Y; Kaya, A; Lee, BC; Tran, U; Nishiyama, R; Fomenko, DE; Gladyshev, VN; Tran, LSP				Dung Tien Le; Tarrago, Lionel; Watanabe, Yasuko; Kaya, Alaattin; Lee, Byung Cheon; Uyen Tran; Nishiyama, Rie; Fomenko, Dmitri E.; Gladyshev, Vadim N.; Lam-Son Phan Tran			Diversity of Plant Methionine Sulfoxide Reductases B and Evolution of a Form Specific for Free Methionine Sulfoxide	PLOS ONE			English	Article							R-SULFOXIDE; AMINO-ACID; OXIDIZED PROTEINS; LIFE-SPAN; OXIDATION; RESIDUES; EXPRESSION; GLUTAREDOXINS; THIOREDOXIN; REDUCTION	Methionine can be reversibly oxidized to methionine sulfoxide (MetO) under physiological conditions. Organisms evolved two distinct methionine sulfoxide reductase families (MSRA & MSRB) to repair oxidized methionine residues. We found that 5 MSRB genes exist in the soybean genome, including GmMSRB1 and two segmentally duplicated gene pairs (GmMSRB2 and GmMSRB5, GmMSRB3 and GmMSRB4). GmMSRB2 and GmMSRB4 proteins showed MSRB activity toward protein-based MetO with either DTT or thioredoxin (TRX) as reductants, whereas GmMSRB1 was active only with DTT. GmMSRB2 had a typical MSRB mechanism with Cys121 and Cys 68 as catalytic and resolving residues, respectively. Surprisingly, this enzyme also possessed the MSRB activity toward free Met-R-O with kinetic parameters similar to those reported for fRMSR from Escherichia coli, an enzyme specific for free Met-R-O. Overexpression of GmMSRB2 or GmMSRB4 in the yeast cytosol supported the growth of the triple MSRA/MSRB/fRMSR (Delta 3MSRs) mutant on MetO and protected cells against H2O2-induced stress. Taken together, our data reveal an unexpected diversity of MSRBs in plants and indicate that, in contrast to mammals that cannot reduce free Met-R-O and microorganisms that use fRMSR for this purpose, plants evolved MSRBs for the reduction of both free and protein-based MetO.	[Dung Tien Le; Watanabe, Yasuko; Uyen Tran; Nishiyama, Rie; Lam-Son Phan Tran] RIKEN Ctr Sustainable Resource Sci, Signaling Pathway Res Unit, Yokohama, Kanagawa, Japan; [Dung Tien Le; Tarrago, Lionel; Kaya, Alaattin; Lee, Byung Cheon; Gladyshev, Vadim N.] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Dung Tien Le; Tarrago, Lionel; Kaya, Alaattin; Lee, Byung Cheon; Gladyshev, Vadim N.] Harvard Univ, Sch Med, Boston, MA USA; [Dung Tien Le] Vietnamese Acad Agr Sci, Natl Key Lab Plant Cell & Biotechnol, Hanoi, Vietnam; [Dung Tien Le] Vietnamese Acad Agr Sci, Agr Genet Inst, Hanoi, Vietnam; [Fomenko, Dmitri E.] Univ Nebraska, Dept Biochem, Lincoln, NE 68583 USA; [Fomenko, Dmitri E.] Univ Nebraska, Redox Biol Ctr, Lincoln, NE USA	RIKEN; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Le, DT (corresponding author), RIKEN Ctr Sustainable Resource Sci, Signaling Pathway Res Unit, Yokohama, Kanagawa, Japan.	tiendung.le@riken.jp; vgladyshev@rics.bwh.harvard.edu; tran@psc.riken.jp	Tarrago, Lionel/CAH-1308-2022; Tarrago, Lionel/N-3534-2016; Kaya, Alaattin/T-6427-2017; Tran, Lam-Son P/A-1346-2009; Le, Dung Tien/A-7276-2008; Gladyshev, Vadim N/J-6187-2013	Tarrago, Lionel/0000-0001-7115-8137; Tarrago, Lionel/0000-0001-7115-8137; Kaya, Alaattin/0000-0002-6132-5197; Tran, Lam-Son P/0000-0001-9883-9768; Le, Dung Tien/0000-0002-5117-3476; Gladyshev, Vadim/0000-0002-0372-7016; Lee, Byung Cheon/0000-0003-1467-1940	RIKEN; JSPS; RIKEN [AP24-1-0076]; NIH [AG021518]; NATIONAL INSTITUTE ON AGING [R01AG021518] Funding Source: NIH RePORTER	RIKEN; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); RIKEN; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by a RIKEN postdoctoral fellowship to DTL, a grant from JSPS Institutional Program for Young Researcher Overseas Visits to DTL, a grant (AP24-1-0076) from the RIKEN Strategic Research Program for R & D to L-SPT & DTL and a NIH grant (AG021518) to VNG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Couturier J, 2012, FEBS LETT, V586, P3894, DOI 10.1016/j.febslet.2012.09.020; Ding D, 2007, BIOCHEM BIOPH RES CO, V361, P629, DOI 10.1016/j.bbrc.2007.07.072; Dos Santos CV, 2007, FEBS LETT, V581, P4371, DOI 10.1016/j.febslet.2007.07.081; Dos Santos CV, 2005, PLANT PHYSIOL, V138, P909, DOI 10.1104/pp.105.062430; Le DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049522; Le DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042411; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Grimaud R, 2001, J BIOL CHEM, V276, P48915, DOI 10.1074/jbc.M105509200; Kim HY, 2008, BIOCHEM BIOPH RES CO, V371, P490, DOI 10.1016/j.bbrc.2008.04.101; Kim HY, 2012, ACTA BIOCH BIOPH SIN, V44, P623, DOI 10.1093/abbs/gms038; Koc A, 2004, P NATL ACAD SCI USA, V101, P7999, DOI 10.1073/pnas.0307929101; Kryukov GV, 2002, P NATL ACAD SCI USA, V99, P4245, DOI 10.1073/pnas.072603099; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Kumar RA, 2002, J BIOL CHEM, V277, P37527, DOI 10.1074/jbc.M203496200; Kwak GH, 2012, ARCH BIOCHEM BIOPHYS, V527, P1, DOI 10.1016/j.abb.2012.07.009; Laugier E, 2010, PLANT J, V61, P271, DOI 10.1111/j.1365-313X.2009.04053.x; Le DT, 2005, BBA-PROTEINS PROTEOM, V1749, P103, DOI 10.1016/j.bbapap.2005.02.012; Le DT, 2008, BIOCHEMISTRY-US, V47, P6685, DOI 10.1021/bi800422s; Le DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046487; Le DT, 2011, DNA RES, V18, P17, DOI 10.1093/dnares/dsq032; Le DT, 2009, J BIOL CHEM, V284, P4354, DOI 10.1074/jbc.M805891200; Lee BC, 2008, J BIOL CHEM, V283, P28361, DOI 10.1074/jbc.M805059200; Lee BC, 2011, FREE RADICAL BIO MED, V50, P221, DOI 10.1016/j.freeradbiomed.2010.11.008; Libault M, 2010, PLANT J, V63, P86, DOI 10.1111/j.1365-313X.2010.04222.x; Lin ZD, 2007, P NATL ACAD SCI USA, V104, P9597, DOI 10.1073/pnas.0703774104; Lowther WT, 2000, P NATL ACAD SCI USA, V97, P6463, DOI 10.1073/pnas.97.12.6463; Moskovitz J, 2001, P NATL ACAD SCI USA, V98, P12920, DOI 10.1073/pnas.231472998; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Romero HM, 2004, PLANT PHYSIOL, V136, P3784, DOI 10.1104/pp.104.046656; Rozen S, 2000, Methods Mol Biol, V132, P365; Ruan H, 2002, P NATL ACAD SCI USA, V99, P2748, DOI 10.1073/pnas.032671199; SANCHEZ J, 1983, PLANT PHYSIOL, V73, P619, DOI 10.1104/pp.73.3.619; STADTMAN ER, 1993, ANNU REV BIOCHEM, V62, P797, DOI 10.1146/annurev.bi.62.070193.004053; Stadtman ER, 2003, ANTIOXID REDOX SIGN, V5, P577, DOI 10.1089/152308603770310239; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tarrago L, 2012, BIOCHEMISTRY-MOSCOW+, V77, P1097, DOI 10.1134/S0006297912100021; Tarrago L, 2012, J BIOL CHEM, V287, P24448, DOI 10.1074/jbc.M112.374520; Tarrago L, 2010, J BIOL CHEM, V285, P14964, DOI 10.1074/jbc.M110.108373; Tarrago L, 2009, J BIOL CHEM, V284, P18963, DOI 10.1074/jbc.M109.015487; Tarrago L, 2009, MOL PLANT, V2, P202, DOI 10.1093/mp/ssn067; VOGT W, 1995, FREE RADICAL BIO MED, V18, P93, DOI 10.1016/0891-5849(94)00158-G	41	24	25	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65637	10.1371/journal.pone.0065637	http://dx.doi.org/10.1371/journal.pone.0065637			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776515	Green Published, Green Submitted, gold			2022-12-27	WOS:000320322400039
J	Kirkpatrick, S; Locock, L; Giles, MF; Lasserson, DS				Kirkpatrick, Susan; Locock, Louise; Giles, Matthew F.; Lasserson, Daniel S.			Non-Focal Neurological Symptoms Associated with Classical Presentations of Transient Ischaemic Attack: Qualitative Analysis of Interviews with Patients	PLOS ONE			English	Article							MINOR STROKE; GENERAL-PRACTITIONER; PRIMARY-CARE; POPULATION; DIAGNOSIS; RECOGNITION; TIA; PHYSICIANS; AGREEMENT; DISEASE	Background: Improving the recognition of transient ischaemic attack (TIA) at initial healthcare contact is essential as urgent specialist assessment and treatment reduces stroke risk. Accurate TIA detection could be achieved with clinical prediction rules but none have been validated in primary care. An alternative approach using qualitative analysis of patients' experiences of TIA may identify novel features of the TIA phenotype that are not detected routinely, as such techniques have revealed novel early features of other important conditions such as meningococcaemia. We sought to determine whether the patient's experience of TIA would reveal additional deficits that can be tested prospectively in cohort studies to determine their additional diagnostic and prognostic utility at the first healthcare contact. Methodology and Findings: Qualitative semi-structured interviews with 25 patients who had experienced definite TIA as determined by a stroke specialist; framework analysis to map symptoms and key words or descriptive phrases used against each individual, with close attention to the detail of the language used. All interview transcripts were reviewed by a specialist clinician with experience in TIA/minor stroke. Patients described non-focal symptoms consistent with higher function deficits in spatial perception and awareness of deficit, as well as feelings of disconnection with their immediate surroundings. Of the classical features, weakness and speech disturbance were described in ways that did not meet the readily recognisable phenotype. Conclusion/Significance: Analysis of patients' narrative accounts reveals a set of overlooked features of the experience of TIA which may provide additional diagnostic utility so that providers of first contact healthcare can recognise TIA more easily. Future research is required in a prospective cohort of patients presenting with transient neurological symptoms to determine how frequent these features are, what they add to diagnostic information and whether they can refine measures to predict stroke risk.	[Kirkpatrick, Susan; Locock, Louise] Univ Oxford, Dept Primary Care Hlth Sci, Hlth Experiences Res Grp, Oxford, England; [Giles, Matthew F.] Univ Oxford, Nuffield Dept Clin Neurosci, Stroke Prevent Unit, Oxford, England; [Lasserson, Daniel S.] Univ Oxford, Dept Primary Care Hlth Sci, Oxford, England	University of Oxford; University of Oxford; University of Oxford	Lasserson, DS (corresponding author), Univ Oxford, Dept Primary Care Hlth Sci, Oxford, England.	daniel.lasserson@phc.ox.ac.uk	Lasserson, Daniel S/T-8978-2017	Lasserson, Daniel/0000-0001-8274-5580	National Institute for Health Research (NIHR) Oxford Biomedical Research Centre Programme; National Institute for Health Research [CL-2007-13-007] Funding Source: researchfish	National Institute for Health Research (NIHR) Oxford Biomedical Research Centre Programme(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	The research was supported by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre Programme. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel E.K., 1998, PRAGMATIC WOMEN BODY, P310; Bots ML, 1997, STROKE, V28, P768, DOI 10.1161/01.STR.28.4.768; Castle J, 2010, STROKE, V41, P1367, DOI 10.1161/STROKEAHA.109.577650; Coull AJ, 2004, BMJ-BRIT MED J, V328, P326, DOI 10.1136/bmj.37991.635266.44; Dawson J, 2009, QJM-INT J MED, V102, P43, DOI 10.1093/qjmed/hcn139; DENNIS MS, 1989, LANCET, V1, P185; Donders RCJM, 1999, J NEUROL, V246, P1145, DOI 10.1007/s004150050533; Easton JD, 2009, STROKE, V40, P2276, DOI 10.1161/STROKEAHA.108.192218; Gibson J, 2012, J ADV NURS, V68, P1707, DOI 10.1111/j.1365-2648.2011.05849.x; Harbison J, 2003, STROKE, V34, P71, DOI 10.1161/01.STR.0000044170.46643.5E; Kamara Stania, 2012, Prim Health Care Res Dev, V13, P165, DOI 10.1017/S146342361100051X; KOUDSTAAL PJ, 1986, STROKE, V17, P723, DOI 10.1161/01.STR.17.4.723; Lasserson DS, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1569; Lavallee PC, 2007, LANCET NEUROL, V6, P953, DOI 10.1016/S1474-4422(07)70248-X; Manawadu D, 2010, EMERG MED J, V27, P364, DOI 10.1136/emj.2009.074831; Moons KGM, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b606; Murray S, 2007, SCOT MED J, V52, P4, DOI 10.1258/rsmsmj.52.1.4; Nor AM, 2005, LANCET NEUROL, V4, P727, DOI 10.1016/S1474-4422(05)70201-5; Patton M. Q., 1990, QUALITATIVE EVALUATI; QUIKVANMILLIGEN MLT, 1992, CEREBROVASC DIS, V2, P102, DOI 10.1159/000108996; Ritchie J, 1993, ANAL QUALITATIVE DAT, P173, DOI DOI 10.1016/J.JPSYCHORES.2008.12.001; Rothwell PM, 2007, LANCET, V370, P1432, DOI 10.1016/S0140-6736(07)61448-2; Spurgeon L, 2012, STROKE RES TREAT, V2012, DOI 10.1155/2012/486261; Thompson MJ, 2006, LANCET, V367, P397, DOI 10.1016/S0140-6736(06)67932-4; Tomasik T, 2003, FAM PRACT, V20, P464, DOI 10.1093/fampra/cmg423; Visintin Cristina, 2010, BMJ, V340, pc3209, DOI 10.1136/bmj.c3209; Wong JN, 2012, AGE AGEING, V41, P115, DOI 10.1093/ageing/afr134	27	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66351	10.1371/journal.pone.0066351	http://dx.doi.org/10.1371/journal.pone.0066351			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776662	Green Published, gold			2022-12-27	WOS:000320322400098
J	Kobayashi, GS; Alvizi, L; Sunaga, DY; Francis-West, P; Kuta, A; Almada, BVP; Ferreira, SG; de Andrade-Lima, LC; Bueno, DF; Raposo-Amaral, CE; Menck, CF; Passos-Bueno, MR				Kobayashi, Gerson Shigeru; Alvizi, Lucas; Sunaga, Daniele Yumi; Francis-West, Philippa; Kuta, Anna; Pimenta Almada, Bruno Vinicius; Ferreira, Simone Gomes; de Andrade-Lima, Leonardo Carmo; Bueno, Daniela Franco; Raposo-Amaral, Cassio Eduardo; Menck, Carlos Frederico; Passos-Bueno, Maria Rita			Susceptibility to DNA Damage as a Molecular Mechanism for Non-Syndromic Cleft Lip and Palate	PLOS ONE			English	Article							STRAND BREAK REPAIR; CELL-CYCLE CONTROL; OXIDATIVE STRESS; GENE-EXPRESSION; HOMOLOGOUS RECOMBINATION; TRANSCRIPTION FACTORS; INDUCED REPLICATION; OROFACIAL CLEFTS; CANCER-RISK; ORAL CLEFTS	Non-syndromic cleft lip/palate (NSCL/P) is a complex, frequent congenital malformation, determined by the interplay between genetic and environmental factors during embryonic development. Previous findings have appointed an aetiological overlap between NSCL/P and cancer, and alterations in similar biological pathways may underpin both conditions. Here, using a combination of transcriptomic profiling and functional approaches, we report that NSCL/P dental pulp stem cells exhibit dysregulation of a co-expressed gene network mainly associated with DNA double-strand break repair and cell cycle control (p = 2.88 x 10(-2)-5.02 x 10(-9)). This network included important genes for these cellular processes, such as BRCA1, RAD51, and MSH2, which are predicted to be regulated by transcription factor E2F1. Functional assays support these findings, revealing that NSCL/P cells accumulate DNA double-strand breaks upon exposure to H2O2. Furthermore, we show that E2f1, Brca1 and Rad51 are co-expressed in the developing embryonic orofacial primordia, and may act as a molecular hub playing a role in lip and palate morphogenesis. In conclusion, we show for the first time that cellular defences against DNA damage may take part in determining the susceptibility to NSCL/P. These results are in accordance with the hypothesis of aetiological overlap between this malformation and cancer, and suggest a new pathogenic mechanism for the disease.	[Kobayashi, Gerson Shigeru; Alvizi, Lucas; Sunaga, Daniele Yumi; Pimenta Almada, Bruno Vinicius; Ferreira, Simone Gomes; Bueno, Daniela Franco; Passos-Bueno, Maria Rita] Univ Sao Paulo, Inst Biosci, Human Genome Res Ctr, Sao Paulo, Brazil; [Francis-West, Philippa; Kuta, Anna] Kings Coll London, Inst Dent, Dept Craniofacial Dev & Stem Cell Biol, London WC2R 2LS, England; [de Andrade-Lima, Leonardo Carmo; Menck, Carlos Frederico] Univ Sao Paulo, Inst Biomed Sci, Sao Paulo, Brazil; [Bueno, Daniela Franco; Raposo-Amaral, Cassio Eduardo] SOBRAPAR Inst, Campinas, SP, Brazil	Universidade de Sao Paulo; University of London; King's College London; Universidade de Sao Paulo	Passos-Bueno, MR (corresponding author), Univ Sao Paulo, Inst Biosci, Human Genome Res Ctr, Sao Paulo, Brazil.	passos@ib.usp.br	Raposo-Amaral, Cassio/D-1397-2013; Kobayashi, Gerson/H-4017-2013; Alvizi, Lucas/F-9043-2012; Passos-Bueno, Maria Rita/I-6796-2016; Francis-West, Philippa/AAR-5607-2020; Menck, Carlos FM/G-6321-2011; Bueno, Daniela/AAK-2926-2020; Kobayashi, Gerson Shigeru/AAB-9113-2019; Bueno, Daniela F/K-9977-2018	Raposo-Amaral, Cassio/0000-0001-6201-0827; Kobayashi, Gerson/0000-0002-6520-5774; Passos-Bueno, Maria Rita/0000-0002-9248-3008; Menck, Carlos FM/0000-0003-1941-0694; Kobayashi, Gerson Shigeru/0000-0002-6520-5774; Bueno, Daniela F/0000-0001-5932-6134; Sunaga-Franze, Daniele Yumi/0000-0002-6851-9162	CNPq (National Counsel of Technological and Scientific Development); FAPESP (Sao Paulo Research Foundation); CAPES (Higher Education Co-Ordination Agency); MCT (Ministry of Science, Technology and Innovation); BBSRC [BB/G021074/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G021074/1] Funding Source: researchfish	CNPq (National Counsel of Technological and Scientific Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP (Sao Paulo Research Foundation)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES (Higher Education Co-Ordination Agency); MCT (Ministry of Science, Technology and Innovation); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work is funded by CNPq (National Counsel of Technological and Scientific Development), FAPESP (Sao Paulo Research Foundation), CAPES (Higher Education Co-Ordination Agency) and MCT (Ministry of Science, Technology and Innovation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albino D, 2011, INT J DEV BIOL, V55, P65, DOI 10.1387/ijdb.092970da; Alsdorf Rachel, 2005, Expert Opin Drug Saf, V4, P345, DOI 10.1517/14740338.4.2.345; Bahado-Singh RO, 2011, J MATERN-FETAL NEO M, V24, P687, DOI 10.3109/14767058.2010.529970; Baroni T, 2010, J CELL PHYSIOL, V222, P748, DOI 10.1002/jcp.22006; Beaty TH, 2010, NAT GENET, V42, P525, DOI 10.1038/ng.580; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bille C, 2005, AM J EPIDEMIOL, V161, P1047, DOI 10.1093/aje/kwi132; Birnbaum S, 2009, NAT GENET, V41, P473, DOI 10.1038/ng.333; Biswas AK, 2012, CANCER RES, V72, P13, DOI 10.1158/0008-5472.CAN-11-2196; Bliek BJB, 2008, BIRTH DEFECTS RES A, V82, P627, DOI 10.1002/bdra.20488; Borlado LR, 2008, CARCINOGENESIS, V29, P237, DOI 10.1093/carcin/bgm268; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Brito LA, 2011, AM J MED GENET A, V155A, P1581, DOI 10.1002/ajmg.a.34036; Bueno DF, 2011, STEM CELL REV REP, V7, P446, DOI 10.1007/s12015-010-9197-3; Calin G, 1998, CANCER RES, V58, P3777; Cookson W, 2009, NAT REV GENET, V10, P184, DOI 10.1038/nrg2537; Cordero DR, 2011, AM J MED GENET A, V155A, P270, DOI 10.1002/ajmg.a.33702; Costa AD, 2008, J CRANIOFAC SURG, V19, P204, DOI 10.1097/scs.0b013e31815c8a54; Dastjerdi A, 2007, DEV DYNAM, V236, P353, DOI 10.1002/dvdy.21010; Deroo LA, 2008, AM J EPIDEMIOL, V168, P638, DOI 10.1093/aje/kwn186; Dixon K, 2004, SEMIN CANCER BIOL, V14, P441, DOI 10.1016/j.semcancer.2004.06.007; Feng WG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008066; Ferone G, 2012, EMBO MOL MED, V4, P192, DOI 10.1002/emmm.201100199; Gao LB, 2011, BREAST CANCER RES TR, V125, P827, DOI 10.1007/s10549-010-0995-8; Gliszczynska-Swiglo A, 2007, J AGR FOOD CHEM, V55, P8237, DOI 10.1021/jf070986x; Grant SFA, 2009, J PEDIATR-US, V155, P909, DOI 10.1016/j.jpeds.2009.06.020; Greene RM, 2010, BIRTH DEFECTS RES C, V90, P133, DOI 10.1002/bdrc.20180; Helleday T, 2007, DNA REPAIR, V6, P923, DOI 10.1016/j.dnarep.2007.02.006; Huang Xuan, 2006, Methods Mol Biol, V314, P73; Iaquinta PJ, 2007, CURR OPIN CELL BIOL, V19, P649, DOI 10.1016/j.ceb.2007.10.006; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Janebodin K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027526; Jiang RL, 2006, DEV DYNAM, V235, P1152, DOI 10.1002/dvdy.20646; Joshi R, 2001, FREE RADICAL BIO MED, V30, P1390, DOI 10.1016/S0891-5849(01)00543-3; Kachhap SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011208; Komada M, 2012, CONGENIT ANOM, V52, P72, DOI 10.1111/j.1741-4520.2012.00368.x; Kondo S, 2002, NAT GENET, V32, P285, DOI 10.1038/ng985; Krenzlin H, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002557; Kusek JC, 2000, INT J DEV BIOL, V44, P267; Langerak P, 2011, PHILOS T R SOC B, V366, P3562, DOI 10.1098/rstb.2011.0070; Lee WY, 1999, HISTOPATHOLOGY, V34, P106; Leite Isabel Cristina Gonçalves, 2009, Braz. oral res., V23, P31, DOI 10.1590/S1806-83242009000100006; Letauayova L, 2006, DNA REPAIR, V5, P602, DOI 10.1016/j.dnarep.2006.01.004; Letra A, 2012, J DENT RES, V91, P473, DOI 10.1177/0022034512440578; Li HC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007091; Linger RJ, 2010, FEBS J, V277, P3086, DOI 10.1111/j.1742-4658.2010.07735.x; Llorente B, 2008, CELL CYCLE, V7, P859, DOI 10.4161/cc.7.7.5613; Lydeard JR, 2010, GENE DEV, V24, P1133, DOI 10.1101/gad.1922610; Maiorano D, 2006, CURR OPIN CELL BIOL, V18, P130, DOI 10.1016/j.ceb.2006.02.006; Mangold E, 2010, NAT GENET, V42, P24, DOI 10.1038/ng.506; Mao ZY, 2008, DNA REPAIR, V7, P1765, DOI 10.1016/j.dnarep.2008.06.018; Marinucci L, 2009, TOXICOLOGY, V257, P10, DOI 10.1016/j.tox.2008.12.002; Mossey PA, 2009, LANCET, V374, P1773, DOI 10.1016/S0140-6736(09)60695-4; Mueller CR, 2003, BREAST CANCER RES, V5, P45, DOI 10.1186/bcr557; Nulman I, 1997, AM J MED GENET, V68, P18, DOI 10.1002/(SICI)1096-8628(19970110)68:1<18::AID-AJMG4>3.0.CO;2-U; Pardo B, 2009, CELL MOL LIFE SCI, V66, P1039, DOI 10.1007/s00018-009-8740-3; Park SC, 2012, MOL MED REP, V5, P1027, DOI 10.3892/mmr.2012.754; Pezzetti F, 2009, PATHOLOGY, V41, P261, DOI 10.1080/00313020902756899; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Raj A, 2010, NATURE, V463, P913, DOI 10.1038/nature08781; Restivo G, 2011, EMBO J, V30, P4571, DOI 10.1038/emboj.2011.325; Rinne T, 2007, CELL CYCLE, V6, P262, DOI 10.4161/cc.6.3.3796; Rocha CR, 2012, MUTAT RES; Rosen EM, 2006, CANCER LETT, V236, P175, DOI 10.1016/j.canlet.2005.04.037; Saha T, 2010, J BIOL CHEM, V285, P19092, DOI 10.1074/jbc.M110.104430; Seifert M, 2006, J MOL HISTOL, V37, P301, DOI 10.1007/s10735-006-9062-5; Severin J, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r39; Sha K, 2010, BIRTH DEFECTS RES B, V89, P124, DOI 10.1002/bdrb.20236; Sharma R, 2004, ANTIOXID REDOX SIGN, V6, P289, DOI 10.1089/152308604322899350; Taioli E, 2010, CANCER INVEST, V28, P958, DOI 10.3109/07357907.2010.483510; THOMPSON ME, 1995, NAT GENET, V9, P444, DOI 10.1038/ng0495-444; Tung EWY, 2011, MOL PHARMACOL, V80, P979, DOI 10.1124/mol.111.072314; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Uno S, 2011, GENES CELLS, V16, P842, DOI 10.1111/j.1365-2443.2011.01535.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vieira AR, 2012, AM J MED GENET A, V158A, P1503, DOI 10.1002/ajmg.a.35359; Vogelaar IP, 2013, HUM MOL GENET, V22, P919, DOI 10.1093/hmg/dds497; Wang Y, 2000, GENE DEV, V14, P927; Washbourne BJ, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-18; Wehby GL, 2010, ORAL DIS, V16, P11, DOI 10.1111/j.1601-0825.2009.01587.x; Wells PG, 2009, TOXICOL SCI, V108, P4, DOI 10.1093/toxsci/kfn263; Weyemi U, 2012, MUTAT RES-REV MUTAT, V751, P77, DOI 10.1016/j.mrrev.2012.04.002; Winn LM, 2003, J PHARMACOL EXP THER, V306, P523, DOI 10.1124/jpet.103.052639; Yarden RI, 2006, MOL CANCER THER, V5, P1396, DOI 10.1158/1535-7163.MCT-05-0471; Yata K, 2009, DNA REPAIR, V8, P6, DOI 10.1016/j.dnarep.2008.09.002; Yu HM, 2012, NEUROSCI LETT, V529, P166, DOI 10.1016/j.neulet.2012.09.013; Yu WL, 2009, INDIAN J PLAST SURG, V42, pS35, DOI 10.4103/0970-0358.57185; Zhu JL, 2002, BRIT J CANCER, V87, P524, DOI 10.1038/sj.bjc.6600488	88	31	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65677	10.1371/journal.pone.0065677	http://dx.doi.org/10.1371/journal.pone.0065677			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776525	gold, Green Published, Green Submitted			2022-12-27	WOS:000320322400045
J	Silva-Santisteban, MC; Westwood, IM; Boxall, K; Brown, N; Peacock, S; McAndrew, C; Barrie, E; Richards, M; Mirza, A; Oliver, AW; Burke, R; Hoelder, S; Jones, K; Aherne, GW; Blagg, J; Collins, I; Garrett, MD; van Montfort, RLM				Silva-Santisteban, M. Cris; Westwood, Isaac M.; Boxall, Kathy; Brown, Nathan; Peacock, Sam; McAndrew, Craig; Barrie, Elaine; Richards, Meirion; Mirza, Amin; Oliver, Antony W.; Burke, Rosemary; Hoelder, Swen; Jones, Keith; Aherne, G. Wynne; Blagg, Julian; Collins, Ian; Garrett, Michelle D.; van Montfort, Rob L. M.			Fragment-Based Screening Maps Inhibitor Interactions in the ATP-Binding Site of Checkpoint Kinase 2	PLOS ONE			English	Article							DNA-DAMAGE CHECKPOINT; CHK2 PROTEIN-KINASE; SELECTIVE INHIBITOR; CRYSTAL-STRUCTURE; POTENT INHIBITOR; P53; PHOSPHORYLATION; IDENTIFICATION; CANCER; ACTIVATION	Checkpoint kinase 2 (CHK2) is an important serine/threonine kinase in the cellular response to DNA damage. A fragment-based screening campaign using a combination of a high-concentration AlphaScreen (TM) kinase assay and a biophysical thermal shift assay, followed by X-ray crystallography, identified a number of chemically different ligand-efficient CHK2 hinge-binding scaffolds that have not been exploited in known CHK2 inhibitors. In addition, it showed that the use of these orthogonal techniques allowed efficient discrimination between genuine hit matter and false positives from each individual assay technology. Furthermore, the CHK2 crystal structures with a quinoxaline-based fragment and its follow-up compound highlight a hydrophobic area above the hinge region not previously explored in rational CHK2 inhibitor design, but which might be exploited to enhance both potency and selectivity of CHK2 inhibitors.	[Silva-Santisteban, M. Cris; Westwood, Isaac M.; Boxall, Kathy; Brown, Nathan; Peacock, Sam; McAndrew, Craig; Barrie, Elaine; Richards, Meirion; Mirza, Amin; Burke, Rosemary; Hoelder, Swen; Jones, Keith; Aherne, G. Wynne; Blagg, Julian; Collins, Ian; Garrett, Michelle D.; van Montfort, Rob L. M.] Canc Res UK, Canc Therapeut Unit, Div Canc Therapeut, Inst Canc Res,Haddow Labs, Sutton, Surrey, England; [Silva-Santisteban, M. Cris; Westwood, Isaac M.; Oliver, Antony W.; van Montfort, Rob L. M.] Inst Canc Res, Chester Beatty Labs, Div Struct Biol, London SW3 6JB, England	Cancer Research UK; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	van Montfort, RLM (corresponding author), Canc Res UK, Canc Therapeut Unit, Div Canc Therapeut, Inst Canc Res,Haddow Labs, Sutton, Surrey, England.	Rob.vanMontfort@icr.ac.uk	Brown, Nathan/I-7711-2016; Jones, Keith/R-7629-2016; Oliver, Antony W./O-5165-2019	Brown, Nathan/0000-0001-9243-8699; Jones, Keith/0000-0002-9440-4094; Oliver, Antony W./0000-0002-2912-8273	Cancer Research United Kingdom [C309/A8274]; Institute of Cancer Research; National Health Service; Wellcome Trust; Cancer Research UK [11566, 14532] Funding Source: researchfish	Cancer Research United Kingdom(Cancer Research UK); Institute of Cancer Research; National Health Service; Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK)	This work was supported by Cancer Research United Kingdom (http://www.cancerresearchuk.org/) program grant number C309/A8274, The Institute of Cancer Research (www.icr.ac.uk), and National Health Service funding to the National Institute for Health Biomedical Research Centre (http://www.nihr.ac.uk/). MCSS is supported by a Wellcome Trust (www.wellcome.ac.uk) doctoral training program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addie M, 2013, J MED CHEM, V56, P2059, DOI 10.1021/jm301762v; Ahn JY, 2002, J BIOL CHEM, V277, P19389, DOI 10.1074/jbc.M200822200; Ahn JY, 2000, CANCER RES, V60, P5934; Anderson VE, 2011, CANCER RES, V71, P463, DOI 10.1158/0008-5472.CAN-10-1252; Antoni L, 2007, NAT REV CANCER, V7, P925, DOI 10.1038/nrc2251; Arienti KL, 2005, J MED CHEM, V48, P1873, DOI 10.1021/jm0495935; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Blanc E., 2011, BUSTER VERSION 2 11; Blasina A, 2008, MOL CANCER THER, V7, P2394, DOI 10.1158/1535-7163.MCT-07-2391; Boettcher A, 2010, J BIOMOL SCREEN, V15, P1029, DOI 10.1177/1087057110380455; Bruno IJ, 2004, J CHEM INF COMP SCI, V44, P2133, DOI 10.1021/ci049780b; Bruno IJ, 1997, J COMPUT AID MOL DES, V11, P525, DOI 10.1023/A:1007934413448; Busby EC, 2000, CANCER RES, V60, P2108; Caldwell JJ, 2011, J MED CHEM, V54, P580, DOI 10.1021/jm101150b; Carlessi L, 2007, MOL CANCER THER, V6, P935, DOI 10.1158/1535-7163.MCT-06-0567; Chen LH, 2005, EMBO J, V24, P3411, DOI 10.1038/sj.emboj.7600812; Chen P, 2000, CELL, V100, P681, DOI 10.1016/S0092-8674(00)80704-7; Congreve M, 2003, DRUG DISCOV TODAY, V8, P876, DOI 10.1016/S1359-6446(03)02831-9; Congreve M, 2008, J MED CHEM, V51, P3661, DOI 10.1021/jm8000373; Davis BJ, 2013, BIOORG MED CHEM LETT, DOI DOI 10.1016/J.BMCL.2013.1003.1028; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; editor Group CC, 2011, MOE201010 CHEM COMP; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ertl P, 2000, J MED CHEM, V43, P3714, DOI 10.1021/jm000942e; Hajduk PJ, 2007, NAT REV DRUG DISCOV, V6, P211, DOI 10.1038/nrd2220; Hilton S, 2010, BIOORGAN MED CHEM, V18, P4591, DOI 10.1016/j.bmc.2010.05.014; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Hopkins AL, 2004, DRUG DISCOV TODAY, V9, P430, DOI 10.1016/S1359-6446(04)03069-7; Howard S, 2009, J MED CHEM, V52, P379, DOI 10.1021/jm800984v; Hubbard RE, 2011, METHOD ENZYMOL, V493, P509, DOI 10.1016/B978-0-12-381274-2.00020-0; Jobson AG, 2007, MOL PHARMACOL, V72, P876, DOI 10.1124/mol.107.035832; Jobson AG, 2009, J PHARMACOL EXP THER, V331, P816, DOI 10.1124/jpet.109.154997; Kamenecka T, 2009, J BIOL CHEM, V284, P12853, DOI 10.1074/jbc.M809430200; Koster H, 2011, J MED CHEM, V54, P7784, DOI 10.1021/jm200642w; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Larson G, 2007, BIOORG MED CHEM LETT, V17, P172, DOI 10.1016/j.bmcl.2006.09.067; Lee JT, 2010, PIGM CELL MELANOMA R, V23, P820, DOI 10.1111/j.1755-148X.2010.00763.x; Levesque AA, 2007, CARCINOGENESIS, V28, P13, DOI 10.1093/carcin/bgl214; Liddle J, 2009, BIOORG MED CHEM LETT, V19, P2504, DOI 10.1016/j.bmcl.2009.03.034; Lountos GT, 2011, J STRUCT BIOL, V176, P292, DOI 10.1016/j.jsb.2011.09.008; Lountos GT, 2009, PROTEIN SCI, V18, P92, DOI 10.1002/pro.16; Matijssen C, 2012, BIOORGAN MED CHEM, V20, P6630, DOI 10.1016/j.bmc.2012.09.024; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Matthews TP, 2009, J MED CHEM, V52, P4810, DOI 10.1021/jm900314j; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McNeely SC, 2011, MOL CANC THER S1, V10; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Murray CW, 2009, NAT CHEM, V1, P187, DOI [10.1038/NCHEM.217, 10.1038/nchem.217]; Neff DK, 2007, BIOORG MED CHEM LETT, V17, P6467, DOI 10.1016/j.bmcl.2007.09.098; Nettleship Joanne E., 2008, V426, P299, DOI 10.1007/978-1-60327-058-8_19; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Okamoto K, 2005, MOL CELL BIOL, V25, P9608, DOI 10.1128/MCB.25.21.9608-9620.2005; Oliver AW, 2006, EMBO J, V25, P3179, DOI 10.1038/sj.emboj.7601209; Orita M, 2011, METHOD ENZYMOL, V493, P383, DOI 10.1016/B978-0-12-381274-2.00015-7; Oza V, 2012, J MED CHEM, V55, P5130, DOI 10.1021/jm300025r; Pollack SJ, 2011, J COMPUT AID MOL DES, V25, P677, DOI 10.1007/s10822-011-9454-9; Pommier Y, 2006, CLIN CANCER RES, V12, P2657, DOI 10.1158/1078-0432.CCR-06-0743; Pommier Y, 2005, CURR PHARM DESIGN, V11, P2855, DOI 10.2174/1381612054546716; Rees DC, 2004, NAT REV DRUG DISCOV, V3, P660, DOI 10.1038/nrd1467; Riesterer O, 2011, INVEST NEW DRUG, V29, P514, DOI 10.1007/s10637-009-9361-2; Rogers D, 2010, J CHEM INF MODEL, V50, P742, DOI 10.1021/ci100050t; Saleem RSZ, 2012, BIOORGAN MED CHEM, V20, P1475, DOI 10.1016/j.bmc.2011.12.054; Saxty G, 2007, J MED CHEM, V50, P2293, DOI 10.1021/jm070091b; Schulz MN, 2009, CURR OPIN PHARMACOL, V9, P615, DOI 10.1016/j.coph.2009.04.009; Schwarz JK, 2003, MOL CANCER RES, V1, P598; Sharma V, 2004, BIOORG MED CHEM LETT, V14, P4319, DOI 10.1016/j.bmcl.2004.05.079; Smart O. S., 2011, GRADE VERSION 1 1 1; Soussi T, 2000, HUM MUTAT, V15, P105, DOI 10.1002/(SICI)1098-1004(200001)15:1<105::AID-HUMU19>3.0.CO;2-G; Stevens C, 2003, NAT CELL BIOL, V5, P401, DOI 10.1038/ncb974; Takai H, 2002, EMBO J, V21, P5195, DOI 10.1093/emboj/cdf506; Tan YJ, 2007, MOL CELL BIOL, V27, P1007, DOI 10.1128/MCB.01068-06; Tanimoto T.T., 1957, NOV, V17, P1957; Villasenor AG, 2009, CHEM BIOL DRUG DES, V73, P466, DOI 10.1111/j.1747-0285.2009.00785.x; VISWANADHAN VN, 1989, J CHEM INF COMP SCI, V29, P163, DOI 10.1021/ci00063a006; von Leoprechting A, 2004, J BIOMOL SCREEN, V9, P719, DOI 10.1177/1087057104268805; Wielens J, 2013, J BIOMOL SCREEN, V18, P147, DOI 10.1177/1087057112465979; Wu W, 2012, CANC RES S1, V72; Wu XL, 2003, J BIOL CHEM, V278, P36163, DOI 10.1074/jbc.M303795200; Wyatt PG, 2008, J MED CHEM, V51, P4986, DOI 10.1021/jm800382h; Yu Q, 2002, CANCER RES, V62, P5743; Zabludoff SD, 2008, MOL CANCER THER, V7, P2955, DOI 10.1158/1535-7163.MCT-08-0492; Zhang JR, 2004, MOL CELL BIOL, V24, P708, DOI 10.1128/MCB.24.2.708-718.2004	83	14	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65689	10.1371/journal.pone.0065689	http://dx.doi.org/10.1371/journal.pone.0065689			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776527	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000320322400046
J	Chang, AN; Huang, J; Battiprolu, PK; Hill, JA; Kamm, KE; Stull, JT				Chang, Audrey N.; Huang, Jian; Battiprolu, Pavan K.; Hill, Joseph A.; Kamm, Kristine E.; Stull, James T.			The Effects of Neuregulin on Cardiac Myosin Light Chain Kinase Gene-Ablated Hearts	PLOS ONE			English	Article							CARDIOMYOCYTE PROLIFERATION; PHOSPHORYLATION; HYPERTROPHY; FAILURE; CAMKII; MICE; ACTIVATION; KINETICS; DISEASE; MODELS	Background: Activation of ErbB2/4 receptor tyrosine kinases in cardiomyocytes by neuregulin treatment is associated with improvement in cardiac function, supporting its use in human patients with heart failure despite the lack of a specific mechanism. Neuregulin infusion in rodents increases cardiac myosin light chain kinase (cMLCK) expression and cardiac myosin regulatory light chain (RLC) phosphorylation which may improve actin-myosin interactions for contraction. We generated a cMLCK knockout mouse to test the hypothesis that cMLCK is necessary for neuregulin-induced improvement in cardiac function by increasing RLC phosphorylation. Principal Findings: The cMLCK knockout mice have attenuated RLC phosphorylation and decreased cardiac performance measured as fractional shortening. Neuregulin infusion for seven days in wildtype mice increased cardiac cMLCK protein expression and RLC phosphorylation while increasing Akt phosphorylation and decreasing phospholamban phosphorylation. There was no change in fractional shortening. In contrast, neuregulin infusion in cMLCK knockout animals increased cardiac performance in the absence of cMLCK without increasing RLC phosphorylation. In addition, CaMKII signaling appeared to be enhanced in neuregulin-treated knockout mice. Conclusions: Thus, Neuregulin may improve cardiac performance in the failing heart without increasing cMLCK and RLC phosphorylation by activating other signaling pathways.	[Chang, Audrey N.; Huang, Jian; Kamm, Kristine E.; Stull, James T.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Battiprolu, Pavan K.; Hill, Joseph A.] Univ Texas SW Med Ctr Dallas, Dept Internal Med Cardiol, Dallas, TX 75390 USA; [Hill, Joseph A.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Chang, AN (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA.	audreyn.chang@utsouthwestern.edu			National Institutes of Health [HL080536, HL026043, HL007360-31]; Moss Heart Fund; Fouad A. and Val Imm Bashour Distinguished Chair in Physiology; American Heart Association; American Diabetes Association Mentor-Based Postdoctoral Fellowship [7-08-MN-21-ADA];  [HL-075173];  [HL-080144];  [HL-090842]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL026043, R37HL026043, T32HL007360, R01HL090842, R01HL075173, R01HL080144, R01HL080536] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Moss Heart Fund; Fouad A. and Val Imm Bashour Distinguished Chair in Physiology; American Heart Association(American Heart Association); American Diabetes Association Mentor-Based Postdoctoral Fellowship(American Diabetes Association); ; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL080536 and HL026043, grants from the Moss Heart Fund and the Fouad A. and Val Imm Bashour Distinguished Chair in Physiology (J. T. Stull.); National Institutes of Health Postdoctoral Fellowship HL007360-31 and a postdoctoral fellowship from the American Heart Association (A. N. Chang); HL-075173, HL-080144, and HL-090842 (J.A. Hill); and American Diabetes Association Mentor-Based Postdoctoral Fellowship 7-08-MN-21-ADA (J.A. Hill and P.K. Battiprolu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ME, 2011, J MOL CELL CARDIOL, V51, P468, DOI 10.1016/j.yjmcc.2011.01.012; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Bian Y, 2009, AM J PHYSIOL-HEART C, V297, pH1974, DOI 10.1152/ajpheart.01010.2008; Chaanine AH, 2011, EUR J HEART FAIL, V13, P825, DOI 10.1093/eurjhf/hfr080; Chan JY, 2008, CIRC RES, V102, P571, DOI 10.1161/CIRCRESAHA.107.161687; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Collins KA, 2001, AM J PHYSIOL-HEART C, V280, pH1954, DOI 10.1152/ajpheart.2001.280.5.H1954; Ding PG, 2010, J BIOL CHEM, V285, P40819, DOI 10.1074/jbc.M110.160499; Gu XH, 2010, CARDIOVASC RES, V88, P334, DOI 10.1093/cvr/cvq223; Huang J, 2008, J BIOL CHEM, V283, P19748, DOI 10.1074/jbc.M802605200; KAMM KE, 1989, J BIOL CHEM, V264, P21223; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; Kamm KE, 2011, J BIOL CHEM, V286, P9941, DOI 10.1074/jbc.R110.198697; Kranias EG, 2012, CIRC RES, V110, P1646, DOI 10.1161/CIRCRESAHA.111.259754; Kuramochi Y, 2006, J MOL CELL CARDIOL, V41, P228, DOI 10.1016/j.yjmcc.2006.04.007; Lemmens K, 2007, CIRCULATION, V116, P954, DOI 10.1161/CIRCULATIONAHA.107.690487; Liu XF, 2006, J AM COLL CARDIOL, V48, P1438, DOI 10.1016/j.jacc.2006.05.057; Mattiazzi A, 2005, CARDIOVASC RES, V68, P366, DOI 10.1016/j.cardiores.2005.08.010; Mishra S, 2011, CIRC RES, V109, P1354, DOI 10.1161/CIRCRESAHA.111.248401; Olsson MC, 2004, AM J PHYSIOL-HEART C, V287, pH2712, DOI 10.1152/ajpheart.01067.2003; Pentassuglia L, 2009, EXP CELL RES, V315, P627, DOI 10.1016/j.yexcr.2008.08.015; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; Sanbe A, 1999, J BIOL CHEM, V274, P21085, DOI 10.1074/jbc.274.30.21085; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; Scruggs SB, 2009, J BIOL CHEM, V284, P5097, DOI 10.1074/jbc.M807414200; Seguchi O, 2007, J CLIN INVEST, V117, P2812, DOI 10.1172/JCI30804; Sheikh F, 2012, J CLIN INVEST, V122, P1209, DOI 10.1172/JCI61134; Stelzer JE, 2006, J GEN PHYSIOL, V128, P261, DOI 10.1085/jgp.200609547; Wadugu B, 2012, AM J PHYSIOL-HEART C, V302, pH2139, DOI 10.1152/ajpheart.00063.2012; Warren SA, 2012, CIRCULATION, V126, P2575, DOI 10.1161/CIRCULATIONAHA.112.116202; Zhang T, 2003, CIRC RES, V92, P912, DOI 10.1161/01.RES.0000069686.31472.C5	31	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66720	10.1371/journal.pone.0066720	http://dx.doi.org/10.1371/journal.pone.0066720			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776695	Green Published, Green Submitted, gold			2022-12-27	WOS:000320755400154
J	Ghatak, A; Willocquet, L; Savary, S; Kumar, J				Ghatak, Abhijeet; Willocquet, Laetitia; Savary, Serge; Kumar, Jatinder			Variability in Aggressiveness of Rice Blast (Magnaporthe oryzae) Isolates Originating from Rice Leaves and Necks: A Case of Pathogen Specialization?	PLOS ONE			English	Article							PYRICULARIA-ORYZAE; PARTIAL RESISTANCE; DYNAMICS; LEAF	Rice blast, caused by Magnaporthe oryzae, causes yield losses associated with injuries on leaves and necks, the latter being in general far more important than the former. Many questions remain on the relationships between leaf and neck blast, including questions related to the population biology of the pathogen. Our objective was to test the hypothesis of adaptation of M. oryzae isolates to the type of organ they infect. To that aim, the components of aggressiveness of isolates originating from leaves and necks were measured. Infection efficiency, latent period, sporulation intensity, and lesion size were measured on both leaves and necks. Univariate and multivariate analyses indicated that isolates originating from leaves were less aggressive than isolates originating from necks, when aggressiveness components were measured on leaves as well as on necks, indicating that there is no specialization within the pathogen population with respect to the type of organ infected. This result suggests that the more aggressive isolates involved in epidemics on leaves during the vegetative stage of the crop cycle have a higher probability to infect necks, and that a population shift may occur during disease transmission from leaves to necks. Implications for disease management are discussed.	[Ghatak, Abhijeet; Willocquet, Laetitia; Savary, Serge] Int Rice Res Inst, Plant Breeding Genet & Biotechnol Div, Los Banos, Philippines; [Ghatak, Abhijeet; Kumar, Jatinder] GBPUAT, Dept Plant Pathol, Pantnagar, Uttarakhand, India; [Willocquet, Laetitia; Savary, Serge] INRA, Unite Mixte Rech Agrosyst & Agr Gest Ressources I, F-31326 Castanet Tolosan, France; [Willocquet, Laetitia; Savary, Serge] INPT, Castanet Tolosan, France	CGIAR; International Rice Research Institute (IRRI); Govind Ballabh Pant University of Agriculture Technology; INRAE; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite de Toulouse; Institut National Polytechnique de Toulouse	Willocquet, L (corresponding author), Int Rice Res Inst, Plant Breeding Genet & Biotechnol Div, Los Banos, Philippines.	Laetitia.Willocquet@toulouse.inra.fr		Ghatak, Abhijeet/0000-0001-8684-7402	IRRI core budget; Bill and Melinda Gates Foundation under the Cereal System Initiative for South Asia Project	IRRI core budget; Bill and Melinda Gates Foundation under the Cereal System Initiative for South Asia Project	This work was partly supported by IRRI core budget. Additional funds were provided by the Bill and Melinda Gates Foundation under the Cereal System Initiative for South Asia Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1979, EPIDEMIOLOGY PLANT D; BONMAN JM, 1992, EUPHYTICA, V63, P115, DOI 10.1007/BF00023917; BONMAN JM, 1989, PLANT DIS, V73, P388, DOI 10.1094/PD-73-0388; Couch BC, 2002, MYCOLOGIA, V94, P683, DOI 10.2307/3761719; Flier WG, 1999, EUR J PLANT PATHOL, V105, P381, DOI 10.1023/A:1008737222830; French R, 2003, ANNU REV PHYTOPATHOL, V41, P199, DOI 10.1146/annurev.phyto.41.052002.095559; GREGORY PH, 1948, ANN APPL BIOL, V35, P412, DOI 10.1111/j.1744-7348.1948.tb07385.x; KATO H, 1970, PHYTOPATHOLOGY, V60, P608, DOI 10.1094/Phyto-60-608; KATO H, 1974, PHYTOPATHOLOGY, V64, P828, DOI 10.1094/Phyto-64-828; Kim C. K., 1983, Korean Journal of Plant Protection, V22, P287; Kumar J, 1999, GENETICS, V152, P971; Ou S H, 1987, RICE DIS; PINNSCHMIDT HO, 1994, RICE BLAST DISEASE, P381; ROUMEN EC, 1992, EUPHYTICA, V64, P173, DOI 10.1007/BF00046046; ROUMEN EC, 1993, EUPHYTICA, V69, P185, DOI 10.1007/BF00022364; ROYER MH, 1984, PHYTOPATHOLOGY, V74, P1001, DOI 10.1094/Phyto-74-1001; Sacristan S, 2011, J VIROL, V85, P4974, DOI 10.1128/JVI.00057-11; Savary S, 2000, PLANT DIS, V84, P357, DOI 10.1094/PDIS.2000.84.3.357; Savary S, 2009, PHYTOPATHOLOGY, V99, P930, DOI 10.1094/PHYTO-99-8-0930; YEH WH, 1986, PLANT PATHOL, V35, P319, DOI 10.1111/j.1365-3059.1986.tb02021.x	21	23	25	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66180	10.1371/journal.pone.0066180	http://dx.doi.org/10.1371/journal.pone.0066180			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776629	Green Submitted, gold, Green Published			2022-12-27	WOS:000320755400118
J	Li, S; Zhang, YJ; Sack, L; Scoffoni, C; Ishida, A; Chen, YJ; Cao, KF				Li, Shuai; Zhang, Yong-Jiang; Sack, Lawren; Scoffoni, Christine; Ishida, Atsushi; Chen, Ya-Jun; Cao, Kun-Fang			The Heterogeneity and Spatial Patterning of Structure and Physiology across the Leaf Surface in Giant Leaves of Alocasia macrorrhiza	PLOS ONE			English	Article							GAS-EXCHANGE; HYDRAULIC ARCHITECTURE; STOMATAL DENSITY; VENATION ARCHITECTURE; HIGH-TEMPERATURE; BANANA LEAVES; WATER-FLOW; EVOLUTION; SIZE; PHOTOINHIBITION	Leaf physiology determines the carbon acquisition of the whole plant, but there can be considerable variation in physiology and carbon acquisition within individual leaves. Alocasia macrorrhiza (L.) Schott is an herbaceous species that can develop very large leaves of up to 1 m in length. However, little is known about the hydraulic and photosynthetic design of such giant leaves. Based on previous studies of smaller leaves, and on the greater surface area for trait variation in large leaves, we hypothesized that A. macrorrhiza leaves would exhibit significant heterogeneity in structure and function. We found evidence of reduced hydraulic supply and demand in the outer leaf regions; leaf mass per area, chlorophyll concentration, and guard cell length decreased, as did stomatal conductance, net photosynthetic rate and quantum efficiency of photosystem II. This heterogeneity in physiology was opposite to that expected from a thinner boundary layer at the leaf edge, which would have led to greater rates of gas exchange. Leaf temperature was 8.8 degrees C higher in the outer than in the central region in the afternoon, consistent with reduced stomatal conductance and transpiration caused by a hydraulic limitation to the outer lamina. The reduced stomatal conductance in the outer regions would explain the observed homogeneous distribution of leaf water potential across the leaf surface. These findings indicate substantial heterogeneity in gas exchange across the leaf surface in large leaves, greater than that reported for smaller-leafed species, though the observed structural differences across the lamina were within the range reported for smaller-leafed species. Future work will determine whether the challenge of transporting water to the outer regions can limit leaf size for plants experiencing drought, and whether the heterogeneity of function across the leaf surface represents a particular disadvantage for large simple leaves that might explain their global rarity, even in resource-rich environments.	[Li, Shuai] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui Province, Peoples R China; [Li, Shuai; Zhang, Yong-Jiang; Chen, Ya-Jun; Cao, Kun-Fang] Chinese Acad Sci, Key Lab Trop Forest Ecol, Xishuangbanna Trop Bot Garden, Mengla, Yunnan Province, Peoples R China; [Zhang, Yong-Jiang] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Sack, Lawren; Scoffoni, Christine] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA; [Ishida, Atsushi] Kyoto Univ, Ctr Ecol Res, Otsu, Shiga, Japan; [Chen, Ya-Jun] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Cao, Kun-Fang] Guangxi Univ, Key Lab, Minist Educ Microbial & Plant Genet Engn, State Key Lab Conservat & Utilizat Subtrop Agrobi, Nanning 530004, Guangxi Provinc, Peoples R China; [Cao, Kun-Fang] Guangxi Univ, Coll Forestry, Nanning 530004, Guangxi Provinc, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Harvard University; University of California System; University of California Los Angeles; Kyoto University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Guangxi University; Guangxi University	Cao, KF (corresponding author), Chinese Acad Sci, Key Lab Trop Forest Ecol, Xishuangbanna Trop Bot Garden, Mengla, Yunnan Province, Peoples R China.	caokf@xtbg.ac.cn	Cao, Kun-Fang/D-2157-2009; Sack, Lawren/A-5492-2008	Cao, Kun-Fang/0000-0002-2253-7189; Sack, Lawren/0000-0002-7009-7202; Zhang, Yongjiang/0000-0001-5637-3015; Ishida, Atsushi/0000-0003-0620-5819; Li, Shuai/0000-0003-2545-7763	National Natural Science Foundation of China [31170399]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (Grant NO.31170399). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affek HP, 2006, NEW PHYTOL, V169, P321, DOI 10.1111/j.1469-8137.2005.01603.x; Aldea M, 2005, PLANT CELL ENVIRON, V28, P402, DOI 10.1111/j.1365-3040.2005.01279.x; Aldea M, 2006, OECOLOGIA, V149, P221, DOI 10.1007/s00442-006-0444-x; BIMOVA A, 1992, BIOL PLANTARUM, V34, P475, DOI 10.1007/BF02923606; Boyce CK, 2005, PALEOBIOLOGY, V31, P117, DOI 10.1666/0094-8373(2005)031&lt;0117:POSACI&gt;2.0.CO;2; Boyce CK, 2002, PALEOBIOLOGY, V28, P70, DOI 10.1666/0094-8373(2002)028&lt;0070:EODPAT&gt;2.0.CO;2; Bragg JG, 2002, FUNCT ECOL, V16, P633, DOI 10.1046/j.1365-2435.2002.00661.x; Brodribb TJ, 2007, PLANT PHYSIOL, V144, P1890, DOI 10.1104/pp.107.101352; Brodribb TJ, 2010, FUNCT PLANT BIOL, V37, P488, DOI 10.1071/FP10010; Brodribb TJ, 2003, NEW PHYTOL, V158, P295, DOI 10.1046/j.1469-8137.2003.00736.x; BROWN VK, 1991, PHILOS T R SOC B, V333, P265, DOI 10.1098/rstb.1991.0076; Buckley TN, 2011, PLANT PHYSIOL, V156, P962, DOI 10.1104/pp.111.175638; Cochard H, 2004, PLANT CELL ENVIRON, V27, P1257, DOI 10.1111/j.1365-3040.2004.01233.x; Coomes DA, 2007, BIOL LETTERS, V3, P86, DOI 10.1098/rsbl.2006.0551; Crafts-Brandner SJ, 2000, P NATL ACAD SCI USA, V97, P13430, DOI 10.1073/pnas.230451497; Delaney KJ, 2006, PLANT CELL ENVIRON, V29, P1245, DOI 10.1111/j.1365-3040.2006.01504.x; Dunbar-Co S, 2009, INT J PLANT SCI, V170, P61, DOI 10.1086/593111; GAMON JA, 1990, PLANT CELL ENVIRON, V13, P267, DOI 10.1111/j.1365-3040.1990.tb01311.x; Guilioni L, 2008, AGR FOREST METEOROL, V148, P1908, DOI 10.1016/j.agrformet.2008.07.009; Hohmann-Marriott MF, 2011, ANNU REV PLANT BIOL, V62, P515, DOI 10.1146/annurev-arplant-042110-103811; Inoue N, 2001, PLANT CELL PHYSIOL, V42, P1140, DOI 10.1093/pcp/pce147; Ishida A, 1999, TREE PHYSIOL, V19, P117; Ishida A, 2001, TREE PHYSIOL, V21, P497, DOI 10.1093/treephys/21.8.497; KATOH S, 1967, ARCH BIOCHEM BIOPHYS, V122, P144, DOI 10.1016/0003-9861(67)90133-6; Koch GW, 2004, NATURE, V428, P851, DOI 10.1038/nature02417; Koniger M, 1998, PLANTA, V205, P214, DOI 10.1007/s004250050314; Lawson T, 1999, J EXP BOT, V50, P1381, DOI 10.1093/jexbot/50.337.1381; Martre P, 2000, NEW PHYTOL, V146, P235, DOI 10.1046/j.1469-8137.2000.00641.x; Martre P, 2001, PLANT CELL ENVIRON, V24, P65, DOI 10.1046/j.1365-3040.2001.00657.x; Martre P, 2001, INT J PLANT SCI, V162, P755, DOI 10.1086/320786; McKown AD, 2010, AM NAT, V175, P447, DOI 10.1086/650721; MIRANDA V, 1981, NEW PHYTOL, V89, P179, DOI 10.1111/j.1469-8137.1981.tb07481.x; Moller M, 2007, J EXP BOT, V58, P827, DOI 10.1093/jxb/erl115; MULKEY SS, 1992, FUNCT ECOL, V6, P719, DOI 10.2307/2389969; Nardini A, 2008, PLANT CELL ENVIRON, V31, P804, DOI 10.1111/j.1365-3040.2008.01798.x; Nardini A, 2010, PLANT CELL ENVIRON, V33, P1091, DOI 10.1111/j.1365-3040.2010.02131.x; Nicotra AB, 2011, FUNCT PLANT BIOL, V38, P535, DOI 10.1071/FP11057; Niinemets U, 2007, FUNCT ECOL, V21, P28, DOI 10.1111/j.1365-2435.2006.01221.x; Niinemets U, 2006, NEW PHYTOL, V171, P91, DOI 10.1111/j.1469-8137.2006.01741.x; NOBEL PS, 1975, J EXP BOT, V26, P120, DOI 10.1093/jxb/26.1.120; Ocheltree TW, 2012, PLANT CELL ENVIRON, V35, P1040, DOI 10.1111/j.1365-3040.2011.02470.x; PARKHURST DF, 1972, J ECOL, V60, P505, DOI 10.2307/2258359; Peppe DJ, 2011, NEW PHYTOL, V190, P724, DOI 10.1111/j.1469-8137.2010.03615.x; Poole I, 1996, PLANT CELL ENVIRON, V19, P705, DOI 10.1111/j.1365-3040.1996.tb00405.x; Powles JE, 2006, PLANT CELL ENVIRON, V29, P981, DOI 10.1111/j.1365-3040.2005.01491.x; Raven JA, 2009, FUNCT PLANT BIOL, V36, P505, DOI 10.1071/FP09087; RAWSON HM, 1987, AUST J PLANT PHYSIOL, V14, P287, DOI 10.1071/PP9870287; ROWLANDBAMFORD AJ, 1990, ENVIRON EXP BOT, V30, P175, DOI 10.1016/0098-8472(90)90062-9; Sack L, 2003, PLANT CELL ENVIRON, V26, P1343, DOI 10.1046/j.0016-8025.2003.01058.x; Sack L, 2006, ECOLOGY, V87, P483, DOI 10.1890/05-0710; Sack L, 2004, PLANT PHYSIOL, V134, P1824, DOI 10.1104/pp.103.031203; Sack L, 2003, PLANT ECOL, V168, P139, DOI 10.1023/A:1024423820136; Sack L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1835; Sack L, 2013, NEW PHYTOL, V198, P983, DOI 10.1111/nph.12253; Salisbury EJ, 1928, PHILOS T R SOC LON B, V216, P1, DOI 10.1098/rstb.1928.0001; SCHUEPP PH, 1993, NEW PHYTOL, V125, P477, DOI 10.1111/j.1469-8137.1993.tb03898.x; Scoffoni C, 2011, PLANT PHYSIOL, V156, P832, DOI 10.1104/pp.111.173856; Shapira O, 2013, PLANT CELL ENVIRON, V36, P275, DOI 10.1111/j.1365-3040.2012.02572.x; Shapira O, 2009, PLANT CELL ENVIRON, V32, P476, DOI 10.1111/j.1365-3040.2009.01941.x; SLAVIK B, 1963, BIOL PLANTARUM, V5, P143, DOI 10.1007/BF02933646; Sperdouli I, 2012, PLANT BIOLOGY, V14, P118, DOI 10.1111/j.1438-8677.2011.00473.x; Sperry JS, 2003, INT J PLANT SCI, V164, pS115, DOI 10.1086/368398; TERASHIMA I, 1992, PHOTOSYNTH RES, V31, P195, DOI 10.1007/BF00035537; Trifilo P, 2003, PHYSIOL PLANTARUM, V119, P409, DOI 10.1034/j.1399-3054.2003.00154.x; Vogel S, 2009, NEW PHYTOL, V183, P13, DOI 10.1111/j.1469-8137.2009.02854.x; White JW, 2005, FIELD CROP RES, V91, P7, DOI 10.1016/j.fcr.2004.05.001; WIEBE HH, 1977, PLANT PHYSIOL, V59, P256, DOI 10.1104/pp.59.2.256; Woodruff DR, 2009, TREE PHYSIOL, V29, P261, DOI 10.1093/treephys/tpn024; Yamane Y, 1998, PHOTOSYNTH RES, V57, P51, DOI 10.1023/A:1006019102619; Zhang YJ, 2009, PLANT CELL ENVIRON, V32, P1456, DOI 10.1111/j.1365-3040.2009.02012.x; Zwieniecki MA, 2004, PLANT CELL ENVIRON, V27, P357, DOI 10.1111/j.1365-3040.2003.01153.x	71	23	25	8	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66016	10.1371/journal.pone.0066016	http://dx.doi.org/10.1371/journal.pone.0066016			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776594	Green Published, gold, Green Submitted			2022-12-27	WOS:000320755400100
J	Wang, Y; Yang, X; Zheng, Y; Wu, ZH; Zhang, XA; Li, QP; He, XY; Wang, CZ; Feng, ZC				Wang, Yan; Yang, Xiao; Zheng, Yong; Wu, Zhi-Hao; Zhang, Xiao-Ai; Li, Qiu-Ping; He, Xi-Yu; Wang, Chun-Zhi; Feng, Zhi-Chun			The SEPS1 G-105A Polymorphism Is Associated with Risk of Spontaneous Preterm Birth in a Chinese Population	PLOS ONE			English	Article							PREMATURE RUPTURE; DISEASE; MEMBRANES	Inflammation plays an important role in the etiology and pathophysiology of spontaneous preterm birth (SPTB), and selenoprotein S (SEPS1) is involved in regulating the inflammatory response. Recently the G-105A promoter polymorphism in SEPS1 was shown to increase pro-inflammatory cytokine expression. We examined whether this functional polymorphism was related to the risk of SPTB in a Chinese population. We also examined the impact of premature rupture of membranes (PROM) on susceptibility to SPTB. The SEPS1 G-105A polymorphism was genotyped in 569 preterm singleton neonates and 673 term neonates by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis. chi(2) tests and logistic regression analyses were used to calculate the odds ratios (ORs) and 95% confidence intervals (95% CIs). We observed that, compared with the GG genotype, -105A positive genotypes (GA + AA genotypes) were associated with significantly increased susceptibility to SPTB (adjusted OR, 1.87; 95% CI, 1.36-2.57; P<0.001). The -105A positive genotypes were also significantly associated with increased susceptibility to SPTB, both in the patients with PROM (adjusted OR, 2.65; 95% CI, 1.73-4.03; P<0.001) and in those without PROM (adjusted OR, 1.56; 95% CI, 1.09-2.24; P = 0.015). The -105A positive genotypes were also significantly associated with increased susceptibility to SPTB between extremely preterm neonates and controls (adjusted OR, 4.46; 95% CI, 1.86-10.73; P = 0.002) and between moderately preterm neonates and controls (adjusted OR, 1.76; 95% CI, 1.25-2.47; P = 0.001). Our findings suggest that the SEPS1 G-105A polymorphism contributes to the risk of developing SPTB in a Chinese population.	[Wang, Yan; Yang, Xiao; Li, Qiu-Ping; He, Xi-Yu; Wang, Chun-Zhi; Feng, Zhi-Chun] Gen Mil Hosp Beijing PLA, BaYi Childrens Hosp, Beijing, Peoples R China; [Wu, Zhi-Hao] Beijing Inst Dis Control & Prevent, Dept Infect Dis Control, Beijing, Peoples R China; [Zhang, Xiao-Ai] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China	Beijing Institute of Microbiology & Epidemiology	Wang, CZ (corresponding author), Gen Mil Hosp Beijing PLA, BaYi Childrens Hosp, Beijing, Peoples R China.	wczzy@126.com; zhichunfeng81@163.com		Liu, Wei/0000-0002-9302-8170	National Natural Science Foundation of China [30973210, 81170602]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (30973210 and 81170602). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanne M, 2007, HUM GENET, V122, P355, DOI 10.1007/s00439-007-0402-7; Anum EA, 2009, PEDIATR RES, V65, P1, DOI 10.1203/PDR.0b013e31818912e7; Chim SSC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034328; Curran JE, 2005, NAT GENET, V37, P1234, DOI 10.1038/ng1655; Day LJ, 2011, REPROD SCI, V18, P286, DOI 10.1177/1933719110391277; Engel SAM, 2005, EPIDEMIOLOGY, V16, P469, DOI 10.1097/01.ede.0000164539.09250.31; Goepfert AR, 2004, OBSTET GYNECOL, V104, P777, DOI 10.1097/01.AOG.0000139836.47777.6d; Graves SW, 2011, AM J OBSTET GYNECOL, V204, pS46, DOI 10.1016/j.ajog.2010.09.021; Gulati S, 2012, J MATERN-FETAL NEO M, V25, P1428, DOI 10.3109/14767058.2011.638952; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Kim KW, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.06.040; Krediet TG, 2007, PEDIATR RES, V62, P474, DOI 10.1203/PDR.0b013e31813c9401; Lee SY, 2011, J IMMUNOL, V186, P3226, DOI 10.4049/jimmunol.1003587; Meplan C, 2010, CARCINOGENESIS, V31, P1074, DOI 10.1093/carcin/bgq076; Moses EK, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.09.024; Moura E, 2009, J REPROD IMMUNOL, V80, P115, DOI 10.1016/j.jri.2008.11.007; Nold C, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.12.036; Olsson M, 2011, METABOLISM, V60, P114, DOI 10.1016/j.metabol.2010.05.011; Parry S, 1998, NEW ENGL J MED, V338, P663, DOI 10.1056/NEJM199803053381006; Pereyra Silvana, 2012, BMC Res Notes, V5, P69, DOI 10.1186/1756-0500-5-69; Rey G, 2008, MOL HUM REPROD, V14, P555, DOI 10.1093/molehr/gan049; Ruiz RJ, 2012, J PERINATOL, V32, P483, DOI 10.1038/jp.2011.193; Sata F, 2009, MOL HUM REPROD, V15, P121, DOI 10.1093/molehr/gan078; Shibata T, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-2; Sutherland A, 2010, GENES NUTR, V5, P215, DOI 10.1007/s12263-010-0176-8; Varner MW, 2005, BJOG-INT J OBSTET GY, V112, P28, DOI 10.1111/j.1471-0528.2005.00581.x; Weiner CP, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.02.034; Winkvist A, 1998, INT J EPIDEMIOL, V27, P248, DOI 10.1093/ije/27.2.248; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Yilmaz Y, 2012, DNA CELL BIOL, V31, P92, DOI 10.1089/dna.2010.1169; Zhao XL, 2012, LANCET, V380, P1144, DOI 10.1016/S0140-6736(12)61661-4	31	5	12	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65657	10.1371/journal.pone.0065657	http://dx.doi.org/10.1371/journal.pone.0065657			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776519	Green Published, Green Submitted, gold			2022-12-27	WOS:000320755400053
J	Gu, L; Xie, J; Long, JX; Chen, Q; Chen, Q; Pan, RD; Yan, Y; Wu, GL; Liang, BY; Tan, JJ; Xie, XF; Wei, B; Su, L				Gu, Lian; Xie, Juanjuan; Long, Jianxiong; Chen, Qing; Chen, Qiang; Pan, Runde; Yan, Yan; Wu, Guangliang; Liang, Baoyun; Tan, Jinjing; Xie, Xinfeng; Wei, Bo; Su, Li			Epidemiology of Major Depressive Disorder in Mainland China: A Systematic Review	PLOS ONE			English	Article							NATIONAL-COMORBIDITY-SURVEY; COMMON MENTAL-DISORDERS; PSYCHIATRIC-DISORDERS; 12-MONTH PREVALENCE; UNITED-STATES; METROPOLITAN CHINA; GENERAL-POPULATION; GENDER-DIFFERENCES; HEALTH SURVEYS; GLOBAL BURDEN	Background: Major depressive disorder (MDD) is one of the important causes of disease burden in the general population. Given the experiencing rapid economic and social changes since the early 1990s and the internationally recognized diagnostic criteria and interview instruments across the surveys during 2001-2010 in china, the epidemiological studies on MDD got varied results. We performed this meta-analysis to investigate current, 12-month and lifetime prevalence rates of MDD in mainland China. Methods: PubMed, Embase, Chinese Biological Medical Literature database (CBM), Chinese National Knowledge Infrastructure database (CNKI), and the Chinese Wanfang and Chongqing VIP database were searched for associated studies. We estimated the overall prevalence of MDD using meta-analysis. Conclusions: Seventeen eligible studies were included. Our study showed that the overall estimation of current, 12-month and lifetime prevalence of MDD was 1.6, 2.3, 3.3%, respectively. The current prevalence was 2.0 and 1.7% in rural and urban areas, respectively; between female and male, it was 2.1 and 1.3%, respectively. In addition, the current prevalence of MDD diagnosed with SCID (Structured Clinical Interview for DSM-IV) was 1.8% and that diagnosed with CIDI (Composite International Diagnostic Interview) was 1.1%. In conclusion, our study revealed a relatively high prevalence rate in the lifetime prevalence of MDD. For current prevalence, MDD diagnosed with SCID had a higher prevalence rate than with CIDI; males showed a lower rate than females, rural residents seemed to have a greater risk of MDD than urban residents.	[Gu, Lian; Xie, Juanjuan; Chen, Qing; Yan, Yan; Wu, Guangliang; Liang, Baoyun; Tan, Jinjing] Guangxi Univ Chinese Med, Affiliated Hosp 1, Dept Internal Neurol, Nanning, Guangxi, Peoples R China; [Long, Jianxiong; Wei, Bo; Su, Li] Guangxi Med Univ, Sch Publ Hlth, Nanning, Guangxi, Peoples R China; [Chen, Qing; Chen, Qiang; Xie, Xinfeng] Guangxi Brain Hosp, Liuzhou, Guangxi, Peoples R China	Guangxi University of Chinese Medicine; Guangxi Medical University	Wei, B (corresponding author), Guangxi Med Univ, Sch Publ Hlth, Nanning, Guangxi, Peoples R China.	weibogx@163.com; suli318@yahoo.cn		Gu, Lian/0000-0002-5865-7940; su, li/0000-0002-1435-9669	Guangxi National Natural Science Foundation [2012GXNSFAA053089]; Guangxi Natural Science Foundation [0991110]; National Natural Science Foundation of China [30660051, 81060244, 81260594]; significant scientific research foundation of the Guangxi health department [200933]; Science and technology project of Traditional Chinese Medicine, Guangxi [GZKZ1107]	Guangxi National Natural Science Foundation(National Natural Science Foundation of Guangxi Province); Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); significant scientific research foundation of the Guangxi health department; Science and technology project of Traditional Chinese Medicine, Guangxi	Guangxi National Natural Science Foundation (grant number 2012GXNSFAA053089), Guangxi Natural Science Foundation (Guikezi 0991110), National Natural Science Foundation of China (grant numbers 30660051, 81060244, 81260594), the significant scientific research foundation of the Guangxi health department (number 200933), Science and technology project of Traditional Chinese Medicine, Guangxi (number GZKZ1107). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadvand A, 2012, ARCH IRAN MED, V15, P205, DOI 012154/AIM.006; Andrade L, 2003, INT J METH PSYCH RES, V12, P3, DOI 10.1002/mpr.138; BLAZER DG, 1994, AM J PSYCHIAT, V151, P979; Bromet E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-90; Chen X, 2012, PSYCHIAT RES; Desai H D, 2000, J Am Pharm Assoc (Wash), V40, P525; [丁志杰 DING Zhi-Jie], 2010, [中国心理卫生杂志, Chinese Mental Health Journal], V24, P183; [段卫东 Duan Weidong], 2010, [中华精神科杂志, Chinese Journal of Psychiatry], V43, P211; Dunlop DD, 2003, AM J PUBLIC HEALTH, V93, P1945, DOI 10.2105/AJPH.93.11.1945; [方向 FANG Xiang], 2011, [中华精神科杂志, Chinese Journal of Psychiatry], V44, P103; Gonzalez HM, 2010, J PSYCHIATR RES, V44, P1043, DOI 10.1016/j.jpsychires.2010.03.017; Greenberg PE, 2003, J CLIN PSYCHIAT, V64, P1465, DOI 10.4088/JCP.v64n1211; [桂立辉 GUI Li-hui], 2009, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V17, P459; Guo WJ, 2011, CURR OPIN PSYCHIATR, V24, P324, DOI 10.1097/YCO.0b013e3283477b0e; Haro JM, 2006, INT J METH PSYCH RES, V15, P167, DOI 10.1002/mpr.196; Kawakami N, 2005, PSYCHIAT CLIN NEUROS, V59, P441, DOI 10.1111/j.1440-1819.2005.01397.x; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Kessler RC, 2006, AM J PSYCHIAT, V163, P1561, DOI 10.1176/appi.ajp.163.9.1561; Kessler RC, 2010, DEPRESS ANXIETY, V27, P351, DOI 10.1002/da.20634; KLEINMAN A, 1982, CULT MED PSYCHIAT, V6, P117, DOI 10.1007/BF00051427; Kovess-Masfety V, 2005, CAN J PSYCHIAT, V50, P926, DOI 10.1177/070674370505001407; Kuehner C, 2003, ACTA PSYCHIAT SCAND, V108, P163, DOI 10.1034/j.1600-0447.2003.00204.x; Lee S, 2006, SOC SCI MED, V62, P1685, DOI 10.1016/j.socscimed.2005.08.016; Lee S, 2007, PSYCHOL MED, V37, P61, DOI 10.1017/S0033291706008993; Lee S, 2009, PSYCHOSOM MED, V71, P886, DOI 10.1097/PSY.0b013e3181baa65e; [栗克清 LI Keqing], 2007, [中华精神科杂志, Chinese Journal of Psychiatry], V40, P36; Lu J, 2008, J AFFECT DISORDERS, V111, P221, DOI 10.1016/j.jad.2008.02.018; Ma X, 2009, J AFFECT DISORDERS, V115, P323, DOI 10.1016/j.jad.2008.09.010; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Ohayon MM, 2003, ARCH GEN PSYCHIAT, V60, P39, DOI 10.1001/archpsyc.60.1.39; Ohayon MM, 1999, BIOL PSYCHIAT, V45, P300, DOI 10.1016/S0006-3223(98)00011-0; [逄淑涛 PANG Shu-Tao], 2010, [中国心理卫生杂志, Chinese Mental Health Journal], V24, P175; Parker G, 2001, AM J PSYCHIAT, V158, P857, DOI 10.1176/appi.ajp.158.6.857; Peen J, 2010, ACTA PSYCHIAT SCAND, V121, P84, DOI 10.1111/j.1600-0447.2009.01438.x; Phillips MR, 2009, LANCET, V373, P2041, DOI 10.1016/S0140-6736(09)60660-7; Phillips MR, 1999, CULT MED PSYCHIAT, V23, P25, DOI 10.1023/A:1005462530658; Pigott TA, 1999, J CLIN PSYCHIAT, V60, P4; REGIER DA, 1988, ARCH GEN PSYCHIAT, V45, P977; Sadeghirad B, 2010, INT J PREVENTIVE MED, V1, P81; Shen Y C, 1986, Zhonghua Shen Jing Jing Shen Ke Za Zhi, V19, P65; Shen YC, 2006, PSYCHOL MED, V36, P257, DOI 10.1017/S0033291705006367; Shen Yucun, 1998, CHINESE J PSYCHIAT, V31, P67; Shi Qi-chang, 2005, Zhonghua Yufang Yixue Zazhi, V39, P229; Simon GE, 2002, PSYCHOL MED, V32, P585, DOI 10.1017/S0033291702005457; [宋志强 SONG Zhi-Qiang], 2010, [中国心理卫生杂志, Chinese Mental Health Journal], V24, P168; Ustun TB, 2004, BRIT J PSYCHIAT, V184, P386, DOI 10.1192/bjp.184.5.386; Wang JR, 1998, CHIN J PSYCHIAT, V5, P75; Wang PS, 2007, LANCET, V370, P841, DOI 10.1016/S0140-6736(07)61414-7; Wei B., 2010, J GUANGXI MED U, V27, P951, DOI DOI 10.3969/J.ISSN.1005-930X.2010.06.061; Weich S, 2004, BRIT J PSYCHIAT, V184, P289, DOI 10.1192/bjp.184.4.289; Weissman MM, 1996, JAMA-J AM MED ASSOC, V276, P293, DOI 10.1001/jama.276.4.293; Wittchen HU, 2005, EUR NEUROPSYCHOPHARM, V15, P357, DOI 10.1016/j.euroneuro.2005.04.012; Ying Y W, 2000, Cultur Divers Ethnic Minor Psychol, V6, P183, DOI 10.1037/1099-9809.6.2.183; Yu C-Y., 2008, CHINESE J PREV CONT, V16, P378, DOI [10.3969/j.issn.1004-6194.2008.04.016, DOI 10.3969/J.ISSN.1004-6194.2008.04.016]; [张敬悬 ZHANG Jing-Xuan], 2010, [中国心理卫生杂志, Chinese Mental Health Journal], V24, P161; [张荣珍 Zhang Rongzhen], 2012, [中国神经精神疾病杂志, Chinese Journal of Nervous and Mental Diseases], V38, P69; [赵振环 ZHAO Zhenhuan], 2009, [中国神经精神疾病杂志, Chinese Journal of Nervous and Mental Diseases], V35, P530	58	110	136	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65356	10.1371/journal.pone.0065356	http://dx.doi.org/10.1371/journal.pone.0065356			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	172XB	23785419	Green Published, gold, Green Submitted			2022-12-27	WOS:000321038800101
J	Quinlivan, EP; Crider, KS; Zhu, JH; Maneval, DR; Hao, L; Li, Z; Rasmussen, SA; Berry, RJ; Bailey, LB				Quinlivan, Eoin P.; Crider, Krista S.; Zhu, Jiang-Hui; Maneval, David R.; Hao, Ling; Li, Zhu; Rasmussen, Sonja A.; Berry, R. J.; Bailey, Lynn B.			Hypomethylation of Serum Blood Clot DNA, but Not Plasma EDTA-Blood Cell Pellet DNA, from Vitamin B12-Deficient Subjects	PLOS ONE			English	Article							METHIONINE SYNTHASE ACTIVITY; MODERATE FOLATE-DEPLETION; COLORECTAL-CANCER RISK; S-ADENOSYLMETHIONINE; METHYLENETETRAHYDROFOLATE REDUCTASE; METHYLTRANSFERASES DNMT3A; CPG METHYLATION; MAMMALIAN DNA; X-CHROMOSOME; HOMOCYSTEINE	Vitamin B12, a co-factor in methyl-group transfer, is important in maintaining DNA (deoxycytidine) methylation. Using two independent assays we examined the effect of vitamin B12-deficiency (plasma vitamin B12<148 pmol/L) on DNA methylation in women of childbearing age. Coagulated blood clot DNA from vitamin B12-deficient women had significantly (p<0.001) lower percentage deoxycytidine methylation (3.23 +/- 0.66%; n = 248) and greater [3 H]methyl-acceptance (42,859 +/- 9,699 cpm; n = 17) than DNA from B12-replete women (4.44 +/- 0.18%; n = 128 and 26,049 +/- 2,814 cpm; n = 11) [correlation between assays: r = -0.8538; p<0.001; n = 28]. In contrast, uncoagulated EDTA-blood cell pellet DNA from vitamin B12-deficient and B12-replete women exhibited similar percentage methylation (4.45 +/- 0.15%; n = 77 vs. 4.47 +/- 0.15%; n = 47) and [3 H]methyl-acceptance (27,378 +/- 4,094 cpm; n = 17 vs. 26,610 +/- 2,292 cpm; n = 11). Therefore, in simultaneously collected paired blood samples, vitamin B12-deficiency was associated with decreased DNA methylation only in coagulated samples. These findings highlight the importance of sample collection methods in epigenetic studies, and the potential impact biological processes can have on DNA methylation during collection.	[Quinlivan, Eoin P.] Univ Florida, Clin & Translat Sci Inst, Biomed Mass Spectrometry Lab, Gainesville, FL 32610 USA; [Crider, Krista S.; Rasmussen, Sonja A.; Berry, R. J.] Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA USA; [Zhu, Jiang-Hui] China Natl Ctr Food Safety Risk Assessment, Dept Surveillance Program & Risk Assessment, Beijing, Peoples R China; [Maneval, David R.] Univ Florida, Food Sci & Human Nutr Dept, Gainesville, FL USA; [Hao, Ling] China Off, Ctr Dis Control & Prevent, Global Aids Program, Beijing, Peoples R China; [Li, Zhu] Peking Univ, Hlth Sci Ctr, Beijing 100871, Peoples R China; [Bailey, Lynn B.] Univ Georgia, Dept Foods & Nutr, Athens, GA 30602 USA	State University System of Florida; University of Florida; Centers for Disease Control & Prevention - USA; State University System of Florida; University of Florida; Chinese Center for Disease Control & Prevention; Peking University; University System of Georgia; University of Georgia	Quinlivan, EP (corresponding author), Univ Florida, Clin & Translat Sci Inst, Biomed Mass Spectrometry Lab, Gainesville, FL 32610 USA.	epq@ufl.edu	Quinlivan, Eoin/AAJ-1979-2021; Quinlivan, Eoin P/B-8454-2008	Quinlivan, Eoin/0000-0002-0908-1762; Quinlivan, Eoin P/0000-0002-0908-1762; Crider, Krista/0000-0001-6997-5955; Berry, Robert/0000-0002-7162-5046	BDB/DBDDD/NCBDDD/CDC (Birth Defects Branch, Division of Birth Defects and Developmental Disabilities, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention); NIH/NCATS Clinical and Translational Science Award [UL1 TR000064]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER	BDB/DBDDD/NCBDDD/CDC (Birth Defects Branch, Division of Birth Defects and Developmental Disabilities, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention); NIH/NCATS Clinical and Translational Science Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Funding for this study was provided by a cooperative agreement from BDB/DBDDD/NCBDDD/CDC (Birth Defects Branch, Division of Birth Defects and Developmental Disabilities, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention). This work was supported in part by the NIH/NCATS Clinical and Translational Science Award to the University of Florida (UL1 TR000064). As a part of a public health scientific agency, CDC employees were directly involved in the study design, analysis, decision to publish and preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, INT PSYCHOGERIATR, P1; [Anonymous], 2012, NUCL ACIDS RES; [Anonymous], 2012, EUR J OBSTET GYNECOL; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; ARAKI A, 1987, J CHROMATOGR-BIOMED, V422, P43, DOI 10.1016/0378-4347(87)80438-3; BALAGHI M, 1993, BIOCHEM BIOPH RES CO, V193, P1184, DOI 10.1006/bbrc.1993.1750; Bartolomei MS, 1997, ANNU REV GENET, V31, P493, DOI 10.1146/annurev.genet.31.1.493; Batra V, 2010, CHEM-BIOL INTERACT, V183, P425, DOI 10.1016/j.cbi.2009.11.010; Bhattacharya SK, 1999, NATURE, V397, P579, DOI 10.1038/17533; Bjornsson HT, 2008, JAMA-J AM MED ASSOC, V299, P2877, DOI 10.1001/jama.299.24.2877; Brena RM, 2007, HUM MOL GENET, V16, pR96, DOI 10.1093/hmg/ddm073; Brunaud L, 2003, DIGESTION, V68, P133, DOI 10.1159/000075307; Brunaud L, 2003, CLIN CHEM LAB MED, V41, P1012, DOI 10.1515/CCLM.2003.155; Bruniquel D, 2003, NAT IMMUNOL, V4, P235, DOI 10.1038/ni887; CANNON SV, 1988, BIOCHEM BIOPH RES CO, V151, P1173, DOI 10.1016/S0006-291X(88)80489-3; Cervoni N, 1999, J BIOL CHEM, V274, P8363, DOI 10.1074/jbc.274.13.8363; Chen CC, 2012, J BIOL CHEM, V287, P33116, DOI 10.1074/jbc.C112.406975; Chen RZ, 1998, NATURE, V395, P89, DOI 10.1038/25779; Choi SW, 2004, J NUTR, V134, P750, DOI 10.1093/jn/134.4.750; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Crider KS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028144; Crider KS, 2011, AM J CLIN NUTR, V93, P1365, DOI 10.3945/ajcn.110.004671; DEMPLE B, 1991, P NATL ACAD SCI USA, V88, P11450, DOI 10.1073/pnas.88.24.11450; DIETZ AA, 1977, CANCER RES, V37, P419; DOI T, 1989, J NUTR SCI VITAMINOL, V35, P1, DOI 10.3177/jnsv.35.1; Eckhardt F, 2004, EXPERT REV MOL DIAGN, V4, P609, DOI 10.1586/14737159.4.5.609; Finkelstein JD, 1998, EUR J PEDIATR, V157, pS40, DOI 10.1007/PL00014300; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Friso S, 2002, P NATL ACAD SCI USA, V99, P5606, DOI 10.1073/pnas.062066299; Gluckman PD, 2009, NAT REV ENDOCRINOL, V5, P401, DOI 10.1038/nrendo.2009.102; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; HALLAM LJ, 1987, BLOOD, V69, P1128; Hammoud SS, 2011, HUM REPROD, V26, P2558, DOI 10.1093/humrep/der192; Hao L, 2008, AM J CLIN NUTR, V88, P448, DOI 10.1093/ajcn/88.2.448; Hao L, 2007, J NUTR, V137, P407, DOI 10.1093/jn/137.2.407; Heard E, 1997, ANNU REV GENET, V31, P571, DOI 10.1146/annurev.genet.31.1.571; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Hellman A, 2007, SCIENCE, V315, P1141, DOI 10.1126/science.1136352; Hodges E, 2009, GENOME RES, V19, P1593, DOI 10.1101/gr.095190.109; Holz-Schietinger C, 2010, J BIOL CHEM, V285, P29091, DOI 10.1074/jbc.M110.142513; HSIEH CL, 1994, MOL CELL BIOL, V14, P5487, DOI 10.1128/MCB.14.8.5487; Hughes LAE, 2010, INT J EPIDEMIOL, V39, P1333, DOI 10.1093/ije/dyq062; Hughes LAE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007951; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jacob RA, 1998, J NUTR, V128, P1204, DOI 10.1093/jn/128.7.1204; Jones PA, 1999, TRENDS GENET, V15, P34, DOI 10.1016/S0168-9525(98)01636-9; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; Juriloff DM, 2000, HUM MOL GENET, V9, P993, DOI 10.1093/hmg/9.6.993; Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640; Kareta MS, 2006, J BIOL CHEM, V281, P25893, DOI 10.1074/jbc.M603140200; KENNEDY DG, 1992, J NUTR, V122, P1384, DOI 10.1093/jn/122.7.1384; KOTB M, 1985, J BIOL CHEM, V260, P3923; Kress C, 2006, P NATL ACAD SCI USA, V103, P11112, DOI 10.1073/pnas.0601793103; LARSEN F, 1992, GENOMICS, V13, P1095, DOI 10.1016/0888-7543(92)90024-M; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; LeGros HL, 1997, J BIOL CHEM, V272, P16040, DOI 10.1074/jbc.272.25.16040; Lenth RV., 2006, JAVA APPLETS POWER S; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Liu Zhenhua, 2006, Proceedings of the American Association for Cancer Research Annual Meeting, V47, P916; Liutkeviciute Z, 2009, NAT CHEM BIOL, V5, P400, DOI 10.1038/nchembio.172; MALINOW MR, 1994, J LAB CLIN MED, V123, P421; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Melnyk S, 2000, CLIN CHEM, V46, P265; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Neddermann P, 1996, J BIOL CHEM, V271, P12767, DOI 10.1074/jbc.271.22.12767; OBROIN S, 1992, J CLIN PATHOL, V45, P344, DOI 10.1136/jcp.45.4.344; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Patra SK, 2002, MOL CARCINOGEN, V33, P163, DOI 10.1002/mc.10033; Quinlivan EP, 2008, ANAL BIOCHEM, V373, P383, DOI 10.1016/j.ab.2007.09.031; Quinlivan EP, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn534; Quinlivan EP, 2005, J NUTR, V135, P389, DOI 10.1093/jn/135.3.389; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Ramchandani S, 1999, P NATL ACAD SCI USA, V96, P6107, DOI 10.1073/pnas.96.11.6107; Rampersaud GC, 2000, AM J CLIN NUTR, V72, P998; Razin A, 1998, EMBO J, V17, P4905, DOI 10.1093/emboj/17.17.4905; RUSSELL GJ, 1976, J MOL BIOL, V108, P1, DOI 10.1016/S0022-2836(76)80090-3; Schwartz S, 2009, NAT STRUCT MOL BIOL, V16, P990, DOI 10.1038/nsmb.1659; Shelnutt KP, 2004, J NUTR BIOCHEM, V15, P554, DOI 10.1016/j.jnutbio.2004.04.003; Sinclair KD, 2007, P NATL ACAD SCI USA, V104, P19351, DOI 10.1073/pnas.0707258104; Smit AFA, 1996, CURR OPIN GENET DEV, V6, P743, DOI 10.1016/S0959-437X(96)80030-X; Smulders YM, 2006, BRIT J HAEMATOL, V132, P623, DOI 10.1111/j.1365-2141.2005.05913.x; STEINBERG RA, 1995, NUCLEIC ACIDS RES, V23, P1621, DOI 10.1093/nar/23.9.1621; Suetake I, 2003, J BIOCHEM, V133, P737, DOI 10.1093/jb/mvg095; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tobi EW, 2009, HUM MOL GENET, V18, P4046, DOI 10.1093/hmg/ddp353; Vairapandi M, 2004, J CELL BIOCHEM, V91, P572, DOI 10.1002/jcb.10749; Vairapandi M, 2000, J CELL BIOCHEM, V79, P249, DOI 10.1002/1097-4644(20001101)79:2<249::AID-JCB80>3.0.CO;2-Z; Van Emburgh BO, 2011, NUCL ACIDS RES; Villalpando S, 2008, FOOD NUTR BULL, V29, pS112, DOI 10.1177/15648265080292S115; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Wilkinson LS, 2007, NAT REV NEUROSCI, V8, P832, DOI 10.1038/nrn2235; Wilson AS, 2007, BBA-REV CANCER, V1775, P138, DOI 10.1016/j.bbcan.2006.08.007; WOLF SF, 1984, P NATL ACAD SCI-BIOL, V81, P2806, DOI 10.1073/pnas.81.9.2806; Wu HC, 2011, EPIGENETICS-US, V6, P76, DOI 10.4161/epi.6.1.13391; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052; Xu MQ, 2009, SCHIZOPHRENIA BULL, V35, P568, DOI 10.1093/schbul/sbn168; Yamada K, 2000, J NUTR, V130, P1894, DOI 10.1093/jn/130.8.1894; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5; Zhang Z, 2012, GENOMICS, V99, P209, DOI 10.1016/j.ygeno.2012.01.002; Zhou YP, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-123; Ziller MJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002389	102	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65241	10.1371/journal.pone.0065241	http://dx.doi.org/10.1371/journal.pone.0065241			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785415	Green Submitted, Green Published, gold			2022-12-27	WOS:000321038800105
J	Wilcox, CL; Terry, NA; Walp, ER; Lee, RA; May, CL				Wilcox, Crystal L.; Terry, Natalie A.; Walp, Erik R.; Lee, Randall A.; May, Catherine Lee			Pancreatic alpha-Cell Specific Deletion of Mouse Arx Leads to alpha-Cell Identity Loss	PLOS ONE			English	Article							BETA-CELLS; ENDOCRINE PANCREAS; PROGENITOR CELLS; IDENTIFICATION; PAX4; DIFFERENTIATION; PLASTICITY; MICE; PP	The specification and differentiation of pancreatic endocrine cell populations (alpha-, beta-, delta, PP-and epsilon-cells) is orchestrated by a combination of transcriptional regulators. In the pancreas, Aristaless-related homeobox gene (Arx) is expressed first in the endocrine progenitors and then restricted to glucagon-producing alpha-cells. While the functional requirement of Arx in early alpha-cell specification has been investigated, its role in maintaining alpha-cell identity has yet to be explored. To study this later role of Arx, we have generated mice in which the Arx gene has been ablated specifically in glucagon-producing alpha-cells. Lineage-tracing studies and immunostaining analysis for endocrine hormones demonstrate that ablation of Arx in neonatal alpha-cells results in an alpha-to-beta-like conversion through an intermediate bihormonal state. Furthermore, these Arx-deficient converted cells express beta-cell markers including Pdx1, MafA, and Glut2. Surprisingly, short-term ablation of Arx in adult mice does not result in a similar alpha-to-beta-like conversion. Taken together, these findings reveal a potential temporal requirement for Arx in maintaining alpha-cell identity.	[Wilcox, Crystal L.; Walp, Erik R.; Lee, Randall A.; May, Catherine Lee] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Terry, Natalie A.] Childrens Hosp Philadelphia, Dept Pediat, Div Gastroenterol, Philadelphia, PA 19104 USA; [May, Catherine Lee] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	May, CL (corresponding author), Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	catheril@mail.med.upenn.edu			Center for Molecular Studies in Digestive and Liver Disease [P30-DK050306]; Penn Institute for Diabetes, Obesity, and Metabolism [DERC: P30-DK19525]; National Institutes of Health [DK078606, NIH-DK019525, JDRF2-2007-730]; National Institutes of Health/National Institute of Diabetes and Digestive and Kidney [T32-DK007066, NIH-5K12HD043245]; CHOP Foerderer Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD043245] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK078606, P30DK019525, P30DK050306, R01DK078606, T32DK007066] Funding Source: NIH RePORTER	Center for Molecular Studies in Digestive and Liver Disease; Penn Institute for Diabetes, Obesity, and Metabolism; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health/National Institute of Diabetes and Digestive and Kidney; CHOP Foerderer Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Part of these studies were supported by the Center for Molecular Studies in Digestive and Liver Disease (P30-DK050306) and Penn Institute for Diabetes, Obesity, and Metabolism (DERC: P30-DK19525). CLM is supported by National Institutes of Health-DK078606, NIH-DK019525 and JDRF2-2007-730. NAT is supported by National Institutes of Health/National Institute of Diabetes and Digestive and Kidney T32-DK007066 and NIH-5K12HD043245. These studies were also supported by the CHOP Foerderer Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borowiak M, 2009, CURR OPIN CELL BIOL, V21, P727, DOI 10.1016/j.ceb.2009.08.006; Bramswig NC, 2011, DIABETES OBES METAB, V13, P13, DOI 10.1111/j.1463-1326.2011.01440.x; Bramswig NC, 2013, J CLIN INVEST, V123, P1275, DOI 10.1172/JCI66514; Chao CS, 2007, DEV BIOL, V312, P523, DOI 10.1016/j.ydbio.2007.09.057; Collombat P, 2005, DEVELOPMENT, V132, P2969, DOI 10.1242/dev.01870; Collombat P, 2003, GENE DEV, V17, P2591, DOI 10.1101/gad.269003; Collombat P, 2007, J CLIN INVEST, V117, P961, DOI 10.1172/JCI29115; Collombat P, 2009, CELL, V138, P449, DOI 10.1016/j.cell.2009.05.035; Collombat P, 2006, MECH DEVELOP, V123, P501, DOI 10.1016/j.mod.2006.05.006; Du AP, 2012, DEV BIOL, V365, P175, DOI 10.1016/j.ydbio.2012.02.024; Fulp CT, 2008, HUM MOL GENET, V17, P3740, DOI 10.1093/hmg/ddn271; Hancock AS, 2010, MOL ENDOCRINOL, V24, P1605, DOI 10.1210/me.2010-0120; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Herrera PL, 2000, DEVELOPMENT, V127, P2317; Itoh M, 2010, DIFFERENTIATION, V80, P118, DOI 10.1016/j.diff.2010.05.003; Jorgensen MC, 2007, ENDOCR REV, V28, P685, DOI 10.1210/er.2007-0016; Juhl K, 2010, CURR OPIN ORGAN TRAN, V15, P79, DOI 10.1097/MOT.0b013e3283344932; Lee SH, 2011, ISLETS, V3, P188, DOI 10.4161/isl.3.4.16338; Li WC, 2010, J CELL SCI, V123, P2792, DOI 10.1242/jcs.065268; Lu JL, 2010, GASTROENTEROLOGY, V138, P1954, DOI 10.1053/j.gastro.2010.01.046; Mastracci TL, 2011, DEV BIOL; Prado CL, 2004, P NATL ACAD SCI USA, V101, P2924, DOI 10.1073/pnas.0308604100; Quoix N, 2007, FEBS LETT, V581, P4235, DOI 10.1016/j.febslet.2007.07.068; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Sussel L, 1998, DEVELOPMENT, V125, P2213; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Yang YP, 2011, GENE DEV, V25, P1680, DOI 10.1101/gad.16875711	27	59	62	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66214	10.1371/journal.pone.0066214	http://dx.doi.org/10.1371/journal.pone.0066214			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785486	Green Published, gold, Green Submitted			2022-12-27	WOS:000321038800035
J	Marras, S; Domenici, P				Marras, Stefano; Domenici, Paolo			Schooling Fish Under Attack Are Not All Equal: Some Lead, Others Follow	PLOS ONE			English	Article							FAST-START PERFORMANCE; EUROPEAN SEA BASS; ESCAPE RESPONSE; DICENTRARCHUS-LABRAX; INFORMATION-TRANSFER; INDIVIDUAL VARIATION; PREDATOR AVOIDANCE; DECISION-MAKING; CLUPEA-HARENGUS; ANIMAL GROUPS	Animal groups such as fish schools, bird flocks and insect swarms appear to move so synchronously that they have long been considered egalitarian, leaderless units. In schooling fish, video observations of their spatial-temporal organization have, however, shown that anti-predator manoeuvres are not perfectly synchronous and that individuals have spatial preferences within the school. Nonetheless, when facing life-or-death situations, it is not known whether schooling fish react to a threat following a random or a hierarchically-based order. Using high-speed video analysis, here we show that schooling fish (Golden grey mullet, Liza aurata) evade a threat in a non-random order, therefore individuals that are first or last to react tend to do so repeatedly over sequential stimulations. Furthermore, startle order is strongly correlated with individual positional preferences. Because school members are known to follow individuals that initiate a manoeuvre, early responders are likely to exert the strongest influence on the escape strategy of the whole school. Our results present new evidence of the intrinsic heterogeneity among school members and provide new rules governing the collective motion of gregarious animals under predator attack.	[Marras, Stefano; Domenici, Paolo] IAMC CNR, Torregrande, Oristano, Italy	Consiglio Nazionale delle Ricerche (CNR); L'Istituto per l'Ambiente Marino Costiero (IAMC-CNR)	Marras, S (corresponding author), IAMC CNR, Torregrande, Oristano, Italy.	stefano.marras@iamc.cnr.it	Marras, Stefano/AAX-6549-2020; Domenici, Paolo/F-6958-2010	Marras, Stefano/0000-0002-8386-7608; 	CNR (Consiglio Nazionale delle Ricerche)	CNR (Consiglio Nazionale delle Ricerche)(Consiglio Nazionale delle Ricerche (CNR))	Funding was provided by the authors' institution, CNR (Consiglio Nazionale delle Ricerche). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barelli C, 2008, BEHAVIOUR, V145, P965, DOI 10.1163/156853908784089243; Bisazza A, 2005, P ROY SOC B-BIOL SCI, V272, P1677, DOI 10.1098/rspb.2005.3145; Bumann D, 1997, BEHAVIOUR, V134, P1063, DOI 10.1163/156853997X00403; Cavagna A, 2010, P NATL ACAD SCI USA, V107, P11865, DOI 10.1073/pnas.1005766107; Cosolo M, 2010, MAR BIOL, V157, P2533, DOI 10.1007/s00227-010-1517-2; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Dadda M, 2010, BIOL LETTERS, V6, P414, DOI 10.1098/rsbl.2009.0904; de Carvalho CD, 2007, NEOTROP ICHTHYOL, V5, P81, DOI 10.1590/S1679-62252007000100012; DILL LM, 1990, ENVIRON BIOL FISH, V27, P147, DOI 10.1007/BF00001944; Domenici P, 1997, MAR BIOL, V128, P29, DOI 10.1007/s002270050065; Domenici P, 1997, J EXP BIOL, V200, P1165; DOMENICI P, 1994, J FISH BIOL, V45, P97, DOI 10.1111/j.1095-8649.1994.tb01086.x; Domenici P., 2009, FISH LOCOMOTION ECO; Domenici P, 2010, J EXP ZOOL PART A, V313A, P59, DOI 10.1002/jez.580; Eaton RC, 2001, PROG NEUROBIOL, V63, P467, DOI 10.1016/S0301-0082(00)00047-2; Eaton RC., 1984, NEURAL MECH STARTLE, DOI [10.1007/978-1-4899-2286-1, DOI 10.1007/978-1-4899-2286-1]; Fuiman LA, 2006, ANIM BEHAV, V71, P1389, DOI 10.1016/j.anbehav.2005.11.013; GODIN JGJ, 1985, BEHAV ECOL SOCIOBIOL, V16, P105, DOI 10.1007/BF00295142; Harcourt JL, 2010, CURR BIOL, V20, P156, DOI 10.1016/j.cub.2009.11.045; Herbert-Read JE, 2011, P NATL ACAD SCI USA, V108, P18726, DOI 10.1073/pnas.1109355108; Herskin J, 1998, J FISH BIOL, V53, P366, DOI 10.1006/jfbi.1998.0708; HUNTER JR, 1969, ANIM BEHAV, V17, P507, DOI 10.1016/0003-3472(69)90154-7; HUTH A, 1992, J THEOR BIOL, V156, P365, DOI 10.1016/S0022-5193(05)80681-2; Jones KA, 2010, P ROY SOC B-BIOL SCI, V277, P625, DOI 10.1098/rspb.2009.1607; Killen SS, 2012, P ROY SOC B-BIOL SCI, V279, P357, DOI 10.1098/rspb.2011.1006; Kohashi T, 2008, J NEUROSCI, V28, P10641, DOI 10.1523/JNEUROSCI.1435-08.2008; Krause J, 2000, P ROY SOC B-BIOL SCI, V267, P2011, DOI 10.1098/rspb.2000.1243; KRAUSE J, 1992, BEHAV ECOL SOCIOBIOL, V30, P177, DOI 10.1007/BF00166700; Krause J, 2002, LIVING GROUPS; Langerhans RB, 2010, INTEGR COMP BIOL, V50, P1167, DOI 10.1093/icb/icq117; Lefrancois C, 2005, J FISH BIOL, V67, P1711, DOI 10.1111/j.1095-8649.2005.00884.x; Lefrancois C, 2006, MAR BIOL, V149, P969, DOI 10.1007/s00227-006-0261-0; Makris NC, 2009, SCIENCE, V323, P1734, DOI 10.1126/science.1169441; Marras S, 2010, J EXP BIOL, V213, P26, DOI 10.1242/jeb.032136; Marras S, 2012, ADAPT BEHAV, V20, P44, DOI 10.1177/1059712311426799; Marras S, 2011, J EXP BIOL, V214, P3102, DOI 10.1242/jeb.056648; Nagy M, 2010, NATURE, V464, P890, DOI 10.1038/nature08891; Nespolo RF, 2007, J EXP BIOL, V210, P2000, DOI 10.1242/jeb.02780; Parrish JK, 2002, BIOL BULL-US, V202, P296, DOI 10.2307/1543482; Pitcher TJ., 1993, Behaviour of teleost fishes, P363, DOI 10.1007/978-94-011-1578-0_12; PYKE GH, 1978, ANIM BEHAV, V26, P241, DOI 10.1016/0003-3472(78)90024-6; Reebs SG, 2000, ANIM BEHAV, V59, P403, DOI 10.1006/anbe.1999.1314; Robert M, 2013, J EXP MAR BIOL ECOL, V440, P238, DOI 10.1016/j.jembe.2013.01.005; SEGHERS BH, 1981, ENVIRON BIOL FISH, V6, P21, DOI 10.1007/BF00001795; STEFANELLI A, 1980, Atti della Accademia Nazionale dei Lincei Memorie Classe di Scienze Fisiche Matematiche e Naturali Sezione IIIA, V16, P1; Sumpter D. J., 2010, COLLECTIVE ANIMAL BE, DOI [10.1515/9781400837106, DOI 10.1515/9781400837106]; TREHERNE JE, 1981, ANIM BEHAV, V29, P911, DOI 10.1016/S0003-3472(81)80028-0; Walker JA, 2005, FUNCT ECOL, V19, P808, DOI 10.1111/j.1365-2435.2005.01033.x; Ward AJW, 2008, P NATL ACAD SCI USA, V105, P6948, DOI 10.1073/pnas.0710344105; WEBB PW, 1978, J EXP BIOL, V74, P211; WEBB PW, 1976, J EXP BIOL, V65, P157; WILSON DS, 1989, J THEOR BIOL, V136, P337, DOI 10.1016/S0022-5193(89)80169-9	52	25	25	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65784	10.1371/journal.pone.0065784	http://dx.doi.org/10.1371/journal.pone.0065784			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776547	gold, Green Submitted, Green Published			2022-12-27	WOS:000320322400056
J	Naranjo, V; Ayllon, N; de la Lastra, JMP; Galindo, RC; Kocan, KM; Blouin, EF; Mitra, R; Alberdi, P; Villar, M; de la Fuente, J				Naranjo, Victoria; Ayllon, Nieves; Perez de la Lastra, Jose M.; Galindo, Ruth C.; Kocan, Katherine M.; Blouin, Edmour F.; Mitra, Ruchira; Alberdi, Pilar; Villar, Margarita; de la Fuente, Jose			Reciprocal Regulation of NF-kB (Relish) and Subolesin in the Tick Vector, Ixodes scapularis	PLOS ONE			English	Article							GRANULOCYTIC EHRLICHIOSIS AGENT; PROTECTIVE ANTIGEN SUBOLESIN; ANAPLASMA-MARGINALE; PATHOGEN INFECTION; A-PHAGOCYTOPHILUM; GENETIC DIVERSITY; EXPRESSION; INFESTATIONS; PROTEINS; DROSOPHILA	Background: Tick Subolesin and its ortholog in insects and vertebrates, Akirin, have been suggested to play a role in the immune response through regulation of nuclear factor-kappa B (NF-kB)-dependent and independent gene expression via interaction with intermediate proteins that interact with NF-kB and other regulatory proteins, bind DNA or remodel chromatin to regulate gene expression. The objective of this study was to characterize the structure and regulation of subolesin in Ixodes scapularis. I. scapularis is a vector of emerging pathogens such as Borrelia burgdorferi, Anaplasma phagocytophilum and Babesia microti that cause in humans Lyme disease, anaplasmosis and babesiosis, respectively. The genome of I. scapularis was recently sequenced, and this tick serves as a model organism for the study of vector-host-pathogen interactions. However, basic biological questions such as gene organization and regulation are largely unknown in ticks and other arthropod vectors. Principal Findings: The results presented here provide evidence that subolesin/akirin are evolutionarily conserved at several levels (primary sequence, gene organization and function), thus supporting their crucial biological function in metazoans. These results showed that NF-kB (Relish) is involved in the regulation of subolesin expression in ticks, suggesting that as in other organisms, different NF-kB integral subunits and/or unknown interacting proteins regulate the specificity of the NF-kB-mediated gene expression. These results suggested a regulatory network involving cross-regulation between NF-kB (Relish) and Subolesin and Subolesin auto-regulation with possible implications in tick immune response to bacterial infection. Significance: These results advance our understanding of gene organization and regulation in I. scapularis and have important implications for arthropod vectors genetics and immunology highlighting the possible role of NF-kB and Subolesin/Akirin in vector-pathogen interactions and for designing new strategies for the control of vector infestations and pathogen transmission.	[Naranjo, Victoria; Galindo, Ruth C.; Kocan, Katherine M.; Blouin, Edmour F.; Mitra, Ruchira; de la Fuente, Jose] Oklahoma State Univ, Ctr Vet Hlth Sci, Dept Vet Pathobiol, Stillwater, OK 74078 USA; [Naranjo, Victoria; Ayllon, Nieves; Perez de la Lastra, Jose M.; Galindo, Ruth C.; Alberdi, Pilar; Villar, Margarita; de la Fuente, Jose] SaBio, Inst Invest Recursos Cineget IREC CSIC UCLM JCCM, Ciudad Real, Spain	Oklahoma State University System; Oklahoma State University - Stillwater; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha	de la Fuente, J (corresponding author), Oklahoma State Univ, Ctr Vet Hlth Sci, Dept Vet Pathobiol, Stillwater, OK 74078 USA.	jose_delafuente@yahoo.com	de la Fuente, José/AAU-1197-2020; Pérez de la Lastra, José/F-9184-2013; Villar-Rayo, Marga M/J-4155-2012; de la Lastra, José Manuel Pérez/M-4397-2019; Alberdi, Pilar/K-7788-2014	de la Fuente, José/0000-0001-7383-9649; Pérez de la Lastra, José/0000-0003-4663-5565; Villar-Rayo, Marga M/0000-0003-4172-9079; de la Lastra, José Manuel Pérez/0000-0003-4663-5565; Alberdi, Pilar/0000-0002-6999-9735	Oklahoma Agricultural Experimental [1669]; Walter R. Sitlington Endowed Chair for Food Animal Research; EU [278976]; European Social Fund; Junta de Comunidades de Castilla-La Mancha, Spain; Ministerio de Educacion y Ciencia (MEC), Spain;  [BFU2008-01244/BMC];  [BFU2011-23896]	Oklahoma Agricultural Experimental; Walter R. Sitlington Endowed Chair for Food Animal Research; EU(European Commission); European Social Fund(European Social Fund (ESF)); Junta de Comunidades de Castilla-La Mancha, Spain(Junta de Comunidades de Castilla-La Mancha); Ministerio de Educacion y Ciencia (MEC), Spain(Spanish Government); ; 	This research was supported by grants BFU2008-01244/BMC and BFU2011-23896 to JF, the Oklahoma Agricultural Experimental Grant 1669 and the Walter R. Sitlington Endowed Chair for Food Animal Research to KMK, and the EU FP7 ANTIGONE project number 278976. V. Naranjo was funded by the European Social Fund and the Junta de Comunidades de Castilla-La Mancha (Program FSE 2007-2013), Spain. N. Ayllon was funded by Ministerio de Educacion y Ciencia (MEC), Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almazan C, 2005, VACCINE, V23, P4403, DOI 10.1016/j.vaccine.2005.04.012; Almazan C, 2003, VACCINE, V21, P1492, DOI 10.1016/S0264-410X(02)00683-7; Barker SC, 2004, PARASITOLOGY, V129, pS15, DOI 10.1017/S0031182004005207; Bensaci M, 2012, VACCINE, V30, P6040, DOI 10.1016/j.vaccine.2012.07.053; Beuder B, 2008, NAT IMMUNOL, V9, P7, DOI 10.1038/ni0108-7; Blouin EF, 2003, VET PARASITOL, V111, P247, DOI 10.1016/S0304-4017(02)00378-3; Busby AT, 2012, MED VET ENTOMOL, V26, P92, DOI 10.1111/j.1365-2915.2011.00973.x; Butler JEF, 2002, GENE DEV, V16, P2583, DOI 10.1101/gad.1026202; DasGupta R, 2005, SCIENCE, V308, P826, DOI 10.1126/science.1109374; De la Fuente J, 2006, BIOCHEM BIOPH RES CO, V344, P332, DOI 10.1016/j.bbrc.2006.03.109; de la Fuente J, 2005, EXP PARASITOL, V109, P16, DOI 10.1016/j.exppara.2004.10.004; de la Fuente J, 2008, FRONT BIOSCI-LANDMRK, V13, P6938, DOI 10.2741/3200; de la Fuente J, 2007, GENOMICS, V90, P712, DOI 10.1016/j.ygeno.2007.08.009; de la Fuente J, 2007, TRENDS PARASITOL, V23, P427, DOI 10.1016/j.pt.2007.07.002; de la Fuente J, 2006, PARASITOL RES, V100, P85, DOI 10.1007/s00436-006-0244-6; de la Fuente J, 2006, VACCINE, V24, P4082, DOI 10.1016/j.vaccine.2006.02.046; de la Fuente J, 2006, PARASITOL RES, V99, P108, DOI 10.1007/s00436-006-0132-0; de la Fuente J, 2011, VET PARASITOL, V181, P17, DOI 10.1016/j.vetpar.2011.04.018; de la Fuente J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-372; de la Fuente J, 2008, ANN NY ACAD SCI, V1149, P27, DOI 10.1196/annals.1428.056; Estrada-Fena A, 1999, EXP APPL ACAROL, V2, P583; FUJITA T, 1992, GENE DEV, V6, P775, DOI 10.1101/gad.6.5.775; Galindo RC, 2009, DEV COMP IMMUNOL, V33, P612, DOI 10.1016/j.dci.2008.11.002; Goto A, 2008, NAT IMMUNOL, V9, P97, DOI 10.1038/ni1543; Havlikova S, 2013, VACCINE, V31, P1582, DOI 10.1016/j.vaccine.2013.01.017; Hill CA, 2005, TRENDS PARASITOL, V21, P151, DOI 10.1016/j.pt.2005.02.004; Iwasaki H, 2002, J BIOL CHEM, V277, P2763, DOI 10.1074/jbc.M108839200; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Jongejan F, 2007, TRENDS PARASITOL, V23, P391, DOI 10.1016/j.pt.2007.07.004; Kocan KM, 2007, PARASITOL RES, V100, P1411, DOI 10.1007/s00436-007-0483-1; Kocan KM, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-42; Koutna I, 2012, FLOW CYTOMETRY RECEN, P421; Krakowetz CN, 2011, TICKS TICK-BORNE DIS, V2, P143, DOI 10.1016/j.ttbdis.2011.05.003; Labruna MB, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-46; LAN Q, 1990, AM J TROP MED HYG, V43, P669, DOI 10.4269/ajtmh.1990.43.669; Lemaitre B, 2004, NAT REV IMMUNOL, V4, P521, DOI 10.1038/nri1390; Lloyd AL, 2005, J MICROBIOL METH, V60, P291, DOI 10.1016/j.mimet.2004.10.009; Macqueen DJ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-34; Mangold AJ, 2009, DEV COMP IMMUNOL, V33, P878, DOI 10.1016/j.dci.2009.02.010; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Megy K, 2009, INFECT GENET EVOL, V9, P308, DOI 10.1016/j.meegid.2007.12.007; Merino O, 2011, VACCINE, V29, P8575, DOI 10.1016/j.vaccine.2011.09.023; Merino O, 2011, VACCINE, V29, P2248, DOI 10.1016/j.vaccine.2011.01.050; Munderloh UG, 1996, J CLIN MICROBIOL, V34, P664, DOI 10.1128/JCM.34.3.664-670.1996; Munderloh UG, 1999, J CLIN MICROBIOL, V37, P2518, DOI 10.1128/JCM.37.8.2518-2524.1999; Nene V, 2009, FRONT BIOSCI-LANDMRK, V14, P2666, DOI 10.2741/3404; Nijhof AM, 2007, INT J PARASITOL, V37, P653, DOI 10.1016/j.ijpara.2006.11.005; Nowak SJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002547; PAHL HL, 1995, EMBO J, V14, P2580, DOI 10.1002/j.1460-2075.1995.tb07256.x; Pena-Rangel MT, 2002, GENETICS, V160, P1035; Sadusky T, 2004, CURR BIOL, V14, P505, DOI 10.1016/j.cub.2004.02.063; Sutterwala FS, 2008, NATURE, V451, P254, DOI 10.1038/451254a; Wan FY, 2010, CELL RES, V20, P24, DOI 10.1038/cr.2009.137; Wan FY, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000067; Yin MJ, 1998, NATURE, V396, P77, DOI 10.1038/23948; Zivkovic Z, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-7	56	34	36	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65915	10.1371/journal.pone.0065915	http://dx.doi.org/10.1371/journal.pone.0065915			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776567	Green Published, gold, Green Submitted			2022-12-27	WOS:000320322400063
J	Samjoo, IA; Safdar, A; Hamadeh, MJ; Glover, AW; Mocellin, NJ; Santana, J; Little, JP; Steinberg, GR; Raha, S; Tarnopolsky, MA				Samjoo, Imtiaz A.; Safdar, Adeel; Hamadeh, Mazen J.; Glover, Alexander W.; Mocellin, Nicholas J.; Santana, Jose; Little, Jonathan P.; Steinberg, Gregory R.; Raha, Sandeep; Tarnopolsky, Mark A.			Markers of Skeletal Muscle Mitochondrial Function and Lipid Accumulation Are Moderately Associated with the Homeostasis Model Assessment Index of Insulin Resistance in Obese Men	PLOS ONE			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE ACTIVITY; TYPE-2 DIABETIC PARENTS; FATTY-ACID OXIDATION; PROTEIN-KINASE-C; WEIGHT-LOSS; SUBSARCOLEMMAL MITOCHONDRIA; TRIGLYCERIDE CONTENT; ENDURANCE EXERCISE; GLUCOSE-TRANSPORT; CERAMIDE CONTENT	Lower skeletal muscle mitochondrial oxidative phosphorylation capacity (OXPHOS) and intramyocellular lipid (IMCL) accumulation have been implicated in the etiology of insulin resistance (IR) in obesity. The purpose of this study was to examine the impact of endurance exercise on biochemical and morphological measures of IMCL and mitochondrial content, and their relationship to IR in obese individuals. We examined mitochondrial content (subunit protein abundance and maximal activity of electron transport chain enzymes), IMCL/mitochondrial morphology in both subsarcolemmal (SS) and intermyofibrillar (IMF) regions by transmission electron microscopy, and intracellular lipid metabolites (diacylglycerol and ceramide) in vastus lateralis biopsies, as well as, the homeostasis model assessment index of IR (HOMA-IR) prior to and following twelve weeks of an endurance exercise regimen in healthy age-and physical activity-matched lean and obese men. Obese men did not show evidence of mitochondrial OXPHOS dysfunction, disproportionate IMCL content in subcellular regions, or diacylglycerol/ceramide accretion despite marked IR vs. lean controls. Endurance exercise increased OXPHOS and mitochondrial size and density, but not number of individual mitochondrial fragments, with moderate improvements in HOMA-IR. Exercise reduced SS IMCL content (size, number and density), increased IMF IMCL content, while increasing IMCL/mitochondrial juxtaposition in both regions. HOMA-IR was inversely associated with SS (r = -0.34; P = 0.051) and IMF mitochondrial density (r = -0.29; P = 0.096), IMF IMCL/mitochondrial juxtaposition (r = -0.30; P = 0.086), and COXII (r = -0.32; P = 0.095) and COXIV protein abundance (r = -0.35; P = 0.052); while positively associated with SS IMCL size (r = 0.28; P = 0.119) and SS IMCL density (r = 0.25; P = 0.152). Our findings suggest that once physical activity and cardiorespiratory fitness have been controlled for, skeletal muscle mitochondrial and IMCL profile in obesity may only partially contribute to the development of IR.	[Samjoo, Imtiaz A.; Hamadeh, Mazen J.; Glover, Alexander W.; Mocellin, Nicholas J.; Santana, Jose; Raha, Sandeep; Tarnopolsky, Mark A.] McMaster Univ, Dept Pediat, Hamilton, ON, Canada; [Samjoo, Imtiaz A.; Hamadeh, Mazen J.; Glover, Alexander W.; Mocellin, Nicholas J.; Santana, Jose; Steinberg, Gregory R.; Tarnopolsky, Mark A.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Safdar, Adeel] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Cardiovasc Inst, Boston, MA 02215 USA; [Hamadeh, Mazen J.] York Univ, Muscle Hlth Res Ctr, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 2R7, Canada; [Little, Jonathan P.] Univ British Columbia Okanagan, Sch Hlth & Exercise Sci, Kelowna, BC, Canada	McMaster University; McMaster University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; York University - Canada; University of British Columbia; University of British Columbia Okanagan	Tarnopolsky, MA (corresponding author), McMaster Univ, Dept Pediat, Hamilton, ON, Canada.	tarnopol@mcmaster.ca	Raha, Sandeep/AAF-3655-2020; Little, Jonathan P./T-4076-2019	Raha, Sandeep/0000-0001-7307-3292; Little, Jonathan P./0000-0002-9796-2008; Safdar, Adeel/0000-0003-2469-0467; Hamadeh, Mazen/0000-0002-3511-4345; Safdar, Adeel/0000-0002-7453-7770; Steinberg, Gregory/0000-0001-5425-8275	Canadian Institutes of Health Research (CIHR); Heart and Stroke Foundation of Ontario; Ontario Graduate Scholarship (OGS); OGS in Science and Technology (OGSST); Banting (CIHR) Postdoctoral Fellowship; American Federation for Aging Research; Ellison Medical Foundation	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Ontario Graduate Scholarship (OGS)(Ontario Graduate Scholarship); OGS in Science and Technology (OGSST); Banting (CIHR) Postdoctoral Fellowship; American Federation for Aging Research; Ellison Medical Foundation(Lawrence Ellison Foundation)	This study was funded by a grant to MAT from the Canadian Institutes of Health Research (CIHR). The authors sincerely thank the Lammert and Corkins family for their generous donation to the McMaster University Neuromuscular and Neurometabolic Centre. IAS was supported by the Heart and Stroke Foundation of Ontario Master's Studentship Award, Ontario Graduate Scholarship (OGS), and the OGS in Science and Technology (OGSST). AS was supported by the Banting (CIHR) Postdoctoral Fellowship and American Federation for Aging Research and the Ellison Medical Foundation Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2004, DIABETES, V53, P25, DOI 10.2337/diabetes.53.1.25; Bajpeyi S, 2011, J CLIN ENDOCRIN META, V96; Bell JA, 2010, J CLIN ENDOCR METAB, V95, P3400, DOI 10.1210/jc.2009-1596; Boushel R, 2007, DIABETOLOGIA, V50, P790, DOI 10.1007/s00125-007-0594-3; Brons C, 2008, J CLIN ENDOCR METAB, V93, P3885, DOI 10.1210/jc.2008-0630; Bruce CR, 2006, AM J PHYSIOL-ENDOC M, V291, pE99, DOI 10.1152/ajpendo.00587.2005; Bruce CR, 2004, DIABETOLOGIA, V47, P23, DOI 10.1007/s00125-003-1265-7; Chomentowski P, 2011, J CLIN ENDOCR METAB, V96, P494, DOI 10.1210/jc.2010-0822; De Feyter HM, 2008, EUR J ENDOCRINOL, V158, P643, DOI 10.1530/EJE-07-0756; Devries MC, 2008, FREE RADICAL BIO MED, V45, P503, DOI 10.1016/j.freeradbiomed.2008.04.039; Devries MC, 2007, AM J PHYSIOL-REG I, V293, pR2336, DOI 10.1152/ajpregu.00510.2007; Dresner A, 1999, J CLIN INVEST, V103, P253, DOI 10.1172/JCI5001; Emoto M, 1999, DIABETES CARE, V22, P818, DOI 10.2337/diacare.22.5.818; FEDERICO A, 1987, J INHERIT METAB DIS, V10, P242, DOI 10.1007/BF01811416; Gallagher IJ, 2010, GENOME MED, V2, DOI 10.1186/gm130; Goodpaster BH, 2000, METABOLISM, V49, P467, DOI 10.1016/S0026-0495(00)80010-4; Goodpaster BH, 2001, J CLIN ENDOCR METAB, V86, P5755, DOI 10.1210/jc.86.12.5755; Griffin ME, 1999, DIABETES, V48, P1270, DOI 10.2337/diabetes.48.6.1270; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Hawley JA, 2007, DIABETOLOGIA, V50, P699, DOI 10.1007/s00125-007-0595-2; He J, 2004, OBES RES, V12, P761, DOI 10.1038/oby.2004.92; Holloszy JO, 2009, AM J CLIN NUTR, V89, p463S, DOI 10.3945/ajcn.2008.26717C; Hood MS, 2011, MED SCI SPORT EXER, V43, P1849, DOI 10.1249/MSS.0b013e3182199834; Houmard JA, 1995, J APPL PHYSIOL, V79, P1936, DOI 10.1152/jappl.1995.79.6.1936; HOWALD H, 1985, PFLUG ARCH EUR J PHY, V403, P369, DOI 10.1007/BF00589248; Hoy AJ, 2009, AM J PHYSIOL-ENDOC M, V297, pE67, DOI 10.1152/ajpendo.90945.2008; Itani SI, 2002, DIABETES, V51, P2005, DOI 10.2337/diabetes.51.7.2005; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Kelley DE, 2002, ANNU REV NUTR, V22, P325, DOI 10.1146/annurev.nutr.22.010402.102912; Kim HJ, 2004, EUR J APPL PHYSIOL, V93, P353, DOI 10.1007/s00421-004-1214-2; Krssak M, 1999, DIABETOLOGIA, V42, P113, DOI 10.1007/s001250051123; Lau DCW, 2007, CAN MED ASSOC J, V176, pS1, DOI 10.1503/cmaj.061409; Li XH, 2007, NATURE, V447, P1012, DOI 10.1038/nature05861; Liu HY, 2009, AM J PHYSIOL-ENDOC M, V297, pE898, DOI 10.1152/ajpendo.00374.2009; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morino K, 2005, J CLIN INVEST, V115, P3587, DOI 10.1172/JCI25151; Morino K, 2006, DIABETES, V55, pS9, DOI 10.2337/db06-S002; Nair KS, 2008, DIABETES, V57, P1166, DOI 10.2337/db07-1556; Nielsen J, 2010, AM J PHYSIOL-ENDOC M, V298, pE706, DOI 10.1152/ajpendo.00692.2009; Pan DA, 1997, DIABETES, V46, P983, DOI 10.2337/diabetes.46.6.983; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Perseghin G, 1999, DIABETES, V48, P1600, DOI 10.2337/diabetes.48.8.1600; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Phillips SM, 1996, AM J PHYSIOL-ENDOC M, V270, pE265, DOI 10.1152/ajpendo.1996.270.2.E265; REN JM, 1994, J BIOL CHEM, V269, P14396; Ritov VB, 2005, DIABETES, V54, P8, DOI 10.2337/diabetes.54.1.8; Ritov VB, 2010, AM J PHYSIOL-ENDOC M, V298, pE49, DOI 10.1152/ajpendo.00317.2009; Ross R, 2000, ANN INTERN MED, V133, P92, DOI 10.7326/0003-4819-133-2-200007180-00008; Safdar A, 2011, J BIOL CHEM; Safdar A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010778; SEGAL KR, 1991, J APPL PHYSIOL, V71, P2402, DOI 10.1152/jappl.1991.71.6.2402; Serlie MJ, 2007, J CLIN ENDOCR METAB, V92, P1524, DOI 10.1210/jc.2006-2347; Short KR, 2003, DIABETES, V52, P1888, DOI 10.2337/diabetes.52.8.1888; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Simoneau JA, 1999, FASEB J, V13, P2051, DOI 10.1096/fasebj.13.14.2051; SIMONEAU JA, 1995, FASEB J, V9, P273, DOI 10.1096/fasebj.9.2.7781930; Simoneau JA, 1997, J APPL PHYSIOL, V83, P166, DOI 10.1152/jappl.1997.83.1.166; Skovbro M, 2008, DIABETOLOGIA, V51, P1253, DOI 10.1007/s00125-008-1014-z; Straczkowski M, 2007, DIABETOLOGIA, V50, P2366, DOI 10.1007/s00125-007-0781-2; Tanner CJ, 2002, AM J PHYSIOL-ENDOC M, V282, pE1191, DOI 10.1152/ajpendo.00416.2001; Tarnopolsky MA, 2007, AM J PHYSIOL-REG I, V292, pR1271, DOI 10.1152/ajpregu.00472.2006; Timmons JA, 2006, GENOMICS, V87, P165, DOI 10.1016/j.ygeno.2005.09.007; van Loon LJC, 2004, AM J PHYSIOL-ENDOC M, V287, pE558, DOI 10.1152/ajpendo.00464.2003; Watt MJ, 2006, NAT MED, V12, P541, DOI 10.1038/nm1383; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200	68	34	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66322	10.1371/journal.pone.0066322	http://dx.doi.org/10.1371/journal.pone.0066322			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776659	Green Published, Green Submitted, gold			2022-12-27	WOS:000320322400097
J	Gish, LA; Gagne, JM; Han, LQ; DeYoung, BJ; Clark, SE				Gish, Lindsey A.; Gagne, Jennifer M.; Han, Linqu; DeYoung, Brody J.; Clark, Steven E.			WUSCHEL-Responsive At5g65480 Interacts with CLAVATA Components In Vitro and in Transient Expression	PLOS ONE			English	Article							DETERGENT-RESISTANT MEMBRANES; STEM-CELL HOMEOSTASIS; ARABIDOPSIS SHOOT; LIPID RAFTS; ORGAN DEVELOPMENT; PROTEIN; RECEPTOR; MICRODOMAINS; MERISTEM; POLTERGEIST	The CLAVATA (CLV) signaling pathway is essential for shoot meristem homeostasis in Arabidopsis. CLV acts to limit the expression domain of the stem cell-promoting gene WUSCHEL (WUS). The closely related receptor-kinases CLV1 and BAM1 are key components in this pathway; however, the downstream factors that link the receptors to WUS regulation are poorly understood. The Arabidopsis gene At5g65480 was recently identified as a direct transcriptional target up-regulated by WUS. We have independently identified this gene which we term CCI1 as a CLV1 and BAM1 interacting protein in vitro and in transient expression. CCI1 has phosphatidylinositide-binding activity in vitro and localizes to the plasma membrane in transient expression. Furthermore, CLV signaling components and CCI1 both partition to detergent-resistant membrane microdomains characterized as lipid rafts.	[Gish, Lindsey A.; Gagne, Jennifer M.; Han, Linqu; DeYoung, Brody J.; Clark, Steven E.] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Clark, SE (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA.	clarks@umich.edu	Gagne, Jennifer M/B-2866-2009	Gagne, Jennifer M/0000-0003-2563-087X	National Institutes of Health [R01GM62962]; U.S. Department of Agriculture National Research Initiative [2006-35304-17403]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062962] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Agriculture National Research Initiative(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (grant no. R01GM62962 to SEC) and the U.S. Department of Agriculture National Research Initiative Competitive Grants Program(grant no. 2006-35304-17403 to SEC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronheim A, 1997, MOL CELL BIOL, V17, P3094, DOI 10.1128/MCB.17.6.3094; Bleckmann A, 2010, PLANT PHYSIOL, V152, P166, DOI 10.1104/pp.109.149930; Borner GHH, 2005, PLANT PHYSIOL, V137, P104, DOI 10.1104/pp.104.053041; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Brown DA, 2006, PHYSIOLOGY, V21, P430, DOI 10.1152/physiol.00032.2006; Busch W, 2010, DEV CELL, V18, P849, DOI 10.1016/j.devcel.2010.03.012; DeYoung BJ, 2006, PLANT J, V45, P1, DOI 10.1111/j.1365-313X.2005.02592.x; DeYoung BJ, 2008, GENETICS, V180, P895, DOI 10.1534/genetics.108.091108; Dowler S, 2000, BIOCHEM J, V351, P19, DOI 10.1042/0264-6021:3510019; Dunn R, 2004, J CELL BIOL, V165, P135, DOI 10.1083/jcb.200309026; Furt F, 2010, PLANT PHYSIOL, V152, P2173, DOI 10.1104/pp.109.149823; Furt F, 2007, PLANT SIGNAL BEHAV, V2, P508, DOI 10.4161/psb.2.6.4636; Gagne JM, 2010, PLANT CELL, V22, P729, DOI 10.1105/tpc.109.068734; Guo YF, 2010, PLANT SIGNAL BEHAV, V5, P1442, DOI [10.4161/psb.5.11.13359, 10.1111/j.1365-313X.2010.04295]; Guo YF, 2010, PLANT J, V63, P889, DOI 10.1111/j.1365-313X.2010.04295.x; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Hong Z, 2008, PLANT CELL, V20, P3418, DOI 10.1105/tpc.108.061879; Hord CLH, 2006, PLANT CELL, V18, P1667, DOI 10.1105/tpc.105.036871; Kleinboelting N, 2012, NUCLEIC ACIDS RES, V40, pD1211, DOI 10.1093/nar/gkr1047; Krugel U, 2012, MOL PLANT, V5, P43, DOI 10.1093/mp/ssr048; Marmagne Anne, 2006, V323, P403; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; Meijer HJG, 2003, ANNU REV PLANT BIOL, V54, P265, DOI 10.1146/annurev.arplant.54.031902.134748; Morsomme P, 1998, J BIOL CHEM, V273, P34837, DOI 10.1074/jbc.273.52.34837; Nimchuk ZL, 2011, CURR BIOL, V21, P345, DOI 10.1016/j.cub.2011.01.039; Ogawa M, 2008, SCIENCE, V319, P294, DOI 10.1126/science.1150083; Ostrom RS, 2004, BRIT J PHARMACOL, V143, P235, DOI 10.1038/sj.bjp.0705930; Peskan T, 2000, EUR J BIOCHEM, V267, P6989, DOI 10.1046/j.1432-1327.2000.01776.x; Premkumar L, 2010, J BIOL CHEM, V285, P13211, DOI 10.1074/jbc.M110.102517; Santagata S, 2001, SCIENCE, V292, P2041, DOI 10.1126/science.1061233; Schoof H, 2000, CELL, V100, P635, DOI 10.1016/S0092-8674(00)80700-X; Shahollari B, 2004, PHYSIOL PLANTARUM, V122, P397, DOI 10.1111/j.1399-3054.2004.00414.x; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Song SK, 2006, DEVELOPMENT, V133, P4691, DOI 10.1242/dev.02652; Song SK, 2005, DEV BIOL, V285, P272, DOI 10.1016/j.ydbio.2005.06.020; Steeves T.A., 1989, PATTERNS PLANT DEV, DOI 10.1017/CBO9780511626227; Tissier AF, 1999, PLANT CELL, V11, P1841, DOI 10.1105/tpc.11.10.1841; Titapiwatanakun B, 2009, PLANT J, V57, P27, DOI 10.1111/j.1365-313X.2008.03668.x; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Yadav RK, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.8; Yadav RK, 2011, GENE DEV, V25, P2025, DOI 10.1101/gad.17258511; Yadav RK, 2010, DEVELOPMENT, V137, P3581, DOI 10.1242/dev.054973; Yadav RK, 2009, P NATL ACAD SCI USA, V106, P4941, DOI 10.1073/pnas.0900843106; Yu LP, 2000, DEVELOPMENT, V127, P1661; Yu LP, 2003, CURR BIOL, V13, P179, DOI 10.1016/S0960-9822(03)00042-3; Zhu YF, 2010, PLANT J, V61, P223, DOI 10.1111/j.1365-313X.2009.04049.x	46	3	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66345	10.1371/journal.pone.0066345	http://dx.doi.org/10.1371/journal.pone.0066345			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776660	Green Published, gold, Green Submitted			2022-12-27	WOS:000320755400138
J	Morey, JS; Van Dolah, FM				Morey, Jeanine S.; Van Dolah, Frances M.			Global Analysis of mRNA Half-Lives and de novo Transcription in a Dinoflagellate, Karenia brevis	PLOS ONE			English	Article							RED-TIDE DINOFLAGELLATE; PENTATRICOPEPTIDE REPEAT PROTEINS; GENOME-WIDE ANALYSIS; GENE-EXPRESSION; MICROARRAY ANALYSIS; URACIL PHOSPHORIBOSYLTRANSFERASE; POSTTRANSCRIPTIONAL REGULATION; CIRCADIAN REGULATION; DECAY-RATES; GONYAULAX	Dinoflagellates possess many physiological processes that appear to be under post-transcriptional control. However, the extent to which their genes are regulated post-transcriptionally remains unresolved. To gain insight into the roles of differential mRNA stability and de novo transcription in dinoflagellates, we biosynthetically labeled RNA with 4-thiouracil to isolate newly transcribed and pre-existing RNA pools in Karenia brevis. These isolated fractions were then used for analysis of global mRNA stability and de novo transcription by hybridization to a K. brevis microarray. Global K. brevis mRNA half-lives were calculated from the ratio of newly transcribed to pre-existing RNA for 7086 array features using the online software HALO (Half-life Organizer). Overall, mRNA half-lives were substantially longer than reported in other organisms studied at the global level, ranging from 42 minutes to greater than 144 h, with a median of 33 hours. Consistent with well-documented trends observed in other organisms, housekeeping processes, including energy metabolism and transport, were significantly enriched in the most highly stable messages. Shorter-lived transcripts included a higher proportion of transcriptional regulation, stress response, and other response/regulatory processes. One such family of proteins involved in post-transcriptional regulation in chloroplasts and mitochondria, the pentatricopeptide repeat (PPR) proteins, had dramatically shorter half-lives when compared to the arrayed transcriptome. As transcript abundances for PPR proteins were previously observed to rapidly increase in response to nutrient addition, we queried the newly synthesized RNA pools at 1 and 4 h following nitrate addition to N-depleted cultures. Transcriptome-wide there was little evidence of increases in the rate of de novo transcription during the first 4 h, relative to that in N-depleted cells, and no evidence for increased PPR protein transcription. These results lend support to the growing consensus of post-transcriptional control of gene expression in dinoflagellates.	[Morey, Jeanine S.; Van Dolah, Frances M.] NOAA, Marine Biotoxins Program, Natl Ocean Serv, Ctr Coastal Environm Hlth & Biomol Res, Charleston, SC USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA	Van Dolah, FM (corresponding author), NOAA, Marine Biotoxins Program, Natl Ocean Serv, Ctr Coastal Environm Hlth & Biomol Res, Charleston, SC USA.	fran.vandolah@noaa.gov			NOAA	NOAA(National Oceanic Atmospheric Admin (NOAA) - USA)	This work was supported by NOAA programmatic funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachvaroff TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002929; Beauchemin M, 2012, P NATL ACAD SCI USA, V109, P15793, DOI 10.1073/pnas.1206683109; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; Brunelle SA, 2011, J EUKARYOT MICROBIOL, V58, P373, DOI 10.1111/j.1550-7408.2011.00560.x; Clayton C, 2007, MOL BIOCHEM PARASIT, V156, P93, DOI 10.1016/j.molbiopara.2007.07.007; Cleary MD, 2005, NAT BIOTECHNOL, V23, P232, DOI 10.1038/nbt1061; Conesa A, 2005, BIOINFORMATICS; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Dolken L, 2008, RNA, V14, P1959, DOI 10.1261/rna.1136108; EHLERS B, 1987, MOL CELL BIOL, V7, P1242, DOI 10.1128/MCB.7.3.1242; Fagan T, 1999, BIOCHEMISTRY-US, V38, P7689, DOI 10.1021/bi9826005; Friedel CC, 2010, BIOINFORMATICS, V26, P1264, DOI 10.1093/bioinformatics/btq117; Friedel CC, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp542; Friedel CC, 2009, MOL BIOSYST, V5, P1271, DOI 10.1039/b911233b; GREENBERG JR, 1975, J CELL BIOL, V64, P269; Hou YB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006978; Islam MR, 2007, PLANT MOL BIOL, V63, P465, DOI 10.1007/s11103-006-9101-3; Johnson JG, 2012, MAR GENOM, V5, P15, DOI 10.1016/j.margen.2011.08.005; Kenzelmann M, 2007, P NATL ACAD SCI USA, V104, P6164, DOI 10.1073/pnas.0610439104; Le QH, 2001, BIOL RHYTHM RES, V32, P579, DOI 10.1076/brhm.32.5.579.1290; Lidie KB, 2005, MAR BIOTECHNOL, V7, P481, DOI 10.1007/s10126-004-4110-6; Lidie KB, 2007, THESIS MED U S CAROL, P249; Lidie KB, 2007, J EUKARYOT MICROBIOL, V54, P427, DOI 10.1111/j.1550-7408.2007.00282.x; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Magana HA, 2006, HARMFUL ALGAE, V5, P192, DOI 10.1016/j.hal.2005.07.003; Manful T, 2011, RNA, V17, P2039, DOI 10.1261/rna.2837311; Miller MR, 2009, NAT METHODS, V6, P439, DOI [10.1038/nmeth.1329, 10.1038/NMETH.1329]; Mittag M, 1998, CHRONOBIOL INT, V15, P93, DOI 10.3109/07420529808998673; Monroe EA, 2010, J PHYCOL, V46, P541, DOI 10.1111/j.1529-8817.2010.00837.x; Morey JS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-346; MORSE D, 1989, P NATL ACAD SCI USA, V86, P172, DOI 10.1073/pnas.86.1.172; Moustafa A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009688; MURPHY WJ, 1986, CELL, V47, P517, DOI 10.1016/0092-8674(86)90616-1; Narsai R, 2007, PLANT CELL, V19, P3418, DOI 10.1105/tpc.107.055046; Okamoto OK, 2001, J BIOL CHEM, V276, P19989, DOI 10.1074/jbc.M101169200; Palenchar JB, 2006, MOL BIOCHEM PARASIT, V146, P135, DOI 10.1016/j.molbiopara.2005.12.008; Pelechano V, 2008, YEAST, V25, P85, DOI 10.1002/yea.1548; Rabani M, 2011, NAT BIOTECHNOL, V29, P436, DOI 10.1038/nbt.1861; Rossini C, 2003, CHRONOBIOL INT, V20, P963, DOI 10.1081/CBI-120025248; Saha D, 2007, PLANT PHYSIOL BIOCH, V45, P521, DOI 10.1016/j.plaphy.2007.03.026; SCHRODERLORENZ A, 1987, PLANTA, V170, P7, DOI 10.1007/BF00392374; Sharova LV, 2009, DNA RES, V16, P45, DOI 10.1093/dnares/dsn030; SHYU AB, 1989, GENE DEV, V3, P60, DOI 10.1101/gad.3.1.60; Small ID, 2000, TRENDS BIOCHEM SCI, V25, P46, DOI 10.1016/S0968-0004(99)01520-0; Song XL, 2012, J BIOL CHEM, V287, P12520, DOI 10.1074/jbc.M111.338079; Steglich C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r54; Steidinger KA, 1998, PHYSL ECOLOGY HARMFU, P113; Striepen B, 2004, P NATL ACAD SCI USA, V101, P3154, DOI 10.1073/pnas.0304686101; Van Dolah FM, 2000, ENVIRON HEALTH PERSP, V108, P133, DOI 10.1289/ehp.00108s1133; Van Dolah FM, 2007, J PHYCOL, V43, P741, DOI 10.1111/j.1529-8817.2007.00354.x; Van Dolah FM, 2009, HARMFUL ALGAE, V8, P562, DOI 10.1016/j.hal.2008.11.004; Wang YL, 2002, P NATL ACAD SCI USA, V99, P5860, DOI 10.1073/pnas.092538799; Weng L, 2006, BIOINFORMATICS, V22, P1111, DOI 10.1093/bioinformatics/btl045; Wisecaver JH, 2011, ANNU REV MICROBIOL, V65, P369, DOI 10.1146/annurev-micro-090110-102841; Yang E, 2003, GENOME RES, V13, P1863, DOI 10.1101/gr.1272403; Yang I, 2011, HARMFUL ALGAE, V12, P55, DOI 10.1016/j.hal.2011.08.012; Zhang H, 2007, P NATL ACAD SCI USA, V104, P4618, DOI 10.1073/pnas.0700258104	57	22	22	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66347	10.1371/journal.pone.0066347	http://dx.doi.org/10.1371/journal.pone.0066347			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776661	Green Submitted, gold, Green Published			2022-12-27	WOS:000320755400139
J	Skerry, C; Pokkali, S; Pinn, M; Be, NA; Harper, J; Karakousis, PC; Jain, SK				Skerry, Ciaran; Pokkali, Supriya; Pinn, Michael; Be, Nicholas A.; Harper, Jamie; Karakousis, Petros C.; Jain, Sanjay K.			Vaccination with Recombinant Mycobacterium tuberculosis PknD Attenuates Bacterial Dissemination to the Brain in Guinea Pigs	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CENTRAL-NERVOUS-SYSTEM; BCG VACCINATION; IMMUNE-RESPONSE; CHILDHOOD TUBERCULOSIS; AEROSOL CHALLENGE; PROTEIN-KINASE; MURINE MODEL; MENINGITIS; PATHOGENESIS	Background: We have previously identified Mycobacterium tuberculosis PknD to be an important virulence factor required for the pathogenesis of central nervous system (CNS) tuberculosis (TB). Specifically, PknD mediates bacillary invasion of the blood-brain barrier, which can be neutralized by specific antisera, suggesting its potential role as a therapeutic target against TB meningitis. Methodology/Principal Findings: We utilized an aerosol challenge guinea pig model of CNS TB and compared the protective efficacy of recombinant M. tuberculosis PknD subunit protein with that of M. bovis BCG against bacillary dissemination to the brain. BCG vaccination limited the pulmonary bacillary burden after aerosol challenge with virulent M. tuberculosis in guinea pigs and also reduced bacillary dissemination to the brain (P = 0.01). PknD vaccination also offered significant protection against bacterial dissemination to the brain, which was no different from BCG (P > 0.24), even though PknD vaccinated animals had almost 100-fold higher pulmonary bacterial burdens. Higher levels of PknD-specific IgG were noted in animals immunized with PknD, but not in BCG-vaccinated or control animals. Furthermore, pre-incubation of M. tuberculosis with sera from PknD-vaccinated animals, but not with sera from BCG-vaccinated or control animals, significantly reduced bacterial invasion in a human blood-brain barrier model (P < 0.01). Conclusion: Current recommendations for administering BCG at birth are based on protection gained against severe disease, such as TB meningitis, during infancy. We demonstrate that vaccination with recombinant M. tuberculosis PknD subunit offers a novel strategy to protect against TB meningitis, which is equivalent to BCG in a guinea pig model. Moreover, since BCG lacks the PknD sensor, BCG could also be boosted to develop a more effective vaccine against TB meningitis, a devastating disease that disproportionately affects young children.	[Skerry, Ciaran; Pokkali, Supriya; Pinn, Michael; Be, Nicholas A.; Harper, Jamie; Karakousis, Petros C.; Jain, Sanjay K.] Johns Hopkins Univ, Sch Med, Ctr TB Res, Baltimore, MD 21218 USA; [Skerry, Ciaran; Pokkali, Supriya; Be, Nicholas A.; Harper, Jamie; Jain, Sanjay K.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Pinn, Michael; Karakousis, Petros C.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Be, Nicholas A.] Lawrence Livermore Natl Lab, Phys & Life Sci Directorate, Livermore, CA USA; [Harper, Jamie; Jain, Sanjay K.] Johns Hopkins Univ, Sch Med, Ctr Infect & Inflammat Imaging Res, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Johns Hopkins University	Jain, SK (corresponding author), Johns Hopkins Univ, Sch Med, Ctr TB Res, Baltimore, MD 21218 USA.	sjain5@jhmi.edu	Pokkali, Supriya/T-2825-2017; Pokkali, Supriya/H-4773-2013; Karakousis, Petros Constantine/AAR-7899-2020; Skerry, Ciaran/AAX-8291-2020	Pokkali, Supriya/0000-0002-6209-1679; Pokkali, Supriya/0000-0002-6209-1679; Jain, Sanjay/0000-0001-9620-7070	NIH [OD006492, AI083125]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083125] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006492] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded by the NIH Director's New Innovator Award OD006492 (SKJ) and NIH grant AI083125 to PCK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad Z, 2011, J ANTIMICROB CHEMOTH, V66, P1560, DOI 10.1093/jac/dkr188; Be NA, 2008, J INFECT DIS, V198, P1520, DOI 10.1086/592447; Be NA, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-7; Be NA, 2011, TUBERCULOSIS, V91, P386, DOI 10.1016/j.tube.2011.07.003; BERENGUER J, 1992, NEW ENGL J MED, V326, P668, DOI 10.1056/NEJM199203053261004; BOUNOUS DI, 1992, AVIAN DIS, V36, P1022, DOI 10.2307/1591566; Campuzano J, 2007, VACCINE, V25, P3722, DOI 10.1016/j.vaccine.2006.12.042; Cisneros-Lira J, 2003, AM J PHYSIOL-LUNG C, V285, pL949, DOI 10.1152/ajplung.00074.2003; Girgis NI, 1998, AM J TROP MED HYG, V58, P28, DOI 10.4269/ajtmh.1998.58.28; Glatman-Freedman A, 1998, CLIN MICROBIOL REV, V11, P514, DOI 10.1128/CMR.11.3.514; Good MC, 2004, J MOL BIOL, V339, P459, DOI 10.1016/j.jmb.2004.03.063; Hiraishi Y, 2011, VACCINE, V29, P2626, DOI 10.1016/j.vaccine.2011.01.042; Jacobs RF, 2003, PRINCIPLES PRACTICE, P796; Jain SK, 2005, CLIN PEDIATR, V44, P443, DOI 10.1177/000992280504400510; Katrak SM, 2000, J NEUROL SCI, V181, P118, DOI 10.1016/S0022-510X(00)00440-8; LINCOLN EM, 1960, J PEDIATR-US, V57, P807, DOI 10.1016/S0022-3476(60)80132-1; Lopez B, 2003, CLIN EXP IMMUNOL, V133, P30, DOI 10.1046/j.1365-2249.2003.02171.x; Mawuenyega KG, 2005, MOL BIOL CELL, V16, P396, DOI 10.1091/mbc.e04-04-0329; Ordway D, 2008, CLIN VACCINE IMMUNOL, V15, P1248, DOI 10.1128/CVI.00019-08; Ottenhoff THM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002607; Padayatchi NI, 2006, PEDIATR INFECT DIS J, V25, P147, DOI 10.1097/01.inf.0000199314.88063.4c; PADUNGCHAN S, 1986, B WORLD HEALTH ORGAN, V64, P247; Parra M, 2004, INFECT IMMUN, V72, P6799, DOI 10.1128/IAI.72.12.6799-6805.2004; Peirs P, 2000, FEMS MICROBIOL LETT, V188, P135; Rana FS, 2000, J ACQ IMMUN DEF SYND, V24, P23; Rich AR, 1933, B JOHNS HOPKINS HOSP, V52, P5; Ritz N, 2012, AM J RESP CRIT CARE, V185, P213, DOI 10.1164/rccm.201104-0714OC; ROMANUS V, 1987, PEDIATR INFECT DIS J, V6, P272, DOI 10.1097/00006454-198703000-00014; ROSENTHAL S, 1961, AM REV RESPIR DIS, V84, P690; ROSENTHAL S, 1961, PEDIATRICS, V28, P622; Roy E, 2005, INFECT IMMUN, V73, P6101, DOI 10.1128/IAI.73.9.6101-6109.2005; Rubin LL, 1999, ANNU REV NEUROSCI, V22, P11, DOI 10.1146/annurev.neuro.22.1.11; Sofia M, 2001, INT J TUBERC LUNG D, V5, P551; Takahashi K, 1999, COMP BIOCHEM PHYS C, V124, P309, DOI 10.1016/S0742-8413(99)00078-X; Teitelbaum R, 1998, P NATL ACAD SCI USA, V95, P15688, DOI 10.1073/pnas.95.26.15688; Thwaites GE, 2004, NEW ENGL J MED, V351, P1741, DOI 10.1056/NEJMoa040573; Thwaites GE, 2005, LANCET NEUROL, V4, P160, DOI 10.1016/S1474-4422(05)01013-6; TIDJANI O, 1986, TUBERCLE, V67, P269, DOI 10.1016/0041-3879(86)90016-4; Udwadia ZF, 2012, THORAX, V67, P286, DOI 10.1136/thoraxjnl-2012-201663; Wang BL, 2007, CLIN VACCINE IMMUNOL, V14, P902, DOI 10.1128/CDLI.00077-07; World Health Organization (WHO), 1993, IMM BAS IMM SER MOD; YOUNG TK, 1986, AM J PUBLIC HEALTH, V76, P783, DOI 10.2105/AJPH.76.7.783	42	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66310	10.1371/journal.pone.0066310	http://dx.doi.org/10.1371/journal.pone.0066310			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776655	Green Published, Green Submitted, gold			2022-12-27	WOS:000320755400135
J	Tytgat, TOG; Verhoeven, KJF; Jansen, JJ; Raaijmakers, CE; Bakx-Schotman, T; McIntyre, LM; van der Putten, WH; Biere, A; van Dam, NM				Tytgat, Tom O. G.; Verhoeven, Koen J. F.; Jansen, Jeroen J.; Raaijmakers, Ciska E.; Bakx-Schotman, Tanja; McIntyre, Lauren M.; van der Putten, Wim H.; Biere, Arjen; van Dam, Nicole M.			Plants Know Where It Hurts: Root and Shoot Jasmonic Acid Induction Elicit Differential Responses in Brassica olracea	PLOS ONE			English	Article							GENE-EXPRESSION; ARABIDOPSIS-THALIANA; JAZ REPRESSORS; MULTITROPHIC INTERACTIONS; 12-OXO-PHYTODIENOIC ACID; STRESS RESPONSES; HERBIVORY; DYNAMICS; DEFENSES; CARBON	Plants respond to herbivore attack by rapidly inducing defenses that are mainly regulated by jasmonic acid (JA). Due to the systemic nature of induced defenses, attack by root herbivores can also result in a shoot response and vice versa, causing interactions between above-and belowground herbivores. However, little is known about the molecular mechanisms underlying these interactions. We investigated whether plants respond differently when roots or shoots are induced. We mimicked herbivore attack by applying JA to the roots or shoots of Brassica oleracea and analyzed molecular and chemical responses in both organs. In shoots, an immediate and massive change in primary and secondary metabolism was observed. In roots, the JA-induced response was less extensive and qualitatively different from that in the shoots. Strikingly, in both roots and shoots we also observed differential responses in primary metabolism, development as well as defense specific traits depending on whether the JA induction had been below-or aboveground. We conclude that the JA response is not only tissue-specific but also dependent on the organ that was induced. Already very early in the JA signaling pathway the differential response was observed. This indicates that both organs have a different JA signaling cascade, and that the signal eliciting systemic responses contains information about the site of induction, thus providing plants with a mechanism to tailor their responses specifically to the organ that is damaged.	[Tytgat, Tom O. G.; van Dam, Nicole M.] Radboud Univ Nijmegen, Dept Ecogen, Inst Water & Wetland Res, NL-6525 ED Nijmegen, Netherlands; [Verhoeven, Koen J. F.; Raaijmakers, Ciska E.; Bakx-Schotman, Tanja; van der Putten, Wim H.; Biere, Arjen] Netherlands Inst Ecol, Dept Terr Ecol, Wageningen, Netherlands; [Jansen, Jeroen J.] Radboud Univ Nijmegen, Dept Chemometr, NL-6525 ED Nijmegen, Netherlands; [McIntyre, Lauren M.] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL USA; [van der Putten, Wim H.] Wageningen Univ, Nematol Lab, NL-6700 AP Wageningen, Netherlands	Radboud University Nijmegen; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Radboud University Nijmegen; State University System of Florida; University of Florida; Wageningen University & Research	Tytgat, TOG (corresponding author), Radboud Univ Nijmegen, Dept Ecogen, Inst Water & Wetland Res, NL-6525 ED Nijmegen, Netherlands.	t.tytgat@science.ru.nl	van Dam, Nicole M./B-3281-2008; van der Putten, Wim H/C-3707-2011; Verhoeven, Koen JF/C-9920-2010; Biere, Arjen/B-8079-2008; Jansen, Jeroen/D-6120-2012; KNAW, NIOO-KNAW/A-4320-2012	van Dam, Nicole M./0000-0003-2622-5446; van der Putten, Wim H/0000-0002-9341-4442; Verhoeven, Koen JF/0000-0003-3002-4102; Biere, Arjen/0000-0002-9006-3448; KNAW, NIOO-KNAW/0000-0002-3835-159X; McIntyre, Lauren/0000-0002-0077-3359				Abdel-Farid IB, 2010, BIOCHEM SYST ECOL, V38, P612, DOI 10.1016/j.bse.2010.07.008; Arimura G, 2009, PLANT CELL PHYSIOL, V50, P911, DOI 10.1093/pcp/pcp030; Balbi V, 2008, NEW PHYTOL, V177, P301, DOI 10.1111/j.1469-8137.2007.02292.x; Baldwin IT, 1996, ENTOMOL EXP APPL, V80, P213, DOI 10.1007/BF00194760; Ballare CL, 2011, TRENDS PLANT SCI, V16, P249, DOI 10.1016/j.tplants.2010.12.001; Bezemer TM, 2005, TRENDS ECOL EVOL, V20, P617, DOI 10.1016/j.tree.2005.08.006; Bottcher C, 2009, FEBS J, V276, P4693, DOI 10.1111/j.1742-4658.2009.07195.x; Broekgaarden C, 2008, PLANT CELL ENVIRON, V31, P1592, DOI 10.1111/j.1365-3040.2008.01871.x; Broekgaarden C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-239; Bruinsma M, 2008, ENTOMOL EXP APPL, V128, P109, DOI 10.1111/j.1570-7458.2008.00695.x; Cheng ZW, 2011, MOL PLANT, V4, P279, DOI 10.1093/mp/ssq073; Chico JM, 2008, CURR OPIN PLANT BIOL, V11, P486, DOI 10.1016/j.pbi.2008.06.003; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Chung HS, 2010, PLANT J, V63, P613, DOI 10.1111/j.1365-313X.2010.04265.x; Chung HS, 2009, PHYTOCHEMISTRY, V70, P1547, DOI 10.1016/j.phytochem.2009.08.022; Chung HS, 2009, PLANT CELL, V21, P131, DOI 10.1105/tpc.108.064097; Chung KM, 2008, MOL CELLS, V26, P107; De Vos M, 2005, MOL PLANT MICROBE IN, V18, P923, DOI 10.1094/MPMI-18-0923; Dicke M, 2010, TRENDS PLANT SCI, V15, P167, DOI 10.1016/j.tplants.2009.12.002; Dicke M, 2009, NAT CHEM BIOL, V5, P317, DOI 10.1038/nchembio.169; Erb M, 2012, TRENDS PLANT SCI, V17, P250, DOI 10.1016/j.tplants.2012.01.003; Erb M, 2009, TRENDS PLANT SCI, V14, P653, DOI 10.1016/j.tplants.2009.08.006; Glauser G, 2008, J BIOL CHEM, V283, P16400, DOI 10.1074/jbc.M801760200; Gomez S, 2010, NEW PHYTOL, V188, P835, DOI 10.1111/j.1469-8137.2010.03414.x; Grini PE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007817; Hasegawa S, 2011, PLANT CELL ENVIRON, V34, P705, DOI 10.1111/j.1365-3040.2011.02274.x; Henkes GJ, 2008, PLANT CELL ENVIRON, V31, P1229, DOI 10.1111/j.1365-3040.2008.01828.x; Ishikawa M, 2006, PLANT J, V46, P736, DOI 10.1111/j.1365-313X.2006.02737.x; Jansen JJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-425; Jansen JJ, 2009, METABOLOMICS, V5, P150, DOI 10.1007/s11306-008-0124-4; Kaplan I, 2008, ECOLOGY, V89, P392, DOI 10.1890/07-0471.1; Karban R, 1999, TRENDS ECOL EVOL, V14, P443, DOI 10.1016/S0169-5347(99)01678-X; Karban R., 1997, INDUCED RESPONSES HE, DOI 10.7208/chicago/9780226424972.001.0001; Kazan K, 2012, TRENDS PLANT SCI, V17, P22, DOI 10.1016/j.tplants.2011.10.006; Koornneef A, 2008, PLANT PHYSIOL, V147, P1358, DOI 10.1104/pp.108.121392; Lee HS, 2004, PLANT BIOTECHNOL J, V2, P45, DOI 10.1046/j.1467-7652.2003.00048.x; Matsuura H, 2012, PHYTOCHEMISTRY, V83, P25, DOI 10.1016/j.phytochem.2012.06.009; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Niu YJ, 2011, J EXP BOT, V62, P2143, DOI 10.1093/jxb/erq408; Pauwels L, 2009, TRENDS PLANT SCI, V14, P87, DOI 10.1016/j.tplants.2008.11.005; Pierre PS, 2011, J CHEM ECOL, V37, P368, DOI 10.1007/s10886-011-9934-3; Qiu BL, 2009, FUNCT ECOL, V23, P496, DOI 10.1111/j.1365-2435.2008.01516.x; Rasmann S, 2008, PLANT PHYSIOL, V146, P875, DOI 10.1104/pp.107.112045; Rasmann S, 2007, ECOL LETT, V10, P926, DOI 10.1111/j.1461-0248.2007.01084.x; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schilmiller AL, 2005, CURR OPIN PLANT BIOL, V8, P369, DOI 10.1016/j.pbi.2005.05.008; Schwachtje J, 2006, P NATL ACAD SCI USA, V103, P12935, DOI 10.1073/pnas.0602316103; Sheard LB, 2010, NATURE, V468, P400, DOI 10.1038/nature09430; Soler R, 2007, OIKOS, V116, P367, DOI 10.1111/j.0030-1299.2007.15501.x; Soppe WJJ, 1999, DEVELOPMENT, V126, P4763; Stintzi A, 2001, P NATL ACAD SCI USA, V98, P12837, DOI 10.1073/pnas.211311098; Strauss SY, 1999, TRENDS ECOL EVOL, V14, P179, DOI 10.1016/S0169-5347(98)01576-6; Taki N, 2005, PLANT PHYSIOL, V139, P1268, DOI 10.1104/pp.105.067058; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Usadel B, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-535; van Dam NM, 2008, PLANT SIGNAL BEHAV, V3, P91, DOI 10.4161/psb.3.2.5220; van Dam NM, 2011, ANNU PLANT REV, V43, P87, DOI 10.1002/9781444339956.ch4; van Dam NM, 2011, J ECOL, V99, P77, DOI 10.1111/j.1365-2745.2010.01761.x; van Dam NM, 2010, J CHEM ECOL, V36, P1006, DOI 10.1007/s10886-010-9844-9; van Dam NM, 2009, PHYTOCHEM REV, V8, P171, DOI 10.1007/s11101-008-9101-9; van Dam NM, 2004, NEW PHYTOL, V161, P801, DOI 10.1111/j.1469-8137.2004.00984.x; Van der Putten WH, 2001, TRENDS ECOL EVOL, V16, P547, DOI 10.1016/S0169-5347(01)02265-0; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Verhoeven KJF, 2005, OIKOS, V108, P643, DOI 10.1111/j.0030-1299.2005.13727.x; Wasternack C, 2010, ACS CHEM BIOL, V5, P63, DOI 10.1021/cb900269u; Zhou LC, 2012, OMICS, V16, P208, DOI 10.1089/omi.2011.0111	66	59	60	3	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65502	10.1371/journal.pone.0065502	http://dx.doi.org/10.1371/journal.pone.0065502			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776489	Green Published, gold			2022-12-27	WOS:000320755400035
J	Kramer, K; Bente, G; Luo, SY; Pfeiffer, UJ; Han, SH; Vogeley, K				Kraemer, Katharina; Bente, Gary; Luo, Siyang; Pfeiffer, Ulrich J.; Han, Shihui; Vogeley, Kai			Influence of Ethnic Group-Membership and Gaze Direction on the Perception of Emotions. A Cross-Cultural Study between Germany and China	PLOS ONE			English	Article							DOMINANCE; RESPONSES; DISPLAYS; BEHAVIOR; MIMICRY; OTHERS; PEOPLE; FACES; SMILE; SELF	Emotional facial expressions provide important nonverbal cues in human interactions. The perception of emotions is not only influenced by a person's ethnic background but also depends on whether a person is engaged with the emotion-encoder. Although these factors are known to affect emotion perception, their impact has only been studied in isolation before. The aim of the present study was to investigate their combined influence. Thus, in order to study the influence of engagement on emotion perception between persons from different ethnicities, we compared participants from China and Germany. Asian-looking and European-looking virtual agents expressed anger and happiness while gazing at the participant or at another person. Participants had to assess the perceived valence of the emotional expressions. Results indicate that indeed two factors that are known to have a considerable influence on emotion perception interacted in their combined influence: We found that the perceived intensity of an emotion expressed by ethnic in-group members was in most cases independent of gaze direction, whereas gaze direction had an influence on the emotion perception of ethnic out-group members. Additionally, participants from the ethnic out-group tended to perceive emotions as more pronounced than participants from the ethnic in-group when they were directly gazed at. These findings suggest that gaze direction has a differential influence on ethnic in-group and ethnic out-group dynamics during emotion perception.	[Kraemer, Katharina; Pfeiffer, Ulrich J.; Vogeley, Kai] Univ Hosp Cologne, Dept Psychiat, Neuroimaging Grp, Cologne, Germany; [Bente, Gary] Univ Cologne, Dept Psychol, D-50931 Cologne, Germany; [Luo, Siyang; Han, Shihui] Beijing Univ, Dept Psychol, Culture & Social Cognit Neurosci Lab, Beijing 100871, Peoples R China; [Vogeley, Kai] Res Ctr Juelich, Inst Neurosci & Med Cognit Neurosci INM3, Julich, Germany	University of Cologne; University of Cologne; Peking University; Helmholtz Association; Research Center Julich	Kramer, K (corresponding author), Univ Hosp Cologne, Dept Psychiat, Neuroimaging Grp, Cologne, Germany.	katharina.kraemer@uk-koeln.de	Vogeley, K/E-4860-2012	Vogeley, K/0000-0002-5891-5831	VolkswagenStiftung; Studienstiftung des deutschen Volkes	VolkswagenStiftung(Volkswagen); Studienstiftung des deutschen Volkes	This research has been funded by a grant of the VolkswagenStiftung (http://www.volkswagenstiftung.de/nc/de.html) and a grant of the Studienstiftung des deutschen Volkes (http://www.studienstiftung.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RB, 2003, PSYCHOL SCI, V14, P644, DOI 10.1046/j.0956-7976.2003.psci_1479.x; Auvray M, 2009, NEW IDEAS PSYCHOL, V27, P32, DOI 10.1016/j.newideapsych.2007.12.002; Bailenson JN, 2005, PSYCHOL SCI, V16, P814, DOI 10.1111/j.1467-9280.2005.01619.x; Bailenson JN, 2003, PERS SOC PSYCHOL B, V29, P819, DOI 10.1177/0146167203029007002; BAVELAS JB, 1986, J PERS SOC PSYCHOL, V50, P322, DOI 10.1037/0022-3514.50.2.322; Bente G, 2001, BEHAV RES METH INS C, V33, P303, DOI 10.3758/BF03195383; Bente G, 2010, CONSCIOUS COGN, V19, P762, DOI 10.1016/j.concog.2010.06.006; Biele C, 2006, EXP BRAIN RES, V171, P1, DOI 10.1007/s00221-005-0254-0; Blascovich J, 2002, PSYCHOL INQ, V13, P103, DOI 10.1207/S15327965PLI1302_01; Brown LM, 2006, BIOL PSYCHOL, V71, P303, DOI 10.1016/j.biopsycho.2005.06.003; CHOVIL N, 1991, J NONVERBAL BEHAV, V15, P141, DOI 10.1007/BF01672216; De Jaegher H, 2010, TRENDS COGN SCI, V14, P441, DOI 10.1016/j.tics.2010.06.009; Dyck M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003628; EKMAN P, 1971, J PERS SOC PSYCHOL, V17, P124, DOI 10.1037/h0030377; EKMAN P., 1969, SEMIOTICA, V1, P49, DOI DOI 10.1515/SEMI.1969.1.1.49; Field A, 2013, DISCOVERING STAT USI; FRIDLUND AJ, 1990, J NONVERBAL BEHAV, V14, P113, DOI 10.1007/BF01670438; Frith C, 2009, PHILOS T R SOC B, V364, P3453, DOI 10.1098/rstb.2009.0142; Garau M, 2005, PRESENCE-TELEOP VIRT, V14, P104, DOI 10.1162/1054746053890242; Hess U, 2000, J NONVERBAL BEHAV, V24, P265, DOI 10.1023/A:1006623213355; Hess U, 2005, COGNITION EMOTION, V19, P515, DOI 10.1080/02699930441000364; Hewstone M, 2002, ANNU REV PSYCHOL, V53, P575, DOI 10.1146/annurev.psych.53.100901.135109; Hofstede G., 2001, CULTURES CONSEQUENCE; Hofstede G, 1984, CULTURES CONSEQUENCE; Kramer NC, 2008, HUMAN BEHAV MILITARY; Likowski KU, 2008, J EXP SOC PSYCHOL, V44, P1065, DOI 10.1016/j.jesp.2007.10.007; MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; MATSUMOTO D, 1990, MOTIV EMOTION, V14, P195, DOI 10.1007/BF00995569; Matsumoto D., 2006, SAGE HDB NONVERBAL C, P219; MESQUITA B, 1992, PSYCHOL BULL, V112, P179, DOI 10.1037/0033-2909.112.2.179; Ouellette M, 2009, CYBERPSYCHOL BEHAV, V12, P215, DOI 10.1089/cpb.2008.0089; Pfeiffer UJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027591; Recio G, 2011, BRAIN RES, V1376, P66, DOI 10.1016/j.brainres.2010.12.041; Rymarczyk K, 2011, INT J PSYCHOPHYSIOL, V79, P330, DOI 10.1016/j.ijpsycho.2010.11.001; Schilbach L, 2006, NEUROPSYCHOLOGIA, V44, P718, DOI 10.1016/j.neuropsychologia.2005.07.017; Schilbach L, 2012, BEHAV BRAIN SCI; Schilbach L, 2008, SOC NEUROSCI-UK, V3, P37, DOI 10.1080/17470910701563228; Schonbrodt FD, 2012, J PERS, V80, P429, DOI 10.1111/j.1467-6494.2011.00736.x; Schrammel F, 2009, PSYCHOPHYSIOLOGY, V46, P922, DOI 10.1111/j.1469-8986.2009.00831.x; SINGELIS TM, 1994, PERS SOC PSYCHOL B, V20, P580, DOI 10.1177/0146167294205014; Smoski MJ, 2003, COGNITION EMOTION, V17, P327, DOI 10.1080/02699930302296; Vogeley K, NEURAL NETW IN PRESS; Weyers P, 2006, PSYCHOPHYSIOLOGY, V43, P450, DOI 10.1111/j.1469-8986.2006.00451.x; Wieser MJ, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00471	44	7	7	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e66335	10.1371/journal.pone.0066335	http://dx.doi.org/10.1371/journal.pone.0066335			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	173QU	23762487	Green Published, gold			2022-12-27	WOS:000321094800096
J	Cen, JR; Shi, MS; Yang, YF; Fu, YX; Zhou, HL; Wang, MQ; Su, ZY; Wei, Q				Cen, Juren; Shi, Mingshu; Yang, Yanfang; Fu, Yanxia; Zhou, Hailing; Wang, Mengqi; Su, Zhenyi; Wei, Qun			Isogarcinol Is a New Immunosuppressant	PLOS ONE			English	Article							CYCLOSPORINE-A; BENZOPHENONE DERIVATIVES; ORGAN-TRANSPLANTATION; MEDICINAL PROPERTIES; CARDIAC GROWTH; CALCINEURIN; INHIBITION; KAEMPFEROL; MECHANISM; FRUIT	Calcineurin (CN), a unique protein phosphatase, plays an important role in immune regulation. In this study we used CN as a target enzyme to investigate the immunosuppressive properties of a series of natural compounds from Garcinia mangostana L., and discovered an active compound, isogarcinol. Enzymatic assays showed that isogarcinol inhibited CN in a dose-dependent manner. At concentrations resulting in relatively low cytotoxicity isogarcinol significantly inhibited proliferation of murine spleen T-lymphocytes induced by concanavalin A (ConA) and the mixed lymphocyte reaction (MLR). In addition, it performed much better in acute toxicity tests and via oral administration in mice than cyclosporin A (CsA), with few adverse reactions and low toxicity in experimental animals. Oral administration of isogarcinol in mice resulted in a dose-dependent decrease in delayed type hypersensitivity (DTH) and prolonged graft survival in allogeneic skin transplantation. These findings suggest that isogarcinol could serve as a new oral immunomodulatory drug for preventing transplant rejection, and for long-term medication in autoimmune diseases.	[Cen, Juren; Shi, Mingshu; Fu, Yanxia; Zhou, Hailing; Wang, Mengqi; Su, Zhenyi; Wei, Qun] Beijing Normal Univ, Gene Engn & Biotechnol Beijing Key Lab, Dept Biochem & Mol Biol, Beijing 100875, Peoples R China; [Yang, Yanfang] Hubei Univ Chinese Med, Prov & Minist Established Key Lab Resource & Comp, Wuhan, Peoples R China	Beijing Normal University; Hubei University of Chinese Medicine	Wei, Q (corresponding author), Beijing Normal Univ, Gene Engn & Biotechnol Beijing Key Lab, Dept Biochem & Mol Biol, Beijing 100875, Peoples R China.	weiq@bnu.edu.cn	Su, Zhenyi/AHC-5959-2022		National Natural Science Foundation of China; National Important Novel Medicine Research Project; International Cooperation Project; Fundamental Research Funds for the Central Universities	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Important Novel Medicine Research Project; International Cooperation Project; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The work was supported by grants from the National Natural Science Foundation of China, the National Important Novel Medicine Research Project, the International Cooperation Project and the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baksh S, 2000, SEMIN IMMUNOL, V12, P405, DOI 10.1006/smim.2000.0221; BENNETT WM, 1986, ANNU REV MED, V37, P215; BIERER BE, 1993, CURR OPIN IMMUNOL, V5, P763, DOI 10.1016/0952-7915(93)90135-F; Cardenas ME, 1998, TRENDS BIOTECHNOL, V16, P427, DOI 10.1016/S0167-7799(98)01239-6; CLIPSTONE NA, 1993, ANN NY ACAD SCI, V696, P20; Cuesta-Rubio O, 2005, STUD NAT PROD CHEM, V32, P671; Cui JH, 2010, PHARMACOL BIOCHEM BE, V95, P166, DOI 10.1016/j.pbb.2009.12.021; Feng YH, 2002, ACTA PHARMACOL SIN, V23, P893; Gonsette RE, 2004, J NEUROL SCI, V223, P87, DOI 10.1016/j.jns.2004.04.025; Ho S, 1996, CLIN IMMUNOL IMMUNOP, V80, pS40, DOI 10.1006/clin.1996.0140; Hong JC, 2000, SEMIN NEPHROL, V20, P108; Iinuma M, 1996, BIOL PHARM BULL, V19, P311, DOI 10.1248/bpb.19.311; Issa F, 2010, EXPERT REV CLIN IMMU, V6, P155, DOI 10.1586/ECI.09.64; Ito C, 2003, J NAT PROD, V66, P206, DOI 10.1021/np020372g; Jorgensen KA, 2003, SCAND J IMMUNOL, V57, P93, DOI 10.1046/j.1365-3083.2003.01221.x; Kobayashi K, 2001, MICROSC RES TECHNIQ, V53, P241, DOI 10.1002/jemt.1090; Lechler RI, 2005, NAT MED, V11, P605, DOI 10.1038/nm1251; Lei H, 2011, FOOD CHEM, V127, P1169, DOI 10.1016/j.foodchem.2011.01.119; Lei H, 2009, BBA-PROTEINS PROTEOM, V1794, P1269, DOI 10.1016/j.bbapap.2009.04.014; Li JY, 2010, PHARM BIOL, V48, P1177, DOI 10.3109/13880200903573169; Li X, 2012, INT IMMUNOPHARMACOLO; Liang QR, 2003, EMBO J, V22, P5079, DOI 10.1093/emboj/cdg474; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Mantelingu K, 2007, CHEM BIOL, V14, P645, DOI 10.1016/j.chembiol.2007.04.011; Marti G, 2010, MOLECULES, V15, P7106, DOI 10.3390/molecules15107106; Matsumoto K, 2003, BIOL PHARM BULL, V26, P569, DOI 10.1248/bpb.26.569; Moussay E, 2010, RES DETERMINATION GE; Pedraza-Chaverri J, 2008, FOOD CHEM TOXICOL, V46, P3227, DOI 10.1016/j.fct.2008.07.024; Peng LQ, 2011, IUBMB LIFE, V63, P14, DOI 10.1002/iub.408; Rathee P, 2012, PHARM INNOVATION J, V1, P90; Roy J, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2100re9; Rukachaisirikul V, 2005, CHEM PHARM BULL, V53, P342, DOI 10.1248/cpb.53.342; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Salem ML, 2005, INT IMMUNOPHARMACOL, V5, P1749, DOI 10.1016/j.intimp.2005.06.008; Shen J, 2006, STUDIES CHEM CONSTIT; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; STALLARD N, 1995, HUM EXP TOXICOL, V14, P315, DOI 10.1177/096032719501400401; THOMSON AW, 1984, AGENTS ACTIONS, V15, P307, DOI 10.1007/BF01972366; Vega RB, 2003, J BIOL CHEM, V278, P36981, DOI 10.1074/jbc.R300023200; Wang HL, 2007, IUBMB LIFE, V59, P388, DOI 10.1080/15216540701370721; Wang H, 2008, IUBMB LIFE, V60, P549, DOI 10.1002/iub.94; Wang H, 2010, J BIOCHEM, V147, P185, DOI 10.1093/jb/mvp163; Yu LM, 2007, FOOD CHEM, V104, P176, DOI 10.1016/j.foodchem.2006.11.018; Zhou R, 2005, INT IMMUNOPHARMACOL, V5, P1895, DOI 10.1016/j.intimp.2005.06.009	44	96	102	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66503	10.1371/journal.pone.0066503	http://dx.doi.org/10.1371/journal.pone.0066503			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785505	gold, Green Published, Green Submitted			2022-12-27	WOS:000321038800016
J	Martin, B; Chesnel, F; Delcros, JG; Jouan, F; Couturier, A; Dugay, F; Le Goff, X; Patard, JJ; Fergelot, P; Vigneau, C; Rioux-Leclercq, N; Arlot-Bonnemains, Y				Martin, Benedicte; Chesnel, Franck; Delcros, Jean-Guy; Jouan, Florence; Couturier, Anne; Dugay, Frederic; Le Goff, Xavier; Patard, Jean-Jacques; Fergelot, Patricia; Vigneau, Cecile; Rioux-Leclercq, Nathalie; Arlot-Bonnemains, Yannick			Identification of pVHL as a Novel Substrate for Aurora-A in Clear Cell Renal Cell Carcinoma (ccRCC)	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; EXPRESSION; CANCER; KINASES; CLASSIFICATION; DROSOPHILA; TISSUES; BREAST; GRADE	Clear cell renal cell carcinoma (ccRCC) is the most common histological subtype of kidney cancer and is often characterized by mutations or deletions of the Von Hippel Lindau (VHL) tumour suppressor gene. Aurora gene family members are implicated in proper mitotic progression and spindle checkpoint function and play a crucial role in cancer progression. In the present study, we assessed the expression of Aurora-A in a cohort of 30 ccRCC with fully characterized VHL status (wt/wt or mut/del) and Fuhrman grade. Aurora-A transcript and protein levels were significantly increased in high Fuhrman grade tumours and in VHLwt/wt tumours. These results suggest that Aurora-A and VHL interact in the ccRCC. We demonstrated that the two proteins interact in vivo and identified the Ser72 on the sequence of VHL as the unique site phosphorylated by Aurora-A.	[Martin, Benedicte; Chesnel, Franck; Jouan, Florence; Couturier, Anne; Dugay, Frederic; Le Goff, Xavier; Vigneau, Cecile; Rioux-Leclercq, Nathalie; Arlot-Bonnemains, Yannick] Univ Rennes 1, BIOSIT, CNRS, IGDR,UMR 6290, Rennes, France; [Delcros, Jean-Guy] Ctr Leon Berard, Ctr Rech Cancerol Lyon, UMR INSERM CNRS U1052 5286, Lyon, France; [Patard, Jean-Jacques] CHU Bordeaux, Serv Genet Mol, Bordeaux, France; [Fergelot, Patricia] Hop Bicetre, AP HP, Serv Chirurg Urol, Le Kremlin Bicetre, France; [Rioux-Leclercq, Nathalie] CHU Pontchaillou, Dept Pathol, Rennes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; CHU Bordeaux; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; CHU Rennes	Arlot-Bonnemains, Y (corresponding author), Univ Rennes 1, BIOSIT, CNRS, IGDR,UMR 6290, Rennes, France.	Yannick.arlot@univ-rennes1.fr	vigneau, cecile/I-3178-2015; FERGELOT, Patricia/M-4493-2014; delcros, jean-guy/N-5813-2017; DUGAY, Frédéric/L-9198-2015	delcros, jean-guy/0000-0002-9593-4046; LE GOFF, Xavier/0000-0002-5297-2421; MARTIN, Benedicte/0000-0003-0897-5884	CNRS, the Ligue Nationale Contre le Cancer	CNRS, the Ligue Nationale Contre le Cancer	This work was supported by the CNRS, the Ligue Nationale Contre le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ampofo E, 2010, INT J BIOCHEM CELL B, V42, P1729, DOI 10.1016/j.biocel.2010.07.008; Arlot-Bonnemains Y, 2001, FEBS LETT, V508, P149, DOI 10.1016/S0014-5793(01)03048-4; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Bodmer D, 2002, CANCER GENET CYTOGEN, V134, P6, DOI 10.1016/S0165-4608(01)00585-4; Bufo P, 2010, HISTOL HISTOPATHOL, V25, P1371, DOI 10.14670/HH-25.1371; Buschhorn HM, 2005, PROSTATE, V64, P341, DOI 10.1002/pros.20247; CHEN F, 1995, CANCER RES, V55, P4804; CROSSEY PA, 1994, HUM MOL GENET, V3, P1303; Ehara H, 2003, UROL RES, V31, P382, DOI 10.1007/s00240-003-0354-x; FOSTER K, 1994, BRIT J CANCER, V69, P230, DOI 10.1038/bjc.1994.44; Hergovich A, 2003, NAT CELL BIOL, V5, P64, DOI 10.1038/ncb899; Hergovich A, 2006, MOL CELL BIOL, V26, P5784, DOI 10.1128/MCB.00232-06; Hoque A, 2003, CANCER EPIDEM BIOMAR, V12, P1518; Kaelin WG, 2002, NAT REV CANCER, V2, P673, DOI 10.1038/nrc885; Kim WY, 2004, J CLIN ONCOL, V22, P4991, DOI 10.1200/JCO.2004.05.061; Kimura M, 1997, J BIOL CHEM, V272, P13766, DOI 10.1074/jbc.272.21.13766; Klotzbucher Andrea, 2002, Biological Procedures Online, V4, P62, DOI 10.1251/bpo35; Kovacs G, 1997, J PATHOL, V183, P131, DOI 10.1002/(SICI)1096-9896(199710)183:2<131::AID-PATH931>3.0.CO;2-G; Kurahashi T, 2007, UROL ONCOL-SEMIN ORI, V25, P128, DOI 10.1016/j.urolonc.2006.06.001; Lei Y, 2011, ACTA HISTOCHEM, V113, P514, DOI 10.1016/j.acthis.2010.05.004; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Motzer RJ, 1996, NEW ENGL J MED, V335, P865, DOI 10.1056/NEJM199609193351207; Patard JJ, 2009, BRIT J CANCER, V101, P1417, DOI 10.1038/sj.bjc.6605298; Patard JJ, 2009, CURR OPIN UROL, V19, P454, DOI 10.1097/MOU.0b013e32832f0ccd; Pause A, 1998, P NATL ACAD SCI USA, V95, P993, DOI 10.1073/pnas.95.3.993; Royce ME, 2004, CANCER, V100, P12, DOI 10.1002/cncr.11879; Seagroves T, 2002, CANCER CELL, V1, P211, DOI 10.1016/S1535-6108(02)00048-X; SEIZINGER BR, 1988, NATURE, V332, P268, DOI 10.1038/332268a0; THOENES W, 1986, PATHOL RES PRACT, V181, P125, DOI 10.1016/S0344-0338(86)80001-2; Thoma CR, 2009, NAT CELL BIOL, V11, P994, DOI 10.1038/ncb1912; Ulisse S, 2007, ENDOCR-RELAT CANCER, V14, P827, DOI 10.1677/ERC-07-0053; Ulisse S, 2006, INT J CANCER, V119, P275, DOI 10.1002/ijc.21842	32	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e67071	10.1371/journal.pone.0067071	http://dx.doi.org/10.1371/journal.pone.0067071			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785518	Green Published, gold			2022-12-27	WOS:000321038800006
J	Vaiman, D; Calicchio, R; Miralles, F				Vaiman, Daniel; Calicchio, Rosamaria; Miralles, Francisco			Landscape of Transcriptional Deregulations in the Preeclamptic Placenta	PLOS ONE			English	Article							NF-KAPPA-B; GENE-EXPRESSION PROFILES; MICROARRAY ANALYSIS; UP-REGULATION; REGULATE TRANSCRIPTION; MOLECULAR REGULATION; ENDOTHELIN-1 GENE; IN-VIVO; HYPOXIA; PROTEIN	Preeclampsia is a pregnancy disease affecting 5 to 8% of pregnant women and a leading cause of both maternal and fetal mortality and morbidity. Because of a default in the process of implantation, the placenta of preeclamptic women undergoes insufficient vascularization. This results in placental ischemia, inflammation and subsequent release of placental debris and vasoactive factors in the maternal circulation causing a systemic endothelial activation. Several microarray studies have analyzed the transcriptome of the preeclamptic placentas to identify genes which could be involved in placental dysfunction. In this study, we compared the data from publicly available microarray analyses to obtain a consensus list of modified genes. This allowed to identify consistently modified genes in the preeclamptic placenta. Of these, 67 were up-regulated and 31 down-regulated. Assuming that changes in the transcription level of co-expressed genes may result from the coordinated action of a limited number of transcription factors, we looked for over-represented putative transcription factor binding sites in the promoters of these genes. Indeed, we found that the promoters of up-regulated genes are enriched in putative binding sites for NFkB, CREB, ANRT, REEB1, SP1, and AP-2. In the promoters of down-regulated genes, the most prevalent putative binding sites are those of MZF-1, NFYA, E2F1 and MEF2A. These transcriptions factors are known to regulate specific biological pathways such as cell responses to inflammation, hypoxia, DNA damage and proliferation. We discuss here the molecular mechanisms of action of these transcription factors and how they can be related to the placental dysfunction in the context of preeclampsia.	[Vaiman, Daniel; Calicchio, Rosamaria; Miralles, Francisco] Univ Paris 05, Inst Cochin, INSERM, CNRS,UMR8104,U1016, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Miralles, F (corresponding author), Univ Paris 05, Inst Cochin, INSERM, CNRS,UMR8104,U1016, Paris, France.	francisco.miralles@inserm.fr	Vaiman, Daniel/O-6030-2015	Vaiman, Daniel/0000-0002-1915-0717	CNRS; INSERM; French Research Ministry (Paris XI University)	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); French Research Ministry (Paris XI University)	This work was conducted in a laboratory supported by the CNRS and INSERM. RC is a recipient of a fellowship from the French Research Ministry (Paris XI University). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman DM, 2000, GENE DEV, V14, P3191, DOI 10.1101/gad.853700; Aerts S, 2005, NUCLEIC ACIDS RES, V33, pW393, DOI 10.1093/nar/gki354; Aerts S, 2003, NUCLEIC ACIDS RES, V31, P1753, DOI 10.1093/nar/gkg268; Atkins GB, 2007, CIRC RES, V100, P1686, DOI 10.1161/01.RES.0000267856.00713.0a; Auer J, 2010, J PROTEOMICS, V73, P1004, DOI 10.1016/j.jprot.2009.12.014; Bamberger AM, 2004, VIRCHOWS ARCH, V444, P149, DOI 10.1007/s00428-003-0935-7; Barcena A, 2009, DEV BIOL, V327, P24, DOI 10.1016/j.ydbio.2008.11.017; Basso K, 2010, ADV IMMUNOL, V105, P193, DOI 10.1016/S0065-2776(10)05007-8; BAVISOTTO L, 1991, J EXP MED, V174, P1097, DOI 10.1084/jem.174.5.1097; Centlow M, 2008, FERTIL STERIL, V90, P1834, DOI 10.1016/j.fertnstert.2007.09.030; Chelbi ST, 2012, HUM MOL GENET, V21, P1968, DOI 10.1093/hmg/dds006; Cheng HC, 2002, J BIOL CHEM, V277, P33930, DOI 10.1074/jbc.M201206200; Cindrova-Davies T, 2007, AM J PATHOL, V170, P1511, DOI 10.2353/ajpath.2007.061035; Cole SW, 2005, BIOINFORMATICS, V21, P803, DOI 10.1093/bioinformatics/bti038; COMBS CA, 1993, AM J OBSTET GYNECOL, V169, P215; Cooke CLM, 2002, AM J PHYSIOL-CELL PH, V282, pC395, DOI 10.1152/ajpcell.00295.2001; Crocker I, 2007, PLACENTA, V28, pS4, DOI 10.1016/j.placenta.2007.01.016; Davidson EH, 2006, REG GEN GEN REG; Dechend R, 2003, CIRCULATION, V107, P1632, DOI 10.1161/01.CIR.0000058200.90059.B1; Depoix C, 2011, REPROD SCI, V18, P219, DOI 10.1177/1933719110389337; Dolfini D, 2012, CRIT REV BIOCHEM MOL, V47, P29, DOI 10.3109/10409238.2011.628970; Dong JT, 2009, CELL MOL LIFE SCI, V66, P2691, DOI 10.1007/s00018-009-0045-z; Doridot L, 2013, HYPERTENSION, V61, P662, DOI 10.1161/HYPERTENSIONAHA.111.202994; ECKNER R, 1994, COLD SPRING HARB SYM, V59, P85, DOI 10.1101/SQB.1994.059.01.012; Flajollet S, 2009, J IMMUNOL, V183, P6948, DOI 10.4049/jimmunol.0902053; Foxler DE, 2012, NAT CELL BIOL, V14, P201, DOI 10.1038/ncb2424; Fritah A, 2010, AM J PHYSIOL-ENDOC M, V299, pE335, DOI 10.1152/ajpendo.00243.2010; Fujimoto K, 2001, BIOCHEM BIOPH RES CO, V280, P164, DOI 10.1006/bbrc.2000.4133; Gascoin-Lachambre G, 2010, PLACENTA, V31, P151, DOI 10.1016/j.placenta.2009.11.008; Gould PS, 2010, HYPERTENSION, V56, P172, DOI 10.1161/HYPERTENSIONAHA.110.152074; Grosfeld A, 2002, J BIOL CHEM, V277, P42953, DOI 10.1074/jbc.M206775200; Haugen F, 2007, ENDOCRINOLOGY, V148, P5478, DOI 10.1210/en.2007-0370; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; HE YF, 1995, J BIOL CHEM, V270, P28887, DOI 10.1074/jbc.270.48.28887; Herrscher RF, 1995, GENE DEV, V9, P3067, DOI 10.1101/gad.9.24.3067; Higgins KJ, 2006, BIOCHEM BIOPH RES CO, V345, P292, DOI 10.1016/j.bbrc.2006.04.111; Hitchens MR, 2003, APOPTOSIS, V8, P461, DOI 10.1023/A:1025586207239; Huang J, 2004, J BIOL CHEM, V279, P16847, DOI 10.1074/jbc.M309491200; Imperatore A, 2010, REPROD SCI, V17, P833, DOI 10.1177/1933719110373147; Ito T, 2002, BIOCHEM BIOPH RES CO, V290, P1048, DOI 10.1006/bbrc.2001.6325; James JL, 2010, J PATHOL, V221, P363, DOI 10.1002/path.2719; Jin SQ, 2001, ONCOGENE, V20, P2683, DOI 10.1038/sj.onc.1204390; Johnson W, 1999, MOL ENDOCRINOL, V13, P1963, DOI 10.1210/me.13.11.1963; Kasper LH, 2010, EMBO J, V29, P3660, DOI 10.1038/emboj.2010.235; Kimura C, 2012, J MATERN FETAL NEONA; Kotani T, 2009, ENDOCRINOLOGY, V150, P4376, DOI 10.1210/en.2008-1645; Kruger I, 2007, DEV DYNAM, V236, P2235, DOI 10.1002/dvdy.21222; Kwon HS, 2012, BIOORG MED CHEM LETT, V22, P5249, DOI 10.1016/j.bmcl.2012.06.054; Lin SY, 1996, MOL CELL BIOL, V16, P1668; Maymo JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046216; Louwen F, 2012, ONCOTARGET, V3, P759; LUNELL NO, 1982, CLIN EXP HYPERTENS B, V1, P105, DOI 10.3109/10641958209037184; Luppi P, 2006, AM J REPROD IMMUNOL, V56, P135, DOI 10.1111/j.1600-0897.2006.00386.x; Meinhardt G, 2005, PLACENTA, V26, P527, DOI 10.1016/j.placenta.2004.09.005; Meng T, 2012, OMICS, V16, P301, DOI 10.1089/omi.2011.0066; Minchenko A, 2000, MOL CELL BIOCHEM, V208, P53, DOI 10.1023/A:1007042729486; Mohibullah N, 1999, NUCLEIC ACIDS RES, V27, P2760, DOI 10.1093/nar/27.13.2760; Montagner M, 2012, NATURE, V487, P380, DOI 10.1038/nature11207; Nakada E, 2009, PLACENTA, V30, P774, DOI 10.1016/j.placenta.2009.07.001; Nakshatri H, 1996, J BIOL CHEM, V271, P28784, DOI 10.1074/jbc.271.46.28784; Nevo O, 2006, AM J PHYSIOL-REG I, V291, pR1085, DOI 10.1152/ajpregu.00794.2005; Nishizawa H, 2007, PLACENTA, V28, P487, DOI 10.1016/j.placenta.2006.05.010; Nishizawa H, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-107; O'Connor DJ, 2000, ONCOGENE, V19, P2369, DOI 10.1038/sj.onc.1203540; Oishi Y, 2010, FASEB J, V24, P1780, DOI 10.1096/fj.09-146589; Pang ZJ, 2004, J PERINAT MED, V32, P25, DOI 10.1515/JPM.2004.004; Piechota M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012465; Pillai S, 2010, CANCER RES, V70, P4931, DOI 10.1158/0008-5472.CAN-10-0501; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Rajakumar A, 2011, PLACENTA, V32, P70, DOI 10.1016/j.placenta.2010.10.004; Reimer T, 2002, MOL HUM REPROD, V8, P674, DOI 10.1093/molehr/8.7.674; Richardson BD, 2000, MOL CELL ENDOCRINOL, V160, P183, DOI 10.1016/S0303-7207(99)00209-9; Rigourd V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003905; Roider HG, 2007, BIOINFORMATICS, V23, P134, DOI 10.1093/bioinformatics/btl565; Roider HG, 2009, BIOINFORMATICS, V25, P435, DOI 10.1093/bioinformatics/btn627; RUBINSTEIN JH, 1963, AM J DIS CHILD, V105, P588, DOI 10.1001/archpedi.1963.02080040590010; Sanchez-Elsner T, 2002, J BIOL CHEM, V277, P43799, DOI 10.1074/jbc.M207160200; Sharp TV, 2004, P NATL ACAD SCI USA, V101, P16531, DOI 10.1073/pnas.0407123101; Shi DQ, 1998, J BIOL CHEM, V273, P27331, DOI 10.1074/jbc.273.42.27331; Sibai BM, 2012, AM J OBSTET GYNECOL, V206, P470, DOI 10.1016/j.ajog.2011.09.002; Sitras V, 2009, PLACENTA, V30, P424, DOI 10.1016/j.placenta.2009.01.012; Soleymanlou N, 2005, J CLIN ENDOCR METAB, V90, P4299, DOI 10.1210/jc.2005-0078; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Steinborn A, 2007, AM J REPROD IMMUNOL, V57, P277, DOI 10.1111/j.1600-0897.2007.00475.x; Suzuki Y, 2004, NUCLEIC ACIDS RES, V32, pD78, DOI 10.1093/nar/gkh076; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Takacs P, 2001, FASEB J, V15, P279; Tan NY, 2009, MOL CELL BIOL, V29, P2483, DOI 10.1128/MCB.01828-08; Tapia A, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-14; Thiagalingam A, 1996, MOL CELL BIOL, V16, P5335; Tonon L, 2010, NUCLEIC ACIDS RES, V38, pW286, DOI 10.1093/nar/gkq473; Tsai ACH, 2011, EUR J HUM GENET, V19, P43, DOI 10.1038/ejhg.2010.121; Tsai S, 2011, PLACENTA, V32, P175, DOI 10.1016/j.placenta.2010.11.014; Tsoi SM, 2003, J SOC GYNECOL INVEST, V10, P496, DOI 10.1016/S1071-5576(03)00154-0; van Dijk M, 2011, J PREGNANCY, V2011, DOI 10.1155/2011/521826; van Thienen JV, 2006, CARDIOVASC RES, V72, P231, DOI 10.1016/j.cardiores.2006.07.008; Vasarhelyi B, 2006, MOL HUM REPROD, V12, P31, DOI 10.1093/molehr/gal001; Vaughan JE, 2012, HYPERTENS PREGNANCY, V31, P243, DOI 10.3109/10641955.2011.642436; Wang A, 2009, PHYSIOLOGY, V24, P147, DOI 10.1152/physiol.00043.2008; Webb CF, 2011, MOL CELL BIOL, V31, P1041, DOI 10.1128/MCB.01448-10; Werling U, 2002, MOL CELL BIOL, V22, P3149, DOI 10.1128/MCB.22.9.3149-3156.2002; Winn VD, 2009, ENDOCRINOLOGY, V150, P452, DOI 10.1210/en.2008-0990; Xiong YL, 2013, J CELL PHYSIOL, V228, P362, DOI 10.1002/jcp.24139; Yamashita K, 2001, J BIOL CHEM, V276, P12645, DOI 10.1074/jbc.M011344200; Zhang Y, 2004, VITAM HORM, V68, P1; Zhang Y, 2000, J BIOL CHEM, V275, P2763, DOI 10.1074/jbc.275.4.2763; Zhou X, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.03.013; Zhu XM, 2012, HYPERTENS PREGNANCY, V31, P252, DOI 10.3109/10641955.2011.638955	108	60	62	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65498	10.1371/journal.pone.0065498	http://dx.doi.org/10.1371/journal.pone.0065498			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785430	Green Submitted, Green Published, gold			2022-12-27	WOS:000321038800091
J	Zhang, ZZ; Matos, SC; Jego, S; Adamantidis, A; Seguela, P				Zhang, Zizhen; Matos, Steven Cordeiro; Jego, Sonia; Adamantidis, Antoine; Seguela, Philippe			Norepinephrine Drives Persistent Activity in Prefrontal Cortex via Synergistic alpha 1 and alpha 2 Adrenoceptors	PLOS ONE			English	Article							LOCUS-COERULEUS NEURONS; SPATIAL WORKING-MEMORY; PROTEIN-KINASE-C; POSTTRAUMATIC-STRESS-DISORDER; AXONAL GABA(A) RECEPTORS; HUMAN FRONTAL-CORTEX; PYRAMIDAL NEURONS; COGNITIVE FUNCTION; RAT-BRAIN; ALPHA-1-ADRENERGIC ANTAGONIST	Optimal norepinephrine levels in the prefrontal cortex (PFC) increase delay-related firing and enhance working memory, whereas stress-related or pathologically high levels of norepinephrine are believed to inhibit working memory via alpha 1 adrenoceptors. However, it has been shown that activation of Gq-coupled and phospholipase C-linked receptors can induce persistent firing, a cellular correlate of working memory, in cortical pyramidal neurons. Therefore, despite its importance in stress and cognition, the exact role of norepinephrine in modulating PFC activity remains elusive. Using electrophysiology and optogenetics, we report here that norepinephrine induces persistent firing in pyramidal neurons of the PFC independent of recurrent fast synaptic excitation. This persistent excitatory effect involves presynaptic alpha 1 adrenoceptors facilitating glutamate release and subsequent activation of postsynaptic mGluR5 receptors, and is enhanced by postsynaptic alpha 2 adrenoceptors inhibiting HCN channel activity. Activation of alpha 2 adrenoceptors or inhibition of HCN channels also enhances cholinergic persistent responses in pyramidal neurons, providing a mechanism of crosstalk between noradrenergic and cholinergic inputs. The present study describes a novel cellular basis for the noradrenergic control of cortical information processing and supports a synergistic combination of intrinsic and network mechanisms for the expression of mnemonic properties in pyramidal neurons.	[Zhang, Zizhen; Matos, Steven Cordeiro; Seguela, Philippe] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Alan Edwards Ctr Res Pain, Montreal, PQ H3A 2B4, Canada; [Jego, Sonia; Adamantidis, Antoine] McGill Univ, Dept Psychiat, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada	McGill University; McGill University	Zhang, ZZ (corresponding author), McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Alan Edwards Ctr Res Pain, Montreal, PQ H3A 2B4, Canada.	zizzhang@ucalgary.ca; philippe.seguela@mcgill.ca	Core, Vector/CAF-4832-2022	Adamantidis, Antoine/0000-0003-2531-5175	CIHR [NRF 77566, NRF 86527]; Savoy Foundation for Epilepsy	CIHR(Canadian Institutes of Health Research (CIHR)); Savoy Foundation for Epilepsy	Supported by CIHR (NRF 77566, NRF 86527) and The Savoy Foundation for Epilepsy. Antoine Adamantidis holds a Canada Research Chair in Neural Circuits and Optogenetics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRADE R, 1991, BRAIN RES, V548, P81, DOI 10.1016/0006-8993(91)91109-E; Arnsten AFT, 1999, BIOL PSYCHIAT, V45, P26, DOI 10.1016/S0006-3223(98)00296-0; ARNSTEN AFT, 1985, SCIENCE, V230, P1273, DOI 10.1126/science.2999977; Arnsten AFT, 2011, INT J DEV NEUROSCI, V29, P215, DOI 10.1016/j.ijdevneu.2011.02.006; Arnsten AFT, 2010, TRENDS COGN SCI, V14, P365, DOI 10.1016/j.tics.2010.05.003; ASTONJONES G, 1981, J NEUROSCI, V1, P876; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Birnbaum S, 1999, BIOL PSYCHIAT, V46, P1266, DOI 10.1016/S0006-3223(99)00138-9; Birnbaum SG, 2004, SCIENCE, V306, P882, DOI 10.1126/science.1100021; Birnbaum SG, 2000, PHARMACOL BIOCHEM BE, V67, P397, DOI 10.1016/S0091-3057(00)00306-3; Bondi CO, 2010, PROG NEURO-PSYCHOPH, V34, P913, DOI 10.1016/j.pnpbp.2010.04.016; Boudaba C, 2003, J NEUROENDOCRINOL, V15, P803, DOI 10.1046/j.1365-2826.2003.01063.x; Carr DB, 2007, J PHYSIOL-LONDON, V584, P437, DOI 10.1113/jphysiol.2007.141671; Carr DB, 2007, J NEUROPHYSIOL, V97, P3432, DOI 10.1152/jn.00828.2006; Carter ME, 2010, NAT NEUROSCI, V13, P1526, DOI 10.1038/nn.2682; CONSTANTI A, 1991, NEUROSCI LETT, V131, P27, DOI 10.1016/0304-3940(91)90329-R; Courtney SM, 1998, SCIENCE, V279, P1347, DOI 10.1126/science.279.5355.1347; Day HEW, 1997, J CHEM NEUROANAT, V13, P115, DOI 10.1016/S0891-0618(97)00042-2; Day M, 2005, J NEUROSCI, V25, P8776, DOI 10.1523/JNEUROSCI.2650-05.2005; Dembrow NC, 2010, J NEUROSCI, V30, P16922, DOI 10.1523/JNEUROSCI.3644-10.2010; Egorov AV, 2002, NATURE, V420, P173, DOI 10.1038/nature01171; FINLAY JM, 1995, NEUROSCIENCE, V64, P619, DOI 10.1016/0306-4522(94)00331-X; FOOTE SL, 1980, P NATL ACAD SCI-BIOL, V77, P3033, DOI 10.1073/pnas.77.5.3033; Fowler MA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000573; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; FUSTER JM, 1973, BRAIN RES, V61, P79, DOI 10.1016/0006-8993(73)90517-9; Garcia-Sainz JA, 2004, BIOCHEM PHARMACOL, V67, P1853, DOI 10.1016/j.bcp.2004.01.025; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Goldstein LE, 1996, J NEUROSCI, V16, P4787; Gordon GRJ, 2005, J NEUROSCI, V25, P11385, DOI 10.1523/JNEUROSCI.2378-05.2005; Gordon GRJ, 2003, J NEUROSCI, V23, P6223; GREENE CC, 1994, J NEUROPHYSIOL, V72, P693, DOI 10.1152/jn.1994.72.2.693; Homayoun H, 2004, NEUROPSYCHOPHARMACOL, V29, P1259, DOI 10.1038/sj.npp.1300417; Huang CH, 2010, J NEUROSCI, V30, P11994, DOI 10.1523/JNEUROSCI.2381-10.2010; Huang Z, 2011, NAT NEUROSCI, V14, P478, DOI 10.1038/nn.2757; Kaouane N, 2012, SCIENCE, V335, P1510, DOI 10.1126/science.1207615; Karreman M, 1996, BRAIN RES, V716, P180, DOI 10.1016/0006-8993(96)00015-7; KRNJEVIC K, 1971, J PHYSIOL-LONDON, V215, P247, DOI 10.1113/jphysiol.1971.sp009467; Krueger DD, 2011, ANNU REV MED, V62, P411, DOI 10.1146/annurev-med-061109-134644; Krystal JH, 1996, J CLIN PSYCHIAT, V57, P23; Kuhlman SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002005; Kullmann DM, 2005, PROG BIOPHYS MOL BIO, V87, P33, DOI 10.1016/j.pbiomolbio.2004.06.003; Lapiz MDS, 2006, NEUROSCIENCE, V137, P1039, DOI 10.1016/j.neuroscience.2005.09.031; LEWIS DA, 1989, J COMP NEUROL, V282, P317, DOI 10.1002/cne.902820302; LI BM, 1994, BEHAV NEURAL BIOL, V62, P134, DOI 10.1016/S0163-1047(05)80034-2; Li BM, 1999, NEUROPSYCHOPHARMACOL, V21, P601, DOI 10.1016/S0893-133X(99)00070-6; Lindeberg J, 2004, GENESIS, V40, P67, DOI 10.1002/gene.20065; Locchi F, 2007, NEUROSCI LETT, V422, P213, DOI 10.1016/j.neulet.2007.06.023; Marek GJ, 1999, EUR J PHARMACOL, V367, P197, DOI 10.1016/S0014-2999(98)00945-5; Matzel LD, 2010, NEUROSCI BIOBEHAV R, V34, P23, DOI 10.1016/j.neubiorev.2009.07.002; Melendez RI, 2004, NEUROPSYCHOPHARMACOL, V29, P1980, DOI 10.1038/sj.npp.1300507; MORROW AL, 1986, MOL PHARMACOL, V29, P321; Murai Y, 2005, NEUROSCI RES, V51, P55, DOI 10.1016/j.neures.2004.09.005; Nakadate K, 2006, NEUROSCIENCE, V141, P1783, DOI 10.1016/j.neuroscience.2006.05.031; Navaroli VL, 2012, HIPPOCAMPUS, V22, P1392, DOI 10.1002/hipo.20975; PIERIBONE VA, 1994, J NEUROSCI, V14, P4252; Postle BR, 2000, J COGNITIVE NEUROSCI, V12, P2, DOI 10.1162/089892900564028; Rahman J, 2011, EUR J NEUROSCI, V34, P22, DOI 10.1111/j.1460-9568.2011.07736.x; Ramos BP, 2005, BIOL PSYCHIAT, V58, P894, DOI 10.1016/j.biopsych.2005.05.022; Ramos BP, 2008, NEUROBIOL AGING, V29, P1060, DOI 10.1016/j.neurobiolaging.2007.02.003; Ramos BP, 2007, PHARMACOL THERAPEUT, V113, P523, DOI 10.1016/j.pharmthera.2006.11.006; Ramos BP, 2006, LEARN MEMORY, V13, P770, DOI 10.1101/lm.298006; Raskind MA, 2003, AM J PSYCHIAT, V160, P371, DOI 10.1176/appi.ajp.160.2.371; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Rommelfanger KS, 2009, NEUROSCIENCE, V158, P1530, DOI 10.1016/j.neuroscience.2008.11.019; Ruiz A, 2010, NAT NEUROSCI, V13, P431, DOI 10.1038/nn.2512; SCHWINDT PC, 1988, J NEUROPHYSIOL, V59, P450, DOI 10.1152/jn.1988.59.2.450; SEGUELA P, 1990, NEUROSCIENCE, V35, P249, DOI 10.1016/0306-4522(90)90079-J; Sidiropoulou K, 2009, NAT NEUROSCI, V12, P190, DOI 10.1038/nn.2245; Simpson TL, 2009, ALCOHOL CLIN EXP RES, V33, P255, DOI 10.1111/j.1530-0277.2008.00807.x; Southwick SM, 1997, ANN NY ACAD SCI, V821, P125, DOI 10.1111/j.1749-6632.1997.tb48274.x; Taylor F, 2002, J CLIN PSYCHOPHARM, V22, P82, DOI 10.1097/00004714-200202000-00013; Trigo FF, 2008, EUR J NEUROSCI, V28, P841, DOI 10.1111/j.1460-9568.2008.06404.x; TROVERO F, 1992, NEUROSCIENCE, V47, P69, DOI 10.1016/0306-4522(92)90121-H; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Venkatachalam K, 2003, J BIOL CHEM, V278, P29031, DOI 10.1074/jbc.M302751200; Villalobos C, 2005, EUR J NEUROSCI, V22, P1120, DOI 10.1111/j.1460-9568.2005.04307.x; Wang M, 2007, CELL, V129, P397, DOI 10.1016/j.cell.2007.03.015; Winterfeld KT, 1998, J NEUROSCI RES, V52, P201, DOI 10.1002/(SICI)1097-4547(19980415)52:2<201::AID-JNR8>3.0.CO;2-E; Yan HD, 2009, J NEUROSCI, V29, P10038, DOI 10.1523/JNEUROSCI.1042-09.2009; Yoshida M, 2008, EUR J NEUROSCI, V28, P1116, DOI 10.1111/j.1460-9568.2008.06409.x; Yoshida M, 2009, J NEUROSCI, V29, P4945, DOI 10.1523/JNEUROSCI.5154-08.2009; Zarahn E, 1999, COGNITIVE BRAIN RES, V7, P255, DOI 10.1016/S0926-6410(98)00029-9; Zhang ZZ, 2011, HIPPOCAMPUS, V21, P386, DOI 10.1002/hipo.20755; Zhang ZZ, 2010, CEREB CORTEX, V20, P2948, DOI 10.1093/cercor/bhq043; Zhu MH, 2005, AM J PHYSIOL-CELL PH, V289, pC591, DOI 10.1152/ajpcell.00440.2004	87	20	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66122	10.1371/journal.pone.0066122	http://dx.doi.org/10.1371/journal.pone.0066122			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785477	gold, Green Submitted, Green Published			2022-12-27	WOS:000321038800045
J	Braun, R; Catalani, C; Wimbush, J; Israelski, D				Braun, Rebecca; Catalani, Caricia; Wimbush, Julian; Israelski, Dennis			Community Health Workers and Mobile Technology: A Systematic Review of the Literature	PLOS ONE			English	Review							HUMAN-RESOURCES; DATA-COLLECTION; CARE; INTERVENTION; MIDWIVES; BRIDGE; GAP	Introduction: In low-resource settings, community health workers are frontline providers who shoulder the health service delivery burden. Increasingly, mobile technologies are developed, tested, and deployed with community health workers to facilitate tasks and improve outcomes. We reviewed the evidence for the use of mobile technology by community health workers to identify opportunities and challenges for strengthening health systems in resource-constrained settings. Methods: We conducted a systematic review of peer-reviewed literature from health, medical, social science, and engineering databases, using PRISMA guidelines. We identified a total of 25 unique full-text research articles on community health workers and their use of mobile technology for the delivery of health services. Results: Community health workers have used mobile tools to advance a broad range of health aims throughout the globe, particularly maternal and child health, HIV/AIDS, and sexual and reproductive health. Most commonly, community health workers use mobile technology to collect field-based health data, receive alerts and reminders, facilitate health education sessions, and conduct person-to-person communication. Programmatic efforts to strengthen health service delivery focus on improving adherence to standards and guidelines, community education and training, and programmatic leadership and management practices. Those studies that evaluated program outcomes provided some evidence that mobile tools help community health workers to improve the quality of care provided, efficiency of services, and capacity for program monitoring. Discussion: Evidence suggests mobile technology presents promising opportunities to improve the range and quality of services provided by community health workers. Small-scale efforts, pilot projects, and preliminary descriptive studies are increasing, and there is a trend toward using feasible and acceptable interventions that lead to positive program outcomes through operational improvements and rigorous study designs. Programmatic and scientific gaps will need to be addressed by global leaders as they advance the use and assessment of mobile technology tools for community health workers.	[Braun, Rebecca] Univ Calif Berkeley, Bixby Ctr Populat Hlth & Sustainabil, Berkeley, CA 94720 USA; [Catalani, Caricia; Wimbush, Julian; Israelski, Dennis] Innovat Support Emergencies Dis & Disasters InSTE, Sunnyvale, CA USA; [Catalani, Caricia] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Israelski, Dennis] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Stanford University	Braun, R (corresponding author), Univ Calif Berkeley, Bixby Ctr Populat Hlth & Sustainabil, Berkeley, CA 94720 USA.	rebeccaannbraun@gmail.com			U.S. President's Emergency Plan for AIDS Relief (PEPFAR); Bixby Center for Population, Health and Sustainability at the University of California, Berkeley	U.S. President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Bixby Center for Population, Health and Sustainability at the University of California, Berkeley(University of California System)	This work was supported by the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) and the Bixby Center for Population, Health and Sustainability at the University of California, Berkeley. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berman P., 2011, IMPROVING DELIVERY H; Bernabe-Ortiz A, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-11; Bhutta Z.A., 2010, GLOB HLTH WORKFORCE, V1, P61; Burket M, 2006, IMPROVING REPROD HLT; Chang LW, 2011, AIDS BEHAV, V15, P1776, DOI 10.1007/s10461-011-9995-x; Chen L, 2004, LANCET, V364, P1984, DOI 10.1016/S0140-6736(04)17482-5; Chib A, 2008, ASIAN J COMMUN, V18, P348, DOI 10.1080/01292980802344182; CONWAY ME, 1968, DATAMATION, V14, P28; Curioso Walter H, 2005, AMIA Annu Symp Proc, P176; DeRenzi Brian, 2012, IMPROVING COMMUNITY, P25, DOI [10.1145/2160673.2160677, DOI 10.1145/2160673.2160677]; Florez-Arango JF, 2011, J AM MED INFORM ASSN, V18, P131, DOI 10.1136/jamia.2010.010025; Health Metrics Network, 2008, FRAM STAND COUNTR HL; Hongoro C, 2004, LANCET, V364, P1451, DOI 10.1016/S0140-6736(04)17229-2; Islam MA, 2002, B WORLD HEALTH ORGAN, V80, P445; Jones COH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038636; Lee S, 2011, J HEALTH COMMUN, V16, P1006, DOI 10.1080/10810730.2011.571344; Lemay NV, 2011, J HLTH COMMUN S1, V1, P105; Mahmud N, 2010, TECHNOL HEALTH CARE, V18, P137, DOI 10.3233/THC-2010-0576; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Narasimhan V, 2004, LANCET, V363, P1469, DOI 10.1016/S0140-6736(04)16108-4; Ngabo F, 2012, PAN AFR MED J, V13; Price N, 2010, COMMUNITY BASED DIST; Rotheram-Borus MJ, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-2; Svoronos T, 2010, COMMCARE AUTOMATED Q; Tomlinson M, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-51; World Health Organization, 2010, TAK STOCK TASK SHIFT; World Health Organization, 2006, WORLD HLTH REP 2006; World Health Organization (WHO), 2007, COMMUNITY HLTH WORKE; Zurovac D, 2011, LANCET, V378, P795, DOI 10.1016/S0140-6736(11)60783-6	29	230	236	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65772	10.1371/journal.pone.0065772	http://dx.doi.org/10.1371/journal.pone.0065772			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	163FW	23776544	Green Submitted, Green Published, gold			2022-12-27	WOS:000320322400053
J	Eusebio, N; Pinheiro, T; Amorim, AA; Gamboa, F; Saraiva, L; Gusmao, L; Amorim, A; Araujo, R				Eusebio, Nadia; Pinheiro, Tiago; Amorim, Adelina A.; Gamboa, Fernanda; Saraiva, Lucilia; Gusmao, Leonor; Amorim, Antonio; Araujo, Ricardo			SNaPaer. A Practical Single Nucleotide Polymorphism Multiplex Assay for Genotyping of Pseudomonas aeruginosa	PLOS ONE			English	Article							CYSTIC-FIBROSIS PATIENTS; PRIMER-EXTENSION ASSAY; CLOSTRIDIUM-DIFFICILE; POPULATION-STRUCTURE; NITRATE-RESPIRATION; PCR ASSAYS; IDENTIFICATION; BACTERIA; CLONES; EVOLUTION	Multilocus sequence typing (MLST) represents the gold standard genotyping method in studies concerning microbial population structure, being particularly helpful in the detection of clonal relatedness. However, its applicability on large-scale genotyping is limited due to the high cost and time spent on the task. The selection of the most informative nucleotide positions simplifies genomic characterization of bacteria. A simple and informative multiplex, SNaPaer assay, was developed and genotyping of Pseudomonas aeruginosa was obtained after a single reaction of multiplex PCR amplification and mini-sequencing. This cost-effective technique allowed the analysis of a Portuguese set of isolates (n = 111) collected from three distinct hospitals and the genotyping data could be obtained in less than six hours. Point mutations were shown to be the most frequent event responsible for diversification of the Portuguese population sample. The Portuguese isolates corroborated the epidemic hypothesis for P. aeruginosa population. SNaPaer genotyping assay provided a discriminatory power of 0.9993 for P. aeruginosa, by testing in silico several hundreds of MLST profiles available online. The newly proposed assay targets less than 0.01% of the total MLST length and guarantees reproducibility, unambiguous analysis and the possibility of comparing and transferring data between different laboratories. The plasticity of the method still supports the addition of extra molecular markers targeting specific purposes/populations. SNaPaer can be of great value to clinical laboratories by facilitating routine genotyping of P. aeruginosa.	[Eusebio, Nadia; Pinheiro, Tiago; Gusmao, Leonor; Amorim, Antonio; Araujo, Ricardo] Univ Porto, Inst Mol Pathol & Immunol, IPATIMUP, P-4100 Oporto, Portugal; [Eusebio, Nadia; Amorim, Antonio; Araujo, Ricardo] Univ Porto, Fac Sci, P-4100 Oporto, Portugal; [Amorim, Adelina A.] Univ Porto, Fac Med, Dept Pneumol, P-4100 Oporto, Portugal; [Amorim, Adelina A.] Hosp Sao Joao, Oporto, Portugal; [Gamboa, Fernanda] Hosp Univ Coimbra CHUC, EPE, Serv Pneumol, Coimbra, Portugal; [Saraiva, Lucilia] Univ Porto, Fac Farm, Dept Ciencias Biol, REQUIMTE,Lab Microbiol, P-4100 Oporto, Portugal; [Gusmao, Leonor] Fed Univ Para, Med & Human Genet Lab, BR-66059 Belem, Para, Brazil	Universidade do Porto; Universidade do Porto; Universidade do Porto; Sao Joao Hospital; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); Universidade do Porto; Universidade Federal do Para	Araujo, R (corresponding author), Univ Porto, Inst Mol Pathol & Immunol, IPATIMUP, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	ricjparaujo@yahoo.com	Gusmão, Leonor/L-8931-2019; Gusmao, Leonor/B-3122-2013; Amorim, Antonio/A-7938-2008; Araujo, Ricardo/H-2297-2018; Saraiva, Lucília/D-4897-2013; Araujo, Ricardo/C-3908-2009	Gusmão, Leonor/0000-0003-0432-6481; Gusmao, Leonor/0000-0003-0432-6481; Amorim, Antonio/0000-0002-7518-6247; Araujo, Ricardo/0000-0001-7382-4834; Saraiva, Lucília/0000-0002-9531-4939; Amorim, Adelina/0000-0003-0357-8900; Eusebio, Nadia/0000-0003-2653-8370	Fundacao Calouste Gulbenkian [35-9924-S/2009]; REQUIMTE [PEst-C/EQB/LA0006/2011]; University of Porto; Santander Totta; Fundacao para a Ciencia e a Tecnologia (FCT) Ciencia; European Social Fund; CAPES/Brazil; FCT	Fundacao Calouste Gulbenkian(European Commission); REQUIMTE; University of Porto; Santander Totta; Fundacao para a Ciencia e a Tecnologia (FCT) Ciencia; European Social Fund(European Social Fund (ESF)); CAPES/Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by grants from Fundacao Calouste Gulbenkian (no. 35-9924-S/2009), REQUIMTE (PEst-C/EQB/LA0006/2011), University of Porto and Santander Totta. RA is supported by Fundacao para a Ciencia e a Tecnologia (FCT) Ciencia 2007 and by the European Social Fund. LG is supported by an Invited Professor grant from CAPES/Brazil. IPATIMUP is an Associate Laboratory of the Portuguese Ministry of Science, Technology and Higher Education and is partially supported by FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anuj SN, 2011, CLIN MICROBIOL INFEC, V17, P1403, DOI 10.1111/j.1469-0691.2010.03439.x; Aydin A, 2001, BIOTECHNIQUES, V31, P920, DOI 10.2144/01314rr03; Ben-Darif E, 2010, J CLIN MICROBIOL, V48, P1055, DOI 10.1128/JCM.01566-09; Boers SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039630; Burns JL, 2001, J INFECT DIS, V183, P444, DOI 10.1086/318075; Cheng HR, 2006, BIOTECHNOL LETT, V28, P55, DOI 10.1007/s10529-005-4688-z; Curran B, 2004, J CLIN MICROBIOL, V42, P5644, DOI 10.1128/JCM.42.12.5644-5649.2004; Cuttelod M, 2011, CLIN MICROBIOL INFEC, V17, P57, DOI 10.1111/j.1469-0691.2010.03164.x; Dalmasso A, 2009, INT J FOOD MICROBIOL, V129, P21, DOI 10.1016/j.ijfoodmicro.2008.10.029; Evans SA, 1996, EUR RESPIR J, V9, P1601, DOI 10.1183/09031936.96.09081601; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FAVERO MS, 1971, SCIENCE, V173, P836, DOI 10.1126/science.173.3999.836; Feil EJ, 1999, MOL BIOL EVOL, V16, P1496, DOI 10.1093/oxfordjournals.molbev.a026061; Green DM, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-140; Griffiths D, 2010, J CLIN MICROBIOL, V48, P770, DOI 10.1128/JCM.01796-09; Hansen SK, 2012, ISME J, V6, P31, DOI 10.1038/ismej.2011.83; HIGASHI T, 1960, J BIOCHEM-TOKYO, V47, P326, DOI 10.1093/oxfordjournals.jbchem.a127070; Jolley KA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-86; Jones AM, 2001, LANCET, V358, P557, DOI 10.1016/S0140-6736(01)05714-2; Kerem Eitan, 2005, J Cyst Fibros, V4, P7, DOI 10.1016/j.jcf.2004.12.002; Kidd TJ, 2011, J CLIN MICROBIOL, V49, P263, DOI 10.1128/JCM.01421-10; Lemee L, 2004, J CLIN MICROBIOL, V42, P2609, DOI 10.1128/JCM.42.6.2609-2617.2004; Lomonaco S, 2011, APPL ENVIRON MICROB, V77, P6290, DOI 10.1128/AEM.00429-11; Maatallah M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025617; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Mathee K, 2008, P NATL ACAD SCI USA, V105, P3100, DOI 10.1073/pnas.0711982105; Morales G, 2004, J BACTERIOL, V186, P4228, DOI 10.1128/JB.186.13.4228-4237.2004; Ou LJ, 2005, ELECTROPHORESIS, V26, P99, DOI 10.1002/elps.200406177; Pirnay JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007740; Pollack M., 2000, PRINCIPLES PRACTICE; Polzin T, 2003, OPER RES LETT, V31, P12, DOI 10.1016/S0167-6377(02)00185-2; Rozen S, 2000, Methods Mol Biol, V132, P365; Schreiber K, 2007, J BACTERIOL, V189, P4310, DOI 10.1128/JB.00240-07; Scott FW, 2004, J MED MICROBIOL, V53, P609, DOI 10.1099/jmm.0.45620-0; SELANDER RK, 1990, INFECT IMMUN, V58, P1891, DOI 10.1128/IAI.58.6.1891-1901.1990; Stuart B, 2010, PAEDIATR RESPIR REV, V11, P177, DOI 10.1016/j.prrv.2010.05.003; Syrmis MW, 2004, J MED MICROBIOL, V53, P1089, DOI 10.1099/jmm.0.45611-0; Vallone PM, 2004, BIOTECHNIQUES, V37, P226, DOI 10.2144/04372ST03; Vernez I, 2005, FEMS IMMUNOL MED MIC, V43, P29, DOI 10.1016/j.femsim.2004.06.024; Vezenegho SB, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-282; Vonberg RP, 2005, INFECT CONT HOSP EP, V26, P401, DOI 10.1086/502558; Waters V, 2012, EUR J CLIN MICROBIOL, P1; Woo PCY, 2011, DIAGN MICR INFEC DIS, V70, P316, DOI 10.1016/j.diagmicrobio.2011.03.006	44	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66083	10.1371/journal.pone.0066083	http://dx.doi.org/10.1371/journal.pone.0066083			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776608	Green Published, Green Submitted, gold			2022-12-27	WOS:000320322400077
J	Lambert, AE; Smyth, FL; Beadel, JR; Teachman, BA				Lambert, Ann E.; Smyth, Frederick L.; Beadel, Jessica R.; Teachman, Bethany A.			Aging and Repeated Thought Suppression Success	PLOS ONE			English	Article							MINI-MENTAL-STATE; SELF-CONTROL; PREFRONTAL FUNCTION; EXECUTIVE FUNCTION; COGNITIVE CONTROL; AGE-DIFFERENCES; LIFE-SPAN; ATTENTION; RESOURCE; EMOTION	Intrusive thoughts and attempts to suppress them are common, but while suppression may be effective in the short-term, it can increase thought recurrence in the long-term. Because intentional suppression involves controlled processing, and many aspects of controlled processing decline with age, age differences in thought suppression outcomes may emerge, especially over repeated thought suppression attempts as cognitive resources are expended. Using multilevel modeling, we examined age differences in reactions to thought suppression attempts across four thought suppression sequences in 40 older and 42 younger adults. As expected, age differences were more prevalent during suppression than during free monitoring periods, with younger adults indicating longer, more frequent thought recurrences and greater suppression difficulty. Further, younger adults' thought suppression outcomes changed over time, while trajectories for older adults' were relatively stable. Results are discussed in terms of older adults' reduced thought recurrence, which was potentially afforded by age-related changes in reactive control and distractibility.	[Lambert, Ann E.; Smyth, Frederick L.; Beadel, Jessica R.; Teachman, Bethany A.] Univ Virginia, Dept Psychol, Charlottesville, VA 22903 USA	University of Virginia	Lambert, AE (corresponding author), Univ Virginia, Dept Psychol, Gilmer Hall, Charlottesville, VA 22903 USA.	ael4n@hscmail.mcc.virginia.edu			National Institute on Aging (NIA) [R01AG033033]; NATIONAL INSTITUTE ON AGING [R01AG033033] Funding Source: NIH RePORTER	National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported in part by a National Institute on Aging (NIA) R01AG033033 grant to BAT. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowitz JS, 2001, CLIN PSYCHOL REV, V21, P683, DOI 10.1016/S0272-7358(00)00057-X; Balota D. A., 2000, OXFORD HDB MEMORY, P395, DOI DOI 10.1037/A0015086; Bauml K.-H., 2008, LEARNING MEMORY COMP, P195, DOI DOI 10.1016/B978-012370509-9.00155-8; Beadel JR, J ANXIETY D IN PRESS; Blakemore SJ, 2006, J CHILD PSYCHOL PSYC, V47, P296, DOI 10.1111/j.1469-7610.2006.01611.x; Blanchard-Fields F, 2004, J GERONTOL B-PSYCHOL, V59, pP261, DOI 10.1093/geronb/59.6.P261; BOWLES NL, 1994, PSYCHOL AGING, V9, P414, DOI 10.1037/0882-7974.9.3.414; Braver T. S., 2007, VARIATION WORKING ME, P76, DOI DOI 10.1093/ACPROF:OSO/9780195168648.003.0004; Brewin CR, 2002, BEHAV RES THER, V40, P923, DOI 10.1016/S0005-7967(01)00127-9; Campbell KL, 2010, PSYCHOL SCI, V21, P399, DOI 10.1177/0956797609359910; Carstensen LL, 2003, MOTIV EMOTION, V27, P103, DOI 10.1023/A:1024569803230; Cepeda NJ, 2001, DEV PSYCHOL, V37, P715, DOI 10.1037/0012-1649.37.5.715; Craik F. I., 1982, AGING COGNITIVE PROC, P191, DOI DOI 10.1007/978-1-4684-4178-9_11; Delis DC, 2001, DELIS KAPLAN EXECUTI; Ehlers A, 2000, BEHAV RES THER, V38, P319, DOI 10.1016/S0005-7967(99)00123-0; Erskine JAK, 2007, PERS INDIV DIFFER, V42, P1047, DOI 10.1016/j.paid.2006.09.016; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gailliot MT, 2007, J PERS SOC PSYCHOL, V92, P325, DOI 10.1037/0022-3514.92.2.325; Hasher L, 1999, ATTENTION PERFORM, V17, P653; Hasher L., 1988, PSYCHOL LEARNING MOT, V22, P193, DOI [10.1016/S0079-7421(08)60041-9, DOI 10.1016/S0079-7421(08)60041-9]; HOWARD DV, 1986, J GERONTOL, V41, P195, DOI 10.1093/geronj/41.2.195; Kahneman D., 1973, ATTENTION EFFORT; Kim S, 2007, PSYCHON B REV, V14, P301, DOI 10.3758/BF03194068; Kray J, 2004, ACTA PSYCHOL, V115, P143, DOI 10.1016/j.actpsy.2003.12.001; Madden DJ, 2003, PSYCHOL AGING, V18, P54, DOI 10.1037/0882-7974.18.1.54; Magee JC, 2012, CLIN PSYCHOL REV, V32, P189, DOI 10.1016/j.cpr.2012.01.001; Magee JC, 2012, PSYCHOL AGING, V27, P199, DOI 10.1037/a0024249; Mather M, 2005, TRENDS COGN SCI, V9, P496, DOI 10.1016/j.tics.2005.08.005; McDaniel M. A., 2008, HDB AGING COGNITION, V3rd, P251, DOI DOI 10.1037/0278-7393.30.3.605; Mitchell JP, 2007, PSYCHOL SCI, V18, P292, DOI 10.1111/j.1467-9280.2007.01891.x; Muraven M, 2002, PSYCHOL ADDICT BEHAV, V16, P113, DOI 10.1037//0893-164X.16.2.113; Muraven M, 1998, J PERS SOC PSYCHOL, V74, P774, DOI 10.1037/0022-3514.74.3.774; Paxton JL, 2008, CEREB CORTEX, V18, P1010, DOI 10.1093/cercor/bhm135; RACHMAN S, 1978, BEHAV RES THER, V16, P233, DOI 10.1016/0005-7967(78)90022-0; Rajah MN, 2005, BRAIN, V128, P1964, DOI 10.1093/brain/awh608; Reich DA, 2008, PERS SOC PSYCHOL B, V34, P706, DOI 10.1177/0146167207313732; Reuter-Lorenz PA, 2002, TRENDS COGN SCI, V6, P394, DOI 10.1016/S1364-6613(02)01957-5; Reuter-Lorenz PA, 2008, CURR DIR PSYCHOL SCI, V17, P177, DOI 10.1111/j.1467-8721.2008.00570.x; Richter M, 2008, PSYCHOPHYSIOLOGY, V45, P869, DOI 10.1111/j.1469-8986.2008.00688.x; Romine CB, 2005, APPL NEUROPSYCHOL, V12, P190, DOI 10.1207/s15324826an1204_2; SALKOVSKIS PM, 1984, BEHAV RES THER, V22, P549, DOI 10.1016/0005-7967(84)90057-3; SALTHOUSE TA, 1988, DEV REV, V8, P238, DOI 10.1016/0273-2297(88)90006-8; Shunk AW, 2006, APPL NEUROPSYCHOLOGY, V13; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Thomas RC, 2012, J EXP PSYCHOL LEARN, V38, P30, DOI 10.1037/a0024882; Thorpe S.J., 1997, PHOBIAS HDB THEORY R, P81; TOMBAUGH TN, 1992, J AM GERIATR SOC, V40, P922, DOI 10.1111/j.1532-5415.1992.tb01992.x; Verhaeghen P, 1997, PSYCHOL BULL, V122, P231, DOI 10.1037/0033-2909.122.3.231; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; WEGNER DM, 1987, J PERS SOC PSYCHOL, V53, P5, DOI 10.1037/0022-3514.53.1.5; WEGNER DM, 1994, PSYCHOL REV, V101, P34, DOI 10.1037/0033-295X.101.1.34; WEGNER DM, 1994, J PERS, V62, P615, DOI 10.1111/j.1467-6494.1994.tb00311.x; Wenzlaff EM, 2000, ANNU REV PSYCHOL, V51, P59, DOI 10.1146/annurev.psych.51.1.59; Wenzlaff RM, 2003, COGNITIVE THER RES, V27, P293, DOI 10.1023/A:1023966400540; West RL, 1996, PSYCHOL BULL, V120, P272, DOI 10.1037/0033-2909.120.2.272; Wyland CL, 2003, NEUROPSYCHOLOGIA, V41, P1863, DOI 10.1016/j.neuropsychologia.2003.08.001; Zelazo PD, 2004, ACTA PSYCHOL, V115, P167, DOI 10.1016/j.actpsy.2003.12.005	58	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65009	10.1371/journal.pone.0065009	http://dx.doi.org/10.1371/journal.pone.0065009			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	163FW	23776442	Green Published, gold, Green Submitted			2022-12-27	WOS:000320322400005
J	Manning, PJ; Sutherland, WHF; Williams, SM; de Jong, SA; Hendry, GP				Manning, Patrick J.; Sutherland, Wayne H. F.; Williams, Sheila M.; de Jong, Sylvia A.; Hendry, Gavin P.			Oral but Not Intravenous Glucose Acutely Decreases Circulating Interleukin-6 Concentrations in Overweight Individuals	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; C-REACTIVE PROTEIN; FACTOR-KAPPA-B; CYTOKINE CONCENTRATIONS; ADIPOSE-TISSUE; MONONUCLEAR-CELLS; FACTOR-ALPHA; INSULIN; OBESE; INFLAMMATION	Background: Plasma interleukin-6 (IL-6) concentrations decrease acutely 1 h after ingestion of a glucose load or mixed meals and this may be mediated by an anti-inflammatory effect of insulin. The aim of the present study was to compare the effect of higher versus lower insulin levels on plasma IL-6 concentrations following oral compared with intravenous glucose administration in overweight/obese subjects. Methods and Findings: Fifteen subjects (12 women and 3 men) with BMI >28 kg/m(2) were given an oral glucose load (75g) followed a week later by an intravenous infusion of glucose aimed at matching plasma glucose concentrations during the oral glucose load. A week later, they drank a volume of water equivalent to the volume consumed with the oral glucose load. Plasma glucose, insulin, nonesterified fatty acids, and IL-6 concentrations and blood hematocrit were measured at 30 minute intervals for 2 h following each intervention. Plasma IL-6 decreased (13-20%) significantly (P = 0.009) at 30 min to 90 min following the oral glucose load and did not change significantly following the other two interventions. The incremental area under the curve for plasma IL-6 concentrations following oral intake of glucose was significantly lower compared with concentrations following intravenous glucose (P = 0.005) and water control (P = 0.02). Circulating insulin concentrations were significantly (P<0.001) and 2.8 fold higher following oral compared with intravenous glucose administration. Conclusions: These data show that plasma IL-6 concentrations did not decrease during isoglycemic, intravenous glucose administration suggesting that the markedly higher circulating insulin levels and/or gut-related factors may mediate the acute decrease in plasma IL-6 after oral glucose intake in overweight/obese subjects.	[Manning, Patrick J.; Sutherland, Wayne H. F.; de Jong, Sylvia A.; Hendry, Gavin P.] Univ Otago, Dunedin Sch Med, Dept Med, Dunedin, New Zealand; [Williams, Sheila M.] Univ Otago, Dunedin Sch Med, Dept Prevent & Social Med, Dunedin, New Zealand	University of Otago; University of Otago	Manning, PJ (corresponding author), Univ Otago, Dunedin Sch Med, Dept Med, Dunedin, New Zealand.	PatrickManning@healthotago.co.nz	Williams, Sheila/L-4028-2019		Healthcare Otago Charitable Trust	Healthcare Otago Charitable Trust	This research was funded by a grant from the Healthcare Otago Charitable Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljada A, 2006, METABOLISM, V55, P1177, DOI 10.1016/j.metabol.2006.04.016; Beisswenger PJ, 2011, DIABETIC MED, V28, P1088, DOI 10.1111/j.1464-5491.2011.03324.x; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Chaudhuri A, 2012, J CLIN ENDOCR METAB, V97, P198, DOI 10.1210/jc.2011-1508; Dandona P, 2001, J CLIN ENDOCR METAB, V86, P3257, DOI 10.1210/jc.86.7.3257; Dandona P, 2002, DIABETOLOGIA, V45, P924, DOI 10.1007/s00125-001-0766-5; Dandona P, 2007, AM J CARDIOL, V99, p15B; Danesh J, 2008, PLOS MED, V5, P600, DOI 10.1371/journal.pmed.0050078; Donath MY, 2004, DIABETOLOGIA, V47, P581, DOI 10.1007/s00125-004-1336-4; Esposito K, 2002, CIRCULATION, V106, P2067, DOI 10.1161/01.CIR.0000034509.14906.AE; Ghanim H, 2010, DIABETES CARE, V33, P1103, DOI 10.2337/dc09-2193; Holmer-Jensen J, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-115; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kern PA, 2001, AM J PHYSIOL-ENDOC M, V280, pE745; LE JM, 1989, LAB INVEST, V61, P588; Lundman P, 2007, NUTR METAB CARDIOVAS, V17, P195, DOI 10.1016/j.numecd.2005.11.009; Makdissi A, 2012, J CLIN ENDOCR METAB, V97, P3333, DOI 10.1210/jc.2012-1544; Manning PJ, 2008, METABOLISM, V57, P1345, DOI 10.1016/j.metabol.2008.04.020; Manning PJ, 2008, OBESITY, V16, P2046, DOI 10.1038/oby.2008.334; Manning PJ, 2004, DIABETES CARE, V27, P2509, DOI 10.2337/diacare.27.10.2509; MATTHEWS JNS, 1990, BRIT MED J, V300, P230, DOI 10.1136/bmj.300.6719.230; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Toft-Nielsen MB, 2001, J CLIN ENDOCR METAB, V86, P3717, DOI 10.1210/jc.86.8.3717; Yu RN, 2006, OBESITY, V14, P1353, DOI 10.1038/oby.2006.153	25	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66395	10.1371/journal.pone.0066395	http://dx.doi.org/10.1371/journal.pone.0066395			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776669	Green Published, Green Submitted, gold			2022-12-27	WOS:000320322400101
J	Neal, MD; Jia, H; Eyer, B; Good, M; Guerriero, CJ; Sodhi, CP; Afrazi, A; Prindle, T; Ma, C; Branca, M; Ozolek, J; Brodsky, JL; Wipf, P; Hackam, DJ				Neal, Matthew D.; Jia, Hongpeng; Eyer, Benjamin; Good, Misty; Guerriero, Christopher J.; Sodhi, Chhinder P.; Afrazi, Amin; Prindle, Thomas, Jr.; Ma, Congrong; Branca, Maria; Ozolek, John; Brodsky, Jeffrey L.; Wipf, Peter; Hackam, David J.			Discovery and Validation of a New Class of Small Molecule Toll-Like Receptor 4 (TLR4) Inhibitors	PLOS ONE			English	Article							NECROTIZING ENTEROCOLITIS; MURINE MODELS; CELLS; PATHOGENESIS; PROLIFERATION; ANTAGONIST; EXPRESSION; ENDOTOXIN; COMPLEX	Many inflammatory diseases may be linked to pathologically elevated signaling via the receptor for lipopolysaccharide (LPS), toll-like receptor 4 (TLR4). There has thus been great interest in the discovery of TLR4 inhibitors as potential anti-inflammatory agents. Recently, the structure of TLR4 bound to the inhibitor E5564 was solved, raising the possibility that novel TLR4 inhibitors that target the E5564-binding domain could be designed. We utilized a similarity search algorithm in conjunction with a limited screening approach of small molecule libraries to identify compounds that bind to the E5564 site and inhibit TLR4. Our lead compound, C34, is a 2-acetamidopyranoside (MW 389) with the formula C17H27NO9, which inhibited TLR4 in enterocytes and macrophages in vitro, and reduced systemic inflammation in mouse models of endotoxemia and necrotizing enterocolitis. Molecular docking of C34 to the hydrophobic internal pocket of the TLR4 co-receptor MD-2 demonstrated a tight fit, embedding the pyran ring deep inside the pocket. Strikingly, C34 inhibited LPS signaling ex-vivo in human ileum that was resected from infants with necrotizing enterocolitis. These findings identify C34 and the beta-anomeric cyclohexyl analog C35 as novel leads for small molecule TLR4 inhibitors that have potential therapeutic benefit for TLR4-mediated inflammatory diseases.	[Neal, Matthew D.; Jia, Hongpeng; Sodhi, Chhinder P.; Afrazi, Amin; Prindle, Thomas, Jr.; Ma, Congrong; Branca, Maria; Hackam, David J.] Univ Pittsburgh, Childrens Hosp Pittsburgh, Sch Med, Div Pediat Surg, Pittsburgh, PA 15260 USA; [Neal, Matthew D.; Jia, Hongpeng; Sodhi, Chhinder P.; Afrazi, Amin; Prindle, Thomas, Jr.; Ma, Congrong; Branca, Maria; Hackam, David J.] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA USA; [Eyer, Benjamin; Wipf, Peter] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA; [Good, Misty; Wipf, Peter] Univ Pittsburgh, Ctr Chem Methodol & Lib Dev, Pittsburgh, PA USA; [Guerriero, Christopher J.; Brodsky, Jeffrey L.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Good, Misty] Univ Pittsburgh, Childrens Hosp Pittsburgh, Sch Med, Div Newborn Med, Pittsburgh, PA USA; [Good, Misty] Univ Pittsburgh, Childrens Hosp Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA USA; [Ozolek, John] Univ Pittsburgh, Childrens Hosp Pittsburgh, Sch Med, Div Pathol, Pittsburgh, PA USA; [Ozolek, John] Univ Pittsburgh, Childrens Hosp Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Hackam, DJ (corresponding author), Univ Pittsburgh, Childrens Hosp Pittsburgh, Sch Med, Div Pediat Surg, Pittsburgh, PA 15260 USA.	david.hackam@chp.edu	Neal, Matthew/GMW-5601-2022; Wipf, Peter/AAG-1771-2021; Good, Misty/AAI-6192-2020	Neal, Matthew/0000-0001-8931-6236; Wipf, Peter/0000-0001-7693-5863; Good, Misty/0000-0002-0264-5721; Guerriero, Christopher/0000-0002-1046-2300; Hackam, David/0000-0001-5195-8807	Hartwell Foundation; National Institutes of Health (NIH) [GM078238]; NIH [GM067082, GM75061, K12HD052892]; NRSA from the NIH [F32-GM090364]; Children's Hospital of Pittsburgh of the UPMC Health System; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD052892] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083752, F30DK085930] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM090364, R01GM075061, P50GM067082, P50GM053789, R01GM078238] Funding Source: NIH RePORTER	Hartwell Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRSA from the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Hospital of Pittsburgh of the UPMC Health System; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	DJH was funded by The Hartwell Foundation (to DJH) and GM078238 from the National Institutes of Health (NIH). PW was funded by GM067082 from the NIH. JLB was funded by GM75061 from the NIH. CB was funded by NRSA F32-GM090364 from the NIH. MG was supported by K12HD052892 from the NIH and the Children's Hospital of Pittsburgh of the UPMC Health System. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrazi A, 2012, J IMMUNOL, V188, P4543, DOI 10.4049/jimmunol.1103114; Afrazi A, 2011, PEDIATR RES, V69, P183, DOI 10.1203/PDR.0b013e3182093280; [Anonymous], 2011, INST JCHEM WAS US CH; Awla D, 2011, INFLAMM RES, V60, P1093, DOI 10.1007/s00011-011-0370-1; Barochia A, 2011, EXPERT OPIN DRUG MET, V7, P479, DOI 10.1517/17425255.2011.558190; Bode L, 2004, THROMB HAEMOSTASIS, V92, P1402, DOI 10.1160/TH04-01-0055; Bode L, 2004, J LEUKOCYTE BIOL, V76, P820, DOI 10.1189/jlb.0304198; Bode L, 2012, ADV NUTR, V3, p383S, DOI 10.3945/an.111.001404; Bortoluci KR, 2010, CELL MOL LIFE SCI, V67, P1643, DOI 10.1007/s00018-010-0335-5; Carlsen H, 2002, J IMMUNOL, V168, P1441, DOI 10.4049/jimmunol.168.3.1441; Chen CM, 2012, J ELECTRON MATER, V41, P1, DOI 10.1007/s11664-011-1777-8; Ciszewicz M, 2007, TRANSL RES, V150, P337, DOI 10.1016/j.trsl.2007.07.002; den Dekker WK, 2010, ATHEROSCLEROSIS, V209, P314, DOI 10.1016/j.atherosclerosis.2009.09.075; Fort MM, 2005, J IMMUNOL, V174, P6416, DOI 10.4049/jimmunol.174.10.6416; Good M, 2012, P NATL ACAD SCI USA, V109, P11330, DOI 10.1073/pnas.1200856109; Gribar SC, 2009, J IMMUNOL, V182, P636, DOI 10.4049/jimmunol.182.1.636; Iglesias-Guerra F, 1998, CARBOHYDR RES, P308; Jilling T, 2006, J IMMUNOL, V177, P3273, DOI 10.4049/jimmunol.177.5.3273; Johnson DA, 2008, CURR TOP MED CHEM, V8, P64, DOI 10.2174/156802608783378882; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Kunz C, 2008, ADV EXP MED BIOL, V606, P455, DOI 10.1007/978-0-387-74087-4_18; Leaphart CL, 2007, J IMMUNOL, V179, P4808, DOI 10.4049/jimmunol.179.7.4808; Lee KH, 2011, J BIOL CHEM, V286, P5727, DOI 10.1074/jbc.M110.108001; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Neal MD, 2012, J BIOL CHEM, V287, P37296, DOI 10.1074/jbc.M112.375881; Neal MD, 2013, J IMMUNOL; Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408; Pierer M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023539; Rajapakse AG, 2009, OXID MED CELL LONGEV, V2, P172, DOI 10.4161/oxim.2.3.8482; Richardson WM, 2010, GASTROENTEROLOGY, V139, P904, DOI 10.1053/j.gastro.2010.05.038; RIETSCHEL ET, 1994, FASEB J, V8, P217, DOI 10.1096/fasebj.8.2.8119492; Sakai S, 2010, LIFE SCI, V86, P337, DOI 10.1016/j.lfs.2010.01.001; Sanlioglu S, 2001, J BIOL CHEM, V276, P30188, DOI 10.1074/jbc.M102061200; Sodhi CP, 2012, GASTROENTEROLOGY, V143, P708, DOI 10.1053/j.gastro.2012.05.053; Sodhi CP, 2010, GASTROENTEROLOGY, V138, P185, DOI 10.1053/j.gastro.2009.09.045; Souza-Fonseca-Guimaraes F, 2012, CRIT CARE, V16, DOI 10.1186/cc11838; Yuan FF, 2008, IMMUNOL CELL BIOL, V86, P268, DOI 10.1038/sj.icb.7100155	37	75	78	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65779	10.1371/journal.pone.0065779	http://dx.doi.org/10.1371/journal.pone.0065779			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776545	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000320322400054
J	Radulovic, K; Rossini, V; Manta, C; Holzmann, K; Kestler, HA; Niess, JH				Radulovic, Katarina; Rossini, Valerio; Manta, Calin; Holzmann, Karlheinz; Kestler, Hans A.; Niess, Jan Hendrik			The Early Activation Marker CD69 Regulates the Expression of Chemokines and CD4 T Cell Accumulation in Intestine	PLOS ONE			English	Article							GENE-DEFICIENT MICE; DENDRITIC CELLS; LYMPHOCYTE EGRESS; CUTTING EDGE; INFLAMMATORY CONDITIONS; IMMUNE-RESPONSES; LAMINA PROPRIA; GUT; COLITIS; PROTECTION	Migration of naive and activated lymphocytes is regulated by the expression of various molecules such as chemokine receptors and ligands. CD69, the early activation marker of C-type lectin domain family, is also shown to regulate the lymphocyte migration by affecting their egress from the thymus and secondary lymphoid organs. Here, we aimed to investigate the role of CD69 in accumulation of CD4 T cells in intestine using murine models of inflammatory bowel disease. We found that genetic deletion of CD69 in mice increases the expression of the chemokines CCL-1, CXCL-10 and CCL-19 in CD4(+) T cells and/or CD4 2 cells. Efficient in vitro migration of CD69-deficient CD4 T cells toward the chemokine stimuli was the result of increased expression and/or affinity of chemokine receptors. In vivo CD69(-/-) CD4 T cells accumulate in the intestine in higher numbers than B6 CD4 T cells as observed in competitive homing assay, dextran sodium sulphate (DSS)-induced colitis and antigen-specific transfer colitis. In DSS colitis CD69(-/-) CD4 T cell accumulation in colonic lamina propria (cLP) was associated with increased expression of CCL-1, CXCL-10 and CCL-19 genes. Furthermore, treatment of DSS-administrated CD69(-/-) mice with the mixture of CCL-1, CXCL-10 and CCL-19 neutralizing Abs significantly decreased the histopathological signs of colitis. Transfer of OT-II6CD69(-/-) CD45RB(high) CD4 T cells into RAG(-/-) hosts induced CD4 T cell accumulation in cLP. This study showed CD69 as negative regulator of inflammatory responses in intestine as it decreases the expression of chemotactic receptors and ligands and reduces the accumulation of CD4 T cells in cLP during colitis.	[Radulovic, Katarina; Rossini, Valerio; Manta, Calin; Niess, Jan Hendrik] Univ Ulm, Dept Internal Med, D-89069 Ulm, Germany; [Radulovic, Katarina] Univ Ulm, Inst Microbiol & Biotechnol, D-89069 Ulm, Germany; [Holzmann, Karlheinz] Univ Ulm, Microarray Core Facil, D-89069 Ulm, Germany; [Kestler, Hans A.] Univ Ulm, Res Grp Bioinformat & Syst Biol, Inst Neural Informat Proc, D-89069 Ulm, Germany; [Niess, Jan Hendrik] Univ Bern, Inselspital, Dept Visceral Surg & Med, CH-3010 Bern, Switzerland	Ulm University; Ulm University; Ulm University; Ulm University; University of Bern; University Hospital of Bern	Radulovic, K (corresponding author), Univ Ulm, Dept Internal Med, D-89069 Ulm, Germany.	katarina.radulovic@uni-ulm.de	Kestler, Hans A./D-5799-2012; Niess, Jan/E-8361-2017; Rossini, Valerio/AAH-1338-2020	Kestler, Hans A./0000-0002-4759-5254; Niess, Jan/0000-0001-6902-5650; Rossini, Valerio/0000-0003-2792-0360	Deutsche Forschungsgemeinschaft (DFG) [Ni575/6-2, Ni575/7-1]; International Graduate School of Molecular Medicine of Ulm University [GSC270]; European Mucosal Immunology Group (EMIG); German Gastroenterology Association (DGVS)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); International Graduate School of Molecular Medicine of Ulm University; European Mucosal Immunology Group (EMIG); German Gastroenterology Association (DGVS)	This work was supported by grants Ni575/6-2 and Ni575/7-1 from the Deutsche Forschungsgemeinschaft (DFG) to J.H.N., the International Graduate School of Molecular Medicine of Ulm University (GSC270) to V. R. and a young investigator travel awards to K. R. by the European Mucosal Immunology Group (EMIG) and by the German Gastroenterology Association (DGVS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERG EL, 1993, NATURE, V366, P695, DOI 10.1038/366695a0; Bromley SK, 2013, J IMMUNOL, V190, P970, DOI 10.4049/jimmunol.1202805; Casazza JP, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000646; Cassani B, 2011, GASTROENTEROLOGY, V141, P2109, DOI 10.1053/j.gastro.2011.09.015; Cauley LS, 2013, MUCOSAL IMMUNOL, V6, P14, DOI 10.1038/mi.2012.96; Cauley LS, 2002, J IMMUNOL, V169, P6655, DOI 10.4049/jimmunol.169.12.6655; CLARK MA, 1993, J HISTOCHEM CYTOCHEM, V41, P1679, DOI 10.1177/41.11.7691933; Cruz-Adalia A, 2010, CIRCULATION, V122, P1396, DOI 10.1161/CIRCULATIONAHA.110.952820; De Calisto J, 2011, METHODS MOL BIOL, V757, P411, DOI 10.1007/978-1-61779-166-6_24; Deguchi Y, 2006, ONCOL REP, V16, P699; Elgueta R, 2008, J IMMUNOL, V180, P6501, DOI 10.4049/jimmunol.180.10.6501; Esplugues E, 2005, BLOOD, V105, P4399, DOI 10.1182/blood-2004-10-3854; Esplugues E, 2003, J EXP MED, V197, P1093, DOI 10.1084/jem.20021337; Feng CG, 2002, INT IMMUNOL, V14, P535, DOI 10.1093/intimm/dxf020; Grigorova IL, 2010, P NATL ACAD SCI USA, V107, P20447, DOI 10.1073/pnas.1009968107; Grigorova IL, 2009, NAT IMMUNOL, V10, P58, DOI 10.1038/ni.1682; Hammerschmidt SI, 2011, J CLIN INVEST, V121, P3051, DOI 10.1172/JCI44262; Han YM, 2009, J IMMUNOL, V182, P111, DOI 10.4049/jimmunol.182.1.111; Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494; Lamana A, 2011, J INVEST DERMATOL, V131, P1503, DOI 10.1038/jid.2011.54; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Lu SY, 2012, CLIN TRANSPLANT, V26, pE158, DOI 10.1111/j.1399-0012.2012.01630.x; Mackay CR, 2008, NAT IMMUNOL, V9, P988, DOI 10.1038/ni.f.210; Martin P, 2010, MOL CELL BIOL, V30, P4877, DOI 10.1128/MCB.00456-10; Martin P, 2010, J ALLERGY CLIN IMMUN, V126, P355, DOI 10.1016/j.jaci.2010.05.010; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; McLoughlin RM, 2006, P NATL ACAD SCI USA, V103, P10408, DOI 10.1073/pnas.0508961103; Miki-Hosokawa T, 2009, J IMMUNOL, V183, P8203, DOI 10.4049/jimmunol.0900646; Mizushima T, 2004, INFLAMM BOWEL DIS, V10, P182, DOI 10.1097/00054725-200405000-00002; Mora JR, 2008, INFLAMM BOWEL DIS, V14, P275, DOI 10.1002/ibd.20280; Murata K, 2003, INT IMMUNOL, V15, P987, DOI 10.1093/intimm/dxg102; Nakayama T, 2002, J IMMUNOL, V168, P87, DOI 10.4049/jimmunol.168.1.87; Nicholson MW, 1998, J BIOL CHEM, V273, P763, DOI 10.1074/jbc.273.2.763; Niess JH, 2008, J IMMUNOL, V180, P559, DOI 10.4049/jimmunol.180.1.559; Niess JH, 2010, J IMMUNOL, V184, P2026, DOI 10.4049/jimmunol.0901936; Radulovic K, 2012, J IMMUNOL, V188, P2001, DOI 10.4049/jimmunol.1100765; Roman E, 2010, J IMMUNOL, V185, P3819, DOI 10.4049/jimmunol.0900665; Sanada Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023933; Sancho D, 2003, J CLIN INVEST, V112, P872, DOI 10.1172/JCI200319112; Sanna MG, 2004, J BIOL CHEM, V279, P13839, DOI 10.1074/jbc.M311743200; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Soler D, 2006, J IMMUNOL, V177, P6940, DOI 10.4049/jimmunol.177.10.6940; Song J, 2008, J PHARMACOL EXP THER, V324, P276, DOI 10.1124/jpet.106.119172; Teijaro JR, 2011, J IMMUNOL, V187, P5510, DOI 10.4049/jimmunol.1102243; Vega-Ramos J, 2010, IMMUNOL CELL BIOL, V88, P707, DOI 10.1038/icb.2010.62; Vintersten K, 2004, GENESIS, V40, P241, DOI 10.1002/gene.20095; Wang C, 2009, MUCOSAL IMMUNOL, V2, P173, DOI 10.1038/mi.2008.84; Wurbel MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016442; Yuan YH, 2001, INFLAMM BOWEL DIS, V7, P281, DOI 10.1097/00054725-200111000-00001; Zhao QY, 2012, J IMMUNOL, V188, P1117, DOI 10.4049/jimmunol.1100164	50	41	41	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65413	10.1371/journal.pone.0065413	http://dx.doi.org/10.1371/journal.pone.0065413			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776480	Green Published, Green Submitted, gold			2022-12-27	WOS:000320322400023
J	Shi, L; Yu, XM; Yang, HL; Wu, XY				Shi, Long; Yu, Xiaoming; Yang, Hongling; Wu, Xinyi			Advanced Glycation End Products Induce Human Corneal Epithelial Cells Apoptosis through Generation of Reactive Oxygen Species and Activation of JNK and p38 MAPK Pathways	PLOS ONE			English	Article							N-EPSILON-CARBOXYMETHYLLYSINE; OXIDATIVE STRESS; NADPH OXIDASE; IN-VITRO; RECEPTOR; RAGE; EXPRESSION; AGES; MECHANISMS; DISEASE	Advanced Glycation End Products (AGEs) has been implicated in the progression of diabetic keratopathy. However, details regarding their function are not well understood. In the present study, we investigated the effects of intracellular reactive oxygen species (ROS) and JNK, p38 MAPK on AGE-modified bovine serum albumin (BSA) induced Human telomerase-immortalized corneal epithelial cells (HUCLs) apoptosis. We found that AGE-BSA induced HUCLs apoptosis and increased Bax protein expression, decreased Bcl-2 protein expression. AGE-BSA also induced the expression of receptor for advanced glycation end product (RAGE). AGE-BSA-RAGE interaction induced intracellular ROS generation through activated NADPH oxidase and increased the phosphorylation of p47phox. AGE-BSA induced HUCLs apoptosis was inhibited by pretreatment with NADPH oxidase inhibitors, ROS quencher N-acetylcysteine (NAC) or neutralizing anti-RAGE antibodies. We also found that AGE-BSA induced JNK and p38 MAPK phosphorylation. JNK and p38 MAPK inhibitor effectively blocked AGE-BSA-induced HUCLs apoptosis. In addition, NAC completely blocked phosphorylation of JNK and p38 MAPK induced by AGE-BSA. Our results indicate that AGE-BSA induced HUCLs apoptosis through generation of intracellular ROS and activation of JNK and p38 MAPK pathways.	[Shi, Long; Yu, Xiaoming; Yang, Hongling; Wu, Xinyi] Shandong Univ, Qilu Hosp, Dept Ophthalmol, Jinan 250100, Peoples R China; [Shi, Long; Yu, Xiaoming] Shandong Univ, Qilu Hosp, Chinese Minist Educ, Key Lab Cardiovasc Remodeling & Funct Res, Jinan 250100, Peoples R China; [Shi, Long; Yu, Xiaoming] Shandong Univ, Qilu Hosp, Chinese Minist Hlth, Jinan 250100, Peoples R China	Shandong University; Shandong University; Shandong University	Wu, XY (corresponding author), Shandong Univ, Qilu Hosp, Dept Ophthalmol, Jinan 250100, Peoples R China.	xywu8868@163.com			Education Ministry Fund of China [20070422081]; Natural Science Foundation of Shandong Province, China [2007GG20002031]	Education Ministry Fund of China; Natural Science Foundation of Shandong Province, China(Natural Science Foundation of Shandong Province)	This work was supported by the Education Ministry Fund of China (No. 20070422081) and Natural Science Foundation of Shandong Province, China (No. 2007GG20002031). The URL of the Education Ministry Fund of China website: http://www.cutech.edu.cn/cn/kyjj/gdxxbsdkyjj/A010301index_1.htm. The URL of Natural Science Foundation of Shandong Province website: http://jihlx.sdstc.gov.cn/stdpms/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Azayzih A, 2012, BIOCHEM BIOPH RES CO, V427, P165, DOI 10.1016/j.bbrc.2012.09.035; Alikhani M, 2007, AM J PHYSIOL-CELL PH, V292, pC850, DOI 10.1152/ajpcell.00356.2006; Alikhani M, 2007, BONE, V40, P345, DOI 10.1016/j.bone.2006.09.011; Alves M, 2005, DIABETOLOGIA, V48, P2675, DOI 10.1007/s00125-005-0010-9; Barlovic DP, 2011, CLIN SCI, V121, P43, DOI 10.1042/CS20100501; Basta G, 2005, ARTERIOSCL THROM VAS, V25, P1401, DOI 10.1161/01.ATV.0000167522.48370.5e; Belambri SA, 2012, AM J BLOOD RES, V2, P187; Busch M, 2008, NEPHRON CLIN PRACT, V108, pC291, DOI 10.1159/000127838; Busch M, 2006, AM J KIDNEY DIS, V48, P571, DOI 10.1053/j.ajkd.2006.07.009; Chen LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046744; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Ferrannini E, 2012, LANCET, V380, P601, DOI 10.1016/S0140-6736(12)60987-8; Guimaraes ELM, 2010, J HEPATOL, V52, P389, DOI 10.1016/j.jhep.2009.12.007; Gul M, 2008, CORNEA, V27, P795, DOI 10.1097/ICO.0b013e318169d67c; Guo WJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046018; Hsu WH, 2007, ARCH TOXICOL, V81, P719, DOI 10.1007/s00204-006-0169-y; Huo YA, 2009, EXP EYE RES, V89, P876, DOI 10.1016/j.exer.2009.07.012; Ishibashi Y, 2012, METABOLISM, V61, P1067, DOI 10.1016/j.metabol.2012.01.006; Jendrysik MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028198; Kaji Y, 2000, INVEST OPHTH VIS SCI, V41, P362; Kim J, 2012, FREE RADICAL BIO MED, V53, P357, DOI 10.1016/j.freeradbiomed.2012.04.030; Kim J, 2011, J PHARM PHARMACOL, V63, P524, DOI 10.1111/j.2042-7158.2010.01206.x; Kim J, 2011, GRAEF ARCH CLIN EXP, V249, P529, DOI 10.1007/s00417-010-1573-9; Klenovics KS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053056; Kumar A, 2006, MICROBES INFECT, V8, P380, DOI 10.1016/j.micinf.2005.07.006; Liu JP, 2012, PLANTA MED, V78, P1757, DOI 10.1055/s-0032-1315257; Liu Y, 2011, ANTIOXID REDOX SIGN, V15, P1769, DOI 10.1089/ars.2010.3764; Malla R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013731; Niiya Y, 2012, J STROKE CEREBROVASC, V21, P293, DOI 10.1016/j.jstrokecerebrovasdis.2010.09.002; Octavia Y, 2012, FREE RADICAL BIO MED, V52, P291, DOI 10.1016/j.freeradbiomed.2011.10.482; Park S, 2011, FRONT BIOSCI-LANDMRK, V16, P486, DOI 10.2741/3700; Patel R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035143; Prasad A, 2012, CARDIOL REV, V20, P177, DOI 10.1097/CRD.0b013e318244e57c; Ramasamy R, 2011, ANN NY ACAD SCI, V1243, P88, DOI 10.1111/j.1749-6632.2011.06320.x; Riemann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022445; Schulze SD, 2006, AM J OPHTHALMOL, V142, P207, DOI 10.1016/j.ajo.2006.04.017; Sheikpranbabu S, 2011, DIABETES METAB, V37, P505, DOI 10.1016/j.diabet.2011.03.006; Shi L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032128; Sorci G, 2013, BBA-MOL CELL RES, V1833, P101, DOI 10.1016/j.bbamcr.2012.10.021; Sugamura K, 2011, FREE RADICAL BIO MED, V51, P978, DOI 10.1016/j.freeradbiomed.2011.05.004; Sukkar MB, 2012, BRIT J PHARMACOL, V167, P1161, DOI 10.1111/j.1476-5381.2012.01984.x; van Zoelen Marieke A D, 2011, Front Biosci (Schol Ed), V3, P1119; Xu KP, 2009, DIABETES, V58, P1077, DOI 10.2337/db08-0997; Xu KP, 2011, INVEST OPHTH VIS SCI, V52, P3301, DOI 10.1167/iovs.10-5670; Xue J, 2011, STRUCTURE, V19, P722, DOI 10.1016/j.str.2011.02.013; Yamagishi S, 2006, J BIOL CHEM, V281, P20213, DOI 10.1074/jbc.M602110200; Yamagishi S, 2011, CURR PHARM BIOTECHNO, V12, P362, DOI 10.2174/138920111794480534; Yamagishi S, 2010, OXID MED CELL LONGEV, V3, P101, DOI 10.4161/oxim.3.2.11148; Yan SF, 2008, NAT CLIN PRACT ENDOC, V4, P285, DOI 10.1038/ncpendmet0786; Yang QS, 2010, EUR J PHARMACOL, V649, P108, DOI 10.1016/j.ejphar.2010.09.025; Yin J, 2010, INVEST OPHTH VIS SCI, V51, P1891, DOI 10.1167/iovs.09-3904; Yuan HP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015726; Yucel I, 2006, CAN J OPHTHALMOL, V41, P60, DOI 10.1016/S0008-4182(06)80068-2; Zhan Y, 2012, MED SCI MONITOR, V18, pBR286, DOI 10.12659/MSM.883207; Zhao ZJ, 2010, MOL VIS, V16, P1576; Zong HL, 2011, CURR DIABETES REP, V11, P244, DOI 10.1007/s11892-011-0198-7; Zou CL, 2012, CORNEA, V31, P1455, DOI 10.1097/ICO.0b013e3182490907	57	77	83	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66781	10.1371/journal.pone.0066781	http://dx.doi.org/10.1371/journal.pone.0066781			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776698	Green Published, gold, Green Submitted			2022-12-27	WOS:000320322400118
J	Shishido, SN; Prasain, K; Beck, A; Nguyen, TDT; Hua, DH; Nguyen, TA				Shishido, Stephanie N.; Prasain, Keshar; Beck, Amanda; Nguyen, Thi D. T.; Hua, Duy H.; Thu Annelise Nguyen			Bioavailability and Efficacy of a Gap Junction Enhancer (PQ7) in a Mouse Mammary Tumor Model	PLOS ONE			English	Article							INTERCELLULAR COMMUNICATION; GENE-THERAPY; SUBSTITUTED QUINOLINES; IN-VIVO; CANCER; INDUCTION; PHOSPHORYLATION; MODULATION; PROTEIN; INHIBITION	The loss of gap junctional intercellular communication is characteristic of neoplastic cells, suggesting that the restoration with a gap junction enhancer may be a new therapeutic treatment option with less detrimental effects than traditional antineoplastic drugs. A gap junction enhancer, 6-methoxy-8-[(2-furanylmethyl) amino]-4-methyl-5-(3-trifluoromethylphenyloxy) quinoline (PQ7), on the normal tissue was evaluated in healthy C57BL/6J mice in a systemic drug distribution study. Immunoblot analysis of the vital organs indicates a reduction in Cx43 expression in PQ7-treated animals with no observable change in morphology. Next the transgenic strain FVB/N-Tg(MMTV-PyVT) 634Mul/J (also known as PyVT) was used as a spontaneous mammary tumor mouse model to determine the biological and histological effects of PQ7 on tumorigenesis and metastasis at three stages of development: Pre tumor, Early tumor, and Late tumor formation. PQ7 was assessed to have a low toxicity through intraperitoneal administration, with the majority of the compound being detected in the heart, liver, and lungs six hours post injection. The treatment of tumor bearing animals with PQ7 had a 98% reduction in tumor growth, while also decreasing the total tumor burden compared to control mice during the Pre stage of development. PQ7 treatment increased Cx43 expression in the neoplastic tissue during Pre-tumor formation; however, this effect was not observed in Late stage tumor formation. This study shows that the gap junction enhancer, PQ7, has low toxicity to normal tissue in healthy C57BL/6J mice, while having clinical efficacy in the treatment of spontaneous mammary tumors of PyVT mice. Additionally, gap junctional intercellular communication and neoplastic cellular growth are shown to be inversely related, while treatment with PQ7 inhibits tumor growth through targeting gap junction expression.	[Shishido, Stephanie N.; Beck, Amanda; Thu Annelise Nguyen] Kansas State Univ, Dept Diagnost Med & Pathobiol, Manhattan, KS 66506 USA; [Prasain, Keshar; Nguyen, Thi D. T.; Hua, Duy H.] Kansas State Univ, Dept Chem, Manhattan, KS 66506 USA	Kansas State University; Kansas State University	Nguyen, TA (corresponding author), Kansas State Univ, Dept Diagnost Med & Pathobiol, Manhattan, KS 66506 USA.	tnguyen@vet.ksu-edu	Beck, Amanda P/H-9573-2017	Beck, Amanda P/0000-0003-1867-4110	National Institute of Health [P30RR030926, 1R15CA152922]; NATIONAL CANCER INSTITUTE [R15CA152922] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P30RR030926] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The authors would like to thank the financial support of National Institute of Health, P30RR030926 and 1R15CA152922. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au JLS, 2001, J CONTROL RELEASE, V74, P31, DOI 10.1016/S0168-3659(01)00308-X; Banerjee D, 2010, INT J CANCER, V127, P839, DOI 10.1002/ijc.25107; BUDUNOVA IV, 1994, CELL BIOL TOXICOL, V10, P71, DOI 10.1007/BF00756491; Burr DB, 2011, EXP EYE RES, V92, P251, DOI 10.1016/j.exer.2011.02.003; Carystinos GD, 1999, CLIN CANCER RES, V5, P61; Ding Y, 2012, ANTI-CANCER DRUG, V23, P897, DOI 10.1097/CAD.0b013e328354ac71; Gakhar G, 2008, DRUG DEVELOP RES, V69, P526, DOI 10.1002/ddr.20281; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hawat G, 2008, PFLUG ARCH EUR J PHY, V456, P519, DOI 10.1007/s00424-007-0426-9; Heiniger B, 2010, ANTICANCER RES, V30, P3927; Huang RP, 2001, INT J CANCER, V92, P130, DOI 10.1002/1097-0215(200102)9999:9999<::AID-IJC1165>3.0.CO;2-G; KLAUNIG JE, 1990, LAB INVEST, V62, P135; Kunishige I, 1998, ANTICANCER RES, V18, P3411; Lampe PD, 2004, INT J BIOCHEM CELL B, V36, P1171, DOI 10.1016/S1357-2725(03)00264-4; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Liu JL, 2011, J BIOL CHEM, V286, P16914, DOI 10.1074/jbc.M111.218735; Maglione JE, 2001, CANCER RES, V61, P8298; Mesnil M, 2005, BBA-BIOMEMBRANES, V1719, P125, DOI 10.1016/j.bbamem.2005.11.004; MUSIL LS, 1991, J CELL BIOL, V115, P1357, DOI 10.1083/jcb.115.5.1357; Nagasawa H, 1999, RADIAT RES, V152, P552, DOI 10.2307/3580153; Park JY, 1997, GENE THER, V4, P909, DOI 10.1038/sj.gt.3300477; PITOT HC, 1994, DRUG METAB REV, V26, P209, DOI 10.3109/03602539409029792; Robe PA, 2000, BIOCHEM PHARMACOL, V60, P241, DOI 10.1016/S0006-2952(00)00315-4; Rosenkranz HS, 2000, CARCINOGENESIS, V21, P1007, DOI 10.1093/carcin/21.5.1007; Saunders MM, 2001, CANCER RES, V61, P1765; Shi AB, 2008, BIOORG MED CHEM LETT, V18, P3364, DOI 10.1016/j.bmcl.2008.04.024; Shishido SN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044963; Tanaka M, 2001, HUM GENE THER, V12, P2225, DOI 10.1089/10430340152710568; Touraine RL, 1998, HUM GENE THER, V9, P2385, DOI 10.1089/hum.1998.9.16-2385; Trosko James E., 1998, Frontiers in Bioscience, V3, pD208; Upham BL, 1998, ENVIRON HEALTH PERSP, V106, P975, DOI 10.2307/3434140; Wei CJ, 2004, ANNU REV CELL DEV BI, V20, P811, DOI 10.1146/annurev.cellbio.19.111301.144309; Zhou HN, 2000, P NATL ACAD SCI USA, V97, P2099, DOI 10.1073/pnas.030420797	33	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e67174	10.1371/journal.pone.0067174	http://dx.doi.org/10.1371/journal.pone.0067174			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776708	Green Published, gold, Green Submitted			2022-12-27	WOS:000320322400124
J	Solomon, AJ; Hills, W; Chen, ZQ; Rosenbaum, J; Bourdette, D; Whitham, R				Solomon, Andrew J.; Hills, William; Chen, Zunqiu; Rosenbaum, James; Bourdette, Dennis; Whitham, Ruth			Autoantibodies and Sjogren's Syndrome in Multiple Sclerosis, a Reappraisal	PLOS ONE			English	Article							ANTICARDIOLIPIN ANTIBODIES; ANTINUCLEAR ANTIBODIES; ANTIPHOSPHOLIPID ANTIBODIES; FOLLOW-UP; CLINICAL-SIGNIFICANCE; NEUROMYELITIS-OPTICA; DIAGNOSTIC-CRITERIA; PREVALENCE; DISEASES; FREQUENCY	Background: Rheumatologic diseases may cause neurologic disorders that mimic multiple sclerosis (MS). A panel of serum autoantibodies is often obtained as part of the evaluation of patients suspected of having MS. Objectives: To determine, in light of recently revised diagnostic criteria for MS, neuromyelitis optica, and Sjogren's Syndrome, if testing for autoantibodies in patients with a confirmed diagnosis of MS would reveal a frequency or demonstrate a clinical utility divergent from previous reports or lead to identification of undiagnosed cases of Sjogren's Syndrome. Methods: Convenience sample cross-sectional study of MS patients recruited from the OHSU Multiple Sclerosis Center. Results: Autoantibodies were detected in 38% (35/91) of patients with MS and were not significantly associated with disease characteristics or severity. While four patients had SSA antibodies, none met diagnostic criteria for Sjogren's Syndrome. Conclusions: Rheumatologic autoantibodies are frequently found in MS patients and are not associated with disease severity or systemic rheumatologic disease. Our demonstration of the low specificity of these autoantibodies suggests that the diagnostic utility and cost-effectiveness of testing is not supported when there is strong clinical suspicion of MS and low clinical suspicion of rheumatologic disease.	[Solomon, Andrew J.] Univ Vermont, Dept Neurol Sci, Coll Med, Burlington, VT 05405 USA; [Hills, William; Rosenbaum, James] Oregon Hlth & Sci Univ, Dept Ophthalmol, Portland, OR 97201 USA; [Chen, Zunqiu] Oregon Hlth & Sci Univ, Dept Publ Hlth & Prevent Med, Portland, OR 97201 USA; [Rosenbaum, James] Oregon Hlth & Sci Univ, Dept Med, Portland, OR 97201 USA; [Rosenbaum, James] Oregon Hlth & Sci Univ, Dept Cell Biol, Portland, OR 97201 USA; [Hills, William; Bourdette, Dennis; Whitham, Ruth] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA; [Bourdette, Dennis; Whitham, Ruth] Portland VA Med Ctr, MS Ctr Excellence West, Portland, OR USA	University of Vermont; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center	Solomon, AJ (corresponding author), Univ Vermont, Dept Neurol Sci, Coll Med, Burlington, VT 05405 USA.	andrew.solomon@uvm.edu			Partners Multiple Sclerosis Fellowship Award; Department of Veterans Affairs; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000128] Funding Source: NIH RePORTER	Partners Multiple Sclerosis Fellowship Award; Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was funded by the Partners Multiple Sclerosis Fellowship Award and the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNED S, 1995, NEUROLOGY, V45, P384, DOI 10.1212/WNL.45.2.384; Bowen J, 2001, MULT SCLER, V7, P201, DOI 10.1191/135245801678438447; Chapman J, 2004, THROMB RES, V114, P477, DOI 10.1016/j.thromres.2004.06.016; Ciccarelli O, 2000, MULT SCLER J, V6, P137; Collard RC, 1997, NEUROLOGY, V49, P857, DOI 10.1212/WNL.49.3.857; D'Olhaberriague L, 1998, NEUROLOGY, V51, P1376, DOI 10.1212/WNL.51.5.1376; de Andres C, 2001, ACTA NEUROL SCAND, V104, P83, DOI 10.1034/j.1600-0404.2001.104002083.x; de Seze J, 2001, NEUROLOGY, V57, P1359, DOI 10.1212/WNL.57.8.1359; DEKEYSER J, 1988, NEUROLOGY, V38, P371; Delalande S, 2004, MEDICINE, V83, P280, DOI 10.1097/01.md.0000141099.53742.16; DOREDUFFY P, 1982, ARCH NEUROL-CHICAGO, V39, P504, DOI 10.1001/archneur.1982.00510200046008; Garg N, 2007, J NEUROIMMUNOL, V187, P159, DOI 10.1016/j.jneuroim.2007.04.008; Heinzlef O, 2002, J NEUROL NEUROSUR PS, V72, P647, DOI 10.1136/jnnp.72.5.647; Karussis D, 1998, ANN NEUROL, V44, P629, DOI 10.1002/ana.410440408; Liedorp M, 2007, J NEUROL NEUROSUR PS, V78, P1146, DOI 10.1136/jnnp.2007.117713; Miller DH, 2008, MULT SCLER J, V14, P1157, DOI 10.1177/1352458508096878; NOSEWORTHY JH, 1989, ANN NEUROL, V25, P95, DOI 10.1002/ana.410250117; Pericot I, 2003, MULT SCLER, V9, P256, DOI 10.1191/1352458503ms905oa; Petri M, 2000, J AUTOIMMUN, V15, P145, DOI 10.1006/jaut.2000.0409; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Roussel V, 2000, J AUTOIMMUN, V14, P259, DOI 10.1006/jaut.2000.0367; Sanchez-Guerrero J, 2006, J RHEUMATOL, V33, P907; SANDBERGWOLLHEIM M, 1992, NEUROLOGY, V42, P845, DOI 10.1212/WNL.42.4.845; Sastre-Garriga J, 2001, ANN NEUROL, V49, P408, DOI 10.1002/ana.81; SEYFERT S, 1990, ACTA NEUROL SCAND, V81, P37; SHI W, 1990, AUST NZ J MED, V20, P231, DOI 10.1111/j.1445-5994.1990.tb01025.x; Spadaro M, 1999, MULT SCLER, V5, P121, DOI 10.1191/135245899678847211; Stosic M, 2010, J NEUROL, V257, P63, DOI 10.1007/s00415-009-5264-6; Szmyrka-Kaczmarek M, 2012, LUPUS, V21, P412, DOI 10.1177/0961203311427550; Tan EM, 1997, ARTHRITIS RHEUM-US, V40, P1601, DOI 10.1002/art.1780400909; Tourbah A, 1998, ARCH NEUROL-CHICAGO, V55, P517, DOI 10.1001/archneur.55.4.517; Verdun E, 2002, J INTERF CYTOK RES, V22, P245, DOI 10.1089/107999002753536220; VILA P, 1994, THROMB HAEMOSTASIS, V72, P209; Vilisaar J, 2005, MULT SCLER J, V11, P378, DOI 10.1191/1352458505ms1208oa; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Wingerchuk DM, 2012, MULT SCLER J, V18, P5, DOI 10.1177/1352458511431077	38	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65385	10.1371/journal.pone.0065385	http://dx.doi.org/10.1371/journal.pone.0065385			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776474	Green Published, Green Submitted, gold			2022-12-27	WOS:000320322400019
J	Van Royen, K; Lachat, C; Holdsworth, M; Smit, K; Kinabo, J; Roberfroid, D; Nago, E; Orach, CG; Kolsteren, P				Van Royen, Kathleen; Lachat, Carl; Holdsworth, Michelle; Smit, Karlien; Kinabo, Joyce; Roberfroid, Dominique; Nago, Eunice; Orach, Christopher Garimoi; Kolsteren, Patrick			How Can the Operating Environment for Nutrition Research Be Improved in Sub-Saharan Africa? The Views of African Researchers	PLOS ONE			English	Article							PUBLIC-HEALTH NUTRITION; CHILD UNDERNUTRITION; DEVELOPING-COUNTRIES; PROGRESS	Optimal nutrition is critical for human development and economic growth. Sub-Saharan Africa is facing high levels of food insecurity and only few sub-Saharan African countries are on track to eradicate extreme poverty and hunger by 2015. Effective research capacity is crucial for addressing emerging challenges and designing appropriate mitigation strategies in sub-Saharan Africa. A clear understanding of the operating environment for nutrition research in sub-Saharan Africa is a much needed prerequisite. We collected data on the barriers and requirements for conducting nutrition research in sub-Saharan Africa through semi-structured interviews with 144 participants involved in nutrition research in 35 countries in sub-Saharan Africa. A total of 133 interviews were retained for coding. The main barriers identified for effective nutrition research were the lack of funding due to poor recognition by policymakers of the importance of nutrition research and under-utilisation of research findings for developing policy, as well as an absence of research priority setting from within Africa. Current research topics were perceived to be mainly determined by funding bodies from outside Africa. Nutrition researchers argued for more commitment from policymakers at national level. The low capacity for nutrition research was mainly seen as a consequence of insufficient numbers of nutrition researchers, limited skills and a poor research infrastructure. In conclusion, African nutrition researchers argued how research priorities need to be identified by African stakeholders, accompanied by consensus building to enable creating a problem-driven national research agenda. In addition, it was considered necessary to promote interactions among researchers, and between researchers and policymakers. Multidisciplinary research and international and cross-African collaboration were seen as crucial to build capacity in sub-Saharan nutrition research.	[Van Royen, Kathleen; Lachat, Carl; Kolsteren, Patrick] Univ Ghent, Dept Food Safety & Food Qual, B-9000 Ghent, Belgium; [Van Royen, Kathleen; Lachat, Carl; Roberfroid, Dominique; Kolsteren, Patrick] Inst Trop Med, Unit Nutr & Child Hlth, B-2000 Antwerp, Belgium; [Holdsworth, Michelle] Univ Sheffield, ScHARR Sect Publ Hlth, Sheffield, S Yorkshire, England; [Smit, Karlien] North West Univ, Africa Unit Transdisciplinary Hlth Res, Potchefstroom, South Africa; [Kinabo, Joyce] Sokoine Univ, Dept Food Sci & Technol, Morogoro, Tanzania; [Nago, Eunice] Univ Abomey Calavi, Fac Agr Sci, Abomey Calavi, Benin; [Orach, Christopher Garimoi] Makerere Univ, Sch Publ Hlth, Kampala, Uganda	Ghent University; Institute of Tropical Medicine (ITM); University of Sheffield; North West University - South Africa; Sokoine University of Agriculture; University of Abomey Calavi; Makerere University	Kolsteren, P (corresponding author), Univ Ghent, Dept Food Safety & Food Qual, B-9000 Ghent, Belgium.	pkolsteren@itg.be	Van Royen, Kathleen/E-9669-2018; holdsworth, michelle/AAH-5400-2020; lachat, carl/AAH-9764-2020	Van Royen, Kathleen/0000-0001-8182-7971; holdsworth, michelle/0000-0001-6028-885X; lachat, carl/0000-0002-1389-8855; van Schalkwyk, Karlien/0000-0001-9444-2288	European Union [266080]	European Union(European Commission)	This work was supported by the European Union as a Coordination and Support Action of the FP7 KBBE programme under grant agreement number 266080. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron GJ, 2010, GLOB PUBLIC HEALTH, V5, pS42, DOI 10.1080/17441692.2010.526128; Adams J., 2010, GLOBAL RES REPORT; Batista R, 2006, 3 COHRED; BEATTIE P, 1999, STRENGTHENING HLTH R; Benson T.D., 2008, IMPROVING NUTR DEV P; Bill & Melinda Gates Foundation, 2011, NUTR STRAT OV; Borregaard N, 2002, DRIVERS KNOWLEDGE PR; Brown KH, 2010, GLOB PUBLIC HEALTH, V5, pS1, DOI 10.1080/17441692.2010.526126; Brownson RC, 2006, AM J PREV MED, V30, P164, DOI 10.1016/j.amepre.2005.10.004; Bryce J, 2008, LANCET, V371, P510, DOI 10.1016/S0140-6736(07)61694-8; Department for International Development, 2010, NEGL CRIS UND DFIDS; Food and Agriculture Organisation (FAO), 2003, STAT FOOD INS WORLD; G8 Camp David Summit, 2012, FACT SHEET G 8 ACT F; GAIN, 2012, FAINS NUTR PROGR; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Leroy JL, 2007, AM J PUBLIC HEALTH, V97, P219, DOI 10.2105/AJPH.2005.083287; Mckee M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001209; Meerman J, 2008, MAKING NUTR NATL PRI; Morris SS, 2008, LANCET, V371, P608, DOI 10.1016/S0140-6736(07)61695-X; Pelletier DL, 2012, HEALTH POLICY PLANN, V27, P19, DOI 10.1093/heapol/czr011; Sawyerr A., 2004, J HIGHER ED AREA, V2, P211; Scaling-Up nutrition Roadmap task team, 2010, ROAD MAP SCAL UP NUT; Stevens GA, 2012, LANCET, V380, P824, DOI 10.1016/S0140-6736(12)60647-3; UNDP, 2012, AFR HUM DEV REP FOOD; UNDP UNECA AU AfDB, 2011, ASS PROGR AFR MILL D; United Nations Standing Committee on Nutrition (UNSCN), 2010, 6 UNSCN ACC; Vincent R, 2006, FINDINGS, P6; Vorster HH, 1999, NUTR REV, V57, P341, DOI 10.1111/j.1753-4887.1999.tb06911.x; Weber R. P., 1990, BASIC CONTENT ANAL, V2nd; Williams JR, 2010, GLOBAL HEALTH ACTION, V3, DOI 10.3402/gha.v3i0.5287; World Bank, 2010, WORLD DEV IND; World Bank, 2006, REP NUTR CENTR DEV S; World Health Organization, 2008, 2008 2013 ACT PLAN G; World Health Organization, 2010, REV NUTR PO IN PRESS; World Health Organization, 2004, GLOB STRAT DIET PHYS	35	12	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66355	10.1371/journal.pone.0066355	http://dx.doi.org/10.1371/journal.pone.0066355			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776663	Green Published, gold, Green Accepted			2022-12-27	WOS:000320322400099
J	Wang, XY; Xue, LN; Yang, Y; Xu, LJ; Zhang, GX				Wang, Xiaoyong; Xue, Lening; Yang, Yang; Xu, Lijuan; Zhang, Guoxin			TLR9 Promoter Polymorphism Is Associated with Both an Increased Susceptibility to Gastric Carcinoma and Poor Prognosis	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; HELICOBACTER-PYLORI INFECTION; THR399ILE POLYMORPHISMS; GENE POLYMORPHISMS; INNATE IMMUNITY; INCREASED RISK; CANCER; TOLL-LIKE-RECEPTOR-4; CHINESE	Objective: Genetic polymorphisms of Toll-like receptors (TLRs) may influence the effects of H. pylori infection and play important roles in gastric carcinogenesis. The aim of this study was to determine whether the polymorphisms of TLR4 and TLR9 are associated with susceptibility to gastric carcinoma and its prognosis. Methods: This study consisted of 314 patients with gastric cancer and 314 healthy controls. The polymorphisms were assessed using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis. Survival was analyzed by Kaplan-Meier survival curves. Results: No variant genotypes of TLR4+896A/G, TLR4+1196C/T, or TLR9 -1237T/C were detected. For TLR9 -1486 T/C, multiple logistic regression analyses revealed that compared with the TT homozygote, patients with both the TC variant (adjusted odds ratio (OR) = 1.47, 95% confidence interval (CI) = 1.04-2.10) and the CC variant (adjusted OR = 1.63, 95% CI = 1.01-2.64) had higher risks of gastric cancer. Further stratification analyses revealed that an increased risk of gastric cancer associated with C carriers was evident among females (adjusted OR = 1.84, 95% CI = 1.02-3.33), in younger subjects aged less than 60 years old (adjusted OR = 1.86, 95% CI = 1.15-3.00), and subjects with H. pylori infection (adjusted OR = 1.53, 95% CI = 1.03-2.27). We also observed a significant association between C carriers and noncardia gastric cancer (adjusted OR = 1.51, 95% CI = 1.03-2.20). In addition, we demonstrated that the C carrier genotype and H. pylori infection may have a synergistic effect and conferred an OR of 2.44 for developing gastric cancer. TLR9 -1486C was also identified as an independent marker of poor survival of carcinoma. Conclusions: Our results suggest that TLR9 -1486C carriers are associated with an increased risk and poor prognosis of gastric carcinoma in the Chinese population.	[Wang, Xiaoyong; Xue, Lening] Nanjing Med Univ, Changzhou Hosp 2, Dept Gastroenterol, Changzhou, Peoples R China; [Yang, Yang; Xu, Lijuan; Zhang, Guoxin] Nanjing Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Xue, LN (corresponding author), Nanjing Med Univ, Changzhou Hosp 2, Dept Gastroenterol, Changzhou, Peoples R China.	wujia19811007@126.com; guoxinz@njmu.edu.cn			Natural Science Funds of Jiangsu Province, China [BK2010194]	Natural Science Funds of Jiangsu Province, China	This work was supported by a grant from the Natural Science Funds of Jiangsu Province, China (No. BK2010194). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achyut BR, 2007, HUM IMMUNOL, V68, P901, DOI 10.1016/j.humimm.2007.10.006; Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Anderson AE, 2007, EUR J IMMUNOL, V37, P1548, DOI 10.1002/eji.200636562; Armant MA, 2002, GENOME BIOL, V3; Burns E A, 2000, Cancer Control, V7, P513; Demirci FYK, 2007, J RHEUMATOL, V34, P1708; El-Omar EM, 2003, GASTROENTEROLOGY, V124, P1193, DOI 10.1016/S0016-5085(03)00157-4; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; Fukata M, 2008, ONCOGENE, V27, P234, DOI 10.1038/sj.onc.1210908; Garza-Gonzalez E, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-70; Hamajima Nobuyuki, 2003, Nagoya J Med Sci, V66, P103; Hamann L, 2006, CLIN CHIM ACTA, V364, P303, DOI 10.1016/j.cca.2005.07.017; Hang JQ, 2004, J ENDOTOXIN RES, V10, P238, DOI 10.1177/09680519040100040601; Hold GL, 2007, GASTROENTEROLOGY, V132, P905, DOI 10.1053/j.gastro.2006.12.026; Hur JW, 2005, TISSUE ANTIGENS, V65, P266, DOI 10.1111/j.1399-0039.2005.00374.x; Ishihara S, 2004, J IMMUNOL, V173, P1406, DOI 10.4049/jimmunol.173.2.1406; Kawahara T, 2001, INFECT IMMUN, V69, P4382, DOI 10.1128/IAI.69.7.4382-4389.2001; Kawahara Tsukasa, 2001, Journal of Medical Investigation, V48, P190; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Lawrence T, 2007, TRENDS PHARMACOL SCI, V28, P162, DOI 10.1016/j.tips.2007.02.003; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lochhead P, 2007, BEST PRACT RES CL GA, V21, P281, DOI 10.1016/j.bpg.2007.02.002; Lorenz E, 2001, BIOTECHNIQUES, V31, P22, DOI 10.2144/01311bm01; Mandell L, 2004, INFECT IMMUN, V72, P6446, DOI 10.1128/IAI.72.11.6446-6454.2004; Maslov AY, 2009, BBA-GEN SUBJECTS, V1790, P963, DOI 10.1016/j.bbagen.2009.03.020; Ng MTH, 2010, INFECT IMMUN, V78, P1345, DOI 10.1128/IAI.01226-09; Ng MW, 2005, RHEUMATOLOGY, V44, P1456, DOI 10.1093/rheumatology/kei120; Novak N, 2007, ALLERGY, V62, P766, DOI 10.1111/j.1398-9995.2007.01358.x; Oldenburg M, 2012, SCIENCE, V337, P1111, DOI 10.1126/science.1220363; Rad R, 2009, GASTROENTEROLOGY, V136, P2247, DOI 10.1053/j.gastro.2009.02.066; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; Santini D, 2008, CLIN EXP IMMUNOL, V154, P360, DOI 10.1111/j.1365-2249.2008.03776.x; Schmausser B, 2005, INT J MED MICROBIOL, V295, P179, DOI 10.1016/j.ijmm.2005.02.009; Schmausser B, 2004, CLIN EXP IMMUNOL, V136, P521, DOI 10.1111/j.1365-2249.2004.02464.x; Smith MF, 2003, J BIOL CHEM, V278, P32552, DOI 10.1074/jbc.M305536200; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Tahara T, 2007, J CLIN BIOCHEM NUTR, V40, P62, DOI 10.3164/jcbn.40.62; Tao K, 2007, ANN RHEUM DIS, V66, P905, DOI 10.1136/ard.2006.065961; Wang XY, 2008, HELICOBACTER, V13, P49, DOI 10.1111/j.1523-5378.2008.00578.x; Wu MS, 2006, HEPATO-GASTROENTEROL, V53, P807; Wu MS, 2005, CANCER EPIDEM BIOMAR, V14, P1878, DOI 10.1158/1055-9965.EPI-04-0792; Zeng Hong-Mei, 2011, Zhonghua Yu Fang Yi Xue Za Zhi, V45, P588	46	25	27	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65731	10.1371/journal.pone.0065731	http://dx.doi.org/10.1371/journal.pone.0065731			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776537	gold, Green Published, Green Submitted			2022-12-27	WOS:000320322400049
J	Barra, GN; Araya, PA; Fernandez, JO; Gabastou, JM; Hormazabal, JC; Seoane, M; Pidal, PC; Valenzuela, MT; Ibarz-Pavon, AB				Barra, Gisselle N.; Araya, Pamela A.; Fernandez, Jorge O.; Gabastou, Jean-Marc; Carlos Hormazabal, Juan; Seoane, Mabel; Pidal, Paola C.; Valenzuela, Maria T.; Ibarz-Pavon, Ana Belen			Molecular Characterization of Invasive Neisseria meningitidis Strains Isolated in Chile during 2010-2011	PLOS ONE			English	Article							PORA GENE; VACCINE; SURVEILLANCE; MENINGOCOCCI; PREVALENCE; SEROGROUPS; PROTEIN; DISEASE; TARGET; CLONE	Background: With the upcoming licensure of Outer Membrane Protein-based vaccines against meningococcal disease, data on disease incidence and molecular characteristic of circulating N. meningitidis strains in Latin American countries is needed. Chile is, to date, one of the few countries in the region that has performed this type of work in a comprehensive collection of disease-associated strains from two consecutive years, 2010-2011. Methods: A total of 119 N. meningitidis strains isolated from patients with invasive disease in Chile in 2010-2011 were characterized by the National Reference Laboratory. Serogroup determination, MLST and porA typing were performed. Results: Serogroup B was predominant in both study years, but W135 experienced a noticeable increase in 2011 compared to 2010. ST-11 complex, ST-41/44 complex ST-32 complex were the most prevalent among the isolates, and were strongly associated with serogroups W135 (ST-11 Complex) and B (ST-41/44 and ST-32 complexes). Likewise, the major porA types detected were strongly associated with these three clonal complexes: P1.5,2 was found exclusively among W135: ST-11 isolates, whereas P1.7, 2-3 was only detected in C: ST-11. ST-41/44 isolates mainly had P1.10-8, and ST-32 complex were associated with a P1.18-8 porA. Conclusions: Our data show disease-associated N. meningitidis circulating in Chile are similar to those found in other parts of the world. The increase on W135: ST-11 isolates observed in 2011 foretold the unusual epidemiological situation experienced in the country in 2012, and MLST data show that this strain is indistinguishable from the one linked to the global Hajj 2000-related outbreak that occurred in 2001. Finally, this work demonstrates the importance of maintaining a strong national surveillance program integrating clinical, epidemiological and laboratory data and incorporating gold standard diagnostic and characterization techniques that allow the data to be compared all over the world.	[Barra, Gisselle N.; Fernandez, Jorge O.] Inst Publ Hlth, Subdept Mol Genet, Santiago, Chile; [Araya, Pamela A.; Carlos Hormazabal, Juan; Seoane, Mabel] Inst Publ Hlth, Bacteriol Sect, Santiago, Chile; [Gabastou, Jean-Marc; Ibarz-Pavon, Ana Belen] Pan Amer Hlth Org, Washington, DC USA; [Pidal, Paola C.; Valenzuela, Maria T.] Inst Publ Hlth, Biomed Lab Dept, Santiago, Chile	Pan American Health Organization	Fernandez, JO (corresponding author), Inst Publ Hlth, Subdept Mol Genet, Santiago, Chile.	jfernand@ispch.cl; ibarzpav@paho.org		Valenzuela, M Teresa/0000-0002-9433-6423	Sanofi-Pasteur through the Pan-American Health and Education Foundation (PAHEF)	Sanofi-Pasteur through the Pan-American Health and Education Foundation (PAHEF)	Funding was provided by Sanofi-Pasteur through the Pan-American Health and Education Foundation (PAHEF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad R, 2009, J INFECTION, V59, P104, DOI 10.1016/j.jinf.2009.06.001; [Anonymous], MMWR MORB MORTAL WKL, V50, P221; [Anonymous], 2012, BOLETIN, V2; Brehony C, 2007, FEMS MICROBIOL REV, V31, P15, DOI 10.1111/j.1574-6976.2006.00056.x; Brehony C, 2009, MICROBIOL-SGM, V155, P4155, DOI 10.1099/mic.0.027995-0; Chiavetta L., 2007, Rev. argent. microbiol., V39, P21; Claus H, 2004, MOL MICROBIOL, V51, P227, DOI 10.1046/j.1365-2958.2003.03819.x; Elias J, 2007, J CLIN MICROBIOL, V45, P159, DOI 10.1128/JCM.01322-06; Giuliani MM, 2006, P NATL ACAD SCI USA, V103, P10834, DOI 10.1073/pnas.0603940103; Gobierno de Chile. Ministerio de Salud. Division de Planificacion Sanitaria. Departamento de Epidemiologia, 2007, B VIGILIANCIA SALUD, V13, P59; Gorla MC, ENFERM INFECC MICROB, V30, P56; Harrison LH, 2009, VACCINE, V27, pB51, DOI 10.1016/j.vaccine.2009.04.063; Ibarz-Pavon AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044102; [Instituto de Salud publica de Chile Ministerio de Salud.], ORD B, V51; Jacobsson S, 2009, VACCINE, V27, P1579, DOI 10.1016/j.vaccine.2008.12.052; Jelfs J, 2000, CLIN DIAGN LAB IMMUN, V7, P390, DOI 10.1128/CDLI.7.3.390-395.2000; Jolley KA, 2007, FEMS MICROBIOL REV, V31, P89, DOI 10.1111/j.1574-6976.2006.00057.x; Kugelberg E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009413; Lucidarme J, 2011, CLIN VACCINE IMMUNOL, V18, P194, DOI 10.1128/CVI.00401-10; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Martin DR, 2006, CLIN VACCINE IMMUNOL, V13, P486, DOI 10.1128/CVI.13.4.486-491.2006; Moriel DG, 2008, HUM VACCINES, V4, P184, DOI 10.4161/hv.4.3.6313; Newcombe J, 1998, MOL MICROBIOL, V30, P453, DOI 10.1046/j.1365-2958.1998.01056.x; Panatto D, 2011, EXPERT REV VACCINES, V10, P1337, DOI [10.1586/ERV.11.103, 10.1586/erv.11.103]; Russell JE, 2004, EMERG INFECT DIS, V10, P674, DOI 10.3201/eid1004.030247; Sorhouet-Pereira C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058065; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; Stephens DS, 2007, FEMS MICROBIOL REV, V31, P3, DOI 10.1111/j.1574-6976.2006.00051.x; Taha MK, 2000, LANCET, V356, P2159, DOI 10.1016/S0140-6736(00)03502-9; Thompson EAL, 2003, MICROBIOL-SGM, V149, P1849, DOI 10.1099/mic.0.26131-0; Urwin R, 2004, INFECT IMMUN, V72, P5955, DOI 10.1128/IAI.72.10.5955-5962.2004; Weidlich L, 2008, J INFECTION, V57, P324, DOI 10.1016/j.jinf.2008.07.014; Yazdankhah SP, 2004, J CLIN MICROBIOL, V42, P5146, DOI 10.1128/JCM.42.11.5146-5153.2004; Yogev R, HUM VACCIN, V7, P828	34	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66006	10.1371/journal.pone.0066006	http://dx.doi.org/10.1371/journal.pone.0066006			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776590	Green Published, gold, Green Submitted			2022-12-27	WOS:000320755400096
J	Bouix, S; Pasternak, O; Rathi, Y; Pelavin, PE; Zafonte, R; Shenton, ME				Bouix, Sylvain; Pasternak, Ofer; Rathi, Yogesh; Pelavin, Paula E.; Zafonte, Ross; Shenton, Martha E.			Increased Gray Matter Diffusion Anisotropy in Patients with Persistent Post-Concussive Symptoms following Mild Traumatic Brain Injury	PLOS ONE			English	Article							PRINCIPAL EIGENVECTOR MEASUREMENTS; TENSOR IMAGING FINDINGS; FRACTIONAL ANISOTROPY; MEAN DIFFUSIVITY; HEAD-INJURY; REPRODUCIBILITY; DEGENERATION; DTI	A significant percentage of individuals diagnosed with mild traumatic brain injury (mTBI) experience persistent post-concussive symptoms (PPCS). Little is known about the pathology of these symptoms and there is often no radiological evidence based on conventional clinical imaging. We aimed to utilize methods to evaluate microstructural tissue changes and to determine whether or not a link with PPCS was present. A novel analysis method was developed to identify abnormalities in high-resolution diffusion tensor imaging (DTI) when the location of brain injury is heterogeneous across subjects. A normative atlas with 145 brain regions of interest (ROI) was built from 47 normal controls. Comparing each subject's diffusion measures to the atlas generated subject-specific profiles of injury. Abnormal ROIs were defined by absolute z-score values above a given threshold. The method was applied to 11 PPCS patients following mTBI and 11 matched controls. Z-score information for each individual was summarized with two location-independent measures: "load'' (number of abnormal regions) and "severity'' (largest absolute z-score). Group differences were then computed using Wilcoxon rank sum tests. Results showed statistically significantly higher load (p = 0.018) and severity (p = 0.006) for fractional anisotropy (FA) in patients compared with controls. Subject-specific profiles of injury evinced abnormally high FA regions in gray matter (30 occurrences over 11 patients), and abnormally low FA in white matter (3 occurrences over 11 subjects). Subject-specific profiles provide important information regarding the pathology associated with PPCS. Increased gray matter (GM) anisotropy is a novel in-vivo finding, which is consistent with an animal model of brain trauma that associates increased FA in GM with pathologies such as gliosis. In addition, the individualized analysis shows promise for enhancing the clinical care of PPCS patients as it could play a role in the diagnosis of brain injury not revealed using conventional imaging.	[Bouix, Sylvain; Pasternak, Ofer; Rathi, Yogesh; Pelavin, Paula E.; Shenton, Martha E.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Shenton, Martha E.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Zafonte, Ross] Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Spaulding Rehabil Hosp, Boston, MA USA; [Zafonte, Ross] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Phys Med & Rehabil, Boston, MA USA; [Shenton, Martha E.] Vet Affairs Boston Healthcare Syst, Dept Psychiat, Brockton Div, Brockton, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Spaulding Rehabilitation Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Bouix, S (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Psychiat, Boston, MA 02115 USA.	sylvain@bwh.harvard.edu	Shenton, Martha/V-8780-2019	Bouix, Sylvain/0000-0003-1326-6054	Center for Integration of Medicine and Innovative Technology Soldier in Medicine Award; National Institute of Health [R01 MH082918, R01 NS078337, NAMIC-U54 EB005149]; INTRuST Posttraumatic Stress Disorder and Traumatic Brain Injury Clinical Consortium; Department of Defense Psychological Health/Traumatic Brain Injury Research Program [X81XWH-07-CC-CSDoD]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U54EB005149] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH082918] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078337] Funding Source: NIH RePORTER	Center for Integration of Medicine and Innovative Technology Soldier in Medicine Award; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); INTRuST Posttraumatic Stress Disorder and Traumatic Brain Injury Clinical Consortium; Department of Defense Psychological Health/Traumatic Brain Injury Research Program; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by the Center for Integration of Medicine and Innovative Technology Soldier in Medicine Award [to S.B.], by the National Institute of Health [R01 MH082918 to S.B., R01 NS078337 to M.E.S., NAMIC-U54 EB005149 to M.E.S.] and by the INTRuST Posttraumatic Stress Disorder and Traumatic Brain Injury Clinical Consortium funded by the Department of Defense Psychological Health/Traumatic Brain Injury Research Program [X81XWH-07-CC-CSDoD to M.E.S., S.B., O.P., Y.R. and R.Z.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; ARNETT JA, 1995, PSYCHOL ASSESSMENT, V7, P220; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Benton LA, MULTILINGUAL APHASIA; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Blumenfeld-Katzir T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020678; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Delis DC, CALIFORNIA VERBAL LE; Dobson AJ, 2008, INTRO GEN LINEAR MOD; Farrell JAD, 2007, J MAGN RESON IMAGING, V26, P756, DOI 10.1002/jmri.21053; Feng Y, 2010, J R SOC INTERFACE, V7, P1677, DOI 10.1098/rsif.2010.0210; Fischer J.S., 2012, NEUROPSYCHOLOGICAL A, V5th; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Gardner A, 2012, J NEUROTRAUM, V29, P2521, DOI 10.1089/neu.2012.2628; Hagmann P, 2006, RADIOGRAPHICS, V26, pS205, DOI 10.1148/rg.26si065510; Hannoun S, 2012, AM J NEURORADIOL, V33, P1363, DOI 10.3174/ajnr.A2983; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Irimia Andrei, 2012, Front Neurol, V3, P10, DOI 10.3389/fneur.2012.00010; Jones DK, 2008, CORTEX, V44, P936, DOI 10.1016/j.cortex.2008.05.002; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Kaufman L., 2005, FINDING GROUPS DATA; Landman BA, 2007, NEUROIMAGE, V36, P1123, DOI 10.1016/j.neuroimage.2007.02.056; Ling J, 2012, HUM BRAIN MAPP, V33, P50, DOI 10.1002/hbm.21192; Lipton ML, 2012, BRAIN IMAGING BEHAV, V6, P329, DOI 10.1007/s11682-012-9175-2; Newcombe VFJ, 2011, BRAIN, V134, P759, DOI 10.1093/brain/awq388; Peled S, 2009, J MAGN RESON IMAGING, V30, P243, DOI 10.1002/jmri.21808; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Rosenbaum SB, 2012, BRAIN IMAGING BEHAV, V6, P255, DOI 10.1007/s11682-012-9162-7; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; Seber G.A.F., 2004, MULTIVARIATE OBSERVA; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Takayama H, 2000, CLIN NEUROL NEUROSUR, V102, P135, DOI 10.1016/S0303-8467(00)00079-2; Taylor MJ, 2001, J INT NEUROPSYCH SOC, V7, P867, DOI 10.1017/S1355617701777107; Westlye LT, 2010, CEREB CORTEX, V20, P2055, DOI 10.1093/cercor/bhp280	41	77	77	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66205	10.1371/journal.pone.0066205	http://dx.doi.org/10.1371/journal.pone.0066205			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776631	Green Published, gold, Green Submitted			2022-12-27	WOS:000320755400120
J	Dinno, A; Whitney, C				Dinno, Alexis; Whitney, Chelsea			Same Sex Marriage and the Perceived Assault on Opposite Sex Marriage	PLOS ONE			English	Article							HEALTH	Background: Marriage benefits both individuals and societies, and is a fundamental determinant of health. Until recently same sex couples have been excluded from legally recognized marriage in the United States. Recent debate around legalization of same sex marriage has highlighted for anti-same sex marriage advocates and policy makers a concern that allowing same sex couples to marry will lead to a decrease in opposite sex marriages. Our objective is to model state trends in opposite sex marriage rates by implementation of same sex marriages and other same sex unions. Methods and Findings: Marriage data were obtained for all fifty states plus the District of Columbia from 1989 through 2009. As these marriage rates are non-stationary, a generalized error correction model was used to estimate long run and short run effects of same sex marriages and strong and weak same sex unions on rates of opposite sex marriage. We found that there were no significant long-run or short run effects of same sex marriages or of strong or weak same sex unions on rates of opposite sex marriage. Conclusion: A deleterious effect on rates of opposite sex marriage has been argued to be a motivating factor for both the withholding and the elimination of existing rights of same sex couples to marry by policy makers-including presiding justices of current litigation over the rights of same sex couples to legally marry. Such claims do not appear credible in the face of the existing evidence, and we conclude that rates of opposite sex marriages are not affected by legalization of same sex civil unions or same sex marriages.	[Dinno, Alexis; Whitney, Chelsea] Portland State Univ, Sch Community Hlth, Portland, OR 97207 USA	Portland State University	Dinno, A (corresponding author), Portland State Univ, Sch Community Hlth, Portland, OR 97207 USA.	alexis.dinno@pdx.edu		Dinno, Alexis/0000-0003-2560-310X				ALTMAN DG, 1995, BRIT MED J, V311, P485, DOI 10.1136/bmj.311.7003.485; Anderson Robert N, 2005, Natl Vital Stat Rep, V53, P1; [Anonymous], 1998, Mon Vital Stat Rep, V46, P1; [Anonymous], 2012, ASS PRESS; [Anonymous], 2010, TESTING STAT HYPOTHE, DOI DOI 10.1201/EBK1439808184; Baard E, 2003, VILLAGE VOICE   1209; Badgett M.V. L., 2011, PATTERNS RELATIONSHI; Badgett M. V. L., 2004, SEXUALITY RES SOCIAL, V1, P1, DOI DOI 10.1525/SRSP.2004.1.3.1; Banerjee A., 1993, COINTEGRATION ERROR, DOI [10.1093/0198288107.001.0001, DOI 10.1093/0198288107.001.0001]; Beck Nathaniel, 1991, POLITICAL ANAL, V3, P51, DOI DOI 10.1093/PAN/3.1.51; Bedrick BR, 1997, GAOOGC9716; Benjamini Y, 2001, ANN STAT, V29, P1165; Brantley M, 2011, ARKANSAS TIMES  0223; Capozzi R, 2012, E COMMUNICATION; Carlin S, 2012, REPORT FIELD CONGREG; [CDC US Department of HHS], 2008, NATL VITAL STAT REPO, V56, P1; Center for Disease Control, 1995, MONTHLY VITAL STAT R, V43, P1; Centers for Disease Control and Prevention, 2007, NATL VITAL STAT REP, V55, P1; Clark TM, 2011, HUMAN LIFE REV, V59, P97; Confessore Nicholas, 2011, NY TIMES; Crow J, 2012, MARRIAGE LICENSE BOY; Cummings P, 2011, E COMMUNICATION; De Boef S, 2001, POLIT ANAL, V9, P78; Diez-Roux AV, 1998, AM J PUBLIC HEALTH, V88, P216, DOI 10.2105/AJPH.88.2.216; Foster K, 2011, COMMUNICATION; Frank N, 2004, NY TIMES; George D, 2011, NUMBER MARRIAGES PAR; GRANGER CWJ, 1981, J ECONOMETRICS, V16, P121, DOI 10.1016/0304-4076(81)90079-8; Hadri K., 2000, ECON J, V3, P148, DOI [10.1111/1368-423x.00043, DOI 10.1111/1368-423X.00043]; Holt-Lunstad J, 2008, ANN BEHAV MED, V35, P239, DOI 10.1007/s12160-008-9018-y; Honaker J, 2010, AM J POLIT SCI, V54, P561, DOI 10.1111/j.1540-5907.2010.00447.x; Horwitz AV, 1996, J MARRIAGE FAM, V58, P895, DOI 10.2307/353978; Im KS, 2003, J ECONOMETRICS, V115, P53, DOI 10.1016/S0304-4076(03)00092-7; Iowa Department of Public Health Bureau of Health Statistics, 2010, ANN REPORT; Langbein L, 2009, SOC SCI QUART, V90, P292, DOI 10.1111/j.1540-6237.2009.00618.x; Matthews T. J., 1994, MONTHLY VITAL STAT R, V42, P1; Mero P, 2008, SALT LAKE TRIBU 1102; Mulkern AC, 2004, DENVER POST     0711, pA; National Center for Health Statistics, 2003, NATL VITAL STAT REPO, V51.; National Center for Health Statistics, 2006, NAT VIT STAT REP, V54, P1; National Center for Health Statistics, 1993, MONTHLY VITAL STAT R, V41, P1; National Center for Health Statistics, 2001, NATL VITAL STAT REPO, V48.; National Center for Health Statistics, 1992, MONTHL VIT STAT REP, V40, P1; National Center for Health Statistics, 2002, NATL VITAL STAT REPO, V50.; National Center for Health Statistics, 1997, MONTHL VIT STAT REP, V45, P1; Pawelski JG, 2006, PEDIATRICS, V118, P349, DOI 10.1542/peds.2006-1279; Robinson WS, 1950, AM SOCIOL REV, V15, P351, DOI 10.2307/2087176; Sauer P, 2009, HUFFINGTON POST; Schaefer K, 2006, NY TIMES; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Schoenborn Charlotte A, 2004, Adv Data, P1; Schultz D, 2002, ENCY AM LAW; Sullivan T, 2010, STATEWIDE MARRIAGE P; Tejada-Vera B., 2010, NATL VITAL STAT REPO, V58, P1; Tryon WW, 2008, PSYCHOL METHODS, V13, P272, DOI 10.1037/a0013158; Turnbull L, 2012, SEATTLE TIMES   0118; Wildermuth John, 2008, SAN FRANCISCO CHRONI; Wilson CM, 2005, 728 U WARW DEP EC	58	9	9	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65730	10.1371/journal.pone.0065730	http://dx.doi.org/10.1371/journal.pone.0065730			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	169CU	23776536	Green Submitted, Green Published, gold			2022-12-27	WOS:000320755400063
J	Shan, ZH; Shakoori, A; Bodaghi, S; Goldsmith, P; Jin, J; Wiest, JS				Shan, Zhihong; Shakoori, Abbas; Bodaghi, Sohrab; Goldsmith, Paul; Jin, Jen; Wiest, Jonathan S.			TUSC1, a Putative Tumor Suppressor Gene, Reduces Tumor Cell Growth In Vitro and Tumor Growth In Vivo	PLOS ONE			English	Article							HOMOZYGOUS DELETIONS; CHROMOSOME 9P; LUNG-CANCER; MELANOMA; HETEROZYGOSITY; REGION; IDENTIFICATION; CARCINOMA; PROTEINS; IDENTIFY	We previously reported the identification of TUSC1 (Tumor Suppressor Candidate 1), as a novel intronless gene isolated from a region of homozygous deletion at D9S126 on chromosome 9p in human lung cancer. In this study, we examine the differential expression of TUSC1 in human lung cancer cell lines by western blot and in a primary human lung cancer tissue microarray by immunohistochemical analysis. We also tested the functional activities and mechanisms of TUSC1 as a tumor suppressor gene through growth suppression in vitro and in vivo. The results showed no expression of TUSC1 in TUSC1 homozygously deleted cells and diminished expression in some tumor cell lines without TUSC1 deletion. Interestingly, the results from a primary human lung cancer tissue microarray suggested that higher expression of TUSC1 was correlated with increased survival times for lung cancer patients. Our data demonstrated that growth curves of tumor cell lines transfected with TUSC1 grew slower in vitro than those transfected with the empty vector. More importantly, xenograph tumors in nude mice grew significantly slower in vivo in cells stably transfected with TUSC1 than those transfected with empty vector. In addition, results from confocal microscopy and immunohistochemical analyses show distribution of TUSC1 in the cytoplasm and nucleus in tumor cell lines and in normal and tumor cells in the lung cancer tissue microarray. Taken together, our results support TUSC1 has tumor suppressor activity as a candidate tumor suppressor gene located on chromosome 9p.	[Shan, Zhihong; Bodaghi, Sohrab; Wiest, Jonathan S.] NCI, Lab Canc Biol & Genet, Ctr Canc Res, Bethesda, MD 20892 USA; [Shakoori, Abbas; Jin, Jen] Mayo Clin & Mayo Fdn, Adv Genome Technol Ctr, Rochester, MN 55905 USA; [Goldsmith, Paul] NCI, Basic Res Lab, Ctr Canc Res, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Mayo Clinic; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Wiest, JS (corresponding author), NCI, Lab Canc Biol & Genet, Ctr Canc Res, Bethesda, MD 20892 USA.	wiestj@mail.nih.gov		shakoori, abbas/0000-0002-4363-1967	Intramural Research Program of the National Cancer Institute, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC010448] Funding Source: NIH RePORTER	Intramural Research Program of the National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the National Cancer Institute, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2012, CANC FACTS FIG 2012; An HX, 1996, GENE CHROMOSOME CANC, V17, P14, DOI 10.1002/(SICI)1098-2264(199609)17:1<14::AID-GCC3>3.3.CO;2-Y; CAIRNS P, 1995, NAT GENET, V11, P210, DOI 10.1038/ng1095-210; CARNEY DN, 1985, CANCER RES, V45, P2913; Castellano M, 1997, CANCER RES, V57, P4868; CHENG JQ, 1993, CANCER RES, V53, P4761; COLEMAN A, 1994, CANCER RES, V54, P344; Fogh J., 1975, HUMAN TUMOR CELLS IN, P115, DOI 10.1007/978-1-4757-1647-4_5; Fukuoka J, 2004, CLIN CANCER RES, V10, P4314, DOI 10.1158/1078-0432.CCR-03-0489; GOLDSMITH P, 1987, J BIOL CHEM, V262, P14683; Hamada K, 1998, GENE CHROMOSOME CANC, V22, P232, DOI 10.1002/(SICI)1098-2264(199807)22:3<232::AID-GCC9>3.0.CO;2-X; Hamada K, 2000, GENE CHROMOSOME CANC, V27, P308, DOI 10.1002/(SICI)1098-2264(200003)27:3<308::AID-GCC12>3.3.CO;2-N; HOLLAND EA, 1994, ONCOGENE, V9, P1361; Howlader N, 2012, SEER CANC STAT REV 1; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; KAMB A, 1994, SCIENCE, V264, P436, DOI 10.1126/science.8153634; La Rochelle J, 2010, CANCER-AM CANCER SOC, V116, P4696, DOI 10.1002/cncr.25279; Mead LJ, 1997, INT J CANCER, V71, P213; MERLO A, 1995, NAT MED, V1, P686, DOI 10.1038/nm0795-686; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; PETTIJOHN DE, 1988, P NATL ACAD SCI USA, V85, P802, DOI 10.1073/pnas.85.3.802; Ploussard G, 2010, UROLOGY, V76, DOI 10.1016/j.urology.2010.03.037; Pollock PM, 2001, CANCER RES, V61, P1154; QUELLE DE, 1995, CELL, V83, P993; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; Shan ZH, 2004, ONCOGENE, V23, P6612, DOI 10.1038/sj.onc.1207857; Sheu JC, 1999, BRIT J CANCER, V80, P468, DOI 10.1038/sj.bjc.6690380; Takeuchi S, 1997, LEUKEMIA, V11, P1636, DOI 10.1038/sj.leu.2400817; Wiest JS, 1997, CANCER RES, V57, P1; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; XIAO S, 1995, CANCER RES, V55, P2968; Yang XR, 2010, FAM CANCER, V9, P625, DOI 10.1007/s10689-010-9356-3; Zochbauer-Muller S, 2002, ANNU REV PHYSIOL, V64, P681, DOI 10.1146/annurev.physiol.64.081501.155828	34	15	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66114	10.1371/journal.pone.0066114	http://dx.doi.org/10.1371/journal.pone.0066114			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776618	Green Submitted, gold, Green Published			2022-12-27	WOS:000320755400111
J	Xu, J; Zhao, XQ; Wang, YL; Wang, CX; Liu, LP; Sun, BY; Wang, AX; Wang, YJ				Xu, Jie; Zhao, Xingquan; Wang, Yilong; Wang, Chunxue; Liu, Liping; Sun, Baoying; Wang, Anxin; Wang, Yongjun			Impact of a Better Persistence with Antihypertensive Agents on Ischemic Stroke Outcomes for Secondary Prevention	PLOS ONE			English	Article							MEDICATION ADHERENCE; THERAPY; EVENTS	Background: The efficacy of antihypertensive (AH) treatment after stroke has been investigated in several randomized clinical trials. However, non-adherence to AH medication is common for stroke patients in "real world" setting. The purpose of this study was to assess the impact of persistence with AH agents on ischemic stroke (IS) outcomes. Methods and Results: Using the China National Stroke Registry, we analyzed data from 8409 IS patients with hypertension. Persistence with AH therapy (high persistence >= 75%, low persistence <75%) was measured by patient self-report at 3, 6, and 12 months after stroke. Multivariate logistic regression model was used to assess the relationship between persistence and IS outcomes (stroke recurrence, combined vascular events and death) at 12 months. Of the 8409 patients in this study, 40.0% were female and the mean age at study entry was 66.7 years. 31.6% of patients had high persistence with AH drugs, and 68.4% had low persistence during 1 year after stroke onset. High persistence with AH drugs significantly decreased the risk of stroke recurrence (odds ratio, 0.78; 95% CI, 0.68 to 0.89), combined vascular events (0.71; 0.63-0.81) and death (0.44; 0.36-0.53) compared with low persistence. Conclusions: Our study reinforces the benefits of AH medications in routine clinical practice and highlights the importance of persistence with AH therapy among IS patients known to be hypertensive within the first year of an event.	[Xu, Jie; Zhao, Xingquan; Wang, Yilong; Wang, Chunxue; Liu, Liping; Wang, Anxin; Wang, Yongjun] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China; [Sun, Baoying] Shandong Univ, Jinan Cent Hosp, Jinan 250100, Shandong, Peoples R China	Capital Medical University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Wang, YJ (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China.	yongjunwang1962@gmail.com	liu, li/HGC-0900-2022		Ministry of Sciences and Technology; Ministry of Health of the People's Republic of China [2006BA101A11, 2009CB521905, 200902004]; National Science Foundation [81071115]	Ministry of Sciences and Technology; Ministry of Health of the People's Republic of China; National Science Foundation(National Science Foundation (NSF))	The China National Stroke Registry was funded by the Ministry of Sciences and Technology and the Ministry of Health of the People's Republic of China (grants 2006BA101A11, 2009CB521905 and 200902004) and the National Science Foundation (grant 81071115). The current analysis of the CNSR data was supported by Beijing Novartis Pharma Co., Ltd. In compliance with the Uniform Requirements for Manuscripts, established by the International Committee of Medical Journal Editors, Novartis did not impose any impediment, directly or indirectly, on the publication of the study's results. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1989, STROKE, V20, P1407; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Bushnell CD, 2011, NEUROLOGY, V77, P1182, DOI 10.1212/WNL.0b013e31822f0423; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Colivicchi F, 2007, STROKE, V38, P2652, DOI 10.1161/STROKEAHA.107.487017; Gehi AK, 2007, ARCH INTERN MED, V167, P1798, DOI 10.1001/archinte.167.16.1798; Gerstein HC, 2000, LANCET, V355, P253; Graves JW, 2012, J HYPERTENS, V30, P1233, DOI 10.1097/HJH.0b013e328353968d; HAYNES RB, 1980, HYPERTENSION, V2, P757, DOI 10.1161/01.HYP.2.6.757; Ho PM, 2009, CIRCULATION, V119, P3028, DOI 10.1161/CIRCULATIONAHA.108.768986; Kettani FZ, 2009, STROKE, V40, P213, DOI 10.1161/STROKEAHA.108.522193; LIU LS, 1995, CHINESE MED J-PEKING, V108, P710; Muntner P, 2011, J CLIN HYPERTENS, V13, P479, DOI 10.1111/j.1751-7176.2011.00464.x; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Ovbiagele B, 2010, CEREBROVASC DIS, V29, P146, DOI 10.1159/000262311; PROGRESS Collaborat Grp, 2001, LANCET, V358, P1556; Rashid P, 2003, STROKE, V34, P2741, DOI 10.1161/01.STR.0000092488.40085.15; Schrader J, 2005, STROKE, V36, P1218, DOI 10.1161/01.STR.0000166048.35740.a9; Walsh JC, 2002, AIDS, V16, P269, DOI 10.1097/00002030-200201250-00017; Wang YJ, 2011, INT J STROKE, V6, P355, DOI 10.1111/j.1747-4949.2011.00584.x; Yusuf S, 2008, NEW ENGL J MED, V359, P1225, DOI 10.1056/NEJMoa0804593	22	13	14	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65233	10.1371/journal.pone.0065233	http://dx.doi.org/10.1371/journal.pone.0065233			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776454	Green Submitted, gold, Green Published			2022-12-27	WOS:000320755400017
J	Zhang, Z; Zhang, XM; Sun, ZZ; Dong, HB; Qiu, LL; Gu, J; Zhou, JP; Wang, XR; Wang, SL				Zhang, Zhan; Zhang, Xiaoming; Sun, Zhenzhen; Dong, Huibin; Qiu, Lianglin; Gu, Jun; Zhou, Jingping; Wang, Xinru; Wang, Shou-Lin			Cytochrome P450 3A1 Mediates 2,2 ',4,4 '-Tetrabromodiphenyl Ether-Induced Reduction of Spermatogenesis in Adult Rats	PLOS ONE			English	Article							POLYBROMINATED DIPHENYL ETHERS; BROMINATED FLAME RETARDANTS; DEVELOPMENTAL EXPOSURE; HUMAN HEPATOCYTES; SOUTH CHINA; IN-VIVO; BDE-47; CELLS; METABOLITES; APOPTOSIS	Background: 2,2',4,4'-tetrabromodiphenyl ether (BDE47) is the dominant PBDE congener in humans, wildlife, and the environment. It has been reported to be metabolized by cytochrome P450 (CYP) enzymes. Still, the effects of BDE47 on spermatogenesis failure are attracting an increasing amount of attention. However, it is unclear whether CYP-mediated metabolism contributes to BDE47-induced reproductive toxicity. Methodology and Principal Findings: The role of cytochrome P450 3A1 (CYP3A1) in the formation of oxidative metabolites of BDE47 and its induced spermatogenesis failure was investigated in SD rats. BDE47 significantly increased the expression and activity of CYP3A1 in rat liver, and 3-OH-BDE47, the major oxidative metabolite of BDE47, dose-dependently increased in rat liver, serum, and testis, which was aggravated by dexamethasone (DEX), an inducer of CYP3A1. Additionally, testicular 3-OH-BDE47 and reactive oxygen species (ROS) in seminiferous tubules increased especially when BDE47 was administered in combination with DEX, which was confirmed in GC-1 and GC-2 cells that 3-OH-BDE47 induced more ROS production and cell apoptosis via the upregulation of FAS/FASL, p-p53 and caspase 3. As a result, daily sperm production dose-dependently decreased, consistent with histological observations in giant cells and vacuolar spaces and increase in TUNEL-positive apoptotic germ cells. Conclusion: CYP3A1-mediated metabolic activation of BDE47 and the active metabolite 3-OH-BDE47 and consequent ROS played an important role in reduction of spermatogenesis by germ cell apoptosis. Our study helps provide new insights into the mechanism of reproductive toxicity of environmental chemicals.	[Zhang, Zhan; Zhang, Xiaoming; Sun, Zhenzhen; Qiu, Lianglin; Wang, Xinru; Wang, Shou-Lin] Nanjing Med Univ, Inst Toxicol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Zhang, Zhan; Zhang, Xiaoming; Sun, Zhenzhen; Dong, Huibin; Qiu, Lianglin; Gu, Jun; Zhou, Jingping; Wang, Xinru; Wang, Shou-Lin] Nanjing Med Univ, Sch Publ Hlth, Minist Educ, Key Lab Modern Toxicol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Wang, SL (corresponding author), Nanjing Med Univ, Inst Toxicol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China.	wangshl@njmu.edu.cn	Zhang, Zhan/AAR-6278-2020; Wang, Xin/AAN-8435-2021	Zhang, Zhan/0000-0002-9685-5753; Wang, Xin/0000-0002-4457-7376	National 973 program [2009CB941701]; National Natural Science Foundation of China [30972508, 81172695]; Environmental protection research special funds for public welfare projects [200909054]; Doctoral Fund of Ministry of Education of China [20093234110002]; Six talents peak project of Jiangsu province [DG216D5047]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), China	National 973 program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Environmental protection research special funds for public welfare projects; Doctoral Fund of Ministry of Education of China(Ministry of Education, China); Six talents peak project of Jiangsu province; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), China	This work was supported by National 973 program (2009CB941701), National Natural Science Foundation of China (30972508, 81172695), Environmental protection research special funds for public welfare projects (200909054), Doctoral Fund of Ministry of Education of China (20093234110002), Six talents peak project of Jiangsu province (DG216D5047), and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelouahab N, 2011, REPROD TOXICOL, V31, P546, DOI 10.1016/j.reprotox.2011.02.005; Akutsu K, 2008, B ENVIRON CONTAM TOX, V80, P345, DOI 10.1007/s00128-008-9370-4; An J, 2011, ENVIRON TOXICOL, V26, P591, DOI 10.1002/tox.20582; Athanasiadou M, 2008, ENVIRON HEALTH PERSP, V116, P400, DOI 10.1289/ehp.10713; Chen SJ, 2010, J HAZARD MATER, V176, P979, DOI 10.1016/j.jhazmat.2009.11.138; Elliott MR, 2010, NATURE, V467, P333, DOI 10.1038/nature09356; Emond C, 2010, TOXICOL APPL PHARM, V242, P290, DOI 10.1016/j.taap.2009.10.019; Erratico CA, 2011, TOXICOL SCI, V123, P37, DOI 10.1093/toxsci/kfr155; Fornari F, 2012, J PATHOL, V227, P275, DOI 10.1002/path.3995; Garcia PC, 2012, REPROD FERT DEVELOP, V24, P559, DOI 10.1071/RD10063; GRAY TJB, 1983, TOXICOL APPL PHARM, V67, P15, DOI 10.1016/0041-008X(83)90240-5; Hamers T, 2008, MOL NUTR FOOD RES, V52, P284, DOI 10.1002/mnfr.200700104; Han XM, 2012, TOXICOLOGY, V302, P44, DOI 10.1016/j.tox.2012.07.010; Jazirehi AR, 2012, AM J CANCER RES, V2, P178; Jin SW, 2010, TOXICOL IN VITRO, V24, P1190, DOI 10.1016/j.tiv.2010.02.012; Kamdem LK, 2006, CHEM RES TOXICOL, V19, P577, DOI 10.1021/tx050358e; Koster R, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.33; Lacorte S, 2010, J CHROMATOGR A, V1217, P337, DOI 10.1016/j.chroma.2009.11.024; Li QZ, 2010, MAR POLLUT BULL, V60, P464, DOI 10.1016/j.marpolbul.2010.01.011; Lilienthal H, 2006, ENVIRON HEALTH PERSP, V114, P194, DOI 10.1289/ehp.8391; Mai BX, 2005, ENVIRON SCI TECHNOL, V39, P3521; Marsh G, 2006, CHEMOSPHERE, V63, P690, DOI 10.1016/j.chemosphere.2005.07.072; Marteau C, 2012, RAPID COMMUN MASS SP, V26, P599, DOI 10.1002/rcm.6136; Nair R, 2003, J BIOL CHEM, V278, P6470, DOI 10.1074/jbc.M209319200; Naomi D., 2010, TOXICOL SCI, V117, P439; Nebert DW, 2006, NAT REV CANCER, V6, P947, DOI 10.1038/nrc2015; Orn U, 1998, XENOBIOTICA, V28, P199, DOI 10.1080/004982598239687; Sanders JM, 2005, TOXICOL SCI, V88, P127, DOI 10.1093/toxsci/kfi288; Shao J, 2008, MAR ENVIRON RES, V66, P7, DOI 10.1016/j.marenvres.2008.02.007; Shao J, 2008, TOXICOL SCI, V101, P81, DOI 10.1093/toxsci/kfm256; Stapleton HM, 2009, ENVIRON HEALTH PERSP, V117, P197, DOI 10.1289/ehp.11807; Staskal DF, 2005, TOXICOL SCI, V84, P225, DOI 10.1093/toxsci/kfi090; Suvorov A, 2010, ENVIRON HEALTH PERSP, V118, P97, DOI 10.1289/ehp.0901031; Vurusaner B, 2012, FREE RADICAL BIO MED, V52, P7, DOI 10.1016/j.freeradbiomed.2011.09.035; Wong EWP, 2011, TRENDS PHARMACOL SCI, V32, P290, DOI 10.1016/j.tips.2011.01.001; Yan C, 2011, EXP TOXICOL PATHOL, V63, P413, DOI 10.1016/j.etp.2010.02.018; Yang XJ, 2012, TOXICOLOGY, V300, P138, DOI 10.1016/j.tox.2012.06.010; Yoshihara A, 2012, THYROID, V22, P1054, DOI 10.1089/thy.2012.0003; Yuan HP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015726	39	62	67	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e66301	10.1371/journal.pone.0066301	http://dx.doi.org/10.1371/journal.pone.0066301			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762486	gold, Green Published, Green Submitted			2022-12-27	WOS:000321094800095
J	Beckers, P; Loesel, R; Bartolomaeus, T				Beckers, Patrick; Loesel, Rudi; Bartolomaeus, Thomas			The Nervous Systems of Basally Branching Nemertea (Palaeonemertea)	PLOS ONE			English	Article							RIBBON WORM RELATIONSHIPS; NEREIS-DIVERSICOLOR; ULTRASTRUCTURE; RECONSTRUCTION; POLYCHAETA; PREDATORS; MOLLUSCA; ORGANS	In recent years, a lot of studies have been published dealing with the anatomy of the nervous system in different spiralian species. The only nemertean species investigated in this context probably shows derived characters and thus the conditions found there are not useful in inferring the relationship between nemerteans and other spiralian taxa. Ingroup relationships within Nemertea are still unclear, but there is some agreement that the palaeonemerteans form a basal, paraphyletic grade. Thus, palaeonemertean species are likely the most informative when comparing with other invertebrate groups. We therefore analyzed the nervous system of several palaeonemertean species by combining histology and immunostaining. 3D reconstructions based on the aligned slices were performed to get an overall impression of the central nervous system, and immunohistochemistry was chosen to reveal fine structures and to be able to compare the data with recently published results. The insights presented here permit a first attempt to reconstruct the primary organization of the nemertean nervous system. This comparative analysis allows substantiating homology hypotheses for nerves of the peripheral nervous system. This study also provides evidence that the nemertean brain primarily consists of two lobes connected by a strong ventral commissure and one to several dorsal commissures. During nemertean evolution, the brain underwent continuous compartmentalization into a pair of dorsal and ventral lobes interconnected by commissures and lateral tracts. Given that this conclusion can be corroborated by cladistic analyses, nemerteans should share a common ancestor with spiralians that primarily have a simple brain consisting of paired medullary, frontally commissurized and reinforced cords. Such an organization resembles the situation found in presumably basally branching annelids or mollusks.	[Beckers, Patrick; Bartolomaeus, Thomas] Univ Bonn, Inst Evolutionary Biol & Ecol, Bonn, Germany; [Loesel, Rudi] Rhein Westfal TH Aachen, Inst Biol 2, Unit Dev Biol & Morphol Anim, Aachen, Germany	University of Bonn; RWTH Aachen University	Beckers, P (corresponding author), Univ Bonn, Inst Evolutionary Biol & Ecol, Bonn, Germany.	pbeckers@evolution.uni-bonn.de	Beckers, Patrick/AAO-7757-2020		German Research Council [BA 1520/11-2]	German Research Council(German Research Foundation (DFG))	Funding provided by the German Research Council BA 1520/11-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMERONGEN HM, 1982, J EXP MAR BIOL ECOL, V64, P11, DOI 10.1016/0022-0981(82)90065-X; Andrade SCS, 2012, CLADISTICS, V28, P141, DOI 10.1111/j.1096-0031.2011.00376.x; AX P, 1996, MULTICELLULAR ANIMAL, V1; Beckers P, 2012, THESIS FRIEDRICH WIL; Beckers P, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-17; BIANCHI S, 1969, GEN COMP ENDOCR, V12, P541, DOI 10.1016/0016-6480(69)90172-5; Brusca R. C., 2004, INVERTEBRATES; BULLOCK TH, 1965, STRUCTURE FUNCTION N, V2, P1719; Burger O., 1895, FAUNA FLORA GOLFES N; Burger O, 1921, MITTHEILUNGEN ZOOLOG, P206; Cardona A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038011; Coe Wesley R., 1943, TRANS CONNECTICUT ACAD ARTS AND SCI, V35, P129; Coe WR, 1905, B MUS COMP ZOOL HARV, V47, P1, DOI DOI 10.1038/199121D0; Coulon J, 1997, CELL TISSUE RES, V1, P95; Edgecombe GD, 2011, ORG DIVERS EVOL, V11, P151, DOI 10.1007/s13127-011-0044-4; Eernisse Douglas J., 1994, P55; Faller S, 2008, J MORPHOL, V269, P1482; FERRARIS JD, 1985, AM ZOOL, V25, P73; Friedrich H, 1956, LUNDS U ARSSKR, V2, P3; FRIEDRICH HERMANN, 1935, ZOOL ANZ, V109, P64; Gibson R., 1982, SYNOPSES BRIT FAUNA, V24; Gibson R, 1972, NEMERTEANS; Gibson R, 1986, P 2 INT MAR BIOL WOR, P33; Golding David W., 1992, P153; HAREL R, 1993, FASEB J, V7, P1115, DOI 10.1096/fasebj.7.12.8375610; HASZPRUNAR G, 1987, PHILOS T R SOC B, V315, P37, DOI 10.1098/rstb.1987.0002; Herrmann Karl, 1997, P207; Heuer CM, 2008, CELL TISSUE RES, V331, P713, DOI 10.1007/s00441-007-0535-y; Heuer CM, 2009, ZOOMORPHOLOGY, V128, P219, DOI 10.1007/s00435-008-0063-7; Heuer CM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-13; Hyman L. H., 1967, INVERTEBRATES MOLLUS, VVI; Iwata F., 1954, Journal of the Faculty of Science Hokkaido University Zoology, V11, P126; Iwata F, 1963, PUBL AKKESHI MAR BIO, V10, P1; IWATA FUMIO, 1954, JOUR FAC SCI HOKKAIDO UNIV SER VI ZOOL, V12, P1; James MA, 1997, MICROSCOPIC ANATOMY, V13, P297; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Loesel R, 2010, ACTA ZOOL-STOCKHOLM, V91, P29, DOI 10.1111/j.1463-6395.2009.00422.x; Maslakova SA, 2004, DEV BIOL, V267, P342, DOI 10.1016/j.ydbio.2003.10.022; MOROZ L, 1994, CELL TISSUE RES, V275, P277, DOI 10.1007/BF00319425; Nielsen C, 2012, ANIMAL EVOLUTION: INTERRELATIONSHIPS OF THE LIVING PHYLA, 3RD EDITION, P1; Nielsen Claus, 1997, P13; NORDHAUSEN W, 1988, HYDROBIOLOGIA, V156, P39, DOI 10.1007/BF00027976; Purschke G, 1997, ACTA ZOOL-STOCKHOLM, V78, P123, DOI 10.1111/j.1463-6395.1997.tb01133.x; Reuter M., 1995, Experientia Supplementum (Basel), V72, P25; Rhode B, 1990, J MORPHOL, V1, P167; Rice Mary E., 1993, P237; Richter S, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-29; RODRIGUEZ J, 1960, VIROLOGY, V12, P316, DOI 10.1016/0042-6822(60)90205-1; Rothe Birgen H., 2008, Meiofauna Marina, V16, P175; Rouse GW, 1997, ZOOL SCR, V26, P139, DOI 10.1111/j.1463-6409.1997.tb00412.x; Ruppert E.E., 2003, INVERTEBRATE ZOOLOGY; RUTKA JT, 1988, J NEUROSURG, V69, P155, DOI 10.3171/jns.1988.69.2.0155; Scharrer B, 1941, J COMP NEUROL, V74, P109, DOI 10.1002/cne.900740109; Scheltema Amelie H., 1994, P13; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Senz W., 2000, Annalen des Naturhistorischen Museums in Wien Serie B Botanik und Zoologie, V102B, P321; Senz W, 1997, SITZUNGSBER AKAD W 1, V204, P3; Senz W, 1990, ANN NATURHISTORISCHE, P47; SENZ W, 1997, SITZUNGSBER ABT 1, V204, P63; Struck TH, 2011, NATURE, V471, P95, DOI 10.1038/nature09864; Sundberg P, 2001, MOL PHYLOGENET EVOL, V20, P327, DOI 10.1006/mpev.2001.0982; Thiel M, 2001, HYDROBIOLOGIA, V456, P21, DOI 10.1023/A:1013005814145; Thiel M, 1998, HYDROBIOLOGIA, V365, P241; Thollesson M, 2003, P ROY SOC B-BIOL SCI, V270, P407, DOI 10.1098/rspb.2002.2254; Todt C, 2008, MAR BIOL RES, V4, P290, DOI 10.1080/17451000801922830; TURBEVILLE JM, 1985, AM ZOOL, V25, P53; Turbeville JM, 1991, MICROSCOPIC ANATOMY, V3, P258; Wang HY, 2006, J EXP MAR BIOL ECOL, V336, P146, DOI 10.1016/j.jembe.2006.05.008; WHITTLE AC, 1974, J MORPHOL, V144, P167, DOI 10.1002/jmor.1051440204; Wijnhoff G., 1910, (Anatom Teil) Zool Jahrb Jena Abt f Anat, V30; Wollesen T, 2008, ACTA BIOL HUNG, V59, P111, DOI 10.1556/ABiol.59.2008.Suppl.18	72	23	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66137	10.1371/journal.pone.0066137	http://dx.doi.org/10.1371/journal.pone.0066137			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785478	Green Published, Green Submitted, gold			2022-12-27	WOS:000321038800044
J	Cernilogar, FM; Burroughs, AM; Lanzuolo, C; Breiling, A; Imhof, A; Orlando, V				Cernilogar, Filippo M.; Burroughs, A. Maxwell; Lanzuolo, Chiara; Breiling, Achim; Imhof, Axel; Orlando, Valerio			RNA-Interference Components Are Dispensable for Transcriptional Silencing of the Drosophila Bithorax-Complex	PLOS ONE			English	Article							NONCODING RNAS; METHYLTRANSFERASE ACTIVITY; HETEROCHROMATIN FORMATION; ARGONAUTE PROTEINS; DISTINCT ROLES; POLYCOMB; ELEMENTS; CHROMATIN; PATHWAY; METHYLATION	Background: Beyond their role in post-transcriptional gene silencing, Dicer and Argonaute, two components of the RNA interference (RNAi) machinery, were shown to be involved in epigenetic regulation of centromeric heterochromatin and transcriptional gene silencing. In particular, RNAi mechanisms appear to play a role in repeat induced silencing and some aspects of Polycomb-mediated gene silencing. However, the functional interplay of RNAi mechanisms and Polycomb group (PcG) pathways at endogenous loci remains to be elucidated. Principal Findings: Here we show that the endogenous Dicer-2/Argonaute-2 RNAi pathway is dispensable for the PcG mediated silencing of the homeotic Bithorax Complex (BX-C). Although Dicer-2 depletion triggers mild transcriptional activation at Polycomb Response Elements (PREs), this does not induce transcriptional changes at PcG-repressed genes. Moreover, Dicer-2 is not needed to maintain global levels of methylation of lysine 27 of histone H3 and does not affect PRE-mediated higher order chromatin structures within the BX-C. Finally bioinformatic analysis, comparing published data sets of PcG targets with Argonaute-2-bound small RNAs reveals no enrichment of these small RNAs at promoter regions associated with PcG proteins. Conclusions: We conclude that the Dicer-2/Argonaute-2 RNAi pathway, despite its role in pairing sensitive gene silencing of transgenes, does not have a role in PcG dependent silencing of major homeotic gene cluster loci in Drosophila.	[Cernilogar, Filippo M.; Lanzuolo, Chiara; Orlando, Valerio] IRCCS Fdn Santa Lucia, Epigenet & Genome Reprogramming Lab, Rome, Italy; [Cernilogar, Filippo M.; Imhof, Axel] Univ Munich, Adolf Butenandt Inst, Munich, Germany; [Breiling, Achim] German Canc Res Ctr, DKFZ ZMBH Alliance, Div Epigenet, Heidelberg, Germany; [Lanzuolo, Chiara] IRCCS Fdn Santa Lucia, Inst Neurobiol & Mol Med, CNR, Rome, Italy; [Burroughs, A. Maxwell] RIKEN Yokohama Inst, RIKEN Om Sci Ctr, Tsurumi Ku, Yokohama, Kanagawa, Japan; [Imhof, Axel] Univ Munich, Munich Ctr Integrated Prot Sci, Munich, Germany	IRCCS Santa Lucia; University of Munich; Helmholtz Association; German Cancer Research Center (DKFZ); Consiglio Nazionale delle Ricerche (CNR); IRCCS Santa Lucia; RIKEN; University of Munich	Cernilogar, FM (corresponding author), IRCCS Fdn Santa Lucia, Epigenet & Genome Reprogramming Lab, Rome, Italy.	filippo.cernilogar@med.uni-muenchen.de	Imhof, Axel/AAU-5313-2021; Lanzuolo, Chiara/AAB-1037-2019; Cernilogar, Filippo/AAC-3243-2021	Imhof, Axel/0000-0003-2993-8249; Cernilogar, Filippo/0000-0003-2814-3436; Burroughs, A. Max/0000-0002-2229-8771; Lanzuolo, Chiara/0000-0003-2649-6334; Breiling, Achim/0000-0002-7928-299X	European Union [EpiGeneSys 257082]; Fondazione Telethon [S00094TELA]; Epigenome Network of Excellence (NoE); Progetto Bandiera EPIGEN	European Union(European Commission); Fondazione Telethon(Fondazione TelethonEuropean Commission); Epigenome Network of Excellence (NoE); Progetto Bandiera EPIGEN	Funding was provided by grants from the European Union to A.I. (EpiGeneSys 257082), and by the Fondazione Telethon (S00094TELA), The Epigenome Network of Excellence (NoE), the Progetto Bandiera EPIGEN to V.O. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams M., 2002, GENOME BIOL, V3, DOI DOI 10.1186/GB-2002; Bantignies F, 2003, GENE DEV, V17, P2406, DOI 10.1101/gad.269503; Bantignies F, 2011, TRENDS GENET, V27, P454, DOI 10.1016/j.tig.2011.06.008; Bantignies F, 2011, CELL, V144, P214, DOI 10.1016/j.cell.2010.12.026; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Bonaldi T, 2004, PROTEOMICS, V4, P1382, DOI 10.1002/pmic.200300743; Bonaldi T, 2004, METHOD ENZYMOL, V377, P111; Breiling A, 2004, EMBO REP, V5, P976, DOI 10.1038/sj.embor.7400260; Breiling A, 2001, NATURE, V412, P651, DOI 10.1038/35088090; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Brower-Toland B, 2007, GENE DEV, V21, P2300, DOI 10.1101/gad.1564307; Burroughs AM, 2011, RNA BIOL, V8, P158, DOI 10.4161/rna.8.1.14300; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cernilogar FM, 2011, NATURE, V480, P391, DOI 10.1038/nature10492; Cleard F, 2006, NAT GENET, V38, P931, DOI 10.1038/ng1833; Comet I, 2006, DEV CELL, V11, P117, DOI 10.1016/j.devcel.2006.05.009; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Deshpande G, 2005, GENE DEV, V19, P1680, DOI 10.1101/gad.1316805; Enderle D, 2011, GENOME RES, V21, P216, DOI 10.1101/gr.114348.110; Fagegaltier D, 2009, P NATL ACAD SCI USA, V106, P21258, DOI 10.1073/pnas.0809208105; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396; Greiner D, 2005, NAT CHEM BIOL, V1, P143, DOI 10.1038/nchembio721; Grewal SIS, 2007, NATURE, V447, P399, DOI 10.1038/nature05914; Grimaud C, 2006, CELL, V124, P957, DOI 10.1016/j.cell.2006.01.036; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hekimoglu B, 2009, RNA BIOL, V6, P129, DOI 10.4161/rna.6.2.8178; Kawamura Y, 2008, NATURE, V453, P793, DOI 10.1038/nature06938; Kim DH, 2006, NAT STRUCT MOL BIOL, V13, P793, DOI 10.1038/nsmb1142; Lanzuolo C, 2007, NAT CELL BIOL, V9, P1167, DOI 10.1038/ncb1637; Lanzuolo C, 2012, ANNU REV GENET, V46, P561, DOI 10.1146/annurev-genet-110711-155603; Lanzuolo C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002370; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Liu Y, 2007, GENE DEV, V21, P1530, DOI 10.1101/gad.1544207; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo Sardo F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003283; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; MARTIN CH, 1995, P NATL ACAD SCI USA, V92, P8398, DOI 10.1073/pnas.92.18.8398; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; MESSMER S, 1992, GENE DEV, V6, P1241, DOI 10.1101/gad.6.7.1241; Mihaly J, 1997, DEVELOPMENT, V124, P1809; Miyoshi K, 2005, GENE DEV, V19, P2837, DOI 10.1101/gad.1370605; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Moshkovich N, 2011, GENE DEV, V25, P1686, DOI 10.1101/gad.16651211; Moshkovich N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000880; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Noma K, 2004, NAT GENET, V36, P1174, DOI 10.1038/ng1452; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Okamura K, 2008, NATURE, V453, P803, DOI 10.1038/nature07015; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; PalBhadra M, 1997, CELL, V90, P479, DOI 10.1016/S0092-8674(00)80508-5; Papp B, 2006, GENE DEV, V20, P2041, DOI 10.1101/gad.388706; Peters L, 2007, MOL CELL, V26, P611, DOI 10.1016/j.molcel.2007.05.001; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rank G, 2002, MOL CELL BIOL, V22, P8026, DOI 10.1128/MCB.22.22.8026-8034.2002; Saito K, 2010, DEV CELL, V19, P687, DOI 10.1016/j.devcel.2010.10.011; Sanchez-Elsner T, 2006, SCIENCE, V311, P1118, DOI 10.1126/science.1117705; Schmitt S, 2005, GENE DEV, V19, P697, DOI 10.1101/gad.326205; Schwartz YB, 2008, CURR OPIN CELL BIOL, V20, P266, DOI 10.1016/j.ceb.2008.03.002; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Zaratiegui M, 2007, CELL, V128, P763, DOI 10.1016/j.cell.2007.02.016	69	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65740	10.1371/journal.pone.0065740	http://dx.doi.org/10.1371/journal.pone.0065740			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785447	Green Published, Green Submitted, gold			2022-12-27	WOS:000321038800075
J	He, Y; Lazaridis, T				He, Yi; Lazaridis, Themis			Activity Determinants of Helical Antimicrobial Peptides: A Large-Scale Computational Study	PLOS ONE			English	Article							POTENT ANTIBACTERIAL PEPTIDES; EFFECTIVE ENERGY FUNCTION; LIPID-BILAYER DISRUPTION; MAGAININ 2; PHOSPHOLIPID-MEMBRANES; PORE FORMATION; HOST-DEFENSE; ESCHERICHIA-COLI; NMR-SPECTROSCOPY; MAMMALIAN-CELLS	Antimicrobial peptides (AMPs), produced by a wide range of organisms, have attracted attention due to their potential use as novel antibiotics. The majority of these peptides are cationic and are thought to function by permeabilizing the bacterial membrane, either by making pores or by dissolving it ('carpet' model). A key hypothesis in the literature is that antimicrobial and hemolytic activity correlate with binding affinity to anionic and zwitterionic membranes, respectively. Here we test this hypothesis by using binding free energy data collected from the literature and theoretical binding energies calculated from implicit membrane models for 53 helical AMPs. We indeed find a correlation between binding energy and biological activity, depending on membrane anionic content: antibacterial activity correlates best with transfer energy to membranes with anionic lipid fraction higher than 30% and hemolytic activity correlates best with transfer energy to a 10% anionic membrane. However, the correlations are weak, with correlation coefficient up to 0.4. Weak correlations of the biological activities have also been found with other physical descriptors of the peptides, such as surface area occupation, which correlates significantly with antibacterial activity; insertion depth, which correlates significantly with hemolytic activity; and structural fluctuation, which correlates significantly with both activities. The membrane surface coverage by many peptides at the MIC is estimated to be much lower than would be required for the 'carpet' mechanism. Those peptides that are active at low surface coverage tend to be those identified in the literature as pore-forming. The transfer energy from planar membrane to cylindrical and toroidal pores was also calculated for these peptides. The transfer energy to toroidal pores is negative in almost all cases while that to cylindrical pores is more favorable in neutral than in anionic membranes. The transfer energy to pores correlates with the deviation from predictions of the 'carpet' model.	[He, Yi; Lazaridis, Themis] CUNY City Coll, Dept Chem, New York, NY 10031 USA	City University of New York (CUNY) System; City College of New York (CUNY)	Lazaridis, T (corresponding author), CUNY City Coll, Dept Chem, New York, NY 10031 USA.	tlazaridis@ccny.cuny.edu			NIH [SC1 GM087190]; RCMI from NIH [2G12RR03060-26A1/8G12MD007603-27]; NSF [CNS-0855217, CNS-0958379]; National Institute on Minority Health and Health Disparities [G12MD007603] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); RCMI from NIH; NSF(National Science Foundation (NSF)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by NIH grant SC1 GM087190. Infrastructure support was provided by RCMI grant 2G12RR03060-26A1/8G12MD007603-27 from NIH. Computational resources were provided by the City University of New York High Performance Computing Center, supported under NSF Grants CNS-0855217 and CNS-0958379. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allende D, 2005, BIOPHYS J, V88, P1828, DOI 10.1529/biophysj.104.049817; Allende D, 2003, CHEM PHYS LIPIDS, V122, P65, DOI 10.1016/S0009-3084(02)00179-2; Almeida PF, 2009, BIOCHEMISTRY-US, V48, P8083, DOI 10.1021/bi900914g; Bastos M, 2008, BIOPHYS J, V94, P2128, DOI 10.1529/biophysj.107.119032; Bechinger B, 2006, BBA-BIOMEMBRANES, V1758, P1529, DOI 10.1016/j.bbamem.2006.07.001; Ben-Tal N, 2000, BIOPHYS J, V79, P1180, DOI 10.1016/S0006-3495(00)76372-7; BESCHIASCHVILI G, 1990, BIOCHEMISTRY-US, V29, P52, DOI 10.1021/bi00453a007; Bhonsle JB, 2007, J MED CHEM, V50, P6545, DOI 10.1021/jm070884y; BROEKAERT WF, 1995, PLANT PHYSIOL, V108, P1353, DOI 10.1016/j.chiabu.2021.105188; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Bulai T, 2003, FEBS LETT, V534, P185, DOI 10.1016/S0014-5793(02)03838-3; Cherkasov A, 2009, ACS CHEM BIOL, V4, P65, DOI 10.1021/cb800240j; Clark KS, 2011, BIOCHEMISTRY-US, V50, P7919, DOI 10.1021/bi200873u; Crandall YM, 2008, BIOPOLYMERS, V89, P197, DOI 10.1002/bip.20891; da Silva A, 2003, BBA-MOL CELL RES, V1643, P95, DOI 10.1016/j.bbamcr.2003.10.001; Dathe M, 2002, BBA-BIOMEMBRANES, V1558, P171, DOI 10.1016/S0005-2736(01)00429-1; Dathe M, 1997, FEBS LETT, V403, P208, DOI 10.1016/S0014-5793(97)00055-0; EISENBERG D, 1982, FARADAY SYMP CHEM S, P109, DOI 10.1039/fs9821700109; Fernandez-Vidall M, 2007, J MOL BIOL, V370, P459, DOI 10.1016/j.jmb.2007.05.016; Fjell CD, 2011, CHEM BIOL DRUG DES, V77, P48, DOI 10.1111/j.1747-0285.2010.01044.x; Frecer V, 2006, BIOORGAN MED CHEM, V14, P6065, DOI 10.1016/j.bmc.2006.05.005; Gable JE, 2009, BIOCHEMISTRY-US, V48, P11264, DOI 10.1021/bi900996q; Ganz T, 1998, CURR OPIN IMMUNOL, V10, P41, DOI 10.1016/S0952-7915(98)80029-0; GLASER RW, 1988, BIOCHIM BIOPHYS ACTA, V940, P275, DOI 10.1016/0005-2736(88)90202-7; Glukhov E, 2005, J BIOL CHEM, V280, P33960, DOI 10.1074/jbc.M507042200; Gregory SM, 2009, BIOPHYS J, V96, P116, DOI 10.1016/j.bpj.2008.09.017; Hall BA, 2011, BIOPHYS J, V100, P1940, DOI 10.1016/j.bpj.2011.02.041; Hallock KJ, 2002, BIOPHYS J, V83, P1004, DOI 10.1016/S0006-3495(02)75226-0; He Y, 2013, J COMPUT CHEM, V34, P1463, DOI 10.1002/jcc.23282; Hilpert K, 2006, CHEM BIOL, V13, P1101, DOI 10.1016/j.chembiol.2006.08.014; Hincha DK, 1996, BBA-BIOMEMBRANES, V1284, P162, DOI 10.1016/S0005-2736(96)00122-8; Hoskin DW, 2008, BBA-BIOMEMBRANES, V1778, P357, DOI 10.1016/j.bbamem.2007.11.008; Imura Y, 2008, BIOPHYS J, V95, P5757, DOI 10.1529/biophysj.108.133488; Jenssen H, 2008, J PEPT SCI, V14, P110, DOI 10.1002/psc.908; Jenssen H, 2007, CHEM BIOL DRUG DES, V70, P134, DOI 10.1111/j.1747-0285.2007.00543.x; JOHN E, 1992, BIOPHYS J, V63, P1536, DOI 10.1016/S0006-3495(92)81737-X; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Lazaridis T, 2005, J CHEM THEORY COMPUT, V1, P716, DOI 10.1021/ct050055x; Lazaridis T, 2005, PROTEINS, V58, P518, DOI 10.1002/prot.20358; Lazaridis T, 2003, PROTEINS, V52, P176, DOI 10.1002/prot.10410; Lazaridis T, 1999, PROTEINS, V35, P133, DOI 10.1002/(SICI)1097-0134(19990501)35:2<133::AID-PROT1>3.0.CO;2-N; Lee CC, 2011, BIOPHYS J, V100, P1688, DOI 10.1016/j.bpj.2011.02.018; LEHRER RI, 1989, J CLIN INVEST, V84, P553, DOI 10.1172/JCI114198; Lehrer RI, 1999, CURR OPIN IMMUNOL, V11, P23, DOI 10.1016/S0952-7915(99)80005-3; Lewis JR, 1999, BIOCHEMISTRY-US, V38, P5932, DOI 10.1021/bi9828167; Liu ZG, 2007, ANTIMICROB AGENTS CH, V51, P597, DOI 10.1128/AAC.00828-06; Loose C, 2006, NATURE, V443, P867, DOI 10.1038/nature05233; Lorian V., 2005, ANTIBIOTICS LAB MED; Mani R, 2004, BIOCHEMISTRY-US, V43, P13839, DOI 10.1021/bi048650t; Marr AK, 2006, CURR OPIN PHARMACOL, V6, P468, DOI 10.1016/j.coph.2006.04.006; Matsuzaki K, 1997, BBA-BIOMEMBRANES, V1327, P119, DOI 10.1016/S0005-2736(97)00051-5; Matsuzaki K, 2009, BBA-BIOMEMBRANES, V1788, P1687, DOI 10.1016/j.bbamem.2008.09.013; Mei H, 2005, BIOPOLYMERS, V80, P775, DOI 10.1002/bip.20296; Melo MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028549; Melo MN, 2009, NAT REV MICROBIOL, V7, P245, DOI 10.1038/nrmicro2095; Mihajlovic M, 2010, BBA-BIOMEMBRANES, V1798, P1494, DOI 10.1016/j.bbamem.2010.02.023; Mowery BP, 2007, J AM CHEM SOC, V129, P15474, DOI 10.1021/ja077288d; Oren Z, 1996, EUR J BIOCHEM, V237, P303, DOI 10.1111/j.1432-1033.1996.0303n.x; Oren Z, 1999, BIOCHEM J, V341, P501, DOI 10.1042/0264-6021:3410501; Oren Z, 1997, BIOCHEMISTRY-US, V36, P1826, DOI 10.1021/bi962507l; Oren Z, 1997, J BIOL CHEM, V272, P14643, DOI 10.1074/jbc.272.23.14643; Oren Z, 1999, EUR J BIOCHEM, V259, P360, DOI 10.1046/j.1432-1327.1999.00047.x; Papo N, 2003, PEPTIDES, V24, P1693, DOI 10.1016/j.peptides.2003.09.013; PATHAK N, 1995, PROTEINS, V22, P182, DOI 10.1002/prot.340220210; Porcelli F, 2008, BIOCHEMISTRY-US, V47, P5565, DOI 10.1021/bi702036s; Ramamoorthy A, 2010, BBA-BIOMEMBRANES, V1798, P223, DOI 10.1016/j.bbamem.2009.08.012; Ramamoorthy A, 2009, SOLID STATE NUCL MAG, V35, P201, DOI 10.1016/j.ssnmr.2009.03.003; RAPAPORT D, 1991, J BIOL CHEM, V266, P23769; RAPAPORT D, 1992, J BIOL CHEM, V267, P6502; Rivas L, 2009, BBA-BIOMEMBRANES, V1788, P1570, DOI 10.1016/j.bbamem.2008.11.002; Sato H, 2006, BIOCHEMISTRY-US, V45, P9997, DOI 10.1021/bi060979m; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; Shai Y, 1996, J BIOL CHEM, V271, P7305, DOI 10.1074/jbc.271.13.7305; Song C, 2013, P NATL ACAD SCI USA, V110, P4586, DOI 10.1073/pnas.1214739110; Sood R, 2008, BBA-BIOMEMBRANES, V1778, P983, DOI 10.1016/j.bbamem.2007.11.016; Takahashi D, 2010, BIOCHIMIE, V92, P1236, DOI 10.1016/j.biochi.2010.02.023; Tamba Y, 2010, J PHYS CHEM B, V114, P12018, DOI 10.1021/jp104527y; Turner J, 1998, ANTIMICROB AGENTS CH, V42, P2206, DOI 10.1128/AAC.42.9.2206; Tziakas DN, 2010, INT J CARDIOL, V142, P2, DOI 10.1016/j.ijcard.2009.10.031; Vad BS, 2010, BIOPHYS J, V98, P576, DOI 10.1016/j.bpj.2009.08.063; Verly RM, 2008, PEPTIDES, V29, P15, DOI 10.1016/j.peptides.2007.10.028; Verly RM, 2009, BIOPHYS J, V96, P2194, DOI 10.1016/j.bpj.2008.11.063; Vermeer LS, 2012, J BIOL CHEM, V287, P34120, DOI 10.1074/jbc.M112.359067; Virtanen JA, 1998, P NATL ACAD SCI USA, V95, P4964, DOI 10.1073/pnas.95.9.4964; Wang Z, 2004, NUCLEIC ACIDS RES, V32, pD590, DOI 10.1093/nar/gkh025; Wieprecht T, 2000, BIOCHEMISTRY-US, V39, P442, DOI 10.1021/bi992146k; Wieprecht T, 1997, BIOCHEMISTRY-US, V36, P6124, DOI 10.1021/bi9619987; Wildman KAH, 2003, BIOCHEMISTRY-US, V42, P6545, DOI 10.1021/bi0273563; Wimley WC, 2011, J MEMBRANE BIOL, V239, P27, DOI 10.1007/s00232-011-9343-0; Yang L, 1999, BIOPHYS J, V77, P2648, DOI 10.1016/S0006-3495(99)77099-2; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; ZASLOFF M, 1988, P NATL ACAD SCI USA, V85, P910, DOI 10.1073/pnas.85.3.910; Zhang LJ, 1999, BIOCHEMISTRY-US, V38, P8102, DOI 10.1021/bi9904104	94	28	29	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66440	10.1371/journal.pone.0066440	http://dx.doi.org/10.1371/journal.pone.0066440			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776672	Green Published, gold, Green Submitted			2022-12-27	WOS:000320322400102
J	Kanakogi, Y; Okumura, Y; Inoue, Y; Kitazaki, M; Itakura, S				Kanakogi, Yasuhiro; Okumura, Yuko; Inoue, Yasuyuki; Kitazaki, Michiteru; Itakura, Shoji			Rudimentary Sympathy in Preverbal Infants: Preference for Others in Distress	PLOS ONE			English	Article							PROSOCIAL BEHAVIOR; SOCIAL-DOMINANCE; TODDLERS; ATTRIBUTION; CAUSALITY; CHILDREN; AGENTS	Despite its essential role in human coexistence, the developmental origins and progression of sympathy in infancy are not yet fully understood. We show that preverbal 10-month-olds manifest sympathetic responses, evinced in their preference for attacked others according to their evaluations of the respective roles of victim, aggressor, and neutral party. In Experiment 1, infants viewing an aggressive social interaction between a victim and an aggressor exhibited preference for the victim. In Experiment 2, when comparing the victim and the aggressor to a neutral object, infants preferred the victim and avoided the aggressor. These findings indicate that 10-month-olds not only evaluate the roles of victims and aggressors in interactions but also show rudimentary sympathy toward others in distress based on that evaluation. This simple preference may function as a foundation for full-fledged sympathetic behavior later on.	[Kanakogi, Yasuhiro; Okumura, Yuko; Itakura, Shoji] Kyoto Univ, Dept Psychol, Grad Sch Letters, Sakyo Ku, Kyoto, Japan; [Inoue, Yasuyuki; Kitazaki, Michiteru] Toyohashi Univ Technol, Dept Comp Sci & Engn, Toyohashi, Aichi, Japan	Kyoto University; Toyohashi University of Technology	Kanakogi, Y (corresponding author), Kyoto Univ, Dept Psychol, Grad Sch Letters, Sakyo Ku, Yoshidahonmachi, Kyoto, Japan.	yakanakogi@gmail.com	Kitazaki, Mitchiteru/AAI-6554-2020	Kitazaki, Mitchiteru/0000-0003-0966-4842; Okumura, Yuko/0000-0002-2389-5818	Japan Society for the Promotion of Science; JSPS [21220005, 20220002, 20220004]; MEXT [21118005]; Nissan Science Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nissan Science Foundation	This work was supported by a grant to Yasuhiro Kanakogi from the Japan Society for the Promotion of Science Research Fellowships for Young Scientists and grants to Shoji Itakura from JSPS (21220005, 20220002 and 20220004), MEXT (21118005) and the Nissan Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Csibra G, 2008, COGNITION, V107, P705, DOI 10.1016/j.cognition.2007.08.001; de Waal FBM, 2012, SO NEUROSCI SER, P87; de Wall, 2009, AGE EMPATHY; Dunfield K, 2011, INFANCY, V16, P227, DOI 10.1111/j.1532-7078.2010.00041.x; Eisenberg N, 2006, HANDBOOK OF MORAL DEVELOPMENT, P517; GERGELY G, 1995, COGNITION, V56, P165, DOI 10.1016/0010-0277(95)00661-H; Hamlin JK, 2007, NATURE, V450, P557, DOI 10.1038/nature06288; Hamlin JK, 2011, P NATL ACAD SCI USA, V108, P19931, DOI 10.1073/pnas.1110306108; Hamlin JK, 2010, DEVELOPMENTAL SCI, V13, P923, DOI 10.1111/j.1467-7687.2010.00951.x; Hepach R, 2012, PSYCHOL SCI, V23, P967, DOI 10.1177/0956797612440571; Hoffman M. L., 2001, EMPATHY MORAL DEV IM; Houston-Price C, 2004, INFANT CHILD DEV, V13, P341, DOI 10.1002/icd.364; Kanakogi Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1342; Kinzler KD, 2007, P NATL ACAD SCI USA, V104, P12577, DOI 10.1073/pnas.0705345104; Kuhlmeier V, 2003, PSYCHOL SCI, V14, P402, DOI 10.1111/1467-9280.01454; LESLIE AM, 1982, PERCEPTION, V11, P173, DOI 10.1068/p110173; LESLIE AM, 1987, COGNITION, V25, P265, DOI 10.1016/S0010-0277(87)80006-9; Mascaro O, 2012, P NATL ACAD SCI USA, V109, P6862, DOI 10.1073/pnas.1113194109; Okumura Y, POWER HUMAN IN PRESS; Premack D, 1997, J COGNITIVE NEUROSCI, V9, P848, DOI 10.1162/jocn.1997.9.6.848; SAGI A, 1976, DEV PSYCHOL, V12, P175, DOI 10.1037/0012-1649.12.2.175; Saxe R, 2005, PSYCHOL SCI, V16, P995, DOI 10.1111/j.1467-9280.2005.01649.x; Scarf D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042698; SIMNER ML, 1971, DEV PSYCHOL, V5, P136, DOI 10.1037/h0031066; Smith Adam, 1966, THEORY MORAL SENTIME; Spelke ES, 2007, DEVELOPMENTAL SCI, V10, P89, DOI 10.1111/j.1467-7687.2007.00569.x; Svetlova M, 2010, CHILD DEV, V81, P1814, DOI 10.1111/j.1467-8624.2010.01512.x; Thomsen L, 2011, SCIENCE, V331, P477, DOI 10.1126/science.1199198; Vaish A, 2011, BRIT J DEV PSYCHOL, V29, P124, DOI 10.1348/026151010X532888; Vaish A, 2009, DEV PSYCHOL, V45, P534, DOI 10.1037/a0014322; Yang CY, 2009, BRAIN RES, V1251, P176, DOI 10.1016/j.brainres.2008.11.062; ZAHNWAXLER C, 1992, DEV PSYCHOL, V28, P126, DOI 10.1037/0012-1649.28.1.126	32	46	46	6	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65292	10.1371/journal.pone.0065292	http://dx.doi.org/10.1371/journal.pone.0065292			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	163FW	23776467	Green Published, Green Submitted, gold			2022-12-27	WOS:000320322400017
J	Muthayya, S; Rah, JH; Sugimoto, JD; Roos, FF; Kraemer, K; Black, RE				Muthayya, Sumithra; Rah, Jee Hyun; Sugimoto, Jonathan D.; Roos, Franz F.; Kraemer, Klaus; Black, Robert E.			The Global Hidden Hunger Indices and Maps: An Advocacy Tool for Action	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIALS; IRON-DEFICIENCY ANEMIA; DEVELOPING-COUNTRIES; VITAMIN-A; CHILDREN; SUPPLEMENTATION; ZINC; CONSEQUENCES; METAANALYSIS; PREGNANCY	The unified global efforts to mitigate the high burden of vitamin and mineral deficiency, known as hidden hunger, in populations around the world are crucial to the achievement of most of the Millennium Development Goals (MDGs). We developed indices and maps of global hidden hunger to help prioritize program assistance, and to serve as an evidence-based global advocacy tool. Two types of hidden hunger indices and maps were created based on i) national prevalence data on stunting, anemia due to iron deficiency, and low serum retinol levels among preschool-aged children in 149 countries; and ii) estimates of Disability Adjusted Life Years (DALYs) attributed to micronutrient deficiencies in 136 countries. A number of countries in sub-Saharan Africa, as well as India and Afghanistan, had an alarmingly high level of hidden hunger, with stunting, iron deficiency anemia, and vitamin A deficiency all being highly prevalent. The total DALY rates per 100,000 population, attributed to micronutrient deficiencies, were generally the highest in sub-Saharan African countries. In 36 countries, home to 90% of the world's stunted children, deficiencies of micronutrients were responsible for 1.5-12% of the total DALYs. The pattern and magnitude of iodine deficiency did not conform to that of other micronutrients. The greatest proportions of children with iodine deficiency were in the Eastern Mediterranean (46.6%), European (44.2%), and African (40.4%) regions. The current indices and maps provide crucial data to optimize the prioritization of program assistance addressing global multiple micronutrient deficiencies. Moreover, the indices and maps serve as a useful advocacy tool in the call for increased commitments to scale up effective nutrition interventions.	[Muthayya, Sumithra] Sax Inst, Sydney, NSW, Australia; [Rah, Jee Hyun] United Nations Childrens Fund UNICEF India, New Delhi, India; [Sugimoto, Jonathan D.] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Epidemiol, Gainesville, FL USA; [Sugimoto, Jonathan D.] Univ Florida, Coll Med, Gainesville, FL USA; [Sugimoto, Jonathan D.] Fred Hutchinson Canc Res Ctr, Vaccine Infect Dis Div, Seattle, WA 98104 USA; [Roos, Franz F.] DSM Nutr Prod Ltd, Kaiseraugst, Switzerland; [Kraemer, Klaus] Sight & Life, Kaiseraugst, Switzerland; [Black, Robert E.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA	University of Sydney; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Fred Hutchinson Cancer Center; DSM NV; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Kraemer, K (corresponding author), Sight & Life, Kaiseraugst, Switzerland.	klaus.kraemer@sightandlife.org		Black, Robert/0000-0001-9926-7984; Sugimoto, Jonathan/0000-0002-1761-328X	Sight and Life	Sight and Life	The technical consultations were supported by Sight and Life (www.sightandlife.org). There was no funding involved in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen LH, 2009, J NUTR, V139, P1022, DOI 10.3945/jn.107.086199; Andersson M, 2012, J NUTR, V142, P744, DOI 10.3945/jn.111.149393; [Anonymous], 2012, POL POL AN NUTR GOV; [Anonymous], 2012, SCALING NUTR SUN MOV; Bhutta ZA, 1999, J PEDIATR-US, V135, P689, DOI 10.1016/S0022-3476(99)70086-7; Black RE, 1998, AM J CLIN NUTR, V68, p476S, DOI 10.1093/ajcn/68.2.476S; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Bloem MW, 2010, J NUTR, V140, p132S, DOI 10.3945/jn.109.112094; Brown KH, 2002, AM J CLIN NUTR, V75, P1062, DOI 10.1093/ajcn/75.6.1062; Christian P, 2000, AM J EPIDEMIOL, V152, P542, DOI 10.1093/aje/152.6.542; Costello AMD, 2003, J NUTR, V133, p1757S, DOI 10.1093/jn/133.5.1757S; Ezzati M, 2004, COMP QUANTIFICATION; FAO, 2008, PREV UND TOT POP 200; FAWZI WW, 1993, JAMA-J AM MED ASSOC, V269, P898, DOI 10.1001/jama.269.7.898; Food and Agriculture Organization, 2002, FOOD INS PEOPL MUST; Haas JD, 2001, J NUTR, V131, p676S, DOI 10.1093/jn/131.2.676S; Horton S., 2008, FOOD FORTIFICATION I; International Food Policy Research Institute, 2010, HUNG GLOB IND CHALL; International Food Policy Research Institute /Welthungerhilfe/Concern, 2007, CHALL HUNG 2007 GLOB; LOZOFF B, 1991, NEW ENGL J MED, V325, P687, DOI 10.1056/NEJM199109053251004; Micronutrient Initiative, 2009, INV FUT UN CALL ACT; Organization WH, 2009, GLOB HLTH RISKS MORT; Pollitt E, 2001, J NUTR, V131, p669S, DOI 10.1093/jn/131.2.669S; Rastogi R, 2000, GLOBAL BURDEN IRON D; SAXENA NC, 2008, HUNGER UNDER NUTR FO; Sommer A., 1996, VITAMIN DEFICIENCY H; Stoltzfus RJ, 2001, J NUTR, V131, p565S, DOI 10.1093/jn/131.2.565S; UNDP (United Nations Development Programme), 2007, HUM DEV REP; United Nations Standing Committee on Nutrition, 2008, IMP HIGH FOOD PRIC M; WHO, 2009, GLOB PREV VIT A DEF, P55; WHO, 2006, WHO CHILD GROWTH STA; World Health Organization, 2008, WORLD PREV AN 1993 2; World Health Organization, 2002, WHO REP 2002 RED RIS; World Health Organization (WHO), 2004, WHO GLOB DAT IOD DEF; Zimmermann MB, 2008, LANCET, V372, P1251, DOI 10.1016/S0140-6736(08)61005-3	35	245	252	2	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e67860	10.1371/journal.pone.0067860	http://dx.doi.org/10.1371/journal.pone.0067860			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776712	gold, Green Published, Green Submitted			2022-12-27	WOS:000320322400128
J	Probst, AJ; Auerbach, AK; Moissl-Eichinger, C				Probst, Alexander J.; Auerbach, Anna K.; Moissl-Eichinger, Christine			Archaea on Human Skin	PLOS ONE			English	Article							AMMONIA-OXIDIZING ARCHAEA; METHANOGENIC ARCHAEA; NATURAL COMMUNITIES; BACTERIAL; DIVERSITY; SEQUENCES; ALIGNMENT; PROBES	The recent era of exploring the human microbiome has provided valuable information on microbial inhabitants, beneficials and pathogens. Screening efforts based on DNA sequencing identified thousands of bacterial lineages associated with human skin but provided only incomplete and crude information on Archaea. Here, we report for the first time the quantification and visualization of Archaea from human skin. Based on 16 S rRNA gene copies Archaea comprised up to 4.2% of the prokaryotic skin microbiome. Most of the gene signatures analyzed belonged to the Thaumarchaeota, a group of Archaea we also found in hospitals and clean room facilities. The metabolic potential for ammonia oxidation of the skin-associated Archaea was supported by the successful detection of thaumarchaeal amoA genes in human skin samples. However, the activity and possible interaction with human epithelial cells of these associated Archaea remains an open question. Nevertheless, in this study we provide evidence that Archaea are part of the human skin microbiome and discuss their potential for ammonia turnover on human skin.	[Moissl-Eichinger, Christine] Univ Regensburg, Inst Microbiol, D-93053 Regensburg, Germany; Univ Regensburg, Archaea Ctr, D-93053 Regensburg, Germany	University of Regensburg; University of Regensburg	Moissl-Eichinger, C (corresponding author), Univ Regensburg, Inst Microbiol, D-93053 Regensburg, Germany.	christine.moissl-eichinger@ur.de	Probst, Alexander J/K-2813-2016; Moissl-Eichinger, Christine/A-6682-2015	Moissl-Eichinger, Christine/0000-0001-6755-6263; Probst, Alexander/0000-0002-9392-6544	Institute for Microbiology and Archaea Center; University of Regensburg; European Space Agency [4000103794/11/NL/PA]; DLR [D/316/67130713]; National German Academic Foundation (Studienstiftung des deutschen Volkes)	Institute for Microbiology and Archaea Center; University of Regensburg; European Space Agency(European Space AgencyEuropean Commission); DLR(Helmholtz AssociationGerman Aerospace Centre (DLR)); National German Academic Foundation (Studienstiftung des deutschen Volkes)	Funding provided by the Institute for Microbiology and Archaea Center (Michael Thomm), the University of Regensburg and the European Space Agency (Contract No. 4000103794/11/NL/PA under subcontract with DLR (D/316/67130713)) is acknowledged. AJP was supported by the National German Academic Foundation (Studienstiftung des deutschen Volkes). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Brunk CF, 1998, APPL ENVIRON MICROB, V64, P5064; BURGGRAF S, 1991, SYST APPL MICROBIOL, V14, P346, DOI 10.1016/S0723-2020(11)80308-5; Burggraf S, 1997, INT J SYST BACTERIOL, V47, P657, DOI 10.1099/00207713-47-3-657; BURGGRAF S, 1992, SYST APPL MICROBIOL, V15, P352, DOI 10.1016/S0723-2020(11)80207-9; Caporaso JG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r50; Casamayor EO, 2002, ENVIRON MICROBIOL, V4, P338, DOI 10.1046/j.1462-2920.2002.00297.x; de Macario EC, 2009, INT J MED MICROBIOL, V299, P99, DOI 10.1016/j.ijmm.2008.06.011; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; EMBLEY TM, 1992, J GEN MICROBIOL, V138, P1479, DOI 10.1099/00221287-138-7-1479; Flores GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028132; Gantner S, 2011, J MICROBIOL METH, V84, P12, DOI 10.1016/j.mimet.2010.10.001; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Huber H, 2002, NATURE, V417, P63, DOI 10.1038/417063a; Hulcr J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047712; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Karner MB, 2001, NATURE, V409, P507, DOI 10.1038/35054051; Klappenbach JA, 2001, NUCLEIC ACIDS RES, V29, P181, DOI 10.1093/nar/29.1.181; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Kwan K, 2011, APPL ENVIRON MICROB, V77, P2943, DOI 10.1128/AEM.02978-10; La Duc MT, 2012, APPL ENVIRON MICROB, V78, P5912, DOI 10.1128/AEM.01435-12; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Lehtovirta-Morley LE, 2011, P NATL ACAD SCI USA, V108, P15892, DOI 10.1073/pnas.1107196108; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Lepp PW, 2004, P NATL ACAD SCI USA, V101, P6176, DOI 10.1073/pnas.0308766101; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Moissl C, 2002, APPL ENVIRON MICROB, V68, P933, DOI 10.1128/AEM.68.2.933-937.2002; Moissl C, 2008, ISME J, V2, P115, DOI 10.1038/ismej.2007.98; Moissl-Eichinger C, 2011, ISME J, V5, P209, DOI 10.1038/ismej.2010.124; Muhl H, 2010, DIAGN MICR INFEC DIS, V66, P41, DOI 10.1016/j.diagmicrobio.2008.07.011; Mussmann M, 2011, P NATL ACAD SCI USA, V108, P16771, DOI 10.1073/pnas.1106427108; Nocker A, 2007, APPL ENVIRON MICROB, V73, P5111, DOI 10.1128/AEM.02987-06; Nose K, 2005, ANAL SCI, V21, P1471, DOI 10.2116/analsci.21.1471; Oxley APA, 2010, ENVIRON MICROBIOL, V12, P2398, DOI 10.1111/j.1462-2920.2010.02212.x; Pester M, 2011, CURR OPIN MICROBIOL, V14, P300, DOI 10.1016/j.mib.2011.04.007; Probst A, 2011, APPL ENVIRON MICROB, V77, P1628, DOI 10.1128/AEM.02037-10; Probst A, 2010, APPL ENVIRON MICROB, V76, P5148, DOI 10.1128/AEM.00399-10; Probst AJ, 2013, ISME J, V7, P635, DOI 10.1038/ismej.2012.133; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; RASKIN L, 1994, APPL ENVIRON MICROB, V60, P1232, DOI 10.1128/AEM.60.4.1232-1240.1994; Sauder LA, 2012, ENVIRON MICROBIOL, V14, P2589, DOI 10.1111/j.1462-2920.2012.02786.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Stahl D.A., 1991, NUCL ACID TECHNIQUES, P205; Tourna M, 2008, ENVIRON MICROBIOL, V10, P1357, DOI 10.1111/j.1462-2920.2007.01563.x	48	117	120	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65388	10.1371/journal.pone.0065388	http://dx.doi.org/10.1371/journal.pone.0065388			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776475	Green Published, Green Submitted, gold			2022-12-27	WOS:000320322400020
J	Thammasri, K; Rauhamaki, S; Wang, LP; Filippou, A; Kivovich, V; Marjomaki, V; Naides, SJ; Gilbert, L				Thammasri, Kanoktip; Rauhamaki, Sanna; Wang, Liping; Filippou, Artemis; Kivovich, Violetta; Marjomaki, Varpu; Naides, Stanley J.; Gilbert, Leona			Human Parvovirus B19 Induced Apoptotic Bodies Contain Altered Self-Antigens that are Phagocytosed by Antigen Presenting Cells	PLOS ONE			English	Article							NONSTRUCTURAL NS1 PROTEIN; AUTOIMMUNE HEPATITIS; INFECTION; VIRUS; DISEASE; LIVER; DNA; MECHANISMS; ANTIBODIES; SURFACE	Human parvovirus B19 (B19V) from the erythrovirus genus is known to be a pathogenic virus in humans. Prevalence of B19V infection has been reported worldwide in all seasons, with a high incidence in the spring. B19V is responsible for erythema infectiosum (fifth disease) commonly seen in children. Its other clinical presentations include arthralgia, arthritis, transient aplastic crisis, chronic anemia, congenital anemia, and hydrops fetalis. In addition, B19V infection has been reported to trigger autoimmune diseases such as systemic lupus erythematosus and rheumatoid arthritis. However, the mechanisms of B19V participation in autoimmunity are not fully understood. B19V induced chronic disease and persistent infection suggests B19V can serve as a model for viral host interactions and the role of viruses in the pathogenesis of autoimmune diseases. Here we investigate the involvement of B19V in the breakdown of immune tolerance. Previously, we demonstrated that the non-structural protein 1 (NS 1) of B19V induces apoptosis in non-permissive cells lines and that this protein can cleave host DNA as well as form NS1-DNA adducts. Here we provide evidence that through programmed cell death, apoptotic bodies (ApoBods) are generated by B19V NS1 expression in a non-permissive cell line. Characterization of purified ApoBods identified potential self-antigens within them. In particular, signature self-antigens such as Smith, ApoH, DNA, histone H4 and phosphatidylserine associated with autoimmunity were present in these ApoBods. In addition, when purified ApoBods were introduced to differentiated macrophages, recognition, engulfment and uptake occurred. This suggests that B19V can produce a source of self-antigens for immune cell processing. The results support our hypothesis that B19V NS1-DNA adducts, and nucleosomal and lysosomal antigens present in ApoBods created in non-permissive cell lines, are a source of self-antigens.	[Thammasri, Kanoktip; Rauhamaki, Sanna; Wang, Liping; Filippou, Artemis; Marjomaki, Varpu; Gilbert, Leona] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland; [Thammasri, Kanoktip; Rauhamaki, Sanna; Wang, Liping; Filippou, Artemis; Marjomaki, Varpu; Gilbert, Leona] Univ Jyvaskyla, Ctr Neurosci, Jyvaskyla, Finland; [Kivovich, Violetta] Penn State Coll Med, Milton S Hershey Med Ctr, Hershey, PA USA; [Naides, Stanley J.] Quest Diagnost Nichols Inst, San Juan Capistrano, CA USA	University of Jyvaskyla; University of Jyvaskyla; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Nichols Institute	Gilbert, L (corresponding author), Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland.	leona.k.gilbert@jyu.fi	Filippou, Artemis/O-8944-2016; Gilbert, Leona/AAF-4258-2021	Filippou, Artemis/0000-0002-4106-1059; Marjomaki, Varpu/0000-0002-4592-5926; Rauhamaki, Sanna/0000-0002-3014-3120; Gilbert, Leona/0000-0002-7470-5770	Academy of Finland [122061]	Academy of Finland(Academy of Finland)	This study was supported by the Academy of Finland Contract Number 122061. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Kenji, 2007, Int J Med Sci, V4, P105; Alcami A, 2003, NAT REV IMMUNOL, V3, P36, DOI 10.1038/nri980; ANDERSON MJ, 1985, J INFECT DIS, V152, P257, DOI 10.1093/infdis/152.2.257; ANDERSON MJ, 1987, LANCET, V1, P738; ARENDS MJ, 1991, INT REV EXP PATHOL, V32, P223; Arista S, 2003, J HEPATOL, V38, P375, DOI 10.1016/S0168-8278(02)00416-6; Baens M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000054; Barber GN, 2001, CELL DEATH DIFFER, V8, P113, DOI 10.1038/sj.cdd.4400823; Bonvicini F, 2008, J GEN VIROL, V89, P3034, DOI 10.1099/vir.0.2008/004341-0; Bruggeman LA, 2007, CLIN J AM SOC NEPHRO, V2, pS13, DOI 10.2215/CJN.04311206; CASCIOLAROSEN LA, 1994, J EXP MED, V179, P1317, DOI 10.1084/jem.179.4.1317; CLEWLEY JP, 1984, J GEN VIROL, V65, P241, DOI 10.1099/0022-1317-65-1-241; Cline AM, 2004, CLIN IMMUNOL, V112, P175, DOI 10.1016/j.clim.2004.02.017; Cline AM, 2004, AUTOIMMUNITY, V37, P85, DOI 10.1080/0891693042000196219; Cocca BA, 2002, J IMMUNOL, V169, P159, DOI 10.4049/jimmunol.169.1.159; Corcoran A, 2004, J MED MICROBIOL, V53, P459, DOI 10.1099/jmm.0.05485-0; COSSART YE, 1975, LANCET, V1, P72; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; Dame C, 2002, PEDIATR PATHOL MOL M, V21, P25, DOI 10.1080/15227950252774138; Diaz F, 2000, J Infect Chemother, V6, P63, DOI 10.1007/s101560050052; Dorsch S, 2002, J VIROL, V76, P2014, DOI 10.1128/JVI.76.4.2014-2018.2002; Drago F, 1999, BRIT J DERMATOL, V141, P160; FADOK VA, 1992, J IMMUNOL, V148, P2207; Frisoni L, 2005, J IMMUNOL, V175, P2692, DOI 10.4049/jimmunol.175.4.2692; Fu Y, 2002, J VIROL, V76, P5395, DOI 10.1128/JVI.76.11.5395-5403.2002; Heegaard ED, 2002, CLIN MICROBIOL REV, V15, P485, DOI 10.1128/CMR.15.3.485-505.2002; Hemauer A, 1999, J CLIN VIROL, V14, P73, DOI 10.1016/S1386-6532(99)00038-4; Kankaanpaa P, 2012, NAT METHODS, V9, P683, DOI [10.1038/NMETH.2047, 10.1038/nmeth.2047]; Karetnyi YV, 1999, ARCH VIROL, V144, P1713, DOI 10.1007/s007050050699; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kerr JR, 1996, EUR J CLIN MICROBIOL, V15, P10, DOI 10.1007/BF01586181; Kerr S, 1999, J MED VIROL, V57, P179, DOI 10.1002/(SICI)1096-9071(199902)57:2&lt;179::AID-JMV16&gt;3.0.CO;2-T; Kivovich V, 2012, INT J BIOL SCI, V8, P79, DOI 10.7150/ijbs.8.79; Kivovich V, 2010, INT J MED SCI, V7, P110; Kordes U, 2011, PEDIATR BLOOD CANCER, V56, P323, DOI 10.1002/pbc.22820; Krygier DS, 2009, WORLD J GASTROENTERO, V15, P4067, DOI 10.3748/wjg.15.4067; Krysko DV, 2006, CELL DEATH DIFFER, V13, P2011, DOI 10.1038/sj.cdd.4401900; LAWSON CM, 1992, IMMUNOLOGY, V75, P513; Lehmann HW, 2003, AUTOIMMUN REV, V2, P218, DOI 10.1016/S1568-9972(03)00014-4; Liu HS, 1999, BIOCHEM BIOPH RES CO, V260, P712, DOI 10.1006/bbrc.1999.0954; Lunardi C, 1998, EUR J IMMUNOL, V28, P936, DOI 10.1002/(SICI)1521-4141(199803)28:03<936::AID-IMMU936>3.3.CO;2-O; Lunardi C, 2008, AUTOIMMUN REV, V8, P116, DOI 10.1016/j.autrev.2008.07.005; Meyer O, 2003, JOINT BONE SPINE, V70, P6, DOI 10.1016/S1297-319X(02)00004-0; Mitchell LA, 2002, J MED VIROL, V67, P267, DOI 10.1002/jmv.2217; Moffatt S, 1996, J VIROL, V70, P8485, DOI 10.1128/JVI.70.12.8485-8491.1996; Moffatt S, 1998, J VIROL, V72, P3018, DOI 10.1128/JVI.72.4.3018-3028.1998; Mogensen TH, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-246; MUNSHI NC, 1993, J VIROL, V67, P562, DOI 10.1128/JVI.67.1.562-566.1993; MURPHY K, 2008, JANEWAYS IMMUNOBIOUL; Murphy PM, 2001, NAT IMMUNOL, V2, P116, DOI 10.1038/84214; Nobili V, 2004, PEDIATR INFECT DIS J, V23, P184, DOI 10.1097/01.inf.0000110270.38240.51; OZAWA K, 1988, J VIROL, V62, P2884, DOI 10.1128/JVI.62.8.2884-2889.1988; OZAWA K, 1987, BLOOD, V70, P384, DOI 10.1182/blood.V70.2.384.384; Panoutsakopoulou V, 2001, IMMUNITY, V15, P137, DOI 10.1016/S1074-7613(01)00172-8; Pinho JRR, 2001, BRAZ J MED BIOL RES, V34, P1131, DOI 10.1590/S0100-879X2001000900005; Poole BD, 2006, J VIROL, V80, P4114, DOI 10.1128/JVI.80.8.4114-4121.2006; Poole BD, 2004, J VIROL, V78, P7775, DOI 10.1128/JVI.78.14.7775-7783.2004; Poole BD, 2011, INT J MED SCI, V8, P88, DOI 10.7150/ijms.8.88; POTTER CG, 1987, J CLIN INVEST, V79, P1486, DOI 10.1172/JCI112978; Raab U, 2002, VIROLOGY, V293, P86, DOI 10.1006/viro.2001.1285; Radic M, 2004, J IMMUNOL, V172, P6692, DOI 10.4049/jimmunol.172.11.6692; Schiller M, 2008, CELL DEATH DIFFER, V15, P183, DOI 10.1038/sj.cdd.4402239; SHADE RO, 1986, J VIROL, V58, P921, DOI 10.1128/JVI.58.3.921-936.1986; Sol N, 1999, J VIROL, V73, P8762, DOI 10.1128/JVI.73.10.8762-8770.1999; SRIVASTAVA A, 1990, BLOOD, V76, P1997; Sun L, 2012, HEPATOLOGY, V55, P329, DOI 10.1002/hep.24720; Takahashi Y, 1998, P NATL ACAD SCI USA, V95, P8227, DOI 10.1073/pnas.95.14.8227; VENTO S, 1995, LANCET, V346, P608, DOI 10.1016/S0140-6736(95)91438-2; von Landenberg P, 2003, ARTHRITIS RHEUM-US, V48, P1939, DOI 10.1002/art.11038; von Landenberg P, 2007, AUTOIMMUN REV, V6, P278, DOI 10.1016/j.autrev.2006.09.006; vonHerrath MG, 1996, CURR OPIN IMMUNOL, V8, P878, DOI 10.1016/S0952-7915(96)80019-7; Wagner B, 1996, BRIT MED J, V312, P640; Wraith DC, 2003, LANCET, V362, P1659, DOI 10.1016/S0140-6736(03)14802-7; Yang SH, 2012, ANN HEMATOL, V91, P291, DOI 10.1007/s00277-011-1238-8; YOUNG N, 1984, J CLIN INVEST, V74, P2024, DOI 10.1172/JCI111625; Young NS, 2004, NEW ENGL J MED, V350, P586, DOI 10.1056/NEJMra030840; Zadori Z, 2001, DEV CELL, V1, P291, DOI 10.1016/S1534-5807(01)00031-4	77	25	26	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e67179	10.1371/journal.pone.0067179	http://dx.doi.org/10.1371/journal.pone.0067179			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776709	Green Published, gold, Green Submitted			2022-12-27	WOS:000320322400125
J	Xia, S; Liu, JM; Cheung, W				Xia, Shang; Liu, Jiming; Cheung, William			Identifying the Relative Priorities of Subpopulations for Containing Infectious Disease Spread	PLOS ONE			English	Article							PANDEMIC INFLUENZA; STRATEGIES; HISTORY	In response to the outbreak of an emerging infectious disease, e. g., H1N1 influenza, public health authorities will take timely and effective intervention measures to contain disease spread. However, due to the scarcity of required resources and the consequent social-economic impacts, interventions may be suggested to cover only certain subpopulations, e. g., immunizing vulnerable children and the elderly as well as closing schools or workplaces for social distancing. Here we are interested in addressing the question of how to identify the relative priorities of subpopulations for two measures of disease intervention, namely vaccination and contact reduction, especially when these measures are implemented together at the same time. We consider the measure of vaccination that immunizes susceptible individuals in different age subpopulations and the measure of contact reduction that cuts down individuals' effective contacts in different social settings, e. g., schools, households, workplaces, and general communities. In addition, we construct individuals' cross-age contact frequency matrix by inferring basic contact patterns respectively for different social settings from the socio-demographical census data. By doing so, we present a prioritization approach to identifying the target subpopulations that will lead to the greatest reduction in the number of disease transmissions. We calculate the relative priorities of subpopulations by considering the marginal effects of reducing the reproduction number for the cases of vaccine allocation by age and contact reduction by social setting. We examine the proposed approach by revisiting the real-world scenario of the 2009 Hong Kong H1N1 influenza epidemic and determine the relative priorities of subpopulations for age-specific vaccination and setting-specific contact reduction. We simulate the influenza-like disease spread under different settings of intervention. The results have shown that the proposed approach can improve the effectiveness of disease control by containing disease transmissions in a host population.	[Xia, Shang; Liu, Jiming; Cheung, William] Hong Kong Baptist Univ, Dept Comp Sci, Hong Kong, Hong Kong, Peoples R China	Hong Kong Baptist University	Liu, JM (corresponding author), Hong Kong Baptist Univ, Dept Comp Sci, Hong Kong, Hong Kong, Peoples R China.	jiming@Comp.HKBU.Edu.HK		Liu, Jiming/0000-0002-8669-9064; Cheung, William Kwok Wai/0000-0002-7428-2050	Hong Kong Baptist University	Hong Kong Baptist University	The research work reported in this article has been supported in part by the HIT Strategic Development Fund at Hong Kong Baptist University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Census and Statistics Department of the Hong Kong Government, 2011 POP CENS; Center for Health Protection, SWIN SEAS FLU MON; Center for Health Protection, HUM SWIN INFL VACC P; Cowling BJ, 2010, EPIDEMIOLOGY, V21, P842, DOI 10.1097/EDE.0b013e3181f20977; Cowling BJ, 2009, EPIDEMIOLOGY, V20, P344, DOI 10.1097/EDE.0b013e31819d1092; Diekmann O, 2010, J R SOC INTERFACE, V7, P873, DOI 10.1098/rsif.2009.0386; DIEKMANN O, 1990, J MATH BIOL, V28, P365; Dushoff J, 2007, PLOS MED, V4, P921, DOI 10.1371/journal.pmed.0040174; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Fine P, 2011, CLIN INFECT DIS, V52, P911, DOI 10.1093/cid/cir007; FINE PEM, 1993, EPIDEMIOL REV, V15, P265, DOI 10.1093/oxfordjournals.epirev.a036121; Fumanelli L, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002673; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Halloran ME, 2008, P NATL ACAD SCI USA, V105, P4639, DOI 10.1073/pnas.0706849105; Heesterbeek JAP, 2002, ACTA BIOTHEOR, V50, P189, DOI 10.1023/A:1016599411804; Hinman AR, 2006, ANNU REV PUBL HEALTH, V27, P235, DOI 10.1146/annurev.publhealth.27.021405.102248; Keeling MJ, 2011, J R SOC INTERFACE, V8, P661, DOI 10.1098/rsif.2010.0474; Kwok KO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022089; Lugner Anna K, 2009, Expert Rev Pharmacoecon Outcomes Res, V9, P547, DOI 10.1586/erp.09.56; Matrajt L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013767; Medlock Jan, 2009, PLoS Curr, V1, pRRN1134; Medlock J, 2009, SCIENCE, V325, P1705, DOI 10.1126/science.1175570; Merler S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002205; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Oshitani H, 2008, EMERG INFECT DIS, V14, P875, DOI 10.3201/eid1406.070839; Sadique MZ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-135; Salathe M, 2010, P NATL ACAD SCI USA, V107, P22020, DOI 10.1073/pnas.1009094108; Tuite AR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010520; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; Wallinga J, 2010, P NATL ACAD SCI USA, V107, P923, DOI 10.1073/pnas.0908491107; Wu JT, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001103; Wu JT, 2010, CLIN INFECT DIS, V51, P1184, DOI 10.1086/656740; Wu JT, 2010, EMERG INFECT DIS, V16, P538, DOI 10.3201/eid1603.091216; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373	36	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65271	10.1371/journal.pone.0065271	http://dx.doi.org/10.1371/journal.pone.0065271			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776461	Green Published, gold			2022-12-27	WOS:000320322400012
J	Zafon, C; Ciudin, A; Valladares, S; Mesa, J; Simo, R				Zafon, Carles; Ciudin, Andreea; Valladares, Silvia; Mesa, Jordi; Simo, Rafael			Variables Involved in the Discordance between HbA1c and Fructosamine: The Glycation Gap Revisited	PLOS ONE			English	Article							IRON-DEFICIENCY ANEMIA; DIABETIC-PATIENTS; HEMOGLOBIN GLYCATION; GLYCOSYLATION GAP; GLYCEMIC CONTROL; RENAL-DISEASE; METFORMIN; COMPLICATIONS; A1C; ERYTHROCYTES	Aims: Glycation gap (GG) is defined as the difference between the measured level of HbA1c and the level that would be predicted from its regression on the fructosamine level. The aims of the study were: 1) To determine the reproducibility and consistency of GC; 2) To discover factors related to GG value. Given that metformin might increase glucose transport through the erythrocyte membrane, this treatment was also considered in the analyses of the results. Methods: GG was calculated in two blood samples separated 30.6 (SD 7.3) weeks, obtained in 508 type 2 diabetic patients. The following variables were considered: HbA1c, fructosamine, glucose, creatinine, hematological parameters and treatment with metformin. Multivariate and logistic regression analyses were performed to explore the variables independently related to CG. Results: GG was reproducible and consistent over time. Creatinine, mean corpuscular hemoglobin concentration (MCHC), and glycemia (inverse relationship); and HbA1c and treatment with metformin (direct relationship) were independently related to GG. Patients treated with metformin showed higher HbA1c values, despite similar fructosamine concentrations, than patients not treated with the drug. Conclusions: GG is independently related to serum levels of creatinine, MCHC and treatment with metformin. The spurious effect of metformin on Hb glycation could have serious clinical implications and should be considered when interpreting the results of clinical trials.	[Zafon, Carles; Ciudin, Andreea; Valladares, Silvia; Mesa, Jordi; Simo, Rafael] Hosp Valle De Hebron, Diabet & Metab Res Unit VHIR, Barcelona, Spain; [Zafon, Carles; Ciudin, Andreea; Valladares, Silvia; Mesa, Jordi; Simo, Rafael] Hosp Valle De Hebron, Dept Endocrinol, Barcelona, Spain; [Zafon, Carles; Ciudin, Andreea; Valladares, Silvia; Mesa, Jordi; Simo, Rafael] Univ Autonoma Barcelona, E-08193 Barcelona, Spain	Hospital Universitari Vall d'Hebron; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona	Zafon, C (corresponding author), Hosp Valle De Hebron, Diabet & Metab Res Unit VHIR, Barcelona, Spain.	26276czl@comb.cat	CIUDIN, ANDREEA/O-5250-2016	CIUDIN, ANDREEA/0000-0001-5622-0203; Zafon, Carles/0000-0003-1554-1451; Simo Canonge, Rafael/0000-0003-0475-3096				[Anonymous], 2009, DIABETES CARE, V32, P1327; ARMBRUSTER DA, 1987, CLIN CHEM, V33, P2153; Bailey CJ, 2008, CARDIOVASC DRUG THER, V22, P215, DOI 10.1007/s10557-008-6092-0; Bennett Wendy L, 2012, J Manag Care Pharm, V18, P1; Bloomgarden Zachary T, 2009, Diabetes Care, V32, pe141, DOI 10.2337/dc09-zb12; BROOKS AP, 1980, LANCET, V2, P141; Chalew SA, 2005, J DIABETES COMPLICAT, V19, P218, DOI 10.1016/j.jdiacomp.2005.01.004; COCKRAM CS, 1990, DIABETES RES CLIN PR, V9, P43, DOI 10.1016/0168-8227(90)90007-G; Cohen RM, 2003, DIABETES CARE, V26, P163, DOI 10.2337/diacare.26.1.163; Cohen RM, 2007, DIABETES CARE, V30, P2756, DOI 10.2337/dc07-1301; Cohen RM, 2006, DIABETES CARE, V29, P1739, DOI 10.2337/dc06-0286; Cosson E, 2012, DIABETES METAB; El-Agouza I, 2002, CLIN LAB HAEMATOL, V24, P285, DOI 10.1046/j.1365-2257.2002.00464.x; Ford ES, 2011, J DIABETES, V3, P67, DOI 10.1111/j.1753-0407.2010.00100.x; Hare MJL, 2012, J INTERN MED, V271, P227, DOI 10.1111/j.1365-2796.2012.02513.x; Khera PK, 2008, DIABETES, V57, P2445, DOI 10.2337/db07-1820; Kim C, 2010, DIABETES CARE, V33, P780, DOI 10.2337/dc09-0836; KOSKINEN P, 1992, SCAND J CLIN LAB INV, V52, P863, DOI 10.3109/00365519209088392; Lachin JM, 2007, DIABETES, V56, P1913, DOI 10.2337/db07-0028; Leslie R David G, 2009, J Diabetes Sci Technol, V3, P635; Narbonne H, 2001, DIABETES METAB, V27, P598; Nayak AU, 2011, DIABETES CARE, V34, P1712, DOI 10.2337/dc10-1767; RAPIN JR, 1991, DIABETES METAB, V17, P164; RIZKALLA SW, 1986, DIABETES METAB, V12, P219; Rodriguez-Segade S, 2012, DIABETES CARE, V35, P2447, DOI 10.2337/dc11-2450; Rodriguez-Segade S, 2011, CLIN CHEM, V57, P264, DOI 10.1373/clinchem.2010.144949; Santos RF, 1997, DIABETES METAB, V23, P143; Selvin E, 2008, ARCH INTERN MED, V168, P2070, DOI 10.1001/archinte.168.19.2070; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Sharif A, 2010, J AM SOC NEPHROL, V21, P383, DOI 10.1681/ASN.2010010031; Shima K, 2012, ANN CLIN BIOCHEM, V49, P68, DOI 10.1258/acb.2011.011161; SMART LM, 1988, DIABETES CARE, V11, P433, DOI 10.2337/diacare.11.5.433; Soranzo N, 2011, CURR DIABETES REP, V11, P562, DOI 10.1007/s11892-011-0232-9; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; YOA RG, 1993, CLIN EXP PHARMACOL P, V20, P563, DOI 10.1111/j.1440-1681.1993.tb01742.x	35	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66696	10.1371/journal.pone.0066696	http://dx.doi.org/10.1371/journal.pone.0066696			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776693	Green Published, gold, Green Submitted			2022-12-27	WOS:000320322400115
J	de Xivry, JJO				de Xivry, Jean-Jacques Orban			Trial-to-Trial Reoptimization of Motor Behavior Due to Changes in Task Demands Is Limited	PLOS ONE			English	Article							OPTIMAL FEEDBACK-CONTROL; REDUCE INTERFERENCE; PARKINSONS-DISEASE; ERROR-CORRECTION; ADAPTATION; MOVEMENTS; ACCURACY; REWARD; GOAL; HAND	Each task requires a specific motor behavior that is tuned to task demands. For instance, writing requires a lot of accuracy while clapping does not. It is known that the brain adjusts the motor behavior to different task demands as predicted by optimal control theory. In this study, the mechanism of this reoptimization process is investigated by varying the accuracy demands of a reaching task. In this task, the width of the reaching target (0.5 or 8 cm) was varied either on a trial-to-trial basis (random schedule) or in blocks (blocked schedule). On some trials, the hand of the subjects was clamped to a rectilinear trajectory that ended 2 cm on the left or right of the target center. The rejection of this perturbation largely varied with target width in the blocked schedule but not in the random schedule. That is, subjects exhibited different motor behavior in the different schedules despite identical accuracy demands. Therefore, while reoptimization has been considered immediate and automatic, the differences in motor behavior observed across schedules suggest that the reoptimization of the motor behavior is neither happening on a trial-by-trial basis nor obligatory. The absence of trial-to-trial mechanisms, the inability of the brain to adapt to two conflicting task demands and the existence of a switching cost are discussed as possible sources of the non-optimality of motor behavior during the random schedule.	[de Xivry, Jean-Jacques Orban] Catholic Univ Louvain, ICTEAM, B-1348 Louvain, Belgium; [de Xivry, Jean-Jacques Orban] Catholic Univ Louvain, IoNS, B-1348 Louvain, Belgium	Universite Catholique Louvain; Universite Catholique Louvain	de Xivry, JJO (corresponding author), Catholic Univ Louvain, ICTEAM, B-1348 Louvain, Belgium.	jean-jacques.orban@uclouvain.be	de Xivry, Jean-Jacques Orban/H-3383-2019	de Xivry, Jean-Jacques Orban/0000-0002-4603-7939	Brussels Regio (Belgium); Fonds National de la Recherche Scientifique; Fondation pour la Recherche Scientifique Medicale; Belgian Program on Interuniversity Attraction Poles initiated by the Belgian Federal Science Policy Office, Actions de Recherche Concertees (French community, Belgium); (Fonds Speciaux de Recherche) of the Universite catholique de Louvain; European Space Agency (ESA) of the European Union	Brussels Regio (Belgium); Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Fondation pour la Recherche Scientifique Medicale(Fondation pour la Recherche Medicale); Belgian Program on Interuniversity Attraction Poles initiated by the Belgian Federal Science Policy Office, Actions de Recherche Concertees (French community, Belgium); (Fonds Speciaux de Recherche) of the Universite catholique de Louvain; European Space Agency (ESA) of the European Union(European Space Agency)	JJOdX is supported by a Brains Back To Brussels Grant from the Brussels Regio (Belgium). This work was supported by the Fonds National de la Recherche Scientifique, the Fondation pour la Recherche Scientifique Medicale, the Belgian Program on Interuniversity Attraction Poles initiated by the Belgian Federal Science Policy Office, Actions de Recherche Concertees (French community, Belgium), an internal research grant (Fonds Speciaux de Recherche) of the Universite catholique de Louvain, and the European Space Agency (ESA) of the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi-Pajouh MA, 2012, J NEUROSCI, V32, P9537, DOI 10.1523/JNEUROSCI.4275-11.2012; Cameron IGM, 2007, EXP BRAIN RES, V182, P233, DOI 10.1007/s00221-007-0983-3; Collins CJS, 2009, J NEUROSCI, V29, P13302, DOI 10.1523/JNEUROSCI.1636-09.2009; Cothros N, 2009, J NEUROPHYSIOL, V102, P2112, DOI 10.1152/jn.00493.2009; Cothros N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001990; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; de Rugy A, 2012, J NEUROSCI, V32, P7384, DOI 10.1523/JNEUROSCI.5792-11.2012; Diedrichsen J, 2010, J NEUROSCI, V30, P5159, DOI 10.1523/JNEUROSCI.5406-09.2010; Diedrichsen J, 2010, TRENDS COGN SCI, V14, P31, DOI 10.1016/j.tics.2009.11.004; Emken JL, 2007, J NEUROPHYSIOL, V97, P3997, DOI 10.1152/jn.01095.2006; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; Franklin DW, 2008, J NEUROSCI, V28, P11165, DOI 10.1523/JNEUROSCI.3099-08.2008; Franklin DW, 2008, J NEUROSCI, V28, P14165, DOI 10.1523/JNEUROSCI.4406-08.2008; Gandolfo F, 1996, P NATL ACAD SCI USA, V93, P3843, DOI 10.1073/pnas.93.9.3843; Gosselin-Kessiby N, 2009, J NEUROSCI, V29, P3485, DOI 10.1523/JNEUROSCI.2374-08.2009; Gribble PL, 2003, J NEUROPHYSIOL, V89, P2396, DOI 10.1152/jn.01020.2002; Haith AM, 2012, J NEUROSCI, V32, P11727, DOI 10.1523/JNEUROSCI.0424-12.2012; Hikosaka O, 2010, TRENDS COGN SCI, V14, P154, DOI 10.1016/j.tics.2010.01.006; Huang VS, 2011, NEURON, V70, P787, DOI 10.1016/j.neuron.2011.04.012; Hudson TE, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000982; Isoda M, 2007, NAT NEUROSCI, V10, P240, DOI 10.1038/nn1830; Izawa J, 2008, J NEUROSCI, V28, P2883, DOI 10.1523/JNEUROSCI.5359-07.2008; Izawa J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002012; Knill DC, 2011, J NEUROSCI, V31, P1219, DOI 10.1523/JNEUROSCI.3522-09.2011; Li W, 2007, INT J CONTROL, V80, P1439, DOI 10.1080/00207170701364913; Madelain L, 2011, J NEUROPHYSIOL, V106, P219, DOI 10.1152/jn.01094.2009; Mazzoni P, 2006, J NEUROSCI, V26, P3642, DOI 10.1523/JNEUROSCI.5317-05.2006; Mazzoni P, 2007, J NEUROSCI, V27, P7105, DOI 10.1523/JNEUROSCI.0264-07.2007; Mitrovic D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013601; Monsell S, 2003, TRENDS COGN SCI, V7, P134, DOI 10.1016/S1364-6613(03)00028-7; NAKAMURA T, 1991, ACTA OTO-LARYNGOL, P559; Nashed JY, 2012, J NEUROPHYSIOL, V108, P999, DOI 10.1152/jn.01089.2011; O'Sullivan I, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000345; Osu R, 2004, NAT NEUROSCI, V7, P111, DOI 10.1038/nn1184; Pruszynski JA, 2012, EXP BRAIN RES, V218, P341, DOI 10.1007/s00221-012-3041-8; Redgrave P, 2010, NAT REV NEUROSCI, V11, P760, DOI 10.1038/nrn2915; Rogers R, 1995, J EXPT PSYCHOL; Ronsse R, 2010, J MOTOR BEHAV, V42, P389, DOI 10.1080/00222895.2010.526451; Scheidt RA, 2001, J NEUROPHYSIOL, V86, P971, DOI 10.1152/jn.2001.86.2.971; Scott SH, 2004, NAT REV NEUROSCI, V5, P534, DOI 10.1038/nrn1427; Selen LPJ, 2006, EXP BRAIN RES, V172, P129, DOI 10.1007/s00221-005-0320-7; Selen LPJ, 2009, J NEUROSCI, V29, P12606, DOI 10.1523/JNEUROSCI.2826-09.2009; Shadmehr R, 2008, EXP BRAIN RES, V185, P359, DOI 10.1007/s00221-008-1280-5; Shadmehr R, 2010, J NEUROSCI, V30, P10507, DOI 10.1523/JNEUROSCI.1343-10.2010; Shadmehr R, 2010, ANNU REV NEUROSCI, V33, P89, DOI 10.1146/annurev-neuro-060909-153135; Smith MA, 2006, PLOS BIOL, V4, P1035, DOI 10.1371/journal.pbio.0040179; Srimal R, 2008, J NEUROPHYSIOL, V99, P1554, DOI 10.1152/jn.01024.2007; Takikawa Y, 2002, EXP BRAIN RES, V142, P284, DOI 10.1007/s00221-001-0928-1; Taylor JA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001096; Todorov E, 2004, NAT NEUROSCI, V7, P907, DOI 10.1038/nn1309; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; van Beers RJ, 2013, J NEUROPHYSIOL, V109, P969, DOI 10.1152/jn.00706.2012; van Beers RJ, 2009, NEURON, V63, P406, DOI 10.1016/j.neuron.2009.06.025; Wei KL, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00011; White O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054771; Wong J, 2009, J NEUROPHYSIOL, V101, P1542, DOI 10.1152/jn.91188.2008; Xu-Wilson M, 2009, EXP BRAIN RES, V196, P475, DOI 10.1007/s00221-009-1879-1	57	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66013	10.1371/journal.pone.0066013	http://dx.doi.org/10.1371/journal.pone.0066013			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776593	gold, Green Published			2022-12-27	WOS:000320755400099
J	Lu, RM; Chen, MS; Chang, DK; Chiu, CY; Lin, WC; Yan, SL; Wang, YP; Kuo, YS; Yeh, CY; Lo, A; Wu, HC				Lu, Ruei-Min; Chen, Min-Shan; Chang, De-Kuan; Chiu, Chien-Yu; Lin, Wei-Chuan; Yan, Shin-Long; Wang, Yi-Ping; Kuo, Yuan-Sung; Yeh, Chen-Yun; Lo, Albert; Wu, Han-Chung			Targeted Drug Delivery Systems Mediated by a Novel Peptide in Breast Cancer Therapy and Imaging	PLOS ONE			English	Article							SINGLE-CHAIN FV; MACROMOLECULAR THERAPEUTICS; EFFICACY; PENETRATION; LIPOSOMES; IMMUNOLIPOSOMES; NANOTECHNOLOGY; MECHANISM; CARCINOMA; AFFINITY	Targeted delivery of drugs to tumors represents a significant advance in cancer diagnosis and therapy. Therefore, development of novel tumor-specific ligands or pharmaceutical nanocarriers is highly desirable. In this study, we utilized phage display to identify a new targeting peptide, SP90, which specifically binds to breast cancer cells, and recognizes tumor tissues from breast cancer patients. We used confocal and electron microscopy to reveal that conjugation of SP90 with liposomes enables efficient delivery of drugs into cancer cells through endocytosis. Furthermore, in vivo fluorescent imaging demonstrated that SP90-conjugated quantum dots possess tumor-targeting properties. In tumor xenograft and orthotopic models, SP90-conjugated liposomal doxorubicin was found to improve the therapeutic index of the chemotherapeutic drug by selectively increasing its accumulation in tumors. We conclude that the targeting peptide SP90 has significant potential in improving the clinical benefits of chemotherapy in the treatment and the diagnosis of breast cancer.	[Lu, Ruei-Min; Chen, Min-Shan; Chang, De-Kuan; Chiu, Chien-Yu; Lin, Wei-Chuan; Yan, Shin-Long; Wang, Yi-Ping; Yeh, Chen-Yun; Lo, Albert; Wu, Han-Chung] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan; [Chen, Min-Shan; Wu, Han-Chung] Natl Taiwan Univ, Coll Med, Grad Inst Oral Biol, Taipei, Taiwan; [Kuo, Yuan-Sung] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Surg, Taipei 10764, Taiwan	Academia Sinica - Taiwan; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Wu, HC (corresponding author), Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan.	hcw0928@gate.sinica.edu.tw	Wu, Han-Chung/B-1209-2011; Lu, Ruei-Min/ABF-4388-2021	Wu, Han-Chung/0000-0002-5185-1169; Lu, Ruei-Min/0000-0003-3792-5499; Wang, Yi-Ping/0000-0001-9574-2194	Academia Sinica; National Science Council, Taiwan [NSC-100-2325-B-001-011, NSC-100-2321-B-001-038]	Academia Sinica(Academia Sinica - Taiwan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	Funding provided by Academia Sinica and National Science Council (NSC-100-2325-B-001-011 and NSC-100-2321-B-001-038), Taiwan (HCW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GP, 2001, CANCER RES, V61, P4750; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashley CE, 2011, NAT MATER, V10, P389, DOI [10.1038/nmat2992, 10.1038/NMAT2992]; Barenholz Y, 2012, J CONTROL RELEASE, V160, P117, DOI 10.1016/j.jconrel.2012.03.020; Bosslet K, 1998, CANCER RES, V58, P1195; Cai WB, 2008, NAT PROTOC, V3, P89, DOI 10.1038/nprot.2007.478; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Chang DK, 2009, J BIOL CHEM, V284, P12905, DOI 10.1074/jbc.M900280200; Chang DK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004171; Cheng WW, 2010, EXPERT OPIN DRUG DEL, V7, P461, DOI 10.1517/17425240903579963; Cho HJ, 2012, BIOMATERIALS, V33, P1190, DOI 10.1016/j.biomaterials.2011.10.064; Cobleigh MA, 2011, SEMIN ONCOL, V38, pS11, DOI 10.1053/j.seminoncol.2011.04.005; Davis ME, 2008, NAT REV DRUG DISCOV, V7, P771, DOI 10.1038/nrd2614; DeSantis C, 2011, CA-CANCER J CLIN, V61, P409, DOI 10.3322/caac.20134; Farokhzad OC, 2009, ACS NANO, V3, P16, DOI 10.1021/nn900002m; Hambley TW, 2009, CANCER RES, V69, P1259, DOI 10.1158/0008-5472.CAN-08-3786; Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456; IBER FL, 1958, J CLIN INVEST, V37, P1442, DOI 10.1172/JCI103735; Kohschutter J, 2008, EXPERT OPIN DRUG DEL, V5, P653, DOI [10.1517/17425240802145320, 10.1517/17425247.5.6.653 ]; Kratz F, 2008, J CONTROL RELEASE, V132, P171, DOI 10.1016/j.jconrel.2008.05.010; Lee CMY, 2007, NAT PROTOC, V2, P3001, DOI 10.1038/nprot.2007.448; Lee TY, 2007, CANCER RES, V67, P10958, DOI 10.1158/0008-5472.CAN-07-2233; Lee TY, 2004, CANCER RES, V64, P8002, DOI 10.1158/0008-5472.CAN-04-1948; Lo A, 2008, MOL CANCER THER, V7, P579, DOI 10.1158/1535-7163.MCT-07-2359; Lu RM, 2011, BIOMATERIALS, V32, P3265, DOI 10.1016/j.biomaterials.2010.12.061; Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5; MATSUMURA Y, 1986, CANCER RES, V46, P6387; Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893; Nellis DF, 2005, BIOTECHNOL PROGR, V21, P205, DOI 10.1021/bp049840y; O'Brien MER, 2004, ANN ONCOL, V15, P440, DOI 10.1093/annonc/mdh097; O'Shaughnessy JA, 2012, ONCOLOGIST, V17, P476, DOI 10.1634/theoncologist.2011-0281; Park JH, 2009, SMALL, V5, P694, DOI 10.1002/smll.200801789; Park JW, 2002, CLIN CANCER RES, V8, P1172; Provenzano PP, 2012, CANCER CELL, V21, P418, DOI 10.1016/j.ccr.2012.01.007; Rudnick SI, 2011, CANCER RES, V71, P2250, DOI 10.1158/0008-5472.CAN-10-2277; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Shadidi M, 2002, FASEB J, V16, P256, DOI 10.1096/fj.02-0280fje; Shi JJ, 2010, NANO LETT, V10, P3223, DOI 10.1021/nl102184c; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Slingerland M, 2012, DRUG DISCOV TODAY, V17, P160, DOI 10.1016/j.drudis.2011.09.015; Svensen N, 2012, TRENDS PHARMACOL SCI, V33, P186, DOI 10.1016/j.tips.2012.02.002; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Torchilin V, 2008, EXPERT OPIN DRUG DEL, V5, P1003, DOI [10.1517/17425247.5.9.1003, 10.1517/17425247.5.9.1003 ]; Wagner V, 2006, NAT BIOTECHNOL, V24, P1211, DOI 10.1038/nbt1006-1211; Wang T, 2010, NANOMEDICINE-UK, V5, P563, DOI [10.2217/nnm.10.30, 10.2217/NNM.10.30]; Wu H, 2006, J CANC MOL, V2, P57; Wu HC, 2010, J ONCOL, V2010, DOI 10.1155/2010/723798	47	55	59	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66128	10.1371/journal.pone.0066128	http://dx.doi.org/10.1371/journal.pone.0066128			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776619	Green Published, Green Submitted, gold			2022-12-27	WOS:000320755400112
J	Lysenko, O; Schulte, D; Mittelbronn, M; Steinle, A				Lysenko, Olga; Schulte, Dorothea; Mittelbronn, Michel; Steinle, Alexander			BACL Is a Novel Brain-Associated, Non-NKC-Encoded Mammalian C-Type Lectin-Like Receptor of the CLEC2 Family	PLOS ONE			English	Article							MHC CLASS-I; HUMAN NKR-P1A; UNEXPECTED ROLE; CUTTING EDGE; LIGAND; RECOGNITION; EXPRESSION; PROTEINS; SUBSET; CELLS	Natural Killer Gene Complex (NKC)-encoded C-type lectin-like receptors (CTLRs) are expressed on various immune cells including T cells, NK cells and myeloid cells and thereby contribute to the orchestration of cellular immune responses. Some NKC-encoded CTLRs are grouped into the C-type lectin family 2 (CLEC2 family) and interact with genetically linked CTLRs of the NKRP1 family. While many CLEC2 family members are expressed by hematopoietic cells (e.g. CD69 (CLEC2C)), others such as the keratinocyte-associated KACL (CLEC2A) are specifically expressed by other tissues. Here we provide the first characterization of the orphan gene CLEC2L. In contrast to other CLEC2 family members, CLEC2L is conserved among mammals and located outside of the NKC. We show that CLEC2L-encoded CTLRs are expressed as non-glycosylated, disulfide-linked homodimers at the cell surface. CLEC2L expression is fairly tissue-restricted with a predominant expression in the brain. Thus CLEC2L-encoded CTLRs were designated BACL (brain-associated C-type lectin). Combining in situ hybridization and immunohistochemistry, we show that BACL is expressed by neurons in the CNS, with a pronounced expression by Purkinje cells. Notably, the CLEC2L locus is adjacent to another orphan CTLR gene (KLRG2), but reporter cell assays did neither indicate interaction of BACL with the KLRG2 ectodomain nor with human NK cell lines or lymphocytes. Along these lines, growth of BACL-expressing tumor cell lines in immunocompetent mice did not provide evidence for an immune-related function of BACL. Altogether, the CLEC2L gene encodes a homodimeric cell surface CTLR that stands out among CLEC2 family members by its conservation in mammals, its biochemical properties and the predominant expression in the brain. Future studies will have to reveal insights into the functional relevance of BACL in the context of its neuronal expression.	[Lysenko, Olga; Steinle, Alexander] Goethe Univ Frankfurt, Inst Mol Med, D-60054 Frankfurt, Germany; [Schulte, Dorothea; Mittelbronn, Michel] Goethe Univ Frankfurt, Inst Neurol, Edinger Inst, D-60054 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt	Steinle, A (corresponding author), Goethe Univ Frankfurt, Inst Mol Med, D-60054 Frankfurt, Germany.	alexander.steinle@kgu.de		Mittelbronn, Michel/0000-0002-2998-052X; Steinle, Alexander/0000-0001-5081-8503; Schulte, Dorothea/0000-0002-7243-6319	Deutsche Forschungsgemeinschaft [STE 828/5-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (STE 828/5-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldemir H, 2005, J IMMUNOL, V175, P7791, DOI 10.4049/jimmunol.175.12.7791; Aust JG, 2009, J IMMUNOL, V183, P106, DOI 10.4049/jimmunol.0804281; Boulanger LM, 2009, NEURON, V64, P93, DOI 10.1016/j.neuron.2009.09.001; Carlyle JR, 2004, P NATL ACAD SCI USA, V101, P3527, DOI 10.1073/pnas.0308304101; Cerwenka A, 2001, P NATL ACAD SCI USA, V98, P11521, DOI 10.1073/pnas.201238598; Chen P, 2011, IMMUNOGENETICS, V63, P627, DOI 10.1007/s00251-011-0542-8; Diefenbach A, 2001, NATURE, V413, P165, DOI 10.1038/35093109; Elmer BM, 2012, TRENDS NEUROSCI, V35, P660, DOI 10.1016/j.tins.2012.08.001; Garay Paula A, 2010, Front Synaptic Neurosci, V2, P136, DOI 10.3389/fnsyn.2010.00136; HAWKES R, 1991, PROG NEUROBIOL, V36, P309, DOI 10.1016/0301-0082(91)90004-K; Heine P, 2008, DEVELOPMENT, V135, P805, DOI 10.1242/dev.012088; Hirata Y, 2012, CEREBELLUM, V11, P455, DOI 10.1007/s12311-012-0385-3; Iizuka K, 2003, NAT IMMUNOL, V4, P801, DOI 10.1038/ni954; Kristensson K, 2011, NAT REV NEUROSCI, V12, P345, DOI 10.1038/nrn3029; Kuttruff S, 2009, BLOOD, V113, P358, DOI [10.1182/blood-2008-04-145615, 10.1182/blood-2008-03-145615]; Kveberg L, 2011, IMMUNOGENETICS, V63, P429, DOI 10.1007/s00251-011-0520-1; LANIER LL, 1994, J IMMUNOL, V153, P2417; Rosen DB, 2008, J IMMUNOL, V180, P6508, DOI 10.4049/jimmunol.180.10.6508; Rosen DB, 2005, J IMMUNOL, V175, P7796, DOI 10.4049/jimmunol.175.12.7796; Shatz CJ, 2009, NEURON, V64, P40, DOI 10.1016/j.neuron.2009.09.044; Spreu J, 2010, P NATL ACAD SCI USA, V107, P5100, DOI 10.1073/pnas.0913108107; Stephan AH, 2012, ANNU REV NEUROSCI, V35, P369, DOI 10.1146/annurev-neuro-061010-113810; Vitale M, 2001, EUR J IMMUNOL, V31, P233, DOI 10.1002/1521-4141(200101)31:1<233::AID-IMMU233>3.3.CO;2-W; Vogler I, 2011, J INNATE IMMUN, V3, P227, DOI 10.1159/000324112; Voogd J, 1998, TRENDS NEUROSCI, V21, P370, DOI 10.1016/S0166-2236(98)01318-6; Welte S, 2006, NAT IMMUNOL, V7, P1334, DOI 10.1038/ni1402; Wiemann K, 2005, J IMMUNOL, V175, P720, DOI 10.4049/jimmunol.175.2.720; Yokoyama WM, 2003, NAT REV IMMUNOL, V3, P304, DOI 10.1038/nri1055; YOKOYAMA WM, 1993, ANNU REV IMMUNOL, V11, P613, DOI 10.1146/annurev.iy.11.040193.003145; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x; Zhang Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050561	32	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65345	10.1371/journal.pone.0065345	http://dx.doi.org/10.1371/journal.pone.0065345			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776472	Green Published, Green Submitted, gold			2022-12-27	WOS:000320755400026
J	Mackiewicz, D; de Oliveira, PMC; de Oliveira, SM; Cebrat, S				Mackiewicz, Dorota; Castro de Oliveira, Paulo Murilo; de Oliveira, Suzana Moss; Cebrat, Stanislaw			Distribution of Recombination Hotspots in the Human Genome - A Comparison of Computer Simulations with Real Data	PLOS ONE			English	Article							MEIOTIC RECOMBINATION; HOT-SPOTS; CONVERSION PARADOX; HAPLOTYPE MAP; EVOLUTION; PRDM9; RATES; REPLICATION; POPULATIONS; PATTERNS	Recombination is the main cause of genetic diversity. Thus, errors in this process can lead to chromosomal abnormalities. Recombination events are confined to narrow chromosome regions called hotspots in which characteristic DNA motifs are found. Genomic analyses have shown that both recombination hotspots and DNA motifs are distributed unevenly along human chromosomes and are much more frequent in the subtelomeric regions of chromosomes than in their central parts. Clusters of motifs roughly follow the distribution of recombination hotspots whereas single motifs show a negative correlation with the hotspot distribution. To model the phenomena related to recombination, we carried out computer Monte Carlo simulations of genome evolution. Computer simulations generated uneven distribution of hotspots with their domination in the subtelomeric regions of chromosomes. They also revealed that purifying selection eliminating defective alleles is strong enough to cause such hotspot distribution. After sufficiently long time of simulations, the structure of chromosomes reached a dynamic equilibrium, in which number and global distribution of both hotspots and defective alleles remained statistically unchanged, while their precise positions were shifted. This resembles the dynamic structure of human and chimpanzee genomes, where hotspots change their exact locations but the global distributions of recombination events are very similar.	[Mackiewicz, Dorota; Cebrat, Stanislaw] Univ Wroclaw, Fac Biotechnol, Dept Genom, PL-50138 Wroclaw, Poland; [Castro de Oliveira, Paulo Murilo; de Oliveira, Suzana Moss] Univ Fed Fluminense, Inst Fis, Rio De Janeiro, Brazil; [Castro de Oliveira, Paulo Murilo; de Oliveira, Suzana Moss] Natl Inst Sci & Technol Complex Syst, Rio De Janeiro, Brazil	University of Wroclaw; Universidade Federal Fluminense	Mackiewicz, D (corresponding author), Univ Wroclaw, Fac Biotechnol, Dept Genom, PL-50138 Wroclaw, Poland.	dorota@smorfland.uni.wroc.pl	Mackiewicz, Dorota/AAJ-8963-2020	Mackiewicz, Dorota/0000-0001-8922-8615	University of Wroclaw	University of Wroclaw	This research was supported by a grant from the University of Wroclaw (http://www.uni.wroc.pl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Auton A, 2012, SCIENCE, V336, P193, DOI 10.1126/science.1216872; Azbel' MY, 1999, PHYSICA A, V273, P75, DOI 10.1016/S0378-4371(99)00342-8; Backstrom N, 2010, GENOME RES, V20, P485, DOI 10.1101/gr.101410.109; Barton AB, 2008, GENETICS, V179, P1221, DOI 10.1534/genetics.107.083493; Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Berg IL, 2011, P NATL ACAD SCI USA, V108, P12378, DOI 10.1073/pnas.1109531108; Berg IL, 2010, NAT GENET, V42, P859, DOI 10.1038/ng.658; Boulton A, 1997, P NATL ACAD SCI USA, V94, P8058, DOI 10.1073/pnas.94.15.8058; Cebrat S, 2012, ACS, V1; Coop G, 2008, SCIENCE, V319, P1395, DOI 10.1126/science.1151851; de Massy B, 2003, TRENDS GENET, V19, P514, DOI 10.1016/S0168-9525(03)00201-4; de Oliveira PMC, 2011, PHYSICA A, V390, P492, DOI 10.1016/j.physa.2010.10.010; de Villena FPM, 2001, MAMM GENOME, V12, P318, DOI 10.1007/s003350020005; Drake JW, 1998, GENETICS, V148, P1667; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Friberg U, 2008, GENETICS, V179, P2229, DOI 10.1534/genetics.107.085563; Groenen MAM, 2009, GENOME RES, V19, P510, DOI 10.1101/gr.086538.108; Hinch AG, 2011, NATURE, V476, P170, DOI 10.1038/nature10336; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Jeffreys AJ, 2009, NAT GENET, V41, P625, DOI 10.1038/ng.346; Jensen-Seaman MI, 2004, GENOME RES, V14, P528, DOI 10.1101/gr.1970304; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kong A, 2004, NAT GENET, V36, P1203, DOI 10.1038/ng1445; Kong A, 2010, NATURE, V467, P1099, DOI 10.1038/nature09525; Liu H, 2006, AM J HUM GENET, V79, P230, DOI 10.1086/505436; Mackiewicz D, 2010, J THEOR BIOL, V267, P186, DOI 10.1016/j.jtbi.2010.08.022; Mackiewicz P, 2004, NUCLEIC ACIDS RES, V32, P3781, DOI 10.1093/nar/gkh699; Mahtani MM, 1998, GENOME RES, V8, P100, DOI 10.1101/gr.8.2.100; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; McVean G, 2010, PHILOS T R SOC B, V365, P1213, DOI 10.1098/rstb.2009.0299; Messer W, 2002, FEMS MICROBIOL REV, V26, P355, DOI 10.1016/S0168-6445(02)00127-4; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; Ogawa T, 2002, MOL MICROBIOL, V44, P1367, DOI 10.1046/j.1365-2958.2002.02969.x; Paigen K, 2010, NAT REV GENET, V11, P221, DOI 10.1038/nrg2712; Payseur BA, 2000, GENETICS, V156, P1285; Peters AD, 2008, GENETICS, V178, P1579, DOI 10.1534/genetics.107.084061; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; Pineda-Krch M, 2005, GENETICS, V169, P2319, DOI 10.1534/genetics.104.034363; Prachumwat A, 2004, GENETICS, V166, P1585, DOI 10.1534/genetics.166.3.1585; Ptak SE, 2005, NAT GENET, V37, P429, DOI 10.1038/ng1529; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Segurel L, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001211; Serre D, 2005, GENOME RES, V15, P1547, DOI 10.1101/gr.4211905; Ubeda F, 2011, J EVOLUTION BIOL, V24, P541, DOI 10.1111/j.1420-9101.2010.02187.x; Waga W, 2007, THEOR BIOSCI, V126, P53, DOI 10.1007/s12064-007-0010-z; Westphal T, 2002, GENETICS, V160, P609; Winckler W, 2005, SCIENCE, V308, P107, DOI 10.1126/science.1105322; WU TC, 1994, SCIENCE, V263, P515, DOI 10.1126/science.8290959; Zawierta M, 2008, INT J MOD PHYS C, V19, P917, DOI 10.1142/S0129183108012595	53	10	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65272	10.1371/journal.pone.0065272	http://dx.doi.org/10.1371/journal.pone.0065272			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776462	Green Published, Green Submitted, gold			2022-12-27	WOS:000320755400022
J	Martinez, C; Cornejo, VH; Lois, P; Ellis, T; Solis, NP; Wainwright, BJ; Palma, V				Martinez, Constanza; Hugo Cornejo, Victor; Lois, Pablo; Ellis, Tammy; Solis, Natalia P.; Wainwright, Brandon J.; Palma, Veronica			Proliferation of Murine Midbrain Neural Stem Cells Depends upon an Endogenous Sonic Hedgehog (Shh) Source	PLOS ONE			English	Article							PROGENITOR CELLS; BRAIN; CEREBELLUM; NEOCORTEX; BEHAVIOR; GROWTH; TECTUM; MICE	The Sonic Hedgehog (Shh) pathway is responsible for critical patterning events early in development and for regulating the delicate balance between proliferation and differentiation in the developing and adult vertebrate brain. Currently, our knowledge of the potential role of Shh in regulating neural stem cells (NSC) is largely derived from analyses of the mammalian forebrain, but for dorsal midbrain development it is mostly unknown. For a detailed understanding of the role of Shh pathway for midbrain development in vivo, we took advantage of mouse embryos with cell autonomously activated Hedgehog (Hh) signaling in a conditional Patched 1 (Ptc1) mutant mouse model. This animal model shows an extensive embryonic tectal hypertrophy as a result of Hh pathway activation. In order to reveal the cellular and molecular origin of this in vivo phenotype, we established a novel culture system to evaluate neurospheres (nsps) viability, proliferation and differentiation. By recreating the three-dimensional (3-D) microenvironment we highlight the pivotal role of endogenous Shh in maintaining the stem cell potential of tectal radial glial cells (RGC) and progenitors by modulating their Ptc1 expression. We demonstrate that during late embryogenesis Shh enhances proliferation of NSC, whereas blockage of endogenous Shh signaling using cyclopamine, a potent Hh pathway inhibitor, produces the opposite effect. We propose that canonical Shh signaling plays a central role in the control of NSC behavior in the developing dorsal midbrain by acting as a niche factor by partially mediating the response of NSC to epidermal growth factor (EGF) and fibroblast growth factor (FGF) signaling. We conclude that endogenous Shh signaling is a critical mechanism regulating the proliferation of stem cell lineages in the embryonic dorsal tissue.	[Martinez, Constanza; Hugo Cornejo, Victor; Lois, Pablo; Solis, Natalia P.; Palma, Veronica] Univ Chile, Fac Sci, FONDAP Ctr Genome Regulat, Lab Stem Cells & Dev, Santiago, Chile; [Ellis, Tammy; Wainwright, Brandon J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia	Universidad de Chile; University of Queensland	Wainwright, BJ (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia.	b.wainwright@imb.uq.edu.au; vpalma@uchile.cl	Cornejo, Victor Hugo/ABD-8410-2021	Palma, Veronica/0000-0002-4320-7525; Wainwright, Brandon/0000-0003-0406-2092; Palma, Veronica/0000-0002-3907-9436	Pew Foundation; FONDECYT [1070248, 1110237]; CONICYT	Pew Foundation; FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	The authors give a special thanks to the Pew Foundation for their support. This work was supported by FONDECYT grants 1070248 and 1110237 (VP) and PhD CONICYT fellowship (CM, VHC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphe C, 2006, CANCER RES, V66, P2081, DOI 10.1158/0008-5472.CAN-05-2146; Blaess S, 2006, DEVELOPMENT, V133, P1799, DOI 10.1242/dev.02339; Briscoe J, 2009, EMBO J, V28, P457, DOI 10.1038/emboj.2009.12; Ciemerych MA, 2002, GENE DEV, V16, P3277, DOI 10.1101/gad.1023602; Conti L, 2010, NAT REV NEUROSCI, V11, P176, DOI 10.1038/nrn2761; Dahmane N, 1999, DEVELOPMENT, V126, P3089; Dahmane N, 2001, DEVELOPMENT, V128, P5201; Dave RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014680; Douet V, 2013, CELL PROLIFERAT, V46, P137, DOI 10.1111/cpr.12023; Ellis T, 2003, GENESIS, V36, P158, DOI 10.1002/gene.10208; Feijoo CG, 2011, EUR J NEUROSCI, V33, P589, DOI 10.1111/j.1460-9568.2010.07560.x; Garcia-Parra P, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-48; Incardona JP, 1998, DEVELOPMENT, V125, P3553; Ingram WJ, 2002, ONCOGENE, V21, P8196, DOI 10.1038/sj.onc.1205975; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Ko HC, 2007, DENT MATER, V23, P1349, DOI 10.1016/j.dental.2006.11.023; LaPlaca MC, 2005, J BIOMECH, V38, P1093, DOI 10.1016/j.jbiomech.2004.05.032; Leone DP, 2005, J CELL SCI, V118, P2589, DOI 10.1242/jcs.02396; Liu Y, 2013, TISSUE ENG PT A, V19, P135, DOI [10.1089/ten.tea.2012.0209, 10.1089/ten.TEA.2012.0209]; Ma W, 2008, TISSUE ENG PT A, V14, P1673, DOI 10.1089/ten.tea.2007.0357; Machold R, 2003, NEURON, V39, P937, DOI 10.1016/S0896-6273(03)00561-0; Palma V, 2005, DEVELOPMENT, V132, P335, DOI 10.1242/dev.01567; Palma V, 2004, DEVELOPMENT, V131, P337, DOI 10.1242/dev.00930; Palma V, 2011, BIOL RES, V44, P63, DOI 10.4067/S0716-97602011000100008; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Rapacioli M, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-117; Serban MA, 2008, METHODS, V45, P93, DOI 10.1016/j.ymeth.2008.01.010; Stecca B, 2009, EMBO J, V28, P663, DOI 10.1038/emboj.2009.16; Sun Y, 2005, NEURON, V45, P873, DOI 10.1016/j.neuron.2005.01.045; Traiffort E, 1999, EUR J NEUROSCI, V11, P3199, DOI 10.1046/j.1460-9568.1999.00777.x; Traiffort E, 1998, J NEUROCHEM, V70, P1327; Ulloa F, 2007, CELL CYCLE, V6, P2640, DOI 10.4161/cc.6.21.4822; Wallace VA, 1999, CURR BIOL, V9, P445, DOI 10.1016/S0960-9822(99)80195-X; Wang XQ, 2009, NATURE, V461, P947, DOI 10.1038/nature08435; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0	35	17	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65818	10.1371/journal.pone.0065818	http://dx.doi.org/10.1371/journal.pone.0065818			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776550	Green Published, Green Submitted, gold			2022-12-27	WOS:000320755400068
J	Rende, D; Baysal, N; Kirdar, B				Rende, Deniz; Baysal, Nihat; Kirdar, Betul			Complex Disease Interventions from a Network Model for Type 2 Diabetes	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; FUNCTIONAL MODULES; BETA-CELL; GENE-EXPRESSION; CIRCADIAN-RHYTHM; RETINOIC ACID; IDENTIFICATION; TOPOLOGY; CARDIOTROPHIN-1; CLASSIFICATION	There is accumulating evidence that the proteins encoded by the genes associated with a common disorder interact with each other, participate in similar pathways and share GO terms. It has been anticipated that the functional modules in a disease related functional linkage network are informative to reveal significant metabolic processes and disease's associations with other complex disorders. In the current study, Type 2 diabetes associated functional linkage network (T2DFN) containing 2770 proteins and 15041 linkages was constructed. The functional modules in this network were scored and evaluated in terms of shared pathways, co-localization, co-expression and associations with similar diseases. The assembly of top scoring overlapping members in the functional modules revealed that, along with the well known biological pathways, circadian rhythm, diverse actions of nuclear receptors in steroid and retinoic acid metabolisms have significant occurrence in the pathophysiology of the disease. The disease's association with other metabolic and neuromuscular disorders was established through shared proteins. Nuclear receptor NRIP1 has a pivotal role in lipid and carbohydrate metabolism, indicating the need to investigate subsequent effects of NRIP1 on Type 2 diabetes. Our study also revealed that CREB binding protein (CREBBP) and cardiotrophin-1 (CTF1) have suggestive roles in linking Type 2 diabetes and neuromuscular diseases.	[Rende, Deniz] Rensselaer Polytech Inst, Dept Mat Sci & Engn, Troy, NY 12180 USA; [Rende, Deniz; Baysal, Nihat] Rensselaer Polytech Inst, Rensselaer Nanotechnol Ctr, Troy, NY USA; [Baysal, Nihat] Rensselaer Polytech Inst, Dept Chem & Biol Engn, Troy, NY USA; [Kirdar, Betul] Bogazici Univ, Dept Chem Engn, Istanbul, Turkey	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Bogazici University	Rende, D (corresponding author), Rensselaer Polytech Inst, Dept Mat Sci & Engn, Troy, NY 12180 USA.	rended3@rpi.edu	Kirdar, Betul/ABI-7250-2020		Bogazici University Research Fund [09HA502D]; Scientific and Technological Research Council of Turkey 2219 Program;  [DPT-09K120520]	Bogazici University Research Fund(Bogazici University); Scientific and Technological Research Council of Turkey 2219 Program(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); 	The work was supported by Bogazici University Research Fund through project 09HA502D and by DPT-09K120520. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. DR is supported by The Scientific and Technological Research Council of Turkey 2219 Program.	Andersen H, 2004, DIABETES, V53, P1543, DOI 10.2337/diabetes.53.6.1543; Ashcroft FM, 2012, CELL, V148, P1160, DOI 10.1016/j.cell.2012.02.010; Babon JJ, 2012, IMMUNITY, V36, P239, DOI 10.1016/j.immuni.2011.12.015; Barabasi AL, 2000, PHYSICA A, V281, P69, DOI 10.1016/S0378-4371(00)00018-2; Barbieri M, 2008, ATHEROSCLEROSIS, V201, P117, DOI 10.1016/j.atherosclerosis.2008.01.005; Barroso I, 2003, PLOS BIOL, V1, P41, DOI 10.1371/journal.pbio.0000020; BAUM D, 2003, FINDING ALL MAXIMAL; Billings LK, 2010, ANN NY ACAD SCI, V1212, P59, DOI 10.1111/j.1749-6632.2010.05838.x; Bonnefond A, 2010, TRENDS MOL MED, V16, P407, DOI 10.1016/j.molmed.2010.06.004; BRON C, 1973, COMMUN ACM, V16, P575, DOI 10.1145/362342.362367; Brown AC, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-12; Butte AJ, 2006, NAT BIOTECHNOL, V24, P55, DOI 10.1038/nbt1150; Camacho J, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.030901; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Catalan V, 2009, OBES SURG, V19, P771, DOI 10.1007/s11695-009-9834-6; Cermakian N, 2003, BRAIN RES REV, V42, P204, DOI 10.1016/S0165-0173(03)00171-1; Chen CL, 2008, J CELL PHYSIOL, V215, P223, DOI 10.1002/jcp.21303; Chen JC, 2006, BIOINFORMATICS, V22, P2283, DOI 10.1093/bioinformatics/btl370; Christian M, 2006, TRENDS ENDOCRIN MET, V17, P243, DOI 10.1016/j.tem.2006.06.008; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Conaway RC, 2011, CURR OPIN GENET DEV, V21, P225, DOI 10.1016/j.gde.2011.01.013; Cvekl A, 2009, EXP EYE RES, V89, P280, DOI 10.1016/j.exer.2009.04.012; Dani C, 2012, INT J OBESITY; Doria A, 2008, CELL METAB, V8, P186, DOI 10.1016/j.cmet.2008.08.006; Ekestern E, 2004, NEURODEGENER DIS, V1, P88, DOI 10.1159/000080049; Emanuelli B, 2000, J BIOL CHEM, V275, P15985, DOI 10.1074/jbc.275.21.15985; Ergun A, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100125; Fritah A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032520; Gaspin C., 2001, Constraints, V6, P201, DOI 10.1023/A:1011433605905; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Gloyn AL, 2001, BEST PRACT RES CL EN, V15, P293, DOI 10.1053/beem.2001.0147; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Hakonarson H, 2011, DIABETES-METAB RES, V27, P685, DOI 10.1002/dmrr.1221; Hussain A, 2007, DIABETES RES CLIN PR, V76, P317, DOI 10.1016/j.diabres.2006.09.020; Hwang D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.10; Hwang S, 2008, J THEOR BIOL, V252, P722, DOI 10.1016/j.jtbi.2008.02.011; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Karimpour-Fard A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-313; Kelly MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032670; Lai SW, 2012, AM J GASTROENTEROL, V107, P46, DOI 10.1038/ajg.2011.384; Lecker SH, 1999, J CLIN INVEST, V104, P1411, DOI 10.1172/JCI7300; Lesbordes JC, 2003, HUM MOL GENET, V12, P1233, DOI 10.1093/hmg/ddg143; Li L, 2007, BRAIN RES REV, V56, P384, DOI 10.1016/j.brainresrev.2007.09.001; Libby P, 2006, AM J CLIN NUTR, V83, p456S; Ling C, 2008, DIABETOLOGIA, V51, P615, DOI 10.1007/s00125-007-0916-5; Liu M, 2007, PLOS GENET, V3, P958, DOI 10.1371/journal.pgen.0030096; LOWE HJ, 1994, JAMA-J AM MED ASSOC, V271, P1103, DOI 10.1001/jama.271.14.1103; Lozano MA, 2006, PATTERN RECOGN, V39, P539, DOI 10.1016/j.patcog.2005.10.008; Malik S, 2005, TRENDS BIOCHEM SCI, V30, P256, DOI 10.1016/j.tibs.2005.03.009; Marfella R, 2006, DIABETES, V55, P622, DOI 10.2337/diabetes.55.03.06.db05-0832; Mayer B, 2007, CLIN RES CARDIOL, V96, P1, DOI 10.1007/s00392-006-0447-y; McCampbell A, 2000, HUM MOL GENET, V9, P2197, DOI 10.1093/hmg/9.14.2197; McCarthy MI, 2002, AM J PHYSIOL-ENDOC M, V283, pE217, DOI 10.1152/ajpendo.00099.2002; McKusick V.A., 1998, MENDELIAN INHERITANC; McNamara P, 2001, CELL, V105, P877, DOI 10.1016/S0092-8674(01)00401-9; Mejhert N, 2010, BMC ENDOCR DISORD, V10, DOI 10.1186/1472-6823-10-1; Nair S, 2005, DIABETOLOGIA, V48, P1784, DOI 10.1007/s00125-005-1868-2; Nakayama S, 2008, DIABETOLOGIA, V51, P1883, DOI 10.1007/s00125-008-1080-2; Natal C, 2008, AM J PHYSIOL-ENDOC M, V294, pE52, DOI 10.1152/ajpendo.00506.2007; Nibbe RK, 2009, MOL CELL PROTEOMICS, V8, P827, DOI 10.1074/mcp.M800428-MCP200; Niederreither K, 2008, NAT REV GENET, V9, P541, DOI 10.1038/nrg2340; Oliveira S, 2007, INT J COMPUT MATH, V84, P683, DOI 10.1080/00207160701332382; Onnela JP, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/6/179; Owen KR, 2007, CURR OPIN GENET DEV, V17, P239, DOI 10.1016/j.gde.2007.04.003; Palmer ND, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029202; Pan A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001141; Parikh H, 2007, PLOS MED, V4, P868, DOI 10.1371/journal.pmed.0040158; Pihlajamaki J, 2009, J CLIN ENDOCR METAB, V94, P3521, DOI 10.1210/jc.2009-0212; Prokopenko I, 2008, TRENDS GENET, V24, P613, DOI 10.1016/j.tig.2008.09.004; Rains JL, 2011, FREE RADICAL BIO MED, V50, P567, DOI 10.1016/j.freeradbiomed.2010.12.006; Ray M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r148; Rende D, 2011, MOL BIOSYST, V7, P2205, DOI 10.1039/c1mb05064h; Richard AJ, 2011, TRENDS ENDOCRIN MET, V22, P325, DOI 10.1016/j.tem.2011.03.007; Ridderstrale M, 2009, MOL CELL ENDOCRINOL, V297, P10, DOI 10.1016/j.mce.2008.10.002; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Sanghera DK, 2012, J DIABETES METAB, V3, DOI 10.4172/2155-6156.1000198; Sengupta U, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008100; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; Sprenger J, 2008, NUCLEIC ACIDS RES, V36, pD230, DOI 10.1093/nar/gkm950; Sreekumar R, 2002, DIABETES, V51, P1913, DOI 10.2337/diabetes.51.6.1913; Stix V, 2004, COMPUT OPTIM APPL, V27, P173, DOI 10.1023/B:COAP.0000008651.28952.b6; Su W, 2008, AM J PHYSIOL-HEART C, V295, pH1634, DOI 10.1152/ajpheart.00257.2008; Thomas MK, 2000, DIABETES, V49, P2039, DOI 10.2337/diabetes.49.12.2039; Tsankov AM, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100106; Ulitsky I, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-8; Wang JG, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000521; Wang XR, 2007, BIOCHEMISTRY-US, V46, P3553, DOI 10.1021/bi061994u; Wang XW, 2008, CURR OPIN BIOTECH, V19, P482, DOI 10.1016/j.copbio.2008.07.011; Welters HJ, 2008, TRENDS ENDOCRIN MET, V19, P349, DOI 10.1016/j.tem.2008.08.004; Wheeler E, 2011, BRIEF FUNCT GENOMICS, V10, P52, DOI 10.1093/bfgp/elr008; Wheelock CE, 2009, MOL BIOSYST, V5, P588, DOI 10.1039/b902356a; White R, 2008, FEBS LETT, V582, P39, DOI 10.1016/j.febslet.2007.11.017; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Xue HL, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100189; Yamauchi T, 2002, NAT GENET, V30, P221, DOI 10.1038/ng829; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zelezniak A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000729; Zhang C, 2006, J PROTEOME RES, V5, P801, DOI 10.1021/pr050366g; Zhang SH, 2006, COMPUT BIOL CHEM, V30, P445, DOI 10.1016/j.compbiolchem.2006.10.001; Zucman-Rossi J, 2010, DIGEST LIVER DIS, V42, pS235, DOI 10.1016/S1590-8658(10)60511-7	102	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65854	10.1371/journal.pone.0065854	http://dx.doi.org/10.1371/journal.pone.0065854			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776558	gold, Green Submitted, Green Published			2022-12-27	WOS:000320755400074
J	Shiu, J; Czinn, SJ; Kobayashi, KS; Sun, YZ; Blanchard, TG				Shiu, Jessica; Czinn, Steven J.; Kobayashi, Koichi S.; Sun, Yezhou; Blanchard, Thomas G.			IRAK-M Expression Limits Dendritic Cell Activation and Proinflammatory Cytokine Production in Response to Helicobacter pylori	PLOS ONE			English	Article							REGULATORY T-CELLS; KINASE-M; GASTRIC INFLAMMATION; NEGATIVE REGULATOR; IMMUNE-RESPONSES; HOST-DEFENSE; INFECTION; FELIS; POLYMORPHISMS; COLONIZATION	Helicobacter pylori (H. pylori) infects the gastric mucosa and persists for the life of the host. Bacterial persistence may be due to the induction of regulatory T cells (T-regs) which may have protective effects against other diseases such as asthma. It has been shown that H. pylori modulates the T cell response through dendritic cell reprogramming but the molecular pathways involved are relatively unknown. The goal of this study was to identify critical elements of dendritic cell (DC) activation and evaluate potential influence on immune activation. Microarray analysis was used to demonstrate limited gene expression changes in H. pylori stimulated bone marrow derived DCs (BMDCs) compared to the BMDCs stimulated with E. coli. IRAK-M, a negative regulator of TLR signaling, was upregulated and we selectedit for investigation of its role in modulating the DC and T cell responses. IRAK-M-/- and wild type BMDC were compared for their response to H. pylori. Cells lacking IRAK-M produced significantly greater amounts of proinflammatory MIP-2 and reduced amounts of immunomodulatory IL-10 than wild type BMDC. IRAK-M-/- cells also demonstrated increased MHC II expression upon activation. However, IRAK-M-/- BMDCs were comparable to wild type BMDCs in inducing T-helper 17 (T(H)17) and T-reg responses as demonstrated in vitro using BMDC CD4+ T cells co-culture assays, and in vivo though the adoptive transfer of CD4(+) FoxP3-GFP T cells into H. pylori infected IRAK-M-/- mice. These results suggest that H. pylori infection leads to the upregulation of anti-inflammatory molecules like IRAK-M and that IRAK-M has a direct impact on innate functions in DCs such as cytokine and costimulation molecule upregulation but may not affect T cell skewing.	[Shiu, Jessica; Czinn, Steven J.; Blanchard, Thomas G.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Kobayashi, Koichi S.] Texas A&M Coll Med, College Stn, TX USA; [Sun, Yezhou] Univ Maryland, Sch Med, Inst Genom Sci, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University System of Maryland; University of Maryland Baltimore	Blanchard, TG (corresponding author), Univ Maryland, Sch Med, Baltimore, MD 21201 USA.	tblanchard@peds.umaryland.edu		Shiu, Jessica/0000-0002-2264-8372; Kobayashi, Koichi/0000-0003-2930-0114	National Institutes of Health [AI-055710, DK-46461]; Canadian Institutes of Health Research [DFSA-236840]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI055710, R01AI055710] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK046461, R01DK046461] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants AI-055710, and DK-46461, and Canadian Institutes of Health Research grant DFSA-236840. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen-Nissen E, 2005, P NATL ACAD SCI USA, V102, P9247, DOI 10.1073/pnas.0502040102; Anderson KM, 2006, J IMMUNOL, V176, P5306, DOI 10.4049/jimmunol.176.9.5306; Arnold IC, 2011, J CLIN INVEST, V121, P3088, DOI 10.1172/JCI45041; Arnold IC, 2011, GASTROENTEROLOGY, V140, P199, DOI 10.1053/j.gastro.2010.06.047; Balaci L, 2007, AM J HUM GENET, V80, P1103, DOI 10.1086/518259; Bamford KB, 1998, GASTROENTEROLOGY, V114, P482, DOI 10.1016/S0016-5085(98)70531-1; Beygo J, 2009, MOL CELL PROBE, V23, P16, DOI 10.1016/j.mcp.2008.10.002; Biswas A, 2011, EUR J IMMUNOL, V41, P182, DOI 10.1002/eji.201040479; Blaser MJ, 2010, GASTROENTEROLOGY, V139, P1819, DOI 10.1053/j.gastro.2010.10.037; Cole TS, 2012, IMMUNOL LETT, V144, P49, DOI 10.1016/j.imlet.2012.03.006; Delyria ES, 2009, GASTROENTEROLOGY, V136, P247, DOI 10.1053/j.gastro.2008.09.017; Deng JC, 2006, J CLIN INVEST, V116, P2532, DOI 10.1172/JCI28054; DOOLEY CP, 1989, NEW ENGL J MED, V321, P1562, DOI 10.1056/NEJM198912073212302; Drakes ML, 2006, INFECT IMMUN, V74, P4624, DOI 10.1128/IAI.00289-06; Eaton KA, 2001, J IMMUNOL, V166, P7456, DOI 10.4049/jimmunol.166.12.7456; FAN XJ, 1994, GUT, V35, P1379, DOI 10.1136/gut.35.10.1379; GENTA RM, 1993, HUM PATHOL, V24, P577, DOI 10.1016/0046-8177(93)90235-9; Hitzler I, 2011, GASTROENTEROLOGY, V141, P186, DOI 10.1053/j.gastro.2011.04.009; Holster IL, 2012, HELICOBACTER, V17, P232, DOI 10.1111/j.1523-5378.2012.00934.x; Hoogerwerf JJ, 2012, MOL MED, V18, P1067, DOI 10.2119/molmed.2011.00450; Horvath DJ, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00056; Kao JY, 2010, GASTROENTEROLOGY, V138, P1046, DOI 10.1053/j.gastro.2009.11.043; Karttunen RA, 1997, SCAND J GASTROENTERO, V32, P22, DOI 10.3109/00365529709025058; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Lee A, 1997, GASTROENTEROLOGY, V112, P1386, DOI 10.1016/S0016-5085(97)70155-0; Lundgren A, 2003, INFECT IMMUN, V71, P1755, DOI 10.1128/IAI.71.4.1755-1762.2003; Lundgren A, 2005, INFECT IMMUN, V73, P523, DOI 10.1128/IAI.73.1.523-531.2005; Mandell L, 2004, INFECT IMMUN, V72, P6446, DOI 10.1128/IAI.72.11.6446-6454.2004; MARSHALL BJ, 1995, JAMA-J AM MED ASSOC, V274, P1064, DOI 10.1001/jama.274.13.1064; MARSHALL BJ, 1984, LANCET, V1, P1311; Nakashima K, 2006, J HUM GENET, V51, P284, DOI 10.1007/s10038-005-0358-1; Oertli M, 2012, J CLIN INVEST, V122, P1082, DOI 10.1172/JCI61029; PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603; Rad R, 2007, GASTROENTEROLOGY, V133, P150, DOI 10.1053/j.gastro.2007.04.071; Rad R, 2006, GASTROENTEROLOGY, V131, P525, DOI 10.1053/j.gastro.2006.05.001; Rad R, 2009, GASTROENTEROLOGY, V136, P2247, DOI 10.1053/j.gastro.2009.02.066; Raghavan S, 2004, SCAND J IMMUNOL, V60, P82, DOI 10.1111/j.0300-9475.2004.01447.x; Raghavan S, 2003, CLIN EXP IMMUNOL, V132, P393, DOI 10.1046/j.1365-2249.2003.02177.x; Rahn W, 2004, VACCINE, V23, P807, DOI 10.1016/j.vaccine.2004.06.051; Roth KA, 1999, J IMMUNOL, V163, P1490; Seki M, 2010, J IMMUNOL, V184, P1410, DOI 10.4049/jimmunol.0901709; Shiomi S, 2008, HELICOBACTER, V13, P518, DOI 10.1111/j.1523-5378.2008.00629.x; Skupsky J, 2010, MOL THER, V18, P1527, DOI 10.1038/mt.2010.95; Smith SM, 2011, J IMMUNOL, V186, P2462, DOI 10.4049/jimmunol.1000864; Sonnenberg A, 2010, GASTROENTEROLOGY, V139, P1894, DOI 10.1053/j.gastro.2010.08.018; Steinman RM, 2012, ANNU REV IMMUNOL, V30, P1, DOI 10.1146/annurev-immunol-100311-102839; STEINMAN RM, 1973, J EXP MED, V137, P1142, DOI 10.1084/jem.137.5.1142; Suda Y, 1997, J BIOCHEM-TOKYO, V121, P1129; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Takahashi N, 2010, J PERIODONTAL RES, V45, P512, DOI 10.1111/j.1600-0765.2009.01266.x; Tran AX, 2005, J ENDOTOXIN RES, V11, P161, DOI 10.1179/096805105X37349; Turnis ME, 2010, J IMMUNOL, V185, P4223, DOI 10.4049/jimmunol.0903507; van der Windt GJW, 2012, J INFECT DIS, V205, P1849, DOI 10.1093/infdis/jis290; van 't Veer C, 2007, J IMMUNOL, V179, P7110, DOI 10.4049/jimmunol.179.10.7110; Velin D, 2009, GASTROENTEROLOGY, V136, P2237, DOI 10.1053/j.gastro.2009.02.077; Wesche H, 1999, J BIOL CHEM, V274, P19403, DOI 10.1074/jbc.274.27.19403; World Health Organization, 1994, IARC MON EV CARC RIS, P177; WOTHERSPOON AC, 1991, LANCET, V338, P1175, DOI 10.1016/0140-6736(91)92035-Z; YAMADA T, 1994, JAMA-J AM MED ASSOC, V272, P65, DOI 10.1001/jama.272.1.65	59	19	21	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66914	10.1371/journal.pone.0066914	http://dx.doi.org/10.1371/journal.pone.0066914			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776703	Green Published, gold, Green Submitted			2022-12-27	WOS:000320755400158
J	Zhang, C; Suckow, AT; Chessler, SD				Zhang, Charles; Suckow, Arthur T.; Chessler, Steven D.			Altered Pancreatic Islet Function and Morphology in Mice Lacking the Beta-Cell Surface Protein Neuroligin-2	PLOS ONE			English	Article							INSULIN-SECRETION; GLUCOSE; RAT; EXPRESSION; NEUREXIN; SENSITIVITY; DEFICIENCY; MATURATION; MUTATIONS; PATHWAYS	Neuroligin-2 is a transmembrane, cell-surface protein originally identified as an inhibitory synapse-associated protein in the central nervous system. Neuroligin-2 is also present on the pancreatic beta-cell surface, and there it engages in transcellular interactions that drive functional maturation of the insulin secretory machinery; these are necessary for normal insulin secretion. The effects of neuroligin-2 deficiency on brain and neuronal function and morphology and on behavior and coordination have been extensively characterized using neuroligin-2 knockout mice. The effects of absent neuroligin-2 expression on islet development and function, however, are unknown. Here, to help test whether neuroligin-2 is necessary for normal islet development, we characterized islet morphology in mice lacking neuroligin-2. To test whether-as predicted by our earlier co-culture studies-absence of neuroligin-2 impairs beta cell function, we compared glucose-stimulated insulin secretion by islets from mutant and wild-type mice. Our results show that while islets from neuroligin-2-deficient mice do not to appear to differ architecturally from wild-type islets, they are smaller, fewer in number, and contain beta cells with lower insulin content. Evaluation of transcript levels suggests that upregulation of neuroligin-1 helps compensate for loss of neuroligin-2. Surprisingly, under both basal and stimulating glucose levels, isolated islets from the knockout mice secreted more of their intracellular insulin content. Rat islets with shRNA-mediated neuroligin-2 knockdown also exhibited increased insulin secretion. Neurexin transcript levels were lower in the knockout mice and, consistent with our prior finding that neurexin is a key constituent of the insulin granule docking machinery, insulin granule docking was reduced. These results indicate that neuroligin-2 is not necessary for the formation of pancreatic islets but that neuroligin-2 influences islet size and number. Neuroligin-2-perhaps through its effects on the expression and/or activity of its binding partner neurexin-promotes insulin granule docking, a known constraint on insulin secretion.	[Zhang, Charles; Chessler, Steven D.] Univ Calif Irvine, Sch Med, Dept Med, Irvine, CA 92717 USA; [Suckow, Arthur T.] Univ Calif San Diego, Pediat Diabet Res Ctr, La Jolla, CA 92093 USA	University of California System; University of California Irvine; University of California System; University of California San Diego	Chessler, SD (corresponding author), Univ Calif Irvine, Sch Med, Dept Med, Irvine, CA 92717 USA.	s.chessler@uci.edu			National Institutes of Health [R01DK080971]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080971, P30DK017047] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grant R01DK080971 (to S. D. C; nih.gov). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaneya Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012486; Blundell J, 2009, GENES BRAIN BEHAV, V8, P114, DOI 10.1111/j.1601-183X.2008.00455.x; Bosco D, 2011, PHYSIOL REV, V91, P1393, DOI 10.1152/physrev.00027.2010; Calabrese A, 2004, EXP CELL RES, V294, P379, DOI 10.1016/j.yexcr.2003.12.007; Chessler SD, 2000, GABA IN THE NERVOUS SYSTEM: THE VIEW AT FIFTY YEARS, P471; Chessler SD, 2002, DIABETES, V51, P1763, DOI 10.2337/diabetes.51.6.1763; Chih B, 2004, HUM MOL GENET, V13, P1471, DOI 10.1093/hmg/ddh158; CIRULLI V, 1994, J CELL SCI, V107, P1429; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; Dalva MB, 2007, NAT REV NEUROSCI, V8, P206, DOI 10.1038/nrn2075; Dean C, 2005, TRENDS NEUROSCI; Efanov AM, 2004, DIABETES, V53, pS75, DOI 10.2337/diabetes.53.suppl_3.S75; Esni F, 1999, J CELL BIOL, V144, P325, DOI 10.1083/jcb.144.2.325; Etherton MR, 2011, EMBO J, V30, P2908, DOI 10.1038/emboj.2011.182; Gomi H, 2005, J CELL BIOL, V171, P99, DOI 10.1083/jcb.200505179; Grouwels G, 2012, DIABETOLOGIA, V55, P2016, DOI 10.1007/s00125-012-2542-0; Hoon M, 2009, J NEUROSCI, V29, P8039, DOI 10.1523/JNEUROSCI.0534-09.2009; Huang HH, 2011, ISLETS, V3, P6, DOI 10.4161/isl.3.1.14132; Ichtchenko K, 1996, J BIOL CHEM, V271, P2676, DOI 10.1074/jbc.271.5.2676; Jain R, 2009, DIABETES OBES METAB, V11, P159, DOI 10.1111/j.1463-1326.2009.01102.x; Jaques F, 2008, ENDOCRINOLOGY, V149, P2494, DOI 10.1210/en.2007-0974; Jedlicka P, 2011, CEREB CORTEX, V21, P357, DOI 10.1093/cercor/bhq100; Kasai K, 2008, TRAFFIC, V9, P1191, DOI 10.1111/j.1600-0854.2008.00744.x; Kelly C, 2011, ISLETS, V3, P41, DOI 10.4161/isl.3.2.14805; Khaldi MZ, 2004, AM J PHYSIOL-ENDOC M, V287, pE207, DOI 10.1152/ajpendo.00426.2003; KIM J, 1993, DIABETES, V42, P1799, DOI 10.2337/diabetes.42.12.1799; Konstantinova I, 2007, CELL, V129, P359, DOI 10.1016/j.cell.2007.02.044; Kwan EP, 2006, DIABETES, V55, P1421, DOI 10.2337/db05-1263; Larrieta E, 2012, J NUTR BIOCHEM, V23, P392, DOI 10.1016/j.jnutbio.2011.01.003; Li DS, 2009, NAT PROTOC, V4, P1649, DOI 10.1038/nprot.2009.150; Lips ES, 2012, MOL PSYCHIATR, V17, P996, DOI 10.1038/mp.2011.117; Morton GJ, 2011, PHYSIOL REV, V91, P389, DOI 10.1152/physrev.00007.2010; Mosedale M, 2012, J BIOL CHEM, V287, P6350, DOI 10.1074/jbc.M111.299081; Ohara-Imaizumi M, 2007, J CELL BIOL, V177, P695, DOI 10.1083/jcb.200608132; Preitner F, 2004, J CLIN INVEST, V113, P635, DOI 10.1172/JCI200420518; Satin LS, 1998, ENDOCRINE, V8, P213, DOI 10.1385/ENDO:8:3:213; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; STEINKE J, 1972, METABOLISM, V21, P465, DOI 10.1016/0026-0495(72)90058-3; Straub SG, 2002, DIABETES-METAB RES, V18, P451, DOI 10.1002/dmrr.329; Suckow AT, 2012, J BIOL CHEM, V287, P19816, DOI 10.1074/jbc.M111.280537; Suckow AT, 2010, AM J PHYSIOL-ENDOC M, V299, pE23, DOI 10.1152/ajpendo.00664.2009; Suckow AT, 2008, ENDOCRINOLOGY, V149, P6006, DOI 10.1210/en.2008-0274; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Sun CC, 2011, HUM MOL GENET, V20, P3042, DOI 10.1093/hmg/ddr208; Sweet IR, 2006, DIABETES, V55, P3509, DOI 10.2337/db06-0400; Sweet IR, 2004, DIABETES, V53, P401, DOI 10.2337/diabetes.53.2.401; Thorens B, 2010, DIABETES METAB, V36, pS45, DOI 10.1016/S1262-3636(10)70466-3; Tsimikas S, 2011, J AM COLL CARDIOL, V58, P1715, DOI 10.1016/j.jacc.2011.07.017; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Wohr M, 2012, BEHAV BRAIN RES; Zhao AZ, 2010, DIABETES, V59, P2522, DOI 10.2337/db09-1719	52	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65711	10.1371/journal.pone.0065711	http://dx.doi.org/10.1371/journal.pone.0065711			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776533	Green Published, gold			2022-12-27	WOS:000320755400061
J	Zhang, J; Xie, PH; Lascoux, M; Meagher, TR; Liu, JQ				Zhang, Jian; Xie, Penghui; Lascoux, Martin; Meagher, Thomas R.; Liu, Jianquan			Rapidly Evolving Genes and Stress Adaptation of Two Desert Poplars, Populus euphratica and P. pruinosa	PLOS ONE			English	Article							COMPARATIVE GENOMICS; SELECTION; SUBSTITUTION; EVOLUTION; TOOL; TRANSCRIPTOMES; EXPRESSION; RESISTANCE; UBIQUITIN; SYSTEM	Understanding which genes have evolved rapidly with the recent tree speciation in arid habitats can provide valuable insights into different adaptation mechanisms. We employed a comparative evolutionary analysis of expressed sequence tags (ESTs) from two desert poplars, Populus pruinosa and P. euphratica, which diverged in the recent past. Following an approach taken previously with P. euphratica, we conducted a deep transcriptomic analysis of P. pruinosa. To maximize representation of conditional transcripts, mRNA was obtained from living tissues of two types of callus and desert-grown trees. De novo assembly generated 114,866 high-quality unique sequences using Solexa sequence data. Following assembly we were able to identify, with high confidence, 2859 orthologous sequence pairs between the two species. Based on the ratio of nonsynonymous (Ka) to synonymous (Ks) substitutions, we identified a total of 84 (2.9%) ortholog pairs exhibiting rapid evolution with signs of strong selection (Ka/Ks>1). Genes homologous to these ortholog pairs in model species are mainly involved in 'responses to stress', 'ubiquitin-dependent protein catabolic processes', and 'biological regulation'. Finally, we examined the expression patterns of candidate genes with rapid evolution in response to salt stress. Only one pair of orthologs up-regulated their expression in both species while three and four genes were found to up-regulated in P. pruinosa and in P. euphratica respectively. Our findings together suggest that the genes at the same category or network but with differentiated expressions or functions may have evolved rapidly during adaptive divergence of the two species to differentiated salty desert habitats.	[Zhang, Jian; Xie, Penghui; Liu, Jianquan] Lanzhou Univ, Sch Life Sci, Mol Ecol Grp, State Key Lab Grassland Agroecosyst, Lanzhou 730000, Gansu, Peoples R China; [Lascoux, Martin] Chinese Acad Sci, CAS MPG Partner Inst Computat Biol, Lab Evolutionary Genom, Shanghai, Peoples R China; [Lascoux, Martin] Uppsala Univ, Evolutionary Biol Ctr, Program Evolutionary Funct Genom, Uppsala, Sweden; [Meagher, Thomas R.] Univ St Andrews, Sch Biol, St Andrews KY16 9AJ, Fife, Scotland	Lanzhou University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Uppsala University; University of St Andrews	Liu, JQ (corresponding author), Lanzhou Univ, Sch Life Sci, Mol Ecol Grp, State Key Lab Grassland Agroecosyst, Lanzhou 730000, Gansu, Peoples R China.	liujq@nwipb.ac.cn		Lascoux, Martin/0000-0003-1699-9042; Zhang, Jian/0000-0002-0790-4462	Ministry of Science and Technology (National Key Project for Basic Research) [2012CB114504]; Ministry of Science and Technology (National High Technology Research and Development Program of China) [2013AA102605]; International Collaboration 111 Projects of China; Fundamental Research Funds for the Central Universities [lzujbky-2009-k05]	Ministry of Science and Technology (National Key Project for Basic Research); Ministry of Science and Technology (National High Technology Research and Development Program of China); International Collaboration 111 Projects of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	Financial support was provided by the Ministry of Science and Technology (National Key Project for Basic Research 2012CB114504 and the National High Technology Research and Development Program of China No. 2013AA102605), the International Collaboration 111 Projects of China and the Fundamental Research Funds for the Central Universities (lzujbky-2009-k05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenhoff AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000262; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barakat A, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-38; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Chen SF, 2011, MAR GENOM, V4, P129, DOI 10.1016/j.margen.2011.03.005; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dreher K, 2007, ANN BOT-LONDON, V99, P787, DOI 10.1093/aob/mcl255; Eckenwalder James E., 1996, P7; Ellegren H, 2008, MOL ECOL, V17, P4586, DOI 10.1111/j.1365-294X.2008.03954.x; Elmer KR, 2010, MOL ECOL, V19, P197, DOI 10.1111/j.1365-294X.2009.04488.x; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Guo YS, 2010, PLANTA, V232, P1499, DOI 10.1007/s00425-010-1271-1; Heras J, 2011, MAR GENOM, V4, P93, DOI 10.1016/j.margen.2011.02.001; Huang JZ, 2012, DNA RES, V19, P195, DOI 10.1093/dnares/dss004; Hughes AL, 1999, ADAPTIVE EVOLUTION G, p[ix, 270]; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kunstner A, 2010, MOL ECOL, V19, P266, DOI 10.1111/j.1365-294X.2009.04487.x; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liu JianPing, 2004, Scientia Silvae Sinicae, V40, P165; Loytynoja A, 2005, P NATL ACAD SCI USA, V102, P10557, DOI 10.1073/pnas.0409137102; MIYATA T, 1979, J MOL EVOL, V12, P219, DOI 10.1007/BF01732340; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; NEI M, 1986, MOL BIOL EVOL, V3, P418; Oh DH, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-3-241, 10.1186/gb4003]; Oleksiak MF, 2002, NAT GENET, V32, P261, DOI 10.1038/ng983; Ottow EA, 2005, PLANT PHYSIOL, V139, P1762, DOI 10.1104/pp.105.069971; Overbeek R, 1999, P NATL ACAD SCI USA, V96, P2896, DOI 10.1073/pnas.96.6.2896; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Qiu Q, 2011, TREE PHYSIOL, V31, P452, DOI 10.1093/treephys/tpr015; Rokas A, 2009, TRENDS ECOL EVOL, V24, P192, DOI 10.1016/j.tree.2008.11.004; Schranz ME, 2007, CURR OPIN PLANT BIOL, V10, P168, DOI 10.1016/j.pbi.2007.01.014; Shi CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-131; Smalle J, 2004, ANNU REV PLANT BIOL, V55, P555, DOI 10.1146/annurev.arplant.55.031903.141801; Sutton KA, 1997, J MOL EVOL, V45, P579, DOI 10.1007/PL00006262; Vierstra RD, 2009, NAT REV MOL CELL BIO, V10, P385, DOI 10.1038/nrm2688; [王海珍 WANG Haizhen], 2007, [干旱地区农业研究, Agricultural Research in the Arid Areas], V25, P125; Wang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026530; Wang S, 1995, ADV POPLAR RES 1991; Wolf JBW, 2010, MOL ECOL, V19, P162, DOI 10.1111/j.1365-294X.2009.04471.x; Wu YX, 2007, PLANT MOL BIOL, V65, P1, DOI 10.1007/s11103-007-9170-y; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 2000, GENETICS, V155, P431; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhang F, 2004, IN VITRO CELL DEV-PL, V40, P491, DOI 10.1079/IVP2004546; Zhang F, 2007, PLANT CELL ENVIRON, V30, P775, DOI 10.1111/j.1365-3040.2007.01667.x; Zhang Zhang, 2006, Genomics Proteomics & Bioinformatics, V4, P259, DOI 10.1016/S1672-0229(07)60007-2	49	34	35	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66370	10.1371/journal.pone.0066370	http://dx.doi.org/10.1371/journal.pone.0066370			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776666	Green Published, gold, Green Submitted			2022-12-27	WOS:000320755400142
J	Barik, S; Banerjee, S; Mallick, A; Goswami, KK; Roy, S; Bose, A; Baral, R				Barik, Subhasis; Banerjee, Saptak; Mallick, Atanu; Goswami, Kuntal Kanti; Roy, Soumyabrata; Bose, Anamika; Baral, Rathindranath			Normalization of Tumor Microenvironment by Neem Leaf Glycoprotein Potentiates Effector T Cell Functions and Therapeutically Intervenes in the Growth of Mouse Sarcoma	PLOS ONE			English	Article							MURINE EHRLICH CARCINOMA; AZADIRACHTA-INDICA; DENDRITIC CELLS; B16 MELANOMA; ADOPTIVE IMMUNOTHERAPY; ANTIGEN PRESENTATION; IMMUNE-RESPONSES; NK CELLS; CANCER; INHIBITION	We have observed restriction of the murine sarcoma growth by therapeutic intervention of neem leaf glycoprotein (NLGP). In order to evaluate the mechanism of tumor growth restriction, here, we have analyzed tumor microenvironment (TME) from sarcoma bearing mice with NLGP therapy (NLGP-TME, in comparison to PBS-TME). Analysis of cytokine milieu within TME revealed IL-10, TGF beta, IL-6 rich type 2 characters was switched to type 1 microenvironment with dominance of IFN gamma secretion within NLGP-TME. Proportion of CD8(+) T cells was increased within NLGP-TME and these T cells were protected from TME-induced anergy by NLGP, as indicated by higher expression of rho NFAT and inhibit related downstream signaling. Moreover, low expression of FasR(+) cells within CD8(+) T cell population denotes prevention from activation induced cell death. Using CFSE as a probe, better migration of T cells was noted within TME from NLGP treated mice than PBS cohort. CD8(+) T cells isolated from NLGP-TME exhibited greater cytotoxicity to sarcoma cells in vitro and these cells show higher expression of cytotoxicity related molecules, perforin and granzyme B. Adoptive transfer of NLGP-TME exposed T cells, but not PBS-TME exposed cells in mice, is able to significantly inhibit the growth of sarcoma in vivo. Such tumor growth inhibition by NLGP-TME exposed T cells was not observed when mice were depleted for CD8(+) T cells. Accumulated evidences strongly suggest NLGP mediated normalization of TME allows T cells to perform optimally to inhibit the tumor growth.	[Barik, Subhasis; Banerjee, Saptak; Mallick, Atanu; Goswami, Kuntal Kanti; Roy, Soumyabrata; Baral, Rathindranath] CNCI, Dept Immunoregulat & Immunodiagnost, Kolkata, India; [Bose, Anamika] CIT Scheme, Bose Inst, Dept Mol Med, Kolkata, India	Department of Science & Technology (India); Bose Institute	Baral, R (corresponding author), CNCI, Dept Immunoregulat & Immunodiagnost, Kolkata, India.	baralrathin@hotmail.com	Banerjee, Dr Saptak/HDO-6987-2022	Banerjee, Dr Saptak/0000-0001-9211-2074; Barik, Subhasis/0000-0002-0488-0434	Council of Scientific and Industrial Research, New Delhi [09/030(0063)/2011-EMR-I, 09/030(0050)/2008-EMR-I, 8463A, 37(1524)/12/EMR-II]; Indian Council of Medical Research, New Delhi [59/6/2011/BMS/TRM]	Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India); Indian Council of Medical Research, New Delhi(Indian Council of Medical Research (ICMR))	This work was partially supported by Council of Scientific and Industrial Research, New Delhi, Grant 09/030(0063)/2011-EMR-I to S Barik, 09/030(0050)/2008-EMR-I to S Banerjee, Scientists's Pool Scheme No: 8463A to AB, 37(1524)/12/EMR-II and Indian Council of Medical Research, New Delhi, Grant- 59/6/2011/BMS/TRM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey JL, 1967, TECHNIQUES PROTEIN C, P340; Baral R, 2005, INT IMMUNOPHARMACOL, V5, P1343, DOI 10.1016/j.intimp.2005.03.008; Baral R, 2004, INT IMMUNOPHARMACOL, V4, P355, DOI 10.1016/j.intimp.2003.09.006; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Biswas K, 2002, CURR SCI INDIA, V82, P1336; Bose A, 2009, HUM IMMUNOL, V70, P6, DOI 10.1016/j.humimm.2008.09.004; Bose A, 2009, J IMMUNOTHER, V32, P42, DOI 10.1097/CJI.0b013e31818e997d; Chakraborty K, 2008, INT IMMUNOPHARMACOL, V8, P330, DOI 10.1016/j.intimp.2007.10.015; Chakraborty K, 2010, CELL MOL IMMUNOL, V7, P396, DOI 10.1038/cmi.2010.29; Chakraborty T, 2011, IMMUNOTHERAPY-UK, V3, P949, DOI [10.2217/IMT.11.81, 10.2217/imt.11.81]; Ebert LA, 2005, MOL IMMUNOL, V42, P799, DOI 10.1016/j.molimm.2004.06.040; Egeblad M, 2010, DEV CELL, V18, P884, DOI 10.1016/j.devcel.2010.05.012; FUJIWARA T, 1982, CHEM PHARM BULL, V30, P4025; Goswami S, 2010, VACCINE, V28, P1241, DOI 10.1016/j.vaccine.2009.11.018; Haque E, 2006, IMMUNOBIOLOGY, V211, P721, DOI 10.1016/j.imbio.2006.02.005; Hayashi RJ, 1998, J IMMUNOL, V160, P33; Hinrichs CS, 2008, BLOOD, V111, P5326, DOI 10.1182/blood-2007-09-113050; KERBEL RS, 1991, BIOESSAYS, V13, P31, DOI 10.1002/bies.950130106; Komita H, 2008, CANC RES; Lorusso G, 2008, HISTOCHEM CELL BIOL, V130, P1091, DOI 10.1007/s00418-008-0530-8; Lu B, 2008, CELL DEATH DIFFER, V15, P70, DOI 10.1038/sj.cdd.4402274; Mallick A, 2013, PLOS ONE, V8; Mallick A, 2013, INT IMMUNOPHARMACOL, V15, P73, DOI 10.1016/j.intimp.2012.11.006; Mbeunkui F, 2009, CANCER CHEMOTH PHARM, V63, P571, DOI 10.1007/s00280-008-0881-9; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Paul R, 2011, CANCER BIOL THER, V12, P467, DOI 10.4161/cbt.12.6.16850; Prager GW, 2012, TRANSL LUNG CANCER R, V1, P14, DOI 10.3978/j.issn.2218-6751.2011.11.02; Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0; ROSENBERG SA, 1986, SCIENCE, V233, P1318, DOI 10.1126/science.3489291; Sarkar K, 2008, VACCINE, V26, P4352, DOI 10.1016/j.vaccine.2008.06.048; Sarkar K, 2010, INT IMMUNOPHARMACOL, V10, P865, DOI 10.1016/j.intimp.2010.04.024; Sarkar K, 2009, INT IMMUNOPHARMACOL, V9, P753, DOI 10.1016/j.intimp.2009.02.016; Stadler WM, 1998, J CLIN ONCOL, V16, P1820, DOI 10.1200/JCO.1998.16.5.1820; Whiteside TL, 2006, SEMIN CANCER BIOL, V16, P3, DOI 10.1016/j.semcancer.2005.07.008; Witz IP, 2009, CANCER MICROENVIRON, V2, pS9, DOI 10.1007/s12307-009-0025-8; Wood KJ, 2003, NAT REV IMMUNOL, V3, P199, DOI 10.1038/nri1027; Xu L, 2010, CLIN IMMUNOL, V135, P466, DOI 10.1016/j.clim.2010.01.014; Yamanaka R, 2003, BRIT J CANCER, V89, P1172, DOI 10.1038/sj.bjc.6601268; Yu JY, 2009, INT J BIOL SCI, V5, P135; Zamarron BF, 2011, INT J BIOL SCI, V7, P651, DOI 10.7150/ijbs.7.651; Zheng Y, 2008, EMBO REP, V9, P50, DOI 10.1038/sj.embor.7401138	41	28	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66501	10.1371/journal.pone.0066501	http://dx.doi.org/10.1371/journal.pone.0066501			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785504	Green Published, Green Submitted, gold			2022-12-27	WOS:000321038800017
J	Bottos, KM; Oliveira, AG; Bersanetti, PA; Nogueira, RF; Lima, AAS; Cardillo, JA; Schor, P; Chamon, W				Bottos, Katia M.; Oliveira, Anselmo G.; Bersanetti, Patricia A.; Nogueira, Regina F.; Lima-Filho, Acacio A. S.; Cardillo, Jose A.; Schor, Paulo; Chamon, Wallace			Corneal Absorption of a New Riboflavin-Nanostructured System for Transepithelial Collagen Cross-Linking	PLOS ONE			English	Article							ULTRAVIOLET-A; BENZALKONIUM CHLORIDE; OCULAR SURFACE; CONTACT-LENS; IN-VITRO; KERATITIS; MICROEMULSIONS; NANOEMULSIONS; BACTERIAL; PORCINE	Corneal collagen cross-linking (CXL) has been described as a promising therapy for keratoconus. According to standard CXL protocol, epithelium should be debrided before treatment to allow penetration of riboflavin into the corneal stroma. However, removal of the epithelium can increase procedure risks. In this study we aim to evaluate stromal penetration of a biocompatible riboflavin-based nanoemulsion system (riboflavin-5-phosphate and riboflavin-base) in rabbit corneas with intact epithelium. Two riboflavin nanoemulsions were developed. Transmittance and absorption coefficient were measured on corneas with intact epithelia after 30, 60, 120, 180, and 240 minutes following exposure to either the nanoemulsions or standard 0.1% or 1% riboflavin-dextran solutions. For the nanoemulsions, the epithelium was removed after measurements to assure that the riboflavin had passed through the hydrophobic epithelium and retained within the stroma. Results were compared to de-epithelialized corneas exposed to 0.1% riboflavin solution and to the same riboflavin nanoemulsions for 30 minutes (standard protocol). Mean transmittance and absorption measured in epithelialized corneas receiving the standard 0.1% riboflavin solution did not reach the levels found on the debrided corneas using the standard technique. Neither increasing the time of exposure nor the concentration of the riboflavin solution from 0.1% to 1% improved riboflavin penetration through the epithelium. When using riboflavin-5-phosphate nanoemulsion for 240 minutes, we found no difference between the mean absorption coefficients to the standard cross-linking protocol (p = 0.54). Riboflavin nanoemulsion was able to penetrate the corneal epithelium, achieving, after 240 minutes, greater stromal concentration when compared to debrided corneas with the standard protocol (p = 0.002). The riboflavin-5-phosphate nanoemulsion diffused better into the stroma than the riboflavin-base nanoemulsion.	[Bottos, Katia M.; Lima-Filho, Acacio A. S.; Cardillo, Jose A.; Schor, Paulo; Chamon, Wallace] Fed Univ Sao Paulo UNIFESP, Paulista Sch Med, Dept Ophthalmol, Sao Paulo, Brazil; [Oliveira, Anselmo G.] Sao Paulo State Univ, UNESP, Sch Pharmaceut Sci, Dept Pharmaceut, Araraquara, SP, Brazil; [Bersanetti, Patricia A.; Nogueira, Regina F.] Fed Univ Sao Paulo UNIFESP, Paulista Sch Med, Dept Ophthalmol, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Estadual Paulista; Universidade Federal de Sao Paulo (UNIFESP)	Bersanetti, PA (corresponding author), Fed Univ Sao Paulo UNIFESP, Paulista Sch Med, Dept Ophthalmol, Sao Paulo, Brazil.	bersanetti@unifesp.br	Oliveira, Anselmo/B-8284-2013; Chamon, Wallace/A-5400-2010; de Souza Lima Filho, Acácio Alves/C-7189-2012; Bersanetti, Patrícia A/B-9703-2012; Schor, Paulo/C-6555-2012	Oliveira, Anselmo/0000-0002-0107-9940; Chamon, Wallace/0000-0002-2528-0526; de Souza Lima Filho, Acácio Alves/0000-0003-1802-9592; Bersanetti, Patrícia A/0000-0002-9262-2151; Schor, Paulo/0000-0002-3999-4706; Cardillo, Jose Augusto/0000-0002-5791-3201	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [BEX 1325-09-4]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported in part by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) BEX 1325-09-4. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammar DA, 2010, ADV THER, V27, P837, DOI 10.1007/s12325-010-0070-1; Ammar HO, 2009, AAPS PHARMSCITECH, V10, P808, DOI 10.1208/s12249-009-9268-4; Badawi AA, 2008, ARCH PHARM RES, V31, P1040, DOI 10.1007/s12272-001-1266-6; Baiocchi S, 2009, J CATARACT REFR SURG, V35, P893, DOI 10.1016/j.jcrs.2009.01.009; Bottos KM, 2008, J REFRACT SURG, V24, pS715, DOI 10.3928/1081597X-20080901-14; Bottos KM, 2011, ARQ BRAS OFTALMOL, V74, P348, DOI 10.1590/S0004-27492011000500008; Calvo P, 1996, J PHARM SCI, V85, P530, DOI 10.1021/js950474+; Caporossi A, 2012, EUR J OPHTHALMOL, V22, pS81, DOI 10.5301/ejo.5000125; Chan CCK, 2007, J CATARACT REFR SURG, V33, P75, DOI 10.1016/j.jcrs.2006.09.012; Formariz TP, 2008, COLLOID SURFACE B, V63, P287, DOI 10.1016/j.colsurfb.2007.12.021; Formariz TP, 2010, COLLOID SURFACE B, V77, P47, DOI 10.1016/j.colsurfb.2010.01.004; Franzini CM, 2012, J BIOMED NANOTECHNOL, V8, P350, DOI 10.1166/jbn.2012.1435; Goldich Y, 2010, CORNEA, V29, P409, DOI 10.1097/ICO.0b013e3181bd9f8c; Hayes S, 2008, J CATARACT REFR SURG, V34, P657, DOI 10.1016/j.jcrs.2008.02.002; Jankov MR, 2008, ARQ BRAS OFTALMOL, V71, P813, DOI 10.1590/S0004-27492008000600009; Kanellopoulos AJ, 2009, J REFRACT SURG, V25, P1034, DOI 10.3928/1081597X-20090901-02; Kim JR, 2011, JPN J OPHTHALMOL, V55, P283, DOI 10.1007/s10384-011-0008-4; Kolozsvari L, 2002, INVEST OPHTH VIS SCI, V43, P2165; Koppen C, 2010, EYE CONTACT LENS, V36, P77, DOI 10.1097/ICL.0b013e3181d0b74b; Krueger RR, 2008, J REFRACT SURG, V24, pS730, DOI 10.3928/1081597X-20080901-17; Kymionis GD, 2007, J CATARACT REFR SURG, V33, P2135, DOI 10.1016/j.jcrs.2007.06.070; Kymionis GD, 2007, J CATARACT REFR SURG, V33, P1982, DOI 10.1016/j.jcrs.2007.06.036; Leccisotti A, 2010, J REFRACT SURG, V26, P942, DOI 10.3928/1081597X-20100212-09; Loch C, 2012, EUR J PHARM SCI, V47, P131, DOI 10.1016/j.ejps.2012.05.007; Martins SAR, 2008, INVEST OPHTH VIS SCI, V49, P3402, DOI 10.1167/iovs.07-1592; Mason TG, 2006, J PHYS-CONDENS MAT, V18, pR635, DOI 10.1088/0953-8984/18/41/R01; Morrison PWJ, 2013, MOL PHARMACEUT, V10, P756, DOI 10.1021/mp3005963; Oliveira AG, 2010, COLLOID SURFACE B, V79, P372, DOI 10.1016/j.colsurfb.2010.04.020; OLIVEIRA AG, 1991, J PHYS ORG CHEM, V4, P19, DOI 10.1002/poc.610040105; Paganelli F, 2010, EXPERT OPIN DRUG DEL, V7, P955, DOI 10.1517/17425247.2010.498817; Pestana KC, 2008, COLLOID SURFACE B, V66, P253, DOI 10.1016/j.colsurfb.2008.06.016; Pollhammer M, 2009, J CATARACT REFR SURG, V35, P588, DOI 10.1016/j.jcrs.2008.09.029; Rama P, 2009, J CATARACT REFR SURG, V35, P788, DOI 10.1016/j.jcrs.2008.09.035; Samaras K, 2009, J REFRACT SURG, V25, P771, DOI 10.3928/1081597X-20090813-03; Sarkar J, 2012, INVEST OPHTH VIS SCI, V53, P1792, DOI 10.1167/iovs.11-8775; Shigeyasu C, 2012, CORNEA, V31, P59, DOI 10.1097/ICO.0b013e318218237e; Spoerl E, 2007, CORNEA, V26, P385, DOI 10.1097/ICO.0b013e3180334f78; Wollensak G, 2003, AM J OPHTHALMOL, V135, P620, DOI 10.1016/S0002-9394(02)02220-1; Wollensak G, 2010, J CATARACT REFR SURG, V36, P114, DOI 10.1016/j.jcrs.2009.07.044; Wollensak G, 2009, J CATARACT REFR SURG, V35, P540, DOI 10.1016/j.jcrs.2008.11.036; Zamora KV, 2009, CORNEA, V28, P474, DOI 10.1097/ICO.0b013e31818d381a; Zhang YT, 2012, INVEST OPHTH VIS SCI, V53, P2620, DOI 10.1167/iovs.12-9537	42	34	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66408	10.1371/journal.pone.0066408	http://dx.doi.org/10.1371/journal.pone.0066408			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785497	Green Published, Green Submitted, gold			2022-12-27	WOS:000321038800025
J	Briet, OJT; Amerasinghe, PH; Vounatsou, P				Briet, Olivier J. T.; Amerasinghe, Priyanie H.; Vounatsou, Penelope			Generalized Seasonal Autoregressive Integrated Moving Average Models for Count Data with Application to Malaria Time Series with Low Case Numbers	PLOS ONE			English	Article							POISSON REGRESSION; DISEASE; PREDICTION; RISK	Introduction: With the renewed drive towards malaria elimination, there is a need for improved surveillance tools. While time series analysis is an important tool for surveillance, prediction and for measuring interventions' impact, approximations by commonly used Gaussian methods are prone to inaccuracies when case counts are low. Therefore, statistical methods appropriate for count data are required, especially during "consolidation" and "pre-elimination" phases. Methods: Generalized autoregressive moving average (GARMA) models were extended to generalized seasonal autoregressive integrated moving average (GSARIMA) models for parsimonious observation-driven modelling of non Gaussian, non stationary and/or seasonal time series of count data. The models were applied to monthly malaria case time series in a district in Sri Lanka, where malaria has decreased dramatically in recent years. Results: The malaria series showed long-term changes in the mean, unstable variance and seasonality. After fitting negative-binomial Bayesian models, both a GSARIMA and a GARIMA deterministic seasonality model were selected based on different criteria. Posterior predictive distributions indicated that negative-binomial models provided better predictions than Gaussian models, especially when counts were low. The G(S)ARIMA models were able to capture the autocorrelation in the series. Conclusions: G(S)ARIMA models may be particularly useful in the drive towards malaria elimination, since episode count series are often seasonal and non-stationary, especially when control is increased. Although building and fitting GSARIMA models is laborious, they may provide more realistic prediction distributions than do Gaussian methods and may be more suitable when counts are low.	[Briet, Olivier J. T.] Int Water Management Inst, Colombo, Sri Lanka; [Briet, Olivier J. T.; Vounatsou, Penelope] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland; [Briet, Olivier J. T.; Vounatsou, Penelope] Univ Basel, Basel, Switzerland; [Amerasinghe, Priyanie H.] Int Water Management Inst, Sub Reg Off South Asia, Patancheru, Andhra Pradesh, India	CGIAR; International Water Management Institute (IWMI); University of Basel; Swiss Tropical & Public Health Institute; University of Basel; CGIAR; International Water Management Institute (IWMI)	Briet, OJT (corresponding author), Int Water Management Inst, Colombo, Sri Lanka.	olivier.briet@unibas.ch	Briët, Olivier/K-1917-2015	Briët, Olivier/0000-0003-1186-2688; Vounatsou, Penelope/0000-0002-4904-5352	National Oceanic and Atmospheric Administration (NOAA); National Science Foundation (NSF); Environmental Protection Agency (EPA); Electric Power Research Institute (EPRI) Joint Program on Climate Variability and Human Health	National Oceanic and Atmospheric Administration (NOAA)(National Oceanic Atmospheric Admin (NOAA) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); Environmental Protection Agency (EPA)(United States Environmental Protection Agency); Electric Power Research Institute (EPRI) Joint Program on Climate Variability and Human Health	This study was funded through the National Oceanic and Atmospheric Administration (NOAA), National Science Foundation (NSF), Environmental Protection Agency (EPA) and Electric Power Research Institute (EPRI) Joint Program on Climate Variability and Human Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALZAID AA, 1993, ANN I STAT MATH, V45, P223, DOI 10.1007/BF00775809; Benjamin MA, 2003, J AM STAT ASSOC, V98, P214, DOI 10.1198/016214503388619238; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Briet O. J. T., 2006, Malaria Journal, V5; Briet Olivier J T, 2008, Malar J, V7, P77, DOI 10.1186/1475-2875-7-77; Briet OJT, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-76; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Chen Y., 2002, ECON BULL, V3, P1; Chris Chatfield, 2004, ANAL TIME SERIES INT; COX DR, 1981, SCAND J STAT, V8, P93; Czado C, 2007, APPL STOCH MODEL BUS, V23, P1, DOI 10.1002/asmb.634; Davis RA, 2003, BIOMETRIKA, V90, P777, DOI 10.1093/biomet/90.4.777; Dunn PK., 1996, J COMPUTATIONAL GRAP, V5, P236, DOI DOI 10.2307/1390802; Gamerman D, 1998, BIOMETRIKA, V85, P215, DOI 10.1093/biomet/85.1.215; Gomez-Elipe A, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-129; Grunwald GK, 2000, AUST NZ J STAT, V42, P479, DOI 10.1111/1467-842X.00143; Heinen, 2003, MODELLING TIME SERIE; Hu WN, 2007, ANN EPIDEMIOL, V17, P679, DOI 10.1016/j.annepidem.2007.03.020; Hu WB, 2010, OCCUP ENVIRON MED, V67, P307, DOI 10.1136/oem.2008.044966; Jackman S, 1998, TIME SERIES MODELS D; JONES MC, 1987, APPL STAT-J ROY ST C, V36, P134, DOI 10.2307/2347544; Jung RC, 2006, COMPUT STAT DATA AN, V51, P2350, DOI 10.1016/j.csda.2006.08.001; Jung RC, 2006, STAT MODEL, V6, P81, DOI 10.1191/1471082X06st114oa; KING G, 1988, AM J POLIT SCI, V32, P838, DOI 10.2307/2111248; Kleinschmidt I, 2002, AM J EPIDEMIOL, V155, P257, DOI 10.1093/aje/155.3.257; Knorr-Held L, 1998, STAT MED, V17, P2045, DOI 10.1002/(SICI)1097-0258(19980930)17:18<2045::AID-SIM943>3.0.CO;2-P; Konradsen F, 2000, MALARIA SRI LANKA CU; LJUNG GM, 1978, BIOMETRIKA, V65, P297, DOI 10.2307/2335207; Mabaso M. L. H., 2006, International Journal of Health Geographics, V5; MCKENZIE E, 1988, ADV APPL PROBAB, V20, P822, DOI 10.2307/1427362; Morina D, 2011, STAT MED, V30, P3125, DOI 10.1002/sim.4336; Nobre AA, 2005, ENVIRONMETRICS, V16, P291, DOI 10.1002/env.704; Plummer M., 2003, JAGS PROGRAM ANAL BA, DOI DOI 10.1.1.13.3406; Ravines RR, 2006, APPL STOCH MODEL BUS, V22, P193, DOI 10.1002/asmb.628; SAID SE, 1984, BIOMETRIKA, V71, P599; Stefani A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-246; Teklehaimanot HD, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-44; Waller LA, 1997, J AM STAT ASSOC, V92, P607, DOI 10.2307/2965708; Wangdi K, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-251; West M., 2006, BAYESIAN FORECASTING; WHO, 2012, WORLD MALARIA REPORT 2012, P1; ZEGER SL, 1988, BIOMETRICS, V44, P1019, DOI 10.2307/2531732; ZEGER SL, 1988, BIOMETRIKA, V75, P621; Zinszer K, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001992	45	20	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65761	10.1371/journal.pone.0065761	http://dx.doi.org/10.1371/journal.pone.0065761			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785448	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000321038800074
J	Hasegawa, A; Iwamura, C; Kitajima, M; Hashimoto, K; Otsuyama, K; Ogino, H; Nakayama, T; Shirai, M				Hasegawa, Akihiro; Iwamura, Chiaki; Kitajima, Masayuki; Hashimoto, Kahoko; Otsuyama, Ken-ichiro; Ogino, Hidetaka; Nakayama, Toshinori; Shirai, Mutsunori			Crucial Role for CD69 in the Pathogenesis of Dextran Sulphate Sodium-Induced Colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; ALLERGIC AIRWAY INFLAMMATION; C-X-C; ULCERATIVE-COLITIS; CROHNS-DISEASE; T-CELLS; CHEMOKINE EXPRESSION; MUCOSAL IMMUNITY; INTESTINAL INFLAMMATION; RECEPTOR EXPRESSION	CD69 is a membrane molecule transiently expressed on activated lymphocytes, and its selective expression in inflammatory infiltrates suggests that it plays a role in the pathogenesis of inflammatory diseases. In this study, we used CD69-deficient (CD69 KO) mice to assess the role of CD69 in the pathogenesis of dextran sulphate sodium (DSS)-induced acute and chronic colitis. The severity of colitis was assessed by the survival rate, clinical signs, colon length, histological examination and the expression of cytokines and chemokines in the large intestines. Both acute and chronic colitis were attenuated in the CD69 KO mice, as reflected by the lower lethality, weight loss, clinical signs, and improved histological findings. CD69(+) cells infiltrated extensively into the inflamed mucosa of the colon in WT mice after DSS treatment. Experiments with the transfer of WT CD4 T cells into CD69 KO mice restored the induction of colitis. The administration of an anti-CD69 antibody also inhibited the induction of the DSS-induced colitis. These results indicate that CD69 expressed on CD4 T cells plays an important role in the pathogenesis of DSS-induced acute and chronic colitis, and that CD69 could be a possible therapeutic target for colitis.	[Hasegawa, Akihiro; Otsuyama, Ken-ichiro; Ogino, Hidetaka; Shirai, Mutsunori] Yamaguchi Univ, Grad Sch Med, Dept Microbiol & Immunol, Ube, Yamaguchi 755, Japan; [Iwamura, Chiaki; Kitajima, Masayuki; Nakayama, Toshinori] Chiba Univ, Grad Sch Med, Dept Immunol, Chiba, Japan; [Hashimoto, Kahoko] Chiba Inst Technol, Dept Life & Environm Sci, Narashino, Chiba 275, Japan; [Hashimoto, Kahoko] Chiba Inst Technol, High Technol Res Ctr, Narashino, Chiba 275, Japan; [Nakayama, Toshinori] CREST, JST, Chiba, Japan	Yamaguchi University; Chiba University; Chiba Institute of Technology; Chiba Institute of Technology; Japan Science & Technology Agency (JST)	Nakayama, T (corresponding author), Chiba Univ, Grad Sch Med, Dept Immunol, Chiba, Japan.	tnakayama@faculty.chiba-u.jp	Nakayama, Toshinori/E-1067-2017	Nakayama, Toshinori/0000-0002-1434-2007	JSPS KAKENHI (Japan) [22591093]; MEXT KAKENHI (Japan) [23111520]; Grants-in-Aid for Scientific Research [24791024] Funding Source: KAKEN	JSPS KAKENHI (Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT KAKENHI (Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI (Japan) (http://www.jsps.go.jp/english/index.html) Grant Number 22591093 and MEXT KAKENHI (Japan) (http://www.mext.go.jp/english/) Grant Number 23111520. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajuebor MN, 1999, J IMMUNOL, V162, P1685; Andres PG, 2000, J IMMUNOL, V164, P6303, DOI 10.4049/jimmunol.164.12.6303; Annunziato F, 1999, J LEUKOCYTE BIOL, V65, P691, DOI 10.1002/jlb.65.5.691; Aranda R, 1997, J IMMUNOL, V158, P3464; Banks C, 2003, J PATHOL, V199, P28, DOI 10.1002/path.1245; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Brandtzaeg P, 1997, SPRINGER SEMIN IMMUN, V18, P555, DOI 10.1007/BF00824058; Cobrin GM, 2005, IMMUNOL REV, V206, P277, DOI 10.1111/j.0105-2896.2005.00293.x; Cong YZ, 1998, J EXP MED, V187, P855, DOI 10.1084/jem.187.6.855; Connor SJ, 2004, GUT, V53, P1287, DOI 10.1136/gut.2003.028225; COOPER HS, 1993, LAB INVEST, V69, P238; Cruz-Adalia A, 2010, CIRCULATION, V122, P1396, DOI 10.1161/CIRCULATIONAHA.110.952820; DIELEMAN LA, 1994, GASTROENTEROLOGY, V107, P1643, DOI 10.1016/0016-5085(94)90803-6; Dieleman LA, 1998, CLIN EXP IMMUNOL, V114, P385; Esplugues E, 2005, BLOOD, V105, P4399, DOI 10.1182/blood-2004-10-3854; Esplugues E, 2003, J EXP MED, V197, P1093, DOI 10.1084/jem.20021337; Feng CG, 2002, INT IMMUNOL, V14, P535, DOI 10.1093/intimm/dxf020; Fiocchi C, 1998, GASTROENTEROLOGY, V115, P182, DOI 10.1016/S0016-5085(98)70381-6; Fuss IJ, 1996, J IMMUNOL, V157, P1261; Grimm MC, 1996, GUT, V38, P90, DOI 10.1136/gut.38.1.90; Guehler SR, 1999, GASTROENTEROLOGY, V116, P327, DOI 10.1016/S0016-5085(99)70129-0; Hasegawa A, 2006, J IMMUNOL, V176, P2546, DOI 10.4049/jimmunol.176.4.2546; Jugde F, 2001, EUR CYTOKINE NETW, V12, P468; Kabashima K, 2002, J CLIN INVEST, V109, P883, DOI 10.1172/JCI14459; Kolios G, 1999, EUR J IMMUNOL, V29, P530, DOI 10.1002/(SICI)1521-4141(199902)29:02<530::AID-IMMU530>3.0.CO;2-Y; Maaser C, 2002, Z GASTROENTEROL, V40, P525, DOI 10.1055/s-2002-32808; Martin P, 2010, J ALLERGY CLIN IMMUN, V126, P355, DOI 10.1016/j.jaci.2010.05.010; MATSUSHIMA K, 1989, J EXP MED, V169, P1485, DOI 10.1084/jem.169.4.1485; Mazzucchelli L, 1996, J PATHOL, V178, P201, DOI 10.1002/(SICI)1096-9896(199602)178:2<201::AID-PATH440>3.0.CO;2-4; McCormack G, 2001, INFLAMM RES, V50, P491, DOI 10.1007/PL00000223; McKay DM, 1999, CAN J GASTROENTEROL, V13, P509, DOI 10.1155/1999/680206; Miki-Hosokawa T, 2009, J IMMUNOL, V183, P8203, DOI 10.4049/jimmunol.0900646; Murata K, 2003, INT IMMUNOL, V15, P987, DOI 10.1093/intimm/dxg102; NAKAYAMA T, 1990, SCIENCE, V249, P1558, DOI 10.1126/science.2120773; Nakayama T, 2002, J IMMUNOL, V168, P87, DOI 10.4049/jimmunol.168.1.87; Nigo YI, 2006, P NATL ACAD SCI USA, V103, P2286, DOI 10.1073/pnas.0510685103; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Radulovic K, 2012, J IMMUNOL, V188, P2001, DOI 10.4049/jimmunol.1100765; REINECKER HC, 1993, CLIN EXP IMMUNOL, V94, P174; Sancho D, 2003, J CLIN INVEST, V112, P872, DOI 10.1172/JCI200319112; Sancho D, 2005, TRENDS IMMUNOL, V26, P136, DOI 10.1016/j.it.2004.12.006; Sartor RB, 1997, RES IMMUNOL, V148, P567, DOI 10.1016/S0923-2494(98)80151-X; Schrum S, 1996, J IMMUNOL, V157, P3598; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Siegmund B, 2001, P NATL ACAD SCI USA, V98, P13249, DOI 10.1073/pnas.231473998; Targan SR, 2005, IMMUNOL REV, V206, P296, DOI 10.1111/j.0105-2896.2005.00286.x; TESTI R, 1994, IMMUNOL TODAY, V15, P479, DOI 10.1016/0167-5699(94)90193-7; Tsuchiya T, 2003, J IMMUNOL, V171, P5507, DOI 10.4049/jimmunol.171.10.5507; Uguccioni M, 1999, AM J PATHOL, V155, P331, DOI 10.1016/S0002-9440(10)65128-0; Yamashita M, 1999, P NATL ACAD SCI USA, V96, P1024, DOI 10.1073/pnas.96.3.1024; Yang SK, 1997, GASTROENTEROLOGY, V113, P1214, DOI 10.1053/gast.1997.v113.pm9322516; ZIEGLER SF, 1993, EUR J IMMUNOL, V23, P1643, DOI 10.1002/eji.1830230737	52	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65494	10.1371/journal.pone.0065494	http://dx.doi.org/10.1371/journal.pone.0065494			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785429	Green Published, Green Submitted, gold			2022-12-27	WOS:000321038800092
J	Rosty, C; Young, JP; Walsh, MD; Clendenning, M; Sanderson, K; Walters, RJ; Parry, S; Jenkins, MA; Win, AK; Southey, MC; Hopper, JL; Giles, GG; Williamson, EJ; English, DR; Buchanan, DD				Rosty, Christophe; Young, Joanne P.; Walsh, Michael D.; Clendenning, Mark; Sanderson, Kristy; Walters, Rhiannon J.; Parry, Susan; Jenkins, Mark A.; Win, Aung Ko; Southey, Melissa C.; Hopper, John L.; Giles, Graham G.; Williamson, Elizabeth J.; English, Dallas R.; Buchanan, Daniel D.			PIK3CA Activating Mutation in Colorectal Carcinoma: Associations with Molecular Features and Survival	PLOS ONE			English	Article							RECEPTOR INHIBITOR CETUXIMAB; ISLAND METHYLATOR PHENOTYPE; BRAF V600E MUTATION; COLON-CANCER CELLS; POOR SURVIVAL; GROWTH; GENE; KRAS; POPULATION; PREVALENCE	Mutations in PIK3CA are present in 10 to 15% of colorectal carcinomas. We aimed to examine how PIK3CA mutations relate to other molecular alterations in colorectal carcinoma, to pathologic phenotype and survival. PIK3CA mutation testing was carried out using direct sequencing on 757 incident tumors from the Melbourne Collaborative Cohort Study. The status of O-6-methylguanine-DNA methyltransferase (MGMT) was assessed using both immunohistochemistry and methyLight techniques. Microsatellite instability, CpG island phenotype (CIMP), KRAS and BRAF V600E mutation status, and pathology review features were derived from previous reports. PIK3CA mutation was observed in 105 of 757 (14%) of carcinomas, characterized by location in the proximal colon (54% vs. 34%; P<0.001) and an increased frequency of KRAS mutation (48% vs. 25%; P<0.001). High-levels of CIMP were more frequently found in PIK3CA-mutated tumors compared with PIK3CA wildtype tumors (22% vs. 11%; P = 0.004). There was no difference in the prevalence of BRAF V600E mutation between these two tumor groups. PIK3CA-mutated tumors were associated with loss of MGMT expression (35% vs. 20%; P = 0.001) and the presence of tumor mucinous differentiation (54% vs. 32%; P<0.001). In patients with wild-type BRAF tumors, PIK3CA mutation was associated with poor survival (HR 1.51 95% CI 1.04-2.19, P = 0.03). In summary, PIK3CA-mutated colorectal carcinomas are more likely to develop in the proximal colon, to demonstrate high levels of CIMP, KRAS mutation and loss of MGMT expression. PIK3CA mutation also contributes to significantly decreased survival for patients with wild-type BRAF tumors.	[Rosty, Christophe; Young, Joanne P.; Walsh, Michael D.; Clendenning, Mark; Sanderson, Kristy; Walters, Rhiannon J.; Buchanan, Daniel D.] Queensland Inst Med Res, Canc & Populat Studies Grp, Herston, Qld 4006, Australia; [Rosty, Christophe; Young, Joanne P.] Univ Queensland, Sch Med, Herston, Qld, Australia; [Rosty, Christophe] Envoi Pathol, Herston, Qld, Australia; [Walsh, Michael D.] Sullivan & Nicolaides Pathol, Taringa, Australia; [Parry, Susan] Middlemore Hosp, Dept Gastroenterol & Hepatol, Auckland 6, New Zealand; [Parry, Susan] Auckland Hosp, New Zealand Familial Gastrointestinal Canc Serv, Auckland, New Zealand; [Jenkins, Mark A.; Win, Aung Ko; Hopper, John L.; Giles, Graham G.; Williamson, Elizabeth J.; English, Dallas R.] Univ Melbourne, Ctr Mol Environm Genet & Analyt Epidemiol, Parkville, Vic 3052, Australia; [Southey, Melissa C.] Univ Melbourne, Dept Pathol, Genet Epidemiol Lab, Parkville, Vic 3052, Australia; [Giles, Graham G.; English, Dallas R.] Canc Council Victoria, Canc Epidemiol Ctr, Carlton, Vic, Australia	QIMR Berghofer Medical Research Institute; University of Queensland; Auckland City Hospital; University of Melbourne; University of Melbourne; Cancer Council Victoria	Rosty, C (corresponding author), Queensland Inst Med Res, Canc & Populat Studies Grp, Bramston Terrace, Herston, Qld 4006, Australia.	c.rosty@uq.edu.au	Jenkins, Mark/P-7803-2015; Young, Joanne P/H-7774-2014; Rosty, Christophe/F-1796-2010; Win, Aung K./J-6204-2015; English, Dallas/AAH-5005-2019; Williamson, Elizabeth/H-3876-2019	Jenkins, Mark/0000-0002-8964-6160; Win, Aung K./0000-0002-2794-5261; English, Dallas/0000-0001-7828-8188; Williamson, Elizabeth/0000-0001-6905-876X; Southey, Melissa/0000-0002-6313-9005; Young, Joanne/0000-0002-1514-1522; Rosty, Christophe/0000-0001-7671-2651; Giles, Graham/0000-0003-4946-9099; Buchanan, Daniel/0000-0003-2225-6675	National Health and Medical Research Council [509348 209057]; Cancer Council Victoria	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria)	This work was supported by the National Health and Medical Research Council (509348 209057) and Cancer Council Victoria. MAJ is a NHMRC Senior Research Fellow and JLH is a NHMRC Australia Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubaker J, 2008, ONCOGENE, V27, P3539, DOI 10.1038/sj.onc.1211013; Baba Y, 2011, CANCER-AM CANCER SOC, V117, P1399, DOI 10.1002/cncr.25630; Bader AG, 2006, P NATL ACAD SCI USA, V103, P1475, DOI 10.1073/pnas.0510857103; Benvenuti S, 2008, HUM MUTAT, V29, P284, DOI 10.1002/humu.20648; Campbell IG, 2004, CANCER RES, V64, P7678, DOI 10.1158/0008-5472.CAN-04-2933; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; English DR, 2008, CANCER EPIDEM BIOMAR, V17, P1774, DOI 10.1158/1055-9965.EPI-08-0091; Furnari FB, 1998, CANCER RES, V58, P5002; Garrido-Laguna I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038033; Guo XN, 2007, CANCER RES, V67, P5851, DOI 10.1158/0008-5472.CAN-07-0049; Herreros-Villanueva M, 2011, MOL BIOL REP, V38, P1347, DOI 10.1007/s11033-010-0236-6; Hsieh LL, 2012, CLIN CHIM ACTA, V413, P1605, DOI 10.1016/j.cca.2012.04.029; Iida S, 2012, ONCOL LETT, V3, P565, DOI 10.3892/ol.2011.544; Janku F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022769; Janku F, 2011, MOL CANCER THER, V10, P558, DOI 10.1158/1535-7163.MCT-10-0994; Jehan Z, 2009, J PATHOL, V219, P337, DOI 10.1002/path.2601; Jhawer M, 2008, CANCER RES, V68, P1953, DOI 10.1158/0008-5472.CAN-07-5659; Kato S, 2007, INT J CANCER, V121, P1771, DOI 10.1002/ijc.22890; Liao XY, 2012, NEW ENGL J MED, V367, P1596, DOI 10.1056/NEJMoa1207756; Liao XY, 2012, CLIN CANCER RES, V18, P2257, DOI 10.1158/1078-0432.CCR-11-2410; Loboda A, 2009, CLIN PHARMACOL THER, V86, P92, DOI 10.1038/clpt.2009.48; Mao C, 2012, ANN ONCOL, V23, P1518, DOI 10.1093/annonc/mdr464; Miled N, 2007, SCIENCE, V317, P239, DOI 10.1126/science.1135394; Miyaki M, 2007, INT J CANCER, V121, P1627, DOI 10.1002/ijc.22829; Naguib A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-123; Nosho K, 2008, NEOPLASIA, V10, P534, DOI 10.1593/neo.08336; Ogino S, 2006, MODERN PATHOL, V19, P59, DOI 10.1038/modpathol.3800482; Ogino S, 2009, J CLIN ONCOL, V27, P1477, DOI 10.1200/JCO.2008.18.6544; Prenen H, 2009, CLIN CANCER RES, V15, P3184, DOI 10.1158/1078-0432.CCR-08-2961; Rosty C, 2013, MODERN PATHOL, DOI [10.1038/mod-pathol.2012.1240, DOI 10.1038/M0D-PATH0L.2012.1240]; Rosty C, 2012, AM J SURG PATHOL, V36, P876, DOI 10.1097/PAS.0b013e31824e133f; Samowitz WS, 2005, CANCER RES, V65, P6063, DOI 10.1158/0008-5472.CAN-05-0404; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sarasqueta AF, 2011, CELL ONCOL, V34, P523, DOI 10.1007/s13402-011-0054-4; Tian S, 2013, GUT, V62, P540, DOI 10.1136/gutjnl-2012-302423; Van Cutsem E, 2007, J CLIN ONCOL, V25, P1658, DOI 10.1200/JCO.2006.08.1620; Velho S, 2005, EUR J CANCER, V41, P1649, DOI 10.1016/j.ejca.2005.04.022; Walsh MD, 2008, CLIN CANCER RES, V14, P1692, DOI 10.1158/1078-0432.CCR-07-1849; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Whitehall VLJ, 2012, INT J CANCER, V131, P813, DOI 10.1002/ijc.26440; Yamauchi M, 2012, GUT, V61, P847, DOI 10.1136/gutjnl-2011-300865; Zhao L, 2010, CELL CYCLE, V9, P596, DOI 10.4161/cc.9.3.10599	43	104	107	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65479	10.1371/journal.pone.0065479	http://dx.doi.org/10.1371/journal.pone.0065479			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785428	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000321038800093
J	Suta, D; Popelar, J; Burianova, J; Syka, J				Suta, Daniel; Popelar, Jiri; Burianova, Jana; Syka, Josef			Cortical Representation of Species-Specific Vocalizations in Guinea Pig	PLOS ONE			English	Article							PRIMARY AUDITORY-CORTEX; PHASE-LOCKED RESPONSES; MEDIAL GENICULATE-BODY; INFERIOR COLLICULUS; NEURONAL RESPONSES; PURE-TONES; AMPLITUDE; MARMOSET; THALAMUS; STIMULI	We investigated the representation of four typical guinea pig vocalizations in the auditory cortex (AI) in anesthetized guinea pigs with the aim to compare cortical data to the data already published for identical calls in subcortical structures - the inferior colliculus (IC) and medial geniculate body (MGB). Like the subcortical neurons also cortical neurons typically responded to many calls with a time-locked response to one or more temporal elements of the calls. The neuronal response patterns in the AI correlated well with the sound temporal envelope of chirp (an isolated short phrase), but correlated less well in the case of chutter and whistle (longer calls) or purr (a call with a fast repetition rate of phrases). Neuronal rate vs. characteristic frequency profiles provided only a coarse representation of the calls' frequency spectra. A comparison between the activity in the AI and those of subcortical structures showed a different transformation of the neuronal response patterns from the IC to the AI for individual calls: i) while the temporal representation of chirp remained unchanged, the representations of whistle and chutter were transformed at the thalamic level and the response to purr at the cortical level; ii) for the wideband calls (whistle, chirp) the rate representation of the call spectra was preserved in the AI and MGB at the level present in the IC, while in the case of low-frequency calls (chutter, purr), the representation was less precise in the AI and MGB than in the IC; iii) the difference in the response strength to natural and time-reversed whistle was found to be smaller in the AI than in the IC or MGB.	[Suta, Daniel; Popelar, Jiri; Burianova, Jana; Syka, Josef] Acad Sci Czech Republic, Inst Expt Med, Dept Auditory Neurosci, Prague, Czech Republic; [Suta, Daniel] Charles Univ Prague, Fac Med 3, Dept Med Biophys & Informat, Prague, Czech Republic	Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences; Charles University Prague	Suta, D (corresponding author), Acad Sci Czech Republic, Inst Expt Med, Dept Auditory Neurosci, Prague, Czech Republic.	suta@biomed.cas.cz	Svobodová Burianová, Jana/AHB-9055-2022; Syka, Josef/H-3103-2014; Popelar, Jiri/H-2558-2014; Suta, Daniel/AAL-7768-2021	Svobodová Burianová, Jana/0000-0002-8927-2381; Suta, Daniel/0000-0002-6178-7770	Grant Agency of the Czech Republic [GACR P303/12/1347, P304/12/G069]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic)	This work was supported by research grants from Grant Agency of the Czech Republic (GACR P303/12/1347 and P304/12/G069). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astl J, 1996, AUDIOLOGY, V35, P335; Barbour DL, 2002, J NEUROPHYSIOL, V88, P2684, DOI 10.1152/jn.00253.2002; BERRYMAN JC, 1976, Z TIERPSYCHOL, V41, P80; CREUTZFELDT O, 1980, EXP BRAIN RES, V39, P87; DOUPE AJ, 1991, P NATL ACAD SCI USA, V88, P11339, DOI 10.1073/pnas.88.24.11339; Esser KH, 1997, P NATL ACAD SCI USA, V94, P14019, DOI 10.1073/pnas.94.25.14019; GAESE BH, 1995, EUR J NEUROSCI, V7, P438, DOI 10.1111/j.1460-9568.1995.tb00340.x; Gehr DD, 2000, HEARING RES, V150, P27, DOI 10.1016/S0378-5955(00)00170-2; GOLDBERG JM, 1969, J NEUROPHYSIOL, V32, P613, DOI 10.1152/jn.1969.32.4.613; Grimsley JMS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051646; Holmstrom LA, 2010, J NEUROSCI, V30, P802, DOI 10.1523/JNEUROSCI.1964-09.2010; Huetz C, 2009, J NEUROSCI, V29, P334, DOI 10.1523/JNEUROSCI.3269-08.2009; Joris PX, 2004, PHYSIOL REV, V84, P541, DOI 10.1152/physrev.00029.2003; Kvasnak E, 2000, PHYSIOL RES, V49, P369; MARGOLIASH D, 1983, J NEUROSCI, V3, P1039; Nagarajan SS, 2002, J NEUROPHYSIOL, V87, P1723, DOI 10.1152/jn.00632.2001; Pasley BN, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001251; Philibert B, 2005, HEARING RES, V209, P97, DOI 10.1016/j.heares.2005.07.004; REES A, 1989, J ACOUST SOC AM, V85, P1978, DOI 10.1121/1.397851; Sadagopan S, 2009, J NEUROSCI, V29, P11192, DOI 10.1523/JNEUROSCI.1286-09.2009; Suta D, 2003, J NEUROPHYSIOL, V90, P3794, DOI 10.1152/jn.01175.2002; Suta D, 2008, PHYSIOL RES, V57, pS149, DOI 10.33549/physiolres.931608; Suta Daniel, 2004, Acta Medica (Hradec Kralove), V47, P339; Suta D, 2007, EXP BRAIN RES, V183, P377, DOI 10.1007/s00221-007-1056-3; Syka J, 2005, HEARING RES, V206, P177, DOI 10.1016/j.heares.2005.01.013; Syka J, 1997, ACOUSTICAL SIGNAL PROCESSING IN THE CENTRAL AUDITORY SYSTEM, P431, DOI 10.1007/978-1-4419-8712-9_39; Syka J, 2000, EXP BRAIN RES, V133, P254, DOI 10.1007/s002210000426; Wallace MN, 2008, EXP BRAIN RES, V184, P179, DOI 10.1007/s00221-007-1092-z; Wallace MN, 2009, EXP BRAIN RES, V194, P395, DOI 10.1007/s00221-009-1714-8; Wallace MN, 2007, J NEUROPHYSIOL, V98, P1941, DOI 10.1152/jn.00697.2007; Wallace MN, 2005, NEUROREPORT, V16, P2001, DOI 10.1097/00001756-200512190-00006; Wallace MN, 2005, HEARING RES, V204, P115, DOI 10.1016/j.heares.2005.01.007; Wallace MN, 2002, HEARING RES, V172, P160, DOI 10.1016/S0378-5955(02)00580-4; Wang X, 2008, NEUROSCIENCE, V154, P294, DOI 10.1016/j.neuroscience.2008.03.065; Wang XQ, 1995, J NEUROPHYSIOL, V74, P2685, DOI 10.1152/jn.1995.74.6.2685; Wang XQ, 2001, J NEUROPHYSIOL, V86, P2616, DOI 10.1152/jn.2001.86.5.2616; YOUNG ED, 1979, J ACOUST SOC AM, V66, P1381, DOI 10.1121/1.383532	37	10	11	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65432	10.1371/journal.pone.0065432	http://dx.doi.org/10.1371/journal.pone.0065432			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785425	Green Published, gold, Green Submitted			2022-12-27	WOS:000321038800095
J	Wu, X; Xu, QQ; Guo, L; Yu, CT; Xiong, YY; Wei, ZY; Huo, R; Li, ST; Shen, L; Niu, JM; Liu, L; Lin, Y; He, L; Qin, SY				Wu, Xi; Xu, Qing-Qing; Guo, Liang; Yu, Chuan-Ting; Xiong, Yu-Yu; Wei, Zhi-Yun; Huo, Ran; Li, Sheng-Tian; Shen, Lu; Niu, Jia-Min; Liu, Lu; Lin, Yi; He, Lin; Qin, Sheng-Ying			Quantitative Assessment of the Association between rs2046210 at 6q25.1 and Breast Cancer Risk	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; COMMON GENETIC-VARIANTS; SUSCEPTIBILITY LOCI; CONFER SUSCEPTIBILITY; ALPHA GENE; CHINESE; ALLELES; BRCA1; WOMEN; JAPANESE	Genome-wide association studies (GWAS) have identified several genetic susceptibility loci for breast cancer (BC). One of them, conducted among Chinese women, found an association of rs2046210 at 6q25.1 with the risk of BC recently. Since then, numerous association studies have been carried out to investigate the relationship between this polymorphism and BC risk in various populations. However, these have yielded contradictory results. We therefore performed a meta-analysis to clarify this inconsistency. Overall, a total of 235003 subjects based on 13 studies were included in our study. Significantly increased BC risk was detected in the pooled analysis [allele contrast: OR = 1.13, 95%CI = 1.10-1.17, P(Z) < 10(-5), P(Q) < 10(-4); dominant model: OR = 1.21, 95%CI = 1.14-1.27, P(Z) < 10(-5), P(Q) < 10(-4); recessive model: OR = 1.18, 95%CI = 1.12-1.24, P(Z) < 10(-5), P(Q) = 0.04]. In addition, our data revealed that rs2046210 conferred greater risk in estrogen receptor (ER)-negative tumors [OR = 1.27, 95%CI = 1.15-1.40, P(Z) < 10(-5), P(Q) < 10(-4)] than in ER-positive ones [OR = 1.18, 95%CI = 1.09-1.28, P(Z) < 10(-4), P(Q) = 0.0003]. When stratified by ethnicity, significant associations were found in Caucasian and Asian populations, but not detected among Africans. There was evidence of heterogeneity (P<0.05), however, the heterogeneity largely disappeared after stratification by ethnicity. The present meta-analysis demonstrated that the rs2046210 polymorphism may be associated with increased BC susceptibility, but this association varies in different ethnicities.	[Wu, Xi; Xu, Qing-Qing; Xiong, Yu-Yu; Wei, Zhi-Yun; Huo, Ran; Li, Sheng-Tian; Shen, Lu; Lin, Yi; He, Lin; Qin, Sheng-Ying] Shanghai Jiao Tong Univ, Minist Educ, Bio X Inst, Key Lab Genet Dev & Neuropsychiat Disorders, Shanghai 200030, Peoples R China; [Wu, Xi; Xu, Qing-Qing; Xiong, Yu-Yu; Wei, Zhi-Yun; Huo, Ran; Shen, Lu; He, Lin; Qin, Sheng-Ying] Shanghai Inst Genome Pilot & Human Hlth, Shanghai, Peoples R China; [Guo, Liang] Fourth Hosp Jinan City, Taishan Med Coll, Jinan, Peoples R China; [Yu, Chuan-Ting] Yantaishan Hosp, Clin Lab, Yantai, Peoples R China; [Lin, Yi] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China; [He, Lin] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Shanghai Jiao Tong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shanghai Jiao Tong University; Fudan University	He, L (corresponding author), Shanghai Jiao Tong Univ, Minist Educ, Bio X Inst, Key Lab Genet Dev & Neuropsychiat Disorders, Shanghai 200030, Peoples R China.	helinhelin3@gmail.com; chinsir@sjtu.edu.cn	Wei, Zhiyun/E-2008-2016	Wei, Zhiyun/0000-0002-3554-4142; Li, Sheng Tian/0000-0002-2836-3802	863 Program [2012AA02A515]; 973 Program [2010CB529600]; National Key Technology RD Program [2012BAI01B09]; National Nature Science Foundation of China [81121001, 81273596, 30900799, 30972823]; Shanghai Municipal Commission of Science and Technology Program [11DZ1950300, 09DJ1400601]; Shanghai Jiaotong University Med-X Fund [YG2010MS61]; Public Science and Technology Research Funds [201210056]; Shanghai Jiaotong University Interdisciplinary Research fund; Shanghai Leading Academic Discipline Project [B205]	863 Program(National High Technology Research and Development Program of China); 973 Program(National Basic Research Program of China); National Key Technology RD Program(National Key Technology R&D Program); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Commission of Science and Technology Program; Shanghai Jiaotong University Med-X Fund; Public Science and Technology Research Funds; Shanghai Jiaotong University Interdisciplinary Research fund; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	The work was supported by grants from the 863 Program (2012AA02A515), the 973 Program (2010CB529600), the National Key Technology R&D Program (2012BAI01B09), the National Nature Science Foundation of China (81121001, 81273596, 30900799, 30972823), the Shanghai Municipal Commission of Science and Technology Program (11DZ1950300, 09DJ1400601), the Shanghai Jiaotong University Med-X Fund (YG2010MS61), the Public Science and Technology Research Funds (201210056), the Shanghai Jiaotong University Interdisciplinary Research fund, and the Shanghai Leading Academic Discipline Project (B205). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2009, NAT GENET, V41, P585, DOI 10.1038/ng.354; Allred DC, 2004, BREAST CANCER RES, V6, P240, DOI 10.1186/bcr938; [Anonymous], 2012, CARCINOGENESIS; Antoniou AC, 2011, HUM MOL GENET, V20, P3304, DOI 10.1093/hmg/ddr226; Beral V, 2001, LANCET, V358, P1389, DOI 10.1016/S0140-6736(01)06524-2; Cai QY, 2011, CANCER RES, V71, P1344, DOI 10.1158/0008-5472.CAN-10-2733; Cai QY, 2003, CANCER RES, V63, P5727; Cai QY, 2003, CANCER EPIDEM BIOMAR, V12, P853; Campa D, 2011, JNCI-J NATL CANCER I, V103, P1252, DOI 10.1093/jnci/djr265; Chan M, 2012, BREAST CANCER RES TR, V136, P209, DOI 10.1007/s10549-012-2234-y; DerSimonian R, 2007, CONTEMP CLIN TRIALS, V28, P105, DOI 10.1016/j.cct.2006.04.004; Dorgan JF, 2002, JNCI-J NATL CANCER I, V94, P606; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Han W, 2011, CANCER EPIDEM BIOMAR, V20, P793, DOI 10.1158/1055-9965.EPI-10-1282; Hein R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042380; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Huo DZ, 2012, CARCINOGENESIS, V33, P835, DOI 10.1093/carcin/bgs093; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiang YD, 2011, BREAST CANCER RES TR, V128, P251, DOI 10.1007/s10549-010-1327-8; Kos M, 2001, MOL ENDOCRINOL, V15, P2057, DOI 10.1210/me.15.12.2057; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Long JR, 2010, CANCER EPIDEM BIOMAR, V19, P2357, DOI 10.1158/1055-9965.EPI-10-0054; Lux MP, 2006, J MOL MED, V84, P16, DOI 10.1007/s00109-005-0696-7; MANTEL N, 1959, J NATL CANCER I, V22, P719; McCracken M, 2007, CA-CANCER J CLIN, V57, P190, DOI 10.3322/canjclin.57.4.190; Mulligan AM, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3052; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Peto J, 1999, J NATL CANCER I, V91, P943, DOI 10.1093/jnci/91.11.943; Stacey SN, 2008, NAT GENET, V40, P703, DOI 10.1038/ng.131; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; Stacey SN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001029; Styrkarsdottir Unnur, 2008, N Engl J Med, V358, P2355, DOI 10.1056/NEJMoa0801197; Thomas G, 2009, NAT GENET, V41, P579, DOI 10.1038/ng.353; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x; Zheng SL, 2003, CANCER RES, V63, P7624; Zheng W, 2009, CANCER EPIDEM BIOMAR, V18, P2761, DOI 10.1158/1055-9965.EPI-09-0624; Zheng W, 2009, NAT GENET, V41, P324, DOI 10.1038/ng.318	37	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65206	10.1371/journal.pone.0065206	http://dx.doi.org/10.1371/journal.pone.0065206			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785413	Green Published, Green Submitted, gold			2022-12-27	WOS:000321038800107
J	Balderas-Martinez, YI; Savageau, M; Salgado, H; Perez-Rueda, E; Morett, E; Collado-Vides, J				Itzel Balderas-Martinez, Yalbi; Savageau, Michael; Salgado, Heladia; Perez-Rueda, Ernesto; Morett, Enrique; Collado-Vides, Julio			Transcription Factors in Escherichia coli Prefer the Holo Conformation	PLOS ONE			English	Article							RESPONSIVE REGULATORY PROTEIN; GENE-REGULATION; DEMAND THEORY; BINDING-SITE; EXPRESSION; BACTERIA; MECHANISMS; NETWORKS; DESIGN	The transcriptional regulatory network of Escherichia coli K-12 is among the best studied gene networks of any living cell. Transcription factors bind to DNA either with their effector bound (holo conformation), or as a free protein (apo conformation) regulating transcription initiation. By using RegulonDB, the functional conformations (holo or apo) of transcription factors, and their mode of regulation (activator, repressor, or dual) were exhaustively analyzed. We report a striking discovery in the architecture of the regulatory network, finding a strong under-representation of the apo conformation (without allosteric metabolite) of transcription factors when binding to their DNA sites to activate transcription. This observation is supported at the level of individual regulatory interactions on promoters, even if we exclude the promoters regulated by global transcription factors, where three-quarters of the known promoters are regulated by a transcription factor in holo conformation. This genome-scale analysis enables us to ask what are the implications of these observations for the physiology and for our understanding of the ecology of E. coli. We discuss these ideas within the framework of the demand theory of gene regulation.	[Itzel Balderas-Martinez, Yalbi; Salgado, Heladia; Collado-Vides, Julio] Univ Nacl Autonoma Mexico, Ctr Ciencias Genom, Programa Genom Computac, Cuernavaca 62191, Morelos, Mexico; [Savageau, Michael] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA; [Perez-Rueda, Ernesto; Morett, Enrique] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Ingn Celular & Biocatalisis, Cuernavaca 62191, Morelos, Mexico	Universidad Nacional Autonoma de Mexico; University of California System; University of California Davis; Universidad Nacional Autonoma de Mexico	Balderas-Martinez, YI (corresponding author), Univ Nacl Autonoma Mexico, Ctr Ciencias Genom, Programa Genom Computac, Cuernavaca 62191, Morelos, Mexico.	balderas@ccg.unam.mx; collado@ccg.unam.mx	Balderas-Martinez, Yalbi Itzel/J-4848-2014; Perez-Rueda, Ernesto/D-7468-2016	Balderas-Martinez, Yalbi Itzel/0000-0001-6400-0526; Collado-Vides, Julio/0000-0001-8780-7664; Perez-Rueda, Ernesto/0000-0002-6879-0673; Morett, Enrique/0000-0001-5723-0032	CONACyT-Mexico [228320]; National Institute of General Medical Sciences, National Institutes of Health, USA [5R01GM071962-08, RO1GM030054-23]; DGAPA [IN209511]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071962, R01GM030054] Funding Source: NIH RePORTER	CONACyT-Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National Institute of General Medical Sciences, National Institutes of Health, USA; DGAPA; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	YIB-M acknowledges the PDCB of CCG-UNAM and her support by a PhD fellowship (228320) from CONACyT-Mexico. This research was supported in part by grants 5R01GM071962-08 to JC-V and RO1GM030054-23 to MS from the National Institute of General Medical Sciences, National Institutes of Health, USA. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the National Institutes of Health. EP-R was partially supported by DGAPA grant IN209511. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 2007, INTRO SYSTEMS BIOL D, Vxvi; Ansaldi M, 2000, J BACTERIOL, V182, P961, DOI 10.1128/JB.182.4.961-966.2000; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Chen SL, 2005, J MOL BIOL, V345, P251, DOI 10.1016/j.jmb.2004.10.047; COLLADOVIDES J, 1991, MICROBIOL REV, V55, P371, DOI 10.1128/MMBR.55.3.371-394.1991; de Lima Morais DA, 2011, NUCLEIC ACIDS RES, V39, pD427; Engelen K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020938; Freyre-Gonzalez JA, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r154; Gama-Castro S, 2011, NUCLEIC ACIDS RES, V39, pD98, DOI 10.1093/nar/gkq1110; Gerland U, 2009, P NATL ACAD SCI USA, V106, P8841, DOI 10.1073/pnas.0808500106; Giedroc DP, 2007, DALTON T, P3107, DOI 10.1039/b706769k; GOTTESMAN S, 1984, ANNU REV GENET, V18, P415; Gutierrez-Rios RM, 2003, GENOME RES, V13, P2435, DOI 10.1101/gr.1387003; Kuriyan J, 2007, NATURE, V450, P983, DOI 10.1038/nature06524; Martinez-Antonio A, 2003, CURR OPIN MICROBIOL, V6, P482, DOI 10.1016/j.mib.2003.09.002; Merino E, 2005, TRENDS GENET, V21, P260, DOI 10.1016/j.tig.2005.03.002; NEWMAN EB, 1995, ANNU REV MICROBIOL, V49, P747, DOI 10.1146/annurev.mi.49.100195.003531; PRIBNOW D, 1975, P NATL ACAD SCI USA, V72, P784, DOI 10.1073/pnas.72.3.784; R Development Core Team, 2011, R LANG ENV STAT COMP; Ray JCJ, 2011, NAT REV MICROBIOL, V9, P817, DOI 10.1038/nrmicro2667; Salgado H, 2013, NUCLEIC ACIDS RES, V41, pD203, DOI 10.1093/nar/gks1201; SAVAGEAU MA, 1977, P NATL ACAD SCI USA, V74, P5647, DOI 10.1073/pnas.74.12.5647; Savageau MA, 1998, GENETICS, V149, P1677; SAVAGEAU MA, 1989, THEORETICAL BIOLOGY, P42; Savageau MA, 1998, GENETICS, V149, P1665; SAVAGEAU MA, 1983, P NATL ACAD SCI-BIOL, V80, P1411, DOI 10.1073/pnas.80.5.1411; SAVAGEAU MA, 1983, AM NAT, V122, P732, DOI 10.1086/284168; Savageau MA, 1976, BIOCH SYSTEMS ANAL S, Vxvii; Savageau MA, 1979, BIOL REGUL DEV, P57; Serres Margrethe Hauge, 2000, Microbial and Comparative Genomics, V5, P205, DOI 10.1089/mcg.2000.5.205; Stec E, 2006, J MOL BIOL, V364, P309, DOI 10.1016/j.jmb.2006.06.033; Swint-Kruse L, 2009, CURR OPIN MICROBIOL, V12, P129, DOI 10.1016/j.mib.2009.01.009; Wall ME, 2004, NAT REV GENET, V5, P34, DOI 10.1038/nrg1244	33	19	19	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65723	10.1371/journal.pone.0065723	http://dx.doi.org/10.1371/journal.pone.0065723			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776535	gold, Green Published			2022-12-27	WOS:000320322400048
J	Kalembo, FW; Zgambo, M; Mulaga, AN; Du, YK; Ahmed, NI				Kalembo, Fatch W.; Zgambo, Maggie; Mulaga, Atupele N.; Du Yukai; Ahmed, Niman I.			Association between Male Partner Involvement and the Uptake of Prevention of Mother-to-Child Transmission of HIV (PMTCT) Interventions in Mwanza District, Malawi: A Retrospective Cohort Study	PLOS ONE			English	Article								Objective: The main objective of this study was to examine the association between male partner involvement and the uptake of prevention of mother-to-child transmission of HIV (PMTCT) interventions. Methods: A retrospective cohort study was used to collect data on women, their male partners and their children who were enrolled in a PMTCT program from January 2004 to December 2006 at Mwanza District Hospital. HIV infected women and their children were followed-up over the 18 months postnatal period. Data were analyzed using descriptive statistics, chi-square test and logistic regression. Results: A total of 476 HIV positive women were enrolled in a PMTCT program and were followed-up in the study. Of those followed-up in the study, 65 (13.7%) had a male partner involvement while 411 (86.3%) had no male partner involvement. Male partner involvement was significantly associated with condom use (Adjusted odds ratio [AOR] = 5.6, 95% confidence interval [CI]: 2.3-13.5, P<0.001), hospital delivery (AOR = 25.9, 95% CI: 10.6-63.6, P<0.001), and completion of follow-up in the program (AOR = 16.8, 95% CI: 8.5-33.4, P<0.001). Conclusion: Male partner involvement increases the uptake of some PMTCT interventions by HIV positive women. Multi-strategic, culturally tailored public health care models are needed to increase the rate of male partner involvement in the program.	[Kalembo, Fatch W.; Du Yukai; Ahmed, Niman I.] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Child Adolescence & Woman Hlth Care, Wuhan 430074, Peoples R China; [Zgambo, Maggie] Cent S Univ, Xiangya Med Coll, Dept Nursing, Changsha, Hunan, Peoples R China; [Mulaga, Atupele N.] Univ Malawi, Dept Math & Stat, The Polytech, Blantyre, Malawi	Huazhong University of Science & Technology; Central South University; University of Malawi	Du, YK (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Child Adolescence & Woman Hlth Care, Wuhan 430074, Peoples R China.	duyukai100@yahoo.com.cn		Kalembo, Fatch W./0000-0003-3032-3495; Zgambo, Maggie/0000-0001-8667-795X	Tongji Medical College of Huazhong University of Science and Technology	Tongji Medical College of Huazhong University of Science and Technology	The study was funded by Tongji Medical College of Huazhong University of Science and Technology. Below is the URL of the funder (http://english.hust.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDALLAH A, 2006, 2006 HIV AIDS IMPL M; Akarro R, 2011, ASSJ, V20; Aluisio A, 2011, JAIDS-J ACQ IMM DEF, V56, P76, DOI 10.1097/QAI.0b013e3181fdb4c4; Bolu OO, 2007, AM J OBSTET GYNECOL, V197, pS83, DOI 10.1016/j.ajog.2007.03.006; Byamugisha R, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-12; Farquhar C, 2004, JAIDS-J ACQ IMM DEF, V37, P1620, DOI 10.1097/00126334-200412150-00016; HALLISSEY M, 2006, 2006 HIV AIDS IMPL M; Homsy J, 2006, JAIDS-J ACQ IMM DEF, V42, P149, DOI 10.1097/01.qai.0000225032.52766.c2; Kakimoto K, 2007, BIOSCI TRENDS, V1, P97; Kalembo F. W., 2012, Open Journal of Preventive Medicine, V2, P35, DOI 10.4236/ojpm.2012.21006; Katz DA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007602; Malawi Ministry of Health, 2008, PMTCT HIV PED HIV CA; Malawi Ministry of Health, 2007, PMTCT TRAIN MOD; Medley M, 2004, B WORLD HEALTH ORGAN, P299; Msuya SE, 2008, AIDS CARE, V20, P700, DOI 10.1080/09540120701687059; Njunga J, 2010, INT BREASTFEED J, V5, DOI 10.1186/1746-4358-5-14; Orne-Gliemann J, 2008, AIDS, V22, P2555, DOI 10.1097/QAD.0b013e32831c54d5; Painter TM, 2001, SOC SCI MED, V53, P1397, DOI 10.1016/S0277-9536(00)00427-5; Pignatelli S, 2006, TROP MED INT HEALTH, V11, P350, DOI 10.1111/j.1365-3156.2006.01564.x; Tweheyo R, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-53; UNAIDS, 2010, REP GLOB AIDS EP 201; UNICEF, 2011, MAL PMTCT FACTSH 201; WHO, 2010, MOTH TO CHILD TRANSM; ZULU EM, 2003, DEMOGRAPHIC RES S, V0001	24	92	93	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66517	10.1371/journal.pone.0066517	http://dx.doi.org/10.1371/journal.pone.0066517			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776683	Green Published, gold, Green Submitted			2022-12-27	WOS:000320322400108
J	Moreau, C; Lefebvre, JF; Jomphe, M; Bherer, C; Ruiz-Linares, A; Vezina, H; Roy-Gagnon, MH; Labuda, D				Moreau, Claudia; Lefebvre, Jean-Francois; Jomphe, Michele; Bherer, Claude; Ruiz-Linares, Andres; Vezina, Helene; Roy-Gagnon, Marie-Helene; Labuda, Damian			Native American Admixture in the Quebec Founder Population	PLOS ONE			English	Article							GENETICS; ANCESTRY; IMPACT; ASSOCIATION; MUTATIONS; LINEAGES; HISTORY; AGE; MAP	For years, studies of founder populations and genetic isolates represented the mainstream of genetic mapping in the effort to target genetic defects causing Mendelian disorders. The genetic homogeneity of such populations as well as relatively homogeneous environmental exposures were also seen as primary advantages in studies of genetic susceptibility loci that underlie complex diseases. European colonization of the St-Lawrence Valley by a small number of settlers, mainly from France, resulted in a founder effect reflected by the appearance of a number of population-specific disease-causing mutations in Quebec. The purported genetic homogeneity of this population was recently challenged by genealogical and genetic analyses. We studied one of the contributing factors to genetic heterogeneity, early Native American admixture that was never investigated in this population before. Consistent admixture estimates, in the order of one per cent, were obtained from genome-wide autosomal data using the ADMIXTURE and HAPMIX software, as well as with the fastIBD software evaluating the degree of the identity-by-descent between Quebec individuals and Native American populations. These genomic results correlated well with the genealogical estimates. Correlations are imperfect most likely because of incomplete records of Native founders' origin in genealogical data. Although the overall degree of admixture is modest, it contributed to the enrichment of the population diversity and to its demographic stratification. Because admixture greatly varies among regions of Quebec and among individuals, it could have significantly affected the homogeneity of the population, which is of importance in mapping studies, especially when rare genetic susceptibility variants are in play.	[Moreau, Claudia; Lefebvre, Jean-Francois; Bherer, Claude; Roy-Gagnon, Marie-Helene; Labuda, Damian] Univ Montreal, Ctr Rech, CHU St Justine, Montreal, PQ, Canada; [Jomphe, Michele; Vezina, Helene] Univ Quebec Chicoutimi, Projet BALSAC, Chicoutimi, PQ, Canada; [Ruiz-Linares, Andres] UCL, Dept Genet Evolut & Environm, London, England; [Roy-Gagnon, Marie-Helene] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON, Canada; [Labuda, Damian] Univ Montreal, Dept Pediat, Montreal, PQ, Canada	Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; University of Quebec; University of Quebec Chicoutimi; University of London; University College London; University of Ottawa; Universite de Montreal	Roy-Gagnon, MH (corresponding author), Univ Montreal, Ctr Rech, CHU St Justine, Montreal, PQ, Canada.	mroygagn@uottawa.ca; damian.labuda@umontreal.ca	Ruiz-Linares, Andres/AAR-1104-2021	Ruiz-Linares, Andres/0000-0001-8372-1011; Roy-Gagnon, Marie-Helene/0000-0001-8747-0846	Reseau de Medecine Genetique Appliquee of Fonds de Recherche en Sante du Quebec (FRSQ); FRSQ grant	Reseau de Medecine Genetique Appliquee of Fonds de Recherche en Sante du Quebec (FRSQ); FRSQ grant	This research was supported by Reseau de Medecine Genetique Appliquee of Fonds de Recherche en Sante du Quebec (FRSQ) (HV and DL) and by FRSQ grant (MHRG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Atzmon G, 2010, AM J HUM GENET, V86, P850, DOI 10.1016/j.ajhg.2010.04.015; BEAUREGARD Y, 1993, HUBERT CHARBONNEAU C, V34, P38; Bedoya G, 2006, P NATL ACAD SCI USA, V103, P7234, DOI 10.1073/pnas.0508716103; Bherer C, 2011, AM J PHYS ANTHROPOL, V144, P432, DOI 10.1002/ajpa.21424; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; BOUCHARD G, 1990, HIST SOC/SOC HIST, V23, P325; Bray SM, 2010, P NATL ACAD SCI USA, V107, P16222, DOI 10.1073/pnas.1004381107; Browning BL, 2011, AM J HUM GENET, V88, P173, DOI 10.1016/j.ajhg.2011.01.010; Campbell DD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033570; CHARBONNEAU H, 1988, ACTION NATIONALE, V78, P220; Charbonneau H., 2000, POPULATION HIST N AM, P99; Chong JX, 2012, AM J HUM GENET, V91, P608, DOI 10.1016/j.ajhg.2012.08.007; Desjardins B, 1990, Cah Que Demogr, V19, P63; Gagnon A, 2001, AM J PHYS ANTHROPOL, V114, P30, DOI 10.1002/1096-8644(200101)114:1<30::AID-AJPA1003>3.0.CO;2-L; Gorlov IP, 2008, AM J HUM GENET, V82, P100, DOI 10.1016/j.ajhg.2007.09.006; Helgason A, 2005, NAT GENET, V37, P90, DOI 10.1038/ng1492; Heutink P, 2002, HUM MOL GENET, V11, P2507, DOI 10.1093/hmg/11.20.2507; Kidd JM, 2012, AM J HUM GENET, V91, P660, DOI 10.1016/j.ajhg.2012.08.025; Laberge AM, 2005, CLIN GENET, V68, P287, DOI 10.1111/j.1399-0004.2005.00497.x; Labuda D, 1997, AM J HUM GENET, V61, P768, DOI 10.1016/S0002-9297(07)64341-9; Loh PR, 2013, GENETICS, V193, P1233, DOI 10.1534/genetics.112.147330; McKusick VA, 2007, AM J HUM GENET, V80, P588, DOI 10.1086/514346; Moorjani P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001373; Moreau C, 2007, M S-MED SCI, V23, P1008, DOI 10.1051/medsci/200723111008; Moreau C, 2011, ANN HUM GENET, V75, P247, DOI 10.1111/j.1469-1809.2010.00617.x; Moreau C, 2009, AM J PHYS ANTHROPOL, V139, P512, DOI 10.1002/ajpa.21012; Morera B, 2004, REV BIOL TROP, V52, P629; Ostrer H, 2001, NAT REV GENET, V2, P891, DOI 10.1038/35098506; PALAMARA PF, 2012, AM J HUM GENET, pR1; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Peltonen L, 2000, NAT REV GENET, V1, P182, DOI 10.1038/35042049; Peltonen L, 1999, HUM MOL GENET, V8, P1913, DOI 10.1093/hmg/8.10.1913; Price AL, 2007, AM J HUM GENET, V80, P1024, DOI 10.1086/518313; Price AL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000519; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rahman P, 2003, HUM MOL GENET, V12, pR167, DOI 10.1093/hmg/ddg257; RCore Team, 2020, R LANG ENV STAT COMP; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Roy-Gagnon MH, 2011, HUM GENET, V129, P521, DOI 10.1007/s00439-010-0945-x; Sarkissian CD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003296; Scriver CR, 2001, ANNU REV GENOM HUM G, V2, P69, DOI 10.1146/annurev.genom.2.1.69; Seldin MF, 2007, AM J PHYS ANTHROPOL, V132, P455, DOI 10.1002/ajpa.20534; Shah AM, 2011, AM J HUM GENET, V89, P154, DOI 10.1016/j.ajhg.2011.05.030; Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856; Torkamani Ali, 2012, Frontiers in Genetics, V3, P211, DOI 10.3389/fgene.2012.00211; Tremblay M, 2000, AM J HUM GENET, V66, P651, DOI 10.1086/302770; Velez C, 2012, HUM GENET, V131, P251, DOI 10.1007/s00439-011-1072-z; VEZMA H, 2012, CAHIERS QUEBECOIS DE, V41, P87; Wang S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000037; Yotova V, 2005, HUM GENET, V117, P177, DOI 10.1007/s00439-005-1298-8; Zeegers MPA, 2004, EUR J HUM GENET, V12, P591, DOI 10.1038/sj.ejhg.5201151	54	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65507	10.1371/journal.pone.0065507	http://dx.doi.org/10.1371/journal.pone.0065507			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	163FW	23776491	Green Submitted, Green Published, gold			2022-12-27	WOS:000320322400029
J	Tang, ZP; Dong, QZ; Cui, QZ; Papavassiliou, P; Wang, ED; Wang, EH				Tang, Zhong-Ping; Dong, Qian-Ze; Cui, Quan-Zhe; Papavassiliou, Paulie; Wang, En-Di; Wang, En-Hua			Ataxia-Telangiectasia Group D Complementing Gene (ATDC) Promotes Lung Cancer Cell Proliferation by Activating NF-kappa B Pathway	PLOS ONE			English	Article							PROSTATE-CANCER; CYCLIN D1; C-MYC; PANCREATIC-CANCER; IN-SITU; EXPRESSION; PROFILES; OVEREXPRESSION; IDENTIFICATION; RESISTANCE	Previous studies suggested Ataxia-telangiectasia group D complementing gene (ATDC) as an oncogene in many types of cancer. However, its expression and biological functions in non-small cell lung cancer (NSCLC) remain unclear. Herein, we investigated its expression pattern in 109 cases of human NSCLC samples by immunohistochemistry and found that ATDC was overexpressed in 62 of 109 NSCLC samples (56.88%). ATDC overexpression correlated with histological type (p<0.0001), tumor status (p = 0.0227) and histological differentiation (p = 0.0002). Next, we overexpressed ATDC in normal human bronchial epithelial cell line HBE and depleted its expression in NSCLC cell lines A549 and H1299. MTT and colony formation assay showed that ATDC overexpression promoted cell proliferation while its depletion inhibited cell growth. Furthermore, cell cycle analysis showed that ATDC overexpression decreased the percentage of cells in G1 phase and increased the percentage of cells in S phase, while ATDC siRNA treatment increased the G1 phase percentage and decreased the S phase percentage. Further study revealed that ATDC overexpression could up-regulate cyclin D1 and c-Myc expression in HBE cells while its depletion down-regulated cyclin D1 and c-Myc expression in A549 and H1299 cells. In addition, ATDC overexpression was also associated with an increased proliferation index, cyclin D1 and c-Myc expression in human NSCLC samples. Further experiments demonstrated that ATDC up-regulated cyclin D1 and c-Myc expression independent of wnt/beta-catenin or p53 signaling pathway. Interestingly, ATDC overexpression increased NF-kappa B reporter luciferase activity and p-I kappa B protein level. Correspondingly, NF-kappa B inhibitor blocked the effect of ATDC on up-regulation of cyclin D1 and c-Myc. In conclusion, we demonstrated that ATDC could promote lung cancer proliferation through NF-kappa B induced up-regulation of cyclin D1 and c-Myc.	[Tang, Zhong-Ping; Dong, Qian-Ze; Cui, Quan-Zhe; Wang, En-Hua] China Med Univ, Affiliated Hosp 1, Dept Pathol, Shenyang, Peoples R China; [Tang, Zhong-Ping; Dong, Qian-Ze; Cui, Quan-Zhe; Wang, En-Hua] China Med Univ, Coll Basic Med Sci, Shenyang, Peoples R China; [Papavassiliou, Paulie; Wang, En-Di] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA	China Medical University; China Medical University; Duke University	Wang, EH (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Pathol, Shenyang, Peoples R China.	wangeh@hotmail.com			National Natural Science Foundation of China [81071905, 81272606]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (grants 81071905 and 81272606). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Ames BN, 1998, BIOTHERAPY, V11, P205, DOI 10.1023/A:1007971204469; Baldwin AS, 2001, J CLIN INVEST, V107, P241, DOI 10.1172/JCI11991; BRZOSKA PM, 1995, P NATL ACAD SCI USA, V92, P7824, DOI 10.1073/pnas.92.17.7824; Burke L, 2005, CLIN CANCER RES, V11, P232; Chen CL, 2000, MOL CELL BIOL, V20, P2687, DOI 10.1128/MCB.20.8.2687-2695.2000; Dyrskjot L, 2004, CANCER RES, V64, P4040, DOI 10.1158/0008-5472.CAN-03-3620; Fernandez-Majada V, 2007, P NATL ACAD SCI USA, V104, P276, DOI 10.1073/pnas.0606476104; Glebov OK, 2006, CANCER EPIDEM BIOMAR, V15, P2253, DOI 10.1158/1055-9965.EPI-05-0694; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; Hawthorn L, 2006, LUNG CANCER, V53, P129, DOI 10.1016/j.lungcan.2006.04.015; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; KAPP LN, 1992, AM J HUM GENET, V51, P45; KARN J, 1989, ONCOGENE, V4, P773; Keum JS, 1999, BRIT J CANCER, V81, P127, DOI 10.1038/sj.bjc.6690661; Knudsen KE, 2006, ONCOGENE, V25, P1620, DOI 10.1038/sj.onc.1209371; Kosaka Y, 2007, ANN SURG ONCOL, V14, P2543, DOI 10.1245/s10434-007-9461-1; LaTulippe E, 2002, CANCER RES, V62, P4499; Li Q, 2011, P NATL ACAD SCI USA, V108, P19341, DOI 10.1073/pnas.1110946108; Li YJ, 2005, WORLD J GASTROENTERO, V11, P2117, DOI 10.3748/wjg.v11.i14.2117; Liu XL, ZHONGHUA SHI YAN HE, V25, P60; Luo J, 2001, CANCER RES, V61, P4683; Minna JD, 2002, CANCER CELL, V1, P49, DOI 10.1016/S1535-6108(02)00027-2; Mutter GL, 2001, GYNECOL ONCOL, V83, P177, DOI 10.1006/gyno.2001.6352; Nacht M, 1999, CANCER RES, V59, P5464; Noguchi K, 2011, CARCINOGENESIS, V32, P995, DOI 10.1093/carcin/bgr068; Ohmachi T, 2006, CLIN CANCER RES, V12, P3057, DOI 10.1158/1078-0432.CCR-05-1961; Oliveira NMM, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-81; POSTE G, 1980, NATURE, V283, P139, DOI 10.1038/283139a0; Rahman KMW, 2007, MOL CANCER THER, V6, P2757, DOI 10.1158/1535-7163.MCT-07-0336; Ratschiller D, 2003, J CLIN ONCOL, V21, P2085, DOI 10.1200/JCO.2003.03.103; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Roy PG, 2006, BREAST, V15, P718, DOI 10.1016/j.breast.2006.02.005; Santin AD, 2004, INT J CANCER, V112, P14, DOI 10.1002/ijc.20408; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; SHICHIRI M, 1993, CELL GROWTH DIFFER, V4, P93; Sho T, 1813, BIOCH BIOPHYS ACTA, P1245; Smith AP, 2005, CANCER BIOL THER, V4, P1018, DOI 10.4161/cbt.4.9.2165; Tew GW, 2008, J BIOL CHEM, V283, P963, DOI 10.1074/jbc.M707526200; Tung JN, 2010, MOL VIS, V16, P2733; Udhayakumar G, 2007, MOL CARCINOGEN, V46, P807, DOI 10.1002/mc.20311; Wang LD, 2009, CANCER CELL, V15, P207, DOI 10.1016/j.ccr.2009.01.018; Yu S, BIOCH BIOPHYS RES CO, V410, P247; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158; Yuan Z, J BIOL CHEM, V285, P39329; Yuan Z, MOL CELL BIOL, V30, P3004; Zhan FH, 2002, BLOOD, V99, P1745, DOI 10.1182/blood.V99.5.1745; Zhang P, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-224; Zhao G, PLOS PATHOG, V7	49	25	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e63676	10.1371/journal.pone.0063676	http://dx.doi.org/10.1371/journal.pone.0063676			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776433	gold, Green Published, Green Submitted			2022-12-27	WOS:000320322400002
J	Galban, S; Jeon, YH; Bowman, BM; Stevenson, J; Sebolt, KA; Sharkey, LM; Lafferty, M; Hoff, BA; Butler, BL; Wigdal, SS; Binkowski, BF; Otto, P; Zimmerman, K; Vidugiris, G; Encell, LP; Fan, F; Wood, KV; Galban, CJ; Ross, BD; Rehemtulla, A				Galban, Stefanie; Jeon, Yong Hyun; Bowman, Brittany M.; Stevenson, James; Sebolt, Katrina A.; Sharkey, Lisa M.; Lafferty, Michael; Hoff, Benjamin A.; Butler, Braeden L.; Wigdal, Susan S.; Binkowski, Brock F.; Otto, Paul; Zimmerman, Kris; Vidugiris, Gediminas; Encell, Lance P.; Fan, Frank; Wood, Keith V.; Galban, Craig J.; Ross, Brian D.; Rehemtulla, Alnawaz			Imaging Proteolytic Activity in Live Cells and Animal Models	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; INDUCED ACUTE-PANCREATITIS; CANCER STEM-CELLS; FIREFLY LUCIFERASE; CASPASE ACTIVATION; APOPTOSIS; ASSAYS; COMPLEMENTATION; CHEMORESISTANCE; THERAPY	In addition to their degradative role in protein turnover, proteases play a key role as positive or negative regulators of signal transduction pathways and therefore their dysregulation contributes to many disease states. Regulatory roles of proteases include their hormone-like role in triggering G protein-coupled signaling (Protease-Activated-Receptors); their role in shedding of ligands such as EGF, Notch and Fas; and their role in signaling events that lead to apoptotic cell death. Dysregulated activation of apoptosis by the caspase family of proteases has been linked to diseases such as cancer, autoimmunity and inflammation. In an effort to better understand the role of proteases in health and disease, a luciferase biosensor is described which can quantitatively report proteolytic activity in live cells and mouse models. The biosensor, hereafter referred to as GloSensor Caspase 3/7 has a robust signal to noise (50-100 fold) and dynamic range such that it can be used to screen for pharmacologically active compounds in high throughput campaigns as well as to study cell signaling in rare cell populations such as isolated cancer stem cells. The biosensor can also be used in the context of genetically engineered mouse models of human disease wherein conditional expression using the Cre/loxP technology can be implemented to investigate the role of a specific protease in living subjects. While the regulation of apoptosis by caspase's was used as an example in these studies, biosensors to study additional proteases involved in the regulation of normal and pathological cellular processes can be designed using the concepts presented herein.	[Galban, Stefanie; Jeon, Yong Hyun; Bowman, Brittany M.; Stevenson, James; Sebolt, Katrina A.; Sharkey, Lisa M.; Lafferty, Michael; Hoff, Benjamin A.; Galban, Craig J.; Ross, Brian D.; Rehemtulla, Alnawaz] Univ Michigan, Sch Med, Ctr Mol Imaging, Ann Arbor, MI 48109 USA; [Galban, Stefanie; Jeon, Yong Hyun; Sebolt, Katrina A.; Sharkey, Lisa M.; Lafferty, Michael; Rehemtulla, Alnawaz] Univ Michigan, Sch Med, Dept Radiat Oncol, Ann Arbor, MI USA; [Rehemtulla, Alnawaz] Univ Michigan, Sch Med, Cellular & Mol Biol Program, Ann Arbor, MI USA; [Bowman, Brittany M.; Ross, Brian D.] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Hoff, Benjamin A.; Galban, Craig J.; Ross, Brian D.] Univ Michigan, Sch Med, Dept Radiol, Ann Arbor, MI USA; [Butler, Braeden L.; Wigdal, Susan S.; Binkowski, Brock F.; Otto, Paul; Zimmerman, Kris; Vidugiris, Gediminas; Encell, Lance P.; Fan, Frank; Wood, Keith V.] Promega, Madison, WI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Promega Corporation	Rehemtulla, A (corresponding author), Univ Michigan, Sch Med, Ctr Mol Imaging, Ann Arbor, MI 48109 USA.	alnawaz@umich.edu	Jeon, Yong hyun/N-6910-2019	Jeon, Yong hyun/0000-0003-3161-7698; Lafferty, Michael/0000-0002-1000-0480; Bowman, Brittany/0000-0003-2054-6169	University of Michigan Cancer Center, NIH [CA46592]; National Institutes of Health [P01CA085878, P50CA093990, R01CA136892]; NATIONAL CANCER INSTITUTE [P30CA046592, R01CA136892, R01CA136829, P50CA093990, P01CA085878] Funding Source: NIH RePORTER	University of Michigan Cancer Center, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Core support was provided by the University of Michigan Cancer Center, NIH grant number CA46592. Financial support was provided by the National Institutes of Health grants P01CA085878, P50CA093990 and R01CA136892. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan SL, 2003, J BIOL CHEM, V278, P20453, DOI 10.1074/jbc.C300138200; Chen Z, 2012, NATURE, V483, P613, DOI 10.1038/nature10937; Chinnaiyan AM, 2000, P NATL ACAD SCI USA, V97, P1754, DOI 10.1073/pnas.030545097; Coppola JM, 2008, CLIN CANCER RES, V14, P2492, DOI 10.1158/1078-0432.CCR-07-0782; di Magliano MP, 2006, GENE DEV, V20, P3161, DOI 10.1101/gad.1470806; Ding SQ, 2010, HEPATOB PANCREAT DIS, V9, P645; Edgington LE, 2009, NAT MED, V15, P967, DOI 10.1038/nm.1938; Fan F, 2008, ACS CHEM BIOL, V3, P346, DOI 10.1021/cb8000414; Galluzzi L, 2009, CELL DEATH DIFFER, V16, P1093, DOI 10.1038/cdd.2009.44; Hall M, 1998, BIOLUMINESCENCE CHEM, P392; Kanno A, 2007, ANGEW CHEM INT EDIT, V46, P7595, DOI 10.1002/anie.200700538; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Kepp O, 2011, NAT REV DRUG DISCOV, V10, P221, DOI 10.1038/nrd3373; Kim H, 2008, GUT LIVER, V2, P74, DOI 10.5009/gnl.2008.2.2.74; Kuehl WM, 2012, BLOOD, V120, P238, DOI 10.1182/blood-2012-04-422501; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Liu Y, 2013, MOL MED REP, V7, P725, DOI 10.3892/mmr.2012.1241; Luker KE, 2004, P NATL ACAD SCI USA, V101, P12288, DOI 10.1073/pnas.0404041101; Morris JP, 2010, J CLIN INVEST, V120, P508, DOI 10.1172/JCI40045; Ozawa T, 2001, ANAL CHEM, V73, P2516, DOI 10.1021/ac0013296; Paulmurugan R, 2002, P NATL ACAD SCI USA, V99, P15608, DOI 10.1073/pnas.242594299; Wigdal Susan S, 2008, Curr Chem Genomics, V2, P16, DOI 10.2174/1875397300802010016; Yang JP, 2011, CHINESE MED J-PEKING, V124, P1055, DOI 10.3760/cma.j.issn.0366-6999.2011.07.020; Yi CH, 2007, J CELL BIOL, V179, P619, DOI 10.1083/jcb.200708090; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang XHF, 2009, CANCER CELL, V16, P67, DOI 10.1016/j.ccr.2009.05.017	26	28	28	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66248	10.1371/journal.pone.0066248	http://dx.doi.org/10.1371/journal.pone.0066248			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776643	gold, Green Published, Green Submitted			2022-12-27	WOS:000320755400125
J	Hu, Q; He, GC; Zhao, J; Soshilov, A; Denison, MS; Zhang, AQ; Yin, HJ; Fraccalvieri, D; Bonati, L; Xie, QH; Zhao, B				Hu, Qin; He, Guochun; Zhao, Jing; Soshilov, Anatoly; Denison, Michael S.; Zhang, Aiqian; Yin, Huijun; Fraccalvieri, Domenico; Bonati, Laura; Xie, Qunhui; Zhao, Bin			Ginsenosides Are Novel Naturally-Occurring Aryl Hydrocarbon Receptor Ligands	PLOS ONE			English	Article							AH RECEPTOR; BINDING DOMAIN; PROTEIN STRUCTURES; HOMOLOGY MODELS; PANAX-GINSENG; IN-VITRO; ACTIVATION; AGONISTS; INDUCTION; DOCKING	The aryl hydrocarbon receptor (AHR) is a ligand-dependent transcription factor that mediates many of the biological and toxicological actions of structurally diverse chemicals. In this study, we examined the ability of a series of ginsenosides extracted from ginseng, a traditional Chinese medicine, to bind to and activate/inhibit the AHR and AHR signal transduction. Utilizing a combination of ligand and DNA binding assays, molecular docking and reporter gene analysis, we demonstrated the ability of selected ginsenosides to directly bind to and activate the guinea pig cytosolic AHR, and to stimulate/inhibit AHR-dependent luciferase gene expression in a recombinant guinea pig cell line. Comparative studies revealed significant species differences in the ability of ginsenosides to stimulate AHR-dependent gene expression in guinea pig, rat, mouse and human cell lines. Not only did selected ginsenosides preferentially activate the AHR from one species and not others, mouse cell line was also significantly less responsive to these chemicals than rat and guinea pig cell lines, but the endogenous gene CYP1A1 could still be inducted in mouse cell line. Overall, the ability of these compounds to stimulate AHR signal transduction demonstrated that these ginsenosides are a new class of naturally occurring AHR agonists.	[Hu, Qin; Zhang, Aiqian; Xie, Qunhui; Zhao, Bin] Chinese Acad Sci, Ecoenvironm Sci Res Ctr, Beijing, Peoples R China; [He, Guochun; Zhao, Jing; Soshilov, Anatoly; Denison, Michael S.] Univ Calif Davis, Dept Environm Toxicol, Davis, CA 95616 USA; [Yin, Huijun] China Acad Chinese Med Sci, Xiyuan Hosp, Beijing, Peoples R China; [Fraccalvieri, Domenico; Bonati, Laura] Univ Milano Bicocca, Dept Earth & Environm Sci, Milan, Italy	Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); University of California System; University of California Davis; China Academy of Chinese Medical Sciences; Xiyuan Hospital, CACMS; University of Milano-Bicocca	Zhao, B (corresponding author), Chinese Acad Sci, Ecoenvironm Sci Res Ctr, POB 934, Beijing, Peoples R China.	binzhao@rcees.ac.cn	Fraccalvieri, Domenico/AAI-2355-2020		Chinese Academy of Sciences [KZCX2-EW-411]; National Natural Science Foundation of China [21177150, 20921063]; National Institutes of Environmental Health Sciences [R01-ES07685, P42-ES004699]; California Agricultural Experiment Station; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007685, P42ES004699] Funding Source: NIH RePORTER	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); California Agricultural Experiment Station; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by Chinese Academy of Sciences Key Program of Knowledge Innovation (KZCX2-EW-411), National Natural Science Foundation of China (21177150 and 20921063), the National Institutes of Environmental Health Sciences (R01-ES07685, P42-ES004699) and the California Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, GLID VERS 5 8; [Anonymous], 2011, AH RECEPTOR BIOL TOX; [Anonymous], 2012, MAESTR VERS 9 3; [Anonymous], 2012, MACROMODEL VERS 9 9; Ashida H, 2000, FEBS LETT, V476, P213, DOI 10.1016/S0014-5793(00)01730-0; Attele AS, 2002, DIABETES, V51, P1851, DOI 10.2337/diabetes.51.6.1851; BJELDANES LF, 1991, P NATL ACAD SCI USA, V88, P9543, DOI 10.1073/pnas.88.21.9543; Bordogna A, 2011, J COMPUT CHEM, V32, P81, DOI 10.1002/jcc.21601; Chen X, 1996, CLIN EXP PHARMACOL P, V23, P728, DOI 10.1111/j.1440-1681.1996.tb01767.x; Ciolino HP, 1998, CANCER RES, V58, P5707; Delescluse C, 2000, TOXICOLOGY, V153, P73, DOI 10.1016/S0300-483X(00)00305-X; Denison M.S., 1998, MOL BIOLOY APPROACHE, P3; Denison MS, 2011, TOXICOL SCI, V124, P1, DOI 10.1093/toxsci/kfr218; DENISON MS, 1986, J BIOL CHEM, V261, P3987; Denison MS, 2003, ANNU REV PHARMACOL, V43, P309, DOI 10.1146/annurev.pharmtox.43.100901.135828; DENISON MS, 2002, CURRENT PROTOCOLS TO; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Fraccalvieri D, 2013, BIOCHEMISTRY-US, V52, P714, DOI 10.1021/bi301457f; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Garrison PM, 1996, FUND APPL TOXICOL, V30, P194, DOI 10.1006/faat.1996.0056; Han D, 2004, BIOFACTORS, V20, P11, DOI 10.1002/biof.5520200102; HANKINSON O, 1995, ANNU REV PHARMACOL, V35, P307, DOI 10.1146/annurev.pharmtox.35.1.307; Henry EC, 2003, MOL PHARMACOL, V63, P392, DOI 10.1124/mol.63.2.392; Hestermann EV, 2000, TOXICOL APPL PHARM, V168, P160, DOI 10.1006/taap.2000.9026; Hooper LV, 2011, CELL, V147, P486, DOI 10.1016/j.cell.2011.10.004; Hu WY, 2007, MOL PHARMACOL, V71, P1475, DOI 10.1124/mol.106.032748; Huang KC, 1999, PHARM CHINESE HERBS; Joh EH, 2011, BIOCHEM PHARMACOL, V82, P278, DOI 10.1016/j.bcp.2011.05.003; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Kazlauskas A, 1999, J BIOL CHEM, V274, P13519, DOI 10.1074/jbc.274.19.13519; Lee KT, 2011, ARCH PHARM RES, V34, P1201, DOI 10.1007/s12272-011-0719-6; Li Y, 2011, CELL, V147, P620; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Meyer BK, 1998, MOL CELL BIOL, V18, P978, DOI 10.1128/MCB.18.2.978; Motto I, 2011, J CHEM INF MODEL, V51, P2868, DOI 10.1021/ci2001617; Mukai R, 2010, ARCH BIOCHEM BIOPHYS, V501, P134, DOI 10.1016/j.abb.2010.05.002; Nagy SR, 2002, TOXICOL SCI, V65, P200, DOI 10.1093/toxsci/65.2.200; Pandini A, 2007, BIOCHEMISTRY-US, V46, P696, DOI 10.1021/bi061460t; Pandini A, 2009, BIOCHEMISTRY-US, V48, P5972, DOI 10.1021/bi900259z; Puga A, 2009, BIOCHEM PHARMACOL, V77, P713, DOI 10.1016/j.bcp.2008.08.031; SAFE S, 1990, CRIT REV TOXICOL, V21, P51, DOI 10.3109/10408449009089873; SAKAKIBARA K, 1975, CHEM PHARM BULL, V23, P1009; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SATO K, 1994, BIOL PHARM BULL, V17, P635; Schmidt JV, 1996, ANNU REV CELL DEV BI, V12, P55, DOI 10.1146/annurev.cellbio.12.1.55; Seidel SD, 2000, TOXICOL SCI, V55, P107, DOI 10.1093/toxsci/55.1.107; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Soshilov A, 2011, J BIOL CHEM, V286, P35275, DOI 10.1074/jbc.M111.246439; STILL WC, 1990, J AM CHEM SOC, V112, P6127, DOI 10.1021/ja00172a038; TODE T, 1993, J CANCER RES CLIN, V120, P24, DOI 10.1007/BF01200720; Uno S, 2009, TOXICOL APPL PHARM, V237, P119, DOI 10.1016/j.taap.2009.03.001; VECCHINI F, 1994, BIOCHEM BIOPH RES CO, V201, P1205, DOI 10.1006/bbrc.1994.1833; Wang YG, 2008, EUR J PHARMACOL, V601, P73, DOI 10.1016/j.ejphar.2008.10.057	53	12	13	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66258	10.1371/journal.pone.0066258	http://dx.doi.org/10.1371/journal.pone.0066258			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776647	Green Published, Green Submitted, gold			2022-12-27	WOS:000320755400129
J	King, AJ; van der Lee, S; Mohangoo, A; van Gent, M; van der Ark, A; van de Waterbeemd, B				King, Audrey J.; van der Lee, Saskia; Mohangoo, Archena; van Gent, Marjolein; van der Ark, Arno; van de Waterbeemd, Bas			Genome-Wide Gene Expression Analysis of Bordetella pertussis Isolates Associated with a Resurgence in Pertussis: Elucidation of Factors Involved in the Increased Fitness of Epidemic Strains	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; MYCOBACTERIUM-TUBERCULOSIS; EVOLUTION; VACCINE; EFFECTOR; SWEDEN; BRONCHISEPTICA; NETHERLANDS; REEMERGENCE; DIVERSITY	Bordetella pertussis (B. pertussis) is the causative agent of whooping cough, which is a highly contagious disease in the human respiratory tract. Despite vaccination since the 1950s, pertussis remains the most prevalent vaccine-preventable disease in developed countries. A recent resurgence pertussis is associated with the expansion of B. pertussis strains with a novel allele for the pertussis toxin (ptx) promoter ptxP3 in place of resident ptxP1 strains. The recent expansion of ptxP3 strains suggests that these strains carry mutations that have increased their fitness. Compared to the ptxP1 strains, ptxP3 strains produce more Ptx, which results in increased virulence and immune suppression. In this study, we investigated the contribution of gene expression changes of various genes on the increased fitness of the ptxP3 strains. Using genome-wide gene expression profiling, we show that several virulence genes had higher expression levels in the ptxP3 strains compared to the ptxP1 strains. We provide the first evidence that wildtype ptxP3 strains are better colonizers in an intranasal mouse infection model. This study shows that the ptxP3 mutation and the genetic background of ptxP3 strains affect fitness by contributing to the ability to colonize in a mouse infection model. These results show that the genetic background of ptxP3 strains with a higher expression of virulence genes contribute to increased fitness.	[King, Audrey J.; van der Lee, Saskia; Mohangoo, Archena; van Gent, Marjolein] Natl Inst Publ Hlth & Environm RIVM, Lab Infect Dis & Screening LIS, Ctr Infect Dis Control, Bilthoven, Netherlands; [van der Ark, Arno; van de Waterbeemd, Bas] Natl Inst Publ Hlth & Environm RIVM, Dept Vaccinol, Bilthoven, Netherlands	Netherlands National Institute for Public Health & the Environment; Netherlands National Institute for Public Health & the Environment	King, AJ (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Lab Infect Dis & Screening LIS, Ctr Infect Dis Control, Bilthoven, Netherlands.	audrey.king@rivm.nl			RIVM (SOR project)	RIVM (SOR project)	This project was supported by the RIVM (SOR project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advani A, 2007, APMIS, V115, P736, DOI 10.1111/j.1600-0463.2007.apm_628.x; Advani A, 2011, VACCINE, V29, P3438, DOI 10.1016/j.vaccine.2011.02.070; Bart MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-627; Bootsma RJ, 2002, PERCEPTION, V31, P901, DOI 10.1068/p3230; Bottero D, 2007, CLIN VACCINE IMMUNOL, V14, P1490, DOI 10.1128/CVI.00177-07; Coote JG, 2001, ADV MICROB PHYSIOL, V44, P141, DOI 10.1016/S0065-2911(01)44013-6; Crowcroft NS, 2006, LANCET, V367, P1926, DOI 10.1016/S0140-6736(06)68848-X; Cummings CA, 2006, J BACTERIOL, V188, P1775, DOI 10.1128/JB.188.5.1775-1785.2006; de Melker HE, 2000, EMERG INFECT DIS, V6, P348, DOI 10.3201/eid0604.000404; Deora R, 2002, J BACTERIOL, V184, P6942, DOI 10.1128/JB.184.24.6942-6951.2002; Deora R, 2001, MOL MICROBIOL, V40, P669, DOI 10.1046/j.1365-2958.2001.02415.x; French CT, 2009, CELL MICROBIOL, V11, P1735, DOI 10.1111/j.1462-5822.2009.01361.x; Gao Q, 2005, MICROBIOL-SGM, V151, P5, DOI 10.1099/mic.0.27539-0; Guris D, 1999, CLIN INFECT DIS, V28, P1230, DOI 10.1086/514776; Han HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017797; He QS, 2008, FUTURE MICROBIOL, V3, P329, DOI 10.2217/17460913.3.3.329; Heikkinen E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000904; Herrou J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006996; Jones AM, 2005, MOL MICROBIOL, V58, P700, DOI 10.1111/j.1365-2958.2005.04875.x; Kallonen T, 2009, EXPERT REV VACCINES, V8, P863, DOI [10.1586/erv.09.46, 10.1586/ERV.09.46]; Kallonen T, 2011, INFECT GENET EVOL, V11, P2034, DOI 10.1016/j.meegid.2011.09.012; King AJ, 2001, MICROBIOL-SGM, V147, P2885, DOI 10.1099/00221287-147-11-2885; King AJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-64; King AJ, 2008, BMC GENOMICS, V9, P1, DOI 10.1186/1471-2164-9-311; Komatsu E, 2010, CLIN VACCINE IMMUNOL, V17, P807, DOI 10.1128/CVI.00449-09; Kuwae A, 2006, J BIOL CHEM, V281, P6589, DOI 10.1074/jbc.M512711200; Lam C, 2012, INFECT GENET EVOL, V12, P492, DOI 10.1016/j.meegid.2012.01.001; Li WM, 2005, INT J TUBERC LUNG D, V9, P1314; Mattoo S, 2005, CLIN MICROBIOL REV, V18, P326, DOI 10.1128/CMR.18.2.326-382.2005; Medhekar B, 2009, MOL MICROBIOL, V71, P492, DOI 10.1111/j.1365-2958.2008.06543.x; Mei Jian, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P707; Mooi FR, 2001, EMERG INFECT DIS, V7, P526, DOI 10.3201/eid0707.017708; Mooi FR, 2010, INFECT GENET EVOL, V10, P36, DOI 10.1016/j.meegid.2009.10.007; Mooi FR, 2009, EMERG INFECT DIS, V15, P1206, DOI 10.3201/eid1508.081511; Octavia S, 2012, J INFECT DIS, V205, P1220, DOI 10.1093/infdis/jis178; Panina EM, 2005, MOL MICROBIOL, V58, P267, DOI 10.1111/j.1365-2958.2005.04823.x; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Shrivastava R, 2009, CURR OPIN MICROBIOL, V12, P88, DOI 10.1016/j.mib.2009.01.001; Streefland M, 2007, VACCINE, V25, P2994, DOI 10.1016/j.vaccine.2007.01.015; Thalen M, 1999, J BIOTECHNOL, V75, P147, DOI 10.1016/S0168-1656(99)00155-8; Thalen M, 2006, BIOLOGICALS, V34, P213, DOI 10.1016/j.biologicals.2005.11.002; van de Waterbeemd B, 2009, BIOTECHNOL BIOENG, V103, P900, DOI 10.1002/bit.22326; van Gent M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020340; van Gent M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018014; Watanabe M, 2002, VACCINE, V20, P1429, DOI 10.1016/S0264-410X(01)00460-1; Watanabe Mineo, 2004, Expert Rev Anti Infect Ther, V2, P447, DOI 10.1586/14787210.2.3.447	46	75	78	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66150	10.1371/journal.pone.0066150	http://dx.doi.org/10.1371/journal.pone.0066150			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776625	Green Published, Green Submitted, gold			2022-12-27	WOS:000320755400116
J	Wang, Y; Jiang, F; Zhuo, Z; Wu, XH; Wu, YD				Wang, Yang; Jiang, Fan; Zhuo, Zhu; Wu, Xian-Hui; Wu, Yun-Dong			A Method for WD40 Repeat Detection and Secondary Structure Prediction	PLOS ONE			English	Article							SER/THR-TRP TETRAD; PARKINSONS-DISEASE; STRUCTURE ASSIGNMENT; COMPARATIVE GENOMICS; DIVERSE FUNCTIONS; PROTEINS; FAMILY; IDENTIFICATION; LRRK2; ARCHITECTURE	WD40-repeat proteins (WD40s), as one of the largest protein families in eukaryotes, play vital roles in assembling protein-protein/DNA/RNA complexes. WD40s fold into similar beta-propeller structures despite diversified sequences. A program WDSP (WD40 repeat protein Structure Predictor) has been developed to accurately identify WD40 repeats and predict their secondary structures. The method is designed specifically for WD40 proteins by incorporating both local residue information and non-local family-specific structural features. It overcomes the problem of highly diversified protein sequences and variable loops. In addition, WDSP achieves a better prediction in identifying multiple WD40-domain proteins by taking the global combination of repeats into consideration. In secondary structure prediction, the average Q3 accuracy of WDSP in jack-knife test reaches 93.7%. A disease related protein LRRK2 was used as a representive example to demonstrate the structure prediction.	[Wang, Yang; Jiang, Fan; Zhuo, Zhu; Wu, Xian-Hui; Wu, Yun-Dong] Peking Univ, Shenzhen Grad Sch, Lab Chem Genom, Lab Computat Chem & Drug Design, Shenzhen, Peoples R China; [Wu, Yun-Dong] Peking Univ, Coll Chem, Beijing 100871, Peoples R China	Peking University; University Town of Shenzhen; Peking University	Wu, XH (corresponding author), Peking Univ, Shenzhen Grad Sch, Lab Chem Genom, Lab Computat Chem & Drug Design, Shenzhen, Peoples R China.	wuxh@pkusz.edu.cn; wuyd@pkusz.edu.cn	Wang, Yang/AAN-7740-2020; z, z/GXZ-4805-2022; z, z/HHN-3970-2022; Jiang, Fan/E-2771-2012; Z, Z/AEN-2153-2022; Wu, Yun-Dong/G-8463-2013		National Science Foundation of China [21133002]; Shenzhen Peacock Program; Peking University Shenzhen Graduate School	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Peacock Program; Peking University Shenzhen Graduate School	Financial support by the National Science Foundation of China (21133002, http://www.nsfc.gov.cn/e_nsfc/desktop/zn/0101.htm), the Shenzhen Peacock Program, and Peking University Shenzhen Graduate School is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade MA, 2000, J MOL BIOL, V298, P521, DOI 10.1006/jmbi.2000.3684; Andreeva A, 2004, NUCLEIC ACIDS RES, V32, pD226, DOI 10.1093/nar/gkh039; Baldi P, 1999, BIOINFORMATICS, V15, P937, DOI 10.1093/bioinformatics/15.11.937; Biedermann S, 2011, TRENDS PLANT SCI, V16, P38, DOI 10.1016/j.tplants.2010.09.007; Brohawn SG, 2008, SCIENCE, V322, P1369, DOI 10.1126/science.1165886; Buchan DWA, 2010, NUCLEIC ACIDS RES, V38, pW563, DOI 10.1093/nar/gkq427; Cai YD, 1998, J PROTEIN CHEM, V17, P363, DOI 10.1023/A:1022559300504; Chakraborty A, 2011, EPIGENETICS-US, V6, P665, DOI 10.4161/epi.6.6.16179; CHAN AWE, 1993, PROTEIN SCI, V2, P1574, DOI 10.1002/pro.5560021004; Coggill P, 2008, CURR PROTOC BIOINFOR, V2, P2; Fulop V, 1999, CURR OPIN STRUC BIOL, V9, P715, DOI 10.1016/S0959-440X(99)00035-4; GIBRAT JF, 1987, J MOL BIOL, V198, P425, DOI 10.1016/0022-2836(87)90292-0; Goldberg D.E., 1989, GENETIC ALGORITHMS S; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Hattendorf DA, 2007, NATURE, V446, P567, DOI 10.1038/nature05635; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; Hsia KC, 2007, CELL, V131, P1313, DOI 10.1016/j.cell.2007.11.038; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; HUTCHINSON EG, 1994, PROTEIN SCI, V3, P2207, DOI 10.1002/pro.5560031206; Jackson S, 2009, TRENDS BIOCHEM SCI, V34, P562, DOI 10.1016/j.tibs.2009.07.002; Jennings BH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-205; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Lee BD, 2012, TRENDS PHARMACOL SCI, V33, P365, DOI 10.1016/j.tips.2012.04.001; Lee JS, 2007, CELL, V131, P1084, DOI 10.1016/j.cell.2007.09.046; Lees J, 2012, NUCLEIC ACIDS RES, V40, pD465, DOI 10.1093/nar/gkr1181; Li D, 2001, CELL MOL LIFE SCI, V58, P2085, DOI 10.1007/PL00000838; Martin J, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-17; Mata IF, 2005, NEUROGENETICS, V6, P171, DOI 10.1007/s10048-005-0005-1; Mata IF, 2006, TRENDS NEUROSCI, V29, P286, DOI 10.1016/j.tins.2006.03.006; Migliori V, 2012, EPIGENETICS-US, V7, P815, DOI 10.4161/epi.21140; Mohri K, 2004, J BIOL CHEM, V279, P31697, DOI 10.1074/jbc.M403351200; MURZIN AG, 1992, PROTEINS, V14, P191, DOI 10.1002/prot.340140206; Mylona A, 2006, MOL CELL, V24, P221, DOI 10.1016/j.molcel.2006.08.013; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Ouali M, 2000, PROTEIN SCI, V9, P1162, DOI 10.1110/ps.9.6.1162; Pirovano W, 2010, METHODS MOL BIOL, V609, P327, DOI 10.1007/978-1-60327-241-4_19; RICHARDSON JS, 1978, P NATL ACAD SCI USA, V75, P2574, DOI 10.1073/pnas.75.6.2574; ROST B, 1994, J MOL BIOL, V235, P13, DOI 10.1016/S0022-2836(05)80007-5; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; Rost B, 2001, J STRUCT BIOL, V134, P204, DOI 10.1006/jsbi.2001.4336; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Scrima A, 2008, CELL, V135, P1213, DOI 10.1016/j.cell.2008.10.045; Shen Z, 2010, MOL CELL, V40, P99, DOI 10.1016/j.molcel.2010.09.021; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Stirnimann CU, 2010, TRENDS BIOCHEM SCI, V35, P565, DOI 10.1016/j.tibs.2010.04.003; Suganuma T, 2008, GENE DEV, V22, P1265, DOI 10.1101/gad.1676208; Tan EK, 2007, HUM MUTAT, V28, P641, DOI 10.1002/humu.20507; Vagin VV, 2009, GENE DEV, V23, P1749, DOI 10.1101/gad.1814809; Webber PJ, 2009, FEBS J, V276, P6436, DOI 10.1111/j.1742-4658.2009.07342.x; Wilson D, 2009, NUCLEIC ACIDS RES, V37, pD380, DOI 10.1093/nar/gkn762; Wu XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043005; Wu XH, 2010, BIOCHEMISTRY-US, V49, P10237, DOI 10.1021/bi101321y; Wu XH, 2010, PROTEINS, V78, P1186, DOI 10.1002/prot.22638; Xu C, 2011, PROTEIN CELL, V2, P202, DOI 10.1007/s13238-011-1018-1; Yu LH, 2000, PROTEIN SCI, V9, P2470, DOI 10.1110/ps.9.12.2470; Zhang W, 2008, PROTEINS, V71, P61, DOI 10.1002/prot.21654	58	26	30	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65705	10.1371/journal.pone.0065705	http://dx.doi.org/10.1371/journal.pone.0065705			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776530	gold, Green Published, Green Submitted			2022-12-27	WOS:000320755400058
J	Higareda-Almaraz, JC; Valtierra-Gutierrez, IA; Hernandez-Ortiz, M; Contreras, S; Hernandez, E; Encarnacion, S				Carlos Higareda-Almaraz, Juan; Valtierra-Gutierrez, Ilse A.; Hernandez-Ortiz, Magdalena; Contreras, Sandra; Hernandez, Erika; Encarnacion, Sergio			Analysis and Prediction of Pathways in HeLa Cells by Integrating Biological Levels of Organization with Systems-Biology Approaches	PLOS ONE			English	Article							SIGNALING PATHWAYS; CERVICAL-CANCER; BREAST-CANCER; TRANSCRIPTIONAL NETWORK; MOLECULAR NETWORKS; C-MYC; PROTEIN; IDENTIFICATION; GENE; COMPLEXITY	It has recently begun to be considered that cancer is a systemic disease and that it must be studied at every level of complexity using many of the currently available approaches, including high-throughput technologies and bioinformatics. To achieve such understanding in cervical cancer, we collected information on gene, protein and phosphoprotein expression of the HeLa cell line and performed a comprehensive analysis of the different signaling pathways, transcription networks and metabolic events in which they participate. A total expression analysis by RNA-Seq of the HeLa cell line showed that 19,974 genes were transcribed. Of these, 3,360 were over-expressed, and 2,129 under-expressed when compared to the NHEK cell line. A protein-protein interaction network was derived from the over-expressed genes and used to identify central elements and, together with the analysis of over-represented transcription factor motifs, to predict active signaling and regulatory pathways. This was further validated by Metal-Oxide Affinity Chromatography (MOAC) and Tandem Mass Spectrometry (MS/MS) assays which retrieved phosphorylated proteins. The 14-3-3 family members emerge as important regulators in carcinogenesis and as possible clinical targets. We observed that the different over-and under-regulated pathways in cervical cancer could be interrelated through elements that participate in crosstalks, therefore belong to what we term "meta-pathways". Additionally, we highlighted the relations of each one of the differentially represented pathways to one or more of the ten hallmarks of cancer. These features could be maintained in many other types of cancer, regardless of mutations or genomic rearrangements, and favor their robustness, adaptations and the evasion of tissue control. Probably, this could explain why cancer cells are not eliminated by selective pressure and why therapy trials directed against molecular targets are not as effective as expected.	[Carlos Higareda-Almaraz, Juan; Valtierra-Gutierrez, Ilse A.; Hernandez-Ortiz, Magdalena; Contreras, Sandra; Encarnacion, Sergio] Univ Nacl Autonoma Mexico, Ctr Genom Sci, Funct Genom Prokaryotes Res Program, Cuernavaca, Morelos, Mexico; [Valtierra-Gutierrez, Ilse A.; Hernandez, Erika] Univ Nacl Autonoma Mexico, Undergrad Program Genom Sci, Cuernavaca, Morelos, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Encarnacion, S (corresponding author), Univ Nacl Autonoma Mexico, Ctr Genom Sci, Funct Genom Prokaryotes Res Program, Cuernavaca, Morelos, Mexico.	encarnac@ccg.unam.mx		Valtierra-Gutierrez, Ilse Ariadna/0000-0003-4128-5914; Higareda-Almaraz, Juan Carlos/0000-0002-4043-8547	DGAPA-PAPIIT [IN-216210]; DGAPAPAPIIT [IN-206113]; CONACyT [CVU 176426]	DGAPA-PAPIIT(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)); DGAPAPAPIIT(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Part of this work was supported by DGAPA-PAPIIT grant IN-216210 and DGAPAPAPIIT grant IN-206113. Juan Carlos Higareda-Almaraz is a recipient of a PhD Studentship from the CONACyT, CVU 176426. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge BB, 2006, NAT CELL BIOL, V8, P1195, DOI 10.1038/ncb1497; Almaas E, 2007, J EXP BIOL, V210, P1548, DOI 10.1242/jeb.003731; Antoniou AC, 2002, BRIT J CANCER, V86, P76, DOI 10.1038/sj.bjc.6600008; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Auffray C, 2009, GENOME MED, V1, DOI 10.1186/gm2; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Bauch A, 2006, IMMUNOL REV, V210, P187, DOI 10.1111/j.0105-2896.2006.00369.x; Benzinger A, 2005, MOL CELL PROTEOMICS, V4, P785, DOI 10.1074/mcp.M500021-MCP200; Boyer SN, 1996, CANCER RES, V56, P4620; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Camon E, 2003, GENOME RES, V13, P662, DOI 10.1101/gr.461403; Higareda-Almaraz JC, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-96; Danes CG, 2008, CANCER RES, V68, P1760, DOI 10.1158/0008-5472.CAN-07-3177; Dang CV, 2010, CANCER RES, V70, P859, DOI 10.1158/0008-5472.CAN-09-3556; Demir E, 2010, NAT BIOTECHNOL, V28, P935, DOI 10.1038/nbt.1666; Eswaran J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00264; Fang F, 2009, ENDOCRINOLOGY, V150, P1597, DOI 10.1210/en.2008-1079; Ferguson EC, 2008, TRENDS BIOCHEM SCI, V33, P359, DOI 10.1016/j.tibs.2008.05.006; Feron O, 2009, RADIOTHER ONCOL, V92, P329, DOI 10.1016/j.radonc.2009.06.025; Gentles AJ, 2011, CANCER RES, V71, P5961, DOI 10.1158/0008-5472.CAN-11-1569; Gerlinger M, 2010, BRIT J CANCER, V103, P1139, DOI 10.1038/sj.bjc.6605912; Gray MW, 2010, SCIENCE, V330, P920, DOI 10.1126/science.1198594; Greaves M, 2010, SEMIN CANCER BIOL, V20, P65, DOI 10.1016/j.semcancer.2010.03.002; Grosso AR, 2008, EMBO REP, V9, P1087, DOI 10.1038/embor.2008.189; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hermeking H, 2003, NAT REV CANCER, V3, P931, DOI 10.1038/nrc1230; Hirschhaeuser F, 2011, CANCER RES, V71, P6921, DOI 10.1158/0008-5472.CAN-11-1457; Hornberg JJ, 2006, BIOSYSTEMS, V83, P81, DOI 10.1016/j.biosystems.2005.05.014; HUBBARD MJ, 1993, TRENDS BIOCHEM SCI, V18, P172, DOI 10.1016/0968-0004(93)90109-Z; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Hyduke DR, 2010, NAT REV GENET, V11, P297, DOI 10.1038/nrg2750; Kalin TV, 2006, CANCER RES, V66, P1712, DOI 10.1158/0008-5472.CAN-05-3138; Kamburov A, 2011, NUCLEIC ACIDS RES, V39, pD712, DOI 10.1093/nar/gkq1156; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lefebvre C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.31; Li FQ, 2008, J CELL BIOL, V181, P1141, DOI 10.1083/jcb.200709091; Lin CY, 2008, NUCLEIC ACIDS RES, V36, pW438, DOI 10.1093/nar/gkn257; Little MP, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-19; Lu J, 2009, CANCER CELL, V16, P195, DOI 10.1016/j.ccr.2009.08.010; Macheda ML, 2005, J CELL PHYSIOL, V202, P654, DOI 10.1002/jcp.20166; Majid S, 2010, CANCER RES, V70, P2809, DOI 10.1158/0008-5472.CAN-09-4176; Manning G, 2002, TRENDS BIOCHEM SCI, V27, P514, DOI 10.1016/S0968-0004(02)02179-5; Martin A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-91; Mazzocchi F, 2008, EMBO REP, V9, P10, DOI 10.1038/sj.embor.7401147; Minn AJ, 2012, CELL CYCLE, V11, P2452, DOI 10.4161/cc.20624; Molano M, 2003, AM J EPIDEMIOL, V158, P486, DOI 10.1093/aje/kwg171; Mumby M, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-230; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Musgrove EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002987; Nagaraj N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.81; Niemantsverdriet M, 2008, ONCOGENE, V27, P1315, DOI 10.1038/sj.onc.1210742; Okuda S, 2008, NUCLEIC ACIDS RES, V36, pW423, DOI 10.1093/nar/gkn282; Palomero T, 2006, P NATL ACAD SCI USA, V103, P18261, DOI 10.1073/pnas.0606108103; Papin JA, 2005, NAT REV MOL CELL BIO, V6, P99, DOI 10.1038/nrm1570; Park J, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.16; Perez-Plasencia Carlos, 2008, Int Arch Med, V1, P10, DOI 10.1186/1755-7682-1-10; Pinto M, 2008, CELL ONCOL, V30, P389, DOI 10.3233/CLO-2008-0439; Porter GW, 2006, SEMIN CANCER BIOL, V16, P193, DOI 10.1016/j.semcancer.2006.03.003; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Raney BJ, 2011, NUCLEIC ACIDS RES, V39, pD871, DOI 10.1093/nar/gkq1017; Ricke RM, 2011, J CELL BIOL, V193, P1049, DOI 10.1083/jcb.201012035; Rosell R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001129; Salazar E, 2010, APPL ENVIRON MICROB, V76, P4510, DOI 10.1128/AEM.02007-09; Salinas S, 2009, EMBO REP, V10, P953, DOI 10.1038/embor.2009.195; Santin AD, 2005, VIROLOGY, V331, P269, DOI 10.1016/j.virol.2004.09.045; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Scotto L, 2008, GENE CHROMOSOME CANC, V47, P755, DOI 10.1002/gcc.20577; Seimiya H, 2000, EMBO J, V19, P2652, DOI 10.1093/emboj/19.11.2652; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sonnenschein C, 2011, SEMIN CANCER BIOL, V21, P147, DOI 10.1016/j.semcancer.2011.05.002; Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375; Takahashi K, 2005, FEBS LETT, V579, P1783, DOI 10.1016/j.febslet.2005.01.072; Tang YX, 2009, MOL CANCER THER, V8, P458, DOI 10.1158/1535-7163.MCT-08-0885; Tanno B, 2010, J BIOL CHEM, V285, P29434, DOI 10.1074/jbc.M109.089045; Nguyen TP, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-179; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vizan P, 2009, INT J CANCER, V124, P2789, DOI 10.1002/ijc.24262; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wolschin F, 2005, PROTEOMICS, V5, P4389, DOI 10.1002/pmic.200402049; Wong EWP, 2009, ENDOCRINOLOGY, V150, P4713, DOI 10.1210/en.2009-0427; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Xu XQ, 2007, GENOME RES, V17, P1550, DOI 10.1101/gr.6783507; Yamagata M, 1998, BRIT J CANCER, V77, P1726, DOI 10.1038/bjc.1998.289; Yamato K, 2006, CANCER GENE THER, V13, P234, DOI 10.1038/sj.cgt.7700891; Zubarev RA, 2008, J PROTEOMICS, V71, P89, DOI 10.1016/j.jprot.2008.01.004	94	7	8	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e65433	10.1371/journal.pone.0065433	http://dx.doi.org/10.1371/journal.pone.0065433			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23785426	Green Published, gold			2022-12-27	WOS:000320440500039
J	Ogbomo, H; Zemp, FJ; Lun, XQ; Zhang, JQ; Stack, D; Rahman, MM; Mcfadden, G; Mody, CH; Forsyth, PA				Ogbomo, Henry; Zemp, Franz J.; Lun, Xueqing; Zhang, Jiqing; Stack, Danuta; Rahman, Masmudur M.; Mcfadden, Grant; Mody, Christopher H.; Forsyth, Peter A.			Myxoma Virus Infection Promotes NK Lysis of Malignant Gliomas In Vitro and In Vivo	PLOS ONE			English	Article							TGF-BETA; MHC-I; CELLS; EXPRESSION; GLIOBLASTOMA; VIROTHERAPY; THERAPY; SURFACE; NKG2D; RESISTANCE	Myxoma virus (MYXV) is a well-established oncolytic agent against different types of tumors. MYXV is also known for its immunomodulatory properties in down-regulating major histocompatibility complex (MHC) I surface expression (via the M153R gene product, a viral E3-ubiquitin ligase) and suppressing T cell killing of infected target cells. MHC I down-regulation, however, favors NK cell activation. Brain tumors including gliomas are characterized by high MHC I expression with impaired NK activity. We thus hypothesized that MYXV infection of glioma cells will promote NK cell-mediated recognition and killing of gliomas. We infected human gliomas with MYXV and evaluated their susceptibility to NK cell-mediated cytotoxicity. MYXV enhanced NK cell-mediated killing of glioma cells (U87 cells, MYXV vs. Mock: 51.73% vs. 28.63%, P =.0001, t test; U251 cells, MYXV vs. Mock: 40.4% vs. 20.03%, P.0007, t test). Using MYXV M153R targeted knockout (designated vMyx-M153KO) to infect gliomas, we demonstrate that M153R was responsible for reduced expression of MHC I on gliomas and enhanced NK cell-mediated antiglioma activity (U87 cells, MYXV vs. vMyx-M153KO: 51.73% vs. 25.17%, P =.0002, t test; U251 cells, MYXV vs. vMyx-M153KO: 40.4% vs. 19.27, P =.0013, t test). Consequently, NK cell-mediated lysis of established human glioma tumors in CB-17 SCID mice was accelerated with improved mouse survival (log-rank P =.0072). These results demonstrate the potential for combining MYXV with NK cells to effectively kill malignant gliomas.	[Ogbomo, Henry; Zemp, Franz J.; Lun, Xueqing; Zhang, Jiqing; Forsyth, Peter A.] Univ Calgary, Dept Oncol, Calgary, AB, Canada; [Ogbomo, Henry; Zemp, Franz J.; Lun, Xueqing; Zhang, Jiqing; Forsyth, Peter A.] Univ Calgary, Dept Biochem, Calgary, AB, Canada; [Ogbomo, Henry; Zemp, Franz J.; Lun, Xueqing; Zhang, Jiqing; Forsyth, Peter A.] Univ Calgary, Dept Mol Biol, Calgary, AB, Canada; [Ogbomo, Henry; Stack, Danuta; Mody, Christopher H.] Univ Calgary, Dept Microbiol & Infect Dis, Calgary, AB, Canada; [Ogbomo, Henry; Stack, Danuta; Mody, Christopher H.] Univ Calgary, Dept Internal Med, Calgary, AB, Canada; [Rahman, Masmudur M.; Mcfadden, Grant] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL USA; [Forsyth, Peter A.] H Lee Moffitt Canc Ctr & Res Inst, Dept Neurooncol, Tampa, FL USA; [Forsyth, Peter A.] Univ S Florida, Tampa, FL USA	University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary; State University System of Florida; University of Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Forsyth, PA (corresponding author), Univ Calgary, Dept Oncol, Calgary, AB, Canada.	Peter.Forsyth@moffitt.org		McFadden, Grant/0000-0002-2556-3526; Mody, Christopher H./0000-0001-7264-3679	National Cancer Institute of Canada; Canadian Cancer Society Research Institute; National Cancer Institutes of Canada-Terry Fox Research Institute; Alberta Cancer Foundation; Alberta Innovates and Health Solutions postdoctoral fellowships; Canadian Institute for Health Research; Jessie Bowden Lloyd Professorship in Immunology; Alberta Innovates and Health Solutions; Killam Memorial Trust; Canadian Institute for Health Research Vanier Award; National Institutes of Health [AI080607, CA138541]; NATIONAL CANCER INSTITUTE [R01CA138541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080607] Funding Source: NIH RePORTER	National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); National Cancer Institutes of Canada-Terry Fox Research Institute; Alberta Cancer Foundation; Alberta Innovates and Health Solutions postdoctoral fellowships; Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Jessie Bowden Lloyd Professorship in Immunology; Alberta Innovates and Health Solutions; Killam Memorial Trust; Canadian Institute for Health Research Vanier Award(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Cancer Institute of Canada; Canadian Cancer Society Research Institute; National Cancer Institutes of Canada-Terry Fox Research Institute; Families of Clark H. Smith and Kathleen Lorette (PAF), Alberta Cancer Foundation and Alberta Innovates and Health Solutions postdoctoral fellowships (HO), Canadian Institute for Health Research grants and Jessie Bowden Lloyd Professorship in Immunology (CHM), Alberta Innovates and Health Solutions, Killam Memorial Trust, and Canadian Institute for Health Research Vanier Award (FJZ), National Institutes of Health R01 grants (AI080607 and CA138541; GM's lab). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Breckenridge CA, 2012, NAT MED, V18, P1827, DOI 10.1038/nm.3013; Alvarez-Breckenridge CA, 2012, ADV VIROL, V2012, DOI 10.1155/2012/702839; Avril T, 2010, J NEUROIMMUNOL, V225, P22, DOI 10.1016/j.jneuroim.2010.04.003; BARBA D, 1989, J NEUROSURG, V70, P175, DOI 10.3171/jns.1989.70.2.0175; Bhat R, 2011, INT J CANCER, V128, P908, DOI 10.1002/ijc.25415; BOSHKOV LK, 1992, J IMMUNOL, V148, P881; Castriconi R, 2009, J IMMUNOL, V182, P3530, DOI 10.4049/jimmunol.0802845; Collin N, 2005, VIROLOGY, V343, P171, DOI 10.1016/j.virol.2005.07.032; Crane CA, 2010, NEURO-ONCOLOGY, V12, P7, DOI 10.1093/neuonc/nop009; Diaz RM, 2007, CANCER RES, V67, P2840, DOI 10.1158/0008-5472.CAN-06-3974; Eisele G, 2006, BRAIN, V129, P2416, DOI 10.1093/brain/awl205; Friese MA, 2003, CANCER RES, V63, P8996; Glynn SA, 2004, BRIT J CANCER, V91, P1800, DOI 10.1038/sj.bjc.6602221; Guerin JL, 2002, J VIROL, V76, P2912, DOI 10.1128/JVI.76.6.2912-2923.2002; Holmes TD, 2011, J IMMUNOL, V186, P1538, DOI 10.4049/jimmunol.1000951; Ishikawa E, 2004, ANTICANCER RES, V24, P1861; JACKSON EW, 1966, NATURE, V211, P313, DOI 10.1038/211313a0; Johnston JB, 2003, J VIROL, V77, P5877, DOI 10.1128/JVI.77.10.5877-5888.2003; JOLY E, 1991, SCIENCE, V253, P1283, DOI 10.1126/science.1891717; Liang YH, 2004, INT J CANCER, V111, P484, DOI 10.1002/ijc.20230; Liu J, 2010, MICROBES INFECT, V12, P1144, DOI 10.1016/j.micinf.2010.08.012; Lun XQ, 2005, CANCER RES, V65, P9982, DOI 10.1158/0008-5472.CAN-05-1201; Lun XQ, 2010, CANCER RES, V70, P598, DOI 10.1158/0008-5472.CAN-09-1510; Mansouri M, 2003, J VIROL, V77, P1427, DOI 10.1128/JVI.77.2.1427-1440.2003; Ogbomo H, 2006, BIOCHEM BIOPH RES CO, V339, P375, DOI 10.1016/j.bbrc.2005.11.025; Ogbomo H, 2011, TRENDS MOL MED, V17, P433, DOI 10.1016/j.molmed.2011.03.004; Ogbomo H, 2010, MED MICROBIOL IMMUN, V199, P93, DOI 10.1007/s00430-009-0139-0; Ogbomo H, 2008, NEOPLASIA, V10, P1402, DOI 10.1593/neo.08972; Parney IF, 2000, NEUROSURGERY, V46, P1169, DOI 10.1097/00006123-200005000-00030; Parsa AT, 2007, NAT MED, V13, P84, DOI 10.1038/nm1517; Preusser M, 2006, WIEN MED WOCHENSCHR, V156, P332, DOI 10.1007/s10354-006-0304-7; Sloan KE, 2005, CANCER RES, V65, P10930, DOI 10.1158/0008-5472.CAN-05-1890; Smallwood Sherin E, 2010, Curr Protoc Microbiol, VChapter 14, DOI 10.1002/9780471729259.mc14a01s17; Stanford MM, 2007, VET RES, V38, P299, DOI 10.1051/vetres:2006054; Stanford MM, 2007, J VIROL, V81, P1251, DOI 10.1128/JVI.01408-06; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Szentirmai O, 2006, NEUROSURGERY, V58, P365, DOI 10.1227/01.NEU.0000195114.24819.4F; Vauleon E, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/689171; Wu AH, 2007, J NEURO-ONCOL, V83, P121, DOI 10.1007/s11060-006-9265-3; Yang WQ, 2003, CANCER RES, V63, P3162	40	38	40	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e66825	10.1371/journal.pone.0066825	http://dx.doi.org/10.1371/journal.pone.0066825			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762498	gold, Green Submitted, Green Published			2022-12-27	WOS:000320440500071
J	O'Leary, SJ; Hice, LA; Feldheim, KA; Frisk, MG; McElroy, AE; Fast, MD; Chapman, DD				O'Leary, Shannon J.; Hice, Lyndie A.; Feldheim, Kevin A.; Frisk, Michael G.; McElroy, Anne E.; Fast, Mark D.; Chapman, Demian D.			Severe Inbreeding and Small Effective Number of Breeders in a Formerly Abundant Marine Fish	PLOS ONE			English	Article							EFFECTIVE POPULATION-SIZE; FLOUNDER PLATICHTHYS-FLESUS; JUVENILE WINTER FLOUNDER; PSEUDOPLEURONECTES-AMERICANUS; SEASONAL MOVEMENTS; BALTIC SEA; DEPRESSION; LARVAL; SOFTWARE; RELATEDNESS	In contrast to freshwater fish it is presumed that marine fish are unlikely to spawn with close relatives due to the dilution effect of large breeding populations and their propensity for movement and reproductive mixing. Inbreeding is therefore not typically a focal concern of marine fish management. We measured the effective number of breeders in 6 New York estuaries for winter flounder (Pseudopleuronectes americanus), a formerly abundant fish, using 11 microsatellite markers (6-56 alleles per locus). The effective number of breeders for 1-2 years was remarkably small, with point estimates ranging from 65-289 individuals. Excess homozygosity was detected at 10 loci in all bays (F-IS = 0.169-0.283) and individuals exhibited high average internal relatedness (IR; mean = 0.226). These both indicate that inbreeding is very common in all bays, after testing for and ruling out alternative explanations such as technical and sampling artifacts. This study demonstrates that even historically common marine fish can be prone to inbreeding, a factor that should be considered in fisheries management and conservation plans.	[O'Leary, Shannon J.; Hice, Lyndie A.; Frisk, Michael G.; McElroy, Anne E.; Fast, Mark D.; Chapman, Demian D.] SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA; [Feldheim, Kevin A.] Field Museum, Pritzker Lab Mol Systemat & Evolut, Chicago, IL USA; [Fast, Mark D.] Univ Prince Edward Isl, Atlantic Vet Coll, Charlottetown, PE C1A 4P3, Canada; [Chapman, Demian D.] Inst Ocean Conservat Sci, Stony Brook, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Field Museum of Natural History (Chicago); University of Prince Edward Island	O'Leary, SJ (corresponding author), SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA.	shannon.oleary@stonybrook.edu			Institute for Ocean Conservation Science; Pew Charitable Trusts; Pritzker Foundation; Laurie Landeau Foundation; Saltonstall-Kennedy Grant Program (NOAA); NY DOS	Institute for Ocean Conservation Science; Pew Charitable Trusts; Pritzker Foundation; Laurie Landeau Foundation; Saltonstall-Kennedy Grant Program (NOAA); NY DOS	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Genetic analyses were supported by the Institute for Ocean Conservation Science with operational funds from The Pew Charitable Trusts. Microsatellite amplification was carried out in the Pritzker Laboratory for Molecular Systematics and Evolution operated with support from the Pritzker Foundation. Shinnecock Bay fish were sampled during the Shinnecock Bay Restoration Project, which is funded by the Laurie Landeau Foundation and matched by a gift from the Simons Foundation. Further funding was granted by the Saltonstall-Kennedy Grant Program (NOAA) and a NY DOS grant for field work in Hempstead Bays.	ALLENDORF FW, 1986, ZOO BIOL, V5, P181, DOI 10.1002/zoo.1430050212; Amos W, 2001, P ROY SOC B-BIOL SCI, V268, P2021, DOI 10.1098/rspb.2001.1751; Anderson JD, 2012, N AM J FISH MANAGE, V32, P656, DOI 10.1080/02755947.2012.686957; Armbruster P, 2005, HEREDITY, V95, P235, DOI 10.1038/sj.hdy.6800721; Bickley LK, 2013, EVOL APPL, V6, P279, DOI 10.1111/j.1752-4571.2012.00288.x; Buckley J, 1989, US FISH WILDL SERV B, V82; Buckley L, 2008, ESTUAR COAST, V31, P745, DOI 10.1007/s12237-008-9065-4; BUCKLEY LJ, 1991, MAR ECOL PROG SER, V74, P117, DOI 10.3354/meps074117; Castric V, 2002, HEREDITY, V89, P27, DOI 10.1038/sj.hdy.6800089; Chant RJ, 2000, ESTUAR COAST SHELF S, V51, P529, DOI 10.1006/ecss.2000.0694; Chapman TW, 1996, HEREDITY, V76, P65, DOI 10.1038/hdy.1996.8; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Crivello JF, 2004, J FISH BIOL, V65, P62, DOI 10.1111/j.0022-1112.2004.00424.x; DeLong AK, 2001, CAN J FISH AQUAT SCI, V58, P2233, DOI 10.1139/cjfas-58-11-2233; Dharmarajan G, 2013, J WILDLIFE MANAGE, V77, P226, DOI 10.1002/jwmg.458; Ferguson PL, 2001, ANAL CHEM, V73, P3890, DOI 10.1021/ac010327y; Florin AB, 2008, HEREDITY, V101, P27, DOI 10.1038/hdy.2008.22; Frankham R, 1996, CONSERV BIOL, V10, P1500, DOI 10.1046/j.1523-1739.1996.10061500.x; Frankham R, 1999, ANIM CONSERV, V2, P255, DOI 10.1111/j.1469-1795.1999.tb00071.x; Frasier TR, 2008, MOL ECOL RESOUR, V8, P1263, DOI 10.1111/j.1755-0998.2008.02358.x; Frisk MG, 2014, FISH FISH, V15, P242, DOI 10.1111/faf.12014; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Hauser L, 2002, PNAS, V99, P1142; Hemmer-Hansen J, 2007, MOL ECOL, V16, P3104, DOI 10.1111/j.1365-294X.2007.03367.x; HENDRICKSON L, 2006, STATUS FISHERY RESOU; Hoarau G, 2005, P ROY SOC B-BIOL SCI, V272, P497, DOI 10.1098/rspb.2004.2963; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Kenchington E., 2002, ICES J MARINE SCI Y, V13, P1; Lacy R. C., 1987, CONSERV BIOL, V1, P143, DOI DOI 10.1111/J.1523-1739.1987.TB00023.X; Langen K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024689; Latch EK, 2006, CONSERV GENET, V7, P295, DOI 10.1007/s10592-005-9098-1; Liao W, 2009, ANIM CONSERV, V12, P54, DOI 10.1111/j.1469-1795.2008.00220.x; Liberg O, 2005, BIOL LETT-UK, V1, P17, DOI 10.1098/rsbl.2004.0266; Lobell M. J., 1939, 28 NEW YORK STAT 1 S, P63; Lotterhos KE, 2012, MOL ECOL, V21, P5009, DOI 10.1111/j.1365-294X.2012.12002.x; Luikart G, 1998, J HERED, V89, P238, DOI 10.1093/jhered/89.3.238; MANTEL N, 1967, CANCER RES, V27, P209; McCairns RJS, 2012, CONSERV GENET, V13, P1509, DOI 10.1007/s10592-012-0394-2; McClelland G, 2005, J FISH BIOL, V66, P1082, DOI 10.1111/j.0022-1112.2005.00659.x; MCCRACKEN FD, 1963, J FISH RES BOARD CAN, V20, P551, DOI 10.1139/f63-040; McNeely J. A., 1990, CONSERVING WORLDS BI; Mena L, 2006, MAR ENVIRON RES, V62, pS233; NEI M, 1978, GENETICS, V89, P583; NMFS (National Marine Fisheries Service), 2007, ANN COMM LAND STAT; Northeast Fisheries Science Center, 2011, 1117 NEFSC; O'Grady JJ, 2006, BIOL CONSERV, V133, P42, DOI 10.1016/j.biocon.2006.05.016; O'Leary SJ, 2013, CONSERV GENET RESOUR, V5, P569, DOI 10.1007/s12686-012-9854-8; Park SDE, 2001, THESIS U DUBLIN; Perlmutter A., 1947, Bulletin of the Bingham Oceanographic Collection, V11, P1; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; POOLE JOHN G., 1966, N Y FISH GAME J, V13, P206; Poulsen NA, 2006, MOL ECOL, V15, P321, DOI 10.1111/j.1365-294X.2005.02777.x; Pritchard JK, 2000, GENETICS, V155, P945; Raymond M, 1995, HEREDITY, V86; Robinson JD, 2013, EVOL APPL, V6, P290, DOI 10.1111/j.1752-4571.2012.00289.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sagarese SR, 2011, MAR COAST FISH, V3, P295, DOI 10.1080/19425120.2011.603957; Slate J, 2000, P ROY SOC B-BIOL SCI, V267, P1657, DOI 10.1098/rspb.2000.1192; SLATKIN M, 1995, GENETICS, V139, P457; Smedbol RK, 2002, FISH FISH, V3, P20, DOI 10.1046/j.1467-2979.2002.00062.x; Socrates JB, 2006, AFC30 NEW YORK STAT; Thorrold SR, 2001, SCIENCE, V291, P297, DOI 10.1126/science.291.5502.297; Todorov JR, 2002, MAR ENVIRON RES, V54, P691, DOI 10.1016/S0141-1136(02)00197-6; Turner TF, 2006, P R SOC B, V273, P3065, DOI 10.1098/rspb.2006.3677; VANGUELPEN L, 1979, T AM FISH SOC, V108, P26, DOI 10.1577/1548-8659(1979)108<26:SMOTWF>2.0.CO;2; Wang CY, 2007, HYDROBIOLOGIA, V586, P321, DOI 10.1007/s10750-007-0702-x; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; Waples RS, 2006, CONSERV GENET, V7, P167, DOI 10.1007/s10592-005-9100-y; WARD RD, 1994, J FISH BIOL, V44, P213, DOI 10.1111/j.1095-8649.1994.tb01200.x; Willi Y, 2006, ANNU REV ECOL EVOL S, V37, P433, DOI 10.1146/annurev.ecolsys.37.091305.110145; Wright S., 1984, EVOLUTION GENETICS P; Wuenschel MJ, 2009, J FISH BIOL, V74, P1508, DOI 10.1111/j.1095-8649.2009.02217.x; Xu DD, 2012, CHIN J OCEANOL LIMN, V30, P604, DOI 10.1007/s00343-012-1197-5; Yencho MA, 2009, THESIS; Zarraonaindia I, 2009, MICROSATELLITE VARIA	77	42	43	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e66126	10.1371/journal.pone.0066126	http://dx.doi.org/10.1371/journal.pone.0066126			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762473	gold, Green Published, Green Submitted			2022-12-27	WOS:000321094800091
J	Cid, E; Yamamoto, M; Buschbeck, M; Yamamoto, F				Cid, Emili; Yamamoto, Miyako; Buschbeck, Marcus; Yamamoto, Fumiichiro			Murine Cell Glycolipids Customization by Modular Expression of Glycosyltransferases	PLOS ONE			English	Article							SSEA-3	Functional analysis of glycolipids has been hampered by their complex nature and combinatorial expression in cells and tissues. We report an efficient and easy method to generate cells with specific glycolipids. In our proof of principle experiments we have demonstrated the customized expression of two relevant glycosphingolipids on murine fibroblasts, stage-specific embryonic antigen 3 (SSEA-3), a marker for stem cells, and Forssman glycolipid, a xenoantigen. Sets of genes encoding glycosyltansferases were transduced by viral infection followed by multi-color cell sorting based on coupled expression of fluorescent proteins.	[Cid, Emili; Yamamoto, Miyako; Yamamoto, Fumiichiro] Inst Med Predict & Personalitzada Canc IMPPC, Canc Genet & Epigenet Program, ABO Histoblood Grp & Canc Lab, Badalona, Catalunya, Spain; [Buschbeck, Marcus] Inst Med Predict & Personalitzada Canc IMPPC, Canc Genet & Epigenet Program, Chromatin & Cell Fate Lab, Badalona, Catalunya, Spain		Cid, E (corresponding author), Inst Med Predict & Personalitzada Canc IMPPC, Canc Genet & Epigenet Program, ABO Histoblood Grp & Canc Lab, Badalona, Catalunya, Spain.	ecid@imppc.org	Yamamoto, Fumiichiro/F-1478-2016; Buschbeck, Marcus/J-8204-2017; Cid, Emili/F-7207-2016; Yamamoto, Miyako/F-1722-2016	Yamamoto, Fumiichiro/0000-0001-9690-7034; Buschbeck, Marcus/0000-0002-3218-4567; Cid, Emili/0000-0002-5025-352X; Yamamoto, Miyako/0000-0001-9516-1402	Spanish Fondo de Investigaciones Sanitarias (Ministerio de Salud, Instituto Carlos III) [PI11/00454]; Institut de Medicina Predictiva I Personalitzada del Cancer (IMPPC); national Ministerio de Economiay Competitividad (MINECO) [SAF2012-39749, RYC2010-07337]	Spanish Fondo de Investigaciones Sanitarias (Ministerio de Salud, Instituto Carlos III); Institut de Medicina Predictiva I Personalitzada del Cancer (IMPPC); national Ministerio de Economiay Competitividad (MINECO)	The work was supported by the Spanish Fondo de Investigaciones Sanitarias (Ministerio de Salud, Instituto Carlos III) grant PI11/00454 [http://www.isciii.es] and the fund from Institut de Medicina Predictiva I Personalitzada del Cancer (IMPPC) to FY [http://www.imppc.org]. MB is a Ramony Cajal Fellow and supported by national Ministerio de Economiay Competitividad (MINECO) grants SAF2012-39749 and RYC2010-07337 [http://www.mineco.gob.es]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buschbeck M, 2005, EMBO REP, V6, P63, DOI 10.1038/sj.embor.7400316; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P10231, DOI 10.1073/pnas.172380699; KANNAGI R, 1983, EMBO J, V2, P2355, DOI 10.1002/j.1460-2075.1983.tb01746.x; KIT S, 1963, EXP CELL RES, V31, P297, DOI 10.1016/0014-4827(63)90007-7; Morozova KS, 2010, BIOPHYS J, V99, pL13, DOI 10.1016/j.bpj.2010.04.025; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Subach OM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028674; Swift S, 2001, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1017cs31; Todeschini AR, 2008, BBA-GEN SUBJECTS, V1780, P421, DOI 10.1016/j.bbagen.2007.10.008; Yamamoto F, 2012, TRANSFUS MED REV, V26, P103, DOI 10.1016/j.tmrv.2011.08.002; Yanagisawa M, 2011, ASN NEURO, V3, DOI 10.1042/AN20110006; Yu R. K., 2007, COMPREHENSIVE GLYCOS, P73; Yu RK, 2012, NEUROCHEM RES, V37, P1230, DOI 10.1007/s11064-012-0744-y; Zhang XB, 2004, ANN CLIN LAB SCI, V34, P3; Zhou DP, 2000, J BIOL CHEM, V275, P22631, DOI 10.1074/jbc.C000263200	15	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e64728	10.1371/journal.pone.0064728	http://dx.doi.org/10.1371/journal.pone.0064728			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23798992	Green Published, Green Submitted, gold			2022-12-27	WOS:000320363300001
J	Cen, JR; Shi, MS; Yang, YF; Fu, YX; Zhou, HL; Wang, MQ; Su, ZY; Wei, Q				Cen, Juren; Shi, Mingshu; Yang, Yanfang; Fu, Yanxia; Zhou, Hailing; Wang, Mengqi; Su, Zhenyi; Wei, Qun			Isogarcinol Is a New Immunosuppressant	PLOS ONE			English	Article							CYCLOSPORINE-A; BENZOPHENONE DERIVATIVES; GARCINIA-MANGOSTANA; LYMPHOCYTE-ACTIVATION; ORGAN-TRANSPLANTATION; MEDICINAL PROPERTIES; CARDIAC GROWTH; CALCINEURIN; FK506; INHIBITION	Calcineurin (CN), a unique protein phosphatase, plays an important role in immune regulation. In this study we used CN as a target enzyme to investigate the immunosuppressive properties of a series of natural compounds from Garcinia mangostana L., and discovered an active compound, isogarcinol. Enzymatic assays showed that isogarcinol inhibited CN in a dose-dependent manner. At concentrations resulting in relatively low cytotoxicity isogarcinol significantly inhibited proliferation of murine spleen T-lymphocytes induced by concanavalin A (ConA) and the mixed lymphocyte reaction (MLR). In addition, it performed much better in acute toxicity tests and via oral administration in mice than cyclosporin A (CsA), with few adverse reactions and low toxicity in experimental animals. Oral administration of isogarcinol in mice resulted in a dose-dependent decrease in delayed type hypersensitivity (DTH) and prolonged graft survival in allogeneic skin transplantation. These findings suggest that isogarcinol could serve as a new oral immunomodulatory drug for preventing transplant rejection, and for long-term medication in autoimmune diseases.	[Cen, Juren; Shi, Mingshu; Fu, Yanxia; Zhou, Hailing; Wang, Mengqi; Su, Zhenyi; Wei, Qun] Beijing Normal Univ, Dept Biochem & Mol Biol, Gene Engn & Biotechnol Beijing Key Lab, Beijing 100875, Peoples R China; [Yang, Yanfang] Hubei Univ Chinese Med, Prov & Minist Established Key Lab Resource & Comp, Wuhan, Peoples R China	Beijing Normal University; Hubei University of Chinese Medicine	Wei, Q (corresponding author), Beijing Normal Univ, Dept Biochem & Mol Biol, Gene Engn & Biotechnol Beijing Key Lab, Beijing 100875, Peoples R China.	weiq@bnu.edu.cn	Su, Zhenyi/AHC-5959-2022		National Natural Science Foundation of China; National Important Novel Medicine Research Project; International Cooperation Project; Fundamental Research Funds for the Central Universities	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Important Novel Medicine Research Project; International Cooperation Project; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The work was supported by grants from the National Natural Science Foundation of China, the National Important Novel Medicine Research Project, the International Cooperation Project and the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baksh S, 2000, SEMIN IMMUNOL, V12, P405, DOI 10.1006/smim.2000.0221; BENNETT WM, 1986, ANNU REV MED, V37, P215; BIERER BE, 1993, CURR OPIN IMMUNOL, V5, P763, DOI 10.1016/0952-7915(93)90135-F; Cardenas ME, 1998, TRENDS BIOTECHNOL, V16, P427, DOI 10.1016/S0167-7799(98)01239-6; CLIPSTONE NA, 1993, ANN NY ACAD SCI, V696, P20; Cuesta-Rubio O, 2005, STUD NAT PROD CHEM, V32, P671; Cui JH, 2010, PHARMACOL BIOCHEM BE, V95, P166, DOI 10.1016/j.pbb.2009.12.021; Feng YH, 2002, ACTA PHARMACOL SIN, V23, P893; Gonsette RE, 2004, J NEUROL SCI, V223, P87, DOI 10.1016/j.jns.2004.04.025; Ho S, 1996, CLIN IMMUNOL IMMUNOP, V80, pS40, DOI 10.1006/clin.1996.0140; Hong JC, 2000, SEMIN NEPHROL, V20, P108; Iinuma M, 1996, BIOL PHARM BULL, V19, P311, DOI 10.1248/bpb.19.311; Issa F, 2010, EXPERT REV CLIN IMMU, V6, P155, DOI 10.1586/ECI.09.64; Ito C, 2003, J NAT PROD, V66, P206, DOI 10.1021/np020372g; Jorgensen KA, 2003, SCAND J IMMUNOL, V57, P93, DOI 10.1046/j.1365-3083.2003.01221.x; Kobayashi K, 2001, MICROSC RES TECHNIQ, V53, P241, DOI 10.1002/jemt.1090; Lechler RI, 2005, NAT MED, V11, P605, DOI 10.1038/nm1251; Lei H, 2011, FOOD CHEM, V127, P1169, DOI 10.1016/j.foodchem.2011.01.119; Lei H, 2009, BBA-PROTEINS PROTEOM, V1794, P1269, DOI 10.1016/j.bbapap.2009.04.014; Li JY, 2010, PHARM BIOL, V48, P1177, DOI 10.3109/13880200903573169; Li X, 2012, INT IMMUNOPHARMACOLO; Liang QR, 2003, EMBO J, V22, P5079, DOI 10.1093/emboj/cdg474; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Mantelingu K, 2007, CHEM BIOL, V14, P645, DOI 10.1016/j.chembiol.2007.04.011; Marti G, 2010, MOLECULES, V15, P7106, DOI 10.3390/molecules15107106; Matsumoto K, 2003, BIOL PHARM BULL, V26, P569, DOI 10.1248/bpb.26.569; Moussay E, 2010, RES DETERMINATION GE; Pedraza-Chaverri J, 2008, FOOD CHEM TOXICOL, V46, P3227, DOI 10.1016/j.fct.2008.07.024; Peng LQ, 2011, IUBMB LIFE, V63, P14, DOI 10.1002/iub.408; Rathee P, 2012, PHARM INNOVATION J, V1, P90; Roy J, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2100re9; Rukachaisirikul V, 2005, CHEM PHARM BULL, V53, P342, DOI 10.1248/cpb.53.342; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Salem ML, 2005, INT IMMUNOPHARMACOL, V5, P1749, DOI 10.1016/j.intimp.2005.06.008; Shen J, 2006, STUDIES CHEM CONSTIT; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; STALLARD N, 1995, HUM EXP TOXICOL, V14, P315, DOI 10.1177/096032719501400401; Thomson A, 1984, INFLAMM RES, V15, P306; Vega RB, 2003, J BIOL CHEM, V278, P36981, DOI 10.1074/jbc.R300023200; Wang HL, 2007, IUBMB LIFE, V59, P388, DOI 10.1080/15216540701370721; Wang H, 2008, IUBMB LIFE, V60, P549, DOI 10.1002/iub.94; Wang H, 2010, J BIOCHEM, V147, P185, DOI 10.1093/jb/mvp163; Yu LM, 2007, FOOD CHEM, V104, P176, DOI 10.1016/j.foodchem.2006.11.018; Zhou R, 2005, INT IMMUNOPHARMACOL, V5, P1895, DOI 10.1016/j.intimp.2005.06.009	44	96	102	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66503	10.1371/journal.pone.0066503	http://dx.doi.org/10.1371/journal.pone.0066503			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785505	Green Published, Green Submitted, gold			2022-12-27	WOS:000321038800024
J	Dall, M; Calloe, K; Haupt-Jorgensen, M; Larsen, J; Schmitt, N; Josefsen, K; Buschard, K				Dall, Morten; Calloe, Kirstine; Haupt-Jorgensen, Martin; Larsen, Jesper; Schmitt, Nicole; Josefsen, Knud; Buschard, Karsten			Gliadin Fragments and a Specific Gliadin 33-mer Peptide Close K-ATP Channels and Induce Insulin Secretion in INS-1E Cells and Rat Islets of Langerhans	PLOS ONE			English	Article							GLUTEN-FREE DIET; INTESTINAL PERMEABILITY; FUNCTIONAL-STATE; BETA-CELLS; DIAZOXIDE; EXPOSURE; MOUSE; ONSET; MICE	In non-obese diabetic (NOD) mice, diabetes incidence is reduced by a gluten-free diet. Gluten peptides, such as the compound gliadin, can cross the intestinal barrier and may directly affect pancreatic beta cells. We investigated the effects of enzymatically-digested gliadin in NOD mice, INS-1E cells and rat islets. Six injections of gliadin digest in 6-week-old NOD mice did not affect diabetes development, but increased weight gain (20% increase by day 100). In INS-1E cells, incubation with gliadin digest induced a dose-dependent increase in insulin secretion, up to 2.5-fold after 24 hours. A similar effect was observed in isolated rat islets (1.6-fold increase). In INS-1E cells, diazoxide reduced the stimulatory effect of gliadin digest. Additionally, gliadin digest was shown to decrease current through K-ATP-channels. A specific gliadin 33-mer had a similar effect, both on current and insulin secretion. Finally, INS-1E incubation with gliadin digest potentiated palmitate-induced insulin secretion by 13% compared to controls. Our data suggest that gliadin fragments may contribute to the beta-cell hyperactivity observed prior to the development of type 1 diabetes.	[Dall, Morten; Haupt-Jorgensen, Martin; Larsen, Jesper; Josefsen, Knud; Buschard, Karsten] Rigshosp, Bartholin Inst, DK-2100 Copenhagen, Denmark; [Calloe, Kirstine; Schmitt, Nicole] Univ Copenhagen, Dept Biomed Sci, Fac Hlth & Med Sci, Danish Natl Res Fdn Ctr Cardiac Arrhythmia, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Danmarks Grundforskningsfond; University of Copenhagen	Dall, M (corresponding author), Rigshosp, Bartholin Inst, DK-2100 Copenhagen, Denmark.	mortendall1988@gmail.com	Haupt-Jorgensen, Martin/K-7424-2019; Calloe, Kirstine/H-8643-2016; Schmitt, Nicole/B-8725-2012	Haupt-Jorgensen, Martin/0000-0003-4088-5862; Calloe, Kirstine/0000-0002-1777-7938; Schmitt, Nicole/0000-0001-9482-9749; Buschard, Karsten/0000-0002-0126-7423; Dall, Morten/0000-0002-8577-3162	Freddy og Kirsten Johansens Fond; Novo Nordisk Foundation; Novo Nordisk Scholarship	Freddy og Kirsten Johansens Fond; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Novo Nordisk Scholarship(Novo Nordisk)	JL was financed by Freddy og Kirsten Johansens Fond. KC was supported by the Novo Nordisk Foundation. MD received a Novo Nordisk Scholarship 2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAEN K, 1990, DIABETES, V39, P697, DOI 10.2337/diabetes.39.6.697; Arancibia SA, 2007, BIOL RES, V40, P97, DOI 10.4067/S0716-97602007000200001; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Bjork E, 1996, DIABETES, V45, P1427, DOI 10.2337/diabetes.45.10.1427; Bollyky PL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005063; BUSCHARD K, 1991, AUTOIMMUNITY, V10, P65, DOI 10.3109/08916939108997149; Buschard K, 2011, APMIS, V119, P1, DOI 10.1111/j.1600-0463.2011.02765.x; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Carlsson PO, 1998, ENDOCRINOLOGY, V139, P3534, DOI 10.1210/en.139.8.3534; Carratu R, 1999, J PEDIATR GASTR NUTR, V28, P264, DOI 10.1097/00005176-199903000-00010; Chirdo FG, 1998, SCAND J GASTROENTERO, V33, P1186, DOI 10.1080/00365529850172557; Coppieters K, 2012, J CLIN INVEST, V122, P119, DOI 10.1172/JCI59285; Cosnes J, 2008, CLIN GASTROENTEROL H, V6, P753, DOI 10.1016/j.cgh.2007.12.022; Czekanska EM, 2011, METHODS MOL BIOL, V740, P27, DOI 10.1007/978-1-61779-108-6_5; Drago S, 2006, SCAND J GASTROENTERO, V41, P408, DOI 10.1080/00365520500235334; Funda DP, 2008, DIABETES-METAB RES, V24, P59, DOI 10.1002/dmrr.748; Funda DP, 1999, DIABETES-METAB RES, V15, P323; Garcia-Manzanares Alvaro, 2011, World J Gastrointest Pathophysiol, V2, P49, DOI 10.4291/wjgp.v2.i3.49; Gros L, 2002, BRIT J PHARMACOL, V137, P98, DOI 10.1038/sj.bjp.0704836; Guldstrand M, 2002, DIABETES METAB, V28, P448; HOLLANDER PH, 1982, DIABETES, V31, P149, DOI 10.2337/diabetes.31.2.149; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; JALONEN T, 1991, PEDIATR RES, V30, P290, DOI 10.1203/00006450-199109000-00019; Josefsen K, 2010, FEBS LETT, V584, P81, DOI 10.1016/j.febslet.2009.10.086; Junker Y, 2009, GASTROENTEROLOGY, V136, pA468; Liu Zhenping, 2008, Rev Diabet Stud, V5, P232, DOI 10.1900/RDS.2008.5.232; Maiuri L, 2003, LANCET, V362, P30, DOI 10.1016/S0140-6736(03)13803-2; MAJNO G, 1987, AM J PATHOL, V128, P210; Matysiak-Budnik T, 2003, GASTROENTEROLOGY, V125, P696, DOI 10.1016/S0016-5085(03)01049-7; Menard S, 2012, AM J PATHOL, V180, P608, DOI 10.1016/j.ajpath.2011.10.019; Neu J, 2005, J PEDIATR GASTR NUTR, V40, P589, DOI 10.1097/01.MPG.0000159636.19346.C1; Newsholme P, 2007, BIOCHEM SOC T, V35, P1180, DOI 10.1042/BST0351180; Pastore MR, 2003, J CLIN ENDOCR METAB, V88, P162, DOI 10.1210/jc.2002-021177; Schmid S, 2004, CLIN IMMUNOL, V111, P108, DOI 10.1016/j.clim.2003.09.012; Schumann M, 2008, GUT, V57, P747, DOI 10.1136/gut.2007.136366; Scott FW, 2002, DIABETES, V51, P73, DOI 10.2337/diabetes.51.1.73; Secondulfo M, 1999, Minerva Gastroenterol Dietol, V45, P187; Shan L, 2002, SCIENCE, V297, P2275, DOI 10.1126/science.1074129; Sildorf SM, 2012, BMJ CASE REP; Takano M, 1996, PFLUG ARCH EUR J PHY, V431, P625; Yin H, 2002, DIABETES, V51, P1964, DOI 10.2337/diabetes.51.6.1964	41	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66474	10.1371/journal.pone.0066474	http://dx.doi.org/10.1371/journal.pone.0066474			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785500	Green Published, Green Submitted, gold			2022-12-27	WOS:000321038800021
J	Ito, K; Date, T; Ikegami, M; Hongo, K; Fujisaki, M; Katoh, D; Yoshino, T; Anzawa, R; Nagoshi, T; Yamashita, S; Inada, K; Matsuo, S; Yamane, T; Yoshimura, M				Ito, Keiichi; Date, Taro; Ikegami, Masahiro; Hongo, Kenichi; Fujisaki, Masami; Katoh, Daisuke; Yoshino, Takuya; Anzawa, Ryuko; Nagoshi, Tomohisa; Yamashita, Seigo; Inada, Keiichi; Matsuo, Seiichiro; Yamane, Teiichi; Yoshimura, Michihiro			An Immunohistochemical Analysis of Tissue Thrombin Expression in the Human Atria	PLOS ONE			English	Article							SMOOTH-MUSCLE; FIBRILLATION; ACTIVATION; BINDING; CELLS	Objective: Thrombin, the final coagulation product of the coagulation cascade, has been demonstrated to have many physiological effects, including pro-fibrotic actions via protease-activated receptor (PAR)-1. Recent investigations have demonstrated that activation of the cardiac local coagulation system was associated with atrial fibrillation. However, the distribution of thrombin in the heart, especially difference between the atria and the ventricle, remains to be clarified. We herein investigated the expression of thrombin and other related proteins, as well as tissue fibrosis, in the human left atria and left ventricle. Methods: We examined the expression of thrombin and other related molecules in the autopsied hearts of patients with and without atrial fibrillation. An immunohistochemical analysis was performed in the left atria and the left ventricle. Results: The thrombin was immunohistologically detected in both the left atria and the left ventricles. Other than in the myocardium, the expression of thrombin was observed in the endocardium and the subendocardium of the left atrium. Thrombin was more highly expressed in the left atrium compared to the left ventricle, which was concomitant with more tissue fibrosis and inflammation, as detected by CD68 expression, in the left atrium. We also confirmed the expression of prothrombin in the left atrium. The expression of PAR-1 was observed in the endocardium, subendocardium and myocardium in the left atrium. In patients with atrial fibrillation, strong thrombin expression was observed in the left atrium. Conclusions: The strong expression levels of thrombin, prothrombin and PAR-1 were demonstrated in the atrial tissues of human autopsied hearts.	[Ito, Keiichi; Date, Taro; Hongo, Kenichi; Fujisaki, Masami; Katoh, Daisuke; Yoshino, Takuya; Anzawa, Ryuko; Nagoshi, Tomohisa; Yamashita, Seigo; Inada, Keiichi; Matsuo, Seiichiro; Yamane, Teiichi; Yoshimura, Michihiro] Jikei Univ, Div Cardiol, Dept Internal Med, Sch Med,Minato Ku, Tokyo, Japan; [Ikegami, Masahiro] Jikei Univ, Dept Pathol, Sch Med, Minato Ku, Tokyo, Japan	Jikei University; Jikei University	Ito, K (corresponding author), Jikei Univ, Div Cardiol, Dept Internal Med, Sch Med,Minato Ku, Tokyo, Japan.	keke-ito@jikei.ac.jp						Aaron NS, 2012, FASEB J, V26, P4540; Akar JG, 2008, J AM COLL CARDIOL, V51, P1790, DOI 10.1016/j.jacc.2007.11.083; Andersen H, 1999, P NATL ACAD SCI USA, V96, P11189, DOI 10.1073/pnas.96.20.11189; AU CL, 1993, HUM REPROD, V8, P17, DOI 10.1093/oxfordjournals.humrep.a137866; Azzawi M, 1997, J ANAT, V191, P417, DOI 10.1046/j.1469-7580.1997.19130417.x; Bogatkevich GS, 2009, ARTHRITIS RHEUM-US, V60, P3455, DOI 10.1002/art.24935; CARNEY DH, 1992, J CLIN INVEST, V89, P1469, DOI 10.1172/JCI115737; Choudhury A, 2003, PATHOPHYSIOL HAEMO T, V33, P282, DOI 10.1159/000083815; Cooper DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021484; HOLLENBERG MD, 1992, MOL PHARMACOL, V42, P186; Horvat R, 1993, EUR J CELL BIOL, V61, P293; LOLLAR P, 1980, J CLIN INVEST, V66, P1222, DOI 10.1172/JCI109973; Macfarlane SR, 2001, PHARMACOL REV, V53, P245; McBane RD, 1997, ARTERIOSCL THROM VAS, V17, P2430, DOI 10.1161/01.ATV.17.11.2430; Pawlinski R, 2007, CIRCULATION, V116, P2298, DOI 10.1161/CIRCULATIONAHA.107.692764; Ruf W, 2003, J THROMB HAEMOST, V1, P1495, DOI 10.1046/j.1538-7836.2003.00300.x; Sabri A, 2003, J BIOL CHEM, V278, P11714, DOI 10.1074/jbc.M213091200; Shiroshita-Takeshita A, 2004, CIRCULATION, V110, P2313, DOI 10.1161/01.CIR.0000145163.56529.D1; Xu J, 2004, CIRCULATION, V109, P363, DOI 10.1161/01.CIR.0000109495.02213.52; Yamashita T, 2010, CIRC J, V74, P262, DOI 10.1253/circj.CJ-09-0644; YAN GX, 1995, AM J PHYSIOL-HEART C, V268, pH1740, DOI 10.1152/ajpheart.1995.268.4.H1740; Yin XL, 2010, AM J PATHOL, V176, P1600, DOI 10.2353/ajpath.2010.090406; ZETTER BR, 1977, P NATL ACAD SCI USA, V74, P596, DOI 10.1073/pnas.74.2.596	23	28	28	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65817	10.1371/journal.pone.0065817	http://dx.doi.org/10.1371/journal.pone.0065817			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785453	Green Published, Green Submitted, gold			2022-12-27	WOS:000321038800069
J	Knudsen, ML; Johansson, DX; Kostic, L; Nordstron, EKL; Tegerstedt, K; Pasetto, A; Applequist, SE; Ljungberg, K; Sirard, JC; Liljestrom, P				Knudsen, Maria L.; Johansson, Daniel X.; Kostic, Linda; Nordstron, Eva K. L.; Tegerstedt, Karin; Pasetto, Anna; Applequist, Steven E.; Ljungberg, Karl; Sirard, Jean-Claude; Liljestrom, Peter			The Adjuvant Activity of Alphavirus Replicons Is Enhanced by Incorporating the Microbial Molecule Flagellin into the Replicon	PLOS ONE			English	Article							SEMLIKI-FOREST-VIRUS; YELLOW-FEVER VACCINE; TOLL-LIKE RECEPTOR-5; BACTERIAL FLAGELLIN; DENDRITIC CELLS; IMMUNE-RESPONSE; FUSION PROTEINS; INNATE IMMUNITY; MESSENGER-RNA; TLR5	Ligands of pattern recognition receptors (PRRs) including Toll-like receptors (TLRs) stimulate innate and adaptive immune responses and are considered as potent adjuvants. Combinations of ligands might act in synergy to induce stronger and broader immune responses compared to stand-alone ligands. Alphaviruses stimulate endosomal TLRs 3, 7 and 8 as well as the cytoplasmic PRR MDA-5, resulting in induction of a strong type I interferon (IFN) response. Bacterial flagellin stimulates TLR5 and when delivered intracellularly the cytosolic PRR NLRC4, leading to secretion of proinflammatory cytokines. Both alphaviruses and flagellin have independently been shown to act as adjuvants for antigen-specific antibody responses. Here, we hypothesized that alphavirus and flagellin would act in synergy when combined. We therefore cloned the Salmonella Typhimurium flagellin (FliC) gene into an alphavirus replicon and assessed its adjuvant activity on the antibody response against co-administered antigen. In mice immunized with recombinant alphavirus, antibody responses were greatly enhanced compared to soluble FliC or control alphavirus. Both IgG1 and IgG2a/c responses were increased, indicating an enhancement of both Th1 and Th2 type responses. The adjuvant activity of FliC-expressing alphavirus was diminished but not abolished in the absence of TLR5 or type I IFN signaling, suggesting the contribution of several signaling pathways and some synergistic and redundant activity of its components. Thus, we have created a recombinant adjuvant that stimulates multiple signaling pathways of innate immunity resulting in a strong and broad antibody response.	[Knudsen, Maria L.; Johansson, Daniel X.; Nordstron, Eva K. L.; Tegerstedt, Karin; Pasetto, Anna; Ljungberg, Karl; Liljestrom, Peter] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Kostic, Linda] Swedish Inst Communicable Dis Control, Unit Immunizat, Solna, Sweden; [Applequist, Steven E.] Karolinska Univ Hosp Huddinge, Karolinska Inst, Ctr Infect Med, Dept Med, Stockholm, Sweden; [Sirard, Jean-Claude] Ctr Infect & Immun Lille, Inst Pasteur Lille, Lille, France; [Sirard, Jean-Claude] Inst Natl Sante & Rech Med, Lille, France; [Sirard, Jean-Claude] Ctr Natl Rech Sci, Lille, France; [Sirard, Jean-Claude] Univ Lille Nord France, Lille, France	Karolinska Institutet; Swedish Institute for Infectious Disease Control; Karolinska Institutet; Karolinska University Hospital; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille	Knudsen, ML (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.	maria.knudsen@ki.se	Sirard, Jean-Claude/B-5932-2011; Pasetto, Anna/AAD-6141-2019; Pasetto, Anna/K-6430-2012	Sirard, Jean-Claude/0000-0001-9854-4652; Pasetto, Anna/0000-0002-5254-2173; Liljestrom, Peter/0000-0002-2132-0981; Ljungberg, Karl/0000-0001-7192-6204	Swedish Research Council; Swedish International Development Cooperation Agency; Karolinska Institutet Faculty Funding for Doctoral Students	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish International Development Cooperation Agency; Karolinska Institutet Faculty Funding for Doctoral Students	This work was supported by the Swedish Research Council (www.vr.se) and the Swedish International Development Cooperation Agency (www.sida.se). MLK is a recipient of Karolinska Institutet Faculty Funding for Doctoral Students (www.ki.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2010, J VIROL, V84, P12093, DOI 10.1128/JVI.00406-10; Applequist SE, 2005, J IMMUNOL, V175, P3882, DOI 10.4049/jimmunol.175.6.3882; Arimilli S, 2008, J VIROL, V82, P10975, DOI 10.1128/JVI.01288-08; Bagchi A, 2007, J IMMUNOL, V178, P1164, DOI 10.4049/jimmunol.178.2.1164; Barry G, 2010, J VIROL, V84, P7369, DOI 10.1128/JVI.02310-09; Barry G, 2009, J GEN VIROL, V90, P1382, DOI 10.1099/vir.0.007336-0; Bates JT, 2009, J IMMUNOL, V182, P7539, DOI 10.4049/jimmunol.0804225; Ben-Yedidia T, 1998, IMMUNOL LETT, V64, P9, DOI 10.1016/S0165-2478(98)00073-X; Bohnenkamp HR, 2007, CELL IMMUNOL, V247, P72, DOI 10.1016/j.cellimm.2007.07.008; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; Cuadros C, 2004, INFECT IMMUN, V72, P2810, DOI 10.1128/IAI.72.5.2810-2816.2004; Cunningham AF, 2004, EUR J IMMUNOL, V34, P2986, DOI 10.1002/eji.200425403; Didierlaurent A, 2004, J IMMUNOL, V172, P6922, DOI 10.4049/jimmunol.172.11.6922; Donnelly MLL, 2001, J GEN VIROL, V82, P1013, DOI 10.1099/0022-1317-82-5-1013; Fink SL, 2007, CELL MICROBIOL, V9, P2562, DOI 10.1111/j.1462-5822.2007.01036.x; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Glasgow GM, 1997, J GEN VIROL, V78, P1559, DOI 10.1099/0022-1317-78-7-1559; Ha H, 2008, J IMMUNOL, V180, P1382, DOI 10.4049/jimmunol.180.3.1382; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hidmark AS, 2005, J VIROL, V79, P10376, DOI 10.1128/JVI.79.16.10376-10385.2005; Hidmark AS, 2006, J VIROL, V80, P7100, DOI 10.1128/JVI.02579-05; Honko AN, 2006, INFECT IMMUN, V74, P1113, DOI 10.1128/IAI.74.2.1113-1120.2006; Huber JP, 2011, IMMUNOLOGY, V132, P466, DOI 10.1111/j.1365-2567.2011.03412.x; Huleatt JW, 2008, VACCINE, V26, P201, DOI 10.1016/j.vaccine.2007.10.062; Huleatt JW, 2007, VACCINE, V25, P763, DOI 10.1016/j.vaccine.2006.08.013; Karlsson GB, 2003, METH MOLEC MED, V87, P69; Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737; Liu F, 2010, BIOCHEM BIOPH RES CO, V392, P582, DOI 10.1016/j.bbrc.2010.01.077; Makela SM, 2011, MOL IMMUNOL, V48, P505, DOI 10.1016/j.molimm.2010.10.005; McDonald WF, 2007, J INFECT DIS, V195, P1607, DOI 10.1086/517613; McSorley SJ, 2002, J IMMUNOL, V169, P3914, DOI 10.4049/jimmunol.169.7.3914; Means TK, 2003, J IMMUNOL, V170, P5165, DOI 10.4049/jimmunol.170.10.5165; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Mizel SB, 2010, J IMMUNOL, V185, P5677, DOI 10.4049/jimmunol.1002156; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Naslund TI, 2007, J IMMUNOL, V178, P6761, DOI 10.4049/jimmunol.178.11.6761; Nempont C, 2008, J IMMUNOL, V181, P2036, DOI 10.4049/jimmunol.181.3.2036; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012; Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Rumbo M, 2004, GASTROENTEROLOGY, V127, P213, DOI 10.1053/j.gastro.2004.04.018; RYAN MD, 1994, EMBO J, V13, P928, DOI 10.1002/j.1460-2075.1994.tb06337.x; Sanders CJ, 2009, EUR J IMMUNOL, V39, P359, DOI 10.1002/eji.200838804; Schulz O, 2005, NATURE, V433, P887, DOI 10.1038/nature03326; Schulz O, 2010, CELL HOST MICROBE, V7, P354, DOI 10.1016/j.chom.2010.04.007; SJOBERG EM, 1994, BIO-TECHNOL, V12, P1127, DOI 10.1038/nbt1194-1127; Smerdou C, 1999, J VIROL, V73, P1092, DOI 10.1128/JVI.73.2.1092-1098.1999; Smith K, 2003, POETRY REV, V93, P5; Sundback M, 2005, VIROLOGY, V341, P190, DOI 10.1016/j.virol.2005.07.017; Talbot HK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014442; Taylor DN, 2011, VACCINE, V29, P4897, DOI 10.1016/j.vaccine.2011.05.001; Thompson JM, 2006, P NATL ACAD SCI USA, V103, P3722, DOI 10.1073/pnas.0600287103; Thompson JM, 2008, VACCINE, V26, P4998, DOI 10.1016/j.vaccine.2008.07.011; Tosch C, 2009, CANCER GENE THER, V16, P310, DOI 10.1038/cgt.2008.85; Treanor JJ, 2010, VACCINE, V28, P8268, DOI 10.1016/j.vaccine.2010.10.009; Turley CB, 2011, VACCINE, V29, P5145, DOI 10.1016/j.vaccine.2011.05.041; Uematsu S, 2006, NAT IMMUNOL, V7, P868, DOI 10.1038/ni1362; Vassilieva EV, 2011, MBIO, V2, DOI 10.1128/mBio.00328-10; Ventoso I, 2006, GENE DEV, V20, P87, DOI 10.1101/gad.357006; Vijay-Kumar M, 2007, J CLIN INVEST, V117, P3909, DOI 10.1172/JCI33084; Vijay-Kumar M, 2010, EUR J IMMUNOL, V40, P3528, DOI 10.1002/eji.201040421; Wang BZ, 2008, J VIROL, V82, P11813, DOI 10.1128/JVI.01076-08; ZHOU XZ, 1995, P NATL ACAD SCI USA, V92, P3009, DOI 10.1073/pnas.92.7.3009	64	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65964	10.1371/journal.pone.0065964	http://dx.doi.org/10.1371/journal.pone.0065964			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785460	Green Published, Green Submitted, gold			2022-12-27	WOS:000321038800062
J	McGroty, SE; Pattaniyil, DT; Patin, D; Blanot, D; Ravichandran, AC; Suzuki, H; Dobson, RCJ; Savka, MA; Hudson, AO				McGroty, Sean E.; Pattaniyil, Dhivya T.; Patin, Delphine; Blanot, Didier; Ravichandran, Arvind C.; Suzuki, Hironori; Dobson, Renwick C. J.; Savka, Michael A.; Hudson, Andre O.			Biochemical Characterization of UDP-N-acetylmuramoyl-L-alanyl-D-glutamate: meso-2,6-diaminopimelate ligase (MurE) from Verrucomicrobium spinosum DSM 4136	PLOS ONE			English	Article							LYSINE BIOSYNTHESIS PATHWAY; L,L-DIAMINOPIMELATE AMINOTRANSFERASE; 2-AMINOPIMELIC ACID; CYTOPLASMIC STEPS; PEPTIDOGLYCAN; DIAMINOPIMELATE; PURIFICATION; PEPTIDES	Verrucomicrobium spinosum is a Gram-negative bacterium that is related to bacteria from the genus Chlamydia. The bacterium is pathogenic towards Drosophila melanogaster and Caenorhabditis elegans, using a type III secretion system to facilitate pathogenicity. V. spinosum employs the recently discovered L, L-diaminopimelate aminotransferase biosynthetic pathway to generate the bacterial cell wall and protein precursors diaminopimelate and lysine. A survey of the V. spinosum genome provides evidence that the bacterium should be able to synthesize peptidoglycan de novo, since all of the necessary genes are present. The enzyme UDP-N-acetylmuramoyl-L-alanyl-D-glutamate: meso-2,6-diaminopimelate ligase (MurE) (E.C. 6.3.2.15) catalyzes a reaction in the cytoplasmic step of peptidoglycan biosynthesis by adding the third amino acid residue to the peptide stem. The murE ortholog from V. spinosum (murE(Vs)) was cloned and was shown to possess UDP-MurNAc-L-Ala-D-Glu: meso-2,6-diaminopimelate ligase activity in vivo using functional complementation. In vitro analysis using the purified recombinant enzyme demonstrated that MurE(Vs) has a pH optimum of 9.6 and a magnesium optimum of 30 mM. meso-Diaminopimelate was the preferred substrate with a Km of 17 mM, when compared to other substrates that are structurally related. Sequence alignment and structural analysis using homology modeling suggest that key residues that make up the active site of the enzyme are conserved in MurE(Vs). Our kinetic analysis and structural model of MurE(Vs) is consistent with other MurE enzymes from Gram-negative bacteria that have been characterized. To verify that V. spinosum incorporates diaminopimelate into its cell wall, we purified peptidoglycan from a V. spinosum culture; analysis revealed the presence of diaminopimelate, consistent with that of a bona fide peptidoglycan from Gram-negative bacteria.	[McGroty, Sean E.; Savka, Michael A.; Hudson, Andre O.] Rochester Inst Technol, Thomas H Gosnell Sch Life Sci, Rochester, NY 14623 USA; [Pattaniyil, Dhivya T.] Rochester Inst Technol, Sch Chem & Mat Sci, Rochester, NY 14623 USA; [Patin, Delphine; Blanot, Didier] Univ Paris 11, Inst Biochim & Biophys Mole culaire & Cellulair, Lab Enveloppes Bacteriennes & Antibiot, Orsay, France; [Patin, Delphine; Blanot, Didier] Ctr Natl Rech Sci, Orsay, France; [Ravichandran, Arvind C.; Suzuki, Hironori; Dobson, Renwick C. J.] Univ Canterbury, Sch Biol Sci, Biomol Interact Ctr, Christchurch 1, New Zealand; [Dobson, Renwick C. J.] Univ Melbourne, Dept Biochem & Mol Biol, Mol & Biotechnol Inst Bio21, Parkville, Vic 3052, Australia	Rochester Institute of Technology; Rochester Institute of Technology; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); University of Canterbury; University of Melbourne	Hudson, AO (corresponding author), Rochester Inst Technol, Thomas H Gosnell Sch Life Sci, Rochester, NY 14623 USA.	aohsbi@rit.edu	Dobson, Renwick/AAZ-7020-2021	Dobson, Renwick/0000-0002-5506-4939; Hudson, Andre/0000-0001-5690-4322; Suzuki, Hironori/0000-0001-9754-4992	National Science Foundation (NSF) [MCB-1120541]; Rochester Institute of Technology (RIT) College of Science; RIT College of Science Faculty Development; NSF [MCB-1120541]; Biochemistry program in the School of Chemical and Material Sciences at RIT; New Zealand Royal Society Marsden Fund [UOC1013]; C.R. Roper Bequest; U.S. Army Research Laboratory; U.S. Army Research Office [W911NF-11-1-0481]; Centre National de la Recherche Scientifique [UMR 8619]; Royal Society of New Zealand; Japan Society for the Promotion of Science	National Science Foundation (NSF)(National Science Foundation (NSF)); Rochester Institute of Technology (RIT) College of Science; RIT College of Science Faculty Development; NSF(National Science Foundation (NSF)); Biochemistry program in the School of Chemical and Material Sciences at RIT; New Zealand Royal Society Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); C.R. Roper Bequest; U.S. Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); U.S. Army Research Office; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Royal Society of New Zealand(Royal Society of New Zealand); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by a National Science Foundation (NSF) (MCB-1120541) and a Rochester Institute of Technology (RIT) College of Science 2012 Dean's Research Initiation Grant to AOH. MAS acknowledges a RIT College of Science Faculty Development (FEAD-2012) grant. SEM and DTP were supported by the NSF MCB-1120541 awarded to AOH as undergraduate students in the Bioinformatics program in the Thomas H. Gosnell School of Life Sciences and the Biochemistry program in the School of Chemical and Material Sciences at RIT. RCJD acknowledges: 1) the C.R. Roper Bequest for Fellowship support; 2) the New Zealand Royal Society Marsden Fund for funding support, in part (contract UOC1013); and 3) the U.S. Army Research Laboratory and U.S. Army Research Office under contract/grant number W911NF-11-1-0481 for supported, in part. DP and DB were supported by grants from the Centre National de la Recherche Scientifique (UMR 8619). HS acknowledges the Royal Society of New Zealand and the Japan Society for the Promotion of Science for salary support by the FY 2012 Researcher Exchange Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Babic A, 2007, PROCEEDINGS OF THE 5TH JOINT MEETING ON MEDICINAL CHEMISTRY, P1; Barreteau H, 2008, FEMS MICROBIOL REV, V32, P168, DOI 10.1111/j.1574-6976.2008.00104.x; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; BERGES DA, 1986, J MED CHEM, V29, P89, DOI 10.1021/jm00151a015; Boniface A, 2006, J BIOL CHEM, V281, P15680, DOI 10.1074/jbc.M506311200; Cox RJ, 1996, NAT PROD REP, V13, P29, DOI 10.1039/np9961300029; Domman DB, 2011, ARCH MICROBIOL, V193, P307, DOI 10.1007/s00203-010-0666-5; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Gordon E, 2001, J BIOL CHEM, V276, P10999, DOI 10.1074/jbc.M009835200; Hudson AO, 2008, J BACTERIOL, V190, P3256, DOI 10.1128/JB.01381-07; Hudson AO, 2006, PLANT PHYSIOL, V140, P292, DOI 10.1104/pp.105.072629; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Hutton CA, 2007, MOL BIOSYST, V3, P458, DOI 10.1039/b705624a; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kuru E, 2012, ANGEW CHEM INT EDIT, V51, P12519, DOI 10.1002/anie.201206749; LEROUX P, 1991, INT J PEPT PROT RES, V37, P103; Liu YC, 2010, J BACTERIOL, V192, P3304, DOI 10.1128/JB.00172-10; Mccoy AJ, 2006, P NATL ACAD SCI USA, V103, P17909, DOI 10.1073/pnas.0608643103; Mengin-Lecreulx D, 1999, J BACTERIOL, V181, P5909, DOI 10.1128/JB.181.19.5909-5914.1999; MENGINLECREULX D, 1982, J BACTERIOL, V151, P1109, DOI 10.1128/JB.151.3.1109-1117.1982; MICHAUD C, 1990, EUR J BIOCHEM, V194, P853, DOI 10.1111/j.1432-1033.1990.tb19479.x; Nachar VR, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00183; Paradis-Bleau C, 2009, BIOCHEM J, V421, P263, DOI 10.1042/BJ20081395; Patin D, 2012, ARCH MICROBIOL, V194, P505, DOI 10.1007/s00203-011-0784-8; Patin D, 2010, BIOCHIMIE, V92, P1793, DOI 10.1016/j.biochi.2010.07.009; Patin D, 2009, J BACTERIOL, V191, P7430, DOI 10.1128/JB.01029-09; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; PRESS WH, 1986, NUMERICAL RECIPES AR; Sait M, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00211; Scheffers DJ, 2005, MICROBIOL MOL BIOL R, V69, P585, DOI 10.1128/MMBR.69.4.585-607.2005; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; VANHEIJENOORT J, 1968, B SOC CHIM FR, P2828; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Wagner M, 2006, CURR OPIN BIOTECH, V17, P241, DOI 10.1016/j.copbio.2006.05.005	35	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66458	10.1371/journal.pone.0066458	http://dx.doi.org/10.1371/journal.pone.0066458			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785498	gold, Green Published			2022-12-27	WOS:000321038800023
J	Mott, PJ; Lazarus, AH				Mott, Patrick J.; Lazarus, Alan H.			CD44 Antibodies and Immune Thrombocytopenia in the Amelioration of Murine Inflammatory Arthritis	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; MONOCLONAL-ANTIBODIES; T-CELL; HYALURONAN; PLATELETS; RECEPTOR; MECHANISM; ADHESION; DISTINCT; PLAYERS	Antibodies to CD44 have been used to successfully ameliorate murine models of autoimmune disease. The most often studied disease model has been murine inflammatory arthritis, where a clear mechanism for the efficacy of CD44 antibodies has not been established. We have recently shown in a murine passive-model of the autoimmune disease immune thrombocytopenia (ITP) that some CD44 antibodies themselves can induce thrombocytopenia in mice, and the CD44 antibody causing the most severe thrombocytopenia (IM7), also is known to be highly effective in ameliorating murine models of arthritis. Recent work in the K/BxN serum-induced model of arthritis demonstrated that antibody-induced thrombocytopenia reduced arthritis, causing us to question whether CD44 antibodies might primarily ameliorate arthritis through their thrombocytopenic effect. We evaluated IM7, IRAWB14.4, 5035-41.1D, KM201, KM114, and KM81, and found that while all could induce thrombocytopenia, the degree of protection against serum-induced arthritis was not closely related to the length or severity of the thrombocytopenia. CD44 antibody treatment was also able to reverse established inflammation, while thrombocytopenia induced by an anti-platelet antibody targeting the GPIIbIIIa platelet antigen, could not mediate this effect. While CD44 antibody-induced thrombocytopenia may contribute to some of its therapeutic effect against the initiation of arthritis, for established disease there are likely other mechanisms contributing to its efficacy. Humans are not known to express CD44 on platelets, and are therefore unlikely to develop thrombocytopenia after CD44 antibody treatment. An understanding of the relationship between arthritis, thrombocytopenia, and CD44 antibody treatment remains critical for continued development of CD44 antibody therapeutics.	[Lazarus, Alan H.] Canadian Blood Serv, Toronto, ON, Canada; [Mott, Patrick J.; Lazarus, Alan H.] St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Lazarus, Alan H.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Mott, Patrick J.; Lazarus, Alan H.] Univ Toronto, Toronto, ON, Canada	Canadian Blood Services; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto	Lazarus, AH (corresponding author), Canadian Blood Serv, Toronto, ON, Canada.	lazarusa@smh.ca		Lazarus, Alan/0000-0002-5051-6916	Canadian Blood Services-Canadian Institutes of Health Research (CIHR); CIHR; University of Toronto; Queen Elizabeth II/Canadian Arthritis Network Graduate Scholarship	Canadian Blood Services-Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); University of Toronto(University of Toronto); Queen Elizabeth II/Canadian Arthritis Network Graduate Scholarship	This work was supported by grants to AHL from the Canadian Blood Services-Canadian Institutes of Health Research (CIHR) Request For Proposals program and the CIHR (www.blood.ca). PJM was supported by a University of Toronto Fellowship and a Queen Elizabeth II/Canadian Arthritis Network Graduate Scholarship. The views expressed herein do not necessarily represent the view of the Federal Government of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergmeier W, 2000, BLOOD, V95, P886, DOI 10.1182/blood.V95.3.886.003k45_886_893; Boilard E, 2012, NAT REV RHEUMATOL, V8, P534, DOI 10.1038/nrrheum.2012.118; Boilard E, 2011, J IMMUNOL, V186, P4361, DOI 10.4049/jimmunol.1002857; Boilard E, 2010, SCIENCE, V327, P580, DOI 10.1126/science.1181928; Bonder CS, 2006, BLOOD, V107, P4798, DOI 10.1182/blood-2005-09-3581; Brocke S, 1999, P NATL ACAD SCI USA, V96, P6896, DOI 10.1073/pnas.96.12.6896; Cloutier N, 2012, BLOOD, V120, P1334, DOI 10.1182/blood-2012-02-413047; Colmegna I, 2012, CLIN PHARMACOL THER, V91, P607, DOI 10.1038/clpt.2011.325; Crow AR, 2011, BLOOD, V117, P971, DOI 10.1182/blood-2010-05-280115; DeGrendele HC, 1997, SCIENCE, V278, P672, DOI 10.1126/science.278.5338.672; FEHR K, 1981, ARTHRITIS RHEUM-US, V24, P510, DOI 10.1002/art.1780240310; Feldmann M, 1996, CELL, V85, P307, DOI 10.1016/S0092-8674(00)81109-5; Feldmann M, 1996, ANNU REV IMMUNOL, V14, P397, DOI 10.1146/annurev.immunol.14.1.397; GINSBERG MH, 1978, ARTHRITIS RHEUM, V21, P994, DOI 10.1002/art.1780210825; GLANT TT, 1987, ARTHRITIS RHEUM-US, V30, P201, DOI 10.1002/art.1780300211; Hutas G, 2008, BLOOD, V112, P4999, DOI 10.1182/blood-2008-04-150383; Ji H, 2002, IMMUNITY, V16, P157, DOI 10.1016/S1074-7613(02)00275-3; KAPLAN RA, 1980, ARTHRITIS RHEUM, V23, P911, DOI 10.1002/art.1780230806; Katoh S, 2003, J CLIN INVEST, V111, P1563, DOI 10.1172/JCI200316583; Khan AI, 2004, J IMMUNOL, V173, P7594, DOI 10.4049/jimmunol.173.12.7594; Kinne RW, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2333; KOSHIISHI I, 1994, BLOOD, V84, P390; Kouskoff V, 1996, CELL, V87, P811, DOI 10.1016/S0092-8674(00)81989-3; LESLEY J, 1993, EUR J IMMUNOL, V23, P1902, DOI 10.1002/eji.1830230826; LESLEY J, 1992, EUR J IMMUNOL, V22, P2719, DOI 10.1002/eji.1830221036; McDonald B, 2008, J EXP MED, V205, P915, DOI 10.1084/jem.20071765; Mikecz K, 1999, ARTHRITIS RHEUM, V42, P659, DOI 10.1002/1529-0131(199904)42:4<659::AID-ANR8>3.0.CO;2-Z; Monach Paul A, 2008, Curr Protoc Immunol, VChapter 15, DOI 10.1002/0471142735.im1522s81; Nagano O, 2004, CANCER SCI, V95, P930, DOI 10.1111/j.1349-7006.2004.tb03179.x; Nedvetzki S, 1999, J AUTOIMMUN, V13, P39, DOI 10.1006/jaut.1999.0294; Nieswandt B, 2000, BLOOD, V96, P2520; Nigrovic PA, 2007, IMMUNOL REV, V217, P19, DOI 10.1111/j.1600-065X.2007.00506.x; Noss EH, 2008, IMMUNOL REV, V223, P252, DOI 10.1111/j.1600-065X.2008.00648.x; PANAYI GS, 1992, ARTHRITIS RHEUM-US, V35, P729, DOI 10.1002/art.1780350702; Schellekens GA, 2000, ARTHRITIS RHEUM-US, V43, P155, DOI 10.1002/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3; SHERMAN L, 1994, CURR OPIN CELL BIOL, V6, P726, DOI 10.1016/0955-0674(94)90100-7; Song S, 2005, BLOOD, V105, P1546, DOI 10.1182/blood-2004-05-1886; Wagner UG, 1998, J IMMUNOL, V161, P6390; Weiss L, 2000, P NATL ACAD SCI USA, V97, P285, DOI 10.1073/pnas.97.1.285; Witz Craig A, 2003, Hum Fertil (Camb), V6, P34, DOI 10.1080/1464770312331368973; Zeidler A, 1995, AUTOIMMUNITY, V21, P245, DOI 10.3109/08916939509001943; ZHENG Z, 1995, J CELL BIOL, V130, P485, DOI 10.1083/jcb.130.2.485; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023	43	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65805	10.1371/journal.pone.0065805	http://dx.doi.org/10.1371/journal.pone.0065805			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785450	Green Published, Green Submitted, gold			2022-12-27	WOS:000321038800072
J	Xu, YM; Xu, XF; Lan, RT; Xiong, YW; Ye, CY; Ren, ZH; Liu, L; Zhao, AL; Wu, LF; Xu, JG				Xu, Yanmei; Xu, Xuefang; Lan, Ruiting; Xiong, Yanwen; Ye, Changyun; Ren, Zhihong; Liu, Li; Zhao, Ailan; Wu, Long-Fei; Xu, Jianguo			An O Island 172 Encoded RNA Helicase Regulates the Motility of Escherichia coli O157:H7	PLOS ONE			English	Article							SHIGA TOXIN; IN-VITRO; GENOME SEQUENCE; GENE-EXPRESSION; VIRULENCE; IDENTIFICATION; FLAGELLA; COMPLEX; PROTEIN; COLONIZATION	Enterohaemorrhagic Escherichia coli (EHEC) O157:H7 is a major cause of zoonotic food- and water-borne intestinal infections worldwide with clinical consequences ranging from mild diarrhoea to hemolytic uraemic syndrome. The genome of EHEC O157:H7 contains many regions of unique DNA that are referred to as O islands including the Shiga toxin prophages and pathogenicity islands encoding key virulence factors. However many of these O islands are of unknown function. In this study, genetic analysis was conducted on OI-172 which is a 44,434 bp genomic island with 27 open reading frames. Comparative genome analysis showed that O1-72 is a composite island with progressive gain of genes since O157:H7 evolved from its ancestral O55:H7. A partial OI-172 island was also found in 2 unrelated E. coli strains and 2 Salmonella strains. OI-172 encodes several putative helicases, one of which (Z5898) is a putative DEAH box RNA helicase. To investigate the function of Z5898, a deletion mutant (EDL933 Delta Z5898) was constructed in the O157:H7 strain EDL933. Comparative proteomic analysis of the mutant with the wild-type EDL933 found that flagellin was down-regulated in the Z5898 mutant. Motility assay showed that EDL933 Delta Z5898 migrated slower than the wild-type EDL933 and electron microscopy found no surface flagella. Quantitative reverse transcription PCR revealed that the fliC expression of EDL933 Delta Z5898 was significantly lower while the expression of its upstream regulator gene, fliA, was not affected. Using a fliA and a fliC promoter - green fluorescent protein fusion contruct, Z5898 was found to affect only the fliC promoter activity. Therefore, Z5898 regulates the flagella based motility by exerting its effect on fliC. We conclude that OI-172 is a motility associated O island and hereby name it the MAO island.	[Xu, Yanmei; Xu, Xuefang; Xiong, Yanwen; Ye, Changyun; Ren, Zhihong; Zhao, Ailan; Xu, Jianguo] State Key Lab Infect Dis Prevent & Control Chin C, Beijing, Peoples R China; [Xu, Yanmei; Xu, Xuefang; Xiong, Yanwen; Ye, Changyun; Ren, Zhihong; Zhao, Ailan; Xu, Jianguo] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent & Co, Beijing, Peoples R China; [Xu, Yanmei; Xu, Xuefang; Xiong, Yanwen; Ye, Changyun; Ren, Zhihong; Zhao, Ailan; Xu, Jianguo] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China; [Lan, Ruiting] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Liu, Li] Chinese Acad Sci, Inst Microbiol, Network Informat Ctr, Beijing, Peoples R China; [Wu, Long-Fei] Univ Aix Marseille 2, Inst Microbiol Mediterrane, CNRS, Lab Chim Bacterienne,UPR9043, Marseille, France	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; University of New South Wales Sydney; Chinese Academy of Sciences; Institute of Microbiology, CAS; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Xu, JG (corresponding author), State Key Lab Infect Dis Prevent & Control Chin C, Beijing, Peoples R China.	xujianguo@icdc.cn		Lan, Ruiting/0000-0001-9834-5258	National Basic Research Program of China [2011CB504901]; China Mega-Project for Infectious Disease Grant [2011ZX10004-001]; Chinese National Natural Science Foundation Grant [81290340, 81290345, 81271788]; State Key Laboratory for Infectious Disease Prevention and Control Development Grants [2008SKLID106, 2011SKLID203, 2012SKLID401]; Beijing Municipal Commission of Education Grant [YB20098450101]	National Basic Research Program of China(National Basic Research Program of China); China Mega-Project for Infectious Disease Grant; Chinese National Natural Science Foundation Grant(National Natural Science Foundation of China (NSFC)); State Key Laboratory for Infectious Disease Prevention and Control Development Grants; Beijing Municipal Commission of Education Grant	This work was supported by the National Basic Research Program of China (2011CB504901), China Mega-Project for Infectious Disease Grant (2011ZX10004-001), Chinese National Natural Science Foundation Grant (81290340, 81290345, 81271788), State Key Laboratory for Infectious Disease Prevention and Control Development Grants (2008SKLID106, 2011SKLID203 and 2012SKLID401) and Beijing Municipal Commission of Education Grant (YB20098450101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SE, 2012, J BACTERIOL, V194, P5343, DOI 10.1128/JB.01025-12; Bender JK, 2012, APPL ENVIRON MICROB, V78, P5083, DOI 10.1128/AEM.00617-12; Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737; Berin MC, 2002, CELL MICROBIOL, V4, P635, DOI 10.1046/j.1462-5822.2002.00218.x; Best A, 2005, INFECT IMMUN, V73, P1836, DOI 10.1128/IAI.73.3.1836-1846.2005; Byrd AK, 2012, FRONT BIOSCI-LANDMRK, V17, P2070, DOI 10.2741/4038; Chevance FFV, 2008, NAT REV MICROBIOL, V6, P455, DOI 10.1038/nrmicro1887; Chilcott GS, 2000, MICROBIOL MOL BIOL R, V64, P694, DOI 10.1128/MMBR.64.4.694-708.2000; Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; De Lay N, 2012, MOL MICROBIOL, V86, P524, DOI 10.1111/j.1365-2958.2012.08209.x; Deng WY, 2004, P NATL ACAD SCI USA, V101, P3597, DOI 10.1073/pnas.0400326101; Dziva F, 2004, MICROBIOL-SGM, V150, P3631, DOI 10.1099/mic.0.27448-0; Francez-Charlot A, 2003, MOL MICROBIOL, V49, P823, DOI 10.1046/j.1365-2958.2003.03601.x; Fricke WF, 2008, J BACTERIOL, V190, P6779, DOI 10.1128/JB.00661-08; Fuller-Pace FV, 2006, NUCLEIC ACIDS RES, V34, P4206, DOI 10.1093/nar/gkl460; Gruenheid S, 2004, MOL MICROBIOL, V51, P1233, DOI 10.1046/j.1365-2958.2003.03911.x; Iost I, 2013, BIOCH BIOPHYS ACTA; Jagessar KL, 2010, RNA, V16, P1386, DOI 10.1261/rna.2015610; Karmali MA, 2003, J CLIN MICROBIOL, V41, P4930, DOI 10.1128/JCM.41.11.4930-4940.2003; Kim T, 2010, P NATL ACAD SCI USA, V107, P15181, DOI 10.1073/pnas.1006539107; Klapproth JA, 2000, INFECT IMMUN, V68, P2148, DOI 10.1128/IAI.68.4.2148-2155.2000; Ko M, 2000, J BACTERIOL, V182, P4670, DOI 10.1128/JB.182.16.4670-4672.2000; Koo JT, 2004, MOL MICROBIOL, V52, P1813, DOI 10.1111/j.1365-2958.2004.04099.x; Lehnen D, 2002, MOL MICROBIOL, V45, P521, DOI 10.1046/j.1365-2958.2002.03032.x; Lehti TA, 2012, MICROBIOL-SGM, V158, P1444, DOI 10.1099/mic.0.056499-0; Lemke JJ, 2009, MOL MICROBIOL, V74, P1368, DOI 10.1111/j.1365-2958.2009.06939.x; Liu RY, 2007, P NATL ACAD SCI USA, V104, P7116, DOI 10.1073/pnas.0700266104; LIU XY, 1994, J BACTERIOL, V176, P7345, DOI 10.1128/JB.176.23.7345-7351.1994; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Ramirez V, 2011, J MOL EVOL, V72, P413, DOI 10.1007/s00239-011-9441-8; MACNAB RM, 1992, ANNU REV GENET, V26, P131, DOI 10.1146/annurev.ge.26.120192.001023; Mahajan A, 2009, CELL MICROBIOL, V11, P121, DOI 10.1111/j.1462-5822.2008.01244.x; Manning SD, 2008, P NATL ACAD SCI USA, V105, P4868, DOI 10.1073/pnas.0710834105; Miyamoto Y, 2006, CELL MICROBIOL, V8, P869, DOI 10.1111/j.1462-5822.2005.00673.x; Naylor SW, 2005, MICROBIOL-SGM, V151, P2773, DOI 10.1099/mic.0.28060-0; Nicholls L, 2000, MOL MICROBIOL, V35, P275, DOI 10.1046/j.1365-2958.2000.01690.x; OKA A, 1981, J MOL BIOL, V147, P217, DOI 10.1016/0022-2836(81)90438-1; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Pradel N, 2003, INFECT IMMUN, V71, P4908, DOI 10.1128/IAI.71.9.4908-4916.2003; Roe AJ, 2003, INFECT IMMUN, V71, P5900, DOI 10.1128/IAI.71.10.5900-5909.2003; Salman-Dilgimen A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022168; SHIN S, 1995, J BACTERIOL, V177, P4696, DOI 10.1128/jb.177.16.4696-4702.1995; SILVERMAN M, 1974, J BACTERIOL, V120, P1196, DOI 10.1128/JB.120.3.1196-1203.1974; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; Soutourina O, 1999, J BACTERIOL, V181, P7500, DOI 10.1128/JB.181.24.7500-7508.1999; Sperandio V, 2002, MOL MICROBIOL, V43, P809, DOI 10.1046/j.1365-2958.2002.02803.x; Stevens MP, 2002, INFECT IMMUN, V70, P5158, DOI 10.1128/IAI.70.9.5158-5166.2002; STOJILJKOVIC I, 1994, J MOL BIOL, V236, P531, DOI 10.1006/jmbi.1994.1163; Su MSW, 2008, MICROBIOL-SGM, V154, P1094, DOI 10.1099/mic.0.2007/013946-0; Tree JJ, 2011, MOL MICROBIOL, V80, P1349, DOI 10.1111/j.1365-2958.2011.07650.x; Tsai NP, 2006, BIOCHEM J, V393, P591, DOI 10.1042/BJ20051201; Wang SY, 2006, J MOL BIOL, V355, P798, DOI 10.1016/j.jmb.2005.11.020; Wells TJ, 2008, ENVIRON MICROBIOL, V10, P589, DOI 10.1111/j.1462-2920.2007.01479.x; Yang XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046828; Yin XH, 2009, APPL ENVIRON MICROB, V75, P5779, DOI 10.1128/AEM.00507-09; Yin XH, 2009, APPL ENVIRON MICROB, V75, P4975, DOI 10.1128/AEM.00297-09; Zhou ZM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008700	58	37	37	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e64211	10.1371/journal.pone.0064211	http://dx.doi.org/10.1371/journal.pone.0064211			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785398	Green Published, Green Submitted, gold			2022-12-27	WOS:000321038800119
J	Borges, CS; Missassi, G; Pacini, ESA; Kiguti, LRA; Sanabria, M; Silva, RF; Banzato, TP; Perobelli, JE; Pupo, AS; Kempinas, WG				Borges, Cibele S.; Missassi, Gabriela; Pacini, Enio S. A.; Kiguti, Luiz Ricardo A.; Sanabria, Marciana; Silva, Raquel F.; Banzato, Thais P.; Perobelli, Juliana E.; Pupo, Andre S.; Kempinas, Wilma G.			Slimmer or Fertile? Pharmacological Mechanisms Involved in Reduced Sperm Quality and Fertility in Rats Exposed to the Anorexigen Sibutramine	PLOS ONE			English	Article							EPIDIDYMAL SPERM; VAS-DEFERENS; SYMPATHOMIMETIC DRUGS; TRANSIT-TIME; IN-VITRO; INNERVATION; CONTRACTILITY; NOREPINEPHRINE; ADRENOCEPTORS; PROSTATE	Sperm acquire motility and fertility capacity during epididymal transit, under the control of androgens and sympathetic innervations. It is already known that the acceleration of epididymal sperm transit time can lead to lower sperm quality. In a previous work we showed that rats exposed to the anorexigen sibutramine, a non-selective serotonin-norepinephrine reuptake inhibitor, presented faster sperm transit time, lower epididymal sperm reserves and potentiation of the tension of epididymal duct to norepinephrine exposed acutely in vitro to sibutramine. In the present work we aimed to further investigate pharmacological mechanisms involved in these alterations and the impact on rat sperm quality. For this, adult male Wistar rats were treated with sibutramine (10 mg/kg/day) or vehicle for 30 days. Sibutramine decreased final body, seminal vesicle, ventral prostate and epididymal weights, as well as sperm transit time in the epididymal cauda. On the contrary of the in vitro pharmacological assays, in which sibutramine was added directly to the bath containing strips of distal epididymal cauda, the ductal tension was not altered after in vivo sub-chronic exposure to sibutramine. However, there is pharmacological evidence that the endogenous epididymal norepinephrine reserves were reduced in these animals. It was also shown that the decrease in prostate weight can be related to increased tension developed of the gland, due to sibutramine sympathomimetic effects. In addition, our results showed reduced sperm quality after in utero artificial insemination, a more sensitive procedure to assess fertility in rodents. The epididymal norepinephrine depletion exerted by sibutramine, associated with decreases in sperm transit time, quantity and quality, leading to reduced fertility in this experimental model, reinforces the concerns about the possible impact on fertility of man taking sibutramine as well as other non-selective serotonin-norepinephrine reuptake inhibitors, especially considering the lower reproductive efficiency of humans compared to males of other species.	[Borges, Cibele S.; Missassi, Gabriela; Sanabria, Marciana; Silva, Raquel F.; Banzato, Thais P.; Perobelli, Juliana E.; Kempinas, Wilma G.] UNESP Univ Estadual Paulista, Inst Biosci, Dept Morphol, Botucatu, SP, Brazil; [Pacini, Enio S. A.; Kiguti, Luiz Ricardo A.; Pupo, Andre S.] UNESP Univ Estadual Paulista, Inst Biosci, Dept Pharmacol, Botucatu, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista	Kempinas, WG (corresponding author), UNESP Univ Estadual Paulista, Inst Biosci, Dept Morphol, Botucatu, SP, Brazil.	kempinas@ibb.unesp.br	Kiguti, Luiz Ricardo LRA/J-7645-2012; Pupo, Andre Sampaio/C-8578-2013; dos Santos Borges, Cibele/I-2145-2014; Kempinas, Wilma De GravaS/E-4671-2012; Missassi, Gabriela/C-3806-2016; Kiguti, Luiz Ricardo/J-8138-2015; Silva, Raquel/B-8442-2015; PEROBELLI, JULIANA ELAINE/D-5722-2012	dos Santos Borges, Cibele/0000-0003-3711-811X; Kempinas, Wilma De GravaS/0000-0002-2112-5123; Missassi, Gabriela/0000-0001-8686-144X; Silva, Raquel/0000-0002-1637-6075; PEROBELLI, JULIANA ELAINE/0000-0002-6797-2117; Kiguti, Luiz Ricardo de Almeida/0000-0002-7609-9313; Arakaki Pacini, Enio Setsuo/0000-0002-8166-1964	FAPESP - The State of Sao Paulo Research Foundation [2010/13948-4, 2011/11840-4]; CNPq National Council for Scientific and Technological Development [304958/2009-3]	FAPESP - The State of Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by FAPESP - The State of Sao Paulo Research Foundation (Grant numbers 2010/13948-4 and 2011/11840-4) and CNPq National Council for Scientific and Technological Development (Grant number 304958/2009-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann R P, 1982, Fundam Appl Toxicol, V2, P13, DOI 10.1016/S0272-0590(82)80059-6; Araujo JR, 2012, CURR NEUROPHARMACOL, V10, P49, DOI 10.2174/157015912799362788; Bellentani FF, 2011, J ANDROL, V32, P718, DOI 10.2164/jandrol.111.013466; BILLUPS KL, 1990, J UROLOGY, V143, P625, DOI 10.1016/S0022-5347(17)40043-7; Choi JW, 2011, PROTEOMICS, V11, P1300, DOI 10.1002/pmic.201000664; Clegg E.D., 2001, PRINC METHODS TOXICO, V4, P1263; Kempinas WD, 2010, COMPREHENSIVE TOXICOLOGY, VOL 11: REPRODUCTIVE AND ENDOCRINE TOXICOLOGY, 2ND EDITION, P149; Fernandez CDB, 2008, INT J ANDROL, V31, P427, DOI 10.1111/j.1365-2605.2007.00788.x; Filler R., 1993, MALE REPROD TOXICOLO, P334, DOI DOI 10.1016/B978-0-12-461207-5.50025-0; Garcia PV, 2012, FERTIL STERIL, V97, P1444, DOI 10.1016/j.fertnstert.2012.03.025; Gerendai I, 2001, AUTON NEUROSCI-BASIC, V92, P1, DOI 10.1016/S1566-0702(01)00292-2; Glandt M, 2011, J OBES, V2011, DOI 10.1155/2011/636181; Haynes WG, 2005, CLIN AUTON RES, V15, P189, DOI 10.1007/s10286-005-0287-2; Jackson HC, 1997, BRIT J PHARMACOL, V121, P1613, DOI 10.1038/sj.bjp.0701311; Janhunen SK, 2011, OBESITY, V19, P1979, DOI 10.1038/oby.2011.51; Jurkiewicz NH, 2012, EUR J PHARMACOL, V691, P52, DOI 10.1016/j.ejphar.2012.07.027; JURKIEWICZ NH, 1992, BRIT J PHARMACOL, V107, P610, DOI 10.1111/j.1476-5381.1992.tb12791.x; KASUYA Y, 1968, EUR J PHARMACOL, V4, P355, DOI 10.1016/0014-2999(68)90019-8; KEMPINAS MG, 1995, ANDROLOGIA, V27, P121; Kempinas WD, 1998, BIOL REPROD, V59, P897, DOI 10.1095/biolreprod59.4.897; Kempinas WD, 1998, BIOL REPROD, V59, P890, DOI 10.1095/biolreprod59.4.890; KENAKIN T, 1997, PHARM ANAL DRUG RECE, P331; Kim SE, 2007, J PHARMACOL EXP THER, V321, P753, DOI 10.1124/jpet.106.117747; KLINEFELTER GR, 1994, J ANDROL, V15, P318; Klinfelter G., 2002, EPIDIDYMIS MOL CLIN, P353; Kontani H, 2002, JPN J PHARMACOL, V90, P281, DOI 10.1254/jjp.90.281; LANGELOH A, 1987, N-S ARCH PHARMACOL, V336, P602, DOI 10.1007/BF00165750; LANGELOH A, 1987, N-S ARCH PHARMACOL, V336, P611, DOI 10.1007/BF00165751; Mangelsdorf I, 2003, REGUL TOXICOL PHARM, V37, P356, DOI 10.1016/S0273-2300(03)00026-6; Nisoli E, 2000, Obes Rev, V1, P127, DOI 10.1046/j.1467-789x.2000.00020.x; Nojimoto FD, 2009, TOXICOL APPL PHARM, V239, P233, DOI 10.1016/j.taap.2009.05.021; Pennefather JN, 2000, J AUTON PHARMACOL, V20, P193, DOI 10.1046/j.1365-2680.2000.00195.x; PHOLPRAMOOL C, 1984, J REPROD FERTIL, V71, P181; RATNASOORIYA WD, 1979, J REPROD FERTIL, V56, P633; RATNASOORIYA WD, 1980, J REPROD FERTIL, V58, P19; RATNASOORIYA WD, 1979, J REPROD FERTIL, V56, P643; Ricker DD, 1998, J ANDROL, V19, P1; Robaire B, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P1071; ROBB GW, 1978, J REPROD FERTIL, V54, P103, DOI 10.1530/jrf.0.0540103; Rodrigues Alexandre Oliveira, 2002, Rev. Hosp. Clin., V57, P287, DOI 10.1590/S0041-87812002000600008; Scheen AJ, 2011, DIABETES CARE, V34, pS114, DOI 10.2337/dc11-s205; Seed J, 1996, REPROD TOXICOL, V10, P237, DOI 10.1016/0890-6238(96)00028-7; Sobey CG, 2001, ARTERIOSCL THROM VAS, V21, P28, DOI 10.1161/01.ATV.21.1.28; SPEDDING M, 1992, PHARMACOL REV, V44, P363; SUJARIT S, 1985, J REPROD FERTIL, V74, P497, DOI 10.1530/jrf.0.0740497; TRENDELENBURG U, 1970, J PHARMACOL EXP THER, V172, P91; VAALASTI A, 1979, AM J ANAT, V154, P231, DOI 10.1002/aja.1001540208; VENTURA S, 1991, BRIT J PHARMACOL, V102, P540, DOI 10.1111/j.1476-5381.1991.tb12207.x; WANG JM, 1991, BIOL REPROD, V44, P1171, DOI 10.1095/biolreprod44.6.1171; Zhou YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039062	50	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66091	10.1371/journal.pone.0066091	http://dx.doi.org/10.1371/journal.pone.0066091			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776614	Green Published, gold, Green Submitted			2022-12-27	WOS:000320322400080
J	Chabierski, S; Makert, GR; Kerzhner, A; Barzon, L; Fiebig, P; Liebert, UG; Papa, A; Richner, JM; Niedrig, M; Diamond, MS; Palu, G; Ulbert, S				Chabierski, Stefan; Makert, Gustavo R.; Kerzhner, Alexandra; Barzon, Luisa; Fiebig, Petra; Liebert, Uwe G.; Papa, Anna; Richner, Justin M.; Niedrig, Matthias; Diamond, Michael S.; Palu, Giorgio; Ulbert, Sebastian			Antibody Responses in Humans Infected with Newly Emerging Strains of West Nile Virus in Europe	PLOS ONE			English	Article							HUMAN MONOCLONAL-ANTIBODIES; DENGUE VIRUS; IMMUNE-RESPONSE; NEUTRALIZING ANTIBODIES; NATURAL INFECTION; GENOME SEQUENCES; EPITOPES; IDENTIFICATION; DETERMINANTS; RECOGNITION	Infection with West Nile Virus (WNV) affects an increasing number of countries worldwide. Although most human infections result in no or mild flu-like symptoms, the elderly and those with a weakened immune system are at higher risk for developing severe neurological disease. Since its introduction into North America in 1999, WNV has spread across the continental United States and caused annual outbreaks with a total of 36,000 documented clinical cases and similar to 1,500 deaths. In recent years, outbreaks of neuroinvasive disease also have been reported in Europe. The WNV strains isolated during these outbreaks differ from those in North America, as sequencing has revealed that distinct phylogenetic lineages of WNV concurrently circulate in Europe, which has potential implications for the development of vaccines, therapeutics, and diagnostic tests. Here, we studied the human antibody response to European WNV strains responsible for outbreaks in Italy and Greece in 2010, caused by lineage 1 and 2 strains, respectively. The WNV structural proteins were expressed as a series of overlapping fragments fused to a carrier-protein, and binding of IgG in sera from infected persons was analyzed. The results demonstrate that, although the humoral immune response to WNV in humans is heterogeneous, several dominant peptides are recognized.	[Chabierski, Stefan; Makert, Gustavo R.; Kerzhner, Alexandra; Ulbert, Sebastian] Fraunhofer Inst Cell Therapy & Immunol, Dept Immunol, Leipzig, Germany; [Barzon, Luisa; Palu, Giorgio] Univ Padua, Dept Mol Med, Padua, Italy; [Fiebig, Petra; Liebert, Uwe G.] Univ Leipzig, Inst Virol, D-04109 Leipzig, Germany; [Papa, Anna] Aristotle Univ Thessaloniki, Sch Med, Dept Microbiol, GR-54006 Thessaloniki, Greece; [Richner, Justin M.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Richner, Justin M.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Richner, Justin M.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Niedrig, Matthias] Robert Koch Inst, Berlin, Germany	Fraunhofer Gesellschaft; University of Padua; Leipzig University; Aristotle University of Thessaloniki; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Robert Koch Institute	Ulbert, S (corresponding author), Fraunhofer Inst Cell Therapy & Immunol, Dept Immunol, Leipzig, Germany.	sebastian.ulbert@izi.fraunhofer.de	Makert, Gustavo R./AGG-4563-2022; Barzon, Luisa/K-7961-2016; Diamond, Michael/AAH-1733-2019	Barzon, Luisa/0000-0003-0720-8456; Diamond, Michael/0000-0002-8791-3165; Richner, Justin/0000-0002-5344-118X; Ulbert, Sebastian/0000-0001-5910-3643	European Commission [261426]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the European Commission under FP7, project number 261426 (WINGS; Epidemiology, Diagnosis and Prevention of West Nile Virus in Europe). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barzon L, 2012, CLIN MICROBIOL INFEC, V18, pE541, DOI 10.1111/1469-0691.12001; Barzon L, 2009, EURO SURVEILL, V14, P19384; Barzon L, 2012, EURO SURVEILL, V17, P20260; Beasley DWC, 2002, J VIROL, V76, P13097, DOI 10.1128/JVI.76.24.13097-13100.2002; Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007; Cherrier MV, 2009, EMBO J, V28, P3269, DOI 10.1038/emboj.2009.245; Danis K, 2011, EMERG INFECT DIS, V17, P1868, DOI 10.3201/eid1710.110525; Davis BS, 2001, J VIROL, V75, P4040, DOI 10.1128/JVI.75.9.4040-4047.2001; de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109; de Alwis R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001188; De Filette M, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-16; Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181; Denisova GF, 2008, MOL IMMUNOL, V46, P125, DOI 10.1016/j.molimm.2008.07.020; Diamond MS, 2008, IMMUNOL REV, V225, P212, DOI 10.1111/j.1600-065X.2008.00676.x; Diamond MS, 2009, FRONT BIOSCI-LANDMRK, V14, P3024, DOI 10.2741/3432; Diamond MS, 2003, J EXP MED, V198, P1853, DOI 10.1084/jem.20031223; Diamond MS, 2003, J VIROL, V77, P2578, DOI 10.1128/JVI.77.4.2578-2586.2003; Faggioni G, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-283; Gangwar RS, 2012, VIRUS RES, V163, P40, DOI 10.1016/j.virusres.2011.08.008; Gubler D, 2007, FIELDS VIROLOGY, P1155; Hayes EB, 2005, EMERG INFECT DIS, V11, P1167, DOI 10.3201/eid1108.050289a; Herrmann S, 2007, J VIROL METHODS, V141, P133, DOI 10.1016/j.jviromet.2006.11.041; Kaufmann B, 2010, P NATL ACAD SCI USA, V107, P18950, DOI 10.1073/pnas.1011036107; Lanciotti RS, 2002, VIROLOGY, V298, P96, DOI 10.1006/viro.2002.1449; Lanteri MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022948; Ledizet M, 2007, J INFECT DIS, V196, P1741, DOI 10.1086/523654; Magurano F, 2012, CLIN MICROBIOL INFEC, V18, pE545, DOI 10.1111/1469-0691.12018; Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067; Murray KO, 2010, VET RES, V41, DOI 10.1051/vetres/2010039; Niedrig M, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-72; Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240; Oliphant T, 2007, J VIROL, V81, P11828, DOI 10.1128/JVI.00643-07; Oliphant T, 2006, J VIROL, V80, P12149, DOI 10.1128/JVI.01732-06; Olsen Lars Ronn, 2011, Immunome Res, V7; Papa A, 2012, EXPERT REV ANTI-INFE, V10, P743, DOI [10.1586/ERI.12.59, 10.1586/eri.12.59]; Papa A, 2011, ARCH VIROL, V156, P1661, DOI 10.1007/s00705-011-1014-z; Papa A, 2011, J MED VIROL, V83, P1861, DOI 10.1002/jmv.22180; Parsons R, 2008, J IMMUNOL, V181, P1563, DOI 10.4049/jimmunol.181.2.1563; Reiter P, 2010, EUROSURVEILLANCE, V15, P4; Savini G, 2012, VET MICROBIOL, V158, P267, DOI 10.1016/j.vetmic.2012.02.018; Sirbu A., 2010, EURO SURVEILL, V16; Sun EC, 2012, J GEN VIROL, V93, P50, DOI 10.1099/vir.0.034900-0; Sun EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031434; Teoh EP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003888; Throsby M, 2006, J VIROL, V80, P6982, DOI 10.1128/JVI.00551-06; Vaughan K, 2010, VIRAL IMMUNOL, V23, P259, DOI 10.1089/vim.2010.0006; Vazquez S, 2002, VACCINE, V20, P1823, DOI 10.1016/S0264-410X(01)00515-1; Vogt MR, 2011, J VIROL, V85, P11567, DOI 10.1128/JVI.05859-11; Vogt MR, 2009, J VIROL, V83, P6494, DOI 10.1128/JVI.00286-09	50	14	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66507	10.1371/journal.pone.0066507	http://dx.doi.org/10.1371/journal.pone.0066507			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776680	gold, Green Submitted, Green Published			2022-12-27	WOS:000320322400106
J	Li, DK; Miao, MH; Zhou, ZH; Wu, CH; Shi, HJ; Liu, XQ; Wang, SQ; Yuan, W				Li, De-Kun; Miao, Maohua; Zhou, ZhiJun; Wu, Chunhua; Shi, Huijing; Liu, Xiaoqin; Wang, Siqi; Yuan, Wei			Urine Bisphenol-A Level in Relation to Obesity and Overweight in School-Age Children	PLOS ONE			English	Article							IN-UTERO EXPOSURE; ENDOCRINE DISRUPTORS; OCCUPATIONAL-EXPOSURE; PHTHALATE METABOLITES; TEMPORAL VARIABILITY; US POPULATION; GIRLS; ADOLESCENTS; EPIDEMIC; PUBERTY	Bisphenol-A (BPA) is a potential endocrine disruptor impacting metabolic processes and increasing the risk of obesity. To determine whether urine BPA level is associated with overweight/obesity in school-age children, we examined 1,326 students in grades 4-12 from three schools (one elementary, one middle, and one high school) in Shanghai. More than 98% of eligible students participated. Total urine BPA concentration was measured and anthropometric measures were taken by trained research staff. Information on risk factors for childhood obesity was collected for potential confounders. Age-and gender-specific weight greater than 90th percentile of the underlying population was the outcome measure. After adjustment for potential confounders, a higher urine BPA level (>= 2 mu g/L), at the level corresponding to the median urine BPA level in the U.S. population, was associated with more than two-fold increased risk of having weight >90th percentile among girls aged 9-12 (adjusted odds ratio (aOR) = 2.32, 95% confidence interval: 1.15-4.65). The association showed a dose-response relationship with increasing urine BPA level associated with further increased risk of overweight (p = 0.006 for trend test). Other anthropometric measures of obesity showed similar results. The same association was not observed among boys. This gender difference of BPA effect was consistent with findings from experimental studies and previous epidemiological studies. Our study suggests that BPA could be a potential new environmental obesogen. Widespread exposure to BPA in the human population may also be contributing to the worldwide obesity epidemic.	[Li, De-Kun] Kaiser Permanente, Kaiser Fdn Res Inst, Div Res, Oakland, CA 94612 USA; [Li, De-Kun] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA USA; [Miao, Maohua; Liu, Xiaoqin; Wang, Siqi; Yuan, Wei] Collaborating Ctr Res Human Reprod, Dept Epidemiol & Social Sci Reprod Hlth, Shanghai Inst Planned Parenthood Res, Shanghai, Peoples R China; [Miao, Maohua; Liu, Xiaoqin; Wang, Siqi; Yuan, Wei] Collaborating Ctr Res Human Reprod, World Hlth Org, Shanghai, Peoples R China; [Zhou, ZhiJun; Wu, Chunhua] Fudan Univ, Sch Publ Hlth, Key Lab Publ Hlth Safety, Shanghai, Peoples R China; [Zhou, ZhiJun; Wu, Chunhua] Fudan Univ, WHO Collaborating Ctr Occupat Hlth, Shanghai, Peoples R China; [Shi, Huijing] Fudan Univ, Dept Child & Adolescent Hlth, Sch Publ Hlth, Shanghai 200433, Peoples R China; [Yuan, Wei] Natl Populat & Family Planning Key Lab Contracept, Shanghai, Peoples R China	Kaiser Permanente; Stanford University; World Health Organization; Fudan University; Fudan University; Fudan University	Li, DK (corresponding author), Kaiser Permanente, Kaiser Fdn Res Inst, Div Res, Oakland, CA 94612 USA.	dkl@dor.kaiser.org	Zhou, Zhiju/D-1616-2019; Shi, Huijing/GRR-8564-2022	Zhou, Zhiju/0000-0002-2407-2071; 	National Natural Science Foundation of China [81172684]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was funded in part by National Natural Science Foundation of China(#81172684). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow SE, 2007, PEDIATRICS, V120, pS164, DOI 10.1542/peds.2007-2329C; Ben-Jonathan N, 2009, MOL CELL ENDOCRINOL, V304, P49, DOI 10.1016/j.mce.2009.02.022; Biro FM, 2001, J PEDIATR-US, V138, P636, DOI 10.1067/mpd.2001.114476; Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P39, DOI 10.1289/ehp.10753; Carwile JL, 2011, ENVIRON RES, V111, P825, DOI 10.1016/j.envres.2011.05.014; Chen CM, 2008, OBES REV, V9, P14, DOI 10.1111/j.1467-789X.2007.00433.x; Dodds EC, 1938, PROC R SOC SER B-BIO, V125, P222, DOI 10.1098/rspb.1938.0023; Dubois L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030153; Galloway T, 2010, ENVIRON HEALTH PERSP, V118, P1603, DOI 10.1289/ehp.1002367; Golub MS, 2010, BIRTH DEFECTS RES B, V89, P441, DOI 10.1002/bdrb.20275; He YH, 2009, J OCCUP HEALTH, V51, P432, DOI 10.1539/joh.O9006; He YH, 2009, ENVIRON RES, V109, P629, DOI 10.1016/j.envres.2009.04.003; Heindel JJ, 2009, MOL CELL ENDOCRINOL, V304, P90, DOI 10.1016/j.mce.2009.02.025; Heindel JJ, 2003, TOXICOL SCI, V76, P247, DOI 10.1093/toxsci/kfg255; Howdeshell KL, 1999, NATURE, V401, P763, DOI 10.1038/44517; Hsu-Hage BH-H, 1992, ASIA PACIFIC J CLIN, P211; Hugo ER, 2008, ENVIRON HEALTH PERSP, V116, P1642, DOI 10.1289/ehp.11537; Jiang Y, 2007, SHANGHAI J PREVEN ME, V19, P544; Kidani T, 2010, J ATHEROSCLER THROMB, V17, P834, DOI 10.5551/jat.4051; Kim YH, 2003, BIOCHEM BIOPH RES CO, V312, P441, DOI 10.1016/j.bbrc.2003.10.135; Kosti Rena I., 2006, Central European Journal of Public Health, V14, P151; Kovacs M., 1992, CHILDRENS DEPRESSION; Lang IA, 2008, JAMA-J AM MED ASSOC, V300, P1303, DOI 10.1001/jama.300.11.1303; Li D, 2010, HUM REPROD, V25, P519, DOI 10.1093/humrep/dep381; Li DK, 2011, FERTIL STERIL, V95, P625, DOI 10.1016/j.fertnstert.2010.09.026; Li DK, 2010, J ANDROL, V31, P500, DOI 10.2164/jandrol.110.010413; Mahalingaiah S, 2008, ENVIRON HEALTH PERSP, V116, P173, DOI 10.1289/ehp.10605; MartiHenneberg C, 1997, J PEDIATR-US, V131, P618, DOI 10.1016/S0022-3476(97)70073-8; Matsumoto A, 2003, ENVIRON HEALTH PERSP, V111, P101, DOI 10.1289/ehp.5512; Miao MH, 2011, BIRTH DEFECTS RES A, V91, P867, DOI 10.1002/bdra.22845; Miao MH, 2011, REPROD TOXICOL, V32, P64, DOI 10.1016/j.reprotox.2011.03.002; Miyamoto Ken-ichi, 2006, Environmental Sciences, V13, P15; National Toxicology Program USDOHAHS, 2008, NTP CERHR MON POT HU, V08-5994; Newbold RR, 2008, INT J ANDROL, V31, P201, DOI 10.1111/j.1365-2605.2007.00858.x; Newbold RR, 2007, REPROD TOXICOL, V23, P290, DOI 10.1016/j.reprotox.2006.12.010; Newbold RR, 2010, HORM-INT J ENDOCRINO, V9, P206, DOI 10.14310/horm.2002.1271; Newbold RR, 2009, MOL CELL ENDOCRINOL, V304, P84, DOI 10.1016/j.mce.2009.02.024; Pantsiotou S, 2008, ACTA PAEDIATR, V97, P217, DOI 10.1111/j.1651-2227.2007.00598.x; Papadimitriou A, 2008, J CLIN ENDOCR METAB, V93, P4422, DOI 10.1210/jc.2008-0661; Rubin BS, 2011, J STEROID BIOCHEM, V127, P27, DOI 10.1016/j.jsbmb.2011.05.002; Rubin BS, 2009, MOL CELL ENDOCRINOL, V304, P55, DOI 10.1016/j.mce.2009.02.023; Rubin BS, 2001, ENVIRON HEALTH PERSP, V109, P675, DOI 10.2307/3454783; Shan XY, 2010, INT J PEDIATR OBES, V5, P383, DOI 10.3109/17477160903572001; Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723; Somm E, 2009, ENVIRON HEALTH PERSP, V117, P1549, DOI 10.1289/ehp.11342; Sun Y, 2012, J ADOLESCENT HEALTH, V51, P279, DOI 10.1016/j.jadohealth.2011.12.019; Teitelbaum SL, 2008, ENVIRON RES, V106, P257, DOI 10.1016/j.envres.2007.09.010; Trasande L, 2012, JAMA-J AM MED ASSOC, V308, P1113, DOI 10.1001/2012.jama.11461; Wang TG, 2012, J CLIN ENDOCR METAB, V97, pE223, DOI 10.1210/jc.2011-1989; Wang Y, 2006, INT J PEDIATR OBES, V1, P11, DOI 10.1080/17477160600586747; Ye XY, 2011, ENVIRON HEALTH PERSP, V119, P983, DOI 10.1289/ehp.1002701	51	59	61	1	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65399	10.1371/journal.pone.0065399	http://dx.doi.org/10.1371/journal.pone.0065399			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776476	Green Submitted, Green Published, gold			2022-12-27	WOS:000320322400021
J	Ye, HY; Zhang, HJ; Xu, AM; Hoo, RLC				Ye, Hongying; Zhang, Herbert J.; Xu, Aimin; Hoo, Ruby L. C.			Resistin Production from Adipose Tissue Is Decreased in db/db Obese Mice, and Is Reversed by Rosiglitazone	PLOS ONE			English	Article							INSULIN-RESISTANCE; ADIPONECTIN; ADIPOKINES; ADIPOCYTOKINES; INFLAMMATION; SENSITIVITY; EXPRESSION; DISEASE; HUMANS	Objective: This study was designed to (1) investigate the expression profiles of resistin in db/db mice and its dynamic association with metabolic parameters; and (2) evaluate the effects of Rosiglitazone on production of resistin. Methods: Db/db mice and their lean litter mates were used for this study. Epididymal fat tissue was excised from mice of different age (from 5 to 12 weeks) for ex vivo incubation. Resistin, along with adiponectin, in serum and conditioned culture medium of epididymal fat pads were measured with immunoassays. The gene expression of resistin was determined by real-time PCR. Rosiglitazone or the vehicle (PBS) was administered into db/db mice by daily intra-gastric gavage. Differentiated 3T3-L1 adipocytes were used for in vitro evaluation. Results: The secretion of resistin from the fat pads in db/db mice was significantly lower than that in lean mice (P<0.01). The mRNA expression of the resistin gene in fat tissue of db/db mice at the age of 5 weeks was decreased by 60.5% compared to lean controls (p<0.05). Serum levels of resistin were comparable between the obese and lean groups, perhaps due to the increased total fat mass in db/db mice. Correlation analysis showed that serum resistin levels were positively correlated to resistin secretion from fat pads(r = 0.844, P = 0.000), while negatively associated with the body weight (r = 20.515, P = 0.000) and fasting glucose level (r = -0.357, P = 0.002). Notably, treatment with rosiglitazone increased the serum resistin levels by 66.4%(P<0.05) in db/db mice. In 3T3-L1 adipocytes, Rosiglitazone (10 uM) markedly enhanced the secretion of resistin by 120% (P<0.01) and its gene expression by 78.1% (P<0.05). Conclusion: Both resistin gene expression and its secretion from the epididymal adipose tissue were decreased in db/db obese mice, while the insulin-sensitizing drug rosiglitazone increased resistin production. Our results do not support the role of resistin as an etiological link between obesity and diabetes.	[Ye, Hongying; Zhang, Herbert J.; Xu, Aimin; Hoo, Ruby L. C.] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Ye, Hongying; Zhang, Herbert J.; Xu, Aimin; Hoo, Ruby L. C.] Univ Hong Kong, Res Ctr Heart Brain Hormone & Hlth Aging, Hong Kong, Hong Kong, Peoples R China; [Ye, Hongying] Fudan Univ, Huashan Hosp, Dept Endocrinol, Shanghai 200433, Peoples R China	University of Hong Kong; University of Hong Kong; Fudan University	Hoo, RLC (corresponding author), Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China.	rubyhoo@hkucc.hku.hk			Chinese State Natural Science Funds [30600300]	Chinese State Natural Science Funds	This work was partly supported by Chinese State Natural Science Funds (Grant No: 30600300). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antuna-Puente B, 2008, DIABETES METAB, V34, P2, DOI 10.1016/j.diabet.2007.09.004; Barnes KM, 2009, CURR PROTEIN PEPT SC, V10, P96, DOI 10.2174/138920309787315239; Fain JN, 2004, ENDOCRINOLOGY, V145, P2273, DOI 10.1210/en.2003-1336; Haluzik MM, 2006, ENDOCRINOLOGY, V147, P4517, DOI 10.1210/en.2005-1624; Haugen F, 2001, FEBS LETT, V507, P105, DOI 10.1016/S0014-5793(01)02968-4; Holcomb IN, 2000, EMBO J, V19, P4046, DOI 10.1093/emboj/19.15.4046; Janowska J, 2006, METABOLISM, V55, P1495, DOI 10.1016/j.metabol.2006.06.020; Kusminski CM, 2005, CLIN SCI, V109, P243, DOI 10.1042/CS20050078; Leal VD, 2013, CLIN CHIM ACTA, V419, P87, DOI 10.1016/j.cca.2013.02.003; Liu Ge-li, 2006, Zhonghua Er Ke Za Zhi, V44, P114; Moore GBT, 2001, BIOCHEM BIOPH RES CO, V286, P735, DOI 10.1006/bbrc.2001.5460; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Pfutzner Andreas, 2003, Clin Lab, V49, P571; Pittas AG, 2004, J CLIN ENDOCR METAB, V89, P447, DOI 10.1210/jc.2003-031005; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Wasim H, 2006, CARDIOVASC DIABETOL, V5, DOI 10.1186/1475-2840-5-10; Way JM, 2001, J BIOL CHEM, V276, P25651, DOI 10.1074/jbc.C100189200; Xu AM, 2004, ENDOCRINOLOGY, V145, P487, DOI 10.1210/en.2003-1140; Xu AM, 2005, J BIOL CHEM, V280, P18073, DOI 10.1074/jbc.M414231200; Yaturu S, 2006, CYTOKINE, V34, P219, DOI 10.1016/j.cyto.2006.05.005; Zou CH, 2008, J NUTR BIOCHEM, V19, P277, DOI 10.1016/j.jnutbio.2007.06.006	21	13	13	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65543	10.1371/journal.pone.0065543	http://dx.doi.org/10.1371/journal.pone.0065543			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776497	Green Published, gold, Green Submitted			2022-12-27	WOS:000320322400032
J	Blix, E; Perski, A; Berglund, H; Savic, I				Blix, Eva; Perski, Aleksander; Berglund, Hans; Savic, Ivanka			Long-Term Occupational Stress Is Associated with Regional Reductions in Brain Tissue Volumes	PLOS ONE			English	Article							SMALLER HIPPOCAMPAL VOLUME; MEDIAL PREFRONTAL CORTEX; GRAY-MATTER VOLUME; ANTERIOR CINGULATE; SENSITIVE PERIODS; CHRONIC BURNOUT; SURVIVORS; VULNERABILITY; DISORDER; MRI	There are increasing reports of cognitive and psychological declines related to occupational stress in subjects without psychiatric premorbidity or major life trauma. The underlying neurobiology is unknown, and many question the notion that the described disabilities represent a medical condition. Using PET we recently found that persons suffering from chronic occupational stress had limbic reductions in the 5-HT1A receptor binding potential. Here we examine whether chronic work-related stress is also associated with changes in brain structure. We performed MRI-based voxel-based morphometry and structural volumetry in stressed subjects and unstressed controls focusing on gray (GM) and white matter (WM) volumes, and the volumes of hippocampus, caudate, and putamen - structures known to be susceptible to neurotoxic changes. Stressed subjects exhibited significant reductions in the GM volumes of the anterior cingulate cortex and the dorsolateral prefrontal cortex. Furthermore, their caudate and putamen volumes were reduced, and the volumes correlated inversely to the degree of perceived stress. Our results add to previous data on chronic psychosocial stress, and indicate a morphological involvement of the frontostriatal circuits. The present findings of morphological changes in these regions confirm our previous conclusion that symptoms from occupational stress merit careful investigations and targeted treatment.	[Blix, Eva; Berglund, Hans; Savic, Ivanka] Karolinska Inst, Stockholm Brain Inst, Dept Womens & Childrens Hlth, Div Pediat Neurol, Stockholm, Sweden; [Perski, Aleksander] Stockholm Univ, Stress Res Inst, S-10691 Stockholm, Sweden	Karolinska Institutet; Stockholm University	Savic, I (corresponding author), Karolinska Inst, Stockholm Brain Inst, Dept Womens & Childrens Hlth, Div Pediat Neurol, Stockholm, Sweden.	ivanka.savic-berglund@ki.se			Swedish Council for Working Life and Social Research (FAS); Swedish Research Council; AFA Insurance; Stockholm City Council; Centre for Gender Related Medicine, Karolinska Institute	Swedish Council for Working Life and Social Research (FAS)(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Research Council(Swedish Research CouncilEuropean Commission); AFA Insurance; Stockholm City Council; Centre for Gender Related Medicine, Karolinska Institute	The study was supported by the Swedish Council for Working Life and Social Research (FAS), Swedish Research Council, AFA Insurance, Stockholm City Council, as well as the Centre for Gender Related Medicine, Karolinska Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahola K, 2006, SOC PSYCH PSYCH EPID, V41, P11, DOI 10.1007/s00127-005-0011-5; Andersen SL, 2008, J NEUROPSYCH CLIN N, V20, P292, DOI 10.1176/appi.neuropsych.20.3.292; Andersen SL, 2008, TRENDS NEUROSCI, V31, P183, DOI 10.1016/j.tins.2008.01.004; Asberg Marie, 2010, Lakartidningen, V107, P1307; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Baker LM, 2012, BRAIN IMAGING BEHAV; Bernal F, 2000, EXP NEUROL, V161, P686, DOI 10.1006/exnr.1999.7293; Bonne O, 2001, AM J PSYCHIAT, V158, P1248, DOI 10.1176/appi.ajp.158.8.1248; Bremner JD, 2007, NEUROIMAG CLIN N AM, V17, P523, DOI 10.1016/j.nic.2007.07.003; Bremner JD, 2007, PROG BRAIN RES, V167, P171, DOI 10.1016/S0079-6123(07)67012-5; Brown ES, 2010, J AFFECT DISORDERS, V126, P415, DOI 10.1016/j.jad.2010.04.010; Brown SM, 2005, CEREB CORTEX, V15, P1714, DOI 10.1093/cercor/bhi048; Chen L, 2011, HUM BRAIN MAPP; CHEN Q, 1995, EXP NEUROL, V136, P212, DOI 10.1006/exnr.1995.1098; Chen SL, 2006, PSYCHIAT RES-NEUROIM, V146, P65, DOI 10.1016/j.pscychresns.2005.09.006; Chida Y, 2009, BIOL PSYCHOL, V80, P265, DOI 10.1016/j.biopsycho.2008.10.004; Ciumas C, 2006, NEUROLOGY, V67, P683, DOI 10.1212/01.wnl.0000230171.23913.cf; Ciumas C, 2010, NEUROIMAGE, V51, P606, DOI 10.1016/j.neuroimage.2010.02.051; Cohen RA, 2006, BIOL PSYCHIAT, V59, P975, DOI 10.1016/j.biopsych.2005.12.016; Colberg C, 2004, NEUROSCI LETT, V364, P130, DOI 10.1016/j.neulet.2004.04.052; Conrad CD, 1999, BEHAV NEUROSCI, V113, P902, DOI 10.1037/0735-7044.113.5.902; Conrad CD, 2008, REV NEUROSCIENCE, V19, P395; Copertaro A, 2010, MED LAV, V101, P427; Copertaro A, 2007, G Ital Med Lav Ergon, V29, P350; Critchley HD, 2009, INT J PSYCHOPHYSIOL, V73, P88, DOI 10.1016/j.ijpsycho.2009.01.012; Dedovic K, 2009, BRAIN RES, V1293, P49, DOI 10.1016/j.brainres.2009.06.044; Fernandez Torres B, 2006, Rev Esp Anestesiol Reanim, V53, P359; Filipovic BR, 2011, CENT EUR NEUROSURG, V72, P133, DOI 10.1055/s-0030-1253349; FLUGGE G, 1995, J NEUROSCI, V15, P7132; Fries E, 2009, INT J PSYCHOPHYSIOL, V72, P67, DOI 10.1016/j.ijpsycho.2008.03.014; Friess E, 2008, J PSYCHIATR RES, V42, P1154, DOI 10.1016/j.jpsychires.2008.01.005; Geuze E, 2008, NEUROIMAGE, V41, P675, DOI 10.1016/j.neuroimage.2008.03.007; Gilbertson MW, 2002, NAT NEUROSCI, V5, P1242, DOI 10.1038/nn958; Goldstein JM, 2010, J NEUROSCI, V30, P431, DOI 10.1523/JNEUROSCI.3021-09.2010; Grossi G, 2005, J PSYCHOSOM RES, V59, P103, DOI 10.1016/j.jpsychores.2005.02.009; Grossi G, 2003, J PSYCHOSOM RES, V55, P309, DOI 10.1016/S0022-3999(02)00633-5; Helms G, 2006, J NEUROL NEUROSUR PS, V77, P489, DOI 10.1136/jnnp.2005.074682; Herman JP, 2005, PROG NEURO-PSYCHOPH, V29, P1201, DOI 10.1016/j.pnpbp.2005.08.006; HOLMES TH, 1967, J PSYCHOSOM RES, V11, P213, DOI 10.1016/0022-3999(67)90010-4; Hunter RG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004328; Iijima M, 2007, PSYCHOPHARMACOLOGY, V190, P233, DOI 10.1007/s00213-006-0618-6; Isovich E, 2000, EUR J NEUROSCI, V12, P1071, DOI 10.1046/j.1460-9568.2000.00969.x; Jovanovic H, 2011, NEUROIMAGE, V55, P1178, DOI 10.1016/j.neuroimage.2010.12.060; Jovanovic H, 2006, PSYCHIAT RES-NEUROIM, V148, P185, DOI 10.1016/j.pscychresns.2006.05.002; Kasai K, 2008, BIOL PSYCHIAT, V63, P550, DOI 10.1016/j.biopsych.2007.06.022; Langelaan S, 2007, INT J BEHAV MED, V14, P213, DOI 10.1007/BF03002995; Leuner B., 2012, NEUROSCIENCE; Liston C, 2009, P NATL ACAD SCI USA, V106, P912, DOI 10.1073/pnas.0807041106; LOWY MT, 1993, J NEUROCHEM, V61, P1957, DOI 10.1111/j.1471-4159.1993.tb09839.x; Lyoo IK, 2011, ARCH GEN PSYCHIAT, V68, P701, DOI 10.1001/archgenpsychiatry.2011.70; MAGARINOS AM, 1995, NEUROSCIENCE, V69, P89, DOI 10.1016/0306-4522(95)00259-L; Martin KP, 2011, CEREB CORTEX, V21, P2366, DOI 10.1093/cercor/bhr021; Matsuoka Y, 2003, BIOL PSYCHIAT, V54, P736, DOI 10.1016/S0006-3223(02)01907-8; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; McEwen BS, 1998, ANN NY ACAD SCI, V840, P33, DOI 10.1111/j.1749-6632.1998.tb09546.x; McEwen BS, 2000, BRAIN RES, V886, P172, DOI 10.1016/S0006-8993(00)02950-4; McEwen BS, 2000, PROG BRAIN RES, V122, P25; McEwen BS, 1997, EUR NEUROPSYCHOPHARM, V7, P323, DOI 10.1016/S0924-977X(97)00064-3; Melamed S, 1999, J PSYCHOSOM RES, V46, P591, DOI 10.1016/S0022-3999(99)00007-0; Moch SL, 2003, ENDOCRINE, V21, P267, DOI 10.1385/ENDO:21:3:267; Mommersteeg PMC, 2006, HEALTH PSYCHOL, V25, P243, DOI 10.1037/0278-6133.25.2.243; Mommersteeg PMC, 2006, PSYCHONEUROENDOCRINO, V31, P216, DOI 10.1016/j.psyneuen.2005.07.003; MONTGOMERY S, 1978, ACTA PSYCHIAT SCAND, P33; Nardo D, 2010, J PSYCHIATR RES, V44, P477, DOI 10.1016/j.jpsychires.2009.10.014; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Papagni SA, 2011, STRESS, V14, P227, DOI 10.3109/10253890.2010.522279; Pavlisa G, 2006, COLLEGIUM ANTROPOL, V30, P565; Pruessner JC, 1999, PSYCHOSOM MED, V61, P197, DOI 10.1097/00006842-199903000-00012; Qin SZ, 2009, BIOL PSYCHIAT, V66, P25, DOI 10.1016/j.biopsych.2009.03.006; Raz N, 2005, CEREB CORTEX, V15, P1676, DOI 10.1093/cercor/bhi044; Rogers MA, 2009, PSYCHIAT RES-NEUROIM, V174, P210, DOI 10.1016/j.pscychresns.2009.06.001; Roozendaal B, 2004, J NEUROSCI, V24, P1385, DOI 10.1523/JNEUROSCI.4664-03.2004; Rydrnark I, 2006, BIOL PSYCHIAT, V60, P867, DOI 10.1016/j.biopsych.2006.04.029; Sandstrom A, 2005, BIOL PSYCHOL, V69, P271, DOI 10.1016/j.biopsycho.2004.08.003; Savic I, 2008, P NATL ACAD SCI USA, V105, P9403, DOI 10.1073/pnas.0801566105; SCHAUFELI WB, 1995, PSYCHOL REP, V76, P1083, DOI 10.2466/pr0.1995.76.3c.1083; Sheu YS, 2010, NEUROIMAGE, V53, P412, DOI 10.1016/j.neuroimage.2010.06.043; Siemiatkowski M, 2000, NEUROREPORT, V11, P3953; Sinha R, 2004, ANN NY ACAD SCI, V1032, P254, DOI 10.1196/annals.1314.032; Stenlund T, 2007, SCAND J PUBLIC HEALT, V35, P516, DOI 10.1080/14034940701271874; Thomaes K, 2010, J CLIN PSYCHIAT, V71, P1636, DOI 10.4088/JCP.08m04754blu; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; van Harmelen AL, 2010, BIOL PSYCHIAT, V68, P832, DOI 10.1016/j.biopsych.2010.06.011; Villarreal G, 2002, BIOL PSYCHIAT, V52, P119, DOI 10.1016/S0006-3223(02)01359-8; Wahlberg K, 2009, BIOL PSYCHIAT, V65, P742, DOI 10.1016/j.biopsych.2008.10.035; Wang JJ, 2007, SOC COGN AFFECT NEUR, V2, P227, DOI 10.1093/scan/nsm018; Wang JJ, 2005, P NATL ACAD SCI USA, V102, P17804, DOI 10.1073/pnas.0503082102; WATSON C, 1992, NEUROLOGY, V42, P1743, DOI 10.1212/WNL.42.9.1743; Wignall EL, 2004, BIOL PSYCHIAT, V56, P832, DOI 10.1016/j.biopsych.2004.09.015; Wong EYH, 2004, EUR J NEUROSCI, V20, P2491, DOI 10.1111/j.1460-9568.2004.03717.x; Yamasue H, 2003, P NATL ACAD SCI USA, V100, P9039, DOI 10.1073/pnas.1530467100; Zhang J, 2011, PSYCHIAT RES-NEUROIM, V192, P84, DOI 10.1016/j.pscychresns.2010.09.001	92	70	71	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e64065	10.1371/journal.pone.0064065	http://dx.doi.org/10.1371/journal.pone.0064065			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	169CU	23776438	Green Submitted, gold, Green Published			2022-12-27	WOS:000320755400007
J	Pitner, MKH; Saavedra, HI				Pitner, Mary Kathryn Harrison; Saavedra, Harold I.			Cdk4 and Nek2 Signal Binucleation and Centrosome Amplification in a Her2+Breast Cancer Model	PLOS ONE			English	Article							MAMMARY EPITHELIAL-CELLS; BREAST-CANCER; CHROMOSOME INSTABILITY; CYCLIN D1; CYTOKINESIS FAILURE; P53-NULL CELLS; PROTEIN-KINASE; DUPLICATION; TUMORIGENESIS; ANEUPLOIDY	Centrosome amplification (CA) is a contributor to carcinogenesis, generating aneuploidy, and chromosome instability. Previous work shows that breast adenocarcinomas have a higher frequency of centrosome defects compared to normal breast tissues. Abnormal centrosome phenotypes are found in pre-malignant lesions, suggesting an early role in breast carcinogenesis. However, the role of CA in breast cancers remains elusive. Identification of pathways and regulatory molecules involved in the generation of CA is essential to understanding its role in breast tumorigenesis. We established a breast cancer model of CA using Her2-positive cells. Our goal was to identify centrosome cycle molecules that are deregulated by aberrant Her2 signaling and the mechanisms driving CA. Our results show some Her2+ breast cancer cell lines harbor both CA and binucleation. Abolishing the expression of Cdk4 abrogated both CA and binucleation in these cells. We also found the source of binucleation in these cells to be defective cytokinesis that is normalized by downregulation of Cdk4. Protein levels of Nek2 diminish upon Cdk4 knockdown and vice versa, suggesting a molecular connection between Cdk4 and Nek2. Knockdown of Nek2 reduces CA and binucleation in this model while its overexpression further enhances centrosome amplification. We conclude that CA is modulated through Cdk4 and Nek2 signaling and that binucleation is a likely source of CA in Her2+ breast cancer cells.	[Pitner, Mary Kathryn Harrison; Saavedra, Harold I.] Emory Univ, Sch Med, Dept Radiat Oncol, Atlanta, GA 30322 USA	Emory University	Saavedra, HI (corresponding author), Emory Univ, Sch Med, Dept Radiat Oncol, Atlanta, GA 30322 USA.	hsaaved@emory.edu			National Institutes of Health [R01 CA151521]; Georgia Cancer Coalition; Emory University Integrated Cellular Imaging Microscopy Core of the Winship Cancer Institute comprehensive cancer center grant [P30CA138292]; NATIONAL CANCER INSTITUTE [R01CA151521, P30CA138292] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Cancer Coalition; Emory University Integrated Cellular Imaging Microscopy Core of the Winship Cancer Institute comprehensive cancer center grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research project was supported by R01 CA151521 from the National Institutes of Health, the Georgia Cancer Coalition, and by the Emory University Integrated Cellular Imaging Microscopy Core of the Winship Cancer Institute comprehensive cancer center grant P30CA138292. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adon AM, 2010, MOL CELL BIOL, V30, P694, DOI 10.1128/MCB.00253-09; Anderhub SJ, 2012, CANC LETT; Basto R, 2008, CELL, V133, P1032, DOI 10.1016/j.cell.2008.05.039; Bouchet BP, 2007, BRIT J CANCER, V97, P1218, DOI 10.1038/sj.bjc.6603936; Boveri T., 1914, FRAGE ENTSTEHUNG MAL; Carroll PE, 1999, ONCOGENE, V18, P1935, DOI 10.1038/sj.onc.1202515; Castellanos E, 2008, CURR BIOL, V18, P1209, DOI 10.1016/j.cub.2008.07.029; Chen DN, 2009, NATURE, V462, P925, DOI 10.1038/nature08544; Chong JL, 2009, NATURE, V462, P930, DOI 10.1038/nature08677; D'Assoro AB, 2002, ONCOGENE, V21, P6146, DOI 10.1038/sj.onc.1205772; D'Assoro AB, 2004, ONCOGENE, V23, P4068, DOI 10.1038/sj.onc.1207568; Doxsey S, 2002, MOL CELL, V10, P439, DOI 10.1016/S1097-2765(02)00654-8; Duensing A, 2006, ONCOGENE, V25, P2943, DOI 10.1038/sj.onc.1209310; Fry AM, 1998, EMBO J, V17, P470, DOI 10.1093/emboj/17.2.470; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Fukasawa K, 2005, CANCER LETT, V230, P6, DOI 10.1016/j.canlet.2004.12.028; Fukasawa K, 1996, SCIENCE, V271, P1744, DOI 10.1126/science.271.5256.1744; Fukasawa K, 2008, BIOCH BIOPHYS ACTA; Fukasawa K, 2007, NAT REV CANCER, V7, P911, DOI 10.1038/nrc2249; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Gao YX, 2011, HUM PATHOL, V42, P1693, DOI 10.1016/j.humpath.2010.12.027; Gopinathan L, 2011, RESULTS PROBL CELL D, V53, P365, DOI 10.1007/978-3-642-19065-0_16; Guo HQ, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1752; Hanashiro K, 2008, ONCOGENE; Harari D, 2000, ONCOGENE, V19, P6102, DOI 10.1038/sj.onc.1203973; Harrison MK, 2011, CELL DIV, V6, DOI 10.1186/1747-1028-6-2; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; Hayward DG, 2006, CANCER LETT, V237, P155, DOI 10.1016/j.canlet.2005.06.017; Hayward DG, 2004, CANCER RES, V64, P7370, DOI 10.1158/0008-5472.CAN-04-0960; Hinchcliffe EH, 1999, SCIENCE, V283, P851, DOI 10.1126/science.283.5403.851; Krzywicka-Racka A, 2011, J CELL BIOL, V194, P199, DOI 10.1083/jcb.201101073; Lacey KR, 1999, P NATL ACAD SCI USA, V96, P2817, DOI 10.1073/pnas.96.6.2817; Lee RJ, 2000, MOL CELL BIOL, V20, P672, DOI 10.1128/MCB.20.2.672-683.2000; Lingle WL, 2002, P NATL ACAD SCI USA, V99, P1978, DOI 10.1073/pnas.032479999; Lingle WL, 1998, P NATL ACAD SCI USA, V95, P2950, DOI 10.1073/pnas.95.6.2950; Matsumoto Y, 1999, CURR BIOL, V9, P429, DOI 10.1016/S0960-9822(99)80191-2; Montagna C, 2002, ONCOGENE, V21, P890, DOI 10.1038/sj.onc.1205146; Nelsen CJ, 2005, J BIOL CHEM, V280, P768, DOI 10.1074/jbc.M407105200; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; Pihan GA, 2003, CANCER RES, V63, P1398; Pihan GA, 1998, CANCER RES, V58, P3974; Prigent C, 2005, EXP CELL RES, V303, P1, DOI 10.1016/j.yexcr.2004.04.052; Ray D, 2011, NEOPLASIA, V13, P439, DOI 10.1593/neo.101704; Reddy HKDL, 2005, CANCER RES, V65, P10174, DOI 10.1158/0008-5472.CAN-05-2639; Roberts PJ, 2012, JNCI-J NATL CANCER I, V104, P476, DOI 10.1093/jnci/djs002; Saavedra HI, 2000, ONCOGENE, V19, P3948, DOI 10.1038/sj.onc.1203723; Saavedra HI, 2003, CANCER CELL, V3, P333, DOI 10.1016/S1535-6108(03)00083-7; Saavedra HI, 1999, J BIOL CHEM, V274, P38083, DOI 10.1074/jbc.274.53.38083; Salisbury JL, 2004, J MAMMARY GLAND BIOL, V9, P275, DOI 10.1023/B:JOMG.0000048774.27697.30; Satyanarayana A, 2009, ONCOGENE, V28, P2925, DOI 10.1038/onc.2009.170; Schliekelman M, 2009, CANCER RES, V69, P45, DOI 10.1158/0008-5472.CAN-07-6330; Schneeweiss A, 2003, INT J CANCER, V107, P346, DOI 10.1002/ijc.11408; Sluder G, 1999, BIOL CELL, V91, P413, DOI 10.1016/S0248-4900(99)80083-5; Tarapore P, 2001, ONCOGENE, V20, P3173, DOI 10.1038/sj.onc.1204424; Tokuyama Y, 2001, J BIOL CHEM, V276, P21529, DOI 10.1074/jbc.M100014200; Tsunoda N, 2009, CANCER SCI, V100, P111, DOI 10.1111/j.1349-7006.2008.01007.x; Weaver BAA, 2007, CANCER RES, V67, P10103, DOI 10.1158/0008-5472.CAN-07-2266; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yu QY, 2001, NATURE, V411, P1017, DOI 10.1038/35082500; Yu QY, 2006, CANCER CELL, V9, P23, DOI 10.1016/j.ccr.2005.12.012; Zeng X, 2010, ONCOGENE, V29, P5103, DOI 10.1038/onc.2010.253; Zeng X, 2010, ONCOGENE; Zyss D, 2009, TRENDS CELL BIOL, V19, P334, DOI 10.1016/j.tcb.2009.04.001	63	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65971	10.1371/journal.pone.0065971	http://dx.doi.org/10.1371/journal.pone.0065971			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776583	Green Published, gold, Green Submitted			2022-12-27	WOS:000320755400091
J	Rugani, R; Vallortigara, G; Regolin, L				Rugani, Rosa; Vallortigara, Giorgio; Regolin, Lucia			Numerical Abstraction in Young Domestic Chicks (Gallus gallus)	PLOS ONE			English	Article							INFANTS DISCRIMINATION; SMALL NUMEROSITIES; CONTOUR LENGTH; NUMBER SENSE; COMPETENCE; QUANTITY; JUDGMENTS; FOOD; REPRESENTATION; MECHANISMS	In a variety of circumstances animals can represent numerical values per se, although it is unclear how salient numbers are relative to non-numerical properties. The question is then: are numbers intrinsically distinguished or are they processed as a last resort only when no other properties differentiate stimuli? The last resort hypothesis is supported by findings pertaining to animal studies characterized by extensive training procedures. Animals may, nevertheless, spontaneously and routinely discriminate numerical attributes in their natural habitat, but data available on spontaneous numerical competence usually emerge from studies not disentangling numerical from quantitative cues. In the study being outlined here, we tested animals' discrimination of a large number of elements utilizing a paradigm that did not require any training procedures. During rearing, newborn chicks were presented with two stimuli, each characterized by a different number of heterogeneous (for colour, size and shape) elements and food was found in proximity of one of the two stimuli. At testing 3 day-old chicks were presented with stimuli depicting novel elements (for colour, size and shape) representing either the numerosity associated or not associated with food. The chicks approached the number associated with food in the 5vs.10 and 10vs.20 comparisons both when quantitative cues were unavailable (stimuli were of random sizes) or being controlled. The findings emerging from the study support the hypothesis that numbers are salient information promptly processed even by very young animals.	[Rugani, Rosa; Regolin, Lucia] Univ Padua, Dept Gen Psychol, Padua, Italy; [Vallortigara, Giorgio] Univ Trento, Ctr Mind Brain Sci, Rovereto, Trento, Italy	University of Padua; University of Trento	Rugani, R (corresponding author), Univ Padua, Dept Gen Psychol, Padua, Italy.	rosa.rugani@unipd.it	Rugani, Rosa/C-2219-2013; Regolin, Lucia/N-9564-2019	Rugani, Rosa/0000-0001-5294-6306; Regolin, Lucia/0000-0001-8960-0309	University of Padova ('Progetto Giovani', Bando, Universita degli Studi di Padova) [GRIC101142]; ERC [PREMESOR ERC-2011-ADG_20110406]	University of Padova ('Progetto Giovani', Bando, Universita degli Studi di Padova); ERC(European Research Council (ERC)European Commission)	This study was supported by a research grant from University of Padova to R. R. ('Progetto Giovani', Bando 2010, Universita degli Studi di Padova, prot.: GRIC101142). G.V. was funded by an ERC Advanced Grant (PREMESOR ERC-2011-ADG_20110406). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew R.J., 1991, NEURAL BEHAV PLASTIC, P536; Baker JM, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00387; Baker JM, 2011, BEHAV PROCESS, V88, P72, DOI 10.1016/j.beproc.2011.08.006; Bateson P., 2000, VIENNA SERIES THEORE, P85; Beran MJ, 2006, J EXP PSYCHOL-ANIM B, V32, P111, DOI 10.1037/0097-7403.32.2.111; Beran MJ, 2001, J COMP PSYCHOL, V115, P181, DOI 10.1037//0735-7036.115.2.181; BOLHUIS JJ, 1991, BIOL REV, V66, P303, DOI 10.1111/j.1469-185X.1991.tb01145.x; BOYSEN ST, 1989, J COMP PSYCHOL, V103, P23, DOI 10.1037/0735-7036.103.1.23; Brannon EM, 1998, SCIENCE, V282, P746, DOI 10.1126/science.282.5389.746; Breukelaar JWC, 1998, J EXP PSYCHOL ANIM B, V24, P84, DOI 10.1037/0097-7403.24.1.84; Call J, 2000, J COMP PSYCHOL, V114, P136, DOI 10.1037/0735-7036.114.2.136; Cantlon JF, 2007, J EXP PSYCHOL-ANIM B, V33, P32, DOI 10.1037/0097-7403.33.1.32; Cantlon JF, 2006, INFANCY, V9, P173, DOI 10.1207/s15327078in0902_5; Clearfield MW, 2001, J COGN DEV, V2, P243, DOI 10.1207/S15327647JCD0203_1; Clearfield MW, 1999, PSYCHOL SCI, V10, P408, DOI 10.1111/1467-9280.00177; DAVIS H, 1982, PSYCHOL BULL, V92, P547, DOI 10.1037/0033-2909.92.3.547; DAVIS H, 1988, BEHAV BRAIN SCI, V11, P561, DOI 10.1017/S0140525X00053437; Davis H., 1993, DEV NUMERICAL COMPET, P109; Emmerton Jacky, 1993, P377; Feigenson L, 2002, PSYCHOL SCI, V13, P150, DOI 10.1111/1467-9280.00427; Feigenson L, 2005, COGNITION, V97, P295, DOI 10.1016/j.cognition.2004.09.010; Feigenson L, 2002, COGNITIVE PSYCHOL, V44, P33, DOI 10.1006/cogp.2001.0760; Fontanari L, 2011, DEVELOPMENTAL SCI, V14, P1235, DOI 10.1111/j.1467-7687.2011.01074.x; GALLISTEL CR, 1992, COGNITION, V44, P43, DOI 10.1016/0010-0277(92)90050-R; Garland A, 2012, ANIM COGN, V15, P1129, DOI 10.1007/s10071-012-0537-3; Hauser MD, 2000, P ROY SOC B-BIOL SCI, V267, P829, DOI 10.1098/rspb.2000.1078; Hyde DC, 2011, DEVELOPMENTAL SCI, V14, P360, DOI 10.1111/j.1467-7687.2010.00987.x; Irie-Sugimoto N, 2009, ANIM COGN, V12, P193, DOI 10.1007/s10071-008-0185-9; JENKINS HM, 1973, J EXP ANAL BEHAV, V20, P163, DOI 10.1901/jeab.1973.20-163; Judge PG, 2005, J EXP PSYCHOL-ANIM B, V31, P79, DOI 10.1037/0097-7403.31.1.79; KREBS JR, 1974, BEHAVIOUR, V51, P99, DOI 10.1163/156853974X00165; Lipton JS, 2004, INFANCY, V5, P271, DOI 10.1207/s15327078in0503_2; Lipton JS, 2003, PSYCHOL SCI, V14, P396, DOI 10.1111/1467-9280.01453; Maclean EL, 2008, ANIM BEHAV, V76, P479, DOI 10.1016/j.anbehav.2008.01.025; Merritt DJ, 2009, J EXP PSYCHOL GEN, V138, P258, DOI 10.1037/a0015231; Olthof A, 1997, J EXP PSYCHOL ANIM B, V23, P325, DOI 10.1037/0097-7403.23.3.325; Pepperberg IM, 2012, ANIM COGN, V15, P711, DOI [10.1007/s10071-012-0470-5, 10.1007/s10071-012-0476-5]; Regolin L, 2005, ANIM BEHAV, V70, P855, DOI 10.1016/j.anbehav.2005.01.014; Regolin L, 2005, BEHAV BRAIN RES, V157, P1, DOI 10.1016/j.bbr.2004.06.012; Regolin L, 2011, BIOL LETTERS, V7, P654, DOI 10.1098/rsbl.2011.0051; Rosa Salva O, 2013, ANIM COGN, V16, P895, DOI 10.1007/s10071-013-0622-2; Rugani R, 2008, J EXP PSYCHOL-ANIM B, V34, P388, DOI 10.1037/0097-7403.34.3.388; Rugani R, 2007, J EXP PSYCHOL ANIM B, V33, P21, DOI 10.1037/0097-7403.33.1.21; Rugani R, 2013, ANIM COGN, V16, P557, DOI 10.1007/s10071-012-0593-8; Rugani R, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00179; Rugani R, 2011, NEUROBIOL LEARN MEM, V95, P231, DOI 10.1016/j.nlm.2010.11.012; Rugani R, 2010, DEVELOPMENTAL SCI, V13, P790, DOI 10.1111/j.1467-7687.2009.00936.x; Rugani R, 2010, BIOL LETTERS, V6, P290, DOI 10.1098/rsbl.2009.0960; Scarf D, 2011, SCIENCE, V334, P1664, DOI 10.1126/science.1213357; Seron X, 2001, MIND LANG, V16, P76, DOI 10.1111/1468-0017.00158; Smith BR, 2003, J COMP PSYCHOL, V117, P217, DOI 10.1037/0735-7036.117.2.217; Uller C, 2003, ANIM COGN, V6, P105, DOI 10.1007/s10071-003-0167-x; Uller C, 2009, ANIM COGN, V12, P733, DOI 10.1007/s10071-009-0225-0; Vallortigara G, 2010, WIRES COGN SCI, V1, P882, DOI 10.1002/wcs.75; Ward C, 2007, ANIM COGN, V10, P71, DOI 10.1007/s10071-006-0042-7; Xu F, 2005, DEVELOPMENTAL SCI, V8, P88, DOI 10.1111/j.1467-7687.2005.00395.x; Xu F, 2000, COGNITION, V74, pB1, DOI 10.1016/S0010-0277(99)00066-9	57	43	44	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65262	10.1371/journal.pone.0065262	http://dx.doi.org/10.1371/journal.pone.0065262			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776457	Green Published, Green Submitted, gold			2022-12-27	WOS:000320755400019
J	Kaabinejadian, S; Piazza, PA; McMurtrey, CP; Vernon, SR; Cate, SJ; Bardet, W; Schafer, FB; Jackson, KW; Campbell, DM; Buchli, R; Rinaldo, CR; Hildebrand, WH				Kaabinejadian, Saghar; Piazza, Paolo A.; McMurtrey, Curtis P.; Vernon, Stephen R.; Cate, Steven J.; Bardet, Wilfried; Schafer, Fredda B.; Jackson, Kenneth W.; Campbell, Diana M.; Buchli, Rico; Rinaldo, Charles R.; Hildebrand, William H.			Identification of Class I HLA T Cell Control Epitopes for West Nile Virus	PLOS ONE			English	Article							PEPTIDE LIGANDS; VACCINE DESIGN; CULTURE METHOD; BLOOD-DONORS; INFECTION; RESPONSES; ENCEPHALITIS; DISCOVERY; CALRETICULIN; VALIDATION	The recent West Nile virus (WNV) outbreak in the United States underscores the importance of understanding human immune responses to this pathogen. Via the presentation of viral peptide ligands at the cell surface, class I HLA mediate the T cell recognition and killing of WNV infected cells. At this time, there are two key unknowns in regards to understanding protective T cell immunity: 1) the number of viral ligands presented by the HLA of infected cells, and 2) the distribution of T cell responses to these available HLA/viral complexes. Here, comparative mass spectroscopy was applied to determine the number of WNV peptides presented by the HLA-A*11: 01 of infected cells after which T cell responses to these HLA/WNV complexes were assessed. Six viral peptides derived from capsid, NS3, NS4b, and NS5 were presented. When T cells from infected individuals were tested for reactivity to these six viral ligands, polyfunctional T cells were focused on the GTL9 WNV capsid peptide, ligands from NS3, NS4b, and NS5 were less immunogenic, and two ligands were largely inert, demonstrating that class I HLA reduce the WNV polyprotein to a handful of immune targets and that polyfunctional T cells recognize infections by zeroing in on particular HLA/WNV epitopes. Such dominant HLA/peptide epitopes are poised to drive the development of WNV vaccines that elicit protective T cells as well as providing key antigens for immunoassays that establish correlates of viral immunity.	[Kaabinejadian, Saghar; McMurtrey, Curtis P.; Vernon, Stephen R.; Cate, Steven J.; Bardet, Wilfried; Schafer, Fredda B.; Jackson, Kenneth W.; Hildebrand, William H.] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73190 USA; [Piazza, Paolo A.; Campbell, Diana M.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15261 USA; [Rinaldo, Charles R.] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA; [Buchli, Rico; Hildebrand, William H.] Pure Prot LLC, Oklahoma City, OK USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Hildebrand, WH (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73190 USA.	William-hildebrand@ouhsc.edu		Delucia, Diana Campbell/0000-0002-1165-6799; Piazza, Paolo/0000-0002-2173-1342	National Institutes of Health [HHSN266200400027C, U01AI082057]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI082057] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (www.nih.gov) Contract HHSN266200400027C (to W.H.H.) and National Institutes of Health grant U01AI082057(to W.H.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akondy RS, 2009, J IMMUNOL, V183, P7919, DOI 10.4049/jimmunol.0803903; Bell EB, 2008, TRENDS IMMUNOL, V29, P405, DOI 10.1016/j.it.2008.06.002; Braun BC, 1999, NAT CELL BIOL, V1, P221, DOI 10.1038/12043; Brown CM, 2012, ANN INTERN MED, V157, P823, DOI 10.7326/0003-4819-157-11-201212040-00543; Buchli R, 2005, BIOCHEMISTRY-US, V44, P12491, DOI 10.1021/bi050255v; Busch MP, 2008, J INFECT DIS, V198, P984, DOI 10.1086/591467; Caccamo N, 2010, EUR J IMMUNOL, V40, P2211, DOI 10.1002/eji.201040455; Custer B, 2009, TRANSFUSION, V49, P278, DOI 10.1111/j.1537-2995.2008.01952.x; De Filette M, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-16; Diamond MS, 2008, IMMUNOL REV, V225, P212, DOI 10.1111/j.1600-065X.2008.00676.x; Diamond MS, 2003, J EXP MED, V198, P1853, DOI 10.1084/jem.20031223; Diamond MS, 2003, J VIROL, V77, P2578, DOI 10.1128/JVI.77.4.2578-2586.2003; Duvall MG, 2008, EUR J IMMUNOL, V38, P350, DOI 10.1002/eji.200737768; Eneslatt K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032367; Rodriguez MDG, 2010, VECTOR-BORNE ZOONOT, V10, P151, DOI 10.1089/vbz.2008.0203; Glass WG, 2006, J EXP MED, V203, P35, DOI 10.1084/jem.20051970; Harari A, 2006, IMMUNOL REV, V211, P236, DOI 10.1111/j.0105-2896.2006.00395.x; Haynes BF, 2012, NAT BIOTECHNOL, V30, P423, DOI 10.1038/nbt.2197; Hickman HD, 2004, J IMMUNOL, V172, P2944, DOI 10.4049/jimmunol.172.5.2944; Jackson HM, 2004, J IMMUNOL METHODS, V291, P51, DOI 10.1016/j.jim.2004.04.017; Kim S, 2010, J IMMUNOL, V184, P4423, DOI 10.4049/jimmunol.0903955; Kloetzel PM, 2004, CURR OPIN IMMUNOL, V16, P76, DOI 10.1016/j.coi.2003.11.004; Larsen MV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012697; Leach MR, 2002, J BIOL CHEM, V277, P29686, DOI 10.1074/jbc.M202405200; Leffell MS, 2007, TRANSPLANTATION, V83, P964, DOI 10.1097/01.tp.0000258588.09356.d7; Lin Y, 2009, CYTOTHERAPY, V11, P912, DOI 10.3109/14653240903136987; Martina BEE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018995; McMurtrey CP, 2008, P NATL ACAD SCI USA, V105, P2981, DOI 10.1073/pnas.0711874105; Mostashari F, 2001, LANCET, V358, P261, DOI 10.1016/S0140-6736(01)05480-0; Oliphant T, 2007, J VIROL, V81, P11828, DOI 10.1128/JVI.00643-07; Piazza P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015343; Prilliman K, 1997, IMMUNOGENETICS, V45, P379, DOI 10.1007/s002510050219; Prilliman KR, 1999, J IMMUNOL, V162, P7277; Robinson HL, 2005, NAT MED, V11, pS25, DOI 10.1038/nm1212; ROELSE J, 1994, J EXP MED, V180, P1591, DOI 10.1084/jem.180.5.1591; Seifert U, 2003, NAT IMMUNOL, V4, P375, DOI 10.1038/ni905; Sette A, 2003, CURR OPIN IMMUNOL, V15, P461, DOI 10.1016/S0952-7915(03)00083-9; Shrestha B, 2004, J VIROL, V78, P8312, DOI [10.1128/JVI.78.15.8312-8321.2004, 10.1128/jvi.78.15.8312-8321.2004]; Smith HL, 2011, J INFECT DIS, V203, P513, DOI 10.1093/infdis/jiq074; Tan ACL, 2011, J IMMUNOL, V187, P1895, DOI 10.4049/jimmunol.1100664; Wahl A, 2006, EXPERT REV PROTEOMIC, V3, P641, DOI 10.1586/14789450.3.6.641; Wang Y, 2003, J VIROL, V77, P13323, DOI [10.1128/JVI.77.24.13323-13334.2003, 10.1128/JVi.77.24.13323-13334.2003]; Wearsch PA, 2004, J BIOL CHEM, V279, P25112, DOI 10.1074/jbc.M401721200; Weiskopf D, 2011, J IMMUNOL, V187, P4268, DOI 10.4049/jimmunol.1101970; Yewdell JW, 2007, CURR OPIN IMMUNOL, V19, P79, DOI 10.1016/j.coi.2006.11.010	45	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e66298	10.1371/journal.pone.0066298	http://dx.doi.org/10.1371/journal.pone.0066298			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762485	Green Published, Green Accepted, gold			2022-12-27	WOS:000320440500067
J	Shibata, D; Choi, JY; Laitano, JC; Santello, M				Shibata, Daisuke; Choi, Jason Y.; Laitano, Juan C.; Santello, Marco			Haptic-Motor Transformations for the Control of Finger Position	PLOS ONE			English	Article							ISOMETRIC VOLUNTARY CONTRACTIONS; KINESTHETIC INFORMATION; OBJECT MANIPULATION; CONTACT POINTS; PRECISION GRIP; HAND SHAPE; MUSCLE; SENSE; RECEPTORS; COMMANDS	Dexterous manipulation relies on modulation of digit forces as a function of digit placement. However, little is known about the sense of position of the vertical distance between finger pads relative to each other. We quantified subjects' ability to match perceived vertical distance between the thumb and index finger pads (d(y)) of the right hand ("reference" hand) using the same or opposite hand ("test" hand) after a 10-second delay without vision of the hands. The reference hand digits were passively placed non-collinearly so that the thumb was higher or lower than the index finger (d(y) = 30 or -30 mm, respectively) or collinearly (d(y) = 0 mm). Subjects reproduced reference hand d(y) by using a congruent or inverse test hand posture while exerting negligible digit forces onto a handle. We hypothesized that matching error (reference hand d(y) minus test hand d(y)) would be greater (a) for collinear than non-collinear d(y)s, (b) when reference and test hand postures were not congruent, and (c) when subjects reproduced d(y) using the opposite hand. Our results confirmed our hypotheses. Underestimation errors were produced when the postures of reference and test hand were not congruent, and when test hand was the opposite hand. These findings indicate that perceived finger pad distance is reproduced less accurately (1) with the opposite than the same hand and (2) when higher-level processing of the somatosensory feedback is required for non-congruent hand postures. We propose that erroneous sensing of finger pad distance, if not compensated for during contact and onset of manipulation, might lead to manipulation performance errors as digit forces have to be modulated to perceived digit placement.	[Shibata, Daisuke] Arizona State Univ, Coll Hlth Solut, Kinesiol Program, Tempe, AZ USA; [Choi, Jason Y.; Laitano, Juan C.; Santello, Marco] Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Santello, M (corresponding author), Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ 85287 USA.	marco.santello@asu.edu			European Commission [FP7-ICT-2009-4-2-1]; Collaborative Project "THE Hand Embodied" [248587]	European Commission(European CommissionEuropean Commission Joint Research Centre); Collaborative Project "THE Hand Embodied"	This work was partially supported by the European Commission with the Collaborative Project no. 248587, "THE Hand Embodied", within the FP7-ICT-2009-4-2-1 program "Cognitive Systems and Robotics". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Adamo D, 2009, EXP BRAIN RES, V192, P87, DOI 10.1007/s00221-008-1560-0; Adamo DE, 2012, EXP BRAIN RES, V217, P273, DOI 10.1007/s00221-011-2991-6; Allen TJ, 2008, EXP PHYSIOL, V93, P391, DOI 10.1113/expphysiol.2007.040741; BURGESS PR, 1982, ANNU REV NEUROSCI, V5, P171, DOI 10.1146/annurev.ne.05.030182.001131; BURKE D, 1988, J PHYSIOL-LONDON, V402, P347, DOI 10.1113/jphysiol.1988.sp017208; Craje C, 2011, EXP BRAIN RES, V212, P119, DOI 10.1007/s00221-011-2704-1; Dimitriou M, 2010, CURR BIOL, V20, P1763, DOI 10.1016/j.cub.2010.08.049; Dimitriou M, 2008, J NEUROSCI, V28, P12632, DOI 10.1523/JNEUROSCI.3357-08.2008; Drewing K, 2006, BRAIN RES, V1078, P92, DOI 10.1016/j.brainres.2005.12.026; EDIN BB, 1995, J PHYSIOL-LONDON, V487, P243, DOI 10.1113/jphysiol.1995.sp020875; EDIN BB, 1992, J NEUROPHYSIOL, V67, P1105, DOI 10.1152/jn.1992.67.5.1105; EDIN BB, 1991, J NEUROPHYSIOL, V65, P657, DOI 10.1152/jn.1991.65.3.657; FERRELL WR, 1980, J PHYSIOL-LONDON, V299, P85, DOI 10.1113/jphysiol.1980.sp013112; Flanagan JR, 1997, J NEUROSCI, V17, P1519; Friedman J, 2007, CORTEX, V43, P444, DOI 10.1016/S0010-9452(08)70469-6; Fu QS, 2011, J NEUROSCI, V31, P13576, DOI 10.1523/JNEUROSCI.1143-11.2011; Fu QS, 2010, J NEUROSCI, V30, P9117, DOI 10.1523/JNEUROSCI.4159-09.2010; Gandevia SC, 2006, J PHYSIOL-LONDON, V571, P703, DOI 10.1113/jphysiol.2005.103093; GANDEVIA SC, 1987, TRENDS NEUROSCI, V10, P81, DOI 10.1016/0166-2236(87)90030-0; Gilster R, 2012, EXP BRAIN RES, V217, P137, DOI 10.1007/s00221-011-2980-9; Goble DJ, 2008, J NEUROPHYSIOL, V99, P3063, DOI 10.1152/jn.90259.2008; Goble DJ, 2007, EXP BRAIN RES, V180, P693, DOI 10.1007/s00221-007-0890-7; Goble DJ, 2009, EXP BRAIN RES, V197, P403, DOI 10.1007/s00221-009-1922-2; GORDON AM, 1994, NEUROPSYCHOLOGIA, V32, P555, DOI 10.1016/0028-3932(94)90144-9; Johansson RS, 2009, NAT REV NEUROSCI, V10, P345, DOI 10.1038/nrn2621; JOHANSSON RS, 1988, EXP BRAIN RES, V71, P72; JOHANSSON RS, 1992, CURR OPIN NEUROBIOL, V2, P815, DOI 10.1016/0959-4388(92)90139-C; JOHANSSON RS, 1993, BIOMED RES-TOKYO, V14, P95; Lukos J, 2007, J NEUROSCI, V27, P3894, DOI 10.1523/JNEUROSCI.4693-06.2007; Lukos JR, 2008, J NEUROSCI, V28, P12765, DOI 10.1523/JNEUROSCI.4335-08.2008; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pesyna C, 2011, J NEUROSCI, V31, P3757, DOI 10.1523/JNEUROSCI.5158-10.2011; Proske U, 2006, MUSCLE NERVE, V34, P545, DOI 10.1002/mus.20627; Proske U, 2009, J PHYSIOL-LONDON, V587, P4139, DOI 10.1113/jphysiol.2009.175372; Santello M, 1997, SOMATOSENS MOT RES, V14, P203; Sartori L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025203; Smith JL, 2009, J APPL PHYSIOL, V106, P950, DOI 10.1152/japplphysiol.91365.2008; VALLBO AB, 1971, J PHYSIOL-LONDON, V218, P405, DOI 10.1113/jphysiol.1971.sp009625; VALLBO AB, 1974, ACTA PHYSIOL SCAND, V90, P319, DOI 10.1111/j.1748-1716.1974.tb05594.x; Van Doren CL, 1998, EXP BRAIN RES, V120, P487, DOI 10.1007/s002210050422; Voudouris D, 2012, J MOTOR BEHAV, V44, P295, DOI 10.1080/00222895.2012.703975; Walsh LD, 2009, EXP BRAIN RES, V195, P603, DOI 10.1007/s00221-009-1832-3; Winter JA, 2005, J PHYSIOL-LONDON, V568, P1035, DOI 10.1113/jphysiol.2005.092619; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Zhang W, 2010, J NEUROPHYSIOL, V103, P2953, DOI 10.1152/jn.00140.2010	45	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e66140	10.1371/journal.pone.0066140	http://dx.doi.org/10.1371/journal.pone.0066140			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762477	gold, Green Published, Green Submitted			2022-12-27	WOS:000321099000127
J	Ambjorn, M; Dubreuil, V; Miozzo, F; Nigon, F; Moller, B; Issazadeh-Navikas, S; Berg, J; Lees, M; Sap, J				Ambjorn, Malene; Dubreuil, Veronique; Miozzo, Federico; Nigon, Fabienne; Moller, Bente; Issazadeh-Navikas, Shohreh; Berg, Jacob; Lees, Michael; Sap, Jan			A Loss-of-Function Screen for Phosphatases that Regulate Neurite Outgrowth Identifies PTPN12 as a Negative Regulator of TrkB Tyrosine Phosphorylation	PLOS ONE			English	Article							RETRACTED ARTICLE. SEE; PEST CONTROLS MOTILITY; SCALE RNAI SCREENS; NEUROTROPHIN RECEPTORS; HUMAN NEUROBLASTOMA; SIGNALING PATHWAYS; NEURONAL POLARITY; HIPPOCAMPAL-NEURONS; CELL-MIGRATION; GROWTH-FACTORS	Alterations in function of the neurotrophin BDNF are associated with neurodegeneration, cognitive decline, and psychiatric disorders. BDNF promotes axonal outgrowth and branching, regulates dendritic tree morphology and is important for axonal regeneration after injury, responses that largely result from activation of its tyrosine kinase receptor TrkB. Although intracellular neurotrophin (NT) signaling presumably reflects the combined action of kinases and phosphatases, little is known about the contributions of the latter to TrkB regulation. The issue is complicated by the fact that phosphatases belong to multiple independently evolved families, which are rarely studied together. We undertook a loss-of-function RNA-interference-based screen of virtually all known (254) human phosphatases to understand their function in BDNF/TrkB-mediated neurite outgrowth in differentiated SH-SY5Y cells. This approach identified phosphatases from diverse families, which either positively or negatively modulate BDNF-TrkB-mediated neurite outgrowth, and most of which have little or no previously established function related to NT signaling. "Classical'' protein tyrosine phosphatases (PTPs) accounted for 13% of the candidate regulatory phosphatases. The top classical PTP identified as a negative regulator of BDNF-TrkB-mediated neurite outgrowth was PTPN12 (also called PTP-PEST). Validation and follow-up studies showed that endogenous PTPN12 antagonizes tyrosine phosphorylation of TrkB itself, and the downstream activation of ERK1/2. We also found PTPN12 to negatively regulate phosphorylation of p130cas and FAK, proteins with previously described functions related to cell motility and growth cone behavior. Our data provide the first comprehensive survey of phosphatase function in NT signaling and neurite outgrowth. They reveal the complexity of phosphatase control, with several evolutionarily unrelated phosphatase families cooperating to affect this biological response, and hence the relevance of considering all phosphatase families when mining for potentially druggable targets.	[Ambjorn, Malene; Moller, Bente; Issazadeh-Navikas, Shohreh; Lees, Michael; Sap, Jan] Univ Copenhagen, Fac Hlth Sci, Dept Biomed Sci, Copenhagen, Denmark; [Ambjorn, Malene; Moller, Bente; Issazadeh-Navikas, Shohreh; Lees, Michael; Sap, Jan] Univ Copenhagen, Fac Hlth Sci, BRIC, Copenhagen, Denmark; [Dubreuil, Veronique; Miozzo, Federico; Nigon, Fabienne; Sap, Jan] Univ Paris, Sorbonne Paris Cite, F-75252 Paris, France; [Berg, Jacob] Tech Univ Denmark, Dept Wind Energy, Roskilde, Denmark	University of Copenhagen; University of Copenhagen; UDICE-French Research Universities; Universite Paris Cite; Technical University of Denmark	Sap, J (corresponding author), Univ Copenhagen, Fac Hlth Sci, Dept Biomed Sci, Copenhagen, Denmark.	jan.sap@univ-paris-diderot.fr	Issazadeh-Navikas, Shohreh/AAI-7900-2021; Miozzo, Federico/AAC-7305-2022; Berg, Jacob/B-5816-2016	Berg, Jacob/0000-0003-2126-6476; Dubreuil, Veronique/0000-0001-8060-3597; Miozzo, Federico/0000-0003-0818-9525	Vera og Carl Johan Michaelsens legat; Arvid Nilssons Fond; Department of Biomedical Sciences, University of Copenhagen	Vera og Carl Johan Michaelsens legat; Arvid Nilssons Fond; Department of Biomedical Sciences, University of Copenhagen	The work was supported by Vera og Carl Johan Michaelsens legat, Arvid Nilssons Fond, and Department of Biomedical Sciences, University of Copenhagen (http://bmi.ku.dk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angers-Loustau A, 1999, J CELL BIOL, V144, P1019, DOI 10.1083/jcb.144.5.1019; Arevalo JC, 2006, CELL MOL LIFE SCI, V63, P1523, DOI 10.1007/s00018-006-6010-1; Arevalo JC, 2006, NEURON, V50, P549, DOI 10.1016/j.neuron.2006.03.044; Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; Assaife-Lopes N, 2010, J NEUROSCI, V30, P8468, DOI 10.1523/JNEUROSCI.5695-09.2010; Atwal JK, 2000, NEURON, V27, P265, DOI 10.1016/S0896-6273(00)00035-0; Barr AJ, 2010, FUTURE MED CHEM, V2, P1563, DOI [10.4155/fmc.10.241, 10.4155/FMC.10.241]; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; BENEDETTI M, 1993, P NATL ACAD SCI USA, V90, P7859, DOI 10.1073/pnas.90.16.7859; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; BIEDLER JL, 1973, CANCER RES, V33, P2643; Boyd JG, 2001, J NEUROBIOL, V49, P314, DOI 10.1002/neu.10013; Buchser WJ, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.52; Chao MV, 2006, CLIN SCI, V110, P167, DOI 10.1042/CS20050163; Cimmino F, 2009, ONCOGENE, V28, P2015, DOI 10.1038/onc.2009.70; Clark K, 2010, J CELL BIOCHEM, V109, P808, DOI 10.1002/jcb.22460; Collinet C, 2010, NATURE, V464, P243, DOI 10.1038/nature08779; Cowansage Kiriana K, 2010, Curr Mol Pharmacol, V3, P12; Cullen BR, 2006, NAT METHODS, V3, P677, DOI 10.1038/NMETH913; Darenfed H, 2007, CELL MOTIL CYTOSKEL, V64, P97, DOI 10.1002/cm.20168; Davidson D, 2001, EMBO J, V20, P3414, DOI 10.1093/emboj/20.13.3414; Defilippi P, 2006, TRENDS CELL BIOL, V16, P257, DOI 10.1016/j.tcb.2006.03.003; Dijkhuizen PA, 2005, J NEUROBIOL, V62, P278, DOI 10.1002/neu.20100; Echeverri CJ, 2006, NAT METHODS, V3, P777, DOI 10.1038/nmeth1006-777; Encinas M, 1999, J NEUROCHEM, V73, P1409, DOI 10.1046/j.1471-4159.1999.0731409.x; Encinas M, 2000, J NEUROCHEM, V75, P991, DOI 10.1046/j.1471-4159.2000.0750991.x; Espejo R, 2010, AM J PHYSIOL-CELL PH, V299, pC454, DOI 10.1152/ajpcell.00148.2010; Estrach S, 2002, CURR BIOL, V12, P307, DOI 10.1016/S0960-9822(02)00658-9; Faisal A, 2002, J BIOL CHEM, V277, P30144, DOI 10.1074/jbc.M203229200; Falschlehner C, 2010, BIOTECHNOL J, V5, P368, DOI 10.1002/biot.200900277; Faux C, 2007, BBA-MOL CELL RES, V1773, P1689, DOI 10.1016/j.bbamcr.2007.06.008; Garton AJ, 1999, J BIOL CHEM, V274, P3811, DOI 10.1074/jbc.274.6.3811; Gerling N, 2004, NEUROCHEM INT, V44, P505, DOI 10.1016/j.neuint.2003.08.013; GOSLIN K, 1990, J CELL BIOL, V110, P1319, DOI 10.1083/jcb.110.4.1319; Grace EA, 2003, J NEUROSCI, V23, P493, DOI 10.1523/JNEUROSCI.23-02-00493.2003; Gratacos M, 2007, BIOL PSYCHIAT, V61, P911, DOI 10.1016/j.biopsych.2006.08.025; Hafizi S, 2005, FASEB J, V19, P971, DOI 10.1096/fj.04-2532fje; Hafizi S, 2002, BIOCHEM BIOPH RES CO, V299, P793, DOI 10.1016/S0006-291X(02)02718-3; Hafizi S, 2010, BIOCHEM BIOPH RES CO, V399, P396, DOI 10.1016/j.bbrc.2010.07.085; He RJ, 2013, FEBS J, V280, P731, DOI 10.1111/j.1742-4658.2012.08718.x; Hocquemiller M, 2010, J NEUROSCI RES, V88, P202, DOI 10.1002/jnr.22190; Huang YZ, 2008, NEURON, V57, P546, DOI 10.1016/j.neuron.2007.11.026; Ivankovic-Dikic I, 2000, NAT CELL BIOL, V2, P574, DOI 10.1038/35023515; Iwakura Y, 2008, J BIOL CHEM, V283, P15799, DOI 10.1074/jbc.M801553200; Jeanneteau F, 2008, P NATL ACAD SCI USA, V105, P4862, DOI 10.1073/pnas.0709102105; Jeanneteau F, 2010, NAT NEUROSCI, V13, P1373, DOI 10.1038/nn.2655; Jung AS, 2011, CELL CYCLE, V10, P1838, DOI 10.4161/cc.10.11.15776; Kashiwaba M, 2003, FEBS LETT, V538, P197, DOI 10.1016/S0014-5793(03)00153-4; Konig R, 2007, NAT METHODS, V4, P847, DOI 10.1038/NMETH1089; Labelle C, 2000, DEV BRAIN RES, V123, P1, DOI 10.1016/S0165-3806(00)00069-9; Lammers T, 2007, CRIT REV BIOCHEM MOL, V42, P437, DOI 10.1080/10409230701693342; Lee FS, 2001, P NATL ACAD SCI USA, V98, P3555, DOI 10.1073/pnas.061020198; Liu YW, 2006, NAT MED, V12, P518, DOI 10.1038/nm1402; Loh SHY, 2008, CELL DEATH DIFFER, V15, P283, DOI 10.1038/sj.cdd.4402258; Lykissas MG, 2007, CURR NEUROVASC RES, V4, P143, DOI 10.2174/156720207780637216; Lynch G, 2008, EUR J PHARMACOL, V585, P2, DOI 10.1016/j.ejphar.2007.11.082; Malo N, 2006, NAT BIOTECHNOL, V24, P167, DOI 10.1038/nbt1186; Markova B, 2003, BIOCHEMISTRY-US, V42, P2691, DOI 10.1021/bi0265574; Massa SM, 2010, J CLIN INVEST, V120, P1774, DOI 10.1172/JCI41356; Minichiello L, 2002, NEURON, V36, P121, DOI 10.1016/S0896-6273(02)00942-X; Minichiello L, 1998, NEURON, V21, P335, DOI 10.1016/S0896-6273(00)80543-7; Miyamoto Y, 2006, P NATL ACAD SCI USA, V103, P10444, DOI 10.1073/pnas.0603914103; Montenegro-Venegas C, 2010, MOL BIOL CELL, V21, P3518, DOI 10.1091/mbc.E09-08-0709; Mustelin Tomas, 2007, V365, P9; Nikolic M, 2002, INT J BIOCHEM CELL B, V34, P731, DOI 10.1016/S1357-2725(01)00167-4; Numakawa T, 2010, HISTOL HISTOPATHOL, V25, P237, DOI 10.14670/HH-25.237; O'Neill GM, 2000, TRENDS CELL BIOL, V10, P111, DOI 10.1016/S0962-8924(99)01714-6; Ohira K, 2009, CURR NEUROPHARMACOL, V7, P276, DOI 10.2174/157015909790031210; PAHLMAN S, 1995, EUR J CANCER, V31A, P453, DOI 10.1016/0959-8049(95)00033-F; Poduslo JF, 1996, MOL BRAIN RES, V36, P280, DOI 10.1016/0169-328X(95)00250-V; Rajagopal R, 2004, J NEUROSCI, V24, P6650, DOI 10.1523/JNEUROSCI.0010-04.2004; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; ROGERS MV, 1994, NEUROSCIENCE, V60, P479, DOI 10.1016/0306-4522(94)90259-3; Roux PP, 2002, PROG NEUROBIOL, V67, P203, DOI 10.1016/S0301-0082(02)00016-3; Sacco F, 2012, FEBS LETT, V586, P2732, DOI 10.1016/j.febslet.2012.05.008; Sasaguri H, 2009, FEBS LETT, V583, P213, DOI 10.1016/j.febslet.2008.12.012; Sastry SK, 2006, J BIOL CHEM, V281, P11627, DOI 10.1074/jbc.M600897200; Sastry SK, 2002, J CELL SCI, V115, P4305, DOI 10.1242/jcs.00105; Schecterson LC, 2010, DEV NEUROBIOL, V70, P332, DOI 10.1002/dneu.20767; Schlaepfer DD, 1998, TRENDS CELL BIOL, V8, P151, DOI 10.1016/S0962-8924(97)01172-0; Sepp KJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000111; Serres F, 2006, BRAIN RES, V1101, P36, DOI 10.1016/j.brainres.2006.05.023; Shintani T, 2008, J BIOCHEM, V144, P259, DOI 10.1093/jb/mvn064; Sigoillot FD, 2011, ACS CHEM BIOL, V6, P47, DOI 10.1021/cb100358f; Simpson KJ, 2008, NAT CELL BIOL, V10, P1027, DOI 10.1038/ncb1762; Sirois J, 2006, MECH DEVELOP, V123, P869, DOI 10.1016/j.mod.2006.08.011; STEPHENS RM, 1994, NEURON, V12, P691, DOI 10.1016/0896-6273(94)90223-2; Sun TT, 2011, CELL, V144, P703, DOI 10.1016/j.cell.2011.02.003; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; Thoenen H, 2002, NAT NEUROSCI, V5, P1046, DOI 10.1038/nn938; Tiganis T, 2007, BIOCHEM J, V402, P1, DOI 10.1042/BJ20061548; Tschuch C, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-60; Tucker BA, 2008, CELL SIGNAL, V20, P241, DOI 10.1016/j.cellsig.2007.10.014; Urena JM, 2005, J COMP NEUROL, V490, P119, DOI 10.1002/cne.20656; Veillette A, 2009, IMMUNOL REV, V228, P312, DOI 10.1111/j.1600-065X.2008.00747.x; Vickers JC, 2009, BRAIN RES BULL, V80, P217, DOI 10.1016/j.brainresbull.2009.08.004; Waterhouse EG, 2009, MOL CELL NEUROSCI, V42, P81, DOI 10.1016/j.mcn.2009.06.009; Xie HR, 2010, CHINESE MED J-PEKING, V123, P1086, DOI 10.3760/cma.j.issn.0366-6999.2010.08.021; Yang P, 2007, EUR J NEUROSCI, V25, P1332, DOI 10.1111/j.1460-9568.2007.05384.x; Yang T, 2006, J NEUROBIOL, V66, P1420, DOI 10.1002/neu.20291; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Zhang JY, 2000, EUR J NEUROSCI, V12, P4171, DOI 10.1046/j.1460-9568.2000.01312.x; Zuccato C, 2009, NAT REV NEUROL, V5, P311, DOI 10.1038/nrneurol.2009.54	105	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65371	10.1371/journal.pone.0065371	http://dx.doi.org/10.1371/journal.pone.0065371			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785422	Green Published, Green Submitted, gold			2022-12-27	WOS:000321038800098
J	Mancini, G; Ferrari, PF; Palagi, E				Mancini, Giada; Ferrari, Pier Francesco; Palagi, Elisabetta			In Play We Trust. Rapid Facial Mimicry Predicts the Duration of Playful Interactions in Geladas	PLOS ONE			English	Article							IMITATION; EMPATHY; EXPRESSIONS; LAUGHTER; SIGNALS	The primate play-face is homologous to the human facial display accompanying laughter. Through facial mimicry, the play-face evokes in the perceiver a similar positive emotional state. This sensorimotor and emotional sharing can be adaptive, as it allows individuals to fine-tune their own motor sequences accordingly thus increasing cooperation in play. It has been recently demonstrated that, not only humans and apes, but also geladas are able to mimic others' facial expressions. Here, we describe two forms of facial mimicry in Theropithecus gelada: rapid (RFM, within 1.0 s) and delayed (DFM, within 5.0 s). Play interactions characterized by the presence of RFM were longer than those with DFM thus suggesting that RFM is a good indicator of the quality of communicative exchanges and behavioral coordination. These findings agree with the proposal of a mirror mechanism operating during perception and imitation of facial expressions. In an evolutionary perspective, our findings suggest that RFM not only was already present in the common ancestor of cercopitecoids and hominoids, but also that there is a relationship between RFM and length and quality of playful interactions.	[Mancini, Giada; Ferrari, Pier Francesco] Univ Parma, Dipartimento Biol Evolut & Funz, I-43100 Parma, Italy; [Mancini, Giada; Palagi, Elisabetta] Univ Pisa, Museo Storia Nat, Pisa, Italy; [Palagi, Elisabetta] CNR, Ist Sci & Tecnol Cogniz, Rome, Italy	University of Parma; University of Pisa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR)	Palagi, E (corresponding author), Univ Pisa, Museo Storia Nat, Pisa, Italy.	betta.palagi@museo.unipi.it	Ferrari, Pier Francesco/G-5547-2017		MIUR (Italy); Direct For Biological Sciences [1300426] Funding Source: National Science Foundation	MIUR (Italy)(Ministry of Education, Universities and Research (MIUR)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	MIUR (Italy) partly covered GM's expenses to stay in Germany to collect data. The authors had no other funding sources for this research, only their salaries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beall PM, 2008, J EXP CHILD PSYCHOL, V101, P206, DOI 10.1016/j.jecp.2008.04.004; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; Davila-Ross M, 2011, EMOTION, V11, P1013, DOI 10.1037/a0022594; de Waal FBM, 2009, NATURE, V460, P175, DOI 10.1038/460175a; Decety J, 2008, DEV PSYCHOPATHOL, V20, P1053, DOI 10.1017/S0954579408000503; Demuru E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049613; Dimberg U, 2000, PSYCHOL SCI, V11, P86, DOI 10.1111/1467-9280.00221; Dimberg U, 1998, SCAND J PSYCHOL, V39, P39, DOI 10.1111/1467-9450.00054; Dimberg U, 2002, COGNITION EMOTION, V16, P449, DOI 10.1080/02699930143000356; Ferrari PF, 2009, PHILOS T R SOC B, V364, P2311, DOI 10.1098/rstb.2009.0062; Gervais M, 2005, Q REV BIOL, V80, P395, DOI 10.1086/498281; Hatfield E., 1994, REV PERSONALITY SOCI; Iacoboni M, 2009, ANNU REV PSYCHOL, V60, P653, DOI 10.1146/annurev.psych.60.110707.163604; Jones SS, 2009, PHILOS T R SOC B, V364, P2325, DOI 10.1098/rstb.2009.0045; Mancini G, 2013, SCI REP-UK, V3, DOI 10.1038/srep01527; Mancini G, 2009, BEHAV PROCESS, V82, P286, DOI 10.1016/j.beproc.2009.07.007; Niedenthal PM, 2010, BEHAV BRAIN SCI, V33, P417, DOI 10.1017/S0140525X10000865; Norscia I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028472; Palagi E, 2008, ANIM BEHAV, V75, P887, DOI 10.1016/j.anbehav.2007.07.016; Palagi E, 2009, P NATL ACAD SCI USA, V106, P19262, DOI 10.1073/pnas.0910891106; Palagi E, 2011, J COMP PSYCHOL, V125, P11, DOI 10.1037/a0020869; Pellis S. M., 2009, PLAYFUL BRAIN VENTUR; Pellis SM, 1996, AGGRESS VIOLENT BEH, V1, P249, DOI 10.1016/1359-1789(95)00016-X; Pellis SM, 1997, AGGRESSIVE BEHAV, V23, P41, DOI 10.1002/(SICI)1098-2337(1997)23:1<41::AID-AB5>3.0.CO;2-W; Pfeifer JH, 2008, NEUROIMAGE, V39, P2076, DOI 10.1016/j.neuroimage.2007.10.032; Preuschoft S, 1995, FOLIA PRIMATOL, V65, P121, DOI 10.1159/000156878; PROVINE RR, 1993, ETHOLOGY, V95, P291; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Ross MD, 2008, BIOL LETTERS, V4, P27, DOI 10.1098/rsbl.2007.0535; Sato W, 2007, COGNITION, V104, P1, DOI 10.1016/j.cognition.2006.05.001; Schmidt KL, 2001, YEARB PHYS ANTHROPOL, V44, P3, DOI 10.1002/ajpa.20001; Waller BM, 2005, ETHOLOGY, V111, P129, DOI 10.1111/j.1439-0310.2004.01045.x; Wicker B, 2003, NEURON, V40, P655, DOI 10.1016/S0896-6273(03)00679-2; Wild B, 2003, PSYCHIAT RES-NEUROIM, V123, P17, DOI 10.1016/S0925-4927(03)00006-4	34	51	51	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66481	10.1371/journal.pone.0066481	http://dx.doi.org/10.1371/journal.pone.0066481			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	172XB	23785501	Green Published, gold			2022-12-27	WOS:000321038800020
J	Telke, AA; Zhuang, N; Ghatge, SS; Lee, SH; Shah, AA; Khan, H; Um, Y; Shin, HD; Chung, YR; Lee, KH; Kim, SW				Telke, Amar A.; Zhuang, Ningning; Ghatge, Sunil S.; Lee, Sook-Hee; Shah, Asad Ali; Khan, Haji; Um, Youngsoon; Shin, Hyun-Dong; Chung, Young Ryun; Lee, Kon Ho; Kim, Seon-Won			Engineering of Family-5 Glycoside Hydrolase (Cel5A) from an Uncultured Bacterium for Efficient Hydrolysis of Cellulosic Substrates	PLOS ONE			English	Article							ENDOGLUCANASE CEL5A; CRYSTAL-STRUCTURE; CELLULASE; BINDING; CRYSTALLOGRAPHY; MECHANISM; SYSTEM; SUITE	Cel5A, an endoglucanase, was derived from the metagenomic library of vermicompost. The deduced amino acid sequence of Cel5A shows high sequence homology with family-5 glycoside hydrolases, which contain a single catalytic domain but no distinct cellulose-binding domain. Random mutagenesis and cellulose-binding module (CBM) fusion approaches were successfully applied to obtain properties required for cellulose hydrolysis. After two rounds of error-prone PCR and screening of 3,000 mutants, amino acid substitutions were identified at various positions in thermotolerant mutants. The most heat-tolerant mutant, Cel5A_2R2, showed a 7-fold increase in thermostability. To enhance the affinity and hydrolytic activity of Cel5A on cellulose substrates, the family-6 CBM from Saccharophagus degradans was fused to the C-terminus of the Cel5A_2R2 mutant using overlap PCR. The Cel5A_2R2-CBM6 fusion protein showed 7-fold higher activity than the native Cel5A on Avicel and filter paper. Cellobiose was a major product obtained from the hydrolysis of cellulosic substrates by the fusion enzyme, which was identified by using thin layer chromatography analysis.	[Telke, Amar A.; Zhuang, Ningning; Ghatge, Sunil S.; Lee, Sook-Hee; Shah, Asad Ali; Khan, Haji; Chung, Young Ryun; Lee, Kon Ho; Kim, Seon-Won] Gyeongsang Natl Univ, Div Appl Life Sci BK21, PMBBRC, Jinju, South Korea; [Um, Youngsoon] KIST, Ctr Environm Technol Res, Seoul, South Korea; [Shin, Hyun-Dong] Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA; [Lee, Kon Ho] Gyeongsang Natl Univ, Sch Med, Dept Microbiol, Jinju, South Korea	Gyeongsang National University; Korea Institute of Science & Technology (KIST); University System of Georgia; Georgia Institute of Technology; Gyeongsang National University	Lee, KH (corresponding author), Gyeongsang Natl Univ, Div Appl Life Sci BK21, PMBBRC, Jinju, South Korea.	lkh@gnu.ac.kr; swkim@gnu.ac.kr	Ghatge, Sunil/AAH-3946-2020; Telke, Amar Anandrao/ABF-3247-2020	Telke, Amar Anandrao/0000-0001-9967-5611	International Collaborative R&D Program of Knowledge Economy Technology Innovation Program, MKE; National Research Foundation [NRF-2010-C1AAA001-0029084]; Ministry of Enviromental Science and Technology (MEST); Korea Institute of Science and Technology (KIST) through Future Key Technology Program, Korea; BK21 Program, MEST, Korea	International Collaborative R&D Program of Knowledge Economy Technology Innovation Program, MKE; National Research Foundation; Ministry of Enviromental Science and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Institute of Science and Technology (KIST) through Future Key Technology Program, Korea; BK21 Program, MEST, Korea(Ministry of Education & Human Resources Development (MOEHRD), Republic of KoreaMinistry of Education, Science & Technology (MEST), Republic of Korea)	International Collaborative R&D Program of Knowledge Economy Technology Innovation Program, MKE, and a grant (NRF-2010-C1AAA001-0029084) from the National Research Foundation, Ministry of Enviromental Science and Technology (MEST), and the financial support from the Korea Institute of Science and Technology (KIST) through Future Key Technology Program, Korea. Dr. Amar A. Telke and SS Ghatge are supported by fellowship from the BK21 Program, MEST, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anbar M, 2010, CHEMCATCHEM, V2, P997, DOI 10.1002/cctc.201000112; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bras JLA, 2011, P NATL ACAD SCI USA, V108, P5237, DOI 10.1073/pnas.1015006108; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Carrard G, 2000, P NATL ACAD SCI USA, V97, P10342, DOI 10.1073/pnas.160216697; CHAN MK, 1995, SCIENCE, V267, P1463, DOI 10.1126/science.7878465; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Eckert K, 2002, APPL MICROBIOL BIOT, V60, P428, DOI 10.1007/s00253-002-1131-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GHOSE TK, 1987, PURE APPL CHEM, V59, P257, DOI 10.1351/pac198759020257; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Kang MS, 2007, J MICROBIOL, V45, P291; KLYOSOV AA, 1990, BIOCHEMISTRY-US, V29, P10577, DOI 10.1021/bi00499a001; Li YC, 2007, APPL ENVIRON MICROB, V73, P3165, DOI 10.1128/AEM.02960-06; Liang CN, 2011, J BIOTECHNOL, V154, P46, DOI 10.1016/j.jbiotec.2011.03.025; Liu WJ, 2010, APPL ENVIRON MICROB, V76, P4914, DOI 10.1128/AEM.00958-10; Lynd LR, 2008, NAT BIOTECHNOL, V26, P169, DOI 10.1038/nbt0208-169; Pereira JH, 2010, J STRUCT BIOL, V172, P372, DOI 10.1016/j.jsb.2010.06.018; RUSSELL RJM, 1994, STRUCTURE, V2, P1157, DOI 10.1016/S0969-2126(94)00118-9; Sambrook J., 2001, MOL CLONING LAB MANU; Santos CR, 2012, BIOCHEM J, V441, P95, DOI 10.1042/BJ20110869; Taylor LE, 2006, J BACTERIOL, V188, P3849, DOI 10.1128/JB.01348-05; Telke AA, 2012, BIORESOURCE TECHNOL, V112, P10, DOI 10.1016/j.biortech.2012.02.066; Vazana Y, 2010, APPL ENVIRON MICROB, V76, P3236, DOI 10.1128/AEM.00009-10; Wang XJ, 2012, APPL MICROBIOL BIOT, V95, P1469, DOI 10.1007/s00253-011-3799-9; Wang YG, 2012, J BIOL CHEM, V287, P29568, DOI 10.1074/jbc.M111.320358; Watson BJ, 2009, J BACTERIOL, V191, P5697, DOI 10.1128/JB.00481-09; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; WOOD TM, 1971, BIOCHEM J, V121, P353, DOI 10.1042/bj1210353; Yasir M, 2013, J MICROBIOL, V51, P329, DOI 10.1007/s12275-013-2697-5; Zhang YHP, 2008, J IND MICROBIOL BIOT, V35, P367, DOI 10.1007/s10295-007-0293-6; Zhang YHP, 2006, BIOTECHNOL ADV, V24, P452, DOI 10.1016/j.biotechadv.2006.03.003; Zhang Y, 2010, APPL ENVIRON MICROB, V76, P6870, DOI 10.1128/AEM.00896-10; Zhang YHP, 2006, BIOMACROMOLECULES, V7, P644, DOI 10.1021/bm050799c; Zhao JQ, 2012, APPL MICROBIOL BIOT, V95, P947, DOI 10.1007/s00253-011-3807-0	36	17	17	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65727	10.1371/journal.pone.0065727	http://dx.doi.org/10.1371/journal.pone.0065727			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785445	gold, Green Published, Green Submitted			2022-12-27	WOS:000321038800077
J	Xiang, B; Wu, JY; Wang, Q; Li, ML; Jiang, LJ; Deng, W; Chen, ZF; He, ZL; Huang, CH; Han, YY; Li, YF; Lin, Y; Liu, X; Wang, YC; Ma, XH; Gong, QY; Li, T; Hu, X				Xiang, Bo; Wu, Jun-yao; Wang, Qiang; Li, Ming-Li; Jiang, Li-Jun; Deng, Wei; Chen, Zhuang-Fei; He, Zong-Ling; Huang, Cao-Hua; Han, Yuan-yuan; Li, Yin-fei; Lin, Yin; Liu, Xiang; Wang, Ying-cheng; Ma, Xiao-Hong; Gong, Qi-yong; Li, Tao; Hu, Xun			Cortical Surface Area Correlates with STON2 Gene Ser307Pro Polymorphism in First-Episode Treatment-Naive Patients with Schizophrenia	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SYNAPTIC VESICLE ENDOCYTOSIS; MAGNETIC-RESONANCE; COMMON VARIANTS; NONPSYCHOTIC SIBLINGS; SYNAPTOTAGMIN; BRAIN; ADAPTER; LOCI; INTERNALIZATION	Background: Evidence shows that STON2 gene is associated with synaptic function and schizophrenia. This study aims to explore the relationship between two functional polymorphisms (Ser307Pro and Ala851Ser) of STON2 gene and the cortical surface area in first-episode treatment-naive patients with schizophrenia and healthy controls. Methodology/Principal Findings: Magnetic resonance imaging of the whole cortical surface area, which was computed by an automated surface-based technique (FreeSurfer), was obtained from 74 first-episode treatment-naive patients with schizophrenia and 55 healthy controls. Multiple regression analysis was performed to investigate the effect of genotype subgroups on the cortical surface area. A significant genotype-by-diagnosis effect on the cortical surface area was observed. Pro-allele carriers of Ser307Pro polymorphism had larger right inferior temporal surface area than Ser/Ser carriers in the patients with schizophrenia; however, no significant difference was found in the same area in the healthy controls. The Ala851Ser polymorphism of STON2 gene was not significantly associated with the cortical surface area in patients with schizophrenia and healthy controls. Conclusions/Significance: The present study demonstrated that the functional variant of the STON2 gene could alter cortical surface area on the right inferior temporal and contribute to the pathogenesis of schizophrenia.	[Xiang, Bo; Wu, Jun-yao; Wang, Qiang; Li, Ming-Li; Jiang, Li-Jun; Deng, Wei; Chen, Zhuang-Fei; He, Zong-Ling; Huang, Cao-Hua; Han, Yuan-yuan; Li, Yin-fei; Lin, Yin; Ma, Xiao-Hong; Li, Tao; Hu, Xun] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu 610064, Sichuan, Peoples R China; [Xiang, Bo; Wu, Jun-yao; Wang, Qiang; Li, Ming-Li; Jiang, Li-Jun; Deng, Wei; Chen, Zhuang-Fei; He, Zong-Ling; Huang, Cao-Hua; Han, Yuan-yuan; Li, Yin-fei; Lin, Yin; Liu, Xiang; Wang, Ying-cheng; Ma, Xiao-Hong; Li, Tao] Sichuan Univ, West China Hosp, Mental Hlth Ctr, Chengdu, Sichuan, Peoples R China; [Xiang, Bo; Wu, Jun-yao; Wang, Qiang; Li, Ming-Li; Jiang, Li-Jun; Deng, Wei; Chen, Zhuang-Fei; He, Zong-Ling; Huang, Cao-Hua; Han, Yuan-yuan; Li, Yin-fei; Lin, Yin; Liu, Xiang; Wang, Ying-cheng; Ma, Xiao-Hong; Li, Tao] Sichuan Univ, West China Hosp, Psychiat Lab, Chengdu, Sichuan, Peoples R China; [Gong, Qi-yong] Sichuan Univ, West China Hosp, Dept Radiol, Huaxi MR Res Ctr, Chengdu, Sichuan, Peoples R China; [Hu, Xun] Sichuan Univ, West China Hosp, Huaxi Biobank, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan University; Sichuan University; Sichuan University; Sichuan University	Li, T (corresponding author), Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu 610064, Sichuan, Peoples R China.	litaohx@scu.edu.cn; hxxhu99@163.com	Deng, Wei/GWC-9207-2022; Deng, Wei/AAU-9945-2020; Gong, Qiyong/W-3052-2019	Gong, Qiyong/0000-0002-5912-4871; Ma, Xiaohong/0000-0003-2627-9946; Li, Tao/0000-0003-3831-901X	National Nature Science Foundation of China [81130024, 30530300, 30125014, 30971056, 81271479, 81171275, 81071089]; National Basic Research Program of China (973 Program) [2007CB512301]; Ph.D. Programs Foundation of Ministry of Education of China [20110181110014]; National Key Technology R & D Program of the Ministry of Science and Technology of China during the 12th Five-Year Plan [2012BAI01B06]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); National Key Technology R & D Program of the Ministry of Science and Technology of China during the 12th Five-Year Plan	This work was partly funded by National Nature Science Foundation of China (81130024, 30530300 and 30125014, TL; 30971056 and 81271479, QW; 81171275, WD, 81071089, YCW), the National Basic Research Program of China (973 Program 2007CB512301, TL), the Ph.D. Programs Foundation of Ministry of Education of China (20110181110014, TL), National Key Technology R & D Program of the Ministry of Science and Technology of China during the 12th Five-Year Plan (2012BAI01B06, TL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews J, 1996, GENETICS, V143, P1699; Association AP DSM-IV APA on, 2000, DIAGN STAT MAN MENT; Bailer U, 2000, NEUROPSYCHOBIOLOGY, V42, P175, DOI 10.1159/000026690; Bakken TE, 2011, ARCH GEN PSYCHIAT, V68, P781, DOI 10.1001/archgenpsychiatry.2011.81; Bishop KM, 2000, SCIENCE, V288, P344, DOI 10.1126/science.288.5464.344; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Centonze D, 2004, J NEUROSCI, V24, P8214, DOI 10.1523/JNEUROSCI.1274-04.2004; Chen CH, 1996, AM J MED GENET, V67, P556, DOI 10.1002/(SICI)1096-8628(19961122)67:6<556::AID-AJMG8>3.3.CO;2-P; Chen CH, 2012, SCIENCE, V335, P1634, DOI 10.1126/science.1215330; Chiu YF, 2002, MOL PSYCHIATR, V7, P658, DOI 10.1038/sj.mp.4001045; CHOWDHURY D, 1995, NEUROSCI LETT, V190, P9, DOI 10.1016/0304-3940(95)11487-H; CIULLA TA, 1988, ANAL BIOCHEM, V174, P485, DOI 10.1016/0003-2697(88)90047-4; Courchesne E, 2000, RADIOLOGY, V216, P672, DOI 10.1148/radiology.216.3.r00au37672; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Diril MK, 2006, DEV CELL, V10, P233, DOI 10.1016/j.devcel.2005.12.011; Dittman J, 2009, ANNU REV CELL DEV BI, V25, P133, DOI 10.1146/annurev.cellbio.042308.113302; Fergestad T, 2001, J NEUROSCI, V21, P1218; Fergestad T, 1999, J NEUROSCI, V19, P5847, DOI 10.1523/JNEUROSCI.19-14-05847.1999; First MB., 1997, USERS GUIDE STRUCTUR; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; FRASER S, 1990, NATURE, V344, P431, DOI 10.1038/344431a0; Fukuchi-Shimogori T, 2001, SCIENCE, V294, P1071, DOI 10.1126/science.1064252; GOTTESMAN II, 1987, SCHIZOPHRENIA BULL, V13, P23, DOI 10.1093/schbul/13.1.23; Herath P, 2001, HUM BRAIN MAPP, V12, P110, DOI 10.1002/1097-0193(200102)12:2<110::AID-HBM1008>3.0.CO;2-0; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hodgkinson CA, 2004, AM J HUM GENET, V75, P862, DOI 10.1086/425586; Ishai A, 1999, P NATL ACAD SCI USA, V96, P9379, DOI 10.1073/pnas.96.16.9379; Ji YY, 2009, P NATL ACAD SCI USA, V106, P19593, DOI 10.1073/pnas.0904289106; JOHNSTONE EC, 1989, J NEUROL NEUROSUR PS, V52, P736, DOI 10.1136/jnnp.52.6.736; Joyner AH, 2009, P NATL ACAD SCI USA, V106, P15483, DOI 10.1073/pnas.0901866106; Lien YJ, 2010, GENES BRAIN BEHAV, V9, P695, DOI 10.1111/j.1601-183X.2010.00599.x; Luan ZL, 2011, NEUROREPORT, V22, P288, DOI 10.1097/WNR.0b013e328345ac22; Maritzen T, 2010, TRAFFIC, V11, P8, DOI 10.1111/j.1600-0854.2009.00971.x; Martina JA, 2001, J CELL BIOL, V153, P1111, DOI 10.1083/jcb.153.5.1111; Mattai AA, 2011, J AM ACAD CHILD PSY, V50, P697, DOI 10.1016/j.jaac.2011.03.016; McGuffin P, 1999, NEW ENGL J MED, V341, P370; O'Leary DDM, 2007, NEURON, V56, P252, DOI 10.1016/j.neuron.2007.10.010; Potkin SG, 2009, SCHIZOPHRENIA BULL, V35, P96, DOI 10.1093/schbul/sbn155; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qiu AQ, 2009, NEUROIMAGE, V47, P1221, DOI 10.1016/j.neuroimage.2009.05.054; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Rapoport J, 2012, MOL PSYCHIAT; Rimol LM, 2010, P NATL ACAD SCI USA, V107, P384, DOI 10.1073/pnas.0908454107; ROSSI A, 1990, BIOL PSYCHIAT, V27, P61, DOI 10.1016/0006-3223(90)90020-3; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Smith SM, 2008, TRENDS NEUROSCI, V31, P559, DOI 10.1016/j.tins.2008.08.005; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Stephan KE, 2006, BIOL PSYCHIAT, V59, P929, DOI 10.1016/j.biopsych.2005.10.005; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Tek C, 2002, ARCH GEN PSYCHIAT, V59, P146, DOI 10.1001/archpsyc.59.2.146; Tseng KY, 2004, J NEUROSCI, V24, P5131, DOI 10.1523/JNEUROSCI.1021-04.2004; Walther K, 2004, P NATL ACAD SCI USA, V101, P964, DOI 10.1073/pnas.0307862100; Walther K, 2001, EMBO REP, V2, P634, DOI 10.1093/embo-reports/kve134; WILKINSON DG, 1989, NATURE, V341, P405, DOI 10.1038/341405a0; Xiang Bo, 2012, Zhonghua Yixue Yichuanxue Zazhi, V29, P255, DOI 10.3760/cma.j.issn.1003-9406.2012.03.002; Xiao MF, 2009, J NEUROSCI, V29, P14752, DOI 10.1523/JNEUROSCI.4860-09.2009	57	5	5	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e64090	10.1371/journal.pone.0064090	http://dx.doi.org/10.1371/journal.pone.0064090			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785397	gold, Green Published, Green Submitted			2022-12-27	WOS:000321038800120
J	Cervello, M; Bachvarov, D; Lampiasi, N; Cusimano, A; Azzolina, A; McCubrey, JA; Montalto, G				Cervello, Melchiorre; Bachvarov, Dimcho; Lampiasi, Nadia; Cusimano, Antonella; Azzolina, Antonina; McCubrey, James A.; Montalto, Giuseppe			Novel Combination of Sorafenib and Celecoxib Provides Synergistic Anti-Proliferative and Pro-Apoptotic Effects in Human Liver Cancer Cells	PLOS ONE			English	Article							HUMAN HEPATOCELLULAR-CARCINOMA; YES-ASSOCIATED PROTEIN; PROTEASOME INHIBITOR MG132; HIPPO PATHWAY; BETA-CATENIN; CYCLOOXYGENASE-2 INHIBITORS; SELECTIVE CYCLOOXYGENASE-1; POOR-PROGNOSIS; EXPRESSION; GROWTH	Molecular targeted therapy has shown promise as a treatment for advanced hepatocellular carcinoma (HCC). Sorafenib, a multikinase inhibitor, recently received FDA approval for the treatment of advanced HCC. However, although sorafenib is well tolerated, concern for its safety has been expressed. Celecoxib (Celebrex (R)) is a selective cyclooxygenase-2 (COX-2) inhibitor which exhibits antitumor effects in human HCC cells. The present study examined the interaction between celecoxib and sorafenib in two human liver tumor cell lines HepG2 and Huh7. Our data showed that each inhibitor alone reduced cell growth and the combination of celecoxib with sorafenib synergistically inhibited cell growth and increased apoptosis. To better understand the molecular mechanisms underlying the synergistic antitumor activity of the combination, we investigated the expression profile of the combination-treated liver cancer cell lines using microarray analysis. Combination treatment significantly altered expression levels of 1,986 and 2,483 transcripts in HepG2 and Huh7 cells, respectively. Genes functionally involved in cell death, signal transduction and regulation of transcription were predominantly up-regulated, while genes implicated in metabolism, cell-cycle control and DNA replication and repair were mainly down-regulated upon treatment. However, combination-treated HCC cell lines displayed specificity in the expression and activity of crucial factors involved in hepatocarcinogenesis. The altered expression of some of these genes was confirmed by semi-quantitative and quantitative RT-PCR and by Western blotting. Many novel genes emerged from our transcriptomic analyses, and further functional analyses may determine whether these genes can serve as potential molecular targets for more effective anti-HCC strategies.	[Cervello, Melchiorre; Lampiasi, Nadia; Cusimano, Antonella; Azzolina, Antonina; Montalto, Giuseppe] Natl Res Council CNR, Inst Biomed & Mol Immunol Alberto Monroy, Palermo, Italy; [Bachvarov, Dimcho] Ctr Hosp Univ Quebec, Canc Res Ctr, Hop Hotel Dieu Quebec, Quebec City, PQ, Canada; [Bachvarov, Dimcho] Univ Laval, Fac Med, Dept Mol Med, Quebec City, PQ G1K 7P4, Canada; [McCubrey, James A.] E Carolina Univ, Dept Microbiol & Immunol, Brody Sch Med, Greenville, NC USA; [Montalto, Giuseppe] Univ Palermo, Biomed Dept Internal Med & Specialties, Palermo, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biomedicina e di Immunologia Molecolare "Alberto Monroy" (IBIM-CNR); Laval University; Laval University; University of North Carolina; East Carolina University; University of Palermo	Cervello, M (corresponding author), Natl Res Council CNR, Inst Biomed & Mol Immunol Alberto Monroy, Palermo, Italy.	cervello@ibim.cnr.it	Lampiasi, Nadia/AAC-8751-2019; Cervello, Melchiorre/K-5080-2016; Lampiasi, Nadia/AAR-8451-2020; Cervello, Melchiore/AAY-2923-2020	Lampiasi, Nadia/0000-0002-6831-4781; Lampiasi, Nadia/0000-0002-6831-4781; MONTALTO, Giuseppe/0000-0002-8731-8577; Bachvarov, Dimcho/0000-0001-6509-9599; McCubrey, James/0000-0001-6027-3156	Italian "Ministero dell'Istruzione, dell'Universita e della Ricerca" (Ministry for Education, Universities and Research) - MIUR FIRB427 MERIT [RBNE08YYBM]; FRSQ-RR Cancer; Italian Ministry of Economy; Finance for the Project FaReBio di Qualita	Italian "Ministero dell'Istruzione, dell'Universita e della Ricerca" (Ministry for Education, Universities and Research) - MIUR FIRB427 MERIT; FRSQ-RR Cancer; Italian Ministry of Economy; Finance for the Project FaReBio di Qualita	This work was supported in part by grants from the Italian "Ministero dell'Istruzione, dell'Universita e della Ricerca (Ministry for Education, Universities and Research) - MIUR FIRB427 MERIT n.RBNE08YYBM to M. C. and G. M.; D. B. is the Head of the Core Genomic Facility at the CHUQ-Cancer Research Centre, supported by FRSQ-RR Cancer. All the genomic experiments and data analyses were performed at this facility; M. C. has also been supported in part by a grant to the CNR from the Italian Ministry of Economy and Finance for the Project FaReBio di Qualita. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachvarov D, 2006, BIOL CHEM, V387, P15, DOI 10.1515/BC.2006.004; Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; Bertini E, 2009, CELL CYCLE, V8, P49, DOI 10.4161/cc.8.1.7259; Cai CL, 2012, CELL CYCLE, V11, P1773, DOI 10.4161/cc.20121; CAO SS, 1989, CANCER CHEMOTH PHARM, V24, P181, DOI 10.1007/BF00300240; Cervello M, 2004, INT J MOL MED, V13, P741; Cervello M, 2001, EUR J CANCER, V37, P512, DOI 10.1016/S0959-8049(00)00421-4; Cervello M, 2006, WORLD J GASTROENTERO, V12, P5113; Cervello M, 2005, WORLD J GASTROENTERO, V11, P4638, DOI 10.3748/wjg.v11.i30.4638; Cervello M, 2012, CELL CYCLE, V11, P2843, DOI 10.4161/cc.21193; Cervello M, 2012, ONCOTARGET, V3, P236, DOI 10.18632/oncotarget.466; Cervello M, 2011, OMICS, V15, P383, DOI 10.1089/omi.2010.0092; Cusimano A, 2007, CANCER BIOL THER, V6, P1461; Cusimano A, 2010, CELL CYCLE, V9, P1399, DOI 10.4161/cc.9.7.11254; Cusimano A, 2009, ANN NY ACAD SCI, V1155, P300, DOI 10.1111/j.1749-6632.2009.03701.x; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Fodera D, 2004, ANN NY ACAD SCI, V1028, P440, DOI 10.1196/annals.1322.052; French DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036713; Giannitrapani L, 2009, ANN NY ACAD SCI, V1155, P293, DOI 10.1111/j.1749-6632.2009.03698.x; Gurzov EN, 2009, CELL DEATH DIFFER, V16, P1539, DOI 10.1038/cdd.2009.99; Hall CA, 2010, CANCER RES, V70, P8517, DOI 10.1158/0008-5472.CAN-10-1242; Hao HY, 2012, J CELL MOL MED, V16, P605, DOI 10.1111/j.1582-4934.2011.01338.x; Ho HK, 2009, J HEPATOL, V50, P118, DOI 10.1016/j.jhep.2008.08.015; Inohara N, 1997, EMBO J, V16, P1686, DOI 10.1093/emboj/16.7.1686; Kern MA, 2002, HEPATOLOGY, V36, P885, DOI 10.1053/jhep.2002.36125; Koga H, 1999, HEPATOLOGY, V29, P688, DOI 10.1002/hep.510290355; Lampiasi N, 2006, INT J MOL MED, V17, P245; Lampiasi N, 2012, CANCER LETT, V322, P35, DOI 10.1016/j.canlet.2012.02.008; Lapi E, 2008, MOL CELL, V32, P803, DOI 10.1016/j.molcel.2008.11.019; Latasa MU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052711; Levy D, 2007, CELL DEATH DIFFER, V14, P743, DOI 10.1038/sj.cdd.4402063; Lin BC, 2007, J BIOL CHEM, V282, P27277, DOI 10.1074/jbc.M704244200; Mercier PL, 2011, MOL ONCOL, V5, P438, DOI 10.1016/j.molonc.2011.07.003; Miura S, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-56; Montalto G, 2002, ANN NY ACAD SCI, V963, P13, DOI 10.1111/j.1749-6632.2002.tb04090.x; Muramatsu T, 2011, CARCINOGENESIS, V32, P389, DOI 10.1093/carcin/bgq254; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Nakamura M, 2008, ONCOGENE, V27, pS105, DOI 10.1038/onc.2009.48; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Poh WJ, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-14; Pyrzynska B, 2013, MOL ONCOL, V7, P67, DOI 10.1016/j.molonc.2012.08.003; Sawey ET, 2011, CANCER CELL, V19, P347, DOI 10.1016/j.ccr.2011.01.040; Schmidt CM, 2003, J GASTROINTEST SURG, V7, P1024, DOI 10.1016/j.gassur.2003.09.009; Wang Y, 2010, CANCER SCI, V101, P1279, DOI 10.1111/j.1349-7006.2010.01511.x; Xu M, 2013, AM J PATHOL, V182, P84, DOI 10.1016/j.ajpath.2012.09.018; Xu MZ, 2009, CANCER-AM CANCER SOC, V115, P4576, DOI 10.1002/cncr.24495; Yee KS, 2010, CELL CYCLE, V9, P1447, DOI 10.4161/cc.9.8.11480; Yu B, 2009, J HEPATOL, V50, P948, DOI 10.1016/j.jhep.2008.11.020; Zhang X, 2011, ONCOGENE, V30, P2810, DOI 10.1038/onc.2011.8; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907	50	29	30	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65569	10.1371/journal.pone.0065569	http://dx.doi.org/10.1371/journal.pone.0065569			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776502	gold, Green Submitted, Green Published			2022-12-27	WOS:000320322400034
J	Cialabrini, L; Ruggieri, S; Kazanov, MD; Sorci, L; Mazzola, F; Orsomando, G; Osterman, AL; Raffaelli, N				Cialabrini, Lucia; Ruggieri, Silverio; Kazanov, Marat D.; Sorci, Leonardo; Mazzola, Francesca; Orsomando, Giuseppe; Osterman, Andrei L.; Raffaelli, Nadia			Genomics-Guided Analysis of NAD Recycling Yields Functional Elucidation of COG1058 as a New Family of Pyrophosphatases	PLOS ONE			English	Article							ESCHERICHIA-COLI MOEA; NICOTINAMIDE MONONUCLEOTIDE DEAMIDASE; ADP-RIBOSE; CRYSTAL-STRUCTURE; IONIZING-RADIATION; TRANSFER-RNA; METABOLISM; PROTEIN; ENZYME; IDENTIFICATION	We have recently identified the enzyme NMN deamidase (PncC), which plays a key role in the regeneration of NAD in bacteria by recycling back to the coenzyme the pyridine by-products of its non redox consumption. In several bacterial species, PncC is fused to a COG1058 domain of unknown function, highly conserved and widely distributed in all living organisms. Here, we demonstrate that the PncC-fused domain is endowed with a novel Co+2- and K+-dependent ADP-ribose pyrophosphatase activity, and discuss the functional connection of such an activity with NAD recycling. An in-depth phylogenetic analysis of the COG1058 domain evidenced that in most bacterial species it is fused to PncC, while in a-and some d-proteobacteria, as well as in archaea and fungi, it occurs as a stand-alone protein. Notably, in mammals and plants it is fused to FAD synthase. We extended the enzymatic characterization to a representative bacterial single-domain protein, which resulted to be a more versatile ADP-ribose pyrophosphatase, active also towards diadenosine 5'-diphosphate and FAD. Multiple sequence alignment analysis, and superposition of the available three-dimensional structure of an archaeal COG1058 member with the structure of the enzyme MoeA of the molybdenum cofactor biosynthesis, allowed identification of residues likely involved in catalysis. Their role has been confirmed by site-directed mutagenesis.	[Cialabrini, Lucia; Ruggieri, Silverio; Raffaelli, Nadia] Polytech Univ Marche, Dept Agr Food & Environm Sci, Ancona, Italy; [Kazanov, Marat D.] Russian Acad Sci, AA Kharkevich Inst Informat Transmiss Problems, Moscow, Russia; [Sorci, Leonardo; Mazzola, Francesca; Orsomando, Giuseppe] Polytech Univ Marche, Dept Clin Sci, Ancona, Italy; [Osterman, Andrei L.] Sanford Burnham Med Res Inst, La Jolla, CA USA	Marche Polytechnic University; Kharkevich Institute for Information Transmission Problems of the RAS; Russian Academy of Sciences; Marche Polytechnic University; Sanford Burnham Prebys Medical Discovery Institute	Raffaelli, N (corresponding author), Polytech Univ Marche, Dept Agr Food & Environm Sci, Ancona, Italy.	n.raffaelli@univpm.it	SORCI, LEONARDO/AAD-7395-2019; Kazanov, Marat D/D-6381-2013; Orsomando, Giuseppe/L-2120-2015; Mazzola, Francesca/ADC-1197-2022	SORCI, LEONARDO/0000-0002-4356-8873; Kazanov, Marat D/0000-0002-2314-5507; Mazzola, Francesca/0000-0001-9140-012X; Orsomando, Giuseppe/0000-0001-6640-097X	Italian Ministry of Foreign Affairs, "Direzione Generale per la Promozione del Sistema Paese"; U.S. Department of Energy (DOE), Office of Biological and Environmental Research (BER) Genomic Science Program (GSP) as part of the Pacific Northwest National Laboratory (PNNL) Foundational Scientific Focus Area; Ministry of Education and Science of Russian Federation [8135, 8049]	Italian Ministry of Foreign Affairs, "Direzione Generale per la Promozione del Sistema Paese"(Ministry of Foreign Affairs and International Cooperation (Italy)); U.S. Department of Energy (DOE), Office of Biological and Environmental Research (BER) Genomic Science Program (GSP) as part of the Pacific Northwest National Laboratory (PNNL) Foundational Scientific Focus Area; Ministry of Education and Science of Russian Federation(Ministry of Education and Science, Russian Federation)	This research was partly supported by the Italian Ministry of Foreign Affairs, "Direzione Generale per la Promozione del Sistema Paese" to NR; by the U.S. Department of Energy (DOE), Office of Biological and Environmental Research (BER) Genomic Science Program (GSP) as part of the Pacific Northwest National Laboratory (PNNL) Foundational Scientific Focus Area to ALO; and by The Ministry of Education and Science of Russian Federation, projects 8135 and 8049 to MDK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arn EA, 1996, J BIOL CHEM, V271, P31145, DOI 10.1074/jbc.271.49.31145; Beitz E, 2000, BIOINFORMATICS, V16, P135, DOI 10.1093/bioinformatics/16.2.135; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHENG WL, 1995, J BACTERIOL, V177, P6711, DOI 10.1128/jb.177.23.6711-6717.1995; de Souza RF, 2012, MOL BIOSYST, V8, P1661, DOI 10.1039/c2mb05487f; Dunn CA, 1999, J BIOL CHEM, V274, P32318, DOI 10.1074/jbc.274.45.32318; Elias M, 2012, J BIOL CHEM, V287, P11, DOI 10.1074/jbc.R111.257329; Galeazzi L, 2011, J BIOL CHEM, V286, P40365, DOI 10.1074/jbc.M111.275818; Gazzaniga F, 2009, MICROBIOL MOL BIOL R, V73, P529, DOI 10.1128/MMBR.00042-08; Gerdes SY, 2006, J BACTERIOL, V188, P3012, DOI 10.1128/JB.188.8.3012-3023.2006; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Holbourn KP, 2006, FEBS J, V273, P4579, DOI 10.1111/j.1742-4658.2006.05442.x; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; Huang N, 2008, STRUCTURE, V16, P196, DOI 10.1016/j.str.2007.11.017; Huang N, 2009, STRUCTURE, V17, P939, DOI 10.1016/j.str.2009.05.012; JACOBSON EL, 1994, MOL CELL BIOCHEM, V138, P207, DOI 10.1007/BF00928463; Koch-Nolte F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.257mr1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lin H, 2007, ORG BIOMOL CHEM, V5, P2541, DOI 10.1039/b706887e; Liu YQ, 2003, P NATL ACAD SCI USA, V100, P4191, DOI 10.1073/pnas.0630387100; Llamas A, 2006, J BIOL CHEM, V281, P18343, DOI 10.1074/jbc.M601415200; LUDDEN PW, 1994, MOL CELL BIOCHEM, V138, P123, DOI 10.1007/BF00928453; Mair RW, 2012, FEMS MICROBIOL LETT, V331, P44, DOI 10.1111/j.1574-6968.2012.02550.x; McLennan AG, 2006, CELL MOL LIFE SCI, V63, P123, DOI 10.1007/s00018-005-5386-7; Nichols JD, 2007, BIOCHEMISTRY-US, V46, P78, DOI 10.1021/bi061551q; Okuda K, 2005, J BACTERIOL, V187, P4984, DOI 10.1128/JB.187.14.4984-4991.2005; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Perraud AL, 2005, J BIOL CHEM, V280, P6138, DOI 10.1074/jbc.M411446200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Raffaelli N, 1999, FEBS LETT, V444, P222, DOI 10.1016/S0014-5793(99)00068-X; Rodionov DA, 2008, NUCLEIC ACIDS RES, V36, P2047, DOI 10.1093/nar/gkn047; Rossi L, 2002, BIOCHIMIE, V84, P1229; Sanishvili R, 2004, J BIOL CHEM, V279, P42139, DOI 10.1074/jbc.M407694200; Schrag JD, 2001, J MOL BIOL, V310, P419, DOI 10.1006/jmbi.2001.4771; Schwarz G, 2009, NATURE, V460, P839, DOI 10.1038/nature08302; Shull NP, 2005, NUCLEIC ACIDS RES, V33, P650, DOI 10.1093/nar/gki211; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sorci L, 2009, P NATL ACAD SCI USA, V106, P3083, DOI 10.1073/pnas.0811718106; Spinelli SL, 1999, J BIOL CHEM, V274, P2637, DOI 10.1074/jbc.274.5.2637; Stallings CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021807; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; Tanaka M, 2004, GENETICS, V168, P21, DOI 10.1534/genetics.104.029249; Tong L, 2010, BBA-PROTEINS PROTEOM, V1804, P1617, DOI 10.1016/j.bbapap.2010.02.007; Waller JC, 2010, P NATL ACAD SCI USA, V107, P10412, DOI 10.1073/pnas.0911586107; Xiang S, 2001, STRUCTURE, V9, P299, DOI 10.1016/S0969-2126(01)00588-3	47	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65595	10.1371/journal.pone.0065595	http://dx.doi.org/10.1371/journal.pone.0065595			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776507	gold, Green Published			2022-12-27	WOS:000320322400036
J	Cortina, MA; Fazel, M; Hlungwani, TM; Kahn, K; Tollman, S; Cortina-Borja, M; Stein, A				Cortina, Melissa A.; Fazel, Mina; Hlungwani, Tintswalo Mercy; Kahn, Kathleen; Tollman, Stephen; Cortina-Borja, Mario; Stein, Alan			Childhood Psychological Problems in School Settings in Rural Southern Africa	PLOS ONE			English	Article							ADOLESCENT MENTAL-HEALTH; DIFFICULTIES QUESTIONNAIRE; PSYCHOMETRIC PROPERTIES; BEHAVIOR CHECKLIST; STRENGTHS; CHILDREN; DISORDERS; PREVALENCE; INCOME; SURVEILLANCE	Background: Many children can be exposed to multiple adversities in low and middle-income countries (LMICs) placing them at potential risk of psychological problems. However, there is a paucity of research using large representative cohorts examining the psychological adjustment of children in school settings in these countries. Children's psychological adjustment has been shown to affect educational progress which is critical for their future. This study, based in a rural, socio-economically disadvantaged area of South Africa, aimed to examine the prevalence of children's psychological problems as well as possible risk and protective factors. Methods: Rates of psychological problems in 10-12 year olds were examined using teacher-and child-report questionnaires. Data on children from 10 rural primary schools, selected by stratified random sampling, were linked to individual and household data from the Agincourt health and socio-demographic surveillance system collected from households over 15 years. Results: A total of 1,025 children were assessed. Teachers identified high levels of behavioural and emotional problems (41%). Children reported lower, but substantial rates of anxiety/depression (14%), and significant post-traumatic stress symptoms (24%); almost a quarter felt unsafe in school. Risk factors included being a second-generation former refugee and being from a large household. Protective factors highlight the importance of maternal factors, such as being more educated and in a stable partnership. Conclusion: The high levels of psychological problems identified by teachers are a serious public health concern, as they are likely to impact negatively on children's education, particularly given the large class sizes and limited resources in rural LMIC settings. Despite the high levels of risk, a proportion of children were managing well and research to understand resilience could inform interventions.	[Cortina, Melissa A.; Fazel, Mina; Stein, Alan] Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford, England; [Cortina, Melissa A.] Univ Witwatersrand, MRC Wits Rural Publ Hlth & Hlth Transit Unit, Johannesburg, South Africa; [Hlungwani, Tintswalo Mercy; Kahn, Kathleen; Tollman, Stephen; Stein, Alan] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [Cortina-Borja, Mario] UCL Inst Child Hlth, MRC Ctr Epidemiol Child Hlth, London, England	University of Oxford; University of Witwatersrand; University of Witwatersrand; University of London; University College London	Cortina, MA (corresponding author), Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford, England.	Cortina.melissa@gmail.com	Borja, Mario Cortina/A-3847-2009	Borja, Mario Cortina/0000-0003-0627-2624; Stein, Alan/0000-0001-8207-2822; Fazel, Mina/0000-0001-9342-2365; Tollman, Stephen/0000-0003-0744-7588; Kahn, Kathleen/0000-0003-3339-3931	Oppenheimer Fund (Oxford); Wellcome Trust [058893/2/99/A, 069683/2/02/Z]; National Institute for Health Research [PDF-2010-03-10] Funding Source: researchfish	Oppenheimer Fund (Oxford); Wellcome Trust(Wellcome Trust); National Institute for Health Research(National Institute for Health Research (NIHR))	The Oppenheimer Fund (Oxford) supported travel expenses for MC and TMH between the UK and South Africa. The Wellcome Trust supports the Agincourt Demographic Health and Surveillance Site (grant numbers 058893/2/99/A and 069683/2/02/Z) which provided the platform for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach T. M., 2007, MULTICULTURAL SUPPLE; Achenbach T.M., 1991, MANUAL CHILD BEHAV C, DOI DOI 10.1023/A; Achenbach TM, 2008, J CHILD PSYCHOL PSYC, V49, P251, DOI 10.1111/j.1469-7610.2007.01867.x; Barbarin OA, 2001, AM J ORTHOPSYCHIAT, V71, P16, DOI 10.1037/0002-9432.71.1.16; Belfer ML, 2008, J CHILD PSYCHOL PSYC, V49, P226, DOI 10.1111/j.1469-7610.2007.01855.x; Bhorat H., 2006, POVERTY POLICY POSTA; Briere J., 1996, TRAUMA SYMPTOM CHECK; Bussing Regina, 2012, J Am Acad Child Adolesc Psychiatry, V51, P663, DOI 10.1016/j.jaac.2012.04.005; Byass P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000325; Catalano RF, 2012, LANCET, V379, P1653, DOI 10.1016/S0140-6736(12)60238-4; Clark SJ, 2007, SCAND J PUBLIC HEALT, V35, P35, DOI 10.1080/14034950701355619; Cohen J.E., 1988, STAT POWER ANAL BEHA; Collinson MA, 2007, SCAND J PUBLIC HEALT, V35, P77, DOI 10.1080/14034950701356401; Condly SJ, 2006, URBAN EDUC, V41, P211, DOI 10.1177/0042085906287902; Cortina MA, 2008, CHILD CARE HLTH DEV, V34, P1, DOI 10.1111/j.1365-2214.2007.00820.x; Cortina MA, 2012, ARCH PEDIAT ADOL MED, V166, P276, DOI 10.1001/archpediatrics.2011.592; Dekker MC, 2007, J CHILD PSYCHOL PSYC, V48, P657, DOI 10.1111/j.1469-7610.2007.01742.x; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Engle PL, 2007, LANCET, V369, P229, DOI 10.1016/S0140-6736(07)60112-3; Engle PL, 2011, LANCET, V378, P1339, DOI 10.1016/S0140-6736(11)60889-1; Friedman RJ, 2002, CHILD ADOLESCENT PSY, P261; Gomez-Olive FX, 2013, AIDS CARE, V25, P1122, DOI 10.1080/09540121.2012.750710; Goodman R, 1998, EUR CHILD ADOLES PSY, V7, P125, DOI 10.1007/s007870050057; Goodman R, 2003, INT REV PSYCHIATR, V15, P166, DOI 10.1080/0954026021000046128; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Goodman R, 1999, J ABNORM CHILD PSYCH, V27, P17, DOI 10.1023/A:1022658222914; Guinness E A, 1992, Br J Psychiatry Suppl, P12; Hargreaves JR, 2008, J EPIDEMIOL COMMUN H, V62, P113, DOI 10.1136/jech.2006.053827; Hunter N, 2011, DEV SO AFR, V28, P1, DOI 10.1080/0376835X.2011.545167; Kahn K, 2012, INT J EPIDEMIOL, V41, P988, DOI 10.1093/ije/dys115; Kashala E, 2005, EUR CHILD ADOLES PSY, V14, P208, DOI 10.1007/s00787-005-0446-y; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kieling C, 2011, LANCET, V378, P1515, DOI 10.1016/S0140-6736(11)60827-1; Lam D, 2011, IMPACT HOUSEHOLD SHO; Lambert MC, 2003, PSYCHOL ASSESSMENT, V15, P550, DOI 10.1037/1040-3590.15.4.550; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mellor D, 2004, PSYCHOL ASSESSMENT, V16, P396, DOI 10.1037/1040-3590.16.4.396; Meltzer H., 2000, MENTAL HLTH CHILDREN; Morris J, 2011, J CHILD PSYCHOL PSYC, V52, P1239, DOI 10.1111/j.1469-7610.2011.02409.x; MRC/Wits Rural Public Health and Health Transitions Research Unit, 2009, AG DHSS DAT DOC; Mulatu MS, 1997, STRESS COPING ADAPTA; Muris P, 2004, BRIT J CLIN PSYCHOL, V43, P437, DOI 10.1348/0144665042388982; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Myer L, 2009, SAMJ S AFR MED J, V99, P354; Nunnaly J, 1994, PSYCHOMETRIC THEORY; Parry C. D. H., 1996, TRANSCULT PSYCHIATRY, V33, P173, DOI [DOI 10.1177/136346159603300203, 10.1177/136346159603300203]; Patel V, 2008, J CHILD PSYCHOL PSYC, V49, P313, DOI 10.1111/j.1469-7610.2007.01824.x; Patel V, 2011, LANCET, V378, P1441, DOI 10.1016/S0140-6736(11)61385-8; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Prothrow-Stith D, 2001, PEACEZONE PROGRAM TE; Reed RV, 2011, LANCET; Robertson BA, 1994, CHILDHOOD ADVERSITY, P136; Rutter M., 2002, CHILD ADOLESCENT PSY, P309; Sawyer SM, 2012, LANCET, V379, P1630, DOI 10.1016/S0140-6736(12)60072-5; Schirmer S, 2010, CDE DEPTH 10 HIDDEN; SDQinfo.com, 2010, YOUTH MIND; Tabachnick B. G., 2019, USING MULTIVARIATE S, V5; Townsend N, 2002, POP STUD-J DEMOG, V56, P215, DOI 10.1080/00324720215925; Twine R, 2007, SCAND J PUBLIC HEALT, V35, P118, DOI 10.1080/14034950701430008; UNICEF, 2007, ANN REP 2006; Unterhalter E, 2007, GENDER SCH GLOBAL SC; Viner RM, 2012, LANCET, V379, P1641, DOI 10.1016/S0140-6736(12)60149-4	62	28	28	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65041	10.1371/journal.pone.0065041	http://dx.doi.org/10.1371/journal.pone.0065041			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	163FW	23776443	Green Published, Green Submitted, gold			2022-12-27	WOS:000320322400006
J	Duan, SB; Li, ZL; Tang, BH; Wu, H; Ma, LL; Zhao, EY; Li, CR				Duan, Si-Bo; Li, Zhao-Liang; Tang, Bo-Hui; Wu, Hua; Ma, Lingling; Zhao, Enyu; Li, Chuanrong			Land Surface Reflectance Retrieval from Hyperspectral Data Collected by an Unmanned Aerial Vehicle over the Baotou Test Site	PLOS ONE			English	Article							ATMOSPHERIC CORRECTION ALGORITHM; VAPOR COLUMN ABUNDANCE; REMOTE-SENSING DATA; SIGNAL-TO-NOISE; TEST FIELD; VICARIOUS CALIBRATION; SPECTRAL CALIBRATION; IMAGES; SIMULATION; SENSORS	To evaluate the in-flight performance of a new hyperspectral sensor onboard an unmanned aerial vehicle (UAV-HYPER), a comprehensive field campaign was conducted over the Baotou test site in China on 3 September 2011. Several portable reference reflectance targets were deployed across the test site. The radiometric performance of the UAV-HYPER sensor was assessed in terms of signal-to-noise ratio (SNR) and the calibration accuracy. The SNR of the different bands of the UAV-HYPER sensor was estimated to be between approximately 5 and 120 over the homogeneous targets, and the linear response of the apparent reflectance ranged from approximately 0.05 to 0.45. The uniform and non-uniform Lambertian land surface reflectance was retrieved and validated using in situ measurements, with root mean square error (RMSE) of approximately 0.01-0.07 and relative RMSE of approximately 5%-12%. There were small discrepancies between the retrieved uniform and non-uniform Lambertian land surface reflectance over the homogeneous targets and under low aerosol optical depth (AOD) conditions (AOD = 0.18). However, these discrepancies must be taken into account when adjacent pixels had large land surface reflectance contrast and under high AOD conditions (e. g. AOD = 1.0).	[Duan, Si-Bo; Tang, Bo-Hui; Wu, Hua] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, State Key Lab Resources & Environm Informat Syst, Beijing, Peoples R China; [Duan, Si-Bo; Zhao, Enyu] Univ Chinese Acad Sci, Beijing, Peoples R China; [Duan, Si-Bo; Li, Zhao-Liang] Univ Strasbourg, CNRS, Lab Sci Ingn Informat & Imagerie, Illkirch Graffenstaden, France; [Li, Zhao-Liang] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Minist Agr, Key Lab Agriinformat, Beijing 100193, Peoples R China; [Ma, Lingling; Zhao, Enyu; Li, Chuanrong] Chinese Acad Sci, Acad Optoelect, Earth Observat Technol Applicat Dept, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Sciences; Academy of Opto-Electronics, CAS	Li, ZL (corresponding author), Univ Strasbourg, CNRS, Lab Sci Ingn Informat & Imagerie, Illkirch Graffenstaden, France.	lizhaoliang@caas.cn	Wu, Hua/G-9271-2012; Duan, Si-Bo/AAF-4296-2019	Wu, Hua/0000-0002-5982-8422; Duan, Si-Bo/0000-0002-4390-2421	Hi-Tech Research and Development Program of China (863 Plan Program) [2012AA12A302]; State Key Laboratory of Resources and Environment Information System [088RA801KA]; China Scholarship Council	Hi-Tech Research and Development Program of China (863 Plan Program)(National High Technology Research and Development Program of China); State Key Laboratory of Resources and Environment Information System; China Scholarship Council(China Scholarship Council)	This work was supported by the Hi-Tech Research and Development Program of China (863 Plan Program) under Grant 2012AA12A302 and by the State Key Laboratory of Resources and Environment Information System under Grant 088RA801KA. Mr. Si-Bo Duan is financially supported by the China Scholarship Council for his stay in LSIIT, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson PM, 2005, INT J REMOTE SENS, V26, P5099, DOI 10.1080/01431160500254999; Brook A, 2011, REMOTE SENS ENVIRON, V115, P1543, DOI 10.1016/j.rse.2011.02.013; BRUEGGE CJ, 1992, J GEOPHYS RES-ATMOS, V97, P18759, DOI 10.1029/92JD01050; CURRAN PJ, 1989, IEEE T GEOSCI REMOTE, V27, P620, DOI 10.1109/TGRS.1989.35945; Estelles V, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006047; GAO BC, 1993, REMOTE SENS ENVIRON, V43, P23, DOI 10.1016/0034-4257(93)90061-2; Gao BC, 2009, REMOTE SENS ENVIRON, V113, pS17, DOI 10.1016/j.rse.2007.12.015; Goetz AFH, 2009, REMOTE SENS ENVIRON, V113, pS5, DOI 10.1016/j.rse.2007.12.014; Green RO, 2003, IEEE T GEOSCI REMOTE, V41, P1194, DOI 10.1109/TGRS.2003.813204; Guanter L, 2007, REMOTE SENS ENVIRON, V109, P54, DOI 10.1016/j.rse.2006.12.005; Guanter L, 2009, INT J REMOTE SENS, V30, P1407, DOI 10.1080/01431160802438555; Halthore RN, 1997, J GEOPHYS RES-ATMOS, V102, P4343, DOI 10.1029/96JD03247; Honkavaara E, 2008, PHOTOGRAMM ENG REM S, V74, P95, DOI 10.14358/PERS.74.1.95; Li ZL, 2013, INT J REMOTE SENS, V34, P3084, DOI 10.1080/01431161.2012.716540; Li ZL, 2013, REMOTE SENS ENVIRON, V131, P14, DOI 10.1016/j.rse.2012.12.008; Liang SL, 2001, IEEE T GEOSCI REMOTE, V39, P2490, DOI 10.1109/36.964986; Markelin L, 2008, PHOTOGRAMM ENG REM S, V74, P1487, DOI 10.14358/PERS.74.12.1487; Markelin L, 2010, ISPRS J PHOTOGRAMM, V65, P409, DOI 10.1016/j.isprsjprs.2010.05.003; PUTSAY M, 1992, INT J REMOTE SENS, V13, P1549, DOI 10.1080/01431169208904208; RICHTER R, 1990, INT J REMOTE SENS, V11, P159, DOI 10.1080/01431169008955008; Richter R, 2011, IEEE T GEOSCI REMOTE, V49, P1772, DOI 10.1109/TGRS.2010.2089799; Sanders LC, 2001, REMOTE SENS ENVIRON, V78, P252, DOI 10.1016/S0034-4257(01)00219-X; Secker J, 2001, REMOTE SENS ENVIRON, V76, P81, DOI 10.1016/S0034-4257(00)00194-2; Semenov AA, 2011, IEEE T GEOSCI REMOTE, V49, P2623, DOI 10.1109/TGRS.2011.2114351; Verhoef W, 2003, REMOTE SENS ENVIRON, V87, P23, DOI 10.1016/S0034-4257(03)00143-3; Vermote EF, 1997, IEEE T GEOSCI REMOTE, V35, P675, DOI 10.1109/36.581987	26	20	23	3	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66972	10.1371/journal.pone.0066972	http://dx.doi.org/10.1371/journal.pone.0066972			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23785513	Green Published, Green Submitted, gold			2022-12-27	WOS:000320322400123
J	Euden, J; Mason, SA; Williams, AJ				Euden, Joanne; Mason, Sammy A.; Williams, Alan J.			Functional Characterization of the Cardiac Ryanodine Receptor Pore-Forming Region	PLOS ONE			English	Article							CALCIUM-RELEASE CHANNEL; TRANSMEMBRANE DOMAINS; CA2+-RELEASE CHANNEL; VOLTAGE-SENSOR; ION CONDUCTION; RYR1; SELECTIVITY; HELIX; MODEL; BLOCK	Ryanodine receptors are homotetrameric intracellular calcium release channels. The efficiency of these channels is underpinned by exceptional rates of cation translocation through the open channel and this is achieved at the expense of the high degree of selectivity characteristic of many other types of channel. Crystallization of prokaryotic potassium channels has provided insights into the structures and mechanisms responsible for ion selection and movement in these channels, however no equivalent structural detail is currently available for ryanodine receptors. Nevertheless both molecular modeling and cryo-electron microscopy have identified the probable pore-forming region (PFR) of the ryanodine receptor (RyR) and suggest that this region contains structural elements equivalent to those of the PFRs of potassium-selective channels. The aim of the current study was to establish if the isolated putative cardiac RyR (RyR2) PFR could form a functional ion channel. We have expressed and purified the RyR2 PFR and shown that function is retained following reconstitution into planar phospholipid bilayers. Our data provide the first direct experimental evidence to support the proposal that the conduction pathway of RyR2 is formed by structural elements equivalent to those of the potassium channel PFR.	[Euden, Joanne; Mason, Sammy A.; Williams, Alan J.] Cardiff Univ, Inst Mol & Expt Med, Cardiff CF10 3AX, S Glam, Wales	Cardiff University	Euden, J (corresponding author), Cardiff Univ, Inst Mol & Expt Med, Cardiff CF10 3AX, S Glam, Wales.	eudenj@cardiff.ac.uk		euden, joanne/0000-0002-2844-6878; Williams, Alan/0000-0002-3770-8761	British Heart Foundation [RG/09/009/28069]	British Heart Foundation(British Heart Foundation)	British Heart Foundation Programme Grant no. RG/09/009/28069. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balshaw D, 1999, P NATL ACAD SCI USA, V96, P3345, DOI 10.1073/pnas.96.7.3345; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bers DM, 2004, J MOL CELL CARDIOL, V37, P417, DOI 10.1016/j.yjmcc.2004.05.026; BORASO A, 1994, AM J PHYSIOL, V267, pH1010, DOI 10.1152/ajpheart.1994.267.3.H1010; Butterwick JA, 2010, J MOL BIOL, V403, P591, DOI 10.1016/j.jmb.2010.09.012; GOLA M, 1990, J PHYSIOL-LONDON, V420, P73, DOI 10.1113/jphysiol.1990.sp017902; HILLE B, 2001, ION CHANNELS EXCITAB, pCH12; Kang GB, 2007, PROTEIN PEPTIDE LETT, V14, P742; LINDSAY ARG, 1991, J PHYSIOL-LONDON, V439, P463, DOI 10.1113/jphysiol.1991.sp018676; LINDSAY ARG, 1991, BIOCHIM BIOPHYS ACTA, V1064, P89, DOI 10.1016/0005-2736(91)90415-5; Ludtke SJ, 2005, STRUCTURE, V13, P1203, DOI 10.1016/j.str.2005.06.005; Mason SA, 2012, J GEN PHYSIOL, V140, P325, DOI 10.1085/jgp.201210851; McCusker EC, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.C111.228122; Mead F, 2002, BIOPHYS J, V82, P1953, DOI 10.1016/S0006-3495(02)75544-6; Mead-Savery FC, 2009, BIOPHYS J, V96, P1374, DOI 10.1016/j.bpj.2008.10.054; Meissner G, 2004, CELL CALCIUM, V35, P621, DOI 10.1016/j.ceca.2004.01.015; Pagliuca C, 2007, BIOCHEMISTRY-US, V46, P1079, DOI 10.1021/bi061530w; Ramachandran S, 2013, J BIOL CHEM; Ramachandran S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000367; Ranatunga KM, 2005, MOL PHARMACOL, V68, P840, DOI 10.1124/mol.105.012807; Samso M, 2005, NAT STRUCT MOL BIOL, V12, P539, DOI 10.1038/nsmb938; Samso M, 2009, PLOS BIOL, V7, P980, DOI 10.1371/journal.pbio.1000085; Santos JS, 2008, J GEN PHYSIOL, V132, P651, DOI 10.1085/jgp.200810077; Shaya D, 2011, P NATL ACAD SCI US; Sugiharto S, 2008, BIOPHYS J, V95, P4698, DOI 10.1529/biophysj.107.125690; Swartz KJ, 2008, NATURE, V456, P891, DOI 10.1038/nature07620; Thompson AJ, 2003, BRIT J PHARMACOL, V140, P359, DOI 10.1038/sj.bjp.0705424; TINKER A, 1992, J GEN PHYSIOL, V100, P495, DOI 10.1085/jgp.100.3.495; TINKER A, 1993, J GEN PHYSIOL, V102, P1107, DOI 10.1085/jgp.102.6.1107; TINKER A, 1995, BIOPHYS J, V68, P111, DOI 10.1016/S0006-3495(95)80165-7; Welch W, 2004, BIOPHYS J, V87, P2335, DOI 10.1529/biophysj.104.044180; West DJ, 2007, CURR PHARM DESIGN, V13, P2428; WILLIAMS AJ, 1992, J MUSCLE RES CELL M, V13, P7, DOI 10.1007/BF01738423; Williams AJ, 2001, Q REV BIOPHYS, V34, P61, DOI 10.1017/S0033583501003675; Williams AJ, 2004, BIOL RES, V37, P527, DOI 10.4067/S0716-97602004000400006; Williams AJ, 2002, FRONT BIOSCI, V7, pD1223, DOI 10.2741/williams	36	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66542	10.1371/journal.pone.0066542	http://dx.doi.org/10.1371/journal.pone.0066542			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776685	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000320322400110
J	Khan, S; Garg, A; Sharma, A; Camacho, N; Picchioni, D; Saint-Leger, A; de Pouplana, LR; Yogavel, M; Sharma, A				Khan, Sameena; Garg, Ankur; Sharma, Arvind; Camacho, Noelia; Picchioni, Daria; Saint-Leger, Adelaide; Ribas de Pouplana, Lluis; Yogavel, Manickam; Sharma, Amit			An Appended Domain Results in an Unusual Architecture for Malaria Parasite Tryptophanyl-tRNA Synthetase	PLOS ONE			English	Article							BINDING; AMINOACYLATION; RECOGNITION; EVOLUTION	Specific activation of amino acids by aminoacyl-tRNA synthetases (aaRSs) is essential for maintaining fidelity during protein translation. Here, we present crystal structure of malaria parasite Plasmodium falciparum tryptophanyl-tRNA synthetase (Pf-WRS) catalytic domain (AAD) at 2.6 angstrom resolution in complex with L-tryptophan. Confocal microscopy-based localization data suggest cytoplasmic residency of this protein. Pf-WRS has an unusual N-terminal extension of AlaX-like domain (AXD) along with linker regions which together seem vital for enzymatic activity and tRNA binding. Pf-WRS is not proteolytically processed in the parasites and therefore AXD likely provides tRNA binding capability rather than editing activity. The N-terminal domain containing AXD and linker region is monomeric and would result in an unusual overall architecture for Pf-WRS where the dimeric catalytic domains have monomeric AXDs on either side. Our PDB-wide comparative analyses of 47 WRS crystal structures also provide new mechanistic insights into this enzyme family in context conserved KMSKS loop conformations.	[Khan, Sameena; Garg, Ankur; Sharma, Arvind; Yogavel, Manickam; Sharma, Amit] ICGEB, Struct & Computat Biol Grp, New Delhi, India; [Camacho, Noelia; Picchioni, Daria; Saint-Leger, Adelaide; Ribas de Pouplana, Lluis] IRB Barcelona, Barcelona, Catalonia, Spain; [Ribas de Pouplana, Lluis] Catalan Inst Res & Adv Studies ICREA, Barcelona, Catalonia, Spain	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; ICREA	Sharma, A (corresponding author), ICGEB, Struct & Computat Biol Grp, New Delhi, India.	amit.icgeb@gmail.com	Sharma, Arvind/ABG-2614-2021; Manickam, Yogavel/O-4570-2015; de Pouplana, Lluis Ribas/AAA-4738-2019	Sharma, Arvind/0000-0002-7029-9867; Manickam, Yogavel/0000-0002-2119-062X; de Pouplana, Lluis Ribas/0000-0002-2087-0359; Garg, Ankur/0000-0003-2397-1670	Department of Biotechnology, Govt. of India; ICREA Funding Source: Custom	Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India); ICREA(ICREA)	The funding agency for this work is the Department of Biotechnology, Govt. of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahel I, 2003, P NATL ACAD SCI USA, V100, P15422, DOI 10.1073/pnas.2136934100; Bahl A, 2003, NUCLEIC ACIDS RES, V31, P212, DOI 10.1093/nar/gkg081; Bhatt TK, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1522; Bhatt TK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-644; Cahuzac B, 2000, EMBO J, V19, P445, DOI 10.1093/emboj/19.3.445; CUSACK S, 1995, NAT STRUCT BIOL, V2, P824, DOI 10.1038/nsb1095-824; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FLECKNER J, 1995, CYTOKINE, V7, P70, DOI 10.1006/cyto.1995.1009; Fukunaga R, 2007, ACTA CRYSTALLOGR D, V63, P390, DOI 10.1107/S090744490605640X; Guo M, 2009, SCIENCE, V325, P744, DOI 10.1126/science.1174343; Hoepfner D, 2012, CELL HOST MICROBE, V11, P654, DOI 10.1016/j.chom.2012.04.015; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Jackson KE, 2011, TRENDS PARASITOL, V27, P467, DOI 10.1016/j.pt.2011.05.005; Khan S, 2013, ACTA CRYSTALLOGR D; Khan S, 2011, SCI REP-UK, V1, DOI 10.1038/srep00188; Kise Y, 2004, NAT STRUCT MOL BIOL, V11, P149, DOI 10.1038/nsmb722; KISSELEV L, 1993, TRENDS BIOCHEM SCI, V18, P263, DOI 10.1016/0968-0004(93)90178-P; KISSELEV LL, 1993, BIOCHIMIE, V75, P1027, DOI 10.1016/0300-9084(93)90002-A; LEMAIRE G, 1975, EUR J BIOCHEM, V51, P237, DOI 10.1111/j.1432-1033.1975.tb03924.x; Merritt EA, 2011, MOL BIOCHEM PARASIT, V177, P20, DOI 10.1016/j.molbiopara.2011.01.003; Naganuma M, 2009, P NATL ACAD SCI USA, V106, P8489, DOI 10.1073/pnas.0901572106; O'Donoghue P, 2003, MICROBIOL MOL BIOL R, V67, P550, DOI 10.1128/MMBR.67.4.550-573.2003; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Retailleau P, 2003, J MOL BIOL, V325, P39, DOI 10.1016/S0022-2836(02)01156-7; SALLAFRANQUE ML, 1986, BIOCHIM BIOPHYS ACTA, V882, P192, DOI 10.1016/0304-4165(86)90155-8; SAMPSON JR, 1988, P NATL ACAD SCI USA, V85, P1033, DOI 10.1073/pnas.85.4.1033; Schimmel P, 2000, TRENDS BIOCHEM SCI, V25, P207, DOI 10.1016/S0968-0004(00)01553-X; SCHULMAN LH, 1983, P NATL ACAD SCI-BIOL, V80, P6755, DOI 10.1073/pnas.80.22.6755; Sokabe M, 2005, P NATL ACAD SCI USA, V102, P11669, DOI 10.1073/pnas.0502119102; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Wolf YI, 1999, GENOME RES, V9, P689; Yu YD, 2004, J BIOL CHEM, V279, P8378, DOI 10.1074/jbc.M311284200	35	15	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66224	10.1371/journal.pone.0066224	http://dx.doi.org/10.1371/journal.pone.0066224			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776638	gold, Green Submitted, Green Published			2022-12-27	WOS:000320322400090
J	Landmark, T; Romundstad, PR; Borchgrevink, PC; Kaasa, S; Dale, O				Landmark, Tormod; Romundstad, Pal R.; Borchgrevink, Petter C.; Kaasa, Stein; Dale, Ola			Longitudinal Associations between Exercise and Pain in the General Population - The HUNT Pain Study	PLOS ONE			English	Article							NORD-TRONDELAG HEALTH; LOW-BACK-PAIN; PHYSICAL-ACTIVITY; LEISURE-TIME; RISK-FACTORS; WORK; INDIVIDUALS; PREVALENCE; DISABILITY; VALIDITY	Background: Population-based studies have reported conflicting findings on the relationship between physical activity and pain, and most studies reporting a relationship are cross sectional. Temporal relationships are therefore difficult to infer and associations may be subject to confounding from a variety of other factors. The aim of the current study was to investigate the association between exercise and pain longitudinally and to use within subjects analyses to remove between subjects confounding. Methods: In the population-based HUNT 3 study, participants reported both pain and level of exercise. A random sub-sample of 6419 participants was in addition invited to report their last week pain and exercise every three months over a 12 month period (five measurements in total). We used multilevel mixed effects linear regression analyses to prospectively estimate the association between regular levels of exercise (measured in HUNT 3) and subsequent longitudinal reporting of pain. We also estimated within-subjects associations (i.e. the variation in pain as a function of variation in exercise, over time, within individuals) to avoid confounding from between subject factors. Results: Among those invited to participate (N = 6419), 4219 subjects returned at least two questionnaires. Compared with subjects who reported no or light exercise, those who reported moderate levels of exercise or more at baseline, reported less pain in repeated measures over a 12 month period in analyses adjusted for age, sex, education and smoking. Adjusting for baseline level of pain distinctly attenuated the findings. Within subjects, an increase in exercise was accompanied by a concurrent reduction in intensity of pain. However, we found no indication that exercise level at one occasion was related to pain reporting three months later. Conclusion: This longitudinal population-based study indicates that exercise is associated with lower level of pain and that this association is close in time.	[Landmark, Tormod; Kaasa, Stein] Norwegian Univ Sci & Technol, Fac Med, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway; [Landmark, Tormod; Borchgrevink, Petter C.] St Olavs Univ Hosp, Natl Competence Ctr Complex Symptom Disorders, Trondheim, Norway; [Romundstad, Pal R.] Norwegian Univ Sci & Technol, Fac Med, Dept Publ Hlth, N-7034 Trondheim, Norway; [Borchgrevink, Petter C.; Dale, Ola] Norwegian Univ Sci & Technol, Fac Med, Dept Circulat & Med Imaging, N-7034 Trondheim, Norway; [Kaasa, Stein] St Olavs Univ Hosp, Dept Oncol, Trondheim, Norway; [Dale, Ola] St Olavs Univ Hosp, Dept Anaesthesia & Emergency Med, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Landmark, T (corresponding author), Norwegian Univ Sci & Technol, Fac Med, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway.	tormod.landmark@ntnu.no		Romundstad, Pal Richard/0000-0003-2061-4336	Research Council of Norway	Research Council of Norway(Research Council of Norway)	This work has been funded by the Research Council of Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell JA, 2009, J OCCUP REHABIL, V19, P8, DOI 10.1007/s10926-009-9164-5; Bergman S, 2007, BEST PRACT RES CL RH, V21, P191, DOI 10.1016/j.berh.2006.08.012; Borg G., 1998, BORGS PERCEIVED EXER, V8; Busch A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003786.pub2; Chen MJ, 2002, J SPORT SCI, V20, P873, DOI 10.1080/026404102320761787; Choi BKL, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006555.pub2; Dagenais S, 2009, SPINE J, V9, P944, DOI 10.1016/j.spinee.2009.07.007; Dugan SA, 2009, J PHYS ACT HEALTH, V6, P33, DOI 10.1123/jpah.6.1.33; Eriksen J, 2004, EUR J PAIN, V8, P517, DOI 10.1016/j.ejpain.2003.12.001; Gerdle B, 2004, J RHEUMATOL, V31, P1399; Gjesdal S, 2004, EUR J PUBLIC HEALTH, V14, P398, DOI 10.1093/eurpub/14.4.398; Glymour MM, 2005, AM J EPIDEMIOL, V162, P267, DOI 10.1093/aje/kwi187; Hayden JA, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000335.pub2; Heneweer H, 2012, EUR SPINE J, V21, P1265, DOI 10.1007/s00586-011-2097-7; Heneweer H, 2011, EUR SPINE J, V20, P826, DOI 10.1007/s00586-010-1680-7; Heneweer H, 2009, PAIN, V143, P21, DOI 10.1016/j.pain.2008.12.033; Hildebrandt VH, 2000, INT ARCH OCC ENV HEA, V73, P507, DOI 10.1007/s004200000167; Holmen J, 2003, NORSK EPIDEMIOLOGI, V13, P19, DOI DOI 10.1093/eurheartj/eht019; Holth HS, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-159; Hoogendoorn WE, 1999, SCAND J WORK ENV HEA, V25, P387, DOI 10.5271/sjweh.451; Jacob T, 2004, MED SCI SPORT EXER, V36, P9, DOI 10.1249/01.MSS.0000106166.94343.02; Kraemer HC, 2001, AM J PSYCHIAT, V158, P848, DOI 10.1176/appi.ajp.158.6.848; Krueger AB, 2008, LANCET, V371, P1519, DOI 10.1016/S0140-6736(08)60656-X; Kurtze N, 2008, SCAND J PUBLIC HEALT, V36, P52, DOI 10.1177/1403494807085373; Landmark T, 2012, PAIN, V153, P1368, DOI 10.1016/j.pain.2012.02.004; Landmark T, 2011, PAIN, V152, P2241, DOI 10.1016/j.pain.2011.04.029; Manchikanti L, 2009, PAIN PHYSICIAN, V12, pE35; Mantyselka PT, 2003, JAMA-J AM MED ASSOC, V290, P2435, DOI 10.1001/jama.290.18.2435; Martin BI, 2008, JAMA-J AM MED ASSOC, V299, P656, DOI 10.1001/jama.299.6.656; Nes BM, 2012, MED SCI SPORT EXER, V44, P1881, DOI 10.1249/MSS.0b013e318258b443; Ospina M., 2002, 28 ALB HER FDN MED R; Shephard RJ, 2003, BRIT J SPORT MED, V37, P197, DOI 10.1136/bjsm.37.3.197; Sloan JA, 2005, J CLIN EPIDEMIOL, V58, P1217, DOI 10.1016/j.jclinepi.2005.07.009; Sprangers MAG, 2000, J CLIN EPIDEMIOL, V53, P895, DOI 10.1016/S0895-4356(00)00204-3; Stewart WF, 2003, JAMA-J AM MED ASSOC, V290, P2443, DOI 10.1001/jama.290.18.2443; Von Korff M, 2000, SPINE, V25, P3140, DOI 10.1097/00007632-200012150-00009; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Ware JE Jr, 2001, SCORE INTERPRET SING; Watkins EA, 2008, PAIN MED, V9, P166, DOI 10.1111/j.1526-4637.2007.00280.x	39	51	51	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65279	10.1371/journal.pone.0065279	http://dx.doi.org/10.1371/journal.pone.0065279			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776464	gold, Green Published, Green Submitted			2022-12-27	WOS:000320322400014
J	Narazaki, T; Sato, K; Abernathy, KJ; Marshall, GJ; Miyazaki, N				Narazaki, Tomoko; Sato, Katsufumi; Abernathy, Kyler J.; Marshall, Greg J.; Miyazaki, Nobuyuki			Loggerhead Turtles (Caretta caretta) Use Vision to Forage on Gelatinous Prey in Mid-Water	PLOS ONE			English	Article							FLIPPER BEAT FREQUENCY; ANIMAL-BORNE VIDEO; SEA-TURTLES; DERMOCHELYS-CORIACEA; GREEN TURTLES; LEATHERBACK TURTLES; WEDDELL SEALS; DIVE PROFILES; FEEDING-BEHAVIOR; DIVING BEHAVIOR	Identifying characteristics of foraging activity is fundamental to understanding an animals' lifestyle and foraging ecology. Despite its importance, monitoring the foraging activities of marine animals is difficult because direct observation is rarely possible. In this study, we use an animal-borne imaging system and three-dimensional data logger simultaneously to observe the foraging behaviour of large juvenile and adult sized loggerhead turtles (Caretta caretta) in their natural environment. Video recordings showed that the turtles foraged on gelatinous prey while swimming in mid-water (i.e., defined as epipelagic water column deeper than 1 m in this study). By linking video and 3D data, we found that mid-water foraging events share the common feature of a marked deceleration phase associated with the capture and handling of the sluggish prey. Analysis of high-resolution 3D movements during mid-water foraging events, including presumptive events extracted from 3D data using deceleration in swim speed as a proxy for foraging (detection rate = 0.67), showed that turtles swam straight toward prey in 171 events (i.e., turning point absent) but made a single turn toward the prey an average of 5.766.0 m before reaching the prey in 229 events (i.e., turning point present). Foraging events with a turning point tended to occur during the daytime, suggesting that turtles primarily used visual cues to locate prey. In addition, an incident of a turtle encountering a plastic bag while swimming in mid-water was recorded. The fact that the turtle's movements while approaching the plastic bag were analogous to those of a true foraging event, having a turning point and deceleration phase, also support the use of vision in mid-water foraging. Our study shows that integrated video and high-resolution 3D data analysis provides unique opportunities to understand foraging behaviours in the context of the sensory ecology involved in prey location.	[Narazaki, Tomoko; Sato, Katsufumi] Univ Tokyo, Atmosphere & Ocean Res Inst, Int Coastal Res Ctr, Kashiwa, Chiba, Japan; [Abernathy, Kyler J.; Marshall, Greg J.] Natl Geog Remote Imaging, Washington, DC USA; [Miyazaki, Nobuyuki] Ocean Policy Res Fdn, Tokyo, Japan	University of Tokyo; National Geographic Society	Narazaki, T (corresponding author), Univ Tokyo, Atmosphere & Ocean Res Inst, Int Coastal Res Ctr, Kashiwa, Chiba, Japan.	tnarazaki@aori.u-tokyo.ac.jp		Miyazaki, Nobuyuki/0000-0001-8094-683X	program 'Bio-logging Science'; University of Tokyo (UTBLS); National Geographic Remote Imaging; JSPS [A1925501, 21-7432]; Japan Science Society [19-526]	program 'Bio-logging Science'; University of Tokyo (UTBLS); National Geographic Remote Imaging(National Geographic Society); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science Society	This work was supported by the program 'Bio-logging Science', The University of Tokyo (UTBLS), National Geographic Remote Imaging, a JSPS research grant (A1925501 to KS), a JSPS Research Fellowship for Young Scientists to TN (21-7432) and a Sasakawa Scientific Research Grant from The Japan Science Society to TN (19-526). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki K, 2012, MAR ECOL PROG SER, V444, P289, DOI 10.3354/meps09371; Barnard CJ, 1983, ANIMAL BEHAV ECOLOGY; Bartol SM, 2002, J COMP PHYSIOL A, V187, P953, DOI 10.1007/s00359-001-0262-x; Bartol SM, 2003, CRC MAR BIOL SER, P79; Bartol SM, 2003, INT J COMP PSYCHOL, V26, P143; Bjorndal Karen A., 1997, P199; Casale P, 2008, MAR ECOL PROG SER, V372, P265, DOI 10.3354/meps07702; Constantino MA, 2003, ZOOLOGY, V106, P173, DOI 10.1078/0944-2006-00114; Davis RW, 1999, SCIENCE, V283, P993, DOI 10.1126/science.283.5404.993; Dodd CK, 1988, BIOL REP, V88, P1; Doyle TK, 2008, J PLANKTON RES, V30, P963, DOI 10.1093/plankt/fbn052; Doyle TK, 2007, J EXP MAR BIOL ECOL, V343, P239, DOI 10.1016/j.jembe.2006.12.010; Endres CS, 2009, J EXP BIOL, V212, P3823, DOI 10.1242/jeb.033068; Fossette S, 2008, J ANIM ECOL, V77, P236, DOI 10.1111/j.1365-2656.2007.01344.x; Fossette S, 2012, BIOL LETTERS, V8, P351, DOI 10.1098/rsbl.2011.0965; Fossette S, 2010, J MARINE SYST, V81, P225, DOI 10.1016/j.jmarsys.2009.12.002; Haddock SHD, 1999, MAR BIOL, V133, P571, DOI 10.1007/s002270050497; Hanuise N, 2010, J EXP BIOL, V213, P3874, DOI 10.1242/jeb.044057; Hatase H, 2002, MAR ECOL PROG SER, V233, P273, DOI 10.3354/meps233273; Hawkes LA, 2006, CURR BIOL, V16, P990, DOI 10.1016/j.cub.2006.03.063; Hays GC, 2001, J EXP BIOL, V204, P4093; Hays GC, 2004, J EXP MAR BIOL ECOL, V303, P243, DOI 10.1016/j.jembe.2003.11.010; Hays GC, 2004, ECOLOGY, V85, P1137, DOI 10.1890/03-0251; Hays GC, 2007, MAR BIOL, V150, P1003, DOI 10.1007/s00227-006-0412-3; Heaslip SG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033259; Heithaus MR, 2002, J MAR BIOL ASSOC UK, V82, P1049, DOI 10.1017/S0025315402006689; Hochscheid S, 1999, MAR ECOL PROG SER, V185, P101, DOI 10.3354/meps185101; Hooker SK, 2002, MAR MAMMAL SCI, V18, P680, DOI 10.1111/j.1748-7692.2002.tb01066.x; Houghton JDR, 2002, MAR ECOL PROG SER, V227, P63, DOI 10.3354/meps227063; Iwata T, 2012, MAR MAMMAL SCI, V28, P345, DOI 10.1111/j.1748-7692.2011.00482.x; Johnson MP, 2003, IEEE J OCEANIC ENG, V28, P3, DOI 10.1109/JOE.2002.808212; Kamezaki N., 1995, UMIGAME NEWSLETTER J, V26, P12; Kokubun N, 2011, J EXP BIOL, V214, P3760, DOI 10.1242/jeb.058263; Kramer Donald L., 2001, P232; Levenson DH, 2004, COPEIA, P908, DOI 10.1643/CP-03-217R1; Liebsch N, 2007, DEEP-SEA RES PT II, V54, P256, DOI 10.1016/j.dsr2.2006.11.014; Madden KM, 2008, MAR ECOL PROG SER, V365, P263, DOI 10.3354/meps07396; Marshall CD, 2012, J EXP BIOL, V215, P4166, DOI 10.1242/jeb.074385; Mazur MM, 2003, ENVIRON BIOL FISH, V67, P397, DOI 10.1023/A:1025807711512; McClellan CM, 2007, BIOLOGY LETT, V3, P592, DOI 10.1098/rsbl.2007.0355; McClellan CM, 2010, J EXP MAR BIOL ECOL, V387, P44, DOI 10.1016/j.jembe.2010.02.020; Miller PJO, 2004, P ROY SOC B-BIOL SCI, V271, P2239, DOI 10.1098/rspb.2004.2863; Minamikawa S, 2000, J EXP BIOL, V203, P2967; Mitani Y, 2003, POLAR BIOL, V26, P311, DOI 10.1007/s00300-003-0487-y; Musick John A., 1997, P137; Myers AE, 2006, MAR ECOL PROG SER, V322, P259, DOI 10.3354/meps322259; Naito Y, 2010, POLAR SCI, V4, P309, DOI 10.1016/j.polar.2010.05.009; Naito Y, 2013, FUNCT ECOL, V27, P710, DOI 10.1111/1365-2435.12083; Narazaki T, 2009, J EXP BIOL, V212, P4019, DOI 10.1242/jeb.034637; Narazaki T, 2010, RECONSTRUCTION 3 D P; Narazaki T, 2009, THESIS U TOKYO TOKYO; NELSON DONALD R., 1963, SCIENCE, V142, P975, DOI 10.1126/science.142.3594.975; Nevitt GA, 2008, J EXP BIOL, V211, P1706, DOI 10.1242/jeb.015412; Nevitt GA, 2008, P NATL ACAD SCI USA, V105, P4576, DOI 10.1073/pnas.0709047105; OGDEN JC, 1983, J EXP MAR BIOL ECOL, V66, P199, DOI 10.1016/0022-0981(83)90160-0; Okuyama Junichi, 2010, Endangered Species Research, V10, P39, DOI 10.3354/esr00215; PLOTKIN PT, 1993, MAR BIOL, V115, P1, DOI 10.1007/BF00349379; Ponganis PJ, 2000, J EXP BIOL, V203, P3275; Reich KJ, 2010, MAR BIOL, V157, P113, DOI 10.1007/s00227-009-1300-4; Reina RD, 2005, J EXP MAR BIOL ECOL, V316, P1, DOI 10.1016/j.jembe.2004.10.002; Sato K, 2003, MAR MAMMAL SCI, V19, P384, DOI 10.1111/j.1748-7692.2003.tb01116.x; Schofield Gail, 2006, Endangered Species Research, V2, P71, DOI 10.3354/esr002071; Seminoff JA, 2006, MAR ECOL PROG SER, V322, P269, DOI 10.3354/meps322269; Seney EE, 2007, COPEIA, P478, DOI 10.1643/0045-8511(2007)7[478:HDAOLS]2.0.CO;2; Shiomi K, 2008, AQUAT BIOL, V3, P265, DOI 10.3354/ab00087; Simeone A, 2003, MAR BIOL, V143, P825, DOI 10.1007/s00227-003-1114-8; Southwood Amanda, 2008, Endangered Species Research, V5, P225, DOI 10.3354/esr00097; Sperling Jannie Bech, 2008, Marine Turtle Newsletter, P9; Takahashi A., 2004, Marine Ornithology, V32, P47; Takahashi A, 2008, POLAR BIOL, V31, P1291, DOI 10.1007/s00300-008-0502-4; Takuma S, 2010, THESIS U TOKYO TOKYO; Tomas J, 2002, MAR POLLUT BULL, V44, P211, DOI 10.1016/S0025-326X(01)00236-3; Vickers NJ, 2000, BIOL BULL, V198, P203, DOI 10.2307/1542524; Watanabe Y, 2004, MAR ECOL PROG SER, V279, P283, DOI 10.3354/meps279283; Watanabe Y, 2003, MAR ECOL PROG SER, V252, P283, DOI 10.3354/meps252283; Watanabe YY, 2013, P NATL ACAD SCI USA, V110, P2199, DOI 10.1073/pnas.1216244110; Watanabe YY, 2011, J ANIM ECOL, V80, P57, DOI 10.1111/j.1365-2656.2010.01760.x; Watanuki Y, 2008, MAR ECOL PROG SER, V356, P283, DOI 10.3354/meps07266; Wilson RP, 2007, DEEP-SEA RES PT II, V54, P193, DOI 10.1016/j.dsr2.2006.11.017; Wilson RP, 2002, MAR BIOL, V140, P17, DOI 10.1007/s002270100659; WILSON RP, 1993, MAR ECOL PROG SER, V94, P101; Wilson RP, 2002, ANIM BEHAV, V63, P85, DOI 10.1006/anbe.2001.1883	82	50	50	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66043	10.1371/journal.pone.0066043	http://dx.doi.org/10.1371/journal.pone.0066043			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776603	Green Published, gold, Green Submitted			2022-12-27	WOS:000320322400074
J	Cabezas-Cruz, A; Passos, LMF; Lis, K; Kenneil, R; Valdes, JJ; Ferrolho, J; Tonk, M; Pohl, AE; Grubhoffer, L; Zweygarth, E; Shkap, V; Ribeiro, MFB; Estrada-Pena, A; Kocan, KM; de la Fuente, J				Cabezas-Cruz, Alejandro; Passos, Lygia M. F.; Lis, Katarzyna; Kenneil, Rachel; Valdes, James J.; Ferrolho, Joana; Tonk, Miray; Pohl, Anna E.; Grubhoffer, Libor; Zweygarth, Erich; Shkap, Varda; Ribeiro, Mucio F. B.; Estrada-Pena, Agustin; Kocan, Katherine M.; de la Fuente, Jose			Functional and Immunological Relevance of Anaplasma marginale Major Surface Protein 1a Sequence and Structural Analysis	PLOS ONE			English	Article							CD4(+) T-LYMPHOCYTES; B-CELL EPITOPES; NEUTRALIZATION-SENSITIVE EPITOPE; TICK-BORNE TRANSMISSION; BOOPHILUS-MICROPLUS; MAMMALIAN RESERVOIR; CYCLIC TRANSMISSION; GENETIC DIVERSITY; SALIVARY-GLANDS; MOLECULAR-BASIS	Bovine anaplasmosis is caused by cattle infection with the tick-borne bacterium, Anaplasma marginale. The major surface protein 1a (MSP1a) has been used as a genetic marker for identifying A. marginale strains based on N-terminal tandem repeats and a 5'-UTR microsatellite located in the msp1a gene. The MSP1a tandem repeats contain immune relevant elements and functional domains that bind to bovine erythrocytes and tick cells, thus providing information about the evolution of host-pathogen and vector-pathogen interactions. Here we propose one nomenclature for A. marginale strain classification based on MSP1a. All tandem repeats among A. marginale strains were classified and the amino acid variability/frequency in each position was determined. The sequence variation at immunodominant B cell epitopes was determined and the secondary (2D) structure of the tandem repeats was modeled. A total of 224 different strains of A. marginale were classified, showing 11 genotypes based on the 5'-UTR microsatellite and 193 different tandem repeats with high amino acid variability per position. Our results showed phylogenetic correlation between MSP1a sequence, secondary structure, B-cell epitope composition and tick transmissibility of A. marginale strains. The analysis of MSP1a sequences provides relevant information about the biology of A. marginale to design vaccines with a cross-protective capacity based on MSP1a B-cell epitopes.	[Cabezas-Cruz, Alejandro; Valdes, James J.; Tonk, Miray; Grubhoffer, Libor] Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic; [Cabezas-Cruz, Alejandro; Valdes, James J.; Tonk, Miray; Grubhoffer, Libor] Acad Sci Czech Republ, Inst Parasitol, Ctr Biol, CR-37005 Ceske Budejovice, Czech Republic; [Passos, Lygia M. F.; Lis, Katarzyna; Kenneil, Rachel; Pohl, Anna E.; Zweygarth, Erich] Univ Munich, Inst Comparat Trop Med & Parasitol, Munich, Germany; [Passos, Lygia M. F.] Univ Fed Minas Gerais, Escola Vet, Dept Vet Prevent Med, Belo Horizonte, MG, Brazil; [Ferrolho, Joana] Pirbright Inst, Pirbright Lab, Pirbright, Surrey, England; [Shkap, Varda] Kimron Vet Inst, Div Parasitol, IL-50250 Bet Dagan, Israel; [Ribeiro, Mucio F. B.] Univ Fed Minas Gerais, Dept Parasitol, Belo Horizonte, MG, Brazil; [Estrada-Pena, Agustin] Univ Zaragoza, Fac Vet, Zaragoza, Spain; [Kocan, Katherine M.; de la Fuente, Jose] Oklahoma State Univ, Ctr Vet Hlth Sci, Dept Vet Pathobiol, Stillwater, OK 74078 USA; [de la Fuente, Jose] IREC CSIC UCLM JCCM, Inst Invest Recursos Cineget, Ciudad Real, Spain	University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of Munich; Universidade Federal de Minas Gerais; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; Kimron Veterinary Institute; Universidade Federal de Minas Gerais; University of Zaragoza; Oklahoma State University System; Oklahoma State University - Stillwater; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha	de la Fuente, J (corresponding author), Oklahoma State Univ, Ctr Vet Hlth Sci, Dept Vet Pathobiol, Stillwater, OK 74078 USA.	jose_delafuente@yahoo.com	Ferrolho, Joana/J-2307-2014; Tonk-Rügen, Miray/AAZ-3868-2020; Cabezas-Cruz, Alejandro/P-2755-2017; Valdés, James/G-9812-2014; Grubhoffer, Libor/G-9762-2014; de la Fuente, José/AAU-1197-2020	Ferrolho, Joana/0000-0002-1300-4487; Tonk-Rügen, Miray/0000-0001-8249-8452; Cabezas-Cruz, Alejandro/0000-0002-8660-730X; Valdés, James/0000-0002-0237-8061; Grubhoffer, Libor/0000-0003-0885-1849; de la Fuente, José/0000-0001-7383-9649; Estrada Pena, Agustin/0000-0001-7483-046X	POSTICK ITN (Post-graduate training network for capacity building to control ticks and tick-borne diseases) within the FP7-PEOPLE-ITN programme (EU) [238511]; European Social Fund; state budget of the Czech Republic;  [BFU2011-23896];  [CZ.1.07/2.3.00/30.0032]	POSTICK ITN (Post-graduate training network for capacity building to control ticks and tick-borne diseases) within the FP7-PEOPLE-ITN programme (EU); European Social Fund(European Social Fund (ESF)); state budget of the Czech Republic; ; 	This research was supported by POSTICK ITN (Post-graduate training network for capacity building to control ticks and tick-borne diseases) within the FP7-PEOPLE-ITN programme (EU Grant No. 238511) and BFU2011-23896 grant to JF. JJV was sponsored by project CZ.1.07/2.3.00/30.0032, co-financed by the European Social Fund and the state budget of the Czech Republic. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLRED DR, 1990, P NATL ACAD SCI USA, V87, P3220, DOI 10.1073/pnas.87.8.3220; Aubry P, 2011, TRANSBOUND EMERG DIS, V58, P1, DOI 10.1111/j.1865-1682.2010.01173.x; BARBET AF, 1987, INFECT IMMUN, V55, P2428, DOI 10.1128/IAI.55.10.2428-2435.1987; Barbet AF, 2001, INFECT IMMUN, V69, P3057, DOI 10.1128/IAI.69.5.3057-3066.2001; Barbet AF, 1999, INFECT IMMUN, V67, P102, DOI 10.1128/IAI.67.1.102-107.1999; Benz I, 2002, MOL MICROBIOL, V45, P267, DOI 10.1046/j.1365-2958.2002.03030.x; Blouin EF, 2003, VET PARASITOL, V111, P247, DOI 10.1016/S0304-4017(02)00378-3; Bowie MV, 2002, GENE, V282, P95, DOI 10.1016/S0378-1119(01)00845-9; Brown WC, 2002, INFECT IMMUN, V70, P5521, DOI 10.1128/IAI.70.10.5521-5532.2002; Brown WC, 2001, INFECT IMMUN, V69, P6853, DOI 10.1128/IAI.69.11.6853-6862.2001; Brown WC, 2001, J IMMUNOL, V166, P1114, DOI 10.4049/jimmunol.166.2.1114; Buchan DWA, 2010, NUCLEIC ACIDS RES, V38, pW563, DOI 10.1093/nar/gkq427; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chavez ASO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036012; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; de la Fuente J, 2005, J VET MED B, V52, P226, DOI 10.1111/j.1439-0450.2005.00851.x; de la Fuente J, 2004, VET PARASITOL, V121, P307, DOI 10.1016/j.vetpar.2004.02.021; de la Fuente J, 2003, VET MICROBIOL, V91, P265, DOI 10.1016/S0378-1135(02)00309-7; de la Fuente J, 2001, INT J PARASITOL, V31, P1705, DOI 10.1016/S0020-7519(01)00287-9; de la Fuente J, 2001, INT J PARASITOL, V31, P145, DOI 10.1016/S0020-7519(00)00162-4; de la Fuente J, 2007, VET MICROBIOL, V119, P382; de la Fuente J, 2003, INT J APPL RES VET M, V1; de la Fuente Jose, 2005, Anim Health Res Rev, V6, P75; de la Fuente Jose, 2001, Animal Health Research Reviews, V2, P163; de la Fuente J, 2010, VET PARASITOL, V167, P175, DOI 10.1016/j.vetpar.2009.09.019; Doytchinova IA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-4; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; El-Manzalawy Y, 2008, J MOL RECOGNIT, V21, P243, DOI 10.1002/jmr.893; Elias I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-89; Estrada-Pena A, 2012, J MED ENTOMOL, V49, P794, DOI 10.1603/ME11223; Estrada-Pena A, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-57; FELSENSTEIN J, 1989, SCIENCE, V246, P941, DOI 10.1126/science.246.4932.941; Futse JE, 2003, J CLIN MICROBIOL, V41, P3829, DOI 10.1128/JCM.41.8.3829-3834.2003; Garcia-Garcia JC, 2004, VET IMMUNOL IMMUNOP, V98, P137, DOI 10.1016/j.vetimm.2003.11.003; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kindt T. J., 2007, KUBY IMMUNOLOGY, p[xxii, 574, A, G, AN, 1]; Kocan KA, 2003, VET PARASITOL, V112, P295, DOI 10.1016/S0304-4017(03)00018-9; Kocan KM, 2010, VET PARASITOL, V167, P95, DOI 10.1016/j.vetpar.2009.09.012; Kocan KM, 2004, PARASITOLOGY, V129, pS285, DOI 10.1017/S0031182003004700; Kocan KM, 2003, CLIN MICROBIOL REV, V16, P698, DOI 10.1128/CMR.16.4.698-712.2003; Kurowski MA, 2003, NUCLEIC ACIDS RES, V31, P3305, DOI 10.1093/nar/gkg557; Leverich CK, 2008, INFECT IMMUN, V76, P4066, DOI 10.1128/IAI.00594-08; Lew AE, 2002, VET MICROBIOL, V86, P325, DOI 10.1016/S0378-1135(02)00017-2; Maritz-Olivier C, 2012, TICKS TICK-BORNE DIS, V3, P179, DOI 10.1016/j.ttbdis.2012.01.003; Mayrose I, 2007, BIOINFORMATICS, V23, P3244, DOI 10.1093/bioinformatics/btm493; Mayrose I, 2007, NUCLEIC ACIDS RES, V35, P69, DOI 10.1093/nar/gkl975; MCGAREY DJ, 1994, INFECT IMMUN, V62, P4594, DOI 10.1128/IAI.62.10.4594-4601.1994; OBERLE SM, 1988, INFECT IMMUN, V56, P1567, DOI 10.1128/IAI.56.6.1567-1573.1988; PALMER GH, 1987, INT J PARASITOL, V17, P1279, DOI 10.1016/0020-7519(87)90093-2; Palmer GH, 1999, PARASITOL TODAY, V15, P281, DOI 10.1016/S0169-4758(99)01469-6; Palmer GH, 2001, J CLIN MICROBIOL, V39, P631, DOI 10.1128/JCM.39.2.631-635.2001; PALMER GH, 1988, INFECT IMMUN, V56, P1526, DOI 10.1128/IAI.56.6.1526-1531.1988; PALMER GH, 1986, SCIENCE, V231, P1299, DOI 10.1126/science.3945825; PALMER GH, 1989, INFECT IMMUN, V57, P3666, DOI 10.1128/IAI.57.11.3666-3669.1989; Rodriguez SD, 2000, COMP IMMUNOL MICROB, V23, P239, DOI 10.1016/S0147-9571(99)00076-4; Ruiz PMG, 2005, VET PARASITOL, V128, P325, DOI 10.1016/j.vetpar.2004.11.017; Saha S, 2006, PROTEINS, V65, P40, DOI 10.1002/prot.21078; Santos PS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033045; Shkap V, 2009, VET MICROBIOL, V134, P254, DOI 10.1016/j.vetmic.2008.08.004; SMITH RD, 1986, AM J VET RES, V47, P127; Suarez CE, 2011, VET PARASITOL, V180, P109, DOI 10.1016/j.vetpar.2011.05.032; Thomas R, 2002, J BIOL CHEM, V277, P2059, DOI 10.1074/jbc.M104364200; Ueti MW, 2007, INFECT IMMUN, V75, P2959, DOI 10.1128/IAI.00284-07; Valdez RA, 2002, CLIN DIAGN LAB IMMUN, V9, P417, DOI 10.1128/CDLI.9.2.417-424.2002; WICKWIRE KB, 1987, AM J VET RES, V48, P96; Zivkovic Zorica, 2007, BMC Vet Res, V3, P32, DOI 10.1186/1746-6148-3-32	67	42	44	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65243	10.1371/journal.pone.0065243	http://dx.doi.org/10.1371/journal.pone.0065243			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776456	Green Published, Green Submitted, gold			2022-12-27	WOS:000320755400018
J	Lichtash, CT; Cui, JR; Guo, XQ; Chen, YDI; Hsueh, WA; Rotter, JI; Goodarzi, MO				Lichtash, Charlene T.; Cui, Jinrui; Guo, Xiuqing; Chen, Yii-Der I.; Hsueh, Willa A.; Rotter, Jerome I.; Goodarzi, Mark O.			Body Adiposity Index versus Body Mass Index and Other Anthropometric Traits as Correlates of Cardiometabolic Risk Factors	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; INTIMA-MEDIA THICKNESS; LIPOPROTEIN-LIPASE; FAT; GENE; ASSOCIATION; OBESITY; SCAN; SEX; AGE	Objective: The worldwide prevalence of obesity mandates a widely accessible tool to categorize adiposity that can best predict associated health risks. The body adiposity index (BAI) was designed as a single equation to predict body adiposity in pooled analysis of both genders. We compared body adiposity index (BAI), body mass index (BMI), and other anthropometric measures, including percent body fat (PBF), in their correlations with cardiometabolic risk factors. We also compared BAI with BMI to determine which index is a better predictor of PBF. Methods: The cohort consisted of 698 Mexican Americans. We calculated correlations of BAI, BMI, and other anthropometric measurements (PBF measured by dual energy X-ray absorptiometry, waist and hip circumference, height, weight) with glucose homeostasis indices (including insulin sensitivity and insulin clearance from euglycemic clamp), lipid parameters, cardiovascular traits (including carotid intima-media thickness), and biomarkers (C-reactive protein, plasminogen activator inhibitor-1 and adiponectin). Correlations between each anthropometric measure and cardiometabolic trait were compared in both sex-pooled and sex-stratified groups. Results: BMI was associated with all but two measured traits (carotid intima-media thickness and fasting glucose in men), while BAI lacked association with several variables. BAI did not outperform BMI in its associations with any cardiometabolic trait. BAI was correlated more strongly than BMI with PBF in sex-pooled analyses (r = 0.78 versus r = 0.51), but not in sex-stratified analyses (men, r = 0.63 versus r = 0.79; women, r = 0.69 versus r = 0.77). Additionally, PBF showed fewer correlations with cardiometabolic risk factors than BMI. Weight was more strongly correlated than hip with many of the cardiometabolic risk factors examined. Conclusions: BAI is inferior to the widely used BMI as a correlate of the cardiometabolic risk factors studied. Additionally, BMI's relationship with total adiposity may not be the sole determinate of its association with cardiometabolic risk.	[Lichtash, Charlene T.; Rotter, Jerome I.; Goodarzi, Mark O.] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA; [Cui, Jinrui; Guo, Xiuqing; Chen, Yii-Der I.; Rotter, Jerome I.; Goodarzi, Mark O.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Hsueh, Willa A.] Methodist Hosp, Res Inst, Div Diabet Obes & Lipids, Diabet Res Ctr, Houston, TX 77030 USA; [Goodarzi, Mark O.] Cedars Sinai Med Ctr, Div Endocrinol Diabet & Metab, Los Angeles, CA 90048 USA; [Goodarzi, Mark O.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; The Methodist Hospital System; The Methodist Hospital - Houston; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Goodarzi, MO (corresponding author), Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA.	mark.goodarzi@cshs.org	Goodarzi, Mark/AAH-7106-2021; Rotter, Jerome/AAY-6598-2021	Goodarzi, Mark/0000-0001-6364-5103; Lichtash, Charlene/0000-0003-3166-1373	National Institutes of Health [R01-HL088457, R01-DK079888, P30-DK063491, M01-RR00425]; General Clinical Research Center Grant from the National Center for Research Resources [UL1TR000124]; University of California Los Angeles Clinical & Translational Research Workshop; Cedars-Sinai Winnick Clinical Scholars Award; Cedars-Sinai Board of Governor's Chair in Medical Genetics; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000425] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491, R01DK079888] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); General Clinical Research Center Grant from the National Center for Research Resources; University of California Los Angeles Clinical & Translational Research Workshop; Cedars-Sinai Winnick Clinical Scholars Award; Cedars-Sinai Board of Governor's Chair in Medical Genetics; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported in part by National Institutes of Health grants R01-HL088457, R01-DK079888, P30-DK063491, M01-RR00425 (General Clinical Research Center Grant from the National Center for Research Resources), and UL1TR000124 (University of California Los Angeles Clinical & Translational Research Workshop), and the Cedars-Sinai Winnick Clinical Scholars Award (to M.O.G) and the Cedars-Sinai Board of Governor's Chair in Medical Genetics (J.I.R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A Geliebter, 2012, OBESITY SILVER SPRIN, DOI [10.1038/oby.2012.187, DOI 10.1038/0BY.2012.187]; A Melmer, 2012, OBESITY SILVER SPRIN, DOI [10.1038/oby.2012.160, DOI 10.1038/0BY.2012.160]; Barreira TV, 2012, MAYO CLIN PROC, V87, P452, DOI 10.1016/j.mayocp.2011.12.017; Barreira TV, 2011, JAMA-J AM MED ASSOC, V306, P828, DOI 10.1001/jama.2011.1189; Bergman RN, 2011, OBESITY, V19, P1083, DOI 10.1038/oby.2011.38; de Lima JG, 2012, OBESITY, V20, P1140, DOI 10.1038/oby.2012.3; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; Eknoyan G, 2008, NEPHROL DIAL TRANSPL, V23, P47, DOI 10.1093/ndt/gfm517; Elisha B, 2013, EUR J NUTR, V52, P145, DOI 10.1007/s00394-011-0296-y; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Freedman DZ, 2012, SUPERGRAVITY, P1, DOI 10.1017/CBO9781139026833; Gallagher D, 1996, AM J EPIDEMIOL, V143, P228, DOI 10.1093/oxfordjournals.aje.a008733; Godoy-Matos AF, 2012, OBESITY, V20, P440, DOI 10.1038/oby.2011.343; Goodarzi MO, 2005, DIABETES, V54, P1222, DOI 10.2337/diabetes.54.4.1222; Goodarzi MO, 2005, DIABETES, V54, P1228, DOI 10.2337/diabetes.54.4.1228; Goodarzi MO, 2004, DIABETES, V53, P214, DOI 10.2337/diabetes.53.1.214; Goodarzi MO, 2003, GENET MED, V5, P322, DOI 10.1097/01.GIM.0000076971.55421.AD; Jackson AS, 2002, INT J OBESITY, V26, P789, DOI 10.1038/sj.ijo.0802006; Johnson W, 2012, OBESITY, V20, P900, DOI 10.1038/oby.2011.346; Li XH, 2006, OBESITY, V14, P1192, DOI 10.1038/oby.2006.136; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Pi-Sunyer FX, 1998, AM J CLIN NUTR, V68, P899; Schulze MB, 2012, DIABETOLOGIA, V55, P1660, DOI 10.1007/s00125-012-2499-z; Schulze MB, 2011, OBESITY, V19, P1729, DOI 10.1038/oby.2011.153; Selzer RH, 2001, ATHEROSCLEROSIS, V154, P185, DOI 10.1016/S0021-9150(00)00461-5; Snijder MB, 2012, OBESITY, V20, P1138, DOI 10.1038/oby.2011.338; Stepien M, 2014, ANGIOLOGY, V65, P22, DOI 10.1177/0003319712468291; Wang D, 2005, STROKE, V36, P540, DOI 10.1161/01.STR.0000155746.65185.4e; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	29	49	51	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65954	10.1371/journal.pone.0065954	http://dx.doi.org/10.1371/journal.pone.0065954			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776578	Green Published, gold, Green Submitted			2022-12-27	WOS:000320755400089
J	Ruan, PY; Hayashida, M; Maruyama, O; Akutsu, T				Ruan, Peiying; Hayashida, Morihiro; Maruyama, Osamu; Akutsu, Tatsuya			Prediction of Heterodimeric Protein Complexes from Weighted Protein-Protein Interaction Networks Using Novel Features and Kernel Functions	PLOS ONE			English	Article							IDENTIFICATION; DATABASE	Since many proteins express their functional activity by interacting with other proteins and forming protein complexes, it is very useful to identify sets of proteins that form complexes. For that purpose, many prediction methods for protein complexes from protein-protein interactions have been developed such as MCL, MCODE, RNSC, PCP, RRW, and NWE. These methods have dealt with only complexes with size of more than three because the methods often are based on some density of subgraphs. However, heterodimeric protein complexes that consist of two distinct proteins occupy a large part according to several comprehensive databases of known complexes. In this paper, we propose several feature space mappings from protein-protein interaction data, in which each interaction is weighted based on reliability. Furthermore, we make use of prior knowledge on protein domains to develop feature space mappings, domain composition kernel and its combination kernel with our proposed features. We perform ten-fold cross-validation computational experiments. These results suggest that our proposed kernel considerably outperforms the naive Bayes-based method, which is the best existing method for predicting heterodimeric protein complexes.	[Ruan, Peiying; Hayashida, Morihiro; Akutsu, Tatsuya] Kyoto Univ, Inst Chem Res, Bioinformat Ctr, Uji, Kyoto, Japan; [Maruyama, Osamu] Kyushu Univ, Inst Math Ind, Nishi Ku, Fukuoka 812, Japan	Kyoto University; Kyushu University	Hayashida, M (corresponding author), Kyoto Univ, Inst Chem Res, Bioinformat Ctr, Uji, Kyoto, Japan.	morihiro@kuicr.kyoto-u.ac.jp; takutsu@kuicr.kyoto-u.ac.jp		Akutsu, Tatsuya/0000-0001-9763-797X	MEXT, Japan [22240009, 24500361]	MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was partially supported by Grants-in-Aid #22240009 and #24500361 from MEXT, Japan (http://www.mext.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Alfarano C, 2005, NUCLEIC ACIDS RES, V33, pD418, DOI 10.1093/nar/gki051; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Ben-Hur A, 2005, BIOINFORMATICS, V21, pI38, DOI 10.1093/bioinformatics/bti1016; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chua Hon Nian, 2008, Journal of Bioinformatics and Computational Biology, V6, P435, DOI 10.1142/S0219720008003497; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Harris MA, 2008, NUCLEIC ACIDS RES, V36, pD440, DOI 10.1093/nar/gkm883; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Kiemer L, 2007, PROTEOMICS, V7, P932, DOI 10.1002/pmic.200600448; King AD, 2004, BIOINFORMATICS, V20, P3013, DOI 10.1093/bioinformatics/bth351; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Macropol K, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-283; Maruyama O., 2011, ACM C BIOINF COMP BI, P499; Maruyama O, 2010, IEEE INT C BIOINFORM, P590, DOI 10.1109/BIBM.2010.5706634; Mewes HW, 2004, NUCLEIC ACIDS RES, V32, pD41, DOI 10.1093/nar/gkh092; Osuna E., 1997, 1602 AI MIT; Ozawa Y, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-350; Pu SY, 2009, NUCLEIC ACIDS RES, V37, P825, DOI 10.1093/nar/gkn1005; Qi Y, 2008, BIOINFORMATICS, V24, pI250, DOI 10.1093/bioinformatics/btn164; Sapkota A, 2011, MOL BIOSYST, V7, P2615, DOI 10.1039/c1mb05120b; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Vapnik V., 1998, STAT LEARNING THEORY, V3, DOI DOI 10.1007/978-1-4419-1428-6_5864; Zanzoni A, 2002, FEBS LETT, V513, P135, DOI 10.1016/S0014-5793(01)03293-8; Zhao XM, 2009, J PROTEOME RES, V8, P4714, DOI 10.1021/pr900415b	27	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65265	10.1371/journal.pone.0065265	http://dx.doi.org/10.1371/journal.pone.0065265			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776458	Green Published, gold			2022-12-27	WOS:000320755400020
J	Tang, Z; Xie, YT; Yang, F; Huang, Y; Wang, CD; Dai, KR; Zheng, XB; Zhang, XL				Tang, Ze; Xie, Youtao; Yang, Fei; Huang, Yan; Wang, Chuandong; Dai, Kerong; Zheng, Xuebin; Zhang, Xiaoling			Porous Tantalum Coatings Prepared by Vacuum Plasma Spraying Enhance BMSCs Osteogenic Differentiation and Bone Regeneration In Vitro and In Vivo	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; GEOMETRIC CONTROL; IMPLANTS; SHAPE; BIOMATERIAL; PERFORMANCE; ADHESION; MATRIX; GROWTH; METAL	Tantalum, as a potential metallic implant biomaterial, is attracting more and more attention because of its excellent anticorrosion and biocompatibility. However, its significantly high elastic modulus and large mechanical incompatibility with bone tissue make it unsuitable for load-bearing implants. In this study, porous tantalum coatings were first successfully fabricated on titanium substrates by vacuum plasma spraying (VPS), which would exert the excellent biocompatibility of tantalum and alleviate the elastic modulus of tantalum for bone tissue. We evaluated cytocompatibility and osteogenesis activity of the porous tantalum coatings using human bone marrow stromal cells (hBMSCs) and its ability to repair rabbit femur bone defects. The morphology and actin cytoskeletons of hBMSCs were observed via electron microscopy and confocal, and the cell viability, proliferation and osteogenic differentiation potential of hBMSCs were examined quantitatively by PrestoBlue assay, Ki67 immunofluorescence assay, real-time PCR technology and ALP staining. For in vivo detection, the repaired femur were evaluated by histomorphology and double fluorescence labeling 3 months postoperation. Porous tantalum coating surfaces promoted hBMSCs adhesion, proliferation, osteogenesis activity and had better osseointegration and faster new bone formation rate than titanium coating control. Our observation suggested that the porous tantalum coatings had good biocompatibility and could enhance osseoinductivity in vitro and promote new bone formation in vivo. The porous tantalum coatings prepared by VPS is a promising strategy for bone regeneration.	[Tang, Ze; Huang, Yan; Wang, Chuandong; Dai, Kerong; Zhang, Xiaoling] Chinese Acad Sci, SIBS, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai, Peoples R China; [Tang, Ze; Huang, Yan; Wang, Chuandong; Dai, Kerong; Zhang, Xiaoling] SJTUSM, Shanghai, Peoples R China; [Tang, Ze; Yang, Fei; Dai, Kerong; Zhang, Xiaoling] SJTUSM, Shanghai Key Lab Orthopaed Implant, Dept Orthopaed Surg, Shanghai Peoples Hosp 9, Shanghai, Peoples R China; [Xie, Youtao; Zheng, Xuebin] Chinese Acad Sci, Shanghai Inst Ceram, Shanghai 200050, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institute of Ceramics, CAS	Xie, YT (corresponding author), Chinese Acad Sci, Shanghai Inst Ceram, Shanghai 200050, Peoples R China.	xieyoutao@mail.sic.ac.cn; xlzhang@sibs.ac.cn		Zhang, Xiaoling/0000-0002-0134-1347	Ministry of Science and Technology of China [2011DFA30790, 2010CB945600]; National Natural Science Foundation of China [81190133, 31101056]; Chinese Academy of Sciences [XDA01030404, KSCX2-EW-Q-1-07]; Science and Technology Commission of Shanghai Municipality [11QH1401600]; Shanghai Municipal Education Commission [J50206, 10SG22]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC))	This work was supported by grants from: The Ministry of Science and Technology of China (No.2011DFA30790, 2010CB945600), www.most.gov.cn; National Natural Science Foundation of China (No.81190133, 31101056), http://www.nsfc.gov.cn; Chinese Academy of Sciences (No.XDA01030404, KSCX2-EW-Q-1-07), http://www.cas.cn/; Science and Technology Commission of Shanghai Municipality (No.11QH1401600), www.stcsm.gov.cn; and Shanghai Municipal Education Commission (No.J50206, 10SG22), www.shmec.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama S K, 1996, Hum Cell, V9, P181; Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2; Balla VK, 2010, ACTA BIOMATER, V6, P3349, DOI 10.1016/j.actbio.2010.01.046; BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7; Black Jonathan, 1994, Clinical Materials, V16, P167, DOI 10.1016/0267-6605(94)90113-9; Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283; Brock A, 2003, LANGMUIR, V19, P1611, DOI 10.1021/la026394k; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Cirri P, 2012, CANCER METAST REV, V31, P195, DOI 10.1007/s10555-011-9340-x; de Groot K, 1998, P I MECH ENG H, V212, P137, DOI 10.1243/0954411981533917; Dike LE, 1999, IN VITRO CELL DEV-AN, V35, P441; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0; Gronowicz G, 1996, J ORTHOPAED RES, V14, P878, DOI 10.1002/jor.1100140606; Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016; Holt GE, 2009, J ARTHROPLASTY, V24, P1079, DOI 10.1016/j.arth.2008.08.010; Huang Y, 2009, BIOMATERIALS, V30, P5041, DOI 10.1016/j.biomaterials.2009.05.077; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Ingber DE, 2003, J CELL SCI, V116, P1397, DOI 10.1242/jcs.00360; Kaiser JP, 2004, J MATER SCI-MATER M, V15, P429, DOI 10.1023/B:JMSM.0000021115.55254.a8; Kato H, 2000, J BIOMED MATER RES, V53, P28, DOI 10.1002/(SICI)1097-4636(2000)53:1<28::AID-JBM4>3.0.CO;2-F; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Levine BR, 2006, BIOMATERIALS, V27, P4671, DOI 10.1016/j.biomaterials.2006.04.041; Long WJ, 2009, J ARTHROPLASTY, V24, P1086, DOI 10.1016/j.arth.2008.08.011; Lyons A Bruce, 2004, Curr Protoc Cytom, VChapter 9, DOI 10.1002/0471142956.cy0911s27; Matsuno H, 2001, BIOMATERIALS, V22, P1253, DOI 10.1016/S0142-9612(00)00275-1; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Miyazaki T, 2002, BIOMATERIALS, V23, P827, DOI 10.1016/S0142-9612(01)00188-0; Nadeau Melissa, 2007, Mcgill J Med, V10, P4; Ni SY, 2007, J BIOMED MATER RES B, V80B, P174, DOI 10.1002/jbm.b.30582; Rojewski MT, 2008, TRANSFUS MED HEMOTH, V35, P168, DOI 10.1159/000129013; Schwartz Z, 1999, Adv Dent Res, V13, P38; Shuler MS, 2007, J ARTHROPLASTY, V22, P26, DOI 10.1016/j.arth.2006.03.007; Sidhu KS, SPINE J, V1, P331; SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320; Smith PJ, 2000, CYTOMETRY, V40, P280, DOI 10.1002/1097-0320(20000801)40:4<280::AID-CYTO4>3.0.CO;2-7; Urbani S, 2006, CYTOTHERAPY, V8, P243, DOI 10.1080/14653240600735834; Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1; Zardiackas LD, 2001, J BIOMED MATER RES, V58, P180, DOI 10.1002/1097-4636(2001)58:2<180::AID-JBM1005>3.0.CO;2-5	40	63	70	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66263	10.1371/journal.pone.0066263	http://dx.doi.org/10.1371/journal.pone.0066263			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776648	Green Published, Green Submitted, gold			2022-12-27	WOS:000320755400130
J	Monti, MR; Morero, NR; Miguel, V; Argarana, CE				Monti, Mariela R.; Morero, Natalia R.; Miguel, Virginia; Argarana, Carlos E.			nfxB as a Novel Target for Analysis of Mutation Spectra in Pseudomonas aeruginosa	PLOS ONE			English	Article							CYSTIC-FIBROSIS PATIENTS; STATIONARY-PHASE MUTAGENESIS; ESCHERICHIA-COLI K-12; SECONDARY STRUCTURE; BASE-SUBSTITUTION; GO SYSTEM; FLUCTUATION ANALYSIS; GENETIC ADAPTATION; RESISTANCE; BACTERIA	nfxB encodes a negative regulator of the mexCD-oprJ genes for drug efflux in the opportunistic pathogen Pseudomonas aeruginosa. Inactivating mutations in this transcriptional regulator constitute one of the main mechanisms of resistance to ciprofloxacin (Cip(r)). In this work, we evaluated the use of nfxB/Cip(r) as a new test system to study mutation spectra in P. aeruginosa. The analysis of 240 mutations in nfxB occurring spontaneously in the wild-type and mutator backgrounds or induced by mutagens showed that nfxB/Cip(r) offers several advantages compared with other mutation detection systems. Identification of nfxB mutations was easy since the entire open reading frame and its promoter region were sequenced from the chromosome using a single primer. Mutations detected in nfxB included all transitions and transversions, 1-bp deletions and insertions, >1-bp deletions and duplications. The broad mutation spectrum observed in nfxB relies on the selection of loss-of-function changes, as we confirmed by generating a structural model of the NfxB repressor and evaluating the significance of each detected mutation. The mutation spectra characterized in the mutS, mutT, mutY and mutM mutator backgrounds or induced by the mutagenic agents 2-aminopurine, cisplatin and hydrogen peroxide were in agreement with their predicted mutational specificities. Additionally, this system allowed the analysis of sequence context effects since point mutations occurred at 85 different sites distributed over the entire nfxB. Significant hotspots and preferred sequence contexts were observed for spontaneous and mutagen-induced mutation spectra. Finally, we demonstrated the utility of a luminescence-based reporter for identification of nfxB mutants previous to sequencing analysis. Thus, the nfxB/Cip(r) system in combination with the luminescent reporter may be a valuable tool for studying mutational processes in Pseudomonas spp. wherein the genes encoding the NfxB repressor and the associated efflux pump are conserved.	[Monti, Mariela R.; Morero, Natalia R.; Miguel, Virginia; Argarana, Carlos E.] Univ Nacl Cordoba, Fac Ciencias Quim, Dept Quim Biol, CONICET,Ctr Invest Quim Biol Cordoba CIQUIBIC, RA-5000 Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Argarana, CE (corresponding author), Univ Nacl Cordoba, Fac Ciencias Quim, Dept Quim Biol, CONICET,Ctr Invest Quim Biol Cordoba CIQUIBIC, Ciudad Univ, RA-5000 Cordoba, Argentina.	carga@fcq.unc.edu.ar		MORERO, Natalia Rosalia/0000-0003-0092-5663	Secretaria de Ciencia y Tecnica-UNC [05/C447]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 20090100420]; Agencia Nacional de Promocion Cientifica y Tecnica [PICT 2011-1797]	Secretaria de Ciencia y Tecnica-UNC; Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnica(ANPCyT)	This work was supported by grants from Secretaria de Ciencia y Tecnica-UNC (05/C447; www.secyt.unc.edu.ar), Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP 20090100420; www.conicet.gov.ar), and Agencia Nacional de Promocion Cientifica y Tecnica (PICT 2011-1797, www.agencia.gov.ar). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bellinzoni M, 2009, J BACTERIOL, V191, P7531, DOI 10.1128/JB.00631-09; Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715; Blazquez J, 2012, CURR OPIN MICROBIOL, V15, P561, DOI 10.1016/j.mib.2012.07.007; BROUWER J, 1981, P NATL ACAD SCI-BIOL, V78, P7010, DOI 10.1073/pnas.78.11.7010; BURNOUF D, 1987, P NATL ACAD SCI USA, V84, P3758, DOI 10.1073/pnas.84.11.3758; Choi KH, 2006, NAT PROTOC, V1, P153, DOI 10.1038/nprot.2006.24; Chuanchuen R, 2001, ANTIMICROB AGENTS CH, V45, P428, DOI 10.1128/AAC.45.2.428-432.2001; Ciofu O, 2005, ANTIMICROB AGENTS CH, V49, P2276, DOI 10.1128/AAC.49.6.2276-2282.2005; Ciofu O, 2010, MICROBIOL-SGM, V156, P1108, DOI 10.1099/mic.0.033993-0; Coggan KA, 2012, CURR ISSUES MOL BIOL, V14, P47; Conibear TCR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006289; COULONDRE C, 1978, NATURE, V274, P775, DOI 10.1038/274775a0; Cuff JA, 1998, BIOINFORMATICS, V14, P892, DOI 10.1093/bioinformatics/14.10.892; Driscoll JA, 2007, DRUGS, V67, P351, DOI 10.2165/00003495-200767030-00003; Esquisabel ABC, 2011, CLIN MICROBIOL INFEC, V17, P1817, DOI 10.1111/j.1469-0691.2011.03530.x; FOSTER PL, 1995, P NATL ACAD SCI USA, V92, P5487, DOI 10.1073/pnas.92.12.5487; Garibyan L, 2003, DNA REPAIR, V2, P593, DOI 10.1016/S1568-7864(03)00024-7; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jackson AL, 2000, MUTAT RES-FUND MOL M, V447, P187, DOI 10.1016/S0027-5107(99)00206-7; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Jalal S, 2000, ANTIMICROB AGENTS CH, V44, P710, DOI 10.1128/AAC.44.3.710-712.2000; Jalal S, 1998, MICROB DRUG RESIST, V4, P257, DOI 10.1089/mdr.1998.4.257; Jatsenko T, 2010, MUTAT RES-FUND MOL M, V683, P106, DOI 10.1016/j.mrfmmm.2009.10.015; Joosten RP, 2011, NUCLEIC ACIDS RES, V39, pD411, DOI 10.1093/nar/gkq1105; Juurik T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048511; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kasak L, 1997, P NATL ACAD SCI USA, V94, P3134, DOI 10.1073/pnas.94.7.3134; Kiser TH, 2010, PHARMACOTHERAPY, V30, P632, DOI 10.1592/phco.30.7.632; Kivisaar M, 2010, FEMS MICROBIOL LETT, V312, P1, DOI 10.1111/j.1574-6968.2010.02027.x; Lobley A, 2009, BIOINFORMATICS, V25, P1761, DOI 10.1093/bioinformatics/btp302; Luria SE, 1943, GENETICS, V28, P491; Maki H, 2002, ANNU REV GENET, V36, P279, DOI 10.1146/annurev.genet.36.042602.094806; MAKI H, 1992, NATURE, V355, P273, DOI 10.1038/355273a0; MICHAELS ML, 1992, J BACTERIOL, V174, P6321, DOI 10.1128/JB.174.20.6321-6325.1992; Miller JH, 1996, ANNU REV MICROBIOL, V50, P625, DOI 10.1146/annurev.micro.50.1.625; Morero NR, 2011, ANTIMICROB AGENTS CH, V55, P3668, DOI 10.1128/AAC.01826-10; Morgan C, 2006, MUTAT RES-GEN TOX EN, V603, P15, DOI 10.1016/j.mrgentox.2005.09.010; OKAZAKI T, 1991, FEMS MICROBIOL LETT, V79, P31, DOI 10.1016/0378-1097(91)90522-C; OKAZAKI T, 1992, FEMS MICROBIOL LETT, V97, P197; Oliver A, 2002, FEMS MICROBIOL LETT, V217, P31, DOI 10.1111/j.1574-6968.2002.tb11452.x; Oliver A, 2002, MOL MICROBIOL, V43, P1641, DOI 10.1046/j.1365-2958.2002.02855.x; Oliver A, 2010, INT J MED MICROBIOL, V300, P563, DOI 10.1016/j.ijmm.2010.08.009; ONEIL KT, 1990, SCIENCE, V250, P646, DOI 10.1126/science.2237415; ONO T, 1995, MUTAT RES-FUND MOL M, V326, P175, DOI 10.1016/0027-5107(94)00167-4; Peix A, 2009, INFECT GENET EVOL, V9, P1132, DOI 10.1016/j.meegid.2009.08.001; Pitsikas P, 2004, MUTAT RES-FUND MOL M, V550, P25, DOI 10.1016/j.mrfmmm.2004.01.008; Poole K, 1996, MOL MICROBIOL, V21, P713, DOI 10.1046/j.1365-2958.1996.281397.x; Rodriguez C, 2002, J BACTERIOL, V184, P5599, DOI 10.1128/JB.184.20.5599-5608.2002; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sanders LH, 2009, FEMS MICROBIOL LETT, V294, P89, DOI 10.1111/j.1574-6968.2009.01550.x; SARKAR S, 1992, GENETICA, V85, P173, DOI 10.1007/BF00120324; SCHAAPER RM, 1987, P NATL ACAD SCI USA, V84, P6220, DOI 10.1073/pnas.84.17.6220; SHIBA T, 1995, J BACTERIOL, V177, P5872, DOI 10.1128/jb.177.20.5872-5877.1995; Silby MW, 2011, FEMS MICROBIOL REV, V35, P652, DOI 10.1111/j.1574-6976.2011.00269.x; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Tegova R, 2004, J BACTERIOL, V186, P2735, DOI 10.1128/JB.186.9.2735-2744.2004; Wong A, 2011, MICROBIOL-SGM, V157, P937, DOI 10.1099/mic.0.046870-0; YAREMA KJ, 1995, NUCLEIC ACIDS RES, V23, P4066, DOI 10.1093/nar/23.20.4066; Zheng Q, 2002, MATH BIOSCI, V176, P237, DOI 10.1016/S0025-5564(02)00087-1	62	16	17	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e66236	10.1371/journal.pone.0066236	http://dx.doi.org/10.1371/journal.pone.0066236			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762483	Green Published, gold			2022-12-27	WOS:000321094800094
J	Spangenberg, T; Burrows, JN; Kowalczyk, P; McDonald, S; Wells, TNC; Willis, P				Spangenberg, Thomas; Burrows, Jeremy N.; Kowalczyk, Paul; McDonald, Simon; Wells, Timothy N. C.; Willis, Paul			The Open Access Malaria Box: A Drug Discovery Catalyst for Neglected Diseases	PLOS ONE			English	Article								Historically, one of the key problems in neglected disease drug discovery has been identifying new and interesting chemotypes. Phenotypic screening of the malaria parasite, Plasmodium falciparum has yielded almost 30,000 submicromolar hits in recent years. To make this collection more accessible, a collection of 400 chemotypes has been assembled, termed the Malaria Box. Half of these compounds were selected based on their drug-like properties and the others as molecular probes. These can now be requested as a pharmacological test set by malaria biologists, but importantly by groups working on related parasites, as part of a program to make both data and compounds readily available. In this paper, the analysis and selection methodology and characteristics of the compounds are described.	[Spangenberg, Thomas; Burrows, Jeremy N.; McDonald, Simon; Wells, Timothy N. C.; Willis, Paul] MMV, Geneva, Switzerland; [Kowalczyk, Paul] SCYNEXIS Inc, Res Triangle Pk, NC USA		Spangenberg, T (corresponding author), MMV, Geneva, Switzerland.	spangenbergt@mmv.org; willisp@mmv.org		Wells, Timothy/0000-0001-9796-847X				Aguero F, 2008, GENOMIC SCALE PRIORI; [Anonymous], 2012, WORLD MAL REP 2012; Anthony MP, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-316; Anzali S, 2001, J MED CHEM, V44, P2432, DOI 10.1021/jm0010670; Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; Bemis GW, 1996, DRUGS, V2623, P2887; Bender A, 2011, REVIEW, V2, DOI [10.1039/c0md00165a, DOI 10.1039/C0MD00165A]; Burrows JN, 2011, CURR TOP MED CHEM, V11, P1226; Burrows JN, 2012, MED CHEM ERADICATION, P112; Crowther GJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000804; Delves M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001169; Derbyshire ER, 2011, PARASITE, P7, DOI [10.1371/journal. ppat.1002178, DOI 10.1371/J0URNAL.PPAT.1002178]; Duffy S, 2012, AM J TROP MED HYG, V86, P84, DOI 10.4269/ajtmh.2012.11-0302; Flower DR, 1999, J MOL GRAPH MODEL, V16, p[239, 264]; Gamo FJ, 2010, NATURE, V465, P305, DOI 10.1038/nature09107; Garcia-Bustos JF, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002156; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Griffen E, 2011, J MED CHEM, V54, P7739, DOI 10.1021/jm200452d; Guiguemde WA, 2012, CHEM BIOL, V19, P116, DOI 10.1016/j.chembiol.2012.01.004; Guiguemde WA, 2010, NATURE, V465, P311, DOI 10.1038/nature09099; Hack MD, 2011, J CHEM INF MODEL, V51, P3275, DOI 10.1021/ci200446y; Hann M, 1999, J CHEM INF COMP SCI, V39, P897, DOI 10.1021/ci990423o; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Maude RJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-31; Meister S, 2011, IMAGING PLASMODIUM L; Mok S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-391; Nicola G, 2012, J MED CHEM; Nwaka S, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001412; Oprea TI, 2000, J COMPUT AID MOL DES, V14, P251, DOI 10.1023/A:1008130001697; Schneider N, 2008, J CHEM INF MODEL, V48, P613, DOI 10.1021/ci700351y; Walters WP, 2003, NAT REV DRUG DISCOV, V2, P259, DOI 10.1038/nrd1063; Wells TN, 2010, DISCOV MED, V9, P389; Wells TNC, 2010, TRENDS PARASITOL, V26, P145, DOI 10.1016/j.pt.2009.12.005; Welsch ME, 2010, CURR OPIN CHEM BIOL, V14, P347, DOI 10.1016/j.cbpa.2010.02.018	34	249	249	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e62906	10.1371/journal.pone.0062906	http://dx.doi.org/10.1371/journal.pone.0062906			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23798988	Green Published, gold, Green Submitted			2022-12-27	WOS:000321397800001
J	Bertram, R; Helle, L; Kaakinen, JK; Svedstrom, E				Bertram, Raymond; Helle, Laura; Kaakinen, Johanna K.; Svedstrom, Erkki			The Effect of Expertise on Eye Movement Behaviour in Medical Image Perception	PLOS ONE			English	Article							VISUAL-SEARCH; EXPERIENCE; RADIOLOGISTS; PERFORMANCE; ATTENTION; EDUCATION; PATTERNS	The present eye-movement study assessed the effect of expertise on eye-movement behaviour during image perception in the medical domain. To this end, radiologists, computed-tomography radiographers and psychology students were exposed to nine volumes of multi-slice, stack-view, axial computed-tomography images from the upper to the lower part of the abdomen with or without abnormality. The images were presented in succession at low, medium or high speed, while the participants had to detect enlarged lymph nodes or other visually more salient abnormalities. The radiologists outperformed both other groups in the detection of enlarged lymph nodes and their eye-movement behaviour also differed from the other groups. Their general strategy was to use saccades of shorter amplitude than the two other participant groups. In the presence of enlarged lymph nodes, they increased the number of fixations on the relevant areas and reverted to even shorter saccades. In volumes containing enlarged lymph nodes, radiologists' fixation durations were longer in comparison to their fixation durations in volumes without enlarged lymph nodes. More salient abnormalities were detected equally well by radiologists and radiographers, with both groups outperforming psychology students. However, to accomplish this, radiologists actually needed fewer fixations on the relevant areas than the radiographers. On the basis of these results, we argue that expert behaviour is manifested in distinct eye-movement patterns of proactivity, reactivity and suppression, depending on the nature of the task and the presence of abnormalities at any given moment.	[Bertram, Raymond; Helle, Laura] Univ Turku, Ctr Learning Res, Turku, Finland; [Bertram, Raymond; Helle, Laura] Univ Turku, Dept Teacher Educ, Turku, Finland; [Kaakinen, Johanna K.] Univ Turku, Dept Psychol, Turku, Finland; [Svedstrom, Erkki] Univ Turku, Dept Diagnost Radiol, Turku, Finland	University of Turku; University of Turku; University of Turku; University of Turku	Bertram, R (corresponding author), Univ Turku, Ctr Learning Res, Turku, Finland.	rayber@utu.fi	Bertram, Raymond/ABH-2715-2021	Bertram, Raymond/0000-0002-2709-3644; Helle, Laura/0000-0002-0808-9965	Academy of Finland; LearnMedImage [128766]; MedEd [138219]	Academy of Finland(Academy of Finland); LearnMedImage; MedEd	This study was funded by the Academy of Finland (www.aka.fi), project 128766 (LearnMedImage) and project 138219 (MedEd). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Baayen R. H., 2008, ANAL LINGUISTIC DATA; Balslev T, 2012, EUR J PAEDIATR NEURO, V16, P161, DOI 10.1016/j.ejpn.2011.07.004; BOSHUIZEN HPA, 1992, COGNITIVE SCI, V16, P153, DOI 10.1207/s15516709cog1602_1; CARMODY DP, 1980, PERCEPTION, V9, P339, DOI 10.1068/p090339; Crundall DE, 1998, ERGONOMICS, V41, P448, DOI 10.1080/001401398186937; Donovan T, 2013, APPL COGNITIVE PSYCH, V27, P43, DOI 10.1002/acp.2869; Drew T, 2013, RADIOGRAPHICS, V33, P263, DOI 10.1148/rg.331125023; ERICSSON KA, 1995, PSYCHOL REV, V102, P211, DOI 10.1037/0033-295X.102.2.211; Gegenfurtner A, 2011, EDUC PSYCHOL REV, V23, P523, DOI 10.1007/s10648-011-9174-7; Ghirardelli ML, 1999, HAEMATOLOGICA, V84, P242; Godwin HJ, 2010, VIS COGN, V18, P1439, DOI 10.1080/13506285.2010.500605; Haikio T, 2011, APPL PSYCHOLINGUIST, V32, P533, DOI 10.1017/S0142716411000208; Haikio T, 2009, J EXP CHILD PSYCHOL, V102, P167, DOI 10.1016/j.jecp.2008.04.002; Helle L, 2012, INSTR SCI, V40, P737, DOI 10.1007/s11251-012-9216-7; Helle L, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-S1-S8; Jarodzka H, 2010, LEARN INSTR, V20, P146, DOI 10.1016/j.learninstruc.2009.02.019; Kocak E, 2005, J LAPAROENDOSC ADV S, V15, P575, DOI 10.1089/lap.2005.15.575; Krupinski EA, 1996, ACAD RADIOL, V3, P137, DOI 10.1016/S1076-6332(05)80381-2; Krupinski EA, 2005, ACAD RADIOL, V12, P965, DOI 10.1016/j.acra.2005.03.071; Krupinski EA, 2006, HUM PATHOL, V37, P1543, DOI 10.1016/j.humpath.2006.08.024; Kundel HL, 2007, RADIOLOGY, V242, P396, DOI 10.1148/radiol.2422051997; KUNDEL HL, 1975, RADIOLOGY, V116, P527, DOI 10.1148/116.3.527; Law B., 2004, P EYE TRACKING RES A, P41, DOI [10.1145/968363.968370, DOI 10.1145/968363.968370]; Litchfield D, 2010, J EXP PSYCHOL-APPL, V16, P251, DOI 10.1037/a0020082; Mann DTY, 2007, J SPORT EXERCISE PSY, V29, P457, DOI 10.1123/jsep.29.4.457; Manning D, 2006, RADIOGRAPHY, V12, P134, DOI 10.1016/j.radi.2005.02.003; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/h0043158; MIURA T, 1990, EYE MIND INFORMATION, P119; MUGGLESTONE MD, 1995, P SOC PHOTO-OPT INS, V2436, P106, DOI 10.1117/12.206840; Nodine CF, 1987, EYE MOVEMENTS PHYSL, P573, DOI DOI 10.1016/B978-0-444-70113-8.50081-3; Pinheiro J, 2001, MIXED EFFECTS MODELS; Posner Michael I., 1988, NATURE EXPERTISE, pxxix; R Development Core Team, 2007, R LANG ENV STAT COMP; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; Rayner K, 2009, Q J EXP PSYCHOL, V62, P1457, DOI 10.1080/17470210902816461; Reingold E. M., 2011, OXFORD HDB EYE MOVEM, P767, DOI 10.1093/oxfordhb/9780199539789.013.0029; Reingold EM, 2001, PSYCHOL SCI, V12, P48, DOI 10.1111/1467-9280.00309; SWENSSON RG, 1980, PERCEPT PSYCHOPHYS, V27, P11, DOI 10.3758/BF03199899; Underwood G, 2003, ERGONOMICS, V46, P629, DOI 10.1080/0014013031000090116; Wilson M, 2010, SURG ENDOSC, V24, P2458, DOI 10.1007/s00464-010-0986-1; Wolfe JM, 2011, TRENDS COGN SCI, V15, P77, DOI 10.1016/j.tics.2010.12.001	42	60	61	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66169	10.1371/journal.pone.0066169	http://dx.doi.org/10.1371/journal.pone.0066169			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	172XB	23785481	Green Submitted, gold, Green Published			2022-12-27	WOS:000321038800041
J	DelGiudice, GD; Fieberg, JR; Sampson, BA				DelGiudice, Glenn D.; Fieberg, John R.; Sampson, Barry A.			A Long-Term Assessment of the Variability in Winter Use of Dense Conifer Cover by Female White-Tailed Deer	PLOS ONE			English	Article							CAUSE-SPECIFIC MORTALITY; CHEMICAL IMMOBILIZATION; HOME RANGES; HABITAT USE; SURVIVAL; PREDATION; TEMPERATURE; VEGETATION; MOVEMENTS; MODELS	Backgound: Long-term studies allow capture of a wide breadth of environmental variability and a broader context within which to maximize our understanding of relationships to specific aspects of wildlife behavior. The goal of our study was to improve our understanding of the biological value of dense conifer cover to deer on winter range relative to snow depth and ambient temperature. Methodology/Principal Findings: We examined variation among deer in their use of dense conifer cover during a 12-year study period as potentially influenced by winter severity and cover availability. Female deer were fitted with a mixture of very high frequency (VHF, n = 267) and Global Positioning System (GPS, n = 24) collars for monitoring use of specific cover types at the population and individual levels, respectively. We developed habitat composites for four study sites. We fit multinomial response models to VHF (daytime) data to describe population-level use patterns as a function of snow depth, ambient temperature, and cover availability. To develop alternative hypotheses regarding expected spatio-temporal patterns in the use of dense conifer cover, we considered two sets of competing sub-hypotheses. The first set addressed whether or not dense conifer cover was limiting on the four study sites. The second set considered four alternative sub-hypotheses regarding the potential influence of snow depth and ambient temperature on space use patterns. Deer use of dense conifer cover increased the most with increasing snow depth and most abruptly on the two sites where it was most available, suggestive of an energy conservation strategy. Deer use of dense cover decreased the most with decreasing temperatures on the sites where it was most available. At all four sites deer made greater daytime use (55 to >80% probability of use) of open vegetation types at the lowest daily minimum temperatures indicating the importance of thermal benefits afforded from increased exposure to solar radiation. Date-time plots of GPS data (24 hr) allowed us to explore individual diurnal and seasonal patterns of habitat use relative to changes in snow depth. There was significant among-animal variability in their propensity to be found in three density classes of conifer cover and other open types, but little difference between diurnal and nocturnal patterns of habitat use. Conclusions/Significance: Consistent with our findings reported elsewhere that snow depth has a greater impact on deer survival than ambient temperature, herein our population-level results highlight the importance of dense conifer cover as snow shelter rather than thermal cover. Collectively, our findings suggest that maximizing availability of dense conifer cover in an energetically beneficial arrangement with quality feeding sites should be a prominent component of habitat management for deer.	[DelGiudice, Glenn D.] Minnesota Dept Nat Resources, Forest Wildlife Populat & Res Grp, Forest Lake, MN USA; [DelGiudice, Glenn D.; Fieberg, John R.] Univ Minnesota, Dept Fisheries Wildlife & Conservat Biol, St Paul, MN 55108 USA; [Fieberg, John R.] Minnesota Dept Nat Resources, Biometr Unit, Forest Lake, MN USA; [Sampson, Barry A.] Minnesota Dept Nat Resources, Forest Wildlife Populat & Res Grp, Grand Rapids, MN USA	University of Minnesota System; University of Minnesota Twin Cities	DelGiudice, GD (corresponding author), Minnesota Dept Nat Resources, Forest Wildlife Populat & Res Grp, Forest Lake, MN USA.	glenn.delgiudice@state.mn.us	Fieberg, John/Y-3988-2019	Fieberg, John/0000-0002-3180-7021	Minnesota Department of Natural Resources; Minnesota Deer Hunters Association	Minnesota Department of Natural Resources; Minnesota Deer Hunters Association	Ninety-nine percent of the funding was from within the Minnesota Department of Natural Resources. The Minnesota Deer Hunters Association provided supplemental funding over the duration of the study, but it was limited to no more than 1 percent of the total. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AN CAR US COMM, 1998, J MAMMAL, V79, P1416; Ballard WB, 1999, J WILDLIFE MANAGE, V63, P574, DOI 10.2307/3802645; Beyer D. B., 2010, 3520 MICH DEP NAT RE; Bunnell FL, 1986, IWIFR28 BRIT COL MIN; Carstensen M, 2009, J WILDLIFE MANAGE, V73, P175, DOI 10.2193/2006-107; Clark RG, 2008, J R STAT SOC C-APPL, V57, P535, DOI 10.1111/j.1467-9876.2008.00629.x; CLOVER MELVIN R., 1956, CALIFORNIA FISH AND GAME, V42, P199; Cook JG, 1998, WILDL MONOGR, V141; DELGIUDICE G D, 1989, Transactions of the North American Wildlife and Natural Resources Conference, P134; DelGiudice G. D., 2010, SUMMARIES WILDLIFE R, P55; DelGiudice GD, 2005, WILDLIFE SOC B, V33, P677, DOI 10.2193/0091-7648(2005)33[677:UMOSCC]2.0.CO;2; DelGiudice GD, 1998, J MAMMAL, V79, P227, DOI 10.2307/1382858; DelGiudice GD, 2002, J WILDLIFE MANAGE, V66, P698, DOI 10.2307/3803136; DelGiudice GD, 2001, WILDLIFE SOC B, V29, P1147; DelGiudice GD, 1996, T N AM WILDL NAT RES, P416; DelGiudice GD, 2012, J WILDL MAN IN PRESS; DelGiudice GD, 2001, WILDL MONOGR, V147; Delgiudice GD, 2006, J WILDLIFE MANAGE, V70, P1556, DOI 10.2193/0022-541X(2006)70[1556:ALASAO]2.0.CO;2; Doenier PB, 1997, WILDLIFE SOC B, V25, P235; Doepker RV, 1991, WORKSH P NO WHIT CED, P13; DROLET C A, 1976, Canadian Field-Naturalist, V90, P123; Erb J., 2004, DISTRIBUTION ABUNDAN; Felix AB, 2007, J WILDLIFE MANAGE, V71, P804, DOI 10.2193/2006-366; Fieberg J, 2009, J APPL ECOL, V46, P1018, DOI 10.1111/j.1365-2664.2009.01692.x; Fieberg J, 2008, J MAMMAL, V89, P1529, DOI 10.1644/07-MAMM-A-277.1; Fieberg JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012114; Fuller Mark R., 2005, P377; Garshelis DL, 2012, STATUS MINNESOTA BLA; HAMERSTROM F. N., 1939, JOUR MAMMAL, V20, P206, DOI 10.2307/1374379; HETT J, 1978, ENVIRON MANAGE, V2, P561, DOI 10.1007/BF01866714; HOLTER JB, 1975, CAN J ZOOL, V53, P679, DOI 10.1139/z75-082; Hurst JE, 2008, J WILDLIFE MANAGE, V72, P367, DOI 10.2193/2006-421; Kelsall J, 1971, CANADIAN WILDLIFE SE, V15; Kneib T, 2011, ENVIRON ECOL STAT, V18, P1, DOI 10.1007/s10651-009-0115-2; Kochanny CO, 2009, J WILDLIFE MANAGE, V73, P779, DOI 10.2193/2008-394; Kochanny CO, 2009, THESIS U MINNESOTA S; Kreeger T. J., 2012, HDB WILDLIFE CHEM IM, V4th; KUNKEL KE, 1994, CAN J ZOOL, V72, P1557, DOI 10.1139/z94-207; Lenarz MS, 2010, J WILDLIFE MANAGE, V74, P1013, DOI 10.2193/2009-493; MAUTZ W W, 1978, Wildlife Society Bulletin, V6, P88; MCCONNELL BR, 1970, J RANGE MANAGE, V23, P208, DOI 10.2307/3896390; Mech L.D., 1971, ECOLOGICAL STUDIES T, P51; Moen A.N., 1971, P S SNOW IC REL WILD, P147; Moen A. N., 1973, WILDLIFE ECOLOGY ANA; MOEN AN, 1976, ECOLOGY, V57, P192, DOI 10.2307/1936411; MOEN AN, 1968, J WILDLIFE MANAGE, V32, P338, DOI 10.2307/3798979; MOEN AN, 1968, ECOLOGY, V49, P676, DOI 10.2307/1935531; Morrison SF, 2003, FOREST ECOL MANAG, V172, P173, DOI 10.1016/S0378-1127(01)00809-X; National Oceanic and Atmospheric Administration, 1990, CLIM DAT MINN, V95-111; NELSON ME, 1986, J WILDLIFE MANAGE, V50, P691, DOI 10.2307/3800983; NELSON ME, 1986, J WILDLIFE MANAGE, V50, P471, DOI 10.2307/3801108; OZOGA JJ, 1972, J WILDLIFE MANAGE, V36, P892, DOI 10.2307/3799445; OZOGA JJ, 1968, J WILDLIFE MANAGE, V32, P574, DOI 10.2307/3798938; PARKER KL, 1984, CAN J ZOOL, V62, P1409, DOI 10.1139/z84-202; Potvin F, 2004, CAN J ZOOL, V82, P671, DOI [10.1139/z04-028, 10.1139/Z04-028]; R Core Team, 2021, R LANGUAGE ENV STAT; ROBINSON WILLIAM L., 1960, JOUR WILDLIFE MANAGEMENT, V24, P364, DOI 10.2307/3796513; RONGSTAD OJ, 1969, J WILDLIFE MANAGE, V33, P366, DOI 10.2307/3799837; SEVERINGHAUS CW, 1981, NEW YORK FISH GAME J, V28, P61; Severinghaus CW, 1947, T N AM WILDL C, V12, P212; Taylor W, 1956, DEER N AM; TIERSON WC, 1985, J WILDLIFE MANAGE, V49, P760, DOI 10.2307/3801708; TINKLE DW, 1979, BIOSCIENCE, V29, P717, DOI 10.1093/bioscience/29.12.717; US Army, 1956, SNOW HYDR; Verme L. J., 1971, P SNOW IC REL WILDL, P16; VERME LOUIS J., 1965, J FOREST, V63, P523; Webb WN, 1948, T N AM WILDL C, V13, P442; Weber SJ, 1984, WILDLIFE SOC B, V14, P331; WETZEL JF, 1975, J WILDLIFE MANAGE, V39, P59, DOI 10.2307/3800466; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734	70	10	10	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65368	10.1371/journal.pone.0065368	http://dx.doi.org/10.1371/journal.pone.0065368			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785421	Green Submitted, Green Published, gold			2022-12-27	WOS:000321038800099
J	Kwon, JH; Lee, N; Park, JY; Yu, YS; Kim, JP; Shin, JH; Kim, DS; Joh, JW; Kim, DS; Choi, KY; Kang, KJ; Kim, G; Moon, YH; Wang, HJ				Kwon, Jung-Hee; Lee, Namgyu; Park, Jin Young; Yu, Yun Suk; Kim, Jin Pyo; Shin, Ji Hye; Kim, Dong-Sik; Joh, Jae Won; Kim, Dae Shick; Choi, Kwan Yong; Kang, Koo-Jeong; Kim, Gundo; Moon, Young Ho; Wang, Hee Jung			Actionable Gene Expression-Based Patient Stratification for Molecular Targeted Therapy in Hepatocellular Carcinoma	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; SORAFENIB; BIOMARKERS; RESISTANCE; MUTATIONS; PROGNOSIS; RAPAMYCIN; SURVIVAL; CANCER; MODEL	Background: The effectiveness of molecular targeted agents is modest in hepatocellular carcinoma (HCC). Efficacy of molecular targeted therapies has been better in cancer patients with high expression of actionable molecules defined as cognate target molecules. However, patient stratification based on the actionable molecules dictating the effectiveness of targeted drugs has remained understudied in HCC. Experimental Design & Results: Paired tumor and non-tumoral tissues derived from a total of 130 HCC patients were studied. Real-time RT-PCR was used to analyze the mRNA expression of actionable molecules in the tissues. mRNA levels of EGFR, VEGFR2, PDGFR beta, FGFR1, and mTOR were up-regulated in tumors compared to non-tumors in 35.4, 42.3, 61.5, 24.6, and 50.0% of patients, respectively. Up-regulation of EGFR was observed at early stage and tended to gradually decrease toward late stages (BCLC stage A: 41.9%; B: 30.8%; C: 17.6%). Frequency of VEGFR2 expression in tumors at stage C was lower than that in the other stages (BCLC stage A: 45.9%; B: 41.0%; C: 29.4%). PDGFR beta and mTOR were observed to be up-regulated in more than 50% of tumors in all the stages whereas FGFR1 was up-regulated in only about 20% of HCC irrespective of stages. A cluster analysis of actionable gene expression revealed that HCC can be categorized into different subtypes that predict the effectiveness of molecular targeted agents and combination therapies in clinical trials. Analysis of in vitro sensitivity to sorafenib demonstrated that HCC cells with up-regulation of PDGFR beta and c-Raf mRNA are more susceptible to sorafenib treatment in a dose and time-dependent manner than cells with low expression of the genes. Conclusions: mRNA expression analysis of actionable molecules could provide the rationale for new companion diagnostics-based therapeutic strategies in the treatment of HCC.	[Kwon, Jung-Hee; Park, Jin Young; Yu, Yun Suk; Kim, Jin Pyo; Moon, Young Ho] Cbs Biosci Inc, Taejon, South Korea; [Lee, Namgyu; Shin, Ji Hye; Choi, Kwan Yong] Pohang Univ Sci & Technol, Dept Life Sci, Pohang, South Korea; [Kim, Dong-Sik] Korea Univ, Div HBP Surg & Liver Transplantat, Dept Surg, Seoul, South Korea; [Joh, Jae Won] Sungkyunkwan Univ, Dept Surg, Samsung Med Ctr, Sch Med, Seoul, South Korea; [Kim, Dae Shick] Sungkyunkwan Univ, Dept Pathol, Samsung Med Ctr, Sch Med, Seoul, South Korea; [Kang, Koo-Jeong] Keimyung Univ, Sch Med, Dept Surg, Taegu, South Korea; [Kim, Gundo] Pukyong Natl Univ, Dept Microbiol, Pusan, South Korea; [Wang, Hee Jung] Ajou Univ, Dept Surg, Sch Med, Suwon 441749, South Korea	Pohang University of Science & Technology (POSTECH); Korea University; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Keimyung University; Pukyong National University; Ajou University	Moon, YH (corresponding author), Cbs Biosci Inc, Taejon, South Korea.	yhmoon62@cbsbio.com; wanghj@ajou.ac.kr	Kang, Koo Jeong/Z-4448-2019	Joh, Jae-Won/0000-0003-1732-6210; Kim, Dong-Sik/0000-0002-0608-1580; Lee, Namgyu/0000-0002-2980-2758	CbsBioscience intramural research funds [CBS-11-13]; National R & D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea; Next-Generation BioGreen 21 Program [PJ009503]; Rural Development Administration	CbsBioscience intramural research funds; National R & D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Next-Generation BioGreen 21 Program(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration(Rural Development Administration (RDA), Republic of Korea)	This work was supported by the CbsBioscience intramural research funds CBS-11-13, and a grant from the National R & D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea. NL, JHS, and KYC were supported by a grant from the Next-Generation BioGreen 21 Program (No. PJ009503), Rural Development Administration. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Blivet-Van Eggelpoel MJ, 2012, J HEPATOL, V57, P108, DOI 10.1016/j.jhep.2012.02.019; Buckley AF, 2008, AM J CLIN PATHOL, V129, P245, DOI 10.1309/WF10QAAED3PP93BH; Chen L, 2011, INT J BIOL MARKER, V26, P108, DOI 10.5301/JBM.2011.8322; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E; Ezzoukhry Z, 2012, INT J CANCER, V131, P2961, DOI 10.1002/ijc.27604; Forner A, 2010, SEMIN LIVER DIS, V30, P61, DOI 10.1055/s-0030-1247133; Gedaly R, 2010, ANTICANCER RES, V30, P4951; Huynh H, 2010, BIOCHEM PHARMACOL, V80, P550, DOI 10.1016/j.bcp.2010.03.034; Huynh H, 2009, J CELL MOL MED, V13, P2673, DOI 10.1111/j.1582-4934.2009.00692.x; Jia JB, 2009, J CANCER RES CLIN, V135, P847, DOI 10.1007/s00432-008-0521-0; Kim SM, 2012, HEPATOLOGY, V55, P1443, DOI 10.1002/hep.24813; Kwon JH, 2010, CLIN CANCER RES, V16, P5511, DOI 10.1158/1078-0432.CCR-10-0825; Lee JS, 2004, HEPATOLOGY, V40, P667, DOI 10.1002/hep.20375; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Llovet JM, 2012, CLIN CANCER RES, V18, P2290, DOI 10.1158/1078-0432.CCR-11-2175; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Morelli MP, 2009, MOL CANCER THER, V8, P2546, DOI 10.1158/1535-7163.MCT-09-0380; Nault JC, 2011, SEMIN LIVER DIS, V31, P173, DOI 10.1055/s-0031-1276646; Newell P, 2009, J HEPATOL, V51, P725, DOI 10.1016/j.jhep.2009.03.028; O'Brien SG, 2003, NEW ENGL J MED, V348, P994, DOI 10.1056/NEJMoa022457; Patel SH, 2011, ANN SURG ONCOL, V18, P3384, DOI 10.1245/s10434-011-1775-3; Poste G, 2012, CLIN CANCER RES, V18, P1515, DOI 10.1158/1078-0432.CCR-11-2206; Sieghart W, 2012, J HEPATOL, V57, P592, DOI 10.1016/j.jhep.2012.04.034; Smith NR, 2010, CLIN CANCER RES, V16, P3548, DOI 10.1158/1078-0432.CCR-09-2797; Su MC, 2005, CANCER LETT, V224, P117, DOI 10.1016/j.canlet.2004.10.010; Tannapfel A, 2003, GUT, V52, P706, DOI 10.1136/gut.52.5.706; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vidwans SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018257; Villanueva A, 2012, CLIN CANCER RES, V18, P1824, DOI 10.1158/1078-0432.CCR-12-0151; Villanueva A, 2011, GASTROENTEROLOGY, V140, P1410, DOI 10.1053/j.gastro.2011.03.006; Villanueva A, 2010, ANNU REV MED, V61, P317, DOI 10.1146/annurev.med.080608.100623; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.20.3.719; Wang Z, 2008, CLIN CANCER RES, V14, P5124, DOI 10.1158/1078-0432.CCR-07-4774; West L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031906; Williams PM, 2012, CLIN CANCER RES, V18, P1531, DOI 10.1158/1078-0432.CCR-11-2203; Yang JD, 2010, NAT REV GASTRO HEPAT, V7, P448, DOI 10.1038/nrgastro.2010.100; Zhou LD, 2010, MED ONCOL, V27, P255, DOI 10.1007/s12032-009-9201-4; Zhu AX, 2012, SEMIN ONCOL, V39, P493, DOI 10.1053/j.seminoncol.2012.05.014; Ziegler A, 2012, HUM GENET, V131, P1627, DOI 10.1007/s00439-012-1188-9	40	13	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e64260	10.1371/journal.pone.0064260	http://dx.doi.org/10.1371/journal.pone.0064260			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785399	Green Published, gold, Green Submitted			2022-12-27	WOS:000321038800118
J	Woodruff, RSY; Winston, CA; Miramontes, R				Woodruff, Rachel S. Yelk; Winston, Carla A.; Miramontes, Roque			Predicting US Tuberculosis Case Counts through 2020	PLOS ONE			English	Article							UNITED-STATES; IMMIGRATION; EPIDEMIOLOGY; RIFAPENTINE; IMPACT	In 2010, foreign-born persons accounted for 60% of all tuberculosis (TB) cases in the United States. Understanding which national groups make up the highest proportion of TB cases will assist TB control programs in concentrating limited resources where they can provide the greatest impact on preventing transmission of TB disease. The objective of our study was to predict through 2020 the numbers of U.S. TB cases among U.S.-born, foreign-born and foreign-born persons from selected countries of birth. TB case counts reported through the National Tuberculosis Surveillance System from 2000-2010 were log-transformed, and linear regression was performed to calculate predicted annual case counts and 95% prediction intervals for 2011-2020. Data were analyzed in 2011 before 2011 case counts were known. Decreases were predicted between 2010 observed and 2020 predicted counts for total TB cases (11,182 to 8,117 [95% prediction interval 7,262-9,073]) as well as TB cases among foreign-born persons from Mexico (1,541 to 1,420 [1,066-1,892]), the Philippines (740 to 724 [569-922]), India (578 to 553 [455-672]), Vietnam (532 to 429 [367-502]) and China (364 to 328 [249-433]). TB cases among persons who are U.S.-born and foreign-born were predicted to decline 47% (4,393 to 2,338 [2,113-2,586]) and 6% (6,720 to 6,343 [5,382-7,476]), respectively. Assuming rates of declines observed from 2000-2010 continue until 2020, a widening gap between the numbers of U.S.-born and foreign-born TB cases was predicted. TB case count predictions will help TB control programs identify needs for cultural competency, such as languages and interpreters needed for translating materials or engaging in appropriate community outreach.	[Woodruff, Rachel S. Yelk; Winston, Carla A.; Miramontes, Roque] Ctr Dis Control & Prevent, Atlanta, GA USA	Centers for Disease Control & Prevention - USA	Woodruff, RSY (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA USA.	ryelkwoodruff@cdc.gov		Miramontes, Roque/0000-0001-9535-460X				Abu-Raddad LJ, 2009, P NATL ACAD SCI USA, V106, P13980, DOI 10.1073/pnas.0901720106; Binkin NJ, 1999, INT J TUBERC LUNG D, V3, P663; Cain KP, 2008, JAMA-J AM MED ASSOC, V300, P405, DOI 10.1001/jama.300.4.405; CDC, 2009, CDC IMM REQ TECHN IN; CDC, 2011, REP TUB US 2011; *CDCP, 2002, CDCS RESP END NEGL E; Centers for Disease Control and Prevention, 1997, TUB MYC TUB 1996 CAS; Centers for Disease Control and Prevention (CDC), 2012, MMWR Morb Mortal Wkly Rep, V61, P1029; Centers for Disease Control and Prevention (CDC), 2009, CDC TUB SURV DAT TRA; Centers for Disease Control and Prevention (CDC), 2013, CDCHAN00345; Debanne SM, 2000, EMERG INFECT DIS, V6, P148, DOI 10.3201/eid0602.000207; Dye C, 1998, LANCET, V352, P1886, DOI 10.1016/S0140-6736(98)03199-7; Dye C, 2008, J R SOC INTERFACE, V5, P653, DOI 10.1098/rsif.2007.1138; Fitchett JR, 2011, REV PANAM SALUD PUBL, V29, P57, DOI 10.1590/S1020-49892011000100009; Getahun H, 2010, CLIN INFECT DIS, V50, pS201, DOI 10.1086/651492; Hill AN, 2012, EPIDEMIOL INFECT, V140, P1862, DOI 10.1017/S095026881100286X; Jereb John A., 2011, Morbidity and Mortality Weekly Report, V60, P1650; Jia ZW, 2008, THEOR POPUL BIOL, V73, P437, DOI 10.1016/j.tpb.2007.12.007; Joseph HA, 2008, J IMMIGR MINOR HEALT, V10, P177, DOI 10.1007/s10903-007-9067-5; Liu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032158; Lowenthal P, 2011, INT J TUBERC LUNG D, V15, P761, DOI 10.5588/ijtld.10.0370; Martinson NA, 2011, NEW ENGL J MED, V365, P11, DOI 10.1056/NEJMoa1005136; Miramontes R, 2013, MMWR-MORBID MORTAL W, V62, P201; Passel Jeffrey S., 2009, PORTRAIT UNAUTHORIZE; Passel JS, 2008, US POPULATION PROJEC; Pew Research Center, 2011, MEX AM BOOM BIRTHS O; Pratt R., 2006, Morbidity and Mortality Weekly Report, V55, P305; Schneider E, 2004, REV PANAM SALUD PUBL, V16, P23, DOI 10.1590/S1020-49892004000700004; Sterling TR, 2011, NEW ENGL J MED, V365, P2155, DOI 10.1056/NEJMoa1104875; U.S. Census Bureau, 2011, CURR POP SURV DEF; Winston CA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-846; Wolleswinkel-van den Bosch JH, 2002, INT J TUBERC LUNG D, V6, P130; World Health Organization, 2011, WHO REP 2011 GLOB TU; Zhou YC, 2008, J THEOR BIOL, V254, P215, DOI 10.1016/j.jtbi.2008.05.026	34	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65276	10.1371/journal.pone.0065276	http://dx.doi.org/10.1371/journal.pone.0065276			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785416	gold, Green Submitted, Green Published			2022-12-27	WOS:000321038800104
J	Koizumi, H; Kurabayashi, N; Watanabe, Y; Sanada, K				Koizumi, Hiroko; Kurabayashi, Nobuhiro; Watanabe, Yuto; Sanada, Kamon			Increased Anxiety in Offspring Reared by Circadian Clock Mutant Mice	PLOS ONE			English	Article							MATERNAL-BEHAVIOR; REPRODUCTIVE-PERFORMANCE; WORK SCHEDULES; STRESS; DISORDER; DEPRESSION; GENE; POLYMORPHISM; SEROTONIN; BRAIN	The maternal care that offspring receive from their mothers early in life influences the offspring's development of emotional behavior in adulthood. Here we found that offspring reared by circadian clock-impaired mice show elevated anxiety-related behavior. Clock mutant mice harboring a mutation in Clock, a key component of the molecular circadian clock, display altered daily patterns of nursing behavior that is fragmented during the light period, instead of long bouts of nursing behavior in wild-type mice. Adult wild-type offspring fostered by Clock mutant mice exhibit increased anxiety-related behavior. This is coupled with reduced levels of brain serotonin at postnatal day 14, whose homeostasis during the early postnatal period is critical for normal emotional behavior in adulthood. Together, disruption of the circadian clock in mothers has an adverse impact on establishing normal anxiety levels in offspring, which may increase their risk of developing anxiety disorders.	[Koizumi, Hiroko; Watanabe, Yuto] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 113, Japan; [Kurabayashi, Nobuhiro; Sanada, Kamon] Univ Tokyo, Grad Sch Sci, Mol Genet Res Lab, Tokyo 113, Japan	University of Tokyo; University of Tokyo	Sanada, K (corresponding author), Univ Tokyo, Grad Sch Sci, Mol Genet Res Lab, Tokyo 113, Japan.	kamon_sanada@gen.s.u-tokyo.ac.jp	KURABAYASHI, NOBUHIRO/G-4891-2014; SANADA, YOSHIKADO/G-5014-2014	Kurabayashi, Nobuhiro/0000-0003-3097-8539; Sanada, Kamon/0000-0002-0280-8957	Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [24650161] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research (B) (to KS), for Exploratory Research (to KS), and for Young Scientists (B) (to NK) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansorge MS, 2004, SCIENCE, V306, P879, DOI 10.1126/science.1101678; Antoch MP, 1997, CELL, V89, P655, DOI 10.1016/S0092-8674(00)80246-9; Caldji C, 1998, P NATL ACAD SCI USA, V95, P5335, DOI 10.1073/pnas.95.9.5335; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Castagne V., 2011, CURR PROTOC NEUROSCI; Dolatshad H, 2006, HUM REPROD, V21, P68, DOI 10.1093/humrep/dei313; Foster RG, 2005, NAT REV NEUROSCI, V6, P407, DOI 10.1038/nrn1670; Francis D, 1999, SCIENCE, V286, P1155, DOI 10.1126/science.286.5442.1155; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Gross C, 2002, NATURE, V416, P396, DOI 10.1038/416396a; GROTA LJ, 1974, HORM BEHAV, V5, P275, DOI 10.1016/0018-506X(74)90014-2; Han WJ, 2008, WORK EMPLOY SOC, V22, P67, DOI 10.1177/0950017007087417; HARLOW HF, 1965, P NATL ACAD SCI USA, V54, P90, DOI 10.1073/pnas.54.1.90; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; Hoshino K, 2006, ENDOCRINOLOGY, V147, P1916, DOI 10.1210/en.2005-1343; Kalinichev M, 2002, PHARMACOL BIOCHEM BE, V73, P131, DOI 10.1016/S0091-3057(02)00781-5; Kaufman J, 2001, DEV PSYCHOPATHOL, V13, P451, DOI 10.1017/S0954579401003030; KENDLER KS, 1992, ARCH GEN PSYCHIAT, V49, P716; Kennaway DJ, 2004, REPROD FERT DEVELOP, V16, P801, DOI 10.1071/RD04023; Kikusui T, 2005, BEHAV BRAIN RES, V162, P200, DOI 10.1016/j.bbr.2005.03.013; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Leonardo ED, 2006, ANNU REV PSYCHOL, V57, P117, DOI 10.1146/annurev.psych.57.102904.190118; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Liu D, 2000, NAT NEUROSCI, V3, P799, DOI 10.1038/77702; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Miller BH, 2004, CURR BIOL, V14, P1367, DOI 10.1016/j.cub.2004.07.055; Moffitt TE, 2007, PSYCHOL MED, V37, P441, DOI 10.1017/S0033291706009640; MYERS MM, 1989, DEV PSYCHOBIOL, V22, P29, DOI 10.1002/dev.420220104; Nilsson KW, 2008, DRUG ALCOHOL DEPEN, V93, P51, DOI 10.1016/j.drugalcdep.2007.08.022; Nilsson KW, 2006, BIOL PSYCHIAT, V59, P121, DOI 10.1016/j.biopsych.2005.06.024; Nordquist N, 2010, UPSALA J MED SCI, V115, P2, DOI 10.3109/03009730903573246; Norman RE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001349; Pena CJ, 2013, BEHAV NEUROSCI, V127, P33, DOI 10.1037/a0031219; Rosenbaum E, 2009, MATERN CHILD HLTH J, V13, P732, DOI 10.1007/s10995-009-0488-8; ROY MA, 1995, PSYCHOL MED, V25, P1037, DOI 10.1017/S0033291700037533; Roybal K, 2007, P NATL ACAD SCI USA, V104, P6406, DOI 10.1073/pnas.0609625104; RUPPENTHAL GC, 1976, J ABNORM PSYCHOL, V85, P341, DOI 10.1037/0021-843X.85.4.341; Sjoberg RL, 2006, INT J NEUROPSYCHOPH, V9, P443, DOI 10.1017/S1461145705005936; Stein MB, 2002, AM J PSYCHIAT, V159, P1675, DOI 10.1176/appi.ajp.159.10.1675; Strazdins L, 2006, J MARRIAGE FAM, V68, P394, DOI 10.1111/j.1741-3737.2006.00260.x; Strazdins L, 2004, SOC SCI MED, V59, P1517, DOI 10.1016/j.socscimed.2004.01.022; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Vinkers CH, 2010, BIOL PSYCHIAT, V67, P309, DOI 10.1016/j.biopsych.2009.08.013; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325	46	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66021	10.1371/journal.pone.0066021	http://dx.doi.org/10.1371/journal.pone.0066021			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776596	Green Published, Green Submitted, gold			2022-12-27	WOS:000320322400070
J	Li, J; Pu, P; Le, WD				Li, Jia; Pu, Pu; Le, Weidong			The SAX-3 Receptor Stimulates Axon Outgrowth and the Signal Sequence and Transmembrane Domain Are Critical for SAX-3 Membrane Localization in the PDE Neuron of C-elegans	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; RHO-GTPASES; ACTIN CYTOSKELETON; CELL-MIGRATION; RAC ACTIVATION; NETRIN CUES; GUIDANCE; PROTEIN; MIDLINE; KINASE	SAX-3, a receptor for Slit in C. elegans, is well characterized for its function in axonal development. However, the mechanism that regulates the membrane localization of SAX-3 and the role of SAX-3 in axon outgrowth are still elusive. Here we show that SAX-3:: GFP caused ectopic axon outgrowth, which could be suppressed by the loss-of-function mutation in unc-73 (a guanine nucleotide exchange factor for small GTPases) and unc-115 (an actin binding protein), suggesting that they might act downstream of SAX-3 in axon outgrowth. We also examined genes related to axon development for their possible involvement in the subcellular localization of SAX-3. We found the unc-51 mutants appeared to accumulate SAX-3:: GFP in the neuronal cell body of the posterior deirid (PDE) neuron, indicating that UNC-51 might play a role in SAX-3 membrane localization. Furthermore, we demonstrate that the N-terminal signal sequence and the transmembrane domain are essential for the subcellular localization of SAX-3 in the PDE neurons.	[Li, Jia; Pu, Pu; Le, Weidong] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Le, WD (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai, Peoples R China.	wdle@sibs.ac.cn			National Natural Science Foundation [81171201, 30970925]; National Basic Research Program of China from Science and Technology Commission [2010CB945200, 2011CB510003]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China from Science and Technology Commission(National Basic Research Program of China)	This work is supported by grants from the National Natural Science Foundation (81171201 and 30970925), and the National Basic Research Program of China from Science and Technology Commission (2010CB945200 and 2011CB510003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernadskaya YY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002863; BRENNER S, 1974, GENETICS, V77, P71; Briancon-Marjollet A, 2008, MOL CELL BIOL, V28, P2314, DOI 10.1128/MCB.00998-07; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Chan SSY, 1996, CELL, V87, P187, DOI 10.1016/S0092-8674(00)81337-9; Demarco RS, 2012, PLOS GENET, V8, P513, DOI 10.1371/journal.pgen.1002665; Demarco RS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001215; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Fan XP, 2003, NEURON, V40, P113, DOI 10.1016/S0896-6273(03)00591-9; Fritz JL, 2002, DEV BIOL, V252, P46, DOI 10.1006/dbio.2002.0842; Ghenea S, 2005, DEVELOPMENT, V132, P3679, DOI 10.1242/dev.01947; Gitai Z, 2003, NEURON, V37, P53, DOI 10.1016/S0896-6273(02)01149-2; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hall A, 2000, PHILOS T R SOC B, V355, P965, DOI 10.1098/rstb.2000.0632; Hao JC, 2001, NEURON, V32, P25, DOI 10.1016/S0896-6273(01)00448-2; HEDGECOCK EM, 1985, DEV BIOL, V111, P158, DOI 10.1016/0012-1606(85)90443-9; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; LEUNGHAGESTEIJN CY, 1992, CELL, V71, P289, DOI 10.1016/0092-8674(92)90357-I; Levy-Strumpf N, 2007, NAT NEUROSCI, V10, P161, DOI 10.1038/nn1835; Li HC, 2008, J NEUROSCI, V28, P3595, DOI 10.1523/JNEUROSCI.5536-07.2008; Matsuura A, 1997, GENE, V192, P245, DOI 10.1016/S0378-1119(97)00084-X; MCINTIRE SL, 1992, NEURON, V8, P307, DOI 10.1016/0896-6273(92)90297-Q; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Mueller BK, 1999, ANNU REV NEUROSCI, V22, P351, DOI 10.1146/annurev.neuro.22.1.351; Nass R, 2002, P NATL ACAD SCI USA, V99, P3264, DOI 10.1073/pnas.042497999; Norris AD, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-38; OGURA K, 1994, GENE DEV, V8, P2389, DOI 10.1101/gad.8.20.2389; Ogura K, 2006, DEVELOPMENT, V133, P3441, DOI 10.1242/dev.02503; Sann S, 2009, TRENDS CELL BIOL, V19, P317, DOI 10.1016/j.tcb.2009.05.001; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Steven R, 1998, CELL, V92, P785, DOI 10.1016/S0092-8674(00)81406-3; Struckhoff EC, 2003, DEVELOPMENT, V130, P693, DOI 10.1242/dev.00300; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Vanderzalm PJ, 2009, DEVELOPMENT, V136, P1201, DOI 10.1242/dev.026666; Wadsworth WG, 1996, NEURON, V16, P35, DOI 10.1016/S0896-6273(00)80021-5; Watari-Goshima N, 2007, NAT NEUROSCI, V10, P169, DOI 10.1038/nn1834; Winckler B, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001826; Wu YC, 2002, DEV BIOL, V250, P145, DOI 10.1006/dbio.2002.0785; Yang L, 2006, NEURON, V52, P595, DOI 10.1016/j.neuron.2006.09.039; Yu TW, 2002, NAT NEUROSCI, V5, P1147, DOI 10.1038/nn956; Yu TW, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn748; Zallen JA, 1999, DEVELOPMENT, V126, P3679; Zallen JA, 1998, CELL, V92, P217, DOI 10.1016/S0092-8674(00)80916-2	45	4	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65658	10.1371/journal.pone.0065658	http://dx.doi.org/10.1371/journal.pone.0065658			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776520	gold, Green Published, Green Submitted			2022-12-27	WOS:000320322400041
J	Niedtfeld, I; Schulze, L; Krause-Utz, A; Demirakca, T; Bohus, M; Schmahl, C				Niedtfeld, Inga; Schulze, Lars; Krause-Utz, Annegret; Demirakca, Traute; Bohus, Martin; Schmahl, Christian			Voxel-Based Morphometry in Women with Borderline Personality Disorder with and without Comorbid Posttraumatic Stress Disorder	PLOS ONE			English	Article							STRUCTURAL BRAIN ABNORMALITIES; HIPPOCAMPAL VOLUME; AMYGDALA VOLUME; MRI; METAANALYSIS; PTSD; REGISTRATION; PREVALENCE; ALGORITHM; SYMPTOMS	Patients with Borderline Personality Disorder (BPD) showed reduced volume of amygdala and hippocampus, but similar findings are evident in Posttraumatic Stress Disorder (PTSD). Applying voxel-based morphometry (VBM) in a larger cohort of patients with BPD, we sought to extend earlier findings of volume abnormalities in limbic regions and to evaluate the influence of co-occurring PTSD in BPD patients. We used voxel-based morphometry to study gray matter volume (GMV) in 60 healthy controls (HC) and 60 patients with BPD. Subgroup analyses on 53 patients concerning the role of co-occurring PTSD were conducted. Additionally, regression analyses were calculated to assess the relation between borderline symptom severity as well as dissociative experiences and GMV. Differences in local GMV between patients with BPD and HC were observed in the amygdale and hippocampus as well as in the fusiform and cingulate gyrus. Co-occurring PTSD was accompanied by increased GMV in the superior temporal gyrus and dorsolateral prefrontal cortex. Independent of co-occurring PTSD, severity of BPD symptoms predicted smaller GMV in the amygdala and dorsal ACC. Dissociation was positively related to GMV in the middle temporal gyrus. We could replicate earlier findings of diminished limbic GMV in patients with BPD and additionally show that patients with co-morbid PTSD feature increased GMV in prefrontal regions associated with cognitive control.	[Niedtfeld, Inga; Krause-Utz, Annegret; Bohus, Martin; Schmahl, Christian] Heidelberg Univ, Med Fac Mannheim, Dept Psychosomat Med, Cent Inst Mental Hlth Mannheim, Mannheim, Germany; [Schulze, Lars] Free Univ Berlin, Div Clin Psychol & Psychotherapy, Deptartment Educ & Psychol, Berlin, Germany; [Demirakca, Traute] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth Mannheim, Dept Neuroimaging, Mannheim, Germany	Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Free University of Berlin; Central Institute of Mental Health; Ruprecht Karls University Heidelberg	Niedtfeld, I (corresponding author), Heidelberg Univ, Med Fac Mannheim, Dept Psychosomat Med, Cent Inst Mental Hlth Mannheim, Mannheim, Germany.	inga.niedtfeld@zi-mannheim.de	Niedtfeld, Inga/GLV-3573-2022; Schmahl, Christian/E-8760-2012	Schmahl, Christian/0000-0003-0141-0821; Krause-Utz, Annegret/0000-0003-0661-6546; Schulze, Lars/0000-0003-4720-2411; Niedtfeld, Inga/0000-0002-6118-1664	Deutsche Forschungsgemeinschaft [DFG SCHM 1526/8-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Preparation of this manuscript was supported by a grant from the Deutsche Forschungsgemeinschaft (DFG SCHM 1526/8-1) to Prof. Schmahl. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MC, 2004, SCIENCE, V303, P232, DOI 10.1126/science.1089504; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Association AP, 1994, DIAGN STAT MAN MENT, V4th; Ball JS, 2009, CURR PSYCHIAT REP, V11, P63, DOI 10.1007/s11920-009-0010-4; Bohus M, 2007, PSYCHOPATHOLOGY, V40, P126, DOI 10.1159/000098493; Brambilla P, 2004, PSYCHIAT RES-NEUROIM, V131, P125, DOI 10.1016/j.pscychresns.2004.04.003; Brunner R, 2010, NEUROIMAGE, V49, P114, DOI 10.1016/j.neuroimage.2009.07.070; Crowell SE, 2009, PSYCHOL BULL, V135, P495, DOI 10.1037/a0015616; Dannlowski U, 2012, BIOL PSYCHIAT, V71, P286, DOI 10.1016/j.biopsych.2011.10.021; Driessen M, 2000, ARCH GEN PSYCHIAT, V57, P1115, DOI 10.1001/archpsyc.57.12.1115; Freyberger HJ, 1999, DTSCH ADAPTATION DIS; Gilbert R, 2009, LANCET, V373, P68, DOI 10.1016/S0140-6736(08)61706-7; Grant BF, 2008, J CLIN PSYCHIAT, V69, P533, DOI 10.4088/JCP.v69n0404; Guitart-Masip M, 2009, PROG NEURO-PSYCHOPH, V33, P1537, DOI 10.1016/j.pnpbp.2009.08.022; Hayasaka S, 2004, NEUROIMAGE, V23, P54, DOI 10.1016/j.neuroimage.2004.04.035; Hazlett EA, 2005, BIOL PSYCHIAT, V58, P614, DOI 10.1016/j.biopsych.2005.04.029; Herpertz SC, 2001, BIOL PSYCHIAT, V50, P292, DOI 10.1016/S0006-3223(01)01075-7; Irle E, 2005, BIOL PSYCHIAT, V57, P173, DOI 10.1016/j.biopsych.2004.10.004; Karl A, 2006, NEUROSCI BIOBEHAV R, V30, P1004, DOI 10.1016/j.neubiorev.2006.03.004; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Kluetsch RC, 2012, ARCH GEN PSYCHIAT, P1; Koenigsberg HW, 2009, BIOL PSYCHIAT, V66, P854, DOI 10.1016/j.biopsych.2009.06.010; Korzekwa MI, 2008, COMPR PSYCHIAT, V49, P380, DOI 10.1016/j.comppsych.2008.01.007; Krause-Utz A, 2010, EUR PSYCHIAT REV, V3, P63; Kuhlmann A, 2013, J PSYCHIATR NEUROSCI, V38, P129, DOI 10.1503/jpn.120039; Lanius RA, 2002, BIOL PSYCHIAT, V52, P305, DOI 10.1016/S0006-3223(02)01367-7; Lanius RA, 2010, AM J PSYCHIAT, V167, P640, DOI 10.1176/appi.ajp.2009.09081168; Lieb K, 2004, LANCET, V364, P453, DOI 10.1016/S0140-6736(04)16770-6; Loranger A. W, 1999, INT PERSONALITY DISO; Lyoo IK, 1998, J AFFECT DISORDERS, V50, P235, DOI 10.1016/S0165-0327(98)00104-9; Nenadic I, 2010, BRIT J PSYCHIAT, V196, P412, DOI 10.1192/bjp.bp.109.070441; New AS, 2007, NEUROPSYCHOPHARMACOL, V32, P1629, DOI 10.1038/sj.npp.1301283; Niedtfeld I, 2010, BIOL PSYCHIAT, V68, P383, DOI 10.1016/j.biopsych.2010.04.015; Nunes PM, 2009, J PERS DISORD, V23, P333, DOI 10.1521/pedi.2009.23.4.333; O'Neill A, 2012, BRAIN STRUCT FUNCT, V217, P767, DOI 10.1007/s00429-012-0379-4; Rodrigues E, 2011, EUR PSYCHIAT, V26, P452, DOI 10.1016/j.eurpsy.2010.07.005; Rusch N, 2003, NEUROIMAGE, V20, P385, DOI 10.1016/S1053-8119(03)00297-0; Sala M, 2011, J AFFECT DISORDERS, V131, P417, DOI 10.1016/j.jad.2010.11.036; Schmahl CG, 2003, PSYCHIAT RES-NEUROIM, V122, P193, DOI 10.1016/S0925-4927(03)00023-4; Schmahl Christian, 2009, J Psychiatry Neurosci, V34, P289; Simeon D, 2000, AM J PSYCHIAT, V157, P1782, DOI 10.1176/appi.ajp.157.11.1782; Skodol AE, 2002, BIOL PSYCHIAT, V51, P936, DOI 10.1016/S0006-3223(02)01324-0; Soloff P, 2008, PSYCHIAT RES-NEUROIM, V164, P223, DOI 10.1016/j.pscychresns.2008.02.003; Soloff PH, 2012, J PSYCHIATR RES, V46, P516, DOI 10.1016/j.jpsychires.2012.01.003; Stein MB, 1997, PSYCHOL MED, V27, P951, DOI 10.1017/S0033291797005242; Stiglmayr C, 2001, STATES AVERSIVE TENS, P135; Stiglmayr CE, 2008, ACTA PSYCHIAT SCAND, V117, P139, DOI 10.1111/j.1600-0447.2007.01126.x; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van Elst LT, 2003, BIOL PSYCHIAT, V54, P163, DOI 10.1016/S0006-3223(03)01743-2; Vollm BA, 2009, CRIM BEHAV MENT HEAL, V19, P64, DOI 10.1002/cbm.716; Wittchen H.U., 1997, SKID STRUKTURIERTES; Zanarini MC, 2000, J NERV MENT DIS, V188, P26, DOI 10.1097/00005053-200001000-00005; Zetzsche T, 2006, BIOL PSYCHIAT, V60, P302, DOI 10.1016/j.biopsych.2005.11.020; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	56	57	59	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65824	10.1371/journal.pone.0065824	http://dx.doi.org/10.1371/journal.pone.0065824			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776553	Green Published, gold, Green Submitted			2022-12-27	WOS:000320322400059
J	Stanisor, OI; van Diest, SA; Yu, ZM; Welting, O; Bekkali, N; Shi, J; de Jonge, WJ; Boeckxstaens, GE; van den Wijngaard, RM				Stanisor, Oana I.; van Diest, Sophie A.; Yu, Zhumei; Welting, Olaf; Bekkali, Noor; Shi, Jing; de Jonge, Wouter J.; Boeckxstaens, Guy E.; van den Wijngaard, Rene M.			Stress-Induced Visceral Hypersensitivity in Maternally Separated Rats Can Be Reversed by Peripherally Restricted Histamine-1-Receptor Antagonists	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; EARLY-LIFE; HISTAMINE; DISORDERS; MECHANISMS; EXPRESSION; KETOTIFEN; RISK	Background: The histamine-1 receptor (H1R) antagonist ketotifen increased the threshold of discomfort in hypersensitive IBS patients. The use of peripherally restricted and more selective H1R antagonists may further improve treatment possibilities. We examined the use of fexofenadine and ebastine to reverse post-stress visceral hypersensitivity in maternally separated rats. Methods: The visceromotor response to colonic distension was assessed in adult maternally separated and nonhandled rats pre- and 24 hours post water avoidance. Subsequently rats were treated with vehicle alone or different dosages of fexofenadine (1.8 and 18 mg/kg) or ebastine (0.1 and 1.0 mg/kg) and re-evaluated. Colonic tissue was collected to assess relative RMCP-2 and occludin expression levels by Western blot and histamine-1 receptor by RT-qPCR. beta-hexosaminidase release by RBL-2H3 cells was used to establish possible mast cell stabilizing properties of the antagonists. Key results: Water avoidance only induced enhanced response to distension in maternally separated rats. This response was reversed by 1.8 and 18 mg/kg fexofenadine. Reversal was also obtained by 1.0 but not 0.1 mg/kg ebastine. RMCP-2 expression levels were comparable in these two ebastine treatment groups but occludin was significantly higher in 1.0 mg/kg treated rats. There were no differences in histamine-1 receptor expression between nonhandled and maternally separated rats. Fexofenadine but not ebastine showed mast cell stabilizing quality. Conclusions: Our results indicate that the peripherally restricted 2nd generation H1-receptor antagonists fexofenadine and ebastine are capable of reversing post stress visceral hypersensitivity in rat. These data justify future IBS patient trials with these well tolerated compounds.	[Stanisor, Oana I.; van Diest, Sophie A.; Yu, Zhumei; Welting, Olaf; Bekkali, Noor; de Jonge, Wouter J.; van den Wijngaard, Rene M.] Univ Amsterdam, Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, NL-1105 AZ Amsterdam, Netherlands; [Yu, Zhumei; Shi, Jing] HUST, Tongji Med Coll, Dept Neurobiol, Wuhan, Peoples R China; [Boeckxstaens, Guy E.] Catholic Univ Louvain, Univ Hosp Gasthuisberg, Div Gastroenterol, B-3000 Louvain, Belgium	University of Amsterdam; Academic Medical Center Amsterdam; Huazhong University of Science & Technology; KU Leuven; University Hospital Leuven; Universite Catholique Louvain	van den Wijngaard, RM (corresponding author), Univ Amsterdam, Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	R.vandenWijngaard@AMC.UVA.NL	Boeckxstaens, Guy/AAP-2502-2020		European Union [202020]; Netherlands Top Institute Pharma [T1-215-1]; Netherlands Digestive Diseases Foundation (MLDS) [WO10-12]; Royal Netherlands Academy of Arts and Sciences (KNAW) [11CDP005]; Dutch Organization for Scientific Research (NWO-VIDI)	European Union(European Commission); Netherlands Top Institute Pharma; Netherlands Digestive Diseases Foundation (MLDS); Royal Netherlands Academy of Arts and Sciences (KNAW); Dutch Organization for Scientific Research (NWO-VIDI)(Netherlands Organization for Scientific Research (NWO))	OIS was supported by funding for the IPODD consortium under Grant Agreement 202020 of the Seventh Research Framework Programme of the European Union (http://www.IPODD.eu). SAvD was supported by the Netherlands Top Institute Pharma, grant number T1-215-1 (www.TIPharma.com) and the Netherlands Digestive Diseases Foundation (MLDS), project number WO10-12 (www.MLDS.NL/). ZY was supported by The China Exchange Programme (CEP) of the Royal Netherlands Academy of Arts and Sciences (KNAW), project number 11CDP005 (www.KNAW.NL). WJdJ was funded by a grant of the Dutch Organization for Scientific Research (NWO-VIDI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Belgnaoui A, 2005, PAIN, V113, P141, DOI 10.1016/j.pain.2004.10.002; Al-Sadi R, 2011, AM J PHYSIOL-GASTR L, V300, pG1054, DOI 10.1152/ajpgi.00055.2011; Azpiroz F, 2007, NEUROGASTROENT MOTIL, V19, P62, DOI 10.1111/j.1365-2982.2006.00875.x; Barbara G, 2007, GASTROENTEROLOGY, V132, P26, DOI 10.1053/j.gastro.2006.11.039; Barreau F, 2007, PEDIATR RES, V62, P240, DOI 10.1203/PDR.0b013e3180db2949; Bertiaux-Vandaele N, 2011, AM J GASTROENTEROL, V106, P2165, DOI 10.1038/ajg.2011.257; Chitkara DK, 2008, AM J GASTROENTEROL, V103, P765, DOI 10.1111/j.1572-0241.2007.01722.x; Coeffier M, 2009, AM J GASTROENTEROL; Coelho AM, 1998, DIGEST DIS SCI, V43, P727, DOI 10.1023/A:1018853728251; Gareau MG, 2008, CURR MOL MED, V8, P274, DOI 10.2174/156652408784533760; Klooker TK, 2010, GUT, V59, P1213, DOI 10.1136/gut.2010.213108; Klooker TK, 2009, AM J GASTROENTEROL, V104, P2250, DOI 10.1038/ajg.2009.282; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Marone G, 2001, INT ARCH ALLERGY IMM, V124, P249, DOI 10.1159/000053725; Sander LE, 2006, GUT, V55, P498, DOI 10.1136/gut.2004.061762; Shim WS, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-29; Simons FER, 2011, J ALLERGY CLIN IMMUN, V128, P1139, DOI 10.1016/j.jaci.2011.09.005; Simpson K, 2000, DRUGS, V59, P301, DOI 10.2165/00003495-200059020-00020; Tashiro M, 2006, BRIT J CLIN PHARMACO, V61, P16, DOI 10.1111/j.1365-2125.2005.02514.x; Van Cauwenberge P, 2004, EXPERT OPIN PHARMACO, V5, P1807, DOI 10.1517/14656566.5.8.1807; van den Wijngaard RM, 2012, NEUROGASTROENT MOTIL, V24, P274, DOI 10.1111/j.1365-2982.2011.01840.x; van den Wijngaard RM, 2009, NEUROGASTROENT MOTIL, V21, DOI 10.1111/j.1365-2982.2009.01339.x; van den Wijngaard RM, 2010, AUTON NEUROSCI-BASIC, V153, P99, DOI 10.1016/j.autneu.2009.07.004; Welting O, 2005, NEUROGASTROENT MOTIL, V17, P838, DOI 10.1111/j.1365-2982.2005.00677.x	24	30	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66884	10.1371/journal.pone.0066884	http://dx.doi.org/10.1371/journal.pone.0066884			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776699	Green Published, gold, Green Submitted			2022-12-27	WOS:000320322400119
J	Wang, YJ; Deng, DX; Ding, HD; Xu, XM; Zhang, R; Wang, SX; Bian, YL; Yin, ZT; Chen, Y				Wang, Yijun; Deng, Dexiang; Ding, Haidong; Xu, Xiangming; Zhang, Rong; Wang, Suxin; Bian, Yunlong; Yin, Zhitong; Chen, Yao			Gibberellin Biosynthetic Deficiency Is Responsible for Maize Dominant Dwarf11 (D11) Mutant Phenotype: Physiological and Transcriptomic Evidence	PLOS ONE			English	Article							GREEN-REVOLUTION; RICE; GENES; MODULATORS; GENETICS; HEIGHT; ROLES	Dwarf stature is introduced to improve lodging resistance and harvest index in crop production. In many crops including maize, mining and application of novel dwarf genes are urgent to overcome genetic bottleneck and vulnerability during breeding improvement. Here we report the characterization and expression profiling analysis of a newly identified maize dwarf mutant Dwarf11 (D11). The D11 displays severely developmental abnormalities and is controlled by a dominant Mendelian factor. The D11 seedlings responds to both GA(3) and paclobutrazol (PAC) application, suggesting that dwarf phenotype of D11 is caused by GA biosynthesis instead of GA signaling deficiency. In contrast, two well-characterized maize dominant dwarf plants D8 and D9 are all insensitive to exogenous GA(3) stimulation. Additionally, sequence variation of D8 and D9 genes was not identified in the D11 mutant. Microarray and qRT-PCR analysis results demonstrated that transcripts encoding GA biosynthetic and catabolic enzymes ent-kaurenoic acid oxidase (KAO), GA 20-oxidase (GA20ox), and GA 2-oxidase (GA2ox) are up-regulated in D11. Our results lay a foundation for the following D11 gene cloning and functional characterization. Moreover, results presented here may aid in crops molecular improvement and breeding, especially breeding of crops with plant height ideotypes.	[Wang, Yijun; Deng, Dexiang; Xu, Xiangming; Zhang, Rong; Wang, Suxin; Bian, Yunlong; Yin, Zhitong; Chen, Yao] Yangzhou Univ, Coll Agr, Key Lab Crop Genet & Physiol Jiangsu Prov, Key Lab Plant Funct Genom,Minist Educ, Yangzhou, Peoples R China; [Ding, Haidong] Yangzhou Univ, Coll Biosci & Biotechnol, Key Lab Crop Genet & Physiol Jiangsu Prov, Yangzhou, Peoples R China	Yangzhou University; Yangzhou University	Wang, YJ (corresponding author), Yangzhou Univ, Coll Agr, Key Lab Crop Genet & Physiol Jiangsu Prov, Key Lab Plant Funct Genom,Minist Educ, Yangzhou, Peoples R China.	yjwang61@163.com	Wang, Yijun/GXW-1763-2022	Yin, Zhitong/0000-0003-2482-8681	National Natural Science Foundation of China [31201213]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Innovative Foundation of Yangzhou University [2011CXJ046]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Innovative Foundation of Yangzhou University	This work was supported by grants from the National Natural Science Foundation of China (31201213), Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), and Innovative Foundation of Yangzhou University (2011CXJ046). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cassani E, 2009, MOL BREEDING, V24, P375, DOI 10.1007/s11032-009-9298-3; Chandler PM, 2002, PLANT PHYSIOL, V129, P181, DOI 10.1104/pp.010917; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Emerson, 1912, J HERED, P385; FUJIOKA S, 1988, PLANT PHYSIOL, V88, P1367, DOI 10.1104/pp.88.4.1367; Gasperini D, 2012, J EXP BOT, V63, P4419, DOI 10.1093/jxb/ers138; HARBERD NP, 1989, GENETICS, V121, P827; Hartwig T, 2011, P NATL ACAD SCI USA, V108, P19814, DOI 10.1073/pnas.1108359108; Hedden P, 2003, TRENDS GENET, V19, P5, DOI 10.1016/S0168-9525(02)00009-4; Huang J, 2010, J GENET GENOMICS, V37, P23, DOI 10.1016/S1673-8527(09)60022-9; Ikeda A, 2001, PLANT CELL, V13, P999, DOI 10.1105/tpc.13.5.999; Jiang FK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037040; Jiang XS, 2012, PLANT J, V72, P768, DOI 10.1111/j.1365-313X.2012.05118.x; Khush GS, 2001, NAT REV GENET, V2, P815, DOI 10.1038/35093585; Larsson SJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003246; Lawit SJ, 2010, PLANT CELL PHYSIOL, V51, P1854, DOI 10.1093/pcp/pcq153; Magome H, 2004, PLANT J, V37, P720, DOI 10.1111/j.1365-313X.2003.01998.x; Makarevitch I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030798; Multani DS, 2003, SCIENCE, V302, P81, DOI 10.1126/science.1086072; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Plackett ARG, 2012, PLANT CELL, V24, P941, DOI 10.1105/tpc.111.095109; Plackett ARG, 2011, TRENDS PLANT SCI, V16, P568, DOI 10.1016/j.tplants.2011.06.007; Qi WW, 2011, PLANT PHYSIOL, V157, P216, DOI 10.1104/pp.111.179945; Ramamoorthy R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028069; Song J, 2011, GENE, V482, P34, DOI 10.1016/j.gene.2011.05.008; Teng F, 2013, PLANT J, V73, P405, DOI 10.1111/tpj.12038; Thornsberry JM, 2001, NAT GENET, V28, P286, DOI 10.1038/90135; Tong HN, 2009, PLANT J, V58, P803, DOI 10.1111/j.1365-313X.2009.03825.x; [王立静 WANG Lijing], 2008, [华北农学报, Acta Agriculturae Boreali-Sinica], V23, P23; [王益军 Wang Yijun], 2010, [华北农学报, Acta Agriculturae Boreali-Sinica], V25, P90; Wang YH, 2008, ANNU REV PLANT BIOL, V59, P253, DOI 10.1146/annurev.arplant.59.032607.092902; Weng JF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029229; WINKLER RG, 1994, PLANTA, V193, P341, DOI 10.1007/BF00201811; Yamaguchi S, 2008, ANNU REV PLANT BIOL, V59, P225, DOI 10.1146/annurev.arplant.59.032607.092804; [张素梅 ZHANG Sumei], 2007, [玉米科学, Maize Science], V15, P15	35	15	26	4	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66466	10.1371/journal.pone.0066466	http://dx.doi.org/10.1371/journal.pone.0066466			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776674	Green Submitted, gold, Green Published			2022-12-27	WOS:000320322400103
J	Ballas, ZK; Buchta, CM; Rosean, TR; Heusel, JW; Shey, MR				Ballas, Zuhair K.; Buchta, Claire M.; Rosean, Timothy R.; Heusel, Jonathan W.; Shey, Michael R.			Role of NK Cell Subsets in Organ-Specific Murine Melanoma Metastasis	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; CPG OLIGODEOXYNUCLEOTIDES; TUMOR-METASTASIS; T-CELLS; IN-VIVO; INDUCTION; MOTIFS; CD27	Tumor metastasis plays a major role in the morbidity and mortality of cancer patients. Among solid tumors that undergo metastasis, there is often a predilection to metastasize to a particular organ with, for example, prostate cancer preferentially metastasizing to bones and colon cancer preferentially metastasizing to the liver. Although many factors are thought to be important in establishing permissiveness for metastasis, the reasons for organ-specific predilection of each tumor are not understood. Using a B16 murine melanoma model, we tested the hypothesis that organ-specific NK cell subsets play a critical role in organ-specific metastasis of this tumor. Melanoma cells, given intravenously, readily colonized the lungs but not the liver. NK cell depletion (either iatrogenically or by using genetically targeted mice) resulted in substantial hepatic metastasis. Analysis of NK cell subsets, defined by the differential expression of a combination of CD27 and CD11b, indicated a significant difference in the distribution of NK cell subsets in the lung and liver with the mature subset being dominant in the lung and the immature subset being dominant in the liver. Several experimental approaches, including adoptive transfer, clearly indicated that the immature hepatic NK cell subset, CD27+ CD11b-, was protective against liver metastasis; this subset mediated its protection by a perforin-dependent cytotoxic mechanism. In contrast, the more mature NK cell subsets were more efficient at reducing pulmonary tumor load. These data indicate that organ-specific immune responses may play a pivotal role in determining the permissiveness of a given organ for the establishment of a metastatic niche.	[Ballas, Zuhair K.; Shey, Michael R.] Univ Iowa, Carver Coll Med, Iowa City VA Med Ctr, Iowa City, IA 52240 USA; [Ballas, Zuhair K.; Shey, Michael R.] Univ Iowa, Carver Coll Med, Dept Internal Med, Iowa City, IA USA; [Buchta, Claire M.; Rosean, Timothy R.] Univ Iowa, Carver Coll Med, Interdisciplinary Grad Program Immunol, Iowa City, IA USA; [Heusel, Jonathan W.] Univ Iowa, Carver Coll Med, Dept Pathol, Iowa City, IA USA	University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Iowa; University of Iowa; University of Iowa	Ballas, ZK (corresponding author), Univ Iowa, Carver Coll Med, Iowa City VA Med Ctr, Iowa City, IA 52240 USA.	ballasz@uiowa.edu; michael-shey@uiowa.edu	Heusel, Jon/AAC-8050-2021	Knaack, Aaron/0000-0001-7712-1415; Ballas, Zuhair/0000-0001-5569-1230	VA Nerit Review award; Iowa City VA Medical Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007485] Funding Source: NIH RePORTER	VA Nerit Review award; Iowa City VA Medical Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by a VA Nerit Review award; Iowa City VA Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALLAS ZK, 1986, J IMMUNOL, V137, P2380; BALLAS ZK, 1990, J IMMUNOL, V145, P1039; Ballas ZK, 2001, J IMMUNOL, V167, P4878, DOI 10.4049/jimmunol.167.9.4878; Ballas ZK, 1996, J IMMUNOL, V157, P1840; Ballas ZK, 2007, IMMUNOL RES, V39, P15, DOI 10.1007/s12026-007-0066-3; Ballas ZK, 2012, ALCOHOL CLIN EXP RES, V36, P826, DOI 10.1111/j.1530-0277.2011.01678.x; Bottcher JP, 2011, DIGEST DIS, V29, P384, DOI 10.1159/000329801; Caligiuri MA, 2008, BLOOD, V112, P461, DOI 10.1182/blood-2007-09-077438; Chiossone L, 2009, BLOOD, V113, P5488, DOI 10.1182/blood-2008-10-187179; Coghlin C, 2010, J PATHOL, V222, P1, DOI 10.1002/path.2727; Guise T, 2010, SEMIN ONCOL, V37, pS2, DOI 10.1053/j.seminoncol.2010.10.007; Hartmann G, 2000, J IMMUNOL, V164, P1617, DOI 10.4049/jimmunol.164.3.1617; Hayakawa Y, 2006, J IMMUNOL, V176, P1517, DOI 10.4049/jimmunol.176.3.1517; Hayakawa Y, 2006, IMMUNOL REV, V214, P47, DOI 10.1111/j.1600-065X.2006.00454.x; HERSEY P, 1979, BRIT J CANCER, V40, P113, DOI 10.1038/bjc.1979.147; Holtan SG, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/316314; Inngjerdingen M, 2011, TISSUE ANTIGENS, V78, P81, DOI 10.1111/j.1399-0039.2011.01714.x; Jovic V, 2001, TUMORI J, V87, P324, DOI 10.1177/030089160108700509; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kim S, 2006, BLOOD, V107, P1024, DOI 10.1182/blood-2005-04-1493; Kim S, 2000, P NATL ACAD SCI USA, V97, P2731, DOI 10.1073/pnas.050588297; Kline JN, 1999, J ALLERGY CLIN IMMUN, V104, P1258, DOI 10.1016/S0091-6749(99)70022-9; Krug A, 2001, EUR J IMMUNOL, V31, P2154, DOI 10.1002/1521-4141(200107)31:7<2154::AID-IMMU2154>3.0.CO;2-U; Orange JS, 2006, CLIN IMMUNOL, V118, P1, DOI 10.1016/j.clim.2005.10.011; Shey Michael R., 2008, V447, P259, DOI 10.1007/978-1-59745-242-7_18; Silva A, 2008, INT IMMUNOL, V20, P625, DOI 10.1093/intimm/dxn022; Spano D, 2012, CLIN EXP METASTAS, V29, P381, DOI 10.1007/s10585-012-9457-5; Sun JC, 2011, NAT REV IMMUNOL, V11, P645, DOI 10.1038/nri3044; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Wu X, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/759765; Yokoyama WM, 2004, ANNU REV IMMUNOL, V22, P405, DOI 10.1146/annurev.immunol.22.012703.104711	31	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65599	10.1371/journal.pone.0065599	http://dx.doi.org/10.1371/journal.pone.0065599			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776508	gold, Green Published, Green Submitted			2022-12-27	WOS:000320755400046
J	Falcon, E; Ozburn, A; Mukherjee, S; Roybal, K; McClung, CA				Falcon, Edgardo; Ozburn, Angela; Mukherjee, Shibani; Roybal, Kole; McClung, Colleen A.			Differential Regulation of the Period Genes in Striatal Regions following Cocaine Exposure	PLOS ONE			English	Article							CIRCADIAN-RHYTHMS; SEEKING BEHAVIOR; CLOCK PROTEIN; EXPRESSION; REWARD; SENSITIZATION; WITHDRAWAL; PATHWAY; OPIATE; BRAIN	Several studies have suggested that disruptions in circadian rhythms contribute to the pathophysiology of multiple psychiatric diseases, including drug addiction. In fact, a number of the genes involved in the regulation of circadian rhythms are also involved in modulating the reward value for drugs of abuse, like cocaine. Thus, we wanted to determine the effects of chronic cocaine on the expression of several circadian genes in the Nucleus Accumbens (NAc) and Caudate Putamen (CP), regions of the brain known to be involved in the behavioral responses to drugs of abuse. Moreover, we wanted to explore the mechanism by which these genes are regulated following cocaine exposure. Here we find that after repeated cocaine exposure, expression of the Period (Per) genes and Neuronal PAS Domain Protein 2 (Npas2) are elevated, in a somewhat regionally selective fashion. Moreover, NPAS2 (but not CLOCK (Circadian Locomotor Output Cycles Kaput)) protein binding at Per gene promoters was enhanced following cocaine treatment. Mice lacking a functional Npas2 gene failed to exhibit any induction of Per gene expression after cocaine, suggesting that NPAS2 is necessary for this cocaine-induced regulation. Examination of Per gene and Npas2 expression over twenty-four hours identified changes in diurnal rhythmicity of these genes following chronic cocaine, which were regionally specific. Taken together, these studies point to selective disruptions in Per gene rhythmicity in striatial regions following chronic cocaine treatment, which are mediated primarily by NPAS2.	[Falcon, Edgardo; Mukherjee, Shibani; Roybal, Kole; McClung, Colleen A.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Ozburn, Angela; McClung, Colleen A.] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA; [Ozburn, Angela; McClung, Colleen A.] Univ Pittsburgh, Sch Med, Translat Neurosci Program, Pittsburgh, PA USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	McClung, CA (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA.	mcclungca@upmc.edu	Ozburn, Angela R/P-5409-2018; McClung, Colleen/AAA-5943-2019	Ozburn, Angela R/0000-0002-8387-1156; 	NIH/NIDA [DA028085, DA023988]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA023988, F31DA028085] Funding Source: NIH RePORTER	NIH/NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	NIH/NIDA grants DA028085 to Edgardo Falcon and DA023988 to Colleen McClung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarca C, 2002, P NATL ACAD SCI USA, V99, P9026, DOI 10.1073/pnas.142039099; Andretic R, 1999, SCIENCE, V285, P1066, DOI 10.1126/science.285.5430.1066; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Crosio C, 2000, NAT NEUROSCI, V3, P1241, DOI 10.1038/81767; Enwright JF, 2010, BRAIN RES, V1329, P10, DOI 10.1016/j.brainres.2010.02.081; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Garcia JA, 2000, SCIENCE, V288, P2226, DOI 10.1126/science.288.5474.2226; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Halbout B, 2011, BEHAV PHARMACOL, V22, P76, DOI 10.1097/FBP.0b013e328341e9ca; Harms E, 2004, J BIOL RHYTHM, V19, P361, DOI 10.1177/0748730404268111; HOPE BT, 1994, NEURON, V13, P1235, DOI 10.1016/0896-6273(94)90061-2; Iijima M, 2002, EUR J NEUROSCI, V16, P921, DOI 10.1046/j.1460-9568.2002.02140.x; Imbesi M, 2009, NEUROSCIENCE, V158, P537, DOI 10.1016/j.neuroscience.2008.10.044; Jones EM, 2003, AM FAM PHYSICIAN, V68, P1971; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Kosobud Ann E K, 2007, ScientificWorldJournal, V7, P203; Lamont EW, 2005, P NATL ACAD SCI USA, V102, P4180, DOI 10.1073/pnas.0500901102; Li SX, 2010, J NEUROCHEM, V115, P353, DOI 10.1111/j.1471-4159.2010.06941.x; Liu Y, 2007, NEUROSCIENCE, V146, P265, DOI 10.1016/j.neuroscience.2007.01.009; Liu Y, 2005, NEUROSCIENCE, V130, P383, DOI 10.1016/j.neuroscience.2004.09.012; Lynch WJ, 2008, BRAIN RES, V1213, P166, DOI 10.1016/j.brainres.2008.02.106; Manev H, 2006, TRENDS PHARMACOL SCI, V27, P186, DOI 10.1016/j.tips.2006.02.003; Masubuchi S, 2000, EUR J NEUROSCI, V12, P4206, DOI 10.1046/j.1460-9568.2000.01313.x; Maywood ES, 2010, J NEUROSCI, V30, P10199, DOI 10.1523/JNEUROSCI.1694-10.2010; McClung CA, 2003, NAT NEUROSCI, V6, P1208, DOI 10.1038/nn1143; Nestler EJ, 2004, TRENDS PHARMACOL SCI, V25, P210, DOI 10.1016/j.tips.2004.02.005; Nestler EJ, 2005, NAT NEUROSCI, V8, P1445, DOI 10.1038/nn1578; Nikaido T, 2001, MOL PHARMACOL, V59, P894, DOI 10.1124/mol.59.4.894; Perreau-Lenz S, 2010, EUR NEUROPSYCHOPHARM, V20, P509, DOI 10.1016/j.euroneuro.2010.03.006; Pieper AA, 2006, POLYMORPHIC VARIATIO; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; Shearman LP, 1999, NEUROSCIENCE, V89, P387, DOI 10.1016/S0306-4522(98)00325-X; Spanagel R, 2005, NAT MED, V11, P35, DOI 10.1038/nm1163; STEPHAN FK, 1984, PHYSIOL BEHAV, V32, P663, DOI 10.1016/0031-9384(84)90323-8; Travnickova-Bendova Z, 2002, P NATL ACAD SCI USA, V99, P7728, DOI 10.1073/pnas.102075599; Wasielewski JA, 2001, ALCOHOL RES HEALTH, V25, P94; Wise RA, 1998, DRUG ALCOHOL DEPEN, V51, P13, DOI 10.1016/S0376-8716(98)00063-5; Yuferov V, 2005, EUR J HUM GENET, V13, P1101, DOI 10.1038/sj.ejhg.5201483; Yuferov V, 2003, SYNAPSE, V48, P157, DOI 10.1002/syn.10198; Zghoul T, 2007, PSYCHOPHARMACOLOGY, V190, P13, DOI 10.1007/s00213-006-0592-z; Zhou YD, 1997, P NATL ACAD SCI USA, V94, P713, DOI 10.1073/pnas.94.2.713	42	42	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66438	10.1371/journal.pone.0066438	http://dx.doi.org/10.1371/journal.pone.0066438			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776671	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000320755400145
J	Garg, H; Li, H; Sivasithamparam, K; Barbetti, MJ				Garg, Harsh; Li, Hua; Sivasithamparam, Krishnapillai; Barbetti, Martin J.			Differentially Expressed Proteins and Associated Histological and Disease Progression Changes in Cotyledon Tissue of a Resistant and Susceptible Genotype of Brassica napus Infected with Sclerotinia sclerotiorum	PLOS ONE			English	Article							PATHOGENESIS-RELATED PROTEINS; GLUTATHIONE-S-TRANSFERASES; HYDROGEN-PEROXIDE; GENE-EXPRESSION; DIHYDROLIPOYL DEHYDROGENASE; LEPTOSPHAERIA-MACULANS; OXALIC-ACID; PLANT; RESPONSES; STRESS	Sclerotinia rot caused by Sclerotinia sclerotiorum is one of the most serious diseases of oilseed rape. To understand the resistance mechanisms in the Brassica napus to S. sclerotiorum, comparative disease progression, histological and proteomic studies were conducted of two B. napus genotypes (resistant cv. Charlton, susceptible cv. RQ001-02M2). At 72 and 96 h post inoculation (hpi), lesion size on cotyledons was significantly (P <= 0.001) smaller in the resistant Charlton. Anatomical investigations revealed impeded fungal growth (at 24 hpi and onwards) and hyphal disintegration only on resistant Charlton. Temporal changes (12, 24, 48 and 72 hpi) in protein profile showed certain enzymes up-regulated only in resistant Charlton, such as those related to primary metabolic pathways, antioxidant defence, ethylene biosynthesis, pathogenesis related proteins, protein synthesis and protein folding, play a role in mediating defence responses against S. sclerotiorum. Similarly a eukaryotic translation initiation factor 5A enzyme with increased abundance in susceptible RQ001-02M2 and decreased levels in resistant Charlton has a role in increased susceptibility to this pathogen. This is the first time that the expression of these enzymes has been shown to be associated with mediating the defence response against S. sclerotinia in cotyledon tissue of a resistant cultivar of B. napus at a proteomics level. This study not only provides important new insights into the resistance mechanisms within B. napus against S. sclerotiorum, but opens the way for novel engineering of new B. napus varieties that over-express these key enzymes as a strategy to enhance resistance and better manage this devastating pathogen.	[Garg, Harsh; Li, Hua; Sivasithamparam, Krishnapillai; Barbetti, Martin J.] Univ Western Australia, Fac Sci, Sch Plant Biol, Crawley, WA, Australia; [Barbetti, Martin J.] Univ Western Australia, Fac Sci, Inst Agr, Crawley, WA, Australia	University of Western Australia; University of Western Australia	Barbetti, MJ (corresponding author), Univ Western Australia, Fac Sci, Sch Plant Biol, Crawley, WA, Australia.	martin.barbetti@uwa.edu.au	Barbetti, Martin J/B-3455-2011	Barbetti, Martin J/0000-0002-5331-0817	School of Plant Biology at The University of Western Australia; Australian Centre for International Agricultural Research; Department of Agriculture and Food Western Australia	School of Plant Biology at The University of Western Australia; Australian Centre for International Agricultural Research; Department of Agriculture and Food Western Australia	This work has been supported by the School of Plant Biology at The University of Western Australia. HG gratefully acknowledges the financial assistance of the Australian Centre for International Agricultural Research by way of a John Allwright PhD fellowship. MB gratefully acknowledges the generous support of a half salary from Department of Agriculture and Food Western Australia during the time of these studies. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALWINE JC, 1973, J BACTERIOL, V115, P1; Berger S, 2007, J EXP BOT, V58, P4019, DOI 10.1093/jxb/erm298; BOLAND GJ, 1994, CAN J PLANT PATHOL, V16, P93, DOI 10.1080/07060669409500766; Bolton MD, 2006, MOL PLANT PATHOL, V7, P1, DOI 10.1111/J.1364-3703.2005.00316.X; Bouchereau A, 1999, PLANT SCI, V140, P103, DOI 10.1016/S0168-9452(98)00218-0; BOWLER C, 1992, ANNU REV PLANT PHYS, V43, P83, DOI 10.1146/annurev.pp.43.060192.000503; Bringans S, 2008, PROTEOMICS, V8, P1081, DOI 10.1002/pmic.200700948; Broekaert WF, 2006, ANNU REV PHYTOPATHOL, V44, P393, DOI 10.1146/annurev.phyto.44.070505.143440; Calla B, 2009, PLANT GENOME-US, V2, P149, DOI 10.3835/plantgenome2008.02.0008; Carpentier SC, 2008, PHYSIOL PLANTARUM, V133, P117, DOI 10.1111/j.1399-3054.2008.01069.x; Cessna SG, 2000, PLANT CELL, V12, P2191, DOI 10.1105/tpc.12.11.2191; Colditz Frank, 2007, P283, DOI 10.1007/978-3-540-72617-3_18; CUSHMAN JC, 1993, PHOTOSYNTH RES, V35, P15, DOI 10.1007/BF02185408; De Gara L, 2003, PLANT PHYSIOL BIOCH, V41, P863, DOI 10.1016/S0981-9428(03)00135-9; Dickman MB, 2001, P NATL ACAD SCI USA, V98, P6957, DOI 10.1073/pnas.091108998; EDWARDS R, 1991, PLANTA, V184, P403, DOI 10.1007/BF00195343; Eynck C, 2012, MOL PLANT PATHOL, V13, P887, DOI 10.1111/j.1364-3703.2012.00798.x; Feng HZ, 2007, PLANT PHYSIOL, V144, P1531, DOI 10.1104/pp.107.098079; Garg H, 2008, AUSTRALAS PLANT PATH, V37, P106, DOI 10.1071/AP08002; Garg H, 2010, ANN BOT-LONDON, V106, P897, DOI 10.1093/aob/mcq196; Garg H, 2010, FIELD CROP RES, V117, P51, DOI 10.1016/j.fcr.2010.01.013; Garg H, 2010, EUR J PLANT PATHOL, V126, P305, DOI 10.1007/s10658-009-9547-7; Gazaryan IG, 2002, J BIOL CHEM, V277, P10064, DOI 10.1074/jbc.M108264200; Ge XT, 2012, FIELD CROP RES, V127, P248, DOI 10.1016/j.fcr.2011.11.022; GODOY G, 1990, PHYSIOL MOL PLANT P, V37, P179, DOI 10.1016/0885-5765(90)90010-U; Govrin EM, 2000, CURR BIOL, V10, P751, DOI 10.1016/S0960-9822(00)00560-1; GROSS GG, 1977, PLANTA, V136, P271, DOI 10.1007/BF00385995; Guimaraes RL, 2004, PLANT PHYSIOL, V136, P3703, DOI 10.1104/pp.104.049650; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Halliwell B, 1989, FREE RADICALS BIOL M, VUK; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Hegedus DD, 2005, FEMS MICROBIOL LETT, V251, P177, DOI 10.1016/j.femsle.2005.07.040; Hegedus DD, 2008, PLANTA, V228, P241, DOI 10.1007/s00425-008-0733-1; Hind-Lanoiselet TL, 2004, DPI490; Hopkins MT, 2008, PLANT PHYSIOL, V148, P479, DOI 10.1104/pp.108.118869; Hu X, 2003, PLANT PHYSIOL, V133, P170, DOI 10.1104/pp.103.024026; ISHIDA A, 1987, PLANT CELL PHYSIOL, V28, P723; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Li C, 2009, 14 INT SCLER WORKSH; Li CX, 2008, AUSTRALAS PLANT PATH, V37, P162, DOI 10.1071/AP08005; Li Hua, 2007, Journal of General Plant Pathology, V73, P297, DOI 10.1007/s10327-007-0011-2; Li RG, 2004, FUNGAL GENET BIOL, V41, P754, DOI 10.1016/j.fgb.2004.03.002; Li RG, 2004, FUNGAL GENET BIOL, V41, P735, DOI 10.1016/j.fgb.2004.03.001; Liang Y, 2008, J AGR FOOD CHEM, V56, P1963, DOI 10.1021/jf073012d; Liang Y, 2009, PROTEOMICS, V9, P3156, DOI 10.1002/pmic.200800966; Liu JJ, 2006, PHYSIOL MOL PLANT P, V68, P3, DOI 10.1016/j.pmpp.2006.06.004; Liu RH, 2005, SCI CHINA SER C, V48, P460, DOI 10.1360/02yc0106; Liu XJ, 2006, J PLANT PHYSIOL, V163, P546, DOI 10.1016/j.jplph.2005.04.031; Loyall L, 2000, PLANT CELL, V12, P1939, DOI 10.1105/tpc.12.10.1939; LUMSDEN RD, 1979, PHYTOPATHOLOGY, V69, P890, DOI 10.1094/Phyto-69-890; Marra R, 2006, CURR GENET, V50, P307, DOI 10.1007/s00294-006-0091-0; Marrs KA, 1996, ANNU REV PLANT PHYS, V47, P127, DOI 10.1146/annurev.arplant.47.1.127; MAUCH F, 1993, PLANT PHYSIOL, V102, P1193, DOI 10.1104/pp.102.4.1193; Mehta A, 2008, FEBS J, V275, P3731, DOI 10.1111/j.1742-4658.2008.06528.x; Micic Z, 2005, THEOR APPL GENET, V111, P233, DOI 10.1007/s00122-005-2004-x; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Neill SJ, 2002, J EXP BOT, V53, P1237, DOI 10.1093/jexbot/53.372.1237; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; Noji M, 2001, PLANT PHYSIOL, V126, P973, DOI 10.1104/pp.126.3.973; Osmark P, 1998, PLANT MOL BIOL, V38, P1243, DOI 10.1023/A:1006060224012; PELEMAN J, 1989, PLANT CELL, V1, P81, DOI 10.1105/tpc.1.1.81; Ravanel S, 1998, P NATL ACAD SCI USA, V95, P7805, DOI 10.1073/pnas.95.13.7805; Sakihama Y, 2000, BIOCHEM BIOPH RES CO, V279, P949, DOI 10.1006/bbrc.2000.4053; Sharma N, 2008, PROTEOMICS, V8, P3516, DOI 10.1002/pmic.200701141; Sharma N, 2007, PLANT SCI, V172, P95, DOI 10.1016/j.plantsci.2006.07.016; SHINSHI H, 1990, PLANT MOL BIOL, V14, P357, DOI 10.1007/BF00028772; Slaymaker DH, 2002, P NATL ACAD SCI USA, V99, P11640, DOI 10.1073/pnas.182427699; Subramanian B, 2005, J AGR FOOD CHEM, V53, P313, DOI 10.1021/jf048922z; Tahara EB, 2007, FASEB J, V21, P274, DOI 10.1096/fj.06-6686com; UPADHYAY RS, 1992, CURR MICROBIOL, V24, P181, DOI 10.1007/BF01579279; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; WINGATE VPM, 1988, PLANT PHYSIOL, V87, P206, DOI 10.1104/pp.87.1.206; Wirtz M, 2001, EUR J BIOCHEM, V268, P686, DOI 10.1046/j.1432-1327.2001.01920.x; Yajima W, 2006, PROTEOMICS, V6, P5995, DOI 10.1002/pmic.200600424; Yang B, 2007, PLANT SCI, V173, P156, DOI 10.1016/j.plantsci.2007.04.012; Yang B, 2010, PLANT MOL BIOL REP, V28, P253, DOI 10.1007/s11105-009-0149-5; YANG SF, 1984, ANNU REV PLANT PHYS, V35, P155, DOI 10.1146/annurev.pp.35.060184.001103; Zhao JW, 2007, PLANTA, V227, P13, DOI 10.1007/s00425-007-0586-z; Zhao JW, 2009, MOL PLANT PATHOL, V10, P635, DOI [10.1111/J.1364-3703.2009.00558.X, 10.1111/j.1364-3703.2009.00558.x]; Zhao JW, 2006, THEOR APPL GENET, V112, P509, DOI 10.1007/s00122-005-0154-5	80	42	43	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65205	10.1371/journal.pone.0065205	http://dx.doi.org/10.1371/journal.pone.0065205			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776450	gold, Green Published, Green Submitted			2022-12-27	WOS:000320755400013
J	Ismadi, MZ; Higgins, S; Samarage, CR; Paganin, D; Hourigan, K; Fouras, A				Ismadi, Mohd-Zulhilmi; Higgins, Simon; Samarage, Chaminda R.; Paganin, David; Hourigan, Kerry; Fouras, Andreas			Optimisation of a Stirred Bioreactor through the Use of a Novel Holographic Correlation Velocimetry Flow Measurement Technique	PLOS ONE			English	Article							PARTICLE IMAGE VELOCIMETRY; EMBRYONIC STEM-CELLS; PIV; THERAPY; SYSTEM	We describe a method for measuring three dimensional (3D) velocity fields of a fluid at high speed, by combining a correlation-based approach with in-line holography. While this method utilizes tracer particles contained within the flow, our method does not require the holographic reconstruction of 3D images. The direct flow reconstruction approach developed here allows for measurements at seeding densities in excess of the allowable levels for techniques based on image or particle reconstruction, thus making it suited for biological flow measurement, such as the flow in bioreactor. We outline the theory behind our method, which we term Holographic Correlation Velocimetry (HCV), and subsequently apply it to both synthetic and laboratory data. Moreover, because the system is based on in-line holography, it is very efficient with regard to the use of light, as it does not rely on side scattering. This efficiency could be utilized to create a very high quality system at a modest cost. Alternatively, this efficiency makes the system appropriate for high-speed flows and low exposure times, which is essential for imaging dynamic systems.	[Ismadi, Mohd-Zulhilmi; Higgins, Simon; Samarage, Chaminda R.; Hourigan, Kerry; Fouras, Andreas] Monash Univ, Dept Mech & Aerosp Engn, Melbourne, Vic 3004, Australia; [Ismadi, Mohd-Zulhilmi; Higgins, Simon; Samarage, Chaminda R.; Hourigan, Kerry; Fouras, Andreas] Monash Univ, Div Biol Engn, Melbourne, Vic 3004, Australia; [Paganin, David] Monash Univ, Sch Phys, Melbourne, Vic 3004, Australia	Monash University; Monash University; Monash University	Ismadi, MZ (corresponding author), Monash Univ, Dept Mech & Aerosp Engn, Melbourne, Vic 3004, Australia.	zac.ismadi@monash.edu	Fouras, Andreas/A-9410-2008; Hourigan, Kerry/B-7999-2009; Ismadi, Mohd-Zulhilmi/H-9022-2016	Fouras, Andreas/0000-0002-8933-1759; Hourigan, Kerry/0000-0002-8995-1851; Ismadi, Mohd-Zulhilmi/0000-0002-7724-114X; Paganin, David/0000-0002-7758-7140	Australian Research Council [DP0987643, DP0773650]; Australia India Strategic Research Fund [BF050038]; Endeavour International Postgraduate Research Scholarship; Monash Graduate Scholarship	Australian Research Council(Australian Research Council); Australia India Strategic Research Fund(Australian GovernmentDepartment of Industry, Innovation and Science); Endeavour International Postgraduate Research Scholarship(Australian Government); Monash Graduate Scholarship(Monash University)	The authors acknowledge funding from the Australian Research Council, via the Discovery Projects scheme under DP0987643 and DP0773650, and the Australia India Strategic Research Fund BF050038. MZI is a recipient of Endeavour International Postgraduate Research Scholarship and Monash Graduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADRIAN RJ, 1991, ANNU REV FLUID MECH, V23, P261, DOI 10.1146/annurev.fl.23.010191.001401; Adrian RJ, 2005, EXP FLUIDS, V39, P159, DOI 10.1007/s00348-005-0991-7; AKIMA H, 1970, J ACM, V17, P589, DOI 10.1145/321607.321609; Arroyo MP, 2008, TOP APPL PHYS, V112, P127, DOI 10.1007/978-3-540-73528-1_7; ARROYO MP, 1991, MEAS SCI TECHNOL, V2, P1181, DOI 10.1088/0957-0233/2/12/012; BARNHART DH, 1994, APPL OPTICS, V33, P7159, DOI 10.1364/AO.33.007159; Born M, 2005, PRINCIPLES OPTICS, V7th edn; COMTEBELLOT G, 1976, ANNU REV FLUID MECH, V8, P209, DOI 10.1146/annurev.fl.08.010176.001233; Cowley J.M., 1995, DIFFRACTION PHYS; Dubsky S, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3285173; Fouras A, 2007, J APPL PHYS, V102, DOI 10.1063/1.2783978; Fouras A, 2008, EXP FLUIDS, V44, P317, DOI 10.1007/s00348-007-0404-1; Fouras A, 2007, EXP FLUIDS, V42, P799, DOI 10.1007/s00348-007-0293-3; Fouras A, 2009, EXP FLUIDS, V47, P569, DOI 10.1007/s00348-009-0616-7; Hemrajani R. R., 2004, HDB IND MIXING SCI P, P345, DOI DOI 10.1002/0471451452.CH6; Hentze H, 2007, TRENDS BIOTECHNOL, V25, P24, DOI 10.1016/j.tibtech.2006.10.010; Hinsch KD, 2002, MEAS SCI TECHNOL, V13, pR61, DOI 10.1088/0957-0233/13/7/201; Ho HY, 2006, REGEN MED, V1, P175, DOI 10.2217/17460751.1.2.175; Hoffman LM, 2005, NAT BIOTECHNOL, V23, P699, DOI 10.1038/nbt1102; Lyon A, 2007, CURR OPIN PHARMACOL, V7, P164, DOI 10.1016/j.coph.2006.10.003; Mahir N, 1996, J FLUID STRUCT, V10, P473, DOI 10.1006/jfls.1996.0032; Meinhart CD, 2000, J FLUID ENG-T ASME, V122, P285, DOI 10.1115/1.483256; Meng H, 2004, MEAS SCI TECHNOL, V15, P673, DOI 10.1088/0957-0233/15/4/009; Mountford JC, 2008, TRANSFUSION MED, V18, P1, DOI 10.1111/j.1365-3148.2007.00807.x; Nguyen CV, 2011, EXPT FLUIDS; Ooms T, 2008, MEAS SCI TECHNOL, V19, DOI 10.1088/0957-0233/19/7/074003; Pan G, 2001, PIV 01 4 INT S PART, p; Pu Y, 2000, EXP FLUIDS, V29, P184, DOI 10.1007/s003489900088; Raffel M, 2007, EXP FLUID MECH, P1, DOI 10.1007/978-3-540-72308-0; Samarage CR, 2012, EXP FLUIDS, V52, P617, DOI 10.1007/s00348-011-1080-8; Smith AG, 2003, ANNU REV CELL DEV BI, V17, P435; Soria J, 2008, MEAS SCI TECHNOL, V19, DOI 10.1088/0957-0233/19/7/074002; Theunissen R, 2007, MEAS SCI TECHNOL, V18, P275, DOI 10.1088/0957-0233/18/1/034; TROPEA C, 1995, MEAS SCI TECHNOL, V6, P605, DOI 10.1088/0957-0233/6/6/001; TYLER GA, 1976, OPT ACTA, V23, P685, DOI 10.1080/713819370; Widjaja J, 2009, OPT LASER ENG, V47, P1325, DOI 10.1016/j.optlaseng.2008.07.016; WILLERT CE, 1991, EXP FLUIDS, V10, P181	37	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65714	10.1371/journal.pone.0065714	http://dx.doi.org/10.1371/journal.pone.0065714			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776534	Green Submitted, Green Published, gold			2022-12-27	WOS:000320755400062
J	Ueyama, T; Yamamoto, Y; Ueda, K; Yajima, A; Maeda, Y; Yamashita, Y; Ito, T; Tsuruo, Y; Ichinose, M				Ueyama, Takashi; Yamamoto, Yuta; Ueda, Kazuki; Yajima, Aiji; Maeda, Yoshimasa; Yamashita, Yasunobu; Ito, Takao; Tsuruo, Yoshihiro; Ichinose, Masao			Is Gastrectomy-Induced High Turnover of Bone with Hyperosteoidosis and Increase of Mineralization a Typical Osteomalacia?	PLOS ONE			English	Article							GROWTH-HORMONE; VITAMIN-D; OSTEOPENIA; DEFICIENCY; GHRELIN; RISK; RAT; HISTOMORPHOMETRY; FUNDECTOMY; REDUCTION	Gastrectomy (GX) is thought to result in osteomalacia due to deficiencies in Vitamin D and Ca. Using a GX rat model, we showed that GX induced high turnover of bone with hyperosteoidosis, prominent increase of mineralization and increased mRNA expression of both osteoclast-derived tartrate-resistant acid phosphatase 5b and osteocalcin. The increased 1, 25(OH)(2)D-3 level and unchanged PTH and calcitonin levels suggested that conventional bone and Ca metabolic pathways were not involved or changed in compensation. Thus, GX-induced bone pathology was different from a typical osteomalacia. Gene expression profiles through microarray analysis and data mining using Ingenuity Pathway Analysis indicated that 612 genes were up-regulated and 1,097 genes were down-regulated in the GX bone. These genes were related functionally to connective tissue development, skeletal and muscular system development and function, Ca signaling and the role of osteoblasts, osteoclasts and chondrocytes. Network analysis indicated 9 genes (Aldehyde dehydrogenase 1 family, member A1; Aquaporin 9; Interleukin 1 receptor accessory protein; Very low density lipoprotein receptor; Periostin, osteoblast specific factor; Aggrecan; Gremlin 1; Angiopoietin-like 4; Wingless-type MMTV integration site family, member 10B) were hubs connected with tissue development and immunological diseases. These results suggest that chronic systemic inflammation might underlie the GX-induced pathological changes in bone.	[Ueyama, Takashi; Yamamoto, Yuta; Ito, Takao; Tsuruo, Yoshihiro] Wakayama Med Univ, Grad Sch Med, Dept Anat & Cell Biol, Wakayama, Japan; [Ueda, Kazuki; Maeda, Yoshimasa; Yamashita, Yasunobu; Ichinose, Masao] Wakayama Med Univ, Grad Sch Med, Dept Internal Med 2, Wakayama, Japan; [Yajima, Aiji] Univ Texas SW Med Ctr Dallas, Kuro Os Lab, Dept Pathol, Dallas, TX 75390 USA; [Yajima, Aiji] Akita Univ, Sch Med, Div Renal Replacement Therapeut Sci, Akita 010, Japan	Wakayama Medical University; Wakayama Medical University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Akita University	Ueyama, T (corresponding author), Wakayama Med Univ, Grad Sch Med, Dept Anat & Cell Biol, Wakayama, Japan.	tueyama@wakayama-med.ac.jp	Yamamoto, Yuta/R-1143-2019; Ichinose, Masao/HAB-1645-2022	Yamamoto, Yuta/0000-0001-5225-6989; 	Ministry of Science and Education of Japan [23592229]; Grants-in-Aid for Scientific Research [24590895] Funding Source: KAKEN	Ministry of Science and Education of Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This paper was in part supported by a Grant-in-Aid from the Ministry of Science and Education of Japan (23592229). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharon R, 2006, J BIOL CHEM, V281, P19305, DOI 10.1074/jbc.M601728200; [Anonymous], 1986, LANCET, V1, P77; CHRISTIANSEN P, 1993, BONE, V14, P755, DOI 10.1016/8756-3282(93)90207-Q; Dorsam ST, 2010, MOL IMMUNOL, V47, P1181, DOI 10.1016/j.molimm.2010.01.003; Eom CS, 2011, ANN FAM MED, V9, P257, DOI 10.1370/afm.1243; Figura N, 2005, DIGEST DIS SCI, V50, P847, DOI 10.1007/s10620-005-2651-4; Fukushima N, 2005, J BONE MINER RES, V20, P790, DOI 10.1359/JBMR.041237; GARRICK R, 1971, ANN INTERN MED, V75, P221, DOI 10.7326/0003-4819-75-2-221; Gentili C, 2009, CURR PHARM DESIGN, V15, P1334, DOI 10.2174/138161209787846739; Giustina A, 2008, ENDOCR REV, V29, P535, DOI 10.1210/er.2007-0036; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Hagiwara T, 2007, DIGEST DIS SCI, V52, P1219, DOI 10.1007/s10620-006-9253-7; Halleen JM, 2006, CLIN LAB, V52, P499; HAUSCHKA PV, 1989, PHYSIOL REV, V69, P990, DOI 10.1152/physrev.1989.69.3.990; Kanno T, 2009, BIOCHEM BIOPH RES CO, V381, P666, DOI 10.1016/j.bbrc.2009.02.109; Knowles HJ, 2010, FASEB J, V24, P4648, DOI 10.1096/fj.10-162230; KOGA S, 1979, AM J SURG, V138, P635, DOI 10.1016/0002-9610(79)90335-0; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Lehto-Axtelius D, 2002, SCAND J GASTROENTERO, V37, P437, DOI 10.1080/003655202317316079; Lehto-Axtelius D, 1998, REGUL PEPTIDES, V78, P41, DOI 10.1016/S0167-0115(98)00101-3; Lehto-Axtelius D, 2002, SCAND J GASTROENTERO, V37, P299, DOI 10.1080/003655202317284200; MALLUCHE H, 1990, KIDNEY INT, V38, P193, DOI 10.1038/ki.1990.187; Merle B, 2012, OSTEOPOROSIS INT, V23, P1199, DOI 10.1007/s00198-011-1892-7; Moe S, 2006, KIDNEY INT, V69, P1945, DOI 10.1038/sj.ki.5000414; Kulak CAM, 2010, ARQ BRAS ENDOCRINOL, V54, P87, DOI 10.1590/S0004-27302010000200002; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Parfitt AM, 1990, METABOLIC BONE DIS C, P329; PERSSON P, 1993, SCAND J GASTROENTERO, V28, P301, DOI 10.3109/00365529309090245; Recker RR, 2011, BONE, V49, P955, DOI 10.1016/j.bone.2011.07.017; Rumenapf G, 1998, CALCIFIED TISSUE INT, V63, P433; Sipponen P, 2010, SCAND J GASTROENTERO, V45, P133, DOI 10.3109/00365520903434117; Stevens JR, 2010, J BONE MINER RES, V25, P2138, DOI 10.1002/jbmr.118; Suda T, 2003, J CELL BIOCHEM, V88, P259, DOI 10.1002/jcb.10331; Sun YX, 2003, MOL CELL BIOL, V23, P7973, DOI 10.1128/MCB.23.22.7973-7981.2003; Tokudome Y, 2009, J BIOMED MATER RES B, V90B, P229, DOI 10.1002/jbm.b.31277; Trouvin AP, 2010, CLIN INTERV AGING, V5, P345, DOI 10.2147/CIA.S10153; Ubara Y, 2005, KIDNEY INT, V68, P833, DOI 10.1111/j.1523-1755.2005.00464.x; Ueyama T, 2002, ENDOCRINOLOGY, V143, P3162, DOI 10.1210/en.143.8.3162; Wojtyczka A, 1998, CLIN SCI, V95, P735, DOI 10.1042/CS19980153; WRONSKI TJ, 1988, ENDOCRINOLOGY, V123, P681, DOI 10.1210/endo-123-2-681; Yajima A, 2007, AM J KIDNEY DIS, V49, P440, DOI 10.1053/j.ajkd.2006.11.045; Yamamoto Y, 2009, PHYSIOL GENOMICS, V39, P227, DOI 10.1152/physiolgenomics.00082.2009; Yang YX, 2006, JAMA-J AM MED ASSOC, V296, P2947, DOI 10.1001/jama.296.24.2947; Zanotti S, 2008, J CELL BIOCHEM, V104, P1421, DOI 10.1002/jcb.21715; Zellin G, 2002, SCAND J GASTROENTERO, V37, P1149, DOI 10.1080/003655202760373353	45	11	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65685	10.1371/journal.pone.0065685	http://dx.doi.org/10.1371/journal.pone.0065685			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776526	Green Published, gold, Green Submitted			2022-12-27	WOS:000320755400056
J	Wan, C; Sun, JP; Chen, WZ; Yuan, XH; Chong, HH; Prabakaran, P; Dimitrov, DS; He, YX				Wan, Chao; Sun, Jianping; Chen, Weizao; Yuan, Xiaohui; Chong, Huihui; Prabakaran, Ponraj; Dimitrov, Dimiter S.; He, Yuxian			Epitope Mapping of M36, a Human Antibody Domain with Potent and Broad HIV-1 Inhibitory Activity	PLOS ONE			English	Article							HUMAN MONOCLONAL-ANTIBODIES; IMMUNODEFICIENCY-VIRUS TYPE-1; AFFINITY-SELECTED PEPTIDES; ENVELOPE GLYCOPROTEIN; COMPUTATIONAL PREDICTION; NEUTRALIZING ANTIBODIES; ENTRY INHIBITORS; FUSION PROTEINS; GP120 ENVELOPE; BINDING-SITE	M36 is the first member of a novel class of potent HIV-1 entry inhibitors based on human engineered antibody domains (eAds). It exhibits broad inhibitory activity suggesting that its CD4-induced epitope is highly conserved. Here, we describe fine mapping of its epitope by using several approaches. First, a panel of mimotopes was affinity-selected from a random peptide library and potential m36-binding residues were computationally predicted. Second, homology modeling of m36 and molecular docking of m36 onto gp120 revealed potentially important residues in gp120-m36 interactions. Third, the predicted contact residues were verified by site-directed mutagenesis. Taken together, m36 epitope comprising three discontinuous sites including six key gp120 residues (Site C1: Thr123 and Pro124; Site C3: Glu370 and Ile371; Site C4: Met426 and Trp427) were identified. In the 3D structure of gp120, the sites C1 and C4 are located in the bridging sheet and the site C3 is within the b15-alpha 3 excursion, which play essential roles for the receptor- and coreceptor-binding and are major targets of neutralizing antibodies. Based on these results we propose a precise localization of the m36 epitope and suggest a mechanism of its broad inhibitory activity which could help in the development of novel HIV-1 therapeutics based on eAds.	[Wan, Chao; Sun, Jianping; Yuan, Xiaohui; Chong, Huihui; He, Yuxian] Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China; [Wan, Chao; Sun, Jianping; Yuan, Xiaohui; Chong, Huihui; He, Yuxian] Chinese Acad Med Sci, Inst Pathogen Biol, AIDS Res Ctr, Beijing 100730, Peoples R China; [Wan, Chao; Sun, Jianping; Yuan, Xiaohui; Chong, Huihui; He, Yuxian] Peking Union Med Coll, Beijing 100021, Peoples R China; [Chen, Weizao; Prabakaran, Ponraj; Dimitrov, Dimiter S.] NCI, Prot Interact Grp, CCRNP, CCR,NIH, Frederick, MD 21701 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	He, YX (corresponding author), Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China.	yhe@ipb.pumc.edu.cn	Ponraj, Prabakaran/D-6325-2011	Ponraj, Prabakaran/0000-0002-4049-4813; chong, huihui/0000-0001-6965-2742	National Major projects for Infectious Diseases Control and Prevention [2012ZX10001008]; National Outstanding Youth Award of Natural Science Foundation of China [81025009]; National 973 Program of China [2010CB530100]; NATIONAL CANCER INSTITUTE [ZIABC011155] Funding Source: NIH RePORTER	National Major projects for Infectious Diseases Control and Prevention; National Outstanding Youth Award of Natural Science Foundation of China; National 973 Program of China(National Basic Research Program of China); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Major projects for Infectious Diseases Control and Prevention (2012ZX10001008), National Outstanding Youth Award of Natural Science Foundation of China (81025009), and National 973 Program of China (2010CB530100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armbruster C, 2002, AIDS, V16, P227, DOI 10.1097/00002030-200201250-00012; Berger EA, 1998, NAT STRUCT BIOL, V5, P671, DOI 10.1038/1362; Bublil EM, 2007, PROTEINS, V68, P294, DOI 10.1002/prot.21387; Bublil EM, 2006, FASEB J, V20, P1762, DOI 10.1096/fj.05-5509rev; Cao ZL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038126; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; Chen L, 2009, SCIENCE, V326, P1123, DOI 10.1126/science.1175868; Chen WZ, 2008, P NATL ACAD SCI USA, V105, P17121, DOI 10.1073/pnas.0805297105; Chen WZ, 2012, BIOCHEM BIOPH RES CO, V425, P931, DOI 10.1016/j.bbrc.2012.08.013; Chen WZ, 2012, AIDS RES HUM RETROV, V28, P425, DOI [10.1089/aid.2011.0226, 10.1089/AID.2011.0226]; Chen WZ, 2010, ANTIVIR RES, V88, P107, DOI 10.1016/j.antiviral.2010.08.004; Chen WZ, 2009, CURR OPIN HIV AIDS, V4, P112, DOI 10.1097/COH.0b013e328322f95e; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Darbha R, 2004, BIOCHEMISTRY-US, V43, P1410, DOI 10.1021/bi035323x; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Este JA, 2007, LANCET, V370, P81, DOI 10.1016/S0140-6736(07)61052-6; Fauci AS, 2008, NATURE, V453, P289, DOI 10.1038/453289a; Forsman A, 2008, J VIROL, V82, P12069, DOI 10.1128/JVI.01379-08; Gong R, 2012, BIODRUGS, V26, P143, DOI 10.2165/11631400-000000000-00000; Gorlani A, 2012, AIDS RES HUM RETROV, V28, P198, DOI 10.1089/aid.2011.0133; Harris A, 2011, P NATL ACAD SCI USA, V108, P11440, DOI 10.1073/pnas.1101414108; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Labrijn AF, 2003, J VIROL, V77, P10557, DOI 10.1128/JVI.77.19.10557-10565.2003; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Mayrose I, 2007, BIOINFORMATICS, V23, P3244, DOI 10.1093/bioinformatics/btm493; McCoy LE, 2012, J EXP MED, V209, P1091, DOI 10.1084/jem.20112655; Meyerson JR, 2013, P NATL ACAD SCI USA, V110, P513, DOI 10.1073/pnas.1214810110; Moulard M, 2002, P NATL ACAD SCI USA, V99, P6913, DOI 10.1073/pnas.102562599; Rose PW, 2013, NUCLEIC ACIDS RES, V41, pD475, DOI 10.1093/nar/gks1200; Tarnovitski N, 2006, J MOL BIOL, V359, P190, DOI 10.1016/j.jmb.2006.03.008; Tran EEH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002797; Trkola A, 2005, NAT MED, V11, P615, DOI 10.1038/nm1244; Veazey RS, 2003, NAT MED, V9, P343, DOI 10.1038/nm833; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; White TA, 2011, J VIROL, V85, P12114, DOI 10.1128/JVI.05297-11; White TA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001249; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Zhang MY, 2004, J VIROL, V78, P9233, DOI 10.1128/JVI.78.17.9233-9242.2004; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817	43	8	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66638	10.1371/journal.pone.0066638	http://dx.doi.org/10.1371/journal.pone.0066638			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776690	Green Submitted, Green Published, gold			2022-12-27	WOS:000320755400152
J	Wang, HY; Wang, GL; Wang, CX; Wei, Y; Wen, ZT; Wang, CY; Zhu, A				Wang, Haiyun; Wang, Guolin; Wang, Chenxu; Wei, Ying; Wen, Zhiting; Wang, Chunyan; Zhu, Ai			RETRACTED: The Early Stage Formation of PI3K-AMPAR GluR2 Subunit Complex Facilitates the Long Term Neuroprotection Induced by Propofol Post-Conditioning in Rats (Retracted article. See vol. 13, artn E0196886, 2018)	PLOS ONE			English	Article; Retracted Publication							FOCAL CEREBRAL-ISCHEMIA; PHOSPHOINOSITIDE 3-KINASE/AKT; SIGNALING PATHWAYS; BRAIN ISCHEMIA; GLUTAMATE; NEUROGENESIS; EXPRESSION; RECEPTORS; CALCIUM; INJURY	Previously, we have shown that the phosphoinositide-3-kinase (PI3K) mediated acute (24 h) post-conditioning neuroprotection induced by propofol. We also found that propofol post-conditioning produced long term neuroprotection and inhibited the internalization of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor GluR2 subunit up to 28 days post middle cerebral artery occlusion (MCAO). However, the relationship between PI3K with AMPA receptor GluR2 subunit trafficking in propofol post-conditioning has never been explored. Here we showed that propofol post-conditioning promoted the binding of PI3K to the C-terminal of AMPA receptor GluR2 subunit and formed a complex within 1 day after transient MCAO. Interestingly, the enhanced activity of PI3K was observed in the hippocampus of post-conditioning rats at day 1 post ischemia, whereas the decrease of AMPA receptor GluR2 subunit internalization was found up to 28 days in the same group. Administration of PI3K selective antagonist wortmannin inhibited the improvement of spatial learning memory and the increase of neurogenesis in the dentate gyrus up to 28 days post ischemia. It also reversed the inhibition of AMPA receptor GluR2 internalization induced by propofol post-conditioning. Together, our data indicated the critical role of PI3K in regulating the long term neuroprotection induced by propofol post-conditioning. Moreover, this role was established by first day activation of PI3K and formation of PI3K-AMPA receptor GluR2 complex, thus stabilized the structure of postsnaptic AMPA receptor and inhibited the internalization of GluR2 subunit during the early stage of propofol post-conditioning.	[Wang, Haiyun; Wang, Guolin; Wang, Chenxu; Wei, Ying; Wen, Zhiting; Wang, Chunyan; Zhu, Ai] Tianjin Med Univ Gen Hosp, Tianjin Res Inst Anesthesiol, Dept Anesthesiol, Tianjin, Peoples R China	Tianjin Medical University	Wang, HY (corresponding author), Tianjin Med Univ Gen Hosp, Tianjin Res Inst Anesthesiol, Dept Anesthesiol, Tianjin, Peoples R China.	wanghy819@hotmail.com			Natural Science Foundation of China [81071059, 81100984, 30972847]; Science and Technology Supported Key Project of Tianjin [12ZCZDSY03000]; Tianjin Health Bureau [09KZ106]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Supported Key Project of Tianjin; Tianjin Health Bureau	This work was supported by Natural Science Foundation of China (81071059, 81100984, 30972847), Science and Technology Supported Key Project of Tianjin (12ZCZDSY03000), Scientific Grant from Tianjin Health Bureau (09KZ106). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arendt KL, 2010, NAT NEUROSCI, V13, P36, DOI 10.1038/nn.2462; Barry MF, 2002, CURR OPIN NEUROBIOL, V12, P279, DOI 10.1016/S0959-4388(02)00329-X; Bhattacharyya S, 2012, DIABETOLOGIA, V55, P194, DOI 10.1007/s00125-011-2333-z; Boudreau AC, 2005, J NEUROSCI, V25, P9144, DOI 10.1523/JNEUROSCI.2252-05.2005; Bredesen DE, 1995, ANN NEUROL, V38, P839, DOI 10.1002/ana.410380604; Burnashev N, 1996, CURR OPIN NEUROBIOL, V6, P311, DOI 10.1016/S0959-4388(96)80113-9; Chan PH, 2004, NEUROCHEM RES, V29, P1943, DOI 10.1007/s11064-004-6869-x; CHOI DW, 1990, J NEUROSCI, V10, P2493; CHOI DW, 1995, TRENDS NEUROSCI, V18, P58; Chuang CC, 2007, ENDOCRINOLOGY, V148, P4267, DOI 10.1210/en.2007-0179; Dingledine R, 1999, PHARMACOL REV, V51, P7; Engelhard K, 2007, ANESTH ANALG, V104, P898, DOI 10.1213/01.ane.0000255730.73018.31; Filippa N, 1999, MOL CELL BIOL, V19, P4989; Franke TF, 2003, ONCOGENE, V22, P8983, DOI 10.1038/sj.onc.1207115; Gryder DS, 2005, J NEUROCHEM, V94, P1728, DOI 10.1111/j.1471-4159.2005.03334.x; Gu ZL, 2005, J NEUROSCI, V25, P4974, DOI 10.1523/JNEUROSCI.1086-05.2005; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; HUME RI, 1991, SCIENCE, V253, P1028, DOI 10.1126/science.1653450; Jackson C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011962; Lie DC, 2004, ANNU REV PHARMACOL, V44, P399, DOI 10.1146/annurev.pharmtox.44.101802.121631; Liu BS, 2006, J NEUROSCI, V26, P5309, DOI 10.1523/JNEUROSCI.0567-06.2006; Liu JL, 1998, J NEUROSCI, V18, P7768; Lu C, 2011, J IMMUNOL, V187, P1458, DOI 10.4049/jimmunol.1003428; MAYAT E, 1995, J NEUROSCI, V15, P2533, DOI 10.1523/JNEUROSCI.15-03-02533.1995; MELDRUM BS, 1995, ANN NY ACAD SCI, V757, P492, DOI 10.1111/j.1749-6632.1995.tb17509.x; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Ohta H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017137; Parent JM, 2003, NEUROSCIENTIST, V9, P261, DOI 10.1177/1073858403252680; Peng PL, 2006, NEURON, V49, P719, DOI 10.1016/j.neuron.2006.01.025; PUTTFARCKEN PS, 1993, BRAIN RES, V624, P223, DOI 10.1016/0006-8993(93)90081-W; Ripple MO, 2005, BREAST CANCER RES TR, V93, P177, DOI 10.1007/s10549-005-4794-6; Robin E, 2011, BRAIN RES, V1375, P137, DOI 10.1016/j.brainres.2010.12.054; ROTHMAN SM, 1986, ANN NEUROL, V19, P105, DOI 10.1002/ana.410190202; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Takasawa K, 2002, J CEREBR BLOOD F MET, V22, P299, DOI 10.1097/00004647-200203000-00007; Tanaka H, 2000, BRAIN RES, V886, P190, DOI 10.1016/S0006-8993(00)02951-6; Tonchev AB, 2011, ARCH ITAL BIOL, V149, P225, DOI 10.4449/aib.v149i2.1368; Vanhaesebroeck B, 1997, TRENDS BIOCHEM SCI, V22, P267, DOI 10.1016/S0968-0004(97)01061-X; Wang HY, 2009, BRAIN RES, V1297, P177, DOI 10.1016/j.brainres.2009.08.054; Wang HY, 2011, J NEUROCHEM, V119, P210, DOI 10.1111/j.1471-4159.2011.07400.x; Xing BZ, 2008, J NEUROCHEM, V105, P1737, DOI 10.1111/j.1471-4159.2008.05276.x; Yuan HS, 2006, J MED CHEM, V49, P740, DOI 10.1021/jm050699p; Yuan H, 2009, BIOORG MED CHEM LETT, V19, P4223, DOI 10.1016/j.bmcl.2009.05.105; Yun YJ, 2007, BIOL PHARM BULL, V30, P337, DOI 10.1248/bpb.30.337; Zhang WQ, 2011, J CLIN NEUROSCI, V18, P685, DOI 10.1016/j.jocn.2010.08.027; Zhang WQ, 2010, INT J MOL SCI, V11, P4407, DOI 10.3390/ijms11114407; Zhao H, 2005, J NEUROSCI, V25, P9794, DOI 10.1523/JNEUROSCI.3163-05.2005	49	11	20	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65187	10.1371/journal.pone.0065187	http://dx.doi.org/10.1371/journal.pone.0065187			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776449	Green Published, Green Submitted, gold			2022-12-27	WOS:000320755400012
J	Weng, SJ; Estevez, ME; Berson, DM				Weng, Shijun; Estevez, Maureen E.; Berson, David M.			Mouse Ganglion-Cell Photoreceptors Are Driven by the Most Sensitive Rod Pathway and by Both Types of Cones	PLOS ONE			English	Article							KNOCKOUT OPN4(-/-) MICE; INNER PLEXIFORM LAYER; MAMMALIAN RETINA; BIPOLAR CELLS; CIRCADIAN CLOCK; AMACRINE CELLS; SUPRACHIASMATIC NUCLEUS; VISUAL SENSITIVITY; LIGHT RESPONSES; PRIMATE RETINA	Intrinsically photosensitive retinal ganglion cells (ipRGCs) are depolarized by light by two mechanisms: directly, through activation of their photopigment melanopsin; and indirectly through synaptic circuits driven by rods and cones. To learn more about the rod and cone circuits driving ipRGCs, we made multielectrode array (MEA) and patch-clamp recordings in wildtype and genetically modified mice. Rod-driven ON inputs to ipRGCs proved to be as sensitive as any reaching the conventional ganglion cells. These signals presumably pass in part through the primary rod pathway, involving rod bipolar cells and AII amacrine cells coupled to ON cone bipolar cells through gap junctions. Consistent with this interpretation, the sensitive rod ON input to ipRGCs was eliminated by pharmacological or genetic disruption of gap junctions, as previously reported for conventional ganglion cells. A presumptive cone input was also detectable as a brisk, synaptically mediated ON response that persisted after disruption of rod ON pathways. This was roughly three log units less sensitive than the rod input. Spectral analysis revealed that both types of cones, the M-and S-cones, contribute to this response and that both cone types drive ON responses. This contrasts with the blue-OFF, yellow-ON chromatic opponency reported in primate ipRGCs. The cone-mediated response was surprisingly persistent during steady illumination, echoing the tonic nature of both the rod input to ipRGCs and their intrinsic, melanopsin-based phototransduction. These synaptic inputs greatly expand the dynamic range and spectral bandpass of the non-image-forming visual functions for which ipRGCs provide the principal retinal input.	[Weng, Shijun; Estevez, Maureen E.; Berson, David M.] Brown Univ, Dept Neurosci, Providence, RI 02912 USA; [Weng, Shijun] Fudan Univ, Inst Brain Sci, Inst Neurobiol, Shanghai 200433, Peoples R China; [Weng, Shijun] Fudan Univ, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China	Brown University; Fudan University; Fudan University	Berson, DM (corresponding author), Brown Univ, Dept Neurosci, Providence, RI 02912 USA.	David_Berson@brown.edu		Stabio, Maureen/0000-0002-2159-5301	National Eye Institute of the National Institutes of Health [R01 EY17137, EY12793, F32-EY021994]; National Science Foundation of China [31100796]; NATIONAL EYE INSTITUTE [F32EY021994, R01EY012793, R01EY017137] Funding Source: NIH RePORTER	National Eye Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This project was supported by grants from the National Eye Institute of the National Institutes of Health (http://www.nei.nih.gov/) to D. Berson (R01 EY17137 and EY12793) and to M. Estevez (F32-EY021994) and by a grant from National Science Foundation of China (http://www.nsfc.gov.cn/e_nsfc/desktop/zn/0101.htm) to S. Weng (31100796). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-El-Barr MM, 2009, J NEUROPHYSIOL, V102, P1945, DOI 10.1152/jn.00142.2009; Aggelopoulos NC, 2000, J PHYSIOL-LONDON, V523, P211, DOI 10.1111/j.1469-7793.2000.t01-1-00211.x; Altimus CM, 2010, NAT NEUROSCI, V13, P1107, DOI 10.1038/nn.2617; ALTIMUS CM, 2008, P NATL ACAD SCI US; Applebury ML, 2000, NEURON, V27, P513, DOI 10.1016/S0896-6273(00)00062-3; BASSI CJ, 1986, PHYSIOL BEHAV, V38, P871, DOI 10.1016/0031-9384(86)90056-9; BASSI CJ, 1987, INVEST OPHTH VIS SCI, V28, P1811; Baver SB, 2008, EUR J NEUROSCI; Belenky MA, 2003, J COMP NEUROL, V460, P380, DOI 10.1002/cne.10652; Berson DM, 2010, J COMP NEUROL, V518, P2405, DOI 10.1002/cne.22381; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Bloomfield SA, 2001, PROG RETIN EYE RES, V20, P351, DOI 10.1016/S1350-9462(00)00031-8; Brown TM, 2011, VISION RES, V51, P280, DOI 10.1016/j.visres.2010.08.010; BURKHARDT DA, 1994, J NEUROSCI, V14, P1091, DOI 10.1523/JNEUROSCI.14-03-01091.1994; Calvert PD, 2000, P NATL ACAD SCI USA, V97, P13913, DOI 10.1073/pnas.250478897; Chang L, 2013, NEURON, V77, P559, DOI 10.1016/j.neuron.2012.12.012; CHUN MH, 1993, J COMP NEUROL, V332, P421, DOI 10.1002/cne.903320404; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; Dang L, 2004, MOL VIS, V10, P323; Deans MR, 2002, NEURON, V36, P703, DOI 10.1016/S0896-6273(02)01046-2; Deans MR, 2001, NEURON, V31, P477, DOI 10.1016/S0896-6273(01)00373-7; DEVRIES SH, 1995, P NATL ACAD SCI USA, V92, P10658, DOI 10.1073/pnas.92.23.10658; Dkhissi-Benyahya O, 2007, NEURON, V53, P677, DOI 10.1016/j.neuron.2007.02.005; Drouyer E, 2007, J NEUROSCI, V27, P9623, DOI 10.1523/JNEUROSCI.1391-07.2007; Dumitrescu ON, 2009, J COMP NEUROL, V517, P226, DOI 10.1002/cne.22158; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; Ekesten B, 2000, VISION RES, V40, P2573, DOI 10.1016/S0042-6989(00)00122-X; Ekesten B, 2005, VISUAL NEUROSCI, V22, P893, DOI 10.1017/S0952523805226172; Estevez ME, 2012, J NEUROSCI, V32, P13608, DOI 10.1523/JNEUROSCI.1422-12.2012; Goz D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003153; Gooley JJ, 2001, NAT NEUROSCI, V4, P1165, DOI 10.1038/nn768; Gooley JJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000741; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Hannibal J, 2004, CELL TISSUE RES, V316, P99, DOI 10.1007/s00441-004-0858-x; Hatori M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002451; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Haverkamp S, 2005, J NEUROSCI, V25, P5438, DOI 10.1523/JNEUROSCI.1117-05.2005; Hoshi H, 2009, J NEUROSCI, V29, P8875, DOI 10.1523/JNEUROSCI.0912-09.2009; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Jusuf PR, 2007, EUR J NEUROSCI, V26, P2906, DOI 10.1111/j.1460-9568.2007.05924.x; KOLB H, 1974, SCIENCE, V186, P47, DOI 10.1126/science.186.4158.47; LAMB TD, 1995, VISION RES, V35, P3083, DOI 10.1016/0042-6989(95)00114-F; Lee EJ, 2003, EUR J NEUROSCI, V18, P2925, DOI 10.1046/j.1460-9568.2003.03049.x; Li HY, 2009, J NEUROSCI, V29, P15178, DOI 10.1523/JNEUROSCI.3517-09.2009; Li L, 1998, VISUAL NEUROSCI, V15, P851, DOI 10.1017/S0952523898155050; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Lupi D, 2006, CHRONOBIOL INT, V23, P167, DOI 10.1080/07420520500545870; LUPI D, 2008, NAT NEUROSCI; Mangel S C, 2001, Prog Brain Res, V131, P505; MCGUIRE BA, 1984, J NEUROSCI, V4, P2920; Mills SL, 2001, J COMP NEUROL, V436, P336; Muller LPD, 2010, J COMP NEUROL, V518, P4813, DOI 10.1002/cne.22490; Nathan J, 2006, PHOTOCHEM PHOTOBIOL, V82, P1489, DOI 10.1562/2006-02-27-RA-818; NORMANN RA, 1979, J PHYSIOL-LONDON, V286, P491, DOI 10.1113/jphysiol.1979.sp012633; Ostergaard J, 2007, INVEST OPHTH VIS SCI, V48, P3812, DOI 10.1167/iovs.06-1322; Pan F, 2007, VISUAL NEUROSCI, V24, P609, DOI 10.1017/S0952523807070472; Panda S, 2003, SCIENCE, V301, P525, DOI 10.1126/science.1086179; Panda S, 2002, SCIENCE, V298, P2213, DOI 10.1126/science.1076848; Pang JJ, 2010, P NATL ACAD SCI USA, V107, P395, DOI 10.1073/pnas.0907178107; PENN JS, 1984, VISION RES, V24, P1673, DOI 10.1016/0042-6989(84)90325-0; Perez-Leon JA, 2006, EUR J NEUROSCI, V24, P1117, DOI 10.1111/j.1460-9568.2006.04999.x; Pickard GE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004984; ROHLICH P, 1994, NEURON, V13, P1159, DOI 10.1016/0896-6273(94)90053-1; ROSENWASSER AM, 1979, PHYSIOL BEHAV, V23, P17, DOI 10.1016/0031-9384(79)90115-X; Ruby NF, 2002, SCIENCE, V298, P2211, DOI 10.1126/science.1076701; Schmidt TM, 2008, J NEUROPHYSIOL, V100, P371, DOI 10.1152/jn.00062.2008; Schmidt TM, 2010, J NEUROSCI, V30, P16262, DOI 10.1523/JNEUROSCI.3656-10.2010; Schmidt TM, 2009, J NEUROSCI, V29, P476, DOI 10.1523/JNEUROSCI.4117-08.2009; Semo M, 2003, EUR J NEUROSCI, V17, P1793, DOI 10.1046/j.1460-9568.2003.02616.x; Sharpe LT, 1999, TRENDS NEUROSCI, V22, P497, DOI 10.1016/S0166-2236(99)01458-7; Tsai JW, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000125; Tsukamoto Y, 2007, J NEUROSCI, V27, P6261, DOI 10.1523/JNEUROSCI.5646-06.2007; Tu DC, 2005, NEURON, V48, P987, DOI 10.1016/j.neuron.2005.09.031; VERUKI ML, 2009, J NEUROPHYSIOL; Viney TJ, 2007, CURR BIOL, V17, P981, DOI 10.1016/j.cub.2007.04.058; Volgyi B, 2004, J NEUROSCI, V24, P11182, DOI 10.1523/JNEUROSCI.3096-04.2004; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; WASSLE H, 1995, J COMP NEUROL, V361, P537, DOI 10.1002/cne.903610315; Weng SJ, 2009, J BIOL RHYTHM, V24, P391, DOI 10.1177/0748730409343767; Wong KY, 2007, J PHYSIOL-LONDON, V582, P279, DOI 10.1113/jphysiol.2007.133751; Wong KY, 2012, J NEUROSCI, V32, P11478, DOI 10.1523/JNEUROSCI.1423-12.2012; Yin L, 2009, J NEUROSCI, V29, P2706, DOI 10.1523/JNEUROSCI.5471-08.2009; Zhang J, 2004, J COMP NEUROL, V470, P1, DOI 10.1002/cne.10967; Zhu YL, 2007, INVEST OPHTH VIS SCI, V48, P1268, DOI 10.1167/iovs.06-0925	85	54	54	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e66480	10.1371/journal.pone.0066480	http://dx.doi.org/10.1371/journal.pone.0066480			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762490	gold, Green Published, Green Submitted			2022-12-27	WOS:000321094800099
J	Ahi, EP; Guobrandsson, J; Kapralova, KH; Franzdottir, SR; Snorrason, SS; Maier, VH; Jonsson, ZO				Ahi, Ehsan Pashay; Guobrandsson, Johannes; Kapralova, Kalina H.; Franzdottir, Sigriour R.; Snorrason, Sigurour S.; Maier, Valerie H.; Jonsson, Zophonias O.			Validation of Reference Genes for Expression Studies during Craniofacial Development in Arctic Charr	PLOS ONE			English	Article							POTENTIAL REFERENCE GENES; POLYMERASE-CHAIN-REACTION; TIME QUANTITATIVE PCR; SALVELINUS-ALPINUS; RELATIVE QUANTIFICATION; ATLANTIC SALMON; LIFE-HISTORY; RNA-SEQ; RT-PCR; SOX9	Arctic charr (Salvelinus alpinus) is a highly polymorphic species and in Lake Thingvallavatn, Iceland, four phenotypic morphs have evolved. These differences in morphology, especially in craniofacial structures are already apparent during embryonic development, indicating that genes important in the formation of the craniofacial features are expressed differentially between the morphs. In order to generate tools to examine these expression differences in Arctic charr, the aim of the present study was to identify reference genes for quantitative real-time PCR (qPCR). The specific aim was to select reference genes which are able to detect very small expression differences among different morphs. We selected twelve candidate reference genes from the literature, identified corresponding charr sequences using data derived from transcriptome sequencing (RNA-seq) and examined their expression using qPCR. Many of the candidate reference genes were found to be stably expressed, yet their quality-rank as reference genes varied considerably depending on the type of analysis used. In addition to commonly used software for reference gene validation, we used classical statistics to evaluate expression profiles avoiding a bias for reference genes with similar expression patterns (co-regulation). Based on these analyses we chose three reference genes, ACTB, UB2L3 and IF5A1 for further evaluation. Their consistency was assessed in an expression study of three known craniofacially expressed genes, sparc (or osteonectin), matrix metalloprotease 2 (mmp2) and sox9 (sex-determining region Y box 9 protein) using qPCR in embryo heads derived from four charr groups at three developmental time points. The three reference genes were found to be very suitable for studying expression differences between the morphotypes, enabling robust detection of small relative expression changes during charr development. Further, the results showed that sparc and mmp2 are differentially expressed in embryos of different Arctic charr morphotypes.	[Ahi, Ehsan Pashay; Guobrandsson, Johannes; Kapralova, Kalina H.; Snorrason, Sigurour S.; Maier, Valerie H.; Jonsson, Zophonias O.] Univ Iceland, Inst Life & Environm Sci, Reykjavik, Iceland; [Franzdottir, Sigriour R.] Univ Iceland, Biomed Ctr, Reykjavik, Iceland	University of Iceland; University of Iceland	Maier, VH (corresponding author), Univ Iceland, Inst Life & Environm Sci, Reykjavik, Iceland.	valerie@hi.is	Franzdottir, Sigridur/M-2534-2015; Jónsson, Zophonías Oddur/AAO-1354-2020; Jónsson, Zophonías/E-1960-2015	Jónsson, Zophonías Oddur/0000-0001-5798-9647; Maier, Valerie Helene/0000-0003-2193-477X; Pashay Ahi, Ehsan/0000-0002-6528-1187; Kapralova, Kalina/0000-0002-5571-0160; Gudbrandsson, Johannes/0000-0002-2231-0910	Icelandic Centre for Research (RANNIS) [100204011]; University of Iceland	Icelandic Centre for Research (RANNIS); University of Iceland	This project was supported by The Icelandic Centre for Research (RANNIS #100204011) and the University of Iceland Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertson RC, 2006, HEREDITY, V97, P211, DOI 10.1038/sj.hdy.6800864; Allendorf F.W., 1984, P1; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Andreassen R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-502; Bell DM, 1997, NAT GENET, V16, P174, DOI 10.1038/ng0697-174; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Bustin SA, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-74; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chiang EFL, 2001, DEV BIOL, V231, P149, DOI 10.1006/dbio.2000.0129; Chlenski A, 2010, SEMIN CELL DEV BIOL, V21, P55, DOI 10.1016/j.semcdb.2009.11.018; Danos N, 2010, J APPL ICHTHYOL, V26, P156, DOI 10.1111/j.1439-0426.2010.01396.x; Derveaux S, 2010, METHODS, V50, P227, DOI 10.1016/j.ymeth.2009.11.001; Eiriksson G. M., 1999, Journal of Fish Biology, V55, P175, DOI 10.1111/j.1095-8649.1999.tb01054.x; Fujita T, 2002, J ORAL PATHOL MED, V31, P345, DOI 10.1034/j.1600-0714.2002.00188.x; Gilles C, 1998, CANCER RES, V58, P5529; Gorodilov YN, 1996, ENVIRON BIOL FISH, V47, P109, DOI 10.1007/BF00005034; Healy C, 1999, DEV DYNAM, V215, P69, DOI 10.1002/(SICI)1097-0177(199905)215:1<69::AID-DVDY8>3.3.CO;2-E; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Henricson A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-412; Hillegass JM, 2008, TOXICOL SCI, V102, P413, DOI 10.1093/toxsci/kfn010; Hulsey CD, 2005, ZEBRAFISH, V2, P243, DOI 10.1089/zeb.2005.2.243; Javidan Y, 2004, METHOD CELL BIOL, V76, P415; JONSSON B, 1988, CAN J FISH AQUAT SCI, V45, P1537, DOI 10.1139/f88-182; Jorgensen SM, 2006, MAR BIOTECHNOL, V8, P398, DOI 10.1007/s10126-005-5164-4; Kapralova KH, 2011, HEREDITY, V106, P472, DOI 10.1038/hdy.2010.161; Kluver N, 2005, DEV GENES EVOL, V215, P297, DOI 10.1007/s00427-005-0477-x; Koop BF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-545; Koopman P, 2004, GENE, V328, P177, DOI 10.1016/j.gene.2003.12.008; LANE TF, 1994, FASEB J, V8, P163, DOI 10.1096/fasebj.8.2.8119487; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Macqueen DJ, 2006, FEBS LETT, V580, P4996, DOI 10.1016/j.febslet.2006.08.016; Macqueen DJ, 2011, MOL ECOL, V20, P3167, DOI 10.1111/j.1365-294X.2011.05172.x; Macqueen DJ, 2010, BIOCHEM BIOPH RES CO, V400, P599, DOI 10.1016/j.bbrc.2010.08.110; Macqueen DJ, 2010, PHYSIOL GENOMICS, V42, P134, DOI 10.1152/physiolgenomics.00045.2010; MALMQUIST HJ, 1992, J ANIM ECOL, V61, P21, DOI 10.2307/5505; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; McClung HM, 2007, NEUROSCI LETT, V419, P172, DOI 10.1016/j.neulet.2007.04.037; Mosig RA, 2007, HUM MOL GENET, V16, P1113, DOI 10.1093/hmg/ddm060; Overgard AC, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-36; Parsons KJ, 2010, EVOL DEV, V12, P246, DOI 10.1111/j.1525-142X.2010.00410.x; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; R Development Core Team, 2021, R PROJECT STAT COMPU; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Renn J, 2006, GENE, V372, P208, DOI 10.1016/j.gene.2006.01.011; Rexroad CE, 2003, CYTOGENET GENOME RES, V102, P347, DOI 10.1159/000075773; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rotllant J, 2008, MATRIX BIOL, V27, P561, DOI 10.1016/j.matbio.2008.03.001; Saele O, 2009, COMP BIOCHEM PHYS B, V152, P94, DOI 10.1016/j.cbpb.2008.10.002; SANDLUND OT, 1992, OIKOS, V64, P305, DOI 10.2307/3545056; Seet LF, 2012, J CELL MOL MED, V16, P1245, DOI 10.1111/j.1582-4934.2011.01400.x; Sibthorpe D, 2006, COMP BIOCHEM PHYS B, V145, P371, DOI 10.1016/j.cbpb.2006.08.013; SKULASON S, 1995, TRENDS ECOL EVOL, V10, P366, DOI 10.1016/S0169-5347(00)89135-1; SKULASON S, 1989, BIOL J LINN SOC, V38, P281, DOI 10.1111/j.1095-8312.1989.tb01579.x; SKULASON S, 1989, J FISH BIOL, V35, P225; Socha MJ, 2007, AM J PATHOL, V171, P1104, DOI 10.2353/ajpath.2007.061273; Szabo-Rogers HL, 2010, DEV BIOL, V341, P84, DOI 10.1016/j.ydbio.2009.11.021; Takamatsu N, 1997, GENE, V202, P167, DOI 10.1016/S0378-1119(97)00483-6; Tang RY, 2007, ACTA BIOCH BIOPH SIN, V39, P384, DOI 10.1111/j.1745-7270.2007.00283.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vesterlund L, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-30; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Ward AJW, 2006, FISH FISH, V7, P231, DOI 10.1111/j.1467-2979.2006.00224.x; Whiteley AR, 2007, BIOL J LINN SOC, V92, P253, DOI 10.1111/j.1095-8312.2007.00845.x; Yamanaka M, 2001, J UROLOGY, V166, P2495, DOI 10.1016/S0022-5347(05)65623-6; Yan YL, 2002, DEVELOPMENT, V129, P5065; Ye X, 2010, BIOTECHNOL LETT, V32, P1031, DOI 10.1007/s10529-010-0258-0; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhao Q, 1997, DEV DYNAM, V209, P377, DOI 10.1002/(SICI)1097-0177(199708)209:4<377::AID-AJA5>3.0.CO;2-F; Zheng WJ, 2011, FISH SHELLFISH IMMUN, V30, P638, DOI 10.1016/j.fsi.2010.12.014; Zhong QW, 2008, MAR BIOTECHNOL, V10, P310, DOI 10.1007/s10126-007-9064-7	74	23	24	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66389	10.1371/journal.pone.0066389	http://dx.doi.org/10.1371/journal.pone.0066389			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785496	Green Published, gold, Green Submitted			2022-12-27	WOS:000321038800026
J	Blanco, G; Hornero-Mendez, D; Lambertucci, SA; Bautista, LM; Wiemeyer, G; Sanchez-Zapata, JA; Garrido-Fernandez, J; Hiraldo, F; Donazar, JA				Blanco, Guillermo; Hornero-Mendez, Damaso; Lambertucci, Sergio A.; Bautista, Luis M.; Wiemeyer, Guillermo; Sanchez-Zapata, Jose A.; Garrido-Fernandez, Juan; Hiraldo, Fernando; Donazar, Jose A.			Need and Seek for Dietary Micronutrients: Endogenous Regulation, External Signalling and Food Sources of Carotenoids in New World Vultures	PLOS ONE			English	Article							PLASMA CAROTENOIDS; INTERSPECIFIC VARIATION; PIGMENTS; COLORATION; BIOAVAILABILITY; METABOLISM; PLUMAGE; ASSOCIATIONS; ABSORPTION; PARASITES	Among birds, vultures show low concentrations of plasma carotenoids due to the combination of their large size, general dull colouration and a diet based on carrion. We recorded the concentration of each carotenoid type present in plasma of the Andean condor (Vultur gryphus) according to age and sex, that determine colour signalling and dominance hierarchies in the carcasses. We compared the carotenoid profile in wild condors with that of captive condors fed with a controlled diet of flesh to test the hypothesis that wild individuals could acquire extra carotenoids from vegetal matter contained in carcass viscera and fresh vegetation. Wild American black vultures (Coragyps atratus) were also sampled to evaluate the potential influence of colouration in the integument on absorption and accumulation patterns of plasma carotenoids. A remarkably higher concentration of lutein than beta-carotene was found in wild condors, while the contrary pattern was recorded in American black vultures and captive condors. We found a consistent decrease in all plasma carotenoids with age, and a lower concentration of most xanthophylls in male compared to female wild condors. Positive correlations of all carotenoids indicated general common absorption and accumulation strategies or a single dietary source containing all pigments found in plasma. The comparatively low total concentration of carotenoids, and especially of lutein rather than beta-carotene, found in captive condors fed with a diet restricted to flesh supports the hypothesis that Andean condors can efficiently acquire carotenoids from vegetal matter in the wild. Andean condors seem to be physiologically more competent in the uptake or accumulation of xanthophylls than American black vultures, which agrees with the use of colour-signalling strategies in sexual and competitive contexts in the Andean condor. This study suggests that vultures may use dietary vegetal supplements that provide pigments and micronutrients that are scarce or missing in carrion.	[Blanco, Guillermo; Bautista, Luis M.] Natl Museum Nat Hist CSIC, Dept Evolutionary Ecol, Madrid, Spain; [Hornero-Mendez, Damaso; Garrido-Fernandez, Juan] Inst Grasa CSIC, Dept Biotecnol, Seville, Spain; [Lambertucci, Sergio A.] CONICET Univ Nacl Comahue, Laboratorio Ecotono INIBIOMA, San Carlos De Bariloche, Rio Negro, Argentina; [Wiemeyer, Guillermo] Jardin Zool Ciudad Buenos Aires, Buenos Aires, DF, Argentina; [Garrido-Fernandez, Juan] Univ Miguel Hernandez, Dept Appl Biol, Alicante, Spain; [Hiraldo, Fernando; Donazar, Jose A.] Estac Biol Donana CSIC, Dept Conservat Biol, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de la Grasa (IG); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional del Comahue; Universidad Miguel Hernandez de Elche; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Blanco, G (corresponding author), Natl Museum Nat Hist CSIC, Dept Evolutionary Ecol, Jose Gutierrez Abascal 2, Madrid, Spain.	gblanco@mncn.csic.es	Garrido-Fernández, Juan/K-8222-2017; Hornero-Mendez, Damaso/H-2507-2012; Sanchez-Zapata, Jose Antonio/H-1413-2015; Hiraldo, Fernando/AAA-8314-2019; Blanco, Guillermo/L-3170-2014; Bautista-Sopelana, Luis M./B-1735-2008	Garrido-Fernández, Juan/0000-0002-6796-5646; Hornero-Mendez, Damaso/0000-0002-1781-5703; Sanchez-Zapata, Jose Antonio/0000-0001-8230-4953; Blanco, Guillermo/0000-0001-5742-4929; Bautista-Sopelana, Luis M./0000-0002-1503-652X; Donazar, Jose Antonio/0000-0002-9433-9755; LAMBERTUCCI, SERGIO/0000-0002-2624-2185	Fundacion Banco Bilbao Vizcaya Argentaria project [BIOCON-08-126]; Spanish Ministerio de Economia y Competitividad [CGL2009-12753-C02-01]; CYTED	Fundacion Banco Bilbao Vizcaya Argentaria project; Spanish Ministerio de Economia y Competitividad(Spanish Government); CYTED	This work was funded by Fundacion Banco Bilbao Vizcaya Argentaria project BIOCON-08-126 and project CGL2009-12753-C02-01 from the Spanish Ministerio de Economia y Competitividad. DHM and JGF are members of the IBERCAROT Network financed by CYTED. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamford AJ, 2010, ETHOLOGY, V116, P1163, DOI 10.1111/j.1439-0310.2010.01834.x; Blanco G, 2005, P ROY SOC B-BIOL SCI, V272, P1893, DOI 10.1098/rspb.2005.3157; Blas J, 2006, P NATL ACAD SCI USA, V103, P18633, DOI 10.1073/pnas.0609189103; Blas J, 2013, J RAPTOR RE IN PRESS; Bortolotti GR, 1996, P ROY SOC B-BIOL SCI, V263, P1171, DOI 10.1098/rspb.1996.0171; Bortolotti GR, 2000, P ROY SOC B-BIOL SCI, V267, P1433, DOI 10.1098/rspb.2000.1160; BRITTON G, 2004, CAROTENOID HDB; Britton G., 1995, SPECTROSCOPY-US, V1B, P13; Britton G., 1991, METHODS PLANT BIOCH, P473; BRUSH AH, 1990, FASEB J, V4, P2969, DOI 10.1096/fasebj.4.12.2394316; Buckley Neil J., 1999, Birds of North America, V411, P1; Senar JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010716; Carrete M, 2010, ANIM CONSERV, V13, P390, DOI 10.1111/j.1469-1795.2010.00352.x; Casagrande S, 2006, J AVIAN BIOL, V37, P190, DOI 10.1111/j.0908-8857.2006.03515.x; CHEW BP, 1993, J DAIRY SCI, V76, P2804, DOI 10.3168/jds.S0022-0302(93)77619-5; Cohen AA, 2008, AM NAT, V172, P178, DOI 10.1086/589456; Cohen AA, 2009, OECOLOGIA, V161, P673, DOI 10.1007/s00442-009-1423-9; Cohen J.E., 1988, STAT POWER ANAL BEHA; Davies BH, 1971, CHEM BIOCH PLANT PIG, V2; Davies BH, 1988, HDB CHROMATOGRAPHY, V1; DEL HOYO J., 1996, HDB BIRDS WORLD, V3; Donazar J.A., 1993, BUITRES IBERICOS BIO; Donazar JA, 1999, BEHAV ECOL SOCIOBIOL, V45, P55, DOI 10.1007/s002650050539; Donazar JA, 2002, CONDOR, V104, P832, DOI 10.1650/0010-5422(2002)104[0832:SSOACR]2.0.CO;2; EUGSTER CH, 1995, CAROTENOIDS, V1, P71; Goodwin TW, 1984, ANIMALS, V2; Grether GF, 1999, P ROY SOC B-BIOL SCI, V266, P1317, DOI 10.1098/rspb.1999.0781; Gross J, 1991, PIGMENTS VEGETABLES, DOI DOI 10.1007/978-1-4615-2033-7_3; Hill GE, 1995, AUK, V112, P1054, DOI 10.2307/4089041; Hill GE, 2012, AM NAT, V180, pE127, DOI 10.1086/667861; Hill GE, 2011, ECOL LETT, V14, P625, DOI 10.1111/j.1461-0248.2011.01622.x; Hof KHV, 2000, J NUTR, V130, P503; HUDON J, 1994, AUK, V111, P218, DOI 10.2307/4088529; Isaksson C, 2009, ARDEA, V97, P125, DOI 10.5253/078.097.0116; Juola FA, 2008, COMP BIOCHEM PHYS B, V149, P370, DOI 10.1016/j.cbpb.2007.10.010; Khoo HE, 2011, MOLECULES, V16, P1710, DOI 10.3390/molecules16021710; Lambertucci SA, 2009, ANIM CONSERV, V12, P338, DOI 10.1111/j.1469-1795.2009.00258.x; Lambertucci SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046347; LOZANO GA, 1994, OIKOS, V70, P309, DOI 10.2307/3545643; McGraw KJ, 2006, FUNCT ECOL, V20, P678, DOI 10.1111/j.1365-2435.2006.01121.x; McGraw K.J., 2006, BIRD COLORATION, V1, P177; McGraw KJ, 2005, COMP BIOCHEM PHYS B, V142, P245, DOI 10.1016/j.cbpb.2005.07.012; McGraw KJ, 2004, BIOL J LINN SOC, V83, P273, DOI 10.1111/j.1095-8312.2004.00388.x; MINGUEZMOSQUERA MI, 1993, J AGR FOOD CHEM, V41, P1616, DOI 10.1021/jf00034a018; Nagao A, 2011, BIOFACTORS, V37, P83, DOI 10.1002/biof.151; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Negro JJ, 2006, COMP BIOCHEM PHYS A, V143, P78, DOI 10.1016/j.cbpa.2005.10.028; Negro JJ, 1998, FUNCT ECOL, V12, P307, DOI 10.1046/j.1365-2435.1998.00176.x; Negro JJ, 2000, PHYSIOL BIOCHEM ZOOL, V73, P97, DOI 10.1086/316724; Negro JJ, 2002, NATURE, V416, P807, DOI 10.1038/416807a; Noziere P, 2006, ANIM FEED SCI TECH, V131, P418, DOI 10.1016/j.anifeedsci.2006.06.018; Olson VA, 2006, OIKOS, V112, P620, DOI 10.1111/j.0030-1299.2006.14208.x; Olson VA, 1998, TRENDS ECOL EVOL, V13, P510, DOI 10.1016/S0169-5347(98)01484-0; Palafox-Carlos H, 2011, J FOOD SCI, V76, pR6, DOI 10.1111/j.1750-3841.2010.01957.x; Parada J, 2007, J FOOD SCI, V72, pR21, DOI 10.1111/j.1750-3841.2007.00274.x; Parker RS, 1996, FASEB J, V10, P542, DOI 10.1096/fasebj.10.5.8621054; Schiedt K., 1995, ISOLATION ANAL, V1A, P81; Sternalski A, 2012, PHYSIOL BIOCHEM ZOOL, V85, P364, DOI 10.1086/665981; Sternalski A, 2010, J COMP PHYSIOL B, V180, P33, DOI 10.1007/s00360-009-0384-y; Stradi R, 1996, COMP BIOCHEM PHYS B, V113, P427, DOI 10.1016/0305-0491(95)02064-0; Svensson PA, 2011, BEHAVIOUR, V148, P131, DOI 10.1163/000579510X548673; Tella JL, 2004, J EVOLUTION BIOL, V17, P156, DOI 10.1046/j.1420-9101.2003.00634.x; Tella JL, 1998, PHYSIOL ZOOL, V71, P708, DOI 10.1086/515991; van den Berg H, 1999, NUTR REV, V57, P1, DOI 10.1111/j.1753-4887.1999.tb01769.x; von Schantz T, 1999, P ROY SOC B-BIOL SCI, V266, P1, DOI 10.1098/rspb.1999.0597; Yang A, 2002, MEAT SCI, V60, P35, DOI 10.1016/S0309-1740(01)00102-4	66	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65562	10.1371/journal.pone.0065562	http://dx.doi.org/10.1371/journal.pone.0065562			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785435	Green Published, gold			2022-12-27	WOS:000321038800086
J	Matulova, M; Havlickova, H; Sisak, F; Rychlik, I				Matulova, Marta; Havlickova, Hana; Sisak, Frantisek; Rychlik, Ivan			Vaccination of Chickens with SPI1-lon and SPI1-lon-fliC Mutant of Salmonella enterica Serovar Enteritidis	PLOS ONE			English	Article							III SECRETION SYSTEM; ESCHERICHIA-COLI K-12; ISLAND SPI 1; PATHOGENICITY ISLANDS; BACTERIAL FLAGELLIN; PROTECTIVE EFFICACY; IMMUNE-RESPONSE; TYPHIMURIUM; IMMUNIZATION; VIRULENCE	The prevalence of Salmonella enterica serovar Enteritidis is gradually decreasing in poultry flocks in the EU, which may result in the demand for a vaccine that allows for the differentiation of vaccinated flocks from those infected by wild-type S. Enteritidis. In this study, we therefore constructed a (Salmonella Pathogenicity Island 1) SPI1-lon mutant with or without fliC encoding for S. Enteritidis flagellin. The combination of SPI1-lon mutations resulted in attenuated but immunogenic mutant suitable for oral vaccination of poultry. In addition, the vaccination of chickens with the SPI1-lon-fliC mutant enabled the serological differentiation of vaccinated and infected chickens. The absence of fliC therefore did not affect the immunogenicity of the vaccine strain and allowed for serological differentiation of the vaccinated chickens. The SPI1-lon-fliC mutant is therefore a suitable marker vaccine strain for oral vaccination of poultry.	[Matulova, Marta; Havlickova, Hana; Sisak, Frantisek; Rychlik, Ivan] Vet Res Inst, CS-62132 Brno, Czech Republic	Czech Veterinary Research Institute	Rychlik, I (corresponding author), Vet Res Inst, CS-62132 Brno, Czech Republic.	rychlik@vri.cz	, Ivan/GPS-9674-2022	, Ivan/0000-0001-7995-6483	Czech Ministry of Agriculture [MZE0002716202, QJ1310019]; AdmireVet project from the Czech Ministry of Education [CZ.1.05/2.1.00/01.0006-ED0006/01/01]	Czech Ministry of Agriculture(Ministry of Agriculture, Czech Republic); AdmireVet project from the Czech Ministry of Education	This work has been supported by the projects MZE0002716202 and QJ1310019 of the Czech Ministry of Agriculture and AdmireVet project CZ.1.05/2.1.00/01.0006-ED0006/01/01 from the Czech Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaensen C, 2007, INFECT IMMUN, V75, P2461, DOI 10.1128/IAI.01357-06; Andersen-Nissen E, 2005, P NATL ACAD SCI USA, V102, P9247, DOI 10.1073/pnas.0502040102; Beal RK, 2004, VET IMMUNOL IMMUNOP, V100, P151, DOI 10.1016/j.vetimm.2004.04.005; Berndt A, 2007, INFECT IMMUN, V75, P5993, DOI 10.1128/IAI.00695-07; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dieye Y, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-3; Garcia-Calderon CB, 2007, J BACTERIOL, V189, P6635, DOI 10.1128/JB.00640-07; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; GOTTESMAN S, 1985, J BACTERIOL, V162, P1111, DOI 10.1128/JB.162.3.1111-1119.1985; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Iqbal M, 2005, INFECT IMMUN, V73, P2344, DOI 10.1128/IAI.73.4.2344-2350.2005; Jones MA, 2001, INFECT IMMUN, V69, P5471, DOI 10.1128/IAI.69.9.5471-5476.2001; Karasova D, 2009, VACCINE, V27, P5265, DOI 10.1016/j.vaccine.2009.06.060; Karasova D, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-75; Kodama C, 2004, INFECT IMMUN, V72, P2449, DOI 10.1128/IAI.72.4.2449-2451.2004; Kremer CJ, 2011, POULTRY SCI, V90, P752, DOI 10.3382/ps.2010-01076; Lahuerta A, 2011, EURO SURVEILL, V16, p[pii, 19832]; Leyman B, 2012, RES VET SCI, V93, P1168, DOI 10.1016/j.rvsc.2012.05.008; Matsuda K, 2010, VET RES, V41, DOI 10.1051/vetres/2010031; Matulova M, 2012, VACCINE, V30, P2090, DOI 10.1016/j.vaccine.2012.01.050; Matulova M, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-37; Matulova M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048101; McNeilly TN, 2008, INFECT IMMUN, V76, P2594, DOI 10.1128/IAI.01452-07; Methner U, 2011, VACCINE, V29, P3248, DOI 10.1016/j.vaccine.2011.02.030; Monack DM, 1996, P NATL ACAD SCI USA, V93, P9833, DOI 10.1073/pnas.93.18.9833; Murray RA, 2000, INFECT IMMUN, V68, P5050, DOI 10.1128/IAI.68.9.5050-5055.2000; Nandre RM, 2011, VET IMMUNOL IMMUNOP, V144, P299, DOI 10.1016/j.vetimm.2011.08.015; Pavlova B, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-16; Pullinger GD, 2007, INFECT IMMUN, V75, P5191, DOI 10.1128/IAI.00784-07; Rychlik I, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-268; Selke M, 2007, INFECT IMMUN, V75, P2476, DOI 10.1128/IAI.01908-06; Slattery A, 2013, J BACTERIOL, V195, P647, DOI 10.1128/JB.01397-12; Takaya A, 2002, J BACTERIOL, V184, P224, DOI 10.1128/JB.184.1.224-232.2002; Wang QF, 2007, J BACTERIOL, V189, P8447, DOI 10.1128/JB.01198-07	34	9	9	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66172	10.1371/journal.pone.0066172	http://dx.doi.org/10.1371/journal.pone.0066172			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785484	Green Submitted, Green Published, gold			2022-12-27	WOS:000321038800038
J	Andrew, EJ; Merchan, S; Lawless, C; Banks, AP; Wilkinson, DJ; Lydall, D				Andrew, Elizabeth J.; Merchan, Stephanie; Lawless, Conor; Banks, A. Peter; Wilkinson, Darren J.; Lydall, David			Pentose Phosphate Pathway Function Affects Tolerance to the G-Quadruplex Binder TMPyP4	PLOS ONE			English	Article							INTERACTIVE AGENTS; OXIDATIVE STRESS; ANTITUMOR-ACTIVITY; C-MYC; TELOMERASE; YEAST; PORPHYRINS; DNA; EXPRESSION; BINDING	G-quadruplexes form in guanine-rich regions of DNA and the presence of these structures at telomeres prevents the activity of telomerase in vitro. Ligands such as the cationic porphyrin TMPyP4 stabilise G-quadruplexes and are therefore under investigation for their potential use as anti-cancer drugs. In order to investigate the mechanism of action of TMPyP4 in vivo, we carried out a genome-wide screen in the budding yeast Saccharomyces cerevisiae. We found that deletion of key pentose phosphate pathway (PPP) genes increased the sensitivity of yeast to the presence of TMPyP4. The PPP plays an important role in the oxidative stress response and sensitivity to TMPyP4 also increased when genes involved in the oxidative stress response, CCS1 and YAP1, were deleted. For comparison we also report genome wide-screens using hydrogen peroxide, which causes oxidative stress, RHPS4, another G-quadruplex binder and hydroxyurea, an S phase poison. We found that a number of TMPyP4-sensitive strains are also sensitive to hydrogen peroxide in a genome-wide screen. Overall our results suggest that treatment with TMPyP4 results in light-dependent oxidative stress response in budding yeast, and that this, rather than G-quadruplex binding, is the major route to cytotoxicity. Our results have implications for the usefulness and mechanism of action of TMPyP4.	[Andrew, Elizabeth J.; Merchan, Stephanie; Lawless, Conor; Banks, A. Peter; Lydall, David] Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Wilkinson, Darren J.] Newcastle Univ, Sch Math & Stat, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Lydall, D (corresponding author), Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	david.lydall@ncl.ac.uk		Wilkinson, Darren James/0000-0003-0736-802X; Lawless, Conor/0000-0002-4186-8506	Biotechnology and Biological Sciences Research Council [BBF016980/1]; Wellcome Trust [WT093088MA]	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a Biotechnology and Biological Sciences Research Council Doctoral Training Grant [BBF016980/1] and the Wellcome Trust [WT093088MA]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addinall SG, 2008, GENETICS, V180, P2251, DOI 10.1534/genetics.108.092577; Addinall SG, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001362; Aoki K, 2003, CHEM PHARM BULL, V51, P899; BALAGURUMOORTHY P, 1994, J BIOL CHEM, V269, P21858; Banks AP, 2012, JOVE-J VIS EXP, DOI 10.3791/4018; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Chen H, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-43; Cookson JC, 2005, MOL PHARMACOL, V68, P1551, DOI 10.1124/mol.105.013300; Cosentino C, 2011, EMBO J, V30, P546, DOI 10.1038/emboj.2010.330; CROKE DT, 1993, J PHOTOCH PHOTOBIO B, V18, P41, DOI 10.1016/1011-1344(93)80039-C; Culotta VC, 1997, J BIOL CHEM, V272, P23469, DOI 10.1074/jbc.272.38.23469; Deutscher D, 2006, NAT GENET, V38, P993, DOI 10.1038/ng1856; Dixon IM, 2005, CHEMBIOCHEM, V6, P123, DOI 10.1002/cbic.200400113; Eichner A, 2013, PHOTOCHEMICAL PHOTOB, V12; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Grand CL, 2002, MOL CANCER THER, V1, P565; Grant CM, 1997, FEBS LETT, V410, P219, DOI 10.1016/S0014-5793(97)00592-9; Granville DJ, 2001, HISTOL HISTOPATHOL, V16, P309, DOI 10.14670/HH-16.309; Han FXG, 1999, J AM CHEM SOC, V121, P3561, DOI 10.1021/ja984153m; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hershman SG, 2008, NUCLEIC ACIDS RES, V36, P144, DOI 10.1093/nar/gkm986; Huang H, 2008, PROTEINS, V73, P1076, DOI 10.1002/prot.22237; Izbicka E, 1999, ANTI-CANCER DRUG DES, V14, P355; Izbicka E, 1999, CANCER RES, V59, P639; Juhnke H, 1996, MOL GEN GENET, V252, P456, DOI 10.1007/BF02173011; Kruger A, 2011, ANTIOXID REDOX SIGN, V15, P311, DOI 10.1089/ars.2010.3797; Langbein S, 2006, BRIT J CANCER, V94, P578, DOI 10.1038/sj.bjc.6602962; Lawless C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-287; Lena S, 2010, ANGEW CHEM INT EDIT, V49, P3657, DOI 10.1002/anie.201000805; Li Q, 2002, EXPERT OPIN THER PAT, V12, P1663, DOI 10.1517/13543776.12.11.1663; Lipps HJ, 2009, TRENDS CELL BIOL, V19, P414, DOI 10.1016/j.tcb.2009.05.002; Martino L, 2009, J PHYS CHEM B, V113, P14779, DOI 10.1021/jp9066394; Mikami-Terao Y, 2008, CANCER LETT, V261, P226, DOI 10.1016/j.canlet.2007.11.017; Mikami-Terao Y, 2009, EXP EYE RES, V89, P200, DOI 10.1016/j.exer.2009.03.008; Morris MJ, 2012, NUCL ACIDS RES; Moye-Rowley WS, 2002, ANTIOXID REDOX SIGN, V4, P123, DOI 10.1089/152308602753625915; Ralser M, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120093; Ren JS, 1999, BIOCHEMISTRY-US, V38, P16067, DOI 10.1021/bi992070s; Romera C, 2011, BIOCHIMIE, V93, P1310, DOI 10.1016/j.biochi.2011.06.008; SCHAAFFGERSTENSCHLAGER I, 1993, EUR J BIOCHEM, V217, P487, DOI 10.1111/j.1432-1033.1993.tb18268.x; Schoonover M, 2012, BIOORGAN MED CHEM, V20, P6904, DOI 10.1016/j.bmc.2012.10.017; Shi DF, 2001, J MED CHEM, V44, P4509, DOI 10.1021/jm010246u; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Slekar KH, 1996, J BIOL CHEM, V271, P28831, DOI 10.1074/jbc.271.46.28831; Smith JS, 2011, NAT STRUCT MOL BIOL, V18, P478, DOI 10.1038/nsmb.2033; Tong Amy Hin Yan, 2006, Methods Mol Biol, V313, P171; Wei CY, 2006, BIOCHEMISTRY-US, V45, P6681, DOI 10.1021/bi052356z; Wei CY, 2009, PHYS CHEM CHEM PHYS, V11, P4025, DOI 10.1039/b901027k; Wei CY, 2009, BIOPHYS CHEM, V143, P79, DOI 10.1016/j.bpc.2009.04.005; Zhao J, 2004, METAB ENG, V6, P164, DOI 10.1016/j.ymben.2004.02.004	50	15	15	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66242	10.1371/journal.pone.0066242	http://dx.doi.org/10.1371/journal.pone.0066242			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776642	gold, Green Submitted, Green Published			2022-12-27	WOS:000320322400093
J	Walsh, F; Duffy, B				Walsh, Fiona; Duffy, Brion			The Culturable Soil Antibiotic Resistome: A Community of Multi-Drug Resistant Bacteria	PLOS ONE			English	Article							MEDIATED QUINOLONE RESISTANCE; PSEUDOMONAS-AERUGINOSA; MULTIPLEX PCR; GENES; ENVIRONMENT; NDM-1; MICROORGANISMS; SEQUENCE	Understanding the soil bacterial resistome is essential to understanding the evolution and development of antibiotic resistance, and its spread between species and biomes. We have identified and characterized multi-drug resistance (MDR) mechanisms in the culturable soil antibiotic resistome and linked the resistance profiles to bacterial species. We isolated 412 antibiotic resistant bacteria from agricultural, urban and pristine soils. All isolates were multi-drug resistant, of which greater than 80% were resistant to 16-23 antibiotics, comprising almost all classes of antibiotic. The mobile resistance genes investigated, (ESBL, blaNDM-1, and plasmid mediated quinolone resistance (PMQR) resistance genes) were not responsible for the respective resistance phenotypes nor were they present in the extracted soil DNA. Efflux was demonstrated to play an important role in MDR and many resistance phenotypes. Clinically relevant Burkholderia species are intrinsically resistant to ciprofloxacin but the soil Burkholderia species were not intrinsically resistant to ciprofloxacin. Using a phenotypic enzyme assay we identified the antibiotic specific inactivation of trimethoprim in 21 bacteria from different soils. The results of this study identified the importance of the efflux mechanism in the soil resistome and variations between the intrinsic resistance profiles of clinical and soil bacteria of the same family.	[Walsh, Fiona; Duffy, Brion] Res Stn Agroscope Changins Wadenswil ACW, Fed Dept Econ Affairs Educ & Res EAER, Bacteriol Res Lab, Wadenswil, Switzerland	Swiss Federal Research Station Agroscope	Walsh, F (corresponding author), Res Stn Agroscope Changins Wadenswil ACW, Fed Dept Econ Affairs Educ & Res EAER, Bacteriol Res Lab, Wadenswil, Switzerland.	fiona.walsh@agroscope.admin.ch	Walsh, Fiona/C-6652-2012	Walsh, Fiona/0000-0003-0789-1689	Swiss Federal Office for Agriculture; Swiss Federal Office for the Environment; Swiss Expert Committee for Biosafety (SECB)	Swiss Federal Office for Agriculture; Swiss Federal Office for the Environment; Swiss Expert Committee for Biosafety (SECB)	This project was funded by the Swiss Federal Office for Agriculture, the Swiss Federal Office for the Environment and the Swiss Expert Committee for Biosafety (SECB). Work was conducted within the European research network COST TD0803 Detecting evolutionary hotspots of antibiotic resistances in Europe (DARE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HK, 2010, NAT REV MICROBIOL, V8, P251, DOI 10.1038/nrmicro2312; Alonso A, 2001, ENVIRON MICROBIOL, V3, P1, DOI 10.1046/j.1462-2920.2001.00161.x; Amann R, 2001, CURR OPIN BIOTECH, V12, P231, DOI 10.1016/S0958-1669(00)00204-4; American Academy of Microbiology, 2009, ANT RES EC PERSP OLD; Aminov RI, 2009, ENVIRON MICROBIOL, V11, P2970, DOI 10.1111/j.1462-2920.2009.01972.x; Bengoechea JA, 2000, MOL MICROBIOL, V37, P67, DOI 10.1046/j.1365-2958.2000.01956.x; BENVENISTE R, 1973, P NATL ACAD SCI USA, V70, P2276, DOI 10.1073/pnas.70.8.2276; Bhullar K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034953; Cases I, 2005, NAT REV MICROBIOL, V3, P105, DOI 10.1038/nrmicro1084; Clinical and Laboratory Standards Institute (CLSI), 2006, M7A5 CLSI; Colom K, 2003, FEMS MICROBIOL LETT, V223, P147, DOI 10.1016/S0378-1097(03)00306-9; D'Costa VM, 2006, SCIENCE, V311, P374, DOI 10.1126/science.1120800; Dantas G, 2008, SCIENCE, V320, P100, DOI 10.1126/science.1155157; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dolejska M, 2013, J ANTIMICROB CHEMOTH, V68, P34, DOI 10.1093/jac/dks357; Fajardo A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001619; Fernandez L, 2010, ANTIMICROB AGENTS CH, V54, P3372, DOI 10.1128/AAC.00242-10; Gay K, 2006, CLIN INFECT DIS, V43, P297, DOI 10.1086/505397; Leclercq R, 2013, Clin Microbiol Infect, V19, P141, DOI 10.1111/j.1469-0691.2011.03703.x; Lee HH, 2010, NATURE, V467, P82, DOI 10.1038/nature09354; Lister PD, 2009, CLIN MICROBIOL REV, V22, P582, DOI 10.1128/CMR.00040-09; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Ma JY, 2009, ANTIMICROB AGENTS CH, V53, P519, DOI 10.1128/AAC.00886-08; Martinez JL, 2008, SCIENCE, V321, P365, DOI 10.1126/science.1159483; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Nordmann P, 2005, J ANTIMICROB CHEMOTH, V56, P463, DOI 10.1093/jac/dki245; Oliver A, 2001, ANTIMICROB AGENTS CH, V45, P616, DOI 10.1128/AAC.45.2.616-620.2001; Poirel L, 2011, J ANTIMICROB CHEMOTH, V66, P1730, DOI 10.1093/jac/dkr174; Pruden A, 2006, ENVIRON SCI TECHNOL, V40, P7445, DOI 10.1021/es060413l; Robicsek A, 2006, NAT MED, V12, P83, DOI 10.1038/nm1347; Rosenblatt-Farrell N, 2009, ENVIRON HEALTH PERSP, V117, pA248; STALEY JT, 1985, ANNU REV MICROBIOL, V39, P321, DOI 10.1146/annurev.mi.39.100185.001541; Walsh TR, 2011, LANCET INFECT DIS, V11, P355, DOI 10.1016/S1473-3099(11)70059-7; Wang CX, 2006, J ANTIMICROB CHEMOTH, V57, P1261, DOI 10.1093/jac/dkl116; Woodford N, 2006, J ANTIMICROB CHEMOTH, V57, P154, DOI DOI 10.1093/jac/dki412; Zheng BW, 2011, PROTEIN CELL, V2, P250, DOI 10.1007/s13238-011-1027-0	37	99	101	1	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65567	10.1371/journal.pone.0065567	http://dx.doi.org/10.1371/journal.pone.0065567			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776501	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000320322400033
J	Wang, P; Zhang, XM; Zhai, ZH; Li, PL				Wang, Ping; Zhang, Xiao-Ming; Zhai, Zhao-Hua; Li, Pei-Ling			MRI Findings of Otic and Sinus Barotrauma in Patients with Carbon Monoxide Poisoning during Hyperbaric Oxygen Therapy	PLOS ONE			English	Article							MIDDLE-EAR BAROTRAUMA; ACUTE OTITIS-MEDIA; PEDIATRIC POPULATION; COMPUTED-TOMOGRAPHY; PARANASAL SINUSES; MASTOID CAVITY; TEMPORAL BONE; RISK-FACTORS; CELL SYSTEM; DIVERS	Background and Purpose: To study the MRI findings of otic and sinus barotrauma in patients with carbon monoxide(CO) poisoning during hyperbaric oxygen (HBO) therapy and examine the discrepancies of otic and sinus abnormalities on MRI between barotrauma and acute otitis media with effusion. Materials and Methods: Eighty patients with CO-poisoning diagnosed with otic and sinus barotrauma after HBO therapy were recruited. Brain MRI was performed to predict delayed encephalopathy. Over the same period, 88 patients with acute otitis media with effusion on MRI served as control. The abnormalities of the middle ear and paranasal sinuses on MRI were noted and were compared between groups. Nine patients with barotrauma were followed up by MRI. Results: In the barotrauma group, 92.5% of patients had bilateral middle ear abnormalities on MRI, and 60% of patients had both middle ear cavity and mastoid cavity abnormalities on MRI in both ears. Both rates were higher than those in the control group (p = 0.000). In the two groups, most abnormalities on MRI were observed in the mastoid cavity. The rate of sinus abnormalities of barotrauma was 66.3%, which was higher than the 50% in the control group (p = 0.033). In the nine patients with barotrauma followed up by MRI, the otic barotrauma and sinus abnormalities had worsened in 2 patients and 5 patients, respectively. Conclusion: MRI is able to depict the abnormalities of otic and sinus barotrauma in patients with CO-poisoning during HBO therapy and to differentiate these from acute otitis media with effusion.	[Zhang, Xiao-Ming] North Sichuan Med Coll, Affiliated Hosp, Sichuan Key Lab Med Imaging, Nanchong, Sichuan, Peoples R China; North Sichuan Med Coll, Affiliated Hosp, Dept Radiol, Nanchong, Sichuan, Peoples R China	North Sichuan Medical University; North Sichuan Medical University	Zhang, XM (corresponding author), North Sichuan Med Coll, Affiliated Hosp, Sichuan Key Lab Med Imaging, Nanchong, Sichuan, Peoples R China.	zhangxm@nsmc.edu.cn	Zhang, Xiao Ming/H-7104-2019	Zhang, Xiao Ming/0000-0001-5327-8506				Alper CM, 2011, LARYNGOSCOPE, V121, P404, DOI 10.1002/lary.21275; Armengol CE, 2011, PEDIATR INFECT DIS J, V30, P518, DOI 10.1097/INF.0b013e3182044930; Balci A, 2008, INT J PEDIATR OTORHI, V72, P1849, DOI 10.1016/j.ijporl.2008.09.015; Bartling SH, 2005, J COMPUT ASSIST TOMO, V29, P305, DOI 10.1097/01.rct.0000160425.63884.5b; Becker GD, 2001, EUR ARCH OTO-RHINO-L, V258, P159, DOI 10.1007/s004050100334; Bessereau J, 2010, UNDERSEA HYPERBAR M, V37, P203; Campbell PA., 1944, ANN OTOL, V53, P291; DIAMENT MJ, 1992, J ALLERGY CLIN IMMUN, V90, P442, DOI 10.1016/0091-6749(92)90166-Y; Edwards ML, 2010, J VET EMERG CRIT CAR, V20, P289, DOI 10.1111/j.1476-4431.2010.00535_1.x; Eggesbo HB, 2006, EUR RADIOL, V16, P872, DOI 10.1007/s00330-005-0068-2; FAGAN P, 1976, ANN OTO RHINOL LARYN, V85, P61, DOI 10.1177/000348947608500110; Fitzpatrick DT, 1999, UNDERSEA HYPERBAR M, V26, P243; Gaihede M, 2010, OTOL NEUROTOL, V31, P603, DOI 10.1097/MAO.0b013e3181dd13e2; Gilony D, 2007, OTOLARYNG HEAD NECK, V136, P610, DOI 10.1016/j.otohns.2006.11.019; Groppo ER, 2011, ARCH OTOLARYNGOL, V137, P1005, DOI 10.1001/archoto.2011.170; Hamilton-Farrell M, 2004, INJURY, V35, P359, DOI 10.1016/j.injury.2003.08.020; IGARASHI Y, 1993, ACTA OTO-LARYNGOL, P143; ISAACSON G, 1986, LARYNGOSCOPE, V96, P1343; Karahatay S, 2008, ENT-EAR NOSE THROAT, V87, P684, DOI 10.1177/014556130808701210; Lee DH, 2006, J OTOLARYNGOL, V35, P13, DOI 10.2310/7070.2005.4131; Linder T, 1996, SCHWEIZ MED WSCHR, V126, P2223; Magnuson B, 2003, J LARYNGOL OTOL, V117, P99, DOI 10.1258/002221503762624512; MALY PV, 1995, NEURORADIOLOGY, V37, P471, DOI 10.1007/BF00600097; Mansfield E L, 1995, J La State Med Soc, V147, P81; Moreira NC, 2011, NEURORADIOLOGY, V53, P1001, DOI 10.1007/s00234-011-0938-z; Nyc MA, 2012, INT J OTOLARYNGOL, V2012; Plafki C, 2000, AVIAT SPACE ENVIR MD, V71, P119; RAK KM, 1991, AM J ROENTGENOL, V156, P381, DOI 10.2214/ajr.156.2.1898819; Sano M, 2007, ACTA OTO-LARYNGOL, V127, P821, DOI 10.1080/00016480601075456; Segev Y, 2003, AM J NEURORADIOL, V24, P346; Shen MH, 2010, MED HYPOTHESES, V75, P235, DOI 10.1016/j.mehy.2010.02.029; Sonmez G, 2011, AVIAT SPACE ENVIR MD, V82, P992, DOI 10.3357/ASEM.3013.2011; Swarts JD, 2011, J LARYNGOL OTOL, V125, P580, DOI 10.1017/S0022215110002811; Swarts JD, 2010, ACTA OTO-LARYNGOL, V130, P1230, DOI 10.3109/00016489.2010.480982; Torpy Janet M, 2010, JAMA, V304, P2194, DOI 10.1001/jama.304.19.2194; Uzun C, 2009, J LARYNGOL OTOL, V123, P80, DOI 10.1017/S0022215108002739; Weaver LK, 2007, AM J RESP CRIT CARE, V176, P491, DOI 10.1164/rccm.200701-026OC; Weiss F, 2001, ROFO-FORTSCHR RONTG, V173, P319, DOI 10.1055/s-2001-12458; Weitzel EK, 2008, AVIAT SPACE ENVIR MD, V79, P50, DOI 10.3357/ASEM.2203.2008	39	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65672	10.1371/journal.pone.0065672	http://dx.doi.org/10.1371/journal.pone.0065672			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776523	Green Published, gold, Green Submitted			2022-12-27	WOS:000320322400044
J	Wernand, MR; van der Woerd, HJ; Gieskes, WWC				Wernand, Marcel R.; van der Woerd, Hendrik J.; Gieskes, Winfried W. C.			Trends in Ocean Colour and Chlorophyll Concentration from 1889 to 2000, Worldwide	PLOS ONE			English	Article							CONTINUOUS PLANKTON RECORDER; LONG-TERM TRENDS; DECADAL CHANGES; ATLANTIC; CLIMATE; ABSORPTION; WATERS; SEA; VARIABILITY; ABUNDANCE	Marine primary productivity is an important agent in the global cycling of carbon dioxide, a major 'greenhouse gas', and variations in the concentration of the ocean's phytoplankton biomass can therefore explain trends in the global carbon budget. Since the launch of satellite-mounted sensors globe-wide monitoring of chlorophyll, a phytoplankton biomass proxy, became feasible. Just as satellites, the Forel-Ule (FU) scale record (a hardly explored database of ocean colour) has covered all seas and oceans - but already since 1889. We provide evidence that changes of ocean surface chlorophyll can be reconstructed with confidence from this record. The EcoLight radiative transfer numerical model indicates that the FU index is closely related to chlorophyll concentrations in open ocean regions. The most complete FU record is that of the North Atlantic in terms of coverage over space and in time; this dataset has been used to test the validity of colour changes that can be translated to chlorophyll. The FU and FU-derived chlorophyll data were analysed for monotonously increasing or decreasing trends with the non-parametric Mann-Kendall test, a method to establish the presence of a consistent trend. Our analysis has not revealed a globe-wide trend of increase or decrease in chlorophyll concentration during the past century; ocean regions have apparently responded differentially to changes in meteorological, hydrological and biological conditions at the surface, including potential long-term trends related to global warming. Since 1889, chlorophyll concentrations have decreased in the Indian Ocean and in the Pacific; increased in the Atlantic Ocean, the Mediterranean, the Chinese Sea, and in the seas west and north-west of Japan. This suggests that explanations of chlorophyll changes over long periods should focus on hydrographical and biological characteristics typical of single ocean regions, not on those of 'the' ocean.	[Wernand, Marcel R.] Royal Netherlands Inst Sea Res Phys Oceanog Marin, Texel, Netherlands; [van der Woerd, Hendrik J.] Vrije Univ Amsterdam, Inst Environm Studies IVM, Amsterdam, Netherlands; [Gieskes, Winfried W. C.] Univ Groningen, ESRIG, Dept Ocean Ecosyst, Groningen, Netherlands	Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Vrije Universiteit Amsterdam; University of Groningen	Wernand, MR (corresponding author), Royal Netherlands Inst Sea Res Phys Oceanog Marin, Texel, Netherlands.	marcel.wernand@nioz.nl	van der Woerd, Hans J/K-9812-2013	van der Woerd, Hans J/0000-0002-8901-7567				Antoine D, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002620; Barton AD, 2003, PROG OCEANOGR, V58, P337, DOI 10.1016/j.pocean.2003.08.012; Batten SD, 2010, J PLANKTON RES, V32, P1619, DOI 10.1093/plankt/fbq140; Beale CM, 2010, ECOL LETT, V13, P246, DOI 10.1111/j.1461-0248.2009.01422.x; Bevington PR, 1969, DATA REDUCTION ERROR; Bidigare RR, 2009, J PLANKTON RES, V31, P1131, DOI 10.1093/plankt/fbp064; Bograd SJ, 2003, DEEP-SEA RES PT II, V50, P2349, DOI 10.1016/S0967-0645(03)00122-X; Boyce DG, 2012, LIMNOL OCEANOGR-METH, V10, P840, DOI 10.4319/lom.2012.10.840; Boyce DG, 2010, NATURE, V466, P591, DOI 10.1038/nature09268; BOYER TP, 2006, WORLD OCEAN DATABASE; Bricaud A, 1998, J GEOPHYS RES-OCEANS, V103, P31033, DOI 10.1029/98JC02712; Dolan JR, 1999, DEEP-SEA RES PT I, V46, P2025, DOI 10.1016/S0967-0637(99)00043-6; Edwards M, 2001, ICES J MAR SCI, V58, P39, DOI 10.1006/jmsc.2000.0987; Edwards M, 2009, SAHFOS TECH REP, V6, P1; ESRI, 2008, WHAT IS ARCGIS 9 3; FALKOWSKI PG, 1992, NATURE, V358, P741, DOI 10.1038/358741a0; Forel FA, 1890, ARCH SCI PHYS, VVI, P25; Frederick MA, 1970, THESIS NAVAL POSTGRA; GCOS Second Adequacy Report, 2003, 1143 WMOTD; GIESKES WW, 1983, LIMNOL OCEANOGR, V28, P757, DOI 10.4319/lo.1983.28.4.0757; Gregg WW, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL014689; Gregg WW, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL016889; HARRISON AW, 1988, SOL ENERGY, V41, P387, DOI 10.1016/0038-092X(88)90035-7; Head EJH, 2010, J PLANKTON RES, V32, P1649, DOI 10.1093/plankt/fbq120; Henson SA, 2010, BIOGEOSCIENCES, V7, P621, DOI 10.5194/bg-7-621-2010; Hinder SL, 2012, NAT CLIM CHANGE, V2, P271, DOI [10.1038/nclimate1388, 10.1038/NCLIMATE1388]; Hipel KW, 1983, DEV WATER SCI, V27, P347; Huot Y, 2007, BIOGEOSCIENCES, V4, P853, DOI 10.5194/bg-4-853-2007; Karl DM, 1996, DEEP SEA RES 2, V43; KASTEN F, 1980, SOL ENERGY, V24, P177, DOI 10.1016/0038-092X(80)90391-6; Kendall M, 1975, MULTIVARIATE ANAL; Kohler H., 2003, P MAR SCI, V6, P281, DOI DOI 10.1016/S1568-2692(03)80042-6; Kowalczuk P, 2005, MAR CHEM, V96, P273, DOI 10.1016/j.marchem.2005.03.002; Krummel O., 1893, GEOPHYSIKALISCHE B C, V11, P89; Leterme SC, 2005, LIMNOL OCEANOGR, V50, P1244, DOI 10.4319/lo.2005.50.4.1244; Luksch J, 1901, BERICHTE COMMISSION, P400; Mann HB, 1945, ECONOMETRICA, V13, P245, DOI 10.2307/1907187; MCGILL DA, 1961, DEEP-SEA RES, V8, P259, DOI 10.1016/0146-6313(61)90027-2; MCLEOD AI, 1991, ENVIRONMETRICS, V2, P169, DOI 10.1002/env.3770020205; Miller C. B., 2003, BIOL OCEANOGRAPHY; Mobley C.D., 2008, HYDROLIGHT 5 ECOLIGH; Mobley C.D.., 1994, LIGHT WATER RAD TRAN; MOBLEY CD, 1993, APPL OPTICS, V32, P7484, DOI 10.1364/AO.32.007484; Mobley CD, 2010, 8 HYDROLIGHT; MOREL A, 1977, LIMNOL OCEANOGR, V22, P709, DOI 10.4319/lo.1977.22.4.0709; Morel A, 2002, APPL OPTICS, V41, P6289, DOI 10.1364/AO.41.006289; Morel A, 2007, LIMNOL OCEANOGR, V52, P217, DOI 10.4319/lo.2007.52.1.0217; Morel A, 2009, REMOTE SENS ENVIRON, V113, P998, DOI 10.1016/j.rse.2009.01.008; Morrison JR, 2004, LIMNOL OCEANOGR, V49, P215, DOI 10.4319/lo.2004.49.1.0215; Mueller JL, 2003, RADIOMETRIC MEASUREM, V3, P21; Nelson NB, 1998, DEEP-SEA RES PT I, V45, P931, DOI 10.1016/S0967-0637(97)00106-4; NRC, 2001, ISS INT RES OP SAT 1; Parker B., 1992, OCEANOGRAPHY, V5, P124; Philip G.M., 1982, AUST PET EXPLOR ASS, V22, P205, DOI [10.1071/AJ81016, DOI 10.1071/AJ81016]; PLASS GN, 1978, APPL OPTICS, V17, P1432, DOI 10.1364/AO.17.001432; Pope RM, 1997, APPL OPTICS, V36, P8710, DOI 10.1364/AO.36.008710; PREISENDORFER RW, 1986, LIMNOL OCEANOGR, V31, P909, DOI 10.4319/lo.1986.31.5.0909; Ribera dAlcala, 2009, BIOGEOSCIENCES DISCU, V6, P11187, DOI DOI 10.5194/BGD-6-11187-2009; Salmi T., 2002, DETECTING TRENDS ANN; SEN PK, 1968, J AM STAT ASSOC, V63, P1379; Sokal R.R., 2012, BIOMETRY PRINCIPLES; Tan Saichun, 2006, Journal of Geographical Sciences, V16, P447, DOI 10.1007/s11442-006-0408-4; Ule W., 1892, KLEINERE MITTHEILUNG, V38, P70; US Navy Hydrographic Office, 1951, US NAV HYDR OFF PUBL, V754, P36; US Navy Hydrographic Office, 1951, US NAV HYDR OFF PUBL, V752, P8; US Navy Hydrographic Office, 1951, US NAV HYDR OFF PUBL, V757, P48; Vasilkov AP, 2005, APPL OPTICS, V44, P2863, DOI 10.1364/AO.44.002863; VENRICK EL, 1987, SCIENCE, V238, P70, DOI 10.1126/science.238.4823.70; Von Drygalski ED, 1897, GRONLAND EXPEDITION, V10, P318; WATSON DF, 1985, GEO-PROCESSING, V2, P315; Wernand MR, 2010, J EUR OPT SOC-RAPID, V5, DOI 10.2971/jeos.2010.10015s; Wernand M.R., 2011, OCEAN OPTICS 1600 HU; YAN XH, 1990, REMOTE SENS ENVIRON, V32, P55, DOI 10.1016/0034-4257(90)90098-7; YANG S, 1991, Chinese Journal of Oceanology and Limnology, V9, P49	74	74	78	2	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e63766	10.1371/journal.pone.0063766	http://dx.doi.org/10.1371/journal.pone.0063766			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776435	gold, Green Published, Green Submitted			2022-12-27	WOS:000320322400003
J	Bai, XN; Zhao, AL; Lan, RT; Xin, YQ; Xie, H; Meng, Q; Jin, D; Yu, B; Sun, H; Lu, S; Xu, JG; Xiong, YW				Bai, Xiangning; Zhao, Ailan; Lan, Ruiting; Xin, Youquan; Xie, Hui; Meng, Qiong; Jin, Dong; Yu, Bo; Sun, Hui; Lu, Shan; Xu, Jianguo; Xiong, Yanwen			Shiga Toxin-Producing Escherichia coli in Yaks (Bos grunniens) from the Qinghai-Tibetan Plateau, China	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; ENTEROCYTE EFFACEMENT; SUBTILASE CYTOTOXIN; MOLECULAR ANALYSIS; VIRULENCE PROFILES; PUTATIVE ADHESINS; MULTIPLEX PCR; UNITED-STATES; BEEF-CATTLE; STRAINS	Shiga toxin (Stx)-producing Escherichia coli (STEC) are recognized as important human pathogens of public health concern. Many animals are the sources of STEC. In this study we determined the occurrence and characteristics of the STEC in yaks (Bos grunniens) from the Qinghai-Tibetan plateau, China. A total of 728 yak fecal samples was collected from June to August, 2012 and was screened for the presence of the stx(1) and stx(2) genes by TaqMan real-time PCR after the sample was enriched in modified Tryptone Soya Broth. Of the 138 (18.96%) stx(1) and/or stx(2)-positive samples, 85 (61.59%) were confirmed to have at least 1 STEC isolate present by culture isolation, from which 128 STEC isolates were recovered. All STEC isolates were serotyped, genotyped by pulsed-field gel electrophoresis (PFGE) and characterized for the presence of 16 known virulence factors. Fifteen different O serogroups and 36 different O: H serotypes were identified in the 128 STEC isolates with 21 and 4 untypable for the O and H antigens respectively. One stx(1) subtype (stx(1a)) and 5 stx(2) subtypes (stx(2a), stx(2b), stx(2c), stx(2d) and stx(2g)) were present in these STEC isolates. Apart from lpfA(O157/OI-141), lpfA(O157/OI-154), lpfA(O113), katP and toxB which were all absent, other virulence factors screened (eaeA, iha, efa1, saa, paa, cnf1, cnf2, astA, subA, exhA and espP) were variably present in the 128 STEC isolates. PFGE were successful for all except 5 isolates and separated them into 67 different PFGE patterns. For the 18 serotypes with 2 or more isolates, isolates of the same serotypes had the same or closely related PFGE patterns, demonstrating clonality of these serotypes. This study was the first report on occurrence and characteristics of STEC isolated from yaks (Bos grunniens) from the Qinghai-Tibetan plateau, China, and extended the genetic diversity and reservoir host range of STEC.	[Bai, Xiangning; Zhao, Ailan; Meng, Qiong; Jin, Dong; Yu, Bo; Sun, Hui; Lu, Shan; Xu, Jianguo; Xiong, Yanwen] Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Collaborat Innovat Ctr Diag & Treatment Infect Di, Beijing, Peoples R China; [Lan, Ruiting] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Xin, Youquan; Xie, Hui] Qinghai Inst Endem Dis Prevent & Control, Xining, Qinghai Provinc, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; University of New South Wales Sydney	Xiong, YW (corresponding author), Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Collaborat Innovat Ctr Diag & Treatment Infect Di, Beijing, Peoples R China.	xiongyanwen@icdc.cn		Meng, Qiong/0000-0002-8378-9021; Lan, Ruiting/0000-0001-9834-5258	National Basic Research Program of China [2011CB504901]; Chinese National Natural Science Foundation [81290340, 81290345]; China Mega-Project for Infectious Disease [2011ZX10004-001, 2012ZX10004-215]; State Key Laboratory for Infectious Disease Prevention and Control Development [2008SKLID106, 2011SKLID203, 2012SKLID401]	National Basic Research Program of China(National Basic Research Program of China); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); China Mega-Project for Infectious Disease; State Key Laboratory for Infectious Disease Prevention and Control Development	This work was supported by the National Basic Research Program of China (2011CB504901), Chinese National Natural Science Foundation Grants (81290340 and 81290345), China Mega-Project for Infectious Disease Grants (2011ZX10004-001 and 2012ZX10004-215) and State Key Laboratory for Infectious Disease Prevention and Control Development Grants (2008SKLID106, 2011SKLID203 and 2012SKLID401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpers K, 2009, EPIDEMIOL INFECT, V137, P389, DOI 10.1017/S0950268808001465; Auvray F, 2012, VET MICROBIOL, V158, P443, DOI 10.1016/j.vetmic.2012.02.029; Bandyopadhyay S, 2012, RES VET SCI, V93, P604, DOI 10.1016/j.rvsc.2011.12.011; Bandyopadhyay S, 2012, TROP ANIM HEALTH PRO, V44, P1063, DOI 10.1007/s11250-011-0041-9; Bandyopadhyay S, 2009, VET MICROBIOL, V138, P403, DOI 10.1016/j.vetmic.2009.04.016; Batisson I, 2003, INFECT IMMUN, V71, P4516, DOI 10.1128/IAI.71.8.4516-4525.2003; Bauwens A, 2011, THROMB HAEMOSTASIS, V105, P515, DOI 10.1160/TH10-02-0140; Bentancor A, 2012, VET MICROBIOL, V156, P336, DOI 10.1016/j.vetmic.2011.10.030; Bielaszewska M, 2011, LANCET INFECT DIS, V11, P671, DOI 10.1016/S1473-3099(11)70165-7; Boerlin P, 1999, J CLIN MICROBIOL, V37, P497, DOI 10.1128/JCM.37.3.497-503.1999; Bosilevac JM, 2011, APPL ENVIRON MICROB, V77, P2103, DOI 10.1128/AEM.02833-10; Brandal LT, 2007, J MICROBIOL METH, V68, P331, DOI 10.1016/j.mimet.2006.09.013; Brunder W, 1999, MICROBIOL-UK, V145, P1005, DOI 10.1099/13500872-145-5-1005; Brunder W, 1996, MICROBIOL-SGM, V142, P3305, DOI 10.1099/13500872-142-11-3305; Buvens G, 2010, EUR J CLIN MICROBIOL, V29, P1395, DOI 10.1007/s10096-010-1014-z; Coombes BK, 2008, APPL ENVIRON MICROB, V74, P2153, DOI 10.1128/AEM.02566-07; Creuzburg K, 2011, ENVIRON MICROBIOL, V13, P439, DOI 10.1111/j.1462-2920.2010.02349.x; DebRoy Chitrita, 2011, Animal Health Research Reviews, V12, P169, DOI 10.1017/S1466252311000193; Doughty S, 2002, INFECT IMMUN, V70, P6761, DOI 10.1128/IAI.70.12.6761-6769.2002; Eggert M, 2012, EPIDEMIOLOGY INFECT, P1; Eklund M, 2002, J CLIN MICROBIOL, V40, P4585, DOI 10.1128/JCM.40.12.4585-4593.2002; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Gault G, 2011, EURO SURVEILL, V16; Grant J, 2008, EMERG INFECT DIS, V14, P1633, DOI 10.3201/eid1410.071341; Hauser E, 2013, APPL ENVIRON MICROB, V79, P2731, DOI 10.1128/AEM.03552-12; Huang XD, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-237; Hussein HS, 2007, J ANIM SCI, V85, pE63, DOI 10.2527/jas.2006-421; Hussein HS, 2005, J FOOD PROTECT, V68, P2224, DOI 10.4315/0362-028X-68.10.2224; Irino K, 2010, J CLIN MICROBIOL, V48, P988, DOI 10.1128/JCM.00010-10; Jenkins C, 2003, J CLIN MICROBIOL, V41, P1775, DOI 10.1128/JCM.41.4.1775-1778.2003; Jourdan-Da Silva N, 2011, EUROSURVEILLANCE, V17; Karmali MA, 2003, J CLIN MICROBIOL, V41, P4930, DOI 10.1128/JCM.41.11.4930-4940.2003; Knust Z, 2010, TOXINS, V2, P116, DOI 10.3390/toxins2010116; Manning SD, 2008, P NATL ACAD SCI USA, V105, P4868, DOI 10.1073/pnas.0710834105; Martin A, 2011, INT J FOOD MICROBIOL, V146, P99, DOI 10.1016/j.ijfoodmicro.2011.01.041; Mellmann A, 2008, EMERG INFECT DIS, V14, P1287, DOI 10.3201/eid1408.071082; Michino H, 1999, AM J EPIDEMIOL, V150, P787, DOI 10.1093/oxfordjournals.aje.a010082; Newton HJ, 2009, EMERG INFECT DIS, V15, P372, DOI [10.3201/eid1502.080631, 10.3201/eid1503.080631]; Nicholls L, 2000, MOL MICROBIOL, V35, P275, DOI 10.1046/j.1365-2958.2000.01690.x; Oporto B, 2008, ZOONOSES PUBLIC HLTH, V55, P73, DOI 10.1111/j.1863-2378.2007.01080.x; Orth D, 2007, DIAGN MICR INFEC DIS, V59, P235, DOI 10.1016/j.diagmicrobio.2007.04.013; Pass MA, 2000, J CLIN MICROBIOL, V38, P2001, DOI 10.1128/JCM.38.5.2001-2004.2000; Paton AW, 2001, INFECT IMMUN, V69, P6999, DOI 10.1128/IAI.69.11.6999-7009.2001; Paton AW, 2002, J CLIN MICROBIOL, V40, P271, DOI 10.1128/JCM.40.1.271-274.2002; Paton AW, 2005, J CLIN MICROBIOL, V43, P2944, DOI 10.1128/JCM.43.6.2944-2947.2005; Paton AW, 2004, J EXP MED, V200, P35, DOI 10.1084/jem.20040392; PATON AW, 1995, GENE, V153, P71, DOI 10.1016/0378-1119(94)00777-P; Qiu Q, 2012, NAT GENET, V44, P946, DOI 10.1038/ng.2343; Rangel JM, 2005, EMERG INFECT DIS, V11, P603, DOI 10.3201/eid1104.040739; Ray PE, 2001, PEDIATR NEPHROL, V16, P823, DOI 10.1007/s004670100660; RILEY LW, 1983, NEW ENGL J MED, V308, P681, DOI 10.1056/NEJM198303243081203; Sanchez S, 2010, VET MICROBIOL, V143, P420, DOI 10.1016/j.vetmic.2009.11.016; Sanchez S, 2010, VET MICROBIOL, V142, P445, DOI 10.1016/j.vetmic.2009.10.009; SAVARINO SJ, 1993, P NATL ACAD SCI USA, V90, P3093, DOI 10.1073/pnas.90.7.3093; Scheutz F, 2012, J CLIN MICROBIOL, V50, P2951, DOI 10.1128/JCM.00860-12; Schmidt H, 2001, INFECT IMMUN, V69, P6863, DOI 10.1128/IAI.69.11.6863-6873.2001; SCHMIDT H, 1995, INFECT IMMUN, V63, P1055, DOI 10.1128/IAI.63.3.1055-1061.1995; Schmidt MA, 2010, CELL MICROBIOL, V12, P1544, DOI 10.1111/j.1462-5822.2010.01518.x; Szalo IM, 2002, RES MICROBIOL, V153, P653, DOI 10.1016/S0923-2508(02)01379-7; Tarr CL, 2002, INFECT IMMUN, V70, P6853, DOI 10.1128/IAI.70.12.6853-6859.2002; Tarr PI, 2000, INFECT IMMUN, V68, P1400, DOI 10.1128/IAI.68.3.1400-1407.2000; Toma C, 2004, J CLIN MICROBIOL, V42, P4937, DOI 10.1128/JCM.42.11.4937-4946.2004; Torres AG, 2002, INFECT IMMUN, V70, P5416, DOI 10.1128/IAI.70.10.5416-5427.2002; Werber D, 2003, EUR J CLIN MICROBIOL, V22, P726, DOI 10.1007/s10096-003-1025-0; Wieler LH, 2011, GUT PATHOG, V3, DOI 10.1186/1757-4749-3-17; Wolfson JJ, 2009, J CLIN MICROBIOL, V47, P3058, DOI 10.1128/JCM.00706-09; Xiong YW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036144; Yamamoto T, 1996, INFECT IMMUN, V64, P1441, DOI 10.1128/IAI.64.4.1441-1445.1996; Zweifel C, 2006, VET MICROBIOL, V117, P328, DOI 10.1016/j.vetmic.2006.06.017	69	29	36	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65537	10.1371/journal.pone.0065537	http://dx.doi.org/10.1371/journal.pone.0065537			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776496	Green Submitted, Green Published, gold			2022-12-27	WOS:000320755400039
J	Hartl, D; Klatt, S; Roch, M; Konthur, Z; Klose, J; Willnow, TE; Rohe, M				Hartl, Daniela; Klatt, Stephan; Roch, Manfred; Konthur, Zoltan; Klose, Joachim; Willnow, Thomas E.; Rohe, Michael			Soluble Alpha-APP (sAPPalpha) Regulates CDK5 Expression and Activity in Neurons	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; CYCLIN-DEPENDENT KINASE-5; SORTILIN-RELATED RECEPTOR; ALZHEIMERS-DISEASE; HIPPOCAMPAL-NEURONS; SECRETED FORMS; NEURODEGENERATIVE DISEASES; TAU PHOSPHORYLATION; CEREBROSPINAL-FLUID; ADULT NEUROGENESIS	A growing body of evidence suggests a role for soluble alpha-amyloid precursor protein (sAPPalpha) in pathomechanisms of Alzheimer disease (AD). This cleavage product of APP was identified to have neurotrophic properties. However, it remained enigmatic what proteins, targeted by sAPPalpha, might be involved in such neuroprotective actions. Here, we used high-resolution two-dimensional polyacrylamide gel electrophoresis to analyze proteome changes downstream of sAPPalpha in neurons. We present evidence that sAPPalpha regulates expression and activity of CDK5, a kinase that plays an important role in AD pathology. We also identified the cytoprotective chaperone ORP150 to be induced by sAPPalpha as part of this protective response. Finally, we present functional evidence that the sAPPalpha receptor SORLA is essential to mediate such molecular functions of sAPPalpha in neurons.	[Hartl, Daniela; Roch, Manfred; Klose, Joachim] Charite, Inst Med Genet & Human Genet, D-13353 Berlin, Germany; [Klatt, Stephan; Konthur, Zoltan] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Klatt, Stephan] Free Univ Berlin, Fac Biol Chem & Pharm, Berlin, Germany; [Konthur, Zoltan] Max Planck Inst Colloids & Interfaces, Potsdam, Germany; [Willnow, Thomas E.; Rohe, Michael] Max Delbruck Ctr Mol Med, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; Free University of Berlin; Max Planck Society; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Hartl, D (corresponding author), Charite, Inst Med Genet & Human Genet, D-13353 Berlin, Germany.	daniela.hartl@charite.de; michael.rohe@mdc-berlin.de	Konthur, Zoltán/E-4575-2010	Konthur, Zoltán/0000-0002-8767-9823; Klatt, Stephan/0000-0003-0064-3367; Willnow, Thomas/0000-0001-9515-7921	American Health Assistance Foundation [A2011601]; German Research Foundation [HA6155/2-2]	American Health Assistance Foundation(BrightFocus Foundation); German Research Foundation(German Research Foundation (DFG))	Studies were funded by grants from the American Health Assistance Foundation (to MR; www.brightfocus.org; project A2011601) and the German Research Foundation (to DH; www.dfg.de; project HA6155/2-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen OM, 2006, BIOCHEMISTRY-US, V45, P2618, DOI 10.1021/bi052120v; Andersen OM, 2005, P NATL ACAD SCI USA, V102, P13461, DOI 10.1073/pnas.0503689102; ARAKI W, 1991, BIOCHEM BIOPH RES CO, V181, P265, DOI 10.1016/S0006-291X(05)81412-3; Bell KFS, 2008, NEUROBIOL AGING, V29, P554, DOI 10.1016/j.neurobiolaging.2006.11.004; BHASIN R, 1991, P NATL ACAD SCI USA, V88, P10307, DOI 10.1073/pnas.88.22.10307; Chasseigneaux S, 2012, J NEUROCHEM, V120, P99, DOI 10.1111/j.1471-4159.2011.07584.x; Cheung ZH, 2012, TRENDS CELL BIOL, V22, P169, DOI 10.1016/j.tcb.2011.11.003; Crews L, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-67; Crews L, 2010, HUM MOL GENET, V19, pR12, DOI 10.1093/hmg/ddq160; Futatsugi A, 2012, CELL CYCLE, V11, P1603, DOI 10.4161/cc.20009; Gillardon F, 2005, J CELL BIOCHEM, V95, P817, DOI 10.1002/jcb.20463; Gillardon F, 2005, PROTEOMICS, V5, P1299, DOI 10.1002/pmic.200400992; Gustafsen C, 2013, J NEUROSCI, V33, P64, DOI 10.1523/JNEUROSCI.2371-12.2013; Han P, 2005, J NEUROSCI, V25, P11542, DOI 10.1523/JNEUROSCI.3831-05.2005; Hoey SE, 2009, J NEUROSCI, V29, P4442, DOI 10.1523/JNEUROSCI.6017-08.2009; Hou ZB, 2007, J BIOL CHEM, V282, P18666, DOI 10.1074/jbc.C700052200; JIN LW, 1994, J NEUROSCI, V14, P5461; Kim D, 2008, NEURON, V60, P803, DOI 10.1016/j.neuron.2008.10.015; Kitao Y, 2001, J CLIN INVEST, V108, P1439, DOI 10.1172/JCI200112978; Klatt S, 2013, J PROTEOME RES, V12, P396, DOI 10.1021/pr300693f; Lalioti V, 2010, CELL CYCLE, V9, P284, DOI 10.4161/cc.9.2.10466; LANNFELT L, 1995, NAT MED, V1, P829, DOI 10.1038/nm0895-829; Lilja L, 2004, J BIOL CHEM, V279, P29534, DOI 10.1074/jbc.M312711200; MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I; Meziane H, 1998, P NATL ACAD SCI USA, V95, P12683, DOI 10.1073/pnas.95.21.12683; Offe K, 2006, J NEUROSCI, V26, P1596, DOI 10.1523/JNEUROSCI.4946-05.2006; Ohsawa I, 1997, BIOCHEM BIOPH RES CO, V236, P59, DOI 10.1006/bbrc.1997.6903; Olsson A, 2003, EXP NEUROL, V183, P74, DOI 10.1016/S0014-4886(03)00027-X; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; QIU WQ, 1995, J NEUROSCI, V15, P2157, DOI 10.1523/JNEUROSCI.15-03-02157.1995; Ramos-Echazabal G, 2012, J CELL BIOCHEM, V113, P2364, DOI 10.1002/jcb.24108; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Ring S, 2007, J NEUROSCI, V27, P7817, DOI 10.1523/JNEUROSCI.1026-07.2007; Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943; Rohe M, 2008, J BIOL CHEM, V283, P14826, DOI 10.1074/jbc.M710574200; Rohe M, 2011, J PROTEOME RES, V10, P1459, DOI 10.1021/pr101008p; Rohe M, 2009, J NEUROSCI, V29, P15472, DOI 10.1523/JNEUROSCI.3960-09.2009; Roselli F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023097; SAITOH T, 1989, CELL, V58, P615, DOI 10.1016/0092-8674(89)90096-2; Scherzer CR, 2004, ARCH NEUROL-CHICAGO, V61, P1200, DOI 10.1001/archneur.61.8.1200; Sdek P, 2011, J CELL BIOL, V194, P407, DOI 10.1083/jcb.201012049; Sennvik K, 2000, NEUROSCI LETT, V278, P169, DOI 10.1016/S0304-3940(99)00929-5; Sharma P, 1999, J BIOL CHEM, V274, P9600, DOI 10.1074/jbc.274.14.9600; Shukla V, 2012, ARCH MED RES, V43, P655, DOI 10.1016/j.arcmed.2012.10.015; Stein TD, 2004, J NEUROSCI, V24, P7707, DOI 10.1523/JNEUROSCI.2211-04.2004; Tamatani M, 2001, NAT MED, V7, P317, DOI 10.1038/85463; Tripathi BK, 2009, MOL CELL BIOL, V29, P6488, DOI 10.1128/MCB.01098-09; Tyan SH, 2012, MOL CELL NEUROSCI, V51, P43, DOI 10.1016/j.mcn.2012.07.009; Uchida Y, 2005, GENES CELLS, V10, P165, DOI 10.1111/j.1365-2443.2005.00827.x; Williamson R, 2011, J ALZHEIMERS DIS, V27, P615, DOI 10.3233/JAD-2011-110617; Willnow TE, 2010, REV NEUROSCIENCE, V21, P315; Zabel C, 2002, MOL CELL PROTEOMICS, V1, P366, DOI 10.1074/mcp.M200016-MCP200; Zabel Claus, 2009, V519, P311, DOI 10.1007/978-1-59745-281-6_20; Zhang J, 2011, CELL CYCLE, V10, P1208, DOI 10.4161/cc.10.8.15328	54	23	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65920	10.1371/journal.pone.0065920	http://dx.doi.org/10.1371/journal.pone.0065920			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776568	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000320755400080
J	Lin, D; Ding, J; Liu, JY; He, YF; Dai, Z; Chen, CZ; Cheng, WZ; Zhou, J; Wang, X				Lin, Dong; Ding, Jing; Liu, Jian-Ying; He, Yi-Feng; Dai, Zhi; Chen, Cai-Zhong; Cheng, Wei-Zhong; Zhou, Jian; Wang, Xin			Decreased Serum Hepcidin Concentration Correlates with Brain Iron Deposition in Patients with HBV-Related Cirrhosis	PLOS ONE			English	Article							SUBCLINICAL HEPATIC-ENCEPHALOPATHY; LIVER-DISEASE; BASAL GANGLIA; NEURODEGENERATIVE DISORDERS; MULTIPLE-SCLEROSIS; PROHEPCIDIN LEVELS; IN-VIVO; HEMOCHROMATOSIS; METABOLISM; ERYTHROPOIESIS	Purpose: Excessive brain iron accumulation contributes to cognitive impairments in hepatitis B virus (HBV)-related cirrhotic patients. The underlying mechanism remains unclear. Hepcidin, a liver-produced, 25-aminoacid peptide, is the major regulator of systemic iron metabolism. Abnormal hepcidin level is a key factor in some body iron accumulation or deficiency disorders, especially in those associated with liver diseases. Our study was aimed to explore the relationship between brain iron content in patients with HBV-related cirrhosis and serum hepcidin level. Methods: Seventy HBV-related cirrhotic patients and forty age-sex-matched healthy controls were enrolled. Brain iron content was quantified by susceptibility weighted phase imaging technique. Serum hepcidin as well as serum iron, serum transferrin, ferritin, soluble transferrin receptor, total iron binding capacity, and transferrin saturation were tested in thirty cirrhotic patients and nineteen healthy controls. Pearson correlation analysis was performed to investigate correlation between brain iron concentrations and serum hepcidin, or other iron parameters. Results: Cirrhotic patients had increased brain iron accumulation compared to controls in the left red nuclear, the bilateral substantia nigra, the bilateral thalamus, the right caudate, and the right putamen. Cirrhotic patients had significantly decreased serum hepcidin concentration, as well as lower serum transferring level, lower total iron binding capacity and higher transferrin saturation, compared to controls. Serum hepcidin level negatively correlated with the iron content in the right caudate, while serum ferritin level positively correlated with the iron content in the bilateral putamen in cirrhotic patients. Conclusions: Decreased serum hepcidin level correlated with excessive iron accumulation in the basal ganglia in HBV-related cirrhotic patients. Our results indicated that systemic iron overload underlined regional brain iron repletion. Serum hepcidin may be a clinical biomarker for brain iron deposition in cirrhotic patients, which may have therapeutic potential.	[Lin, Dong; Ding, Jing; Liu, Jian-Ying; Wang, Xin] Fudan Univ, Zhongshan Hosp, Dept Neurol, Shanghai 200433, Peoples R China; [Wang, Xin] Inst Brain Sci, Shanghai, Peoples R China; [Wang, Xin] State Key Lab Med Neurobiol, Shanghai, Peoples R China; [He, Yi-Feng; Dai, Zhi; Zhou, Jian] Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Shanghai 200433, Peoples R China; [Chen, Cai-Zhong; Cheng, Wei-Zhong] Fudan Univ, Zhongshan Hosp, Dept Radiol, Shanghai 200433, Peoples R China; [Zhou, Jian] Shanghai Key Lab Organ Transplantat, Shanghai, Peoples R China	Fudan University; Fudan University; Fudan University	Wang, X (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Neurol, Shanghai 200433, Peoples R China.	wang.xin@zs-hospital.sh.cn			State 863 High Technology R&D Project of China [2007AA02Z479]; Shanghai Municipal Human Resources and Social Security Bureau [2009001]	State 863 High Technology R&D Project of China; Shanghai Municipal Human Resources and Social Security Bureau	This work was supported by the State 863 High Technology R&D Project of China [grant number 2007AA02Z479] and grants from Shanghai Municipal Human Resources and Social Security Bureau (Grant No. 2009001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abo-Krysha N, 2008, MULT SCLER J, V14, P602, DOI 10.1177/1352458507085550; Atanasiu V, 2007, EUR J HAEMATOL, V78, P1, DOI 10.1111/j.1600-0609.2006.00772.x; Berg D, 2000, NEURORADIOLOGY, V42, P9, DOI 10.1007/s002340050002; Bonkovsky HL, 1997, HEPATOLOGY, V25, P759, DOI 10.1002/hep.510250345; Burdo JR, 2003, BIOMETALS, V16, P63, DOI 10.1023/A:1020718718550; Burkhard PR, 2003, ARCH NEUROL-CHICAGO, V60, P521, DOI 10.1001/archneur.60.4.521; Cade JE, 2005, AM J CLIN NUTR, V82, P813, DOI 10.1093/ajcn/82.4.813; Casanova MF, 2003, PSYCHIAT RES, V121, P59, DOI 10.1016/S0165-1781(03)00202-6; Corengia C, 2005, AM J CLIN PATHOL, V124, P846, DOI 10.1309/X4UH5Q68Q4J3GDNV; Crompton DE, 2002, BLOOD CELL MOL DIS, V29, P522, DOI 10.1006/bcmd.2002.0589; Das A, 2001, J GASTROEN HEPATOL, V16, P531, DOI 10.1046/j.1440-1746.2001.02487.x; DIBISCEGLIE AM, 1992, GASTROENTEROLOGY, V102, P2108, DOI 10.1016/0016-5085(92)90339-Z; Eng SC, 2005, LIVER INT, V25, P513, DOI 10.1111/j.1478-3231.2005.01004.x; Fujita N, 2007, MOL MED, V13, P97, DOI 10.2119/2006-00057.Fujita; Gordon N, 2000, BRAIN DEV-JPN, V22, P465, DOI 10.1016/S0387-7604(00)00175-3; Groeneweg M, 1998, HEPATOLOGY, V28, P45, DOI 10.1002/hep.510280108; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P561, DOI 10.1002/jmri.22293; Haacke EM, 2009, J MAGN RESON IMAGING, V29, P537, DOI 10.1002/jmri.21676; Haacke EM, 2005, MAGN RESON IMAGING, V23, P1, DOI 10.1016/j.mri.2004.10.001; Hadley KB, 2006, AM J CLIN NUTR, V84, P150, DOI 10.1093/ajcn/84.1.150; HALLGREN B, 1958, J NEUROCHEM, V3, P41, DOI 10.1111/j.1471-4159.1958.tb12607.x; Hayflick SJ, 2003, CURR OPIN PEDIATR, V15, P572, DOI 10.1097/00008480-200312000-00005; Honda K, 2004, ANN NY ACAD SCI, V1012, P179, DOI 10.1196/annals.1306.015; House MJ, 2010, MAGN RESON MED, V63, P275, DOI 10.1002/mrm.22263; Jalan R, 1995, J HEPATOL, V23, P697, DOI 10.1016/0168-8278(95)80036-0; Jones EA, 1997, J NEUROL NEUROSUR PS, V63, P279, DOI 10.1136/jnnp.63.3.279; Ke Y, 2003, LANCET NEUROL, V2, P246, DOI 10.1016/S1474-4422(03)00353-3; Ke Y, 2007, PROG NEUROBIOL, V83, P149, DOI 10.1016/j.pneurobio.2007.07.009; Klos KJ, 2005, ARCH NEUROL-CHICAGO, V62, P1385, DOI 10.1001/archneur.62.9.1385; KOHGO Y, 1987, BLOOD, V70, P1955; Langkammer C, 2010, RADIOLOGY, V257, P455, DOI 10.1148/radiol.10100495; Lee WC, 1999, J GASTROEN HEPATOL, V14, P370, DOI 10.1046/j.1440-1746.1999.01853.x; Liu JY, 2013, J MAGN RESON IMAGING, V37, P179, DOI 10.1002/jmri.23811; Martinelli AL, 2004, J GASTROEN HEPATOL, V19, P1036, DOI 10.1111/j.1440-1746.2004.03410.x; Mittal S, 2009, AM J NEURORADIOL, V30, P232, DOI 10.3174/ajnr.A1461; Nagashima M, 2006, HEPATOL RES, V36, P288, DOI 10.1016/j.hepres.2006.08.006; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Pantiga C, 2003, J NEUROPSYCH CLIN N, V15, P84, DOI 10.1176/appi.neuropsych.15.1.84; Pfefferbaum A, 2009, NEUROIMAGE, V47, P493, DOI 10.1016/j.neuroimage.2009.05.006; Ramey G, 2010, HAEMATOL-HEMATOL J, V95, P501, DOI 10.3324/haematol.2009.014399; SICILIANO M, 1995, HEPATOLOGY, V22, P1132, DOI 10.1016/0270-9139(95)90620-7; Singh B, 2011, CLIN CHIM ACTA, V412, P823, DOI 10.1016/j.cca.2011.02.014; van Deuren M, 2009, HAEMATOL-HEMATOL J, V94, P1297, DOI 10.3324/haematol.2009.005975; Vokurka M, 2006, PHYSIOL RES, V55, P667, DOI 10.33549/physiolres.930841; Weissenborn K, 2005, AIDS, V19, pS93, DOI 10.1097/01.aids.0000192076.03443.6d; World Health Organization/Centers for Disease Control and Prevention, 2007, ASS IR STAT POP; Worwood M, 1997, CLIN CHIM ACTA, V259, P3, DOI 10.1016/S0009-8981(96)06488-1; Wypijewska A, 2010, PARKINSONISM RELAT D, V16, P329, DOI 10.1016/j.parkreldis.2010.02.007; Yao B, 2009, NEUROIMAGE, V44, P1259, DOI 10.1016/j.neuroimage.2008.10.029; Yonal O, 2010, DIGEST DIS SCI, V55, P3548, DOI 10.1007/s10620-010-1183-8; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537; Zhang JQ, 2010, BRAIN RES, V1330, P124, DOI 10.1016/j.brainres.2010.03.036; Zhu WZ, 2009, RADIOLOGY, V253, P497, DOI 10.1148/radiol.2532082324	54	20	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65551	10.1371/journal.pone.0065551	http://dx.doi.org/10.1371/journal.pone.0065551			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776499	Green Published, Green Submitted, gold			2022-12-27	WOS:000320755400041
J	Seidel, G; Weger, M; Stadlmuller, L; Pichler, T; Haas, A				Seidel, Gerald; Weger, Martin; Stadlmueller, Lisa; Pichler, Tamara; Haas, Anton			Association of Preoperative Optical Coherence Tomography Markers with Residual Inner Limiting Membrane in Epiretinal Membrane Peeling	PLOS ONE			English	Article							BRILLIANT BLUE-G; INDOCYANINE GREEN; MACULAR PUCKER; RETINAL DAMAGE; TRYPAN BLUE; SURGERY; FEATURES; REMOVAL	Purpose: To identify preoperative markers on spectral domain optical coherence tomography (SD-OCT) for residual inner limiting membrane (ILM) in epiretinal membrane (ERM) peeling. Methods: In this retrospective case series the preoperative SD-OCTs from 119 eyes of 119 consecutive patients who underwent surgery for idiopathic ERM by a single surgeon were evaluated for markers predisposing for ILM persistence after ERM removal. ILM persistence was determined via intraoperative indocyanine green staining. The main outcome measures were correlation of central foveal thickness (CFT), ERM thickness, extent of elevated ERM and retinal folding, intraretinal cysts, and discontinuation of the ERM, with ILM persistence after ERM peeling. Results: The persistence of the ILM was found in 50.4% (n = 60). After Bonferroni correction for multiple testing, a greater extent of elevated ERM and thicker ERMs were associated with persistence of the ILM (p < 0.005). The other parameters showed no statistically significant correlations with the persistence of the ILM (p >= 0.005). Conclusion: Residual ILM can be found in nearly half of the eyes after ERM peeling. A loose connection between the ERM and the retinal surface predisposes for ILM persistence. Preoperative SD-OCT is helpful in identifying risk markers for the persistence of the ILM in ERM surgery.	[Seidel, Gerald; Weger, Martin; Pichler, Tamara; Haas, Anton] Med Univ Graz, Dept Ophthalmol, Graz, Austria; [Stadlmueller, Lisa] Med Univ Graz, Inst Med Informat Stat & Documentat, Graz, Austria	Medical University of Graz; Medical University of Graz	Seidel, G (corresponding author), Med Univ Graz, Dept Ophthalmol, Graz, Austria.	gerald.seidel@medunigraz.at		Seidel, Gerald/0000-0003-2622-2894				Abdelkader E, 2008, SURV OPHTHALMOL, V53, P368, DOI 10.1016/j.survophthal.2008.04.006; Bovey EH, 2004, RETINA-J RET VIT DIS, V24, P728, DOI 10.1097/00006982-200410000-00007; Enaida H, 2006, RETINA-J RET VIT DIS, V26, P631, DOI 10.1097/00006982-200607000-00007; Gandorfer A, 2003, INVEST OPHTH VIS SCI, V44, P316, DOI 10.1167/iovs.02-0545; Gandorfer A, 2001, AM J OPHTHALMOL, V132, P431, DOI 10.1016/S0002-9394(01)01087-X; Gandorfer A, 2012, RETINA-J RET VIT DIS, V32, P477, DOI 10.1097/IAE.0b013e3182246e2a; Gandorfer Arnd, 2008, Dev Ophthalmol, V42, P69, DOI 10.1159/000138974; Grewing R, 1996, BRIT J OPHTHALMOL, V80, P323, DOI 10.1136/bjo.80.4.323; Hattenbach LO, 2009, KLIN MONATSBL AUGENH, V226, P649, DOI 10.1055/s-0028-1109490; Henrich PB, 2011, INVEST OPHTH VIS SCI, V52, P4345, DOI 10.1167/iovs.10-6972; Hwang JU, 2012, INVEST OPHTH VIS SCI, V53, P3562, DOI 10.1167/iovs.12-9762; KAMPIK A, 1980, AM J OPHTHALMOL, V90, P797; Kiernan DF, 2010, AM J OPHTHALMOL, V149, P18, DOI 10.1016/j.ajo.2009.08.037; Kifuku K, 2009, BRIT J OPHTHALMOL, V93, P1016, DOI 10.1136/bjo.2008.150623; Kim JS, 2012, AM J OPHTHALMOL, V153, P692; Kwok AKH, 2005, CLIN EXP OPHTHALMOL, V33, P379, DOI 10.1111/j.1442-9071.2005.01015.x; Li K, 2003, BRIT J OPHTHALMOL, V87, P216, DOI 10.1136/bjo.87.2.216; Naumann GOH, 2008, APPL PATHOLOGY OPHTH, pxxii; Ooi YL, 2013, EYE, V27, P425, DOI 10.1038/eye.2012.260; Park DW, 2003, OPHTHALMOLOGY, V110, P62, DOI 10.1016/S0161-6420(02)01440-9; Shimozono M, 2012, AM J OPHTHALMOL, V153, P698, DOI 10.1016/j.ajo.2011.09.011; Shukla D, 2011, RETINA-J RET VIT DIS, V31, P2021, DOI 10.1097/IAE.0b013e318213618c; Tari SR, 2007, RETINA-J RET VIT DIS, V27, P567, DOI 10.1097/IAE.0b013e31802ea53d	23	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66217	10.1371/journal.pone.0066217	http://dx.doi.org/10.1371/journal.pone.0066217			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776634	gold, Green Published, Green Submitted			2022-12-27	WOS:000320755400123
J	Zhao, Y; Yu, B; Xiang, YH; Han, XJ; Xu, Y; So, KF; Xu, AD; Ruan, YW				Zhao, Ying; Yu, Bo; Xiang, Yong-Hui; Han, Xin-Jia; Xu, Ying; So, Kwok-Fai; Xu, An-Ding; Ruan, Yi-Wen			Changes in Retinal Morphology, Electroretinogram and Visual Behavior after Transient Global Ischemia in Adult Rats	PLOS ONE			English	Article							PHOTOPIC NEGATIVE RESPONSE; CAROTID-ARTERY OCCLUSION; CA1 PYRAMIDAL NEURONS; BLACK-WHITE BOX; ANXIETY-LIKE BEHAVIOR; GANGLION-CELL DEATH; VEIN OCCLUSION; OPTIC-NERVE; IMMUNOHISTOCHEMICAL CHANGES; FLASH ELECTRORETINOGRAM	The retina is a light-sensitive tissue of the central nervous system that is vulnerable to ischemia. The pathological mechanism underlying retinal ischemic injury is not fully understood. The purpose of this study was to investigate structural and functional changes of different types of rat retinal neurons and visual behavior following transient global ischemia. Retinal ischemia was induced using a 4-vessel occlusion model. Compared with the normal group, the number of beta III-tubulin positive retinal ganglion cells and calretinin positive amacrine cells were reduced from 6 h to 48 h following ischemia. The number of recoverin positive cone bipolar cells transiently decreased at 6 h and 12 h after ischemia. However, the fluorescence intensity of rhodopsin positive rod cells and fluorescent peanut agglutinin positive cone cells did not change after reperfusion. An electroretinogram recording showed that the a-wave, b-wave, oscillatory potentials and the photopic negative response were completely lost during ischemia. The amplitudes of the a-and b-waves were partially recovered at 1 h after ischemia, and returned to the control level at 48 h after reperfusion. However, the amplitudes of oscillatory potentials and the photopic negative response were still reduced at 48 h following reperfusion. Visual behavior detection showed there was no significant change in the time spent in the dark chamber between the control and 48 h group, but the distance moved, mean velocity in the black and white chambers and intercompartmental crosses were reduced at 48 h after ischemia. These results indicate that transient global ischemia induces dysfunction of retinal ganglion cells and amacrine cells at molecular and ERG levels. However, transient global ischemia in a 17 minute duration does not appear to affect photoreceptors.	[Xiang, Yong-Hui; Han, Xin-Jia; Xu, Ying; So, Kwok-Fai; Ruan, Yi-Wen] Jinan Univ, Guangdong Hongkong Macau Inst CNS Regenerat GHMIC, Dept Cent Nervous Syst Regenerat, Guangzhou, Guangdong, Peoples R China; [Zhao, Ying; Xu, An-Ding] Jinan Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou, Guangdong, Peoples R China; [Ruan, Yi-Wen] Jinan Univ, Sch Med, Dept Human Anat, Guangzhou, Guangdong, Peoples R China; [Yu, Bo] Shanghai Univ Tradit Chinese Med, Coll Med, Dept Human Anat, Shanghai, Peoples R China	Jinan University; Jinan University; Jinan University; Shanghai University of Traditional Chinese Medicine	Xu, AD (corresponding author), Jinan Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou, Guangdong, Peoples R China.	andingxu@gmail.com; tyiwen@jnu.edu.cn		Xu, Ying/0000-0002-9987-2057; Xu, An-Ding/0000-0003-3154-0985; So, Kwok-Fai/0000-0003-4039-4246	National Program on Key Basic Research Project of China (973 Program) [2011CB707501]; National Natural Science Foundation of China [30971530]; Open Fund of the First Affiliated Hospital of Jinan University	National Program on Key Basic Research Project of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Fund of the First Affiliated Hospital of Jinan University	This work was supported by the following grants: National Program on Key Basic Research Project of China (973 Program, 2011CB707501), the National Natural Science Foundation of China (30971530), and the Open Fund of the First Affiliated Hospital of Jinan University (2012-2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 1996, GRAEF ARCH CLIN EXP, V234, P445, DOI 10.1007/BF02539411; BARNETT NL, 1995, EXP EYE RES, V61, P83, DOI 10.1016/S0014-4835(95)80061-1; BLANKS JC, 1983, J COMP NEUROL, V221, P31, DOI 10.1002/cne.902210103; BLOCK F, 1992, NEUROSCI LETT, V144, P124, DOI 10.1016/0304-3940(92)90731-L; Bradley BF, 2011, BEHAV BRAIN RES, V216, P285, DOI 10.1016/j.bbr.2010.08.006; Chen HL, 2008, DOC OPHTHALMOL, V117, P129, DOI 10.1007/s10633-008-9114-0; Chen HL, 2006, DOC OPHTHALMOL, V113, P53, DOI 10.1007/s10633-006-9015-z; Chun MH, 1999, NEUROSCI LETT, V260, P125, DOI 10.1016/S0304-3940(98)00973-2; DELCERRO M, 1995, CELL TRANSPLANT, V4, P133, DOI 10.1016/0963-6897(94)00045-L; Dijk F, 2004, BRAIN RES, V1026, P194, DOI 10.1016/j.brainres.2004.08.034; Dijk F, 2004, BRAIN RES, V997, P207, DOI 10.1016/j.brainres.2003.08.069; Gianfranceschi L, 1999, VISION RES, V39, P569, DOI 10.1016/S0042-6989(98)00169-2; Hernandez M, 2009, MOL VIS, V15, P2696; Hogue CW, 2008, CRIT CARE CLIN, V24, P83, DOI 10.1016/j.ccc.2007.09.004; Jehle T, 2008, INVEST OPHTH VIS SCI, V49, P1056, DOI 10.1167/iovs.07-1050; JOHNSON MA, 1993, ARCH OPHTHALMOL-CHIC, V111, P806, DOI 10.1001/archopht.1993.01090060094030; KLINE RP, 1978, P NATL ACAD SCI USA, V75, P5727, DOI 10.1073/pnas.75.11.5727; Kwon OJ, 2005, MOL CELLS, V19, P382; Lafuente MP, 2002, NEUROSCIENCE, V109, P157, DOI 10.1016/S0306-4522(01)00458-4; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lavinsky D, 2006, GRAEF ARCH CLIN EXP, V244, P199, DOI 10.1007/s00417-005-0006-7; Lee JH, 2011, ANAT CELL BIOL, V44, P25, DOI 10.5115/acb.2011.44.1.25; Li B, 2005, DOC OPHTHALMOL, V111, P23, DOI [10.1007/s10633-005-2629-8, 10.1007/S10633-005-2629-8]; Li SY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016380; Lin B, 2008, P NATL ACAD SCI USA, V105, P16009, DOI 10.1073/pnas.0806114105; Luan LJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018938; Madl Christian, 2004, Curr Opin Crit Care, V10, P213, DOI 10.1097/01.ccx.0000127542.32890.fa; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; Meier P, 2011, J VIS, V11, P22; Mi XS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045469; NEITZ J, 1986, J COMP PSYCHOL, V100, P21, DOI 10.1037/0735-7036.100.1.21; Osborne NN, 2004, PROG RETIN EYE RES, V23, P91, DOI 10.1016/j.preteyeres.2003.12.001; Ozden S, 2001, OPHTHALMOLOGICA, V215, P309, DOI 10.1159/000050880; PULSINELLI WA, 1979, STROKE, V10, P267, DOI 10.1161/01.STR.10.3.267; Ren C, 2013, NEUROPSYCHOPHARMACOL; Ruan YW, 2006, NEUROSCIENCE, V140, P191, DOI 10.1016/j.neuroscience.2006.01.039; Ruan YW, 2012, NEUROSCIENCE, V218, P268, DOI 10.1016/j.neuroscience.2012.05.035; Ruan YW, 2007, J NEUROSCI RES, V85, P193, DOI 10.1002/jnr.21101; Ruan YW, 2009, J NEUROSCI RES, V87, P61, DOI 10.1002/jnr.21816; Russo R, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.29; SABATES R, 1983, ARCH OPHTHALMOL-CHIC, V101, P232; Schmucker C, 2005, INVEST OPHTH VIS SCI, V46, P398, DOI 10.1167/iovs.04-0959; Shumyatsky GP, 2002, CELL, V111, P905, DOI 10.1016/S0092-8674(02)01116-9; Smythe JW, 1997, PHARMACOL BIOCHEM BE, V56, P507, DOI 10.1016/S0091-3057(96)00244-4; Smythe JW, 1998, BRAIN RES BULL, V45, P89, DOI 10.1016/S0361-9230(97)00311-0; STEFANSSON E, 1988, INVEST OPHTH VIS SCI, V29, P1050; Stevens WD, 2002, STROKE, V33, P1107, DOI 10.1161/01.STR.0000014204.05597.0C; Thomas BB, 2007, J NEUROSCI METH, V162, P84, DOI 10.1016/j.jneumeth.2006.12.010; Timothy C, 1999, PHARMACOL BIOCHEM BE, V62, P323, DOI 10.1016/S0091-3057(98)00157-9; Vidal-Sanz M, 2001, SURV OPHTHALMOL, V45, pS261, DOI 10.1016/S0039-6257(01)00205-3; Viswanathan S, 2001, INVEST OPHTH VIS SCI, V42, P514; Wachtmeister L, 1998, PROG RETIN EYE RES, V17, P485, DOI 10.1016/S1350-9462(98)00006-8; Wang X, 2011, EXP EYE RES, V93, P753, DOI 10.1016/j.exer.2011.09.022; Xu ZC, 1999, BIOL SIGNAL RECEPT, V8, P294; Yamamoto H, 2006, EXP EYE RES, V82, P767, DOI 10.1016/j.exer.2005.09.019	55	23	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65555	10.1371/journal.pone.0065555	http://dx.doi.org/10.1371/journal.pone.0065555			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776500	gold, Green Published, Green Submitted			2022-12-27	WOS:000320755400042
J	Baird, BN; Schliekelman, MJ; Ahn, YH; Chen, Y; Roybal, JD; Gill, BJ; Mishra, DK; Erez, B; O'Reilly, M; Yang, Y; Patel, M; Liu, X; Thilaganathan, N; Larina, IV; Dickinson, ME; West, JL; Gibbons, DL; Liu, DD; Kim, MP; Hicks, JM; Wistuba, II; Hanash, SM; Kurie, JM				Baird, Brandi N.; Schliekelman, Mark J.; Ahn, Young-Ho; Chen, Yulong; Roybal, Jonathon D.; Gill, Bartley J.; Mishra, Dhruva K.; Erez, Baruch; O'Reilly, Michael; Yang, Yanan; Patel, Mayuri; Liu, Xin; Thilaganathan, Nishan; Larina, Irina V.; Dickinson, Mary E.; West, Jennifer L.; Gibbons, Don L.; Liu, Diane D.; Kim, Min P.; Hicks, John M.; Wistuba, Ignacio I.; Hanash, Samir M.; Kurie, Jonathan M.			Fibulin-2 Is a Driver of Malignant Progression in Lung Adenocarcinoma	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; TENASCIN-C; METASTASIS; EXPRESSION; CELLS; HOMEOSTASIS; MIR-200; FAMILY; ROLES; GENE	The extracellular matrix of epithelial tumors undergoes structural remodeling during periods of uncontrolled growth, creating regional heterogeneity and torsional stress. How matrix integrity is maintained in the face of dynamic biophysical forces is largely undefined. Here we investigated the role of fibulin-2, a matrix glycoprotein that functions biomechanically as an inter-molecular clasp and thereby facilitates supra-molecular assembly. Fibulin-2 was abundant in the extracellular matrix of human lung adenocarcinomas and was highly expressed in tumor cell lines derived from mice that develop metastatic lung adenocarcinoma from co-expression of mutant K-ras and p53. Loss-offunction experiments in tumor cells revealed that fibulin-2 was required for tumor cells to grow and metastasize in syngeneic mice, a surprising finding given that other intra-tumoral cell types are known to secrete fibulin-2. However, tumor cells grew and metastasized equally well in Fbln2-null and -wild-type littermates, implying that malignant progression was dependent specifically upon tumor cellderived fibulin-2, which could not be offset by other cellular sources of fibulin-2. Fibulin-2 deficiency impaired the ability of tumor cells to migrate and invade in Boyden chambers, to create a stiff extracellular matrix in mice, to cross-link secreted collagen, and to adhere to collagen. We conclude that fibulin-2 is a driver of malignant progression in lung adenocarcinoma and plays an unexpected role in collagen cross-linking and tumor cell adherence to collagen.	[Baird, Brandi N.; Ahn, Young-Ho; Chen, Yulong; Roybal, Jonathon D.; Yang, Yanan; Patel, Mayuri; Liu, Xin; Thilaganathan, Nishan; Gibbons, Don L.; Wistuba, Ignacio I.; Kurie, Jonathan M.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA; [Schliekelman, Mark J.; Hanash, Samir M.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Gill, Bartley J.; West, Jennifer L.] Rice Univ, Dept Bioengn, Houston, TX USA; [Mishra, Dhruva K.; Kim, Min P.] Methodist Hosp Res Inst, Dept Surg, Houston, TX USA; [Erez, Baruch; O'Reilly, Michael] Univ Texas Houston, MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA; [Larina, Irina V.; Dickinson, Mary E.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Liu, Diane D.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Hicks, John M.] Texas Childrens Hosp, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; Fred Hutchinson Cancer Center; Rice University; The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital Research Institute; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; Baylor College of Medicine	Kurie, JM (corresponding author), Univ Texas Houston, MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	jkurie@mdanderson.org	West, Jennifer L/A-4582-2008	West, Jennifer L/0000-0001-8550-2875; Mishra, Dhruva/0000-0001-8651-005X	Elza and Ina Shackelford-Freeman Lung Cancer Research Professorship [U01 CA141550, T32 GM008362, K08 CA151651];  [R01 CA157450]; NATIONAL CANCER INSTITUTE [K08CA151651, P30CA016672, U01CA141550, R01CA157450] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008362] Funding Source: NIH RePORTER	Elza and Ina Shackelford-Freeman Lung Cancer Research Professorship; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported in part by R01 CA157450 (J.M.K., http://grants.nih.gov), The Elza and Ina Shackelford-Freeman Lung Cancer Research Professorship (J.M.K.), U01 CA141550 (S.H., http://grants.nih.gov), T32 GM008362 (B.J.G., http://grants.nih.gov), and K08 CA151651 (D.L.G., http://grants.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcendor DJ, 2011, AM J PATHOL, V179, P1443, DOI 10.1016/j.ajpath.2011.05.024; Argraves WS, 2003, EMBO REP, V4, P1127, DOI 10.1038/sj.embor.7400033; de Vega S, 2009, CELL MOL LIFE SCI, V66, P1890, DOI 10.1007/s00018-009-8632-6; Dunwell TL, 2009, EPIGENETICS-US, V4, P185, DOI 10.4161/epi.4.3.8752; Gibbons DL, 2009, GENE DEV, V23, P2140, DOI 10.1101/gad.1820209; Grassel S, 1999, EUR J BIOCHEM, V263, P471, DOI 10.1046/j.1432-1327.1999.00523.x; Law EWL, 2012, ONCOGENE, V31, P728, DOI 10.1038/onc.2011.272; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; Nelson CM, 2006, ANNU REV CELL DEV BI, V22, P287, DOI 10.1146/annurev.cellbio.22.010305.104315; O'Connell JT, 2011, P NATL ACAD SCI USA, V108, P16002, DOI 10.1073/pnas.1109493108; Olson MF, 2009, CLIN EXP METASTAS, V26, P273, DOI 10.1007/s10585-008-9174-2; Oskarsson T, 2011, NAT MED, V17, P867, DOI 10.1038/nm.2379; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Reinhardt DP, 1996, J BIOL CHEM, V271, P19489, DOI 10.1074/jbc.271.32.19489; SAINTIGNY P, 2013, PUBMED; Sasaki T, 1996, J CELL SCI, V109, P2895; Sasaki T, 1997, EMBO J, V16, P3035, DOI 10.1093/emboj/16.11.3035; Schliekelman MJ, 2011, CANCER RES, V71, P7670, DOI 10.1158/0008-5472.CAN-11-0964; Senapati S, 2012, ONCOGENE, V31, P3346, DOI 10.1038/onc.2011.505; Sicot FX, 2008, MOL CELL BIOL, V28, P1061, DOI 10.1128/MCB.01876-07; Timpl R, 2003, NAT REV MOL CELL BIO, V4, P479, DOI 10.1038/nrm1130; Tsuda T, 2001, DEV DYNAM, V222, P89, DOI 10.1002/dvdy.1172; Tsuda T, 2012, J MOL CELL CARDIOL, V52, P273, DOI 10.1016/j.yjmcc.2011.11.001; White DJ, 2004, INT J BIOCHEM CELL B, V36, P1405, DOI 10.1016/j.biocel.2003.08.016; Yi CH, 2007, AM J PATHOL, V170, P1535, DOI 10.2353/ajpath.2007.060478	27	30	30	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e67054	10.1371/journal.pone.0067054	http://dx.doi.org/10.1371/journal.pone.0067054			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23785517	Green Submitted, Green Published, gold			2022-12-27	WOS:000320440500072
J	de Vries, NKS; van der Veere, CN; Reijneveld, SA; Bos, AF				de Vries, Nathalie K. S.; van der Veere, Christine N.; Reijneveld, Sijmen A.; Bos, Arend F.			Early Neurological Outcome of Young Infants Exposed to Selective Serotonin Reuptake Inhibitors during Pregnancy: Results from the Observational SMOK Study	PLOS ONE			English	Article							ANTIDEPRESSANT DRUG-USE; MEDICATION EXPOSURE; GENERAL MOVEMENTS; PRETERM INFANTS; DEPRESSION; NEWBORN; POPULATION; PREVALENCE; DISORDERS; PATTERNS	Background: Use of selective serotonin reuptake inhibitors (SSRI) during pregnancy is common while the effect on the infant's neurological outcome is unknown. Our objective was to determine the effects of prenatal SSRI-exposure on the infants' neurological functioning, adjusted for maternal mental health. Methods: A prospective observational study from May 2007 to April 2010. The study groups comprised 63 SSRI-exposed infants (SSRI group) and 44 non-exposed infants (non-SSRI group). Maternal depression and anxiety were measured using questionnaires. The main outcome measures during the first week after birth and at three to four months were the quality of the infants' general movements (GMs) according to Prechtl and a detailed motor optimality score. We calculated odds ratios (ORs) and 95% confidence intervals (CIs) for abnormal GM quality in the SSRI and non-SSRI groups, and adjusted for maternal depression, anxiety, and other confounders. The study was registered under 53506435 in the ISRCTN. Findings: All infants were born around term. During the first week, abnormal GMs occurred more frequently in the SSRI group than in the non-SSRI group (59% versus 33%) and the median MOS was lower (13 versus 18). The OR for abnormal GMs in the SSRI versus the non-SSRI group was 3.0 (95% CI, 1.3 to 6.9) and increased after adjustment for confounders. At three to four months, more SSRI-exposed infants had monotonous movements (48% versus 20%) with lower median MOSs (26 versus 28). The OR for monotonous movements was 3? 5 (95% CI, 1.5 to 8.6) and increased after adjusting for confounders. Interpretation: Prenatal exposure to SSRI had an adverse effect on early neurological functioning as reflected by GM quality, irrespective of maternal depression and anxiety, and other confounders. Physicians should take this into account in consultation with parents.	[de Vries, Nathalie K. S.] Med Ctr Leeuwarden, Dept Paediat, Leeuwarden, Netherlands; [van der Veere, Christine N.] Wilhelmina Gasthuis, Dept Paediat, Assen, Netherlands; [Reijneveld, Sijmen A.] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Sci, Groningen, Netherlands; [Bos, Arend F.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Div Neonatol, Groningen, Netherlands	Medical Center Leeuwarden; University of Groningen; University of Groningen	de Vries, NKS (corresponding author), Med Ctr Leeuwarden, Dept Paediat, Leeuwarden, Netherlands.	nathalie.de.vries@znb.nl		Reijneveld, Sijmen/0000-0002-1206-7523	science foundation for the medical staff of Medical Centre Leeuwarden	science foundation for the medical staff of Medical Centre Leeuwarden	The science foundation for the medical staff of Medical Centre Leeuwarden funded the study. Their grant was used toward paying the research assistant's salary and reimbursement of expenses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson L, 2003, AM J OBSTET GYNECOL, V189, P148, DOI 10.1067/mob.2003.336; Bruggink JLM, 2008, J PEDIATR-US, V153, P32, DOI 10.1016/j.jpeds.2007.12.047; Bruggink JLM, 2009, EARLY HUM DEV, V85, P25, DOI 10.1016/j.earlhumdev.2008.05.010; Cooper WO, 2007, AM J OBSTET GYNECOL, V196, P544, DOI 10.1016/j.ajog.2007.01.033; Costei AM, 2002, ARCH PEDIAT ADOL MED, V156, P1129, DOI 10.1001/archpedi.156.11.1129; de Vries NKS, 2010, EARLY HUM DEV, V86, P225, DOI 10.1016/j.earlhumdev.2010.03.004; Debonnel G, 2007, INT J NEUROPSYCHOPH, V10, P51, DOI 10.1017/S1461145705006413; Einspieler C, 2005, MENT RETARD DEV D R, V11, P61, DOI 10.1002/mrdd.20051; Field T, 2006, INFANT BEHAV DEV, V29, P445, DOI 10.1016/j.infbeh.2006.03.003; Field T, 2010, INFANT BEHAV DEV, V33, P409, DOI 10.1016/j.infbeh.2010.04.005; Gentile S, 2011, J AFFECT DISORDERS, V128, P1, DOI 10.1016/j.jad.2010.02.125; Gentile S, 2009, EVID-BASED MENT HEAL, V12, P27, DOI 10.1136/ebmh.12.1.27; Gentile S, 2010, CNS SPECTRUMS, V15, P167, DOI 10.1017/S1092852900027449; Lasa L, 2000, J AFFECT DISORDERS, V57, P261, DOI 10.1016/S0165-0327(99)00088-9; Lattimore Keri A, 2005, J Perinatol, V25, P595; Martini J, 2010, EARLY HUM DEV, V86, P305, DOI 10.1016/j.earlhumdev.2010.04.004; Meades R, 2011, J AFFECT DISORDERS, V133, P1, DOI 10.1016/j.jad.2010.10.009; Montgomery SA, 2008, CNS SPECTRUMS, V13, P27, DOI 10.1017/S1092852900028297; Moses-Kolko EL, 2005, JAMA-J AM MED ASSOC, V293, P2372, DOI 10.1001/jama.293.19.2372; Mulder EJH, 2011, NEUROPSYCHOPHARMACOL, V36, P1961, DOI 10.1038/npp.2011.67; Oberlander TF, 2005, PEDIATRICS, V115, P411, DOI 10.1542/peds.2004-0420; Oberlander TF, 2004, J CLIN PSYCHIAT, V65, P230; PRECHTL HFR, 1974, BRAIN RES, V76, P185, DOI 10.1016/0006-8993(74)90454-5; PRECHTL HFR, 1980, EARLY HUM DEV, V4, P201; Rampono J, 2009, PHARMACOPSYCHIATRY, V42, P95, DOI 10.1055/s-0028-1103296; Salisbury AL, 2011, DEPRESS ANXIETY, V28, P1008, DOI 10.1002/da.20883; Stewart DE, 2011, NEW ENGL J MED, V365, P1605, DOI 10.1056/NEJMcp1102730; Talge NM, 2007, J CHILD PSYCHOL PSYC, V48, P245, DOI 10.1111/j.1469-7610.2006.01714.x; Veere vd, 2007, NED TIJDSCHR GENEES, V151, P2873; Ververs TF, 2009, BJOG-INT J OBSTET GY, V116, P1568, DOI 10.1111/j.1471-0528.2009.02292.x; Ververs T, 2006, EUR J CLIN PHARMACOL, V62, P863, DOI 10.1007/s00228-006-0177-0; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Zeskind PS, 2004, PEDIATRICS, V113, P368, DOI 10.1542/peds.113.2.368	33	29	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e64654	10.1371/journal.pone.0064654	http://dx.doi.org/10.1371/journal.pone.0064654			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23785389	Green Published, Green Submitted, gold			2022-12-27	WOS:000319733000074
J	Lin, HJ; Weng, SF; Yang, CM; Wu, MP				Lin, Huey-Juan; Weng, Shih-Feng; Yang, Chun-Ming; Wu, Ming-Ping			Risk of Hospitalization for Acute Cardiovascular Events among Subjects with Lower Urinary Tract Symptoms: A Nationwide Population-Based Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; OVERACTIVE BLADDER; ERECTILE DYSFUNCTION; NERVOUS-SYSTEM; HEALTH-CARE; INCONTINENCE; PREVALENCE; BURDEN; MEN	Background and Purpose: Lower urinary tract symptoms (LUTS) have been reported to be associated with metabolic syndrome and may predispose subjects to cardiovascular disease. The magnitude of the impact on the medical care remains to be elucidated. Based on a population-based claims dataset in Taiwan, we explored the association between LUTS and the risk of subsequent hospitalization for acute cardiovascular events. Materials and Methods: Among a representative sample of one million subjects from nationwide health insurance enrollees, subjects with codes of LUTS in service claims and without previous cardiovascular diseases including stroke were compared with age-and sex-matched non-LUTS subjects in subsequent hospitalization for acute coronary syndrome or stroke from the recruited date (between 2001-2004) to 2009. The risk of outcomes was assessed with Kaplan-Meier curves and the impact of LUTS was estimated with Poison regression analysis and Cox proportional hazards models. Results: We included 4,553 LUTS subjects and 22,765 matched non-LUTS subjects, with a mean age of 47 years and 43% of men. Hypertension, diabetes, and hyperlipidemia were more prevalent in the LUTS group. The incidence rate of the composite endpoint was significantly higher in the LUTS group than in the non-LUTS group (5.4/1000 vs. 4.0/1000 person-years). The difference mainly derived from stroke rather than acute coronary syndrome. After adjusting for age, sex, diabetes, hypertension, and hyperlipidemia in multivariable analysis, LUTS remained a significant predictor (hazard ratio, 1.29; 95% confidence incidence, 1.06-1.50). Conclusion: Subjects free of cardiovascular disease and presenting with LUTS are at risk of subsequent hospitalization for acute cardiovascular events, mainly stroke. The information might prompt practitioners encountering such patients to undergo appropriate diagnostic and preventive measures.	[Lin, Huey-Juan; Yang, Chun-Ming] Chi Mei Med Ctr, Dept Neurol, Tainan, Taiwan; [Weng, Shih-Feng; Wu, Ming-Ping] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Wu, Ming-Ping] Chi Mei Med Ctr, Dept Obstet & Gynecol, Div Urogynecol, Tainan, Taiwan; [Lin, Huey-Juan] Chia Nan Univ Pharm & Sci, Dept Cosmet Sci, Tainan, Taiwan; [Wu, Ming-Ping] Chia Nan Univ Pharm & Sci, Ctr Gen Educ, Tainan, Taiwan; [Weng, Shih-Feng] Chia Nan Univ Pharm & Sci, Dept Hosp & Hlth Care Adm, Tainan, Taiwan	Chi Mei Hospital; Chi Mei Hospital; Chi Mei Hospital; Chia Nan University of Pharmacy & Science; Chia Nan University of Pharmacy & Science; Chia Nan University of Pharmacy & Science	Wu, MP (corresponding author), Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan.	mpwu@mail.chimei.org.tw		Weng, Shih-Feng/0000-0001-8684-3487	Chi Mei Medical Center	Chi Mei Medical Center	The study was funded by Chi Mei Medical Center (http://www.chimei.org.tw/main/cmh_department/54220/english/2012/index.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson KE, 2010, BJU INT, V106, P268, DOI 10.1111/j.1464-410X.2009.09073.x; Asche CV, 2012, BJU INT, V109, P572, DOI 10.1111/j.1464-410X.2011.10436.x; Baumhakel M, 2007, INT J CLIN PRACT, V61, P361, DOI 10.1111/j.1742-1241.2006.01274.x; Bouwman II, 2009, EUR J GEN PRACT, V15, P128, DOI 10.3109/13814780903329536; Coyne KS, 2009, BJU INT, V103, P4, DOI 10.1111/j.1464-410X.2009.08371.x; Glavind K, 2011, INT UROGYNECOL J, V22, P907, DOI 10.1007/s00192-011-1411-6; Hubeaux K, 2011, NEUROUROL URODYNAM, V30, P1467, DOI 10.1002/nau.21154; Irwin DE, 2006, EUR UROL, V50, P1306, DOI 10.1016/j.eururo.2006.09.019; Karatas OF, 2010, INT J CARDIOL, V144, P452, DOI 10.1016/j.ijcard.2009.03.099; Kirby MG, 2010, NEUROUROL URODYNAM, V29, P1360, DOI 10.1002/nau.20892; Lukacz ES, 2011, INT J CLIN PRACT, V65, P1026, DOI 10.1111/j.1742-1241.2011.02763.x; Malmsten UGH, 2010, EUR UROL, V58, P149, DOI 10.1016/j.eururo.2010.03.014; McVary KT, 2011, J UROLOGY, V185, P1793, DOI 10.1016/j.juro.2011.01.074; Parthasarathy S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030969; Penson DF, 2011, J UROLOGY, V186, P2316, DOI 10.1016/j.juro.2011.07.067; Wehrberger C, 2011, UROLOGY, V78, P1063, DOI 10.1016/j.urology.2011.05.065; Wu MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057825; Wu MP, 2013, UROLOGY, V81, P61, DOI 10.1016/j.urology.2012.08.033; Zhang XW, 2011, UROL INT, V86, P173, DOI 10.1159/000321895	19	62	66	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66661	10.1371/journal.pone.0066661	http://dx.doi.org/10.1371/journal.pone.0066661			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23826095	Green Submitted, Green Published, gold			2022-12-27	WOS:000320322400114
J	Zhang, LF; Thomas, JC; Miragaia, M; Bouchami, O; Chaves, F; d'Azevedo, PA; Aanensen, DM; de Lencastre, H; Gray, BM; Robinson, DA				Zhang, Liangfen; Thomas, Jonathan C.; Miragaia, Maria; Bouchami, Ons; Chaves, Fernando; d'Azevedo, Pedro A.; Aanensen, David M.; de Lencastre, Herminia; Gray, Barry M.; Robinson, D. Ashley			Multilocus Sequence Typing and Further Genetic Characterization of the Enigmatic Pathogen, Staphylococcus hominis	PLOS ONE			English	Article							CASSETTE CHROMOSOME MEC; COAGULASE-NEGATIVE STAPHYLOCOCCI; METHICILLIN-RESISTANT; LEVEL RESISTANCE; BLOOD CULTURES; IDENTIFICATION; NOVOBIOCIN; EMERGENCE; SKIN; INFECTIONS	Staphylococcus hominis is a commensal resident of human skin and an opportunistic pathogen. The species is subdivided into two subspecies, S. hominis subsp. hominis and S. hominis subsp. novobiosepticus, which are difficult to distinguish. To investigate the evolution and epidemiology of S. hominis, a total of 108 isolates collected from 10 countries over 40 years were characterized by classical phenotypic methods and genetic methods. One nonsynonymous mutation in gyrB, scored with a novel SNP typing assay, had a perfect association with the novobiocin-resistant phenotype. A multilocus sequence typing (MLST) scheme was developed from six housekeeping gene fragments, and revealed relatively high levels of genetic diversity and a significant impact of recombination on S. hominis population structure. Among the 40 sequence types (STs) identified by MLST, three STs (ST2, ST16 and ST23) were S. hominis subsp. novobiosepticus, and they distinguished between isolates from different outbreaks, whereas 37 other STs were S. hominis subsp. hominis, one of which was widely disseminated (ST1). A modified PCR assay was developed to detect the presence of ccrAB4 from the SCCmec genetic element. S. hominis subsp. novobiosepticus isolates were oxacillin-resistant and carriers of specific components of SCCmec (mecA class A, ccrAB3, ccrAB4, ccrC), whereas S. hominis subsp. hominis included both oxacillin-sensitive and -resistant isolates and a more diverse array of SCCmec components. Surprisingly, phylogenetic analyses indicated that S. hominis subsp. novobiosepticus may be a polyphyletic and, hence, artificial taxon. In summary, these results revealed the genetic diversity of S. hominis, the identities of outbreak-causing clones, and the evolutionary relationships between subspecies and clones. The pathogenic lifestyle attributed to S. hominis subsp. novobiosepticus may have originated on more than one occasion.	[Zhang, Liangfen; Thomas, Jonathan C.; Robinson, D. Ashley] Univ Mississippi, Med Ctr, Dept Microbiol, Jackson, MS 39216 USA; [Miragaia, Maria; Bouchami, Ons; de Lencastre, Herminia] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Mol Genet Lab, P-2780156 Oeiras, Portugal; [Chaves, Fernando] Hosp Univ 12 Octubre, Microbiol Serv, Madrid, Spain; [d'Azevedo, Pedro A.] Univ Fed Ciencias Saude Porto Alegre, Porto Alegre, RS, Brazil; [Aanensen, David M.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England; [de Lencastre, Herminia] Rockefeller Univ, Microbiol Lab, New York, NY 10021 USA; [Gray, Barry M.] Univ Illinois, Dept Pediat, Peoria, IL USA	University of Mississippi; University of Mississippi Medical Center; Universidade Nova de Lisboa; Hospital Universitario 12 de Octubre; Universidade Federal de Ciencias da Saude de Porto Alegre; Imperial College London; Rockefeller University; University of Illinois System; University of Illinois Peoria	Robinson, DA (corresponding author), Univ Mississippi, Med Ctr, Dept Microbiol, Jackson, MS 39216 USA.	darobinson@umc.edu	Miragaia, Maria/J-2704-2015; Chaves, Fernando/C-6176-2016	Miragaia, Maria/0000-0002-1323-7184; /0000-0001-6816-8932; Bouchami, Ons/0000-0002-9425-3513; Thomas, Jonathan/0000-0002-1599-9123	National Institutes of Health [GM080602]; Spanish Network for Research in Infectious Diseases [RD06/0008]; Fundacao para a Ciencia e Tecnologia, Portugal [PTDC/BIA-EVF/117507/2010, Pest-OE/EQB/LAO004/2011]; NIGMS NIH HHS [R01 GM080602, GM080602] Funding Source: Medline	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Network for Research in Infectious Diseases; Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by grant GM080602 from the National Institutes of Health (to DAR) and grant RD06/0008 from the Spanish Network for Research in Infectious Diseases (to FC). The work performed in Portugal was supported by grants PTDC/BIA-EVF/117507/2010 (to MM) and grant #Pest-OE/EQB/LAO004/2011 (to ITQB) from Fundacao para a Ciencia e Tecnologia, Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannoehr J, 2007, J BACTERIOL, V189, P8685, DOI 10.1128/JB.01150-07; Bouchami O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021940; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cavanagh JP, 2012, J MICROBIOL METH, V89, P159, DOI 10.1016/j.mimet.2012.03.014; Chassain B, 2012, J CLIN MICROBIOL, V50, P3003, DOI 10.1128/JCM.00988-12; Chen LA, 2010, ANTIMICROB AGENTS CH, V54, P3347, DOI 10.1128/AAC.00001-10; CLSI, 2007, M100S17 CLSI; Cunha BA, 2007, HEART LUNG, V36, P380, DOI 10.1016/j.hrtlng.2006.11.002; d'Azevedo PA, 2008, J MED MICROBIOL, V57, P256, DOI 10.1099/jmm.0.47345-0; Santos OCDS, 2009, DIAGN MICR INFEC DIS, V64, P1, DOI 10.1016/j.diagmicrobio.2008.12.017; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ELLENDER RD, 1995, J FOOD PROTECT, V58, P853, DOI 10.4315/0362-028X-58.8.853; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; FAGHRI MA, 1984, APPL ENVIRON MICROB, V47, P1054, DOI 10.1128/AEM.47.5.1054-1061.1984; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Fitzgibbon JE, 2001, RES MICROBIOL, V152, P805, DOI 10.1016/S0923-2508(01)01264-5; Fournier B, 1998, ANTIMICROB AGENTS CH, V42, P121, DOI 10.1128/AAC.42.1.121; Fujimoto-Nakamura M, 2005, ANTIMICROB AGENTS CH, V49, P3810, DOI 10.1128/AAC.49.9.3810-3815.2005; Gao Z, 2007, P NATL ACAD SCI USA, V104, P2927, DOI 10.1073/pnas.0607077104; Garza-Gonzalez E, 2011, SCAND J INFECT DIS, V43, P930, DOI 10.3109/00365548.2011.598873; Gilad J, 2007, J CLIN MICROBIOL, V45, P685, DOI 10.1128/JCM.02228-06; Grundmann H, 2001, J CLIN MICROBIOL, V39, P4190, DOI 10.1128/JCM.39.11.4190-4192.2001; GUNN BA, 1983, INT J SYST BACTERIOL, V33, P751, DOI 10.1099/00207713-33-4-751; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Heikens E, 2005, J CLIN MICROBIOL, V43, P2286, DOI 10.1128/JCM.43.5.2286-2290.2005; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Ito T, 2001, ANTIMICROB AGENTS CH, V45, P1323, DOI 10.1128/AAC.45.5.1323-1336.2001; Iyer MN, 2005, AM J OPHTHALMOL, V139, P930, DOI 10.1016/j.ajo.2004.10.060; Katayama Y, 2003, J BACTERIOL, V185, P2711, DOI 10.1128/JB.185.9.2711-2722.2003; Kim SD, 2000, INFECT CONT HOSP EP, V21, P213, DOI 10.1086/501747; KLOOS WE, 1975, J CLIN MICROBIOL, V1, P82, DOI 10.1128/JCM.1.1.82-88.1975; Kloos WE, 1998, INT J SYST BACTERIOL, V48, P799, DOI 10.1099/00207713-48-3-799; KLOOS WE, 1975, INT J SYST BACTERIOL, V25, P62, DOI 10.1099/00207713-25-1-62; KLOOS WE, 1975, APPL MICROBIOL, V30, P381, DOI 10.1128/AEM.30.3.381-395.1975; KLOOS WE, 1994, CLIN MICROBIOL REV, V7, P117, DOI 10.1128/CMR.7.1.117-140.1994; Kondo Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; Larson EL, 1998, AM J INFECT CONTROL, V26, P513, DOI 10.1016/S0196-6553(98)70025-2; Lebeaux D, 2012, ANTIMICROB AGENTS CH, V56, P315, DOI 10.1128/AAC.00547-11; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Oliveira DC, 2006, ANTIMICROB AGENTS CH, V50, P3457, DOI 10.1128/AAC.00629-06; Petinaki E, 2005, J ANTIMICROB CHEMOTH, V55, P811, DOI 10.1093/jac/dki072; Robinson DA, 2003, ANTIMICROB AGENTS CH, V47, P3926, DOI 10.1128/AAC.47.12.3926-3934.2003; Rogers KL, 2009, INFECT DIS CLIN N AM, V23, P73, DOI 10.1016/j.idc.2008.10.001; Ruhe J, 2004, EUR J CLIN MICROBIOL, V23, P495, DOI 10.1007/s10096-004-1134-4; de Gopegui ER, 2011, ENFERM INFEC MICR CL, V29, P339, DOI 10.1016/j.eimc.2011.02.001; Slatkin M, 2008, NAT REV GENET, V9, P477, DOI 10.1038/nrg2361; SMITH JM, 1994, J EVOLUTION BIOL, V7, P525, DOI 10.1046/j.1420-9101.1994.7050525.x; SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384; Thomas JC, 2007, J CLIN MICROBIOL, V45, P616, DOI 10.1128/JCM.01934-06; Palazzo ICV, 2008, J ANTIMICROB CHEMOTH, V62, P1222, DOI 10.1093/jac/dkn375; Vickers AA, 2007, ANTIMICROB AGENTS CH, V51, P4484, DOI 10.1128/AAC.00708-07; von Eiff C, 2002, LANCET INFECT DIS, V2, P677, DOI 10.1016/S1473-3099(02)00438-3; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Weinstein MP, 1998, J CLIN MICROBIOL, V36, P2089, DOI 10.1128/JCM.36.7.2089-2092.1998; Wohoush A, 2011, CLIN MICROBIOL INFEC, V17, P569, DOI 10.1111/j.1469-0691.2010.03372.x; Zhang LF, 2012, J MOL EVOL, V75, P43, DOI 10.1007/s00239-012-9520-5	63	59	65	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66496	10.1371/journal.pone.0066496	http://dx.doi.org/10.1371/journal.pone.0066496			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776678	Green Published, Green Submitted, gold			2022-12-27	WOS:000320755400148
J	Montanari, S; Saeed, M; Knabel, M; Kim, Y; Troggio, M; Malnoy, M; Velasco, R; Fontana, P; Won, K; Durel, CE; Perchepied, L; Schaffer, R; Wiedow, C; Bus, V; Brewer, L; Gardiner, SE; Crowhurst, RN; Chagne, D				Montanari, Sara; Saeed, Munazza; Knaebel, Mareike; Kim, YoonKyeong; Troggio, Michela; Malnoy, Mickael; Velasco, Riccardo; Fontana, Paolo; Won, KyungHo; Durel, Charles-Eric; Perchepied, Laure; Schaffer, Robert; Wiedow, Claudia; Bus, Vincent; Brewer, Lester; Gardiner, Susan E.; Crowhurst, Ross N.; Chagne, David			Identification of Pyrus Single Nucleotide Polymorphisms (SNPs) and Evaluation for Genetic Mapping in European Pear and Interspecific Pyrus Hybrids	PLOS ONE			English	Article							LINKAGE MAPS; GENOME SEQUENCE; VENTURIA-PIRINA; DIVERSITY; JAPANESE; FRUIT; RESISTANCE	We have used new generation sequencing (NGS) technologies to identify single nucleotide polymorphism (SNP) markers from three European pear (Pyrus communis L.) cultivars and subsequently developed a subset of 1096 pear SNPs into high throughput markers by combining them with the set of 7692 apple SNPs on the IRSC apple Infinium (R) II 8K array. We then evaluated this apple and pear Infinium (R) II 9K SNP array for large-scale genotyping in pear across several species, using both pear and apple SNPs. The segregating populations employed for array validation included a segregating population of European pear ('Old Home' x 'Louise Bon Jersey') and four interspecific breeding families derived from Asian (P. pyrifolia Nakai and P. bretschneideri Rehd.) and European pear pedigrees. In total, we mapped 857 polymorphic pear markers to construct the first SNP-based genetic maps for pear, comprising 78% of the total pear SNPs included in the array. In addition, 1031 SNP markers derived from apple (13% of the total apple SNPs included in the array) were polymorphic and were mapped in one or more of the pear populations. These results are the first to demonstrate SNP transferability across the genera Malus and Pyrus. Our construction of high density SNP-based and gene-based genetic maps in pear represents an important step towards the identification of chromosomal regions associated with a range of horticultural characters, such as pest and disease resistance, orchard yield and fruit quality.	[Montanari, Sara; Troggio, Michela; Malnoy, Mickael; Velasco, Riccardo; Fontana, Paolo] Fdn Edmund Mach, Ist Agr San Michele Adige, Res & Innovat Ctr, San Michele All Adige, Trento, Italy; [Montanari, Sara; Saeed, Munazza; Knaebel, Mareike; Wiedow, Claudia; Gardiner, Susan E.; Chagne, David] New Zealand Inst Plant & Food Res Ltd Plant & Foo, Palmerston North Res Ctr, Palmerston North, New Zealand; [Montanari, Sara; Durel, Charles-Eric; Perchepied, Laure] INRA, Inst Rech Hort & Semences, UMR1345, F-49071 Beaucouze, France; [Montanari, Sara; Durel, Charles-Eric; Perchepied, Laure] Univ Angers, UMR1345, Inst Rech Hort & Semences, F-49045 Angers, France; [Montanari, Sara; Durel, Charles-Eric; Perchepied, Laure] AgroCampus Ouest, UMR1345, Inst Rech Hort & Semences, F-49045 Angers, France; [Saeed, Munazza] Massey Univ, Inst Food Nutr & Human Hlth, Palmerston North, New Zealand; [Knaebel, Mareike; Schaffer, Robert] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Kim, YoonKyeong; Won, KyungHo] Pear Res Stn, Natl Inst Hort & Herbal Sci, Naju, South Korea; [Schaffer, Robert; Crowhurst, Ross N.] DSIR, Mt Albert Res Ctr, Auckland, New Zealand; [Bus, Vincent] Hawkes Bay Res Ctr, Havelock North, New Zealand; [Brewer, Lester] Motueka Res Ctr, Motueka, New Zealand	Fondazione Edmund Mach; New Zealand Institute for Plant & Food Research Ltd; INRAE; Universite d'Angers; Institut Agro; Agrocampus Ouest; Universite d'Angers; Massey University; University of Auckland; National Institute of Horticultural & Herbal Science (NIHHS), Republic of Korea; New Zealand Institute for Plant & Food Research Ltd	Chagne, D (corresponding author), New Zealand Inst Plant & Food Res Ltd Plant & Foo, Palmerston North Res Ctr, Palmerston North, New Zealand.	David.Chagne@plantandfood.co.nz	Crowhurst, Ross N/N-8892-2017; Bus, Vincent/B-1318-2011; Chagne, David/A-2596-2010; Gardiner, Susan Elizabeth/A-2477-2010; Louys, Julien/GLN-6714-2022; Malnoy, Mickael/AAO-5431-2021; Price, Gilbert J/N-3282-2013; Knaebel, Mareike/O-5631-2016; malnoy, mickael/C-5007-2012; Wiedow, Claudia/O-9291-2016	Crowhurst, Ross N/0000-0003-0608-2134; Bus, Vincent/0000-0003-4071-4457; Chagne, David/0000-0003-4018-0694; Gardiner, Susan Elizabeth/0000-0002-4884-8743; Malnoy, Mickael/0000-0002-5158-534X; Price, Gilbert J/0000-0001-8406-4594; Knaebel, Mareike/0000-0002-0293-1250; malnoy, mickael/0000-0002-5158-534X; Wiedow, Claudia/0000-0003-3402-5460; Schaffer, Robert/0000-0003-1272-667X; Louys, Julien/0000-0001-7539-0689; Velasco, Riccardo/0000-0002-8760-5031; Montanari, Sara/0000-0001-9224-056X	FEM PhD school; Massey University Doctoral Scholarship; New Zealand Ministry of Science and Innovation grant "Pipfruit: a juicy future" [27744]; National Institute of Horticultural and Herbal Science grant	FEM PhD school; Massey University Doctoral Scholarship; New Zealand Ministry of Science and Innovation grant "Pipfruit: a juicy future"; National Institute of Horticultural and Herbal Science grant	SM is funded by the FEM PhD school. MS is funded by a Massey University Doctoral Scholarship. MK is funded by the New Zealand Ministry of Science and Innovation grant "Pipfruit: a juicy future" (Contract number: 27744). The visiting scientist fellowship of YKK to PFR was funded by a National Institute of Horticultural and Herbal Science grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antanaviciute L, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-203; Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; Brewer L, 2005, ACTA HORTIC, P595, DOI 10.17660/ActaHortic.2005.671.83; Brewer L. R., 2002, Acta Horticulturae, P571; Brewer LR, 2009, NEW ZEAL J CROP HORT, V37, P211, DOI 10.1080/01140670909510266; Bus V, 2013, ACTA HORTIC, V976, P493, DOI 10.17660/ActaHortic.2013.976.69; Carlson CS, 2006, HUM MOL GENET, V15, P1931, DOI 10.1093/hmg/ddl115; Celton Jean-Marc, 2009, BMC Res Notes, V2, P182, DOI 10.1186/1756-0500-2-182; Chagne D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031745; Costa F, 2008, TREE GENET GENOMES, V4, P575, DOI 10.1007/s11295-008-0133-5; Dondini L, 2004, MOL BREEDING, V14, P407, DOI 10.1007/s11032-004-0505-y; Doyle J. J., 1987, PHYTOCHEM B, P11; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Grattapaglia D, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-65; Hand ML, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-219; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Hyten DL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-38; Iketani H, 2001, BREEDING SCI, V51, P179, DOI 10.1270/jsbbs.51.179; Jacob HB, 1998, ACTA HORTIC, P169, DOI 10.17660/ActaHortic.1998.475.20; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Lu Min, 2010, American-Eurasian Journal of Agricultural and Environmental Science, V9, P303; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; Micheletti D, 2011, TREE GENET GENOMES, V7, P857, DOI 10.1007/s11295-011-0380-8; Ollitrault P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-13; Peace C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048305; Pierantoni L, 2004, THEOR APPL GENET, V109, P1519, DOI 10.1007/s00122-004-1775-9; Rice KM, 2003, ANN HUM GENET, V67, P165, DOI 10.1046/j.1469-1809.2003.00020.x; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Sawcer SJ, 2004, HUM MOL GENET, V13, P1943, DOI 10.1093/hmg/ddh202; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Stothard P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-559; Terakami S, 2013, ACTA HORTIC, V976, P463; Van Ooijen J.W, 2006, JOINMAP R 4 SOFTWARE; Velasco R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001326; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Verde I, 2013, NAT GENET, V45, P487, DOI 10.1038/ng.2586; Verde I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035668; Vezzulli S, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-128; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wu J, 2013, GENOME RES, V23, P396, DOI 10.1101/gr.144311.112; Xu X, 2012, NAT BIOTECHNOL, V30, P105, DOI 10.1038/nbt.2050; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Yamamoto T, 2004, ACTA HORTIC, P51, DOI 10.17660/ActaHortic.2004.663.2; Yamamoto T, 2002, THEOR APPL GENET, V106, P9, DOI 10.1007/s00122-002-0966-5; Yamamoto T, 2007, BREEDING SCI, V57, P321, DOI 10.1270/jsbbs.57.321; Yamamoto Toshiya, 2009, V6, P163, DOI 10.1007/978-0-387-77491-6_8	47	59	64	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77022	10.1371/journal.pone.0077022	http://dx.doi.org/10.1371/journal.pone.0077022			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155917	Green Published, Green Submitted, gold			2022-12-27	WOS:000325887300051
J	Santoro, AL; Bastviken, D; Gudasz, C; Tranvik, L; Enrich-Prast, A				Santoro, Ana Lucia; Bastviken, David; Gudasz, Cristian; Tranvik, Lars; Enrich-Prast, Alex			Dark Carbon Fixation: An Important Process in Lake Sediments	PLOS ONE			English	Article							ORGANIC-CARBON; BACTERIAL PRODUCTION; DIOXIDE FIXATION; ACTIVE BACTERIA; WATER INTERFACE; METHANE; CYCLE; TEMPERATE; OXIDATION; CO2	Close to redox boundaries, dark carbon fixation by chemoautotrophic bacteria may be a large contributor to overall carbon fixation. Still, little is known about the relative importance of this process in lake systems, in spite the potentially high chemoautotrophic potential of lake sediments. We compared rates of dark carbon fixation, bacterial production and oxygen consumption in sediments from four Swedish boreal and seven tropical Brazilian lakes. Rates were highly variable and dark carbon fixation amounted up to 80% of the total heterotrophic bacterial production. The results indicate that non-photosynthetic carbon fixation can represent a substantial contribution to bacterial biomass production, especially in sediments with low organic matter content.	[Santoro, Ana Lucia; Enrich-Prast, Alex] Univ Fed Rio de Janeiro, Dept Ecol, Inst Biol, Rio De Janeiro, Brazil; [Bastviken, David] Linkoping Univ, Dept Themat Studies Water & Environm Studies, Linkoping, Sweden; [Gudasz, Cristian; Tranvik, Lars] Uppsala Univ, Dept Ecol & Evolut Limnol, Uppsala, Sweden	Universidade Federal do Rio de Janeiro; Linkoping University; Uppsala University	Enrich-Prast, A (corresponding author), Univ Fed Rio de Janeiro, Dept Ecol, Inst Biol, Rio De Janeiro, Brazil.	aenrichprast@gmail.com	Prast, Alex Enrich/AAL-4722-2021; Enrich-Prast, Alex/H-5391-2012; Nilsson, Markus/C-6920-2012	Prast, Alex Enrich/0000-0003-3561-0936; wahlund, lars-olof/0000-0002-9905-8426; Martensson, Johanna/0000-0002-5936-1439; Nilsson, Markus/0000-0002-3140-8223; van Westen, Danielle/0000-0001-8649-9874; Tranvik, Lars J./0000-0003-3509-8266; Bastviken, David/0000-0003-0038-2152	STINT (Sweden); CNPq (Brazil); Brazilian Research Council (CNPq)	STINT (Sweden); CNPq (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Ana Lucia Santoro received a STINT (Sweden) and CNPq (Brazil) scholarships to develop this research. Alex Enrich-Prast receives a research fellowship from the Brazilian Research Council (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Saez L, 2010, ISME J, V4, P1581, DOI 10.1038/ismej.2010.69; Bastviken D, 2003, ECOLOGY, V84, P969, DOI 10.1890/0012-9658(2003)084[0969:MAASOC]2.0.CO;2; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Buesing N, 2005, LIMNOL OCEANOGR-METH, V3, P101, DOI 10.4319/lom.2005.3.101; Camacho A, 2001, AQUAT SCI, V63, P91, DOI 10.1007/PL00001346; Christian BW, 2007, FUND APPL LIMNOL, V168, P189, DOI 10.1127/1863-9135/2007/0168-0189; Dalsgaard R, 2000, PROTOCOL HDB NICE NI; Dean WE, 1999, J PALEOLIMNOL, V21, P375, DOI 10.1023/A:1008066118210; DETMER AE, 1993, MAR ECOL PROG SER, V99, P197, DOI 10.3354/meps099197; DIJKHUIZEN L, 1984, A VAN LEEUW J MICROB, V50, P473, DOI 10.1007/BF02386221; Enrich-prast A, 2018, ENCY INLAND WATERS, P211, DOI [10.1016/B978-012370626-3.00126-5, DOI 10.1016/B978-012370626-3.00126-5]; Erb TJ, 2009, P NATL ACAD SCI USA, V106, P8871, DOI 10.1073/pnas.0903939106; Evrard V, 2008, AQUAT MICROB ECOL, V53, P257, DOI 10.3354/ame01248; Feisthauer S, 2008, ENVIRON MICROBIOL, V10, P1641, DOI 10.1111/j.1462-2920.2008.01573.x; Fenchel T., 1979, BACTERIA MINERAL CYC; Fenchel T, 2008, J EXP MAR BIOL ECOL, V366, P99, DOI 10.1016/j.jembe.2008.07.013; GALCHENKO VF, 1994, MICROBIOLOGY+, V63, P388; Garcia-Cantizano J, 2005, MICROB ECOL, V50, P230, DOI 10.1007/s00248-004-0144-9; Grey J, 2004, FRESHWATER BIOL, V49, P681, DOI 10.1111/j.1365-2427.2004.01217.x; Gudasz C, 2012, LIMNOL OCEANOGR, V57, P163, DOI 10.4319/lo.2012.57.1.0163; Gudasz C, 2010, NATURE, V466, P478, DOI 10.1038/nature09186; Hadas O, 2001, LIMNOL OCEANOGR, V46, P1968, DOI 10.4319/lo.2001.46.8.1968; Haglund AL, 2003, FEMS MICROBIOL ECOL, V46, P31, DOI 10.1016/S0168-6496(03)00190-9; Haglund AL, 2002, MICROBIAL ECOL, V43, P232, DOI 10.1007/s00248-002-2005-0; Heinen EA, 2004, J GREAT LAKES RES, V30, P113, DOI 10.1016/S0380-1330(04)70381-0; Heip CHR, 1995, OCEANOGR MAR BIOL, V33, P1; JORGENSEN BB, 1991, DEEP-SEA RES, V38, pS1083; Kankaala P, 2006, LIMNOL OCEANOGR, V51, P2821, DOI 10.4319/lo.2006.51.6.2821; Kranzberg G, 1985, ENVIRON POLLUT A, V39, P23; KUUPPOLEINIKKI P, 1992, HYDROBIOLOGIA, V229, P159, DOI 10.1007/BF00006998; Levin LA, 2009, DEEP-SEA RES PT II, V56, P1632, DOI 10.1016/j.dsr2.2009.05.010; Luyssaert S, 2007, GLOBAL CHANGE BIOL, V13, P2509, DOI 10.1111/j.1365-2486.2007.01439.x; Marotta H, 2009, LIMNOLOGY, V10, P195, DOI 10.1007/s10201-009-0272-x; Merlin C, 2003, J BACTERIOL, V185, P6415, DOI 10.1128/JB.185.21.6415-6424.2003; Mitsch W.J., 2007, WETLANDS, V4th ed., DOI DOI 10.1017/CBO9781107415324.004; Molari M, 2013, GLOBAL BIOGEOCHEM CY, V27, P212, DOI 10.1002/gbc.20030; PEDROSALIO C, 1991, PROC INT ASSOC THE 2, V24, P1212; Pimenov NV, 2010, MICROBIOLOGY+, V79, P247, DOI 10.1134/S0026261710020177; Ravinet M, 2010, OIKOS, V119, P409, DOI 10.1111/j.1600-0706.2009.17859.x; Rawcliffe R, 2010, FRESHWATER BIOL, V55, P600, DOI 10.1111/j.1365-2427.2009.02280.x; Richey JE, 2002, NATURE, V416, P617, DOI 10.1038/416617a; SANDER BC, 1993, MICROB ECOL, V26, P79, DOI 10.1007/BF00177045; Sanseverino AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042723; SCHALLENBERG M, 1993, ECOLOGY, V74, P919, DOI 10.2307/1940816; Scheffer M., 1998, ECOLOGY SHALLOW LAKE; Schink B, 2009, MOL MICROBIOL, V73, P975, DOI 10.1111/j.1365-2958.2009.06835.x; Shively JM, 1998, ANNU REV MICROBIOL, V52, P191, DOI 10.1146/annurev.micro.52.1.191; SOUTHWARD AJ, 1981, NATURE, V293, P616, DOI 10.1038/293616a0; Svensson JM, 2001, AQUAT MICROB ECOL, V23, P177, DOI 10.3354/ame023177; SWEERTS JPRA, 1991, LIMNOL OCEANOGR, V36, P1124, DOI 10.4319/lo.1991.36.6.1124; Taylor GT, 2001, LIMNOL OCEANOGR, V46, P148, DOI 10.4319/lo.2001.46.1.0148; THAUER RK, 1988, EUR J BIOCHEM, V176, P497, DOI 10.1111/j.1432-1033.1988.tb14307.x; Thomsen U, 1997, AQUAT MICROB ECOL, V12, P165, DOI 10.3354/ame012165; Tomaszek JA, 2003, HYDROBIOLOGIA, V504, P59, DOI 10.1023/B:HYDR.0000008508.81690.10; Trimmer M, 2012, SCI TOTAL ENVIRON, V434, P143, DOI 10.1016/j.scitotenv.2011.10.074	55	40	41	2	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65813	10.1371/journal.pone.0065813	http://dx.doi.org/10.1371/journal.pone.0065813			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776549	Green Published, Green Submitted, gold			2022-12-27	WOS:000320755400067
J	Serra, D; Paixao, J; Nunes, C; Dinis, TCP; Almeida, LM				Serra, Diana; Paixao, Joana; Nunes, Carla; Dinis, Teresa C. P.; Almeida, Leonor M.			Cyanidin-3-Glucoside Suppresses Cytokine-Induced Inflammatory Response in Human Intestinal Cells: Comparison with 5-Aminosalicylic Acid	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; NF-KAPPA-B; ACTIVATED PROTEIN-KINASE; BOWEL-DISEASE; DIETARY ANTHOCYANINS; SIGNAL-TRANSDUCTION; ENDOTHELIAL-CELLS; EPITHELIAL-CELLS; IMMUNE-SYSTEM; EXPRESSION	The potential use of polyphenols in the prevention and treatment of chronic inflammatory diseases has been extensively investigated although the mechanisms involved in cellular signaling need to be further elucidated. Cyanidin-3-glucoside is a typical anthocyanin of many pigmented fruits and vegetables widespread in the human diet. In the present study, the protection afforded by cyanidin-3-glucoside against cytokine-triggered inflammatory response was evaluated in the human intestinal HT-29 cell line, in comparison with 5-aminosalicylic acid, a well-established anti-inflammatory drug, used in inflammatory bowel disease. For this purpose, some key inflammatory mediators and inflammatory enzymes were examined. Our data showed that cyanidin-3-glucoside reduced cytokine-induced inflammation in intestinal cells, in terms of NO, PGE(2) and IL-8 production and of iNOS and COX-2 expressions, at a much lower concentration than 5-aminosalicylic acid, suggesting a higher anti-inflammatory efficiency. Interestingly, cyanidin-3-glucoside and 5-aminosalicylic acid neither prevented IkB-alpha degradation nor the activation of NF-kB, but significantly reduced cytokine-induced levels of activated STAT1 accumulated in the cell nucleus. In addition, we established that phosphorylated p38 MAPK was not involved in the protective effect of cyanidin-3-glucoside or 5-aminosalicylic acid. Taking into account the high concentrations of dietary anthocyanins potentially reached in the gastrointestinal tract, cyanidin-3-glucoside may be envisaged as a promising nutraceutical giving complementary benefits in the context of inflammatory bowel disease.	[Serra, Diana; Paixao, Joana; Nunes, Carla; Dinis, Teresa C. P.; Almeida, Leonor M.] Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Serra, Diana; Paixao, Joana; Nunes, Carla; Dinis, Teresa C. P.; Almeida, Leonor M.] Univ Coimbra, Fac Pharm, Coimbra, Portugal	Universidade de Coimbra; Universidade de Coimbra	Dinis, TCP (corresponding author), Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal.	tcpdinis@ci.uc.pt	Nunes, Carla/AAM-3056-2021; Serra, Francois Jose/A-8789-2011; Nunes, Carla/L-3456-2017; Serra, Diana/M-4062-2017	Nunes, Carla/0000-0002-7452-1592; Serra, Francois Jose/0000-0003-3895-4742; Nunes, Carla/0000-0002-7452-1592; Serra, Diana/0000-0002-5965-0281; Almeida, Leonor Martins/0000-0002-7769-4712; Becher, Veronica/0000-0002-5425-8563; Felix Paixao, Joana Isabel/0000-0002-2050-405X; Dinis, Teresa/0000-0001-6350-5741; Dopazo, Hernan/0000-0001-6125-2357	FCT (Fundacao para a Ciencia e a Tecnologia) [PTDC/SAU-OSM/102907/2008, PEst-C/SAU/LA0001/2013-2014]; FEDER/COMPETE (Fundo Europeu de Desenvolvimento Regional, Portugal through Programa Operacional Factores de Competitividade); FCT [SFRH/BD/7541/2010]	FCT (Fundacao para a Ciencia e a Tecnologia)(Portuguese Foundation for Science and Technology); FEDER/COMPETE (Fundo Europeu de Desenvolvimento Regional, Portugal through Programa Operacional Factores de Competitividade); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by the grants PTDC/SAU-OSM/102907/2008 and PEst-C/SAU/LA0001/2013-2014, funded by FCT (Fundacao para a Ciencia e a Tecnologia) and FEDER/COMPETE (Fundo Europeu de Desenvolvimento Regional, Portugal through Programa Operacional Factores de Competitividade). Diana Serra is a recipient of the grant SFRH/BD/7541/2010 from FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atreya I, 2008, J INTERN MED, V263, P591, DOI 10.1111/j.1365-2796.2008.01953.x; Aura AM, 2005, EUR J NUTR, V44, P133, DOI 10.1007/s00394-004-0502-2; Chun KS, 2004, BIOCHEM PHARMACOL, V68, P1089, DOI 10.1016/j.bcp.2004.05.031; CROTTY B, 1992, BRIT J CLIN PHARMACO, V34, P189, DOI 10.1111/j.1365-2125.1992.tb04124.x; DINIS TCP, 1994, ARCH BIOCHEM BIOPHYS, V315, P161, DOI 10.1006/abbi.1994.1485; Egan LJ, 1999, J BIOL CHEM, V274, P26448, DOI 10.1074/jbc.274.37.26448; Feng YJ, 2011, J DIGEST DIS, V12, P327, DOI 10.1111/j.1751-2980.2011.00525.x; Haspel RL, 1999, P NATL ACAD SCI USA, V96, P10188, DOI 10.1073/pnas.96.18.10188; He JA, 2010, ANNU REV FOOD SCI T, V1, P163, DOI 10.1146/annurev.food.080708.100754; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Jijon HB, 2002, AM J PHYSIOL-CELL PH, V283, pC31, DOI 10.1152/ajpcell.00113.2001; Kay CD, 2009, MOL NUTR FOOD RES, V53, pS92, DOI 10.1002/mnfr.200800461; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Klampfer L, 2006, CURR CANCER DRUG TAR, V6, P107, DOI 10.2174/156800906776056491; Kleinert H, 2004, EUR J PHARMACOL, V500, P255, DOI 10.1016/j.ejphar.2004.07.030; Kolios G, 2006, EUR J CLIN INVEST, V36, P720, DOI 10.1111/j.1365-2362.2006.01710.x; Kolios G, 2004, IMMUNOLOGY, V113, P427, DOI 10.1111/j.1365-2567.2004.01984.x; KOLIOS G, 1995, BRIT J PHARMACOL, V116, P2866, DOI 10.1111/j.1476-5381.1995.tb15938.x; Kramer OH, 2010, MOL CELL ENDOCRINOL, V315, P40, DOI 10.1016/j.mce.2009.10.007; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Liu PW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050363; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; Mauray A, 2010, GENES NUTR, V5, P343, DOI 10.1007/s12263-010-0171-0; McCune LM, 2011, CRIT REV FOOD SCI, V51, P1, DOI 10.1080/10408390903001719; McGhie TK, 2007, MOL NUTR FOOD RES, V51, P702, DOI 10.1002/mnfr.200700092; Miguel M. G., 2011, Journal of Applied Pharmaceutical Science, V1, P7; Min SW, 2010, INT IMMUNOPHARMACOL, V10, P959, DOI 10.1016/j.intimp.2010.05.009; NATHAN C, 1992, FASEB J, V6, P3051, DOI 10.1096/fasebj.6.12.1381691; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Paixao J, 2012, CHEM-BIOL INTERACT, V199, P192, DOI 10.1016/j.cbi.2012.08.013; Paixao J, 2011, APOPTOSIS, V16, P976, DOI 10.1007/s10495-011-0632-y; Paul S, 2009, CANCER PREV RES, V2, P650, DOI 10.1158/1940-6207.CAPR-08-0224; Piberger H, 2011, MOL NUTR FOOD RES, V55, P1724, DOI 10.1002/mnfr.201100380; Prior RL, 2006, FREE RADICAL RES, V40, P1014, DOI 10.1080/10715760600758522; Ramana CV, 2000, ONCOGENE, V19, P2619, DOI 10.1038/sj.onc.1203525; Romier B, 2009, NUTR REV, V67, P363, DOI 10.1111/j.1753-4887.2009.00210.x; Salerno L, 2002, CURR PHARM DESIGN, V8, P177, DOI 10.2174/1381612023396375; Santos CI, 2011, BBA-REV CANCER, V1816, P38, DOI 10.1016/j.bbcan.2011.03.003; Scalbert A, 2005, CRIT REV FOOD SCI, V45, P287, DOI 10.1080/1040869059096; Schreiber S, 2002, GUT, V51, P379, DOI 10.1136/gut.51.3.379; Sheibanie AF, 2007, J IMMUNOL, V178, P8138, DOI 10.4049/jimmunol.178.12.8138; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; Singer II, 1998, GASTROENTEROLOGY, V115, P297, DOI 10.1016/S0016-5085(98)70196-9; Stein RB, 2000, DRUG SAFETY, V23, P429, DOI 10.2165/00002018-200023050-00006; Surh YJ, 2001, J KOREAN MED SCI, V16, pS38, DOI 10.3346/jkms.2001.16.S.S38; Tedeschi E, 2004, MOL PHARMACOL, V65, P111, DOI 10.1124/mol.65.1.111; Wang LS, 2008, CANCER LETT, V269, P281, DOI 10.1016/j.canlet.2008.05.020; Wright K, 1997, J BIOL CHEM, V272, P12626, DOI 10.1074/jbc.272.19.12626; Yoshimura A, 2006, CANCER SCI, V97, P439, DOI 10.1111/j.1349-7006.2006.00197.x; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	50	82	86	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e73001	10.1371/journal.pone.0073001	http://dx.doi.org/10.1371/journal.pone.0073001			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	23798991	Green Published, Green Submitted, gold			2022-12-27	WOS:000324856500030
J	Montanari, S; Louys, J; Price, GJ				Montanari, Shaena; Louys, Julien; Price, Gilbert J.			Pliocene Paleoenvironments of Southeastern Queensland, Australia Inferred from Stable Isotopes of Marsupial Tooth Enamel	PLOS ONE			English	Article							CHINCHILLA LOCAL FAUNA; EASTERN AUSTRALIA; LATE PLEISTOCENE; OXYGEN ISOTOPES; ATMOSPHERIC CO2; CARBON ISOTOPES; BONE PHOSPHATE; ICE CORE; ECOLOGY; BIOGEOCHEMISTRY	The Chinchilla Local Fauna is a diverse assemblage of both terrestrial and aquatic Pliocene vertebrates from the fluviatile Chinchilla Sand deposits of southeastern Queensland, Australia. It represents one of Australia's few but exceptionally rich Pliocene vertebrate localities, and as such is an important source of paleoecological data concerning Pliocene environmental changes and its effects on ecosystems. Prior inferences about the paleoenvironment of this locality made on the basis of qualitative observations have ranged from grassland to open woodland to wetland. Examination of the carbon and oxygen isotopes in the tooth enamel of marsupials from this site represents a quantitative method for inferring the paleoenvironments and paleoecology of the fossil fauna. Results from Chinchilla show that Protemnodon sp. indet. consumed both C3 and C4 photosynthesis plant types (mean delta C-13= -14.5 +/- 2.0%), and therefore probably occupied a mixed vegetation environment. Macropus sp. indet. from Chinchilla also consumed a mixed diet of both C3 and C4 plants, with more of a tendency for C4 plant consumption (mean delta C-13= -10.3 +/- 2.3%). Interestingly, their isotopic dietary signature is more consistent with tropical and temperate kangaroo communities than the sub-tropical communities found around Chinchilla today. Other genera sampled in this study include the extinct kangaroo Troposodon sp. indet. and the fossil diprotodontid Euryzygoma dunense each of which appear to have occupied distinct dietary niches. This study suggests that southeastern Queensland hosted a mosaic of tropical forests, wetlands and grasslands during the Pliocene and was much less arid than previously thought.	[Montanari, Shaena] Amer Museum Nat Hist, Richard Gilder Grad Sch, New York, NY 10024 USA; [Louys, Julien; Price, Gilbert J.] Univ Queensland, Sch Earth Sci, St Lucia, Qld, Australia	American Museum of Natural History (AMNH); University of Queensland	Montanari, S (corresponding author), Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA.	smontanari@amnh.org	Crowhurst, Ross N/N-8892-2017; Bus, Vincent/B-1318-2011; Chagne, David/A-2596-2010; Gardiner, Susan Elizabeth/A-2477-2010; Louys, Julien/GLN-6714-2022; Malnoy, Mickael/AAO-5431-2021; Price, Gilbert J/N-3282-2013; Knaebel, Mareike/O-5631-2016; malnoy, mickael/C-5007-2012; Wiedow, Claudia/O-9291-2016	Crowhurst, Ross N/0000-0003-0608-2134; Bus, Vincent/0000-0003-4071-4457; Chagne, David/0000-0003-4018-0694; Gardiner, Susan Elizabeth/0000-0002-4884-8743; Malnoy, Mickael/0000-0002-5158-534X; Price, Gilbert J/0000-0001-8406-4594; Knaebel, Mareike/0000-0002-0293-1250; malnoy, mickael/0000-0002-5158-534X; Wiedow, Claudia/0000-0003-3402-5460; Schaffer, Robert/0000-0003-1272-667X; Louys, Julien/0000-0001-7539-0689; Velasco, Riccardo/0000-0002-8760-5031; Montanari, Sara/0000-0001-9224-056X	National Science Foundation; Richard Gilder Graduate School; University of Queensland; University of Queensland [2012003222]; Australian Research Council [DE120101533]; Australian Research Council (ARC) [DP0881279]	National Science Foundation(National Science Foundation (NSF)); Richard Gilder Graduate School; University of Queensland(University of Queensland); University of Queensland(University of Queensland); Australian Research Council(Australian Research Council); Australian Research Council (ARC)(Australian Research Council)	SM was supported by the National Science Foundation Graduate Research Fellowship and the Richard Gilder Graduate School. JL is supported by University of Queensland Postdoctoral Fellowship and University of Queensland Early Career Research Grant 2012003222. GJP is supported by Australian Research Council grant DE120101533 and Australian Research Council (ARC) Discovery Grant DP0881279. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer M, 1994, HIST AUSTR VEGETATIO, P80; AYLIFFE LK, 1990, GEOCHIM COSMOCHIM AC, V54, P2603, DOI 10.1016/0016-7037(90)90246-H; BARTHOLOMAI A, 1975, Memoirs of the Queensland Museum, V17, P195; Bartholomai A., 1976, BUREAU MINERAL RESOU, V166, P151; Black KH, 2012, EARTH LIFE GLOBAL BI, P983, DOI DOI 10.1007/978-90-481-3428-1_35; Bocherens H, 1996, PALAIOS, V11, P306, DOI 10.2307/3515241; Cerling TE, 1999, OECOLOGIA, V120, P364, DOI 10.1007/s004420050869; COPLEN TB, 1994, PURE APPL CHEM, V66, P273, DOI 10.1351/pac199466020273; DANSGAARD W, 1964, TELLUS, V16, P436; Dawson L, 2004, ALCHERINGA, V28, P275, DOI 10.1080/03115510408619285; Dawson L, 2004, ALCHERINGA, V28, P267, DOI 10.1080/03115510408619284; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; EPSTEIN S, 1977, SCIENCE, V198, P1209, DOI 10.1126/science.198.4323.1209; Forbes MS, 2010, PALAEOGEOGR PALAEOCL, V291, P319, DOI 10.1016/j.palaeo.2010.03.003; Fraser RA, 2008, PALAEOGEOGR PALAEOCL, V269, P66, DOI 10.1016/j.palaeo.2008.08.004; FRIEDLI H, 1986, NATURE, V324, P237, DOI 10.1038/324237a0; GAFFNEY E S, 1981, American Museum Novitates, P1; GAFFNEY ES, 1979, J PALEONTOL, V53, P1354; Greenwood D. R., 2005, Tropical rainforests: past, present and future, P336; Grocke DR, 1997, AUST J BOT, V45, P607, DOI 10.1071/BT96040; HATTERSLEY PW, 1983, OECOLOGIA, V57, P113, DOI 10.1007/BF00379569; Hill Robert S., 1992, Beagle, V9, P1; Hill RS, 1994, HIST AUSTR VEGETATIO; HILLSON S, 1996, DENT ANTHR; Johnson BJ, 1997, PALAEOGEOGR PALAEOCL, V136, P121, DOI 10.1016/S0031-0182(97)00043-6; Koch PL, 1998, CHEM GEOL, V152, P119, DOI 10.1016/S0009-2541(98)00101-6; Kohn MJ, 1999, SCIENCE, V283, P335, DOI 10.1126/science.283.5400.335; LEETHORP JA, 1989, J HUM EVOL, V18, P183, DOI 10.1016/0047-2484(89)90048-1; LEUENBERGER M, 1992, NATURE, V357, P488, DOI 10.1038/357488a0; LOCKER S, 1986, INITIAL REP DEEP SEA, V90, P1079; LONGINELLI A, 1984, GEOCHIM COSMOCHIM AC, V48, P385, DOI 10.1016/0016-7037(84)90259-X; MacFadden BJ, 2004, OECOLOGIA, V140, P169, DOI 10.1007/s00442-004-1571-x; Mackness BS, 2000, AUST J EARTH SCI, V47, P807, DOI 10.1046/j.1440-0952.2000.00812.x; Martin HA, 2006, J ARID ENVIRON, V66, P533, DOI 10.1016/j.jaridenv.2006.01.009; McGowran B., 2000, Memoir of the Association of Australasian Palaeontologists, V23, P405; Murphy BP, 2007, GEOCHIM COSMOCHIM AC, V71, P3847, DOI 10.1016/j.gca.2007.05.012; Murphy BP, 2007, FUNCT ECOL, V21, P757, DOI 10.1111/j.1365-2435.2007.01284.x; OLEARY MH, 1988, BIOSCIENCE, V38, P328, DOI 10.2307/1310735; OLSON S L, 1975, Emu, V75, P49; OLSON S L, 1977, Emu, V77, P127; Price GJ, 2012, EPISODES, V35, P160, DOI 10.18814/epiiugs/2012/v35i1/015; Price GJ, 2008, QUATERNARY SCI REV, V27, P2516, DOI 10.1016/j.quascirev.2008.08.026; Price GJ, 2009, REC AUST MUS, V61, P39, DOI 10.3853/j.0067-1975.61.2009.1518; Prideaux GJ, 2007, NATURE, V445, P422, DOI 10.1038/nature05471; Sponheimer M, 1999, J ARCHAEOL SCI, V26, P723, DOI 10.1006/jasc.1998.0388; Tedford R. H., 1992, Beagle, V9, P173; Tedford R. H., 2006, ALCHERINGA AUSTRALAS, V30, P313, DOI [10.1080/03115510609506870, DOI 10.1080/03115510609506870]; TIESZEN LL, 1991, J ARCHAEOL SCI, V18, P227, DOI 10.1016/0305-4403(91)90063-U; Travouillon KJ, 2009, PALAEOGEOGR PALAEOCL, V276, P24, DOI 10.1016/j.palaeo.2009.02.025; Woods J.T., 1960, J GEOL SOC AUST, V7, P393; Wroe S, 2000, ALCHERINGA, V24, P319, DOI 10.1080/03115510008619535; Yeakel JD, 2007, P ROY SOC B-BIOL SCI, V274, P1723, DOI 10.1098/rspb.2007.0330	52	59	64	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66221	10.1371/journal.pone.0066221	http://dx.doi.org/10.1371/journal.pone.0066221			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	24155917	gold, Green Published, Green Submitted			2022-12-27	WOS:000320322400088
J	Zhang, L; Zhang, DD; Yu, BW; Wang, SB; Liu, YL; Wang, J; Li, X; Shang, XY; Li, HY				Zhang, Ling; Zhang, Dandan; Yu, Baowen; Wang, Shangbo; Liu, Yanlin; Wang, Jian; Li, Xin; Shang, Xiaoyun; Li, Hongyuan			Prevalence of HIV Infection and Associated Risk Factors among Men Who Have Sex with Men (MSM) in Harbin, P. R. China	PLOS ONE			English	Article							EPIDEMIC; BEHAVIOR; HIV/AIDS; SHANGHAI; SYPHILIS	Objective: To assess the prevalence of HIV infection and characteristically risk of factors which associated with HIV infection among MSM in Harbin, China. Methods: A face-to-face questionnaire interview was conducted among 463 Men Who Have Sex with Men (MSM) who were recruited by the snowball sampling in Harbin from April, 2011 to July, 2011. The questionnaire mainly included demographics, AIDS knowledge, homosexual behavior and the status of intervention in MSM. Blood specimens were obtained and tested for the diagnoses of HIV, syphilis and hepatitis C virus (HCV). Associations between above exposed factors and HIV infection were analyzed using a univariate analysis and forward stepwise logistic regression. Results: The prevalence of HIV and syphilis was 9.5 and 14.3%. The awareness rate of AIDS was 86.8%. The rate of unprotected sexual behavior was 57.6% of MSM during the past 6 months. The univariate analysis identified that the age (age >= 35 years old), cohabitation, more than 10 years of homosexual behavior and more than 10 homosexual partners were risk factors which associated with the HIV infection, and that protected sex during the past 6 months was a protective factor for the HIV infection. The multivariate analysis identified that the duration of homosexual behavior and commercial sexual behavior were independent risk factors which associated with the HIV infection, and the protected sex during the past 6 months was a protective factor for the HIV infection. Conclusion: The prevalence of HIV among MSM in Harbin has been rapidly increasing in the past few years. Targeted, tailored, and comprehensive interventions are urgently needed to prevent the HIV infection from MSM.	[Zhang, Ling; Li, Xin; Shang, Xiaoyun; Li, Hongyuan] Harbin Med Univ, Coll Publ Hlth, Dept Epidemiol, Harbin, Peoples R China; [Zhang, Dandan] AntiTB Stn, Harbin, Peoples R China; [Yu, Baowen] Sanitat Supervis Stn, Harbin, Peoples R China; [Zhang, Ling; Wang, Shangbo; Liu, Yanlin; Wang, Jian] Ctr Dis Control & Prevent, Harbin, Peoples R China	Harbin Medical University; Chinese Center for Disease Control & Prevention	Li, HY (corresponding author), Harbin Med Univ, Coll Publ Hlth, Dept Epidemiol, Harbin, Peoples R China.	lihongyuan00@126.com	Miragaia, Maria/J-2704-2015; Chaves, Fernando/C-6176-2016	Miragaia, Maria/0000-0002-1323-7184; /0000-0001-6816-8932; Bouchami, Ons/0000-0002-9425-3513; Thomas, Jonathan/0000-0002-1599-9123	NIGMS NIH HHS [R01 GM080602, GM080602] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adimora AA, 2006, SEX TRANSM DIS, V33, P596, DOI 10.1097/01.olq.0000233666.67788.fc; Center of control and prevention of STD and AIDS of Chinese Center for Disease Control and Prevention, 2007, CTR CONTR PREV STD A; China Ministry of Health, 2011, CHIN EST REP EN; China's Ministry of Health/ WHO / UNAIDS, 2005 UPD HIV AIDS EP; De Cock KM, 2012, AIDS, V26, P1205, DOI 10.1097/QAD.0b013e328354622a; Feng TJ, 2008, SEX TRANSM DIS, V35, P1022, DOI 10.1097/OLQ.0b013e31818600f4; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; He N, 2007, AIDS CARE, V19, P109, DOI 10.1080/09540120600888394; He Q, 2008, AIDS BEHAV, V12, pS93, DOI 10.1007/s10461-008-9388-y; Jia MH, 2010, JAIDS-J ACQ IMM DEF, V53, pS34, DOI 10.1097/QAI.0b013e3181c7d6ff; Koblin BA, 2006, AIDS, V20, P731, DOI 10.1097/01.aids.0000216374.61442.55; Lau JTF, 2011, PUBLIC HEALTH, V125, P260, DOI 10.1016/j.puhe.2011.01.007; Lau JTF, 2008, SEX TRANSM DIS, V35, P406, DOI 10.1097/OLQ.0b013e318164467f; Li HM, 2011, PLOS ONE, V6; Ma XY, 2007, JAIDS-J ACQ IMM DEF, V45, P581, DOI 10.1097/QAI.0b013e31811eadbc; Mi GD, 2007, AIDS, V21, pS67, DOI 10.1097/01.aids.0000304699.85379.32; Millett GA, 2006, AM J PUBLIC HEALTH, V96, P1007, DOI 10.2105/AJPH.2005.066720; Office for AIDS prevention and control committee of the State Council, 2004, JOINT EV REP AIDS PR, P7; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Qian ZH, 2005, SEX TRANSM INFECT, V81, P442, DOI 10.1136/sti.2004.014258; Qiu RZ, 1997, AIDS SEXUAL ETHICS, P121; *STAT COUNC AIDS W, 2004, JOINT ASS HIV AIDS P; State Council AIDS Working Committee Office and UN Theme Group on AIDS in China, 2007, JOINT ASS HIV AIDS P; Guevara WJU, 2012, J SEX MED, V9, P1634, DOI 10.1111/j.1743-6109.2012.02713.x; USAID, 2007, HLTH POL INT VAL INV; USAID, 2006, VAL INV MSM PROGR AS; WANG J, 2008, CHIN J AIDS STD, V14, P75; Wang Lan, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P20; Wong FY, 2008, AIDS CARE, V20, P170, DOI 10.1080/09540120701534707; Xu Juan, 2010, Zhonghua Yu Fang Yi Xue Za Zhi, V44, P975; Zhang BC, 2012, CHIN J AIDS STD PREV, V8, P197; Zhang DP, 2007, J INFECTION, V55, P456, DOI 10.1016/j.jinf.2007.06.015; Zhang XX, 2007, AIDS, V21, pS53, DOI 10.1097/01.aids.0000304697.39637.4c	33	59	65	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58440	10.1371/journal.pone.0058440	http://dx.doi.org/10.1371/journal.pone.0058440			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	115YY	23776678	Green Published, gold, Green Submitted			2022-12-27	WOS:000316849200068
J	Lee, JK; So, KA; Piyathilake, CJ; Kim, MK				Lee, Jae Kwan; So, Kyeong A.; Piyathilake, Chandrika J.; Kim, Mi Kyung			Mild Obesity, Physical Activity, Calorie Intake, and the Risks of Cervical Intraepithelial Neoplasia and Cervical Cancer	PLOS ONE			English	Article							BODY-MASS INDEX; POSTMENOPAUSAL BREAST-CANCER; NIH-AARP DIET; OVARIAN-CANCER; WOMEN; ASSOCIATION; PROSTATE; IMPACT; COHORT; EPIDEMIOLOGY	Objective: We investigated whether obesity, physical activity, and calorie intake are associated with the risks of cervical intraepithelial neoplasia (CIN) and cervical cancer. Methods: We enrolled 1125 women (age, 18-65 years) into a human papillomavirus cohort study established from 2006 to 2012. Multinomial logistic regression models were used to estimate crude and multivariate odds ratios (ORs) and the corresponding 95% confidence intervals (95% CIs), and to assess whether body mass index (BMI), height, weight, total calorie intake, and physical activity were associated with the risks of CIN and cervical cancer. Results: Cervical cancer risk was positively associated with BMI and inversely associated with physical activity. When compared with women with a normal BMI (18.5-23 kg/m(2)), the multivariate ORs (95% CIs) for those overweight (23-25 kg/m(2)) and mild obesity (>= 25 kg/m(2)) were 1.25 (0.79-2.00) and 1.70 (1.10-2.63), respectively. When compared with women with the lowest tertile of physical activity (<38.5 MET-hours/week), the ORs (95% CIs) for cervical cancer were 0.95 (0.61-1.48) and 0.61 (0.38-0.98) for women with medium physical activity (38.5-71.9 MET-hours/week) and those with high physical activity (72 MET-hours/week), respectively (p for linear trend = 0.03). The CIN2/3 risk was inversely associated with physical activity after adjustment for confounders. Compared with women with low physical activity (< 38.5 MET-hours/week), the ORs (95% CIs) for CIN2/3 were 0.64 (0.40-1.01) and 0.58 (0.36-0.93) for the medium and high physical activity groups, respectively (p for linear trend = 0.02). Total calorie intake was not statistically associated with the risks of CIN and cervical cancer after adjustment for confounders. Conclusion: Our results indicate that in addition to screening for and treatment of CIN, recommendations on the maintenance of an appropriate BMI with an emphasis on physical activity could be an important preventive strategy against the development of cervical cancer.	[Lee, Jae Kwan; So, Kyeong A.] Korea Univ, Coll Med, Dept Obstet & Gynecol, Seoul 136705, South Korea; [Piyathilake, Chandrika J.] Univ Alabama Birmingham, Dept Nutr Sci, Birmingham, AL 35294 USA; [Kim, Mi Kyung] Natl Canc Ctr, Canc Epidemiol Branch, Goyang, South Korea	Korea University; Korea University Medicine (KU Medicine); University of Alabama System; University of Alabama Birmingham; National Cancer Center - Korea (NCC)	Kim, MK (corresponding author), Natl Canc Ctr, Canc Epidemiol Branch, Goyang, South Korea.	alrud@ncc.re.kr	Auger, Cyril/N-4702-2016; Kang, Moonkyu/AAR-8974-2021; Oak, Min-Ho/AAE-7405-2020	LEE, Jae Kwan/0000-0003-3101-6403; Kang, Moonkyu/0000-0002-2039-4866	Korea National Cancer Center [NCC-1110320, NCC-1310361]	Korea National Cancer Center	This study was supported by a grant-in-aid from the Korea National Cancer Center (grant no. NCC-1110320, NCC-1310361). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Aldrich T, 2010, J MIDWIFERY WOM HEAL, V55, P344, DOI 10.1016/j.jmwh.2009.10.001; [Anonymous], 2002, WEIGHT CONTR PHYS AC; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Brown Pamela, 2002, W V Med J, V98, P271; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Castellsague Xavier, 2003, J Natl Cancer Inst Monogr, P20; Castle Philip E, 2003, J Natl Cancer Inst Monogr, P29; Chang SC, 2006, CANCER EPIDEM BIOMAR, V15, P334, DOI 10.1158/1055-9965.EPI-05-0479; Choo V, 2002, LANCET, V360, P235, DOI 10.1016/S0140-6736(02)09512-0; Deurenberg-Yap M, 2001, INT J OBESITY, V25, P1554, DOI 10.1038/sj.ijo.0801739; Gierach GL, 2009, INT J CANCER, V124, P2139, DOI 10.1002/ijc.24059; Hwang JH, 2010, INT J GYNECOL CANCER, V20, P398, DOI 10.1111/IGC.0b013e3181d02ff2; Hwang JH, 2010, CANCER CAUSE CONTROL, V21, P51, DOI 10.1007/s10552-009-9433-9; Inoue M, 2008, AM J EPIDEMIOL, V168, P391, DOI 10.1093/aje/kwn146; James PT, 2001, OBES RES, V9, p228S, DOI 10.1038/oby.2001.123; Kim YO, 2009, BRIT J NUTR, V101, P1218, DOI 10.1017/S0007114508061497; Ko GTC, 1999, INT J OBESITY, V23, P1136, DOI 10.1038/sj.ijo.0801043; Korea Health Industry Development Institute Ministry of Health and Welfare, 2000, DEV NUTR DAT REC PRO; Lacey JV, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-84; Lacey JV, 2003, CANCER-AM CANCER SOC, V98, P814, DOI 10.1002/cncr.11567; Lane Geoffrey, 2008, Menopause Int, V14, P33, DOI 10.1258/mi.2007.007036; Lee GJ, 2005, J KOREAN MED SCI, V20, P267, DOI 10.3346/jkms.2005.20.2.267; Lundqvist E, 2007, INT J CANCER, V121, P810, DOI 10.1002/ijc.22746; Maruthur NM, 2009, OBESITY, V17, P375, DOI 10.1038/oby.2008.480; Mitchell RS, 2008, AM J PREV MED, V35, P127, DOI 10.1016/j.amepre.2008.03.031; Modesitt SC, 2005, OBSTET GYNECOL SURV, V60, P683, DOI 10.1097/01.ogx.0000180866.62409.01; Nobbenhuis MAE, 1999, LANCET, V354, P20, DOI 10.1016/S0140-6736(98)12490-X; Patil V, 2006, Indian J Public Health, V50, P38; Pereira M A, 1997, Med Sci Sports Exerc, V29, pS1; Peters TM, 2009, CANCER EPIDEM BIOMAR, V18, P289, DOI 10.1158/1055-9965.EPI-08-0768; PRENTICE RL, 1979, BIOMETRIKA, V66, P403, DOI 10.1093/biomet/66.3.403; Rajkumar T, 2003, BRIT J CANCER, V88, P1388, DOI 10.1038/sj.bjc.6600902; Regional Office for the Western Pacific/World Health Organization International Obesity TaskForce/International Association for the Study of Obesity, 2000, AS PAC PERSP RED OB; Rieck G, 2006, BEST PRACT RES CL OB, V20, P227, DOI 10.1016/j.bpobgyn.2005.10.010; SALLIS JF, 1985, AM J EPIDEMIOL, V121, P91, DOI 10.1093/oxfordjournals.aje.a113987; SCHIFFMAN MH, 1995, CANCER-AM CANCER SOC, V76, P1888, DOI 10.1002/1097-0142(19951115)76:10+<1888::AID-CNCR2820761305>3.0.CO;2-H; SCHILL W, 1993, BIOMETRIKA, V80, P339, DOI 10.2307/2337204; Schouten LJ, 2008, CANCER EPIDEM BIOMAR, V17, P902, DOI 10.1158/1055-9965.EPI-07-2524; Schouten LJ, 2004, JNCI-J NATL CANCER I, V96, P1635, DOI 10.1093/jnci/djh291; SHEPHARD RJ, 1995, CAN J APPL PHYSIOL, V20, P1, DOI 10.1139/h95-001; Song SH, 2008, GYNECOL ONCOL, V108, P543, DOI 10.1016/j.ygyno.2007.11.006; Song YM, 2004, STROKE, V35, P831, DOI 10.1161/01.STR.0000119386.22691.1C; Stefanescu B I, 2007, Rev Med Chir Soc Med Nat Iasi, V111, P155; Stein CJ, 2004, BRIT J CANCER, V90, P299, DOI 10.1038/sj.bjc.6601509; Tong SY, 2010, CANCER CAUSE CONTROL, V21, P23, DOI 10.1007/s10552-009-9430-z; TORNBERG SA, 1994, BRIT J CANCER, V69, P358, DOI 10.1038/bjc.1994.65; Ulmer H, 2012, GYNECOL ONCOL, V125, P330, DOI 10.1016/j.ygyno.2012.01.052; van Gils CH, 2009, CANCER EPIDEM BIOMAR, V18, P377, DOI 10.1158/1055-9965.EPI-08-0823; Velthuis MJ, 2009, MENOPAUSE, V16, P777, DOI [10.1097/GME.0b013e318197122a, 10.1097/gme.0b013e318197122a]; WANG SS, 2003, J NATL CANC I MONOGR, V31, P35, DOI DOI 10.1093/OXFORDJOURNALS.JNCIMONOGRAPHS.A003480; WHO, 2004, LANCET, V363, P902; Wolin KY, 2009, BRIT J CANCER, V100, P611, DOI 10.1038/sj.bjc.6604917; Wolk A, 2001, CANCER CAUSE CONTROL, V12, P13, DOI 10.1023/A:1008995217664; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; World Health Organization, 2000, INT ASS STUD OB INT; Yajnik C S, 2002, Obes Rev, V3, P217, DOI 10.1046/j.1467-789X.2002.00072.x; Yoo K Y, 1997, J Epidemiol, V7, P117; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P83	60	41	42	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66555	10.1371/journal.pone.0066555	http://dx.doi.org/10.1371/journal.pone.0066555			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23755196	Green Published, Green Submitted, gold			2022-12-27	WOS:000320322400111
J	Rayhan, RU; Stevens, BW; Timbol, CR; Adewuyi, O; Walitt, B; VanMeter, JW; Baraniuk, JN				Rayhan, Rakib U.; Stevens, Benson W.; Timbol, Christian R.; Adewuyi, Oluwatoyin; Walitt, Brian; VanMeter, John W.; Baraniuk, James N.			Increased Brain White Matter Axial Diffusivity Associated with Fatigue, Pain and Hyperalgesia in Gulf War Illness	PLOS ONE			English	Article							ATTENTION; VETERANS; MOTION; VALIDATION; MECHANISMS; DISTORTION; MIGRAINE; STIMULI; NETWORK; DORSAL	Background: Gulf War exposures in 1990 and 1991 have caused 25% to 30% of deployed personnel to develop a syndrome of chronic fatigue, pain, hyperalgesia, cognitive and affective dysfunction. Methods: Gulf War veterans (n=31) and sedentary veteran and civilian controls (n=20) completed fMRI scans for diffusion tensor imaging. A combination of dolorimetry, subjective reports of pain and fatigue were correlated to white matter diffusivity properties to identify tracts associated with symptom constructs. Results: Gulf War Illness subjects had significantly correlated fatigue, pain, hyperalgesia, and increased axial diffusivity in the right inferior fronto-occipital fasciculus. ROC generated thresholds and subsequent binary regression analysis predicted CMI classification based upon axial diffusivity in the right inferior fronto-occipital fasciculus. These correlates were absent for controls in dichotomous regression analysis. Conclusion: The right inferior fronto-occipital fasciculus may be a potential biomarker for Gulf War Illness. This tract links cortical regions involved in fatigue, pain, emotional and reward processing, and the right ventral attention network in cognition. The axonal neuropathological mechanism(s) explaining increased axial diffusivity may account for the most prominent symptoms of Gulf War Illness.	[Rayhan, Rakib U.; Timbol, Christian R.; Adewuyi, Oluwatoyin; Baraniuk, James N.] Georgetown Univ, Med Ctr, Dept Med, Div Rheumatol Immunol & Allergy, Washington, DC 20007 USA; [Stevens, Benson W.; VanMeter, John W.] Georgetown Univ, Med Ctr, Dept Neurol, Ctr Funct & Mol Imaging, Washington, DC 20007 USA; [Walitt, Brian] Washington Hosp Ctr, Div Rheumatol, Washington, DC 20010 USA	Georgetown University; Georgetown University; MedStar Washington Hospital Center	Rayhan, RU (corresponding author), Georgetown Univ, Med Ctr, Dept Med, Div Rheumatol Immunol & Allergy, Washington, DC 20007 USA.	rur@georgetown.edu	VanMeter, John W/D-2589-2018	VanMeter, John W/0000-0002-7012-5197; Baraniuk, James Nicholas/0000-0002-1866-4177	Department of Defense Congressionally Directed Medical Research Program (CDMRP) award [W81-XWH-09-1-0526]; National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), through the Clinical and Translational Science Awards Program (CTSA) [UL1TR000101, UL1RR031975]	Department of Defense Congressionally Directed Medical Research Program (CDMRP) award; National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), through the Clinical and Translational Science Awards Program (CTSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Sources of funding were provided by the Department of Defense Congressionally Directed Medical Research Program (CDMRP) award W81-XWH-09-1-0526. Research support for the Clinical Research Unit at Georgetown University Medical Center was funded in whole or in part with federal funds (Grant #UL1TR000101, previously UL1RR031975) from the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), through the Clinical and Translational Science Awards Program (CTSA), a trademark of DHHS, part of the Roadmap Initiative, "Re-Engineering the Clinical Research Enterprise." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Andersson J.L.R., 2007, TR07JA1 FMRIB; Andersson J.L.R, 2007, TR07JA2 FMRIB; Baliki MN, 2012, NAT NEUROSCI, V15, P1117, DOI 10.1038/nn.3153; Baliki MN, 2010, NEURON, V66, P149, DOI 10.1016/j.neuron.2010.03.002; Baraniuk JN, 2013, AM J TRANSL RES, V5, P53; Baraniuk JN, 1998, ANN ALLERG ASTHMA IM, V81, P359, DOI 10.1016/S1081-1206(10)63129-8; Barnden LR, 2011, NMR BIOMED, V24, P1302, DOI 10.1002/nbm.1692; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brodersen KH, 2012, NEUROIMAGE, V63, P1162, DOI 10.1016/j.neuroimage.2012.08.035; Brown R., 1828, PHILOS MAG, V4, P161, DOI [10.1080/14786442808674769, DOI 10.1080/14786442808674769]; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Burdach K., 1822, BAUE LEBEN GEHIRNS Z, VSecond; Camara E, 2010, J NEUROSCI, V30, P11398, DOI 10.1523/JNEUROSCI.0111-10.2010; CHALDER T, 1993, J PSYCHOSOM RES, V37, P147, DOI 10.1016/0022-3999(93)90081-P; Chang LC, 2012, MAGN RESON MED, V68, P1654, DOI 10.1002/mrm.24173; Chen JYW, 2011, BRAIN RES, V1392, P121, DOI 10.1016/j.brainres.2011.03.069; Cook DB, 2007, NEUROIMAGE, V36, P108, DOI 10.1016/j.neuroimage.2007.02.033; Cook DB, 2004, J RHEUMATOL, V31, P364; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Crombez G, 2005, PAIN, V116, P4, DOI 10.1016/j.pain.2005.03.035; EBELING U, 1992, ACTA NEUROCHIR, V115, P143, DOI 10.1007/BF01406373; Eccleston C, 1999, PSYCHOL BULL, V125, P356, DOI 10.1037/0033-2909.125.3.356; Einstein A, 1905, ANN PHYS-BERLIN, V17, P549, DOI 10.1002/andp.19053220806; Eisen SA, 2005, ANN INTERN MED, V142, P881, DOI 10.7326/0003-4819-142-11-200506070-00005; Farmer MA, 2012, NEUROSCI LETT, V520, P197, DOI 10.1016/j.neulet.2012.05.001; Farmer MA, 2011, J UROLOGY, V186, P117, DOI 10.1016/j.juro.2011.03.027; Forkel J, 2012, CORTEX; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Fukuda K, 1998, JAMA-J AM MED ASSOC, V280, P981, DOI 10.1001/jama.280.11.981; Geha PY, 2008, NEURON, V60, P570, DOI 10.1016/j.neuron.2008.08.022; Granziera C, 2006, PLOS MED, V3, P1915, DOI 10.1371/journal.pmed.0030402; Gu L, 2012, J TRAUMA AC IN PRESS; Harrison DM, 2013, J NEUROL, V260, P397, DOI 10.1007/s00415-012-6638-8; Jellison BJ, 2004, AM J NEURORADIOL, V25, P356; Kang HK, 2009, J OCCUP ENVIRON MED, V51, P401, DOI 10.1097/JOM.0b013e3181a2feeb; Kumar R, 2011, J NEUROL SCI, V307, P106, DOI 10.1016/j.jns.2011.04.028; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; Lima D, 2008, SCI PAIN, V5, P477; Loeser JD, 2008, PAIN, V137, P473, DOI 10.1016/j.pain.2008.04.025; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8; Mori S., 2005, MRI ATLAS HUMAN WHIT; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Nagae LM, 2012, AM J NEURORADIOL, V33, P1720, DOI 10.3174/ajnr.A3037; Naranch K, 2002, OTOLARYNG HEAD NECK, V127, P387, DOI 10.1067/mhn.2002.129038; Pardini M, 2010, NEUROLOGY, V74, P749, DOI 10.1212/WNL.0b013e3181d25b6b; Petrides M., 2002, PRINCIPLES FRONTAL L; Pierpaoli C, 2010, STOCKH SWED ISMRM 18; Ravindran MK, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-30; Research Advisory Committee on Gulf War Veterans' Illness (RAC-GWVI), 2008, GULF WAR ILLN HLTH G; Rohde GK, 2004, MAGN RESON MED, V51, P103, DOI 10.1002/mrm.10677; Sandkuhler J, 2009, PHYSIOL REV, V89, P707, DOI 10.1152/physrev.00025.2008; Senapati AK, 2005, BRAIN RES, V1036, P173, DOI 10.1016/j.brainres.2004.12.043; SMETS EMA, 1995, J PSYCHOSOM RES, V39, P315, DOI 10.1016/0022-3999(94)00125-O; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Steele L, 2012, ENVIRON HEALTH PERSP, V120, P112, DOI 10.1289/ehp.1003399; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tajima S, 2010, NEUROL RES INT, V2010, DOI 10.1155/2010/671421; Tang YY, 2012, P NATL ACAD SCI USA, V109, P10570, DOI 10.1073/pnas.1207817109; Tillman GD, 2012, NEUROTOXICOLOGY; Vogt BA, 2005, NAT REV NEUROSCI, V6, P533, DOI 10.1038/nrn1704; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Wallin MT, 2009, COGN BEHAV NEUROL, V22, P155, DOI 10.1097/WNN.0b013e3181b278e8; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wasserfallen JB, 1997, J ALLERGY CLIN IMMUN, V100, P16, DOI 10.1016/S0091-6749(97)70189-1; Weissman DH, 2012, NEUROIMAGE, V61, P798, DOI 10.1016/j.neuroimage.2012.03.032; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Wolfe F, 2010, ARTHRIT CARE RES, V62, P600, DOI 10.1002/acr.20140; Wu M, 2008, LECT NOTES COMPUT SC, V5242, P321, DOI 10.1007/978-3-540-85990-1_39	75	119	119	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58493	10.1371/journal.pone.0058493	http://dx.doi.org/10.1371/journal.pone.0058493			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23798990	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562600025
J	Serra, FCO; Becher, V; Dopazo, H				Serra, Francois; Becher, Veronica; Dopazo, Hernan			Neutral Theory Predicts the Relative Abundance and Diversity of Genetic Elements in a Broad Array of Eukaryotic Genomes	PLOS ONE			English	Article								It is universally true in ecological communities, terrestrial or aquatic, temperate or tropical, that some species are very abundant, others are moderately common, and the majority are rare. Likewise, eukaryotic genomes also contain classes or "species'' of genetic elements that vary greatly in abundance: DNA transposons, retrotransposons, satellite sequences, simple repeats and their less abundant functional sequences such as RNA or genes. Are the patterns of relative species abundance and diversity similar among ecological communities and genomes? Previous dynamical models of genomic diversity have focused on the selective forces shaping the abundance and diversity of transposable elements (TEs). However, ideally, models of genome dynamics should consider not only TEs, but also the diversity of all genetic classes or ``species'' populating eukaryotic genomes. Here, in an analysis of the diversity and abundance of genetic elements in >500 eukaryotic chromosomes, we show that the patterns are consistent with a neutral hypothesis of genome assembly in virtually all chromosomes tested. The distributions of relative abundance of genetic elements are quite precisely predicted by the dynamics of an ecological model for which the principle of functional equivalence is the main assumption. We hypothesize that at large temporal scales an overarching neutral or nearly neutral process governs the evolution of abundance and diversity of genetic elements in eukaryotic genomes.	[Serra, Francois] Ctr Invest Principe Felipe, Evolutionary Genom Lab, Bioinformat & Genom Dept, Valencia, Spain; [Becher, Veronica] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Comp, Buenos Aires, Argentina; [Dopazo, Hernan] Banco Nacl Datos Genet, Inst Genom Humana, Buenos Aires, Argentina; [Dopazo, Hernan] Univ Buenos Aires, Dept Ecol Genet Evoluc, Fac Ciencias Exactas & Nat, Buenos Aires, Argentina; [Serra, Francois] Ctr Nacl Anal Genom CNAG, Struct Genom Team, Barcelona, Spain		Dopazo, H (corresponding author), Banco Nacl Datos Genet, Inst Genom Humana, Buenos Aires, Argentina.; Dopazo, H (corresponding author), Univ Buenos Aires, Dept Ecol Genet Evoluc, Fac Ciencias Exactas & Nat, Buenos Aires, Argentina.	hdopazo@bndg.gob.ar	Nunes, Carla/AAM-3056-2021; Serra, Francois Jose/A-8789-2011; Nunes, Carla/L-3456-2017; Serra, Diana/M-4062-2017	Nunes, Carla/0000-0002-7452-1592; Serra, Francois Jose/0000-0003-3895-4742; Nunes, Carla/0000-0002-7452-1592; Serra, Diana/0000-0002-5965-0281; Almeida, Leonor Martins/0000-0002-7769-4712; Becher, Veronica/0000-0002-5425-8563; Felix Paixao, Joana Isabel/0000-0002-2050-405X; Dinis, Teresa/0000-0001-6350-5741; Dopazo, Hernan/0000-0001-6125-2357	El Ministerio de Ciencia, Tecnologia e Innovacion Productiva-Ministerio de Ciencia e Innovacio' n (MINCy-TMICINN) [AR2009-0009]; MINCyT [BFU2009-13409-C02-01];  [BSC-2009]	El Ministerio de Ciencia, Tecnologia e Innovacion Productiva-Ministerio de Ciencia e Innovacio' n (MINCy-TMICINN); MINCyT; 	This work was supported by El Ministerio de Ciencia, Tecnologia e Innovacion Productiva-Ministerio de Ciencia e Innovacio ' n (MINCy-TMICINN)(AR2009-0009) to BV and HD, by MINCyT (BFU2009-13409-C02-01) to HD, and by BSC-2009 to HD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso D, 2006, TRENDS ECOL EVOL, V21, P451, DOI 10.1016/j.tree.2006.03.019; Arrhenius O, 1921, J ECOL, V9, P95, DOI 10.2307/2255763; Bartolome C, 2002, MOL BIOL EVOL, V19, P926, DOI 10.1093/oxfordjournals.molbev.a004150; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blythe RA, 2007, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2007/07/P07018; Brookfield JFY, 2005, NAT REV GENET, V6, P128, DOI 10.1038/nrg1524; BYRD RH, 1995, SIAM J SCI COMPUT, V16, P1190, DOI 10.1137/0916069; Cavalier-Smith T, 2005, ANN BOT-LONDON, V95, P147, DOI 10.1093/aob/mci010; Etienne RS, 2007, ECOL LETT, V10, P608, DOI 10.1111/j.1461-0248.2007.01052.x; Etienne RS, 2006, SCIENCE, V311, p610B, DOI 10.1126/science.1121914; Etienne RS, 2005, ECOL LETT, V8, P253, DOI 10.1111/j.1461-0248.2004.00717.x; EWENS WJ, 1972, THEOR POPUL BIOL, V3, P87, DOI 10.1016/0040-5809(72)90035-4; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Fousse L, 2007, ACM T MATH SOFTWARE, V33, DOI 10.1145/1236463.1236468; Granlund T., 2008, GNU MULTIPLE PRECISI; Hankin RKS, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i12; Hubbell Stephen P., 2001, V32, pi; Jabot F, 2008, OIKOS, V117, P1308, DOI 10.1111/j.0030-1299.2008.16724.x; Jabot F, 2011, AM NAT, V178, pE37, DOI 10.1086/660829; Jones E., 2001, SCIPY OPEN SOURCE SC; Kapitonov Vladimir V, 2008, Nat Rev Genet, V9, P411, DOI 10.1038/nrg2165-c1; Kimura M., 1983, NEUTRAL THEORY MOL E; Kinsella RJ, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar030; Le Rouzic A, 2007, P NATL ACAD SCI USA, V104, P19375, DOI 10.1073/pnas.0705238104; Leonardo TE, 2002, GENET RES, V80, P155, DOI 10.1017/S0016672302009710; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Magurran A.E, 2004, MEASURING BIOL DIVER; McGill BJ, 2007, ECOL LETT, V10, P995, DOI 10.1111/j.1461-0248.2007.01094.x; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Ohta T, 2011, GENOME BIOL EVOL, V3, P1034, DOI 10.1093/gbe/evr012; Rizzon C, 2002, GENOME RES, V12, P400, DOI 10.1101/gr.210802; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Rosindell J, 2011, TRENDS ECOL EVOL, V26, P340, DOI 10.1016/j.tree.2011.03.024; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Venner S, 2009, TRENDS GENET, V25, P317, DOI 10.1016/j.tig.2009.05.003; Volkov I, 2003, NATURE, V424, P1035, DOI 10.1038/nature01883; Wilks SS, 1938, ANN MATH STAT, V9, P60, DOI 10.1214/aoms/1177732360; Wright S, 1931, GENETICS, V16, P0097	39	82	86	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6					1	9	e63915	10.1371/journal.pone.0063915	http://dx.doi.org/10.1371/journal.pone.0063915			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VL6AY	23798991	Green Published, gold, Green Submitted			2022-12-27	WOS:000891778000001
J	Liu, ZY; Li, W; Wang, J; Pan, J; Sun, SP; Yu, YH; Zhao, B; Ma, YZ; Zhang, TJ; Qi, J; Liu, GJ; Lu, FM				Liu, Zhiyuan; Li, Wei; Wang, Jie; Pan, Jian; Sun, Shipeng; Yu, Yanhua; Zhao, Bing; Ma, Yuzhi; Zhang, Tingju; Qi, Jie; Liu, Guijian; Lu, Fengmin			Identification and Characterization of the First Escherichia coli Strain Carrying NDM-1 Gene in China	PLOS ONE			English	Article							METALLO-BETA-LACTAMASE; ACINETOBACTER-BAUMANNII; EMERGENCE; ENTEROBACTERIACEAE; RESISTANCE; CARBAPENEMASES; DISSEMINATION; WORLDWIDE; INFECTION; SPREAD	New Delhi metallo-beta-lactamase-1 (NDM-1), an acquired class B carbapenemase, is a significant clinical threat due to its extended hydrolysis of beta-lactams including carbapenems. In this study, we identified the first confirmed clinical isolate of Escherichia coli BJ01 harboring bla(NDM-1) in China. The isolate is highly resistant to all tested antimicrobials except polymyxin. bla(NDM-1), bla(CTX-M-57), and bla(TEM-1) were identified in the isolate. bla(NDM-1) was transferable to E. coli EC600 and DH5 alpha in both plasmid conjugation experiments and plasmid transformation tests. BJ01 was identified as a new sequence type, ST224, by multilocus sequence typing. Analysis of genetic environment shows complex transposon-like structures surrounding the blaNDM-1 gene. Genetic analysis revealed that the region flanking blaNDM-1 was very similar to previously identified NDM-positive Acinetobacter spp. isolated in China. The findings of this study raise attention to the emergence and spread of NDM-1-carrying Enterobacteriaceae in China.	[Liu, Zhiyuan; Wang, Jie; Pan, Jian; Sun, Shipeng; Zhao, Bing; Ma, Yuzhi; Zhang, Tingju; Qi, Jie; Liu, Guijian] China Acad Chinese Med Sci, Guanganmen Hosp, Beijing, Peoples R China; [Liu, Zhiyuan; Lu, Fengmin] Peking Univ, Hlth Sci Ctr, Dept Microbiol, Ctr Infect Dis, Beijing 100871, Peoples R China; [Li, Wei] Capital Med Univ, Beijing Youan Hosp, Ctr Infect Dis, Beijing, Peoples R China; [Yu, Yanhua] Capital Med Univ, Beijing Youan Hosp, Dept Clin Lab, Beijing, Peoples R China	China Academy of Chinese Medical Sciences; Guang'anmen Hospital, CACMS; Peking University; Capital Medical University; Capital Medical University	Liu, GJ (corresponding author), China Acad Chinese Med Sci, Guanganmen Hosp, Beijing, Peoples R China.	GuijianLiu234@gmail.com; Fengmingqqq@gmail.com	Li, Wei/I-8060-2014; Yang, Jian/H-3169-2011; Liu, ZH/H-7536-2012	Yang, Jian/0000-0002-2170-589X; Liu, ZH/0000-0002-0086-5659; He, Hong S./0000-0002-3983-2512; Liu, Zhiyuan/0000-0002-4253-1753; Li, Wei/0000-0002-9991-7892	Guang'anmen Hospital [2011S242]; Beijing You'an Project for Liver diseases and AIDS [JYAN-2011-064]	Guang'anmen Hospital; Beijing You'an Project for Liver diseases and AIDS	This work was supported by Internal Funding of Guang'anmen Hospital (Grant# 2011S242) and Beijing You'an Project for Liver diseases and AIDS ( Grant# JYAN-2011-064). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birgy A, 2012, J CLIN MICROBIOL, V50, P1295, DOI 10.1128/JCM.06131-11; Bonnet R, 2004, ANTIMICROB AGENTS CH, V48, P1, DOI 10.1128/AAC.48.1.1-14.2004; Bonomo RA, 2011, CLIN INFECT DIS, V52, P485, DOI 10.1093/cid/ciq179; Chen SD, 2011, AM J INFECT CONTROL, V39, pE55, DOI 10.1016/j.ajic.2011.02.009; Chen Y, 2011, J ANTIMICROB CHEMOTH, V66, P1255, DOI 10.1093/jac/dkr082; Chen Y, 2012, J BACTERIOL, V194, P204, DOI 10.1128/JB.06202-11; Clinical and Laboratory Standards Institute (CLSI), 1999, M26A CLSI, V19, P1; CLSI, 2012, M100S22 CLSI; D'Andrea MM, 2011, J CLIN MICROBIOL, V49, P2755, DOI 10.1128/JCM.00016-11; Espinal P, 2011, ANTIMICROB AGENTS CH, V55, P5396, DOI 10.1128/AAC.00679-11; Fang H, 2008, J CLIN MICROBIOL, V46, P707, DOI 10.1128/JCM.01943-07; Fu Y, 2012, J ANTIMICROB CHEMOTH; Gaibani P, 2011, EUROSURVEILLANCE, V16, P2; Ho PL, 2012, J ANTIMICROB CHEMOTH, DOI [10.1093/jac/dks095, DOI 10.1093/JAC/DKS095.EPUB]; Hopkins TA, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2903479; Hu FP, 2012, J MED MICROBIOL, V61, P132, DOI 10.1099/jmm.0.036483-0; Hu HY, 2012, ANTIMICROB AGENTS CH, V56, P1698, DOI 10.1128/AAC.06199-11; Jovcic B, 2011, ANTIMICROB AGENTS CH, V55, P3929, DOI 10.1128/AAC.00226-11; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Lascols C, 2011, J ANTIMICROB CHEMOTH, V66, P1992, DOI 10.1093/jac/dkr240; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Moellering RC, 2010, NEW ENGL J MED, V363, P2377, DOI 10.1056/NEJMp1011715; Mulvey MR, 2011, EMERG INFECT DIS, V17, P103, DOI 10.3201/eid1701.101358; Nielsen J, 2012, FEMS YEAST RES, V12, P1, DOI [10.1111/j.1567-1364.2011.00764.x, 10.1111/j.1574-6941.2011.01260.x]; OBRIEN TF, 1985, SCIENCE, V230, P87, DOI 10.1126/science.2994226; Pfeifer Y, 2011, ANTIMICROB AGENTS CH, V55, P1318, DOI 10.1128/AAC.01585-10; Poirel L, 2010, ANTIMICROB AGENTS CH, V54, P4914, DOI 10.1128/AAC.00878-10; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07; Rolain JM, 2010, CLIN MICROBIOL INFEC, V16, P1699, DOI 10.1111/j.1469-0691.2010.03385.x; Shakil S, 2011, J CHEMOTHERAPY, V23, P263, DOI 10.1179/joc.2011.23.5.263; Shi DS, 2012, EUR J CLIN MICROBIOL, V31, P797, DOI 10.1007/s10096-011-1377-9; Shibata N, 2003, J CLIN MICROBIOL, V41, P5407, DOI 10.1128/JCM.41.12.5407-5413.2003; Sowmiya M, 2012, INVEST OPHTH VIS SCI, V53, P5251, DOI 10.1167/iovs.12-10467; Struelens MJ, 2010, EUROSURVEILLANCE, V15, P9; Wang XS, 2013, CLIN INFECT DIS, V56, P161, DOI 10.1093/cid/cis782; Wang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037152; Williamson DA, 2012, INT J ANTIMICROB AG, V39, P529, DOI 10.1016/j.ijantimicag.2012.02.017; Wilson ME, 2012, CURR INFECT DIS REP, V14, P213, DOI 10.1007/s11908-012-0252-x; Yong D, 2009, ANTIMICROB AGENTS CH, V53, P5046, DOI 10.1128/AAC.00774-09; Zhang R, 2011, J MED MICROBIOL, V60, P977, DOI 10.1099/jmm.0.015826-0; Zhou ZW, 2012, CAN J MICROBIOL, V58, P112, DOI [10.1139/W11-112, 10.1139/w11-112]	41	246	257	5	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e66666	10.1371/journal.pone.0066666	http://dx.doi.org/10.1371/journal.pone.0066666			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23383247	Green Submitted, gold, Green Published			2022-12-27	WOS:000320440500069
J	Wang, YP; Hu, YJ; Chao, C; Yuksel, M; Colle, I; Flavell, RA; Ma, Y; Yan, HP; Wen, L				Wang, Yipeng; Hu, Youjia; Chao, Chen; Yuksel, Muhammed; Colle, Isabelle; Flavell, Richard A.; Ma, Yun; Yan, Huiping; Wen, Li			Role of IRAK-M in Alcohol Induced Liver Injury	PLOS ONE			English	Article							INNATE IMMUNITY; KUPFFER CELLS; T-CELLS; NEGATIVE REGULATOR; DISEASE; MICE; LIPOPOLYSACCHARIDE; INTERLEUKIN-1; INFLAMMATION; PERMEABILITY	Increasing evidence suggests that innate immunity plays an important role in alcohol-induced liver injury and most studies have focused on positive regulation of innate immunity. The main objective of this study was to investigate the negative regulator of innate immunity, IL-1/Toll-like receptor (TLR) signaling pathways and interleukin receptor-associated kinase-M (IRAK-M) in alcoholic liver injury. We established an alcohol-induced liver injury model using wild type and IRAK-M deficient B6 mice and investigated the possible mechanisms. We found that in the absence of IRAK-M, liver damage by alcohol was worse with higher alanine transaminase (ALT), more immune cell infiltration and increased numbers of IFN gamma producing cells. We also found enhanced phagocytic activity in CD68(+) cells. Moreover, our results revealed altered gut bacteria after alcohol consumption and this was more striking in the absence of IRAK-M. Our study provides evidence that IRAK-M plays an important role in alcohol-induced liver injury and IRAK-M negatively regulates the innate and possibly the adaptive immune response in the liver reacting to acute insult by alcohol. In the absence of IRAK-M, the hosts developed worse liver injury, enhanced gut permeability and altered gut microbiota.	[Wang, Yipeng; Hu, Youjia; Chao, Chen; Yuksel, Muhammed; Wen, Li] Yale Univ, Sch Med, Endocrinol Sect, New Haven, CT 06520 USA; [Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA; [Wang, Yipeng; Yan, Huiping] Capital Med Univ, Beijing You An Hosp, Clin Res Ctr Autoimmune Liver Dis, Beijing, Peoples R China; [Yuksel, Muhammed; Colle, Isabelle] Ghent Univ Hosp, Dept Gastroenterol, Ghent, Belgium; [Yuksel, Muhammed; Colle, Isabelle; Ma, Yun] Univ London, Inst Liver Study, Kings Coll, Sch Med, London, England	Yale University; Yale University; Capital Medical University; Ghent University; Ghent University Hospital; University of London; King's College London	Wen, L (corresponding author), Yale Univ, Sch Med, Endocrinol Sect, New Haven, CT 06520 USA.	li.wen@yale.edu	yuksel, muhammed/AAT-4783-2021; yuksel, muhammed/F-1706-2019; yuksel, muhammed/C-7861-2017; Wang, Yilong/E-3536-2015; Chen, Bingdi/I-5857-2012	yuksel, muhammed/0000-0002-3390-6007; Wen, Li/0000-0002-8805-2934; Wang, Yilong/0000-0001-7483-9296; Chen, Bingdi/0000-0002-2086-0898	National Institutes of Health [RC1DK087699]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC1DK087699] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (RC1DK087699 to LW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajakaiye M, 2011, MOL MED REP, V4, P597, DOI 10.3892/mmr.2011.471; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Apajalahti JHA, 1998, APPL ENVIRON MICROB, V64, P4084; Aziz-Seible RS, 2011, ALCOHOL CLIN EXP RES, V35, P717, DOI 10.1111/j.1530-0277.2010.01389.x; Biswas A, 2011, EUR J IMMUNOL, V41, P182, DOI 10.1002/eji.201040479; Covert MW, 2005, SCIENCE, V309, P1854, DOI 10.1126/science.1112304; Crispe IN, 2009, ANNU REV IMMUNOL, V27, P147, DOI 10.1146/annurev.immunol.021908.132629; Enomoto N, 2001, ALCOHOL CLIN EXP RES, V25, p51S, DOI 10.1097/00000374-200106001-00012; Flannery S, 2010, BIOCHEM PHARMACOL, V80, P1981, DOI 10.1016/j.bcp.2010.06.020; FOX ES, 1989, GASTROENTEROLOGY, V96, P456, DOI 10.1016/0016-5085(89)91571-0; Gao B, 2011, AM J PHYSIOL-GASTR L, V300, pG516, DOI 10.1152/ajpgi.00537.2010; Hubbard L. L., 2010, INFECT DIS REP, V2; Kim SK, 2011, DIGESTION, V84, P43, DOI 10.1159/000333212; Kinoshita M, 2010, J HEPATOL, V53, P903, DOI 10.1016/j.jhep.2010.04.037; Kirpich IA, 2012, ALCOHOL CLIN EXP RES, V36, P835, DOI 10.1111/j.1530-0277.2011.01673.x; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Koop DR, 2006, ALCOHOL RES HEALTH, V29, P274; Laso FJ, 1999, ALCOHOL CLIN EXP RES, V23, P1306, DOI 10.1097/00000374-199908000-00003; Lech M, 2011, ANN RHEUM DIS, V70, P2207, DOI 10.1136/ard.2011.155515; Li TK, 2008, J GASTROEN HEPATOL, V23, pS2, DOI 10.1111/j.1440-1746.2007.05298.x; Lucey MR, 2009, NEW ENGL J MED, V360, P2758, DOI 10.1056/NEJMra0805786; Mandrekar P, 2009, J IMMUNOL, V183, P1320, DOI 10.4049/jimmunol.0803206; Mandrekar P, 2009, J HEPATOL, V50, P1258, DOI 10.1016/j.jhep.2009.03.007; Mathurin P, 2009, GUT, V58, P613, DOI 10.1136/gut.2007.145573; Mehal WZ, 2001, J IMMUNOL, V167, P667, DOI 10.4049/jimmunol.167.2.667; Mehal WZ, 1999, J IMMUNOL, V163, P3202; Mehal WZ, 2001, GASTROENTEROLOGY, V120, P250, DOI 10.1053/gast.2001.20947; Miller AM, 2011, ALCOHOL CLIN EXP RES, V35, P787, DOI 10.1111/j.1530-0277.2010.01399.x; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Sakaguchi S, 2011, DRUG METAB PHARMACOK, V26, P30, DOI 10.2133/dmpk.DMPK-10-RV-087; Seki S, 2000, IMMUNOL REV, V174, P35, DOI 10.1034/j.1600-0528.2002.017404.x; Seth D, 2011, J GASTROEN HEPATOL, V26, P1089, DOI 10.1111/j.1440-1746.2011.06756.x; Suzuki N, 2002, NATURE, V416, P750, DOI 10.1038/nature736; Szabo G, 2011, ALCOHOL CLIN EXP RES, V35, P782, DOI 10.1111/j.1530-0277.2010.01398.x; Uesugi T, 2001, HEPATOLOGY, V34, P101, DOI 10.1053/jhep.2001.25350; Vidali M, 2008, TRENDS MOL MED, V14, P63, DOI 10.1016/j.molmed.2007.12.005; Xie QF, 2007, MOL IMMUNOL, V44, P3453, DOI 10.1016/j.molimm.2007.03.018; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262	38	51	52	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57085	10.1371/journal.pone.0057085	http://dx.doi.org/10.1371/journal.pone.0057085			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23776514	Green Published, gold, Green Submitted			2022-12-27	WOS:000315186000074
J	Lee, JO; Auger, C; Park, DH; Kang, M; Oak, MH; Kim, KR; Schini-Kerth, VB				Lee, Jung-Ok; Auger, Cyril; Park, Dong Hyun; Kang, Moonkyu; Oak, Min-Ho; Kim, Kyoung Rak; Schini-Kerth, Valerie B.			An Ethanolic Extract of Lindera obtusiloba Stems, YJP-14, Improves Endothelial Dysfunction, Metabolic Parameters and Physical Performance in Diabetic db/db Mice	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; II-INDUCED HYPERTENSION; OXIDATIVE STRESS; CARDIOVASCULAR-DISEASE; VASCULAR REACTIVITY; PIOGLITAZONE; PREVALENCE; CELLS; RISK; RATS	Lindera obtusiloba is a medicinal herb traditionally used in Asia for improvement of blood circulation, treatment of inflammation, and prevention of liver damage. A previous study has shown that an ethanolic extract of Lindera obtusiloba stems (LOE) has vasoprotective and antihypertensive effects. The possibility that Lindera obtusiloba improves endothelial function and metabolic parameters in type 2 diabetes mellitus (T2DM) remains to be examined. Therefore, the aim of the present study was to determine the potential of LOE to prevent the development of an endothelial dysfunction, and improve metabolic parameters including hyperglycemia, albuminuria and physical exercise capacity in db/db mice, an experimental model of T2DM. The effect of LOE (100 mg/kg/day by gavage for 8 weeks) on these parameters was compared to that of an oral antidiabetic drug, pioglitazone (30 mg/kg/day by gavage). Reduced blood glucose level, body weight and albumin-creatinine ratio were observed in the group receiving LOE compared to the control db/db group. The LOE treatment improved endothelium-dependent relaxations, abolished endothelium-dependent contractions to acetylcholine in the aorta, and normalized the increased vascular oxidative stress and expression of NADPH oxidase, cyclooxygenases, angiotensin II, angiotensin type 1 receptors and peroxynitrite and the decreased expression of endothelial NO synthase in db/db mice. The angiotensin-converting enzyme (ACE) activity was reduced in the LOE group compared to that in the control db/db group. LOE also inhibited the activity of purified ACE, COX-1 and COX-2 in a dose-dependent manner. In addition, LOE improved physical exercise capacity. Thus, the present findings indicate that LOE has a beneficial effect on the vascular system in db/db mice by improving endothelium-dependent relaxations and vascular oxidative stress most likely by normalizing the angiotensin system, and also on metabolic parameters, and these effects are associated with an enhanced physical exercise capacity.	[Lee, Jung-Ok; Auger, Cyril; Schini-Kerth, Valerie B.] Univ Strasbourg, CNRS, Fac Pharm, Lab Biophoton & Pharmacol,UMR 7213, Illkirch Graffenstaden, France; [Lee, Jung-Ok; Kang, Moonkyu; Kim, Kyoung Rak] Hanwha Pharma Co Ltd, Ctr Res & Dev, Chunchon, South Korea; [Park, Dong Hyun] YangJi Chem, Res Ctr, Suwon, South Korea; [Oak, Min-Ho] Mokpo Natl Univ, Coll Pharm, Muan, Jeonam, South Korea	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Mokpo National University	Schini-Kerth, VB (corresponding author), Univ Strasbourg, CNRS, Fac Pharm, Lab Biophoton & Pharmacol,UMR 7213, Illkirch Graffenstaden, France.	valerie.schini-kerth@unistra.fr	Auger, Cyril/N-4702-2016; Kang, Moonkyu/AAR-8974-2021; Oak, Min-Ho/AAE-7405-2020	LEE, Jae Kwan/0000-0003-3101-6403; Kang, Moonkyu/0000-0002-2039-4866	The Ministry of Knowledge Economy, Republic of Korea, under the Leading Industry Development for Gangwon Economic Region (LIDGER) program [70007579]; Hanwha Pharma. Co., Ltd; Hanwha Pharma. Co., Ltd, Chuncheon, Republic of Korea	The Ministry of Knowledge Economy, Republic of Korea, under the Leading Industry Development for Gangwon Economic Region (LIDGER) program(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea); Hanwha Pharma. Co., Ltd; Hanwha Pharma. Co., Ltd, Chuncheon, Republic of Korea	The study was supported, in part, by The Ministry of Knowledge Economy, Republic of Korea, under the Leading Industry Development for Gangwon Economic Region (LIDGER) program (number 70007579), and by Hanwha Pharma. Co., Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Jung-Ok Lee, Moonkyu Kang and Kyoung Rak Kim are all employees of Hanwha Pharma. Co., Ltd, Chuncheon, Republic of Korea, whose company provided funding toward this study. Dong Hyun Park is an employee of YangJi Chemicals, Suwon, Republic of Korea, which is a daughter company of Hanwha. Hanwha has filed a European and US patent on YJP14 and endothelial dysfunction. The Korean FDA have approved further clinical studies regarding YJP-14 and endothelial dysfunction in diabetes. At present there are no further patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.	Ajay M, 2006, VASC PHARMACOL, V45, P127, DOI 10.1016/j.vph.2006.05.001; Alhaider AA, 2011, CHEM-BIOL INTERACT, V192, P233, DOI 10.1016/j.cbi.2011.03.014; Bakker W, 2009, CELL TISSUE RES, V335, P165, DOI 10.1007/s00441-008-0685-6; Balletshofer BM, 2000, CIRCULATION, V101, P1780, DOI 10.1161/01.CIR.101.15.1780; Capellini VK, 2010, CURR VASC PHARMACOL, V8, P526; CHANG KC, 1993, J PHARMACOL EXP THER, V266, P992; Chen WG, 2010, BIOCHEMISTRY-US, V49, P3129, DOI 10.1021/bi9016632; Cohen RA, 2010, J CARDIOVASC PHARM, V55, P308, DOI 10.1097/FJC.0b013e3181d89670; Ding H, 2010, PFLUG ARCH EUR J PHY, V459, P977, DOI 10.1007/s00424-010-0807-3; Dunstan DW, 2002, DIABETES CARE, V25, P829, DOI 10.2337/diacare.25.5.829; Feletou M, 2010, CURR HYPERTENS REP, V12, P267, DOI 10.1007/s11906-010-0118-2; Fowler MJ, 2008, CLIN DIABETES, V26, P77, DOI [DOI 10.2337/DIACLIN.26.2.77, 10.2337/diaclin.26.2.77]; Freise C, 2010, J NUTR BIOCHEM, V21, P1170, DOI 10.1016/j.jnutbio.2009.09.013; Gao L, 2009, CARDIOVASC RES, V82, P9, DOI 10.1093/cvr/cvp031; Grundy SM, 1999, CIRCULATION, V100, P1134, DOI 10.1161/01.CIR.100.10.1134; Hartge Martin M, 2007, Diab Vasc Dis Res, V4, P84; Heitzer T, 2001, CIRCULATION, V104, P2673, DOI 10.1161/hc4601.099485; Henry RMA, 2004, ATHEROSCLEROSIS, V174, P49, DOI 10.1016/j.atherosclerosis.2004.01.002; Idris-Khodja N, 2012, N-S ARCH PHARMACOL, V385, P749, DOI 10.1007/s00210-012-0749-8; Ihm SH, 2009, ATHEROSCLEROSIS, V206, P47, DOI 10.1016/j.atherosclerosis.2009.01.036; Jimenez R, 2007, FREE RADICAL BIO MED, V43, P462, DOI 10.1016/j.freeradbiomed.2007.05.007; Johnson DK, 2002, ENDOTHELIUM-J ENDOTH, V9, P191, DOI 10.1080/10623320213638; Junker N, 2005, CANCER SCI, V96, P183, DOI 10.1111/j.1349-7006.2005.00026.x; Kanda Y, 2010, AM J PHYSIOL-ENDOC M, V298, pE278, DOI 10.1152/ajpendo.00388.2009; Kusunoki M, 2011, EUR J PHARMACOL, V668, P486, DOI 10.1016/j.ejphar.2011.07.030; Lee JO, 2011, N-S ARCH PHARMACOL, V383, P635, DOI 10.1007/s00210-011-0643-9; Lewis TV, 1999, J AM COLL CARDIOL, V33, P805, DOI 10.1016/S0735-1097(98)00667-6; Liang W, 2008, J PHYSIOL SCI, V58, P405, DOI 10.2170/physiolsci.RP012808; Lim YK, 2002, ATHEROSCLEROSIS, V160, P311, DOI 10.1016/S0021-9150(01)00576-7; Mohan S, 2008, LAB INVEST, V88, P515, DOI 10.1038/labinvest.2008.23; Musicki B, 2010, J SEX MED, V7, P3023, DOI 10.1111/j.1743-6109.2010.01880.x; Nichols GA, 2001, DIABETES CARE, V24, P1614, DOI 10.2337/diacare.24.9.1614; ODriscoll G, 1997, J CLIN INVEST, V100, P678, DOI 10.1172/JCI119580; Okudan N, 2011, J MED FOOD, V14, P1298, DOI 10.1089/jmf.2010.0030; Ota H, 2010, ARTERIOSCL THROM VAS, V30, P2205, DOI 10.1161/ATVBAHA.110.210500; Park JH, 2011, J BIOCHEM MOL TOXIC, V25, P238, DOI 10.1002/jbt.20381; Park Y, 2008, AM J PHYSIOL-HEART C, V295, pH1982, DOI 10.1152/ajpheart.01261.2007; Plutzky J, 2011, AM J CARDIOL, V108, p25B, DOI 10.1016/j.amjcard.2011.03.014; Regensteiner JG, 2003, VASC MED, V8, P169, DOI 10.1191/1358863x03vm489oa; Sallam N, 2011, N-S ARCH PHARMACOL, V383, P483, DOI 10.1007/s00210-011-0614-1; Sarr M, 2006, CARDIOVASC RES, V71, P794, DOI 10.1016/j.cardiores.2006.05.022; Savage S, 1996, DIABETES CARE, V19, P1243, DOI 10.2337/diacare.19.11.1243; Schalkwijk CG, 2005, CLIN SCI, V109, P143, DOI 10.1042/CS20050025; Schmidt TS, 2007, CLIN SCI, V113, P47, DOI 10.1042/CS20070108; Selvin E, 2004, CIRCULATION, V110, P738, DOI 10.1161/01.CIR.0000137913.26087.F0; Senador D, 2009, EXP PHYSIOL, V94, P648, DOI 10.1113/expphysiol.2008.046474; Sharma A, 2012, INT J VASC MED, V2012, DOI 10.1155/2012/750126; Smith SR, 2005, METABOLISM, V54, P24, DOI 10.1016/j.metabol.2004.07.008; Sowers JR, 2001, HYPERTENSION, V37, P1053, DOI 10.1161/01.HYP.37.4.1053; Sridulyakul P, 2006, CLIN HEMORHEOL MICRO, V34, P315; Stapleton PA, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-54; Thompson D, 2001, Obes Rev, V2, P189, DOI 10.1046/j.1467-789x.2001.00037.x; Ting HH, 1996, J CLIN INVEST, V97, P22, DOI 10.1172/JCI118394; Title LM, 2000, J AM COLL CARDIOL, V36, P758, DOI 10.1016/S0735-1097(00)00809-3; Urso C, 2011, MINERVA MED, V102, P59; W.H. Organization, 1999, DEFINITION DIAGNOSIS; Wang XR, 2011, AM J PHYSIOL-ENDOC M, V300, pE1135, DOI 10.1152/ajpendo.00001.2011; Wong WT, 2010, ANTIOXID REDOX SIGN, V13, P757, DOI 10.1089/ars.2009.2831; Ying CJ, 2003, HYPERTENS RES, V26, P823, DOI 10.1291/hypres.26.823; Yook C., 1997, COLORED MED PLANTS K, P588; Zanetti M, 2010, EXP GERONTOL, V45, P848, DOI 10.1016/j.exger.2010.07.002; Zhang HR, 2010, AM J PHYSIOL-HEART C, V299, pH985, DOI 10.1152/ajpheart.00489.2010; Zhang SL, 2007, PEDIATR NEPHROL, V22, P813, DOI 10.1007/s00467-007-0444-z; Zheng Z, 2011, DIABETES	64	41	42	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65227	10.1371/journal.pone.0065227	http://dx.doi.org/10.1371/journal.pone.0065227			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755196	gold, Green Published, Green Submitted			2022-12-27	WOS:000319872300059
J	Liu, ZH; Yang, J; He, HS				Liu, Zhihua; Yang, Jian; He, Hong S.			Identifying the Threshold of Dominant Controls on Fire Spread in a Boreal Forest Landscape of Northeast China	PLOS ONE			English	Article							ENVIRONMENTAL CONTROLS; CLIMATE-CHANGE; WILDFIRE; MIXEDWOOD; AREA; FREQUENCY; PATTERNS; BEHAVIOR; WEATHER; REGIMES	The relative importance of fuel, topography, and weather on fire spread varies at different spatial scales, but how the relative importance of these controls respond to changing spatial scales is poorly understood. We designed a "moving window'' resampling technique that allowed us to quantify the relative importance of controls on fire spread at continuous spatial scales using boosted regression trees methods. This quantification allowed us to identify the threshold value for fire size at which the dominant control switches from fuel at small sizes to weather at large sizes. Topography had a fluctuating effect on fire spread across the spatial scales, explaining 20-30% of relative importance. With increasing fire size, the dominant control switched from bottom-up controls (fuel and topography) to top-down controls (weather). Our analysis suggested that there is a threshold for fire size, above which fires are driven primarily by weather and more likely lead to larger fire size. We suggest that this threshold, which may be ecosystem-specific, can be identified using our "moving window'' resampling technique. Although the threshold derived from this analytical method may rely heavily on the sampling technique, our study introduced an easily implemented approach to identify scale thresholds in wildfire regimes.	[Liu, Zhihua; Yang, Jian; He, Hong S.] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China; [He, Hong S.] Univ Missouri, Sch Nat Resources, Columbia, MO USA	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; University of Missouri System; University of Missouri Columbia	Yang, J (corresponding author), Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China.	yangjian@iae.ac.cn	Li, Wei/I-8060-2014; Yang, Jian/H-3169-2011; Liu, ZH/H-7536-2012	Yang, Jian/0000-0002-2170-589X; Liu, ZH/0000-0002-0086-5659; He, Hong S./0000-0002-3983-2512; Liu, Zhiyuan/0000-0002-4253-1753; Li, Wei/0000-0002-9991-7892	National Natural Science Foundation of China [31100345, 41071121]; Hundred Talent Program of the Chinese Academy of Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hundred Talent Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This research was funded by National Natural Science Foundation of China (31100345 & 41071121) and the Hundred Talent Program of the Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agee JK, 2005, FOREST ECOL MANAG, V211, P83, DOI 10.1016/j.foreco.2005.01.034; Arienti MC, 2009, INT J WILDLAND FIRE, V18, P970, DOI 10.1071/WF08011; Bergeron Y, 2004, ECOLOGY, V85, P1916, DOI 10.1890/02-0716; Bergeron Y, 2002, SILVA FENN, V36, P81, DOI 10.14214/sf.553; BESSIE WC, 1995, ECOLOGY, V76, P747, DOI 10.2307/1939341; Bond WJ, 2005, TRENDS ECOL EVOL, V20, P387, DOI 10.1016/j.tree.2005.04.025; Bond WJ, 2005, NEW PHYTOL, V165, P525, DOI 10.1111/j.1469-8137.2004.01252.x; Bowman DMJS, 2009, SCIENCE, V324, P481, DOI 10.1126/science.1163886; Chang Y, 2007, INT J WILDLAND FIRE, V16, P34, DOI 10.1071/WF05093; Cumming SG, 2001, ECOL APPL, V11, P97, DOI 10.1890/1051-0761(2001)011[0097:FTAWIT]2.0.CO;2; Cyr D, 2007, LANDSCAPE ECOL, V22, P1325, DOI 10.1007/s10980-007-9109-3; De'ath G, 2007, ECOLOGY, V88, P243, DOI 10.1890/0012-9658(2007)88[243:BTFEMA]2.0.CO;2; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Falk DA, 2011, FRONT ECOL ENVIRON, V9, P446, DOI 10.1890/100052; Franklin J., 2000, TERRAIN ANAL PRINCIP; Hargrove WW, 2000, ECOL MODEL, V135, P243, DOI 10.1016/S0304-3800(00)00368-9; Hely C, 2000, J VEG SCI, V11, P813, DOI 10.2307/3236551; Hely C, 2010, INT J WILDLAND FIRE, V19, P1099, DOI 10.1071/WF09112; Johnson E.A., 1996, FIRE VEGETATION DYNA; Keeley JE, 2011, TRENDS PLANT SCI, V16, P406, DOI 10.1016/j.tplants.2011.04.002; Larsen CPS, 1997, J BIOGEOGR, V24, P663, DOI 10.1111/j.1365-2699.1997.tb00076.x; Littell JS, 2009, ECOL APPL, V19, P1003, DOI 10.1890/07-1183.1; Liu Zhi-hua, 2008, Yingyong Shengtai Xuebao, V19, P487; Liu ZH, 2012, J VEG SCI, V23, P782, DOI 10.1111/j.1654-1103.2012.01397.x; Liu ZH, 2012, GLOBAL CHANGE BIOL, V18, P2041, DOI 10.1111/j.1365-2486.2012.02649.x; Liu ZH, 2010, FOREST ECOL MANAG, V259, P1255, DOI 10.1016/j.foreco.2009.12.022; McKenzie D, 2011, NATURE PRECED; Parisien MA, 2011, ECOL APPL, V21, P789, DOI 10.1890/10-0326.1; Parisien MA, 2009, ECOL MONOGR, V79, P127, DOI 10.1890/07-1289.1; Parks SA, 2011, INT J WILDLAND FIRE, V20, P815, DOI 10.1071/WF10051; Peters DPC, 2004, P NATL ACAD SCI USA, V101, P15130, DOI 10.1073/pnas.0403822101; Peterson GD, 2002, ECOSYSTEMS, V5, P329, DOI 10.1007/s10021-001-0077-1; Podur JJ, 2009, ECOL APPL, V19, P1246, DOI 10.1890/08-0790.1; Prasad AM, 2006, ECOSYSTEMS, V9, P181, DOI 10.1007/s10021-005-0054-1; Ridgeway G., 2006, GEN BOOSTED REGRESSI, P5; Rollins MG, 2002, LANDSCAPE ECOL, V17, P539, DOI 10.1023/A:1021584519109; Schoennagel T, 2004, BIOSCIENCE, V54, P661, DOI 10.1641/0006-3568(2004)054[0661:TIOFFA]2.0.CO;2; Slocum MG, 2010, ECOSYSTEMS, V13, P828, DOI 10.1007/s10021-010-9357-y; Turetsky MR, 2011, NAT GEOSCI, V4, P27, DOI 10.1038/NGEO1027; Van Wagner CE, 1987, FTR35 PET NAT FOR I; Wotton BM, 2010, INT J WILDLAND FIRE, V19, P253, DOI 10.1071/WF09002; Wu ZW, 2011, ENVIRON MANAGE, V48, P1148, DOI 10.1007/s00267-011-9707-3; Xu C. H., 1997, ACTA ECOLOGICA SINIC, V17, P3; Xu HC, 1998, FOREST GREAT XING MO, P1; Yang J, 2008, ECOL APPL, V18, P1212, DOI 10.1890/07-0825.1; Zhou YL, 1991, VEGETATION GREAT XIN, P1	48	246	257	5	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55618	10.1371/journal.pone.0055618	http://dx.doi.org/10.1371/journal.pone.0055618			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383247	Green Published, Green Submitted, gold			2022-12-27	WOS:000314610600137
J	Zhang, C; Zhou, YH; Xu, CL; Chi, FL; Ju, HN				Zhang, Chi; Zhou, Yu-Hao; Xu, Chun-Li; Chi, Feng-Ling; Ju, Hai-Ning			Efficacy of Intensive Control of Glucose in Stroke Prevention: A Meta-Analysis of Data from 59197 Participants in 9 Randomized Controlled Trials	PLOS ONE			English	Article							RISK	Background: The efficacy of treatments that lower glucose in reducing the risk of incident stroke remains unclear. We therefore did a systematic review and meta-analysis to evaluate the efficacy of intensive control of glucose in the prevention of stroke. Methodology/Principal Findings: We systematically searched Medline, EmBase, and the Cochrane Library for trials published between 1950 and June, 2012. We included randomized controlled trials that reported on the effects of intensive control of glucose on incident stroke compared with standard care. Summary estimates of relative risk (RR) reductions were calculated with a random effects model, and the analysis was further stratified by factors that could affect the treatment effects. Of 649 identified studies, we included nine relevant trials, which provided data for 59197 patients and 2037 events of stroke. Overall, intensive control of glucose as compared to standard care had no effect on incident stroke (RR, 0.96; 95% CI 0.88-1.06; P = 0.445). In the stratified analyses, a beneficial effect was seen in those trials when body mass index (BMI) more than 30 (RR, 0.86; 95% CI: 0.75-0.99; P = 0.041). No other significant differences were detected between the effect of intensive control of glucose and standard care when based on other subset factors. Conclusions/Significance: Our study indicated intensive control of glucose can effectively reduce the risk of incident stroke when patients with BMI more than 30.	[Zhang, Chi; Chi, Feng-Ling] Shanghai Seventh Peoples Hosp, Dept Neurosurg, Shanghai, Peoples R China; [Zhou, Yu-Hao] Shanghai Seventh Peoples Hosp, Dept Rehabil Inst, Shanghai, Peoples R China; [Xu, Chun-Li] Shanghai Seventh Peoples Hosp, Dept Neurol, Shanghai, Peoples R China; [Ju, Hai-Ning] Shanghai Seventh Peoples Hosp, Dept Cardiol, Shanghai, Peoples R China		Zhou, YH (corresponding author), Shanghai Seventh Peoples Hosp, Dept Rehabil Inst, Shanghai, Peoples R China.	yuhao860407@yahoo.com.cn	; Pearce, Joshua/C-9240-2013	Chen, Maogen/0000-0001-9319-5334; Pearce, Joshua/0000-0001-9802-3056				Ades AE, 2005, MED DECIS MAKING, V25, P646, DOI 10.1177/0272989X05282643; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gerstein HC, 2012, NEW ENGL J MED, V367, P319, DOI 10.1056/NEJMoa1203858; Goff DC, 2007, AM J CARDIOL, V99, p4I, DOI 10.1016/j.amjcard.2007.03.002; Gray CS, 2007, LANCET NEUROL, V6, P397, DOI 10.1016/S1474-4422(07)70080-7; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Holman RR, 2010, NEW ENGL J MED, V362, P1463, DOI 10.1056/NEJMoa1001122; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jefferson T, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000975.pub2; Malmberg K, 1996, EUR HEART J, V17, P1337; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1136/bmj.b2535, 10.1186/2046-4053-4-1]; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Ratner R, 2005, DIABETES CARE, V28, P888, DOI 10.2337/diacare.28.4.888; Ray KK, 2009, LANCET, V373, P1765, DOI 10.1016/S0140-6736(09)60697-8; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Selvin E, 2004, ANN INTERN MED, V141, P421, DOI 10.7326/0003-4819-141-6-200409210-00007; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Wang XB, 2007, LANCET, V369, P1876, DOI 10.1016/S0140-6736(07)60854-X; Webb AJS, 2010, LANCET, V375, P906, DOI 10.1016/S0140-6736(10)60235-8; Wilcox R, 2007, STROKE, V38, P865, DOI 10.1161/01.STR.0000257974.06317.49; Williams GR, 1999, STROKE, V30, P2523, DOI 10.1161/01.STR.30.12.2523; Yusuf S, 2001, CIRCULATION, V104, P2855, DOI 10.1161/hc4701.099488	30	109	113	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54465	10.1371/journal.pone.0054465	http://dx.doi.org/10.1371/journal.pone.0054465			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23544104	Green Submitted, Green Published, gold			2022-12-27	WOS:000314021500075
J	Zhang, ZZ; Wang, W; Li, WL				Zhang, Zhengzhi; Wang, Wei; Li, Wanlong			Genetic Interactions Underlying the Biosynthesis and Inhibition of beta-Diketones in Wheat and Their Impact on Glaucousness and Cuticle Permeability	PLOS ONE			English	Article							CUTICULAR WAX BIOSYNTHESIS; FATTY-ACID ELONGASE; DROUGHT TOLERANCE; EPICUTICULAR WAXES; CONDENSING ENZYME; ABC TRANSPORTER; CELL EXPANSION; COA REDUCTASE; PISUM-SATIVUM; SURFACE WAXES	Cuticular wax composition greatly impacts plant responses to dehydration. Two parallel pathways exist in Triticeae for manipulating wax composition: the acyl elongation, reduction, and decarbonylation pathway that is active at the vegetative stage and yields primary alcohols and alkanes, and the beta-diketone pathway that predominates at the reproductive stage and synthesizes beta-diketones. Variation in glaucousness during the reproductive stage of wheat is mainly controlled by the wax production genes, W1 and W2, and wax inhibitor genes, Iw1 and Iw2. Little is known about the metabolic and physiological effects of the genetic interactions among these genes and their roles in shifting wax composition during plant development. We characterized the effect of W1, W2, Iw1, and Iw2 and analyzed their interaction using a set of six near-isogenic lines (NILs) by metabolic, molecular and physiological approaches. Loss of functional alleles of both W genes or the presence of either Iw gene depletes beta-diketones and results in the nonglaucous phenotype. Elimination of beta-diketones is compensated for by an increase in aldehydes and primary alcohols in the Iw NILs. Accordingly, transcription of CER4-6, which encodes an alcohol-forming fatty acyl-CoA reductase, was elevated 120-fold in Iw1/Iw2. CER4-6 was transcribed at much higher levels in seedlings than in adult plants, and showed little difference between the glaucous and nonglaucous NILs, suggesting that Iw2 counteracts the developmental repression of CER4-6 at the reproductive stage. While W1 and W2 redundantly function in beta-diketone biosynthesis, a combination of both functional alleles led to the beta-diketone hydroxylation. Consistent with this, transcription of MAH1-9, which encodes a mid-chain alkane hydroxylase, increased seven-fold only in W1W2. In parallel with the hydroxyl-beta-diketone production patterns, glaucousness was intensified and cuticle permeability was reduced significantly in W1W2 compared to the other NILs. This suggests that both W1 and W2 are required for enhancing drought tolerance.	[Zhang, Zhengzhi; Wang, Wei; Li, Wanlong] S Dakota State Univ, Dept Biol & Microbiol, Brookings, SD 57007 USA; [Li, Wanlong] S Dakota State Univ, Dept Plant Sci, Brookings, SD 57007 USA	South Dakota State University; South Dakota State University	Li, WL (corresponding author), S Dakota State Univ, Dept Biol & Microbiol, Brookings, SD 57007 USA.	wanlong.li@sdstate.edu	zhang, zhengzhi/I-5403-2016; Wu, Jian/AAU-5221-2020; Vu, Gia-Phong/HCH-7906-2022; Zhang, Zhanhui/AAX-9545-2021; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Wong, Matthew Man-Kin/0000-0003-3296-3277; Wu, Jianguo/0000-0002-8326-2895; ALZAHARNA, Mazen/0000-0002-1111-958X; Wu, Jian/0000-0002-3394-1507; Cheung, Hon-Yeung/0000-0002-6750-3628; Chiu, Sung Kay/0000-0002-9927-7346	South Dakota Agricultural Experiment Station; South Dakota Wheat Commission; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091536, R01AI041927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014842] Funding Source: NIH RePORTER	South Dakota Agricultural Experiment Station; South Dakota Wheat Commission; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Funding for this research was provided by South Dakota Agricultural Experiment Station and South Dakota Wheat Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni A, 2004, PLANT CELL, V16, P2463, DOI 10.1105/tpc.104.022897; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bach L, 2008, P NATL ACAD SCI USA, V105, P14727, DOI 10.1073/pnas.0805089105; BARBER HN, 1968, PHYTOCHEMISTRY, V7, P2089, DOI 10.1016/S0031-9422(00)85661-7; Beaudoin F, 2009, PLANT PHYSIOL, V150, P1174, DOI 10.1104/pp.109.137497; Bennett D, 2012, THEOR APPL GENET, V124, P697, DOI 10.1007/s00122-011-1740-3; Bernard A, 2012, PLANT CELL, V24, P3106, DOI 10.1105/tpc.112.099796; BIANCHI G, 1984, CEREAL CHEM, V61, P45; BIANCHI G, 1986, J AGR FOOD CHEM, V34, P429, DOI 10.1021/jf00069a012; Bianchi G., 1995, WAXES CHEM MOL BIOL, P175; Bird D, 2007, PLANT J, V52, P485, DOI 10.1111/j.1365-313X.2007.03252.x; Bonaventure G, 2003, PLANT CELL, V15, P1020, DOI 10.1105/tpc.008946; Broun P, 2004, P NATL ACAD SCI USA, V101, P4706, DOI 10.1073/pnas.0305574101; CHEESBROUGH TM, 1984, P NATL ACAD SCI-BIOL, V81, P6613, DOI 10.1073/pnas.81.21.6613; Cominelli E, 2008, PLANT J, V53, P53, DOI 10.1111/j.1365-313X.2007.03310.x; DeBono A, 2009, PLANT CELL, V21, P1230, DOI 10.1105/tpc.108.064451; Dietrich CR, 2005, PLANT J, V42, P844, DOI 10.1111/j.1365-313X.2005.02418.x; Dudnikov AJ, 2012, MOL BIOL REP, V39, P2355, DOI 10.1007/s11033-011-0986-9; Fiebig A, 2000, PLANT CELL, V12, P2001, DOI 10.1105/tpc.12.10.2001; Greer S, 2007, PLANT PHYSIOL, V145, P653, DOI 10.1104/pp.107.107300; Hansen JD, 1997, PLANT PHYSIOL, V113, P1091, DOI 10.1104/pp.113.4.1091; Hooker TS, 2007, PLANT CELL, V19, P904, DOI 10.1105/tpc.106.049304; Hooker TS, 2002, PLANT PHYSIOL, V129, P1568, DOI 10.1104/pp.003707; Javelle M, 2011, PLANT PHYSIOL, V157, P790, DOI 10.1104/pp.111.182147; Javelle M, 2010, PLANT PHYSIOL, V154, P273, DOI 10.1104/pp.109.150540; JENKS M. A., 2010, HORTICULTURAL REV, V23, P1, DOI [10.1002/9780470650752.ch1, DOI 10.1002/9780470650752.CH1]; JOHNSON DA, 1983, CROP SCI, V23, P318, DOI 10.2135/cropsci1983.0011183X002300020033x; KOLATTUKUDY PE, 1980, SCIENCE, V208, P990, DOI 10.1126/science.208.4447.990; Kosma DK, 2010, PLANT J, V63, P31, DOI 10.1111/j.1365-313X.2010.04229.x; Lam P, 2012, PLANT PHYSIOL, V159, P1385, DOI 10.1104/pp.112.199646; Li F, 2008, PLANT PHYSIOL, V148, P97, DOI 10.1104/pp.108.123471; Liu Q, 2007, EUPHYTICA, V155, P71, DOI 10.1007/s10681-006-9302-5; Liu SZ, 2009, GENETICS, V183, P1215, DOI 10.1534/genetics.109.108936; Lolle SJ, 1997, DEV BIOL, V189, P311, DOI 10.1006/dbio.1997.8671; Long XY, 2010, PLANT MOL BIOL, V74, P307, DOI 10.1007/s11103-010-9666-8; MIKKELSEN JD, 1978, CARLSBERG RES COMMUN, V43, P15, DOI 10.1007/BF02906546; Millar AA, 1999, PLANT CELL, V11, P825, DOI 10.1105/tpc.11.5.825; Monneveux P, 2004, J AGRON CROP SCI, V190, P395, DOI 10.1111/j.1439-037X.2004.00116.x; Moose SP, 1996, GENE DEV, V10, P3018, DOI 10.1101/gad.10.23.3018; Nawrath Christiane, 2002, Arabidopsis Book, V1, pe0021, DOI 10.1199/tab.0021; NELSON JC, 1995, GENOME, V38, P516, DOI 10.1139/g95-067; Panikashvili D, 2007, PLANT PHYSIOL, V145, P1345, DOI 10.1104/pp.107.105676; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Pighin JA, 2004, SCIENCE, V306, P702, DOI 10.1126/science.1102331; Pollard M, 2008, TRENDS PLANT SCI, V13, P236, DOI 10.1016/j.tplants.2008.03.003; Raffaele S, 2008, PLANT CELL, V20, P752, DOI 10.1105/tpc.107.054858; Richards R.A., 1984, P 6 INT WHEAT GEN S, P447; RICHARDS RA, 1986, AUST J PLANT PHYSIOL, V13, P465, DOI 10.1071/PP9860465; Richardson A, 2007, PLANTA, V226, P1459, DOI 10.1007/s00425-007-0585-0; Rowland O, 2006, PLANT PHYSIOL, V142, P866, DOI 10.1104/pp.106.086785; Samuels L, 2008, ANNU REV PLANT BIOL, V59, P683, DOI 10.1146/annurev.arplant.59.103006.093219; Schnurr JA, 2002, PLANT PHYSIOL, V129, P1700, DOI 10.1104/pp.003251; Seo PJ, 2011, PLANT CELL, V23, P1138, DOI 10.1105/tpc.111.083485; Seo PJ, 2009, PLANT PHYSIOL, V151, P275, DOI 10.1104/pp.109.144220; Shepherd T, 2006, NEW PHYTOL, V171, P469, DOI 10.1111/j.1469-8137.2006.01826.x; Simmonds JR, 2008, EUPHYTICA, V159, P333, DOI 10.1007/s10681-007-9514-3; Sturaro M, 2005, PLANT PHYSIOL, V138, P478, DOI 10.1104/pp.104.058164; Suh MC, 2005, PLANT PHYSIOL, V139, P1649, DOI 10.1104/pp.105.070805; Tacke E, 1995, PLANT J, V8, P907, DOI 10.1046/j.1365-313X.1995.8060907.x; Todd J, 1999, PLANT J, V17, P119, DOI 10.1046/j.1365-313X.1999.00352.x; Tsunewaki K, 1999, GENES GENET SYST, V74, P33, DOI 10.1266/ggs.74.33; TULLOCH AP, 1980, CAN J BOT, V58, P2602, DOI 10.1139/b80-302; TULLOCH AP, 1973, PHYTOCHEMISTRY, V12, P2225, DOI 10.1016/0031-9422(73)85124-6; Vailleau F, 2002, P NATL ACAD SCI USA, V99, P10179, DOI 10.1073/pnas.152047199; Vioque J, 1997, ARCH BIOCHEM BIOPHYS, V340, P64, DOI 10.1006/abbi.1997.9932; von Wettstein-Knowles P., 1995, WAXES CHEM MOL BIOL, P91; VONWETTSTEINKNOWLES P, 1980, CARLSBERG RES COMMUN, V45, P125, DOI 10.1007/BF02906514; VONWETTSTEINKNOWLES P, 1972, PLANTA, V106, P113, DOI 10.1007/BF00383991; Xu XJ, 2002, PLANT PHYSIOL, V128, P924, DOI 10.1104/pp.010621; Xu XJ, 1997, PLANT PHYSIOL, V115, P501, DOI 10.1104/pp.115.2.501; Xue GP, 2006, PLANT MOL BIOL, V61, P863, DOI 10.1007/s11103-006-0055-2; Yu DM, 2008, PLANTA, V228, P675, DOI 10.1007/s00425-008-0770-9; Zhang JY, 2007, PLANT MOL BIOL, V64, P265, DOI 10.1007/s11103-007-9150-2; Zhang JY, 2005, PLANT J, V42, P689, DOI 10.1111/j.1365-313X.2005.02405.x; Zheng HQ, 2005, PLANT CELL, V17, P1467, DOI 10.1105/tpc.104.030155	75	243	268	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54129	10.1371/journal.pone.0054129	http://dx.doi.org/10.1371/journal.pone.0054129			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349804	Green Published, gold, Green Submitted			2022-12-27	WOS:000313738900042
J	Zhang, ZH; Liu, ZH; Cui, ZT; Hu, YM; Wang, B; Tang, JH				Zhang, Zhanhui; Liu, Zonghua; Cui, Zitian; Hu, Yanmin; Wang, Bin; Tang, Jihua			Genetic Analysis of Grain Filling Rate Using Conditional QTL Mapping in Maize	PLOS ONE			English	Article							KERNEL WATER RELATIONS; WEIGHT RESPONSE; SINK; GROWTH; EXPRESSION; ENDOSPERM; TEMPERATURE; DISSECTION; DURATION; ENCODES	The grain filling rate (GFR) is an important dynamic trait that determines the final grain yield and is controlled by a network of genes and environment factors. To determine the genetic basis of the GFR, a conditional quantitative trait locus (QTL) analysis method was conducted using time-related phenotypic values of the GFR collected from a set of 243 immortalized F-2 (IF2) population, which were evaluated at two locations over 2 years. The GFR gradually rose in the 0-15 days after pollination (DAP) and 16-22 DAP, reaching a maximum at 23-29 DAP, and then gradually decreasing. The variation of kernel weight (KW) was mainly decided by the GFR, and not by the grain filling duration (GFD). Thirty-three different unconditional QTLs were identified for the GFR at the six sampling stages over 2 years. Among them, QTLs qGFR7b, qGFR9 and qGFR6d were identified at the same stages at two locations over 2 years. In addition, 14 conditional QTLs for GFR were detected at five stages. The conditional QTL qGFR7c was identified at stage V|IV (37-43 DAP) at two locations over 2 years, and qGFR7b was detected at the sixth stage (44-50 DAP) in all four environments, except at Anyang location in 2009. QTLs qQTL7b and qQTL6f were identified by unconditional and conditional QTL mapping at the same stages, and might represent major QTLs for regulating the GFR in maize in the IF2 population. Moreover, most of the QTLs identified were co-located with QTLs from previous studies that were associated with GFR, enzyme activities of starch synthesis, soluble carbohydrates, and grain filling related genes. These results indicated that the GFR is regulated by many genes, which are specifically expressed at different grain filling stages, and the specific expression of the genes between 16-35 DAP might be very important for deciding the final kernel weight.	[Zhang, Zhanhui; Liu, Zonghua; Cui, Zitian; Hu, Yanmin; Wang, Bin; Tang, Jihua] Henan Agr Univ, Coll Agron, Key Lab Physiol Ecol & Genet Improvement Food Cro, Zhengzhou, Peoples R China	Henan Agricultural University	Tang, JH (corresponding author), Henan Agr Univ, Coll Agron, Key Lab Physiol Ecol & Genet Improvement Food Cro, Zhengzhou, Peoples R China.	tangjihua1@163.com	zhang, zhengzhi/I-5403-2016; Wu, Jian/AAU-5221-2020; Vu, Gia-Phong/HCH-7906-2022; Zhang, Zhanhui/AAX-9545-2021; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Wong, Matthew Man-Kin/0000-0003-3296-3277; Wu, Jianguo/0000-0002-8326-2895; ALZAHARNA, Mazen/0000-0002-1111-958X; Wu, Jian/0000-0002-3394-1507; Cheung, Hon-Yeung/0000-0002-6750-3628; Chiu, Sung Kay/0000-0002-9927-7346	National Project 973 of China [2012CB723001]; National High Technology Research and Development Program of China [2012AA10A305]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091536, R01AI041927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014842] Funding Source: NIH RePORTER	National Project 973 of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by a grant from the National Project 973 of China (2012CB723001) and the National High Technology Research and Development Program of China (2012AA10A305). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blewley JD, 1985, SEEDS PHYSL DEV GERM, P41; Borras L, 2006, FIELD CROP RES, V95, P223, DOI 10.1016/j.fcr.2005.03.001; Borras L, 2004, FIELD CROP RES, V86, P131, DOI 10.1016/j.fcr.2003.08.002; Borras L, 2003, ANN BOT-LONDON, V91, P857, DOI 10.1093/aob/mcg090; Borras L, 2001, CROP SCI, V41, P1816, DOI 10.2135/cropsci2001.1816; Borras L, 2009, CROP SCI, V49, P999, DOI 10.2135/cropsci2008.08.0475; Borras L, 2010, FIELD CROP RES, V118, P1, DOI 10.1016/j.fcr.2010.04.010; Carlson SJ, 1999, PLANT PHYSIOL, V121, P1025, DOI 10.1104/pp.121.3.1025; CAVALIERI AJ, 1985, CROP SCI, V25, P856, DOI 10.2135/cropsci1985.0011183X002500050031x; Cheng WH, 1996, PLANT CELL, V8, P971, DOI 10.1105/tpc.8.6.971; Gambin BL, 2007, FIELD CROP RES, V101, P1, DOI 10.1016/j.fcr.2006.09.001; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; Guo M, 2010, PLANT CELL, V22, P1057, DOI 10.1105/tpc.109.073676; Gupta PK, 2006, GENOME, V49, P565, DOI 10.1139/G06-063; Hua JP, 2002, GENETICS, V162, P1885; Li ShaoChang, 2003, Acta Agronomica Sinica, V29, P775; Li YB, 2011, NAT GENET, V43, P1266, DOI 10.1038/ng.977; Lid SE, 2002, P NATL ACAD SCI USA, V99, P5460, DOI 10.1073/pnas.042098799; Liu ZH, 2011, MOL BREEDING, V27, P25, DOI 10.1007/s11032-010-9410-8; Liu ZongHua, 2007, Acta Agronomica Sinica, V33, P782; Loffler CM, 2005, CROP SCI, V45, P1708, DOI 10.2135/cropsci2004.0370; Maitz M, 2000, PLANT J, V23, P29, DOI 10.1046/j.1365-313x.2000.00747.x; MUCHOW RC, 1990, FIELD CROP RES, V23, P145, DOI 10.1016/0378-4290(90)90109-O; Ohdan T, 2005, J EXP BOT, V56, P3229, DOI 10.1093/jxb/eri292; PRIOUL JL, 1994, PLANT PHYSIOL, V104, P179, DOI 10.1104/pp.104.1.179; SAS Institute, 2009, SAS STAT 9 2 US GUID; SEKA D, 1995, CROP SCI, V35, P74, DOI 10.2135/cropsci1995.0011183X003500010013x; SEKA D, 1995, CROP SCI, V35, P80, DOI 10.2135/cropsci1995.0011183X003500010014x; Setter TL, 2001, J EXP BOT, V52, P1401, DOI 10.1093/jexbot/52.360.1401; Stewart DW, 1998, AGRON J, V90, P73, DOI 10.2134/agronj1998.00021962009000010014x; Takai T, 2005, J EXP BOT, V56, P2107, DOI 10.1093/jxb/eri209; Tang JH, 2010, THEOR APPL GENET, V120, P333, DOI 10.1007/s00122-009-1213-0; Thevenot C, 2005, J EXP BOT, V56, P945, DOI 10.1093/jxb/eri087; Vilhar B, 2002, PLANT PHYSIOL, V129, P23, DOI 10.1104/pp.001826; Wang E, 2008, NAT GENET, V40, P1370, DOI 10.1038/ng.220; Wang GL, 1999, FIELD CROP RES, V61, P211, DOI 10.1016/S0378-4290(98)00163-4; Wilhelm EP, 1999, CROP SCI, V39, P1733, DOI 10.2135/cropsci1999.3961733x; Wu W, 2002, THEOR APPL GENET, V105, P1043, DOI 10.1007/s00122-002-1052-8; Wu WR, 1999, GENETICS, V151, P297; Yan HB, 2009, THEOR APPL GENET, V119, P815, DOI 10.1007/s00122-009-1091-5; Yang JC, 2010, J EXP BOT, V61, P1, DOI 10.1093/jxb/erp348; ZENG ZB, 1994, GENETICS, V136, P1457; Zheng H, 2001, J MAIZE SCI, V9, P69; ZHU J, 1995, GENETICS, V141, P1633	44	243	268	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56344	10.1371/journal.pone.0056344	http://dx.doi.org/10.1371/journal.pone.0056344			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23349804	Green Submitted, Green Published, gold			2022-12-27	WOS:000315159200037
J	Zhang, ZG; Vu, GP; Gong, H; Xia, C; Chen, YC; Liu, FY; Wu, JG; Lu, SW				Zhang, Zhigang; Vu, Gia-Phong; Gong, Hao; Xia, Chuan; Chen, Yuan-Chuan; Liu, Fenyong; Wu, Jianguo; Lu, Sangwei			Engineered External Guide Sequences Are Highly Effective in Inhibiting Gene Expression and Replication of Hepatitis B Virus in Cultured Cells	PLOS ONE			English	Article							P-MEDIATED INHIBITION; RNASE-P; ATTENUATED SALMONELLA; MESSENGER-RNA; CLEAVAGE; TYPHIMURIUM; STABILITY; SELECTION; DELIVERY; VECTORS	External guide sequences (EGSs) are RNA molecules that consist of a sequence complementary to a target mRNA and recruit intracellular ribonuclease P (RNase P), a tRNA processing enzyme, for specific degradation of the target mRNA. We have previously used an in vitro selection procedure to generate EGS variants that efficiently induce human RNase P to cleave a target mRNA in vitro. In this study, we constructed EGSs from a variant to target the overlapping region of the S mRNA, pre-S/L mRNA, and pregenomic RNA (pgRNA) of hepatitis B virus (HBV), which are essential for viral replication and infection. The EGS variant was about 50-fold more efficient in inducing human RNase P to cleave the mRNA in vitro than the EGS derived from a natural tRNA. Following Salmonella-mediated gene delivery, the EGSs were expressed in cultured HBV-carrying cells. A reduction of about 97% and 75% in the level of HBV RNAs and proteins and an inhibition of about 6,000- and 130-fold in the levels of capsid-associated HBV DNA were observed in cells treated with Salmonella vectors carrying the expression cassette for the variant and the tRNA-derived EGS, respectively. Our study provides direct evidence that the EGS variant is more effective in blocking HBV gene expression and DNA replication than the tRNA-derived EGS. Furthermore, these results demonstrate the feasibility of developing Salmonella-mediated gene delivery of highly active EGS RNA variants as a novel approach for gene-targeting applications such as anti-HBV therapy.	[Zhang, Zhigang; Xia, Chuan; Liu, Fenyong; Wu, Jianguo] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan, Hunan, Peoples R China; [Vu, Gia-Phong; Chen, Yuan-Chuan; Liu, Fenyong; Lu, Sangwei] Univ Calif Berkeley, Program Comparat Biochem, Berkeley, CA 94720 USA; [Gong, Hao; Liu, Fenyong; Lu, Sangwei] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA	Wuhan University; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Liu, FY (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan, Hunan, Peoples R China.	liu_fy@berkeley.edu; jwu@whu.edu.cn; sangwei@berkeley.edu	zhang, zhengzhi/I-5403-2016; Wu, Jian/AAU-5221-2020; Vu, Gia-Phong/HCH-7906-2022; Zhang, Zhanhui/AAX-9545-2021; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Wong, Matthew Man-Kin/0000-0003-3296-3277; Wu, Jianguo/0000-0002-8326-2895; ALZAHARNA, Mazen/0000-0002-1111-958X; Wu, Jian/0000-0002-3394-1507; Cheung, Hon-Yeung/0000-0002-6750-3628; Chiu, Sung Kay/0000-0002-9927-7346	National Basic Research Program of China (973 Program) [2011CB504800, 2012CB518900]; National Natural Science Foundation of China [31100128, 81030031, 31230005, 812111146]; NIH [RO1-AI041927, RO1-AI091536, RO1-DE014842]; University of California at Berkeley; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091536, R01AI041927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014842] Funding Source: NIH RePORTER	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California at Berkeley; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research has been supported by grants from National Basic Research Program of China (973 Program; No. 2011CB504800 and 2012CB518900), National Natural Science Foundation of China (No. 31100128, 81030031, 31230005, and 812111146) and NIH (RO1-AI041927, RO1-AI091536, and RO1-DE014842). G. V. and Y. C. were partially supported by a predoctoral Block grant from University of California at Berkeley. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman S., 1999, RNA WORLD, P351; ARES M, 1990, GENE DEV, V4, P2132, DOI 10.1101/gad.4.12a.2132; Belongia E A, 2008, NIH Consens State Sci Statements, V25, P1; Block TM, 2013, ANTIVIR RES, V98, P27, DOI 10.1016/j.antiviral.2013.01.006; Cai DW, 2012, ANTIMICROB AGENTS CH, V56, P4277, DOI 10.1128/AAC.00473-12; Chen YN, 2011, FASEB J, V25, P4511, DOI 10.1096/fj.11-187781; Clairmont C, 2000, J INFECT DIS, V181, P1996, DOI 10.1086/315497; Darji A, 1997, CELL, V91, P765, DOI 10.1016/S0092-8674(00)80465-1; Evans D, 2006, TRENDS BIOCHEM SCI, V31, P333, DOI 10.1016/j.tibs.2006.04.007; FORSTER AC, 1990, SCIENCE, V249, P783, DOI 10.1126/science.1697102; Giladi H, 2003, MOL THER, V8, P769, DOI 10.1016/S1525-0016(03)00244-2; GOLD L, 1995, ANNU REV BIOCHEM, V64, P763, DOI 10.1146/annurev.bi.64.070195.003555; Gong H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002120; GOPALAN V, 2006, RNA WORLD; Grillot-Courvalin C, 1999, CURR OPIN BIOTECH, V10, P477, DOI 10.1016/S0958-1669(99)00013-0; GUERRIERTAKADA C, 1995, P NATL ACAD SCI USA, V92, P11115, DOI 10.1073/pnas.92.24.11115; Guidotti LG, 2006, ANNU REV PATHOL-MECH, V1, P23, DOI 10.1146/annurev.pathol.1.110304.100230; Hnatyszyn HJ, 2001, GENE THER, V8, P1863, DOI 10.1038/sj.gt.3301606; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; JOYCE GF, 1992, SCI AM, V267, P90, DOI 10.1038/scientificamerican1292-90; Kawa D, 1998, RNA, V4, P1397, DOI 10.1017/S1355838298980918; Kazantsev AV, 2006, NAT REV MICROBIOL, V4, P729, DOI 10.1038/nrmicro1491; Khan SA, 1998, MOL MICROBIOL, V29, P571, DOI 10.1046/j.1365-2958.1998.00952.x; LEVINE MM, 1987, J CLIN INVEST, V79, P888, DOI 10.1172/JCI112899; Li HJ, 2006, RNA, V12, P63, DOI 10.1261/rna.2184706; Liu FY, 2010, PROTEIN REV, V10, P257, DOI 10.1007/978-1-4419-1142-1_14; LIU FY, 1994, CELL, V77, P1093, DOI 10.1016/0092-8674(94)90448-0; LIU FY, 1995, GENE DEV, V9, P471, DOI 10.1101/gad.9.4.471; Loessner H, 2006, FEMS MICROBIOL LETT, V265, P81, DOI 10.1111/j.1574-6968.2006.00470.x; Ma M, 2000, NAT BIOTECHNOL, V18, P58, DOI 10.1038/71924; Marvin MC, 2009, J CELL BIOCHEM, V108, P1244, DOI 10.1002/jcb.22367; McCaffrey AP, 2003, NAT BIOTECHNOL, V21, P639, DOI 10.1038/nbt824; Paglia P, 2000, GENE THER, V7, P1725, DOI 10.1038/sj.gt.3301290; Plehn-Dujowich D, 1998, P NATL ACAD SCI USA, V95, P7327, DOI 10.1073/pnas.95.13.7327; PYLE AM, 1990, P NATL ACAD SCI USA, V87, P8187, DOI 10.1073/pnas.87.21.8187; Scherer LJ, 2003, NAT BIOTECHNOL, V21, P1457, DOI 10.1038/nbt915; Seegar C., 2007, FIELDS VIROLOGY, P2978; SELLS MA, 1987, P NATL ACAD SCI USA, V84, P1005, DOI 10.1073/pnas.84.4.1005; Su J, 2009, INFECT IMMUN, V77, P667, DOI 10.1128/IAI.01027-08; SZOSTAK JW, 1992, TRENDS BIOCHEM SCI, V17, P89, DOI 10.1016/0968-0004(92)90242-2; Uprichard SL, 2005, P NATL ACAD SCI USA, V102, P773, DOI 10.1073/pnas.0409028102; Werner M, 1998, RNA, V4, P847, DOI 10.1017/S1355838298980323; Xia C, 2013, MOL THER, V21, P995, DOI 10.1038/mt.2013.37; Yang Nan, 2008, Cancer Biol Ther, V7, P145; YUAN Y, 1994, SCIENCE, V263, P1269, DOI 10.1126/science.8122108; YUAN Y, 1992, P NATL ACAD SCI USA, V89, P8006, DOI 10.1073/pnas.89.17.8006; ZAUG AJ, 1995, RNA, V1, P363; Zhang L, 2007, CANCER RES, V67, P5859, DOI 10.1158/0008-5472.CAN-07-0098; Zhou TH, 2002, J BIOL CHEM, V277, P30112, DOI 10.1074/jbc.M200183200; Zhu JM, 2004, P NATL ACAD SCI USA, V101, P9073, DOI 10.1073/pnas.0403164101	51	243	268	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65268	10.1371/journal.pone.0065268	http://dx.doi.org/10.1371/journal.pone.0065268			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23349804	Green Submitted, gold, Green Published			2022-12-27	WOS:000320322400011
J	Lin, CW; Chen, PN; Chen, MK; Yang, WE; Tang, CH; Yang, SF; Hsieh, YS				Lin, Chiao-Wen; Chen, Pei-Ni; Chen, Mu-Kuan; Yang, Wei-En; Tang, Chih-Hsin; Yang, Shun-Fa; Hsieh, Yih-Shou			Kaempferol Reduces Matrix Metalloproteinase-2 Expression by Down-Regulating ERK1/2 and the Activator Protein-1 Signaling Pathways in Oral Cancer Cells	PLOS ONE			English	Article							NF-KAPPA-B; PROGNOSTIC-SIGNIFICANCE; COLORECTAL-CANCER; TISSUE INHIBITOR; INVASION; FLAVONOIDS; CARCINOMA; MIGRATION; INACTIVATION; INFLAMMATION	Background: Kaempferol has been proposed as a potential drug for cancer chemoprevention and treatment because it is a natural polyphenol contained in plant-based foods. Recent studies have demonstrated that kaempferol protects against cardiovascular disease and cancer. Based on this finding, we investigated the mechanisms by which kaempferol produces the anti-metastatic effect in human tongue squamous cell carcinoma SCC4 cells. Methodology/Principal Findings: In this study, we provided molecular evidence associated with the anti-metastatic effect of kaempferol by demonstrating a substantial suppression of SCC4 cell migration and invasion. This effect was associated with reduced expressions of MMP-2 and TIMP-2 mRNA and protein levels. Analysis of the transcriptional regulation indicated that kaempferol inhibited MMP-2 transcription by suppressing c-Jun activity. Kaempferol also produced an inhibitory effect on the phosphorylation of ERK1/2. Conclusions: These findings provide new insights into the molecular mechanisms involved in the anti-metastatic effect of kaempferol, and are valuable in the prevention of oral cancer metastasis.	[Lin, Chiao-Wen] Chung Shan Med Univ, Inst Oral Sci, Taichung, Taiwan; [Lin, Chiao-Wen] Chung Shan Med Univ Hosp, Dept Dent, Taichung, Taiwan; [Chen, Pei-Ni; Hsieh, Yih-Shou] Chung Shan Med Univ, Inst Biochem & Biotechnol, Taichung, Taiwan; [Chen, Pei-Ni; Hsieh, Yih-Shou] Chung Shan Med Univ Hosp, Dept Clin Lab, Taichung, Taiwan; [Chen, Mu-Kuan] Changhua Christian Hosp, Dept Otorhinolaryngol Head & Neck Surg, Changhua, Taiwan; [Yang, Wei-En; Yang, Shun-Fa] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Tang, Chih-Hsin] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Tang, Chih-Hsin] Asia Univ, Coll Hlth Sci, Dept Biotechnol, Taichung, Taiwan; [Yang, Shun-Fa] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Changhua Christian Hospital; Chung Shan Medical University; China Medical University Taiwan; Asia University Taiwan; Chung Shan Medical University; Chung Shan Medical University Hospital	Yang, SF (corresponding author), Chung Shan Med Univ, Inst Med, Taichung, Taiwan.	ysf@csmu.edu.tw; csmcysh@csmu.edu.tw	Zou, Quan/A-7801-2015; Tang, Chih Hsin/O-5212-2015; Yang, Shun-Fa/AAN-1519-2020	Tang, Chih Hsin/0000-0002-7113-8352; Yang, Shun-Fa/0000-0002-0365-7927; Tsai, Kelvin/0000-0002-1612-2868	National Science Council, Taiwan [NSC-100-2632-B-040-001-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was financially supported by grants from National Science Council, Taiwan (NSC-100-2632-B-040-001-MY3). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker EA, 2006, BRIT J ORAL MAX SURG, V44, P482, DOI 10.1016/j.bjoms.2005.10.005; Bestwick CS, 2005, BBA-MOL BASIS DIS, V1740, P340, DOI 10.1016/j.bbadis.2004.10.005; Bosetti C, 2005, CANCER EPIDEM BIOMAR, V14, P805, DOI 10.1158/1055-9965.EPI-04-0838; Bosetti C, 2006, NUTR CANCER, V56, P123, DOI 10.1207/s15327914nc5602_1; Bourboulia D, 2013, ONCOTARGET, V4, P166; Calderon-Montano JM, 2011, MINI-REV MED CHEM, V11, P298, DOI 10.2174/138955711795305335; Chen HJ, 2013, ONCOL REP, V30, P925, DOI 10.3892/or.2013.2490; Chen PN, 2006, J DENT RES, V85, P220, DOI 10.1177/154405910608500303; Chen PN, 2005, CHEM-BIOL INTERACT, V156, P141, DOI 10.1016/j.cbi.2005.08.005; Chen YJ, 2008, CANCER SCI, V99, P1507, DOI 10.1111/j.1349-7006.2008.00863.x; Chien MH, 2012, FOOD CHEM TOXICOL, V50, P558, DOI 10.1016/j.fct.2011.12.016; Cortes JR, 2007, J IMMUNOL, V179, P3881, DOI 10.4049/jimmunol.179.6.3881; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; de Vicente JC, 2005, ORAL ONCOL, V41, P568, DOI 10.1016/j.oraloncology.2004.12.008; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Douglas DA, 1997, J PROTEIN CHEM, V16, P237, DOI 10.1023/A:1026348808069; Forastiere AA, 2003, NEW ENGL J MED, V349, P2091, DOI 10.1056/NEJMoa031317; Fuhrman B, 2001, CURR OPIN LIPIDOL, V12, P41, DOI 10.1097/00041433-200102000-00008; Gohji K, 1996, CANCER RES, V56, P3196; Hong IK, 2005, EXP MOL MED, V37, P230, DOI 10.1038/emm.2005.31; Hong S, 2005, J BIOL CHEM, V280, P25202, DOI 10.1074/jbc.M413985200; Hsieh YS, 2007, CARCINOGENESIS, V28, P977, DOI 10.1093/carcin/bgl221; Huang WW, 2013, INT J ONCOL, V42, P2069, DOI 10.3892/ijo.2013.1909; Huang YB, 2013, INT J UROL; Iype E M, 2001, J Postgrad Med, V47, P171; Jeong JC, 2009, NEUROCHEM RES, V34, P991, DOI 10.1007/s11064-008-9868-5; Kang JW, 2010, PHYTOTHER RES, V24, pS77, DOI 10.1002/ptr.2913; Kawabata K, 2005, BIOSCI BIOTECH BIOCH, V69, P307, DOI 10.1271/bbb.69.307; Labbe D, 2009, J NUTR, V139, P646, DOI 10.3945/jn.108.102616; Leifler KS, 2013, J IMMUNOL, V190, P4420, DOI 10.4049/jimmunol.1202610; LIOTTA LA, 1980, NATURE, V284, P67, DOI 10.1038/284067a0; Luo HT, 2009, NUTR CANCER, V61, P554, DOI 10.1080/01635580802666281; Ma CY, 2011, J AGR FOOD CHEM, V59, P9032, DOI 10.1021/jf202027n; Marfe G, 2009, J CELL BIOCHEM, V106, P643, DOI 10.1002/jcb.22044; Massano J, 2006, ORAL SURG ORAL MED O, V102, P67, DOI 10.1016/j.tripleo.2005.07.038; Mink PJ, 2007, AM J CLIN NUTR, V85, P895, DOI 10.1093/ajcn/85.3.895; Nijveldt RJ, 2001, AM J CLIN NUTR, V74, P418; Peng CY, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/732578; Rossi M, 2006, CANCER EPIDEM BIOMAR, V15, P1555, DOI 10.1158/1055-9965.EPI-06-0017; Shan B, 2013, ASIAN PAC J TROP MED, V6, P826, DOI 10.1016/S1995-7645(13)60146-7; Sun CY, 2006, ACTA PHARMACOL SIN, V27, P1447, DOI 10.1111/j.1745-7254.2006.00343.x; Valente P, 1998, INT J CANCER, V75, P246, DOI 10.1002/(SICI)1097-0215(19980119)75:2<246::AID-IJC13>3.0.CO;2-B; Wang XX, 2013, TUMOUR BIOL; Weng CJ, 2008, CARCINOGENESIS, V29, P147, DOI 10.1093/carcin/bgm261; Westermarck J, 1999, FASEB J, V13, P781, DOI 10.1096/fasebj.13.8.781; Xiao HB, 2009, EUR J PHARMACOL, V616, P213, DOI 10.1016/j.ejphar.2009.06.022; Yang JS, 2013, FOOD CHEM TOXICOL, V59, P801, DOI 10.1016/j.fct.2013.06.028; Yang SF, 2010, FOOD CHEM TOXICOL, V48, P1052, DOI 10.1016/j.fct.2010.01.019; Yu YL, 2010, J AGR FOOD CHEM, V58, P1630, DOI 10.1021/jf903043r; Zhao MJ, 2013, INT J MED SCI, V10, P995, DOI 10.7150/ijms.5963	50	410	418	5	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e80883	10.1371/journal.pone.0080883	http://dx.doi.org/10.1371/journal.pone.0080883			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278338	Green Published, Green Submitted, gold			2022-12-27	WOS:000327313100123
J	Lin, C; Zou, Y; Qin, J; Liu, XR; Jiang, Y; Ke, CH; Zou, Q				Lin, Chen; Zou, Ying; Qin, Ji; Liu, Xiangrong; Jiang, Yi; Ke, Caihuan; Zou, Quan			Hierarchical Classification of Protein Folds Using a Novel Ensemble Classifier	PLOS ONE			English	Article							REPRESENTATIVE SET; SCOP; RECOGNITION; SELECTION; DATABASE; IMPACT	The analysis of biological information from protein sequences is important for the study of cellular functions and interactions, and protein fold recognition plays a key role in the prediction of protein structures. Unfortunately, the prediction of protein fold patterns is challenging due to the existence of compound protein structures. Here, we processed the latest release of the Structural Classification of Proteins (SCOP, version 1.75) database and exploited novel techniques to impressively increase the accuracy of protein fold classification. The techniques proposed in this paper include ensemble classifying and a hierarchical framework, in the first layer of which similar or redundant sequences were deleted in two manners; a set of base classifiers, fused by various selection strategies, divides the input into seven classes; in the second layer of which, an analogous ensemble method is adopted to predict all protein folds. To our knowledge, it is the first time all protein folds can be intelligently detected hierarchically. Compared with prior studies, our experimental results demonstrated the efficiency and effectiveness of our proposed method, which achieved a success rate of 74.21%, which is much higher than results obtained with previous methods (ranging from 45.6% to 70.5%). When applied to the second layer of classification, the prediction accuracy was in the range between 23.13% and 46.05%. This value, which may not be remarkably high, is scientifically admirable and encouraging as compared to the relatively low counts of proteins from most fold recognition programs. The web server Hierarchical Protein Fold Prediction (HPFP) is available at http://datamining.xmu.edu.cn/software/hpfp.	[Lin, Chen; Zou, Ying; Liu, Xiangrong; Jiang, Yi; Zou, Quan] Xiamen Univ, Sch Informat Sci & Technol, Xiamen, Peoples R China; [Qin, Ji; Ke, Caihuan] Xiamen Univ, Coll Oceanog & Environm Sci, Xiamen, Peoples R China; [Lin, Chen; Liu, Xiangrong] Xiamen Univ, Shenzhen Res Inst, Shenzhen, Peoples R China	Xiamen University; Xiamen University; Xiamen University	Lin, C (corresponding author), Xiamen Univ, Sch Informat Sci & Technol, Xiamen, Peoples R China.	chenlin@xmu.edu.cn; zouquan@xmu.edu.cn	Zou, Quan/A-7801-2015; Tang, Chih Hsin/O-5212-2015; Yang, Shun-Fa/AAN-1519-2020	Tang, Chih Hsin/0000-0002-7113-8352; Yang, Shun-Fa/0000-0002-0365-7927; Tsai, Kelvin/0000-0002-1612-2868	Natural Science Foundation of China [61001013, 61102136]; Natural Science Foundation of Fujian Province of China [2011J05158, 2010J01350]; National Basic Research Program of China [2010CB1264000]; Base Research Project of Shenzhen Bureau of Science, Technology and Information [JC201006030858A, JCYJ20120618155655087]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian Province of China(Natural Science Foundation of Fujian Province); National Basic Research Program of China(National Basic Research Program of China); Base Research Project of Shenzhen Bureau of Science, Technology and Information	The work was supported by the Natural Science Foundation of China (No. 61001013, No. 61102136), Natural Science Foundation of Fujian Province of China (No. 2011J05158, No. 2010J01350), The National Basic Research Program of China (No. 2010CB1264000) and the Base Research Project of Shenzhen Bureau of Science, Technology and Information(JC201006030858A, JCYJ20120618155655087). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; BOBERG J, 1992, PROTEINS, V14, P265, DOI 10.1002/prot.340140212; Boisvert S, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-110; Bologna G, 2003, ARTIF INTELL MED, V28, P141, DOI 10.1016/S0933-3657(03)00055-1; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Cai CZ, 2003, NUCLEIC ACIDS RES, V31, P3692, DOI 10.1093/nar/gkg600; Cai YD, 2003, ANAL BIOCHEM, V268, P407; Cai YD, 2010, MOL CELLS, V30, P99, DOI 10.1007/s10059-010-0093-0; Chen K, 2007, BIOINFORMATICS, V23, P2843, DOI 10.1093/bioinformatics/btm475; Chen W, 2012, GENET MOL RES, V11, P174, DOI 10.4238/2012.January.27.4; Cheng XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038979; Chou KC, 2004, CURR MED CHEM, V11, P2105, DOI 10.2174/0929867043364667; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; CHOU KC, 1991, PROTEINS, V9, P280, DOI 10.1002/prot.340090406; Ding CHQ, 2001, BIOINFORMATICS, V17, P349, DOI 10.1093/bioinformatics/17.4.349; Dubchak I, 1999, PROTEINS, V35, P401, DOI 10.1002/(SICI)1097-0134(19990601)35:4<401::AID-PROT3>3.0.CO;2-K; Feng JH, 2012, VLDB J, V21, P437, DOI 10.1007/s00778-011-0252-8; FINKELSTEIN AV, 1987, PROG BIOPHYS MOL BIO, V50, P171, DOI 10.1016/0079-6107(87)90013-7; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; HOBOHM U, 1994, PROTEIN SCI, V3, P522; HOBOHM U, 1992, PROTEIN SCI, V1, P409; Holm L, 1999, NUCLEIC ACIDS RES, V27, P244, DOI 10.1093/nar/27.1.244; Honda M, 2005, J AUTOIMMUN, V25, P133, DOI 10.1016/j.jaut.2005.03.009; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nanni L, 2006, NEUROCOMPUTING, V69, P2434, DOI 10.1016/j.neucom.2006.01.026; Shen HB, 2006, BIOINFORMATICS, V22, P1717, DOI 10.1093/bioinformatics/btl170; Shen HB, 2009, J THEOR BIOL, V256, P441, DOI 10.1016/j.jtbi.2008.10.007; Vendruscolo M, 2005, P NATL ACAD SCI USA, V102, P5641, DOI 10.1073/pnas.0500274102; Zhang W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002325; Zhou ZH, 2002, ARTIF INTELL, V137, P239, DOI 10.1016/S0004-3702(02)00190-X; Zou Q, 2013, J COMPUT THEOR NANOS, V10, P1038, DOI 10.1166/jctn.2013.2804	31	410	418	5	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56499	10.1371/journal.pone.0056499	http://dx.doi.org/10.1371/journal.pone.0056499			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	24278338	Green Submitted, Green Published, gold			2022-12-27	WOS:000315184200085
